<SEC-DOCUMENT>0001214659-24-003435.txt : 20240223
<SEC-HEADER>0001214659-24-003435.hdr.sgml : 20240223
<ACCEPTANCE-DATETIME>20240223154735
ACCESSION NUMBER:		0001214659-24-003435
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		150
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20240223
DATE AS OF CHANGE:		20240223

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WisdomTree, Inc.
		CENTRAL INDEX KEY:			0000880631
		STANDARD INDUSTRIAL CLASSIFICATION:	SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
		ORGANIZATION NAME:           	02 Finance
		IRS NUMBER:				133487784
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10932
		FILM NUMBER:		24670945

	BUSINESS ADDRESS:	
		STREET 1:		250 WEST 34TH STREET
		STREET 2:		3RD FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10119
		BUSINESS PHONE:		212-801-2080

	MAIL ADDRESS:	
		STREET 1:		250 WEST 34TH STREET
		STREET 2:		3RD FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10119

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WisdomTree Investments, Inc.
		DATE OF NAME CHANGE:	20090401

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INDEX DEVELOPMENT PARTNERS INC
		DATE OF NAME CHANGE:	20020812

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FINANCIAL DATA SYSTEMS
		DATE OF NAME CHANGE:	19951120
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>wt-20231231.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:dtr="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:compsci="http://compsciresources.com" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt="http://fasb.org/srt/2023" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:wt="http://www.wisdomtreeinvestmentsinc.com/20231231" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml">
<head><title> </title>
<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div style="margin:0;padding:0;border-width:0;text-justify-trim: punctuation; margin: 0; padding: 10pt;"><div style="margin:0;padding:0;border-width:0;width:800px;margin: 0 auto;">
	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<div style="border: none; border-bottom: double windowtext 6.0pt; padding: 0in 0in 4.0pt 0in; margin-left: 0in; margin-right: 0.0pt;"></div>
		<p class="H1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:3pt;margin-top:3pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:18pt;"> UNITED STATES<br/>SECURITIES AND EXCHANGE COMMISSION</span><span class="Bold" style="font-style:normal;font-weight:bold;"><br/></span><span class="Bold" style="font-style:normal;font-weight:bold;font-size:12pt;">Washington, D.C. 20549</span></p>
		<p class="H1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:7pt;">____________________________</span></p>
		<p class="H1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:18pt;">Form&#160;<ix:nonNumeric contextRef="c0" name="dei:DocumentType" id="ixv-26434">10-K</ix:nonNumeric></span></p>
		<p class="H1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:7pt;">____________________________</span></p>
		<table class="Basic-Table" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">	<tr class="Basic-Table _idGenTableRowColumn-4">	<td class="TB" colspan="3" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 100.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">	<p class="H1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;text-align:left;"><span class="Bold" style="font-style:normal;font-weight:bold;">(Mark One)</span></p>	</td>	</tr>	<tr class="Basic-Table _idGenTableRowColumn-5" style="height:12pt;">	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:0pt;vertical-align:top;width: 3.85%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">	<p class="Text_flush_Center" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:3;margin-top:0pt;text-align:left;"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:DocumentAnnualReport" id="ixv-30"><span class="GrepStyle" style="font-family:'Wingdings 24', sans-serif;font-size:12pt;">&#9746;</span></ix:nonNumeric></p>	</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:0pt;vertical-align:top;width: 94.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">	<p class="Text_flush_Center" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:3;margin-top:0pt;text-align:left;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:12pt;">ANNUAL REPORT PURSUANT TO SECTION 13 OR&#160;15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></p>	</td>	</tr>	</table>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:10pt;text-align:center;margin-top:10pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">For fiscal year ended&#160;<ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="ixv-26435"><ix:nonNumeric contextRef="c0" format="ixt:date-monthname-day-en" name="dei:CurrentFiscalYearEndDate" id="ixv-26436">December&#160;31</ix:nonNumeric>,&#160;<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalYearFocus" id="ixv-26437">2023</ix:nonNumeric></ix:nonNumeric></span></p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:10pt;text-align:center;margin-top:10pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">or</span></p>
		<table class="Basic-Table" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">	<tr class="Basic-Table _idGenTableRowColumn-6" style="height:12pt;">	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 3.85%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">	<p class="Text_flush_Center" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:3;margin-top:0pt;text-align:left;"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentTransitionReport" id="ixv-44"><span class="GrepStyle" style="font-family:'Wingdings 24', sans-serif;font-size:12pt;">&#9744;</span></ix:nonNumeric></p>	</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 94.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">	<p class="Text_flush_Center" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:3;margin-top:0pt;text-align:left;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:12pt;">TRANSITION REPORT PURSUANT TO SECTION 13 OR&#160;15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></p>	</td>	</tr>	</table>
		<p class="Text_flush_Center" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:3;margin-top:10pt;margin-top:10pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">For the transition period from _______ to ________.</span></p>
		<p class="Text_flush_Center" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:3;margin-top:10pt;margin-top:10pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Commission File Number&#160;<ix:nonNumeric contextRef="c0" continuedAt="_EntityFileNumber-c0_cont_1" name="dei:EntityFileNumber" id="ixv-26438">001</ix:nonNumeric></span><ix:continuation id="_EntityFileNumber-c0_cont_1"><span class="nobreak"><span class="Bold" style="font-style:normal;font-weight:bold;">-10932</span></span></ix:continuation></p>
		<p class="H1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:10pt;margin-top:10pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:7pt;">____________________________</span></p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:10pt;text-align:center;margin-top:10pt;"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-60"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:24pt;">WisdomTree, Inc.<br/></span></ix:nonNumeric><span class="Bold" style="font-style:normal;font-weight:bold;">(Exact name of registrant as specified in its charter)</span></p>
		<p class="H1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:10pt;margin-top:10pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:7pt;">____________________________</span></p>
		<table class="No-Table-Style" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">	<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">	<td class="No-Table-Style TCH" style="width: 48.72%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;"><ix:nonNumeric contextRef="c0" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="ixv-70"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:10pt;">Delaware</span></ix:nonNumeric></p>	</td>	<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>	<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 50.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><ix:nonNumeric contextRef="c0" name="dei:EntityTaxIdentificationNumber" id="ixv-75"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:10pt;">13-3487784</span></ix:nonNumeric></p>	</td>	</tr>	<tr class="No-Table-Style _idGenTableRowColumn-10" style="height:12pt;">	<td class="No-Table-Style TB _idGenCellOverride-1" style="width: 48.72%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="ParaOverride-10" style="margin:0;padding:0;border-width:0;margin-bottom:8pt;text-align:center;"><span class="CharOverride-7" style="font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-weight:bold;">(State or other jurisdiction of <br/>incorporation or organization)</span></p>	</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 50.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="ParaOverride-10" style="margin:0;padding:0;border-width:0;margin-bottom:8pt;text-align:center;"><span class="CharOverride-7" style="font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-weight:bold;">(IRS&#160;Employer <br/>Identification No.)</span></p>	</td>	</tr>	</table>
		<table class="No-Table-Style" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">	<tr class="No-Table-Style _idGenTableRowColumn-11" style="height:12pt;">	<td class="No-Table-Style TCH" style="width: 48.72%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;"><ix:nonNumeric contextRef="c0" continuedAt="_EntityAddressAddressLine1-c0_cont_1" name="dei:EntityAddressAddressLine1" id="ixv-91"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:10pt;">250 West 34</span><span class="Superscript" style="vertical-align:super;font-size:6pt;">th</span></ix:nonNumeric><span class="Bold" style="font-style:normal;font-weight:bold;font-size:10pt;"><ix:continuation id="_EntityAddressAddressLine1-c0_cont_1"> Street</ix:continuation><br/><ix:nonNumeric contextRef="c0" continuedAt="_EntityAddressAddressLine2-c0_cont_1" name="dei:EntityAddressAddressLine2" id="ixv-26440">3</ix:nonNumeric></span><ix:continuation continuedAt="_EntityAddressAddressLine2-c0_cont_2" id="_EntityAddressAddressLine2-c0_cont_1"><span class="Superscript" style="vertical-align:super;font-size:6pt;">rd</span></ix:continuation><span class="Bold" style="font-style:normal;font-weight:bold;font-size:10pt;"><ix:continuation id="_EntityAddressAddressLine2-c0_cont_2"> Floor</ix:continuation><br/><ix:nonNumeric contextRef="c0" name="dei:EntityAddressCityOrTown" id="ixv-26442">New York</ix:nonNumeric>, <ix:nonNumeric contextRef="c0" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="ixv-26443">New York</ix:nonNumeric></span></p>	</td>	<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>	<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 50.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><ix:nonNumeric contextRef="c0" name="dei:EntityAddressPostalZipCode" id="ixv-103"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:10pt;">10119</span></ix:nonNumeric></p>	</td>	</tr>	<tr class="No-Table-Style _idGenTableRowColumn-12" style="height:12pt;">	<td class="No-Table-Style TB _idGenCellOverride-1" style="width: 48.72%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="ParaOverride-10" style="margin:0;padding:0;border-width:0;margin-bottom:8pt;text-align:center;"><span class="CharOverride-7" style="font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-weight:bold;">(Address of principal executive offices)</span></p>	</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 50.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="ParaOverride-10" style="margin:0;padding:0;border-width:0;margin-bottom:8pt;text-align:center;"><span class="CharOverride-7" style="font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-weight:bold;">(Zip Code)</span></p>	</td>	</tr>	</table>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:10pt;text-align:center;margin-top:10pt;"><span class="Bold" style="font-style:normal;font-weight:bold;"><ix:nonNumeric contextRef="c0" name="dei:CityAreaCode" id="ixv-26444">212</ix:nonNumeric>-<ix:nonNumeric contextRef="c0" name="dei:LocalPhoneNumber" id="ixv-26445">801-2080</ix:nonNumeric><br/></span><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">(Registrant&#8217;s telephone number, including area code)</span></p>
		<p class="H1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:10pt;margin-top:10pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:7pt;">____________________________</span></p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:10pt;text-align:center;margin-top:10pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</span></p>
		<table class="No-Table-Style" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">	<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">	<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 36.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;"><span class="CharOverride-10" style="font-size:8pt;font-style:normal;font-weight:bold;text-decoration:underline;">Title of each class</span></p>	</td>	<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>	<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 18.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="CharOverride-10" style="font-size:8pt;font-style:normal;font-weight:bold;text-decoration:underline;">Trading Symbol(s)</span></p>	</td>	<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>	<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 42.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:9pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="CharOverride-10" style="font-size:8pt;font-style:normal;font-weight:bold;text-decoration:underline;">Name of each exchange on which registered</span></p>	</td>	</tr>	<tr class="No-Table-Style _idGenTableRowColumn-12" style="height:12pt;">	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 36.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:center;"><ix:nonNumeric contextRef="c1" name="dei:Security12bTitle" id="ixv-137"><span class="Bold" style="font-style:normal;font-weight:bold;">Common Stock, $0.01 par value</span></ix:nonNumeric></p>	</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 18.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:center;"><ix:nonNumeric contextRef="c1" name="dei:TradingSymbol" id="ixv-142"><span class="Bold" style="font-style:normal;font-weight:bold;">WT</span></ix:nonNumeric></p>	</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 42.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:center;"><ix:nonNumeric contextRef="c1" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-147"><span class="Bold" style="font-style:normal;font-weight:bold;">The New&#160;York Stock Exchange</span></ix:nonNumeric></p>	</td>	</tr>	<tr class="No-Table-Style _idGenTableRowColumn-12" style="height:12pt;">	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 36.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:center;"><ix:nonNumeric contextRef="c2" name="dei:Security12bTitle" id="ixv-152"><span class="Bold" style="font-style:normal;font-weight:bold;">Preferred Stock Purchase Rights</span></ix:nonNumeric></p>	</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 18.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 42.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:center;"><ix:nonNumeric contextRef="c2" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-159"><span class="Bold" style="font-style:normal;font-weight:bold;">The New&#160;York Stock Exchange</span></ix:nonNumeric></p>	</td>	</tr>	</table>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:10pt;text-align:center;margin-top:10pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Securities registered pursuant to Section&#160;12(g)&#160;of the Act: <br/>None</span></p>
		<p class="H1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:8pt;page-break-after:auto;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:7pt;">____________________________</span></p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">&#160;</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>


	<div class="Basic-Text-Frame" style="margin:0;padding:0;border-width:0;">
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;text-align:left;text-indent:24pt;margin-top:8pt;">Indicate by check mark if the registrant is a well<span class="nobreak">-known</span> seasoned issuer, as defined in Rule&#160;405 of the Securities Act. <span class="GrepStyle" style="font-family:'Wingdings 24', sans-serif;">&#9746;</span>&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityWellKnownSeasonedIssuer" id="ixv-26446">Yes</ix:nonNumeric>&#160;<span class="GrepStyle" style="font-family:'Wingdings 24', sans-serif;">&#9744;</span> No</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:6pt;text-align:left;text-indent:24pt;margin-top:6pt;">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d)&#160;of the Act. <span class="GrepStyle" style="font-family:'Wingdings 24', sans-serif;">&#9744;</span>&#160;Yes&#160;<span class="GrepStyle" style="font-family:'Wingdings 24', sans-serif;">&#9746;</span> <ix:nonNumeric contextRef="c0" name="dei:EntityVoluntaryFilers" id="ixv-26447">No</ix:nonNumeric></p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:6pt;text-align:left;text-indent:24pt;margin-top:6pt;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12<span class="nobreak"> </span>months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90&#160;days.&#160;<span class="GrepStyle" style="font-family:'Wingdings 24', sans-serif;">&#9746;</span>&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityCurrentReportingStatus" id="ixv-26448">Yes</ix:nonNumeric>&#160;<span class="GrepStyle" style="font-family:'Wingdings 24', sans-serif;">&#9744;</span> No</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:6pt;text-align:left;text-indent:24pt;margin-top:6pt;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S<span class="nobreak">-T</span> (&#167;232.405 of this chapter) during the preceding 12<span class="nobreak"> </span>months (or for such shorter period that the registrant was required to submit such files).&#160;<span class="GrepStyle" style="font-family:'Wingdings 24', sans-serif;">&#9746;</span>&#160;<ix:nonNumeric contextRef="c0" name="dei:EntityInteractiveDataCurrent" id="ixv-26449">Yes</ix:nonNumeric>&#160;<span class="GrepStyle" style="font-family:'Wingdings 24', sans-serif;">&#9744;</span> No</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:6pt;text-align:left;text-indent:24pt;margin-top:6pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non<span class="nobreak">-accelerated</span> filer, a smaller reporting company, or emerging growth company. See definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b<span class="nobreak">-2</span> of the Exchange Act.</p>
		<table class="No-Table-Style" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">	<tr class="No-Table-Style _idGenTableRowColumn-21" style="height:12pt;">	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:4pt;padding-left:0pt;padding-top:4pt;width: 23.93%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><ix:nonNumeric contextRef="c0" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="ixv-26450">Large&#160;accelerated&#160;filer</ix:nonNumeric></p>	</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:4pt;padding-left:0pt;padding-right:0pt;padding-top:4pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:4pt;padding-left:0pt;padding-right:0pt;padding-top:4pt;width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">	<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:24pt;widows:3;margin-top:0pt;text-align:left;text-indent:0pt;"><span class="GrepStyle" style="font-family:'Wingdings 24', sans-serif;">&#9746;</span></p>	</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:4pt;padding-left:0pt;padding-right:0pt;padding-top:4pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:4pt;padding-left:0pt;padding-right:0pt;padding-top:4pt;width: 36.11%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:4pt;padding-left:0pt;padding-right:0pt;padding-top:4pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:4pt;padding-left:0pt;padding-right:0pt;padding-top:4pt;width: 29.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">Accelerated filer</p>	</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:4pt;padding-left:0pt;padding-right:0pt;padding-top:4pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:4pt;padding-left:0pt;padding-right:0pt;padding-top:4pt;width: 3.21%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:right;"><span class="GrepStyle" style="font-family:'Wingdings 24', sans-serif;">&#9744;</span></p>	</td>	</tr>	<tr class="No-Table-Style _idGenTableRowColumn-21" style="height:12pt;">	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:4pt;padding-left:0pt;padding-top:4pt;width: 23.93%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Non-accelerated filer</p>	</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:4pt;padding-left:0pt;padding-right:0pt;padding-top:4pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:4pt;padding-left:0pt;padding-right:0pt;padding-top:4pt;width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:left;"><span class="GrepStyle" style="font-family:'Wingdings 24', sans-serif;">&#9744;</span></p>	</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:4pt;padding-left:0pt;padding-right:0pt;padding-top:4pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:4pt;padding-left:0pt;padding-right:0pt;padding-top:4pt;width: 36.11%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:4pt;padding-left:0pt;padding-right:0pt;padding-top:4pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:4pt;padding-left:0pt;padding-right:0pt;padding-top:4pt;width: 29.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">Smaller reporting company</p>	</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:4pt;padding-left:0pt;padding-right:0pt;padding-top:4pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:4pt;padding-left:0pt;padding-right:0pt;padding-top:4pt;width: 3.21%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:right;"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntitySmallBusiness" id="ixv-221"><span class="GrepStyle" style="font-family:'Wingdings 24', sans-serif;">&#9744;</span></ix:nonNumeric></p>	</td>	</tr>	<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:4pt;padding-left:0pt;padding-top:0pt;vertical-align:top;width: 23.93%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:4pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:4pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;vertical-align:top;width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:4pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:4pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;vertical-align:top;width: 36.11%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:4pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:4pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;vertical-align:top;width: 29.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">Emerging growth company</p>	</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:4pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:4pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;vertical-align:top;width: 3.21%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:right;"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityEmergingGrowthCompany" id="ixv-235"><span class="GrepStyle" style="font-family:'Wingdings 24', sans-serif;">&#9744;</span></ix:nonNumeric></p>	</td>	</tr>	</table>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:6pt;text-align:left;text-indent:24pt;margin-top:6pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange&#160;Act.&#160;<span class="GrepStyle" style="font-family:'Wingdings 24', sans-serif;">&#9744;</span></p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:6pt;text-align:left;text-indent:24pt;margin-top:6pt;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section&#160;404(b)&#160;of the Sarbanes<span class="nobreak">-Oxley</span> Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.&#160;<ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:IcfrAuditorAttestationFlag" id="ixv-241"><span class="GrepStyle" style="font-family:'Wingdings 24', sans-serif;">&#9746;</span></ix:nonNumeric></p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:6pt;text-align:left;text-indent:24pt;margin-top:6pt;">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.&#160;<ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:DocumentFinStmtErrorCorrectionFlag" id="ixv-244"><span class="GrepStyle" style="font-family:'Wingdings 24', sans-serif;">&#9744;</span></ix:nonNumeric></p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:6pt;text-align:left;text-indent:24pt;margin-top:6pt;">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive<span class="nobreak">-based</span> compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D<span class="nobreak">-1</span>(b).&#160;<span class="GrepStyle" style="font-family:'Wingdings 24', sans-serif;">&#9744;</span></p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:6pt;text-align:left;text-indent:24pt;margin-top:6pt;">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b<span class="nobreak">-2</span> of the Exchange Act). Yes&#160;<span class="GrepStyle" style="font-family:'Wingdings 24', sans-serif;">&#9744;</span>&#160;No <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityShellCompany" id="ixv-253"><span class="GrepStyle" style="font-family:'Wingdings 24', sans-serif;">&#9746;</span></ix:nonNumeric></p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:6pt;text-align:left;text-indent:24pt;margin-top:6pt;">At June<span class="nobreak"> </span>30, 2023, the aggregate market value of the registrant&#8217;s Common Stock held by non<span class="nobreak">-affiliates</span> (computed by reference to the closing sale price of such shares on The New York Stock Exchange on June<span class="nobreak"> </span>30, 2023) was $<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="dei:EntityPublicFloat" scale="0" unitRef="usd" id="ixv-26451">948,550,832</ix:nonFraction>. At February<span class="nobreak"> </span>20, 2024, there were <ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-26452">151,853,699</ix:nonFraction><span class="nobreak"> </span>shares of the registrant&#8217;s Common Stock outstanding.</p>
		<p class="H1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">DOCUMENTS INCORPORATED BY REFERENCE</span></p>
		<ix:nonNumeric contextRef="c0" escape="true" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="ixv-263"><p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:6pt;text-align:left;text-indent:24pt;margin-top:6pt;">The information required by Part III of this Report, to the extent not set forth herein, is incorporated herein by reference from the registrant&#8217;s definitive proxy statement relating to the Annual Meeting of Stockholders to be held in 2024, which definitive proxy statement shall be filed with the Securities and Exchange Commission within 120&#160;days after the end of the fiscal year to which this Report relates. &#160;<span class="CharOverride-9" style="font-size:8pt;">&#160;</span></p></ix:nonNumeric>
		<div style="border: none; border-bottom: double windowtext 6.0pt; padding: 0in 0in 4.0pt 0in; margin-left: 0in; margin-right: 0.0pt;"></div>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">&#160;</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">WISDOMTREE, INC.</span></p>
		<a id="TOC001"></a><p class="H1_TOC" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Form&#160;10-K<br/>For the Fiscal Year Ended December&#160;31, 2023<br/>TABLE OF CONTENTS</span></p>
		<table class="No-Table-Style" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-5" style="background: #CCEEFF;height:12pt;">
					<td class="TB" colspan="3" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 91.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">

						<p class="TOC_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T99201">PART I</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:right;">2</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="TOC_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ITEM 1.</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 79.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="TOC_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T99202">Business</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:right;">2</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="TOC_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ITEM&#160;1A.</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 79.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="TOC_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T99203">Risk Factors</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:right;">25</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="TOC_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ITEM 1B.</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 79.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="TOC_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T99204">Unresolved Staff Comments</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:right;">40</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="TOC_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ITEM 1C.</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 79.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="TOC_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T99205">Cybersecurity</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:right;">40</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="TOC_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ITEM 2.</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 79.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="TOC_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T99206">Properties</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:right;">41</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="TOC_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ITEM&#160;3.</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 79.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="TOC_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T99207">Legal Proceedings</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:right;">41</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="TOC_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ITEM&#160;4.</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 79.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="TOC_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T99208">Mine Safety Disclosures</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:right;">41</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="background: #CCEEFF;height:12pt;">
					<td class="TB" colspan="3" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:middle;width: 91.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="TOC_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"><a href="#T99209">PART II</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:middle;width: 7.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-align:right;text-indent:0pt;">42</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="TOC_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ITEM 5.</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 79.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="TOC_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T99210">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:right;">42</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="TOC_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ITEM&#160;6.</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 79.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="TOC_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T99211">[Reserved]</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:right;">42</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="TOC_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ITEM&#160;7.</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 79.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="TOC_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T99212">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:right;">43</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="TOC_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ITEM&#160;7A.</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 79.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="TOC_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T99213">Quantitative and Qualitative Disclosures about Market Risk</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:right;">73</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="TOC_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ITEM 8.</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 79.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="TOC_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T99214">Financial Statements and Supplementary Data</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:right;">74</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="TOC_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ITEM 9.</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 79.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="TOC_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T99215">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:right;">74</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="TOC_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ITEM 9A.</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 79.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="TOC_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T99216">Controls and Procedures</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:right;">74</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="TOC_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ITEM&#160;9B.</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 79.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="TOC_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T99217">Other Information</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:right;">75</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="TOC_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ITEM 9C.</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 79.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="TOC_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T99218">Disclosure Regarding Foreign Jurisdictions That Prevent Inspections</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:right;">75</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="background: #CCEEFF;height:12pt;">
					<td class="TB" colspan="3" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 91.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="TOC_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"><a href="#T99219">PART III</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-align:right;text-indent:0pt;">75</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="TOC_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ITEM 10.</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 79.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="TOC_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T99220">Directors, Executive Officers and Corporate Governance</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:right;">75</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="TOC_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ITEM&#160;11.</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 79.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="TOC_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T99221">Executive Compensation</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:right;">76</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="TOC_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ITEM 12.</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 79.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="TOC_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T99222">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:right;">76</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="TOC_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ITEM 13.</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 79.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="TOC_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T99223">Certain Relationships and Related Transactions, and Director Independence</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:right;">76</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="TOC_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ITEM 14.</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 79.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="TOC_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T99224">Principal Accountant Fees and Services</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:right;">76</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="background: #CCEEFF;height:12pt;">
					<td class="TB" colspan="3" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 91.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="TOC_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"><a href="#T99225">PART IV</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-align:right;text-indent:0pt;">76</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="TOC_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ITEM 15.</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 79.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="TOC_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T99226">Exhibits; Financial Statement Schedules</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:right;">76</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="TOC_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ITEM&#160;16.</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 79.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="TOC_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T99227">Form&#160;10-K Summary</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 7.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;text-align:right;">76</p>
					</td>
				</tr>

		</table>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Unless otherwise indicated, references to &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and &#8220;WisdomTree&#8221; mean WisdomTree,</span><span class="bold" style="font-style:normal;font-weight:bold;"> </span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Inc. and its subsidiaries.</span></p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:6pt;"><span class="bold" style="font-style:normal;font-weight:bold;">WisdomTree</span><span class="Superscript" style="vertical-align:super;font-size:58%;">&#174;</span><span class="bold" style="font-style:normal;font-weight:bold;">, WisdomTree Prime&#8482; and Modern Alpha</span><span class="Superscript" style="vertical-align:super;font-size:58%;">&#174;</span><span class="bold" style="font-style:normal;font-weight:bold;"> are trademarks of WisdomTree, Inc. in the United&#160;States and in other countries. All other trademarks are the property of their respective owners.</span></p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">i</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>




	<div class="Basic-Text-Frame" style="margin:0;padding:0;border-width:0;">
		<p class="H1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">This Annual Report on Form&#160;10<span class="nobreak">-K</span>, or Report, contains forward<span class="nobreak">-looking</span> statements that are based on our management&#8217;s beliefs and assumptions and on information currently available to our management. Although we believe that the expectations reflected in these forward<span class="nobreak">-looking</span> statements are reasonable, these statements relate to future events or our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward<span class="nobreak">-looking</span> statements.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In some cases, you can identify forward<span class="nobreak">-looking</span> statements by terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;predicts,&#8221; &#8220;potential,&#8221; &#8220;continue&#8221; or the negative of these terms or other comparable terminology. These statements are only predictions. You should not place undue reliance on forward<span class="nobreak">-looking</span> statements because they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond our control and which could materially affect our results. Factors that may cause actual results to differ materially from current expectations include, among other things, those listed in the section entitled &#8220;Risk Factors&#8221; and elsewhere in this Report. If one or more of these or other risks or uncertainties occur, or if our underlying assumptions prove to be incorrect, actual events or results may vary significantly from those implied or projected by the forward<span class="nobreak">-looking</span> statements. No forward<span class="nobreak">-looking</span> statement is a guarantee of future performance. You should read this Report and the documents that we reference in this Report and have filed with the Securities and Exchange Commission, or the SEC, as exhibits to this Report, completely and with the understanding that our actual future results may be materially different from any future results expressed or implied by these forward<span class="nobreak">-looking</span> statements.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In particular, forward<span class="nobreak">-looking</span> statements in this Report may include statements about:</p>
		<p class="BL_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>anticipated trends, conditions and investor sentiment in the global markets and exchange<span class="nobreak">-traded</span> products, or ETPs;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>anticipated levels of inflows into and outflows out of our ETPs;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>our ability to deliver favorable rates of return to investors;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>competition in our business;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>whether we will experience future growth;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>our ability to develop new products and services and their potential for success;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>our ability to maintain current vendors or find new vendors to provide services to us at favorable costs;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>our ability to successfully implement our strategy relating to digital assets and blockchain<span class="nobreak">-enabled</span> financial services, including WisdomTree Prime, and achieve its objectives;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>our ability to successfully operate and expand our business in non<span class="nobreak">-U</span>.S.&#160;markets;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>the effect of laws and regulations that apply to our business; and</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>actions of activist stockholders.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The forward<span class="nobreak">-looking</span> statements in this Report represent our views as of the date of this Report. We anticipate that subsequent events and developments may cause our views to change. However, while we may elect to update these forward<span class="nobreak">-looking</span> statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. Therefore, these forward<span class="nobreak">-looking</span> statements do not represent our views as of any date other than the date of this Report.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">1</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<a id="T99201"></a><p class="H1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">PART&#160;I</span></p>
		<a id="T99202"></a><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:48pt;text-indent:-48pt;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">ITEM 1.<span style="width: 13px;display: inline-block;">&#160;&#160;&#160;&#160;</span>BUSINESS</span></p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Our Company</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We are a global financial innovator, offering a well<span class="nobreak">-diversified</span> suite of exchange traded products, or ETPs, models, solutions and products leveraging blockchain technology. We empower investors and consumers to shape their future and support financial professionals to better serve their clients and grow their businesses. We are leveraging the latest financial infrastructure to create products that provide access, transparency and an enhanced user experience. Building on our heritage of innovation, we are also developing and have launched next<span class="nobreak">-generation</span> digital products, services and structures, including digital or blockchain<span class="nobreak">-enabled</span> mutual funds (&#8220;Digital Funds&#8221;) and tokenized assets, as well as our blockchain<span class="nobreak">-native</span> digital wallet, WisdomTree Prime, which is currently available in the U.S.&#160;in 38 states, representing approximately 70% of the U.S.&#160;population.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We had approximately $100.1&#160;billion in assets under management, or AUM, as of December&#160;31, 2023. Our family of ETPs includes products that provide exposure to equities, fixed income, commodities, leveraged<span class="nobreak">-and-inverse</span>, currency, alternatives and cryptocurrency strategies. We have launched many first<span class="nobreak">-to-market</span> products and pioneered alternative weighting we call &#8220;Modern Alpha,&#8221; which combines the outperformance potential of active management with the benefits of passive management to offer investors cost<span class="nobreak">-effective</span> funds that are built to perform. Most of our equity<span class="nobreak">-based</span> funds employ a fundamentally weighted investment methodology, which weights securities based on factors such as dividends, earnings or investment factors, whereas most other industry indexes use a capitalization weighted methodology. These products are distributed through all major channels in the asset management industry, including banks, brokerage firms, registered investment advisers, institutional investors, private wealth managers and online brokers primarily through our sales force. We believe technology is altering the way financial advisors conduct business and through our Advisor and Portfolio Solutions programs we offer technology<span class="nobreak">-enabled</span> and research<span class="nobreak">-driven</span> solutions including portfolio construction, asset allocation, practice management services and digital tools to help financial advisors address technology challenges and grow and scale their businesses.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We are at the forefront of innovation and believe that tokenization and leveraging the utility of blockchain technology is the next evolution in financial services. We are building the foundation that we believe will allow us to lead in this coming evolution. WisdomTree Prime, our blockchain<span class="nobreak">-native</span> digital wallet, positions us to expand our blockchain<span class="nobreak">-enabled</span> financial product and services offerings with a new direct<span class="nobreak">-to-consumer</span> channel where spending, saving and investing are united. As we continue to pursue our digital assets strategy, we are embracing what we refer to as &#8220;responsible DeFi,&#8221; which we believe upholds the foundational principles of regulation in this innovative and quickly evolving space. We believe that our expansion into digital assets and blockchain<span class="nobreak">-enabled</span> finance complements our existing core competencies in a holistic manner and will diversify our revenue streams and contribute to our growth.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We were incorporated under the laws of the state of Delaware on September&#160;19, 1985 as Financial Data Systems, Inc. and were ultimately renamed WisdomTree, Inc. on November&#160;7, 2022.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">2</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="Basic-Text-Frame" style="margin:0;padding:0;border-width:0;">
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Assets Under Management</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">WisdomTree ETPs</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We offer ETPs covering equity, fixed income, commodities, leveraged<span class="nobreak">-and-inverse</span>, currency, alternatives and cryptocurrency. The chart below sets forth the asset mix of our ETPs at December&#160;31, 2021, 2022 and 2023:</p>
		<p class="Text_flush_Center" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:3;margin-top:6pt;"><img alt="" src="tbarchart_001.jpg" style="width:532.48px;max-width:100%;"/></p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Our Operating and Financial Results</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We operate as an ETP sponsor and asset manager, providing investment advisory services globally through our subsidiaries in the U.S.&#160;and Europe.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">U.S.&#160;Listed ETFs</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The AUM of our U.S.&#160;listed exchange traded funds, or U.S.&#160;listed ETFs, increased from $56.0&#160;billion at December&#160;31, 2022 to $72.5&#160;billion at December&#160;31, 2023 due to net inflows and market appreciation.</p>
		<p class="Text_flush_Center" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:3;margin-top:6pt;"><img alt="" src="tbarchart_002.jpg" style="width:395.52px;max-width:100%;"/></p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">3</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">European Listed ETPs</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The AUM of our European listed (including internationally cross<span class="nobreak">-listed</span>) ETPs, or European listed ETPs, increased from $26.0&#160;billion at December&#160;31, 2022 to $27.6&#160;billion at December&#160;31, 2023, due to market appreciation, partly offset by net outflows.</p>
		<p class="Text_flush_Center" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:3;margin-top:6pt;"><img alt="" src="tbarchart_003.jpg" style="width:336.64px;max-width:100%;"/></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Consolidated Operating Results</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The following table sets forth our revenues and net income for the last three&#160;years.</p>
		<p class="Text_flush_Center" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:3;margin-top:6pt;"><img alt="" src="tbarchart_004.jpg" style="width:337.92px;max-width:100%;"/></p>
		<p class="BL_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Revenues&#160;</span>&#8211;&#160;We recorded operating revenues of $349.0&#160;million during the year ended December<span class="nobreak">&#160;</span>31, 2023, up 15.8% from the year ended December<span class="nobreak">&#160;</span>31, 2022 due to higher average AUM and higher other income from large flows from some of our European products, partly offset by a lower average advisory fee.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Expenses&#160;</span>&#8211;&#160;Total operating expenses increased 8.4% from the year ended December<span class="nobreak">&#160;</span>31, 2022 to $261.5&#160;million primarily due to higher stock<span class="nobreak">-based</span> compensation and headcount, fund management and administration costs, professional fees, marketing expenses, third<span class="nobreak">-party</span> distribution fees, sales and business development expenses and other expenses. These increases were partly offset by the termination of our deferred consideration&#8212;gold payments obligation on May<span class="nobreak">&#160;</span>10, 2023.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Other Income/(Expenses) </span>&#8211; Other income/(expenses) includes interest income and interest expense, gains and losses on revaluation/termination of deferred consideration&#8212;gold payments, impairments and other losses and gains. See &#8220;Other Income/(Expenses)&#8221; in Item&#160;7 &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; for additional information.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Net income</span> &#8211; We reported net income of $50.7&#160;million and $102.5&#160;million during the&#160;years ended December<span class="nobreak">&#160;</span>31, 2022 and 2023, respectively.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">See &#8220;Non<span class="nobreak">-GAAP</span> Financial Measures&#8221; included in Item&#160;7 &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; for additional information.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">4</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Seasonality</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We believe seasonal fluctuations in the asset management industry are common, however such trends are generally masked by global market events and market volatility in general. Therefore, period<span class="nobreak">-to-period</span> comparisons of our or the industry&#8217;s flows and operating results may not be meaningful or indicative of results in future periods.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Our Industry&#160;&#8211;&#160;ETPs</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We believe ETPs have been one of the most innovative investment products to emerge in the last two decades in the asset management industry. As of December&#160;31, 2023, aggregate AUM of ETPs globally was $11.6&#160;trillion.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The chart below reflects the AUM of the global ETP industry since 2006:</p>
		<p class="Text_flush_Center" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:3;margin-top:6pt;"><img alt="" src="tbarchart_005.jpg" style="width:545.28px;max-width:100%;"/></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:4pt;margin-top:4pt;">Source: ETFGI LLP</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">As of December&#160;31, 2023, we were the fourteenth largest ETP sponsor globally based on AUM.</p>
		<table class="Table56-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;">


				<tr class="Table56-">
					<td class="Table56- TCH CellOverride-1" colspan="5" style="background-color:#4b72b8;width: 100.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">

						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;color:#ffffff;">GLOBAL RANKING</span></p>
					</td>
				</tr>
				<tr class="Table56-" style="height:12pt;">
					<td class="Table56- TCH CellOverride-2 _idGenCellOverride-1" style="width: 19.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Rank</span></p>
					</td>
					<td class="Table56- TCH CellOverride-3" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table56- TCH CellOverride-4 _idGenCellOverride-1" style="width: 42.43%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">ETP Sponsor</span></p>
					</td>
					<td class="Table56- TCH CellOverride-3" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table56- TCH CellOverride-4 _idGenCellOverride-1" style="width: 31.31%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">AUM<br/>($ in billions)</span></p>
					</td>
				</tr>
				<tr class="Table56-" style="background: #CCEEFF;height:12pt;">
					<td class="Table56- TB CellOverride-5 _idGenCellOverride-1" style="width: 19.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_centeralign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">1</p>
					</td>
					<td class="Table56- TB CellOverride-5 _idGenCellOverride-2" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5 _idGenCellOverride-1" style="width: 42.43%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:5pt;text-indent:0pt;">iShares</p>
					</td>
					<td class="Table56- TB CellOverride-5 _idGenCellOverride-2" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5 _idGenCellOverride-1" style="width: 31.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">3,552&#160;&#160;</p>
					</td>
				</tr>
				<tr class="Table56-" style="height:12pt;">
					<td class="Table56- TB CellOverride-5" style="width: 19.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_centeralign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">2</p>
					</td>
					<td class="Table56- TB CellOverride-5" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5" style="width: 42.43%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:5pt;text-indent:0pt;">Vanguard</p>
					</td>
					<td class="Table56- TB CellOverride-5" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5" style="width: 31.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">2,505&#160;&#160;</p>
					</td>
				</tr>
				<tr class="Table56-" style="background: #CCEEFF;height:12pt;">
					<td class="Table56- TB CellOverride-5" style="width: 19.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_centeralign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">3</p>
					</td>
					<td class="Table56- TB CellOverride-5" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5" style="width: 42.43%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:5pt;text-indent:0pt;">State Street</p>
					</td>
					<td class="Table56- TB CellOverride-5" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5" style="width: 31.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">1,303&#160;&#160;</p>
					</td>
				</tr>
				<tr class="Table56-" style="height:12pt;">
					<td class="Table56- TB CellOverride-5" style="width: 19.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_centeralign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">4</p>
					</td>
					<td class="Table56- TB CellOverride-5" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5" style="width: 42.43%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:5pt;text-indent:0pt;">Invesco</p>
					</td>
					<td class="Table56- TB CellOverride-5" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5" style="width: 31.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">543&#160;&#160;</p>
					</td>
				</tr>
				<tr class="Table56-" style="background: #CCEEFF;height:12pt;">
					<td class="Table56- TB CellOverride-5" style="width: 19.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_centeralign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">5</p>
					</td>
					<td class="Table56- TB CellOverride-5" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5" style="width: 42.43%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:5pt;text-indent:0pt;">Charles Schwab</p>
					</td>
					<td class="Table56- TB CellOverride-5" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5" style="width: 31.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">319&#160;&#160;</p>
					</td>
				</tr>
				<tr class="Table56-" style="height:12pt;">
					<td class="Table56- TB CellOverride-5" style="width: 19.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_centeralign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">6</p>
					</td>
					<td class="Table56- TB CellOverride-5" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5" style="width: 42.43%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:5pt;text-indent:0pt;">Nomura</p>
					</td>
					<td class="Table56- TB CellOverride-5" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5" style="width: 31.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">230&#160;&#160;</p>
					</td>
				</tr>
				<tr class="Table56-" style="background: #CCEEFF;height:12pt;">
					<td class="Table56- TB CellOverride-5" style="width: 19.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_centeralign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">7</p>
					</td>
					<td class="Table56- TB CellOverride-5" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5" style="width: 42.43%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:5pt;text-indent:0pt;">Amundi</p>
					</td>
					<td class="Table56- TB CellOverride-5" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5" style="width: 31.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">229&#160;&#160;</p>
					</td>
				</tr>
				<tr class="Table56-" style="height:12pt;">
					<td class="Table56- TB CellOverride-5" style="width: 19.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_centeralign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">8</p>
					</td>
					<td class="Table56- TB CellOverride-5" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5" style="width: 42.43%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:5pt;text-indent:0pt;">Xtrackers</p>
					</td>
					<td class="Table56- TB CellOverride-5" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5" style="width: 31.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">207&#160;&#160;</p>
					</td>
				</tr>
				<tr class="Table56-" style="background: #CCEEFF;height:12pt;">
					<td class="Table56- TB CellOverride-5" style="width: 19.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_centeralign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">9</p>
					</td>
					<td class="Table56- TB CellOverride-5" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5" style="width: 42.43%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:5pt;text-indent:0pt;">First Trust</p>
					</td>
					<td class="Table56- TB CellOverride-5" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5" style="width: 31.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">155&#160;&#160;</p>
					</td>
				</tr>
				<tr class="Table56-" style="height:12pt;">
					<td class="Table56- TB CellOverride-5" style="width: 19.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_centeralign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">10</p>
					</td>
					<td class="Table56- TB CellOverride-5" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5" style="width: 42.43%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:5pt;text-indent:0pt;">JPMorgan</p>
					</td>
					<td class="Table56- TB CellOverride-5" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5" style="width: 31.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">153&#160;&#160;</p>
					</td>
				</tr>
				<tr class="Table56-" style="background: #CCEEFF;height:12pt;">
					<td class="Table56- TB CellOverride-5" style="width: 19.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_centeralign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">11</p>
					</td>
					<td class="Table56- TB CellOverride-5" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5" style="width: 42.43%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:5pt;text-indent:0pt;">Dimensional</p>
					</td>
					<td class="Table56- TB CellOverride-5" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5" style="width: 31.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">118&#160;&#160;</p>
					</td>
				</tr>
				<tr class="Table56-" style="height:12pt;">
					<td class="Table56- TB CellOverride-5" style="width: 19.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_centeralign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">12</p>
					</td>
					<td class="Table56- TB CellOverride-5" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5" style="width: 42.43%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:5pt;text-indent:0pt;">Nikko AM</p>
					</td>
					<td class="Table56- TB CellOverride-5" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5" style="width: 31.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">106&#160;&#160;</p>
					</td>
				</tr>
				<tr class="Table56-" style="background: #CCEEFF;height:12pt;">
					<td class="Table56- TB CellOverride-6" style="width: 19.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="Tbody_centeralign_JOIN" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">13</p>
					</td>
					<td class="Table56- TB CellOverride-5" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5" style="width: 42.43%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="Tbody_JOIN" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:5pt;text-indent:0pt;">Daiwa</p>
					</td>
					<td class="Table56- TB CellOverride-5" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5" style="width: 31.31%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="Tbody_rightalign_JOIN" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">101&#160;&#160;</p>
					</td>
				</tr>
				<tr class="Table56-" style="height:12pt;">
					<td class="Table56- TB CellOverride-7" style="width: 19.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-left: windowtext 1pt none; border-left-style: solid;border-top: windowtext 1pt none; border-top-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="Tbody_centeralign_JOIN" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">14</p>
					</td>
					<td class="Table56- TB CellOverride-5" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5" style="width: 42.43%; padding: 0in 0in 3px 0in;border-width: 0pt;border-top: windowtext 1pt none; border-top-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="Tbody_JOIN" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:5pt;text-indent:0pt;">WisdomTree</p>
					</td>
					<td class="Table56- TB CellOverride-5" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5" style="width: 31.31%; padding: 0in 0in 3px 0in;border-width: 0pt;border-right: windowtext 1pt none; border-right-style: solid;border-top: windowtext 1pt none; border-top-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="Tbody_rightalign_JOIN" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">100&#160;&#160;</p>
					</td>
				</tr>
				<tr class="Table56-" style="background: #CCEEFF;height:12pt;">
					<td class="Table56- TB CellOverride-5" style="width: 19.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-top: windowtext 1pt none; border-top-style: solid;" valign="bottom">
						<p class="Tbody_centeralign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">15</p>
					</td>
					<td class="Table56- TB CellOverride-5" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5" style="width: 42.43%; padding: 0in 0in 3px 0in;border-width: 0pt;border-top: windowtext 1pt none; border-top-style: solid;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:5pt;text-indent:0pt;">UBS</p>
					</td>
					<td class="Table56- TB CellOverride-5" style="width: 3.30%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table56- TB CellOverride-5" style="width: 31.31%; padding: 0in 0in 3px 0in;border-width: 0pt;border-top: windowtext 1pt none; border-top-style: solid;" valign="bottom">
						<p class="Tbody_rightalign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;">97&#160;&#160;</p>
					</td>
				</tr>

		</table>


		<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:24pt;">Source: Morningstar</p>

		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Exchange traded funds, or ETFs, have become more popular among a broad range of investors as they come to understand the benefits of ETFs and use them for a variety of purposes and strategies, including low<span class="nobreak">-cost</span> index investing and asset allocation, access to specific asset classes, protective hedging, income generation, arbitrage opportunities and diversification.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">5</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">While ETFs are similar to mutual funds in many respects, they also have some important differences:</p>
		<p class="BL_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:5.5pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Transparency.</span> ETFs disclose the composition of their underlying portfolios on a daily basis, unlike mutual funds, which typically disclose their holdings every 90&#160;days.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:5.5pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Intraday trading, hedging strategies and complex orders</span>. Like stocks, ETFs and other exchange<span class="nobreak">-traded</span> products can be bought and sold on exchanges throughout the&#160;trading day at market prices. ETFs update the indicative values of their underlying portfolios every 15 seconds. As publicly<span class="nobreak">-traded</span> securities, ETF shares can be purchased on margin and sold short, enabling the use of hedging strategies, and traded using limit orders, allowing investors to specify the price points at which they are willing to trade.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:5.5pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Tax efficiency.</span> In the U.S., whenever a mutual fund or ETF realizes a capital gain that is not balanced by a realized loss, it must distribute the capital gain to its shareholders. These gains are taxable to all shareholders, even those who reinvest the gain distributions in additional shares of the fund. However, most ETFs typically redeem their shares through &#8220;in<span class="nobreak">-kind</span>&#8221; redemptions in which low<span class="nobreak">-cost</span> securities are transferred out of the ETF in exchange for fund shares in a non<span class="nobreak">-taxable</span> transaction. By using this process, ETFs can avoid the transaction fees and tax impact incurred by mutual funds that sell securities to generate cash to pay out redemptions.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:5.5pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Uniform pricing.</span> From a cost perspective, ETFs are one of the most equitable investment products on the market. Investors in a U.S.&#160;listed ETF pay identical advisory fees regardless of the investors&#8217; size, structure or sophistication. Unlike mutual funds, U.S.&#160;listed ETFs generally do not have different share classes or different expense structures for retail and institutional clients and ETFs typically are not sold with sales loads or 12b<span class="nobreak">-1</span> fees. In many cases, ETFs offer lower expense ratios than comparable mutual funds.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:5.5pt;">ETFs are used in various ways by a range of investors, from conservative to speculative uses including:</p>
		<p class="BL_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:5.5pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Low</span><span class="nobreak"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">-cost</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;"> index investing. </span>ETFs provide exposure to a variety of broad<span class="nobreak">-based</span> indexes across equities, fixed income, commodities and other asset classes and strategies, and can be used as both long<span class="nobreak">-term</span> portfolio holdings or short<span class="nobreak">-term</span> trading tools. ETFs offer an efficient and less costly method by which to gain exposure to indexes as compared to individual stock ownership.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:5.5pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Improved access to specific asset classes. </span>Investors often use ETFs to gain access to specific market sectors or regions around the world or a particular asset, such as physical gold or crypto, by investing in an ETF that holds a portfolio of securities in that sector, region or asset rather than gaining exposure by purchasing individual securities, physical commodities or currencies.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:5.5pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Asset allocation. </span>Investors seeking to invest in various asset classes to develop an asset allocation model in a cost<span class="nobreak">-effective</span> manner can do so easily with ETFs, which offer broad exposure to various asset classes in a single security.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:5.5pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Protective hedging. </span>Investors seeking to protect their portfolios may use ETFs as a hedge against unexpected declines in prices of securities arising from market movements and changes in currency and interest rates.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:5.5pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Income generation. </span>Investors seeking to obtain income from their portfolios may buy fixed income ETFs that typically distribute monthly income or dividend<span class="nobreak">-paying</span> ETFs that encompass a basket of dividend<span class="nobreak">-paying</span> stocks rather than buying individual stocks.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:5.5pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Speculative investing. </span>Investors with a specific directional opinion about a market sector may choose to buy or sell (long or short) an ETF covering or leveraging that market sector.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:5.5pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Arbitrage. </span>Sophisticated investors may use ETFs to exploit perceived value differences between the ETF and the value of the ETF&#8217;s underlying portfolio of securities.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:5.5pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Diversification. </span>By definition, ETFs represent a basket of securities and each fund may contain hundreds or even thousands of different individual securities. The &#8220;instant diversification&#8221; of ETFs provides investors with broad exposure to an asset class, market sector or geography.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The ETF sector of the asset management industry continues to demonstrate that it is favored among investors. According to Morningstar, from January&#160;1, 2021 through December&#160;31, 2023, equity ETFs have generated positive inflows of approximately $1.9&#160;trillion, while long<span class="nobreak">-term</span> equity mutual funds have generated outflows of approximately ($830) billion. In addition, ETF fixed income flows are benefiting from a broader range of investors gravitating toward fixed income products in the ETF structure. We believe this trend is due to the inherent benefits of ETFs&#160;&#8211;&#160;transparency, liquidity and tax efficiency.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">6</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We believe that our growth, and the growth of the industry in which we operate, will continue to be driven by the following factors:</p>
		<p class="BL_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Education and greater investor awareness.</span> Over the last several&#160;years, ETPs have been taking a greater share of inflows and AUM from mutual funds. We believe investors have become more aware of some of the deficiencies of mutual funds and other financial products and are increasing their focus on important characteristics of their traditional investments&#160;&#8211;&#160;namely transparency, tradability, liquidity, tax efficiency and fees. Their attention and education focused on these important investment characteristics may be one of the drivers of the shift in inflows from traditional mutual funds to ETPs. We believe these products will continue to take market share from traditional mutual funds and other financial products or structures such as hedge funds, separate accounts and individual stocks as investors continue to become more aware and educated about ETPs and their benefits.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Move to fee</span><span class="nobreak"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">-based</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;"> models.</span> Financial advisors are shifting their business model from one that is &#8220;transaction<span class="nobreak">-based</span>,&#8221; that is, based on commissions for trades or receiving sales loads, to a &#8220;fee<span class="nobreak">-based</span>&#8221; approach, where an overall fee is charged based on the value of AUM.&#160;This fee<span class="nobreak">-based</span> approach lends itself to the advisor selecting lower<span class="nobreak">-fee</span> financial products, and in our opinion, better aligns advisers with the interests of their clients. Since ETFs generally charge lower fees than mutual funds, we believe this model shift will benefit the ETF industry.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Innovative product offerings.</span> ETPs are now available for virtually every asset class including equities, fixed income, commodities, leveraged<span class="nobreak">-and-inverse</span>, currencies, alternative strategies and cryptocurrencies (with greater access in markets outside the U.S.). However, we believe that there remain substantial areas for sponsors to continue to innovate, including cryptocurrency, liquid alternative, thematic and other strategies. We also believe the further expansion of ETPs will fuel additional growth and investments from investors who typically access these products through hedge funds, separate accounts, stock investments or the futures and commodity markets.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Changing demographics.</span> As the &#8220;baby boomer&#8221; generation continues to mature and retire, we expect that there will be a greater demand for a broad range of investment solutions, with an emphasis on income generation and principal protection, and that more of these investors will seek advice from professional financial advisors. We believe these financial advisors will migrate more of their clients&#8217; portfolios to ETPs due to their lower fees, better fit within fee<span class="nobreak">-based</span> models, and their ability to provide access to more diverse market sectors, improve multi<span class="nobreak">-asset</span> class allocation, and be used for different investment strategies, including income generation. Overall, we believe ETFs are well<span class="nobreak">-suited</span> to meet the needs of this large and important group of investors. In addition, since many younger investors and financial advisors have demonstrated a preference for the ETP structure over traditional product structures, we believe that wealth transfers from one generation to another will also have a positive effect on ETP industry growth.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">International markets.</span> We believe the growth of ETPs is a global phenomenon. While the U.S.&#160;currently represents the vast majority of global ETP assets, many of the same growth drivers in the U.S.&#160;market are also taking hold in global markets.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Our Industry&#160;&#8211;&#160;Digital Assets</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We believe that digital assets, tokenization and blockchain technology will help to innovate and evolve financial services from an investments, savings, payments and operational perspective. The digital assets industry has picked up significant momentum among market participants, including asset management firms, fintech firms, banks, broker<span class="nobreak">-dealers</span> and investors, which has spurred unprecedented adoption, growth and innovation. We believe that the benefits of blockchain technology can provide for the best product structures and executions in financial services. We expect that over time, benefits will include the following:</p>
		<p class="BL_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Transparency.</span> Blockchain technology employs mutualized standards, protocols and shared processes, acting as a single shared source of truth for network participants. The increased transparency among financial institutions and market participants may also improve regulatory reporting and monitoring.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;font-style:italic;font-weight:bold;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Economic benefits.</span> Automated, more efficient processes may lead to reduced operational, transactional and infrastructure costs.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">7</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;font-style:italic;font-weight:bold;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Streamlined processes.</span> Automation and overall operational efficiency increases with the use of blockchain technology. It enables real<span class="nobreak">-time</span> (near instant) settlement, auditability and reporting; and it reduces processing times, the potential for error and delay, and the number of steps and intermediaries required to achieve the same levels of confidence in traditional processes, thereby reducing counterparty risks.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">New products and potential markets.</span> Blockchain technology can make fractionalized ownership of real<span class="nobreak">-world</span> assets and tokenized economies a reality, with the same, if not better, level of security and scalability found in traditional finance.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Programmable capabilities.</span> Through the creation and execution of smart contracts, governance protocols, compliance, data privacy, customer identification (e.g., KYC/AML), system incentives and features can be programmed or built into the assets themselves.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Scalability.</span> Blockchain technology supports interoperability between private and public blockchains, thereby expanding the global reach and resiliency of transactions.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The laws and regulatory frameworks pertaining to digital assets and blockchain technology continue to evolve with an increase in scope and complexity. Contemporaneously, there has been heightened regulatory scrutiny of digital asset activities, which include material litigation and regulatory proceedings (e.g., enforcement actions) by government authorities, an increase in cybersecurity incidents leading to the theft or severe loss of assets, and insolvency proceedings (including bankruptcies) resulting from a variety of factors including poor risk management and oversight controls, speculative or risky behavior, and/or fraud or the misappropriation of customer funds. As a financial innovator seeking to bridge the gap between traditional finance and blockchain<span class="nobreak">-enabled</span> finance, we are embracing what we refer to as &#8220;responsible DeFi&#8221; for our digital assets and blockchain<span class="nobreak">-enabled</span> products and services, which we believe upholds the foundational principles of regulation in this innovative and rapidly evolving space. We are committed to being a trusted provider of innovative products and services guided by proactive engagement and continued collaboration with current and new regulators.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Competition in the digital assets industry on a global basis is increasing, ranging from large, established financial incumbents to smaller, early<span class="nobreak">-stage</span> financial technology providers and companies. There are jurisdictions with more stringent and robust regulatory and compliance requirements than others, which could impact the ability of a company to compete in the digital assets industry. We believe that we will continue to successfully compete in the digital assets industry by offering innovative products through digital asset exposures, generating strong after<span class="nobreak">-fee</span> performance and track records, embracing regulation, developing strategic partnerships with participants in the digital assets ecosystem, promoting thought leadership and investor education or awareness, building upon our brand and attracting and retaining talented employees. We remain focused on providing the best structures and executions in financial services through digital assets and blockchain technology.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Our Competitive Strengths</span></p>
		<p class="BL_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Well</span><span class="nobreak"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">-positioned</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;"> in large and growing markets. </span>We believe that ETPs are well positioned to grow significantly faster than the asset management industry as a whole, making our focus on ETPs an advantage over traditional asset management firms. We also believe that asset tokenization will be the future of financial services and expect our early<span class="nobreak">-mover</span> position in digital assets will serve to solidify our position as a forward<span class="nobreak">-thinking</span> innovator and industry leader in blockchain<span class="nobreak">-enabled</span> financial services.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;font-style:italic;font-weight:bold;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Strong, seasoned and creative management team. </span>We have built a strong and dedicated senior leadership team. Most of our leadership team has significant ETP or financial services industry experience in fund operations, regulatory and compliance oversight, product development and management or marketing and communications. We also continue to expand our global digital assets team, which is focused on growing existing and developing new investment products, indexes and strategies that provide exposure to digital assets, along with new blockchain<span class="nobreak">-enabled</span> products and services across global markets. Whether through ETPs, digital assets or decentralized finance, we will continue to be a trusted provider of innovative products and services guided by proactive engagement and regulatory collaboration. We believe that our team has demonstrated an ability to innovate as well as recognize and respond to market opportunities and effectively execute our strategy and has a proven track record including developing an ETP sponsor from the ground up despite significant competitive regulatory and operational barriers.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">8</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:6pt;margin-top:5.5pt;"><span class="bullet" style="font-size:10pt;font-style:italic;font-weight:bold;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Strong performance.</span> We create our own indexes, most of which weight companies in our equity ETFs by a measure of fundamental value and are rebalanced annually. By contrast, traditional indexes are market capitalization weighted and tend to track the momentum of the market. We also offer actively managed ETFs, as well as ETFs based on third<span class="nobreak">-party</span> indexes. In evaluating the performance of our U.S.&#160;listed equity, fixed income and alternative ETFs against actively managed and index based mutual funds and ETFs, over 80% of our U.S.&#160;listed AUM covered by Morningstar were in the top two quartiles of peer performance in the 3<span class="nobreak">-year</span> and 10<span class="nobreak">-year</span> timeframes. In addition, approximately 50% of our U.S.&#160;listed AUM is rated 4- or 5<span class="nobreak">-star</span> by Morningstar.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:5pt;margin-top:5pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Differentiated product set, powered by innovation and performance</span>. Our products span a variety of traditional and high growth asset classes covering equity, fixed income, commodity, leveraged<span class="nobreak">-and-inverse</span>, currency, alternative strategies and cryptocurrency, and include both passive and actively managed funds. We are also developing and have launched next<span class="nobreak">-generation</span> digital products, services and structures, including Digital Funds and tokenized assets. Our innovations include the following:</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:66pt;margin-top:4pt;margin-top:4.2pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>the launch of the WisdomTree Prime mobile application, our blockchain<span class="nobreak">-native</span> digital wallet that serves as a new direct<span class="nobreak">-to-consumer</span> channel positioning us as an early mover and industry leader in blockchain<span class="nobreak">-enabled</span> financial services; the application is currently available in 38 states in the U.S., representing approximately 70% of the U.S.&#160;population;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:66pt;margin-top:4pt;margin-top:4.2pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>the tokenization of real<span class="nobreak">-world</span> assets like physical gold (i.e., gold tokens) and U.S.&#160;dollars (i.e., dollar tokens);</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:66pt;margin-top:4pt;margin-top:4.2pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>13 Digital Funds accessible through WisdomTree Prime including a government money market fund and other digital funds offering asset allocation, fixed income and equity exposures that use blockchain technology to maintain a secondary record of their respective shares on one or more blockchains (e.g., Stellar or Ethereum);</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:66pt;margin-top:4pt;margin-top:4.2pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>among the first to launch a spot bitcoin ETF in the U.S.;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:66pt;margin-top:4pt;margin-top:4.2pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>the first ETF to add bitcoin futures exposure;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:66pt;margin-top:4pt;margin-top:4.2pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>the first gold and oil ETPs via our acquisition of the European exchange<span class="nobreak">-traded</span> commodity, currency and leveraged<span class="nobreak">-and-inverse</span> business of ETFS Capital Limited, or ETFS Capital. Throughout this Report, we refer to the acquired business as ETFS and the acquisition as the ETFS Acquisition;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:66pt;margin-top:4pt;margin-top:4.2pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>the first emerging markets small<span class="nobreak">-cap</span> equity ETF;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:66pt;margin-top:4pt;margin-top:4.2pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>the first actively managed currency ETF;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:66pt;margin-top:4pt;margin-top:4.2pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>the first ETF to provide investors with access to the Additional Tier 1 Contingent Convertible, or CoCo, bond market;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:66pt;margin-top:4pt;margin-top:4.2pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>one of the first international local currency denominated fixed income ETFs;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:66pt;margin-top:4pt;margin-top:4.2pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>the first managed futures strategy ETF;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:66pt;margin-top:4pt;margin-top:4.2pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>the first currency hedged international equity ETFs in the U.S.;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:66pt;margin-top:4pt;margin-top:4.2pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>the first 90/60 balanced ETF;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:66pt;margin-top:4pt;margin-top:4.2pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>the first multifactor ETFs incorporating dynamic currency hedging as a factor; and</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:66pt;margin-top:4pt;margin-top:4.2pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>the first smart beta corporate bond suite.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-left:48pt;margin-top:5pt;text-indent:0pt;margin-top:5pt;">Our product development strategy utilizes our Modern Alpha approach, which combines the outperformance potential of active management with the benefits of passive management to offer investors cost<span class="nobreak">-effective</span> funds that are built to perform. Self<span class="nobreak">-indexing</span> is a significant component of this approach. Many of our products are based on proprietary WisdomTree indexes which we believe gives us several advantages. First, it minimizes our third<span class="nobreak">-party</span> index licensing fees, which increases our profitability. Second, because we develop our own intellectual property, we are intimately familiar with our strategies and able to effectively communicate their value proposition in the market with research content and support. Third, it can enhance our speed to market and first mover advantage. Fourth, because these indexes are proprietary to WisdomTree, we may face similar competition, but we never face exact competition. Our expertise in product development combined with our self<span class="nobreak">-indexing</span> capabilities provides a strategic advantage, enabling us to launch innovative products. Building on our heritage of innovation, we are developing and have launched next<span class="nobreak">-generation</span> digital products and structures, including Digital Funds and tokenized assets.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">9</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;font-style:italic;font-weight:bold;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Extensive marketing, research and sales efforts.</span> We have invested significant resources to establish the WisdomTree brand and to promote our products through online and television targeted advertising and social media, as well as through our public relations efforts. Close to 40% of our employees are dedicated to marketing, research and sales. Our sales professionals are the primary points of contact for financial advisors, independent advisory firms and institutional investors who invest in our ETPs. Their efforts are enhanced through value<span class="nobreak">-added</span> services provided by our research and marketing efforts. We have strong relationships with financial advisors and institutional investors and we believe that by strategically aligning these advisor relationships and marketing campaigns with targeted research and sales initiatives and products that align with market sentiment, we differentiate ourselves from our competitors.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Efficient business model with lower risk profile.</span> We have invested heavily in digital tools and data to market and sell our products and in the internal development of our core competencies with respect to product development, marketing, research and sales of our products. We outsource to third parties those services that are not our core competencies or may be resource or risk intensive, such as the portfolio management responsibilities and fund accounting operations of our products. In addition, our licensing costs are moderated since we create our own indexes for most of our ETFs.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Our Growth Strategies</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We are a global financial innovator, offering a well<span class="nobreak">-diversified</span> suite of ETPs, models, solutions and products leveraging blockchain<span class="nobreak">-enabled</span> technology, with AUM of $100.1&#160;billion as of December&#160;31, 2023. We are at the forefront of innovation and believe that tokenization and leveraging the utility of blockchain technology is the next evolution in financial services. We are building the foundation that we believe will allow us to lead in this coming evolution. WisdomTree Prime, our blockchain<span class="nobreak">-native</span> digital wallet, positions us to expand our blockchain<span class="nobreak">-enabled</span> financial services product offerings with a new direct<span class="nobreak">-to-consumer</span> channel where spending, saving and investing are united. As we continue to pursue our digital assets strategy, we are embracing what we refer to as &#8220;responsible DeFi,&#8221; which we believe upholds the foundational principles of regulation in this innovative and rapidly evolving space. We believe that our expansion into digital assets complements our existing core competencies in a holistic manner and will diversify our revenue streams and contribute to our growth. Our strategy includes the following:</p>
		<p class="BL_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Launch innovative ETPs that diversify our product offerings and revenues. </span>We have launched many first<span class="nobreak">-to-market</span> ETFs in the U.S.&#160;and pioneered alternative weighting and performance methods we call &#8220;Modern Alpha,&#8221; which combines the outperformance potential of active management with the benefits of passive management to offer investors cost<span class="nobreak">-effective</span> funds that are built to perform. Our growth plan focuses on filling strategic gaps and seizing tactical opportunities by launching new products globally.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Establish ourselves as a leader in digital assets and blockchain</span><span class="nobreak"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">-enabled</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;"> financial services. </span>Our deep experience with innovation and proven track record of entering new asset classes and markets, coupled with our firmwide strategic attention on blockchain<span class="nobreak">-enabled</span> finance and a culture focused on governance and risk management with a regulatory minded approach positions us to become a leader in the digital assets industry. We are an early mover in this space, with the launch of our blockchain<span class="nobreak">-native</span> digital wallet, WisdomTree Prime, a new direct<span class="nobreak">-to-consumer</span> channel where spending, saving and investing are united. WisdomTree Prime provides access to bitcoin, ether, tokenized gold and U.S. dollar tokens, as well as 13 Digital Funds, including a government money market fund and other digital funds offering asset allocation, fixed income and equity exposures. In addition, we have partnered with a financial institution to provide co<span class="nobreak">-branded</span> debit cards to our retail customers on the WisdomTree Prime platform. We continue to focus on enhancing the products and capabilities of the platform with plans to allow for peer<span class="nobreak">-to-peer</span> transfers and payments. We are also exploring strategic partnerships and other business development opportunities for both our platform and product suite that could unlock additional tokenization revenue streams in the future.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;font-style:italic;font-weight:bold;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Foster deeper client relationships through technology</span><span class="nobreak"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">-enabled</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;"> and research</span><span class="nobreak"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">-driven</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;"> solutions</span><span class="Bold" style="font-style:normal;font-weight:bold;">.</span><span class="BoldItalic" style="font-style:italic;font-weight:bold;"> </span>We believe technology is altering the way financial advisors conduct business. Our Advisor and Portfolio Solutions programs provide technology<span class="nobreak">-enabled</span> and research<span class="nobreak">-driven</span> solutions to help financial advisors grow and scale their businesses and address their technology challenges.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">10</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-left:48pt;text-indent:0pt;margin-top:6pt;">The Advisor and Portfolio Solutions programs include:</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:66pt;margin-top:5pt;margin-top:5pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>access to our U.S.&#160;model portfolios which are available to over 70,000 advisors across a number of platforms, including, Merrill Lynch, Morgan Stanley, LPL Financial, Charles Schwab, Envestnet, 55ip and others. Our model portfolios are a natural extension of our research capabilities and provide advisors access to an open<span class="nobreak">-architecture</span> approach, a tenured team and a firm dedicated to innovation and value creation. As part of this initiative, we launched a series of model portfolios in collaboration with Professor Jeremy Siegel;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:66pt;margin-top:5pt;margin-top:5pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>providing customized portfolio and asset allocation services to support registered investment advisers and independent broker dealers in building, implementing, and managing their client portfolios while providing strategic guidance for advisors to support their business growth;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:66pt;margin-top:5pt;margin-top:5pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>access to portfolio construction tools such as our award<span class="nobreak">-winning</span> Portfolio Analysis Tools Hub (PATH), an enhanced portfolio construction tool that assists financial advisors in analyzing an existing investment portfolio by examining the data and providing alternative portfolio approaches to consider in seeking to improve outcomes based on different measures;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:66pt;margin-top:5pt;margin-top:5pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>wealth investment research and ETF education; and</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:66pt;margin-top:5pt;margin-top:5pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>practice management resources, including access to thought leaders in behavioral finance, leadership, and transforming wealth management technology.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:5pt;margin-top:5pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Deepen relationships with distribution platforms.</span> We maintain relationships with certain distribution platforms that allow commission<span class="nobreak">-free</span> trading of our ETFs. These relationships are beneficial to us as they can provide greater marketing privileges and access to the platforms&#8217; advisors. As financial advisors continue to migrate away from mutual funds, we use our expertise in ETFs to build new relationships and educate advisors about the benefits of ETFs. Some of these relationships that exist today are with LPL Financial, BNY Mellon/Pershing, Raymond James, Charles Schwab, Cetera and others.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:5pt;margin-top:5pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Leverage data intelligence to serve and expand investor base and improve sales and marketing effectiveness.</span> We utilize a cognitive customer<span class="nobreak">-focused</span> lead prioritization system which has enhanced our distribution efforts. The system evaluates data across structured and unstructured sources such as historical investment data, market data and investor activity history, extracting behavioral insights, and is designed to enable our sales and marketing teams to optimize outreach to our current and potential investor base.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:5pt;margin-top:5pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Selectively pursue acquisitions or other strategic transactions.</span> We may pursue acquisitions or other strategic transactions that will enable us to strengthen our current business, expand and diversify our product offerings, complement our Advisor and Portfolio Solutions programs, increase our AUM or enter into new markets. We believe pursuing acquisitions or other strategic transactions is a cost<span class="nobreak">-effective</span> means of growing our business and AUM.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Human Capital Resources</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:5pt;margin-top:5pt;">We compete in the highly competitive asset management industry. Attracting, retaining and motivating highly skilled, and sometimes highly specialized, employees in operations, product development, research, technology, sales and marketing and other positions is crucial to our ability to compete effectively. Our ability to recruit and retain such employees depends on a number of factors, including our corporate culture and work environment, informed by our values and behaviors, talent development and career opportunities and compensation and benefits. We strive to differentiate ourselves through our sense of community and purpose integrated into our culture, while encouraging a culture where every employee has a voice.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Employee Profile</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:5pt;margin-top:5pt;">At December&#160;31, 2023, we had 303 full<span class="nobreak">-time</span> employees globally, consisting of 190 in the U.S.&#160;and 113 in Europe. We consider our relations with employees to be good.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Diversity, Equity and Inclusion (DEI)</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:5pt;margin-top:5pt;">We recognize that a diverse set of perspectives is critical to innovation and have built a diverse global workforce, inclusive of gender, race, ethnicity, religion, age, gender identity, gender expression and sexual orientation, as well as those in the disabled community. We actively seek candidates from different backgrounds and outside traditional fields and reinforce our commitment to diversity through organizational policies, such as mandating fairness and equality for all employees and creating performance appraisal systems that are non<span class="nobreak">-discriminatory</span>.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">11</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">At WisdomTree, we envision a future of investment excellence driven by a commitment to continuously strengthen our diverse, equitable and inclusive workplace culture. Our DEI Council, formed in 2021, is comprised of senior leaders and employees from both the U.S.&#160;and Europe and provides oversight and guidance in connection with the implementation of programs designed to foster a culture where every employee thrives, leveraging diverse perspectives and inclusive practices. For example, in 2023, the DEI Council held training sessions on understanding neurodiversity, implicit bias and embedding inclusion in feedback, roundtables on success and failure, and financial literacy workshops for employees and secondary school students. The DEI Council also promoted awareness&#160;days and&#160;months across the firm including with respect to black history, women&#8217;s history, pride, mental health and men&#8217;s health.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our Women&#8217;s Initiative Network, or WIN, is a global employee<span class="nobreak">-led</span> network designed to provide opportunities and support from all genders for women at WisdomTree, career development and professional training opportunities, and female empowerment and leadership within the organization. Since its inception in 2019, WIN has held numerous global events, including panel discussions on women in the workforce featuring WisdomTree employees and notable guest speakers, interactive seminars on topics including negotiation skills, workshops and coaching sessions to enhance confidence to speak up, and various roundtable forums, informal coffee catch<span class="nobreak">-ups</span> and in<span class="nobreak">-person</span> and virtual social gatherings to promote connectivity and increase engagement. WIN also produces regular internal &#8220;spotlight&#8221; newsletters to increase visibility and raise the profile of our female employees. Both this initiative and WIN&#8217;s coffee catch<span class="nobreak">-up</span> initiative evolved into successful firm<span class="nobreak">-wide</span> initiatives. In addition, through WIN&#8217;s mentorship program, WIN members of all genders are connected with firm leaders who can help them achieve their career development goals.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Employee Wellness, Health and Safety</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The wellbeing of our employees is a primary focus. We are continuously evolving and refining how we work best to achieve individual, team and Company goals. To that end, we have embraced a &#8220;Work Smart&#8221; philosophy that transcends physical work settings, with a focus on optimizing productivity, efficiency and effectiveness of our work. Time in the office generally is not prescribed, and team leaders are empowered to determine how their teams work best, based on their roles, with employees remaining accountable for achieving individual, team and Company outcomes. To foster employee wellbeing and a healthy work<span class="nobreak">-life</span> balance, we offer numerous wellness programs including meditation and yoga classes, health webinars, a weekly wellness newsletter and access to mental health professionals and other resources. Leveraging technology, we enhance the employee experience through digital wellness platforms, facilitating remote access to health and wellbeing resources. We also offer paid vacation (unlimited in the U.S.) and sick leave policies to provide employees additional flexibility, and our U.S.&#160;employees enjoy additional &#8220;wellness&#160;days,&#8221; which are scheduled office closures around major market holidays for employees to collectively disconnect and rejuvenate. We support employees with their information technology needs, provide a monthly stipend to cover remote work<span class="nobreak">-related</span> business expenses and provide guidance for managers to ensure that employees remain connected and maintain physical, mental and emotional wellbeing.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In keeping with &#8220;Work Smart,&#8221; we now maintain a smaller office footprint globally to better align with the number of employees expected to collaborate in person on any given&#160;day, while providing a space for employees to work and socialize. As the safety and security of our employees who choose to work in our office space are of critical importance, we have selected office buildings with robust security procedures, fire safety and sanitation and health practices.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Compliance, Training and Development</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We comply with all applicable government laws, rules and regulations and it is the responsibility of each employee to adhere to the standards and restrictions imposed by those laws, rules and regulations. All new employees attend a compliance training session with a compliance officer, and thereafter, employees are required to attend firmwide annual compliance training and to complete compliance certifications annually and in some instances, quarterly. We also conduct mandatory cybersecurity training and other training programs as required by law.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">As we believe that our employees are our greatest asset, we recognize the importance of investing in their continued development. We provide a variety of opportunities for our employees to build new skills and further their career development. These include role<span class="nobreak">-specific</span> training courses, virtual lunches with senior leaders in a small group setting and webinars hosted by various departments to gain a holistic view of the Company. We also support employees&#8217; continuing education, including through our educational assistance program. In addition, we invest in our current and future leaders through leadership development courses and individual and team coaching. We also hold monthly regional and quarterly global town halls to inform our employees of business developments, employee news and job openings, as well as to provide opportunities for employees to hone their presentation skills by sharing department updates.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">12</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Employee Engagement</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We believe engaging our employees is key to fostering new ideas and driving commitment and productivity. We communicate frequently and transparently with our employees through a variety of communication methods, including an annual global virtual offsite where senior leaders review the firm&#8217;s prior<span class="nobreak">-year</span> accomplishments and articulate the objectives for the coming year, and each department presents its respective prior<span class="nobreak">-year</span> accomplishments and current<span class="nobreak">-year</span> objectives, monthly regional and quarterly global town halls and firmwide weekly emails championing the team&#8217;s work. We also seek feedback from our employees through annual engagement surveys and follow<span class="nobreak">-up</span> pulse surveys on various topics. In addition, we provide opportunities for employees to participate in volunteer and charitable events.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We also believe it is important to celebrate employee and Company accomplishments. In 2023, we celebrated our fourth annual &#8220;Team Alpha&#8221; Awards to mark significant events and successes and to recognize employees who led those successes while exhibiting extraordinary teamwork and demonstrating strong character. Over 50 nominations were submitted and narrowed down by a selection committee. The winners received a modest incentive compensation award, the opportunity to donate to a charity of their choice and to recognize other employees who assisted them.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The success of our employee engagement efforts is demonstrated by our employee retention rate of approximately 93.4% in 2023. We also achieved overall positive results from our 2023 global employee engagement survey, with a 99% participation rate. Additionally, in the U.S., we were named a &#8220;2023 Best Places to Work in Money Management&#8221; by <span class="Italic" style="font-style:italic;font-weight:normal;">Pensions&#160;&amp; Investments</span> for the fourth consecutive year and seventh year since the award was created. We ranked second within the category for managers with&#160;100<span class="nobreak">-499</span> employees, the second consecutive year earning a ranking among the top five employers. In the U.K., we were also named Best Workplace for medium<span class="nobreak">-sized</span> companies for a fourth consecutive year and a 2023 Best Workplace for Women for medium<span class="nobreak">-sized</span> companies by <span class="Italic" style="font-style:italic;font-weight:normal;">Great Place to Work</span>.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Compensation and Benefits</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We are committed to rewarding and supporting our employees in order to continue to attract and retain top talent. Our incentive compensation program has been designed to reward our employees for their individual performance as well as the Company&#8217;s performance and includes various quantitative metrics and qualitative results that incentivize growth. We believe a key factor in our success has been and continues to be fostering an entrepreneurial culture where our employees act and think like our owners. As such, we believe that equity awards are an important part of our employees&#8217; overall compensation package and that incentivizing our employees with equity aligns the interests of our employees with our stockholders. We also offer a wide array of benefits including generous healthcare coverage, paid vacation (unlimited in the U.S.), parental, sabbatical and sick leave, life and travel insurance, short- and long<span class="nobreak">-term</span> disability benefits and, in the U.S., a 401(k)&#160;plan with a matching contribution of up to 50% of eligible employee contributions.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Our Product Categories</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">U.S.&#160;Equity</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We offer equity products that provide access to the securities of large, mid and small<span class="nobreak">-cap</span> companies located in the U.S., as well as particular market sectors and styles. Our U.S.&#160;Equity products track our own indexes, the majority of which are fundamentally weighted as opposed to market capitalization weighted indexes, which assign more weight to stocks with the highest market capitalizations. These fundamentally weighted indexes focus on securities of companies that pay regular cash dividends or on securities of companies that have generated positive cumulative earnings over a certain period. We believe weighting equity markets by dividends and income, rather than by market capitalization, can provide investors with better risk<span class="nobreak">-adjusted</span> returns over longer term periods in core equity exposures. Total AUM of our U.S.&#160;Equity products was $29.2&#160;billion at December&#160;31, 2023.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Commodity&#160;&amp; Currency</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We offer products in Europe with exposure to gold and other precious metals and commodities such as silver and platinum, oil and energy, agriculture and broad basket commodities. Our currency products provide investors with exposure to developed and emerging markets currencies, as well as exposures to foreign currencies relative to the U.S.&#160;dollar. Total AUM of our Commodity&#160;&amp; Currency products was $21.3&#160;billion at December&#160;31, 2023.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">13</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Fixed Income</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our Fixed Income products seek to enhance income potential within the fixed income universe. We offer a suite of rising rate bond products based on leading fixed income benchmarks we license from third parties. We also launched the industry&#8217;s first smart beta corporate bond suite. Other product offerings include those that seek to track a yield<span class="nobreak">-enhanced</span> index of U.S.&#160;investment grade bonds and international fixed income products which are denominated in either local or U.S.&#160;currencies. Total AUM of our Fixed Income products was $21.2&#160;billion at December&#160;31, 2023.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">International Developed Market Equity</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our International Developed Market Equity products offer a variety of strategies including currency hedged and dynamic currency hedged products, exposures to large, mid and small<span class="nobreak">-cap</span> companies in these markets and multifactor strategies. Total AUM of our International Developed Market Equity products was $15.1&#160;billion at December&#160;31, 2023.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Emerging Market Equity</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our Emerging Market Equity products provide access to exposure of large, mid and small<span class="nobreak">-cap</span> companies located in Taiwan, China, India, Russia, South Africa, South Korea and other emerging markets regions. These products also track our own indexes, which are fundamentally weighted focusing on securities of companies that pay regular cash dividends or that have generated positive cumulative earnings over a certain period. Total AUM of our Emerging Market Equity products was $10.7&#160;billion at December&#160;31, 2023.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Leveraged&#160;&amp; Inverse</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We offer leveraged products which seek to achieve a return that is a multiple of the performance of the underlying index and inverse products that seek to deliver the opposite of the performance in the index or benchmark they track. Strategies span across equity, commodity, government bond and currency exposures. Total AUM of our Leveraged&#160;&amp; Inverse products was $1.8&#160;billion at December&#160;31, 2023.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Cryptocurrency</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our cryptocurrency ETPs provide investors with a simple, secure and cost<span class="nobreak">-efficient</span> way to gain exposure to the price of cryptocurrencies, while utilizing the best of traditional financial infrastructure and product structuring. We offer exposures to bitcoin, ether, crypto asset baskets and other cryptocurrency exposures. Total AUM of our cryptocurrency products was $0.4&#160;billion at December&#160;31, 2023.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Alternatives</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our Alternative products include the industry&#8217;s first managed futures strategy ETF and a global real return ETF.&#160;We also offer a dynamic long/short U.S.&#160;equity ETF, a dynamic bearish U.S.&#160;equity ETF and a collateralized put write strategy ETF on the S&amp;P 500 index. We also intend to explore additional alternative strategy products in the future. Total AUM of our Alternative products was $0.4&#160;billion at December&#160;31, 2023.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Our Sales, Marketing and Research Efforts</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Sales</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We distribute our ETPs through all major channels within the asset management industry, including banks, brokerage firms, registered investment advisers, institutional investors, private wealth managers and online brokers. Our primary sales efforts are not directed towards the retail segment but rather are directed towards the financial or investment adviser who acts as the intermediary between the end<span class="nobreak">-client</span> and us. We do not pay commissions, nor do we offer 12b<span class="nobreak">-1</span> fees to financial advisors to use or recommend the use of our products.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We have developed an extensive network and relationships with financial advisors and we believe that our ETPs and related research are well structured to meet their needs and those of their clients. We have taken steps to enhance and form new relationships through our Advisor and Portfolio Solutions programs, including providing customized portfolio and asset allocation services to support registered investment advisers and independent broker dealers in building, implementing and managing their client portfolios while providing strategic guidance for advisors to support their business growth. Our Advisor and Portfolio Solutions programs also provide technology<span class="nobreak">-enabled</span> and research<span class="nobreak">-driven</span> solutions to help financial advisors grow and scale their businesses.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">14</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In addition, senior and academic advisors of ours, including Professor Jeremy Siegel, Senior Economist to WisdomTree, participate as keynote speakers in various industry and WisdomTree hosted conferences and events. Our sales professionals act in a consultative role to provide financial advisors with value<span class="nobreak">-added</span> services. We seek to consistently grow our network of financial advisors and we opportunistically seek to introduce new products and services that best deliver our investment strategies to investors through these distribution channels. We have our own team of 77 sales professionals globally as of December&#160;31, 2023.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In addition, we have agreements with third parties to serve as the external marketing agents for our products in Latin America and Israel, as well as with select brokerage firms and independent broker<span class="nobreak">-dealers</span> to allow certain of our products to trade commission free on their platforms in exchange for a percentage of our advisory fee revenues from certain AUM.&#160;We believe these arrangements expand our distribution capabilities in a cost<span class="nobreak">-effective</span> manner and we may continue to enter into such arrangements in the future.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Marketing</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our marketing efforts are focused on the following objectives: increase our global brand awareness, leverage a robust data<span class="nobreak">-driven</span> digital sales experience to generate new clients and drive inflows to our products and model portfolios and retain existing clients, with a focus on cross<span class="nobreak">-selling</span> additional WisdomTree ETPs. We also anticipate launching marketing campaigns to drive awareness and user adoption for WisdomTree Prime and to position ourselves to become a leader in asset tokenization and blockchain<span class="nobreak">-enabled</span> funds. We pursue these objectives utilizing the following strategies:</p>
		<p class="BL_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Targeted advertising.</span> We create highly targeted multi<span class="nobreak">-media</span> advertising campaigns limited to established core financial media. For example, our television advertising to promote our ETPs runs exclusively on the cable networks CNBC, Fox Business and Bloomberg. It is anticipated that television advertising also will be utilized to promote WisdomTree Prime. Also, our digital advertising runs on many investing and ETF<span class="nobreak">-specific</span> web<span class="nobreak">-sites</span>, such as <span class="CharOverride-3" style="text-decoration:underline;">www.etftrends.com</span> and <span class="CharOverride-3" style="text-decoration:underline;">www.etfdb.com,</span> using targeted dynamic and personalized ad messaging. We also utilize non<span class="nobreak">-linear</span> TV advertising that leverages the same targeted segments of users who use streaming devices. In Europe, we filter the targeting of promotions by both region and language, focusing heavily on professional investors.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Media relations.</span> We have a full<span class="nobreak">-time</span> global corporate communications and public relations team that has established relationships with major financial and digital assets media outlets. We utilize these relationships to help increase global awareness of WisdomTree ETPs, the ETP industry in general in the U.S.&#160;and Europe and our digital assets efforts. Several members of our management team and multiple members of our research team are frequent market commentators and conference panelists.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Database Messaging Strategy.</span> We have a database of financial advisors to whom we regularly market through a series of messages across channels (email, display, site) that are triggered based on user interest and predictive analytics, on<span class="nobreak">-demand</span> research presentations, ETP<span class="nobreak">-specific</span> or educational events and presentations, and market commentary from Professor Jeremy Siegel, Senior Economist to WisdomTree. Additionally, in the U.S., we communicate to our retail database about new product launches and provide ETF education through a monthly newsletter.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Social media.</span> We have implemented a social media strategy that allows us to connect directly with financial advisors and investors by offering timely access to our research material and more general market commentary. Our social media strategy allows us to continually enhance our brand reputation of expertise and thought leadership in the ETP industry. For example, we have an established presence on LinkedIn,&#160;X (formerly Twitter), Instagram, Reddit and YouTube, and our blog content is syndicated across multiple business<span class="nobreak">-oriented</span> websites. We also leverage the strength and reach of our existing brand, in addition to utilizing a highly focused &#8220;test, learn, iterate&#8221; paid and social media marketing strategy, to drive awareness and user adoption for WisdomTree Prime.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Sales support.</span> We create comprehensive materials to support our sales process of our ETP products, including whitepapers, research reports, webinars, blogs, podcasts, videos and performance data for our products. Our marketing automation system connects seamlessly to our database of financial advisors to provide the sales team with additional insights about their clients.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We will continue to evolve our marketing and communication efforts in response to changes in the ETP industry, market conditions, marketing trends and our evolving strategy around digital assets.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">15</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Research and Chief Investment Office</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our research team and chief investment office has four core functions: product development and oversight, investment research, model portfolio management and sales support across equities, fixed income, alternatives, crypto and asset allocation portfolios. In its index and active product development and oversight role, the group is responsible for creating the investment methodologies and overseeing the maintenance of indexes and active strategies. The team also provides a variety of investment research around these indexes and markets and manages a series of model portfolios that incorporate WisdomTree and third<span class="nobreak">-party</span> products for various investment platforms, including WisdomTree Prime. Our research is typically academic<span class="nobreak">-type</span> research to support our products, including white papers on the strategies underlying our indexes and ETPs, investment insights on current market trends, and types of investment strategies that drive long<span class="nobreak">-term</span> performance. We distribute our research and insights through our sales professionals, online through our website and blog, targeted emails to financial advisors, or through financial media or social media outlets. Finally, the team supports our sales professionals in meetings as market experts and through custom analysis on client portfolio holdings. In addition, we consult with our senior advisers, including Professor Jeremy Siegel, Senior Economist to WisdomTree, on product development ideas, model collaboration and market commentaries.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Product Development</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We are focused on driving continued growth through innovative product development including through our Modern Alpha approach and our digital assets offerings. Modern Alpha combines the outperformance potential of active management with the benefits of passive management to offer investors cost<span class="nobreak">-effective</span> products that are built to perform.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Due to our proprietary index development capabilities and a strategic focus on product development, we have demonstrated an ability to launch innovative and differentiated ETPs. Building on our heritage of innovation, we are also developing next<span class="nobreak">-generation</span> digital products and structures, including Digital Funds and tokenized assets. When developing new products, we seek to position ourselves as first to market, offering improvement in structure or strategy relative to an incumbent product or offering some other key distinction relative to an incumbent product. In short, we want to add choice in the market and seek to introduce thoughtful investment solutions. Lastly, when launching new products, we seek to expand and diversify our overall product line.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Competition</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The asset management industry is highly competitive and we face substantial competition in virtually all aspects of our business. Factors affecting our business include fees for our products, our offerings and investment performance, brand recognition, business reputation, quality of service and the continuity of our financial advisor and platform relationships. We compete directly with other ETP sponsors and mutual fund companies and indirectly against other investment management firms, insurance companies, banks, brokerage firms and other financial institutions. Many of the firms we compete with are subsidiaries of large diversified financial companies and many others are much larger in terms of AUM,&#160;years in operations and revenues and, accordingly, have much larger sales organizations and budgets. In addition, these larger competitors may attract business through means that are not available to us, including retail bank offices, investment banking, insurance agencies and traditional broker<span class="nobreak">-dealers</span>.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">ETPs are now available for virtually every asset class including equities, fixed income, commodities, alternative strategies, leveraged<span class="nobreak">-and-inverse</span>, currencies and cryptocurrencies. Existing players have broadened their suite of products offering strategies that are, in some cases, similar to ours and large traditional asset managers are also launching ETPs, some with similar strategies as well. There remain substantial areas for sponsors to continue to innovate, including but not limited to cryptocurrency, liquid alternative, thematic and other strategies.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Price competition exists in not only commoditized product categories such as traditional, market capitalization weighted index exposures and commodities, but also in non<span class="nobreak">-market</span> capitalization weighted or factor<span class="nobreak">-based</span> exposures and commodities. Fee reductions by certain of our competitors has been a trend over the last few&#160;years and continues to persist and many of our competitors are well positioned to benefit from this trend. Certain larger competitors are able to offer products at lower price points or otherwise as loss leaders due to other revenue sources available within such competitors that are currently unavailable to us. Newer players have also been entering the ETP industry and frequently seek to differentiate by offering ETPs at a lower price point. Funds are being offered with fees of 20 basis points or less, which have attracted approximately 80% of the net flows globally during the last three&#160;years. However, while these low<span class="nobreak">-cost</span> products have accumulated a significant amount of AUM recently, we estimate that these same funds represent only approximately 34% of global revenues.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">16</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Being a first mover, or one of the first providers of ETPs in a particular asset class, can be a significant advantage, as the first ETP in a category to attract scale in AUM and trading liquidity is generally viewed as the most attractive product. We believe that our early launch of products in a number of asset classes or strategies, including fundamental weighting and currency hedging, along with commodities including gold, certain fixed income, alternative and thematic categories, positions us well to maintain our standing as one of the leaders of the ETP industry. Additionally, we believe that our affiliated indexing or &#8220;self<span class="nobreak">-indexing</span>&#8221; model, as well as our more recent active ETFs, enable us to launch proprietary products that do not have direct competition and are positioned to generate alpha versus benchmarks. As investors increasingly become more comfortable with the product structure, we believe there will be a greater focus on after<span class="nobreak">-fee</span> performance rather than using ETPs primarily as low<span class="nobreak">-cost</span> market access vehicles. While we have selectively lowered fee rates on certain products that have yet to attain scale, and there is no assurance that we will not lower fee rates on certain products in the future, our strategy continues to include launching new funds in the same category with a differentiated exposure at a lower fee rate, rather than reducing fees on existing products with a significant amount of AUM, long performance track records, and secondary market liquidity, which continue to remain competitively priced for the value provided, among other factors. We generally believe we are well positioned from a product pricing perspective.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We also have been positioning ourselves to expand beyond our existing ETP business by leveraging blockchain technology, digital assets and principles of DeFi to deliver transparency, choice and inclusivity to customers and consumers around the world. Our blockchain<span class="nobreak">-native</span> digital wallet, WisdomTree Prime, provides access to bitcoin, ether, tokenized gold and U.S.&#160;dollar tokens, as well as 13 Digital Funds, including a government money market fund and other digital funds offering asset allocation, fixed income and equity exposures. These products have been developed with the ability to be recorded and/or transferred on multiple public and/or permissioned blockchains with interoperability between blockchains. In addition, we were among the first to launch a spot bitcoin ETF in the United&#160;States.&#160;We believe this expansion complements our core competencies in a holistic manner, will diversify our revenue streams and contribute to our growth. Competition in the digital assets industry on a global basis is increasing, ranging from large, established financial incumbents to smaller, early<span class="nobreak">-stage</span> financial technology providers and companies. There are jurisdictions with more stringent and robust regulatory and compliance requirements than others which could impact the ability of a company to compete in the digital assets industry. We are embracing what we refer to as &#8220;responsible DeFi&#8221; for our anticipated and expanded products and services which we believe upholds the foundational principles of regulation in this innovative and quickly evolving space. We remain committed to being a trusted provider of innovative products and services guided by proactive engagement and continued collaboration with current and new regulators.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our ability to successfully compete will depend largely on offering innovative products through traditional ETPs and digital asset exposures (and more broadly in blockchain<span class="nobreak">-enabled</span> finance, including savings and payments), having strong internal controls and risk management infrastructure to enable customer trust, generating strong after<span class="nobreak">-fee</span> performance and track records, embracing regulation, developing distribution relationships, promoting thought leadership and a differentiated solutions program, building upon our brand and attracting and retaining talented sales professionals and other employees.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Regulatory Framework of the ETP Industry and Digital Assets Business</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">ETPs</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Not all ETPs are ETFs. ETFs are a distinct type of security with features that are different than other ETPs. ETFs are open<span class="nobreak">-end</span> investment companies or unit investment trusts regulated in the U.S.&#160;by the Investment Company Act&#160;of&#160;1940, as amended, or the Investment Company Act. This regulatory structure is designed to provide investor protection within a pooled investment product. For example, the Investment Company Act requires that at least 40% of the Trustees for each ETF must not be affiliated persons of the fund&#8217;s investment manager, or Independent Trustees. If the ETF seeks to rely on certain rules under the Investment Company Act, a majority of the Trustees for that ETF must be Independent Trustees. ETFs generally operate under regulations that allow them to operate within the ETF structure, while ETFs also operate under regulations that prohibit affiliated transactions, are subject to standard pricing and valuation rules and have mandated compliance programs. ETPs can take a number of forms in addition to ETFs, including exchange<span class="nobreak">-traded</span> notes, grantor trusts or limited partnerships. In the U.S.&#160;market, a key factor differentiating ETFs, grantor trusts and limited partnerships from exchange<span class="nobreak">-traded</span> notes is that the former hold assets underlying the ETP.&#160;Exchange traded notes, on the other hand, are debt instruments issued by the exchange<span class="nobreak">-traded</span> note sponsor. Also, each of these structures has implications for taxes, liquidity, tracking error and credit risk.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">17</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Digital Assets</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">As we continue to make progress and pursue various initiatives in connection with our digital assets business, we believe it is necessary and important to do so in compliance with applicable laws and regulations. As a result, we are actively engaged with a variety of U.S.&#160;federal and state regulators (e.g., the SEC, FINRA, New&#160;York Department of Financial Services (NYDFS) and other state regulators) to secure, as necessary, or maintain the appropriate regulatory, registration and/or licensing approvals for various business initiatives and operations, including but not limited to: a New&#160;York state<span class="nobreak">-chartered</span> limited purpose trust company; money services and money transmitter business; limited purpose broker<span class="nobreak">-dealer</span>; transfer agent; investment adviser; and investment funds. As we seek to expand globally, similar approvals and/or reliance on exemptions will be required in applicable foreign markets, which also may involve approvals specific to a digital assets or related business. As we secure the appropriate regulatory, registration and/or licensing approvals, or otherwise rely on, seek or confirm exemptions therefrom, in connection with our digital assets business, we are and will be subject to a myriad of complex and evolving global policy frameworks and associated regulatory requirements that we need to comply with, or otherwise be exempt from, to ensure that our digital assets products and services are successfully brought to different markets in a compliant manner. We remain committed to being a trusted provider of innovative products and services guided by proactive engagement and regulatory collaboration.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">U.S.&#160;Regulation</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">All aspects of our business are subject to various federal and state laws and regulations. These laws and regulations are primarily intended to protect the end user, which may include retail and institutional customers, investment advisory clients and shareholders of registered investment companies. These laws generally grant supervisory agencies broad administrative powers, including the power to limit or restrict the conduct of our business and to impose fines, sanctions or other penalties for failure to comply with these laws and regulations. Further, such laws and regulations provide the basis for examination, inquiry, investigation, enforcement action and/or litigation which could materially affect our business.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We are primarily subject to the following laws and regulations, among others. The costs of complying with such laws and regulations have increased and will continue to contribute to the costs of doing business:</p>
		<p class="BL_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">The Investment Advisers Act&#160;of&#160;1940 (Investment Advisers Act).</span> The SEC is the federal agency generally responsible for administering the U.S.&#160;federal securities laws. WisdomTree Asset Management, Inc., or WT Asset Management, and WisdomTree Digital Management, Inc., or WT Digital Management, two of our subsidiaries, are registered as investment advisers under the Investment Advisers Act and, as such, are regulated by the SEC.&#160;The Investment Advisers Act requires registered investment advisers to comply with numerous obligations, including, among others, recordkeeping requirements, fiduciary duties, operational procedures, and registration, reporting and disclosure obligations.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">The Investment Company Act&#160;of&#160;1940 (Investment Company Act).</span> All of our Digital Funds and U.S.&#160;listed ETFs are registered with the SEC pursuant to the Investment Company Act. These products must comply with the applicable requirements of the Investment Company Act and other regulations, such as those related to publicly offering and listing shares, as well as requirements of Rule&#160;6c<span class="nobreak">-11</span>, or the ETF Rule, including, among others, requirements relating to operations, fees charged, sales, accounting, recordkeeping, disclosure, transparency and governance. In addition, the SEC continues to take an active approach in its rulemaking activity by finalizing and proposing new rules and/or rule amendments under the Investment Company Act that will impact current and future Digital Fund and ETF operations and/or investments.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;font-style:italic;font-weight:bold;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Broker</span><span class="nobreak"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">-Dealer</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;"> Regulations. </span>WisdomTree Securities, Inc., or WT Securities, is a FINRA member firm. As a limited purpose broker<span class="nobreak">-dealer</span>, WT Securities is operating as a mutual fund retailer for the Digital Funds offered through WisdomTree Prime. This business is separate from other WisdomTree subsidiaries operating as Digital Fund and ETF sponsors in the U.S.&#160;which are not required to be registered with the SEC as broker<span class="nobreak">-dealers</span> under the Securities Exchange&#160;Act&#160;of&#160;1934, as amended, or Exchange&#160;Act. However, many of our employees, including all of our salespersons, are licensed with FINRA and are registered either as associated persons of WT Securities or the distributor of the WisdomTree Digital Funds and U.S.&#160;listed ETFs and, as such, are subject to FINRA rules that relate to licensing, continuing education requirements and sales practices. FINRA rules also apply to our fund marketing and sales material.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">18</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;font-style:italic;font-weight:bold;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Federal Money Services Business and State Money Transmission Laws. </span>WisdomTree Digital Movement, Inc. is a money services business registered with the Financial Crimes Enforcement Network, or FinCEN, and a state licensed money transmitter operating a platform for the purchase, sale and exchange of digital assets, while also providing blockchain<span class="nobreak">-enabled</span> digital wallet services through WisdomTree Prime to facilitate such activity. Navigating state regulations across the U.S.&#160;provides compliance challenges and significant costs as regulations and expectations differ between states, with different states seeking to achieve different objectives with their regulations, from consumer protection to preventing money laundering. In addition, licensure requirements are quickly evolving (including regulators not permitting certain activities related to digital assets pursuant to such licenses), with the associated timeframes for licensure increasing and licensure being further complicated by recent market events and bankruptcies of firms in the digital assets space.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Internal Revenue Code. </span>The WisdomTree Trust generally has obligations with respect to the qualification of the registered investment companies for pass<span class="nobreak">-through</span> tax treatment under the Internal Revenue Code.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">U.S.&#160;Commodity Futures Trading Commission (CFTC) and National Futures Association (NFA). </span>Regulations adopted by the CFTC have required WT Asset Management to become a member of the NFA and register as a commodity pool operator for a select number of our ETFs.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Products Exchange Listing Requirements. </span>Each WisdomTree U.S.&#160;listed ETF is listed on a secondary market (each, an Exchange), including NYSE Arca, the NASDAQ Market and the Cboe Exchange, and accordingly is subject to the listing requirements of these Exchanges. Any new WisdomTree U.S.&#160;listed ETF will seek listing on an Exchange and also will need to meet continued Exchange listing requirements, which generally align with requirements of the ETF Rule. However, the SEC or an Exchange may ultimately determine not to allow the issuance of potential new WisdomTree U.S.&#160;listed ETFs or may require strategy or operational modifications as part of the registration and/or listing process.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Corporate Exchange Listing Requirements. </span>In addition, our common stock is listed on the New&#160;York Stock Exchange and we are therefore also subject to its rules including corporate governance listing standards, as well as federal and state securities laws.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">FINRA Rules. </span>FINRA rules and guidance may affect how WisdomTree U.S.&#160;listed ETFs are sold by member firms. Although we currently do not offer so<span class="nobreak">-called</span> leveraged ETFs in the U.S., which may include within their holdings derivative instruments such as options, futures or swaps to obtain leveraged exposures. FINRA guidance, the recently effective SEC Rule&#160;18f<span class="nobreak">-4</span>, or the Derivatives Rule, and/or other future rules or regulations may influence how member firms effect sales of certain WisdomTree U.S.&#160;listed ETFs, such as our currency ETFs, or how such ETFs operate, which also use some forms of derivatives, including forward currency contracts and swaps, our international hedged equity ETFs, which use currency forwards, and our rising rates bond ETFs and alternative strategy ETFs, which use futures or options.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Section&#160;17A of the Exchange&#160;Act. </span>WisdomTree Transfers, Inc., or WT Transfers, is a transfer agent registered with the SEC.&#160;As a transfer agent, WT Transfers provides transfer agency and registrar services for the Digital Funds offered through WisdomTree Prime. WT Transfers&#8217; transfer agency and registrar services are subject to Section&#160;17A of the Exchange&#160;Act&#160;and applicable rules promulgated thereunder.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">International Regulation</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our operations outside the U.S.&#160;are subject to the laws and regulations of various non<span class="nobreak">-U</span>.S.&#160;jurisdictions and non<span class="nobreak">-U</span>.S.&#160;regulatory agencies and bodies. As we have expanded our international presence, a number of our subsidiaries and international operations have become subject to regulatory systems, in various jurisdictions, comparable to those covering our operations in the U.S.&#160;Regulators in these non<span class="nobreak">-U</span>.S.&#160;jurisdictions may have broad authority with respect to the regulation of financial services including, among other things, the authority to grant or cancel required licenses or registrations.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">19</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Jersey-Domiciled Issuers (Managed by WisdomTree Management Jersey Limited)</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:5pt;margin-top:4.5pt;">One of our subsidiaries, WisdomTree Management Jersey Limited, or ManJer, is a Jersey based management company providing investment and other management services to several Jersey<span class="nobreak">-domiciled</span> issuers, or ManJer Issuers, of exchange<span class="nobreak">-traded</span> commodities, or ETCs, each of which was established as a special purpose vehicle to issue exchange<span class="nobreak">-traded</span> securities. All ETCs are listed and marketed across the European Union, or EU, under Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June&#160;2017 (as amended), or the Prospectus Regulation. Since January&#160;4, 2021, the Central Bank of Ireland, or Central Bank, approves all ETC Base Prospectuses (with the exception of WisdomTree Issuer&#160;X Limited&#8217;s prospectus which is approved by the Swedish Financial Supervisory Authority) as meeting the requirements imposed under EU law pursuant to the Prospectus Regulation. Such approval relates only to those securities to be admitted to trading on a regulated market for the purpose of Markets in Financial Instruments Directive (recast) &#8211; Directive 2014/65/EU of the European Parliament and the Council, or MiFID&#160;II, and/or which are to be offered to the public in any European Economic Area, or EEA, Member State. All ETC prospectuses (except WisdomTree Issuer&#160;X Limited&#8217;s prospectus) are also approved by the Financial Conduct Authority, or FCA, as U.K.&#160;Listing Authority, as competent authority pursuant to the U.K. version of Regulation (EU) No 2017/1129 of the European Parliament and the Council of 14 June&#160;2017 on the form and content of such prospectuses and repealing Directive 2003/71/EC which is part of U.K. law by virtue of the European Union (Withdrawal) Act&#160;2018, or the U.K.&#160;Prospectus Regulation. Each prospectus (except WisdomTree Issuer&#160;X Limited&#8217;s prospectus) is prepared, and a copy is sent to the Jersey Financial Services Commission, or JFSC, in accordance with the Collective Investment Funds (Certified Funds&#160;&#8211;&#160;Prospectuses) (Jersey) Order 2012. Each ManJer Issuer (other than WisdomTree Issuer&#160;X Limited) has obtained a certificate under the Collective Investment Funds (Jersey) Law 1988 (as amended), to enable it to undertake its functions in relation to its ETCs. At the request of the relevant ManJer Issuer, the Central Bank has notified the approval of the Base Prospectus in accordance with the Prospectus Regulation to other EU listing authorities, including Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, the Netherlands, Norway, Poland, Spain and Sweden, by providing them with certificates of approval attesting that the Base Prospectus has been prepared in accordance with the Prospectus Regulation. Each issuer may request the Central Bank to provide competent authorities in other EEA Member States with such certificates for the purposes of making a public offer in such Member States and/or for admission to trading of all or any securities on a regulated market. WisdomTree Issuer&#160;X Limited&#8217;s program for the issuance of WisdomTree digital securities does not constitute a collective investment fund for the purpose of the Collective Investment Funds (Jersey) Law 1988 (as amended) as it satisfies the requirements of Article&#160;2 of the Collective Investments Funds (Restriction of Scope) (Jersey) Order 2000. A copy of WisdomTree Issuer&#160;X Limited&#8217;s prospectus has been delivered to the Registrar of Companies in Jersey in accordance with Article&#160;5 of the Companies (General Provisions) (Jersey) Order 2002, and the Registrar has consented to its circulation. The JFSC has consented under Article&#160;4 of the Control of Borrowing (Jersey) Order 1958 to the issue of the WisdomTree digital securities by WisdomTree Issuer&#160;X Limited. The prospectus of WisdomTree Issuer&#160;X Limited is also recognized by the Swiss Prospectus Office.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:5pt;margin-top:4.5pt;">The ManJer Issuers are primarily subject to the following legislation and regulatory requirements:</p>
		<p class="BL_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:5pt;margin-top:4.5pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">The Companies (Jersey) Law 1991.</span> Each ManJer Issuer is incorporated as a public limited liability company under the Companies (Jersey) Law 1991. Therefore, the ManJer Issuers are required to comply with various obligations under this law including, but not limited to, convening general meetings, keeping proper books and records and filing financial statements.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:5pt;margin-top:4.5pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">The Foreign Account Tax Compliance Act, or FATCA</span>, a U.S.&#160;federal law that was passed as part of the Hiring Incentives to Restore Employment (HIRE) Act, generally requires that foreign financial institutions and certain other non<span class="nobreak">-financial</span> foreign entities report on the foreign assets held by their U.S.&#160;account holders or be subject to withholding on withholdable payments. The HIRE Act also contained legislation requiring U.S.&#160;persons to report, depending on the value, their foreign financial accounts and foreign assets. ETCs benefit from the so called &#8220;listing exemption&#8221; and Jersey local authorities have determined that for companies which can benefit from such exemption the filing of a nil report is optional.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:5pt;margin-top:4.5pt;"><span class="bullet" style="font-size:10pt;font-style:italic;font-weight:bold;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">The Common Reporting Standards, or CRS</span>, were developed by the Organization for Economic Cooperation and Development and is a global reporting standard for the automatic exchange of information. The ManJer Issuers need to conduct FATCA style due diligence and annual local reporting in relation to financial accounts held directly and indirectly by residents of those jurisdictions with which the Foreign Financial Institutions (FFIs) jurisdiction of residence has signed an Intergovernmental Agreement (IGA) to implement the CRS.&#160;Unlike FATCA, there is no clear listing exemption available under the CRS so the ManJer Issuers are required to conduct full due diligence to identify such accounts and report on them on an annual basis to their local tax authorities, at least in respect of the certificated interests and primary market issuances. However, Jersey tax authorities have applied less onerous reporting obligations to interests such as ETCs that are regularly traded on an established securities market and are held through CREST, the U.K. based central securities depository.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">20</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;font-style:italic;font-weight:bold;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">The Collective Investment Funds (Jersey) Law 1988.</span> Each ManJer Issuer (other than WisdomTree Issuer&#160;X Limited) is a collective investment fund and therefore required to comply with the obligations under the Collective Investment Funds (Jersey) Law 1988 and the Code of Practice for Certified Funds.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">The Prospectus Regulation.</span> The Base Prospectus of each ManJer Issuer has been drafted, and any offer of ETCs in any EEA Member State that has implemented the Prospectus Regulation is made in compliance with the Prospectus Regulation and any relevant implementing measure in such Member States.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Regulation (EU) No 648/2012 of the European Parliament and of the Council of 4&#160;July&#160;2012 on OTC derivatives, central counterparties and trade repositories, known as the European Market Infrastructure Regulation (&#8220;EMIR&#8221;).</span> EMIR, which became effective on August<span class="nobreak">&#160;</span>16, 2012, provides for certain over<span class="nobreak">-the-counter</span>, or OTC, derivative contracts to be submitted to central clearing and imposes margin posting and other risk mitigation techniques, reporting and record keeping requirements. The clearing obligations under EMIR are still under discussion, and currently there are no mandatory clearing obligations in relation to equity, FX or commodity derivatives. The clearing obligation only applies to EU<span class="nobreak">-based</span> financial counterparties (defined as those authorized under MiFID, CRR, AIFMD, UCITS or insurance regulations) or those non<span class="nobreak">-financial</span> entities that have a rolling three<span class="nobreak">-month</span> notional exposure above a certain amount (between &#8364;1 and &#8364;3&#160;billion, depending on asset class), which means that the ManJer Issuers are not directly subject to these obligations, but could indirectly be subject to them by virtue of their interaction with EU<span class="nobreak">-based</span> financial counterparties. In terms of reporting obligations, being non<span class="nobreak">-EU</span> entities, the ManJer Issuers are only indirectly subject to such obligations when they interact with their EU<span class="nobreak">-based</span> financial counterparties. Each ManJer Issuer has adhered to the 2013 EMIR Portfolio Reconciliation, Dispute Resolution and Disclosure Protocol published by the International Swaps and Derivatives Association, Inc.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Regulation (EU) No 596/2014 of the European Parliament and of the Council on market abuse (the &#8220;Regulation&#8221;) and Directive 2014/57/EU of the European Parliament and of the Council on criminal sanctions for market abuse (the &#8220;Directive&#8221; and, together with the Regulation, &#8220;MAD&#8221;).</span> Obligations imposed on the relevant ManJer Issuer and distributor under MAD, which became effective on July<span class="nobreak">&#160;</span>3, 2016, include the requirement to publish inside information in a public and timely manner, to prepare and maintain a list of insiders and to refrain from market manipulation.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Regulation (EU) 2016/1011 of the European Parliament and of the Council of 8 June&#160;2016 on indices used as benchmarks in financial instruments and financial contracts or to measure the performance of investment funds and amending Directives 2008/48/EC and 2014/17/EU and Regulation (EU) No 596/2014 (&#8220;BMR&#8221;).</span> Supervised EU entities which issue financial instruments that reference a benchmark are required to comply with applicable obligations as set out under the BMR.&#160;The BMR was published on June<span class="nobreak">&#160;</span>30, 2016 and the majority of the provisions became effective on January<span class="nobreak">&#160;</span>1, 2018. The ManJer Issuers are non<span class="nobreak">-EU</span> entities and as a result, BMR application is very limited, although in some circumstances a few residual obligations could be deemed to be applicable because the ETCs are marketed across Europe.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Regulation (EU) No 1286/2014 of the European Parliament and of the Council of 26 November&#160;2014 on key information documents for packaged retail and insurance</span><span class="nobreak"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">-based</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;"> investment products (&#8220;PRIIPS&#8221;). </span>PRIIPs became effective on January<span class="nobreak">&#160;</span>1, 2018 and applies to investment product manufacturers and distributors. Under PRIIPs, manufacturers need to provide a key information document (KIDs) to investors. The intention of KIDs is to improve transparency for investors on the products and enhance investor protection. The product manufacturer is responsible for drafting the KID and for its content. All ETCs are currently subject to PRIIPs and KIDs have been produced since January<span class="nobreak">&#160;</span>1, 2018.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">MiFID&#160;II.</span>&#160;MiFID&#160;II covers a wide range of areas that affect the relevant issuer and distributor, such as product governance, a definition of complex products which captures all physical and synthetic ETCs and the production of a European MiFID template, or an EMT, to facilitate the dissemination of relevant information to the markets and distributors in relation to each financial product.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;font-style:italic;font-weight:bold;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Regulation (EU) 2015/2365 of the European Parliament and of the Council of 25 November&#160;2015 on transparency of securities financing transactions and of reuse and amending Regulation (EU) No 648/2012. (&#8220;SFTR&#8221;).</span> Counterparties to securities financing transactions must report the transaction to trade repositories. The SFTR introduces a reporting requirement for transactions, and a disclosure requirement to investors with a requirement for prior consent. It also designates that financial instruments used for re<span class="nobreak">-hypothecation</span> are transferred to an account in the name of the other counterparty. Since the ManJer Issuers are based in non<span class="nobreak">-EU</span> jurisdictions, obligations are only indirectly applicable to them, but a certain level of interaction with EU counterparties is required to comply with some of these requirements.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">21</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">WisdomTree Issuer&#160;X Limited is also primarily subject to the following legislation and regulatory requirements:</p>
		<p class="BL_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">The Control of Borrowing (Jersey) Order 1958.</span> WisdomTree Issuer&#160;X Limited is required to comply with the obligations under the Control of Borrowing (Jersey) Order 1958 in respect of its issue of the WisdomTree digital securities.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">The Companies (General Provisions) (Jersey) Order 2002.</span> WisdomTree Issuer&#160;X Limited is required to comply with the obligations under the Companies (General Provisions) (Jersey) Order 2002 in respect of its circulation of the WisdomTree digital securities prospectus.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Irish-Domiciled Issuer of UCITS ETFs (Managed by WisdomTree Management Limited)</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The investment management industry in Ireland is subject to both Irish domestic law and EU law. The Central Bank of Ireland, or the Central Bank, is responsible for the authorization and supervision of collective investment schemes, or CIS, in Ireland. CIS&#8217;s are also commonly known as funds/schemes. There are two main categories of funds authorized by the Central Bank, Undertakings for Collective Investment in Transferable Securities (UCITS) and funds that are not UCITS known as alternative investment funds. ETFs form part of the Irish and European regulatory frameworks that govern UCITS, with ETFs having been the subject of specific consideration at the European level which is then repeated and/or interpreted by Irish regulators and the Central Bank in regulations and related guidance issued by the Central Bank.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">One of our subsidiaries, WisdomTree Management Limited, is an Ireland based management company authorized in Ireland providing collective portfolio management services to WisdomTree Issuer ICAV, or WTICAV, and WisdomTree UCITS ETFs. The WisdomTree UCITS ETFs, or Sub<span class="nobreak">-Funds</span>, are issued by WTICAV.&#160;WTICAV, a non<span class="nobreak">-consolidated</span> third party, is an Irish<span class="nobreak">-collective-asset-management</span> vehicle, or ICAV, organized in Ireland and is authorized as a UCITS by the Central Bank. All UCITS have their basis in EU legislation and once authorized in one EEA Member State, may be marketed throughout the EU, without further authorization. This is described as an EU passport. WisdomTree Management Limited registered with the FCA as an Authorised Schedule&#160;5 &#8211; operator of a temporary recognized scheme, and under the Temporary Marketing Permissions Regime, the WisdomTree UCITS ETFs continue to be available to U.K. investors.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">WTICAV is established and operated as an ICAV with segregated liability between its Sub<span class="nobreak">-Funds</span>. The Sub<span class="nobreak">-Funds</span> are segregated portfolios, each with their own investment objective and policies and assets. Each Sub<span class="nobreak">-Fund</span> has a separate approval from the Central Bank, and each is structured as an ETF.&#160;Each Sub<span class="nobreak">-Fund</span> tracks a different index. The index must comply with regulatory criteria that govern, among others, the eligibility and diversification of its constituents, and the availability of information on the index such as the frequency of calculation of the index, the index&#8217;s transparency, its methodology and frequency of calculation. Each Sub<span class="nobreak">-Fund</span> has shares admitted to trading on the London Stock Exchange and, typically, on various European stock exchanges, and accordingly, is subject to the listing requirements of those exchanges.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">WTICAV is primarily subject to the following legislation and regulatory requirements:</p>
		<p class="BL_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">European Communities (Undertakings for Collective Investment in Transferable Securities) Regulations 2011 (as amended) (&#8220;UCITS Regulations&#8221;).</span> The UCITS Regulations, which transpose Council Directive 2009/65/EC, Commission Directive 2010/43/EC and Commission Directive 2010/44/EC into Irish law, became effective on July<span class="nobreak">&#160;</span>1, 2011. UCITS established in Ireland are authorized under the UCITS Regulations.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Central Bank (Supervision and Enforcement) Act&#160;2013 (Section&#160;48(1)) (Undertakings for Collective Investment in Transferable Securities) Regulations 2019 (&#8220;Central Bank UCITS Regulations&#8221;).</span> The Central Bank UCITS Regulations were adopted in May&#160;2019 and, together with the UCITS Regulations, any guidance produced by the Central Bank, and the Central Bank forms, form the basis for all the requirements that the Central Bank imposes on UCITS, UCITS management companies and depositaries of UCITS.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Central Bank Guidance. </span>The Central Bank also has produced guidance that provides direction on issues relating to the funds industry, certain of which set forth conditions not contained in the UCITS Regulations or the Central Bank Regulations with which UCITS must conform.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;font-style:italic;font-weight:bold;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">The Irish Collective Asset</span><span class="nobreak"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">-Management</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;"> Vehicle Act&#160;2015 (&#8220;ICAV Act&#8221;). </span>WTICAV is registered as an ICAV under the ICAV Act. Therefore, WTICAV is required to comply with various obligations under the ICAV Act such as, but not limited to, keeping proper books and records. The segregation of liability between Sub<span class="nobreak">-funds</span> means there cannot be, as a matter of Irish law, cross<span class="nobreak">-contamination</span> of liability between Sub<span class="nobreak">-funds</span>. Therefore, the insolvency of one Sub<span class="nobreak">-fund</span> cannot affect another Sub<span class="nobreak">-fund</span>.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">22</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;font-style:italic;font-weight:bold;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">EMIR.&#160;</span>EMIR provides for OTC derivative contracts to be submitted to central clearing and imposes, inter alia, margin posting and other risk mitigation techniques, reporting and record keeping requirements. WTICAV uses OTC derivatives instruments to hedge the currency risk of some of its sub<span class="nobreak">-funds</span>, which are subject to EMIR.&#160;WTICAV has adhered to the 2013 EMIR Portfolio Reconciliation, Dispute Resolution and Disclosure Protocol published by the International Swaps and Derivatives Association, Inc. The Central Bank has been designated as the competent authority for EMIR.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">BMR.&#160;</span>The BMR is directly applicable law across the EU and applies to certain &#8220;administrators,&#8221; &#8220;contributors&#8221; and &#8220;users&#8221; of benchmarks with the aim of reducing the risk of benchmark manipulation and promoting confidence in their integrity and that of the financial markets which they support. Since WTICAV issues financial instruments that reference a benchmark, it will be required to comply with applicable obligations as set out under the BMR.&#160;In addition, non<span class="nobreak">-EU</span> administrators of benchmarks are required to satisfy a number of requirements to enable the benchmarks they provide to be used in the EU.&#160;To ensure investor protection, the BMR provides equivalence, recognition and endorsement conditions under which third country benchmarks may be used by supervised entities in the EU.&#160;Since we control the provision of benchmarks, we are required to comply with applicable obligations within the timeframes set out under the BMR.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Regulation (EU) No 1286/2014 of the European Parliament and of the Council of 26 November&#160;2014 on key information documents for packaged retail and insurance</span><span class="nobreak"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">-based</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;"> investment products (&#8220;PRIIPS&#8221;). </span>As above,<span class="BoldItalic" style="font-style:italic;font-weight:bold;"> </span>WisdomTree&#8217;s ETCs have been subject to PRIIPS since January<span class="nobreak">&#160;</span>1, 2018. On January<span class="nobreak">&#160;</span>1, 2023, PRIIPS also began to apply to UCITS.&#160;WTICAV has been producing and publishing these KIDs for share classes of the Sub<span class="nobreak">-funds</span> of the ICAV since January<span class="nobreak">&#160;</span>1, 2023.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Regulation on Disclosures (EU/2019/2088) (&#8220;SFDR&#8221;) and the EU Taxonomy Regulation (2020/852) (&#8220;EU Taxonomy&#8221;). </span>SFDR requires WisdomTree Management Limited, as a UCITS management company, to disclose in a consistent and harmonized manner how environmental, social and governance, or ESG, factors are adopted in its decision<span class="nobreak">-making</span> process. SFDR also requires certain pre<span class="nobreak">-contractual</span> and periodic disclosure requirements for in scope WTICAV&#8217;s Sub<span class="nobreak">-funds</span>, such as UCITS financial products. Level 1 of SFDR requirements applied from March<span class="nobreak">&#160;</span>1, 2021 and Level 2 of the SFDR requirements applied from January<span class="nobreak">&#160;</span>1, 2023. The EU Taxonomy Regulation amends the disclosure requirements in place under SFDR.&#160;The EU Taxonomy disclosures for the economically sustainable objectives of climate change mitigation and climate change adaptation were applicable from January<span class="nobreak">&#160;</span>1, 2022, while the requirement for disclosures for the remaining objectives applied from January<span class="nobreak">&#160;</span>1, 2023. The WTICAV Prospectus, as well as supplements and product pages of the WTICAV Sub<span class="nobreak">-funds</span> in scope of SFDR and EU Taxonomy, have been updated to reflect the respective regulatory requirements.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Regulation (EU) 2019/1156 on the cross</span><span class="nobreak"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">-border</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;"> distribution framework (&#8220;CBDF&#8221;). </span>The CBDF amend the UCITS Directive to increase the harmonization of cross<span class="nobreak">-border</span> marketing between both (a)&#160;the UCITS regime and (b)&#160;different practices adopted by EU member states and came into effect on August<span class="nobreak">&#160;</span>2, 2021. The CBDF eliminated the need for WTICAV to have local paying agents within EU member states the Sub<span class="nobreak">-funds</span> passported into, but introduced rules around marketing communications, pre<span class="nobreak">-marketing</span> notifications and the discontinuation of marketing.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Regulatory technical standards on settlement discipline (&#8220;CSDR&#8221;). </span>CSDR introduced measures to prevent settlement failures, with settlement failures resulting in penalty charges applied by the Central Securities Depositaries to failing parties. Since most WTICAV sub<span class="nobreak">-funds</span> employ physical replication using equities and bonds, trades in these equities that take place within the EU come into scope of CSDR.&#160;This regulation came into force on February<span class="nobreak">&#160;</span>1, 2022.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Irish-Domiciled Issuer (Managed by WisdomTree Multi Asset Management Limited)</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">One of our subsidiaries, WisdomTree Multi Asset Management Limited, is a Jersey based management company providing investment and other management services to WisdomTree Multi Asset Issuer PLC, or WMAI, in respect of the ETPs issued by WMAI.&#160;WisdomTree Multi Asset Management Limited operates under the Schedule&#160;2 businesses (Schedule&#160;2 of the Proceeds of Crime (Jersey) Law 1999) must adhere to Jersey AML/CFT/CPF regulations, and is supervised for compliance by the JFSC.&#160;WMAI, a non<span class="nobreak">-consolidated</span> third party, is a public limited company incorporated in the laws of Ireland. It was established as a special purpose vehicle for the purposes of issuing collateralized exchange<span class="nobreak">-traded</span> securities, or ETP Securities, under the Collateralized ETP Securities Programme described in its Base Prospectus. WMAI is a &#8216;qualifying company&#8217; within the meaning of section 110 of the Taxes Consolidation Act&#160;1997 (as amended), of Ireland. WMAI is not authorized or regulated by the Central Bank by virtue of issuing ETPs.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">23</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Central Bank, as competent authority under the Prospectus Regulation, has approved the Base Prospectus as meeting the requirements imposed under Irish and EU law pursuant to the Prospectus Regulation. Such approval relates only to ETP Securities which are to be admitted to trading on a regulated market for the purpose of MiFID&#160;II and/or which are to be offered to the public in any EEA Member State. The Base Prospectus also has been approved by the FCA as competent authority pursuant to the U.K. version of Regulation (EU) No 2017/1129 of the European Parliament and the Council of 14 June&#160;2017 on the form and content of such prospectuses and repealing Directive 2003/71/EC which is part of U.K. law by virtue of the U.K.&#160;Prospectus Regulation.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">At the request of WMAI, the Central Bank has notified the approval of the Base Prospectus in accordance with the Prospectus Regulation to the Commissione Nazionale per le Societ&#225; e la Borsa (the Italian financial supervisory authority), the Bundesanstalt f&#252;r Finanzdienstleistungsaufsicht (the German Federal Financial Supervisory Authority), the Financial Market Authority of Austria, the Commission de Surveillance du Secteur Financier (the financial regulator in Luxembourg), the Finanstilsynet (the Norwegian financial supervisory authority), the Autorit&#233; des Services et March&#233;s Financiers (the Belgian Financial Services and Markets Authority), the Finanstilsynet (the Danish Financial Supervisory Authority), the Finanssivalvonta (the Finnish Financial Supervisory Authority), the Autorit&#233; des March&#233;s Financiers (the French Authority for the Financial Markets), the Autoriteit Financi&#235;le Markten (the Netherlands Authority for the Financial Markets), the Komisja Nadzoru Finansowego (the Polish Financial Supervisory Authority), the Comisi&#243;n Nacional del Mercado de Valores (the Securities Market Commission in Spain) and Finansinspektionen (the Swedish Financial Supervisory Authority) by providing them, <span class="Italic" style="font-style:italic;font-weight:normal;">inter alia</span>, with certificates of approval attesting that the Base Prospectus has been prepared in accordance with the Prospectus Regulation. WMAI may request the Central Bank to provide competent authorities in other EEA Member States with such certificates whether for the purposes of making a public offer in such Member States or for admission to trading of all or any ETP Securities on a regulated market therein or both.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">WMAI is primarily subject to the following legislation and regulatory requirements:</p>
		<p class="BL_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">The Companies Act. </span>WMAI is incorporated as a public limited liability company under the Companies Act. Therefore, WMAI is required to comply with various obligations under the Companies Act such as, but not limited to, convening general meetings, keeping proper books and records and filing financial statements.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">The Prospectus Regulation. </span>The Base Prospectus has been drafted, and any offer of ETP Securities in any EEA Member State that has implemented the Prospectus Regulation is made in compliance with the Prospectus Regulation and any relevant implementing measure in such Member States.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">EMIR.&#160;</span>WMAI hedges its payment obligations in respect of the ETP Securities by entering into swap transactions with swap providers, which are subject to EMIR.&#160;The Central Bank has been designated as the competent authority for EMIR and, to assess compliance with EMIR, requests that WMAI submits annually an EMIR Regulatory Return.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">BMR.&#160;</span>Since WMAI issues financial instruments that reference a benchmark, it also will be required to comply with applicable obligations within the timeframes set out under the BMR.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">MAD.&#160;</span>MAD has a direct effect in Ireland and strengthens the legal framework underpinning the function of detecting, sanctioning and deterring market abuse. Broadly, MAD applies to any financial instrument admitted to, or for which a request for admission has been made to, trading on a regulated market in at least one member state of the EU or in an EEA Member State. Obligations imposed on WMAI under MAD include the requirement to publish inside information in a public and timely manner, to draw up and maintain a list of insiders and to refrain from market manipulation.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;">CSDR.&#160;</span>As above,<span class="BoldItalic" style="font-style:italic;font-weight:bold;"> </span>CSDR introduced measures to prevent settlement failures, with settlement failures resulting in penalty charges applied by the Central Securities Depositaries to failing parties.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Intellectual Property</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We regard our name, WisdomTree, as material to our business and have registered the WisdomTree name and logo design as a service mark with the U.S.&#160;Patent and Trademark Office and in various foreign jurisdictions. We also have registered Modern Alpha as a service mark with the U.S.&#160;Patent and Trademark Office and in various foreign jurisdictions and have applied for trademark registration of the WisdomTree Prime name and logo design.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Many of our index<span class="nobreak">-based</span> equity ETFs are based on our own indexes and we do not license them from, nor do we pay licensing fees to, third parties for these indexes. We do, however, license third<span class="nobreak">-party</span> indexes for certain of our fixed income, currency and alternative ETFs.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">24</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On March&#160;6, 2012, the U.S.&#160;Patent and Trademark Office issued to us our patent on Financial Instrument Selection and Weighting System and Method, which is embodied in our dividend weighted equity indexes. We currently do not rely upon our patent for a competitive advantage.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Available Information</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Company Website and Public Filings</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">Our website is located at <span class="CharOverride-3" style="text-decoration:underline;">www.wisdomtree.com</span>, and our investor relations website is located at <span class="CharOverride-3" style="text-decoration:underline;">https://ir.wisdomtree.com</span>. We make available, free of charge through our investor relations website, our Annual&#160;Reports on Form&#160;10<span class="nobreak">-K</span>, Quarterly Reports on Form&#160;10<span class="nobreak">-Q</span> and Current Reports on Form&#160;8<span class="nobreak">-K</span>, and amendments to those reports, filed or furnished pursuant to Sections&#160;13(a)&#160;or Section&#160;15(d)&#160;of the Exchange&#160;Act as soon as reasonably practicable after they have been electronically filed with, or furnished to, the SEC.&#160;The SEC maintains a website that contains reports, proxy and information statements, and other information regarding the Company at <span class="CharOverride-3" style="text-decoration:underline;">www.sec.gov</span>.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">We webcast our earnings calls and certain events we participate in or host with members of the investment community on our investor relations website. Additionally, we provide notifications of news or announcements regarding our financial performance, SEC filings, investor events and press and earnings releases on our investor relations website. Further corporate governance information, including board committee charters and our code of business conduct and ethics, is also available on our investor relations website under the heading &#8220;Governance.&#8221; The contents of our websites are not incorporated by reference into this Annual Report on Form&#160;10<span class="nobreak">-K</span> or in any other report or document we file with the SEC, and any references to our websites are intended to be inactive textual references only.</p>
		<a id="T99203"></a><p class="Q-A-Style" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-left:52pt;margin-top:10pt;text-indent:-52pt;margin-top:10pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">ITEM&#160;1A.<span style="width: 10px;display: inline-block;">&#160;&#160;&#160;</span>RISK FACTORS</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Any investment in our common stock involves a high degree of risk. You should carefully consider the specific risk factors described below in addition to the other information contained in this Report before making a decision to invest in our common stock. If any of these risks actually occur, our business, operating results, financial condition and prospects could be harmed. This could cause the trading price of our common stock to decline and a loss of all or part of your investment. Certain statements below are forward</span><span class="nobreak"><span class="Italic" style="font-style:italic;font-weight:normal;">-looking</span></span><span class="Italic" style="font-style:italic;font-weight:normal;"> statements. See the section entitled &#8220;Cautionary Note&#160;Regarding Forward</span><span class="nobreak"><span class="Italic" style="font-style:italic;font-weight:normal;">-Looking</span></span><span class="Italic" style="font-style:italic;font-weight:normal;"> Statements.&#8221;</span></p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Market Risks</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;margin-top:3pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Declining prices of securities, gold and other precious metals and other commodities and changes in interest rates and general market conditions can adversely affect our business by reducing the market value of the assets we manage or causing WisdomTree ETP investors to sell their fund shares and trigger redemptions.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">We are subject to risks arising from declining prices of securities, gold and other precious metals and other commodities, which may result in a decrease in demand for investment products, a higher redemption rate and/or a decline in AUM.&#160;The financial markets are highly volatile and prices for financial assets may increase or decrease for many reasons, including general economic conditions, trade uncertainties, rising or falling interest rates, the strengthening or weakening of the U.S.&#160;dollar, events such as a pandemic or war, geopolitical conflicts, political events, acts of terrorism and other matters beyond our control. Substantially all our revenues are derived from advisory fees earned on our AUM, in both the international and U.S.&#160;markets. As a result, our business can be expected to generate lower revenues in declining market environments or general economic downturns. Such adverse conditions would likely cause the value of our AUM to decrease, which would result in lower advisory fees, or cause investors in the WisdomTree ETPs to sell their shares in favor of investments they perceive to offer greater opportunity or lower risk, thus triggering redemptions that would also result in decreased AUM and lower fees.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Fluctuations in the amount and mix of our AUM may negatively impact revenues and operating margins.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">The level of our revenues depends on the amount and mix of our AUM.&#160;Our revenues are derived primarily from advisory fees based on a percentage of the value of our AUM and vary with the nature of the ETPs, which have different fee levels. Fluctuations in the amount and mix of our AUM may be attributable in part to market conditions outside of our control that have had, and in the future could have, a negative impact on our revenues and operating margins.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Abnormally wide bid/ask spreads and market disruptions that halt or disrupt trading or create extreme volatility could undermine investor confidence in the ETP investment structure and limit investor acceptance of ETPs.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">ETPs trade on exchanges in market transactions that generally approximate the value of the referenced assets or underlying portfolio of securities held by the particular ETP.&#160;Trading involves risks including the potential lack of an active market for fund shares, abnormally wide bid/ask spreads (the difference between the prices at which shares of an ETP can be bought and sold) that can exist for a variety of reasons and losses from trading. These risks can be exacerbated during periods when there is low demand for an ETP, when the markets in the underlying investments are closed, when market conditions are extremely volatile or when trading is disrupted. This could result in limited growth or a reduction in the overall ETP market and result in our revenues not growing as rapidly as it has in the recent past or even in a reduction of revenues.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">25</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">

<p class="H2" style="break-before: auto; border-width: 0; font: normal bold 10pt Times New Roman PS Std, serif; margin: 0pt 0 0; padding: 0; margin-bottom: 0; margin-left: 0; margin-right: 0; margin-top: 0pt; orphans: 99; text-align: left; text-indent: 0; widows: 1; margin-top: 8pt; margin-top: 8pt; break-after: avoid"><span class="Bold" style="font-style:normal;font-weight:bold;">Concentration Risks</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;margin-top:3pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">We derive a substantial portion of our revenues from a limited number of products and, as a result, our operating results are particularly exposed to investor sentiment toward investing in the products&#8217; strategies and our ability to maintain the AUM of these products, as well as the performance of these products.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">At December&#160;31, 2023, 54% of our AUM was concentrated in ten of our WisdomTree ETPs with approximately 18% in three of our domestic equity ETFs, 17% in the WisdomTree Floating Rate Treasury Fund, or USFR, 10% in three of our precious metal products, 6% in two of our emerging markets ETFs, and 3% in one of our international developed market equity ETPs. As a result, our operating results are particularly exposed to the performance of these funds and our ability to maintain the AUM of these funds, as well as investor sentiment toward investing in the funds&#8217; strategies. If the AUM in these funds were to decline, either because of declining market values or net outflows from these funds, our revenues would be adversely affected.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Declining commodity prices, and gold prices in particular, including as a result of changes in demand for commodities and gold as an investment, could materially and adversely affect our business.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">At December&#160;31, 2023, approximately 12% of our AUM were in ETPs backed by gold and approximately 10% were in ETPs backed by other commodities. Precious metals such as gold are often viewed as &#8220;safe haven&#8221; assets as they tend to attract demand during periods of economic and geopolitical uncertainty. Accommodative monetary policies are also favorable as the opportunity cost of forgoing investment in interest<span class="nobreak">-bearing</span> assets is low. Market conditions that are not conducive to investment in precious metals, such as a rising interest rate environment, may lead to declining prices that are linked to our ETPs and thereby adversely affect our AUM and revenues. We cannot provide any assurance that our products backed by precious metals will benefit from favorable market conditions. In addition, changes in long<span class="nobreak">-term</span> demand cycles for commodities generally and cyclicality in demand for commodities as an investment asset, could reduce demand for certain of our products, limit our ability to successfully launch new products and also may lead to redemptions by existing investors.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">Also, a portion of the advisory fee revenues we receive on our ETPs backed by gold are paid in gold ounces. While we may readily sell the gold that we earn under these advisory contracts, we still may maintain a position. We currently do not enter into arrangements to hedge against fluctuations in the price of gold and any hedging we may undertake in the future may not be cost<span class="nobreak">-effective</span> or sufficient to hedge against this gold exposure.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">A significant portion of our AUM is held in products with exposure to U.S.&#160;and international developed markets, and we therefore have exposure to domestic and foreign market conditions and are subject to currency exchange rate risks.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">At December&#160;31, 2023, approximately 29% and 15% of our AUM was held in products with exposure to the U.S.&#160;and international developed markets, respectively. Therefore, the success of our business is closely tied to various conditions in these markets which may be affected by domestic and foreign political, social and economic uncertainties, monetary policies conducted in these regions and other factors.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">In addition, fluctuations in foreign currency exchange rates could reduce the revenues we earn from certain foreign invested products. This occurs because an increase in the value of the U.S.&#160;dollar relative to non<span class="nobreak">-U</span>.S.&#160;currencies may result in a decrease in the dollar value of the AUM in these products, which, in turn, would result in lower revenues. Furthermore, investors may perceive certain foreign invested products, as well as certain of our currency and fixed income products to be a less attractive investment opportunity when the value of the U.S.&#160;dollar rises relative to non<span class="nobreak">-U</span>.S.&#160;currencies, which could have the effect of reducing investments in these products, thus reducing revenues. Our products exposed to the U.S.&#160;market may benefit from a rising U.S.&#160;dollar, but we can provide no assurance that this will be the case. Also, a weakening U.S.&#160;dollar relative to the euro or yen may make less attractive our international hedged equity products, as unhedged alternatives would benefit from the appreciation of the foreign currency or currencies while our products would not, which could result in redemptions in our funds.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Withdrawals or broad changes in investments in our ETPs by investors with significant positions may negatively impact revenues and operating margins.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">We have had in the past, and may have in the future, investors who maintain significant positions in one or more of our ETPs. If such an investor were to broadly change or withdraw its investments in our ETPs because of a change to its investment strategy, market conditions or any other reason, it may significantly change the amount and mix of our AUM, which may negatively affect our revenues and operating margins.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">26</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Third-Party Provider Risks</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;margin-top:3pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">We primarily depend on Mellon Investments Corporation, Newton Investment Management North&#160;America, LLC and Voya Investment Management Co., LLC to provide portfolio management services, State&#160;Street Bank and Trust Company to provide us with critical administrative services to operate our business and our U.S.&#160;listed ETFs, and other third parties to provide many other critical services to operate our business and our U.S.&#160;listed ETFs. The failure of key vendors to adequately provide such services could materially affect our operating business and harm investors in our products.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">We depend on third<span class="nobreak">-party</span> vendors to provide us with many services that are critical to operating our business, including Mellon Investments Corporation, Newton Investment Management North America, LLC and Voya Investment Management Co., LLC as sub<span class="nobreak">-advisers</span> providing portfolio management services, and State Street Bank and Trust Company, or State Street, to provide custody services, fund accounting, administration, transfer agency and securities lending services. We also rely on third<span class="nobreak">-party</span> providers to license indexes to certain of our U.S.&#160;listed ETFs, perform index calculation services for our indexes and a third<span class="nobreak">-party</span> distributor for our products. The failure of any of these key vendors to provide us and our products with these services could lead to operational issues and result in financial loss to us and investors in our products.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">We depend on HSBC and JP Morgan to provide us with critical physical custody services for precious metals that back our ETCs. The failure of HSBC and JP Morgan to adequately safeguard the physical assets could materially adversely affect our business and harm investors in our products.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">We depend on HSBC and JP Morgan to provide us with critical physical custody services for precious metals that back our ETCs. Such products that are backed by physical metal are subject to risks associated with the custody of physical assets, including the risk that access to the metal held in the secure facilities managed by HSBC and JP&#160;Morgan could be restricted by a pandemic (such as the COVID<span class="nobreak">-19</span> pandemic), natural events (such as an earthquake) or human actions (such as a terrorist attack). In addition, there is a risk that the physical metal could be lost, stolen, damaged or restricted. The failure of HSBC and JP Morgan to successfully provide us with these services could result in financial loss to us and investors in our products and our recovery of any losses from a custodian, sub<span class="nobreak">-custodian</span> or insurer may be inadequate.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">We depend on Swissquote Bank Ltd and Coinbase Custody Trust LLC to provide us with critical custody services for digital currencies that back WisdomTree digital assets. The failure of Swissquote and/or Coinbase to adequately safeguard these digital assets could materially adversely affect our business and harm investors in this product.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">We depend on Swissquote Bank Ltd and Coinbase Custody Trust LLC to provide us with critical custody services for digital currencies that back WisdomTree digital assets. Products that are backed by digital currencies are subject to the risks associated with the custody of digital assets, including the risk that the digital currencies or the blockchain infrastructure could be impacted by hacks or other malicious actions. WisdomTree Issuer&#160;X Limited is reliant on the security procedures and infrastructure of the custodian to safeguard the underlying digital currency cryptographic keys. There is no guarantee that the arrangements of the custodian will fully protect from loss of assets. Damage to the infrastructure or loss of these assets may render the digital currency inaccessible and adversely impact the value of an investment in digital assets. The digital currencies may also be exposed to the Internet briefly before reaching the secure accounts of the custodian. There are additional risks involved with an investment backed by digital currencies such as changes to the protocol (such as forks) which could damage the reputation of digital assets or result in losses for investors. The risks associated with digital currencies and the failure of the custodian to safeguard the underlying assets could result in financial loss to us and investors in our products and our recovery of any losses from a custodian may be inadequate. The custodians perform additional services to crypto ETPs that may derive additional revenue by delegating a part of our assets to validate transactions on the relevant blockchain (&#8220;staking&#8221;). There are certain operational and technological risks associated with staking such as penalties due to bad validator behavior. Operational and technical errors in the context of staking could damage the reputation of digital assets or result in losses for investors.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">We depend on R&amp;H Fund Services (Jersey) Limited in respect of the products issued by our Jersey-domiciled issuers, or ManJer Issuers, of ETCs (except WisdomTree Issuer&#160;X Limited), JTC Trust Company Jersey in respect of products issued by WisdomTree Issuer&#160;X Limited, APEX IFS Limited in respect of the products issued by WMAI and State Street Fund Services (Ireland) Limited in respect of the WisdomTree UCITS ETFs to provide us with critical administrative services to those products. The failure of any of those providers to adequately provide such services could materially affect our operating business and harm investors in those products.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">We depend on R&amp;H Fund Services (Jersey) Limited in respect of the products issued by the ManJer Issuers (except WisdomTree Issuer&#160;X Limited), JTC Trust Company Jersey in respect of products issued by WisdomTree Issuer&#160;X Limited, APEX IFS Limited in respect of the products issued by WMAI and State Street Fund Services (Ireland) Limited in respect of the WisdomTree UCITS ETFs, to provide fund accounting, administration and, transfer agency services, as well as custody services in the case of the WisdomTree UCITS ETFs. The failure of any service provider to successfully provide these services could result in financial loss to the products, us and investors in those products. In addition, because each of the service providers provides a multitude of important services, changing these vendor relationships would be challenging. It might require us to devote a significant portion of management&#8217;s time to negotiate a similar relationship with other vendors or have these services provided by multiple vendors, which would require us to coordinate the transfer of these functions to another vendor or vendors.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">27</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">

<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">The WisdomTree UCITS ETFs primarily depend on either of Assenagon Asset Management S.A. or Irish Life Investment Managers Limited to provide portfolio management services and other third parties to provide many critical services to operate the WisdomTree UCITS ETFs. The failure of key vendors to adequately provide such services could materially affect our operating business and harm investors in the WisdomTree UCITS ETFs.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">The WisdomTree UCITS ETFs depend on third<span class="nobreak">-party</span> vendors to provide many services that are critical to operating our business, including Assenagon Asset Management S.A. and Irish Life Investment Managers Limited as investment managers that provide us with portfolio management services and third<span class="nobreak">-party</span> providers of index calculation services. The failure of any of these key vendors to provide the WisdomTree UCITS ETFs with these services could lead to operational issues and result in financial loss to us and investors in the WisdomTree UCITS ETFs.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Failure of third-party vendors to maintain sufficient internal controls could adversely affect us.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">If a&#160;third<span class="nobreak">-party</span> vendor&#160;fails to develop and maintain sufficient internal control processes or adequate data privacy&#160;controls&#160;and security systems, such failure could adversely affect us. For example, we have been notified of a deficiency in the internal controls of a third<span class="nobreak">-party</span> vendor of software we utilize in our accounting processes. We have identified sufficient mitigating controls to alleviate the deficiency and do not believe the third<span class="nobreak">-party</span>&#8217;s deficiency has a material impact on our operations or financial reporting. Any internal control failures that may arise in the future could adversely affect us if not sufficiently mitigated.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">The products issued by our European business are subject to counterparty risks.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">The products issued by our European business depend on the services of counterparties, custodians and other agents and are therefore subject to a variety of counterparty risks, which are detailed above. Products issued by WMAI, certain WisdomTree UCITS ETFs and certain products issued by the ManJer Issuers are backed by swap, derivative or similar arrangements, which are subject to risks associated with the creditworthiness of their counterparties, including the risk that a counterparty will not settle a transaction in accordance with its terms and conditions because of a dispute over the terms of the relevant arrangement (whether or not bona fide) or because of a credit, liquidity, regulatory, tax or operational problem. Any deterioration of the credit or downgrade in the credit rating of a counterparty, or the custodian holding the collateral, could cause the associated products to trade at a discount to the value of the underlying assets.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">The terms of contracts with counterparties are generally complex, often customized and often not subject to regulatory oversight. A voluntary or involuntary default by a counterparty may occur at any time without notice. In the event of any default by, or the insolvency of, any counterparty, the relevant products may be exposed to the under<span class="nobreak">-segregation</span> of assets, fraud or other factors that may result in the recovery of less than all of the property of our issuers that was held in custody or safekeeping in the case of physically backed products or the recovery of property that is insufficient in value to cover all amounts payable to holders of the applicable products upon their redemption.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">The impact of market stress or counterparty financial condition may not be accurately foreseen or evaluated and, as a result, we may not take sufficient action to reduce counterparty risks effectively. Any losses due to a counterparty&#8217;s failure to perform its contractual obligations will be borne by the relevant product issuer and there could be a substantial delay in recovering assets due from counterparties or it may not be possible to do so at all. Defaults by, or even rumors or questions about, the solvency of counterparties may increase operational risks or transaction costs, which may negatively affect the investment performance of the relevant products and have a material adverse effect on our business and operations.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Our risk management policies and procedures, and those of our third-party vendors upon which we rely, may not be fully effective in identifying or mitigating risk exposure, including employee misconduct. If our policies and procedures do not adequately protect us from exposure to these risks, we may incur losses that would adversely affect our financial condition, reputation and market share.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">We have developed risk management policies and procedures and we continue to refine them as we conduct our business. Many of our procedures involve oversight of third<span class="nobreak">-party</span> vendors that provide us with critical services such as portfolio management, custody, fund accounting and administration, and index calculation as further described in &#8220;Third<span class="nobreak">-Party</span> Provider Risks&#8221; above. However, our policies and procedures to identify, monitor and manage risks may not be fully effective in mitigating our risk exposure. Deficiencies in the risk management policies and procedures, internal systems and controls of our third<span class="nobreak">-party</span> vendors may adversely affect our systems and controls. Moreover, we are subject to the risks of errors and misconduct by our employees, including fraud and non<span class="nobreak">-compliance</span> with policies. These risks are difficult to detect in advance and deter, and could harm our business, results of operations or financial condition. Although we maintain insurance and use other traditional risk<span class="nobreak">-shifting</span> tools, such as third<span class="nobreak">-party</span> indemnification, to manage certain exposures, they are subject to terms such as deductibles, coinsurance, limits and policy exclusions, as well as risk of counterparty denial of coverage, default or insolvency. If our policies and procedures do not adequately protect us from exposure and our exposure is not adequately covered by insurance or other risk<span class="nobreak">-shifting</span> tools, we may incur losses that would adversely affect our financial condition and could cause a reduction in our revenues as investors in our products shift their investments to the products of our competitors.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">28</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">

<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Competition and Distribution Risks</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;margin-top:3pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">The asset management business is intensely competitive, and we may experience pressures on our pricing and market share, which could reduce revenues and profit margins.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">Our business operates in a highly competitive industry. We compete directly with other ETP sponsors and mutual fund companies and indirectly against other investment management firms, insurance companies, banks, brokerage firms and other financial institutions that offer products that have similar features and investment objectives to those offered by us. This includes fundamentally weighted or factor<span class="nobreak">-based</span> indexes or currency hedged products with fees that are generally equivalent to, and in some instances lower than, our products. We compete based on a number of factors, including name recognition, service, investment performance, product features, breadth of product choices and fees.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">In addition, the adoption of Rule&#160;6c<span class="nobreak">-11</span>, or the ETF Rule, removed the need to file for exemptive relief in order to issue ETFs, thereby creating fewer barriers to entry for competitors. We continue to expect that additional companies, both new and traditional asset managers, will enter and expand in the ETP space.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">Also, non<span class="nobreak">-transparent</span> active ETFs have been launched. These products are not required to disclose their holdings daily, as most ETFs currently are required to do. Such products may allow traditional actively managed mutual fund sponsors to compete more effectively against ETFs.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">Several ETP sponsors with whom we directly compete continue to migrate toward offering low and no fee products targeting gains in market share. Price competition exists in not only commoditized product categories such as traditional, market capitalization weighted index exposures and commodities, but also in non<span class="nobreak">-market</span> capitalization weighted or factor<span class="nobreak">-based</span> exposures and commodities. Fee reductions by certain of our competitors has been a trend over the last few&#160;years and continues to persist and many of our competitors are well positioned to benefit from this trend. Certain larger competitors are able to offer products at lower price points or otherwise as loss leaders due to other revenue sources available within such competitor that are unavailable to us. Newer players have also been entering the ETP industry and frequently seek to differentiate by offering ETPs at a lower price point. Funds are being offered with fees of 20 basis points or less, which have attracted approximately 80% of the net flows globally during the last three&#160;years. Fee reduction by certain of our competitors has been a trend over the last few&#160;years and continues to persist and many of our competitors are well positioned to benefit from this trend.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">Our competition may have greater market share, offer a broader range of products and platforms and have greater financial resources than we do. Some financial institutions operate in a more favorable regulatory environment and/or have proprietary products, sources of revenue and distribution channels, which may provide them and their investment products with certain competitive advantages, including in pricing ETPs as loss leaders. Further consolidation within the industry may also put us at a competitive disadvantage.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">We believe that due to the continuing evolution of the competitive landscape described above, we have experienced, and may in the future experience, pressures on our pricing and market share, which could reduce our revenues and profit margins.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">We rely on third-party distribution channels to sell our products, and increased competition, a failure to maintain business relationships and other factors could adversely impact our business.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">We rely on various third<span class="nobreak">-party</span> distribution channels, including registered investment advisers, wirehouse and institutional channels to sell our products. Increasing competition, a failure to maintain business relationships and other factors could impair our distribution capabilities and increase the cost of conducting business. In addition, several of the largest custodial platforms and online brokerage firms eliminated trading commissions for ETFs. Any inability to access and successfully sell our products through our distribution channels could have a negative effect on our AUM levels and adversely impact our business.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">29</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">

		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Performance and Investment Risks</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;margin-top:3pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Many of our ETPs have a limited track record and poor investment performance could cause our revenues to decline.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">Many of our ETPs have a limited track record upon which an evaluation of their investment performance can be made. Certain investors limit their investments to ETPs with track records of ten&#160;years or more. Furthermore, as part of our strategy, we continuously evaluate our product offerings to ensure that all our funds are useful, compelling and differentiated investment offerings, to align our overall product line more competitively in the current ETP landscape and to reallocate our resources to areas of greater client interest. As a result, we may further adjust our product offerings, which may result in the closing of some of our ETPs, changing their investment objective or offering of new funds. The investment performance of our products is important to our success. While strong investment performance could stimulate sales of our ETPs, poor investment performance, on an absolute basis or as compared to third<span class="nobreak">-party</span> benchmarks or competitive products, could lead to a decrease in sales or stimulate redemptions, thereby lowering the AUM and reducing our revenues. Our fundamentally<span class="nobreak">-weighted</span> equity products are designed to provide the potential for better risk<span class="nobreak">-adjusted</span> investment returns over full market cycles and are best suited for investors with a longer<span class="nobreak">-term</span> investment horizon. However, the investment approach of our equity products may not perform well during certain shorter periods of time during different points in the economic cycle.</p>

<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Operational Risks</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;margin-top:3pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Our European business subjects us to increased operational, regulatory, financial and other risks.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">We face increased operational, regulatory, financial, compliance, reputational and foreign exchange rate risks as a result of conducting our business internationally. The failure of our compliance and internal control systems to properly mitigate such additional risks, or of our infrastructure to support our European business, could result in operational failures and regulatory fines or sanctions. If our European products and operations experience any negative consequences or are perceived negatively in non<span class="nobreak">-U</span>.S.&#160;markets, it may also harm our reputation in other markets, including the U.S.&#160;market.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">We have and may continue to pursue acquisitions or other strategic transactions. Any strategic transactions that we are a party to will result in increased demands on our management and other resources, may be significant in size relative to our assets and operations, result in significant changes in our business and materially and adversely affect our stock price. If we were unable to manage our strategic initiatives, it could have a material adverse effect on our business.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">We have and may continue to pursue acquisitions or strategic transactions. These initiatives have placed increased demands on our management and other resources and may continue to do so in the future. We may not be able to manage our operations effectively or achieve our desired objectives on a timely or profitable basis. To do so may require, among other things:</p>
		<p class="BL_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>continuing to retain, motivate and manage our existing employees and/or attract and integrate new employees;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>developing, implementing and improving our operational, financial, accounting, reporting and other internal systems and controls on a timely basis; and</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>maintaining and developing our various support functions including human resources, information technology, legal and corporate communications.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">If we are unable to manage these initiatives effectively, there could be a material adverse effect on our ability to maintain or increase revenues and profitability.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">Managing strategic initiatives may require continued investment in personnel, information technology infrastructure and marketing activities, as well as further development and implementation of financial, operational and compliance systems and controls. We may not be successful in implementing all of the processes that are necessary. Unless such initiatives result in an increase in our revenues that is at least proportionate to the increase in the costs associated with implementing them, our future profitability will be adversely affected.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">In addition, any future strategic transactions may result in the issuance of a significant amount of our common stock or other securities that could be dilutive to our stockholders, require substantial borrowings, result in changes in our board composition and/or management team, constitute a change of control of our Company, lead to significant changes in our product offering, business operations and earning and risk profiles, and/or result in a decline in the price of our common stock.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">Our ability to complete future strategic transactions depends upon a number of factors that are not entirely within our control, including our ability to identify suitable merger or acquisition candidates, negotiate acceptable terms, conclude satisfactory agreements and secure financing. Our failure to complete strategic transactions or to integrate and manage acquired or combined businesses successfully could materially and adversely affect our business, results of operations and financial conditions.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">30</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">We instruct trades and perform other operational processes in respect of crypto basket ETPs that we have launched in Europe. Operational failures could materially affect our business and harm investors in these products.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">We have launched products in Europe that are indexed to baskets of cryptocurrencies or that may allow for staking. We have outsourced the administrator, transfer agent and custodial functions for these products. While we typically outsource portfolio management services to third<span class="nobreak">-party</span> sub<span class="nobreak">-advisers</span> for our products, in this case, we instead act as determination agent and place buy and sell orders directly with a broker to rebalance these crypto basket ETPs in line with the indices. These rebalances typically occur quarterly. Expanding trading volumes may increase the risk of trading errors. The failure of any of our vendors to provide us and our products with the outsourced services and our failure to correctly place trade orders could lead to operational issues and result in financial loss to us and/or investors in our products. For products through which we derive additional revenue by staking, we operationally delegate the relevant assets to validators in our role as determination agent. Operational errors in the process could materially affect our business and harm investors in these products. In addition, staking features, such as lock<span class="nobreak">-up</span> periods, staking reward payout periods and reward amounts, are not necessarily fixed over time and can cause liquidity risk or delay the standard settlement period. This may cause redemptions to be delayed and may result in a financial loss to investors.</p>

<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Catastrophic and unpredictable events could have a material adverse effect on our business.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">A terrorist attack, war, power failure, cyber<span class="nobreak">-attack</span>, natural disaster, pandemic event or other catastrophic or unpredictable event could adversely affect our revenues, expenses and operating results by: interrupting our normal business operations; inflicting employee casualties, including loss of our key employees; requiring substantial expenditures and expenses to repair, replace and restore normal business operations; and reducing investor confidence. We have a disaster recovery plan to address certain contingencies, but this plan may not be sufficient in responding or ameliorating the effects of all disaster scenarios. Similarly, these types of events could also affect the ability of the third<span class="nobreak">-party</span> vendors that we rely upon to conduct our business, including parties that provide us with sub<span class="nobreak">-advisory</span> portfolio management services, custodial, fund accounting and administration services or index calculation services, to continue to provide these necessary services to us, even though they may also have disaster recovery plans to address these contingencies. In addition, a failure of the stock exchanges on which our products trade to function properly could cause a material disruption to our business. If we or our third<span class="nobreak">-party</span> vendors are unable to respond adequately or in a timely manner, these failures may result in a loss of revenues and/or increased expenses, either of which would have a material adverse effect on our operating results.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Technology Risks</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;margin-top:3pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Any significant limitation or failure of our technology systems, or of our third-party vendors&#8217; technology systems, or any security breach of our information and cyber security infrastructure, software applications, technology or other systems that are critical to our operations could interrupt or damage our operations and result in material financial loss, regulatory violations, reputational harm or legal liability.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">We are dependent upon the effectiveness of our own, and our vendors&#8217;, information security policies, procedures and capabilities to protect the technology systems used to operate our business, to protect the data that reside on or are transmitted through them and to maintain adequate internal controls. Although we and our third<span class="nobreak">-party</span> vendors take protective measures to secure information, our and our vendors&#8217; technology systems have experienced cybersecurity threats and may still be vulnerable to unauthorized access, computer viruses or other events that could result in inaccuracies in our information or system disruptions or failures, which could materially interrupt or damage our operations. These risks have increased with the launch of the WisdomTree Prime mobile application and may continue to increase in the future as the mobile application&#8217;s availability expands. In addition, technology is subject to rapid change and we cannot guarantee that our competitors may not implement more advanced technology platforms for their products, which could affect our business. Any inaccuracies, delays, system failures or breaches, or advancements in technology, and the cost necessary to address them, could subject us to client dissatisfaction and losses or result in material financial loss, regulatory violations, reputational harm or legal liability, which, in turn, could cause a decline in our earnings or stock price.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Human Capital Risks</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;margin-top:3pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Our ability to operate effectively could be impaired if we fail to retain or recruit key personnel.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">The success of our business is highly dependent on our ability to attract, retain and motivate highly skilled, and sometimes highly specialized, employees, including in particular, operations, product development, research, technology, sales and marketing personnel. Our U.S.&#160;employees generally may voluntarily terminate their employment at any time. The market for these individuals is extremely competitive and is likely to become more so as additional investment management firms enter the ETF industry and as the digital assets market continues to develop. Our compensation methods may not enable us to recruit and retain required personnel. For example, price volatility in our common stock may impact our ability to effectively use equity grants as an employee compensation incentive. Also, we may need to increase compensation levels, which would decrease our net income or increase our losses. If we are unable to retain and attract key personnel, it could have an adverse effect on our business, our results of operations and financial condition.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">31</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Expense and Cash Management Risks</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;margin-top:3pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Our expenses are subject to fluctuations that could materially affect our operating results.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">Our results of operations are impacted by the magnitude of our expenses and may fluctuate as a result of inflation, as well as discretionary spending, including additional headcount, accruals for incentive compensation, marketing, advertising, sales and other expenses we incur in connection with our operations. We also have launched our digital assets business and expenses ultimately incurred in the near and long<span class="nobreak">-term</span> may be higher than anticipated. Accordingly, fluctuations in our expenses could materially affect our operating results and may vary from quarter to quarter.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Legal and Regulatory Risks</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;margin-top:3pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Compliance with extensive, complex and changing regulation imposes significant financial and strategic costs on our business, and non-compliance could result in fines and penalties.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">We are subject to extensive regulation of our business and operations. One of our U.S.&#160;subsidiaries, WT Asset Management, is a registered investment adviser and is subject to oversight by the SEC pursuant to its regulatory authority under the Investment Advisers Act. We also must comply with certain requirements under the Investment Company Act, with respect to the WisdomTree U.S.&#160;listed ETFs for which WT Asset Management acts as investment adviser. WT Asset Management is also a member of the NFA and registered as a commodity pool operator for certain of our ETFs. As a commodity pool operator, we are subject to oversight by the NFA and the CFTC pursuant to regulatory authority under the Commodity Exchange&#160;Act. In addition, the content and use of our marketing and sales materials and of our sales force in the U.S.&#160;regarding our U.S.&#160;listed ETFs is subject to the regulatory authority of FINRA.&#160;The SEC also has recently adopted rule amendments that are designed to modernize sales and marketing materials and, as a result, impact marketing materials. We are also subject to foreign laws and regulatory authorities with respect to operational aspects of our products that invest in securities of issuers in foreign countries, in the marketing, offer and/or sales of our products in foreign jurisdictions and in our offering of investment products domiciled outside of the U.S., such as our ETPs issued by the ManJer Issuers, UCITS ETFs and ETPs issued by WMAI.&#160;Each of the regulatory bodies with jurisdiction over us has regulatory powers dealing with many aspects of our business, including the authority to grant, and, in specific circumstances to cancel, permissions to carry on particular businesses. Our or our ETPs&#8217; failure to comply with applicable laws or regulations could result in fines, censure, suspensions of personnel or other sanctions, including revocation of our registration as an investment adviser. Even if a sanction imposed against us, our personnel or our ETPs is small in monetary amount, the adverse publicity arising from the imposition of sanctions against us, our personnel or our ETPs by regulators could harm our reputation and thus result in redemptions from our products and impede our ability to retain and attract investors in WisdomTree ETPs, all of which may reduce our revenues.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">We face the risk of significant intervention by regulatory authorities, including extended investigation activity, adoption of costly or restrictive new regulations and judicial or administrative proceedings that may result in substantial penalties. Among other things, we could be fined or be prohibited from engaging in some of our business activities. The requirements imposed by our regulators are designed to ensure the integrity of the financial markets and to protect investors in WisdomTree ETPs and our advisory clients and are not designed to protect our stockholders. Consequently, these regulations often serve to limit our activities, including through WisdomTree ETP investor protection and market conduct requirements.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">The regulatory environment in which we operate also is subject to modifications and further regulation. Concerns have been raised at various times about ETFs&#8217; possible contribution to market volatility as well as the disclosure requirements applicable to certain types of more complex ETFs. In addition, the SEC recently approved a broad set of rules regarding data reporting and fund liquidity, fund valuation and funds&#8217; use of derivatives, which are imposing additional expense and require additional administrative services and requirements, among other matters, in seeking to comply with these rules. New laws or regulations, or changes in the enforcement of existing laws or regulations, applicable to us or investors in our products also may adversely affect our business, and our ability to function in this environment will depend on our ability to constantly monitor and react to these changes. Compliance with new laws and regulations may result in increased compliance costs and expenses.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">Specific regulatory changes also may have a direct impact on our revenues. In addition to regulatory scrutiny and potential fines and sanctions, regulators continue to examine different aspects of the asset management industry. New regulation, revised regulatory or judicial interpretations, revised viewpoints, outcomes of lawsuits against other fund complexes or growth in our ETP assets and/or profitability related to the annual approval process for investment advisory agreements may result in the reduction of fees under these agreements, which would mean a reduction in our revenues or otherwise may lead to an increase in costs or expenses.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">Our operations outside the U.S.&#160;are subject to the laws and regulations of various non<span class="nobreak">-U</span>.S.&#160;jurisdictions and non<span class="nobreak">-U</span>.S.&#160;regulatory agencies and bodies. As we have expanded our international presence, a number of our subsidiaries and international operations have become subject to regulatory systems in various jurisdictions, comparable to those covering our operations in the U.S.&#160;Regulators in these non<span class="nobreak">-U</span>.S.&#160;jurisdictions may have broad authority with respect to the regulation of financial services including, among other things, the authority to grant or cancel required licenses or registrations.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">32</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">

<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">From time to time, we may be involved in legal proceedings that could require significant management time and attention, possibly resulting in significant expense or in an unfavorable outcome, which could have a material adverse effect on our business, financial condition, results of operations and cash flows.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">From time to time, we may be subject to litigation. In any litigation in which we are involved, we may be forced to incur costs and expenses to defend ourselves or to pay a settlement or judgment or comply with any injunctions in connection therewith if there is an unfavorable outcome. The expense of defending litigation may be significant. The amount of time to resolve lawsuits is unpredictable and defending ourselves may divert management&#8217;s attention from the&#160;day<span class="nobreak">-to-day</span> operations of our business, which could adversely affect our business, results of operations, financial condition and cash flows. In addition, an unfavorable outcome in any such litigation, including actual and potential claims by investors in our WisdomTree WTI Crude Oil 3x Daily Leveraged ETP totaling approximately &#8364;23.6&#160;million ($26.1&#160;million), could have a material adverse effect on our business, results of operations, financial condition and cash flows. See Note&#160;14 to our Consolidated Financial Statements for additional information.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">We may from time to time be subject to claims of infringement of third-party intellectual property rights, which could harm our business.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">Third parties may assert against us alleged patent, copyright, trademark or other intellectual property rights to intellectual property that is important to our business. Any claims that our products or processes infringe the intellectual property rights of others, regardless of the merit or resolution of such claims, could cause us to incur significant costs in responding to, defending and resolving such claims, and may divert the efforts and attention of our management from our business. As a result of such intellectual property infringement claims, we could be required or otherwise decide that it is appropriate to:</p>
		<p class="BL_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>pay third<span class="nobreak">-party</span> infringement claims;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>discontinue selling the particular funds subject to infringement claims;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>discontinue using the processes subject to infringement claims;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>develop other intellectual property or products not subject to infringement claims, which could be time<span class="nobreak">-consuming</span> and costly or may not be possible; or</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>license the intellectual property from the third party claiming infringement, which license may not be available on commercially reasonable terms.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">The occurrence of any of the foregoing could result in unexpected expenses, reduce our revenues and adversely affect our business and financial results.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">We have been issued trademark and other intellectual property rights, but may not be able to enforce or protect such intellectual property rights, which may harm our business.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">Although we have trademarks, including the marks WisdomTree<span class="Superscript" style="vertical-align:super;font-size:58%;">&#174;</span>, WisdomTree Prime&#8482; and Modern Alpha<span class="Superscript" style="vertical-align:super;font-size:58%;">&#174;</span>, and other intellectual property rights that are registered in the U.S.&#160;and certain other countries, including a patent relating to our index methodology and the operation of our ETFs, our ability to enforce such intellectual property rights is subject to general litigation risks. If we cannot successfully enforce our intellectual property rights, we may lose the value of our brand and business reputation. If we seek to enforce our rights, we could be subject to litigation, including challenges to our registered intellectual property right and claims that our intellectual property right is invalid or is otherwise not enforceable in jurisdictions where our intellectual property right is not registered. Furthermore, our assertion of intellectual property rights could result in the other party seeking to assert alleged intellectual property rights of its own or assert other claims against us, which could harm our business. If we are not ultimately successful in defending ourselves against these claims in litigation, we may be subject to the risks described in the immediately preceding risk factor entitled &#8220;We may from time to time be subject to claims of infringement of third<span class="nobreak">-party</span> intellectual property rights, which could harm our business.&#8221;</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Digital Assets Risks</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">As we endeavor to expand our digital assets product offerings and services beyond our existing ETP business, we believe the risks associated with our digital assets business include, but are not limited to, the following risks:</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">33</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">

		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Competition risks</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">Competition in the digital assets industry on a global basis is increasing, ranging from large, established financial incumbents to smaller, early<span class="nobreak">-stage</span> financial technology providers and companies. There are jurisdictions with more stringent and robust regulatory and compliance requirements than others which could impact the ability of a company to compete in the digital assets industry. Our ability to successfully compete will depend largely on offering innovative products through digital asset exposures (and more broadly in blockchain<span class="nobreak">-enabled</span> finance, including savings and payments), having strong internal controls and risk management infrastructure to enable customer trust, embracing regulation, developing strategic partnerships with participants in the digital assets ecosystem and broader financial services ecosystem, promoting thought leadership and consumer education or awareness, building upon our brand and attracting and retaining talented employees. Failure to do so could negatively impact the success of our digital assets business.</p>

<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;">New product risks</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">We have and may continue to spend substantial time and resources developing our digital assets product offerings and services. If these products and initiatives are not successful, or their implementation or launches are delayed, including in connection with our inability to obtain new product regulatory approvals, we may not be able to offset their costs, which could have an adverse effect on our business, reputation, financial condition and operating results. </p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">Our digital assets business subjects us to risks similar to those associated with any new product offerings, including, but not limited to, our ability to accurately anticipate market demand and adoption, technical issues with the operation of the products, and legal and regulatory risks as discussed herein. Substantial risks and uncertainties are associated with the introduction of new products and services, including rapid technological change in the industry, significant and ongoing investments required to bring new products and services to market in a timely manner at competitive prices, protection of intellectual property and other confidential information, the competition for employees with the necessary expertise and experience, and producing sales and other materials that fully and accurately describe the product or service and its underlying risks and that are compliant with applicable regulations. New products or services may fail to operate or perform as expected and may not produce anticipated efficiencies, savings or benefits. Our failure to manage these risks and uncertainties also exposes us to enhanced risk of operational lapses and third<span class="nobreak">-party</span> claims, which may result in the recognition of financial statement liabilities.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">Failure to successfully manage these risks in the development and implementation of our digital assets business could have a material adverse effect on our business, reputation, financial condition and operating results.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Outsourced service provider risks</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">We rely on third<span class="nobreak">-party</span> service providers in connection with different facets of our digital assets business, including but not limited to custodial arrangements, blockchain and wallet infrastructure, banking relationships, cloud computing, payment platforms and processors, data infrastructure, customer support, compliance support and product development, including mobile application development, all of which are critical to the success of our digital assets business. In addition, we have partnered with a financial institution to provide co<span class="nobreak">-branded</span> debit cards to retail customers. The loss of, or interruption of service from, a critical third<span class="nobreak">-party</span> service provider could adversely impact our digital assets business, operating results and financial condition. We may incur significant costs to resolve any such disruptions in service. In addition, such third<span class="nobreak">-party</span> service providers may be subject to financial, legal, regulatory and labor issues, data security and cybersecurity incidents, denial<span class="nobreak">-of-service</span> attacks, sabotage, privacy breaches or violations, fraud and other misconduct, which could directly or indirectly have an impact on our digital assets products and services. If any third<span class="nobreak">-party</span> service provider fails to adequately or appropriately render services or fails to meet its contractual requirements (including compliance with applicable laws and regulations), we could be subject to regulatory enforcement actions and claims from third parties (including our customers), and suffer economic and reputational harm that could have an adverse effect on our digital assets business, operating results and financial condition.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Cybersecurity risks</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">The use of various technologies is vital to our digital assets business and will become more prevalent, which will make us more susceptible to operational and data security risks resulting from a breach in cybersecurity, including cyberattacks. A breach in cybersecurity, intentional or unintentional, may have an adverse impact on our digital assets business in many ways, including but not limited to, the loss or destruction of proprietary information, theft or corruption of data, denial<span class="nobreak">-of-service</span> attacks on websites or network resources, and the unauthorized release or misuse of confidential information.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Regulatory risks</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">The digital assets industry is rapidly evolving at an unprecedented rate. There is a high degree of regulatory uncertainty associated with the digital assets industry, which means that the products and services our digital assets business provides or may provide in the future could subject us to enhanced regulatory scrutiny or otherwise materially impact the quality or nature of such products or services. The effect of any future legal or regulatory change or interpretation both domestically and internationally is unknown and such change could be substantial and adverse to our digital assets business.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">34</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">

<p style="border-width: 0; font: normal 10pt Times New Roman PS Std, serif; margin: 6pt 0 0; padding: 0; margin-bottom: 0; margin-left: 0; margin-right: 0; margin-top: 6pt; orphans: 2; page-break-after: auto; page-break-before: auto; text-align: left; text-indent: 24pt; widows: 3; margin-top: 3pt; margin-top: 3pt">In addition, we are actively engaged with a variety of U.S.&#160;federal and state regulators (e.g., the SEC, FINRA, NYDFS and other state regulators) to secure, as necessary, or maintain the appropriate regulatory, registration and/or licensing approvals for various business initiatives and operations, including but not limited to: a New&#160;York state<span class="nobreak">-chartered</span> limited purpose trust company; money services and money transmitter business; limited purpose broker<span class="nobreak">-dealer</span>; transfer agent; investment adviser; and investment funds. For example, we are licensed as a money transmitter or the equivalent in many U.S.&#160;states and the District of Columbia, but we may be unable to obtain such licenses in all U.S.&#160;states (including in the state of New&#160;York) or may experience significant delays, and this could have an adverse effect on our digital assets business. As we seek to expand globally, similar approvals and/or reliance on exemptions will be required in applicable foreign markets, which also may involve approvals specific to a digital assets or related business. As we secure the appropriate regulatory, registration and/or licensing approvals, or otherwise rely on, seek or confirm exemptions therefrom, in connection with our digital assets business, we are and will be subject to a myriad of complex and evolving global policy frameworks and associated regulatory requirements that we need to comply with, or otherwise be exempt from, to ensure our digital assets products and services are successfully brought to different markets in a compliant manner. Failure to secure and/or comply with any such approvals and exemptions could result in, among other things, revocation of required licenses or registrations, loss of approved status, private litigation, administrative enforcement actions, sanctions, civil and criminal liability, and constraints on our ability to continue to operate our digital assets business, and have an adverse effect on our digital assets business.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Blockchain infrastructure risks</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">The consensus or governance mechanisms of blockchain networks are subject to change and malfunctions and may not receive adequate adoption from users and miners, which could negatively impact the blockchain network&#8217;s ability to scale and improve programmability, transparency, auditability and security. In addition, blockchain networks face significant challenges in connection with the volume, speed, security and cost of transactions, and their efforts to increase or enhance such characteristics of the blockchain network may not be successful or adversely affect other characteristics of the blockchain network. If the digital asset awards for verifying and confirming transactions on a blockchain network are not sufficiently high to incentivize miners, miners may cease to verify and confirm such transactions or otherwise demand higher fees, which could negatively affect the value of a digital asset.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Blockchain technology risks</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">Blockchain technology is a relatively new and untested technology which operates as a distributed ledger. Blockchain systems could be vulnerable to fraud, particularly if a significant minority of participants colluded to defraud the rest. Access to a given blockchain requires an individualized key, which if compromised, could result in loss due to theft, destruction or inaccessibility. There is little regulation of blockchain technology other than the intrinsic public nature of the blockchain system. Any future regulatory developments could affect the viability and expansion of our use of blockchain technology. There are currently a number of competing blockchain platforms with competing intellectual property claims. The uncertainty inherent in these competing technologies could cause companies to use alternatives to blockchain. In addition, blockchain networks may undergo technological developments, such as the Ethereum blockchain&#8217;s change in September&#160;2022 from proof<span class="nobreak">-of-work</span> mining to a blockchain based on proof<span class="nobreak">-of-stake</span> validation. Segments of the mining community were against this change, which was complex and involved a merger of the then existing Ethereum blockchain with the new Ethereum blockchain, which could potentially lead to greater centralization. Further, certain miners and other users resisted adoption of the new Ethereum blockchain and it is possible that the two Ethereum blockchains (among potentially others) will endure and compete going forward, which may also slow or impede transactions. The risks associated with blockchain technology may not emerge until the technology is widely used, which could adversely impact our digital assets business.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Fork risks</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">Blockchain software is generally open<span class="nobreak">-source</span>. Any user can download the software, modify it and then propose that the blockchain network adopt the modification. When a modification is introduced and a substantial majority of users consent to the modification, the change is implemented and the blockchain network remains uninterrupted. However, if less than a substantial majority of users consent to the proposed modification, and the blockchain consensus mechanism, such as that used by Ethereum, allows for the modification to nonetheless be implemented by some users and the modification is not compatible with the software prior to its modification, the consequence would be what is known as a &#8220;fork&#8221; (i.e., &#8220;split&#8221;) of the blockchain network (and the blockchain), with one version running the pre<span class="nobreak">-modified</span> software and the other running the modified software. The effect of such a fork would be the existence of two (or more) versions of the blockchain network running in parallel, but with each version&#8217;s native asset lacking interchangeability. Additionally, a fork could be introduced by an unintentional, unanticipated software flaw in the multiple versions of otherwise compatible software users run. If a fork occurs, the original blockchain and the forked blockchain could potentially compete with each other for users and other participants, leading to a loss of these for the original blockchain. A fork could adversely affect our digital assets business.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">35</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">

<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Anti-Money Laundering (&#8220;AML&#8221;) risks</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">The decentralized infrastructure and anonymous or pseudonymous nature of digital assets could facilitate and create the opportunity for money laundering and terrorist financing activities, thereby circumventing certain anti<span class="nobreak">-money</span> laundering and counter terrorist financing laws and regulations designed to prevent financial crimes which could negatively impact our digital assets business. In addition, certain aspects of our digital assets business will have significantly greater anti<span class="nobreak">-money</span> laundering risk, including risk of fines or sanctions, than our historical ETP business due to the greater number of potential customers, which may also include customers considered to be higher risk and/or customer types considered to be higher risk, for which anti<span class="nobreak">-money</span> laundering and related obligations will apply.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Data privacy risks</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">In connection with the products or services offered by our digital assets business, we may collect, store, process, or transmit nonpublic information (including personally identifiable information and sensitive personally identifiable information) of a customer or consumer to a significantly greater extent than in our historical ETP business. Any change or failure to comply with data privacy laws or regulations related to the collection, processing, use and storage of such nonpublic information could materially affect our digital assets business and overall financial health.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;margin-top:3pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Other risks</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">The risk of loss in purchasing, selling, trading, using or holding digital assets can be substantial. The price and liquidity of digital assets may be subject to high degrees of volatility resulting in large deviations or fluctuations from normalized levels. There is also heightened custodial risk due to the unique safekeeping attributes associated with public and private keys of digital assets.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Other Company Risks</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;margin-top:3pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Responding to actions of activist stockholders against us has been costly and the possibility that activist stockholders may wage proxy contests or seek representation on our Board of Directors in the future may be disruptive and cause uncertainty about the strategic direction of our business.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">During fiscal&#160;years 2022 and 2023, we were the target of stockholder activism whereby a certain investor, acting together with other investors during 2022 (the &#8220;Investor Group&#8221;) and acting alone during 2023 (the &#8220;Investor&#8221;), notified us of their intention to nominate director candidates to stand for election to the Board of Directors at the 2022 and 2023 Annual Meetings of Stockholders. On May&#160;25, 2022, we entered into a cooperation agreement (the &#8220;Cooperation Agreement&#8221;) with the Investor Group whereby we agreed, among other things, to increase the size of our Board of Directors by two to a total of nine directors and appoint two nominees proposed by the Investor Group. At the 2023 Annual Meeting of Stockholders, our stockholders elected five of our six nominees to the Board of Directors and one of three nominees proposed by the Investor. Responding to actions by the Investor and the Investor Group has been costly and actions by activist stockholders to seek representation on our Board of Directors in the future may similarly impact us.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">Activist stockholders, such as the Investor, may from time to time attempt to effect changes in our strategic direction, and in furtherance thereof, may seek changes in how our Company is governed. Our Board of Directors and management strive to maintain constructive, ongoing communications with our stockholders, including the Investor, and welcome their views and opinions with the goal of enhancing value for all stockholders. However, an activist campaign that seeks to replace members of our Board of Directors or changes in our strategic direction could have an adverse effect on us because:</p>
		<p class="BL_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:2pt;margin-top:1.5pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>responding to actions by activist stockholders is costly and may be disruptive, time<span class="nobreak">-consuming</span> and divert the attention of our Board of Directors and senior management from the pursuit of business strategies, which could adversely affect our results of operations and financial condition;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:2pt;margin-top:1.5pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>perceived uncertainties about our future direction as a result of changes to the composition of our Board of Directors or changes to our stockholder base may lead to the perception of a change in the direction of the business, instability or lack of continuity which may be exploited by our competitors, may result in the loss of potential business opportunities and may make it more difficult to attract and retain qualified personnel and business partners;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:2pt;margin-top:1.5pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>these types of actions could cause significant fluctuations in our stock price based on temporary or speculative market perceptions or other factors that do not necessarily reflect the underlying fundamentals and prospects of our business; and</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:2pt;margin-top:1.5pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>if individuals are elected to our Board of Directors with a specific agenda, it may adversely affect our ability to effectively implement our business strategy and to create additional value for our stockholders.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">36</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;margin-top:3pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">A change of control of our Company would automatically terminate our investment management agreements relating to the WisdomTree U.S.&#160;listed ETFs and Digital Funds, unless the Board of Trustees of the WisdomTree Trust, WisdomTree Digital Trust and shareholders of each voted to continue the agreements. A change in control could occur if a third party were to acquire a controlling interest in our Company.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:2pt;margin-top:1.5pt;">Under the Investment Company Act, an investment management agreement with a fund must provide for its automatic termination in the event of its assignment. The fund&#8217;s board must vote to continue such an agreement following any such assignment and the shareholders of the WisdomTree Trust and WisdomTree Digital Trust must approve the assignment. The cost of obtaining such shareholder approval can be significant and ordinarily would be borne by us. Similarly, under the Investment Advisers Act, a client&#8217;s investment management agreement may not be &#8220;assigned&#8221; by the investment adviser without the client&#8217;s consent.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:2pt;margin-top:1.5pt;">An investment management agreement is considered under both acts to be assigned to another party when a controlling block of the adviser&#8217;s securities is transferred. Under both acts, there is a presumption that a stockholder beneficially owning 25% or more of an adviser&#8217;s voting stock controls the adviser and conversely a stockholder beneficially owning less than 25% is presumed not to control the adviser. In our case, an assignment of our investment management agreements may occur if a third party were to acquire a controlling interest in our Company. We cannot be certain that the Trustees of the WisdomTree Trust and WisdomTree Digital Trust would consent to assignments of our investment management agreements or approve new agreements with us if a change of control occurs. And even if such approval were obtained, approval from the shareholders of the WisdomTree Trust and WisdomTree Digital Trust would be required to be obtained; such approval could not be guaranteed and even if obtained, likely would result in significant expense. This restriction may discourage potential purchasers from acquiring a controlling interest in our Company.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;margin-top:3pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Our revenues could be adversely affected if the Independent Trustees of the WisdomTree Trust or WisdomTree Digital Trust, as applicable, do not approve the continuation of our advisory agreements or determine that the advisory fees we receive from the WisdomTree U.S.&#160;listed ETFs or Digital Funds should be reduced.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:2pt;margin-top:1.5pt;">Our revenues are derived primarily from investment advisory agreements with related parties. Our advisory agreements with the WisdomTree Trust and WisdomTree Digital Trust, and the fees we collect from the WisdomTree U.S.&#160;listed ETFs and Digital Funds are subject to review and approval by the Independent Trustees of the WisdomTree Trust and WisdomTree Digital Trust, as applicable. The advisory agreements are subject to initial review and approval. After the initial two<span class="nobreak">-year</span> term of the agreement for each ETF or Digital Fund, the continuation of such agreement must be reviewed and approved at least annually by a majority of the Independent Trustees. In determining whether to approve the agreements, the Independent Trustees consider factors such as the nature and quality of the services provided by us, the fees charged by us and the costs and profits realized by us in connection with such services, as well as any ancillary or &#8220;fall<span class="nobreak">-out</span>&#8221; benefits from such services, the extent to which economies of scale are shared with the WisdomTree U.S.&#160;listed ETFs or Digital Funds, and the level of fees paid by other similar funds. Our revenues would be adversely affected if the Independent Trustees do not approve the continuation of our advisory agreements or determines that the advisory fees we charge to any particular fund are too high, resulting in a reduction of our fees.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;margin-top:3pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Damage to our reputation could adversely affect our business.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:2pt;margin-top:1.5pt;">We believe we have developed a strong brand and a reputation for innovative, thoughtful products, favorable long<span class="nobreak">-term</span> investment performance and excellent client services. The WisdomTree name and brand is a valuable asset and any damage to it could hamper our ability to maintain and grow our AUM and attract and retain employees, thereby having a material adverse effect on our revenues. Risks to our reputation may range from regulatory issues to unsubstantiated accusations. Managing such matters may be expensive, time<span class="nobreak">-consuming</span> and difficult.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Risks Relating to our Common and Preferred Stock and Convertible Notes</span></p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:3pt;margin-top:3pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">The market price of our common stock has been fluctuating significantly and may continue to do so, and you could lose all or part of your investment.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">The market price of our common stock has been fluctuating significantly and may continue to do so, depending upon many factors, some of which may be beyond our control, including:</p>
		<p class="BL_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>actions of activist stockholders against us, which have been costly and may be disruptive and may cause uncertainty about the strategic direction of our business;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>decreases in our AUM;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>variations in our quarterly operating results;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>differences between our actual financial operating results and those expected by investors and analysts;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>publication of research reports about us or the investment management industry;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>changes in expectations concerning our future financial performance and the future performance of the ETP industry and the asset management industry in general, including financial estimates and recommendations by securities analysts;</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">37</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>our strategic moves and those of our competitors, such as acquisitions or consolidations;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>changes in the regulatory framework of the ETP industry and the asset management industry in general and regulatory action, including action by the SEC to lessen the regulatory requirements or shorten the process under the Investment Company Act to become an ETP sponsor;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>the level of demand for our stock, including the amount of short interest in our stock;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>changes in general economic or market conditions; and</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>realization of any other of the risks described elsewhere in this section.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">In addition, stock markets in general have experienced volatility that has often been unrelated to the operating performance of a particular company. These broad market fluctuations may adversely affect the trading price of our common stock. Furthermore, in the past, market fluctuations and price declines in a company&#8217;s stock have led to securities class action litigations or other derivative stockholder lawsuits. If such a suit were to arise, it could cause substantial costs to us and divert our resources regardless of the outcome.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">If equity research analysts issue unfavorable commentary or downgrade our common stock, the price of our common stock could decline.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">The trading market for our common stock relies in part on the research and reports that equity research analysts publish about us and our business. We do not control the opinions of these analysts. The price and trading volume of our common stock could decline if one or more equity analysts issue unfavorable commentary or downgrade our common stock or cease publishing reports about us or our business.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;margin-top:3pt;">We may not have the ability to raise the funds necessary to settle conversions of the Convertible Notes or to repurchase the Convertible Notes upon a fundamental change. </p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">We currently have outstanding $150.0<span class="nobreak"> </span>million of 3.25% convertible senior notes due 2026 and $130.0<span class="nobreak"> </span>million in aggregate principal amount of 5.75% convertible senior notes due 2028, which we collectively refer to as the Convertible Notes. Holders of the Convertible Notes have the right to require us to repurchase their notes upon the occurrence of certain change of control transactions or liquidation, dissolution or common stock delisting events (each, a &#8220;fundamental change&#8221;), at a repurchase price equal to 100% of the principal amount of the notes to be repurchased, plus accrued and unpaid interest, if any, as described in the respective indentures between us and the trustee. In addition, upon conversion of the Convertible Notes, we will be required to make cash payments in respect of the notes being converted as described in the indentures. However, we may not have enough available cash or be able to obtain financing at the time we are required to make repurchases of notes surrendered therefor or notes being converted. In addition, our ability to repurchase the notes or to pay cash upon conversions of the notes may be limited by law, regulatory authority or agreements governing our future indebtedness. Further, if the fundamental change also constitutes a change of control under the Certificate of Designations for our Series A Preferred Stock and we are required to make other redemption payments as a result of the change of control, we would be required to satisfy that obligation before making any payments on the notes. Our failure to repurchase notes at a time when the repurchase is required by the applicable indenture or to pay any cash payable on future conversions of the notes as required by the indenture would constitute a default under the indenture.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">The conditional conversion feature of the Convertible Notes, if triggered, may adversely affect our financial condition and liquidity.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">We currently have outstanding $150.0&#160;million in aggregate principal amount of 3.25% convertible senior notes due 2026 and $130.0&#160;million in aggregate principal amount of 5.75% convertible senior notes due 2028, which we collectively refer to as the Convertible Notes. In the event the conditional conversion feature of the Convertible Notes is triggered, holders of notes will be entitled to convert the notes at any time during specified periods at their option, as described in the indentures. If one or more holders elect to convert their notes, we would be required to settle any converted principal through the payment of cash, which could adversely affect our liquidity.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Series&#160;A Non-Voting Convertible Preferred Stock issued in connection with the ETFS Acquisition contain redemption rights, which, if triggered, could materially impact our financial position.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">In connection with the ETFS Acquisition, we issued 14,750<span class="nobreak"> </span>shares of Series&#160;A Non<span class="nobreak">-Voting</span> Convertible Preferred Stock, or Series&#160;A Preferred Stock, to ETFS Capital, which are convertible into 14,750,000<span class="nobreak"> </span>shares of our common stock, subject to certain restrictions. ETFS Capital also has redemption rights for the Series&#160;A Preferred Stock to protect against corporate events such as our having an insufficient number of shares of authorized common stock to permit full conversion and if, upon a change of control of us, ETFS Capital does not receive the same amount per share of Series&#160;A Preferred Stock that it would have received had these shares been converted prior to a change of control. Any such redemption will be at a price per share of Series&#160;A Preferred Stock equal to the dollar volume<span class="nobreak">-weighted</span> average price for a share of common stock for the 30<span class="nobreak">-trading</span>&#160;day period ending on the date of such attempted conversion or change of control, as applicable, multiplied by 1,000. The redemption value of the Series&#160;A Preferred Stock was $96.9&#160;million at December&#160;31, 2023.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">38</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Future issuances of our common stock or equity-linked securities could lower our stock price and dilute the interests of existing stockholders.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">We may issue additional shares of our common stock or equity<span class="nobreak">-linked</span> securities in the future, either in connection with an acquisition or for other business reasons. The issuance of a substantial amount of common stock or equity<span class="nobreak">-linked</span> securities could have the effect of substantially diluting the interests of our current stockholders. In addition, the sale of a substantial amount of common stock or equity<span class="nobreak">-linked</span> securities in the public market, either in the initial issuance or in a subsequent resale by the target company in an acquisition which received such common stock as consideration or by investors who acquired such common stock in a private placement, could have a material adverse effect on the market price of our common stock.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Provisions in our certificate of incorporation and by-laws may prevent or delay an acquisition of our Company, which could decrease the market value of our common stock.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">Provisions of Delaware law, our certificate of incorporation and our by<span class="nobreak">-laws</span> may discourage, delay or prevent a merger, acquisition or other change in control that stockholders may consider favorable. These provisions may also prevent or delay attempts by stockholders to replace or remove our current management or members of our Board of Directors. These provisions include:</p>
		<p class="BL_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>limitations on the removal of directors;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>advance notice requirements for stockholder proposals and nominations;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>the inability of stockholders to act by written consent or to call special meetings;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>the ability of our Board of Directors to make, alter or repeal our by<span class="nobreak">-laws</span>; and</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>the authority of our Board of Directors to issue preferred stock with such terms as our Board of Directors may determine.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">In addition, we are subject to the provisions of Section&#160;203 of the Delaware General Corporation Law, which limits business combination transactions with stockholders of 15% or more of our outstanding voting stock that our Board of Directors has not approved. These provisions and other similar provisions make it more difficult for stockholders or potential acquirers to acquire us without negotiation. These provisions may apply even if some stockholders may consider the transaction beneficial to them.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">As a result, these provisions could limit the price that investors are willing to pay in the future for shares of our common stock. These provisions might also discourage a potential acquisition proposal or tender offer, even if the acquisition proposal or tender offer is at a premium over the then current market price for our common stock.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Our stockholder rights plan, or &#8220;poison pill,&#8221; includes terms and conditions that could discourage a takeover or other transaction that stockholders may consider favorable.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">On June&#160;16, 2023, our stockholders voted to ratify the adoption by our Board of Directors of the Stockholder Rights Agreement, dated March&#160;17, 2023 and subsequently amended on May&#160;4, 2023 and on May&#160;10, 2023 (as amended, the &#8220;Stockholder Rights Agreement&#8221;), by and between the Company and Continental Stock Transfer &amp;&#160;Trust Company, as Rights Agent. The Stockholder Rights Agreement was adopted in response to stockholder activism concerns and is intended to protect the Company and its stockholders from efforts by a single stockholder or group of stockholders to obtain control of the Company without paying a control premium through a number of recognized stockholder protections. Generally, the Stockholder Rights Agreement works by causing substantial dilution to any person or group (other than specified exempt persons) that acquires 10% (or 20% in the case of passive stockholders) or more of the shares of common stock without the approval of the Board of Directors (such person or group, an &#8220;Acquiring Person&#8221;) through the issuance of &#8220;Rights&#8221; to stockholders of record as of, and subsequent to, the close of business on March&#160;28, 2023, which Rights entitle the registered holders thereof (other than the Acquiring Person) to receive additional shares of our common stock upon exercise of such Rights. As a result, the overall effect of the Stockholder Rights Agreement may be to render more difficult or discourage a merger, tender or exchange offer or other business combination involving our Company that is not approved by the Board of Directors even if the offer may be considered beneficial by some stockholders. The Rights will expire at the close of business on March&#160;16, 2024, unless previously redeemed or exchanged by the Company. See Note&#160;19 to our Consolidated Financial Statements for additional information.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:5pt;margin-top:5pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">The payment of dividends to our stockholders and our ability to repurchase our common stock is subject to the discretion of our Board of Directors and may be limited by our financial condition and any applicable laws.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">Any determination as to the payment of dividends or stock repurchases, as well as the level of such dividends or repurchases, will depend on, among other things, general economic and business conditions, our level of AUM, our strategic plans, our financial results and condition, limitations associated with new credit facilities or other agreements that could limit the amount of dividends we are permitted to pay or the stock we may repurchase, and any applicable laws, including the Inflation Reduction Act, which includes an excise tax that would impose a 1% surcharge on stock repurchases. If, as a consequence of these various limitations and restrictions, we are unable to generate sufficient income from our business, we may need to reduce or eliminate the payment of dividends on our common stock or cease repurchasing our common stock. Any change in our stock repurchases or the level of our dividends or the suspension of the payment thereof could adversely affect our stock price.</p>


		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">In addition, our Board of Directors is authorized, without stockholder approval, to issue preferred stock with such terms as our Board of Directors may, in its discretion, determine. Our Board of Directors could, therefore, issue preferred stock with dividend rights superior to that of the common stock, which could also limit the payment of dividends on the common stock.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">39</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">


		<a id="T99204"></a><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:52pt;margin-top:10pt;text-indent:-52pt;margin-top:10pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">ITEM 1B.&#160;&#160;&#160;UNRESOLVED STAFF COMMENTS</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">We have no unresolved comments from the SEC staff relating to our periodic or current reports filed with the SEC pursuant to the Exchange&#160;Act.</p>
		<a id="T99205"></a><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:52pt;text-indent:-52pt;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">ITEM 1C.<span style="width: 10px;display: inline-block;">&#160;&#160;&#160;</span>CYBERSECURITY</span></p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Cybersecurity Risk Management and Strategy</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">Under the oversight of our Board of Directors, we have implemented and maintain cybersecurity risk management policies and procedures that include processes for the identification, assessment and treatment through mitigation, transfer, avoidance and/or acceptance of cybersecurity risks.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">Our cybersecurity risk management policies and procedures are informed by industry standards, and they are designed to address cybersecurity risks identified by external auditors and assessors, threat intelligence providers, internal stakeholders, vulnerability management programs and security management programs. Our team of information technology and cybersecurity professionals, led by our Chief Information Officer, or CIO, manages and maintains remediation strategies for identified cybersecurity risks and regularly reports on such risks to senior management, including our Governance Committee as described below.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:3pt;margin-top:3pt;">Our cybersecurity risk management program is designed to be aligned with our business strategy. It shares common methodologies, reporting channels and governance processes that apply to other areas of enterprise risk, including legal, compliance, strategic, operational and financial risk. Key elements of our cybersecurity risk management program include:</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>periodic risk assessments designed to help identify cybersecurity risks to our critical systems, information, products, services and our broader enterprise information technology environment;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>a security and infrastructure team principally responsible for managing our cybersecurity risk assessment processes, our security controls and our response to cybersecurity incidents;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>the use of external service providers, where appropriate, to assess, test or otherwise assist with aspects of our security controls;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>employee training and awareness programs that include periodic and ongoing assessments in an effort to drive adoption and awareness of cybersecurity processes and controls;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:3pt;margin-top:3pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>a cybersecurity incident response plan that includes procedures for responding to cybersecurity incidents; and</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:0pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>processes to evaluate cybersecurity risks posed by critical third<span class="nobreak">-party</span> vendors, including through the use of security questionnaires.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Additionally, as a public company, we are subject to Sarbanes<span class="nobreak">-Oxley</span> (SOX) requirements and must undergo independent audits of Information Technology General Controls (ITGC) in support of Internal Control over Financial Reporting (ICFR). These audits assess key information security and cybersecurity risks in the environment that may affect the confidentiality, integrity and availability of financial reporting systems and data. If any control deficiencies that represent material cybersecurity risks were identified, those would be reported to the Audit Committee, and the results of these evaluations would be considered in the overall audit opinion for the Company.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Governance Related to Cybersecurity Risks</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our cybersecurity risk management program and related operations and processes are directed by our CIO.&#160;Currently, the CIO role is held by an individual who has been in the role for over nine&#160;years, has over 22&#160;years of cybersecurity, information technology and systems engineering experience, and has advanced training in the field of technology.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">40</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The CIO is a member of our Governance Committee and regularly reports on cybersecurity risk management to other members of the Governance Committee comprised of the Company&#8217;s senior executive officers. The Governance Committee oversees the prioritization and escalation of risks from cybersecurity threats and is responsible for strategy, operations, financial management, information technology, compliance, legal, administration and corporate governance. The members of the Governance Committee collectively possess experience in these areas, including cybersecurity and risk management.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Audit Committee oversees our management of cybersecurity risks. Pursuant to the Audit Committee charter, the Audit Committee is responsible for discussing cybersecurity<span class="nobreak">-related</span> risks with management and the steps management has taken to monitor and control such risks, including our risk assessment and risk management policies. The CIO regularly reports to the Audit Committee on our cybersecurity risks, and the chair of the Audit Committee reports on these discussions with the full Board of Directors. In addition, the CIO provides periodic reports to our Board of Directors.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">While we have not, as of the date of this Report, experienced a cybersecurity incident that resulted in a material adverse impact to our business or operations, there can be no guarantee that we will not experience such an incident in the future. For information regarding cybersecurity risks that may materially affect our Company, see &#8220;Item 1A. Risk Factors&#8221; included in this Report.</p>
		<a id="T99206"></a><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:48pt;text-indent:-48pt;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">ITEM 2.<span style="width: 13px;display: inline-block;">&#160;&#160;&#160;&#160;</span>PROPERTIES</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our principal executive office is located at 250 West 34<span class="Superscript" style="vertical-align:super;font-size:58%;">th</span> Street, 3<span class="Superscript" style="vertical-align:super;font-size:58%;">rd</span> Floor, New&#160;York, New&#160;York, pursuant to a license agreement that expires in April&#160;2025, with the option to terminate in April&#160;2024. This reduced footprint, as compared to our prior headquarters, better aligns with the number of employees expected to collaborate in person on any given&#160;day. While we believe having a physical office space for employees to work and socialize is important, we embrace a &#8220;Work Smart&#8221; philosophy that transcends physical work settings, with a focus on optimizing productivity, efficiency and effectiveness of our work. Time in the office generally is not prescribed, and team leaders are empowered to determine how their teams work best, based on their roles, with employees remaining accountable for achieving individual, team and Company outcomes. We believe that this space is sufficient to meet our needs until the expiration of the license agreement.</p>
		<a id="T99207"></a><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:48pt;text-indent:-48pt;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">ITEM&#160;3.<span style="width: 13px;display: inline-block;">&#160;&#160;&#160;&#160;</span>LEGAL PROCEEDINGS</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We may be subject to reviews, inspections and investigations by the SEC, CFTC, NFA, state and foreign regulators, as well as legal proceedings arising in the ordinary course of business. See Note&#160;14 to our Consolidated Financial Statements for additional information regarding actual and potential claims by investors in our WisdomTree WTI Crude Oil 3x Daily Leveraged ETP totaling approximately &#8364;23.6&#160;million ($26.1&#160;million).</p>
		<a id="T99208"></a><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:48pt;text-indent:-48pt;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">ITEM&#160;4.<span style="width: 13px;display: inline-block;">&#160;&#160;&#160;&#160;</span>MINE SAFETY DISCLOSURES</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Not applicable.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">41</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>




	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<a id="T99209"></a><p class="H1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">PART&#160;II</span></p>
		<a id="T99210"></a><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">ITEM 5.<span style="width: 13px;display: inline-block;">&#160;&#160;&#160;&#160;</span>MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Market Information</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our common stock is traded on the New&#160;York Stock Exchange under the symbol &#8220;WT.&#8221; As of December&#160;31, 2023, there were 30 holders of record of shares of our common stock and we believe there were approximately 18,000 beneficial owners of our common stock.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In November&#160;2014, we commenced a quarterly cash dividend and intend to continue to pay regular dividends to our stockholders. Any determination as to the payment of dividends, as well as the level of such dividends, will depend on, among other things, general economic and business conditions, our level of AUM, our strategic plans, our financial results and condition, limitations associated with new credit facilities or other agreements that could limit the amount of dividends we are permitted to pay, and any applicable laws.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Issuer Purchases of Equity Securities</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The following table provides information with respect to purchases made by or on behalf of the Company or any &#8220;affiliated purchaser&#8221; of shares of our common stock as part of publicly announced plans or programs.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;orphans:99;widows:1;margin-top:6pt;">On February&#160;22, 2022, our Board of Directors approved an increase of $85.7&#160;million to our share repurchase program and extended the term for three&#160;years through April&#160;27, 2025. There were no shares repurchased under this program during the three&#160;months ended December&#160;31, 2023. As of December&#160;31, 2023, approximately $96.4&#160;million remained under this program for future purchases.</p>
		<table class="No-Table-Style _idGenTablePara-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-7" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 35.55%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.40%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.31%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Total&#160;Number <br/>of&#160;Shares <br/>Purchased</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.40%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.01%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Average&#160;Price <br/>Paid&#160;Per&#160;Share</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.40%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.35%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Total Number<br/>of Shares<br/>Purchased <br/>as Part&#160;of<br/>Publicly <br/>Announced&#160;Plans <br/>or Programs</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.40%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Approximate <br/>Dollar Value <br/>of Shares that <br/>May&#160;Yet&#160;Be <br/>Purchased <br/>Under&#160;the <br/>Plans&#160;or <br/>Programs</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 35.55%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH_left" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Period</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.40%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 13.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.40%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 14.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.40%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 16.35%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.40%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 15.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">(in&#160;thousands)</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 35.55%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">October&#160;1, 2023 to October&#160;31, 2023</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.40%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.40%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.87%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.40%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.35%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.40%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.87%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-10" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 35.55%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">November&#160;1, 2023 to November&#160;30, 2023</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.40%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.40%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.87%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.40%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.35%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.40%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.87%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-10" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 35.55%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">December&#160;1,&#160;2023&#160;to&#160;December&#160;31, 2023</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.40%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.31%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.40%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.87%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.40%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.35%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.40%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.87%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.31%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 35.55%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.40%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.31%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.40%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.87%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.40%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.35%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.40%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.87%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.31%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">96,406</p>
					</td>
				</tr>

		</table>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;orphans:99;widows:1;margin-top:8pt;">In addition, on November&#160;20, 2023, we repurchased our Series&#160;C Non<span class="nobreak">-Voting</span> Convertible Preferred Stock, par value $0.01 per share (the &#8220;Series&#160;C Preferred Stock&#8221;), which was convertible into approximately 13.1&#160;million shares of our common stock, for aggregate cash consideration of approximately $84.4&#160;million. See Note&#160;23 to our Consolidated Financial Statements for additional information.</p>
		<a id="T99211"></a><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:48pt;orphans:1;page-break-after:auto;text-indent:-48pt;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">ITEM&#160;6.<span style="width: 13px;display: inline-block;">&#160;&#160;&#160;&#160;</span>[RESERVED]</span></p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">42</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="Basic-Text-Frame" style="margin:0;padding:0;border-width:0;">
		<a id="T99212"></a><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;orphans:1;page-break-after:auto;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">ITEM&#160;7.<span style="width: 13px;display: inline-block;">&#160;&#160;&#160;&#160;</span>MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">The following discussion and analysis of our financial condition and results of operations should be read together with our consolidated financial statements and the related notes and the other financial information included elsewhere in this Report. In addition to historical consolidated financial information, the following discussion contains forward</span><span class="nobreak"><span class="Italic" style="font-style:italic;font-weight:normal;">-looking</span></span><span class="Italic" style="font-style:italic;font-weight:normal;"> statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward</span><span class="nobreak"><span class="Italic" style="font-style:italic;font-weight:normal;">-looking</span></span><span class="Italic" style="font-style:italic;font-weight:normal;"> statements. Factors that could cause or contribute to these differences include those discussed below. For a more complete description of the risks noted above and other risks that could cause our actual results to materially differ from our current expectations, please see Item&#160;1A. &#8220;Risk Factors&#8221; of this Report. We assume no obligation to update or revise publicly any forward</span><span class="nobreak"><span class="Italic" style="font-style:italic;font-weight:normal;">-looking</span></span><span class="Italic" style="font-style:italic;font-weight:normal;"> statements, whether as a result of new information, future events or otherwise, unless required by law.</span></p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Introduction</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We are a global financial innovator, offering a well<span class="nobreak">-diversified</span> suite of ETPs, models, solutions and products leveraging blockchain technology. We empower investors and consumers to shape their future and support financial professionals to better serve their clients and grow their businesses. We are leveraging the latest financial infrastructure to create products that provide access, transparency and an enhanced user experience. Building on our heritage of innovation, we are also developing and have launched next<span class="nobreak">-generation</span> digital products, services and structures, including Digital Funds and tokenized assets, as well as our blockchain<span class="nobreak">-native</span> digital wallet, WisdomTree Prime, which is currently available in the U.S.&#160;in 38 states, representing approximately 70% of the U.S.&#160;population.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We had approximately $100.1&#160;billion in AUM as of December&#160;31, 2023. Our family of ETPs includes products that provide exposure to equities, fixed income, commodities, leveraged<span class="nobreak">-and-inverse</span>, currency, alternatives and cryptocurrency strategies. We have launched many first<span class="nobreak">-to-market</span> products and pioneered alternative weighting we call &#8220;Modern Alpha,&#8221; which combines the outperformance potential of active management with the benefits of passive management to offer investors cost<span class="nobreak">-effective</span> funds that are built to perform. Most of our equity<span class="nobreak">-based</span> funds employ a fundamentally weighted investment methodology, which weights securities based on factors such as dividends, earnings or investment factors, whereas most other industry indexes use a capitalization weighted methodology. These products are distributed through all major channels in the asset management industry, including banks, brokerage firms, registered investment advisers, institutional investors, private wealth managers and online brokers primarily through our sales force. We believe technology is altering the way financial advisors conduct business and through our Advisor and Portfolio Solutions programs we offer technology<span class="nobreak">-enabled</span> and research<span class="nobreak">-driven</span> solutions including portfolio construction, asset allocation, practice management services and digital tools to help financial advisors address technology challenges and grow and scale their businesses.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We are at the forefront of innovation and believe that tokenization and leveraging the utility of blockchain technology is the next evolution in financial services. We are building the foundation that we believe will allow us to lead in this coming evolution. WisdomTree Prime, our blockchain<span class="nobreak">-native</span> digital wallet, positions us to expand our blockchain<span class="nobreak">-enabled</span> financial product and services offerings with a new direct<span class="nobreak">-to-consumer</span> channel where spending, saving and investing are united. As we continue to pursue our digital assets strategy, we are embracing what we refer to as &#8220;responsible DeFi,&#8221; which we believe upholds the foundational principles of regulation in this innovative and quickly evolving space. We believe that our expansion into digital assets and blockchain<span class="nobreak">-enabled</span> finance complements our existing core competencies in a holistic manner, and will diversify our revenue streams and contribute to our growth.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Executive Summary</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our business continues to generate significant positive momentum while executing against our long<span class="nobreak">-term</span> strategic initiatives. We ended 2023 with record AUM of $100.1&#160;billion. Our revenues and operating income increased 15.8% and 45.6%, respectively, during the year ended December&#160;31, 2023 as compared to the prior year, which translated into 520 basis points of operating margin expansion. This past year we generated over $10.4&#160;billion of net inflows, representing annual organic flow growth of approximately 13%. Our inflow profile is both broad and deep as we have gathered net inflows into 6 of our 8 major product categories, including fixed income, international equity and emerging markets products, representing organic flow growth in these categories of 39%, 28% and 21%, respectively. This diversification is driving upward our year<span class="nobreak">-to-date</span> average fee capture on our flows, which was approximately two times greater than our fee capture in the prior year. AUM diversification and product performance have us well<span class="nobreak">-positioned</span> for this growth trajectory to continue.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">43</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our models strategy is another growth driver where we are succeeding, with our model portfolios available to over 70,000 advisors. We are focused on adding new clients and continuing to deepen our impact on partner platforms such as Merrill Lynch, Morgan Stanley, LPL Financial and others, as well as being an outsourced solution for smaller registered investment advisers and independent broker<span class="nobreak">-dealers</span> to make model portfolios easier to trade through our Portfolio Solutions program. In 2023, we observed a 20% increase in the number of clients that hold multiple WisdomTree products, while at the same time we also grew our overall client base by more than 20%. We believe that continued success penetrating our accessible market and winning advisor mindshare should lead to model flows that are recurring in nature and stackable on top of our current inflow profile.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">While we remain focused on providing investors with the best product structure to access various asset classes through ETFs, we believe that by leveraging blockchain technology, tokenized assets are the best product structure of tomorrow and the future of financial services. We are an early mover in this space, with the launch of our blockchain<span class="nobreak">-native</span> wallet, WisdomTree Prime, a new direct<span class="nobreak">-to-consumer</span> channel where spending, saving and investing are united. WisdomTree Prime provides access to bitcoin, ether, tokenized gold and U.S.&#160;dollar tokens, as well as 13 Digital Funds, including a government money market fund and other digital funds offering asset allocation, fixed income and equity exposures. In addition, we have partnered with a financial institution to provide co<span class="nobreak">-branded</span> debit cards to our retail customers on the WisdomTree Prime platform. We continue to focus on enhancing the products and capabilities of the platform with plans to allow for peer<span class="nobreak">-to-peer</span> transfers and payments in the upcoming quarters. We are also exploring strategic partnerships and other business development opportunities for both our platform and product suite that could unlock additional tokenization revenue streams in the future.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We are executing on our long<span class="nobreak">-term</span> growth strategy and expect ongoing flows and AUM growth to translate into further margin expansion and outperformance going forward, with our recent investments in digital assets creating additional value for our stockholders over time.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Additional business highlights include the following:</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>Strong product performance with over 80% of our U.S.&#160;listed AUM covered by Morningstar in the top two quartiles of peer performance on the 3<span class="nobreak">-year</span> and 10<span class="nobreak">-year</span> timeframes. In addition, approximately 50% of our U.S.&#160;listed AUM is rated 4- or 5<span class="nobreak">-star</span> by Morningstar (less than 5% in 1<span class="nobreak">-and</span> 2<span class="nobreak">-star</span> funds).</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>We launched nine new European listed ETPs, three new U.S.&#160;listed ETPs (including the WisdomTree Bitcoin Fund which was among the first to launch in the U.S.) and 12 new Digital Funds. The WisdomTree Bitcoin Fund launched in the U.S.&#160;on the Cboe BZX Exchange in January&#160;2024.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>We reduced our convertible senior notes outstanding by $45.0&#160;million, by issuing $130.0&#160;million of convertible senior notes due 2028 and retiring $175.0&#160;million of convertible senior notes due 2023. We also returned approximately $24.1&#160;million to our stockholders through our ongoing quarterly cash dividend and common stock repurchases.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>In May&#160;2023, we closed a transaction resulting in the termination of our contractual gold payments obligation to ETFS Capital for $50.0&#160;million in cash and Series&#160;C Preferred Stock convertible into approximately 13.1&#160;million shares of our common stock. The value of these shares was $86.9&#160;million based on the closing price of our common stock on May<span class="nobreak">&#160;</span>9, 2023 of $6.64 per share. The Series&#160;C Preferred Stock was issued to Gold Bullion Holdings (Jersey) Limited, or GBH, a subsidiary of the World Gold Council, which was the entity that ultimately received a portion of the contractual gold payments the Company was previously obligated to make to ETFS Capital. The transaction expanded our operating margin by over 500 basis points, was accretive to earnings per share and reduced volatility in our financial results.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>In November&#160;2023, we repurchased our Series&#160;C Preferred Stock, which was convertible into approximately 13.1&#160;million shares of our common stock from GBH for aggregate cash consideration of approximately $84.4&#160;million. Under the terms of the transaction, we paid GBH $40.0&#160;million on the closing date, with the remainder of the purchase price payable in equal, interest<span class="nobreak">-free</span> installments on the first, second and third anniversaries of the closing date. The implied price per share was $6.02 when considering the interest<span class="nobreak">-free</span> financing element of the transaction, and the repurchase was also accretive to earnings per share.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">44</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>In the U.S., we were named a &#8220;2023 Best Places to Work in Money Management&#8221; by <span class="Italic" style="font-style:italic;font-weight:normal;">Pensions&#160;&amp;&#160;Investments</span> for the fourth consecutive year and seventh year since the award was created. We ranked second within the category for managers with&#160;100<span class="nobreak">-499</span> employees, the second consecutive year earning a ranking among the top five employers. In the U.K., we were also named Best Workplace for medium<span class="nobreak">-sized</span> companies for a fourth consecutive year and a 2023 Best Workplace for Women for medium<span class="nobreak">-sized</span> companies by <span class="Italic" style="font-style:italic;font-weight:normal;">Great Place to Work</span>.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>We won &#8220;Best Leveraged&#160;&amp; Inverse ETF Issuer ($100M+)&#8221; and &#8220;Best Crypto Issuer Linked ETF Issuer ($100M+)&#8221; at the 2023 ETF Express Europe Awards and our European business won &#8220;Best ETF Issuer&#8221; at the Online Money Awards, marking the second consecutive year of winning the award. The WisdomTree Siegel Strategic Value Index&#8482;, an index developed by Professor Jeremy Siegel, Senior Economist to WisdomTree, also won the FIA Index of the Year Award by <span class="Italic" style="font-style:italic;font-weight:normal;">Structured Retail Products</span>.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Market Environment</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The following chart reflects the annual returns of the broad<span class="nobreak">-based</span> equity indexes and gold prices over the last three&#160;years.</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;text-align:center;margin-top:6pt;"><img alt="" src="tlinechart_001.jpg" style="width:600.32px;max-width:100%;"/></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Source: FactSet</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">45</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">U.S.&#160;Listed ETF Industry Flows</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">U.S.&#160;listed ETF net flows for the year ended December&#160;31, 2023 were $489.1&#160;billion. U.S.&#160;equity and fixed income gathered the majority of those flows.</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:8pt;text-align:center;margin-top:8pt;"><img alt="" src="tbarchart_006.jpg" style="width:541.44px;max-width:100%;"/></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Source: Morningstar</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">European Listed ETP Industry Flows</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">European listed ETP net flows were $146.5&#160;billion for the year ended December&#160;31, 2023. Equities and fixed income gathered the majority of those flows.</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:8pt;text-align:center;margin-top:8pt;"><img alt="" src="tbarchart_007.jpg" style="width:538.88px;max-width:100%;"/></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Source: Morningstar</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">46</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Industry Developments</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Asset Management&#160;&#8211;&#160;Consolidation</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In the recent past, a number of acquisitions in the asset management industry have either been announced or completed. These trends have accelerated, as fee compression, cost pressures and increased regulations have weighed on the industry, highlighting the importance of scale and operating efficiency to compete in today&#8217;s market. We have significant opportunities ahead in both ETPs and the Portfolio Solutions business and as an early mover in digital assets and blockchain<span class="nobreak">-enabled</span> financial services, which positions us well for success to grow in this competitive landscape.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Components of Operating Revenue</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Advisory fees</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Substantially all of our revenues are comprised of advisory fees we earn from our ETPs. These advisory fees are calculated based on a percentage of the ETPs&#8217; average daily net assets. As of the date of this Report, our weighted average fee rates by product category are as follows:</p>
		<table class="No-Table-Style _idGenTablePara-2" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 44.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">

						<p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Commodity&#160;&amp; Currency:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.57%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 13.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">37bps</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.57%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 27.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Leveraged&#160;&amp; Inverse:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.57%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 10.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">84bps</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 44.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">International Developed Market Equity:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.57%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 13.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">49bps</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.57%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 27.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Fixed Income:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.57%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 10.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">16bps</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 44.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">U.S.&#160;Equity:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.57%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 13.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">31bps</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.57%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 27.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Alternatives:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.57%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 10.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">58bps</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 44.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Emerging Market Equity:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.57%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 13.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">59bps</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.57%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 27.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Cryptocurrency:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.57%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 10.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">36bps</p>
					</td>
				</tr>

		</table>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We determine the appropriate advisory fee to charge for our ETPs based on the cost of operating each ETP considering the types of securities the ETPs will hold, fees third<span class="nobreak">-party</span> service providers will charge us for operating the ETPs and our competitors&#8217; fees for similar ETPs. From time to time, we implement voluntary waivers of a portion of our advisory fee. In addition, we earn a fee based on daily aggregate AUM of our ETPs in exchange for bearing certain fund expenses.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our advisory fee revenues may fluctuate based on general stock market trends, which include market value appreciation or depreciation, currency fluctuations against the U.S.&#160;dollar, increased competition and level of inflows or outflows from our ETPs.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Other income</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Other income includes rebates from swap providers to our European listed ETPs, creation/redemption fees earned on our European non<span class="nobreak">-UCITS</span> products and fees from licensing our indexes to third parties.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Components of Operating Expenses</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our operating expenses consist primarily of costs related to selling, operating and marketing our ETPs as well as the infrastructure needed to run our business.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Compensation and benefits</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Employee compensation and benefits expenses are expensed when incurred and include salaries, incentive compensation, and related benefit costs. To attract and retain qualified personnel, we must maintain competitive employee compensation and benefit plans and amounts we pay may be affected by inflation. Virtually all of our employees receive incentive compensation which is variable and will fluctuate taking into consideration our operating and financial results, as well as discretion.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Also included in compensation and benefits are costs related to equity awards granted to our employees. Our executive management and Board of Directors strongly believe that equity awards are an important part of our employees&#8217; overall compensation package and that incentivizing our employees with equity in the Company aligns the interests of our employees with that of our stockholders. We use the fair value method in recording compensation expense for equity<span class="nobreak">-based</span> awards. Under the fair value method, compensation expense is measured at the grant date based on the estimated fair value of the award and is recognized as an expense over the vesting period.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">47</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Fund management and administration</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Fund management and administration expenses are expensed when incurred and are comprised of the following costs we pay third<span class="nobreak">-party</span> service providers to operate our ETPs and Digital Funds:</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>portfolio management of our ETPs (sub<span class="nobreak">-advisory</span>);</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:0pt;margin-top:0pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>fund accounting and administration;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:0pt;margin-top:0pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>custodial and storage services;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:0pt;margin-top:0pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>market making;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:0pt;margin-top:0pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>transfer agency;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:0pt;margin-top:0pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>accounting and tax services;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:0pt;margin-top:0pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>printing and mailing of shareholder materials;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:0pt;margin-top:0pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>index calculation;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:0pt;margin-top:0pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>indicative values;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:0pt;margin-top:0pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>distribution fees;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:0pt;margin-top:0pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>legal and compliance services;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:0pt;margin-top:0pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>exchange listing fees;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:0pt;margin-top:0pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>trustee fees and expenses;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:0pt;margin-top:0pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>preparation of regulatory reports and filings;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:0pt;margin-top:0pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>insurance;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:0pt;margin-top:0pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>certain local income taxes; and</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:0pt;margin-top:0pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>other administrative services.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We are not responsible for extraordinary expenses, taxes and certain other expenses related to the funds.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We depend on a number of parties to provide critical portfolio management services to our ETPs. The fees we pay our sub<span class="nobreak">-advisers</span> generally are the higher of the fixed minimums per fund, which range from $25,000 to $180,000 per year, or the percentage fee, which ranges between 0.01% and 0.50% per annum of average daily AUM at various breakpoint levels depending on the nature of the ETP.&#160;In addition, we pay certain costs based on transactions in our ETPs or based on inflow levels.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The fees we pay for accounting, tax, transfer agency, index calculation, indicative values and exchange listing are based on the number of ETPs we have. The remaining fees are based on a combination of both AUM and number of funds, or as incurred.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Marketing and advertising</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Marketing and advertising expenses are recorded when incurred and include the following:</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>advertising and product promotion campaigns that are initiated to promote our existing and new ETPs as well as brand awareness;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:0pt;margin-top:0pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>development and maintenance of our website; and</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:0pt;margin-top:0pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>creation and preparation of marketing materials.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our discretionary advertising comprises the largest portion of this expense. In addition, we may incur expenditures in certain periods to attract inflows, the benefit of which may or may not be recognized from increases to our AUM in future periods. However, due to the discretionary nature of some of these costs, they can generally be reduced if there were a decline in the markets.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Sales and business development</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Sales and business development expenses are recorded when incurred and include the following:</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>travel and entertainment or conference related expenses for our sales force;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:0pt;margin-top:0pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>market data services for our research team;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:0pt;margin-top:0pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>sales related software tools;</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:0pt;margin-top:0pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>voluntary payment of certain costs associated with the creation or redemption of ETP shares, as we may elect from time to time; and</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:0pt;margin-top:0pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>legal and other advisory fees associated with the development of new funds or business initiatives.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">48</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Contractual gold payments</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Contractual gold payments expense represented an obligation requiring us to pay 9,500 ounces of gold annually from the advisory fee income we earned for managing physically backed gold ETPs. Our obligation to continue making these payments was terminated on May&#160;10, 2023. See Note&#160;9 to our Consolidated Financial Statements for additional information.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Professional fees</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Professional fees are expensed when incurred and consist of fees we pay to corporate advisers including accountants, tax advisers, legal counsel, investment bankers, human resources or other consultants. Professional fees also include expenses we pay third<span class="nobreak">-party</span> service providers related to WisdomTree Prime and expenses incurred in response to an activist campaign. These expenses fluctuate based on our needs or requirements at the time. Certain of these costs are at our discretion and can fluctuate year to year.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Occupancy, communications and equipment</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Occupancy, communications and equipment expense includes costs for our corporate headquarters in New&#160;York City as well as office related costs in our other locations.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Depreciation and amortization</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Depreciation and amortization expense results from amortization of internally<span class="nobreak">-developed</span> software as well as depreciation on fixed assets, which are depreciated/amortized over three to five&#160;years.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Third-party distribution fees</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Third<span class="nobreak">-party</span> distribution fees, which are expensed as incurred, include payments made to enable our products and models to be included on certain third<span class="nobreak">-party</span> platforms in exchange for commission<span class="nobreak">-free</span> trading or other preferential access. These expenses also include payments to our third<span class="nobreak">-party</span> marketing agents in Latin America and Israel.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Other</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Other expenses consist primarily of insurance premiums, general office related expenses, securities license fees for our sales force, public company related expenses, corporate related travel and entertainment and Board of Director fees, including stock<span class="nobreak">-based</span> compensation related to equity awards we granted to our directors.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Components of Other Income/(Expenses) of a Recurring Nature</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Interest expense</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We recognize interest expense using the effective interest method which includes the amortization of discounts, premiums and issuance costs.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Revaluation/termination of deferred consideration&#8211;gold payments</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Deferred consideration arose in connection with the ETFS Acquisition and was remeasured each reporting period using forward<span class="nobreak">-looking</span> gold prices observed on the CMX exchange, a selected discount rate and perpetual growth rate. This obligation was terminated on May&#160;10, 2023 for approximately $137.0&#160;million. See Note&#160;9 to our Consolidated Financial Statements for additional information.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Interest income</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Interest income, which is recognized on an accrual basis, arises from investing our corporate cash into interest<span class="nobreak">-bearing</span> financial instruments.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">49</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Other losses, net</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Included herein are gains and losses arising from our financial instruments owned and investments, the sale of gold earned from advisory fees paid by physically<span class="nobreak">-backed</span> gold ETPs, foreign exchange and other miscellaneous items. Also included are losses arising from the release of tax<span class="nobreak">-related</span> indemnification assets upon the expiration of the statute of limitations, for which an equal and offsetting benefit is recognized in income tax expense.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Income Taxes</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our income tax expense consists of taxes due to federal, various state and local and certain foreign authorities.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Expense Guidance for the Year Ending December&#160;31, 2024</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Compensation Expense</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our compensation expense for the year ending December&#160;31, 2024 is currently estimated to range from $108.0&#160;million to $118.0&#160;million and takes into consideration planned hires as well as year<span class="nobreak">-end</span> compensation adjustments and the annualization of hires made during 2023. The range also considers variability in incentive compensation with drivers including the magnitude of our flows, revenue and operating income growth, margin expansion and our share price performance in relation to our peers. A wide range is provided in consideration of uncertain market conditions.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Discretionary Spending</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Discretionary spending includes marketing, sales, professional fees, occupancy and equipment, depreciation and amortization and other expenses. We currently estimate our discretionary spending for the year ending December&#160;31, 2024 to range from $64.0&#160;million to $68.0&#160;million.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Not included in the guidance above are any potential non<span class="nobreak">-recurring</span> expenses we may incur in response to a potential proxy contest. Such expenses could be material to our results of operations for the year ending December&#160;31, 2024.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Gross Margin</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We define gross margin as total operating revenues less fund management and administration expenses. Gross margin percentage is calculated as gross margin divided by total operating revenues. For the year ending December&#160;31, 2024, we currently estimate that our gross margin percentage will be 79.0% to 80.0% at current AUM and revenue levels. If AUM drives higher from continued organic flow growth or favorable market conditions, we would anticipate further gross margin expansion.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Third-Party Distribution Expense</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We currently estimate third<span class="nobreak">-party</span> distribution expense to be approximately $10.0&#160;million to $11.0&#160;million for the year ending December&#160;31, 2024, which is dependent upon the AUM growth on our respective platforms.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Income Tax Expense</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We currently estimate that our consolidated normalized effective tax rate will be approximately 24.0% to 25.0% for the year ending December&#160;31, 2024, a slight increase as compared to the year ended December&#160;31, 2022 to account for the full year impact of the U.K. tax rate change to 25.0% that went into effect on April&#160;1, 2023.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">This estimated rate may change and is dependent upon our actual taxable income earned in relation to our forecasts as well as any other items which may arise that are not currently forecasted. Such items may include, but are not limited to, reductions in unrecognized tax benefits, increases or decreases in valuation allowances and any stock<span class="nobreak">-based</span> compensation windfalls or shortfalls. Additional corporate tax legislation could also impact our normalized effective tax rate.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">50</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Factors that May Impact our Future Financial Results</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our AUM is well diversified across the commodity, U.S.&#160;equity, international developed markets and emerging markets sectors. As a result, our operating results are particularly exposed to investor sentiment toward investing in these products&#8217; strategies and our ability to maintain AUM of these products, as well as the performance of these products.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our revenues are also highly correlated to the level and relative mix of our AUM, as well as the fee rate associated with our ETPs. Changes in product mix have led to a decline in our average advisory fee, which for the&#160;years ended December&#160;31, 2021, 2022 and 2023 were 0.41%, 0.38% and 0.36%, respectively.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The chart below sets forth the asset mix of our ETPs at December&#160;31, 2021, 2022 and 2023:</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;text-align:center;margin-top:6pt;"><img alt="" src="tbarchart_001.jpg" style="width:560.64px;max-width:100%;"/></p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">51</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Key Operating Statistics</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The following table presents key operating statistics that serve as indicators for the performance of our business:</p>
		<table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-18" style="height:12pt;">
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="8" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 51.55%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Year Ended December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height:12pt;">
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="TCH_left" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:0pt;"><span class="Bold" style="font-style: normal; text-decoration: underline"><b>GLOBAL ETPs (in millions</b></span><b><span style="font-style: normal">)</span></b></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 17.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Beginning of period assets</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">81,993</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">77,479</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">67,392&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Inflows</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;">10,396</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;">12,182</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;">4,660&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Market appreciation/(depreciation)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;">7,735</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;">(7,668)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;">5,427&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">End of period assets</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">100,124</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">81,993</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">77,479&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-19" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Average assets during the period</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">92,847</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">76,969</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">73,430&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-10" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Average advisory fee during the period</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;">0.36%</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;">0.38%</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;">0.41%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Number of ETPs&#8212;end of the period</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;">337</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;">339</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;">329&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-20" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:8pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;"><span class="Bold" style="font-style: normal; text-decoration: underline"><b>US
      LISTED ETFs (in millions</b></span><b><span style="font-style: normal">)</span></b></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Beginning of period assets</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">55,973</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">48,210</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">38,517&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Inflows</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;">10,795</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;">14,572</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;">4,950&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Market appreciation/(depreciation)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">5,718</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(6,809)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">4,743&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">End of period assets</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">72,486</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">55,973</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">48,210&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-19" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Average assets during the period</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">64,967</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">49,723</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">44,325&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Number of ETPs&#8212;end of the period</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">76</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">79</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">75&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-20" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:8pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;"><span class="Bold" style="font-style: normal; text-decoration: underline"><b>EUROPEAN
      LISTED ETPs (in millions</b></span><b><span style="font-style: normal">)</span></b></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Beginning of period assets</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">26,020</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">29,269</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">28,875&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Outflows</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;">(399)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;">(2,390)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;">(290)&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Market appreciation/(depreciation)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">2,017</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(859)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">684&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">End of period assets</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">27,638</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">26,020</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">29,269&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-19" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Average assets during the period</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">27,880</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">27,246</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">29,105&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Number of ETPs&#8212;end of the period</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">261</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">260</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">254&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-20" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:8pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;"><span class="Bold" style="font-style: normal; text-decoration: underline"><b>PRODUCT
      CATEGORIES (in millions</b></span><b><span style="font-style: normal">)</span></b></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-20" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:8pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">U.S.&#160;Equity</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Beginning of period assets</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">24,112</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">23,860</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">18,367&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Inflows</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;">1,616</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;">3,346</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;">1,544&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Market appreciation/(depreciation)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">3,428</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(3,094)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">3,949&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">End of period assets</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">29,156</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">24,112</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">23,860&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-19" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Average assets during the period</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">25,701</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">22,881</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">21,254&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-20" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:8pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Commodity&#160;&amp; Currency</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Beginning of period assets</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">22,097</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">24,599</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">25,879&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Outflows</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;">(1,774)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;">(2,912)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;">(1,479)&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Market appreciation</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,013</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">410</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">199&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">End of period assets</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">21,336</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">22,097</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">24,599&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-19" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Average assets during the period</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">22,843</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">23,406</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">25,027&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-20" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:8pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Fixed Income</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Beginning of period assets</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">15,273</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">4,356</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">3,324&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Inflows</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;">5,940</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;">11,300</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;">1,130&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Market depreciation</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(16)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(383)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(98)&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">End of period assets</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">21,197</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">15,273</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">4,356&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-22" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Average assets during the period</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">19,804</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">9,039</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">3,565&#160;&#160;</p>
					</td>
				</tr>

		</table>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">52</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-18" style="height:12pt;">
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="8" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 51.55%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Year Ended December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height:12pt;">
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="TCH_left" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:10pt;">International Developed Market Equity</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Beginning of period assets</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">10,195</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">11,894</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">9,414</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Inflows</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">2,850</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">101</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,260</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Market appreciation/(depreciation)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">2,058</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(1,800)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,220</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">End of period assets</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">15,103</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">10,195</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">11,894</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-19" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Average assets during the period</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">12,824</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">10,568</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">10,750</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-20" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:8pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Emerging Market Equity</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Beginning of period assets</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">8,116</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">10,375</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">8,539</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Inflows</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,678</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">27</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">2,041</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Market appreciation/(depreciation)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">932</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(2,286)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(205)</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">End of period assets</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">10,726</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">8,116</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">10,375</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-19" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Average assets during the period</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">9,287</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">8,843</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">10,619</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-20" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:8pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Leveraged&#160;&amp; Inverse</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Beginning of period assets</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,754</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,777</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,486</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">(Outflows)/inflows</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(5)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">193</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">41</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Market appreciation/(depreciation)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">66</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(216)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">250</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">End of period assets</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,815</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,754</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,777</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-19" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Average assets during the period</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">1,813</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">1,704</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">1,679</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-20" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:8pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Cryptocurrency</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Beginning of period assets</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">136</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">357</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">168</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Inflows</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">50</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">36</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">84</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Market appreciation/(depreciation)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">228</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(257)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">105</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">End of period assets</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">414</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">136</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">357</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-19" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Average assets during the period</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">247</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">230</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">312</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-20" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:8pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Alternatives</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:8pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Beginning of period assets</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">310</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">261</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">215</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Inflows</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">41</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">91</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">39</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Market appreciation/(depreciation)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">26</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(42)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">7</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">End of period assets</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">377</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">310</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">261</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-19" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Average assets during the period</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">328</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">298</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">224</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-23" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;width: 47.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Headcount</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:8pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:8pt;margin-right:6pt;">303</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:8pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 13.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:8pt;margin-right:6pt;">273</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:8pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 15.27%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:8pt;margin-right:6pt;">241</p>
					</td>
				</tr>

		</table>
		<p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:10pt;text-indent:0pt;margin-top:10pt;">Note: Previously issued statistics may be restated due to fund closures and trade adjustments</p>
		<p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-top:5pt;text-indent:0pt;margin-top:5pt;">Source: WisdomTree</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:10pt;margin-top:10pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Year Ended December&#160;31, 2023 Compared to Year Ended December&#160;31, 2022</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:10pt;margin-top:10pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Selected Operating and Financial Information</span></p>
		<table class="No-Table-Style TableOverride-2" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-20" style="height:12pt;">
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 39.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="5" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 29.33%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Year Ended<br/>December&#160;31,</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Change</span></p>
					</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.87%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Percent <br/>Change</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height:12pt;">
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.92%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.92%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 39.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="TCH_left" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:10pt;">AUM (in millions)</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.36%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 39.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Average AUM</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.99%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.93%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">92,847</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.99%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.93%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">76,969</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.99%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.37%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">15,878</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.87%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">20.6%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-23" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;width: 39.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Operating Revenues (in thousands)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.99%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 11.93%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.99%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 11.93%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.99%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 11.37%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 12.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 39.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Advisory fees</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.99%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.93%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">333,227</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.99%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.93%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">293,632</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.99%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.37%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">39,595</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">13.5%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 39.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other income</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.99%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.93%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">15,808</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.99%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.93%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">7,713</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.99%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.37%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">8,095</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.87%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">105.0%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 39.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total revenues</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.99%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.93%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">349,035</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.99%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.93%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">301,345</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.99%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.37%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">47,690</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.87%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">15.8%</p>
					</td>
				</tr>

		</table>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">53</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Operating Revenues</span></p>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Advisory fees</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Advisory fee revenues increased 13.5% from $293.6&#160;million during the year ended December&#160;31, 2022 to $333.2&#160;million during the year ended December&#160;31, 2023 as higher average AUM was partially offset by a decline in our average advisory fee. Our average advisory fee declined from 0.38% during the year ended December&#160;31, 2022 to 0.36% during the year ended December&#160;31, 2023.</p>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Other income</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Other income increased 105.0% from $7.7&#160;million during the year ended December&#160;31, 2022 to $15.8&#160;million during the year ended December&#160;31, 2023 primarily due to large flows from some of our European products.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Operating Expenses</span></p>
		<table class="No-Table-Style _idGenTablePara-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-20" style="height:12pt;">
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 44.34%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">

						<p class="TCH_left" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:0pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">(in thousands)</span></p>
					</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="5" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 29.25%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Year Ended<br/>December&#160;31,</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Change</span></p>
					</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.79%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Percent <br/>Change</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height:12pt;">
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.92%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.92%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.34%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Compensation and benefits</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.03%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">109,532</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.03%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">97,897</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">11,635</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.79%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">11.9%&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.34%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Fund management and administration</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.03%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">71,348</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.03%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">64,761</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,587</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.79%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">10.2%&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.34%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Marketing and advertising</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.03%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">17,256</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.03%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">15,302</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,954</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.79%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">12.8%&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.34%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Sales and business development</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.03%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">13,584</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.03%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">11,871</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,713</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.79%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">14.4%&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.34%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Contractual gold payments</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.03%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,069</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.03%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">17,108</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(11,039)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.79%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(64.5%)</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.34%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Professional fees</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.03%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">18,969</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.03%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">13,800</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">5,169</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.79%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">37.5%&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.34%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Occupancy, communications and equipment</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.03%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">4,684</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.03%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">3,898</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">786</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.79%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">20.2%&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.34%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Depreciation and amortization</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.03%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">872</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.03%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">262</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">610</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.79%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">232.8%&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.34%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Third-party distribution fees</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.03%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">9,377</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.03%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">7,656</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,721</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.79%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">22.5%&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.34%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.03%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">9,852</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.03%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">8,705</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,147</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.79%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">13.2%&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 44.34%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total operating expenses</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.03%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">261,543</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.03%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">241,260</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.89%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">20,283</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.79%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">8.4%&#160;</p>
					</td>
				</tr>

		</table>
		<table class="No-Table-Style _idGenTablePara-3" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-20" style="height:12pt;">
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-left-color:#000000;border-right-color:#000000;border-top-color:#000000;padding-left:0pt;width: 69.89%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">

						<p class="TCH_left" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">As a Percent of Revenues:</span></p>
					</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-left-color:#000000;border-right-color:#000000;border-top-color:#000000;padding-left:0pt;padding-right:0pt;width: 1.70%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="3" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-color:#000000;border-left-color:#000000;border-top-color:#000000;padding-left:0pt;padding-right:0pt;width: 28.41%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Year&#160;Ended <br/>December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-left-color:#000000;border-right-color:#000000;border-top-color:#000000;padding-left:0pt;padding-right:0pt;width: 12.50%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-left-color:#000000;border-right-color:#000000;border-top-color:#000000;padding-left:0pt;padding-right:0pt;width: 1.70%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-left-color:#000000;border-top-color:#000000;padding-left:0pt;padding-right:0pt;width: 14.20%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 69.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Compensation and benefits</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.70%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.50%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">31.6%</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.70%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.20%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">32.5%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 69.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Fund management and administration</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.70%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.50%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">20.4%</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.70%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.20%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">21.5%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 69.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Marketing and advertising</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.70%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.50%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">4.9%</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.70%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.20%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">5.1%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 69.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Sales and business development</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.70%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.50%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">3.9%</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.70%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.20%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">3.9%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 69.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Contractual gold payments</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.70%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.50%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1.7%</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.70%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.20%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">5.7%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 69.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Professional fees</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.70%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.50%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">5.4%</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.70%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.20%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">4.6%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 69.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Occupancy, communications and equipment</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.70%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.50%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1.3%</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.70%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.20%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1.3%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 69.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Depreciation and amortization</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.70%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.50%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">0.2%</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.70%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.20%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">0.1%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 69.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Third-party distribution fees</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.70%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.50%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">2.7%</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.70%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.20%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">2.5%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 69.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.70%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.50%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">2.8%</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.70%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.20%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">2.9%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 69.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total operating expenses</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.70%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.50%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">74.9%</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.70%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.20%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">80.1%</p>
					</td>
				</tr>

		</table>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Compensation and benefits</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Compensation and benefits expense increased 11.9% from $97.9&#160;million during the year ended December&#160;31, 2022 to $109.5&#160;million during the year ended December&#160;31, 2023 due to higher stock<span class="nobreak">-based</span> compensation and headcount. Headcount was 273 and 303 at December&#160;31, 2022 and 2023, respectively.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">54</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Fund management and administration</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Fund management and administration expense increased 10.2% from $64.8&#160;million during the year ended December&#160;31, 2022 to $71.3&#160;million during the year ended December&#160;31, 2023 primarily due to higher average AUM and inflows. We had 79 U.S.&#160;listed ETFs and 260 European listed ETPs at December&#160;31, 2022 compared to 76&#160;U.S.&#160;listed ETFs and 261 European listed ETPs at December&#160;31, 2023.</p>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Marketing and advertising</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Marketing and advertising expense increased 12.8% from $15.3&#160;million during the year ended December&#160;31, 2022 to $17.3&#160;million during the year ended December&#160;31, 2023 primarily resulting from higher spending related to our U.S.&#160;listed products.</p>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Sales and business development</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Sales and business development expense increased 14.4% from $11.9&#160;million during the year ended December&#160;31, 2022 to $13.6&#160;million during the year ended December&#160;31, 2023 primarily resulting from increases in travel and events spending.</p>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Contractual gold payments</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Contractual gold payments expense decreased 64.5% from $17.1&#160;million during the year ended December&#160;31, 2022 to $6.1&#160;million during the year ended December&#160;31, 2023 due to the termination of our deferred consideration&#8212;gold payments obligation on May&#160;10, 2023. See Note&#160;9 to our Consolidated Financial Statements for additional information.</p>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Professional fees</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Professional fees increased 37.5% from $13.8&#160;million during the year ended December&#160;31, 2022 to $19.0&#160;million during the year ended December&#160;31, 2023 due to higher expenses related to our digital assets business, as well as expenses incurred to terminate our deferred consideration&#8212;gold payments obligation and higher expenses related to an activist campaign.</p>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Occupancy, communications and equipment</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Occupancy, communications and equipment expense increased 20.2% from $3.9&#160;million during the year ended December&#160;31, 2022 to $4.7&#160;million during the year ended December&#160;31, 2023 as our New&#160;York office lease became effective in May&#160;2022.</p>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Depreciation and amortization</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Depreciation and amortization expense increased 232.8% from $0.3&#160;million during the year ended December&#160;31, 2022 to $0.9&#160;million during the year ended December&#160;31, 2023 due to amortization of software development costs.</p>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Third-party distribution fees</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Third<span class="nobreak">-party</span> distribution fees increased 22.5% from $7.7&#160;million during the year ended December&#160;31, 2022 to $9.4&#160;million during the year ended December&#160;31, 2023 primarily due to AUM growth we are experiencing in Latin America.</p>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Other</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Other expenses increased 13.2% from $8.7&#160;million during the year ended December&#160;31, 2022 to $9.9&#160;million during the year ended December&#160;31, 2023 primarily due to higher travel, public relations and Board of Directors expenses.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">55</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Other Income/(Expenses)</span></p>
		<table class="No-Table-Style _idGenTablePara-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-20" style="height:12pt;">
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 45.02%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">

						<p class="TCH_left" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:0pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">(in thousands)</span></p>
					</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="5" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 26.54%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Year Ended<br/>December&#160;31,</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Change</span></p>
					</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Percent <br/>Change</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height:12pt;">
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 45.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Interest expense</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(15,242)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(14,935)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.72%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(307)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">2.1%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-10" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 45.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Gain on revaluation/termination of deferred consideration&#8212;gold payments</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">61,953</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">27,765</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.72%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">34,188</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">123.1%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 45.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Interest income</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">4,099</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">3,320</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.72%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">779</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">23.5%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 45.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Impairments</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(7,942)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.72%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(7,942)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">n/a</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 45.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Loss on extinguishment of convertible notes</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(9,721)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.72%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(9,721)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">n/a</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 45.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other losses, net</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.66%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(1,631)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.66%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(36,285)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.72%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">34,654</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">95.5%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:8pt;width: 45.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total other income/(expenses), net</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.66%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">31,516</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.66%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(20,135)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 9.72%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">51,651</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.42%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">256.5%</p>
					</td>
				</tr>

		</table>
		<table class="No-Table-Style _idGenTablePara-4" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-20" style="height:12pt;">
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 68.31%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">

						<p class="TCH_left" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">As a Percent of Revenues:</span></p>
					</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="3" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 29.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Year Ended <br/>December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.95%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 68.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Interest expense</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(4.4%)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(5.0%)</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-10" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 68.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Gain on revaluation/termination of deferred consideration&#8212;gold payments</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">17.8%</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">9.2%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 68.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Interest income</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">1.2%</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">1.1%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 68.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Impairments</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(2.3%)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 68.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Loss on extinguishment of convertible notes</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(2.8%)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 68.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other losses, net</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(0.5%)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.95%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(12.0%)</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 68.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total other income/(expenses), net</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">9.0%</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.95%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(6.7%)</p>
					</td>
				</tr>

		</table>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Interest expense</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Interest expense was essentially unchanged during the year ended December&#160;31, 2023.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our effective interest rate on our outstanding convertible notes during the&#160;years ended December&#160;31, 2022 and 2023 was 4.6% and 4.9%, respectively.</p>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Gain on revaluation/termination of deferred consideration</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We recognized a gain on revaluation/termination of deferred consideration&#8212;gold payments of $27.8&#160;million and $62.0&#160;million during the&#160;years ended December&#160;31, 2022 and 2023, respectively. This obligation was terminated on May&#160;10, 2023 for approximately $137.0&#160;million. See Note&#160;9 to our Consolidated Financial Statements for additional information.</p>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Interest income</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Interest income increased 23.5% from $3.3&#160;million during the year ended December&#160;31, 2022 to $4.1&#160;million during the year ended December&#160;31, 2023 due to rising interest rates, partially offset by a decrease in our interest<span class="nobreak">-bearing</span> assets.</p>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Impairments</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">During the year ended December&#160;31, 2023, we recognized a non<span class="nobreak">-cash</span> impairment charge of $7.9&#160;million primarily related to our investment in Securrency, Inc. upon the sale of Securrency, Inc. to an unrelated third party. (See Notes<span class="nobreak"> </span>7,<span class="nobreak"> </span>8, 13 and 26 to our Consolidated Financial Statements).</p>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Other losses, net</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Other losses, net were $36.3&#160;million and $1.6&#160;million during the&#160;years ended December&#160;31, 2022 and 2023, respectively. This includes a charge of $19.9&#160;million and $1.4&#160;million during the&#160;years ended December&#160;31, 2022 and 2023, respectively, arising from the release of a tax<span class="nobreak">-related</span> indemnification asset upon the expiration of the statute of limitations. An equal and offsetting benefit has been recognized in income tax expense. During the&#160;years ended December&#160;31, 2022 and 2023, we also recognized losses on our financial instruments owned and investments of $16.9&#160;million and $0.7&#160;million, respectively. Gains and losses also generally arise from the sale of gold earned from advisory fees paid by our physically<span class="nobreak">-backed</span> gold ETPs, foreign exchange fluctuations and other miscellaneous items.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">56</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Income Taxes</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our effective income tax rate for 2023 was 13.8%, resulting in income tax expense of $16.5&#160;million. The effective tax rate differs from the federal statutory rate of 21% primarily due to a non<span class="nobreak">-taxable</span> gain on revaluation/termination of deferred consideration, a reduction in unrecognized tax benefits associated with the release of the tax<span class="nobreak">-related</span> indemnification asset described above and a lower tax rate on foreign earnings. These items were partly offset by a non<span class="nobreak">-deductible</span> loss on extinguishment of our 4.25% Convertible Senior Notes due 2023 during the first quarter of 2023, an increase in the deferred tax asset valuation allowance on losses recognized on our investments and non<span class="nobreak">-deductible</span> executive compensation.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our effective income tax rate for the year ended December&#160;31, 2022 was negative 26.9%, resulting in an income tax benefit of $10.7&#160;million. Our tax rate differs from the federal statutory rate of 21% primarily due to a $19.9&#160;million reduction in unrecognized tax benefits associated with the release of the tax<span class="nobreak">-related</span> indemnification asset described above, a reduction in the valuation allowance on foreign net operating losses, a non<span class="nobreak">-taxable</span> gain on revaluation of deferred consideration and a lower tax rate on foreign earnings. These items were partly offset by an increase in the deferred tax asset valuation allowance on losses recognized on financial instruments owned.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Year Ended December&#160;31, 2022 Compared to Year Ended December&#160;31, 2021</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Selected Operating and Financial Information</span></p>
		<table class="No-Table-Style TableOverride-3" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-20" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 42.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="5" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 27.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Year Ended<br/>December&#160;31,</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.31%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Change</span></p>
					</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Percent<br/>Change</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 42.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 42.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="TCH_left" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:10pt;">AUM (in millions)</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 42.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Average AUM</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.95%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">76,969</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.95%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">73,430</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.95%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">3,539</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">4.8%&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-23" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;width: 42.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Operating Revenues (in thousands)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.95%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 11.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.95%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 11.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.95%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 11.36%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 42.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Advisory fees</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.95%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">293,632</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.95%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">298,052</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.95%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.36%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(4,420)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(1.5%)</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 42.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other income</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.95%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">7,713</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.95%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">6,266</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.95%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,447</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">23.1%&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 42.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total revenues</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.95%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">301,345</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.95%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">304,318</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.95%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(2,973)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(1.0%)</p>
					</td>
				</tr>

		</table>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:14pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Operating Revenues</span></p>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Advisory fees</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Advisory fee revenues decreased 1.5% from $298.1&#160;million during the year ended December&#160;31, 2021 to $293.6&#160;million in the comparable period in 2022 as higher average AUM was offset by a decline in our average advisory fee. Our average advisory fee decreased from 0.41% during the year ended December&#160;31, 2021 to 0.38% during the year ended December&#160;31, 2022 due to AUM mix shift.</p>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Other income</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Other income increased 23.1% from $6.3&#160;million during the year ended December&#160;31, 2021 to $7.7&#160;million in the comparable period in 2022 primarily due to higher fees associated with our European listed products.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">57</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Operating Expenses</span></p>
		<table class="No-Table-Style TableOverride-4" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-20" style="height:12pt;">
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.02%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">

						<p class="TCH_left" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:0pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">(in thousands)</span></p>
					</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="5" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 28.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Year Ended<br/>December&#160;31,</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.86%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Change</span></p>
					</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.50%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Percent <br/>Change</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height:12pt;">
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.35%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.35%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Compensation and benefits</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.37%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">97,897</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.37%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">88,163</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">9,734</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.50%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">11.0%&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Fund management and administration</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.37%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">64,761</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.37%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">58,912</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">5,849</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.50%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">9.9%&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Marketing and advertising</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.37%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">15,302</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.37%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">14,090</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,212</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.50%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">8.6%&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Sales and business development</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.37%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">11,871</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.37%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">9,907</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,964</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.50%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">19.8%&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Contractual gold payments</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.37%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">17,108</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.37%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">17,096</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">12</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.50%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">0.1%&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Professional fees</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.37%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">13,800</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.37%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">7,616</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,184</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.50%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">81.2%&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-10" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Occupancy, communications and equipment</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.37%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">3,898</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.37%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">4,629</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(731)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.50%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(15.8%)</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Depreciation and amortization</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.37%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">262</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.37%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">738</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(476)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.50%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(64.5%)</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Third-party distribution fees</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.37%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">7,656</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.37%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">7,176</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">480</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.50%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">6.7%&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.37%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">8,705</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.37%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">6,933</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.88%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,772</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.50%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">25.6%&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:50pt;">Total operating expenses</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.37%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">241,260</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.37%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">215,260</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.88%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">26,000</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.50%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">12.1%&#160;</p>
					</td>
				</tr>

		</table>
		<table class="No-Table-Style _idGenTablePara-5" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-20" style="height:12pt;">
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 68.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">

						<p class="TCH_left" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">As a Percent of Revenues:</span></p>
					</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="3" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 29.85%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Year&#160;Ended <br/>December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.93%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 68.36%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Compensation and benefits</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">32.5%</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.93%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">28.9%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 68.36%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Fund management and administration</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">21.5%</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.93%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">19.4%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 68.36%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Marketing and advertising</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">5.1%</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.93%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">4.6%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 68.36%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Sales and business development</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">3.9%</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.93%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">3.3%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 68.36%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Contractual gold payments</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">5.7%</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.93%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">5.6%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 68.36%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Professional fees</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">4.6%</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.93%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">2.5%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 68.36%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Occupancy, communications and equipment</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">1.3%</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.93%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">1.5%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 68.36%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Depreciation and amortization</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">0.1%</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.93%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">0.2%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 68.36%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Third-party distribution fees</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">2.5%</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.93%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">2.4%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 68.36%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">2.9%</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.93%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">2.3%</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 68.36%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total operating expenses</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">80.1%</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.93%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">70.7%</p>
					</td>
				</tr>

		</table>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Compensation and benefits</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Compensation and benefits expense increased 11.0% from $88.2&#160;million during the year ended December&#160;31, 2021 to $97.9&#160;million in the comparable period in 2022 due to higher incentive compensation and headcount. Headcount was 241 and 273 at December&#160;31, 2021 and 2022, respectively.</p>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Fund management and administration</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Fund management and administration expense increased 9.9% from $58.9&#160;million during the year ended December&#160;31, 2021 to $64.8&#160;million in the comparable period in 2022 primarily due to higher average AUM, product launches and inflows. We had 75 U.S.&#160;listed ETFs and 254 European listed ETPs at December&#160;31, 2021 compared to 79 U.S.&#160;listed ETFs and 269 European listed ETPs at December&#160;31, 2022.</p>
		<p class="H4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:12pt;margin-top:6pt;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Marketing and advertising</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Marketing and advertising expense increased 8.6% from $14.1&#160;million during the year ended December&#160;31, 2021 to $15.3&#160;million in the comparable period in 2022 primarily resulting from an increase in online and television advertising.</p>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Sales and business development</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Sales and business development expense increased 19.8% from $9.9&#160;million during the year ended December&#160;31, 2021 to $11.9&#160;million in the comparable period in 2022 primarily resulting from increases in conference and events spending as well as market data costs.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">58</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Contractual gold payments</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Contractual gold payments expense was essentially unchanged from the year ended December&#160;31, 2021. This expense was associated with the annual payment of 9,500 ounces of gold and was calculated using the average daily spot price of $1,800 per ounce during the&#160;years ended December&#160;31, 2021 and 2022, respectively.</p>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Professional fees</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Professional fees increased 81.2% from $7.6&#160;million during the year ended December&#160;31, 2021 to $13.8&#160;million in the comparable period in 2022 due to $4.5&#160;million incurred in response to an activist campaign and spending related to our digital assets business.</p>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Occupancy, communications and equipment</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Occupancy, communications and equipment expense decreased 15.8% from $4.6&#160;million during the year ended December&#160;31, 2021 to $3.9&#160;million in the comparable period in 2022 as we reduced our office footprint in the U.S.&#160;and Europe.</p>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Depreciation and amortization</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Depreciation and amortization expense decreased 64.5% from $0.7&#160;million during the year ended December&#160;31, 2021 to $0.3&#160;million in the comparable period in 2022 as we reduced our office footprint in the U.S.&#160;and Europe.</p>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Third-party distribution fees</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Third<span class="nobreak">-party</span> distribution fees increased 6.7% from $7.2&#160;million during the year ended December&#160;31, 2021 to $7.7&#160;million in the comparable period in 2022 primarily due to new platform relationships in Europe and higher U.S.&#160;listed AUM on third<span class="nobreak">-party</span> platforms, partly offset by lower fees paid to our third<span class="nobreak">-party</span> marketing agent in Latin America.</p>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Other</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Other expenses increased 25.6% from $6.9&#160;million during the year ended December&#160;31, 2021 to $8.7&#160;million in the comparable period in 2022 primarily due to higher insurance, public company compliance, travel and directors expenses.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Other Income/(Expenses)</span></p>
		<table class="No-Table-Style _idGenTablePara-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-20" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 42.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="5" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Year Ended<br/>December&#160;31,</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Change</span></p>
					</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Percent <br/>Change</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 42.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH_left" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">(in thousands)</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.86%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.86%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 42.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Interest expense</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(14,935)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(12,332)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(2,603)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">21.1%&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-10" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 42.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Gain on revaluation/termination of deferred consideration&#8212;gold payments</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">27,765</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">2,018</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">25,747</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">1,275.9%&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 42.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Interest income</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">3,320</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">2,009</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,311</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">65.3%&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 42.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Impairments</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(16,156)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">16,156</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">n/a&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 42.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other losses, net</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.95%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(36,285)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.95%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(7,926)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(28,359)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">357.8%&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 42.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:50pt;">Total other expenses, net</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.95%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(20,135)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.95%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(32,387)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 11.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">12,252</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.43%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(37.8%)</p>
					</td>
				</tr>

		</table>
		<table class="No-Table-Style TableOverride-5" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-20" style="height:12pt;">
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 64.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">

						<p class="TCH_left" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">As a Percent of Revenues:</span></p>
					</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="3" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 34.29%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Year Ended<br/>December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.43%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.14%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 64.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Interest expense</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.43%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(5.0%)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(4.1%)</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-10" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 64.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Gain on revaluation/termination of deferred consideration&#8212;gold payments</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.43%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">9.2%&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">0.7%&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 64.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Interest income</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.43%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">1.1%&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">0.7%&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 64.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Impairments</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.43%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(5.3%)</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 64.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other losses, net</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.43%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(12.0%)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.14%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(2.6%)</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 64.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total other expenses, net</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.43%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(6.7%)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.14%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(10.6%)</p>
					</td>
				</tr>

		</table>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">59</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Interest expense</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Interest expense increased 21.1% from $12.3&#160;million during the year ended December&#160;31, 2021 to $14.9&#160;million in the comparable period in 2022 due to a higher level of debt outstanding in the current period. Our effective interest rate was 4.6% during the&#160;years ended December&#160;31, 2021 and 2022.</p>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Gain on revaluation/termination of deferred consideration</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We recognized a gain on revaluation/termination of deferred consideration&#8212;gold payments of $2.0&#160;million and $27.8&#160;million during the&#160;years ended December&#160;31, 2021 and 2022, respectively. The gain was primarily due to an increase in the discount rate (from 9.0% to 11.0%) used to compute the present value of the annual payment obligations as well as a steepening of the forward<span class="nobreak">-looking</span> gold curve. The magnitude of any gain or loss is highly correlated to changes in the discount rate and the magnitude of the change in the forward<span class="nobreak">-looking</span> price of gold.</p>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Interest income</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Interest income increased 65.3% from $2.0&#160;million during the year ended December&#160;31, 2021 to $3.3&#160;million in the comparable period in 2022 due to an increase in our interest<span class="nobreak">-bearing</span> assets.</p>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Impairments</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">During the year ended December&#160;31, 2021, we recognized impairment charges totaling $16.2&#160;million, including a loss of $9.3&#160;million upon the termination of the lease of our former principal executive office at 245 Park Avenue, New&#160;York, New&#160;York, $6.6&#160;million related to the write<span class="nobreak">-off</span> of leasehold improvements and fixed assets associated with our former New&#160;York office and $0.3&#160;million upon exiting our London office (See Notes<span class="nobreak"> </span>7,<span class="nobreak"> </span>8, 13 and 26 to our Consolidated Financial Statements).</p>
		<p class="H3_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:12pt;margin-right:0;margin-top:6pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Other losses, net</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Other losses, net were ($7.9) million and ($36.3) million during the&#160;years ended December&#160;31, 2021 and 2022, respectively. This includes a charge of $5.2&#160;million and $19.9&#160;million during the&#160;years ended December&#160;31, 2021 and 2022, respectively, arising from the release of a tax<span class="nobreak">-related</span> indemnification asset upon the expiration of the statute of limitations. An equal and offsetting benefit has been recognized in income tax expense. During the year ended December&#160;31, 2021 and 2022, we also recognized losses on our financial instruments owned of $3.7&#160;million and $16.5&#160;million, respectively. In addition, during the year ended December&#160;31, 2021, we recognized a gain of $0.8&#160;million related to the remeasurement of contingent consideration payable to us from the sale of our former Canadian ETF business.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Gains and losses also generally arise from the sale of gold earned from advisory fees paid by our physically<span class="nobreak">-backed</span> gold ETPs, foreign exchange fluctuations and other miscellaneous items.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Income Taxes</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our effective income tax rate for the year ended December&#160;31, 2022 was negative 26.9%, resulting in an income tax benefit of $10.7&#160;million. Our tax rate differs from the federal statutory rate of 21% primarily due to a $19.9&#160;million reduction in unrecognized tax benefits associated with the release of the tax<span class="nobreak">-related</span> indemnification asset described above, a reduction in the valuation allowance on foreign net operating losses, a non<span class="nobreak">-taxable</span> gain on revaluation of deferred consideration and a lower tax rate on foreign earnings. These items were partly offset by an increase in the deferred tax asset valuation allowance on losses recognized on financial instruments owned.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our effective income tax rate for the year ended December&#160;31, 2021 of 12.1% resulted in income tax expense of $6.9&#160;million. Our effective income tax rate differs from the federal statutory rate of 21% primarily due to a $5.2&#160;million reduction in unrecognized tax benefits and a lower tax rate on foreign earnings. These items were partly offset by tax shortfalls associated with the vesting and exercise of stock<span class="nobreak">-based</span> compensation and non<span class="nobreak">-deductible</span> executive compensation.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">60</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>




	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Quarterly Results</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The following tables set forth our unaudited consolidated quarterly statement of operations data, both in dollar amounts and as a percentage of total revenues, and our unaudited consolidated quarterly operating data for the quarters in 2023 and 2022. In our opinion, this unaudited information has been prepared on substantially the same basis as the consolidated financial statements appearing elsewhere in this Report and includes all adjustments (consisting of normal recurring adjustments) necessary for a fair statement of the unaudited consolidated quarterly data. The unaudited consolidated quarterly data should be read together with the consolidated financial statements and related notes included elsewhere in this Report. The results for any quarter are not necessarily indicative of results for any future period, and you should not rely on them as such.</p>
		<table class="No-Table-Style TableOverride-6" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-19" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">

						<p class="TCH_left" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;font-size:8pt;">(in thousands, except per share amounts)</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.72%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q4/23</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.72%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q3/23</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.72%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q2/23</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q1/23</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.72%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q4/22</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.72%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q3/22</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q2/22</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 9.65%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q1/22</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-47" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:6pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="TCH_left" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Operating Revenues:</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 8.72%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 8.72%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 8.72%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 8.53%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 8.72%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 8.72%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 9.65%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:10pt;margin-right:3pt;text-indent:-5pt;"><span class="CharOverride-4" style="font-size:8pt;">Advisory fees</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">86,988</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">86,598</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">82,004</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">77,637</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">70,913</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">70,616</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">75,586</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">76,517</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:10pt;margin-right:3pt;text-indent:-5pt;"><span class="CharOverride-4" style="font-size:8pt;">Other income</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">3,856</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">3,825</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">3,720</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">4,407</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,397</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,798</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,667</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,851</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;margin-right:3pt;margin-top:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Total revenues</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">90,844</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">90,423</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">85,724</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">82,044</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">73,310</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">72,414</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">77,253</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">78,368</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-47" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:6pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-right:3pt;margin-top:3pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Operating Expenses:</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:10pt;margin-right:3pt;text-indent:-5pt;"><span class="CharOverride-4" style="font-size:8pt;">Compensation and benefits</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">27,860</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">27,955</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">26,319</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">27,398</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">24,831</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">23,714</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">24,565</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">24,787</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-48" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Fund management and administration</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">18,445</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">18,023</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">17,727</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">17,153</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">16,906</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">16,285</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">16,076</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">15,494</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:10pt;margin-right:3pt;text-indent:-5pt;"><span class="CharOverride-4" style="font-size:8pt;">Marketing and advertising</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">4,951</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">3,833</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">4,465</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">4,007</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">4,240</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">3,145</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">3,894</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">4,023</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Sales and business development</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">3,881</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">3,383</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">3,326</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,994</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">3,407</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,724</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">3,131</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,609</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:10pt;margin-right:3pt;text-indent:-5pt;"><span class="CharOverride-4" style="font-size:8pt;">Contractual gold payments</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,583</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">4,486</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">4,107</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">4,105</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">4,446</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">4,450</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:10pt;margin-right:3pt;text-indent:-5pt;"><span class="CharOverride-4" style="font-size:8pt;">Professional fees</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">3,201</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">3,719</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">8,334</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">3,715</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,666</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,367</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">4,308</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">4,459</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-48" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Occupancy, communications and equipment</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,208</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,203</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,172</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,101</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,110</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">986</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,049</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">753</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Depreciation and amortization</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">335</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">307</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">121</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">109</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">104</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">58</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">53</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">47</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Third-party distribution fees</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,549</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,694</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,881</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,253</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,793</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,833</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,818</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,212</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:10pt;margin-right:3pt;text-indent:-5pt;"><span class="CharOverride-4" style="font-size:8pt;">Other</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,379</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,601</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,615</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,257</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,427</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,324</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,109</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,845</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;margin-right:3pt;margin-top:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Total operating expenses</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">64,809</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">63,718</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">67,543</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">65,473</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">61,591</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">57,541</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">61,449</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">60,679</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-47" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:6pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Operating income</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">26,035</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">26,705</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">18,181</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">16,571</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">11,719</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">14,873</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">15,804</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">17,689</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-47" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:6pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-right:3pt;margin-top:3pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Other Income/(Expenses):</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Interest expense</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(3,758)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(3,461)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(4,021)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(4,002)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(3,736)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(3,734)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(3,733)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(3,732)</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-49" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Gain/(loss) on revaluation/termination of deferred consideration</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">41,361</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">20,592</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:6pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(35,423)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">77,895</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,311</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(17,018)</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Interest income</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,225</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">791</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,000</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,083</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">945</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">811</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">770</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">794</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Impairments</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:6pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(339)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:6pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(2,703)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:6pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(4,900)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-48" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Loss on extinguishment of convertible notes</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:6pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(9,721)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Other gains and losses, net</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,602</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(2,512)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,286</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(2,007)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(1,815)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(5,289)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(4,474)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(24,707)</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-20" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Income/(loss) before income taxes</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">24,765</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">18,820</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">57,807</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">17,616</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(28,310)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">84,556</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">10,678</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(26,974)</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Income tax expense/(benefit)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">5,688</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">5,836</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">3,555</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,383</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(21)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">3,327</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,673</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(16,713)</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:6pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-right:3pt;margin-top:3pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Net income/(loss)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">19,077</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">12,984</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">54,252</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">16,233</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(28,289)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">81,229</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">8,005</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(10,261)</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:6pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:10pt;margin-right:3pt;margin-top:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Earnings/(loss) per share&#8212;basic</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">0.16</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">0.07</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">0.32</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">0.10</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(0.20)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">0.50</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">0.05</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(0.08)</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:6pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:10pt;margin-right:3pt;margin-top:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Earnings/(loss) per share&#8212;diluted</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">0.16</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">0.07</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">0.32</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">0.10</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(0.20)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">0.50</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">0.05</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(0.08)</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:6pt;width: 21.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:10pt;margin-right:3pt;margin-top:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Dividends per common share</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">0.03</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">0.03</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">0.03</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.05%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">0.03</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">0.03</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 7.24%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">0.03</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 6.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">0.03</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">0.03</span></p>
					</td>
				</tr>

		</table>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">61</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<table class="No-Table-Style TableOverride-6" style="width: 100%; border-collapse: collapse; border: #000 0pt solid; border-width: 0pt; margin: 6pt 0 0pt">


				<tr class="No-Table-Style _idGenTableRowColumn-21" style="height:12pt;">
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">

					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q4/23</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q3/23</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q2/23</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q1/23</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q4/22</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q3/22</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q2/22</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q1/22</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="height:12pt;">
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-left:0pt;text-align:left;"><span class="CharOverride-1" style="font-style:normal;font-weight:bold;text-decoration:underline;">Percent of Total Revenues</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="height:12pt;">
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">
						<p class="TCH_left" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Operating Revenues</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 21.15%; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Advisory fees</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 7.24%; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:6pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">95.8%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 7.24%; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">95.8%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 7.24%; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:6pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">95.7%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 7.05%; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">94.6%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 7.24%; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">96.7%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 7.24%; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">97.5%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 6.68%; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">97.8%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 8.16%; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">97.6%&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="height:12pt;">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:10pt;margin-right:3pt;text-indent:-5pt;"><span class="CharOverride-4" style="font-size:8pt;">Other income</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">4.2%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">4.2%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">4.3%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">5.4%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">3.3%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">2.5%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">2.2%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">2.4%&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Total revenues</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">100.0%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">100.0%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">100.0%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">100.0%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">100.0%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">100.0%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">100.0%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">100.0%&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-47" style="height:12pt;">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-right:3pt;margin-top:3pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Operating Expenses</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Compensation and benefits</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">30.6%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">31.0%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:6pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">30.7%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">33.5%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">34.0%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">32.7%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">31.7%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">31.5%&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-48" style="height:12pt;">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Fund management and administration</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">20.3%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">20.0%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:6pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">20.7%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">20.9%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">23.1%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">22.5%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">20.7%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">19.8%&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Marketing and advertising</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">5.5%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">4.2%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:6pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">5.2%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">4.9%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">5.8%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">4.3%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">5.0%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">5.1%&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="height:12pt;">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Sales and business development</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">4.3%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">3.7%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:6pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">3.9%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">3.6%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">4.6%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">3.8%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">4.1%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">3.3%&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Contractual gold payments</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">n/a&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:6pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">1.8%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">5.5%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">5.6%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">5.7%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">5.8%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">5.7%&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="height:12pt;">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Professional fees</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">3.5%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">4.1%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:6pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">9.7%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">4.5%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">3.6%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">3.3%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">5.6%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">5.7%&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-48" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Occupancy, communications and equipment</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">1.3%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">1.3%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:6pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">1.4%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">1.3%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">1.5%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">1.4%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">1.4%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">1.0%&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="height:12pt;">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Depreciation and amortization</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">0.4%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">0.3%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:6pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">0.1%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">0.1%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">0.1%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">0.1%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">0.1%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">0.1%&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Third-party distribution fees</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">2.8%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">3.0%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:6pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">2.2%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">2.7%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">2.4%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">2.5%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">2.4%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">2.8%&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height:12pt;">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;"><span class="CharOverride-4" style="font-size:8pt;">Other</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">2.6%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">2.9%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">3.1%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">2.8%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">3.3%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">3.2%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">2.7%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">2.4%&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;margin-top:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Total operating expenses</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">71.3%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">70.5%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">78.8%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">79.8%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">84.0%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">79.5%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">79.5%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">77.4%&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height:12pt;">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;"><span class="CharOverride-4" style="font-size:8pt;">Operating income</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">28.7%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">29.5%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:6pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">21.2%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">20.2%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">16.0%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">20.5%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">20.5%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">22.6%&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-47" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-right:3pt;margin-top:3pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Other Income/(Expenses)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="height:12pt;">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Interest expense</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:6pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(4.1%)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(3.8%)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(4.7%)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(4.9%)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(5.1%)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(5.2%)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(4.8%)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(4.8%)</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-49" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Gain/(loss) on revaluation/termination of deferred consideration</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:6pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">48.2%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">25.1%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(48.3%)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">107.6%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">3.0%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(21.7%)</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="height:12pt;">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Interest income</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:6pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">1.3%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">0.9%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:6pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">1.2%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">1.3%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">1.3%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">1.1%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">1.0%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">1.0%&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Impairments</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(0.4%)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(3.0%)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(6.0%)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;&#160;&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-48" style="height:12pt;">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Loss on extinguishment of convertible notes</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(11.8%)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;&#160;&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Other gains and losses, net</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">1.8%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(2.8%)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">1.5%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(2.4%)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(2.5%)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(7.3%)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(5.8%)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(31.5%)</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-20" style="height:12pt;">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Income/(loss) before income taxes</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:6pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">27.3%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:6pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">20.8%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:6pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">67.4%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">21.5%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(38.6%)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">116.8%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">13.8%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(34.4%)</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Income tax expense/(benefit)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">6.3%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">6.5%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">4.1%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">1.7%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(0.0%)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">4.6%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">3.5%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(21.3%)</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height:12pt;">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-right:3pt;margin-top:3pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Net income/(loss)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">21.0%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">14.4%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">63.3%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">19.8%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(38.6%)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">112.2%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">10.4%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(13.1%)</span></p>
					</td>
				</tr>
</table>

<p style="margin: 0">&#160;</p>


		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">62</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>





	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">


		<table class="No-Table-Style TableOverride-6" style="width: 100%; border-collapse: collapse; border: #000 0pt solid; border-width: 0pt; margin: 6pt 0 0pt">


				<tr class="No-Table-Style _idGenTableRowColumn-21" style="height:12pt;">
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">

					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q4/23</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q3/23</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q2/23</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q1/23</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q4/22</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q3/22</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q2/22</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q1/22</span></p>
					</td>
				</tr>



								<tr class="No-Table-Style _idGenTableRowColumn-47" style="background-color: White; height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 21.15%; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-right:3pt;margin-top:3pt;"><span class="CharOverride-5" style="font-size:8pt;font-style:normal;font-weight:bold;text-decoration:underline;">Operating Statistics</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 7.24%; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 7.24%; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 7.24%; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 7.05%; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 7.24%; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 7.24%; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 6.68%; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 8.16%; vertical-align: bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-47" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:5pt;margin-right:5pt;margin-top:3pt;text-indent:-5pt;"><span class="CharOverride-5" style="font-size:8pt;font-style:normal;font-weight:bold;text-decoration:underline;">GLOBAL ETPs (in millions</span><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="background-color: rgb(204,238,255); height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Beginning of period assets</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">93,735&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">93,666&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">90,740&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">81,993&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">70,878&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">74,302&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">79,407&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">77,479&#160;&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(Outflows)/inflows</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(255)&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,983&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,327&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">6,341&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">5,264&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,747&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">3,852&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,319&#160;&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-48" style="background-color: rgb(204,238,255); height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Market appreciation/(depreciation)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">6,644&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(1,914)&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">599&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,406&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">5,851&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(5,171)&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(8,957)&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">609&#160;&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;margin-top:3pt;"><span class="CharOverride-4" style="font-size:8pt;">End of period assets</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">100,124&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">93,735&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">93,666&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">90,740&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">81,993&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">70,878&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">74,302&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">79,407&#160;&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-50" style="background-color: rgb(204,238,255); height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;margin-top:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Average assets during the period</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">96,557&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">95,743&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">91,578&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">87,508&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">77,649&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">74,677&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">77,738&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">77,809&#160;&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-48" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Average advisory fee during the period</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">0.36%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">0.36%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">0.36%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">0.36%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">0.36%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">0.41%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">0.40%&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">0.41%&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-48" style="background-color: rgb(204,238,255); height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Number of ETPs&#8212;end of the period</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">337&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">344&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">344&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">341&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">339&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">347&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">344&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">341&#160;&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-50" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:5pt;margin-right:5pt;margin-top:3pt;text-indent:-5pt;"><span class="CharOverride-5" style="font-size:8pt;font-style:normal;font-weight:bold;text-decoration:underline;">U.S.&#160;LISTED ETFs (in millions</span><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-51" style="background-color: rgb(204,238,255); height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Beginning of period assets</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">68,018&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">65,903&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">61,283&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">55,973&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">48,043&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">47,255&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">48,622&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">48,210&#160;&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-51" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(Outflows)/inflows</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(67)&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">3,601&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">3,249&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">4,012&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">4,232&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">3,812&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">4,278&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,250&#160;&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-48" style="background-color: rgb(204,238,255); height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Market appreciation/(depreciation)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">4,535&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(1,486)&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,371&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,298&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">3,698&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(3,024)&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(5,645)&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(1,838)&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-18" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;margin-top:3pt;"><span class="CharOverride-4" style="font-size:8pt;">End of period assets</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">72,486&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">68,018&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">65,903&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">61,283&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">55,973&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">48,043&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">47,255&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">48,622&#160;&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="background-color: rgb(204,238,255); height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;margin-top:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Average assets during the period</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">69,717&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">68,008&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">62,712&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">59,430&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">53,655&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">49,466&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">48,270&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">47,499&#160;&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-48" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Number of ETFs&#8212;end of the period</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">76&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">80&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">80&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">80&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">79&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">78&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">77&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">77&#160;&#160;</span></p>
					</td>
				</tr>






				<tr class="No-Table-Style _idGenTableRowColumn-50" style="height: 12pt; background-color: rgb(204,238,255)">
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">
						<p class="TCH_left" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:0pt;margin-top:6pt;"><span class="CharOverride-1" style="font-style:normal;font-weight:bold;text-decoration:underline;">EUROPEAN LISTED ETPs </span><span class="Bold" style="font-style:normal;font-weight:bold;">(</span><span class="CharOverride-1" style="font-style:normal;font-weight:bold;text-decoration:underline;">in millions</span><span class="Bold" style="font-style:normal;font-weight:bold;">)</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="background-color: White; height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom; width: 21.15%">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Beginning of period assets</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1.11%">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1.48%">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom; width: 7.24%">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">25,717</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1.11%">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1.48%">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom; width: 7.24%">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">27,763</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1.11%">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1.48%">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom; width: 7.24%">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">29,457</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1.11%">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1.48%">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom; width: 7.05%">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">26,020</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1.11%">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1.48%">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom; width: 7.24%">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">22,835</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1.11%">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1.48%">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom; width: 7.24%">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">27,047</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1.11%">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1.48%">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom; width: 6.68%">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">30,785</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1.11%">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom; width: 1.48%">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom; width: 8.16%">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">29,269</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="height: 12pt; background-color: rgb(204,238,255)">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(Outflows)/inflows</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(188)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(1,618)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(922)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,329</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,032</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(2,065)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(426)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(931)</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-48" style="background-color: White; height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Market appreciation/(depreciation)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,109</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(428)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(772)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,108</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,153</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(2,147)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(3,312)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,447</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height: 12pt; background-color: rgb(204,238,255)">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;margin-top:3pt;"><span class="CharOverride-4" style="font-size:8pt;">End of period assets</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">27,638</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">25,717</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">27,763</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">29,457</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">26,020</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">22,835</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">27,047</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">30,785</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-50" style="background-color: White; height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Average assets during the period</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">26,840</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">27,735</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">28,866</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">28,078</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">23,994</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">25,211</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">29,468</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">30,310</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-48" style="height: 12pt; background-color: rgb(204,238,255)">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Number of ETPs&#8212;end of the period</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">261</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">264</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">264</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">261</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">260</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">269</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">267</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">264</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-47" style="background-color: White; height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:5pt;margin-right:5pt;margin-top:3pt;text-indent:-5pt;"><span class="CharOverride-5" style="font-size:8pt;font-style:normal;font-weight:bold;text-decoration:underline;">PRODUCT CATEGORIES</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-47" style="height: 12pt; background-color: rgb(204,238,255)">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-right:3pt;margin-top:3pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">U.S.&#160;Equity</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="background-color: White; height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Beginning of period assets</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">25,644</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">26,001</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">24,534</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">24,112</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">20,952</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">21,058</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">23,738</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">23,860</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="height: 12pt; background-color: rgb(204,238,255)">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Inflows/(outflows)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">487</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">864</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">414</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(149)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,022</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,239</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">306</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">779</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-48" style="background-color: White; height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Market appreciation/(depreciation)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">3,025</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(1,221)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,053</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">571</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,138</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(1,345)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(2,986)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(901)</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height: 12pt; background-color: rgb(204,238,255)">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;margin-top:3pt;"><span class="CharOverride-4" style="font-size:8pt;">End of period assets</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">29,156</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">25,644</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">26,001</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">24,534</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">24,112</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">20,952</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">21,058</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">23,738</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-50" style="background-color: White; height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Average assets during the period</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">26,844</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">26,501</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">24,732</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">24,725</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">23,492</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">22,534</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">22,362</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">23,134</span></p>
					</td>
				</tr>
</table>
		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">63</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>





<table class="No-Table-Style TableOverride-6" style="width: 100%; border-collapse: collapse; border: #000 0pt solid; border-width: 0pt; margin: 6pt 0 0pt">


<tr class="No-Table-Style _idGenTableRowColumn-21" style="height:12pt;">
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">

					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q4/23</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q3/23</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q2/23</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q1/23</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q4/22</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q3/22</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q2/22</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q1/22</span></p>
					</td>
				</tr>



				<tr class="No-Table-Style _idGenTableRowColumn-47" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-right:3pt;margin-top:3pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Commodity&#160;&amp; Currency</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="background-color: rgb(204,238,255); height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Beginning of period assets</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">20,465</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">22,384</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">24,924</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">22,097</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">19,561</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">23,624</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">26,302</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">24,599</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(Outflows)/inflows</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(449)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(1,815)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(1,513)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,003</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">796</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(2,180)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(475)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(1,053)</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-48" style="background-color: rgb(204,238,255); height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Market appreciation/(depreciation)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,320</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(104)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(1,027)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">824</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,740</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(1,883)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(2,203)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,756</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;margin-top:3pt;"><span class="CharOverride-4" style="font-size:8pt;">End of period assets</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">21,336</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">20,465</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">22,384</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">24,924</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">22,097</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">19,561</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">23,624</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">26,302</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-50" style="background-color: rgb(204,238,255); height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;margin-top:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Average assets during the period</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">21,254</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">22,278</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">24,033</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">23,807</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">20,345</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">21,625</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">25,766</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">25,891</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-47" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-right:3pt;margin-top:3pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Fixed Income</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="background-color: rgb(204,238,255); height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Beginning of period assets</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">21,797</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">20,215</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">18,708</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">15,273</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">11,695</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">9,192</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">5,418</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">4,356</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(Outflows)/inflows</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(715)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,671</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,471</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">3,513</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">3,392</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">2,628</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">4,038</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,242</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-48" style="background-color: rgb(204,238,255); height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Market appreciation/(depreciation)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">115</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(89)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">36</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(78)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">186</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(125)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(264)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(180)</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;margin-top:3pt;"><span class="CharOverride-4" style="font-size:8pt;">End of period assets</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">21,197</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">21,797</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">20,215</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">18,708</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">15,273</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">11,695</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">9,192</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">5,418</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-10" style="background-color: rgb(204,238,255); height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;margin-top:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Average assets during the period</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">21,889</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">20,965</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">19,185</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">17,176</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">13,962</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">10,077</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">7,426</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">4,691</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-50" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-right:3pt;margin-top:3pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">International Developed Market Equity</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="background-color: rgb(204,238,255); height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Beginning of period assets</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">13,902</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">13,423</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">11,433</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">10,195</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">9,183</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">9,968</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">11,422</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">11,894</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Inflows/(outflows)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">9</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">798</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,593</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">450</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">40</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(115)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">79</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">97</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-48" style="background-color: rgb(204,238,255); height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Market appreciation/(depreciation)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,192</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(319)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">397</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">788</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">972</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(670)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(1,533)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(569)</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;margin-top:3pt;"><span class="CharOverride-4" style="font-size:8pt;">End of period assets</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">15,103</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">13,902</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">13,423</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">11,433</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">10,195</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">9,183</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">9,968</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">11,422</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="background-color: rgb(204,238,255); height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;margin-top:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Average assets during the period</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">14,267</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">13,873</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">12,276</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">10,879</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">10,000</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">10,032</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">10,695</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">11,543</span></p>
					</td>
				</tr>




								<tr class="No-Table-Style _idGenTableRowColumn-8" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 21.15%; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-right:3pt;margin-top:3pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Emerging Market Equity</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 7.24%; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 7.24%; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 7.24%; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 7.05%; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 7.24%; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 7.24%; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 6.68%; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 8.16%; vertical-align: bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-51" style="background-color: rgb(204,238,255); height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Beginning of period assets</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">9,569</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">9,191</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">8,811</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">8,116</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">7,495</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">8,386</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">9,991</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">10,375</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-51" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Inflows/(outflows)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">412</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">451</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">329</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">486</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(53)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">114</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(223)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">189</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-48" style="background-color: rgb(204,238,255); height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Market appreciation/(depreciation)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">745</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(73)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">51</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">209</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">674</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(1,005)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(1,382)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(573)</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-18" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;margin-top:3pt;"><span class="CharOverride-4" style="font-size:8pt;">End of period assets</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">10,726</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">9,569</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">9,191</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">8,811</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">8,116</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">7,495</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">8,386</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">9,991</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="background-color: rgb(204,238,255); height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;margin-top:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Average assets during the period</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">9,833</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">9,652</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">8,998</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">8,666</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">7,770</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">8,329</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">9,155</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">10,116</span></p>
					</td>
				</tr>



</table>

<p style="margin: 0">&#160;</p>


		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">64</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">




<table class="No-Table-Style TableOverride-6" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">

<tr class="No-Table-Style _idGenTableRowColumn-21" style="height:12pt;">
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">

					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q4/23</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q3/23</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q2/23</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q1/23</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q4/22</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q3/22</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q2/22</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Q1/22</span></p>
					</td>
				</tr>



				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height: 12pt; background-color: White">
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">
						<p class="TCH_left" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Leveraged&#160;&amp; Inverse</span></p>
					</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style: solid; border-width: 0pt; padding: 0in 0in 3px; border-top-style: solid; vertical-align: bottom; vertical-align: bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="background-color: rgb(204,238,255); height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 21.15%; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Beginning of period assets</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 7.24%; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,781</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 7.24%; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,864</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 7.24%; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,785</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 7.05%; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,754</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 7.24%; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,523</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 7.24%; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,618</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 6.68%; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,860</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.11%; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 1.48%; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; width: 8.16%; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,777</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(Outflows)/inflows</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(59)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(1)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">12</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">43</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">59</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">45</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">90</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(1)</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-48" style="background-color: rgb(204,238,255); height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Market appreciation/(depreciation)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">93</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(82)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">67</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(12)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">172</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(140)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(332)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">84</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;margin-top:3pt;"><span class="CharOverride-4" style="font-size:8pt;">End of period assets</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,815</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,781</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,864</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,785</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,754</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,523</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,618</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,860</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-50" style="background-color: rgb(204,238,255); height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;margin-top:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Average assets during the period</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,803</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,894</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,798</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,757</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,623</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,589</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,770</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">1,835</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-47" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-right:3pt;margin-top:3pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Cryptocurrency</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="background-color: rgb(204,238,255); height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Beginning of period assets</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">243</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">248</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">239</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">136</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">163</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">151</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">383</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">357</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Inflows/(outflows)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">28</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">10</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(1)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">13</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(4)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">3</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">37</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-48" style="background-color: rgb(204,238,255); height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Market appreciation/(depreciation)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">143</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(15)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">10</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">90</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(23)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">12</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(235)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(11)</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">End of period assets</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">414</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">243</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">248</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">239</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">136</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">163</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">151</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">383</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-50" style="background-color: rgb(204,238,255); height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;margin-top:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Average assets during the period</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">325</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">238</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">236</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">190</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">152</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">178</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">265</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">324</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-47" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-right:3pt;margin-top:3pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Alternatives</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="background-color: rgb(204,238,255); height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Beginning of period assets</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">334</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">340</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">306</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">310</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">306</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">305</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">293</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">261</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Inflows/(outflows)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">32</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">5</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">22</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(18)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">12</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">16</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">34</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">29</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-48" style="background-color: rgb(204,238,255); height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Market appreciation/(depreciation)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">11</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(11)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">12</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">14</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(8)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(15)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">(22)</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">3</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;"><span class="CharOverride-4" style="font-size:8pt;">End of period assets</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">377</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">334</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">340</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">306</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">310</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">306</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">305</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; vertical-align: bottom; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">293</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-50" style="background-color: rgb(204,238,255); height: 12pt">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;margin-right:3pt;margin-top:3pt;"><span class="CharOverride-4" style="font-size:8pt;">Average assets during the period</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">342</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">342</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">320</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">308</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">305</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">313</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">299</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">275</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-47" style="height: 12pt; background-color: White">
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-right:3pt;margin-top:3pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Headcount</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">303</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">299</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">291</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">279</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">273</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">274</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">264</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">&#160;</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; white-space: nowrap; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><span class="CharOverride-4" style="font-size:8pt;">253</span></p>
					</td>
				</tr>

		</table>
		<p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-left:0pt;margin-top:10pt;text-indent:0pt;margin-top:10pt;">Note: Previously issued statistics may be restated due to fund closures and trade adjustments</p>
		<p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-24pt;widows:3;margin-left:0pt;margin-top:5pt;text-indent:0pt;margin-top:5pt;">Source: WisdomTree</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Non-GAAP Financial Measurements</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In an effort to provide additional information regarding our results as determined by GAAP, we also disclose certain non<span class="nobreak">-GAAP</span> information which we believe provides useful and meaningful information. Our management reviews these non<span class="nobreak">-GAAP</span> financial measurements when evaluating our financial performance and results of operations; therefore, we believe it is useful to provide information with respect to these non<span class="nobreak">-GAAP</span> measurements so as to share this perspective of management. Non<span class="nobreak">-GAAP</span> measurements do not have any standardized meaning, do not replace nor are superior to GAAP financial measurements and are unlikely to be comparable to similar measures presented by other companies. These non<span class="nobreak">-GAAP</span> financial measurements should be considered in the context with our GAAP results. The non<span class="nobreak">-GAAP</span> financial measurements contained in this Report include:</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Adjusted net income and diluted earnings per share.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We disclose adjusted net income and diluted earnings per share as non<span class="nobreak">-GAAP</span> financial measurements in order to report our results exclusive of items that are non<span class="nobreak">-recurring</span> or not core to our operating business. We believe presenting these non<span class="nobreak">-GAAP</span> financial measurements provides investors with a consistent way to analyze our performance. These non<span class="nobreak">-GAAP</span> financial measurements exclude the following:</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:6pt;"><span class="bullet" style="font-size:10pt;font-style:italic;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Unrealized gains or losses on revaluation/termination of deferred consideration&#8212;gold payments: </span>Deferred consideration&#8212;gold payments was an obligation we assumed in connection with the ETFS Acquisition that was carried at fair value. This item represented the present value of an obligation to pay fixed ounces of gold into perpetuity and is measured using forward<span class="nobreak">-looking</span> gold prices. Changes in the forward<span class="nobreak">-looking</span> price of gold and changes in the discount rate used to compute the present value of the annual payment obligations have had a material impact on the carrying value of the deferred consideration and our reported financial results. We exclude this item when calculating our non<span class="nobreak">-GAAP</span> financial measurements as it was not core to our operating business. The item was not adjusted for income taxes as the obligation was assumed by a wholly<span class="nobreak">-owned</span> subsidiary of ours that is based in Jersey, a jurisdiction where we are subject to a zero percent tax rate. During the second quarter of 2023, we terminated this obligation for aggregate consideration totaling approximately $137.0&#160;million.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">65</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:6pt;"><span class="bullet" style="font-size:10pt;font-style:italic;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Gains or losses on financial instruments owned:</span> We account for our financial instruments owned as trading securities, which requires these instruments to be measured at fair value with gains and losses reported in net income. We exclude these items when calculating our non<span class="nobreak">-GAAP</span> financial measurements as the gains and losses introduce volatility in earnings and are not core to our operating business.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Tax windfalls and shortfalls upon vesting and exercise of stock</span><span class="nobreak"><span class="Italic" style="font-style:italic;font-weight:normal;">-based</span></span><span class="Italic" style="font-style:italic;font-weight:normal;"> compensation awards: </span>GAAP requires the recognition of tax windfalls and shortfalls within income tax expense. These items arise upon the vesting and exercise of stock<span class="nobreak">-based</span> compensation awards and the magnitude is directly correlated to the number of awards vesting/exercised as well as the difference between the price of our stock on the date the award was granted and the date the award vested or was exercised. We exclude these items when calculating our non<span class="nobreak">-GAAP</span> financial measurements as they introduce volatility in earnings and are not core to our operating business.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Imputed interest on our payable to GBH:</span>&#160;During the fourth quarter of 2023, we repurchased our Series&#160;C Preferred Stock, which was convertible into approximately 13.1&#160;million shares of our common stock, from GBH for aggregate cash consideration of approximately $84.4&#160;million. Under the terms of the transaction, we paid GBH $40.0&#160;million on the closing date, with the remainder of the purchase price payable in equal, interest<span class="nobreak">-free</span> installments on the first, second and third anniversaries of the closing date. Under U.S.&#160;GAAP, the obligation is recorded at its present value utilizing a market rate of interest on the closing date of 7.0% and the corresponding discount is amortized as interest expense pursuant to the effective interest method of accounting over the life of the obligation. We exclude this item when calculating our non<span class="nobreak">-GAAP</span> financial measurements as recognition of interest expense is non<span class="nobreak">-cash</span> and contrary to the stated terms of our obligation.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:6pt;"><span class="bullet" style="font-size:10pt;font-style:italic;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Other items: </span>Unrealized gains and losses recognized on our investments, changes in deferred tax asset valuation allowances, expenses incurred in response to an activist campaign, impairment charges, a loss on extinguishment of debt and a gain recognized upon the sale of our Canadian ETF business (including the remeasurement of contingent consideration) are excluded when calculating our non<span class="nobreak">-GAAP</span> financial measurements.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">66</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<table class="No-Table-Style" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-18" style="height:12pt;">
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">

						<p class="TCH_left" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Adjusted Net Income and Diluted Earnings per Share:</span></p>
					</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="8" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 46.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years
      Ended December 31,</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-20" style="height:12pt;">
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net income, as reported</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">102,546</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">50,684</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">49,797</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-10" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deduct: Gain on revaluation/termination of deferred consideration</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(61,953)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(27,765)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(2,018)</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-10" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Add back: Loss on extinguishment of convertible notes, net of income taxes</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">9,623</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Add back: Impairments, net of income taxes</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,013</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">12,247</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-10" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Add back: Expenses incurred in response to an activist campaign, net of income taxes</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">4,452</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">3,376</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-10" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Add back: Increase in deferred tax valuation allowance on financial instruments owned and investments</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">2,113</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">4,729</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-52" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deduct: Gain recognized from the sale of Canadian ETF business, including remeasurement of contingent consideration</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(1,477)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(787)</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-10" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Add back/(deduct): Unrealized loss/(gain) recognized on our investments, net of income taxes</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">607</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">290</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(284)</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-10" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Add back: Losses on financial instruments owned, at fair value, net of income taxes</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">392</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">12,505</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">2,507</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-52" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Add back: Litigation expenses associated with certain provisions of the Stockholder Rights Agreement, net of income taxes</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">367</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-10" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Add back: Imputed interest on payable to GBH, net of income taxes</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">224</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-10" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deduct: Tax windfalls upon vesting and exercise of stock-based compensation awards</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(176)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(541)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(110)</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-10" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deduct: Decrease in deferred tax valuation allowance on net operating losses of a European subsidiary</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(1,609)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;">Adjusted net income</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:8pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:8pt;margin-right:6pt;">62,731</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:8pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:8pt;margin-right:6pt;">41,669</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:8pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:8pt;margin-right:6pt;">61,352</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deduct: Income distributed to participating securities</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(2,770)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(2,186)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(2,168)</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-10" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deduct: Undistributed income allocable to participating securities</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(5,868)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(2,509)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(4,630)</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Adjusted net income available to common stockholders</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">54,093</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">36,974</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">54,554</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-52" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Weighted average diluted shares, excluding participating securities (See Note&#160;21 to our Consolidated Financial Statements)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">147,827</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">143,295</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">145,055</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Adjusted earnings per share&#8212;diluted</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">0.37</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">0.26</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">0.38</p>
					</td>
				</tr>

		</table>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;">Adjusted net income as reported on a non<span class="nobreak">-GAAP</span> basis during the year ended December&#160;31, 2023 also excludes a gain of $8.0&#160;million recognized upon the repurchase of our Series&#160;C Preferred Stock, which was convertible into approximately 13.1&#160;million shares of our common stock. Under U.S.&#160;GAAP, this amount is excluded from net income, but is required to be added to net income to arrive at income available to common stockholders in the calculation of earnings per share.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">67</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Liquidity and Capital Resources</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The following table summarizes key data regarding our liquidity, capital resources and use of capital to fund our operations:</p>
		<table class="No-Table-Style TableOverride-5" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-20" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 59.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31,<br/>2023</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 19.35%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31,<br/>2022</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 59.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH_left" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Balance Sheet Data (in thousands):</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 19.35%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 59.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Cash and cash equivalents</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">129,305</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.20%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">132,101</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 59.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Financial instruments owned, at fair value</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">58,722</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.20%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">126,239</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 59.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Accounts receivable</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">35,473</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.20%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">30,549</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 59.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Securities held-to-maturity</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.59%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">230</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.20%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">259</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 59.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;">Total:&#160;Liquid assets</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:8pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:8pt;margin-right:6pt;">223,730</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:8pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.20%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:8pt;margin-right:6pt;">289,148</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 59.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Less:&#160;Total current liabilities</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(103,216)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.20%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(148,434)</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-10" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 59.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Less: Other assets&#8212;seed capital (WisdomTree Digital Funds)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(18,308)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.20%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(1,765)</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 59.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Less:&#160;Regulatory capital requirements</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.59%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(29,156)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.20%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(25,988)</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 59.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total:&#160;Available liquidity</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.59%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">73,050</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.20%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">112,961</p>
					</td>
				</tr>

		</table>
		<table class="No-Table-Style _idGenTablePara-3" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 40.32%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="8" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 58.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Year Ended December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 40.32%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 19.35%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 40.32%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Cash Flow Data (in thousands):</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 19.35%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 40.32%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Operating cash flows</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">85,600</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">55,087</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.20%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">75,318</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 40.32%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Investing cash flows</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">82,049</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(37,657)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.20%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(99,632)</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 40.32%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Financing cash flows</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(171,636)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(22,780)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.20%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">92,553</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 40.32%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Foreign exchange rate effect</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.59%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,191</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.59%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(3,258)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.20%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(955)</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-10" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 40.32%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">(Decrease)/increase in cash and cash equivalents</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.59%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(2,796)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.59%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(8,608)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.61%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 2.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 17.20%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">67,284</p>
					</td>
				</tr>

		</table>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Liquidity</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We consider our available liquidity to be our liquid assets, less our current liabilities and regulatory capital requirements of certain European subsidiaries. Liquid assets consist of cash and cash equivalents, financial instruments owned, at fair value, accounts receivable and securities held<span class="nobreak">-to-maturity</span>. Our financial instruments owned, at fair value are highly liquid investments. Accounts receivable are current assets and primarily represent receivables from advisory fees we earn from our ETPs. Our current liabilities consist primarily of payments owed to vendors and third parties in the normal course of business, deferred consideration and accrued incentive compensation for employees.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Cash and cash equivalents decreased $2.8&#160;million during the year ended December&#160;31, 2023 due to $184.3&#160;million used to repurchase and settle our 4.25% Convertible Senior Notes due 2023, $57.4&#160;million used to purchase financial instruments owned, at fair value, $50.0&#160;million used to terminate our deferred consideration&#8212;gold payments obligation, $40.0&#160;million used to repurchase our Series&#160;C Preferred Stock, $20.1&#160;million used to pay dividends on our common stock, $11.2&#160;million used to purchase investments, $3.6&#160;million used to repurchase our common stock, $3.5&#160;million used to pay issuance costs in respect of our 5.75% Convertible Senior Notes due 2028, or the 2023 Notes, $2.1&#160;million used for software development and $1.2&#160;million used in other activities. These decreases were partly offset by $130.0&#160;million of proceeds from the issuance of the 2023 Notes, $123.6&#160;million of proceeds from the sale of financial instruments owned, at fair value, $85.6&#160;million of net cash provided by operating activities, $28.8&#160;million of proceeds from the exit from our investment in Securrency, Inc. in connection with the sale of Securrency, Inc. to an unaffiliated third party, $1.5&#160;million from receipt of contingent consideration related to the sale of our Canadian ETF business, and $1.1&#160;million from other activities.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Cash and cash equivalents decreased $8.6&#160;million during the year ended December&#160;31, 2022 due to $55.1&#160;million of net cash provided by operating activities and $52.1&#160;million of proceeds from the sale of financial instruments owned, at fair value. These increases were partly offset by $67.7&#160;million used to purchase financial instruments owned, at fair value, $21.9&#160;million used to purchase investments, $19.4&#160;million used to pay dividends, $3.4&#160;million used to repurchase our common stock and $3.4&#160;million from other activities.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">68</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Cash and cash equivalents increased $67.3&#160;million during the year ended December&#160;31, 2021 due to $150.0&#160;million of proceeds from the issuance of our 3.25% Convertible Senior Notes due 2026, or the 2021 Notes, $75.3&#160;million of net cash provided by operating activities, $19.4&#160;million of proceeds from the sale of financial instruments owned, at fair value and $2.4&#160;million of proceeds from the receipt of contingent consideration from the sale of our Canadian ETF business. These increases were partly offset by $115.5&#160;million used to purchase financial instruments owned, at fair value, $34.5&#160;million used to repurchase our common stock, $19.5&#160;million used to pay dividends on our common stock, $5.8&#160;million used to purchase investments, $4.3&#160;million used to pay the 2021 Notes issuance costs and $0.2&#160;million from other activities.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Issuance of Convertible Notes</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On February&#160;14, 2023, we issued and sold $130.0&#160;million in aggregate principal amount of 5.75% Convertible Senior Notes due 2028 (the &#8220;2023 Notes&#8221;) pursuant to an indenture dated February&#160;14, 2023, between us and U.S.&#160;Bank Trust Company, National Association, as trustee, in a private offering to qualified institutional buyers pursuant to Rule&#160;144A under the Securities Act&#160;of&#160;1933, as amended (&#8220;Rule&#160;144A&#8221;).</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On June&#160;14, 2021, we issued and sold $150.0&#160;million in aggregate principal amount of 3.25% Convertible Senior Notes due 2026 (the &#8220;2021 Notes&#8221;) pursuant to an indenture dated June&#160;14, 2021, between us and the trustee, in a private offering to qualified institutional buyers pursuant to Rule&#160;144A.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On June&#160;16, 2020, we issued and sold $150.0&#160;million in aggregate principal amount of 4.25% Convertible Senior Notes due 2023 (the &#8220;June&#160;2020 Notes&#8221;) pursuant to an indenture dated June&#160;16, 2020, between us and the trustee, in a private offering to qualified institutional buyers pursuant to Rule&#160;144A.&#160;On August&#160;13, 2020, we issued and sold $25.0&#160;million in aggregate principal amount of 4.25% Convertible Senior Notes due 2023 at a price equal to 101% of the principal amount thereof, plus interest deemed to have accrued since June&#160;16, 2020, which constituted a further issuance of, and formed a single series with, our June&#160;2020 Notes (the &#8220;August&#160;2020 Notes&#8221; and together with the June&#160;2020 Notes, the &#8220;2020 Notes&#8221;).</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In connection with the issuance of the 2023 Notes, we repurchased $115.0&#160;million in aggregate principal amount of the 2020 Notes. As a result of this repurchase, we recognized a loss on extinguishment of approximately $9.7&#160;million during the year ended December&#160;31, 2023. The remainder of the 2020 Notes matured on June&#160;15, 2023 and were settled for approximately $59.9&#160;million of cash and approximately 1.0&#160;million shares of our common stock.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">After the repurchase and maturity of the 2020 Notes and the issuance of the 2023 Notes (such 2023 Notes, together with the 2021 Notes, the &#8220;Convertible Notes&#8221;), we had $280.0&#160;million in aggregate principal amount of Convertible Notes outstanding.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Key terms of the Convertible Notes are as follows:</p>
		<table class="No-Table-Style _idGenTablePara-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 58.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 18.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023 Notes</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 19.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021 Notes</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 58.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Principal outstanding</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">130.0<span style="width: 10px;display: inline-block;">&#160;&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 18.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">150.0<span style="width: 10px;display: inline-block;">&#160;&#160;&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-10" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 58.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Maturity date (unless earlier converted, repurchased or redeemed)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;">August&#160;15,&#160;2028<span style="width: 10px;display: inline-block;">&#160;&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 18.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;">June&#160;15,&#160;2026&#160;&#160;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 58.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Interest rate</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;">5.75%<span style="width: 10px;display: inline-block;">&#160;&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 18.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;">3.25%<span style="width: 10px;display: inline-block;">&#160;&#160;&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 58.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Conversion price</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">9.54<span style="width: 10px;display: inline-block;">&#160;&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 18.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">11.04<span style="width: 10px;display: inline-block;">&#160;&#160;&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 58.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Conversion rate</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;">104.8658<span style="width: 10px;display: inline-block;">&#160;&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 18.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;">90.5797<span style="width: 10px;display: inline-block;">&#160;&#160;&#160;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 58.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Redemption price</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 16.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">12.40<span style="width: 10px;display: inline-block;">&#160;&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 18.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">14.35<span style="width: 10px;display: inline-block;">&#160;&#160;&#160;</span></p>
					</td>
				</tr>

		</table>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Interest rate: </span>Payable semiannually in arrears on February&#160;15 and August&#160;15 of each year for the 2023 Notes (beginning on August<span class="nobreak">&#160;</span>15, 2023) and on June&#160;15 and December&#160;15 of each year for the 2021 Notes.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:6pt;"><span class="bullet" style="font-size:10pt;font-style:italic;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Conversion price:</span> Convertible at an initial conversion rate set forth in the table above into shares of our common stock, per $1,000 principal amount of notes (equivalent to an initial conversion price set forth in the table above), subject to adjustment.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">69</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:6pt;"><span class="bullet" style="font-size:10pt;font-style:italic;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Conversion: </span>Holders may convert at their option at any time prior to the close of business on the business&#160;day immediately preceding May<span class="nobreak">&#160;</span>15, 2028 and March<span class="nobreak">&#160;</span>15, 2026 for the 2023 Notes and the 2021 Notes, respectively, only under the following circumstances: (i)&#160;if the last reported sale price of our common stock for at least 20&#160;trading days during a period of 30 consecutive&#160;trading days ending on the last&#160;trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the respective Convertible Notes on each applicable&#160;trading day; (ii)&#160;during the five business&#160;day period after any ten consecutive&#160;trading day period (the &#8220;measurement period&#8221;) in which the trading price per $1,000 principal amount of the Convertible Notes for each&#160;trading day of the measurement period was less than 98% of the product of the last reported sales price of our common stock and the conversion rate on each such&#160;trading day; (iii)&#160;upon a notice of redemption delivered by us in accordance with the terms of the indentures but only with respect to the Convertible Notes called (or deemed called) for redemption; or (iv)&#160;upon the occurrence of specified corporate events. On or after May<span class="nobreak">&#160;</span>15, 2028 and March<span class="nobreak">&#160;</span>15, 2026 in respect of the 2023 Notes, and the 2021 Notes, respectively, until the close of business on the second scheduled&#160;trading day immediately preceding the maturity date, holders may convert their Convertible Notes at any time, regardless of the foregoing circumstances.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Cash settlement of principal amount: </span>Upon conversion, we will pay cash up to the aggregate principal amount of the Convertible Notes to be converted. At our election, we will also settle our conversion obligation in excess of the aggregate principal amount of the Convertible Notes being converted in either cash, shares of our common stock or a combination of cash and shares of its common stock.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Redemption price: </span>We may redeem for cash all or any portion of the Convertible Notes, at our option, on or after August<span class="nobreak">&#160;</span>20, 2025 and June<span class="nobreak">&#160;</span>20, 2023 in respect of the 2023 Notes and the 2021 Notes, respectively, and on or prior to the 55<span class="CharOverride-7" style="font-size:58%;vertical-align:super;">th</span> scheduled&#160;trading day immediately preceding the maturity date, if the last reported sale price of our common stock has been at least 130% of the conversion price for the respective Convertible Notes then in effect for at least 20&#160;trading days, including the&#160;trading day immediately preceding the date on which we provide notice of redemption, during any 30 consecutive&#160;trading day period ending on, and including, the&#160;trading day immediately preceding the date on which we provide notice of redemption, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding the redemption date. No sinking fund is provided for the Convertible Notes.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Limited investor put rights: </span>Holders of the Convertible Notes have the right to require us to repurchase for cash all or a portion of their notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of certain change of control transactions or liquidation, dissolution or common stock delisting events.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Conversion rate increase in certain customary circumstances: </span>In certain circumstances, conversions in connection with a &#8220;make<span class="nobreak">-whole</span> fundamental change&#8221; (as defined in the indentures) or conversions of Convertible Notes called (or deemed called) for redemption may result in an increase to the conversion rate, provided that the conversion rate will not exceed 167.7853<span class="nobreak"> </span>shares and 144.9275<span class="nobreak"> </span>shares of our common stock per $1,000 principal amount of the 2023 Notes and the 2021 Notes, respectively (the equivalent of 43,551,214<span class="nobreak"> </span>shares of our common stock), subject to adjustment.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-size:10pt;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Seniority and Security: </span>The 2023 Notes and 2021 Notes rank equal in right of payment, and are our senior unsecured obligations, but are subordinated in right of payment to our obligations to make certain redemption payments (if and when due) in respect of our Series&#160;A Preferred Stock (See Note&#160;11 to our Consolidated Financial Statements).</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The indentures contain customary terms and covenants, including that upon certain events of default occurring and continuing, either the trustee or the respective holders of not less than 25% in aggregate principal amount of the respective series of Convertible Notes outstanding may declare the entire principal amount of all such respective Convertible Notes to be repurchased, plus any accrued special interest, if any, to be immediately due and payable.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Capital Resources</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our principal source of financing is our operating cash flow. We believe that current cash flows generated by our operating activities and existing cash balances should be sufficient for us to fund our operations for the foreseeable future.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">70</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our ability to satisfy our contractual obligations as they arise are discussed in the section titled &#8220;Contractual Obligations&#8221; below.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Use of Capital</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our business does not require us to maintain a significant cash position. However, certain of our subsidiaries are required to maintain a minimum level of regulatory capital, which at December&#160;31, 2023 was approximately $29.2&#160;million in the aggregate. Notwithstanding these regulatory capital requirements, we expect that our main uses of cash will be to fund the ongoing operations of our business. We also maintain a capital return program which includes a $0.03 per share quarterly cash dividend and authority to purchase our common stock through April&#160;27, 2025, including purchases to offset future equity grants made under our equity plans.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">During the year ended December&#160;31, 2023, we repurchased 635,653<span class="nobreak"> </span>shares of our common stock under the repurchase program for an aggregate cost of $3.6&#160;million. Currently, approximately $96.4&#160;million remains under this program for future purchases. We also repurchased our Series&#160;C Preferred Stock, which was convertible into approximately 13.1&#160;million shares of common stock, from GBH for aggregate cash consideration of approximately $84.4&#160;million. Under the terms of the transaction, we paid GBH $40.0&#160;million on the closing date, with the remainder of the purchase price payable in equal, interest<span class="nobreak">-free</span> installments on the first, second and third anniversaries of the closing date.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Contractual Obligations</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Convertible Notes</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We currently have $280.0&#160;million aggregate principal amount of Convertible Notes outstanding, of which $150.0&#160;million and $130.0&#160;million are scheduled to mature on June&#160;15, 2026 and August&#160;15, 2028, respectively, unless earlier converted, repurchased or redeemed. Conditional conversions or a requirement to repurchase the Convertible Notes upon the occurrence of a fundamental change may accelerate payment.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Convertible Notes require cash settlement of the principal amount, while settlement of the conversion obligation in excess of the aggregate principal amount may be satisfied in either cash, shares of our common stock or a combination of cash and shares of its common stock. We currently anticipate refinancing these obligations when due.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">See the section titled &#8220;Issuance of Convertible Notes&#8221; above for additional information.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Deferred Consideration&#8211;Gold Payments</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On
  May&#160;10, 2023, we entered into and closed on a Sale, Purchase and Assignment Deed to terminate our obligations relating to the
  contractual gold payments. Pursuant to that agreement, we paid consideration totaling $136.9&#160;million, including an aggregate of
  $50.0&#160;million in cash and the issuance of 13,087 shares of Series&#160;C Preferred Stock (valued at $86.9&#160;million, based
  on the closing price of our common stock on May&#160;9, 2023 of $6.64 per share), which was convertible into 13,087,000 shares of
  our common stock. The Series&#160;C Preferred Stock was subsequently repurchased on November&#160;20, 2023 as described in
  &#8220;Payable to GBH&#8221; below. See Note&#160;12 to our Consolidated Financial Statements for additional information.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Payable to GBH</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On November&#160;20, 2023, we repurchased our Series&#160;C Preferred Stock from GBH for aggregate cash consideration of approximately $84.4&#160;million. Under the terms of the transaction, we paid GBH $40.0&#160;million on the closing date, with the remainder of the purchase price payable in equal, interest<span class="nobreak">-free</span> installments on the first, second and third anniversaries of the closing date. The implied price per share was $6.02 when considering the interest<span class="nobreak">-free</span> financing element of the transaction.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Operating Leases</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Total
  future minimum lease payments with respect to our operating lease liabilities were $0.6&#160;million at December&#160;31, 2023. Cash
  flows generated by our operating activities and existing cash balances should be sufficient to satisfy the future minimum lease
  payments. See Note&#160;13 to our Consolidated Financial Statements for additional information.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">71</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Off-Balance Sheet Arrangements</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We do not have any off<span class="nobreak">-balance</span> sheet financing or other arrangements and have neither created nor are party to any special<span class="nobreak">-purpose</span> or off<span class="nobreak">-balance</span> sheet entities for the purpose of raising capital, incurring debt or operating our business.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Critical Accounting Policies and Estimates</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Goodwill and Intangible Assets</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Goodwill is the excess of the purchase price over the fair values of the identifiable net assets at the acquisition date. We test goodwill for impairment at least annually and at the time of a triggering event requiring re<span class="nobreak">-evaluation</span>, if one were to occur. Goodwill is considered impaired when the estimated fair value of the reporting unit that was allocated the goodwill is less than its carrying value. If the estimated fair value of such reporting unit is less than its carrying value, goodwill impairment is recognized based on that difference, not to exceed the carrying amount of goodwill. A reporting unit is an operating segment or a component of an operating segment provided that the component constitutes a business for which discrete financial information is available and management regularly reviews the operating results of that component.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Goodwill is allocated to our U.S.&#160;business and European business components. For impairment testing purposes, these components are aggregated as a single reporting unit as they fall under the same operating segment and have similar economic characteristics.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Goodwill is assessed for impairment annually on November&#160;30<span class="Superscript" style="vertical-align:super;font-size:58%;">th</span>. When performing our goodwill impairment test, we consider a qualitative assessment, when appropriate, and the market approach and its market capitalization when determining the fair value of the reporting unit. The results of our analysis indicated no impairment based upon a quantitative assessment.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Indefinite<span class="nobreak">-lived</span> intangible assets are tested for impairment at least annually and are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indefinite<span class="nobreak">-lived</span> intangible assets are impaired if their estimated fair value is less than their carrying value. We may rely on a qualitative assessment when performing our intangible asset impairment test. Otherwise, the impairment evaluation is performed at the lowest level of reasonably identifiable cash flows independent of other assets. The annual impairment testing date for our intangible assets is November&#160;30<span class="Superscript" style="vertical-align:super;font-size:58%;">th</span>. The results of our analysis identified no indicators of impairment to be recognized based upon a quantitative assessment (discounted cash flow analysis) which relied upon significant unobservable inputs including projected revenue growth rates of 3.0% and a weighted average cost of capital of 10.5%.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Investments</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We account for equity investments that do not have a readily determinable fair value under the measurement alternative prescribed within ASU&#160;2016<span class="nobreak">-01</span>, <span class="Italic" style="font-style:italic;font-weight:normal;">Financial Instruments&#160;&#8211;&#160;Recognition and Measurement of Financial Assets and Financial Liabilities</span>, to the extent such investments are not subject to consolidation or the equity method. Under the measurement alternative, these financial instruments are carried at cost, less any impairment (assessed quarterly), plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. In addition, income is recognized when dividends are received only to the extent they are distributed from net accumulated earnings of the investee. Otherwise, such distributions are considered returns of investment and are recorded as a reduction of the cost of the investment. See Note&#160;7 to our Consolidated Financial Statements for information.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Investments in debt instruments are accounted for at fair value, with changes in fair value reported in other income/(expenses).</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Revenue Recognition</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We earn substantially all of our revenue in the form of advisory fees from our ETPs and recognize this revenue over time, as the performance obligation is satisfied. Advisory fees are based on a percentage of the ETPs&#8217; average daily net assets. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which we have a right to invoice.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">72</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<a id="T99213"></a><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:48pt;text-indent:-48pt;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">ITEM&#160;7A.&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The following information, together with information included in other parts of this Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, describes key aspects of our market risk.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Market Risk</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Market risk to us generally represents the risk of changes in the value of our ETPs that results from fluctuations in securities or commodity prices, foreign currency exchange rates against the U.S.&#160;dollar, and interest rates. Nearly all our revenues are derived from advisory agreements for the WisdomTree ETPs. Under these agreements, the advisory fee we receive is based on the average market value of the assets in the WisdomTree ETP portfolios we manage.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Fluctuations in the value of the ETPs are common and are generated by numerous factors such as market volatility, the global economy, inflation, changes in investor strategies and sentiment, availability of alternative investment vehicles, domestic and foreign government regulations, emerging markets developments and others. Accordingly, changes in any one or a combination of these factors may reduce the value of investment securities and, in turn, the underlying AUM on which our revenues are earned. These declines may cause investors to withdraw funds from our ETPs in favor of investments that they perceive as offering greater opportunity or lower risk, thereby compounding the impact on our revenues. We believe challenging and volatile market conditions will continue to be present in the foreseeable future.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Interest Rate Risk</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We invest our corporate cash in short<span class="nobreak">-term</span> interest earning assets, primarily in federal agency debt instruments, WisdomTree fixed income ETFs, U.S.&#160;treasuries, corporate bonds, money market instruments at a commercial bank and other financial instruments which totaled $127.4&#160;million and $109.2&#160;million as of December&#160;31, 2022 and 2023, respectively. During the&#160;years ended December&#160;31, 2022 and 2023, we recognized losses on these financial instruments of $16.5&#160;million and $0.5&#160;million, respectively, and any losses recognized in the future may be material to our operating results. We do not anticipate that changes in interest rates will have a material impact on our financial condition or cash flows.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In addition, our Convertible Notes bear interest at fixed rates of 5.75% and 3.25% for the 2023 Notes and the 2021 Notes, respectively. Therefore, we have no direct financial statement risk associated with changes in interest rates. However, the fair value of the Convertible Notes changes primarily when the market price of our common stock fluctuates or interest rates change.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Exchange Rate Risk</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We are subject to currency translation exposure on the results of our non<span class="nobreak">-U</span>.S.&#160;operations, primarily in the U.K. and Europe. Foreign currency translation risk is the risk that exchange rate gains or losses arise from translating foreign entities&#8217; statements of earnings and balance sheets from functional currency to our reporting currency (the U.S.&#160;dollar) for consolidation purposes. The advisory fees earned on our European listed ETPs are predominantly in U.S.&#160;dollars (and also paid in gold ounces, as described below); however, expenses for corporate overhead are generally incurred in British pounds. Currently, we do not enter into derivative financial instruments aimed at offsetting certain exposures in the statement of operations or the balance sheet but may seek to do so in the future.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Exchange rate risk associated with the euro is not considered to be significant.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Commodity and Cryptocurrency Price Risk</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Fluctuations in the prices of commodities and cryptocurrencies that are linked to certain of our ETPs could have a material adverse effect on our AUM and revenues. In addition, a portion of the advisory fee revenues we receive on our ETPs backed by gold, other precious metals and cryptocurrencies are paid in the underlying metal or cryptocurrency. While we readily sell the gold, precious metals and cryptocurrencies that we earn under these advisory contracts, we still may maintain a position. We currently do not enter into arrangements to hedge against fluctuations in the price of these commodities and cryptocurrencies and any hedging we may undertake in the future may not be cost<span class="nobreak">-effective</span> or sufficient to hedge against this exposure.</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">73</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="Basic-Text-Frame" style="margin:0;padding:0;border-width:0;">
		<a id="T99214"></a><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:48pt;text-indent:-48pt;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">ITEM 8.<span style="width: 13px;display: inline-block;">&#160;&#160;&#160;&#160;</span>FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The report of the independent registered public accounting firm and financial statements listed in the accompanying index are included in Item&#160;15 of this Report. See Index to our Consolidated Financial Statements on page F<span class="nobreak">-1</span> of this Report.</p>
		<a id="T99215"></a><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">ITEM 9.<span style="width: 13px;display: inline-block;">&#160;&#160;&#160;&#160;</span>CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">None.</p>
		<a id="T99216"></a><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:48pt;text-indent:-48pt;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">ITEM 9A.&#160;CONTROLS AND PROCEDURES</span></p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;margin-top:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Evaluation of Disclosure Controls and Procedures</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">As of December&#160;31, 2023, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule&#160;13a<span class="nobreak">-15</span>(b)&#160;promulgated under the Exchange&#160;Act. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of December&#160;31, 2023, our disclosure controls and procedures were effective at a reasonable assurance level in ensuring that material information required to be disclosed by us in the reports that we file or submit under the Exchange&#160;Act is recorded, processed, summarized and reported within the time periods specified in the rules, regulations and forms of the SEC, including ensuring that such material information is accumulated by and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Changes in Internal Control over Financial Reporting</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">During the quarter ended December&#160;31, 2023, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Report of Management on Internal Control over Financial Reporting</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rules 13a<span class="nobreak">-15</span>(f)&#160;and 15d<span class="nobreak">-15</span>(f)&#160;under the Exchange&#160;Act. In order to evaluate the effectiveness of internal control over financial reporting, management has conducted an assessment, including testing, using the criteria in <span class="Italic" style="font-style:italic;font-weight:normal;">Internal Control&#8212;Integrated Framework</span> issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 Framework) (the COSO criteria). Our system of internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Our internal control over financial reporting includes those policies and procedures that (i)&#160;pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the Company&#8217;s assets; (ii)&#160;provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii)&#160;provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company&#8217;s assets that could have a material effect on the financial statements.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Based on the assessment, management has concluded that the Company maintained effective internal control over financial reporting as of December&#160;31, 2023, based on the COSO criteria.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The effectiveness of the Company&#8217;s internal control over financial reporting as of December&#160;31, 2023 has been audited by Ernst&#160;&amp; Young LLP, an independent registered public accounting firm, as stated in their report, which is included herein.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">74</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<a id="T99217"></a><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:48pt;text-indent:-48pt;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">ITEM 9B.&#160;OTHER INFORMATION</span></p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">10b5-1 Trading Arrangements</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">During the three months ended December&#160;31, 2023, none of our directors or officers (as defined in Rule&#160;16a<span class="nobreak">-1</span>(f)&#160;of the Exchange Act) <ix:nonNumeric contextRef="c58" format="ixt:fixed-false" name="ecd:Rule10b51ArrAdoptedFlag" id="ixv-26453"><ix:nonNumeric contextRef="c58" format="ixt:fixed-false" name="ecd:NonRule10b51ArrAdoptedFlag" id="ixv-26454">adopted</ix:nonNumeric></ix:nonNumeric>, <ix:nonNumeric contextRef="c58" format="ixt:fixed-false" name="ecd:NonRule10b51ArrTrmntdFlag" id="ixv-26455"><ix:nonNumeric contextRef="c58" format="ixt:fixed-false" name="ecd:Rule10b51ArrTrmntdFlag" id="ixv-26456">terminated</ix:nonNumeric></ix:nonNumeric> or modified a Rule&#160;10b5<span class="nobreak">-1</span> trading arrangement or non<span class="nobreak">-Rule</span>&#160;10b5<span class="nobreak">-1</span> trading arrangement (as such terms are defined in Item&#160;408 of Regulation S<span class="nobreak">-K</span>).</p>
		<a id="T99218"></a><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">ITEM 9C.&#160;DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Not applicable.</p>



				<a id="T99219"></a><p class="H1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;">PART III</p>
		<a id="T99220"></a><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;">ITEM 10.&#160;&#160;DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The information required by Item 401 of Regulation S<span class="nobreak">-K</span> regarding directors and officers will be contained in our definitive proxy statement to be filed pursuant to Regulation 14A for our 2024 Annual Meeting of Stockholders, expected to be filed within 120 days of our fiscal year end, or in an amendment to this Form 10<span class="nobreak">-K</span>, and is incorporated herein by reference.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The information required by Item 405 of Regulation S<span class="nobreak">-K</span> will be contained in our definitive proxy statement or in an amendment to this Form 10<span class="nobreak">-K</span> and is incorporated herein by reference.</p>



		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We have adopted a Code of Business Conduct and Ethics that applies to all of our directors, officers and employees, including our principal executive officer and principal financial and accounting officer. The Code of Business Conduct and Ethics is posted on our website at <span class="nobreak" style="text-decoration:underline;">https://ir.wisdomtree.com/corporate-governance/governance-documents</span>.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">We will post any amendments to, or waivers from, a provision of the Code of Business Conduct and Ethics by posting such information on our website, at the address and location specified above.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The information required by Item 407(c)(3), (d)(4) and (d)(5) of Regulation S<span class="nobreak">-K</span> will be contained in our definitive proxy statement or in an amendment to this Form 10<span class="nobreak">-K</span> and is incorporated herein by reference.</p>

		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">75</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>




	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">

		<a id="T99221"></a><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;">ITEM 11.&#160;&#160;EXECUTIVE COMPENSATION</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The information required by Item 402 and Item 407(e)(4) and (e)(5) of Regulation S<span class="nobreak">-K</span> will be contained in our definitive proxy statement or in an amendment to this Form 10<span class="nobreak">-K</span> and is incorporated herein by reference.</p>
		<a id="T99222"></a><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;">ITEM 12.&#160;&#160;SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The information required by Item 201(d) and Item 403 of Regulation S<span class="nobreak">-K</span> will be contained in our definitive proxy statement or in an amendment to this Form 10<span class="nobreak">-K</span> and is incorporated herein by reference.</p>
		<a id="T99223"></a><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;">ITEM 13.&#160;&#160;CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The information required by Item 404 and Item 407(a) of Regulation S<span class="nobreak">-K</span> will be contained in our definitive proxy statement or in an amendment to this Form 10<span class="nobreak">-K</span> and is incorporated herein by reference.</p>
		<a id="T99224"></a><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;">ITEM 14.&#160;&#160;PRINCIPAL ACCOUNTANT FEES AND SERVICES</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Our independent public accounting firm is Ernst &amp; Young LLP, NewYork, <ix:nonNumeric contextRef="c0" name="dei:AuditorLocation" id="ixv-26457">New York</ix:nonNumeric>, PCAOB Auditor ID <ix:nonNumeric contextRef="c0" name="dei:AuditorFirmId" id="ixv-26458">42</ix:nonNumeric>.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The information required by Item 9(e) of Schedule 14A will be contained in our definitive proxy statement or in an amendment to this Form 10<span class="nobreak">-K</span> and is incorporated herein by reference.</p>

				<a id="T99225"></a><p class="H1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;">PART IV</p>
		<a id="T99226"></a><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;">ITEM 15.&#160;&#160;EXHIBITS; FINANCIAL STATEMENT SCHEDULES</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">(a). The following are filed as part of this Report:</p>
		<p class="NL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:6pt;margin-top:6pt;">1.<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;&#160;</span><span class="Italic" style="font-style:italic;font-weight:normal;">Consolidated Financial Statements</span>: The consolidated financial statements and reports of independent registered public accounting firm required by this item are included beginning on page F<span class="nobreak">-1</span>.</p>
		<p class="NL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:6pt;margin-top:6pt;">2.<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;&#160;</span><span class="Italic" style="font-style:italic;font-weight:normal;">Financial Statement Schedules</span>: None.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">All other schedules are omitted because they are not applicable or not required, or because the required information is shown either in the consolidated financial statements or in the notes thereto.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">(b). Exhibits: The list of exhibits in the Exhibit Index immediately preceding the exhibits to this Report is incorporated herein by reference in response to this item.</p>
		<a id="T99227"></a><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;">ITEM 16.&#160;&#160;FORM 10-K SUMMARY</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">None.</p>

		</div>








		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">76</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>




	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">WISDOMTREE, INC.<br/>INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>
		<table class="No-Table-Style" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 93.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Consolidated Financial Statements</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.34%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 93.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T501">Reports of Independent Registered Public Accounting Firm</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.34%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_centeralign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">F-2</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 93.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T502">Consolidated Balance Sheets as of December&#160;31, 2023 and 2022</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.34%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_centeralign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">F-5</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 93.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T503">Consolidated Statements of Operations for the&#160;Years Ended December&#160;31, 2023, 2022 and 2021</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.34%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_centeralign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">F-6</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 93.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T504">Consolidated Statements of Comprehensive Income for the&#160;Years Ended December&#160;31, 2023, 2022 and 2021</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.34%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_centeralign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">F-7</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 93.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T505">Consolidated Statements of Changes in Stockholders&#8217; Equity for the&#160;Years Ended December&#160;31, 2023, 2022 and 2021</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.34%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_centeralign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">F-8</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 93.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T506">Consolidated Statements of Cash Flows for the&#160;Years Ended December&#160;31, 2023, 2022 and 2021</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.34%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_centeralign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">F-9</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 93.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><a href="#T507">Notes to Consolidated Financial Statements</a></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.34%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_centeralign" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;">F-11</p>
					</td>
				</tr>

		</table>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-1</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="Basic-Text-Frame" style="margin:0;padding:0;border-width:0;">
		<a id="T501"></a><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Report of Independent Registered Public Accounting Firm</span></p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:12pt;margin-top:12pt;">To the Stockholders and the Board of Directors of WisdomTree, Inc.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Opinion on the Financial Statements</span></p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:6pt;">We have audited the accompanying consolidated balance sheets of WisdomTree, Inc. and subsidiaries (the Company) as of December&#160;31, 2023 and 2022, the related consolidated statements of operations, comprehensive income, changes in stockholders&#8217; equity and cash flows for each of the three&#160;years in the period ended December&#160;31, 2023, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December&#160;31, 2023 and 2022, and the results of its operations and its cash flows for each of the three&#160;years in the period ended December&#160;31, 2023, in conformity with U.S.&#160;generally accepted accounting principles.</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:6pt;">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United&#160;States) (PCAOB), the Company&#8217;s internal control over financial reporting as of December&#160;31, 2023, based on criteria established in Internal Control<span class="nobreak">-Integrated</span> Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated February&#160;23, 2024 expressed an unqualified opinion thereon.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Basis for Opinion</span></p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:6pt;">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S.&#160;federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:6pt;">We conducted our audits in accordance with the standards of the PCAOB.&#160;Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Critical Audit Matter</span></p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:6pt;">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1)&#160;relates to accounts or disclosures that are material to the financial statements and (2)&#160;involved our especially challenging, subjective or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</p>
		<table class="No-Table-Style" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 36.54%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">

					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 62.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">ETFS Indefinite</span><span class="nobreak"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">-Lived</span></span><span class="BoldItalic" style="font-style:italic;font-weight:bold;"> Intangible Assets&#160;&#8211;&#160;Assessment of Carrying Value</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 36.54%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Description of the Matter</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 62.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;">At December&#160;31, 2023, the Company held indefinite<span class="nobreak">-lived</span> intangible assets related to the right to manage assets under management through customary advisory agreements, which have no expiration date, in connection with the ETFS acquisition, with an aggregate carrying value of $601,247,000. As described in Notes 2 and 24 to the consolidated financial statements, these assets were assessed for impairment based upon a quantitative test. Indefinite<span class="nobreak">-lived</span> intangible assets are impaired if their estimated fair values are less than their carrying values. The Company determined the fair value of its ETFS intangible assets using an income approach (discounted cash flow analysis) with significant unobservable inputs that included the weighted average cost of capital and projected revenue growth rates.</p>
					</td>
				</tr>

		</table>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-2</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<table class="No-Table-Style" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 36.54%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">

					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 62.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Auditing the Company&#8217;s quantitative impairment assessment for its ETFS indefinite<span class="nobreak">-lived</span> intangible assets was complex due to the significant unobservable inputs required in determining fair value. In particular, the fair value estimate of the ETFS indefinite<span class="nobreak">-lived</span> intangible assets was sensitive to the significant unobservable inputs described above which are affected by future economic and market conditions and thus require significant judgment.</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-10" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 36.54%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">How we addressed the Matter in Our Audit</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 62.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company&#8217;s indefinite<span class="nobreak">-lived</span> intangible asset impairment assessment process. This included controls around management&#8217;s review of the significant unobservable inputs described above and the completeness and accuracy of the inputs to the valuation model.</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-11" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 36.54%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 62.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;">To test the Company&#8217;s quantitative impairment assessment of ETFS indefinite<span class="nobreak">-lived</span> intangible assets, our audit procedures included, among others, evaluating the Company&#8217;s selection of its fair value methodology, testing the significant unobservable inputs used in the valuation model, evaluating the clerical accuracy of the valuation model and testing the completeness and accuracy of the underlying data used by the Company to determine fair value. For example, we agreed certain inputs used to calculate the weighted average cost of capital to market data. We compared the projected revenue growth rates to the Company&#8217;s historical results, to those of other guideline public companies in the same industry, and to historical returns for the underlying asset classes. In addition, we assessed the accuracy of the Company&#8217;s historical projections by comparing them to actual operating results. We involved our valuation specialists to assist in our evaluation of the Company&#8217;s valuation model, the weighted average cost of capital used by the Company and the comparability of the guideline public companies selected by the Company and to calculate an independent estimate of the indefinite<span class="nobreak">-lived</span> intangible assets which we compared to the Company&#8217;s fair value estimate.</p>
					</td>
				</tr>

		</table>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:6pt;">/s/ Ernst&#160;&amp; Young LLP</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:6pt;">We have served as the Company&#8217;s auditor since 2010.</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:6pt;">New&#160;York, New&#160;York<br/>February&#160;23, 2024</p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-3</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Report of Independent Registered Public Accounting Firm</span></p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:12pt;margin-top:12pt;">To the Stockholders and the Board of Directors of WisdomTree, Inc.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Opinion on Internal Control Over Financial Reporting</span></p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:6pt;">We have audited WisdomTree, Inc. and subsidiaries&#8217; internal control over financial reporting as of December&#160;31, 2023, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, WisdomTree, Inc. and subsidiaries (the Company) maintained, in all material respects, effective internal control over financial reporting as of December&#160;31, 2023, based on the COSO criteria.</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:6pt;">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United&#160;States) (PCAOB), the 2023 consolidated financial statements of the Company and our report dated February&#160;23, 2024, expressed an unqualified opinion thereon.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Basis for Opinion</span></p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:6pt;">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Report of Management on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S.&#160;federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:6pt;">We conducted our audit in accordance with the standards of the PCAOB.&#160;Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:6pt;">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</p>
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Definition and Limitations of Internal Control Over Financial Reporting</span></p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:6pt;">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1)&#160;pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2)&#160;provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3)&#160;provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:6pt;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:6pt;">/s/ <ix:nonNumeric contextRef="c0" name="dei:AuditorName" id="ixv-26459">Ernst&#160;&amp; Young LLP</ix:nonNumeric></p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:6pt;">New&#160;York, New&#160;York<br/>February&#160;23, 2024</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-4</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<a id="T502"></a><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">WisdomTree, Inc. and Subsidiaries</span></p>
		<p class="Text_ind_center" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:3;margin-top:12pt;margin-top:12pt;">Consolidated Balance Sheets<br/><span class="Italic" style="font-style:italic;font-weight:normal;">(In Thousands, Except Per Share Amounts)</span></p>
		<table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-16" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">


					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-color:#000000;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2023</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-color:#000000;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-color:#000000;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2022</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Assets</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-color:#000000;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-color:#000000;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-color:#000000;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-2" style="font-size:8pt;">Current assets:</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:39pt;text-indent:-15pt;"><span class="CharOverride-2" style="font-size:8pt;">Cash and cash equivalents (including $<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsAndCash" scale="3" unitRef="usd" id="ixv-26460">5,007</ix:nonFraction> and $<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsAndCash" scale="3" unitRef="usd" id="ixv-26461">0</ix:nonFraction> invested in WisdomTree Government Money Market Digital Fund at December&#160;31, 2023 and 2022, respectively)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">$</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd" id="ixv-26462">129,305</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">$</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd" id="ixv-26463">132,101</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:39pt;text-indent:-15pt;"><span class="CharOverride-2" style="font-size:8pt;">Financial instruments owned, at fair value (including $<ix:nonFraction contextRef="c7" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" scale="3" unitRef="usd" id="ixv-26464">47,559</ix:nonFraction> and $<ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" scale="3" unitRef="usd" id="ixv-26465">25,283</ix:nonFraction> invested in WisdomTree products at December&#160;31, 2023 and 2022, respectively)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinancialInstrumentsOwnedAtFairValue" scale="3" unitRef="usd" id="ixv-26466">58,722</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinancialInstrumentsOwnedAtFairValue" scale="3" unitRef="usd" id="ixv-26467">126,239</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:39pt;text-indent:-15pt;"><span class="CharOverride-2" style="font-size:8pt;">Accounts receivable (including $<ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNet" scale="3" unitRef="usd" id="ixv-26468">28,511</ix:nonFraction> and $<ix:nonFraction contextRef="c10" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNet" scale="3" unitRef="usd" id="ixv-26469">24,139</ix:nonFraction> due from related parties at December&#160;31, 2023 and 2022, respectively)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" unitRef="usd" id="ixv-26470">35,473</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" unitRef="usd" id="ixv-26471">30,549</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:34pt;"><span class="CharOverride-2" style="font-size:8pt;">Prepaid expenses</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseCurrent" scale="3" unitRef="usd" id="ixv-26472">5,258</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PrepaidExpenseCurrent" scale="3" unitRef="usd" id="ixv-26473">4,684</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:34pt;"><span class="CharOverride-2" style="font-size:8pt;">Other current assets</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="middle">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="middle">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="3" unitRef="usd" id="ixv-26474">1,036</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="middle">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="middle">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsCurrent" scale="3" unitRef="usd" id="ixv-26475">390</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:49pt;"><span class="CharOverride-2" style="font-size:8pt;">Total current assets</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" unitRef="usd" id="ixv-26476">229,794</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsCurrent" scale="3" unitRef="usd" id="ixv-26477">293,963</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-2" style="font-size:8pt;">Fixed assets, net</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd" id="ixv-26478">427</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd" id="ixv-26479">544</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-2" style="font-size:8pt;">Indemnification receivable (Note&#160;22)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-0; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wt:IndemnificationReceivableNoncurrent" scale="3" unitRef="usd" id="ixv-26480">1,353</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-2" style="font-size:8pt;">Securities held-to-maturity</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:HeldToMaturitySecuritiesNoncurrent" scale="3" unitRef="usd" id="ixv-26481">230</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:HeldToMaturitySecuritiesNoncurrent" scale="3" unitRef="usd" id="ixv-26482">259</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-2" style="font-size:8pt;">Deferred tax assets, net</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" unitRef="usd" id="ixv-26483">11,057</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" unitRef="usd" id="ixv-26484">10,536</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-2" style="font-size:8pt;">Investments (Note&#160;7)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" unitRef="usd" id="ixv-26485">9,684</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" unitRef="usd" id="ixv-26486">35,721</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-2" style="font-size:8pt;">Right of use assets&#8212;operating leases (Note13)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd" id="ixv-26487">563</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" unitRef="usd" id="ixv-26488">1,449</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-2" style="font-size:8pt;">Goodwill (Note&#160;24)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" unitRef="usd" id="ixv-26489">86,841</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" unitRef="usd" id="ixv-26490">85,856</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-2" style="font-size:8pt;">Intangible assets, net (Note&#160;24)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" unitRef="usd" id="ixv-26491">605,082</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" unitRef="usd" id="ixv-26492">603,567</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-2" style="font-size:8pt;">Other noncurrent assets</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="middle">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="middle">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" unitRef="usd" id="ixv-26493">459</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="middle">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="middle">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" unitRef="usd" id="ixv-26494">571</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-2" style="font-size:8pt;">Total assets</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="middle">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="middle">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" unitRef="usd" id="ixv-26495">944,137</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="middle">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="middle">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Assets" scale="3" unitRef="usd" id="ixv-26496">1,033,819</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-18" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:6pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Liabilities and stockholders&#8217; equity</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Liabilities</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-2" style="font-size:8pt;">Current liabilities:</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:39pt;text-indent:-15pt;"><span class="CharOverride-2" style="font-size:8pt;">Fund management and administration payable</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableTradeCurrent" scale="3" unitRef="usd" id="ixv-26497">30,085</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableTradeCurrent" scale="3" unitRef="usd" id="ixv-26498">36,521</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:39pt;text-indent:-15pt;"><span class="CharOverride-2" style="font-size:8pt;">Compensation and benefits payable</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-26499">38,111</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-26500">24,121</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:39pt;text-indent:-15pt;"><span class="CharOverride-2" style="font-size:8pt;">Payable to Gold Bullion Holdings (Jersey) Limited (&#8220;GBH&#8221;) (Note&#160;12)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesPayableCurrent" scale="3" unitRef="usd" id="ixv-26501">14,804</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:39pt;text-indent:-15pt;"><span class="CharOverride-2" style="font-size:8pt;">Income taxes payable</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TaxesPayableCurrent" scale="3" unitRef="usd" id="ixv-26502">3,866</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TaxesPayableCurrent" scale="3" unitRef="usd" id="ixv-26503">1,599</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:39pt;text-indent:-15pt;"><span class="CharOverride-2" style="font-size:8pt;">Operating lease liabilities (Note&#160;13)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" unitRef="usd" id="ixv-26504">578</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" unitRef="usd" id="ixv-26505">1,125</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:39pt;text-indent:-15pt;"><span class="CharOverride-2" style="font-size:8pt;">Convertible notes&#8212;current (Note&#160;10)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-1; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebtCurrent" scale="3" unitRef="usd" id="ixv-26506">59,197</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:39pt;text-indent:-15pt;"><span class="CharOverride-2" style="font-size:8pt;">Deferred consideration&#8212;gold payments (Note&#160;9)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-2; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wt:DeferredConsiderationCurrent" scale="3" unitRef="usd" id="ixv-26507">16,796</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:39pt;text-indent:-15pt;"><span class="CharOverride-2" style="font-size:8pt;">Accounts payable and other liabilities</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="middle">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="middle">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-26508">15,772</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="middle">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="middle">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-26509">9,075</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:49pt;"><span class="CharOverride-2" style="font-size:8pt;">Total current liabilities</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-26510">103,216</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesCurrent" scale="3" unitRef="usd" id="ixv-26511">148,434</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-2" style="font-size:8pt;">Convertible notes (Note&#160;10)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="wt:CarryingValueOfConvertibleNotes" scale="3" unitRef="usd" id="ixv-26512">274,888</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wt:CarryingValueOfConvertibleNotes" scale="3" unitRef="usd" id="ixv-26513">262,019</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-2" style="font-size:8pt;">Payable to GBH (Note&#160;12)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsPayableCurrentAndNoncurrent" scale="3" unitRef="usd" id="ixv-26514">24,328</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-2" style="font-size:8pt;">Deferred consideration&#8212;gold payments (Note&#160;9)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-3; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wt:DeferredConsiderationNoncurrent" scale="3" unitRef="usd" id="ixv-26515">183,494</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-2" style="font-size:8pt;">Operating lease liabilities (Note&#160;13)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-4; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" unitRef="usd" id="ixv-26516">339</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-2" style="font-size:8pt;">Other noncurrent liabilities (Note&#160;22)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="middle">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="middle">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-5; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="middle">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="middle">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" unitRef="usd" id="ixv-26517">1,353</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-2" style="font-size:8pt;">Total liabilities</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" unitRef="usd" id="ixv-26518">402,432</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Liabilities" scale="3" unitRef="usd" id="ixv-26519">595,639</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-19" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:13pt;text-indent:-13pt;"><span class="CharOverride-2" style="font-size:8pt;">Preferred stock&#8212;Series&#160;A Non-Voting Convertible, par value $<ix:nonFraction contextRef="c11" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-26520"><ix:nonFraction contextRef="c12" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-26521">0.01</ix:nonFraction></ix:nonFraction>; <ix:nonFraction contextRef="c11" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" unitRef="shares" id="ixv-26522"><ix:nonFraction contextRef="c12" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" unitRef="shares" id="ixv-26523"><ix:nonFraction contextRef="c11" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" unitRef="shares" id="ixv-26524"><ix:nonFraction contextRef="c12" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" unitRef="shares" id="ixv-26525"><ix:nonFraction contextRef="c11" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" unitRef="shares" id="ixv-26526"><ix:nonFraction contextRef="c12" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" unitRef="shares" id="ixv-26527">14.750</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares authorized, issued and outstanding; redemption value of $<ix:nonFraction contextRef="c11" decimals="-3" format="ixt:num-dot-decimal" name="wt:PreferredStockRedemptionValue" scale="3" unitRef="usd" id="ixv-26528">96,869</ix:nonFraction> and $<ix:nonFraction contextRef="c12" decimals="-3" format="ixt:num-dot-decimal" name="wt:PreferredStockRedemptionValue" scale="3" unitRef="usd" id="ixv-26529">77,969</ix:nonFraction> at December&#160;31, 2023 and 2022, respectively) (Note&#160;11)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityValueExcludingAdditionalPaidInCapital" scale="3" unitRef="usd" id="ixv-26530">132,569</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityValueExcludingAdditionalPaidInCapital" scale="3" unitRef="usd" id="ixv-26531">132,569</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-18" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:6pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"><span class="Italic" style="font-style:italic;font-weight:normal;font-size:8pt;">Contingencies (Note&#160;14)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-6">&#160;</div></td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-7">&#160;</div></td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Stockholders&#8217; equity</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:8pt;text-indent:0pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:39pt;text-indent:-15pt;"><span class="CharOverride-2" style="font-size:8pt;">Preferred stock, par value $<ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-26532"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-26533">0.01</ix:nonFraction></ix:nonFraction>; <ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-26534"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-26535">2,000</ix:nonFraction></ix:nonFraction> shares authorized:</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-8; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-9; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:39pt;text-indent:-15pt;"><span class="CharOverride-2" style="font-size:8pt;">Common stock, par value $<ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-26536"><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-26537">0.01</ix:nonFraction></ix:nonFraction>; <ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-26538"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" unitRef="shares" id="ixv-26539">400,000</ix:nonFraction></ix:nonFraction> shares authorized; issued and outstanding: <ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-26540"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-26541">150,330</ix:nonFraction></ix:nonFraction> and <ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="0" unitRef="shares" id="ixv-26542"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" unitRef="shares" id="ixv-26543">146,517</ix:nonFraction></ix:nonFraction> at December&#160;31, 2023 and 2022, respectively</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="3" unitRef="usd" id="ixv-26544">1,503</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommonStockValue" scale="3" unitRef="usd" id="ixv-26545">1,465</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-20" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:39pt;text-indent:-15pt;"><span class="CharOverride-2" style="font-size:8pt;">Additional paid-in capital</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" unitRef="usd" id="ixv-26546">312,440</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" unitRef="usd" id="ixv-26547">291,847</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-20" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:39pt;text-indent:-15pt;"><span class="CharOverride-2" style="font-size:8pt;">Accumulated other comprehensive loss</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" sign="-" unitRef="usd" id="ixv-26548">548</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" sign="-" unitRef="usd" id="ixv-26549">1,420</ix:nonFraction>)</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-20" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:39pt;text-indent:-15pt;"><span class="CharOverride-2" style="font-size:8pt;">Retained earnings</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="middle">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="middle">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" unitRef="usd" id="ixv-26550">95,741</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="middle">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="middle">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" unitRef="usd" id="ixv-26551">13,719</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-20" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-2" style="font-size:8pt;">Total stockholders&#8217; equity</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="middle">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="middle">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26552">409,136</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="middle">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="middle">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26553">305,611</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-21" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;vertical-align:middle;width: 67.95%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="middle">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-2" style="font-size:8pt;">Total liabilities and stockholders&#8217; equity</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="middle">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;vertical-align:middle;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="middle">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" unitRef="usd" id="ixv-26554">944,137</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;vertical-align:middle;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="middle">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;vertical-align:middle;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="middle">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;vertical-align:middle;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="middle">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" unitRef="usd" id="ixv-26555">1,033,819</ix:nonFraction></span></p>	</td>
				</tr>

		</table>
		<p class="Text_flush_Center" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:3;margin-top:8pt;margin-top:8pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">The accompanying notes are an integral part of these consolidated financial statements</span></p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-5</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<a id="T503"></a><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">WisdomTree, Inc. and Subsidiaries</span></p>
		<p class="Text_flush_Center" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:3;margin-top:12pt;margin-top:12pt;">Consolidated Statements of Operations<br/><span class="Italic" style="font-style:italic;font-weight:normal;">(In Thousands, Except Per Share Amounts)</span></p>
		<table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="No-Table-Style TCH" style="width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="8" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 46.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Year Ended December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="No-Table-Style TCH _idGenCellOverride-5" style="width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Operating Revenues:</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Advisory fees</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-26556">333,227</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-26557">293,632</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-26558">298,052</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other income</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c16" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-26559">15,808</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c17" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-26560">7,713</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c18" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-26561">6,266</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total revenues</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-26562">349,035</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-26563">301,345</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-26564">304,318</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-23" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Operating Expenses:</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Compensation and benefits</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LaborAndRelatedExpense" scale="3" unitRef="usd" id="ixv-26565">109,532</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LaborAndRelatedExpense" scale="3" unitRef="usd" id="ixv-26566">97,897</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LaborAndRelatedExpense" scale="3" unitRef="usd" id="ixv-26567">88,163</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Fund management and administration</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:FundManagementAndAdministration" scale="3" unitRef="usd" id="ixv-26568">71,348</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="wt:FundManagementAndAdministration" scale="3" unitRef="usd" id="ixv-26569">64,761</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wt:FundManagementAndAdministration" scale="3" unitRef="usd" id="ixv-26570">58,912</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Marketing and advertising</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MarketingAndAdvertisingExpense" scale="3" unitRef="usd" id="ixv-26571">17,256</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MarketingAndAdvertisingExpense" scale="3" unitRef="usd" id="ixv-26572">15,302</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:MarketingAndAdvertisingExpense" scale="3" unitRef="usd" id="ixv-26573">14,090</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Sales and business development</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessDevelopment" scale="3" unitRef="usd" id="ixv-26574">13,584</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessDevelopment" scale="3" unitRef="usd" id="ixv-26575">11,871</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessDevelopment" scale="3" unitRef="usd" id="ixv-26576">9,907</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Contractual gold payments (Note&#160;9)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:ContractualGoldPayments" scale="3" unitRef="usd" id="ixv-26577">6,069</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="wt:ContractualGoldPayments" scale="3" unitRef="usd" id="ixv-26578">17,108</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wt:ContractualGoldPayments" scale="3" unitRef="usd" id="ixv-26579">17,096</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Professional fees</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfessionalFees" scale="3" unitRef="usd" id="ixv-26580">18,969</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfessionalFees" scale="3" unitRef="usd" id="ixv-26581">13,800</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfessionalFees" scale="3" unitRef="usd" id="ixv-26582">7,616</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Occupancy, communications and equipment</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommunicationsInformationTechnologyAndOccupancy" scale="3" unitRef="usd" id="ixv-26583">4,684</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommunicationsInformationTechnologyAndOccupancy" scale="3" unitRef="usd" id="ixv-26584">3,898</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CommunicationsInformationTechnologyAndOccupancy" scale="3" unitRef="usd" id="ixv-26585">4,629</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Depreciation and amortization</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationAndAmortization" scale="3" unitRef="usd" id="ixv-26586">872</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationAndAmortization" scale="3" unitRef="usd" id="ixv-26587">262</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationAndAmortization" scale="3" unitRef="usd" id="ixv-26588">738</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Third-party distribution fees</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:ThirdPartyDistribution" scale="3" unitRef="usd" id="ixv-26589">9,377</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="wt:ThirdPartyDistribution" scale="3" unitRef="usd" id="ixv-26590">7,656</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wt:ThirdPartyDistribution" scale="3" unitRef="usd" id="ixv-26591">7,176</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherExpenses" scale="3" unitRef="usd" id="ixv-26592">9,852</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherExpenses" scale="3" unitRef="usd" id="ixv-26593">8,705</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherExpenses" scale="3" unitRef="usd" id="ixv-26594">6,933</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total operating expenses</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" unitRef="usd" id="ixv-26595">261,543</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" unitRef="usd" id="ixv-26596">241,260</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingExpenses" scale="3" unitRef="usd" id="ixv-26597">215,260</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Operating income</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" unitRef="usd" id="ixv-26598">87,492</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" unitRef="usd" id="ixv-26599">60,085</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingIncomeLoss" scale="3" unitRef="usd" id="ixv-26600">89,058</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-23" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Other Income/(Expenses):</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Interest expense</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" unitRef="usd" id="ixv-26601">15,242</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" unitRef="usd" id="ixv-26602">14,935</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" unitRef="usd" id="ixv-26603">12,332</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-24" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:35pt;text-indent:-15pt;">Gain on revaluation/termination of deferred consideration&#8212;gold payments (Note&#160;9)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:GainLossFromChangeInDeferredConsideration" scale="3" unitRef="usd" id="ixv-26604">61,953</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="wt:GainLossFromChangeInDeferredConsideration" scale="3" unitRef="usd" id="ixv-26605">27,765</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wt:GainLossFromChangeInDeferredConsideration" scale="3" unitRef="usd" id="ixv-26606">2,018</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Interest income</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="3" unitRef="usd" id="ixv-26607">4,099</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="3" unitRef="usd" id="ixv-26608">3,320</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentIncomeInterest" scale="3" unitRef="usd" id="ixv-26609">2,009</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Impairments (Note&#160;26)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GoodwillImpairmentLoss" scale="3" unitRef="usd" id="ixv-26610">7,942</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-10; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GoodwillImpairmentLoss" scale="3" unitRef="usd" id="ixv-26611">16,156</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Loss on extinguishment of debt (Note&#160;10)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" sign="-" unitRef="usd" id="ixv-26612">9,721</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-11; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-12; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other losses, net</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingGainsLosses" scale="3" sign="-" unitRef="usd" id="ixv-26613">1,631</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingGainsLosses" scale="3" sign="-" unitRef="usd" id="ixv-26614">36,285</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNonoperatingGainsLosses" scale="3" sign="-" unitRef="usd" id="ixv-26615">7,926</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Income before income taxes</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" unitRef="usd" id="ixv-26616">119,008</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" unitRef="usd" id="ixv-26617">39,950</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" unitRef="usd" id="ixv-26618">56,671</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Income tax expense/(benefit)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-26619">16,462</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" sign="-" unitRef="usd" id="ixv-26620">10,734</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-26621">6,874</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-23" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Net income</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" unitRef="usd" id="ixv-26622">102,546</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" unitRef="usd" id="ixv-26623">50,684</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" unitRef="usd" id="ixv-26624">49,797</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-23" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Earnings per share&#8212;basic</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares" id="ixv-26625">0.66</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares" id="ixv-26626">0.31</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares" id="ixv-26627">0.31</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-23" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Earnings per share&#8212;diluted</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" unitRef="usdPershares" id="ixv-26628">0.64</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" unitRef="usdPershares" id="ixv-26629">0.31</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" unitRef="usdPershares" id="ixv-26630">0.31</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-23" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Weighted-average common shares&#8212;basic</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-26631">144,707</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-26632">143,020</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-26633">143,847</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-23" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Weighted-average common shares&#8212;diluted</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-26634">170,413</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-26635">158,914</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-26636">161,263</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-23" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Cash dividends declared per common share</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" unitRef="usdPershares" id="ixv-26637">0.12</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" unitRef="usdPershares" id="ixv-26638">0.12</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" unitRef="usdPershares" id="ixv-26639">0.12</ix:nonFraction></p>	</td>
				</tr>

		</table>
		<p class="Text_flush_Center" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:3;margin-top:8pt;margin-top:8pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">The accompanying notes are an integral part of these consolidated financial statements</span></p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-6</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<a id="T504"></a><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">WisdomTree, Inc. and Subsidiaries</span></p>
		<p class="Text_flush_Center" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:3;margin-top:12pt;margin-top:12pt;">Consolidated Statements of Comprehensive Income<br/><span class="Italic" style="font-style:italic;font-weight:normal;">(In Thousands)</span></p>
		<table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-20" style="height:12pt;">
					<td class="No-Table-Style TCH" rowspan="2" style="width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="8" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 46.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Year Ended December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Net income</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" unitRef="usd" id="ixv-26640">102,546</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" unitRef="usd" id="ixv-26641">50,684</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" unitRef="usd" id="ixv-26642">49,797</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Other comprehensive income/(loss)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-24" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Foreign currency translation adjustment, net of income taxes</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" unitRef="usd" id="ixv-26643">872</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" sign="-" unitRef="usd" id="ixv-26644">2,102</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" sign="-" unitRef="usd" id="ixv-26645">420</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other comprehensive income/(loss)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" unitRef="usd" id="ixv-26646">872</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" sign="-" unitRef="usd" id="ixv-26647">2,102</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" sign="-" unitRef="usd" id="ixv-26648">420</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Comprehensive income</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" unitRef="usd" id="ixv-26649">103,418</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" unitRef="usd" id="ixv-26650">48,582</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" unitRef="usd" id="ixv-26651">49,377</ix:nonFraction></p>	</td>
				</tr>

		</table>
		<p class="Text_flush_Center" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:3;margin-top:8pt;margin-top:8pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">The accompanying notes are an integral part of these consolidated financial statements</span></p>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-7</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<a id="T505"></a><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">WisdomTree, Inc. and Subsidiaries</span></p>
		<p class="Text_flush_Center" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:3;margin-top:12pt;margin-top:12pt;">Consolidated Statements of Changes in Stockholders&#8217; Equity<br/><span class="Italic" style="font-style:italic;font-weight:normal;">(In Thousands)</span></p>
		<table class="No-Table-Style TableOverride-2" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-23" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="4" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 14.83%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Series&#160;C Preferred<br/>Stock</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="4" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 16.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Common Stock</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Additional<br/>Paid-In<br/>Capital</span></p>
					</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 11.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Accumulated<br/>Other<br/>Comprehensive<br/>Income/(Loss)</span></p>
					</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 11.86%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">(Accumulated<br/>Deficit)/Retained<br/>Earnings</span></p>
					</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 9.64%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Total</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-23" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Shares<br/>Issued</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Par<br/>Value</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Shares<br/>Issued</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:8pt;">Par<br/>Value</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">Balance&#8212;December&#160;31, 2020</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-13; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-14; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c22" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-26652">148,716</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c22" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26653">1,487</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c23" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26654">317,075</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c24" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26655">1,102</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c25" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-26656">53,399</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26657">266,265</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-33" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-2" style="font-size:8pt;">Reclassification of equity component related to convertible notes, net of deferred taxes of $<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wt:ReclassificationOfEquity" scale="3" unitRef="usd" id="ixv-26658">1,022</ix:nonFraction>, upon the implementation of Accounting Standards Update&#160;2020-06 (Note&#160;10)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-15; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-16; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="wt:StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes" scale="3" sign="-" unitRef="usd" id="ixv-26659">3,682</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-17; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c31" decimals="-3" format="ixt:num-dot-decimal" name="wt:StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes" scale="3" unitRef="usd" id="ixv-26660">616</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wt:StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes" scale="3" sign="-" unitRef="usd" id="ixv-26661">3,066</ix:nonFraction>)</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-34" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">Balance&#8212;January&#160;1, 2021 (as&#160;adjusted)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-18">&#160;</div></td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"><div style="-sec-ix-hidden: hidden-fact-19">&#160;</div></td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c33" decimals="INF" format="ixt:num-dot-decimal" name="wt:TemporaryEquityShareOutstanding" scale="0" unitRef="shares" id="ixv-26662">148,716</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c33" decimals="-3" format="ixt:num-dot-decimal" name="wt:TemporaryStockholdersEquity" scale="3" unitRef="usd" id="ixv-26663">1,487</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c34" decimals="-3" format="ixt:num-dot-decimal" name="wt:TemporaryStockholdersEquity" scale="3" unitRef="usd" id="ixv-26664">313,393</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c35" decimals="-3" format="ixt:num-dot-decimal" name="wt:TemporaryStockholdersEquity" scale="3" unitRef="usd" id="ixv-26665">1,102</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c36" decimals="-3" format="ixt:num-dot-decimal" name="wt:TemporaryStockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-26666">52,783</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c37" decimals="-3" format="ixt:num-dot-decimal" name="wt:TemporaryStockholdersEquity" scale="3" unitRef="usd" id="ixv-26667">263,199</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-35" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:20pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">Restricted stock issued and vesting of restricted stock units, net</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-20; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-21; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c28" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="0" unitRef="shares" id="ixv-26668">1,369</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" unitRef="usd" id="ixv-26669">13</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" sign="-" unitRef="usd" id="ixv-26670">13</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-22; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-23; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-24; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:20pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">Shares repurchased</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-25; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-26; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c28" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" unitRef="shares" id="ixv-26671">5,121</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" unitRef="usd" id="ixv-26672">51</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" unitRef="usd" id="ixv-26673">34,455</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-27; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-28; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" unitRef="usd" id="ixv-26674">34,506</ix:nonFraction>)</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:20pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">Exercise of stock options, net</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-29; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-30; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c28" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" unitRef="shares" id="ixv-26675">143</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c28" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" unitRef="usd" id="ixv-26676">2</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" unitRef="usd" id="ixv-26677">813</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-31; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-32; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" unitRef="usd" id="ixv-26678">815</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:20pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">Stock-based compensation</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-33; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-34; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c29" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" unitRef="usd" id="ixv-26679">9,998</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-35; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-36; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" unitRef="usd" id="ixv-26680">9,998</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:20pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">Other comprehensive loss</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-37; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-38; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-39; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c30" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" sign="-" unitRef="usd" id="ixv-26681">420</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-40; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" sign="-" unitRef="usd" id="ixv-26682">420</ix:nonFraction>)</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:20pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">Dividends</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-41; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-42; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-43; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-44; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c31" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Dividends" scale="3" unitRef="usd" id="ixv-26683">19,459</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Dividends" scale="3" unitRef="usd" id="ixv-26684">19,459</ix:nonFraction>)</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:20pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">Net income</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-45; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-46; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-47; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-48; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c31" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" unitRef="usd" id="ixv-26685">49,797</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" unitRef="usd" id="ixv-26686">49,797</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">Balance&#8212;December&#160;31, 2021</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-49; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-50; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c33" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-26687">145,107</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c33" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26688">1,451</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c34" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26689">289,736</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c35" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26690">682</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c36" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-26691">22,445</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c37" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26692">269,424</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-35" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:20pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">Restricted stock issued and vesting of restricted stock units, net</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-51; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-52; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c39" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="0" unitRef="shares" id="ixv-26693">2,003</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c39" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" unitRef="usd" id="ixv-26694">20</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c40" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" sign="-" unitRef="usd" id="ixv-26695">20</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-53; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-54; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-55; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:20pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">Shares repurchased</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-56; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-57; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c39" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" unitRef="shares" id="ixv-26696">593</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c39" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" unitRef="usd" id="ixv-26697">6</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c40" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" unitRef="usd" id="ixv-26698">3,412</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-58; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-59; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" unitRef="usd" id="ixv-26699">3,418</ix:nonFraction>)</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:20pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">Stock-based compensation</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-60; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-61; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c40" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" unitRef="usd" id="ixv-26700">10,385</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-62; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-63; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" unitRef="usd" id="ixv-26701">10,385</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:20pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">Other comprehensive loss</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-64; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-65; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-66; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c41" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" sign="-" unitRef="usd" id="ixv-26702">2,102</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-67; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" sign="-" unitRef="usd" id="ixv-26703">2,102</ix:nonFraction>)</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:20pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">Dividends</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-68; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-69; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c40" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Dividends" scale="3" unitRef="usd" id="ixv-26704">4,842</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-70; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c42" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Dividends" scale="3" unitRef="usd" id="ixv-26705">14,520</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Dividends" scale="3" unitRef="usd" id="ixv-26706">19,362</ix:nonFraction>)</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:20pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">Net income</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-71; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-72; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-73; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-74; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c42" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" unitRef="usd" id="ixv-26707">50,684</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" unitRef="usd" id="ixv-26708">50,684</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">Balance&#8212;December&#160;31, 2022</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-75; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-76; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c44" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-26709">146,517</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c44" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26710">1,465</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c45" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26711">291,847</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;text-align:left;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c46" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-26712">1,420</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c47" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26713">13,719</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26714">305,611</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-35" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:20pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">Restricted stock issued and vesting of restricted stock units, net</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-77; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-78; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c49" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="0" unitRef="shares" id="ixv-26715">3,412</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c49" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" unitRef="usd" id="ixv-26716">34</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c50" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" sign="-" unitRef="usd" id="ixv-26717">34</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-79; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"><p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-79; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p></td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-81; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-36" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:20pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">Shares issued in connection with convertible notes that matured on June&#160;15, 2023 (Note&#160;10)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-82; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-83; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c49" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" unitRef="shares" id="ixv-26718">1,037</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c49" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" unitRef="usd" id="ixv-26719">10</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c50" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" unitRef="usd" id="ixv-26720">35</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-84; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-85; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" unitRef="usd" id="ixv-26721">45</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-37" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:20pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">Shares issued in connection with termination of the deferred consideration&#8212;gold payments obligation, net of issuance costs (Note&#160;9)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c48" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodSharesOther" scale="0" unitRef="shares" id="ixv-26722">13</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-86; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-87; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-88; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c50" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" unitRef="usd" id="ixv-26723">86,801</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-89; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-90; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" unitRef="usd" id="ixv-26724">86,801</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-33" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:20pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">Shares repurchased that were issued in connection with termination of the deferred consideration&#8212;gold payments obligation, net of issuance costs (Notes 12 and 23)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c48" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="0" sign="-" unitRef="shares" id="ixv-26725">13</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-91; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-92; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-93; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c50" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" sign="-" unitRef="usd" id="ixv-26726">78,835</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-94; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-95; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" sign="-" unitRef="usd" id="ixv-26727">78,835</ix:nonFraction>)</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:20pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">Shares repurchased</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-96; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-97; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c49" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" unitRef="shares" id="ixv-26728">636</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c49" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" unitRef="usd" id="ixv-26729">6</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c50" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" unitRef="usd" id="ixv-26730">3,564</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-98; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-99; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" unitRef="usd" id="ixv-26731">3,570</ix:nonFraction>)</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:20pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">Stock-based compensation</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-100; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-101; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c50" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" unitRef="usd" id="ixv-26732">16,190</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-102; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-103; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" unitRef="usd" id="ixv-26733">16,190</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:20pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">Other comprehensive income</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-104; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-105; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-106; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c51" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" unitRef="usd" id="ixv-26734">872</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-107; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" unitRef="usd" id="ixv-26735">872</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:20pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">Dividends</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-108; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-109; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-110; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.23%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-111; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c52" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Dividends" scale="3" unitRef="usd" id="ixv-26736">20,524</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Dividends" scale="3" unitRef="usd" id="ixv-26737">20,524</ix:nonFraction>)</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-38" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:20pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">Net income</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-112; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-113; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-114; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-115; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c52" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" unitRef="usd" id="ixv-26738">102,546</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" unitRef="usd" id="ixv-26739">102,546</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-38" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 20.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">Balance&#8212;December&#160;31, 2023</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.86%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-116; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-117; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c54" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:SharesOutstanding" scale="0" unitRef="shares" id="ixv-26740">150,330</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 5.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c54" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26741">1,503</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 6.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c55" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26742">312,440</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-2" style="font-size:8pt;">(<ix:nonFraction contextRef="c56" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" sign="-" unitRef="usd" id="ixv-26743">548</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c57" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26744">95,741</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.11%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.16%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-2" style="font-size:8pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockholdersEquity" scale="3" unitRef="usd" id="ixv-26745">409,136</ix:nonFraction></span></p>	</td>
				</tr>

		</table>
		<p class="Text_flush_Center" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:3;margin-top:8pt;margin-top:8pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">The accompanying notes are an integral part of these consolidated financial statements</span></p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-8</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>




	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<a id="T506"></a><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">WisdomTree, Inc. and Subsidiaries</span></p>
		<p class="Text_flush_Center" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:3;margin-top:12pt;margin-top:12pt;">Consolidated Statements of Cash Flows<br/><span class="Italic" style="font-style:italic;font-weight:normal;">(In Thousands)</span></p>
		<table class="No-Table-Style TableOverride-2" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="8" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 46.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Year Ended December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Cash flows from operating activities:</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net income</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" unitRef="usd" id="ixv-26746">102,546</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" unitRef="usd" id="ixv-26747">50,684</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" unitRef="usd" id="ixv-26748">49,797</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-24" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:15pt;text-indent:-15pt;">Adjustments to reconcile net income to net cash provided by operating activities:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-24" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:43pt;text-indent:-15pt;">Gain on revaluation of deferred consideration&#8212;gold payments</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:GainLossFromChangeInDeferredConsideration" scale="3" unitRef="usd" id="ixv-26749">61,953</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="wt:GainLossFromChangeInDeferredConsideration" scale="3" unitRef="usd" id="ixv-26750">27,765</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wt:GainLossFromChangeInDeferredConsideration" scale="3" unitRef="usd" id="ixv-26751">2,018</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-24" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:38pt;">Advisory fees received in gold and other precious metals</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:AdvisoryFeesReceivedInGold" scale="3" unitRef="usd" id="ixv-26752">49,400</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="wt:AdvisoryFeesReceivedInGold" scale="3" unitRef="usd" id="ixv-26753">57,290</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wt:AdvisoryFeesReceivedInGold" scale="3" unitRef="usd" id="ixv-26754">74,970</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:38pt;">Stock-based compensation</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-26755">16,190</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-26756">10,385</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-26757">9,998</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:38pt;">Loss on extinguishment of debt</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" sign="-" unitRef="usd" id="ixv-26758">9,721</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-118; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-119; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:38pt;">Impairments</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GoodwillImpairmentLoss" scale="3" unitRef="usd" id="ixv-26759">7,942</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-120; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GoodwillImpairmentLoss" scale="3" unitRef="usd" id="ixv-26760">16,156</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:38pt;">Contractual gold payments</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:ContractualGoldPayments" scale="3" unitRef="usd" id="ixv-26761">6,069</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="wt:ContractualGoldPayments" scale="3" unitRef="usd" id="ixv-26762">17,108</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wt:ContractualGoldPayments" scale="3" unitRef="usd" id="ixv-26763">17,096</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:38pt;">Amortization of issuance costs&#8212;convertible notes</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:AmortizationOfIssuanceCostsConvertibleNotes" scale="3" unitRef="usd" id="ixv-26764">1,817</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="wt:AmortizationOfIssuanceCostsConvertibleNotes" scale="3" unitRef="usd" id="ixv-26765">2,592</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wt:AmortizationOfIssuanceCostsConvertibleNotes" scale="3" unitRef="usd" id="ixv-26766">2,187</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:38pt;">Amortization of right of use asset</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" unitRef="usd" id="ixv-26767">1,285</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" unitRef="usd" id="ixv-26768">963</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" unitRef="usd" id="ixv-26769">1,950</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:38pt;">Depreciation and amortization</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationAndAmortization" scale="3" unitRef="usd" id="ixv-26770">872</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationAndAmortization" scale="3" unitRef="usd" id="ixv-26771">262</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DepreciationAndAmortization" scale="3" unitRef="usd" id="ixv-26772">738</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:38pt;">Losses on financial instruments owned, at fair value</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrealizedGainLossOnInvestments" scale="3" sign="-" unitRef="usd" id="ixv-26773">517</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrealizedGainLossOnInvestments" scale="3" sign="-" unitRef="usd" id="ixv-26774">16,516</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrealizedGainLossOnInvestments" scale="3" sign="-" unitRef="usd" id="ixv-26775">3,715</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:38pt;">Deferred income taxes</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" sign="-" unitRef="usd" id="ixv-26776">481</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" sign="-" unitRef="usd" id="ixv-26777">1,296</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-26778">316</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:38pt;">Imputed interest on payable to GBH</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpenseDebt" scale="3" unitRef="usd" id="ixv-26779">297</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-121; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-122; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:38pt;">Losses on investments</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RealizedInvestmentGainsLosses" scale="3" sign="-" unitRef="usd" id="ixv-26780">242</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-123; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-124; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-24" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:43pt;text-indent:-15pt;">Gain on sale&#8212;Canadian ETF business, including remeasurement of contingent consideration</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-125; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-126; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="3" unitRef="usd" id="ixv-26781">787</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:38pt;">Other</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-127; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNoncashIncomeExpense" scale="3" unitRef="usd" id="ixv-26782">1,984</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherNoncashIncomeExpense" scale="3" unitRef="usd" id="ixv-26783">272</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:38pt;">Changes in operating assets and liabilities:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:71pt;">Accounts receivable</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" unitRef="usd" id="ixv-26784">6,212</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" unitRef="usd" id="ixv-26785">720</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" unitRef="usd" id="ixv-26786">3,506</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:71pt;">Prepaid expenses</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="3" unitRef="usd" id="ixv-26787">518</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="3" unitRef="usd" id="ixv-26788">808</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="3" unitRef="usd" id="ixv-26789">139</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:71pt;">Gold and other precious metals</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:IncreaseDecreaseInGoldAndOtherPreciousMetals" scale="3" sign="-" unitRef="usd" id="ixv-26790">42,150</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="wt:IncreaseDecreaseInGoldAndOtherPreciousMetals" scale="3" sign="-" unitRef="usd" id="ixv-26791">41,847</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wt:IncreaseDecreaseInGoldAndOtherPreciousMetals" scale="3" sign="-" unitRef="usd" id="ixv-26792">57,417</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:71pt;">Other assets</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" sign="-" unitRef="usd" id="ixv-26793">281</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" unitRef="usd" id="ixv-26794">309</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" unitRef="usd" id="ixv-26795">394</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-24" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:71pt;">Fund management and administration payable</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:IncreaseDecreaseInFundManagementAndAdministrationPayable" scale="3" unitRef="usd" id="ixv-26796">5,837</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="wt:IncreaseDecreaseInFundManagementAndAdministrationPayable" scale="3" unitRef="usd" id="ixv-26797">3,723</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wt:IncreaseDecreaseInFundManagementAndAdministrationPayable" scale="3" unitRef="usd" id="ixv-26798">1,348</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:71pt;">Compensation and benefits payable</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" unitRef="usd" id="ixv-26799">1,209</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" unitRef="usd" id="ixv-26800">4,485</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" unitRef="usd" id="ixv-26801">10,242</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:71pt;">Income taxes payable</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" scale="3" unitRef="usd" id="ixv-26802">2,260</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" scale="3" sign="-" unitRef="usd" id="ixv-26803">2,308</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" scale="3" unitRef="usd" id="ixv-26804">3,101</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:71pt;">Operating lease liabilities</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:IncreaseDecreaseInOperatingLeaseLiabilities" scale="3" unitRef="usd" id="ixv-26805">1,284</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="wt:IncreaseDecreaseInOperatingLeaseLiabilities" scale="3" unitRef="usd" id="ixv-26806">965</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wt:IncreaseDecreaseInOperatingLeaseLiabilities" scale="3" unitRef="usd" id="ixv-26807">15,560</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:71pt;">Accounts payable and other liabilities</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" scale="3" unitRef="usd" id="ixv-26808">6,213</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" scale="3" sign="-" unitRef="usd" id="ixv-26809">33</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" scale="3" sign="-" unitRef="usd" id="ixv-26810">1,097</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net cash provided by operating activities</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" unitRef="usd" id="ixv-26811">85,600</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" unitRef="usd" id="ixv-26812">55,087</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" unitRef="usd" id="ixv-26813">75,318</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-23" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Cash flows from investing activities:</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Purchase of financial instruments owned, at fair value</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:PurchaseOfFinancialInstrumentsOwnedAtFairValue" scale="3" unitRef="usd" id="ixv-26814">57,364</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="wt:PurchaseOfFinancialInstrumentsOwnedAtFairValue" scale="3" unitRef="usd" id="ixv-26815">67,734</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wt:PurchaseOfFinancialInstrumentsOwnedAtFairValue" scale="3" unitRef="usd" id="ixv-26816">115,526</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Purchase of investments</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:PurchaseOfInvestments" scale="3" unitRef="usd" id="ixv-26817">11,228</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="wt:PurchaseOfInvestments" scale="3" unitRef="usd" id="ixv-26818">21,863</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wt:PurchaseOfInvestments" scale="3" unitRef="usd" id="ixv-26819">5,750</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Cash paid&#8212;software development</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment" scale="3" unitRef="usd" id="ixv-26820">2,149</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-24" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Cash paid&#8212;acquisition of Securrency Transfers, Inc. (net of cash acquired)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherPaymentsToAcquireBusinesses" scale="3" unitRef="usd" id="ixv-26821">985</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-128; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Purchase of fixed assets</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-26822">113</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-26823">220</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-26824">293</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-24" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Proceeds from the sale of financial instruments owned, at fair value</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue" scale="3" unitRef="usd" id="ixv-26825">123,564</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="wt:ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue" scale="3" unitRef="usd" id="ixv-26826">52,115</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wt:ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue" scale="3" unitRef="usd" id="ixv-26827">19,441</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Proceeds from the exit from investment in Securrency, Inc.</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" scale="3" unitRef="usd" id="ixv-26828">28,818</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-129; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-130; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-24" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Proceeds from receipt of contingent consideration related to the sale of Canadian ETF business</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="3" unitRef="usd" id="ixv-26829">1,477</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-131; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="3" unitRef="usd" id="ixv-26830">2,360</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-24" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Proceeds from held-to-maturity securities maturing or called prior to maturity</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity" scale="3" unitRef="usd" id="ixv-26831">29</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="wt:ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity" scale="3" unitRef="usd" id="ixv-26832">45</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wt:ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity" scale="3" unitRef="usd" id="ixv-26833">136</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-39" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net cash provided by/(used in) investing activities</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" unitRef="usd" id="ixv-26834">82,049</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" sign="-" unitRef="usd" id="ixv-26835">37,657</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" sign="-" unitRef="usd" id="ixv-26836">99,632</ix:nonFraction>)</p>	</td>
				</tr>

		</table>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-9</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>




	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">WisdomTree, Inc. and Subsidiaries</span></p>
		<p class="Text_flush_Center" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:3;margin-top:12pt;margin-top:12pt;">Consolidated Statements of Cash Flows&#8212;(Continued)<br/><span class="Italic" style="font-style:italic;font-weight:normal;">(In Thousands)</span></p>
		<table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="8" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 46.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Year Ended December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Cash flows from financing activities:</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Repurchase and maturity of convertible notes</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromRepaymentsOfNotesPayable" scale="3" sign="-" unitRef="usd" id="ixv-26837">184,272</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-132; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-133; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Termination of deferred consideration&#8212;gold payments</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:PaymentOfDeferredConsideration" scale="3" unitRef="usd" id="ixv-26838">50,005</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-134; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-135; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Repurchase of Series&#160;C Preferred Stock</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" scale="3" sign="-" unitRef="usd" id="ixv-26839">40,000</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-136; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-137; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Dividends paid</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfDividends" scale="3" unitRef="usd" id="ixv-26840">20,144</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfDividends" scale="3" unitRef="usd" id="ixv-26841">19,362</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfDividends" scale="3" unitRef="usd" id="ixv-26842">19,459</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Shares repurchased</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" unitRef="usd" id="ixv-26843">3,570</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" unitRef="usd" id="ixv-26844">3,418</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" unitRef="usd" id="ixv-26845">34,506</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Issuance costs&#8212;convertible notes</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:PaymentOfConvertibleNotesIssuanceCosts" scale="3" unitRef="usd" id="ixv-26846">3,548</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-138; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wt:PaymentOfConvertibleNotesIssuanceCosts" scale="3" unitRef="usd" id="ixv-26847">4,297</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Issuance costs&#8212;Series&#160;C Preferred Stock</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" unitRef="usd" id="ixv-26848">97</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Proceeds from the issuance of convertible notes (Note&#160;10)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:ProceedsFromIssuanceOfConvertibleNotes" scale="3" unitRef="usd" id="ixv-26849">130,000</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-139; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wt:ProceedsFromIssuanceOfConvertibleNotes" scale="3" unitRef="usd" id="ixv-26850">150,000</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Proceeds from exercise of stock options</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-140; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-141; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" unitRef="usd" id="ixv-26851">815</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net cash (used in)/provided by financing activities</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" sign="-" unitRef="usd" id="ixv-26852">171,636</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" sign="-" unitRef="usd" id="ixv-26853">22,780</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" unitRef="usd" id="ixv-26854">92,553</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-24" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Increase/(decrease) in cash flow due to changes in foreign exchange rate</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-26855">1,191</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" sign="-" unitRef="usd" id="ixv-26856">3,258</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" sign="-" unitRef="usd" id="ixv-26857">955</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net (decrease)/increase in cash and cash equivalents</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" sign="-" unitRef="usd" id="ixv-26858">2,796</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" sign="-" unitRef="usd" id="ixv-26859">8,608</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" unitRef="usd" id="ixv-26860">67,284</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Cash and cash equivalents&#8212;beginning of year</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-26861">132,101</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c37" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-26862">140,709</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c26" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-26863">73,425</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Cash and cash equivalents&#8212;end of year</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-26864">129,305</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-26865">132,101</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c37" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" unitRef="usd" id="ixv-26866">140,709</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Supplemental disclosure of cash flow information:</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Cash paid for income taxes</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaidNet" scale="3" unitRef="usd" id="ixv-26867">16,156</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaidNet" scale="3" unitRef="usd" id="ixv-26868">12,500</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaidNet" scale="3" unitRef="usd" id="ixv-26869">8,456</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-40" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Cash paid for interest</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="3" unitRef="usd" id="ixv-26870">10,709</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="3" unitRef="usd" id="ixv-26871">12,313</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPaidNet" scale="3" unitRef="usd" id="ixv-26872">9,898</ix:nonFraction></p>	</td>
				</tr>

		</table>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:6pt;"><span class="CharOverride-3" style="font-size:12pt;">NON-CASH ACTIVITIES</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On January&#160;1, 2021, the Company reclassified the equity component related to the convertible notes, net of deferred taxes, reducing accumulated deficit by $616, increasing the carrying value of the convertible notes by $4,088, reducing additional paid in capital by $3,682 and reducing deferred tax liabilities by $1,022, upon the implementation of Accounting Standards Update (&#8220;ASU&#8221;)&#160;2020<span class="nobreak">-06</span><span class="Italic" style="font-style:italic;font-weight:normal;">, Debt&#160;&#8211;&#160;Debt with Conversion and Other Options</span> (Note&#160;10).</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On May&#160;10, 2023, the Company issued 13.087<span class="nobreak"> </span>shares of Series&#160;C Non<span class="nobreak">-Voting</span> Convertible Preferred Stock (the &#8220;Series&#160;C Preferred Stock&#8221;) (valued at $86,898) in connection with the termination of its deferred consideration&#8212;gold payments obligation. Those shares were subsequently repurchased on November&#160;20, 2023 for aggregate consideration of approximately $84,411, with $40,000 paid on the closing date and the remainder of the purchase price payable in equal annual installments on the first, second and third anniversaries of the closing date, with no requirement to pay interest. See Notes 11 and 12 for additional information.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On June&#160;15, 2023, the Company issued 1,037<span class="nobreak"> </span>shares of common stock (as the conversion option was in the money) in connection with the maturity of $60,000 aggregate principal amount of 4.25% Convertible Senior Notes due 2023.</p>
		<p class="Text_flush_Center" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:3;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">The accompanying notes are an integral part of these consolidated financial statements</span></p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-10</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>




	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<a id="T507"></a><p class="H1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">WisdomTree, Inc. and Subsidiaries</span></p>
		<p class="H1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><span class="CharOverride-1" style="font-style:normal;font-weight:normal;">Notes to Consolidated Financial Statements<br/></span><span class="Italic" style="font-style:italic;font-weight:normal;">(In Thousands, Except Share and Per Share Amounts)</span></p>
		<ix:nonNumeric contextRef="c0" continuedAt="_BusinessDescriptionAndBasisOfPresentationTextBlock-c0_cont_1" escape="true" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="ixv-18851"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">1. Organization and Description of Business</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">WisdomTree, Inc., through its global subsidiaries (collectively, &#8220;WisdomTree&#8221; or the &#8220;Company&#8221;), is a global financial innovator, offering a well<span class="nobreak">-diversified</span> suite of exchange<span class="nobreak">-traded</span> products (&#8220;ETPs&#8221;), models, solutions and products leveraging blockchain technology. Building on its heritage of innovation, the Company is also developing and has launched next<span class="nobreak">-generation</span> digital products, services and structures, including digital or blockchain<span class="nobreak">-enabled</span> mutual funds (&#8220;Digital Funds&#8221;) and tokenized assets, as well as its blockchain<span class="nobreak">-native</span> digital wallet, WisdomTree Prime. The Company has the following wholly<span class="nobreak">-owned</span> operating subsidiaries:</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">WisdomTree Asset Management, Inc.</span> is a New&#160;York based investment adviser registered with the SEC, providing investment advisory and other management services to the WisdomTree Trust (&#8220;WTT&#8221;) and WisdomTree exchange<span class="nobreak">-traded</span> funds (&#8220;ETFs&#8221;). The WisdomTree ETFs are issued in the U.S.&#160;by WTT.&#160;WTT is a non<span class="nobreak">-consolidated</span> Delaware statutory trust registered with the SEC as an open<span class="nobreak">-end</span> management investment company. The Company has licensed to WTT the use of certain of its own indexes on an exclusive basis for the WisdomTree ETFs in the U.S.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">WisdomTree Management Jersey Limited </span>(&#8220;ManJer&#8221;) is a Jersey based management company providing management services to seven issuers (the &#8220;ManJer Issuers&#8221;) in respect of the ETPs issued and listed by the ManJer Issuers covering commodity, currency, cryptocurrency and leveraged<span class="nobreak">-and-inverse</span> strategies.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">WisdomTree Multi Asset Management Limited</span> (&#8220;WTMAML&#8221;) is a Jersey based management company providing management services to WisdomTree Multi Asset Issuer PLC (&#8220;WMAI&#8221;) in respect of the ETPs issued by WMAI.&#160;WMAI is a non<span class="nobreak">-consolidated</span> public limited company domiciled in Ireland.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">WisdomTree Management Limited</span> (&#8220;WML&#8221;) is an Ireland based management company providing management services to WisdomTree Issuer ICAV (&#8220;WTICAV&#8221;) in respect of the WisdomTree UCITS ETFs issued by WTICAV.&#160;WTICAV is a non<span class="nobreak">-consolidated</span> public limited company domiciled in Ireland.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">WisdomTree UK Limited</span> (&#8220;WTUK&#8221;) is a U.K. based company registered with the Financial Conduct Authority currently providing distribution and support services to ManJer, WTMAML and WML.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">WisdomTree Europe Limited</span> is a U.K. based company which is the legacy distributor of the WMAI ETPs and WisdomTree UCITS ETFs. These services are now provided directly by WTUK.&#160;WisdomTree Europe Limited is no longer regulated and does not provide any regulated services.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">WisdomTree Ireland Limited</span> is an Ireland based company authorized by the Central Bank of Ireland providing distribution services to ManJer, WTMAML and WML.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">WisdomTree Digital Commodity Services, LLC</span> is a New&#160;York based company that serves as the sponsor of the WisdomTree Bitcoin Fund, which is currently effective with the SEC.&#160;The WisdomTree Bitcoin Fund is an exchange<span class="nobreak">-traded</span> fund that issues common shares of beneficial interest and is listed on the Cboe BZX Exchange, Inc. The WisdomTree Bitcoin Fund provides exposure to the spot price of bitcoin.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">WisdomTree Digital Management, Inc.</span> (&#8220;WT Digital Management&#8221;) is a New&#160;York based investment adviser registered with the SEC, providing investment advisory and other management services to the WisdomTree Digital Trust (&#8220;WTDT&#8221;) and WisdomTree Digital Funds. The WisdomTree Digital Funds are issued in the U.S.&#160;by WTDT.&#160;WTDT is a non<span class="nobreak">-consolidated</span> Delaware statutory trust registered with the SEC as an open<span class="nobreak">-end</span> management investment company. Each Digital Fund uses blockchain technology to maintain a secondary record of its shares on one or more blockchains (e.g., Stellar or Ethereum), but does not directly or indirectly invest in any assets that rely on blockchain technology, such as cryptocurrencies.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">WisdomTree Digital Movement, Inc. </span>(&#8220;WT Digital Movement&#8221;) is a New&#160;York based company operating as a money services business registered with the Financial Crimes Enforcement Network. WT Digital Movement has obtained and is seeking additional state money transmitter licenses to operate a platform for the purchase, sale and exchange of tokenized assets, while also providing blockchain<span class="nobreak">-native</span> digital wallet services through WisdomTree Prime to facilitate such activity.</p></ix:nonNumeric>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-11</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="Basic-Text-Frame" style="margin:0;padding:0;border-width:0;">
		<ix:continuation id="_BusinessDescriptionAndBasisOfPresentationTextBlock-c0_cont_1"><p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">WisdomTree Securities, Inc. </span>is a New&#160;York based limited purpose broker<span class="nobreak">-dealer</span> (i.e., mutual fund retailer), facilitating transactions in WisdomTree Digital Funds.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">WisdomTree Transfers, Inc. </span>is a New&#160;York based transfer agent registered with the SEC, providing transfer agency and registrar services for the Digital Funds. The transfer agent maintains the official record of share ownership in book entry form and reconciles the official record with the secondary record of ownership of shares on one or more blockchains.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">WisdomTree Digital Trust Company, LLC</span> is a New&#160;York based limited liability trust company that has been formed to operate as a limited purpose trust company under New&#160;York Banking Law upon receiving a charter from the New&#160;York State Department of Financial Services.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_1" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="ixv-18929"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2. Significant Accounting Policies</span></p>
		<ix:nonNumeric contextRef="c0" continuedAt="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="ixv-18932"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Basis of Presentation</span></p></ix:nonNumeric>
		<ix:continuation id="_BasisOfAccountingPolicyPolicyTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">These consolidated financial statements have been prepared in conformity with U.S.&#160;generally accepted accounting principles (&#8220;GAAP&#8221;) and in the opinion of management reflect all adjustments, consisting of only normal recurring adjustments, necessary for a fair presentation of the financial statements. The consolidated financial statements include the accounts of the Company&#8217;s wholly<span class="nobreak">-owned</span> subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="_ConsolidationPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ConsolidationPolicyTextBlock" id="ixv-18938"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Consolidation</span></p></ix:nonNumeric>
		<ix:continuation continuedAt="_ConsolidationPolicyTextBlock-c0_cont_2" id="_ConsolidationPolicyTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company consolidates entities in which it has a controlling financial interest. The Company determines whether it has a controlling financial interest in an entity by first evaluating whether the entity is a voting interest entity (&#8220;VOE&#8221;) or a variable interest entity (&#8220;VIE&#8221;). The usual condition for a controlling financial interest in a VOE is ownership of a majority voting interest. If the Company has a majority voting interest in a VOE, the entity is consolidated. The Company has a controlling financial interest in a VIE when the Company has a variable interest that provides it with (i)&#160;the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (ii)&#160;the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE.</p></ix:continuation>
		<ix:continuation id="_ConsolidationPolicyTextBlock-c0_cont_2"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company reassesses its evaluation of whether an entity is a VOE or VIE when certain reconsideration events occur.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="_SegmentReportingPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="ixv-18945"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Segment and Geographic Information</span></p></ix:nonNumeric>
		<ix:continuation id="_SegmentReportingPolicyPolicyTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company, through its subsidiaries in the U.S.&#160;and Europe, conducts business as a single operating segment as an ETP sponsor and asset manager which is based upon the Company&#8217;s current organizational and management structure, as well as information used by the chief operating decision maker to allocate resources and other factors.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="ixv-18950"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Foreign Currency Translation</span></p></ix:nonNumeric>
		<ix:continuation id="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Assets and liabilities of subsidiaries whose functional currency is not the U.S.&#160;dollar are translated based on the end of period exchange rates from local currency to U.S.&#160;dollars. Results of operations are translated at the average exchange rates in effect during the period. The impact of the foreign currency translation adjustment is included in the Consolidated Statements of Comprehensive Income as a component of other comprehensive income/(loss).</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="_UseOfEstimates-c0_cont_1" escape="true" name="us-gaap:UseOfEstimates" id="ixv-18955"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Use of Estimates</span></p></ix:nonNumeric>
		<ix:continuation id="_UseOfEstimates-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The preparation of the Company&#8217;s consolidated financial statements in conformity with U.S.&#160;GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the balance sheet dates and the reported amounts of revenues and expenses for the periods presented. Actual results could differ materially from those estimates.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="_RevenueRecognitionPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="ixv-18960"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Revenue Recognition</span></p></ix:nonNumeric>
		<ix:continuation id="_RevenueRecognitionPolicyTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company earns substantially all of its revenue in the form of advisory fees from its ETPs and recognizes this revenue over time, as the performance obligation is satisfied. Advisory fees are based on a percentage of the ETPs&#8217; average daily net assets. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice.</p></ix:continuation></ix:nonNumeric>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-12</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_2" id="_SignificantAccountingPoliciesTextBlock-c0_cont_1"><div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<ix:nonNumeric contextRef="c0" continuedAt="wt_ContractualGoldPaymentsPolicyPolicyTextBlock-c0_cont_1" escape="true" name="wt:ContractualGoldPaymentsPolicyPolicyTextBlock" id="ixv-18970"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Contractual Gold Payments</span></p></ix:nonNumeric>
		<ix:continuation id="wt_ContractualGoldPaymentsPolicyPolicyTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Contractual gold payments are measured and paid monthly based upon the average daily spot price of gold (Note&#160;9). The Company&#8217;s obligation to continue making these payments terminated on May&#160;10, 2023.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="_AdvertisingCostsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="ixv-18975"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Marketing and Advertising</span></p></ix:nonNumeric>
		<ix:continuation id="_AdvertisingCostsPolicyTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Marketing and advertising costs, including media advertising and production costs, are expensed when incurred.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="_RegulatoryDepreciationAndAmortizationPolicy-c0_cont_1" escape="true" name="us-gaap:RegulatoryDepreciationAndAmortizationPolicy" id="ixv-18980"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Depreciation and Amortization</span></p></ix:nonNumeric>
		<ix:continuation continuedAt="_RegulatoryDepreciationAndAmortizationPolicy-c0_cont_2" id="_RegulatoryDepreciationAndAmortizationPolicy-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c63" continuedAt="_PropertyPlantAndEquipmentTextBlock-c63_cont_1" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="ixv-18985">Depreciation and amortization is provided for using the straight<span class="nobreak">-line</span> method over the estimated useful lives of the related assets as follows:</ix:nonNumeric></p></ix:continuation>
		<ix:continuation id="_PropertyPlantAndEquipmentTextBlock-c63_cont_1"><ix:continuation continuedAt="_RegulatoryDepreciationAndAmortizationPolicy-c0_cont_3" id="_RegulatoryDepreciationAndAmortizationPolicy-c0_cont_2"><table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;">


				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 74.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Equipment</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 23.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:right;"><ix:nonNumeric contextRef="c64" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-26873">3</ix:nonNumeric>&#160;to&#160;<ix:nonNumeric contextRef="c65" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-26874">5</ix:nonNumeric> years</p>	</td>
				</tr>
				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 74.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Internally<span class="nobreak">-developed</span> software</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 23.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:right;"><ix:nonNumeric contextRef="c66" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="ixv-26875">3</ix:nonNumeric>&#160;years</p>	</td>
				</tr>

		</table></ix:continuation></ix:continuation>
		<ix:continuation id="_RegulatoryDepreciationAndAmortizationPolicy-c0_cont_3"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The assets listed above are recorded at cost less accumulated depreciation and amortization.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="_CompensationRelatedCostsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" id="ixv-19005"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Stock-Based Awards</span></p></ix:nonNumeric>
		<ix:continuation id="_CompensationRelatedCostsPolicyTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Accounting for stock<span class="nobreak">-based</span> compensation requires the measurement and recognition of compensation expense for all equity awards based on estimated fair values. Stock<span class="nobreak">-based</span> compensation is measured based on the grant<span class="nobreak">-date</span> fair value of the award and is amortized over the relevant service period. Forfeitures are recognized when they occur.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="wt_ThirdPartyDistributionFeesPolicyTextBlock-c0_cont_1" escape="true" name="wt:ThirdPartyDistributionFeesPolicyTextBlock" id="ixv-19013"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Third-Party Distribution Fees</span></p></ix:nonNumeric>
		<ix:continuation id="wt_ThirdPartyDistributionFeesPolicyTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company pays a percentage of its advisory fee revenues based on incremental growth in assets under management (&#8220;AUM&#8221;), subject to caps or minimums, to marketing agents to sell WisdomTree ETPs and for including WisdomTree ETPs on third<span class="nobreak">-party</span> customer platforms and recognizes these expenses as incurred.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="_CashAndCashEquivalentsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="ixv-19019"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Cash and Cash Equivalents</span></p></ix:nonNumeric>
		<ix:continuation id="_CashAndCashEquivalentsPolicyTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company considers all highly liquid investments with an original maturity of 90&#160;days or less at the time of purchase to be classified as cash equivalents. The Company maintains deposits with financial institutions in an amount that is in excess of federally insured limits.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="_ReceivablesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ReceivablesPolicyTextBlock" id="ixv-19024"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Accounts Receivable</span></p></ix:nonNumeric>
		<ix:continuation id="_ReceivablesPolicyTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Accounts receivable are customer and other obligations due under normal trade terms. The Company measures credit losses, if any, by applying historical loss rates, adjusted for current conditions and reasonable and supportable forecasts to amounts outstanding using the aging method.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="ixv-19029"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Impairment of Long-Lived Assets</span></p></ix:nonNumeric>
		<ix:continuation id="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company performs a review for the impairment of long<span class="nobreak">-lived</span> assets when events or changes in circumstances indicate that the estimated undiscounted future cash flows expected to be generated by the assets are less than their carrying amounts or when other events occur which may indicate that the carrying amount of an asset may not be recoverable.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="_FairValueOfFinancialInstrumentsPolicy-c0_cont_1" escape="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="ixv-19035"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Financial Instruments Owned and Financial Instruments Sold, but Not yet Purchased (at Fair Value)</span></p></ix:nonNumeric>
		<ix:continuation id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Financial instruments owned and financial instruments sold, but not yet purchased are financial instruments classified as either trading or available<span class="nobreak">-for-sale</span> (&#8220;AFS&#8221;). These financial instruments are recorded on their trade date and are measured at fair value. All equity instruments that have readily determinable fair values are classified by the Company as trading. Debt instruments are classified based primarily on the Company&#8217;s intent to hold or sell the instrument. Changes in the fair value of debt instruments classified as trading and AFS are reported in other income/(expenses) and other comprehensive income, respectively, in the period the change occurs. Debt instruments classified as AFS are assessed for impairment on a quarterly basis and an estimate for credit loss is provided when the fair value of the AFS debt instrument is below its amortized cost basis. Credit<span class="nobreak">-related</span> impairments are recognized in earnings with a corresponding adjustment to the instrument&#8217;s amortized cost basis if the Company intends to sell the impaired AFS debt instrument or it is more likely than not the Company will be required to sell the instrument before recovering its amortized cost basis. Other credit<span class="nobreak">-related</span> impairments are recognized as an allowance with a corresponding adjustment to earnings. Impairments resulting from noncredit<span class="nobreak">-related</span> factors are recognized in other comprehensive income. Amounts recorded in other comprehensive income are reclassified into earnings upon sale of the AFS debt instrument using the specific identification method.</p></ix:continuation>
		</div></ix:continuation>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-13</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_3" id="_SignificantAccountingPoliciesTextBlock-c0_cont_2"><div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<ix:nonNumeric contextRef="c0" continuedAt="_MarketableSecuritiesPolicy-c0_cont_1" escape="true" name="us-gaap:MarketableSecuritiesPolicy" id="ixv-19049"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Securities Held-to-Maturity</span></p></ix:nonNumeric>
		<ix:continuation continuedAt="_MarketableSecuritiesPolicy-c0_cont_2" id="_MarketableSecuritiesPolicy-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company accounts for certain of its securities as held<span class="nobreak">-to-maturity</span> on a trade date basis, which are recorded at amortized cost. For held<span class="nobreak">-to-maturity</span> securities, the Company has the intent and ability to hold these securities to maturity and it is not more<span class="nobreak">-likely-than-not</span> that the Company will be required to sell these securities before recovery of their amortized cost bases, which may be maturity. Held<span class="nobreak">-to-maturity</span> securities are placed on non<span class="nobreak">-accrual</span> status when the Company is in receipt of information indicating collection of interest is doubtful. Cash received on held<span class="nobreak">-to-maturity</span> securities placed on non<span class="nobreak">-accrual</span> status is recognized on a cash basis as interest income if and when received.</p></ix:continuation>
		<ix:continuation continuedAt="_MarketableSecuritiesPolicy-c0_cont_3" id="_MarketableSecuritiesPolicy-c0_cont_2"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company reviews its portfolio of held<span class="nobreak">-to-maturity</span> securities for impairment on a quarterly basis, recognizing an allowance, if any, by applying an estimated loss rate after consideration for the nature of collateral securing the financial asset as well as potential future changes in collateral values and historical loss information for financial assets secured with similar collateral.</p></ix:continuation>
		<ix:continuation id="_MarketableSecuritiesPolicy-c0_cont_3"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Investments in pass<span class="nobreak">-through</span> government<span class="nobreak">-sponsored</span> enterprises (&#8220;GSEs&#8221;) are determined to have an estimated loss rate of zero due to an implicit U.S.&#160;government guarantee.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="_InvestmentPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:InvestmentPolicyTextBlock" id="ixv-19068"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Investments</span></p></ix:nonNumeric>
		<ix:continuation continuedAt="_InvestmentPolicyTextBlock-c0_cont_2" id="_InvestmentPolicyTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company accounts for equity investments that do not have a readily determinable fair value under the measurement alternative prescribed in Accounting Standards Codification (&#8220;ASC&#8221;) Topic&#160;321, <span class="Italic" style="font-style:italic;font-weight:normal;">Investments&#160;&#8211;&#160;Equity Securities </span>(&#8220;ASC&#160;321&#8221;), to the extent such investments are not subject to consolidation or the equity method. Under the measurement alternative, these financial instruments are carried at cost, less any impairment (assessed quarterly), plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. In addition, income is recognized when dividends are received only to the extent they are distributed from net accumulated earnings of the investee. Otherwise, such distributions are considered returns of investment and are recorded as a reduction of the cost of the investment.</p></ix:continuation>
		<ix:continuation id="_InvestmentPolicyTextBlock-c0_cont_2"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Investments in debt instruments are accounted for at fair value, with changes in fair value reported in other income/(expenses).</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="_GoodwillAndIntangibleAssetsGoodwillPolicy-c0_cont_1" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="ixv-19076"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Goodwill</span></p></ix:nonNumeric>
		<ix:continuation continuedAt="_GoodwillAndIntangibleAssetsGoodwillPolicy-c0_cont_2" id="_GoodwillAndIntangibleAssetsGoodwillPolicy-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Goodwill is the excess of the purchase price over the fair values of the identifiable net assets at the acquisition date. The Company tests goodwill for impairment at least annually and at the time of a triggering event requiring re<span class="nobreak">-evaluation</span>, if one were to occur. Goodwill is considered impaired when the estimated fair value of the reporting unit that was allocated the goodwill is less than its carrying value. If the estimated fair value of such reporting unit is less than its carrying value, goodwill impairment is recognized based on that difference, not to exceed the carrying amount of goodwill. A reporting unit is an operating segment or a component of an operating segment provided that the component constitutes a business for which discrete financial information is available and management regularly reviews the operating results of that component.</p></ix:continuation>
		<ix:continuation continuedAt="_GoodwillAndIntangibleAssetsGoodwillPolicy-c0_cont_3" id="_GoodwillAndIntangibleAssetsGoodwillPolicy-c0_cont_2"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Goodwill is allocated to the Company&#8217;s U.S.&#160;business and European business components. For impairment testing purposes, these components are aggregated as a single reporting unit as they fall under the same operating segment and have similar economic characteristics.</p></ix:continuation>
		<ix:continuation id="_GoodwillAndIntangibleAssetsGoodwillPolicy-c0_cont_3"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Goodwill is assessed for impairment annually on November&#160;30<span class="Superscript" style="vertical-align:super;font-size:58%;">th</span>. When performing its goodwill impairment test, the Company considers a qualitative assessment, when appropriate, and a quantitative assessment using the market approach and its market capitalization when determining the fair value of the reporting unit.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy-c0_cont_1" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" id="ixv-19087"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Intangible Assets</span></p></ix:nonNumeric>
		<ix:continuation continuedAt="_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy-c0_cont_2" id="_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Indefinite<span class="nobreak">-lived</span> intangible assets are tested for impairment at least annually and are also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indefinite<span class="nobreak">-lived</span> intangible assets are impaired if their estimated fair values are less than their carrying values.</p></ix:continuation>
		<ix:continuation continuedAt="_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy-c0_cont_3" id="_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy-c0_cont_2"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Finite<span class="nobreak">-lived</span> intangible assets, if any, are amortized over their estimated useful life, which is the period over which the assets are expected to contribute directly or indirectly to the future cash flows of the Company. These intangible assets are tested for impairment at the time of a triggering event, if one were to occur. Finite<span class="nobreak">-lived</span> intangible assets may be impaired when the estimated undiscounted future cash flows generated from the assets are less than their carrying amounts.</p></ix:continuation>
		</div></ix:continuation>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-14</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_4" id="_SignificantAccountingPoliciesTextBlock-c0_cont_3"><div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<ix:continuation id="_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy-c0_cont_3"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company may rely on a qualitative assessment when performing its intangible asset impairment test. Otherwise, the impairment evaluation is performed at the lowest level of reasonably identifiable cash flows independent of other assets. The annual impairment testing date for all of the Company&#8217;s intangible assets is November&#160;30<span class="Superscript" style="vertical-align:super;font-size:58%;">th</span>.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" id="ixv-19106"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Software Development Costs</span></p></ix:nonNumeric>
		<ix:continuation id="_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Software development costs incurred after the preliminary project stage is complete are capitalized if it is probable that the project will be completed and the software will be used as intended. Capitalized costs consist of employee compensation costs and fees paid to third parties who are directly involved in the application development efforts and are included in intangible assets, net in the Consolidated Balance Sheets. Such costs are amortized over the estimated useful life of the software on a straight<span class="nobreak">-line</span> basis and are included in depreciation and amortization in the Consolidated Statements of Operations. Once the application development stage is complete, additional costs are expensed as incurred.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:LesseeLeasesPolicyTextBlock" id="ixv-19112"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Leases</span></p></ix:nonNumeric>
		<ix:continuation continuedAt="_LesseeLeasesPolicyTextBlock-c0_cont_2" id="_LesseeLeasesPolicyTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company accounts for its lease obligations in accordance with ASC Topic&#160;842, <span class="Italic" style="font-style:italic;font-weight:normal;">Leases </span>(&#8220;ASC&#160;842&#8221;), which requires the recognition of both (i)&#160;a lease liability equal to the present value of the remaining lease payments and (ii)&#160;an offsetting right<span class="nobreak">-of-use</span> asset. The remaining lease payments are discounted using the rate implicit in the lease, if known, or otherwise the Company&#8217;s incremental borrowing rate. After lease commencement, right<span class="nobreak">-of-use</span> assets are assessed for impairment and otherwise are amortized over the remaining lease term on a straight<span class="nobreak">-line</span> basis. These recognition requirements are not applied to short<span class="nobreak">-term</span> leases which are those with a lease term of 12&#160;months or less. Instead, lease payments associated with short<span class="nobreak">-term</span> leases are recognized as an expense on a straight<span class="nobreak">-line</span> basis over the lease term.</p></ix:continuation>
		<ix:continuation id="_LesseeLeasesPolicyTextBlock-c0_cont_2"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">ASC&#160;842 also provides a practical expedient which allows for consideration in a contract to be accounted for as a single lease component rather than allocated between lease and non<span class="nobreak">-lease</span> components. The Company has elected to apply this practical expedient to all lease contracts, where applicable.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="wt_DeferredConsiderationGoldPaymentsPolicyTextBlock-c0_cont_1" escape="true" name="wt:DeferredConsiderationGoldPaymentsPolicyTextBlock" id="ixv-19127"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Deferred Consideration&#8212;Gold Payments</span></p></ix:nonNumeric>
		<ix:continuation id="wt_DeferredConsiderationGoldPaymentsPolicyTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Deferred consideration&#8212;gold payments represented the present value of an obligation to pay gold to a third party into perpetuity and was measured using forward<span class="nobreak">-looking</span> gold prices observed on the CMX exchange, a selected discount rate and perpetual growth rate (Note&#160;9). Changes in the fair value of this obligation were reported as gain on revaluation/termination of deferred consideration&#8212;gold payments in the Consolidated Statements of Operations.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="_DebtPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:DebtPolicyTextBlock" id="ixv-19133"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Convertible Notes</span></p></ix:nonNumeric>
		<ix:continuation id="_DebtPolicyTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Convertible notes are carried at amortized cost, net of issuance costs. The Company accounts for convertible instruments as a single liability (applicable to the convertible notes) or equity with no separate accounting for embedded conversion features unless the conversion feature meets the criteria for accounting under the substantial premium model or does not qualify for a derivative scope exception. Interest expense is recognized using the effective interest method and includes amortization of issuance costs over the life of the debt.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="_CommitmentsAndContingenciesPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="ixv-19138"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Contingencies</span></p></ix:nonNumeric>
		<ix:continuation id="_CommitmentsAndContingenciesPolicyTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company may be subject to reviews, inspections and investigations by regulatory authorities as well as legal proceedings arising in the ordinary course of business. The Company evaluates the likelihood of an unfavorable outcome of all legal or regulatory proceedings to which it is a party and accrues a loss contingency when the loss is probable and reasonably estimable.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="wt_ContingentPaymentsPolicyTextBlock-c0_cont_1" escape="true" name="wt:ContingentPaymentsPolicyTextBlock" id="ixv-19143"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Contingent Payments</span></p></ix:nonNumeric>
		<ix:continuation id="wt_ContingentPaymentsPolicyTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company recognizes a gain on contingent payments when the contingency is resolved and the gain is realized.</p></ix:continuation>
		</div></ix:continuation>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-15</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<ix:continuation continuedAt="_SignificantAccountingPoliciesTextBlock-c0_cont_5" id="_SignificantAccountingPoliciesTextBlock-c0_cont_4"><div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<ix:nonNumeric contextRef="c0" continuedAt="_EarningsPerSharePolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock" id="ixv-19153"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Earnings per Share</span></p></ix:nonNumeric>
		<ix:continuation continuedAt="_EarningsPerSharePolicyTextBlock-c0_cont_2" id="_EarningsPerSharePolicyTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Basic earnings per share (&#8220;EPS&#8221;) is computed by dividing net income available to common stockholders by the weighted<span class="nobreak">-average</span> number of common shares outstanding for the period. Net income available to common stockholders represents net income of the Company reduced by an allocation of earnings to participating securities. The Series&#160;A non<span class="nobreak">-voting</span> convertible preferred stock (Note&#160;11) and unvested share<span class="nobreak">-based</span> payment awards that contain non<span class="nobreak">-forfeitable</span> rights to dividends or dividend equivalents (whether paid or unpaid) are participating securities and are included in the computation of EPS pursuant to the two<span class="nobreak">-class</span> method. Stock<span class="nobreak">-based</span> equity awards that do not contain such rights are not deemed participating securities and are included in diluted shares outstanding (if dilutive).</p></ix:continuation>
		<ix:continuation id="_EarningsPerSharePolicyTextBlock-c0_cont_2"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Diluted EPS is calculated under the treasury stock method and the two<span class="nobreak">-class</span> method. The calculation that results in the lowest diluted EPS amount for the common stock is reported in the Company&#8217;s consolidated financial statements. The treasury stock method includes the dilutive effect of potential common shares including unvested stock<span class="nobreak">-based</span> awards, the Series&#160;A non<span class="nobreak">-voting</span> convertible preferred stock and the convertible notes, if any. Potential common shares associated with the Series&#160;A non<span class="nobreak">-voting</span> convertible preferred stock and the convertible notes are computed under the if<span class="nobreak">-converted</span> method. Potential common shares associated with the conversion option embedded in the convertible notes are dilutive when the Company&#8217;s average stock price exceeds the conversion price.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock" id="ixv-19171"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Income Taxes</span></p></ix:nonNumeric>
		<ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_2" id="_IncomeTaxPolicyTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company accounts for income taxes using the liability method, which requires the determination of deferred tax assets and liabilities based on the differences between the financial and tax bases of assets and liabilities using the enacted tax rates in effect for the year in which differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is more<span class="nobreak">-likely-than-not</span> that some portion or all the deferred tax assets will not be realized.</p></ix:continuation>
		<ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_3" id="_IncomeTaxPolicyTextBlock-c0_cont_2"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Tax positions are evaluated utilizing a two<span class="nobreak">-step</span> process. The Company first determines whether any of its tax positions are more<span class="nobreak">-likely-than-not</span> to be sustained upon examination, based solely on the technical merits of the position. Once it is determined that a position meets this recognition threshold, the position is measured as the largest amount of benefit that is greater than <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wt:PercentageOfTaxRateRealizedOnSettlement" scale="-2" unitRef="pure" id="ixv-26876">50</ix:nonFraction>% likely of being realized upon ultimate settlement. The Company records interest expense and penalties related to tax expenses as income tax expense.</p></ix:continuation>
		<ix:continuation continuedAt="_IncomeTaxPolicyTextBlock-c0_cont_4" id="_IncomeTaxPolicyTextBlock-c0_cont_3"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Global Intangible Low<span class="nobreak">-Taxed</span> Income (&#8220;GILTI&#8221;) provisions of the Tax Reform Act requires the Company to include in its U.S.&#160;income tax return foreign subsidiary earnings in excess of an allowable return on the foreign subsidiary&#8217;s tangible assets. An accounting policy election is available to either account for the tax effects of GILTI in the period that is subject to such taxes or to provide deferred taxes for book and tax basis differences that upon reversal may be subject to such taxes. The Company accounts for the tax effects of these provisions in the period that is subject to such tax.</p></ix:continuation>
		<ix:continuation id="_IncomeTaxPolicyTextBlock-c0_cont_4"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Non<span class="nobreak">-income</span> based taxes are recorded as part of other liabilities and other expenses.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="wt_RecentlyIssuedAccountingPronouncementsPolicyTextBlock-c0_cont_1" escape="true" name="wt:RecentlyIssuedAccountingPronouncementsPolicyTextBlock" id="ixv-19187"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Recently Issued Accounting Pronouncements</span></p></ix:nonNumeric>
		<ix:continuation continuedAt="wt_RecentlyIssuedAccountingPronouncementsPolicyTextBlock-c0_cont_2" id="wt_RecentlyIssuedAccountingPronouncementsPolicyTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On November&#160;27, 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU&#160;2023<span class="nobreak">-07</span>, <span class="Italic" style="font-style:italic;font-weight:normal;">Segment&#160;Reporting&#8212;Improvements to Reportable Segment Disclosures</span>, which requires public entities to provide disclosures of significant segment expenses and other segment items. The guidance requires public entities to provide in interim periods all disclosures about a reportable segment&#8217;s profit or loss and assets that are currently required annually and also applies to public entities with a single reportable segment. Entities are permitted to disclose more than one measure of a segment&#8217;s profit or loss if such measures are used by the chief operating decision<span class="nobreak">-maker</span> to allocate resources and assess performance, as long as at least one of those measures is determined in a way that is most consistent with the measurement principles used to measure the corresponding amounts in the consolidated financial statements. The guidance is applied retrospectively to all periods presented in financial statements, unless it is impracticable, and is effective for fiscal&#160;years beginning after December&#160;15, 2023, and for interim periods beginning after December&#160;15, 2024. Early adoption is permitted. This standard will only impact disclosures and will be adopted by the Company on January&#160;1, 2024.</p></ix:continuation>
		</div></ix:continuation>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-16</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<ix:continuation id="_SignificantAccountingPoliciesTextBlock-c0_cont_5"><ix:continuation continuedAt="wt_RecentlyIssuedAccountingPronouncementsPolicyTextBlock-c0_cont_3" id="wt_RecentlyIssuedAccountingPronouncementsPolicyTextBlock-c0_cont_2"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On December&#160;13, 2023, the FASB issued ASU&#160;2023<span class="nobreak">-08</span>, <span class="Italic" style="font-style:italic;font-weight:normal;">Accounting for and Disclosure of Crypto Assets</span>, which contains final guidance requiring all entities to measure certain crypto assets at fair value each reporting period and to reflect changes from remeasurement in net income. Entities are required to present crypto assets measured at fair value separately from other intangible assets on the balance sheet and present changes from the remeasurement of crypto assets separately from changes in the carrying amounts of other intangible assets in the income statement. Entities are required to provide interim and annual disclosures about the types of crypto assets they hold and any changes in their holdings of crypto assets. The guidance is effective for fiscal&#160;years beginning after December&#160;15, 2024, including interim periods within those fiscal&#160;years. Early adoption is permitted. The Company has determined that this standard will not have a material impact on its financial statements and will early adopt the standard on January&#160;1, 2024.</p></ix:continuation>
		<ix:continuation id="wt_RecentlyIssuedAccountingPronouncementsPolicyTextBlock-c0_cont_3"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On December&#160;14, 2023, the FASB issued ASU&#160;2023<span class="nobreak">-09</span>,<span class="Italic" style="font-style:italic;font-weight:normal;"> Improvements to Income Tax Disclosures</span>, which establishes new income tax disclosure requirements in addition to modifying and eliminating certain existing requirements. Under the new guidance, entities must consistently categorize and provide greater disaggregation of information in the rate reconciliation. They must also further disaggregate income taxes paid. The standard is intended to benefit investors by providing more detailed income tax disclosures that would be useful in making capital allocation decisions. The guidance applies to all entities subject to income taxes and is effective for annual periods beginning after December&#160;15, 2024. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively. Early adoption is permitted. The Company plans to adopt this standard on January&#160;1, 2025.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_1" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="ixv-19208"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Recently Adopted Accounting Pronouncements</span></p></ix:nonNumeric>
		<ix:continuation id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On January&#160;1, 2021, the Company early adopted ASU&#160;2020<span class="nobreak">-06</span>, <span class="Italic" style="font-style:italic;font-weight:normal;">Debt&#160;&#8211;&#160;Debt with Conversion and Other Options </span>(ASU&#160;2020<span class="nobreak">-06</span>) under the modified retrospective approach. Under the ASU, the accounting for convertible instruments was simplified by removing major separation models required under current GAAP.&#160;Accordingly, more convertible instruments are reported as a single liability or equity with no separate accounting for embedded conversion features. Certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception are removed and, as a result, more equity contracts will qualify for the scope exception. The ASU also simplifies the diluted earnings<span class="nobreak">-per-share</span> calculation in certain areas. Upon the adoption of this ASU, the Company reclassified the equity component related to the convertible notes, net of deferred taxes, reducing accumulated deficit by $<ix:nonFraction contextRef="c59" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" unitRef="usd" id="ixv-26877">616</ix:nonFraction>, increasing the carrying value of the convertible notes by $<ix:nonFraction contextRef="c59" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleNotesPayableCurrent" scale="3" unitRef="usd" id="ixv-26878">4,088</ix:nonFraction>, reducing additional paid<span class="nobreak">-in</span> capital by $<ix:nonFraction contextRef="c60" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalOther" scale="3" unitRef="usd" id="ixv-26879">3,682</ix:nonFraction> and reducing deferred tax liabilities by $<ix:nonFraction contextRef="c59" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxLiabilities" scale="3" unitRef="usd" id="ixv-26880">1,022</ix:nonFraction>. These updates also reduced interest expense recognized on the Company&#8217;s convertible notes by approximately $<ix:nonFraction contextRef="c61" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" unitRef="usd" id="ixv-26881">420</ix:nonFraction> per quarter and $<ix:nonFraction contextRef="c62" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" unitRef="usd" id="ixv-26882">1,680</ix:nonFraction> for the year ended December&#160;31, 2021 (Note&#160;10) and the impact on earnings per share was negligible.</p></ix:continuation></ix:continuation>
		<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:CashAndCashEquivalentsDisclosureTextBlock" id="ixv-19218"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">3. Cash and Cash Equivalents</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Of the total cash and cash equivalents of $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd" id="ixv-26883">129,305</ix:nonFraction> and $<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd" id="ixv-26884">132,101</ix:nonFraction> at December&#160;31, 2023 and 2022, $<ix:nonFraction contextRef="c67" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd" id="ixv-26885">116,895</ix:nonFraction> and $<ix:nonFraction contextRef="c68" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" unitRef="usd" id="ixv-26886">131,104</ix:nonFraction>, respectively, were held at three financial institutions. At December&#160;31, 2023 and 2022, cash equivalents were approximately $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashEquivalentsAtCarryingValue" scale="3" unitRef="usd" id="ixv-26887">50,226</ix:nonFraction> and $<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashEquivalentsAtCarryingValue" scale="3" unitRef="usd" id="ixv-26888">930</ix:nonFraction>, respectively.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Certain of the Company&#8217;s subsidiaries are required to maintain a minimum level of regulatory capital, which was $<ix:nonFraction contextRef="c69" decimals="-3" format="ixt:num-dot-decimal" name="wt:NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements" scale="3" unitRef="usd" id="ixv-26889">29,156</ix:nonFraction> and $<ix:nonFraction contextRef="c70" decimals="-3" format="ixt:num-dot-decimal" name="wt:NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements" scale="3" unitRef="usd" id="ixv-26890">25,988</ix:nonFraction> at December&#160;31, 2023 and 2022, respectively. These requirements are generally satisfied by cash on hand.</p></ix:nonNumeric>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-17</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<ix:nonNumeric contextRef="c0" continuedAt="_FairValueDisclosuresTextBlock-c0_cont_1" escape="true" name="us-gaap:FairValueDisclosuresTextBlock" id="ixv-19227"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">4. Fair Value Measurements</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;">The fair value of financial instruments is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., &#8220;the exit price&#8221;) in an orderly transaction between market participants at the measurement date. ASC&#160;820, <span class="Italic" style="font-style:italic;font-weight:normal;">Fair Value Measurement</span>, establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from independent sources. Unobservable inputs reflect assumptions that market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into three levels based on the transparency of inputs as follows:</p>
		<table class="Basic-Table" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="Basic-Table _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 3.85%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">

					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 5.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Level&#160;1</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 2.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 85.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Quoted prices for identical instruments in active markets.</p>
					</td>
				</tr>
				<tr class="Basic-Table _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 3.85%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 5.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;">Level&#160;2</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 2.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 85.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;">Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model<span class="nobreak">-derived</span> valuations whose inputs are observable or whose significant value drivers are observable.</p>
					</td>
				</tr>
				<tr class="Basic-Table _idGenTableRowColumn-10" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 3.85%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 5.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;">Level&#160;3</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 2.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 85.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;">Instruments whose significant drivers are unobservable.</p>
					</td>
				</tr>

		</table>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The availability of observable inputs can vary from product to product and is affected by a wide variety of factors, including, for example, the type of product, whether the product is new and not yet established in the marketplace, and other characteristics particular to the transaction. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by management in determining fair value is greatest for instruments categorized in Level&#160;3. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level input that is significant to the fair value measurement in its entirety.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock-c0_cont_1" escape="true" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="ixv-26891">The tables below summarize the categorization of the Company&#8217;s assets and liabilities measured at fair value. During the&#160;years ended December&#160;31, 2023 and 2022, there were no transfers between Levels 2 and 3.</ix:nonNumeric></p>
		<ix:continuation continuedAt="_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock-c0_cont_2" id="_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock-c0_cont_1"><table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="No-Table-Style TCH" style="width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="11" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 55.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, 2023</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="No-Table-Style TCH _idGenCellOverride-1" style="width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Total</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Level 1</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Level 2</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Level 3</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Assets:</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Recurring fair value measurements:</p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:30pt;">Cash equivalents</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c71" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" unitRef="usd" id="ixv-26892">50,226</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c72" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" unitRef="usd" id="ixv-26893">50,226</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-142; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-143; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:30pt;">Financial instruments owned, at fair value:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:50pt;">ETFs</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c75" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" scale="3" unitRef="usd" id="ixv-26894">35,181</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c76" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" scale="3" unitRef="usd" id="ixv-26895">35,181</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-144; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-145; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:50pt;">Pass-through GSEs</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c79" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" scale="3" unitRef="usd" id="ixv-26896">10,240</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-146; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c81" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" scale="3" unitRef="usd" id="ixv-26897">10,240</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-147; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:50pt;">Other assets&#8212;seed capital (WisdomTree Digital Funds):</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:70pt;">U.S.&#160;treasuries</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c83" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" scale="3" unitRef="usd" id="ixv-26898">5,007</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c84" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" scale="3" unitRef="usd" id="ixv-26899">5,007</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-148; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:70pt;">Equities</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c86" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" scale="3" unitRef="usd" id="ixv-26900">6,337</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c87" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" scale="3" unitRef="usd" id="ixv-26901">6,337</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-149; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-150; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:70pt;">Fixed income</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c90" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" scale="3" unitRef="usd" id="ixv-26902">1,957</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c91" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" scale="3" unitRef="usd" id="ixv-26903">1,008</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c92" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" scale="3" unitRef="usd" id="ixv-26904">949</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-151; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c71" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" unitRef="usd" id="ixv-26905">108,948</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c72" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" unitRef="usd" id="ixv-26906">92,752</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c73" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" unitRef="usd" id="ixv-26907">16,196</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-152; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Non-recurring fair value measurements:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:30pt;">Fnality International Limited&#8212;Series&#160;B-1 Preference Shares<span class="Superscript" style="vertical-align:super;font-size:6pt;">(</span><span class="CharOverride-5" style="font-size:6pt;vertical-align:super;">1)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c94" decimals="-3" format="ixt:num-dot-decimal" id="ix_0_fact" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" unitRef="usd">9,684</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-style:normal;font-weight:normal;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-153; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-style:normal;font-weight:normal;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-style:normal;font-weight:normal;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-154; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-style:normal;font-weight:normal;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c97" decimals="-3" format="ixt:num-dot-decimal" id="ix_1_fact" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" unitRef="usd">9,684</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:30pt;">Other investments<span class="Superscript" style="vertical-align:super;font-size:6pt;">(</span><span class="CharOverride-5" style="font-size:6pt;vertical-align:super;">2</span><span class="Superscript" style="vertical-align:super;font-size:6pt;">)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-155; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-156; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-157; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-158; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c102" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" unitRef="usd" id="ixv-26910">9,684</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-159; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-160; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c105" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" unitRef="usd" id="ixv-26911">9,684</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation></ix:nonNumeric>
		<div style="border: none; border-top: windowtext 0pt none; border-top-style: solid; padding: 0in 0in 2.0pt 0in;"><p class="Tablefootnotef" style="margin-top: 0in;  border: none; margin-right: 0in; margin-bottom: -5pt; margin-left: 24.0pt; text-align: justify; text-justify: inter-ideograph; text-indent: -24.0pt; padding: 0in; font-size: 9.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">____________</p><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_2" id="_FairValueDisclosuresTextBlock-c0_cont_1"><ix:continuation continuedAt="_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock-c0_cont_3" id="_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock-c0_cont_2"><p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><ix:footnote id="ix_0_footnote" xml:lang="en-US">Fair value determined on October 31, 2023</ix:footnote></p></ix:continuation></ix:continuation></div>
		<ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_3" id="_FairValueDisclosuresTextBlock-c0_cont_2"><ix:continuation continuedAt="_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock-c0_cont_4" id="_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock-c0_cont_3"><p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:0pt;"><span class="Superscript" style="vertical-align:super;font-size:6pt;"> (2)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><ix:footnote id="ix_2_footnote" xml:lang="en-US">Fair value determined on September 30, 2023</ix:footnote></p></ix:continuation></ix:continuation>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-18</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_4" id="_FairValueDisclosuresTextBlock-c0_cont_3"><ix:continuation continuedAt="_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock-c0_cont_5" id="_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock-c0_cont_4"><table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="11" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 55.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, 2022</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Total</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Level 1</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Level 2</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Level 3</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Assets:</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Recurring fair value measurements:</p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Cash equivalents</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c106" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" unitRef="usd" id="ixv-26914">930</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c107" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" unitRef="usd" id="ixv-26915">930</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-161; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-162; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Financial instruments owned, at fair value:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ETFs</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c110" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" scale="3" unitRef="usd" id="ixv-26916">23,772</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c111" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" scale="3" unitRef="usd" id="ixv-26917">23,772</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-163; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-164; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">U.S.&#160;treasuries</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c114" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" scale="3" unitRef="usd" id="ixv-26918">2,980</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c115" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" scale="3" unitRef="usd" id="ixv-26919">2,980</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-165; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-166; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Pass-through GSEs</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c118" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" scale="3" unitRef="usd" id="ixv-26920">96,837</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c119" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" scale="3" unitRef="usd" id="ixv-26921">23,290</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c120" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" scale="3" unitRef="usd" id="ixv-26922">73,547</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-167; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Fixed income</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c122" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" scale="3" unitRef="usd" id="ixv-26923">885</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-168; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c124" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" scale="3" unitRef="usd" id="ixv-26924">885</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-169; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other assets&#8212;seed capital (WisdomTree Digital Funds):</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c126" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" scale="3" unitRef="usd" id="ixv-26925">1,765</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-170; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c128" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" scale="3" unitRef="usd" id="ixv-26926">1,765</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-171; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Investments in Convertible Notes</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Securrency, Inc.&#8212;convertible note (Note&#160;7)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c130" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" unitRef="usd" id="ixv-26927">14,500</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-172; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-173; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c133" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" unitRef="usd" id="ixv-26928">14,500</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Fnality International Limited&#8212;convertible note (Note&#160;7)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c134" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" unitRef="usd" id="ixv-26929">6,921</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-174; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-175; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c137" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsFairValueDisclosure" scale="3" unitRef="usd" id="ixv-26930">6,921</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c106" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" unitRef="usd" id="ixv-26931">148,590</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c107" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" unitRef="usd" id="ixv-26932">50,972</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c108" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" unitRef="usd" id="ixv-26933">76,197</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c109" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" unitRef="usd" id="ixv-26934">21,421</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Non-recurring fair value measurements:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other investments<span class="Superscript" style="vertical-align:super;font-size:58%;">(</span><span class="CharOverride-6" style="font-size:58%;vertical-align:super;">1)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c138" decimals="-3" format="ixt:num-dot-decimal" id="ix_2_fact" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" unitRef="usd">312</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-176; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-177; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c141" decimals="-3" format="ixt:num-dot-decimal" id="ix_3_fact" name="us-gaap:InvestmentOwnedAtFairValue" scale="3" unitRef="usd">312</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-top:1pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Liabilities:</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Recurring fair value measurements:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deferred consideration (Note&#160;9)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c106" decimals="-3" format="ixt:num-dot-decimal" name="wt:BusinessCombinationDeferredConsiderationLiability" scale="3" unitRef="usd" id="ixv-26937">200,290</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-178; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-179; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c109" decimals="-3" format="ixt:num-dot-decimal" name="wt:BusinessCombinationDeferredConsiderationLiability" scale="3" unitRef="usd" id="ixv-26938">200,290</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation></ix:continuation>
		<div style="border: none; border-top: windowtext 0pt none; border-top-style: solid; padding: 0in 0in 2.0pt 0in;"><p class="Tablefootnotef" style="margin-top: 0in;  border: none; margin-right: 0in; margin-bottom: -5pt; margin-left: 24.0pt; text-align: justify; text-justify: inter-ideograph; text-indent: -24.0pt; padding: 0in; font-size: 9.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">____________</p><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_5" id="_FairValueDisclosuresTextBlock-c0_cont_4"><ix:continuation id="_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock-c0_cont_5"><p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;">&#8203;<span class="CharOverride-6" style="font-size:58%;vertical-align:super;">(1)&#160;&#160;&#160;&#160;&#160;</span><ix:footnote id="ix_1_footnote" xml:lang="en-US">Fair value determined on May 10, 2022</ix:footnote></p></ix:continuation></ix:continuation></div>
		<ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_6" id="_FairValueDisclosuresTextBlock-c0_cont_5"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;"> Recurring Fair Value Measurements&#160;-&#160;Methodology</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Cash Equivalents (Note&#160;3) &#8211; </span>These financial assets represent cash invested in highly liquid investments with original maturities of less than <span style="-sec-ix-hidden: hidden-fact-185">90</span>&#160;days. These investments are valued at par, which approximates fair value, and are classified as Level 1 in the fair value hierarchy.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Financial instruments owned (Note&#160;5) &#8211; </span>Financial instruments owned are investments in ETFs, pass<span class="nobreak">-through</span> GSEs, U.S.&#160;treasuries, equities and fixed income. ETFs, U.S.&#160;treasuries and equities are generally traded in active, quoted and highly liquid markets and are therefore classified as Level 1 in the fair value hierarchy. Pricing of pass<span class="nobreak">-through</span> GSEs and fixed income includes consideration given to collateral characteristics and market assumptions related to yields, credit risk and timing of prepayments and are therefore generally classified as Level&#160;2. Pass<span class="nobreak">-through</span> GSE positions invested in through a fund structure with a quoted market price on an exchange are generally classified as Level 1.</p></ix:continuation>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-19</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_7" id="_FairValueDisclosuresTextBlock-c0_cont_6"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Fair Value Measurements classified as Level 3</span> &#8211;&#160;The following table presents a reconciliation of beginning and ending balances of recurring fair value measurements classified as Level 3:</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-left:24pt;text-indent:0pt;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock-c0_cont_1" escape="true" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="ixv-26940">These instruments consist of the following:</ix:nonNumeric></p>
		<ix:continuation continuedAt="_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock-c0_cont_2" id="_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock-c0_cont_1"><table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;">


				<tr class="Table75-" style="height:12pt;">
					<td class="Table75-" style="border-left-width:1pt;border-left-style:solid;border-left-color:#000000;border-top-width:1pt;border-top-style:solid;border-top-color:#000000;border-right-width:1pt;border-right-style:solid;border-right-color:#000000;border-bottom-width:1pt;border-bottom-style:solid;border-bottom-color:#000000;padding-top:4pt;padding-bottom:4pt;padding-left:4pt;padding-right:4pt;vertical-align:top;width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="5" style="width: 37.50%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75-" style="border-left-width:1pt;border-left-style:solid;border-left-color:#000000;border-top-width:1pt;border-top-style:solid;border-top-color:#000000;border-right-width:1pt;border-right-style:solid;border-right-color:#000000;border-bottom-width:1pt;border-bottom-style:solid;border-bottom-color:#000000;padding-top:4pt;padding-bottom:4pt;padding-left:4pt;padding-right:4pt;vertical-align:top;width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December 31, <br/>2023</span></p>
					</td>
					<td class="Table75- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December 31, <br/>2022</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Investments in Convertible Notes (Note&#160;7):</p>
					</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Beginning balance</p>
					</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" unitRef="usd" id="ixv-26941">21,421</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-180; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Purchases</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="3" unitRef="usd" id="ixv-26942">11,228</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="3" unitRef="usd" id="ixv-26943">21,863</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Settlements</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales" scale="3" sign="-" unitRef="usd" id="ixv-26944">28,818</ix:nonFraction>)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-181; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Conversions<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)</span></p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" id="ix_4_fact" name="wt:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions" scale="3" sign="-" unitRef="usd">9,684</ix:nonFraction>)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-182; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net realized gains/(losses)<span class="Superscript" style="vertical-align:super;font-size:6pt;">(2)</span></p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" id="ix_5_fact" name="wt:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome" scale="3" unitRef="usd">5,853</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" id="ix_6_fact" name="wt:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome" scale="3" sign="-" unitRef="usd">442</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Ending balance</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-183; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" unitRef="usd" id="ixv-26948">21,421</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deferred Consideration (Note&#160;7):</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Beginning balance</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c142" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" unitRef="usd" id="ixv-26949">200,290</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c143" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" unitRef="usd" id="ixv-26950">228,062</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net realized losses<span class="Superscript" style="vertical-align:super;font-size:6pt;">(3)</span></p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c144" decimals="-3" format="ixt:num-dot-decimal" id="ix_7_fact" name="wt:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome" scale="3" unitRef="usd">6,069</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c145" decimals="-3" format="ixt:num-dot-decimal" id="ix_8_fact" name="wt:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome" scale="3" unitRef="usd">17,108</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net unrealized gains<span class="Superscript" style="vertical-align:super;font-size:6pt;">(4)</span></p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c144" decimals="-3" format="ixt:num-dot-decimal" id="ix_9_fact" name="wt:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings" scale="3" sign="-" unitRef="usd">61,953</ix:nonFraction>)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c145" decimals="-3" format="ixt:num-dot-decimal" id="ix_10_fact" name="wt:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings" scale="3" sign="-" unitRef="usd">27,765</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Settlements</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c144" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales" scale="3" sign="-" unitRef="usd" id="ixv-26955">144,406</ix:nonFraction>)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c145" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales" scale="3" sign="-" unitRef="usd" id="ixv-26956">17,115</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Ending balance</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-184; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c142" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" unitRef="usd" id="ixv-26957">200,290</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation></ix:continuation>

		<div style="border: none; border-top: windowtext 0pt none; border-top-style: solid; padding: 0in 0in 0in 0in;"><p class="Tablefootnotef" style="margin-top: 0in;  border: none; margin-right: 0in; margin-bottom: -5pt; margin-left: 24.0pt; text-align: justify; text-justify: inter-ideograph; text-indent: -24.0pt; padding: 0in; font-size: 9.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">____________</p><ix:continuation continuedAt="_FairValueDisclosuresTextBlock-c0_cont_8" id="_FairValueDisclosuresTextBlock-c0_cont_7"><ix:continuation continuedAt="_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock-c0_cont_3" id="_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock-c0_cont_2"><p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;">&#8203;<span class="CharOverride-5" style="font-size:6pt;vertical-align:super;">(1)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><ix:footnote id="ix_3_footnote" xml:lang="en-US">The Fnality convertible notes converted into Series B<span class="nobreak">-1</span> Preference Shares on October 31, 2023 (Note 7)</ix:footnote>.</p></ix:continuation></ix:continuation></div>
		<ix:continuation id="_FairValueDisclosuresTextBlock-c0_cont_8"><ix:continuation continuedAt="_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock-c0_cont_4" id="_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock-c0_cont_3"><p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:0pt;"><span class="CharOverride-5" style="font-size:6pt;vertical-align:super;"> (2)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><ix:footnote id="ix_4_footnote" xml:lang="en-US">Recorded in impairments and other losses, net in the Consolidated Statements of Operations.</ix:footnote></p></ix:continuation>
		<ix:continuation continuedAt="_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock-c0_cont_5" id="_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock-c0_cont_4"><p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:0pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(3)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><ix:footnote id="ix_5_footnote" xml:lang="en-US">Recorded as contractual gold payments expense in the Consolidated Statements of Operations.</ix:footnote></p></ix:continuation>
		<ix:continuation id="_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock-c0_cont_5"><p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:0pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(4)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><ix:footnote id="ix_6_footnote" xml:lang="en-US">Recorded as gain on revaluation/termination of deferred consideration&#8212;gold payments in the Consolidated Statements of Operations.</ix:footnote>&#160;</p></ix:continuation></ix:continuation>
		<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:FinancialInstrumentsDisclosureTextBlock" id="ixv-20281"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">5. Financial instruments owned</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-left:24pt;text-indent:0pt;margin-top:8pt;"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock" id="ixv-26961">These instruments consist of the following:</ix:nonNumeric></p>
		<ix:continuation id="_ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock-c0_cont_1"><table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;">


				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1 _idGenCellOverride-2" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2023</span></p>
					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2022</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Financial instruments owned:</p>
					</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Trading securities</p>
					</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c147" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinancialInstrumentsOwnedAtFairValue" scale="3" unitRef="usd" id="ixv-26962">45,421</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c148" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinancialInstrumentsOwnedAtFairValue" scale="3" unitRef="usd" id="ixv-26963">124,474</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other assets&#8212;seed capital (WisdomTree Digital Funds)</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c149" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinancialInstrumentsOwnedAtFairValue" scale="3" unitRef="usd" id="ixv-26964">13,301</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c150" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinancialInstrumentsOwnedAtFairValue" scale="3" unitRef="usd" id="ixv-26965">1,765</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinancialInstrumentsOwnedAtFairValue" scale="3" unitRef="usd" id="ixv-26966">58,722</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FinancialInstrumentsOwnedAtFairValue" scale="3" unitRef="usd" id="ixv-26967">126,239</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:6pt;">The Company recognized net trading losses on financial instruments owned that were still held at the reporting dates of $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TradingGainsLosses" scale="3" unitRef="usd" id="ixv-26968">536</ix:nonFraction> and $<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TradingGainsLosses" scale="3" unitRef="usd" id="ixv-26969">12,721</ix:nonFraction> during the&#160;years ended December&#160;31, 2023 and 2022, respectively, which were recorded in other losses, net, in the Consolidated Statements of Operations.</p></ix:nonNumeric>
		<ix:nonNumeric contextRef="c0" continuedAt="_HeldToMaturitySecuritiesTextBlock-c0_cont_1" escape="true" name="us-gaap:HeldToMaturitySecuritiesTextBlock" id="ixv-20346"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">6. Securities Held-to-Maturity</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"><ix:nonNumeric contextRef="c0" continuedAt="_DebtSecuritiesAvailableForSaleTableTextBlock-c0_cont_1" escape="true" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="ixv-20350">The following table is a summary of the Company&#8217;s securities held<span class="nobreak">-to-maturity</span>:</ix:nonNumeric></p>
		<ix:continuation id="_DebtSecuritiesAvailableForSaleTableTextBlock-c0_cont_1"><table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;">


				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2023</span></p>
					</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2022</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Debt instruments: Pass-through GSEs (amortized cost)</p>
					</td>
					<td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c151" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" unitRef="usd" id="ixv-26970">230</ix:nonFraction></p>	</td>
					<td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c152" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" unitRef="usd" id="ixv-26971">259</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation>

		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">During the&#160;years ended December&#160;31, 2023 and 2022, the Company received proceeds of $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" scale="3" unitRef="usd" id="ixv-26972">29</ix:nonFraction> and $<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" scale="3" unitRef="usd" id="ixv-26973">45</ix:nonFraction>, respectively, from held<span class="nobreak">-to-maturity</span> securities maturing or being called prior to maturity.</p></ix:nonNumeric>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-20</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<ix:continuation id="_HeldToMaturitySecuritiesTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="_UnrealizedGainLossOnInvestmentsTableTextBlock-c0_cont_1" escape="true" name="us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock" id="ixv-20387">The following table summarizes unrealized gains, losses, and fair value (classified as Level 2 within the fair value hierarchy) of securities held<span class="nobreak">-to-maturity</span>:</ix:nonNumeric></p>
		<ix:continuation id="_UnrealizedGainLossOnInvestmentsTableTextBlock-c0_cont_1"><table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;">


				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1 _idGenCellOverride-2" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="5" style="width: 37.50%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Cost/amortized cost</p>
					</td>
					<td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c153" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" unitRef="usd" id="ixv-26974">230</ix:nonFraction></p>	</td>
					<td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c154" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" unitRef="usd" id="ixv-26975">259</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Gross unrealized losses</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c153" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" unitRef="usd" id="ixv-26976">15</ix:nonFraction>)</p>	</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c154" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" unitRef="usd" id="ixv-26977">20</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Gross unrealized gains</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-186; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-187; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Fair value</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c153" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="3" unitRef="usd" id="ixv-26978">215</ix:nonFraction></p>	</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c154" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="3" unitRef="usd" id="ixv-26979">239</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;">An allowance for credit losses was not provided on the Company&#8217;s held<span class="nobreak">-to-maturity</span> securities as all securities are investments in pass<span class="nobreak">-through</span> GSEs which are determined to have an estimated loss rate of zero due to an implicit U.S.&#160;government guarantee.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="_InvestmentsClassifiedByContractualMaturityDateTableTextBlock-c0_cont_1" escape="true" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="ixv-20463">The following table sets forth the maturity profile of the securities held<span class="nobreak">-to-maturity</span>; however, these securities may be called prior to maturity date:</ix:nonNumeric></p>
		<ix:continuation id="_InvestmentsClassifiedByContractualMaturityDateTableTextBlock-c0_cont_1"><table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;">


				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1 _idGenCellOverride-2" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="5" style="width: 37.50%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-10 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Due within one year</p>
					</td>
					<td class="Table70- TB CellOverride-11 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-3 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-188; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"> &#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-11 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-3 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-189; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"> &#8212;</p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-10" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Due one year through five&#160;years</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-190; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-191; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-10" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Due five&#160;years through ten&#160;years</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount" scale="3" unitRef="usd" id="ixv-26980">22</ix:nonFraction></p>	</td>
					<td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount" scale="3" unitRef="usd" id="ixv-26981">27</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-10" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Due over ten&#160;years</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="top">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="top">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount" scale="3" unitRef="usd" id="ixv-26982">208</ix:nonFraction></p>	</td>
					<td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="top">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="top">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount" scale="3" unitRef="usd" id="ixv-26983">232</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-10" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="top">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="top">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"> <ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" scale="3" unitRef="usd" id="ixv-26984">230</ix:nonFraction></p>	</td>
					<td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="top">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="top">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" scale="3" unitRef="usd" id="ixv-26985">259</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation></ix:continuation>

		<ix:nonNumeric contextRef="c0" continuedAt="_InvestmentTextBlock-c0_cont_1" escape="true" name="us-gaap:InvestmentTextBlock" id="ixv-20548"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">7. Investments</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="_InvestmentTableTextBlock-c0_cont_1" escape="true" name="us-gaap:InvestmentTableTextBlock" id="ixv-26986">The following table sets forth the Company&#8217;s investments:</ix:nonNumeric></p>
		<ix:continuation id="_InvestmentTableTextBlock-c0_cont_1"><table class="Table90-" style="width: 90.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0.33in 0pt 0.33in;">


				<tr class="Table90-" style="height:12pt;">
					<td class="Table90-" style="border-left-width:1pt;border-left-style:solid;border-left-color:#000000;border-top-width:1pt;border-top-style:solid;border-top-color:#000000;border-right-width:1pt;border-right-style:solid;border-right-color:#000000;border-bottom-width:1pt;border-bottom-style:solid;border-bottom-color:#000000;padding-top:4pt;padding-bottom:4pt;padding-left:4pt;padding-right:4pt;vertical-align:top;width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="5" style="width: 27.93%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December 31, 2023</span></p>
					</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="5" style="width: 30.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December 31, 2022</span></p>
					</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90-" style="border-left-width:1pt;border-left-style:solid;border-left-color:#000000;border-top-width:1pt;border-top-style:solid;border-top-color:#000000;border-right-width:1pt;border-right-style:solid;border-right-color:#000000;border-bottom-width:1pt;border-bottom-style:solid;border-bottom-color:#000000;padding-top:4pt;padding-bottom:4pt;padding-left:4pt;padding-right:4pt;vertical-align:top;width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Carrying <br/>Value</span></p>
					</td>
					<td class="Table90- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Cost</span></p>
					</td>
					<td class="Table90- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Carrying <br/>Value</span></p>
					</td>
					<td class="Table90- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 15.54%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Cost</span></p>
					</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TCH CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Securrency, Inc.:</p>
					</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="2" style="width: 15.54%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1 _idGenCellOverride-3" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Series&#160;A Shares</p>
					</td>
					<td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-192; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-193; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c172" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" unitRef="usd" id="ixv-26987">8,488</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c172" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedAtCost" scale="3" unitRef="usd" id="ixv-26988">8,112</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Series&#160;B Shares</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-194; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-195; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c174" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" unitRef="usd" id="ixv-26989">5,500</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c174" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedAtCost" scale="3" unitRef="usd" id="ixv-26990">5,500</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Convertible note</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-196; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-197; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c176" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" unitRef="usd" id="ixv-26991">14,500</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c176" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedAtCost" scale="3" unitRef="usd" id="ixv-26992">15,000</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Subtotal&#8212;Securrency, Inc.</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-198; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-199; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c178" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" unitRef="usd" id="ixv-26993">28,488</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c178" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedAtCost" scale="3" unitRef="usd" id="ixv-26994">28,612</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Fnality International Limited:</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Convertible note</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-200; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-201; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c180" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" unitRef="usd" id="ixv-26995">6,921</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c180" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedAtCost" scale="3" unitRef="usd" id="ixv-26996">6,863</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Series&#160;B-1 Preference Shares</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c181" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" unitRef="usd" id="ixv-26997">9,684</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c181" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedAtCost" scale="3" unitRef="usd" id="ixv-26998">8,091</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-202; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-203; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Subtotal&#8212;Fnality International Limited</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c183" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" unitRef="usd" id="ixv-26999">9,684</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c183" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedAtCost" scale="3" unitRef="usd" id="ixv-27000">8,091</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c184" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" unitRef="usd" id="ixv-27001">6,921</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c184" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedAtCost" scale="3" unitRef="usd" id="ixv-27002">6,863</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other investments</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-204; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c185" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedAtCost" scale="3" unitRef="usd" id="ixv-27003">250</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c186" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" unitRef="usd" id="ixv-27004">312</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c186" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedAtCost" scale="3" unitRef="usd" id="ixv-27005">250</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" unitRef="usd" id="ixv-27006">9,684</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedAtCost" scale="3" unitRef="usd" id="ixv-27007">8,341</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" unitRef="usd" id="ixv-27008">35,721</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedAtCost" scale="3" unitRef="usd" id="ixv-27009">35,725</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:8pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Securrency, Inc.</span></p>
		<p class="H4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:12pt;margin-top:8pt;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Exit from Investment&#160;&#8211;&#160;Year Ended December&#160;31, 2023</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;">On December&#160;7, 2023, the Company received proceeds of $<ix:nonFraction contextRef="c157" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" scale="3" unitRef="usd" id="ixv-27010">28,818</ix:nonFraction> relating to the exit from its investment in Securrency, Inc. (&#8220;Securrency&#8221;), a developer of institutional<span class="nobreak">-grade</span> blockchain<span class="nobreak">-based</span> financial and regulatory technology, in connection with the sale of Securrency to an unaffiliated third party. This resulted in a net impairment charge of $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="3" unitRef="usd" id="ixv-27011">7,630</ix:nonFraction> and additional losses of $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProvisionForOtherLosses" scale="3" unitRef="usd" id="ixv-27012">1,777</ix:nonFraction>, recorded in other losses, net, recognized during the year ended December&#160;31, 2023.</p></ix:nonNumeric>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-21</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_2" id="_InvestmentTextBlock-c0_cont_1"><div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:12pt;margin-top:12pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Disclosures Pertaining to December&#160;31, 2022</span></p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-left:24pt;margin-top:8pt;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Preferred Stock</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company owned approximately <ix:nonFraction contextRef="c158" decimals="2" format="ixt:num-dot-decimal" name="wt:CapitalStockPercentage" scale="-2" unitRef="pure" id="ixv-27013">22</ix:nonFraction>% (or <ix:nonFraction contextRef="c159" decimals="2" format="ixt:num-dot-decimal" name="wt:CapitalStockPercentage" scale="-2" unitRef="pure" id="ixv-27014">18</ix:nonFraction>% on a fully<span class="nobreak">-diluted</span> basis) of the capital stock of Securrency, issued as a result of strategic investments totaling $<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Investments" scale="3" unitRef="usd" id="ixv-27015">13,612</ix:nonFraction>. In consideration of such investments, the Company had received <ix:nonFraction contextRef="c160" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockConvertibleSharesIssuable" scale="0" unitRef="shares" id="ixv-27016">5,178,488</ix:nonFraction><span class="nobreak"> </span>shares of Series&#160;A convertible preferred stock (&#8220;Series&#160;A Shares&#8221;) in December&#160;2019 and <ix:nonFraction contextRef="c161" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockConvertibleSharesIssuable" scale="0" unitRef="shares" id="ixv-27017">2,004,665</ix:nonFraction><span class="nobreak"> </span>shares of Series&#160;B convertible preferred stock (&#8220;Series&#160;B Shares&#8221;) in March&#160;2021. The Series&#160;B Shares contained a liquidation preference that was pari passu with shares of Series&#160;B<span class="nobreak">-1</span> convertible preferred stock (which were substantially the same as the Series&#160;B Shares except that they had limited voting rights) and senior to that of the holders of the Series&#160;A Shares, which were senior to the holders of common stock. Otherwise, the Series&#160;A Shares and Series&#160;B Shares had substantially the same terms, were convertible into common stock at the option of the Company and contained various rights and protections including a non<span class="nobreak">-cumulative</span> <ix:nonFraction contextRef="c19" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockDividendRatePercentage" scale="-2" unitRef="pure" id="ixv-27018">6.0</ix:nonFraction>% dividend, payable if and when declared by the board of directors of Securrency. In addition, the Series&#160;A Shares and Series&#160;B Shares (together with the Series&#160;B<span class="nobreak">-1</span> convertible preferred stock) were separately redeemable, with respect to all of the shares outstanding of the applicable series of preferred stock (subject to certain regulatory restrictions of certain investors), for the original issue price thereof, plus all declared and unpaid dividends, upon approval by holders of at least <ix:nonFraction contextRef="c11" decimals="2" format="ixt:num-dot-decimal" name="wt:SharesPercentage" scale="-2" unitRef="pure" id="ixv-27019">60</ix:nonFraction>% of the Series&#160;A Shares (at any time on or after December&#160;31, 2029) and <ix:nonFraction contextRef="c162" decimals="2" format="ixt:num-dot-decimal" name="wt:SharesPercentage" scale="-2" unitRef="pure" id="ixv-27020">90</ix:nonFraction>% of the Series&#160;B Shares (at any time on or after March&#160;31, 2031).</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">These investments were accounted for under the measurement alternative prescribed in ASC&#160;321, as they did not have a readily determinable fair value and were not considered to be in<span class="nobreak">-substance</span> common stock. The investments were assessed for impairment and similar observable transactions on a quarterly basis. There was no impairment recognized during the&#160;years ended December&#160;31, 2022 and 2021 based upon a qualitative assessment.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">During the year ended December&#160;31, 2021, the Company recognized a gain of $<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainOrLossOnSaleOfStockInSubsidiary" scale="3" unitRef="usd" id="ixv-27021">376</ix:nonFraction> on its Series&#160;A Shares, which were re<span class="nobreak">-measured</span> to fair value upon the issuance of Securrency&#8217;s Series&#160;B Shares. Fair value was determined using the backsolve method, a valuation approach that determines the value of shares for companies with complex capital structures based upon the price paid for shares recently issued. Fair value was allocated across the capital structure using the Black<span class="nobreak">-Scholes</span> option pricing model.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock-c0_cont_1" escape="true" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="ixv-27022">The table below presents the inputs used in the backsolve valuation approach (classified as Level 3 in the fair value hierarchy):</ix:nonNumeric></p>
		<ix:continuation continuedAt="_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock-c0_cont_2" id="_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock-c0_cont_1"><table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;">


				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TCH CellOverride-1 _idGenCellOverride-2" style="width: 55.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table55- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TCH CellOverride-2 _idGenCellOverride-2" colspan="3" style="width: 42.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="CharOverride-7" style="font-style:normal;font-weight:bold;">Inputs</span></p>
					</td>
				</tr>
				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TCH CellOverride-1" style="width: 55.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table55- TCH CellOverride-5" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TCH CellOverride-2" style="width: 19.69%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="CharOverride-7" style="font-style:normal;font-weight:bold;">June&#160;9, <br/>2021</span></p>
					</td>
					<td class="Table55- TCH CellOverride-5" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TCH CellOverride-2" style="width: 21.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="CharOverride-7" style="font-style:normal;font-weight:bold;">March&#160;8, <br/>2021</span></p>
					</td>
				</tr>
				<tr class="Table55-" style="background: #CCEEFF;height:12pt;">
					<td class="Table55- TB CellOverride-1 _idGenCellOverride-3" style="width: 55.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Expected volatility</p>
					</td>
					<td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 19.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c187" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="pure" id="ixv-27023">50</ix:nonFraction>%</p>	</td>
					<td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 21.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c188" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="pure" id="ixv-27024">55</ix:nonFraction>%</p>	</td>
				</tr>
				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 55.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Time to exit (in&#160;years)</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 19.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonNumeric contextRef="c187" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="ixv-27025">4.75</ix:nonNumeric></p>	</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 21.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonNumeric contextRef="c188" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="ixv-27026">5.00</ix:nonNumeric></p>	</td>
				</tr>

		</table></ix:continuation>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-left:24pt;margin-top:14pt;margin-top:14pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Convertible Note</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In April and November&#160;2022, the Company participated in a convertible note financing, making an aggregate investment of $<ix:nonFraction contextRef="c163" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebt" scale="3" unitRef="usd" id="ixv-27027"><ix:nonFraction contextRef="c164" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConvertibleDebt" scale="3" unitRef="usd" id="ixv-27028">15,000</ix:nonFraction></ix:nonFraction> in Securrency. In consideration for its investment, the Company was issued a <ix:nonFraction contextRef="c165" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtConversionConvertedInstrumentRate" scale="-2" unitRef="pure" id="ixv-27029">7</ix:nonFraction>% Convertible Promissory Note maturing on <ix:nonNumeric contextRef="c165" format="ixt:date-monthname-day-year-en" name="us-gaap:DebtInstrumentMaturityDate" id="ixv-27030">April&#160;21, 2023</ix:nonNumeric>.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The note was convertible into either Securrency&#8217;s common stock or the class of securities convertible into, exchangeable for, or conferring the right to purchase Securrency&#8217;s common stock that was issued in the event of a future equity financing at a conversion price equal to a discount of <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wt:ConvertibleNoteDiscountRate" scale="-2" unitRef="pure" id="ixv-27031">25</ix:nonFraction>% (or, if applicable, a greater discount offered to other holders of convertible securities in such future equity financing round) to the lowest price paid per equity share issued in the future equity financing round.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The note was redeemable upon the occurrence of a corporate transaction for an amount which was the greater of (i)&#160;the principal amount and all accrued interest and (ii)&#160;the amount that would be received had the note been converted to common stock immediately prior to the occurrence of the corporate transaction. At maturity, redemption or conversion could occur upon the election by the holders of a majority<span class="nobreak">-in-interest</span> of the aggregate principal amount of outstanding notes. If no such election was made, Securrency could elect to pay or convert the notes in its sole discretion.</p>
		</div></ix:continuation>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-22</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<ix:continuation continuedAt="_InvestmentTextBlock-c0_cont_3" id="_InvestmentTextBlock-c0_cont_2"><div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The note was accounted for at fair value. Fair value was determined by the Company using the probability<span class="nobreak">-weighted</span> expected return method (&#8220;PWERM&#8221;), a valuation approach that estimated the value of the note assuming various outcomes. During the year ended December&#160;31, 2022, the Company recognized an unrealized loss of $<ix:nonFraction contextRef="c166" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrealizedGainLossOnInvestments" scale="3" unitRef="usd" id="ixv-27032">500</ix:nonFraction> when re<span class="nobreak">-measuring</span> the notes to fair value.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfCondensedFinancialStatementsTableTextBlock-c0_cont_1" escape="true" name="srt:ScheduleOfCondensedFinancialStatementsTableTextBlock" id="ixv-27033">The table below presents the probability ascribed to potential outcomes used in the PWERM (classified as Level 3 in the fair value hierarchy) and the time to exit:</ix:nonNumeric></p>
		<ix:continuation continuedAt="_ScheduleOfCondensedFinancialStatementsTableTextBlock-c0_cont_2" id="_ScheduleOfCondensedFinancialStatementsTableTextBlock-c0_cont_1"><table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;">


				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TCH CellOverride-1" style="width: 78.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table55- TCH CellOverride-5" style="width: 1.64%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TCH CellOverride-2" style="width: 19.70%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="CharOverride-7" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2022</span></p>
					</td>
				</tr>
				<tr class="Table55-" style="background: #CCEEFF;height:12pt;">
					<td class="Table55- TB CellOverride-1 _idGenCellOverride-3" style="width: 78.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Conversion of note upon a future equity financing</p>
					</td>
					<td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.64%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 19.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><ix:nonFraction contextRef="c189" decimals="2" format="ixt:num-dot-decimal" name="wt:ConversionOfNotesUponAFutureEquityFinancing" scale="-2" unitRef="pure" id="ixv-27034">60</ix:nonFraction>%</p>	</td>
				</tr>
				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 78.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Redemption of note upon a corporate transaction</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.64%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 19.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><ix:nonFraction contextRef="c189" decimals="2" format="ixt:num-dot-decimal" name="wt:RedemptionOfNoteUponACorporateTransaction" scale="-2" unitRef="pure" id="ixv-27035">25</ix:nonFraction>%</p>	</td>
				</tr>
				<tr class="Table55-" style="background: #CCEEFF;height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 78.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Default</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.64%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 19.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><ix:nonFraction contextRef="c189" decimals="2" format="ixt:num-dot-decimal" name="wt:FairValueAssumptionOfDissolutionRate" scale="-2" unitRef="pure" id="ixv-27036">15</ix:nonFraction>%</p>	</td>
				</tr>
				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 78.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Time to potential outcome (in&#160;years)</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.64%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 19.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><ix:nonNumeric contextRef="c189" format="ixt-sec:duryear" name="wt:TimeToPotentialOutcomeinYear" id="ixv-27037">0.33</ix:nonNumeric></p>	</td>
				</tr>

		</table></ix:continuation>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Fnality International Limited</span></p>
		<p class="H4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:12pt;margin-top:8pt;margin-top:8pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Series&#160;B-1 Preference Shares (December&#160;31, 2023)</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company owns approximately <ix:nonFraction contextRef="c0" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" unitRef="pure" id="ixv-27038">5.4</ix:nonFraction>% (or <ix:nonFraction contextRef="c167" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" unitRef="pure" id="ixv-27039">4.8</ix:nonFraction>% on a fully<span class="nobreak">-diluted</span> basis) of capital stock of Fnality International Limited (&#8220;Fnality&#8221;), a company incorporated in England and Wales and focused on creating a peer<span class="nobreak">-to-peer</span> digital wholesale settlement ecosystem comprised of a consortium of financial institutions, offering real time cross<span class="nobreak">-border</span> payments from a single pool of liquidity. The Company&#8217;s ownership interest is represented by <ix:nonFraction contextRef="c168" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherOwnershipInterestsUnitsIssued" scale="0" unitRef="shares" id="ixv-27040">2,340,378</ix:nonFraction> Series&#160;B<span class="nobreak">-1</span> Preference Shares, resulting from the conversion of its investment of &#163;<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="wt:CostMethodInvestmentFairValueDisclosure" scale="3" unitRef="eur" id="ixv-27041">6,000</ix:nonFraction> ($<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="wt:CostMethodInvestmentFairValueDisclosure" scale="3" sign="-" unitRef="usd" id="ixv-27042">8,091</ix:nonFraction>) in convertible notes upon Fnality&#8217;s qualified equity financing which occurred in October&#160;2023. The Series&#160;B<span class="nobreak">-1</span> Preference Shares carry a 1.0x liquidation preference, are convertible into ordinary shares at the option of the Company and contain various rights and protections.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">This investment is accounted for under the measurement alternative prescribed in ASC&#160;321, as it does not have a readily determinable fair value and is otherwise not subject to the equity method of accounting. The investment is assessed for impairment and similar observable transactions on a quarterly basis. During the year ended December&#160;31, 2023, the Company recognized a gain of $<ix:nonFraction contextRef="c167" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnInvestments" scale="3" unitRef="usd" id="ixv-27043">1,534</ix:nonFraction> on its investment in Fnality which was re<span class="nobreak">-measured</span> to fair value upon the issuance by Fnality of Series&#160;B<span class="nobreak">-2</span> Preference Shares to new investors in the qualified equity financing. The Series&#160;B<span class="nobreak">-2</span> Preference Shares carry a 1.5x liquidation preference, rank pari passu to the Series&#160;B<span class="nobreak">-1</span> Preference Shares and automatically convert into Series&#160;B<span class="nobreak">-1</span> Preference Shares if certain conditions are met no later than June&#160;30, 2024.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Fair value of the Company&#8217;s investments in Fnality were determined using the backsolve method, a valuation approach that determines the value of shares for companies with complex capital structures based upon the price paid for shares recently issued. Fair value is allocated across the capital structure using the Black<span class="nobreak">-Scholes</span> option pricing model.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The table below presents the inputs used in the backsolve valuation approach (classified as Level 3 in the fair value hierarchy):</p>
		<ix:continuation id="_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock-c0_cont_2"><table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;">


				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TCH CellOverride-1" style="width: 85.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table55- TCH CellOverride-5" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TCH CellOverride-2" style="width: 13.41%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2023</span></p>
					</td>
				</tr>
				<tr class="Table55-" style="background: #CCEEFF;height:12pt;">
					<td class="Table55- TB CellOverride-1 _idGenCellOverride-3" style="width: 85.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Expected volatility</p>
					</td>
					<td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 13.41%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><ix:nonFraction contextRef="c58" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="pure" id="ixv-27044">60</ix:nonFraction>%</p>	</td>
				</tr>
				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 85.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Time to exit (in&#160;years)</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 13.41%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonNumeric contextRef="c58" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="ixv-27045">5.00</ix:nonNumeric></p>	</td>
				</tr>
				<tr class="Table55-" style="background: #CCEEFF;height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 85.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Probability that Series&#160;B-2 Preference Shares convert into Series&#160;B-1 Preference Shares</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 13.41%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><ix:nonFraction contextRef="c58" decimals="2" format="ixt:num-dot-decimal" name="wt:ProbabilityThatSeriesB2PreferenceSharesCovertIntoSeriesB1PreferenceShares" scale="-2" unitRef="pure" id="ixv-27046">75</ix:nonFraction>%</p>	</td>
				</tr>

		</table></ix:continuation>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">There was no impairment recognized during the year ended December&#160;31, 2023 based upon a qualitative assessment.</p>
		<p class="H4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:12pt;margin-top:12pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Convertible Note (December&#160;31, 2022)</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In February&#160;2022, the Company participated in a convertible note financing, making a &#163;<ix:nonFraction contextRef="c169" decimals="-3" format="ixt:num-dot-decimal" name="wt:CostMethodInvestmentFairValueDisclosure" scale="3" unitRef="eur" id="ixv-27047">5,000</ix:nonFraction> ($<ix:nonFraction contextRef="c169" decimals="-3" format="ixt:num-dot-decimal" name="wt:CostMethodInvestmentFairValueDisclosure" scale="3" sign="-" unitRef="usd" id="ixv-27048">6,863</ix:nonFraction>) investment in Fnality International Limited (&#8220;Fnality&#8221;), a company incorporated in England and Wales and focused on creating a peer<span class="nobreak">-to-peer</span> digital wholesale settlement ecosystem comprised of a consortium of financial institutions, offering real time cross<span class="nobreak">-border</span> payments from a single pool of liquidity. In consideration for its investment, the Company was issued a <ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="wt:CostMethodInvestmentOwnershipPercentage" scale="-2" unitRef="pure" id="ixv-27049">5</ix:nonFraction>% Convertible Unsecured Loan Note maturing on December&#160;31, 2023.</p>
		</div></ix:continuation>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-23</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<ix:continuation id="_InvestmentTextBlock-c0_cont_3"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The note was convertible into equity shares in the event of a future financing round at a conversion price equal to the lower of (i)&#160;a discount of <ix:nonFraction contextRef="c5" decimals="2" format="ixt:num-dot-decimal" name="wt:PercentageOfDiscountOnFutureEquityFinancingForPreferredStock" scale="-2" unitRef="pure" id="ixv-27050">20</ix:nonFraction>% to lowest price paid per equity share issued pursuant to such future financing round and (ii)&#160;an amount paid per share subject to a pre<span class="nobreak">-money</span> valuation cap. Mandatory conversion could occur on or after the maturity date or, if earlier, in the event a future financing round had not been completed within a specified time from an initial closing of such financing round (&#8220;Long Stop Date&#8221;), upon the approval of holders of at least <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wt:PercentageOfOutstandingConvertibleNotes" scale="-2" unitRef="pure" id="ixv-27051">75</ix:nonFraction>% of the outstanding notes. The note was also convertible, at the option of the Company, following the earlier of the maturity date or such Long Stop Date.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The note was redeemable upon the occurrence of a change of control for an amount which was the greater of (i)&#160;the principal amount and all accrued interest and (ii)&#160;the amount that would have been received had the note been converted to equity shares immediately prior to the occurrence of the change of control. Redemption could also occur on or after maturity or prior to maturity upon approval by holders of at least <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wt:PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity" scale="-2" unitRef="pure" id="ixv-27052">50</ix:nonFraction>% and <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wt:PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity" scale="-2" unitRef="pure" id="ixv-27053">75</ix:nonFraction>%, respectively, of the outstanding notes, or in connection with bankruptcy or other liquidation events.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The note was accounted for at fair value. Fair value was determined by the Company using the PWERM and was also remeasured for changes in the British pound and U.S.&#160;dollar exchange rate. During the year ended December&#160;31, 2022, the Company recognized a gain of $<ix:nonFraction contextRef="c170" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrealizedGainLossOnInvestments" scale="3" unitRef="usd" id="ixv-27054">58</ix:nonFraction> when re<span class="nobreak">-measuring</span> the notes to fair value.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The table below presents the probability ascribed to potential outcomes used in the PWERM (classified as Level 3 in the fair value hierarchy) and the time to exit:</p>
		<ix:continuation id="_ScheduleOfCondensedFinancialStatementsTableTextBlock-c0_cont_2"><table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;">


				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TCH CellOverride-1" style="width: 78.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table55- TCH CellOverride-5" style="width: 1.86%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TCH CellOverride-2" style="width: 20.12%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2022</span></p>
					</td>
				</tr>
				<tr class="Table55-" style="background: #CCEEFF;height:12pt;">
					<td class="Table55- TB CellOverride-1 _idGenCellOverride-3" style="width: 78.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Conversion of note upon a future financing round</p>
					</td>
					<td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.86%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 20.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><ix:nonFraction contextRef="c189" decimals="2" format="ixt:num-dot-decimal" name="wt:ConversionOfNoteUponAFutureFinancingRound" scale="-2" unitRef="pure" id="ixv-27055">85</ix:nonFraction>%</p>	</td>
				</tr>
				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 78.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Redemption of note upon a change of control</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.86%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 20.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><ix:nonFraction contextRef="c189" decimals="2" format="ixt:num-dot-decimal" name="wt:RedemptionOfNoteUponAChangeOfControl" scale="-2" unitRef="pure" id="ixv-27056">10</ix:nonFraction>%</p>	</td>
				</tr>
				<tr class="Table55-" style="background: #CCEEFF;height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 78.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Default</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.86%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 20.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><ix:nonFraction contextRef="c189" decimals="2" format="ixt:num-dot-decimal" name="wt:Default" scale="-2" unitRef="pure" id="ixv-27057">5</ix:nonFraction>%</p>	</td>
				</tr>
				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 78.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Time to potential outcome (in&#160;years)</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.86%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 20.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonNumeric contextRef="c189" format="ixt-sec:duryear" name="wt:TimeToPotentialOutcomesinYears" id="ixv-27058">0.25</ix:nonNumeric></p>	</td>
				</tr>

		</table></ix:continuation>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:14pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Other Investments</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">During the year ended December&#160;31, 2023, the Company recognized an impairment of $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherInvestments" scale="3" unitRef="usd" id="ixv-27059">312</ix:nonFraction> on its other investments.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="ixv-21035"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">8. Fixed Assets, net</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="_PropertyPlantAndEquipmentTextBlock-c0_cont_1" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="ixv-27060">The following table summarizes fixed assets:</ix:nonNumeric></p>
		<ix:continuation id="_PropertyPlantAndEquipmentTextBlock-c0_cont_1"><table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;">


				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1 _idGenCellOverride-2" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="5" style="width: 37.50%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Equipment</p>
					</td>
					<td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c190" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-27061">1,097</ix:nonFraction></p>	</td>
					<td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c191" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" unitRef="usd" id="ixv-27062">962</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Less: accumulated depreciation</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-27063">670</ix:nonFraction>)</p>	</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" unitRef="usd" id="ixv-27064">418</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd" id="ixv-27065">427</ix:nonFraction></p>	</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" unitRef="usd" id="ixv-27066">544</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation></ix:nonNumeric>
		<ix:nonNumeric contextRef="c0" continuedAt="wt_DeferredConsiderationTextBlock-c0_cont_1" escape="true" name="wt:DeferredConsiderationTextBlock" id="ixv-21096"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">9. Deferred Consideration&#8212;gold payments</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;">Deferred consideration&#8212;gold payments represented an obligation the Company assumed in connection with its acquisition of the European exchange<span class="nobreak">-traded</span> commodity, currency and leveraged<span class="nobreak">-and-inverse</span> business of ETFS Capital Limited (&#8220;ETFS Capital&#8221;) which occurred on April&#160;11, 2018 (&#8220;ETFS Acquisition&#8221;). The obligation was for fixed payments to ETFS Capital of physical gold bullion equating to <ix:nonFraction contextRef="c192" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedBalanceOtherMeasure" scale="0" unitRef="oz" id="ixv-27067">9,500</ix:nonFraction> ounces of gold per year through March&#160;31, 2058 and then subsequently reduced to <ix:nonFraction contextRef="c193" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedBalanceOtherMeasure" scale="0" unitRef="oz" id="ixv-27068">6,333</ix:nonFraction> ounces of gold continuing into perpetuity (&#8220;Contractual Gold Payments&#8221;). ETFS Capital passed through these payments to other parties to meet its payment obligations under prior royalty agreements it had with such parties, including to Gold Bullion Holdings (Jersey) Limited (&#8220;GBH&#8221;), a subsidiary of the World Gold Council (&#8220;WGC&#8221;), Graham Tuckwell (&#8220;GT&#8221;), and Rodber Investments Limited (&#8220;RIL&#8221;), an entity controlled by GT, who is also the Chairman of ETFS Capital.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:5.5pt;">On May&#160;10, 2023, the Company terminated its Contractual Gold Payments obligation for aggregate consideration totaling $<ix:nonFraction contextRef="c194" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration" scale="3" unitRef="usd" id="ixv-27069">136,903</ix:nonFraction> pursuant to a Sale, Purchase and Assignment Deed (the &#8220;SPA Agreement&#8221;) with WisdomTree International Holdings Ltd, Electra Target HoldCo Limited, ETFS Capital, WGC, GBH, GT and RIL.&#160;Under the terms of the transaction, GBH received approximately $<ix:nonFraction contextRef="c195" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Cash" scale="3" unitRef="usd" id="ixv-27070">4,371</ix:nonFraction> in cash and <ix:nonFraction contextRef="c196" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockSharesIssued" scale="0" unitRef="shares" id="ixv-27071">13,087</ix:nonFraction><span class="nobreak"> </span>shares of Series&#160;C Preferred Stock, convertible into <ix:nonFraction contextRef="c197" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConversionOfStockSharesConverted1" scale="0" unitRef="shares" id="ixv-27072">13,087,000</ix:nonFraction><span class="nobreak"> </span>shares of the Company&#8217;s common stock, and RIL received approximately $<ix:nonFraction contextRef="c198" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Cash" scale="3" unitRef="usd" id="ixv-27073">45,634</ix:nonFraction> in cash.</p></ix:nonNumeric>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-24</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<ix:continuation continuedAt="wt_DeferredConsiderationTextBlock-c0_cont_2" id="wt_DeferredConsiderationTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:5.5pt;">On November&#160;20, 2023, the Company repurchased the <ix:nonFraction contextRef="c199" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" unitRef="shares" id="ixv-27074">13,087</ix:nonFraction><span class="nobreak"> </span>shares of Series&#160;C Preferred Stock issued to GBH for aggregate consideration of $<ix:nonFraction contextRef="c200" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="3" unitRef="usd" id="ixv-27075">84,411</ix:nonFraction>, $<ix:nonFraction contextRef="c201" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="3" unitRef="usd" id="ixv-27076">40,000</ix:nonFraction> of which was paid on the closing date, with the remaining $<ix:nonFraction contextRef="c202" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="3" unitRef="usd" id="ixv-27077">44,411</ix:nonFraction> payable in equal, interest<span class="nobreak">-free</span> installments on the first, second and third anniversaries of the closing date. See Note&#160;12 for additional information.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:5.5pt;"><ix:nonNumeric contextRef="c0" continuedAt="wt_DisclosureOfValuationOfDeferredConsiderationTableTextBlock-c0_cont_1" escape="true" name="wt:DisclosureOfValuationOfDeferredConsiderationTableTextBlock" id="ixv-27078">The Company determined the present value of the deferred consideration of $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedBalanceOtherMeasure" scale="3" unitRef="g" id="ixv-27079">0</ix:nonFraction> and $<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentOwnedBalanceOtherMeasure" scale="3" unitRef="g" id="ixv-27080">200,290</ix:nonFraction> at December&#160;31, 2022 using the following assumptions:</ix:nonNumeric></p>
		<ix:continuation id="wt_DisclosureOfValuationOfDeferredConsiderationTableTextBlock-c0_cont_1"><table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 20.22%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, 2022</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-12 _idGenCellOverride-3" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Forward-looking gold price (low)&#8212;per ounce</p>
					</td>
					<td class="Table60- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-14 _idGenCellOverride-3" style="width: 2.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-14 _idGenCellOverride-3" style="width: 17.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c203" decimals="-3" format="ixt:num-dot-decimal" name="wt:ForwardsLookingGoldPrice" scale="3" unitRef="oz" id="ixv-27081">1,858</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-12" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Forward-looking gold price (high)&#8212;per ounce</p>
					</td>
					<td class="Table60- TB CellOverride-14" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-14" style="width: 2.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-14" style="width: 17.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c204" decimals="-3" format="ixt:num-dot-decimal" name="wt:ForwardsLookingGoldPrice" scale="3" unitRef="oz" id="ixv-27082">3,126</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-12" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Forward-looking gold price (weighted average)&#8212;per ounce</p>
					</td>
					<td class="Table60- TB CellOverride-14" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-14" style="width: 2.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-14" style="width: 17.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c205" decimals="-3" format="ixt:num-dot-decimal" name="wt:ForwardsLookingGoldPrice" scale="3" unitRef="oz" id="ixv-27083">2,237</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-12" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Discount rate</p>
					</td>
					<td class="Table60- TB CellOverride-14" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-14" style="width: 2.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-14" style="width: 17.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="3" format="ixt:num-dot-decimal" name="wt:BusinessCombinationConsiderationTransferredDeferredPaymentInterest" scale="-2" unitRef="pure" id="ixv-27084">11.0</ix:nonFraction>%</p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-12" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Perpetual growth rate</p>
					</td>
					<td class="Table60- TB CellOverride-14" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-14" style="width: 2.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-14" style="width: 17.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="3" format="ixt:num-dot-decimal" name="wt:DeferredConsiderationPerpetualGrowthRate" scale="-2" unitRef="pure" id="ixv-27085">1.3</ix:nonFraction>%</p>	</td>
				</tr>

		</table></ix:continuation>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:7pt;margin-top:7pt;">The forward<span class="nobreak">-looking</span> gold prices at December&#160;31, 2022 were extrapolated from the last observable CMX exchange price (beyond 2028) and the weighted<span class="nobreak">-average</span> price per ounce was derived from the relative present values of the annual payment obligations. The perpetual growth rate at December&#160;31, 2022 was determined based upon the increase in observable forward<span class="nobreak">-looking</span> gold prices through 2028. This obligation is classified as Level 3 as the discount rate, the extrapolated forward<span class="nobreak">-looking</span> gold prices and perpetual growth rate are significant unobservable inputs. An increase in spot gold prices, forward<span class="nobreak">-looking</span> gold prices and the perpetual growth rate would result in an increase in deferred consideration, whereas an increase in the discount rate would reduce the fair value.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:5.5pt;">Current and long<span class="nobreak">-term</span> amounts payable were $<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wt:DeferredConsiderationCurrent" scale="3" unitRef="usd" id="ixv-27086">16,796</ix:nonFraction> and $<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wt:DeferredConsiderationNoncurrent" scale="3" unitRef="usd" id="ixv-27087">183,494</ix:nonFraction>, respectively, at December&#160;31, 2022.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:5.5pt;"><ix:nonNumeric contextRef="c0" continuedAt="wt_ScheduleOfDeferredConsiderationTableTextBlock-c0_cont_1" escape="true" name="wt:ScheduleOfDeferredConsiderationTableTextBlock" id="ixv-27088">During the&#160;years ended December&#160;31, 2023 and 2022, the Company recognized the following in respect of deferred consideration:</ix:nonNumeric></p>
		<ix:continuation continuedAt="wt_ScheduleOfDeferredConsiderationTableTextBlock-c0_cont_2" id="wt_ScheduleOfDeferredConsiderationTableTextBlock-c0_cont_1"><table class="Table90-" style="width: 90.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0.33in 0pt 0.33in;">


				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TCH CellOverride-1 _idGenCellOverride-2" style="width: 45.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TCH CellOverride-1" style="width: 45.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="2" style="width: 16.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="2" style="width: 16.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="2" style="width: 17.65%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-12 _idGenCellOverride-3" style="width: 45.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Contractual gold payments</p>
					</td>
					<td class="Table90- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:ContractualGoldPayments" scale="3" unitRef="usd" id="ixv-27089">6,069</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="wt:ContractualGoldPayments" scale="3" unitRef="usd" id="ixv-27090">17,108</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 15.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wt:ContractualGoldPayments" scale="3" unitRef="usd" id="ixv-27091">17,096</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-12" style="width: 45.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Contractual gold payments&#8212;gold ounces paid</p>
					</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-14" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:ContractualGoldPaymentgoldOuncesPaid" scale="3" unitRef="oz" id="ixv-27092">3,167</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-14" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="wt:ContractualGoldPaymentgoldOuncesPaid" scale="3" unitRef="oz" id="ixv-27093">9,500</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-14" style="width: 15.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wt:ContractualGoldPaymentgoldOuncesPaid" scale="3" unitRef="oz" id="ixv-27094">9,500</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-12" style="width: 45.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Gain on revaluation/termination of deferred consideration&#8212;gold payments<span class="Superscript" style="vertical-align:super;font-size:6pt;">(</span><span class="CharOverride-5" style="font-size:6pt;vertical-align:super;">1</span><span class="Superscript" style="vertical-align:super;font-size:6pt;">)</span></p>
					</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-14" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" id="ix_11_fact" name="wt:GainLossFromChangeInDeferredConsideration" scale="3" unitRef="usd">61,953</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-14" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" id="ix_12_fact" name="wt:GainLossFromChangeInDeferredConsideration" scale="3" unitRef="usd">27,765</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-14" style="width: 15.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" id="ix_13_fact" name="wt:GainLossFromChangeInDeferredConsideration" scale="3" unitRef="usd">2,018</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation></ix:continuation>

		<div style="border: none; border-top: windowtext 0pt none; border-top-style: solid; padding: 0in 0in 2.0pt 0in;"><p class="Tablefootnotef" style="margin-top: 0in;  border: none; margin-right: 0in; margin-bottom: -5pt; margin-left: 24.0pt; text-align: justify; text-justify: inter-ideograph; text-indent: -24.0pt; padding: 0in; font-size: 9.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">____________</p><ix:continuation id="wt_DeferredConsiderationTextBlock-c0_cont_2"><ix:continuation id="wt_ScheduleOfDeferredConsiderationTableTextBlock-c0_cont_2"><p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:11pt;margin-top:12pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><ix:footnote id="ix_7_footnote" xml:lang="en-US">Gains on revaluation/termination of deferred consideration&#8212;gold payments result from a decrease in spot gold prices, a decrease in the forward<span class="nobreak">-looking</span> price of gold, a decrease in the perpetual growth rate and an increase in the discount rate used to compute the present value of the annual payment obligations.</ix:footnote></p></ix:continuation></ix:continuation></div>
		<ix:nonNumeric contextRef="c0" continuedAt="_DebtDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:DebtDisclosureTextBlock" id="ixv-21259"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;"> 10. Convertible Notes</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:6pt;">On February&#160;14, 2023, the Company issued and sold $<ix:nonFraction contextRef="c206" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-27098">130,000</ix:nonFraction> in aggregate principal amount of <ix:nonFraction contextRef="c206" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" unitRef="pure" id="ixv-27099">5.75</ix:nonFraction>% Convertible Senior Notes due 2028 (the &#8220;2023 Notes&#8221;) pursuant to an indenture dated February&#160;14, 2023, between the Company and U.S.&#160;Bank Trust Company, National Association, as trustee (or its successor in interest, the &#8220;Trustee&#8221;), in a private offering to qualified institutional buyers pursuant to Rule&#160;144A under the Securities Act&#160;of&#160;1933, as amended (&#8220;Rule&#160;144A&#8221;).</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On June&#160;14, 2021, the Company issued and sold $<ix:nonFraction contextRef="c207" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-27100">150,000</ix:nonFraction> in aggregate principal amount of <ix:nonFraction contextRef="c207" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" unitRef="pure" id="ixv-27101">3.25</ix:nonFraction>% Convertible Senior Notes due 2026 (the &#8220;2021 Notes&#8221;) pursuant to an indenture dated June&#160;14, 2021, between the Company and the Trustee, in a private offering to qualified institutional buyers pursuant to Rule&#160;144A.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;">On June&#160;16, 2020, the Company issued and sold $<ix:nonFraction contextRef="c208" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-27102">150,000</ix:nonFraction> in aggregate principal amount of <ix:nonFraction contextRef="c208" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" unitRef="pure" id="ixv-27103">4.25</ix:nonFraction>% Convertible Senior Notes due 2023 (the &#8220;June&#160;2020 Notes&#8221;) pursuant to an indenture dated June&#160;16, 2020, between the Company and the Trustee, in a private offering to qualified institutional buyers pursuant to Rule&#160;144A.&#160;On August&#160;13, 2020, the Company issued and sold $<ix:nonFraction contextRef="c209" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-27104">25,000</ix:nonFraction> in aggregate principal amount of <ix:nonFraction contextRef="c209" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" unitRef="pure" id="ixv-27105">4.25</ix:nonFraction>% Convertible Senior Notes due 2023 at a price equal to <ix:nonFraction contextRef="c210" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" unitRef="pure" id="ixv-27106">101</ix:nonFraction>% of the principal amount thereof, plus interest deemed to have accrued since June&#160;16, 2020, which constitute a further issuance of, and form a single series with, the Company&#8217;s June&#160;2020 Notes (the &#8220;August&#160;2020 Notes&#8221; and together with the June&#160;2020 Notes, the &#8220;2020 Notes&#8221;).</p></ix:nonNumeric>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-25</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_2" id="_DebtDisclosureTextBlock-c0_cont_1"><div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In connection with the issuance of the 2023 Notes, the Company repurchased $<ix:nonFraction contextRef="c211" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-27107">115,000</ix:nonFraction> in aggregate principal amount of the 2020 Notes. As a result of this repurchase, the Company recognized a loss on extinguishment of approximately $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ExtinguishmentOfDebtGainLossNetOfTax" scale="3" unitRef="usd" id="ixv-27108">9,721</ix:nonFraction> during the year ended December&#160;31, 2023. The remainder of the 2020 Notes matured on June&#160;15, 2023 and were settled for $<ix:nonFraction contextRef="c212" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Cash" scale="3" unitRef="usd" id="ixv-27109">59,955</ix:nonFraction> in cash and <ix:nonFraction contextRef="c213" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockSharesIssued" scale="3" unitRef="shares" id="ixv-27110">1,037,288</ix:nonFraction><span class="nobreak"> </span>shares of common stock, as the conversion option was in the money.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">After the repurchase and maturity of the 2020 Notes and the issuance of the 2023 Notes (and together with the 2021 Notes, the &#8220;Convertible Notes&#8221;), the Company had $<ix:nonFraction contextRef="c214" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-27111">280,000</ix:nonFraction> in aggregate principal amount of Convertible Notes outstanding.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfDebtTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfDebtTableTextBlock" id="ixv-27112">Key terms of the Convertible Notes are as follows:</ix:nonNumeric></p>
		<ix:continuation id="_ScheduleOfDebtTableTextBlock-c0_cont_1"><table class="Table85-" style="width: 85.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 10% 0pt 0.33in;">


				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TCH CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table85- TCH CellOverride-5" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TCH CellOverride-2" colspan="2" style="width: 20.17%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023 Notes</span></p>
					</td>
					<td class="Table85- TCH CellOverride-5" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TCH CellOverride-2" colspan="2" style="width: 18.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021 Notes</span></p>
					</td>
				</tr>
				<tr class="Table85-" style="background: #CCEEFF;height:12pt;">
					<td class="Table85- TB CellOverride-1 _idGenCellOverride-3" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Principal outstanding</p>
					</td>
					<td class="Table85- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c226" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-27113">130,000</ix:nonFraction></p>	</td>
					<td class="Table85- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c227" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-27114">150,000</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Maturity date (unless earlier converted, repurchased or redeemed)</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonNumeric contextRef="c228" format="ixt:date-monthname-day-year-en" name="us-gaap:DebtInstrumentMaturityDate" id="ixv-27115">August&#160;15,&#160;2028</ix:nonNumeric></p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonNumeric contextRef="c229" format="ixt:date-monthname-day-year-en" name="us-gaap:DebtInstrumentMaturityDate" id="ixv-27116">June&#160;15,&#160;2026</ix:nonNumeric></p>	</td>
				</tr>
				<tr class="Table85-" style="background: #CCEEFF;height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Interest rate</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c226" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" unitRef="pure" id="ixv-27117">5.75</ix:nonFraction>%</p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c227" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" unitRef="pure" id="ixv-27118">3.25</ix:nonFraction>%</p>	</td>
				</tr>
				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Conversion price</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c226" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" unitRef="usdPershares" id="ixv-27119">9.54</ix:nonFraction></p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c227" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" unitRef="usdPershares" id="ixv-27120">11.04</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table85-" style="background: #CCEEFF;height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Conversion rate</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c228" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" unitRef="pure" id="ixv-27121">104.8658</ix:nonFraction></p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c229" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" unitRef="pure" id="ixv-27122">90.5797</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Redemption price</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c228" decimals="INF" format="ixt:num-dot-decimal" name="wt:DebtInstrumentRedemptionPrice" scale="0" unitRef="usdPershares" id="ixv-27123">12.40</ix:nonFraction></p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c229" decimals="INF" format="ixt:num-dot-decimal" name="wt:DebtInstrumentRedemptionPrice" scale="0" unitRef="usdPershares" id="ixv-27124">14.35</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:42pt;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Interest rate: </span>Payable semiannually in arrears on February&#160;15 and August&#160;15 of each year for the 2023 Notes and on June&#160;15 and December&#160;15 of each year for the 2021 Notes.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:42pt;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Conversion price: </span>Convertible at an initial conversion rate into shares of the Company&#8217;s common stock, per $<ix:nonFraction contextRef="c215" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ConversionOfStockAmountIssued1" scale="3" unitRef="usd" id="ixv-27125">1,000</ix:nonFraction> principal amount of notes (equivalent to an initial conversion price set forth in the table above), subject to adjustment.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:42pt;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Conversion: </span>Holders may convert at their option at any time prior to the close of business on the business&#160;day immediately preceding May<span class="nobreak">&#160;</span>15, 2028 and March<span class="nobreak">&#160;</span>15, 2026 for the 2023 Notes and 2021 Notes, respectively, only under the following circumstances: (i)&#160;if the last reported sale price of the Company&#8217;s common stock for at least <ix:nonFraction contextRef="c216" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" unitRef="pure" id="ixv-27126">20</ix:nonFraction>&#160;trading days during a period of <ix:nonFraction contextRef="c216" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" unitRef="pure" id="ixv-27127">30</ix:nonFraction> consecutive&#160;trading days ending on the last&#160;trading day of the immediately preceding calendar quarter is greater than or equal to <ix:nonFraction contextRef="c217" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtConversionConvertedInstrumentRate" scale="-2" unitRef="pure" id="ixv-27128">130</ix:nonFraction>% of the conversion price for the respective Convertible Notes on each applicable&#160;trading day; (ii)&#160;during the <span style="-sec-ix-hidden: hidden-fact-209">five</span> business&#160;day period after any <span style="-sec-ix-hidden: hidden-fact-210">ten</span> consecutive&#160;trading day period (the &#8220;measurement period&#8221;) in which the trading price per $<ix:nonFraction contextRef="c215" decimals="-3" format="ixt:num-dot-decimal" name="wt:PrincipalAmountOfTradingPrice" scale="3" unitRef="usd" id="ixv-27129">1,000</ix:nonFraction> principal amount of the Convertible Notes for each&#160;trading day of the measurement period was less than <ix:nonFraction contextRef="c218" decimals="2" format="ixt:num-dot-decimal" name="wt:SharePriceAsAPercentageOfLastReportedPriceAndConversionRate" scale="-2" unitRef="pure" id="ixv-27130">98</ix:nonFraction>% of the product of the last reported sales price of the Company&#8217;s common stock and the conversion rate on each such&#160;trading day; (iii)&#160;upon a notice of redemption delivered by the Company in accordance with the terms of the indentures but only with respect to the Convertible Notes called (or deemed called) for redemption; or (iv)&#160;upon the occurrence of specified corporate events. On or after May<span class="nobreak">&#160;</span>15, 2028 and March<span class="nobreak">&#160;</span>15, 2026 in respect of the 2023 Notes and the 2021 Notes, respectively, until the close of business on the second scheduled&#160;trading day immediately preceding the maturity date, holders may convert their Convertible Notes at any time, regardless of the foregoing circumstances.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:42pt;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Cash settlement of principal amount: </span>Upon conversion, the Company will pay cash up to the aggregate principal amount of the Convertible Notes to be converted. At its election, the Company will also settle its conversion obligation in excess of the aggregate principal amount of the Convertible Notes being converted in either cash, shares of its common stock or a combination of cash and shares of its common stock.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-left:42pt;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Redemption price: </span>The Company may redeem for cash all or any portion of the Convertible Notes, at its option, on or after August<span class="nobreak">&#160;</span>20, 2025 and June<span class="nobreak">&#160;</span>20, 2023 in respect of the 2023 Notes and the 2021 Notes, respectively, and on or prior to the 55<span class="CharOverride-6" style="font-size:58%;vertical-align:super;">th</span> scheduled&#160;trading day immediately preceding the maturity date, if the last reported sale price of the Company&#8217;s common stock has been at least <ix:nonFraction contextRef="c219" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" unitRef="pure" id="ixv-27131">130</ix:nonFraction>% of the conversion price for the respective Convertible Notes then in effect for at least <ix:nonFraction contextRef="c219" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" unitRef="pure" id="ixv-27132">20</ix:nonFraction>&#160;trading days, including the&#160;trading day immediately preceding the date on which the Company provides notice of redemption, during any <ix:nonFraction contextRef="c215" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" unitRef="pure" id="ixv-27133">30</ix:nonFraction> consecutive&#160;trading day period ending on, and including, the&#160;trading day immediately preceding the date on which the Company provides notice of redemption, at a redemption price equal to <ix:nonFraction contextRef="c215" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" unitRef="pure" id="ixv-27134">100</ix:nonFraction>% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding the redemption date. No sinking fund is provided for the Convertible Notes.</p>
		</div></ix:continuation>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-26</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_3" id="_DebtDisclosureTextBlock-c0_cont_2"><p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-left:42pt;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Limited investor put rights: </span>Holders of the Convertible Notes have the right to require the Company to repurchase for cash all or a portion of their notes at <ix:nonFraction contextRef="c219" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" unitRef="pure" id="ixv-27135">100</ix:nonFraction>% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of certain change of control transactions or liquidation, dissolution or common stock delisting events.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:42pt;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Conversion rate increase in certain customary circumstances: </span>In certain circumstances, conversions in connection with a &#8220;make<span class="nobreak">-whole</span> fundamental change&#8221; (as defined in the indentures) or conversions of Convertible Notes called (or deemed called) for redemption may result in an increase to the conversion rate, provided that the conversion rate will not exceed <ix:nonFraction contextRef="c219" decimals="4" format="ixt:num-dot-decimal" name="wt:MaximumConversionRate" scale="0" unitRef="pure" id="ixv-27136">167.7853</ix:nonFraction><span class="nobreak"> </span>shares and <ix:nonFraction contextRef="c215" decimals="4" format="ixt:num-dot-decimal" name="wt:MaximumConversionRate" scale="0" unitRef="pure" id="ixv-27137">144.9275</ix:nonFraction><span class="nobreak"> </span>shares of the Company&#8217;s common stock per $<ix:nonFraction contextRef="c218" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" unitRef="usdPershares" id="ixv-27138">1,000</ix:nonFraction> principal amount of the 2023 Notes and the 2021 Notes, respectively (the equivalent of <ix:nonFraction contextRef="c220" decimals="INF" format="ixt:num-dot-decimal" name="wt:MaximumNumberOfSharesIssuableUponConversion" scale="0" unitRef="shares" id="ixv-27139"><ix:nonFraction contextRef="c221" decimals="INF" format="ixt:num-dot-decimal" name="wt:MaximumNumberOfSharesIssuableUponConversion" scale="0" unitRef="shares" id="ixv-27140">43,551,214</ix:nonFraction></ix:nonFraction><span class="nobreak"> </span>shares of the Company&#8217;s common stock), subject to adjustment.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:42pt;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Seniority and Security: </span>The 2023 Notes and 2021 Notes rank equal in right of payment, and are the Company&#8217;s senior unsecured obligations, but are subordinated in right of payment to the Company&#8217;s obligations to make certain redemption payments (if and when due) in respect of its Series&#160;A Non<span class="nobreak">-Voting</span> Convertible Preferred Stock (Note&#160;11).</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The indentures contain customary terms and covenants, including that upon certain events of default occurring and continuing, either the Trustee or the respective holders of not less than <ix:nonFraction contextRef="c214" decimals="2" format="ixt:num-dot-decimal" name="wt:MinimumPercentageOfLendersRequiredToHaveEntirePrincipalAmountOfConvertibleNotesRepurchasedByTheCompanyUponCertainEventsOfDefault" scale="-2" unitRef="pure" id="ixv-27141">25</ix:nonFraction>% in aggregate principal amount of the respective series of Convertible Notes outstanding may declare the entire principal amount of all such respective Convertible Notes to be repurchased, plus any accrued special interest, if any, to be immediately due and payable.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="_ConvertibleDebtTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ConvertibleDebtTableTextBlock" id="ixv-27142">The following table provides a summary of the Convertible Notes at December&#160;31, 2023 and December&#160;31, 2022:</ix:nonNumeric></p>
		<ix:continuation continuedAt="_ConvertibleDebtTableTextBlock-c0_cont_2" id="_ConvertibleDebtTableTextBlock-c0_cont_1"><table class="Table90-" style="width: 90.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0.33in 0pt 0.33in;">


				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TCH CellOverride-1 _idGenCellOverride-2" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 39.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, 2023</span></p>
					</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 40.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, 2022</span></p>
					</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TCH CellOverride-1" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 12.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023 Notes</span></p>
					</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 12.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021 Notes</span></p>
					</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 12.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Total</span></p>
					</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 12.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021 Notes</span></p>
					</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 12.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2020 Notes</span></p>
					</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 13.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Total</span></p>
					</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1 _idGenCellOverride-3" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Principal amount</span></p>
					</td>
					<td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c226" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-27143">130,000</ix:nonFraction></span></p>	</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c227" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-27144">150,000</ix:nonFraction></span></p>	</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c230" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-27145">280,000</ix:nonFraction></span></p>	</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-27146">150,000</ix:nonFraction></span></p>	</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c232" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-27147">175,000</ix:nonFraction></span></p>	</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c233" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" unitRef="usd" id="ixv-27148">325,000</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Plus: Premium</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-205; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-206; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-207; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-208; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c232" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedPremium" scale="3" unitRef="usd" id="ixv-27149">250</ix:nonFraction></span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c233" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedPremium" scale="3" unitRef="usd" id="ixv-27150">250</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Gross proceeds</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c226" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" unitRef="usd" id="ixv-27151">130,000</ix:nonFraction></span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c227" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" unitRef="usd" id="ixv-27152">150,000</ix:nonFraction></span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c230" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" unitRef="usd" id="ixv-27153">280,000</ix:nonFraction></span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" unitRef="usd" id="ixv-27154">150,000</ix:nonFraction></span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c232" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" unitRef="usd" id="ixv-27155">175,250</ix:nonFraction></span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c233" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" unitRef="usd" id="ixv-27156">325,250</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Less: Unamortized issuance costs</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(<ix:nonFraction contextRef="c226" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" unitRef="usd" id="ixv-27157">2,987</ix:nonFraction>)</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(<ix:nonFraction contextRef="c227" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" unitRef="usd" id="ixv-27158">2,125</ix:nonFraction>)</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(<ix:nonFraction contextRef="c230" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" unitRef="usd" id="ixv-27159">5,112</ix:nonFraction>)</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(<ix:nonFraction contextRef="c231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" unitRef="usd" id="ixv-27160">2,981</ix:nonFraction>)</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(<ix:nonFraction contextRef="c232" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" unitRef="usd" id="ixv-27161">1,053</ix:nonFraction>)</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(<ix:nonFraction contextRef="c233" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" unitRef="usd" id="ixv-27162">4,034</ix:nonFraction>)</span></p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Carrying amount</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c226" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="3" unitRef="usd" id="ixv-27163">127,013</ix:nonFraction></span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c227" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="3" unitRef="usd" id="ixv-27164">147,875</ix:nonFraction></span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c230" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="3" unitRef="usd" id="ixv-27165">274,888</ix:nonFraction></span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c231" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="3" unitRef="usd" id="ixv-27166">147,019</ix:nonFraction></span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c232" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="3" unitRef="usd" id="ixv-27167">174,197</ix:nonFraction></span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c233" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermDebt" scale="3" unitRef="usd" id="ixv-27168">321,216</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-15" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"><span class="CharOverride-8" style="font-size:9pt;">Effective interest rate</span><span class="Superscript" style="vertical-align:super;font-size:6pt;">(</span><span class="CharOverride-5" style="font-size:6pt;vertical-align:super;">1)</span></p>
					</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-16" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c226" decimals="4" format="ixt:num-dot-decimal" id="ix_14_fact" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" unitRef="pure">6.25</ix:nonFraction>%</span></p>	</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-16" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c227" decimals="4" format="ixt:num-dot-decimal" id="ix_15_fact" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" unitRef="pure">3.83</ix:nonFraction>%</span></p>	</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-16" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c230" decimals="4" format="ixt:num-dot-decimal" id="ix_16_fact" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" unitRef="pure">4.96</ix:nonFraction>%</span></p>	</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-16" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c231" decimals="4" format="ixt:num-dot-decimal" id="ix_17_fact" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" unitRef="pure">3.83</ix:nonFraction>%</span></p>	</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-16" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c232" decimals="4" format="ixt:num-dot-decimal" id="ix_18_fact" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" unitRef="pure">5.26</ix:nonFraction>%</span></p>	</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-16" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c233" decimals="4" format="ixt:num-dot-decimal" id="ix_19_fact" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" unitRef="pure">4.60</ix:nonFraction>%</span></p>	</td>
				</tr>

		</table></ix:continuation></ix:continuation>
		<div style="border: none; border-top: windowtext 0pt none; border-top-style: solid; padding: 0in 0in 2.0pt 0in;"><p class="Tablefootnotef" style="margin-top: 0in;  border: none; margin-right: 0in; margin-bottom: -5pt; margin-left: 24.0pt; text-align: justify; text-justify: inter-ideograph; text-indent: -24.0pt; padding: 0in; font-size: 9.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">____________</p><ix:continuation continuedAt="_DebtDisclosureTextBlock-c0_cont_4" id="_DebtDisclosureTextBlock-c0_cont_3"><ix:continuation id="_ConvertibleDebtTableTextBlock-c0_cont_2"><p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;">&#8203;<span class="CharOverride-5" style="font-size:6pt;vertical-align:super;">(1)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><ix:footnote id="ix_8_footnote" xml:lang="en-US">Includes amortization of the issuance costs and premium.</ix:footnote></p></ix:continuation></ix:continuation></div>
		<ix:continuation id="_DebtDisclosureTextBlock-c0_cont_4"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"> Interest expense on the Convertible Notes during the&#160;years ended December&#160;31, 2023, 2022 and 2021 was $<ix:nonFraction contextRef="c216" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" unitRef="usd" id="ixv-27176">14,945</ix:nonFraction>, $<ix:nonFraction contextRef="c222" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" unitRef="usd" id="ixv-27177">14,935</ix:nonFraction> and $<ix:nonFraction contextRef="c223" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestExpense" scale="3" unitRef="usd" id="ixv-27178">12,332</ix:nonFraction>, respectively. Interest payable of $<ix:nonFraction contextRef="c224" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPayableCurrentAndNoncurrent" scale="3" unitRef="usd" id="ixv-27179">3,041</ix:nonFraction> and $<ix:nonFraction contextRef="c225" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestPayableCurrentAndNoncurrent" scale="3" unitRef="usd" id="ixv-27180">621</ix:nonFraction> at December&#160;31, 2023 and 2022, respectively, is included in accounts payable and other liabilities on the Consolidated Balance Sheets.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The fair value of the Convertible Notes (classified as Level 2 in the fair value hierarchy) was $<ix:nonFraction contextRef="c153" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="3" unitRef="usd" id="ixv-27181">281,897</ix:nonFraction> and $<ix:nonFraction contextRef="c154" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DebtInstrumentFairValue" scale="3" unitRef="usd" id="ixv-27182">320,513</ix:nonFraction> at December&#160;31, 2023 and 2022, respectively. The if<span class="nobreak">-converted</span> value of the Convertible Notes did not exceed the principal amount at December&#160;31, 2023 and 2022.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="_PreferredStockTextBlock-c0_cont_1" escape="true" name="us-gaap:PreferredStockTextBlock" id="ixv-21744"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">11. Series&#160;A Preferred Stock</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On April&#160;10, 2018, the Company filed a Certificate of Designations of Series&#160;A Non<span class="nobreak">-Voting</span> Convertible Preferred Stock with the Secretary of State of the State of Delaware establishing the rights, preferences, privileges, qualifications, restrictions, and limitations relating to the Series&#160;A Preferred Stock (defined below). The Series&#160;A Preferred Stock is intended to provide ETFS Capital with economic rights equivalent to the Company&#8217;s common stock on an as<span class="nobreak">-converted</span> basis. The Series&#160;A Preferred Stock has no voting rights, are not transferable and have the same priority with regard to dividends, distributions and payments as the common stock.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">As described in the Certificate of Designations, the Company will not issue, and ETFS Capital does not have the right to require the Company to issue, any shares of common stock upon conversion of the Series&#160;A Preferred Stock, if, as a result of such conversion, ETFS Capital (together with certain attribution parties) would beneficially own more than <ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="wt:OutstandingCommonStockPercentage" scale="-2" unitRef="pure" id="ixv-27183">9.99</ix:nonFraction>% of the Company&#8217;s outstanding common stock immediately after giving effect to such conversion.</p></ix:nonNumeric>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-27</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<ix:continuation id="_PreferredStockTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In connection with the completion of the ETFS Acquisition, the Company issued <ix:nonFraction contextRef="c234" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="0" unitRef="shares" id="ixv-27184">14,750</ix:nonFraction><span class="nobreak"> </span>shares of Series&#160;A Non<span class="nobreak">-Voting</span> Convertible Preferred Stock (the &#8220;Series&#160;A Preferred Stock&#8221;), which are convertible into an aggregate of <ix:nonFraction contextRef="c235" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" scale="0" unitRef="shares" id="ixv-27185">14,750,000</ix:nonFraction><span class="nobreak"> </span>shares of common stock. The fair value of this consideration was $<ix:nonFraction contextRef="c236" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="3" unitRef="usd" id="ixv-27186">132,750</ix:nonFraction>, based on the closing price of the Company&#8217;s common stock on April&#160;10, 2018 of $<ix:nonFraction contextRef="c237" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionSharePrice" scale="0" unitRef="usdPershares" id="ixv-27187">9.00</ix:nonFraction> per share, the&#160;trading day prior to the closing of the acquisition.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfPreferredUnitsTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfPreferredUnitsTextBlock" id="ixv-27188">The following is a summary of the Series&#160;A Preferred Stock balance:</ix:nonNumeric></p>
		<ix:continuation id="_ScheduleOfPreferredUnitsTextBlock-c0_cont_1"><table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;">


				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.60%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31,<br/>2023</span></p>
					</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 19.20%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31,<br/>2022</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Issuance of Series&#160;A Preferred Stock</p>
					</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c240" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" unitRef="usd" id="ixv-27189">132,750</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c241" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" unitRef="usd" id="ixv-27190">132,750</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Less: Issuance costs</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c240" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" unitRef="usd" id="ixv-27191">181</ix:nonFraction>)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c241" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" unitRef="usd" id="ixv-27192">181</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Series&#160;A Preferred Stock&#8212;carrying value</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c238" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockValue" scale="3" unitRef="usd" id="ixv-27193">132,569</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c239" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockValue" scale="3" unitRef="usd" id="ixv-27194">132,569</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Cash dividends declared per share (quarterly)</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c240" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockDividendsPerShareDeclared" scale="0" unitRef="usdPershares" id="ixv-27195">0.03</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c241" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockDividendsPerShareDeclared" scale="0" unitRef="usdPershares" id="ixv-27196">0.03</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation>

		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:6pt;">Temporary equity classification is required for redeemable instruments for which redemption triggers are outside of the issuer&#8217;s control. ETFS Capital has the right to redeem all the Series&#160;A Preferred Stock specified to be converted during the period of time specified in the Certificate of Designations in the event that: (a)&#160;the number of shares of the Company&#8217;s common stock authorized by its certificate of incorporation is insufficient to permit the Company to convert all of the Series&#160;A Preferred Stock requested by ETFS Capital to be converted; or (b)&#160;ETFS Capital does not, upon completion of a change of control of the Company, receive the same amount per share of Series&#160;A Preferred Stock as it would have received had each outstanding share of Series&#160;A Preferred Stock been converted into common stock immediately prior to the change of control. However, the Company will not be obligated to make any such redemption payments to the extent such payments would be a breach of any covenant or obligation the Company owes to any of its secured creditors or is otherwise prohibited by applicable law.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Any such redemption will be at a price per Preferred Share equal to the dollar volume<span class="nobreak">-weighted</span> average price for a share of common stock for the 30<span class="nobreak">-trading</span>&#160;day period ending on the date of such attempted conversion or change of control, as applicable, multiplied by 1,000. Such redemption payment will be made in one payment no later than 10&#160;business days following the last&#160;day of the Company&#8217;s first fiscal quarter that begins on a date following the date ETFS Capital exercises such redemption right. The redemption value of the Series&#160;A Preferred Stock was $<ix:nonFraction contextRef="c238" decimals="-3" format="ixt:num-dot-decimal" name="wt:PreferredStockRedemptionValue" scale="3" unitRef="usd" id="ixv-27197">96,869</ix:nonFraction> and $<ix:nonFraction contextRef="c239" decimals="-3" format="ixt:num-dot-decimal" name="wt:PreferredStockRedemptionValue" scale="3" unitRef="usd" id="ixv-27198">77,969</ix:nonFraction> at December&#160;31, 2023 and 2022, respectively.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:12pt;">The carrying amount of the Series&#160;A Preferred Stock was not adjusted as it was not probable that such shares would become redeemable.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" escape="true" name="wt:OtherPayablesTextBlock" id="ixv-21832"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">12. Payable to Gold Bullion Holdings (Jersey) Limited (&#8220;GBH&#8221;)</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On November&#160;20, 2023, the Company repurchased its Series&#160;C Preferred Stock which was convertible into <ix:nonFraction contextRef="c242" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockConvertibleSharesIssuable" scale="0" unitRef="shares" id="ixv-27199">13,087,000</ix:nonFraction><span class="nobreak"> </span>shares of the Company&#8217;s common stock, from GBH, a subsidiary of WGC, for aggregate cash consideration of approximately $<ix:nonFraction contextRef="c243" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AssetAcquisitionConsiderationTransferred" scale="3" unitRef="usd" id="ixv-27200">84,411</ix:nonFraction>. Under the terms of the transaction, the Company paid GBH $<ix:nonFraction contextRef="c244" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="3" unitRef="usd" id="ixv-27201">40,000</ix:nonFraction> on the closing date, with the remainder of the purchase price payable in equal, interest<span class="nobreak">-free</span> installments on the first, second and third anniversaries of the closing date. The implied price per share was $<ix:nonFraction contextRef="c243" decimals="2" format="ixt:num-dot-decimal" name="wt:RepurchasePricePerShareInterestRateTransaction" scale="0" unitRef="usdPershares" id="ixv-27202">6.02</ix:nonFraction> when considering the interest<span class="nobreak">-free</span> financing element of the transaction. The investor rights agreement that the Company and GBH entered into in May&#160;2023 in connection with the issuance of the Series&#160;C Preferred Stock, which provided GBH with certain rights and obligations with respect to the shares, including registration rights, was terminated in this transaction.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Under U.S.&#160;GAAP, the obligation was recorded at its present value utilizing a market rate of interest on the closing date of <ix:nonFraction contextRef="c0" decimals="3" format="ixt:num-dot-decimal" name="wt:PresentValueOfMarketRateInterest" scale="-2" unitRef="pure" id="ixv-27203">7.0</ix:nonFraction>% and the corresponding discount is being amortized as interest expense pursuant to the effective interest method of accounting over the life of the obligation. <ix:nonNumeric contextRef="c0" continuedAt="wt_ScheduleOfAggregateConsiderationPayableTableTextBlock-c0_cont_1" escape="true" name="wt:ScheduleOfAggregateConsiderationPayableTableTextBlock" id="ixv-27204">The aggregate consideration payable was valued at $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:AggregateConsiderationPayable" scale="3" unitRef="usd" id="ixv-27205">38,835</ix:nonFraction> on the closing date and the carrying value of this obligation is as follows:</ix:nonNumeric></p>
		<ix:continuation id="wt_ScheduleOfAggregateConsiderationPayableTableTextBlock-c0_cont_1"><table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1" style="width: 76.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 21.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2023</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 76.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Current:</p>
					</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 19.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesPayableCurrent" scale="3" unitRef="usd" id="ixv-27206">14,804</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 76.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Long-term</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 19.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LongTermNotesPayable" scale="3" unitRef="usd" id="ixv-27207">24,328</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 76.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 19.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NotesPayable" scale="3" unitRef="usd" id="ixv-27208">39,132</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Interest expense recognized during the year ended December&#160;31, 2023 was $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InterestAndDebtExpense" scale="3" unitRef="usd" id="ixv-27209">297</ix:nonFraction> and is included as a component of total interest expense recognized on the Statements of Operations.</p></ix:nonNumeric>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-28</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<ix:nonNumeric contextRef="c0" continuedAt="_LesseeOperatingLeasesTextBlock-c0_cont_1" escape="true" name="us-gaap:LesseeOperatingLeasesTextBlock" id="ixv-21877"><div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">13. Leases</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;">The Company has entered into operating leases for its corporate headquarters office facilities, financial data terminals and equipment. The Company has no finance leases.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="_LeaseCostTableTextBlock-c0_cont_1" escape="true" name="us-gaap:LeaseCostTableTextBlock" id="ixv-27210">The following table provides additional information regarding the Company&#8217;s leases:</ix:nonNumeric></p>
		<ix:continuation id="_LeaseCostTableTextBlock-c0_cont_1"><table class="Table85-" style="width: 85.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 10% 0pt 0.33in;">


				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TCH CellOverride-1 _idGenCellOverride-2" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" colspan="5" style="width: 35.64%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended<br/>December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TCH CellOverride-1 _idGenCellOverride-2" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.34%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.82%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
				</tr>
				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TCH CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Lease cost:</p>
					</td>
					<td class="Table85- TCH CellOverride-5" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TCH CellOverride-2" colspan="2" style="width: 16.34%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table85- TCH CellOverride-5" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TCH CellOverride-2" colspan="2" style="width: 17.82%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table85-" style="background: #CCEEFF;height:12pt;">
					<td class="Table85- TB CellOverride-1 _idGenCellOverride-3" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Operating lease cost</p>
					</td>
					<td class="Table85- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="3" unitRef="usd" id="ixv-27211">1,285</ix:nonFraction></p>	</td>
					<td class="Table85- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseCost" scale="3" unitRef="usd" id="ixv-27212">963</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Short-term lease cost</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShortTermLeaseCost" scale="3" unitRef="usd" id="ixv-27213">191</ix:nonFraction></p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShortTermLeaseCost" scale="3" unitRef="usd" id="ixv-27214">223</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table85-" style="background: #CCEEFF;height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total lease cost</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LeaseCost" scale="3" unitRef="usd" id="ixv-27215">1,476</ix:nonFraction></p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LeaseCost" scale="3" unitRef="usd" id="ixv-27216">1,186</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other information:</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table85-" style="background: #CCEEFF;height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Cash paid for amounts included in the measurement of operating liabilities (operating leases)</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="3" unitRef="usd" id="ixv-27217">1,284</ix:nonFraction></p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeasePayments" scale="3" unitRef="usd" id="ixv-27218">965</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Right-of-use assets obtained in exchange for new operating lease liabilities</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-211; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">n/a</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-212; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">n/a</p>
					</td>
				</tr>
				<tr class="Table85-" style="background: #CCEEFF;height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Weighted-average remaining lease term (in&#160;years)&#8212;operating leases</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonNumeric contextRef="c5" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="ixv-27219">0.4</ix:nonNumeric></p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonNumeric contextRef="c6" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="ixv-27220">1.2</ix:nonNumeric></p>	</td>
				</tr>
				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Weighted-average discount rate&#8212;operating leases</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" unitRef="pure" id="ixv-27221">5.9</ix:nonFraction>%</p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" unitRef="pure" id="ixv-27222">6.4</ix:nonFraction>%</p>	</td>
				</tr>

		</table></ix:continuation>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;">None of the Company&#8217;s leases include variable payments, residual value guarantees or any restrictions or covenants relating to the Company&#8217;s ability to pay dividends or incur additional financing obligations.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On September&#160;9, 2021, the Company entered into a Surrender Agreement to terminate the lease for its principal executive office at 245 Park Avenue, New&#160;York, New&#160;York effective immediately. In consideration for the landlord&#8217;s agreement to enter into the Surrender Agreement and accelerate the expiration date of the term of the lease from August&#160;31, 2029, the Company paid a termination fee of $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:PaymentOfLeaseTerminationFee" scale="3" unitRef="usd" id="ixv-27223">12,725</ix:nonFraction>. As a result, the Company recognized a loss on the termination of a lease of $<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnContractTermination" scale="3" unitRef="usd" id="ixv-27224">9,277</ix:nonFraction> during the year ended December&#160;31, 2021, which was inclusive of the write<span class="nobreak">-off</span> of the right<span class="nobreak">-of-use</span> asset, broker fees and a reduction in operating lease liabilities. This loss is included in impairments in the Company&#8217;s Consolidated Statements of Operations (Note&#160;26).</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Additionally, the Company recognized an impairment loss of $<ix:nonFraction contextRef="c245" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseImpairmentLoss" scale="3" unitRef="usd" id="ixv-27225">303</ix:nonFraction> resulting from the derecognition of a right<span class="nobreak">-of-use</span> asset upon exiting its London office in February&#160;2021, as well as costs incurred to restore the office space to its original condition.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company&#8217;s leases also included extension, automatic renewal and termination provisions. These provisions were also not reasonably certain of being exercised and were therefore not recognized as part of the right<span class="nobreak">-of-use</span> asset and lease liability.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="_LesseeOperatingLeaseLiabilityMaturityTableTextBlock-c0_cont_1" escape="true" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="ixv-27226">The following table discloses future minimum lease payments at December&#160;31, 2023 with respect to the Company&#8217;s operating lease liabilities:</ix:nonNumeric></p>
		<ix:continuation id="_LesseeOperatingLeaseLiabilityMaturityTableTextBlock-c0_cont_1"><table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2024</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" unitRef="usd" id="ixv-27227">584</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2025</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-213; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2026</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-214; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2027</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-215; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2028</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-216; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2029 and thereafter</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-217; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total future minimum lease payments (undiscounted)</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" unitRef="usd" id="ixv-27228">584</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation>
		</div></ix:nonNumeric>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-29</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<ix:continuation id="_LesseeOperatingLeasesTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="wt_ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock-c0_cont_1" escape="true" name="wt:ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock" id="ixv-27229">The following table reconciles the future minimum lease payments (disclosed above) at December&#160;31, 2023 to the operating lease liabilities recognized in the Company&#8217;s Consolidated Balance Sheets:</ix:nonNumeric></p>
		<ix:continuation id="wt_ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock-c0_cont_1"><table class="Table60-" style="width: 60%; border-collapse: collapse; border: #000 0pt solid; border-width: 0pt; margin: 6pt 30% 0pt 0.33in">


				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1" colspan="4" style="border-width: 0pt; vertical-align: bottom; padding: 0in 0in 3px"><p class="Tbody" style="border-width: 0; font: normal 10pt Times New Roman PS Std, serif; margin: 0; padding: 0; margin-bottom: 0; margin-left: 10pt; margin-right: 0; margin-top: 0; orphans: 1; page-break-after: auto; page-break-before: auto; text-align: left; text-indent: -10pt; widows: 1">Amounts recognized in the Company&#8217;s Consolidated Balance Sheets</p>

</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 74%; padding: 0in 0in 3px; border-width: 0pt; vertical-align: bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Lease liability&#8212;short term</p>
					</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 2%; padding: 0in 0in 3px; border-width: 0pt; vertical-align: bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.67%; padding: 0in 0in 3px; border-width: 0pt; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 21.33%; padding: 0in 0in 3px; border-width: 0pt; vertical-align: bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" unitRef="usd" id="ixv-27230">578</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Lease liability&#8212;long term</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-218; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Subtotal</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLeaseLiability" scale="3" unitRef="usd" id="ixv-27231">578</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Difference between undiscounted and discounted cash flows</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" unitRef="usd" id="ixv-27232">6</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total future minimum lease payments (undiscounted)</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" unitRef="usd" id="ixv-27233">584</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation></ix:continuation>

		<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:LossContingencyDisclosures" id="ixv-22129"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">14. Contingencies</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company may be subject to reviews, inspections and investigations by regulatory authorities as well as legal proceedings arising in the ordinary course of business.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Closure of the WisdomTree WTI Crude Oil 3x Daily Leveraged ETP</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In December&#160;2020, WMAI, WTMAML, WTUK and WisdomTree Ireland Limited (&#8220;WT Ireland&#8221;) were served with a writ of summons to appear before the Court of Milan, Italy. In January&#160;2021, WTUK was served with a writ of summons to appear before the Court of Udine, Italy. Investors had filed actions seeking damages resulting from the closure of the WisdomTree WTI Crude Oil 3x Daily Leveraged ETP (&#8220;3OIL&#8221;) in March&#160;2020. The product was dependent on the receipt of payments from a swap provider to satisfy payment obligations to the investors. Due to an extreme adverse move in oil futures relative to the oil futures&#8217; closing price, the swap contract underlying 3OIL was terminated by the swap provider, which resulted in the compulsory redemption of 3OIL, all in accordance with the prospectus.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In February&#160;2022, the Court of Udine ruled in the Company&#8217;s favor. Also in February&#160;2022, WMAI, WTMAML, WTUK and WT Ireland were served with another writ of summons to appear before the Court of Milan by additional investors seeking damages resulting from the closure of 3OIL.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In March&#160;2022, WMAI and WTUK were served with a writ of summons to appear before the Court of Turin and two writs of summons to appear before the Court of Milan by additional investors seeking damages. These writs also were served on the intermediary brokers for the respective claimants, with the claimants alleging joint and several liability of WMAI, WTUK and such intermediary brokers. In July&#160;2023, the Court of Milan ruled in favor of WMAI and WTUK in respect of one of these claims.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Total damages sought by all investors related to these claims are approximately &#8364;<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyDamagesSoughtValue" scale="3" unitRef="eur" id="ixv-27234">15,200</ix:nonFraction> ($<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyDamagesSoughtValue" scale="3" unitRef="usd" id="ixv-27235">16,778</ix:nonFraction>) at December&#160;31, 2023.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Additionally, in July&#160;2023, WT Ireland received a letter from counsel on behalf of additional investors seeking damages of up to approximately &#8364;<ix:nonFraction contextRef="c246" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyDamagesSoughtValue" scale="3" unitRef="eur" id="ixv-27236">8,400</ix:nonFraction> ($<ix:nonFraction contextRef="c246" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:LossContingencyDamagesSoughtValue" scale="3" unitRef="usd" id="ixv-27237">9,272</ix:nonFraction>) resulting from the closure of 3OIL.&#160;The claim is in its preliminary stages and a writ of summons has not been served.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:12pt;">The Company is currently assessing these claims with its external counsel. The Company expects that losses, if any, arising from these claims will be covered under its insurance policies, less a $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="wt:LossContingencyCoveredByInsuranceDeductible" scale="3" unitRef="usd" id="ixv-27238">500</ix:nonFraction> deductible. An accrual has not been made with respect to these matters at December&#160;31, 2023 and 2022.</p></ix:nonNumeric>
		<ix:nonNumeric contextRef="c0" continuedAt="_VariableInterestEntityDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:VariableInterestEntityDisclosureTextBlock" id="ixv-22141"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">15. Variable Interest Entities</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:6pt;">VIEs are entities with any of the following characteristics: (i)&#160;the entity does not have enough equity to finance its activities without additional financial support; (ii)&#160;the equity holders, as a group, lack the characteristics of a controlling financial interest; or (iii)&#160;the entity is structured with non<span class="nobreak">-substantive</span> voting rights.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;">Consolidation of a VIE is required for the party deemed to be the primary beneficiary, if any. The primary beneficiary is the party who has both (a)&#160;the power to direct the activities of a VIE that most significantly impact the entity&#8217;s economic performance and (b)&#160;an obligation to absorb losses of the entity or a right to receive benefits from the entity that could potentially be significant to the entity. The Company is not the primary beneficiary of any entities in which it has a variable interest as it does not have the power to direct the activities that most significantly impact the entities&#8217; economic performance. Such power is conveyed through the entities&#8217; boards of directors and the Company does not have control over the boards.</p></ix:nonNumeric>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-30</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<ix:continuation id="_VariableInterestEntityDisclosureTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfVariableInterestEntitiesTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfVariableInterestEntitiesTextBlock" id="ixv-22153">The following table presents information about the Company&#8217;s variable interests in non<span class="nobreak">-consolidated</span> VIEs:</ix:nonNumeric></p>
		<ix:continuation id="_ScheduleOfVariableInterestEntitiesTextBlock-c0_cont_1"><table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;">


				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1 _idGenCellOverride-2" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.02%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2023</span></p>
					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2022</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Carrying Amount&#8212;Assets (Securrency):</p>
					</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 16.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;">Preferred stock&#8212;Series&#160;A Shares</p>
					</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-219; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c248" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" unitRef="usd" id="ixv-27239">8,488</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;">Preferred stock&#8212;Series&#160;B Shares</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-220; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c250" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" unitRef="usd" id="ixv-27240">5,500</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;">Convertible note</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-221; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c252" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" unitRef="usd" id="ixv-27241">14,500</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Subtotal&#8212;Securrency</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-222; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c254" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" unitRef="usd" id="ixv-27242">28,488</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Carrying Amount&#8212;Assets (Fnality):</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;">Convertible note</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-223; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c256" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" unitRef="usd" id="ixv-27243">6,921</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;">Series&#160;B-1 Preference Shares</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c257" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" unitRef="usd" id="ixv-27244">9,684</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-224; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Subtotal&#8212;Fnality</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c259" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" unitRef="usd" id="ixv-27245">9,684</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c260" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" unitRef="usd" id="ixv-27246">6,921</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Carrying Amount&#8212;Assets (Other investments):</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-225; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c262" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" unitRef="usd" id="ixv-27247">312</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total (Note&#160;7)</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" unitRef="usd" id="ixv-27248">9,684</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" unitRef="usd" id="ixv-27249">35,721</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-15" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Maximum exposure to loss</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><ix:nonFraction contextRef="c263" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" unitRef="usd" id="ixv-27250">9,684</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><ix:nonFraction contextRef="c264" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" unitRef="usd" id="ixv-27251">35,721</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation></ix:continuation>

		<ix:nonNumeric contextRef="c0" continuedAt="_RevenueFromContractWithCustomerTextBlock-c0_cont_1" escape="true" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="ixv-22317"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">16. Revenues from Contracts with Customers</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="wt_SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock-c0_cont_1" escape="true" name="wt:SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock" id="ixv-27252">The following table presents the Company&#8217;s total revenues from contracts with customers:</ix:nonNumeric></p>
		<ix:continuation id="wt_SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock-c0_cont_1"><table class="Table80-" style="width: 80.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 15% 0pt 0.33in;">


				<tr class="Table80-" style="height:12pt;">
					<td class="Table80- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table80-" style="height:12pt;">
					<td class="Table80- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table80-" style="height:12pt;">
					<td class="Table80- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Revenues from contracts with customers:</p>
					</td>
					<td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table80-" style="background: #CCEEFF;height:12pt;">
					<td class="Table80- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Advisory fees</p>
					</td>
					<td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c13" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27253">333,227</ix:nonFraction></p>	</td>
					<td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c14" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27254">293,632</ix:nonFraction></p>	</td>
					<td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c15" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27255">298,052</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table80-" style="height:12pt;">
					<td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c16" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27256">15,808</ix:nonFraction></p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c17" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27257">7,713</ix:nonFraction></p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c18" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27258">6,266</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table80-" style="background: #CCEEFF;height:12pt;">
					<td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total operating revenues</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27259">349,035</ix:nonFraction></p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27260">301,345</ix:nonFraction></p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27261">304,318</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:6pt;">The Company recognizes revenues from contracts with customers when the performance obligation is satisfied, which is when the promised services are transferred to the customer. A service is considered to be transferred when the customer obtains control, which is represented by the transfer of rights with regard to the service. Transfer of control happens either over time or at a point in time. When a performance obligation is satisfied over time, an entity is required to select a single method of measuring progress for each performance obligation that depicts the entity&#8217;s performance in transferring control of services to the customer.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Substantially all the Company&#8217;s revenues from contracts with customers are derived primarily from investment advisory agreements with related parties (Note&#160;17). These advisory fees are recognized over time, are earned from the Company&#8217;s ETPs and are calculated based on a percentage of the ETPs&#8217; average daily net assets. There is no significant judgment in calculating amounts due which are invoiced monthly in arrears and are not subject to any potential reversal. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">There are no contract assets or liabilities that arise in connection with the recognition of advisory fee revenue. In addition, there are no costs incurred to obtain or fulfill the contracts with customers, all of which are investment advisory agreements with related parties.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;">Other income includes revenues the Company earns from swap providers associated with certain of the Company&#8217;s European listed ETPs, the nature of which are either based on a percentage of the ETPs&#8217; average daily net assets or flows associated with certain products. There is no significant judgment in calculating amounts due, which are invoiced monthly or quarterly in arrears and are not subject to any potential reversal. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice.</p></ix:nonNumeric>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-31</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<ix:continuation id="_RevenueFromContractWithCustomerTextBlock-c0_cont_1"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Geographic Distribution of Revenues</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="_RevenueFromExternalCustomersByGeographicAreasTableTextBlock-c0_cont_1" escape="true" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="ixv-27262">The following table presents the Company&#8217;s total revenues geographically as determined by where the respective management companies reside:</ix:nonNumeric></p>
		<ix:continuation id="_RevenueFromExternalCustomersByGeographicAreasTableTextBlock-c0_cont_1"><table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;">


				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1 _idGenCellOverride-2" rowspan="2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" rowspan="2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Revenues from contracts with customers:</p>
					</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">United&#160;States</p>
					</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c265" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27263">220,117</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c266" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27264">184,036</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c267" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27265">179,016</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Jersey</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c268" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27266">113,325</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c269" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27267">103,692</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c270" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27268">114,623</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Ireland</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c271" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27269">15,593</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c272" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27270">13,617</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c273" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27271">10,679</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total operating revenues</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27272">349,035</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27273">301,345</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27274">304,318</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation></ix:continuation>

		<ix:nonNumeric contextRef="c0" continuedAt="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="ixv-22519"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">17. Related Party Transactions</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Investment Advisory Agreements</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company&#8217;s revenues are derived primarily from investment advisory agreements with related parties. Under these agreements, the Company has licensed to related parties the use of certain of its own indexes for the U.S.&#160;WisdomTree ETFs, WisdomTree Digital Funds and WisdomTree UCITS ETFs. The relevant board of trustees or board of directors (including certain officers of the Company) of each of the related parties is primarily responsible for overseeing the management and affairs of the entities for the benefit of their respective stakeholders and have contracted with the Company to provide for general management and administration services. The Company is also responsible for certain expenses of the related parties, including the cost of transfer agency, custody, fund administration and accounting, legal, audit, and other non<span class="nobreak">-distribution</span> services, excluding extraordinary expenses, taxes and certain other expenses, which are included in fund management and administration in the Consolidated Statements of Operations. In exchange, the Company receives fees based on a percentage of the ETPs&#8217; and the Digital Funds&#8217; average daily net assets. A majority of the independent members of the respective board of trustees or board of directors are required to initially and annually (after the first two&#160;years) approve the advisory agreements of the U.S.&#160;WisdomTree ETFs and the Digital Funds and these agreements may be terminated by such board of trustees or board of directors upon notice.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="wt_ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock-c0_cont_1" escape="true" name="wt:ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock" id="ixv-27275">The following table summarizes accounts receivable from related parties which are included as a component of accounts receivable in the Consolidated Balance Sheets:</ix:nonNumeric></p>
		<ix:continuation id="wt_ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock-c0_cont_1"><table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;">


				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1" rowspan="2" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" rowspan="2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="5" style="width: 38.40%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.60%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 19.20%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Receivable from WTT</p>
					</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c279" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNet" scale="3" unitRef="usd" id="ixv-27276">21,226</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c280" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNet" scale="3" unitRef="usd" id="ixv-27277">16,399</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Receivable from ManJer Issuers</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c281" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNet" scale="3" unitRef="usd" id="ixv-27278">4,411</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c282" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNet" scale="3" unitRef="usd" id="ixv-27279">4,485</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Receivable from WMAI and WTICAV</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c283" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNet" scale="3" unitRef="usd" id="ixv-27280">2,874</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c284" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNet" scale="3" unitRef="usd" id="ixv-27281">3,255</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c9" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNet" scale="3" unitRef="usd" id="ixv-27282">28,511</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c10" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:AccountsReceivableNet" scale="3" unitRef="usd" id="ixv-27283">24,139</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:6pt;">The allowance for credit losses on accounts receivable from related parties is insignificant when applying historical loss rates, adjusted for current conditions and supportable forecasts, to the amounts outstanding in the table above. Amounts outstanding are all invoiced in arrears, are less than 30&#160;days aged and are collected shortly after the applicable reporting period.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfRelatedPartyTransactionsTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock" id="ixv-27284">The following table summarizes revenues from advisory services provided to related parties:</ix:nonNumeric></p>
		<ix:continuation id="_ScheduleOfRelatedPartyTransactionsTableTextBlock-c0_cont_1"><table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;">


				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1" rowspan="2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" rowspan="2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table75- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table75- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Advisory services provided to WTT</p>
					</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c285" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27285">218,834</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c286" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27286">183,409</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c287" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27287">178,511</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Advisory services provided to ManJer Issuers</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c288" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27288">98,800</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c289" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27289">96,606</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c290" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27290">108,862</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Advisory services provided to WMAI and WTICAV</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c291" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27291">15,593</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c292" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27292">13,617</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c293" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27293">10,679</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c294" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27294">333,227</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c295" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27295">293,632</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c296" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Revenues" scale="3" unitRef="usd" id="ixv-27296">298,052</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation></ix:nonNumeric>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-32</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<ix:continuation id="_RelatedPartyTransactionsDisclosureTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;">Pursuant to a license agreement between WisdomTree, Inc. (&#8220;WTI&#8221;) and WML to provide indices for a number of the sub<span class="nobreak">-funds</span> of WTICAV, WTI earned revenue amounting to &#8364;<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherIncome" scale="0" unitRef="eur" id="ixv-27297">1,044</ix:nonFraction> ($<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherIncome" scale="3" sign="-" unitRef="usd" id="ixv-27298">1,128</ix:nonFraction>), &#8364;<ix:nonFraction contextRef="c19" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherIncome" scale="0" unitRef="eur" id="ixv-27299">642</ix:nonFraction> ($<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherIncome" scale="3" sign="-" unitRef="usd" id="ixv-27300">671</ix:nonFraction>) and &#8364;<ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:OtherIncome" scale="0" unitRef="eur" id="ixv-27301">612</ix:nonFraction> ($<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherIncome" scale="3" sign="-" unitRef="usd" id="ixv-27302">710</ix:nonFraction>) for the&#160;years ended December&#160;31, 2023, 2022 and 2021, respectively, which has been eliminated in consolidation. No other revenue was earned by WTI from providing indices for use in the European Union during 2023, 2022 or 2021.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Investments in WisdomTree Products</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company also has investments in certain WisdomTree products of approximately $<ix:nonFraction contextRef="c274" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Investments" scale="3" unitRef="usd" id="ixv-27303">52,566</ix:nonFraction> and $<ix:nonFraction contextRef="c275" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Investments" scale="3" unitRef="usd" id="ixv-27304">25,283</ix:nonFraction> at December&#160;31, 2023 and 2022, respectively. This includes $<ix:nonFraction contextRef="c276" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Investments" scale="3" unitRef="usd" id="ixv-27305">18,308</ix:nonFraction> and $<ix:nonFraction contextRef="c277" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Investments" scale="3" unitRef="usd" id="ixv-27306">1,765</ix:nonFraction>, respectively, of investments in certain consolidated affiliated Digital Funds advised by WT Digital Management, referred to herein as &#8220;other assets&#8211;seed capital.&#8221; Net unrealized and realized gains and losses related to trading WisdomTree products during the&#160;years ended December&#160;31, 2023, 2022 and 2021 were $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnInvestments" scale="3" unitRef="usd" id="ixv-27307">1,294</ix:nonFraction>, ($<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnInvestments" scale="3" sign="-" unitRef="usd" id="ixv-27308">107</ix:nonFraction>) and ($<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:GainLossOnInvestments" scale="3" sign="-" unitRef="usd" id="ixv-27309">451</ix:nonFraction>), respectively, which are recorded in other losses, net on the Consolidated Statements of Operations.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Deferred Consideration&#8212;Gold Payments &#8211; Termination</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On May&#160;10, 2023, the Company terminated its contractual gold payments obligation to ETFS Capital, which included the payment of $<ix:nonFraction contextRef="c278" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ContractualObligation" scale="3" unitRef="usd" id="ixv-27310">45,634</ix:nonFraction> to an entity controlled by GT, a stockholder of the Company. See Note&#160;9 for additional information.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_1" escape="true" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="ixv-22702"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">18. Stock-Based Awards</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On July&#160;15, 2022, the Company&#8217;s stockholders approved the 2022 Equity Plan under which the Company may issue up to <ix:nonFraction contextRef="c297" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" scale="0" unitRef="shares" id="ixv-27311">16,000,000</ix:nonFraction><span class="nobreak"> </span>shares of common stock (less one share for every share granted under the 2016 Equity Plan since March&#160;31, 2022 and inclusive of shares available under the 2016 Equity Plan as of March&#160;31, 2022) in the form of stock options and other stock<span class="nobreak">-based</span> awards.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company grants equity awards to employees and directors which include restricted stock awards (&#8220;RSAs&#8221;), restricted stock units (&#8220;RSUs&#8221;), performance<span class="nobreak">-based</span> restricted stock units (&#8220;PRSUs&#8221;) and stock options. Certain awards described below are subject to acceleration under certain conditions.</p>
		<table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">	<tr class="No-Table-Style _idGenTableRowColumn-49" style="height:12pt;">	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 18.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:24pt;">Stock options:</p>	</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 80.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Generally issued for terms of <ix:nonNumeric contextRef="c298" continuedAt="_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2-c298_cont_1" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="ixv-27312">ten</ix:nonNumeric>&#160;years and may vest after at least <ix:nonNumeric contextRef="c0" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="ixv-27313">one<ix:continuation id="_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2-c298_cont_1"> year</ix:continuation></ix:nonNumeric> of service and have an exercise price equal to the Company&#8217;s stock price on the grant date. The Company estimates the fair value of stock options (when granted) using the Black<span class="nobreak">-Scholes</span> option pricing model.</p>	</td>	</tr>	<tr class="No-Table-Style _idGenTableRowColumn-39" style="height:12pt;">	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 18.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:24pt;margin-top:8pt;">RSAs/RSUs:</p>	</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 80.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;">Awards are valued based on the Company&#8217;s stock price on grant date and generally vest ratably, on an annual basis, over three&#160;years.</p>	</td>	</tr>	<tr class="No-Table-Style _idGenTableRowColumn-50" style="height:12pt;">	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 18.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:24pt;margin-top:8pt;">PRSUs:</p>	</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 80.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;">These awards cliff vest three&#160;years from the grant date and contain a market condition whereby the number of PRSUs ultimately vesting is tied to how the Company&#8217;s total shareholder return (&#8220;TSR&#8221;) compares to a peer group of other publicly traded asset managers over the three<span class="nobreak">-year</span> period. A Monte Carlo simulation is used to value these awards.</p>	<ix:nonNumeric contextRef="c0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" id="ixv-22731"><p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;">The number of PRSUs vesting ranges from 0% to 200% of the target number of PRSUs granted, as follows:</p>	<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:18pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>If the relative TSR is below the 25<span class="Superscript" style="vertical-align:super;font-size:58%;">th</span> percentile, then 0% of the target number of PRSUs granted will vest;</p>	<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:18pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>If the relative TSR is at the 25<span class="CharOverride-6" style="font-size:58%;vertical-align:super;">th</span> percentile, then 50% of the target number of PRSUs granted will vest;</p>	<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:18pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>If the relative TSR is above the 25<span class="CharOverride-6" style="font-size:58%;vertical-align:super;">th</span> percentile, then linear scaling is applied such that the percent of the target number of PRSUs vesting is 100% at the 50<span class="CharOverride-6" style="font-size:58%;vertical-align:super;">th</span> percentile and capped at 200% of the target number of PRSUs granted for performance at the 85<span class="CharOverride-6" style="font-size:58%;vertical-align:super;">th</span> percentile; and</p>	<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:18pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>If the Company&#8217;s TSR is negative, the target number of PRSUs vesting is capped at 100% regardless of the relative TSR percentile.</p></ix:nonNumeric>	</td>	</tr>	</table></ix:nonNumeric>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-33</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_2" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">During the&#160;years ended December&#160;31, 2023, 2022 and 2021, total stock<span class="nobreak">-based</span> compensation expense was $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-27315">16,190</ix:nonFraction>, $<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-27316">10,385</ix:nonFraction> and $<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensation" scale="3" unitRef="usd" id="ixv-27317">9,998</ix:nonFraction>, respectively, and the related tax benefit recognized on the Consolidated Statements of Operations was $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="3" unitRef="usd" id="ixv-27318">3,919</ix:nonFraction>, $<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="3" unitRef="usd" id="ixv-27319">2,371</ix:nonFraction> and $<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="3" unitRef="usd" id="ixv-27320">2,327</ix:nonFraction>, respectively.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The actual tax benefit realized for the tax deductions for share<span class="nobreak">-based</span> compensation was $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-27321">1,820</ix:nonFraction>, $<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OtherTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-27322">1,548</ix:nonFraction> and $<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit" scale="3" unitRef="usd" id="ixv-27323">2,032</ix:nonFraction> during the&#160;years ended December&#160;31, 2023, 2022 and 2021, respectively.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="wt_ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock-c0_cont_1" escape="true" name="wt:ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock" id="ixv-22760">A summary of unrecognized stock<span class="nobreak">-based</span> compensation expense and average remaining vesting period is as follows:</ix:nonNumeric></p>
		<ix:continuation id="wt_ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock-c0_cont_1"><table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1" rowspan="2" style="width: 42.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" rowspan="2" style="width: 2.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" colspan="4" style="width: 55.60%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="CharOverride-7" style="font-style:normal;font-weight:bold;">December&#160;31, 2023</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 24.63%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="CharOverride-7" style="font-style:normal;font-weight:bold;">Unrecognized <br/>Stock-Based <br/>Compensation</span></p>
					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 2.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" style="width: 28.73%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="CharOverride-7" style="font-style:normal;font-weight:bold;">Weighted-Average <br/>Remaining <br/>Vesting Period <br/>(Years)</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 42.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Employees and directors</p>
					</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 2.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 21.64%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c305" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="3" unitRef="usd" id="ixv-27324">19,165</ix:nonFraction></p>	</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 2.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 28.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonNumeric contextRef="c306" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="ixv-27325">0.92</ix:nonNumeric></p>	</td>
				</tr>

		</table></ix:continuation>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Stock Options</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">There was <span style="-sec-ix-hidden: hidden-fact-235"><span style="-sec-ix-hidden: hidden-fact-236">no</span></span> option activity during the&#160;years ended December&#160;31, 2023 and 2022 and there were no options outstanding as of December&#160;31, 2023 and 2022. The total intrinsic value of options exercised during the year ended December&#160;31, 2021 was $<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="3" unitRef="usd" id="ixv-27326">51</ix:nonFraction>. Cash received from option exercises during the year ended December&#160;31, 2021 was $<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" unitRef="usd" id="ixv-27327">815</ix:nonFraction>.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">RSAs, RSUs and PRSUs</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The aggregate fair value of RSAs, RSUs and PRSUs that vested during the&#160;years ended December&#160;31, 2023, 2022 and 2021 was $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="3" unitRef="usd" id="ixv-27328">10,158</ix:nonFraction>, $<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="3" unitRef="usd" id="ixv-27329">9,466</ix:nonFraction> and $<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="3" unitRef="usd" id="ixv-27330">10,940</ix:nonFraction>, respectively. <ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="ixv-27331">A summary of activity is as follows:</ix:nonNumeric></p>
		<ix:continuation continuedAt="_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock-c0_cont_2" id="_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock-c0_cont_1"><table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-57" style="height:12pt;">
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="4" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 22.65%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">RSA</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="4" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 22.65%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">RSU</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="4" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 23.72%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">PRSU</span><span class="Bold-Superscript" style="font-style:normal;font-weight:bold;vertical-align:super;font-size:58%;">(1)</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-58" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Shares</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Weighted <br/>Average <br/>Grant Date <br/>Fair Value</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Shares</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Weighted <br/>Average <br/>Grant Date <br/>Fair Value</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Shares</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 11.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Weighted <br/>Average <br/>Grant Date <br/>Fair Value</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-59" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Unvested Balance at January&#160;1, 2021</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c307" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" unitRef="shares" id="ixv-27332">3,580,743</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c307" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-27333">5.38</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c308" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" unitRef="shares" id="ixv-27334">39,408</ix:nonFraction>&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c308" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-27335">4.46</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c309" decimals="INF" format="ixt:num-dot-decimal" id="ix_20_fact" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" unitRef="shares">341,312</ix:nonFraction>&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c309" decimals="2" format="ixt:num-dot-decimal" id="ix_21_fact" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares">5.17</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Granted</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c310" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" unitRef="shares" id="ixv-27338">1,642,266</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c310" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-27339">5.46</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c311" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" unitRef="shares" id="ixv-27340">31,170</ix:nonFraction>&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c311" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-27341">5.43</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_b" style="-sec-ix-hidden: hidden-fact-226; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">257,043</span><span class="Superscript" style="vertical-align:super;font-size:6pt;">(2)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c312" decimals="2" format="ixt:num-dot-decimal" id="ix_22_fact" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares">6.49</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Vested</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(<ix:nonFraction contextRef="c310" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" unitRef="shares" id="ixv-27343">1,897,699</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c310" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-27344">5.78</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(<ix:nonFraction contextRef="c311" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" unitRef="shares" id="ixv-27345">15,136</ix:nonFraction>)&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c311" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-27346">4.73</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-227; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-228; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Forfeited</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(<ix:nonFraction contextRef="c310" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" unitRef="shares" id="ixv-27347">288,405</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c310" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-27348">5.11</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(<ix:nonFraction contextRef="c311" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" unitRef="shares" id="ixv-27349">452</ix:nonFraction>)&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c311" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-27350">5.37</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(<ix:nonFraction contextRef="c312" decimals="INF" format="ixt:num-dot-decimal" id="ix_23_fact" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" unitRef="shares">47,669</ix:nonFraction>)&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c312" decimals="2" format="ixt:num-dot-decimal" id="ix_24_fact" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares">5.74</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-59" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Unvested Balance at December&#160;31, 2021</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c313" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" unitRef="shares" id="ixv-27353">3,036,905</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c313" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-27354">5.20</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c314" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" unitRef="shares" id="ixv-27355">54,990</ix:nonFraction>&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c314" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-27356">4.93</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c315" decimals="INF" format="ixt:num-dot-decimal" id="ix_25_fact" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" unitRef="shares">550,686</ix:nonFraction>&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c315" decimals="2" format="ixt:num-dot-decimal" id="ix_26_fact" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares">5.73</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Granted</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c316" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" unitRef="shares" id="ixv-27359">2,170,432</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c316" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-27360">5.71</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c317" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" unitRef="shares" id="ixv-27361">116,247</ix:nonFraction>&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c317" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-27362">5.18</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="-sec-ix-hidden: hidden-fact-229; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">319,838</span><span class="Superscript" style="vertical-align:super;font-size:6pt;">(2)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c318" decimals="2" format="ixt:num-dot-decimal" id="ix_27_fact" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares">6.80</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Vested</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(<ix:nonFraction contextRef="c316" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" unitRef="shares" id="ixv-27364">1,621,201</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c316" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-27365">5.31</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(<ix:nonFraction contextRef="c317" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" unitRef="shares" id="ixv-27366">27,894</ix:nonFraction>)&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c317" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-27367">5.10</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(<ix:nonFraction contextRef="c318" decimals="INF" format="ixt:num-dot-decimal" id="ix_28_fact" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" unitRef="shares">202,336</ix:nonFraction>)&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c318" decimals="2" format="ixt:num-dot-decimal" id="ix_29_fact" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares">6.24</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Forfeited</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(<ix:nonFraction contextRef="c316" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" unitRef="shares" id="ixv-27370">195,054</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c316" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-27371">5.43</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(<ix:nonFraction contextRef="c317" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" unitRef="shares" id="ixv-27372">1,380</ix:nonFraction>)&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c317" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-27373">5.73</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-230; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-231; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-59" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Unvested Balance at December&#160;31, 2022</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c319" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" unitRef="shares" id="ixv-27374">3,391,082</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c319" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-27375">5.46</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c320" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" unitRef="shares" id="ixv-27376">141,963</ix:nonFraction>&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c320" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-27377">5.09</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c321" decimals="INF" format="ixt:num-dot-decimal" id="ix_30_fact" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" unitRef="shares">668,188</ix:nonFraction>&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c321" decimals="2" format="ixt:num-dot-decimal" id="ix_31_fact" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares">6.09</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Granted</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c322" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" unitRef="shares" id="ixv-27380">3,363,501</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c322" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-27381">5.63</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c304" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" unitRef="shares" id="ixv-27382">152,265</ix:nonFraction>&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c304" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-27383">6.24</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="-sec-ix-hidden: hidden-fact-232; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">576,240</span><span class="Superscript" style="vertical-align:super;font-size:6pt;">(2)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c323" decimals="2" format="ixt:num-dot-decimal" id="ix_32_fact" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares">6.49</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Vested</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(<ix:nonFraction contextRef="c322" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" unitRef="shares" id="ixv-27385">1,629,925</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c322" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-27386">5.28</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(<ix:nonFraction contextRef="c304" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" unitRef="shares" id="ixv-27387">72,461</ix:nonFraction>)&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c304" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-27388">5.66</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(<ix:nonFraction contextRef="c323" decimals="INF" format="ixt:num-dot-decimal" id="ix_33_fact" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" unitRef="shares">108,113</ix:nonFraction>)&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c323" decimals="2" format="ixt:num-dot-decimal" id="ix_34_fact" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares">3.11</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Forfeited</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(<ix:nonFraction contextRef="c322" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" unitRef="shares" id="ixv-27391">114,436</ix:nonFraction>)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c322" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-27392">5.55</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(<ix:nonFraction contextRef="c304" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" unitRef="shares" id="ixv-27393">34,385</ix:nonFraction>)&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c304" decimals="2" format="ixt:num-dot-decimal" id="ix_35_fact" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares">5.70</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-233; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Stock dividends accrued</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c304" decimals="INF" format="ixt:num-dot-decimal" id="ix_36_fact" name="us-gaap:StockDividendsShares" scale="0" unitRef="shares">2,762</ix:nonFraction>&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c324" decimals="2" format="ixt:num-dot-decimal" id="ix_37_fact" name="us-gaap:DividendsPayableAmountPerShare" scale="0" unitRef="usdPershares">6.24</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c323" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockDividendsShares" scale="0" unitRef="shares" id="ixv-27397">37,777</ix:nonFraction>&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c325" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:DividendsPayableAmountPerShare" scale="0" unitRef="usdPershares" id="ixv-27398">6.49</ix:nonFraction></span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-59" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Unvested Balance at December&#160;31, 2023</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c326" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" unitRef="shares" id="ixv-27399">5,010,222</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c326" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-27400">5.63</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="-sec-ix-hidden: hidden-fact-234; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">190,144</span><span class="Superscript" style="vertical-align:super;font-size:6pt;">(</span><span class="CharOverride-5" style="font-size:6pt;vertical-align:super;">3</span><span class="Superscript" style="vertical-align:super;font-size:6pt;">)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c324" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares" id="ixv-27401">5.70</ix:nonFraction></span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c325" decimals="INF" format="ixt:num-dot-decimal" id="ix_38_fact" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" unitRef="shares">1,174,092</ix:nonFraction>&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;"><ix:nonFraction contextRef="c325" decimals="2" format="ixt:num-dot-decimal" id="ix_39_fact" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" unitRef="usdPershares">6.58</ix:nonFraction></span></p>	</td>
				</tr>

		</table></ix:continuation></ix:continuation>
		<div style="border: none; border-top: windowtext 0pt none; border-top-style: solid; padding: 0in 0in 2.0pt 0in;"><p class="Tablefootnotef" style="margin-top: 0in;  border: none; margin-right: 0in; margin-bottom: -5pt; margin-left: 24.0pt; text-align: justify; text-justify: inter-ideograph; text-indent: -24.0pt; padding: 0in; font-size: 9.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">____________</p><ix:continuation continuedAt="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_3" id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_2"><ix:continuation continuedAt="_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock-c0_cont_3" id="_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock-c0_cont_2"><p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><ix:footnote id="ix_9_footnote" xml:lang="en-US">Represents the target number of PRSUs granted and outstanding. The number of PRSUs that ultimately vest ranges from <ix:nonFraction contextRef="c299" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" unitRef="pure" id="ixv-27405">0</ix:nonFraction>% to <ix:nonFraction contextRef="c300" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" unitRef="pure" id="ixv-27406">200</ix:nonFraction>% of this amount. During the years ended December 31, 2023, 2022 and 2021, <ix:nonFraction contextRef="c301" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" unitRef="pure" id="ixv-27407">200</ix:nonFraction>%, <ix:nonFraction contextRef="c302" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" unitRef="pure" id="ixv-27408">77</ix:nonFraction>% and <ix:nonFraction contextRef="c303" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" unitRef="pure" id="ixv-27409">0</ix:nonFraction>%, respectively, of the target number of PRSUs granted ultimately vested, inclusive of accrued stock dividends.</ix:footnote></p></ix:continuation></ix:continuation></div>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-34</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<ix:continuation id="_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock-c0_cont_3"><ix:continuation continuedAt="_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock-c0_cont_4" id="_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock-c0_cont_3"><p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:6pt;text-align:left;margin-top:6pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(2)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><ix:footnote id="ix_10_footnote" xml:lang="en-US">A Monte Carlo simulation was used to value these awards using the following assumptions for the Company and the peer group: (i) beginning 90<span class="nobreak">-day</span> average stock prices; (ii) valuation date stock prices; (iii) correlation coefficients based upon the price data used to calculate the historical volatilities; and (iv) <ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="ixv-27410">the following additional assumptions:</ix:nonNumeric></ix:footnote></p></ix:continuation>
		<ix:continuation id="_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock-c0_cont_1"><table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Granted in <br/>2023</span></p>
					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Granted in <br/>2022</span></p>
					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Granted in <br/>2021</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1 _idGenCellOverride-4" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Historical stock price volatility (low)</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" unitRef="pure" id="ixv-27411">37</ix:nonFraction>%</p>	</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><ix:nonFraction contextRef="c19" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" unitRef="pure" id="ixv-27412">33</ix:nonFraction>%</p>	</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><ix:nonFraction contextRef="c20" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" unitRef="pure" id="ixv-27413">34</ix:nonFraction>%</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Historical stock price volatility (high)</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" unitRef="pure" id="ixv-27414">56</ix:nonFraction>%</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><ix:nonFraction contextRef="c19" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" unitRef="pure" id="ixv-27415">57</ix:nonFraction>%</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><ix:nonFraction contextRef="c20" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" unitRef="pure" id="ixv-27416">57</ix:nonFraction>%</p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Historical stock price volatility (average)</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" unitRef="pure" id="ixv-27417">47</ix:nonFraction>%</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><ix:nonFraction contextRef="c19" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" unitRef="pure" id="ixv-27418">44</ix:nonFraction>%</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><ix:nonFraction contextRef="c20" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" unitRef="pure" id="ixv-27419">44</ix:nonFraction>%</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Risk free interest rate</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure" id="ixv-27420">3.80</ix:nonFraction>%</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><ix:nonFraction contextRef="c19" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure" id="ixv-27421">1.28</ix:nonFraction>%</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><ix:nonFraction contextRef="c20" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="pure" id="ixv-27422">0.17</ix:nonFraction>%</p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Expected dividend yield</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><ix:nonFraction contextRef="c0" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" unitRef="pure" id="ixv-27423">0.00</ix:nonFraction>%</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><ix:nonFraction contextRef="c19" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" unitRef="pure" id="ixv-27424">0.00</ix:nonFraction>%</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><ix:nonFraction contextRef="c20" decimals="4" format="ixt:num-dot-decimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" unitRef="pure" id="ixv-27425">0.00</ix:nonFraction>%</p>	</td>
				</tr>

		</table></ix:continuation>
		<ix:continuation id="_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock-c0_cont_4"><p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:6pt;margin-top:6pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(3)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><ix:footnote id="ix_11_footnote" xml:lang="en-US">Includes <ix:nonFraction contextRef="c304" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" scale="0" unitRef="shares" id="ixv-27427">57,779</ix:nonFraction> deferred RSUs that have vested.</ix:footnote></p></ix:continuation></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="wt_DisclosureOfStockholderRightsPlanTextBlock-c0_cont_1" escape="true" name="wt:DisclosureOfStockholderRightsPlanTextBlock" id="ixv-23477"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">19. Stockholder Rights Plan</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;">On March&#160;17, 2023, the Board of Directors of the Company adopted a stockholder rights plan, as set forth in the Stockholder Rights Agreement, dated March&#160;17, 2023, between the Company and Continental Stock Transfer&#160;&amp; Trust Company, as Rights Agent, as amended by Amendment No. 1 thereto, dated May&#160;4, 2023 (&#8220;Amendment No. 1&#8221;), and by Amendment No. 2 thereto, dated May&#160;10, 2023 (&#8220;Amendment No. 2&#8221;) (as amended, the &#8220;Stockholder Rights Agreement&#8221;). At the Company&#8217;s 2023 Annual Meeting of Stockholders held on June&#160;16, 2023, the Company&#8217;s stockholders ratified the adoption by the Board of Directors of the Stockholder Rights Agreement.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Pursuant to the terms of the Stockholder Rights Agreement, the Board of Directors declared a dividend distribution of (i)&#160;<ix:nonFraction contextRef="c327" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares" id="ixv-27428">one</ix:nonFraction> Right (as defined below) for each outstanding share of common stock, par value $<ix:nonFraction contextRef="c328" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-27429">0.01</ix:nonFraction> per share, of the Company&#8217;s common stock and (ii)&#160;<ix:nonFraction contextRef="c329" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares" id="ixv-27430">1,000</ix:nonFraction> Rights for each outstanding share of the Company&#8217;s Series&#160;A Non<span class="nobreak">-Voting</span> Convertible Preferred Stock (&#8220;Series&#160;A Preferred Stock&#8221;), to stockholders of record as of the close of business on March&#160;28, 2023 (the &#8220;Record Date&#8221;). In addition, one Right will automatically attach to each share of common stock and <ix:nonFraction contextRef="c330" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" unitRef="shares" id="ixv-27431">1,000</ix:nonFraction> Rights will automatically attach to each share of Series&#160;A Preferred Stock, in each case, issued between the Record Date and the earlier of the Distribution Date (as defined below) and the expiration date of the Rights. Each &#8220;Right&#8221; entitles the registered holder thereof to purchase from the Company a unit consisting of one ten<span class="nobreak">-thousandth</span> of a share (a &#8220;Unit&#8221;) of Series&#160;B Junior Participating Cumulative Preferred Stock, par value $<ix:nonFraction contextRef="c331" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-27432">0.01</ix:nonFraction> per share, of the Company (the &#8220;Series&#160;B Preferred Stock&#8221;) at a cash exercise price of $<ix:nonFraction contextRef="c332" decimals="INF" format="ixt:num-dot-decimal" name="wt:ExercisePricePerUnit" scale="0" unitRef="usdPershares" id="ixv-27433">32.00</ix:nonFraction> per Unit (the &#8220;Exercise Price&#8221;), subject to adjustment, under certain conditions specified in the Stockholder Rights Agreement and summarized below.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Initially, the Rights are not exercisable and are attached to and trade with all shares of common stock and Series&#160;A Preferred Stock outstanding as of, and issued subsequent to, the Record Date. The Rights will separate from the common stock and Series&#160;A Preferred Stock and will become exercisable upon the earlier of (i)&#160;the close of business on the tenth calendar&#160;day following the first public announcement that a person or group of affiliated or associated persons (an &#8220;Acquiring Person&#8221;) has acquired beneficial ownership of <ix:nonFraction contextRef="c333" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" unitRef="pure" id="ixv-27434">10</ix:nonFraction>% (or <ix:nonFraction contextRef="c334" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" unitRef="pure" id="ixv-27435">20</ix:nonFraction>% in the case of a person or group which, together with all affiliates and associates of such person or group, is the beneficial owner of shares of common stock of the Company representing less than <ix:nonFraction contextRef="c335" decimals="2" format="ixt:num-dot-decimal" name="wt:PercentageOfCommonStockAcquired" scale="-2" unitRef="pure" id="ixv-27436">20</ix:nonFraction>% of the shares of common stock of the Company then outstanding, and which is entitled to file, and files, a statement on Schedule&#160;13G pursuant to Rule&#160;13d<span class="nobreak">-1</span>(b)&#160;or Rule&#160;13d<span class="nobreak">-1</span>(c)&#160;of the General Rules and Regulations under the Exchange&#160;Act as in effect at the time of the first public announcement of the declaration of the Rights dividend with respect to the shares of common stock beneficially owned by such person or group) or more of the outstanding shares of common stock, other than as a result of repurchases of stock by the Company or certain inadvertent actions by a stockholder (the date of such announcement being referred to as the &#8220;Stock Acquisition Date&#8221;), or (ii)&#160;the close of business on the tenth business&#160;day (or such later&#160;day as the Board of Directors may determine) following the commencement of a tender offer or exchange offer that could result upon its consummation in a person or group becoming an Acquiring Person (the earlier of such dates being herein referred to as the &#8220;Distribution Date&#8221;). A person or group who beneficially owned <ix:nonFraction contextRef="c336" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" unitRef="pure" id="ixv-27437">10</ix:nonFraction>% or more (or <ix:nonFraction contextRef="c337" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" unitRef="pure" id="ixv-27438">20</ix:nonFraction>% or more in the case of passive stockholders) of the Company&#8217;s outstanding common stock prior to the first public announcement by the Company of the adoption of the Stockholder Rights Agreement will not trigger the Stockholder Rights Agreement so long as they do not acquire beneficial ownership of any additional shares of common stock at a time when they still beneficially own <ix:nonFraction contextRef="c338" decimals="2" format="ixt:num-dot-decimal" name="wt:PercentageOfBeneficialOwnership" scale="-2" unitRef="pure" id="ixv-27439">10</ix:nonFraction>% or more (or <ix:nonFraction contextRef="c339" decimals="2" format="ixt:num-dot-decimal" name="wt:PercentageOfBeneficialOwnership" scale="-2" unitRef="pure" id="ixv-27440">20</ix:nonFraction>% or more in the case of passive stockholders) of such common stock, subject to certain exceptions as set forth in the Stockholder Rights Agreement.</p></ix:nonNumeric>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-35</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<ix:continuation continuedAt="wt_DisclosureOfStockholderRightsPlanTextBlock-c0_cont_2" id="wt_DisclosureOfStockholderRightsPlanTextBlock-c0_cont_1"><div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">For purposes of the Stockholder Rights Agreement, beneficial ownership is defined to include ownership of securities that are subject to a derivative transaction and acquired derivative securities. Swaps dealers unassociated with any control intent or intent to evade the purposes of the Stockholder Rights Agreement are excepted from such imputed beneficial ownership. Pursuant to Amendment No.<span class="nobreak"> </span>1, beneficial ownership did not include the right to vote pursuant to any agreement, arrangement or understanding with respect to voting on the proposal to approve and ratify the Stockholder Rights Agreement presented to the Company&#8217;s stockholders at the Company&#8217;s 2023 annual meeting of stockholders. Pursuant to Amendment No.<span class="nobreak"> </span>2, the parties to the SPA Agreement are not deemed to be &#8220;Acquiring Persons&#8221; solely by virtue of, or as a result of, the parties&#8217; entry into the SPA Agreement, the issuance of the Series&#160;C Preferred Stock to GBH, and the performance or consummation of any of the other transactions contemplated by the SPA Agreement, among other conditions, under the terms and conditions set forth in Amendment No. 2.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In the event that a Stock Acquisition Date occurs, proper provision will be made so that each holder of a Right (other than an Acquiring Person or its associates or affiliates, whose Rights shall become null and void) will thereafter have the right to receive upon exercise, in lieu of a number of shares of Series&#160;B Preferred Stock, that number of shares of common stock of the Company (or, in certain circumstances, including if there are insufficient shares of common stock to permit the exercise in full of the Rights, Units&#160;of Series&#160;B Preferred Stock, other securities, cash or property, or any combination of the foregoing) having a market value of two times the Exercise Price of the Right (such right being referred to as the &#8220;Subscription Right&#8221;). In the event that, at any time following the Stock Acquisition Date, (i)&#160;the Company consolidates with, or merges with and into, any other person, and the Company is not the continuing or surviving corporation, (ii)&#160;any person consolidates with the Company, or merges with and into the Company and the Company is the continuing or surviving corporation of such merger and, in connection with such merger, all or part of the shares of common stock are changed into or exchanged for stock or other securities of any other person or cash or any other property, or (iii)&#160;<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wt:PercentageOfAssetsSold" scale="-2" unitRef="pure" id="ixv-27441">50</ix:nonFraction>% or more of the Company&#8217;s assets or earning power is sold, mortgaged or otherwise transferred, each holder of a Right (other than an Acquiring Person or its associates or affiliates, whose Rights shall become null and void) will thereafter have the right to receive, upon exercise, common stock of the acquiring company having a market value equal to two times the Exercise Price of the Right (such right being referred to as the &#8220;Merger Right&#8221;). The holder of a Right will continue to have the Merger Right whether or not such holder has exercised the Subscription Right. Rights that are or were beneficially owned by an Acquiring Person may (under certain circumstances specified in the Stockholder Rights Agreement) become null and void.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Rights may be redeemed in whole, but not in part, at a price of $<ix:nonFraction contextRef="c340" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" unitRef="usdPershares" id="ixv-27442">0.01</ix:nonFraction> per Right (payable in cash, common stock or other consideration deemed appropriate by the Board of Directors) by the Board of Directors only until the earlier of (i)&#160;the time at which any person becomes an Acquiring Person or (ii)&#160;the expiration date of the Stockholder Rights Agreement. Immediately upon the action of the Board of Directors ordering redemption of the Rights, the Rights will terminate and thereafter the only right of the holders of Rights will be to receive the redemption price.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Stockholder Rights Agreement may be amended by the Board of Directors in its sole discretion at any time prior to the time at which any person becomes an Acquiring Person. After such time the Board of Directors may, subject to certain limitations set forth in the Stockholder Rights Agreement, amend the Stockholder Rights Agreement only to cure any ambiguity, defect or inconsistency, to shorten or lengthen any time period, or to make changes that do not adversely affect the interests of Rights holders (excluding the interests of an Acquiring Person or its associates or affiliates).</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Until a Right is exercised, the holder will have no rights as a stockholder of the Company (beyond those as an existing stockholder), including the right to vote or to receive dividends. While the distribution of the Rights will not be taxable to stockholders or to the Company, stockholders may, depending upon the circumstances, recognize taxable income in the event that the Rights become exercisable for shares of common stock, other securities of the Company, other consideration or for common stock of an acquiring company.</p>
		</div></ix:continuation>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-36</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<ix:continuation id="wt_DisclosureOfStockholderRightsPlanTextBlock-c0_cont_2"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Rights are not exercisable until the Distribution Date and will expire at the close of business on March&#160;16, 2024, unless previously redeemed or exchanged by the Company.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Stockholder Rights Agreement provides the holders of the common stock with the ability to exempt an offer to acquire, or engage in another business combination transaction involving, the Company that is deemed a &#8220;Qualifying Offer&#8221; (as defined in the Stockholder Rights Agreement) from the terms of the Stockholder Rights Agreement. A Qualifying Offer is, in summary, an offer determined by a majority of the independent members of the Board to have specific characteristics that are generally intended to preclude offers that are coercive, abusive or highly contingent. Among those characteristics are that it be: (i)&#160;a fully financed all<span class="nobreak">-cash</span> tender offer or an exchange offer offering shares of common stock of the offeror, or a combination thereof, for any and all of the common stock; and (ii)&#160;an offer that is otherwise in the best interests of the Company&#8217;s stockholders. The Stockholder Rights Agreement provides additional characteristics necessary for an acquisition offer to be deemed a &#8220;Qualifying Offer,&#8221; including if the consideration offered in a proposed transaction is stock of the acquiror.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Pursuant to the Stockholder Rights Agreement, if the Company receives a Qualifying Offer and the Board of Directors has not redeemed the outstanding Rights or exempted such Qualifying Offer from the terms of the Stockholder Rights Agreement or called a special meeting of stockholders (the &#8220;Special Meeting&#8221;) for the purpose of voting on whether to exempt such Qualifying Offer from the terms of the Stockholder Rights Agreement, in each case by the end of the 90 business&#160;day period following the commencement of such Qualifying Offer, provided such offer remains a Qualifying Offer during such period, the holders of <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wt:PercentageOfCommonStock" scale="-2" unitRef="pure" id="ixv-27443">10</ix:nonFraction>% of the common stock may request that the Board call a Special Meeting to vote on a resolution authorizing the exemption of the Qualifying Offer from the terms of the Stockholder Rights Agreement. If such a Special Meeting is not held by the 90th business&#160;day following the receipt of such a request from stockholders to call a Special Meeting, the Qualifying Offer will be deemed exempt from the terms of the Stockholder Rights Agreement on the 10th business&#160;day thereafter.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="ixv-23508"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">20. Employee Benefit Plans</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company has a 401(k)&#160;savings plan covering all eligible employees in which the Company can make discretionary contributions from its profits. The amounts included in the table below are recorded in compensation expense in the Consolidated Statements of Operations.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" id="ixv-27444">A summary of discretionary contributions made by the Company is as follows:</ix:nonNumeric></p>
		<ix:continuation id="_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock-c0_cont_1"><table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;">


				<tr class="Table55-">
					<td class="Table55- TCH CellOverride-2" colspan="8" style="width: 100.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">

						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December 31,</span></p>
					</td>
				</tr>
				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 30.26%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table55- TCH CellOverride-7" style="width: 3.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table55- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 30.26%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table55- TCH CellOverride-7" style="width: 3.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table55- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 33.33%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table55-" style="background: #CCEEFF;height:12pt;">
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 4.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table55- TB CellOverride-23 _idGenCellOverride-3" style="width: 26.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="3" unitRef="usd" id="ixv-27445">1,450</ix:nonFraction></p>	</td>
					<td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 3.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 4.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 26.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="3" unitRef="usd" id="ixv-27446">1,342</ix:nonFraction></p>	</td>
					<td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 3.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 4.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 29.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="3" unitRef="usd" id="ixv-27447">1,080</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation></ix:nonNumeric>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-37</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<ix:nonNumeric contextRef="c0" continuedAt="_EarningsPerShareTextBlock-c0_cont_1" escape="true" name="us-gaap:EarningsPerShareTextBlock" id="ixv-23549"><div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:14pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">21. Earnings Per Share</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="ixv-27448">The following tables set forth reconciliations of the basic and diluted earnings per share computations for the periods presented:</ix:nonNumeric></p>
		<ix:continuation continuedAt="_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock-c0_cont_2" id="_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock-c0_cont_1"><table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;">


				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December 31,</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1 _idGenCellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table75- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table75- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-15" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Basic Earnings per Share</span></p>
					</td>
					<td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-16" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-16" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-16" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-15 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Net income</p>
					</td>
					<td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" unitRef="usd" id="ixv-27449">102,546</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" unitRef="usd" id="ixv-27450">50,684</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="3" unitRef="usd" id="ixv-27451">49,797</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Add: Gain on repurchase of Series&#160;C Preferred Stock</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" scale="3" unitRef="usd" id="ixv-27452">7,966</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-237; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-238; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Less: Income distributed to participating securities</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:IncomeDistributedToParticipatingSecurities" scale="3" unitRef="usd" id="ixv-27453">2,770</ix:nonFraction>)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="wt:IncomeDistributedToParticipatingSecurities" scale="3" unitRef="usd" id="ixv-27454">2,186</ix:nonFraction>)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wt:IncomeDistributedToParticipatingSecurities" scale="3" unitRef="usd" id="ixv-27455">2,168</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Less: Undistributed income allocable to participating securities</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="3" unitRef="usd" id="ixv-27456">12,680</ix:nonFraction>)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="3" unitRef="usd" id="ixv-27457">3,528</ix:nonFraction>)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="3" unitRef="usd" id="ixv-27458">3,378</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net income available to common stockholders&#8212;Basic EPS</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" unitRef="usd" id="ixv-27459">95,062</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" unitRef="usd" id="ixv-27460">44,970</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" unitRef="usd" id="ixv-27461">44,251</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-15" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Weighted average common shares (in<span class="nobreak"> </span>thousands)</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-27462">144,707</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-27463">143,020</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-27464">143,847</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Basic earnings per share</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares" id="ixv-27465">0.66</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares" id="ixv-27466">0.31</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareBasic" scale="0" unitRef="usdPershares" id="ixv-27467">0.31</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation>
		<ix:continuation id="_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock-c0_cont_2"><table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;">


				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-15" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Diluted Earnings per Share</span></p>
					</td>
					<td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-16" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-16" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-16" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-15 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Net income available to common stockholders</p>
					</td>
					<td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" unitRef="usd" id="ixv-27468">95,062</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" unitRef="usd" id="ixv-27469">44,970</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" unitRef="usd" id="ixv-27470">44,251</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Add back: Undistributed income allocable to participating securities</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:UndistributedIncomeAllocableToParticipatingSecurities" scale="3" sign="-" unitRef="usd" id="ixv-27471">12,680</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="wt:UndistributedIncomeAllocableToParticipatingSecurities" scale="3" sign="-" unitRef="usd" id="ixv-27472">3,528</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wt:UndistributedIncomeAllocableToParticipatingSecurities" scale="3" sign="-" unitRef="usd" id="ixv-27473">3,378</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Less: Reallocation of undistributed income allocable to participating securities considered potentially dilutive</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" scale="3" unitRef="usd" id="ixv-27474">12,449</ix:nonFraction>)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" scale="3" unitRef="usd" id="ixv-27475">3,522</ix:nonFraction>)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" scale="3" unitRef="usd" id="ixv-27476">3,353</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net income available to common stockholders&#8212;Diluted EPS</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" unitRef="usd" id="ixv-27477">95,293</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" unitRef="usd" id="ixv-27478">44,976</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="3" unitRef="usd" id="ixv-27479">44,276</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-15" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"><span class="CharOverride-9" style="text-decoration:underline;">Weighted Average Diluted Shares (in thousands)</span>:</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Weighted average common shares</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-27480">144,707</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-27481">143,020</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" unitRef="shares" id="ixv-27482">143,847</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Dilutive effect of common stock equivalents, excluding participating securities</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="0" unitRef="shares" id="ixv-27483">3,120</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="0" unitRef="shares" id="ixv-27484">275</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="0" unitRef="shares" id="ixv-27485">1,208</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Weighted average diluted shares, excluding participating securities (in thousands)</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="wt:WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities" scale="0" unitRef="shares" id="ixv-27486">147,827</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="0" format="ixt:num-dot-decimal" name="wt:WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities" scale="0" unitRef="shares" id="ixv-27487">143,295</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="wt:WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities" scale="0" unitRef="shares" id="ixv-27488">145,055</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-15" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Diluted earnings per share</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" unitRef="usdPershares" id="ixv-27489">0.64</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" unitRef="usdPershares" id="ixv-27490">0.31</ix:nonFraction></p>	</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EarningsPerShareDiluted" scale="0" unitRef="usdPershares" id="ixv-27491">0.31</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;">Diluted earnings per share presented above is calculated using the two<span class="nobreak">-class</span> method as this method results in the lowest diluted earnings per share amount for common stock. The year ended December&#160;31, 2023 includes a gain of $<ix:nonFraction contextRef="c341" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" scale="3" unitRef="usd" id="ixv-27492">7,966</ix:nonFraction> recognized upon the repurchase of the Series&#160;C Preferred Stock, which is excluded from net income, but required to be added to net income to arrive at income available to common stockholders in the calculation of earnings per share.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Total antidilutive non<span class="nobreak">-participating</span> common stock equivalents were <ix:nonFraction contextRef="c19" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-27493">405</ix:nonFraction> and <ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" unitRef="shares" id="ixv-27494">132</ix:nonFraction> during the&#160;years ended December&#160;31, 2022 and 2021, respectively (shares herein are reported in thousands). There were no antidilutive non<span class="nobreak">-participating</span> common stock equivalents during the year ended December&#160;31, 2023.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">There were no potential common shares associated with the conversion option embedded in the Convertible Notes included in weighted average diluted shares for the&#160;years ended December&#160;31, 2023 and 2022 as the Company&#8217;s average stock price was lower than the conversion price. Potential common shares associated with the conversion option embedded in the Convertible Notes for the year ended December&#160;31, 2021 were <ix:nonFraction contextRef="c20" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="0" unitRef="shares" id="ixv-27495">1,186</ix:nonFraction> (shares herein are reported in thousands).</p>
		</div></ix:nonNumeric>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-38</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<ix:continuation id="_EarningsPerShareTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="ixv-27496">The following table reconciles weighted average diluted shares as reported on the Company&#8217;s Consolidated Statements of Operations for the&#160;years ended December&#160;31, 2023, 2022 and 2021, which are determined pursuant to the treasury stock method, to the weighted average diluted shares used to calculate diluted earnings per share as disclosed in the table above:</ix:nonNumeric></p>
		<ix:continuation id="_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock-c0_cont_1"><table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="5" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 46.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December 31,</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Reconciliation of Weighted Average Diluted Shares (in</span><span class="nobreak"> </span><span class="Bold" style="font-style:normal;font-weight:bold;">thousands)</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Weighted average diluted shares as disclosed on the Consolidated Statements of Operations</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-27497">170,413</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-27498">158,914</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" unitRef="shares" id="ixv-27499">161,263</ix:nonFraction></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Less: Participating securities:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Weighted average shares of common stock issuable upon conversion of the Series&#160;A Preferred Stock (Note&#160;11)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="wt:WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares" scale="0" sign="-" unitRef="shares" id="ixv-27500">14,750</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="0" format="ixt:num-dot-decimal" name="wt:WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares" scale="0" sign="-" unitRef="shares" id="ixv-27501">14,750</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="wt:WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares" scale="0" sign="-" unitRef="shares" id="ixv-27502">14,750</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Weighted average shares of common stock issuable upon conversion of the Series&#160;C Preferred Stock (Note&#160;11)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c342" decimals="0" format="ixt:num-dot-decimal" name="wt:WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares" scale="0" sign="-" unitRef="shares" id="ixv-27503">6,992</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-239; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-240; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Potentially dilutive restricted stock awards</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="wt:PotentiallyDilutiveRestrictedStockAwards" scale="0" sign="-" unitRef="shares" id="ixv-27504">844</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="0" format="ixt:num-dot-decimal" name="wt:PotentiallyDilutiveRestrictedStockAwards" scale="0" sign="-" unitRef="shares" id="ixv-27505">869</ix:nonFraction>)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="wt:PotentiallyDilutiveRestrictedStockAwards" scale="0" sign="-" unitRef="shares" id="ixv-27506">1,458</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Weighted average diluted shares used to calculate diluted earnings/(loss) per share as disclosed in the table above</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="wt:WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities" scale="0" unitRef="shares" id="ixv-27507">147,827</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="0" format="ixt:num-dot-decimal" name="wt:WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities" scale="0" unitRef="shares" id="ixv-27508">143,295</ix:nonFraction></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="wt:WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities" scale="0" unitRef="shares" id="ixv-27509">145,055</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation></ix:continuation>

		<ix:nonNumeric contextRef="c0" continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock" id="ixv-24020"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">22. Income Taxes</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Income before Income Tax Expense&#160;&#8211;&#160;Domestic and Foreign</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="ixv-27510">The U.S.&#160;and foreign components of income before income tax expense for the&#160;years ended December&#160;31, 2023, 2022 and 2021 are as follows:</ix:nonNumeric></p>
		<ix:continuation id="_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock-c0_cont_1"><table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;">


				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Year Ended December 31,</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-12 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">U.S.</p>
					</td>
					<td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c265" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" unitRef="usd" id="ixv-27511">4,652</ix:nonFraction></p>	</td>
					<td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c266" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" sign="-" unitRef="usd" id="ixv-27512">4,067</ix:nonFraction>)</p>	</td>
					<td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c267" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" unitRef="usd" id="ixv-27513">15,986</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Foreign</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c347" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" unitRef="usd" id="ixv-27514">114,356</ix:nonFraction></p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c348" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" unitRef="usd" id="ixv-27515">44,017</ix:nonFraction></p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c349" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" unitRef="usd" id="ixv-27516">40,685</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" unitRef="usd" id="ixv-27517">119,008</ix:nonFraction></p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" unitRef="usd" id="ixv-27518">39,950</ix:nonFraction></p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" unitRef="usd" id="ixv-27519">56,671</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Income Tax Expense/(Benefit) &#8211; By Jurisdiction</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="ixv-27520">The components of current and deferred income tax expense included in the Consolidated Statement of Operations for&#160;years ended December&#160;31, 2023, 2022 and 2021 are as follows:</ix:nonNumeric></p>
		<ix:continuation id="_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock-c0_cont_1"><table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;">


				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Current:</p>
					</td>
					<td class="Table70- TCH CellOverride-26" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-14" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-26" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-14" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-26" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-14" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-12 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">Federal</p>
					</td>
					<td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-27521">6,957</ix:nonFraction></p>	</td>
					<td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-27522">4,685</ix:nonFraction></p>	</td>
					<td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-27523">5,857</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">State and local</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-27524">1,883</ix:nonFraction></p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-27525">1,415</ix:nonFraction></p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-27526">1,538</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">Foreign</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-27527">8,103</ix:nonFraction></p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" sign="-" unitRef="usd" id="ixv-27528">15,538</ix:nonFraction>)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" sign="-" unitRef="usd" id="ixv-27529">837</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-27530">16,943</ix:nonFraction></p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" sign="-" unitRef="usd" id="ixv-27531">9,438</ix:nonFraction>)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-27532">6,558</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">Deferred:</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">Federal</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" sign="-" unitRef="usd" id="ixv-27533">494</ix:nonFraction>)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" sign="-" unitRef="usd" id="ixv-27534">6</ix:nonFraction>)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" sign="-" unitRef="usd" id="ixv-27535">1,217</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">State and local</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" sign="-" unitRef="usd" id="ixv-27536">102</ix:nonFraction>)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" sign="-" unitRef="usd" id="ixv-27537">1</ix:nonFraction>)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" sign="-" unitRef="usd" id="ixv-27538">251</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">Foreign</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-27539">115</ix:nonFraction></p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" sign="-" unitRef="usd" id="ixv-27540">1,289</ix:nonFraction>)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-27541">1,784</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" sign="-" unitRef="usd" id="ixv-27542">481</ix:nonFraction>)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" sign="-" unitRef="usd" id="ixv-27543">1,296</ix:nonFraction>)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-27544">316</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">Income tax expense/(benefit)</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-27545">16,462</ix:nonFraction></p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" sign="-" unitRef="usd" id="ixv-27546">10,734</ix:nonFraction>)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-27547">6,874</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation></ix:nonNumeric>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-39</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_2" id="_IncomeTaxDisclosureTextBlock-c0_cont_1"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Reconciliation of Statutory Federal Income Tax Rate to the Effective Income Tax Rate</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="ixv-27548">A reconciliation of the statutory federal income tax expense and the Company&#8217;s total income tax expense is as follows:</ix:nonNumeric></p>
		<ix:continuation continuedAt="_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock-c0_cont_2" id="_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock-c0_cont_1"><table class="Table90-" style="width: 90.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0.33in 0pt 0.33in;">


				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TCH CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="8" style="width: 51.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December 31,</span></p>
					</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TCH CellOverride-1 _idGenCellOverride-3" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-7" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 15.79%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table90- TCH CellOverride-7" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 15.79%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table90- TCH CellOverride-7" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 17.22%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">U.S.&#160;federal statutory income tax</p>
					</td>
					<td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="3" unitRef="usd" id="ixv-27549">24,992</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="3" unitRef="usd" id="ixv-27550">8,386</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="3" unitRef="usd" id="ixv-27551">11,901</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Gain on revaluation/termination of deferred consideration<span class="Superscript" style="vertical-align:super;font-size:58%;">(1)</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" id="ix_40_fact" name="wt:IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration" scale="3" unitRef="usd">13,007</ix:nonFraction>)</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" id="ix_41_fact" name="wt:IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration" scale="3" unitRef="usd">5,842</ix:nonFraction>)</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" id="ix_42_fact" name="wt:IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration" scale="3" unitRef="usd">424</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Non-deductible loss on extinguishment of convertible notes</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:NondeductibleLossOnExtinguishmentOfConvertibleNotes" scale="3" sign="-" unitRef="usd" id="ixv-27555">2,263</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Foreign operations</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:IncomeTaxReconciliationInternationalOperations" scale="3" unitRef="usd" id="ixv-27556">1,868</ix:nonFraction>)</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="wt:IncomeTaxReconciliationInternationalOperations" scale="3" unitRef="usd" id="ixv-27557">2,919</ix:nonFraction>)</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wt:IncomeTaxReconciliationInternationalOperations" scale="3" unitRef="usd" id="ixv-27558">3,211</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Non-deductible executive compensation</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense" scale="3" sign="-" unitRef="usd" id="ixv-27559">1,833</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="wt:IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense" scale="3" sign="-" unitRef="usd" id="ixv-27560">789</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wt:IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense" scale="3" sign="-" unitRef="usd" id="ixv-27561">881</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Decrease in unrecognized tax benefits, net</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:IncomeTaxReconciliationUnrecognizedTaxBenefits" scale="3" unitRef="usd" id="ixv-27562">1,386</ix:nonFraction>)</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="wt:IncomeTaxReconciliationUnrecognizedTaxBenefits" scale="3" unitRef="usd" id="ixv-27563">19,871</ix:nonFraction>)</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wt:IncomeTaxReconciliationUnrecognizedTaxBenefits" scale="3" unitRef="usd" id="ixv-27564">4,998</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Change in valuation allowance&#160;&#8211;&#160;Capital losses</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses" scale="3" sign="-" unitRef="usd" id="ixv-27565">1,340</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="wt:IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses" scale="3" sign="-" unitRef="usd" id="ixv-27566">4,761</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wt:IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses" scale="3" sign="-" unitRef="usd" id="ixv-27567">5</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Expiration of capital losses</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:IncomeTaxReconciliationExpirationOfCapitalLosses" scale="3" sign="-" unitRef="usd" id="ixv-27568">796</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Stock-based compensation tax shortfalls</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="3" unitRef="usd" id="ixv-27569">373</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="3" unitRef="usd" id="ixv-27570">507</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="3" unitRef="usd" id="ixv-27571">647</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Change in tax-related indemnification assets, net</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets" scale="3" unitRef="usd" id="ixv-27572">291</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="wt:EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets" scale="3" unitRef="usd" id="ixv-27573">4,173</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="wt:EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets" scale="3" unitRef="usd" id="ixv-27574">1,053</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Change in foreign net operating losses (&#8220;NOLs&#8221;)</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:ChangeInForeignNetOperatingLosses" scale="3" unitRef="usd" id="ixv-27575">174</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Blended state income tax rate, net of federal benefit</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" unitRef="usd" id="ixv-27576">153</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" sign="-" unitRef="usd" id="ixv-27577">134</ix:nonFraction>)</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" unitRef="usd" id="ixv-27578">526</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Change in valuation allowance&#8212;Foreign NOLs and interest carryforwards</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" sign="-" unitRef="usd" id="ixv-27579">1,609</ix:nonFraction>)</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">GILTI</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount" scale="3" unitRef="usd" id="ixv-27580">499</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other differences, net</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" unitRef="usd" id="ixv-27581">508</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" unitRef="usd" id="ixv-27582">526</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" unitRef="usd" id="ixv-27583">494</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Income tax expense/(benefit)</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-27584">16,462</ix:nonFraction></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" sign="-" unitRef="usd" id="ixv-27585">10,734</ix:nonFraction>)</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-27586">6,874</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation></ix:continuation>
		<div style="border: none; border-top: windowtext 0pt none; border-top-style: solid; padding: 0in 0in 2.0pt 0in;"><p class="Tablefootnotef" style="margin-top: 0in;  border: none; margin-right: 0in; margin-bottom: -5pt; margin-left: 24.0pt; text-align: justify; text-justify: inter-ideograph; text-indent: -24.0pt; padding: 0in; font-size: 9.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">____________</p><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_3" id="_IncomeTaxDisclosureTextBlock-c0_cont_2"><ix:continuation id="_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock-c0_cont_2"><p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><ix:footnote id="ix_12_footnote" xml:lang="en-US">The gain on revaluation of deferred consideration is not adjusted for income taxes as the obligation was assumed by a wholly<span class="nobreak">-owned</span> subsidiary that is based in Jersey, a jurisdiction where the Company is subject to a zero percent tax rate.</ix:footnote></p></ix:continuation></ix:continuation></div>
		<ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_4" id="_IncomeTaxDisclosureTextBlock-c0_cont_3"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;"> Income Tax Payments</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="wt_SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock-c0_cont_1" escape="true" name="wt:SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock" id="ixv-27587">A summary of income taxes paid by jurisdiction for the&#160;years ended December&#160;31, 2023, 2022 and 2021 is as follows:</ix:nonNumeric></p>
		<ix:continuation id="wt_SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock-c0_cont_1"><table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December 31,</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table60- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table60- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-15 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Federal</p>
					</td>
					<td class="Table60- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><ix:nonFraction contextRef="c350" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-27588">4,824</ix:nonFraction></p>	</td>
					<td class="Table60- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><ix:nonFraction contextRef="c351" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-27589">6,424</ix:nonFraction></p>	</td>
					<td class="Table60- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-16 _idGenCellOverride-4" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-16 _idGenCellOverride-4" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"><ix:nonFraction contextRef="c352" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-27590">4,258</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">State and local</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c353" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-27591">1,457</ix:nonFraction></p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c354" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-27592">1,431</ix:nonFraction></p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c355" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-27593">1,020</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Foreign</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c356" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-27594">9,875</ix:nonFraction></p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c357" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-27595">4,645</ix:nonFraction></p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c358" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="3" unitRef="usd" id="ixv-27596">3,178</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaidNet" scale="3" unitRef="usd" id="ixv-27597">16,156</ix:nonFraction></p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaidNet" scale="3" unitRef="usd" id="ixv-27598">12,500</ix:nonFraction></p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxesPaidNet" scale="3" unitRef="usd" id="ixv-27599">8,456</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation></ix:continuation>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-40</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_5" id="_IncomeTaxDisclosureTextBlock-c0_cont_4"><div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Deferred Tax Assets</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="ixv-27600">A summary of the components of the Company&#8217;s deferred tax assets at December&#160;31, 2023 and 2022 is as follows:</ix:nonNumeric></p>
		<ix:continuation id="_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock-c0_cont_1"><table class="Table6in" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TCH CellOverride-1 _idGenCellOverride-2" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table6in TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.60%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table6in TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 19.20%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TCH CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deferred tax assets:</p>
					</td>
					<td class="Table6in TCH CellOverride-5" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TCH CellOverride-2" colspan="2" style="width: 17.60%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table6in TCH CellOverride-5" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TCH CellOverride-2" colspan="2" style="width: 19.20%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1 _idGenCellOverride-3" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Capital losses</p>
					</td>
					<td class="Table6in TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table6in TB CellOverride-2 _idGenCellOverride-3" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsCapitalLossCarryforwards" scale="3" unitRef="usd" id="ixv-27601">22,489</ix:nonFraction></p>	</td>
					<td class="Table6in TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table6in TB CellOverride-2 _idGenCellOverride-3" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsCapitalLossCarryforwards" scale="3" unitRef="usd" id="ixv-27602">17,541</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Accrued expenses</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" scale="3" unitRef="usd" id="ixv-27603">6,000</ix:nonFraction></p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" scale="3" unitRef="usd" id="ixv-27604">6,030</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Stock-based compensation</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="3" unitRef="usd" id="ixv-27605">2,468</ix:nonFraction></p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="3" unitRef="usd" id="ixv-27606">1,526</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">NOLs&#8212;Foreign</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" scale="3" unitRef="usd" id="ixv-27607">1,502</ix:nonFraction></p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign" scale="3" unitRef="usd" id="ixv-27608">1,609</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Goodwill and intangible assets</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="3" unitRef="usd" id="ixv-27609">895</ix:nonFraction></p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="3" unitRef="usd" id="ixv-27610">1,085</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Unrealized losses</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="wt:DeferredTaxAssetUnrealizedLosses" scale="3" unitRef="usd" id="ixv-27611">335</ix:nonFraction></p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wt:DeferredTaxAssetUnrealizedLosses" scale="3" unitRef="usd" id="ixv-27612">3,821</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Foreign currency translation adjustment</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses" scale="3" unitRef="usd" id="ixv-27613">146</ix:nonFraction></p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses" scale="3" unitRef="usd" id="ixv-27614">173</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">NOLs&#8212;U.S.</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="wt:DeferredTaxAssetOperatingLossCarryForwardUnitedStates" scale="3" unitRef="usd" id="ixv-27615">127</ix:nonFraction></p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wt:DeferredTaxAssetOperatingLossCarryForwardUnitedStates" scale="3" unitRef="usd" id="ixv-27616">255</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Operating lease liabilities</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="wt:DeferredTaxAssetsOperatingLeaseLiabilities" scale="3" unitRef="usd" id="ixv-27617">96</ix:nonFraction></p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wt:DeferredTaxAssetsOperatingLeaseLiabilities" scale="3" unitRef="usd" id="ixv-27618">313</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Outside basis differences</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-241; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wt:DeferredTaxAssetsOutsideBasisDifference" scale="3" sign="-" unitRef="usd" id="ixv-27619">122</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOther" scale="3" unitRef="usd" id="ixv-27620">401</ix:nonFraction></p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsOther" scale="3" unitRef="usd" id="ixv-27621">341</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deferred tax assets</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" unitRef="usd" id="ixv-27622">34,459</ix:nonFraction></p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" unitRef="usd" id="ixv-27623">32,816</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-27" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-28" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-28" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-28" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-28" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-28" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-28" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deferred tax liabilities:</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Fixed assets and prepaid assets</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="wt:DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses" scale="3" unitRef="usd" id="ixv-27624">296</ix:nonFraction></p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wt:DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses" scale="3" unitRef="usd" id="ixv-27625">278</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Unremitted earnings&#8212;European subsidiaries</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" scale="3" unitRef="usd" id="ixv-27626">186</ix:nonFraction></p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" scale="3" unitRef="usd" id="ixv-27627">205</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Right of use assets&#8212;operating leases</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="wt:DeferredTaxLiabilitiesRightOfUseAssets" scale="3" unitRef="usd" id="ixv-27628">96</ix:nonFraction></p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wt:DeferredTaxLiabilitiesRightOfUseAssets" scale="3" unitRef="usd" id="ixv-27629">313</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deferred tax liabilities</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="3" unitRef="usd" id="ixv-27630">578</ix:nonFraction></p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="3" unitRef="usd" id="ixv-27631">796</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total deferred tax assets less deferred tax liabilities</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="wt:DeferredTaxAssetsLiabilitiesGross" scale="3" unitRef="usd" id="ixv-27632">33,881</ix:nonFraction></p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="wt:DeferredTaxAssetsLiabilitiesGross" scale="3" unitRef="usd" id="ixv-27633">32,020</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Less: Valuation allowance</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" unitRef="usd" id="ixv-27634">22,824</ix:nonFraction>)</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" unitRef="usd" id="ixv-27635">21,484</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deferred tax assets, net</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsNet" scale="3" unitRef="usd" id="ixv-27636">11,057</ix:nonFraction></p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsNet" scale="3" unitRef="usd" id="ixv-27637">10,536</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:14pt;text-indent:0pt;margin-top:14pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Net Operating and Capital Losses &#8211; U.S.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company&#8217;s tax effected NOLs at December&#160;31, 2023 were $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:OperatingLossCarryforwards" scale="3" unitRef="usd" id="ixv-27638">127</ix:nonFraction>, which expire in <span style="-sec-ix-hidden: hidden-fact-246">2024</span>. The net operating loss carryforwards have been reduced by the impact of annual limitations described in the Internal Revenue Code Section&#160;382 that arose as a result of an ownership change.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company&#8217;s tax effected capital losses at December&#160;31, 2023 were $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxAssetsCapitalLossCarryforwards" scale="3" unitRef="usd" id="ixv-27639">22,489</ix:nonFraction>. These capital losses expire between the&#160;years 2024 and 2028. During the year ended December&#160;31, 2023, tax effected capital losses in the amount of $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="wt:DeferredTaxAssetsCapitalLossCarryforwardsSubjectToExpiration" scale="3" unitRef="usd" id="ixv-27640">3,278</ix:nonFraction> expired.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Net Operating Losses &#8211; Europe</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">One of the Company&#8217;s European subsidiaries generated NOLs outside the U.S.&#160;These tax effected NOLs, all of which are carried forward indefinitely, were $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="wt:DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax" scale="3" unitRef="usd" id="ixv-27641">1,502</ix:nonFraction> at December&#160;31, 2023.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Valuation Allowance</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company&#8217;s valuation allowance has been established on its net capital losses, unrealized losses and outside basis differences, as it is more<span class="nobreak">-likely-than-not</span> that these deferred tax assets will not be realized.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">During the year ended December&#160;31, 2022, the Company released the valuation allowance on its European net operating losses of $<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" sign="-" unitRef="usd" id="ixv-27642">1,609</ix:nonFraction> as it is more<span class="nobreak">-likely-than-not</span> that these deferred tax assets will be realized.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Uncertain Tax Positions</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Tax positions are evaluated utilizing a two<span class="nobreak">-step</span> process. The Company first determines whether any of its tax positions are more<span class="nobreak">-likely-than-not</span> to be sustained upon examination, based solely on the technical merits of the position. Once it is determined that a position meets this recognition threshold, the position is measured as the largest amount of benefit that is greater than <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" unitRef="pure" id="ixv-27643">50</ix:nonFraction>% likely of being realized upon ultimate settlement.</p>
		</div></ix:continuation>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-41</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_6" id="_IncomeTaxDisclosureTextBlock-c0_cont_5"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In connection with the ETFS Acquisition, the Company accrued a liability for uncertain tax positions and interest and penalties at the acquisition date. The Company also recorded an offsetting indemnification asset provided by ETFS Capital as part of its agreement to indemnify the Company for any potential claims. <ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="ixv-27644">The table below sets forth the aggregate changes in the balance of these gross unrecognized tax benefits:</ix:nonNumeric></p>
		<ix:continuation continuedAt="_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock-c0_cont_2" id="_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock-c0_cont_1"><table class="Table80-" style="width: 80.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 15% 0pt 0.33in;">


				<tr class="Table80-" style="height:12pt;">
					<td class="Table80- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">


					</td>
					<td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Total</span></p>
					</td>
					<td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Unrecognized <br/>Tax Benefits</span></p>
					</td>
					<td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Interest and <br/>Penalties</span></p>
					</td>
				</tr>
				<tr class="Table80-" style="background: #CCEEFF;height:12pt;">
					<td class="Table80- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Balance at January&#160;1, 2022</p>
					</td>
					<td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c37" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" unitRef="usd" id="ixv-27645">21,925</ix:nonFraction></p>	</td>
					<td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c359" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" unitRef="usd" id="ixv-27646">18,218</ix:nonFraction></p>	</td>
					<td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c360" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" unitRef="usd" id="ixv-27647">3,707</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table80-" style="height:12pt;">
					<td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Decrease&#8212;Settlements<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)</span></p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" id="ix_43_fact" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="3" unitRef="usd">13,052</ix:nonFraction>)</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c361" decimals="-3" format="ixt:num-dot-decimal" id="ix_44_fact" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="3" unitRef="usd">11,865</ix:nonFraction>)</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c362" decimals="-3" format="ixt:num-dot-decimal" id="ix_45_fact" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="3" unitRef="usd">1,187</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="Table80-" style="background: #CCEEFF;height:12pt;">
					<td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Decrease&#8212;Lapse of statute of limitations<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)</span></p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" id="ix_46_fact" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" unitRef="usd">6,845</ix:nonFraction>)</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c361" decimals="-3" format="ixt:num-dot-decimal" id="ix_47_fact" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" unitRef="usd">4,825</ix:nonFraction>)</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c362" decimals="-3" format="ixt:num-dot-decimal" id="ix_48_fact" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" unitRef="usd">2,020</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="Table80-" style="height:12pt;">
					<td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Increases</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" unitRef="usd" id="ixv-27654">26</ix:nonFraction></p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-242; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c362" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" unitRef="usd" id="ixv-27655">26</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table80-" style="background: #CCEEFF;height:12pt;">
					<td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Foreign currency translation<span class="Superscript" style="vertical-align:super;font-size:6pt;">(2)</span></p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" id="ix_49_fact" name="wt:UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation" scale="3" sign="-" unitRef="usd">701</ix:nonFraction>)</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c361" decimals="-3" format="ixt:num-dot-decimal" id="ix_50_fact" name="wt:UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation" scale="3" sign="-" unitRef="usd">571</ix:nonFraction>)</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c362" decimals="-3" format="ixt:num-dot-decimal" id="ix_51_fact" name="wt:UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation" scale="3" sign="-" unitRef="usd">130</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="Table80-" style="height:12pt;">
					<td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Balance at December&#160;31, 2022</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" unitRef="usd" id="ixv-27659">1,353</ix:nonFraction></p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c363" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" unitRef="usd" id="ixv-27660">957</ix:nonFraction></p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c364" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" unitRef="usd" id="ixv-27661">396</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table80-" style="background: #CCEEFF;height:12pt;">
					<td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Decrease&#8212;Lapse of statute of limitations</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" unitRef="usd" id="ixv-27662">1,353</ix:nonFraction>)</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c365" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" unitRef="usd" id="ixv-27663">957</ix:nonFraction>)</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c366" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" unitRef="usd" id="ixv-27664">396</ix:nonFraction>)</p>	</td>
				</tr>
				<tr class="Table80-" style="height:12pt;">
					<td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Balance at December&#160;31, 2023</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-243; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-244; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-245; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>

		</table></ix:continuation></ix:continuation>
		<div style="border: none; border-top: windowtext 0pt none; border-top-style: solid; padding: 0in 0in 2.0pt 0in;"><p class="Tablefootnotef" style="margin-top: 0in;  border: none; margin-right: 0in; margin-bottom: -5pt; margin-left: 24.0pt; text-align: justify; text-justify: inter-ideograph; text-indent: -24.0pt; padding: 0in; font-size: 9.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">____________</p><ix:continuation continuedAt="_IncomeTaxDisclosureTextBlock-c0_cont_7" id="_IncomeTaxDisclosureTextBlock-c0_cont_6"><ix:continuation continuedAt="_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock-c0_cont_3" id="_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock-c0_cont_2"><p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><ix:footnote id="ix_13_footnote" xml:lang="en-US">In January 2022, an audit of ManJer&#8217;s tax returns (a Jersey<span class="nobreak">-based</span> subsidiary) for the years ended December&#160;31, 2014, 2016, 2017 and 2018 were resolved in favor of ManJer. The settlement, as well as the reduction in unrecognized tax benefits from the lapse of the statute of limitations totaling $<ix:nonFraction contextRef="c345" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" unitRef="usd" id="ixv-27665">19,897</ix:nonFraction> during the year ended December 31, 2022 was recorded as an income tax benefit along with an equal and offsetting amount recorded in other losses and gains, net, to recognize a reduction in the indemnification asset.</ix:footnote></p></ix:continuation></ix:continuation></div>
		<ix:continuation id="_IncomeTaxDisclosureTextBlock-c0_cont_7"><ix:continuation id="_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock-c0_cont_3"><p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="Superscript" style="vertical-align:super;font-size:6pt;"> (2)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><ix:footnote id="ix_14_footnote" xml:lang="en-US">The gross unrecognized tax benefits were accrued in British pounds.</ix:footnote></p></ix:continuation>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The gross unrecognized tax benefits and interest and penalties totaling $<ix:nonFraction contextRef="c346" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="3" unitRef="usd" id="ixv-27667">1,353</ix:nonFraction> at December&#160;31, 2022 is included in other non<span class="nobreak">-current</span> liabilities on the Consolidated Balance Sheets.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Income Tax Examinations</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company is subject to U.S.&#160;federal income tax as well as income tax of multiple state, local and certain foreign jurisdictions.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">ManJer&#8217;s tax returns (a Jersey<span class="nobreak">-based</span> subsidiary) were previously under review for the&#160;years ended December&#160;31, 2014, 2016, 2017 and 2018. In January&#160;2022, the audit was resolved in favor of ManJer. In addition, the Company&#8217;s tax returns were previously under review by the State of Michigan for the&#160;years ended 2017 through 2020. In August&#160;2022, the audit was resolved in favor of the Company.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">As of December&#160;31, 2023, with few exceptions, the Company was no longer subject to income tax examinations by any taxing authority for the&#160;years before 2019.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Undistributed Earnings of Foreign Subsidiaries</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">ASC&#160;740<span class="nobreak">-30</span> Income Taxes provides guidance that U.S.&#160;companies do not need to recognize tax effects on foreign earnings that are indefinitely reinvested. The Company repatriates earnings of its foreign subsidiaries and therefore has recognized a deferred tax liability of $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" scale="3" unitRef="usd" id="ixv-27668">186</ix:nonFraction> and $<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" scale="3" unitRef="usd" id="ixv-27669">205</ix:nonFraction> at December&#160;31, 2023 and 2022, respectively.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="_TreasuryStockTextBlock-c0_cont_1" escape="true" name="us-gaap:TreasuryStockTextBlock" id="ixv-25247"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">23. Shares Repurchased</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;">On February&#160;22, 2022, the Company&#8217;s Board of Directors approved an increase of $<ix:nonFraction contextRef="c369" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="3" unitRef="usd" id="ixv-27670">85,709</ix:nonFraction> to the Company&#8217;s share repurchase program to $<ix:nonFraction contextRef="c370" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="3" unitRef="usd" id="ixv-27671">100,000</ix:nonFraction> and extended the term for <span style="-sec-ix-hidden: hidden-fact-247">three</span>&#160;years through <ix:nonNumeric contextRef="c372" format="ixt:date-monthname-day-year-en" name="us-gaap:StockRepurchaseProgramExpirationDate" id="ixv-27672">April&#160;27, 2025</ix:nonNumeric>. Included under the Company&#8217;s share repurchase program are purchases to offset future equity grants made under the Company&#8217;s equity plans and purchases made in open market or privately negotiated transactions. This authority may be exercised from time to time, subject to regulatory considerations. The timing and actual number of shares repurchased will depend on a variety of factors including price, corporate and regulatory requirements, market conditions and other corporate liquidity requirements and priorities. The repurchase program may be suspended or terminated at any time without prior notice. Shares repurchased under this program are returned to the status of authorized and unissued on the Company&#8217;s books and records.</p></ix:nonNumeric>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-42</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<ix:continuation id="_TreasuryStockTextBlock-c0_cont_1"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">During the&#160;years ended December&#160;31, 2023, 2022 and 2021, the Company repurchased <ix:nonFraction contextRef="c373" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" unitRef="shares" id="ixv-27673">635,653</ix:nonFraction>, <ix:nonFraction contextRef="c374" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" unitRef="shares" id="ixv-27674">593,261</ix:nonFraction> and <ix:nonFraction contextRef="c375" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" unitRef="shares" id="ixv-27675">5,120,496</ix:nonFraction><span class="nobreak"> </span>shares of its common stock, respectively, under this program for an aggregate cost of $<ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" unitRef="usd" id="ixv-27676">3,570</ix:nonFraction>, $<ix:nonFraction contextRef="c19" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" unitRef="usd" id="ixv-27677">3,418</ix:nonFraction> and $<ix:nonFraction contextRef="c20" decimals="INF" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" unitRef="usd" id="ixv-27678">34,506</ix:nonFraction>, respectively. Shares repurchased under this program were returned to the status of authorized and unissued on the Company&#8217;s books and records.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">As of December&#160;31, 2023, $<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="3" unitRef="usd" id="ixv-27679">96,406</ix:nonFraction> remained under this program for future purchases.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In addition, as further described in Note&#160;11, the Company also repurchased its Series&#160;C Preferred Stock, which was convertible into <ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:ConversionOfStockSharesConverted1" scale="0" unitRef="shares" id="ixv-27680">13,087,000</ix:nonFraction><span class="nobreak"> </span>shares of common stock, from GBH, for aggregate cash consideration of $<ix:nonFraction contextRef="c376" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" unitRef="usd" id="ixv-27681">84,411</ix:nonFraction>. Under the terms of the transaction, the Company paid GBH $<ix:nonFraction contextRef="c377" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" scale="3" unitRef="usd" id="ixv-27682">40,000</ix:nonFraction> on the closing date, with the remainder of the purchase price payable in equal, interest<span class="nobreak">-free</span> installments on the first, second and third anniversaries of the closing date.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" continuedAt="_GoodwillAndIntangibleAssetsDisclosureTextBlock-c0_cont_1" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="ixv-25263"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">24. Goodwill and Intangible Assets</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Goodwill</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfGoodwillTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfGoodwillTextBlock" id="ixv-25269">The table below sets forth goodwill which is tested annually for impairment on November&#160;30<span class="Superscript" style="vertical-align:super;font-size:58%;">th</span>:</ix:nonNumeric></p>
		<ix:continuation continuedAt="_ScheduleOfGoodwillTextBlock-c0_cont_2" id="_ScheduleOfGoodwillTextBlock-c0_cont_1"><table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 23.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Total</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Balance at January&#160;1, 2023</p>
					</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" unitRef="usd" id="ixv-27683">85,856</ix:nonFraction>&#160;&#160;</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Changes</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="Superscript" style="vertical-align:super;font-size:6pt;">&#160;</span></p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="-sec-ix-hidden: hidden-fact-248; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">985<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Balance at December&#160;31, 2023</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" unitRef="usd" id="ixv-27684">86,841</ix:nonFraction>&#160;&#160;</p>	</td>
				</tr>

		</table></ix:continuation></ix:nonNumeric>
		<div style="border: none; border-top: windowtext 0pt none; border-top-style: solid; padding: 0in 0in 2.0pt 0in;"><p class="Tablefootnotef" style="margin-top: 0in;  border: none; margin-right: 0in; margin-bottom: -5pt; margin-left: 24.0pt; text-align: justify; text-justify: inter-ideograph; text-indent: -24.0pt; padding: 0in; font-size: 9.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">____________</p><ix:continuation continuedAt="_GoodwillAndIntangibleAssetsDisclosureTextBlock-c0_cont_2" id="_GoodwillAndIntangibleAssetsDisclosureTextBlock-c0_cont_1"><ix:continuation id="_ScheduleOfGoodwillTextBlock-c0_cont_2"><p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><ix:footnote id="ix_15_footnote" xml:lang="en-US">On April 11, 2023, the Company acquired <ix:nonFraction contextRef="c378" decimals="2" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" unitRef="pure" id="ixv-27686">100</ix:nonFraction>% of the capital stock of Securrency Transfers, Inc. (renamed WisdomTree Transfers, Inc.) for an aggregate purchase price of $<ix:nonFraction contextRef="c379" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:PaymentsToAcquireBusinessesGross" scale="3" unitRef="usd" id="ixv-27687">985</ix:nonFraction> (net of cash acquired). The acquisition has been accounted for under the acquisition method of accounting in accordance with ASC Topic 805, Business Combinations, and resulted in all consideration being allocated to goodwill</ix:footnote>.</p></ix:continuation></ix:continuation></div>
		<ix:continuation continuedAt="_GoodwillAndIntangibleAssetsDisclosureTextBlock-c0_cont_3" id="_GoodwillAndIntangibleAssetsDisclosureTextBlock-c0_cont_2"><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"> Goodwill was tested for impairment on November&#160;30, 2023. The quantitative impairment test was performed using a market approach, whereby the market capitalization of the Company (a single reporting unit) was compared to its carrying value. The market capitalization was derived from the Company&#8217;s publicly traded stock price plus a reasonable control premium. The fair value of the reporting unit exceeded its carrying value and therefore no impairment was recognized.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Of the total goodwill of $<ix:nonFraction contextRef="c380" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:Goodwill" scale="3" unitRef="usd" id="ixv-27688">86,841</ix:nonFraction> at December&#160;31, 2023, $<ix:nonFraction contextRef="c380" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" scale="3" unitRef="usd" id="ixv-27689">85,042</ix:nonFraction> is not deductible for tax purposes as the acquisitions that gave rise to the goodwill were structured as stock acquisitions. The remainder of the goodwill is deductible for U.S.&#160;tax purposes.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Intangible Assets</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="ixv-25318">The table below sets forth the Company&#8217;s intangible assets which are tested annually for impairment on November&#160;30<span class="Superscript" style="vertical-align:super;font-size:58%;">th</span>:</ix:nonNumeric></p>
		<ix:continuation continuedAt="_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock-c0_cont_2" id="_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock-c0_cont_1"><table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Balance at December&#160;31, 2023</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-left:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Item</span></p>
					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Gross Asset</span></p>
					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Accumulated <br/>Amortization</span></p>
					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Net Asset</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ETFS acquisition</p>
					</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c384" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" unitRef="usd" id="ixv-27690">601,247</ix:nonFraction></p>	</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-249; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c384" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" unitRef="usd" id="ixv-27691">601,247</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Software development</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c385" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" unitRef="usd" id="ixv-27692">4,519</ix:nonFraction></p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c385" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" unitRef="usd" id="ixv-27693">684</ix:nonFraction>)</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c385" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" unitRef="usd" id="ixv-27694">3,835</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Balance at December&#160;31, 2023</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" unitRef="usd" id="ixv-27695">605,766</ix:nonFraction></p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" unitRef="usd" id="ixv-27696">684</ix:nonFraction>)</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" unitRef="usd" id="ixv-27697">605,082</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation>
		<ix:continuation id="_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock-c0_cont_2"><table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Balance at December&#160;31, 2022</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Item</span></p>
					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Gross Asset</span></p>
					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Accumulated <br/>Amortization</span></p>
					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Net Asset</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ETFS acquisition</p>
					</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c386" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" unitRef="usd" id="ixv-27698">601,247</ix:nonFraction></p>	</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-250; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c386" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" unitRef="usd" id="ixv-27699">601,247</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Software development</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c387" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" unitRef="usd" id="ixv-27700">2,370</ix:nonFraction></p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c387" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" unitRef="usd" id="ixv-27701">50</ix:nonFraction>)</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c387" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" unitRef="usd" id="ixv-27702">2,320</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Balance at December&#160;31, 2022</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" unitRef="usd" id="ixv-27703">603,617</ix:nonFraction></p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(<ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" unitRef="usd" id="ixv-27704">50</ix:nonFraction>)</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" unitRef="usd" id="ixv-27705">603,567</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation></ix:continuation>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-43</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>



	<div class="Basic-Text-Frame" style="margin:0;padding:0;border-width:0;">
		<ix:continuation id="_GoodwillAndIntangibleAssetsDisclosureTextBlock-c0_cont_3"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:14pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">ETFS Acquisition (Indefinite-Lived)</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In connection with the ETFS Acquisition, which was completed on <ix:nonNumeric contextRef="c381" format="ixt:date-monthname-day-year-en" name="us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1" id="ixv-27706">April&#160;11, 2018</ix:nonNumeric>, the Company identified intangible assets valued at $<ix:nonFraction contextRef="c382" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" unitRef="usd" id="ixv-27707">601,247</ix:nonFraction> related to the right to manage AUM through customary advisory agreements. These intangible assets were determined to have indefinite useful lives and are not deductible for tax purposes.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company performed its indefinite<span class="nobreak">-lived</span> intangible asset impairment test related to these customary advisory agreements on November&#160;30, 2023. The results of this analysis identified no indicators of impairment to be recognized based upon a quantitative assessment (discounted cash flow analysis) which relied upon significant unobservable inputs including a projected revenue growth rate of <ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="wt:PercentageOfRevenueGrowth" scale="-2" unitRef="pure" id="ixv-27708">3</ix:nonFraction>% and a weighted average cost of capital of <ix:nonFraction contextRef="c5" decimals="3" format="ixt:num-dot-decimal" name="us-gaap:PercentageOfWeightedAverageCostInventory" scale="-2" unitRef="pure" id="ixv-27709">10.5</ix:nonFraction>%.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Software Development (Finite-Lived)</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Internally<span class="nobreak">-developed</span> software is amortized over a useful life of <span style="-sec-ix-hidden: hidden-fact-252">three</span>&#160;years. During the&#160;years ended December&#160;31, 2023 and 2022, the Company recognized amortization expense on internally<span class="nobreak">-developed</span> software of $<ix:nonFraction contextRef="c66" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" unitRef="usd" id="ixv-27710">634</ix:nonFraction> and $<ix:nonFraction contextRef="c383" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" unitRef="usd" id="ixv-27711">50</ix:nonFraction>, respectively.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock-c0_cont_1" escape="true" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="ixv-25495">As of December&#160;31, 2023, expected amortization expense for the unamortized finite<span class="nobreak">-lived</span> intangible assets for the next <span style="-sec-ix-hidden: hidden-fact-253">five</span>&#160;years and thereafter is as follows:</ix:nonNumeric></p>
		<ix:continuation id="_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock-c0_cont_1"><table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2024</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" unitRef="usd" id="ixv-27712">1,375</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2025</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" unitRef="usd" id="ixv-27713">1,440</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2026</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" unitRef="usd" id="ixv-27714">873</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2027</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" unitRef="usd" id="ixv-27715">130</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2028</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" unitRef="usd" id="ixv-27716">17</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2029 and thereafter</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-251; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-15" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Total expected amortization expense</p>
					</td>
					<td class="Table60- TB CellOverride-16" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-16" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-16" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c5" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" unitRef="usd" id="ixv-27717">3,835</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;">The weighted<span class="nobreak">-average</span> remaining useful life of the finite<span class="nobreak">-lived</span> intangible assets is <span style="-sec-ix-hidden: hidden-fact-254">2.6</span>&#160;years.</p></ix:continuation>
		<ix:nonNumeric contextRef="c0" escape="true" name="wt:ContingentPaymentTextBlock" id="ixv-25560"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">25. Contingent Payments</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company recognized a gain of $<ix:nonFraction contextRef="c388" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="3" unitRef="usd" id="ixv-27718">1,477</ix:nonFraction> and $<ix:nonFraction contextRef="c389" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="3" unitRef="cad" id="ixv-27719">787</ix:nonFraction> during the&#160;years ended December&#160;31, 2023 and 2021, respectively, from remeasuring contingent payments arising from the sale of its former Canadian ETF business to their realizable value. These gains were recorded in other losses, net.</p></ix:nonNumeric>
		<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:AssetImpairmentChargesTextBlock" id="ixv-25564"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">26. Impairments</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><ix:nonNumeric contextRef="c0" continuedAt="_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock-c0_cont_1" escape="true" name="us-gaap:DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" id="ixv-27720">The following table summarizes impairments recognized by the Company:</ix:nonNumeric></p>
		<ix:continuation id="_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock-c0_cont_1"><table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;">


				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Lease termination&#8211;New&#160;York office (Note&#160;13)</p>
					</td>
					<td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-255; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-256; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c392" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="3" unitRef="usd" id="ixv-27721">9,277</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Fixed assets&#8211;New&#160;York office (Note&#160;8)</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-257; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-258; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c395" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="3" unitRef="usd" id="ixv-27722">6,576</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Lease termination&#8211;London office (Note&#160;13)</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-259; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-260; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c398" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="3" unitRef="usd" id="ixv-27723">303</ix:nonFraction></p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Securrency (Note&#160;7)</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c399" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="3" unitRef="usd" id="ixv-27724">7,630</ix:nonFraction></p>	</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-261; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-262; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other investments (Note&#160;7)</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c402" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="3" unitRef="usd" id="ixv-27725">312</ix:nonFraction></p>	</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-263; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-264; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="3" unitRef="usd" id="ixv-27726">7,942</ix:nonFraction></p>	</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-265; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><ix:nonFraction contextRef="c20" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="3" unitRef="usd" id="ixv-27727">16,156</ix:nonFraction></p>	</td>
				</tr>

		</table></ix:continuation></ix:nonNumeric>
		<ix:nonNumeric contextRef="c0" escape="true" name="us-gaap:SubsequentEventsTextBlock" id="ixv-25698"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:14pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">27. Subsequent Events</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company evaluated subsequent events through the date of issuance of the consolidated financial statements. There were no events requiring disclosure.</p></ix:nonNumeric>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">F-44</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>




	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">EXHIBIT INDEX</span></p>
		<table class="No-Table-Style" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">

						<p class="TCH_left" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:9pt;">Exhibit Number</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:9pt;">Description</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">3.1</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312511084915/dex31.htm">Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 of the Registrant&#8217;s Registration Statement on Form&#160;10, filed with the SEC on March&#160;31, 2011)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">3.2</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312522278698/d213103dex31.htm">Certificate of Amendment to the Amended and Restated Certificate of Incorporation (Name Change) (incorporated by reference to Exhibit 3.1 of the Registrant&#8217;s Current Report on Form&#160;8-K, filed with the SEC on November&#160;7, 2022)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">3.3</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312522198126/d354970dex31.htm">Certificate of Amendment to the Amended and Restated Certificate of Incorporation (Declassification of Board of Directors) (incorporated by reference to Exhibit 3.1 of the Registrant&#8217;s Current Report on Form&#160;8-K, filed with the SEC on July&#160;20, 2022)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">3.4</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312522198126/d354970dex32.htm">Certificate of Amendment to the Amended and Restated Certificate of Incorporation (Increase in Authorized Shares) (incorporated by reference to Exhibit 3.2 of the Registrant&#8217;s Current Report on Form&#160;8-K, filed with the SEC on July&#160;20, 2022)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">3.5</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312518116454/d563842dex31.htm">Certificate of Designations of Series&#160;A Non-Voting Convertible Preferred Stock of the Registrant (incorporated by reference to Exhibit 3.1 of the Registrant&#8217;s Current Report on Form&#160;8-K filed with the SEC on April&#160;13, 2018)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">3.6</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312523074123/d469501dex31.htm">Certificate of Designations of Series&#160;B Junior Participating Cumulative Preferred Stock of the Registrant (incorporated by reference to Exhibit 3.1 of the Registrant&#8217;s Registration Statement on Form&#160;8-A filed with the SEC on March&#160;20, 2023)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">3.7</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312523140747/d503634dex31.htm">Certificate of Designations of Series&#160;C Non-Voting Convertible Preferred Stock of the Registrant (incorporated by reference to Exhibit 3.1 of the Registrant&#8217;s Current Report on Form&#160;8-K, filed with the SEC on May&#160;10, 2023)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">3.8</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000121465923015375/ex3_1.htm">Certificate of Elimination of Series&#160;C Non-Voting Convertible Preferred Stock of the Registrant (incorporated by reference to Exhibit 3.1 of the Registrant&#8217;s Current Report on Form&#160;8-K, filed with the SEC on November&#160;20, 2023)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">3.9</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312522278698/d213103dex32.htm">Fourth Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 of the Registrant&#8217;s Current Report on Form&#160;8-K, filed with the SEC on November&#160;7, 2022)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">4.1</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312511084915/dex41.htm">Specimen Common Stock Certificate (incorporated by reference to Exhibit 4.1 of the Registrant&#8217;s Registration Statement on Form&#160;10, filed with the SEC on March&#160;31, 2011)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">4.2</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312511084915/dex42.htm">Amended and Restated Stockholders Agreement among the Registrant and certain investors dated December&#160;21, 2006 (incorporated by reference to Exhibit 4.2 of the Registrant&#8217;s Registration Statement on Form&#160;10, filed with the SEC on March&#160;31, 2011)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">4.3</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312511084915/dex43.htm">Securities Purchase Agreement among the Registrant and certain investors dated December&#160;21, 2006 (incorporated by reference to Exhibit 4.3 of the Registrant&#8217;s Registration Statement on Form&#160;10, filed with the SEC on March&#160;31, 2011)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">4.4</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312511084915/dex44.htm">Securities Purchase Agreement among the Registrant and certain investors dated October&#160;15, 2009 (incorporated by reference to Exhibit 4.4 of the Registrant&#8217;s Registration Statement on Form&#160;10, filed with the SEC on March&#160;31, 2011)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">4.5</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312511084915/dex45.htm">Third Amended and Restated Registration Rights Agreement dated October&#160;15, 2009 (incorporated by reference to Exhibit 4.5 of the Registrant&#8217;s Registration Statement on Form&#160;10, filed with the SEC on March&#160;31, 2011)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">4.6</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312518116454/d563842dex41.htm">Investor Rights Agreement, dated April&#160;11, 2018, between the Registrant and ETFS Capital (incorporated by reference to Exhibit 4.1 of the Registrant&#8217;s Current Report on Form&#160;8-K filed with the SEC on April&#160;13, 2018)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">4.7</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312520170621/d944078dex41.htm">Indenture, dated as of June&#160;16, 2020, by and between the Registrant and U.S.&#160;Bank National Association, as Trustee (incorporated by reference to Exhibit 4.1 of the Registrant&#8217;s Current Report on Form&#160;8-K filed with the SEC on June&#160;17, 2020)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">4.8</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312520170621/d944078dex41.htm">Form of Global Note, representing the Registrant&#8217;s 4.25% Convertible Senior Notes due 2023 (included as Exhibit A to the Indenture filed as Exhibit 4.1 of the Registrant&#8217;s Current Report on Form&#160;8-K filed with the SEC on June&#160;17, 2020)</a></p>
					</td>
				</tr>

		</table>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">&#160;</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>


	<div class="Basic-Text-Frame" style="margin:0;padding:0;border-width:0;">
		<table class="No-Table-Style" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">

						<p class="TCH_left" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:9pt;">Exhibit Number</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:9pt;">Description</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">4.9</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312521190085/d156828dex41.htm">Indenture, dated as of June&#160;14, 2021, by and between the Registrant and U.S.&#160;Bank National Association, as Trustee (incorporated by reference to Exhibit 4.1 of the Registrant&#8217;s Current Report on Form&#160;8-K filed with the SEC on June&#160;14, 2021)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">4.10</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312521190085/d156828dex42.htm">Form of Global Note, representing the Registrant&#8217;s 3.25% Convertible Senior Notes due 2026 (incorporated by reference to Exhibit 4.2 of the Registrant&#8217;s Current Report on Form&#160;8-K filed with the SEC on June&#160;14, 2021)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">4.11</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312523039327/d457595dex41.htm">Indenture, dated as of February&#160;14, 2023, by and between the Registrant and U.S.&#160;Bank National Association, as Trustee (incorporated by reference to Exhibit 4.1 of the Registrant&#8217;s Current Report on Form&#160;8-K filed with the SEC on February&#160;14, 2023)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">4.12</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="https://www.sec.gov/Archives/edgar/data/880631/000119312523039327/d457595dex42.htm">Form of Global Note, representing the Registrant&#8217;s 5.75% Convertible Senior Notes due 2028 (incorporated by reference to Exhibit 4.2 of the Registrant&#8217;s Current Report on Form&#160;8-K filed with the SEC on February&#160;14, 2023)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">4.13</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312523074123/d469501dex41.htm">Stockholder Rights Agreement, dated March&#160;17, 2023, between the Registrant and Continental Stock Transfer&#160;&amp; Trust Company, as Rights Agent (incorporated by reference to Exhibit 4.1 of the Registrant&#8217;s Registration Statement on Form&#160;8-A filed with the SEC on March&#160;20, 2023)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">4.14</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312523137101/d380576dex41.htm">Amendment No. 1 to Stockholder Rights Agreement, dated as of May&#160;4, 2023, between the Registrant and Continental Stock Transfer&#160;&amp; Trust Company, as Rights Agent (incorporated by reference to Exhibit 4.1 of the Registrant&#8217;s Current Report on Form&#160;8-K filed with the SEC on May&#160;5, 2023)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">4.15</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312523140747/d503634dex42.htm">Amendment No. 2 to Stockholder Rights Agreement, dated as of May&#160;10, 2023, between the Registrant and Continental Stock Transfer&#160;&amp; Trust Company, as Rights Agent (incorporated by reference to Exhibit 4.2 of the Registrant&#8217;s Current Report on Form&#160;8-K, filed with the SEC on May&#160;10, 2023)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">4.16</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312523140747/d503634dex41.htm">Investor Rights Agreement, dated as of May&#160;10, 2023, by and between the Registrant and Gold Bullion Holdings (Jersey) Limited (incorporated by reference to Exhibit 4.1 of the Registrant&#8217;s Current Report on Form&#160;8-K, filed with the SEC on May&#160;10, 2023)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">4.17</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000121465923015375/ex4_1.htm">Termination Agreement, dated as of November&#160;20, 2023, by and between Gold Bullion Holdings (Jersey) Limited and WisdomTree, Inc. (incorporated by reference to Exhibit 4.1 of the Registrant&#8217;s Current Report on Form&#160;8-K, filed with the SEC on November&#160;20, 2023)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.1</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312511084915/dex101.htm">Representative Form of Advisory Agreement between WisdomTree Asset Management, Inc. and WisdomTree Trust (incorporated by reference to Exhibit 10.1 of the Registrant&#8217;s Registration Statement on Form&#160;10, filed with the SEC on March&#160;31, 2011)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.2</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312511084915/dex1034.htm">Form of Proprietary Rights and Confidentiality Agreement (incorporated by reference to Exhibit&#160;10.34 of the Registrant&#8217;s Registration Statement on Form&#160;10, filed with the SEC on March&#160;31, 2011)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.3</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312511151715/dex1035.htm">Form of Indemnification Agreement for Officers and Directors (incorporated by reference to Exhibit&#160;10.35 of the Registrant&#8217;s Amendment to Registration Statement on Form&#160;10, filed with the SEC on May&#160;26, 2011)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.4</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312512230654/d331608dex102.htm">Amended and Restated License Agreement between the Registrant and WisdomTree Trust dated March&#160;1, 2012 (incorporated by reference to Exhibit 10.2 of the Registrant&#8217;s Quarterly Report on Form&#160;10-Q filed with the SEC on May&#160;14, 2012)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.5</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312516676716/d232510dex101.htm">WisdomTree Investments, Inc. 2016 Equity Plan (incorporated by reference to Exhibit 10.1 of the Registrant&#8217;s Quarterly Report on Form&#160;10-Q filed with the SEC on August&#160;9, 2016)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.6</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312516803273/d318993dex101.htm">Form of Employment Agreement for Executive Officers dated December&#160;22, 2016 (incorporated by reference to Exhibit 10.1 of the Registrant&#8217;s Current Report on Form&#160;8-K filed with the SEC on December&#160;23, 2016)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.7(a)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312516803273/d318993dex101a.htm">Appendix A to Employment Agreement between the Registrant and Jonathan Steinberg, dated December&#160;22, 2016 (incorporated by reference to Exhibit 10.1(A)&#160;of the Registrant&#8217;s Current Report on Form&#160;8-K filed with the SEC on December&#160;23, 2016)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.7(b)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312516803273/d318993dex101e.htm">Appendix A to Employment Agreement between the Registrant and Peter M.&#160;Ziemba, dated December&#160;22, 2016 (incorporated by reference to Exhibit 10.1(E)&#160;of the Registrant&#8217;s Current Report on Form&#160;8-K filed with the SEC on December&#160;23, 2016)</a></p>
					</td>
				</tr>

		</table>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">&#160;</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>


	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<table class="No-Table-Style" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">

						<p class="TCH_left" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:9pt;">Exhibit Number</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:9pt;">Description</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.8</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312517162660/d379196dex101.htm">Form of Amendment, dated May&#160;5, 2017, to Form of Employment Agreement for Executive Officers, dated December&#160;22, 2016 (incorporated by reference to Exhibit 10.1 of the Registrant&#8217;s Quarterly Report on Form&#160;10-Q filed with the SEC on May&#160;8, 2017)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.9</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312518066712/d533910dex1019.htm">Employment Agreement between the Registrant and R.&#160;Jarrett Lilien, dated November&#160;27, 2017 (incorporated by reference to Exhibit 10.19 of the Registrant&#8217;s Annual Report on Form&#160;10-K filed with the SEC on March&#160;1, 2018)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.10</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312520287606/d928858dex101.htm">Employment Agreement between the Registrant and Marci Frankenthaler, dated November&#160;5, 2020 (incorporated by reference to Exhibit 10.1 of the Registrant&#8217;s Quarterly Report on Form&#160;10-Q filed with the SEC on November&#160;6, 2020)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-7" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.11</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312523139497/d452823dex102.htm">Form of Amendment, dated April&#160;21, 2023, to Employment Agreements between the Registrant and each of Jonathan Steinberg, Peter M.&#160;Ziemba, R.&#160;Jarrett Lilien and Marci Frankenthaler (incorporated by reference to Exhibit 10.2 of the Registrant&#8217;s Quarterly Report on Form&#160;10-Q, filed with the SEC on May&#160;9, 2023)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.12</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312518066712/d533910dex46.htm">Share Sale Agreement among the Registrant, WisdomTree International and ETFS Capital dated November&#160;13, 2017 (incorporated by reference to Exhibit 4.6 of the Registrant&#8217;s Annual Report on Form&#160;10-K filed with the SEC on March&#160;1, 2018)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.13</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312518116454/d563842dex102.htm">Waiver and Variation Agreement, dated April&#160;11, 2018, by and among the Registrant, WisdomTree International and ETFS Capital (incorporated by reference to Exhibit 10.2 of the Registrant&#8217;s Current Report on Form&#160;8-K filed with the SEC on April&#160;13, 2018)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.14</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312519060708/d698907dex1015.htm">Form of Restricted Stock Agreement for Executive Officers (2016 Equity Plan) (incorporated by reference to Exhibit 10.15 of the Registrant&#8217;s Annual Report on Form&#160;10-K filed with the SEC on March&#160;1, 2019)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.15</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312521145238/d108124dex1021.htm">Employment Agreement between the Registrant and Alexis Marinof, dated June&#160;8, 2017 (incorporated by reference to Exhibit 10.21 of Amendment No. 1 to the Registrant&#8217;s Annual Report on Form&#160;10-K on Form&#160;10-K/A filed with the SEC on April&#160;30, 2021)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.16</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312521145238/d108124dex1022.htm">Amendment to Employment Agreement between the Registrant and Alexis Marinof, dated July&#160;20, 2017 (incorporated by reference to Exhibit 10.22 of Amendment No. 1 to the Registrant&#8217;s Annual Report on Form&#160;10-K on Form&#160;10-K/A filed with the SEC on April&#160;30, 2021)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.17</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312523139497/d452823dex101.htm">Amendment to Employment Agreement between the Registrant and Alexis Marinof, dated April&#160;21, 2023 (incorporated by reference to Exhibit 10.1 of the Registrant&#8217;s Quarterly Report on Form&#160;10-Q, filed with the SEC on May&#160;9, 2023)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-7" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.18</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312521145238/d108124dex1023.htm">Form of Performance-Based Restricted Stock Unit Award Agreement for U.S.&#160;Executive Officers applicable to grants after January&#160;1, 2021 and prior to January&#160;1, 2023 (2016 Equity Plan) (incorporated by reference to Exhibit 10.23 of Amendment No. 1 to the Registrant&#8217;s Annual Report on Form&#160;10-K on Form&#160;10-K/A filed with the SEC on April&#160;30, 2021)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-7" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.19</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312521145238/d108124dex1024.htm">Form of Performance-Based Restricted Stock Unit Award Agreement for U.K.&#160;Executive Officers applicable to grants after January&#160;1, 2021 and prior to January&#160;1, 2023 (2016 Equity Plan) (incorporated by reference to Exhibit 10.24 of Amendment No. 1 to the Registrant&#8217;s Annual Report on Form&#160;10-K on Form&#160;10-K/A filed with the SEC on April&#160;30, 2021)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.20</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312522200997/d145669dex991.htm">WisdomTree Investments, Inc. 2022 Equity Plan (incorporated by reference to Exhibit 99.1 of the Registrant&#8217;s Registration Statement on Form&#160;S-8 filed with the SEC on July&#160;25, 2022)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.21</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312522277525/d404266dex101.htm">Form of Restricted Stock Agreement for Non-Employee Directors (2022 Equity Plan) (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Quarterly Report on Form&#160;10-Q filed with the SEC on November&#160;4, 2022)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.22</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312522277525/d404266dex102.htm">Form of Restricted Stock Unit Award Agreement (Deferred) for Non-Employee Directors (2022 Equity Plan) (incorporated by reference to Exhibit 10.2 to the Registrant&#8217;s Quarterly Report on Form&#160;10-Q filed with the SEC on November&#160;4, 2022)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.23</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312523054126/d426509dex1026.htm">Non-Employee Director Deferred Compensation Program (incorporated by reference to Exhibit 10.26 to the Registrant&#8217;s Annual Report on Form&#160;10-K filed with the SEC on February&#160;28, 2023)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.24</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="https://www.sec.gov/Archives/edgar/data/880631/000119312523054126/d426509dex1023.htm">Form of Restricted Stock Agreement for Executive Officers applicable to grants after January 1, 2023 and prior to January 1, 2024 (2022 Equity Plan) (incorporated by reference to Exhibit 10.23 to the Registrant&#8217;s Annual Report on Form 10-K filed with the SEC on February 28, 2023)</a></p>
					</td>
				</tr>

		</table>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">&#160;</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>


	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<table class="No-Table-Style" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">

						<p class="TCH_left" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:9pt;">Exhibit Number</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-size:9pt;">Description</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.25</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312523054126/d426509dex1024.htm">Form of Performance-Based Restricted Stock Unit Award Agreement for U.S.&#160;Executive Officers applicable to grants after January&#160;1, 2023 (2022 Equity Plan) (incorporated by reference to Exhibit&#160;10.24 to the Registrant&#8217;s Annual Report on Form&#160;10-K filed with the SEC on February&#160;28, 2023)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.26</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312523054126/d426509dex1025.htm">Form of Performance-Based Restricted Stock Unit Award Agreement for U.K.&#160;Executive Officers applicable to grants after January&#160;1, 2023 (2022 Equity Plan) (incorporated by reference to Exhibit&#160;10.25 to the Registrant&#8217;s Annual Report on Form&#160;10-K filed with the SEC on February&#160;28, 2023)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.27</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312523139497/d452823dex103.htm">WisdomTree, Inc. Executive Severance Plan (incorporated by reference to Exhibit 10.3 of the Registrant&#8217;s Quarterly Report on Form&#160;10-Q, filed with the SEC on May&#160;9, 2023)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.28</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312523139497/d452823dex104.htm">Form of Employee Confidentiality, Assignment and Restrictive Covenant Agreement executed by participants of the WisdomTree, Inc. Executive Severance Plan (incorporated by reference to Exhibit&#160;10.4 of the Registrant&#8217;s Quarterly Report on Form&#160;10-Q, filed with the SEC on May&#160;9, 2023)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-8" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.29*</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000119312523140747/d503634dex101.htm">Sale, Purchase and Assignment Deed, dated as of May&#160;10, 2023, by and between the Registrant, WisdomTree International Holdings Ltd, Electra Target HoldCo Limited, ETFS Capital Limited, World Gold Council, Gold Bullion Holdings (Jersey) Limited, Rodber Investments Limited and Graham Tuckwell (incorporated by reference to Exhibit 10.1 of the Registrant&#8217;s Current Report on Form&#160;8-K, filed with the SEC on May&#160;10, 2023)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-6" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.30</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="http://www.sec.gov/Archives/edgar/data/880631/000121465923015375/ex10_1.htm">Stock Repurchase Agreement, dated as of November&#160;20, 2023, by and between WisdomTree, Inc. and Gold Bullion Holdings (Jersey) Limited (incorporated by reference to Exhibit 10.1 of the Registrant&#8217;s Current Report on Form&#160;8-K, filed with the SEC on November&#160;20, 2023)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">10.31<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="ex10-31.htm">Form of Restricted Stock Agreement for Executive Officers applicable to grants after January 1, 2024 (2022 Equity Plan)</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">21.1<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="ex21-1.htm">Subsidiaries of the Registrant</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">23.1<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="ex23-1.htm">Consent of Ernst&#160;&amp; Young LLP, independent registered public accounting firm</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">31.1<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="ex31-1.htm">Rule&#160;13a-14(a)&#160;/ 15d-14(a)&#160;Certification</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">31.2<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="ex31-2.htm">Rule&#160;13a-14(a)&#160;/ 15d-14(a)&#160;Certification</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">32.1<span class="Superscript" style="vertical-align:super;font-size:6pt;">(2)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="ex32-1.htm">Certification pursuant to 18 U.S.C.&#160;Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act&#160;of&#160;2002</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-9" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">97<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"><a href="ex97.htm">Amended and Restated Compensation Clawback Policy</a></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-10" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">101</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Financial Statements from the Annual Report on Form&#160;10-K of the Company are attached to this report, formatted in XBRL pursuant to Rule&#160;405 of Regulation&#160;S-T: (i)&#160;Consolidated Balance Sheets at December&#160;31, 2023 and December&#160;31, 2022; (ii)&#160;Consolidated Statements of Operations for the&#160;years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021; (iii)&#160;Consolidated Statements of Comprehensive Income/(Loss) for the&#160;years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021; (iv)&#160;Consolidated Statements of Changes in Stockholders&#8217; Equity for the&#160;years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021; (v)&#160;Consolidated Statements of Cash Flows for the&#160;years ended December&#160;31, 2023, December&#160;31, 2022 and December&#160;31, 2021 and (vi)&#160;Notes to the Consolidated Financial Statements.</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">101.SCH</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Inline XBRL Taxonomy Extension Schema Document</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">101.CAL</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Inline XBRL Taxonomy Extension Calculation Linkbase Document</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">101.DEF</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Inline XBRL Taxonomy Extension Definition Linkbase Document</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">101.LAB</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Inline XBRL Taxonomy Extension Labels Linkbase Document</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">101.PRE</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Inline XBRL Taxonomy Extension Presentation Linkbase Document</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-5" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:6pt;vertical-align:top;width: 10.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:11pt;">104<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 88.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_nowrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101.*)</p>
					</td>
				</tr>

		</table>
		<div style="border: none; border-top: windowtext 0pt none; border-top-style: solid; padding: 0in 0in 2.0pt 0in;"><p class="Tablefootnotef" style="margin-top: 0in;  border: none; margin-right: 0in; margin-bottom: -5pt; margin-left: 24.0pt; text-align: justify; text-justify: inter-ideograph; text-indent: -24.0pt; padding: 0in; font-size: 9.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">____________</p><p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;text-align:left;margin-top:10pt;"><span class="CharOverride-3" style="font-size:8pt;">*<span style="width: 13px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>Schedules and exhibits to these Exhibits have been omitted in accordance with Item&#160;601 of Regulation&#160;S<span class="nobreak">-K</span>.&#160;The Company agrees to furnish supplementally a copy of all omitted schedules and exhibits to the Securities and Exchange Commission or its staff upon request.</p></div>
		<p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;text-align:left;margin-top:0pt;"><span class="Superscript" style="vertical-align:super;font-size:6pt;"> (1)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>Filed herewith.</p>
		<p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;text-align:left;margin-top:0pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(2)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>Furnished herewith.</p>
		</div>

		<p class="LRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">&#160;</p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:2;margin-top:8pt;"><a href="#TOC001">Table of Contents</a></p>


	<div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold-AllCaps" style="font-style:normal;font-variant:normal;font-weight:bold;text-transform:uppercase;">SIGNATURES</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Pursuant to the requirements of Section&#160;13 or 15(d)&#160;of the Securities Exchange&#160;Act&#160;of&#160;1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>
		<table class="No-Table-Style" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-14" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 55.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" colspan="3" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 42.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">WISDOMTREE, INC.</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;width: 55.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 3.42%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;">By:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 38.14%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="Signature_rule" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;text-align:center;">/s/<span class="CharOverride-4"> Jonathan Steinberg</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 55.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">February&#160;23, 2024</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 3.42%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 38.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;"><span class="Bold" style="font-style:normal;font-weight:bold;">Jonathan Steinberg<br/>Chief Executive Officer and Director</span></p>
					</td>
				</tr>

		</table>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Pursuant to the requirements of the Securities Exchange&#160;Act&#160;of&#160;1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated below on the 23<span class="Superscript" style="vertical-align:super;font-size:58%;">rd</span>&#160;day of February,&#160;2024.</p>
		<table class="No-Table-Style" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-19" style="height:12pt;">
					<td class="No-Table-Style TCH" style="width: 40.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">

						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Signature</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 57.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Title</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 40.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="top">
						<p class="Signature_rule" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;text-align:center;">/s/ Jonathan Steinberg</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 57.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;text-align:center;">Chief Executive Officer and Director</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-14" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 40.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;"><span class="Bold" style="font-style:normal;font-weight:bold;">Jonathan Steinberg</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 57.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;">(Principal Executive Officer)</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 40.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="top">
						<p class="Signature_rule" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;text-align:center;">/s/ Bryan Edmiston</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 57.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;text-align:center;">Chief Financial Officer</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-14" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 40.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;"><span class="Bold" style="font-style:normal;font-weight:bold;">Bryan Edmiston</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 57.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;">(Principal Financial Officer and Principal Accounting Officer)</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 40.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="top">
						<p class="Signature_rule" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;text-align:center;">/s/ Win Neuger</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 57.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;text-align:center;">Non<span class="nobreak">-Executive</span> Chair of the Board</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-14" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 40.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;"><span class="Bold" style="font-style:normal;font-weight:bold;">Win Neuger</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 57.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 40.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="top">
						<p class="Signature_rule" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;text-align:center;">/s/ Lynn S.&#160;Blake</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 57.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;text-align:center;">Director</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-14" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 40.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;"><span class="Bold" style="font-style:normal;font-weight:bold;">Lynn S.&#160;Blake</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 57.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 40.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="top">
						<p class="Signature_rule" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;text-align:center;">/s/ Anthony Bossone</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 57.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;text-align:center;">Director</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-14" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 40.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;"><span class="Bold" style="font-style:normal;font-weight:bold;">Anthony Bossone</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 57.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 40.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="top">
						<p class="Signature_rule" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;text-align:center;">/s/ Smita Conjeevaram</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 57.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;text-align:center;">Director</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-14" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 40.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;"><span class="Bold" style="font-style:normal;font-weight:bold;">Smita Conjeevaram</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 57.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 40.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="top">
						<p class="Signature_rule" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;text-align:center;">/s/ Rilla Delorier</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 57.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;text-align:center;">Director</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-14" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 40.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;"><span class="Bold" style="font-style:normal;font-weight:bold;">Rilla Delorier</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 57.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 40.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="top">
						<p class="Signature_rule" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;text-align:center;">/s/ Daniela Mielke</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 57.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;text-align:center;">Director</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-14" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 40.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;"><span class="Bold" style="font-style:normal;font-weight:bold;">Daniela Mielke</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 57.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 40.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="top">
						<p class="Signature_rule" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;text-align:center;">/s/ Shamla Naidoo</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 57.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;text-align:center;">Director</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-14" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 40.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;"><span class="Bold" style="font-style:normal;font-weight:bold;">Shamla Naidoo</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 57.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 40.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="top">
						<p class="Signature_rule" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;text-align:center;">/s/ Tonia Pankopf</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 57.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;text-align:center;">Director</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-14" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 40.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;"><span class="Bold" style="font-style:normal;font-weight:bold;">Tonia Pankopf</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 57.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">&#160;</td>
				</tr>

		</table>
		</div>

		<p class="RRH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">&#160;</p>


</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonFraction contextRef="c5" id="hidden-fact-0" name="wt:IndemnificationReceivableNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-1" name="us-gaap:ConvertibleDebtCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-2" name="wt:DeferredConsiderationCurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-3" name="wt:DeferredConsiderationNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-4" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-5" name="us-gaap:OtherLiabilitiesNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-6" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-7" name="us-gaap:CommitmentsAndContingencies" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-8" name="us-gaap:PreferredStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-9" name="us-gaap:PreferredStockValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-10" name="us-gaap:GoodwillImpairmentLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-11" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-12" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-13" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-14" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-15" name="wt:StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-16" name="wt:StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-17" name="wt:StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c32" id="hidden-fact-18" name="wt:TemporaryEquityShareOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c32" id="hidden-fact-19" name="wt:TemporaryStockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-20" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-21" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-22" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c31" id="hidden-fact-23" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-24" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-25" name="us-gaap:StockRepurchasedDuringPeriodShares" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-26" name="us-gaap:StockRepurchasedDuringPeriodValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-27" name="us-gaap:StockRepurchasedDuringPeriodValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c31" id="hidden-fact-28" name="us-gaap:StockRepurchasedDuringPeriodValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-29" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-30" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-31" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c31" id="hidden-fact-32" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-33" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-34" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-35" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c31" id="hidden-fact-36" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-37" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-38" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-39" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c31" id="hidden-fact-40" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-41" name="us-gaap:Dividends" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-42" name="us-gaap:Dividends" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-43" name="us-gaap:Dividends" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-44" name="us-gaap:Dividends" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c27" id="hidden-fact-45" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c28" id="hidden-fact-46" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c29" id="hidden-fact-47" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c30" id="hidden-fact-48" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c32" id="hidden-fact-49" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c32" id="hidden-fact-50" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c38" id="hidden-fact-51" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c38" id="hidden-fact-52" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c41" id="hidden-fact-53" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c42" id="hidden-fact-54" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-55" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c38" id="hidden-fact-56" name="us-gaap:StockRepurchasedDuringPeriodShares" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c38" id="hidden-fact-57" name="us-gaap:StockRepurchasedDuringPeriodValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c41" id="hidden-fact-58" name="us-gaap:StockRepurchasedDuringPeriodValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c42" id="hidden-fact-59" name="us-gaap:StockRepurchasedDuringPeriodValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c38" id="hidden-fact-60" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-61" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c41" id="hidden-fact-62" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c42" id="hidden-fact-63" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c38" id="hidden-fact-64" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-65" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c40" id="hidden-fact-66" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c42" id="hidden-fact-67" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c38" id="hidden-fact-68" name="us-gaap:Dividends" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-69" name="us-gaap:Dividends" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c41" id="hidden-fact-70" name="us-gaap:Dividends" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c38" id="hidden-fact-71" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-72" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c40" id="hidden-fact-73" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c41" id="hidden-fact-74" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c43" id="hidden-fact-75" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c43" id="hidden-fact-76" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c48" id="hidden-fact-77" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c48" id="hidden-fact-78" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c51" id="hidden-fact-79" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c52" id="hidden-fact-80" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-81" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c48" id="hidden-fact-82" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c48" id="hidden-fact-83" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c51" id="hidden-fact-84" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c52" id="hidden-fact-85" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c48" id="hidden-fact-86" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c49" id="hidden-fact-87" name="us-gaap:StockIssuedDuringPeriodSharesOther" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c49" id="hidden-fact-88" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c51" id="hidden-fact-89" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c52" id="hidden-fact-90" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c48" id="hidden-fact-91" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c49" id="hidden-fact-92" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c49" id="hidden-fact-93" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c51" id="hidden-fact-94" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c52" id="hidden-fact-95" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c48" id="hidden-fact-96" name="us-gaap:StockRepurchasedDuringPeriodShares" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c48" id="hidden-fact-97" name="us-gaap:StockRepurchasedDuringPeriodValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c51" id="hidden-fact-98" name="us-gaap:StockRepurchasedDuringPeriodValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c52" id="hidden-fact-99" name="us-gaap:StockRepurchasedDuringPeriodValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c48" id="hidden-fact-100" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c49" id="hidden-fact-101" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c51" id="hidden-fact-102" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c52" id="hidden-fact-103" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c48" id="hidden-fact-104" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c49" id="hidden-fact-105" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c50" id="hidden-fact-106" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c52" id="hidden-fact-107" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c48" id="hidden-fact-108" name="us-gaap:Dividends" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c49" id="hidden-fact-109" name="us-gaap:Dividends" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c50" id="hidden-fact-110" name="us-gaap:Dividends" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c51" id="hidden-fact-111" name="us-gaap:Dividends" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c48" id="hidden-fact-112" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c49" id="hidden-fact-113" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c50" id="hidden-fact-114" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c51" id="hidden-fact-115" name="us-gaap:NetIncomeLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c53" id="hidden-fact-116" name="us-gaap:SharesOutstanding" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c53" id="hidden-fact-117" name="us-gaap:StockholdersEquity" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-118" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-119" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-120" name="us-gaap:GoodwillImpairmentLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-121" name="us-gaap:InterestExpenseDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-122" name="us-gaap:InterestExpenseDebt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-123" name="us-gaap:RealizedInvestmentGainsLosses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-124" name="us-gaap:RealizedInvestmentGainsLosses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-125" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-126" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-127" name="us-gaap:OtherNoncashIncomeExpense" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-128" name="us-gaap:OtherPaymentsToAcquireBusinesses" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-129" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-130" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-131" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-132" name="us-gaap:ProceedsFromRepaymentsOfNotesPayable" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-133" name="us-gaap:ProceedsFromRepaymentsOfNotesPayable" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-134" name="wt:PaymentOfDeferredConsideration" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-135" name="wt:PaymentOfDeferredConsideration" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-136" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-137" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-138" name="wt:PaymentOfConvertibleNotesIssuanceCosts" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-139" name="wt:ProceedsFromIssuanceOfConvertibleNotes" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-140" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-141" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c73" id="hidden-fact-142" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c74" id="hidden-fact-143" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c77" id="hidden-fact-144" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c78" id="hidden-fact-145" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c80" id="hidden-fact-146" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c82" id="hidden-fact-147" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c85" id="hidden-fact-148" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c88" id="hidden-fact-149" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c89" id="hidden-fact-150" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c93" id="hidden-fact-151" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c74" id="hidden-fact-152" name="us-gaap:AssetsFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c95" id="hidden-fact-153" name="us-gaap:InvestmentOwnedAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c96" id="hidden-fact-154" name="us-gaap:InvestmentOwnedAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c98" id="hidden-fact-155" name="us-gaap:InvestmentOwnedAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c99" id="hidden-fact-156" name="us-gaap:InvestmentOwnedAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c100" id="hidden-fact-157" name="us-gaap:InvestmentOwnedAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c101" id="hidden-fact-158" name="us-gaap:InvestmentOwnedAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c103" id="hidden-fact-159" name="us-gaap:AssetsFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c104" id="hidden-fact-160" name="us-gaap:AssetsFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c108" id="hidden-fact-161" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c109" id="hidden-fact-162" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c112" id="hidden-fact-163" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c113" id="hidden-fact-164" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c116" id="hidden-fact-165" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c117" id="hidden-fact-166" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c121" id="hidden-fact-167" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c123" id="hidden-fact-168" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c125" id="hidden-fact-169" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c127" id="hidden-fact-170" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c129" id="hidden-fact-171" name="us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c131" id="hidden-fact-172" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c132" id="hidden-fact-173" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c135" id="hidden-fact-174" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c136" id="hidden-fact-175" name="us-gaap:InvestmentsFairValueDisclosure" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c139" id="hidden-fact-176" name="us-gaap:InvestmentOwnedAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c140" id="hidden-fact-177" name="us-gaap:InvestmentOwnedAtFairValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c107" id="hidden-fact-178" name="wt:BusinessCombinationDeferredConsiderationLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c108" id="hidden-fact-179" name="wt:BusinessCombinationDeferredConsiderationLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c37" id="hidden-fact-180" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-181" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-182" name="wt:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-183" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c146" id="hidden-fact-184" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" id="hidden-fact-185" name="wt:CashEquivalentsMaturityPeriod">P90D</ix:nonNumeric>
<ix:nonFraction contextRef="c155" id="hidden-fact-186" name="us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c156" id="hidden-fact-187" name="us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-188" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-189" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-190" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c6" id="hidden-fact-191" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c171" id="hidden-fact-192" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c171" id="hidden-fact-193" name="us-gaap:InvestmentOwnedAtCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c173" id="hidden-fact-194" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c173" id="hidden-fact-195" name="us-gaap:InvestmentOwnedAtCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c175" id="hidden-fact-196" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c175" id="hidden-fact-197" name="us-gaap:InvestmentOwnedAtCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c177" id="hidden-fact-198" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c177" id="hidden-fact-199" name="us-gaap:InvestmentOwnedAtCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c179" id="hidden-fact-200" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c179" id="hidden-fact-201" name="us-gaap:InvestmentOwnedAtCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c182" id="hidden-fact-202" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c182" id="hidden-fact-203" name="us-gaap:InvestmentOwnedAtCost" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c185" id="hidden-fact-204" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c226" id="hidden-fact-205" name="us-gaap:DebtInstrumentUnamortizedPremium" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c227" id="hidden-fact-206" name="us-gaap:DebtInstrumentUnamortizedPremium" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c230" id="hidden-fact-207" name="us-gaap:DebtInstrumentUnamortizedPremium" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c231" id="hidden-fact-208" name="us-gaap:DebtInstrumentUnamortizedPremium" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c215" id="hidden-fact-209" name="wt:NumberOfThresholdTradingDaysForDeterminingTheSharePrice">P5Y</ix:nonNumeric>
<ix:nonNumeric contextRef="c215" id="hidden-fact-210" name="wt:MeasurementPeriodForDeterminingSharePrice">P10Y</ix:nonNumeric>
<ix:nonFraction contextRef="c0" id="hidden-fact-211" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-212" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-213" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-214" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-215" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-216" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-217" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-218" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c247" id="hidden-fact-219" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c249" id="hidden-fact-220" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c251" id="hidden-fact-221" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c253" id="hidden-fact-222" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c255" id="hidden-fact-223" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c258" id="hidden-fact-224" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c261" id="hidden-fact-225" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c312" id="hidden-fact-226" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c312" id="hidden-fact-227" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c312" id="hidden-fact-228" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c318" id="hidden-fact-229" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c318" id="hidden-fact-230" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c318" id="hidden-fact-231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" unitRef="usdPershares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c323" id="hidden-fact-232" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c323" id="hidden-fact-233" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c324" id="hidden-fact-234" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c0" id="hidden-fact-235" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-236" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-237" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c20" id="hidden-fact-238" name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c343" id="hidden-fact-239" name="wt:WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c344" id="hidden-fact-240" name="wt:WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares" unitRef="shares" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-241" name="wt:DeferredTaxAssetsOutsideBasisDifference" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c361" id="hidden-fact-242" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-243" name="us-gaap:UnrecognizedTaxBenefits" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c367" id="hidden-fact-244" name="us-gaap:UnrecognizedTaxBenefits" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c368" id="hidden-fact-245" name="us-gaap:UnrecognizedTaxBenefits" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" id="hidden-fact-246" name="wt:OperatingLossCarryForwardExpirationYear">2024</ix:nonNumeric>
<ix:nonNumeric contextRef="c371" id="hidden-fact-247" name="us-gaap:StockRepurchaseProgramPeriodInForce1">P3Y</ix:nonNumeric>
<ix:nonFraction contextRef="c0" id="hidden-fact-248" name="us-gaap:GoodwillPeriodIncreaseDecrease" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c384" id="hidden-fact-249" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c386" id="hidden-fact-250" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c5" id="hidden-fact-251" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c66" id="hidden-fact-252" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">P3Y</ix:nonNumeric>
<ix:nonNumeric contextRef="c5" id="hidden-fact-253" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">P5Y</ix:nonNumeric>
<ix:nonNumeric contextRef="c66" id="hidden-fact-254" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">P2Y219D</ix:nonNumeric>
<ix:nonFraction contextRef="c390" id="hidden-fact-255" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c391" id="hidden-fact-256" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c393" id="hidden-fact-257" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c394" id="hidden-fact-258" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c396" id="hidden-fact-259" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c397" id="hidden-fact-260" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c400" id="hidden-fact-261" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c401" id="hidden-fact-262" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c403" id="hidden-fact-263" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c404" id="hidden-fact-264" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c19" id="hidden-fact-265" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag" id="ixv-27996">false</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:DocumentFiscalPeriodFocus" id="ixv-27997">FY</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-27998">0000880631</ix:nonNumeric>
<ix:nonNumeric contextRef="c2" name="dei:TradingSymbol" id="ixv-27999">None</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="wt-20231231.xsd" xlink:type="simple"/></ix:references>
<ix:resources><ix:relationship fromRefs="ix_0_fact hidden-fact-153 hidden-fact-154 ix_1_fact" toRefs="ix_0_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_2_fact hidden-fact-176 hidden-fact-177 ix_3_fact" toRefs="ix_1_footnote"></ix:relationship>
<ix:relationship fromRefs="hidden-fact-155 hidden-fact-156 hidden-fact-157 hidden-fact-158" toRefs="ix_2_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_4_fact" toRefs="ix_3_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_5_fact ix_6_fact" toRefs="ix_4_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_7_fact ix_8_fact" toRefs="ix_5_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_9_fact ix_10_fact" toRefs="ix_6_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_11_fact ix_12_fact ix_13_fact" toRefs="ix_7_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_14_fact ix_15_fact ix_16_fact ix_17_fact ix_18_fact ix_19_fact" toRefs="ix_8_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_20_fact ix_21_fact hidden-fact-226 ix_22_fact hidden-fact-227 hidden-fact-228 ix_23_fact ix_24_fact ix_25_fact ix_26_fact hidden-fact-229 ix_27_fact ix_28_fact ix_29_fact hidden-fact-230 hidden-fact-231 ix_30_fact ix_31_fact hidden-fact-232 ix_32_fact ix_33_fact ix_34_fact ix_35_fact hidden-fact-233 ix_36_fact ix_37_fact ix_38_fact ix_39_fact" toRefs="ix_9_footnote"></ix:relationship>
<ix:relationship fromRefs="hidden-fact-226 hidden-fact-229 hidden-fact-232" toRefs="ix_10_footnote"></ix:relationship>
<ix:relationship fromRefs="hidden-fact-234" toRefs="ix_11_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_40_fact ix_41_fact ix_42_fact" toRefs="ix_12_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_43_fact ix_44_fact ix_45_fact ix_46_fact ix_47_fact ix_48_fact" toRefs="ix_13_footnote"></ix:relationship>
<ix:relationship fromRefs="ix_49_fact ix_50_fact ix_51_fact" toRefs="ix_14_footnote"></ix:relationship>
<ix:relationship fromRefs="hidden-fact-248" toRefs="ix_15_footnote"></ix:relationship>
<xbrli:context id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wt:CommonStock001ParValueMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wt:PreferredStockPurchaseRightsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2024-02-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">wt:WisdomtreeETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">wt:WisdomtreeETFMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="wt:RelatedPartiesAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="wt:RelatedPartiesAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c13">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:InvestmentAdvisoryManagementAndAdministrativeServiceMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c14">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:InvestmentAdvisoryManagementAndAdministrativeServiceMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c15">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:InvestmentAdvisoryManagementAndAdministrativeServiceMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c16">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wt:OtherServicesIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c17">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wt:OtherServicesIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c18">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wt:OtherServicesIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c19">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c20">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c21">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c22">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c23">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c24">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c25">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c26">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c27">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c28">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c29">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c30">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c31">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c32">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c33">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c34">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c35">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c36">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c37">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c38">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c39">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c40">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c41">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c42">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c43">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c44">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c45">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c46">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c47">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c48">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c49">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c50">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c51">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c52">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c53">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c54">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c55">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c56">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c57">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c58">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-10-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c59">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-01-01</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c60">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-01-01</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c61">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">wt:ImplementationOfASU202006Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c62">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">wt:ImplementationOfASU202006Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c63">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:StraightLineDepreciationMethodMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c64">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c65">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c66">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c67">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wt:TwoFinancialInstitutionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c68">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wt:TwoFinancialInstitutionsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c69">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wt:EuropeanBusinessSegmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c70">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wt:EuropeanBusinessSegmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c71">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c72">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c73">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c74">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c75">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c76">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c77">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c78">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c79">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">wt:FederalAgencyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c80">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">wt:FederalAgencyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c81">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">wt:FederalAgencyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c82">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">wt:FederalAgencyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c83">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c84">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c85">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c86">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c87">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c88">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c89">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c90">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeInvestmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c91">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeInvestmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c92">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeInvestmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c93">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeInvestmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c94">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">wt:FnalityInternationalLimitedBOnePreferenceSharesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c95">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">wt:FnalityInternationalLimitedBOnePreferenceSharesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c96">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">wt:FnalityInternationalLimitedBOnePreferenceSharesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c97">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">wt:FnalityInternationalLimitedBOnePreferenceSharesMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c98">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c99">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c100">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c101">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c102">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c103">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c104">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c105">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c106">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c107">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c108">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c109">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c110">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c111">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c112">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c113">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c114">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c115">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c116">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c117">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c118">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">wt:FederalAgencyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c119">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">wt:FederalAgencyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c120">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">wt:FederalAgencyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c121">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">wt:FederalAgencyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c122">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:AllOtherCorporateBondsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c123">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:AllOtherCorporateBondsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c124">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:AllOtherCorporateBondsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c125">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:AllOtherCorporateBondsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c126">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">wt:OtherAssetsseedCapitalWisdomtreeDigitalFundsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c127">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">wt:OtherAssetsseedCapitalWisdomtreeDigitalFundsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c128">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">wt:OtherAssetsseedCapitalWisdomtreeDigitalFundsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c129">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">wt:OtherAssetsseedCapitalWisdomtreeDigitalFundsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c130">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">wt:SecurrencyConvertibleNoteMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c131">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">wt:SecurrencyConvertibleNoteMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c132">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">wt:SecurrencyConvertibleNoteMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c133">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">wt:SecurrencyConvertibleNoteMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c134">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wt:FnalityConvertibleNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c135">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wt:FnalityConvertibleNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c136">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wt:FnalityConvertibleNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c137">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wt:FnalityConvertibleNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c138">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c139">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c140">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c141">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c142">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wt:DeferredConsiderationObligationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c143">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wt:DeferredConsiderationObligationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c144">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wt:DeferredConsiderationObligationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c145">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wt:DeferredConsiderationObligationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c146">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wt:DeferredConsiderationObligationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c147">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">wt:TradingSecuritiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c148">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">wt:TradingSecuritiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c149">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">wt:OtherAssetsseedCapitalWisdomTreeDigitalFundsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c150">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">wt:OtherAssetsseedCapitalWisdomTreeDigitalFundsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c151">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">wt:FederalAgencyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c152">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">wt:FederalAgencyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c153">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c154">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c155">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c156">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c157">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-12-07</xbrli:startDate>
    <xbrli:endDate>2023-12-07</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c158">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c159">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c160">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2019-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c161">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-03-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c162">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c163">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-04-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c164">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-11-30</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c165">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c166">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c167">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:FnalityInternationalLimitedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c168">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:FnalityInternationalLimitedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c169">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-02-28</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c170">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wt:FnalityInternationalLimitedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c171">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:SecurrencyseriesaconvertiblepreferredstockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c172">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:SecurrencyseriesaconvertiblepreferredstockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c173">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:SecurrencyseriesbconvertiblepreferredstockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c174">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:SecurrencyseriesbconvertiblepreferredstockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c175">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:SecurrencyConvertibleNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c176">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:SecurrencyConvertibleNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c177">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:SecurrencyIncSubTotalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c178">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:SecurrencyIncSubTotalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c179">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:ConvertibleNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c180">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:ConvertibleNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c181">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:B1ConvertiblePreferenceSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c182">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:B1ConvertiblePreferenceSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c183">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:SubtotalFnalityInternationalLimitedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c184">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:SubtotalFnalityInternationalLimitedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c185">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c186">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c187">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-03-09</xbrli:startDate>
    <xbrli:endDate>2021-06-09</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c188">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-12-09</xbrli:startDate>
    <xbrli:endDate>2021-03-08</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c189">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c190">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrY11ZqAmQBqDS9evb2UjxxqoT1dX+ftwW5Dmnj+XgBA5xugKgU5REylsG34PyUGaDd+s8Vz6UhUE2XjAqeTDG+GsAAOBng9N8lGsEAjX/LwTSBIBqd4ygj3svooWB2H37ux1jJEZgBFLWzkzuTALB4aTs3k+tWR6XSXbRFQ/yCjbpbt2c8W6UbmkB4l9nqSlCk=] CSR-->
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c191">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c192">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">wt:ETFSCapitalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c193">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">wt:ContractualGoldPaymentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c194">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="wt:AgreementAxis">wt:SpaAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-05-10</xbrli:startDate>
    <xbrli:endDate>2023-05-10</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c195">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wt:SeriesCRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wt:GoldBullionHoldingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-05-10</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c196">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wt:SeriesCRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-05-10</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c197">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wt:SeriesCRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-05-10</xbrli:startDate>
    <xbrli:endDate>2023-05-10</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c198">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wt:SeriesCRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wt:RodberInvestmentsLimitedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-05-10</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c199">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wt:GoldBullionHoldingsJerseyLimitedMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wt:SeriesCRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-11-20</xbrli:startDate>
    <xbrli:endDate>2023-11-20</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c200">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wt:FirstInstallmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-11-20</xbrli:startDate>
    <xbrli:endDate>2023-11-20</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c201">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wt:SecondInstallmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-11-20</xbrli:startDate>
    <xbrli:endDate>2023-11-20</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c202">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wt:ThirdInstallmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-11-20</xbrli:startDate>
    <xbrli:endDate>2023-11-20</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c203">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c204">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c205">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c206">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertibleSeniorNotesDue2028Member</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-02-14</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c207">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-06-14</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c208">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-06-16</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c209">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-08-13</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c210">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-08-13</xbrli:startDate>
    <xbrli:endDate>2020-08-13</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c211">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:TwoThousandAndTwentyNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c212">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-15</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c213">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:TwoThousandAndTwentyNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-06-15</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c214">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c215">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertibleSeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c216">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c217">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c218">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertibleSeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c219">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c220">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertibleSeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-02-14</xbrli:startDate>
    <xbrli:endDate>2023-02-14</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c221">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertibleSeniorNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-06-14</xbrli:startDate>
    <xbrli:endDate>2021-06-14</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c222">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c223">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c224">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c225">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c226">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:TwoThousandAndTwentyThreeNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c227">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:TwothousandandtwentyonenotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c228">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:TwoThousandAndTwentyThreeNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c229">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:TwothousandandtwentyonenotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c230">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c231">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:TwothousandandtwentyonenotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c232">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:TwoThousandAndTwentyNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c233">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertibleNotesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c234">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wt:ETFSAcquisitionMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wt:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c235">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wt:ETFSAcquisitionMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c236">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wt:ETFSAcquisitionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2018-04-10</xbrli:startDate>
    <xbrli:endDate>2018-04-10</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c237">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wt:ETFSAcquisitionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2018-04-10</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c238">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c239">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c240">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c241">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c242">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-11-20</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c243">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-11-20</xbrli:startDate>
    <xbrli:endDate>2023-11-20</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c244">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wt:GBHMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-11-20</xbrli:startDate>
    <xbrli:endDate>2023-11-20</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c245">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-02-01</xbrli:startDate>
    <xbrli:endDate>2021-02-28</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c246">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-07-01</xbrli:startDate>
    <xbrli:endDate>2023-07-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c247">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:SecurrencyseriesaconvertiblepreferredstockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c248">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:SecurrencyseriesaconvertiblepreferredstockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c249">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:SecurrencyseriesbconvertiblepreferredstockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c250">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:SecurrencyseriesbconvertiblepreferredstockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c251">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:SecurrencyConvertibleNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c252">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:SecurrencyConvertibleNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c253">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:SecurrencyIncSubTotalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c254">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:SecurrencyIncSubTotalMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c255">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:ConvertibleNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c256">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:ConvertibleNoteMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c257">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:B1ConvertiblePreferenceSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c258">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:B1ConvertiblePreferenceSharesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c259">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:SubtotalFnalityInternationalLimitedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c260">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:SubtotalFnalityInternationalLimitedMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c261">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:OtherInvestmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c262">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:OtherInvestmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c263">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:MaximumExposureToLossMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c264">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:MaximumExposureToLossMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c265">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c266">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c267">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c268">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c269">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c270">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c271">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c272">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c273">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c274">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wt:WisdomTreeProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c275">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wt:WisdomTreeProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c276">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:AffiliatedBlockchainEnabledFundsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wt:WisdomTreeProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c277">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:AffiliatedBlockchainEnabledFundsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wt:WisdomTreeProductsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c278">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-05-10</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c279">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="wt:RelatedPartiesAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wt:ReceivableFromWTTMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c280">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="wt:RelatedPartiesAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wt:ReceivableFromWTTMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c281">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="wt:RelatedPartiesAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wt:ReceivableFromManJerIssuersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c282">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="wt:RelatedPartiesAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wt:ReceivableFromManJerIssuersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c283">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="wt:RelatedPartiesAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wt:WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c284">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="wt:RelatedPartiesAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wt:WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c285">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wt:AdvisoryServicesProvidedToWTTMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c286">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wt:AdvisoryServicesProvidedToWTTMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c287">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wt:AdvisoryServicesProvidedToWTTMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c288">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wt:AdvisoryServicesProvidedToManJerIssuersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c289">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wt:AdvisoryServicesProvidedToManJerIssuersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c290">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wt:AdvisoryServicesProvidedToManJerIssuersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c291">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wt:AdvisoryServicesProvidedToWMAIAndWTICAVMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c292">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wt:AdvisoryServicesProvidedToWMAIAndWTICAVMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c293">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wt:AdvisoryServicesProvidedToWMAIAndWTICAVMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c294">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c295">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c296">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c297">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-07-15</xbrli:startDate>
    <xbrli:endDate>2022-07-15</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c298">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c299">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wt:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c300">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wt:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c301">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:VestingAxis">wt:BelowTwentyFifthPercentileMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c302">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:VestingAxis">wt:BelowTwentyFifthPercentileMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c303">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:VestingAxis">wt:BelowTwentyFifthPercentileMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c304">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c305">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">wt:EmployeesAndDirectorsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c306">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">wt:EmployeesAndDirectorsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c307">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c308">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c309">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wt:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2020-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c310">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c311">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c312">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wt:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c313">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c314">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c315">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wt:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c316">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c317">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c318">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wt:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c319">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c320">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c321">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wt:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c322">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c323">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wt:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c324">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c325">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wt:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c326">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c327">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-17</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c328">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wt:StockholderRightAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-17</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c329">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wt:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-17</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c330">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-17</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c331">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="wt:AgreementAxis">wt:StockholderRightAgreementMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wt:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-17</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c332">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wt:StockholderRightAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-03-17</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c333">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:OwnershipAxis">wt:AcquiringPersonMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wt:StockholderRightAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c334">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:OwnershipAxis">wt:AcquiringPersonMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wt:StockholderRightAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c335">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wt:StockholderRightAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c336">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:OwnershipAxis">wt:PassiveStockholdersMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wt:StockholderRightAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c337">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:OwnershipAxis">wt:PassiveStockholdersMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wt:StockholderRightAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c338">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wt:StockholderRightAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c339">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wt:StockholderRightAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c340">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wt:StockholderRightAgreementMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c341">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c342">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c343">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c344">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c345">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">wt:ManJersMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c346">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c347">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wt:ForeignMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c348">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wt:ForeignMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c349">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wt:ForeignMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c350">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c351">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c352">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c353">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c354">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c355">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c356">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c357">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c358">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c359">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">wt:UnrecognizedTaxBenefitsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c360">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">wt:InterestAndPenaltiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2021-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c361">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">wt:UnrecognizedTaxBenefitsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c362">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">wt:InterestAndPenaltiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c363">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">wt:UnrecognizedTaxBenefitsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c364">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">wt:InterestAndPenaltiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c365">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">wt:UnrecognizedTaxBenefitsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c366">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">wt:InterestAndPenaltiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c367">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">wt:UnrecognizedTaxBenefitsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c368">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">wt:InterestAndPenaltiesMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c369">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-02-22</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c370">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-02-22</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c371">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-02-01</xbrli:startDate>
    <xbrli:endDate>2022-02-22</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c372">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-02-22</xbrli:startDate>
    <xbrli:endDate>2022-02-22</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c373">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c374">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c375">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c376">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">wt:WorldGoldCouncilMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c377">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">wt:GoldBullionHoldingsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c378">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wt:SecurrencyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-04-11</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c379">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wt:SecurrencyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-04-11</xbrli:startDate>
    <xbrli:endDate>2023-04-11</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c380">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wt:SecurrencyMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c381">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wt:ETFSAcquisitionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c382">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wt:ETFSAcquisitionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2018-04-11</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c383">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c384">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">wt:ETFSAcquisitionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c385">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2023-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c386">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">wt:ETFSAcquisitionMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c387">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:instant>2022-12-31</xbrli:instant>
  </xbrli:period>
</xbrli:context><xbrli:context id="c388">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wt:SaleOfCanadianETFBusinessMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c389">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wt:SaleOfCanadianETFBusinessMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c390">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">wt:NewYorkOfficeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wt:LeaseTerminationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c391">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">wt:NewYorkOfficeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wt:LeaseTerminationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c392">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">wt:NewYorkOfficeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wt:LeaseTerminationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c393">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">wt:NewYorkOfficeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wt:FixedAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c394">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">wt:NewYorkOfficeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wt:FixedAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c395">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">wt:NewYorkOfficeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wt:FixedAssetsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c396">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">wt:LondonOfficeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wt:LeaseTerminationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c397">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">wt:LondonOfficeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wt:LeaseTerminationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c398">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">wt:LondonOfficeMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wt:LeaseTerminationMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c399">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">wt:SecurrencyIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c400">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">wt:SecurrencyIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c401">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">wt:SecurrencyIncMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c402">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c403">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context id="c404">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000880631</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit id="shares">
  <xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit><xbrli:unit id="usdPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit><xbrli:unit id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit><xbrli:unit id="eur">
  <xbrli:measure>iso4217:EUR</xbrli:measure>
</xbrli:unit><xbrli:unit id="oz">
  <xbrli:measure>utr:oz</xbrli:measure>
</xbrli:unit><xbrli:unit id="g">
  <xbrli:measure>utr:g</xbrli:measure>
</xbrli:unit><xbrli:unit id="cad">
  <xbrli:measure>iso4217:CAD</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.31
<SEQUENCE>2
<FILENAME>ex10-31.htm
<DESCRIPTION>EXHIBIT 10.31
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif"><DIV STYLE="margin:0;padding:0;border-width:0;width:600px;margin: 0 auto;">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: right"><B>EXHIBIT 10.31</B></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><I>[General Form for Grants to US Resident Executive
Officers after January 1, 2024]</I></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0; text-align: center"><B>RESTRICTED STOCK AGREEMENT<BR>
UNDER THE WISDOMTREE INVESTMENTS, INC.<BR>
2022 EQUITY PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 0.5in">RESTRICTED STOCK AGREEMENT
(the &#8220;Agreement&#8221;), effective as of the Grant Date (as defined below), by and between WisdomTree, Inc., a Delaware corporation
(formerly known as WisdomTree Investments, Inc., the &#8220;Company&#8221;)<FONT STYLE="font-size: 10pt"><SUP>1</SUP></FONT>, and the
employee of WisdomTree Asset Management, Inc. (&#8220;WTAM&#8221;), a wholly-owned subsidiary of the Company, whose name is set forth
on the signature page of this Agreement (the &#8220;Employee&#8221;). Capitalized terms used and not defined in this Agreement have the
respective meanings assigned to them in the Company&#8217;s 2022 Equity Plan (the &#8220;Plan&#8221;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 0.5in">WHEREAS, the Board of
Directors of the Company (the &#8220;Board&#8221;) or the Compensation Committee of the Board (the &#8220;Committee&#8221;) has authorized
the issuance to the Employee of the aggregate number of shares of the authorized but unissued common stock of the Company, $0.01 par value
per share, set forth on <U>Schedule A</U> included on the signature page of this Agreement (the &#8220;Shares&#8221;), pursuant and subject
to the terms and conditions of the Plan and conditioned upon the Employee&#8217;s acceptance thereof upon the terms and conditions set
forth in this Agreement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 0.5in">WHEREAS, the Employee
desires to acquire the Shares on the terms and conditions set forth in this Agreement and subject to the terms of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 0.5in">IT IS AGREED:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Grant
of Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 1in">1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Company has issued to the Employee, effective as of the grant date set forth on <U>Schedule A</U> included on the signature page of this
Agreement (the &#8220;Grant Date&#8221;), the Shares on the terms and conditions set forth herein and in the Plan. Subject to Section
1.6 hereof, the Shares shall be subject to forfeiture in the event the Employee&#8217;s employment by WTAM is terminated for any reason
prior to the vesting date(s) set forth on <U>Schedule A</U> (each, a &#8220;Vesting Date&#8221;). The period prior to the applicable Vesting
Date is considered the &#8220;Restriction Period&#8221; for the Shares relating to such Vesting Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 1in">1.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Shares shall constitute issued and outstanding shares of common stock for all corporate purposes, and the Employee shall have the right
to vote such Shares and to exercise all of the rights, powers and privileges of a holder of common stock with respect to such Shares,
except that (a) the Employee shall not be entitled to delivery of evidence of book-entry or a share certificate until the Shares vest
in accordance with Section 1.3 or 1.6, as the case may be; and (b) the Company will retain custody of all distributions and dividends
made, paid or declared with respect to the Shares during the applicable Restriction Period (&#8220;Retained Distributions&#8221;), and
such Retained Distributions shall accrue and shall not be paid to the Employee until and only to the extent the Shares with respect to
which such Retained Distributions relate vest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 1in">1.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If
the Employee is still an employee of WTAM at the end of a Restriction Period, all the Shares relating to the applicable Vesting Date shall
vest and shall no longer be subject to forfeiture by the Employee. After the date that any Shares become vested, the Company, in its discretion,
shall either instruct its transfer agent to issue and deliver to the Employee evidence of book-entry or a certificate for the Shares that
have vested or otherwise permit the Shares that have vested to be transferred by the Employee. In addition, after the Shares become vested,
the Company shall pay or distribute, as applicable, the Retained Distributions with respect thereto to the Employee. Subject to the provisions
of Section 1.6, if, at any time prior to the vesting of the Shares in accordance with the first sentence of this Section 1.3, the Employee&#8217;s
employment is terminated for any reason, then the Shares that have not then vested (and the Retained Distributions with respect thereto)
shall be automatically forfeited to the Company and the Employee shall not thereafter have any rights with respect to such Shares (or
the Retained Distributions with respect thereto). In such event, the Company is authorized by the Employee to instruct the Company&#8217;s
transfer agent to cancel and return the Shares (and, if applicable, the Retained Distributions with respect thereto, to the extent such
Retained Distributions were in the form of shares) to the status of authorized but unissued shares of Common Stock and to return to the
Company any Retained Distributions in the form of cash.</P>
<P STYLE="margin: 0"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><SUP>1</SUP>
<FONT STYLE="font-family: Times New Roman, Times, Serif">The name of the Company was changed to &#8220;WisdomTree, Inc.&#8221; effective
November 7, 2022.</FONT></P>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>
<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 1in">1.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>&#8220;Employment&#8221;</U>.
The Employee shall be considered to be employed by WTAM for purposes hereof if the Employee is a full-time employee of WTAM (or of the
Company or any Subsidiary of the Company) or, if the Committee (or the Board in the absence of a decision by the Committee or in over-riding
the decision of the Committee) determines in its sole and absolute discretion, the Employee is rendering substantial services to the Company
(or any Subsidiary of the Company, including WTAM) as a part-time employee, consultant or contractor of the Company (or of any Subsidiary
of the Company, including WTAM). The Committee (or the Board in the absence of a decision by the Committee or in over-riding the decision
of the Committee) shall have the sole and absolute discretion to determine whether the Employee has ceased to be employed by WTAM (or
the Company or any Subsidiary of the Company) and the effective date on which such employment terminated. For purposes of this Agreement,
if the Employee&#8217;s employment is transferred from WTAM to the Company or to a Subsidiary of the Company, references herein to WTAM
shall be read to be such new employing entity, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 1in">1.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>No
Right to Employment</U>. Nothing in the Plan or in this Agreement shall confer on the Employee any right to continue in the employ of,
or in any other relationship with, WTAM or the Company (or with any Subsidiary of the Company) or limit in any way the right of WTAM and
the Company (or of any Subsidiary of the Company) to terminate the Employee&#8217;s employment or other relationship with WTAM or the
Company (or with any Subsidiary of the Company) at any time, with or without cause.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 1in">1.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Accelerated
or Continued Vesting in Certain Circumstances</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt 4.5pt; text-align: justify; text-indent: 1.5in">1.6.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Defined
Terms</U>. As used in this Section 1.6, the terms &#8220;Cause&#8221;, &#8220;Change of Control&#8221;, &#8220;Disability,&#8221; &#8220;Good
Reason&#8221;, and &#8220;Involuntary Termination&#8221; shall have the definitions given thereto in the then effective employment agreement
between the Employee and WTAM.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt 4.5pt; text-align: justify; text-indent: 1.5in">1.6.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Upon
the Employee&#8217;s Death</U>. Notwithstanding the provisions of Sections 1.1 and 1.3, in the event of the Employee&#8217;s death prior
to the end of a Restriction Period, all the Shares that are subject to forfeiture at the time of death shall immediately vest and shall
no longer be subject to forfeiture by the Employee. After the date of the Employee&#8217;s death, the Company, in its discretion, shall
either instruct its transfer agent to issue and deliver to the legal representative of the estate or the legatee of the Employee under
the will of the Employee evidence of book-entry or a certificate for the Shares that have vested, and pay or distribute the Retained Distributions,
if any, with respect to such Shares to such legal representative or legatee, or otherwise permit the Shares that have vested and Retained
Distributions with respect to such Shares to be transferred by the legal representative of the estate or the legatee of the Employee under
the will of the Employee.</P>
<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>
<P STYLE="margin: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt 4.5pt; text-align: justify; text-indent: 1.5in">1.6.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<U>Upon Termination of Employment Due to the Occurrence of a Disability</U>. Notwithstanding the provisions of Sections 1.1 and 1.3, in
the event of the termination by the Company or WTAM of the Employee&#8217;s employment due to the occurrence of a Disability prior to
the end of a Restriction Period, all the Shares that are subject to forfeiture at the time of termination due to the occurrence of a Disability
shall immediately vest and shall no longer be subject to forfeiture by the Employee. After the date of the termination of the Employee&#8217;s
employment due to the occurrence of a Disability, the Company, in its discretion, shall either instruct its transfer agent to issue and
deliver to the Employee evidence of book-entry or a certificate for the Shares that have vested, and pay or distribute the Retained Distributions,
if any, with respect to such Shares, to the Employee or otherwise permit the Shares that have vested and Retained Distributions with respect
to such Shares to be transferred by the Employee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt 4.5pt; text-align: justify; text-indent: 1.5in">1.6.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Upon
the Employee&#8217;s Normal Retirement</U>. Notwithstanding the provisions of Sections 1.1 and 1.3, in the event of the Employee&#8217;s
Normal Retirement (as defined below) prior to the end of a Restriction Period, all the Shares that are subject to forfeiture at the time
of Normal Retirement shall immediately vest and shall no longer be subject to forfeiture by the Employee. Notwithstanding the foregoing,
in the event that the Employee commences work in the asset management or financial services industries (other than serving as a non-employee
director) after the date of the Employee&#8217;s Normal Retirement but prior to the end of the Restriction Period, the Employee shall
be required to pay to WTAM an amount in cash equal to (a) the Fair Market Value of the Shares (as of the date of the Employee&#8217;s
Normal Retirement) that would have remained subject to forfeiture as of the date of such commencement of work under the original vesting
schedule set forth on <U>Schedule A</U>, plus (b) the value of the Retained Distributions paid with respect to such Shares. After the
date of the Employee&#8217;s Normal Retirement prior to the end of a Restriction Period, the Company, in its discretion, shall either
instruct its transfer agent to issue and deliver to the Employee evidence of book-entry or a certificate for the Shares that have vested,
and pay or distribute the Retained Distributions, if any, with respect to such Shares, to the Employee or otherwise permit the Shares
that have vested and Retained Distributions with respect to such Shares to be transferred by the Employee. For purposes of this Agreement,
the term &#8220;Normal Retirement&#8221; means retirement from active employment on or after reaching age 62 and having been employed
by WTAM (or the Company or any Subsidiary of the Company) for at least seven (7) years as of the retirement date, provided that the Employee
provides WTAM with written notice of the Employee&#8217;s intent to retire at least six (6) months in advance of the date of such retirement,
which written notice specifies the retirement date. The Committee (or the Board in the absence of a decision by the Committee or in over-riding
the decision of the Committee) shall have the sole and absolute discretion to determine whether a Normal Retirement has occurred and whether
the Employee has commenced work in the asset management or financial services industries (other than serving as a non-employee director)
after the date of the Employee&#8217;s Normal Retirement and prior to the end of the Restriction Period. For purposes of clarity, the
definition of &#8220;Normal Retirement&#8221; set forth herein shall only apply to this Agreement and shall not impact the Employee&#8217;s
rights under circumstances of retirement under applicable law in the ordinary course.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt 4.5pt; text-align: justify; text-indent: 1.5in">1.6.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Upon
a Change of Control</U>. Notwithstanding the provisions of Sections 1.1 and 1.3, in the event of a Change of Control while the Employee
is employed by WTAM, the vesting of any Shares that are unvested at such time shall accelerate and all Shares shall be vested simultaneously
with such Change of Control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt 4.5pt; text-align: justify; text-indent: 1.5in">1.6.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Involuntary
Termination</U>. In the event of an Involuntary Termination of the Employee&#8217;s employment prior to the end of a Restriction Period:
(i) all of the Shares (and the Retained Distributions with respect thereto), if any, that would have vested during the 12-month period
immediately following the date of such termination (&#8220;Post-Employment Period&#8221;) if the Employee&#8217;s employment had not been
so terminated shall immediately vest upon the date of such termination; (ii) except as provided in clause (iii) below, vesting shall otherwise
cease as of the last day of the Employee&#8217;s employment, but any Shares (and the Retained Distributions with respect thereto) which
have not then vested (after taking into account the vesting of Shares pursuant to the preceding clause (i)) shall not be automatically
forfeited until the last day of the Post-Employment Period; and (iii) if a Change of Control occurs during the Post-Employment Period,
the remaining unvested Shares (and the Retained Distributions with respect thereto) shall automatically vest upon the Change of Control
as if the Employee had been employed on the date of the Change of Control. For the avoidance of doubt, if no Change of Control occurs
during the Post-Employment Period, then all Shares which are not then vested on the last day of the Post-Employment Period (and the Retained
Distributions with respect thereto) shall be automatically forfeited to the Company and the Employee shall not thereafter have any rights
with respect to such Shares (or the Retained Distributions with respect thereto).</P>
<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>
<P STYLE="margin: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt 4.5pt; text-align: justify; text-indent: 1.5in">1.6.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Post-Change
of Control Termination</U>. Notwithstanding anything to the contrary in this Agreement, if a Change of Control occurs and the Employee&#8217;s
employment is terminated either (i) by the Company (or its successor) without Cause or (i) by the Employee for Good Reason, in each case
within 18 months after such Change of Control, then (x) all of the Shares (and the Retained Distributions with respect thereto) that would
otherwise have vested within the 21-month period following the date of such termination if the Employee&#8217;s employment had not been
so terminated shall automatically vest upon the date of such termination, and (y) vesting shall otherwise cease as of the last day of
the Employee&#8217;s employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Withholding
Tax</U>. Not later than the date as of which an amount first becomes includible in the gross income of the Employee for Federal income
tax purposes with respect to the Shares, the Employee shall pay to WTAM, or make arrangements satisfactory to WTAM regarding the payment
of, any Federal, state and local taxes of any kind required by law to be withheld or paid with respect to such amount. Notwithstanding
anything in this Agreement to the contrary, the obligations of the Company under the Plan and pursuant to this Agreement shall be conditional
upon such payment or arrangements with WTAM, and WTAM shall, to the extent permitted by law, have the right to deduct any such taxes from
any payment of any kind otherwise due to the Employee from WTAM. Unless otherwise determined by the Committee (or the Board in the absence
of a decision by the Committee or in over-riding the decision of the Committee), WTAM&#8217;s tax withholding obligation shall be satisfied,
in whole or in part, by the Company withholding from the Shares to be issued or released by the transfer agent a number of shares with
an aggregate Fair Market Value (as of the date the withholding is effected) that would satisfy the withholding amount due; provided, however,
that the amount withheld does not exceed the maximum statutory tax rate or such lesser amount as is necessary to avoid liability accounting
treatment. The Employee is advised to consult with the Employee&#8217;s counsel or tax advisor about the Employee&#8217;s tax status and
tax treatment of the Shares granted under the Plan pursuant to this Agreement. Neither the Company nor any Subsidiary may be held liable
for the personal tax treatment of any Employee under this Agreement or the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 0.5in">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Nonassignability
of Shares</U>. The Shares shall not be assignable or transferable until they have vested. Upon vesting, the Employee will have the right
to sell or transfer the Shares, subject to the provisions of the Company&#8217;s insider trading policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 0.5in">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Employee
Representations</U>. The Employee hereby represents and warrants to the Company that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 1.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Employee has received a copy of the Plan and the prospectus filed pursuant to Rule 424 under the Securities Act of 1933, as amended, as
in effect as of the date of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 1.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Employee has received a copy of all reports and documents required to be filed by the Company with the Securities and Exchange Commission
pursuant to the Securities Exchange Act of 1934, as amended, within the last twenty-four (24) months and all reports issued by the Company
to its stockholders;</P>
<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>
<P STYLE="margin: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 1.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Employee (x) has reviewed with the Employee&#8217;s own tax advisors the applicable tax (U.S. federal, state, local and foreign) consequences
of the transactions contemplated by this Agreement, (y) is relying solely on such advisors and not on any statements or representations
of the Company or WTAM or any of their respective agents, and (z) understands that the Employee (and not the Company or its Subsidiaries)
shall be responsible for any tax liability that may arise as a result of the transactions contemplated by this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 1.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Employee understands that the Employee must bear the economic risk of the investment in the Shares;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 1.5in">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Employee has had such an opportunity as the Employee has deemed adequate to obtain from the Company such information as is necessary to
permit the Employee to evaluate the merits and risks of the Employee&#8217;s investment in the Company and has had the opportunity to
consult with the Employee&#8217;s own advisers with respect to the investment in the Company; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 1.5in">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
Employee understands and agrees that if a stock certificate evidencing the Shares is issued prior to the Vesting Date, it shall also bear
the following legend:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0.5in 3pt 1in; text-align: justify">&#8220;The shares represented by
this certificate have been acquired pursuant to a Restricted Stock Agreement, a copy of which is on file with the Company, and may not
be transferred, pledged or disposed of except in accordance with the terms and conditions thereof and the terms and conditions of the
WisdomTree Investments, Inc. 2022 Equity Plan.&#8221;&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 0.5in">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 1in">5.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>.
All notices, requests, deliveries, payments, demands and other communications which are required or permitted to be given under this Agreement
shall be in writing and shall be either (a) delivered personally or by private courier (<U>e.g.</U>, Federal Express), (b) sent by registered
or certified mail, return receipt requested, postage prepaid, or (c) sent by electronic communication (via e-mail or through an electronic
platform approved by the Company), with confirmation of transmission thereof, and shall be deemed duly given hereunder when delivered
in person or by private courier, on the third business day following deposit in the United States mail as set forth in subsection (b)
above, or, if sent by electronic communication, on the date sent by such transmission during normal business hours of the recipient, and
on the next business day if sent after normal business hours of the recipient. Such communications shall be sent to the respective parties
at the following addresses: (i) if to the Company or WTAM, at their respective principal executive offices, attention: Legal Department,
at legalnotice@wisdomtree.com; and (ii) if to the Employee, at the Employee&#8217;s last known residence address or e-mail address as
indicated in the employment records of the Company or WTAM, as the case may be. Either party may designate another address in writing
(or by such other method approved by the Company) from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 1in">5.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Plan
Paramount; Conflicts with Plan</U>. This Agreement shall, in all respects, be subject to and governed by the terms and conditions of the
Plan, whether or not stated herein. In the event of a conflict between the provisions of the Plan and the provisions of this Agreement,
the provisions of the Plan shall in all respects be controlling.</P>
<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>
<P STYLE="margin: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 1in">5.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Discretionary
Nature of Plan</U>. The Plan is discretionary and may be amended, cancelled or terminated by the Company at any time, in its discretion,
in accordance with the terms of the Plan. The grant of the Shares in this Agreement does not create any contractual right or other right
to receive any restricted stock or other Awards in the future. Future Awards, if any, will be at the sole discretion of the Company. Any
amendment, modification, or termination of the Plan shall not constitute a change or impairment of the terms and conditions of the Employee&#8217;s
employment with WTAM. The Employee acknowledges that no claim or entitlement to compensation or damages arises from the diminution in
value of the Shares, resulting, in whole or in part, from (i) the amendment, cancellation, or termination of the Plan at any time by the
Company, (ii) any company ceasing to be a Subsidiary or an affiliate of the Company, (iii) the transfer of any business from the Company
or any Subsidiary or affiliate of the Company to any third party, or (iv) any other extraordinary transaction or event regarding the Company
or its affiliates (including but not limited to liquidation, winding-up, closure of all or a portion of its business, etc.).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 1in">5.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendments;
Waiver</U>. This Agreement may not be modified, amended, or terminated except by an instrument in writing, signed by each of the parties.
No failure to exercise and no delay in exercising any right, remedy, or power under this Agreement shall operate as a waiver thereof,
nor shall any single or partial exercise of any right, remedy, or power under this Agreement preclude any other or further exercise thereof,
or the exercise of any other right, remedy, or power provided herein or by law or in equity. All rights and remedies, whether conferred
by this Agreement, by any other instrument or by law, shall be cumulative, and may be exercised singularly or concurrently.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 1in">5.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Entire
Agreement</U>. This Agreement constitutes the entire agreement of the parties hereto with respect to the subject matter hereof and supersedes
all prior undertakings and agreements, oral or written, with respect to the subject matter hereof. This Agreement may not be contradicted
by evidence of any prior or contemporaneous agreement. To the extent that the policies and procedures of WTAM or the Company apply to
the Employee and are inconsistent with the terms of this Agreement, the provisions of the Agreement shall control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 1in">5.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Binding
Effect; Successors</U>. This Agreement shall inure to the benefit of and be binding upon the parties hereto and, to the extent not prohibited
herein, their respective heirs, successors, assigns and representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 1in">5.7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Severability;
Enforcement</U>. If any provision of this Agreement is held invalid, illegal or unenforceable in any respect (an &#8220;Impaired Provision&#8221;),
(a) such Impaired Provision shall be interpreted in such a manner as to preserve, to the maximum extent possible, the intent of the parties,
(b) the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby, and (c)
such decision shall not affect the validity, legality or enforceability of such Impaired Provision under other circumstances. The parties
agree to negotiate in good faith and agree upon a provision to substitute for the Impaired Provision in the circumstances in which the
Impaired Provision is invalid, illegal or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 1in">5.8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Rights
of Third Parties</U>. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto
or their respective permitted successors and assigns any rights, remedies, obligations, or&nbsp;liabilities under or by reason of this
Agreement, except as expressly provided in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 1in">5.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Headings</U>.
The Section headings used herein are for convenience only and do not define, limit or construe the content of such sections. All references
in this Agreement to Section numbers refer to Sections of this Agreement, unless otherwise indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 1in">5.10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Agreement
to Arbitrate</U>. The Employee, the Company and WTAM recognize that differences may arise between them during or following the Employee&#8217;s
employment by WTAM, and that those differences may or may not be related to the issuance of the Shares herein or to the Employee&#8217;s
employment. The Employee, the Company and WTAM agree that disputes between the Employee, the Company and WTAM will be resolved by arbitration
as provided by the arbitration provisions set forth in the then effective employment agreement between the Employee and WTAM, which are
incorporated herein by reference.</P>
<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>
<P STYLE="margin: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 1in">5.11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing
Law; Jurisdiction</U>. The Agreement shall be governed by and construed in accordance with the laws of the State of New York, without
reference to that body of law concerning choice of law or conflicts of law, except that the General Corporation Law of the State of Delaware
(&#8220;GCL&#8221;) shall apply to all matters governed by the GCL, including without limitation matters concerning the validity of grants
of restricted stock and actions of the Board or the Committee. The Company and the Employee agree that, subject to the agreement to arbitrate
disputes set forth in Section 5.10, the sole and exclusive judicial venues for any dispute, difference, cause of action or legal action
of any kind that any party, or any officer, director, employee, agent or permitted successor or assign of any party may bring against
any other party or any subsidiary of a party, or against any officer, director, employee, agent or permitted successor or assign of any
of the foregoing, relating in any manner whatsoever to the Employee&#8217;s employment by the Company or any Subsidiary of the Company
(including WTAM), as the case may be, or to the termination thereof, including without limitation all disputes arising under this Agreement
(a &#8220;Proceeding&#8221;), shall be (a) the United States District Court for the Southern District of New York, if such court has statutory
jurisdiction over the Proceeding, and (b) the Supreme Court of the State of New York in the County of New York (collectively, the &#8220;New
York Courts&#8221;). Each of the parties hereby expressly (i) consents to the personal jurisdiction of each of the New York Courts with
respect to any Proceeding; (ii) agrees that service of process in any Proceeding may be effected upon such party in the manner set forth
in Section 5.1 (other than by electronic communication), as well as in any other manner prescribed by law; and (iii) waives any objection,
whether on the grounds of venue, residence or domicile or on the ground that the Proceeding has been brought in an inconvenient forum,
to any Proceeding brought in either of the New York Courts. Notwithstanding the foregoing, nothing in this paragraph alters the parties&#8217;
agreement to arbitrate disputes as set forth in Section 5.10.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 3pt; text-align: justify; text-indent: 1in">5.12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Counterparts;
Electronic Delivery</U>. This Agreement may be executed in counterparts, each of which shall be deemed an original but all of which together
will constitute one and the same instrument. Counterpart signature pages to this Agreement transmitted by electronic mail in portable
document format (.pdf) or by any other electronic means intended to preserve the original graphic and pictorial appearance of a document
will have the same effect as physical delivery of the paper document bearing an original signature. The Company may, in its sole discretion,
decide to deliver any documents related to this Agreement or future Awards made under the Plan by electronic means or request the Employee&#8217;s
consent to participate in the Plan by electronic means. The Employee hereby consents to receive such documents by electronic delivery
and, if requested, agrees to participate in the Plan through an on-line or electronic system established and maintained by the Company
or another third party designated by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">[Balance of page left blank intentionally. Signature
page follows.]</P>
<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>
<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">IN WITNESS WHEREOF, the parties hereto have signed
this Restricted Stock Agreement effective as of the Grant Date indicated below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">WISDOMTREE, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 35%; padding-right: 5.4pt; padding-left: 5.4pt; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="width: 63%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Authorized Signatory</I>]</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
* * * * * * * * * * * * * * * * * * * * * * </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0"><B><U>Schedule A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of Employee: </FONT></TD>
    <TD STYLE="layout-grid-mode: line; width: 80%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant Date: </FONT></TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Number of Shares: </FONT></TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  </TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Vesting Schedule: </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
* * * * * * * * * * * * * * * * * * * * * * </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 0"><U>Confirmation</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">WisdomTree Asset Management, Inc. hereby executes
this Agreement solely to confirm its agreement to be bound by the term and provisions of Sections 5.10 and 5.11 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">WISDOMTREE ASSET MANAGEMENT, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 35%; padding-right: 5.4pt; padding-left: 5.4pt; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="width: 63%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Authorized Signatory</I>]</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 24pt 0 0"><U>Acceptance</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Employee hereby acknowledges: I have received
a copy of this Agreement; I have had the opportunity to consult legal counsel in regard to this Agreement, and have availed myself of
that opportunity to the extent I wish to do so (I understand the Company&#8217;s attorneys represent the Company and not myself, and I
have not relied on any advice from the Company&#8217;s attorneys); I have read and understand this Agreement; I AM FULLY AWARE OF THE
LEGAL EFFECT OF THIS AGREEMENT, INCLUDING WITHOUT LIMITATION THE EFFECT OF SECTION 5.10 CONCERNING ARBITRATION; I acknowledge that there
may be adverse tax consequences upon the grant or vesting of the Shares or disposition thereof and that I have been advised to consult
a tax advisor prior to such grant, vesting or disposition; and I have entered into this Agreement freely and voluntarily and based on
my own judgment and not on any representations and promises other than those contained in this Agreement. The Employee accepts these Shares
subject to all the terms and conditions of this Agreement and the rules of the Plan. Electronic acceptance of this Agreement pursuant
to the Company&#8217;s instructions to the Employee (including through an online acceptance process) is acceptable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">8</P>


<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</DIV></BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>3
<FILENAME>ex21-1.htm
<DESCRIPTION>EXHIBIT 21.1
<TEXT>
<HTML>
<HEAD><TITLE></TITLE></HEAD>
 <BODY STYLE="margin:0;padding:0;border-width:0;text-justify-trim: punctuation; margin: 0; padding: 10pt;"><DIV STYLE="margin:0;padding:0;border-width:0;width:600px;margin: 0 auto;">
	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:right;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Exhibit 21.1</FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:center;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Subsidiaries of the Registrant</FONT></P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 52.99%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="top">

						<P CLASS="TCH_left" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Name of Subsidiary</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.73%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="top">
						<P CLASS="TCH_left" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Jurisdiction of Incorporation</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 52.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">WisdomTree&#x00a0;Asset&#x00a0;Management,&#x00a0;Inc.</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:3pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">Delaware</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 52.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">WisdomTree&#x00a0;International&#x00a0;Group, Inc.</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:3pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">Delaware</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 52.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">WisdomTree Digital Commodity Services, LLC</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:3pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">Delaware</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 52.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">WisdomTree Digital Holdings, Inc.</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:3pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">Delaware</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 52.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">WisdomTree Digital Management, Inc.</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:3pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">Delaware</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 52.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">WisdomTree Securities, Inc.</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:3pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">Delaware</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 52.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">WisdomTree Digital Movement, Inc.</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:3pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">Delaware</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 52.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">WisdomTree Transfers, Inc.</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:3pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">Delaware</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 52.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">WisdomTree Digital Trust Company, LLC</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:3pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">New&#x00a0;York</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 52.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">WisdomTree&#x00a0;International&#x00a0;Holdings Ltd</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:3pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">United Kingdom</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 52.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">WisdomTree&#x00a0;Europe&#x00a0;Holdings&#x00a0;Limited</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:3pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">Jersey</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 52.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Electra Target HoldCo Limited</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:3pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">Jersey</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 52.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">WisdomTree Holdings (Jersey) Limited</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:3pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">Jersey</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 52.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">WisdomTree Management Limited</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:3pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">Ireland</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 52.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">WisdomTree Management Jersey Limited</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:3pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">Jersey</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 52.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">WisdomTree Multi Asset Management Limited</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:3pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">Jersey</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 52.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">WisdomTree UK Limited</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:3pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">United Kingdom</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 52.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">WisdomTree Europe Ltd</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:3pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">United Kingdom</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 52.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">WisdomTree Ireland Limited</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:3pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">Ireland</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 52.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">WisdomTree Metal Securities Limited</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:3pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">Jersey</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 52.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">WisdomTree Commodity Securities Limited</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:3pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">Jersey</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 52.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">WisdomTree Hedged Commodity Securities Limited</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:3pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">Jersey</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 52.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">WisdomTree Foreign Exchange Limited</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:3pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">Jersey</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 52.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">WisdomTree Hedged Metal Securities Limited</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:3pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">Jersey</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 52.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">WisdomTree Issuer&#x00a0;X Limited</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:3pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">Jersey</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-4" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 52.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable_wrap" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Gold Bullion Securities Limited</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:3pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">Jersey</P>
					</TD>
				</TR>

		</TABLE>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">&#x00a0;</P>


</DIV></BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>ex23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<HTML>
<HEAD><TITLE></TITLE></HEAD>
 <BODY STYLE="margin:0;padding:0;border-width:0;text-justify-trim: punctuation; margin: 0; padding: 10pt;"><DIV STYLE="margin:0;padding:0;border-width:0;width:600px;margin: 0 auto;">
	<DIV CLASS="Basic-Text-Frame" STYLE="margin:0;padding:0;border-width:0;border-style:solid;">
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:right;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Exhibit 23.1</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Consent of Independent Registered Public Accounting Firm</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;text-align:left;margin-top:6pt;">We consent to the incorporation by reference in the Registration Statements on Form&#x00a0;S<FONT CLASS="nobreak">-8</FONT> (No.&#x00a0;333<FONT CLASS="nobreak">-212128</FONT> and&#x00a0;333<FONT CLASS="nobreak">-266321</FONT>) pertaining to the equity plans of WisdomTree, Inc. filed with the Securities and Exchange Commission on June&#x00a0;20, 2016 and July&#x00a0;25, 2022 of our reports dated February&#x00a0;23, 2024, with respect to the consolidated financial statements of WisdomTree, Inc. and Subsidiaries and the effectiveness of internal control over financial reporting of WisdomTree, Inc. and Subsidiaries included in this Annual Report (Form&#x00a0;10<FONT CLASS="nobreak">-K</FONT>) for the year ended December&#x00a0;31, 2023.</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:6pt;">/s/ Ernst&#x00a0;&amp; Young LLP</P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;text-align:left;margin-top:6pt;">New&#x00a0;York, New&#x00a0;York<BR>February&#x00a0;23, 2024</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">&#x00a0;</P>


</DIV></BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>ex31-1.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<HTML>
<HEAD><TITLE></TITLE></HEAD>
 <BODY STYLE="margin:0;padding:0;border-width:0;text-justify-trim: punctuation; margin: 0; padding: 10pt;"><DIV STYLE="margin:0;padding:0;border-width:0;width:600px;margin: 0 auto;">
	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:right;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Exhibit 31.1</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Certification</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;text-align:justify;margin-top:6pt;">I, Jonathan Steinberg, certify that:</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:6pt;margin-top:6pt;">1.<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>I have reviewed this annual report on Form&#x00a0;10<FONT CLASS="nobreak">-K</FONT> of WisdomTree, Inc.;</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:6pt;margin-top:6pt;">2.<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:6pt;margin-top:6pt;">3.<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:6pt;margin-top:6pt;">4.<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The registrant&#x2019;s other certifying officers and&#x00a0;I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange&#x00a0;Act Rules 13a<FONT CLASS="nobreak">-15</FONT>(e)&#x00a0;and 15d<FONT CLASS="nobreak">-15</FONT>(e)) and internal controls over financial reporting (as defined in Exchange&#x00a0;Act Rules 13a<FONT CLASS="nobreak">-15</FONT>(f)&#x00a0;and 15d<FONT CLASS="nobreak">-15</FONT>(f)) for the registrant and have:</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:48pt;margin-top:6pt;margin-top:6pt;">a)<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:48pt;margin-top:6pt;margin-top:6pt;">b)<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:48pt;margin-top:6pt;margin-top:6pt;">c)<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Evaluated the effectiveness of the registrant&#x2019;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:48pt;margin-top:6pt;margin-top:6pt;">d)<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Disclosed in this report any change in the registrant&#x2019;s internal control over financial reporting that occurred during the registrant&#x2019;s most recent fiscal quarter (the registrant&#x2019;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#x2019;s internal control over financial reporting; and</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:6pt;margin-top:6pt;">5.<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The registrant&#x2019;s other certifying officers and&#x00a0;I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#x2019;s auditors and the audit committee of the registrant&#x2019;s Board of Directors (or persons performing the equivalent functions):</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:48pt;margin-top:6pt;margin-top:6pt;">a)<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#x2019;s ability to record, process, summarize and report financial information; and</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:24pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:48pt;margin-top:6pt;margin-top:6pt;">b)<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#x2019;s internal control over financial reporting.</P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;width: 47.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">

					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 3.85%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:8pt;">By:</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 45.83%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="bottom">
						<P CLASS="Signature_rule" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;text-align:center;">/s/ Jonathan Steinberg</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 3.85%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 45.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:center;">Jonathan Steinberg</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 3.85%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 45.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:center;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Chief Executive Officer</FONT></P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 47.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 3.85%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="bottom">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 45.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="bottom">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:center;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">(Principal Executive Officer)</FONT></P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:6pt;margin-top:6pt;">Date: February&#x00a0;23, 2024</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">&#x00a0;</P>


</DIV></BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>ex31-2.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<HTML>
<HEAD><TITLE></TITLE></HEAD>
 <BODY STYLE="margin:0;padding:0;border-width:0;text-justify-trim: punctuation; margin: 0; padding: 10pt;"><DIV STYLE="margin:0;padding:0;border-width:0;width:600px;margin: 0 auto;">
	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:right;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Exhibit 31.2</FONT></P>
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Certification</FONT></P>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:6pt;">I, Bryan Edmiston, certify that:</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:24pt;margin-top:6pt;margin-top:6pt;">1.<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>I have reviewed this annual report on Form&#x00a0;10<FONT CLASS="nobreak">-K</FONT> of WisdomTree, Inc.;</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:24pt;margin-top:6pt;margin-top:6pt;">2.<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:24pt;margin-top:6pt;margin-top:6pt;">3.<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:24pt;margin-top:6pt;margin-top:6pt;">4.<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The registrant&#x2019;s other certifying officers and&#x00a0;I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange&#x00a0;Act Rules 13a<FONT CLASS="nobreak">-15</FONT>(e)&#x00a0;and 15d<FONT CLASS="nobreak">-15</FONT>(e)) and internal controls over financial reporting (as&#x00a0;defined in Exchange&#x00a0;Act Rules 13a<FONT CLASS="nobreak">-15</FONT>(f)&#x00a0;and 15d<FONT CLASS="nobreak">-15</FONT>(f)) for the registrant and have:</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:6pt;margin-top:6pt;">a)<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:6pt;margin-top:6pt;">b)<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:6pt;margin-top:6pt;">c)<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Evaluated the effectiveness of the registrant&#x2019;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of&#x00a0;the period covered by this report based on such evaluation; and</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:6pt;margin-top:6pt;">d)<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Disclosed in this report any change in the registrant&#x2019;s internal control over financial reporting that occurred during the registrant&#x2019;s most recent fiscal quarter (the registrant&#x2019;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#x2019;s internal control over financial reporting; and</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:24pt;margin-top:6pt;margin-top:6pt;">5.<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The registrant&#x2019;s other certifying officers and&#x00a0;I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#x2019;s auditors and the audit committee of the registrant&#x2019;s Board of&#x00a0;Directors (or persons performing the equivalent functions):</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:6pt;margin-top:6pt;">a)<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#x2019;s ability to record, process, summarize and report financial information; and</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-top:6pt;margin-top:6pt;">b)<FONT STYLE="width: 20px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#x2019;s internal control over financial reporting.</P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 47.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">

					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 3.85%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;">By:</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 45.83%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="top">
						<P CLASS="Signature_rule" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;text-align:center;">/s/ Bryan Edmiston</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 47.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 3.85%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;">Bryan Edmiston</P>
					</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 47.76%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 3.85%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 45.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:center;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Chief&#x00a0;Financial Officer</FONT> <BR><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">(Principal Financial Officer and <BR>Principal Accounting Officer)</FONT></P>
					</TD>
				</TR>

		</TABLE>
		<P CLASS="Text_flush" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-top:6pt;">Date: February&#x00a0;23, 2024</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">&#x00a0;</P>


</DIV></BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>ex32-1.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<HTML>
<HEAD><TITLE></TITLE></HEAD>
 <BODY STYLE="margin:0;padding:0;border-width:0;text-justify-trim: punctuation; margin: 0; padding: 10pt;"><DIV STYLE="margin:0;padding:0;border-width:0;width:600px;margin: 0 auto;">
	<DIV CLASS="_idGenObjectStyleOverride-1" STYLE="margin:0;padding:0;border-width:0;border-width:0pt;">
		<P CLASS="H2" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:right;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">Exhibit 32.1</FONT></P>
		<P CLASS="H1" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-top:12pt;"><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">CERTIFICATION PURSUANT TO<BR>18 U.S.C.&#x00a0;SECTION 1350,<BR>AS ADOPTED PURSUANT TO<BR>SECTION 906 OF THE </FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;">SARBANES-OXLEY</FONT><FONT CLASS="Bold" STYLE="font-style:normal;font-weight:bold;"> ACT OF 2002</FONT></P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:24pt;widows:3;text-align:left;margin-top:6pt;">In connection with the Annual Report of WisdomTree, Inc. (the &#x201c;Company&#x201d;) on Form&#x00a0;10<FONT CLASS="nobreak">-K</FONT> for the period ended December&#x00a0;31, 2023 as filed with the Securities and Exchange Commission (the &#x201c;SEC&#x201d;) on the date hereof (the &#x201c;Report&#x201d;), we, Jonathan Steinberg, Chief Executive Officer of the Company, and Bryan Edmiston, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C.&#x00a0;Section&#x00a0;1350, as adopted pursuant to Section&#x00a0;906 of the Sarbanes<FONT CLASS="nobreak">-Oxley</FONT> Act&#x00a0;of&#x00a0;2002, to our knowledge, that:</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:24pt;margin-top:6pt;margin-top:6pt;">(1)<FONT STYLE="width: 13px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The Report fully complies with the requirements of section 13(a)&#x00a0;or 15(d)&#x00a0;of the Securities Exchange Act&#x00a0;of&#x00a0;1934, as amended; and</P>
		<P CLASS="NL_m" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-24pt;widows:3;margin-left:24pt;margin-top:6pt;margin-top:6pt;">(2)<FONT STYLE="width: 13px;display: inline-block;">&#x00a0;&#x00a0;&#x00a0;&#x00a0;</FONT>The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</P>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:24pt;widows:3;text-align:left;margin-top:6pt;">This certification is being furnished and not filed, and shall not be incorporated into any documents for any purpose, under the Securities Exchange&#x00a0;Act&#x00a0;of&#x00a0;1934, as amended. A signed original of this written statement require by Section&#x00a0;906 has been provided to the Company and will be retained by the Company and furnished to the SEC or its staff upon request.</P>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 4.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">

						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">By:</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 53.21%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="top">
						<P CLASS="Signature_rule" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">/s/ Jonathan Steinberg</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 40.17%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 4.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 53.21%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">Jonathan Steinberg</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 40.17%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 4.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 53.21%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:left;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Chief Executive Officer</FONT> <BR><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">(Principal Executive Officer)</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 40.17%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">&#x00a0;</TD>
				</TR>

		</TABLE>
		<TABLE CLASS="No-Table-Style" STYLE="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 10pt 0 10pt 0;">


				<TR CLASS="No-Table-Style _idGenTableRowColumn-5" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 4.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">

						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;margin-top:8pt;">By:</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 53.21%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" VALIGN="top">
						<P CLASS="Signature_rule" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;">/s/ Bryan Edmiston</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 40.17%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-6" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 4.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 53.21%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;">Bryan Edmiston</P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 40.17%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">&#x00a0;</TD>
				</TR>
				<TR CLASS="No-Table-Style _idGenTableRowColumn-7" STYLE="height:12pt;">
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 4.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 53.21%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">
						<P CLASS="Texttable" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:1;text-align:left;"><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">Chief&#x00a0;Financial Officer</FONT> <BR><FONT CLASS="Italic" STYLE="font-style:italic;font-weight:normal;">(Principal Financial Officer and Principal Accounting Officer)</FONT></P>
					</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" VALIGN="top">&#x00a0;</TD>
					<TD CLASS="TB" STYLE="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 40.17%; padding: 0in 0in 3px 0in;border-width: 0pt;" VALIGN="top">&#x00a0;</TD>
				</TR>

		</TABLE>
		<P CLASS="Text_ind" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:24pt;widows:3;text-align:left;text-indent:0pt;margin-top:6pt;">February&#x00a0;23, 2024</P>
		</DIV>

		<P CLASS="RRH" STYLE="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin: 10px 0px 10px 0pt; page-break-after: always; border-bottom: 1px solid; margin-top: 10.0pt; margin-right: 0in; margin-bottom: 10.0pt; margin-left: 0in; text-align: center; font-size: 10.0pt; font-family: TimesNewRomanPSStd-Regular; color: black;">&#x00a0;</P>


</DIV></BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97.1
<SEQUENCE>8
<FILENAME>ex97.htm
<DESCRIPTION>EXHIBIT 97
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif"><DIV STYLE="margin:0;padding:0;border-width:0;width:600px;margin: 0 auto;">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: right"><B>EXHIBIT 97</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>WisdoMTree,
inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><B>AMENDED AND RESTATED COMPENSATION CLAWBACK
POLICY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><B>Adopted as of October 23, 2023</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">WisdomTree, Inc. (formerly known as WisdomTree Investments, Inc.),
a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), has adopted this Amended and Restated Compensation Clawback Policy (this &ldquo;<U>Policy</U>&rdquo;)
as of the date set forth above. This Policy supersedes and replaces the Company&rsquo;s Compensation Clawback Policy adopted as of March
12, 2022, with respect to Incentive-Based Compensation received after the Effective Date. Capitalized terms used and not otherwise defined
herein shall have the meanings given to such terms in Section 3 below.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>1.</B></TD><TD><B>Overview</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">The Policy sets forth the circumstances and procedures under which
the Company shall recover Erroneously Awarded Compensation from (i) Covered Persons in accordance with rules issued by the United States
Securities and Exchange Commission (the &ldquo;<U>SEC</U>&rdquo;) under the Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange
Act</U>&rdquo;), and the New York Stock Exchange (the &ldquo;<U>Exchange</U>&rdquo;) and (ii) Participating Employees.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.</B></TD><TD><B>Compensation Recovery Requirement</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">In the event the Company is required to prepare a Financial Restatement,
the Company shall recover reasonably promptly all Erroneously Awarded Compensation with respect to such Financial Restatement.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>3.</B></TD><TD><B>Definitions</B></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">a.</TD><TD>&ldquo;<U>Applicable Recovery Period</U>&rdquo; means the three completed fiscal years immediately preceding the Restatement Date
for a Financial Restatement. In the event the Company has changed its fiscal year: (i) any transition period of less than nine months
occurring within or immediately following such three completed fiscal years shall also be part of such Applicable Recovery Period and
(ii) any transition period of nine to 12 months will be deemed to be a completed fiscal year.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">b.</TD><TD>&ldquo;<U>Applicable Rules</U>&rdquo; means any rules or regulations adopted by the Exchange pursuant to Rule 10D-1 under the Exchange
Act and any applicable rules or regulations adopted by the SEC pursuant to Section 10D of the Exchange Act.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">c.</TD><TD>&ldquo;<U>Board</U>&rdquo; means the Board of Directors of the Company.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">d.</TD><TD>&ldquo;<U>Committee</U>&rdquo; means the Compensation Committee of the Board or, in the absence of such committee, a majority of independent
directors serving on the Board.</TD></TR></TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">e.</TD><TD>&ldquo;<U>Covered Person</U>&rdquo; means any Executive Officer. A person&rsquo;s status as a Covered Person with respect to Erroneously
Awarded Compensation shall be determined as of the time of receipt of such Erroneously Awarded Compensation regardless of the person&rsquo;s
current role or status with the Company (e.g., if a person began service as an Executive Officer after the beginning of an Applicable
Recovery Period, that person would not be considered a Covered Person with respect to Erroneously Awarded Compensation received before
the person began service as an Executive Officer, but would be considered a Covered Person with respect to Erroneously Awarded Compensation
received after the person began service as an Executive Officer where such person served as an Executive Officer at any time during the
performance period for such Erroneously Awarded Compensation).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">f.</TD><TD>&ldquo;<U>Effective Date</U>&rdquo; means October 2, 2023.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">g.</TD><TD>&ldquo;<U>Erroneously Awarded Compensation</U>&rdquo; means the amount of any Incentive-Based Compensation received by a Covered Person
on or after the Effective Date and during the Applicable Recovery Period that exceeds the amount that otherwise would have been received
by the Covered Person had such compensation been determined based on the restated amounts in a Financial Restatement, computed without
regard to any taxes paid. Calculation of Erroneously Awarded Compensation with respect to Incentive-Based Compensation based on stock
price or total shareholder return, where the amount of Erroneously Awarded Compensation is not subject to mathematical recalculation directly
from the information in a Financial Restatement, shall be based on a reasonable estimate of the effect of the Financial Restatement on
the stock price or total shareholder return upon which the Incentive-Based Compensation was based, and the Company shall maintain documentation
of the determination of such reasonable estimate and provide such documentation to the Exchange in accordance with the Applicable Rules.
Incentive-Based Compensation is deemed received in the fiscal period when the Financial Reporting Measure is attained, not when the actual
payment, grant, or vesting occurs.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">h.</TD><TD>&ldquo;<U>Executive Officer</U>&rdquo; means any person who served the Company in any of the following roles at any time during the
performance period applicable to Incentive-Based Compensation and received Incentive-Based Compensation after beginning service in any
such role (regardless of whether such Incentive-Based Compensation was received during or after such person&rsquo;s service in such role):
the president; principal financial officer; principal accounting officer (or if there is no such accounting officer, the controller);
any vice president in charge of a principal business unit, division, or function (such as sales, administration, or finance); any other
officer who performs a policy making function; or any other person who performs similar policy making functions for the Company. Officers
of subsidiaries of the Company may be deemed Executive Officers if they perform such policy making functions for the Company.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">i.</TD><TD>&ldquo;<U>Financial Reporting Measures</U>&rdquo; mean measures that are determined and presented in accordance with the accounting
principles used in preparing the Company&rsquo;s financial statements, any measures that are derived wholly or in part from such measures
(including, for example, a non-GAAP financial measure), and stock price and total shareholder return.</TD></TR></TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">j.</TD><TD>&ldquo;<U>Financial Restatement</U>&rdquo; means a restatement of previously issued financial statements of the Company due to the
material noncompliance of the Company with any financial reporting requirement under the securities laws, including any required restatement
to correct an error in previously-issued financial statements that is material to the previously-issued financial statements or that would
result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">k.</TD><TD>&ldquo;<U>Incentive-Based Compensation</U>&rdquo; means any compensation provided, directly or indirectly, by the Company or any of
its subsidiaries that is granted, earned or vested based, in whole or in part, upon the attainment of a Financial Reporting Measure and
any other equity-based compensation provided by the Company or any of its subsidiaries, including, without limitation, stock options,
restricted stock awards, restricted stock units, and stock appreciation rights, regardless of whether such equity-based compensation is
granted, earned, or vested based, in whole or in part, upon the attainment of a Financial Reporting Measure.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">l.</TD><TD>&ldquo;<U>Restatement Date</U>&rdquo; means, with respect to a Financial Restatement, the earlier to occur of: (i) the date the Board
concludes, or reasonably should have concluded, that the Company is required to prepare the Financial Restatement or (ii) the date a court,
regulator, or other legally authorized body directs the Company to prepare the Financial Restatement.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>4.</B></TD><TD><B>Exception to Compensation Recovery Requirement</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">The Company may elect not to recover Erroneously Awarded Compensation
pursuant to this Policy if the Committee determines that recovery would be impracticable, and one or more of the following conditions,
together with any further requirements set forth in the Applicable Rules, are met: (i) the direct expense paid to third parties including
outside legal counsel, to assist in enforcing this Policy would exceed the amount to be recovered, and the Company has made a reasonable
attempt to recover such Erroneously Awarded Compensation; or (ii) recovery would likely cause an otherwise tax-qualified retirement plan
to fail to be so qualified under applicable regulations.</P>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>5.</B></TD><TD><B>Recovery from Participating Employees</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">In addition to (and without limiting) the provisions of paragraph
2 above, in the event the Company is required to prepare a Financial Restatement after the Effective Date, the Company will use reasonable
efforts to recover from any current or former employee of the Company who is not a Covered Person but received Incentive-Based Compensation
from the Company during the three completed fiscal years immediately preceding the date on which the Board concludes that the Company
is required to prepare a Financial Restatement (each a &ldquo;<U>Participating Employee</U>&rdquo;), the amount that exceeds what would
have been paid to the Participating Employee under the Financial Restatement; provided that, this paragraph 5 will apply only to the extent
the Board (or a duly established committee thereof), in its sole discretion, determines that the Participating Employee committed any
act or omission that materially contributed to the circumstances requiring the Financial Restatement and which involved any of the following:
(i) misconduct, wrongdoing, or a violation of any of the Company&rsquo;s rules or of any applicable legal or regulatory requirements in
the course of the Participating Employee&rsquo;s employment by, or service with, the Company; or (ii) a breach of a fiduciary duty to
the Company or its stockholders by the Participating Employee.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>6.</B></TD><TD><B>Recovery for Intentional Misconduct</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">In addition to (and without limiting) the provisions of paragraphs
2 and 5 above, in the event that the Company is required to prepare a Financial Restatement after the Effective Date and the Board (or
a duly established committee thereof), in its sole discretion, determines that a Covered Person&rsquo;s or a Participating Employee&rsquo;s
act or omission contributed to the circumstances requiring the Financial Restatement and such act or omission involved any of the following:
(i) willful, knowing, or intentional misconduct or a willful, knowing, or intentional violation of any of the Company&rsquo;s rules or
any applicable legal or regulatory requirements in the course of the Covered Person&rsquo;s or the Participating Employee&rsquo;s employment
by, or service with, the Company; or (ii) fraud in the course of the Covered Person&rsquo;s or the Participating Employee&rsquo;s employment
by, or service with, the Company, then in each such case, the Company will use reasonable efforts to recover from such Covered Person
or Participating Employee, up to 100% (as determined by the Board or a duly established committee thereof in its sole discretion) of the
Incentive-Based Compensation received by such Covered Person or Participating Employee from the Company during the three fiscal years
immediately preceding the date on which the Board concludes that the Company is required to prepare such Financial Restatement, and not
just the amount that is in excess of what would have been paid to the Covered Person or the Participating Employee had such compensation
been determined based on the restated amounts in such Financial Restatement.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>7.</B></TD><TD><B>Tax Considerations</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">To the extent that, pursuant to this Policy, the Company is entitled
to recover any compensation, the gross amount of the recoverable compensation received (i.e., the amount the Covered Person or Participating
Employee received, or was entitled to receive, before any deductions for tax withholding or other payments) shall be returned by the Covered
Person or Participating Employee, as applicable.</P>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>8.</B></TD><TD><B>Method of Compensation Recovery</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">The Committee shall determine, in its sole discretion, the method
for recovering Erroneously Awarded Compensation or other compensation recoverable hereunder, which may include, without limitation, any
one or more of the following:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">a.</TD><TD>requiring reimbursement of cash Incentive-Based Compensation previously paid;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">b.</TD><TD>seeking recovery of any gain realized on the vesting, exercise, settlement, sale, transfer, or other disposition of any equity-based
awards;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">c.</TD><TD>cancelling or rescinding some or all outstanding vested or unvested equity-based awards;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">d.</TD><TD>adjusting or withholding from unpaid compensation or other offset;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">e.</TD><TD>cancelling or offsetting against planned future grants of equity-based awards; and/or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">f.</TD><TD>any other method permitted by applicable law or contract.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Notwithstanding the foregoing, a Covered Person or Participating
Employee will be deemed to have satisfied such person&rsquo;s obligation to return Erroneously Awarded Compensation or other recoverable
compensation to the Company if such compensation is returned in the exact same form in which it was received; provided that equity withheld
to satisfy tax obligations will be deemed to have been received in cash in an amount equal to the tax withholding payment made.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>9.</B></TD><TD><B>Policy Interpretation</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">This Policy shall be interpreted in a manner that is consistent with
the Applicable Rules and any other applicable law. The Committee shall take into consideration any applicable interpretations and guidance
of the SEC in interpreting this Policy, including, for example, in determining whether a financial restatement qualifies as a Financial
Restatement hereunder. To the extent the Applicable Rules require recovery of Incentive-Based Compensation in additional circumstances
besides those specified above, nothing in this Policy shall be deemed to limit or restrict the right or obligation of the Company to recover
Incentive-Based Compensation to the fullest extent required by the Applicable Rules.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>10.</B></TD><TD><B>Policy Administration</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">This Policy shall be administered by the Committee; provided, however,
that the Board shall have exclusive authority to authorize the Company to prepare a Financial Restatement. In doing so, the Board may
rely on a recommendation of the Audit Committee of the Board. Except for such authority reserved for the Board, the Committee shall have
such powers and authorities related to the administration of this Policy as are consistent with the governing documents of the Company
and applicable law. The Committee shall have full power and authority to take, or direct the taking of, all actions and to make all determinations
required or provided for under this Policy and shall have full power and authority to take, or direct the taking of, all such other actions
and make all such other determinations not inconsistent with the specific terms and provisions of this Policy that the Committee deems
to be necessary or appropriate to the administration of this Policy. The interpretation and construction by the Committee of any provision
of this Policy and all determinations made by the Committee under this Policy shall be final, binding, and conclusive.</P>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="font-size: 10pt; width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>11.</B></TD><TD><B>Compensation Recovery Repayments not Subject to Indemnification</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Notwithstanding anything to the contrary set forth in any agreement
with, or the organizational documents of, the Company or any of its subsidiaries, Covered Persons and Participating Employees are not
entitled to indemnification for Erroneously Awarded Compensation or other recoverable compensation or for any losses arising out of or
in any way related to Erroneously Awarded Compensation or other recoverable compensation recovered under this Policy.</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt">6</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>


</DIV></BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>wt-20231231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Feb 23 00:25:24 UTC 2024 -->
<xs:schema elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2023" targetNamespace="http://www.wisdomtreeinvestmentsinc.com/20231231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:wt="http://www.wisdomtreeinvestmentsinc.com/20231231" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="wt-20231231_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="wt-20231231_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="wt-20231231_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="wt-20231231_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet" id="wt_r_ConsolidatedBalanceSheet">
        <link:definition>995301 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals" id="wt_r_ConsolidatedBalanceSheet_Parentheticals">
        <link:definition>995302 - Statement - Consolidated Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement" id="wt_r_ConsolidatedIncomeStatement">
        <link:definition>995303 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedComprehensiveIncome" id="wt_r_ConsolidatedComprehensiveIncome">
        <link:definition>995304 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3" id="wt_r_ShareholdersEquityType2or3">
        <link:definition>995305 - Statement - Consolidated Statements of Changes in Stockholders&#8217; Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3_Parentheticals" id="wt_r_ShareholdersEquityType2or3_Parentheticals">
        <link:definition>995306 - Statement - Consolidated Statements of Changes in Stockholders&#8217; Equity (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow" id="wt_r_ConsolidatedCashFlow">
        <link:definition>995307 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/OrganizationandDescriptionofBusiness" id="wt_r_OrganizationandDescriptionofBusiness">
        <link:definition>995308 - Disclosure - Organization and Description of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPolicies" id="wt_r_SignificantAccountingPolicies">
        <link:definition>995309 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/CashandCashEquivalents" id="wt_r_CashandCashEquivalents">
        <link:definition>995310 - Disclosure - Cash and Cash Equivalents</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurements" id="wt_r_FairValueMeasurements">
        <link:definition>995311 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwned" id="wt_r_FinancialInstrumentsOwned">
        <link:definition>995312 - Disclosure - Financial Instruments Owned</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturity" id="wt_r_SecuritiesHeldtoMaturity">
        <link:definition>995313 - Disclosure - Securities Held-to-Maturity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/Investments" id="wt_r_Investments">
        <link:definition>995314 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNet" id="wt_r_FixedAssetsNet">
        <link:definition>995315 - Disclosure - Fixed Assets, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpayments" id="wt_r_DeferredConsiderationgoldpayments">
        <link:definition>995316 - Disclosure - Deferred Consideration&#8212;gold payments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotes" id="wt_r_ConvertibleNotes">
        <link:definition>995317 - Disclosure - Convertible Notes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStock" id="wt_r_SeriesAPreferredStock">
        <link:definition>995318 - Disclosure - Series A Preferred Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBH" id="wt_r_PayabletoGoldBullionHoldingsJerseyLimitedGBH">
        <link:definition>995319 - Disclosure - Payable to Gold Bullion Holdings Jersey Limited GBH</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/Leases" id="wt_r_Leases">
        <link:definition>995320 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/Contingencies" id="wt_r_Contingencies">
        <link:definition>995321 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntities" id="wt_r_VariableInterestEntities">
        <link:definition>995322 - Disclosure - Variable Interest Entities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/RevenuesfromContractswithCustomers" id="wt_r_RevenuesfromContractswithCustomers">
        <link:definition>995323 - Disclosure - Revenues from Contracts with Customers</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactions" id="wt_r_RelatedPartyTransactions">
        <link:definition>995324 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwards" id="wt_r_StockBasedAwards">
        <link:definition>995325 - Disclosure - Stock-Based Awards</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlan" id="wt_r_StockholderRightsPlan">
        <link:definition>995326 - Disclosure - Stockholder Rights Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/EmployeeBenefitPlans" id="wt_r_EmployeeBenefitPlans">
        <link:definition>995327 - Disclosure - Employee Benefit Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShare" id="wt_r_EarningsPerShare">
        <link:definition>995328 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxes" id="wt_r_IncomeTaxes">
        <link:definition>995329 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchased" id="wt_r_SharesRepurchased">
        <link:definition>995330 - Disclosure - Shares Repurchased</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssets" id="wt_r_GoodwillandIntangibleAssets">
        <link:definition>995331 - Disclosure - Goodwill and Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ContingentPayments" id="wt_r_ContingentPayments">
        <link:definition>995332 - Disclosure - Contingent Payments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/Impairments" id="wt_r_Impairments">
        <link:definition>995333 - Disclosure - Impairments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SubsequentEvents" id="wt_r_SubsequentEvents">
        <link:definition>995334 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy" id="wt_r_AccountingPoliciesByPolicy">
        <link:definition>996000 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesTables" id="wt_r_SignificantAccountingPoliciesTables">
        <link:definition>996001 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsTables" id="wt_r_FairValueMeasurementsTables">
        <link:definition>996002 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedTables" id="wt_r_FinancialInstrumentsOwnedTables">
        <link:definition>996003 - Disclosure - Financial Instruments Owned (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturityTables" id="wt_r_SecuritiesHeldtoMaturityTables">
        <link:definition>996004 - Disclosure - Securities Held-to-Maturity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsTables" id="wt_r_InvestmentsTables">
        <link:definition>996005 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNetTables" id="wt_r_FixedAssetsNetTables">
        <link:definition>996006 - Disclosure - Fixed Assets, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsTables" id="wt_r_DeferredConsiderationgoldpaymentsTables">
        <link:definition>996007 - Disclosure - Deferred Consideration&#8212;gold payments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesTables" id="wt_r_ConvertibleNotesTables">
        <link:definition>996008 - Disclosure - Convertible Notes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockTables" id="wt_r_SeriesAPreferredStockTables">
        <link:definition>996009 - Disclosure - Series A Preferred Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHTables" id="wt_r_PayabletoGoldBullionHoldingsJerseyLimitedGBHTables">
        <link:definition>996010 - Disclosure - Payable to Gold Bullion Holdings Jersey Limited GBH (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/LeasesTables" id="wt_r_LeasesTables">
        <link:definition>996011 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesTables" id="wt_r_VariableInterestEntitiesTables">
        <link:definition>996012 - Disclosure - Variable Interest Entities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/RevenuesfromContractswithCustomersTables" id="wt_r_RevenuesfromContractswithCustomersTables">
        <link:definition>996013 - Disclosure - Revenues from Contracts with Customers (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsTables" id="wt_r_RelatedPartyTransactionsTables">
        <link:definition>996014 - Disclosure - Related Party Transactions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsTables" id="wt_r_StockBasedAwardsTables">
        <link:definition>996015 - Disclosure - Stock-Based Awards (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/EmployeeBenefitPlansTables" id="wt_r_EmployeeBenefitPlansTables">
        <link:definition>996016 - Disclosure - Employee Benefit Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShareTables" id="wt_r_EarningsPerShareTables">
        <link:definition>996017 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesTables" id="wt_r_IncomeTaxesTables">
        <link:definition>996018 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsTables" id="wt_r_GoodwillandIntangibleAssetsTables">
        <link:definition>996019 - Disclosure - Goodwill and Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ImpairmentsTables" id="wt_r_ImpairmentsTables">
        <link:definition>996020 - Disclosure - Impairments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesDetails" id="wt_r_SignificantAccountingPoliciesDetails">
        <link:definition>996021 - Disclosure - Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDepreciationandAmortizationTable" id="wt_r_ScheduleofDepreciationandAmortizationTable">
        <link:definition>996022 - Disclosure - Significant Accounting Policies (Details) - Schedule of Depreciation and Amortization</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/CashandCashEquivalentsDetails" id="wt_r_CashandCashEquivalentsDetails">
        <link:definition>996023 - Disclosure - Cash and Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsDetails" id="wt_r_FairValueMeasurementsDetails">
        <link:definition>996024 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable" id="wt_r_ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable">
        <link:definition>996025 - Disclosure - Fair Value Measurements (Details) - Schedule of Assets and Liabilities Measured at Fair Value</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBeginningandEndingBalancesofRecurringFairValueMeasurementsClassifiedTable" id="wt_r_ScheduleofBeginningandEndingBalancesofRecurringFairValueMeasurementsClassifiedTable">
        <link:definition>996026 - Disclosure - Fair Value Measurements (Details) - Schedule of Beginning and Ending Balances of Recurring Fair Value Measurements Classified</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedDetails" id="wt_r_FinancialInstrumentsOwnedDetails">
        <link:definition>996027 - Disclosure - Financial Instruments Owned (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFinancialInstrumentsOwnedTable" id="wt_r_ScheduleofFinancialInstrumentsOwnedTable">
        <link:definition>996028 - Disclosure - Financial Instruments Owned (Details) - Schedule of Financial Instruments Owned</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturityDetails" id="wt_r_SecuritiesHeldtoMaturityDetails">
        <link:definition>996029 - Disclosure - Securities Held-to-Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSecuritiesHeldtoMaturityTable" id="wt_r_ScheduleofSecuritiesHeldtoMaturityTable">
        <link:definition>996030 - Disclosure - Securities Held-to-Maturity (Details) - Schedule of Securities Held-to-Maturity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable" id="wt_r_ScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable">
        <link:definition>996031 - Disclosure - Securities Held-to-Maturity (Details) - Schedule of Unrealized Losses, Gains and Fair Value of Securities Held-to-Maturity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofMaturityProfileoftheSecuritiesHeldtoMaturityTable" id="wt_r_ScheduleofMaturityProfileoftheSecuritiesHeldtoMaturityTable">
        <link:definition>996032 - Disclosure - Securities Held-to-Maturity (Details) - Schedule of Maturity Profile of the Securities Held-to-Maturity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails" id="wt_r_InvestmentsDetails">
        <link:definition>996033 - Disclosure - Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInvestmentsTable" id="wt_r_ScheduleofInvestmentsTable">
        <link:definition>996034 - Disclosure - Investments (Details) - Schedule of Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBacksolveValuationApproachTable" id="wt_r_ScheduleofBacksolveValuationApproachTable">
        <link:definition>996035 - Disclosure - Investments (Details) - Schedule of Backsolve Valuation Approach</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofPresentstheProbabilityAscribedtoPotentialOutcomesUsedinthePwermTable" id="wt_r_ScheduleofPresentstheProbabilityAscribedtoPotentialOutcomesUsedinthePwermTable">
        <link:definition>996036 - Disclosure - Investments (Details) - Schedule of Presents the Probability Ascribed to Potential Outcomes Used in the Pwerm</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFixedAssetsTable" id="wt_r_ScheduleofFixedAssetsTable">
        <link:definition>996037 - Disclosure - Fixed Assets, Net (Details) - Schedule of Fixed Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails" id="wt_r_DeferredConsiderationgoldpaymentsDetails">
        <link:definition>996038 - Disclosure - Deferred Consideration&#8212;gold payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofValuationofDeferredConsiderationTable" id="wt_r_ScheduleofValuationofDeferredConsiderationTable">
        <link:definition>996039 - Disclosure - Deferred Consideration&#8212;gold payments (Details) - Schedule of Valuation of Deferred Consideration</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDeferredConsiderationTable" id="wt_r_ScheduleofDeferredConsiderationTable">
        <link:definition>996040 - Disclosure - Deferred Consideration&#8212;gold payments (Details) - Schedule of Deferred Consideration</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails" id="wt_r_ConvertibleNotesDetails">
        <link:definition>996041 - Disclosure - Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofKeyTermsofConvertibleNotesTable" id="wt_r_ScheduleofKeyTermsofConvertibleNotesTable">
        <link:definition>996042 - Disclosure - Convertible Notes (Details) - Schedule of Key Terms of Convertible Notes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofConvertibleNotesTable" id="wt_r_ScheduleofConvertibleNotesTable">
        <link:definition>996043 - Disclosure - Convertible Notes (Details) - Schedule of Convertible Notes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockDetails" id="wt_r_SeriesAPreferredStockDetails">
        <link:definition>996044 - Disclosure - Series A Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSeriesAPreferredStockBalanceTable" id="wt_r_ScheduleofSeriesAPreferredStockBalanceTable">
        <link:definition>996045 - Disclosure - Series A Preferred Stock (Details) - Schedule of Series A Preferred Stock Balance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHDetails" id="wt_r_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetails">
        <link:definition>996046 - Disclosure - Payable to Gold Bullion Holdings Jersey Limited GBH (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAggregateConsiderationPayableTable" id="wt_r_ScheduleofAggregateConsiderationPayableTable">
        <link:definition>996047 - Disclosure - Payable to Gold Bullion Holdings Jersey Limited GBH (Details) - Schedule of Aggregate Consideration Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/LeasesDetails" id="wt_r_LeasesDetails">
        <link:definition>996048 - Disclosure - Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrY11ZqAmQBqDS9evb2UjxxqoT1dX+ftwW5Dmnj+XgBA5xugKgU5REylsG34PyUGaDd+s8Vz6UhUE2XjAqeTDG+GsAAOBng9N8lGsEAjX/LwTSBIBqd4ygj3svooWB2H37ux1jJEZgBFLWzkzuTALB4aTs3k+tWR6XSXbRFQ/yCjbgWHhVp8IVv+ya/tI0cD8QM=] CSR-->
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAdditionalInformationRelatedtoOperatingLeaseTable" id="wt_r_ScheduleofAdditionalInformationRelatedtoOperatingLeaseTable">
        <link:definition>996049 - Disclosure - Leases (Details) - Schedule of Additional Information Related to Operating Lease</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFutureMinimumLeasePaymentsTable" id="wt_r_ScheduleofFutureMinimumLeasePaymentsTable">
        <link:definition>996050 - Disclosure - Leases (Details) - Schedule of Future Minimum Lease Payments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofFutureMinimumLeasePaymentstoBalanceSheetTable" id="wt_r_ScheduleofReconciliationofFutureMinimumLeasePaymentstoBalanceSheetTable">
        <link:definition>996051 - Disclosure - Leases (Details) - Schedule of Reconciliation of Future Minimum Lease Payments to Balance Sheet</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ContingenciesDetails" id="wt_r_ContingenciesDetails">
        <link:definition>996052 - Disclosure - Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInformationaboutVariableInterestsTable" id="wt_r_ScheduleofInformationaboutVariableInterestsTable">
        <link:definition>996053 - Disclosure - Variable Interest Entities (Details) - Schedule of Information about Variable Interests</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromContractswithCustomersTable" id="wt_r_ScheduleofRevenuesfromContractswithCustomersTable">
        <link:definition>996054 - Disclosure - Revenues from Contracts with Customers (Details) - Schedule of Revenues from Contracts with Customers</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGeographicDistributionofRevenuesTable" id="wt_r_ScheduleofGeographicDistributionofRevenuesTable">
        <link:definition>996055 - Disclosure - Revenues from Contracts with Customers (Details) - Schedule of Geographic Distribution of Revenues</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsDetails" id="wt_r_RelatedPartyTransactionsDetails">
        <link:definition>996056 - Disclosure - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAccountsReceivablefromRelatedPartiesTable" id="wt_r_ScheduleofAccountsReceivablefromRelatedPartiesTable">
        <link:definition>996057 - Disclosure - Related Party Transactions (Details) - Schedule of Accounts Receivable from Related Parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromAdvisoryServicesProvidedtoRelatedPartiesTable" id="wt_r_ScheduleofRevenuesfromAdvisoryServicesProvidedtoRelatedPartiesTable">
        <link:definition>996058 - Disclosure - Related Party Transactions (Details) - Schedule of Revenues from Advisory Services Provided to Related Parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails" id="wt_r_StockBasedAwardsDetails">
        <link:definition>996059 - Disclosure - Stock-Based Awards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable" id="wt_r_ScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable">
        <link:definition>996060 - Disclosure - Stock-Based Awards (Details) - Schedule of Unrecognized Stock-Based Compensation Expense and Average Remaining Vesting Period</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRestrictedStockActivityandRestrictedStockUnitTable" id="wt_r_ScheduleofRestrictedStockActivityandRestrictedStockUnitTable">
        <link:definition>996061 - Disclosure - Stock-Based Awards (Details) - Schedule of Restricted Stock Activity and Restricted Stock Unit</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofShareBasedPaymentAwardsOtherthanOptionsValuationAssumptionsTable" id="wt_r_ScheduleofShareBasedPaymentAwardsOtherthanOptionsValuationAssumptionsTable">
        <link:definition>996062 - Disclosure - Stock-Based Awards (Details) - Schedule of Share Based Payment Awards Other than Options Valuation Assumptions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails" id="wt_r_StockholderRightsPlanDetails">
        <link:definition>996063 - Disclosure - Stockholder Rights Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SummaryofDiscretionaryContributionsTable" id="wt_r_SummaryofDiscretionaryContributionsTable">
        <link:definition>996064 - Disclosure - Employee Benefit Plans (Details) - Summary of Discretionary Contributions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShareDetails" id="wt_r_EarningsPerShareDetails">
        <link:definition>996065 - Disclosure - Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofBasicandDilutedEarningsPerShareTable" id="wt_r_ScheduleofReconciliationofBasicandDilutedEarningsPerShareTable">
        <link:definition>996066 - Disclosure - Earnings Per Share (Details) - Schedule of Reconciliation of Basic and Diluted Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofWeightedAverageNumberofSharesTable" id="wt_r_ScheduleofWeightedAverageNumberofSharesTable">
        <link:definition>996067 - Disclosure - Earnings Per Share (Details) - Schedule of Weighted Average Number of Shares</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesDetails" id="wt_r_IncomeTaxesDetails">
        <link:definition>996068 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable" id="wt_r_ScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable">
        <link:definition>996069 - Disclosure - Income Taxes (Details) - Schedule of Domestic and Foreign Components of Income before Income Tax Expense</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable" id="wt_r_ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable">
        <link:definition>996070 - Disclosure - Income Taxes (Details) - Schedule of Components of Current and Deferred Income Tax Expense</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable" id="wt_r_ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable">
        <link:definition>996071 - Disclosure - Income Taxes (Details) - Schedule of Reconciliation of Statutory Federal Income Tax Rate and Company's Effective Rate</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIncomeTaxPaymentsByJurisdictionTable" id="wt_r_ScheduleofIncomeTaxPaymentsByJurisdictionTable">
        <link:definition>996072 - Disclosure - Income Taxes (Details) - Schedule of Income Tax Payments By Jurisdiction</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable" id="wt_r_ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable">
        <link:definition>996073 - Disclosure - Income Taxes (Details) - Schedule of Components of the Company&#8217;s Deferred Tax Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable" id="wt_r_ScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable">
        <link:definition>996074 - Disclosure - Income Taxes (Details) - Schedule of Changes in Balance of Gross Unrecognized Tax Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails" id="wt_r_SharesRepurchasedDetails">
        <link:definition>996075 - Disclosure - Shares Repurchased (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsDetails" id="wt_r_GoodwillandIntangibleAssetsDetails">
        <link:definition>996076 - Disclosure - Goodwill and Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGoodwillTable" id="wt_r_ScheduleofGoodwillTable">
        <link:definition>996077 - Disclosure - Goodwill and Intangible Assets (Details) - Schedule of Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIntangibleAssetsTable" id="wt_r_ScheduleofIntangibleAssetsTable">
        <link:definition>996078 - Disclosure - Goodwill and Intangible Assets (Details) - Schedule of Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofExpectedAmortizationExpenseTable" id="wt_r_ScheduleofExpectedAmortizationExpenseTable">
        <link:definition>996079 - Disclosure - Goodwill and Intangible Assets (Details) - Schedule of Expected Amortization Expense</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsDetails" id="wt_r_ContingentPaymentsDetails">
        <link:definition>996080 - Disclosure - Contingent Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSummarizesImpairmentsRecognizedTable" id="wt_r_ScheduleofSummarizesImpairmentsRecognizedTable">
        <link:definition>996081 - Disclosure - Impairments (Details) - Schedule of Summarizes Impairments Recognized</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.wisdomtreeinvestmentsinc.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei-sub/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-sub-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"/>
  <xs:element name="ScheduleOfDepreciationAndAmortizationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfDepreciationAndAmortizationAbstract"/>
  <xs:element name="ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueAbstract"/>
  <xs:element name="ScheduleOfBeginningAndEndingBalancesOfRecurringFairValueMeasurementsClassifiedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfBeginningAndEndingBalancesOfRecurringFairValueMeasurementsClassifiedAbstract"/>
  <xs:element name="ScheduleOfFinancialInstrumentsOwnedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfFinancialInstrumentsOwnedAbstract"/>
  <xs:element name="ScheduleOfBacksolveValuationApproachAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfBacksolveValuationApproachAbstract"/>
  <xs:element name="ScheduleOfPresentsTheProbabilityAscribedToPotentialOutcomesUsedInThePwermAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfPresentsTheProbabilityAscribedToPotentialOutcomesUsedInThePwermAbstract"/>
  <xs:element name="DeferredConsiderationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_DeferredConsiderationAbstract"/>
  <xs:element name="ScheduleOfValuationOfDeferredConsiderationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfValuationOfDeferredConsiderationAbstract"/>
  <xs:element name="ScheduleOfKeyTermsOfConvertibleNotesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfKeyTermsOfConvertibleNotesAbstract"/>
  <xs:element name="ScheduleOfConvertibleNotesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfConvertibleNotesAbstract"/>
  <xs:element name="ScheduleOfAdditionalInformationRelatedToOperatingLeaseAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfAdditionalInformationRelatedToOperatingLeaseAbstract"/>
  <xs:element name="ScheduleOfFutureMinimumLeasePaymentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfFutureMinimumLeasePaymentsAbstract"/>
  <xs:element name="ScheduleOfReconciliationOfFutureMinimumLeasePaymentsToBalanceSheetAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfReconciliationOfFutureMinimumLeasePaymentsToBalanceSheetAbstract"/>
  <xs:element name="ScheduleOfInformationAboutVariableInterestsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfInformationAboutVariableInterestsAbstract"/>
  <xs:element name="ScheduleOfRevenuesFromContractsWithCustomersAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfRevenuesFromContractsWithCustomersAbstract"/>
  <xs:element name="ScheduleOfGeographicDistributionOfRevenuesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfGeographicDistributionOfRevenuesAbstract"/>
  <xs:element name="ScheduleOfAccountsReceivableFromRelatedPartiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfAccountsReceivableFromRelatedPartiesAbstract"/>
  <xs:element name="ScheduleOfRevenuesFromAdvisoryServicesProvidedToRelatedPartiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfRevenuesFromAdvisoryServicesProvidedToRelatedPartiesAbstract"/>
  <xs:element name="ScheduleOfUnrecognizedStockBasedCompensationExpenseAndAverageRemainingVestingPeriodAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfUnrecognizedStockBasedCompensationExpenseAndAverageRemainingVestingPeriodAbstract"/>
  <xs:element name="ScheduleOfRestrictedStockActivityAndRestrictedStockUnitAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfRestrictedStockActivityAndRestrictedStockUnitAbstract"/>
  <xs:element name="ScheduleOfShareBasedPaymentAwardsOtherThanOptionsValuationAssumptionsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfShareBasedPaymentAwardsOtherThanOptionsValuationAssumptionsAbstract"/>
  <xs:element name="DisclosureOfStockholderRightsPlanAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_DisclosureOfStockholderRightsPlanAbstract"/>
  <xs:element name="ScheduleOfWeightedAverageNumberOfSharesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfWeightedAverageNumberOfSharesAbstract"/>
  <xs:element name="ScheduleOfComponentsOfCurrentAndDeferredIncomeTaxExpenseAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfComponentsOfCurrentAndDeferredIncomeTaxExpenseAbstract"/>
  <xs:element name="ScheduleOfComponentsOfTheCompanySDeferredTaxAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfComponentsOfTheCompanySDeferredTaxAssetsAbstract"/>
  <xs:element name="ScheduleOfChangesInBalanceOfGrossUnrecognizedTaxBenefitsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfChangesInBalanceOfGrossUnrecognizedTaxBenefitsAbstract"/>
  <xs:element name="ScheduleOfGoodwillAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfGoodwillAbstract"/>
  <xs:element name="ScheduleOfIntangibleAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfIntangibleAssetsAbstract"/>
  <xs:element name="ScheduleOfExpectedAmortizationExpenseAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfExpectedAmortizationExpenseAbstract"/>
  <xs:element name="ScheduleOfSummarizesImpairmentsRecognizedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfSummarizesImpairmentsRecognizedAbstract"/>
  <xs:element name="RecurringFairValueMeasurementsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_RecurringFairValueMeasurementsAbstract"/>
  <xs:element name="FinancialInstrumentsOwnedAtFairValueAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_FinancialInstrumentsOwnedAtFairValueAbstract0"/>
  <xs:element name="OtherAssetsSeedCapitalWisdomtreeDigitalFundsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_OtherAssetsSeedCapitalWisdomtreeDigitalFundsAbstract"/>
  <xs:element name="NonRecurringFairValueMeasurementsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_NonRecurringFairValueMeasurementsAbstract"/>
  <xs:element name="AssetsAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_AssetsAbstract0"/>
  <xs:element name="RecurringFairValueMeasurementsAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_RecurringFairValueMeasurementsAbstract0"/>
  <xs:element name="FinancialInstrumentsOwnedAtFairValueAbstract0Alt0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_FinancialInstrumentsOwnedAtFairValueAbstract0Alt0"/>
  <xs:element name="NonRecurringFairValueMeasurementsAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_NonRecurringFairValueMeasurementsAbstract0"/>
  <xs:element name="UnlabeledAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_UnlabeledAbstract"/>
  <xs:element name="RecurringFairValueMeasurementsAbstract1" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_RecurringFairValueMeasurementsAbstract1"/>
  <xs:element name="DeferredConsiderationNote7Abstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_DeferredConsiderationNote7Abstract"/>
  <xs:element name="FinancialInstrumentsOwnedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_FinancialInstrumentsOwnedAbstract"/>
  <xs:element name="SecurrencyIncAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_SecurrencyIncAbstract"/>
  <xs:element name="FnalityInternationalLimitedAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_FnalityInternationalLimitedAbstract"/>
  <xs:element name="OtherInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_OtherInformationAbstract"/>
  <xs:element name="CarryingAmountAssetsSecurrencyAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_CarryingAmountAssetsSecurrencyAbstract"/>
  <xs:element name="CarryingAmountAssetsFnalityAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_CarryingAmountAssetsFnalityAbstract"/>
  <xs:element name="RevenuesFromContractsWithCustomersAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_RevenuesFromContractsWithCustomersAbstract"/>
  <xs:element name="BasicEarningsPerShareAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_BasicEarningsPerShareAbstract"/>
  <xs:element name="DilutedEarningsPerShareAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_DilutedEarningsPerShareAbstract"/>
  <xs:element name="WeightedAverageDilutedSharesInThousandsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_WeightedAverageDilutedSharesInThousandsAbstract"/>
  <xs:element name="LessParticipatingSecuritiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_LessParticipatingSecuritiesAbstract"/>
  <xs:element name="UnlabeledAbstract0" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_UnlabeledAbstract0"/>
  <xs:element name="IndemnificationReceivableNoncurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wt_IndemnificationReceivableNoncurrent"/>
  <xs:element name="DeferredConsiderationCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_DeferredConsiderationCurrent"/>
  <xs:element name="CarryingValueOfConvertibleNotes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_CarryingValueOfConvertibleNotes"/>
  <xs:element name="DeferredConsiderationNoncurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_DeferredConsiderationNoncurrent"/>
  <xs:element name="RelatedPartiesDomainDomain" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_RelatedPartiesDomainDomain"/>
  <xs:element name="PreferredStockRedemptionValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_PreferredStockRedemptionValue"/>
  <xs:element name="FundManagementAndAdministration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wt_FundManagementAndAdministration"/>
  <xs:element name="ContractualGoldPayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wt_ContractualGoldPayments"/>
  <xs:element name="ThirdPartyDistribution" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wt_ThirdPartyDistribution"/>
  <xs:element name="GainLossFromChangeInDeferredConsideration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_GainLossFromChangeInDeferredConsideration"/>
  <xs:element name="StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes"/>
  <xs:element name="TemporaryStockholdersEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_TemporaryStockholdersEquity"/>
  <xs:element name="TemporaryEquityShareOutstanding" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wt_TemporaryEquityShareOutstanding"/>
  <xs:element name="ReclassificationOfEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_ReclassificationOfEquity"/>
  <xs:element name="AdvisoryFeesReceivedInGold" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_AdvisoryFeesReceivedInGold"/>
  <xs:element name="AmortizationOfIssuanceCostsConvertibleNotes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wt_AmortizationOfIssuanceCostsConvertibleNotes"/>
  <xs:element name="IncreaseDecreaseInGoldAndOtherPreciousMetals" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_IncreaseDecreaseInGoldAndOtherPreciousMetals"/>
  <xs:element name="IncreaseDecreaseInFundManagementAndAdministrationPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wt_IncreaseDecreaseInFundManagementAndAdministrationPayable"/>
  <xs:element name="IncreaseDecreaseInOperatingLeaseLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_IncreaseDecreaseInOperatingLeaseLiabilities"/>
  <xs:element name="PurchaseOfFinancialInstrumentsOwnedAtFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_PurchaseOfFinancialInstrumentsOwnedAtFairValue"/>
  <xs:element name="PurchaseOfInvestments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_PurchaseOfInvestments"/>
  <xs:element name="ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wt_ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue"/>
  <xs:element name="ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wt_ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity"/>
  <xs:element name="PaymentOfDeferredConsideration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_PaymentOfDeferredConsideration"/>
  <xs:element name="PaymentOfConvertibleNotesIssuanceCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_PaymentOfConvertibleNotesIssuanceCosts"/>
  <xs:element name="ProceedsFromIssuanceOfConvertibleNotes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wt_ProceedsFromIssuanceOfConvertibleNotes"/>
  <xs:element name="DeferredConsiderationTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_DeferredConsiderationTextBlock"/>
  <xs:element name="OtherPayablesTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_OtherPayablesTextBlock"/>
  <xs:element name="DisclosureOfStockholderRightsPlanTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_DisclosureOfStockholderRightsPlanTextBlock"/>
  <xs:element name="ContingentPaymentTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ContingentPaymentTextBlock"/>
  <xs:element name="ContractualGoldPaymentsPolicyPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ContractualGoldPaymentsPolicyPolicyTextBlock"/>
  <xs:element name="ThirdPartyDistributionFeesPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ThirdPartyDistributionFeesPolicyTextBlock"/>
  <xs:element name="DeferredConsiderationGoldPaymentsPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_DeferredConsiderationGoldPaymentsPolicyTextBlock"/>
  <xs:element name="ContingentPaymentsPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ContingentPaymentsPolicyTextBlock"/>
  <xs:element name="RecentlyIssuedAccountingPronouncementsPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_RecentlyIssuedAccountingPronouncementsPolicyTextBlock"/>
  <xs:element name="SignificantAccountingPoliciesTablesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_SignificantAccountingPoliciesTablesTable"/>
  <xs:element name="SignificantAccountingPoliciesTablesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_SignificantAccountingPoliciesTablesLineItems"/>
  <xs:element name="DisclosureOfValuationOfDeferredConsiderationTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_DisclosureOfValuationOfDeferredConsiderationTableTextBlock"/>
  <xs:element name="ScheduleOfDeferredConsiderationTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfDeferredConsiderationTableTextBlock"/>
  <xs:element name="ScheduleOfAggregateConsiderationPayableTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfAggregateConsiderationPayableTableTextBlock"/>
  <xs:element name="ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock"/>
  <xs:element name="SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock"/>
  <xs:element name="ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock"/>
  <xs:element name="ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock"/>
  <xs:element name="SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock"/>
  <xs:element name="BusinessCombinationDeferredConsiderationLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_BusinessCombinationDeferredConsiderationLiability"/>
  <xs:element name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions"/>
  <xs:element name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome"/>
  <xs:element name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings"/>
  <xs:element name="SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable"/>
  <xs:element name="SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityLineItems"/>
  <xs:element name="InvestmentsDetailsScheduleofInvestmentsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_InvestmentsDetailsScheduleofInvestmentsTable"/>
  <xs:element name="InvestmentsDetailsScheduleofInvestmentsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_InvestmentsDetailsScheduleofInvestmentsLineItems"/>
  <xs:element name="ProbabilityThatSeriesB2PreferenceSharesCovertIntoSeriesB1PreferenceShares" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ProbabilityThatSeriesB2PreferenceSharesCovertIntoSeriesB1PreferenceShares"/>
  <xs:element name="ConversionOfNotesUponAFutureEquityFinancing" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ConversionOfNotesUponAFutureEquityFinancing"/>
  <xs:element name="RedemptionOfNoteUponACorporateTransaction" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_RedemptionOfNoteUponACorporateTransaction"/>
  <xs:element name="FairValueAssumptionOfDissolutionRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_FairValueAssumptionOfDissolutionRate"/>
  <xs:element name="TimeToPotentialOutcomeinYear" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_TimeToPotentialOutcomeinYear"/>
  <xs:element name="ConversionOfNoteUponAFutureFinancingRound" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ConversionOfNoteUponAFutureFinancingRound"/>
  <xs:element name="RedemptionOfNoteUponAChangeOfControl" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_RedemptionOfNoteUponAChangeOfControl"/>
  <xs:element name="Default" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_Default"/>
  <xs:element name="TimeToPotentialOutcomesinYears" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_TimeToPotentialOutcomesinYears"/>
  <xs:element name="DeferredConsiderationgoldpaymentsDetailsScheduleofValuationofDeferredConsiderationTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_DeferredConsiderationgoldpaymentsDetailsScheduleofValuationofDeferredConsiderationTable"/>
  <xs:element name="ForwardsLookingGoldPrice" type="dtr:massItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ForwardsLookingGoldPrice"/>
  <xs:element name="BusinessCombinationConsiderationTransferredDeferredPaymentInterest" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_BusinessCombinationConsiderationTransferredDeferredPaymentInterest"/>
  <xs:element name="DeferredConsiderationPerpetualGrowthRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wt_DeferredConsiderationPerpetualGrowthRate"/>
  <xs:element name="ContractualGoldPaymentgoldOuncesPaid" type="dtr:massItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ContractualGoldPaymentgoldOuncesPaid"/>
  <xs:element name="ConvertibleNotesDetailsScheduleofKeyTermsofConvertibleNotesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_ConvertibleNotesDetailsScheduleofKeyTermsofConvertibleNotesTable"/>
  <xs:element name="DebtInstrumentRedemptionPrice" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_DebtInstrumentRedemptionPrice"/>
  <xs:element name="ConvertibleNotesDetailsScheduleofConvertibleNotesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_ConvertibleNotesDetailsScheduleofConvertibleNotesTable"/>
  <xs:element name="RevenuesfromContractswithCustomersDetailsScheduleofRevenuesfromContractswithCustomersTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_RevenuesfromContractswithCustomersDetailsScheduleofRevenuesfromContractswithCustomersTable"/>
  <xs:element name="RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesTable"/>
  <xs:element name="RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesLineItems"/>
  <xs:element name="RelatedPartyTransactionsDetailsScheduleofAccountsReceivablefromRelatedPartiesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_RelatedPartyTransactionsDetailsScheduleofAccountsReceivablefromRelatedPartiesTable"/>
  <xs:element name="StockBasedAwardsDetailsScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_StockBasedAwardsDetailsScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable"/>
  <xs:element name="StockBasedAwardsDetailsScheduleofRestrictedStockActivityandRestrictedStockUnitTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_StockBasedAwardsDetailsScheduleofRestrictedStockActivityandRestrictedStockUnitTable"/>
  <xs:element name="EarningsPerShareDetailsScheduleofReconciliationofBasicandDilutedEarningsPerShareTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_EarningsPerShareDetailsScheduleofReconciliationofBasicandDilutedEarningsPerShareTable"/>
  <xs:element name="IncomeDistributedToParticipatingSecurities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wt_IncomeDistributedToParticipatingSecurities"/>
  <xs:element name="UndistributedIncomeAllocableToParticipatingSecurities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wt_UndistributedIncomeAllocableToParticipatingSecurities"/>
  <xs:element name="WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities"/>
  <xs:element name="EarningsPerShareDetailsScheduleofWeightedAverageNumberofSharesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_EarningsPerShareDetailsScheduleofWeightedAverageNumberofSharesTable"/>
  <xs:element name="WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares"/>
  <xs:element name="PotentiallyDilutiveRestrictedStockAwards" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_PotentiallyDilutiveRestrictedStockAwards"/>
  <xs:element name="IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable"/>
  <xs:element name="IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseLineItems"/>
  <xs:element name="IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration"/>
  <xs:element name="NondeductibleLossOnExtinguishmentOfConvertibleNotes" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_NondeductibleLossOnExtinguishmentOfConvertibleNotes"/>
  <xs:element name="IncomeTaxReconciliationInternationalOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_IncomeTaxReconciliationInternationalOperations"/>
  <xs:element name="IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense"/>
  <xs:element name="IncomeTaxReconciliationUnrecognizedTaxBenefits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_IncomeTaxReconciliationUnrecognizedTaxBenefits"/>
  <xs:element name="IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses"/>
  <xs:element name="IncomeTaxReconciliationExpirationOfCapitalLosses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_IncomeTaxReconciliationExpirationOfCapitalLosses"/>
  <xs:element name="EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wt_EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets"/>
  <xs:element name="ChangeInForeignNetOperatingLosses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wt_ChangeInForeignNetOperatingLosses"/>
  <xs:element name="IncomeTaxesDetailsScheduleofIncomeTaxPaymentsByJurisdictionTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_IncomeTaxesDetailsScheduleofIncomeTaxPaymentsByJurisdictionTable"/>
  <xs:element name="DeferredTaxAssetUnrealizedLosses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wt_DeferredTaxAssetUnrealizedLosses"/>
  <xs:element name="DeferredTaxAssetOperatingLossCarryForwardUnitedStates" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wt_DeferredTaxAssetOperatingLossCarryForwardUnitedStates"/>
  <xs:element name="DeferredTaxAssetsOperatingLeaseLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wt_DeferredTaxAssetsOperatingLeaseLiabilities"/>
  <xs:element name="DeferredTaxAssetsOutsideBasisDifference" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_DeferredTaxAssetsOutsideBasisDifference"/>
  <xs:element name="DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses"/>
  <xs:element name="DeferredTaxLiabilitiesRightOfUseAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_DeferredTaxLiabilitiesRightOfUseAssets"/>
  <xs:element name="DeferredTaxAssetsLiabilitiesGross" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wt_DeferredTaxAssetsLiabilitiesGross"/>
  <xs:element name="IncomeTaxesDetailsScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_IncomeTaxesDetailsScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable"/>
  <xs:element name="UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation"/>
  <xs:element name="GoodwillandIntangibleAssetsDetailsScheduleofIntangibleAssetsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_GoodwillandIntangibleAssetsDetailsScheduleofIntangibleAssetsTable"/>
  <xs:element name="SignificantAccountingPoliciesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_SignificantAccountingPoliciesDetailsTable"/>
  <xs:element name="PercentageOfTaxRateRealizedOnSettlement" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_PercentageOfTaxRateRealizedOnSettlement"/>
  <xs:element name="CashandCashEquivalentsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_CashandCashEquivalentsDetailsTable"/>
  <xs:element name="NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wt_NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements"/>
  <xs:element name="CashEquivalentsMaturityPeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_CashEquivalentsMaturityPeriod"/>
  <xs:element name="FinancialInstrumentsOwnedDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_FinancialInstrumentsOwnedDetailsTable"/>
  <xs:element name="InvestmentsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_InvestmentsDetailsTable"/>
  <xs:element name="CapitalStockPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wt_CapitalStockPercentage"/>
  <xs:element name="SharesPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wt_SharesPercentage"/>
  <xs:element name="ConvertibleNoteDiscountRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ConvertibleNoteDiscountRate"/>
  <xs:element name="CostMethodInvestmentFairValueDisclosure" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wt_CostMethodInvestmentFairValueDisclosure"/>
  <xs:element name="CostMethodInvestmentOwnershipPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wt_CostMethodInvestmentOwnershipPercentage"/>
  <xs:element name="PercentageOfDiscountOnFutureEquityFinancingForPreferredStock" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wt_PercentageOfDiscountOnFutureEquityFinancingForPreferredStock"/>
  <xs:element name="PercentageOfOutstandingConvertibleNotes" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_PercentageOfOutstandingConvertibleNotes"/>
  <xs:element name="PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity"/>
  <xs:element name="PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity"/>
  <xs:element name="AgreementDomainDomain" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_AgreementDomainDomain"/>
  <xs:element name="DeferredConsiderationgoldpaymentsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_DeferredConsiderationgoldpaymentsDetailsTable"/>
  <xs:element name="ConvertibleNotesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_ConvertibleNotesDetailsTable"/>
  <xs:element name="NumberOfThresholdTradingDaysForDeterminingTheSharePrice" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_NumberOfThresholdTradingDaysForDeterminingTheSharePrice"/>
  <xs:element name="MeasurementPeriodForDeterminingSharePrice" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_MeasurementPeriodForDeterminingSharePrice"/>
  <xs:element name="PrincipalAmountOfTradingPrice" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_PrincipalAmountOfTradingPrice"/>
  <xs:element name="SharePriceAsAPercentageOfLastReportedPriceAndConversionRate" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wt_SharePriceAsAPercentageOfLastReportedPriceAndConversionRate"/>
  <xs:element name="MaximumConversionRate" type="xbrli:pureItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_MaximumConversionRate"/>
  <xs:element name="MaximumNumberOfSharesIssuableUponConversion" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_MaximumNumberOfSharesIssuableUponConversion"/>
  <xs:element name="MinimumPercentageOfLendersRequiredToHaveEntirePrincipalAmountOfConvertibleNotesRepurchasedByTheCompanyUponCertainEventsOfDefault" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wt_MinimumPercentageOfLendersRequiredToHaveEntirePrincipalAmountOfConvertibleNotesRepurchasedByTheCompanyUponCertainEventsOfDefault"/>
  <xs:element name="SeriesAPreferredStockDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_SeriesAPreferredStockDetailsTable"/>
  <xs:element name="OutstandingCommonStockPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_OutstandingCommonStockPercentage"/>
  <xs:element name="PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsTable"/>
  <xs:element name="PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems"/>
  <xs:element name="RepurchasePricePerShareInterestRateTransaction" type="dtr:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_RepurchasePricePerShareInterestRateTransaction"/>
  <xs:element name="PresentValueOfMarketRateInterest" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_PresentValueOfMarketRateInterest"/>
  <xs:element name="AggregateConsiderationPayable" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wt_AggregateConsiderationPayable"/>
  <xs:element name="PaymentOfLeaseTerminationFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_PaymentOfLeaseTerminationFee"/>
  <xs:element name="ContingenciesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_ContingenciesDetailsTable"/>
  <xs:element name="LossContingencyCoveredByInsuranceDeductible" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="wt_LossContingencyCoveredByInsuranceDeductible"/>
  <xs:element name="RelatedPartyTransactionsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_RelatedPartyTransactionsDetailsTable"/>
  <xs:element name="StockBasedAwardsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_StockBasedAwardsDetailsTable"/>
  <xs:element name="StockholderRightsPlanDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_StockholderRightsPlanDetailsTable"/>
  <xs:element name="ExercisePricePerUnit" type="dtr:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="wt_ExercisePricePerUnit"/>
  <xs:element name="PercentageOfCommonStockAcquired" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_PercentageOfCommonStockAcquired"/>
  <xs:element name="PercentageOfBeneficialOwnership" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_PercentageOfBeneficialOwnership"/>
  <xs:element name="PercentageOfAssetsSold" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_PercentageOfAssetsSold"/>
  <xs:element name="PercentageOfCommonStock" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_PercentageOfCommonStock"/>
  <xs:element name="EarningsPerShareDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_EarningsPerShareDetailsTable"/>
  <xs:element name="EarningsPerShareDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_EarningsPerShareDetailsLineItems"/>
  <xs:element name="IncomeTaxesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_IncomeTaxesDetailsTable"/>
  <xs:element name="OperatingLossCarryForwardExpirationYear" type="dtr:gYearListItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_OperatingLossCarryForwardExpirationYear"/>
  <xs:element name="DeferredTaxAssetsCapitalLossCarryforwardsSubjectToExpiration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wt_DeferredTaxAssetsCapitalLossCarryforwardsSubjectToExpiration"/>
  <xs:element name="DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="wt_DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax"/>
  <xs:element name="SharesRepurchasedDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_SharesRepurchasedDetailsTable"/>
  <xs:element name="SharesRepurchasedDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_SharesRepurchasedDetailsLineItems"/>
  <xs:element name="GoodwillandIntangibleAssetsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_GoodwillandIntangibleAssetsDetailsTable"/>
  <xs:element name="PercentageOfRevenueGrowth" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_PercentageOfRevenueGrowth"/>
  <xs:element name="ContingentPaymentsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="wt_ContingentPaymentsDetailsTable"/>
  <xs:element name="AgreementAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem" id="wt_AgreementAxis"/>
  <xs:element name="RelatedPartiesAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:dimensionItem" id="wt_RelatedPartiesAxis"/>
  <xs:element name="AcquiringPersonMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_AcquiringPersonMember"/>
  <xs:element name="AdvisoryServicesProvidedToManJerIssuersMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_AdvisoryServicesProvidedToManJerIssuersMember"/>
  <xs:element name="AdvisoryServicesProvidedToWMAIAndWTICAVMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_AdvisoryServicesProvidedToWMAIAndWTICAVMember"/>
  <xs:element name="AdvisoryServicesProvidedToWTTMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_AdvisoryServicesProvidedToWTTMember"/>
  <xs:element name="AffiliatedBlockchainEnabledFundsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_AffiliatedBlockchainEnabledFundsMember"/>
  <xs:element name="B1ConvertiblePreferenceSharesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_B1ConvertiblePreferenceSharesMember"/>
  <xs:element name="BelowTwentyFifthPercentileMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_BelowTwentyFifthPercentileMember"/>
  <xs:element name="CommonStock001ParValueMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_CommonStock001ParValueMember"/>
  <xs:element name="ContractualGoldPaymentsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ContractualGoldPaymentsMember"/>
  <xs:element name="ConvertibleNoteMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ConvertibleNoteMember"/>
  <xs:element name="ConvertibleNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ConvertibleNotesMember"/>
  <xs:element name="ConvertiblePromissoryNoteMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ConvertiblePromissoryNoteMember"/>
  <xs:element name="ConvertibleSeniorNotesDue2028Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ConvertibleSeniorNotesDue2028Member"/>
  <xs:element name="ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember"/>
  <xs:element name="ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember"/>
  <xs:element name="ConvertibleSeniorNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ConvertibleSeniorNotesMember"/>
  <xs:element name="DeferredConsiderationObligationMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_DeferredConsiderationObligationMember"/>
  <xs:element name="ETFSAcquisitionMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ETFSAcquisitionMember"/>
  <xs:element name="ETFSCapitalMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ETFSCapitalMember"/>
  <xs:element name="EmployeesAndDirectorsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_EmployeesAndDirectorsMember"/>
  <xs:element name="EuropeanBusinessSegmentMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_EuropeanBusinessSegmentMember"/>
  <xs:element name="FederalAgencyMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_FederalAgencyMember"/>
  <xs:element name="FirstInstallmentsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_FirstInstallmentsMember"/>
  <xs:element name="FixedAssetsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_FixedAssetsMember"/>
  <xs:element name="FnalityConvertibleNoteMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_FnalityConvertibleNoteMember"/>
  <xs:element name="FnalityInternationalLimitedBOnePreferenceSharesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_FnalityInternationalLimitedBOnePreferenceSharesMember"/>
  <xs:element name="FnalityInternationalLimitedMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_FnalityInternationalLimitedMember"/>
  <xs:element name="ForeignMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ForeignMember"/>
  <xs:element name="GBHMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_GBHMember"/>
  <xs:element name="GoldBullionHoldingsJerseyLimitedMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_GoldBullionHoldingsJerseyLimitedMember"/>
  <xs:element name="GoldBullionHoldingsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_GoldBullionHoldingsMember"/>
  <xs:element name="ImplementationOfASU202006Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ImplementationOfASU202006Member"/>
  <xs:element name="InterestAndPenaltiesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_InterestAndPenaltiesMember"/>
  <xs:element name="LeaseTerminationMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_LeaseTerminationMember"/>
  <xs:element name="LondonOfficeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_LondonOfficeMember"/>
  <xs:element name="ManJersMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ManJersMember"/>
  <xs:element name="MaximumExposureToLossMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_MaximumExposureToLossMember"/>
  <xs:element name="NewYorkOfficeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_NewYorkOfficeMember"/>
  <xs:element name="OtherAssetsseedCapitalWisdomTreeDigitalFundsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_OtherAssetsseedCapitalWisdomTreeDigitalFundsMember"/>
  <xs:element name="OtherAssetsseedCapitalWisdomtreeDigitalFundsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_OtherAssetsseedCapitalWisdomtreeDigitalFundsMember"/>
  <xs:element name="OtherInvestmentMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_OtherInvestmentMember"/>
  <xs:element name="OtherServicesIncomeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_OtherServicesIncomeMember"/>
  <xs:element name="PassiveStockholdersMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_PassiveStockholdersMember"/>
  <xs:element name="PerformanceBasedRestrictedStockUnitMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_PerformanceBasedRestrictedStockUnitMember"/>
  <xs:element name="PreferredStockPurchaseRightsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_PreferredStockPurchaseRightsMember"/>
  <xs:element name="ReceivableFromManJerIssuersMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ReceivableFromManJerIssuersMember"/>
  <xs:element name="ReceivableFromWTTMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ReceivableFromWTTMember"/>
  <xs:element name="RodberInvestmentsLimitedMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_RodberInvestmentsLimitedMember"/>
  <xs:element name="SaleOfCanadianETFBusinessMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_SaleOfCanadianETFBusinessMember"/>
  <xs:element name="SecondInstallmentsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_SecondInstallmentsMember"/>
  <xs:element name="SecurrencyConvertibleNoteMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_SecurrencyConvertibleNoteMember"/>
  <xs:element name="SecurrencyIncMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_SecurrencyIncMember"/>
  <xs:element name="SecurrencyIncSubTotalMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_SecurrencyIncSubTotalMember"/>
  <xs:element name="SecurrencyMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_SecurrencyMember"/>
  <xs:element name="SecurrencyseriesaconvertiblepreferredstockMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_SecurrencyseriesaconvertiblepreferredstockMember"/>
  <xs:element name="SecurrencyseriesbconvertiblepreferredstockMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_SecurrencyseriesbconvertiblepreferredstockMember"/>
  <xs:element name="SeriesANonVotingConvertiblePreferredStockMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_SeriesANonVotingConvertiblePreferredStockMember"/>
  <xs:element name="SeriesCRedeemableConvertiblePreferredStockMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_SeriesCRedeemableConvertiblePreferredStockMember"/>
  <xs:element name="SpaAgreementMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_SpaAgreementMember"/>
  <xs:element name="StockholderRightAgreementMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_StockholderRightAgreementMember"/>
  <xs:element name="SubtotalFnalityInternationalLimitedMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_SubtotalFnalityInternationalLimitedMember"/>
  <xs:element name="ThirdInstallmentsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ThirdInstallmentsMember"/>
  <xs:element name="TradingSecuritiesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_TradingSecuritiesMember"/>
  <xs:element name="TwoFinancialInstitutionsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_TwoFinancialInstitutionsMember"/>
  <xs:element name="TwoThousandAndTwentyNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_TwoThousandAndTwentyNotesMember"/>
  <xs:element name="TwoThousandAndTwentyThreeNotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_TwoThousandAndTwentyThreeNotesMember"/>
  <xs:element name="TwothousandandtwentyonenotesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_TwothousandandtwentyonenotesMember"/>
  <xs:element name="UnrecognizedTaxBenefitsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_UnrecognizedTaxBenefitsMember"/>
  <xs:element name="WisdomTreeProductsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_WisdomTreeProductsMember"/>
  <xs:element name="WisdomtreeETFMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_WisdomtreeETFMember"/>
  <xs:element name="WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember"/>
  <xs:element name="WorldGoldCouncilMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_WorldGoldCouncilMember"/>
  <xs:element name="ContingentPaymentsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ContingentPaymentsLineItems"/>
  <xs:element name="DisclosureOfStockholderRightsPlanLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_DisclosureOfStockholderRightsPlanLineItems"/>
  <xs:element name="DisclosureOfValuationOfDeferredConsiderationLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_DisclosureOfValuationOfDeferredConsiderationLineItems"/>
  <xs:element name="IncomeTaxDisclosureLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_IncomeTaxDisclosureLineItems"/>
  <xs:element name="PayableToGoldBullionHoldingJerseyLimitedGBHAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_PayableToGoldBullionHoldingJerseyLimitedGBHAbstract"/>
  <xs:element name="ScheduleOfDeferredConsiderationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfDeferredConsiderationAbstract"/>
  <xs:element name="ScheduleOfIncomeTaxLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_ScheduleOfIncomeTaxLineItems"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="wt_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>wt-20231231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Feb 23 00:25:24 UTC 2024 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ConsolidatedBalanceSheet" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ConsolidatedIncomeStatement" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ConsolidatedComprehensiveIncome" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ConsolidatedCashFlow" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofMaturityProfileoftheSecuritiesHeldtoMaturityTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofMaturityProfileoftheSecuritiesHeldtoMaturityTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofFixedAssetsTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFixedAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofAggregateConsiderationPayableTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAggregateConsiderationPayableTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofFutureMinimumLeasePaymentsTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFutureMinimumLeasePaymentsTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofReconciliationofFutureMinimumLeasePaymentstoBalanceSheetTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofFutureMinimumLeasePaymentstoBalanceSheetTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofExpectedAmortizationExpenseTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofExpectedAmortizationExpenseTable"/>
  <calculationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_FinancialInstrumentsOwnedAtFairValue" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="wt_IndemnificationReceivableNoncurrent" xlink:href="wt-20231231.xsd#wt_IndemnificationReceivableNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="wt_IndemnificationReceivableNoncurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_HeldToMaturitySecuritiesNoncurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Goodwill" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="10" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_NotesPayableCurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_TaxesPayableCurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_ConvertibleDebtCurrent" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredConsiderationCurrent" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="wt_DeferredConsiderationCurrent" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="wt_CarryingValueOfConvertibleNotes" xlink:href="wt-20231231.xsd#wt_CarryingValueOfConvertibleNotes"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="wt_CarryingValueOfConvertibleNotes" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_AccountsPayableCurrentAndNoncurrent" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredConsiderationNoncurrent" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="wt_DeferredConsiderationNoncurrent" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="4" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="5" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LaborAndRelatedExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LaborAndRelatedExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_LaborAndRelatedExpense" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="wt_FundManagementAndAdministration" xlink:href="wt-20231231.xsd#wt_FundManagementAndAdministration"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="wt_FundManagementAndAdministration" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketingAndAdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_MarketingAndAdvertisingExpense" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDevelopment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_BusinessDevelopment" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="wt_ContractualGoldPayments" xlink:href="wt-20231231.xsd#wt_ContractualGoldPayments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="wt_ContractualGoldPayments" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalFees"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ProfessionalFees" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommunicationsInformationTechnologyAndOccupancy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommunicationsInformationTechnologyAndOccupancy"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_CommunicationsInformationTechnologyAndOccupancy" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_DepreciationAndAmortization" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="wt_ThirdPartyDistribution" xlink:href="wt-20231231.xsd#wt_ThirdPartyDistribution"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="wt_ThirdPartyDistribution" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OtherExpenses" order="10" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_Revenues" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="wt_GainLossFromChangeInDeferredConsideration" xlink:href="wt-20231231.xsd#wt_GainLossFromChangeInDeferredConsideration"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="wt_GainLossFromChangeInDeferredConsideration" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_InvestmentIncomeInterest" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingGainsLosses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OtherNonoperatingGainsLosses" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_InterestExpense" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_GoodwillImpairmentLoss" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedComprehensiveIncome">
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GoodwillImpairmentLoss" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="wt_ContractualGoldPayments" xlink:href="wt-20231231.xsd#wt_ContractualGoldPayments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="wt_ContractualGoldPayments" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="wt_AmortizationOfIssuanceCostsConvertibleNotes" xlink:href="wt-20231231.xsd#wt_AmortizationOfIssuanceCostsConvertibleNotes"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="wt_AmortizationOfIssuanceCostsConvertibleNotes" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationAndAmortization" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_InterestExpenseDebt" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="wt_IncreaseDecreaseInFundManagementAndAdministrationPayable" xlink:href="wt-20231231.xsd#wt_IncreaseDecreaseInFundManagementAndAdministrationPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="wt_IncreaseDecreaseInFundManagementAndAdministrationPayable" order="10" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" order="11" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" order="12" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" order="13" weight="1"/>
    <loc xlink:type="locator" xlink:label="wt_GainLossFromChangeInDeferredConsideration" xlink:href="wt-20231231.xsd#wt_GainLossFromChangeInDeferredConsideration"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="wt_GainLossFromChangeInDeferredConsideration" order="14" weight="-1"/>
    <loc xlink:type="locator" xlink:label="wt_AdvisoryFeesReceivedInGold" xlink:href="wt-20231231.xsd#wt_AdvisoryFeesReceivedInGold"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="wt_AdvisoryFeesReceivedInGold" order="15" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="16" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_UnrealizedGainLossOnInvestments" order="17" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RealizedInvestmentGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_RealizedInvestmentGainsLosses" order="18" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" order="19" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OtherNoncashIncomeExpense" order="20" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="21" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense" order="22" weight="-1"/>
    <loc xlink:type="locator" xlink:label="wt_IncreaseDecreaseInGoldAndOtherPreciousMetals" xlink:href="wt-20231231.xsd#wt_IncreaseDecreaseInGoldAndOtherPreciousMetals"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="wt_IncreaseDecreaseInGoldAndOtherPreciousMetals" order="23" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="24" weight="-1"/>
    <loc xlink:type="locator" xlink:label="wt_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:href="wt-20231231.xsd#wt_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="wt_IncreaseDecreaseInOperatingLeaseLiabilities" order="25" weight="-1"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrY11ZqAmQBqDS9evb2UjxxqoT1dX+ftwW5Dmnj+XgBA5xugKgU5REylsG34PyUGaDd+s8Vz6UhUE2XjAqeTDG+GsAAOBng9N8lGsEAjX/LwTSBIBqd4ygj3svooWB2H37ux1jJEZgBFLWzkzuTALB4aTs3k+tWR6XSXbRFQ/yCjbm0BKEBXBa/7meTz2aTz1S8=] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="wt_ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue" xlink:href="wt-20231231.xsd#wt_ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="wt_ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="wt_ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity" xlink:href="wt-20231231.xsd#wt_ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="wt_ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="wt_PurchaseOfFinancialInstrumentsOwnedAtFairValue" xlink:href="wt-20231231.xsd#wt_PurchaseOfFinancialInstrumentsOwnedAtFairValue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="wt_PurchaseOfFinancialInstrumentsOwnedAtFairValue" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="wt_PurchaseOfInvestments" xlink:href="wt-20231231.xsd#wt_PurchaseOfInvestments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="wt_PurchaseOfInvestments" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherPaymentsToAcquireBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPaymentsToAcquireBusinesses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_OtherPaymentsToAcquireBusinesses" order="8" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="9" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfNotesPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromRepaymentsOfNotesPayable" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="wt_ProceedsFromIssuanceOfConvertibleNotes" xlink:href="wt-20231231.xsd#wt_ProceedsFromIssuanceOfConvertibleNotes"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="wt_ProceedsFromIssuanceOfConvertibleNotes" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="wt_PaymentOfDeferredConsideration" xlink:href="wt-20231231.xsd#wt_PaymentOfDeferredConsideration"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="wt_PaymentOfDeferredConsideration" order="5" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividends"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfDividends" order="6" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock" order="7" weight="-1"/>
    <loc xlink:type="locator" xlink:label="wt_PaymentOfConvertibleNotesIssuanceCosts" xlink:href="wt-20231231.xsd#wt_PaymentOfConvertibleNotesIssuanceCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="wt_PaymentOfConvertibleNotesIssuanceCosts" order="8" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="9" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="4" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofMaturityProfileoftheSecuritiesHeldtoMaturityTable">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount" order="4" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFixedAssetsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAggregateConsiderationPayableTable">
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayableCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermNotesPayable"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_LongTermNotesPayable" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFutureMinimumLeasePaymentsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="6" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofFutureMinimumLeasePaymentstoBalanceSheetTable">
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_OperatingLeaseLiability" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable">
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="2" weight="1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="wt_EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets" xlink:href="wt-20231231.xsd#wt_EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="wt_EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="wt_ChangeInForeignNetOperatingLosses" xlink:href="wt-20231231.xsd#wt_ChangeInForeignNetOperatingLosses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="wt_ChangeInForeignNetOperatingLosses" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration" xlink:href="wt-20231231.xsd#wt_IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="wt_IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration" order="9" weight="-1"/>
    <loc xlink:type="locator" xlink:label="wt_NondeductibleLossOnExtinguishmentOfConvertibleNotes" xlink:href="wt-20231231.xsd#wt_NondeductibleLossOnExtinguishmentOfConvertibleNotes"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="wt_NondeductibleLossOnExtinguishmentOfConvertibleNotes" order="10" weight="-1"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxReconciliationInternationalOperations" xlink:href="wt-20231231.xsd#wt_IncomeTaxReconciliationInternationalOperations"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="wt_IncomeTaxReconciliationInternationalOperations" order="11" weight="-1"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense" xlink:href="wt-20231231.xsd#wt_IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="wt_IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense" order="12" weight="-1"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxReconciliationUnrecognizedTaxBenefits" xlink:href="wt-20231231.xsd#wt_IncomeTaxReconciliationUnrecognizedTaxBenefits"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="wt_IncomeTaxReconciliationUnrecognizedTaxBenefits" order="13" weight="-1"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses" xlink:href="wt-20231231.xsd#wt_IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="wt_IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses" order="14" weight="-1"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxReconciliationExpirationOfCapitalLosses" xlink:href="wt-20231231.xsd#wt_IncomeTaxReconciliationExpirationOfCapitalLosses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="wt_IncomeTaxReconciliationExpirationOfCapitalLosses" order="15" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredTaxAssetUnrealizedLosses" xlink:href="wt-20231231.xsd#wt_DeferredTaxAssetUnrealizedLosses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="wt_DeferredTaxAssetUnrealizedLosses" order="6" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" order="7" weight="1"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredTaxAssetOperatingLossCarryForwardUnitedStates" xlink:href="wt-20231231.xsd#wt_DeferredTaxAssetOperatingLossCarryForwardUnitedStates"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="wt_DeferredTaxAssetOperatingLossCarryForwardUnitedStates" order="8" weight="1"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:href="wt-20231231.xsd#wt_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="wt_DeferredTaxAssetsOperatingLeaseLiabilities" order="9" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOther" order="10" weight="1"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredTaxAssetsOutsideBasisDifference" xlink:href="wt-20231231.xsd#wt_DeferredTaxAssetsOutsideBasisDifference"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="wt_DeferredTaxAssetsOutsideBasisDifference" order="11" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses" xlink:href="wt-20231231.xsd#wt_DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="wt_DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredTaxLiabilitiesRightOfUseAssets" xlink:href="wt-20231231.xsd#wt_DeferredTaxLiabilitiesRightOfUseAssets"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="wt_DeferredTaxLiabilitiesRightOfUseAssets" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredTaxAssetsLiabilitiesGross" xlink:href="wt-20231231.xsd#wt_DeferredTaxAssetsLiabilitiesGross"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="wt_DeferredTaxAssetsLiabilitiesGross" xlink:to="us-gaap_DeferredTaxAssetsGross" order="1" weight="1"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="wt_DeferredTaxAssetsLiabilitiesGross" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="2" weight="-1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="wt_DeferredTaxAssetsLiabilitiesGross" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="2" weight="-1"/>
  </calculationLink>
  <calculationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofExpectedAmortizationExpenseTable">
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="1" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="2" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="3" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="4" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" order="5" weight="1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" order="6" weight="1"/>
  </calculationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>wt-20231231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Feb 23 00:25:24 UTC 2024 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ConsolidatedBalanceSheet" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ConsolidatedIncomeStatement" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ConsolidatedComprehensiveIncome" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ShareholdersEquityType2or3" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ShareholdersEquityType2or3_Parentheticals" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ConsolidatedCashFlow" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_OrganizationandDescriptionofBusiness" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/OrganizationandDescriptionofBusiness"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_SignificantAccountingPolicies" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_CashandCashEquivalents" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/CashandCashEquivalents"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_FairValueMeasurements" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurements"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_FinancialInstrumentsOwned" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwned"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_SecuritiesHeldtoMaturity" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturity"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_Investments" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/Investments"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_FixedAssetsNet" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNet"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_DeferredConsiderationgoldpayments" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpayments"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ConvertibleNotes" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotes"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_SeriesAPreferredStock" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStock"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_PayabletoGoldBullionHoldingsJerseyLimitedGBH" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBH"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_Leases" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/Leases"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_Contingencies" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/Contingencies"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_VariableInterestEntities" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntities"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_RevenuesfromContractswithCustomers" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/RevenuesfromContractswithCustomers"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_RelatedPartyTransactions" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactions"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_StockBasedAwards" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwards"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_StockholderRightsPlan" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlan"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_EmployeeBenefitPlans" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/EmployeeBenefitPlans"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_EarningsPerShare" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShare"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_IncomeTaxes" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxes"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_SharesRepurchased" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchased"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_GoodwillandIntangibleAssets" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssets"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ContingentPayments" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ContingentPayments"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_Impairments" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/Impairments"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_SubsequentEvents" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_AccountingPoliciesByPolicy" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_SignificantAccountingPoliciesTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_FairValueMeasurementsTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_FinancialInstrumentsOwnedTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_SecuritiesHeldtoMaturityTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturityTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_InvestmentsTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_FixedAssetsNetTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNetTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_DeferredConsiderationgoldpaymentsTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ConvertibleNotesTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_SeriesAPreferredStockTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_PayabletoGoldBullionHoldingsJerseyLimitedGBHTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_LeasesTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/LeasesTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_VariableInterestEntitiesTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_RevenuesfromContractswithCustomersTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/RevenuesfromContractswithCustomersTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_RelatedPartyTransactionsTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_StockBasedAwardsTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_EmployeeBenefitPlansTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/EmployeeBenefitPlansTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_EarningsPerShareTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShareTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_IncomeTaxesTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_GoodwillandIntangibleAssetsTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ImpairmentsTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ImpairmentsTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofDepreciationandAmortizationTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDepreciationandAmortizationTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofBeginningandEndingBalancesofRecurringFairValueMeasurementsClassifiedTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBeginningandEndingBalancesofRecurringFairValueMeasurementsClassifiedTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofFinancialInstrumentsOwnedTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFinancialInstrumentsOwnedTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofSecuritiesHeldtoMaturityTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSecuritiesHeldtoMaturityTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofMaturityProfileoftheSecuritiesHeldtoMaturityTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofMaturityProfileoftheSecuritiesHeldtoMaturityTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofInvestmentsTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInvestmentsTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofBacksolveValuationApproachTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBacksolveValuationApproachTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofPresentstheProbabilityAscribedtoPotentialOutcomesUsedinthePwermTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofPresentstheProbabilityAscribedtoPotentialOutcomesUsedinthePwermTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofFixedAssetsTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFixedAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofValuationofDeferredConsiderationTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofValuationofDeferredConsiderationTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofDeferredConsiderationTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDeferredConsiderationTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofKeyTermsofConvertibleNotesTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofKeyTermsofConvertibleNotesTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofConvertibleNotesTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofConvertibleNotesTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofSeriesAPreferredStockBalanceTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSeriesAPreferredStockBalanceTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofAggregateConsiderationPayableTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAggregateConsiderationPayableTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofAdditionalInformationRelatedtoOperatingLeaseTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAdditionalInformationRelatedtoOperatingLeaseTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofFutureMinimumLeasePaymentsTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFutureMinimumLeasePaymentsTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofReconciliationofFutureMinimumLeasePaymentstoBalanceSheetTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofFutureMinimumLeasePaymentstoBalanceSheetTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofInformationaboutVariableInterestsTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInformationaboutVariableInterestsTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofRevenuesfromContractswithCustomersTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromContractswithCustomersTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofGeographicDistributionofRevenuesTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGeographicDistributionofRevenuesTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofAccountsReceivablefromRelatedPartiesTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAccountsReceivablefromRelatedPartiesTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofRevenuesfromAdvisoryServicesProvidedtoRelatedPartiesTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromAdvisoryServicesProvidedtoRelatedPartiesTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofRestrictedStockActivityandRestrictedStockUnitTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRestrictedStockActivityandRestrictedStockUnitTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofShareBasedPaymentAwardsOtherthanOptionsValuationAssumptionsTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofShareBasedPaymentAwardsOtherthanOptionsValuationAssumptionsTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_SummaryofDiscretionaryContributionsTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SummaryofDiscretionaryContributionsTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofReconciliationofBasicandDilutedEarningsPerShareTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofBasicandDilutedEarningsPerShareTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofWeightedAverageNumberofSharesTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofWeightedAverageNumberofSharesTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofIncomeTaxPaymentsByJurisdictionTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIncomeTaxPaymentsByJurisdictionTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofGoodwillTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGoodwillTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofIntangibleAssetsTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIntangibleAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofExpectedAmortizationExpenseTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofExpectedAmortizationExpenseTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofSummarizesImpairmentsRecognizedTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSummarizesImpairmentsRecognizedTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_SignificantAccountingPoliciesDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_CashandCashEquivalentsDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/CashandCashEquivalentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_FairValueMeasurementsDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_FinancialInstrumentsOwnedDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_SecuritiesHeldtoMaturityDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturityDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_InvestmentsDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_DeferredConsiderationgoldpaymentsDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ConvertibleNotesDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_SeriesAPreferredStockDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_LeasesDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/LeasesDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ContingenciesDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ContingenciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_RelatedPartyTransactionsDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_StockBasedAwardsDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_StockholderRightsPlanDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_EarningsPerShareDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShareDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_IncomeTaxesDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_SharesRepurchasedDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_GoodwillandIntangibleAssetsDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ContingentPaymentsDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#DocumentAndEntityInformation" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_FinancialInstrumentsOwnedAtFairValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_AssetsCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_IndemnificationReceivableNoncurrent" xlink:href="wt-20231231.xsd#wt_IndemnificationReceivableNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="wt_IndemnificationReceivableNoncurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_HeldToMaturitySecuritiesNoncurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Goodwill" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Assets" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableTradeCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_NotesPayableCurrent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_TaxesPayableCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ConvertibleDebtCurrent" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredConsiderationCurrent" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="wt_DeferredConsiderationCurrent" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_CarryingValueOfConvertibleNotes" xlink:href="wt-20231231.xsd#wt_CarryingValueOfConvertibleNotes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="wt_CarryingValueOfConvertibleNotes" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AccountsPayableCurrentAndNoncurrent" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredConsiderationNoncurrent" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="wt_DeferredConsiderationNoncurrent" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Liabilities" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquity" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="22" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_RelatedPartiesAxis" xlink:href="wt-20231231.xsd#wt_RelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="wt_RelatedPartiesAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_RelatedPartiesDomainDomain" xlink:href="wt-20231231.xsd#wt_RelatedPartiesDomainDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="wt_RelatedPartiesAxis" xlink:to="wt_RelatedPartiesDomainDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_RelatedPartiesDomainDomain_0" xlink:href="wt-20231231.xsd#wt_RelatedPartiesDomainDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="wt_RelatedPartiesAxis" xlink:to="wt_RelatedPartiesDomainDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_WisdomtreeETFMember" xlink:href="wt-20231231.xsd#wt_WisdomtreeETFMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="wt_WisdomtreeETFMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_RelatedPartiesDomainDomain" xlink:to="us-gaap_RelatedPartyMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsAndCash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAndCash"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InvestmentsAndCash" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccountsReceivableNet" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_PreferredStockRedemptionValue" xlink:href="wt-20231231.xsd#wt_PreferredStockRedemptionValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="wt_PreferredStockRedemptionValue" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="14" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ProductOrServiceAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_OtherServicesIncomeMember" xlink:href="wt-20231231.xsd#wt_OtherServicesIncomeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="wt_OtherServicesIncomeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenuesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_Revenues" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LaborAndRelatedExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LaborAndRelatedExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_LaborAndRelatedExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_FundManagementAndAdministration" xlink:href="wt-20231231.xsd#wt_FundManagementAndAdministration"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="wt_FundManagementAndAdministration" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketingAndAdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_MarketingAndAdvertisingExpense" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDevelopment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_BusinessDevelopment" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ContractualGoldPayments" xlink:href="wt-20231231.xsd#wt_ContractualGoldPayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="wt_ContractualGoldPayments" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalFees"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ProfessionalFees" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommunicationsInformationTechnologyAndOccupancy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommunicationsInformationTechnologyAndOccupancy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_CommunicationsInformationTechnologyAndOccupancy" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ThirdPartyDistribution" xlink:href="wt-20231231.xsd#wt_ThirdPartyDistribution"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="wt_ThirdPartyDistribution" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OtherExpenses" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpenses" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InterestExpense" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_GainLossFromChangeInDeferredConsideration" xlink:href="wt-20231231.xsd#wt_GainLossFromChangeInDeferredConsideration"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="wt_GainLossFromChangeInDeferredConsideration" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InvestmentIncomeInterest" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_GoodwillImpairmentLoss" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingGainsLosses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingGainsLosses" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasic" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared" order="13" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedComprehensiveIncome">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_PreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_TemporaryStockholdersEquity" xlink:href="wt-20231231.xsd#wt_TemporaryStockholdersEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="wt_TemporaryStockholdersEquity" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_TemporaryEquityShareOutstanding" xlink:href="wt-20231231.xsd#wt_TemporaryEquityShareOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="wt_TemporaryEquityShareOutstanding" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_TemporaryEquityShareOutstanding" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_TemporaryEquityShareOutstanding" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_TemporaryEquityShareOutstanding" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_TemporaryEquityShareOutstanding" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_TemporaryEquityShareOutstanding" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_TemporaryEquityShareOutstanding" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_TemporaryEquityShareOutstanding" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_TemporaryEquityShareOutstanding" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Dividends" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Dividends"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_TemporaryEquityShareOutstanding" xlink:to="us-gaap_Dividends" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_TemporaryEquityShareOutstanding" xlink:to="us-gaap_NetIncomeLoss" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes" xlink:href="wt-20231231.xsd#wt_StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="wt_StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="wt_ReclassificationOfEquity" xlink:href="wt-20231231.xsd#wt_ReclassificationOfEquity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="wt_ReclassificationOfEquity" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_GainLossFromChangeInDeferredConsideration" xlink:href="wt-20231231.xsd#wt_GainLossFromChangeInDeferredConsideration"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="wt_GainLossFromChangeInDeferredConsideration" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_AdvisoryFeesReceivedInGold" xlink:href="wt-20231231.xsd#wt_AdvisoryFeesReceivedInGold"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="wt_AdvisoryFeesReceivedInGold" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GoodwillImpairmentLoss" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ContractualGoldPayments" xlink:href="wt-20231231.xsd#wt_ContractualGoldPayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="wt_ContractualGoldPayments" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_AmortizationOfIssuanceCostsConvertibleNotes" xlink:href="wt-20231231.xsd#wt_AmortizationOfIssuanceCostsConvertibleNotes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="wt_AmortizationOfIssuanceCostsConvertibleNotes" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_UnrealizedGainLossOnInvestments" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_InterestExpenseDebt" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RealizedInvestmentGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_RealizedInvestmentGainsLosses" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OtherNoncashIncomeExpense" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_IncreaseDecreaseInGoldAndOtherPreciousMetals" xlink:href="wt-20231231.xsd#wt_IncreaseDecreaseInGoldAndOtherPreciousMetals"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="wt_IncreaseDecreaseInGoldAndOtherPreciousMetals" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_IncreaseDecreaseInFundManagementAndAdministrationPayable" xlink:href="wt-20231231.xsd#wt_IncreaseDecreaseInFundManagementAndAdministrationPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="wt_IncreaseDecreaseInFundManagementAndAdministrationPayable" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:href="wt-20231231.xsd#wt_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="wt_IncreaseDecreaseInOperatingLeaseLiabilities" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_PurchaseOfFinancialInstrumentsOwnedAtFairValue" xlink:href="wt-20231231.xsd#wt_PurchaseOfFinancialInstrumentsOwnedAtFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="wt_PurchaseOfFinancialInstrumentsOwnedAtFairValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_PurchaseOfInvestments" xlink:href="wt-20231231.xsd#wt_PurchaseOfInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="wt_PurchaseOfInvestments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherPaymentsToAcquireBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPaymentsToAcquireBusinesses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_OtherPaymentsToAcquireBusinesses" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue" xlink:href="wt-20231231.xsd#wt_ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="wt_ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity" xlink:href="wt-20231231.xsd#wt_ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="wt_ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfNotesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromRepaymentsOfNotesPayable" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_PaymentOfDeferredConsideration" xlink:href="wt-20231231.xsd#wt_PaymentOfDeferredConsideration"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="wt_PaymentOfDeferredConsideration" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividends"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfDividends" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_PaymentOfConvertibleNotesIssuanceCosts" xlink:href="wt-20231231.xsd#wt_PaymentOfConvertibleNotesIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="wt_PaymentOfConvertibleNotesIssuanceCosts" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ProceedsFromIssuanceOfConvertibleNotes" xlink:href="wt-20231231.xsd#wt_ProceedsFromIssuanceOfConvertibleNotes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="wt_ProceedsFromIssuanceOfConvertibleNotes" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_IncomeTaxesPaidNet" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/OrganizationandDescriptionofBusiness">
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/CashandCashEquivalents">
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurements">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwned">
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract" xlink:to="us-gaap_FinancialInstrumentsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturity">
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_HeldToMaturitySecuritiesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/Investments">
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="us-gaap_InvestmentTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNet">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpayments">
    <loc xlink:type="locator" xlink:label="wt_DeferredConsiderationAbstract" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationAbstract"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredConsiderationTextBlock" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_DeferredConsiderationAbstract" xlink:to="wt_DeferredConsiderationTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotes">
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStock">
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract" xlink:to="us-gaap_PreferredStockTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBH">
    <loc xlink:type="locator" xlink:label="wt_PayableToGoldBullionHoldingJerseyLimitedGBHAbstract" xlink:href="wt-20231231.xsd#wt_PayableToGoldBullionHoldingJerseyLimitedGBHAbstract"/>
    <loc xlink:type="locator" xlink:label="wt_OtherPayablesTextBlock" xlink:href="wt-20231231.xsd#wt_OtherPayablesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_PayableToGoldBullionHoldingJerseyLimitedGBHAbstract" xlink:to="wt_OtherPayablesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/Leases">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/Contingencies">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LossContingencyDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDisclosures"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LossContingencyDisclosures" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntities">
    <loc xlink:type="locator" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:to="us-gaap_VariableInterestEntityDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/RevenuesfromContractswithCustomers">
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactions">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwards">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlan">
    <loc xlink:type="locator" xlink:label="wt_DisclosureOfStockholderRightsPlanAbstract" xlink:href="wt-20231231.xsd#wt_DisclosureOfStockholderRightsPlanAbstract"/>
    <loc xlink:type="locator" xlink:label="wt_DisclosureOfStockholderRightsPlanTextBlock" xlink:href="wt-20231231.xsd#wt_DisclosureOfStockholderRightsPlanTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_DisclosureOfStockholderRightsPlanAbstract" xlink:to="wt_DisclosureOfStockholderRightsPlanTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/EmployeeBenefitPlans">
    <loc xlink:type="locator" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShare">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxes">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchased">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TreasuryStockTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_TreasuryStockTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssets">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ContingentPayments">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionContingentConsiderationLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiabilityAbstract"/>
    <loc xlink:type="locator" xlink:label="wt_ContingentPaymentTextBlock" xlink:href="wt-20231231.xsd#wt_ContingentPaymentTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetAcquisitionContingentConsiderationLiabilityAbstract" xlink:to="wt_ContingentPaymentTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/Impairments">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetImpairmentChargesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentChargesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetImpairmentChargesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentChargesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetImpairmentChargesAbstract" xlink:to="us-gaap_AssetImpairmentChargesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/SubsequentEvents">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ContractualGoldPaymentsPolicyPolicyTextBlock" xlink:href="wt-20231231.xsd#wt_ContractualGoldPaymentsPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="wt_ContractualGoldPaymentsPolicyPolicyTextBlock" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RegulatoryDepreciationAndAmortizationPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RegulatoryDepreciationAndAmortizationPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RegulatoryDepreciationAndAmortizationPolicy" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ThirdPartyDistributionFeesPolicyTextBlock" xlink:href="wt-20231231.xsd#wt_ThirdPartyDistributionFeesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="wt_ThirdPartyDistributionFeesPolicyTextBlock" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ReceivablesPolicyTextBlock" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_MarketableSecuritiesPolicy" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredConsiderationGoldPaymentsPolicyTextBlock" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationGoldPaymentsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="wt_DeferredConsiderationGoldPaymentsPolicyTextBlock" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DebtPolicyTextBlock" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ContingentPaymentsPolicyTextBlock" xlink:href="wt-20231231.xsd#wt_ContingentPaymentsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="wt_ContingentPaymentsPolicyTextBlock" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_RecentlyIssuedAccountingPronouncementsPolicyTextBlock" xlink:href="wt-20231231.xsd#wt_RecentlyIssuedAccountingPronouncementsPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="wt_RecentlyIssuedAccountingPronouncementsPolicyTextBlock" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="28" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:label="wt_SignificantAccountingPoliciesTablesLineItems" xlink:href="wt-20231231.xsd#wt_SignificantAccountingPoliciesTablesLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_SignificantAccountingPoliciesTablesTable" xlink:href="wt-20231231.xsd#wt_SignificantAccountingPoliciesTablesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wt_SignificantAccountingPoliciesTablesLineItems" xlink:to="wt_SignificantAccountingPoliciesTablesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_SignificantAccountingPoliciesTablesTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StraightLineDepreciationMethodMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StraightLineDepreciationMethodMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_StraightLineDepreciationMethodMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_SignificantAccountingPoliciesTablesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedTables">
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract" xlink:to="us-gaap_ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturityTables">
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="us-gaap_InvestmentTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfCondensedFinancialStatementsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNetTables">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsTables">
    <loc xlink:type="locator" xlink:label="wt_DeferredConsiderationAbstract" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationAbstract"/>
    <loc xlink:type="locator" xlink:label="wt_DisclosureOfValuationOfDeferredConsiderationTableTextBlock" xlink:href="wt-20231231.xsd#wt_DisclosureOfValuationOfDeferredConsiderationTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_DeferredConsiderationAbstract" xlink:to="wt_DisclosureOfValuationOfDeferredConsiderationTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfDeferredConsiderationTableTextBlock" xlink:href="wt-20231231.xsd#wt_ScheduleOfDeferredConsiderationTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_DeferredConsiderationAbstract" xlink:to="wt_ScheduleOfDeferredConsiderationTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract" xlink:to="us-gaap_ConvertibleDebtTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockTables">
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPreferredUnitsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPreferredUnitsTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract" xlink:to="us-gaap_ScheduleOfPreferredUnitsTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHTables">
    <loc xlink:type="locator" xlink:label="wt_PayableToGoldBullionHoldingJerseyLimitedGBHAbstract" xlink:href="wt-20231231.xsd#wt_PayableToGoldBullionHoldingJerseyLimitedGBHAbstract"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfAggregateConsiderationPayableTableTextBlock" xlink:href="wt-20231231.xsd#wt_ScheduleOfAggregateConsiderationPayableTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_PayableToGoldBullionHoldingJerseyLimitedGBHAbstract" xlink:to="wt_ScheduleOfAggregateConsiderationPayableTableTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/LeasesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock" xlink:href="wt-20231231.xsd#wt_ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesAbstract" xlink:to="wt_ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/RevenuesfromContractswithCustomersTables">
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <loc xlink:type="locator" xlink:label="wt_SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock" xlink:href="wt-20231231.xsd#wt_SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="wt_SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock" xlink:href="wt-20231231.xsd#wt_ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="wt_ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock" xlink:href="wt-20231231.xsd#wt_ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="wt_ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/EmployeeBenefitPlansTables">
    <loc xlink:type="locator" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShareTables">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock" xlink:href="wt-20231231.xsd#wt_SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="wt_SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfGoodwillTextBlock" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ImpairmentsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetImpairmentChargesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentChargesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetImpairmentChargesAbstract" xlink:to="us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDepreciationandAmortizationTable">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="srt_RangeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareDevelopmentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_InvestmentTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:to="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:to="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExchangeTradedFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExchangeTradedFundsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" xlink:to="us-gaap_ExchangeTradedFundsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_FederalAgencyMember" xlink:href="wt-20231231.xsd#wt_FederalAgencyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" xlink:to="wt_FederalAgencyMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllOtherCorporateBondsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllOtherCorporateBondsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" xlink:to="us-gaap_AllOtherCorporateBondsMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_OtherAssetsseedCapitalWisdomtreeDigitalFundsMember" xlink:href="wt-20231231.xsd#wt_OtherAssetsseedCapitalWisdomtreeDigitalFundsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" xlink:to="wt_OtherAssetsseedCapitalWisdomtreeDigitalFundsMember" order="4" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USTreasurySecuritiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_EquitySecuritiesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FixedIncomeInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FixedIncomeInvestmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_FixedIncomeInvestmentsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_FnalityInternationalLimitedBOnePreferenceSharesMember" xlink:href="wt-20231231.xsd#wt_FnalityInternationalLimitedBOnePreferenceSharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="wt_FnalityInternationalLimitedBOnePreferenceSharesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInvestmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_OtherInvestmentsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_SecurrencyConvertibleNoteMember" xlink:href="wt-20231231.xsd#wt_SecurrencyConvertibleNoteMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="wt_SecurrencyConvertibleNoteMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_FnalityConvertibleNoteMember" xlink:href="wt-20231231.xsd#wt_FnalityConvertibleNoteMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="wt_FnalityConvertibleNoteMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsNonrecurringMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_RecurringFairValueMeasurementsAbstract" xlink:href="wt-20231231.xsd#wt_RecurringFairValueMeasurementsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="wt_RecurringFairValueMeasurementsAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_RecurringFairValueMeasurementsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_FinancialInstrumentsOwnedAtFairValueAbstract0" xlink:href="wt-20231231.xsd#wt_FinancialInstrumentsOwnedAtFairValueAbstract0"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_RecurringFairValueMeasurementsAbstract" xlink:to="wt_FinancialInstrumentsOwnedAtFairValueAbstract0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_FinancialInstrumentsOwnedAtFairValueAbstract0" xlink:to="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_OtherAssetsSeedCapitalWisdomtreeDigitalFundsAbstract" xlink:href="wt-20231231.xsd#wt_OtherAssetsSeedCapitalWisdomtreeDigitalFundsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_FinancialInstrumentsOwnedAtFairValueAbstract0" xlink:to="wt_OtherAssetsSeedCapitalWisdomtreeDigitalFundsAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_RecurringFairValueMeasurementsAbstract" xlink:to="us-gaap_InvestmentsAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="us-gaap_InvestmentsFairValueDisclosure" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsFairValueDisclosure" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_NonRecurringFairValueMeasurementsAbstract" xlink:href="wt-20231231.xsd#wt_NonRecurringFairValueMeasurementsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="wt_NonRecurringFairValueMeasurementsAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_NonRecurringFairValueMeasurementsAbstract" xlink:to="us-gaap_InvestmentOwnedAtFairValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_LiabilitiesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_RecurringFairValueMeasurementsAbstract1" xlink:href="wt-20231231.xsd#wt_RecurringFairValueMeasurementsAbstract1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="wt_RecurringFairValueMeasurementsAbstract1" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_BusinessCombinationDeferredConsiderationLiability" xlink:href="wt-20231231.xsd#wt_BusinessCombinationDeferredConsiderationLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_RecurringFairValueMeasurementsAbstract1" xlink:to="wt_BusinessCombinationDeferredConsiderationLiability" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBeginningandEndingBalancesofRecurringFairValueMeasurementsClassifiedTable">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByLiabilityClassAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredConsiderationObligationMember" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationObligationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="wt_DeferredConsiderationObligationMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_InvestmentsAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions" xlink:href="wt-20231231.xsd#wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome" xlink:href="wt-20231231.xsd#wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings" xlink:href="wt-20231231.xsd#wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFinancialInstrumentsOwnedTable">
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:to="us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_TradingSecuritiesMember" xlink:href="wt-20231231.xsd#wt_TradingSecuritiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="wt_TradingSecuritiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_OtherAssetsseedCapitalWisdomTreeDigitalFundsMember" xlink:href="wt-20231231.xsd#wt_OtherAssetsseedCapitalWisdomTreeDigitalFundsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="wt_OtherAssetsseedCapitalWisdomTreeDigitalFundsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_FinancialInstrumentsOwnedAbstract" xlink:href="wt-20231231.xsd#wt_FinancialInstrumentsOwnedAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:to="wt_FinancialInstrumentsOwnedAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_FinancialInstrumentsOwnedAbstract" xlink:to="us-gaap_FinancialInstrumentsOwnedAtFairValue" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSecuritiesHeldtoMaturityTable">
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_FederalAgencyMember" xlink:href="wt-20231231.xsd#wt_FederalAgencyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="wt_FederalAgencyMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable">
    <loc xlink:type="locator" xlink:label="wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityLineItems" xlink:href="wt-20231231.xsd#wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable" xlink:href="wt-20231231.xsd#wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityLineItems" xlink:to="wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityLineItems" xlink:to="us-gaap_HeldToMaturitySecuritiesFairValue" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofMaturityProfileoftheSecuritiesHeldtoMaturityTable">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAbstract" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAbstract" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAbstract" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAbstract" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAbstract" xlink:to="us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInvestmentsTable">
    <loc xlink:type="locator" xlink:label="wt_InvestmentsDetailsScheduleofInvestmentsLineItems" xlink:href="wt-20231231.xsd#wt_InvestmentsDetailsScheduleofInvestmentsLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_InvestmentsDetailsScheduleofInvestmentsTable" xlink:href="wt-20231231.xsd#wt_InvestmentsDetailsScheduleofInvestmentsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wt_InvestmentsDetailsScheduleofInvestmentsLineItems" xlink:to="wt_InvestmentsDetailsScheduleofInvestmentsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_InvestmentsDetailsScheduleofInvestmentsTable" xlink:to="us-gaap_InvestmentTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_SecurrencyseriesaconvertiblepreferredstockMember" xlink:href="wt-20231231.xsd#wt_SecurrencyseriesaconvertiblepreferredstockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="wt_SecurrencyseriesaconvertiblepreferredstockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_SecurrencyseriesbconvertiblepreferredstockMember" xlink:href="wt-20231231.xsd#wt_SecurrencyseriesbconvertiblepreferredstockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="wt_SecurrencyseriesbconvertiblepreferredstockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_SecurrencyConvertibleNoteMember" xlink:href="wt-20231231.xsd#wt_SecurrencyConvertibleNoteMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="wt_SecurrencyConvertibleNoteMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_SecurrencyIncSubTotalMember" xlink:href="wt-20231231.xsd#wt_SecurrencyIncSubTotalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="wt_SecurrencyIncSubTotalMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ConvertibleNoteMember" xlink:href="wt-20231231.xsd#wt_ConvertibleNoteMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="wt_ConvertibleNoteMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_B1ConvertiblePreferenceSharesMember" xlink:href="wt-20231231.xsd#wt_B1ConvertiblePreferenceSharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="wt_B1ConvertiblePreferenceSharesMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_SubtotalFnalityInternationalLimitedMember" xlink:href="wt-20231231.xsd#wt_SubtotalFnalityInternationalLimitedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="wt_SubtotalFnalityInternationalLimitedMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInvestmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_OtherInvestmentsMember" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_SecurrencyIncAbstract" xlink:href="wt-20231231.xsd#wt_SecurrencyIncAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_InvestmentsDetailsScheduleofInvestmentsLineItems" xlink:to="wt_SecurrencyIncAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_SecurrencyIncAbstract" xlink:to="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedAtCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_SecurrencyIncAbstract" xlink:to="us-gaap_InvestmentOwnedAtCost" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBacksolveValuationApproachTable">
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfBacksolveValuationApproachAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfBacksolveValuationApproachAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfBacksolveValuationApproachAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfBacksolveValuationApproachAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ProbabilityThatSeriesB2PreferenceSharesCovertIntoSeriesB1PreferenceShares" xlink:href="wt-20231231.xsd#wt_ProbabilityThatSeriesB2PreferenceSharesCovertIntoSeriesB1PreferenceShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfBacksolveValuationApproachAbstract" xlink:to="wt_ProbabilityThatSeriesB2PreferenceSharesCovertIntoSeriesB1PreferenceShares" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofPresentstheProbabilityAscribedtoPotentialOutcomesUsedinthePwermTable">
    <loc xlink:type="locator" xlink:label="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedFinancialStatementsTable" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="srt_ScheduleOfCondensedFinancialStatementsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="srt_ScheduleOfCondensedFinancialStatementsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ConversionOfNotesUponAFutureEquityFinancing" xlink:href="wt-20231231.xsd#wt_ConversionOfNotesUponAFutureEquityFinancing"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="wt_ConversionOfNotesUponAFutureEquityFinancing" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_RedemptionOfNoteUponACorporateTransaction" xlink:href="wt-20231231.xsd#wt_RedemptionOfNoteUponACorporateTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="wt_RedemptionOfNoteUponACorporateTransaction" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_FairValueAssumptionOfDissolutionRate" xlink:href="wt-20231231.xsd#wt_FairValueAssumptionOfDissolutionRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="wt_FairValueAssumptionOfDissolutionRate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_TimeToPotentialOutcomeinYear" xlink:href="wt-20231231.xsd#wt_TimeToPotentialOutcomeinYear"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="wt_TimeToPotentialOutcomeinYear" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ConversionOfNoteUponAFutureFinancingRound" xlink:href="wt-20231231.xsd#wt_ConversionOfNoteUponAFutureFinancingRound"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="wt_ConversionOfNoteUponAFutureFinancingRound" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_RedemptionOfNoteUponAChangeOfControl" xlink:href="wt-20231231.xsd#wt_RedemptionOfNoteUponAChangeOfControl"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="wt_RedemptionOfNoteUponAChangeOfControl" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_Default" xlink:href="wt-20231231.xsd#wt_Default"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="wt_Default" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_TimeToPotentialOutcomesinYears" xlink:href="wt-20231231.xsd#wt_TimeToPotentialOutcomesinYears"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="wt_TimeToPotentialOutcomesinYears" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFixedAssetsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofValuationofDeferredConsiderationTable">
    <loc xlink:type="locator" xlink:label="wt_DisclosureOfValuationOfDeferredConsiderationLineItems" xlink:href="wt-20231231.xsd#wt_DisclosureOfValuationOfDeferredConsiderationLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredConsiderationgoldpaymentsDetailsScheduleofValuationofDeferredConsiderationTable" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationgoldpaymentsDetailsScheduleofValuationofDeferredConsiderationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wt_DisclosureOfValuationOfDeferredConsiderationLineItems" xlink:to="wt_DeferredConsiderationgoldpaymentsDetailsScheduleofValuationofDeferredConsiderationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_DeferredConsiderationgoldpaymentsDetailsScheduleofValuationofDeferredConsiderationTable" xlink:to="srt_RangeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_WeightedAverageMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_WeightedAverageMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_WeightedAverageMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ForwardsLookingGoldPrice" xlink:href="wt-20231231.xsd#wt_ForwardsLookingGoldPrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_DisclosureOfValuationOfDeferredConsiderationLineItems" xlink:to="wt_ForwardsLookingGoldPrice" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_BusinessCombinationConsiderationTransferredDeferredPaymentInterest" xlink:href="wt-20231231.xsd#wt_BusinessCombinationConsiderationTransferredDeferredPaymentInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_DisclosureOfValuationOfDeferredConsiderationLineItems" xlink:to="wt_BusinessCombinationConsiderationTransferredDeferredPaymentInterest" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredConsiderationPerpetualGrowthRate" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationPerpetualGrowthRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_DisclosureOfValuationOfDeferredConsiderationLineItems" xlink:to="wt_DeferredConsiderationPerpetualGrowthRate" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDeferredConsiderationTable">
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfDeferredConsiderationAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfDeferredConsiderationAbstract"/>
    <loc xlink:type="locator" xlink:label="wt_ContractualGoldPayments" xlink:href="wt-20231231.xsd#wt_ContractualGoldPayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfDeferredConsiderationAbstract" xlink:to="wt_ContractualGoldPayments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ContractualGoldPaymentgoldOuncesPaid" xlink:href="wt-20231231.xsd#wt_ContractualGoldPaymentgoldOuncesPaid"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfDeferredConsiderationAbstract" xlink:to="wt_ContractualGoldPaymentgoldOuncesPaid" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_GainLossFromChangeInDeferredConsideration" xlink:href="wt-20231231.xsd#wt_GainLossFromChangeInDeferredConsideration"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfDeferredConsiderationAbstract" xlink:to="wt_GainLossFromChangeInDeferredConsideration" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofKeyTermsofConvertibleNotesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_ConvertibleNotesDetailsScheduleofKeyTermsofConvertibleNotesTable" xlink:href="wt-20231231.xsd#wt_ConvertibleNotesDetailsScheduleofKeyTermsofConvertibleNotesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="wt_ConvertibleNotesDetailsScheduleofKeyTermsofConvertibleNotesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_ConvertibleNotesDetailsScheduleofKeyTermsofConvertibleNotesTable" xlink:to="us-gaap_DebtInstrumentAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_TwoThousandAndTwentyThreeNotesMember" xlink:href="wt-20231231.xsd#wt_TwoThousandAndTwentyThreeNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="wt_TwoThousandAndTwentyThreeNotesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_TwothousandandtwentyonenotesMember" xlink:href="wt-20231231.xsd#wt_TwothousandandtwentyonenotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="wt_TwothousandandtwentyonenotesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionRatio1" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_DebtInstrumentRedemptionPrice" xlink:href="wt-20231231.xsd#wt_DebtInstrumentRedemptionPrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="wt_DebtInstrumentRedemptionPrice" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofConvertibleNotesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_ConvertibleNotesDetailsScheduleofConvertibleNotesTable" xlink:href="wt-20231231.xsd#wt_ConvertibleNotesDetailsScheduleofConvertibleNotesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="wt_ConvertibleNotesDetailsScheduleofConvertibleNotesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_ConvertibleNotesDetailsScheduleofConvertibleNotesTable" xlink:to="us-gaap_DebtInstrumentAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_TwoThousandAndTwentyThreeNotesMember" xlink:href="wt-20231231.xsd#wt_TwoThousandAndTwentyThreeNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="wt_TwoThousandAndTwentyThreeNotesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_TwothousandandtwentyonenotesMember" xlink:href="wt-20231231.xsd#wt_TwothousandandtwentyonenotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="wt_TwothousandandtwentyonenotesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ConvertibleNotesMember" xlink:href="wt-20231231.xsd#wt_ConvertibleNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="wt_ConvertibleNotesMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_TwoThousandAndTwentyNotesMember" xlink:href="wt-20231231.xsd#wt_TwoThousandAndTwentyNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="wt_TwoThousandAndTwentyNotesMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedPremium" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebt" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSeriesAPreferredStockBalanceTable">
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredUnitsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredUnitsLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPreferredUnitsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPreferredUnitsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PreferredUnitsLineItems" xlink:to="us-gaap_ScheduleOfPreferredUnitsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPreferredUnitsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_PreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PreferredUnitsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PreferredUnitsLineItems" xlink:to="us-gaap_PreferredStockValue" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockDividendsPerShareDeclared"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PreferredUnitsLineItems" xlink:to="us-gaap_PreferredStockDividendsPerShareDeclared" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAggregateConsiderationPayableTable">
    <loc xlink:type="locator" xlink:label="us-gaap_NotesAndLoansPayableAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesAndLoansPayableAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NotesAndLoansPayableAbstract" xlink:to="us-gaap_NotesPayableCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermNotesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NotesAndLoansPayableAbstract" xlink:to="us-gaap_LongTermNotesPayable" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NotesAndLoansPayableAbstract" xlink:to="us-gaap_NotesPayable" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAdditionalInformationRelatedtoOperatingLeaseTable">
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfAdditionalInformationRelatedToOperatingLeaseAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfAdditionalInformationRelatedToOperatingLeaseAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfAdditionalInformationRelatedToOperatingLeaseAbstract" xlink:to="us-gaap_LeaseCostAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_OperatingLeaseCost" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermLeaseCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_ShortTermLeaseCost" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_LeaseCost" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_OtherInformationAbstract" xlink:href="wt-20231231.xsd#wt_OtherInformationAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfAdditionalInformationRelatedToOperatingLeaseAbstract" xlink:to="wt_OtherInformationAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_OtherInformationAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_OtherInformationAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_OtherInformationAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_OtherInformationAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFutureMinimumLeasePaymentsTable">
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfFutureMinimumLeasePaymentsAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfFutureMinimumLeasePaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfFutureMinimumLeasePaymentsAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfFutureMinimumLeasePaymentsAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfFutureMinimumLeasePaymentsAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfFutureMinimumLeasePaymentsAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfFutureMinimumLeasePaymentsAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofFutureMinimumLeasePaymentstoBalanceSheetTable">
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfReconciliationOfFutureMinimumLeasePaymentsToBalanceSheetAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfReconciliationOfFutureMinimumLeasePaymentsToBalanceSheetAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfReconciliationOfFutureMinimumLeasePaymentsToBalanceSheetAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfReconciliationOfFutureMinimumLeasePaymentsToBalanceSheetAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfReconciliationOfFutureMinimumLeasePaymentsToBalanceSheetAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfReconciliationOfFutureMinimumLeasePaymentsToBalanceSheetAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfReconciliationOfFutureMinimumLeasePaymentsToBalanceSheetAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInformationaboutVariableInterestsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" xbrldt:closed="true"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrY11ZqAmQBqDS9evb2UjxxqoT1dX+ftwW5Dmnj+XgBA5xugKgU5REylsG34PyUGaDd+s8Vz6UhUE2XjAqeTDG+GsAAOBng9N8lGsEAjX/LwTSBIBqd4ygj3svooWB2H37ux1jJEZgBFLWzkzuTALB4aTs3k+tWR6XSXbRFQ/yCjbh+z8SCy2SGVHIZDO6anR6c=] CSR-->
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_SecurrencyseriesaconvertiblepreferredstockMember" xlink:href="wt-20231231.xsd#wt_SecurrencyseriesaconvertiblepreferredstockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="wt_SecurrencyseriesaconvertiblepreferredstockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_SecurrencyseriesbconvertiblepreferredstockMember" xlink:href="wt-20231231.xsd#wt_SecurrencyseriesbconvertiblepreferredstockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="wt_SecurrencyseriesbconvertiblepreferredstockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_SecurrencyConvertibleNoteMember" xlink:href="wt-20231231.xsd#wt_SecurrencyConvertibleNoteMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="wt_SecurrencyConvertibleNoteMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_SecurrencyIncSubTotalMember" xlink:href="wt-20231231.xsd#wt_SecurrencyIncSubTotalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="wt_SecurrencyIncSubTotalMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ConvertibleNoteMember" xlink:href="wt-20231231.xsd#wt_ConvertibleNoteMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="wt_ConvertibleNoteMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_B1ConvertiblePreferenceSharesMember" xlink:href="wt-20231231.xsd#wt_B1ConvertiblePreferenceSharesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="wt_B1ConvertiblePreferenceSharesMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_SubtotalFnalityInternationalLimitedMember" xlink:href="wt-20231231.xsd#wt_SubtotalFnalityInternationalLimitedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="wt_SubtotalFnalityInternationalLimitedMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_OtherInvestmentMember" xlink:href="wt-20231231.xsd#wt_OtherInvestmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="wt_OtherInvestmentMember" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_MaximumExposureToLossMember" xlink:href="wt-20231231.xsd#wt_MaximumExposureToLossMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="wt_MaximumExposureToLossMember" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_CarryingAmountAssetsSecurrencyAbstract" xlink:href="wt-20231231.xsd#wt_CarryingAmountAssetsSecurrencyAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="wt_CarryingAmountAssetsSecurrencyAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_CarryingAmountAssetsSecurrencyAbstract" xlink:to="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromContractswithCustomersTable">
    <loc xlink:type="locator" xlink:label="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_RevenuesfromContractswithCustomersDetailsScheduleofRevenuesfromContractswithCustomersTable" xlink:href="wt-20231231.xsd#wt_RevenuesfromContractswithCustomersDetailsScheduleofRevenuesfromContractswithCustomersTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="wt_RevenuesfromContractswithCustomersDetailsScheduleofRevenuesfromContractswithCustomersTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_RevenuesfromContractswithCustomersDetailsScheduleofRevenuesfromContractswithCustomersTable" xlink:to="srt_ProductOrServiceAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_OtherServicesIncomeMember" xlink:href="wt-20231231.xsd#wt_OtherServicesIncomeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="wt_OtherServicesIncomeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="us-gaap_Revenues" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGeographicDistributionofRevenuesTable">
    <loc xlink:type="locator" xlink:label="wt_RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesLineItems" xlink:href="wt-20231231.xsd#wt_RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesTable" xlink:href="wt-20231231.xsd#wt_RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wt_RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesLineItems" xlink:to="wt_RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesTable" xlink:to="srt_StatementGeographicalAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_JE" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_JE"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_JE" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_IE" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IE"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_IE" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_RevenuesFromContractsWithCustomersAbstract" xlink:href="wt-20231231.xsd#wt_RevenuesFromContractsWithCustomersAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesLineItems" xlink:to="wt_RevenuesFromContractsWithCustomersAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_RevenuesFromContractsWithCustomersAbstract" xlink:to="us-gaap_Revenues" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAccountsReceivablefromRelatedPartiesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_RelatedPartyTransactionsDetailsScheduleofAccountsReceivablefromRelatedPartiesTable" xlink:href="wt-20231231.xsd#wt_RelatedPartyTransactionsDetailsScheduleofAccountsReceivablefromRelatedPartiesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="wt_RelatedPartyTransactionsDetailsScheduleofAccountsReceivablefromRelatedPartiesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_RelatedPartyTransactionsDetailsScheduleofAccountsReceivablefromRelatedPartiesTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_RelatedPartiesAxis" xlink:href="wt-20231231.xsd#wt_RelatedPartiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_RelatedPartyTransactionsDetailsScheduleofAccountsReceivablefromRelatedPartiesTable" xlink:to="wt_RelatedPartiesAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_RelatedPartiesDomainDomain" xlink:href="wt-20231231.xsd#wt_RelatedPartiesDomainDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="wt_RelatedPartiesAxis" xlink:to="wt_RelatedPartiesDomainDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_RelatedPartiesDomainDomain_0" xlink:href="wt-20231231.xsd#wt_RelatedPartiesDomainDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="wt_RelatedPartiesAxis" xlink:to="wt_RelatedPartiesDomainDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ReceivableFromWTTMember" xlink:href="wt-20231231.xsd#wt_ReceivableFromWTTMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="wt_ReceivableFromWTTMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ReceivableFromManJerIssuersMember" xlink:href="wt-20231231.xsd#wt_ReceivableFromManJerIssuersMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="wt_ReceivableFromManJerIssuersMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember" xlink:href="wt-20231231.xsd#wt_WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="wt_WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_RelatedPartiesDomainDomain" xlink:to="us-gaap_RelatedPartyMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_AccountsReceivableNet" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromAdvisoryServicesProvidedtoRelatedPartiesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="dei_LegalEntityAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain_0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_AdvisoryServicesProvidedToWTTMember" xlink:href="wt-20231231.xsd#wt_AdvisoryServicesProvidedToWTTMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="wt_AdvisoryServicesProvidedToWTTMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_AdvisoryServicesProvidedToManJerIssuersMember" xlink:href="wt-20231231.xsd#wt_AdvisoryServicesProvidedToManJerIssuersMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="wt_AdvisoryServicesProvidedToManJerIssuersMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_AdvisoryServicesProvidedToWMAIAndWTICAVMember" xlink:href="wt-20231231.xsd#wt_AdvisoryServicesProvidedToWMAIAndWTICAVMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="wt_AdvisoryServicesProvidedToWMAIAndWTICAVMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_Revenues" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_StockBasedAwardsDetailsScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable" xlink:href="wt-20231231.xsd#wt_StockBasedAwardsDetailsScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="wt_StockBasedAwardsDetailsScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_StockBasedAwardsDetailsScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable" xlink:to="srt_TitleOfIndividualAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_EmployeesAndDirectorsMember" xlink:href="wt-20231231.xsd#wt_EmployeesAndDirectorsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="wt_EmployeesAndDirectorsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRestrictedStockActivityandRestrictedStockUnitTable">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_StockBasedAwardsDetailsScheduleofRestrictedStockActivityandRestrictedStockUnitTable" xlink:href="wt-20231231.xsd#wt_StockBasedAwardsDetailsScheduleofRestrictedStockActivityandRestrictedStockUnitTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="wt_StockBasedAwardsDetailsScheduleofRestrictedStockActivityandRestrictedStockUnitTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_StockBasedAwardsDetailsScheduleofRestrictedStockActivityandRestrictedStockUnitTable" xlink:to="us-gaap_AwardTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_PerformanceBasedRestrictedStockUnitMember" xlink:href="wt-20231231.xsd#wt_PerformanceBasedRestrictedStockUnitMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="wt_PerformanceBasedRestrictedStockUnitMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockDividendsShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockDividendsShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockDividendsShares" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsPayableAmountPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_DividendsPayableAmountPerShare" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofShareBasedPaymentAwardsOtherthanOptionsValuationAssumptionsTable">
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfShareBasedPaymentAwardsOtherThanOptionsValuationAssumptionsAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfShareBasedPaymentAwardsOtherThanOptionsValuationAssumptionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfShareBasedPaymentAwardsOtherThanOptionsValuationAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfShareBasedPaymentAwardsOtherThanOptionsValuationAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfShareBasedPaymentAwardsOtherThanOptionsValuationAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfShareBasedPaymentAwardsOtherThanOptionsValuationAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfShareBasedPaymentAwardsOtherThanOptionsValuationAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/SummaryofDiscretionaryContributionsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofBasicandDilutedEarningsPerShareTable">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_EarningsPerShareDetailsScheduleofReconciliationofBasicandDilutedEarningsPerShareTable" xlink:href="wt-20231231.xsd#wt_EarningsPerShareDetailsScheduleofReconciliationofBasicandDilutedEarningsPerShareTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EarningsPerShareBasicLineItems" xlink:to="wt_EarningsPerShareDetailsScheduleofReconciliationofBasicandDilutedEarningsPerShareTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_EarningsPerShareDetailsScheduleofReconciliationofBasicandDilutedEarningsPerShareTable" xlink:to="srt_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_BasicEarningsPerShareAbstract" xlink:href="wt-20231231.xsd#wt_BasicEarningsPerShareAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareBasicLineItems" xlink:to="wt_BasicEarningsPerShareAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_BasicEarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_BasicEarningsPerShareAbstract" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeDistributedToParticipatingSecurities" xlink:href="wt-20231231.xsd#wt_IncomeDistributedToParticipatingSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_BasicEarningsPerShareAbstract" xlink:to="wt_IncomeDistributedToParticipatingSecurities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_BasicEarningsPerShareAbstract" xlink:to="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_BasicEarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_UndistributedIncomeAllocableToParticipatingSecurities" xlink:href="wt-20231231.xsd#wt_UndistributedIncomeAllocableToParticipatingSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_BasicEarningsPerShareAbstract" xlink:to="wt_UndistributedIncomeAllocableToParticipatingSecurities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_BasicEarningsPerShareAbstract" xlink:to="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_BasicEarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_BasicEarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_BasicEarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities" xlink:href="wt-20231231.xsd#wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_BasicEarningsPerShareAbstract" xlink:to="wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_BasicEarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_BasicEarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="12" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofWeightedAverageNumberofSharesTable">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDilutedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_EarningsPerShareDetailsScheduleofWeightedAverageNumberofSharesTable" xlink:href="wt-20231231.xsd#wt_EarningsPerShareDetailsScheduleofWeightedAverageNumberofSharesTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EarningsPerShareDilutedLineItems" xlink:to="wt_EarningsPerShareDetailsScheduleofWeightedAverageNumberofSharesTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_EarningsPerShareDetailsScheduleofWeightedAverageNumberofSharesTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesCPreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareDilutedLineItems" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_LessParticipatingSecuritiesAbstract" xlink:href="wt-20231231.xsd#wt_LessParticipatingSecuritiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareDilutedLineItems" xlink:to="wt_LessParticipatingSecuritiesAbstract" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares" xlink:href="wt-20231231.xsd#wt_WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_LessParticipatingSecuritiesAbstract" xlink:to="wt_WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_PotentiallyDilutiveRestrictedStockAwards" xlink:href="wt-20231231.xsd#wt_PotentiallyDilutiveRestrictedStockAwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_LessParticipatingSecuritiesAbstract" xlink:to="wt_PotentiallyDilutiveRestrictedStockAwards" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities" xlink:href="wt-20231231.xsd#wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_LessParticipatingSecuritiesAbstract" xlink:to="wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable">
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseLineItems" xlink:href="wt-20231231.xsd#wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable" xlink:href="wt-20231231.xsd#wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseLineItems" xlink:to="wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable" xlink:to="srt_StatementGeographicalAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ForeignMember" xlink:href="wt-20231231.xsd#wt_ForeignMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="wt_ForeignMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable">
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfComponentsOfCurrentAndDeferredIncomeTaxExpenseAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfComponentsOfCurrentAndDeferredIncomeTaxExpenseAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfComponentsOfCurrentAndDeferredIncomeTaxExpenseAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration" xlink:href="wt-20231231.xsd#wt_IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="wt_IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_NondeductibleLossOnExtinguishmentOfConvertibleNotes" xlink:href="wt-20231231.xsd#wt_NondeductibleLossOnExtinguishmentOfConvertibleNotes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="wt_NondeductibleLossOnExtinguishmentOfConvertibleNotes" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxReconciliationInternationalOperations" xlink:href="wt-20231231.xsd#wt_IncomeTaxReconciliationInternationalOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="wt_IncomeTaxReconciliationInternationalOperations" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense" xlink:href="wt-20231231.xsd#wt_IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="wt_IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxReconciliationUnrecognizedTaxBenefits" xlink:href="wt-20231231.xsd#wt_IncomeTaxReconciliationUnrecognizedTaxBenefits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="wt_IncomeTaxReconciliationUnrecognizedTaxBenefits" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses" xlink:href="wt-20231231.xsd#wt_IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="wt_IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxReconciliationExpirationOfCapitalLosses" xlink:href="wt-20231231.xsd#wt_IncomeTaxReconciliationExpirationOfCapitalLosses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="wt_IncomeTaxReconciliationExpirationOfCapitalLosses" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets" xlink:href="wt-20231231.xsd#wt_EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="wt_EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ChangeInForeignNetOperatingLosses" xlink:href="wt-20231231.xsd#wt_ChangeInForeignNetOperatingLosses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="wt_ChangeInForeignNetOperatingLosses" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIncomeTaxPaymentsByJurisdictionTable">
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxDisclosureLineItems" xlink:href="wt-20231231.xsd#wt_IncomeTaxDisclosureLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxesDetailsScheduleofIncomeTaxPaymentsByJurisdictionTable" xlink:href="wt-20231231.xsd#wt_IncomeTaxesDetailsScheduleofIncomeTaxPaymentsByJurisdictionTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wt_IncomeTaxDisclosureLineItems" xlink:to="wt_IncomeTaxesDetailsScheduleofIncomeTaxPaymentsByJurisdictionTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_IncomeTaxesDetailsScheduleofIncomeTaxPaymentsByJurisdictionTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_ForeignCountryMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_IncomeTaxesPaidNet" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable">
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfComponentsOfTheCompanySDeferredTaxAssetsAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfComponentsOfTheCompanySDeferredTaxAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfComponentsOfTheCompanySDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsGrossAbstract" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredTaxAssetUnrealizedLosses" xlink:href="wt-20231231.xsd#wt_DeferredTaxAssetUnrealizedLosses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="wt_DeferredTaxAssetUnrealizedLosses" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredTaxAssetOperatingLossCarryForwardUnitedStates" xlink:href="wt-20231231.xsd#wt_DeferredTaxAssetOperatingLossCarryForwardUnitedStates"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="wt_DeferredTaxAssetOperatingLossCarryForwardUnitedStates" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:href="wt-20231231.xsd#wt_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="wt_DeferredTaxAssetsOperatingLeaseLiabilities" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredTaxAssetsOutsideBasisDifference" xlink:href="wt-20231231.xsd#wt_DeferredTaxAssetsOutsideBasisDifference"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="wt_DeferredTaxAssetsOutsideBasisDifference" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfComponentsOfTheCompanySDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses" xlink:href="wt-20231231.xsd#wt_DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="wt_DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredTaxLiabilitiesRightOfUseAssets" xlink:href="wt-20231231.xsd#wt_DeferredTaxLiabilitiesRightOfUseAssets"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="wt_DeferredTaxLiabilitiesRightOfUseAssets" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredTaxAssetsLiabilitiesGross" xlink:href="wt-20231231.xsd#wt_DeferredTaxAssetsLiabilitiesGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfComponentsOfTheCompanySDeferredTaxAssetsAbstract" xlink:to="wt_DeferredTaxAssetsLiabilitiesGross" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfComponentsOfTheCompanySDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfComponentsOfTheCompanySDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxesDetailsScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable" xlink:href="wt-20231231.xsd#wt_IncomeTaxesDetailsScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="wt_IncomeTaxesDetailsScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_IncomeTaxesDetailsScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable" xlink:to="us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis" xlink:to="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis" xlink:to="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_UnrecognizedTaxBenefitsMember" xlink:href="wt-20231231.xsd#wt_UnrecognizedTaxBenefitsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain" xlink:to="wt_UnrecognizedTaxBenefitsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_InterestAndPenaltiesMember" xlink:href="wt-20231231.xsd#wt_InterestAndPenaltiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain" xlink:to="wt_InterestAndPenaltiesMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation" xlink:href="wt-20231231.xsd#wt_UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="wt_UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation" order="5" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGoodwillTable">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_ScheduleOfGoodwillTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="srt_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_Goodwill" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_GoodwillPeriodIncreaseDecrease" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIntangibleAssetsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_GoodwillandIntangibleAssetsDetailsScheduleofIntangibleAssetsTable" xlink:href="wt-20231231.xsd#wt_GoodwillandIntangibleAssetsDetailsScheduleofIntangibleAssetsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_GoodwillLineItems" xlink:to="wt_GoodwillandIntangibleAssetsDetailsScheduleofIntangibleAssetsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_GoodwillandIntangibleAssetsDetailsScheduleofIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ETFSAcquisitionMember" xlink:href="wt-20231231.xsd#wt_ETFSAcquisitionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="wt_ETFSAcquisitionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_SoftwareDevelopmentMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_IntangibleAssetsGrossExcludingGoodwill" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofExpectedAmortizationExpenseTable">
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfExpectedAmortizationExpenseAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfExpectedAmortizationExpenseAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfExpectedAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfExpectedAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfExpectedAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfExpectedAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfExpectedAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSummarizesImpairmentsRecognizedTable">
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems" xlink:to="us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable" xlink:to="us-gaap_RestructuringCostAndReserveAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TypeOfRestructuringDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable" xlink:to="srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:to="srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:to="srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_NewYorkOfficeMember" xlink:href="wt-20231231.xsd#wt_NewYorkOfficeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:to="wt_NewYorkOfficeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_LondonOfficeMember" xlink:href="wt-20231231.xsd#wt_LondonOfficeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:to="wt_LondonOfficeMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_SecurrencyIncMember" xlink:href="wt-20231231.xsd#wt_SecurrencyIncMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="wt_SecurrencyIncMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInvestmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_OtherInvestmentsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_LeaseTerminationMember" xlink:href="wt-20231231.xsd#wt_LeaseTerminationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="wt_LeaseTerminationMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_FixedAssetsMember" xlink:href="wt-20231231.xsd#wt_FixedAssetsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="wt_FixedAssetsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems" xlink:to="us-gaap_RestructuringCostsAndAssetImpairmentCharges" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_SignificantAccountingPoliciesDetailsTable" xlink:href="wt-20231231.xsd#wt_SignificantAccountingPoliciesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="wt_SignificantAccountingPoliciesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_SignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfAdoptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TypeOfAdoptionMember_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfAdoptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ImplementationOfASU202006Member" xlink:href="wt-20231231.xsd#wt_ImplementationOfASU202006Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="wt_ImplementationOfASU202006Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_PercentageOfTaxRateRealizedOnSettlement" xlink:href="wt-20231231.xsd#wt_PercentageOfTaxRateRealizedOnSettlement"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="wt_PercentageOfTaxRateRealizedOnSettlement" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_DeferredTaxLiabilities" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_InterestExpense" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/CashandCashEquivalentsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_CashandCashEquivalentsDetailsTable" xlink:href="wt-20231231.xsd#wt_CashandCashEquivalentsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CashAndCashEquivalentsLineItems" xlink:to="wt_CashandCashEquivalentsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_CashandCashEquivalentsDetailsTable" xlink:to="dei_LegalEntityAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain_0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_CashandCashEquivalentsDetailsTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_EuropeanBusinessSegmentMember" xlink:href="wt-20231231.xsd#wt_EuropeanBusinessSegmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="wt_EuropeanBusinessSegmentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_TwoFinancialInstitutionsMember" xlink:href="wt-20231231.xsd#wt_TwoFinancialInstitutionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="wt_TwoFinancialInstitutionsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashAndCashEquivalentsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashAndCashEquivalentsLineItems" xlink:to="us-gaap_CashEquivalentsAtCarryingValue" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements" xlink:href="wt-20231231.xsd#wt_NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashAndCashEquivalentsLineItems" xlink:to="wt_NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="wt_CashEquivalentsMaturityPeriod" xlink:href="wt-20231231.xsd#wt_CashEquivalentsMaturityPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="wt_CashEquivalentsMaturityPeriod" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_FinancialInstrumentsOwnedDetailsTable" xlink:href="wt-20231231.xsd#wt_FinancialInstrumentsOwnedDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralLineItems" xlink:to="wt_FinancialInstrumentsOwnedDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TradingGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradingGainsLosses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralLineItems" xlink:to="us-gaap_TradingGainsLosses" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturityDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" order="0" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_InvestmentsDetailsTable" xlink:href="wt-20231231.xsd#wt_InvestmentsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="wt_InvestmentsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_InvestmentsDetailsTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_InvestmentsDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExtinguishmentOfDebtAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_InvestmentsDetailsTable" xlink:to="us-gaap_ExtinguishmentOfDebtAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ExtinguishmentOfDebtAxis" xlink:to="us-gaap_ExtinguishmentOfDebtTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExtinguishmentOfDebtTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ExtinguishmentOfDebtAxis" xlink:to="us-gaap_ExtinguishmentOfDebtTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_InvestmentsDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_InvestmentsDetailsTable" xlink:to="srt_RangeAxis" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_InvestmentsDetailsTable" xlink:to="dei_LegalEntityAxis" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain_0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_FnalityInternationalLimitedMember" xlink:href="wt-20231231.xsd#wt_FnalityInternationalLimitedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="wt_FnalityInternationalLimitedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:to="us-gaap_ConvertibleDebtMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ConvertiblePromissoryNoteMember" xlink:href="wt-20231231.xsd#wt_ConvertiblePromissoryNoteMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="wt_ConvertiblePromissoryNoteMember" order="0" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="wt_FnalityInternationalLimitedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProvisionForOtherLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForOtherLosses"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_ProvisionForOtherLosses" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_CapitalStockPercentage" xlink:href="wt-20231231.xsd#wt_CapitalStockPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="wt_CapitalStockPercentage" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_Investments" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockConvertibleSharesIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockConvertibleSharesIssuable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_PreferredStockConvertibleSharesIssuable" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendRatePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_PreferredStockDividendRatePercentage" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_SharesPercentage" xlink:href="wt-20231231.xsd#wt_SharesPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="wt_SharesPercentage" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainOrLossOnSaleOfStockInSubsidiary" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainOrLossOnSaleOfStockInSubsidiary"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_GainOrLossOnSaleOfStockInSubsidiary" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebt"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_ConvertibleDebt" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentRate" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ConvertibleNoteDiscountRate" xlink:href="wt-20231231.xsd#wt_ConvertibleNoteDiscountRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="wt_ConvertibleNoteDiscountRate" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_UnrealizedGainLossOnInvestments" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableInterestEntityOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_VariableInterestEntityOwnershipPercentage" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherOwnershipInterestsUnitsIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOwnershipInterestsUnitsIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_OtherOwnershipInterestsUnitsIssued" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_CostMethodInvestmentFairValueDisclosure" xlink:href="wt-20231231.xsd#wt_CostMethodInvestmentFairValueDisclosure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="wt_CostMethodInvestmentFairValueDisclosure" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_GainLossOnInvestments" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_CostMethodInvestmentOwnershipPercentage" xlink:href="wt-20231231.xsd#wt_CostMethodInvestmentOwnershipPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="wt_CostMethodInvestmentOwnershipPercentage" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_PercentageOfDiscountOnFutureEquityFinancingForPreferredStock" xlink:href="wt-20231231.xsd#wt_PercentageOfDiscountOnFutureEquityFinancingForPreferredStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="wt_PercentageOfDiscountOnFutureEquityFinancingForPreferredStock" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_PercentageOfOutstandingConvertibleNotes" xlink:href="wt-20231231.xsd#wt_PercentageOfOutstandingConvertibleNotes"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="wt_PercentageOfOutstandingConvertibleNotes" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity" xlink:href="wt-20231231.xsd#wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity" xlink:href="wt-20231231.xsd#wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_OtherInvestments" order="24" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredConsiderationgoldpaymentsDetailsTable" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationgoldpaymentsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="wt_DeferredConsiderationgoldpaymentsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_DeferredConsiderationgoldpaymentsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_DeferredConsiderationgoldpaymentsDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_DeferredConsiderationgoldpaymentsDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_AgreementAxis" xlink:href="wt-20231231.xsd#wt_AgreementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_DeferredConsiderationgoldpaymentsDetailsTable" xlink:to="wt_AgreementAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_AgreementDomainDomain" xlink:href="wt-20231231.xsd#wt_AgreementDomainDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="wt_AgreementAxis" xlink:to="wt_AgreementDomainDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_AgreementDomainDomain_0" xlink:href="wt-20231231.xsd#wt_AgreementDomainDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="wt_AgreementAxis" xlink:to="wt_AgreementDomainDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_DeferredConsiderationgoldpaymentsDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_DeferredConsiderationgoldpaymentsDetailsTable" xlink:to="dei_LegalEntityAxis" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain_0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_SeriesCRedeemableConvertiblePreferredStockMember" xlink:href="wt-20231231.xsd#wt_SeriesCRedeemableConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="wt_SeriesCRedeemableConvertiblePreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_FirstInstallmentsMember" xlink:href="wt-20231231.xsd#wt_FirstInstallmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="wt_FirstInstallmentsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_SecondInstallmentsMember" xlink:href="wt-20231231.xsd#wt_SecondInstallmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="wt_SecondInstallmentsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ThirdInstallmentsMember" xlink:href="wt-20231231.xsd#wt_ThirdInstallmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="wt_ThirdInstallmentsMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_SpaAgreementMember" xlink:href="wt-20231231.xsd#wt_SpaAgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_AgreementDomainDomain" xlink:to="wt_SpaAgreementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_GoldBullionHoldingsJerseyLimitedMember" xlink:href="wt-20231231.xsd#wt_GoldBullionHoldingsJerseyLimitedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="wt_GoldBullionHoldingsJerseyLimitedMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ETFSCapitalMember" xlink:href="wt-20231231.xsd#wt_ETFSCapitalMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="wt_ETFSCapitalMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ContractualGoldPaymentsMember" xlink:href="wt-20231231.xsd#wt_ContractualGoldPaymentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="wt_ContractualGoldPaymentsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_GoldBullionHoldingsMember" xlink:href="wt-20231231.xsd#wt_GoldBullionHoldingsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="wt_GoldBullionHoldingsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_RodberInvestmentsLimitedMember" xlink:href="wt-20231231.xsd#wt_RodberInvestmentsLimitedMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="wt_RodberInvestmentsLimitedMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedBalanceOtherMeasure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedBalanceOtherMeasure"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_InvestmentOwnedBalanceOtherMeasure" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_Cash" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredConsiderationCurrent" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="wt_DeferredConsiderationCurrent" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredConsiderationNoncurrent" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="wt_DeferredConsiderationNoncurrent" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_ConvertibleNotesDetailsTable" xlink:href="wt-20231231.xsd#wt_ConvertibleNotesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="wt_ConvertibleNotesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_ConvertibleNotesDetailsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_ConvertibleNotesDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_ConvertibleNotesDetailsTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ConvertibleSeniorNotesDue2028Member" xlink:href="wt-20231231.xsd#wt_ConvertibleSeniorNotesDue2028Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="wt_ConvertibleSeniorNotesDue2028Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember" xlink:href="wt-20231231.xsd#wt_ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="wt_ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember" xlink:href="wt-20231231.xsd#wt_ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="wt_ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_TwoThousandAndTwentyNotesMember" xlink:href="wt-20231231.xsd#wt_TwoThousandAndTwentyNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="wt_TwoThousandAndTwentyNotesMember" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ConvertibleSeniorNotesMember" xlink:href="wt-20231231.xsd#wt_ConvertibleSeniorNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="wt_ConvertibleSeniorNotesMember" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_ConvertibleNotesPayableMember" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ConvertibleNotesMember" xlink:href="wt-20231231.xsd#wt_ConvertibleNotesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="wt_ConvertibleNotesMember" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtGainLossNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_Cash" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockAmountIssued1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ConversionOfStockAmountIssued1" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdTradingDays" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentRate" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_NumberOfThresholdTradingDaysForDeterminingTheSharePrice" xlink:href="wt-20231231.xsd#wt_NumberOfThresholdTradingDaysForDeterminingTheSharePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="wt_NumberOfThresholdTradingDaysForDeterminingTheSharePrice" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_MeasurementPeriodForDeterminingSharePrice" xlink:href="wt-20231231.xsd#wt_MeasurementPeriodForDeterminingSharePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="wt_MeasurementPeriodForDeterminingSharePrice" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_PrincipalAmountOfTradingPrice" xlink:href="wt-20231231.xsd#wt_PrincipalAmountOfTradingPrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="wt_PrincipalAmountOfTradingPrice" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_SharePriceAsAPercentageOfLastReportedPriceAndConversionRate" xlink:href="wt-20231231.xsd#wt_SharePriceAsAPercentageOfLastReportedPriceAndConversionRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="wt_SharePriceAsAPercentageOfLastReportedPriceAndConversionRate" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionRatio1" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentage" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_MaximumConversionRate" xlink:href="wt-20231231.xsd#wt_MaximumConversionRate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="wt_MaximumConversionRate" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_MaximumNumberOfSharesIssuableUponConversion" xlink:href="wt-20231231.xsd#wt_MaximumNumberOfSharesIssuableUponConversion"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="wt_MaximumNumberOfSharesIssuableUponConversion" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_MinimumPercentageOfLendersRequiredToHaveEntirePrincipalAmountOfConvertibleNotesRepurchasedByTheCompanyUponCertainEventsOfDefault" xlink:href="wt-20231231.xsd#wt_MinimumPercentageOfLendersRequiredToHaveEntirePrincipalAmountOfConvertibleNotesRepurchasedByTheCompanyUponCertainEventsOfDefault"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="wt_MinimumPercentageOfLendersRequiredToHaveEntirePrincipalAmountOfConvertibleNotesRepurchasedByTheCompanyUponCertainEventsOfDefault" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpense" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFairValue" order="23" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredUnitsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredUnitsLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_SeriesAPreferredStockDetailsTable" xlink:href="wt-20231231.xsd#wt_SeriesAPreferredStockDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PreferredUnitsLineItems" xlink:to="wt_SeriesAPreferredStockDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_SeriesAPreferredStockDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_SeriesAPreferredStockDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_SeriesAPreferredStockDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ETFSAcquisitionMember" xlink:href="wt-20231231.xsd#wt_ETFSAcquisitionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="wt_ETFSAcquisitionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_SeriesANonVotingConvertiblePreferredStockMember" xlink:href="wt-20231231.xsd#wt_SeriesANonVotingConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="wt_SeriesANonVotingConvertiblePreferredStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_PreferredStockMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_OutstandingCommonStockPercentage" xlink:href="wt-20231231.xsd#wt_OutstandingCommonStockPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PreferredUnitsLineItems" xlink:to="wt_OutstandingCommonStockPercentage" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PreferredUnitsLineItems" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PreferredUnitsLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PreferredUnitsLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionSharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PreferredUnitsLineItems" xlink:to="us-gaap_BusinessAcquisitionSharePrice" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_PreferredStockRedemptionValue" xlink:href="wt-20231231.xsd#wt_PreferredStockRedemptionValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PreferredUnitsLineItems" xlink:to="wt_PreferredStockRedemptionValue" order="6" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHDetails">
    <loc xlink:type="locator" xlink:label="wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems" xlink:href="wt-20231231.xsd#wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsTable" xlink:href="wt-20231231.xsd#wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems" xlink:to="wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_GBHMember" xlink:href="wt-20231231.xsd#wt_GBHMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="wt_GBHMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockConvertibleSharesIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockConvertibleSharesIssuable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems" xlink:to="us-gaap_PreferredStockConvertibleSharesIssuable" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferred" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferred" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_RepurchasePricePerShareInterestRateTransaction" xlink:href="wt-20231231.xsd#wt_RepurchasePricePerShareInterestRateTransaction"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems" xlink:to="wt_RepurchasePricePerShareInterestRateTransaction" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_PresentValueOfMarketRateInterest" xlink:href="wt-20231231.xsd#wt_PresentValueOfMarketRateInterest"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems" xlink:to="wt_PresentValueOfMarketRateInterest" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_AggregateConsiderationPayable" xlink:href="wt-20231231.xsd#wt_AggregateConsiderationPayable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems" xlink:to="wt_AggregateConsiderationPayable" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestAndDebtExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestAndDebtExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems" xlink:to="us-gaap_InterestAndDebtExpense" order="7" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/LeasesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="wt_PaymentOfLeaseTerminationFee" xlink:href="wt-20231231.xsd#wt_PaymentOfLeaseTerminationFee"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesAbstract" xlink:to="wt_PaymentOfLeaseTerminationFee" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnContractTermination" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnContractTermination"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_GainLossOnContractTermination" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseImpairmentLoss" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ContingenciesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_GainContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainContingenciesLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_ContingenciesDetailsTable" xlink:href="wt-20231231.xsd#wt_ContingenciesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_GainContingenciesLineItems" xlink:to="wt_ContingenciesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LossContingencyDamagesSoughtValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GainContingenciesLineItems" xlink:to="us-gaap_LossContingencyDamagesSoughtValue" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_LossContingencyCoveredByInsuranceDeductible" xlink:href="wt-20231231.xsd#wt_LossContingencyCoveredByInsuranceDeductible"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GainContingenciesLineItems" xlink:to="wt_LossContingencyCoveredByInsuranceDeductible" order="2" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_RelatedPartyTransactionsDetailsTable" xlink:href="wt-20231231.xsd#wt_RelatedPartyTransactionsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="wt_RelatedPartyTransactionsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_InvestmentTypeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_WisdomTreeProductsMember" xlink:href="wt-20231231.xsd#wt_WisdomTreeProductsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="wt_WisdomTreeProductsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_AffiliatedBlockchainEnabledFundsMember" xlink:href="wt-20231231.xsd#wt_AffiliatedBlockchainEnabledFundsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="wt_AffiliatedBlockchainEnabledFundsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncome"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OtherIncome" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_Investments" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestments"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_GainLossOnInvestments" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractualObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractualObligation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ContractualObligation" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_StockBasedAwardsDetailsTable" xlink:href="wt-20231231.xsd#wt_StockBasedAwardsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="wt_StockBasedAwardsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_StockBasedAwardsDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_StockBasedAwardsDetailsTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_StockBasedAwardsDetailsTable" xlink:to="us-gaap_VestingAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VestingDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_StockBasedAwardsDetailsTable" xlink:to="srt_RangeAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockOptionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_StockOptionMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_PerformanceBasedRestrictedStockUnitMember" xlink:href="wt-20231231.xsd#wt_PerformanceBasedRestrictedStockUnitMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="wt_PerformanceBasedRestrictedStockUnitMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_BelowTwentyFifthPercentileMember" xlink:href="wt-20231231.xsd#wt_BelowTwentyFifthPercentileMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="wt_BelowTwentyFifthPercentileMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_OtherTaxExpenseBenefit" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" order="13" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails">
    <loc xlink:type="locator" xlink:label="wt_DisclosureOfStockholderRightsPlanLineItems" xlink:href="wt-20231231.xsd#wt_DisclosureOfStockholderRightsPlanLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_StockholderRightsPlanDetailsTable" xlink:href="wt-20231231.xsd#wt_StockholderRightsPlanDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wt_DisclosureOfStockholderRightsPlanLineItems" xlink:to="wt_StockholderRightsPlanDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_StockholderRightsPlanDetailsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_StockholderRightsPlanDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_AgreementAxis" xlink:href="wt-20231231.xsd#wt_AgreementAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_StockholderRightsPlanDetailsTable" xlink:to="wt_AgreementAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_AgreementDomainDomain" xlink:href="wt-20231231.xsd#wt_AgreementDomainDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="wt_AgreementAxis" xlink:to="wt_AgreementDomainDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_AgreementDomainDomain_0" xlink:href="wt-20231231.xsd#wt_AgreementDomainDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="wt_AgreementAxis" xlink:to="wt_AgreementDomainDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_StockholderRightsPlanDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_StockholderRightsPlanDetailsTable" xlink:to="srt_RangeAxis" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_StockholderRightsPlanDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_StockholderRightsPlanDetailsTable" xlink:to="srt_OwnershipAxis" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_OwnershipDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_StockholderRightAgreementMember" xlink:href="wt-20231231.xsd#wt_StockholderRightAgreementMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="wt_StockholderRightAgreementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_SeriesANonVotingConvertiblePreferredStockMember" xlink:href="wt-20231231.xsd#wt_SeriesANonVotingConvertiblePreferredStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="wt_SeriesANonVotingConvertiblePreferredStockMember" order="0" xbrldt:closed="true"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_AgreementDomainDomain" xlink:to="wt_StockholderRightAgreementMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_BoardOfDirectorsChairmanMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_BoardOfDirectorsChairmanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_BoardOfDirectorsChairmanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_AcquiringPersonMember" xlink:href="wt-20231231.xsd#wt_AcquiringPersonMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_OwnershipDomain" xlink:to="wt_AcquiringPersonMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_PassiveStockholdersMember" xlink:href="wt-20231231.xsd#wt_PassiveStockholdersMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_OwnershipDomain" xlink:to="wt_PassiveStockholdersMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_DisclosureOfStockholderRightsPlanLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_DisclosureOfStockholderRightsPlanLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_DisclosureOfStockholderRightsPlanLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ExercisePricePerUnit" xlink:href="wt-20231231.xsd#wt_ExercisePricePerUnit"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_DisclosureOfStockholderRightsPlanLineItems" xlink:to="wt_ExercisePricePerUnit" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_DisclosureOfStockholderRightsPlanLineItems" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_PercentageOfCommonStockAcquired" xlink:href="wt-20231231.xsd#wt_PercentageOfCommonStockAcquired"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_DisclosureOfStockholderRightsPlanLineItems" xlink:to="wt_PercentageOfCommonStockAcquired" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_PercentageOfBeneficialOwnership" xlink:href="wt-20231231.xsd#wt_PercentageOfBeneficialOwnership"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_DisclosureOfStockholderRightsPlanLineItems" xlink:to="wt_PercentageOfBeneficialOwnership" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_PercentageOfAssetsSold" xlink:href="wt-20231231.xsd#wt_PercentageOfAssetsSold"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_DisclosureOfStockholderRightsPlanLineItems" xlink:to="wt_PercentageOfAssetsSold" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_PercentageOfCommonStock" xlink:href="wt-20231231.xsd#wt_PercentageOfCommonStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_DisclosureOfStockholderRightsPlanLineItems" xlink:to="wt_PercentageOfCommonStock" order="9" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShareDetails">
    <loc xlink:type="locator" xlink:label="wt_EarningsPerShareDetailsLineItems" xlink:href="wt-20231231.xsd#wt_EarningsPerShareDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_EarningsPerShareDetailsTable" xlink:href="wt-20231231.xsd#wt_EarningsPerShareDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wt_EarningsPerShareDetailsLineItems" xlink:to="wt_EarningsPerShareDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_EarningsPerShareDetailsTable" xlink:to="srt_StatementScenarioAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_EarningsPerShareDetailsLineItems" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_EarningsPerShareDetailsLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_EarningsPerShareDetailsLineItems" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" order="3" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesDetails">
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfIncomeTaxLineItems" xlink:href="wt-20231231.xsd#wt_ScheduleOfIncomeTaxLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxesDetailsTable" xlink:href="wt-20231231.xsd#wt_IncomeTaxesDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wt_ScheduleOfIncomeTaxLineItems" xlink:to="wt_IncomeTaxesDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_IncomeTaxesDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_IncomeTaxesDetailsTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ManJersMember" xlink:href="wt-20231231.xsd#wt_ManJersMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="wt_ManJersMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherNoncurrentLiabilitiesMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfIncomeTaxLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_OperatingLossCarryForwardExpirationYear" xlink:href="wt-20231231.xsd#wt_OperatingLossCarryForwardExpirationYear"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfIncomeTaxLineItems" xlink:to="wt_OperatingLossCarryForwardExpirationYear" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfIncomeTaxLineItems" xlink:to="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredTaxAssetsCapitalLossCarryforwardsSubjectToExpiration" xlink:href="wt-20231231.xsd#wt_DeferredTaxAssetsCapitalLossCarryforwardsSubjectToExpiration"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfIncomeTaxLineItems" xlink:to="wt_DeferredTaxAssetsCapitalLossCarryforwardsSubjectToExpiration" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax" xlink:href="wt-20231231.xsd#wt_DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfIncomeTaxLineItems" xlink:to="wt_DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfIncomeTaxLineItems" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfIncomeTaxLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfIncomeTaxLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfIncomeTaxLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ScheduleOfIncomeTaxLineItems" xlink:to="us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" order="10" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails">
    <loc xlink:type="locator" xlink:label="wt_SharesRepurchasedDetailsLineItems" xlink:href="wt-20231231.xsd#wt_SharesRepurchasedDetailsLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_SharesRepurchasedDetailsTable" xlink:href="wt-20231231.xsd#wt_SharesRepurchasedDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wt_SharesRepurchasedDetailsLineItems" xlink:to="wt_SharesRepurchasedDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_SharesRepurchasedDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_SharesRepurchasedDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_SharesRepurchasedDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_SharesRepurchasedDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_SharesRepurchasedDetailsTable" xlink:to="srt_RangeAxis" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_WorldGoldCouncilMember" xlink:href="wt-20231231.xsd#wt_WorldGoldCouncilMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="wt_WorldGoldCouncilMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_BoardOfDirectorsChairmanMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_BoardOfDirectorsChairmanMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_BoardOfDirectorsChairmanMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_GoldBullionHoldingsMember" xlink:href="wt-20231231.xsd#wt_GoldBullionHoldingsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="wt_GoldBullionHoldingsMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_SharesRepurchasedDetailsLineItems" xlink:to="us-gaap_StockRepurchaseProgramAuthorizedAmount1" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_SharesRepurchasedDetailsLineItems" xlink:to="us-gaap_StockRepurchaseProgramPeriodInForce1" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchaseProgramExpirationDate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramExpirationDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_SharesRepurchasedDetailsLineItems" xlink:to="us-gaap_StockRepurchaseProgramExpirationDate" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_SharesRepurchasedDetailsLineItems" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_SharesRepurchasedDetailsLineItems" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_SharesRepurchasedDetailsLineItems" xlink:to="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_SharesRepurchasedDetailsLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_SharesRepurchasedDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="8" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_GoodwillandIntangibleAssetsDetailsTable" xlink:href="wt-20231231.xsd#wt_GoodwillandIntangibleAssetsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_GoodwillLineItems" xlink:to="wt_GoodwillandIntangibleAssetsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_GoodwillandIntangibleAssetsDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_GoodwillandIntangibleAssetsDetailsTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_SecurrencyMember" xlink:href="wt-20231231.xsd#wt_SecurrencyMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="wt_SecurrencyMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_ETFSAcquisitionMember" xlink:href="wt-20231231.xsd#wt_ETFSAcquisitionMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="wt_ETFSAcquisitionMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareDevelopmentMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_Goodwill" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_PercentageOfRevenueGrowth" xlink:href="wt-20231231.xsd#wt_PercentageOfRevenueGrowth"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="wt_PercentageOfRevenueGrowth" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PercentageOfWeightedAverageCostInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PercentageOfWeightedAverageCostInventory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_PercentageOfWeightedAverageCostInventory" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" order="11" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsDetails">
    <loc xlink:type="locator" xlink:label="wt_ContingentPaymentsLineItems" xlink:href="wt-20231231.xsd#wt_ContingentPaymentsLineItems"/>
    <loc xlink:type="locator" xlink:label="wt_ContingentPaymentsDetailsTable" xlink:href="wt-20231231.xsd#wt_ContingentPaymentsDetailsTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wt_ContingentPaymentsLineItems" xlink:to="wt_ContingentPaymentsDetailsTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wt_ContingentPaymentsDetailsTable" xlink:to="srt_ProductOrServiceAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain_0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_SaleOfCanadianETFBusinessMember" xlink:href="wt-20231231.xsd#wt_SaleOfCanadianETFBusinessMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="wt_SaleOfCanadianETFBusinessMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wt_ContingentPaymentsLineItems" xlink:to="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" order="1" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_0" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_CommonStock001ParValueMember" xlink:href="wt-20231231.xsd#wt_CommonStock001ParValueMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="wt_CommonStock001ParValueMember" order="0" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="wt_PreferredStockPurchaseRightsMember" xlink:href="wt-20231231.xsd#wt_PreferredStockPurchaseRightsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="wt_PreferredStockPurchaseRightsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCommonStockSharesOutstanding" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityPublicFloat" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCurrentReportingStatus" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityVoluntaryFilers" order="10" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="11" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="12" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="13" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalYearFocus" order="14" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFiscalPeriodFocus" order="15" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="16" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="17" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityShellCompany" order="18" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_IcfrAuditorAttestationFlag" order="19" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentAnnualReport" order="20" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentTransitionReport" order="21" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" order="22" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="23" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="24" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="25" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine2" order="26" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="27" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="28" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="29" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" order="30" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="31" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" order="32" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" order="33" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityInteractiveDataCurrent" order="34" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag" order="35" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" order="36" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorLocation" order="37" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorFirmId" order="38" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AuditorName" order="39" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>wt-20231231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Feb 23 00:25:24 UTC 2024 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"/>
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"/>
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xml:lang="en-US">Financial Instrument [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_RelatedPartiesAxis" xlink:href="wt-20231231.xsd#wt_RelatedPartiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_RelatedPartiesAxis_lbl" xml:lang="en-US">Related Parties [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RelatedPartiesAxis" xlink:to="wt_RelatedPartiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl0" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl1" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Income before income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl0" xml:lang="en-US">income tax expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_lbl0" xml:lang="en-US">Net income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xml:lang="en-US">Other comprehensive income/(loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl0" xml:lang="en-US">Other comprehensive income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US">Comprehensive income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_lbl0" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash provided by operating activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash provided by/(used in) investing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash (used in)/provided by financing activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net (decrease)/increase in cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents&#8212;beginning of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0" xml:lang="en-US">Cash and cash equivalents&#8212;end of year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization and Description of Business [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Significant Accounting Policies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAbstract_lbl" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US">Fair Value Measurements [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xml:lang="en-US">Measurement Frequency [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis_lbl" xml:lang="en-US">Security Owned and Sold, Not yet Purchased, at Fair Value [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:to="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xml:lang="en-US">Investment Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xml:lang="en-US">Asset Class [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueByAssetClassAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xml:lang="en-US">Beginning balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl0" xml:lang="en-US">Ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByLiabilityClassAxis_lbl" xml:lang="en-US">Liability Class [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueByLiabilityClassAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract_lbl" xml:lang="en-US">Financial Instruments Owned [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract" xlink:to="us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xml:lang="en-US">Securities Held-to-Maturity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesTransfersAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesTransfersAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HeldToMaturitySecuritiesTransfersAbstract_lbl" xml:lang="en-US">Schedule of Securities Held-to-Maturity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesTransfersAbstract" xlink:to="us-gaap_HeldToMaturitySecuritiesTransfersAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesTransfersToTradingGainsLossesNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesTransfersToTradingGainsLossesNetAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesTransfersToTradingGainsLossesNetAbstract_lbl" xml:lang="en-US">Schedule of Unrealized Losses Gains And Fair Value of Securities Held to Maturity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesTransfersToTradingGainsLossesNetAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesTransfersToTradingGainsLossesNetAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAbstract_lbl" xml:lang="en-US">Schedule of Maturity Profile of the Securities Held to Maturity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAbstract" xlink:to="us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:to="us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsAbstract_lbl" xml:lang="en-US">Investments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="us-gaap_InvestmentsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentsAbstract_lbl0" xml:lang="en-US">Investments in Convertible Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="us-gaap_InvestmentsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InvestmentsAbstract_lbl1" xml:lang="en-US">Investments in Convertible Notes (Note 7):</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="us-gaap_InvestmentsAbstract_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Fixed Assets, net [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGrossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGrossAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGrossAbstract_lbl" xml:lang="en-US">Schedule of Fixed Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGrossAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentGrossAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl0" xml:lang="en-US">Fixed assets, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredConsiderationAbstract" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_DeferredConsiderationAbstract_lbl" xml:lang="en-US">Deferred Consideration Gold Payments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredConsiderationAbstract" xlink:to="wt_DeferredConsiderationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfDeferredConsiderationAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfDeferredConsiderationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfDeferredConsiderationAbstract_lbl" xml:lang="en-US">Schedule Of Deferred Consideration [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfDeferredConsiderationAbstract" xlink:to="wt_ScheduleOfDeferredConsiderationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract_lbl" xml:lang="en-US">Convertible Notes [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract" xlink:to="us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfConvertibleNotesAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfConvertibleNotesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfConvertibleNotesAbstract_lbl" xml:lang="en-US">Schedule of Convertible Notes [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfConvertibleNotesAbstract" xlink:to="wt_ScheduleOfConvertibleNotesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract_lbl" xml:lang="en-US">Series A Preferred Stock [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract" xlink:to="us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl" xml:lang="en-US">Schedule of Preferred Stock Balance [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_PayableToGoldBullionHoldingJerseyLimitedGBHAbstract" xlink:href="wt-20231231.xsd#wt_PayableToGoldBullionHoldingJerseyLimitedGBHAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_PayableToGoldBullionHoldingJerseyLimitedGBHAbstract_lbl" xml:lang="en-US">Payable to Gold Bullion Holdings Jersey Limited GBH [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PayableToGoldBullionHoldingJerseyLimitedGBHAbstract" xlink:to="wt_PayableToGoldBullionHoldingJerseyLimitedGBHAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesAndLoansPayableAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesAndLoansPayableAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesAndLoansPayableAbstract_lbl" xml:lang="en-US">Schedule of Aggregate Consideration Payable [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesAndLoansPayableAbstract" xlink:to="us-gaap_NotesAndLoansPayableAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NotesPayable_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasesAbstract_lbl" xml:lang="en-US">Leases [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfAdditionalInformationRelatedToOperatingLeaseAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfAdditionalInformationRelatedToOperatingLeaseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfAdditionalInformationRelatedToOperatingLeaseAbstract_lbl" xml:lang="en-US">Schedule for Summary of Additional Information Related to Operating Lease [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfAdditionalInformationRelatedToOperatingLeaseAbstract" xlink:to="wt_ScheduleOfAdditionalInformationRelatedToOperatingLeaseAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfFutureMinimumLeasePaymentsAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfFutureMinimumLeasePaymentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfFutureMinimumLeasePaymentsAbstract_lbl" xml:lang="en-US">Schedule of Future Minimum Lease Payments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfFutureMinimumLeasePaymentsAbstract" xlink:to="wt_ScheduleOfFutureMinimumLeasePaymentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Total future minimum lease payments (undiscounted)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfReconciliationOfFutureMinimumLeasePaymentsToBalanceSheetAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfReconciliationOfFutureMinimumLeasePaymentsToBalanceSheetAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfReconciliationOfFutureMinimumLeasePaymentsToBalanceSheetAbstract_lbl" xml:lang="en-US">Schedule of Reconciliation of Future Minimum Lease Payments to Balance Sheet [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfReconciliationOfFutureMinimumLeasePaymentsToBalanceSheetAbstract" xlink:to="wt_ScheduleOfReconciliationOfFutureMinimumLeasePaymentsToBalanceSheetAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Subtotal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Contingencies [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_lbl" xml:lang="en-US">Variable Interest Entities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:to="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xml:lang="en-US">Investment, Name [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract_lbl" xml:lang="en-US">Revenues from Contracts with Customers [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfAccountsReceivableFromRelatedPartiesAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfAccountsReceivableFromRelatedPartiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfAccountsReceivableFromRelatedPartiesAbstract_lbl" xml:lang="en-US">Summary of Accounts Receivable from Related Parties [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfAccountsReceivableFromRelatedPartiesAbstract" xlink:to="wt_ScheduleOfAccountsReceivableFromRelatedPartiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party, Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfRevenuesFromAdvisoryServicesProvidedToRelatedPartiesAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfRevenuesFromAdvisoryServicesProvidedToRelatedPartiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfRevenuesFromAdvisoryServicesProvidedToRelatedPartiesAbstract_lbl" xml:lang="en-US">Summary of Revenues from Advisory Services Provided to Related Parties [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfRevenuesFromAdvisoryServicesProvidedToRelatedPartiesAbstract" xlink:to="wt_ScheduleOfRevenuesFromAdvisoryServicesProvidedToRelatedPartiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Stock-Based Awards [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US">Unvested Beginning Balance, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl0" xml:lang="en-US">Unvested, Ending Balance, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Unvested, Beginning Balance, Weighted Average Grant Date Fair Value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl0" xml:lang="en-US">Unvested, Ending Balance,Weighted Average Grant Date Fair Value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfShareBasedPaymentAwardsOtherThanOptionsValuationAssumptionsAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfShareBasedPaymentAwardsOtherThanOptionsValuationAssumptionsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfShareBasedPaymentAwardsOtherThanOptionsValuationAssumptionsAbstract_lbl" xml:lang="en-US">Schedule of Share Based Payment Awards Other than Options Valuation Assumptions [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfShareBasedPaymentAwardsOtherThanOptionsValuationAssumptionsAbstract" xlink:to="wt_ScheduleOfShareBasedPaymentAwardsOtherThanOptionsValuationAssumptionsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_DisclosureOfStockholderRightsPlanAbstract" xlink:href="wt-20231231.xsd#wt_DisclosureOfStockholderRightsPlanAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_DisclosureOfStockholderRightsPlanAbstract_lbl" xml:lang="en-US">Stockholder Rights Plan [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DisclosureOfStockholderRightsPlanAbstract" xlink:to="wt_DisclosureOfStockholderRightsPlanAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xml:lang="en-US">Employee Benefit Plans [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Earnings Per Share [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Taxes [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Total current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Total deferred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Deferred income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax expense/(benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Income tax expense/(benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US">Income Tax Authority [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfComponentsOfTheCompanySDeferredTaxAssetsAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfComponentsOfTheCompanySDeferredTaxAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfComponentsOfTheCompanySDeferredTaxAssetsAbstract_lbl" xml:lang="en-US">Schedule of Components of the Company&#8217;s Deferred Tax Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfComponentsOfTheCompanySDeferredTaxAssetsAbstract" xlink:to="wt_ScheduleOfComponentsOfTheCompanySDeferredTaxAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Deferred tax assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xml:lang="en-US">Deferred tax liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredTaxAssetsLiabilitiesGross" xlink:href="wt-20231231.xsd#wt_DeferredTaxAssetsLiabilitiesGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="wt_DeferredTaxAssetsLiabilitiesGross_lbl" xml:lang="en-US">Total deferred tax assets less deferred tax liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredTaxAssetsLiabilitiesGross" xlink:to="wt_DeferredTaxAssetsLiabilitiesGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Deferred tax assets, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xml:lang="en-US">Beginning balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl0" xml:lang="en-US">Ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl1" xml:lang="en-US">Unrecognized tax benefits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_lbl" xml:lang="en-US">Nature of Uncertainty [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis" xlink:to="us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract_lbl" xml:lang="en-US">Shares Repurchased [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_DisclosureTextBlockSupplementAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfGoodwillAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfGoodwillAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfGoodwillAbstract_lbl" xml:lang="en-US">Schedule of Goodwill [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfGoodwillAbstract" xlink:to="wt_ScheduleOfGoodwillAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Beginning balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_Goodwill_lbl0" xml:lang="en-US">Ending balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Goodwill_lbl1" xml:lang="en-US">Goodwill (Note 24)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Goodwill_lbl2" xml:lang="en-US">Goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl2"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfIntangibleAssetsAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfIntangibleAssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfIntangibleAssetsAbstract_lbl" xml:lang="en-US">Schedule of Intangible Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfIntangibleAssetsAbstract" xlink:to="wt_ScheduleOfIntangibleAssetsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfExpectedAmortizationExpenseAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfExpectedAmortizationExpenseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfExpectedAmortizationExpenseAbstract_lbl" xml:lang="en-US">Schedule of Unamortized Finite-Lived Intangible Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfExpectedAmortizationExpenseAbstract" xlink:to="wt_ScheduleOfExpectedAmortizationExpenseAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Total expected amortization expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionContingentConsiderationLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiabilityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionContingentConsiderationLiabilityAbstract_lbl" xml:lang="en-US">Contingent Payments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionContingentConsiderationLiabilityAbstract" xlink:to="us-gaap_AssetAcquisitionContingentConsiderationLiabilityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetImpairmentChargesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentChargesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetImpairmentChargesAbstract_lbl" xml:lang="en-US">Impairments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetImpairmentChargesAbstract" xlink:to="us-gaap_AssetImpairmentChargesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_lbl" xml:lang="en-US">Real Estate, Type of Property [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:to="srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringCostAndReserveAxis_lbl" xml:lang="en-US">Restructuring Type [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_RestructuringCostAndReserveAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetsAbstract_lbl0" xml:lang="en-US">Assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents (including $5,007 and $0 invested in WisdomTree Government Money Market Digital Fund at December 31, 2023 and 2022, respectively)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0" xml:lang="en-US">Total cash and cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsAndCash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAndCash"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentsAndCash_lbl" xml:lang="en-US">Cash and cash equivalents (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsAndCash" xlink:to="us-gaap_InvestmentsAndCash_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue_lbl" xml:lang="en-US">Financial instruments owned, at fair value (including $47,559 and $25,283 invested in WisdomTree products at December 31, 2023 and 2022, respectively)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:to="us-gaap_FinancialInstrumentsOwnedAtFairValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue_lbl0" xml:lang="en-US">Financial instruments owned</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:to="us-gaap_FinancialInstrumentsOwnedAtFairValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned_lbl" xml:lang="en-US">Financial instruments owned, at fair value (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" xlink:to="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned_lbl0" xml:lang="en-US">Financial instruments owned, at fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" xlink:to="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable (including $28,511 and $24,139 due from related parties at December 31, 2023 and 2022, respectively)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsReceivableNet_lbl" xml:lang="en-US">Accounts receivable from related parties (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNet" xlink:to="us-gaap_AccountsReceivableNet_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsReceivableNet_lbl0" xml:lang="en-US">Accounts receivable from related parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNet" xlink:to="us-gaap_AccountsReceivableNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xml:lang="en-US">Other current assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_IndemnificationReceivableNoncurrent" xlink:href="wt-20231231.xsd#wt_IndemnificationReceivableNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_IndemnificationReceivableNoncurrent_lbl" xml:lang="en-US">Indemnification receivable (Note 22)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IndemnificationReceivableNoncurrent" xlink:to="wt_IndemnificationReceivableNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_HeldToMaturitySecuritiesNoncurrent_lbl" xml:lang="en-US">Securities held-to-maturity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:to="us-gaap_HeldToMaturitySecuritiesNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet_lbl" xml:lang="en-US">Deferred tax assets, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl" xml:lang="en-US">Investments (Note 7)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl0" xml:lang="en-US">Carrying value of investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl1" xml:lang="en-US">Carrying Amount&#8212;Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right of use assets&#8212;operating leases (Note13)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets, net (Note 24)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl0" xml:lang="en-US">Intangible assets, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US">Other noncurrent assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities and stockholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LiabilitiesAbstract_lbl0" xml:lang="en-US">Liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl" xml:lang="en-US">Fund management and administration payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Compensation and benefits payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NotesPayableCurrent_lbl" xml:lang="en-US">Payable to Gold Bullion Holdings (Jersey) Limited (&#8220;GBH&#8221;) (Note 12)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NotesPayableCurrent_lbl0" xml:lang="en-US">Current:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TaxesPayableCurrent_lbl" xml:lang="en-US">Income taxes payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxesPayableCurrent" xlink:to="us-gaap_TaxesPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating lease liabilities (Note 13)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl0" xml:lang="en-US">Lease liability&#8212;short term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertibleDebtCurrent_lbl" xml:lang="en-US">Convertible notes&#8212;current (Note 10)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtCurrent" xlink:to="us-gaap_ConvertibleDebtCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredConsiderationCurrent" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_DeferredConsiderationCurrent_lbl" xml:lang="en-US">Deferred consideration&#8212;gold payments (Note 9)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredConsiderationCurrent" xlink:to="wt_DeferredConsiderationCurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="wt_DeferredConsiderationCurrent_lbl0" xml:lang="en-US">Deferred consideration current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredConsiderationCurrent" xlink:to="wt_DeferredConsiderationCurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts payable and other liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_CarryingValueOfConvertibleNotes" xlink:href="wt-20231231.xsd#wt_CarryingValueOfConvertibleNotes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_CarryingValueOfConvertibleNotes_lbl" xml:lang="en-US">Convertible notes (Note 10)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_CarryingValueOfConvertibleNotes" xlink:to="wt_CarryingValueOfConvertibleNotes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Payable to GBH (Note 12)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableCurrentAndNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredConsiderationNoncurrent" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_DeferredConsiderationNoncurrent_lbl" xml:lang="en-US">Deferred consideration&#8212;gold payments (Note 9)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredConsiderationNoncurrent" xlink:to="wt_DeferredConsiderationNoncurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="wt_DeferredConsiderationNoncurrent_lbl0" xml:lang="en-US">Deferred consideration noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredConsiderationNoncurrent" xlink:to="wt_DeferredConsiderationNoncurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liabilities (Note 13)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl0" xml:lang="en-US">Lease liability&#8212;long term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Other noncurrent liabilities (Note 22)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital_lbl" xml:lang="en-US">Preferred stock&#8212;Series A Non-Voting Convertible, par value $0.01; 14.750 shares authorized, issued and outstanding; redemption value of $96,869 and $77,969 at December 31, 2023 and 2022, respectively) (Note 11)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital" xlink:to="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_PreferredStockRedemptionValue" xlink:href="wt-20231231.xsd#wt_PreferredStockRedemptionValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_PreferredStockRedemptionValue_lbl" xml:lang="en-US">Preferred stock redemption value (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PreferredStockRedemptionValue" xlink:to="wt_PreferredStockRedemptionValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="wt_PreferredStockRedemptionValue_lbl0" xml:lang="en-US">Preferred shares redemption value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PreferredStockRedemptionValue" xlink:to="wt_PreferredStockRedemptionValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Contingencies (Note 14)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders&#8217; equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, par value $0.01; 2,000 shares authorized:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockValue_lbl0" xml:lang="en-US">Series A Preferred Stock&#8212;carrying value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl0" xml:lang="en-US">Preferred stock, par or stated value per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, par value $0.01; 400,000 shares authorized; issued and outstanding: 150,330 and 146,517 at December 31, 2023 and 2022, respectively</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl0" xml:lang="en-US">Common stock, par or stated value per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Retained earnings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0" xml:lang="en-US">Accumulated deficit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US">Operating Revenues:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RevenuesAbstract_lbl0" xml:lang="en-US">Revenues from contracts with customers:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Total revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Revenues_lbl0" xml:lang="en-US">Total operating revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_Revenues_lbl1" xml:lang="en-US">Revenues from advisory services</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating Expenses:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LaborAndRelatedExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LaborAndRelatedExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LaborAndRelatedExpense_lbl" xml:lang="en-US">Compensation and benefits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LaborAndRelatedExpense" xlink:to="us-gaap_LaborAndRelatedExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_FundManagementAndAdministration" xlink:href="wt-20231231.xsd#wt_FundManagementAndAdministration"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_FundManagementAndAdministration_lbl" xml:lang="en-US">Fund management and administration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FundManagementAndAdministration" xlink:to="wt_FundManagementAndAdministration_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketingAndAdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MarketingAndAdvertisingExpense_lbl" xml:lang="en-US">Marketing and advertising</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketingAndAdvertisingExpense" xlink:to="us-gaap_MarketingAndAdvertisingExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDevelopment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessDevelopment_lbl" xml:lang="en-US">Sales and business development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDevelopment" xlink:to="us-gaap_BusinessDevelopment_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ContractualGoldPayments" xlink:href="wt-20231231.xsd#wt_ContractualGoldPayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ContractualGoldPayments_lbl" xml:lang="en-US">Contractual gold payments (Note 9)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ContractualGoldPayments" xlink:to="wt_ContractualGoldPayments_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="wt_ContractualGoldPayments_lbl0" xml:lang="en-US">Contractual gold payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ContractualGoldPayments" xlink:to="wt_ContractualGoldPayments_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalFees"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProfessionalFees_lbl" xml:lang="en-US">Professional fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommunicationsInformationTechnologyAndOccupancy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommunicationsInformationTechnologyAndOccupancy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommunicationsInformationTechnologyAndOccupancy_lbl" xml:lang="en-US">Occupancy, communications and equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommunicationsInformationTechnologyAndOccupancy" xlink:to="us-gaap_CommunicationsInformationTechnologyAndOccupancy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ThirdPartyDistribution" xlink:href="wt-20231231.xsd#wt_ThirdPartyDistribution"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ThirdPartyDistribution_lbl" xml:lang="en-US">Third-party distribution fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ThirdPartyDistribution" xlink:to="wt_ThirdPartyDistribution_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherExpenses_lbl" xml:lang="en-US">Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpenses" xlink:to="us-gaap_OtherExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other Income/(Expenses):</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_GainLossFromChangeInDeferredConsideration" xlink:href="wt-20231231.xsd#wt_GainLossFromChangeInDeferredConsideration"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_GainLossFromChangeInDeferredConsideration_lbl" xml:lang="en-US">Gain on revaluation/termination of deferred consideration&#8212;gold payments (Note 9)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_GainLossFromChangeInDeferredConsideration" xlink:to="wt_GainLossFromChangeInDeferredConsideration_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wt_GainLossFromChangeInDeferredConsideration_lbl0" xml:lang="en-US">Gain on revaluation of deferred consideration&#8212;gold payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_GainLossFromChangeInDeferredConsideration" xlink:to="wt_GainLossFromChangeInDeferredConsideration_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="wt_GainLossFromChangeInDeferredConsideration_lbl1" xml:lang="en-US">Gain on revaluation/termination of deferred consideration&#8212;gold payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_GainLossFromChangeInDeferredConsideration" xlink:to="wt_GainLossFromChangeInDeferredConsideration_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xml:lang="en-US">Interest income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US">Loss on extinguishment of debt (Note 10)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl0" xml:lang="en-US">Loss on extinguishment of debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingGainsLosses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherNonoperatingGainsLosses_lbl" xml:lang="en-US">Other losses, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingGainsLosses" xlink:to="us-gaap_OtherNonoperatingGainsLosses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Earnings per share&#8212;basic (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_lbl0" xml:lang="en-US">Basic earnings per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Earnings per share&#8212;diluted (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_lbl0" xml:lang="en-US">Diluted earnings per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted-average common shares&#8212;basic (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl0" xml:lang="en-US">Weighted average common shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted-average common shares&#8212;diluted (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl0" xml:lang="en-US">Weighted average diluted shares as disclosed on the Consolidated Statements of Operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared_lbl" xml:lang="en-US">Cash dividends declared per common share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_lbl" xml:lang="en-US">Other comprehensive income/(loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl" xml:lang="en-US">Foreign currency translation adjustment, net of income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes" xlink:href="wt-20231231.xsd#wt_StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes_lbl" xml:lang="en-US">Reclassification of equity component related to convertible notes, net of deferred taxes of $1,022, upon the implementation of Accounting Standards Update 2020-06 (Note 10)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes" xlink:to="wt_StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ReclassificationOfEquity" xlink:href="wt-20231231.xsd#wt_ReclassificationOfEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ReclassificationOfEquity_lbl" xml:lang="en-US">Reclassification of equity component related to convertible notes, net of deferred taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ReclassificationOfEquity" xlink:to="wt_ReclassificationOfEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_TemporaryStockholdersEquity" xlink:href="wt-20231231.xsd#wt_TemporaryStockholdersEquity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_TemporaryStockholdersEquity_lbl" xml:lang="en-US">Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_TemporaryStockholdersEquity" xlink:to="wt_TemporaryStockholdersEquity_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_TemporaryEquityShareOutstanding" xlink:href="wt-20231231.xsd#wt_TemporaryEquityShareOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_TemporaryEquityShareOutstanding_lbl" xml:lang="en-US">Balance (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_TemporaryEquityShareOutstanding" xlink:to="wt_TemporaryEquityShareOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US">Restricted stock issued and vesting of restricted stock units, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl" xml:lang="en-US">Restricted stock issued and vesting of restricted stock units, net (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Exercise of stock options, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercise of stock options, net (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Shares issued in connection with convertible notes that matured on June 15, 2023 (Note 10)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl0" xml:lang="en-US">Issuance of Series A Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Shares issued in connection with convertible notes that matured on June 15, 2023 (Note 10) (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Shares issued in connection with termination of the deferred consideration&#8212;gold payments obligation, net of issuance costs (Note 9)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Shares issued in connection with termination of the deferred consideration&#8212;gold payments obligation, net of issuance costs (Note 9) (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_lbl" xml:lang="en-US">Shares repurchased that were issued in connection with termination of the deferred consideration&#8212;gold payments obligation, net of issuance costs (Notes 12 and 23)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_lbl" xml:lang="en-US">Shares repurchased that were issued in connection with termination of the deferred consideration&#8212;gold payments obligation, net of issuance costs (Notes 12 and 23) (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl0" xml:lang="en-US">Stock-based compensation expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xml:lang="en-US">Impairments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl0" xml:lang="en-US">Impairments (Note 26)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_AmortizationOfIssuanceCostsConvertibleNotes" xlink:href="wt-20231231.xsd#wt_AmortizationOfIssuanceCostsConvertibleNotes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_AmortizationOfIssuanceCostsConvertibleNotes_lbl" xml:lang="en-US">Amortization of issuance costs&#8212;convertible notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_AmortizationOfIssuanceCostsConvertibleNotes" xlink:to="wt_AmortizationOfIssuanceCostsConvertibleNotes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xml:lang="en-US">Amortization of right of use asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestExpenseDebt_lbl" xml:lang="en-US">Imputed interest on payable to GBH</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_IncreaseDecreaseInFundManagementAndAdministrationPayable" xlink:href="wt-20231231.xsd#wt_IncreaseDecreaseInFundManagementAndAdministrationPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_IncreaseDecreaseInFundManagementAndAdministrationPayable_lbl" xml:lang="en-US">Fund management and administration payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncreaseDecreaseInFundManagementAndAdministrationPayable" xlink:to="wt_IncreaseDecreaseInFundManagementAndAdministrationPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl" xml:lang="en-US">Compensation and benefits payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_lbl" xml:lang="en-US">Income taxes payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:to="us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_lbl" xml:lang="en-US">Accounts payable and other liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from investing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue" xlink:href="wt-20231231.xsd#wt_ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue_lbl" xml:lang="en-US">Proceeds from the sale of financial instruments owned, at fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue" xlink:to="wt_ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_lbl" xml:lang="en-US">Proceeds from the exit from investment in Securrency, Inc.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:to="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_lbl0" xml:lang="en-US">Proceeds received (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:to="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_lbl" xml:lang="en-US">Proceeds from receipt of contingent consideration related to the sale of Canadian ETF business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:to="us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity" xlink:href="wt-20231231.xsd#wt_ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity_lbl" xml:lang="en-US">Proceeds from held-to-maturity securities maturing or called prior to maturity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity" xlink:to="wt_ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash flows from financing activities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfNotesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromRepaymentsOfNotesPayable_lbl" xml:lang="en-US">Repurchase and maturity of convertible notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:to="us-gaap_ProceedsFromRepaymentsOfNotesPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl" xml:lang="en-US">Repurchase of Series C Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl0" xml:lang="en-US">Purchase price payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_ProceedsFromIssuanceOfConvertibleNotes" xlink:href="wt-20231231.xsd#wt_ProceedsFromIssuanceOfConvertibleNotes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ProceedsFromIssuanceOfConvertibleNotes_lbl" xml:lang="en-US">Proceeds from the issuance of convertible notes (Note 10)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ProceedsFromIssuanceOfConvertibleNotes" xlink:to="wt_ProceedsFromIssuanceOfConvertibleNotes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Proceeds from exercise of stock options</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl0" xml:lang="en-US">Cash received from option exercises</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Increase/(decrease) in cash flow due to changes in foreign exchange rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental disclosure of cash flow information:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Cash paid for income taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl0" xml:lang="en-US">Income taxes paid net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Cash paid for interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestExpense_lbl0" xml:lang="en-US">Interest expense recognized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InterestExpense_lbl1" xml:lang="en-US">Interest expense on the convertible notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xml:lang="en-US">Shares repurchased</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_lbl0" xml:lang="en-US">Aggregate cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US">Shares repurchased (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl0" xml:lang="en-US">Repurchased shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Dividends" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Dividends"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_Dividends_lbl" xml:lang="en-US">Dividends</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Dividends" xlink:to="us-gaap_Dividends_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_AdvisoryFeesReceivedInGold" xlink:href="wt-20231231.xsd#wt_AdvisoryFeesReceivedInGold"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wt_AdvisoryFeesReceivedInGold_lbl" xml:lang="en-US">Advisory fees received in gold and other precious metals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_AdvisoryFeesReceivedInGold" xlink:to="wt_AdvisoryFeesReceivedInGold_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xml:lang="en-US">Losses on financial instruments owned, at fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl0" xml:lang="en-US">Recognized gain (loss) (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RealizedInvestmentGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RealizedInvestmentGainsLosses_lbl" xml:lang="en-US">Losses on investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RealizedInvestmentGainsLosses" xlink:to="us-gaap_RealizedInvestmentGainsLosses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_lbl" xml:lang="en-US">Gain on sale&#8212;Canadian ETF business, including remeasurement of contingent consideration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_lbl0" xml:lang="en-US">Recognized a gain</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl" xml:lang="en-US">Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashIncomeExpense" xlink:to="us-gaap_OtherNoncashIncomeExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_IncreaseDecreaseInGoldAndOtherPreciousMetals" xlink:href="wt-20231231.xsd#wt_IncreaseDecreaseInGoldAndOtherPreciousMetals"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wt_IncreaseDecreaseInGoldAndOtherPreciousMetals_lbl" xml:lang="en-US">Gold and other precious metals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncreaseDecreaseInGoldAndOtherPreciousMetals" xlink:to="wt_IncreaseDecreaseInGoldAndOtherPreciousMetals_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xml:lang="en-US">Other assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:href="wt-20231231.xsd#wt_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wt_IncreaseDecreaseInOperatingLeaseLiabilities_lbl" xml:lang="en-US">Operating lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="wt_IncreaseDecreaseInOperatingLeaseLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_PurchaseOfFinancialInstrumentsOwnedAtFairValue" xlink:href="wt-20231231.xsd#wt_PurchaseOfFinancialInstrumentsOwnedAtFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wt_PurchaseOfFinancialInstrumentsOwnedAtFairValue_lbl" xml:lang="en-US">Purchase of financial instruments owned, at fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PurchaseOfFinancialInstrumentsOwnedAtFairValue" xlink:to="wt_PurchaseOfFinancialInstrumentsOwnedAtFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_PurchaseOfInvestments" xlink:href="wt-20231231.xsd#wt_PurchaseOfInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wt_PurchaseOfInvestments_lbl" xml:lang="en-US">Purchase of investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PurchaseOfInvestments" xlink:to="wt_PurchaseOfInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_lbl" xml:lang="en-US">Cash paid&#8212;software development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:to="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherPaymentsToAcquireBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPaymentsToAcquireBusinesses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherPaymentsToAcquireBusinesses_lbl" xml:lang="en-US">Cash paid&#8212;acquisition of Securrency Transfers, Inc. (net of cash acquired)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPaymentsToAcquireBusinesses" xlink:to="us-gaap_OtherPaymentsToAcquireBusinesses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of fixed assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_PaymentOfDeferredConsideration" xlink:href="wt-20231231.xsd#wt_PaymentOfDeferredConsideration"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wt_PaymentOfDeferredConsideration_lbl" xml:lang="en-US">Termination of deferred consideration&#8212;gold payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PaymentOfDeferredConsideration" xlink:to="wt_PaymentOfDeferredConsideration_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividends"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDividends_lbl" xml:lang="en-US">Dividends paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividends" xlink:to="us-gaap_PaymentsOfDividends_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl" xml:lang="en-US">Shares repurchased</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_PaymentOfConvertibleNotesIssuanceCosts" xlink:href="wt-20231231.xsd#wt_PaymentOfConvertibleNotesIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wt_PaymentOfConvertibleNotesIssuanceCosts_lbl" xml:lang="en-US">Issuance costs&#8212;convertible notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PaymentOfConvertibleNotesIssuanceCosts" xlink:to="wt_PaymentOfConvertibleNotesIssuanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xml:lang="en-US">Issuance costs&#8212;Series C Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_CommonStock001ParValueMember" xlink:href="wt-20231231.xsd#wt_CommonStock001ParValueMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_CommonStock001ParValueMember_lbl" xml:lang="en-US">Common Stock, $0.01 par value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_CommonStock001ParValueMember" xlink:to="wt_CommonStock001ParValueMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_PreferredStockPurchaseRightsMember" xlink:href="wt-20231231.xsd#wt_PreferredStockPurchaseRightsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_PreferredStockPurchaseRightsMember_lbl" xml:lang="en-US">Preferred Stock Purchase Rights</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PreferredStockPurchaseRightsMember" xlink:to="wt_PreferredStockPurchaseRightsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_WisdomtreeETFMember" xlink:href="wt-20231231.xsd#wt_WisdomtreeETFMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_WisdomtreeETFMember_lbl" xml:lang="en-US">WisdomTree ETF</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_WisdomtreeETFMember" xlink:to="wt_WisdomtreeETFMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyMember_lbl" xml:lang="en-US">Related Party</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyMember" xlink:to="us-gaap_RelatedPartyMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RelatedPartyMember_lbl0" xml:lang="en-US">Related Party [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyMember" xlink:to="us-gaap_RelatedPartyMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xml:lang="en-US">Series A Non-Voting Convertible</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl0" xml:lang="en-US">Series A Preferred Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember_lbl" xml:lang="en-US">Advisory fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember" xlink:to="us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember_lbl0" xml:lang="en-US">Advisory fees [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember" xlink:to="us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_OtherServicesIncomeMember" xlink:href="wt-20231231.xsd#wt_OtherServicesIncomeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_OtherServicesIncomeMember_lbl" xml:lang="en-US">Other income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_OtherServicesIncomeMember" xlink:to="wt_OtherServicesIncomeMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="wt_OtherServicesIncomeMember_lbl0" xml:lang="en-US">Other [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_OtherServicesIncomeMember" xlink:to="wt_OtherServicesIncomeMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl" xml:lang="en-US">Series C</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesCPreferredStockMember" xlink:to="us-gaap_SeriesCPreferredStockMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl0" xml:lang="en-US">Series C Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesCPreferredStockMember" xlink:to="us-gaap_SeriesCPreferredStockMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockMember_lbl0" xml:lang="en-US">Preferred Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_PreferredStockMember_lbl1" xml:lang="en-US">Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockMember_lbl0" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-In Capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">Accumulated Other Comprehensive Income/(Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">(Accumulated Deficit)/Retained Earnings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xml:lang="en-US">Organization and Description of Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Significant Accounting Policies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of Depreciation and Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl0" xml:lang="en-US">Schedule of Fixed Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Estimated useful lives</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsDisclosureTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US">Fair Value Measurements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xml:lang="en-US">Schedule of Assets and Liabilities Measured at Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_RecurringFairValueMeasurementsAbstract" xlink:href="wt-20231231.xsd#wt_RecurringFairValueMeasurementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_RecurringFairValueMeasurementsAbstract_lbl" xml:lang="en-US">Recurring fair value measurements:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RecurringFairValueMeasurementsAbstract" xlink:to="wt_RecurringFairValueMeasurementsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xml:lang="en-US">Cash equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_FinancialInstrumentsOwnedAtFairValueAbstract0" xlink:href="wt-20231231.xsd#wt_FinancialInstrumentsOwnedAtFairValueAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_FinancialInstrumentsOwnedAtFairValueAbstract0_lbl" xml:lang="en-US">Financial instruments owned, at fair value:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FinancialInstrumentsOwnedAtFairValueAbstract0" xlink:to="wt_FinancialInstrumentsOwnedAtFairValueAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_OtherAssetsSeedCapitalWisdomtreeDigitalFundsAbstract" xlink:href="wt-20231231.xsd#wt_OtherAssetsSeedCapitalWisdomtreeDigitalFundsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_OtherAssetsSeedCapitalWisdomtreeDigitalFundsAbstract_lbl" xml:lang="en-US">Other assets&#8212;seed capital (WisdomTree Digital Funds):</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_OtherAssetsSeedCapitalWisdomtreeDigitalFundsAbstract" xlink:to="wt_OtherAssetsSeedCapitalWisdomtreeDigitalFundsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_NonRecurringFairValueMeasurementsAbstract" xlink:href="wt-20231231.xsd#wt_NonRecurringFairValueMeasurementsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_NonRecurringFairValueMeasurementsAbstract_lbl" xml:lang="en-US">Non-recurring fair value measurements:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_NonRecurringFairValueMeasurementsAbstract" xlink:to="wt_NonRecurringFairValueMeasurementsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentOwnedAtFairValue_lbl" xml:lang="en-US">Non-recurring fair value measurements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedAtFairValue" xlink:to="us-gaap_InvestmentOwnedAtFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_AssetsAbstract0" xlink:href="wt-20231231.xsd#wt_AssetsAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_AssetsAbstract0_lbl" xml:lang="en-US">Assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_AssetsAbstract0" xlink:to="wt_AssetsAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_RecurringFairValueMeasurementsAbstract0" xlink:href="wt-20231231.xsd#wt_RecurringFairValueMeasurementsAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_RecurringFairValueMeasurementsAbstract0_lbl" xml:lang="en-US">Recurring fair value measurements:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RecurringFairValueMeasurementsAbstract0" xlink:to="wt_RecurringFairValueMeasurementsAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_FinancialInstrumentsOwnedAtFairValueAbstract0Alt0" xlink:href="wt-20231231.xsd#wt_FinancialInstrumentsOwnedAtFairValueAbstract0Alt0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_FinancialInstrumentsOwnedAtFairValueAbstract0Alt0_lbl" xml:lang="en-US">Financial instruments owned, at fair value:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FinancialInstrumentsOwnedAtFairValueAbstract0Alt0" xlink:to="wt_FinancialInstrumentsOwnedAtFairValueAbstract0Alt0_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentsFairValueDisclosure_lbl" xml:lang="en-US">Investments in Convertible Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsFairValueDisclosure" xlink:to="us-gaap_InvestmentsFairValueDisclosure_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_NonRecurringFairValueMeasurementsAbstract0" xlink:href="wt-20231231.xsd#wt_NonRecurringFairValueMeasurementsAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_NonRecurringFairValueMeasurementsAbstract0_lbl" xml:lang="en-US">Non-recurring fair value measurements:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_NonRecurringFairValueMeasurementsAbstract0" xlink:to="wt_NonRecurringFairValueMeasurementsAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_UnlabeledAbstract" xlink:href="wt-20231231.xsd#wt_UnlabeledAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_UnlabeledAbstract_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_UnlabeledAbstract" xlink:to="wt_UnlabeledAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_RecurringFairValueMeasurementsAbstract1" xlink:href="wt-20231231.xsd#wt_RecurringFairValueMeasurementsAbstract1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_RecurringFairValueMeasurementsAbstract1_lbl" xml:lang="en-US">Recurring fair value measurements:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RecurringFairValueMeasurementsAbstract1" xlink:to="wt_RecurringFairValueMeasurementsAbstract1_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_BusinessCombinationDeferredConsiderationLiability" xlink:href="wt-20231231.xsd#wt_BusinessCombinationDeferredConsiderationLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_BusinessCombinationDeferredConsiderationLiability_lbl" xml:lang="en-US">Deferred consideration (Note 9)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_BusinessCombinationDeferredConsiderationLiability" xlink:to="wt_BusinessCombinationDeferredConsiderationLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xml:lang="en-US">Schedule of Beginning and Ending Balances of Recurring Fair Value Measurements Classified</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_lbl" xml:lang="en-US">Purchases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales_lbl" xml:lang="en-US">Settlements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions" xlink:href="wt-20231231.xsd#wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions_lbl" xml:lang="en-US">Conversions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions" xlink:to="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome" xlink:href="wt-20231231.xsd#wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome_lbl" xml:lang="en-US">Net realized gains/(losses)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome" xlink:to="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredConsiderationNote7Abstract" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationNote7Abstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_DeferredConsiderationNote7Abstract_lbl" xml:lang="en-US">Deferred Consideration (Note 7):</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredConsiderationNote7Abstract" xlink:to="wt_DeferredConsiderationNote7Abstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings" xlink:href="wt-20231231.xsd#wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings_lbl" xml:lang="en-US">Net unrealized gains</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings" xlink:to="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FinancialInstrumentsDisclosureTextBlock_lbl" xml:lang="en-US">Financial instruments owned</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:to="us-gaap_FinancialInstrumentsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock_lbl" xml:lang="en-US">Schedule of Financial Instruments Owned</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock" xlink:to="us-gaap_ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_FinancialInstrumentsOwnedAbstract" xlink:href="wt-20231231.xsd#wt_FinancialInstrumentsOwnedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_FinancialInstrumentsOwnedAbstract_lbl" xml:lang="en-US">Financial instruments owned:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FinancialInstrumentsOwnedAbstract" xlink:to="wt_FinancialInstrumentsOwnedAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_HeldToMaturitySecuritiesTextBlock_lbl" xml:lang="en-US">Securities Held-to-Maturity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesTextBlock" xlink:to="us-gaap_HeldToMaturitySecuritiesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl" xml:lang="en-US">Schedule of Securities Held-to-Maturity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xml:lang="en-US">Debt instruments: Pass-through GSEs (amortized cost)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl0" xml:lang="en-US">Cost/amortized cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_lbl" xml:lang="en-US">Schedule of Unrealized Losses, Gains and Fair Value of Securities Held-to-Maturity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:to="us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_lbl" xml:lang="en-US">Gross unrealized gains</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_HeldToMaturitySecuritiesFairValue_lbl" xml:lang="en-US">Fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesFairValue" xlink:to="us-gaap_HeldToMaturitySecuritiesFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl" xml:lang="en-US">Schedule of Maturity Profile of the Securities Held-to-Maturity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount_lbl" xml:lang="en-US">Due within one year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount_lbl" xml:lang="en-US">Due one year through five years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount_lbl" xml:lang="en-US">Due five years through ten years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount_lbl" xml:lang="en-US">Due over ten years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentTextBlock_lbl" xml:lang="en-US">Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTextBlock" xlink:to="us-gaap_InvestmentTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentTableTextBlock_lbl" xml:lang="en-US">Schedule of Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTableTextBlock" xlink:to="us-gaap_InvestmentTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_SecurrencyIncAbstract" xlink:href="wt-20231231.xsd#wt_SecurrencyIncAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_SecurrencyIncAbstract_lbl" xml:lang="en-US">Securrency, Inc.:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SecurrencyIncAbstract" xlink:to="wt_SecurrencyIncAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedAtCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentOwnedAtCost_lbl" xml:lang="en-US">Cost of investment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedAtCost" xlink:to="us-gaap_InvestmentOwnedAtCost_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_FnalityInternationalLimitedAbstract" xlink:href="wt-20231231.xsd#wt_FnalityInternationalLimitedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_FnalityInternationalLimitedAbstract_lbl" xml:lang="en-US">Fnality International Limited:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FnalityInternationalLimitedAbstract" xlink:to="wt_FnalityInternationalLimitedAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl" xml:lang="en-US">Schedule of Backsolve Valuation Approach</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Expected volatility</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Time to exit (in years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ProbabilityThatSeriesB2PreferenceSharesCovertIntoSeriesB1PreferenceShares" xlink:href="wt-20231231.xsd#wt_ProbabilityThatSeriesB2PreferenceSharesCovertIntoSeriesB1PreferenceShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ProbabilityThatSeriesB2PreferenceSharesCovertIntoSeriesB1PreferenceShares_lbl" xml:lang="en-US">Probability that Series B-2 Preference Shares convert into Series B-1 Preference Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ProbabilityThatSeriesB2PreferenceSharesCovertIntoSeriesB1PreferenceShares" xlink:to="wt_ProbabilityThatSeriesB2PreferenceSharesCovertIntoSeriesB1PreferenceShares_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfCondensedFinancialStatementsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock_lbl" xml:lang="en-US">Schedule of Presents the Probability Ascribed to Potential Outcomes Used in the Pwerm</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock" xlink:to="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ConversionOfNotesUponAFutureEquityFinancing" xlink:href="wt-20231231.xsd#wt_ConversionOfNotesUponAFutureEquityFinancing"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ConversionOfNotesUponAFutureEquityFinancing_lbl" xml:lang="en-US">Conversion of note upon a future equity financing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConversionOfNotesUponAFutureEquityFinancing" xlink:to="wt_ConversionOfNotesUponAFutureEquityFinancing_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_RedemptionOfNoteUponACorporateTransaction" xlink:href="wt-20231231.xsd#wt_RedemptionOfNoteUponACorporateTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_RedemptionOfNoteUponACorporateTransaction_lbl" xml:lang="en-US">Redemption of note upon a corporate transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RedemptionOfNoteUponACorporateTransaction" xlink:to="wt_RedemptionOfNoteUponACorporateTransaction_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_FairValueAssumptionOfDissolutionRate" xlink:href="wt-20231231.xsd#wt_FairValueAssumptionOfDissolutionRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_FairValueAssumptionOfDissolutionRate_lbl" xml:lang="en-US">Default</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FairValueAssumptionOfDissolutionRate" xlink:to="wt_FairValueAssumptionOfDissolutionRate_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_TimeToPotentialOutcomeinYear" xlink:href="wt-20231231.xsd#wt_TimeToPotentialOutcomeinYear"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_TimeToPotentialOutcomeinYear_lbl" xml:lang="en-US">Time to potential outcome (in years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_TimeToPotentialOutcomeinYear" xlink:to="wt_TimeToPotentialOutcomeinYear_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ConversionOfNoteUponAFutureFinancingRound" xlink:href="wt-20231231.xsd#wt_ConversionOfNoteUponAFutureFinancingRound"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ConversionOfNoteUponAFutureFinancingRound_lbl" xml:lang="en-US">Conversion of note upon a future financing round</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConversionOfNoteUponAFutureFinancingRound" xlink:to="wt_ConversionOfNoteUponAFutureFinancingRound_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_RedemptionOfNoteUponAChangeOfControl" xlink:href="wt-20231231.xsd#wt_RedemptionOfNoteUponAChangeOfControl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_RedemptionOfNoteUponAChangeOfControl_lbl" xml:lang="en-US">Redemption of note upon a change of control</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RedemptionOfNoteUponAChangeOfControl" xlink:to="wt_RedemptionOfNoteUponAChangeOfControl_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_Default" xlink:href="wt-20231231.xsd#wt_Default"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_Default_lbl" xml:lang="en-US">Default</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_Default" xlink:to="wt_Default_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_TimeToPotentialOutcomesinYears" xlink:href="wt-20231231.xsd#wt_TimeToPotentialOutcomesinYears"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_TimeToPotentialOutcomesinYears_lbl" xml:lang="en-US">Time to potential outcome (in years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_TimeToPotentialOutcomesinYears" xlink:to="wt_TimeToPotentialOutcomesinYears_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Fixed Assets, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredConsiderationTextBlock" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_DeferredConsiderationTextBlock_lbl" xml:lang="en-US">Deferred Consideration&#8212;gold payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredConsiderationTextBlock" xlink:to="wt_DeferredConsiderationTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_DisclosureOfValuationOfDeferredConsiderationTableTextBlock" xlink:href="wt-20231231.xsd#wt_DisclosureOfValuationOfDeferredConsiderationTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_DisclosureOfValuationOfDeferredConsiderationTableTextBlock_lbl" xml:lang="en-US">Schedule of Valuation of Deferred Consideration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DisclosureOfValuationOfDeferredConsiderationTableTextBlock" xlink:to="wt_DisclosureOfValuationOfDeferredConsiderationTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ForwardsLookingGoldPrice" xlink:href="wt-20231231.xsd#wt_ForwardsLookingGoldPrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ForwardsLookingGoldPrice_lbl" xml:lang="en-US">Forward Looking Gold Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ForwardsLookingGoldPrice" xlink:to="wt_ForwardsLookingGoldPrice_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_BusinessCombinationConsiderationTransferredDeferredPaymentInterest" xlink:href="wt-20231231.xsd#wt_BusinessCombinationConsiderationTransferredDeferredPaymentInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_BusinessCombinationConsiderationTransferredDeferredPaymentInterest_lbl" xml:lang="en-US">Discount rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_BusinessCombinationConsiderationTransferredDeferredPaymentInterest" xlink:to="wt_BusinessCombinationConsiderationTransferredDeferredPaymentInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredConsiderationPerpetualGrowthRate" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationPerpetualGrowthRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_DeferredConsiderationPerpetualGrowthRate_lbl" xml:lang="en-US">Perpetual growth rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredConsiderationPerpetualGrowthRate" xlink:to="wt_DeferredConsiderationPerpetualGrowthRate_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfDeferredConsiderationTableTextBlock" xlink:href="wt-20231231.xsd#wt_ScheduleOfDeferredConsiderationTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ScheduleOfDeferredConsiderationTableTextBlock_lbl" xml:lang="en-US">Schedule of Deferred Consideration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfDeferredConsiderationTableTextBlock" xlink:to="wt_ScheduleOfDeferredConsiderationTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ContractualGoldPaymentgoldOuncesPaid" xlink:href="wt-20231231.xsd#wt_ContractualGoldPaymentgoldOuncesPaid"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ContractualGoldPaymentgoldOuncesPaid_lbl" xml:lang="en-US">Contractual gold payments&#8212;gold ounces paid (in Ounces)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ContractualGoldPaymentgoldOuncesPaid" xlink:to="wt_ContractualGoldPaymentgoldOuncesPaid_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Convertible Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock_lbl" xml:lang="en-US">Schedule of Key Terms of Convertible Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Principal outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl0" xml:lang="en-US">Principal amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Maturity date (unless earlier converted, repurchased or redeemed)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl0" xml:lang="en-US">Convertible debt, maturity date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US">Conversion price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1_lbl" xml:lang="en-US">Conversion rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionRatio1_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1_lbl0" xml:lang="en-US">Conversion price ratio</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionRatio1_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_DebtInstrumentRedemptionPrice" xlink:href="wt-20231231.xsd#wt_DebtInstrumentRedemptionPrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_DebtInstrumentRedemptionPrice_lbl" xml:lang="en-US">Redemption price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DebtInstrumentRedemptionPrice" xlink:to="wt_DebtInstrumentRedemptionPrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertibleDebtTableTextBlock_lbl" xml:lang="en-US">Schedule of Convertible Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtTableTextBlock" xlink:to="us-gaap_ConvertibleDebtTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentUnamortizedPremium_lbl" xml:lang="en-US">Plus: Premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="us-gaap_DebtInstrumentUnamortizedPremium_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xml:lang="en-US">Gross proceeds</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US">Carrying amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xml:lang="en-US">Effective interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockTextBlock_lbl" xml:lang="en-US">Series A Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockTextBlock" xlink:to="us-gaap_PreferredStockTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPreferredUnitsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPreferredUnitsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfPreferredUnitsTextBlock_lbl" xml:lang="en-US">Schedule of Series A Preferred Stock Balance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPreferredUnitsTextBlock" xlink:to="us-gaap_ScheduleOfPreferredUnitsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockDividendsPerShareDeclared"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockDividendsPerShareDeclared_lbl" xml:lang="en-US">Cash dividends declared per share (quarterly) (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendsPerShareDeclared" xlink:to="us-gaap_PreferredStockDividendsPerShareDeclared_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_OtherPayablesTextBlock" xlink:href="wt-20231231.xsd#wt_OtherPayablesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_OtherPayablesTextBlock_lbl" xml:lang="en-US">Payable to Gold Bullion Holdings Jersey Limited GBH</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_OtherPayablesTextBlock" xlink:to="wt_OtherPayablesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfAggregateConsiderationPayableTableTextBlock" xlink:href="wt-20231231.xsd#wt_ScheduleOfAggregateConsiderationPayableTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ScheduleOfAggregateConsiderationPayableTableTextBlock_lbl" xml:lang="en-US">Schedule of Aggregate Consideration Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfAggregateConsiderationPayableTableTextBlock" xlink:to="wt_ScheduleOfAggregateConsiderationPayableTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermNotesPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LongTermNotesPayable_lbl" xml:lang="en-US">Long-term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">Leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US">Schedule of Additional Information Related to Operating Lease</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseCostAbstract_lbl" xml:lang="en-US">Lease cost:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_LeaseCostAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Operating lease cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermLeaseCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShortTermLeaseCost_lbl" xml:lang="en-US">Short-term lease cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermLeaseCost" xlink:to="us-gaap_ShortTermLeaseCost_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LeaseCost_lbl" xml:lang="en-US">Total lease cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_OtherInformationAbstract" xlink:href="wt-20231231.xsd#wt_OtherInformationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_OtherInformationAbstract_lbl" xml:lang="en-US">Other information:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_OtherInformationAbstract" xlink:to="wt_OtherInformationAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Cash paid for amounts included in the measurement of operating liabilities (operating leases)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xml:lang="en-US">Right-of-use assets obtained in exchange for new operating lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Weighted-average remaining lease term (in years)&#8212;operating leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Weighted-average discount rate&#8212;operating leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Schedule of Future Minimum Lease Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2024</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2025</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2026</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">2027</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">2028</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US">2029 and thereafter</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock" xlink:href="wt-20231231.xsd#wt_ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock_lbl" xml:lang="en-US">Schedule of Reconciliation of Future Minimum Lease Payments to Balance Sheet</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock" xlink:to="wt_ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">Difference between undiscounted and discounted cash flows</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LossContingencyDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDisclosures"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LossContingencyDisclosures_lbl" xml:lang="en-US">Contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyDisclosures" xlink:to="us-gaap_LossContingencyDisclosures_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_VariableInterestEntityDisclosureTextBlock_lbl" xml:lang="en-US">Variable Interest Entities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:to="us-gaap_VariableInterestEntityDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_lbl" xml:lang="en-US">Schedule of Information about Variable Interests</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_CarryingAmountAssetsSecurrencyAbstract" xlink:href="wt-20231231.xsd#wt_CarryingAmountAssetsSecurrencyAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_CarryingAmountAssetsSecurrencyAbstract_lbl" xml:lang="en-US">Carrying Amount&#8212;Assets (Securrency):</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_CarryingAmountAssetsSecurrencyAbstract" xlink:to="wt_CarryingAmountAssetsSecurrencyAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_CarryingAmountAssetsFnalityAbstract" xlink:href="wt-20231231.xsd#wt_CarryingAmountAssetsFnalityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_CarryingAmountAssetsFnalityAbstract_lbl" xml:lang="en-US">Carrying Amount&#8212;Assets (Fnality):</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_CarryingAmountAssetsFnalityAbstract" xlink:to="wt_CarryingAmountAssetsFnalityAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl" xml:lang="en-US">Revenues from Contracts with Customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock" xlink:href="wt-20231231.xsd#wt_SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock_lbl" xml:lang="en-US">Schedule of Revenues from Contracts with Customers</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock" xlink:to="wt_SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_lbl" xml:lang="en-US">Schedule of Geographic Distribution of Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_RevenuesFromContractsWithCustomersAbstract" xlink:href="wt-20231231.xsd#wt_RevenuesFromContractsWithCustomersAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_RevenuesFromContractsWithCustomersAbstract_lbl" xml:lang="en-US">Revenues from contracts with customers:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RevenuesFromContractsWithCustomersAbstract" xlink:to="wt_RevenuesFromContractsWithCustomersAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related Party Transactions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock" xlink:href="wt-20231231.xsd#wt_ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock_lbl" xml:lang="en-US">Schedule of Accounts Receivable from Related Parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock" xlink:to="wt_ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Revenues from Advisory Services Provided to Related Parties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Stock-Based Awards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock" xlink:href="wt-20231231.xsd#wt_ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock_lbl" xml:lang="en-US">Schedule of Unrecognized Stock-Based Compensation Expense and Average Remaining Vesting Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock" xlink:to="wt_ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US">Unrecognized Stock-Based Compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Weighted-Average Remaining Vesting Period (Years)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Restricted Stock Activity and Restricted Stock Unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US">Granted, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Granted, Weighted Average Grant Date Fair Value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Vested, Weighted Average Grant Date Fair Value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Forfeited, Weighted Average Grant Date Fair Value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockDividendsShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockDividendsShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockDividendsShares_lbl" xml:lang="en-US">Stock dividends, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockDividendsShares" xlink:to="us-gaap_StockDividendsShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsPayableAmountPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DividendsPayableAmountPerShare_lbl" xml:lang="en-US">Stock dividends, Weighted Average Grant Date Fair Value (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableAmountPerShare" xlink:to="us-gaap_DividendsPayableAmountPerShare_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Share Based Payment Awards Other than Options Valuation Assumptions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xml:lang="en-US">Historical stock price volatility (low)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xml:lang="en-US">Historical stock price volatility (high)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl" xml:lang="en-US">Historical stock price volatility (average)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk free interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Expected dividend yield</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_DisclosureOfStockholderRightsPlanTextBlock" xlink:href="wt-20231231.xsd#wt_DisclosureOfStockholderRightsPlanTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_DisclosureOfStockholderRightsPlanTextBlock_lbl" xml:lang="en-US">Stockholder Rights Plan</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DisclosureOfStockholderRightsPlanTextBlock" xlink:to="wt_DisclosureOfStockholderRightsPlanTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xml:lang="en-US">Employee Benefit Plans</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_lbl" xml:lang="en-US">Summary of Discretionary Contributions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xml:lang="en-US">Discretionary contributions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">Earnings Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of Reconciliation of Basic and Diluted Earnings Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_BasicEarningsPerShareAbstract" xlink:href="wt-20231231.xsd#wt_BasicEarningsPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_BasicEarningsPerShareAbstract_lbl" xml:lang="en-US">Basic Earnings per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_BasicEarningsPerShareAbstract" xlink:to="wt_BasicEarningsPerShareAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl" xml:lang="en-US">Add: Gain on redemption of Series C Non-Voting Convertible Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl0" xml:lang="en-US">Recognized redemption (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net income available to common stockholders&#8212;Basic EPS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_DilutedEarningsPerShareAbstract" xlink:href="wt-20231231.xsd#wt_DilutedEarningsPerShareAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_DilutedEarningsPerShareAbstract_lbl" xml:lang="en-US">Diluted Earnings per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DilutedEarningsPerShareAbstract" xlink:to="wt_DilutedEarningsPerShareAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xml:lang="en-US">Net income available to common stockholders&#8212;Diluted EPS</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_WeightedAverageDilutedSharesInThousandsAbstract" xlink:href="wt-20231231.xsd#wt_WeightedAverageDilutedSharesInThousandsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_WeightedAverageDilutedSharesInThousandsAbstract_lbl" xml:lang="en-US">Weighted Average Diluted Shares (in thousands):</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_WeightedAverageDilutedSharesInThousandsAbstract" xlink:to="wt_WeightedAverageDilutedSharesInThousandsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xml:lang="en-US">Dilutive effect of common stock equivalents, excluding participating securities (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities" xlink:href="wt-20231231.xsd#wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities_lbl" xml:lang="en-US">Weighted average diluted shares, excluding participating securities (in thousands) (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities" xlink:to="wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities_lbl0" xml:lang="en-US">Weighted average diluted shares used to calculate diluted earnings/(loss) per share as disclosed in the table above</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities" xlink:to="wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl" xml:lang="en-US">Schedule of Weighted Average Number of Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_LessParticipatingSecuritiesAbstract" xlink:href="wt-20231231.xsd#wt_LessParticipatingSecuritiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_LessParticipatingSecuritiesAbstract_lbl" xml:lang="en-US">Less: Participating securities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_LessParticipatingSecuritiesAbstract" xlink:to="wt_LessParticipatingSecuritiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares" xlink:href="wt-20231231.xsd#wt_WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares_lbl" xml:lang="en-US">Weighted average shares of common stock issuable upon conversion of the Preferred Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares" xlink:to="wt_WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_PotentiallyDilutiveRestrictedStockAwards" xlink:href="wt-20231231.xsd#wt_PotentiallyDilutiveRestrictedStockAwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_PotentiallyDilutiveRestrictedStockAwards_lbl" xml:lang="en-US">Potentially dilutive restricted stock awards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PotentiallyDilutiveRestrictedStockAwards" xlink:to="wt_PotentiallyDilutiveRestrictedStockAwards_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xml:lang="en-US">Schedule of Domestic and Foreign Components of Income before Income Tax Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xml:lang="en-US">Schedule of Components of Current and Deferred Income Tax Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US">Current:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Federal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">State and local</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xml:lang="en-US">Foreign</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xml:lang="en-US">Deferred:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Federal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">State and local</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Foreign</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of Reconciliation of Statutory Federal Income Tax Rate and Company&apos;s Effective Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">U.S. federal statutory income tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xml:lang="en-US">Stock-based compensation tax shortfalls</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets" xlink:href="wt-20231231.xsd#wt_EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets_lbl" xml:lang="en-US">Change in tax-related indemnification assets, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets" xlink:to="wt_EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ChangeInForeignNetOperatingLosses" xlink:href="wt-20231231.xsd#wt_ChangeInForeignNetOperatingLosses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ChangeInForeignNetOperatingLosses_lbl" xml:lang="en-US">Change in foreign net operating losses (&#8220;NOLs&#8221;)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ChangeInForeignNetOperatingLosses" xlink:to="wt_ChangeInForeignNetOperatingLosses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xml:lang="en-US">Blended state income tax rate, net of federal benefit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in valuation allowance&#8212;Foreign NOLs and interest carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">European net operating losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount_lbl" xml:lang="en-US">GILTI</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xml:lang="en-US">Other differences, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock" xlink:href="wt-20231231.xsd#wt_SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock_lbl" xml:lang="en-US">Schedule of Income Tax Payments By Jurisdiction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock" xlink:to="wt_SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_lbl" xml:lang="en-US">State and local</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Components of the Company&#8217;s Deferred Tax Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsGrossAbstract_lbl" xml:lang="en-US">Deferred tax assets:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsGrossAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_lbl" xml:lang="en-US">Capital losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl" xml:lang="en-US">Accrued expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xml:lang="en-US">Stock-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl" xml:lang="en-US">NOLs&#8212;Foreign</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl" xml:lang="en-US">Goodwill and intangible assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredTaxAssetUnrealizedLosses" xlink:href="wt-20231231.xsd#wt_DeferredTaxAssetUnrealizedLosses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_DeferredTaxAssetUnrealizedLosses_lbl" xml:lang="en-US">Unrealized losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredTaxAssetUnrealizedLosses" xlink:to="wt_DeferredTaxAssetUnrealizedLosses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_lbl" xml:lang="en-US">Foreign currency translation adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:to="us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredTaxAssetOperatingLossCarryForwardUnitedStates" xlink:href="wt-20231231.xsd#wt_DeferredTaxAssetOperatingLossCarryForwardUnitedStates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_DeferredTaxAssetOperatingLossCarryForwardUnitedStates_lbl" xml:lang="en-US">NOLs&#8212;U.S.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredTaxAssetOperatingLossCarryForwardUnitedStates" xlink:to="wt_DeferredTaxAssetOperatingLossCarryForwardUnitedStates_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:href="wt-20231231.xsd#wt_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_DeferredTaxAssetsOperatingLeaseLiabilities_lbl" xml:lang="en-US">Operating lease liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:to="wt_DeferredTaxAssetsOperatingLeaseLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xml:lang="en-US">Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_UnlabeledAbstract0" xlink:href="wt-20231231.xsd#wt_UnlabeledAbstract0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_UnlabeledAbstract0_lbl" xml:lang="en-US"></label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_UnlabeledAbstract0" xlink:to="wt_UnlabeledAbstract0_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl" xml:lang="en-US">Deferred tax liabilities:</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses" xlink:href="wt-20231231.xsd#wt_DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses_lbl" xml:lang="en-US">Fixed assets and prepaid assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses" xlink:to="wt_DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_lbl" xml:lang="en-US">Unremitted earnings&#8212;European subsidiaries</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:to="us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_lbl0" xml:lang="en-US">Deferred tax liabilities and earnings of foreign subsidaries</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:to="us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredTaxLiabilitiesRightOfUseAssets" xlink:href="wt-20231231.xsd#wt_DeferredTaxLiabilitiesRightOfUseAssets"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_DeferredTaxLiabilitiesRightOfUseAssets_lbl" xml:lang="en-US">Right of use assets&#8212;operating leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredTaxLiabilitiesRightOfUseAssets" xlink:to="wt_DeferredTaxLiabilitiesRightOfUseAssets_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xml:lang="en-US">Schedule of Changes in Balance of Gross Unrecognized Tax Benefits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xml:lang="en-US">Increases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation" xlink:href="wt-20231231.xsd#wt_UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation_lbl" xml:lang="en-US">Foreign currency translation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation" xlink:to="wt_UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TreasuryStockTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TreasuryStockTextBlock_lbl" xml:lang="en-US">Shares Repurchased</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockTextBlock" xlink:to="us-gaap_TreasuryStockTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Goodwill and Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xml:lang="en-US">Schedule of Goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="us-gaap_ScheduleOfGoodwillTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease_lbl" xml:lang="en-US">Changes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillPeriodIncreaseDecrease" xlink:to="us-gaap_GoodwillPeriodIncreaseDecrease_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xml:lang="en-US">Schedule of Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill_lbl" xml:lang="en-US">Gross Asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsGrossExcludingGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Net Asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US">Schedule of Expected Amortization Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">2024</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">2025</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US">2026</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US">2027</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xml:lang="en-US">2028</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl" xml:lang="en-US">2029 and thereafter</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ContingentPaymentTextBlock" xlink:href="wt-20231231.xsd#wt_ContingentPaymentTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ContingentPaymentTextBlock_lbl" xml:lang="en-US">Contingent Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ContingentPaymentTextBlock" xlink:to="wt_ContingentPaymentTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetImpairmentChargesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentChargesTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetImpairmentChargesTextBlock_lbl" xml:lang="en-US">Impairments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetImpairmentChargesTextBlock" xlink:to="us-gaap_AssetImpairmentChargesTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock_lbl" xml:lang="en-US">Schedule of Summarizes Impairments Recognized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" xlink:to="us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestructuringCostsAndAssetImpairmentCharges_lbl" xml:lang="en-US">Total</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:to="us-gaap_RestructuringCostsAndAssetImpairmentCharges_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xml:lang="en-US">Gross unrealized losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less: accumulated depreciation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xml:lang="en-US">Less: Unamortized issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Less: Issuance costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US">Vested, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US">Forfeited, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeDistributedToParticipatingSecurities" xlink:href="wt-20231231.xsd#wt_IncomeDistributedToParticipatingSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wt_IncomeDistributedToParticipatingSecurities_lbl" xml:lang="en-US">Less: Income distributed to participating securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncomeDistributedToParticipatingSecurities" xlink:to="wt_IncomeDistributedToParticipatingSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_lbl" xml:lang="en-US">Less: Undistributed income allocable to participating securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:to="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_UndistributedIncomeAllocableToParticipatingSecurities" xlink:href="wt-20231231.xsd#wt_UndistributedIncomeAllocableToParticipatingSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wt_UndistributedIncomeAllocableToParticipatingSecurities_lbl" xml:lang="en-US">Add back: Undistributed income allocable to participating securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_UndistributedIncomeAllocableToParticipatingSecurities" xlink:to="wt_UndistributedIncomeAllocableToParticipatingSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_lbl" xml:lang="en-US">Less: Reallocation of undistributed income allocable to participating securities considered potentially dilutive</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:to="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration" xlink:href="wt-20231231.xsd#wt_IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wt_IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration_lbl" xml:lang="en-US">Gain on revaluation/termination of deferred consideration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration" xlink:to="wt_IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_NondeductibleLossOnExtinguishmentOfConvertibleNotes" xlink:href="wt-20231231.xsd#wt_NondeductibleLossOnExtinguishmentOfConvertibleNotes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wt_NondeductibleLossOnExtinguishmentOfConvertibleNotes_lbl" xml:lang="en-US">Non-deductible loss on extinguishment of convertible notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_NondeductibleLossOnExtinguishmentOfConvertibleNotes" xlink:to="wt_NondeductibleLossOnExtinguishmentOfConvertibleNotes_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxReconciliationInternationalOperations" xlink:href="wt-20231231.xsd#wt_IncomeTaxReconciliationInternationalOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wt_IncomeTaxReconciliationInternationalOperations_lbl" xml:lang="en-US">Foreign operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncomeTaxReconciliationInternationalOperations" xlink:to="wt_IncomeTaxReconciliationInternationalOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense" xlink:href="wt-20231231.xsd#wt_IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wt_IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense_lbl" xml:lang="en-US">Non-deductible executive compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense" xlink:to="wt_IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxReconciliationUnrecognizedTaxBenefits" xlink:href="wt-20231231.xsd#wt_IncomeTaxReconciliationUnrecognizedTaxBenefits"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wt_IncomeTaxReconciliationUnrecognizedTaxBenefits_lbl" xml:lang="en-US">Decrease in unrecognized tax benefits, net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncomeTaxReconciliationUnrecognizedTaxBenefits" xlink:to="wt_IncomeTaxReconciliationUnrecognizedTaxBenefits_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses" xlink:href="wt-20231231.xsd#wt_IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wt_IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses_lbl" xml:lang="en-US">Change in valuation allowance &#8211; Capital losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses" xlink:to="wt_IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxReconciliationExpirationOfCapitalLosses" xlink:href="wt-20231231.xsd#wt_IncomeTaxReconciliationExpirationOfCapitalLosses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wt_IncomeTaxReconciliationExpirationOfCapitalLosses_lbl" xml:lang="en-US">Expiration of capital losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncomeTaxReconciliationExpirationOfCapitalLosses" xlink:to="wt_IncomeTaxReconciliationExpirationOfCapitalLosses_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredTaxAssetsOutsideBasisDifference" xlink:href="wt-20231231.xsd#wt_DeferredTaxAssetsOutsideBasisDifference"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="wt_DeferredTaxAssetsOutsideBasisDifference_lbl" xml:lang="en-US">Outside basis differences</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredTaxAssetsOutsideBasisDifference" xlink:to="wt_DeferredTaxAssetsOutsideBasisDifference_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Less: Valuation allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_lbl" xml:lang="en-US">Decrease&#8212;Settlements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_lbl" xml:lang="en-US">Decrease&#8212;Lapse of statute of limitations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl0" xml:lang="en-US">Amortization expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StraightLineDepreciationMethodMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StraightLineDepreciationMethodMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StraightLineDepreciationMethodMember_lbl" xml:lang="en-US">Depreciation Method, Straight-Line [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StraightLineDepreciationMethodMember" xlink:to="us-gaap_StraightLineDepreciationMethodMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquipmentMember_lbl" xml:lang="en-US">Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SoftwareDevelopmentMember_lbl" xml:lang="en-US">Software Development [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareDevelopmentMember" xlink:to="us-gaap_SoftwareDevelopmentMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SoftwareDevelopmentMember_lbl0" xml:lang="en-US">Software development [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareDevelopmentMember" xlink:to="us-gaap_SoftwareDevelopmentMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xml:lang="en-US">Fair Value, Recurring [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExchangeTradedFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExchangeTradedFundsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ExchangeTradedFundsMember_lbl" xml:lang="en-US">ETFs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExchangeTradedFundsMember" xlink:to="us-gaap_ExchangeTradedFundsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ExchangeTradedFundsMember_lbl0" xml:lang="en-US">ETFs [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExchangeTradedFundsMember" xlink:to="us-gaap_ExchangeTradedFundsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_FederalAgencyMember" xlink:href="wt-20231231.xsd#wt_FederalAgencyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_FederalAgencyMember_lbl" xml:lang="en-US">Pass-through GSEs [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FederalAgencyMember" xlink:to="wt_FederalAgencyMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="wt_FederalAgencyMember_lbl0" xml:lang="en-US">Federal Agency [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FederalAgencyMember" xlink:to="wt_FederalAgencyMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xml:lang="en-US">U.S. treasuries [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasurySecuritiesMember" xlink:to="us-gaap_USTreasurySecuritiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquitySecuritiesMember_lbl" xml:lang="en-US">Equities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesMember" xlink:to="us-gaap_EquitySecuritiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FixedIncomeInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FixedIncomeInvestmentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FixedIncomeInvestmentsMember_lbl" xml:lang="en-US">Fixed income [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FixedIncomeInvestmentsMember" xlink:to="us-gaap_FixedIncomeInvestmentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_FnalityInternationalLimitedBOnePreferenceSharesMember" xlink:href="wt-20231231.xsd#wt_FnalityInternationalLimitedBOnePreferenceSharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_FnalityInternationalLimitedBOnePreferenceSharesMember_lbl" xml:lang="en-US">Fnality International Limited&#8212;B-1 Preference Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FnalityInternationalLimitedBOnePreferenceSharesMember" xlink:to="wt_FnalityInternationalLimitedBOnePreferenceSharesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementsNonrecurringMember_lbl" xml:lang="en-US">Fair Value, Nonrecurring [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="us-gaap_FairValueMeasurementsNonrecurringMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInvestmentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherInvestmentsMember_lbl" xml:lang="en-US">Other Investments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInvestmentsMember" xlink:to="us-gaap_OtherInvestmentsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherInvestmentsMember_lbl0" xml:lang="en-US">Other investments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInvestmentsMember" xlink:to="us-gaap_OtherInvestmentsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllOtherCorporateBondsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllOtherCorporateBondsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllOtherCorporateBondsMember_lbl" xml:lang="en-US">Corporate bonds [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllOtherCorporateBondsMember" xlink:to="us-gaap_AllOtherCorporateBondsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_OtherAssetsseedCapitalWisdomtreeDigitalFundsMember" xlink:href="wt-20231231.xsd#wt_OtherAssetsseedCapitalWisdomtreeDigitalFundsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_OtherAssetsseedCapitalWisdomtreeDigitalFundsMember_lbl" xml:lang="en-US">WisdomTree Digital Funds [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_OtherAssetsseedCapitalWisdomtreeDigitalFundsMember" xlink:to="wt_OtherAssetsseedCapitalWisdomtreeDigitalFundsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_SecurrencyConvertibleNoteMember" xlink:href="wt-20231231.xsd#wt_SecurrencyConvertibleNoteMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_SecurrencyConvertibleNoteMember_lbl" xml:lang="en-US">Securrency, Inc.&#8212;convertible note [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SecurrencyConvertibleNoteMember" xlink:to="wt_SecurrencyConvertibleNoteMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="wt_SecurrencyConvertibleNoteMember_lbl0" xml:lang="en-US">Securrency Convertible Note [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SecurrencyConvertibleNoteMember" xlink:to="wt_SecurrencyConvertibleNoteMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_FnalityConvertibleNoteMember" xlink:href="wt-20231231.xsd#wt_FnalityConvertibleNoteMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_FnalityConvertibleNoteMember_lbl" xml:lang="en-US">Fnality International Limited&#8212;convertible note [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FnalityConvertibleNoteMember" xlink:to="wt_FnalityConvertibleNoteMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xml:lang="en-US">Level 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US">Level 2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US">Level 3 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl0" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredConsiderationObligationMember" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationObligationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_DeferredConsiderationObligationMember_lbl" xml:lang="en-US">Deferred Consideration Obligation [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredConsiderationObligationMember" xlink:to="wt_DeferredConsiderationObligationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_TradingSecuritiesMember" xlink:href="wt-20231231.xsd#wt_TradingSecuritiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_TradingSecuritiesMember_lbl" xml:lang="en-US">Trading Securities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_TradingSecuritiesMember" xlink:to="wt_TradingSecuritiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_OtherAssetsseedCapitalWisdomTreeDigitalFundsMember" xlink:href="wt-20231231.xsd#wt_OtherAssetsseedCapitalWisdomTreeDigitalFundsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_OtherAssetsseedCapitalWisdomTreeDigitalFundsMember_lbl" xml:lang="en-US">Other assets&#8212;seed capital (WisdomTree Digital Funds) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_OtherAssetsseedCapitalWisdomTreeDigitalFundsMember" xlink:to="wt_OtherAssetsseedCapitalWisdomTreeDigitalFundsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_SecurrencyseriesaconvertiblepreferredstockMember" xlink:href="wt-20231231.xsd#wt_SecurrencyseriesaconvertiblepreferredstockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_SecurrencyseriesaconvertiblepreferredstockMember_lbl" xml:lang="en-US">Securrency, Inc. Series A convertible preferred stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SecurrencyseriesaconvertiblepreferredstockMember" xlink:to="wt_SecurrencyseriesaconvertiblepreferredstockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_SecurrencyseriesbconvertiblepreferredstockMember" xlink:href="wt-20231231.xsd#wt_SecurrencyseriesbconvertiblepreferredstockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_SecurrencyseriesbconvertiblepreferredstockMember_lbl" xml:lang="en-US">Securrency, Inc. Series B convertible preferred stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SecurrencyseriesbconvertiblepreferredstockMember" xlink:to="wt_SecurrencyseriesbconvertiblepreferredstockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_SecurrencyIncSubTotalMember" xlink:href="wt-20231231.xsd#wt_SecurrencyIncSubTotalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_SecurrencyIncSubTotalMember_lbl" xml:lang="en-US">Securrency Inc Sub Total [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SecurrencyIncSubTotalMember" xlink:to="wt_SecurrencyIncSubTotalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ConvertibleNoteMember" xlink:href="wt-20231231.xsd#wt_ConvertibleNoteMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ConvertibleNoteMember_lbl" xml:lang="en-US">Convertible note [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConvertibleNoteMember" xlink:to="wt_ConvertibleNoteMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_B1ConvertiblePreferenceSharesMember" xlink:href="wt-20231231.xsd#wt_B1ConvertiblePreferenceSharesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_B1ConvertiblePreferenceSharesMember_lbl" xml:lang="en-US">B-1 convertible preference shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_B1ConvertiblePreferenceSharesMember" xlink:to="wt_B1ConvertiblePreferenceSharesMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="wt_B1ConvertiblePreferenceSharesMember_lbl0" xml:lang="en-US">B-1 Preference Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_B1ConvertiblePreferenceSharesMember" xlink:to="wt_B1ConvertiblePreferenceSharesMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_SubtotalFnalityInternationalLimitedMember" xlink:href="wt-20231231.xsd#wt_SubtotalFnalityInternationalLimitedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_SubtotalFnalityInternationalLimitedMember_lbl" xml:lang="en-US">Subtotal&#8212;Fnality International Limited [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SubtotalFnalityInternationalLimitedMember" xlink:to="wt_SubtotalFnalityInternationalLimitedMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="wt_SubtotalFnalityInternationalLimitedMember_lbl0" xml:lang="en-US">Subtotal&#8212;Fnality [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SubtotalFnalityInternationalLimitedMember" xlink:to="wt_SubtotalFnalityInternationalLimitedMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="srt_WeightedAverageMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_WeightedAverageMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_WeightedAverageMember_lbl" xml:lang="en-US">Weighted Average [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_WeightedAverageMember" xlink:to="srt_WeightedAverageMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_TwoThousandAndTwentyThreeNotesMember" xlink:href="wt-20231231.xsd#wt_TwoThousandAndTwentyThreeNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_TwoThousandAndTwentyThreeNotesMember_lbl" xml:lang="en-US">2023 Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_TwoThousandAndTwentyThreeNotesMember" xlink:to="wt_TwoThousandAndTwentyThreeNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_TwothousandandtwentyonenotesMember" xlink:href="wt-20231231.xsd#wt_TwothousandandtwentyonenotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_TwothousandandtwentyonenotesMember_lbl" xml:lang="en-US">2021 Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_TwothousandandtwentyonenotesMember" xlink:to="wt_TwothousandandtwentyonenotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ConvertibleNotesMember" xlink:href="wt-20231231.xsd#wt_ConvertibleNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ConvertibleNotesMember_lbl" xml:lang="en-US">Convertible Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConvertibleNotesMember" xlink:to="wt_ConvertibleNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_TwoThousandAndTwentyNotesMember" xlink:href="wt-20231231.xsd#wt_TwoThousandAndTwentyNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_TwoThousandAndTwentyNotesMember_lbl" xml:lang="en-US">2020 Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_TwoThousandAndTwentyNotesMember" xlink:to="wt_TwoThousandAndTwentyNotesMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="wt_TwoThousandAndTwentyNotesMember_lbl0" xml:lang="en-US">Two Thousand And Twenty Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_TwoThousandAndTwentyNotesMember" xlink:to="wt_TwoThousandAndTwentyNotesMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_OtherInvestmentMember" xlink:href="wt-20231231.xsd#wt_OtherInvestmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_OtherInvestmentMember_lbl" xml:lang="en-US">Other investments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_OtherInvestmentMember" xlink:to="wt_OtherInvestmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_MaximumExposureToLossMember" xlink:href="wt-20231231.xsd#wt_MaximumExposureToLossMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_MaximumExposureToLossMember_lbl" xml:lang="en-US">Maximum exposure to loss [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_MaximumExposureToLossMember" xlink:to="wt_MaximumExposureToLossMember_lbl"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_US_lbl" xml:lang="en-US">United States [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="country_US_lbl0" xml:lang="en-US">U.S. [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl0"/>
    <loc xlink:type="locator" xlink:label="country_JE" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_JE"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_JE_lbl" xml:lang="en-US">Jersey [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_JE" xlink:to="country_JE_lbl"/>
    <loc xlink:type="locator" xlink:label="country_IE" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IE"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="country_IE_lbl" xml:lang="en-US">Ireland [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IE" xlink:to="country_IE_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ReceivableFromWTTMember" xlink:href="wt-20231231.xsd#wt_ReceivableFromWTTMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ReceivableFromWTTMember_lbl" xml:lang="en-US">Receivable from WTT [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ReceivableFromWTTMember" xlink:to="wt_ReceivableFromWTTMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ReceivableFromManJerIssuersMember" xlink:href="wt-20231231.xsd#wt_ReceivableFromManJerIssuersMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ReceivableFromManJerIssuersMember_lbl" xml:lang="en-US">Receivable from ManJer Issuers [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ReceivableFromManJerIssuersMember" xlink:to="wt_ReceivableFromManJerIssuersMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember" xlink:href="wt-20231231.xsd#wt_WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember_lbl" xml:lang="en-US">Receivable from WMAI and WTICAV [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember" xlink:to="wt_WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_AdvisoryServicesProvidedToWTTMember" xlink:href="wt-20231231.xsd#wt_AdvisoryServicesProvidedToWTTMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_AdvisoryServicesProvidedToWTTMember_lbl" xml:lang="en-US">Advisory services provided to WTT [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_AdvisoryServicesProvidedToWTTMember" xlink:to="wt_AdvisoryServicesProvidedToWTTMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_AdvisoryServicesProvidedToManJerIssuersMember" xlink:href="wt-20231231.xsd#wt_AdvisoryServicesProvidedToManJerIssuersMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_AdvisoryServicesProvidedToManJerIssuersMember_lbl" xml:lang="en-US">Advisory services provided to ManJer Issuers [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_AdvisoryServicesProvidedToManJerIssuersMember" xlink:to="wt_AdvisoryServicesProvidedToManJerIssuersMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_AdvisoryServicesProvidedToWMAIAndWTICAVMember" xlink:href="wt-20231231.xsd#wt_AdvisoryServicesProvidedToWMAIAndWTICAVMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_AdvisoryServicesProvidedToWMAIAndWTICAVMember_lbl" xml:lang="en-US">Advisory services provided to WMAI and WTICAV	[Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_AdvisoryServicesProvidedToWMAIAndWTICAVMember" xlink:to="wt_AdvisoryServicesProvidedToWMAIAndWTICAVMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_EmployeesAndDirectorsMember" xlink:href="wt-20231231.xsd#wt_EmployeesAndDirectorsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_EmployeesAndDirectorsMember_lbl" xml:lang="en-US">Employees And Directors [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_EmployeesAndDirectorsMember" xlink:to="wt_EmployeesAndDirectorsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US">RSA	[Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US">RSU [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl0" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_PerformanceBasedRestrictedStockUnitMember" xlink:href="wt-20231231.xsd#wt_PerformanceBasedRestrictedStockUnitMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_PerformanceBasedRestrictedStockUnitMember_lbl" xml:lang="en-US">PRSU [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PerformanceBasedRestrictedStockUnitMember" xlink:to="wt_PerformanceBasedRestrictedStockUnitMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="wt_PerformanceBasedRestrictedStockUnitMember_lbl0" xml:lang="en-US">Performance Based Restricted Stock Unit [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PerformanceBasedRestrictedStockUnitMember" xlink:to="wt_PerformanceBasedRestrictedStockUnitMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_ForeignMember" xlink:href="wt-20231231.xsd#wt_ForeignMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ForeignMember_lbl" xml:lang="en-US">Foreign [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ForeignMember" xlink:to="wt_ForeignMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DomesticCountryMember_lbl" xml:lang="en-US">Federal [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xml:lang="en-US">State and local [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ForeignCountryMember_lbl" xml:lang="en-US">Foreign [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_UnrecognizedTaxBenefitsMember" xlink:href="wt-20231231.xsd#wt_UnrecognizedTaxBenefitsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_UnrecognizedTaxBenefitsMember_lbl" xml:lang="en-US">Unrecognized Tax Benefits [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_UnrecognizedTaxBenefitsMember" xlink:to="wt_UnrecognizedTaxBenefitsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_InterestAndPenaltiesMember" xlink:href="wt-20231231.xsd#wt_InterestAndPenaltiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_InterestAndPenaltiesMember_lbl" xml:lang="en-US">Interest And Penalties [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_InterestAndPenaltiesMember" xlink:to="wt_InterestAndPenaltiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ETFSAcquisitionMember" xlink:href="wt-20231231.xsd#wt_ETFSAcquisitionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ETFSAcquisitionMember_lbl" xml:lang="en-US">ETFS acquisition [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ETFSAcquisitionMember" xlink:to="wt_ETFSAcquisitionMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="wt_ETFSAcquisitionMember_lbl0" xml:lang="en-US">ETFS Acquisition [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ETFSAcquisitionMember" xlink:to="wt_ETFSAcquisitionMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_NewYorkOfficeMember" xlink:href="wt-20231231.xsd#wt_NewYorkOfficeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_NewYorkOfficeMember_lbl" xml:lang="en-US">New York office [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_NewYorkOfficeMember" xlink:to="wt_NewYorkOfficeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_LeaseTerminationMember" xlink:href="wt-20231231.xsd#wt_LeaseTerminationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_LeaseTerminationMember_lbl" xml:lang="en-US">Lease termination [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_LeaseTerminationMember" xlink:to="wt_LeaseTerminationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_FixedAssetsMember" xlink:href="wt-20231231.xsd#wt_FixedAssetsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_FixedAssetsMember_lbl" xml:lang="en-US">Fixed assets [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FixedAssetsMember" xlink:to="wt_FixedAssetsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_LondonOfficeMember" xlink:href="wt-20231231.xsd#wt_LondonOfficeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_LondonOfficeMember_lbl" xml:lang="en-US">London office [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_LondonOfficeMember" xlink:to="wt_LondonOfficeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_SecurrencyIncMember" xlink:href="wt-20231231.xsd#wt_SecurrencyIncMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_SecurrencyIncMember_lbl" xml:lang="en-US">Securrency [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SecurrencyIncMember" xlink:to="wt_SecurrencyIncMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xml:lang="en-US">Accounting Standards Update [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementBusinessSegmentsAxis_lbl" xml:lang="en-US">Segments [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_StatementBusinessSegmentsAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExtinguishmentOfDebtAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExtinguishmentOfDebtAxis_lbl" xml:lang="en-US">Extinguishment of Debt [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtinguishmentOfDebtAxis" xlink:to="us-gaap_ExtinguishmentOfDebtAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_AgreementAxis" xlink:href="wt-20231231.xsd#wt_AgreementAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_AgreementAxis_lbl" xml:lang="en-US">Agreement [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_AgreementAxis" xlink:to="wt_AgreementAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xml:lang="en-US">Balance Sheet Location [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VestingAxis_lbl" xml:lang="en-US">Vesting [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_OwnershipAxis_lbl" xml:lang="en-US">Ownership [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xml:lang="en-US">Consolidated Entities [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xml:lang="en-US">Related Party Transaction [Axis]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_PercentageOfTaxRateRealizedOnSettlement" xlink:href="wt-20231231.xsd#wt_PercentageOfTaxRateRealizedOnSettlement"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_PercentageOfTaxRateRealizedOnSettlement_lbl" xml:lang="en-US">Benefit percentage of tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfTaxRateRealizedOnSettlement" xlink:to="wt_PercentageOfTaxRateRealizedOnSettlement_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertibleNotesPayableCurrent_lbl" xml:lang="en-US">Increasing carrying value of convertible notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableCurrent" xlink:to="us-gaap_ConvertibleNotesPayableCurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl" xml:lang="en-US">Additional paid-in capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xml:lang="en-US">Deferred tax liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash equivalents, at carrying value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements" xlink:href="wt-20231231.xsd#wt_NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements_lbl" xml:lang="en-US">Net liquid assets international subsidiary regulatory capital requirements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements" xlink:to="wt_NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_CashEquivalentsMaturityPeriod" xlink:href="wt-20231231.xsd#wt_CashEquivalentsMaturityPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_CashEquivalentsMaturityPeriod_lbl" xml:lang="en-US">Liquid investments, original maturities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_CashEquivalentsMaturityPeriod" xlink:to="wt_CashEquivalentsMaturityPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TradingGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradingGainsLosses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TradingGainsLosses_lbl" xml:lang="en-US">Net trading losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradingGainsLosses" xlink:to="us-gaap_TradingGainsLosses_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_lbl" xml:lang="en-US">Proceeds received</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_lbl" xml:lang="en-US">Net impairment charge (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProvisionForOtherLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForOtherLosses"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProvisionForOtherLosses_lbl" xml:lang="en-US">Additional losses (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForOtherLosses" xlink:to="us-gaap_ProvisionForOtherLosses_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_CapitalStockPercentage" xlink:href="wt-20231231.xsd#wt_CapitalStockPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_CapitalStockPercentage_lbl" xml:lang="en-US">Capital stock, percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_CapitalStockPercentage" xlink:to="wt_CapitalStockPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Investments_lbl" xml:lang="en-US">Preferred stock investment (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Investments" xlink:to="us-gaap_Investments_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_Investments_lbl0" xml:lang="en-US">Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Investments" xlink:to="us-gaap_Investments_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockConvertibleSharesIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockConvertibleSharesIssuable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockConvertibleSharesIssuable_lbl" xml:lang="en-US">Convertible preferred stock (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockConvertibleSharesIssuable" xlink:to="us-gaap_PreferredStockConvertibleSharesIssuable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockConvertibleSharesIssuable_lbl0" xml:lang="en-US">Convertible preferred stock shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockConvertibleSharesIssuable" xlink:to="us-gaap_PreferredStockConvertibleSharesIssuable_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendRatePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockDividendRatePercentage_lbl" xml:lang="en-US">Dividend payable, percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendRatePercentage" xlink:to="us-gaap_PreferredStockDividendRatePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_SharesPercentage" xlink:href="wt-20231231.xsd#wt_SharesPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_SharesPercentage_lbl" xml:lang="en-US">Shares percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SharesPercentage" xlink:to="wt_SharesPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainOrLossOnSaleOfStockInSubsidiary" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainOrLossOnSaleOfStockInSubsidiary"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GainOrLossOnSaleOfStockInSubsidiary_lbl" xml:lang="en-US">Gain on shares (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainOrLossOnSaleOfStockInSubsidiary" xlink:to="us-gaap_GainOrLossOnSaleOfStockInSubsidiary_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebt"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertibleDebt_lbl" xml:lang="en-US">Convertible notes (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebt" xlink:to="us-gaap_ConvertibleDebt_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate_lbl" xml:lang="en-US">Percentage of convertible promissory note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentRate" xlink:to="us-gaap_DebtConversionConvertedInstrumentRate_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate_lbl0" xml:lang="en-US">Conversion price of convertible notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentRate" xlink:to="us-gaap_DebtConversionConvertedInstrumentRate_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_ConvertibleNoteDiscountRate" xlink:href="wt-20231231.xsd#wt_ConvertibleNoteDiscountRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ConvertibleNoteDiscountRate_lbl" xml:lang="en-US">Conversion price discount rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConvertibleNoteDiscountRate" xlink:to="wt_ConvertibleNoteDiscountRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableInterestEntityOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_VariableInterestEntityOwnershipPercentage_lbl" xml:lang="en-US">Ownership interest percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableInterestEntityOwnershipPercentage" xlink:to="us-gaap_VariableInterestEntityOwnershipPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherOwnershipInterestsUnitsIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOwnershipInterestsUnitsIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherOwnershipInterestsUnitsIssued_lbl" xml:lang="en-US">Ownership interest shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOwnershipInterestsUnitsIssued" xlink:to="us-gaap_OtherOwnershipInterestsUnitsIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_CostMethodInvestmentFairValueDisclosure" xlink:href="wt-20231231.xsd#wt_CostMethodInvestmentFairValueDisclosure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_CostMethodInvestmentFairValueDisclosure_lbl" xml:lang="en-US">Investment of fair value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_CostMethodInvestmentFairValueDisclosure" xlink:to="wt_CostMethodInvestmentFairValueDisclosure_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GainLossOnInvestments_lbl" xml:lang="en-US">Recognized gain of investment (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnInvestments" xlink:to="us-gaap_GainLossOnInvestments_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GainLossOnInvestments_lbl0" xml:lang="en-US">Net gains (losses) related to certain WisdomTree ETFs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnInvestments" xlink:to="us-gaap_GainLossOnInvestments_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_CostMethodInvestmentOwnershipPercentage" xlink:href="wt-20231231.xsd#wt_CostMethodInvestmentOwnershipPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_CostMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Ownership interest percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_CostMethodInvestmentOwnershipPercentage" xlink:to="wt_CostMethodInvestmentOwnershipPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_PercentageOfDiscountOnFutureEquityFinancingForPreferredStock" xlink:href="wt-20231231.xsd#wt_PercentageOfDiscountOnFutureEquityFinancingForPreferredStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_PercentageOfDiscountOnFutureEquityFinancingForPreferredStock_lbl" xml:lang="en-US">Percentage of discount on future equity financing for preferred stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfDiscountOnFutureEquityFinancingForPreferredStock" xlink:to="wt_PercentageOfDiscountOnFutureEquityFinancingForPreferredStock_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_PercentageOfOutstandingConvertibleNotes" xlink:href="wt-20231231.xsd#wt_PercentageOfOutstandingConvertibleNotes"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_PercentageOfOutstandingConvertibleNotes_lbl" xml:lang="en-US">Percentage of outstanding convertible note</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfOutstandingConvertibleNotes" xlink:to="wt_PercentageOfOutstandingConvertibleNotes_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity" xlink:href="wt-20231231.xsd#wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity_lbl" xml:lang="en-US">Percentage of voting approval required to redeem all of the outstanding notes at maturity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity" xlink:to="wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity" xlink:href="wt-20231231.xsd#wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity_lbl" xml:lang="en-US">Percentage of voting approval required to redeem all of the outstanding notes before maturity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity" xlink:to="wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInvestments"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherInvestments_lbl" xml:lang="en-US">Other investment (in Dollars)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInvestments" xlink:to="us-gaap_OtherInvestments_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedBalanceOtherMeasure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedBalanceOtherMeasure"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentOwnedBalanceOtherMeasure_lbl" xml:lang="en-US">Deferred consideration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedBalanceOtherMeasure" xlink:to="us-gaap_InvestmentOwnedBalanceOtherMeasure_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_lbl" xml:lang="en-US">Aggregate consideration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Cash_lbl" xml:lang="en-US">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock shares issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xml:lang="en-US">Conversion of stock shares converted (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl0" xml:lang="en-US">Convertible shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xml:lang="en-US">Aggregate consideration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl0" xml:lang="en-US">Fair value of consideration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl1" xml:lang="en-US">Transaction paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xml:lang="en-US">Principal interest rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtGainLossNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_lbl" xml:lang="en-US">Loss on extinguishment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:to="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockAmountIssued1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConversionOfStockAmountIssued1_lbl" xml:lang="en-US">Conversion shares value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountIssued1" xlink:to="us-gaap_ConversionOfStockAmountIssued1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdTradingDays_lbl" xml:lang="en-US">Trading days</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdTradingDays_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_lbl" xml:lang="en-US">Consecutive trading days</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_NumberOfThresholdTradingDaysForDeterminingTheSharePrice" xlink:href="wt-20231231.xsd#wt_NumberOfThresholdTradingDaysForDeterminingTheSharePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_NumberOfThresholdTradingDaysForDeterminingTheSharePrice_lbl" xml:lang="en-US">Measurement days</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_NumberOfThresholdTradingDaysForDeterminingTheSharePrice" xlink:to="wt_NumberOfThresholdTradingDaysForDeterminingTheSharePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_MeasurementPeriodForDeterminingSharePrice" xlink:href="wt-20231231.xsd#wt_MeasurementPeriodForDeterminingSharePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_MeasurementPeriodForDeterminingSharePrice_lbl" xml:lang="en-US">Measurement period for determining share price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_MeasurementPeriodForDeterminingSharePrice" xlink:to="wt_MeasurementPeriodForDeterminingSharePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_PrincipalAmountOfTradingPrice" xlink:href="wt-20231231.xsd#wt_PrincipalAmountOfTradingPrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_PrincipalAmountOfTradingPrice_lbl" xml:lang="en-US">Principal amount of trading price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PrincipalAmountOfTradingPrice" xlink:to="wt_PrincipalAmountOfTradingPrice_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_SharePriceAsAPercentageOfLastReportedPriceAndConversionRate" xlink:href="wt-20231231.xsd#wt_SharePriceAsAPercentageOfLastReportedPriceAndConversionRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_SharePriceAsAPercentageOfLastReportedPriceAndConversionRate_lbl" xml:lang="en-US">Parentage of sale and conversion price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SharePriceAsAPercentageOfLastReportedPriceAndConversionRate" xlink:to="wt_SharePriceAsAPercentageOfLastReportedPriceAndConversionRate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl" xml:lang="en-US">Redemption price equal percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_MaximumConversionRate" xlink:href="wt-20231231.xsd#wt_MaximumConversionRate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_MaximumConversionRate_lbl" xml:lang="en-US">Maximum conversion rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_MaximumConversionRate" xlink:to="wt_MaximumConversionRate_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_MaximumNumberOfSharesIssuableUponConversion" xlink:href="wt-20231231.xsd#wt_MaximumNumberOfSharesIssuableUponConversion"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_MaximumNumberOfSharesIssuableUponConversion_lbl" xml:lang="en-US">Number of shares issuable upon conversion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_MaximumNumberOfSharesIssuableUponConversion" xlink:to="wt_MaximumNumberOfSharesIssuableUponConversion_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_MinimumPercentageOfLendersRequiredToHaveEntirePrincipalAmountOfConvertibleNotesRepurchasedByTheCompanyUponCertainEventsOfDefault" xlink:href="wt-20231231.xsd#wt_MinimumPercentageOfLendersRequiredToHaveEntirePrincipalAmountOfConvertibleNotesRepurchasedByTheCompanyUponCertainEventsOfDefault"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_MinimumPercentageOfLendersRequiredToHaveEntirePrincipalAmountOfConvertibleNotesRepurchasedByTheCompanyUponCertainEventsOfDefault_lbl" xml:lang="en-US">Aggregate principal amount, percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_MinimumPercentageOfLendersRequiredToHaveEntirePrincipalAmountOfConvertibleNotesRepurchasedByTheCompanyUponCertainEventsOfDefault" xlink:to="wt_MinimumPercentageOfLendersRequiredToHaveEntirePrincipalAmountOfConvertibleNotesRepurchasedByTheCompanyUponCertainEventsOfDefault_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Interest payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentFairValue_lbl" xml:lang="en-US">Fair value of the convertible notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFairValue" xlink:to="us-gaap_DebtInstrumentFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_OutstandingCommonStockPercentage" xlink:href="wt-20231231.xsd#wt_OutstandingCommonStockPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_OutstandingCommonStockPercentage_lbl" xml:lang="en-US">Outstanding common stock percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_OutstandingCommonStockPercentage" xlink:to="wt_OutstandingCommonStockPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xml:lang="en-US">Issued shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xml:lang="en-US">Convertible into common stock (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionSharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessAcquisitionSharePrice_lbl" xml:lang="en-US">Common stock per share (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionSharePrice" xlink:to="us-gaap_BusinessAcquisitionSharePrice_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferred" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferred_lbl" xml:lang="en-US">Aggregate cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferred" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferred_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_RepurchasePricePerShareInterestRateTransaction" xlink:href="wt-20231231.xsd#wt_RepurchasePricePerShareInterestRateTransaction"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_RepurchasePricePerShareInterestRateTransaction_lbl" xml:lang="en-US">Repurchase price per share interest rate transaction (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RepurchasePricePerShareInterestRateTransaction" xlink:to="wt_RepurchasePricePerShareInterestRateTransaction_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_PresentValueOfMarketRateInterest" xlink:href="wt-20231231.xsd#wt_PresentValueOfMarketRateInterest"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_PresentValueOfMarketRateInterest_lbl" xml:lang="en-US">Present value of market rate interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PresentValueOfMarketRateInterest" xlink:to="wt_PresentValueOfMarketRateInterest_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_AggregateConsiderationPayable" xlink:href="wt-20231231.xsd#wt_AggregateConsiderationPayable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_AggregateConsiderationPayable_lbl" xml:lang="en-US">Aggregate consideration payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_AggregateConsiderationPayable" xlink:to="wt_AggregateConsiderationPayable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestAndDebtExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestAndDebtExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestAndDebtExpense_lbl" xml:lang="en-US">interest expense recognized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndDebtExpense" xlink:to="us-gaap_InterestAndDebtExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_PaymentOfLeaseTerminationFee" xlink:href="wt-20231231.xsd#wt_PaymentOfLeaseTerminationFee"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_PaymentOfLeaseTerminationFee_lbl" xml:lang="en-US">Termination fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PaymentOfLeaseTerminationFee" xlink:to="wt_PaymentOfLeaseTerminationFee_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnContractTermination" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnContractTermination"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GainLossOnContractTermination_lbl" xml:lang="en-US">Lease termination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnContractTermination" xlink:to="us-gaap_GainLossOnContractTermination_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLeaseImpairmentLoss_lbl" xml:lang="en-US">Operating lease, impairment loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseImpairmentLoss" xlink:to="us-gaap_OperatingLeaseImpairmentLoss_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LossContingencyDamagesSoughtValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LossContingencyDamagesSoughtValue_lbl" xml:lang="en-US">Loss contingency acrual</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyDamagesSoughtValue" xlink:to="us-gaap_LossContingencyDamagesSoughtValue_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_LossContingencyCoveredByInsuranceDeductible" xlink:href="wt-20231231.xsd#wt_LossContingencyCoveredByInsuranceDeductible"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_LossContingencyCoveredByInsuranceDeductible_lbl" xml:lang="en-US">Amount of deductible</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_LossContingencyCoveredByInsuranceDeductible" xlink:to="wt_LossContingencyCoveredByInsuranceDeductible_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncome"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherIncome_lbl" xml:lang="en-US">Earned revenue</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractualObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractualObligation"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ContractualObligation_lbl" xml:lang="en-US">Contractual obligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractualObligation" xlink:to="us-gaap_ContractualObligation_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares issued (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Stock option issuance period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Vesting period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_lbl" xml:lang="en-US">Stock-based awards,description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_lbl" xml:lang="en-US">Related tax benefit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherTaxExpenseBenefit_lbl" xml:lang="en-US">Tax benefit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherTaxExpenseBenefit" xlink:to="us-gaap_OtherTaxExpenseBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit_lbl" xml:lang="en-US">Actual tax benefit for share-based compensation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US">Total intrinsic value of options exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" xml:lang="en-US">Aggregate fair value of awards that vested</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xml:lang="en-US">Shares granted and outstanding, vesting percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xml:lang="en-US">Deferred RSUs that have vested (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Right for outstanding shares (in Shares)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ExercisePricePerUnit" xlink:href="wt-20231231.xsd#wt_ExercisePricePerUnit"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ExercisePricePerUnit_lbl" xml:lang="en-US">Exercise price per unit (in Dollars per share)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ExercisePricePerUnit" xlink:to="wt_ExercisePricePerUnit_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xml:lang="en-US">Ownership percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_PercentageOfCommonStockAcquired" xlink:href="wt-20231231.xsd#wt_PercentageOfCommonStockAcquired"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_PercentageOfCommonStockAcquired_lbl" xml:lang="en-US">Percentage of common stock acquired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfCommonStockAcquired" xlink:to="wt_PercentageOfCommonStockAcquired_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_PercentageOfBeneficialOwnership" xlink:href="wt-20231231.xsd#wt_PercentageOfBeneficialOwnership"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_PercentageOfBeneficialOwnership_lbl" xml:lang="en-US">Percentage of beneficial ownership</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfBeneficialOwnership" xlink:to="wt_PercentageOfBeneficialOwnership_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_PercentageOfAssetsSold" xlink:href="wt-20231231.xsd#wt_PercentageOfAssetsSold"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_PercentageOfAssetsSold_lbl" xml:lang="en-US">Percentage of assets sold</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfAssetsSold" xlink:to="wt_PercentageOfAssetsSold_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_PercentageOfCommonStock" xlink:href="wt-20231231.xsd#wt_PercentageOfCommonStock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_PercentageOfCommonStock_lbl" xml:lang="en-US">Percentage of common stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfCommonStock" xlink:to="wt_PercentageOfCommonStock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Antidilutive non-participating common stock equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_lbl" xml:lang="en-US">Conversion option embedded in the Convertible Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_OperatingLossCarryForwardExpirationYear" xlink:href="wt-20231231.xsd#wt_OperatingLossCarryForwardExpirationYear"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_OperatingLossCarryForwardExpirationYear_lbl" xml:lang="en-US">NOL expiration date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_OperatingLossCarryForwardExpirationYear" xlink:to="wt_OperatingLossCarryForwardExpirationYear_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredTaxAssetsCapitalLossCarryforwardsSubjectToExpiration" xlink:href="wt-20231231.xsd#wt_DeferredTaxAssetsCapitalLossCarryforwardsSubjectToExpiration"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_DeferredTaxAssetsCapitalLossCarryforwardsSubjectToExpiration_lbl" xml:lang="en-US">Tax effected capital losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredTaxAssetsCapitalLossCarryforwardsSubjectToExpiration" xlink:to="wt_DeferredTaxAssetsCapitalLossCarryforwardsSubjectToExpiration_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax" xlink:href="wt-20231231.xsd#wt_DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax_lbl" xml:lang="en-US">Tax of carried forward</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax" xlink:to="wt_DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Uncertain tax rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xml:lang="en-US">Unrecognized tax benefits and interest and penalties</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl" xml:lang="en-US">Common stock purchase authorized amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockRepurchaseProgramPeriodInForce1_lbl" xml:lang="en-US">Stock repurchase program period in force</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:to="us-gaap_StockRepurchaseProgramPeriodInForce1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchaseProgramExpirationDate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramExpirationDate"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockRepurchaseProgramExpirationDate_lbl" xml:lang="en-US">Stock repurchase program period in force date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramExpirationDate" xlink:to="us-gaap_StockRepurchaseProgramExpirationDate_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl" xml:lang="en-US">Remained future purchases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xml:lang="en-US">Percentage of equity interest Acquired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xml:lang="en-US">Aggregate purchase price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl" xml:lang="en-US">Goodwill not deductible for tax purposes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_lbl" xml:lang="en-US">Acquisition completion date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:to="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_PercentageOfRevenueGrowth" xlink:href="wt-20231231.xsd#wt_PercentageOfRevenueGrowth"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_PercentageOfRevenueGrowth_lbl" xml:lang="en-US">Revenue growth rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfRevenueGrowth" xlink:to="wt_PercentageOfRevenueGrowth_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PercentageOfWeightedAverageCostInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PercentageOfWeightedAverageCostInventory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PercentageOfWeightedAverageCostInventory_lbl" xml:lang="en-US">Percentage of weighted average cost capital</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PercentageOfWeightedAverageCostInventory" xlink:to="us-gaap_PercentageOfWeightedAverageCostInventory_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Finite-lived useful life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_lbl" xml:lang="en-US">Finite-lived intangible assets remaining useful life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Consolidation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Segment and Geographic Information</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Foreign Currency Translation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</label>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrY11ZqAmQBqDS9evb2UjxxqoT1dX+ftwW5Dmnj+XgBA5xugKgU5REylsG34PyUGaDd+s8Vz6UhUE2XjAqeTDG+GsAAOBng9N8lGsEAjX/LwTSBIBqd4ygj3svooWB2H37ux1jJEZgBFLWzkzuTALB4aTs3k+tWR6XSXbRFQ/yCjbvE35zot7VxptMN7n1hk4Sk=] CSR-->
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ContractualGoldPaymentsPolicyPolicyTextBlock" xlink:href="wt-20231231.xsd#wt_ContractualGoldPaymentsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ContractualGoldPaymentsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Contractual Gold Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ContractualGoldPaymentsPolicyPolicyTextBlock" xlink:to="wt_ContractualGoldPaymentsPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xml:lang="en-US">Marketing and Advertising</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RegulatoryDepreciationAndAmortizationPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RegulatoryDepreciationAndAmortizationPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RegulatoryDepreciationAndAmortizationPolicy_lbl" xml:lang="en-US">Depreciation and Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RegulatoryDepreciationAndAmortizationPolicy" xlink:to="us-gaap_RegulatoryDepreciationAndAmortizationPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xml:lang="en-US">Stock-Based Awards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ThirdPartyDistributionFeesPolicyTextBlock" xlink:href="wt-20231231.xsd#wt_ThirdPartyDistributionFeesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ThirdPartyDistributionFeesPolicyTextBlock_lbl" xml:lang="en-US">Third-Party Distribution Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ThirdPartyDistributionFeesPolicyTextBlock" xlink:to="wt_ThirdPartyDistributionFeesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ReceivablesPolicyTextBlock_lbl" xml:lang="en-US">Accounts Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesPolicyTextBlock" xlink:to="us-gaap_ReceivablesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Impairment of Long-Lived Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Financial Instruments Owned and Financial Instruments Sold, but Not yet Purchased (at Fair Value)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xml:lang="en-US">Securities Held-to-Maturity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xml:lang="en-US">Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xml:lang="en-US">Goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl" xml:lang="en-US">Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_lbl" xml:lang="en-US">Software Development Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Leases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredConsiderationGoldPaymentsPolicyTextBlock" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationGoldPaymentsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_DeferredConsiderationGoldPaymentsPolicyTextBlock_lbl" xml:lang="en-US">Deferred Consideration&#8212;Gold Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredConsiderationGoldPaymentsPolicyTextBlock" xlink:to="wt_DeferredConsiderationGoldPaymentsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtPolicyTextBlock_lbl" xml:lang="en-US">Convertible Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtPolicyTextBlock" xlink:to="us-gaap_DebtPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl" xml:lang="en-US">Contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ContingentPaymentsPolicyTextBlock" xlink:href="wt-20231231.xsd#wt_ContingentPaymentsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ContingentPaymentsPolicyTextBlock_lbl" xml:lang="en-US">Contingent Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ContingentPaymentsPolicyTextBlock" xlink:to="wt_ContingentPaymentsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_RecentlyIssuedAccountingPronouncementsPolicyTextBlock" xlink:href="wt-20231231.xsd#wt_RecentlyIssuedAccountingPronouncementsPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_RecentlyIssuedAccountingPronouncementsPolicyTextBlock_lbl" xml:lang="en-US">Recently Issued Accounting Pronouncements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RecentlyIssuedAccountingPronouncementsPolicyTextBlock" xlink:to="wt_RecentlyIssuedAccountingPronouncementsPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recently Adopted Accounting Pronouncements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ImplementationOfASU202006Member" xlink:href="wt-20231231.xsd#wt_ImplementationOfASU202006Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ImplementationOfASU202006Member_lbl" xml:lang="en-US">Accounting Standards Update 2020-06 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ImplementationOfASU202006Member" xlink:to="wt_ImplementationOfASU202006Member_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_TwoFinancialInstitutionsMember" xlink:href="wt-20231231.xsd#wt_TwoFinancialInstitutionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_TwoFinancialInstitutionsMember_lbl" xml:lang="en-US">Two Financial Institutions [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_TwoFinancialInstitutionsMember" xlink:to="wt_TwoFinancialInstitutionsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_EuropeanBusinessSegmentMember" xlink:href="wt-20231231.xsd#wt_EuropeanBusinessSegmentMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_EuropeanBusinessSegmentMember_lbl" xml:lang="en-US">European Business Segment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_EuropeanBusinessSegmentMember" xlink:to="wt_EuropeanBusinessSegmentMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series A convertible preferred stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xml:lang="en-US">Series B Preferred Shares [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ConvertiblePromissoryNoteMember" xlink:href="wt-20231231.xsd#wt_ConvertiblePromissoryNoteMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ConvertiblePromissoryNoteMember_lbl" xml:lang="en-US">Convertible Promissory Note [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConvertiblePromissoryNoteMember" xlink:to="wt_ConvertiblePromissoryNoteMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertibleDebtMember_lbl" xml:lang="en-US">Convertible Note [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtMember" xlink:to="us-gaap_ConvertibleDebtMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_FnalityInternationalLimitedMember" xlink:href="wt-20231231.xsd#wt_FnalityInternationalLimitedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_FnalityInternationalLimitedMember_lbl" xml:lang="en-US">Fnality International Limited [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FnalityInternationalLimitedMember" xlink:to="wt_FnalityInternationalLimitedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ETFSCapitalMember" xlink:href="wt-20231231.xsd#wt_ETFSCapitalMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ETFSCapitalMember_lbl" xml:lang="en-US">ETFS Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ETFSCapitalMember" xlink:to="wt_ETFSCapitalMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ContractualGoldPaymentsMember" xlink:href="wt-20231231.xsd#wt_ContractualGoldPaymentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ContractualGoldPaymentsMember_lbl" xml:lang="en-US">Contractual gold payments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ContractualGoldPaymentsMember" xlink:to="wt_ContractualGoldPaymentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_SpaAgreementMember" xlink:href="wt-20231231.xsd#wt_SpaAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_SpaAgreementMember_lbl" xml:lang="en-US">SPA Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SpaAgreementMember" xlink:to="wt_SpaAgreementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_SeriesCRedeemableConvertiblePreferredStockMember" xlink:href="wt-20231231.xsd#wt_SeriesCRedeemableConvertiblePreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_SeriesCRedeemableConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series C Redeemable Convertible Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SeriesCRedeemableConvertiblePreferredStockMember" xlink:to="wt_SeriesCRedeemableConvertiblePreferredStockMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_GoldBullionHoldingsMember" xlink:href="wt-20231231.xsd#wt_GoldBullionHoldingsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_GoldBullionHoldingsMember_lbl" xml:lang="en-US">Gold Bullion Holdings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_GoldBullionHoldingsMember" xlink:to="wt_GoldBullionHoldingsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_RodberInvestmentsLimitedMember" xlink:href="wt-20231231.xsd#wt_RodberInvestmentsLimitedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_RodberInvestmentsLimitedMember_lbl" xml:lang="en-US">Rodber Investments Limited [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RodberInvestmentsLimitedMember" xlink:to="wt_RodberInvestmentsLimitedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_GoldBullionHoldingsJerseyLimitedMember" xlink:href="wt-20231231.xsd#wt_GoldBullionHoldingsJerseyLimitedMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_GoldBullionHoldingsJerseyLimitedMember_lbl" xml:lang="en-US">Gold Bullion Holdings (Jersey) Limited [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_GoldBullionHoldingsJerseyLimitedMember" xlink:to="wt_GoldBullionHoldingsJerseyLimitedMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_FirstInstallmentsMember" xlink:href="wt-20231231.xsd#wt_FirstInstallmentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_FirstInstallmentsMember_lbl" xml:lang="en-US">First Installments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FirstInstallmentsMember" xlink:to="wt_FirstInstallmentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_SecondInstallmentsMember" xlink:href="wt-20231231.xsd#wt_SecondInstallmentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_SecondInstallmentsMember_lbl" xml:lang="en-US">Second Installments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SecondInstallmentsMember" xlink:to="wt_SecondInstallmentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ThirdInstallmentsMember" xlink:href="wt-20231231.xsd#wt_ThirdInstallmentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ThirdInstallmentsMember_lbl" xml:lang="en-US">Third Installments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ThirdInstallmentsMember" xlink:to="wt_ThirdInstallmentsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ConvertibleSeniorNotesDue2028Member" xlink:href="wt-20231231.xsd#wt_ConvertibleSeniorNotesDue2028Member"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ConvertibleSeniorNotesDue2028Member_lbl" xml:lang="en-US">Convertible Senior Notes due 2028 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConvertibleSeniorNotesDue2028Member" xlink:to="wt_ConvertibleSeniorNotesDue2028Member_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember" xlink:href="wt-20231231.xsd#wt_ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember_lbl" xml:lang="en-US">Convertible Senior Notes due 2026 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember" xlink:to="wt_ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember" xlink:href="wt-20231231.xsd#wt_ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember_lbl" xml:lang="en-US">Convertible Senior Notes due 2023 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember" xlink:to="wt_ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ConvertibleSeniorNotesMember" xlink:href="wt-20231231.xsd#wt_ConvertibleSeniorNotesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ConvertibleSeniorNotesMember_lbl" xml:lang="en-US">Convertible Senior Notes [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConvertibleSeniorNotesMember" xlink:to="wt_ConvertibleSeniorNotesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ConvertibleNotesPayableMember_lbl" xml:lang="en-US">Convertible Notes Payable [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableMember" xlink:to="us-gaap_ConvertibleNotesPayableMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesMember_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_SeriesANonVotingConvertiblePreferredStockMember" xlink:href="wt-20231231.xsd#wt_SeriesANonVotingConvertiblePreferredStockMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_SeriesANonVotingConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series A Non-Voting Convertible Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SeriesANonVotingConvertiblePreferredStockMember" xlink:to="wt_SeriesANonVotingConvertiblePreferredStockMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="wt_SeriesANonVotingConvertiblePreferredStockMember_lbl0" xml:lang="en-US">Series A Non Voting Convertible Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SeriesANonVotingConvertiblePreferredStockMember" xlink:to="wt_SeriesANonVotingConvertiblePreferredStockMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_GBHMember" xlink:href="wt-20231231.xsd#wt_GBHMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_GBHMember_lbl" xml:lang="en-US">GBH [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_GBHMember" xlink:to="wt_GBHMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_WisdomTreeProductsMember" xlink:href="wt-20231231.xsd#wt_WisdomTreeProductsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_WisdomTreeProductsMember_lbl" xml:lang="en-US">WisdomTree Products [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_WisdomTreeProductsMember" xlink:to="wt_WisdomTreeProductsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_AffiliatedBlockchainEnabledFundsMember" xlink:href="wt-20231231.xsd#wt_AffiliatedBlockchainEnabledFundsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_AffiliatedBlockchainEnabledFundsMember_lbl" xml:lang="en-US">Affiliated Blockchain Enabled Funds [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_AffiliatedBlockchainEnabledFundsMember" xlink:to="wt_AffiliatedBlockchainEnabledFundsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockOptionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockOptionMember_lbl" xml:lang="en-US">Stock options [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionMember" xlink:to="us-gaap_StockOptionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_BelowTwentyFifthPercentileMember" xlink:href="wt-20231231.xsd#wt_BelowTwentyFifthPercentileMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_BelowTwentyFifthPercentileMember_lbl" xml:lang="en-US">Below Twenty Fifth Percentile [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_BelowTwentyFifthPercentileMember" xlink:to="wt_BelowTwentyFifthPercentileMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_StockholderRightAgreementMember" xlink:href="wt-20231231.xsd#wt_StockholderRightAgreementMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_StockholderRightAgreementMember_lbl" xml:lang="en-US">Stockholder Right Agreement [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_StockholderRightAgreementMember" xlink:to="wt_StockholderRightAgreementMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_BoardOfDirectorsChairmanMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_BoardOfDirectorsChairmanMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl" xml:lang="en-US">Board of Directors Chairman [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl0" xml:lang="en-US">Board of Directors [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_AcquiringPersonMember" xlink:href="wt-20231231.xsd#wt_AcquiringPersonMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_AcquiringPersonMember_lbl" xml:lang="en-US">Acquiring Person [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_AcquiringPersonMember" xlink:to="wt_AcquiringPersonMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_PassiveStockholdersMember" xlink:href="wt-20231231.xsd#wt_PassiveStockholdersMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_PassiveStockholdersMember_lbl" xml:lang="en-US">Passive stockholders [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PassiveStockholdersMember" xlink:to="wt_PassiveStockholdersMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="srt_ScenarioForecastMember_lbl" xml:lang="en-US">Forecast [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ManJersMember" xlink:href="wt-20231231.xsd#wt_ManJersMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_ManJersMember_lbl" xml:lang="en-US">ManJers [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ManJersMember" xlink:to="wt_ManJersMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherNoncurrentLiabilitiesMember_lbl" xml:lang="en-US">Other Noncurrent Liabilities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="us-gaap_OtherNoncurrentLiabilitiesMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_WorldGoldCouncilMember" xlink:href="wt-20231231.xsd#wt_WorldGoldCouncilMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_WorldGoldCouncilMember_lbl" xml:lang="en-US">World Gold Council [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_WorldGoldCouncilMember" xlink:to="wt_WorldGoldCouncilMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_SecurrencyMember" xlink:href="wt-20231231.xsd#wt_SecurrencyMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_SecurrencyMember_lbl" xml:lang="en-US">Securrency [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SecurrencyMember" xlink:to="wt_SecurrencyMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_SaleOfCanadianETFBusinessMember" xlink:href="wt-20231231.xsd#wt_SaleOfCanadianETFBusinessMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="wt_SaleOfCanadianETFBusinessMember_lbl" xml:lang="en-US">Sale of Canadian ETF Business [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SaleOfCanadianETFBusinessMember" xlink:to="wt_SaleOfCanadianETFBusinessMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xml:lang="en-US">Financial Instruments [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_RelatedPartiesDomainDomain" xlink:href="wt-20231231.xsd#wt_RelatedPartiesDomainDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_RelatedPartiesDomainDomain_lbl" xml:lang="en-US">RelatedPartiesDomain [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RelatedPartiesDomainDomain" xlink:to="wt_RelatedPartiesDomainDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfStockDomain_lbl" xml:lang="en-US">Class of Stock [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductsAndServicesDomain_lbl" xml:lang="en-US">Product and Service [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductsAndServicesDomain" xlink:to="srt_ProductsAndServicesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US">Equity Component [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_SignificantAccountingPoliciesTablesTable" xlink:href="wt-20231231.xsd#wt_SignificantAccountingPoliciesTablesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_SignificantAccountingPoliciesTablesTable_lbl" xml:lang="en-US">Significant Accounting Policies (Tables) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SignificantAccountingPoliciesTablesTable" xlink:to="wt_SignificantAccountingPoliciesTablesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_SignificantAccountingPoliciesTablesLineItems" xlink:href="wt-20231231.xsd#wt_SignificantAccountingPoliciesTablesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_SignificantAccountingPoliciesTablesLineItems_lbl" xml:lang="en-US">Significant Accounting Policies (Tables) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SignificantAccountingPoliciesTablesLineItems" xlink:to="wt_SignificantAccountingPoliciesTablesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeMember_lbl" xml:lang="en-US">Statistical Measurement [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Schedule of Depreciation and Amortization [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xml:lang="en-US">Investments [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_InvestmentTypeCategorizationMember_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xml:lang="en-US">Measurement Frequency [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain_lbl" xml:lang="en-US">Security Owned and Sold, Not yet Purchased Fair Value, Security Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" xlink:to="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xml:lang="en-US">Asset Class [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US">Schedule of Assets and Liabilities Measured at Fair Value [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl" xml:lang="en-US">Fair Value by Liability Class [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl" xml:lang="en-US">Schedule of Beginning and Ending Balances of Recurring Fair Value Measurements Classified [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralTable_lbl" xml:lang="en-US">Financial Instruments Owned and Pledged as Collateral [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralTable" xlink:to="us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_lbl" xml:lang="en-US">Debt and Equity Securities, FV-NI [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:to="us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable" xlink:href="wt-20231231.xsd#wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable_lbl" xml:lang="en-US">Securities Held-to-Maturity (Details) - Schedule of Unrealized Losses, Gains and Fair Value of Securities Held-to-Maturity [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable" xlink:to="wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityLineItems" xlink:href="wt-20231231.xsd#wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityLineItems_lbl" xml:lang="en-US">Securities Held-to-Maturity (Details) - Schedule of Unrealized Losses, Gains and Fair Value of Securities Held-to-Maturity [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityLineItems" xlink:to="wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_InvestmentsDetailsScheduleofInvestmentsTable" xlink:href="wt-20231231.xsd#wt_InvestmentsDetailsScheduleofInvestmentsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_InvestmentsDetailsScheduleofInvestmentsTable_lbl" xml:lang="en-US">Investments (Details) - Schedule of Investments [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_InvestmentsDetailsScheduleofInvestmentsTable" xlink:to="wt_InvestmentsDetailsScheduleofInvestmentsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_InvestmentsDetailsScheduleofInvestmentsLineItems" xlink:href="wt-20231231.xsd#wt_InvestmentsDetailsScheduleofInvestmentsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_InvestmentsDetailsScheduleofInvestmentsLineItems_lbl" xml:lang="en-US">Schedule of Investments [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_InvestmentsDetailsScheduleofInvestmentsLineItems" xlink:to="wt_InvestmentsDetailsScheduleofInvestmentsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedFinancialStatementsTable" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfCondensedFinancialStatementsTable_lbl" xml:lang="en-US">Condensed Financial Statements [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedFinancialStatementsTable" xlink:to="srt_ScheduleOfCondensedFinancialStatementsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CondensedFinancialStatementsCaptionsLineItems_lbl" xml:lang="en-US">Condensed Financial Statements, Captions [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="srt_CondensedFinancialStatementsCaptionsLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl0" xml:lang="en-US">Property, Plant and Equipment [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredConsiderationgoldpaymentsDetailsScheduleofValuationofDeferredConsiderationTable" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationgoldpaymentsDetailsScheduleofValuationofDeferredConsiderationTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_DeferredConsiderationgoldpaymentsDetailsScheduleofValuationofDeferredConsiderationTable_lbl" xml:lang="en-US">Deferred Consideration&#8212;gold payments (Details) - Schedule of Valuation of Deferred Consideration [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredConsiderationgoldpaymentsDetailsScheduleofValuationofDeferredConsiderationTable" xlink:to="wt_DeferredConsiderationgoldpaymentsDetailsScheduleofValuationofDeferredConsiderationTable_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_DisclosureOfValuationOfDeferredConsiderationLineItems" xlink:href="wt-20231231.xsd#wt_DisclosureOfValuationOfDeferredConsiderationLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_DisclosureOfValuationOfDeferredConsiderationLineItems_lbl" xml:lang="en-US">Disclosure Of Valuation Of Deferred Consideration [Line Item]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DisclosureOfValuationOfDeferredConsiderationLineItems" xlink:to="wt_DisclosureOfValuationOfDeferredConsiderationLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xml:lang="en-US">Debt Instrument, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ConvertibleNotesDetailsScheduleofKeyTermsofConvertibleNotesTable" xlink:href="wt-20231231.xsd#wt_ConvertibleNotesDetailsScheduleofKeyTermsofConvertibleNotesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ConvertibleNotesDetailsScheduleofKeyTermsofConvertibleNotesTable_lbl" xml:lang="en-US">Convertible Notes (Details) - Schedule of Key Terms of Convertible Notes [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConvertibleNotesDetailsScheduleofKeyTermsofConvertibleNotesTable" xlink:to="wt_ConvertibleNotesDetailsScheduleofKeyTermsofConvertibleNotesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xml:lang="en-US">Schedule of Key Terms of Convertible Notes [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ConvertibleNotesDetailsScheduleofConvertibleNotesTable" xlink:href="wt-20231231.xsd#wt_ConvertibleNotesDetailsScheduleofConvertibleNotesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ConvertibleNotesDetailsScheduleofConvertibleNotesTable_lbl" xml:lang="en-US">Convertible Notes (Details) - Schedule of Convertible Notes [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConvertibleNotesDetailsScheduleofConvertibleNotesTable" xlink:to="wt_ConvertibleNotesDetailsScheduleofConvertibleNotesTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentLineItems_lbl0" xml:lang="en-US">Debt Instrument [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPreferredUnitsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPreferredUnitsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPreferredUnitsTable_lbl" xml:lang="en-US">Schedule of Preferred Units [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPreferredUnitsTable" xlink:to="us-gaap_ScheduleOfPreferredUnitsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredUnitsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredUnitsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredUnitsLineItems_lbl" xml:lang="en-US">Preferred Units [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredUnitsLineItems" xlink:to="us-gaap_PreferredUnitsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_EquityMethodInvesteeNameDomain_lbl" xml:lang="en-US">Investment, Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="srt_EquityMethodInvesteeNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTable_lbl" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableInterestEntityLineItems_lbl" xml:lang="en-US">Schedule of Information about Variable Interests [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_VariableInterestEntityLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_RevenuesfromContractswithCustomersDetailsScheduleofRevenuesfromContractswithCustomersTable" xlink:href="wt-20231231.xsd#wt_RevenuesfromContractswithCustomersDetailsScheduleofRevenuesfromContractswithCustomersTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_RevenuesfromContractswithCustomersDetailsScheduleofRevenuesfromContractswithCustomersTable_lbl" xml:lang="en-US">Revenues from Contracts with Customers (Details) - Schedule of Revenues from Contracts with Customers [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RevenuesfromContractswithCustomersDetailsScheduleofRevenuesfromContractswithCustomersTable" xlink:to="wt_RevenuesfromContractswithCustomersDetailsScheduleofRevenuesfromContractswithCustomersTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_lbl" xml:lang="en-US">Schedule of Revenues from Contracts with Customers [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_SegmentGeographicalDomain_lbl" xml:lang="en-US">Geographical [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesTable" xlink:href="wt-20231231.xsd#wt_RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesTable_lbl" xml:lang="en-US">Revenues from Contracts with Customers (Details) - Schedule of Geographic Distribution of Revenues [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesTable" xlink:to="wt_RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesLineItems" xlink:href="wt-20231231.xsd#wt_RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesLineItems_lbl" xml:lang="en-US">Revenues from Contracts with Customers (Details) - Schedule of Geographic Distribution of Revenues [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesLineItems" xlink:to="wt_RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyDomain_lbl" xml:lang="en-US">Related Party, Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_RelatedPartyTransactionsDetailsScheduleofAccountsReceivablefromRelatedPartiesTable" xlink:href="wt-20231231.xsd#wt_RelatedPartyTransactionsDetailsScheduleofAccountsReceivablefromRelatedPartiesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_RelatedPartyTransactionsDetailsScheduleofAccountsReceivablefromRelatedPartiesTable_lbl" xml:lang="en-US">Related Party Transactions (Details) - Schedule of Accounts Receivable from Related Parties [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RelatedPartyTransactionsDetailsScheduleofAccountsReceivablefromRelatedPartiesTable" xlink:to="wt_RelatedPartyTransactionsDetailsScheduleofAccountsReceivablefromRelatedPartiesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US">Schedule of Accounts Receivable from Related Parties [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl0" xml:lang="en-US">Schedule of Revenues from Advisory Services Provided to Related Parties [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xml:lang="en-US">Title of Individual [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_StockBasedAwardsDetailsScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable" xlink:href="wt-20231231.xsd#wt_StockBasedAwardsDetailsScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_StockBasedAwardsDetailsScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable_lbl" xml:lang="en-US">Stock-Based Awards (Details) - Schedule of Unrecognized Stock-Based Compensation Expense and Average Remaining Vesting Period [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_StockBasedAwardsDetailsScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable" xlink:to="wt_StockBasedAwardsDetailsScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US">Award Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_StockBasedAwardsDetailsScheduleofRestrictedStockActivityandRestrictedStockUnitTable" xlink:href="wt-20231231.xsd#wt_StockBasedAwardsDetailsScheduleofRestrictedStockActivityandRestrictedStockUnitTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_StockBasedAwardsDetailsScheduleofRestrictedStockActivityandRestrictedStockUnitTable_lbl" xml:lang="en-US">Stock-Based Awards (Details) - Schedule of Restricted Stock Activity and Restricted Stock Unit [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_StockBasedAwardsDetailsScheduleofRestrictedStockActivityandRestrictedStockUnitTable" xlink:to="wt_StockBasedAwardsDetailsScheduleofRestrictedStockActivityandRestrictedStockUnitTable_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_EarningsPerShareDetailsScheduleofReconciliationofBasicandDilutedEarningsPerShareTable" xlink:href="wt-20231231.xsd#wt_EarningsPerShareDetailsScheduleofReconciliationofBasicandDilutedEarningsPerShareTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_EarningsPerShareDetailsScheduleofReconciliationofBasicandDilutedEarningsPerShareTable_lbl" xml:lang="en-US">Earnings Per Share (Details) - Schedule of Reconciliation of Basic and Diluted Earnings Per Share [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_EarningsPerShareDetailsScheduleofReconciliationofBasicandDilutedEarningsPerShareTable" xlink:to="wt_EarningsPerShareDetailsScheduleofReconciliationofBasicandDilutedEarningsPerShareTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicLineItems_lbl" xml:lang="en-US">Schedule of Reconciliation of Basic and Diluted Earnings Per Share [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicLineItems" xlink:to="us-gaap_EarningsPerShareBasicLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_EarningsPerShareDetailsScheduleofWeightedAverageNumberofSharesTable" xlink:href="wt-20231231.xsd#wt_EarningsPerShareDetailsScheduleofWeightedAverageNumberofSharesTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_EarningsPerShareDetailsScheduleofWeightedAverageNumberofSharesTable_lbl" xml:lang="en-US">Earnings Per Share (Details) - Schedule of Weighted Average Number of Shares [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_EarningsPerShareDetailsScheduleofWeightedAverageNumberofSharesTable" xlink:to="wt_EarningsPerShareDetailsScheduleofWeightedAverageNumberofSharesTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDilutedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDilutedLineItems_lbl" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDilutedLineItems" xlink:to="us-gaap_EarningsPerShareDilutedLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable" xlink:href="wt-20231231.xsd#wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable_lbl" xml:lang="en-US">Income Taxes (Details) - Schedule of Domestic and Foreign Components of Income before Income Tax Expense [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable" xlink:to="wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseLineItems" xlink:href="wt-20231231.xsd#wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseLineItems_lbl" xml:lang="en-US">Income Taxes (Details) - Schedule of Domestic and Foreign Components of Income before Income Tax Expense [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseLineItems" xlink:to="wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xml:lang="en-US">Income Tax Authority [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxesDetailsScheduleofIncomeTaxPaymentsByJurisdictionTable" xlink:href="wt-20231231.xsd#wt_IncomeTaxesDetailsScheduleofIncomeTaxPaymentsByJurisdictionTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_IncomeTaxesDetailsScheduleofIncomeTaxPaymentsByJurisdictionTable_lbl" xml:lang="en-US">Income Taxes (Details) - Schedule of Income Tax Payments By Jurisdiction [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncomeTaxesDetailsScheduleofIncomeTaxPaymentsByJurisdictionTable" xlink:to="wt_IncomeTaxesDetailsScheduleofIncomeTaxPaymentsByJurisdictionTable_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxDisclosureLineItems" xlink:href="wt-20231231.xsd#wt_IncomeTaxDisclosureLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_IncomeTaxDisclosureLineItems_lbl" xml:lang="en-US">Income Taxes [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncomeTaxDisclosureLineItems" xlink:to="wt_IncomeTaxDisclosureLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_lbl" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Nature of Uncertainty [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain" xlink:to="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxesDetailsScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable" xlink:href="wt-20231231.xsd#wt_IncomeTaxesDetailsScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_IncomeTaxesDetailsScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable_lbl" xml:lang="en-US">Income Taxes (Details) - Schedule of Changes in Balance of Gross Unrecognized Tax Benefits [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncomeTaxesDetailsScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable" xlink:to="wt_IncomeTaxesDetailsScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxContingencyLineItems_lbl" xml:lang="en-US">Income Taxes [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_IncomeTaxContingencyLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfGoodwillTable_lbl" xml:lang="en-US">Schedule of Goodwill [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="us-gaap_ScheduleOfGoodwillTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillLineItems_lbl" xml:lang="en-US">Goodwill [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_GoodwillLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_GoodwillandIntangibleAssetsDetailsScheduleofIntangibleAssetsTable" xlink:href="wt-20231231.xsd#wt_GoodwillandIntangibleAssetsDetailsScheduleofIntangibleAssetsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_GoodwillandIntangibleAssetsDetailsScheduleofIntangibleAssetsTable_lbl" xml:lang="en-US">Goodwill and Intangible Assets (Details) - Schedule of Intangible Assets [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_GoodwillandIntangibleAssetsDetailsScheduleofIntangibleAssetsTable" xlink:to="wt_GoodwillandIntangibleAssetsDetailsScheduleofIntangibleAssetsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_lbl" xml:lang="en-US">Real Estate [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:to="srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfRestructuringDomain_lbl" xml:lang="en-US">Type of Restructuring [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfRestructuringDomain" xlink:to="us-gaap_TypeOfRestructuringDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_lbl" xml:lang="en-US">Schedule of Impaired Long-Lived Assets Held and Used [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable" xlink:to="us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_lbl" xml:lang="en-US">Impaired Long-Lived Assets Held and Used [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems" xlink:to="us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfAdoptionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xml:lang="en-US">Accounting Standards Update [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_TypeOfAdoptionMember_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_SignificantAccountingPoliciesDetailsTable" xlink:href="wt-20231231.xsd#wt_SignificantAccountingPoliciesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_SignificantAccountingPoliciesDetailsTable_lbl" xml:lang="en-US">Significant Accounting Policies (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SignificantAccountingPoliciesDetailsTable" xlink:to="wt_SignificantAccountingPoliciesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" xml:lang="en-US">Significant Accounting Policies [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentDomain_lbl" xml:lang="en-US">Segments [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentDomain" xlink:to="us-gaap_SegmentDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_CashandCashEquivalentsDetailsTable" xlink:href="wt-20231231.xsd#wt_CashandCashEquivalentsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_CashandCashEquivalentsDetailsTable_lbl" xml:lang="en-US">Cash and Cash Equivalents (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_CashandCashEquivalentsDetailsTable" xlink:to="wt_CashandCashEquivalentsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsLineItems_lbl" xml:lang="en-US">Cash and Cash Equivalents [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_FinancialInstrumentsOwnedDetailsTable" xlink:href="wt-20231231.xsd#wt_FinancialInstrumentsOwnedDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_FinancialInstrumentsOwnedDetailsTable_lbl" xml:lang="en-US">Financial Instruments Owned (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FinancialInstrumentsOwnedDetailsTable" xlink:to="wt_FinancialInstrumentsOwnedDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralLineItems_lbl" xml:lang="en-US">Financial Instruments Owned [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralLineItems" xlink:to="us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExtinguishmentOfDebtTypeDomain_lbl" xml:lang="en-US">Extinguishment of Debt, Type [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:to="us-gaap_ExtinguishmentOfDebtTypeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_InvestmentsDetailsTable" xlink:href="wt-20231231.xsd#wt_InvestmentsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_InvestmentsDetailsTable_lbl" xml:lang="en-US">Investments (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_InvestmentsDetailsTable" xlink:to="wt_InvestmentsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInvestmentsLineItems_lbl" xml:lang="en-US">Investments [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_ScheduleOfInvestmentsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_AgreementDomainDomain" xlink:href="wt-20231231.xsd#wt_AgreementDomainDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_AgreementDomainDomain_lbl" xml:lang="en-US">AgreementDomain [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_AgreementDomainDomain" xlink:to="wt_AgreementDomainDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_DeferredConsiderationgoldpaymentsDetailsTable" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationgoldpaymentsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_DeferredConsiderationgoldpaymentsDetailsTable_lbl" xml:lang="en-US">Deferred Consideration&#8212;gold payments (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredConsiderationgoldpaymentsDetailsTable" xlink:to="wt_DeferredConsiderationgoldpaymentsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US">Deferred Consideration [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xml:lang="en-US">Balance Sheet Location [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_BalanceSheetLocationDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ConvertibleNotesDetailsTable" xlink:href="wt-20231231.xsd#wt_ConvertibleNotesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ConvertibleNotesDetailsTable_lbl" xml:lang="en-US">Convertible Notes (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConvertibleNotesDetailsTable" xlink:to="wt_ConvertibleNotesDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentLineItems_lbl1" xml:lang="en-US">Convertible Senior Notes [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl1"/>
    <loc xlink:type="locator" xlink:label="wt_SeriesAPreferredStockDetailsTable" xlink:href="wt-20231231.xsd#wt_SeriesAPreferredStockDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_SeriesAPreferredStockDetailsTable_lbl" xml:lang="en-US">Series A Preferred Stock (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SeriesAPreferredStockDetailsTable" xlink:to="wt_SeriesAPreferredStockDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredUnitsLineItems_lbl0" xml:lang="en-US">Preferred Stock [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredUnitsLineItems" xlink:to="us-gaap_PreferredUnitsLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsTable" xlink:href="wt-20231231.xsd#wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsTable_lbl" xml:lang="en-US">Payable to Gold Bullion Holdings Jersey Limited GBH (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsTable" xlink:to="wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems" xlink:href="wt-20231231.xsd#wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems_lbl" xml:lang="en-US">Payable to Gold Bullion Holdings Jersey Limited GBH (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems" xlink:to="wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ContingenciesDetailsTable" xlink:href="wt-20231231.xsd#wt_ContingenciesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ContingenciesDetailsTable_lbl" xml:lang="en-US">Contingencies (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ContingenciesDetailsTable" xlink:to="wt_ContingenciesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainContingenciesLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainContingenciesLineItems_lbl" xml:lang="en-US">Contingencies [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainContingenciesLineItems" xlink:to="us-gaap_GainContingenciesLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_RelatedPartyTransactionsDetailsTable" xlink:href="wt-20231231.xsd#wt_RelatedPartyTransactionsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_RelatedPartyTransactionsDetailsTable_lbl" xml:lang="en-US">Related Party Transactions (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RelatedPartyTransactionsDetailsTable" xlink:to="wt_RelatedPartyTransactionsDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl1" xml:lang="en-US">Related Party Transactions [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VestingDomain_lbl" xml:lang="en-US">Vesting [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_VestingDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_StockBasedAwardsDetailsTable" xlink:href="wt-20231231.xsd#wt_StockBasedAwardsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_StockBasedAwardsDetailsTable_lbl" xml:lang="en-US">Stock-Based Awards (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_StockBasedAwardsDetailsTable" xlink:to="wt_StockBasedAwardsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_OwnershipDomain_lbl" xml:lang="en-US">Ownership [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipDomain" xlink:to="srt_OwnershipDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_StockholderRightsPlanDetailsTable" xlink:href="wt-20231231.xsd#wt_StockholderRightsPlanDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_StockholderRightsPlanDetailsTable_lbl" xml:lang="en-US">Stockholder Rights Plan (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_StockholderRightsPlanDetailsTable" xlink:to="wt_StockholderRightsPlanDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_DisclosureOfStockholderRightsPlanLineItems" xlink:href="wt-20231231.xsd#wt_DisclosureOfStockholderRightsPlanLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_DisclosureOfStockholderRightsPlanLineItems_lbl" xml:lang="en-US">Stockholder Rights Plan [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DisclosureOfStockholderRightsPlanLineItems" xlink:to="wt_DisclosureOfStockholderRightsPlanLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xml:lang="en-US">Scenario [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_EarningsPerShareDetailsTable" xlink:href="wt-20231231.xsd#wt_EarningsPerShareDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_EarningsPerShareDetailsTable_lbl" xml:lang="en-US">Earnings Per Share (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_EarningsPerShareDetailsTable" xlink:to="wt_EarningsPerShareDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_EarningsPerShareDetailsLineItems" xlink:href="wt-20231231.xsd#wt_EarningsPerShareDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_EarningsPerShareDetailsLineItems_lbl" xml:lang="en-US">Earnings Per Share (Details) [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_EarningsPerShareDetailsLineItems" xlink:to="wt_EarningsPerShareDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_IncomeTaxesDetailsTable" xlink:href="wt-20231231.xsd#wt_IncomeTaxesDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_IncomeTaxesDetailsTable_lbl" xml:lang="en-US">Income Taxes (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncomeTaxesDetailsTable" xlink:to="wt_IncomeTaxesDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfIncomeTaxLineItems" xlink:href="wt-20231231.xsd#wt_ScheduleOfIncomeTaxLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfIncomeTaxLineItems_lbl" xml:lang="en-US">Schedule Of Income Tax [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfIncomeTaxLineItems" xlink:to="wt_ScheduleOfIncomeTaxLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xml:lang="en-US">Related Party Transaction [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyTransactionDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xml:lang="en-US">Consolidated Entities [Domain]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="srt_ConsolidatedEntitiesDomain_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_SharesRepurchasedDetailsTable" xlink:href="wt-20231231.xsd#wt_SharesRepurchasedDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_SharesRepurchasedDetailsTable_lbl" xml:lang="en-US">Shares Repurchased (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SharesRepurchasedDetailsTable" xlink:to="wt_SharesRepurchasedDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_SharesRepurchasedDetailsLineItems" xlink:href="wt-20231231.xsd#wt_SharesRepurchasedDetailsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_SharesRepurchasedDetailsLineItems_lbl" xml:lang="en-US">Shares Repurchased [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SharesRepurchasedDetailsLineItems" xlink:to="wt_SharesRepurchasedDetailsLineItems_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_GoodwillandIntangibleAssetsDetailsTable" xlink:href="wt-20231231.xsd#wt_GoodwillandIntangibleAssetsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_GoodwillandIntangibleAssetsDetailsTable_lbl" xml:lang="en-US">Goodwill and Intangible Assets (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_GoodwillandIntangibleAssetsDetailsTable" xlink:to="wt_GoodwillandIntangibleAssetsDetailsTable_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GoodwillLineItems_lbl0" xml:lang="en-US">Goodwill and Intangible Assets [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_GoodwillLineItems_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_ContingentPaymentsDetailsTable" xlink:href="wt-20231231.xsd#wt_ContingentPaymentsDetailsTable"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ContingentPaymentsDetailsTable_lbl" xml:lang="en-US">Contingent Payments (Details) [Table]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ContingentPaymentsDetailsTable" xlink:to="wt_ContingentPaymentsDetailsTable_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ContingentPaymentsLineItems" xlink:href="wt-20231231.xsd#wt_ContingentPaymentsLineItems"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ContingentPaymentsLineItems_lbl" xml:lang="en-US">Contingent Payments [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ContingentPaymentsLineItems" xlink:to="wt_ContingentPaymentsLineItems_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_AdvisoryFeesReceivedInGold_lbl0" xml:lang="en-US">Advisory fees received in gold and other precious metals.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_AdvisoryFeesReceivedInGold" xlink:to="wt_AdvisoryFeesReceivedInGold_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_AggregateConsiderationPayable_lbl0" xml:lang="en-US">Amount of aggregate consideration payable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_AggregateConsiderationPayable" xlink:to="wt_AggregateConsiderationPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_AmortizationOfIssuanceCostsConvertibleNotes_lbl0" xml:lang="en-US">Amortization of issuance costs &#8211; convertible notes.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_AmortizationOfIssuanceCostsConvertibleNotes" xlink:to="wt_AmortizationOfIssuanceCostsConvertibleNotes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_BusinessCombinationConsiderationTransferredDeferredPaymentInterest_lbl0" xml:lang="en-US">Discount rate used to value the deferred consideration.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_BusinessCombinationConsiderationTransferredDeferredPaymentInterest" xlink:to="wt_BusinessCombinationConsiderationTransferredDeferredPaymentInterest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_BusinessCombinationDeferredConsiderationLiability_lbl0" xml:lang="en-US">Amount of liability arising from deferred consideration in a business combination.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_BusinessCombinationDeferredConsiderationLiability" xlink:to="wt_BusinessCombinationDeferredConsiderationLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_CapitalStockPercentage_lbl0" xml:lang="en-US">Capital stock percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_CapitalStockPercentage" xlink:to="wt_CapitalStockPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_CarryingValueOfConvertibleNotes_lbl0" xml:lang="en-US">Carrying value of convertible notes (with maturities initially due after one year), net of unamortized issuance costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_CarryingValueOfConvertibleNotes" xlink:to="wt_CarryingValueOfConvertibleNotes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_CashEquivalentsMaturityPeriod_lbl0" xml:lang="en-US">Cash equivalents maturity period.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_CashEquivalentsMaturityPeriod" xlink:to="wt_CashEquivalentsMaturityPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_ChangeInForeignNetOperatingLosses_lbl0" xml:lang="en-US">Change in foreign net operating losses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ChangeInForeignNetOperatingLosses" xlink:to="wt_ChangeInForeignNetOperatingLosses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_ContingentPaymentTextBlock_lbl0" xml:lang="en-US">Contingent payment text block.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ContingentPaymentTextBlock" xlink:to="wt_ContingentPaymentTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_ContingentPaymentsPolicyTextBlock_lbl0" xml:lang="en-US">Contingent payments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ContingentPaymentsPolicyTextBlock" xlink:to="wt_ContingentPaymentsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_ContractualGoldPaymentgoldOuncesPaid_lbl0" xml:lang="en-US">Contractual gold payments gold ounces paid.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ContractualGoldPaymentgoldOuncesPaid" xlink:to="wt_ContractualGoldPaymentgoldOuncesPaid_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_ContractualGoldPayments_lbl1" xml:lang="en-US">Contractual gold payments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ContractualGoldPayments" xlink:to="wt_ContractualGoldPayments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_ContractualGoldPaymentsPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Contractual gold payments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ContractualGoldPaymentsPolicyPolicyTextBlock" xlink:to="wt_ContractualGoldPaymentsPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_ConversionOfNoteUponAFutureFinancingRound_lbl0" xml:lang="en-US">The percentage of conversion of note upon a future financing round.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConversionOfNoteUponAFutureFinancingRound" xlink:to="wt_ConversionOfNoteUponAFutureFinancingRound_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_ConversionOfNotesUponAFutureEquityFinancing_lbl0" xml:lang="en-US">The percentage of conversion of note upon a future equity financing.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConversionOfNotesUponAFutureEquityFinancing" xlink:to="wt_ConversionOfNotesUponAFutureEquityFinancing_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_ConvertibleNoteDiscountRate_lbl0" xml:lang="en-US">Convertible notes discount rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConvertibleNoteDiscountRate" xlink:to="wt_ConvertibleNoteDiscountRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_CostMethodInvestmentFairValueDisclosure_lbl0" xml:lang="en-US">Cost method investment fair value disclosure</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_CostMethodInvestmentFairValueDisclosure" xlink:to="wt_CostMethodInvestmentFairValueDisclosure_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_CostMethodInvestmentOwnershipPercentage_lbl0" xml:lang="en-US">Cost method investment ownership percentage.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_CostMethodInvestmentOwnershipPercentage" xlink:to="wt_CostMethodInvestmentOwnershipPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_DebtInstrumentRedemptionPrice_lbl0" xml:lang="en-US">Debt instrument redemption price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DebtInstrumentRedemptionPrice" xlink:to="wt_DebtInstrumentRedemptionPrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_Default_lbl0" xml:lang="en-US">The percentage of default.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_Default" xlink:to="wt_Default_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_DeferredConsiderationCurrent_lbl1" xml:lang="en-US">Deferred Consideration Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredConsiderationCurrent" xlink:to="wt_DeferredConsiderationCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_DeferredConsiderationGoldPaymentsPolicyTextBlock_lbl0" xml:lang="en-US">Accounting policy related to deferred consideration - gold payments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredConsiderationGoldPaymentsPolicyTextBlock" xlink:to="wt_DeferredConsiderationGoldPaymentsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_DeferredConsiderationNoncurrent_lbl1" xml:lang="en-US">Deferred consideration - noncurrent.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredConsiderationNoncurrent" xlink:to="wt_DeferredConsiderationNoncurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_DeferredConsiderationPerpetualGrowthRate_lbl0" xml:lang="en-US">Rate at which represents the deferred consideration perpetual growth.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredConsiderationPerpetualGrowthRate" xlink:to="wt_DeferredConsiderationPerpetualGrowthRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_DeferredConsiderationTextBlock_lbl0" xml:lang="en-US">DeferredConsiderationTextBlock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredConsiderationTextBlock" xlink:to="wt_DeferredConsiderationTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_DeferredTaxAssetOperatingLossCarryForwardUnitedStates_lbl0" xml:lang="en-US">Amount of deferred tax asset operating loss carryforward united states.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredTaxAssetOperatingLossCarryForwardUnitedStates" xlink:to="wt_DeferredTaxAssetOperatingLossCarryForwardUnitedStates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_DeferredTaxAssetUnrealizedLosses_lbl0" xml:lang="en-US">Deferred Tax Asset Unrealized Losses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredTaxAssetUnrealizedLosses" xlink:to="wt_DeferredTaxAssetUnrealizedLosses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_DeferredTaxAssetsCapitalLossCarryforwardsSubjectToExpiration_lbl0" xml:lang="en-US">Deferred tax assets capital loss carryforwards subject to expiration.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredTaxAssetsCapitalLossCarryforwardsSubjectToExpiration" xlink:to="wt_DeferredTaxAssetsCapitalLossCarryforwardsSubjectToExpiration_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_DeferredTaxAssetsLiabilitiesGross_lbl0" xml:lang="en-US">Deferred Tax Assets Liabilities Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredTaxAssetsLiabilitiesGross" xlink:to="wt_DeferredTaxAssetsLiabilitiesGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_DeferredTaxAssetsOperatingLeaseLiabilities_lbl0" xml:lang="en-US">Deferred tax assets operating lease liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:to="wt_DeferredTaxAssetsOperatingLeaseLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax_lbl0" xml:lang="en-US">Deferred tax assets, operating loss carryforwards, net of tax.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax" xlink:to="wt_DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_DeferredTaxAssetsOutsideBasisDifference_lbl0" xml:lang="en-US">Deferred tax assets outside basis difference.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredTaxAssetsOutsideBasisDifference" xlink:to="wt_DeferredTaxAssetsOutsideBasisDifference_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses_lbl0" xml:lang="en-US">Amount of deferred tax consequences attributable to taxable temporary differences derived from fixed assets and prepaid expenses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses" xlink:to="wt_DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_DeferredTaxLiabilitiesRightOfUseAssets_lbl0" xml:lang="en-US">Deferred tax liabilities right of use assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredTaxLiabilitiesRightOfUseAssets" xlink:to="wt_DeferredTaxLiabilitiesRightOfUseAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_DisclosureOfStockholderRightsPlanTextBlock_lbl0" xml:lang="en-US">Disclosure of stockholder rights plan.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DisclosureOfStockholderRightsPlanTextBlock" xlink:to="wt_DisclosureOfStockholderRightsPlanTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_DisclosureOfValuationOfDeferredConsiderationTableTextBlock_lbl0" xml:lang="en-US">Disclosure of valuation of deferred consideration.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DisclosureOfValuationOfDeferredConsiderationTableTextBlock" xlink:to="wt_DisclosureOfValuationOfDeferredConsiderationTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets_lbl0" xml:lang="en-US">Effective income tax reconcilation changes in tax related indemnification assets.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets" xlink:to="wt_EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_ExercisePricePerUnit_lbl0" xml:lang="en-US">Exercise price per unit.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ExercisePricePerUnit" xlink:to="wt_ExercisePricePerUnit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_FairValueAssumptionOfDissolutionRate_lbl0" xml:lang="en-US">Fair value assumption of dissolution rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FairValueAssumptionOfDissolutionRate" xlink:to="wt_FairValueAssumptionOfDissolutionRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions_lbl0" xml:lang="en-US">The amount of fair value measurement with unobservable inputs reconciliation recurring basis liability conversions.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions" xlink:to="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome_lbl0" xml:lang="en-US">Fair value measurement with unobservable inputs reconciliation recurring basis liability net unrealized gain loss included in earnings and other comprehensive income.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome" xlink:to="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings_lbl0" xml:lang="en-US">Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Realized Gain Loss Included In Earnings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings" xlink:to="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_ForwardsLookingGoldPrice_lbl0" xml:lang="en-US">Forward looking gold price per ounce.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ForwardsLookingGoldPrice" xlink:to="wt_ForwardsLookingGoldPrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_FundManagementAndAdministration_lbl0" xml:lang="en-US">Fund management and administration.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FundManagementAndAdministration" xlink:to="wt_FundManagementAndAdministration_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_GainLossFromChangeInDeferredConsideration_lbl2" xml:lang="en-US">Gain/loss from revaluation of deferred consideration.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_GainLossFromChangeInDeferredConsideration" xlink:to="wt_GainLossFromChangeInDeferredConsideration_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_IncomeDistributedToParticipatingSecurities_lbl0" xml:lang="en-US">Dividends to participating securities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncomeDistributedToParticipatingSecurities" xlink:to="wt_IncomeDistributedToParticipatingSecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses_lbl0" xml:lang="en-US">Income tax reconciliation change in valuation allowance capital losses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses" xlink:to="wt_IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_IncomeTaxReconciliationExpirationOfCapitalLosses_lbl0" xml:lang="en-US">Income tax reconciliation expiration of capital losses.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncomeTaxReconciliationExpirationOfCapitalLosses" xlink:to="wt_IncomeTaxReconciliationExpirationOfCapitalLosses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration_lbl0" xml:lang="en-US">Income tax reconciliation gain on revaluation termination of deferred consideration.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration" xlink:to="wt_IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_IncomeTaxReconciliationInternationalOperations_lbl0" xml:lang="en-US">Income tax reconciliation international operations.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncomeTaxReconciliationInternationalOperations" xlink:to="wt_IncomeTaxReconciliationInternationalOperations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense_lbl0" xml:lang="en-US">Income tax reconciliation nondeductible executive compensation expense.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense" xlink:to="wt_IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_IncomeTaxReconciliationUnrecognizedTaxBenefits_lbl0" xml:lang="en-US">Income tax reconciliation unrecognized tax benefits.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncomeTaxReconciliationUnrecognizedTaxBenefits" xlink:to="wt_IncomeTaxReconciliationUnrecognizedTaxBenefits_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_IncreaseDecreaseInFundManagementAndAdministrationPayable_lbl0" xml:lang="en-US">Increase (decrease) in fund management and administration payable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncreaseDecreaseInFundManagementAndAdministrationPayable" xlink:to="wt_IncreaseDecreaseInFundManagementAndAdministrationPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_IncreaseDecreaseInGoldAndOtherPreciousMetals_lbl0" xml:lang="en-US">Cash realized upon sale of gold and other precious metals.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncreaseDecreaseInGoldAndOtherPreciousMetals" xlink:to="wt_IncreaseDecreaseInGoldAndOtherPreciousMetals_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_IncreaseDecreaseInOperatingLeaseLiabilities_lbl0" xml:lang="en-US">Amount of increase or decrease in operating lease liabilities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="wt_IncreaseDecreaseInOperatingLeaseLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_IndemnificationReceivableNoncurrent_lbl0" xml:lang="en-US">Indemnification receivable noncurrent.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IndemnificationReceivableNoncurrent" xlink:to="wt_IndemnificationReceivableNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_LossContingencyCoveredByInsuranceDeductible_lbl0" xml:lang="en-US">Loss contingency covered by insurance deductible.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_LossContingencyCoveredByInsuranceDeductible" xlink:to="wt_LossContingencyCoveredByInsuranceDeductible_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_MaximumConversionRate_lbl0" xml:lang="en-US">Maximum conversion rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_MaximumConversionRate" xlink:to="wt_MaximumConversionRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_MaximumNumberOfSharesIssuableUponConversion_lbl0" xml:lang="en-US">Maximum number of shares issuable upon conversion.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_MaximumNumberOfSharesIssuableUponConversion" xlink:to="wt_MaximumNumberOfSharesIssuableUponConversion_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_MeasurementPeriodForDeterminingSharePrice_lbl0" xml:lang="en-US">Measurement period for determining share price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_MeasurementPeriodForDeterminingSharePrice" xlink:to="wt_MeasurementPeriodForDeterminingSharePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_MinimumPercentageOfLendersRequiredToHaveEntirePrincipalAmountOfConvertibleNotesRepurchasedByTheCompanyUponCertainEventsOfDefault_lbl0" xml:lang="en-US">Represents the percentage amount of minimum percentage of lenders required to have entire principal amount of convertible notes repurchased by the Company upon certain events of default.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_MinimumPercentageOfLendersRequiredToHaveEntirePrincipalAmountOfConvertibleNotesRepurchasedByTheCompanyUponCertainEventsOfDefault" xlink:to="wt_MinimumPercentageOfLendersRequiredToHaveEntirePrincipalAmountOfConvertibleNotesRepurchasedByTheCompanyUponCertainEventsOfDefault_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements_lbl0" xml:lang="en-US">Minimum regulatory net liquid asset requirement for certain of the Company&apos;s international subsidiaries.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements" xlink:to="wt_NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_NondeductibleLossOnExtinguishmentOfConvertibleNotes_lbl0" xml:lang="en-US">Non-deductible loss on extinguishment of convertible notes.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_NondeductibleLossOnExtinguishmentOfConvertibleNotes" xlink:to="wt_NondeductibleLossOnExtinguishmentOfConvertibleNotes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_NumberOfThresholdTradingDaysForDeterminingTheSharePrice_lbl0" xml:lang="en-US">Number Of Threshold Trading Days For Determining The Share Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_NumberOfThresholdTradingDaysForDeterminingTheSharePrice" xlink:to="wt_NumberOfThresholdTradingDaysForDeterminingTheSharePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_OperatingLossCarryForwardExpirationYear_lbl0" xml:lang="en-US">Operating loss carry forward expiration year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_OperatingLossCarryForwardExpirationYear" xlink:to="wt_OperatingLossCarryForwardExpirationYear_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_OtherPayablesTextBlock_lbl0" xml:lang="en-US">The disclosure of other payables.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_OtherPayablesTextBlock" xlink:to="wt_OtherPayablesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_OutstandingCommonStockPercentage_lbl0" xml:lang="en-US">Percentage of outstanding common stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_OutstandingCommonStockPercentage" xlink:to="wt_OutstandingCommonStockPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_PaymentOfConvertibleNotesIssuanceCosts_lbl0" xml:lang="en-US">Payment of convertible notes issuance costs.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PaymentOfConvertibleNotesIssuanceCosts" xlink:to="wt_PaymentOfConvertibleNotesIssuanceCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_PaymentOfDeferredConsideration_lbl0" xml:lang="en-US">Payment of deferred consideration.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PaymentOfDeferredConsideration" xlink:to="wt_PaymentOfDeferredConsideration_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_PaymentOfLeaseTerminationFee_lbl0" xml:lang="en-US">Amount of payment of lease termination fee.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PaymentOfLeaseTerminationFee" xlink:to="wt_PaymentOfLeaseTerminationFee_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_PercentageOfAssetsSold_lbl0" xml:lang="en-US">Percentage of assets sold.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfAssetsSold" xlink:to="wt_PercentageOfAssetsSold_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_PercentageOfBeneficialOwnership_lbl0" xml:lang="en-US">Percentage of beneficial ownership.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfBeneficialOwnership" xlink:to="wt_PercentageOfBeneficialOwnership_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_PercentageOfCommonStock_lbl0" xml:lang="en-US">Percentage of common stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfCommonStock" xlink:to="wt_PercentageOfCommonStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_PercentageOfCommonStockAcquired_lbl0" xml:lang="en-US">Percentage of common stock acquired.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfCommonStockAcquired" xlink:to="wt_PercentageOfCommonStockAcquired_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_PercentageOfDiscountOnFutureEquityFinancingForPreferredStock_lbl0" xml:lang="en-US">Percentage of Discount on future equity financing for preferred stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfDiscountOnFutureEquityFinancingForPreferredStock" xlink:to="wt_PercentageOfDiscountOnFutureEquityFinancingForPreferredStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_PercentageOfOutstandingConvertibleNotes_lbl0" xml:lang="en-US">Percentage of outstanding convertible note.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfOutstandingConvertibleNotes" xlink:to="wt_PercentageOfOutstandingConvertibleNotes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_PercentageOfRevenueGrowth_lbl0" xml:lang="en-US">Percentage of revenue growth.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfRevenueGrowth" xlink:to="wt_PercentageOfRevenueGrowth_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_PercentageOfTaxRateRealizedOnSettlement_lbl0" xml:lang="en-US">Percentage of tax rate.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfTaxRateRealizedOnSettlement" xlink:to="wt_PercentageOfTaxRateRealizedOnSettlement_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity_lbl0" xml:lang="en-US">Percentage of voting approval required to redeem all of the outstanding notes at maturity.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity" xlink:to="wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity_lbl0" xml:lang="en-US">Percentage of voting approval required to redeem all of the outstanding notes before maturity.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity" xlink:to="wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_PotentiallyDilutiveRestrictedStockAwards_lbl0" xml:lang="en-US">Potentially dilutive restricted stock awards .</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PotentiallyDilutiveRestrictedStockAwards" xlink:to="wt_PotentiallyDilutiveRestrictedStockAwards_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_PreferredStockRedemptionValue_lbl1" xml:lang="en-US">Preferred Stock Redemption Value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PreferredStockRedemptionValue" xlink:to="wt_PreferredStockRedemptionValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_PresentValueOfMarketRateInterest_lbl0" xml:lang="en-US">Present value of market rate interest.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PresentValueOfMarketRateInterest" xlink:to="wt_PresentValueOfMarketRateInterest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_PrincipalAmountOfTradingPrice_lbl0" xml:lang="en-US">Principal amount of trading price.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PrincipalAmountOfTradingPrice" xlink:to="wt_PrincipalAmountOfTradingPrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_ProbabilityThatSeriesB2PreferenceSharesCovertIntoSeriesB1PreferenceShares_lbl0" xml:lang="en-US">Probability that series B-2 preference shares covert into series B-1 preference shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ProbabilityThatSeriesB2PreferenceSharesCovertIntoSeriesB1PreferenceShares" xlink:to="wt_ProbabilityThatSeriesB2PreferenceSharesCovertIntoSeriesB1PreferenceShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity_lbl0" xml:lang="en-US">The amount of Proceeds from held-to-maturity securities maturing or called prior to maturity.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity" xlink:to="wt_ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_ProceedsFromIssuanceOfConvertibleNotes_lbl0" xml:lang="en-US">Proceeds from issuance of convertible notes.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ProceedsFromIssuanceOfConvertibleNotes" xlink:to="wt_ProceedsFromIssuanceOfConvertibleNotes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue_lbl0" xml:lang="en-US">Proceeds from the sale of financial instruments owned, at fair value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue" xlink:to="wt_ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_PurchaseOfFinancialInstrumentsOwnedAtFairValue_lbl0" xml:lang="en-US">Purchase of financial instruments owned, at fair value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PurchaseOfFinancialInstrumentsOwnedAtFairValue" xlink:to="wt_PurchaseOfFinancialInstrumentsOwnedAtFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_PurchaseOfInvestments_lbl0" xml:lang="en-US">Purchase of investments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PurchaseOfInvestments" xlink:to="wt_PurchaseOfInvestments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_RecentlyIssuedAccountingPronouncementsPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy for recently issued accounting pronouncements.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RecentlyIssuedAccountingPronouncementsPolicyTextBlock" xlink:to="wt_RecentlyIssuedAccountingPronouncementsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_ReclassificationOfEquity_lbl0" xml:lang="en-US">Reclassification of equity.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ReclassificationOfEquity" xlink:to="wt_ReclassificationOfEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_RedemptionOfNoteUponAChangeOfControl_lbl0" xml:lang="en-US">The percentage of redemption of note upon a change of control.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RedemptionOfNoteUponAChangeOfControl" xlink:to="wt_RedemptionOfNoteUponAChangeOfControl_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_RedemptionOfNoteUponACorporateTransaction_lbl0" xml:lang="en-US">The percentage of redemption of note upon a corporate transaction.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RedemptionOfNoteUponACorporateTransaction" xlink:to="wt_RedemptionOfNoteUponACorporateTransaction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_RepurchasePricePerShareInterestRateTransaction_lbl0" xml:lang="en-US">Repurchase price per share interest rate transaction.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RepurchasePricePerShareInterestRateTransaction" xlink:to="wt_RepurchasePricePerShareInterestRateTransaction_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock_lbl0" xml:lang="en-US">Schedule For Supplemental Balance Sheet Information Related To Operating Lease</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock" xlink:to="wt_ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock_lbl0" xml:lang="en-US">Schedule Of Accounts Receivable From Related Party [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock" xlink:to="wt_ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_ScheduleOfAggregateConsiderationPayableTableTextBlock_lbl0" xml:lang="en-US">Tabular of  aggregate consideration payable.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfAggregateConsiderationPayableTableTextBlock" xlink:to="wt_ScheduleOfAggregateConsiderationPayableTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_ScheduleOfDeferredConsiderationTableTextBlock_lbl0" xml:lang="en-US">Tabular disclosure of deferred consideration.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfDeferredConsiderationTableTextBlock" xlink:to="wt_ScheduleOfDeferredConsiderationTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock_lbl0" xml:lang="en-US">Schedule Of Unrecognized Stock Based Compensation Expenses And Average Remaining Vesting Period Table [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock" xlink:to="wt_ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_SharePriceAsAPercentageOfLastReportedPriceAndConversionRate_lbl0" xml:lang="en-US">Share price as a percentage of last reported price and conversion rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SharePriceAsAPercentageOfLastReportedPriceAndConversionRate" xlink:to="wt_SharePriceAsAPercentageOfLastReportedPriceAndConversionRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_SharesPercentage_lbl0" xml:lang="en-US">Percentage of shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SharesPercentage" xlink:to="wt_SharesPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes_lbl0" xml:lang="en-US">Amount of reclassification of equity component related to convertible notes.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes" xlink:to="wt_StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock_lbl0" xml:lang="en-US">Schedule of income tax payments by jurisdiction [table text block].</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock" xlink:to="wt_SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock_lbl0" xml:lang="en-US">Summary of revenues categorized as revenues from contracts with customers and other sources of revenues.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock" xlink:to="wt_SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_TemporaryEquityShareOutstanding_lbl0" xml:lang="en-US">Temporary equity shares outstanding.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_TemporaryEquityShareOutstanding" xlink:to="wt_TemporaryEquityShareOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_TemporaryStockholdersEquity_lbl0" xml:lang="en-US">Temporary stockholders equity.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_TemporaryStockholdersEquity" xlink:to="wt_TemporaryStockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_ThirdPartyDistribution_lbl0" xml:lang="en-US">Third Party Distribution.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ThirdPartyDistribution" xlink:to="wt_ThirdPartyDistribution_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_ThirdPartyDistributionFeesPolicyTextBlock_lbl0" xml:lang="en-US">Disclosure of accounting policy related to third-party distribution fees.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ThirdPartyDistributionFeesPolicyTextBlock" xlink:to="wt_ThirdPartyDistributionFeesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_TimeToPotentialOutcomeinYear_lbl0" xml:lang="en-US">Time to potential outcome.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_TimeToPotentialOutcomeinYear" xlink:to="wt_TimeToPotentialOutcomeinYear_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_TimeToPotentialOutcomesinYears_lbl0" xml:lang="en-US">Time to potential outcome.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_TimeToPotentialOutcomesinYears" xlink:to="wt_TimeToPotentialOutcomesinYears_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_UndistributedIncomeAllocableToParticipatingSecurities_lbl0" xml:lang="en-US">Undistributed income allocable to participating securities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_UndistributedIncomeAllocableToParticipatingSecurities" xlink:to="wt_UndistributedIncomeAllocableToParticipatingSecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation_lbl0" xml:lang="en-US">Amount of increase in unrecognized tax benefits and interest/penalties resulting from foreign currency translation.&quot; through out the disclosure as per the table structure.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation" xlink:to="wt_UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities_lbl1" xml:lang="en-US">Weighted average number of diluted shares outstanding excluding participating securities.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities" xlink:to="wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares_lbl0" xml:lang="en-US">Weighted average shares of common stock issuable upon conversion of the preferred shares.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares" xlink:to="wt_WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_AgreementAxis_lbl0" xml:lang="en-US">Agreement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_AgreementAxis" xlink:to="wt_AgreementAxis_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_AffiliatedBlockchainEnabledFundsMember_lbl0" xml:lang="en-US">Affiliated blockchain enabled funds.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_AffiliatedBlockchainEnabledFundsMember" xlink:to="wt_AffiliatedBlockchainEnabledFundsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_BelowTwentyFifthPercentileMember_lbl0" xml:lang="en-US">Below Twenty Fifth Percentile</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_BelowTwentyFifthPercentileMember" xlink:to="wt_BelowTwentyFifthPercentileMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember_lbl0" xml:lang="en-US">Convertible Senior Notes Due Two Thousand And Twenty Six [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember" xlink:to="wt_ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember_lbl0" xml:lang="en-US">Convertible senior notes due two thousand and twenty three [Member].</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember" xlink:to="wt_ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_ConvertibleSeniorNotesMember_lbl0" xml:lang="en-US">Convertible Senior Notes.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConvertibleSeniorNotesMember" xlink:to="wt_ConvertibleSeniorNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_DeferredConsiderationObligationMember_lbl0" xml:lang="en-US">DeferredConsiderationObligationMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredConsiderationObligationMember" xlink:to="wt_DeferredConsiderationObligationMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_EmployeesAndDirectorsMember_lbl0" xml:lang="en-US">Employees and Directors [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_EmployeesAndDirectorsMember" xlink:to="wt_EmployeesAndDirectorsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_EuropeanBusinessSegmentMember_lbl0" xml:lang="en-US">European Business Segment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_EuropeanBusinessSegmentMember" xlink:to="wt_EuropeanBusinessSegmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_FederalAgencyMember_lbl1" xml:lang="en-US">Federal Agency [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FederalAgencyMember" xlink:to="wt_FederalAgencyMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_FnalityConvertibleNoteMember_lbl0" xml:lang="en-US">Fnality convertible note.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FnalityConvertibleNoteMember" xlink:to="wt_FnalityConvertibleNoteMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_FnalityInternationalLimitedMember_lbl0" xml:lang="en-US">Fnality international limited.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FnalityInternationalLimitedMember" xlink:to="wt_FnalityInternationalLimitedMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_OtherAssetsseedCapitalWisdomtreeDigitalFundsMember_lbl0" xml:lang="en-US">Other assets&#8212;seed capital (WisdomTree digital funds)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_OtherAssetsseedCapitalWisdomtreeDigitalFundsMember" xlink:to="wt_OtherAssetsseedCapitalWisdomtreeDigitalFundsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_RodberInvestmentsLimitedMember_lbl0" xml:lang="en-US">Rodber Investments Limited member.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RodberInvestmentsLimitedMember" xlink:to="wt_RodberInvestmentsLimitedMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_SecurrencyConvertibleNoteMember_lbl1" xml:lang="en-US">Securrency convertible note.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SecurrencyConvertibleNoteMember" xlink:to="wt_SecurrencyConvertibleNoteMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_SecurrencyIncMember_lbl0" xml:lang="en-US">Securrenc, Inc.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SecurrencyIncMember" xlink:to="wt_SecurrencyIncMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_SecurrencyMember_lbl0" xml:lang="en-US">Securrency.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SecurrencyMember" xlink:to="wt_SecurrencyMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_SecurrencyseriesaconvertiblepreferredstockMember_lbl0" xml:lang="en-US">SecurrencySeriesAConvertiblePreferredStock .</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SecurrencyseriesaconvertiblepreferredstockMember" xlink:to="wt_SecurrencyseriesaconvertiblepreferredstockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_SecurrencyseriesbconvertiblepreferredstockMember_lbl0" xml:lang="en-US">SecurrencySeriesBConvertiblePreferredStock .</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SecurrencyseriesbconvertiblepreferredstockMember" xlink:to="wt_SecurrencyseriesbconvertiblepreferredstockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_SeriesANonVotingConvertiblePreferredStockMember_lbl1" xml:lang="en-US">Series a non voting convertible preferred stock.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SeriesANonVotingConvertiblePreferredStockMember" xlink:to="wt_SeriesANonVotingConvertiblePreferredStockMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_StockholderRightAgreementMember_lbl0" xml:lang="en-US">Stockholder right agreement.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_StockholderRightAgreementMember" xlink:to="wt_StockholderRightAgreementMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_TwoFinancialInstitutionsMember_lbl0" xml:lang="en-US">Two Financial Institutions Member.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_TwoFinancialInstitutionsMember" xlink:to="wt_TwoFinancialInstitutionsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_TwoThousandAndTwentyNotesMember_lbl1" xml:lang="en-US">Two thousand and twenty notes.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_TwoThousandAndTwentyNotesMember" xlink:to="wt_TwoThousandAndTwentyNotesMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_TwoThousandAndTwentyThreeNotesMember_lbl0" xml:lang="en-US">Two thousand and twenty three notes [Member].</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_TwoThousandAndTwentyThreeNotesMember" xlink:to="wt_TwoThousandAndTwentyThreeNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_TwothousandandtwentyonenotesMember_lbl0" xml:lang="en-US">TwoThousandAndTwentyOneNotes.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_TwothousandandtwentyonenotesMember" xlink:to="wt_TwothousandandtwentyonenotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_WisdomtreeETFMember_lbl0" xml:lang="en-US">WisdomTree ETF.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_WisdomtreeETFMember" xlink:to="wt_WisdomtreeETFMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="wt_WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember_lbl0" xml:lang="en-US">Wisdomtree Multi Asset Issuer plc And Wisdomtree issuer icav</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember" xlink:to="wt_WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_lbl0" xml:lang="en-US">Schedule of Variable Interest Entities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl0" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ChangeInForeignNetOperatingLosses_lbl1" xml:lang="en-US">Change In Foreign Net Operating Losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ChangeInForeignNetOperatingLosses" xlink:to="wt_ChangeInForeignNetOperatingLosses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesCPreferredStockMember_lbl1" xml:lang="en-US">Series C Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesCPreferredStockMember" xlink:to="us-gaap_SeriesCPreferredStockMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital_lbl0" xml:lang="en-US">Temporary Equity, Par Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital" xlink:to="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl0" xml:lang="en-US">Adjustments to Additional Paid in Capital, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl0" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetImpairmentChargesTextBlock_lbl0" xml:lang="en-US">Asset Impairment Charges [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetImpairmentChargesTextBlock" xlink:to="us-gaap_AssetImpairmentChargesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeInterest_lbl0" xml:lang="en-US">Investment Income, Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl0" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl0" xml:lang="en-US">Series B Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl0" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl0" xml:lang="en-US">Temporary Equity, Par or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_TemporaryStockholdersEquity_lbl1" xml:lang="en-US">Temporary Stockholders Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_TemporaryStockholdersEquity" xlink:to="wt_TemporaryStockholdersEquity_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue_lbl1" xml:lang="en-US">Financial Instruments, Owned, at Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:to="us-gaap_FinancialInstrumentsOwnedAtFairValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_OtherPayablesTextBlock_lbl1" xml:lang="en-US">Other Payables Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_OtherPayablesTextBlock" xlink:to="wt_OtherPayablesTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl0" xml:lang="en-US">Prepaid Expense, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl0" xml:lang="en-US">Preferred Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet_lbl0" xml:lang="en-US">Deferred Income Tax Assets, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockDividendsPerShareDeclared_lbl0" xml:lang="en-US">Preferred Stock, Dividends Per Share, Declared</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendsPerShareDeclared" xlink:to="us-gaap_PreferredStockDividendsPerShareDeclared_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_LeaseTerminationMember_lbl0" xml:lang="en-US">Lease Termination Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_LeaseTerminationMember" xlink:to="wt_LeaseTerminationMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl1" xml:lang="en-US">Earnings Per Share, Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl0" xml:lang="en-US">Other Assets, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl0" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl0" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl0" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedPremium_lbl0" xml:lang="en-US">Debt Instrument, Unamortized Premium</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="us-gaap_DebtInstrumentUnamortizedPremium_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_DeferredConsiderationNoncurrent_lbl2" xml:lang="en-US">Deferred Consideration Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredConsiderationNoncurrent" xlink:to="wt_DeferredConsiderationNoncurrent_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue_lbl1" xml:lang="en-US">Proceeds From The Sale Of Financial Instruments Owned At Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue" xlink:to="wt_ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill_lbl0" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsGrossExcludingGoodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_PresentValueOfMarketRateInterest_lbl1" xml:lang="en-US">Present Value Of Market Rate Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PresentValueOfMarketRateInterest" xlink:to="wt_PresentValueOfMarketRateInterest_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0" xml:lang="en-US">Significant Accounting Policies [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl0" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentOwnedAtCost_lbl0" xml:lang="en-US">Investment Owned, Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedAtCost" xlink:to="us-gaap_InvestmentOwnedAtCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl0" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl0" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockTextBlock_lbl0" xml:lang="en-US">Treasury Stock [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockTextBlock" xlink:to="us-gaap_TreasuryStockTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_DeferredTaxAssetsCapitalLossCarryforwardsSubjectToExpiration_lbl1" xml:lang="en-US">Deferred Tax Assets Capital Loss Carryforwards Subject To Expiration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredTaxAssetsCapitalLossCarryforwardsSubjectToExpiration" xlink:to="wt_DeferredTaxAssetsCapitalLossCarryforwardsSubjectToExpiration_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentTextBlock_lbl0" xml:lang="en-US">Investment [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTextBlock" xlink:to="us-gaap_InvestmentTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl0" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl0" xml:lang="en-US">Common Stock, Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl0" xml:lang="en-US">Minimum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseImpairmentLoss_lbl0" xml:lang="en-US">Operating Lease, Impairment Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseImpairmentLoss" xlink:to="us-gaap_OperatingLeaseImpairmentLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RealizedInvestmentGainsLosses_lbl0" xml:lang="en-US">Realized Investment Gains (Losses)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RealizedInvestmentGainsLosses" xlink:to="us-gaap_RealizedInvestmentGainsLosses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl0" xml:lang="en-US">Additional Paid-in Capital [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_DeferredTaxLiabilitiesRightOfUseAssets_lbl1" xml:lang="en-US">Deferred Tax Liabilities Right Of Use Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredTaxLiabilitiesRightOfUseAssets" xlink:to="wt_DeferredTaxLiabilitiesRightOfUseAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl0" xml:lang="en-US">Compensation Related Costs, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGrossAbstract_lbl0" xml:lang="en-US">Deferred Tax Assets, Gross [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsGrossAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl0" xml:lang="en-US">Operating Expenses [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_SecurrencyIncAbstract_lbl0" xml:lang="en-US">Securrency Inc Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SecurrencyIncAbstract" xlink:to="wt_SecurrencyIncAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl0" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock_lbl1" xml:lang="en-US">Schedule For Supplemental Balance Sheet Information Related To Operating Lease Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock" xlink:to="wt_ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned_lbl1" xml:lang="en-US">Security Owned and Sold, Not yet Purchased Fair Value, Security Owned</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" xlink:to="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_lbl0" xml:lang="en-US">Business Acquisition, Effective Date of Acquisition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:to="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_CostMethodInvestmentFairValueDisclosure_lbl1" xml:lang="en-US">Cost Method Investment Fair Value Disclosure</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_CostMethodInvestmentFairValueDisclosure" xlink:to="wt_CostMethodInvestmentFairValueDisclosure_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl0" xml:lang="en-US">Payments for Repurchase of Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl0" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl3" xml:lang="en-US">Goodwill</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommunicationsInformationTechnologyAndOccupancy_lbl0" xml:lang="en-US">Communications, Information Technology and Occupancy</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommunicationsInformationTechnologyAndOccupancy" xlink:to="us-gaap_CommunicationsInformationTechnologyAndOccupancy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxContingencyLineItems_lbl0" xml:lang="en-US">Income Tax Contingency [Line Items]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_IncomeTaxContingencyLineItems_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_RedemptionOfNoteUponACorporateTransaction_lbl1" xml:lang="en-US">Redemption Of Note Upon ACorporate Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RedemptionOfNoteUponACorporateTransaction" xlink:to="wt_RedemptionOfNoteUponACorporateTransaction_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl0" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_LossContingencyCoveredByInsuranceDeductible_lbl1" xml:lang="en-US">Loss Contingency Covered By Insurance Deductible</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_LossContingencyCoveredByInsuranceDeductible" xlink:to="wt_LossContingencyCoveredByInsuranceDeductible_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_lbl1" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_BusinessCombinationDeferredConsiderationLiability_lbl1" xml:lang="en-US">Business Combination Deferred Consideration Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_BusinessCombinationDeferredConsiderationLiability" xlink:to="wt_BusinessCombinationDeferredConsiderationLiability_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_lbl0" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:to="us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl2" xml:lang="en-US">Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncome_lbl0" xml:lang="en-US">Other Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncome" xlink:to="us-gaap_OtherIncome_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAbstract_lbl1" xml:lang="en-US">Liabilities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl0" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_Default_lbl1" xml:lang="en-US">Default</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_Default" xlink:to="wt_Default_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_DilutedEarningsPerShareAbstract_lbl0" xml:lang="en-US">Diluted Earnings Per Share Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DilutedEarningsPerShareAbstract" xlink:to="wt_DilutedEarningsPerShareAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ETFSCapitalMember_lbl0" xml:lang="en-US">ETFSCapital Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ETFSCapitalMember" xlink:to="wt_ETFSCapitalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_WeightedAverageMember_lbl0" xml:lang="en-US">Weighted Average [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_WeightedAverageMember" xlink:to="srt_WeightedAverageMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebt_lbl0" xml:lang="en-US">Long-Term Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_OtherAssetsseedCapitalWisdomTreeDigitalFundsMember_lbl0" xml:lang="en-US">Other Assetsseed Capital Wisdom Tree Digital Funds Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_OtherAssetsseedCapitalWisdomTreeDigitalFundsMember" xlink:to="wt_OtherAssetsseedCapitalWisdomTreeDigitalFundsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl0" xml:lang="en-US">AOCI Attributable to Parent [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_AmortizationOfIssuanceCostsConvertibleNotes_lbl1" xml:lang="en-US">Amortization Of Issuance Costs Convertible Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_AmortizationOfIssuanceCostsConvertibleNotes" xlink:to="wt_AmortizationOfIssuanceCostsConvertibleNotes_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_WorldGoldCouncilMember_lbl0" xml:lang="en-US">World Gold Council Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_WorldGoldCouncilMember" xlink:to="wt_WorldGoldCouncilMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_MinimumPercentageOfLendersRequiredToHaveEntirePrincipalAmountOfConvertibleNotesRepurchasedByTheCompanyUponCertainEventsOfDefault_lbl1" xml:lang="en-US">Minimum Percentage Of Lenders Required To Have Entire Principal Amount Of Convertible Notes Repurchased By The Company Upon Certain Events Of Default</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_MinimumPercentageOfLendersRequiredToHaveEntirePrincipalAmountOfConvertibleNotesRepurchasedByTheCompanyUponCertainEventsOfDefault" xlink:to="wt_MinimumPercentageOfLendersRequiredToHaveEntirePrincipalAmountOfConvertibleNotesRepurchasedByTheCompanyUponCertainEventsOfDefault_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl0" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_EuropeanBusinessSegmentMember_lbl1" xml:lang="en-US">European Business Segment Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_EuropeanBusinessSegmentMember" xlink:to="wt_EuropeanBusinessSegmentMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtMember_lbl0" xml:lang="en-US">Convertible Debt [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtMember" xlink:to="us-gaap_ConvertibleDebtMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_PercentageOfOutstandingConvertibleNotes_lbl1" xml:lang="en-US">Percentage Of Outstanding Convertible Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfOutstandingConvertibleNotes" xlink:to="wt_PercentageOfOutstandingConvertibleNotes_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl0" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_FnalityInternationalLimitedMember_lbl1" xml:lang="en-US">Fnality International Limited Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FnalityInternationalLimitedMember" xlink:to="wt_FnalityInternationalLimitedMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl0" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl0" xml:lang="en-US">Common Stock, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfPresentsTheProbabilityAscribedToPotentialOutcomesUsedInThePwermAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfPresentsTheProbabilityAscribedToPotentialOutcomesUsedInThePwermAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfPresentsTheProbabilityAscribedToPotentialOutcomesUsedInThePwermAbstract_lbl" xml:lang="en-US">Schedule Of Presents The Probability Ascribed To Potential Outcomes Used In The Pwerm Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfPresentsTheProbabilityAscribedToPotentialOutcomesUsedInThePwermAbstract" xlink:to="wt_ScheduleOfPresentsTheProbabilityAscribedToPotentialOutcomesUsedInThePwermAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl0" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Periodic Reduction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_PercentageOfRevenueGrowth_lbl1" xml:lang="en-US">Percentage Of Revenue Growth</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfRevenueGrowth" xlink:to="wt_PercentageOfRevenueGrowth_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_IncomeTaxReconciliationInternationalOperations_lbl1" xml:lang="en-US">Income Tax Reconciliation International Operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncomeTaxReconciliationInternationalOperations" xlink:to="wt_IncomeTaxReconciliationInternationalOperations_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl0" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableInterestEntityDisclosureTextBlock_lbl0" xml:lang="en-US">Variable Interest Entity Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:to="us-gaap_VariableInterestEntityDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnInvestments_lbl1" xml:lang="en-US">Gain (Loss) on Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnInvestments" xlink:to="us-gaap_GainLossOnInvestments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl0" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl2" xml:lang="en-US">Equity, Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherOwnershipInterestsUnitsIssued_lbl0" xml:lang="en-US">Other Ownership Interests, Units Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOwnershipInterestsUnitsIssued" xlink:to="us-gaap_OtherOwnershipInterestsUnitsIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit_lbl0" xml:lang="en-US">Share-Based Goods and Nonemployee Services Transaction, Tax Benefit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherExpenses_lbl0" xml:lang="en-US">Other Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpenses" xlink:to="us-gaap_OtherExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_SecondInstallmentsMember_lbl0" xml:lang="en-US">Second Installments Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SecondInstallmentsMember" xlink:to="wt_SecondInstallmentsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_NewYorkOfficeMember_lbl0" xml:lang="en-US">New York Office Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_NewYorkOfficeMember" xlink:to="wt_NewYorkOfficeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl0" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfUnrecognizedStockBasedCompensationExpenseAndAverageRemainingVestingPeriodAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfUnrecognizedStockBasedCompensationExpenseAndAverageRemainingVestingPeriodAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfUnrecognizedStockBasedCompensationExpenseAndAverageRemainingVestingPeriodAbstract_lbl" xml:lang="en-US">Schedule Of Unrecognized Stock Based Compensation Expense And Average Remaining Vesting Period Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfUnrecognizedStockBasedCompensationExpenseAndAverageRemainingVestingPeriodAbstract" xlink:to="wt_ScheduleOfUnrecognizedStockBasedCompensationExpenseAndAverageRemainingVestingPeriodAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_OtherAssetsSeedCapitalWisdomtreeDigitalFundsAbstract_lbl0" xml:lang="en-US">Other Assets Seed Capital Wisdomtree Digital Funds Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_OtherAssetsSeedCapitalWisdomtreeDigitalFundsAbstract" xlink:to="wt_OtherAssetsSeedCapitalWisdomtreeDigitalFundsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_lbl0" xml:lang="en-US">Asset Acquisition, Consideration Transferred, Contingent Consideration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl0" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_AgreementAxis_lbl1" xml:lang="en-US">Agreement Axis</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_AgreementAxis" xlink:to="wt_AgreementAxis_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_FirstInstallmentsMember_lbl0" xml:lang="en-US">First Installments Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FirstInstallmentsMember" xlink:to="wt_FirstInstallmentsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_AdvisoryFeesReceivedInGold_lbl1" xml:lang="en-US">Advisory Fees Received In Gold</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_AdvisoryFeesReceivedInGold" xlink:to="wt_AdvisoryFeesReceivedInGold_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayableMember_lbl0" xml:lang="en-US">Convertible Notes Payable [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableMember" xlink:to="us-gaap_ConvertibleNotesPayableMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfKeyTermsOfConvertibleNotesAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfKeyTermsOfConvertibleNotesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfKeyTermsOfConvertibleNotesAbstract_lbl" xml:lang="en-US">Schedule Of Key Terms Of Convertible Notes Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfKeyTermsOfConvertibleNotesAbstract" xlink:to="wt_ScheduleOfKeyTermsOfConvertibleNotesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_NonRecurringFairValueMeasurementsAbstract_lbl0" xml:lang="en-US">Non Recurring Fair Value Measurements Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_NonRecurringFairValueMeasurementsAbstract" xlink:to="wt_NonRecurringFairValueMeasurementsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_SpaAgreementMember_lbl0" xml:lang="en-US">Spa Agreement Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SpaAgreementMember" xlink:to="wt_SpaAgreementMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl0" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl0" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostAbstract_lbl0" xml:lang="en-US">Lease, Cost [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_LeaseCostAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdTradingDays_lbl0" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdTradingDays_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl1" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock_lbl1" xml:lang="en-US">Summary Of Income Taxes Paid By Jurisdiction Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock" xlink:to="wt_SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl0" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl0" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_lbl1" xml:lang="en-US">Deferred Tax Liabilities, Undistributed Foreign Earnings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:to="us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent_lbl0" xml:lang="en-US">Interest Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionMember_lbl0" xml:lang="en-US">Equity Option [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionMember" xlink:to="us-gaap_StockOptionMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl0" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl0" xml:lang="en-US">Deferred Tax Liabilities, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Tax Benefit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_RecurringFairValueMeasurementsAbstract0_lbl0" xml:lang="en-US">Recurring Fair Value Measurements Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RecurringFairValueMeasurementsAbstract0" xlink:to="wt_RecurringFairValueMeasurementsAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_RecurringFairValueMeasurementsAbstract1_lbl0" xml:lang="en-US">Recurring Fair Value Measurements Abstract1</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RecurringFairValueMeasurementsAbstract1" xlink:to="wt_RecurringFairValueMeasurementsAbstract1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfChangesInBalanceOfGrossUnrecognizedTaxBenefitsAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfChangesInBalanceOfGrossUnrecognizedTaxBenefitsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfChangesInBalanceOfGrossUnrecognizedTaxBenefitsAbstract_lbl" xml:lang="en-US">Schedule Of Changes In Balance Of Gross Unrecognized Tax Benefits Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfChangesInBalanceOfGrossUnrecognizedTaxBenefitsAbstract" xlink:to="wt_ScheduleOfChangesInBalanceOfGrossUnrecognizedTaxBenefitsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl0" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl0" xml:lang="en-US">Operating Lease, Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl0" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ExercisePricePerUnit_lbl1" xml:lang="en-US">Exercise Price Per Unit</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ExercisePricePerUnit" xlink:to="wt_ExercisePricePerUnit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockDividendsShares_lbl0" xml:lang="en-US">Stock Dividends, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockDividendsShares" xlink:to="us-gaap_StockDividendsShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl0" xml:lang="en-US">US Treasury Securities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasurySecuritiesMember" xlink:to="us-gaap_USTreasurySecuritiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl0" xml:lang="en-US">Current Federal Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_lbl0" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Other Operating Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ConvertibleSeniorNotesMember_lbl1" xml:lang="en-US">Convertible Senior Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConvertibleSeniorNotesMember" xlink:to="wt_ConvertibleSeniorNotesMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Statement of Stockholders&apos; Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtCurrent_lbl0" xml:lang="en-US">Convertible Debt, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtCurrent" xlink:to="us-gaap_ConvertibleDebtCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl0" xml:lang="en-US">Assets, Fair Value Disclosure</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl0" xml:lang="en-US">Stock Issued During Period, Value, New Issues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ConvertibleSeniorNotesDue2028Member_lbl0" xml:lang="en-US">Convertible Senior Notes Due2028 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConvertibleSeniorNotesDue2028Member" xlink:to="wt_ConvertibleSeniorNotesDue2028Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl0" xml:lang="en-US">Commitments and Contingencies</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl0" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl1" xml:lang="en-US">Series A Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermNotesPayable_lbl0" xml:lang="en-US">Notes Payable, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_lbl0" xml:lang="en-US">Proceeds from Divestiture of Businesses, Net of Cash Divested</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:to="us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl0" xml:lang="en-US">Common Stock, Value, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_OtherServicesIncomeMember_lbl1" xml:lang="en-US">Other Services Income Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_OtherServicesIncomeMember" xlink:to="wt_OtherServicesIncomeMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Unrecognized Stock Based Compensation Expenses And Average Remaining Vesting Period Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock" xlink:to="wt_ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_StockholderRightAgreementMember_lbl1" xml:lang="en-US">Stockholder Right Agreement Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_StockholderRightAgreementMember" xlink:to="wt_StockholderRightAgreementMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfValuationOfDeferredConsiderationAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfValuationOfDeferredConsiderationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfValuationOfDeferredConsiderationAbstract_lbl" xml:lang="en-US">Schedule Of Valuation Of Deferred Consideration Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfValuationOfDeferredConsiderationAbstract" xlink:to="wt_ScheduleOfValuationOfDeferredConsiderationAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl1" xml:lang="en-US">Temporary Equity, Accretion to Redemption Value, Adjustment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertiblePreferredStockMember_lbl0" xml:lang="en-US">Convertible Preferred Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockMember" xlink:to="us-gaap_ConvertiblePreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl0" xml:lang="en-US">Subsequent Events [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfInformationAboutVariableInterestsAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfInformationAboutVariableInterestsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfInformationAboutVariableInterestsAbstract_lbl" xml:lang="en-US">Schedule Of Information About Variable Interests Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfInformationAboutVariableInterestsAbstract" xlink:to="wt_ScheduleOfInformationAboutVariableInterestsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl0" xml:lang="en-US">Convertible Preferred Stock, Shares Issued upon Conversion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrentAndNoncurrent_lbl0" xml:lang="en-US">Accounts Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableCurrentAndNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Dividends_lbl0" xml:lang="en-US">Dividends</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Dividends" xlink:to="us-gaap_Dividends_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_PaymentOfConvertibleNotesIssuanceCosts_lbl1" xml:lang="en-US">Payment Of Convertible Notes Issuance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PaymentOfConvertibleNotesIssuanceCosts" xlink:to="wt_PaymentOfConvertibleNotesIssuanceCosts_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradingGainsLosses_lbl0" xml:lang="en-US">Trading Gain (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradingGainsLosses" xlink:to="us-gaap_TradingGainsLosses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_PrincipalAmountOfTradingPrice_lbl1" xml:lang="en-US">Principal Amount Of Trading Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PrincipalAmountOfTradingPrice" xlink:to="wt_PrincipalAmountOfTradingPrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl1" xml:lang="en-US">Income Taxes Paid, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquipmentMember_lbl0" xml:lang="en-US">Equipment [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl0" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInvestments_lbl0" xml:lang="en-US">Other Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInvestments" xlink:to="us-gaap_OtherInvestments_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfRevenuesFromContractsWithCustomersAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfRevenuesFromContractsWithCustomersAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfRevenuesFromContractsWithCustomersAbstract_lbl" xml:lang="en-US">Schedule Of Revenues From Contracts With Customers Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfRevenuesFromContractsWithCustomersAbstract" xlink:to="wt_ScheduleOfRevenuesFromContractsWithCustomersAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl0" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_AffiliatedBlockchainEnabledFundsMember_lbl1" xml:lang="en-US">Affiliated Blockchain Enabled Funds Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_AffiliatedBlockchainEnabledFundsMember" xlink:to="wt_AffiliatedBlockchainEnabledFundsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockAmountIssued1_lbl0" xml:lang="en-US">Conversion of Stock, Amount Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountIssued1" xlink:to="us-gaap_ConversionOfStockAmountIssued1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_TwothousandandtwentyonenotesMember_lbl1" xml:lang="en-US">Twothousandandtwentyonenotes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_TwothousandandtwentyonenotesMember" xlink:to="wt_TwothousandandtwentyonenotesMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SoftwareDevelopmentMember_lbl1" xml:lang="en-US">Software Development [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareDevelopmentMember" xlink:to="us-gaap_SoftwareDevelopmentMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_RepurchasePricePerShareInterestRateTransaction_lbl1" xml:lang="en-US">Repurchase Price Per Share Interest Rate Transaction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RepurchasePricePerShareInterestRateTransaction" xlink:to="wt_RepurchasePricePerShareInterestRateTransaction_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableCurrent_lbl1" xml:lang="en-US">Notes Payable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl1" xml:lang="en-US">Common Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl0" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense_lbl1" xml:lang="en-US">Income Tax Reconciliation Nondeductible Executive Compensation Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense" xlink:to="wt_IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ConvertibleNoteDiscountRate_lbl1" xml:lang="en-US">Convertible Note Discount Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConvertibleNoteDiscountRate" xlink:to="wt_ConvertibleNoteDiscountRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl0" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl0" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfGeographicDistributionOfRevenuesAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfGeographicDistributionOfRevenuesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfGeographicDistributionOfRevenuesAbstract_lbl" xml:lang="en-US">Schedule Of Geographic Distribution Of Revenues Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfGeographicDistributionOfRevenuesAbstract" xlink:to="wt_ScheduleOfGeographicDistributionOfRevenuesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl0" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Accounts Receivable From Related Party Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock" xlink:to="wt_ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl0" xml:lang="en-US">Additional Paid in Capital, Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_lbl0" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_lbl0" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl1" xml:lang="en-US">Conversion of Stock, Shares Converted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_lbl0" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_B1ConvertiblePreferenceSharesMember_lbl1" xml:lang="en-US">B1 Convertible Preference Shares Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_B1ConvertiblePreferenceSharesMember" xlink:to="wt_B1ConvertiblePreferenceSharesMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions_lbl1" xml:lang="en-US">Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Conversions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions" xlink:to="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl0" xml:lang="en-US">Fair Value, Recurring [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity_lbl1" xml:lang="en-US">Percentage Of Voting Approval Required To Redeem All Of The Outstanding Notes Before Maturity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity" xlink:to="wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax_lbl1" xml:lang="en-US">Deferred Tax Assets Operating Loss Carryforwards Net Of Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax" xlink:to="wt_DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl0" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_FixedAssetsMember_lbl0" xml:lang="en-US">Fixed Assets Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FixedAssetsMember" xlink:to="wt_FixedAssetsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ConvertibleNotesMember_lbl0" xml:lang="en-US">Convertible Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConvertibleNotesMember" xlink:to="wt_ConvertibleNotesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_RelatedPartiesAxis_lbl0" xml:lang="en-US">Related Parties Axis</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RelatedPartiesAxis" xlink:to="wt_RelatedPartiesAxis_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_AcquiringPersonMember_lbl0" xml:lang="en-US">Acquiring Person Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_AcquiringPersonMember" xlink:to="wt_AcquiringPersonMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl0" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_lbl0" xml:lang="en-US">Deferred Tax Assets, Capital Loss Carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxesPayableCurrent_lbl0" xml:lang="en-US">Taxes Payable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxesPayableCurrent" xlink:to="us-gaap_TaxesPayableCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_PreferredStockRedemptionValue_lbl2" xml:lang="en-US">Preferred Stock Redemption Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PreferredStockRedemptionValue" xlink:to="wt_PreferredStockRedemptionValue_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermLeaseCost_lbl0" xml:lang="en-US">Short-Term Lease, Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermLeaseCost" xlink:to="us-gaap_ShortTermLeaseCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_MaximumConversionRate_lbl1" xml:lang="en-US">Maximum Conversion Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_MaximumConversionRate" xlink:to="wt_MaximumConversionRate_lbl1"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfRestrictedStockActivityAndRestrictedStockUnitAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfRestrictedStockActivityAndRestrictedStockUnitAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfRestrictedStockActivityAndRestrictedStockUnitAbstract_lbl" xml:lang="en-US">Schedule Of Restricted Stock Activity And Restricted Stock Unit Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfRestrictedStockActivityAndRestrictedStockUnitAbstract" xlink:to="wt_ScheduleOfRestrictedStockActivityAndRestrictedStockUnitAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl0" xml:lang="en-US">Employee-related Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_SecurrencyIncSubTotalMember_lbl0" xml:lang="en-US">Securrency Inc Sub Total Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SecurrencyIncSubTotalMember" xlink:to="wt_SecurrencyIncSubTotalMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_SeriesCRedeemableConvertiblePreferredStockMember_lbl0" xml:lang="en-US">Series CRedeemable Convertible Preferred Stock Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SeriesCRedeemableConvertiblePreferredStockMember" xlink:to="wt_SeriesCRedeemableConvertiblePreferredStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl0" xml:lang="en-US">Long-Term Debt, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl0" xml:lang="en-US">Operating Lease, Liability</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl0" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl0" xml:lang="en-US">Liabilities, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_DisclosureOfValuationOfDeferredConsiderationTableTextBlock_lbl1" xml:lang="en-US">Disclosure Of Valuation Of Deferred Consideration Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DisclosureOfValuationOfDeferredConsiderationTableTextBlock" xlink:to="wt_DisclosureOfValuationOfDeferredConsiderationTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_OutstandingCommonStockPercentage_lbl1" xml:lang="en-US">Outstanding Common Stock Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_OutstandingCommonStockPercentage" xlink:to="wt_OutstandingCommonStockPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_lbl0" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:to="us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_DeferredTaxAssetOperatingLossCarryForwardUnitedStates_lbl1" xml:lang="en-US">Deferred Tax Asset Operating Loss Carry Forward United States</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredTaxAssetOperatingLossCarryForwardUnitedStates" xlink:to="wt_DeferredTaxAssetOperatingLossCarryForwardUnitedStates_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsDisclosureTextBlock_lbl0" xml:lang="en-US">Cash and Cash Equivalents Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_SaleOfCanadianETFBusinessMember_lbl0" xml:lang="en-US">Sale Of Canadian ETFBusiness Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SaleOfCanadianETFBusinessMember" xlink:to="wt_SaleOfCanadianETFBusinessMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsCurrent_lbl0" xml:lang="en-US">Other Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_GBHMember_lbl0" xml:lang="en-US">GBHMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_GBHMember" xlink:to="wt_GBHMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LaborAndRelatedExpense_lbl0" xml:lang="en-US">Labor and Related Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LaborAndRelatedExpense" xlink:to="us-gaap_LaborAndRelatedExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_lbl1" xml:lang="en-US">Stock Repurchased During Period, Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_lbl2" xml:lang="en-US">Interest Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl2"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfBeginningAndEndingBalancesOfRecurringFairValueMeasurementsClassifiedAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfBeginningAndEndingBalancesOfRecurringFairValueMeasurementsClassifiedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfBeginningAndEndingBalancesOfRecurringFairValueMeasurementsClassifiedAbstract_lbl" xml:lang="en-US">Schedule Of Beginning And Ending Balances Of Recurring Fair Value Measurements Classified Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfBeginningAndEndingBalancesOfRecurringFairValueMeasurementsClassifiedAbstract" xlink:to="wt_ScheduleOfBeginningAndEndingBalancesOfRecurringFairValueMeasurementsClassifiedAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_lbl0" xml:lang="en-US">Undistributed Earnings (Loss) Allocated to Participating Securities, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:to="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl1" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ProbabilityThatSeriesB2PreferenceSharesCovertIntoSeriesB1PreferenceShares_lbl1" xml:lang="en-US">Probability That Series B2 Preference Shares Covert Into Series B1 Preference Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ProbabilityThatSeriesB2PreferenceSharesCovertIntoSeriesB1PreferenceShares" xlink:to="wt_ProbabilityThatSeriesB2PreferenceSharesCovertIntoSeriesB1PreferenceShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_UndistributedIncomeAllocableToParticipatingSecurities_lbl1" xml:lang="en-US">Undistributed Income Allocable To Participating Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_UndistributedIncomeAllocableToParticipatingSecurities" xlink:to="wt_UndistributedIncomeAllocableToParticipatingSecurities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl0" xml:lang="en-US">Income Tax Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_TwoFinancialInstitutionsMember_lbl1" xml:lang="en-US">Two Financial Institutions Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_TwoFinancialInstitutionsMember" xlink:to="wt_TwoFinancialInstitutionsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl0" xml:lang="en-US">Cash Equivalents, at Carrying Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_BusinessCombinationConsiderationTransferredDeferredPaymentInterest_lbl1" xml:lang="en-US">Business Combination Consideration Transferred Deferred Payment Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_BusinessCombinationConsiderationTransferredDeferredPaymentInterest" xlink:to="wt_BusinessCombinationConsiderationTransferredDeferredPaymentInterest_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInvestmentsAbstract_lbl" xml:lang="en-US">Schedule of Investments [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInvestmentsAbstract" xlink:to="us-gaap_ScheduleOfInvestmentsAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl0" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsNonrecurringMember_lbl0" xml:lang="en-US">Fair Value, Nonrecurring [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="us-gaap_FairValueMeasurementsNonrecurringMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0" xml:lang="en-US">Liabilities and Equity [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl2" xml:lang="en-US">Unrecognized Tax Benefits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_CapitalStockPercentage_lbl1" xml:lang="en-US">Capital Stock Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_CapitalStockPercentage" xlink:to="wt_CapitalStockPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_FundManagementAndAdministration_lbl1" xml:lang="en-US">Fund Management And Administration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FundManagementAndAdministration" xlink:to="wt_FundManagementAndAdministration_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_lbl0" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ContractualGoldPaymentgoldOuncesPaid_lbl1" xml:lang="en-US">Contractual Gold Paymentgold Ounces Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ContractualGoldPaymentgoldOuncesPaid" xlink:to="wt_ContractualGoldPaymentgoldOuncesPaid_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_MeasurementPeriodForDeterminingSharePrice_lbl1" xml:lang="en-US">Measurement Period For Determining Share Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_MeasurementPeriodForDeterminingSharePrice" xlink:to="wt_MeasurementPeriodForDeterminingSharePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_lbl0" xml:lang="en-US">Advertising Cost [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl0" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock_lbl1" xml:lang="en-US">Summary Of Revenues Categorized As Revenues From Contracts With Customers And Other Sources Of Revenues Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock" xlink:to="wt_SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_NumberOfThresholdTradingDaysForDeterminingTheSharePrice_lbl1" xml:lang="en-US">Number Of Threshold Trading Days For Determining The Share Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_NumberOfThresholdTradingDaysForDeterminingTheSharePrice" xlink:to="wt_NumberOfThresholdTradingDaysForDeterminingTheSharePrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl1" xml:lang="en-US">Stock Repurchased During Period, Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl1" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales_lbl0" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Sales</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_IncomeTaxReconciliationUnrecognizedTaxBenefits_lbl1" xml:lang="en-US">Income Tax Reconciliation Unrecognized Tax Benefits</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncomeTaxReconciliationUnrecognizedTaxBenefits" xlink:to="wt_IncomeTaxReconciliationUnrecognizedTaxBenefits_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl0" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPayableAmountPerShare_lbl0" xml:lang="en-US">Dividends Payable, Amount Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableAmountPerShare" xlink:to="us-gaap_DividendsPayableAmountPerShare_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_PurchaseOfInvestments_lbl1" xml:lang="en-US">Purchase Of Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PurchaseOfInvestments" xlink:to="wt_PurchaseOfInvestments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_IncreaseDecreaseInOperatingLeaseLiabilities_lbl1" xml:lang="en-US">Increase Decrease In Operating Lease Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="wt_IncreaseDecreaseInOperatingLeaseLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_AggregateConsiderationPayable_lbl1" xml:lang="en-US">Aggregate Consideration Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_AggregateConsiderationPayable" xlink:to="wt_AggregateConsiderationPayable_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl2" xml:lang="en-US">Revenues</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_lbl0" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl0" xml:lang="en-US">Other Liabilities, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StraightLineDepreciationMethodMember_lbl0" xml:lang="en-US">Depreciation Method, Straight-Line [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StraightLineDepreciationMethodMember" xlink:to="us-gaap_StraightLineDepreciationMethodMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl0" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_PotentiallyDilutiveRestrictedStockAwards_lbl1" xml:lang="en-US">Potentially Dilutive Restricted Stock Awards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PotentiallyDilutiveRestrictedStockAwards" xlink:to="wt_PotentiallyDilutiveRestrictedStockAwards_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl0" xml:lang="en-US">Liabilities and Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_WeightedAverageDilutedSharesInThousandsAbstract_lbl0" xml:lang="en-US">Weighted Average Diluted Shares In Thousands Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_WeightedAverageDilutedSharesInThousandsAbstract" xlink:to="wt_WeightedAverageDilutedSharesInThousandsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_RecurringFairValueMeasurementsAbstract_lbl0" xml:lang="en-US">Recurring Fair Value Measurements Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RecurringFairValueMeasurementsAbstract" xlink:to="wt_RecurringFairValueMeasurementsAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl0" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_PreferredStockPurchaseRightsMember_lbl0" xml:lang="en-US">Preferred Stock Purchase Rights Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PreferredStockPurchaseRightsMember" xlink:to="wt_PreferredStockPurchaseRightsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl0" xml:lang="en-US">Assets, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, GILTI, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfComponentsOfCurrentAndDeferredIncomeTaxExpenseAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfComponentsOfCurrentAndDeferredIncomeTaxExpenseAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfComponentsOfCurrentAndDeferredIncomeTaxExpenseAbstract_lbl" xml:lang="en-US">Schedule Of Components Of Current And Deferred Income Tax Expense Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfComponentsOfCurrentAndDeferredIncomeTaxExpenseAbstract" xlink:to="wt_ScheduleOfComponentsOfCurrentAndDeferredIncomeTaxExpenseAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl0" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl0" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl0" xml:lang="en-US">Common Stock, Shares, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities_lbl2" xml:lang="en-US">Weighted Average Number Of Diluted Shares Outstanding Excluding Participating Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities" xlink:to="wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_RecentlyIssuedAccountingPronouncementsPolicyTextBlock_lbl1" xml:lang="en-US">Recently Issued Accounting Pronouncements Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RecentlyIssuedAccountingPronouncementsPolicyTextBlock" xlink:to="wt_RecentlyIssuedAccountingPronouncementsPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl1" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity_lbl1" xml:lang="en-US">Percentage Of Voting Approval Required To Redeem All Of The Outstanding Notes At Maturity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity" xlink:to="wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ContingentPaymentTextBlock_lbl1" xml:lang="en-US">Contingent Payment Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ContingentPaymentTextBlock" xlink:to="wt_ContingentPaymentTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares_lbl1" xml:lang="en-US">Weighted Average Shares Of Common Stock Issuable Upon Conversion Of The Preferred Shares</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares" xlink:to="wt_WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_IncomeTaxReconciliationExpirationOfCapitalLosses_lbl1" xml:lang="en-US">Income Tax Reconciliation Expiration Of Capital Losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncomeTaxReconciliationExpirationOfCapitalLosses" xlink:to="wt_IncomeTaxReconciliationExpirationOfCapitalLosses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl0" xml:lang="en-US">Retirement Benefits [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl0" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_NondeductibleLossOnExtinguishmentOfConvertibleNotes_lbl1" xml:lang="en-US">Nondeductible Loss On Extinguishment Of Convertible Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_NondeductibleLossOnExtinguishmentOfConvertibleNotes" xlink:to="wt_NondeductibleLossOnExtinguishmentOfConvertibleNotes_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringCostsAndAssetImpairmentCharges_lbl0" xml:lang="en-US">Restructuring Costs and Asset Impairment Charges</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:to="us-gaap_RestructuringCostsAndAssetImpairmentCharges_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_SecurrencyIncMember_lbl1" xml:lang="en-US">Securrency Inc Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SecurrencyIncMember" xlink:to="wt_SecurrencyIncMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl0" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchaseProgramExpirationDate_lbl0" xml:lang="en-US">Stock Repurchase Program Expiration Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramExpirationDate" xlink:to="us-gaap_StockRepurchaseProgramExpirationDate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_lbl0" xml:lang="en-US">Deferred Tax Assets, Unrealized Currency Losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:to="us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_DeferredTaxAssetUnrealizedLosses_lbl1" xml:lang="en-US">Deferred Tax Asset Unrealized Losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredTaxAssetUnrealizedLosses" xlink:to="wt_DeferredTaxAssetUnrealizedLosses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_CostMethodInvestmentOwnershipPercentage_lbl1" xml:lang="en-US">Cost Method Investment Ownership Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_CostMethodInvestmentOwnershipPercentage" xlink:to="wt_CostMethodInvestmentOwnershipPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_GoldBullionHoldingsMember_lbl0" xml:lang="en-US">Gold Bullion Holdings Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_GoldBullionHoldingsMember" xlink:to="wt_GoldBullionHoldingsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Plan Modification, Description and Terms</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Cash_lbl0" xml:lang="en-US">Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl0" xml:lang="en-US">Operating Lease, Right-of-Use Asset</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_lbl0" xml:lang="en-US">Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:to="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl0" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_lbl1" xml:lang="en-US">Shares, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate_lbl1" xml:lang="en-US">Debt Conversion, Converted Instrument, Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentRate" xlink:to="us-gaap_DebtConversionConvertedInstrumentRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl0" xml:lang="en-US">Temporary Equity, Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl1" xml:lang="en-US">Operating Lease, Liability, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_CarryingAmountAssetsSecurrencyAbstract_lbl0" xml:lang="en-US">Carrying Amount Assets Securrency Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_CarryingAmountAssetsSecurrencyAbstract" xlink:to="wt_CarryingAmountAssetsSecurrencyAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_DeferredConsiderationNote7Abstract_lbl0" xml:lang="en-US">Deferred Consideration Note7 Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredConsiderationNote7Abstract" xlink:to="wt_DeferredConsiderationNote7Abstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_IncreaseDecreaseInGoldAndOtherPreciousMetals_lbl1" xml:lang="en-US">Increase Decrease In Gold And Other Precious Metals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncreaseDecreaseInGoldAndOtherPreciousMetals" xlink:to="wt_IncreaseDecreaseInGoldAndOtherPreciousMetals_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember_lbl1" xml:lang="en-US">Convertible Senior Notes Due Two Thousand And Twenty Three Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember" xlink:to="wt_ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ConversionOfNoteUponAFutureFinancingRound_lbl1" xml:lang="en-US">Conversion Of Note Upon AFuture Financing Round</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConversionOfNoteUponAFutureFinancingRound" xlink:to="wt_ConversionOfNoteUponAFutureFinancingRound_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_lbl0" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ConvertiblePromissoryNoteMember_lbl0" xml:lang="en-US">Convertible Promissory Note Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConvertiblePromissoryNoteMember" xlink:to="wt_ConvertiblePromissoryNoteMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ConvertibleNoteMember_lbl0" xml:lang="en-US">Convertible Note Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConvertibleNoteMember" xlink:to="wt_ConvertibleNoteMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl1" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_PassiveStockholdersMember_lbl0" xml:lang="en-US">Passive Stockholders Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PassiveStockholdersMember" xlink:to="wt_PassiveStockholdersMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExchangeTradedFundsMember_lbl1" xml:lang="en-US">Exchange Traded Funds [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExchangeTradedFundsMember" xlink:to="us-gaap_ExchangeTradedFundsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses_lbl1" xml:lang="en-US">Income Tax Reconciliation Change In Valuation Allowance Capital Losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses" xlink:to="wt_IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl0" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl0" xml:lang="en-US">Investment, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl0" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl0" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_CommonStock001ParValueMember_lbl0" xml:lang="en-US">Common Stock001 Par Value Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_CommonStock001ParValueMember" xlink:to="wt_CommonStock001ParValueMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioForecastMember_lbl0" xml:lang="en-US">Forecast [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_lbl0" xml:lang="en-US">Extinguishment of Debt, Gain (Loss), Net of Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:to="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl1" xml:lang="en-US">Assets [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1" xml:lang="en-US">Operating Lease, Liability, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_DeferredConsiderationTextBlock_lbl1" xml:lang="en-US">Deferred Consideration Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredConsiderationTextBlock" xlink:to="wt_DeferredConsiderationTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock_lbl0" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="us-gaap_ScheduleOfGoodwillTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_lbl0" xml:lang="en-US">Proceeds from Sale and Maturity of Held-to-Maturity Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl0" xml:lang="en-US">Operating Loss Carryforwards</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingGainsLosses_lbl0" xml:lang="en-US">Other Nonoperating Gains (Losses)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingGainsLosses" xlink:to="us-gaap_OtherNonoperatingGainsLosses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherPaymentsToAcquireBusinesses_lbl0" xml:lang="en-US">Other Payments to Acquire Businesses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPaymentsToAcquireBusinesses" xlink:to="us-gaap_OtherPaymentsToAcquireBusinesses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl0" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings_lbl1" xml:lang="en-US">Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Realized Gain Loss Included In Earnings</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings" xlink:to="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl0" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_BasicEarningsPerShareAbstract_lbl0" xml:lang="en-US">Basic Earnings Per Share Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_BasicEarningsPerShareAbstract" xlink:to="wt_BasicEarningsPerShareAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_PercentageOfCommonStock_lbl1" xml:lang="en-US">Percentage Of Common Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfCommonStock" xlink:to="wt_PercentageOfCommonStock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl1" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockConvertibleSharesIssuable_lbl1" xml:lang="en-US">Preferred Stock, Convertible, Shares Issuable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockConvertibleSharesIssuable" xlink:to="us-gaap_PreferredStockConvertibleSharesIssuable_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ConversionOfNotesUponAFutureEquityFinancing_lbl1" xml:lang="en-US">Conversion Of Notes Upon AFuture Equity Financing</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConversionOfNotesUponAFutureEquityFinancing" xlink:to="wt_ConversionOfNotesUponAFutureEquityFinancing_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl0" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyMember_lbl1" xml:lang="en-US">Related Party [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyMember" xlink:to="us-gaap_RelatedPartyMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl1" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableTradeCurrent_lbl0" xml:lang="en-US">Accounts Payable, Trade, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableTradeCurrent" xlink:to="us-gaap_AccountsPayableTradeCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchaseProgramPeriodInForce1_lbl0" xml:lang="en-US">Stock Repurchase Program, Period in Force</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:to="us-gaap_StockRepurchaseProgramPeriodInForce1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_lbl0" xml:lang="en-US">Equity Method Investment, Other than Temporary Impairment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_US_lbl1" xml:lang="en-US">UNITED STATES</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_SeriesANonVotingConvertiblePreferredStockMember_lbl2" xml:lang="en-US">Series ANon Voting Convertible Preferred Stock Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SeriesANonVotingConvertiblePreferredStockMember" xlink:to="wt_SeriesANonVotingConvertiblePreferredStockMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ThirdPartyDistributionFeesPolicyTextBlock_lbl1" xml:lang="en-US">Third Party Distribution Fees Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ThirdPartyDistributionFeesPolicyTextBlock" xlink:to="wt_ThirdPartyDistributionFeesPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl0" xml:lang="en-US">Deferred Tax Assets, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember_lbl1" xml:lang="en-US">Convertible Senior Notes Due Two Thousand And Twenty Six Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember" xlink:to="wt_ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_lbl0" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnContractTermination_lbl0" xml:lang="en-US">Gain (Loss) on Contract Termination</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnContractTermination" xlink:to="us-gaap_GainLossOnContractTermination_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_lbl0" xml:lang="en-US">Payments to Acquire in Process Research and Development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:to="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl0" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl0" xml:lang="en-US">Debt Instrument, Unamortized Discount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl2" xml:lang="en-US">Business Combination, Consideration Transferred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl0" xml:lang="en-US">Retained Earnings [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl0" xml:lang="en-US">Preferred Stock, Shares Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_BoardOfDirectorsChairmanMember_lbl1" xml:lang="en-US">Board of Directors Chairman [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_BoardOfDirectorsChairmanMember" xlink:to="srt_BoardOfDirectorsChairmanMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl0" xml:lang="en-US">Fair Value Disclosures [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_lbl0" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueAbstract_lbl" xml:lang="en-US">Schedule Of Assets And Liabilities Measured At Fair Value Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueAbstract" xlink:to="wt_ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl0" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses_lbl1" xml:lang="en-US">Deferred Tax Liabilities Fixed Assets And Prepaid Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses" xlink:to="wt_DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ReceivableFromManJerIssuersMember_lbl0" xml:lang="en-US">Receivable From Man Jer Issuers Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ReceivableFromManJerIssuersMember" xlink:to="wt_ReceivableFromManJerIssuersMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl0" xml:lang="en-US">Debt Securities, Available-for-Sale [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl0" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Foreign</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_WisdomTreeProductsMember_lbl0" xml:lang="en-US">Wisdom Tree Products Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_WisdomTreeProductsMember" xlink:to="wt_WisdomTreeProductsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PercentageOfWeightedAverageCostInventory_lbl0" xml:lang="en-US">Percentage of Weighted Average Cost Inventory</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PercentageOfWeightedAverageCostInventory" xlink:to="us-gaap_PercentageOfWeightedAverageCostInventory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_CarryingValueOfConvertibleNotes_lbl1" xml:lang="en-US">Carrying Value Of Convertible Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_CarryingValueOfConvertibleNotes" xlink:to="wt_CarryingValueOfConvertibleNotes_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl0" xml:lang="en-US">Maximum [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl1" xml:lang="en-US">Goodwill, Impairment Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherTaxExpenseBenefit_lbl0" xml:lang="en-US">Other Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherTaxExpenseBenefit" xlink:to="us-gaap_OtherTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractualObligation_lbl0" xml:lang="en-US">Contractual Obligation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractualObligation" xlink:to="us-gaap_ContractualObligation_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl0" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl1" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockDividendRatePercentage_lbl0" xml:lang="en-US">Preferred Stock, Dividend Rate, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendRatePercentage" xlink:to="us-gaap_PreferredStockDividendRatePercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentOwnedAtFairValue_lbl0" xml:lang="en-US">Investment Owned, Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedAtFairValue" xlink:to="us-gaap_InvestmentOwnedAtFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_IncreaseDecreaseInFundManagementAndAdministrationPayable_lbl1" xml:lang="en-US">Increase Decrease In Fund Management And Administration Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncreaseDecreaseInFundManagementAndAdministrationPayable" xlink:to="wt_IncreaseDecreaseInFundManagementAndAdministrationPayable_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_TimeToPotentialOutcomesinYears_lbl1" xml:lang="en-US">Time To Potential Outcomesin Years</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_TimeToPotentialOutcomesinYears" xlink:to="wt_TimeToPotentialOutcomesinYears_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentOwnedBalanceOtherMeasure_lbl0" xml:lang="en-US">Investment Owned, Balance, Other Measure</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentOwnedBalanceOtherMeasure" xlink:to="us-gaap_InvestmentOwnedBalanceOtherMeasure_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_lbl0" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation_lbl1" xml:lang="en-US">Unrecognized Tax Benefits And Interest And Penalties Increases Resulting From Foreign Currency Translation</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation" xlink:to="wt_UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl1" xml:lang="en-US">Property, Plant and Equipment, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ForwardsLookingGoldPrice_lbl1" xml:lang="en-US">Forwards Looking Gold Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ForwardsLookingGoldPrice" xlink:to="wt_ForwardsLookingGoldPrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl0" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Investments_lbl1" xml:lang="en-US">Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Investments" xlink:to="us-gaap_Investments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl0" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_GainLossFromChangeInDeferredConsideration_lbl3" xml:lang="en-US">Gain Loss From Change In Deferred Consideration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_GainLossFromChangeInDeferredConsideration" xlink:to="wt_GainLossFromChangeInDeferredConsideration_lbl3"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_OtherInvestmentMember_lbl0" xml:lang="en-US">Other Investment Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_OtherInvestmentMember" xlink:to="wt_OtherInvestmentMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_IndemnificationReceivableNoncurrent_lbl1" xml:lang="en-US">Indemnification Receivable Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IndemnificationReceivableNoncurrent" xlink:to="wt_IndemnificationReceivableNoncurrent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease_lbl0" xml:lang="en-US">Goodwill, Period Increase (Decrease)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillPeriodIncreaseDecrease" xlink:to="us-gaap_GoodwillPeriodIncreaseDecrease_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl0" xml:lang="en-US">Debt Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ForeignMember_lbl0" xml:lang="en-US">Foreign Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ForeignMember" xlink:to="wt_ForeignMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayableCurrent_lbl0" xml:lang="en-US">Convertible Notes Payable, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableCurrent" xlink:to="us-gaap_ConvertibleNotesPayableCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancialInstrumentsDisclosureTextBlock_lbl0" xml:lang="en-US">Financial Instruments Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:to="us-gaap_FinancialInstrumentsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl0" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_lbl0" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_RodberInvestmentsLimitedMember_lbl1" xml:lang="en-US">Rodber Investments Limited Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RodberInvestmentsLimitedMember" xlink:to="wt_RodberInvestmentsLimitedMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCost_lbl0" xml:lang="en-US">Lease, Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_SharesPercentage_lbl1" xml:lang="en-US">Shares Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SharesPercentage" xlink:to="wt_SharesPercentage_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilities_lbl0" xml:lang="en-US">Deferred Tax Liabilities, Net</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ThirdInstallmentsMember_lbl0" xml:lang="en-US">Third Installments Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ThirdInstallmentsMember" xlink:to="wt_ThirdInstallmentsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDividends_lbl0" xml:lang="en-US">Payments of Dividends</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividends" xlink:to="us-gaap_PaymentsOfDividends_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl0" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_FinancialInstrumentsOwnedAtFairValueAbstract0_lbl0" xml:lang="en-US">Financial Instruments Owned At Fair Value Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FinancialInstrumentsOwnedAtFairValueAbstract0" xlink:to="wt_FinancialInstrumentsOwnedAtFairValueAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_MaximumNumberOfSharesIssuableUponConversion_lbl1" xml:lang="en-US">Maximum Number Of Shares Issuable Upon Conversion</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_MaximumNumberOfSharesIssuableUponConversion" xlink:to="wt_MaximumNumberOfSharesIssuableUponConversion_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl0" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl0" xml:lang="en-US">Temporary Equity, Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_SecurrencyseriesaconvertiblepreferredstockMember_lbl1" xml:lang="en-US">Securrencyseriesaconvertiblepreferredstock Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SecurrencyseriesaconvertiblepreferredstockMember" xlink:to="wt_SecurrencyseriesaconvertiblepreferredstockMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl0" xml:lang="en-US">Payments of Stock Issuance Costs</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl0" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_lbl1" xml:lang="en-US">Proceeds from Sale, Maturity and Collection of Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:to="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_UnlabeledAbstract0_lbl0" xml:lang="en-US">Unlabeled Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_UnlabeledAbstract0" xlink:to="wt_UnlabeledAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl0" xml:lang="en-US">Temporary Equity, Shares Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ETFSAcquisitionMember_lbl1" xml:lang="en-US">ETFSAcquisition Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ETFSAcquisitionMember" xlink:to="wt_ETFSAcquisitionMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ContractualGoldPaymentsMember_lbl0" xml:lang="en-US">Contractual Gold Payments Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ContractualGoldPaymentsMember" xlink:to="wt_ContractualGoldPaymentsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebt_lbl0" xml:lang="en-US">Convertible Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebt" xlink:to="us-gaap_ConvertibleDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_GoldBullionHoldingsJerseyLimitedMember_lbl0" xml:lang="en-US">Gold Bullion Holdings Jersey Limited Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_GoldBullionHoldingsJerseyLimitedMember" xlink:to="wt_GoldBullionHoldingsJerseyLimitedMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl0" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl0" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfFinancialInstrumentsOwnedAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfFinancialInstrumentsOwnedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfFinancialInstrumentsOwnedAbstract_lbl" xml:lang="en-US">Schedule Of Financial Instruments Owned Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfFinancialInstrumentsOwnedAbstract" xlink:to="wt_ScheduleOfFinancialInstrumentsOwnedAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl2" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements_lbl1" xml:lang="en-US">Net Liquid Assets International Subsidiary Regulatory Capital Requirements</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements" xlink:to="wt_NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl0" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl0" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_DeferredTaxAssetsLiabilitiesGross_lbl1" xml:lang="en-US">Deferred Tax Assets Liabilities Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredTaxAssetsLiabilitiesGross" xlink:to="wt_DeferredTaxAssetsLiabilitiesGross_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockTextBlock_lbl0" xml:lang="en-US">Preferred Stock [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockTextBlock" xlink:to="us-gaap_PreferredStockTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionSharePrice_lbl0" xml:lang="en-US">Business Acquisition, Share Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionSharePrice" xlink:to="us-gaap_BusinessAcquisitionSharePrice_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_UnlabeledAbstract_lbl0" xml:lang="en-US">Unlabeled Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_UnlabeledAbstract" xlink:to="wt_UnlabeledAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_FnalityInternationalLimitedBOnePreferenceSharesMember_lbl0" xml:lang="en-US">Fnality International Limited BOne Preference Shares Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FnalityInternationalLimitedBOnePreferenceSharesMember" xlink:to="wt_FnalityInternationalLimitedBOnePreferenceSharesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_CashEquivalentsMaturityPeriod_lbl1" xml:lang="en-US">Cash Equivalents Maturity Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_CashEquivalentsMaturityPeriod" xlink:to="wt_CashEquivalentsMaturityPeriod_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome_lbl1" xml:lang="en-US">Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Net Unrealized Gain Loss Included In Earnings And Other Comprehensive Income</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome" xlink:to="wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl0" xml:lang="en-US">State and Local Jurisdiction [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_DisclosureOfStockholderRightsPlanTextBlock_lbl1" xml:lang="en-US">Disclosure Of Stockholder Rights Plan Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DisclosureOfStockholderRightsPlanTextBlock" xlink:to="wt_DisclosureOfStockholderRightsPlanTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ProceedsFromIssuanceOfConvertibleNotes_lbl1" xml:lang="en-US">Proceeds From Issuance Of Convertible Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ProceedsFromIssuanceOfConvertibleNotes" xlink:to="wt_ProceedsFromIssuanceOfConvertibleNotes_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_FnalityInternationalLimitedAbstract_lbl0" xml:lang="en-US">Fnality International Limited Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FnalityInternationalLimitedAbstract" xlink:to="wt_FnalityInternationalLimitedAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ThirdPartyDistribution_lbl1" xml:lang="en-US">Third Party Distribution</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ThirdPartyDistribution" xlink:to="wt_ThirdPartyDistribution_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock_lbl0" xml:lang="en-US">Condensed Financial Statements [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock" xlink:to="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquitySecuritiesMember_lbl0" xml:lang="en-US">Equity Securities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesMember" xlink:to="us-gaap_EquitySecuritiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HeldToMaturitySecuritiesNoncurrent_lbl0" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss, Noncurrent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:to="us-gaap_HeldToMaturitySecuritiesNoncurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl0" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_DeferredConsiderationGoldPaymentsPolicyTextBlock_lbl1" xml:lang="en-US">Deferred Consideration Gold Payments Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredConsiderationGoldPaymentsPolicyTextBlock" xlink:to="wt_DeferredConsiderationGoldPaymentsPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_BelowTwentyFifthPercentileMember_lbl1" xml:lang="en-US">Below Twenty Fifth Percentile Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_BelowTwentyFifthPercentileMember" xlink:to="wt_BelowTwentyFifthPercentileMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_PercentageOfCommonStockAcquired_lbl1" xml:lang="en-US">Percentage Of Common Stock Acquired</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfCommonStockAcquired" xlink:to="wt_PercentageOfCommonStockAcquired_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl0" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl0" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_TwoThousandAndTwentyNotesMember_lbl2" xml:lang="en-US">Two Thousand And Twenty Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_TwoThousandAndTwentyNotesMember" xlink:to="wt_TwoThousandAndTwentyNotesMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock_lbl0" xml:lang="en-US">Schedule of Debt [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount_lbl0" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, after Year 5 through 10</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_PercentageOfTaxRateRealizedOnSettlement_lbl1" xml:lang="en-US">Percentage Of Tax Rate Realized On Settlement</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfTaxRateRealizedOnSettlement" xlink:to="wt_PercentageOfTaxRateRealizedOnSettlement_lbl1"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl0" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_FederalAgencyMember_lbl2" xml:lang="en-US">Federal Agency Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FederalAgencyMember" xlink:to="wt_FederalAgencyMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl1" xml:lang="en-US">Proceeds from Issuance of Convertible Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl0" xml:lang="en-US">Lease, Cost [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_PercentageOfAssetsSold_lbl1" xml:lang="en-US">Percentage Of Assets Sold</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfAssetsSold" xlink:to="wt_PercentageOfAssetsSold_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HeldToMaturitySecuritiesFairValue_lbl0" xml:lang="en-US">Debt Securities, Held-to-Maturity, Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesFairValue" xlink:to="us-gaap_HeldToMaturitySecuritiesFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyDisclosures_lbl0" xml:lang="en-US">Contingencies Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyDisclosures" xlink:to="us-gaap_LossContingencyDisclosures_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_DeferredConsiderationObligationMember_lbl1" xml:lang="en-US">Deferred Consideration Obligation Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredConsiderationObligationMember" xlink:to="wt_DeferredConsiderationObligationMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRepaymentsOfNotesPayable_lbl0" xml:lang="en-US">Proceeds from (Repayments of) Notes Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:to="us-gaap_ProceedsFromRepaymentsOfNotesPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl0" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_DeferredConsiderationPerpetualGrowthRate_lbl1" xml:lang="en-US">Deferred Consideration Perpetual Growth Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredConsiderationPerpetualGrowthRate" xlink:to="wt_DeferredConsiderationPerpetualGrowthRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_SecurrencyseriesbconvertiblepreferredstockMember_lbl1" xml:lang="en-US">Securrencyseriesbconvertiblepreferredstock Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SecurrencyseriesbconvertiblepreferredstockMember" xlink:to="wt_SecurrencyseriesbconvertiblepreferredstockMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl0" xml:lang="en-US">Schedule of Related Party Transactions [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_OperatingLossCarryForwardExpirationYear_lbl1" xml:lang="en-US">Operating Loss Carry Forward Expiration Year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_OperatingLossCarryForwardExpirationYear" xlink:to="wt_OperatingLossCarryForwardExpirationYear_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_TemporaryEquityShareOutstanding_lbl1" xml:lang="en-US">Temporary Equity Share Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_TemporaryEquityShareOutstanding" xlink:to="wt_TemporaryEquityShareOutstanding_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ContingentPaymentsPolicyTextBlock_lbl1" xml:lang="en-US">Contingent Payments Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ContingentPaymentsPolicyTextBlock" xlink:to="wt_ContingentPaymentsPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl0" xml:lang="en-US">Payments to Acquire Businesses, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity_lbl1" xml:lang="en-US">Proceeds From Heldtomaturity Securities Maturing Or Called Prior To Maturity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity" xlink:to="wt_ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNoncurrentLiabilitiesMember_lbl0" xml:lang="en-US">Other Noncurrent Liabilities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="us-gaap_OtherNoncurrentLiabilitiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_LondonOfficeMember_lbl0" xml:lang="en-US">London Office Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_LondonOfficeMember" xlink:to="wt_LondonOfficeMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl1" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ImplementationOfASU202006Member_lbl0" xml:lang="en-US">Implementation Of ASU202006 Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ImplementationOfASU202006Member" xlink:to="wt_ImplementationOfASU202006Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesPolicyTextBlock_lbl0" xml:lang="en-US">Receivable [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesPolicyTextBlock" xlink:to="us-gaap_ReceivablesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl1" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes_lbl1" xml:lang="en-US">Stock Issued During Period Value Reclassification Of Equity Component Related To Convertible Notes</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes" xlink:to="wt_StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_lbl0" xml:lang="en-US">Operating Expenses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_EmployeesAndDirectorsMember_lbl1" xml:lang="en-US">Employees And Directors Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_EmployeesAndDirectorsMember" xlink:to="wt_EmployeesAndDirectorsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtTableTextBlock_lbl0" xml:lang="en-US">Convertible Debt [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtTableTextBlock" xlink:to="us-gaap_ConvertibleDebtTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_PaymentOfLeaseTerminationFee_lbl1" xml:lang="en-US">Payment Of Lease Termination Fee</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PaymentOfLeaseTerminationFee" xlink:to="wt_PaymentOfLeaseTerminationFee_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_DeferredTaxAssetsOutsideBasisDifference_lbl1" xml:lang="en-US">Deferred Tax Assets Outside Basis Difference</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredTaxAssetsOutsideBasisDifference" xlink:to="wt_DeferredTaxAssetsOutsideBasisDifference_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl0" xml:lang="en-US">Property, Plant and Equipment, Useful Life</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_PerformanceBasedRestrictedStockUnitMember_lbl1" xml:lang="en-US">Performance Based Restricted Stock Unit Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PerformanceBasedRestrictedStockUnitMember" xlink:to="wt_PerformanceBasedRestrictedStockUnitMember_lbl1"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfWeightedAverageNumberOfSharesAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfWeightedAverageNumberOfSharesAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfWeightedAverageNumberOfSharesAbstract_lbl" xml:lang="en-US">Schedule Of Weighted Average Number Of Shares Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfWeightedAverageNumberOfSharesAbstract" xlink:to="wt_ScheduleOfWeightedAverageNumberOfSharesAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl1" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_RedemptionOfNoteUponAChangeOfControl_lbl1" xml:lang="en-US">Redemption Of Note Upon AChange Of Control</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RedemptionOfNoteUponAChangeOfControl" xlink:to="wt_RedemptionOfNoteUponAChangeOfControl_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_OtherAssetsseedCapitalWisdomtreeDigitalFundsMember_lbl1" xml:lang="en-US">Other Assetsseed Capital Wisdomtree Digital Funds Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_OtherAssetsseedCapitalWisdomtreeDigitalFundsMember" xlink:to="wt_OtherAssetsseedCapitalWisdomtreeDigitalFundsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNoncashIncomeExpense_lbl0" xml:lang="en-US">Other Noncash Income (Expense)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncashIncomeExpense" xlink:to="us-gaap_OtherNoncashIncomeExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllOtherCorporateBondsMember_lbl0" xml:lang="en-US">Other Corporate Bonds [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllOtherCorporateBondsMember" xlink:to="us-gaap_AllOtherCorporateBondsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl1" xml:lang="en-US">Earnings Per Share, Basic</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl0" xml:lang="en-US">Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember_lbl1" xml:lang="en-US">Investment Advisory, Management and Administrative Service [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember" xlink:to="us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl0" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl0" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_MaximumExposureToLossMember_lbl0" xml:lang="en-US">Maximum Exposure To Loss Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_MaximumExposureToLossMember" xlink:to="wt_MaximumExposureToLossMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl0" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ReceivableFromWTTMember_lbl0" xml:lang="en-US">Receivable From WTTMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ReceivableFromWTTMember" xlink:to="wt_ReceivableFromWTTMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ContractualGoldPayments_lbl2" xml:lang="en-US">Contractual Gold Payments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ContractualGoldPayments" xlink:to="wt_ContractualGoldPayments_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_PercentageOfDiscountOnFutureEquityFinancingForPreferredStock_lbl1" xml:lang="en-US">Percentage Of Discount On Future Equity Financing For Preferred Stock</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfDiscountOnFutureEquityFinancingForPreferredStock" xlink:to="wt_PercentageOfDiscountOnFutureEquityFinancingForPreferredStock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_lbl0" xml:lang="en-US">Current Federal, State and Local, Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_lbl0" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_AdvisoryServicesProvidedToManJerIssuersMember_lbl0" xml:lang="en-US">Advisory Services Provided To Man Jer Issuers Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_AdvisoryServicesProvidedToManJerIssuersMember" xlink:to="wt_AdvisoryServicesProvidedToManJerIssuersMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestAndDebtExpense_lbl0" xml:lang="en-US">Interest and Debt Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndDebtExpense" xlink:to="us-gaap_InterestAndDebtExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNet_lbl1" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNet" xlink:to="us-gaap_AccountsReceivableNet_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RegulatoryDepreciationAndAmortizationPolicy_lbl0" xml:lang="en-US">Regulatory Depreciation and Amortization, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RegulatoryDepreciationAndAmortizationPolicy" xlink:to="us-gaap_RegulatoryDepreciationAndAmortizationPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl0" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl0" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared_lbl0" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl0" xml:lang="en-US">Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesAbstract_lbl1" xml:lang="en-US">Revenues [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_LessParticipatingSecuritiesAbstract_lbl0" xml:lang="en-US">Less Participating Securities Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_LessParticipatingSecuritiesAbstract" xlink:to="wt_LessParticipatingSecuritiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl1" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount_lbl0" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, after Year 10</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentTableTextBlock_lbl0" xml:lang="en-US">Investment [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTableTextBlock" xlink:to="us-gaap_InvestmentTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl0" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_SharePriceAsAPercentageOfLastReportedPriceAndConversionRate_lbl1" xml:lang="en-US">Share Price As APercentage Of Last Reported Price And Conversion Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SharePriceAsAPercentageOfLastReportedPriceAndConversionRate" xlink:to="wt_SharePriceAsAPercentageOfLastReportedPriceAndConversionRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl1" xml:lang="en-US">Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_PaymentOfDeferredConsideration_lbl1" xml:lang="en-US">Payment Of Deferred Consideration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PaymentOfDeferredConsideration" xlink:to="wt_PaymentOfDeferredConsideration_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl0" xml:lang="en-US">Lessee, Operating Leases [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_DeferredTaxAssetsOperatingLeaseLiabilities_lbl1" xml:lang="en-US">Deferred Tax Assets Operating Lease Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:to="wt_DeferredTaxAssetsOperatingLeaseLiabilities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtPolicyTextBlock_lbl0" xml:lang="en-US">Debt, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtPolicyTextBlock" xlink:to="us-gaap_DebtPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration_lbl1" xml:lang="en-US">Income Tax Reconciliation Gain On Revaluation Termination Of Deferred Consideration</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration" xlink:to="wt_IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl0" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForOtherLosses_lbl0" xml:lang="en-US">Provision for Other Losses</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForOtherLosses" xlink:to="us-gaap_ProvisionForOtherLosses_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ManJersMember_lbl0" xml:lang="en-US">Man Jers Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ManJersMember" xlink:to="wt_ManJersMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_PercentageOfBeneficialOwnership_lbl1" xml:lang="en-US">Percentage Of Beneficial Ownership</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PercentageOfBeneficialOwnership" xlink:to="wt_PercentageOfBeneficialOwnership_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_TwoThousandAndTwentyThreeNotesMember_lbl1" xml:lang="en-US">Two Thousand And Twenty Three Notes Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_TwoThousandAndTwentyThreeNotesMember" xlink:to="wt_TwoThousandAndTwentyThreeNotesMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferred_lbl0" xml:lang="en-US">Asset Acquisition, Consideration Transferred</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetAcquisitionConsiderationTransferred" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferred_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsFairValueDisclosure_lbl0" xml:lang="en-US">Investments, Fair Value Disclosure</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsFairValueDisclosure" xlink:to="us-gaap_InvestmentsFairValueDisclosure_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_lbl0" xml:lang="en-US">Research, Development, and Computer Software, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl0" xml:lang="en-US">Property, Plant and Equipment, Gross</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_SecurrencyConvertibleNoteMember_lbl2" xml:lang="en-US">Securrency Convertible Note Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SecurrencyConvertibleNoteMember" xlink:to="wt_SecurrencyConvertibleNoteMember_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfDeferredConsiderationTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Deferred Consideration Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfDeferredConsiderationTableTextBlock" xlink:to="wt_ScheduleOfDeferredConsiderationTableTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl1" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember_lbl1" xml:lang="en-US">Wisdomtree Multi Asset Issuer Plc And Wisdomtree Issuer Icav Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember" xlink:to="wt_WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl0" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl0" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_SubtotalFnalityInternationalLimitedMember_lbl1" xml:lang="en-US">Subtotal Fnality International Limited Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SubtotalFnalityInternationalLimitedMember" xlink:to="wt_SubtotalFnalityInternationalLimitedMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl1" xml:lang="en-US">Unrealized Gain (Loss) on Investments</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl0" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalFees_lbl0" xml:lang="en-US">Professional Fees</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockMember_lbl0" xml:lang="en-US">Restricted Stock [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayable_lbl0" xml:lang="en-US">Notes Payable</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_IncomeDistributedToParticipatingSecurities_lbl1" xml:lang="en-US">Income Distributed To Participating Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_IncomeDistributedToParticipatingSecurities" xlink:to="wt_IncomeDistributedToParticipatingSecurities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesMember_lbl0" xml:lang="en-US">Accounts Payable and Accrued Liabilities [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInvestmentsMember_lbl1" xml:lang="en-US">Other Investments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInvestmentsMember" xlink:to="us-gaap_OtherInvestmentsMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract_lbl0" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl0" xml:lang="en-US">Subsidiary, Ownership Percentage, Parent</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl0" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FixedIncomeInvestmentsMember_lbl0" xml:lang="en-US">Fixed Income Investments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FixedIncomeInvestmentsMember" xlink:to="us-gaap_FixedIncomeInvestmentsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl0" xml:lang="en-US">Operating Income (Loss)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_lbl0" xml:lang="en-US">Unrealized Gain (Loss) on Investments [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:to="us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_SecurrencyMember_lbl1" xml:lang="en-US">Securrency Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_SecurrencyMember" xlink:to="wt_SecurrencyMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1_lbl1" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionRatio1_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl0" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl0" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DomesticCountryMember_lbl0" xml:lang="en-US">Domestic Tax Authority [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HeldToMaturitySecuritiesTextBlock_lbl0" xml:lang="en-US">Debt Securities, Held-to-Maturity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesTextBlock" xlink:to="us-gaap_HeldToMaturitySecuritiesTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_lbl0" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_OtherInformationAbstract_lbl0" xml:lang="en-US">Other Information Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_OtherInformationAbstract" xlink:to="wt_OtherInformationAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl0" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_FinancialInstrumentsOwnedAtFairValueAbstract0Alt0_lbl0" xml:lang="en-US">Financial Instruments Owned At Fair Value Abstract0 Alt0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FinancialInstrumentsOwnedAtFairValueAbstract0Alt0" xlink:to="wt_FinancialInstrumentsOwnedAtFairValueAbstract0Alt0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_InterestAndPenaltiesMember_lbl0" xml:lang="en-US">Interest And Penalties Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_InterestAndPenaltiesMember" xlink:to="wt_InterestAndPenaltiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl1" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl1" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_TradingSecuritiesMember_lbl0" xml:lang="en-US">Trading Securities Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_TradingSecuritiesMember" xlink:to="wt_TradingSecuritiesMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseCost_lbl0" xml:lang="en-US">Operating Lease, Cost</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_AssetsAbstract0_lbl0" xml:lang="en-US">Assets Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_AssetsAbstract0" xlink:to="wt_AssetsAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketingAndAdvertisingExpense_lbl0" xml:lang="en-US">Marketing and Advertising Expense</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketingAndAdvertisingExpense" xlink:to="us-gaap_MarketingAndAdvertisingExpense_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_WisdomtreeETFMember_lbl1" xml:lang="en-US">Wisdomtree ETFMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_WisdomtreeETFMember" xlink:to="wt_WisdomtreeETFMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl0" xml:lang="en-US">Assets, Current [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_PurchaseOfFinancialInstrumentsOwnedAtFairValue_lbl1" xml:lang="en-US">Purchase Of Financial Instruments Owned At Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_PurchaseOfFinancialInstrumentsOwnedAtFairValue" xlink:to="wt_PurchaseOfFinancialInstrumentsOwnedAtFairValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl0" xml:lang="en-US">Revenue [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_DeferredConsiderationCurrent_lbl2" xml:lang="en-US">Deferred Consideration Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DeferredConsiderationCurrent" xlink:to="wt_DeferredConsiderationCurrent_lbl2"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl0" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets_lbl1" xml:lang="en-US">Effective Income Tax Reconcilation Changes In Tax Related Indemnification Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets" xlink:to="wt_EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainOrLossOnSaleOfStockInSubsidiary_lbl0" xml:lang="en-US">Gain (Loss) on Disposition of Stock in Subsidiary</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainOrLossOnSaleOfStockInSubsidiary" xlink:to="us-gaap_GainOrLossOnSaleOfStockInSubsidiary_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_TimeToPotentialOutcomeinYear_lbl1" xml:lang="en-US">Time To Potential Outcomein Year</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_TimeToPotentialOutcomeinYear" xlink:to="wt_TimeToPotentialOutcomeinYear_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl0" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl0" xml:lang="en-US">Class of Warrant or Right, Outstanding</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ReclassificationOfEquity_lbl1" xml:lang="en-US">Reclassification Of Equity</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ReclassificationOfEquity" xlink:to="wt_ReclassificationOfEquity_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl0" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl0" xml:lang="en-US">Earnings Per Share [Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl1" xml:lang="en-US">Proceeds from Stock Options Exercised</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyDamagesSoughtValue_lbl0" xml:lang="en-US">Loss Contingency, Damages Sought, Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyDamagesSoughtValue" xlink:to="us-gaap_LossContingencyDamagesSoughtValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount_lbl0" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Year One</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_DebtInstrumentRedemptionPrice_lbl1" xml:lang="en-US">Debt Instrument Redemption Price</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_DebtInstrumentRedemptionPrice" xlink:to="wt_DebtInstrumentRedemptionPrice_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_AdvisoryServicesProvidedToWMAIAndWTICAVMember_lbl0" xml:lang="en-US">Advisory Services Provided To WMAIAnd WTICAVMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_AdvisoryServicesProvidedToWMAIAndWTICAVMember" xlink:to="wt_AdvisoryServicesProvidedToWMAIAndWTICAVMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl1" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock_lbl0" xml:lang="en-US">Details of Impairment of Long-Lived Assets Held and Used by Asset [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" xlink:to="us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl1" xml:lang="en-US">Debt Instrument, Face Amount</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl1"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfBacksolveValuationApproachAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfBacksolveValuationApproachAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfBacksolveValuationApproachAbstract_lbl" xml:lang="en-US">Schedule Of Backsolve Valuation Approach Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfBacksolveValuationApproachAbstract" xlink:to="wt_ScheduleOfBacksolveValuationApproachAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl0" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl0" xml:lang="en-US">Liabilities, Current</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDevelopment_lbl0" xml:lang="en-US">Business Development</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDevelopment" xlink:to="us-gaap_BusinessDevelopment_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_UnrecognizedTaxBenefitsMember_lbl0" xml:lang="en-US">Unrecognized Tax Benefits Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_UnrecognizedTaxBenefitsMember" xlink:to="wt_UnrecognizedTaxBenefitsMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ContractualGoldPaymentsPolicyPolicyTextBlock_lbl1" xml:lang="en-US">Contractual Gold Payments Policy Policy Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ContractualGoldPaymentsPolicyPolicyTextBlock" xlink:to="wt_ContractualGoldPaymentsPolicyPolicyTextBlock_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl0" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_NonRecurringFairValueMeasurementsAbstract0_lbl0" xml:lang="en-US">Non Recurring Fair Value Measurements Abstract0</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_NonRecurringFairValueMeasurementsAbstract0" xlink:to="wt_NonRecurringFairValueMeasurementsAbstract0_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFairValue_lbl0" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFairValue" xlink:to="us-gaap_DebtInstrumentFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl0" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount_lbl0" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, after Year One through Five</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_AdvisoryServicesProvidedToWTTMember_lbl0" xml:lang="en-US">Advisory Services Provided To WTTMember</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_AdvisoryServicesProvidedToWTTMember" xlink:to="wt_AdvisoryServicesProvidedToWTTMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPreferredUnitsTextBlock_lbl0" xml:lang="en-US">Schedule of Preferred Units [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPreferredUnitsTextBlock" xlink:to="us-gaap_ScheduleOfPreferredUnitsTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl1" xml:lang="en-US">Debt Instrument, Maturity Date</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_FnalityConvertibleNoteMember_lbl1" xml:lang="en-US">Fnality Convertible Note Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FnalityConvertibleNoteMember" xlink:to="wt_FnalityConvertibleNoteMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock_lbl0" xml:lang="en-US">Schedule of Financial Instruments Owned and Pledged as Collateral [Table Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock" xlink:to="us-gaap_ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_FairValueAssumptionOfDissolutionRate_lbl1" xml:lang="en-US">Fair Value Assumption Of Dissolution Rate</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FairValueAssumptionOfDissolutionRate" xlink:to="wt_FairValueAssumptionOfDissolutionRate_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl0" xml:lang="en-US">Current Income Tax Expense (Benefit)</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl1" xml:lang="en-US">Preferred Stock, Value, Issued</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCountryMember_lbl0" xml:lang="en-US">Foreign Tax Authority [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfAggregateConsiderationPayableTableTextBlock_lbl1" xml:lang="en-US">Schedule Of Aggregate Consideration Payable Table Text Block</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfAggregateConsiderationPayableTableTextBlock" xlink:to="wt_ScheduleOfAggregateConsiderationPayableTableTextBlock_lbl1"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfSummarizesImpairmentsRecognizedAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfSummarizesImpairmentsRecognizedAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfSummarizesImpairmentsRecognizedAbstract_lbl" xml:lang="en-US">Schedule Of Summarizes Impairments Recognized Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfSummarizesImpairmentsRecognizedAbstract" xlink:to="wt_ScheduleOfSummarizesImpairmentsRecognizedAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_IE_lbl0" xml:lang="en-US">IRELAND</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IE" xlink:to="country_IE_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_CarryingAmountAssetsFnalityAbstract_lbl0" xml:lang="en-US">Carrying Amount Assets Fnality Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_CarryingAmountAssetsFnalityAbstract" xlink:to="wt_CarryingAmountAssetsFnalityAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl0" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl0" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_FinancialInstrumentsOwnedAbstract_lbl0" xml:lang="en-US">Financial Instruments Owned Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_FinancialInstrumentsOwnedAbstract" xlink:to="wt_FinancialInstrumentsOwnedAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_RevenuesFromContractsWithCustomersAbstract_lbl0" xml:lang="en-US">Revenues From Contracts With Customers Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_RevenuesFromContractsWithCustomersAbstract" xlink:to="wt_RevenuesFromContractsWithCustomersAbstract_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl0" xml:lang="en-US">Lessee, Leases [Policy Text Block]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsAndCash_lbl0" xml:lang="en-US">Investments and Cash</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsAndCash" xlink:to="us-gaap_InvestmentsAndCash_lbl0"/>
    <loc xlink:type="locator" xlink:label="wt_ScheduleOfDepreciationAndAmortizationAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfDepreciationAndAmortizationAbstract"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="wt_ScheduleOfDepreciationAndAmortizationAbstract_lbl" xml:lang="en-US">Schedule Of Depreciation And Amortization Abstract</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wt_ScheduleOfDepreciationAndAmortizationAbstract" xlink:to="wt_ScheduleOfDepreciationAndAmortizationAbstract_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseDebt_lbl0" xml:lang="en-US">Interest Expense, Debt</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VariableInterestEntityOwnershipPercentage_lbl0" xml:lang="en-US">Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableInterestEntityOwnershipPercentage" xlink:to="us-gaap_VariableInterestEntityOwnershipPercentage_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="country_JE_lbl0" xml:lang="en-US">JERSEY</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_JE" xlink:to="country_JE_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl0" xml:lang="en-US">Deferred Tax Assets, Other</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>wt-20231231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Feb 23 00:25:24 UTC 2024 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ConsolidatedBalanceSheet" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ConsolidatedBalanceSheet_Parentheticals" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ConsolidatedIncomeStatement" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ConsolidatedComprehensiveIncome" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedComprehensiveIncome"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ShareholdersEquityType2or3" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ShareholdersEquityType2or3_Parentheticals" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3_Parentheticals"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ConsolidatedCashFlow" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_OrganizationandDescriptionofBusiness" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/OrganizationandDescriptionofBusiness"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_SignificantAccountingPolicies" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPolicies"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_CashandCashEquivalents" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/CashandCashEquivalents"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_FairValueMeasurements" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurements"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_FinancialInstrumentsOwned" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwned"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_SecuritiesHeldtoMaturity" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturity"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_Investments" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/Investments"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_FixedAssetsNet" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNet"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_DeferredConsiderationgoldpayments" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpayments"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ConvertibleNotes" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotes"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_SeriesAPreferredStock" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStock"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_PayabletoGoldBullionHoldingsJerseyLimitedGBH" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBH"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_Leases" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/Leases"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_Contingencies" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/Contingencies"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_VariableInterestEntities" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntities"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_RevenuesfromContractswithCustomers" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/RevenuesfromContractswithCustomers"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_RelatedPartyTransactions" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactions"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_StockBasedAwards" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwards"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_StockholderRightsPlan" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlan"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_EmployeeBenefitPlans" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/EmployeeBenefitPlans"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_EarningsPerShare" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShare"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_IncomeTaxes" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxes"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_SharesRepurchased" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchased"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_GoodwillandIntangibleAssets" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssets"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ContingentPayments" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ContingentPayments"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_Impairments" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/Impairments"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_SubsequentEvents" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SubsequentEvents"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_AccountingPoliciesByPolicy" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_SignificantAccountingPoliciesTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_FairValueMeasurementsTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_FinancialInstrumentsOwnedTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_SecuritiesHeldtoMaturityTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturityTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_InvestmentsTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_FixedAssetsNetTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNetTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_DeferredConsiderationgoldpaymentsTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ConvertibleNotesTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_SeriesAPreferredStockTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_PayabletoGoldBullionHoldingsJerseyLimitedGBHTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_LeasesTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/LeasesTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_VariableInterestEntitiesTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_RevenuesfromContractswithCustomersTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/RevenuesfromContractswithCustomersTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_RelatedPartyTransactionsTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_StockBasedAwardsTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_EmployeeBenefitPlansTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/EmployeeBenefitPlansTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_EarningsPerShareTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShareTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_IncomeTaxesTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_GoodwillandIntangibleAssetsTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ImpairmentsTables" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ImpairmentsTables"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofDepreciationandAmortizationTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDepreciationandAmortizationTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofBeginningandEndingBalancesofRecurringFairValueMeasurementsClassifiedTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBeginningandEndingBalancesofRecurringFairValueMeasurementsClassifiedTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofFinancialInstrumentsOwnedTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFinancialInstrumentsOwnedTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofSecuritiesHeldtoMaturityTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSecuritiesHeldtoMaturityTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofMaturityProfileoftheSecuritiesHeldtoMaturityTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofMaturityProfileoftheSecuritiesHeldtoMaturityTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofInvestmentsTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInvestmentsTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofBacksolveValuationApproachTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBacksolveValuationApproachTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofPresentstheProbabilityAscribedtoPotentialOutcomesUsedinthePwermTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofPresentstheProbabilityAscribedtoPotentialOutcomesUsedinthePwermTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofFixedAssetsTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFixedAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofValuationofDeferredConsiderationTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofValuationofDeferredConsiderationTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofDeferredConsiderationTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDeferredConsiderationTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofKeyTermsofConvertibleNotesTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofKeyTermsofConvertibleNotesTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofConvertibleNotesTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofConvertibleNotesTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofSeriesAPreferredStockBalanceTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSeriesAPreferredStockBalanceTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofAggregateConsiderationPayableTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAggregateConsiderationPayableTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofAdditionalInformationRelatedtoOperatingLeaseTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAdditionalInformationRelatedtoOperatingLeaseTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofFutureMinimumLeasePaymentsTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFutureMinimumLeasePaymentsTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofReconciliationofFutureMinimumLeasePaymentstoBalanceSheetTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofFutureMinimumLeasePaymentstoBalanceSheetTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofInformationaboutVariableInterestsTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInformationaboutVariableInterestsTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofRevenuesfromContractswithCustomersTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromContractswithCustomersTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofGeographicDistributionofRevenuesTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGeographicDistributionofRevenuesTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofAccountsReceivablefromRelatedPartiesTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAccountsReceivablefromRelatedPartiesTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofRevenuesfromAdvisoryServicesProvidedtoRelatedPartiesTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromAdvisoryServicesProvidedtoRelatedPartiesTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofRestrictedStockActivityandRestrictedStockUnitTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRestrictedStockActivityandRestrictedStockUnitTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofShareBasedPaymentAwardsOtherthanOptionsValuationAssumptionsTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofShareBasedPaymentAwardsOtherthanOptionsValuationAssumptionsTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_SummaryofDiscretionaryContributionsTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SummaryofDiscretionaryContributionsTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofReconciliationofBasicandDilutedEarningsPerShareTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofBasicandDilutedEarningsPerShareTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofWeightedAverageNumberofSharesTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofWeightedAverageNumberofSharesTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofIncomeTaxPaymentsByJurisdictionTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIncomeTaxPaymentsByJurisdictionTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofGoodwillTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGoodwillTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofIntangibleAssetsTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIntangibleAssetsTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofExpectedAmortizationExpenseTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofExpectedAmortizationExpenseTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ScheduleofSummarizesImpairmentsRecognizedTable" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSummarizesImpairmentsRecognizedTable"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_SignificantAccountingPoliciesDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_CashandCashEquivalentsDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/CashandCashEquivalentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_FairValueMeasurementsDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_FinancialInstrumentsOwnedDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_SecuritiesHeldtoMaturityDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturityDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_InvestmentsDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_DeferredConsiderationgoldpaymentsDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ConvertibleNotesDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_SeriesAPreferredStockDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_LeasesDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/LeasesDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ContingenciesDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ContingenciesDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_RelatedPartyTransactionsDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_StockBasedAwardsDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_StockholderRightsPlanDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_EarningsPerShareDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShareDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_IncomeTaxesDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_SharesRepurchasedDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_GoodwillandIntangibleAssetsDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsDetails"/>
  <roleRef xlink:type="simple" xlink:href="wt-20231231.xsd#wt_r_ContingentPaymentsDetails" roleURI="http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsDetails"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#cover" roleURI="http://xbrl.sec.gov/dei/role/document/Cover"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_FinancialInstrumentsOwnedAtFairValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_AssetsCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IndemnificationReceivableNoncurrent" xlink:href="wt-20231231.xsd#wt_IndemnificationReceivableNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="IndemnificationReceivableNoncurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_HeldToMaturitySecuritiesNoncurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_DeferredIncomeTaxAssetsNet" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Goodwill" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Assets" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableTradeCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_NotesPayableCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TaxesPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_TaxesPayableCurrent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ConvertibleDebtCurrent" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredConsiderationCurrent" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="DeferredConsiderationCurrent" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="CarryingValueOfConvertibleNotes" xlink:href="wt-20231231.xsd#wt_CarryingValueOfConvertibleNotes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="CarryingValueOfConvertibleNotes" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AccountsPayableCurrentAndNoncurrent" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredConsiderationNoncurrent" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="DeferredConsiderationNoncurrent" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_Liabilities" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StockholdersEquity" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="WisdomtreeETFMember" xlink:href="wt-20231231.xsd#wt_WisdomtreeETFMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="WisdomtreeETFMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RelatedPartiesAxis" xlink:href="wt-20231231.xsd#wt_RelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="RelatedPartiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RelatedPartiesDomainDomain" xlink:href="wt-20231231.xsd#wt_RelatedPartiesDomainDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesAxis" xlink:to="RelatedPartiesDomainDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesAxis" xlink:to="us-gaap_RelatedPartyMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsAndCash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAndCash"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InvestmentsAndCash" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AccountsReceivableNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquitySharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PreferredStockRedemptionValue" xlink:href="wt-20231231.xsd#wt_PreferredStockRedemptionValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="PreferredStockRedemptionValue" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ProductOrServiceAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherServicesIncomeMember" xlink:href="wt-20231231.xsd#wt_OtherServicesIncomeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="OtherServicesIncomeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenuesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LaborAndRelatedExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LaborAndRelatedExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_LaborAndRelatedExpense" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FundManagementAndAdministration" xlink:href="wt-20231231.xsd#wt_FundManagementAndAdministration"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="FundManagementAndAdministration" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketingAndAdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketingAndAdvertisingExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_MarketingAndAdvertisingExpense" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDevelopment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_BusinessDevelopment" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ContractualGoldPayments" xlink:href="wt-20231231.xsd#wt_ContractualGoldPayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="ContractualGoldPayments" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalFees"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ProfessionalFees" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommunicationsInformationTechnologyAndOccupancy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommunicationsInformationTechnologyAndOccupancy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_CommunicationsInformationTechnologyAndOccupancy" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ThirdPartyDistribution" xlink:href="wt-20231231.xsd#wt_ThirdPartyDistribution"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="ThirdPartyDistribution" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OtherExpenses" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpenses" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InterestExpense" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="GainLossFromChangeInDeferredConsideration" xlink:href="wt-20231231.xsd#wt_GainLossFromChangeInDeferredConsideration"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="GainLossFromChangeInDeferredConsideration" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentIncomeInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InvestmentIncomeInterest" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_GoodwillImpairmentLoss" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNonoperatingGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingGainsLosses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingGainsLosses" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasic" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockDividendsPerShareDeclared" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedComprehensiveIncome">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesCPreferredStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="1.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_PreferredStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_RetainedEarningsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="5.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="TemporaryStockholdersEquity" xlink:href="wt-20231231.xsd#wt_TemporaryStockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="TemporaryStockholdersEquity" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TemporaryEquityShareOutstanding" xlink:href="wt-20231231.xsd#wt_TemporaryEquityShareOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="TemporaryEquityShareOutstanding" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TemporaryEquityShareOutstanding" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TemporaryEquityShareOutstanding" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TemporaryEquityShareOutstanding" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TemporaryEquityShareOutstanding" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TemporaryEquityShareOutstanding" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TemporaryEquityShareOutstanding" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TemporaryEquityShareOutstanding" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TemporaryEquityShareOutstanding" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Dividends" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Dividends"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TemporaryEquityShareOutstanding" xlink:to="us-gaap_Dividends" order="8.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TemporaryEquityShareOutstanding" xlink:to="us-gaap_NetIncomeLoss" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockholdersEquity_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TemporaryEquityShareOutstanding" xlink:to="us-gaap_StockholdersEquity_0" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharesOutstanding_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="TemporaryEquityShareOutstanding" xlink:to="us-gaap_SharesOutstanding_0" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes" xlink:href="wt-20231231.xsd#wt_StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3_Parentheticals">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <loc xlink:type="locator" xlink:label="ReclassificationOfEquity" xlink:href="wt-20231231.xsd#wt_ReclassificationOfEquity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="ReclassificationOfEquity" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GainLossFromChangeInDeferredConsideration" xlink:href="wt-20231231.xsd#wt_GainLossFromChangeInDeferredConsideration"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="GainLossFromChangeInDeferredConsideration" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="AdvisoryFeesReceivedInGold" xlink:href="wt-20231231.xsd#wt_AdvisoryFeesReceivedInGold"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AdvisoryFeesReceivedInGold" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GoodwillImpairmentLoss" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ContractualGoldPayments" xlink:href="wt-20231231.xsd#wt_ContractualGoldPayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ContractualGoldPayments" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="AmortizationOfIssuanceCostsConvertibleNotes" xlink:href="wt-20231231.xsd#wt_AmortizationOfIssuanceCostsConvertibleNotes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AmortizationOfIssuanceCostsConvertibleNotes" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationAndAmortization" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_UnrealizedGainLossOnInvestments" order="9.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_InterestExpenseDebt" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RealizedInvestmentGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_RealizedInvestmentGainsLosses" order="12.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" order="13.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OtherNoncashIncomeExpense" order="14.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseInGoldAndOtherPreciousMetals" xlink:href="wt-20231231.xsd#wt_IncreaseDecreaseInGoldAndOtherPreciousMetals"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInGoldAndOtherPreciousMetals" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseInFundManagementAndAdministrationPayable" xlink:href="wt-20231231.xsd#wt_IncreaseDecreaseInFundManagementAndAdministrationPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInFundManagementAndAdministrationPayable" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncreaseDecreaseInOperatingLeaseLiabilities" xlink:href="wt-20231231.xsd#wt_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOperatingLeaseLiabilities" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PurchaseOfFinancialInstrumentsOwnedAtFairValue" xlink:href="wt-20231231.xsd#wt_PurchaseOfFinancialInstrumentsOwnedAtFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PurchaseOfFinancialInstrumentsOwnedAtFairValue" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="PurchaseOfInvestments" xlink:href="wt-20231231.xsd#wt_PurchaseOfInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PurchaseOfInvestments" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherPaymentsToAcquireBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherPaymentsToAcquireBusinesses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_OtherPaymentsToAcquireBusinesses" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue" xlink:href="wt-20231231.xsd#wt_ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity" xlink:href="wt-20231231.xsd#wt_ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromRepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfNotesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromRepaymentsOfNotesPayable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PaymentOfDeferredConsideration" xlink:href="wt-20231231.xsd#wt_PaymentOfDeferredConsideration"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentOfDeferredConsideration" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividends"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfDividends" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="PaymentOfConvertibleNotesIssuanceCosts" xlink:href="wt-20231231.xsd#wt_PaymentOfConvertibleNotesIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentOfConvertibleNotesIssuanceCosts" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="ProceedsFromIssuanceOfConvertibleNotes" xlink:href="wt-20231231.xsd#wt_ProceedsFromIssuanceOfConvertibleNotes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromIssuanceOfConvertibleNotes" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_IncomeTaxesPaidNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/OrganizationandDescriptionofBusiness">
    <loc xlink:type="locator" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPolicies">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/CashandCashEquivalents">
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurements">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwned">
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract" xlink:to="us-gaap_FinancialInstrumentsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturity">
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_HeldToMaturitySecuritiesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/Investments">
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="us-gaap_InvestmentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNet">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpayments">
    <loc xlink:type="locator" xlink:label="DeferredConsiderationAbstract" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationAbstract"/>
    <loc xlink:type="locator" xlink:label="DeferredConsiderationTextBlock" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredConsiderationAbstract" xlink:to="DeferredConsiderationTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotes">
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStock">
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract" xlink:to="us-gaap_PreferredStockTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBH">
    <loc xlink:type="locator" xlink:label="PayableToGoldBullionHoldingJerseyLimitedGBHAbstract" xlink:href="wt-20231231.xsd#wt_PayableToGoldBullionHoldingJerseyLimitedGBHAbstract"/>
    <loc xlink:type="locator" xlink:label="OtherPayablesTextBlock" xlink:href="wt-20231231.xsd#wt_OtherPayablesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayableToGoldBullionHoldingJerseyLimitedGBHAbstract" xlink:to="OtherPayablesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/Leases">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/Contingencies">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LossContingencyDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDisclosures"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LossContingencyDisclosures" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntities">
    <loc xlink:type="locator" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:to="us-gaap_VariableInterestEntityDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/RevenuesfromContractswithCustomers">
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactions">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwards">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlan">
    <loc xlink:type="locator" xlink:label="DisclosureOfStockholderRightsPlanAbstract" xlink:href="wt-20231231.xsd#wt_DisclosureOfStockholderRightsPlanAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfStockholderRightsPlanTextBlock" xlink:href="wt-20231231.xsd#wt_DisclosureOfStockholderRightsPlanTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfStockholderRightsPlanAbstract" xlink:to="DisclosureOfStockholderRightsPlanTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/EmployeeBenefitPlans">
    <loc xlink:type="locator" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShare">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxes">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchased">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TreasuryStockTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="us-gaap_TreasuryStockTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssets">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ContingentPayments">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionContingentConsiderationLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiabilityAbstract"/>
    <loc xlink:type="locator" xlink:label="ContingentPaymentTextBlock" xlink:href="wt-20231231.xsd#wt_ContingentPaymentTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionContingentConsiderationLiabilityAbstract" xlink:to="ContingentPaymentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/Impairments">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetImpairmentChargesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentChargesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetImpairmentChargesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentChargesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetImpairmentChargesAbstract" xlink:to="us-gaap_AssetImpairmentChargesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/SubsequentEvents">
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ContractualGoldPaymentsPolicyPolicyTextBlock" xlink:href="wt-20231231.xsd#wt_ContractualGoldPaymentsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ContractualGoldPaymentsPolicyPolicyTextBlock" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RegulatoryDepreciationAndAmortizationPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RegulatoryDepreciationAndAmortizationPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RegulatoryDepreciationAndAmortizationPolicy" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ThirdPartyDistributionFeesPolicyTextBlock" xlink:href="wt-20231231.xsd#wt_ThirdPartyDistributionFeesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ThirdPartyDistributionFeesPolicyTextBlock" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ReceivablesPolicyTextBlock" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MarketableSecuritiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_MarketableSecuritiesPolicy" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredConsiderationGoldPaymentsPolicyTextBlock" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationGoldPaymentsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="DeferredConsiderationGoldPaymentsPolicyTextBlock" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DebtPolicyTextBlock" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesPolicyTextBlock" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ContingentPaymentsPolicyTextBlock" xlink:href="wt-20231231.xsd#wt_ContingentPaymentsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="ContingentPaymentsPolicyTextBlock" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RecentlyIssuedAccountingPronouncementsPolicyTextBlock" xlink:href="wt-20231231.xsd#wt_RecentlyIssuedAccountingPronouncementsPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="RecentlyIssuedAccountingPronouncementsPolicyTextBlock" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="28.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesTablesTable" xlink:href="wt-20231231.xsd#wt_SignificantAccountingPoliciesTablesTable"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesTablesLineItems" xlink:href="wt-20231231.xsd#wt_SignificantAccountingPoliciesTablesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="SignificantAccountingPoliciesTablesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesTablesTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StraightLineDepreciationMethodMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StraightLineDepreciationMethodMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_StraightLineDepreciationMethodMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesTablesTable" xlink:to="SignificantAccountingPoliciesTablesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesTablesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedTables">
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract" xlink:to="us-gaap_ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturityTables">
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="us-gaap_InvestmentTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfCondensedFinancialStatementsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="srt_ScheduleOfCondensedFinancialStatementsTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNetTables">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsTables">
    <loc xlink:type="locator" xlink:label="DeferredConsiderationAbstract" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationAbstract"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfValuationOfDeferredConsiderationTableTextBlock" xlink:href="wt-20231231.xsd#wt_DisclosureOfValuationOfDeferredConsiderationTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredConsiderationAbstract" xlink:to="DisclosureOfValuationOfDeferredConsiderationTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfDeferredConsiderationTableTextBlock" xlink:href="wt-20231231.xsd#wt_ScheduleOfDeferredConsiderationTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredConsiderationAbstract" xlink:to="ScheduleOfDeferredConsiderationTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract" xlink:to="us-gaap_ScheduleOfDebtTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract" xlink:to="us-gaap_ConvertibleDebtTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockTables">
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPreferredUnitsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPreferredUnitsTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract" xlink:to="us-gaap_ScheduleOfPreferredUnitsTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHTables">
    <loc xlink:type="locator" xlink:label="PayableToGoldBullionHoldingJerseyLimitedGBHAbstract" xlink:href="wt-20231231.xsd#wt_PayableToGoldBullionHoldingJerseyLimitedGBHAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfAggregateConsiderationPayableTableTextBlock" xlink:href="wt-20231231.xsd#wt_ScheduleOfAggregateConsiderationPayableTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayableToGoldBullionHoldingJerseyLimitedGBHAbstract" xlink:to="ScheduleOfAggregateConsiderationPayableTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/LeasesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock" xlink:href="wt-20231231.xsd#wt_ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/RevenuesfromContractswithCustomersTables">
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <loc xlink:type="locator" xlink:label="SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock" xlink:href="wt-20231231.xsd#wt_SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock" xlink:href="wt-20231231.xsd#wt_ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock" xlink:href="wt-20231231.xsd#wt_ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/EmployeeBenefitPlansTables">
    <loc xlink:type="locator" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShareTables">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesTables">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock" xlink:href="wt-20231231.xsd#wt_SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfGoodwillTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ImpairmentsTables">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetImpairmentChargesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentChargesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetImpairmentChargesAbstract" xlink:to="us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDepreciationandAmortizationTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfDepreciationAndAmortizationAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfDepreciationAndAmortizationAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDepreciationAndAmortizationAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_EquipmentMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_SoftwareDevelopmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="srt_RangeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_InvestmentTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_USTreasurySecuritiesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquitySecuritiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_EquitySecuritiesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FixedIncomeInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FixedIncomeInvestmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_FixedIncomeInvestmentsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementsNonrecurringMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="FnalityConvertibleNoteMember" xlink:href="wt-20231231.xsd#wt_FnalityConvertibleNoteMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="FnalityConvertibleNoteMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel1Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel2Member" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel3Member" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:to="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExchangeTradedFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExchangeTradedFundsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:to="us-gaap_ExchangeTradedFundsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="FederalAgencyMember" xlink:href="wt-20231231.xsd#wt_FederalAgencyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:to="FederalAgencyMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_USTreasurySecuritiesMember_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:to="us-gaap_USTreasurySecuritiesMember_0" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AllOtherCorporateBondsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllOtherCorporateBondsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:to="us-gaap_AllOtherCorporateBondsMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherAssetsseedCapitalWisdomtreeDigitalFundsMember" xlink:href="wt-20231231.xsd#wt_OtherAssetsseedCapitalWisdomtreeDigitalFundsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis" xlink:to="OtherAssetsseedCapitalWisdomtreeDigitalFundsMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="FnalityInternationalLimitedBOnePreferenceSharesMember" xlink:href="wt-20231231.xsd#wt_FnalityInternationalLimitedBOnePreferenceSharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="FnalityInternationalLimitedBOnePreferenceSharesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInvestmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_OtherInvestmentsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SecurrencyConvertibleNoteMember" xlink:href="wt-20231231.xsd#wt_SecurrencyConvertibleNoteMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="SecurrencyConvertibleNoteMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="RecurringFairValueMeasurementsAbstract" xlink:href="wt-20231231.xsd#wt_RecurringFairValueMeasurementsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="RecurringFairValueMeasurementsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RecurringFairValueMeasurementsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FinancialInstrumentsOwnedAtFairValueAbstract0" xlink:href="wt-20231231.xsd#wt_FinancialInstrumentsOwnedAtFairValueAbstract0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RecurringFairValueMeasurementsAbstract" xlink:to="FinancialInstrumentsOwnedAtFairValueAbstract0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsOwnedAtFairValueAbstract0" xlink:to="us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherAssetsSeedCapitalWisdomtreeDigitalFundsAbstract" xlink:href="wt-20231231.xsd#wt_OtherAssetsSeedCapitalWisdomtreeDigitalFundsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsOwnedAtFairValueAbstract0" xlink:to="OtherAssetsSeedCapitalWisdomtreeDigitalFundsAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RecurringFairValueMeasurementsAbstract" xlink:to="us-gaap_InvestmentsAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="us-gaap_InvestmentsFairValueDisclosure" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsFairValueDisclosure" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NonRecurringFairValueMeasurementsAbstract" xlink:href="wt-20231231.xsd#wt_NonRecurringFairValueMeasurementsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="NonRecurringFairValueMeasurementsAbstract" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NonRecurringFairValueMeasurementsAbstract" xlink:to="us-gaap_InvestmentOwnedAtFairValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_LiabilitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="RecurringFairValueMeasurementsAbstract1" xlink:href="wt-20231231.xsd#wt_RecurringFairValueMeasurementsAbstract1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="RecurringFairValueMeasurementsAbstract1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BusinessCombinationDeferredConsiderationLiability" xlink:href="wt-20231231.xsd#wt_BusinessCombinationDeferredConsiderationLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RecurringFairValueMeasurementsAbstract1" xlink:to="BusinessCombinationDeferredConsiderationLiability" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBeginningandEndingBalancesofRecurringFairValueMeasurementsClassifiedTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfBeginningAndEndingBalancesOfRecurringFairValueMeasurementsClassifiedAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfBeginningAndEndingBalancesOfRecurringFairValueMeasurementsClassifiedAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBeginningAndEndingBalancesOfRecurringFairValueMeasurementsClassifiedAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueByLiabilityClassAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="DeferredConsiderationObligationMember" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationObligationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByLiabilityClassAxis" xlink:to="DeferredConsiderationObligationMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="us-gaap_InvestmentsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions" xlink:href="wt-20231231.xsd#wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome" xlink:href="wt-20231231.xsd#wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings" xlink:href="wt-20231231.xsd#wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFinancialInstrumentsOwnedTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfFinancialInstrumentsOwnedAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfFinancialInstrumentsOwnedAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFinancialInstrumentsOwnedAbstract" xlink:to="us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TradingSecuritiesMember" xlink:href="wt-20231231.xsd#wt_TradingSecuritiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="TradingSecuritiesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherAssetsseedCapitalWisdomTreeDigitalFundsMember" xlink:href="wt-20231231.xsd#wt_OtherAssetsseedCapitalWisdomTreeDigitalFundsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="OtherAssetsseedCapitalWisdomTreeDigitalFundsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralTable" xlink:to="us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="FinancialInstrumentsOwnedAbstract" xlink:href="wt-20231231.xsd#wt_FinancialInstrumentsOwnedAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems" xlink:to="FinancialInstrumentsOwnedAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsOwnedAbstract" xlink:to="us-gaap_FinancialInstrumentsOwnedAtFairValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSecuritiesHeldtoMaturityTable">
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesTransfersAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesTransfersAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_HeldToMaturitySecuritiesTransfersAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="FederalAgencyMember" xlink:href="wt-20231231.xsd#wt_FederalAgencyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="FederalAgencyMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable">
    <loc xlink:type="locator" xlink:label="us-gaap_AvailableForSaleSecuritiesTransfersToTradingGainsLossesNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesTransfersToTradingGainsLossesNetAbstract"/>
    <loc xlink:type="locator" xlink:label="SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable" xlink:href="wt-20231231.xsd#wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable"/>
    <loc xlink:type="locator" xlink:label="SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityLineItems" xlink:href="wt-20231231.xsd#wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesTransfersToTradingGainsLossesNetAbstract" xlink:to="SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel2Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable" xlink:to="SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityLineItems" xlink:to="us-gaap_HeldToMaturitySecuritiesFairValue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofMaturityProfileoftheSecuritiesHeldtoMaturityTable">
    <loc xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAbstract" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAbstract" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAbstract" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAbstract" xlink:to="us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAbstract" xlink:to="us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInvestmentsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="InvestmentsDetailsScheduleofInvestmentsTable" xlink:href="wt-20231231.xsd#wt_InvestmentsDetailsScheduleofInvestmentsTable"/>
    <loc xlink:type="locator" xlink:label="InvestmentsDetailsScheduleofInvestmentsLineItems" xlink:href="wt-20231231.xsd#wt_InvestmentsDetailsScheduleofInvestmentsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsAbstract" xlink:to="InvestmentsDetailsScheduleofInvestmentsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofInvestmentsTable" xlink:to="us-gaap_InvestmentTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SecurrencyseriesaconvertiblepreferredstockMember" xlink:href="wt-20231231.xsd#wt_SecurrencyseriesaconvertiblepreferredstockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="SecurrencyseriesaconvertiblepreferredstockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SecurrencyseriesbconvertiblepreferredstockMember" xlink:href="wt-20231231.xsd#wt_SecurrencyseriesbconvertiblepreferredstockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="SecurrencyseriesbconvertiblepreferredstockMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SecurrencyConvertibleNoteMember" xlink:href="wt-20231231.xsd#wt_SecurrencyConvertibleNoteMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="SecurrencyConvertibleNoteMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="SecurrencyIncSubTotalMember" xlink:href="wt-20231231.xsd#wt_SecurrencyIncSubTotalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="SecurrencyIncSubTotalMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleNoteMember" xlink:href="wt-20231231.xsd#wt_ConvertibleNoteMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="ConvertibleNoteMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="B1ConvertiblePreferenceSharesMember" xlink:href="wt-20231231.xsd#wt_B1ConvertiblePreferenceSharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="B1ConvertiblePreferenceSharesMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SubtotalFnalityInternationalLimitedMember" xlink:href="wt-20231231.xsd#wt_SubtotalFnalityInternationalLimitedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="SubtotalFnalityInternationalLimitedMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInvestmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_OtherInvestmentsMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofInvestmentsTable" xlink:to="InvestmentsDetailsScheduleofInvestmentsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="SecurrencyIncAbstract" xlink:href="wt-20231231.xsd#wt_SecurrencyIncAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsScheduleofInvestmentsLineItems" xlink:to="SecurrencyIncAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecurrencyIncAbstract" xlink:to="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedAtCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedAtCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SecurrencyIncAbstract" xlink:to="us-gaap_InvestmentOwnedAtCost" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBacksolveValuationApproachTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfBacksolveValuationApproachAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfBacksolveValuationApproachAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBacksolveValuationApproachAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBacksolveValuationApproachAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ProbabilityThatSeriesB2PreferenceSharesCovertIntoSeriesB1PreferenceShares" xlink:href="wt-20231231.xsd#wt_ProbabilityThatSeriesB2PreferenceSharesCovertIntoSeriesB1PreferenceShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfBacksolveValuationApproachAbstract" xlink:to="ProbabilityThatSeriesB2PreferenceSharesCovertIntoSeriesB1PreferenceShares" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofPresentstheProbabilityAscribedtoPotentialOutcomesUsedinthePwermTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfPresentsTheProbabilityAscribedToPotentialOutcomesUsedInThePwermAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfPresentsTheProbabilityAscribedToPotentialOutcomesUsedInThePwermAbstract"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfCondensedFinancialStatementsTable" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <loc xlink:type="locator" xlink:label="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfPresentsTheProbabilityAscribedToPotentialOutcomesUsedInThePwermAbstract" xlink:to="srt_ScheduleOfCondensedFinancialStatementsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfCondensedFinancialStatementsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel3Member" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfCondensedFinancialStatementsTable" xlink:to="srt_CondensedFinancialStatementsCaptionsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ConversionOfNotesUponAFutureEquityFinancing" xlink:href="wt-20231231.xsd#wt_ConversionOfNotesUponAFutureEquityFinancing"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="ConversionOfNotesUponAFutureEquityFinancing" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RedemptionOfNoteUponACorporateTransaction" xlink:href="wt-20231231.xsd#wt_RedemptionOfNoteUponACorporateTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="RedemptionOfNoteUponACorporateTransaction" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FairValueAssumptionOfDissolutionRate" xlink:href="wt-20231231.xsd#wt_FairValueAssumptionOfDissolutionRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="FairValueAssumptionOfDissolutionRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TimeToPotentialOutcomeinYear" xlink:href="wt-20231231.xsd#wt_TimeToPotentialOutcomeinYear"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="TimeToPotentialOutcomeinYear" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConversionOfNoteUponAFutureFinancingRound" xlink:href="wt-20231231.xsd#wt_ConversionOfNoteUponAFutureFinancingRound"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="ConversionOfNoteUponAFutureFinancingRound" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RedemptionOfNoteUponAChangeOfControl" xlink:href="wt-20231231.xsd#wt_RedemptionOfNoteUponAChangeOfControl"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="RedemptionOfNoteUponAChangeOfControl" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="Default" xlink:href="wt-20231231.xsd#wt_Default"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="Default" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TimeToPotentialOutcomesinYears" xlink:href="wt-20231231.xsd#wt_TimeToPotentialOutcomesinYears"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="TimeToPotentialOutcomesinYears" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFixedAssetsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGrossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGrossAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentGrossAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquipmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_EquipmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofValuationofDeferredConsiderationTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfValuationOfDeferredConsiderationAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfValuationOfDeferredConsiderationAbstract"/>
    <loc xlink:type="locator" xlink:label="DeferredConsiderationgoldpaymentsDetailsScheduleofValuationofDeferredConsiderationTable" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationgoldpaymentsDetailsScheduleofValuationofDeferredConsiderationTable"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfValuationOfDeferredConsiderationLineItems" xlink:href="wt-20231231.xsd#wt_DisclosureOfValuationOfDeferredConsiderationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfValuationOfDeferredConsiderationAbstract" xlink:to="DeferredConsiderationgoldpaymentsDetailsScheduleofValuationofDeferredConsiderationTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredConsiderationgoldpaymentsDetailsScheduleofValuationofDeferredConsiderationTable" xlink:to="srt_RangeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_WeightedAverageMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_WeightedAverageMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_WeightedAverageMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredConsiderationgoldpaymentsDetailsScheduleofValuationofDeferredConsiderationTable" xlink:to="DisclosureOfValuationOfDeferredConsiderationLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="ForwardsLookingGoldPrice" xlink:href="wt-20231231.xsd#wt_ForwardsLookingGoldPrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfValuationOfDeferredConsiderationLineItems" xlink:to="ForwardsLookingGoldPrice" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="BusinessCombinationConsiderationTransferredDeferredPaymentInterest" xlink:href="wt-20231231.xsd#wt_BusinessCombinationConsiderationTransferredDeferredPaymentInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfValuationOfDeferredConsiderationLineItems" xlink:to="BusinessCombinationConsiderationTransferredDeferredPaymentInterest" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredConsiderationPerpetualGrowthRate" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationPerpetualGrowthRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfValuationOfDeferredConsiderationLineItems" xlink:to="DeferredConsiderationPerpetualGrowthRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDeferredConsiderationTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfDeferredConsiderationAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfDeferredConsiderationAbstract"/>
    <loc xlink:type="locator" xlink:label="ContractualGoldPayments" xlink:href="wt-20231231.xsd#wt_ContractualGoldPayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredConsiderationAbstract" xlink:to="ContractualGoldPayments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ContractualGoldPaymentgoldOuncesPaid" xlink:href="wt-20231231.xsd#wt_ContractualGoldPaymentgoldOuncesPaid"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredConsiderationAbstract" xlink:to="ContractualGoldPaymentgoldOuncesPaid" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="GainLossFromChangeInDeferredConsideration" xlink:href="wt-20231231.xsd#wt_GainLossFromChangeInDeferredConsideration"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfDeferredConsiderationAbstract" xlink:to="GainLossFromChangeInDeferredConsideration" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofKeyTermsofConvertibleNotesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfKeyTermsOfConvertibleNotesAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfKeyTermsOfConvertibleNotesAbstract"/>
    <loc xlink:type="locator" xlink:label="ConvertibleNotesDetailsScheduleofKeyTermsofConvertibleNotesTable" xlink:href="wt-20231231.xsd#wt_ConvertibleNotesDetailsScheduleofKeyTermsofConvertibleNotesTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfKeyTermsOfConvertibleNotesAbstract" xlink:to="ConvertibleNotesDetailsScheduleofKeyTermsofConvertibleNotesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleNotesDetailsScheduleofKeyTermsofConvertibleNotesTable" xlink:to="us-gaap_DebtInstrumentAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="TwoThousandAndTwentyThreeNotesMember" xlink:href="wt-20231231.xsd#wt_TwoThousandAndTwentyThreeNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="TwoThousandAndTwentyThreeNotesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwothousandandtwentyonenotesMember" xlink:href="wt-20231231.xsd#wt_TwothousandandtwentyonenotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="TwothousandandtwentyonenotesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleNotesDetailsScheduleofKeyTermsofConvertibleNotesTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionRatio1" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DebtInstrumentRedemptionPrice" xlink:href="wt-20231231.xsd#wt_DebtInstrumentRedemptionPrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="DebtInstrumentRedemptionPrice" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofConvertibleNotesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfConvertibleNotesAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfConvertibleNotesAbstract"/>
    <loc xlink:type="locator" xlink:label="ConvertibleNotesDetailsScheduleofConvertibleNotesTable" xlink:href="wt-20231231.xsd#wt_ConvertibleNotesDetailsScheduleofConvertibleNotesTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfConvertibleNotesAbstract" xlink:to="ConvertibleNotesDetailsScheduleofConvertibleNotesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleNotesDetailsScheduleofConvertibleNotesTable" xlink:to="us-gaap_DebtInstrumentAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="TwoThousandAndTwentyThreeNotesMember" xlink:href="wt-20231231.xsd#wt_TwoThousandAndTwentyThreeNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="TwoThousandAndTwentyThreeNotesMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwothousandandtwentyonenotesMember" xlink:href="wt-20231231.xsd#wt_TwothousandandtwentyonenotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="TwothousandandtwentyonenotesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleNotesMember" xlink:href="wt-20231231.xsd#wt_ConvertibleNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="ConvertibleNotesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoThousandAndTwentyNotesMember" xlink:href="wt-20231231.xsd#wt_TwoThousandAndTwentyNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="TwoThousandAndTwentyNotesMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleNotesDetailsScheduleofConvertibleNotesTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedPremium" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebt" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSeriesAPreferredStockBalanceTable">
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfPreferredUnitsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPreferredUnitsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredUnitsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredUnitsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfPreferredUnitsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPreferredUnitsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_PreferredStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPreferredUnitsTable" xlink:to="us-gaap_PreferredUnitsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PreferredUnitsLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PreferredUnitsLineItems" xlink:to="us-gaap_PreferredStockValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockDividendsPerShareDeclared"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PreferredUnitsLineItems" xlink:to="us-gaap_PreferredStockDividendsPerShareDeclared" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAggregateConsiderationPayableTable">
    <loc xlink:type="locator" xlink:label="us-gaap_NotesAndLoansPayableAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesAndLoansPayableAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NotesAndLoansPayableAbstract" xlink:to="us-gaap_NotesPayableCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermNotesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NotesAndLoansPayableAbstract" xlink:to="us-gaap_LongTermNotesPayable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NotesAndLoansPayableAbstract" xlink:to="us-gaap_NotesPayable" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAdditionalInformationRelatedtoOperatingLeaseTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfAdditionalInformationRelatedToOperatingLeaseAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfAdditionalInformationRelatedToOperatingLeaseAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAdditionalInformationRelatedToOperatingLeaseAbstract" xlink:to="us-gaap_LeaseCostAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_OperatingLeaseCost" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrY11ZqAmQBqDS9evb2UjxxqoT1dX+ftwW5Dmnj+XgBA5xugKgU5REylsG34PyUGaDd+s8Vz6UhUE2XjAqeTDG+GsAAOBng9N8lGsEAjX/LwTSBIBqd4ygj3svooWB2H37ux1jJEZgBFLWzkzuTALB4aTs3k+tWR6XSXbRFQ/yCjbsgF9d1q1s+Ftk/3SncB1pc=] CSR-->
    <loc xlink:type="locator" xlink:label="us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermLeaseCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_ShortTermLeaseCost" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseCostAbstract" xlink:to="us-gaap_LeaseCost" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherInformationAbstract" xlink:href="wt-20231231.xsd#wt_OtherInformationAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAdditionalInformationRelatedToOperatingLeaseAbstract" xlink:to="OtherInformationAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherInformationAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherInformationAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherInformationAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OtherInformationAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFutureMinimumLeasePaymentsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfFutureMinimumLeasePaymentsAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfFutureMinimumLeasePaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFutureMinimumLeasePaymentsAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFutureMinimumLeasePaymentsAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFutureMinimumLeasePaymentsAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFutureMinimumLeasePaymentsAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfFutureMinimumLeasePaymentsAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofFutureMinimumLeasePaymentstoBalanceSheetTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfReconciliationOfFutureMinimumLeasePaymentsToBalanceSheetAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfReconciliationOfFutureMinimumLeasePaymentsToBalanceSheetAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationOfFutureMinimumLeasePaymentsToBalanceSheetAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationOfFutureMinimumLeasePaymentsToBalanceSheetAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationOfFutureMinimumLeasePaymentsToBalanceSheetAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationOfFutureMinimumLeasePaymentsToBalanceSheetAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfReconciliationOfFutureMinimumLeasePaymentsToBalanceSheetAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInformationaboutVariableInterestsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfInformationAboutVariableInterestsAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfInformationAboutVariableInterestsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfInformationAboutVariableInterestsAbstract" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SecurrencyseriesaconvertiblepreferredstockMember" xlink:href="wt-20231231.xsd#wt_SecurrencyseriesaconvertiblepreferredstockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="SecurrencyseriesaconvertiblepreferredstockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SecurrencyseriesbconvertiblepreferredstockMember" xlink:href="wt-20231231.xsd#wt_SecurrencyseriesbconvertiblepreferredstockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="SecurrencyseriesbconvertiblepreferredstockMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SecurrencyConvertibleNoteMember" xlink:href="wt-20231231.xsd#wt_SecurrencyConvertibleNoteMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="SecurrencyConvertibleNoteMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="SecurrencyIncSubTotalMember" xlink:href="wt-20231231.xsd#wt_SecurrencyIncSubTotalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="SecurrencyIncSubTotalMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleNoteMember" xlink:href="wt-20231231.xsd#wt_ConvertibleNoteMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="ConvertibleNoteMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="B1ConvertiblePreferenceSharesMember" xlink:href="wt-20231231.xsd#wt_B1ConvertiblePreferenceSharesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="B1ConvertiblePreferenceSharesMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="SubtotalFnalityInternationalLimitedMember" xlink:href="wt-20231231.xsd#wt_SubtotalFnalityInternationalLimitedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="SubtotalFnalityInternationalLimitedMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherInvestmentMember" xlink:href="wt-20231231.xsd#wt_OtherInvestmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="OtherInvestmentMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MaximumExposureToLossMember" xlink:href="wt-20231231.xsd#wt_MaximumExposureToLossMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="MaximumExposureToLossMember" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="us-gaap_VariableInterestEntityLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="CarryingAmountAssetsSecurrencyAbstract" xlink:href="wt-20231231.xsd#wt_CarryingAmountAssetsSecurrencyAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="CarryingAmountAssetsSecurrencyAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CarryingAmountAssetsSecurrencyAbstract" xlink:to="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromContractswithCustomersTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfRevenuesFromContractsWithCustomersAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfRevenuesFromContractsWithCustomersAbstract"/>
    <loc xlink:type="locator" xlink:label="RevenuesfromContractswithCustomersDetailsScheduleofRevenuesfromContractswithCustomersTable" xlink:href="wt-20231231.xsd#wt_RevenuesfromContractswithCustomersDetailsScheduleofRevenuesfromContractswithCustomersTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRevenuesFromContractsWithCustomersAbstract" xlink:to="RevenuesfromContractswithCustomersDetailsScheduleofRevenuesfromContractswithCustomersTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesfromContractswithCustomersDetailsScheduleofRevenuesfromContractswithCustomersTable" xlink:to="srt_ProductOrServiceAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="OtherServicesIncomeMember" xlink:href="wt-20231231.xsd#wt_OtherServicesIncomeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="OtherServicesIncomeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesfromContractswithCustomersDetailsScheduleofRevenuesfromContractswithCustomersTable" xlink:to="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGeographicDistributionofRevenuesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfGeographicDistributionOfRevenuesAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfGeographicDistributionOfRevenuesAbstract"/>
    <loc xlink:type="locator" xlink:label="RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesTable" xlink:href="wt-20231231.xsd#wt_RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesTable"/>
    <loc xlink:type="locator" xlink:label="RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesLineItems" xlink:href="wt-20231231.xsd#wt_RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfGeographicDistributionOfRevenuesAbstract" xlink:to="RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesTable" xlink:to="srt_StatementGeographicalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_US" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_JE" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_JE"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_JE" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="country_IE" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IE"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_IE" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesTable" xlink:to="RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="RevenuesFromContractsWithCustomersAbstract" xlink:href="wt-20231231.xsd#wt_RevenuesFromContractsWithCustomersAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesLineItems" xlink:to="RevenuesFromContractsWithCustomersAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RevenuesFromContractsWithCustomersAbstract" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAccountsReceivablefromRelatedPartiesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfAccountsReceivableFromRelatedPartiesAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfAccountsReceivableFromRelatedPartiesAbstract"/>
    <loc xlink:type="locator" xlink:label="RelatedPartyTransactionsDetailsScheduleofAccountsReceivablefromRelatedPartiesTable" xlink:href="wt-20231231.xsd#wt_RelatedPartyTransactionsDetailsScheduleofAccountsReceivablefromRelatedPartiesTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfAccountsReceivableFromRelatedPartiesAbstract" xlink:to="RelatedPartyTransactionsDetailsScheduleofAccountsReceivablefromRelatedPartiesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsScheduleofAccountsReceivablefromRelatedPartiesTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ReceivableFromWTTMember" xlink:href="wt-20231231.xsd#wt_ReceivableFromWTTMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="ReceivableFromWTTMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ReceivableFromManJerIssuersMember" xlink:href="wt-20231231.xsd#wt_ReceivableFromManJerIssuersMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="ReceivableFromManJerIssuersMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember" xlink:href="wt-20231231.xsd#wt_WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RelatedPartiesAxis" xlink:href="wt-20231231.xsd#wt_RelatedPartiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsScheduleofAccountsReceivablefromRelatedPartiesTable" xlink:to="RelatedPartiesAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartiesAxis" xlink:to="us-gaap_RelatedPartyMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsScheduleofAccountsReceivablefromRelatedPartiesTable" xlink:to="us-gaap_RelatedPartyTransactionLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_AccountsReceivableNet" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromAdvisoryServicesProvidedtoRelatedPartiesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfRevenuesFromAdvisoryServicesProvidedToRelatedPartiesAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfRevenuesFromAdvisoryServicesProvidedToRelatedPartiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRevenuesFromAdvisoryServicesProvidedToRelatedPartiesAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="dei_LegalEntityAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="AdvisoryServicesProvidedToWTTMember" xlink:href="wt-20231231.xsd#wt_AdvisoryServicesProvidedToWTTMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="AdvisoryServicesProvidedToWTTMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdvisoryServicesProvidedToManJerIssuersMember" xlink:href="wt-20231231.xsd#wt_AdvisoryServicesProvidedToManJerIssuersMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="AdvisoryServicesProvidedToManJerIssuersMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AdvisoryServicesProvidedToWMAIAndWTICAVMember" xlink:href="wt-20231231.xsd#wt_AdvisoryServicesProvidedToWMAIAndWTICAVMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="AdvisoryServicesProvidedToWMAIAndWTICAVMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_Revenues" order="0.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfUnrecognizedStockBasedCompensationExpenseAndAverageRemainingVestingPeriodAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfUnrecognizedStockBasedCompensationExpenseAndAverageRemainingVestingPeriodAbstract"/>
    <loc xlink:type="locator" xlink:label="StockBasedAwardsDetailsScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable" xlink:href="wt-20231231.xsd#wt_StockBasedAwardsDetailsScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfUnrecognizedStockBasedCompensationExpenseAndAverageRemainingVestingPeriodAbstract" xlink:to="StockBasedAwardsDetailsScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockBasedAwardsDetailsScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable" xlink:to="srt_TitleOfIndividualAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="EmployeesAndDirectorsMember" xlink:href="wt-20231231.xsd#wt_EmployeesAndDirectorsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="EmployeesAndDirectorsMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockBasedAwardsDetailsScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRestrictedStockActivityandRestrictedStockUnitTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfRestrictedStockActivityAndRestrictedStockUnitAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfRestrictedStockActivityAndRestrictedStockUnitAbstract"/>
    <loc xlink:type="locator" xlink:label="StockBasedAwardsDetailsScheduleofRestrictedStockActivityandRestrictedStockUnitTable" xlink:href="wt-20231231.xsd#wt_StockBasedAwardsDetailsScheduleofRestrictedStockActivityandRestrictedStockUnitTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfRestrictedStockActivityAndRestrictedStockUnitAbstract" xlink:to="StockBasedAwardsDetailsScheduleofRestrictedStockActivityandRestrictedStockUnitTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockBasedAwardsDetailsScheduleofRestrictedStockActivityandRestrictedStockUnitTable" xlink:to="us-gaap_AwardTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_RestrictedStockMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PerformanceBasedRestrictedStockUnitMember" xlink:href="wt-20231231.xsd#wt_PerformanceBasedRestrictedStockUnitMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="PerformanceBasedRestrictedStockUnitMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockBasedAwardsDetailsScheduleofRestrictedStockActivityandRestrictedStockUnitTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockDividendsShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockDividendsShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockDividendsShares" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DividendsPayableAmountPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_DividendsPayableAmountPerShare" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofShareBasedPaymentAwardsOtherthanOptionsValuationAssumptionsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfShareBasedPaymentAwardsOtherThanOptionsValuationAssumptionsAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfShareBasedPaymentAwardsOtherThanOptionsValuationAssumptionsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedPaymentAwardsOtherThanOptionsValuationAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedPaymentAwardsOtherThanOptionsValuationAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedPaymentAwardsOtherThanOptionsValuationAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedPaymentAwardsOtherThanOptionsValuationAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfShareBasedPaymentAwardsOtherThanOptionsValuationAssumptionsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/SummaryofDiscretionaryContributionsTable">
    <loc xlink:type="locator" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofBasicandDilutedEarningsPerShareTable">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="EarningsPerShareDetailsScheduleofReconciliationofBasicandDilutedEarningsPerShareTable" xlink:href="wt-20231231.xsd#wt_EarningsPerShareDetailsScheduleofReconciliationofBasicandDilutedEarningsPerShareTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasicLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="EarningsPerShareDetailsScheduleofReconciliationofBasicandDilutedEarningsPerShareTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareDetailsScheduleofReconciliationofBasicandDilutedEarningsPerShareTable" xlink:to="srt_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareDetailsScheduleofReconciliationofBasicandDilutedEarningsPerShareTable" xlink:to="us-gaap_EarningsPerShareBasicLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="BasicEarningsPerShareAbstract" xlink:href="wt-20231231.xsd#wt_BasicEarningsPerShareAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareBasicLineItems" xlink:to="BasicEarningsPerShareAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasicEarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasicEarningsPerShareAbstract" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncomeDistributedToParticipatingSecurities" xlink:href="wt-20231231.xsd#wt_IncomeDistributedToParticipatingSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasicEarningsPerShareAbstract" xlink:to="IncomeDistributedToParticipatingSecurities" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasicEarningsPerShareAbstract" xlink:to="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasicEarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UndistributedIncomeAllocableToParticipatingSecurities" xlink:href="wt-20231231.xsd#wt_UndistributedIncomeAllocableToParticipatingSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasicEarningsPerShareAbstract" xlink:to="UndistributedIncomeAllocableToParticipatingSecurities" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasicEarningsPerShareAbstract" xlink:to="us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasicEarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasicEarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasicEarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities" xlink:href="wt-20231231.xsd#wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasicEarningsPerShareAbstract" xlink:to="WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasicEarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="BasicEarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofWeightedAverageNumberofSharesTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfWeightedAverageNumberOfSharesAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfWeightedAverageNumberOfSharesAbstract"/>
    <loc xlink:type="locator" xlink:label="EarningsPerShareDetailsScheduleofWeightedAverageNumberofSharesTable" xlink:href="wt-20231231.xsd#wt_EarningsPerShareDetailsScheduleofWeightedAverageNumberofSharesTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareDilutedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfWeightedAverageNumberOfSharesAbstract" xlink:to="EarningsPerShareDetailsScheduleofWeightedAverageNumberofSharesTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareDetailsScheduleofWeightedAverageNumberofSharesTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesCPreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareDetailsScheduleofWeightedAverageNumberofSharesTable" xlink:to="us-gaap_EarningsPerShareDilutedLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareDilutedLineItems" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="LessParticipatingSecuritiesAbstract" xlink:href="wt-20231231.xsd#wt_LessParticipatingSecuritiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareDilutedLineItems" xlink:to="LessParticipatingSecuritiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares" xlink:href="wt-20231231.xsd#wt_WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LessParticipatingSecuritiesAbstract" xlink:to="WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PotentiallyDilutiveRestrictedStockAwards" xlink:href="wt-20231231.xsd#wt_PotentiallyDilutiveRestrictedStockAwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LessParticipatingSecuritiesAbstract" xlink:to="PotentiallyDilutiveRestrictedStockAwards" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities" xlink:href="wt-20231231.xsd#wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LessParticipatingSecuritiesAbstract" xlink:to="WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable" xlink:href="wt-20231231.xsd#wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseLineItems" xlink:href="wt-20231231.xsd#wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable" xlink:to="srt_StatementGeographicalAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="country_US" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ForeignMember" xlink:href="wt-20231231.xsd#wt_ForeignMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="ForeignMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable" xlink:to="IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfComponentsOfCurrentAndDeferredIncomeTaxExpenseAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfComponentsOfCurrentAndDeferredIncomeTaxExpenseAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfComponentsOfCurrentAndDeferredIncomeTaxExpenseAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration" xlink:href="wt-20231231.xsd#wt_IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="NondeductibleLossOnExtinguishmentOfConvertibleNotes" xlink:href="wt-20231231.xsd#wt_NondeductibleLossOnExtinguishmentOfConvertibleNotes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="NondeductibleLossOnExtinguishmentOfConvertibleNotes" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxReconciliationInternationalOperations" xlink:href="wt-20231231.xsd#wt_IncomeTaxReconciliationInternationalOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxReconciliationInternationalOperations" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense" xlink:href="wt-20231231.xsd#wt_IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense" order="4.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxReconciliationUnrecognizedTaxBenefits" xlink:href="wt-20231231.xsd#wt_IncomeTaxReconciliationUnrecognizedTaxBenefits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxReconciliationUnrecognizedTaxBenefits" order="5.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses" xlink:href="wt-20231231.xsd#wt_IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses" order="6.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxReconciliationExpirationOfCapitalLosses" xlink:href="wt-20231231.xsd#wt_IncomeTaxReconciliationExpirationOfCapitalLosses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxReconciliationExpirationOfCapitalLosses" order="7.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets" xlink:href="wt-20231231.xsd#wt_EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ChangeInForeignNetOperatingLosses" xlink:href="wt-20231231.xsd#wt_ChangeInForeignNetOperatingLosses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="ChangeInForeignNetOperatingLosses" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIncomeTaxPaymentsByJurisdictionTable">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxesDetailsScheduleofIncomeTaxPaymentsByJurisdictionTable" xlink:href="wt-20231231.xsd#wt_IncomeTaxesDetailsScheduleofIncomeTaxPaymentsByJurisdictionTable"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxDisclosureLineItems" xlink:href="wt-20231231.xsd#wt_IncomeTaxDisclosureLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxesDetailsScheduleofIncomeTaxPaymentsByJurisdictionTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsScheduleofIncomeTaxPaymentsByJurisdictionTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_DomesticCountryMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_ForeignCountryMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsScheduleofIncomeTaxPaymentsByJurisdictionTable" xlink:to="IncomeTaxDisclosureLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureLineItems" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureLineItems" xlink:to="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureLineItems" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxDisclosureLineItems" xlink:to="us-gaap_IncomeTaxesPaidNet" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfComponentsOfTheCompanySDeferredTaxAssetsAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfComponentsOfTheCompanySDeferredTaxAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfComponentsOfTheCompanySDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsGrossAbstract" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetUnrealizedLosses" xlink:href="wt-20231231.xsd#wt_DeferredTaxAssetUnrealizedLosses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="DeferredTaxAssetUnrealizedLosses" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetOperatingLossCarryForwardUnitedStates" xlink:href="wt-20231231.xsd#wt_DeferredTaxAssetOperatingLossCarryForwardUnitedStates"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="DeferredTaxAssetOperatingLossCarryForwardUnitedStates" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetsOperatingLeaseLiabilities" xlink:href="wt-20231231.xsd#wt_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="DeferredTaxAssetsOperatingLeaseLiabilities" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetsOutsideBasisDifference" xlink:href="wt-20231231.xsd#wt_DeferredTaxAssetsOutsideBasisDifference"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="DeferredTaxAssetsOutsideBasisDifference" order="9.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfComponentsOfTheCompanySDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesAbstract" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses" xlink:href="wt-20231231.xsd#wt_DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxLiabilitiesRightOfUseAssets" xlink:href="wt-20231231.xsd#wt_DeferredTaxLiabilitiesRightOfUseAssets"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="DeferredTaxLiabilitiesRightOfUseAssets" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetsLiabilitiesGross" xlink:href="wt-20231231.xsd#wt_DeferredTaxAssetsLiabilitiesGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfComponentsOfTheCompanySDeferredTaxAssetsAbstract" xlink:to="DeferredTaxAssetsLiabilitiesGross" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfComponentsOfTheCompanySDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfComponentsOfTheCompanySDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfChangesInBalanceOfGrossUnrecognizedTaxBenefitsAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfChangesInBalanceOfGrossUnrecognizedTaxBenefitsAbstract"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxesDetailsScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable" xlink:href="wt-20231231.xsd#wt_IncomeTaxesDetailsScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfChangesInBalanceOfGrossUnrecognizedTaxBenefitsAbstract" xlink:to="IncomeTaxesDetailsScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable" xlink:to="us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis" xlink:to="us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="UnrecognizedTaxBenefitsMember" xlink:href="wt-20231231.xsd#wt_UnrecognizedTaxBenefitsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis" xlink:to="UnrecognizedTaxBenefitsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="InterestAndPenaltiesMember" xlink:href="wt-20231231.xsd#wt_InterestAndPenaltiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis" xlink:to="InterestAndPenaltiesMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable" xlink:to="us-gaap_IncomeTaxContingencyLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" order="3.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation" xlink:href="wt-20231231.xsd#wt_UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxContingencyLineItems" xlink:to="UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGoodwillTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfGoodwillAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfGoodwillAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfGoodwillAbstract" xlink:to="us-gaap_ScheduleOfGoodwillTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="srt_StatementScenarioAxis" order="1.0"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfGoodwillTable" xlink:to="us-gaap_GoodwillLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_Goodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_GoodwillPeriodIncreaseDecrease" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Goodwill_0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_Goodwill_0" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIntangibleAssetsTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfIntangibleAssetsAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfIntangibleAssetsAbstract"/>
    <loc xlink:type="locator" xlink:label="GoodwillandIntangibleAssetsDetailsScheduleofIntangibleAssetsTable" xlink:href="wt-20231231.xsd#wt_GoodwillandIntangibleAssetsDetailsScheduleofIntangibleAssetsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIntangibleAssetsAbstract" xlink:to="GoodwillandIntangibleAssetsDetailsScheduleofIntangibleAssetsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillandIntangibleAssetsDetailsScheduleofIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ETFSAcquisitionMember" xlink:href="wt-20231231.xsd#wt_ETFSAcquisitionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="ETFSAcquisitionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_SoftwareDevelopmentMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillandIntangibleAssetsDetailsScheduleofIntangibleAssetsTable" xlink:to="us-gaap_GoodwillLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_IntangibleAssetsGrossExcludingGoodwill" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="1.0" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofExpectedAmortizationExpenseTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfExpectedAmortizationExpenseAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfExpectedAmortizationExpenseAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpectedAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpectedAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpectedAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpectedAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfExpectedAmortizationExpenseAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSummarizesImpairmentsRecognizedTable">
    <loc xlink:type="locator" xlink:label="ScheduleOfSummarizesImpairmentsRecognizedAbstract" xlink:href="wt-20231231.xsd#wt_ScheduleOfSummarizesImpairmentsRecognizedAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfSummarizesImpairmentsRecognizedAbstract" xlink:to="us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable" xlink:to="us-gaap_RestructuringCostAndReserveAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="us-gaap_TypeOfRestructuringDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="LeaseTerminationMember" xlink:href="wt-20231231.xsd#wt_LeaseTerminationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="LeaseTerminationMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="FixedAssetsMember" xlink:href="wt-20231231.xsd#wt_FixedAssetsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringCostAndReserveAxis" xlink:to="FixedAssetsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SecurrencyIncMember" xlink:href="wt-20231231.xsd#wt_SecurrencyIncMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="SecurrencyIncMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInvestmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_OtherInvestmentsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable" xlink:to="srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:to="srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="NewYorkOfficeMember" xlink:href="wt-20231231.xsd#wt_NewYorkOfficeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:to="NewYorkOfficeMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LondonOfficeMember" xlink:href="wt-20231231.xsd#wt_LondonOfficeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:to="LondonOfficeMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable" xlink:to="us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems" xlink:to="us-gaap_RestructuringCostsAndAssetImpairmentCharges" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <loc xlink:type="locator" xlink:label="SignificantAccountingPoliciesDetailsTable" xlink:href="wt-20231231.xsd#wt_SignificantAccountingPoliciesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="SignificantAccountingPoliciesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfAdoptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ImplementationOfASU202006Member" xlink:href="wt-20231231.xsd#wt_ImplementationOfASU202006Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="ImplementationOfASU202006Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SignificantAccountingPoliciesDetailsTable" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="PercentageOfTaxRateRealizedOnSettlement" xlink:href="wt-20231231.xsd#wt_PercentageOfTaxRateRealizedOnSettlement"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="PercentageOfTaxRateRealizedOnSettlement" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ConvertibleNotesPayableCurrent" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalOther"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalOther" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_DeferredTaxLiabilities" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_InterestExpense" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/CashandCashEquivalentsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <loc xlink:type="locator" xlink:label="CashandCashEquivalentsDetailsTable" xlink:href="wt-20231231.xsd#wt_CashandCashEquivalentsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsAbstract" xlink:to="CashandCashEquivalentsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashandCashEquivalentsDetailsTable" xlink:to="dei_LegalEntityAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="TwoFinancialInstitutionsMember" xlink:href="wt-20231231.xsd#wt_TwoFinancialInstitutionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="TwoFinancialInstitutionsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashandCashEquivalentsDetailsTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="EuropeanBusinessSegmentMember" xlink:href="wt-20231231.xsd#wt_EuropeanBusinessSegmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="EuropeanBusinessSegmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CashandCashEquivalentsDetailsTable" xlink:to="us-gaap_CashAndCashEquivalentsLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsLineItems" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsLineItems" xlink:to="us-gaap_CashEquivalentsAtCarryingValue" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements" xlink:href="wt-20231231.xsd#wt_NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashAndCashEquivalentsLineItems" xlink:to="NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <loc xlink:type="locator" xlink:label="CashEquivalentsMaturityPeriod" xlink:href="wt-20231231.xsd#wt_CashEquivalentsMaturityPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="CashEquivalentsMaturityPeriod" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract"/>
    <loc xlink:type="locator" xlink:label="FinancialInstrumentsOwnedDetailsTable" xlink:href="wt-20231231.xsd#wt_FinancialInstrumentsOwnedDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract" xlink:to="FinancialInstrumentsOwnedDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="FinancialInstrumentsOwnedDetailsTable" xlink:to="us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TradingGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradingGainsLosses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralLineItems" xlink:to="us-gaap_TradingGainsLosses" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturityDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="InvestmentsDetailsTable" xlink:href="wt-20231231.xsd#wt_InvestmentsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ScheduleOfInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfInvestmentsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsAbstract" xlink:to="InvestmentsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="FnalityInternationalLimitedMember" xlink:href="wt-20231231.xsd#wt_FnalityInternationalLimitedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="FnalityInternationalLimitedMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ConvertiblePreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesAPreferredStockMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_SeriesBPreferredStockMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExtinguishmentOfDebtAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsTable" xlink:to="us-gaap_ExtinguishmentOfDebtAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ExtinguishmentOfDebtAxis" xlink:to="us-gaap_ExtinguishmentOfDebtTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebtMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ExtinguishmentOfDebtAxis" xlink:to="us-gaap_ConvertibleDebtMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ConvertiblePromissoryNoteMember" xlink:href="wt-20231231.xsd#wt_ConvertiblePromissoryNoteMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="ConvertiblePromissoryNoteMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsTable" xlink:to="srt_RangeAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsTable" xlink:to="dei_LegalEntityAxis" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="FnalityInternationalLimitedMember_0" xlink:href="wt-20231231.xsd#wt_FnalityInternationalLimitedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="FnalityInternationalLimitedMember_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="InvestmentsDetailsTable" xlink:to="us-gaap_ScheduleOfInvestmentsLineItems" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProvisionForOtherLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForOtherLosses"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_ProvisionForOtherLosses" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CapitalStockPercentage" xlink:href="wt-20231231.xsd#wt_CapitalStockPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="CapitalStockPercentage" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_Investments" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockConvertibleSharesIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockConvertibleSharesIssuable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_PreferredStockConvertibleSharesIssuable" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendRatePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_PreferredStockDividendRatePercentage" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharesPercentage" xlink:href="wt-20231231.xsd#wt_SharesPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="SharesPercentage" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainOrLossOnSaleOfStockInSubsidiary" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainOrLossOnSaleOfStockInSubsidiary"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_GainOrLossOnSaleOfStockInSubsidiary" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleDebt"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_ConvertibleDebt" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentRate" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentMaturityDate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleNoteDiscountRate" xlink:href="wt-20231231.xsd#wt_ConvertibleNoteDiscountRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="ConvertibleNoteDiscountRate" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_UnrealizedGainLossOnInvestments" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VariableInterestEntityOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_VariableInterestEntityOwnershipPercentage" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherOwnershipInterestsUnitsIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherOwnershipInterestsUnitsIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_OtherOwnershipInterestsUnitsIssued" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CostMethodInvestmentFairValueDisclosure" xlink:href="wt-20231231.xsd#wt_CostMethodInvestmentFairValueDisclosure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="CostMethodInvestmentFairValueDisclosure" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_GainLossOnInvestments" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="CostMethodInvestmentOwnershipPercentage" xlink:href="wt-20231231.xsd#wt_CostMethodInvestmentOwnershipPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="CostMethodInvestmentOwnershipPercentage" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfDiscountOnFutureEquityFinancingForPreferredStock" xlink:href="wt-20231231.xsd#wt_PercentageOfDiscountOnFutureEquityFinancingForPreferredStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="PercentageOfDiscountOnFutureEquityFinancingForPreferredStock" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfOutstandingConvertibleNotes" xlink:href="wt-20231231.xsd#wt_PercentageOfOutstandingConvertibleNotes"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="PercentageOfOutstandingConvertibleNotes" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity" xlink:href="wt-20231231.xsd#wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity" xlink:href="wt-20231231.xsd#wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfInvestmentsLineItems" xlink:to="us-gaap_OtherInvestments" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails">
    <loc xlink:type="locator" xlink:label="DeferredConsiderationAbstract" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationAbstract"/>
    <loc xlink:type="locator" xlink:label="DeferredConsiderationgoldpaymentsDetailsTable" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationgoldpaymentsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredConsiderationAbstract" xlink:to="DeferredConsiderationgoldpaymentsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredConsiderationgoldpaymentsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="GoldBullionHoldingsJerseyLimitedMember" xlink:href="wt-20231231.xsd#wt_GoldBullionHoldingsJerseyLimitedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="GoldBullionHoldingsJerseyLimitedMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredConsiderationgoldpaymentsDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="FirstInstallmentsMember" xlink:href="wt-20231231.xsd#wt_FirstInstallmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="FirstInstallmentsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SecondInstallmentsMember" xlink:href="wt-20231231.xsd#wt_SecondInstallmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="SecondInstallmentsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ThirdInstallmentsMember" xlink:href="wt-20231231.xsd#wt_ThirdInstallmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="ThirdInstallmentsMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredConsiderationgoldpaymentsDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ETFSCapitalMember" xlink:href="wt-20231231.xsd#wt_ETFSCapitalMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="ETFSCapitalMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ContractualGoldPaymentsMember" xlink:href="wt-20231231.xsd#wt_ContractualGoldPaymentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="ContractualGoldPaymentsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AgreementAxis" xlink:href="wt-20231231.xsd#wt_AgreementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredConsiderationgoldpaymentsDetailsTable" xlink:to="AgreementAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AgreementDomainDomain" xlink:href="wt-20231231.xsd#wt_AgreementDomainDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementAxis" xlink:to="AgreementDomainDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SpaAgreementMember" xlink:href="wt-20231231.xsd#wt_SpaAgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementAxis" xlink:to="SpaAgreementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredConsiderationgoldpaymentsDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SeriesCRedeemableConvertiblePreferredStockMember" xlink:href="wt-20231231.xsd#wt_SeriesCRedeemableConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="SeriesCRedeemableConvertiblePreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredConsiderationgoldpaymentsDetailsTable" xlink:to="dei_LegalEntityAxis" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="GoldBullionHoldingsMember" xlink:href="wt-20231231.xsd#wt_GoldBullionHoldingsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="GoldBullionHoldingsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="RodberInvestmentsLimitedMember" xlink:href="wt-20231231.xsd#wt_RodberInvestmentsLimitedMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="RodberInvestmentsLimitedMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DeferredConsiderationgoldpaymentsDetailsTable" xlink:to="us-gaap_BusinessAcquisitionLineItems" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentOwnedBalanceOtherMeasure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentOwnedBalanceOtherMeasure"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_InvestmentOwnedBalanceOtherMeasure" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_Cash" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredConsiderationCurrent" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationCurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="DeferredConsiderationCurrent" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredConsiderationNoncurrent" xlink:href="wt-20231231.xsd#wt_DeferredConsiderationNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="DeferredConsiderationNoncurrent" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract"/>
    <loc xlink:type="locator" xlink:label="ConvertibleNotesDetailsTable" xlink:href="wt-20231231.xsd#wt_ConvertibleNotesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract" xlink:to="ConvertibleNotesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleNotesDetailsTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleNotesDetailsTable" xlink:to="us-gaap_DebtInstrumentAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ConvertibleSeniorNotesDue2028Member" xlink:href="wt-20231231.xsd#wt_ConvertibleSeniorNotesDue2028Member"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="ConvertibleSeniorNotesDue2028Member" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember" xlink:href="wt-20231231.xsd#wt_ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember" xlink:href="wt-20231231.xsd#wt_ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="TwoThousandAndTwentyNotesMember" xlink:href="wt-20231231.xsd#wt_TwoThousandAndTwentyNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="TwoThousandAndTwentyNotesMember" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleSeniorNotesMember" xlink:href="wt-20231231.xsd#wt_ConvertibleSeniorNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="ConvertibleSeniorNotesMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertibleNotesPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_ConvertibleNotesPayableMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ConvertibleNotesMember" xlink:href="wt-20231231.xsd#wt_ConvertibleNotesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="ConvertibleNotesMember" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleNotesDetailsTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ConvertibleNotesDetailsTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtGainLossNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ExtinguishmentOfDebtGainLossNetOfTax" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Cash"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_Cash" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockAmountIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockAmountIssued1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ConversionOfStockAmountIssued1" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdTradingDays" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtConversionConvertedInstrumentRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentRate" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="NumberOfThresholdTradingDaysForDeterminingTheSharePrice" xlink:href="wt-20231231.xsd#wt_NumberOfThresholdTradingDaysForDeterminingTheSharePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="NumberOfThresholdTradingDaysForDeterminingTheSharePrice" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MeasurementPeriodForDeterminingSharePrice" xlink:href="wt-20231231.xsd#wt_MeasurementPeriodForDeterminingSharePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="MeasurementPeriodForDeterminingSharePrice" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PrincipalAmountOfTradingPrice" xlink:href="wt-20231231.xsd#wt_PrincipalAmountOfTradingPrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="PrincipalAmountOfTradingPrice" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="SharePriceAsAPercentageOfLastReportedPriceAndConversionRate" xlink:href="wt-20231231.xsd#wt_SharePriceAsAPercentageOfLastReportedPriceAndConversionRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="SharePriceAsAPercentageOfLastReportedPriceAndConversionRate" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionRatio1" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentRedemptionPricePercentage" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MaximumConversionRate" xlink:href="wt-20231231.xsd#wt_MaximumConversionRate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="MaximumConversionRate" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MaximumNumberOfSharesIssuableUponConversion" xlink:href="wt-20231231.xsd#wt_MaximumNumberOfSharesIssuableUponConversion"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="MaximumNumberOfSharesIssuableUponConversion" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="MinimumPercentageOfLendersRequiredToHaveEntirePrincipalAmountOfConvertibleNotesRepurchasedByTheCompanyUponCertainEventsOfDefault" xlink:href="wt-20231231.xsd#wt_MinimumPercentageOfLendersRequiredToHaveEntirePrincipalAmountOfConvertibleNotesRepurchasedByTheCompanyUponCertainEventsOfDefault"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="MinimumPercentageOfLendersRequiredToHaveEntirePrincipalAmountOfConvertibleNotesRepurchasedByTheCompanyUponCertainEventsOfDefault" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpense" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFairValue" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract"/>
    <loc xlink:type="locator" xlink:label="SeriesAPreferredStockDetailsTable" xlink:href="wt-20231231.xsd#wt_SeriesAPreferredStockDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredUnitsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredUnitsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract" xlink:to="SeriesAPreferredStockDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeriesAPreferredStockDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ETFSAcquisitionMember" xlink:href="wt-20231231.xsd#wt_ETFSAcquisitionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="ETFSAcquisitionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeriesAPreferredStockDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SeriesANonVotingConvertiblePreferredStockMember" xlink:href="wt-20231231.xsd#wt_SeriesANonVotingConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="SeriesANonVotingConvertiblePreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_PreferredStockMember" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeriesAPreferredStockDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SeriesAPreferredStockDetailsTable" xlink:to="us-gaap_PreferredUnitsLineItems" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OutstandingCommonStockPercentage" xlink:href="wt-20231231.xsd#wt_OutstandingCommonStockPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PreferredUnitsLineItems" xlink:to="OutstandingCommonStockPercentage" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PreferredUnitsLineItems" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PreferredUnitsLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PreferredUnitsLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionSharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PreferredUnitsLineItems" xlink:to="us-gaap_BusinessAcquisitionSharePrice" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PreferredStockRedemptionValue" xlink:href="wt-20231231.xsd#wt_PreferredStockRedemptionValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PreferredUnitsLineItems" xlink:to="PreferredStockRedemptionValue" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHDetails">
    <loc xlink:type="locator" xlink:label="PayableToGoldBullionHoldingJerseyLimitedGBHAbstract" xlink:href="wt-20231231.xsd#wt_PayableToGoldBullionHoldingJerseyLimitedGBHAbstract"/>
    <loc xlink:type="locator" xlink:label="PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsTable" xlink:href="wt-20231231.xsd#wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsTable"/>
    <loc xlink:type="locator" xlink:label="PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems" xlink:href="wt-20231231.xsd#wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayableToGoldBullionHoldingJerseyLimitedGBHAbstract" xlink:to="PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="GBHMember" xlink:href="wt-20231231.xsd#wt_GBHMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="GBHMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsTable" xlink:to="PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockConvertibleSharesIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockConvertibleSharesIssuable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems" xlink:to="us-gaap_PreferredStockConvertibleSharesIssuable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionConsiderationTransferred" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems" xlink:to="us-gaap_AssetAcquisitionConsiderationTransferred" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1" order="2.0" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <loc xlink:type="locator" xlink:label="RepurchasePricePerShareInterestRateTransaction" xlink:href="wt-20231231.xsd#wt_RepurchasePricePerShareInterestRateTransaction"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems" xlink:to="RepurchasePricePerShareInterestRateTransaction" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PresentValueOfMarketRateInterest" xlink:href="wt-20231231.xsd#wt_PresentValueOfMarketRateInterest"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems" xlink:to="PresentValueOfMarketRateInterest" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AggregateConsiderationPayable" xlink:href="wt-20231231.xsd#wt_AggregateConsiderationPayable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems" xlink:to="AggregateConsiderationPayable" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InterestAndDebtExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestAndDebtExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems" xlink:to="us-gaap_InterestAndDebtExpense" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/LeasesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <loc xlink:type="locator" xlink:label="PaymentOfLeaseTerminationFee" xlink:href="wt-20231231.xsd#wt_PaymentOfLeaseTerminationFee"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="PaymentOfLeaseTerminationFee" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnContractTermination" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnContractTermination"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_GainLossOnContractTermination" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLeaseImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseImpairmentLoss" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ContingenciesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="ContingenciesDetailsTable" xlink:href="wt-20231231.xsd#wt_ContingenciesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainContingenciesLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="ContingenciesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContingenciesDetailsTable" xlink:to="us-gaap_GainContingenciesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_LossContingencyDamagesSoughtValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GainContingenciesLineItems" xlink:to="us-gaap_LossContingencyDamagesSoughtValue" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="LossContingencyCoveredByInsuranceDeductible" xlink:href="wt-20231231.xsd#wt_LossContingencyCoveredByInsuranceDeductible"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GainContingenciesLineItems" xlink:to="LossContingencyCoveredByInsuranceDeductible" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <loc xlink:type="locator" xlink:label="RelatedPartyTransactionsDetailsTable" xlink:href="wt-20231231.xsd#wt_RelatedPartyTransactionsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="RelatedPartyTransactionsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="WisdomTreeProductsMember" xlink:href="wt-20231231.xsd#wt_WisdomTreeProductsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="WisdomTreeProductsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_InvestmentTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="AffiliatedBlockchainEnabledFundsMember" xlink:href="wt-20231231.xsd#wt_AffiliatedBlockchainEnabledFundsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="AffiliatedBlockchainEnabledFundsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="RelatedPartyTransactionsDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherIncome"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OtherIncome" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Investments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_Investments" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnInvestments"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_GainLossOnInvestments" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ContractualObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractualObligation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ContractualObligation" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <loc xlink:type="locator" xlink:label="StockBasedAwardsDetailsTable" xlink:href="wt-20231231.xsd#wt_StockBasedAwardsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="StockBasedAwardsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockBasedAwardsDetailsTable" xlink:to="us-gaap_AwardTypeAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="PerformanceBasedRestrictedStockUnitMember" xlink:href="wt-20231231.xsd#wt_PerformanceBasedRestrictedStockUnitMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="PerformanceBasedRestrictedStockUnitMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockBasedAwardsDetailsTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockOptionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_StockOptionMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockBasedAwardsDetailsTable" xlink:to="us-gaap_VestingAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="BelowTwentyFifthPercentileMember" xlink:href="wt-20231231.xsd#wt_BelowTwentyFifthPercentileMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="BelowTwentyFifthPercentileMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockBasedAwardsDetailsTable" xlink:to="srt_RangeAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockBasedAwardsDetailsTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensation" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_OtherTaxExpenseBenefit" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails">
    <loc xlink:type="locator" xlink:label="DisclosureOfStockholderRightsPlanAbstract" xlink:href="wt-20231231.xsd#wt_DisclosureOfStockholderRightsPlanAbstract"/>
    <loc xlink:type="locator" xlink:label="StockholderRightsPlanDetailsTable" xlink:href="wt-20231231.xsd#wt_StockholderRightsPlanDetailsTable"/>
    <loc xlink:type="locator" xlink:label="DisclosureOfStockholderRightsPlanLineItems" xlink:href="wt-20231231.xsd#wt_DisclosureOfStockholderRightsPlanLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfStockholderRightsPlanAbstract" xlink:to="StockholderRightsPlanDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfArrangementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholderRightsPlanDetailsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="StockholderRightAgreementMember" xlink:href="wt-20231231.xsd#wt_StockholderRightAgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="StockholderRightAgreementMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholderRightsPlanDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_BoardOfDirectorsChairmanMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_BoardOfDirectorsChairmanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_BoardOfDirectorsChairmanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AgreementAxis" xlink:href="wt-20231231.xsd#wt_AgreementAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholderRightsPlanDetailsTable" xlink:to="AgreementAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="AgreementDomainDomain" xlink:href="wt-20231231.xsd#wt_AgreementDomainDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementAxis" xlink:to="AgreementDomainDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="StockholderRightAgreementMember_0" xlink:href="wt-20231231.xsd#wt_StockholderRightAgreementMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AgreementAxis" xlink:to="StockholderRightAgreementMember_0" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholderRightsPlanDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SeriesANonVotingConvertiblePreferredStockMember" xlink:href="wt-20231231.xsd#wt_SeriesANonVotingConvertiblePreferredStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="SeriesANonVotingConvertiblePreferredStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholderRightsPlanDetailsTable" xlink:to="srt_RangeAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholderRightsPlanDetailsTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholderRightsPlanDetailsTable" xlink:to="srt_OwnershipAxis" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="AcquiringPersonMember" xlink:href="wt-20231231.xsd#wt_AcquiringPersonMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_OwnershipAxis" xlink:to="AcquiringPersonMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PassiveStockholdersMember" xlink:href="wt-20231231.xsd#wt_PassiveStockholdersMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_OwnershipAxis" xlink:to="PassiveStockholdersMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholderRightsPlanDetailsTable" xlink:to="DisclosureOfStockholderRightsPlanLineItems" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfStockholderRightsPlanLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfStockholderRightsPlanLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfStockholderRightsPlanLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="ExercisePricePerUnit" xlink:href="wt-20231231.xsd#wt_ExercisePricePerUnit"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfStockholderRightsPlanLineItems" xlink:to="ExercisePricePerUnit" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfStockholderRightsPlanLineItems" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfCommonStockAcquired" xlink:href="wt-20231231.xsd#wt_PercentageOfCommonStockAcquired"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfStockholderRightsPlanLineItems" xlink:to="PercentageOfCommonStockAcquired" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfBeneficialOwnership" xlink:href="wt-20231231.xsd#wt_PercentageOfBeneficialOwnership"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfStockholderRightsPlanLineItems" xlink:to="PercentageOfBeneficialOwnership" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfAssetsSold" xlink:href="wt-20231231.xsd#wt_PercentageOfAssetsSold"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfStockholderRightsPlanLineItems" xlink:to="PercentageOfAssetsSold" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfCommonStock" xlink:href="wt-20231231.xsd#wt_PercentageOfCommonStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DisclosureOfStockholderRightsPlanLineItems" xlink:to="PercentageOfCommonStock" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShareDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <loc xlink:type="locator" xlink:label="EarningsPerShareDetailsTable" xlink:href="wt-20231231.xsd#wt_EarningsPerShareDetailsTable"/>
    <loc xlink:type="locator" xlink:label="EarningsPerShareDetailsLineItems" xlink:href="wt-20231231.xsd#wt_EarningsPerShareDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="EarningsPerShareDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementScenarioAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareDetailsTable" xlink:to="srt_StatementScenarioAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioUnspecifiedDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioForecastMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioForecastMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareDetailsTable" xlink:to="EarningsPerShareDetailsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareDetailsLineItems" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareDetailsLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EarningsPerShareDetailsLineItems" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="IncomeTaxesDetailsTable" xlink:href="wt-20231231.xsd#wt_IncomeTaxesDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ScheduleOfIncomeTaxLineItems" xlink:href="wt-20231231.xsd#wt_ScheduleOfIncomeTaxLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="IncomeTaxesDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="ManJersMember" xlink:href="wt-20231231.xsd#wt_ManJersMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="ManJersMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_OtherNoncurrentLiabilitiesMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeTaxesDetailsTable" xlink:to="ScheduleOfIncomeTaxLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="OperatingLossCarryForwardExpirationYear" xlink:href="wt-20231231.xsd#wt_OperatingLossCarryForwardExpirationYear"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxLineItems" xlink:to="OperatingLossCarryForwardExpirationYear" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsCapitalLossCarryforwards"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxLineItems" xlink:to="us-gaap_DeferredTaxAssetsCapitalLossCarryforwards" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetsCapitalLossCarryforwardsSubjectToExpiration" xlink:href="wt-20231231.xsd#wt_DeferredTaxAssetsCapitalLossCarryforwardsSubjectToExpiration"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxLineItems" xlink:to="DeferredTaxAssetsCapitalLossCarryforwardsSubjectToExpiration" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax" xlink:href="wt-20231231.xsd#wt_DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxLineItems" xlink:to="DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxLineItems" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ScheduleOfIncomeTaxLineItems" xlink:to="us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureTextBlockSupplementAbstract"/>
    <loc xlink:type="locator" xlink:label="SharesRepurchasedDetailsTable" xlink:href="wt-20231231.xsd#wt_SharesRepurchasedDetailsTable"/>
    <loc xlink:type="locator" xlink:label="SharesRepurchasedDetailsLineItems" xlink:href="wt-20231231.xsd#wt_SharesRepurchasedDetailsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureTextBlockSupplementAbstract" xlink:to="SharesRepurchasedDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SharesRepurchasedDetailsTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="GoldBullionHoldingsMember" xlink:href="wt-20231231.xsd#wt_GoldBullionHoldingsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="GoldBullionHoldingsMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SharesRepurchasedDetailsTable" xlink:to="srt_TitleOfIndividualAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_BoardOfDirectorsChairmanMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_BoardOfDirectorsChairmanMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_BoardOfDirectorsChairmanMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SharesRepurchasedDetailsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_CommonStockMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SharesRepurchasedDetailsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="WorldGoldCouncilMember" xlink:href="wt-20231231.xsd#wt_WorldGoldCouncilMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="WorldGoldCouncilMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SharesRepurchasedDetailsTable" xlink:to="srt_RangeAxis" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0.0"/>
    <loc xlink:type="locator" xlink:label="srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MinimumMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_MaximumMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SharesRepurchasedDetailsTable" xlink:to="SharesRepurchasedDetailsLineItems" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SharesRepurchasedDetailsLineItems" xlink:to="us-gaap_StockRepurchaseProgramAuthorizedAmount1" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SharesRepurchasedDetailsLineItems" xlink:to="us-gaap_StockRepurchaseProgramPeriodInForce1" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchaseProgramExpirationDate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramExpirationDate"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SharesRepurchasedDetailsLineItems" xlink:to="us-gaap_StockRepurchaseProgramExpirationDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SharesRepurchasedDetailsLineItems" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SharesRepurchasedDetailsLineItems" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SharesRepurchasedDetailsLineItems" xlink:to="us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ConversionOfStockSharesConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SharesRepurchasedDetailsLineItems" xlink:to="us-gaap_ConversionOfStockSharesConverted1" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="SharesRepurchasedDetailsLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <loc xlink:type="locator" xlink:label="GoodwillandIntangibleAssetsDetailsTable" xlink:href="wt-20231231.xsd#wt_GoodwillandIntangibleAssetsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GoodwillLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="GoodwillandIntangibleAssetsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillandIntangibleAssetsDetailsTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="SecurrencyMember" xlink:href="wt-20231231.xsd#wt_SecurrencyMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="SecurrencyMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="ETFSAcquisitionMember" xlink:href="wt-20231231.xsd#wt_ETFSAcquisitionMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="ETFSAcquisitionMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillandIntangibleAssetsDetailsTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_SoftwareDevelopmentMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="GoodwillandIntangibleAssetsDetailsTable" xlink:to="us-gaap_GoodwillLineItems" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_Goodwill" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <loc xlink:type="locator" xlink:label="PercentageOfRevenueGrowth" xlink:href="wt-20231231.xsd#wt_PercentageOfRevenueGrowth"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="PercentageOfRevenueGrowth" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_PercentageOfWeightedAverageCostInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PercentageOfWeightedAverageCostInventory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_PercentageOfWeightedAverageCostInventory" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsDetails">
    <loc xlink:type="locator" xlink:label="us-gaap_AssetAcquisitionContingentConsiderationLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationLiabilityAbstract"/>
    <loc xlink:type="locator" xlink:label="ContingentPaymentsDetailsTable" xlink:href="wt-20231231.xsd#wt_ContingentPaymentsDetailsTable"/>
    <loc xlink:type="locator" xlink:label="ContingentPaymentsLineItems" xlink:href="wt-20231231.xsd#wt_ContingentPaymentsLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetAcquisitionContingentConsiderationLiabilityAbstract" xlink:to="ContingentPaymentsDetailsTable" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContingentPaymentsDetailsTable" xlink:to="srt_ProductOrServiceAxis" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="SaleOfCanadianETFBusinessMember" xlink:href="wt-20231231.xsd#wt_SaleOfCanadianETFBusinessMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="SaleOfCanadianETFBusinessMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContingentPaymentsDetailsTable" xlink:to="ContingentPaymentsLineItems" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ContingentPaymentsLineItems" xlink:to="us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
  <presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/dei/role/document/Cover">
    <loc xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="10.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitiesTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntitiesTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="11.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityAddressesTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityAddressesTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="12.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityListingsTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityListingsTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="13.0"/>
    <loc xlink:type="locator" xlink:label="dei_NameChangeEventTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NameChangeEventTable"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_NameChangeEventTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="14.0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0.0"/>
    <loc xlink:type="locator" xlink:label="CommonStock001ParValueMember" xlink:href="wt-20231231.xsd#wt_CommonStock001ParValueMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="CommonStock001ParValueMember" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="PreferredStockPurchaseRightsMember" xlink:href="wt-20231231.xsd#wt_PreferredStockPurchaseRightsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="PreferredStockPurchaseRightsMember" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>tbarchart_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tbarchart_001.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2      04  DE$_]L
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MJJ'")/,L9@BERDF&SC4R/(&E3'5C("(&M[KW3_\ SNO^W1/\Q?\ \5+[@_\
M=7-[]U[H/?Y\GP)B_F'?RSOD!U!A,!_'NW=B82;O#H.&GAI6JWW;UC35-52X
MZCEJP(X)=PX]\CAR_FA 6O)>54#'W[KW6B=_PETW+WQW_P!O]E?RU\3'DZKX
MI]N[NZD^4WR2R%/F)<>,7AOC7E:?(5.'AB2CGCJ*;LS+#:6WLW#)4P"HPJ5,
M(UW;3[KW6PQ_PMA_[=S?&/\ \77VW_[PN^??NO=*C_A%3_VZR[\_\7_[3_\
M?==5>_=>ZV_??NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=56_P#=0;_R8O\
MY6_:C_0_]7KTSY_GT-WP!_YDYN7_ ,29F?\ W58;W6?C^75TX='D]L]7Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJ?OYX'\LD_P U
M;X-YSX\;>R>WML]L8#L#8?9'46]-R4KU--C,AA:U:3*F41/'*8ZS;==F:?2K
M@&9X68'0/?NO=63=!]*;#^-O2'4GQ^ZNQAP_772W7.S^L=EX]YGJ9$QVRJ"#
M'TIFFE:26>IDC@#S322/)-*SR2.SNS'W7NJF_P"9G_*"VI_, ^:7\LSY/Y/^
M$Q4'Q&[AR^8[FQU95"CDSFU<=!_>3!4*A:6:2M:EWKA\9 U.:F",4&6RLA9I
M%0>_=>ZN_P#?NO=:\'_"AG^65\T?YLW0/4GQE^-];\8=D[+V5W-AN]-R[^[N
M[4W5M_)RY#;N"W%@*7$T6%P/7^XJ8T;P;DJIY*N7-))KBCB6DTEI??NO=(OX
M'_RL_F_\9/Y*7RH_E<]KO\8,SO;?70GS"Z_Z=[(ZM[<W1G:*MR?R+PN:@H(,
M_19K8&WWQ--1Y++R++54U37DP*C"E#Z@?=>Z?.^?C1_.F['_ )??87\N[?.V
M_@O\I\IVGT95](5GS.W=W9NGJ*K@BRM,*(YG/[ '7NY4R.?QT6B:*OH=SQ+-
M5Q1U[444VJF;W7NK ?Y7G\LWK;^6Y\#MI?"JDS,?:<,\6[\SW)N_(X=,-%N;
M-=C@KFI?LD>0P8\4@@Q]+&\\DPH::!9I9)=;GW7NM</X_?R"OYG_ /*3_F%[
MU^0O\J/L7XN]B_'/LC#5NSZWK;Y6[QW-@Y8-O9[)4=?+ALQ'A,;4/556$FI(
MFQF:I:J2IT"3[B@<2U%/5^Z]T@_YD_\ PE\^??\ ,3^;2_(3>7R^Z<GQ^Z.J
M]BT7:&_=VTV<C-/N/%_=K5XG8.QZ.EJZ?#;'QE*]'#CZ>LW6:V21:FMKIZNN
MK*FJF]U[K:L^2_P<@^>GP2W=\/\ YM;@V?N_</8NSZ6@W3V+T_LFHV)28_<.
M(=:C&;CV]B<SEMQST51CJ^*&H2*;)SK(/) Y\,C*?=>ZIP^&GP/_ )P/\NOX
M!]T?RX^H\!\/.^L3//V?COC+\G=P=U[BZG_@>/[E%5+7S;GV9_<W<$\U;B,I
M6UM=3PT.=DAE-0M.\Q$)EF]U[HX?\D;^2ML;^3KT3OW#T>[Z'NCY)]R55%E>
MUNSGQS[3QLD>VUJ1A-N8>$K75=%A<>:J=Y:B435-753SU3Q1Q+2T--[KW5'/
M8/\ PG^_F][H_G#'^;-@-[_R^L)F*3Y,[-[RH>I)^]-_U(EP^SFH*,[;GS#]
M+2QQR9/ 4+44U>F):2!YWJ8(O+'&??NO='3_ .%#7\F+Y_\ \XW=_P 7H.F\
MM\/.J]A?&_;O9DHRG9G<V]7R^5RW<R;6;*P?88KK&NHJ7'8B3:\,=)/_ !*2
M:M6=YIJ>B*K![]U[HV\/P(_F#P?R-)/Y8<6)^'\'>I^.A^**=A0_(+>R;5;;
MU50RXR?<+..J1F!E6H&"?PK^'M3/([R-DEC'@?W7NBF_\)V/Y+WSV_D[]A_(
MZG[TW#\1NR.JODEANL!F<WU+VSO&MS^%K^GAN9L;]OB,SUOB*#)TN1.YJF.H
M+9VC>F$22QI5$F+W[KW6U!N2HW)2X/(U&T,3@\YN2*%6Q.)W)N"?:M#-(74%
M:C(4N,S,]*@C+D,F,J"6 70 Q9?=>ZT'?YH__"8G^:?_ #'_ )Y_(+YH#?WP
M!ZOI>YLOLLXO8C]X=B;EDH*'KW;.%VKCQ/6CJ&D6>JJ*+!T\\^BG1%FED1-2
M*K-[KW6[I\8Q\E*7J[;&#^3^R^E=I]@;=VSMW"5M3T?V[G.V,7D:G&1RTU55
MA\]L;9%5CTG2&DG2'P591YYJ=IF6F2HJO=>ZK5_GP_!'Y<?S*OA?6?$'XP5G
MQZVO3[VWQLG=&_=\=Z=B;BVL:>EV)6_Q&"BQN/P.R=T?=R55;#2,\TM;2^)$
M=!'+KN/=>Z!W_A//_+,^8W\IKXZ]K_&/Y'5'QGWIMK>?=^?[VV]V)TEVQNG<
M=<M7N; ;9V_/AZW!9[K[;=/%3P1[9AJ(ZV+.2O(U2\+4:"%99?=>ZNQ^1'0W
M7/RBZ*[;^.O;F+FS/6G=.P=R]=;SH*6I-%.:+<]-)3234LZ@M3UE,76:GF +
M13QQR#E1[]U[K2%^+O\ PGX_GF?RG?E/O[?O\M+Y0?%?<W4V]FIL'6Q]T9/*
MXF#<&%I#*^/AWEMF/;U>D-?AJBLJ7@J<1F'FX=XI8HZRIQY]U[K;Y^+/QD[;
MVKM+?6YOFEVUMSY*_(;N;#Q;:[)S.V]EC8NS<1MVFAFAI]E[/P,DU344N!C-
M56U%;55M5/D<O75,L]7+'2PXW'X[W7NM0$_\)G?YH/\ +K^=%1\G_P"3I\D^
MF<=L82Y)-L8?NC<5=B,O2X;/5:U%=LS<=&^ S&*W)@6CIJ-%K!605DK(DP@H
MZREAK7]U[K;%^%'QZ^9>(KX^]/YBO>/6?</R);:R[3V?L3H79U1LOKW8E!DS
M%/F/X,F1>3+Y_<.<J(:9*W,U_B\='2T]#C:*ABDR4F3]U[JQ_P!^Z]U0?VA\
M<?YPW8/\SGHSYA2X'X U7QF^.&V>U=C=;?'S(?)WL:CRTA[9B&.R6]JO*P],
M38^'=,F*A@AAI/L*FFHZ9ZS'PUK_ 'D^0?W7NKV*.?<#[?I:G(8S#4NZGPT$
M];AJ/.SUV/CR#0!I*6+)OCJ>IFHTJ=2+5-B8I'C E-(C'PCW7NM&C^<A_P )
MI?Y@'\S+YS[X^6_5M3\"^A<7O7:&PL%GL#E>]-_;CK\OD]GT"T$F=R$E+U#3
M4T%5/1Q45((H_*/#112O*999%3W7NMJ?^6EL'YX=/?%_KKI;Y]5WQ^WGVCU+
MM;";$QO;W1/9FYM[?WIQ^W8_MJ*OSM#N79NV9L;F4H8Z6*KEAKLA'7U"2UH6
MC\WVL?NO=4H_SX/^$U6!_F>=@'Y5_&C?VS^E_E=/@L?@^P*+?-!5+MK>\.VZ
M-*/$5&2K<;!55^)S5#24]-1"M7'UJ3T45/!+"GVT<GOW7NC@_&G<7_"B_8W5
MNQ^L>].DOY=/;6_<'CJ;;N3^0N6^1^[=IO6QTD20PY;.;>Q.Q:Y*[)#29*O[
M"HH8JR0VBAHM1<>Z]U8?\0OB'N#H[<':7>O>O9E)WQ\N>_FV_#VYVWCMJG8V
M'I,/LPU9V_LS9V"DKLG-@]H[?^_K7@AFR=75U=94U5?75,L\]H_=>Z W^;G\
M?_G%\O?B%W1\3?B'COB_@1WWLP]?;M[0^0':VZ-NR8W$YN0KFH:# 8'K_<D=
M9555"GVT%1+FH! 9Y)_ [P1I)[KW1Y?C[D?DID.OL5_LT^R^D=G=I4U%1T^:
M3H3M+.]H8*LJ(O(D]53R[@V;LVOH(Y@L4J4S4]48C(\)J91"L\_NO=$*_ES?
MRG^H?Y>'>OS_ .Z>OEQ\U9\S._:;L; TM*U66P.V8*%*]=NE*B1H(_!N_,;N
MJ$:G6ST$N-BE=VIE2'W7NB$_\* ?Y7_\PC^;IU5U9\?^EU^'/5O7/67<61[9
MFWCV?WEO2?,926AQN4PN*A&)Q75=91XU3096IGJ5_C%7IG9(8W=(C/+[KW2@
M_P"$_G\M#Y\_RDNB^R/C/WE'\1.RNO\ ?O>]7W92;\ZI[OWD^6Q\NX\'@<#D
MZ1\+E^KL=25RQT^W*":G(S=-J>2:.32-+^_=>ZV/O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=56_\ =0;_ ,F+_P"5OVH_T/\ U>O3/G^?0W? '_F3FY?_
M !)F9_\ =5AO=9^/Y=73AT>3VSU?KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJK?^Z@W_DQ?_*W[4?Z'
M_J]>F?/\^AN^ /\ S)S<O_B3,S_[JL-[K/Q_+JZ<.CR>V>K]>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]TP0[JVQ4;DK=FT^XL'4;NQN*I<[DMKP96"7(T
M]%72-%!5ST2R&HAIIY4D2.5XU21D<(25:WNO=,>]^T.M^M/[N?Z0]][3V1_?
M#<N+V=M;^].>IL'_ !#*YMBE'CZ3[B2/SU=2ZE8XTNS'@"_OW7NEO%+%/%'/
M!)'-#-&DL,T3B1760 JRL"0RL"""#8CD>_=>ZR>_=>Z!_>WR%Z$ZT["Z[ZE[
M%[LZFV%VGV[-6P=4];;R[$Q&V<]N5\;I^X7 XBMJX:_+-"64.*6"72S*I]3
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M355&,CIOXQ#AI*1%JHZXO_#DEJE]U[H<OF5_+P[+_GL_SSNJ.\:3I;LO9_\
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MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=56_P#=0;_R8O\
MY6_:C_0_]7KTSY_GT-WP!_YDYN7_ ,29F?\ W58;W6?C^75TX='D]L]7Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[JJW_NH-_P"3%_\ *W[4?Z'_ *O7IGS_ #Z&[X _\R<W+_XDS,_^
MZK#>ZS\?RZNG#H\GMGJ_7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=56_]U!O_)B_^5OVH_T/_5Z],^?Y
M]#=\ ?\ F3FY?_$F9G_W58;W6?C^75TX='D]L]7Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JJW_ +J#
M?^3%_P#*W[4?Z'_J]>F?/\^AN^ /_,G-R_\ B3,S_P"ZK#>ZS\?RZNG#H\GM
MGJ_7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=56_]U!O_ "8O_E;]J/\ 0_\ 5Z],^?Y]#=\ ?^9.;E_\
M29F?_=5AO=9^/Y=73AT>3VSU?KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJK?^Z@W_DQ?_*W[4?Z'_J]
M>F?/\^AN^ /_ #)S<O\ XDS,_P#NJPWNL_'\NKIPZ/)[9ZOU[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW0 ?*'Y0]&?#3HS?OR-^1N_<9USU+USC%R.X=PY%7J7=ZEUAI*"@I(5>
MIR&3R%2\<%+2P1O-/,ZHBFY(]U[JF+>7\W#YP[F['_EWU'QZ_E\X5>GOG/G^
MY6V?MWY'=UT_5_8.XL+U[L7.[SH*S&4&.I,Q@]ER5V+Q4>1I?XU75K5\<D.+
MJ*?!M5-F*+W7NCP_ 7^:3U5\[M]=]='1]1=Y_'+Y-_%O)8O%]_= ][[3@Q&2
MPAS\DZXRKI<GCJNOQ&6QV3CIWFI:B"J'GIS'51QM23TU1/[KW63^8!_-X^#_
M /+;V+GMV_('L;)97/864XV+K#JG;T_8>X)LE-2_>4F,J4I-.+P%370F,P29
MO*8RF<21D3VD35[KW1.OY)?\[Y/YRF^_FJNW>B6Z6ZQ^-M3T-#UY-FMU#<F>
MS,/;1WJ*BHS,<$$6/Q\L(VO3&.GII:E4\\JM53Z5;W[KW5V?<7;O7?075/8G
M=O;>YJ+9O6756S\]OS?6Z,@'>*BQFVJ>2JJIC'$KRS.(HR(XHXWEED*QQ(\C
MJI]U[J@CJ3^<3\R/EA\+ODU_,?\ BO\ $?JV?XP=%UW8];UAUUVYV%FL?O[L
MK ],4:5>Y\KCVP.*RF,VW4+X\C#CJ&6DRDM964KTKO3JT=3)[KW5H7\MG^8]
M\?/YH?QHP?R2^/M=7TU"<E-M3L'8&X?''F-K;AQ\$%15X;)I$6BD98:FGFIZ
MF)F@JJ>6.6,@EXX_=>Z)_P!V?S>*G*_S(]I?RIOA3UWM;N#Y(TN(R6\?D-V1
MV'N"JP6S.M\+BL6,E(*R/'PRY/<.;D%5B8A14DE/%%-7TT,]7&_W/VONO=1?
MC)_.,IL[_,3[<_E2?,KK_;/1ORWV554V2Z>W-LG/U^?V7V9A,EA*?<5-58.?
M*T%!78K,_P )FEEEQTK5D(DIJRF@R-344KHWNO=7D>_=>Z:,_G\#M7"97<NZ
M,WB-M[<P5!597.9_/Y*'#T5'2T2&2:IJZJH>."GIX44L\DDBHB@EB /?NO=:
MQ7\S+_A51\)/@OFL]U-T]M'??RH[\QM#,W\-PV.J.N]GT$\BP-3-7[FRU*DV
M2IZB.9I(9<'B\I32^&2)ZNG>Q]^Z]U?Y\-^[\M\FOB'\5ODCGL'CMLYSY!?&
M_H[N_-;;Q%1)54F/J^U]L8O/5-#2RS?O24])-7O%&\GK9$4MZB??NO=&0]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U5;_W4&_\F+_Y6_:C_0_]7KTSY_GT
M-WP!_P"9.;E_\29F?_=5AO=9^/Y=73AT>3VSU?KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NM4__
M (6!= ]W=T?RM\'NOJ:BR^?VM\?^^]L=P=U;9PD5153';D&&SF&;,M3TZ2-4
M4N!K<M33U>I?'34;U&0E9(J.1Q[KW5#O\M?_ (4&;/[[^07\F+K+YNU6U^F:
M_P"#&]>_=N[H^2^<S5/@MK9? ;LZ6W3L?:U3FA*5_@F9_B%5BZ2MG+-CIF<U
M[R4,;201>Z]U]!?;_1764'R W#\L-LQ49WWV7TSLGJ?<>;Q;1U%/E\+LO)9+
M,X&H,T9*S-2MG,FL<JEA)#.@U%8XP/=>ZKK_ .%!%!0UO\F?^8+'64=)5QIT
MA+7I'54Z5"B?'Y;%RP3 ."!+!+'&\;_J1D5E(*@CW7NM9+_A#'_W5$_\LF_^
M:Y[]U[JRK_A9-WAN'K;^5AL_JS 24\=+\B?D[USLG>@G69F?"[&Q^8W=XX3'
M)'&LO\?P>WWO+Y%\:2!8C(4FA]U[H1/^$Y6W,;D_^$Y6SL75K,]'NS:WS4I\
MNJRZ"4K=S[PH)!&P%TO!$MCR0US_ (>_=>ZUU?\ A&#\G,MUI\I?F?T5D#65
M&P]Z?%N?O^JC_B$ABI\GT%F:&B41T@BE425V-W;7>2=65O\ )((VCFU(8?=>
MZ1__  DS[%W)W[_/%^0_>?8$T-1OOL[X]?)GN#=,] )8H'S/8N]MI5V2=%GE
MJ)_"T^3JB@DJ)'%UUR.P+'W7NL7_  I[[;SGQ6_X4!]*_)/80K/[W]6]9_%7
MNFE@@RKXLU59L#.95UI/N$CE,%/6TV+BIYAX9%9))-<<BNR-[KW7TX<=7T^4
MQ]!DZ0LU+D:.EKZ9G70QCK$61"5/T.EA<?CW[KW4ME5E*L RL"K*PN"#]01^
M0??NO=?-V_X6Z45''\N?A7D(Z2FCKZOXY[SI:NM2!$FECH=RRM#')(!K=(6G
MF**6(0R.5 UM?W7NMXO^4[_VZR_EI_\ B@'PW_\ ?=;<]^Z]T?\ ]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U5;_W4&_\ )B_^5OVH_P!#_P!7KTSY_GT-
MWP!_YDYN7_Q)F9_]U6&]UGX_EU=.'1Y/;/5^O>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z3&X=U[
M.P%=M+;VZ=P;?Q&1[*W!6[)V1ALWD8*.7.9.FP^5SU1B\=!,RM7UB8'!YJOD
MIXE=Q14-74,OAIY67W7NM!7_ (4%_P#">7J/*_);XO5/\N78N-ZY[T^:>[>]
ML3DNE6ST.VMD5-?TOLC-;_K*K"0&CF;!9;-TF)JJ2.F2IBP[57VMHL<DE55'
MW7NO?\)#OG_\HL-\D.X_Y5??E=NW.;'V%UUO3>/7V WU73SY+8&;ZFS./P^;
MVM315(::FQ-4,C,ST9E$5!64-J>%?O*D^_=>ZVC?Y_W_ &YJ_F#_ /B!<A_[
MLL=[]U[K6'_X0Q_]U1/_ "R;_P":Y[]U[H]'_"U#8.Y=Q?RX_C_OC#XZHKL'
MUW\M]NONVH@0.*.GW7M?<M%2U4QU K"U>*>GOI(\M1$I(U"_NO=&,_X3KYJD
MV_\ \)P-BY^L6::DP&R/FUEJZ*D"R2F/&;LWM4.B*SHID:-?2&=021<@&_OW
M7NM73_A'?TSN[L;YP?+K=>&BC3;^WO@EV3U[D:^47"Y7MS/;<BP].;E54318
MC*REBXXIR+>HLONO=9_^$=F S.T/YPG<&U-S8ZIPFY-M_$+O+;N=PU>GAGI:
M["[QV-3U=+*E^)H)H94=?P5/]/?NO=)S_A69@<QV_P#SO-J=5;)Q\]=O'/\
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MM=?]+6?_ +1+'JL3WBIUEUU9W_*?_P"RB=Y_^(6W%_[O-N>\J_N@?\K+<_\
M2LF_[2K+K$7[Z'_*K6O_ $M8/^T2^ZOJWC_QZ.Z?_#<S?_N-+[Z.]<R>J#/^
M$U?_ &0MVO\ ^+9;Z_\ >/V)[N_'KW6PM[IU[HA?\M)E?XD8)E8,K=X?,-E9
M3<$'N+?I!!'U!][/7NCZ>]=>ZI&_F,_RBD^3&_Z;Y2_&#L.;H/Y;8)**K_O%
M1Y"KP=!G:C"Q)!15%378Z]?A\O!31K M?3QRB2)4BJ(&L)DL&ICKW1-_C_\
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M@#@!T7[_ &?3Y;_\_DRO_H.X7_ZV>XV_X(GG+_HY/_V3VG_;/U)G_ W<D_\
M1KC_ .<]W_UOZ]_L^GRW_P"?R97_ -!W"_\ UL]^_P"")YR_Z.3_ /9/:?\
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M7_1R?_LGM/\ MGZ]_P #=R3_ -&N/_G/=_\ 6_KW^SZ?+?\ Y_)E?_0=PO\
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M/>WE_P!MMBGL=VFDCFDOY9U5()) 8VM[6,&J*175$V..*^?1'_\ AM?Y8?\
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MJB"Y)L%'))]^Z]U+]^Z]U'GI*6J,!J::GJ32U"5=,9X5F\<L0(61-0.B10S
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M'X   ]A&YN9+R1I9G:1V)9G=BS,3YDL22?F3T+[:VCLXUBA5410%5$4*J@<
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MU=M_+:[&WUV=T;NO/=@[KS>\,S2=L9W$4V3SU:U?,E+3X?!3) KOR(UEJ)G
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M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U5;_W4&_\
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M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=;!O\ *?\
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MGL?#/5YJ/<DZ/F:.IIZJ5SC_ !5:B@A2&" +''I.NO=$S_E1=M]G;ISOS/\
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M>7QHVX_R#_EL][?(GL?NCKC;^Z.R/D#F\CT779O*9/=V/-6V2V_F,AVY29O
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MJ212?KBJ,=>ZLZI:6FHJ:GHZ.G@I*.D@BI:2DI8E@CBC@4)'''&@"HB* %4
M    6]ZZ]UG]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U5;
M_P!U!O\ R8O_ )6_:C_0_P#5Z],^?Y]#=\ ?^9.;E_\ $F9G_P!U6&]UGX_E
MU=.'1Y/;/5^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NJ+_YN'_'\].?^&GN;_W,@]X$_?*_W,VS_FC<_P#'XNNB/W)?^2?N
MG_/1;_\ 5I^JA_>%O6;_ %[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6P;_ "G_
M /LG;>?_ (FG<7_NCVY[Z._= _Y5JY_Z6<W_ &BV77,G[Z'_ "M-K_TJH/\
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M=>Z][]U[KWOW7NO>_=>ZVW_C;_V3MT)_XA;JW_W1T/OL?[8?\JUM/_2LL/\
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M3^0=;_)=^8OR8Z.^3>U-W4WQ3^0?8F8[>Z;[<V[@9\Y2TLN1DE>-3'%=ZJ]
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M?\R_\HVV?\X;K_MMZ]_P%_*W_*5NO_.>T_[8>O?\.P?(G_GC.EO_ $'<Y_\
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M;K_MMZ]_P%_*W_*5NO\ SGM/^V'KW_#L'R)_YXSI;_T'<Y_]D?OW_!?\R_\
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M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=;;_ ,;?^R=NA/\
MQ"W5O_NCH??8_P!L/^5:VG_I66'_ &BQ=<3?=;_E:=X_Z6NX?]I<W0T^QST
M>O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[JJW_ +J#?^3%_P#*W[4?Z'_J]>F?/\^AN^ /_,G-R_\ B3,S_P"Z
MK#>ZS\?RZNG#H\GMGJ_7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW1&/YCW_ &21V#_VM=C?^[JA]P+]YC_E3;W_ $]I_P!I<'61'W5_^5VLO^:=
MW_VB3=:SWOECUUHZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JUW^4M_P S=[._
M\1Q#_P"[.D]YB?<Y_P"2KN'_ #R1_P#5X=88_?5_Y(EA_P ]Q_[1Y.KZ_?03
MKF[U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW5%_\W#_ (_GIS_PT]S?^YD'O G[Y7^YFV?\
MT;G_ (_%UT1^Y+_R3]T_YZ+?_JT_50_O"WK-_KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NM@W^4_\ ]D[;S_\ $T[B_P#='MSWT=^Z!_RK5S_TLYO^T6RZYD_?
M0_Y6FU_Z54'_ &EWW5G?O*OK$7KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NM5WYL_\ 957=
M?_AV+_[B4OODO[^_\KAN?_-9/^K$778W[OO_ "IFU?\ /.?^KLG16?</]3'U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6V_P#&W_LG;H3_ ,0MU;_[HZ'WV/\
M;#_E6MI_Z5EA_P!HL77$WW6_Y6G>/^EKN'_:7-T-/L<] 'KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZJM_P"Z
M@W_DQ?\ RM^U'^A_ZO7IGS_/H;O@#_S)S<O_ (DS,_\ NJPWNL_'\NKIPZ/)
M[9ZOU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T1C^8]_P!DD=@_
M]K78W_NZH?<"_>8_Y4V]_P!/:?\ :7!UD1]U?_E=K+_FG=_]HDW6L][Y8]=:
M.O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZM=_E+?\ ,W>SO_$<0_\ NSI/>8GW
M.?\ DJ[A_P \D?\ U>'6&/WU?^2)8?\ /<?^T>3J^OWT$ZYN]>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U1?_-P_P"/YZ<_\-/<W_N9![P)^^5_N9MG_-&Y_P"/Q==$?N2_
M\D_=/^>BW_ZM/U4/[PMZS?Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K8-_E/_
M /9.V\__ !-.XO\ W1[<]]'?N@?\JU<_]+.;_M%LNN9/WT/^5IM?^E5!_P!I
M=]U9W[RKZQ%Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K5=^;/_ &55W7_X=B_^XE+[Y+^_
MO_*X;G_S63_JQ%UV-^[[_P J9M7_ #SG_J[)T5GW#_4Q]>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]UMO\ QM_[)VZ$_P#$+=6_^Z.A]]C_ &P_Y5K:?^E98?\
M:+%UQ-]UO^5IWC_I:[A_VES=#3['/0!Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJK?\ NH-_Y,7_ ,K?M1_H
M?^KUZ9\_SZ&[X _\R<W+_P"),S/_ +JL-[K/Q_+JZ<.CR>V>K]>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=$8_F/?\ 9)'8/_:UV-_[NJ'W OWF
M/^5-O?\ 3VG_ &EP=9$?=7_Y7:R_YIW?_:)-UK/>^6/76CKWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NK7?Y2W_ #-WL[_Q'$/_ +LZ3WF)]SG_ )*NX?\ /)'_
M -7AUAC]]7_DB6'_ #W'_M'DZOK]]!.N;O7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=47_S
M</\ C^>G/_#3W-_[F0>\"?OE?[F;9_S1N?\ C\771'[DO_)/W3_GHM_^K3]5
M#^\+>LW^O>_=>Z][]U[KWOW7NBM]V=^;FV5DJC:?6&P<IV#NK'T<5?N"HI<3
M69:BQ:52%X4JEH5\K32)ID*F6(+&RMK):RY">U'LW8<U6Z[ES!N$6W6DKM';
M*TT$,]VR'2QC,YTA0:H"%<EPPH M3CK[N>]&X<I3MMO+VVS;E>1H)+EDAGFM
M[17&I!(+<:B["CZ2R (5.HZL!GT/\PJWL#=U)L;L# 8K"Y7,2RTV&RN"$]/
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M=>]^Z]U[W[KW7O?NO=>]^Z]UJN_-G_LJKNO_ ,.Q?_<2E]\E_?W_ )7#<_\
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M;:DJ(J EI9G57N)W-9)6+-EG=JG)I4*, #H1597565@RL RLIN"#R""/J#[
MS*5-#@C!!X@]#E6#"HR#D$>?7?O76^O>_=>Z][]U[KWOW7NM@W^4_P#]D[;S
M_P#$T[B_]T>W/?1W[H'_ "K5S_TLYO\ M%LNN9/WT/\ E:;7_I50?]I=]U9W
M[RKZQ%Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[K7E^5,<?^S#=J_MISN9B?2/J8(23_L3[
MY?>]D:GFK<<#^V7R_P"%1]1#ON[74%Y*B32JH;"K(X P. !IT7[QQ_\ '-/^
M21[BWPU]!^P=%/[\O?\ E(G_ .<LG_077O''_P <T_Y)'OWAKZ#]@Z]^_+W_
M )2)_P#G+)_T%U[QQ_\ '-/^21[]X:^@_8.O?OR]_P"4B?\ YRR?]!=>\<?_
M !S3_DD>_>&OH/V#KW[\O?\ E(G_ .<LG_077O''_P <T_Y)'OWAKZ#]@Z]^
M_+W_ )2)_P#G+)_T%U[QQ_\ '-/^21[]X:^@_8.O?OR]_P"4B?\ YRR?]!=>
M\<?_ !S3_DD>_>&OH/V#KW[\O?\ E(G_ .<LG_077O''_P <T_Y)'OWAKZ#]
M@Z]^_+W_ )2)_P#G+)_T%U[QQ_\ '-/^21[]X:^@_8.O?OR]_P"4B?\ YRR?
M]!=>\<?_ !S3_DD>_>&OH/V#KW[\O?\ E(G_ .<LG_077O''_P <T_Y)'OWA
MKZ#]@Z]^_+W_ )2)_P#G+)_T%U[QQ_\ '-/^21[]X:^@_8.O?OR]_P"4B?\
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M?J+"&*&68"<%KA_#1GH(@05K2A\1D(XA6ZQ[YB^\YRYM=[!MVWN=PGFGA@K
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M[KW7O?NO=47_ ,W#_C^>G/\ PT]S?^YD'O G[Y7^YFV?\T;G_C\771'[DO\
MR3]T_P">BW_ZM/U4/[PMZS?Z][]U[KWOW7NO>_=>Z*MO[XC[$[+W3DMW[JW?
MV/593(NH$<.6QL4%/#%Q%34T;8E_%!$O"KJ+$EG=GD9W;(;D[[R>\<B;?%MF
MW6>V)%$.+0W1DD<Y9Y&%X-3L<DT &%4*H51CASK]V/9O<#<9=TW*]W1YI2,+
M-:B.)%PL<:FR;2BC@*DDU9BS,S%IVS\*.J-K;CP6YJ/,[\K:S;^7QV:HZ3)9
M3'RT[RXR5)HEF2+%PN\>M%U*)%N.+V/LRW[[U?,?,%C<6$D&WQI<0R0.\45R
MLBI*A1BA:[<!J,:$J:'-.BSE[[I/+7+E_;[A%/N,CVTT4Z)+-;&-GB<.H<):
M(Q74HJ PKPX=&6W)@<MGHC24>[,OMBCDB$=1)M^FI5K&)8ZM%55PU2PAELMT
M@61>6616TE8)V'>;;9F\66SANY U5%R\QA&!2L<+PER#GN<J< H16N0._;-<
M[ROA17DUHA%&-LL(F.<TDFCF"@C':@89*N#0AHV-U?LKKI*X[7Q IZ_*R&;,
MYRNJ9<KD*UV9G+U594/)/*2[,UM84$DA1?V9<W^X.[<\&,;A-JCA%(((T6*W
M@6@6D<485%P *T+4%">BOD_V\VGD42';H-,DQU3W$CO-<SM4M6265F=LDFE:
M DD ="![!?0UZ"_L'K?_ $BY#:<.8S 39N RRYW,;27'&096IHQ>C6IJON%"
MTE/+ZV@^V<3&P=@ +2#R5SW_ %'@O&M8*WMQ#]/#>&6GTD3_ -J4C\,UD=>T
M2>(I0<!QK'O.W(?]>I[-+J>EC;3"XGLA$3]9+'F(22>**11MW&/PV$AIJ- .
MA0    %@. !Q]/<?$UZD("G1=LG\?J2FWYN/L38&XALO/;QPF2P.YH9\(,]2
MRIF&CDJ*JFB%51/35SR0Q2!S+)%Y%+- ^IPTW[?[T23[/:[)O-K]=;V4\5Q:
MLL_T\J& ,J1NQAG$D05V73I5])H)!12(-O\ V3BM]ZNM]V6Y^AN;ZWEM[M6@
M%Q"ZS,K/)&HF@,<Q9%;5J=-0U-$VIJKKJ;J;:_3VUQMG;(J9EFJ6K\IE*]E>
MHJJAU5#)(45455155$50JJ/RQ9F!_N/[C[A[G;A]??Z5TJ(XHHP1'%&"305)
M))))9B:D^@  &'MI[:;=[6[=^[]OUL&<R2RR$&2:0@#4U     %4   >9))$
M_P!@#J0NO>_=>Z][]U[KWOW7NM@W^4__ -D[;S_\33N+_P!T>W/?1W[H'_*M
M7/\ TLYO^T6RZYD_?0_Y6FU_Z54'_:7?=6=^\J^L1>O>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>ZUZ/E3_V4+VK_ .'*?_<>#WS!]Z_^5IW'_FLO_5J/J$>8O]SIO]/_ )!T
M7[W%O1+U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6R+T9_S)/IW_Q%G7W_ +J:
M3WU>]NO^5>VO_I767_:-%U.^S_[B0?\ -&/_ (XO0I^QET8]>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW55O\
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MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:]'RI_[*%[5_P##E/\
M[CP>^8/O7_RM.X_\UE_ZM1]0CS%_N=-_I_\ (.B_>XMZ)>O>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>ZV1>C/\ F2?3O_B+.OO_ '4TGOJ][=?\J]M?_2NLO^T:
M+J=]G_W$@_YHQ_\ '%Z%/V,NC'KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZJM_P"Z@W_DQ?\ RM^U'^A_ZO7I
MGS_/H;O@#_S)S<O_ (DS,_\ NJPWNL_'\NKIPZ/)[9ZOU[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]T1C^8]_P!DD=@_]K78W_NZH?<"_>8_Y4V]
M_P!/:?\ :7!UD1]U?_E=K+_FG=_]HDW6L][Y8]=:.O>_=>Z][]U[KWOW7NN#
M&-CX7*,9$<^)K'4JV#>D_51J /%N1?Z^[J&7O%<$=PK@Y(SY'!I]A].J,5;M
M-,@X/F, X],BOV]5W_,SHS:5!M5NT]KXVBP&4QV0HJ3<-'CH$HZ>LARLOC6H
M,2*$%7'421W=0/(C,7U%$/O-G[KONYN5]N']7MPE>XBDC=[9Y69Y(7B744U,
M23&44T!KI8 +0,>L&OO7>SVV6>VGF/;XH[::*6-+E(E5(YTF?0'*J /%5V6K
M"FI2=52J]&R^/T>4BZ5ZT3,&4UHVGC&'F#!A ZEJ53J /II3"/I^/S]?>.7O
M0]O)S7NAM:>']7)\-*>(*"0X)&9 YZR7]DTN8^4MJ%U7Q/HH?BK4(16,&H!Q
M&5'1!/E!_P!E4[-_\IY_[G-[S)^[_P#].\O/^IC_ -6>L+/O#_\ 3R=O_P"I
M9_VDGJUSWSGZZ2=0JC&XZKFAJ:J@HJFHI[?;SU%*DSI8W]#,I9>>>".?:N"_
MGMD:..21%;XE5V56Q3(! ./7I+-8P7+*\D:,R_"S(K,OG@D$C\NBUY]5[V[*
M;9T>FHZKZMR=/5[T>S&/+YZ#U4^)O^B6EQX(DJ5N09"L;*?2PGG9B?9_8?WH
MW;N^[1,EB,:K/;VP]QZK)-\,1XA>X'XEZ@+>@/>/?_W4M&V?:)5>_.=%[N*]
MT=MZ-'!\<PR"Y"$<#T&'>N_MQY3Y"]5]/4>4KL-M*7);8R.X(,94O1OD#753
M%H)Y(F1S2B"$((PP4M([N'*QZ!_[0<G6.W\E;MS/)%'->"*[CMFE17%L(X0
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M8-_E/_\ 9.V\_P#Q-.XO_='MSWT=^Z!_RK5S_P!+.;_M%LNN9/WT/^5IM?\
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MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW55O\
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M7_LFOO\ O9=>_P!&N"_Y6\M_U/A_Z\>_?NB+U;]H_P"@>O?\G">=/^4+9?\
MLFOO^]EU[_1K@O\ E;RW_4^'_KQ[]^Z(O5OVC_H'KW_)PGG3_E"V7_LFOO\
MO9=>_P!&N"_Y6\M_U/A_Z\>_?NB+U;]H_P"@>O?\G">=/^4+9?\ LFOO^]EU
M[_1K@O\ E;RW_4^'_KQ[]^Z(O5OVC_H'KW_)PGG3_E"V7_LFOO\ O9=>_P!&
MN"_Y6\M_U/A_Z\>_?NB+U;]H_P"@>O?\G">=/^4+9?\ LFOO^]EU[_1K@O\
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MA\6NU-P5&[.S_C7T#V/NFJ2-*K<N_.G-N[OR$BQ*%425F0QU14N%55 !D-@
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M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW11_G'_V3?O+_ +66TO\ W:4GN$_O#?\
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M FP-[#VDMK26\)6%'<@5(12Q ]>T'IM4+\ 3]@KTT_WSV?\ \]9MK_S^TO\
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MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U0U\E_^9\=F_\
MAQO_ -:8O;XX=,'CT!GO?6NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZV#>E_^
M9.]3_P#B--B?^ZNE]L'CT^.'0E^]=;Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJK?^Z@W_DQ?_*W[4?Z'_J]
M>F?/\^AN^ /_ #)S<O\ XDS,_P#NJPWNL_'\NKIPZ/)[9ZOU[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T4?YQ_]DW[R_P"UEM+_ -VE)[A/[PW_
M "J=W_I[;_M)BZ#/-_\ N _VI_Q\=4/^^;?4.]>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U8E_+B_YF9OS_P ,5?\ W84OO*G[J7_)4O?^>5?^KR]#CD7_ '(D
M_P":?_/PZN&]YS]2AU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW51W\R/_C\.LO_  VLW_[E
M1^\)?O8?[F;?_P T9_\ C\?49\]_VL7^D;_#U6Q[Q)Z ?7O?NO=>]^Z]U[W[
MKW55'S![1[[W/O3&[*ZSZ/[#W%L+969I\GEZO)=6YG+XW/Y'&D/ &B6E1:O%
M8^<*\8+F*IJ$$I62&.%GRY]E^5.7MJL7OMTW2SAN[J,I&J7]M'-:0OALER4F
MD6H;&J-"5JKE@!YR[86D,1EGGC61U( $J*T:GCYX8C'J :8)-$%B.X?G?V=G
M-N=?[HZWW9M/:>Z]QX+![JSE/U'D]O"#%U]3%%7F6MJ862E@^T:7R.I1PEPC
MJ3[$%YR7[?\ *UO-N-I>V]Q<6\,LL$1W"";5.B,T=(T8%VU@:0:BO$$=*I-L
MVJQ1IHY5=T5F13*C58 TP*5-> ZN4]X3=1ST1CH7#9C?GR5^0'>6?Q.2H,;B
MIJ/J?KC^+4$M"7H<25-;54Z2*H:"IDIZ>:.4%BPJ95N@NAGWW"OH>7^5]HV&
MVD1WD#;A>^&RM262NA&()HRAV5EQ30ISQZ$^ZRK:V4%JA!)K+)0@]QX T\P"
M01\AQX]'G]P%T&.BY_(7LK/;:QF#ZYZY,53V_P!K5<^WMF0^2W\/@"DY#/5%
MKE*;%T^J0$CU2Z JOI=?<E^V_*]ONDLNY[G5=NL%$UR:?VS5_3MU]6E:@(\E
MK4BH/1OM-DD[---B&(:G_I'\*#YL<?97H2>JNML%U+L3!;%V_P"::EQ-.S5N
M2JSKJ*ZLJV,M775+_5YZJ=G=C>RW"+954 ,<W<SW'..X2[A<4#2&BHN$BC4:
M4C4>2HH 'KQ.2>D=]>ON$K2OQ/ #@H& !\@,=5C]6X2L^,OR1^03]G1_P3:N
M]-H;TRVR]W59,-'DWJ\C'6TF/I92OCER<\+S+]L)/-YH2B1R>2-CE1S9?)[I
M\L;0-J/BSVUQ;1W-NN9( L)B>1Q6JQ*P4^(1HTM4L-+ #:_E&]V5N(.YT9%=
M!DK1:%C_ $109X4/$4/0L?RX.F]X=<[)WSN_>.+K\!-V'7;=3#X7*4S4=0*/
M;*5I2KDA<"2,54F0D"*ZABD0D T2*2$/O-<ZV7,M]:V5E(DHLUF,DL;!D\2<
MQ50,*@Z!""2"15J<5-$/.>YQWLJ1Q$,(PU6!J*M3'Y:1^WY=61^\8N@9U[W[
MKW7O?NO=>]^Z]U<__+I_YDGNC_Q*>;_]U.#]Y]?=8_Y5ZX_Z6,O_ &C6G4J\
MC?[B/_S6;_CD?1^?>2W0SZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JAKY+_P#,^.S?_#C?
M_K3%[?'#I@\>@,][ZUU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6P;TO\ \R=Z
MG_\ $:;$_P#=72^V#QZ?'#H2_>NM]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW55O_ '4&_P#)B_\ E;]J/]#_
M -7KTSY_GT-WP!_YDYN7_P 29F?_ '58;W6?C^75TX='D]L]7Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z*/\ ./\ [)OWE_VLMI?^[2D]PG]X
M;_E4[O\ T]M_VDQ=!GF__<!_M3_CXZH?]\V^H=Z][]U[KWOW7NO>_=>Z;<QF
M,3M_%UV;SV3H,-A\9325F1RN4JXZ"G@BB%VDFFE98XT7\EF ]J;*RFW&5(+=
M'ED=@J1QJ7=V/ *J@DGY =7CC:5@J@DDT  J2?D!T VU_EM\=-Y;F@V?M[M/
M!UF?JJE**CI:FCKL3%/-(=*14]764L%'422-946.H8NQ"H&8@&0MU]G>9MDM
M3>W-A*L*KJ9E:*1D49)9(Y'=0!DEE  R:#HUGY?O+:/Q'B8+Q)J"0/F 21^8
MZ,62 "2; <DGCZ>XT KT3]%IRGS$^-&&W&VU*_MK )EXZDTDK4])75]&D@9E
M*R9.GI)<;'I92&+58"_VB+CW*-I[+<T7MK]9'M\QC*ZAJ:))"* XB>1934'%
M$SY='4?+E[*GB")J<>*@_P"\DAOY=&-HJVCR-'2Y#'U=-7T%=3PU=%744ZU4
M,T50H>.6*5"R21R(0RLK$,"""0?<9SP/:NT<BLCJ2K*P*LK T((-""#@@Y!Z
M)F4H2"""#0@X((Z!_<?R'Z<VKF,]@<QO%!D=J0TU1NP8O!9/<,&)2KD2&,Y6
MKQ]%54F-U22*MJF>(CFX !(&FV>VV];O!%<06W9<%A;^)+!"]P54L?!2:6-Y
M: $_IJW\QT8P[1<3JKJF'KHJRJ7IGM#$%OR!Z%G%97&9W&T68PN1HLMB<E3Q
MU>/R6.JDK8)XIA=9(I8RR.C#Z$,1[!UW:2V$K0SHT<B$JZ.I5U8<000"#\CT
M7NC1$JP((P010@])G??8NS>M,519G>N8_A%#DLQC]OXT18ZJS$]36Y5BE/2T
MU)0P5-7432D&RQP,0 6-E!/LUY?Y:O>:9F@L8_$9(WF>KQQHD48JSL\KHBJ/
M5F'IQZ?M;.2]8K&*D L<@ *,DDL0 /M/2V!N >>>>1;V1''2;KWOW7NO>_=>
MZ][]U[KWOW7NK$OY<7_,S-^?^&*O_NPI?>5/W4O^2I>_\\J_]7EZ''(O^Y$G
M_-/_ )^'5PWO.?J4.O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZJ._F1_P#'X=9?^&UF_P#W
M*C]X2_>P_P!S-O\ ^:,__'X^HSY[_M8O](W^'JMCWB3T ^O>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>ZN?_ )=/_,D]T?\ B4\W_P"ZG!^\^ONL?\J]<?\ 2QE_
M[1K3J5>1O]Q'_P":S?\ '(^C\^\ENAGU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5#7R7_Y
MGQV;_P"'&_\ UIB]OCATP>/0&>]]:Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MK8-Z7_YD[U/_ .(TV)_[JZ7VP>/3XX="7[UUOKWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZJM_[J#?^3%_\K?M
M1_H?^KUZ9\_SZ&[X _\ ,G-R_P#B3,S_ .ZK#>ZS\?RZNG#H\GMGJ_7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW11_G'_V3?O+_ +66TO\ W:4G
MN$_O#?\ *IW?^GMO^TF+H,\W_P"X#_:G_'QU0_[YM]0[U[W[KW7O?NO=>]^Z
M]T%W8?4^W>U*C"TF^#-F=GX9IZZ39+,]/1UM<2GV]5D#'(CU4=$@E\5.W[)D
MD:659&2'QBOEOF^YY265["D5S)1!=8,D45#J2/4"$+FFIQWT4*I4%M2VSOWL
M=1B[7.-?XE7S ]*^9XXH*9K41\TOCEM/"=Q]6[1Z&VW]EN[?^/KYJ[9V$G<Q
M0MCYHDI:](V9C112(M696#+"HI7ETJPD9LRO8[W,O+[9+Z]Y@FU6]HZ!;F4#
M4P=6+QDT&L@E-(RQ,@6I&D"0^6=ZDDMI9+MJI&11VXFH-1\SPIYYIZ=6\[PV
M)E]Y]<1=?U>Y:O%G+8_$X7=^>Q<A6KFHXT09*.DD=3XYLBB/ 964F..9Y I=
M54X:[+S!#LFYG<4@63PWDEMXI!^FLI),1< Y$9(?2#W,H%:$GJ/+>Z6VF\4*
M#0ED4\ ?PU^0XT\Z4X=5K?,GX9]-];=+Y+L?K;%UNULKM"KP,>1I9,[69F+(
MP9FLIZ!M:UT]0T53'+4Q2 Q/''H613&;J4R?]D_>[>^9]\3;-TD6>.X64HPB
MCB:%HHWEQX2("I"%2&!-2I#<01MRWS+<WMR(9B&#AJ'2H*D*6_"!C%,U^WH>
MO@+5[VE^*<DM9))52TV:WK#U\'8RM]G3(@BC_<.FRY85ZJ =(4*O%B!'OWAH
M;%.;@$ 4-':F\X >(Q-3CUA\,D\2:GHHYM6(7]%QVIXG^F/V?T:=$I^+4D5=
M\:_F_69-VJMPU6U8JG,3US-+.Y>BS4D3S>2Y\AJC4M<^HO<GD#W.?NRIM^:.
M5TB&F%;@K&%H$%);92!3RT:!3A2E.A-ORZ+VR"X4-1:</B3A^5.CG?RW\AG!
M\<JV7<4[0X/&[YW*FVZBND\21X^*GHY:AE=B$6F2O>N-[V#B6]@![A'[S=O;
MGF91;"LKVL'CA14F8O(JU SJ,8CQZ:?7H-\YH@O>SB4753^*I _.E/Y=+/K*
M&;Y&=L3=[Y:*1NK.N:K)[;Z+QD]S%D*R-F@R>Z7C8 &[H8*,D'2%+V26(,Q)
MS2X]M-G'+\)'U]ZJ3[JXIJAB(#16@(^1UR^M:5*M0)+T_NB#Z5?[62C3GS4<
M5C_RM^SAT=/W!O0<Z][]U[KWOW7NO>_=>Z][]U[JQ+^7%_S,S?G_ (8J_P#N
MPI?>5/W4O^2I>_\ /*O_ %>7H<<B_P"Y$G_-/_GX=7#>\Y^I0Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[JH[^9'_Q^'67_ (;6;_\ <J/WA+][#_<S;_\ FC/_ ,?CZC/G
MO^UB_P!(W^'JMCWB3T ^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZN?_ET_P#,
MD]T?^)3S?_NIP?O/K[K'_*O7'_2QE_[1K3J5>1O]Q'_YK-_QR/H_/O);H9]>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U0U\E_\ F?'9O_AQO_UIB]OCATP>/0&>]]:Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[K8-Z7_ .9.]3_^(TV)_P"ZNE]L'CT^.'0E
M^]=;Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NJK?^Z@W_ ),7_P K?M1_H?\ J]>F?/\ /H;O@#_S)S<O_B3,
MS_[JL-[K/Q_+JZ<.CR>V>K]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=%'^<?\ V3?O+_M9;2_]VE)[A/[PW_*IW?\ I[;_ +28N@SS?_N _P!J
M?\?'5#_OFWU#O7O?NO=>]^Z]U[W[KW6*HA%1!-3L\T0GADA,M/*8)%$H*ZD=
M;,CB]PP-P;$>[QOX;!J T(-"*@T-<@\1ZCK8-#7JCSYM?&?<_3^6H>\MI;YW
MGN'&5>:I:?(97<&>GR&9Q%=(7>CEBR(*3/1DIXXG++)!((T+R>12N>7L5[I6
MO.<+;!>6MM"ZQ,4CAB1+:XB  <&+*A\U8"JNI)H-)K)_+&]Q[@IM)$130T"J
M CKY@KPKYGR(KPIU;!\=MYYSL'H_K+>.Y=3Y[-[6H9LK4/$(3/-3EH&J2@55
M7[KQ>:RJ%]?I&FWO$+W*V2WY<WZ^LK7$44[",5KI4T8)4DGLU:<FN,YZ &[V
MRVEU+&GPJY ^0XT_+AT7_P"2V.R_R*W/B/C3LNHFI\)B\GB=T]X;O@C62'%T
MD2F;'XM6:Z29.M+"H6'ZHJ02L#$9-,B^UUQ#[:VDG-%\ 9722#:[<DAIY#VR
M2FF1$E-!;@274=P6IOLLB[.AO9/B(*P)YNW M_I1PKYY''HX6TMO[;V7@L1L
M;;$%+C\7M;#8VAH<3#*'DAI5#Q022"_D)G:"8F1A>619&)9@Y]POO&XW6^7$
ME_=EGDGD=GD(H&?#,!Y=H9>T?"I44 IT';B5[EC*]26))/J>)_P\/+'029OX
MQ=19O([VR'\&RF&7LJ&E@[#QNV]P5F!I,R*2;SHU73T\J(LAD+EY(?"\GDEU
MLWEDU#"Q]U-YL8[6/Q8Y?HBQLWFACEDMM2Z3H9U)(I2@?4%TK0#2M#"/>KB(
M(-0/A5,9958I44P2/Y&HP/0=!9VY"NZ,CMKX@=1QIM;#SX:EK^T\IM^!8(L%
MM6(Z1CXB 5CR&<:\:*UW,3/+(KI(S 6\FO\ NJ*?G/>3X\@D9+".8DM=7YSX
MA\S'!\1(QJ 4$%0.EVWGP0VX7'<0Q$0;)DE]?L3B?G0=,G;W?-3U1V7TK\7^
MG,+A,76YZ;:>,K\E74IJJ?#XBLJ11PQ4=/Y(Q-5BGAGE+2N5550:)7F+1+^3
M?;Y.;]KW/FO>I99%B%PZ(C:7N+A4\1B[:6TIJ95 4 DDY4+1G=OVH7\$U]<,
MQ"ZB #EWI7)S05(X?RIEQZP^2N?D^2>^?C3V%_#<CD,7/5R['W9CZ+^%RU<=
M-1QY(TM=3K(\)J10O)()85B0^%P8AJ%DO-?M?;KRQ:\T;;K1'"BZMW;Q%C+2
M&'7&Q ;3X@ TL6/<.XT/5+W9%%DE[#4 _&A-:'45J#Z5Q0UX\>CO>X(Z#/7O
M?NO=>]^Z]U[W[KW5B7\N+_F9F_/_  Q5_P#=A2^\J?NI?\E2]_YY5_ZO+T..
M1?\ <B3_ )I_\_#JX;WG/U*'7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5'?S(_^/PZR_\
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M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JY_\
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MBZ_Z6D__ &B675;_ +!/66G5D'\K[_F?N[__ !#^?_\ =UM_V-N0_P#<Q_\
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M/_C\.LO_  VLW_[E1^\)?O8?[F;?_P T9_\ C\?49\]_VL7^D;_#U6Q[Q)Z
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MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U8E_+B_YF9OS_PQ5_\ =A2^\J?NI?\
M)4O?^>5?^KR]#CD7_<B3_FG_ ,_#JX;WG/U*'7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5
M5_S"H(9=W]=-)#%(1MO+ %XPYM]TG'(]E&Y\L;;OY5K^TMKDI4(9X(IBH-"0
MID1J TS3CTANK.&Z(,J(]!C4JM3]H/5>?VE+_P JU/\ ]25_XI[*_P#6XY>_
MZ->W?]D5M_UJZ2_NFU_WS%_SC3_-U[[2E_Y5J?\ ZDK_ ,4]^_UN.7O^C7MW
M_9%;?]:NO?NFU_WS%_SC3_-U[[2E_P"5:G_ZDK_Q3W[_ %N.7O\ HU[=_P!D
M5M_UJZ]^Z;7_ 'S%_P XT_S=>^TI?^5:G_ZDK_Q3W[_6XY>_Z->W?]D5M_UJ
MZ]^Z;7_?,7_.-/\ -U[[2E_Y5J?_ *DK_P 4]^_UN.7O^C7MW_9%;?\ 6KKW
M[IM?]\Q?\XT_S=>^TI?^5:G_ .I*_P#%/?O];CE[_HU[=_V16W_6KKW[IM?]
M\Q?\XT_S=>^TI?\ E6I_^I*_\4]^_P!;CE[_ *->W?\ 9%;?]:NO?NFU_P!\
MQ?\ .-/\W7OM*7_E6I_^I*_\4]^_UN.7O^C7MW_9%;?]:NO?NFU_WS%_SC3_
M #=>^TI?^5:G_P"I*_\ %/?O];CE[_HU[=_V16W_ %JZ]^Z;7_?,7_.-/\W7
MOM*7_E6I_P#J2O\ Q3W[_6XY>_Z->W?]D5M_UJZ]^Z;7_?,7_.-/\W7OM*7_
M )5J?_J2O_%/?O\ 6XY>_P"C7MW_ &16W_6KKW[IM?\ ?,7_ #C3_-U[[2E_
MY5J?_J2O_%/?O];CE[_HU[=_V16W_6KKW[IM?]\Q?\XT_P W7OM*7_E6I_\
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MVG54-=@<948:KQ]5D:J//2&IGRT63:3QPQ B")8QH<#U[K8AZSVGNO96TZ7
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M .MG7O\ @,^5_P#E*W3_ )SVG_;#U[_2-F_^57%?]2)O^O\ []_K@7G\$/\
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M]?J]^KU[H?J6EIJ*FIZ.CIX*2CI((J6DI*6)8(XHX%"1QQQH J(B@!5
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MI0P1!B6;3'& -3L2S,;LS$LQ+$GW[K73_P"_=>Z][]U[KWOW7NO>_=>ZMW^
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M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW55O_ '4&_P#)B_\
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MLGDZ#"XVOR^5JX:#&8NCJ<AD*VI?QQPPT:&261S^%1%)/^ ]AB.-IF"*"22
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M[QW_ (F_:>O?NFU_WS%_SC3_ #=>^ZJ?^5B?_J:W_%??O'?^)OVGKW[IM?\
M?,7_ #C3_-U[[JI_Y6)_^IK?\5]^\=_XF_:>O?NFU_WS%_SC3_-U[[JI_P"5
MB?\ ZFM_Q7W[QW_B;]IZ]^Z;7_?,7_.-/\W7ONJG_E8G_P"IK?\ %??O'?\
MB;]IZ]^Z;7_?,7_.-/\ -U[[JI_Y6)_^IK?\5]^\=_XF_:>O?NFU_P!\Q?\
M.-/\W7ONJG_E8G_ZFM_Q7W[QW_B;]IZ]^Z;7_?,7_.-/\W7ONJG_ )6)_P#J
M:W_%??O'?^)OVGKW[IM?]\Q?\XT_S=>^ZJ?^5B?_ *FM_P 5]^\=_P")OVGK
MW[IM?]\Q?\XT_P W7ONJG_E8G_ZFM_Q7W[QW_B;]IZ]^Z;7_ 'S%_P XT_S=
M>^ZJ?^5B?_J:W_%??O'?^)OVGKW[IM?]\Q?\XT_S=>^ZJ?\ E8G_ .IK?\5]
M^\=_XF_:>O?NFU_WS%_SC3_-U[[JI_Y6)_\ J:W_ !7W[QW_ (F_:>O?NFU_
MWS%_SC3_ #=7N?RP)'DZ#W<TCNY';^? +L6-OX+M_CGW*_(KE[1R23^LW'/X
M(^N;OWPK>.VYFMEC54'[LA-%4**_57HK0 9QU8[[&G6*/7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=:ROS%_P"RF^XO_#J/_N-3^X+YE_W.F_T_^0==@?8/_E3MK_YY_P#K
M))T6GV1]2_U[W[KW7O?NO=>]^Z]U75_,;_YEYU__ .'G5?\ N#-['_M]_N1+
M_P T_P#GX=8;??/_ .2-8?\ /:W_ %8DZ-%\9G1^@NJ&1E=1L[&H2K!A>,,K
M#C\JP((_!!!Y]AKF(4OI_P#FHW^'J=_9%@W*6U$&O^)1#'J!0_L..A.I=Y[0
MKMPUVTJ+=&WJO=.,C67([<I\Q3S5T"NH<&6E60SH-!5C=!8,I-@PN6M9RI&)
M2CA#P<J=)^PTIT.(.9-NNKQ]OCNK=[J( R6ZS1F= 17NC#:A@@Y' @^8ZK_^
M;W0.VJS%;<WSLK!TF-WMF-X8?:-1C\5#'1KE7W")5@+1+I1JQ)D7UJNIXV<R
M%A&I4=\F;[(C/!,Q,:QLX+5.C10G/I3R]:4X]8C?>B]H[*\M[?==L@2.^ENX
M;1DB"H+HW&I4JHH#(& [@*E2VJH4$6,X^">FQ]#354WW-53T=-!4U'_'22)%
M5W^@_4P)^@^ON/Y"&8D8!)H/EUF7:1M#$B.=3*BAF_B8  G\SGH*>ZNR:KKS
M;%/#MZC_ (QV!O"O3;'7V 0"1JC(UPL)I%/TI*)#YIW-D55"LRZP?9GL^W"_
MD)D.F*,:Y6]$'E]K< /7H ^YG.C\GV*K9IXU_=R"UV^ 9,EP_!F'^^XAWR,<
M!10D5!Z0-5MJL^/GQWW[7X6M.3WW3[<W#NS<.[*B(2S5V<R$3//D) P;6L,K
M Q(]P(XU5K^HE<MR-^W")7%(RZ1J@X+&#0*/RX_,]!.?99/:'DZ_EM7\6^6V
MN+NXNF%7GOG0L\S5K4*WP@U 55!KDD@&(QM-5?![?.]*LRUF[)NWJ/.-N.KD
M-16BI6HQE-Y5JFO.'T2S$MY-1>1VOZC['DLA7>HX1A! 5T#"Z:.:4X>0_8.L
M1MOLDF]K+[=)"SW;;LEP;AR6F$HEMHM0D/?6C,:UK5F-<]64?&7>&=WYT5U[
MN?<LLE1FZS&U]%6U<W+S_P #KJJ@CJ)";%I)XJ9)'8CU,Q;D&YCKF.T2QO98
MH\*"" . U*&I^1-.LU?8_F.[YLY5V^^OB6G>)T=V^*3P)I8 YX5+K&&)\R2?
MGT._LDZE;KWOW7NO>_=>Z][]U[K:@^/7_,@NCO\ Q#_6G_NEHO<_;-_N'!_S
M1B_XXO7%OW3_ .5GWC_I:;A_VES=#![,N@'U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=56_\ =0;_ ,F+_P"5
MOVH_T/\ U>O3/G^?0W? '_F3FY?_ !)F9_\ =5AO=9^/Y=73AT>3VSU?KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[HE?\P;_LEC??\ VM-E_P#N
MXHO87YQ_Y)\GVI_Q\=9"?=<_Y72S_P":=W_VBS=:Z?N%^NKG7O?NO=>]^Z]U
M[W[KW7O?NO=4\_$S_LK_ 'S_ .5+_P#=@ON6.:?^21%_S9_XX>N<OW??^GC7
M_P#U,_\ M)'5GW;'6U!VWL?)[#RN7R^%Q>8FH'KZG"-$D[ICYDJ%BO-'*@1I
M8XRWHN0+?0GW&^U[BVU3+.JJS+6@:M,BE<$>1ZSG]P.2H?<+:Y=IN)IH8IC&
M9&@*"0K&ZR!:NKBA917&0*>?5<O8W\N[+8S&563ZTWD=PU5+ TJ[<W#1)CII
MO&+E8*R)_ 97YTI)!$M[ RCZ^Y"V[G]9&"W,>D$_&A) ^U3FGV$_9UACSG]S
M>>R@:?8[PW#JM1;7*+&[T'!94.G4?(,BBO%QQZ%_X(=I;PW+B-Z=;;UFR%;7
M=?38\XRJRSR2U<4-8]1!-05#2^L?9S4X$8=BRJ[1\)$@!3SOMD-L\=Q#0"4&
MH6FDD4(84]0<_97SZD;[J7/FY;Y;WNR[HTCR;>T?AO,6,JHYD1HG+9_2:/MJ
M:@,5P$ Z&"7XJ;/HV[)I-H[@S^S-O]LTE)2;RV]B8:.HATTLDLE\>U13R/1>
M1:BI0K^[&JS.$1 L80H',\S^"9561H"3&S:@<@#NH16E ?(XR>-9&D]A-MMO
MWE'M\]Q9P;LB)>6\0A9**S-^B9(V,6H2.I'<H#D*JT72R]@4L&S,!M'XO]'P
MQX/<.[Z&HCJJZ+5.V&P(8C*9JJD!#M5U+,\<+,P:29VTLC+'[>L6-Y))N5[W
M)&10'_1)/PH/D.)] .BWFV!.6K2TY&Y7 @N+N-@SK5C96 -)[IR,F1R2J$D%
MI&-""!UDW5VGMCX_9#J7X^==;:CRVX<]+A<1CJ*>J-+3T%)DJK[<Y"NDCC>2
M>>HG^XF=552VF661TN@DU;;9+ORSW]P^E5U,32I9@M=*U. !0?L \Z6W_GVQ
M]HIMIY/V:V$MQ<&&*-"VB."&27PS-*54L[NVMR  6H[LR]H92=>_(*/<';6\
M.D-VXJDPN]=L2328VMQM4]1192GABBG+1),BS4U0*>9)#$6E&@.1*='*>_V$
MV]I'>Q,6C?B" &0U(S0T(J*5Q]G1WRC[O+N_,-YRON$2PWMJ28WC9FAN8PJ2
M54. R/H<,4)84J0YIT97V'>IJZ][]U[KWOW7NO>_=>ZL^_E:_P#,UNQO_$>Q
M_P#NRI/8\Y!_W(D_YI_\_#K#C[YW_)$L/^>X_P#5B7J\+W*G7.;KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NJ5?YJ'_ !^_4W_AJ[@_]RX?<7\__P!K#_I&_P (ZZ$_<L_Y
M)^Y_\]$'_5I^JJ?<?]9K]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U?!_*^_YD
M%N__ ,3!G_\ W2[?]RUR'_N&_P#S6;_CD?7-/[Y/_*SVO_2K@_[2[WJR#V-N
ML2^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>ZUE?F+_V4WW%_P"'4?\ W&I_<%\R_P"YTW^G
M_P @Z[ ^P?\ RIVU_P#//_UDDZ+3[(^I?Z][]U[KWOW7NO>_=>Z+OV_\<-O=
MW-CX]Z[X[#&,Q-145>-PN'J\/CZ:&2I4(S\X62>5M TJ99Y"H+:;:FN?[3S#
M)LM3#'%J84+,)"2!_P W !^0'4.^XWLO9^Z/AKN=[N'A1,SQPPO:1QJS"A.;
M-G8TP"S-0$TI4U775G5]'U-MRCVGAMU;MSNW\;'-%BZ#<\N.JOMEGE:5A'+2
M8VBG8:W>PDE=5#$*  +(MSW([I(971%8_$4UBN*9#.P_93H5<A\C1^W]DFWV
MUU=SV\0(B2Y-NWA@L6(5HK>%B*DT#%@ :#RH"/8?PXV'O;?<W9&)W-O'8NZZ
MNN3)U=9MJOB5#5(!_E4/DB,U/.Q%V*3A">0@)8DYL.;I[*#Z=DCD0"@#@_#Z
M&AH1]HZC#G#[M^T\T;L=[M[F\L;MW$CO;2* 90*:UU(61S3)5@#_  @DDC=M
M?K&FPM1BLGN/=&Y^P\]A$G7$9C=]33R_:&I3Q224U-24]+2I.\5T,[Q25.AG
M3S:9'5B6YW$S!EC1(E:FI8P>ZAKDL6-*YI4#AC ZE#8^24VUHIKVYN=PG@#>
M%-=M&?"++I)1(8XHPQ7M\0JTNDLNNC,")WLNZ&_02T?5HD[8R':VX\VN?K*;
M#Q8#8F'_ (6:&'!TTUS6NC&IG%565SD:ZCQ1,L=XE70; T;<Z6HM8UT@MJD:
MM3(?P^0H%\A4YSU']OR+KW^3?[V;QW6$6]C#X6A+*,YE()D?7+*?BDTH0O8!
MIZ$W)8ZAS&.K\3E*2"OQN3HZG'Y"BJ4$D<T%8C1RQ.IX9)$9E(_(/LNCD:%@
MZD@@@@CB",@]#>]LXMQA>WG17CE1HY$855T<%64CS!!(/1/U^'>+IMJ9KK'&
M;\R=!U1N#>,6],CMS^#1U.3$\*PHM-#EWJ?&M%IIZ?TR8R6;5$K>?EPPL/-K
MM*MRT8,ZQ^&'U42F<E /BR># 9X=8ZK]W&W@V^;8H+Z6/:KB\%[+;>"K7/B*
M$ 1;@R4$5(TPT#R54'Q.-3:;>P&)VK@L1MO T<>/PV#Q]+C,91QDL(X:- B+
M<DLS6%RQ)9C=F)))]A6>=KEVD<U9B6)]2<]9!;/M-OL-K%96B".&"-8HD'!4
M0!0,Y/#).2<G/3S[:Z,>O>_=>Z][]U[KWOW7NMJ#X]?\R"Z._P#$/]:?^Z6B
M]S]LW^X<'_-&+_CB]<6_=/\ Y6?>/^EIN'_:7-T,'LRZ ?7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= +VE\B-E=2;@H]M[DQ>Z:VNK</
M3YN*7"45)4Q"*IGJ(%5FGKJ9Q('II"0(R+%?422!B/[]_?-Y7^[MO$.R;W:[
MI///9QWR/8P6DD0BDGN( "9[ZV;7JMG) 0KI*D,22!*G(WM#N7/]H]Y9RVR(
MDS0D3/*K:E2-R0$AD%*2#SK6N.!(;?[.UU5_SS_8/_GJQO\ ]=O<(_\ )TCV
M_P#^C?S#_P!DFV_][;H9_P# T;[_ +_L/^<MQ_VR]"3U;\B-E=M[@K-M[;Q>
MZ:*NHL/49N67-T5)31&*FGIX&56@KJES(7J8R 8P+!O4" #-WL)]\WE?[Q.\
M3;)LEKND$\%G)?.]]!:1Q&*.>W@(!@OKEM>JY0@% ND,2P( (,YY]H=RY M$
MO+R6V='F6$"%Y6;4R2."0\,8I2,^=:TQQ(%+=^U8=WX:HQ,F:W/MZ9XYOM,Q
MM/<%3M^KIY9$9%F1X'6*8QZM2QU$4T)8 M$UA[RXZBOK7C_DQ]@?(OYU].]N
M[Y[T^6'R#;-[+[+HMIX4;/S>"V]"*6?%TU8WEC;;]29)3-,WJU@:;"WY-G%.
MO=6@=G?&[O?;E1U=O#I_Y5?(G,UFU.[.G,GO[8F],U@=PXW/;1?<V*BW512K
M%MZDJX)HL"]?/&\-2I?QM"5+2I)%H=>ZL$]ZZ]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=!;W=U@G=/4/9'4LF[-S[%3L/9^;VFV\-F5HQ
MV4QW\8A:+[JCE((62/5R.-2ZDU+JU#W7NF+XW=,'X\=&];]+-OO=O9C=?8#^
M"OOG?-8U=D\@SSS5#23NSR%(XC,8J>+RN(*>.*$.PC#'W7NAO]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW58W\U?\ TU;.^+&ZNU/CCVKOOK3N+![RZ>V]MY,'GXAC
MLDW8VZ\+M1:*LHLG#68^!"^;27SPQT\@DB4R2M'K1]CKW0=_R:_F;O7Y4_'C
M<VS^[LO69'Y(?'S?&7V'VP<TE/19"ICKJFJGQ5?54E.(Q RK'5XY_P!A T^.
ME;DL?>V%.O=6YUU=1XRBK,ED*F&CH,?2U%=75E0XBCBAI$,DLDC'A4C169B>
M  3[KU[K6*^*WR[^4WRT_FJ9#96Y^VNPMA?&/=VPMQ=Y=9=2X">GV^:S:/VL
M%/M*>KJ$HURE$<]02T6:G2*M28&H$?DC#-&MR*#KW6SO24L=%24M'"U0\-)3
MPTL3U=7+D)2M.H13+/.\D\\A &J221Y'-V=F8DFG7NI'OW7NO>_=>Z1'8FSZ
MW?FTLKM:AWMO#KZ?*4\T']YMB5E-CLE!Y(W13!45-+5^$J[))JC5)+HJB0(7
M5O=>ZJ)_D'[VWGV'\$JG=F_]W;GWSNG)]Y=E-DMR[PSU5N;(5!CAQ04SUE;+
M/4RD#@:I#8>[-QZ]U=;[KU[KWOW7NO>_=>Z+_1?(G9.8^3&4^,6"K*/+;TVK
MU++VKOLTM:)&Q,>1R=!08>BGC5&7[G(135M2RM*DD,,5.YC9*M'7W7NC >_=
M>ZJ[_F];U[#Z2^#O<O?W3O8^]^M^S>O9.L?X)E=NYQVI7BW'NW"86JAJ,95K
M4XV0/292H(D%*LP=8SY2JZ3914]>Z;OA+UOV1WW\2_C_ -S;]^5_R?;>?9/6
MFWMV;D.&W=@<=2_=91"\GV\!VU(8H@?TJ9&('Y/O1Z]T/O7_ $OWCU=\G\5G
M'[_[=[9^/^Y.D]^XS,[0[.J\1E?X/N[&YG:LN&K:6JQV(QL[PY##MN%&29G$
M4D1LS">-(?=>Z.Q[UU[KWOW7NO>_=>Z][]U[H+>[NL$[IZA[(ZEDW9N?8J=A
M[/S>TVWALRM&.RF._C$+1?=4<I!"R1ZN1QJ74FI=6H>Z]TP_&_IG_9=NC.N.
MEY-^;L[+/7FW_P"#2;[WU6FMR5>6GFJ&EJ'9Y"D41F,4$7E<04T<4(=A&&/N
MO=0/CY\A]E?)'%]E;FZ[JJ3+;/V+VWNGJC%[EH*S[V#*R[,IL=]_6P,$5/MQ
MDJFLIX61Y(YHH$J4D*S!5]U[H?\ W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U5;_P!U!O\ R8O_ )6_:C_0_P#5Z],^?Y]#
M=\ ?^9.;E_\ $F9G_P!U6&]UGX_EU=.'1Y/;/5^O>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NB5_S!O^R6-]_P#:TV7_ .[BB]A?G'_DGR?:G_'Q
MUD)]US_E=+/_ )IW?_:+-UKI^X7ZZN=>]^Z]U[W[KW7O?NO=-69S-)@J)Z^M
MARM1#'>\>&P5;N&8_GTT]!3U-0W^PC/MV&$S-I&D?Z9E4?M8@?SZ0;CN,>UQ
M&6196 \H8)KA_P D@CD<_DO52/QVPV_=F_)/)[ZW#U;VIB=J;AJMZ1')576N
M:D,"9V5ZBF:5(:.1UNZQJQ"L%U$G@%A*>_RP7>W+!'-"SH(\":/)44-*L/GU
MSW]F]NW;EOG:;=;S:]TBM;EKT>*^VWAT"=S(A8+"Q&0 <&E<XR+)>Z-S]C[;
MZXR&X>IML0;JW7"]!-!A\A13S/\ ;3,#/(E$DE-4SU$:$6A#+)<DZ&*^-H\V
M>WM[BX$=TY1#6K CCY9(( ^?#_#UFI[E[WO6R[+)><OVRW5VIC*PR(Y/ADC6
M1&&C=G"\$!#5\B1I(0]2?*');QHUQ>^.I^Q]M;RA)BDIL3LK)9*BJ6!MJBE:
M(-1<WU+4NL<?YJ&YL:[KRVMH=4$\+Q^ID0,/M%<_[7)].H\]O/?.?F2,0;KM
M6XVMX,%8[*YD@D/JK%*Q?,2D*O\ OP]"'TQU;)LW)]C[\S%%!C]U=K[JGW'D
M,7!*M3_#Z1&E-'0O*K/'+4KYII:EXSXFFD*1ETB21D&[[G]6L,"$E($T \-3
M8JU,4& %!S05-"2.AA[;<B'EN?<=VN$6.ZW6Z-Q)$I#>!$"WAQ%@2&<:V>5E
M[2[%5U*JL1#[$WY@^L]G9O>>X)2M!AZ4R1TT9'EJJB4Z*>D@'.J>IF*(@MP3
MJ-E!(06%B^XS+#'Q8\?(#B2?D!D]##G'FNUY)VV;<KP_IPK4*/CED.$C0>;N
MQ"J/4U. >@XZ+V'G,329OLCL"._9_9L\&7W#"TGE7&4<0/\ #\+3_P"HBH8"
MHD )+3%M3.%4^S#>KU)2MO!_8PU5/Z;?B<_-CP^70,]K.5;K;XYMZW<?[L]R
M99K@5J+:$#]&U3T6)3W>KEB2: ]%@^1^R-P[;^2_47=S8^>MV'3Y/:..W)E:
M=&=,7_#*R03U%:45S#2K2S>42L EXW1F0Z"PEY>O8[C;9[*M)2'9%/XZJ*!?
M4U%*<<@BO4&>\_*][LO.^T<T>&TEBLEI%<RJ"1:^'*VIY: Z8Q&^O6>VJLI*
MU6L7K#9&4[!^9N\.ZL-%-)UUM^IKSC-SHA-'DYY\.N'$=!/PE5%>2>7RQ%X]
M*+=OW$O;<KU;'9X[-Z>*P&I/Q(!)XG</(X H:'/RZ3\C\K3\W^Y=YS/;!CMU
MNS^%<@?HW,C68LZ1-PD7N=]:$K11GN%;)O<>=9J=>]^Z]U[W[KW7O?NO=6??
MRM?^9K=C?^(]C_\ =E2>QYR#_N1)_P T_P#GX=8<??._Y(EA_P ]Q_ZL2]7A
M>Y4ZYS=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U2K_ #4/^/WZF_\ #5W!_P"Y</N+^?\
M^UA_TC?X1UT)^Y9_R3]S_P">B#_JT_55/N/^LU^O>_=>Z][]U[KWOW7N@.[M
M[9W%U7M7,[BP?6^:WE#AJ+[S(9)<E18F@I4)4:YC).:^<)KNPIZ&10 VN2.U
M_9ULVUQ[G*L;S+'J- *,S,?E0:1^;#Y ]1=[G^X%YR%837MKMTUX(4UR2"2&
M*")<9;4YE:E:D1Q.  =3+QZ#7XB]T;S[NP&^MQ[Q?'(]#NJ"@Q..Q5$*."E@
M>ECD\2$EYY;NQ):69VN>"%LH,.:]GAV62..&N8ZL6-23J(KZ#\@.@3]WCW,W
M+W1L[Z]W+PP4NQ'%'$FA(H_"1M(J69LFI+LQ]*#'0E=U]@[XVKC\=M[JG:+;
MT[*W*M6^)H)"L5)14M#H6?(UTLDL$,<2230QQK)41"21_P!1",I+]GL(;IC)
M=/X<*4U'\3,>"J ":X)- : ?,=#;W-YNW7888[/8+0WNY7.LQ1F@BAB2@>:5
MF:-0H9U50SIK9N-%(ZKIJOE9\I>F=_PXON6CBKJ5WAJJS;&0PF-H U'/(P:3
M'5^,C19"H#JDAJ*B,.NEPS!O<@+ROMF\0:K,T/ .&<]U/Q*YQ]E ?3K#2?W]
MY\]M-W6#F9 Z$AWMGAMD!A9C4P2VR@,1D*Q>1:BC5->K'.T>Z,/L#IJK[=H(
M!FJ.IPN'R.VJ4MXEJGW*(OL=;+?3$1.DDA!OXU;3=K>X]VW9WO[P6C'20S!S
MZ:*ZOSQ0?/K,_GOW+MN4>6GYBB7QD:&&2V6M!*USH\*I%:+WAF(SI!IFG1.,
MO\A>Y]C].=4=Z9;<=)N [YW5EZ+.;%J<)CZ+'QT6NK^U6BGIJ:/(Q2K#1,Y>
M:NG]<H#(0A4BZ'8+.]O)[)$*^&BE9 S%RW;74"2I%6\E&!\^L<-R]X>9>5N6
MMJYJN;A+CZZZE2>Q:&!+=829?#$31QK,K!8":O+)EZ%2%IU8OMK/X_=>W<#N
M?%.SXS<6&QF<Q[N-+&'*PI/%J'X;1(+C\&X]Q_<0-:R-$WQ(Q4_:IH?\'69.
MR[M#O]G!?6YK%<0QSQD\2DJ!UK\Z,*CH#MC;[W9VGVGN/);;RK8_IC87W6UP
MT=#2U']X\V+BIEBJ9(9)X\?C 0JM!+&)I=)UR(713J]L8MLM461:W$M'XD>%
M'Y8! U-\ZT'D#U%W*W-6X<][]<3V4ICV:PU6N(XF_>-[_HC*[(SB&#@#&RZW
MSJ9:J#&>P_U,G7O?NO=>]^Z]U[W[KW7O?NO=7P?ROO\ F06[_P#Q,&?_ /=+
MM_W+7(?^X;_\UF_XY'US3^^3_P K/:_]*N#_ +2[WJR#V-NL2^O>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>ZUE?F+_V4WW%_X=1_]QJ?W!?,O^YTW^G_ ,@Z[ ^P?_*G;7_S
MS_\ 623HM/LCZE_KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NMJ#X]?\R"Z._\
M$/\ 6G_NEHO<_;-_N'!_S1B_XXO7%OW3_P"5GWC_ *6FX?\ :7-T,'LRZ ?7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5=?-K_F:NW_\
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MW7O?NO=56_\ =0;_ ,F+_P"5OVH_T/\ U>O3/G^?0W? '_F3FY?_ !)F9_\
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MWR+PN1W+M_'YA>X\+E&Q-;F::EJ1356$IHHJ@P22+*())8)D631H9XW4$E6
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M)7L^+9_QJW%C>U=E;.QM9FNWNTL)15-5@:"2L@\>'V_09,B"FK,]7SS?>2+
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M1@>'&8Y);"GQU(JI%"K."X57E(LJQB_<N7-PO=,,<:I#'B-/$7\V:G%CQ/\
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M2_\ /21_^>D__5'OW_)QK;?^C)<_]ED7_6GKW]=A_OG_ *J?]"=>_P!"$O\
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MG9]7343Y&AK0BS054=725D&N18X@9XHHZE="%)E9%(.;??)H(A P61%8.BR
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M_!(<^?\ 1]W'_LH;KW[VNO\ ?TO^]M_GZ]_<_:G_ #SF$_\ /9#_ -&>_?\
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M'#$RT]341S,LDLL2*0EF=T079E!&^P>V',O-5J;[:]IW*\ME+!KBUL;J>$%
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M #IF_P#/E5_]?_?O^#^YY_WUM7_9+/\ ]M?7OZRWW^_3_O$7_0'7O]%VQ_\
MG3-_Y\JO_K_[]_P?W//^^MJ_[)9_^VOKW]9;[_?I_P!XB_Z Z]_HNV/_ ,Z9
MO_/E5_\ 7_W[_@_N>?\ ?6U?]DL__;7U[^LM]_OT_P"\1?\ 0'7O]%VQ_P#G
M3-_Y\JO_ *_^_?\ !_<\_P"^MJ_[)9_^VOKW]9;[_?I_WB+_ * Z]_HNV/\
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M<&B>YL9F@F:!F>$NH!.AG2-B,\2H^SHQV+>8N8;.&^@#".9!(@< -I/"H!8
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M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U2]\A_\
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MZ->O>_=>Z][]U[KWOW7NO>_=>ZO'ZE_YE5UG_P"(^V9_[K:;W]5WW=_^G?\
M+/\ XKVR_P#=MMNN8G/W_)=W+_GOO/\ M(DZ$'W,702Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJK?\ NH-_
MY,7_ ,K?M1_H?^KUZ9\_SZ&[X _\R<W+_P"),S/_ +JL-[K/Q_+JZ<.CR>V>
MK]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=%P^6/_,CMT?]1NW/
M_=A3>\+?[P;_ *=1N_\ S5VW_NYVG4Q^PO\ RL]M_I+C_M'DZJ&]_.#UT%Z]
M[]U[KWOW7NO>_=>Z][]U[K7+^$'_ &\8W3_VON\?^ME=[[^_?)_Z<1#_ ,\^
MP?\ 'K7K![VE_P"5WE_YJ7_^&3K8T]\ NLX>JC_YE'QZ[VWYLRO[ VSV5D]U
M[$V1/+NJOZB?%4N*%!#00R>;)T=32K')DI:.%Y69*D--'"96@D9KQ-U-_N^_
M?;DKD[=8MAOMIAL=RW!5LX][$\L_U<LCKIMY4F+"V$SJH4PD1/)H#HN&&-GO
MMR5O&\6K7MO=/-;P$RM9Z$3PU4&LBL@!D* FH>K!:E2>!$S^69W]OCNSI_<>
M+["RE3N'<'7&X*/"4^Y*Y_)4U=!DZ?RTJU<EKSU-.T4Z&9B7DC\9D+2!Y'CG
M^\2]D=F]H^:+.\V*%+6WW:WEF>UC&F&*Y@E"R-$O!$D$B-X:@*K!]("D*I_[
M"\Y7?->V2QWKF22VD6,2MEGC9:KJ/FRT(U')%*U-21)K/@UU_23=R4^P]W;O
MZYVWW[14M#V9M? )CZRGE6GFJ)6;&/64D\N-,RUE;&ZWEB"3NL4<8"!0)9??
M3WJY39)-\V^QW6\Y<=Y-IO;AKF*5&>../_&%@E1;C3X,3 TC<M&K.S'42>2^
MT=E&;U;.::VBW!0MU%&(V4@,Q_3+HQ2NMP1W"C&@&*)[M.FH^L=I]??"OXS0
M0[9WGV'05=&^1I&>IDVUMA&;^.[IKI5(E:NJ2TL5+(\D;35<A,4BR1(A/O;&
MXF]QMTW/W@]Q6:ZV_:I$=(F 1-TW;'T>W0(05$,7:\J@,$B5?$#*\C!%S"B;
M!;6W*NP 13W*LI85)M;7/C7#GCK:I5"2"SG!! '6/L3O79'Q%K^@/BGU+M"D
MS.ZMX5FV-KX#'5N1^PH\71YW()CURN5DABDJ*FHK:Z2HF94C4RLE3-)+&="R
M^Y"]F-V^]-%S)[F\UWTEO8V27=W<20Q"2>[EM;4W)MK99&5(XX(5CC4L6T@Q
M1JC=S)K>^;[3VU?;N7=MA#S3-%%&K-I2)))!'XDA +,SN68T J0[$C *SZJ^
M64.Y?D%V!\8NP,)CL!V1LZ26?!Y;!5TE5C<W2Q4L%:6BBG5:BAK%I)TF:G,E
M0H19;3GQ7<)^Z'W7?ZN\C;;[B[!<37.U7JH+F"ZC1+NPE>5X!J>(^'-$94,?
MB!8CJ*'PZ/VFG+GN.+_>KG8+V-8[J DQO&Q,4Z!5? 8:D;2P;35A2O=C)S?>
M(/4I=>]^Z]U[W[KW7O?NO='9^#__ !_&\?\ PU(O_<R'WU4_NJO^5BWS_I70
M?]I/6-'WF_\ DF6G_/4?^K3]67^^WG6%W7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5P?.3
M_CX]@_\ :DS'_6^+WQ9_O6_^2IR[_P \NX?]7;7K,?[L/^X=]_S6B_XXW1%O
M?)7K*'KWOW7NO>_=>Z][]U[HCWSTZLVQO#X[]L;GSE5NJ7([4V=79O TM'O+
M)XS'Q3XWQR*TN*IZJ+&5I<I8M54D[H&;Q-&3<9H_<B]S-QY8Y[V7:[-+)8;R
M\$%R[6-I+=2QRK(*"ZDB>XB"UPL,L:F@UJ_42>\7+UON>R7EQ,9BT,+/&!/*
ML:LM#F-7$;UIQ=6(SI(Z+)_)Y_YE#VO_ .)(I/\ W64WO(3^]8_Y638_^E;/
M_P!I3= +[LG_ "3;S_GI7_JTO3=_-Y[7S&!V1UQU)B*J>DHM]Y#+[CW287\8
MGI=JFE6CI'MR\4E74F9EX&NFB//T]KO[K/VSM=WW7=>:;I%>2PCAL[/4*F.6
M[$K32#T81QK&IXZ99!BN6/O+<QRV=I;;;&2%N&>66GXDBTA5/R+-J/S4=9_Y
MA^U!A_@WT4F+%)12;!W#U1'!/2AJ-HX8=NY"BTTFA;H3.U,]M2V5+ZM2@'7W
M%^96W3WGYF\<NZ[A;[TS*Y#AG_>UM*#)J.:)XB^?Q4I0DB_O7MWTW*.W^'I4
MV\EI0CMHOTTB=M.'<5/EP]>N7;O;^\^U?Y5M-O\ BK,C-G\EBMM;9WYD8@(Y
MYDP>>CP^1GF,5@$R#TR/+I&DQSLK*JEU%?:[VMVCVU^\I+LK1Q+;1O=7FV1'
M,:/<[>;V)$#5S )9%CKD&(%22%)WS+S-=<Q>W@O S&1DBBN&&&81W A<FGDY
M4%J>3$$ 5'13^^TQ<7\LOXCRXD0*$[!S#>6 DL*AWW,U;9CZ@WWBOK -@P '
M 6V37LL]Q)]X/G=;C4?]UMF*-P\,1;6(L</[,C3YT)]3U'/.0C7D/9C%3_<B
M3(_BK=:_^-5K\^KFL=VZ.H_BILOM3N2HGBS6'ZFV3D-RTLS!*RMS-9C:4?8H
MK#U9"MKG\>D A9&8GT*6');<?:H^ZON?N'+/*BCP)][W".W=16"WL8[N:LQ*
MF@@BB&I34%E"J.]@.LHX.9?ZM<NP;CNA(=+.!I0?C>9HD[!7\;.:4]2?(=,W
MQ<ZLW1A:/<W=G;4'_&;N[*BGSFYZ61FE&"Q4()Q&VJ37S%#CJ8IYP "]02)&
MD\*.3;[S'N9MN[RVG)O*S4Y>Y?5K>T9:#]XWAQ=7\FG#M-)J$;9 CJRZ?%90
ME]ON7KBU67==R'^/WQ$DH.?IXA_90+7@$6FKU;C72#T;/WBQU)'7O?NO=>]^
MZ]U[W[KW7O?NO=6B_"7_ )E5N#_Q(.5_]UN)]]ZO[K?_ *=_N'_BPW?_ ';=
MIZP>^\O_ ,EV#_G@B_[2+KHX?OI-UCQU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5+WR'_Y
MG3V%_P!KM?\ K1#[^97[['_3TN8/^>J'_M#MNND/M%_RK=A_S1_Y_?H&/>+/
M4C]>]^Z]U[W[KW7O?NO=5!_SAO\ F4/5'_B2*O\ ]UE3[ZJ_W4__ "LF^?\
M2M@_[2EZQG^\W_R3;/\ YZ6_ZM-T>+X9?]DJ]"_^(WV__P!:S[PY^][_ -/-
MYC_Z64W^!>I:]K?^5=V__GFC_P '7OF;_P!DJ]]?^(WW!_UK'OWW0O\ IYO+
MG_2RA_P-U[W2_P"5=W#_ )YI/\'1'?Y//_,H>U__ !)%)_[K*;WF-_>L?\K)
ML?\ TK9_^TINHE^[)_R3;S_GI7_JTO5KVYMK;:WIA*[;6[\!AMS[>R<:QY#"
M9_&PY:EF"$,OD@G1XV*, RDK=6 92" ??,;EOF?<>3KR/<=INI[.ZB-8[BVE
M>&5*BAH\94T(PPK1@2"""1UD9?[=!NL307,:2QN*,DBAT;[0P(^ST.1T"^[1
MTI\6]D[T[9CVG@MO&CPU#2UM5C*)!D\HU B4V)P\52^NIG+R"&"E@,ACBN"%
M5%)$R\L2\Y?><WFPY8DOKFZ#SR2(LK'Z2S5RTMS=M&FB-=*EY)9*!W/;J+,
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M,R'6HX+(CM&X%<TU(:5\J=#;[ASH5]>]^Z]U[W[KW7O?NO=7C]2_\RJZS_\
M$?;,_P#=;3>_JN^[O_T[_EG_ ,5[9?\ NVVW7,3G[_DN[E_SWWG_ &D2="#[
MF+H)=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW55O_ '4&_P#)B_\ E;]J/]#_ -7KTSY_GT-WP!_YDYN7_P 2
M9F?_ '58;W6?C^75TX='D]L]7Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z+A\L?^9';H_ZC=N?^["F]X6_W@W_ $ZC=_\ FKMO_=SM.IC]A?\
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MY_TLH?\  W0!]TO^5=W#_GFD_P '1'?Y//\ S*'M?_Q)%)_[K*;WF-_>L?\
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M>Z][]U[KWOW7NO>_=>ZI>^0__,Z>PO\ M=K_ -:(??S*_?8_Z>ES!_SU0_\
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MF&J>ACRNX-Y5]-B,'15%1&DCT]$V0K8'JY51GCI8YF0%PH/NO=:L7;O\YO\
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M\WL;;-;N^J_BN;R,60HL16TV/2>>@(O5PO53P+1D^"5ZF%6D5.FO._N_R_\
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M:+%T6T,(U,U!6Y0Q14=;F,CF**N;*Y168P4^,BH\;3>Z]UK'_P#"4_IOY#=
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M#Z]8_P!#_MO?O]9OF_\ Z,>\?]RR]_ZT=>_KGL__ "GV?_95!_T'UZQ_H?\
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MW[_6;YO_ .C'O'_<LO?^M'7OZY[/_P I]G_V50?]!]>L?Z'_ &WOW^LWS?\
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M_P FV?>[_IEKG_LMVK_MOZ]_P:'M?_TT%I_SCN_^V?KW^ESK?_GK<;_MI?\
MKW[]_P FV?>[_IEKG_LMVK_MOZ]_P:'M?_TT%I_SCN_^V?KW^ESK?_GK<;_M
MI?\ KW[]_P FV?>[_IEKG_LMVK_MOZ]_P:'M?_TT%I_SCN_^V?KW^ESK?_GK
M<;_MI?\ KW[]_P FV?>[_IEKG_LMVK_MOZ]_P:'M?_TT%I_SCN_^V?KW^ESK
M?_GK<;_MI?\ KW[]_P FV?>[_IEKG_LMVK_MOZ]_P:'M?_TT%I_SCN_^V?KW
M^ESK?_GK<;_MI?\ KW[]_P FV?>[_IEKG_LMVK_MOZ]_P:'M?_TT%I_SCN_^
MV?KW^ESK?_GK<;_MI?\ KW[]_P FV?>[_IEKG_LMVK_MOZ]_P:'M?_TT%I_S
MCN_^V?KW^ESK?_GK<;_MI?\ KW[]_P FV?>[_IEKG_LMVK_MOZ]_P:'M?_TT
M%I_SCN_^V?J_;JS/X6EZ/ZTW)5Y2BI, O5^R,H^7JZA:6!:>7%TKK,TDA4*A
M5E/-OJ!]??>CV>Y:ON3>4MDV?<XC!>6.T;;9W<!9&:&YM;*&"6,M&SJ2DB,I
M*LRFE5)%#UBAS'O5KS)N%UN-C();:ZN)[FWE6H66">5I8W&H @,C!A4 T.0#
MT53>OR,W]W'G:GK7XS8NKEC/[&9['J86HTAADNKRT[RJ!0PVU6GD7[AS<4T*
MR!&:2Q&%RW[.B(M7 ZD4_P 0.UG@A>L^46]8:MXD:IBIZ3)52+(P!=4E;/PM
M(H:X#&)"PY*K]![Q!_"/]7Y=>T=9O]D][-_[RFWW_P">W(?_ &2>_>(/X1_J
M_+KWA]&BZ?Z]S76>TGVYGM\93L&N?+5F2&>R\,L$H2J2)5@TS5E<^B,QL0?-
M;U&RCZEMCJ/"G5U%.A3]UZWT3?YT=#_(_P"170FYNM_B[\MMQ?#?L[*TM3%1
M=H[=Z^Q'8+LDJA31S19-!4T,4HU+]WCZJFK8"WDAEU*%/NO=: '\C/OW^8#_
M "D/YR.)_E0?(ROR;==]Q]I9S:/976=?7KN7%/G-W8DU^W^P]JY.6):HIEDI
M<>SR*\25E!52KD:-<E2Q"C]U[K>X_F3?RPOBU_-/Z/INDODU@LVJ;>RD^X.N
MNQ]D5T&&W)MG)54:Q356)K*FEK:;Q5<2)'54M11STU2B1F2+RPP2Q>Z]T%%'
M_+=^-W5GRRS_ /-2^4O9F:[E[YZIZ*QNR,!V=VG18;;.WMB;<Z\Q^0?)YK%X
MK&4-/%3YBO@K,K/7Y"HJ*@QBHJ(\=%0PRR1-[KW11OA]E\;\A>P.X_Y^/S">
M/8?0^QNI=^XW^7[MG=E)/3'9?2N&II,CN#LO(T4@9HMS]E14;54>B,U$&"6E
MI(V<5C1+[KW1>,7_ ,*,>Q-S_P OCMG^:WMSX?45-\0NK?E5A.AH-B[H[%EQ
MV_,WMK*5& Q\V\:6:EH*S;U'64N3SL=-_!WDFADEAG3^,H(EDE]U[K8Z^-WR
M#ZR^5W0W4WR/Z:S,F>ZP[FV1A-^;.R-13-0S_:YJ(.:>KIV]5/6T<PEIZF$D
MF*HBDC))6_OW7NAL]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=56_]U!O_ "8O_E;]J/\ 0_\ 5Z],^?Y]#=\ ?^9.
M;E_\29F?_=5AO=9^/Y=73AT>3VSU?KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[HAW\RG_LD+L+_ +6^Q/\ W=T/L?\ MC_R68?]++_U:?J$OO$?
M\JE>?Z:U_P"TJ'K6(]Y4]<U.O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z/_P#
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M>_=>ZU0OG!_V5AW?_P"'?_\ &E-[RYY"_P"2/:_\TS_Q]NN7GO?_ ,K7N/\
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M1YZY2BY[VR7;)W>-)3&2\8!8>'(L@IJ!&2@!^75=_P#PV#!_SN.Q/_/)3_\
M7OW)'^O%=?[XA_WI_P#/U /_  *.U_\ *9=_[S#_ - =>_X;!@_YW'8G_GDI
M_P#KW[]_KQ77^^(?]Z?_ #]>_P"!1VO_ )3+O_>8?^@.O?\ #8,'_.X[$_\
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M11H_B,K$N2*:01BA^?41>YGM%:>YTL$MS--"8%=5$00ZM94FNM3PTXIT5?\
MX;!@_P"=QV)_YY*?_KW[%O\ KQ77^^(?]Z?_ #]1A_P*.U_\IEW_ +S#_P!
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M@.O?\-@P?\[CL3_SR4__ %[]^_UXKK_?$/\ O3_Y^O?\"CM?_*9=_P"\P_\
M0'7O^&P8/^=QV)_YY*?_ *]^_?Z\5U_OB'_>G_S]>_X%':_^4R[_ -YA_P"@
M.O?\-@P?\[CL3_SR4_\ U[]^_P!>*Z_WQ#_O3_Y^O?\  H[7_P IEW_O,/\
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M:_\ E,N_]YA_Z Z]_P -@P?\[CL3_P \E/\ ]>_?O]>*Z_WQ#_O3_P"?KW_
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MZ]U6+_-Z@WEC?@?WWOW9';/:'6&<V+M&DRM"W7&Y$VK]VU1EL;!+'6U4%/\
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M][]U[KWOW7NO>_=>Z][]U[KWOW7NJK?^Z@W_ ),7_P K?M1_H?\ J]>F?/\
M/H;O@#_S)S<O_B3,S_[JL-[K/Q_+JZ<.CR>V>K]>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:[W\VW_LH[97_B$MN?\ N^W)[R1]
MGO\ DF2_\]3_ /5J'K #[U?_ "L-O_TKH?\ M)N^JN/<K]8S=6C_ ,I+_LH[
M>O\ XA+<?_N^VW[BCWA_Y)D7_/4G_5J;K)G[JG_*PW'_ $KIO^TFTZ'/_A0#
MGLYAOY<.]Z/#FJ6CW+V5U9@=R/3>0 4*Y'[\>4I8")JZAH5]?H+,J_J*^\<%
MX]9_]''_ )9./QV,_E]?#RFQD<,5-)T%U[D)5@"A349>BCJZMCH &MZN:9GX
MU%RVHEKDZ/'KW1Y)8HYHY(9HTEAE1XI8I4$BLL@LRLIN&5@2""+$>]=>ZU0O
M^$^V#?,9[^8OT8N8W7ANN8,YL&"BBVQN:OVU74,DM=NO'M+0Y:AGAR%#5U%%
M14\;3PU*3D0(RN&35[N_EU[H7OY1_P 7.O9^_?YD."QVZ.[]JX3I#YH9_:>R
ML/L?Y ;SV32S4.U,UN"&CCSM/B\W2P[D98J*%)'RB5;RH9%E+K+(&\Q_P=>Z
M%7Y.X_?V7_GS_&O$];Y_#[2W%D_@KE**3=F7QW\:;&4<^:["%964-"Z-35F4
MBAU"DCJC]HLS++4I411-2SZ\OSZ]TC_E)M/LG^7=\UO@OVEUW\FODAV=M?Y,
M=UTO3?>&P^[.R9=_4F0@SM?BJ5Z^DI1%0X^DEA@RL\E/##20Q4DU/3I2""F:
M6$^&>O=6'_.7Y15O77:_QL^,F"R796V9>_*[?.Y.Q]\=1];Y[M+<F+VCUI1+
M45=-@L9MK%9S+Q93/9">CHA7PXJ;^&T9K*L/3U"4TZ: KU[JM7YCYKL+IJNZ
MK[T_EI8K^8UN3M7"[[Q.,[5Z:W_TU\B-X[;W1MTT4S35N6C[&P,].U=#/0T-
M*TE-7153I635*?Y1&9Q8"O'_ "=>Z$G^=)OGO[:'1OQE[MZU[@[EZ[H^S.[.
MH]A[EZ @RU'L&B?^]N(R6;^TR-92X6EW+'4_<8DTM;#69.:E"NR_P]65P=+U
M[H^>POA)W)MWY<[=^6&Z/FAW/NFGJ-IYO&]B?'ZK9#LVIK<Q1/34]/A*6"6C
M@Q> Q$TBU%+!-C:O(2U$$514Y*266I\VJ]>ZL#W'FJ?;>WL]N*K1I*7 8;*9
MJIC3AFCQ4#SNHX/)6,@<'_6/O77NJ,?^$_\ 7[C["^/'R2^0V]T$N]>^OEOV
M%NS+Y+S_ ''W$<>,PT]U+2RRI%#DJ_*QQI(0RJH(!1E8V;'7NA5_G@97MW8'
MPGWSV]U1W]VQU)6[0K]E8>MVUU[78S TN6BWAFZ/&3O69),8=RTTT,-6?&*'
M.TM.P#+44\^H,GER>O="1\AF[5;^5C)V)UKW-V1U;OCKOX=4?:0SFR)\1]UD
MY=J[-AR<L-?6Y;&9&MAA<4\KO+CZNBKBYNE23Z&T./7NBP?#?XR=E?-C^7CT
M#D^Y?E=\A-J19C8N;J-N4_3V_9]K54E9-E,JO\<W7F*E*K,;IR;U#&04\E93
MX^*()&::>J0U[>.#U[H0/Y,/R<[%[%^&W9Y^0N]LAO'._&+MKL3K7)]AYNJE
MRE56839V-Q^4CJ:VKG8U5944OW5;%Y9096IXJ?R.\NL^]MU[I:?#(57\QSJ#
M*?*SO7,]AQ['[/WEV)BNC.H-I]CY_K'&[<VKM3*382"2N3;.7QQS>Y:JNQ57
M/-D:N68TK,(<<M+$)#+HBF.O="5_+RZJ^;7255W_ -:?*#>D78_4N [!/^RO
M;TSV]&WKN2;;TLU</!E:J16K'ABI%Q9C%;.U5%.U5$I>F$!3QZ]T3/X<?]OR
M/YFG_B,NL?\ W VE[V> Z]UGBS._>LOYZ'7/2&W.XN]Z[IK=7QDRW862ZNWG
MWCNOL#!KE&I<[2^>*ASF7R$:@?PRGF4-J\<YDDCT:@![R_/KW3W_ #.\AOGJ
MCY>_RRMT=;=Q=[;*@[D^7O7?7G:6R,#W;NBDVQF\6F?VR/MZK;7\4;#(CPU%
M5#,D%'%%513R)5QS^@IY?/KW1F?Y@7R=WWLC?GQA^('2&Y!LONGY=]A?W?E[
M$6E@K9=J[1VZT4NXLO015<%322YN6E>2+&K+"T8D6:1BCI$WO0'7NBN_S8_B
M!M;8_P  ^\=[=9]A=S[=W)M+:V'EW;-N/N?=/8=-NW&U&3QM/7T6XJ+/9;(T
M5542:DJ:>K2FCJ*:HB18)(J=Y8F\O'KW3O51]C8[^1SUCOSK'NGL;I?<O6/P
M?V]OVDR'7/\ "*>7(OM[:T-3'0UE5D,57Y"CIF,1_=Q=9CZQ7(85)13$^_/\
M^O=#E\!:/LSN?^5GT&U)W'V5M/LG='7&>KY.S\+68O<.?FK7RF7*F6KW3CLY
M32-42^,2RR0><+_FJB![2+H\>O=$2_E0;$[J^<_P>RU?WC\I>^,9MS+=R=B?
MQ2KZYWY48/=>;J_'C&+9C==6E;D(,32+HCI<9CA2QFSFKGJ:>1**#;8/7NAS
M_E!]C=LX#MWYZ?"SLOL[=W<6"^*?;.(H>K-\;[RDF>RYQ&Y*K.4[4=;6SL9G
M$4>+H)8XQJCBEFJDB*0"%!YO7KW2RZR[<W/\OOYEWRQZ,WWN#=F*Z.^)&U-I
M8C:75FW-Q5VS:/.9G=:!<CG-QR8YZ"OS,<*M-#1T-142XQ$:*K%.]4L=3[U2
M@Z]T6_+Q]];'_FQ/\'=@?+CY"==]$=H]/5W>6T,1B<IA^PJO;N0*59J,;35V
M]L+N>ICP;28?(/#2)+''3FIACA94C*/ORZ]UL6 $  DL0 "QM<V_)L +G_ >
MZ]>ZK5^:?R/WMA^^OB9\)^H-PU.R^Q?E-NC<F3W;V%044%?5X'9?6M%-E,X<
M8E1JBBS69IZ6JIJ.J:&5*,15$_C,RP>]@=>Z"3Y>?#7Y*;(_T-=H?RY-\;XQ
M/;NSM]8RC[(V_P!I?(+<^[</NG;D\+><YZ#=67R]+D9X*F& 22Z$K6@FF>"4
MSPTX7P^?7N@0_GDY_O[JSJ_H3LOK3O7L[;-%NWY#=<=4[EZ<VQN*AVG@Z_\
MC./RV4]>4HL/!N*1*FHPQ@G6JRL]&T,H(H%(8-M>O=&SI/Y?7:F6^2$7R#W[
M\W_D9E,/N?8>X=N=G=(;8W?D-BX)JO.T+TU.FU:[ 9##5FV\1A9W2IHU6GFR
M<E1!'/59.1YJL3ZKU[HF?\M3)]F=(_/GY;?#GY-]Y_(#MGL#;>.Q.^?CAG^V
MNZ]U;PH<MLR9YS431XVNR!P<V4%-6XEYI%HWD2:#(1TYB2DFU;.<]>Z.WV?L
MC+=\_/S;>UMI]N][=?[1^/W259O3NF@ZW[EW-M/%93<':59'2["QM5AZ>N&"
ME?%4>&W%E*E#1VJ1-00U\=92RM$NNO=5\="XSY==I?S"/YAWQ?J_F#VTNS-G
M8CK+'R=GU^5HY-RX?"[@@;)1TFTL=18K'[5PF:KOOUAJ,K#AXC310$P4LM3+
M#44FSP'7N@VW7)\DOY1'SJ^.&$?Y$=T?(OX?_+#=E-L+)8?NK<U3O?(8BNJ:
MZCHJJ85,G^309*DFS%)7QSTE/2')0+4TD].[4ZSC?Q#KW2]_FC?'S9$O\R3^
M6#N 9OM&FSO>7;'8> WAF<?VYN/&5-'1[1FVDV/I]MSTV2BDVJE.^7R#@XEJ
M1FDE:5RTGK]Z' ]>Z/;\Y^]<E_+Z^,FSMD])YC=NZ>X>[NU<+TSTSF^Y^P,U
MV[44&5W],[3Y?(Y/<=?D<E5TF)A#FG@EJ9(DGDIHS$:821^]#/7NEKV_\!:O
M.=19*7K#OOY#[;^4N%PKYG:O?DG=VY*FJR&?Q\?F2++86HRS[:.!R=4@BEQD
M>,BHJ6!]-)'"$%_#KW3)_*9^;>YOF_\ &)MU]DT$>-[BZQW?D.L>T5AH/X5'
M5UN,@IZJGR4=*%44IJZ6I19H0JB.JBJ B)'H'OQ%.O=$X_F@;UK>@_YF'\I[
MNO!DPU>]MV[XZ1W7]O4FF:IP>;RNV\94PU "!9X:6/=]74PQN[(:A%8")E$O
MO:BH/7NM@;W7KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=56_P#=0;_R8O\ Y6_:C_0_]7KTSY_GT-WP!_YDYN7_ ,29F?\ W58;W6?C
M^75TX='D]L]7Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NB&_.;Y%=]=2[;V[US\1NG)N\OD]V?%F)=G[>J
M9(J/$8/%8+PQU^Y,]5U-5CZ*"E@J:RBIJ6*HR-*M54S<2,L$L;;'7NM:;*_S
M<_YLOPB^1%!M;YOX*CSN'J9Z++YGJS<&Q=LX!),-75$BRU&V-P;6IX8JIXU6
M6*">3(Y*G$L7CJ [K(?=](/#KW6VGNSY(=6[/^-V0^5>3S+OU%1=44W<=/EZ
M9%EEJL1DL='DJ$4T8<K+4U\4]/'!&'M)+*B!O5?VWU[JE?J3YB?-7Y4?"_Y,
M_P P3:G<&(Z4QO3TO:V;ZP^/>$Z^V_O+!U^'Z?Q$.8JTW5ELOC)MQ5.0KHS4
MPJ^,RF,B1HTF$)$AA2U*&G7NCX_"'^9+UY\K/ASG_D_N/'_W-RG5%)G*#N[:
M>(AGROV62VQ11UTAQ$3 U-;3Y6EF@DH(E,DIEE^RURU$+LVB*=>ZI3^9_P X
MOYZO7E!4_(R/IVJ^+_QNBR,$F,P4.T]F]D55+0ULT4='_>[[T9K/8R>9BD<L
MCT>)B66;Q*J2&+W8 =>ZM_\ Y2G\Q2K_ )@O2.Y<IO7"X;;O<W4N9Q6WNR,?
MMP-#05<.X(IYL3F*2GEFGGI(Z]:2NB>%Y7"STLS1-XV5(],*=>ZZ_F4_S"NX
M/A%UCE=][#^*NY]^8.CRV/VW+VUO'<V(P>UZ*NS#2QTP;&4>4GW9D$,L:KJ;
M&8^C<R(L>09V"'0%>O=+7^4[\E^UOEQ\.=M]X=SY3%Y3?&Y-^=D4<[83"P8"
MDIZ7#Y2:"CI*>G@6_BIH%5%>626=P+RS2/=CYA0]>ZLH]ZZ]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=4N_/3Y+_S%L[N[='3/\M7H]]SS]<4T$7;G?&:7 I3T66KZ1*Q<!MN
M#=%;1XG*9&AHJJBGK&6#(%))TI?MDDCD+V%//KW5;7\M[^<W\IZ[Y58'XE?.
MJ.DS60WMO*;K.BW-D]E4'7&X,#NF>=J:AQF2HL;38S'S4U57!:'Q_P -CJHZ
MB6%_+(H>-MLOF.O=6J?S5_YC^4^$6W>M.O>I\1MW<?R([US#XK9%/NOS2XO#
M4,4\%)-FLC#3LDM1JJZF&"E@\B+(PGF9G2E:":H%>O= +\LOFWWU_*Z[L^,,
M'?/<==\F>B._Z?>5!V#6;@Z[V_LW-;9JMERX..MR6 .U,7BHZG&PKG()5H:Z
MEK:J2.*6):PRO'(FP-77NK.OE=\C-R=*]0X_<73/75?WOW%V3746V>C.M< Y
M:/,Y'*4LM=]Y65*,J4F#QN-@J*VKJ7EBB$4:PF>%YXY!7KW6K?WM_,Q_G<?"
MGMC;F8^4V!V[MW;FZ9I\CA>M,ML':F4VO7049A^ZHZ'<.V7JLD9Z=70NAW/+
M40>9'FC*-&I<"@\.O=;2G3WR_P"LNVOB%MKYD0"NQ'7F7ZVR78&8QT:C-5E%
M)MS[B#+8J)*<7KJZCR=%5T4:1J'J)T5$0.X04(IU[K73^9_SB_GJ]>4%3\C(
M^G:KXO\ QNBR,$F,P4.T]F]D55+0ULT4='_>[[T9K/8R>9BD<LCT>)B66;Q*
MJ2&+W8 =>ZM__E*?S%*O^8+TCN7*;UPN&V[W-U+F<5M[LC'[<#0T%7#N"*>;
M$YBDIY9IYZ2.O6DKHGA>5PL]+,T3>-E2/3"G7NK7/=>O=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U'J
MZNEH*6IKJVHAI*.BIYJNKJJB00QQ14ZEY)'=B%5$0$L2;  D^_=>ZU@?FC\U
M?YR^Y,1NCOKXI=)9[ICX@[8CK,OMK?$NT=J[OW/F\%0K(Z[DR. W",EF:'%U
MM+HK8Q#MR$4U+H>:ID422&Z@>?7NC5_R9_YJ6\?G52[[ZA[QH-OT_=_6^"I=
MX4>X=M4:X>GS^"DJ(:&IJIJ 2.E-7XZNJ:-)V@5*:1:N I%"RL'TRTZ]TK.V
MOGWV+V]_,9VU_+D^->[J#K*EP6.SF4[T[VAP-!NW,4E1@\1-EGPVV:',4E=@
MUJ(?\C@J:FMH*M5EFF1($:C/W'J8KU[J'\>OYAN_MC?S$^TOY:GR7W11]B9G
M&U>+?I/O ;=HMIY#*-E=MT.Z(\1N*AQ%/3845DF,K&\-5245%$U1 \!@+5,"
MQ^*XKU[H>/GM\D?F/M[*470W\OOI!.VN\ZK;]/N[?F],[-CL?@MH8K)2S0XU
M)*C,U^+Q%1G,P]'7-3TTU<3%!3F9J6=9XM.A3SZ]U0YT)_.B^>WQG^4E%TG_
M #$8HLYMQMT8G;78M)N?86#V#F]M09KQ+#F*"IV_28O&UM!"DL=4YEBJ8ZJD
MU-35":HY/=RH/#KW6U1\BNWMT]3;*ICUKUUD.WNX=YY([7ZKZVH*V/#Q5V2>
M"6IDJ<KDIK4V(P6,I8)JFNK)F5514IH?)655+!*WU[K6%^8GSK_G@_!+L':&
M_._*WJ$=:[SKY4P>V]F[)P^X=FS5-$3-/AI<@L$>[J.J%,NM1-F4:6+4]/+,
MT,YB< !Z]UM#?&;NRA^2'Q^Z?[WQV'GV]3=J;"V_O X&IG%4U%+E(5:HI?,%
M43+!4"5%DT+Y%4/I75I#9QU[H<O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=4*?S2>M.QMY?(
M#9^3VAL#>VZL;!T[M^@GR.V]JU^<@2>+-[AD:%YJ6"6-95CEB8H6U!75B+,"
M<@O:C=;6QVZ1)YHHV-RY"O(B$CPH16C$&E0<_+K!O[S'+.Y;UOT$MG:7,Z"P
MB0O#!+*H87%T2I*(P! 8&G&A!\^JV/\ 01WA_P ^:[6_]%WE_P#ZC]R=_6';
M_P#E)M_^<T?_ $%UCO\ U"WW_HW7_P#V1W'_ %KZLG_E;=:=C;-^0&\,GN_8
M&]MJXV?IW<%!!D=R;5K\' \\N;V](L*354$4;2M'%*P0-J*HS 64D1C[K[K:
MWVW1I!-%(PN4)5)$<@>%,*T4DTJ1GY]9$?=GY9W+9=^GEO+2Y@0V$J!YH)8E
M+&XM2%!=%!)"DTXT!/EU9[\W_C#BOF+\7.V_CYD:V#%5F]L!'+M;.5"NT=!F
M]O3Q9'#U<HCM(:>/(4L J%7U/3M+&/U6]X_ TZSDZ(/_ ">^\\EMKJC_ &0;
MY 0R=??*7XN/DMO2;&W+IQM1FMJU-7-4X?,X1G<)EZ"F@G6E>6F5@D4=+-)8
M5,;OMO7KW1YOFG\N-D_$KJ#.;FR%;'F>U=PX^LP'2'5&(B.9SNZ-S9-#!B<?
MC,33K+6U<9KI(/N)(Z=UABU$W<QQOH"O7NBG_P G+X,;H^%OQMR53VK"8N]N
M\L_3=@=G4TU1'7SXY((6CQ6&J*I"_P!S44*3U<]0WED5:NLJ41W50[[8UZ]T
M4/\ EG=Y]3=/?++^;EM#LK?&#V?O/-?-7>>Y=L;+S=3]CE\U39;<NXZ6C&"Q
MT@6JS5165-90Q0P4<<TTCU=(%3_*H#)YO+KW0@]N;@P<7_"A?XQT<N6Q\54?
MA%FMOBGDJD1S735G8%>E( 2":AZ)EF"?J,9# 6]^\OSZ]TT_SM*ZBI.Y/Y5A
MJJNEIA%\Q\!72FHJ$ATPTN5VQY9FU$:8H]0U.?2MQ<B_OR^?V=>Z]_-[W+O_
M .*'R9^#W\Q/;^U\QN_KCI?);QZN[@QN$GF$L6-["C,$?D4DT<:5=-591()9
MA'%_$(Z&*:0M+3Z/+G'7NCJ4'\VGX3;RVEALCU!VI3]N=C[S6EQO7G1VTL37
M'=F6S.35EI,2V+FI8Y,<3.--15U1BHJ:)7J):@0*)&U0]>Z)5_/OSKX'XD_$
MJ;?N5P=-N&B^8W2N=W0^+$D-,3@=L[K.7JJ.GD>6J^Q@GF6US(Z))$KLSL+[
M7S^SKW5_=+54U;34]91U$%71U<$5525=+*L\<L<ZAXY(Y$)5T=2"K D$$$&W
MNO7NFC=.#CW/MC<>VI9WIHMPX'+X.2IC 9HURU/)3EU!N"4$EQ?^GOW7NJ+/
M^$\_\=VS\5.]NF]X(M%O'IGY8]C;1S6&TH&HRF*P*2PNRV:1AE:?+#4P^BA0
M2%L+/QZ]T,G\^FIIX/Y9O<\4]1!#+6[JZ?IJ..658VED7=.*F,<0)!D<0Q2N
M56YT([6TJ2/)QZ]T+/<N8QM'_)X[&R,]9 *&J_ET;@H::J202(\N:ZYDI*55
M920WFJ)XD6QY+#WH<>O=2OY/U72U/\M;XHRT]33SQ0[#S%/++#,LJK)1YS*Q
MS(S*2%>*1&5U)NK A@""/?CQZ]U7K_(\V[CNSOBI\^=BPY2F%-OSY*=R;=^^
MI9UJ E/O';F.HXZI2A;5&RR.R,+A])TDV/O;>7V=>Z0'\H/YU]9?$G8._/Y?
M_P SMRXKX^]H?'WL+>46WZ[L&I_@.)KJ'/UTE=54R9&95IHZB#(U-34P/+)'
M%74-933T33*LI7;"N>O=7G] ?)G;'R>SV\=Q]-U(W+T1M".#;&.[0&)JJ.CW
M'N+S2-DTP$]2(?O<3@8(H()JR.!Z>JK*F2&GF;["8O3AU[JJ+X:5U%-_/+_F
M9)#5TLKR=:=>)&D=0CEFQ])M**H  )),$OHD _0WI:QX]V/ =>Z9ODAO#:W2
M/\^OXT]E=LY_%[ Z]WI\4\KL[ [XW15+A\2^4,VZH/LI<A/HI:>833TB'R2J
MJM54H8@SQW]Q'7ND=_-O^2?3>9[Y_ED;HVUO;";EV9U+\T-H[DWYV'ALC#5[
M:H5PV4VS755*^X%<XN6LHZ.)YZN.&HD-#$4:M^W\T(D\OG]G7NLG\U[=U1U!
M\L_Y=_\ ,DVU'!V-\>.O\M-LK?.[MD5(W)2TM%G*V4-5Q5-$[P3K78W(Y04;
M"8PS5-*L#L/-&'\N:CKW1M/YIOR8^/F_OY9??.1V1W+UUNV#LO8>+I]B1;=W
M32Y>HR<DF3Q]0R4])!(]47@ABE>H#0J:94<U'CT-;0X]>Z"W;7:/6^\?Y".Y
MJ+:F_-H;BK=E? 239^\*+#[AI:^;%96/:\E#_#<C%'*TE%7-6121)#,J2.P
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M<?SOZ+'])?RHY.IMEPRX[:M)F>A^H,724L@I5BQ6SYJ>HI(61 %:)8\'3)H
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M7KW63M#J#JGNS;8V=W#UQLCM#:BU]+E$V]OS;-'NJC6IHB3%4)!6PS1I,EV
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M7O\ 9I>^O^\4M]_^<&9_^LOOWAC^(?ZOSZ]J/IU[_9I>^O\ O%+??_G!F?\
MZR^_>&/XA_J_/KVH^G7O]FE[Z_[Q2WW_ .<&9_\ K+[]X8_B'^K\^O:CZ=>_
MV:7OK_O%+??_ )P9G_ZR^_>&/XA_J_/KVH^G7O\ 9I>^O^\4M]_^<&9_^LOO
MWAC^(?ZOSZ]J/IU[_9I>^O\ O%+??_G!F?\ ZR^_>&/XA_J_/KVH^G7O]FE[
MZ_[Q2WW_ .<&9_\ K+[]X8_B'^K\^O:CZ=>_V:7OK_O%+??_ )P9G_ZR^_>&
M/XA_J_/KVH^G7O\ 9I>^O^\4M]_^<&9_^LOOWAC^(?ZOSZ]J/IU[_9I>^O\
MO%+??_G!F?\ ZR^_>&/XA_J_/KVH^G7O]FE[Z_[Q2WW_ .<&9_\ K+[]X8_B
M'^K\^O:CZ=>_V:7OK_O%+??_ )P9G_ZR^_>&/XA_J_/KVH^G7O\ 9I>^O^\4
MM]_^<&9_^LOOWAC^(?ZOSZ]J/IU[_9I>^O\ O%+??_G!F?\ ZR^_>&/XA_J_
M/KVH^G7O]FE[Z_[Q2WW_ .<&9_\ K+[]X8_B'^K\^O:CZ=>_V:7OK_O%+??_
M )P9G_ZR^_>&/XA_J_/KVH^G7O\ 9I>^O^\4M]_^<&9_^LOOWAC^(?ZOSZ]J
M/IU[_9I>^O\ O%+??_G!F?\ ZR^_>&/XA_J_/KVH^G7O]FE[Z_[Q2WW_ .<&
M9_\ K+[]X8_B'^K\^O:CZ=>_V:7OK_O%+??_ )P9G_ZR^_>&/XA_J_/KVH^G
M7O\ 9I>^O^\4M]_^<&9_^LOOWAC^(?ZOSZ]J/IU[_9I>^O\ O%+??_G!F?\
MZR^_>&/XA_J_/KVH^G7O]FE[Z_[Q2WW_ .<&9_\ K+[]X8_B'^K\^O:CZ=>_
MV:7OK_O%+??_ )P9G_ZR^_>&/XA_J_/KVH^G7O\ 9I>^O^\4M]_^<&9_^LOO
MWAC^(?ZOSZ]J/IU[_9I>^O\ O%+??_G!F?\ ZR^_>&/XA_J_/KVH^G7O]FE[
MZ_[Q2WW_ .<&9_\ K+[]X8_B'^K\^O:CZ=>_V:7OK_O%+??_ )P9G_ZR^_>&
M/XA_J_/KVH^G7O\ 9I>^O^\4M]_^<&9_^LOOWAC^(?ZOSZ]J/IU[_9I>^O\
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M7O\ 9I>^O^\4M]_^<&9_^LOOWAC^(?ZOSZ]J/IU[_9I>^O\ O%+??_G!F?\
MZR^_>&/XA_J_/KVH^G7O]FE[Z_[Q2WW_ .<&9_\ K+[]X8_B'^K\^O:CZ=>_
MV:7OK_O%+??_ )P9G_ZR^_>&/XA_J_/KVH^G7O\ 9I>^O^\4M]_^<&9_^LOO
MWAC^(?ZOSZ]J/IU[_9I>^O\ O%+??_G!F?\ ZR^_>&/XA_J_/KVH^G7O]FE[
MZ_[Q2WW_ .<&9_\ K+[]X8_B'^K\^O:CZ=>_V:7OK_O%+??_ )P9G_ZR^_>&
M/XA_J_/KVH^G7O\ 9I>^O^\4M]_^<&9_^LOOWAC^(?ZOSZ]J/IU[_9I>^O\
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M7O\ 9I>^O^\4M]_^<&9_^LOOWAC^(?ZOSZ]J/IU[_9I>^O\ O%+??_G!F?\
MZR^_>&/XA_J_/KVH^G7O]FE[Z_[Q2WW_ .<&9_\ K+[]X8_B'^K\^O:CZ=>_
MV:7OK_O%+??_ )P9G_ZR^_>&/XA_J_/KVH^G7O\ 9I>^O^\4M]_^<&9_^LOO
MWAC^(?ZOSZ]J/IU[_9I>^O\ O%+??_G!F?\ ZR^_>&/XA_J_/KVH^G7O]FE[
MZ_[Q2WW_ .<&9_\ K+[]X8_B'^K\^O:CZ=>_V:7OK_O%+??_ )P9G_ZR^_>&
M/XA_J_/KVH^G7O\ 9I>^O^\4M]_^<&9_^LOOWAC^(?ZOSZ]J/IU[_9I>^O\
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M7O\ 9I>^O^\4M]_^<&9_^LOOWAC^(?ZOSZ]J/IU[_9I>^O\ O%+??_G!F?\
MZR^_>&/XA_J_/KVH^G7O]FE[Z_[Q2WW_ .<&9_\ K+[]X8_B'^K\^O:CZ=>_
MV:7OK_O%+??_ )P9G_ZR^_>&/XA_J_/KVH^G7O\ 9I>^O^\4M]_^<&9_^LOO
MWAC^(?ZOSZ]J/IU[_9I>^O\ O%+??_G!F?\ ZR^_>&/XA_J_/KVH^G7O]FE[
MZ_[Q2WW_ .<&9_\ K+[]X8_B'^K\^O:CZ=>_V:7OK_O%+??_ )P9G_ZR^_>&
M/XA_J_/KVH^G7O\ 9I>^O^\4M]_^<&9_^LOOWAC^(?ZOSZ]J/IU[_9I>^O\
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M7O\ 9I>^O^\4M]_^<&9_^LOOWAC^(?ZOSZ]J/IU[_9I>^O\ O%+??_G!F?\
MZR^_>&/XA_J_/KVH^G7O]FE[Z_[Q2WW_ .<&9_\ K+[]X8_B'^K\^O:CZ=>_
MV:7OK_O%+??_ )P9G_ZR^_>&/XA_J_/KVH^G7O\ 9I>^O^\4M]_^<&9_^LOO
MWAC^(?ZOSZ]J/IU[_9I>^O\ O%+??_G!F?\ ZR^_>&/XA_J_/KVH^G7O]FE[
MZ_[Q2WW_ .<&9_\ K+[]X8_B'^K\^O:CZ=>_V:7OK_O%+??_ )P9G_ZR^_>&
M/XA_J_/KVH^G7O\ 9I>^O^\4M]_^<&9_^LOOWAC^(?ZOSZ]J/IU[_9I>^O\
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M7O\ 9I>^O^\4M]_^<&9_^LOOWAC^(?ZOSZ]J/IU[_9I>^O\ O%+??_G!F?\
MZR^_>&/XA_J_/KVH^G7O]FE[Z_[Q2WW_ .<&9_\ K+[]X8_B'^K\^O:CZ=>_
MV:7OK_O%+??_ )P9G_ZR^_>&/XA_J_/KVH^G7O\ 9I>^O^\4M]_^<&9_^LOO
MWAC^(?ZOSZ]J/IU[_9I>^O\ O%+??_G!F?\ ZR^_>&/XA_J_/KVH^G7O]FE[
MZ_[Q2WW_ .<&9_\ K+[]X8_B'^K\^O:CZ=>_V:7OK_O%+??_ )P9G_ZR^_>&
M/XA_J_/KVH^G7O\ 9I>^O^\4M]_^<&9_^LOOWAC^(?ZOSZ]J/IU[_9I>^O\
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M7O\ 9I>^O^\4M]_^<&9_^LOOWAC^(?ZOSZ]J/IU[_9I>^O\ O%+??_G!F?\
MZR^_>&/XA_J_/KVH^G7O]FE[Z_[Q2WW_ .<&9_\ K+[]X8_B'^K\^O:CZ=>_
MV:7OK_O%+??_ )P9G_ZR^_>&/XA_J_/KVH^G7O\ 9I>^O^\4M]_^<&9_^LOO
MWAC^(?ZOSZ]J/IU[_9I>^O\ O%+??_G!F?\ ZR^_>&/XA_J_/KVH^G7O]FE[
MZ_[Q2WW_ .<&9_\ K+[]X8_B'^K\^O:CZ=>_V:7OK_O%+??_ )P9G_ZR^_>&
M/XA_J_/KVH^G7O\ 9I>^O^\4M]_^<&9_^LOOWAC^(?ZOSZ]J/IU[_9I>^O\
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M7O\ 9I>^O^\4M]_^<&9_^LOOWAC^(?ZOSZ]J/IU[_9I>^O\ O%+??_G!F?\
MZR^_>&/XA_J_/KVH^G7O]FE[Z_[Q2WW_ .<&9_\ K+[]X8_B'^K\^O:CZ=>_
MV:7OK_O%+??_ )P9G_ZR^_>&/XA_J_/KVH^G7O\ 9I>^O^\4M]_^<&9_^LOO
MWAC^(?ZOSZ]J/IU[_9I>^O\ O%+??_G!F?\ ZR^_>&/XA_J_/KVH^G7O]FE[
MZ_[Q2WW_ .<&9_\ K+[]X8_B'^K\^O:CZ=>_V:7OK_O%+??_ )P9G_ZR^_>&
M/XA_J_/KVH^G7O\ 9I>^O^\4M]_^<&9_^LOOWAC^(?ZOSZ]J/IU[_9I>^O\
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M7O\ 9I>^O^\4M]_^<&9_^LOOWAC^(?ZOSZ]J/IU[_9I>^O\ O%+??_G!F?\
MZR^_>&/XA_J_/KVH^G7O]FE[Z_[Q2WW_ .<&9_\ K+[]X8_B'^K\^O:CZ=>_
MV:7OK_O%+??_ )P9G_ZR^_>&/XA_J_/KVH^G7O\ 9I>^O^\4M]_^<&9_^LOO
MWAC^(?ZOSZ]J/IU[_9I>^O\ O%+??_G!F?\ ZR^_>&/XA_J_/KVH^G7O]FE[
MZ_[Q2WW_ .<&9_\ K+[]X8_B'^K\^O:CZ=>_V:7OK_O%+??_ )P9G_ZR^_>&
M/XA_J_/KVH^G7O\ 9I>^O^\4M]_^<&9_^LOOWAC^(?ZOSZ]J/IU[_9I>^O\
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M7O\ 9I>^O^\4M]_^<&9_^LOOWAC^(?ZOSZ]J/IU[_9I>^O\ O%+??_G!F?\
MZR^_>&/XA_J_/KVH^G7O]FE[Z_[Q2WW_ .<&9_\ K+[]X8_B'^K\^O:CZ=>_
MV:7OK_O%+??_ )P9G_ZR^_>&/XA_J_/KVH^G7O\ 9I>^O^\4M]_^<&9_^LOO
MWAC^(?ZOSZ]J/IT3]=_;Z;Y'S=K#K?(#=\.?IE;J]I9ER9EJL/+ $2D--_$7
:1:>%IGD6@*IJ0,1Y$)=TC32OY_GU3SZ__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>tbarchart_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tbarchart_002.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2      04  DE$_]L
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MI IV#*2!8Z65XMI6H^750*FG5F7_  U;\>_^>Q[E_P#0AV1_]KSVSXY^75]
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M_P!KSW[QS\NO:!U[_AJWX]_\]CW+_P"A#LC_ .UY[]XY^77M Z]_PU;\>_\
MGL>Y?_0AV1_]KSW[QS\NO:!U[_AJWX]_\]CW+_Z$.R/_ +7GOWCGY=>T#KW_
M  U;\>_^>Q[E_P#0AV1_]KSW[QS\NO:!U[_AJWX]_P#/8]R_^A#LC_[7GOWC
MGY=>T#KW_#5OQ[_Y['N7_P!"'9'_ -KSW[QS\NO:!U[_ (:M^/?_ #V/<O\
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M_P"UY[]XY^77M Z]_P -6_'O_GL>Y?\ T(=D?_:\]^\<_+KV@=>_X:M^/?\
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M]H'7O^&K?CW_ ,]CW+_Z$.R/_M>>_>.?EU[0.O?\-6_'O_GL>Y?_ $(=D?\
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M2IKI&6$$'W7NOJW>_=>Z^8)_PM6_[>F]!_\ B@'5G_P17RJ]^Z]UO^?RG?\
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MO#83#T<..Q6*QM% J)#3T\%/'##$@"HB!0 ![]U[K5QZ8_X3);5ZA_G%YO\
MF>P_*3/YO8LW=W9/R.V[TD^QXJ#=5!V5V;59_+Y/!YCL>#<+P5>"I,ANJNGI
MT3$4]3+3B"DJ))"D]34>Z]T<G=W\EO<4_P#,;^2_\T;IWYK=L]$_)7N.38&'
MV5MW [0V?N[H6GV%L?H/JWJN7:'>G6F=BI,CN^"NS'7KY=_X;N3:SP020PTT
MD-7']][]U[H9ODG\0?YAGS&Z3R_QB[@^6?QUZHZ=[3V?E]@?(W='QW^.>^8.
MX.QMD9^CH\7NC:O7&0[7[OWWA-H09NB?(4.1GK,7NV>.GKM%,\<L?W#^Z]T8
M&'^7'\;-L?R^-[?RU^IL!6=0?'W>/1/8?1(;:,M/+NK&X_LO;>9P6YM[S97+
M4]:M?G:F?.3Y.KK:^.?[FJ=FF5D8I[]U[JL/^13_ "#(?Y.&X?D#OG/?(R3O
MW>?=./VSM&A?$;%FZYVQ@-F;6R%?EX):O"U6ZMWRU.3JJFON\OW0CIXH_%&'
M,DDA]U[K8ME$IBD$#QQS&-Q#)+&TT22E2(WDA26 NH-B5#H2. P^OOW7NM5W
M^;9_PG-[R_F\=[;-[E[A_F);$ZTQG6W7]/UYL'K_ *_^$F6J<;B<=+E*S/Y_
M,Y;.9[YAUE775]?6UYU.!3014]-30QTXE2>HJ?=>Z/+\:OY?7\T?XK_'OJCX
MU]<_S2_CSD]A]+[#PO6^Q<EO'^6;D,MNNDVIMJA3%[=HJ_(X[YV86FJ'HJ6&
M*GBE>CU,D*F7R/J9O=>Z27Q _D_?)OJ#^8I5_P Q;Y?_ ,RC.?-[?L'3V_.H
M]F['R/QJQ72NV^NJ#?&>P&6>;8T>)[GW]08VDIH<954IHJ'$TTM1]YY)ZMRC
MK-[KW5YNZZ;==9@*^GV/FMO;>W1)]K_"\QNO;&2WE@*/16T\E;]_MO$;NV)4
M5/DIUFBB\>5I?'(Z2MY51H9/=>ZT\^^_^$IW=7R"^=&Z/Y@FY_YH6V,3W=N#
MNK;O>%#1X;X(,=H;>W!LO)X2NV5AZ'$U_P P:N2:AQT6VJ"D"U4TTLT=/JGD
M>1W<^Z]UMY==8[LS%[=2E[8W?L;>^ZUG4OG.ONNL]UA@'I10T,;1?W9W%V?V
MW4"4U,=3-Y1E=/CECB\>J)IIO=>Z(Q_,T^%_>GS\^-/:/Q5V)\D.M_C[USW+
MM_'[6WYF<Y\<,]W3OEL%%7MDLO2;;RD7R*ZHQ]&]7)242+-/BJYH8HZA5U23
MQ2TWNO=57_R>?^$_7=G\G?LGM7>75OSZV#VWMGNO ;5P/86R]\?#3<&&DF&R
MLAF<AMO)[>W!@OF$?M*F$[CKHV:HHJY&2H(T*1?W[KW6SE[]U[JG:O\ Y?WS
M$ZO^6_R^^7GQ*^:>R-A5/RLWQUUN7.?&_O+X_5W;_P >D@V!T%U3U%%N.4;/
M[9Z@W51;LGKMA5M8^7QN?CH):&LAHJO$U,]-!6P^Z]UP_EM?RFJ#X4]X_*OY
MD=O]JXWOKYF?,W<]?GNV>P-L]>4G5/6^T,%6[DK-S?W ZJV)'G-U5=-CVF>B
M^]J\GE:^JK&Q=++,PE$K2^Z]U<9[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NJT/G%_V4)\"/\ Q,L__O;]->WH^#?9_GZHW$=>_E6_]D][Q_\
M$R[A_P#>(Z\]^GX_EUY.'5E_MGJ_7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6OA\:O^WD3
M?^)/[[_]YSLGVJ;X/R'^3IH?%UL'^TO3O7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5:'SB
M_P"RA/@1_P")EG_][?IKV]'P;[/\_5&XCKW\JW_LGO>/_B9=P_\ O$=>>_3\
M?RZ\G#JR_P!L]7Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N@@["[OV+UUN/:FPZVH
MKMQ=G;]CR%1LCJS:4--E=][EQV':G7.Y^+'5%9CZ>AQ% :N%:[-Y:JQ^.@DG
M@@DJEJ*FGBE]U[I-=^_*KH+XQ46W:CNCL&EVYE=ZUM=B]@['PN$W-O\ [3[(
MR^,Q=;F\AA^L^H^O,+NK<^XZR&DQTU1+2X3$UTB(A9E M[]U[HG/2W\X+X7]
MFKL7#]B;QW5\7=^=C95L%LO:7RIZF[M^-N.WMFYLU68;%83KG?GR!ZNZHPNY
M*^J>F11C\-5U54DTJP/")"FOW7NK2O?NO=1,A74^,H*W)59D%+CZ2IKJDQ0R
MU$HIZ2%YYC%!"CN[:8SI1%+$\ $GW[KW1 OY;W\S'XV?S3NE]X][?&!.Q(=E
M;&[8W/T[FX>RMI0;2S;;DVUB\!GUR-#2T68S\$M!7X[=./KZ-_N5J%CJ5CJZ
M>EJ%>!?=>ZL(]^Z]U[W[KW7O?NO=$$^?/\S'XD_RUNM_])GRDWANC"8RIDHZ
M7$87977V\=_9[+U^3&6_A%$?[NXFIH,:*Q\'50TU7G*_%4CRQ>+[@2,BM[KW
M1R>NM\8GLWK[8G9.!I\C28/L'9NV-\86DR\5-3Y:EQ.[,)0Y['4^4@HZNOA2
MH2&O19TBGF0.&"R.MF/NO=++W[KW5=G6G\S_ .,G:_\ ,/[T_EC[67L@?)+X
M]]98GM3?-5E-FK1=;U>#R<6QZFHQNW]T+EIZF:MHX.R<%/4?<XZDIG7(HM+4
MU,D<Z1>Z]TC_ ).?S@?A7\4_DC\>OB1O[<F_=P]^?)?N'K_I;K[9^Q.O<WE<
M92;@[![#VYUG3YG<6^LY_=O;\5!B\CN:!LS%1Y2NR%/$CZ*"68Q0R>Z]T+_S
MJ_F+?%7^7-U;6]M_*'>>>V[MZF6B6EQNT]C[LWWN#)5.4K'QV)I5I-LXJN@H
M15U$3T]/59>IQU*TBF/SA^/?NO=&$^/7=>U?DIT%T?\ (O8N/W!B=D]_=/\
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MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U6A\XO^RA/@1_XF6?\
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MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JM#YQ?]E"?
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M9&6WULK9_P /:#(O55]7U"C4>-J*GH3/PT&4K$IZ6HTT[QRE:J#R>Z]TX?\
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M.ID3Y^USM&&!=4D^1?P$6-V6]P&,3 $_72;?0^_=>ZY?\+5O^W670?\ XO\
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MZ/$[JF9#+182?^(*ZTU#6 ^Z]U9M\A/C)\9/F[U3B^OOD)UEL3OCJNJR>([
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MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW0,=\?(OH;XO;
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M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NM?#XU?]O(F_\
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M[KW5"/\ /:_X\CXZ_P#AU=@_^ZC;'O([[NW^Y-[_ ,TH?^/OU"GO3_N/;?\
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MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJT/G%_P!E"? C_P 3+/\
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MZ][]U[KWOW7NO>_=>Z][]U[JMC^;;_V0MVG_ -KOK;_WX>VO<J^RW_*Q6_\
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M4(_SVO\ CR/CK_X=78/_ +J-L>\CON[?[DWO_-*'_C[]0I[T_P"X]M_S4?\
MXZ.M;WWE5UCUU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5K/\FO\
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M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U6A\XO\
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MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U0C_ #VO^/(^.O\
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M['=7_H0Y?_ZL]^_=EM_OJ+_G&G^;KW[RN/\ ?LG^]M_GZ]_?K>__ #V.ZO\
MT(<O_P#5GOW[LMO]]1?\XT_S=>_>5Q_OV3_>V_S]>_OUO?\ Y['=7_H0Y?\
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M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U]!7;7_'N;?_ .U)BO\
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MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=;DG\JC_L@?H;_RJ/\
M[^?L3W@K[R?\K)>?]0__ &BP=9:>V7_)#MO^;W_:1+U89[C'H>=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:
M\_\ /F_[E4_\KE_\Q[WDY]W+_EH_]0G_ &L]0/[V_P#$+_J)_P"L'6O/[R<Z
M@?KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z^@KMK_CW-O\
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MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJT/G%_V4)\"/\
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MRUVV.C.M=O[&I\O44]-2U>X\M10&JW/NROIZ.&GB6IR^4JZS)U(1%'EJW/\
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M_P"?-_W*I_Y7+_YCWO)S[N7_ "T?^H3_ +6>H'][?^(7_43_ -8.M>?WDYU
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M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW52_\Z#_ +(Y@_\
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M_A\'Y7_\^^^//_H)]D__ &V??O\ @?-F_P!_7O\ SD@_[9NO?Z\FZ?[ZM?\
M>)?^M_7O^'P?E?\ \^^^//\ Z"?9/_VV??O^!\V;_?U[_P Y(/\ MFZ]_KR;
MI_OJU_WB7_K?U[_A\'Y7_P#/OOCS_P"@GV3_ /;9]^_X'S9O]_7O_.2#_MFZ
M]_KR;I_OJU_WB7_K?U[_ (?!^5__ #[[X\_^@GV3_P#;9]^_X'S9O]_7O_.2
M#_MFZ]_KR;I_OJU_WB7_ *W]>_X?!^5__/OOCS_Z"?9/_P!MGW[_ ('S9O\
M?U[_ ,Y(/^V;KW^O)NG^^K7_ 'B7_K?U[_A\'Y7_ //OOCS_ .@GV3_]MGW[
M_@?-F_W]>_\ .2#_ +9NO?Z\FZ?[ZM?]XE_ZW]6G_P L_P"<';'S+_TU_P"D
M_;W7F!_T<?Z./X'_ '"Q.Y,7]U_?#^_G\3_BO]X=V[HUZ/[K4_@\/@TZY->N
MZZ(>]V/;ZRY$^E^C>=_'\?7XS1M3PO!IIT1QTKXAK6OE2GG)?MWSE=<W?4?4
MK$OA>%I\)7%?$\6M=3O_  "E*>?'JT_W#O4E]>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5L?S;?^R%NT_P#M
M=];?^_#VU[E7V6_Y6*W_ -+/_P!6).H_]T/^2)/]L/\ U>CZT]O><?6)_7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UN2?RJ/^R!^AO_ "J/
M_OY^Q/>"OO)_RLEY_P!0_P#VBP=9:>V7_)#MO^;W_:1+U89[C'H>=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=:\_\^;_ +E4_P#*Y?\ S'O>3GW<O^6C_P!0G_:SU _O;_Q"_P"HG_K!UKS^
M\G.H'Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NOH*[:_P"/
M<V__ -J3%?\ N!![YG77]J_^F;_">L[(?@7[!_@Z>_;'3G7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5:'SB_[*$^!'_B99_\ WM^F
MO;T?!OL_S]4;B.O?RK?^R>]X_P#B9=P_^\1UY[]/Q_+KR<.K+_;/5^O>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z([_,F_P"R
M'OD)_P"&KB?_ 'L-N>Y ]K/^5@LO^:I_ZMOT$.?O^2/=?\T_^?EZTL?>?'6'
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=*K8O_'[[._\.K;W_NWH
M_:'<_P#<:7_FE)_QP]+=M_W(B_YJ)_QX=?0&]\U>LX^O>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJE_YT'_9'
M,'_B7-D?^ZW='N9_8?\ Y+O_ %#S?X4ZC+W:_P"20?\ FM'_ ,_=:F_O-'K%
MSKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NCI_RZ_^RV?CO_X?+?\
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MOW7NO>_=>Z][]U[KWOW7NO>_=>ZK8_FV_P#9"W:?_:[ZV_\ ?A[:]RK[+?\
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MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?05VU_Q[FW_ /M28K_W @]\SKK^U?\
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MP^Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[I5;%_X_?9W_AU;>_\
M=O1^T.Y_[C2_\TI/^.'I;MO^Y$7_ #43_CPZ^@-[YJ]9Q]>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5+_P Z
M#_LCF#_Q+FR/_=;NCW,_L/\ \EW_ *AYO\*=1E[M?\D@_P#-:/\ Y^ZU-_>:
M/6+G7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO='3_EU_\ 9;/QW_\
M#Y;_ -T>8]@#W2_Y5^]_YI#_ (^G0R]OO^2S:_Z<_P#'&ZW7?> W67W7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW5"/\ /:_X\CXZ_P#AU=@_^ZC;'O([[NW^Y-[_ ,TH?^/OU"GO3_N/;?\
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MO>_=>Z][]U[KWOW7NO>_=>Z][]U[HZ?\NO\ [+9^._\ X?+?^Z/,>P![I?\
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M]^Z]U[W[KW1T_P"77_V6S\=__#Y;_P!T>8]@#W2_Y5^]_P":0_X^G0R]OO\
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MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U6A\XO^RA/@1_XF6?\
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M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U0C_/:_P"/(^.O_AU=@_\
MNHVQ[R.^[M_N3>_\TH?^/OU"GO3_ +CVW_-1_P#CHZUO?>576/77O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=6L_R:_P#LLZA_\1EOO_H7$^X9]]_^
M2"?^>B'_  /U*'M%_P E;_FQ)_A3K;7]X6]90=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6OA\:O\ MY$W_B3^^_\
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MZ][]U[KWOW7NO>_=>ZH1_GM?\>1\=?\ PZNP?_=1MCWD=]W;_<F]_P":4/\
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M _7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U]!7;7_'N;?\
M^U)BO_<"#WS.NO[5_P#3-_A/6=D/P+]@_P '3W[8Z<Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZK0^<7_ &4)\"/_ !,L_P#[V_37
MMZ/@WV?Y^J-Q'7OY5O\ V3WO'_Q,NX?_ 'B.O/?I^/Y=>3AU9?[9ZOU[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW1'?YDW_9#
MWR$_\-7$_P#O8;<]R![6?\K!9?\ -4_]6WZ"'/W_ "1[K_FG_P _+UI8^\^.
ML/NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z56Q?^/WV=_P"'5M[_
M -V]'[0[G_N-+_S2D_XX>ENV_P"Y$7_-1/\ CPZ^@-[YJ]9Q]>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5+_
M ,Z#_LCF#_Q+FR/_ '6[H]S/[#_\EW_J'F_PIU&7NU_R2#_S6C_Y^ZU-_>:/
M6+G7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO='3_EU_P#9;/QW_P##
MY;_W1YCV /=+_E7[W_FD/^/IT,O;[_DLVO\ IS_QQNMUWW@-UE]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M0C_/:_X\CXZ_^'5V#_[J-L>\CON[?[DWO_-*'_C[]0I[T_[CVW_-1_\ CHZU
MO?>576/77O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=6L_R:_\ LLZA
M_P#$9;[_ .A<3[AGWW_Y()_YZ(?\#]2A[1?\E;_FQ)_A3K;7]X6]90=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6OA
M\:O^WD3?^)/[[_\ ><[)]JF^#\A_DZ:'Q=;!_M+T[U[W[KW7O?NO=-.>SV'V
MOA<IN/<&0I\3@\)0U.3RV3JV*4M!04<335-54. Q"(JEF-CP/?AGKW0!?[.%
M\8O^?U;(_P#/A+_]3^[^&WIU76.O?[.%\8O^?U;(_P#/A+_]3^_>&WIU[6.O
M?[.%\8O^?U;(_P#/A+_]3^_>&WIU[6.O?[.%\8O^?U;(_P#/A+_]3^_>&WIU
M[6.O?[.%\8O^?U;(_P#/A+_]3^_>&WIU[6.O?[.%\8O^?U;(_P#/A+_]3^_>
M&WIU[6.FG/\ R\^,]3@LU3P=S;*EGGQ.1AAB2OE+R2RT<R1QJ/M_J2P ]O6Z
ME9%)X!E)_:.J2L"I ]#_ (.M*O\ T>;U_P">=K_]M#_U]]Y[_P"N5L7_ "FP
M_M;_ *!ZQ!_J)N__ "BR?\9_Z"Z]_H\WK_SSM?\ [:'_ *^^_?ZY6Q?\IL/[
M6_Z!Z]_43=_^463_ (S_ -!=>_T>;U_YYVO_ -M#_P!???O]<K8O^4V']K?]
M ]>_J)N__*+)_P 9_P"@NO?Z/-Z_\\[7_P"VA_Z^^_?ZY6Q?\IL/[6_Z!Z]_
M43=_^463_C/_ $%U[_1YO7_GG:__ &T/_7WW[_7*V+_E-A_:W_0/7OZB;O\
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ME;%_RFP_M;_H'KW]1-W_ .463_C/_077O]'F]?\ GG:__;0_]???O]<K8O\
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M -KSW[QS\NO:!U[_ (:M^/?_ #V/<O\ Z$.R/_M>>_>.?EU[0.O?\-6_'O\
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M]H'7O^&K?CW_ ,]CW+_Z$.R/_M>>_>.?EU[0.O?\-6_'O_GL>Y?_ $(=D?\
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MR^M,]W+NS>FW-O\ 5.U]DY'LC</864RM+2[3Q&P<1A)=RY+=U=FGD\*4$-!
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M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K7P^-7_;R)O\
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MLN'^ZTWQ<@2DH:C>\GR7R>Y<7@^KMN=<R5"-,,AGZG(O@JN*G*F3'Y"L$I6
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M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JM#YQ?\ 90GP(_\
M$RS_ /O;]->WH^#?9_GZHW$=>_E6_P#9/>\?_$R[A_\ >(Z\]^GX_EUY.'5E
M_MGJ_7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6OA\:O^WD3?\ B3^^_P#WG.R?:IO@_(?Y
M.FA\76P?[2].]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5H?.+_LH3X$?^)EG_ />WZ:]O
M1\&^S_/U1N(Z]_*M_P"R>]X_^)EW#_[Q'7GOT_'\NO)PZLO]L]7Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>ZU\/C5_V\B;_P 2?WW_ .\YV3[5-\'Y#_)TT/BZV#_:7IWK
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[JM#YQ?]E"? C_Q,L_\ [V_37MZ/@WV?Y^J-Q'7O
MY5O_ &3WO'_Q,NX?_>(Z\]^GX_EUY.'5E_MGJ_7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M6OA\:O\ MY$W_B3^^_\ WG.R?:IO@_(?Y.FA\76P?[2].]>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=5H?.+_LH3X$?^)EG_P#>WZ:]O1\&^S_/U1N(Z*%\->V/DMUQUWNK
M:O4715/V7AHNP<K7YG+S553%)CL_-@]NXZIQ!6"NIE(2+$PR@V)O*>;6]N2*
M&.3U121PZ-U_LR/SM_[Q$H__ #OKO_KO[;T+Z]6U'TZ]_LR/SM_[Q$H__.^N
M_P#KO[]H7UZ]J/IU[_9D?G;_ -XB4?\ YWUW_P!=_?M"^O7M1].O?[,C\[?^
M\1*/_P [Z[_Z[^_:%]>O:CZ=>_V9'YV_]XB4?_G?7?\ UW]^T+Z]>U'TZ]_L
MR/SM_P"\1*/_ ,[Z[_Z[^_:%]>O:CZ=>_P!F1^=O_>(E'_YWUW_UW]^T+Z]>
MU'TZ]_LR/SM_[Q$H_P#SOKO_ *[^_:%]>O:CZ=>_V9'YV_\ >(E'_P"=]=_]
M=_?M"^O7M1].O?[,C\[?^\1*/_SOKO\ Z[^_:%]>O:CZ=>_V9'YV_P#>(E'_
M .=]=_\ 7?W[0OKU[4?3KW^S(_.W_O$2C_\ .^N_^N_OVA?7KVH^G7O]F1^=
MO_>(E'_YWUW_ -=_?M"^O7M1].O?[,C\[?\ O$2C_P#.^N_^N_OVA?7KVH^G
M7O\ 9D?G;_WB)1_^=]=_]=_?M"^O7M1].O?[,C\[?^\1*/\ \[Z[_P"N_OVA
M?7KVH^G7O]F1^=O_ 'B)1_\ G?7?_7?W[0OKU[4?3KW^S(_.W_O$2C_\[Z[_
M .N_OVA?7KVH^G7O]F1^=O\ WB)1_P#G?7?_ %W]^T+Z]>U'TZ]_LR/SM_[Q
M$H__ #OKO_KO[]H7UZ]J/IU[_9D?G;_WB)1_^=]=_P#7?W[0OKU[4?3KW^S(
M_.W_ +Q$H_\ SOKO_KO[]H7UZ]J/IU[_ &9'YV_]XB4?_G?7?_7?W[0OKU[4
M?3KW^S(_.W_O$2C_ /.^N_\ KO[]H7UZ]J/IU[_9D?G;_P!XB4?_ )WUW_UW
M]^T+Z]>U'TZ]_LR/SM_[Q$H__.^N_P#KO[]H7UZ]J/IU[_9D?G;_ -XB4?\
MYWUW_P!=_?M"^O7M1].O?[,C\[?^\1*/_P [Z[_Z[^_:%]>O:CZ=>_V9'YV_
M]XB4?_G?7?\ UW]^T+Z]>U'TZ]_LR/SM_P"\1*/_ ,[Z[_Z[^_:%]>O:CZ=>
M_P!F1^=O_>(E'_YWUW_UW]^T+Z]>U'TZ]_LR/SM_[Q$H_P#SOKO_ *[^_:%]
M>O:CZ=>_V9'YV_\ >(E'_P"=]=_]=_?M"^O7M1].O?[,C\[?^\1*/_SOKO\
MZ[^_:%]>O:CZ=>_V9'YV_P#>(E'_ .=]=_\ 7?W[0OKU[4?3KW^S(_.W_O$2
MC_\ .^N_^N_OVA?7KVH^G7O]F1^=O_>(E'_YWUW_ -=_?M"^O7M1].O?[,C\
M[?\ O$2C_P#.^N_^N_OVA?7KVH^G7O\ 9D?G;_WB)1_^=]=_]=_?M"^O7M1]
M.O?[,C\[?^\1*/\ \[Z[_P"N_OVA?7KVH^G7O]F1^=O_ 'B)1_\ G?7?_7?W
M[0OKU[4?3KW^S(_.W_O$2C_\[Z[_ .N_OVA?7KVH^G7O]F1^=O\ WB)1_P#G
M?7?_ %W]^T+Z]>U'TZ]_LR/SM_[Q$H__ #OKO_KO[]H7UZ]J/IU[_9D?G;_W
MB)1_^=]=_P#7?W[0OKU[4?3KW^S(_.W_ +Q$H_\ SOKO_KO[]H7UZ]J/IU[_
M &9'YV_]XB4?_G?7?_7?W[0OKU[4?3KW^S(_.W_O$2C_ /.^N_\ KO[]H7UZ
M]J/IU[_9D?G;_P!XB4?_ )WUW_UW]^T+Z]>U'TZ]_LR/SM_[Q$H__.^N_P#K
MO[]H7UZ]J/IU[_9D?G;_ -XB4?\ YWUW_P!=_?M"^O7M1].O?[,C\[?^\1*/
M_P [Z[_Z[^_:%]>O:CZ=>_V9'YV_]XB4?_G?7?\ UW]^T+Z]>U'TZ]_LR/SM
M_P"\1*/_ ,[Z[_Z[^_:%]>O:CZ=>_P!F1^=O_>(E'_YWUW_UW]^T+Z]>U'TZ
M]_LR/SM_[Q$H_P#SOKO_ *[^_:%]>O:CZ=>_V9'YV_\ >(E'_P"=]=_]=_?M
M"^O7M1].O?[,C\[?^\1*/_SOKO\ Z[^_:%]>O:CZ=>_V9'YV_P#>(E'_ .=]
M=_\ 7?W[0OKU[4?3KW^S(_.W_O$2C_\ .^N_^N_OVA?7KVH^G7O]F1^=O_>(
ME'_YWUW_ -=_?M"^O7M1].O?[,C\[?\ O$2C_P#.^N_^N_OVA?7KVH^G7O\
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M,+_,F_[QFV1_Z#>Y?_MI^_:$]?\ 5^SKVH^G7O\ 9A?YDW_>,VR/_0;W+_\
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MIU[_ &87^9-_WC-LC_T&]R__ &T_?M">O^K]G7M1].O?[,+_ #)O^\9MD?\
MH-[E_P#MI^_:$]?]7[.O:CZ=>_V87^9-_P!XS;(_]!O<O_VT_?M">O\ J_9U
M[4?3KW^S"_S)O^\9MD?^@WN7_P"VG[]H3U_U?LZ]J/IU[_9A?YDW_>,VR/\
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MD?\ H-[E_P#MI^_:$]?]7[.O:CZ=>_V87^9-_P!XS;(_]!O<O_VT_?M">O\
MJ_9U[4?3KW^S"_S)O^\9MD?^@WN7_P"VG[]H3U_U?LZ]J/IU[_9A?YDW_>,V
MR/\ T&]R_P#VT_?M">O^K]G7M1].O?[,+_,F_P"\9MD?^@WN7_[:?OVA/7_5
M^SKVH^G7O]F%_F3?]XS;(_\ 0;W+_P#;3]^T)Z_ZOV=>U'TZ]_LPO\R;_O&;
M9'_H-[E_^VG[]H3U_P!7[.O:CZ=>_P!F%_F3?]XS;(_]!O<O_P!M/W[0GK_J
M_9U[4?3KW^S"_P R;_O&;9'_ *#>Y?\ [:?OVA/7_5^SKVH^G7O]F%_F3?\
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MO3/65=2XSLGMSK'KW)5\#55#C]\;]VKM.NK*9&5'J*6DSV6H))(P6 +HI )
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MDFI4R5(E)(:84_NO=?44^6?2&_OD?U?_ *$]I]M[HZ0VAOW*IBNY.P.M<I_
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M)2QS2R#Y\_S$Y66!'=Q3P;<^4<]7(RQ@G0D4;O(?H$5BW /OW7NOJ:Y;+8O
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M^]=X;;>T]X;.BIQ19' T+Y""N@PTT7VOW6,HG>-T@\;>Z]T]?S<>E=A]!?\
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M*DVG@<71$4].U3'1R,;R-4E_=>ZL?_E =)?-_P"-_P#.O_F%9>C^-/??5?\
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M0R1LRGW7NJL_B+_,6SN?^8G<O\LGY=X_;NS_ )C=.[=QG8FP-W[;I_X%UO\
M+7H_.1U57C>S^L=O5^:SE7C,ICX81#N7;\U55""HCJ)*.>>G@J12^Z]U;I[]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>ZK7^77_96'PA_\/+*_P#N]VA[=3X6_+JC<1U[^6?_
M ,R^[E_\39GO_=)@O?I>(^SKR<.K*/;75^O>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K3^_F$?R3
M-L_S3/Y4_P >>RNJL528CYK=%=39*KZFSD<B4</:.UX\UF\EE>EMVO)+#"Z5
MDBF?!UTWKH:TZ0ZTM76(_NO=41_\)D_YTN:^ G=%9_+A^8E7G-K= =C=BY7#
M[/R>_)*W#5?Q@[XJ:\XK-;;W)C=R2TKXG 9G(4CT^6H_'#_#LPYK)(4%5DYA
M[KW6\E_+=96[@_FZLI#*W\TG<+*RD%64_!/X'$$$?4'W[KW55F=_FB]V?/\
M_G>R_P J_P")W;==T/\ '+XIT6\M\?*WN+K[';1SG:G<NXNK)</AMT=/;.W#
MN3%[NHMOX2EW%NK'8/+U=-1091Y:+(+%54ZB)9/=>Z<_CS_,M[_^,7\]?M?^
M3[\F^S<EWUT]W#C:'LKX?=N;UI=MT_:VP)\UUB.R:CJ+>N1V3L[:U)E<8SX?
M.T6*K*^!JZ)J*E$U94K5B.F]U[K5-_X6$8KN3:_\SC86W^S.^=T=O[9S_P :
MMO=K=:;.K\+0;5V9TCA-X=L=N;-J]B;)V]BZRL24RIU=1UF3S=:\M?7SR!9Y
M!3TM%!3^Z]U]&?X>_''Y(_'[_2)_LP?SK[1^:O\ >W^Z/]T?])/5/2_6/^C3
M^ _WG_C_ /!?]$&U=L_??QG^-47W/\1\_A_A47@T>6;7[KW1UO?NO=?)_P#^
M%=O_ &^5WY_X@7H?_P!YNM]^Z]U]*'Y<TG:$GP'[BR_2G:^XNE.W-G_&_=V^
M.MNP]NT6U\H^&WMM#K'*9W;(S>)W?MC=M%5XN2MHX5R-,:/R20ZA#)%)ID7W
M7NM.K_A/_P#S!/YUO\V*7YC=0Y;YO[;VG3;3VIU#7-\C-X]*]8;PWQTNFX\K
MV#25&'ZDZFVIMSK/%93*[CCQ3^3-[CR-738=,*IBQM;-6@P>Z]T(/\B'^;W\
M_MQ_S?N]_P"61\V_DE0?);;=!E/D-UWLK=>X]J;+V;N*F[5^-NX,VE9D]ER[
M;P^#FGH,SAMHYFJK,-6_Q!XA2PU-/+3B"M^[]U[J9_PM&ZI[8QOQXZ6[AR7R
M-W?G.G-P_)39.TMN_&"HV9L2DV3LK=M'TOVS4UO9=!OJEQ0W%55U5'CJBG>B
MJ:UJ-$K69(1(BO[]U[JY3_A-;U#W#L?^69\:^P=\_)S>G;O7G9O2NT:KK'I7
M<&Q>N]N[;Z I,5N+>BY3&[2W/M7"X[+Y=,C]Y"9WSM16/&:5/"R!I WNO=:=
M_P#*<_[B\,O_ .+K_P T+_WV'R]]^Z]UL>?SBOYTG>V#_F.?&7^3G\#MVR]:
M]J=L]N=![&^1WR)PNW,!O?=_56+[HW7MD#;/7^!W#A]T8^GK*';>;7<&;RU?
MC:O[:DJHA3K#)'-/%[KW33_. _F3?*K^0W\J/A-NV#NGLGY:_$GY)X3L?$=N
M]-]X4G6F3WWAZ_I[)]?0[AWGU7V+M#9G7]529*IHNUJ.:/'9#S8Z2:@:-DB6
M<2TWNO=':_GI]M_,K%_RW:+^8C_+%^6^[NO:?KK9&S>X\QMS:.T^F.P-A=S_
M !Z[ BPN1FWU35&_=E;IJ*6MPU!GJ;/4];C<A]M-C8:R*2EJ)GI9Z?W7NBG?
MR-_GIWE_,>_E*_*G?O<'S@[6V?\ *WI[<785#O;O*HV_T114_4F+PNSI]^];
M[VV]LK'=73XJ7;LE%+-%F$RV,GJ:J;#Y!()842"1?=>ZK?\ ^$XG\X_YW?*S
M^9)NCXJ?S#_E-V?F<RO6?8B]:]4[BV-TGUC35?<?7>5H:G>.R]Z8?#]4;7S\
MF4H<+C\W61X^*MI? <35FJ@D**8?=>ZVG/CY4=ZU7RN^?_=.Z_DEW1O?XK=,
M[JQ77'371N7V[TW2[2CWCM3J3";S[[SF$W7MW9U+N3+4%'E]SQ;?Q5-DZZE:
MCR6'RT<AK8/M&@]U[K7V_DW?S6.ROYPW8ORAI.UOYB_8?P\^3^2['I<S\2?B
MOUQB>DO]%FW>H,%C<9D\=#10]F=0YJJ[!KWK8ZJDW70SY:FK9J-'JJ*/'1RI
M)0^Z]ULT?RWI_E[1_%B*B^>^=H\_\D-M=R?);#[RW;1X;%[8V[N':>+[^[(/
M6>X]L8O&$04V#J-KMB9L,CLTT= 8(ZIFJ4F)]U[JN[^1G'%\C]Z?S'_YI=9]
MOD(/G#\M\_L?I#-QY>OS"5?Q4^)"5G2_4E31BJ6*&D%;74F<J9X*2/2Y2)GD
MDTQB/W7NJ'?BCWA7?S'_ /A7QV%OG=.0R4^Q?@SAOD;L#IC;=7)'38^EQW2.
M-S?1%16I0-%E?(E?N'L++[GA824,Q:2F:4IX#2-[KW1]/^%GG;V]MC?RT.H^
ML]L923%[=[O^4NT<%V-%"L#MN#:VR-E;WW_BMMU/G@F*P'.X3$91GA:*3RXF
M%=1B>5']U[I,?\(H-MT%+_+>^2^\(XXAD\[\W=U[;K)1"5G>@VIT/T)E,=')
M/Y#J19-YU11-"Z2S&[:[+[KW6XGD*"CRM!78O(T\=7C\E1U-!74DP)BJJ.LA
M>GJJ>4 BZNDC*W/T/OW7NOD/?R"]U;R^*/\ /I^//7FTMR5&0I*KNWM#XS[U
MJ8Z=,13;VV;DZ+=NU*M\AC7DR_BC^]P]!F8J832%)Z&%1,=.OW[KW5]/_"F?
M^:K_ #+/Y;_\PO:74GQ3^9?8&R>K^S?C3LCO*7963V!T/NFBVIN;<7:'<NP\
MEB-M93<'4N0R'\.\'6])4115M762)+/,!*8]")[KW5GG_"G+YF_-?X'?$OXK
M?)SXC_*/?O3NY-\=H83J/?>UJ':W4&Z]H;DI-P=7[LWY3[D>BWYUENJLILC3
MU&S7A#TF0IX'BJW$E/(ZQ/%[KW5H?\NG??R9^;W\F_XU;^S7R+S&P_DGWOT7
M#7;@^1M%L'9.X-SX7.Y'<&8HZ_=&"V9)187 )D%I:;QT9DH7IH'TRFFET:#[
MKW6@!_PE^ZV^1GRE_F3]_)UC\S.U?C%VQEOB;VIV+O?O';FTNONXM];^BK^^
MN@!N3 [F3NG#;LIIFRN2W#3YBMRA0UKU&/6\Q6:</[KW6U/_ ,*C.A>_,5_)
M_P _NO+?,?L/<>T^H-E?&W87<'757UMU518GY/=@+W+UG@W[EWQFJ# 15N#R
M!KI5RXQFVGQ]#YD\1C:G(C7W7ND5_P (_>H>X:?X'XCNFH^3F]*[I.NW]WAL
M^@^*,NQ>NXMB8;>";AVE4/V?2]@4^%CW-+7-'1S0&AGKY*,+5N1%K2-E]U[K
M7N_E.?\ <7AE_P#Q=?\ FA?^^P^7OOW7NMCS^<5_.D[VP?\ ,<^,O\G/X';M
MEZU[4[9[<Z#V-\COD3A=N8#>^[^JL7W1NO;(&V>O\#N'#[HQ]/64.V\VNX,W
MEJ_&U?VU)51"G6&2.:>+W7NFG^<!_,F^57\AOY4?";=L'=/9/RU^)/R3PG8^
M([=Z;[PI.M,GOO#U_3V3Z^AW#O/JOL7:&S.OZJDR531=K4<T>.R'FQTDU T;
M)$LXEIO=>Z.U_/3[;^96+_ENT7\Q'^6+\M]W=>T_76R-F]QYC;FT=I],=@;"
M[G^/78$6%R,V^J:HW[LK=-12UN&H,]39ZGK<;D/MIL;#6124M1,]+/3^Z]T4
M[^1O\].\OYCW\I7Y4[][@^<':VS_ )6]/;B["H=[=Y5&W^B**GZDQ>%V=/OW
MK?>VWME8[JZ?%2[=DHI9HLPF6QD]3538?()!+"B02+[KW5;_ /PG$_G'_.[Y
M6?S)-T?%3^8?\INS\SF5ZS[$7K7JG<6QND^L::K[CZ[RM#4[QV7O3#X?JC:^
M?DRE#A<?FZR/'Q5M+X#B:LU4$A13#[KW6UO\5L5W[O+YI?-_L3<'R8[AW?\
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MNOOAYWC\T<OO+N':G6%7UWT50Y2MW#MK$YVAS65R>]<H,+M/>L_B@AP;TU%
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MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJU_EU_V5A\(?\
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M>]^Z]U6O\NO^RL/A#_X>65_]WNT/;J?"WY=4;B.O?RS_ /F7W<O_ (FS/?\
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ME1HLL5-NN'9U9D*^MP&1E2G63*X>26NI8)I@*+(5<180>Z]T*&2PN'S7\/\
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M[P_Y]KMK_P _.4_Z\>_?ZUT'^_W_ -X7_/U[^O\ +_OE/]Z/^;KW_#C>\/\
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M_=>Z][]U[KWOW7NO>_=>Z7_5'_,TNM?_  _]G?\ O18[V6[S_N'/_P T9?\
MCC=+ML_W)B_YJQ_\?'6R3[Q9ZR"Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJU_EU_V5A\(?_#RRO\
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M7;AS.2K_ .8/U)3Q8S#8RAER61KJR.3HH21K#! \DBL@90I!%Q;W[KW5S?\
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M=!L_N3(5$WR"W4(*9HECBPO6VWMW9%ZFJ=:>.2&(2+,72FG]U[JU;9NT=O[
MVAM38>T\=!A]J[)VW@]H[9Q-,BQTV+V_MO%TN&PV.IT15"I!344<2   !18>
M_=>Z4GOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZU,O^%4_3G5T/4W\O3O)
M-C;>;N'_ (=+^,NP$[(FHEJ-WT^Q=P;([;S.:V;29JH:6:'%U-9L3$5DE!$R
M0&>B2;0)2[-[KW6V;[]U[KWOW7NJGG_DJ?RZ]\;^[-[L^1?QJZS^3/?G=6\\
MIOKLSM/N7 #=];6U]8M-083;>UL'E:BIH</A<'B\;0X7$T=%!')]K01R5DU5
M625%5-[KW1'?AE\(_B'M[^==\C-^?%CXY=0=)=:_ ?XU;%Z$K:CJ[85%M.#=
M'RC^33MVCOZHR&1IHHHZR;;.PL?MS'Q"F333MNRMBEFDE9H*;W7NC]?SI.G.
MKNV?Y7'S]G[,V-M[?+; ^%WRBW_LJ/<M$N4I=L;ZV7TUNS>&T-Y8:BJ6>&'*
M8S)[>HZN@KU03P/%:-U5Y%;W7ND)_(!_[<U?R^/_ ! N/_\ >DW%[]U[HHWP
M=[@KOD]_/\_FN3]F1BNJ?@YU5\>_C]\8\/7QY%(=A;+[$IL[NWO#<>%QF3+1
MQ9'<F8Q6,^_RU+%3O54%-CZ8O/3P0M[]U[H'?YI?:Z_R]_YX/\H[Y*]?&;"X
M[Y^Y#>7PI^5.W</7O!1=C[=QV\^J,%U%O'<&UER4$=96[:RG>;5BY>*DEJHJ
M6B%&TC)-! _NO=;3_OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z@Y.B;)8Z
MOQZ5U=C&KJ.HI%R.,DBAR-":B)XONZ":>"I1)H]>J-VC<!@#8V]^Z]UJN?RT
M]H#KG_A23_.=ZYHMW=E;OV[L_H+XP2;8G[4[+WQVON+"T._MG]9=MYO 4.ZN
MP<YN'(KC8LUV%E9J"@^Y,-+'4>&!$C4#W[KW6UC[]U[I#=G=E;(Z:ZXWYVWV
M7N+';2Z\ZRVAN+?F]]SY:=*;&X#:NU,359O.Y:LFD90$@IJ*20_DZ;"Y('OW
M7NJ OY?5+V3_ #I(LG_,%^8^(R>+^$F=W/G<5\$_@=F!74>R,KLC:>=S6WZO
MY#_*W;L-8V/WQGLS54?^X/"Y-<G@\2E *V@BJ*B:&O'NO=;$.%P6#VWCX<3M
MW#8K XJG %/C,+CJ3%X^ !%C AHZ&&"-?2BCTJ. !^/?NO=4-_SR^W^R-_?#
MKYU_'KX_[LW%L8=/?#OM?NKY0=N8#&EH=O[:AV!N;+; ^.FW-PU<+4PW#O=\
M1)4;@2F,U3B]L0RO**.HSV$JG]U[HUO\DG7_ ,-#?RZ_%H\G^RD=0^/7?1K_
M +K4FC7IYM?ZV]^Z]T"WR0_D2? #Y8;([+W%\O\ 9U?VQ\@>Q,'DLAO'Y3Y_
M>V]Z/>^R\PE,:RBEZNIFW4,=MK;& DA!Q&UJ2G7&I DGWL=945=?4U7NO=)W
M_A-S6?*'(?RB/C16_*^;=]3O.I.]).OZGL#[\[VJ.DCN:N'5]1GI,J!5.CT0
M9L5+479\::)P61E)]U[J]?W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW5:_P NO^RL/A#_ .'EE?\ W>[0]NI\+?EU1N(Z]_+/_P"9?=R_^)LS
MW_NDP7OTO$?9UY.'5E'MKJ_7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6OI
M\I/^R@NT_P#PY7_]P:/WDIRA_P DRW_TG_/QZ@OF7_<Z;_3_ .0= %[$G1'U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=+_JC_F:76O_ (?^
MSO\ WHL=[+=Y_P!PY_\ FC+_ ,<;I=MG^Y,7_-6/_CXZV2?>+/6077O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=$ _FQ?\ ;K+^99_XH!\R/_@=>QO?NO=%Z_D
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M_P H[?M3_H+KW]9[#_?R_L;_ #=>_P!FU^.W_/S\1_Y[MP?_ %H]^_J9N?\
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MW[KW7O?NO=5K_+K_ +*P^$/_ (>65_\ =[M#VZGPM^75&XCKW\L__F7W<O\
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M71EVX"""+@CWHWTIP6/[3_GZ\+6,?A'[!_FZ=O\ AL_K[_G\O=G_ )_L)_\
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MNS_S_83_ .L7OWBGT'7M Z]_PV?U]_S^7NS_ ,_V$_\ K%[]XI]!U[0.O?\
M#9_7W_/Y>[/_ #_83_ZQ>_>*?0=>T#KW_#9_7W_/Y>[/_/\ 83_ZQ>_>*?0=
M>T#KW_#9_7W_ #^7NS_S_83_ .L7OWBGT'7M Z]_PV?U]_S^7NS_ ,_V$_\
MK%[]XI]!U[0.BG=B?$W";/\ E#TUT90=F=GU.W>R,#D\KELM5YND.:H9J*'<
MLD<>/:&@B@"G^"QW\D,A];6/TM</52:#JNG-.C8_\-G]??\ /Y>[/_/]A/\
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M_([4_P#.O:__ -CGNWU\O\1_:?\ /UKZ6/\ A'[!_FZ]_P -7=/?\_([4_\
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MPV/UM_S][N;_ ,_.!_\ K#[]]0W^JO\ GZ]X0Z]_PV/UM_S][N;_ ,_.!_\
MK#[]]0W^JO\ GZ]X0Z]_PV/UM_S][N;_ ,_.!_\ K#[]]0W^JO\ GZ]X0Z]_
MPV/UM_S][N;_ ,_.!_\ K#[]]0W^JO\ GZ]X0Z]_PV/UM_S][N;_ ,_.!_\
MK#[]]0W^JO\ GZ]X0Z]_PV/UM_S][N;_ ,_.!_\ K#[]]0W^JO\ GZ]X0Z]_
MPV/UM_S][N;_ ,_.!_\ K#[]]0W^JO\ GZ]X0Z]_PV/UM_S][N;_ ,_.!_\
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MZV]>_P!D3^5'_.FW9_Z,C9/_ -E?OWT/+_\ RER_\XG_ .M/7OK-Y_Y1H_\
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M<SN.LVUD<M!7BD%ZN1*&&<%U:-)$&A%6ZEXX6OR!ZIYTZLT_EB4-/1=>=PK
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MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5:_P NO^RL/A#_ .'EE?\
MW>[0]NI\+?EU1N(Z]_+/_P"9?=R_^)LSW_NDP7OTO$?9UY.'5E'MKJ_7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U6O\NO^RL/
MA#_X>65_]WNT/;J?"WY=4;B.O?RS_P#F7W<O_B;,]_[I,%[]+Q'V=>3AU91[
M:ZOU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5
MK_+K_LK#X0_^'EE?_=[M#VZGPM^75&XCKW\L_P#YE]W+_P")LSW_ +I,%[]+
MQ'V=>3AU91[:ZOU[W[KW0)?(CM_)=!]/=@]Q4?6FZ>UJ#K39NZ-]Y_:6R,GM
M6@W?7X+:6%J\[E(MN0[RS>VZ"IJS!12F&GFKZ4.RZ0^IE!]U[HD/PU_F7Y?Y
MX?&WKCY6_'WX;=^9/J'M3^^']T:[<^]OCAMG.3_W'WYNCK?/??8.K[HDD@TY
M/9]:D6ICKC5)!PX]^Z]T+/4WS/WGW=T'\F^Q-F?$WNS:W>_QKW-V3UMD/BEV
MWD>N]H=@[L[:V9U?M/M+:VS\/OG;F[=];4DH=S46_L)_"MP468R% 4R D:4^
M.1%]U[HQWQYWUV;V;T=U7V#W/U#5=!=K[PV3@\]V!TO6[JQ>]ZKK7=%?2)+E
M=J2[MPM/24U>::0E1410Q:A;4B.&4>Z]T,GOW7NO>_=>Z][]U[KWOW7NJP?C
M!_,>J?D?\^_FO\&*[H+<W4N7^%NT.D,_N+<V[MZ;2SV4WAD>[\+6;PPE/18#
M9$VX<?1TD.$GQ=6)_P".5LSRUTL$M/3-3:IO=>ZLRR,]934-748^A_B5;#3R
M24N/^YBH_O)U4F.G^ZF#)'J/&M@0/J??NO=5C_&3^9YM_P"47R]^5'PQVQ\=
M^XMF]D_#7*;(QW=^X=[9?JQ-D4B=A"KJMK5>T\AM??>YJS(BJHL?/71QO14C
M"--,GCE/C'NO=6B>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJN>_
M?YGN"^//S8^,?P4W1\=.XL_VC\O$WK4=+[LVMF>JZCKJMHNO:"MS&[JC<^0R
MN^L3E,<:*BH_NI4_A,^I9%6(RN&5?=>ZL\H9:F>BHYZVD^PK)J6GEJZ'SQU7
MV53)$CSTGW,0"R>-R4\B@!K7'!]^Z]U*]^Z]TU9#.X7%5N#QN3RV.Q^1W-D:
MC$;=H:RL@IZO.92DP^3W!58_$T\KJU1-'0X6KK'CB#,L--)(0%1B/=>Z(5@_
MYA&V=P?S%.Y_Y=&,Z;[1KM]]-_%K _*&J[(HQMP;#W+CL]N3"[:H.O,94Y/+
MXK[?,U4N>1L>U=-3TT_V5?KF@6D+R>Z]TD_Y<?\ ,6F_F 9GYHXJ?I'+]'U/
MP]^5V\_BCEL/N#>>'WCG<_NCKK'8Y-X9FO;;M!'CZ)8\I-544%/25V5C>*F2
MH^YO-XHO=>ZL9W'D<SB\345N!V])NC)16,6&AR=!B)JI;,6$5;DWC@5N %$C
MH"3RRBY]^Z]U5#\(?YLO_#@>P.RNQ_C[\,/D7-@NH^[MY?'K?5/O/>'QIVUE
M,7V?L+"[3SVY\5!3CO+(15-/!#O2B5:RGFDBD<N(V8+J/NO='3ZH^1V[=]]Q
M[LZ7W[\;^VNC\S@-@X7L3 [FWSFNI]P;.["P^2S=5@,M1;.RO6O8>]9#68:H
MBIQEJ:OIZ%HER%(Z>1*A&]^Z]T:CW[KW7O?NO=>]^Z]T'?;NZ=Y[&ZI[+WIU
MSUU6]O=@;2V%NW<NR.J<;GL3M;(]E[MP>!K\EM[8=#N7/$46/FRU7314$=;5
M_LPM.))+JI]^Z]TG/CYOWLKLGHOJ[L7NOJ2H^/W:>[-CX7</8G3>1W9BMZS]
M9;EK*-9\OM:HW?AX*.EKA2/<?<QQ0W'ZD1@RCW7NA4PN:Q&Y,-B=Q;?R=#FL
M#GL909K"9G%U4-=C,MB,I2Q5V-R>.K:=Y(YH)X9TEAE1F5T<,I((]^Z]TY^_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[H
MA/\ ,8^>VV/Y;/QKWE\L.SNINQ^R^H>NZK9M)O:;JRJV5-NC!G?6\L3L+!UG
M\#WGN?:,<]-_$]PX^GF>&K9U-6I$3(LC)[KW1C/CWV[D>^.H.O>X:KKG<W5^
M/[,V3M+?V VIO/);:KMVX_";QP-%N''4NY(=I9?/T--6Q0U\:5$$%=5JCW42
M-8^_=>Z!;<_R\S.V_EYL;X>I\?>QLONGL3J+LOO+;O8]#N/KB'K2/K[JC>NP
M]B;MER]17[KI<S#D(JWM';NBBAP]2&7+1D2D1U!B]U[HZ?OW7NB!P_.&N[,[
MH[HZ2^*_2^5[\RGQMW+CMB]];^R6^,'U;U9LSLK(X'&;H/5."W)E<=N*MSNX
MJ/'9NCJ\K#08O["B^Z2GJ,BE:)*5/=>ZD_'/YVXOOOY!]L?%W.=%=Q=%=T=&
M[ VKV!V5MCM:#9[TB8??FZ=T;:V-E-B[GV'NC>>)S^+RJ;,R%;!D:2NC,2(E
M/54]/7+4TM+[KW1\_?NO=0,G45U+CZJHQN/_ (K70Q%Z7'?=PT/W<H(M#]W.
MK)'>_P"I@1Q[]U[JIKX^?S8$^3GR!^87QHZI^'7R$K^S/@]OC:NP^\(\QN[X
MY8;!)D]\3[Y3:60VCEJGND_Q"DKH>OZZJ5FBIYHHWA6HAAF9HD]U[HV^V?DY
MOVK[LV)TWV%\5.YNJ:;L7;F\LSMSM#/;DZ4W/UTV:V7!0U]7L7(5.P>T-T9*
MFS%71U4U?012XU8)J>@JV6?53N@]U[HWOOW7NO>_=>Z][]U[H.^W=T[SV-U3
MV7O3KGKJM[>[ VEL+=NY=D=4XW/8G:V1[+W;@\#7Y+;VPZ'<N>(HL?-EJNFB
MH(ZVK_9A:<22753[]U[I.?'S?O979/1?5W8O=?4E1\?NT]V;'PNX>Q.F\CNS
M%;UGZRW+64:SY?:U1N_#P4=+7"D>X^YCBAN/U(C!E'NO="IA<UB-R8;$[BV_
MDZ'-8'/8R@S6$S.+JH:[&9;$92EBKL;D\=6T[R1S03PSI+#*C,KHX9201[]U
M[IS]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW0.=]]K9+I#J??O;-'U[G^S*'KK9F[-\YS:^U<QM;$;EK\1M# UNX*ZDP
M+;SS.W<=+5S14#QT\=7D**(N1Y)HU)8>Z]T1?X:_S+\O\\/C;UQ\K?C[\-N_
M,GU#VI_?#^Z-=N?>WQPVSG)_[C[\W1UOGOOL'5]T220:<GL^M2+4QUQJD@X<
M>_=>Z-5TQ\A]V=L9#N?;.=^/79W36^NG<]@L2VU.R\UUI.-^8K<V!ASN"WIL
MK<'7N]=]T$V'J2*JB6>HFIYEJ\?5020(\+>_=>Z)G\,OYPW0GS'^9/RB^!E'
MUOVWTK\D?BF^5?>.TNUX]@"CWACMO;I7:6X\UU[D]D[YW<*VCHY\ABYS+.E*
M9*?,4TT:L/*(_=>ZMM]^Z]U4=\8OYP72OS'^;/R<^%/QWZK[5WOE/B3D)<7V
MYWC-4=>XKI2')TVX(=JU>(VYD'WI4YRNJAD(,G31*N$CAD.%JW$XC^W>?W7N
MK;)WD2&9X8O/,D4CQ0:UB\TBH2D7E<$+J( U'@7O[]U[JINB_FKTN8^?G9_\
MM[ ?$KOC._(;JKI:A^0.9JJ+=?0-)UYF>KLAD]AX.'-[>W+F^V\34M**[L*B
MI7HJW'T4^J*=Q&85CEE]U[HRV1^5?9FV-[=3;9WY\.>\=H[:[4W]1==R=F#=
M_0.Y]G]?9C+8[(56 K=^T^U>W,ME:>CR%30IBZ2II,=6*:VKIH)/'YT8^Z]T
M=/W[KW7O?NO=>]^Z]U[W[KW15_C9W'\@.U]P_(K&]W_%S,?'#"]7]Y;FZ\Z5
MSV6['VKOX?(#JK#PT_\ !>Z**@VU!$V#AR;L[Q8JL:::*-D#R>598X_=>Z,G
MC<[A<Q4YNCQ.6QV2J]M95<%N&FH:R"JFPF:?$XO.KB<I'"[F"H-%G*.K\,@5
MO%51/;2ZD^Z]TZ^_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NB2_)[Y]= _$KNSX;=#=LY^'%[W^;7;^7Z?ZNB?)
MX2AAH<IB]J5V5AS.8BR>1HYGI:O-56 VO2K2QS.^1W+11@68W]U[H[7OW7NJ
MO!_,@K1_-:PG\L&O^/\ N3;=;E?B[NKY20=RY_>^UIJ#.;0Q.^_]'>WX-L[+
MVS_>&7Q5]?B\NTDV4R&,J8(Z*'50DU)\'NO=672YW"PYRBVS+EL='N+)8K*9
MW'X-ZR!<M6X7"5F(Q^7RU-0%Q*]/33Y^AAGF52J/5Q*Q!D4'W7NG7W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]TU9C.X7;U-35F=RV.P])697"X*DJ<G6044-
M3FMQY:CP6 Q,$E0\8>HK:W(04E+"I+22S(B LP'OW7NBV?*[N/Y =,[>ZIR7
MQZ^+F8^5&:WGWEU[UYO_  .(['VKUJ>K>JMR39'^^7=%=7[I@J5R$.%2CA3^
M%4JB:>2K0F2*))9%]U[HU'OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[I']@=@;'ZHV/NWLSLS=NW]A]>[#V_E-U
M[SWGNO*4F$VWMC;>$I):_+9K-9:OEAA@IX(86DDDD8  ?U]^Z]T1[HKYQ;^^
M6.T,?V]\9?BSO7/] ;CCHLGUWV_W5O3"]&1=Q[1KZ*BKZ3?75O7U3A]Z[C.*
MJ4JR*&?=.-VH]3X_+%&:9XYW]U[I?=0_-+ ]H?([=7Q3S74O:_5'<VPNJ(^W
MMX8;L#%8E<$NULEO=]C[8R6S-Y[9RVX<1GZ3*34-94Q3T%;Y*:.!8J^GI*QI
M*:'W7NCI^_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>ZK!;^8]4I_-6V_P#RPZWH+<VW<EF/B[NWY3)W%N#>FTI<;F=GXC?O^CG;
M<&U]G[7FW+,8\A7XG,-++EJ[$U-/'0P$T+_=7@]U[HRV3[C^0%)\Q]M=%4'Q
M<S&2^-&4Z-RG8>>^7P['VK387;W:M-NF;#X[I?\ T6O V7J)IJ"!<B^565(0
M*F.-(W\<[Q^Z]T9.7.X6'.46V9<MCH]Q9+%93.X_!O60+EJW"X2LQ&/R^6IJ
M N)7IZ:?/T,,\RJ51ZN)6(,B@^Z]TZ^_=>Z][]U[KWOW7NB3=[_-7;W5GR%Z
M@^(?7VQLOW/\GNY]H;M[.Q'7F*SV%VE@=B=/;(J(<5GNW.U=Y9LU'\,PK92L
MI\-CTQ^/S%?65LQ2GHGA@JIX/=>Z5_QF^4V)^0N4[RV'DME9WK#N7XS]FT?5
M'=O6^;KJ#.Q8+/YS8^UNSMG9W:^[<0$ILMA<YM[>N,RF-K/%1U 6=H:JCI9X
MVC]^Z]T:KW[KW7O?NO=>]^Z]U6O\NO\ LK#X0_\ AY97_P!WNT/;J?"WY=4;
MB.O?RS_^9?=R_P#B;,]_[I,%[]+Q'V=>3AU91[:ZOU[W[KW1>OEQ_P!DH_)S
M_P 5Z[H_]]ON7W[KW6M1_(/^96<^.7\@7X[YO'?$?Y8=U_Z+=D?++=U+5]0[
M VKN;"[UFQGR6^0.YTQ.V&DW[09*HEUM]C,J8QI!/%*L4<P52_NO=7R?*?OW
MLKX__P OWN[Y?]5[,ZPSO8_7OQKW;\F=SXC>,F;P&V]RU77O2-3O7+&J.UZ.
MJK*RKEIMI4N-I(YJFFM"D2-5HD"*?=>Z KI#Y"_.OY1?RE^A?E5\?)?CI'\Q
M.U/CCM7N.#:O:W7V^LMTSNW>68P*9Z?8M!1[1[;V)DL)#6.6HJ'(3Y+*"F9X
MWJ(IU61C[KW1</A3_-#^0/SW^.'QZHNF:_H;!_.&M[(W!LSYJ]>[EZ:['R&Q
M?BK2]4Y9L=W%%NS9,'R'PF9Q]7),]'C=GK59^LDRM5DDE%*E)0Y:6@]U[JQ[
MY@?+W"_%NBZ$V5D]Q]?X?M;Y,]ER=/\ 76X^PZEMN]5[:S&&Z_W7V5OCL?>Z
M3;AQ\PQ&(Q&RJV:'%1Y:FFKJVHH,6*^D^[:O@]U[JO/<_P#,J[;Z'_F ?$OX
M^Y;L#IOYG?&GYE5FY=C_ .DGX];+JH]Y_%;MG#5&U:'; [4KME]@=EXF7;&Z
M:S>,%'BGR$.)JJ<TM7*U761TDU_=>Z.-A?E7V#\E_EO\@OC%\;LQMW8^R_A\
MFQ\'\B.ZMR[0J-Z9#,=O]D;>J=UX/IGJ;!2;AV]1Q2X7%?9Y/<V?R"92%&KX
M,92T9J&J:NC]U[JI?^5A!VC2_P#"@#^>S2=S9/9N<[%H^O\ X#4>9SFP<)E-
MM;7SF/I.B<)3[5S5'MW,Y[=%103U>(CH*BOHSD:Q(:N2>.*5HE0^_=>ZVC/?
MNO=:P?\ *R:N3^>K_P *+'QD-)4Y),Q\+&Q]/7U4U%0U%<O5V_#20UE93TF0
MDAB>0*LDJ03LBDLL;D!3[KW0]?%'YM?S*OE_W?\ S-/CKA<%\6>I=R?$CY!8
MGIO8?<%9@=\=A=;X; U.U\GEZ:>IV&F^=F[@W/N.L/VU37?<56U,50121QTS
MY25)T?W7NAO_ )3_ /,-[.^4?37S$IOEU%UMMON;X!?+'Y _%OO+>_6N,S>W
MNKMV4W1U3YI.S<'A,]F=S55!#+2+,*NG>LG&NC>>-88YD@C]U[KC%\FOG;\E
MO@?N3YU_#^AZSQF1W+L3.=R?%/XV[KZSRV^=Q=R]=86HKLGM'#=D;H3LW8OV
M&=WSBL:DN+I<1'3IA9<E3I4RY=XY8O?NO=+SM3^8AV!U;\7_ (5[KW?T'5=>
M_,?YS;\Z9Z.V!\9][9>K>EZZ[E[)I17[\F[ SU%0450^ V5C\?E,QDI8J>EJ
M:N*BAI(E@JJR/1[KW05_/WYM?)W^5IM[J;Y.=VY+KGY"?#6M[!VGUG\J*[:7
M6.9ZT[1Z#_T@5]#AMN]W;%B@[$WS#FML4F1O09#:LU#79@ODJ-Z?*3K'.I]U
M[I5_S _F]\F_C5WW_+KVATSLKJ3>O3_S ^36%Z6W+D:S)9:J[)JL?5[$S6^Z
M-]J25M9MO!XR&M&&EBGKJE\R\5- SPP-45,2TWNO= 3\@OFQ_,:^%OSI^'G7
M7<6)^-7?_P >OGAOCL#I_9&R>HMK;LZN[,Z0[3PFUH-Q;$I,EV/OWL?<5#N;
M$U3,\6:RC8+"RK#'+4TN/2:.#'U?NO=*/=GRU_F,_%C^8Q\,^CODK+\7NWOC
M#\^-R=S=>[5K.E]B;YZX[!^.78G7NRJGL?:.)R^8WGV;O)=XT5?CZ2:BJ\A'
MBL'Y9():Q8,9XX,=7^Z]T8;<7SFPO:/<GR1Z8ZX^37Q[^-=/\9=UT?4.Z=W=
MPIM[<&[-W]SY'8.S^R:N#:>U,]V3U_3P;<P%%O?&T>1K)5KYLC73UE)3MC!C
M?N:[W7ND[_*;_F!]H_-C;_R6V!WSL'#;8[J^)7>FXNFMQ[^Z^P&Z<-TC\@=H
MTF9W)BMB]]=+MNBMSCG#;@3:5=-'3P9?,1HB13QU;PU4(7W7NK<??NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UK'?S*?\ N(C_ ) O_AN?./\
M]\SD_?NO='-_F4?.WY;?$GY3?RYNI>G>LNI=]=9_,#Y&3].[J&1S.6B[79<9
MMRCSX@P4F6FV]M_$44K3SG)9*>;-5,%)1,:*@JJNICAA]U[I ;O^;?SJ^+'\
MT3X2?%KY0Y/XT]A="_S$<7\@,3UM!TUUYV%M+?'1/8?1.TMK;P;&9K=VZ^P]
MQQ;GQM;%N:"BDKCA<+)++.)TIJ&.G>"?W7NBY_+C(?/*K_G^_#/J_8'RIZ>V
M]LG,?%KY+]F=/[%WM\9]^;UZ\Z\\%-AMJ;JJNP-M[5^5W5E7O'<=;'3,F.W
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MV:[/WUN[:^W,(,C4TF/K<5MW'87*9J:LRLD3+$^-IZ^KI_=>ZK!^)WR;V?\
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M4[5WAA)=T0=?]ZXS>^Q=M=J;8BII:^26@=FJIL?E(8*B!GHV*E])!]U[I_\
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M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW59_\XWXC;J^=?\ ++^7OQ;V%2ID-_\
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M/N#O?K[L?I;:N/H).GL'C\!53[CJZ>;9\M/+1X85U0T[20I"6IY2/=>ZC?\
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MV[UCV#_)N^%T&S-\[;S]7UKU55[/[#H*/)P+D]D;DV]O'>%!D\7NO&5#0U%
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M_*P4C>;-47NO=;HM U:]!1/DHX8<B])3-7PTS,]/%6M"AJHX'8DE%<L$)))
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M &:;XW_\_P >L/\ T,<+_P#5?MO0?0_LZO4=>_V:;XW_ //\>L/_ $,<+_\
M5?OV@^A_9UZHZ]_LTWQO_P"?X]8?^ACA?_JOW[0?0_LZ]4=>_P!FF^-__/\
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MT/[.O5'7O]FF^-__ #_'K#_T,<+_ /5?OV@^A_9UZHZ]_LTWQO\ ^?X]8?\
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MZ]_LTWQO_P"?X]8?^ACA?_JOW[0?0_LZ]4=>_P!FF^-__/\ 'K#_ -#'"_\
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M7_ZK]^T'T/[.O5'7O]FF^-__ #_'K#_T,<+_ /5?OV@^A_9UZHZ]_LTWQO\
M^?X]8?\ H8X7_P"J_?M!]#^SKU1U[_9IOC?_ ,_QZP_]#'"__5?OV@^A_9UZ
MHZ]_LTWQO_Y_CUA_Z&.%_P#JOW[0?0_LZ]4=>_V:;XW_ //\>L/_ $,<+_\
M5?OV@^A_9UZHZ]_LTWQO_P"?X]8?^ACA?_JOW[0?0_LZ]4=>_P!FF^-__/\
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4]R?H_P";O_'#_FYH]Z/Y]>Z__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>tbarchart_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tbarchart_003.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2      04  DE$_]L
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M_P#0XVQ_]@GOWBGT'7M Z]_PVKU#_P _3^07_H<;8_\ L$]^\4^@Z]H'7O\
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MQ_\ 8)[]XI]!U[0.O?\ #:O4/_/T_D%_Z'&V/_L$]^\4^@Z]H'7O^&U>H?\
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M.O?\-J]0_P#/T_D%_P"AQMC_ .P3W[Q3Z#KV@=>_X;5ZA_Y^G\@O_0XVQ_\
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M_7M Z]_PV)\:_P#E9[(_]"G'?_8][]XS]>T#KW_#8GQK_P"5GLC_ -"G'?\
MV/>_>,_7M Z]_P -B?&O_E9[(_\ 0IQW_P!CWOWC/U[0.O?\-B?&O_E9[(_]
M"G'?_8][]XS]>T#KW_#8GQK_ .5GLC_T*<=_]CWOWC/U[0.O?\-B?&O_ )6>
MR/\ T*<=_P#8][]XS]>T#KW_  V)\:_^5GLC_P!"G'?_ &/>_>,_7M Z]_PV
M)\:_^5GLC_T*<=_]CWOWC/U[0.O?\-B?&O\ Y6>R/_0IQW_V/>_>,_7M Z]_
MPV)\:_\ E9[(_P#0IQW_ -CWOWC/U[0.O?\ #8GQK_Y6>R/_ $*<=_\ 8][]
MXS]>T#KW_#8GQK_Y6>R/_0IQW_V/>_>,_7M Z]_PV)\:_P#E9[(_]"G'?_8]
M[]XS]>T#KW_#8GQK_P"5GLC_ -"G'?\ V/>_>,_7M Z]_P -B?&O_E9[(_\
M0IQW_P!CWOWC/U[0.O?\-B?&O_E9[(_]"G'?_8][]XS]>T#KW_#8GQK_ .5G
MLC_T*<=_]CWOWC/U[0.O?\-B?&O_ )6>R/\ T*<=_P#8][]XS]>T#KW_  V)
M\:_^5GLC_P!"G'?_ &/>_>,_7M Z]_PV)\:_^5GLC_T*<=_]CWOWC/U[0.O?
M\-B?&O\ Y6>R/_0IQW_V/>_>,_7M Z]_PV)\:_\ E9[(_P#0IQW_ -CWOWC/
MU[0.O?\ #8GQK_Y6>R/_ $*<=_\ 8][]XS]>T#KW_#8GQK_Y6>R/_0IQW_V/
M>_>,_7M Z]_PV)\:_P#E9[(_]"G'?_8][]XS]>T#KW_#8GQK_P"5GLC_ -"G
M'?\ V/>_>,_7M Z]_P -B?&O_E9[(_\ 0IQW_P!CWOWC/U[0.O?\-B?&O_E9
M[(_]"G'?_8][]XS]>T#KW_#8GQK_ .5GLC_T*<=_]CWOWC/U[0.O?\-B?&O_
M )6>R/\ T*<=_P#8][]XS]>T#KW_  V)\:_^5GLC_P!"G'?_ &/>_>,_7M Z
M]_PV)\:_^5GLC_T*<=_]CWOWC/U[0.O?\-B?&O\ Y6>R/_0IQW_V/>_>,_7M
M Z]_PV)\:_\ E9[(_P#0IQW_ -CWOWC/U[0.O?\ #8GQK_Y6>R/_ $*<=_\
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M?NO=:;7_  AN_P"/T_F2_P#AK_%7_P!VWR!]^Z]UO^;W_P"/+W?_ .&OG_\
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M=#E\?4M3S*LCT&5H<C052AJ>MI*FFDEA?W7NB>?#/Y7[E[9WE\@OB_WK18;
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M]U[W[KW7O?NO=>]^Z]U[W[KW6M]_PIEZGS=?\2_C3\N\#C\EE8OY?/S<^/\
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M*1ST4M+-@ZWKK?&STJ@]--'$T+4KXW)^E@F@H?TVX]^Z]UIC_P O+!;[P?\
MPCH^57]]*7)46.S'3/S3SO7E/DJ2HHS_ '$R&:SOAJJ%*E(R]-4Y6+*U,,R
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M]^Z]U[W[KW5=O:__ &\9^+G_ (C??W_O,]G^W5_LF_+JA^,=>_EB?]DUU/\
MXDC=/_NNV][]-\?7DX=6)>VNK]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=4>_R^?\ LLSO+_PT>S/_
M 'ZFR_:F7^S'^KRZ:3CU>%[3=.]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5V]K_\ ;QGXN?\ B-]_
M?^\SV?[=7^R;\NJ'XQU[^6)_V374_P#B2-T_^Z[;WOTWQ]>3AU8E[:ZOU[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U1[_+Y_P"RS.\O_#1[,_\ ?J;+]J9?[,?ZO+II./5X7M-T[U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U7;VO_P!O&?BY_P"(WW]_[S/9_MU?[)ORZH?C'7OY8G_9-=3_
M .)(W3_[KMO>_3?'UY.'5B7MKJ_7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW2=W?NW;.P-J;FWUO7.8W;&SMF8#,;JW7N3,U4=%B,!
MMS;^/J,KFLSDZR4A8J>EIJ22::1C940D_3W[KW5%N5_X46_##9'9NSMJ]V]%
M?/?XT]-]D[EQ.T>M/F)\DOB7O+I?XK;[S>;B2HQ@Q&]=YY''YFGI983)4&MR
M.WJ*&&"DJ:JJ:GI8?.WNO=7&]V_('JGX]]>P]F]G;FCQFV\EN#9^SML18RFJ
M,[G-\[X[#SE!MGK_ &-L7!8I*FIRV7S>1RE/1XVBHTD>5Y0>(U=U]U[H$,/\
MX=DT?=?6/Q_[GZO[=^-79'>.&S&3Z3I^Y*;K6HVQVGE-M8ZGR^Z-A;:WSU-V
M9VEAX]SXZDF:KEV_D*VBJZBGIYZB@2LIX)I4]U[HZWOW7NB:_*GYH;?^,D<&
M'PW1WR.^47:-7A&W-#TQ\6.M8.Q]_46UQ628Z+=&YZC-;@V?A,-0S3T\\5$V
M4R]+/7O1U4>-IZV:FGB3W7NF3X#_ ,POX]?S&NJ-P=I="OOG!U.Q-ZY3K3M?
MJOMG:<FPNW^GNR<)%!-F-B=D;.>NRB4E?3_<!7--5UD!=)(TG9XI53W7NCR^
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JCW^7S_ -EF=Y?^&CV9
M_P"_4V7[4R_V8_U>732<>KPO:;IWKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JNWM?_ +>,_%S_ ,1O
MO[_WF>S_ &ZO]DWY=4/QCKW\L3_LFNI_\21NG_W7;>]^F^/KR<.K$O;75^O>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7ND]NG:FW=[86
M?;FZL73YO!557B:VLQ56TWV5;+A,O0YR@BKH8I(A/!]SC83/32ZX9T#0SI)"
M\D;>Z]U51_/-V'C.Z_Y;W=7QLIMDX[LKM3Y.5^Q^C/CYL6K./6IR'>&[]WXB
M;9^[*.:O#>"#:46-J]XYBMB5I*7%8"NJ K>,HWNO=$=_G$9?(?#6C_D==J[\
MJLCF?CM\4?FUT[MGY#;\D@JWV]LZGRO4.7Z;VQW'O>H5HUHJ#&R9C(U+UU5,
MB)+4I!:6:HBAD]U[IK_X4J=O;&H?BE\,MU=7[PV=N;Y&X'^87\3^R?BMA<!O
MZEH-P;LW=39+<%%KP%?@)Z^9\968[.S4]75>"II M3#(RR2BG!]U[K9N]^Z]
MT%7:>_MJ=(;+WAVGE=G[YW%'0T3Y/,XOJ#JG>7:W8VYI,3C)FI:;'[.ZWV]N
M#+9&H$%%X*<"!@#HB#*613[KW5+O\C[OGXB?)3<O\P7O;I2MWYM#Y'=V_)B#
ML+Y3_'3MK:!ZY[*Z"JJ';%/L7K':^3V9*T[2)4X_:]375^7CJ*E*C+562BO%
MX%A3W7NK]_?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U1[_+Y_[+
M,[R_\-'LS_WZFR_:F7^S'^KRZ:3CU>%[3=.]>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5V]K_]O&?B
MY_XC??W_ +S/9_MU?[)ORZH?C'7OY8G_ &374_\ B2-T_P#NNV][]-\?7DX=
M6)>VNK]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= 3
M\E_DMTE\/^C^P/D7\B-^XCK?J/K/"OFMT;FRS2.1KECI,;AL-CJ9):BOR>0J
MIX:+&8VCCFJ*NIGB@@C>1U4^Z]UKF]>?\*3/Y+V:W;'\AN[?F&)^R$QM?A.K
M^JL5\<?E%E:/H39>=>!LO11YV;HVGI,ANO,)1TYW1EZ6J:F1((L7C#+203UV
M4]U[K8+VOW'TIW_\7]L=R]EXC;FW>BNY]@TF]H\)WW1X+$XBOZRW/3G.;6K=
M_;?WO'!2TAK\1+29&JQF00M2F<P37>)C[]U[JEG9?P/ZG^9WR^^/N]^H_C5U
M]\7_ .6-\!>R,EV_U;M3:/1^T^EZ+YK_ "YCA^PP?;N)V'1;0VW41;#V0R2M
MA,]4T].-QU]3455&M9AS1Y"?W7NKD=Y?-?H+8?S!Z>^"^XLYN*#Y#=Z=;;S[
M7Z^P--L[<=7MJLV=L09-LY4Y'>D- V-I9[82L,=-)4:_V%#B,U%*)_=>Z#KM
MO^:+_+[^/_R$R/Q<[^^5W4G0_=&-V/@>QI<'W9G)>IMLU6TMRS92GQ%?B>S-
M_P!+M[;%;+(^'J%:CI,Q-4(4TO$&X]^Z]T7'XH="8;<_\SWYG_S"^N,%0X;I
MON3H'X_]"X7==)COX2._>RNM,WO3*[^[BQD1H:=LEA:;%5.UMMX?<1=X\B<7
M5&D,M#!35,_NO=7"^_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[K%//!2P35-3-%3TU/%)/45$\B10001(9)9II9"JJBJI9
MF8@ "Y]^Z]T7CJGYA?$KO?>.YNN^D/E#\>.XM_[+EJ(-W['ZM[IZX[ W?M>6
MDGFI:M-P;;VIN3+5E)XIJ:6&4SPQA)(I(VL\;JONO="KOGLSK?K"@H\KV7V#
MLCKS%Y&L_A^/R6^=UX':5!75XADJ30T=9GZ_'QRS>.%Y/$C,VE2UK GW[KW2
M$POR>^-6X\OC-O[>^0W1N>SV:KZ7%X;"87MK8.4R^6R==,E-18[&8VAS\\T\
M\TDBQQ0Q([NS!5!) ]^Z]T.7OW7NNF954LQ"JH+,S$!54"Y))^@'OW7N@WV9
MW)U+V/ELO@NO>S-B;\RVWVJH\]1[,W3A=T/A*BAJ8:.MHLO)@ZRN2FJ89*B-
M9::9DE36I9 ""?=>Z$GW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=4>_R^?\ LLSO+_PT>S/_ 'ZFR_:F7^S'^KRZ:3CU
M>%[3=.]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=5V]K_\ ;QGXN?\ B-]_?^\SV?[=7^R;\NJ'XQU[
M^6)_V374_P#B2-T_^Z[;WOTWQ]>3AU8E[:ZOU[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=->1P>%R\M%/EL/B\I/C)G
MJ,;-D<?25LN/GD4))-125,,IB=E !:,J2!8GW[KW3I[]U[K U+2O4Q5CTU.U
M9#%+!#5-#&U3#!.T;30Q3E2RHYB4LH(!*B_T'OW7NH=9A</D:BFJ\AB<9755
M&0U'4UE!2U512LKB56IIIXG9"&4,"I'(O]??NO=.?OW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[H#OD-T+M'Y,=;U
M73?9+U%;U3NG*XW_ $I[.@DK*6'LO96/,U=4=<YG(8^OH)HL3DZR"B7-0*9$
MKL?'58R9#!6RLONO=:XO\X7^6;\3_CY'\"ODK\%.D>NOBC\Q]D?/;XT]:],M
M\9-FX3I^J[>H>RMW)CNP^OMV;=ZYQN$@S,";<Q64S.1JZN&66+%XO)QSS?PZ
MIKXY?=>ZO9^3?P ^+_S0WIL/<?RMZSP7>^V.K,+GJ3KSJ[?J5^3ZVPNY=WST
MR[JWUE=G?Q%,;ELK)1XBAH,94Y&CG?&Q"M^S=#D*CW[KW57F'_ES? G9?\V?
MXP;7^,GQ-^/_ $]DOB9TSV#\LNW-T=:;3Q6U]RKN?M!\CT+\;=G93^$4:-)1
MU:)V!N!H995 J-MT$Q6P02>Z]UL*^_=>ZUL_F+\O]I_++^9;DOY;>;[=7KCX
MB_%+K? ]R_.2AVME,A_I!^2._MUMCLIU?\4<5C=I+79ZJVTF/E.=WS18BFF:
MOI1_#*PQTCSQS^Z]U=Q\6_D!\6>_>O:B;XE]A]9;VZ]ZTS,_6>3PW6<M#1TG
M6VX=NT].*C8.=VC3T^/GP5;1Q3Q$XRLHZ26-'4^,*0??NO=&4]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5'O\OG_LLS
MO+_PT>S/_?J;+]J9?[,?ZO+II./5X7M-T[U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U7;VO_V\9^+G
M_B-]_?\ O,]G^W5_LF_+JA^,=>_EB?\ 9-=3_P")(W3_ .Z[;WOTWQ]>3AU8
ME[:ZOU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=<7=(P&D=44
MLB!G8*"\KK'&@+$<LSA5'Y) '/OW7NN7OW7NO>_=>ZP1U5+-/44L533RU-)X
MONZ>.:-YZ7[A#)!]Q$K%DUJ"R:@+CD7'OW7NL_OW7NN(=&9T5T9X]/D0,"R:
MQ==:@W%QR+^_=>ZY>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z3F[MW;8V#MC.[TWIG<9MC:FV,959G/Y
M_,U4=%C,5C**,RU%75U$I "@"P N6)"J"Q /NO=$]V]@J#L?L?;WRY^0$$?6
M^W.N,/N6#XV[![$R=+MV;8N&W#C&I]X]X]A8G+-1QX_=68QBO14='4N\^"PD
MD\$YIJ_*9:E@]U[HZ.#S6,W)A,/N+"52UV&S^+Q^:Q%<L<T*UF,RM)#74%4L
M-3'#(@DBG1PLB(PO9@#<>_=>ZK9_EL?<=L?[-7\VLE]])_LW'R+W1_HODR'\
M,?[?XT?'7R]!]&_PB;'>35C<W_=#.;YHM<C@_P!\I)%OY#))[KW5D-1N+;])
MF\=MFJSN&IMR9BCKLAB-OU&3HH<WE,?BV@7)UV.Q4DZSSPTYJHA/+%&RQF1=
M9&H7]U[K79_E:[3J>JOYU7\^_9V_<#68SL'M#=/Q%[UV#N#)US3?WVZ.S.U>
MTL;CIMN4,T+%*3#9*K..JZF*HD62=UIFCA-$NOW7NE'\7ND\YUQ_PHT_F-;V
MZJQ,.'Z+[.^#_P ==X?(-*)Y?X;6_*O+[R_AO7E1#3P0"F@JWVGM3/9'(P%U
MF:7++6NK??F0^Z]UL.>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[JCW^7S_V69WE_X:/9G_OU-E^U,O\ 9C_5Y=-)QZO"
M]ING>O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NJ[>U_^WC/Q<_\1OO[_P!YGL_VZO\ 9-^75#\8Z]_+
M$_[)KJ?_ !)&Z?\ W7;>]^F^/KR<.K$O;75^O>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[I)[\WOMSK79>Z>P-WUDF.VMLS!9+<FX*^&DJJ^6
MCQ&(I9*ROJ(Z*BBGFE*1Q,1'$CLUK $^UNW;?=;K?P[;8KKFG=8T%0*LQHHJ
M2 ,GB33I->7=O86DM]='3%"K.YH315%2:"I.!Y=$&_X=J^#'_/TLW_Z+;L+_
M .QOW)'^LM[B?\H2_P#.>#_K9T"/]=#DK_E+/_.&;_K7U[_AVKX,?\_2S?\
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M_8[[]_P/.Z_\I\/^\2=>_P!>?;/^4.7_ 'I.O?\ #K'R8_Y^-N?_ ,]&Q?\
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M?_ZS>_:HOX?Y]>H_KU[_ $#_ #K_ .\O</\ ^@#A_P#ZS>_:HOX?Y]>H_KT
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M?Y(7_9*/8/\ XL+NO_WV_4_O#S[P?_*YVW_/%'_U?N>LEO9O_E6)_P#GJ?\
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MU[W[KW7O?NO=>]^Z]UIP_P U7_LO;OC_ ,I?_P"^9Z[]YU>S?_3M]M_ZB/\
MM*GZQ+]S?^5WOO\ FS_VCQ=5Z^Y.Z ?7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW6TS_)"_[)1[!_\ %A=U_P#OM^I_>'GW@_\ E<[;_GBC_P"K]SUDM[-_
M\JQ/_P ]3_\ 5J#JX_W!74M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]UKH?SV_^/C^-?_:D[1_]S]B>\H_NZ?[C;M_IK?\
MP3=0'[V?VNV_9/\ X8NJ!O>2O4%]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=7M_P BW_F97?G_ (8VT?\ W?Y'WCE]XG_DE[9_S5E_XXO4W^RO^YFX?Z2+
M_CS];)OO%3K('KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJ[>U_\
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MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JO7^:K_V03WQ_P"4O_\
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MW7NJ[>U_^WC/Q<_\1OO[_P!YGL_VZO\ 9-^75#\8Z]_+$_[)KJ?_ !)&Z?\
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M<;O7<77.R,[O#')"M.E!NG+;9QE?N"B6G5G$8BJZB:,("0NFU^/?NO=:_/\
MPFF.YTZB_F;T>03(Q[-HOYP/S*AZ]CJ5E3%08G1UX<M3;722R)0+6^4E*8"
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M)W0#Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZVF?Y(7_9*/8/_ (L+NO\
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M?NO=>]^Z]U[W[KW7O?NO=:</\U7_ ++V[X_\I?\ ^^9Z[]YU>S?_ $[?;?\
MJ(_[2I^L2_<W_E=[[_FS_P!H\75>ON3N@'U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]UM,_R0O^R4>P?_%A=U_^^WZG]X>?>#_Y7.V_YXH_^K]SUDM[-_\
M*L3_ //4_P#U:@ZN/]P5U+77O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5=O:
M_P#V\9^+G_B-]_?^\SV?[=7^R;\NJ'XQU[^6)_V374_^)(W3_P"Z[;WOTWQ]
M>3AU8E[:ZOU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=%?\
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MM.'^:K_V7MWQ_P"4O_\ ?,]=^\ZO9O\ Z=OMO_41_P!I4_6)?N;_ ,KO??\
M-G_M'BZKU]R=T ^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NMIG^2%_V2CV
M#_XL+NO_ -]OU/[P\^\'_P KG;?\\4?_ %?N>LEO9O\ Y5B?_GJ?_JU!U<?[
M@KJ6NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJ[>U_^WC/Q<_\ $;[^_P#>
M9[/]NK_9-^75#\8Z]_+$_P"R:ZG_ ,21NG_W7;>]^F^/KR<.K$O;75^O>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[HK_S8_[)#^2O_B%>P_\
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M7O?NO=>]^Z]U[W[KW7O?NO=;YO0/_,B.E/\ Q$G7'_O'8;WS@YC_ .5AO_\
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MNJ]?YJO_ &03WQ_Y2_\ ]_-UW[D[V;_Z>1MO_41_VBS] /W-_P"5(OO^;/\
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M;T#_ ,R(Z4_\1)UQ_P"\=AO?.#F/_E8;_P#YZ)_^KK=9O[/_ ,DFU_YHQ_\
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M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJ[>U_\ MXS\7/\ Q&^_O_>9[/\
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MKWOW7NO>_=>Z][]U[K3A_FJ_]E[=\?\ E+__ 'S/7?O.KV;_ .G;[;_U$?\
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MW7NO>_=>ZKM[7_[>,_%S_P 1OO[_ -YGL_VZO]DWY=4/QCKW\L3_ +)KJ?\
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M[]U[K4+_ )NW_9;^_?\ PU>N_P#WD,9[S<]D/^G?V_\ S5G_ .KAZQ8]U_\
ME<)/^:<7_'>JR_<N=1MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UOF] _\
MR(Z4_P#$2=<?^\=AO?.#F/\ Y6&__P">B?\ ZNMUF_L__))M?^:,?_'%Z%OV
M3=&/7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5>O\
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M@=>_X;$^-?\ RL]D?^A3CO\ ['O?O&?KV@=>_P"&Q/C7_P K/9'_ *%.._\
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M?_*SV1_Z%.._^Q[W[QGZ]H'7O^&Q/C7_ ,K/9'_H4X[_ .Q[W[QGZ]H'7O\
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MKW7O?NO=>]^Z]U[W[KW7O?NO==,RJI9B%5069F("JH%R23] /?NO=4)]U?\
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M;RM@-U[:^)&1Z[W6VR-ST]-E,=)/#D*GL.!J:)UFACGIDK&7S4E.K^Z]T_\
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MQV(Q[XK QXZCTK2+#0U%*T%-I33!)$570R$^Z]UKZ_R^_P#N(+_X4%_^&O\
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MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJ[>U_^WC/Q<_\
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MPW].O:UZ]_LX7QB_Y_5LC_SX2_\ U/[]X;^G7M:]>_V<+XQ?\_JV1_Y\)?\
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M^V_$?UZMH7KW^R/?%3_GSF"_\^NY_P#Z^^_>(_KU[0O7O]D>^*G_ #YS!?\
MGUW/_P#7WW[Q']>O:%Z]_LCWQ4_Y\Y@O_/KN?_Z^^_>(_KU[0O7O]D>^*G_/
MG,%_Y]=S_P#U]]^\1_7KVA>O?[(]\5/^?.8+_P ^NY__ *^^_>(_KU[0O7O]
MD>^*G_/G,%_Y]=S_ /U]]^\1_7KVA>O?[(]\5/\ GSF"_P#/KN?_ .OOOWB/
MZ]>T+U[_ &1[XJ?\^<P7_GUW/_\ 7WW[Q']>O:%Z]_LCWQ4_Y\Y@O_/KN?\
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MO:%Z]_LCWQ4_Y\Y@O_/KN?\ ^OOOWB/Z]>T+U[_9'OBI_P ^<P7_ )]=S_\
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MOOOWB/Z]>T+U[_9'OBI_SYS!?^?7<_\ ]???O$?UZ]H7KW^R/?%3_GSF"_\
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M7_GUW/\ _7WW[Q']>O:%Z]_LCWQ4_P"?.8+_ ,^NY_\ Z^^_>(_KU[0O7O\
M9'OBI_SYS!?^?7<__P!???O$?UZ]H7KW^R/?%3_GSF"_\^NY_P#Z^^_>(_KU
M[0O7O]D>^*G_ #YS!?\ GUW/_P#7WW[Q']>O:%Z]_LCWQ4_Y\Y@O_/KN?_Z^
M^_>(_KU[0O7O]D>^*G_/G,%_Y]=S_P#U]]^\1_7KVA>O?[(]\5/^?.8+_P ^
MNY__ *^^_>(_KU[0O7O]D>^*G_/G,%_Y]=S_ /U]]^\1_7KVA>O?[(]\5/\
MGSF"_P#/KN?_ .OOOWB/Z]>T+U[_ &1[XJ?\^<P7_GUW/_\ 7WW[Q']>O:%Z
M]_LCWQ4_Y\Y@O_/KN?\ ^OOOWB/Z]>T+U[_9'OBI_P ^<P7_ )]=S_\ U]]^
M\1_7KVA>O?[(]\5/^?.8+_SZ[G_^OOOWB/Z]>T+U[_9'OBI_SYS!?^?7<_\
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M7(T4$L57/@]ITN1R=!6Q^2GFRDM'.B202(/=>ZZ_X4M_.NC^)7\MGOWJ>DZ
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MQ?\ PWE\]\0:V)<AB>^*G-9&G?7&*3%Y;H_ TN/K99G58]$CX"L7AR5\!+
MJ3[KW17O^$-S*-[?S)%U#4=K?%=@MQJ*KEN_PS ?T&L7/^(]^Z]UN1?S9I8H
M?Y6'\RMYI(XD/P$^8<0:1U13+/\ 'KL."",,Q U.\BH@^I9@!R1[]U[K3:_X
M0WS0KOK^9%3M+&)Y=I_%J:. NHFDA@S'?:3RI&3J*HU1&'8"P,B@_J%_=>ZV
M_OYRDD<7\IO^9 TCI&I^%?R-C#.RHIDFZMW+%$@+$<LSA5'U)( Y/OW7NJ _
M^$3S*?Y='R=74-0^:VXF*W&H*W1?1X5B/Z'0;'_ ^_=>Z+!_PL4ZT[0Z][O_
M )<'SRQ/7]1V!U#TKG<AMC>T<H<[:Q>[L'V%M'LG:&WMW30I424M-N:&BR%%
M%5"%XPV/>-V$LE/'+[KW5Y71/:7\A'YAU7QV[#Z,V+\+N]N_L[4[0W=U+U=M
M[;O5>ZOD_P!59C[W$;BR&>R6QZ]SGMI?W6DI/XEE\I5Q8^*F..UQ2R3FE27W
M7NM<O_A033U?PE_X4%?"_P#F ]Z]85._/B)N_;G5.'W)DJS&RY;;<]!MEMU=
M>]P;3^UIXJQI,KB<'N&'<=)021(*PU$:1,Q6H,/NO=;3WQSK_P"2MW1WYUIV
M-\-=J?"WOKY%XS&RY[&]C_'W'=4[Y[1Z3V8^"RU'-N??FZ,'+/E=J4<JY=\-
M%1Y"2DJIY\H::.E=?NS%[KW5R/OW7NOF/_\ "H/.83#_ /"@3XZ9C+9C%XO$
M[<Z[^(5=N'*9'(4E%CL%14';>[LK75F9K:F:**EBAI7%3+).R*D1$C$)S[]U
M[KZ$O9F[OB[U7O0_,KLGN;JCKK%[*Z5W5UWNG?.Y-W[2PV!J]CYG=&T]]8F;
M)[DK,E#J3'5&W:PXZG1I/(V9G\8+LH;W7NJI?D3\IH/YE_\ (B_F,_(KI'#[
MESW6_:74/S"PO06-DVU5T6Y]Q]=]00;AZU_CL6#CB>MD?-9'KS,YJEIZB&.K
MAAKXJ2:))8&0>Z]UK"_R>/D;T;UC_P )A_YM/6&]^T-G83M#L;L+Y=X+8?6,
MF:HZGL;=U9O#X7=,4.'J-O;&I))\I5TBKM7+UE;70TKT])1X;(5M5)%2T53+
M%[KW5M/_  B>93_+H^3JZAJ'S6W$Q6XU!6Z+Z/"L1_0Z#8_X'W[KW5:O_"?"
M:&3_ (4\_P SR2.6-XYU_F"M!(CJR3*_S'V#*K1,I(8%06!%^.?I[]U[K9;_
M .%,?Q@[1^5?\HGOS:/3NW<GO#?'7>=V!W5!M'"4E1D,YN/ ==9]*S>%)A<=
M24]3-4U4&)K:VOAI84,DQI/%&&=E5O=>ZI]K?D%UU2_\(LX=QPY"2L@G^/5'
M\?5Q\34<64'8M1\F8^JZK'FDJ:R'TT]09,FX#>1L?":F.-KJC>Z]UCZ9^,/:
M?Q5_X1Z_(W:/<FW,CL[>_8?4G9_=,NT<U35-!G=O;>[&[!V]6[0I<YC:REI)
MJ2KGQ5%1UTM),ODA-7XY-,BLB>Z]T*G_  EZ^4/076W\CKMZ/>W:FSMKY'HW
M>'R.WUV9B-PYBGP64V]M*LP<.>QFY#1Y8T;U./JXJ*HAIJZD%1!)4TM11K(:
MJFGAC]U[JE[^0!\!/D1W?_)W_G=[JV5M7(5"_)OJ':_4/0&)%/4T.3[0WWT=
MB^R-\[IQF J,G'CZ26FJJC=N,P%)4QU,D3UTE7!,\!I'U^Z]T;/_ (3<?*7^
M4[6?"3L3X>?S&Z/XH=5]N]-=C[YIIX?EO5[*V;CNR^MMZ5SYJ7&SU?:QP]!/
MD,3EI<MBZ_ F26>.&.ED,1\KJGNO=;'OS>^8_4G\J[^3QV7\F_A=\<-A[2Z_
MV\E+C^@>L*;8U%LCJ>LK^X.PH=N[>[.K]B;;JMOR+M[*3[A.X_MHVQ]57P5*
M&3[:2J9T]U[K2S_F:?(KKWYM_P B[H#Y'[D[SW!\HOG;FOF3@-V?)ZOAVWNZ
M';WQ9V!5;1^1NUMO]-8':^/QTFV=@[;$]?M:GH8(7H9=RU2+D0:TP6H_=>ZV
M>^K.S>N=\_\ "2O>D.R]^;.W=)L;^5%OW8&]%VUN3$9P;4WWC>B,K2Y+9>X6
MQM94BCRU-+4QPU&.G,=1%(ZI)&KD#W[KW5/_ /(ZG@'_  E3_G00F:(2Q[F^
M;SO$9$\B)4_"/H"*G=TO<"1H75"1ZBI N0??NO=6 _\ ")V2,_RZOD]$'0RI
M\U-PR/&&4R)'+T9TBL;LE[@,87"DBQ*FWT/OW7NMRCW[KW7S$/Y$6\-I;?\
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M<NTLWGL3O+)3?)79M3B<M31T?\.EV#CWS$6(IJ*6GFOFKR2/7SQ^Z]ULB_R
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M=]Y#:_5?R)W%TS-UEN?.[KP^U>JMS]=8*KEV=-DMQ;-V34@P[@@SF0BB:GJ
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MQT23^5"\<B+)')_+S9'1U#(Z-\;BK(ZL"""#8@^_=>ZUP_\ A$I_V0I\M_\
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MQ]W[0W5T!MS>G9^]LOUKD=[;#7H[?5'E\CU[A<GB)]L9;!9:CJIJFACHJF*
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M.V?F9+++*ZQQQ1Q]R=TN\DCN0%50"220 ![]U[JO'_A$)_V3!\Y?_$]=;?\
MOO:_W[KW0:?\)@?^WS/\[#_P[^T?_@J=X^_=>Z]_PF!_[?,_SL/_  [^T?\
MX*G>/OW7NN'Q#ECF_P"%H7R_>*1)5&T^RXBT;JZB2'X_]6PS1DJ3ZD>-D8?4
M%2#R/?NO=<OC7M'<O3'_  L\[VH.TC5XBJ[MVCVYN[J>JRYGT;VVUN7HS&[E
MP8V]42-,)8J6BV9EJ/AE6-\+40 *T03W[KW4/Y&[>W%WA_PM Z6QG5$64R]7
MT)MWJ#</;M9C(*N"GV?MW;G0<^[\]+E*YS2H:6>AW]B:!Y(WDC:;+)2'5,7A
M]^Z]T&O\]7_N*P_E'?\ AT?RV?\ X.#>GOW7NDO_ ,*#/^XGS^5]_P"8^/\
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MU[]X[?\ [_C_ -[7_/U[_2AUG_S\38O_ *%V _\ KA[]^Z=U_P"4:7_G&_\
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M2?\ 7[W[]^;+_P ID'_.6/\ Z"Z]^Z=U_P"4:7_G&_\ FZ]_',+_ ,[C%_\
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M:']#^SKU1Z]>_P!F,^/?_/\ ?IK_ -&?LC_Z^>_:']#^SKU1Z]>_V8SX]_\
M/]^FO_1G[(_^OGOVA_0_LZ]4>O7O]F,^/?\ S_?IK_T9^R/_ *^>_:']#^SK
MU1Z]>_V8SX]_\_WZ:_\ 1G[(_P#KY[]H?T/[.O5'KU[_ &8SX]_\_P!^FO\
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M[_9C/CW_ ,_WZ:_]&?LC_P"OGOVA_0_LZ]4>O7O]F,^/?_/]^FO_ $9^R/\
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M_0_LZ]4>O7O]F,^/?_/]^FO_ $9^R/\ Z^>_:']#^SKU1Z]>_P!F,^/?_/\
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MLZ]4>O7O]F,^/?\ S_?IK_T9^R/_ *^>_:']#^SKU1Z]>_V8SX]_\_WZ:_\
M1G[(_P#KY[]H?T/[.O5'KU[_ &8SX]_\_P!^FO\ T9^R/_KY[]H?T/[.O5'K
MU[_9C/CW_P _WZ:_]&?LC_Z^>_:']#^SKU1Z]>_V8SX]_P#/]^FO_1G[(_\
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MA>O?[(]\5/\ GSF"_P#/KN?_ .OOOWB/Z]>T+U[_ &1[XJ?\^<P7_GUW/_\
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MO7M"]>_V1[XJ?\^<P7_GUW/_ /7WW[Q']>O:%Z]_LCWQ4_Y\Y@O_ #Z[G_\
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MNJLH!%.CG?[(]\5/^?.8+_SZ[G_^OOMOQ']>K:%Z]_LCWQ4_Y\Y@O_/KN?\
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M7_>G_P"@NO?UDWO_ )2#^Q?^@>O?W2V[_P ZR+_J;4_]?O?OZI<N_P#**O\
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MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO==,RJI9B%5069F("JH%R23]
M/?NO=8*2KI:^EIJZAJ:>MHJVGAJZ.LI)HZFEJZ6IC6:GJ::HA9TDCD1PZ.A(
M8$$$@^_=>ZY5-33T=//65D\-+24L,M35553*D%/34\"-+////*RJB(JEG=B
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MVY8,/]G_ !FLV]USUAMK>.=JZ2A_B-.<A70X]J:D6='JIH48-[]U[I[^+_S
M^-_S5Z<HN^_BCVIM_O+K+(2UE%39G:9JZ"OAS5#24]94;9SFW]V4VW*_$91(
MZR R8_,T^/FC$\;2I&C!O?NO="MUUV?LGM3#U^8V5F4R*X7,UFV=S8JH@J,;
MN':&ZL;'3RY/:F[]O9"*GJ\;DJ9:N)Y:.KBBDT31RJ&BEC=O=>Z7_OW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z)Q\[?\ LGW+?^'+MG_W.;V-
MO;__ )6-/](_^#H+<X_\D-_],G^'JC[W/740=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW6PE\8_^9 ]5?^&G1_\ 6R?WC?S5_P K%>?\U#_DZG#E_P#Y(MM_I!T.
MWL/]''7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5=N^?^WE_3?_ (K[E/\
MW/[5]NC^Q/V]4/QCKW\L3_LFNI_\21NG_P!UVWO?IOCZ\G#JQ+VUU?KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>ZJKW#WIC?E?_,1WS\$L#F(ZKJ7XA]0[#[?^6N)H*N$
MC?W97=55D_\ 0;T1N@0&27^!TV&P5;NS<F-9J=<C]QAJ.H^YQLF3HZCW7NBY
M?SN/F[\9OCCL[IWH'Y5Y;O?8OQU[RR65R'?_ &3T5L[LFKK=H]9[1^RI=K;3
MJNP^LZB@K-KR[CW3DL3$E73O-//C\3DZ&&$254<T7NO="]_*J^+7\MW:.V:K
MY6_R^>T][]V[3[7VU_=$;ZW3\B^U^\J+'T%#E*;*93;\&&[.W/FI=OY-:FE@
M&3HY:6AK%,,:5" *H]^Z]T^YGNN+X3_S#^@OB_6Q9"'XX_S!-L=KU/34+)DZ
MK;_2ORBZ4H<-NG<W7F#J!3U-/C,%OK;><GR>,Q+3TM/2Y3;E6,? 5R-0L'NO
M=6S>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZI
MN_G4?*G<O0_1OQ\Z'ZZRF8V]VE_,)^8/0'P9VKN[ U,=#E]A[>[KWA2XWLS>
MF+R+U5*:6MAP$%9C\95QF1J:NR=+4Z&2%[>Z]U;3M796T]D[,V[UWM3;V)P6
MQ]I[9Q6S=N[6Q]#3T^#Q.UL)C(,+BL#1XZ.,1)2P4M,D"0A=(10MK>_=>ZU^
M/Y>-'24'_"@7_A0534-+345,-M_RPYA3TD$5/ ):KXLO55,HBA5%U22S/([6
MNS.6-R2??NO=9/G-V7N'MW^?O_*-^%D.<B/6?476G?/ST[5V/4PR1TFX]PT6
MSNS>L.@-Q>>7%54=358+/[=KZJCIEGA$(FFJ9/WDH3[]U[IR_F][^KOC'_,+
M_DA?*;;>2R&(K-X_*[<WP+[*IZ*KH*;';OZJ^7%)M"ABQ^ZX*RG4S4F#S>SJ
M+/4SBJA%/+ \GBGD,7B]U[JZKLW=G0?QXQV^_D;V[N78O5N-IMMT5'OCM;?&
M8I,/!2;5VI#E<M08>3-9:H'BHZ7[FNK(Z"F*H99JB<1-+)*[>Z]U43_(YB^)
M780^?ORY^'W;VPM[];_,#Y<Y+M =8[#H:G;W^A48K:F+V_#1[UV=DJ;%5>,S
M^Z:B*MW77138^D BRE/"IF:!YF]U[I7?,SN3*_"O^:-_+T[,Q];C\9TU_,#R
MV[OA!\A\75UK8^FK^X*#'8_=OP[W]10''30S9>.MFW#M*1FJJ22:DS4$6FK-
M+3"E]U[J[?W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=!WVAUC
MMOMW:<^S-UMDDP]16T5?(<551T=9YZ"4RP!9Y:>J 6Y]0T<_U'LRVG=;K9KP
M7UGIU@$=PJ*'!Q4=(=QV^WW.V-I<UT$@X-#CAY'HL_\ L@71/_*QOK_T(:'_
M .LGL5?ZXO,'I%_O!_Z#Z#_]2MF]9/\ >A_T#U[_ &0+HG_E8WU_Z$-#_P#6
M3W[_ %Q>8/2+_>#_ -!]>_J5LWK)_O0_Z!Z]_L@71/\ RL;Z_P#0AH?_ *R>
M_?ZXO,'I%_O!_P"@^O?U*V;UD_WH?] ]>_V0+HG_ )6-]?\ H0T/_P!9/?O]
M<7F#TB_W@_\ 0?7OZE;-ZR?[T/\ H'KW^R!=$_\ *QOK_P!"&A_^LGOW^N+S
M!Z1?[P?^@^O?U*V;UD_WH?\ 0/7O]D"Z)_Y6-]?^A#0__63W[_7%Y@](O]X/
M_0?7OZE;-ZR?[T/^@>C:;*VCB=A;4P6SL&:ML1MZ@CQV/:NF2HJS3Q,S+]Q,
MD4 9O6;D(O\ K>P=?7LVXWDE[<4URG4:"@K\AGH36EM'9VR6L-=,8H*Y-/GT
MJ/:3I1U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U7;OG_MY?TW_ .*^Y3_W
M/[5]NC^Q/V]4/QCKW\L3_LFNI_\ $D;I_P#==M[WZ;X^O)PZL2]M=7Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NM;G^3U68RI_FU_P#"BN/(TVX%['A^2?Q1&;K<@M-'
MA:CKI>MNV*3JFDQ44<WD^XABHLHU0[PHK4\]$5DD;R:/=>ZV/:RBH\C25-!D
M*2FKZ&L@DIJRBK((JJDJJ:9#'-3U--.CI(CJQ5D92"#8CW[KW5#/P]^'N*^%
MO\YGY8[;^+U#@ME?$/O_ .'.P/D!VYTOMW^*46V>KOE94=RYC9&S\OLS;5)4
M+A\31;IVY@=R5=3204\<IFQ:B(1TD<4?OW7N@B_X4%G<\/;O\C6LV,F1_OE#
M_.!^.D.,DPJR_P 5_A-2]4-STQ>GL_V$M%%(,HCD0-3!Q47A#>_=>ZV3/?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:Y'\^J/<
M6T^^_P"1GW71X3'Y;:6POYLO1NR-Z5>6Q5;EL;M^C[DJ:3;%/GZB*B>,PRTL
M.-K)L?4NVF.O2D.F0D1/[KW6QO[]U[K73_E]U$'_ $$(?\*!X//#YY-J?RPY
M(X?(GEDCI?BM!#4R)'JN5C>=%<@64NH-B1[]U[I]_F#=<93H[^<M_*>_F&-1
MX>CZESV.[9^ GR!WI7PF([2/;>WMVYWXTRY/+F!(*.BKMYYNHQ*5=;4)&*K(
MP442FHR,9]^Z]UD_F;];Y3Y=_P TO^3S\;]HT$VX,1\8>VMW?S#?D17X[,U4
M5/U;MOJ5MO8_X[56Z<?0HZK)NO==%DJ+#"JDA:9<-D5A2>&.M,'NO=7>0=U=
M,UW:>5Z(INU^M*ONK#[<Q^[,UT]#O?;$_9N-VIF/NEQFXLCL),FV4BH*C[*7
MQ54E*(G"$AB/?NO=4^?"GXM;(Z\_G"?S(/D5\=]L8S:_0'8_2OQWV%V-5[16
M*CZ_W9\O]L;A["K.S8-NT%%4+1_>X+!?P'^/M0TZPID\]5)*_P#$CDD7W7N@
M6_GU;(RW;OR!_D9=2;3G@_OEEOYJ?6/9M/2S-*K)LGI' 5^_^R,W'XE8M_#\
M92&8)==3,BZE!++[KW6QW[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJ[=\_]O+^F_P#Q7W*?^Y_:OMT?V)^W
MJA^,=>_EB?\ 9-=3_P")(W3_ .Z[;WOTWQ]>3AU8E[:ZOU[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=5-U/05/\3/YF'9OS=Q./QM'TC\V^F^N>K/DOGD II>N.]NC:ZI
MQW1_9FXBD13^ ;@P&Y:[;66R,C1KCZ[&XEYR:>NJ)Z7W7NA.[\^ &Y>W?DA0
M?)SK;YV_-GXN[N_T;4G5FXMD=+[VZLS_ $YN3;U!FY<W29B;J/O?J+N/ 4N<
M5ZB2+^,TU D_C.E=.J?S>Z]T</JKI[:'4&,S%+MU\YF,YNK+ON+?&^=X9FJW
M-OK?>X7IX:-<ONG<5;9Y3#3TT5)0T<"4]'0TL,5)0TU-2110I[KW5?78/1LG
MS%_F,?''NJK:>;X^_P NW#=K9C;=:%3^"]I_+CM_$XG9B'!52.&K*#KS;E#D
M%KJN(O2G-;A6A5GK,1D8J7W7NK6/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=%H^7OQ=V-\Q_C]OOH+?E?E<!2;HCP^8VMOC;H
MIANOK/LC9N;Q^[NM>T-HR5D<T0R>W\WA:'*4BS(\4K4WAG5X))$;W7NE[U'G
MM_YO:JX/M[;,>&[&VU!2X7=]9C*:2;86]:D4YA.\]AU[F8'&Y/P23_PRJ9:W
M'LYIJJ,J(*FI]U[I&[1^'OQ(Z_[&S/<.P_BU\<]D]M[BJ%J]P=I;1Z1ZSVWV
M-G:I)HZA*G,[WPVV*+)U4@DA1P\]4Y#(#>X!]^Z]T,6^=B;([/V?N3KSLG9^
MU^P-@[RP];M[=VR=[8#%;IVENG Y*%J?(87<.W<Y2UU'6TDZ,4FIZB&2-P;,
MI'OW7NF#KCIWJGJ"FS-+U;UULW8$6Y*^FRFXVVIM[&86HW%DJ+'TV(H<AGZR
MBIXIJV:"DHH:2"2I>5HX(8X4*QHJCW7N@-[P_E__  8^3&]Z3LKY$?#[XT]X
M]@T.*H<#3[U[7Z4Z\W[N<8+%U%35XW"39K<VW\E/+1P25LS0TLKO$AFDTJ [
M7]U[HS6$P.V=A[:HL#M7;V+VQM7;6.-/B=M[3P,./Q6*QM(CR+08/;N HT5%
M4 ^.FI8+DG2B%B ?=>Z)MM_X\3=L_,'!?-7M7!MC)>F>L=V]._%/9.5BTYW:
M6([1K<!D^ZNW]U4XED2CS&YAM;$X7&XP:I:#$8QY*ITK,M58_&^Z]T>KW[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=5V[Y_[>7]-_^*^Y3_W/[5]NC^Q/V]4/QCKW\L3_ +)KJ?\ Q)&Z?_==
MM[WZ;X^O)PZL2]M=7Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NL4\$%5!-35,,5135$4
MD%13SQI+!/!*ACEAFBD#*R,K%65@00;'W[KW6.BHJ/&T=)CL=24U!CZ"F@HJ
M&AHH(J6CHJ.EB2"EI*2E@2-(XHTC5(XT5555   'OW7NN=334]93ST=9!#54
ME5#+355+4Q)/3U-/.C13P3P2JRNCJQ5T8$$$@BWOW7NL5#04.+HJ3&XRCI,=
MCJ"GAI*&@H:>&DHJ*DIT6*"EI*6G2-(XT50J(B@    #W[KW4OW[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW1/?DQ\DJ[K;?/1?QUZQ3"Y/Y%?)S/;EQ^P*/.)45V$V)U[U]BZ
M;.]N]W[NQ%!/35%5C-NT=?24U)0K-1KD,OEL9C6JZ..JDJX/=>Z,G083/;?V
M=3X3%;@J=R;DHZ'P)NC?;+65.4RD\IDJ\WG:? 4V$A.IYI)OL<?%CJ=0%IJ9
M:2 )XO=>ZJ,_DX_+[Y+_ "SJ/YD5!\G=S;&W)N?XN_S(^^?B7M%^M]ER[%V;
M2;,Z5Q.S,)!)B<+D,UN?(?Y=72UN1D?)97)3JU7XO-XHXT7W7NKHO?NO=5J?
M-WN7NW*;^Z[^)/Q"^0O1WQ]^2.\<#7=M9G?'<VW\#V+087K/#Y6+:V*VUB.K
M:K>&U:_(Y;<^4KI_X;44_EA@IMN91IF64TJ3>Z]T(7Q1V/\ .3J#97:.7^;'
MR,V'\J=SA8,KL&@Z4Z&ING*?#XC"8G(U.2Q"8==P;GJ<ID\G421I$SU21J(8
MDCB#O([^Z]T0:'HS_A0#G<=/O'<7\PGX1],/E?XAN*MZVHOB96=GXCK&@JYZ
MC(0[2/:.3WGL-\TN)IG2FFR\N)QPG:%IO$JD'W[KW0R_!;Y?]I8#^5I7_.[Y
M[=K[6WO1X[:O=/?M1V#L'84.S,'DOCMM+)[BJ.K\_M_9.)6MG$^X-M[=H\]3
MT335U29LVE*'=E2-?=>Z!_!?(;YW;L_EEG^:5A-^K5=AY+I.M^9>S_AAB^N]
MGU/3V?\ CY#BZSM';G2DV8&V<EON?>.7V-X4&Z*'<8IUS\\,]/@I\:C8JJ]U
M[H[3?(K<'>_Q$ZP^>?P^K*W>&+W!U!A^[,1T[G5CBHNW=AY'#4^Z,UUO*97!
MP>[H(XJFAQ>4@=H8LBAI\A#5TI7P>Z]T:3X_][=9?)[I+JWY"]-;@7='5O<>
MR<#O_8^<^WFHIZO!;AH8JVFBR&.J526DK*<NU/6T<RK+3U$4D,JK)&P'NO="
M_P"_=>Z][]U[KWOW7NO>_=>Z][]U[JNW?/\ V\OZ;_\ %?<I_P"Y_:OMT?V)
M^WJA^,=>_EB?]DUU/_B2-T_^Z[;WOTWQ]>3AU8E[:ZOU[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6NCU]E:_
ML+_A49WRFX-T4;8_X]_RFMH;5Z^V)69B5JTS=H=Z;&W?NO?6WL$9HD58-:XS
M+U*Q2$_>XY9).($7W7NMB[W[KW6NS_( _P"/T_GC_P#C=;YV?^[;:?OW7NMB
M;W[KW56GSL_DS?R]_P"8ME*K>?R1Z6EKNX!B\=B]O=Z;)WCNS9';.T(\'2U]
M/MPX+/8;+QTTD./DR<U738[(T5=0?<N:B2EDF]?OW7NB^?R:=R?*GJK=?S9_
MEP_*W?F\.],M\"=^=1T_2?R4WA0S?QCM[XZ=^;-SN[>KJ'<>XJC+Y*3)9[;Z
M[3K*#+R2*K1++2Q&6HMY/?NO=' _FB[VW7@_B+NGJSK;(Y3%=N_+'=FQ_AYU
M5D\')0IF\#N3Y$YV'8FXM\XPU\D::]J[8J\_NV4K=DAP4C^D*73W7NB9?S].
MM\ULG^0S\R.KNA:>/;M%UUT+UAMO#8ZF@@\&.Z=Z[[%ZNAWUA88(L?41HG]S
M<%DZ4:(8PBFZO!82)[KW1Q>J,GU[COY2?6N8P5+AZOJB@_ET;.R>&HMOT]"<
M!5=>TOQHQU5CZ7"4NNFIOLWQJ(E-'JCB\9475/I[KW1./^$S6(WAA/Y'_P %
MJ3>PK$R=1M[N/+XJ+(O)-61[/SWR+[>S>QRU1)6UNN&3$9"BFHE7PB*ED@A\
M:F(W]U[H&_\ A,]O"I;XS?.#H>DHJ#&[#^*_\S_Y@=-]1XK&TL5#1X+K:?<&
M W_0;?BH:98X(UILGO+*O&*:*GB6*>.-8E*%G]U[K9!]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW5=N^?^WE_3?_BON4_]S^U?;H_L3]O5#\8Z]_+$_P"R:ZG_ ,21
MNG_W7;>]^F^/KR<.K$O;75^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZHU[=Z%EZ _GI?'/YZK#7Q]<?*_XF
M[Y_E_P#8F8AI(Y\/M/N'&;TV[W7TK6;CJUIW:DAW53['J]NT=5*Z1'(X_'4
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MNO>_=>Z][]U[KWOW7NJ[=\_]O+^F_P#Q7W*?^Y_:OMT?V)^WJA^,=>_EB?\
M9-=3_P")(W3_ .Z[;WOTWQ]>3AU8E[:ZOU[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW2;WAL_;&_]LYC9N\\)
M0;BVQGZ0T66P^1B,M-50^1)XG!5D>.:&6))Z>HB:.6&6-)8G21%8>Z]U)VWA
M3MS!XW!?Q?-YY,73BCARNY*Y<IG*FFB=A2IDLIX('JI(HRD/W-1Y)Y1&)*B6
M:=I)G]U[I[]^Z]TEX]E[6CW=-OTX6CFWE-AO[NIN.K\M;DZ' -405=1A,//5
MR3_8TE1-20SU=/1B".HE@BEG622-&7W7NE1[]U[KWOW7NO>_=>Z][]U[KWOW
M7N@^WEUGMKL'(8"?>*UN>PNV\GC-P4&S*V6G;9]1NG Y.GS.W-S9G%)2J]?5
M8RKHX:O'15DT]-3U5/!6QTZUM/3U$7NO="#[]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>ZKMWS_P!O+^F__%?<I_[G]J^W1_8G[>J'XQU[^6)_V374_P#B2-T_
M^Z[;WOTWQ]>3AU8E[:ZOU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M5V[Y_P"WE_3?_BON4_\ <_M7VZ/[$_;U0_&.O?RQ/^R:ZG_Q)&Z?_==M[WZ;
MX^O)PZL2]M=7Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJ[=\_P#;
MR_IO_P 5]RG_ +G]J^W1_8G[>J'XQU[^6)_V374_^)(W3_[KMO>_3?'UY.'5
MB7MKJ_7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U7;OG_MY?TW_P"*
M^Y3_ -S^U?;H_L3]O5#\8Z]_+$_[)KJ?_$D;I_\ ==M[WZ;X^O)PZL2]M=7Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJ[=\_]O+^F_\ Q7W*?^Y_
M:OMT?V)^WJA^,=>_EB?]DUU/_B2-T_\ NNV][]-\?7DX=6)>VNK]>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5=N^?^WE_3?\ XK[E/_<_M7VZ/[$_
M;U0_&.O?RQ/^R:ZG_P 21NG_ -UVWO?IOCZ\G#JQ+VUU?KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>ZKMWS_V\OZ;_ /%?<I_[G]J^W1_8G[>J'XQU
M[^6)_P!DUU/_ (DC=/\ [KMO>_3?'UY.'5B7MKJ_7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U7;OG_MY?TW_XK[E/_<_M7VZ/[$_;U0_&.O?RQ/\
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MIZG@[6Q74%"F*R6)WG7Y2#)U63ROD2CKL32JD$+M)*K&-']U[IX^-WS?VO\
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MI[UVE@=UY/,;4QV=GK8((,E/35<-!+411YHXMV95]U[J#OW^:'L#9OS?W+\
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MK]Z9'.4&=R&9Q\^3IZ24[5IZ:IBPU9BJEX9)52KC9@1[KW76W-__ ";^+_\
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MXX]*M'V#T/TO@(</T'W;BIII^D-P9':^W6GJ,91Y?KZMF.3PZ8*ODHLTU'Y
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M0M>_=>Z][]U[KWOW7NJ[=\_]O+^F_P#Q7W*?^Y_:OMT?V)^WJA^,=>_EB?\
M9-=3_P")(W3_ .Z[;WOTWQ]>3AU8E[:ZOU[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U2C_ #D/A-\O?G%C/AGB/C/0_'ND
M7XL_-[I'YF9+(]T]L=@[&EW3/TMC]WP4>PL=2;-Z([66F^^EW4Q?(S-.(EA5
MA32EB@]U[I[_ )I'PW^6'S7H_P"7M)U-AN@<%7_%+Y__ !W^;?8M)V!W!O\
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M"4=%CY)ZJ1Y<K.:*JHO=>ZH"V%_*P_F)]=?RFOD1_*(PN6^*AZMH=D=V]?\
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MM>O?[/#\5/\ G\>"_P#/5N?_ .L7OWAOZ=>UKU[_ &>'XJ?\_CP7_GJW/_\
M6+W[PW].O:UZ]_L\/Q4_Y_'@O_/5N?\ ^L7OWAOZ=>UKU[_9X?BI_P _CP7_
M )ZMS_\ UB]^\-_3KVM>O?[/#\5/^?QX+_SU;G_^L7OWAOZ=>UKU[_9X?BI_
MS^/!?^>K<_\ ]8O?O#?TZ]K7KW^SP_%3_G\>"_\ /5N?_P"L7OWAOZ=>UKU[
M_9X?BI_S^/!?^>K<_P#]8O?O#?TZ]K7KW^SP_%3_ )_'@O\ SU;G_P#K%[]X
M;^G7M:]>_P!GA^*G_/X\%_YZMS__ %B]^\-_3KVM>O?[/#\5/^?QX+_SU;G_
M /K%[]X;^G7M:]>_V>'XJ?\ /X\%_P">K<__ -8O?O#?TZ]K7KW^SP_%3_G\
M>"_\]6Y__K%[]X;^G7M:]>_V>'XJ?\_CP7_GJW/_ /6+W[PW].O:UZ]_L\/Q
M4_Y_'@O_ #U;G_\ K%[]X;^G7M:]>_V>'XJ?\_CP7_GJW/\ _6+W[PW].O:U
MZ]_L\/Q4_P"?QX+_ ,]6Y_\ ZQ>_>&_IU[6O7O\ 9X?BI_S^/!?^>K<__P!8
MO?O#?TZ]K7KW^SP_%3_G\>"_\]6Y_P#ZQ>_>&_IU[6O7O]GA^*G_ #^/!?\
MGJW/_P#6+W[PW].O:UZ]_L\/Q4_Y_'@O_/5N?_ZQ>_>&_IU[6O7O]GA^*G_/
MX\%_YZMS_P#UB]^\-_3KVM>O?[/#\5/^?QX+_P ]6Y__ *Q>_>&_IU[6O7O]
MGA^*G_/X\%_YZMS_ /UB]^\-_3KVM>O?[/#\5/\ G\>"_P#/5N?_ .L7OWAO
MZ=>UKU[_ &>'XJ?\_CP7_GJW/_\ 6+W[PW].O:UZ]_L\/Q4_Y_'@O_/5N?\
M^L7OWAOZ=>UKU[_9X?BI_P _CP7_ )ZMS_\ UB]^\-_3KVM>O?[/#\5/^?QX
M+_SU;G_^L7OWAOZ=>UKU[_9X?BI_S^/!?^>K<_\ ]8O?O#?TZ]K7KW^SP_%3
M_G\>"_\ /5N?_P"L7OWAOZ=>UKU[_9X?BI_S^/!?^>K<_P#]8O?O#?TZ]K7K
MW^SP_%3_ )_'@O\ SU;G_P#K%[]X;^G7M:]>_P!GA^*G_/X\%_YZMS__ %B]
M^\-_3KVM>O?[/#\5/^?QX+_SU;G_ /K%[]X;^G7M:]>_V>'XJ?\ /X\%_P">
MK<__ -8O?O#?TZ]K7KW^SP_%3_G\>"_\]6Y__K%[]X;^G7M:]>_V>'XJ?\_C
MP7_GJW/_ /6+W[PW].O:UZ]_L\/Q4_Y_'@O_ #U;G_\ K%[]X;^G7M:]>_V>
M'XJ?\_CP7_GJW/\ _6+W[PW].O:UZ]_L\/Q4_P"?QX+_ ,]6Y_\ ZQ>_>&_I
MU[6O7O\ 9X?BI_S^/!?^>K<__P!8O?O#?TZ]K7KW^SP_%3_G\>"_\]6Y_P#Z
MQ>_>&_IU[6O7O]GA^*G_ #^/!?\ GJW/_P#6+W[PW].O:UZ]_L\/Q4_Y_'@O
M_/5N?_ZQ>_>&_IU[6O7O]GA^*G_/X\%_YZMS_P#UB]^\-_3KVM>O?[/#\5/^
M?QX+_P ]6Y__ *Q>_>&_IU[6O7O]GA^*G_/X\%_YZMS_ /UB]^\-_3KVM>O?
M[/#\5/\ G\>"_P#/5N?_ .L7OWAOZ=>UKU[_ &>'XJ?\_CP7_GJW/_\ 6+W[
MPW].O:UZ]_L\/Q4_Y_'@O_/5N?\ ^L7OWAOZ=>UKU[_9X?BI_P _CP7_ )ZM
MS_\ UB]^\-_3KVM>O?[/#\5/^?QX+_SU;G_^L7OWAOZ=>UKU[_9X?BI_S^/!
M?^>K<_\ ]8O?O#?TZ]K7KW^SP_%3_G\>"_\ /5N?_P"L7OWAOZ=>UKU[_9X?
MBI_S^/!?^>K<_P#]8O?O#?TZ]K7KW^SP_%3_ )_'@O\ SU;G_P#K%[]X;^G7
MM:]>_P!GA^*G_/X\%_YZMS__ %B]^\-_3KVM>O?[/#\5/^?QX+_SU;G_ /K%
M[]X;^G7M:]>_V>'XJ?\ /X\%_P">K<__ -8O?O#?TZ]K7KW^SP_%3_G\>"_\
M]6Y__K%[]X;^G7M:]>_V>'XJ?\_CP7_GJW/_ /6+W[PW].O:UZ]_L\/Q4_Y_
M'@O_ #U;G_\ K%[]X;^G7M:]>_V>'XJ?\_CP7_GJW/\ _6+W[PW].O:UZ]_L
M\/Q4_P"?QX+_ ,]6Y_\ ZQ>_>&_IU[6O7O\ 9X?BI_S^/!?^>K<__P!8O?O#
M?TZ]K7KW^SP_%3_G\>"_\]6Y_P#ZQ>_>&_IU[6O7O]GA^*G_ #^/!?\ GJW/
M_P#6+W[PW].O:UZ]_L\/Q4_Y_'@O_/5N?_ZQ>_>&_IU[6O7O]GA^*G_/X\%_
MYZMS_P#UB]^\-_3KVM>O?[/#\5/^?QX+_P ]6Y__ *Q>_>&_IU[6O7O]GA^*
MG_/X\%_YZMS_ /UB]^\-_3KVM>O?[/#\5/\ G\>"_P#/5N?_ .L7OWAOZ=>U
MKU[_ &>'XJ?\_CP7_GJW/_\ 6+W[PW].O:UZ]_L\/Q4_Y_'@O_/5N?\ ^L7O
MWAOZ=>UKU[_9X?BI_P _CP7_ )ZMS_\ UB]^\-_3KVM>O?[/#\5/^?QX+_SU
M;G_^L7OWAOZ=>UKU[_9X?BI_S^/!?^>K<_\ ]8O?O#?TZ]K7KW^SP_%3_G\>
M"_\ /5N?_P"L7OWAOZ=>UKU[_9X?BI_S^/!?^>K<_P#]8O?O#?TZ]K7KW^SP
M_%3_ )_'@O\ SU;G_P#K%[]X;^G7M:]>_P!GA^*G_/X\%_YZMS__ %B]^\-_
M3KVM>O?[/#\5/^?QX+_SU;G_ /K%[]X;^G7M:]>_V>'XJ?\ /X\%_P">K<__
M -8O?O#?TZ]K7KW^SP_%3_G\>"_\]6Y__K%[]X;^G7M:]>_V>'XJ?\_CP7_G
MJW/_ /6+W[PW].O:UZ]_L\/Q4_Y_'@O_ #U;G_\ K%[]X;^G7M:]>_V>'XJ?
M\_CP7_GJW/\ _6+W[PW].O:UZ]_L\/Q4_P"?QX+_ ,]6Y_\ ZQ>_>&_IU[6O
M7O\ 9X?BI_S^/!?^>K<__P!8O?O#?TZ]K7KW^SP_%3_G\>"_\]6Y_P#ZQ>_>
M&_IU[6O7O]GA^*G_ #^/!?\ GJW/_P#6+W[PW].O:UZ]_L\/Q4_Y_'@O_/5N
M?_ZQ>_>&_IU[6O7O]GA^*G_/X\%_YZMS_P#UB]^\-_3KVM>O?[/#\5/^?QX+
M_P ]6Y__ *Q>_>&_IU[6O7O]GA^*G_/X\%_YZMS_ /UB]^\-_3KVM>O?[/#\
M5/\ G\>"_P#/5N?_ .L7OWAOZ=>UKU[_ &>'XJ?\_CP7_GJW/_\ 6+W[PW].
MO:UZ]_L\/Q4_Y_'@O_/5N?\ ^L7OWAOZ=>UKU[_9X?BI_P _CP7_ )ZMS_\
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*^?\ @ZV.!Z__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>tbarchart_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tbarchart_004.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2      04  DE$_]L
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M]D?^A3CO_L>]^\9^O:!U[_AL3XU_\K/9'_H4X[_['O?O&?KV@=>_X;$^-?\
MRL]D?^A3CO\ ['O?O&?KV@=>_P"&Q/C7_P K/9'_ *%.._\ L>]^\9^O:!U[
M_AL3XU_\K/9'_H4X[_['O?O&?KV@=>_X;$^-?_*SV1_Z%.._^Q[W[QGZ]H'7
MO^&Q/C7_ ,K/9'_H4X[_ .Q[W[QGZ]H'7O\ AL3XU_\ *SV1_P"A3CO_ +'O
M?O&?KV@=>_X;$^-?_*SV1_Z%.._^Q[W[QGZ]H'7O^&Q/C7_RL]D?^A3CO_L>
M]^\9^O:!U[_AL3XU_P#*SV1_Z%.._P#L>]^\9^O:!U[_ (;$^-?_ "L]D?\
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M?_*SV1_Z%.._^Q[W[QGZ]H'7O^&Q/C7_ ,K/9'_H4X[_ .Q[W[QGZ]H'7O\
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M^\9^O:!U[_AL3XU_\K/9'_H4X[_['O?O&?KV@=>_X;$^-?\ RL]D?^A3CO\
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M%.._^Q[W[QGZ]H'7O^&Q/C7_ ,K/9'_H4X[_ .Q[W[QGZ]H'7O\ AL3XU_\
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M@=>_X;$^-?\ RL]D?^A3CO\ ['O?O&?KV@=>_P"&Q/C7_P K/9'_ *%.._\
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M-L9C<V^-S;6E>"=4RL@I*'%TDY"M3KDI:J%UJ*>$^_=>ZK9_F U.<^%O7O\
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M/N]HX[&T-%TYL7?_ &+E:**NS,[9F20SY1J6.2''5E-32>26DDGD]U[JH/\
ME1]'U_\ ,;_D]?.WY\_+O=M5VA\V>P]R?+G.=&?)_--DZWL_XLKLSIO"T>SX
M.B<K!D\14;2IJ'/4-=7OC=KUF'IZFCEAH9CXDL/=>Z</Y?O\R;NOY_?\)POY
MCF8[UW=N+-?(OX5]/=TX/;_=='G<OB.P,LN!Z3J]\=1]DU&Z\,V*JXMQT$R5
ME!4U\-4\]2M E152/)5S!_=>Z+'_ "5OCAD/YF'\C7Y_[I^9?R-^57;E)LOM
M3Y&8OKC;>0^0?9]%BMH[HVC\7.H=XTV\\HU%N6*3<P:HSE,L&W]UMFL'3&BD
MF@QJ5%=6RR^Z]T(O_"<GK#>O\SO^6%\C.M?F9\BOD1V-T9T7VCN_9O6G5> [
MA["ZZG@FR_5&VL^*C>?8VR-SX;<&?Q&)DKF;;VT\A6MA:66IJIJNBR-\<F,]
MU[I;?\(GODWV_P!A]9_-GXX[\WKN/=W7?2E?T%O#J/&;AS.4S2[$B[ H^TMO
M[OVUM]LI7U:T>*=>O<1/28VDC@@AF^[E"EZEC[]U[I:?"'YN=<?S5?YIG\RN
MJ^=.-S79_P 7_C+4P=._%7XU3]==C=O]18;'Q=D[QV]6=O[CZWV1LS=5)-NR
MI7K:DR='G\M!]SC)\B\.+G3P1O'[KW5@W_"=+N/YAU"_.+XH_)?K[Y-TG4WQ
MU[TR-=\..XODOMOMJAW/O_H?>F].RJ/&[0@W7V[@<9D,Q%@:?:V,JZ2H:IJY
M$IL]'3-'2PT].LGNO=;,WOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[K6S_ /NW/:S_ #=)^K.OY8G_ &374_\ B2-T_P#NNV][8F^/IU.'
M5B7MKJ_7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW1?OE'OJAV!T)
MVUEZO;?9&[II.M]\T^.VYU5U9V)V]O+-9&;;60@HL5A]H]:;9W37S5%1+.D4
M"^!5+-RRJK,ONO=:07_"1/H?Y+_#7OKY>87Y5?$/YC]%4_<G6W5U+L/</97Q
M'^1.W=F9:OV3N3=LV>Q-?NVNZV7'T,_AW13RP)73TZS*DH1BR:3[KW2#_FF_
MRJ_FQ_*E_FF=8_S)OY0G17<O:6PNP]\9??FX.I^B.M]X]H)U[NS(SK/VSU5N
MK:&RL/N6KBV1O.ER-8]"XI%I\>U1-24KTDE)BS[]U[JW#^>!\3^WOYY'\J+J
M;MCX^=*=V]7?(OI#>--V[+\9/D#U)OWIOM>O:JV77X'M'J;&XCLG![0-5DJ:
M2OIJO$Y2B6LH,D<6U/2S,]4KQ>Z]T(O\I#^:Y\S^YNB.E/B%VC_+2^<VTOEO
MUWU[ANM=X]^=N=.#K;XJT4.RZ/&;7H^U.R][[[S&P<O'D'I&I<AD-JX7 U];
M65'F2B*P,T]-[KW5V/\ ,&^'.U/GO\*>_?B7OO\ A\@[8ZZR&)P&>JJ*)H]L
M]CXI(LWU_O6D@E%68FQN<QE%6V1F;1&\>HAFO[KW51W_  F#^#'>?PX_E[8^
MJ^3M)N+!=O;\WAO.BP'6^YXZ:*MZ5Z@VQOS>$V"V%!%1U^1AUY3<6>W-NZIJ
M8VC>9-P4L,H(HHB/=>ZK._X4+_!/YQ].?S(_BO\ SI/@SU;O#OVIZG'6&)[.
MZNZXVSF-V[WQF8ZVSV8T5M9M[;U!G<A5[<W/M_.-M_)U%!CY9,=X))Y6"5*/
M![KW6Q-\%OYAW:?S]&)SNW?@S\L?B1L#;C>;LG=OS)Z]P76QW+D7PL<U-LWH
MO;M'O2OS.;1JG)T]1/N>OQ6+Q\=/2301I-6R^*E]U[K5J_G+=*_)#M?_ (4A
M_ GY(]7?$?YE=C="_&G>WP:H.VNW-D_$3Y&[EV!BGZK^3V:[0W]68'=&*ZTJ
M:/-4>.P^?@GDKL/+6TSN)(8Y7EBD5?=>Z:?YY/0/R:[>_P"%!WP8^2'4OQ)^
M87:'171R_"D]E=I=?_$SY$[LV;@SL#Y';H[+WBM+FL+UK5PUYQ^'SM-45/V#
M5(5V:G)^XBEB3W7NAS_X6'_!3Y0_*+;GPT^1_P =>G>P.Y-G]4X;M':79&"V
M%L_<VX=_;53L*OZ\RVS\]6[#H,1+E!12-B*NFK7^W#T<HB6HCC#EE]U[HG/_
M  IQVY\U/YH<WP5[1^.'\MKYX3=9;2VIW?2T,F5^.G8.4[-J\CNINE\ID*[=
M?5FQ\-N_(;6Q8:A%#AIMR-C*W*3T&3FIZ!<=3T==D/=>ZO1_X4+?RY.V?YI7
M\L3IW*_&O;^XJ_NCH',83N+:_5F[MI[CV'O;?NV:G8M?MC?.P8-K;ZH=L9'%
MY]?-2U]'29*DBDF?&M1B-9*J*1/=>ZC_ ,I#^:Y\S^YNB.E/B%VC_+2^<VTO
MEOUWU[ANM=X]^=N=.#K;XJT4.RZ/&;7H^U.R][[[S&P<O'D'I&I<AD-JX7 U
M];65'F2B*P,T]-[KW1P/G55=/=^]I=P?"G^8;\/NR^WOAOF.M.J]X=;_ "3V
M-TQV+V/@MA=I;AQG8]%OC 9'+]0[<W)GMH5U"FRJ')8K<2!J829?["MJ8?+0
MPUGNO=5Z_P#"6?\ E\]Z_"O$?/O>>[J/MS9WQK[K[RPV/^)>Q^[<'E-F=C;F
MZOZRR78M'B.]MV==9BCP53@*[<N)W/A::>GK,/AZN9L06FIEIXJ'W[KW6Q/\
MXZ[Y#8WX<_)RN^)F-?,?)BEZ1[%EZ-QL(QK5=7V4-M9 ;73'KF*S'TC50J"K
M4BU$R1F94#7!*GW7NM#'XM_&C^95W[_(F_F4?$_._P NGY+47R;[G[:V]W3V
M-\F/DKD]U[5[)^0+]9=@=,]B4FTMO[3[2PU7O;<VXJ>#K"?#XZEBIX<.9*FH
MF;*19-IZ.I]U[J^+_A.JW<GQO_DP9GK?Y"?$_P"5_3><Z9K.],O-C]X='[KF
MWKV4N\MU[HW%1TO5/2VVH=P;]RDD,>2@IW$VUZ+S3LPHQ4PHTX]U[JKC_A)Q
MT7\D_AAM?^9_0_*7XF_,#I"H[&ZZZ$S^P4WY\3?D1B#O2'K/'?)"'=V*VLC]
M;.U?DXFW_BA3XJD6:KJ?N#]O#*4<+[KW3Y_PCN^-GR?^*/:'SBP/R<^*_P I
M?C[-VML_HBHV#E>Y?C?W5UOM;<#;!R?;DFZ**'=^[MCXG&15,";MH6CIIZN*
M282'PJY1@/=>Z:/B7T%\DOY%'\]SY/=@;]^._P F^Y/@W\Q,7W!1[&[1^.71
MN_\ O&@Q8WKV!@^X]@Q;DVWUICMS9"/+8"6@K=KU%.\(GG6MER%/3-3,6B]U
M[I [&^/7SBW7_P *K<C\\\I\#OE#M_H;#=CT>;SFY3L&:MP6&VUGOAS!U=M^
M:;?+S4.W:W)PR9.C?.XO#Y;)OCZG[FC$E0]-KD]U[KZ"GOW7NJHOEW\CZ78O
MS9^!FV8>A_EUV#A</OKN)^Q.S.I_B5\A>S>K.JZ3=?4.>V3M&OWIOK9G768H
M3!D,KFH:7R8V3("D0255?]K2(9_?NO=6&]H]7]:?(GJ/>/4_:NT:+>W5O;.S
MZ[;6[]G[IQ%3!!F-N;AH=%119+$Y6FIJBFG595=5EBAGIYD5K1RQC3[KW6L_
M_(K_ )1797\I/^85_,6V!5RUF[?CQVEUWTYNOXW=HR4\B'-[1IM[=E&NV/N=
MCJ1-P[=&2IJ3)>,Z*F.6GKXEB6J-/![KW5<7\P;XQ_.K^5#_ #XJ3^;O\;OC
MOVQ\KOC-WSEYJKMK9W2&SLWO#=.#QNZ-C8S:';6P]VT. Q>XJBC,E5B8]U;=
MS$T%)12524]!-*AAD,_NO=;:GPM^7_9GS5Q2=II\3OD3\2NG*7'U]#28CY@;
M(P'6_=_8&ZC7QTJUFW>M]O[YW=48C 8Y*"JUU^<^UGR3U=.]%3+2Q/43^Z]U
MJL?RD>B/FG_+A_G;_P R:A[4^$GR#WKM'Y5-VSN/I;MS8&UJO(],9B3)_(.3
M>>QI=Q]KSTB8##XZNQFX:FHR5379&.MQST20'&5,]5#&/=>ZWGD+E$,BJDA5
M3(J.9$5R!J5)&2(L > 2JW^MA]/?NO=:!?\ PKTZ!^37S%[[^(>'^+7Q)^8/
M?2=/=<]KTN_]P=8_$[Y#;KV=B<AO+=&TGP6-I-Y8SK>;&5\[Q[6JI95H*JI$
M:-$SD>5+^Z]UM[]$=L8['_R\MA;GRG7O?V(K-A_%G96/W+UYEOC?WQCNXX,[
MANN*/ Y#;.*Z<J^O(MRY/))68Z6 4>,QE8[>B108I$D;W7NM2/\ X2<=%_)/
MX8;7_F?T/RE^)OS Z0J.QNNNA,_L%-^?$WY$8@[TAZSQWR0AW=BMK(_6SM7Y
M.)M_XH4^*I%FJZG[@_;PRE'"^Z]U _X24_#SY%=*9C^8IU%\N?BM\J?C]B?D
M?U)U3M;;65[>^./=/6NW-PXS#1]T8G?-%1[QWAL;%8N&LAI]]4C0T]151R3>
M4^%9"C@>Z]T!_P#+ I_YBG_";OYF_(SX_=Q_!CY<?+SXK]W5.!_@^_\ XJ=3
M;I[+I<_7;+KMUT^P>RNN,=03U>$CR.4Q^4J*?<&V:_+X[(PK'1M+))%2TQJ/
M=>ZW.>V>J>POYE'P$^1W2_=?5^<^+:_)GK+>&QMC[*WO7[;W%V?U]CLQMRG7
M:NZNTX=EYW=6%I\FF805[87&9#("GI884FJC5R304WNO=:X?\M^3Y+?RU?Y/
MWSU_EX=[?&KNZF^9>U<O\D]O?&?:FPNA>Z^X=A_(N7O#KJDV_P!5[GV+V%U[
ML[)X3(8]]S2URY5?XG02T&-IXZC()1,[Z/=>Z?/A=_*L[U_ES?\ "=G^8!UA
MV;L#?N[_ )9_,[J#N#(S=(]0['W1W)O';6>WIU-5=>]5=8C$=88#<U345\>L
MU68JHA-14<U?)$:CQP&:3W7NDY_PG@Z][W^+7\EG^8QTC\@/BO\ +[J[M>NW
M_P#('L+:O7VZ/B=\B:+>'8&$[&^,W4_7&UZ?KW MUIY\W639C9M52O1XX5,T
M(*S3I%3_ +OOW7NN_P#A+%L[O;X;_"+Y\=:_*+XH_,'I3<D.\9^Y-NXS>7Q)
M^2M)F=_;;K.KJ+:E;CNO\-%U1-+F\K!5;;1%PV)-;D)ONT:.DT*7/NO=!)_P
MCM^-?R>^*/9WSCP7R<^+/RC^/L_:NT.AIM@9/N7XW]V=;[8W$VPLEV]+NFD@
MW?N[8N)Q4513KNNA9*:HK(99A,? DA1]/NO=!1UKU3\YO^$]/\YSY&=Q8CXC
M?)'Y?_!'Y?Y+?U8V1^,76.9[$S%/MW>._)M_;&II*7&4M93TVZ]IU^0FPO\
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M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6MG_\
M=N>UG^;I/U9U_+$_[)KJ?_$D;I_]UVWO;$WQ].IPZL2]M=7Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZUL__NW/:S_-TGZLZ_EB?]DUU/\
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MQ_V2C\G/_%>NZ/\ WV^Y??NO=4=_\)V?^X<;XY?^(T^:G_P37R7]^Z]TH_\
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M[O\ A]V/\YODWU%WC\Q=K8S9/QM^*F[J'LSXO_$ZIR^(W9N3=7?-)1S4V/\
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MK,5G7^TJZ7;>Z\Q)E.O*C/[BDWOCMUP54M;)CEB.(2.F?W7NC>_RE_F[NO\
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M_KAU[_A^;_P%3_V.7_Z'O?O^!R_Z3/\ V:?]O/7O]>W_ *1G_9S_ -<.O?\
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MO>_=>ZMW_DI_]E?9S_Q"F\__ 'I=C>X1]_?^5(B_YZXO^K<W4K>SW_*TR_\
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MW\ZS_LK[!_\ B%-F?^]+OGWF5[!?\J1+_P ]<O\ U;AZQE]X?^5IB_YYH_\
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MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NK-OY0__9<.P?\
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MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZLV_E#_\
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M]U[KWOW7NM>?^?-_W*I_Y7+_ .8][R<^[E_RV?\ J$_[6>H'][?^69_U$_\
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M\ZS_ +*^P?\ XA39G_O2[Y]YE>P7_*D2_P#/7+_U;AZQE]X?^5IB_P">:/\
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M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T?'^6/\
M]ET_'_\ [7>Z_P#WWF[_ '''NY_T[O<_]+%_U?BZ''MO_P KK8_;)_U9DZW/
M_>!W67'7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UK%_SS/\
MF?'3O_B(YO\ WLL_[RU^[S_RKU__ ,] _P"K2]8[>]'_ "5K/_FBW_'SU2'[
MR#ZACKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NK-OY0__9<.P?\ PU>Q?_>/R?N(_>__ *=_<?\ -6#_ *N#J2?:C_E<(_\
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MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZLV_E#_\
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MWJ@\\T42O(ONO=4G;N^3/_"@3K_KO<_9^^OAY_+)VGM;9.R\UOW>,^7^57<
M?;6 VW@ZG<.X9<G44?7E92WHZ>BF,SQ5,L7[;%962SGW7NK;/AIVCVUW?\4_
MC]W-WILC"]:=K]L=5[1[(WCUY@&R#X[9-9O7%P[CH=K:\K55E0:BAH\C3T]:
M97!-1'*=$8M&GNO=&7]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=:HW\ZS_LK[!_^(4V9_[TN^?>97L%_P J1+_SUR_]6X>L
M9?>'_E:8O^>:/_JY+U41[F[J*>O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>ZMW_DI_P#97V<_\0IO/_WI=C>X1]_?^5(B_P">
MN+_JW-U*WL]_RM,O_/-)_P!7(NMKGWAKUDUU[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UK9__ ';G
MM9_FZ3]6=?RQ/^R:ZG_Q)&Z?_==M[VQ-\?3J<.K$O;75^O>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K7G_GS?\ <JG_
M )7+_P"8][R<^[E_RV?^H3_M9Z@?WM_Y9G_43_U@ZUY_>3G4#]>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T?'^6/_P!ET_'_
M /[7>Z__ 'WF[_<<>[G_ $[O<_\ 2Q?]7XNAQ[;_ /*ZV/VR?]69.MS_ -X'
M=9<=>]^Z]U[W[KW7O?NO=4I/_,?_ )>'9_R7W#N#N'YZ?#GKK9/Q5WUO#KWK
MCJ?LWY)]&;&W-FN^]MU.3V7V1W7NC:VZM]T.3AAP5\AM?9L552T2N9\QF!'5
MP56"K*?W7NJ__P#A/?VA\>^^?@+\J_B;MSY!=/5_;W9/R$^?&87KK;_9>R,W
MV;1]8=A;TJ<!CNTX=@T.:J<F^#<;FI9*?+?:&DE^XA"RMY4U>Z]T//\ *([[
M[N^$_P *]L?!GYJ_%SY.;9[T^&> [ VG3[WV;TKOC>'QU[@ZCV=G-RYS9&^-
MB?).*CCV/0PC"M#1/2;GS^WJH&B\S4T*2>.+W7NLW_"7C&[NJ_Y8^1[7W%!G
M,7M[Y$_+3Y.=[=7[7SM!3T4NT>N=V[WAP^/PM#)!1T?W--+D=LY/)1U3>42-
M7OXG\ B5?=>Z/?\ S@NE/C!W[\'-]]?_ "HW3N;8>VZG=W7=3U+OKKQD/;FU
M?D=+NN@PW1E7TU3M449J-S5F<S$&*H*034XJ$R$T$D]/#))41>Z]U25\4_DI
M\D>F/G;\6OB!_/UP\F2[4VU-1?\ #:GRBQDV$;XX]Q]M9O;E3M&NR78IQD+!
M.W4H]W2;:QM75U*T8EK9H*2@BJZRCS6=]U[K;T]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6L7_/,_P"9\=._^(CF_P#>RS_O+7[O
M/_*O7_\ ST#_ *M+UCM[T?\ )6L_^:+?\?/5(?O(/J&.O>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZLV_E#_]EP[!_P##5[%_
M]X_)^XC][_\ IW]Q_P U8/\ JX.I)]J/^5PC_P":<O\ QWK;Z]X1]93]>]^Z
M]T1#Y^_R]NG?YB_6.V>KNY=[]X;"QVR=T5&^]F[CZ([,K.LMV;=WY_ ,KMO$
M;OI\E38_)Q5%3C:?.5GV4-;3U-,&J7:6"7TZ?=>ZJC^&&?\ F9_++_F%]6_R
MROD[\@]Y?,;XJ_+C87:NZO@M\@>UDK<CWCLC>_1FVTWMV'T/V?N:EQ]:F42/
M;L4^3I,E7U<"M]NBTHB\S4%/[KW4#^1Q#F,Q_,)_X4,;\WUCX:#LO)_S!<+L
M"J\=9.[3]2=7TO9F,Z(G?'ODLA'%Y<'F34F9!&TK5#*RHL*0P^Z]TZ=2Y;+4
M_P#PJD^56"VU)7/M/*_RENMLMV=#HK4Q4>_<+W?U]1[%GDJ9:":,U2X?-U24
MT$<T*/%/5R7>6!T'NO=;(WOW7NJQ/YI4LG8_5?3OPNQCA\K\\>_=C]!;DI_X
M96Y1%Z#PD.2[B^4=16+1R0B""IV#UMG,$M3(ZJE3G*5;@N&7W7NK-::FIZ.G
M@HZ."&EI*6&*FI:6FB2"GIJ>!%B@@@@B551$50J(H    %O?NO=9O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6J-_.L_P"R
MOL'_ .(4V9_[TN^?>97L%_RI$O\ SUR_]6X>L9?>'_E:8O\ GFC_ .KDO51'
MN;NHIZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[JP7^6OW!4=(=_9O>U-@8=Q2'K#<.'_ (=/D'QJ::_<.T9#/]S'25INOVMM
M.CG5]1;W&7NOL:\P<M1V#2&(?4(VH+JX)+BE1Z]#SV\W9MFWR2[5/$K"RT)I
MQ>,UK0^G5ZO_  Y#F/\ GTV-_P#0PJO_ +'?>.O^M;!_RFM_SB'_ $'U-'^N
M!+_RBC_G(?\ H'KW_#D.8_Y]-C?_ $,*K_['??O]:V#_ )36_P"<0_Z#Z]_K
M@2_\HH_YR'_H'KW_  Y#F/\ GTV-_P#0PJO_ +'??O\ 6M@_Y36_YQ#_ *#Z
M]_K@2_\ **/^<A_Z!Z]_PY#F/^?38W_T,*K_ .QWW[_6M@_Y36_YQ#_H/KW^
MN!+_ ,HH_P"<A_Z!Z]_PY#F/^?38W_T,*K_['??O]:V#_E-;_G$/^@^O?ZX$
MO_**/^<A_P"@>O?\.0YC_GTV-_\ 0PJO_L=]^_UK8/\ E-;_ )Q#_H/KW^N!
M+_RBC_G(?^@>O?\ #D.8_P"?38W_ -#"J_\ L=]^_P!:V#_E-;_G$/\ H/KW
M^N!+_P HH_YR'_H'KW_#D.8_Y]-C?_0PJO\ ['??O]:V#_E-;_G$/^@^O?ZX
M$O\ RBC_ )R'_H'KW_#D.8_Y]-C?_0PJO_L=]^_UK8/^4UO^<0_Z#Z]_K@2_
M\HH_YR'_ *!Z]_PY#F/^?38W_P!#"J_^QWW[_6M@_P"4UO\ G$/^@^O?ZX$O
M_**/^<A_Z!Z]_P .0YC_ )]-C?\ T,*K_P"QWW[_ %K8/^4UO^<0_P"@^O?Z
MX$O_ "BC_G(?^@>E#M'^8+E=S[KVQMI^K\?1IN'<.%P;U:[KJ9FI5RV2IJ!J
ME83@8@Y05&H*66]K7'U]IKWVUAM+.:Z%VS>$C/3PP*Z5)I77\NG[7GJ6YNH[
M<VP'B,JUUG&H@5^'Y]6:^XGZD7KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K6S_\ NW/:S_-TGZLZ_EB?]DUU
M/_B2-T_^Z[;WMB;X^G4X=6)>VNK]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6O/_/F_P"Y5/\ RN7_ ,Q[WDY]W+_E
ML_\ 4)_VL]0/[V_\LS_J)_ZP=:\_O)SJ!^O>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z/C_+'_P"RZ?C_ /\ :[W7_P"^\W?[
MCCW<_P"G=[G_ *6+_J_%T./;?_E=;'[9/^K,G6Y_[P.ZRXZ][]U[KWOW7NO>
M_=>Z(OG_ .5[_+/W7G<UNG=/\N[X+;EW-N7+Y+/[CW'G_B1T#F<[G\[F:R;(
MY?-9K+Y'K^IJ*JKJJBIDGJ:F>222621G=F9B3[KW5>_\C'^6K2?!#HWLW<?<
MOQ-ZBZ?^2V2[^^2L^&WQMG:73F>[2JOCKNK?U-G^O-ITG8G6#[AK!A9*3$TD
ME+MLY!1 ::%'HXI(T4>Z]T:GYB]2?(3Y_P"U:CXK8?#Y_P".?Q+[#67$?*/M
M?<F2P])W-VQU5410C-=&]&[(PU7GWP]-NB&>7';EW7N6;&5-'0K/1X_$5LM?
M]_C_ '7NC%=O8W?WQ-^&><V_\#OCAM?L_>O2766!VO\ 'SXVP[JQG6FV,Q2;
M>;$8'&;9BW-EF6GI8Z/'++5*)Y8FJ7IA"T\<D_G7W7NBI_.[XK]Y_,?HSX,=
MIXW:>U-K_)3XE_)GXR_.&KZ$W-G<5F]E;AWUUWALA#V+TG_?AJ:HI(JVGBWC
MDXMN[F6,Q0Y&@I*DF.)VEC]U[KE\R^@-P_S&-M_&7K?/?'[>?5..ZY^2_1OR
M<W)V1VRW4K9SJ6?I'<M%O*HVGL6DVIO/L2>MW'GM#[;EJ\<5Q<6.K<C.^3E9
M*:BK_=>ZMG]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW6L7_/,_P"9\=._^(CF_P#>RS_O+7[O/_*O7_\ ST#_ *M+UCM[T?\ )6L_
M^:+?\?/5(?O(/J&.O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>ZLV_E#_]EP[!_P##5[%_]X_)^XC][_\ IW]Q_P U8/\ JX.I
M)]J/^5PC_P":<O\ QWK;Z]X1]93]>]^Z]T0[Y:_(?Y@]#]B=++T/\%=R_,+I
M;=,>[Z;NS.]9=R=4;&[:ZMR-%1TT^RI]M]?]P[@V%B\]2U\OFBJV_O#0- !J
M)U"..H]U[IPV)UKV%WGW9U;\I.].N*OIENGMD[SPW2?2.;W)M/=^^-M[A[<Q
MNW*3L'?O:F:V%D]QX"',04&%.WL7B\!FL[204U5D*J3(U,E=%!C_ '7NBO8K
MXM]@?#_^9;\AOF9TWU;N#MKICY^==]48+Y'[6V%F=KTF^^K>]/CYC-TXW8':
MT&W]^[KVO2Y;;F?PFX)<-D8,/5??T&42"K-#5T==75>-]U[I:?!OX=[[V7\G
MOFO_ #!.^L>^VN\/FGN#KO![<ZH;<5)NO_0+\>.DMJ4FR^LMB9+-XBJK,6V?
MS!I)=R;J@PLU7CJ:OK?M*6LR(IWR59[KW1E/A?VC\KNV^L-T[D^87QLPOQ;[
M*Q_;._MM;:Z_P79F$[6H\YU?A:RDCV5OV3<>!M%'+DDFG5J618I *99VB@$Z
MPQ^Z]T'-+U;V#V'_ #*\GW5O/:N1Q747QI^+U'UET1FJW(SB@WCVK\BMY_WH
M[[W'CL/&1&1A<)U)LW#P5D@U:\MD8DU#5H]U[JP#W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6J-_.L_[*^P?_ (A3
M9G_O2[Y]YE>P7_*D2_\ /7+_ -6X>L9?>'_E:8O^>:/_ *N2]5$>YNZBGKWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NC/_$[_
M )F+FO\ PRLC_P"[W;GL'\[?\DJ/_FJO_').A)RO_P E!_\ FF?^/)U83[B_
MH>=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T
MO^J/^9I=:_\ A_[._P#>BQWLMWG_ )(]W_S1E_XXW2[;/^2E;_\ -6/_ (^.
MMDGWBSUD%U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]UK9_P#W;GM9_FZ3]6=?RQ/^R:ZG_P 21NG_ -UVWO;$
MWQ].IPZL2]M=7Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NM>?^?-_W*I_Y7+_YCWO)S[N7_+9_ZA/^UGJ!_>W_ )9G
M_43_ -8.M>?WDYU _7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO='Q_EC_ /9=/Q__ .UWNO\ ]]YN_P!QQ[N?].[W/_2Q?]7X
MNAQ[;_\ *ZV/VR?]69.MS_W@=UEQU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=:Q?\\S_ )GQT[_XB.;_ -[+/^\M?N\_\J]?_P#/0/\ JTO6
M.WO1_P E:S_YHM_Q\]4A^\@^H8Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[JS;^4/_V7#L'_ ,-7L7_WC\G[B/WO_P"G?W'_
M #5@_P"K@ZDGVH_Y7"/_ )IR_P#'>MOKWA'UE/U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=:HW\ZS_LK[!_^(4V9_P"]+OGWF5[!?\J1+_SU
MR_\ 5N'K&7WA_P"5IB_YYH_^KDO51'N;NHIZ][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[HS_Q._YF+FO_  RLC_[O=N>P?SM_
MR2H_^:J_\<DZ$G*__)0?_FF?^/)U83[B_H>=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]TO\ JC_F:76O_A_[._\ >BQWLMWG
M_DCW?_-&7_CC=+ML_P"2E;_\U8_^/CK9)]XL]9!=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:V?_ -VY[6?Y
MND_5G7\L3_LFNI_\21NG_P!UVWO;$WQ].IPZL2]M=7Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NM>?^?-_W*I_Y7+_
M .8][R<^[E_RV?\ J$_[6>H'][?^69_U$_\ 6#K7G]Y.=0/U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW1\?Y8_\ V73\?_\
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M )=/^JO_ %SZ]_PY-_WYC_V(O_YB^_?ZUG_+_P#]4/\ KMU[_7!_Y=/^JO\
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M7^?KW_#BW9G_ #PNQ?\ ;Y__ .NWOW^MAM7_ "D2_P#&/^@>O?U^W#_?$?\
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MKW6J-_.L_P"ROL'_ .(4V9_[TN^?>97L%_RI$O\ SUR_]6X>L9?>'_E:8O\
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M]U[I?]4?\S2ZU_\ #_V=_P"]%CO9;O/_ "1[O_FC+_QQNEVV?\E*W_YJQ_\
M'QULD^\6>L@NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NM;/_ .[<]K/\W2?JSK^6)_V374_^)(W3_P"Z[;WM
MB;X^G4X=6)>VNK]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW6O/_/F_[E4_\KE_\Q[WDY]W+_EL_P#4)_VL]0/[V_\
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M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T9KXH_\
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M^Z]U[W[KW7O?NO=>]^Z]U[W[KW1G_B=_S,7-?^&5D?\ W>[<]@_G;_DE1_\
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M05^P=!5_PS#C?^?E;/\ _19O_P#9/[./]<7G7_HYW/\ SF?_ #]%O]3.5O\
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M[_7%YU_Z.=S_ ,YG_P _7OZF<K?]&^W_ .<2?YNO?\,PXW_GY6S_ /T6;_\
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M^'^?7M)]>O?[*+\L/^\WMY?^>K.__9?[]K3^'^?7M)]>O?[*+\L/^\WMY?\
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MN?\ G,_^?KW]3.5O^C?;_P#.)/\ -U[_ (9AQO\ S\K9_P#Z+-__ +)_?O\
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M\O\ SU9W_P"R_P!^UI_#_/KVD^O7O]E%^6'_ 'F]O+_SU9W_ .R_W[6G\/\
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M<;_S\K9__HLW_P#LG]^_UQ>=?^CG<_\ .9_\_7OZF<K?]&^W_P"<2?YNO?\
M#,.-_P"?E;/_ /19O_\ 9/[]_KB\Z_\ 1SN?^<S_ .?KW]3.5O\ HWV__.)/
M\W7O^&8<;_S\K9__ *+-_P#[)_?O]<7G7_HYW/\ SF?_ #]>_J9RM_T;[?\
MYQ)_FZ]_PS#C?^?E;/\ _19O_P#9/[]_KB\Z_P#1SN?^<S_Y^O?U,Y6_Z-]O
M_P XD_S=>_X9AQO_ #\K9_\ Z+-__LG]^_UQ>=?^CG<_\YG_ ,_7OZF<K?\
M1OM_^<2?YNO?\,PXW_GY6S__ $6;_P#V3^_?ZXO.O_1SN?\ G,_^?KW]3.5O
M^C?;_P#.)/\ -U[_ (9AQO\ S\K9_P#Z+-__ +)_?O\ 7%YU_P"CG<_\YG_S
M]>_J9RM_T;[?_G$G^;KW_#,.-_Y^5L__ -%F_P#]D_OW^N+SK_T<[G_G,_\
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M?1KI/KU[_91?EA_WF]O+_P ]6=_^R_W[6G\/\^O:3Z]>_P!E%^6'_>;V\O\
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MUC+ .R1E%D=5O<A3*H)'TU"_U'OW7NN7OW7NN*NCEU5U9HF"2*K F-RB2!'
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MM[]E[3[ [WS&\-Z]J_):#(;.S7R"W9VKO6A&.KNV*W.[JV3N# _Q2@ABIZ?
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M+O+ XY'Q5#GJ!*;[FB>*FR]/E(Z'&"A]U[J+D_@5U=COAQG/A1TIO_NCXP[
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M1Z]>_P!,G4/_ #]7K?\ ]#G;'_UT]^H?3KU1Z]>_TR=0_P#/U>M__0YVQ_\
M73WZA].O5'KU[_3)U#_S]7K?_P!#G;'_ -=/?J'TZ]4>O7O],G4/_/U>M_\
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MYVQ_]=/?J'TZ]4>O7O\ 3)U#_P _5ZW_ /0YVQ_]=/?J'TZ]4>O7O],G4/\
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MO5'KU[_3)U#_ ,_5ZW_]#G;'_P!=/?J'TZ]4>O7O],G4/_/U>M__ $.=L?\
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M3WZA].O5'KU[_3)U#_S]7K?_ -#G;'_UT]^H?3KU1Z]>_P!,G4/_ #]7K?\
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M>M__ $.=L?\ UT]^H?3KU1Z]>_TR=0_\_5ZW_P#0YVQ_]=/?J'TZ]4>O7O\
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M<?Y[_@+_ --'^;_VKVK_ ,W3'1/ZK_@54_\  ?\ X$3?\!?^ O\ G&_X#?\
M-O\ U'^%O;@X=>ZC^_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
+O>_=>Z][]U[K_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>tbarchart_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tbarchart_005.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &2      04  DE$_]L
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M_DJ#_KS[]K/7M Z]_H+V[_SM\U_R5!_UY]^UGKV@=>_T%[=_YV^:_P"2H/\
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M_DJ#_KS[]K/7M Z]_H+V[_SM\U_R5!_UY]^UGKV@=>_T%[=_YV^:_P"2H/\
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M_DJ#_KS[]K/7M Z]_H+V[_SM\U_R5!_UY]^UGKV@=>_T%[=_YV^:_P"2H/\
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M_DJ#_KS[]K/7M Z]_H+V[_SM\U_R5!_UY]^UGKV@=>_T%[=_YV^:_P"2H/\
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M_DJ#_KS[]K/7M Z]_H+V[_SM\U_R5!_UY]^UGKV@=>_T%[=_YV^:_P"2H/\
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M_DJ#_KS[]K/7M Z]_H+V[_SM\U_R5!_UY]^UGKV@=>_T%[=_YV^:_P"2H/\
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M_DJ#_KS[]K/7M Z]_H+V[_SM\U_R5!_UY]^UGKV@=>_T%[=_YV^:_P"2H/\
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M_DJ#_KS[]K/7M Z]_H+V[_SM\U_R5!_UY]^UGKV@=>_T%[=_YV^:_P"2H/\
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M_DJ#_KS[]K/7M Z]_H+V[_SM\U_R5!_UY]^UGKV@=>_T%[=_YV^:_P"2H/\
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M[KW7O?NO=>]^Z]U[W[KW19_^:Z_^1#_Y'^W/P_ZO7IO\7^KTZ571?_'NY?\
M[73?]:(?>GX];3AT-WNG5^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NBS_\ -=?_ "(?_(_VY^'_ %>O3?XO]7ITJNB_^/=R_P#VNF_ZT0^]/QZV
MG#H;O=.K]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=1JVMH\;1U>1R
M-734&/H*:>MKJZMG2EAAAI4,DLTTLA5(XHT5F9F8*J@DD >_=>ZU::S_ (4%
M]H?.7YC9/X*?R7>A]E=Z9[;:9JH[%^9'R R61Q76F!Q^$>GAJ,Y18K"O#F<]
MBON)9*:DE?(8]Z^L$7V5-54,GWOOW7NK1!UQ_.DVCB_[RT7RL_E^=V;@A2JK
MJGJ3<?Q WKTCC:ID5S'CJ3>N/[5W968Y9&*J*R?9U>8K O33C4#[KW01_ ?^
M:5W?\MOF[WK\,>\/B+G/B/V+\6^F<=NSM7;^>WQ3=CT^8R^\,O04V+KMLY>E
MH,='5[9^PCK9H*DP:ZO[I%DCIY*1T?W7NB>?S\OYX_R(_DW;]^/>-V3T_P!+
M]W;1^0V#[(R>+@W3)G-I9+#2]92X*&HBGJ:3(55+DXZTYR-XW2DI#%XVC9).
M)#[KW5]7PW[ORWR:^(?Q6^2.>P>.VSG/D%\;^CN[\UMO$5$E528^K[7VQB\]
M4T-++-^])3TDU>\4;R>MD12WJ)]^Z]T9#W[KW4#*1Y2;&UT6$K*#'Y>2EG3&
M5V4QLF8IH9V4B.2>DAJJ&6HB1K%HTK(&<7 E0G4/=>ZU5_Y='_"@3Y _,'^;
M;VI_+1[%Z(Z<VO@NI]R_)7:N0[3V5E<W]WD)^@,A68Q*B''5U140TD62EI?*
MT;5$[0HWC#N?W/?NO=;6_OW7NO>_=>Z][]U[I"]F5>\<?L+=>2V!7;9Q^[L7
M@\AD\+/O#"U6?QK2XZ)IO%54U%D,95&.8(4UQU8,6KR:)=/C;W7NM6C^0Y_P
MHK[M_FZ?+SL;XW=D_'7JSJ/![)^-^[^[Z3<FQ]S9;,U<]7MO<^S\#'0R15_[
M*T\D.Y9Y6<>L/#&!Z6;W[KW6VC[]U[JD;^=S_,2^3?\ *O\ C)%\M>K]E]&=
MQ;&INR-I=?[BZ_WW29[:>5I$WA'5+39"DRU!E*NDR.FKITCDIWQ='HCD\JSR
M-'XW]U[HN7\G'^:K\Z_YOWQ[[*[]VEL/XE](4O77<62Z@EVSN+'[QWI)5S8_
M"87-?>K54V7H%AB=<RD7C,#L#$7U$,%'NO=##NOYQ_S3.@?GC\/OC=\C_C-\
M5Z_XY?++L[.=987Y)](;WW3ES0Y+"[:R^Y!BJ[$YJGHGQV6K*?#5IIU9JFGE
M@AGECG=X9(5]U[H:OF%\O?GMM'YT]#?#7X5?'SI'LVC[&Z1W)W9VGVKWCN;<
M&U</M#';<SL6&,E1/A*:M>HEK7J(EHZ1:<U%1,)-)6".>:G]U[JJO^<]_/6^
M<'\G#=70.U=Y=-_%/O*I[WVQOC<5/5;9FW=LR/&'8]3C*:6%Q59"N:J$[9)2
MC@16"&Z786]U[JP7JCY9_P UOY"_ 7J7YJ]!=2_"C?.Z.W.F]M=QX'H#.Y;>
MFSJUX=P4T=6<32YXU5=15&26%G6+S4=+!-*%1IH0^M?=>Z'?I/Y<_*7Y"_RP
M-C?-;9^Q.K-A]\YKHS?O:F8Z.WYM[<-;C7R^T?XCX]MFKI\E1Y?#2-+C7IIY
MY<;7RQ2R:OLB8S"_NO=45_R?_P#A1/\ -[^;O\D.POC=L;H#XJ],Y[8W0>ZN
M\HMQ[KR^[MT4E6NV<_MC _PQHZ.IIYJ9IY-RQ3?< 2A%@9?"Y<%?=>Z%"I_X
M4M[Y^'?SOJ_@;_-G^+&SOCQEHZS;%/!\A.BNSJWL7: I-YWDQN?FI,QB<9DQ
MMJ6)XTFJUD:JI9(J@5-!&8Y4A]U[K;1IJFGK*>"LHYX:JDJH8JFEJJ:59XY(
MYU#))&ZDJZ.I!5@2"""#;W[KW1;_ ):;T[KZPZ%[8[5Z.?K"OW9U?UIOGL"D
MVGVEA<I44&8EV=CY\BM V3Q63I9\0M2E,\?W'\.K_&SJ_@8*5/NO=:N_\F;_
M (4:_+C^;=\PIOB^G0OQRZ.Q6#ZJW7V_N7>S56YM^U!H-I5^'QS4-#CAD<3&
M]75U&9I@)9:Y(X8UDE*3,JP2>Z]UN+4BU24M,E=-3U-:E/"M944E,U%%)*J@
M2/%"\M0\4;/<JC3R%00ID<C4?=>ZD>_=>Z][]U[KWOW7NM./^<U_PHT^6G\H
M_P"7M#\7ST3\=>]J#.]2;4[@PN]@^Y>NYDI-V9+-8U:"JQW\6S2?<4LN%F)F
MCKBDJ.C".(ZHU]U[K<<]^Z]U[W[KW7O?NO=>]^Z]U[W[KW17>W/EWU!TW\AO
MBC\7MR91ZON/Y@;J[-P/6FU<9/325$%#U'LW/[RS6?R$,L\<T>'IXL)#CQ)%
M'*[5^1HT$?B%1+![KW1HO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=4
MT?S0OYP'5?\ +5[O^ /4&]H<=6R?+;OJ/9V_JVLE:#^[>REA.*J=SO*\E/20
M1T6Y<QMUI6GJ.<=#E'A@GEB4+[KW5RRLK*&4AE8!E93<$'Z$'\@^_=>Z)Y\]
M.YNVOC7\3/D3\ENJ!UUE<A\=>C.V>\LCLSL/;^3KX<W3]48.MST^-@R&-R]
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MLM!I7;O6VT?+_HNSRM3?>(]+V%-2;TW%)//64XA3-8:B2E%0U0[>Z]UN7_\
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MV]3@4J+%$!!210Q6CB547T^E0%%@ /?NO=*?W[KW1>OEQ_V2C\G/_%>NZ/\
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M=?>_=>ZJO_X1KLJ?RL/F8S,%5?E=V(S,QL !UULPDDGZ >_=>ZK,_P"$0_\
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M^1G(2[353LS,Q+'W7NA]]^Z]U5G_ #9=W=N9[H#%?#KXTRX0?)CYUY?-=$;
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M=>Z][]U[KWOW7NO>_=>Z+/\ \UU_\B'_ ,C_ &Y^'_5Z]-_B_P!7ITJNB_\
MCW<O_P!KIO\ K1#[T_'K:<.AN]TZOU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T@.S>T^ONF]HUN^NS=TXW:.UZ*J
MQ^.^_P AY)I*BLS,R4U#CJ"D@2:LR64R-5)%!1T5)3S5=74.D%-#+,ZH?=>Z
MDTN_,1%L5^PMX05/6. I<56YW-'LBKH=NMC**B,C-5925:R>CH(OMT$["6J5
MX(V"U*P3++%'[KW5:53_ #F?AO#OV+#T3=[[DZCFV#1[ZA^26R_B;V[OC8DD
M-=5)#'40;GQ&P*W;]3M[[>1)GW!#F),/'<QRU*>.1D]U[JP[I;O3ICY'=>X?
MMGH'M7K_ +FZSS[U4.(WWUGNRBWGBYI<>YBJ:<5E!-/"M52S!HYX&99H) T<
MJ(ZE1[KW0J^_=>ZKL[#_ )G_ ,9.L?YBG2/\L+<R]D?[,IWYUEF^U-DU6.V:
M*S;45#AX,W5)35^4^[2IBK:VFVWG)(?#CIZ9!2.M54TTDD"2^Z]U8G[]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>ZB9"NI\905N2JS(*7'TE375)BA:H<1TB-(
M^F- SNVE3954L3P 2??NO=$"_EO?S,?C9_-.Z7WCWM\8$[$AV5L;MC<_3N;A
M[*VDFTJTY+;5+CZ\5$$4%9D():"OQV4Q]53M]R*A8YECJZ>EJ%>!?=>Z0DO\
MX'X5S_/GJ/\ EM[:W)OW>7R5[>IMWU]!!@NO:ZBV_BJ39VV<_NF6MR&=RW\,
MIJRDJZ';M;#328=<J'JWBCE\4?GF@]U[KW\QO^<#\*_Y76TZ7<7R8W)OVKS6
M6J6H-N;"ZOZ]KMYY/(58I36+1)62?8[;Q]7)2@2QQY+/T)>,B1+QAF'NO='G
M[][LV+\:^D.V_D'V=/E:;KKI/KK=_:.^:C!XN3-UB8K9%#/D:YJ:DBL]1,M/
M3R%$!4$VNRK=A[KW02?!;YI]/?S"_BWU?\NNAJ?>=#UCVO3[B?"8WL+ Q;;S
M-)/M++5V$R-)7TU/5U]&)J7)8ZJB+TV0JJ>33JBGD4W]^Z]T;?W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]T"N[>_>O.O^T-E]5;^JLELO*]F#[/K/<^X:(4F
M S^5B$TD^W:'+K))30[CCIXON(L=6?:U&0@,LF+2N6CR'VGNO=#5[]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NBS_P#-=?\ R(?_ "/]N?A_U>O3?XO]7ITJNB_^/=R__:Z;_K1#[T_'
MK:<.AN]TZOU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]UKV_$CO)_YG/\ -D^6/8TU*F8^)W\JG-T_QW^.5-4)'4X_
M,]P[IBR%)V!OGQ34Z3?Q3:V/I:G 8N4.],N.RD]?222/D6-/[KW2&_X5;-WU
M!_*,WIDNEL:^<VMANZ^HLM\E=OQ-E8_XAUU1RU_\0HYFPTU+7ICIMQ';'\29
M*VF"XP5I-1%:_OW7NCT? WYO_&/Y];\V7WC\6M[[8W'LRI^*&#Q^=V?AJRF7
M(;0R39N">7;&=QL)5\3DL;'(B>%X4CDB$<]*9*66&5_=>Z.#\7/C'M7XM4'=
M^VMB4&#PNR^S_D-V%WK@=O8"C_A\-!)V?3XNIRT#0A$BC>7/196I B'C$<\8
M%F#*ONO=&B]^Z]U7^W\Q+^7IE/F'UQ\2,-W]T]OKYA[V.]-O;6V'L62/L#,X
M]=HX+(;GR])E<GBH*VFVXJ8G%U<Y@KZZE:9E1$C>21%/NO=/_=?\R?X+_'KN
M3K#X[=J?)?K/#=^]Q]C]?=4; Z7Q&7;>&YZG,]HY:#"86.LPV'CKJW$455D:
MA8S79"*EHHPKL\ZA#[]U[HN/9W\]G^5#T]\EZ3XD[_\ F+L#$]T39REVQDZ.
MEQ69S>"Q63K7>),?F=V4.-J-L8FL69/'-'4Y:,TDC*M7X-0]^Z]U;<K*RAE(
M96 964W!!^A!_(/OW7N@A[V[QV+\=.L-S=L]B+NJHVYMFBGJ6Q6Q=E97L7-5
M\R12214&*PF%I*W)9"NJ?&RQ114Y%_5(T<:LZ^Z]U0U_(_\ YR&VOG_M;Y4=
MK]F5V]-IY#M#^8#N39OQ[ZSJ=H;@W=!@MH4NQNLL1MW&2Y7%XNLP>-FJ\@N0
MK\@DF02*&OKJRI9Q3RI,_NO=6LY3^9I\"\9\G-H?#9?E%U5FODKO*3>J4W5N
MU<\-VU6,'7>W<ENK,/N.JQJ56.VP*/!XFLJ2,M64;R!56)79U'OW7N@MZ#_G
M.?RP_DO#WO7=3?,+JNNP?QLF7_2]NO=U55]9X6@II9:B"/)4V8W)2XK&97$3
MS4E0L5;155132Z5>.1HY87D]U[H>_A;\O/B'\R>O]^[W^%V^MJ]B=8]>]N;C
MZHW/N/9&VJG;N*;<N*QV(S612B>HH:&+)QM29[&RFNIEEIIWD8)/(\<FGW7N
MM;_YB001?\+)_P"5))%#%%)5? 7L6>I>.,(9'7;_ ,DX@[D %W$<<:7-SI55
M^B@#W7NO?\+5X(&_E<?'^I:&)JF+Y]=9015!C!=4J.N^T6D17MJ5':*(L ;,
M44F^D6]U[K:1^07R(^/'QHZ^R78'R8[>ZOZ;ZX$<M#6Y[M7==!M>AJ#4 1M2
M1"OEC^^GF\BHM-$DLLI<(L;%@#[KW3#\2?D5\?/E=\?=A=\?%;<&.W3T'O"7
M>&+Z_P [B-L5>S:2=-@9[)[<R'VN.KJ.@J8*>++8BOCC+4D:2HBS1:HI$=O=
M>Z2'>?SJ^./Q^WBO6>Z\_OS?';IP^,W)-TO\?NE=Y_)K>5+B\P]3'2Y?([8Z
M^P.Y,SB,/4/15:Q5]?24U'+)$T,4[S%8V]U[KOXL?/+XH_,_^^5#\>NV:+=.
M[NM:J*@[/ZMW)MS,=8[SVO43RSP)#N/9NY\?A]SX4RS4U0D3U6*CBG\9>GDE
MC*N?=>Z3?=?\R?X+_'KN3K#X[=J?)?K/#=^]Q]C]?=4; Z7Q&7;>&YZG,]HY
M:#"86.LPV'CKJW$455D:A8S79"*EHHPKL\ZA#[]U[HN/9W\]G^5#T]\EZ3XD
M[_\ F+L#$]T39REVQDZ.EQ69S>"Q63K7>),?F=V4.-J-L8FL69/'-'4Y:,TD
MC*M7X-0]^Z]U97VGVSUMTEL'.]H]K[RPFQ=@;;AHY<QN?.5)B@C.2GBI:2&,
M('EJ:JMJYX*>FIX8Y)ZF>6."".261$;W7NBB5G\S;XDX#<G5^S^P<[VWTWN?
MNW=W6.P^G</WI\;.Q.DVW/F.X,E#BL'BL/-NC:^+IJK+R5<Z&KQWG7(XR&]1
MDJ2D@M(?=>Z,C\D.@.O?E)T?V3T)VCCGK]G=D[:KL#63TTTE'64%0X\E!E\9
M50R0U%%EL/7)3UE#50S1S4]5!%-%(CH"/=>ZK$_D=?.W??S!^-_9W5??F9&>
M^6'P3[RWS\0_D7N-XX*-MQY#K.IEH\=N\4L3EJ<9^FIY5J \<>K)4>1,:"'Q
MD^Z]U=3[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[HL_\ S77_ ,B'_P C_;GX?]7KTW^+_5Z=*KHO_CW<O_VN
MF_ZT0^]/QZVG#H;O=.K]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW21[ SU3M;8>]MST:"2KVYM'<F>I8V( :3$44U0@)97
M !:,#E&']0?I[]U[K4L_X1=FNS?\N7Y1;^SN4R&<W5N_Y]]CG<6<S%2^2K*R
M>FV+UY6R55763,]355%14Y2IDD>61F9V9R2SN3[KW6W;G,'A=S8;+;<W)A\7
MN';V>QM;A\[@<YCXLM15M'DHVAJ:6KI9TD@J::HA=TDBD1D=&*LI4D>_=>ZT
MJOE__)0^1_P+^8F=^5O\@;>&3ZB[&HNLZGM_LCXBY/.#([:W5119PPU6WL%1
M9"U)+0SCRNF'KZK3$SVPM9C9HZ6(>Z]U?W_)M_FF;?\ YJOQAR7:%9L*KZA[
MPZFWE5]3?(CJ*M>H<X7<F)A25I*4U4%/5"@R$;&2*.:+S4LJU%%,\LM*\K^Z
M]U;=[]U[K3E^5FV-N[8_X61_RL$V[A,9@X\Q\$.P\MDX<51I0I-4Q[8^1M$)
MFCC"IK%)1TL5PH],:C\>_=>Z;_\ A2?L7:F7_F=_\)O,9/AX**+?/SFSN!W3
M68.23;M;54]=V#T5&]Z^@>GK8IT%;5-'/'.DT4DC212))ZO?NO='A_X4^]-]
M5X7^0W\E<7@.O=F[=Q'2V0^-62ZIP^ VU18>DP$DW9&S]O-_":>G@2+'(<-E
MJ^EM3K%^S,\7^;9E/NO=6X?RTMX[F[$_EQ_ #L#>F6GS^\=]?";XJ;QW9G:I
M(XI:W)[GV)@:VOJY%B2.)9*FJGED8)&J L0JJ+ >Z]T=GW[KW6H%_P (J?\
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MOCD,/BNG:#X:=IXS>]3E9-TZ(\6VW<EM*AJJ%GELK5M8:?%Q1G[F6O2D_?\
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M)YO^RKO^%"'_ (UY[_\ _>DW7[]U[K:#]^Z]UJ^?!7_N*%_GA?\ BO7PI_\
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M %<7J&_>?_<*#_FN?^K;=:S7O+3K'/KWOW7NO>_=>ZW)/Y5'_9 _0W_E4?\
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M^2A=?\\Z_P#5Q>H;]Y_]PH/^:Y_ZMMUK->\M.L<^O>_=>Z][]U[K<D_E4?\
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MN?\ FS_VCQ=5Y^Y.Z ?7O?NO=";TI_S.7J3_ ,2;L/\ ]VM)[)^8?^2?<_\
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M\=\_^4N_]XS;OO.KV;_Y5NS_ .HC_M*GZQ+]S?\ DN7/_-G_ +1XNJ\_<G=
M/KWOW7NA-Z4_YG+U)_XDW8?_ +M:3V3\P_\ )/N?^>>;_JVW1IL?^YMO_P U
MXO\ JXO6_'[YO]9N=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=4
M:?ST/^9-=(_^)-R__NJE]Y"?=X_Y*%U_SSK_ -7%ZAOWG_W"@_YKG_JVW6LU
M[RTZQSZ][]U[KWOW7NMR3^51_P!D#]#?^51_][/<7O!7WD_Y62\_ZA_^T6#K
M+3VR_P"2';?\WO\ M(EZL,]QCT/.O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z+/\ \UU_\B'_ ,C_ &Y^'_5Z]-_B_P!7ITJNB_\ CW<O_P!KIO\
MK1#[T_'K:<.AN]TZOU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UIM_S5_P#LOCOG_P I=_[QFW?>
M=7LW_P JW9_]1'_:5/UB7[F_\ERY_P";/_:/%U7G[D[H!]>]^Z]T)O2G_,Y>
MI/\ Q)NP_P#W:TGLGYA_Y)]S_P \\W_5MNC38_\ <VW_ .:\7_5Q>M^/WS?Z
MS<Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZHT_GH?\R:Z1_P#$
MFY?_ -U4OO(3[O'_ "4+K_GG7_JXO4-^\_\ N%!_S7/_ %;;K6:]Y:=8Y]>]
M^Z]U[W[KW6Y)_*H_[('Z&_\ *H_^]GN+W@K[R?\ *R7G_4/_ -HL'66GME_R
M0[;_ )O?]I$O5AGN,>AYU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M19_^:Z_^1#_Y'^W/P_ZO7IO\7^KTZ571?_'NY?\ [73?]:(?>GX];3AT-WNG
M5^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NJD_YM'\RS-_R]]E_'?:74G6&&[I^57S,[\VC\;/C-UONC<PVG
MA9<YNRJI*,Y7/5B7JUP^/J,AC8I5IU$DD]93HTU-$SSQ^Z]U7'\L_G/_ #S_
M .5WU/A/F-\S-C?RZ_DC\5]J9;9.,^26T/BW2;[ZZW=MF/?N8HL+3UF"KMU9
M*JQN7I8<AD*.F5IJ-)99IXDD@IX3)6P^Z]ULP[)W=ANP-F;1WYMR6:;;V]ML
M8#=V!FJ(O!(]%N2DBK:5G2[:':"9"RZC8W%S[]U[H&/EW\I.J_A1\:NX_E/W
M7E&Q76O2^SZG=6?>%XTGJI9)8J/&XJB$KQQR9+,Y6JHJ"BC+CRU=3#&#=Q[]
MU[K7ZVC\L?\ A2]\@^F:7YI]%_&'^7+L;H_=^W/]*?5/Q,[<SF^Z[MO,;8\7
MW>.IY:^CGH]JQ9K<E J3T8GK<<(14P)4T\,BR*?=>ZMW_E7?S&-B?S0/B+M?
MY*;4VK7=;[KI=PY_K7N?J/+Y%,I6[3WALPPC*X>>94ADDB:*HI*RD>:EIYY*
M*JIWGIJ>8R0I[KW5CGOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K3;_FK_P#9
M?'?/_E+O_>,V[[SJ]F_^5;L_^HC_ +2I^L2_<W_DN7/_ #9_[1XNJ\_<G= /
MKWOW7NA-Z4_YG+U)_P")-V'_ .[6D]D_,/\ R3[G_GGF_P"K;=&FQ_[FV_\
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M7NMR3^51_P!D#]#?^51_][/<7O!7WD_Y62\_ZA_^T6#K+3VR_P"2';?\WO\
MM(EZL,]QCT/.O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z+/\ \UU_
M\B'_ ,C_ &Y^'_5Z]-_B_P!7ITJNB_\ CW<O_P!KIO\ K1#[T_'K:<.AN]TZ
MOU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]UK[?\ "BGX_P#1/8_Q0ZL[_P"POE1B?AEWG\/.[=L]V?$OO/);
M<;?#_P!],6\532;<AV_34M=E<W)F:C'4,T4&/HZBIBK*"DJGIJNEIZFCJ/=>
MZH1^17\P3Y<_/G;OP[^(/\[3I[._RFO@SWDFS]Y=X]YU>Q,S+0]N9G9]?CLO
MM_9LF0KH5BZ>H<C44,V4JUKZFIKJ0T4$TLU-2:@_NO=;[.U<;M["[7VWA]HP
MT%/M/$X'#XW;$&+F%13)CJ&GCBHDII SAX%IDB$;!V!0 W-[^_=>ZUL?^%<F
M<R.)_DR=FT%%,8J;<W=W0F#S"<_N4U/FOXDJ<$#BKQ]*_((]/TO8CW7NME;
M82@VU@L+MS%1^'%X#$XW"8V$A5TT^*A2"%;(J(-,<:CTHH_H ./?NO=:N_\
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MYO\ 6;G7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW01_(#_F0_=G_B(^R/\
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M?NO=>]^Z]U[W[KW7O?NO=:;?\U?_ ++X[Y_\I=_[QFW?>=7LW_RK=G_U$?\
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M=:;?\U?_ ++X[Y_\I=_[QFW?>=7LW_RK=G_U$?\ :5/UB7[F_P#)<N?^;/\
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M7O?NO=>]^Z]U[W[KW19_^:Z_^1#_ .1_MS\/^KUZ;_%_J].E5T7_ ,>[E_\
MM=-_UHA]Z?CUM.'0W>Z=7Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[JF#Y+_\ "?#^43\M^W\WWKW1\1L-6]E[
MJJGK]XYK8_8N[>JH,Q4S3//-69+'[9SN)Q\^0J9)9#/6"F6KGU#S3.4C*>Z]
MU:%T5T%TM\8^L-M]+?'WK'9O4'56T8ZM-O;%V)A8L%04[9"9ZBIF\40!FJJN
MIDDFJ)Y6>:>9WEFD>1F8^Z]T#?Q>^ WQ(^&&Z^_]\_&CIW'=9;M^4?8)[0[V
MST&Y<WN>HSV9%1DJM)W;-9/)?8TL%5F<M+!140IJ*G>KG\%/&'(]^Z]T<'W[
MKW19?BS\.?C=\*MH;YV'\9.M8.L-J]E=K[O[PWQC8=S9K=C9#=6_(Z*'*Y:6
MISN2RE6DE5#CJ*,0QSI31)"BP0QK<'W7NC->_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NJ4OYY'_9.?5/_B:Z/_W19KW/GW>O^2K<?\\A_P"KT740^\W_ "3H
M?^>E?^K4O6KY[R\ZQMZ][]U[KWOW7NMPG^4E_P!D+=6?]KOLG_WHLE[P<]Z?
M^5BN/]+!_P!6(^LL/:__ )(D'VS?]7I.K)_<5=2!U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]UIM_S5_P#LOCOG_P I=_[QFW?>=7LW_P JW9_]1'_:5/UB
M7[F_\ERY_P";/_:/%U7G[D[H!]>]^Z]T)O2G_,Y>I/\ Q)NP_P#W:TGLGYA_
MY)]S_P \\W_5MNC38_\ <VW_ .:\7_5Q>M^/WS?ZS<Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z"/Y ?\ ,A^[/_$1]D?^Z:M]G/+G_)0M?^>B#_JZO1=O
M'^XD_P#S1D_XXW6A7[Z/]80=>]^Z]U[W[KW5WG\C/_F?'<7_ (B.'_W<T'O'
MS[PW_)/M?^>@_P#5INIG]E_]R[C_ )HK_P ?'6SI[Q*ZR)Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>ZHT_GH?\R:Z1_P#$FY?_ -U4OO(3[O'_ "4+K_GG
M7_JXO4-^\_\ N%!_S7/_ %;;K6:]Y:=8Y]>]^Z]U[W[KW6Y)_*H_[('Z&_\
M*H_^]GN+W@K[R?\ *R7G_4/_ -HL'66GME_R0[;_ )O?]I$O5AGN,>AYU[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW19_^:Z_^1#_Y'^W/P_ZO7IO\
M7^KTZ571?_'NY?\ [73?]:(?>GX];3AT-WNG5^O>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJ4OYY'_9.?5/_
M (FNC_\ =%FO<^?=Z_Y*MQ_SR'_J]%U$/O-_R3H?^>E?^K4O6KY[R\ZQMZ][
M]U[KWOW7NMPG^4E_V0MU9_VN^R?_ 'HLE[P<]Z?^5BN/]+!_U8CZRP]K_P#D
MB0?;-_U>DZLG]Q5U('7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6FW_ #5_
M^R^.^?\ REW_ +QFW?>=7LW_ ,JW9_\ 41_VE3]8E^YO_)<N?^;/_:/%U7G[
MD[H!]>]^Z]T)O2G_ #.7J3_Q)NP__=K2>R?F'_DGW/\ SSS?]6VZ--C_ -S;
M?_FO%_U<7K?C]\W^LW.O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N@C^0'_,
MA^[/_$1]D?\ NFK?9SRY_P E"U_YZ(/^KJ]%V\?[B3_\T9/^.-UH5^^C_6$'
M7O?NO=>]^Z]U=Y_(S_YGQW%_XB.'_P!W-![Q\^\-_P D^U_YZ#_U:;J9_9?_
M '+N/^:*_P#'QULZ>\2NLB>O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJ-/
MYZ'_ #)KI'_Q)N7_ /=5+[R$^[Q_R4+K_GG7_JXO4-^\_P#N%!_S7/\ U;;K
M6:]Y:=8Y]>]^Z]U[W[KW6Y)_*H_[('Z&_P#*H_\ O9[B]X*^\G_*R7G_ %#_
M /:+!UEI[9?\D.V_YO?]I$O5AGN,>AYU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW19_\ FNO_ )$/_D?[<_#_ *O7IO\ %_J].E5T7_Q[N7_[73?]
M:(?>GX];3AT-WNG5^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NJ4OYY'_9.?5/\ XFNC_P#=%FO<^?=Z_P"2
MK<?\\A_ZO1=1#[S?\DZ'_GI7_JU+UJ^>\O.L;>O>_=>Z][]U[K<)_E)?]D+=
M6?\ :[[)_P#>BR7O!SWI_P"5BN/]+!_U8CZRP]K_ /DB0?;-_P!7I.K)_<5=
M2!U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UIM_S5_^R^.^?_*7?^\9MWWG
M5[-_\JW9_P#41_VE3]8E^YO_ "7+G_FS_P!H\75>?N3N@'U[W[KW0F]*?\SE
MZD_\2;L/_P!VM)[)^8?^2?<_\\\W_5MNC38_]S;?_FO%_P!7%ZWX_?-_K-SK
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[H(_D!_S(?NS_P 1'V1_[IJWV<\N
M?\E"U_YZ(/\ JZO1=O'^XD__ #1D_P".-UH5^^C_ %A!U[W[KW7O?NO=7>?R
M,_\ F?'<7_B(X?\ W<T'O'S[PW_)/M?^>@_]6FZF?V7_ -R[C_FBO_'QULZ>
M\2NLB>O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJ-/YZ'_,FND?_$FY?_W5
M2^\A/N\?\E"Z_P">=?\ JXO4-^\_^X4'_-<_]6VZUFO>6G6.?7O?NO=>]^Z]
MUN2?RJ/^R!^AO_*H_P#O9[B]X*^\G_*R7G_4/_VBP=9:>V7_ "0[;_F]_P!I
M$O5AGN,>AYU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW19_P#FNO\
MY$/_ )'^W/P_ZO7IO\7^KTZ571?_ ![N7_[73?\ 6B'WI^/6TX=#=[IU?KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[IJ
MSV8IMO8/,Y^M2>6CP>*R.8JXJ55>5HL9"\TBQJ[(AD*(0H9U!-KL!S[>MX3<
MR+&M*LP45X58@9X^O3<L@A4N>"@DTXT KU4%_P /@_%#_GWWR&_]!/;?_P!E
MON;_ /@?-Y_W]9?\Y)_^V;J*?]>3:_\ ?5U_O$7_ %OZ]_P^#\4/^???(;_T
M$]M__9;[]_P/F\_[^LO^<D__ &S=>_UY-K_WU=?[Q%_UOZ]_P^#\4/\ GWWR
M&_\ 03VW_P#9;[]_P/F\_P"_K+_G)/\ ]LW7O]>3:_\ ?5U_O$7_ %OZ,O\
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M_P JW9_]1'_:5/UB7[F_\ERY_P";/_:/%U7G[D[H!]>]^Z]T)O2G_,Y>I/\
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M6&>XQZ'G7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=%G_YKK_Y$/\
MY'^W/P_ZO7IO\7^KTZ571?\ Q[N7_P"UTW_6B'WI^/6TX=#=[IU?KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[I#=G_\
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M>]^Z]U[W[KW6FW_-7_[+X[Y_\I=_[QFW?>=7LW_RK=G_ -1'_:5/UB7[F_\
M)<N?^;/_ &CQ=5Y^Y.Z ?7O?NO=";TI_S.7J3_Q)NP__ ':TGLGYA_Y)]S_S
MSS?]6VZ--C_W-M_^:\7_ %<7K?C]\W^LW.O>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7N@C^0'_,A^[/_ !$?9'_NFK?9SRY_R4+7_GH@_P"KJ]%V\?[B3_\
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M^Y4/_-6/_CXZ2WW]A)_I'_XZ>M CWTIZP9Z][]U[KWOW7NKDOY'W_95_8/\
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M]\W^LW.O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N@C^0'_,A^[/_$1]D?\
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M_P"<T?\ T%UFI_FC\2:RH@I*7Y(=,5%55314]-3P]@XV1WDG8*B(HG)9F8@
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M2=63^XJZD#KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K3;_ )J__9?'?/\
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M/14WNO=7K^_=>ZT=OY4&WOYH'=/RN_G3Y#X@=R_&'H3:V?\ YFGR(Q_;W?\
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M](__ !T]:!'OI3U@SU[W[KW7O?NO=7)?R/O^RK^P?_%>=V?^])M+W!7W@_\
MDC0_\]L?_5BYZEKV;_Y*DO\ SRO_ -78.MI[WAYUDMU[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U2E_/(_[)SZI_P#$UT?_ +HLU[GS[O7_ "5;C_GD/_5Z
M+J(?>;_DG0_\]*_]6I>M7SWEYUC;U[W[KW7O?NO=;A/\I+_LA;JS_M=]D_\
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M]U[KWOW7NO>_=>Z][]U[K3;_ )J__9?'?/\ Y2[_ -XS;OO.KV;_ .5;L_\
MJ(_[2I^L2_<W_DN7/_-G_M'BZKS]R=T ^O>_=>Z$WI3_ )G+U)_XDW8?_NUI
M/9/S#_R3[G_GGF_ZMMT:;'_N;;_\UXO^KB];\?OF_P!9N=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=!'\@/^9#]V?^(C[(_P#=-6^SGES_ )*%K_ST0?\
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M?BGE-V[1QN6V96''Y&@&9RD^(6L:EK(YHWG@@>D;2KPU$T<B,?=>ZLG^ ?\
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MJF98UBIX(E)EED:RBY9V-R3[]U[K6'_X3@;7BWYW+_.4^<_7.&BVO\7/E_\
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M))6+4322^_=>Z!C"?REMA;Q_E38/^5K\LNZ.R?D[@H=DUVV]R=_YK1@-TSY
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M]_K-\M_\H?\ V<77_6_KW^N;OG_*3_U1M_\ K5U[_AU?Y\?\_P"?_87;,_\
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M\.OH#>^:O6<?7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW2&[/\ ^9:]A_\
MAC;M_P#<"H]K]J_W*A_YJQ_\?'26^_L)/](__'3UH$>^E/6#/7O?NO=>]^Z]
MU<E_(^_[*O[!_P#%>=V?^])M+W!7W@_^2-#_ ,]L?_5BYZEKV;_Y*DO_ #RO
M_P!78.MI[WAYUDMU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U2E_/(_[)SZ
MI_\ $UT?_NBS7N?/N]?\E6X_YY#_ -7HNHA]YO\ DG0_\]*_]6I>M7SWEYUC
M;U[W[KW7O?NO=;A/\I+_ +(6ZL_[7?9/_O19+W@Y[T_\K%<?Z6#_ *L1]98>
MU_\ R1(/MF_ZO2=63^XJZD#KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K3;
M_FK_ /9?'?/_ )2[_P!XS;OO.KV;_P"5;L_^HC_M*GZQ+]S?^2Y<_P#-G_M'
MBZKS]R=T ^O>_=>Z$WI3_F<O4G_B3=A_^[6D]D_,/_)/N?\ GGF_ZMMT:;'_
M +FV_P#S7B_ZN+UOQ^^;_6;G7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW01
M_(#_ )D/W9_XB/LC_P!TU;[.>7/^2A:_\]$'_5U>B[>/]Q)_^:,G_'&ZT*_?
M1_K"#KWOW7NO>_=>ZN\_D9_\SX[B_P#$1P_^[F@]X^?>&_Y)]K_ST'_JTW4S
M^R_^Y=Q_S17_ (^.MG3WB5UD3U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M1I_/0_YDUTC_ .)-R_\ [JI?>0GW>/\ DH77_/.O_5Q>H;]Y_P#<*#_FN?\
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M_P E;_FQ'_A?JJ;W,W47]>]^Z]TJMB_\?OL[_P .K;W_ +EP^T.Y_P"XTO\
MS2D_XX>ENV_[D1?\U$_X\.OH#>^:O6<?7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW2&[/\ ^9:]A_\ AC;M_P#<"H]K]J_W*A_YJQ_\?'26^_L)/](__'3U
MH$>^E/6#/7O?NO=>]^Z]U<E_(^_[*O[!_P#%>=V?^])M+W!7W@_^2-#_ ,]L
M?_5BYZEKV;_Y*DO_ #RO_P!78.MI[WAYUDMU[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U2E_/(_[)SZI_\ $UT?_NBS7N?/N]?\E6X_YY#_ -7HNHA]YO\
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M #]UJ;^\T>L7.O>_=>Z][]U[K;(_DO\ _9',_P#XES>__N-B_>%WOQ_R7?\
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M *N+U#?O/_N%!_S7/_5MNM9KWEIUCGU[W[KW7O?NO=;DG\JC_L@?H;_RJ/\
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M7HNHA]YO^2=#_P ]*_\ 5J7K5\]Y>=8V]>]^Z]U[W[KW6X3_ "DO^R%NK/\
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M=4I?SR/^R<^J?_$UT?\ [HLU[GS[O7_)5N/^>0_]7HNHA]YO^2=#_P ]*_\
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M=>]^Z]U[W[KW01_(#_F0_=G_ (B/LC_W35OLYY<_Y*%K_P ]$'_5U>B[>/\
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M4:KK*3'TTM97U5-14D #3557.M-&@8A06=RJJ"2!R?J0/?NO=:M7<VYMMO\
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MWN9NHOZ][]U[I5;%_P"/WV=_X=6WO_<N'VAW/_<:7_FE)_QP]+=M_P!R(O\
MFHG_ !X=?0&]\U>LX^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7ND-V?_P R
MU[#_ /#&W;_[@5'M?M7^Y4/_ #5C_P"/CI+??V$G^D?_ (Z>M CWTIZP9Z][
M]U[KWOW7NKDOY'W_ &5?V#_XKSNS_P!Z3:7N"OO!_P#)&A_Y[8_^K%SU+7LW
M_P E27_GE?\ ZNP=;3WO#SK);KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[J
ME+^>1_V3GU3_ .)KH_\ W19KW/GW>O\ DJW'_/(?^KT740^\W_).A_YZ5_ZM
M2]:OGO+SK&WKWOW7NO>_=>ZW"?Y27_9"W5G_ &N^R?\ WHLE[P<]Z?\ E8KC
M_2P?]6(^LL/:_P#Y(D'VS?\ 5Z3JR?W%74@=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=:;?\U?_LOCOG_REW_O&;=]YU>S?_*MV?\ U$?]I4_6)?N;_P E
MRY_YL_\ :/%U7G[D[H!]>]^Z]T)O2G_,Y>I/_$F[#_\ =K2>R?F'_DGW/_//
M-_U;;HTV/_<VW_YKQ?\ 5Q>M^/WS?ZS<Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z"/Y ?\R'[L_\ $1]D?^Z:M]G/+G_)0M?^>B#_ *NKT7;Q_N)/_P T
M9/\ CC=:%?OH_P!80=>]^Z]U[W[KW5WG\C/_ )GQW%_XB.'_ -W-![Q\^\-_
MR3[7_GH/_5INIG]E_P#<NX_YHK_Q\=;.GO$KK(GKWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[JC3^>A_S)KI'_Q)N7_]U4OO(3[O'_)0NO\ GG7_ *N+U#?O
M/_N%!_S7/_5MNM9KWEIUCGU[W[KW7O?NO=;DG\JC_L@?H;_RJ/\ [V>XO>"O
MO)_RLEY_U#_]HL'66GME_P D.V_YO?\ :1+U89[C'H>=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]T6?\ YKK_ .1#_P"1_MS\/^KUZ;_%_J].E5T7
M_P >[E_^UTW_ %HA]Z?CUM.'0W>Z=7Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NM8G;7\RK^:[_ #+^RNZLE_)TZT^$NV?B#T+V
M#F>I8ODW\V,MN[(TW8^>P6DUTNR:;98J'CPU$C0N*B>FDBJ8ZJF>.J203TT7
MNO=&N_E<?S0^\OD7WY\D/Y??SVZ6V=\?OG[\4Z#$;HW%B^N<W+DMI;YVGF6I
MHH-X;22NJ*C)0T(DK<:TT4L]0$BR%"S315+U5!1>Z]U>1[]U[K7"SG\RC^8Y
M\[OE#\C.@?Y0'67Q6P_4OPW[)/3W>_RO^:]1NN3#YC=^)FJJ?,[>V9A=J(M9
M4_P>2G):KGD:&I 20-34U51U%3[KW0P_R\_YE?RIW3\Q^U/Y8O\ ,NZIZ<ZO
M^:'7G5]#WEU_OGX\Y?*Y'8O86SZZK%+)D,+!F3/DL=5X^22..6.IJ5DJ6BK7
M2DI!2O%[]U[J]SW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UCEEB@BDGGDCAA
MAC>6::5Q&J+&"69F) 55 )))L!R??NO=$BP/\S3^73NGLN#IK;7SJ^)&>[6J
MMP5.U*3K[$?(/:V0RLV4HW>.7&PT<64:66O26.2,P(IE\BM'IU@K[]U[H\/O
MW7NO>_=>Z);W!_,?_E^_'W>U7UKWE\V/BOU+V'CXXI<EL?L'O?;6ULM2+.2$
M-7CZS)155('L=/FB34 2+@$^_=>Z-AM+=^TM_P"VL)O38FZ-N[UV=N6@ARNW
M-V;2S=-N3&9"EJ1>.IHJ^CEFI:JGD'Z9(I61OP3[]U[I1>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>ZU?/^$\W_ &5=_P *$/\ QKSW_P#^])NOW[KW
M6T'[]U[I@W5NK;6Q=L;AWIO//XC:NT-I87)[CW1N;<&0BQ-#C\?A87J*NMK*
MJ=DAIZ:F@CDDDD=PJ(I9B /?NO=:Q'6%/N+^?I\Y>HOEC48G(8;^4;\!^P\O
MN?XTPYV@;'5/=';&T:N2A;=[4<^IUV;M>H@DCHC)%#+)412P.'-57T]![KW6
MTM[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JDCN'_A.9_)G[[[7[)[O
M[6^&D&Y>S^WM\[H[)[$W)3]^=H[97(YS>M;-D<I7F@Q.]J#&TLE;6U$\SI34
M<,6MV*QK?W[KW0__  H_DW_RW/Y=?96Y>X/AS\;H.G^R-W;&K.MMP;H;M;?'
M8<LV#R-?C\I/0)#NK<V<I::.:OQ6.F=X8(Y6,"*9-%U/NO=#OUM\!OB1U#\K
MNZOG!UYT[CMO_*;Y#;=H-I]N=LG<N;R]1D\=CQB]-)#CZ[)U.(Q,,QPF(:H&
M/Q])]S)1P2U'DD76?=>Z(=\BO^$['\GOY1]I[F[I[4^(6)C[(WMELKG]Z9S8
M'9.[^KX<KD,W4R5E7D:W&;?SV.Q+Y"JJIYY9ZE*%)ZB21FJ))2%*^Z]U8E\4
M/A9\5O@SUN.I?B9T=L;H_8LD])69/'[2H9)*O)U-#3I2Q5N:R];+59C.9!:>
M-(S5Y"OJ:EE'JE-S?W7NC0>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N@'^3?
MQDZ-^9'1N^_C;\DMB0=F=*=F08.GWMLFHSF4VRM:NV<I19J@(K\+6XW*4LE+
ME,;0U"/3UT3AXE!8J64^Z]U3S_T"X_R*/^\&?_9F>XO_ +8/OW7NK-MG_P O
M[XA;!^&-7_+WVCT]2X;X?U^R-\]<U?3T6\=Q5*/A^R:W(9'-TQSD^7EW*):^
MNRM?.U2,R*J.28M%-&533[KW4;"_R[OA5@OAWBO@#3?'K8]?\/L+B&PU!TAN
M+[S=6."/EY-P-/)59*KJ\I-D#G9I<A][)7-6"M8U(G$MF]^Z]U75UW_PF6_D
ME]9[ZQN_\+\*</GLCAJJIJ\9@>Q.UM\=FX)7J R 5."S^Y,CBLI%'&[*D=?2
MU48-I"IF2.1?=>ZO9QN-QV&QU!B,1046*Q.*HJ7&XO%XVE2AIZ:GH46*""""
M)5BAAAB541$4*B@*H  'OW7NIOOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KY_.^O^/WWC_X=6X?_ '+F]]*ML_W&B_YI1_\ '!U@YN7^Y$O_ #4?
M_CQZ2OM=TBZ][]U[JS;^4/\ ]EP[!_\ #5[%_P#=/5>XC][_ /E7Y?\ FK!_
MU<'4D^U'_)83_FG+_P =ZV^O>$?64_7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW577\X3_LB;=7_A\]??\ N</<N^Q__*P1?\TIO^.'J.?=7_DC2?Z>+_CX
MZU%/>;?6*O7O?NO=>]^Z]UM/?R/O^R4.P?\ Q8;=G_O-[2]X>?>#_P"2S#_S
MQ1_]7[GK);V;_P"27+_SU/\ ]6H.KDO<%=2UU[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]UJC?SK/^ROL'_XA39G_NSSOO,KV"_Y(C_\]<O_ %;AZQE]X?\
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M_O-'K%SKWOW7NO>_=>ZVR/Y+_P#V1S/_ .)<WO\ ^XV+]X7>_'_)=_ZAX?\
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M]U[JY+^1]_V5?V#_ .*\[L_]Z3:7N"OO!_\ )&A_Y[8_^K%SU+7LW_R5)?\
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MYT]PVY2NDMA )=42R:C)HI5W6E-#?P5K7SX=$L_X?>W'_P!XU83_ -&E/_\
M6'V/?^!TB_Y3V_[)Q_UNZ"/^O8__ "AC_G.?^M77O^'WMQ_]XU83_P!&E/\
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MYHK_ ,?'6SI[Q*ZR)Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZHT_GH?\
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M))PU+N"EEI*A2DBM&X:*9QI92I^C BX]^Z]UIC?RH?YG/2?\C3I[?_\ *O\
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M[KWOW7NMI[^1]_V2AV#_ .+#;L_]YO:7O#S[P?\ R68?^>*/_J_<]9+>S?\
MR2Y?^>I_^K4'5R7N"NI:Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZU1OYU
MG_97V#_\0ILS_P!V>=]YE>P7_)$?_GKE_P"K</6,OO#_ ,E5/^>:/_JY+U41
M[F[J*>O>_=>Z][]U[KZ"NVO^/<V__P!J3%?]:(_?,ZZ_M7_TS?X3UG9#\"_8
M/\'3W[8Z<Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z^>?[Z<=8']>]^Z]U
M[W[KW5K/\FO_ ++.H?\ Q&6^_P#>J3W#/OO_ ,D$_P#/1#_@?J4/:+_DK?\
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M?/\ Y2[_ -XS;OO.KV;_ .5;L_\ J(_[2I^L2_<W_DN7/_-G_M'BZKS]R=T
M^O>_=>Z$WI3_ )G+U)_XDW8?_NUI/9/S#_R3[G_GGF_ZMMT:;'_N;;_\UXO^
MKB];\?OF_P!9N=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=!'\@/^9#]V?^
M(C[(_P#=-6^SGES_ )*%K_ST0?\ 5U>B[>/]Q)_^:,G_ !QNM"OWT?ZP@Z][
M]U[KWOW7NKO/Y&?_ #/CN+_Q$</_ +N:#WCY]X;_ ))]K_ST'_JTW4S^R_\
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M8 -2C '@PZ';V'>CGKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K5A_G@_\
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M(G_'1TN?:#I5U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U\_G?7_'[[Q_\
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MSRI_U=GZIM]SKU$O7O?NO=>]^Z]UO[]8?\RUZ\_\,;:7_N!3^^:VZ_[E3?\
M-63_ (^>LYK'^PC_ -(G_'1TN?:#I5U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U\_G?7_'[[Q_\.K</_N7-[Z5;9_N-%_S2C_XX.L'-R_W(E_YJ/\ \>/2
M5]KND77O?NO=6;?RA_\ LN'8/_AJ]B_^Z>J]Q'[W_P#*OR_\U8/^K@ZDGVH_
MY+"?\TY?^.];?7O"/K*?KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JKK^<)
M_P!D3;J_\/GK[_W.'N7?8_\ Y6"+_FE-_P </4<^ZO\ R1I/]/%_Q\=:BGO-
MOK%7KWOW7NO>_=>ZVGOY'W_9*'8/_BPV[/\ WF]I>\//O!_\EF'_ )XH_P#J
M_<]9+>S?_)+E_P">I_\ JU!U<E[@KJ6NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NM4;^=9_P!E?8/_ ,0ILS_W9YWWF5[!?\D1_P#GKE_ZMP]8R^\/_)53
M_GFC_P"KDO51'N;NHIZ][]U[KWOW7NOH*[:_X]S;_P#VI,5_UHC]\SKK^U?_
M $S?X3UG9#\"_8/\'3W[8Z<Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z^>
M?[Z<=8']>]^Z]U[W[KW5K/\ )K_[+.H?_$9;[_WJD]PS[[_\D$_\]$/^!^I0
M]HO^2M_S8D_PIUMK^\+>LH.O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJE_
MYT'_ &1S!_XES9'_ +C93W,_L/\ \EW_ *AYO\*=1E[M?\D@_P#-:/\ Y^ZU
M-_>:/6+G7O?NO=>]^Z]UMD?R7_\ LCF?_P 2YO?_ -QL7[PN]^/^2[_U#P_X
M7ZRC]I?^20/^:TG_ #[U;1[ACJ3>O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NM2C^<I_P!EG5W_ (C+8G^]5?O-+V(_Y((_YZ)O\"=8O^[O_)6_YL1_X7ZJ
MF]S-U%_7O?NO=*K8O_'[[._\.K;W_N7#[0[G_N-+_P TI/\ CAZ6[;_N1%_S
M43_CPZ^@-[YJ]9Q]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=(;L_\ YEKV
M'_X8V[?_ ' J/:_:O]RH?^:L?_'QTEOO["3_ $C_ /'3UH$>^E/6#/7O?NO=
M>]^Z]U<E_(^_[*O[!_\ %>=V?^])M+W!7W@_^2-#_P ]L?\ U8N>I:]F_P#D
MJ2_\\K_]78.MI[WAYUDMU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U2E_/(
M_P"R<^J?_$UT?_NBS7N?/N]?\E6X_P">0_\ 5Z+J(?>;_DG0_P#/2O\ U:EZ
MU?/>7G6-O7O?NO=>]^Z]UN$_RDO^R%NK/^UWV3_[T62]X.>]/_*Q7'^E@_ZL
M1]98>U__ "1(/MF_ZO2=63^XJZD#KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[K3;_FK_P#9?'?/_E+O_>,V[[SJ]F_^5;L_^HC_ +2I^L2_<W_DN7/_ #9_
M[1XNJ\_<G= /KWOW7NA-Z4_YG+U)_P")-V'_ .[6D]D_,/\ R3[G_GGF_P"K
M;=&FQ_[FV_\ S7B_ZN+UOQ^^;_6;G7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW01_(#_F0_=G_B(^R/_=-6^SGES_DH6O\ ST0?]75Z+MX_W$G_ .:,G_'&
MZT*_?1_K"#KWOW7NO>_=>ZN\_D9_\SX[B_\ $1P_^[F@]X^?>&_Y)]K_ ,]!
M_P"K3=3/[+_[EW'_ #17_CXZV=/>)761/7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW5&G\]#_F372/_ (DW+_\ NJE]Y"?=X_Y*%U_SSK_U<7J&_>?_ '"@
M_P":Y_ZMMUK->\M.L<^O>_=>Z][]U[K<D_E4?]D#]#?^51_][/<7O!7WD_Y6
M2\_ZA_\ M%@ZRT]LO^2';?\ -[_M(EZL,]QCT/.O>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z+/_S77_R(?_(_VY^'_5Z]-_B_U>G2JZ+_ ./=R_\
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M_-G_ +2(NM-OWG5UB7U[W[KW7O?NO=;,O\B__F37=W_B3<1_[JHO>)?WA_\
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M4ZC+W:_Y)!_YK1_\_=:F_O-'K%SKWOW7NO>_=>ZVR/Y+_P#V1S/_ .)<WO\
M^XV+]X7>_'_)=_ZAX?\ "_64?M+_ ,D@?\UI/^?>K:/<,=2;U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]UJ4?SE/^RSJ[_Q&6Q/]ZJ_>:7L1_R01_ST3?X$
MZQ?]W?\ DK?\V(_\+]53>YFZB_KWOW7NE5L7_C]]G?\ AU;>_P#<N'VAW/\
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MU_ZN+U#?O/\ [A0?\US_ -6VZUFO>6G6.?7O?NO=>]^Z]UN2?RJ/^R!^AO\
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MET_'_P#[7>Z__>=S'N./=S_E7;S_ $L7_5^+H<>V_P#R6[;[9/\ JS)UN?\
MO [K+CKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JO/^:O\ ]D#]\_\ E+O_
M 'L]N^Y.]F_^5DL_^HC_ +19^@'[F_\ )#N?^;/_ &D1=:;?O.KK$OKWOW7N
MO>_=>ZV9?Y%__,FN[O\ Q)N(_P#=5%[Q+^\/_P E"U_YYV_ZN-UD9[,?[A3_
M /-<?]6UZO+]X]]3)U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UK%_SS/\
MF?'3O_B(YO\ W<U_O+7[O/\ R3[K_GH'_5I>L=O>C_<NW_YHM_Q\]4A^\@^H
M8Z][]U[KWOW7NM]3X_\ _,A^D_\ Q$?6_P#[IJ+WS@YC_P"2A=?\]$__ %=;
MK-_9_P#<2#_FC'_QQ>A<]DW1CU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
MH.=U_P#,Y>V__$F[\_\ =K5^^D'+W_)/MO\ GGA_ZMKUA'OG^YMQ_P UY?\
MJXW09>SCHKZ][]U[JPS^51_V7QT-_P"51_\ >,W%[C'WD_Y5N\_ZA_\ M*@Z
M'GME_P ERV_YO?\ :/+UN2>\%>LM.O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NJV/YMO_9"W:?_ &N^MO\ WHL;[E7V6_Y6*W_TL_\ U8DZC_W0_P"2)/\
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MK_U<7J&_>?\ W"@_YKG_ *MMUK->\M.L<^O>_=>Z][]U[K<D_E4?]D#]#?\
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MPQT?=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:'7R4_P"RC._O_$U]J?\
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M"'_K7T1?ZU^S?[X/_.:7_K9U[_AI#HS_ )]A6?\ HR,C_P#7'W[_ %Z>8/\
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M=:B*)2=#JXRJ CN4'!^71AM7(>V[+.MS;1%9$U:6\21J:E*'#.1P8CAT=_\
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M];.O?\-(=&?\^PK/_1D9'_ZX^_?Z]/,'_*0O_."'_K7U[_6OV;_?!_YS2_\
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MPX(\AY=%6\;+!OT/T]TNM-0:@8KD<,J0?/UZ)S_PTAT9_P ^PK/_ $9&1_\
MKC['/^O3S!_RD+_S@A_ZU]!3_6OV;_?!_P"<TO\ ULZ]_P -(=&?\^PK/_1D
M9'_ZX^_?Z]/,'_*0O_."'_K7U[_6OV;_ 'P?^<TO_6SKW_#2'1G_ #["L_\
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M_53KW_&=/^K;_P"J/OW;_JKU[N_U4Z]_QG3_ *MO_JC[]V_ZJ]>[O]5.O?\
M&=/^K;_ZH^_=O^JO7N[_ %4Z]_QG3_JV_P#JC[]V_P"JO7N[_53KW_&=/^K;
M_P"J/OW;_JKU[N_U4Z;\MB^Z,WBLGA<C'CY<?E\?6XNNB22BB+0Y"-HI5#*0
MRDH["X((^HY]N0R^ ZNN"I# _,&HZI(AE4JW @@_8<=5R_\ #2'1G_/L*S_T
M9&1_^N/N4?\ 7IY@_P"4A?\ G!#_ -:^@%_K7[-_O@_\YI?^MG7O^&D.C/\
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M];5L6)R&?J<6(_NJ_)Y2:&JAP. H6EC-57RTLRPQB68Q^"FJ98?=>Z(=M_\
MGB?)[X_=\]%]1?S8?Y9&\?@+LCY-;SH>L^G>_=M_(+;GR9VNFY,DRI38O<U3
MMJF6' K5R2P"*1ZMYE7S5,E*M#2UM73>Z]U9[_,?_F,]-?RU>CL9VWVAA-X=
M@[JWWO+$]7])]*=:X[^,[EWINK<(<T.$P]* S&2303)+H?0"J)'+/+##+[KW
M51F^?YZ?SO\ B!!LKMC^9M_)P[$^)_Q'W9NC ;2SW?O7/R;VQ\EZC:T^ZY5C
MH:O<.V]OT,5?1X\799GG>EG,NBFI:>IKIH**7W7NMASL#O;J3J_I'<WR.WOO
MG!X7I3:'7E7VKF^P9:GS4"8&DHOXC_$(W0,9XYJ0J\*QAGF+HD:L[J#[KW5#
M6T_YPG\S7Y/[<A[J^!'\DKL'N7XN9ZA?(];=K=[_ "VV3\8LQNNECJ?$N1Q6
MU<S%55L>+K*<BIHJIZAX:J ,\3EVBBD]U[J^WI#?.\^S.HNN]_\ 8G5F<Z0W
MUNW:N*S>[.H=RYBEW#7[<KZQ-51B:NOH0*.LFHY+H9H/VI+:HR5(/OW7NA3]
M^Z]U[W[KW7O?NO=:\W8/\V[^9'O?.[IR'P9_DB]^][],[0W%N_;#=K]Y]X[7
M^+DV>EVED),<^0VSMO+I7Y3)86JE@EDI*H$25,+(_P!M$RR(ONO=';_E8_S2
M>I?YI73F]M^[*V'OKI;L_IO?E3U9WWT)V= (,[M3<%''K:FG81P-44DKI510
MS24E+/Y:6IAJ*2FG@DB7W7NB.[]_G5?)?N/OGNGI;^5'_+9W5_,&P'QHW96=
M=][=XYCY![;^->TJ7<U$S+-@MNY#<D#T^XZJC,4WW9@JD>$>%U@DIZF"H?W7
MNC8?RQ_YL&VOY@6;[VZ/["Z-W]\2?F=\5LSC<'\AOC)V16QYR?'#+:EI<MA,
MU!3TD&<P=3+&ZI4+2PMI:GG$;T=;05=7[KW0*_*G^<1VM@_ECO+X+?RX/@WN
M[^8=\E>G,)B=S?(B.C[<PO0FT-D4V=C22BH,ANO/038V?/U0FA*4!DIR4\_C
MDFEI:F&+W7NE)\ OYP6<^2/R?W_\!?F)\2]]? SYU[#V6O9M'U!NG>=#VI@M
MS[;=U#93:^[<73TV/RC4J2Q&>..-XC:H%+55+T.0CH_=>Z;_ )4_S%_YI_2_
M?_8W6/0?\D#??REZBVID,33;+[\Q7S0VQUG3[CAKL;15=1418*LVIDJK'BEK
M:BII"DE;(SFG,OH$@1?=>Z)77_S_ #YY=8?)KX>_&WY0_P D[=_QYR7S*[JV
MYU'U]EZSYLX7L2M$-3E,10Y[-4^$PVP7J*RDVU1YBGK*OR5-)!X["2K@4M*G
MNO=;37OW7NO>_=>Z][]U[HJ'S/\ E3'\/.DJKMN#I/NSY%[AJ]U[4V%LOIOX
M_;27>.Y<UF-ZU(I:*&&"2>G@IJ*$ZYJRKEE"4U-')($E<)$_NO=43=J_SYOG
M?\.4P/;O\P_^2_VO\:OA_F]VX_:N2[PV1\D]K]]9/ '<M1)%BZG-[>PU%$U)
M%)XS'+]Q74?[[Q0T[35$]-35'NO=;#>_OD9TQUG\?-Q?*?=^^\1C^A]L]82=
MQY'L*-VJ*1MO#'KDXJ^G"CR5 JJ1XFIT1#),TD<:*7=5/NO=:]V._GB?S)^T
M.M:_Y9?'#^1KVYVG\&!0Y'>&UNV<]\GML;%WIG]JX(NU7G\9UN^-K-Q5 J8(
M9YL?!20UPKH1#+3SR).I7W7NKJOA!\]_C[\^OB5LOYD]+YRMQ_5FY\3FZO/T
MV]((\'D-N5NT6DCSF+SD8EEIZ>IQ,L,ODECJ)*::'QU=/-+2S12O[KW5.N&_
MG@_.3Y42[X[&_E>?RAM]?,CXG;+W'G=GX[Y&[Y^3.V/C:FZ*_:LC)D9MK;?S
M]')D,MBHF CBJ::2H>2<2T\E/!4P20^_=>ZL[_EB?S-.G_YG_2&X^S^O=H[X
MZG[ ZOWWENJ.^NA^T,><9N'9NY\& U1C:Y3'$*B"126@J!%$Q*RT]1!2UM-5
M4L'NO=$=I_YQ'RF^3O<'?6POY7?\NFH^7?5GQG["W9T[VA\C>T_DIA/C5MRL
MWCLR.G>MV]M>EKL5E\CF7C-0H^[=*:G ,4LGCIJFFJ)O=>Z,S_+3_FI47SMW
M?\@/CWVS\>]]_$'YH_%#);?Q_?WQQWSG*;>J44&Z8C)CLMA-Q4$%-1YG%U:@
M,L@IHCHEIYHO/2U-/4R^Z]U;9[]U[KWOW7NO>_=>ZI^^9W\QSY4=3=V9GXU?
M"+^69WS\W^UMK;9V=NS>>])]Z8/X_P#6^+AWHTS4V/&]-P-+3Y#.K34YEEHX
MJ6-88Y8G-0Q$L<?NO=!7\ OYS>XOD9\LMV?R^?F;\/-_? KYO;=V//V=@.M-
MS[VH>T,#N; QK'.:G ;DH*6B@K:F*EDDEDCB@FIBM+6K'6-/255-![KW1A?Y
ME'\T7:?P#EZ9ZLV=T]O?Y3?,#Y.YS([8^-GQ;ZVK8L3D,_4XL1_=5^3RDT-5
M#@<!0M+&:JOEI9EAC$LQC\%-4RP^Z]T0[;_\\3Y/?'[OGHOJ+^;#_+(WC\!=
MD?)K>=#UGT[W[MOY!;<^3.UTW)DF5*;%[FJ=M4RPX%:N26 12/5O,J^:IDI5
MH:6MJZ;W7NK/?YC_ /,9Z:_EJ]'8SMOM#";P[!W5OO>6)ZOZ3Z4ZUQW\9W+O
M3=6X0YH<)AZ4!F,DF@F270^@%42.6>6&&7W7NJC-\_ST_G?\0(-E=L?S-OY.
M'8GQ/^(^[-T8#:6>[]ZY^3>V/DO4;6GW7*L=#5[AVWM^ABKZ/'B[+,\[TLYE
MT4U+3U-=-!12^Z]U<1\Y/YB_QK^ OQ4F^7'<&XZK-["S']W<9U7@=BQ1YS+[
MVS6]J66LP6#VS3F2*.MK<K30S5",TJ0Q4D,]7,Z00NP]U[JHO?\ _.M_F3?'
M#9E/\D_E]_)#[-Z=^%]-D8JG?'9VS_E7M/MC>.U\#E7@2@SF8V)04$%="FJI
MA6K@J*NC^R*S&IFB\<0J/=>ZV*NL>RMD=R]<;#[;ZTW%CMV]>=F[0V[OS9&Y
M\3.M335^*W7215U!5PNI(*3TTT;#\B]C8@CW[KW2Y]^Z]U[W[KW2=W?N?';)
MVGNC>>8CKYL3M';N;W/E(<50ODZIZ? TTM5.M-31@R5%0T43".)1JD>RKR1[
M]U[K7(WE_.9_FD5&UJ_OGIO^09\B]Q?%G%[>&]'W-VQ\@-L=5[_J<+1135M7
M61=;0T>;SR5!H(F>GI(1633/H":C+&I]U[JWW^7E\]^D?YE7Q9V+\K>A3G*/
M:.[:K,X/,;6W53PTF7P69VU-X,CA\G'3RU%.*F F*5'BG>.:FF@G1M,H ]U[
MJKO?O\ZKY+]Q]\]T]+?RH_Y;.ZOY@V ^-&[*SKOO;O',?(/;?QKVE2[FHF99
ML%MW(;D@>GW'549BF^[,%4CPCPNL$E/4P5#^Z]T;#^6/_-@VU_,"S?>W1_87
M1N_OB3\SOBMF<;@_D-\9.R*V/.3XX9;4M+EL)FH*>D@SF#J98W5*A:6%M+4\
MXC>CK:"KJ_=>Z2_\RG^=;\=?Y?<._.N]M[7W?\J_ECLOJK=_<&1^,_2=-+EZ
MW!;>V;C5RM;N/?V8IJ6OI-C;:I*&2&IFJZR&2I-*ZSTU#4JRW]U[HZ'\OCY7
M5'SE^%OQV^6U7L:'K2I[VZ^I=[3[$I]Q-NR/&-/45%.:=,BU%CFJUO3Z@YHH
MCZM.DVU'W7NB8_/W^;/E?C/W_P!??"'XE?%S>?SL^>'96TI>QJ'HC:&]*#K+
M%8#;-+)(DF=W;NS)P5..P5-+X913+/$J32F".2>G-52F;W7N@:^,W\Z+MVH^
M8_7?P+_F5? K>O\ +U[_ .^</E<W\<<J>W,-\@MF[O.%C9ZC$Q[GP%/#CZ/-
MJ(IM,"S5*:C!#424M16X^&L]U[J_OW[KW7O?NO=>]^Z]T5#YG_*F/X>=)57;
M<'2?=GR+W#5[KVIL+9?3?Q^VDN\=RYK,;UJ12T4,,$D]/!344)US5E7+*$IJ
M:.20)*X2)_=>ZHF[5_GS?._X<I@>W?YA_P#)?[7^-7P_S>[<?M7)=X;(^2>U
M^^LG@#N6HDBQ=3F]O8:BB:DBD\9CE^XKJ/\ ?>*&G::HGIJ:H]U[K8;W]\C.
MF.L_CYN+Y3[OWWB,?T/MGK"3N/(]A1NU12-MX8]<G%7TX4>2H%52/$U.B(9)
MFDCC12[JI]U[K7NQW\\3^9/VAUK7_++XX?R->W.T_@P*'([PVMVSGOD]MC8N
M],_M7!%VJ\_C.MWQM9N*H%3!#/-CX*2&N%="(9:>>1)U*^Z]U=Q\#/G)T=_,
M4^+G7?RQZ!K\LVP=^TV0IZO"[GHUQ>6P>6V_,U-EL+EH$DEACK<=5(RL\4\M
M//$8JJFFFIIHI7]U[JF;YG_\*6OC_P!&=@[#V+\5>G=U?,W;N1^2_7OQG[3^
M0>V,Q/LWK#;N?WXDM0F$Q^\UP^7H=T[H2A@GJA0T"?:BGAFD?(*\8A?W7NME
M_P!^Z]UKQ?S0?^%#_P >_@;C.XMM=%]9;J^;/='0#;7;OG!=8UD^+V=UTFZL
MW#@*:/?V^8,;E\=A,I49.7[.FQ<5-4UKUNFFJ4H[M*GNO=7L]0[\;M/J;J_L
MYL6,&W8W7>RM^-A5K?XD*,[OQM-D#2BH\4'G%/\ <>/R>"/7IU:$OI'NO=")
M[]U[KWOW7NO>_=>ZI^^9W\QSY4=3=V9GXU?"+^69WS\W^UMK;9V=NS>>])]Z
M8/X_];XN'>C3-38\;TW TM/D,ZM-3F66CBI8UACEB<U#$2QQ^Z]T%?P"_G-[
MB^1GRRW9_+Y^9OP\W]\"OF]MW8\_9V ZTW/O:A[0P.YL#&L<YJ<!N2@I:*"M
MJ8J62262.*":F*TM:L=8T])54T'NO=&%_F4?S1=I_ .7IGJS9W3V]_E-\P/D
M[G,CMCXV?%OK:MBQ.0S]3BQ']U7Y/*30U4.!P%"TL9JJ^6EF6&,2S&/P4U3+
M#[KW1#MO_P \3Y/?'[OGHOJ+^;#_ "R-X_ 79'R:WG0]9].]^[;^06W/DSM=
M-R9)E2FQ>YJG;5,L.!6KDE@$4CU;S*OFJ9*5:&EK:NF]U[J['Y6_+KXY_"+I
MK</?ORA[4VWU+UAMTBFDS>>F>2>MK98IIH,7B*"!):_,9>KCIYC!14=/-42B
M-V6/1&[+[KW57W\MO^=%5?S$/FC\K?BROQ+[-^.>$^._7G7?8VW<[W5DI,!N
MS-4'8J45103Y79LF*A;;D=?C\A25U(K9BKEDHY8))4B>8Q0^Z]U9%\S_ )4Q
M_#SI*J[;@Z3[L^1>X:O=>U-A;+Z;^/VTEWCN7-9C>M2*6BAA@DGIX*:BA.N:
MLJY90E-31R2!)7"1/[KW5$W:O\^;YW_#E,#V[_,/_DO]K_&KX?YO=N/VKDN\
M-D?)/:_?63P!W+4218NIS>WL-11-212>,QR_<5U'^^\4-.TU1/34U1[KW6S3
MM3=.WM\[7VWO7:.7H\_M3>& P^Z=L9['2>6GK<=N"GCJZ*K@>PU0U---%(AL
M+JP/OW7NG_W[KW7O?NO=)W=^Y\=LG:>Z-YYB.OFQ.T=NYO<^4AQ5"^3JGI\#
M32U4ZTU-&#)45#11,(XE&J1[*O)'OW7NM<C>7\YG^:14;6K^^>F_Y!GR+W%\
M6<7MX;T?<W;'R VQU7O^IPM%%-6U=9%UM#1YO/)4&@B9Z>DA%9-,^@)J,L:G
MW7NK??Y>7SWZ1_F5?%G8ORMZ%.<H]H[MJLS@\QM;=5/#29?!9G;4W@R.'R<=
M/+44XJ8"8I4>*=XYJ::"=&TR@#W7NJN]^_SJODOW'WSW3TM_*C_EL[J_F#8#
MXT;LK.N^]N\<Q\@]M_&O:5+N:B9EFP6W<AN2!Z?<=51F*;[LP52/"/"ZP24]
M3!4/[KW1L/Y8_P#-@VU_,"S?>W1_871N_OB3\SOBMF<;@_D-\9.R*V/.3XX9
M;4M+EL)FH*>D@SF#J98W5*A:6%M+4\XC>CK:"KJ_=>Z2_P#,I_G6_'7^7W#O
MSKO;>U]W_*OY8[+ZJW?W!D?C/TG32Y>MP6WMFXU<K6[CW]F*:EKZ38VVJ2AD
MAJ9JNLADJ32NL]-0U*LM_=>Z.A_+X^5U1\Y?A;\=OEM5[&AZTJ>]NOJ7>T^Q
M*?<3;LCQC3U%13FG3(M18YJM;T^H.:*(^K3I-M1]U[HI7S+_ )AGS"ZO[MRO
MQR^"_P#+#[C^;_8>T]O;0W1V!O\ R_:.W_C5UYBH=XI634^.I-V[E$M-G-P1
MPTT,E1001PK3Q54,KU#./ _NO=!?\ OYQ^[?D;\M=]_R]_F5\-]^? _YM;+V
M'-VEB^NL_ON@[9V_N/;\4D.JLP&YL;34E)72Q0U =A E12OX*Q8JQIZ2IIX?
M=>ZO-]^Z]U[W[KW7O?NO=%0^9_RIC^'G255VW!TGW9\B]PU>Z]J;"V7TW\?M
MI+O'<N:S&]:D4M%##!)/3P4U%"=<U95RRA*:FCDD"2N$B?W7NJ)NU?Y\WSO^
M'*8'MW^8?_)?[7^-7P_S>[<?M7)=X;(^2>U^^LG@#N6HDBQ=3F]O8:BB:DBD
M\9CE^XKJ/]]XH:=IJB>FIJCW7NMAO?WR,Z8ZS^/FXOE/N_?>(Q_0^V>L).X\
MCV%&[5%(VWACUR<5?3A1Y*@55(\34Z(ADF:2.-%+NJGW7NM>['?SQ/YD_:'6
MM?\ ++XX?R->W.T_@P*'([PVMVSGOD]MC8N],_M7!%VJ\_C.MWQM9N*H%3!#
M/-CX*2&N%="(9:>>1)U*^Z]U<]\,/YA'QM^<7P[VO\WNKMV+MKIC*[?W%F=X
M578\M/M.?:<^Q_*-PT.XY)9S14+X1H)FGJ!5/1O3A*R">2DEBF;W7NJFF_X4
M;=0=A?.CX>?%CXS] =A=P='?*KMO?/3^,^9FXIJWK+:%?DNO&IX<S_<&.LPM
M3)O>GPU35T\==5+44%*CS0+3RU*S&2/W7NMD7W[KW54W\UG^9[C/Y;O6G7;[
M.ZEJ/DK\F.\=T93;G1OQNPV](=CUN9IMFT4F7W5GZJODHLD]#@=K8:%ZBLJO
ML)(UEEI8)9*>.=JF'W7NA=_E=_.2/^9)\$NAOFG'UL_41[GI.P#4==OND;V&
M.GZ[W7G=J5 3*"@Q?W<53/@I*B,F@A9(YEC92R%V]U[H_GOW7NO>_=>Z][]U
M[JG[YG?S'/E1U-W9F?C5\(OY9G?/S?[6VMMG9V[-Y[TGWI@_C_UOBX=Z-,U-
MCQO3<#2T^0SJTU.99:.*EC6&.6)S4,1+''[KW05_ +^<WN+Y&?++=G\OGYF_
M#S?WP*^;VW=CS]G8#K3<^]J'M# [FP,:QSFIP&Y*"EHH*VIBI9))9(XH)J8K
M2UJQUC3TE530>Z]T87^91_-%VG\ Y>F>K-G=/;W^4WS ^3N<R.V/C9\6^MJV
M+$Y#/U.+$?W5?D\I-#50X' 4+2QFJKY:6988Q+,8_!35,L/NO=$.V_\ SQ/D
M]\?N^>B^HOYL/\LC>/P%V1\FMYT/6?3O?NV_D%MSY,[73<F294IL7N:IVU3+
M#@5JY)8!%(]6\RKYJF2E6AI:VKIO=>ZMP^;/S_\ C#_+^V!A=\?(K?,N+R6]
M<Q'M?JCJW:6)GWGO'>F:J):>GAPVT]M4*R9',5TE164<;&.(04[3PFIFA216
M/NO=%!_E&?S7,Y_-#_V< ;@^,NY/B]DOBOW]5=(U&S-[;O\ [PY^22D6K$RY
MZ@&*QR8',T4U))#64"5%:L$^N$54GB\DGNO=*?\ F[?S-]S?RPNI^@=];(^-
M<ORGWM\A?DMLOXT;/ZUB[=@Z7/\ $]]XW,5E!.,M4X#<-.S2U>,@I1%+3T\?
M^4>:2JC6$J_NO=%OZ_\ YDG\YK<F_-D[=WM_PGYW/U[LS/;NVWA=W;^/\Q[K
MW= P>+RE9#!7Y@XRGVS#49'^&4DDM3]K%,DD_C\2.K.&'NO=7\>_=>Z][]U[
MKWOW7ND[N_<^.V3M/=&\\Q'7S8G:.W<WN?*0XJA?)U3T^!II:J=::FC!DJ*A
MHHF$<2C5(]E7DCW[KW6N1O+^<S_-(J-K5_?/3?\ (,^1>XOBSB]O#>C[F[8^
M0&V.J]_U.%HHIJVKK(NMH:/-YY*@T$3/3TD(K)IGT!-1EC4^Z]U;[_+R^>_2
M/\RKXL[%^5O0ISE'M'=M5F<'F-K;JIX:3+X+,[:F\&1P^3CIY:BG%3 3%*CQ
M3O'-3303HVF4 >Z]U5WOW^=5\E^X^^>Z>EOY4?\ +9W5_,&P'QHW96==][=X
MYCY![;^->TJ7<U$S+-@MNY#<D#T^XZJC,4WW9@JD>$>%U@DIZF"H?W7NC8?R
MQ_YL&VOY@6;[VZ/["Z-W]\2?F=\5LSC<'\AOC)V16QYR?'#+:EI<MA,U!3TD
M&<P=3+&ZI4+2PMI:GG$;T=;05=7[KW27_F4_SK?CK_+[AWYUWMO:^[_E7\L=
ME]5;O[@R/QGZ3II<O6X+;VS<:N5K=Q[^S%-2U])L;;5)0R0U,U760R5)I76>
MFH:E66_NO='0_E\?*ZH^<OPM^.WRVJ]C0]:5/>W7U+O:?8E/N)MV1XQIZBHI
MS3ID6HL<U6MZ?4'-%$?5ITFVH^Z]T"O\P_\ F==:_ .3IWKZ'K'LKY)?*#Y)
M;@R&U_CO\7NEZ.&MW%N.HQ*HU;6SS3L(,1@\>LJ-5U\R2+"FN01/'#.T7NO=
M 7\9_FY_-PWSW;UQLGY4_P FQ_CGTYOV6MHLWW1M3YN[&[O;;$T<=3+3-F<!
MB*>/(2TU0*94,M.Q6)ZBGUD'SI#[KW5TWOW7NO>_=>Z][]U[HAWSN^:FZ?A]
MMKK>#K/XH=^?,;N'N7=65V?UOU+T7BZ6-5GPM!)D*G([FSV0E2@VS@((TCCD
MKIHY],LL8$#)Y'C]U[JHNB_GQ_*'XW]U]'=<_P US^5QOKX(=:?(_>F*ZVZR
M[]V]W]@/D-M^ESN4>!4I=R282CIX,1 T=5%(6:N:J2**JE6BEAI:N2F]U[J[
MOYK?,GI'X"_&WL;Y2_(/.56&ZXZYH:1ZF#%TPK\ADJ[+S)2X[$XNF9XQ49#(
MU<L<42F1$6[2RO'#'(Z^Z]U1%NW^>5_,OZDZM'RZ[Q_D4]P;%^#5/0T.],]V
M9BOE'M3<^^<5M+,E&I<YDNN5Q]/G*":*FF@J*ZFKA1PT$9E-76PPPO4>_=>Z
MV#>IODYT=W5\<=F_+38_8&$;X_[WZSINWL;V+N&H&U:*EP,E&U=45F5?(&G&
M*&.A285JU1C-(\,R3Z#&]O=>ZHT;_A1MU!V%\Z/AY\6/C/T!V%W!T=\JNV]\
M]/XSYF;BFK>LMH5^2Z\:GAS/]P8ZS"U,F]Z?#5-73QUU4M104J/- M/+4K,9
M(_=>ZOL[XWMV%UMTOVEV!U-U/6=[]F[-V+N3<>P^F,?NFFV1/NC*XFEDFHL'
M%F*N"JIL:^1G5(1424TJQ:M9B>VD^Z]U0?\ \.S_ ,Z__OG [+_].%;._P#L
M']^Z]T8K^43_ #=>T?YF?87S)ZT[/^$V3^(NXOAMO':/6^\#+WK3]ZTM9N7+
MU&X*;,X(UU%M;;^/I\CMV3!QBJC@JZXWJD$OV^E/-[KW5W_OW7NO>_=>Z][]
MU[JC3Y'_ ,T+YST'<O9_3GP)_E$]\_+BGZ4W?/LOL+N3L;M;;GQ=V?6UU%0Q
M5E3#L^NW!]S-NA*9YT@FFCC@59XY(HXY0T4C^Z]TO_Y7W\W7!?S MZ=]?'7M
M#X_[^^(/S2^+%5CJ7O7XY=AY6'<9@BR$KTZY3!9B&GHQEL5YA!>8T,*Z*NCF
MIVJJ2JIZJ7W7NHOS]_FSY7XS]_\ 7WPA^)7Q<WG\[/GAV5M*7L:AZ(VAO2@Z
MRQ6 VS2R2))G=V[LR<%3CL%32^&44RSQ*DTI@CDGIS54IF]U[H&OC-_.B[=J
M/F/UW\"_YE7P*WK_ "]>_P#OG#Y7-_''*GMS#?(+9N[SA8V>HQ,>Y\!3PX^C
MS:B*;3 LU2FHP0U$E+45N/AK/=>ZLJ^;/S_^,/\ +^V!A=\?(K?,N+R6]<Q'
MM?JCJW:6)GWGO'>F:J):>GAPVT]M4*R9',5TE164<;&.(04[3PFIFA216/NO
M=%!_E&?S7,Y_-#_V< ;@^,NY/B]DOBOW]5=(U&S-[;O_ +PY^22D6K$RYZ@&
M*QR8',T4U))#64"5%:L$^N$54GB\DGNO=#Y_,C_F.]:_RX>JM@;OW/L3?'<O
M:7>/:NV.BOCOT-UM'",UO#=V\7T4.,@J:DBEQ],#I\U5+KT%XHHH9ZB:&%_=
M>ZK*[A_G0_/KX1X+8_=?\QK^4ED>A_B;G\MMS"=B=S=+?+3;_P D,CL.HW=6
M14=#_>/;V/PF-DFB$TT<<DU+7& R/'#!--5RPTDONO=;&6 SN(W3@L+N;;]?
M!E<#N/$XW.X3)TUS'4T>7A2HIIX]05M$T,B.MP#8BX'OW7NG;W[KW7O?NO=)
MW=^Y\=LG:>Z-YYB.OFQ.T=NYO<^4AQ5"^3JGI\#32U4ZTU-&#)45#11,(XE&
MJ1[*O)'OW7NM<C>7\YG^:14;6K^^>F_Y!GR+W%\6<7MX;T?<W;'R VQU7O\
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MH\OV?V[3;JPU;M!,J!+!D(\#C-R5CRPPLCT&0H:M)G(J4C;W7NG7;$,79/\
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M!T:T\W<_\J6>/>4T3+ 9Y<5G\@T4TH6.\Q$&T\5$ S7 C0ZM,:I[]U[JV/\
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MM+C:"CIHC-(_CBB15L!S[KW0=?R ?^W-7\OC_P 0+C__ '99'W[KW0X_/?\
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M4V+R$T3U-#%D7Q>/-0(9$\O@C#7 M[]U[K6\_P"$\W_95W_"A#_QKSW_ /\
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M"3-*,?@J&,.0"(XXX[6C!/NO= /E9*78G_"O/;2X.C6GF[G_ )4L\>\IHF6
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MM&+&4BY>LV+UAUM3Y>',;OJG42IAI)7JI5HIJB%DJXZ6OI(T>25/?NO=.O\
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M$?Y6^^OA1LOY.;[^8'2W7^XZ7JFFW!V%T9NOL;'P]@T6;V]16R^%IMHRU/\
M>3,U9R$%1%12TN/FCR*-#44\DD4RM[]U[JKG^79\!N[OD;_)'_FJ;KW'LJIV
M?W%_-NW_ /*GY/=1]<;HA_@M320;X@-5L>FR$Z".11E,M3-51N8UA%'5T\O@
M*O(K^Z]T:;^2Q_.<^ F/_EH?'CJOY%_)WI_XO]Y_$CK+ ?&KM[I_Y%=C8_JK
M<=+7=%T<6#BEH<7GJBBR&4@JJ"BI9 E'3S-35!EQTB)4TLD2^Z]TB_Y+^-W_
M /)_Y#_SDOYO'7FWLO@=D_,G=>%ZS^&!W9@#AJC/8?X_X6KQ%'N81U<<$\>.
MS%9!ADCC>)"LU/5QSEWA##W7N@1_X3=?,SX ](?$#L;'?*GY(]$])?S$\SWW
MWM+\VJKY1]HX?K'?&8S6$SF1E@DKJS==;15>6H<=AA"LHIYI::EJXZ\2K'.M
M03[KW2F_ENGI3??_  HH^:G;_P#+2;"Y/X-YCXFX*D^5>^>HRK]<YKN'(YJF
MK*1L+44^K$5^2?'RU%2\N,_8,[YFH9R]7*]3[KW6WC[]U[KWOW7NO>_=>ZU9
M?YU'\WNFP7=V+_E.?%[Y/=0_%?O??E+CIOE/\O\ NC>F/V#@NH]F[@H(*Z6/
M%561KJ!LIO[+XNNHY*"DHG:>&&HCD$M(\CY#&^Z]T>G^7K\C/Y*?Q-ZOZH^&
M7P^^;'Q#RU9FMRXK!XC%XSY#;8W-NC>^\M]3TU$V1KWBR+5>;W/N+(-3Q@*K
M.[F"DI8TAC@A3W7NJW?F_P!H[7_EA?\ "BWX_?/'OYJC9WQ+^;/PYR'P\W)W
M6XJWQ.V]W[?S5+DX?[PRHKT]%030XK;($CND:PR5E>Z+#BZN=?=>Z;OY]/S5
M^.O\QCX\]6_RK?@5WEU5\J_D+\VN].J,)4KT#O?&=PXS:6U^O<S1;AR^YMQY
M' U%=08^EH)**C9H):V&H> 54R@QTTH/NO=.O\["A@_EZ_-K^2M_,YRFW\_E
MOC1\1,UOGXN_('<VV<;5UU5M_"=K8#^[^&R\]#01R+]A#25NX6D6.-#-/'38
M]!++6TT0]U[H8OYSG\W'X2]B?R[>Z_CO\3/D5T]\M_DG\S]G2?&?I3I3XY]B
M8GMO/5==W4G\*GGKJ##3U\V'@HL;45DA-?'3%IUBI5*SRI;W7NK(^B<A\>OY
M3O\ +F^&72?S&[KZKZFV[L_K/JOXX9;>?965I-J[?R6[9=MU==DL>:JJ(H8H
MJPXS.RH:F54DAA;RR-(WK]U[JLO^9!_,=_EN; ^-/9_47\N#,?%'Y'_//Y4;
M+W3\?OCKL#X64.S.VL\<QVK1U.*ERU?5;7AR%#CZ'"4M14U\HR51'%-X CH\
M32,ONO=7)?RR/B0?@E\!/BK\3JG^%-G>GNI\/B][38--%'-N7<4L^:W144YU
M-Y(JG<62R<HD)O+K\A"ERH]U[H]GOW7NO>_=>Z1/9?8^R>GNNM^=M=E[AH=H
M]==8[-W-V!OO=.3+"GQN'V?139#)5T^A7<Q4M'3S2,%1F(6RJS$ ^Z]UI:;$
M^??PR_G$?+Q_DA\^?F+\8>BOY;_QIWG4CXA_!?N#O#;NT,]O_<VWY$C'9/9N
M GRP>+&4[K4#%8FNB)F5U+01TJU$V:]U[K:YV#\DOB!\^NM^Z^N_C;\DND._
ML9'LJKV1V(>G>RL7O\8:#M"@RE#0G(C#ULLM$M='2Y'[<LT9E^VG\37B<K[K
MW6N-_P )YOYAOQD^%'Q#WC_+*^=G=_5GQ%^37P0[J[DV+N?;7R#[%H.JZ',8
M[>&Y,KN*FRFV\CN*?&T>3II*O)9!5AIG:5X!2Y 1&GR-/))[KW0N? 7<F%_F
M2_S[?E-_,LZ8DGS_ ,1/BY\7L-\'>J>VABV7&;UW1597^,9JMV_5311&HQN(
M%1EH6J(PXGCJ*&>*8TU2JGW7NCW_ ,X[Y\_"+8?PE_F0?&+>ORU^.^U?D9D/
MA)\EMG471N?[<P>+W7+ENQ>M\K+@,:F"FK5R)KLS%D\<]%!]OY*E*JG:)665
M"WNO= ;_ ,)Z_F_\.<[_ "Z/Y?WQ4PWRBZ%RGR8INE:C$S]!T/:>&J=W+5;>
M;+Y:OICM]:LY/ST>+IZBKFC^VU1TT4DS@1HS#W7NB9]6]_=6_P I;_A0G_,1
MVW\N]SXCH[HO^9]LCI;O'H3O;?&7?;^T9,MU50UM/EL5F,S7,F,Q=6<EE=QC
MR5%6L-/HHHV:#^+4<;^Z]U-_F;?(#I'^;U\Z_P"5W\!OA1V=LGY'8;IKY1[7
M^;_RC[:Z>S5#V?M/:NV.GEEAIZ.KSF.>JP]1D,V*K(TT<,==)X9Y*):B)A51
M#W[KW6W/[]U[KWOW7NO>_=>Z(!_,N_F+]&?RO?BQNCY.]Z35U;1T^1@V;USL
M;"KJR&Y]TYBEK*K&X*B9AXX#-#05<\]1*1'34M//,VMD6-_=>ZU^OY8/R-^"
MA[,SO\S;^9W_ #)_@=O/^89V]CJBCV'L2A^2VU<C@>CMDY6(BFV-M>/^-5%)
M%EVAFG&8KZ=G9VFEI$J:K56U^2]U[H\G\^OK["_S,?Y(/?&YOAWNC:7R(Q^-
M&W>\.ML]U1N&/?5!G8>C]QZ-SP8:IP\E5%DZ^DQU'N*!*:,3,]=3FD"+46*>
MZ]T)?07_  H1_E;[Z^%&R_DYOOY@=+=?[CI>J:;<'871FZ^QL?#V#19O;U%;
M+X6FVC+4_P!Y,S5G(05$5%+2X^:/(HT-13R213*WOW7N@F_X37]']D[8^*?R
M+^6_;.U,EL+='\Q?YA=Q_,# ;'SF/6BK\;MG?E0G\#6K.E'=JTBNK83H1#25
M-/(D:^1RWNO=5P_\*2_YB/P-^0OQL^#>V^B?F-\:NX<_LG^:)\9^R-WX?K7N
M7 [SJ,9M_;>!WU3Y#-UL5!73M38JBFK:-)JIP(8VFB#."ZW]U[K:Z^/7S'^)
MWRU7=S?%[Y(])?(,; .!&^/]#O96)[".(_O3]Y_#?XD,755)HQD/X=D/MS*%
M$WVT_CU>)]/NO=:[G_"F3Y\_"+?/\IWYW_&#9GRU^.^Z_D91;DZ7V=6=&[>[
M<P>7W5%ENO.W=F3Y[&R8."M?()78:+&9%ZV P"2F%+.9E3Q/I]U[JXS^7-\W
M_AS\A.F>C.G>BOE%T+V_VOL?XU=89;>/6_7/:>&W?F\72[<Q6$Q>0J:[&4-7
M-64T%%DJRDI9Y'B"Q5$T43E7D0'W7NK*??NO=>]^Z]U[W[KW6K+_ #J/YO=-
M@N[L7_*<^+WR>ZA^*_>^_*7'3?*?Y?\ =&],?L'!=1[-W!005TL>*JLC74#9
M3?V7Q==1R4%)1.T\,-1'():1Y'R&-]U[H]/\O7Y&?R4_B;U?U1\,OA]\V/B'
MEJS-;EQ6#Q&+QGR&VQN;=&]]Y;ZGIJ)LC7O%D6J\WN?<60:GC 56=W,%)2QI
M#'!"GNO=5N_-_M':_P#+"_X46_'[YX]_-4;.^)?S9^'.0^'FY.ZW%6^)VWN_
M;^:I<G#_ 'AE17IZ*@FAQ6V0)'=(UADK*]T6'%U<Z^Z]TW?SZ?FK\=?YC'QY
MZM_E6_ KO+JKY5_(7YM=Z=482I7H'>^,[AQFTMK]>YFBW#E]S;CR.!J*Z@Q]
M+0245&S02UL-0\ JIE!CII0?=>ZV4NQ^[?C;\(NGMAU_R [NZNZ(ZRPXVMU/
MMK>/;F\\7UUCJJOH<9,U%CH*BOGI:5JZ:@Q59.E/$=7BIYG1/'$Q7W7NM43X
M;_S$O@9M'_A1/_.![_W3\QOC9M[H_MCHWXD87K'MO,]QX+';=W!6;5V5L>CR
M=-A\O+6K19">@JZ*KAJ$AF=HI(94<!D8#W7NMBKY^_S1_C!\ /A4OS=WONNA
M[ ZZWCC-N#H:FZ^R,&>7?N3W_BY\OMRDP5= TE'+197'4\M=]_Y331X^.6J5
MI $23W7NJ'OY8/R-^"A[,SO\S;^9W_,G^!V\_P"89V]CJBCV'L2A^2VU<C@>
MCMDY6(BFV-M>/^-5%)%EVAFG&8KZ=G9VFEI$J:K56U^2]U[K:\ZB[CZG[_Z\
MV[VYT=V3LCMWJW=HRAVOV'USN:CWAALA_ ZVIQM;]GD:"6>EJ#29&CJZ:8)*
M3'/#+$]GC91[KW0D>_=>Z][]U[I$]E]C[)Z>ZZWYVUV7N&AVCUUUCLW<W8&^
M]TY,L*?&X?9]%-D,E73Z%=S%2T=/-(P5&8A;*K,0#[KW6EIL3Y]_#+^<1\O'
M^2'SY^8OQAZ*_EO_ !IWG4CXA_!?N#O#;NT,]O\ W-M^1(QV3V;@)\L'BQE.
MZU Q6)KHB9E=2T$=*M1-FO=>ZVN=@_)+X@?/KK?NOKOXV_)+I#O[&1[*J]D=
MB'IWLK%[_&&@[0H,I0T)R(P];++1+71TN1^W+-&9?MI_$UXG*^Z]UKC?\)YO
MYAOQD^%'Q#WC_+*^=G=_5GQ%^37P0[J[DV+N?;7R#[%H.JZ',8[>&Y,KN*FR
MFV\CN*?&T>3II*O)9!5AIG:5X!2Y 1&GR-/))[KW0N? 7<F%_F2_S[?E-_,L
MZ8DGS_Q$^+GQ>PWP=ZI[:&+9<9O7=%5E?XQFJW;]5-%$:C&X@5&6A:HC#B>.
MHH9XIC35*J?=>Z/?_..^?/PBV'\)?YD'QBWK\M?COM7Y&9#X2?);9U%T;G^W
M,'B]URY;L7K?*RX#&I@IJU<B:[,Q9/'/10?;^2I2JIVB5EE0M[KW0&_\)Z_F
M_P##G._RZ/Y?WQ4PWRBZ%RGR8INE:C$S]!T/:>&J=W+5;>;+Y:OICM]:LY/S
MT>+IZBKFC^VU1TT4DS@1HS#W7NK"=R_S=?Y;O7_?W;OQA[;^7W3'1O=72.6V
M]B=\[5[UW?2].PAMU8>@SM#-CLKN&3'XG*02X_)4S,:6ND:)R8Y41K:O=>ZH
M0^27;/QY_F#?\*#?Y4&[OY=6?V7WMO#XJ8KNG=OS3^1G2#TVX\'0[.S-%3TF
MW,/E=WX\/CLGH+;GI8((JZH"MFA GJFF5/=>ZW#O?NO=>]^Z]U[W[KW1 /YE
MW\Q?HS^5[\6-T?)WO2:NK:.GR,&S>N=C85=60W/NG,4M958W!43,/' 9H:"K
MGGJ)2(Z:EIYYFULBQO[KW6OU_+!^1OP4/9F=_F;?S._YD_P.WG_,,[>QU11[
M#V)0_);:N1P/1VR<K$13;&VO'_&JBDBR[0S3C,5].SL[32TB5-5JK:_)>Z]T
M>3^?7U]A?YF/\D'OC<WP[W1M+Y$8_&C;O>'6V>ZHW#'OJ@SL/1^X]&YX,-4X
M>2JBR=?28ZCW% E-&)F>NIS2!%J+%/=>Z$OH+_A0C_*WWU\*-E_)S??S Z6Z
M_P!QTO5--N#L+HS=?8V/A[!HLWMZBME\+3;1EJ?[R9FK.0@J(J*6EQ\T>11H
M:BGDDBF5O?NO= %_PGAV!GNE/A)\M?GM\E8*7H_'?-[Y/=_?/'*4W8<E-M:/
M:^P\JK5M)D,Y75!@BIJ,4D&4R9GE,4$>/FAGTQJTC'W7NB"?S;?YB7P,[4_F
MK?R!NSNM?F-\;-^===%]Y?)_-=S[YVEW'@L]BMJT>Y*;KM<?4Y^NIJV2GQ4%
M:V/KA ]1)&LA@F"$^-K>Z]U?9\O=H=7?SHOY=_R"Z'^&'S:ZVI-O=I5^)ZNW
M#WWTWD*#O#&T#X*OPF:SVVZZ+$YFA1I<K@9HZ:I@.2AD2ER,<KI)#((Y?=>Z
MJ(['_E3?SH^DOB;O_9^(_GFX9.E>I_CUNW;^/ZCV[_+WV'M6@_NSLC;E1 FW
MJ)Z:MOCJ5L73"DB:);P(0R"ZCW[KW3Q_PDPZ;^5&W?Y=O2O<V]_EF-]?%3L'
M:'<N'Z8^)/\ HAQ.#.R,K@^TMTT^5R_]\(96R^:&6K:/+U/VT\2Q0_Q 1J2*
M6(GW7NML#W[KW7O?NO=>]^Z]UJR_SJ/YO=-@N[L7_*<^+WR>ZA^*_>^_*7'3
M?*?Y?]T;TQ^P<%U'LW<%!!72QXJJR-=0-E-_9?%UU')04E$[3PPU$<@EI'D?
M(8WW7NCT_P O7Y&?R4_B;U?U1\,OA]\V/B'EJS-;EQ6#Q&+QGR&VQN;=&]]Y
M;ZGIJ)LC7O%D6J\WN?<60:GC 56=W,%)2QI#'!"GNO=5N_-_M':_\L+_ (46
M_'[YX]_-4;.^)?S9^'.0^'FY.ZW%6^)VWN_;^:I<G#_>&5%>GHJ":'%;9 D=
MTC6&2LKW18<75SK[KW3=_/I^:OQU_F,?'GJW^5;\"N\NJOE7\A?FUWIU1A*E
M>@=[XSN'&;2VOU[F:+<.7W-N/(X&HKJ#'TM!)14;-!+6PU#P"JF4&.FE!]U[
MK8M[2^3_ ,0/@GLWJ;9OR-^272?Q^QF0VV=K=;GN+L7#=:G,0=;TN-I:TXZ+
M(5-(E3]A'68[[@0*5@^Y@#:1+&#[KW6K5_(R_F(_ WICY+?SPMP=N?,;XU=9
MX+NK^:)W9V1U%F=]=RX':]+N7;^:S^Y)Z3-X2>LKH8LEBJF&IIWCJH&>%TD1
M@Y# ^_=>ZVB/DA_,!^&?P^W[UCUQ\I?D-UUT#N'N/";SS_75;VIECL[#U\'7
M\V*@RJMGZQ(\)15-.^:QQ2"KR$$U0KN].DJP3F/W7NM=7_A0Y_,$^'OS,^"&
M9_EY_#'N'J_YK?+CY;]G=*[1Z:ZW^,V]<1W3+25.TMV87<=;D:[(86MJ\9B8
M!CL754S23UB%4J9)) E+#53P>Z]UM(_'W8.6ZHZ%Z1ZMSV5J<[G.MNHNMM@Y
MG-ULRU,U95[.PU%CJBJED0*LDM1-3/(S!0&9B0 #[]U[H7??NO=>]^Z]TB>R
M^Q]D]/==;\[:[+W#0[1ZZZQV;N;L#?>Z<F6%/C</L^BFR&2KI]"NYBI:.GFD
M8*C,0ME5F(!]U[K2TV)\^_AE_.(^7C_)#Y\_,7XP]%?RW_C3O.I'Q#^"_<'>
M&W=H9[?^YMOR)&.R>S<!/E@\6,IW6H&*Q-=$3,KJ6@CI5J)LU[KW6USL'Y)?
M$#Y]=;]U]=_&WY)=(=_8R/957LCL0].]E8O?XPT':%!E*&A.1&'K99:):Z.E
MR/VY9HS+]M/XFO$Y7W7NM<;_ (3S?S#?C)\*/B'O'^65\[.[^K/B+\FO@AW5
MW)L7<^VOD'V+0=5T.8QV\-R97<5-E-MY'<4^-H\G325>2R"K#3.TKP"ER B-
M/D:>23W7NA<^ NY,+_,E_GV_*;^99TQ)/G_B)\7/B]AO@[U3VT,6RXS>NZ*K
M*_QC-5NWZJ:*(U&-Q J,M"U1&'$\=10SQ3&FJ54^Z]T>_P#G'?/GX1;#^$O\
MR#XQ;U^6OQWVK\C,A\)/DMLZBZ-S_;F#Q>ZY<MV+UOE9<!C4P4U:N1-=F8LG
MCGHH/M_)4I54[1*RRH6]U[H#?^$]?S?^'.=_ET?R_OBIAOE%T+E/DQ3=*U&)
MGZ#H>T\-4[N6JV\V7RU?3';ZU9R?GH\73U%7-']MJCIHI)G C1F'NO=%<SW;
M6Q?Y5_\ PHZ^1O:7R=W5C^HOBS_-$^,O6F1V7WCOVL&#VO0;\Z)I,5AI,'D,
MU*?L,:&H,;DJEY*V>!(I,C0H&$<RGW[KW2/_ )MWR8Z _FB?,#^4S\(?@?V9
ML'Y3=D;"^;>P?ESW!V%T?N&A[4VSLG8_3A"Y6JS6X<+4U>/@DK%K]44*SL&G
MIH*:>2GJ*W'QU7NO=;??OW7NO>_=>Z][]U[JG?\ G+_S:NN?Y5?0.$S$L>%W
M/\D^]:K-[)^,'6NX,K3;>QE=FJ(4<-1F=Q92NJJ"@Q.UMORY3'2Y&IJ*^G73
M-%$)8A(\\'NO=5S_ ,K/NS^5W\1\5O7Y'_*K^:M\&^__ .9!\F0,Y\G/D!)\
MD=KU<5-'42K44FQ]I^;(I_#MI;?2.E@CC@IZ9*V6F2H:G@ACHZ.D]U[I\_X4
M@4&1W3\1_@;_ #)NA*.#NW8_P;^87QX^:60R/7.8.93*]>SM3UYSF%K*!YJ:
MJH)ITV]4?>(3%%02R5XG2GAE9O=>Z--\E?Y_O\L7;'PBWYW[U;\N.ENU=Z;G
MZDKJSJ?H79^^\=ENP,GG]Y4/@P>$J]EQ25&XL16'(U5-%6BMQ4:4*B:2HLD3
M>_=>Z??Y%?QPR/\ +?\ Y.?16VODGDL5UAE]N;'[%^17>%;O.:GVG2[5I=Y5
MF0W/4IG*FHD2*C_N]@'IDR,U1,%@>GGULD48"^Z]U3G_ #;?YB7P,[4_FK?R
M!NSNM?F-\;-^===%]Y?)_-=S[YVEW'@L]BMJT>Y*;KM<?4Y^NIJV2GQ4%:V/
MKA ]1)&LA@F"$^-K>Z]UMP="_)7X]_*?9V0["^-?=O5O?.Q<3N2LV=E=W]2;
MXQV_L=39;'4U'6SXV>KQE14P0UT-'D*&=X&<2+%40R%=$J$^Z]UK:?S!B?YI
MW\\7X<_RV,4LFX/C+_+TIHOF_P#-:F5?/C:O=$M/ =D;<K&%'4QFJ@AK: -3
M25-.E5CL]EP0\M"H'NO=;7'OW7NO>_=>Z][]U[KWOW7NM.K^9W_-0ZL^;GRY
MSO\ *CZ]^:G4/PQ^*W5^?K\-_,>^4?8W:6)ZLRN<BP5<:/)]3]<')5U)5UE?
M5RT];19G(0PFFI;2++*\$7V67]U[J]_X4_+;^4[B,+U%\+/@U\HOB'EXMN[?
MKMN]2]&=.]S[?W/DIJ;;='5Y;(-24%)D*BOR-4M-3Y#(5TY66>4K55M2[-Y9
M/?NO=4@]6]_=6_REO^%"?\Q';?R[W/B.CNB_YGVR.EN\>A.]M\9=]O[1DRW5
M5#6T^6Q68S-<R8S%U9R65W&/)45:PT^BBC9H/XM1QO[KW4W^9M\@.D?YO7SK
M_E=_ ;X4=G;)^1V&Z:^4>U_F_P#*/MKI[-4/9^T]J[8Z>66&GHZO.8YZK#U&
M0S8JLC31PQUTGAGDHEJ(F%5$/?NO=;*OR%^8_P 3OB4NT6^4/R1Z2^/@W^<\
M-C_Z8NRL3UZ<O_=;[/\ B7\-&4JJ8U@Q_P#$<?\ <&(,(?N8/)I\J:O=>ZU1
M?Y&7\Q'X&],?);^>%N#MSYC?&KK/!=U?S1.[.R.HLSOKN7 [7I=R[?S6?W)/
M29O"3UE=#%DL54PU-.\=5 SPNDB,'(8'W[KW1B?^% &\-I;0_F$_R8:[YDU<
ME+_+'7M[M";O!-QPSU>S9-\PXU&V9)N^GB#T\]+152Q3Q_=Q-3142Y:64?;K
M5$>Z]THOY]ORX_D]?);^6'W1UW5?(7XF_(SM>IV<LOQ V-TCVAMWMO=\._)Y
M#C=KS[;Q^UZZNR]'3C(WI:YDCCI7HA5T=5K1G@;W7NKS_P"7'B.\MO\ P%^&
MV$^2YS0[]Q7QMZ?H>VH]S3K4Y./-T^#HUK(<I(MP^3A<>.K;4Q-0LI9W:[GW
M7NCI>_=>Z][]U[I$]E]C[)Z>ZZWYVUV7N&AVCUUUCLW<W8&^]TY,L*?&X?9]
M%-D,E73Z%=S%2T=/-(P5&8A;*K,0#[KW6EIL3Y]_#+^<1\O'^2'SY^8OQAZ*
M_EO_ !IWG4CXA_!?N#O#;NT,]O\ W-M^1(QV3V;@)\L'BQE.ZU Q6)KHB9E=
M2T$=*M1-FO=>ZVN=@_)+X@?/KK?NOKOXV_)+I#O[&1[*J]D=B'IWLK%[_&&@
M[0H,I0T)R(P];++1+71TN1^W+-&9?MI_$UXG*^Z]UKC?\)YOYAOQD^%'Q#WC
M_+*^=G=_5GQ%^37P0[J[DV+N?;7R#[%H.JZ',8[>&Y,KN*FRFV\CN*?&T>3I
MI*O)9!5AIG:5X!2Y 1&GR-/))[KW0N? 7<F%_F2_S[?E-_,LZ8DGS_Q$^+GQ
M>PWP=ZI[:&+9<9O7=%5E?XQFJW;]5-%$:C&X@5&6A:HC#B>.HH9XIC35*J?=
M>Z/?_..^?/PBV'\)?YD'QBWK\M?COM7Y&9#X2?);9U%T;G^W,'B]URY;L7K?
M*RX#&I@IJU<B:[,Q9/'/10?;^2I2JIVB5EE0M[KW0&_\)Z_F_P##G._RZ/Y?
MWQ4PWRBZ%RGR8INE:C$S]!T/:>&J=W+5;>;+Y:OICM]:LY/ST>+IZBKFC^VU
M1TT4DS@1HS#W7NK$^^_F_P#RK,;V1NWX^_*SY+_";;O9?4]5A)=S=9?)CL':
M&UZK%R[LQ=!F**2*EW?/31.U9BLC03J]-Y+QR*&8,K*ONO=4=5NX^F?YM?\
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M>L.PJ'>.(7>N*P\&7Q>&K,CB:FHAI*LU4^%>2-VU1PU4,LD3Q2 /[KW5<?\
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M?Y67_>M/X ?^D;]=?_8Y[]U[HQW8?QB^-?;O6.W.D^U_CUT=V?TSL_\ N_\
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M1B#[KW0P=S]#=(?(S957UO\ (#J#K/NSK^NGIJNJV7VML?&[^QCS4;K+#/\
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MT]>F-S='74:UD$534)',(1(B2R*K .P/NO=%8_X:=_E9?]ZT_@!_Z1OUU_\
M8Y[]U[H\VW=N[?V?M_!;2VE@L-M?:NU\-C-N[9VSMW&083'X['X2!*:BH*"B
MIDBIJ2CI*:*.*&&*-(XHT6.-550![KW3S[]U[KWOW7NF;<6W=O[PV_G=I;MP
M6&W1M7=&&R>W=S;9W%C(,WC\CC\W ]-6T%?15*2TU71U=-+)%-#+&\<L;M'(
MK*Q!]U[HC/\ PT[_ "LO^]:?P _](WZZ_P#L<]^Z]T8?HWXL?&+XPTVXZ+XU
M_''H?X\T>\)\95;NI.C>H-O=31967"K.E')D8\!CL>E=)2)4U*PM,',0ED"%
M0[7]U[I%=]?!/X5_*;.8S='R2^)OQU[VW/A:(XW$[F[7Z=P&^LC3TQ-_MHJ_
M(T%15I3:N?$)O&&]6F_/OW7NA_V'U_L/JS9^W^O>L-D[1ZXV!M+&T^&VKL?8
M>VZ/:&'QE'2#3%28_&8^&GHJ*FB'"10P(BC@*/?NO=$UJOY4_P#*[KJFHK:W
M^6Y\!ZRLK)YJJKJZKX>=>5$LLM0Q>2221]NEWD=R69F))))))/OW7NA@Z2^%
MGPX^-&X,KNWXX_$SXS_'_=6=PS;=SFYNDNA]K=59"LQ[SPU)H*NMP6*H*FHH
MS4T\$IADD:,R1QR:=2*1[KW0?[U_EI_RY>R=W;DW_P!B_ 'X3[^WWO',U^XM
MW;VWK\5=B[IR^5R&5D::JK\EDJ[ SUE=65,K,\LTTSR2.2SL22??NO=*#JCX
M ? [H;>^,[,Z-^$WQ'Z8[(PL&1I<-V#U1\;MF]=9RDBS%/)2U<=-EL/AJ.O@
MCJJ666&94J%$L3O&X9&(/NO=&X]^Z]U[W[KW7O?NO= /WE\6/C%\GJ;;E%\E
M/CCT/\AJ/9\^3JMHTG>74&WNV8L5+FE@2LDQT>?QV02ADJTIJ99FA"&411AR
MP1;>Z]T7C_AIW^5E_P!ZT_@!_P"D;]=?_8Y[]U[H\&&VIM;;FUL3L?;VVL!@
M=E8' 4.U,'L_#8>GQ>+HL7BZ=*.FQM)CX(XZ2GQ]/21I!%3QPK#'"JQH@0!?
M?NO=%*V-_+<_E[]8]G4G=77/P?\ B;L7MO'9.MS>+['VG\?MK8',T==D=8GK
M:*OIL7'4459,))0\\#QRLLDBE[2.&]U[H?.Y>A.B_D9M&'8'R$Z7ZF[WV)3Y
MFCW%!LGN7KG#]GXA,ACHYH:>O3&YNCKJ-:R"*IJ$CF$(D1)9%5@'8'W7NBL?
M\-._RLO^]:?P _\ 2-^NO_L<]^Z]T;?973?4/6W6V/Z:ZZZKZWV#U!B,;D,/
MBNJ=E;'QFU=MTM)EIIJBJI:?!4-+!BX::IGJ:B26)*4)))+([J6=B?=>Z+!M
MW^6%_+@VCV!!VMM;X%_#_;W9%)EI\_1;UP_QTVGC\A!7U3,TE;3U$6*5X*MV
M=V,T>F34S-JNQ)]U[H\RJJJ%4!54!5518 #Z #\ >_=>Z[]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=%G_YKK_Y$/_D?[<_#_J]>F_Q?ZO3I5=%_\>[E_P#M
M=-_UHA]Z?CUM.'0W>Z=7Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z+/_P UU_\ (A_\C_;GX?\ 5Z]-_B_U>G2JZ+_X]W+_ /:Z;_K1#[T_'K:<
M.AN]TZOU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T6?_ )KK_P"1
M#_Y'^W/P_P"KUZ;_ !?ZO3I5=%_\>[E_^UTW_6B'WI^/6TX=#=[IU?KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[HL_\ S77_ ,B'_P C_;GX?]7K
MTW^+_5Z=-/7E7V#28W(1[.QF.R=!_$6^XJ*B2./]T1H/2)JBG?24"D>C\\V/
M VU//K2U\NA _BG>'_/-X7_J?3?_ %?[K1>K5;KW\4[P_P">;PO_ %/IO_J_
MWZB]>JW7OXIWA_SS>%_ZGTW_ -7^_47KU6Z]_%.\/^>;PO\ U/IO_J_WZB]>
MJW7OXIWA_P \WA?^I]-_]7^_47KU6Z]_%.\/^>;PO_4^F_\ J_WZB]>JW7OX
MIWA_SS>%_P"I]-_]7^_47KU6Z]_%.\/^>;PO_4^F_P#J_P!^HO7JMU[^*=X?
M\\WA?^I]-_\ 5_OU%Z]5NO?Q3O#_ )YO"_\ 4^F_^K_?J+UZK=>_BG>'_/-X
M7_J?3?\ U?[]1>O5;KW\4[P_YYO"_P#4^F_^K_?J+UZK=>_BG>'_ #S>%_ZG
MTW_U?[]1>O5;KW\4[P_YYO"_]3Z;_P"K_?J+UZK=>_BG>'_/-X7_ *GTW_U?
M[]1>O5;KW\4[P_YYO"_]3Z;_ .K_ 'ZB]>JW7OXIWA_SS>%_ZGTW_P!7^_47
MKU6Z]_%.\/\ GF\+_P!3Z;_ZO]^HO7JMU[^*=X?\\WA?^I]-_P#5_OU%Z]5N
MO?Q3O#_GF\+_ -3Z;_ZO]^HO7JMU[^*=X?\ /-X7_J?3?_5_OU%Z]5NO?Q3O
M#_GF\+_U/IO_ *O]^HO7JMU[^*=X?\\WA?\ J?3?_5_OU%Z]5NO?Q3O#_GF\
M+_U/IO\ ZO\ ?J+UZK=>_BG>'_/-X7_J?3?_ %?[]1>O5;KW\4[P_P">;PO_
M %/IO_J_WZB]>JW7OXIWA_SS>%_ZGTW_ -7^_47KU6Z]_%.\/^>;PO\ U/IO
M_J_WZB]>JW7OXIWA_P \WA?^I]-_]7^_47KU6Z]_%.\/^>;PO_4^F_\ J_WZ
MB]>JW7OXIWA_SS>%_P"I]-_]7^_47KU6Z]_%.\/^>;PO_4^F_P#J_P!^HO7J
MMU[^*=X?\\WA?^I]-_\ 5_OU%Z]5NO?Q3O#_ )YO"_\ 4^F_^K_?J+UZK=>_
MBG>'_/-X7_J?3?\ U?[]1>O5;KW\4[P_YYO"_P#4^F_^K_?J+UZK=>_BG>'_
M #S>%_ZGTW_U?[]1>O5;KW\4[P_YYO"_]3Z;_P"K_?J+UZK=>_BG>'_/-X7_
M *GTW_U?[]1>O5;KW\4[P_YYO"_]3Z;_ .K_ 'ZB]>JW7OXIWA_SS>%_ZGTW
M_P!7^_47KU6Z]_%.\/\ GF\+_P!3Z;_ZO]^HO7JMU[^*=X?\\WA?^I]-_P#5
M_OU%Z]5NO?Q3O#_GF\+_ -3Z;_ZO]^HO7JMU[^*=X?\ /-X7_J?3?_5_OU%Z
M]5NO?Q3O#_GF\+_U/IO_ *O]^HO7JMU[^*=X?\\WA?\ J?3?_5_OU%Z]5NO?
MQ3O#_GF\+_U/IO\ ZO\ ?J+UZK=>_BG>'_/-X7_J?3?_ %?[]1>O5;KW\4[P
M_P">;PO_ %/IO_J_WZB]>JW7OXIWA_SS>%_ZGTW_ -7^_47KU6Z]_%.\/^>;
MPO\ U/IO_J_WZB]>JW7OXIWA_P \WA?^I]-_]7^_47KU6Z]_%.\/^>;PO_4^
MF_\ J_WZB]>JW7OXIWA_SS>%_P"I]-_]7^_47KU6Z]_%.\/^>;PO_4^F_P#J
M_P!^HO7JMU[^*=X?\\WA?^I]-_\ 5_OU%Z]5NO?Q3O#_ )YO"_\ 4^F_^K_?
MJ+UZK=>_BG>'_/-X7_J?3?\ U?[]1>O5;KW\4[P_YYO"_P#4^F_^K_?J+UZK
M=>_BG>'_ #S>%_ZGTW_U?[]1>O5;KW\4[P_YYO"_]3Z;_P"K_?J+UZK=>_BG
M>'_/-X7_ *GTW_U?[]1>O5;KW\4[P_YYO"_]3Z;_ .K_ 'ZB]>JW7OXIWA_S
MS>%_ZGTW_P!7^_47KU6Z]_%.\/\ GF\+_P!3Z;_ZO]^HO7JMU[^*=X?\\WA?
M^I]-_P#5_OU%Z]5NO?Q3O#_GF\+_ -3Z;_ZO]^HO7JMU[^*=X?\ /-X7_J?3
M?_5_OU%Z]5NO?Q3O#_GF\+_U/IO_ *O]^HO7JMU[^*=X?\\WA?\ J?3?_5_O
MU%Z]5NO?Q3O#_GF\+_U/IO\ ZO\ ?J+UZK=>_BG>'_/-X7_J?3?_ %?[]1>O
M5;KW\4[P_P">;PO_ %/IO_J_WZB]>JW7OXIWA_SS>%_ZGTW_ -7^_47KU6Z]
M_%.\/^>;PO\ U/IO_J_WZB]>JW7OXIWA_P \WA?^I]-_]7^_47KU6Z]_%.\/
M^>;PO_4^F_\ J_WZB]>JW7OXIWA_SS>%_P"I]-_]7^_47KU6Z]_%.\/^>;PO
M_4^F_P#J_P!^HO7JMU[^*=X?\\WA?^I]-_\ 5_OU%Z]5NO?Q3O#_ )YO"_\
M4^F_^K_?J+UZK=>_BG>'_/-X7_J?3?\ U?[]1>O5;KW\4[P_YYO"_P#4^F_^
MK_?J+UZK=>_BG>'_ #S>%_ZGTW_U?[]1>O5;KW\4[P_YYO"_]3Z;_P"K_?J+
MUZK=>_BG>'_/-X7_ *GTW_U?[]1>O5;KW\4[P_YYO"_]3Z;_ .K_ 'ZB]>JW
M7OXIWA_SS>%_ZGTW_P!7^_47KU6Z]_%.\/\ GF\+_P!3Z;_ZO]^HO7JMU[^*
M=X?\\WA?^I]-_P#5_OU%Z]5NO?Q3O#_GF\+_ -3Z;_ZO]^HO7JMU[^*=X?\
M/-X7_J?3?_5_OU%Z]5NO?Q3O#_GF\+_U/IO_ *O]^HO7JMU[^*=X?\\WA?\
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M]-_]7^_47KU6Z]_%.\/^>;PO_4^F_P#J_P!^HO7JMU[^*=X?\\WA?^I]-_\
M5_OU%Z]5NO?Q3O#_ )YO"_\ 4^F_^K_?J+UZK=>_BG>'_/-X7_J?3?\ U?[]
M1>O5;KW\4[P_YYO"_P#4^F_^K_?J+UZK=>_BG>'_ #S>%_ZGTW_U?[]1>O5;
MKW\4[P_YYO"_]3Z;_P"K_?J+UZK=>_BG>'_/-X7_ *GTW_U?[]1>O5;KW\4[
MP_YYO"_]3Z;_ .K_ 'ZB]>JW7OXIWA_SS>%_ZGTW_P!7^_47KU6Z]_%.\/\
MGF\+_P!3Z;_ZO]^HO7JMU[^*=X?\\WA?^I]-_P#5_OU%Z]5NO?Q3O#_GF\+_
M -3Z;_ZO]^HO7JMU[^*=X?\ /-X7_J?3?_5_OU%Z]5NO?Q3O#_GF\+_U/IO_
M *O]^HO7JMU[^*=X?\\WA?\ J?3?_5_OU%Z]5NO?Q3O#_GF\+_U/IO\ ZO\
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M;PO_ %/IO_J_WZB]>JW7OXIWA_SS>%_ZGTW_ -7^_47KU6Z]_%.\/^>;PO\
MU/IO_J_WZB]>JW03?<;Q_P!(AJOL:+^^(JQ_N-UIXBYI2/U>;Q6$(O\ Y_ZD
,6OR!?%.J9K\^O__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>tbarchart_006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tbarchart_006.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &0      04  DE$_]L
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M=>Z][]U[KWOW7NO>_=>Z 3Y3?]DW]X_^(PWC_P"X4ONR<1]HZT>'08?R_/\
MLD3J3_R??_>GS7NTOQ'_ %>76DX='*]M]6Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NB:_S _^R1.V
M_P#R0O\ WI\+[<B^(?ZO+JK\.A/^+/\ V3?T=_XC#9W_ +A1>ZOQ/VGK8X=#
MW[KUOKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[H!/E-_V3?WC_P"(PWC_ .X4ONR<1]HZT>'08?R_/^R1.I/_ "??
M_>GS7NTOQ'_5Y=:3AT<KVWU;KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>ZU"?^%<.Y.X/BY\.^E_E#\:?DO\ +'H#M+</ROVKU%N6
M3J'Y5=B;!Q-=A]T[-WAEI(GV_C=S4^ IY(:S:] T<D&,BE]<]W/EDU^Z]T,?
M_"6)^PN__P"7UC_E3\@?D-\L.^>Y\]W9V3MR7,=R_+'L7L?&4^/V7XZ2AI*;
M;N4W+4;?6,+65,DK/C))9I3&\DC?;4H@]U[HW_\ .D^/^7W+M/XV=C=>?)KY
ME_';>.[/GG\(NC]Y5?QZ^6W8/5>.RFU^_M^;>V)G,=+@,9N&';]-(*'*K5P5
M=+BX*Q*VG61IV2HJTG]U[JZ;8FR</UWM;%;0P-=N[)8O#PM#2UN^]_9WL[*2
M!B6)JLWN3(Y7,UKW)LU172$#TJ0H 'NO=$\_F=?-*B_EX_ WY)?,2IPE-N:N
MZ<V325&U=N5SS1TU=N#>>3H-N[<I:MJ9'G6BFSV7QRU+( 4I_*^N,*9%]U[J
MH?\ E(=%;(_F@_"#K/YO?*;Y8?*3O[Y#]P5V\LMO*MZF^8W9GQKP'7^1I<ED
M*6+:6W=G=:[RVU@\.<)0-2!Y*NAJ*JM=OO)7,%2D0]U[HR_Q\V!\]>AOYN^.
MZ=[>^36]OD;\'L[\$_D=O_XYU>^\!C:?<.(SV+[!Z@H\I@MW9S&8ZA&YZW#4
M.0C.'R59_EDE!6U44PEJ(:JJJ/=>ZO2]^Z]U[W[KW6O=_P *6X=X=7_RK?DC
M\I^G>[/DGT=WATW/T3)LG=?1WR6WWU!3JF[.PML[:KX:[#[>W!C\+D4J,7GZ
M]2U1CWE$H@D$@:".WNO=4B_\)A-I=N?S-^COE'OCY>?.;^93O?</5_:^RMJ;
M/J=O?S$NX-BI!19G$35E0DD6*W?3).SSJI#R!F4"P('OW7NK4.T/Y>/R%^.O
MS%^#/RO^,7\RO^81VI\7,E\LMF]=?(?XV=]?,#>O<&WX\;NN2HP=)58Z3)Y3
MRUV-AW%%!25M!EER+R35D<\-5'%3F!O=>Z-_\W/A'\A?FM_,*Z9HL+\S/F3\
M5?BOTY\<I-T]J8#XI][;CZ0EW?N3=6Z:N'#XRIJ\74)0A$Q^*R)K9_ ]>E.8
M8J:2G,RU$7NO=:<G_"F'M?Y6?RU?G=U-T7\2_G[_ #&]E=<[K^).Q.V<UB\_
M\^NU]\329O.[QWYAZFH6KRFZZFHCB>@P.-00JXC5D9PH:1R?=>ZVA>R/Y2?:
M/>?P%V3O?XV?S(?YI?3WRCS?0>S^S-M[B?\ F'=J;RP^:W!E=LPUPQ68Q>7W
M)7)!C,CD)Q=\>U+44[:&1Y(5>GE]U[I]_FY[3[)C_D@[I^2FUOD#\K^C?DIT
M[\5^C^Q\=V#U7\E.P.KZV3)X:##'*T^;QF*W%C\?DY<M%6Y&"LDK:*6I\TB5
M#.9Z:$K[KW5"7_"6Q.]OYH?^SS_[.'\[?YDN^?\ 0=_LLG^CO^[O\POMW8?V
MO^DS_2%_%_-_"=W4OW?G_N_C-'EU>+QMHMY'O[KW5R_S _EN?(#X[=X?#;Y0
M_$W^9?\ S'MR]9;)_F ?"/8'R7^,7:OS5WYW5@,AMGLOL[:VWLDB+6YB>L>-
M/XY0IE,=E'K*6?%RU$TAA2-DJ/=>ZVB_?NO=:B'_  K?W1VS\6_AETY\G/C5
M\D/ECT'VUN/Y;;,ZFW!7=0_*_L78&(J\'N79>]<K44S[<QNYJ?;\,JUNVL9)
M'-!C8I5_?&L_<2ZO=>Z$K_A*Q2]F]\_ AOEI\B?DU\N?D-W!NCO+L/;M'4=S
M_*OL#?\ A\9B]D0TU#2T%)M[(;CGP<JR25-94S2U./FFDEDCNX6EIA'[KW6U
M+[]U[KWOW7NO>_=>Z))_,0ZDHNV/B)WFC=B]\=4[AV'U7VCV#L??GQY[\W?\
M?L[C<UM[;>6:@K#7[2S&)_BU/2RN)ACLK%7XJ69(I:BAF>&,K[KW6IW_ ,(X
M/EQ\K?D]N[^8!3?)7Y.?(7Y#4VS-N?&J?9]/WEW1N3MI,2^=J=\+7/C4S^2R
M"T+UBTE()S $,PAB$FKQI;W7NMY_W[KW7O?NO=>]^Z]U[W[KW5=?\T+^9!TK
M_*]^*.]?D;VUD\?59Q*:JP'3_6S5JPU^[-SU4+M08FBA!\S0(P\U=.JE:2C2
M69R"$#>Z]T;GH'>.:[%Z(Z4[!W(]-)N+?74G7&\<_)1TXI(6K=SX:BK:HQ1
MD1QF>>0J@)TK87X]^Z]T+?OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NB:_S _^R1.V_P#R0O\
MWI\+[<B^(?ZO+JK\.A/^+/\ V3?T=_XC#9W_ +A1>ZOQ/VGK8X=#W[KUOKWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[H!/E-_V3?WC_P"(PWC_ .X4ONR<1]HZT>'08?R_/^R1.I/_ "??_>GS7NTO
MQ'_5Y=:3AT<KVWU;KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>ZU O^%JW_;K+H/\ \7_ZL_\ ?==J^_=>Z'K_ (2$_P#;G#:7_BPO
M>O\ [ET7OW7NK.?YL_\ S)[XH_\ C4K^5E_[_;8_OW7NK2O?NO=%5^;_ ,2.
MNOG=\3N\_B/VK+5TFRN[ME3;9K,MCX8:BIQM;0U%/DL-F*6.H22%ZO#9FBQ]
M= '0J9:=+V^H]U[KY;';?QK_ )U?_";?O7-[WV!N+LC8W6%1G:>#']Z=812;
MTZNWI14\T HX]QXVHBJ\725DS3+ *#.4-/7QRF;^'/+#XZR7W7NMSK^1%_PH
MVV#_ #3MUQ?'/Y!==[<Z7^9^#VGDLIMNIVO-+6;<WMCL;%3SYJ3 _>>6OP62
M@-.M148>:MK%DI8!5T];/X9X*3W7NMI?W[KW7O?NO=4 _P#"H[_MQ1\YO_+9
MO_?Q=?>_=>ZU;_\ A,[WY\X/C]_+K_F+;S^$7Q POROW_CNS]DUL&,R/<%#L
M"7&SIMVK'WL6%JZ)I-RK01@5+4%/E*.IK AIJ9C,R!O=>ZW9OY/V[-P]E?RN
M?@GOW?62DW)N_?'QTZWWMNO-UT,0DK,KGX%R-76R)&B0K--6RO-Z(U57-T50
M ![KW5E'OW7NOF"?\+5O^WIO0?\ XH!U9_[\7M7W[KW7T=OB/_V2C\8__%>N
ME_\ WF\;[]U[H@'\_P"_[<U?S!__ ! N0_\ =ECO?NO=:9'_  DO[D^5'2?6
M'\U+=?Q1^(\?R^WQ3X7XEUC;%'=>)Z:EBJ,;'VHU"J29:DJ$R"U6NJ+1PR1S
M P)$BNU0K1^Z]UN'?R!^]>Z/DQ\ 9N]?D1C:_!=U]C?*#Y99CL7:V3Q$^WYL
M)7TV^LQ2';[4%4D=51+M^&FBQR05""HA2E6.>\JN3[KW5UOOW7NM0+_A:M_V
MZRZ#_P#%_P#JS_WW7:OOW7NAZ_X2$_\ ;G#:7_BPO>O_ +ET7OW7NM:S^8]V
MW\F-@?\ "HW#_%WH3Y/]X]+=;Y?YF?R\]L;4VEA.R<]E]M8>;MC#=8UM=-_=
M6HRBX>OQ[Y;,5E5/C981250DDIY$$4C#W[KW2E_X40XKL[^3K_,<^)/R!^(_
MR8^3M9V+O;K8]F[VR/</=V<[)3,Y?9VY:@54>1CGJH(Y,%G8Y]%9AHEAQB)Y
M(Z*FI8Y-"^Z]UM/_ /"B_P#F=]B?R[/Y;4/8_1%7/MSO7Y&;PVUT[U;NS[&'
M)-ML;EQE;F<OG DS"$UM%B,=4T]$Q2415]32U#0R10R#W[KW5>O\OG^6W3;D
M_D:U/R]W%WO\A,;\[^^?C;W'\@LU\H:ON'<F\Z^6+,XC<'\"P.9P66S57@-S
M[9_NU+!#5X_)T<PFJ*BHKH9*.N6DGI/=>ZKW_P"$-W_'Z?S)?_#7^*O_ +E]
M@>_=>Z2G:O:/<G57_"O+:OQEV;W=W/BOC]3?)'X\34G3$/:^XGVO%#O;K';6
MXZRC3!RY.7'"D.4R-1,(?!XE<ZDC0!57W7NHW_"PCL?N;XU?-+XW;BZ [^[]
MZ<@[;^/N3KM\;4ZU[BSVR<-59':FX\A''F/X?C:VEC&4JZ:O2GJIB2)8:2D
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MMK^3%\^ZO<&6H,/39'IZDV[039"I6F$U?N/.8FBH*2+41KJ*NJFBBC079F8
M#Z^_=>ZUFO\ A#+4TZU'\S^C:>%:N>'X75,%*TJB1XZ5NV%ED1+ZF2-IH0S
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M[[IIZ#-LK9"2JI,722335!)IH_=>Z*3_ ,)!-W]T]^8?,_'3?V(KVZ _E_\
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MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NB:_S _\
MLD3MO_R0O_>GPOMR+XA_J\NJOPZ$_P"+/_9-_1W_ (C#9W_N%%[J_$_:>MCA
MT/?NO6^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7N@$^4W_9-_>/\ XC#>/_N%+[LG$?:.M'AT&'\OS_LD3J3_ ,GW
M_P!Z?->[2_$?]7EUI.'1RO;?5NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K#4Q//3S
MP15,U'+-#+%'64RQM)$TBD"2,31RQ%T)U*'B=+@:E9;@^Z]U6!M7^6)_=+YF
M;N^<M'\[OG+D>V]^[&P/5^[]M9?*=35.U*W;6U):JIQ.$_@<?4L(I:;&5U=6
M5<$U-4P5HJ)ZAGJG6JJ4F]U[JT7W[KW1+<=\#>AL#\^,C_,7VSB*K;??VZ?C
M;N'XR=BR8EHX,?N/$9'/;8SV.R>3I]&ILWAFVVM'#5(ZO-15 IZGRK1T/@]U
M[H)_YE_\I_X@_P UOJ[;_7'RAVOG$R^Q*W+9/K#M?K_*0[=W3MJHSL4<-:,=
M73TM;334-<L-,:JAK**IHYWIZ:9X?/34\T7NO=%&_E]?R!/CS\"\SMS)2?)#
MY>_)C =?Y+&YWJGJ+OGMU\EU_M?*8B>2JILUB]CXVGH,$^9I:MUJ*6JJH)S1
MU,<=51I!5*)_?NO=&[_F;_RI_BG_ #7^H-N]3?)O';NH:C8>;R.Y>M.R.N<W
M#M_<&WZW+TZTU8:.:JI*^AJ*2NBC@%52U5!/!,88) J300RQ^Z]T*WPB^#G7
M?P8ZEV[U;L_L3N[N2LV_M;;FRH>R/D)V/4=E9X8?:,/AQF&HG:*EQV&PF/0O
M]O08['TM.I8R2K+,3*?=>Z.+DJ2>NQ]91TN3K<-455-+!!EL;'32U%,T@($T
M*UE/5TK21GE1+32QW'J1A<>_=>ZUH/E#_P )7OA3\P_DGV#\M.]/E?\ S L]
MWCV3N+#[DSNZL+V)UIM402[9HZ+&XB''P4'4\"4<.(QN-Q]+2Z/W5CIHVDED
MFURO[KW5T7<7P]F[Y^)/8OQ$[-^3/R*S>W^V>OLUU;V%VU2Q]>8;>.2P>ZL9
M+B,Q1/+1]?0[9@.6HIZA:B:#:\4RF5S3R0"P'NO=$*_EK_R'_CI_*EJ^\:OX
MH?)#Y@4H^0&UL!MS>]+V#N+KO=T,51LX93^"9G'HO6M&8<IAVS63-/YFGHY#
M.PJZ.I4(J^Z]T'/P5_X3H_%;^7E\J9OF#T+\G?FW7]KYJCW-B-^4W8^\.M]V
M8O<N.WG74V2RN/R\*=7T=<D-=D*.DJ'FH,A0UB21#Q54:M(K^Z]TL_YF/\@?
MXR_S7^SMG=F?*3Y%?,&E/7.#S&WNO=C]8;FZ\VGA,-3;@J4JJX4RU?6V3RU3
M)520TP>2LRU4X2"-49;-J]U[H['<7P(H^\OA3E_@WOCY2_)[^X6Z-AKU9O7L
MW#OUQC]Y9K;<E F-JL/759ZYEP$4-=1JT=144>W*6N<.Y6J35[]U[HNG\KG^
M2YT%_*0/8^/^-'?'REW5LWM6LQ.6WCU[W/N#8VZ,5+D,'!-34N0@EP^P<!F*
M:IC@G9"(\J() J>6%](]^Z]TH-R?RBNFL+\T=Q_/_P"+_:/:'Q"^2?8VVL_M
M/NNNZJI-O[EVUOFEW ]#,\^XML;FPV8H1DH:O'4E4E7CY*"62I5IJK[EY)-?
MNO=+3X&_RI_C3\!MW=R=Q;-K-]]P_)OY%;CW!NGO3Y/]V9*@SV[MP3[ER4N6
MJJ53B\=B,/A\6U=*)/L\=BJ6)S%3F?S-3PLGNO='4[^Z2V)\E.CNW?CYV?CW
MRG7G=?7&\NK]YT44K4\K8[>U!/CZEX)D*R05,4<YD@E1EDBE5)(V5U4CW7NF
MKXR_'_8WQ3^//2OQKZT2L&Q.C>L]G]8[9GR4BRU513;1HH:05E8ZA4>LK7C>
MHJ&555II'*JH( ]U[H(/AO\ !'HWX.-\D3TICZ^B7Y/_ "6[#^3^^TR$_P!Q
MX,QV,E(M1CZ$_6'$T;4KM2P?2(S2A; V]^Z]U&^;'P0ZJ^=F*Z)Q?9^[>UMC
MR_'OO/'?(+86XNG-[2=?YB'/83;VX<%CW7)PQ2SP1T4V?7()XM+25-%3PS&2
MBDJZ6H]U[HK-'_* V9OSY.=!_*?YC?*/Y!_.C>?Q-FW!D/C%M;O7;W6^U,#M
M7);AGQE0V>DQ^P=B;0&=W!2SX?&RTU77O*D,\$-2*<U-/2RP>Z]U<![]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[HFO\P/_LD3MO\ \D+_ -Z?"^W(OB'^
MKRZJ_#H3_BS_ -DW]'?^(PV=_P"X47NK\3]IZV.'0]^Z];Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z 3Y3?]DW]
MX_\ B,-X_P#N%+[LG$?:.M'AT&'\OS_LD3J3_P GW_WI\U[M+\1_U>76DX='
M*]M]6Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NB:_S _\ LD3MO_R0O_>GPOMR+XA_J\NJOPZ$_P"+
M/_9-_1W_ (C#9W_N%%[J_$_:>MCAT/?NO6^O>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N@$^4W_9-_>/\ XC#>/_N%
M+[LG$?:.M'AT&'\OS_LD3J3_ ,GW_P!Z?->[2_$?]7EUI.'1RO;?5NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[HD>Q?FGMOO'Y&;[Z#^.FWH^T\3T-GX]M?)GNH9Q,
M;M?:V9DITJ1M#&U$4-7+N7>BQ3025E%3K#1XJ!F;(Y"&L^WQ]5[KW0/=M?S.
M]A8COKM?XH?&_K+>WRE^0G1>P9>P.^*/9%?B-N;4Z\I*S'U-;BTWEN;,Y&BB
MCR.3,"+#B\32Y3)Z&>66E@CBE=/=>Z+9\??YW^Q]RI\(\'\N/C3WC\2,]\^M
MD="9CXT]C9*@H.U.N-X9SOC$8FOQVW\5N?;=;7UV(RDE3E888Z3/X7$SZ"LT
M@6,E_?NO=7H>_=>ZIE_G>?S;!_)^^,6R>\Z/I&J[SW)V5VOCNJ-K[?GW7_<K
M%TE148W(9::KR>02BR,X44>,J%@@BI"TTA]4D2(S'W7NCV_!KY2XOYM?$3X^
M?+##;1RVP<?WMUMA-^ILW-5 K:C&R9 /'/2_<"* 54,=1%+X*@0QBHA\<P1
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MQD6$K,W5TTD]2*7&XR&:JCPV'2MK*RI%/]Y4SRS3%ZJKJ/' (?=>ZJZ^1O\
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MO>_=>Z][]U[KWOW7NB:_S _^R1.V_P#R0O\ WI\+[<B^(?ZO+JK\.A/^+/\
MV3?T=_XC#9W_ +A1>ZOQ/VGK8X=#W[KUOKWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[H!/E-_V3?WC_P"(PWC_ .X4
MONR<1]HZT>'08?R_/^R1.I/_ "??_>GS7NTOQ'_5Y=:3AT<KVWU;KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[IGS^XMO[5Q=3G-T9W#;;PE$%-9
MF,_DX,/2Q!R%4RU%0\<,=R0!J<7/'OW7NLV(S6'W!CX,M@<MC,WBJK7]MD\1
M7Q9*GD\;%6\<T+O&^E@0;,;$$'D>_=>Z[RV8Q& QU3E\[E,=A<31K&U9D\M7
M18ZGB$KK&IDFF9(T#.ZJ-3"[$ <D>_=>ZX87.87<>-ILSM[,8O/8BM5GH\KA
M<A%E*:4(2I,4\#R12 ,"#I8V((]^Z]UCSNX=O[6QTN8W-G,/MW$0,B3Y3.Y.
M#$4R&4V4//4/'$I8\ %N?Q[]U[KV"W#M_=..BS&V<YA]Q8B=G2#*8+)P9>F<
MQ&S!)Z=Y(F*G@@-Q^??NO=/'OW7NF[+9C$8#'5.7SN4QV%Q-&L;5F3RU=%CJ
M>(2NL:F2:9DC0,[JHU,+L0!R1[]U[KAA<YA=QXVFS.WLQB\]B*U6>CRN%R$6
M4II0A*DQ3P/)%( P(.EC8@CW[KW3I[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NB:_S _^R1.V_P#R0O\ WI\+[<B^(?ZO+JK\.A/^+/\ V3?T=_XC
M#9W_ +A1>ZOQ/VGK8X=#W[KUOKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[H!/E-_V3?WC_P"(PWC_ .X4ONR<1]HZ
MT>'08?R_/^R1.I/_ "??_>GS7NTOQ'_5Y=:3AT<KVWU;KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[K77^*G:&&^?G\Z?^9CMWNK$XG>>Q/Y9^(^
M/'47QBZXW+3G-X?&YCMBAW3+OC>PQ-7&:%]U5$N/7$P9-J=ZFCQ$LU%131P5
M]?\ =>Z]TCM^;LR7\N?^?K\6NJNHZ6#"?%S^;%U3V50=C],8:*7$X;!]F]#T
MU=D_[^8:@C#8VFK]P4-1AL=E(:6"E:INV0K9:B6*F0>Z]TH=F]K2?S#?Y[_R
M+Z$WO]OF_BY_*OZ;V#+ANI\M3_>XO</;?<,E#D(]X92C>9J3(?W2QD60Q^-A
MJ:.04E:&R$#1S%6/NO=/78W;$7\O;^>+\6NEMDQ1X#XV_P U3JOLS';GZOQ-
M''C<-A.U.C5%;!O#%4L;04M#4[HQ=708S*QPPDUE0M-6S!IE+GW7NF3LGY1]
M<;*_X4%TW07S9FBQNP-X?$GK>N_EW5_9&-B39D6\*G*Y2+>WV,U6W\/&]\RD
ME-1TU8T33QTE&<;'44S5\,&0]U[HPFWX,G1_SQJK%_&;$9#%=18OX:YW_9_&
MVS3?9;/DWKD<QC9>L8JJ%&CQQ[&BP@R\E3+!"<B=OS4"9!S2C'"/W7NKM??N
MO=:X^S>UI/YAO\]_Y%]";W^WS?Q<_E7]-[!EPW4^6I_O<7N'MON&2AR$>\,I
M1O,U)D/[I8R+(8_&PU-'(*2M#9"!HYBK'W7NGKL;MB+^7M_/%^+72VR8H\!\
M;?YJG5?9F.W/U?B:./&X;"=J=&J*V#>&*I8V@I:&IW1BZN@QF5CAA)K*A::M
MF#3*7/NO=;#WOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z)K_,#_[)
M$[;_ /)"_P#>GPOMR+XA_J\NJOPZ$_XL_P#9-_1W_B,-G?\ N%%[J_$_:>MC
MAT/?NO6^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7N@$^4W_9-_>/_ (C#>/\ [A2^[)Q'VCK1X=!A_+\_[)$ZD_\
M)]_]Z?->[2_$?]7EUI.'1RO;?5NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NJ".T/Y</R]^.W\S/L'^93_+FW!T;N:+Y0;.P6R?F'\6/D9O#/==
M8G.5&UJ6.#%;IVYN;"8/=4V+R](]'1:X)L%+#HDR)0LU;IB]U[H@6<H^^_G+
M_P *7_BY@MUUG4=3M?\ E9?'/<':W=QZ>I\GGL=M[=?>M!7T5-LVHW%DY*5\
MU72^?;U?!.<#B7%/'D(FH%DIS(?=>Z%C^4)CJG:7\^7_ (4.[6S86FS67WG\
M7-YT%)Z@7Q^<H,_DH)AJ538TN9Q['BW[@TEELQ]U[KW\WO&5F[?Y\G_">+;&
M%B-1EL3O/Y1[RK(;$A:'!4& R53(-(9KI28>N?E0HT"[ :BONO=#G_,HZ:Z+
M_G-_)G<W\IC-8+#4>'^+NPMD?(7Y)?)+&TE%D]W;*R79WD;9>RMB-,9X<7G-
MR4=-_$\]59*BJ:,;=$5%344U?E:?*83W7N@"_E2=X_*G^6_\RJ'^29\]GP_9
M$?9&%["[D^$7S)P&W1MM>PZ?'?=9;<..W&;R-6;M2.GR-;6S55;5943 C(55
M<E;CJZI]U[K:F]^Z]UJQ_P H3'5.TOY\O_"AW:V;"TV:R^\_BYO.@I/4"^/S
ME!G\E!,-2J;&ES./8\6_<&DLMF/NO=>_F]XRLW;_ #Y/^$\6V,+$:C+8G>?R
MCWE60V)"T."H,!DJF0:0S72DP]<_*A1H%V U%?=>ZVG/?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]T37^8'_V2)VW_ .2%_P"]/A?;D7Q#_5Y=5?AT
M)_Q9_P"R;^CO_$8;._\ <*+W5^)^T];'#H>_=>M]>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= )\IO^R;^\?_ !&&
M\?\ W"E]V3B/M'6CPZ##^7Y_V2)U)_Y/O_O3YKW:7XC_ *O+K2<.CE>V^K=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=%@[LKOEEN"CSNR?CM@N
MKNO,K7Q-CJ'OCN#*3[QH\2M9 ]\GCMDXA8*G<=;23% E%7;BP5,QO*]7*L8I
MJCW7NDU\+?A)U)\'^NMP[0Z[J=R;PWIV5O+*]I][=U]A9!,UNG?>[]R6;)[C
MW!61QPPFHJ9+B&FIX(:.CAM!2P1H#J]U[H">Z/A9O?;?SEVG_,;^+$6T:SNB
MOZB_V6WY#]2]@[SR6PL!OC9C96DR>.R<>3Q^*SPQV\=HU$$C4$TV$J(<A1R2
M8JHGH(WCK8/=>ZR=-?"O>FXOG%N;^8U\I?[HP=U4'3K?&[X^]2]?;KR.]MO[
M%V<,Q793(9%\ID,;@_XKO'=LM1 V1J8\'318^F1<1335\,;5]3[KW39F_A9V
M;TW_ #!^POG]\7WV%N"3Y-]9]>]7?+KI;L/-U.R_XM-U"HI=I[SVUGZ+$YDQ
M9O%XAYL;58RMHEHZZE%/(E=134Y%1[KW2PJ?B'NCO3YM]%_-/Y$X?9&VJKX?
M[,[BVE\6NN]D[BJ-Y5$=?\@J3&8_=6Z=SY6IQ.(C%9_"L7%CL9BJ."HIZ2*:
MMKILA4SU<5-C_=>Z43;9_F&_\.+INM>Q^DQ_+4'Q[.+DZR;",V]CV%]\6^_%
M7_#@ZTGVVGU'-&E\ ,7\.^Z/W8]U[H/.Z/A9O?;?SEVG_,;^+$6T:SNBOZB_
MV6WY#]2]@[SR6PL!OC9C96DR>.R<>3Q^*SPQV\=HU$$C4$TV$J(<A1R28JHG
MH(WCK8/=>ZR=-?"O>FXOG%N;^8U\I?[HP=U4'3K?&[X^]2]?;KR.]MO[%V<,
MQ793(9%\ID,;@_XKO'=LM1 V1J8\'318^F1<1335\,;5]3[KW5FWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z)K_,#_[)$[;_ /)"_P#>GPOMR+XA
M_J\NJOPZ$_XL_P#9-_1W_B,-G?\ N%%[J_$_:>MCAT/?NO6^O>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N@$^4W_9-
M_>/_ (C#>/\ [A2^[)Q'VCK1X=!A_+\_[)$ZD_\ )]_]Z?->[2_$?]7EUI.'
M1RO;?5NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[HFO\P/_ +)$[;_\D+_WI\+[<B^(?ZO+JK\.A/\
MBS_V3?T=_P"(PV=_[A1>ZOQ/VGK8X=#W[KUOKWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[H!/E-_V3?WC_ .(PWC_[
MA2^[)Q'VCK1X=!A_+\_[)$ZD_P#)]_\ >GS7NTOQ'_5Y=:3AT<KVWU;KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z)K_,#_ .R1.V__ "0O_>GPOMR+XA_J\NJOPZ$_XL_]DW]'?^(P
MV=_[A1>ZOQ/VGK8X=#W[KUOKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[H!/E-_P!DW]X_^(PWC_[A2^[)Q'VCK1X=
M!A_+\_[)$ZD_\GW_ -Z?->[2_$?]7EUI.'1RO;?5NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MI!=B=G;'ZHPM+N+?^;_@&'K<I!A::L_AM9E-53413SI%XZ*GJ91>*FF;44"#
M38L"5!,=LVFXWF0Q6R:V"EB-2KV@@5JQ4<6'SZ0W^XP[8@DG;2I;2#1FR033
MM!/ 'H&O]G0^-/\ S\G_ -<[/_\ UJ]GO]1-U_WQ_P!58?\ K9T4_P!;MN_W
M[_U3E_Z Z]_LZ'QI_P"?D_\ KG9__P"M7OW]1-U_WQ_U5A_ZV=>_K=MW^_?^
MJ<O_ $!U[_9T/C3_ ,_)_P#7.S__ -:O?OZB;K_OC_JK#_ULZ]_6[;O]^_\
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MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=6M_RX/^+#VK_P!K?:O_ %IK?<.>Z/\
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ML8_B=-D8XZB=8RL/NO=%SZ ^3G\^3:O\R#XJ_$7YK4W\MZNZZ[GV!WIW)O\
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MIV5N',4,Q2T<AP$-M>CR-[KW5O\ []U[K''%%"I2&..)#)+*5C0("T[%W8@
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M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[HFO\P/\ [)$[;_\
M)"_]Z?"^W(OB'^KRZJ_#H3_BS_V3?T=_XC#9W_N%%[J_$_:>MCAT/?NO6^O>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7N@$^4W_ &3?WC_XC#>/_N%+[LG$?:.M'AT&'\OS_LD3J3_R??\ WI\U[M+\
M1_U>76DX='*]M]6Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NB&?S#_P#F2NV/_$HX7_W4YOW(
MOME_N?)_SSM_U<BZ!//G^X:?\UE_XY)U35[G/J)>O>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZM;_EP?
M\6'M7_M;[5_ZTUON'/='^UM_]+)_A7J3O;_^SF_TR?X&ZLM]Q5U(77O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U4C\'_@5W!\:?YAO
M\V?Y:;[W)UMENN?GCN_XLY_J'"[2S&4K\WCH>D,#N/%Y9=R4U9AZ"@HY:BHS
M%,U(*+)9!9(UE,S0,J(_NO=*7-_"SLWIO^8/V%\_OB^^PMP2?)OK/KWJ[Y==
M+=AYNIV7_%INH5%+M/>>VL_18G,F+-XO$/-C:K&5M$M'74HIY$KJ*:G(J/=>
MZ6%3\0]T=Z?-OHOYI_(G#[(VU5?#_9G<6TOBUUWLG<51O*HCK_D%28S'[JW3
MN?*U.)Q$8K/X5BXL=C,51P5%/2135M=-D*F>KBIL?[KW0]=V5WRRW!1YW9/Q
MVP75W7F5KXFQU#WQW!E)]XT>)6L@>^3QVR<0L%3N.MI)B@2BKMQ8*F8WE>KE
M6,4U1[KW2:^%OPDZD^#_ %UN':'7=3N3>&].RMY97M/O;NOL+()FMT[[W?N2
MS9/<>X*R..&$U%3)<0TU/!#1T<-H*6"- =7NO=(QML_S#?\ AQ=-UKV/TF/Y
M:@^/9Q<G6381FWL>POOBWWXJ_P"'!UI/MM/J.:-+X 8OX=]T?NQ[KW6?^9;T
MCWS\G/A-\COC1\>\5U%5;S^0?3W8/3CYSN7L?,]=XO$0=A8^3%RY,-A-H;OJ
M\A+24]543)3?;4RRR1QQ&HC61I(O=>Z:_P"5YT%WY\4?@_\ '?XO_(7'=0)O
M'H#J[:O5L6X>F>Q,UO\ QF7AVHDE+'7M_'-H[2JL?+-31TKM (*E5D>5!,5C
M1Y?=>ZL$]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=$U_F!_]DB=M
M_P#DA?\ O3X7VY%\0_U>757X="?\6?\ LF_H[_Q&&SO_ '"B]U?B?M/6QPZ'
MOW7K?7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW0"?*;_LF_O'_P 1AO'_ -PI?=DXC[1UH\.@P_E^?]DB=2?^3[_[
MT^:]VE^(_P"KRZTG#HY7MOJW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T0S^8?_S)7;'_ (E'
M"_\ NIS?N1?;+_<^3_GG;_JY%T">?/\ <-/^:R_\<DZIJ]SGU$O7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=6M_RX/^+#VK_P!K?:O_ %IK?<.>Z/\ :V_^ED_PKU)WM_\ V<W^F3_
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MZ]T0S^8?_P R5VQ_XE'"_P#NIS?N1?;+_<^3_GG;_JY%T">?/]PT_P":R_\
M').J:O<Y]1+U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW5P?\NO_ )E;O;_P_P"7_P!UU#[A'W._W,B_
MYHC_ (^_4K<A?[C2?\U?^?%ZL%]QKT.NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NB:_S _^R1.V_P#R0O\ WI\+[<B^(?ZO+JK\.A/^
M+/\ V3?T=_XC#9W_ +A1>ZOQ/VGK8X=#W[KUOKWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[H!/E-_V3?WC_P"(PWC_
M .X4ONR<1]HZT>'08?R_/^R1.I/_ "??_>GS7NTOQ'_5Y=:3AT<KVWU;KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z(9_,/_YDKMC_ ,2CA?\ W4YOW(OME_N?)_SSM_U<BZ!/
M/G^X:?\ -9?^.2=4U>YSZB7KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NK6_Y<'_ !8>U?\ M;[5_P"M
M-;[ASW1_M;?_ $LG^%>I.]O_ .SF_P!,G^!NK+?<5=2%U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=$,_F'_ /,E=L?^)1PO_NIS
M?N1?;+_<^3_GG;_JY%T">?/]PT_YK+_QR3JFKW.?42]>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U<'_
M "Z_^96[V_\ #_E_]UU#[A'W._W,B_YHC_C[]2MR%_N-)_S5_P"?%ZL%]QKT
M.NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[HHGR^
M^;/2_P (]J[2WCW4N[SA]Z;@J=M88[0P4>>E^YI:9JIO,DE52Z(S$C68,W/%
MA[$?+?*UUS5(\5IHU(NMM;:12H'H?,]$V][];[!&LEP6"LVD:5U9H3_@'1 _
M^'_?@3_J.[?_ $75/_\ 7;V,/]9[>/2'_G+_ -"]!K_7*VO^*3_G&>O?\/\
MOP)_U'=O_HNJ?_Z[>_?ZSV\>D/\ SE_Z%Z]_KE;7_%)_SC/7O^'_ 'X$_P"H
M[M_]%U3_ /UV]^_UGMX](?\ G+_T+U[_ %RMK_BD_P"<9Z]_P_[\"?\ 4=V_
M^BZI_P#Z[>_?ZSV\>D/_ #E_Z%Z]_KE;7_%)_P XSU[_ (?]^!/^H[M_]%U3
M_P#UV]^_UGMX](?^<O\ T+U[_7*VO^*3_G&>O?\ #_OP)_U'=O\ Z+JG_P#K
MM[]_K/;QZ0_\Y?\ H7KW^N5M?\4G_.,]>_X?]^!/^H[M_P#1=4__ -=O?O\
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M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z 3Y3?\
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M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[HAG\P_\
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M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UN<_\
M"=;_ +(G[0_\6EWM_P"\ELCWB_[U_P#)5B_YY$_ZO3]3[[5_\D^3_GH?_JU#
MU??[A_J2^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[HFO\P/\ [)$[;_\ )"_]Z?"^W(OB'^KR
MZJ_#H3_BS_V3?T=_XC#9W_N%%[J_$_:>MCAT/?NO6^O>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N@$^4W_ &3?WC_X
MC#>/_N%+[LG$?:.M'AT&'\OS_LD3J3_R??\ WI\U[M+\1_U>76DX='*]M]6Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NB&?S#_P#F2NV/_$HX7_W4YOW(OME_N?)_SSM_U<BZ
M!//G^X:?\UE_XY)U35[G/J)>O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZM;_EP?\6'M7_M;[5_ZTUON
M'/='^UM_]+)_A7J3O;_^SF_TR?X&ZLM]Q5U(77O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T0S^8?_P R5VQ_XE'"_P#NIS?N1?;+
M_<^3_GG;_JY%T">?/]PT_P":R_\ ').J:O<Y]1+U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5P?\NO_
M )E;O;_P_P"7_P!UU#[A'W._W,B_YHC_ (^_4K<A?[C2?\U?^?%ZL%]QKT.N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K7-_P"%
M'?\ V3_\>O\ Q,69_P#=)4>YK]D?]SKC_F@/^KB]1=[J_P"X</\ S6_Y\?K4
M)]Y*]01U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW6YS_P )UO\ LB?M#_Q:7>W_ +R6R/>+_O7_ ,E6
M+_GD3_J]/U/OM7_R3Y/^>A_^K4/5]_N'^I+Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NB:_S
M_P#LD3MO_P D+_WI\+[<B^(?ZO+JK\.A/^+/_9-_1W_B,-G?^X47NK\3]IZV
M.'0]^Z];Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z 3Y3?\ 9-_>/_B,-X_^X4ONR<1]HZT>'08?R_/^R1.I/_)]
M_P#>GS7NTOQ'_5Y=:3AT<KVWU;KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z(9_,/_ .9*[8_\
M2CA?_=3F_<B^V7^Y\G_/.W_5R+H$\^?[AI_S67_CDG5-7N<^HEZ][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[JUO^7!_Q8>U?^UOM7_K36^X<]T?[6W_TLG^%>I.]O_[.;_3)_@;JRWW%
M74A=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW1#/
MYA__ #)7;'_B4<+_ .ZG-^Y%]LO]SY/^>=O^KD70)Y\_W#3_ )K+_P <DZIJ
M]SGU$O7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=7!_RZ_\ F5N]O_#_ )?_ '74/N$?<[_<R+_FB/\
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MNO>_=>ZUS?\ A1W_ -D__'K_ ,3%F?\ W25'N:_9'_<ZX_YH#_JXO47>ZO\
MN'#_ ,UO^?'ZU"?>2O4$=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UN<_\ "=;_ +(G[0_\6EWM_P"\
MELCWB_[U_P#)5B_YY$_ZO3]3[[5_\D^3_GH?_JU#U??[A_J2^O>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[HFO\P/\ [)$[;_\ )"_]Z?"^W(OB'^KRZJ_#H3_BS_V3?T=_XC#9
MW_N%%[J_$_:>MCAT/?NO6^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7N@$^4W_ &3?WC_XC#>/_N%+[LG$?:.M'AT&
M'\OS_LD3J3_R??\ WI\U[M+\1_U>76DX='*]M]6Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NB
M&?S#_P#F2NV/_$HX7_W4YOW(OME_N?)_SSM_U<BZ!//G^X:?\UE_XY)U35[G
M/J)>O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>ZM;_EP?\6'M7_M;[5_ZTUON'/='^UM_]+)_A7J3O;_^
MSF_TR?X&ZLM]Q5U(77O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]T0S^8?_P R5VQ_XE'"_P#NIS?N1?;+_<^3_GG;_JY%T">?/]PT
M_P":R_\ ').J:O<Y]1+U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5P?\NO_ )E;O;_P_P"7_P!UU#[A
M'W._W,B_YHC_ (^_4K<A?[C2?\U?^?%ZL%]QKT.NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K7-_P"%'?\ V3_\>O\ Q,69_P#=
M)4>YK]D?]SKC_F@/^KB]1=[J_P"X</\ S6_Y\?K4)]Y*]01U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW6YS_P )UO\ LB?M#_Q:7>W_ +R6R/>+_O7_ ,E6+_GD3_J]/U/OM7_R3Y/^
M>A_^K4/5]_N'^I+Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NB:_S _P#LD3MO_P D+_WI\+[<
MB^(?ZO+JK\.A/^+/_9-_1W_B,-G?^X47NK\3]IZV.'0]^Z];Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z 3Y3?\
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M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[HAG\P_\
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M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UN<_\
M"=;_ +(G[0_\6EWM_P"\ELCWB_[U_P#)5B_YY$_ZO3]3[[5_\D^3_GH?_JU#
MU??[A_J2^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[HFO\P/\ [)$[;_\ )"_]Z?"^W(OB'^KR
MZJ_#H3_BS_V3?T=_XC#9W_N%%[J_$_:>MCAT/?NO6^O>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N@$^4W_ &3?WC_X
MC#>/_N%+[LG$?:.M'AT&'\OS_LD3J3_R??\ WI\U[M+\1_U>76DX='*]M]6Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NB&?S#_P#F2NV/_$HX7_W4YOW(OME_N?)_SSM_U<BZ
M!//G^X:?\UE_XY)U35[G/J)>O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZM;_EP?\6'M7_M;[5_ZTUON
M'/='^UM_]+)_A7J3O;_^SF_TR?X&ZLM]Q5U(77O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T0S^8?_P R5VQ_XE'"_P#NIS?N1?;+
M_<^3_GG;_JY%T">?/]PT_P":R_\ ').J:O<Y]1+U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5P?\NO_
M )E;O;_P_P"7_P!UU#[A'W._W,B_YHC_ (^_4K<A?[C2?\U?^?%ZL%]QKT.N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K7-_P"%
M'?\ V3_\>O\ Q,69_P#=)4>YK]D?]SKC_F@/^KB]1=[J_P"X</\ S6_Y\?K4
M)]Y*]01U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW6YS_P )UO\ LB?M#_Q:7>W_ +R6R/>+_O7_ ,E6
M+_GD3_J]/U/OM7_R3Y/^>A_^K4/5]_N'^I+Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NB:_S
M_P#LD3MO_P D+_WI\+[<B^(?ZO+JK\.A/^+/_9-_1W_B,-G?^X47NK\3]IZV
M.'0]^Z];Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z 3Y3?\ 9-_>/_B,-X_^X4ONR<1]HZT>'08?R_/^R1.I/_)]
M_P#>GS7NTOQ'_5Y=:3AT<KVWU;KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z(9_,/_ .9*[8_\
M2CA?_=3F_<B^V7^Y\G_/.W_5R+H$\^?[AI_S67_CDG5-7N<^HEZ][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[JUO^7!_Q8>U?^UOM7_K36^X<]T?[6W_TLG^%>I.]O_[.;_3)_@;JRWW%
M74A=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW1#/
MYA__ #)7;'_B4<+_ .ZG-^Y%]LO]SY/^>=O^KD70)Y\_W#3_ )K+_P <DZIJ
M]SGU$O7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=7!_RZ_\ F5N]O_#_ )?_ '74/N$?<[_<R+_FB/\
MC[]2MR%_N-)_S5_Y\7JP7W&O0ZZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NM<W_ (4=_P#9/_QZ_P#$Q9G_ -TE1[FOV1_W.N/^
M: _ZN+U%WNK_ +AP_P#-;_GQ^M0GWDKU!'7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=;G/_  G6_P"R
M)^T/_%I=[?\ O);(]XO^]?\ R58O^>1/^KT_4^^U?_)/D_YZ'_ZM0]7W^X?Z
MDOKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z)K_,#_ .R1.V__ "0O_>GPOMR+XA_J\NJOPZ$_
MXL_]DW]'?^(PV=_[A1>ZOQ/VGK8X=#W[KUOKWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[H!/E-_P!DW]X_^(PWC_[A
M2^[)Q'VCK1X=!A_+\_[)$ZD_\GW_ -Z?->[2_$?]7EUI.'1RO;?5NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[HAG\P_\ YDKMC_Q*.%_]U.;]R+[9?[GR?\\[?]7(N@3SY_N&
MG_-9?^.2=4U>YSZB7KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NK6_Y<'_%A[5_[6^U?^M-;[ASW1_M;
M?_2R?X5ZD[V__LYO],G^!NK+?<5=2%U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=$,_F'_\ ,E=L?^)1PO\ [J<W[D7VR_W/D_YY
MV_ZN1= GGS_<-/\ FLO_ !R3JFKW.?42]>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U<'_+K_P"96[V_
M\/\ E_\ ==0^X1]SO]S(O^:(_P"/OU*W(7^XTG_-7_GQ>K!?<:]#KKWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZUS?\ A1W_ -D_
M_'K_ ,3%F?\ W25'N:_9'_<ZX_YH#_JXO47>ZO\ N'#_ ,UO^?'ZU"?>2O4$
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]UN<_\ "=;_ +(G[0_\6EWM_P"\ELCWB_[U_P#)5B_YY$_Z
MO3]3[[5_\D^3_GH?_JU#U??[A_J2^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[HFO\P/\ [)$[
M;_\ )"_]Z?"^W(OB'^KRZJ_#H3_BS_V3?T=_XC#9W_N%%[J_$_:>MCAT/?NO
M6^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7N@$^4W_ &3?WC_XC#>/_N%+[LG$?:.M'AT&'\OS_LD3J3_R??\ WI\U
M[M+\1_U>76DX='*]M]6Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NB&?S#_P#F2NV/_$HX7_W4
MYOW(OME_N?)_SSM_U<BZ!//G^X:?\UE_XY)U35[G/J)>O>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZM;
M_EP?\6'M7_M;[5_ZTUON'/='^UM_]+)_A7J3O;_^SF_TR?X&ZLM]Q5U(77O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T0S^8?_P R
M5VQ_XE'"_P#NIS?N1?;+_<^3_GG;_JY%T">?/]PT_P":R_\ ').J:O<Y]1+U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW5P?\NO_ )E;O;_P_P"7_P!UU#[A'W._W,B_YHC_ (^_4K<A
M?[C2?\U?^?%ZL%]QKT.NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[K7-_P"%'?\ V3_\>O\ Q,69_P#=)4>YK]D?]SKC_F@/^KB]
M1=[J_P"X</\ S6_Y\?K4)]Y*]01U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6YS_P )UO\ LB?M#_Q:
M7>W_ +R6R/>+_O7_ ,E6+_GD3_J]/U/OM7_R3Y/^>A_^K4/5]_N'^I+Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NB:_S _P#LD3MO_P D+_WI\+[<B^(?ZO+JK\.A/^+/_9-_
M1W_B,-G?^X47NK\3]IZV.'0]^Z];Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z 3Y3?\ 9-_>/_B,-X_^X4ONR<1]
MHZT>'08?R_/^R1.I/_)]_P#>GS7NTOQ'_5Y=:3AT<KVWU;KWOW7NO>_=>Z][
M]U[HO/=/RCZ;Z#J\3C>PMQO#ELQ%+408;#0#,UD4*<+/4TL3^>"GF;6L4CH$
MD9)%4DHUKJA?AU4M3H#?^')_B[_SN]W?^@?4_P#%?=O!;K6L=>_X<G^+O_.[
MW=_Z!]3_ ,5]^\%NO:QU[_AR?XN_\[O=W_H'U/\ Q7W[P6Z]K'7O^')_B[_S
MN]W?^@?4_P#%??O!;KVL=>_X<G^+O_.[W=_Z!]3_ ,5]^\%NO:QU[_AR?XN_
M\[O=W_H'U/\ Q7W[P6Z]K'7O^')_B[_SN]W?^@?4_P#%??O!;KVL=>_X<G^+
MO_.[W=_Z!]3_ ,5]^\%NO:QU[_AR?XN_\[O=W_H'U/\ Q7W[P6Z]K'7O^')_
MB[_SN]W?^@?4_P#%??O!;KVL=%7^7GS.Z.[CZVPFV-DY/<%3E:'?&-SU1'7[
M=FQZ"GI:#)T[D.YL6\E5%9?J02?Q[&')6YQ;'=/-<$A3$R#2-1U%XV_P*>@U
MS3MTN[6ZQP@%A(&-33 5Q_E'5<W]^MO_ /':I_\ .5O<G_U^V[^)_P#>#T ?
MZFWWHG^]CKW]^MO_ /':I_\ .5O?OZ_;=_$_^\'KW]3;[T3_ 'L=>_OUM_\
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M?^@?4_\ %??O!;KVL=>_X<G^+O\ SN]W?^@?4_\ %??O!;KVL=>_X<G^+O\
MSN]W?^@?4_\ %??O!;KVL=>_X<G^+O\ SN]W?^@?4_\ %??O!;KVL=>_X<G^
M+O\ SN]W?^@?4_\ %??O!;KVL=>_X<G^+O\ SN]W?^@?4_\ %??O!;KVL=>_
MX<G^+O\ SN]W?^@?4_\ %??O!;KVL=>_X<G^+O\ SN]W?^@?4_\ %??O!;KV
ML=>_X<G^+O\ SN]W?^@?4_\ %??O!;KVL=>_X<G^+O\ SN]W?^@?4_\ %??O
M!;KVL=>_X<G^+O\ SN]W?^@?4_\ %??O!;KVL=>_X<G^+O\ SN]W?^@?4_\
M%??O!;KVL=>_X<G^+O\ SN]W?^@?4_\ %??O!;KVL=>_X<G^+O\ SN]W?^@?
M4_\ %??O!;KVL=>_X<G^+O\ SN]W?^@?4_\ %??O!;KVL=>_X<G^+O\ SN]W
M?^@?4_\ %??O!;KVL=>_X<G^+O\ SN]W?^@?4_\ %??O!;KVL=>_X<G^+O\
MSN]W?^@?4_\ %??O!;KVL=>_X<G^+O\ SN]W?^@?4_\ %??O!;KVL=4^?SB>
MV-F?-/JCJ/9_1U965^9V=V'DMRYI=QT$FWHUI:G&RTJ&.20/Y',KCT@<"YO[
MDGVTYBMN5KF:6[U!7B"+H74:ZP?4>0Z!//.QS\PV\<5OIJLFHZC04TL/0^O6
MOM_LG_<?_*OMO_S^C_KU[F7_ %VMH]9O^<?_ $-U&'^MKN7_  K_ 'L_] ]>
M_P!D_P"X_P#E7VW_ .?T?]>O?O\ 7:VCUF_YQ_\ 0W7O];7<O^%?[V?^@>O?
M[)_W'_RK[;_\_H_Z]>_?Z[6T>LW_ #C_ .ANO?ZVNY?\*_WL_P#0/7O]D_[C
M_P"5?;?_ )_1_P!>O?O]=K:/6;_G'_T-U[_6UW+_ (5_O9_Z!Z]_LG_<?_*O
MMO\ \_H_Z]>_?Z[6T>LW_./_ *&Z]_K:[E_PK_>S_P! ]>_V3_N/_E7VW_Y_
M1_UZ]^_UVMH]9O\ G'_T-U[_ %M=R_X5_O9_Z!Z]_LG_ ''_ ,J^V_\ S^C_
M *]>_?Z[6T>LW_./_H;KW^MKN7_"O][/_0/7O]D_[C_Y5]M_^?T?]>O?O]=K
M:/6;_G'_ -#=>_UM=R_X5_O9_P"@>O?[)_W'_P J^V__ #^C_KU[]_KM;1ZS
M?\X_^ANO?ZVNY?\ "O\ >S_T#U[_ &3_ +C_ .5?;?\ Y_1_UZ]^_P!=K:/6
M;_G'_P!#=>_UM=R_X5_O9_Z!Z]_LG_<?_*OMO_S^C_KU[]_KM;1ZS?\ ./\
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MJNM__0&QG_U+[]4]>H.O?Z&^H?\ GU76_P#Z V,_^I??JGKU!U[_ $-]0_\
M/JNM_P#T!L9_]2^_5/7J#KW^AOJ'_GU76_\ Z V,_P#J7WZIZ]0=>_T-]0_\
M^JZW_P#0&QG_ -2^_5/7J#KW^AOJ'_GU76__ * V,_\ J7WZIZ]0=>_T-]0_
M\^JZW_\ 0&QG_P!2^_5/7J#KW^AOJ'_GU76__H#8S_ZE]^J>O4'7O]#?4/\
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M7WZIZ]0=>_T-]0_\^JZW_P#0&QG_ -2^_5/7J#KW^AOJ'_GU76__ * V,_\
MJ7WZIZ]0=>_T-]0_\^JZW_\ 0&QG_P!2^_5/7J#KW^AOJ'_GU76__H#8S_ZE
M]^J>O4'7O]#?4/\ SZKK?_T!L9_]2^_5/7J#KW^AOJ'_ )]5UO\ ^@-C/_J7
MWZIZ]0=>_P!#?4/_ #ZKK?\ ] ;&?_4OOU3UZ@Z]_H;ZA_Y]5UO_ .@-C/\
MZE]^J>O4'7O]#?4/_/JNM_\ T!L9_P#4OOU3UZ@Z]_H;ZA_Y]5UO_P"@-C/_
M *E]^J>O4'7O]#?4/_/JNM__ $!L9_\ 4OOU3UZ@Z]_H;ZA_Y]5UO_Z V,_^
MI??JGKU!U[_0WU#_ ,^JZW_] ;&?_4OOU3UZ@Z]_H;ZA_P"?5=;_ /H#8S_Z
ME]^J>O4'7O\ 0WU#_P ^JZW_ /0&QG_U+[]4]>H.O?Z&^H?^?5=;_P#H#8S_
M .I??JGKU!U[_0WU#_SZKK?_ - ;&?\ U+[]4]>H.O?Z&^H?^?5=;_\ H#8S
M_P"I??JGKU!U[_0WU#_SZKK?_P! ;&?_ %+[]4]>H.O?Z&^H?^?5=;_^@-C/
M_J7WZIZ]0=>_T-]0_P#/JNM__0&QG_U+[]4]>H.O?Z&^H?\ GU76_P#Z V,_
M^I??JGKU!U[_ $-]0_\ /JNM_P#T!L9_]2^_5/7J#JMO)["V,G\RO;VUUV9M
M-=LR]9SU<FW5V[1B@:48NN?R-2"'[<R:E4ZC'>X!O<#V]7L_/ING=U9)_H;Z
MA_Y]5UO_ .@-C/\ ZE]LU/3E!U[_ $-]0_\ /JNM_P#T!L9_]2^_5/7J#KW^
MAOJ'_GU76_\ Z V,_P#J7WZIZ]0=>_T-]0_\^JZW_P#0&QG_ -2^_5/7J#KW
M^AOJ'_GU76__ * V,_\ J7WZIZ]0=>_T-]0_\^JZW_\ 0&QG_P!2^_5/7J#K
MW^AOJ'_GU76__H#8S_ZE]^J>O4'7O]#?4/\ SZKK?_T!L9_]2^_5/7J#KW^A
MOJ'_ )]5UO\ ^@-C/_J7WZIZ]0=>_P!#?4/_ #ZKK?\ ] ;&?_4OOU3UZ@Z]
M_H;ZA_Y]5UO_ .@-C/\ ZE]^J>O4'7O]#?4/_/JNM_\ T!L9_P#4OOU3UZ@Z
M]_H;ZA_Y]5UO_P"@-C/_ *E]^J>O4'7O]#?4/_/JNM__ $!L9_\ 4OOU3UZ@
MZ]_H;ZA_Y]5UO_Z V,_^I??JGKU!U[_0WU#_ ,^JZW_] ;&?_4OOU3UZ@Z]_
MH;ZA_P"?5=;_ /H#8S_ZE]^J>O4'7O\ 0WU#_P ^JZW_ /0&QG_U+[]4]>H.
MO?Z&^H?^?5=;_P#H#8S_ .I??JGKU!U[_0WU#_SZKK?_ - ;&?\ U+[]4]>H
M.O?Z&^H?^?5=;_\ H#8S_P"I??JGKU!U[_0WU#_SZKK?_P! ;&?_ %+[]4]>
MH.O?Z&^H?^?5=;_^@-C/_J7WZIZ]0=>_T-]0_P#/JNM__0&QG_U+[]4]>H.O
M?Z&^H?\ GU76_P#Z V,_^I??JGKU!U[_ $-]0_\ /JNM_P#T!L9_]2^_5/7J
M#KW^AOJ'_GU76_\ Z V,_P#J7WZIZ]0=>_T-]0_\^JZW_P#0&QG_ -2^_5/7
MJ#KW^AOJ'_GU76__ * V,_\ J7WZIZ]0=>_T-]0_\^JZW_\ 0&QG_P!2^_5/
M7J#KW^AOJ'_GU76__H#8S_ZE]^J>O4'7O]#?4/\ SZKK?_T!L9_]2^_5/7J#
MKW^AOJ'_ )]5UO\ ^@-C/_J7WZIZ]0=>_P!#?4/_ #ZKK?\ ] ;&?_4OOU3U
MZ@Z]_H;ZA_Y]5UO_ .@-C/\ ZE]^J>O4'7O]#?4/_/JNM_\ T!L9_P#4OOU3
MUZ@ZKPZJPV'V_P#S.NY<1@<5C<)B:3K#'_:8O$4,6-IXON,3M.63QP0JD2:Y
M'=VLHNS,QY)/MUO@'V_Y^JCCU:O[9ZOU[W[KW7O?NO=>]^Z]T37^8'_V2)VW
M_P"2%_[T^%]N1?$/]7EU5^'0G_%G_LF_H[_Q&&SO_<*+W5^)^T];'#H>_=>M
M]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO= )\IO\ LF_O'_Q&&\?_ '"E]V3B/M'6CPZ##^7Y_P!DB=2?^3[_ .]/
MFO=I?B/^KRZTG#HY7MOJW7O?NO=>]^Z]U[W[KW3%+M?;-1G:7=,^W<%-N>B@
M:EHMQRXBGDKX8G61#'%6&,U$<92:52JR %7<6LQOZO6J=/OOW6^O>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[IB;:^V6SJ;I;;N";<T<!I8]Q-B*<UZQ%2GC6L\?W CT,RZ1):Q(
MM8^_5Z]3I]]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=,3;7VRV=3=+;=P3;FC@-+'N)L13
MFO6(J4\:UGC^X$>AF72)+6)%K'WZO7J=/OOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[IBBV
MOMFGSM5NF#;N"AW/6P+2UNXXL13QU\T2+&@CEK!&*B2,)#$H5I" J(+646]7
MK5.GWW[K?7O?NO=>]^Z]U[W[KW1-?Y@?_9(G;?\ Y(7_ +T^%]N1?$/]7EU5
M^'0G_%G_ +)OZ._\1AL[_P!PHO=7XG[3UL<.A[]UZWU[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T GRF_[)O[Q_\
M$8;Q_P#<*7W9.(^T=:/#H,/Y?G_9(G4G_D^_^]/FO=I?B/\ J\NM)PZ.5[;Z
MMU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=$U_F!_\ 9(G;?_DA?^]/A?;D7Q#_ %>757X="?\ %G_L
MF_H[_P 1AL[_ -PHO=7XG[3UL<.A[]UZWU[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T GRF_[)O[Q_P#$8;Q_]PI?
M=DXC[1UH\.@P_E^?]DB=2?\ D^_^]/FO=I?B/^KRZTG#HY7MOJW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW51/R0Z0_F+?,+MG=E%TU\T<K_+Y
M^-76LM5M#:T_7G3.'['WQOS/TL2#)9_(9#<<C4.$VECJN62@H*&DH?NZ^6DJ
M<A-6K3U%%'#[KW1'OY67S"_F =6?S%_D+_)__F/;\POR,WWU[TO#\F/CW\K<
M!M2@V=+N;:%5D\?02Q9G'8YDBIIEJ,J(85DI1-!/CZZ"6IK(6H:J?W7NCD_.
M#YH=C3_./XC_ ,K7XT;G?9/;_P B]N[V[J[_ .X<;C\?F\AU_P!6[$IJ]36X
MFER0J*,;BW7F**3%8VHGQ]9%0L'JGI9#XV3W7NFSO/Y.;\_EU?-?X>]?=F=E
M[I[-^(?SSW?E>@<9F^S<C0Y'+[ [2AAAJ-L)399*:@GK=M[VC>II)*:K>JEH
M<A#'-32Q4LKTX]U[H;/EWUY\[_DSV71=/?&+Y(_[)!TKL/&8S,=L]\8?JS']
MG[RW1F<XKSTFV-HQ9R083"XK$T2T]3E<G-1UD]5-6T]#1K3BDK6F]U[JIWXV
M?);^91_+Z_FU=._RT_G;WY'\X.@/FQL_L;=WQ:^259L'$;!W)B,IUMC:W)Y#
M"YJBQ+1AH::EQJQU)>.J5I:^AJZ6ICC-=24ONO=;&'R A[DEZGWJ>A]Z;"Z^
M['I]NYJLP.[.Q^OJWL_&TLU'2RR1-)AJ'/[:EJ29507.45$%V:*8#QGW7NJI
M/^$\'RK[Y^:W\L/K7Y'?)7?M7V1V[OWL_O/^/[DJ<?289/#A-SY"BH:2EHJ"
M"FHJ.CHJ."&&**&! %74VJ1G=O=>ZO"]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW51/R0Z0_F+?,+MG=E%TU\T<K_+Y^-76LM5M#:T_7G3.'['
MWQOS/TL2#)9_(9#<<C4.$VECJN62@H*&DH?NZ^6DJ<A-6K3U%%'#[KW1'OY6
M7S"_F =6?S%_D+_)_P#YCV_,+\C-]]>]+P_)CX]_*W ;4H-G2[FVA59/'T$L
M69QV.9(J:9:C*B&%9*4303X^N@EJ:R%J&JG]U[HV^_/E]V-\F?YIN2_EK= [
MVRW6W77QDZ6PO??S4[>V=%CY\W)D]WU>-.T.M</55J5BX=LICZO^*96NCH'J
M30K]G2U%'.[2GW7NG+:'RNWY\7?YG.V/Y=G>F^\MV1UI\K.GMP]T?#+M+>T]
M"<_2YKKF2?\ OEUUF*NF@H%RT=+CHHLMB*QZ9ZSP/-1U<]4Z12#W7NGCY(=(
M?S%OF%VSNRBZ:^:.5_E\_&KK66JVAM:?KSIG#]C[XWYGZ6)!DL_D,AN.1J'"
M;2QU7+)04%#24/W=?+25.0FK5IZBBCA]U[HCW\K+YA?S .K/YB_R%_D__P Q
M[?F%^1F^^O>EX?DQ\>_E;@-J4&SI=S;0JLGCZ"6+,X[',D5-,M1E1#"LE*)H
M)\?702U-9"U#53^Z]T>'Y(=(?S%OF%VSNRBZ:^:.5_E\_&KK66JVAM:?KSIG
M#]C[XWYGZ6)!DL_D,AN.1J'";2QU7+)04%#24/W=?+25.0FK5IZBBCA]U[HC
MW\K+YA?S .K/YB_R%_D__P Q[?F%^1F^^O>EX?DQ\>_E;@-J4&SI=S;0JLGC
MZ"6+,X[',D5-,M1E1#"LE*)H)\?702U-9"U#53^Z]ULK^_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[JHGY(=(?S%OF%VSNRBZ:^:.5_E\_&KK66
MJVAM:?KSIG#]C[XWYGZ6)!DL_D,AN.1J'";2QU7+)04%#24/W=?+25.0FK5I
MZBBCA]U[HCW\K+YA?S .K/YB_P A?Y/_ /,>WYA?D9OOKWI>'Y,?'OY6X#:E
M!LZ7<VT*K)X^@EBS..QS)%33+4940PK)2B:"?'UT$M360M0U4_NO=&WWY\ON
MQODS_--R7\M;H'>V6ZVZZ^,G2V%[[^:G;VSHL?/FY,GN^KQIVAUKAZJM2L7#
MME,?5_Q3*UT= ]2:%?LZ6HHYW:4^Z]TY;0^5V_/B[_,YVQ_+L[TWWENR.M/E
M9T]N'NCX9=I;VGH3GZ7-=<R3_P!\NNLQ5TT% N6CI<=%%EL16/3/6>!YJ.KG
MJG2*0>Z]T\?)#I#^8M\PNV=V4737S1RO\OGXU=:RU6T-K3]>=,X?L??&_,_2
MQ(,EG\AD-QR-0X3:6.JY9*"@H:2A^[KY:2IR$U:M/444</NO=$>_E9?,+^8!
MU9_,7^0O\G_^8]OS"_(S??7O2\/R8^/?RMP&U*#9TNYMH563Q]!+%F<=CF2*
MFF6HRHAA62E$T$^/KH):FLA:AJI_=>ZM%^3OQX^8_P FMRYG#]>_,G?'P=ZJ
MVQ2I0;5FZ2V1MC>>ZMSY.HI]4^8S65W'296FQ> I7G--2XFAHX*Z:2!Z^JR<
M8EIZ.G]U[HAG\E3Y/?.[<W<W\P[X"_/3=^$[Z[#^ 79O6>"VU\K=O;:BV@N[
ML1W-09+,XRCR>/HZ.EQ\&5QV*I<?4/XB\R+7?:U+U#TJU];[KW6P+[]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[HFO\ ,#_[)$[;_P#)"_\
M>GPOMR+XA_J\NJOPZ$_XL_\ 9-_1W_B,-G?^X47NK\3]IZV.'0]^Z];Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M 3Y3?]DW]X_^(PWC_P"X4ONR<1]HZT>'08?R_/\ LD3J3_R??_>GS7NTOQ'_
M %>76DX='*]M]6Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZB5]
M?0XJAK<IE*VDQN,QM)4U^1R-?4I1P4\%&C233332,L<4,4:LSNS!54%F( )]
M^Z]U4C\,^A6[A^;?R0_FL[QPC8Q>VNN-F_%_XBT&3IVBKH^J.O:ELI5;GJ8I
MHTEHFW_NF6IR%%3_ *AA*?%U,NB>MG@A]U[JM39:U-;_ ,*].W#EQ4-%B?Y4
M^-;:YJ-4*K%)G=L+(8/TB6/S5.1!_4H<R?VD]/NO=<O^%4DM5!U#_*^FQ!E7
M<,/\UKX[2X1J)2U6)8\7N(H:8*#*7$XI[!1^OQ_G3[]U[K:B]^Z]U3WM?I2C
M^9?\SC;'SGRE#3571WP3ZX[(Z$^+N8E(J5W)OWM&?[3L?=F/!0I_ \!C:.CV
M]0U<;D5U><RZ6@HZ6:H]U[JUS>__ !Y>[_\ PU\__P"XDWOW7NM=[_A)O_VY
M0Z"_\27\A?\ WL<K[]U[K9)]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW42OKZ'%4-;E,I6TF-QF-I*FOR.1KZE*."G@HT:2::::1ECBABC5F=V
M8*J@LQ !/OW7NJD?AGT*W</S;^2'\UG>.$;&+VUUQLWXO_$6@R=.T5='U1U[
M4ME*K<]3%-&DM$V_]TRU.0HJ?]0PE/BZF71/6SP0^Z]U6I_)U6IJ_P">U_PH
MCR&9%0V7INPOC3CZ)ZO5"XH33[F6!5C.D-$:6FH?&Y4_MA"K6<EO=>ZY?SC9
M:J'^>G_PG8?$&5<H>R/DS%5FA4M/]E/3[52H$F@%_MS2M6!R?2(_*38:S[]U
M[K:7KZ^AQ5#6Y3*5M)C<9C:2IK\CD:^I2C@IX*-&DFFFFD98XH8HU9G=F"JH
M+,0 3[]U[JI'X9]"MW#\V_DA_-9WCA&QB]M=<;-^+_Q%H,G3M%71]4=>U+92
MJW/4Q31I+1-O_=,M3D**G_4,)3XNIET3UL\$/NO=6W5]?0XJAK<IE*VDQN,Q
MM)4U^1R-?4I1P4\%&C233332,L<4,4:LSNS!54%F( )]^Z]U4C\,^A6[A^;?
MR0_FL[QPC8Q>VNN-F_%_XBT&3IVBKH^J.O:ELI5;GJ8IHTEHFW_NF6IR%%3_
M *AA*?%U,NB>MG@A]U[JWGW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=1*^OH<50UN4RE;28W&8VDJ:_(Y&OJ4HX*>"C1I)IIII&6.*&*-69W9@
MJJ"S$ $^_=>ZJ1^&?0K=P_-OY(?S6=XX1L8O;77&S?B_\1:#)T[15T?5'7M2
MV4JMSU,4T:2T3;_W3+4Y"BI_U#"4^+J9=$];/!#[KW5:G\G5:FK_ )[7_"B/
M(9D5#9>F["^-./HGJ]4+BA-/N98%6,Z0T1I::A\;E3^V$*M9R6]U[KE_.-EJ
MH?YZ?_"=A\095RA[(^3,56:%2T_V4]/M5*@2: 7^W-*U8')](C\I-AK/OW7N
MMI>OKZ'%4-;E,I6TF-QF-I*FOR.1KZE*."G@HT:2::::1ECBABC5F=V8*J@L
MQ !/OW7NJD?AGT*W</S;^2'\UG>.$;&+VUUQLWXO_$6@R=.T5='U1U[4ME*K
M<]3%-&DM$V_]TRU.0HJ?]0PE/BZF71/6SP0^Z]U9/W(>ZO\ 1_N"/X_1]7_Z
M4IL;7Q[6JNX*G*QX&"K,$GVTM?#AH7R%53BH\0DCBF@;QEBLFH!3[KW6NE_)
M.^7OR4V=\Q/EU_+$_F!]"]<]9_-*CBS?S,R7=W4[5E;C>U*'=^3H\7D-P5M1
M5-,9'HH:G T6*>.6""+%THQ,>.Q@PRT[^Z]UL_\ OW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NB:_P P/_LD3MO_ ,D+_P!Z?"^W(OB'^KRZ
MJ_#H3_BS_P!DW]'?^(PV=_[A1>ZOQ/VGK8X=#W[KUOKWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[H!/E-_V3?WC_XC
M#>/_ +A2^[)Q'VCK1X=!A_+\_P"R1.I/_)]_]Z?->[2_$?\ 5Y=:3AT<KVWU
M;KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K6!^>/\TKN*J^3^X?
MCY_PT_\ S9>]?B-U%EZ9=S;HZ,^)>ZTQW:6X\%4RB7&S5==CJ$U'6>+GBAD/
MVLKQ[LJ%"2M_=N)XMP>Z]T;KXF_S7/D=\Q_D#L'I3!_RK/G=\2-F21YO=?:/
M>'S-Z9RO4F"H,+MBF+1XS EJ":FRVY,UDY:"DBI9JZB6"B>MR"-4/1K2R^Z]
MUU\V_BUO/J/^9/\ %'^;EU'M'<&^L5USU=OOXO?-'8&Q-JY/?>Y:WKO<Z5F0
MP6Y=M8+%F:NS&0VIN.=9:^AH,;69.OQSA**FJ)J2*%O=>Z37RCZ-S'\U'YN?
M!)L;M#>V&^%_P)[7RWR@[7WGV7UEN'JU]X=AX2DQK; VWM2GW!2X;)9/&8:6
M>LKLYD(Z"?%2>G$+425L=;3T_NO=(O\ FH_S)^\>L>Y<?\3.KOY>/\SWOKIU
M\/!D?D5WK\1OC;NO("MBR,=-4TVR-G;F7'T]&RY2EE=<]G<;D3/C8"V,Q4D>
M7FJ*_!^Z]UBZ'_F__(#N#>_37QEZ7_DM?S%?C72;GW#M/8%'V=\FOCOE>G^N
M]D;;Q:K_ !')UM;3XZKB4XK"4M0,7CV%+!75XI*!ZRD2<S+[KW5Y'>N^<5UU
MU-OO=&8P^_<_24FV,]&N'ZTZSW%V[F:B1Z*H9(J/!;6Q>8S-9)(4TJ(:%[N4
M3]3J#[KW5$O_  EZVOV-TY_*XZY^/7=?2_?_ $;V_P!>=@=S9#<NT.[^@=Y=
M/L*?<^X9\G0ST=9N/!XW'Y*.>DR$!'VE5,RL)D90T$H3W7NMC7W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:P/SQ_FE=Q57R?W#\?/^&G_ .;+
MWK\1NHLO3+N;='1GQ+W6F.[2W'@JF42XV:KKL=0FHZSQ<\4,A^UE>/=E0H25
MO[MQ/%N#W7NC=?$W^:Y\COF/\@=@]*8/^59\[OB1LR2/-[K[1[P^9O3.5ZDP
M5!A=L4Q:/&8$M034V6W)FLG+04D5+-742P43UN01JAZ-:67W7NFG/_'7<GP6
M_FY=H?S!=L;3W9NSXO\ SMZ6V5U9\G*7K?86<[-S>T^QNLJF@HMI;KFPV"BR
M63DVEF,(LU!D9Z/$2IC*T#)9!X**:IJHO=>ZS83XY;G^<W\VWJ?^8)NK9^ZM
MG_%_X*])[XZS^,-)V1L7,=:Y[=O8O9]9D<?NS=D>&S4>.RT&T<3@EIZ+&25^
M)A7)UC?Q7'&:A6EJIO=>Z*K\\?YI7<55\G]P_'S_ (:?_FR]Z_$;J++TR[FW
M1T9\2]UICNTMQX*IE$N-FJZ['4)J.L\7/%#(?M97CW94*$E;^[<3Q;@]U[HW
M7Q-_FN?([YC_ "!V#TI@_P"59\[OB1LR2/-[K[1[P^9O3.5ZDP5!A=L4Q:/&
M8$M034V6W)FLG+04D5+-742P43UN01JAZ-:67W7NBB_/'^:5W%5?)_</Q\_X
M:?\ YLO>OQ&ZBR],NYMT=&?$O=:8[M+<>"J91+C9JNNQU":CK/%SQ0R'[65X
M]V5"A)6_NW$\6X/=>Z-U\3?YKGR.^8_R!V#TI@_Y5GSN^)&S)(\WNOM'O#YF
M],Y7J3!4&%VQ3%H\9@2U!-39;<F:R<M!214LU=1+!1/6Y!&J'HUI9?=>ZO$]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6L#\\?YI7<55\G]P_'
MS_AI_P#FR]Z_$;J++TR[FW1T9\2]UICNTMQX*IE$N-FJZ['4)J.L\7/%#(?M
M97CW94*$E;^[<3Q;@]U[HW7Q-_FN?([YC_('8/2F#_E6?.[XD;,DCS>Z^T>\
M/F;TSE>I,%087;%,6CQF!+4$U-EMR9K)RT%)%2S5U$L%$];D$:H>C6EE]U[I
MIS_QUW)\%OYN7:'\P7;&T]V;L^+_ ,[>EME=6?)REZWV%G.S<WM/L;K*IH*+
M:6ZYL-@HLEDY-I9C"+-09&>CQ$J8RM R60>"BFJ:J+W7NLV$^.6Y_G-_-MZG
M_F";JV?NK9_Q?^"O2>^.L_C#2=D;%S'6N>W;V+V?69''[LW9'ALU'CLM!M'$
MX):>BQDE?B85R=8W\5QQFH5I:J;W7NBJ_/'^:5W%5?)_</Q\_P"&G_YLO>OQ
M&ZBR],NYMT=&?$O=:8[M+<>"J91+C9JNNQU":CK/%SQ0R'[65X]V5"A)6_NW
M$\6X/=>Z-U\3?YKGR.^8_P @=@]*8/\ E6?.[XD;,DCS>Z^T>\/F;TSE>I,%
M087;%,6CQF!+4$U-EMR9K)RT%)%2S5U$L%$];D$:H>C6EE]U[H>MS_S4]C=;
M?)?M3XY]N_$SY_;'H]@U.&CVCWEMGX;[X[^V7O"++4XE\N!KNML1N_( QSDP
ME*G&0DM;44</&GNO=-G1WQCRG:W\R7L3^:+O;96YNL8U^).T/A7T-L3>M#_
M\]5X+&;LR^\,_N_.XQ:F5L4^7R%=CZ/&T%9''D(*.BDFK8*2:I%-'[KW5KOO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NB:_S _^R1.V_P#R
M0O\ WI\+[<B^(?ZO+JK\.A/^+/\ V3?T=_XC#9W_ +A1>ZOQ/VGK8X=#W[KU
MOKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[H!/E-_V3?WC_P"(PWC_ .X4ONR<1]HZT>'08?R_/^R1.I/_ "??_>GS
M7NTOQ'_5Y=:3AT<KVWU;KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z)K_,#_P"R1.V__)"_]Z?"^W(O
MB'^KRZJ_#H3_ (L_]DW]'?\ B,-G?^X47NK\3]IZV.'0]^Z];Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z 3Y3?]
MDW]X_P#B,-X_^X4ONR<1]HZT>'08?R_/^R1.I/\ R??_ 'I\U[M+\1_U>76D
MX='*]M]6Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NB:_S _P#LD3MO_P D+_WI\+[<B^(?ZO+JK\.A
M/^+/_9-_1W_B,-G?^X47NK\3]IZV.'0]^Z];Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z 3Y3?\ 9-_>/_B,-X_^
MX4ONR<1]HZT>'08?R_/^R1.I/_)]_P#>GS7NTOQ'_5Y=:3AT<KVWU;KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z)K_ # _^R1.V_\ R0O_ 'I\+[<B^(?ZO+JK\.A/^+/_ &3?T=_X
MC#9W_N%%[J_$_:>MCAT/?NO6^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7N@$^4W_9-_>/_B,-X_\ N%+[LG$?:.M'
MAT1GX>_,+XY]6?'/KO8>_.Q/X%NO!?WN_BN*_NCG<GXOXGG<G60?OT>,J*9]
M=-40OZ)FTZM+68,H=DC+&HZHK #HR_\ PX'\1/\ G[?_ *X6Y_\ ZR^Z>$WI
M_@ZMK'7O^' _B)_S]O\ ]<+<_P#]9??O";T_P=>UCKW_  X'\1/^?M_^N%N?
M_P"LOOWA-Z?X.O:QU[_AP/XB?\_;_P#7"W/_ /67W[PF]/\ !U[6.O?\.!_$
M3_G[?_KA;G_^LOOWA-Z?X.O:QU[_ (<#^(G_ #]O_P!<+<__ -9??O";T_P=
M>UCKW_#@?Q$_Y^W_ .N%N?\ ^LOOWA-Z?X.O:QU[_AP/XB?\_;_]<+<__P!9
M??O";T_P=>UCKW_#@?Q$_P"?M_\ KA;G_P#K+[]X3>G^#KVL=>_X<#^(G_/V
M_P#UPMS_ /UE]^\)O3_!U[6.O?\ #@?Q$_Y^W_ZX6Y__ *R^_>$WI_@Z]K'7
MO^' _B)_S]O_ -<+<_\ ]9??O";T_P '7M8Z]_PX'\1/^?M_^N%N?_ZR^_>$
MWI_@Z]K'7O\ AP/XB?\ /V__ %PMS_\ UE]^\)O3_!U[6.O?\.!_$3_G[?\
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MKVL=>_X<#^(G_/V__7"W/_\ 67W[PF]/\'7M8Z]_PX'\1/\ G[?_ *X6Y_\
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M[6.O?\.!_$3_ )^W_P"N%N?_ .LOOWA-Z?X.O:QU[_AP/XB?\_;_ /7"W/\
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MWA-Z?X.O:QU[_AP/XB?\_;_]<+<__P!9??O";T_P=>UCKW_#@?Q$_P"?M_\
MKA;G_P#K+[]X3>G^#KVL=>_X<#^(G_/V_P#UPMS_ /UE]^\)O3_!U[6.O?\
M#@?Q$_Y^W_ZX6Y__ *R^_>$WI_@Z]K'7O^' _B)_S]O_ -<+<_\ ]9??O";T
M_P '7M8Z]_PX'\1/^?M_^N%N?_ZR^_>$WI_@Z]K'7O\ AP/XB?\ /V__ %PM
MS_\ UE]^\)O3_!U[6.O?\.!_$3_G[?\ ZX6Y_P#ZR^_>$WI_@Z]K'7O^' _B
M)_S]O_UPMS__ %E]^\)O3_!U[6.O?\.!_$3_ )^W_P"N%N?_ .LOOWA-Z?X.
MO:QU[_AP/XB?\_;_ /7"W/\ _67W[PF]/\'7M8Z]_P .!_$3_G[?_KA;G_\
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M]U[W[KW1!_YD_P#V2[F__#NV?_[DGV[#\75'X=%7]WZ:Z%O^5/\ \R8["_\
M$GS_ /NJQONL_'\NG4X=6B^V>K]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T0?^
M9/\ ]DNYO_P[MG_^Y)]NP_%U1^'15_=^FNA;_E3_ /,F.PO_ !)\_P#[JL;[
MK/Q_+IU.'5HOMGJ_7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]T4#N[^8+\$_C5O.#KGY"?,?XQ])]@5%!2Y9=D
M=H]X;;V1EDI*YBL%7-C\AD8*NGI9V60132Q)')HDT,WC?3[KW1J\)G,)N;#X
MS<.V\QB]P8#-45/DL/G,)D(<M1U=/5J'BJ*:I@>2&>&5"&1T=E8$$$CW[KW0
M<=U=^]&_&_951V1\@NX>LND=@4M52T$V\^UM\8W8.,%16N$AIQ692IIH'J)G
M8+'$KEW)LJD^_=>Z]TKW[T;\D-E4_9'Q][AZR[NV!555500[SZIWQC=_8PU%
M$Y2:G-9BZFI@2HA=2LD3.'0BS*#[]U[I6[\[ V'U9L_<'879^]MH]<; VEC:
MC,[JWQOS<E'M##XRCI!JEJ\AD\A-3T5%31#EY9IT11R6'OW7N@(Z"^<7PT^5
M64S>"^-'RI^/G?6=VW2T]?G\%U)VY@M^UU%3U198JBIH\;75%3#3R,CJLK1!
M"RE0UP1[]U[HTOOW7NB;#^8G\!6[<CZ"7YJ_%9^[)<R-N)U4G?>V'SQR1!88
M[^&C)FJ&0('%,8_/>P\=R![]U[HY/OW7NFO-YS";9P^3W#N3,8O;^ PM%49+
M,9S-Y"'$T=)3TBEY:BIJ9WCA@AB0%G=W55 )) ]^Z]T1ZN_FI_RO\775F,R?
M\R#X%8[)8ZJJ*'(8^N^8'7M)/!/2.8Y89HI-Q+)%+%(K*Z,H96!! ((]^Z]T
M:#9'>_1_9FQ:WM'K?N7JGL#K/&XQLUD>Q=D=AXC=>"@HTHTR)JYLO05E1CXJ
M48^2.I,K5 04[+-J\9#'W7N@2V?_ ##?@#V'O>#K/8'SD^'N^>QZG(2XFFZ_
MV?\ )G96YLW)5P2B!Z9,519N>O>H2<B-HQ3EPYT$:N/?NO='"]^Z]TG=V[OV
MEL#;6;WIOO=&W=E;.VU0397<>[-VYNFVWC,?2TPO)4UM?62PTM+3QC]4DLJH
MOY(]^Z]T4SIC^9%_+]^1>]O]&W1'S3^,';?83^5J79.P>[=O;DRM2L'C#R45
M#35[U-=$AFC!>GCD0,P4M>X]^Z]T;G;VY=O[LH*C*;:S%!G,=2YS<^VJFMQM
M0M3&F0V7DJO#Y:C9EN!48_*T%92SI]8YX9(VY4^_=>Z?/?NO=8Y98H(I)YY(
MX888WEFFE<1JBQ@EF9B0%50"22; <GW[KW1'MP_S/OY:>T<U7[<W9_,.^#6V
M-PXJ58,I@=P_+38.%K:9W19%2HI:G<$4\+%'1@'C!*L#]"/?NO=,O_#L7\K+
M_O99\ /_ $LCKK_[(_?NO=#]U/\ +/XK]];5WAOKHSY,?'[NC9/7@D;?^\>I
M^Y=N=BXK!B*F>L<YC(8?)5E)C M)').?N9H[0HTI]"EA[KW0 _\ #L7\K+_O
M99\ /_2R.NO_ +(_?NO=>_X=B_E9?][+/@!_Z61UU_\ 9'[]U[H6^K/G)\*.
M]%W<_27S!^+7<2=?X'^]._&ZL^0.TNPAA,9J*?Q'+G$9>L&-H-8*_<5'CBU
MC7?W[KW08Y+^:A_+#PV1K\/F/YCOP-Q66Q5;58W*8O)?+[KVAJ*:HH9&BGIZ
MB"7<*RPSPRJR.CJ&1@58 @CW[KW4+_AV+^5E_P![+/@!_P"ED==?_9'[]U[H
MS_2GR%Z"^2FU<AOKXZ=X=/\ ?VR<3N"JVGE-X]*=EX7M3%4V5H::DK)\949#
M!5M?20Y"&DKZ&=Z=YA,D-1!*R!)HV;W7NEMO3?6R.MMN5^\>Q-X[5V#M'%")
MLING>FX:3:V-IA.XC0U%=7304T(=V55URB[$ <GW[KW1*O\ AV+^5E_WLL^
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MO=?)_P#Y\G_<3OVM_P")Z^ W_OONK??NO=?6 ]^Z]U5K\?O^WNW\S#_Q4O\
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M21Q<>_=>Z/Q_PM[V_A/]EU^ V<&*H5R^$[B[>V_B,@M.J24U#G,%B9JNEA(
M\<%1+C,>SH+ FGB_U ]^Z]T>KX;?R'_@+\\/Y8O\NS?_ ,P^N]V=C]Q93XM_
M&[=\O:]+O[);6SK8+^Z&*BV]M%:BAEBAAVKB-O#'4M-10T\>EHY*_P O\1K*
MVKJ/=>Z+S_PL%_ES8[M;X8]9?-/JW:$ WQ\/:[&[*WXN(I)6EDZVWA(E(MXJ
M>FG>=-M9YL=-'Y98H:2AK,K4/)QI;W7NC._R\/Y@5/\ S)?Y'O376&7W6DGR
M-[OR%+_+$['AH]TQ8O,G(UN-EI=R[FI9A!2R#*1=/4^8WB%IJ<E)J:>"*;5
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M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z(/\
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MY3+0TD<534PX<]5-213S*HDECIC55)B5F(C\LFFVMK^Z]T@/YL?P'^,NSO\
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MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW1!_P"9/_V2[F__  [MG_\
MN2?;L/Q=4?AT5?W?IKH6_P"5/_S)CL+_ ,2?/_[JL;[K/Q_+IU.'5HOMGJ_7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]T"W??R*Z/^+_7.>[7[^[1V1U3L3;N+RF4K,YO;<E'MY)AB8'J)*>B6
MJFB:MK7C0B*FA#S2N51$9F /NO=5F_R$_DQT+WK_ "M_A'M;JGM?8V\]X=1_
M&7J?K/L[96&W+1U>9P.9Z[P^/Q63I,MBDF:NH"E2L;1M- BS03T\\9:.>-F]
MU[HMO_"A7^27MK^:A\?AV)U5C*##?-;HK Y6LZDSPD2@3=.,4-4U6R<Q(S)$
MT=9*ODQ=5*0:"N) DCI*NM$GNO=*K_A-OL+)K_(A^*G5^^,/F]KYA8OF#L+=
M^W\UCIL+D<=4CN#LC'Y"CJZ2H2*HI*VDE\T<L,L:212HR.JLI ]U[K3L_E>?
M)/L+_A,G_- ^0/Q^^=O7N^<9T+VU2GKS</8V+VA4.M?1[%R4]3M#L3;L44E3
M'FL'/19"M%524E1/54PR#126R&/FHI/=>Z^A;\/?F]M;YW4X[7^/.V-ZR_%@
M;:5\%W%V1U]E^LY-VYC*RPO"NU,9FX\?EIL'B:*.H-;D:G$QTM945=)%BYYQ
M25[)[KW6AA\.LBG\LC_A4]\A,_\ ,3#;VZUVKVGVS\QZSK;<=+UUGMWQYVC[
MTR&1S6U:W$4F&QU?D,M!E*>IIH!]C25315LGVLH62.7Q^Z]U])+9NX*S=>UL
M'N6NVYFMHU&<H(LF-M[CB6FR%)'5W>&*NA1G%-5^$QM- 6+02%H7)=&]^Z]U
M7!_.@[?ZJZK_ )6_\P.G[*['V3L.JWQ\*_E!L79='NS<U'@I\MF=[;-R^&Q.
M+QL%1+'+75V0RN0HJ6&&%'=YIHU ]7OW7NM&#_A&A\@NENG?FQ\E]F]K]F;,
MZXS7;70&(H>N1OC<5)M:#+UNT\]35-9C:*IKIH(9\F*2H-1'2(YGEIX*J:-&
M2FE*^Z]T;W_A<1OO96<W5_+>V/AMU[>RV\MG8KY8YS=FU\=EX*VNQM'O;_1C
M_!ZFNIHW:6EAR8QM>:9I%43+!*T>I5)]^Z]T)W\X/O;IC,_\)1OY<FS\/VEL
M3+;LW+U/\!MI8+;6,W-2Y"NJ<EU'LNAIMT4:4L,CSB7;]332P9#4@%+-HAF*
MR2QJ_NO=6T?\)6^Y^H*+^2-TW25W:G75#4],[L[TC[>@KMZ8VC;:QW)OK<>3
MQW]X1+4J<,*_'5-/4TYJ_$)H)%EC+(;^_=>ZUBO^$^'>736%_P"%&ORGWYF^
MT]@879/:]5\U*+K3=V9W718K&YV;=N]:7*XN'&5M1-'3U<N1QU/-44RQR%IX
MT)C#<>_=>Z,5_P +=>S.N]S]S_ _KK;>^=IY_?O6VS?D'6]A;.PV?ILGDL''
MO2JV8V(;+4<,CSX\Y),=7-3K.B-*D+N@*BY]U[JV_P#G _"_(_S7?Y#GQ?W-
M\/\ .8?NGL'XY[)Z6[?VEM_KK)4VZFW#%@]G1X;<VWJ1J5Y6_C5-2UK5,=&/
M\HDJ:):+Q>:9 /=>Z+V?G_\ '*/_ (2KOT5-OO;X^3*?'&3X!M\83EHX^P1V
M*,@=G#!G:)!SPKUBME#!]AJ-$";AOI[KW5E7_"7K^7'VY_+W_E[9.3Y X*?:
M'<WR7[,J>Z,YL')8Y:#([=PZXR@Q6!Q&6]3R?Q)H:2JR$T+E&HSD!1R0QU,%
M07]U[JH_^>#_ "D]]=O_ ,_7^77V;TM%N/9^VOF]EL5A.Z-[;$J,KL^HQE5\
M<HEJ=Y9 Y[!Z*G'9++]:+##0?N4\E144%1_E(0S24_NO=&^_X5[_  "7O7X"
M=6?)'K':$U?O[X:[YQ>%_A.V\555U1+LGM^7'X*NHJ:CH@_F^PSD&V)X]<#"
MFIEK6C>)9)1)[KW6PW_+>^,^8^(7P?\ CAT+NW+UFY.R-I=;8.N[>W7D\C59
MFJRV\=T)_$]TY"IK:V6>LJWGS=76!))I2YB6-;*JJB^Z]UKI_-'=7\HO^;QT
MEWIL+^8QOKJ_X2_+7XR]V_+#I?J[N'M+=%)TME:R'H_>&X-N4.5VK7YP8VFW
M_@*M,;3QY7#4XKY*#*I54BQPU<=-5R^Z]U7!_**W!\I/Y?O_  FT^=W=V?P&
M_P#;^9^4/84>R_@MM"3'H^3K\K\@<?@M@XG=.#H*V8)]E79G)+5TWD@7[J'$
M25L,-73U-,:CW7NMX+X/_&O#?#OX?_&SXO8)_/2='=-[%Z_K*XA%:LR&&H8A
ME:]Q$!'Y,AE&K*E](TZY3;CW[KW6E=_*=Z6R7PQ_X5F?.[IG?!^RD[3V/\H-
MW]6U%=')CER>*[@SNW.Q\5]@9?)]^]-A4JX9VCE*B:BK+LKP21#W7NMNW^:7
M_+^V5_,U^$W;WQ,W=E(MLY/=M%1;AZTWS+1FN_@&Z]J.:K!Y1HE(DEI5J-5/
M6QQLLDU!454,;H\@=?=>ZU4/^$_7=N[/Y'&]OD=_+?\ YJ^!3XE;=[![2_TN
M=%?(/L:M.(ZZS^77'4N$S-+1[RFCCP'@R&+PV&K*.:6NA9!%44];'2U02#W[
MKW5M'\\+^:CTP/A_W7\+_A7OG%?+?YP?*G8F5Z0V3TI\7\NG<F;Q&+[0I$H\
MWN#,KMDY)L+3TNWLA*])YVBGGGJ:.2)12^:J@]U[I&?\)G_Y*6[_ .6)TIO;
MN_Y(X_%T?RV^2&+P5'FMJTDD.2?9.U<8WW=-MN6MB>2*;+5]:R5>6^WE:F62
M"BI4:5J-IY?=>ZHK_P"%@G7_ &-U/_,K^!WS?R6R<SF.B\1U%U;U^NX\;3RF
M!MQ],[^W7NZNPE15F$T=%65^'SE)+0I+-KJ5AKGCC*4<S#W7NFK_ (58?S .
MHOGW\5?A-O[XP8+L/=GQWH^V=_U%-\@-X]?Y_J7&9;.5F%IU;!;=QNZ,1BLK
MG$QU,DLF0RD$ QD,ST])2U%;.U6*'W7NMF+HK#Q_,O\ X3,;+ZG^/&;V]V-O
M/>/\HK#_ !^PN/VYG:3+K_?3;?5$&W*K;E3+332QTF3I\]3/13P2LLM--=9X
MT964>Z]U0+_PCY^1^T_CWB_F5\0=_;4[0I/E#N?N+KG-[?Z;'66<2N\%!056
M,R4N7JC0&AVS!A94\E?+F)Z)8XV18?/4.L!]U[H!O^%LW9G76[OD7\*-C[4W
MUM'<N\>NNM>Z%W_MC ;AI<O781MPY;!BACRM-3RR2T$M4<?6^..=4=A"Y"V%
M_?NO=;3W\QOY,?';)_R#ODIOO'=Y]39#9O8_P.WIUYL#<M%O_%U5'F<_NW9+
MT>-P>,FCJ62LR]755$,24<1:HUM8QBQM[KW5!G_"+;<O5^Y/CM\^?C_N+>6V
M8-Z;^WWM.K7K^HSE+3YBLP>2VW7X^LKJ2@E?[BII8CY4DDCB=(FL)-.I;^Z]
MU"_X3^=1R_R4OYI?SH^&GS3SN+Z>H.W.O*"N^-?<W9U=#L7;6_<7T_FJFH6;
M"9BO>#%U60J,)N"&LJ*..K:6D>GJH)5$D5C[KW43^7G\2MV?S'O^%)7R*_FG
M]>8JJD^"_1W=N]LWLKN>IQGWF$WYF]G;>.Q<3!M*NE$<.2ISD::7,O74R5$-
M/3TL4#/'45=-(/=>ZV&/^%''PJ'S9_E0?(O;^"P)S?:'1>+B^2?5"TF';-5Q
MK^I8YJO+45!#$/N9:O+[8DSM##%#=Y)YX;1RLJQM[KW0"?R+/Y==)3_R(]J]
M!?)+^-[BJ/G#T[O7<?8M#F\[E<M+CMJ]V8V6AVMB,<:^2&HP\6+VC)BJF.DH
MQ3P463GJYJ8F61JJ7W7NJXO^$E?\N?MOXR=A_P P;?W>7\:@J>E>]-U?$#K[
M;]>N2HL>N:V=+33;YW)C**K,=(8\U34^SX(*^*G,M134[Q&;Q(%;W7NK[?YB
MWS$^./47>71OQ"^;'7>!W+\0_E]T7\C\AV+OG>NV9=P;9V]5=0Y#9%/%-NR8
M4LU-A]MU5/NN2*;,U%33P8NN.-,LL2U?W$'NO=:BGPK_ )>'3/57_"EGH<_R
MB^Y*+O[X>=8[+3OGN;L[K/LBB[?V[L3'[SQ^[,/5[&R6[,96STF4ER;TM##1
M4\E94U[)D%>=9ACZVHB]U[K8?_X5E;IQ>W_Y*/?>)R$\457OGLWX][6PD<CE
M#+54F[\7FW1 $8,PHL/6/8E!I1CJ) 5O=>Z,Y_PG<^-FZ?BS_)\^''7^^:>M
MH=X[KV=G^Z<]BLA02XN>B'=N8K]S8^AGII[305-'B,ECXIT=583I+=$/I'NO
M=77^_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[H@_\R?_ +)=S?\ X=VS_P#W)/MV'XNJ/PZ*O[OTUT+?\J?_ )DQ
MV%_XD^?_ -U6-]UGX_ETZG#JT7VSU?KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZC4E%1
MT$3P4-)344$E36UKPTD"4R--DII*BHF*H%!EJ*B6661K:GD=G8EF)/NO=-6>
MVKM?=45-!NC;>!W)!13_ '5'#GL/3YA(I;:?)$M1'((Y+<:E -N+^_=>Z>HH
MHH(HX((XX888TBAAB01JBQ@!550 %50   + <#W[KW6&6AHIZFDK9Z.EFK*#
MS_8U<M.DDL/W2A)?%(07C\B@!M)&H<&X]^Z]U*]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=)O\ N;M#^._WH_NIMO\ O-;3_>+^!TOW
MUOZ?=^+[BW_3SW[KW2D]^Z]U%FH:*HJ*.LJ*.EGJ\>\TE!534Z2R0-4H8Y&A
M=@6B,D;%6*D:E)4W!M[]U[KJOQ]!E*2:@R=%29&AJ JU%%7TR5D,@1@P#QR*
MR, R@BZFQ /U'OW7NI?OW7ND_D]I;5S=-#19G;.W\O1T]?-E:>DR>&IJ^*.J
MJ)'FDJ4CEC=%G>621VD #L[,Q)))]^Z]U(RVWL!GH**FSN#P^:IL;74^3QU/
MEL9#D4@J:,,L-1"DR.L4\2NX210&4,0I%S[]U[IX]^Z]U3G_ #(_Y;&3[Z[E
M^-O\P3XNQ[7VU\__ (69U<OUO5[AJ!M_%;_VQ.:A,QUUNC*0TU14T5'DJ"OS
M$&.R AF&+FR%6Q@DAJIM/NO=6>=.=D5O:W7N WEF.N]_=2;BKJ6.+='6G9>)
MCQF7P>2A1/O,;42TLU7B\DM+*Q1*_&Y"LQM6H$U'5SPL']^Z]TOLMAL/GZ&;
M%YW%8W-8RH %1CLM0Q9*"2WTUPS*\;?[%3[]U[IKV_LK9NTC.=J[2VSMDU(M
M4G;^!I<-Y/I^O[:*/7^E?K?Z#^GOW7NE-[]U[IJS6"P>Y,?+B=Q8;%9[%3M$
M\^,S6.ARE.[0,'0O#.DD;%' 925X(!'(]^Z]U/IJ:GHZ>"CHX(:6DI88J:EI
M::)8(XXX%"I'&B@*B(H 50    !;W[KW6;W[KW46*AHH*FKK8*.EAK*_P??5
M<5.D<LWVJE(O+( 'D\:DA=1.D<"P]^Z]U*]^Z]U[W[KW7O?NO=,F>VSMO=-(
MM!N?;^#W'0I()DHL]B8,O$'7Z,(ZB.1 P_K:_OW7NG*CHZ3'TL%%04M-0T5-
M&L--24<"TT4:+]%2- J(H_   ]^Z]UEEBBGBD@GCCFAFC>*:&5!(KK("&5E(
M(96!(((L1P??NO=<::FIZ.G@HZ."&EI*6&*FI:6FB6"...!0J1QHH"HB* %4
M     6]^Z]UBI,?04!JC0T5)1&NJY<A6FDIDIO-/.%#SRZ%7R3.%4,[78@"Y
MX'OW7NN4M'23RK//2TTTZ4U31I-+ LCB&M,;31!B"1',88BZWTL40L#I%O=>
MZ;\)MS;^V:5Z';>"PVWZ*2>2IDH\)BX,5$TDOZI&C@2-"[?EB+G\GW[KW5('
MRS^$NY?YN7R:Z8Q'R)Z[S6R/Y='PZ[!/:-!LO?=)'097NS?M-3_:TDM1@IE-
M;A>N=O4D^0I6;(QTU=N"6JK$BHHL5]KD*SW7NKU(HHH(HX((XX888TBAAB01
MJBQ@!550 %50   + <#W[KW63W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=$'_F3_P#9+N;_ /#NV?\ ^Y)]NP_%
MU1^'15_=^FNA;_E3_P#,F.PO_$GS_P#NJQONL_'\NG4X=6B^V>K]>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]T0?^9/_ -DNYO\ \.[9_P#[DGV[#\75'X=%7]WZ
M:Z%O^5/_ ,R8["_\2?/_ .ZK&^ZS\?RZ=3AU:+[9ZOU[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U2]_,>_F49WI_Y
M$_%_^6O\4ZC;N6^=OS.SD<>%RF>BCR^,ZYV5CA5U6=WUF,?K5LC608G%9V7$
M8XE4JYJ&=ZAQ#$L-5[KW0.?SDOYB.4_D>?R\<#NWKV/=?>W??9F^H.K.NMX]
MU9RHW@LVX\W05N6RNZ]T.*BCU4M/2X^I:GQ>-2DHTJ)*2BHZ6BQD3+![KW0.
M8_I/Y"]I?,SXL[.V[_-)^4U7O#M[^5W\C^_O]F&Z_J-C3X2JSM#V)TQ_"JC'
M;)7:\VQZC:L,.Y*^*"E?'R9!J%EB_C7F:6ID]U[JRG^5IW!\T^QNO/DMUS\]
MXNOJ[OSXM?+3=_QV.^^M-JU&S,;N[;U!M#9&[MO[L..FJ*B&FJ<U0;O222.F
M\=/&%6)8DDCEO[KW5GWOW7NM6K^7?\)OYV/4G\YSY:?(+Y7=[Y?>/P=WF_:+
M;*HLEW;_ 'SQ.:H=R9.6;9=#@=G";7M>JVM01TZ5C2XK'Q)JD@HYLBD\TP]U
M[K:5]^Z]U[W[KW7O?NO=!+WOL?'=C=/=B[/RF<W[MJDRVTLXG\>ZQ['SW4N=
MI)(:>22*HQVX-M9'%9G'U$4BJRO!6I>VEPZ%E/NO=:3?_".CY??+/Y.]K?.C
M'?)3Y0_(GY"X_:/7O1U;M2A[Q[LW+VS#BYLMDMQQU<V.BS^3R"44M2D$"RM"
MJ-(L:!R0BV]U[K>^]^Z]UK._\*&OAM_.!^5U5\1YOY8';^X]D;<V1NW/R=P;
M7VEWF.BJE<ADJK$_P+<U;4FHH!F<1@X(\H:BD6KJ*B/4KTF,KI9"(_=>Z</^
M%&55WGTM_)HSG>FV_D+WMU5\G^AXOCS0S]F_'?O;=_24.2R>[]P;=V[N5JZA
MV[EL51Y:AKA6UDM.E;22O2OXWIS"?(K^Z]T'W_">?>7;'S1_D=[AR'R/^0'R
M3[#WQN'L;Y X:7N"I^1.\\;OFDBP34[X_P#A^\Z7-P[DHOL) &A2/)"$"\;Q
MO"\D;^Z]U5#_ ,(]OF1\O/DU\F/F#@?DC\J?DA\@L'MGHO967VWA>[^\=S]K
MTF/JZK/^&6JH:;/92OAI*B2']MY(D1V3TEBO'OW7NK7-V?";^=C6?\*#MO?*
M?"][Y<_RVJ:?%5K81N[?#@:7:]-@:6BR6S)NOQ-%++G:[-M65<-:N)FIK".L
MFRL=2D=)[]U[K:5]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=!CV_UC3]N[#R
MVRI-X;\Z]KZIJ:OP&^^L]T5&TLWA\CC'$M%D*.HA)AJ/MYPIDHZRGJL=71:Z
M3(T=71S34\GNO=57?RV_YD^?[J[^^4'\N7Y656U\3\\/ACN&HI]R56W8DP^.
M["V97?:5&#WWA\<#;'U%1C<KA7RV/C9XZ.HK8'A805"Q0>Z]U<_[]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z(/_,G_
M .R7<W_X=VS_ /W)/MV'XNJ/PZ*O[OTUT+?\J?\ YDQV%_XD^?\ ]U6-]UGX
M_ETZG#JT7VSU?KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KY_W\H'NC,_+O\ X5@?/_N3>PDEJMD['^4NU=A4E742
M5_V&*ZFW+M?8&'B@,K'[9FPD;/*L8">:>HTJ!(3[]U[K:;_G,_RLME?S:OA[
MDOC]F=SR;"[&V?N6#M#H_?\ XWJ:;';EQ-#74,,64IX_74X;(TE?4TU6B_N1
MAXZJ(--3QJWNO=?.\^._RQ_F4_\ ";GYV[3V[\JNI]P[ZVYL7KSLKJ+ ]7;_
M -VUU?@*S8_9N=VWF,SD.L-PQO4T%%%6Y7:6#JD*4LT$3BH@KL=35M34&+W7
MNOIK? +YW?'G^8Y\;-H_*3XVYBLK-G;OEGH-Q;?SU"F*S> SN)CBCR.#SU+'
M),D63H+PJ7CGFIZB P5-)//22PRO[KW1P,UAL9N+$9+!9JCCR&(R]'/C\C12
MEE66&I4K(C%2K ,I(N&!_H??NO=?.U_DA=W][9#_ (4H_(WH7<7?/>.\NGNO
MM_?//;.T>N]\]N;@WEB*.DV+G,GC\2D=!D<A44@>AI(ECA<0AD6X4@$^_=>Z
M"[_A77WAWI\;OYFW6.WN@.]N\>F-N;\^'/7O9FZ]M]9=P[DV5CJS/9?>_8F.
MJ\H]!C\G3TJU=31XK'QRND2E_"K-=KD^Z]T87_A4Q\>.PO@IC?AA\Q^N_EW\
MK,Q\I=Z]D[YV_P!A]D5G<.6Q%#-6XW&XW(P5>VMO453'C-FT-++3O!#CL8D=
M,U*8UJ_NJB-JF7W7NMV?^7MW=NWY*_ _X:_(+?YHVW[W1\8.C>R]]2XVE^QI
MI,UO';>.KLK+30:Y#!32U\U0\49D8I&RH68@D^Z]T9K>_P#QY>[_ /PU\_\
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M[?Z63K3,[IP4#8_&8ZLAJ]M39K#Y#& [EH8164QCGJY:F*GKZJH7W7NMUO\
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M]U[W[KW1!_YD_P#V2[F__#NV?_[DGV[#\75'X=%7]WZ:Z%O^5/\ \R8["_\
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M>7+?_7OW[_6RL/\ ?EQ_O4?_ %JZ]_7R\_@A_P!Y?_K9U[_AP_NK_GF.KO\
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MYC=V.W'D:;.Y&;&TB;<I*:KD62"/RDR"JK*-0A4<%68W_%N?9]L/+TW,+M'
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M':/_ )Y<3_\ 7OW[_6RO_P#?EO\ [U)_UJZ]_7RS_@F_WE/^MG7O^'#^E?\
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M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5S_P QG_CQNNO_  [,C_[AGW)_M?\
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MW[KW7O?NO=>]^Z]U[W[KW7O?NO=;,>S/^//VG_X;6"_]Q8O>*-]_;R?Z=_\
MCQZR(M/[)/\ 2+_@'2E]I>E'7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]T0?^9/_P!DNYO_ ,.[9_\ [DGV[#\75'X=%7]WZ:Z%O^5/_P R
M8["_\2?/_P"ZK&^ZS\?RZ=3AU:+[9ZOU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5=_P R;_FC'_E1?_D%[ESVL_XE
M?\V/^LW4;^X/_$?_ )N_]8^JN_<N=1OU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=.^W_P#B_83_ +6^-_ZW)[8NO[)_]*W^ ]/6_P#:+_IE
M_P (ZV<?>)W6177O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U7/_,9_X\;KK_P[,C_[AGW)_M?_
M +D3?\TQ_P >Z //W]A%_IS_ ,=ZJ/\ <T]1;U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]ULQ[,_X\_:?_ (;6"_\ <6+WBC??V\G^
MG?\ X\>LB+3^R3_2+_@'2E]I>E'7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]T0?^9/_ -DNYO\ \.[9_P#[DGV[#\75'X=%7]WZ:Z%O^5/_
M ,R8["_\2?/_ .ZK&^ZS\?RZ=3AU:+[9ZOU[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5=_S)O^:,?^5%_^07N7/:S_
M (E?\V/^LW4;^X/_ !'_ .;O_6/JKOW+G4;]>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW3OM_P#XOV$_[6^-_P"MR>V+K^R?_2M_@/3UO_:+
M_IE_PCK9Q]XG=9%=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5<_\ ,9_X\;KK_P .S(_^X9]R
M?[7_ .Y$W_-,?\>Z //W]A%_IS_QWJH_W-/46]>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=;,>S/\ CS]I_P#AM8+_ -Q8O>*-]_;R
M?Z=_^/'K(BT_LD_TB_X!TI?:7I1U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=$'_F3_ /9+N;_\.[9__N2?;L/Q=4?AT5?W?IKH6_Y4_P#S
M)CL+_P 2?/\ ^ZK&^ZS\?RZ=3AU:+[9ZOU[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5=_S)O\ FC'_ )47_P"07N7/
M:S_B5_S8_P"LW4;^X/\ Q'_YN_\ 6/JKOW+G4;]>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW3OM__B_83_M;XW_K<GMBZ_LG_P!*W^ ]/6_]
MHO\ IE_PCK9Q]XG=9%=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5<_P#,9_X\;KK_ ,.S(_\
MN&?<G^U_^Y$W_-,?\>Z //W]A%_IS_QWJH_W-/46]>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=;,>S/^//VG_X;6"_]Q8O>*-]_;R?
MZ=_^/'K(BT_LD_TB_P" =*7VEZ4=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW1!_P"9/_V2[F__  [MG_\ N2?;L/Q=4?AT5?W?IKH6_P"5
M/_S)CL+_ ,2?/_[JL;[K/Q_+IU.'5HOMGJ_7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U5W_,F_YHQ_Y47_ .07N7/:
MS_B5_P V/^LW4;^X/_$?_F[_ -8^JN_<N=1OU[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=.^W_\ B_83_M;XW_K<GMBZ_LG_ -*W^ ]/6_\
M:+_IE_PCK9Q]XG=9%=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5<_\QG_ (\;KK_P[,C_ .X9
M]R?[7_[D3?\ -,?\>Z //W]A%_IS_P =ZJ/]S3U%O7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6S'LS_CS]I_^&U@O_<6+WBC??V\G
M^G?_ (\>LB+3^R3_ $B_X!TI?:7I1U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=$'_F3_\ 9+N;_P##NV?_ .Y)]NP_%U1^'15_=^FNA;_E
M3_\ ,F.PO_$GS_\ NJQONL_'\NG4X=6B^V>K]>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW57?\ ,F_YHQ_Y47_Y!>Y<
M]K/^)7_-C_K-U&_N#_Q'_P";O_6/JKOW+G4;]>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW3OM_\ XOV$_P"UOC?^MR>V+K^R?_2M_@/3UO\
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M$'_F3_\ 9+N;_P##NV?_ .Y)]NP_%U1^'15_=^FNA;_E3_\ ,F.PO_$GS_\
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M7O?NO=>]^Z]U[W[KW7O?NO=5S_S&?^/&ZZ_\.S(_^X9]R?[7_P"Y$W_-,?\
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M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=$'_F3_\
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M(*TRI4^?KT&^:K^;;;7Q(6TMK45HIP:^3 CRZJ^_V=#Y+?\ /R?_ %SL!_\
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M[KW6QOT?_P R5Z@_\1=U_P#^ZFD]XO<P?[GW/_/1-_U<;J?MF_W#@_YHQ?\
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M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5S_P QG_CQNNO_  [,C_[AGW)_M?\
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M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW1!_YD__ &2[F_\
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MZ]U[W[KW5<_\QG_CQNNO_#LR/_N&?<G^U_\ N1-_S3'_ ![H \_?V$7^G/\
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M]^Z]U[W[KW6QOT?_ ,R5Z@_\1=U__P"ZFD]XO<P?[GW/_/1-_P!7&ZG[9O\
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M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[H@_P#,G_[)=S?_ (=VS_\
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MO?U0O_X!_O:?Y^O?WWV[_P K<O\ YR2?]&^_?UZVW_?C?\XW_P"@>O?U0O\
M^ ?[VG^?KW]]]N_\K<O_ )R2?]&^_?UZVW_?C?\ .-_^@>O?U0O_ . ?[VG^
M?KW]]]N_\K<O_G))_P!&^_?UZVW_ 'XW_.-_^@>O?U0O_P" ?[VG^?KW]]]N
M_P#*W+_YR2?]&^_?UZVW_?C?\XW_ .@>O?U0O_X!_O:?Y^O?WWV[_P K<O\
MYR2?]&^_?UZVW_?C?\XW_P"@>O?U0O\ ^ ?[VG^?J[K;7\PCXL8[;FW\?5[Y
MRL=7083%453&-EY>0+)2P1HX#+1E39E(N"0?Q[@&Z4RRNR\"S$?823U,5O\
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MPX"I\^BG?+=KVTDBCRS  #AY@\3U4?\ WWV[_P K<O\ YR2?]&^YI_KUMO\
MOQO^<;_] ]1;_5"__@'^]I_GZ]_??;O_ "MR_P#G))_T;[]_7K;?]^-_SC?_
M *!Z]_5"_P#X!_O:?Y^O?WWV[_RMR_\ G))_T;[]_7K;?]^-_P XW_Z!Z]_5
M"_\ X!_O:?Y^O?WWV[_RMR_^<DG_ $;[]_7K;?\ ?C?\XW_Z!Z]_5"__ (!_
MO:?Y^O?WWV[_ ,K<O_G))_T;[]_7K;?]^-_SC?\ Z!Z]_5"__@'^]I_GZ]_?
M?;O_ "MR_P#G))_T;[]_7K;?]^-_SC?_ *!Z]_5"_P#X!_O:?Y^O?WWV[_RM
MR_\ G))_T;[]_7K;?]^-_P XW_Z!Z]_5"_\ X!_O:?Y^O?WWV[_RMR_^<DG_
M $;[]_7K;?\ ?C?\XW_Z!Z]_5"__ (!_O:?Y^O?WWV[_ ,K<O_G))_T;[]_7
MK;?]^-_SC?\ Z!Z]_5"__@'^]I_GZ]_??;O_ "MR_P#G))_T;[]_7K;?]^-_
MSC?_ *!Z]_5"_P#X!_O:?Y^K</CY\Y?C=L'IS8VT-S[RR5#GL)CJRGR-+%M+
M*5BHTU942J!+#2/&]TD0W5C];?4>X6YEN%W&^EGARCL"IX5[5' T/EU*6QV[
M65I'%)AE!!''S)XCH9?^'%/BA_SWF6_] C,?_47LC\)O3_!T;:QU[_AQ3XH?
M\]YEO_0(S'_U%[]X3>G^#KVL=>_X<4^*'_/>9;_T",Q_]1>_>$WI_@Z]K'7O
M^'%/BA_SWF6_] C,?_47OWA-Z?X.O:QU[_AQ3XH?\]YEO_0(S'_U%[]X3>G^
M#KVL=>_X<4^*'_/>9;_T",Q_]1>_>$WI_@Z]K'7O^'%/BA_SWF6_] C,?_47
MOWA-Z?X.O:QU[_AQ3XH?\]YEO_0(S'_U%[]X3>G^#KVL=>_X<4^*'_/>9;_T
M",Q_]1>_>$WI_@Z]K'7O^'%/BA_SWF6_] C,?_47OWA-Z?X.O:QU[_AQ3XH?
M\]YEO_0(S'_U%[]X3>G^#KVL=>_X<4^*'_/>9;_T",Q_]1>_>$WI_@Z]K'7O
M^'%/BA_SWF6_] C,?_47OWA-Z?X.O:QU[_AQ3XH?\]YEO_0(S'_U%[]X3>G^
M#KVL=!OW#\\OC-NWJOL';&"WKE*K,Y_:.<Q.+IGV?E:8//6P/'&IDDI%C0%B
M.68 ?D^S39)!97D,TF%21&8\: $$X'1?NL1NK:6-,LR,H'#)%//JG+^^^W?^
M5N7_ ,Y)/^C?<X_UZVW_ 'XW_.-_^@>HG_JA?_P#_>T_S]>_OOMW_E;E_P#.
M23_HWW[^O6V_[\;_ )QO_P! ]>_JA?\ \ _WM/\ /U[^^^W?^5N7_P Y)/\
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MQ_\ 47OWA-Z?X.O:QU[_ (<4^*'_ #WF6_\ 0(S'_P!1>_>$WI_@Z]K'7O\
MAQ3XH?\ />9;_P! C,?_ %%[]X3>G^#KVL=>_P"'%/BA_P ]YEO_ $",Q_\
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MFVJ]_IXZ>3Z6YO;Z\7YM5H"/0_9_LTZV) ?4?ZOE7K/_ ,.*?%#_ )[S+?\
MH$9C_P"HO=?";T_P=6UCKW_#BGQ0_P">\RW_ *!&8_\ J+W[PF]/\'7M8Z]_
MPXI\4/\ GO,M_P"@1F/_ *B]^\)O3_!U[6.O?\.*?%#_ )[S+?\ H$9C_P"H
MO?O";T_P=>UCKW_#BGQ0_P">\RW_ *!&8_\ J+W[PF]/\'7M8Z]_PXI\4/\
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M'(/BQ_SU&Y?_ $#*[_KW[]].?4?S_P W7O%^1_E_GZSP?S&_BK*6$F\<]3
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M&.3UI1CHV/\ LN?Q[_Y\1TU_Z+#"?_4/MO6?4_MZM0=>_P!ES^/?_/B.FO\
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M?_4/OVL^I_;UZ@Z]_LN?Q[_Y\1TU_P"BPPG_ -0^_:SZG]O7J#KW^RY_'O\
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MRD'_ )SR_P";KW_#<7;/_*MU9_Y\)?\ ZV>_?ULV'_E%'_9/#_GZ]_5W>/\
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M(_?NO=5@_P VCIWYX=]?&'&]:? +)]"8CL>M[8ZUW1OV7Y!9[+XG%5VVNO\
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M3^[&1\5M7&ORZ-'YUZ;<V]^Z]T&_\A.7)3?R<OY>CY4U;50^.VVHHC6JRO\
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M][]U[KWOW7NO>_=>Z(/_ #)_^R7<W_X=VS__ ')/MV'XNJ/PZ*O[OTUT+?\
M*G_YDQV%_P")/G_]U6-]UGX_ETZG#JT7VSU?KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NB#_P R?_LEW-_^'=L__P!R3[=A^+JC\.BK^[]-="W_ "I_^9,=A?\
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MV;>A@$+Y;.U*5=74&Y)DGDCCAC9R3_9B10+ *  /?NO=5$_S4OG%O;X_]C_
MSX<=0=A;>Z7[A_F(]Y;CZNQ?>FY\12YZ/9VV>O:*BJMS9;$462AGPM9NVHES
M&$Q^"@R4<U$U?6I+44M7%"\#^Z]TLODC\5_F5UUT[O;?OPA^;G=M1W_M'8NY
M<IM[8?R7CP/=^S=XY*EA6=*?+4;8"BS&#KZA:=X:&; Y3'T%-43"6JQ-=$#
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ME?S)/E'T#TWOC%[=VYC<K@L#U-58VAFAP\=?A,EC7HZ?*'(4L"5^-K&@:*=
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MX[-HYY]Z[D<-3UD(K^L-K4.ZLE)%)"T4N3Q<- SJ]5&??NO=5%TW6>R>E_\
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M1P>"VA%0SXZ/%9"EI\/)/59RF@@R]?52F>:I5(Z6"F]U[H-OY07RF[EZ\_F
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M-1E*&-:.H,56YE&F J&(]U[IV_G1=*_,+']T_ S^<9_+ZZRW1WEV#\,*;?\
MA.TOC-5[<S^T-Q[NV%V;$D>0IZ/"5-+3YI*ZFIY,M&U$V#GKEEJZ2NBH:IL?
M]K-[KW1S?BG_ #'N[/YAVX]J[=ZP^!7S<^(G7> W#A<_W7W9\O=A8KI>&.#:
ME53U[[7V=C&R>4R^Z:O<4\*8^LJOX?0TM!C9*^5JB/("B@E]U[HFV/Z?[9_E
M7_SD?E!\NI.K>T.V/@=_,PVYL>J[1["ZCV/E.V<KUAV#UYKCI)]RX#!TM;G?
M[H93[[*LN1I,?5QTDM:B50IX*5I9/=>Z'ON#X^9#^9)_- _E^?)?$;/WQM_X
MN?RW,-WEV)%V!V+L3)=<'>F_.Y%P-'B,1MO%9^EH<W5X[;']VX<E7963%P4#
M3M2TN/J:V5JLT?NO=%]%?O0_\*<V[V/0'RQ7HA?Y;7^RKCO _$?LK^Z#;T_O
MB-U?8C<0VL<5]A_"B1_$S4C'?= TGW7GLA]U[I@^;U)O_*_\*,/Y5'>N Z#^
M5&Z>DOCMU+\E=D]R=O[1^)_9.Z]LX;)=H;7WMA<-"^;Q^UJG'5D4]?D*)9*B
MDJ)Z:".9)IY8X;N/=>Z4W\V:HW]DOYNO\COL[97Q]^4_9W77Q?["^4>1[ZW[
MU=\6>P^Q<)MRC[UP^S\-A*JJRN%VS7T50HFHJZ6I2FFFDI8H&:H6*X]^Z]TD
M/YC^V_G1\"?YENR?YOOP[^/^_/E_\>^X.A=E?'OYH_&WKW!9*KWG!2;=R,D^
M(W-A\.D$V2:II(*JATHN)D^S:EKHLBM-3Y!ZZA]U[JRKX5_.OO[^8+NO:^\=
MN_#'Y*_#7XY;)&8R^]-T_+C;U#USN3>&4GI):/%;?VQM>"HR56^!@>JDR61S
M55/1J):2AH:""M%76S4'NO=6T^_=>Z][]U[KWOW7NO>_=>Z][]U[JL/^<C7Y
M:M_EG_-KKG:?7_;W9W8';7QE[@ZSZ_V5TWTUNKN3)Y#,;[Q%1B,=3"DVOB,M
M+31O65L)DFG$4,,(DGED2**1U]U[HN7\A#?&X]G_ ,J3XT=4]P]&?);HKM7X
M\]>YS9/9'7G;OQJW]L3(H^W<O6M35.*CR6VJ4;@BR>.JJ&KA3%FLD7RR4S#[
MBDJ4C]U[HJW_  G4QW874VUOYF%/W#T-\GNFJCM/^8S\@OD=UY3]O?%[L'K5
M\QM'?5+BCC<C0KF=MT9GJ)C13@T*WKD8*K4X9E!]U[K!_(.P'9>P/EA_.H?L
M[H7Y+]1XSY$_S$^W>_\ I/<G;WQJWUU9B-Q;5W1GMSU%)D*'+9[;]!CA(\$U
M-(:::IBJ=,\16)KD+[KW3?\ R1L3\@?B%W__ #+_ (E=G?$SY$4&X^S/YE?<
MGR+VEW'DMAS83K:JV%V:*#[/.T^]9#+C*^KDH<:\D&,HONJV2KGAHJE*(PY*
M?'>Z]ULW;CS]#M7!93<63@S=5C\/225M73[<VUD=XUSI%]5I<7B*2NR==,;\
M14U)+*W]E#[]U[K6M_X3&[2[/ZFZ#^;^P.Y>B_D5T?NO??\ ,5[\[^V=C>\/
MCOO;IU,EM3L/";.I,5DJ2KW)@L91S/-48BO1Z5:@U</C!F@170M[KW6S!DLA
M!BL?69*JCK9:>AII:J>/&XRIS-0RP@L1#24<4]54R$#TQQ0O(QX522![]U[K
M3U^(G;N\>BOY\?\ -A^6G97P^_F(X[X]?(C:/5FR^H.R<#_+O[HWA39>JZNH
M-NXJM=*3&[(J,G#35,F,JY::>2A6&6)0PD >+R>Z]U<OW+_-3J)=IT^V/C%\
M//YA'8?>'8.X,!UWU\=]?R[>Y>J=JX/([UJHL=3[EWCGMV;/P&.H-JX&2H6L
MR4BUAE%+#)I"+JFC]U[JKWYJ;8^6?\JS^;;1_P T?J/XW=R_-#XM?)SXX;)Z
M!^9N Z%V?#NW>^-S?5\>-HL7NU\12I')62S8[%8Q89;P4-DKJ.LJ:+5CG?W7
MN@H_F'?(+/\ R6_FN?\ ";3LR7H/N;H39.4[^^4;[*Q7R%V_!U_N[(BHH>M9
M:RJJ]JQU-=5X+'QAJ2.F_B%3!7U$HJS)CZ:FBI:FN]U[JPC_ (4)=0]V[@ZV
M^ OR?Z8ZEWOWK'\"?YB?QY^6?:'5?5^#?=&Y\AM;KNJEGR,N#Q<;))DJJ"5*
M96@5U(BE>=G2&"5U]U[HFG\[KN#O'YN_&W^7AV'\5?A5\L=^;9V#_-)^+W:Z
M;>W7TQFNMMWY:39.'WS-(M'M/+4D&4QFWZ9$D2MSV:3%XN*2HH'IIZNDDJ:J
ME]U[H6/^%/N"[B^2O\JS&=1]-?&3Y1=A=Q]B=R]6;JH>JNNNB,]V_E,=C]KS
M9*:KJ,U4[*IMR83&!(TB*I+E_*QGB0)Y/(L?NO=*S^?SLSM7NWI'^6Q\I.BN
MC>]^X]L?%S^8E\=?DIVIUSL[I_/0[YI]I;=>H>NKHME9*BH-RR5%+.*6&:F_
MAGG@\_W$Z14D%340^Z]U?[TOV3E^X-B4V_<MU?OGJ?'Y^JGDVUM+M+'K@=QM
MC!'$L57F\+ZWP-553?<E*":>2JCI1!)6+2U4LU#2^Z]UKL_ [X+=F]!?S6OE
M?\:,3DHY?Y>'1W9>U?YCO1NS:>IK(TPW8'RAPVY=LIM0+'.,><%@VIMTY6GQ
M1@M1U"8+)E#/-#/[]U[K:!]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=:I?_  I[Q_:O;^Q_@KUGT7\:_E?W[N;JKYQ];?('L+_0?\7=
M^]H4.-V[L#&Y.GJI7RV)V]4X:6JGDRT(AIX\BTSF.6Z (Q'NO=7$M_-/Z-6%
MI!\>_P"96[B,N*=?Y57R*#D@7T GK41ZB>.7"W^K6Y]^Z]TKOB=\H.Q.YNI^
MR_D]W!TQW[T1L;-=@9_!]/\ 1G8?1NY*+?U%M;KT''C,YS9U#C*_<<66W/EX
MLO6P4Z43C^$G$"-&E>22;W7NBU?RA(J???P+S/3?;?2G>'7M5N3N7YZY/>/6
MWR'^/F[NG9:G;O??<78&YL='-%N?"XZFJXLIMC=6.=XH9I2/+-"XUP3!/=>Z
M(W_(H_E6]\?!3M?Y58SOS.9W.]+_ !D[J[KZH_ETX',_<5R4FR>\9-O;LW'N
MBCD'AAK9L_!2[7H)6%$[T.4H-QTE-4&.KJ1+[KW0.=HYGL9?^%1'1_R=QWQ;
M^:F;^-FW_A?5_&G=7>^(^&?9M3MG&[DR;;LRT1DK_P"ZP%5B[Y'&TCUU*D]-
M%4U%I)%A@J98?=>ZVT:2ICK:6FK(5J$AJZ>&IB2KI):"4+.H=1+!.D<\,@!&
MJ.2-70W5U5@0/=>ZU4_^%/>/[5[?V/\ !7K/HOXU_*_OW<W57SCZV^0/87^@
M_P"+N_>T*'&[=V!C<G3U4KY;$[>J<-+53R9:$0T\>1:9S'+= $8CW7NKB6_F
MG]&K"T@^/?\ ,K=Q&7%.O\JKY%!R0+Z 3UJ(]1/'+A;_ %:W/OW7NBQ]M];=
MO?SD?Y9GS@V%OGJSL'XVTWR/IMT[)^,G4GR0Z[J^M]PXB'IRKI:G;6X=W83(
M0C(8RLW!O;$RY",%#X,,,5-"C3B22;W7NBW_ ,J/^9-\P_\ 11UM\#_E#_+5
M^:^U_F1T#LG:_4N7W]D>MZ;#]7YFDV=!'B*#<V1[ GJH,504STU-%-7-04N3
M^Y EEP4>6D84:>Z]T%/_  E$V]/NW^1Q+M2FJ(J2IW-VW\EMO4]5.I=(GS0@
MIDD<+ZBB-("0.2!Q[]U[I[_D&]P=V_%GX5;)_E@=C?#?Y083Y9?%_>W>.TJ_
M(;EZDRNVNM*ZCWCO;-;GH]RIV7-"^W7P(CW'IM3R396KCI97QF+KP8VD]U[I
M2?\ "80=T="_RG=J];?(;XO_ ")Z3FZXWEV_NG'Y3>G6U2M1G<7NG-MD::;%
M;7I'J=\3SN];5QI&=KA9HJ7[B"62*HIC+[KW77_"8G:G:'5/0'S<V%W/T1\C
M>BMV[^_F)=]?(#:&)[T^/&].GER&U>Q<'LVEQ>0I:O<.#QU!-)+48BO22F2J
M:JA,8,L*+)&S>Z]TR_R1L3\@?B%W_P#S+_B5V=\3/D10;C[,_F5]R?(O:7<>
M2V'-A.MJK879HH/L\[3[UD,N,KZN2AQKR08RB^ZK9*N>&BJ4HC#DI\=[KW1M
M/^% ?QUW+O\ ^%]'\L^EJP;>^5_\NO?F!^6OQWW+3QRM//4;+J(#G=L.M.\5
M56T>Y<6K0MCXI <A5PT=,5<.4;W7NK*?A5T_N?I?X[[.PO8DD=3W%O>NW/W-
MWM7Q5D^0CEWOW/DJG<NYHJ:6IDEG_AN.R>2FQ^-B+Z:;&TE'2Q*D,$:+[KW1
MK/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U2[\S>\*KLKYR?#
M;XIY+HGY5YGX\;&W]E_D=WUVYM_X?=A;ZV55;FZ=@-3UGM";.TNSLAB9J;^]
M+Q[EER-+5F&EK-OX>E^XOD)?#[KW5S=4\,=+4O41O-3I!,\\4=,]8S(JDLJP
MQJ[REEN BHS-^D*2;>_=>ZT[_P"2_G.R?Y>W\P_^8C\/*#X@?-G _P N_O'Y
M [A[B^*O<LWP8[0P6V\+G*P04U?AI7_NE :';\] E+CZ'(2T<=&$PE/(9A!6
MI+[]U[HR7S?Q_8.4_P"%&G\J7O' ="_*/=72GQZZD^1^RNXNX=H?%7L;=NU\
M+DNUMJ[TP^%ADSV.VQ4XNJCFKLC0K-/2U,]/2I,LM3+%&'9?=>Z5G\W?9/</
M7_\ -3_DQ?/#;/Q_[X[VZ,Z$S?R3Z^[@'Q]ZQK^V,Y@ZGN+;T>+P-358+&K)
MDEH:J>IJ-=2:<4\!IFAFFCJ*BDAG]U[IO_FX]4_S ,1V=\%_YPOPAZ(S.]NZ
M?BC@>S]J]Y?#6MK3F=P[DZX[/>&I?'0Q8IJA9=P4='#4FJH<=%DIX,E54[4/
M\7&+"5WNO=&M^)G\S3Y%_P P[<^U]H=8?R]_F#\0-GX'=&$RW?'=GR]VA2=5
MT-#C=N2I5U>WMF4$DM5E-V9W.5<"XR1VH*"DQM!-65\]0*R"DQ]7[KW1/)L_
MO>D_X4WU7?\ 5?';Y<M\?HOY<H^*,'>-!\/>T*[:IW@-WINDTCYN/:1H30?9
M>2,9*.63&^?1#]WK+!/=>Z>/^%"^ [(["["_E-8GJSHGY)=QS=+_ ,R#H[Y#
M=J5_3'QNWSVWC\'M+855%_$LE7Y3;V R.-BDC%2A2E^Z-7*J2M' RQ.1[KW3
M1_PI=PO9'>?QH^#&WNBNA/DYW?N'9W\P[X_?(;=."ZC^,F_=_P!5CMJ;#P6]
M*;)5]?%CMO3FAGAJ,I0QK1U!BJW,HTP%0Q'NO=*O^9_OONC9G\Q+^5;\MLA\
M;_D]\D_Y?_7V'[D&^=D]1=3;LW9E-K;_ -XX^:FVYO+</6U/0QYNNGQE*%CH
M&R6$ QDCU<U*T.2DI8JGW7N@9[?C^359_P *'OA-\X*/X1_)NOZ4WM\"NPOC
MIM:HH-GQ553C,KB,MO#-05N_Y_.N&Z^H\@,_2+!%D<L]:L;1M/2Q59GH*;W7
MNA>_FY[([IZ]_FH?R7_G=A/CYWCWCTOT%F/DAU[W3%\<^NJ_N3+X&M[AV[%B
M\)/-B,;'_$I,;4U-34WK#2)3Q?;&.:2*HJ:2&?W7ND-_PIIP_>GR=_E.X/JS
MJ_XM_)+>W=_9O<?5V\Z#I_JGI;<W=^2Q.)V_49.J:3<-;M/$93#XFNAHA2_=
M4S9!UBK)C2TT]=%&*N3W7NMCK(8[KSY*]+Y_;>ZMIYC,=7]S;"SVTMU[*[+V
M#E-DU59AM[4,M#D,=EL!N*@H,E2?<4=3-%-3U=!&UF963W[KW5%?\B7X??*+
MXVXKM3J#Y0MELEL3X'=F]U_%7X19S.Y*:OJLSLG?>:I=W5FZ*AC**>HCJL?+
MMC&XTK10G&P4>0H(/'$\L">Z]U&_G9=#_.'KKY _#7^:]_+[Z\F[Y[2^&F,[
M,V'W;\:J 5-1D=Z]?=BBFGKJ;#T]+Y*BIK:/PY +!2T=56M45%%5TU+6-0&C
MJ/=>Z'OXF?S-/D7_ ##MS[7VAUA_+W^8/Q V?@=T83+=\=V?+W:%)U70T.-V
MY*E75[>V9022U64W9G<Y5P+C)':@H*3&T$U97SU K(*3'U?NO=7>>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[I =K]7[
M([MZO[%Z;[+PE/N7KOM;8^ZNNM\[?JN(ZW$[SH9\=D*9B.5\U+42J&'J4D,I
M! /OW7NM8;^79#\F?Y!E/O[X,?)SI?Y _(OX'_Z1]T;_ /B9\Q_CAU!DN]#M
M[&[P::NR.V-_;3VC05VY\/)'60RUHKDQ=93/65U1'',:9H$I?=>ZO#Z_^=NU
M/DC!58CXJ]<=_;NS;O%1S[T[A^,'8WQKVIA!6K4*,E79#L?;6SY<]'2/ 0^/
MP*9&O>1X(YDHJ>5ZZ#W7NJ>O^% 6-[7S'_#3VS]B=,_*CY*9GH'^8?\ '#Y*
M]T[IZ8^+6]NUQ3;9ZA2HBR^8JZC:.V:O!1UU2]<9%QT%2M4[!A3TIC1BONO=
M;+VVMPT&[,#B]QXNGSE+C\O2K5TE/N7;&2V77HC$BU5BLQ24&3H9;@WCJ:.*
M0"Q*V()]U[K6J_F@_"OMY/YG/Q7[@^+.>DVA1_S(MC=A_P OGYX8[$UM;BYJ
MG9.+P59N5MY4<F.GIY:/<6'VWB,OCZ7+N2U+/_":2*2)ZH%O=>ZO<^46)QF
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MMGYBKW'UQ0T>%J:+:^TDH*K<^X:2U%5SRU<6,B1-=+3TZ5D[UJX_W7NB)?\
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M/4T@AH8YFK:@)+X:=A$UO=>Z</\ A4;MWL?Y(?RO8.F_CYT9\D^[^SM^]O\
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M)+H'"^1P6L.!>WOW7NIGOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[H@_\R?\
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MCB<3%*E/6U=)C\?C:>FI*N=JJOEG]U[HX/RLQ>]=R_';NC9/7FQ\IO[>._\
MJWL+8FWL-CLQB<#&M9NS#UE!335E7EZ^@AAHHYYT,SQ^>94N4@E(TGW7NJ__
M .15\7>_?@W_ "V.@OAW\C]@Q;5[+Z4G[?3+9O!;LQ&[\)DH^P-\[CW51R8Z
MHH:V2M!BI,]%#,M3CZ?3-#+H,D9C=_=>ZN$]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW1
M!_YD_P#V2[F__#NV?_[DGV[#\75'X=%7]WZ:Z%O^5/\ \R8["_\ $GS_ /NJ
MQONL_'\NG4X=6B^V>K]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T0?^9/\ ]DNY
MO_P[MG_^Y)]NP_%U1^'15_=^FNA;_E3_ /,F.PO_ !)\_P#[JL;[K/Q_+IU.
M'5HOMGJ_7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=$'_F3_ /9+N;_\.[9__N2?
M;L/Q=4?AT5?W?IKJ'_+P^0W3/3_5V],%V3OO';5RV2W]+EJ&BK*.LJ6DIVQU
M#")0:>FF0#RQ2+8L#Q]+6/OTJECCTZ<1@.C_ /\ L\/Q4_Y_'@O_ #U93_ZA
M]M>&WIU;6.O?[/#\5/\ G\>"_P#/5E/_ *A]^\-O3KVL=>_V>'XJ?\_CP7_G
MJRG_ -0^_>&WIU[6.O?[/#\5/^?QX+_SU93_ .H??O#;TZ]K'7O]GA^*G_/X
M\%_YZLI_]0^_>&WIU[6.O?[/#\5/^?QX+_SU93_ZA]^\-O3KVL=>_P!GA^*G
M_/X\%_YZLI_]0^_>&WIU[6.O?[/#\5/^?QX+_P ]64_^H??O#;TZ]K'7O]GA
M^*G_ #^/!?\ GJRG_P!0^_>&WIU[6.O?[/#\5/\ G\>"_P#/5E/_ *A]^\-O
M3KVL=>_V>'XJ?\_CP7_GJRG_ -0^_>&WIU[6.O?[/#\5/^?QX+_SU93_ .H?
M?O#;TZ]K'7O]GA^*G_/X\%_YZLI_]0^_>&WIU[6.O?[/#\5/^?QX+_SU93_Z
MA]^\-O3KVL=>_P!GA^*G_/X\%_YZLI_]0^_>&WIU[6.O?[/#\5/^?QX+_P ]
M64_^H??O#;TZ]K'7O]GA^*G_ #^/!?\ GJRG_P!0^_>&WIU[6.O?[/#\5/\
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M64_^H??O#;TZ]K'7O]GA^*G_ #^/!?\ GJRG_P!0^_>&WIU[6.O?[/#\5/\
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M64_^H??O#;TZ]K'7O]GA^*G_ #^/!?\ GJRG_P!0^_>&WIU[6.O?[/#\5/\
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M64_^H??O#;TZ]K'7O]GA^*G_ #^/!?\ GJRG_P!0^_>&WIU[6.O?[/#\5/\
MG\>"_P#/5E/_ *A]^\-O3KVL=>_V>'XJ?\_CP7_GJRG_ -0^_>&WIU[6.O?[
M/#\5/^?QX+_SU93_ .H??O#;TZ]K'7O]GA^*G_/X\%_YZLI_]0^_>&WIU[6.
MO?[/#\5/^?QX+_SU93_ZA]^\-O3KVL=>_P!GA^*G_/X\%_YZLI_]0^_>&WIU
M[6.O?[/#\5/^?QX+_P ]64_^H??O#;TZ]K'7O]GA^*G_ #^/!?\ GJRG_P!0
M^_>&WIU[6.O?[/#\5/\ G\>"_P#/5E/_ *A]^\-O3KVL=>_V>'XJ?\_CP7_G
MJRG_ -0^_>&WIU[6.O?[/#\5/^?QX+_SU93_ .H??O#;TZ]K'7O]GA^*G_/X
M\%_YZLI_]0^_>&WIU[6.O?[/#\5/^?QX+_SU93_ZA]^\-O3KVL=>_P!GA^*G
M_/X\%_YZLI_]0^_>&WIU[6.O?[/#\5/^?QX+_P ]64_^H??O#;TZ]K'7O]GA
M^*G_ #^/!?\ GJRG_P!0^_>&WIU[6.O?[/#\5/\ G\>"_P#/5E/_ *A]^\-O
M3KVL=>_V>'XJ?\_CP7_GJRG_ -0^_>&WIU[6.O?[/#\5/^?QX+_SU93_ .H?
M?O#;TZ]K'7O]GA^*G_/X\%_YZLI_]0^_>&WIU[6.O?[/#\5/^?QX+_SU93_Z
MA]^\-O3KVL=>_P!GA^*G_/X\%_YZLI_]0^_>&WIU[6.O?[/#\5/^?QX+_P ]
M64_^H??O#;TZ]K'7O]GA^*G_ #^/!?\ GJRG_P!0^_>&WIU[6.O?[/#\5/\
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M64_^H??O#;TZ]K'7O]GA^*G_ #^/!?\ GJRG_P!0^_>&WIU[6.O?[/#\5/\
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M64_^H??O#;TZ]K'7O]GA^*G_ #^/!?\ GJRG_P!0^_>&WIU[6.O?[/#\5/\
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M64_^H??O#;TZ]K'7O]GA^*G_ #^/!?\ GJRG_P!0^_>&WIU[6.O?[/#\5/\
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M64_^H??O#;TZ]K'7O]GA^*G_ #^/!?\ GJRG_P!0^_>&WIU[6.O?[/#\5/\
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0OW7NO>_=>ZV&/9?THZ__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>tbarchart_007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tbarchart_007.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &0      04  DE$_]L
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MZ:P.!EK\9F5D2LQ4S0T*D8FJ21TEHETTLB$(\)4*![KW2BZ=^"?P@^.^\/\
M2%\?_AO\5>C-_?PJMP7]^.G?CSM'K+,?8Y,QM4T?\3PF(H:W[6H:&(R1>?QR
M%$+*2HM[KW2(W1_+&_EL[WW#F-W;T_E[?![=^Z]Q5]1E=P;GW1\3MA9_(UU5
M5G5+4UE;5X"6IJJB5N7DDE9V/))/OW7NCG87"X;;>(QFW]NXG&8' X6AI<7A
ML)A:"+%T=)34*".&GIJ:!(X8((8U54C1%1% 50 +>_=>Z![O+XQ?'7Y,XS;V
M'^0G2/5_<U#M#.TVZ=GKV+LN@W3+A\G1!A#DL3454,E1C*^(,P2HI98IE!(#
MB_OW7NN/1OQ@^.?QEQVXL5\>^C^KNF:3>.;GW-O$]<[*H-K39G)55A)D<O4T
ML$=3E*Z0 :JBJEEE/Y?W[KW6B!_PN,R^,G[*_ET8*&NII<QC-D?)?*9#')(&
MEAI\S7;)BI)9%^JI424-6J'\F)_Z>_=>ZW"=G? S^7E\GMJ] ?);L'XF_&#N
MKL"MZGZFS^W^WMS]1X#=E?7008>@FQE3+D*BBE?(I!&(FIC4-+X0 (]%K>_=
M>ZLG@@@I8(::FABIZ:GBC@IZ>",1(B1 *B(B@*J*H     %A[]U[HD_=7\M/
M^7Q\CM_GM3OCX6?&;MKLB2.&*MWOOOIO![@R58E-;Q+D*N>C:7(K$.$%4TH1
M256RD@^Z]T<7$[>V_@,%0[7P6#P^%VUB\=%B,;MW$XR#'4-/20)XTI8*2%$I
MX:=(_2L:1A OI"VX]^Z]T"G3'Q,^+?QRK]W97H#XY='=)Y3?^1J,MO?)=5=5
MX38-1EJBI=I'DR$^+HJ:6K];NP61F52S:5%S?W7NL/3_ ,0_BG\>]U[VWUT-
M\:^B.F-Z]DU#U78&[NK>IL%L/)9EY)GJ&_B5;BZ&EJ:Q34RRS%9)&7S222V\
MCNQ]U[H+,W_+._EP;FW17;XW)_+\^$>X-ZY3*G.Y/>&;^*6P\ME*BN+B0UD^
M0GP,E7-5&0!O*\QDU -JOS[]U[I\[+_EZ? /N?=,V^>X?@[\/NV-[5%!CL74
M;P[+^-&R]]Y22FP\2P4E,^0RF$JJMH*6!5CAC,Q2) $0*H ]^Z]T9#K_ *\V
M!U/LS;W7/5FQMG=:=>[1H%Q6U-A]?[9HMFX;&4J,SBFQ^+QT%-0T5.'=V$<,
M"("Q-KD^_=>Z@]D]4]7=R[5R&Q>W^MM@]K;)RT%13979W9.SL=OG%5,=7&\,
ML=1C\I355),DL,CHZO"0R,RD%21[]U[HGW_#3O\ *R_[UI_ #_TC?KK_ .QS
MW[KW7O\ AIW^5E_WK3^ '_I&_77_ -CGOW7NCK[*V1LOK7:.W.O^N=H;7V!L
M/9V'H=O;1V3LK 4FU<1BL?BT$5-0XW&T,4%'0T=/$JI%##"D<:@*B@"WOW7N
M@*[D^$OPQ^16:H]R_(+XC?&'O7<6/2HBH,_W)T'M3LZM@6K$*RK#59O$UT\2
MRBG@#A9 &$<8-]"V]U[KW3?PE^&/QUS59N7X^_$;XP]%;BR"4\5?G^F^@]J=
M8ULZT@F6)9JK"8FAGE6(5$X0-(0HDD MK:_NO=#!V5U5U?W-M.OV%W!UOL+M
M?8V529,ILSLK9^.WUB:E:B&6GD%1CLI3U5','IYYXF#PF\<DB&ZNP/NO=%,Q
M7\K+^6-@LIC<Y@_Y<OP/PV:PU?1Y7$9?%?$/K['55)58Z19J>IIJB';R2P5$
M$J(\<B.KHZAE((!]^Z]T>/&XW'8;'4&(Q%!18K$XJBI<;B\7C:5*&GIJ>A18
MH((((E6*&&&)51$10J* J@  >_=>ZF^_=>Z"'N'X^]"_(?;XVEW_ -(]0]Y;
M55XY1MGN'K7#=F8\-#+'.C"BS5%6TVI)H89 ?'<.B./4JD>Z]T 6T/Y9_P#+
MAZ^W)B]X["_E_?"39&[L'-+483=6T/BGL3;62HY)XWA=Z6NHL##54[O#)(C&
M.5249E)TL0?=>Z6O</P9^$_R&W'3;Q[^^'GQ9[RW=1X^#$TFZ>X?C[M+LS)1
M4E* L5-'79K$5M4E/&% 6-90B@  "WOW7NFS<'\O[X&[MV)L[JW=7PE^(VYN
ML>NY\E5=?]<[@^-NS<S@<%+F"#628;$5.%DQ^,DJB!YFIJ>(RV&LM;W[KW0D
M](?&/XV?&7%YW!_&[X]]'_'S"[HKZ;*[EQ'2'4^!ZHI<C5449AAJ:ZGP-!01
M5=1%$2B22H[JA*J0./?NO=!3OK^7E\$>SNYL?\B>Q?A[\;][]YXS(XK,TG:N
MZ.GL%FLW][@G22AK9*ZHHGEGK:&2.-Z>HE+S0,B-$Z%%(]U[I=X'X@?%':_8
MV\^X<!\:^BL9VYV+G#N3?G:<'56$.Y,Q7>K349'.-1-E*MX@[B(253+$&81A
M Q!]U[I;=S=&=,_(KKG-]0]\]6["[AZNW']B<WL'L;:U'N[%5#8N9*BDE>BK
M8IH1/25$44L$JJ)()422)D=58>Z]T"F"_E[_  0VWTU4?';$_#3XO1]#UN?I
M=UY+I^LZ*VSEMN5F5H2Q@RE;B*O&ST5;DH-3".JGADGC'I20* ![KW2OV-\-
M_B/U=UEV+TMU=\7OCWU?U!V]CLWB.U>L.M>F]O=?X'<=-N7'MB<A#F\5A\=1
M4636MQ;M23?<0R&2G/A8F/T^_=>Z"[)?RR_Y=N8[:HN^,I\'?BI7=Q8_+XW<
M5)V)4=$[;?)KDL,\4E'DS/\ P[UY.CDA@>"K934PM'&T<JF-"/=>Z.S6T5'D
MJ.KQV1I*:OQ]?33T5=0UL"54,T-4ACEAFBD#))%(C,K*RE64D$$'W[KW0!](
M?$GXL_&>LW9D?CM\<NCNB\AORO?)[TKNI.K<)U[-E)I'\EZZ7%45*]0BO=D1
MV*(Q)15)-_=>Z"/='\L;^6SO?<.8W=O3^7M\'MW[KW%7U&5W!N?='Q.V%G\C
M7556=4M365M7@):FJJ)6Y>225G8\DD^_=>Z.=A<+AMMXC&;?V[B<9@<#A:&E
MQ>&PF%H(L71TE-0H(X:>FIH$CA@@AC552-$5$4!5  M[]U[K6!^(G\__ &W_
M #(O]GN^)S]$8WI#Y+;3W3D.B/CWTWO_ ';%NW([S'8-1G=N2UN5V_+04%93
M1;,:@-?NV!8JBDH,=(1)5 \O[KW6QKT#TGL7XV]']1?'[K'&_P )Z]Z6ZXV=
MUALV@,CSNF/V5008^F::65Y9IZB6. /-+)*\LLK/)([NS,?=>Z%SW[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW576P?^WI7=W_B,,3_ .Z7:/MYO@'V_P"?J@^+JT7VSU?KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JK_\ ED?\
M>[WO_P")4;_K0WMZ;R^SIN/JT#VSTYU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW0,;F^-_QXWKG<ANC>70O2^[=RY:2*7*[BW-U=@\]75+01I$C5%75
M4,M1,R11QHI>0D(JJ.  /=>Z6NQ^NNONLL348'K;8FS>OL'5Y&7+U>%V/MBB
MVG22U=1'##)524U!!3PO4/#3P1M(4+E(XU+:44#W7NEE[]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z1F,ZXZ]PNZ
MLOOK#[#V9B=[[@C$.>WCC-KT-!E:Y%((2KR$4"5=2H('$DS#CW[KW2S]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW576P?^WI7=W_ (C#$_\ NEVC[>;X!]O^?J@^+JT7VSU?KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MJK_^61_Q[O>__B5&_P"M#>WIO+[.FX^K0/;/3G7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW2"[,[5ZOZ6V=E>Q.X^R-A=3=?X)$?-[Z[
M,WACMB8:C62^DU63RE12T5.&L;&2=;^_=>Z+QUG_ #$/Y?\ W3OC ]8].?.?
MX=]L]D[JEK(-L=>]9_)K96_,YDGQU--65"4&)Q6;JJ^L>"CIJB>014[E(8I)
M6LB,P]U[HTFZ]V[5V)MW+;OWQN;;VS=IX"D:OSNZ-UYJFV[CJ*!2%,U76UDD
M--31!F4%Y)56Y OS[]U[HM/5'S\^"/?.\J/KKHWYK?$GN?L'(4U56T&Q.J/D
M?L[L7,SPT(#3RPXO#YFLK98H5(+LL!5 06(O[]U[HVWOW7NO>_=>Z][]U[KW
MOW7N@U[4[FZ?Z+VQ-O?NWM?K7IW9E.\B3[N[4WUB^O<6C0QO,X>OR]51TBE8
M8Y'(,HLBLQ]*DCW7NBKXW^:A_+#S.1H,/A_YCOP-RN6RM;2XW%XO&_+[KVNJ
M*FHKI%B@IZ>"+<+2S3S2LJ(B*6=B%4$D#W[KW1WL)G,)N;#XS<.V\QB]P8#-
M45/DL/G,)D(<M1U=/5J'BJ*:I@>2&>&5"&1T=E8$$$CW[KW3I[]U[KWOW7N@
MJ[6[SZ9Z+QN&RW<O:>P>KZ#<F8@V[MF7?.ZJ/;;9/(5-O'08R*JFCER-<X-Q
M!3I)+INVC2"1[KW15*7^:_\ ROZG&0Y>7^8E\),513Y')X=#N/Y0[+VM**O"
MB$UE*]/DLU25$=32BIIS-$\2O&)8RZC6M_=>Z.AU_P!A[ [8V9M[L;JS?.SN
MR^O=W4"Y7:F_.O\ <U%O+#9.E=F05./RF.GJ:&MIRZ.HDAG="5(O<'W[KW2P
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5
M76P?^WI7=W_B,,3_ .Z7:/MYO@'V_P"?J@^+JT7VSU?KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JK_\ ED?\>[WO
M_P")4;_K0WMZ;R^SIN/JT#VSTYU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U'JZ2EKZ6IH:ZFIZVBK:>:DK*.KA6IBEBJ5*212QN&22.
M1&*LK A@2""#[]U[KY&_\SW^7!WG\'.P]T_S-/BM#5[-Z&B_F(_-[K_:>0ZL
MQ8V\.I,_\?.[MZ;:VCCUCIB5I<+78S!T/\+J%B6GCJ89L;4+$7H!6^Z]UO\
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MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW576P?^WI7=W_ (C#$_\
MNEVC[>;X!]O^?J@^+JT7VSU?KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[JK_^61_Q[O>__B5&_P"M#>WIO+[.FX^K
M0/;/3G7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U\_[_A2AW1F
M>V_YZW\IGX=982?Z+NOM\?&C=5;C9:B2:"MRO?O95+CLE+-2%A3R+!B,#C8H
MF*ZQY:E-01[>_=>ZWHOD#T=L#Y,=&]N?'GM2@JLEUQW7UUN[K'>M)05;8^I.
M.WG0S4-2]+4*"U/5Q1S&2"4 F.54< E??NO=?*U^</\ +R_F4?\ ">GOK#]B
M[#SFY.P?B-1][]/=N]?=D43UN0V1N'+=);JH-U[/Q_8NWJ.K@3'YZ@R>(HC:
M1H14(TZ8K(%9:F*+W7NM\[^2I_/.Z$_G ;)S^-H]KOTY\I^J\-25O9_3>2K1
MEX9<?DGBB.?VMDRD;Y'!35:QQ3Q21Q5E!4>**JB>&2BK*OW7NKV_?NO=?./_
M .%%G:W<?Q^_GI?&7KKI7NWNWK+KKLG9OQ@WMO+KW9O;VXL!@JS([KW[G\;E
M)I,339&.ATY&DQ].M0G@T2G47!#$>_=>ZN4_X6';QWSTU_+]Z%[CZ>[![$ZF
M[/D^8VP>LZG>O6._LQL&NGP.:V5V+E*C%U,V)K:0U-(^0Q=#.$DU!9(@RVNU
M_=>ZJGP/QKWS\F?^$KL'S?[W^7/ROWSVSU;L?NC>_35 .Z,SC,3BH]D]P9VA
MGAS=&M6YWAD,E+1U!&1RTD]1CZ7[&CQ@I(Z$M4>Z]U=9_P )*/EUWA\K/Y9>
MZ:3OG?&=[)W%T'\C=X=.[1WENK)5.<RL^W%V_MG/T%+DLA5SU%373X^KS>1@
MAE=AHHEI*< ^#4WNO=;1'OW7NOFL=Y;4S>^/^%G64VEM[?>X^L\GG>[=B40W
MOM""CFRE# W1^,:L./-?3U=+!5U%&L\$50U-(U,\HJ(U,L2>_=>Z'G_A1%TS
MV+_)+[[^%/S=_EY=S_(S861['R?8FV.V3V'\B]U]WTF5S&P1AZ[%19J'>.>S
M&0S-%GJ')YY:NFF>:BC^U#HM)/-$S^Z]U;S_ #PODC6]^_\ "=W _P P7J[,
M[YZ;[-W?U_\ $KM?9V?Z]WODMEY7"-W%N#:T&:Q KL56PRRTPCR5732(TS*Y
MC1SR/?NO="!_PF![+[&[:_DP56\^U-_[V[,WA5]J?(FCJ]U]@[JK]YY*6&@2
MGC@BDKLC/4U3QP1@+&IE*HOI4 <>_=>ZU\_^$0__ &5=\W/_ !7K8?\ [TGO
MW7NDOW;_ -QJ.%_\6M^/W_OK=M>_=>Z-K_PLI[*[7^./;'P?W5T#W'W)TME>
MVMJ=^CL5.KNU\_L2FRTFQZG9Z8VHJZ7&9"F@EJ:>+)U48D,>HH54FRCW[KW5
MPG\XO^9_V?\ RV/Y*OQ\[*Z?R4\/R-^0&P>B.F>M-\Y*@CW'_!*O<.T%RV:W
M-.E9*(ZBNI,7CJQ:-I4J5&3J:2>HIJFGCGC/NO=$*VM\.<'B/^$VE=\^Y^P^
MWH/YA=5\89?E_P#[.^>T,SE.RS7X;+3[KQF$.Z:BMDR1VVV,(QTN-:9J8I45
M-48S7RO4GW7NK/O^$]/\PO='\V_^6UE5^3JINKN'J/>F2Z'[BW%! -O?WDBI
M**ARN%W$%Q\D7VF0JJ"LABJG@^WOD:.HJH(X(Y8HT]U[K4;_ .$P^ZOE+\\O
MGAW1T+W!\W?ENO557\->Q]P[_P 50]Y[BJ\CD\=1[QV#1-C<7EJO)3U6UZJJ
MGR$'FRN-\626A6LH::HIOOI)X_=>Z-#_ "M>V>W?@K_PI][1_E]=;]R=L[O^
M+F_NY/D+UIG=B]H[\R6_-=/C-JYK=^%R.NLJC&V=QV3Q]' ^2>)JFHHFJHYB
M\E09%]U[HV?_  H?_F'Y7XZ?SCOAEU3\L]K;^[#_ )9VU^FHNP.S/C_MBLJL
M-C=]U/8R[NV_7UN8A6JI*+=$.WJB/$2_PJJE:E:.GFIY$ R,I?W7NK^?Y;/7
MOQU["[YS?SM^"?R5W3W#\,N[_CS2;#Q?4.3[7SF[L/UYNG;F:Q];+0X+;.>J
MI:K9:Y6@F<UN(%/3"DJ:/4(8X:F%%]U[JH;_ (6JXX8SX2_#?L[$U-5B-Z[(
M^8M-CMK[BQ=1)05U#_'-I;@R$DM)5PNDU-*M7@L=*KHP<20QNK*R#W[KW6SA
M_+Q[[SGRD^"/P_\ D5NB*.#=?<OQRZAW_NV.!F>,9?/X2CERIC+@,8FR!J2E
MQ?21R?J?=>Z./[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NJNM@_\ ;TKN[_Q&&)_]TNT?;S? /M_S]4'Q=6B^
MV>K]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=5?\ \LC_ (]WO?\ \2HW_6AO;TWE]G3<?5H'MGISKWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z^?%_PHZZKSO6?_"A+^4[\CLW'X^M
MNS=S?$_%X[*M*J6R/1W:<4N?IO6(HD6FQV=P,VIIB+U+:BBJ/?NO=;M/ST[X
MW)\6_A3\K/DEL_'T&6W3T/T%VEVU@,3E"5IJJJV#B*K)PTTY"N5BG>F",P1B
MH;4%)%C[KW587SF^0OQH_F"? 3X:=K]5;CV9W+T1W=_,,_E<TV:Q50:;-P/1
M;H[JV739;;VXL;(9/M:N!9*JBR./JXE>.19H)H^&'OW7NJ'_ .3-\&MN=;_\
M*3_GIOGX8X*7_9#_ (V8GL3KF7>VW,M_%]N4NX.Q<=MZ>HV)0Y#SE:Z?#9U\
MR/MD:H-##BXEJF1VI7E]U[K?1]^Z]U\TO_A4?7T*?S__ (<R/6TBQXSJ/XAK
MDI&J45:<IV/NJ<B<DVA(@DCD.NUD97_203[KW5V7_"U>>!?Y7'Q_IFFB6IE^
M?764\5.9 '9*?KOM%9'5+ZF1&EB#$"REU!MJ%_=>Z+C\=LIC*;_A$EN4U.1H
M:<1])_)W%R&>KCB"U.1[UW6M/3G4PM/.T\ CC/K<R1A0=:W]U[H:/^$3LD9_
MEU?)Z(.AE3YJ;AD>,,"P678VR K$?4!BC@&UB5-OH??NO=;E'OW7NOFW]M[I
MP?7_ /PM"FW[N^M7![+Q'R0Z7VYF=T5RF&@HJOL?J#";?PL=95-:"E%?E\A2
M4\;2R*&=[ FQ]^Z]T?#_ (6.U6Z?D'O;^6A\#.B-IU7:OR"[*W[VQO7&; VM
M6)5Y:/[N'!X7"1R49LD-)E9*C-RM65%1!3TL.+J)IF$"S2P^Z]T=;^>YT#1?
M$3_A,)6_%]LW#EJCI/KSX3]2OEY)%B_B5?LS=NSX*ZH@2R7^YFI:NH5 NI8K
MD\(Q]^Z]TZ?\)1:^AA_D;9">:MI(H,9VY\EVR4TE2D:4XBBI9V,[$@1!8720
MZB+(P<^D@^_=>ZHN_P"$1513I\M?FM2O/"E34?';9,L%.TJK(ZT^Y4$C(A.I
MEC,B:B 0NI;VN/?NO=)'N[(X\?\ "TG#U1KJ/[5?EOT#1-4_=)XQ-'UIMNF:
M$OJTB45(,12^H2_MVU<>_=>Z,7_PN0J*=M^?RWZ19X6JH-H_*.HFIEE4R)'5
M5FPUBD9+ZE21H90K$68HX!)5K>Z]U8#_ ,*(_ASV/\KOY$GQ [0Z>Q,V\,K\
M5]F=%=T;DP6%IGRM55[4RNQHL5F:RA6#5YAC/NJ"OFL"/LJ>IE!N@#>Z]TIE
M^1'4I_X1V?WN;=N+7$_[(,WQW!6MA:7^]HJ#L@8CQF0-]T<W:\=O(*?]_04%
MS[KW0D_\)%?AUV=\5_Y;^^.VNZ-O3;&R7RF[9E[8V?B,XL^-K(]F[<P]%C<1
MD<C!5+$M'_$JF/,5=.-%I,=)1U1E99TCA]U[K6Y_X16SP1?S4.]8Y9HHI*KX
M"]J04R22!#(Z]A=6RE$!(+N(XY'L+G2K-]%)'NO="7T5D<?5_P#"TG-5=+74
M=32_[-O\AZ'[FGJDFC\U-UIN:FDAUJQ7RQU*-$R7U+*#&0&!'OW7NMM#^8EU
MG_+K_F=?(C>7\ICY@XO';>[RPW06R/D-\<>QJ7(T6 W-''V!D=PXC)OLZOJ/
M*9LAAJG;='-D,9+32TU;1U,+M!4+3U#4ONO=:Y__  GA^*?R,_E\?S\/FY\&
M=J]C93L_H#IOJ+*#NK=.#AJ*7;E9+FHMN978]574Z-4T%%NR-<M-3"!JC[A%
MBS<43214U0![KW1W/^%L^9H(/@#\4]OR3(N4R?S#H\S1TYD0,]/@ME;K@J7"
M%A(PCDR-("50JI<!F4L@;W7NME'^6)TONKXZ_P NOX1](;ZB2FWOUI\8.F-L
M;RHHV,BTV6I,%1MD:56*H76EK'FA#%06"7(%_?NO='H]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW576P?^WI7
M=W_B,,3_ .Z7:/MYO@'V_P"?J@^+JT7VSU?KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JK_\ ED?\>[WO_P")4;_K
M0WMZ;R^SIN/JT#VSTYU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=50_P XK^5OL7^:W\2\ATKD\XNP>X=B9R'LKXZ]MH)]6WMT8N)XD^Y%-)'-
M-B<K3/)2UD8+% T-;"C5=%3%?=>Z&WX0?(+=7??3M-UI\F.O,IUG\K>L=OX_
M8WR5ZBWMB *>MR-!314M5N;;E1(KX_=.Q=SO>IQ^2HI)Z<"9\=6?;Y.DK*.#
MW7N@'[__ )(?\M/OFJQF6;XE] =:[B/;G6':&^-P]<=,;;VY/NFFZ^W-C=SU
M^V]P10X]*7)83=E1C8Z?,QST\CU4$LQ+"=EF7W7NK+NM.K>L^F-EX7KCJ#KS
M9'5G7VVZ9:/;^Q^N]JT.R\111( !'2X['04U) M@.$B%[<^_=>Z7?OW7NB4[
MV_EK?RZ.R]V9W?O8_P !/A3V!OG=-?)E=S[SWM\5]B[KRV1JI@ ]37Y&OP4]
M965#!5!DEF=R +GCW[KW2T[&^#WPK[AP>SML=M_$#XN]I;:Z[Q[8GK_;W8W0
M&T][T."I7+,:;#4F3Q-53XRG+,Q,=-'$ER3;D^_=>Z:(_P"7]\#8NL:CI.+X
M2_$:/IJKW'#O"JZDC^-NS4VQ+EZ=#''E),",*,4^11"56I-(9E4D!P/?NO=*
MGI#X;_$/XRY;.9[XW?%;XW_'W.;FQU/B-R9KI#H[;'5%7D*2ED\T5+75.!Q=
M!-5T\<W[B1RNZ*_J"AN??NO=&0]^Z]T!6>^+_P ;]U8_N+$[IZ'ZCW-C/D)7
MTN3[UH-Q]?8O.Q;OJ*#'4N(IY=QI54LJY=J;%T5)2P_<B3PP1)'%I50/?NO=
M)+I;X3?$3XZ[NSW8/1_QOZ=ZS["W10T.*W%V#M?8M#1YZLH\7!%34U%49IHG
MR<E%!3PPQQTYJO"B(H5 %%O=>Z5G=_Q;^,OR:H\)CODC\=.B?D%C]LU,];MN
MA[OZBV_VO#CYJI-$LM#%GL?7I22R)Z6:)49EX)(]^Z]T@-K? 3X)['V9O3KC
M97PJ^)6S^O.R*>.D[$V'M;XX[.V_A<_%"4*19K%TF&AH<I&ICC(6I@E *J0/
M2+>Z]U"ZU_EY? +IG=='OSI_X-_#WJC?..BF@Q^\^M?C/LK8N6@2IMY$AR.+
MPE+61+)I&H+, UA>]O?NO=)F3^5]_+0ES[[JE_EW_!>3=$F7;<$FY)/B3L!Z
M]J]YON37-6';YJ#6&H/E,QD\AD]>K5S[]U[I4]E?R]O@+W/N8[T[A^#WQ [8
MWB<9C<*=V=E?&G9>^\G]GAH_%1TGW^4PM55?;4L7HAB\NB)/2BJ./?NO=#]U
MKU+U5TSLS']<=/\ 677W5'7F)22+%;#ZUV9C=BX6F68!76GQ>+IJ6AA5E4 A
M( "  ?I[]U[HK;?RR?Y>#[K;>K_"?XQON)]^GM5ZANFL&U.=T,_D.Y30&C^P
M.X#)ZOXC]M]YJ]7FOS[]U[HW^[-E;-W[M;+[&WSM+;.]-D[@Q[8G/;.W9@:7
M<>*KJ1[:J:LQ]9%-25-.=*WCDA9#8<<>_=>Z+#UM_+O_ )?_ $UN['=@=0?!
MGX=]4[\Q"5,>)WMUM\9=E;&R]*M:ABF6GR6+PE+60++&S(X290RDJUP;>_=>
MZ3T'\L'^6G3;AAW=3?R\?@U3[LI\U'N2#<\'Q+V#%D4R,4XJDKTK5V^*E:U:
MD"43B42B4>0-KY]^Z]T*_<_P]^*7R,DW#-W[\<.DNYZC=6V]J;0W!5=G]9XC
M>\M3C-B5N6R.%HWER-)42+#B<AGLS4T@1E-//6U,L15Y68^Z]U+Z)^,WQ@^'
MFQLUM;X[=)]/?'78%15U&ZMT8_K39>+Z]HJBHI:=8Y<GE9*.&G%5/%20(C5-
M3([I#&J%Q&@ ]U[JDOM?X@5W\X_^8=\?_D5VEMS=.W_Y=G\O?*9G+=*8+=^+
MK=L2]R]C5E=25%5N6DQM2T$[=<8.;#8B.AKZFD1=PF&J-"M3@JX5=1[KW6QO
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>ZJZV#_V]*[N_P#$88G_ -TNT?;S? /M_P _5!\75HOMGJ_7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW57_\ +(_X]WO?_P 2HW_6AO;TWE]G3<?5H'MGISKWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[JL'YW_S6NAO@-N[HOKOL+8W=N\=[_(CN38?2
M'7S;3ZORM-MI,OORNIJ.(9'>F0I:;;,34L=0:B6CI:^LR9ACD=*!D1W7W7NK
M/O?NO=$ P?SJJ.W,SW)#\6.@.P/D;LWHG=.X>O-X]FX;=&WMAX/+[JV>)US6
MU]F3YO(02[ER.#J8H:6OK/#282.LG^R@R]364>3IZ'W7NA;^('S"Z6^;W3T/
M<O263S+8NCW/N?8&]]G[NP[[9W%M;<^QZIZ+.;9W)BI&>3'9C%5:%)4$DD,J
M&.HI9IZ6:&:3W7N@Q?YST&^.X.Z^E?C5U!O+Y';C^-K1X?O+<&W-PX79>!P^
MXZNGIZVGV72Y7-5E-%E=VM03^>>FA04F/!BCR-?233I'[]U[H:_B]\H.I_EY
MU-1=O]09.OJ,*,_N796Z=NY^@.&S.W=R;(JWH,]MK/T!9VH,UA:^*2"IAUNE
MPLL,DL$D4K^Z]T8?W[KW1#7^<]!OCN#NOI7XU=0;R^1VX_C:T>'[RW!MS<.%
MV7@</N.KIZ>MI]ETN5S593197=K4$_GGIH4%)CP8H\C7TDTZ1^_=>Z&OXO?*
M#J?Y>=347;_4&3KZC"C/[EV5NG;N?H#ALSMW<FR*MZ#/;:S] 6=J#-86OBD@
MJ8=;I<++#)+!)%*_NO=&']^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO==:5U!K#4 5#6Y :UQ?\ H;#_
M &P]^Z]UW[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>ZZ9592K ,K JRL+@@_4$?D'W[KW7?OW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJNM@_]
MO2N[O_$88G_W2[1]O-\ ^W_/U0?%U:+[9ZOU[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U5_\ RR/^/=[W_P#$J-_U
MH;V]-Y?9TW'U:![9Z<Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZUCO^%,__'H_RD/_ !L7\3O_ '&W![]U[K8J[B3=TO4?:<77X8[\DZXWPFR0
MID4G+OC*H8T Q6E!^\\/Z#J_U/-O?NO=4#?\)3^RMO[O_D\=1=?)7ANR^B^U
M_D3U_P!T8+(&2++X_/9S?&=W.B9B">U5%5RXS/T#7E4%K%"?)'(%]U[HLW\N
M[L9^C?YLW_"F.AZZ?Q];;'I^K_D53[1H-*XM-WU&U\WE\_D(J1:AZ:+(9G*2
M59KID"R5CPQFITF&../W7NC-_P#"53'U&0_E%[*[>STZY7L'Y%?(+Y,=S]I;
MLJ KUV;S^1W9786JRF2E$:&:MG@P=*C,2WHCC ( T+[KW2%_E:[VRVROY]7\
M^?XU8B8P]:9//_'KY%TF AC2"FI=R;PVYBVS]?'&%+"IS+YB%JI]=I6I8W9=
M7OW7NMBSNG>U3UKTYVSV-10K45FP.L]^;VI(&4.'EVKBJJOC0J2 0S0 6) -
M^2/?NO=4&_\ "53'U&0_E%[*[>STZY7L'Y%?(+Y,=S]I;LJ KUV;S^1W9786
MJRF2E$:&:MG@P=*C,2WHCC ( T+[KW2%_E:[VRVROY]7\^?XU8B8P]:9//\
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MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JK_P#ED?\
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M_P"N7OW]6MM_Y1+;_G!%_P! ]>_?]]_RDS_\YI/^@NO?[-U\K_\ O)[Y#?\
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M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UM[?\
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MNO=7@_!+_LGW$_\ AR[F_P"MX]X_^X?_ "4V_P!)'_QWJ9.2_P#<%?\ 3O\
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M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NMO;_A.)_V3_\
M(7_Q,6&_]TE/[QJ][O\ <ZW_ .:!_P"KC=3O[5?[AS?\UO\ GQ.MC+W"G4H]
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW576P?^WI7=W_B,,3_ .Z7:/MYO@'V_P"?J@^+JT7V
MSU?KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[JK_\ ED?\>[WO_P")4;_K0WMZ;R^SIN/JT#VSTYU[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=4#_+K_ +*,[._[66'_ /=90^\C^2O^27!_I6_ZN/U!_-/_ "4)OM7_
M (XO1;_8IZ#_ %[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5X/P2_P"R?<3_ .'+N;_K>/>/_N'_ ,E-
MO])'_P =ZF3DO_<%?]._^'HX_L#]"SKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NB)?S ^TO
MEUL+IK&[8^!&Q>O>P?EUV5N[!8+K>@[>CJCM'$XO&5,%7N?<6YY**MQ]5#BL
M?B%>FB:&I,K9.NQT4<%09#"_NO=47_)+Y _\*AOBI\?.Y/DKVL_\F>'KOH[K
M;=G9^[X,'2]H5^1FH]I4<M9)1X^"6HIJ>?(UAC6GI8Y*N&*2HDC1YHT)D7W7
MNMD7XMYSNG<_QMZ(W/\ (ZAVMBN^]S=2["W'W#A]DT%1C,10[BSN-IZO*T&/
M@JZBKJ8Z6AJYI8$\E3(Y$>HL;^_=>ZIF_F=?S6^X?CU\OOY?OQI^,6(VGF-J
M=H_S#?C)\7OE[VGEQ3YZ/#-W-5XVI38.-I->I-R5NULC_&*VJU"3$4LN&_;D
M.81H?=>ZV$??NO=%%^8W<7>O6/7^'VW\5>L-K]N_)SM3-2;4ZFVUV%N"IVEM
M3&FD@>JRFZ-WY.BIZNMIMN8"C37)%2T[U=?6S4.,IS"];]S![KW5 'RD_F*?
MSF/Y1>\.H>Z_YANW_B)\FO@9OS>6W>N>V>P_BKL;=6S,_L.OW.Y\>0J:7)U5
M<9L?%'!/X&>"6.NETT334%9/1I4>Z]UM84=92Y"DI:^BGCJ:*NIH*RDJ86U)
M)%4J'C=3^5=&!!_H??NO=2??NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:8W_"BG_LMCJ__P 5
M:V3_ .];O?WE![*?\DJ7_GK?_JS!U 7NI_R4(_\ GG3_ *NS=4(>Y@ZC3KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NMO;_A.)_V3_\ (7_Q,6&_]TE/[QJ][O\ <ZW_ .:!_P"KC=3O
M[5?[AS?\UO\ GQ.MC+W"G4H]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW576P?^WI7=W_B,,3_
M .Z7:/MYO@'V_P"?J@^+JT7VSU?KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JK_\ ED?\>[WO_P")4;_K0WMZ;R^S
MIN/JT#VSTYU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=4#_+K_ +*,[._[66'_ /=90^\C^2O^
M27!_I6_ZN/U!_-/_ "4)OM7_ (XO1;_8IZ#_ %[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5X/P2_P"R
M?<3_ .'+N;_K>/>/_N'_ ,E-O])'_P =ZF3DO_<%?]._^'HX_L#]"SKWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>ZJ _FC$]Z]B? [^7S0,:JE^3GR3P_;_ 'A04]4%
M9>K_ (:M2[ZSR5<7(:@SFZ:?96#D#W61<E(BHQ!:/W7NCL?*?NO<_6N VGUY
MU)00YWY&=\YFOV#T?B:S$5.9Q]!54U*]5E-W;C6F ^UVKM#'@UM=++- E54&
M@PM/,,EE\?%+[KW6OS_.-Z2VO\?,E_PG^ZTVO59',&A_G<_%'.[JWCGO%)EM
MQ[@W5GGR.?W+FIH8XHZC+Y[*U-5653K&D8DE,<*1PI'&GNO=;5OOW7NL9BB,
MJ3F.,S1QR11S% 659BA=0UKA7,:$@&Q*J3]![]U[JEK^<KTN?GEL3IO^63@*
M>>OJ_D7VYUQV5WOEZ.UMI=5='YJFSN>SM5,&5Z6JS>4H<9@,0J,)JFMKI9(U
M:EH<A)#[KW5T%'24V/I*6@HXA!245-!24L*DL$CIE"(H+$DA54#DD_U/OW7N
MI/OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NM,;_A13_V6QU?_ .*M;)_]ZW>_O*#V4_Y)4O\
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MNO>_=>Z][]U[KWOW7NO>_=>ZO!^"7_9/N)_\.7<W_6\>\?\ W#_Y*;?Z2/\
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MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K;V_X3B?\
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MW[MM_P#?4?\ O"_YNO?73_[\?_>V_P _7O[^[Y_Y[3=G_H1UG_7[W[]VV_\
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MZ][]U[KWOW7NO>_=>Z][]U[KWOW7N@)^3G_,@>U?_#3K/^AD]B'E/_DI6_\
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MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T*/1__,ZNH/\
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M]^Z]U0/\NO\ LHSL[_M98?\ ]UE#[R/Y*_Y)<'^E;_JX_4'\T_\ )0F^U?\
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MNO=:8W_"BG_LMCJ__P 5:V3_ .];O?WE![*?\DJ7_GK?_JS!U 7NI_R4(_\
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MW7O?NO=>]^Z]U0/\NO\ LHSL[_M98?\ ]UE#[R/Y*_Y)<'^E;_JX_4'\T_\
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MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO="CT?_S.KJ#_ ,2CU_\
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MWOW7NO>_=>Z][]U[K;V_X3B?]D__ "%_\3%AO_=)3^\:O>[_ '.M_P#F@?\
MJXW4[^U7^X<W_-;_ )\3K8R]PIU*/7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U5UL'_MZ5W=_
MXC#$_P#NEVC[>;X!]O\ GZH/BZM%]L]7Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZJ__ )9'_'N][_\ B5&_ZT-[
M>F\OLZ;CZM ]L].=>]^Z]U[W[KW0*_(KL?+]1]*[_P"Q<%245;E]L8JFJ:&F
MR(<PL]75T]-=_&R/Z%G+"S?J O<7'NRC4:=:8T'5=O6VT_YC?:.Q-K]A;?\
MD3L*CPN[,5#E\=2YA%IZI(YRP"SI!M*HB5_2;A9W'^U>W3H4TH?]7Y]4%3TM
M_P#0M_,S_P"\DNL/^2W_ /L,]ZU)Z'_5^?6Z-U[_ $+?S,_^\DNL/^2W_P#L
M,]^U)Z'_ %?GUZC=>_T+?S,_^\DNL/\ DM__ +#/?M2>A_U?GUZC=>_T+?S,
M_P#O)+K#_DM__L,]^U)Z'_5^?7J-U[_0M_,S_P"\DNL/^2W_ /L,]^U)Z'_5
M^?7J-U[_ $+?S,_^\DNL/^2W_P#L,]^U)Z'_ %?GUZC=>_T+?S,_^\DNL/\
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M@>O?U5L?]]+_ +T__077O^&VOE-_S\7I_P#\_F7_ /L:]^_KON/^_F_WF/\
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M\R__ -C7L1?UWW'_ '\W^\Q_] ]$O]5;'_?2_P"]/_T%U[_AMKY3?\_%Z?\
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MU[_AMKY3?\_%Z?\ _/YE_P#[&O?OZ[[C_OYO]YC_ .@>O?U5L?\ ?2_[T_\
MT%TY8;^7E\N-O9C%9_#]G=0T67P>2H<OBJU,SE)##4XV59H)0K[99&,<J*P#
M*5-K$$<>VI^<+ZY1HWF8JZE6&E,JPH1@>8/3D/+5G ZND2AE(935L$&H/'UZ
M'_\ T+?S,_\ O)+K#_DM_P#[#/8;U)Z'_5^?1Y1NO?Z%OYF?_>276'_);_\
MV&>_:D]#_J_/KU&Z]_H6_F9_]Y)=8?\ );__ &&>_:D]#_J_/KU&Z]_H6_F9
M_P#>276'_);_ /V&>_:D]#_J_/KU&Z]_H6_F9_\ >276'_);_P#V&>_:D]#_
M *OSZ]1NO?Z%OYF?_>276'_);_\ V&>_:D]#_J_/KU&Z]_H6_F9_]Y)=8?\
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MU&Z]_H6_F9_]Y)=8?\EO_P#89[]J3T/^K\^O4;KW^A;^9G_WDEUA_P EO_\
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M[S'_ - ](/ZD[9_RCI^UO^@NO?\ #$&9_P"5'H;_ -"S<_\ ]9O?O]<G>/\
ME*D_WF/_ *!Z]_4G;/\ E'3]K?\ 077O^&(,S_RH]#?^A9N?_P"LWOW^N3O'
M_*5)_O,?_0/7OZD[9_RCI^UO^@NO?\,09G_E1Z&_]"S<_P#]9O?O]<G>/^4J
M3_>8_P#H'KW]2=L_Y1T_:W_077O^&(,S_P J/0W_ *%FY_\ ZS>_?ZY.\?\
M*5)_O,?_ $#U[^I.V?\ *.G[6_Z"Z]_PQ!F?^5'H;_T+-S__ %F]^_UR=X_Y
M2I/]YC_Z!Z]_4G;/^4=/VM_T%U[_ (8@S/\ RH]#?^A9N?\ ^LWOW^N3O'_*
M5)_O,?\ T#U[^I.V?\HZ?M;_ *"Z]_PQ!F?^5'H;_P!"S<__ -9O?O\ 7)WC
M_E*D_P!YC_Z!Z]_4G;/^4=/VM_T%U[_AB#,_\J/0W_H6;G_^LWOW^N3O'_*5
M)_O,?_0/7OZD[9_RCI^UO^@NO?\ #$&9_P"5'H;_ -"S<_\ ]9O?O]<G>/\
ME*D_WF/_ *!Z]_4G;/\ E'3]K?\ 077O^&(,S_RH]#?^A9N?_P"LWOW^N3O'
M_*5)_O,?_0/7OZD[9_RCI^UO^@NO?\,09G_E1Z&_]"S<_P#]9O?O]<G>/^4J
M3_>8_P#H'KW]2=L_Y1T_:W_077O^&(,S_P J/0W_ *%FY_\ ZS>_?ZY.\?\
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M*N#3RZUD=7!^V.G.O>_=>Z][]U[KWOW7NJNM@_\ ;TKN[_Q&&)_]TNT?;S?
M/M_S]4'Q=6B^V>K]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=5?\ \LC_ (]WO?\ \2HW_6AO;TWE]G3<?5H'MGIS
MKWOW7NO>_=>Z!/Y&=;YSM[I3?W6^VJO$T.<W3C:*CQ]5G)YJ:D1J:LIJAC,]
M/!4S*I2%@-,#G40+ 7(LITFO6F%1TX=#;!S'5W3O7O7NX*G&UF:VGMVEQ&1J
ML/-+44KR0,Y+0//#3RLGJ%BT"'_:??F.HUZ\HH.A<]UZWU[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=$T["^.^]=V?,#J3Y 8[*;6AV;L+9R[>S&,K:VKCR<DP;<!U4T,=#)2O%
M;*T_+UL;>F3T\+K<#T4CJM,UZ.7[;ZMU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=,6Z,949O;.
MXL-2O#'59?!9?&4TE0S)&LE?3R1(7*J[! S@L0I-KV!/'O8QUHYZ+C\.NC-V
M_'OJ.;8.],CMW)YB3=N:SPJ=L5=36TWAR,5+&BEZNDHI?*# ^H>'2 19CS:T
MC:C7K2BG1J_=.K=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW1-/E!\=]Z]U]@_'7=>U<IM;'X[J
M+>-?N'<D.X*VKI9IX:JMP-2JT*TU#5I+*$Q=0")9(5U-& Q!8HXCZ01Z]5(K
M3HY?MOJW7O?NO=>]^Z]U[W[KW576P?\ MZ5W=_XC#$_^Z7:/MYO@'V_Y^J#X
MNK1?;/5^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NJO\ ^61_Q[O>_P#XE1O^M#>WIO+[.FX^K0/;/3G7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW576P?^WI7=W_B,,3_ .Z7:/MYO@'V_P"?J@^+JT7VSU?KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[J
MK_\ ED?\>[WO_P")4;_K0WMZ;R^SIN/JT#VSTYU[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U2M\B_\ A07_ "N/C!V%O[KCL/N[=F;R/5&Y_P"X
M_:>Y^K^F]U=I;<V[G(Y##/A,IN/"8JLPT68HYP(:FCCK)*BGGO3RQI.DD:>Z
M]U:MTIW=U)\CNK]H=T]%]@[9[1ZKWYC!EMI;WVCD%R-%60ZFC?2P"O%-#*CQ
MS0RHDT$J/%-&DB,H]U[H'-Z?-3I?:G9N\^FL%#V%VYV?UGMBEWAVEL_I/KW)
M=G5&V*')*DE"N<?'Q/3T>2R<#//18OS/E*R"*2:FHI(U#'W7NAJZ=[DZQ[_Z
MXVQVWT[O+#[]Z\WA1R5F!W)A96:-_MY'@J()HI%CJ*2MHZF.6"JI:B**HI:B
M.2"HBCEC=![KW547R+_X4%_RN/C!V%O[KCL/N[=F;R/5&Y_[C]I[GZOZ;W5V
MEMS;N<CD,,^$RFX\)BJS#19BCG AJ:..LDJ*>>]/+&DZ21I[KW5JW2G=W4GR
M.ZOVAW3T7V#MGM'JO?F,&6VEO?:.07(T59#J:-]+ *\4T,J/'-#*B302H\4T
M:2(RCW7N@$^9O\PGX<_R_=@R=B?+/O79O5.+DBD;"8"NJFR^>R\B!B(,-@*%
M*C+Y.4Z3<P4C1Q@%Y7C168>Z]T;/;6>HMU;<P&Y\:M0F.W)A,5GJ!*M%BE$&
M8@CJ(A*JLZK((Y%U .P!N 2.??NO=/?OW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z!WO_Y!=+_%GJ'>O?/R#[%VUU3U'U[CHLGNW>^ZZS[2EIDJ
MIHZ:FA155YJJLK:N:"FI*6"*6IJJF6*GIXI9I$1O=>ZK'Z!_G[_RQ/D3WMMG
MXV[8[IW5L/M_?,%'+L+;/>'3^Z.E%SC9-E2C@QM7N/%T%++4U[,121/+')5L
MK)3K*X"GW7NK>MV;LVQL/;&X-Z[UW!AMI[/VGALCN+<^Y]Q9&+$4&/H,1$T]
M565E5.R0T]-3PH[R2.X55!)( ]^Z]T3W:O\ ,,^.&Z).IZZ6L[#V?L?OO/#;
M'1_:_8?6.9V+M;=.0K&E&-I,=F,E2P14\V>BA>;#"N2C&8B*-C#5>1 WNO=&
M [_^072_Q9ZAWKWS\@^Q=M=4]1]>XZ+)[MWONNL^TI:9*J:.FIH455>:JK*V
MKF@IJ2E@BEJ:JIEBIZ>*6:1$;W7NJQ^@?Y^_\L3Y$][;9^-NV.Z=U;#[?WS!
M1R["VSWAT_NCI1<XV394HX,;5[CQ=!2RU->S$4D3RQR5;*R4ZRN I]U[JSCO
M_P"072_Q9ZAWKWS\@^Q=M=4]1]>XZ+)[MWONNL^TI:9*J:.FIH455>:JK*VK
MF@IJ2E@BEJ:JIEBIZ>*6:1$;W7NJQ^@?Y^_\L3Y$][;9^-NV.Z=U;#[?WS!1
MR["VSWAT_NCI1<XV394HX,;5[CQ=!2RU->S$4D3RQR5;*R4ZRN I]U[JYKW[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U4Y\OOYVG\N_X1
M]E[EZ>[G[:W+D^R=A8+';F[/VOU+U;N+N!]I468BCJ*.7==1M_'5U%MYZNDE
M2IBAK:F*=J9DJ/%X987D]U[HY7Q+^8OQL^<W3F%[Y^+/:N [9ZSS4KT1RV'$
MU%4T-; D<D^-RV.K(J?(8K)4ZRQF2FJJ:*559'"F-T=O=>Z=N[OD_P!/] 9;
MKO:N^LWD:SL/M[.R[<ZIZLV9@JK>>YMPU-$$DK7QN'H(YJEJ#%T[BHR%=*(J
M&@@_=JZF%2NKW7NLG2OR9ZI[XR_8.T]GY',XGL7J7+4&%[1ZKWUM^JV7N7 R
MYB'[C'S5V)KDCF;'92F!EH:^G,]!6QJYI:F4QR!/=>Z+)\T/YK?PE^!.[-M=
M==_=E9QNU-U[;J][8KJ7JWKW.=P[F3!44DL+YVNP^W*'(5.+PS5$$T,=96""
M":6.9(7D,$_C]U[I<?!C^8]\-_YC_7^7[&^(7<F)[-Q6V<@F+W?@IL;6[6SF
M&GG:40+E,+E*>DR-)'5K#(U/,T!@J%5C#*^APONO=1_EU_,9^,7PIK<7@.W<
MOV)N'?&6V_4;PAZVZ4ZAW+WEN&GPE*\\+9W)8S;&-R4N'PC55/+3QUU>::FE
MJ%>**1VBF\?NO=*;X2?/CXH_S$NH7[N^(_:V.[0V/19RKVOGU&,K=MY/$9.B
M57>AR^(R=/29''SM$\<L1EIQ'40ND]/)+$P<^Z]T<3W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW576P?^WI7=W_ (C#$_\ NEVC[>;X!]O^
M?J@^+JT7VSU?KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[JK_^61_Q[O>__B5&_P"M#>WIO+[.FX^K0/;/3G7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]TU9W'3YC!YG$TN4KL'593%9''4V:QA
M5:FCDK87B2JIRX9!/3LPDCU*1J47!'OW7N@IVK\=^C]D](T_QVPW6FSDZ3@V
MG+LVNZ^R.$ILCC:['U,/AJUR<$\;QY"6N4N]7-4*\E3*[RS,\CLQ]U[K7O\
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M:VIK:BIFN)-210Z*:)4@BCC7W7NJ _Y(_P :J+HO^8A_/3S/2F)_NE\.LO\
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MJ+Q2F&&J$=.&V]D)7@2*HC56EJ6D-CJ+'U%0P1,$'_5^?38);H:?[@_S2O\
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M2>A_U?GUZC=>_N#_ #2O^?W=8?\ GIPO_P!B/OVI/0_ZOSZ]1NO?W!_FE?\
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M]S_YJG_/U=A?^>[;7_V-^_53_57KU&Z]_<_^:I_S]787_GNVU_\ 8W[]5/\
M57KU&Z]_<_\ FJ?\_5V%_P">[;7_ -C?OU4_U5Z]1NO?W/\ YJG_ #]787_G
MNVU_]C?OU4_U5Z]1NO?W/_FJ?\_5V%_Y[MM?_8W[]5/]5>O4;KW]S_YJG_/U
M=A?^>[;7_P!C?OU4_P!5>O4;KW]S_P":I_S]787_ )[MM?\ V-^_53_57KU&
MZ]_<_P#FJ?\ /U=A?^>[;7_V-^_53_57KU&Z]_<_^:I_S]787_GNVU_]C?OU
M4_U5Z]1NO?W/_FJ?\_5V%_Y[MM?_ &-^_53_ %5Z]1NO?W/_ )JG_/U=A?\
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M^>[;7_V-^_53_57KU&Z]_<_^:I_S]787_GNVU_\ 8W[]5/\ 57KU&Z]_<_\
MFJ?\_5V%_P">[;7_ -C?OU4_U5Z]1NO?W/\ YJG_ #]787_GNVU_]C?OU4_U
M5Z]1NO?W/_FJ?\_5V%_Y[MM?_8W[]5/]5>O4;KW]S_YJG_/U=A?^>[;7_P!C
M?OU4_P!5>O4;KW]S_P":I_S]787_ )[MM?\ V-^_53_57KU&Z]_<_P#FJ?\
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M]J3T/^K\^O4;KW]P?YI7_/[NL/\ STX7_P"Q'W[4GH?]7Y]>HW7O[@_S2O\
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MVTL.9Z)<AEJZ:.%)JNBH8!-7UU)3R^Z]UIM=F_\ "GS^<!\ ?E;MSKW^9Y\
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M%[7WAGZK"[%VK5[HBH,S6?Z6L918'+Y"&D,0@C7(BF$B/.ZS"2FC]U[H@O\
M)D_GF_S>/YQ/:/<W66U*;^6_T94=/;!P>^ZO+[A^.O9V^$KDS>1_AZTT<--W
M-CF@:-O67:1P1Z=(^OOW7NKLOAM\B/YL65^9_P B_B/\\=E_#?;F+VWT%2]O
M_&WNOXV[$WHN(S_\1STV$$V5H]Q[TK:AVQI^VDK\3%-1SQ/*B1Y*2&:&J;W7
MNJ%OYD'_  H._FR_ /\ F4S? '^Z_P#+U["QV<W!U'#L;M*;HGL;!2RXSN/[
M-:6;(XI.X*I8:O&SU,\$R1UK)4"G$\9A$XAB]U[JQC^9A_.%_F)_R;QT=OSY
M7?&3XR?)CXZ]G[AI=@YWMWXX[QW'TWD:'/Q02UU11-MG<[[J^WDJL72U]5CD
M&:JX9_M*B&JK:)A$TONO=7M?"[YA])?/7XV=:?*;X^YVHSG6O9F+J*FCCR5-
M]A7XZNQ4TE)D\1E*;4WV^1QE=#-!,H=XV*"6"26"2*5_=>Z'O>E'O>NVY7TO
M7>X=J[6W=((OX7G-Z;.J]_8V$AP7^XQ5#G=MU-2&34%T9B#2Q#$L!I/NO=:(
MVS_^%(G\WC?'\T^K_E>X39'\N8;GHOF-OGXF3=M5G1_94%%;KW<V0P&0W$,2
M.WWF*?;8RIK(J'[_ %.VBF-4I;S#W7NM[S9U)O.BV_1TW8&?VQN;=*-/_$,S
ML[:-7L;'RAG8Q"'&5N;W%4P%(]*L6RTVM@7 0$(ONO=*?W[KW7O?NO=>]^Z]
MUIC_ ,]K^>C_ #0_Y//R0V%UIMC&? CNKK3NC9FX.Q^O\CGNA.P]JYW$4N/S
M=90#"YA:?MVIH,I44E&,>3E*8425TS5#?PG')'&DGNO=;C^W,C/E]O8++5*Q
M)4Y3#8O(U"0*50/6P)*X0,S,$#,; L3;ZD_7W[KW3S[]U[KWOW7NO>_=>Z][
M]U[HM>)^5?4NX/E;N;X=;=S46;[>V%TW0]U=B4%!41S)A,=N'*08S#4M;9BZ
M5V5O65"1D QT\"2.--1$3[KW1E/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=:T/\ W4(_\O*_^7?VL_!^7^3IGS_/JQG^
M5/\ \R8["_\ $GS_ /NJQOMF?C^75TX=6B^V>K]>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]TPYW:^WMSG"G<.'H,R-NYZ@W1A$R$ J5I\CBA(*6LC1KKYZ8RLT3$$
MQR:9$M(B,ONO=:\G_"KS-[&Q7\DCY*4.['Q:Y_<N^_CMA.L5KQ'Y6SD&^\#D
M:A:'6P;[K^[6/W"6\8+_ &XJ+CQZR/=>ZC?R"?B-O_\ EB_R5J[)]I82?:G;
MV^J#N+YC;YVS5*U=48N;,8&DCPM'4T\WC$5;%MK;F#>JI/2(:MYX7)<2.?=>
MZUT?^$4&8R^X?F)\\,_G\ID<YGLYT7M#,9O-YBNER=765>3W2T]35553.SS5
M%343.\DLLCL\CLS,Q8D^_=>Z0G3W:.<ZM_X6:[TJ<1EYL71;Z^5_:O5VY8$C
M::.MH=];.K*5:.=%Y9#D/L)D/TCFABE;TQGW[KW7TC<#M?;VV!F!M_#T&).X
M,]DMT9QZ* 1-5Y'+E345E0_ZIIY D:ZF)(C2.-;1QHJ^Z]U\^F@^%[?.O_A8
M'WQOWJO"T57T3\/^\^B>^NZ]U8N7[2BH-P=-;/VMXZ!GI]239;*=EX:HCFIV
M=6E6GR<LP_8F0^Z]U]!W(C$8S[W<]911_<XW$58J,E38MLA6"CIKU$D$0IXI
M:N92R:A!&KL[@:$9R![]U[KYMW_"@3^99_+P_F$?S)?A?T?VZ/D%L[XI?$/.
M]C8'Y#=F8CJ&MVMN:OJ>UJO;KU5#2;>W"V$W#28/%P;>HGGJY* 9$Q5E;)C<
M752)2FJ]U[KZ+W36>ZNW1U%U?N+I#+[>S_369Z_VAD.J<UM*N&2Q=3MVIH*=
ML--CYPS^6C?'_;F)M1)2US>_OW7NA*]^Z]U\ECJ/>.W^O_\ A5GOW>>ZJJKH
MMN[=_F[_ "LR&6JJ'$5F?F2)-^;N4F.CQ]/55M0UV'HAIY'/X7@^_=>ZW]/@
ME_-5Z7_F+?S!OE7UO\<J[<.>ZE^*/2'76V\AO#/;?RFR3D]U[VW'G5SL4.%S
M-%09.GI\/%A,?3++54L4LM0:L)"L"1S5'NO=6H/UA)L;J7<&P>BZZ'KK)"3>
M&=VA6OCH]SP4>3W7E:S.U&JDKI5CEI*C(UM2IA\T8BAET0/#HC9/=>ZU7?\
MA-__ #NOFW_-A[M^3'7'R:;I_$X7JWIW ;MVC4=6=?S[8G7(9[+B@::I:MRF
M42H2&(7CCT(NHDOK%@/=>Z2?Q4_G:?S#]U_\*%:S^4[W-7_'_<71N&[H^3FQ
M6W/M/K:MP>?J\-UILG=VZML5$M:^5-+!DY4Q>'_B*QXXP>4U4-.3$8YO?NO=
M&7_X4E?S3?G=_*;Q?QI[/^+F:Z=S6P^[-P=B;-WCMKM?KN3<D^,R&U*+#5>+
MDQ5119+&2RT]?%-F&JA4&0Q214XB.B1E3W7NB^]T_P QO_A0O\AOBI\&/DO_
M "W/BSU_N'8/8_572V3[>W%4[7Q^4SFY=Z9'"XVKW7)1;9SF4ISM_K1,\,IB
MZ6M%1]_4+%+6Q5=-028^NJ?=>Z./_/+_ )WG8?\ +H_V6[XK_'+9O7F\_GQ\
MJ&VN<50;TJI<SMK9N/SV2I\*F3R-#1U5+E,A-F,PU;1XA+QT_P#D=;65+2_:
M)05ONO=!_P#S.?YBGSH_D;1_$KN?N7M;#?/+X\]T;^SO77R&P>XNM]N]/;FP
M.5:"#+4\W7DVV*+%T+XE,?#G%@I,\F0JA]I20U67EDJY*V#W7NC>_P X[^8;
MV_\ &7^5H?YD7P<[#ZZS>(BQ_2&\-MTV]]E?WVPVX]O=Y97#4%%61-!78^LI
M:B*#,TU1&5J2A421RQ%RI3W7NJ]_@3\TOYYW\V/^7'4?(KHK?'Q<^,&_<%)V
MGC,%N_</3S[ZD[&S^V*RK^SQF!QU3EJG&[)V]00PT5!/E<A39RLK\I/7F/&T
M%'C()LI[KW0O?\)TOY[>]/YIF+[7^/WR@V_M?:7R[Z,Q,.\*JJVKCSMNBW3M
MJ:N&.J<@F'FJ)I\=E,!D9Z"ER<: 4Q-912PB-I9:>'W7NE_E?YK?;'S3_F][
M[_E.?"7?&WNI]A?'OK3L+=WRE^5N+V[CNR]RT^5V7-186MV_LO'9JFR&U*&K
MPFXLYAZ.LK<OBLM']W'6TQQZFF J?=>Z?O@)_-@[<W#_ #5?F/\ R?/EK4[6
MWGV?T:U9OCH+OS:6W8-B_P!YMMC'8/,?P?<>&BK)Z5-T4N)SU+5"IQL4%'4Q
MT]?KHZ(T\(J?=>Z0^P/YR>ZOFI_-\^0W\J_I?>8^+^!Z P'9> I^TJOJZ+L'
M=6\-W]5UU)2YZ'%IG'_N_M["XD+DS"U5@\K)EXHEJZ>>DB9$D]U[HJ7\NO\
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M>MA_^])[]U[KZ,LVV<!/N7'[QFQ-%)NC%8/,;9QV<,7^414&X*BAJJRD5_\
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MNJ+/Y?\ _--_G7_S-_Y9/RF^2O5V<^(G2F]_CWOCN"!.U<OUM6YQ<W%L+9&
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MWUZQI]U[IC^)?\X#MW^9!_,V^:?Q,V?\J]D?"7;GQFWS4[%^-'5]9U=M[?\
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M:=I=<E16R,I_;!5$5%]U[H\W_"YS_NEW_P"7L_\ S(_?NO=#U_.4_P"X2/X
M?^(%_EA?^\+B??NO=6N?\)4O^W'OQ1_\.CY'?^_'W5[]U[K8F]^Z]U\G_P#G
MR?\ <3OVM_XGKX#?^^^ZM]^Z]U]-W>WQ@V7NCY7]%_+6EPN&I>R^INONW>I:
M_<9>6EK*O;G:0Q56U RQ(8:P4N6PE#-#]P0:9)*K[=U^XF27W7NLW7/R?V5V
MO\E_D'\=]C5-+GJGXR[4ZAJ>U-P4!DJ::BW'V^V?J:?;/W"@TQRN+PN&HJ^O
MIQ(9J:'+8TRJGG /NO= [_-B_P"W67\RS_Q0#YD?^^ZW'[]U[K1]_P"$0_\
MV5=\W/\ Q7K8?_O2>_=>Z^D#[]U[KY>__"D=$D_X49=71R(LD<B_"E'1U#!@
MU?2@@@\$$?4>_=>Z^GUC\9C<3 :7%8^AQE,9&E-/CZ2.CCU. "VB-5740!<V
MN;#W[KW4[W[KW7O?NO=?)_\ CA_W%N;B_P#&PGRI_P#>ZWA[]U[K>"_X5'?]
MN*/G-_Y;-_[^+K[W[KW5/?\ PEB_[<"?S&?_ !/7R[_]\MU[[]U[HKO_  AN
M_P"/T_F2_P#AK_%7_P!R^P/?NO=%\_D=Y(]+?\*GOEGU]V;32[:W9OK?_P ^
M-A8*ASROCI9LA/N*JW/3F 3QAIA78C#U,],XTK402)+$[JZ!_=>Z>_\ A;G7
MT,WRZ^%N.BK*27(47QTWE45M#'4(\T,==N600/+$"7C28PS!&90'T/I)TM;W
M7NMF;_A2M_W#Z?+;_P -?XC?^_7ZX]^Z]T0'_A.MN?;6"_X38?(O,YO<.#P^
M'VPOS@?<F5RN6I\?38\1X U+&NGFD2*D"T\T,I,KI:.1'/I92?=>Z)/_ ,(8
M_P#NJ)_Y9-_\USW[KW4#^<]_PGLE^0.X.R?YHO\ *0W=#N'/579W:&\NZ.C]
MO9P8BOIMW]99[(T6Z<OL6NI64T^=H=TXG)M6XF6>&:.N29Z"9952A/NO=7"_
M\)I/YCWR)_F)?RZ.Y8?DI756^.ROCMNG)]247:L]*XK-RXRNV]!D*!\K(%\=
M7G:$S2P5,Z6>HA-)-.IJ))9IO=>ZH#_X1$LJ_*SYNLQ"JOQYV&S,QL !N3DD
M_@#W[KW1]O\ A;K7451\7_@CX*REG^][P[+KJ+PU"2>:%-O4=YHM)/DB'FBN
MZW7UISZA?W7NMG[^47C*/$_RJOY:]+0Q>*&7X'_$S)NH_,V:V)@JRH;Z#]=1
M/*W^Q]^Z]T$/\[_X!4?\Q[^7%WST-C\129'M3 X?_2YT)530PF:GWCUS%/58
MZ"GFEIJEJ8YNE>OP\TD:+)]MD9T#H&+#W7NM5[_A*=\GNQOE5TIMW^6AG<)7
M5W5WQ2^0>/\ EMN'=53AON,<VTJ*JGW!@=G"JCKZ8T^5/<:8K<$9FI*I*G'T
MV2I?%I434WNO=?0-]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:T/_=0
MC_R\K_Y=_:S\'Y?Y.F?/\^K&?Y4__,F.PO\ Q)\__NJQOMF?C^75TX=6B^V>
MK]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T3GYX?#';'S^^-V\_BWOWN+O?IGKOL=
MJ&DW_E?CUN7"[0S>7Q5,_DGP-5D,UM_<2)ALBXC%=#!30R5<"M233-13U5//
M[KW6N1_T!4_RLO\ G_GS_P#_ $:?77_VJO?NO=7H_P KO^5=\=?Y2O2>^>BO
MCAN?MW>6VNP>T\AVUGL_W5N##;CRXKJ_$XC#BC@FP6 VY1)CH*?#Q21(U \X
MFGJ&>H>-HHX?=>Z;>U?Y6?4VXOF,?Y@70?8V_OB;\NLUU_6]5=F]D=2X7;6=
MH-Z[?K?M&%+NO;^Y<'F,;7UU-+C<2\&1@6EKK4%'#/-404\,4?NO="#\$_Y;
MGQS_ )?]!VMD^J*/<&[^X?D)OK)]H?(OY"=DU-'E]W;VW!FZBHK:JMRE30T6
M/H*.C^^K:ZH@QN/H*3'TTM342Q4XFGGED]U[JK?YQ_\ "8;X8_S#?DCOKY2?
M)/Y0?/;.]B;V:BI*?%87L_85!A,%BL0ACQ^!V[CZGK2L?&X:@0R&.'[F622>
M6HJZJ:HK:JIJ)O=>Z!KHS_A('_+.Z"[LZ>[UVOW+\W-P;EZ5[3Z^[:V[@-X=
MD[$K<175W7&6I,Q24>4AH>ML?6S8ZIJ*...I2GKZ:=X6=8JB&0K(ONO=';_F
M=?R!_B7_ #.^Z.OODMO3L;OOH;Y%=;87;FW,%VIT9O*EQ$[T>SZ^JR>)\M+D
M:'(14U?BZZMJ)J6MH7HZI'9?+),(H!%[KW1D.MOY96/2@Z_QGRV^5_R7^?F&
MZGW1MK>W6^S_ )*U>TZ? 4&9V>M2N-R^2QFT]K[<EWED:1JA)X9-TUV=CIJV
MGILA1Q4U="M1[]U[JS_W[KW3#N;#Y#/86MQ6+W5GME5U4BI!N7;-/BZJMIB"
M#J@CS.-RV.9B!8^;'RBQX -C[]U[K6)J?^$F7P<J_D34?+.7Y>?S%4^153W3
M+\B9.TZ;LSK"BKQO6;.'<IW!'%#U''1158SI^[54I5@62P6(1@)[]U[JP_N'
M^4MO7O?8^5ZY[&_FW?S8Y]HYRC@QV8H=F=G]0=55%33P,6,$V1VKTKA<D\,X
M)2H0U>FIC)BJ!+$2GOW7NC3?R\?@)TQ_+0^,&U?B=T+F^P]R]>[3W!O'<M+G
M^U,IB\UG:FJWMD)LA5-656'P^"H91$\HAATXV-E@CC1VD92Y]U[JIFF_X3&_
M#7:WS/WW\PNF/D-\UOC:_9^5SV4WYU'\<N]9>G<760[NJ8J[-8.+.8:DIMV4
M>U\QD8(JJHQL6;"QN!'1S4M/%20TWNO=++8__";'X0=2?.S"?S!ND.W/E5TI
MW%M?>AW?M79VP=P]?R;/QL53BGP57AJ7$9GKC+U?\)KL+-54DWERDE:$J)9H
M:R*J\=1'[KW0X?S3/Y&WQJ_F[[IZHW#\GN[OE)MO&=)XW=]!USLKIK<>R-K8
MNBDW^<4<U5N^6V#GLM55.0_@F+#>;*O#$(!]O%#KEU^Z]U89\0?C-COAY\>N
MLOC9M[M?MCM[973VTL!U]U[G.Y7VQ49FAV_M"C@QV'PQJ-J[8VK155+BZ"F@
MIX99\?+6.B U%5.]W]^Z]T#/\PW^6G\6/YF_4-!U-\F-LYJ63:^2JMP]9=F;
M%S/]U]T[2RU1#X?XG@<GXJB..46B9Z>II:FBG:*%JBFE,493W7NBR;]_DP=6
M_)'MSX\]K?.WY"=Y?-^G^+&*GING>K^VL?M#:FU!DZR2@DJ-Q[CQ>U=M863<
MV<JOX90K/]W5?PZ58]+8[2[JWNO=%P_X55JJ_P CSY6JH"JNY_C@JJHL !V/
MM6P _ 'OW7NJQO\ A/C_ "\J;Y+_ ,E'KW*=:?*7Y-?#C=W;.Z/D-M'M_<'Q
MLW5BL9%NJ@_O#E<3')EL?G,1F*>FS=)BPE)39O%'&YF.GBIJ=Z^6GI*2*#W7
MNMC[^6C_ "K/B;_*GZ@S'5'QAP&XI:O>62H,[V9V;O[,KN+<>Y*[&0?;T\M?
M40P4E'34U+$9!3T=%0TM)"9)91":B>>:7W7NB6?S,O\ A.?\#_YF7;D'R)W?
M7=H="?(:2+!4VY.U.BLQC\/+GTVU&L%!+G,?DL=D*2JR-%31P0PY" 4U;X8*
M:":>>"EIXH_=>Z.[\#/Y:O57P1Q-35T/;7R)^37;60PTNV*WOCY7=L5O<.YH
M,/-4I5G X:6J$='M_!-/#2R2T>/I(%JI*:FEK7J9:>%T]U[JOG>?_"8_^6KO
MGYR[C^=.37OC%[IW;O/+=F[CZCVGVF=I;5JMR[CJ9JO*97R8^A@W33)DJFHF
MFGI*;<D-*TDDB",4TC4_OW7NI>;_ .$S_P#+BJ/F_M?YP;#;N_HS/;8FPE9!
MTGT#OVCZ?V2TV"Q8PRI3P87$4NX,105F- AK:+&;@HJ>J76C((:BKBJ/=>Z&
M?^:'_(K^,?\ -LW-U-G?DOW;\IMKX?H_#[GQ'6>P^F=R[(VKA\=_?7^%#+U
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M?NO=>]^Z]U&K:RDQU'5Y"OJ8*.AH*:>LK:RID$,<45*I>221V(5$C169B38
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MH*49'<M-787$083*RF" FBI)\A"FIB*R3@#W7NM4O_A$/_V5=\W/_%>MA_\
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M%0SF19\E56F3W7NMQ3?V_/YJ,_Q2[VRN[OCM\+,)W#34-32;5VIMWY-;NS>
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M9FGW'D,]C-C]6;LQE!F*_(T:1TM?6Y&EI8JB>IAC2*>61Y455< >Z]UL%_R
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M&!W?MS)TTBS1U%!N6EBK:.>-U)5TFIYHW4@D$$$<>_=>ZT4_^%P'<6WHMD_
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M;FVMC8:]E,;PYC;M=G(9J6L]?DH?N:*=)--#)2>Z]TX_S6/Y6/0O\VCXVQ]
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M:FQMV]<;YP%2+QUV'WQ05&,R=')<$:*FBJIXVX/#'W[KW6K3_+X_X39?(/\
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MOXW[ ^4VQ?\ 13VY6;LK^ILK60S;_P"M\!N*7:]!NRDII(Y5PNXJBB6+*5>
MFDC'WN.AR%/2Y. O19-*S'S3TDONO=#3@L%A-KX3$;:VUB,9M_;NW\90X7!8
M+"T,6,HZ*CQD2PTU+2TT*I#3T]/"B)'&B*B(H50  /?NO=.OOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
M6A_[J$?^7E?_ "[^UGX/R_R=,^?Y]6,_RI_^9,=A?^)/G_\ =5C?;,_'\NKI
MPZM%]L]7Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z"#<7?'56V>TMI=(UVZZ>M[<WK0U.:PW7>!HZC<64CQ="VBH
MS>2IZ**<X?!02%8FR-<:>C:H>*ECF>JFAAD]U[I)]\_+;XV_&1<-!WCW)L/8
M&>W12YBKV9LK+Y^G_O!GA@*6>LJTP6!C=\KEW@IZ:9G^UI) FGUE??NO=!M\
M6_YBOPF^9U+B!\<_DAU=V!N;*[.VIOJ7K6#=%-B]VT..WICJ?*T$N2VO5R0Y
MNA\E%4Q.WDH@JDD%KCW[KW1U/?NO=$R^<?\ ,!^*/\N7J.C[L^7'9T76VR,O
MN6BV;MW[?!9#=>1RF4KXY9THL=C,735=;4R)303S2N(A%#%&SRR(+7]U[HP'
M3'<G6GR%ZHZ_[OZ<W7C]\]6]I;6Q6\]C;LQBRQ0UV/S,8D@F$<Z13PO8E9(I
M8DEBD5HY41U91[KW0F^_=>Z][]U[KWOW7NJO_F1_.6_ET?R_.P,7UA\PN\=V
M=)[NS^+DS6W$S/QO[1W#C<I2P,B32XG.X39>3P65%*\D25 I,E,U,[HDXC9U
M!]U[JRW"YC';AP^)S^'J/O,1G,909C%U?ADI_+39.))X)/'*J2IKB=6TNBL+
MV9001[]U[J17UU%BZ&LR>2JZ>@QV.I*BNKZZKF6GBAAI$,DLLLC$*D<:*S,Q
M(  ))L/?NO=5[_"?^:U\$?YB&?[BVQ\1>[J;M7-=&UE/%OFA@VIF=ONU+6R3
M0T^4Q:9*@I'RV+J)Z>:..HI5D5F"\ 2PF3W7N@NVE_/$_EB[U^4F)^%&(^0F
MY\?\ILUOH]:4?36\OC5VMUWDTS@1I!054FX-CXRAH6:)2ZR5-7%"\91UD*.C
M-[KW3[\Q?YSW\N+X =C4/5'S [TW7TGO3+8H9S T^:^-_:6?Q^3I 562HQ.<
MPNRLE@\M'!(ZQSFCR4_V\I$4_CD]/OW7NC1=[_-+XT?&CXQ5_P Q>Z>SJ#97
MQYHMJ[9W@F^:W$9"=ZFDWJM,</'28N*D?+5%=DVK*9(*1:+[@O(%>--+Z?=>
MZG_$;Y>_'[YS]$[3^2'QEWW#V'U/O*3)TF,S8QE7@ZB&JP<[4U;0UU!70T]9
M15E).A62*6%38JZ%HW1V]U[HRWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[H'
MMM=]=4[I[2WGTC0;JAH>W=ATU)E<YUWN&@J=LY27&9 #[?.8JGKX:<YS 3/J
MA&3QQJJ%*J.:BEGCK()Z>/W7NAA]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UK0_]U"/_ "\K_P"7?VL_!^7^
M3IGS_/JQG^5/_P R8["_\2?/_P"ZK&^V9^/Y=73AU:+[9ZOU[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5__P T3YU[:_EN
M_!KO?Y<9_&0;AR?7FW*?']?;3J7DCCR^Z=W5$6,V]CYWA!DCHY,E4P25DB^J
M*CCJ)%NR 'W7NB0_\)Z^MM^5WP0P/S4^0F>F[!^6'\P'.Y?Y&]R]EY2;[RIG
MQF2J9Z+9>$I"8H5Q^$Q&V:>A>EQL"+2T<U55+ "C!C[KW6JM\4_YN>T/BC_.
M3_G"Q_S+I-T4.^N^\WV9\>>M.XMR[<>N_N)C^N,ON&BVYMH4D%,]7C-I9G%5
M6%"U5(C0?Y'25]9YHZB:OC]U[K9+Z4_ES]8_-+^71_(7[]P>-VGAOD3\/^N/
MY5G<^R^U8HQ25TVW>LZ/8M;O?:57D*1&J:BBR&"ILPL-'*6A3*1P!Q"KU#^_
M=>ZV//?NO=:[O_"B&M_E9;F^.G7/5O\ -8K^_P#KKJ_*]E4N<ZB[AZ3V[75]
M70;HHL9DHY*>DJJ/'9ZC^XDQ$M?Y*?)X2>EDC(EC4SPI)%[KW1UOC%\@/A+\
M8_Y5W4??GQVQ?8:? SJ?HVMW;M3)4>U\GN+,4&S-F1Y"JR.>R6/JC_&9EC6C
MK:NK;PO4^LR&!1J">Z]T7[JC_A1?_*T[RV)VEOKJ7M7LW?K=33;/ILQL/;70
MF[LMNK)R;VCS$U,,!MR#%/E,Q#2TV"R4^0J(8/M<;"B2UT].DT1?W7NC#_RV
M/YPWPD_FKXK?=1\5MX;J?='628FIWUUQV1M5MFYZ@I<\TT='7>!9ZRBK**>6
M"6,RTE?.L4@5)_$TD8?W7NK1O?NO=?/;_P"%R/\ Q^G\MK_PU_E5_P"Y?7_O
MW7NMB[L/^?G\"OA]U[T[2]I4GR5RO74FWMA;+KOD3L'XV;FW1UI#D1AJ>22G
MIM[FEI\+GW@9&BE7!SY1TG62$KY(9A'[KW5M3_(7I7L3XU?[,/L7*'O/H7>&
MPJK=5%F^K*;^^*Y; UL,BU<U+!%)%-4"* 5"SP+:IC:.6$Q>=#&/=>ZUT/\
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MMK$15%75Y([#IZZBS^/I::ECFGKJR;:V6S;TE*D,CU-;%30H [JR^Z]T.?\
MPGU[HVUWE_)S^!VX=MUIJO[E=*8GI?/T\H1):7)])S3[8JH940#0'_AD<\-Q
MJ>GFAE))>Y]U[HIW4^^?YE_PIP/S,Z!^1OPF[%^17QSW;W!\K.S_ (T?)#XS
M=E;+WG/A-K=][EW-N/\ @>]-N;IW1MC<%.FW&RS5 J*"DK M)/\ P^CIJ@T$
M9F]U[JN3X_?RT>\/YM.W_P"0]VGW%U-D_C7\.?Y>7PQ^-^2IMP[PW;MS<&[.
MW,M#MK8E?2?P/"X"OS]-A-B5K;;Q\JUF9K:/,S4E551-A:*=TEB]U[K=?]^Z
M]UJV?\*BOA-\W?YBOQRZ%^.7PU^+>[.XLKL_O&C[HW7OQNT>NNO,)24N+V_G
M\(F,5-T;SPN9J<E/-FHYKQ8EJ5(8FO4F1EC]^Z]T*O17QT^9VS?^$[&[_@=N
M3X>]D8[Y6I\+>[_BEC.L_P#2GU;5P5^4[0P^Y,/0YJEST&_I<%'A*<9.EFJ?
MNJ^GKE!:.&CG*ZO?NO=$ _X2^?RY_P"8G_*QJ_G7#\N/AOO3;=+W;M;H[.]=
MUNT^Y.JMZBMK>EAO<U.%:.AW](]+793^\](*.:H\-"&BE^[JZ9=#-[KW1>/Y
M$'\K+^:%\(?YM7:WRS^3'P?WALGISO?:'=NS#G\%WOU'O9]N3]J;JPNXJ2LR
M]'C^P7R51CJ2'%S0SMCJ&MJO))&8J.1-93W7NM\3W[KW6IM_PI#_ ).WRT_F
MW=V?!G;GQUBV5MW:'4^Q/DQ6]E]H=BYXXK%8NHW'/LQL-CA3TL=7E*VNR[X^
ML$0@H7AB2&22IF@'C$ONO=+O^8?MC^99\Y_Y8>!_EN]??!KL[K#Y$]JXGJGK
M#OWN'>'9VS,%UIMV@Z@R>#R&8S&.W#B]S5^=SF&W7+B$CHJ2FVVU<<;4U461
MHJ>=/M9O=>ZL;^"7P*@_E,_RRL=\8>G-H;L^2_9&W=M[QW3O&GV54[<V9DMY
M;TWZC/D)Z27<^9V[A*&AA;[6BHS6Y=)(L91TRS25%2CM+[KW6NW_ ,)C/Y6W
M\RS^6+\GN^=R_+?X:;MVAL/N?J+"[,P^]MM]U=4[WI\=7[?S$5?;)46-W_/E
M13U$#2A)*6AJ661%5XPKZU]U[H.>R/Y8O\U#=?\ PHII/YIN+_E^]C#XW4/R
M-ZSWG]A5=_\ 2<.XI,)L?;.)VM45ZXX=G/ ))CCY:V*G:L$I@9(WT3ZD7W7N
MC _\*A/Y;?\ ,=_FB=G?$VE^(GPQWKN[;'0>S>T?[T[WW-W/U/L>CJZSM>7;
M<\=#CZ3)=@095Y,6N#E2KEFH886ED44KU$8,I]U[H^'\U?XY_.'Y<?R.=G?"
MOI_X2=J5WR+W?L_XW;1W1L[,]N=1X6DVS)TA7[<R>2J<CEYNQEQU=35S8::"
MA_AL]9*[.KU45(@Y]U[J9_(:_E]]]=+?RJ^T?Y=/\PKXM[EZQAWIG>[L=N<9
M#L78F_L/GMN]S4L%++#15.T-VYZNI:V**2J5Q4T5,L91)89G9@J^Z]T!'\G[
MX:_-G^17D_FG\=-Q_&7LOYA]!=B[GQ_<OQG[@^.V>V@9LCD,=2U>*EVYNC%;
MEW'MVNV_EZZAIL&_W(AGQ,+K4?Y:P*CW[KW2]_D"?R5>X_AKV[\BOYA_S;I=
MM8CY@_*6JW>^/ZLVIFXMQTNR,1V9FUW-GZ:MKJ*1\56YS)9.*AB8T;3P45-2
M-'3UDPKJA4]U[JI;YL?RF?YJG='_  H6Q/\ ,SZ^^"F\\K\<MJ?+3X7=M0_=
M]^=.XK,U^%^,]%L*@RT]/CJCL5&BFR!VK6RTD4SQOHEA$PB<NJ^Z]T-/_"G+
M^5M_,Q_F=?*'H3<OQ*^&>Y]W]?=.=+5>U<MO?</=_5>RHZ[)[JR;Y.:FHL?E
M-]TV2$6-B\,4LTU-$LLYD$ D@C2>;W7NMC/Y09G^86_7?\OGLKXE=!5=/V'M
M7N_&S_)KXY=N=C[5VS+_ ''DZ_WE29?&Y+.X7*;GP"UG\:BP?\,GQN4K47*2
MXPU)7'G)&'W7NJ/OFE_*U[0_FQ?S/?A#\B\'\".TO@-LOH[<S[V^:/='>F4Z
MWILCO8[)S&WLGM_![?H>N]^;MJLSE72@R](N:J7IHH:>J6:1W:CIJ2J]U[JY
MC_A0/W)MWI'^3G\\]P[AKEI!O'I'+]-X.&VIZC(]U3T^UZ6"-1%,6-\H\C^@
M:8HY'+QA3(GNO= )_P )EO@SN;X.?RK>K\=V-MZLVMVU\B]RYOY*]@X#*1U%
M/5T WY34-'MZ@JZ>JBAGH:N#:^+PTE52/$K4U9-4Q.#(')]U[K8+]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:T/\
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M?NO=>]^Z]UK0_P#=0C_R\K_Y=_:S\'Y?Y.F?/\^K&?Y4_P#S)CL+_P 2?/\
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M-?\ >%_S=>_V>+Y$_P#/4XC_ -!7'_\ 7CW[_6_VS_?;?\Y'_P _7OZYW_\
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MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NK1/Y;/\
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MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K6A_[J$?\
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MX?%56=J($>;*80-34@IZF@R$5-5TT\=%31I6P+44]-31B.&/W7N@/^/O2_\
M,<Z)^'^/^'TFX?C[OK>766T(NDNF/EYG-W[BCDEVIB,>F-P6Y=U;(&*:LJ-X
M82B6**HQ]+O'[/,3TR5;9K&?=RPTWNO=&^^$WQ ZE^!?Q<Z>^)W2-+61=?\
M3^V%PE)D\L(6R&5KJZ:6MRV;R;T\4,,F2S.3J:NKJ#'"D2R3%(8XX4CC7W7N
MC4>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>ZUH?^ZA'_ )>5_P#+O[6?@_+_ "=,^?Y]6,_RI_\ F3'87_B3
MY_\ W58WVS/Q_+JZ<.K1?;/5^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJ^OYBG_ #*W9/\ X?\ %_[KJ[W)
M7MC_ +F2_P#-$_\ 'TZ O/O^XT?_ #5_Y\;JGSW-W44]>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U:)_+9_YK/\ ^4Z_^3ON
M(_=/_B+_ ,W_ /K#U)'M]_Q(_P";7_63JT3W$?4D=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U2Q_,!_YGI0_^&!@/_<K(>YX]MO\ DGG_ )K/_P =3J(>>?\
M<T?\TE_X\W1'O<@= WKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NKYOA?_P!DT];?^3C_ .[_ "OO'7GO_DJS_P#-K_JS'U-G
M*/\ R3HO^;G_ %=?HT7L(]"3KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZUH?^ZA'_EY7_P N_M9^#\O\
MG3/G^?5C/\J?_F3'87_B3Y__ '58WVS/Q_+JZ<.K1?;/5^O>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJ^OYBG
M_,K=D_\ A_Q?^ZZN]R5[8_[F2_\ -$_\?3H"\^_[C1_\U?\ GQNJ?/<W=13U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5HG\
MMG_FL_\ Y3K_ .3ON(_=/_B+_P W_P#K#U)'M]_Q(_YM?]9.K1/<1]21U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5+'\P'_F>E#_X8& _]RLA[GCVV_Y)Y_YK
M/_QU.HAYY_W-'_-)?^/-T1[W('0-Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[J^;X7_]DT];?^3C_P"[_*^\=>>_^2K/_P V
MO^K,?4V<H_\ ).B_YN?]77Z-%["/0DZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NM:'_NH1_Y>5_\N_M9
M^#\O\G3/G^?5C/\ *G_YDQV%_P")/G_]U6-]LS\?RZNG#JT7VSU?KWOW7NO>
M_=>Z][]U[H$^[_D#UM\?<#09[L/)SPC+5,E-B,/BTBJZ^K^V,0J)*:FDF@,L
M=+YX3,P;T"1"?U#W95+<.M$TZ*S_ ,.=_&O_ )5NR/\ T%J?_P"N/N_@MU76
M.O?\.=_&O_E6[(_]!:G_ /KC[]X+=>UCKW_#G?QK_P"5;LC_ -!:G_\ KC[]
MX+=>UCKW_#G?QK_Y5NR/_06I_P#ZX^_>"W7M8Z]_PYW\:_\ E6[(_P#06I__
M *X^_>"W7M8Z]_PYW\:_^5;LC_T%J?\ ^N/OW@MU[6.O?\.=_&O_ )5NR/\
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M1_Z!Z]_?_!?ZBO\ _.=?^OGOW^N%8>DO^\#_ *"Z]_4J\_X7_O1_Z!Z]_?\
MP7^HK_\ SG7_ *^>_?ZX5AZ2_P"\#_H+KW]2KS_A?^]'_H'KW]_\%_J*_P#\
MYU_Z^>_?ZX5AZ2_[P/\ H+KW]2KS_A?^]'_H'KW]_P#!?ZBO_P#.=?\ KY[]
M_KA6'I+_ +P/^@NO?U*O/^%_[T?^@>O?W_P7^HK_ /SG7_KY[]_KA6'I+_O
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M?\+_ -Z/_0/7O[_X+_45_P#YSK_U\]^_UPK#TE_W@?\ 077OZE7G_"_]Z/\
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MZ]K'7O\ ASOXU_\ *MV1_P"@M3__ %Q]^\%NO:QU[_ASOXU_\JW9'_H+4_\
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ME_Z$Z]_PZ]L3_GT^YO\ T(J?_P"I??OW?:?[_?\ YP?]=>O?5W/^^5_YR_\
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MT/\ >Q_T#U[_ (=8ZI_Y]QOO_P Z:'_K[[]]#!_OX_\ .,_]!=>^IF_WT/\
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M *X^_>"W7M8Z]_PYW\:_^5;LC_T%J?\ ^N/OW@MU[6.O?\.=_&O_ )5NR/\
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M+=>UCKW_  YW\:_^5;LC_P!!:G_^N/OW@MU[6.O?\.=_&O\ Y5NR/_06I_\
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MN/OW@MU[6.O?\.=_&O\ Y5NR/_06I_\ ZX^_>"W7M8Z]_P .=_&O_E6[(_\
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M[_1_L/\ YXG:/_H-T?\ UY]^J>O4'7O]'^P_^>)VC_Z#='_UY]^J>O4'7O\
M1_L/_GB=H_\ H-T?_7GWZIZ]0=>_T?[#_P">)VC_ .@W1_\ 7GWZIZ]0=>_T
M?[#_ .>)VC_Z#='_ ->??JGKU!U[_1_L/_GB=H_^@W1_]>??JGKU!U[_ $?[
M#_YXG:/_ *#='_UY]^J>O4'7O]'^P_\ GB=H_P#H-T?_ %Y]^J>O4'7O]'^P
M_P#GB=H_^@W1_P#7GWZIZ]0=>_T?[#_YXG:/_H-T?_7GWZIZ]0=>_P!'^P_^
M>)VC_P"@W1_]>??JGKU!U[_1_L/_ )XG:/\ Z#='_P!>??JGKU!U[_1_L/\
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M?_/$[1_]!NC_ .O/OU3UZ@Z]_H_V'_SQ.T?_ $&Z/_KS[]4]>H.O?Z/]A_\
M/$[1_P#0;H_^O/OU3UZ@Z]_H_P!A_P#/$[1_]!NC_P"O/OU3UZ@Z]_H_V'_S
MQ.T?_0;H_P#KS[]4]>H.O?Z/]A_\\3M'_P!!NC_Z\^_5/7J#KW^C_8?_ #Q.
MT?\ T&Z/_KS[]4]>H.O?Z/\ 8?\ SQ.T?_0;H_\ KS[]4]>H.O?Z/]A_\\3M
M'_T&Z/\ Z\^_5/7J#KW^C_8?_/$[1_\ 0;H_^O/OU3UZ@Z]_H_V'_P \3M'_
M -!NC_Z\^_5/7J#KW^C_ &'_ ,\3M'_T&Z/_ *\^_5/7J#KW^C_8?_/$[1_]
M!NC_ .O/OU3UZ@Z]_H_V'_SQ.T?_ $&Z/_KS[]4]>H.DIOS8>QHMC;SEBV9M
M..2/:>XGCD3;M&C*R4<Q!!$-P0>01]/>P37K1 IT2C^6KM7:^9^.E369?;>
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MY]^J>O4'7O\ 1_L/_GB=H_\ H-T?_7GWZIZ]0=>_T?[#_P">)VC_ .@W1_\
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M\3M'_P!!NC_Z\^_5/7J#KW^C_8?_ #Q.T?\ T&Z/_KS[]4]>H.O?Z/\ 8?\
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M\3M'_P!!NC_Z\^_5/7J#KW^C_8?_ #Q.T?\ T&Z/_KS[]4]>H.O?Z/\ 8?\
MSQ.T?_0;H_\ KS[]4]>H.O?Z/]A_\\3M'_T&Z/\ Z\^_5/7J#KW^C_8?_/$[
M1_\ 0;H_^O/OU3UZ@Z]_H_V'_P \3M'_ -!NC_Z\^_5/7J#KW^C_ &'_ ,\3
MM'_T&Z/_ *\^_5/7J#KW^C_8?_/$[1_]!NC_ .O/OU3UZ@Z]_H_V'_SQ.T?_
M $&Z/_KS[]4]>H.O?Z/]A_\ /$[1_P#0;H_^O/OU3UZ@Z]_H_P!A_P#/$[1_
M]!NC_P"O/OU3UZ@Z]_H_V'_SQ.T?_0;H_P#KS[]4]>H.O?Z/]A_\\3M'_P!!
MNC_Z\^_5/7J#KW^C_8?_ #Q.T?\ T&Z/_KS[]4]>H.O?Z/\ 8?\ SQ.T?_0;
MH_\ KS[]4]>H.O?Z/]A_\\3M'_T&Z/\ Z\^_5/7J#KW^C_8?_/$[1_\ 0;H_
M^O/OU3UZ@Z]_H_V'_P \3M'_ -!NC_Z\^_5/7J#KW^C_ &'_ ,\3M'_T&Z/_
M *\^_5/7J#KW^C_8?_/$[1_]!NC_ .O/OU3UZ@ZK1^*VV-M5WS$^8&/K=O8.
MLH,?F9UH*&JQ-/40P#^*3K:&)XRD0L /2HXX]O.>T=-J,]67?Z/]A_\ /$[1
M_P#0;H_^O/MFIZ<H.O?Z/]A_\\3M'_T&Z/\ Z\^_5/7J#KW^C_8?_/$[1_\
M0;H_^O/OU3UZ@Z]_H_V'_P \3M'_ -!NC_Z\^_5/7J#KW^C_ &'_ ,\3M'_T
M&Z/_ *\^_5/7J#KW^C_8?_/$[1_]!NC_ .O/OU3UZ@Z]_H_V'_SQ.T?_ $&Z
M/_KS[]4]>H.O?Z/]A_\ /$[1_P#0;H_^O/OU3UZ@Z@Y+JWK3+T4^-R?7^RZV
MAJE5:BEGVS1NCA&# ,/#S9E!_P!A[<BF>%@R$@C@1Y=4>)9058 @\1TC_P#9
M;>@/^?-=;_\ H(T7_7KVM_?%U_OU_P!O27]V6_\ OM?V=>_V6WH#_GS76_\
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M\+_FZQX^KE_C?_>C_GZ]]G1_\JE-_P!2%_XI[]]#!_OM/]X7_-U[ZN7^-_\
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MJQCO=>ZMD^87=^^OB1L_-?*J2+([_P#CYUGA$RWR-ZZH<=2-D\!M;#N\V8[
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M%3X?=V?H**EI*NLR5=L^F5ZX4<"AIZ.6N-G:*,#W7N@P_G$5^R/YLW1G1O\
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M>&^6IO!-ELSW=E)ZO'^4F:H<QX?:T&WL12H9BL%'CZ>GAC@@BC@B]U[HAO\
M+)['KMK_ /"@_P#GL]0=PUW\-[-[5Q_Q1[$Z9QV=>>GER.RNK</DZ+R8;[JP
MJ*.GI]RX3SK3EHQ,LI46AET^Z]U@_F0Y&'8G_"CK^1ONO8]0V(WUV-UW\I.J
M^T*C$,*6;+;4H<365>-QF5,<ZM6XZDK\CEJRG@GA,4%4HJH=<Z*8O=>ZVC??
MNO=4$?S2^O?YV8^2_4WR0_EL[>^'W8O7G0O3._L;C^FN\]RY;^,Y[<^_ZFDD
MRE;3T!3 82EK(\1B:7%XJI;>5.\<.1S,<SP)6!E]U[H6OY3G\W:@_F'5G=/1
M'<O2&Y?B9\Z/BWDXL3\@_C9NVK?)>"&HG>FI\Y@JV6GI9:W%5$BQB5'@U4CS
MTX6:LI*JBKZOW7ND/_PH<R>].H?Y?H^;'45%52]Y_ /OKHSY+]75F/CJY)56
M3/TNSMT4=4M'ZYL)DMH;KSL.6CE!I_L#-/)I>GBEC]U[JX+HWMK;/?G2O4/>
M>RJB.KV?W+UCL/M/:U1%)YE?'[_Q=+E:,AK+?_)ZN.]U!O\ 4 \>_=>Z%/W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]UK0_P#=0C_R\K_Y=_:S\'Y?Y.F?/\^K&?Y4_P#S
M)CL+_P 2?/\ ^ZK&^V9^/Y=73AU:+[9ZOU[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW57G\Z_9&X>P_Y
M2O\ ,*VMM6+)U.<F^+/:>:I:/#1/45-0FTJ!\M44L449$DIJJ:AFB,:AF=7*
M*CDA&]U[K#_)&S<&?_E%?RZ*ZFDI98X/B5T[A&:D!5!)MK%0XZ53<D^5):1U
MDYL9 Y  L/?NO="C\N?Y=/PH^6&Z]E=X_(7KZ;&]G])460K=G=_[![3W)\?M
MUX''QT]6*R+^^&T,UM_+Q8H4U77&2&;(&GC6660*A9F]^Z]U2-_+9^'^T?ES
M_-9[%_FW[=ZYDVG\2^ANLC\7/@+G=UU>5W#G.Q)*!*ZFSO;E3E,^:G,YC'5T
M.7S=#B,K6Y"IJLC0U$3^7QT<9?W7NMGC_2?UK_I%_P!$'^D/8W^EK^ZO]^O]
M%W][:#^\7\$^X^S_ (S_  3[C^)_PK[O]C[O[;[?S?M^37Z??NO=.^-W?M/,
M9W/;7Q&Z-NY7<NU?L/[T;=QN;IJZNQO\50RTOW])%*U11_<Q@O%Y8T\B@LEQ
MS[]U[JG<=#[/WU_/FH/D_P!64-*<GTE\!-U=(_*?=N,CJ12RYOL3<^%RNP-N
M5$R 8Z?<%+A*3<.0KHUD>MH\:^"-<B4];B&;W7NIO_"AO<&%VU_)>^?^0SV1
MI\71U?3V/V_35%2Q57K=U;@PN,QU,M@29*NOJZ:%!:VN07(%R/=>Z-/_ "K]
MA;IZN_EH_ +KS>^,?"[PVA\._CIA-SX65Q))15U'M/%"IHY64E#-2RZHI-+,
MGD1M#NMF/NO='V]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:T/_=0C_R\K_Y=_:S\'Y?Y
M.F?/\^K&?Y4__,F.PO\ Q)\__NJQOMF?C^75TX=6B^V>K]>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M"R>-Q^9QV0P^6HZ;(XO*T57C<ECZR(3PST]=&T4T,J,"KQRQLRLI%BI(/'OW
M7NJH/Y;7357_ "[,-G_Y>&XFJ(NG=K=A]@[Q^#._LGF*C*QY?978N3K=QS['
MK:NLN\>[]CY.MRD/VSU#MDL&:+)T9D:'+08_W7NCM=M_%+J3OV2NH>\J?=':
M^PLA44]16=-[NW962;*JA3QF/P9;;%))28O<E"]R[46:AR5&90DP@$L43Q^Z
M]T8FBHJ/&T=)CL=24U!CZ"F@HJ&AHH$I888:5!'%##%&%2.*-%5555"JH
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M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZUH?\
MNH1_Y>5_\N_M9^#\O\G3/G^?5C/\J?\ YDQV%_XD^?\ ]U6-]LS\?RZNG#JT
M7VSU?KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>ZB5E!0Y&..'(4=)70PU=%7PQ5E.E2J3XV5)Z
M>95<,%E@GCCDC<#4DBJZD,H(]U[J7[]U[KWOW7NO>_=>Z][]U[KWOW7NH=#C
MZ#%TRT6,H:/'4:25$R4E#3)21!ZN1YI6$<:JH:661W<VNSLS&Y)/OW7NIGOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NM:'_NH1_Y>5_\N_M9^#\O\G3/G^?5C/\
M*G_YDQV%_P")/G_]U6-]LS\?RZNG#JT7VSU?KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NM:'_NH1_Y>5_\ +O[6?@_+_)TSY_GU8S_*G_YDQV%_XD^?_P!U6-]L
MS\?RZNG#JT7VSU?KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NM:'_NH1_P"7E?\
MR[^UGX/R_P G3/G^?5C/\J?_ )DQV%_XD^?_ -U6-]LS\?RZNG#JT7VSU?KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NM:'_ +J$?^7E?_+O[6?@_+_)TSY_GU8S
M_*G_ .9,=A?^)/G_ /=5C?;,_'\NKIPZM%]L]7Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JAO_ (43
M]Y?(_P"(G\MOMKY:?%GO[?/2O:G5VY>GZ*D&%Q6W]S8RMI-Z;HQN!K(:K'Y_
M"9:(2>+*^198C$X:% 25+*?=>Z&KHSX?_(KLWI+IWLG/?S9?YBU)G.P>K.OM
M\9JDQ&+^.]/215>[,325]3'2QS?'ZHF2G2:H<1K)/(X0*&D=KL?=>Z--\,NL
M_DIT_#\@MA?(KO\ WY\FZ"E[R7.=#=L=E;;VQMC-'9><VAM,C"Y&+:.#V[AZ
MFJQ.ZH=TC[I,7$T\4T)8)811>Z]T=3W[KW7O?NO=>]^Z]U[W[KW1,?A+\4]\
M?$K8_9VT]^_*GO'Y8Y7L7O'L/N&CW;WGDHLC58*EWS+#)%MG#K&9#38;'&%G
MCA$HA6::=J:GI(72GC]U[I2?&[Y?]2_*K=OR:V[T_EZ/<^*^+W>4GQZW?NW$
MY.'*T%9N/$[?PF<S%/120:D*X:;-ICJ@^1BM=2U41"^+GW7NC5>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NM?S_A1SWO\E?AU_+NWW\L_BM\B^QND>S^OM^]2XB*DP6(V
MQNG$9&BWCEXL-5T];0;CV_F=!T5RSI+334\HF@C#,T32QR>Z]T:G8?PF^0N[
M>O=F;HJOYM?\QJERVYMF;=SU2M/B?CLU-'4YFAAJ'"1-\?S*8$ED-E,^K2 #
M)?U>_=>Z'+XL=5?*C!?%W?'2?R<^06Z.QN[:7<O>>S,)\G:#;F%VAEZW";DR
M&0EV?N&GQF+H*7#4>5Q&$K\=$R)1F+[VBD9_(&-_=>Z$/X6?'/='Q-^,_6/0
M&\_D#VQ\H]R=?4&7I,EW?W;DOXON/,G*Y"KKT%7.TD\S04,=4M)2K-5U,T=+
M!#')42E=7OW7NC2^_=>Z][]U[KWOW7NO>_=>ZH@_X4B=B=Z=&_REODQW[\??
MD)VUT)OSK.#JZBIZKJROQ>#DR-/V?OG:^TJZ.HR<N*J=P8V6FQV<K)*6HQ&8
MQM1%4>.5I7T(%]U[JV?XL9+(YGXQ?'++Y>OK<KELKT/U#DLIE,E5/75%345V
MWL=+/45$\K-+---*S.[NQ9V)9B22??NO=%=_FP[G[/ZN_E]_+KO?ICMW?73W
M:/1/QU[;[6V/N'9T6&R,;9'8N(J,I2QU]#G<1F*&KI99:18I5-.LGB>3QR1N
M5=?=>Z!3^1CO;Y#]Y?RWOC-\F?E)WYO'O3N;O/9>X=Y[AR66QN$VYBZ6FR6?
MR2XFFH<9@\-B((I:3$4]!%/)()6DJ/N'5Q'(JK[KW5POOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>ZU??\ A1CWG_,.^(6U?CKV[_+\^178NW-W;PWYVVF^
M>F*C:6T][X+(X/I[8.>[&RU5 N5V]5YBFDH,+L[,%X*;)C[F.9EC$<R1-[]U
M[J\OX'_+G8OSN^(/07RQZ]FHAA.YNO,-N3)8BBK4K_X1FHE-+G\%-(CN/N<)
MFH*^BE!:^N GZ$>_=>Z)!_/-^;7;GPP^#'8^5^,LZQ?*3>^T>Q:SJNN_AT>5
M& Q/4N!K=U[UWE415%+5T*T^W=N8V=*9JR%J67,UV(H9%D:LCBD]U[I\_D=;
MW[\[O_EP?&;Y*?)CY [W[][@[UV+DM\;DS&X,%@MHX^C3)9G("AH<?B\!C,=
M3Q_8X^&D@DGD:22IE26>T*RB"+W7NK>O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]T7GY3[8WAN7H?M#_1_P!M[[Z3WKAM@[US.UNP-@08BOJZ
M&OH,9524D\E%G,9EL9700U"1R-!-2$2!2FM-1/OW7NM='_A-K_-3^4GRN/<G
MQ,_F%;T3='RGVKL7I[Y4]1[FRN&PVU:S<G67R V[ALU020T>&I,=15(PJ9;#
MS231408)F8H)6:2F<CW7NMI?=.Y]O[)VSN/>>[<O0[?VKM'!9?<^YL]DYA3T
MU#C\!3R5=;65$AXC@IJ:*221C^E5)_'OW7NM2G^4_P#.GY\_/[^;U\XMB]X]
MX=A=2_&?J7J_9/<73GQ9PFR]O;=GIL1W.NW<ILQL[EJO!'<]-6KM.OCJ<ICY
M*E9DRE?)"9*:.B^VD]U[K;S]^Z]U[W[KW7O?NO=:WOSGW]\BNK_Y\7\F_KO#
M?)SNFHZ!^1L_RSRN\N@6S.+P6V16]3;)R,M$7IL)AL379:FU9J*01YG)Y54G
MI8)X1!+%K?W7NMD+W[KW7O?NO=>]^Z]T57K[Y?\ 4O:7RN[]^(VQ<O1[CW_\
M:.O>HMZ]O5N+R<-=!BJSN:HSZXS 5*1:FARL-!@OOJB-W5HZ>MHCH_=.GW7N
MC5>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NJROYJG\RC9?\LWX\XGLBKV;D^V>Z.V]]8?I;XS]'X2?[2IW9O3=
M:O\ P^BFJM+B@Q5/H\E95%3I7QT\(>JJ:>-_=>ZR_'SXI?++<.Q\#OCYP_,?
MM3</?>XX<+N3='7GQLR5)TCUSM"K6,2-M_;5-04,FX<]043R-%45VX,]D7R4
MB&=::B@:.CA]U[I-8C&_.3IOY[] ;%WAWQ0]R_"7?G5O>F,QN4W9M#';?WS!
MOS&C&Y;$XK<&1PD>-PV;Q\>WJ+.R8R>GP%%4**:M&2>KG^WJ6]U[JU7W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=%5^6GR_P"I?AWM+KC<79^7HX\KW#WETY\>NK=I
M?Q.&AK\YN/N7<%!@Z2GH(Y-3SKCX:R?(UA2-S%0TE1*1Z1?W7NC5>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZI/\
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M5Y<UE5'D:6&JBFC=I"_NO=;&?Q'_ .R4?C'_ .*]=+_^\WC??NO=%=_G(_\
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M_'8-I&+IJQ]%3-'&Y6!HBL93W7NB$?\ "8BJWAVM\)/GGM7NKM/MWO"IQ/\
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M_)1Y2JH]:M4U(H:EIL?3^Z]T-O\ .4^!_P V?DC\7?A%\LNOMH;2[ ^?_P
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M_&#L'#;B3^]G8^\=PXT8G"R[:7([A-7BLK0RK_"Z>K"-)XY2DB.J^Z]T1?\
MDV_#SLOOC_A/7W/_ "RN\.I^_/B]W3N7"_)'9PB[\Z!WIU5#35._LE-F=LYJ
M";.8?%4N6H(:^LHFJ(*2MDF9:>HC=4Y(]U[I1?!;^;+_ #$_BOL/8GP!^;7\
MI;YV=P?*'IFEQ_3^S.WOCSL"FW)LK>F)VQ2T]-@\U7;LR]=C,!0?Y(:2&OR4
M>4JJ/6K5-2*&I:;'T_NO=;/O1-/VY#U7M6J[X; P]NYJ'(;DWSA-J9-\[B<-
M5[DJIZX;>Q>0DI*";)T&WH9XL=#72T-/)7+3?=O! TYA3W7NA=]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=4X?.GL2HB^?'\J9,3U#\F-YX/J+Y$=^[W[5WU
MUY\6^PNP=N;>QV[>F>P-DXN?)9_#[;K,4OWNX-SXR%1%52^.+S5,_A@C\C>Z
M]T4S^>Q_+U^17R@W7\ /FC\!\ED]C?,+X[_(#8NQH=^08::.LQ^P>]:R/%Y3
M*Y#&3TZ5553;4K*V&LK:2H-,*?$56>>4HZE#[KW1J?YC?56WOC[_ "9OD)\0
M>C.K^Y^PJ@_"W?/QQZ8V'U!U!N_O/-9*OR^W9<!C35KM_&9NL$]965"5%=75
MTPNSU%74SL?)(?=>Z*-_+K^.&6^77_"?/;'\NWN7K;Y!?&?M"O\ C-OOHC>>
M%[QZ+W7U'6X?+4>2R'\)RL)SN)H:7*4$DYQF0C6EJ96EI7:&58IDJ(HO=>Z$
MG^5+\H>P_BA\/>O?A!\YNA/D%UG\DOAYM>DZ2Q,>R>@]X]N[=[#V[L@MC]K9
M[86XMLX7*XK,15>+BHJ:>GFJJ6LI:F-WK*:F@=7'NO=<_@'\1-Y_"GXL?S(?
MDMWCL+>^/[R_F!=^_)SY;[KZ<Z_V3D.XMR;>H.SI<Q6;5V8V,V;39ZJRN=H8
M,A.]7'CS6P15U;+305$Z1">7W7NDM_PG$AWK\:/Y.O476/?W2?R2ZC[+Z>SO
M>-=O7KO?7QFW]@<X(MS;TSN8H&QF*FVXM;F_NJ#(4SJN/AJ6!9D<*R,![KW1
M$/Y*'PD[2[F_X3^?)G^6SWKU3WS\8.Y>Q*SY#82F@[\Z"WEU3%23;ZAH:O;6
M9@ESF)Q=/F*"')I3/40TE8\Q6">)U0$,?=>Z$3X+?S9?YB?Q7V'L3X _-K^4
MM\[.X/E#TS2X_I_9G;WQYV!3;DV5O3$[8I:>FP>:KMV9>NQF H/\D-)#7Y*/
M*55'K5JFI%#4M-CZ?W7NMGSHNE[:3JK:]1WT<!'VUG(,CN/?>"VKDFSV(PU5
MN:JGKAMW&9"6DH)<IC]OP5$6-AKI:&GDKDIONY*>!IS"GNO=:[GP.^"W9O07
M\UKY7_&C$Y*.7^7AT=V7M7^8[T;LVGJ:R-,-V!\H<-N7;*;4"QSC'G!8-J;=
M.5I\48+4=0F"R90SS0S^_=>ZV@??NO=%X^5?8-!UQT!VUFJS:W9^])Y>N=\4
MF+VQU%U/N3N/-UU548VHCIZ2CQ&V<9E*Z2>IFDCCC+0I%J:[R(BNZ^Z]U7G\
M2?C[M+Y;?R3>AOA'WOU]VIL+^*?R^^C/C?V]M'M7J+<74^9PF;VWLG&8.KDI
MZ/=&)QLDM;@\YC&J::>&.6)98*>H1RDD3-[KW1=O^$^_P?\ DE\-?BAE-S?.
M.MS&;^06!@ROQJV7C3CZ_-2[=ZJ^-VY-RT^V,-B88T>:NH,KE<CGLQ15,&-B
MJ*_$5>$2594HZ41^Z]T4/X"9?L?:O_"B+^:?WKNOXM_-/:?0/R9Z]ZWVQU#W
MCNKX:]F;<VWD,EU%CMJ8NNIGK*S:\+TD=;+19*2AJIX8Z2IAI6=9P9Z59_=>
MZ&7H#M+O[XP_SD/YD\OR8^'_ ,N^YLC\C<EU*_PG[[ZOZWR?:VUX]B;4QE;&
M-CTV8DGBVGU]%'7?Y56FJR>,BJJ\RU67,=J"HJ/=>Z3/\E[ ?(WXQ?,W^=3M
M_O/XH=Z;-I.X/G5O#Y1479--LO)9W9LFW.S:C<6:AI]M9F"@%?OC,4WWM' U
M)A<)4'7*&E> *ZK[KW2O_P"$[LW8>S,S_,WVWVW\?/E)TCF>]OYDWR%^4/6-
M1W3\6^PNH\7E]I=H+1'&UE-E]Q[;QF/CJ2<=/Y**HJ(*V,/#JIPT@4>Z]UB_
MF5T.Z=__ ,[O^3QNS%?'7Y,=C],?'*B^7N+^0O8FW?B7V%OO9^+B[XVJ,!B*
M6KS-'M:KPN1IZNII94JOMZFIB@@D1ZHQQ2*6]U[H/?C9C>Z_Y+/\Q3>7Q-ZQ
MZ&^67?/\IWY3%NZ>M\IU/\:NQ.VZ;H/=N[Y)#D-NR3XG!Y*"3:M?4QB9H*4^
M>@%5#)4TXGI\C45GNO=/7\QK ?.;X'_S*=D?S@?AS\?NP/E[\>>XNA=F?'KY
MH?&S86W<I)O6"DVUDI9L3N;$87[>3*&II8:FATH,0_VAI:Z/(+34V1>NH?=>
MZLN^%?SK[^_F"[KVOO';OPQ^2OPU^.6R1F,OO3=/RXV]0]<[DWAE)Z26CQ6W
M]L;7@J,E5O@8'JI,ED<U53T:B6DH:&@@K15ULU![KW5;_P 9<3\@?A__ #V/
MYL>2SOQ,^1'86U_G5C?BSO'XY=K[*V'-5;"J$Z^PM1C<NNY=Y@R8K:Z8VOR4
MB5*5.NO$5*\M-CJIJK&Q5WNO=;1/OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JCG^>3_*MW;_,?Z7ZEWQ\>]VXG
MK;YL_#WL2'N?XN;\S,<(I'R%+)1U55@JZ::"ICIZ?(5F*Q%5#/)3RQPUM!3>
M:-J:2H!]U[I]Z+_G&X&+9^$VQ\Y/BC\V/B/\E</34.#[!V%%\,NT._-O5V7I
MX:<557M#=76VU-X8?.86JGEU4T@JDE4$PR*64/)[KW5A_77:6]>[*_";]P.T
M.Q>J^E<11S9N$]G;!JME;FW>V2H#X(QM3+4R;EVUBL>9VDDBRF+QV;J:^".)
M**"BC:3(>Z]U0_\ RTLSOK$?SO\ ^<EV;O+X\?+3876'RIR'Q>HNA^T]]?$3
MLW9.V<Y_H)P53M_,L<WE]J45#CE-341/3R5LM/!50B2:FEEA57;W7NME7>>S
M]L]A;0W3L+>N%H-R;.WMMW-;2W7M[*TZU=+78W<5-)25M'41,"LD-33321NI
M%BK$>_=>ZUQ_Y'?Q%[RZ,[4^1W4/<&ZJO>_1'\M?M_NOXK?!/*UN0KJJ>; =
MZOMO?F7J<DTM0]%D*[ 8J;;F'I*B.(''>;-XJ$0H)XV]U[H-O^%).=J]K_(#
M^0QN:@V]F=W5VW?YJW3>=HMJ;<CCFR&3EQ&;VS41XZ@25XHFK*UXQ# 'D1#(
MZAF47(]U[HXG\UQ<U_,U^)DG\OKXNX7MK^\GROW3U92]G]I9[J3=G66&ZZV/
ML/<^!W-N;);FR&X,5AXZ3-U=)CHL91;;;R9C(RUSAL>F.I\A6TGNO= 1_/S^
M-W:.-Z"_E@[XZ#Z9[4[SV;\!OGM\6^U>Q-B]1;6F[!W3'LGK&!Z2;(4.&H@:
M[*R4QIZ**5*6GD:/[C[F98J."IGA]U[I6_S>OBO\B?YC_P 2OCY\G/C3U)NW
M8OR9^%WR4V;\L_CGTIW,\>RLUNJBV))2SU.+S.+E;1MS,Y2:E2HH**KK/,J4
MU/%7/05-=/2T7NO=#!\H/EKE/G;_ "[^].@NAOCO\F,9\IOE5T'V!\>)^C>V
M.@MU=62;'RO<.)GVSF:S>>X,YBZ#;&.PVUX\G4U<M;!F*H9""!?X+%DYYH*>
M3W7NK'?@M\6\)\)OA[\<_BC@,DF;H^B^JML;%K,_'3BD7)9"BA\N6R0B 'C&
M1RDU94Z3ROEL22"3[KW1K_?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=:\/R\^ ?=/QT_FD=>?SE_A3L&7MS*[DV2.C?GA\:L%4T6-S^ZMJ5
ML>-H:?=.S6KIJ&AJ]PX6'&8::KH*C(P&MAP](E'KJ)9XY?=>ZL6R'\RKH?\
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M=>Z][]U[KWOW7NO>_=>Z][]U[JM?^8ANS^:EM0]"5'\LOJOXL=II6;VRU/\
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ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
MU%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/
M>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KV
ML=>_X<4^*'_/>9;_ - C,?\ U%[]X3>G^#KVL=>_X<4^*'_/>9;_ - C,?\
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H][]U[KWOW7NO>_=>Z][]U[KWOW7NA6_YH?\ ^56_^1'NOG^77NO_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>tlinechart_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tlinechart_001.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     ! !+     $  0$L     0 !_^X $T%D;V)E &0      04  DE$_]L
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M]5-7S567JO))]T%91'^V&#NZF20QF@Z:5=75B7_0/Q\-/^?E_)O_ -#+:O\
M]A?NGCGY=6T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
M]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E
M_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#
MKW_0/Q\-/^?E_)O_ -#+:O\ ]A?OWCGY=>T#KW_0/Q\-/^?E_)O_ -#+:O\
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M7O?NO=>]^Z]U63_.-_[=P_(S_P I%_[W>U_;D7Q#_5Y=5?AUHN^UG3/6X/\
M\)^/^R-.R_\ Q9O>7_O*[+]I9^/Y=.IPZO1]L]7Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[K7BV]\MOYT_R2_F"?-KH3XP[/^ '77Q#^)?:&VNK(^]?D
M!UKV!O3.9#+9K:V"W'/BJ:@V]V)A*?*9"BAS,$U0_@QM-#3U%( \TSL/?NO=
M4B_S6_\ A1]_-L_E9_+S.?$S<FU?Y='<.3PFQ]C[V;>N#Z%[+VA!(F]:9ZA*
M<451W#72*U.$*EON"'^H"_3W[KW5\&\NQ?\ A05)\5,+\B>A\A_*P[MWGG>J
MMM]JXKHR;X]=J=?9'(19[%T^4_A.+RT_<N0Q]1E_',8H$J5HJ>>4*KU$ >X]
MU[JP_P#EG_)3LWYA? _XS_)?N;;>V=G]J=N]>KN7?>UMG8?(;?QE!D8JZLI)
MZ6EH<K7Y/(TJQ&F :.HKYI5?4&;^R/=>Z/1[]U[KWOW7N@>^0/?/5OQ>Z4[.
M^0G=>YH-G]5]0[.S6^=[9^:%ZMHJ+!PM*Z4]/$&GK*VH8+#34T*--4U$D<$*
M-)(JGW7NE/U?OJD[0ZTZ[[,Q]#4XN@[$V+M+?5%C*R199J>'=N/I\A'!*Z>A
MI(4J%1BOI+ D<>_=>Z77OW7NO>_=>ZUZ/^%#'\S/YD?RFOCOU/\ )SXX4WQF
MWIM?>?=V"Z)W%UYW;U1NG<=>E9N; ;ES]/EZ+.8'L';E/'301[9GIY*.7"2N
M[5$<JU:")HI/=>Z,+_(E_F&]T_S/?@-@_E/WYMCJ_:/8.3[3[)V//A^H,+EL
M!AA2;.GIXZ61*?-9O<%<*B196\K'(E&(&B-.0?=>ZN.E$IBD$#QQS&-Q#)+&
M9E5B#I+('C+J#8D!U)' 8?7W[KW6G5_/C_G<_P S_P#DY]R]-;3VM0? WNOK
MSO;9FXMS;6KMP=!=@[5S&,J-DS4-'DZ.O6F[>J:.LBEEKH)Z:>(0'0[020:H
M!45'NO='W^(/R%_GE?-/X/=/?+_JS?O\J3!YKNSKG^_>U>J]]_&SMW%T\$LD
M]3!'0UVX:#M_)/$K-3W,\>!ETZO\RUN?=>Z(1T'_ ,*GMQ]??.'*_ C^:9\4
M<'\6.P<'V%1]3Y_M?K7?M1NW;^*S60=5HJK*XZNIC4P[<R:5-!+#DZ?*U2Q4
M\\=3-!]LTDT'NO=;C"LK*&4AE8!E93<$'Z$'\@^_=>Z[]^Z]U[W[KW19/D'\
ML^H?C;NCX\[$W_F&&_/E%W7MSHSI[:-"IFJ\CDLM'+65U6P 84^.P^+I:JIJ
M:B33'K%/2!_N*RG1_=>Z,W[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z;LO%EIL3E(<#6X[&YR7'5L6%R.7Q<F;I*>KDC84T]510UF/F
MJZ>*8HTD$=?3/*@:-:B%F$B^Z]UI"_SJ_P#A0S_-$_E+_-%_C%B=K_ GN#:^
M=ZLVAV]M#=F2Z+["VS7IC]V5F5QWV61IHNW*FG-735F&J_W89!'+$T3^.)BT
M:^Z]T??LC^8C_.ZZ9_EW=2_S0'ZW_EV?([HW='QNZK^37:?377>P^Q^EMX[?
MP/9V"Q>=DFHLGE-^;QQ.5@V_39$M7R?802>"&6IB@949/?NO=&U_DN_SY_CW
M_.!P>[MJ8G:57T5\F.ML/3[CWKT;G=RP[I%7AY)(*5]P[;RBTU ^5Q,%=404
M]6KT$%10S3TR3HT=333S>Z]U>_[]U[KWOW7NO>_=>Z][]U[IBW3N;!;*VQN/
M>6Z,E3X;;.TL#E]S;BR]6VB*DH,#3R5574RG\1P4\4CL?P%/OW7NM/WXT?SX
M?FK_ #4<C_,QW'\$]G;3ZLV'\,OCC7]B?'?K[)]63=N[[[%W+4S9:3"PY1VS
M%/C<;292#"20'$T.)GK%EK(_'E)'BTO[KW5PO\CCYL?-[YT_$;-=G?/+XU5'
MQT[9VUV=G-D8=FV7F>M(-T8J@I:.ICS4&WL^TV1QWAJ*F>BE<5,M-4S4SRT_
MB&N"+W7NKFO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U63_ #C?^W</R,_\I%_[W>U_;D7Q
M#_5Y=5?AUHN^UG3/6X/_ ,)^/^R-.R__ !9O>7_O*[+]I9^/Y=.IPZO1]L]7
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[I)[4V/MK9)W,VW,?]B^\-VY?
M?&XG-1)4&HR><$2U%03(S:-200J$6R*J *![]U[KY5?_  KM_P"WRN_/_$"]
M#_\ NMG]^Z]U]/OXC_\ 9*/QC_\ %>NE_P#WF\;[]U[I%]X]R_&_^6_\5NRN
M[.R<I!UST3T_3;MWUF%29JV5ZO>^9J<A_#<7#/*&J<AF,[EC38^C60!IJB&G
MBT1A=/NO=4A_!S^9/_-D_FE=!]P_-;XK==?"_H3HG9NZ=\[6Z+Z1[TVCO'M[
M=F_Y]A4RU%5_$-U;?W?MG&[6AJY9H*&FEBVQDGAKDJGE@JJ6.%JCW7NC8_R5
M/YX72G\XCKK>PPFS,CTS\A.GXL)/VOT[E,J-PT_V6X3+'19W;^6$%+_$\1/4
M03P2K)30U=#4*L=3%X9Z*JJ_=>ZU-O\ A8;\GOGO'W+U;\8.TJ[K_KGXC;EQ
MV6[*ZPZ[ZLWID-RUVYFVQ7G'Q9S?TU3BL3$E9#+=Z#$TQJ:.BU&:2HJJH1S1
M>Z]UM]?RW^P?YCV-ZFZHR?S#ZW^%G7?Q8VO\5=HY[!;[Z>[;W=NW=%L'A</+
MCI<OC<SMS&8NDI#AEK9ZUX:^9H9XXXXDDC9I%]U[HIWQ!_G ]Z_SA<Q\G*#^
M61F_BWTIMGX\;EP> Q6<^6^T]T=H[GW72Y^GR7V^>CVAMO/[07:F JZFEA6D
MK*C,9BI8I4Q5>)I95C5_=>Z '^3]_P **>QOES\UM^?RTOG-T]UIUA\J=J[F
M[;V;M3?G1=5E8=IY_,])SY7^/85L3GZJORN,JX<?B:RJIJG^)3Q5JT]0'I\?
M)X(9?=>Z0G_"U;_MUET'_P"+_P#5G_ONNU??NO=#U_PD)_[<X;2_\6%[U_\
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M^>WKA_YRFQ\?M6!9<%NKH+O? ]E2&O:C\6$I\?3Y2!Q&*>851.X\;@$\320
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M7KNC_P!YO)>_=>ZT _\ A$/_ -E7?-S_ ,5ZV'_[TGOW7NB)?S9?^XJW._\
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MEZ(6+;_7&*KII3XZ.IK>PMR4N>Q[:'D>3:%0T*AH6F@]U[JT?W[KW5:GRJ[
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MCW[KW7O?NO=!IW1_S)WMC_Q&F^__ '5U7OW7NM<?_A(3_P!N<-I?^+"]Z_\
MN71>_=>Z#3=W_<87U?\ ^,T<A_T-N+W[KW1A?^%9'_;E#OW_ ,27\>O_ 'L<
M5[]U[JJ7_A4__?#_ (8Z_EJ_PC^,?W/_ +^?'?\ OC]CK^U\O^BS,_PO[[1Q
MI\GW/BU^CR6_W9X_?NO=;K/3.ZL%OKI_JC>^UZ^'*;:WCUKL7=6W<G3R++'4
MT.X<72U=).C(S(R34\T;J58@@@@D<^_=>ZT^Z/K?<>+_ .%I55GNI4CPV#R?
MQ1G[(^2,%+,S+7XZIZV&VZ<O&8YDA9MPQ[&E=4-.KR0F=G:6619_=>Z,!_-"
M_P"XES^13_X8O=W_ +A;D]^Z]T=#_A4=_P!N*/G-_P"6S?\ OXNOO?NO=*_^
M7]_W#M]"?^,QJC_WAZWW[KW0"_\ "3?_ +<H=!?^)+^0O_O8Y7W[KW10/YPW
M_<1[_(9_\CO_ +N:WW[KW5NO_"A#%8O,_P F+^8'29?&T&5I(>E(LK%2Y*CC
MKHUJL%G,174-2J2JRK44=;3T]1!(!KAGBCEC*R(K#W7NA)_DB_\ ;HG^71_X
MJ7T__P"ZN'W[KW5/?_"3[_F6?\T?_P :7=M_^Z_'^_=>Z%3_ (4]_$OL#='Q
MFZD_F0_&U:C$?*G^61V+C^]-O[AQCR)/+LV&II:G<<,L:5--'40XBJH<7EY/
M+Y"M!292GB3_ "Z4-[KW0D8?Y?\ 7_\ .3R_\J_KGK&JAFZUWAMS!?S*_E[M
M?&U$69BQ-+\=,G%C=H[$S$]/-)]K-7=T1BH2-Y$>L@V9D8G66G^[@;W7NMC+
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW59/\ .-_[
M=P_(S_RD7_O=[7]N1?$/]7EU5^'6B[[6=,];@_\ PGX_[(T[+_\ %F]Y?^\K
MLOVEGX_ETZG#J]'VSU?KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJ1_^Z[?_EI?_$>W/P?G_DZKY_EU
M=Q[;ZMU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U2!_/*^%7S>_F/\ Q$WI\,/C7C?BWM;9
M_9.=V%FMU=J=V=V;KVYD:>/8&7QF=AHJ/;F#ZSW'3S?=5]$$>H?<<1BBC4B"
M4SLL'NO='$_EM=3_ "A^._Q%^//QJ^2VV.AJ',_'7HKJSH_%[OZ.[>W!V/39
MR#JG#4.!I<A/19[86SI<3)54=#%+)$E37!)2RK(RD,/=>Z?_ ([= [XVO\F/
MFG\F.UZ7;8W1W=O7KGKWJ08AEK:B@ZQZ0P,46#HZNHNQ2IR.[,SO;+30K8(M
M=3HY+1*L?NO='<]^Z]U2!_/*^%7S>_F/_$3>GPP^->-^+>UMG]DYW86:W5VI
MW9W9NO;F1IX]@9?&9V&BH]N8/K/<=/-]U7T01ZA]QQ&**-2()3.RP>Z]T<3^
M6UU/\H?CO\1?CS\:ODMMCH:AS/QUZ*ZLZ/Q>[^CNWMP=CTV<@ZIPU#@:7(3T
M6>V%LZ7$R55'0Q2R1)4UP24LJR,I##W7NG_X[= [XVO\F/FG\F.UZ7;8W1W=
MO7KGKWJ08AEK:B@ZQZ0P,46#HZNHNQ2IR.[,SO;+30K8(M=3HY+1*L?NO=3O
MGGBOG=N'X]Y_;'\NS+?'?:?R(W+74V'I.P?DKG<YC,-MW%U,<QK<KCZ/!;;W
M)+ELZC+#%1T]5!!11-*U9.]0*84%7[KW6L#U#_+1_P"%;71&S(M@]5?S//Y?
MFV-MKELUN&L279E!N*NK\GN6H>KR65R^7RGQRK<OFLOD:J1Y:JNKZZIJZASJ
MFF<@6]U[JQ#^7[\$?YXM#\LMG]S_ ,VWYZ])_(WIOJ';VZ,]U7U-T*)MKT\N
M]<U3?P>BRV>QV-ZWZYQF0H\5ALAFWIEJSD?%7R4M5#315$$55#[KW6Q!N2HW
M)2X/(U&T,3@\YN2*%6Q.)W)N"?:M#-(74%:C(4N,S,]*@C+D,F,J"6 70 Q9
M?=>ZUA/BU_+(_FH=)?SF_DW_ #6MYX+X#9S"_*;K6OZEW)TUM[Y0=@K5X'%R
M'9)HZFBS4_1T,&6JZ1=CT".DN-HDJ!/*VN%E6_NO=;1](U4]+3/70T]-6O3P
MM64])4M6Q1RLH,B13/%3O+&KW"NT$98 ,8T)TCW7NI'OW7NO>_=>Z][]U[KW
MOW7NB_?)7_9BZCJS<^(^,NSNF]W=C9[!9G"X\]V]KYGJC$4,F3B6GBK7J,)L
MC?-56_;K+-,:?[" 2M%'#YXUF::'W7NJ1O\ A/W_ "TOGI_*3Z+["^,7>E/\
M1NQNOM^=ZYGO"+L;J;O/>51F*"?<> V[@*K'G;^8ZMQ='6QI%MNEFBE_O#3'
M5+)&T=E5S[KW5MGSSQ7SNW#\>\_MC^79EOCOM/Y$;EKJ;#TG8/R5SN<QF&V[
MBZF.8UN5Q]'@MM[DERV=1EABHZ>J@@HHFE:LG>H%,*"K]U[K6!ZA_EH_\*VN
MB-F1;!ZJ_F>?R_-L;;7+9K<-8DNS*#<5=7Y/<M0]7DLKE\OE/CE6Y?-9?(U4
MCRU5=7UU35U#G5-,Y M[KW5B'\OWX(_SQ:'Y9;/[G_FV_/7I/Y&]-]0[>W1G
MNJ^INA1-M>GEWKFJ;^#T66SV.QO6_7.,R%'BL-D,V],M6<CXJ^2EJH::*H@B
MJH?=>ZM@^#70.^.F-I=V;S[AI=MQ]Z?)3Y*=Q=]=G3;:9:J&*GS.0_@VRL3]
MW=C5?P#K["[5Q[,"$\\$[("79W]U[I)_S*M@_P Q7L#X_P".HOY8_>74O1GR
M'PO86V-P5^0[FVC!N7$9O;] )QD<%YZC$9]<5-52/32"H7#S.\<4E,DU$TXJ
MX?=>Z +I_*?SRM^==P["[TV/_+[Z"WS/A&Q.:^1W7?9&[^X)H9W1(VR6'ZTJ
M]N8G'M5E6D>,5O8/VT50JM)25,%Z=O=>Z/#\.?B-U=\)>CL-TAU9)G<Q3KG=
MS[[W[O\ WE6QY7<&[MV;_K),EN/=FXJV.*".JS.;R,TDLICAB@@C$5)20P4=
M/3P1^Z]T,_960[/QFT<G6=/;1V%OC?L<,QPVW>RNQ,AU9B)I!%(8Q59G%[7W
MC6TJ-.(58I@9RL;/( S(L<GNO=:WW\GK^6%_,O\ Y=?RI^>_>/;]'\'^RMK?
M/_M/#]K[QINOOD+OK'9+;%=B,[O+,B.@IZ_IZ*CS4$O]]*V,K)68X@T\3AK.
MR+[KW5T7S!Z!WQ\C]V_$?9D%+MNHZ+V+\E-N=]?(.'.,M1-7T_26/K\SLO$T
M=(Q G\O8*;9R$[,"B08QU<,)=#^Z]T=SW[KW6K)_,*^$'_"C;Y/?+?$=R_&S
MY0_R]/CUTWTIN3<%1\:M@YNNS?9572BMC-'%NO<=)N7IG<F$EWI/2>;PS4T!
M7"154]#C:F7R5=?7^Z]T"E9\+/\ A9!74L])-_-D^!*15$;12/1[%Q&/E ;\
MI/3_ !MBFB;^C)(K#\'W[KW5TE)\3?G5U'_*UC^//QQ^3^U,/_,/_N1'N/-_
M*'M+&5'9N*RW86[<J,]O'(5!S=#E)Q092LJLI1XV:;!U,>,HS1+#B%IZ2*@C
M]U[H+OC'G_\ A0#2[,HM@?)OJ_\ ENY/>5+'-CY_D;@^X]YTR,FF00Y"?K['
M;-2#,5J,$:6"'=6W:>8-^W]K8@>Z]T>#X8?"_;/Q'PW:F<K=XY?N#Y ?(OL2
MH[>^2W?NY\;3X?(;JW!+3QT5)'!04I:FPNW,!C88*#"XF"1XJ"DCN\M363UE
M94^Z]U5%_/9^//\ .![2RO2/;'\N'YD[2^+?4O0.T.S>R>\8=Q=AU_7$517;
M6IC6TM=E/LL!G(=Q8=<6E=&<=7QMCHZA4J*BG<Z)Z;W7NKJOB-V/V!W%\4OC
M-VWVQMG^YG:7:'0'3O878^T0GB&,SN\]O8[(Y:A"6!C%+7U,\80@,H72P!!'
MOW7NH?RUQ?R*W#T)V-M3XN;?Z=SO;>\=K9[:6"G[R[#S/76!QQW'234AR<\^
M#VEO"NKGH?-YEHA00+4E!$U93AC(ONO=5-?R'/@'\[OY7OQ6R_Q)^1%)\2=]
M[7Q?8.\^P]A]A]+]R[QK*]SO*GBDEQ>7P^<ZXQ=.!%DJ52M?3Y7_ (#5)4X\
MRT>NN]U[H!]P_P NW^:OE_YVVT?YK='MW^7Y1[ VMU34?'J7I:?Y*]BU&7K-
MJS0Y.'^*?QH=,I1TV>^XR*U@IQCY:4)%_#_.Q<Y(>Z]T9G^>1\'_ )T?S+?A
M[7_#OX^X?XF[,P>_,YL#=6_^QNY.\-X8VKH9]C5M)E5QN'P^$ZRR\-;%/70E
M#75.5IF$$=QC_)4?Y-[KW0V'X#;S^7?\L&F^ '\Q[;'4-)EVZ=V-U9E=X?&[
ML/+;XI?XEUQ1TL&*WEAWW+L[;,^&RM/6T%)71T3T=?3HYDI99ZJF9Q+[KW12
M_@?T/_.=_EN='8;X;4NQ?AW\\.H.JG.W/C[WGNCY);E^+>=Q^VG -)B]R[>'
M778$50N'E>6.F6BRSF.@2&G$T[HI7W7NCO?!+^7A_LN'<?R>^9O>6YMM]I?-
M_P"9NXL/D^Y-_;3Q-3B,#@L!M&EIJ#;NQMHT];)+6KA,+CZ*ACGK:DI5Y>>G
MAJ:F*!(*6EI_=>ZK/^=W\N'^:A\D?YKOP]_F#]24?P,VYL#X3T/\(V3USOKY
M"=@09G=$&;GR$F=DRM=0]/UU%@C74>0^TIX8(<C]J8C5//4F<4U/[KW1T_YS
M7P_^9W\Q7^7WV#\,^D\!\8=G;@[P/6,G8.\>T^\=UT5'@AUWNS$[K,.&AQ/6
M>3GSIJI\#0T_FJ5Q>A*B=_ S0QB7W7NA3_ES?%3Y%=)?R\^N_@U\NL1T49.M
MNC!T N\.@.S]P[XILWB1156*%544FX=E[6FQ-7_#I(0ZI/71R3^1U,*%8Q[K
MW5:/\G/^5E_-6_ET8O(_$OL7Y1_&#-? K:W;=;VAM7+=>;.W'_I0S,=;+%5S
M8&&KFFQN%VCA,K74\,^4\@W!7F.6LH<?64J5$=93>Z]UB^??\M/^:+\IOYJ7
MPX^?G6V'^ V!Z\^$,E'%L;KC?'R*[#@S6Z4FR-579&?+5]!U!5T.":IBJ(H*
M:"GI\B*5XGJ):BL$XIJ?W7NK#/YL?QO^</S>^!79_P 3>@-O?%K9V]N_MJ87
M:?8>[>V>[MUQXS 4HR4-;E(\-%B>M,A4Y^2HIJ..F@GJ4Q/B:IDJ&@8TJ0U/
MNO=.W\O7I+YW?#[^7QU'\9=]]?\ Q)WGW'\>>K,)UCL'([2^1>\<;MG<,>V(
MIX*&IS%96=3OE< YA2C6<4V*RHD<S21^)0D)]U[HA_\ (L_EM_S(OY9F4^2F
MUODC5?"[LCKCY+]R5O?67W'TOW#O6'+8//9E!!D8*3"9KK*BI<ECZR$1&,2[
MDIGIFIU4>?SO)'[KW6Q?N?%[>SFVMPX7=M)C:_:F8P>6Q>YZ',A&HYL?D*>2
M*MBJQ(1&::2F>59=1TZ"VKB_OW7NM=/_ (33_ CK7XG?&+O;O#KZ:MS&V?EE
M\B>S]R=$YS-TY%<O377NX,UC.LHGE>IJWEBRU%+D]P*X>,2)FH]<;2(9I?=>
MZV2/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5D_SC
M?^W</R,_\I%_[W>U_;D7Q#_5Y=5?AUHN^UG3/6X/_P )^/\ LC3LO_Q9O>7_
M +RNR_:6?C^73J<.KT?;/5^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZI'_ .Z[?_EI?_$>W/P?G_DZ
MKY_EU=Q[;ZMU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= %W3T%A^
M_OL-L]D;ESE?TXG\.J=T=-X^.GQ^,W-/C*K[I*?<M6(WK\C@7,=.)\1'-3T=
M<J209-:^BGDI#[KW0]HB1(D<:+''&JI'&BA%54%@ !P !P /?NO=<O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW6JSMKX;?\*-.\^]_DCTA\KOFSU)L_\ E^]O;PW90U&[
M>K<#M\;ZCV-D\C5D;;V-/0;<QE=MZJS6!GCQU97Y:HJZG'Q!IZ"22L#5$WNO
M=;0.S-G[9Z]VAM;86RL+0;;V=LG;N%VEM3;V*IUI*6AQNW::.DHJ.GB4!8X:
M:FACC10+!5 ]^Z]TI??NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=5D_SC?^W</R,_\ *1?^]WM?VY%\0_U>757X=:+OM9TSUN#_ /"?
MC_LC3LO_ ,6;WE_[RNR_:6?C^73J<.KT?;/5^O>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZI'_[KM_\
MEI?_ !'MS\'Y_P"3JOG^75W'MOJW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5D_SC?^W</R
M,_\ *1?^]WM?VY%\0_U>757X=:+OM9TSUN#_ /"?C_LC3LO_ ,6;WE_[RNR_
M:6?C^73J<.KT?;/5^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZI'_[KM_\ EI?_ !'MS\'Y_P"3JOG^
M75W'MOJW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5D_SC?^W</R,_\ *1?^]WM?VY%\0_U>
M757X=:+OM9TSUN#_ /"?C_LC3LO_ ,6;WE_[RNR_:6?C^73J<.KT?;/5^O>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>ZI'_[KM_\ EI?_ !'MS\'Y_P"3JOG^75W'MOJW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=5D_SC?^W</R,_\ *1?^]WM?VY%\0_U>757X=:+OM9TSUN#_ /"?
MC_LC3LO_ ,6;WE_[RNR_:6?C^73J<.KT?;/5^H62R6.P^/K<MEZ^BQ6+QM+-
M6Y')9*JCH:>"&F4O)---*RQQ11J"69F"J 22![]U[HE.#_F"=![P^26T?C%L
M.IW#O'>6Y9=PQUNXL?BC0X:@_N_A:S-D-4U;035IJ(*33$U+32P-K#^?38-?
MPS2O5=0/1X_=.K=>]^Z]T3_9WS0ZQW_\J-W_ !4VC2Y/,[DV+M?)YS<F[J:6
M%L9%5X6>EIZS%)9S-+54DE9$DK!="2K+"3KC8>[%"!7JNK-.C=S30TT,M142
MQ4]/3Q233SS2")$2(%F=V8A555!))-@.3[KU;HF.(^8Z]AT^Z-Q=$=(=F]W]
M<[.R%9BLCV+MFKPFWJ+(U&*8"MBVW!FLG05>?%*NK]V&)*>:1?'!-*2";::<
M<=5U5Z,%T[W+UYWSL/%]C]99U,[MK)R5%*S/ ]%4TE50D+44-=2RA9J2LIV(
M#Q.H-BKKJC=';1&GK8->A1]ZZWU[W[KW7O?NO=>]^Z]U[W[KW5(__==O_P M
M+_XCVY^#\_\ )U7S_+J[CVWU;KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NDMO?>VU>M]H[BWYOC-T>W-I;4Q55FL_FZ]BL5/3
MT:ZG8A0SNYX5(T5I)'*QQJSLJE^UMI+V18HE+.Y"JHXDGJR(9"%45)P!U7KB
M?YO?P.R(7[SM7.X&^NXRW6>XIK:/I?['&5OZOQ:_^-O8Q?VYW=.$(;[)8O\
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M0D!?3C_+I/-L:(I8,V 3FGD*_+K98]PCT&>O>_=>Z][]U[KWOW7NJR?YQO\
MV[A^1G_E(O\ WN]K^W(OB'^KRZJ_#K1=]K.F>MP?_A/Q_P!D:=E_^+-[R_\
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M^[MH]844Q=9*;K[9E,CE&%@HJLRV8K(B.#KBJ(WO^0#;V+[+VUVNTRZ/*?\
MACG_  )H'[:]&$>RP1\06^T_YJ=$,[![R[G[8DE?LWM?L/?J2S?<&EW7O"OS
M=.C!M2^*FGG>GA5"?2L<2JO]D#V+;+:+7;O["&..F*HB@_M J?S/1A';QP_
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M4VIOS^[;^@'M^/W5W)!0I;M\RCU_XS(!_+JXWV8>2'\C_D8=0?\ AB[XD_\
M/Q/D7_Z%NV?_ +$?=_\ 77W'_?=M_O$O_6[K?[^F]$_8W_077O\ AB[XD_\
M/Q/D7_Z%NV?_ +$??O\ 77W'_?=M_O$O_6[KW[^F]$_8W_077O\ AB[XD_\
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MZ(XPAGEA\T'E.>8^;+7ED+X^IG>NE$ +4'F:D +7%?,\ :&BF\OX[*FJI)X
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M<FX5@/\ 0&B00$>A50K?[;5J_I4Z0#=)@VK5^5!3JQ/IOY_]8[Z^UQ'8</\
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M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JD?\
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MJBT;Y2M4Z2I=$@B(!@@C<N[YD\C>VECR2@=1XMR11KAP*BHR$&="_F6/FQ%
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MZK)_G&_]NX?D9_Y2+_WN]K^W(OB'^KRZJ_#K1=]K.F>MP?\ X3\?]D:=E_\
MBS>\O_>5V7[2S\?RZ=3AU>C[9ZOU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5(__==O_P M+_XCVY^#
M\_\ )U7S_+J[CVWU;KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZUR_YGO\R.7+SY[XV_'S<4?\"1
M)\3VIV-@ZLEJQ[M'48+&5"6 HT *UM3&Y^X)--&PA68SY1>T?M4(@FZ[FG=A
MK>!Q\(XB1P?/S13P^(YI2!/<?W!+%MOL'QE9I5/'R**?3^(CC\(\ZT;[#ZYW
M_P!I9T[7ZWV9N??>XQCZW*G![3PM1GJH4V.4--,8::.201I=1?3R[(@N[HIR
M&W+=;;9H_&NY8X4U!=<C!%U-P%6(S_D!/ 'J%K';I]T?PK>-Y'H6THI8T'$T
M'^JI XD=*3/]#=Y;45VW3TQVQMI8C:1L_P!=9C#!?4J^HU%'';U.@Y_+ ?4C
MVEM^9=NO/[*ZMG_TD\3?\=8]*IMAOK?^TMIU_P!-#(O^%1T%4D<D,CQ2H\4L
M3M')'(I1E9#8JP-B"""""+@^SD$,*C(/ ]%1!4T/7*">>EGAJJ6:6FJ::6.>
MGJ()#"\;PD,CHZD,KJP!!!!!%QS[TRAP58 @BA!R"#Y'K:L4(()!!J",$$="
MW@?D-W]M9$CVQWCW!MR.)0D4>![,S6(50JZ0%%/6Q@ +Q8?CCZ>R2XY7VR[-
M9;2U?_3V\3?X4/1K%S#?P82YN%_TLT@_P-T/&!_F-?-O;94X_P"0^]*@HX<?
MQZGQVZA<,&Y&4H:P,+@<&XM=;:200Y<>UG+]U\5E$/\ 2&2/_JVZ]'D/N%O,
M'PW3G_3+&_\ Q]&Z>.ROYE7S$[8Z_KNN-V]I:<)ET6#.5NW-NX_:5=70:"DE
M+456-IZ4BEJ+DS1Q)&LHO&]XBT98VKVGV+9KD74-OW+E%D=Y$0UJ" Y;(\B2
M:<1G/3NX>XN[;G;FWDE 4X9D54=A3@2H&#YT KPX8Z*IU9U)V/W9O+&[ ZLV
MEEMY;KRC$P8W%Q"T<:$!ZBJGD9*>CI8[C7//+'$EQJ<7%QEO.]VG+\#7-Y(L
M4:\6;S/HH%2Q/D%!)].@QM>TW&]3""U1I'/D. 'J2: #YD@=;0'PF_E7=<_'
MO^$=A]OC$=H=QP?;UU%%)3?=8+ U$9#H<=!.BFNKH7 *UL\*F-@K4T$+KY7Q
M$Y_]X;KF?5:V6JWM34&AI+,.'>0>U3_ I-?Q%A@9(<G^VMOL&F>ZTS7 H1BL
M<9X]H/$C^(BOH!U;7[A?J3^O>_=>ZZ) !)(  N2>/I[]U[JNWY$?/3 ]>9!]
MI]3TV(WMN6BJHUS6;K7>IQ--X7'EIHS3RQ25M20"K-',L4)(]<KAHTQZ]Q/?
MBWY;D^DVL1W,ZL!([$F".ARM4(+OY&A"J>))!7HFO=V$)TQT8^9\A^SCT(G2
M/S=ZJ[7%+A\_41]=;RET1C$Y^M4452YTBU%D6$<+,[, L4PBE8\(LEBWL0\D
M>]FT\VZ89F^DN30>%*PT.<?!)A34F@5M+GR4\>GK7=([C![6]#P_(]'/]S)T
M9]>]^Z]U3Q_,"_E@;?[]CR_;G1M)C-J]U!9J_.;?'CQN,W0Q+/(TK'1'0YJ0
MFZU1(AJ&]%4%9_NHIP]M/=R7EDK9;@6DM,!'RTEO]G$M&/->*\5X:3%7/7MS
M'OP-U9A4N.++@)-]OH_HW \&_B&KWE\/N[KO==5A\U09W9F]-I994JJ*LBFP
MF0Q];CG5T-CXYZ>>)PKHPL0=+J?H?>7L$\&ZP"2,I+%*N"*.CHPI\P0>!'Y'
MK&V:&;;I2CAHY(VR#575AD>A!\P?S'6Q9_+Y_FKT>]&P?2GR>S,&.W@XI\7L
M[MJO:.DI<JY)2*CSC^B.DR)!C2*KTB&J((J&BJ=+U6+GN9[-MMVO<-H4M%EI
M;85+1CS:/B63S*\5\JK73/W(ON8M]IL]Q8+)@1S&@60^0?@%;T/!O.C4U7O^
M\=>IIZ][]U[KWOW7NO>_=>Z][]U[J-5UM'01>>NJZ:CA+A!-5SI3KJ:]AJ<@
M7-CQ?W9$:0T4$GT KUIF"\33[>DS6=@["Q\H@R&]]H4,Y02"&LW+14SZ6N V
MEYE-B0>;6X]JDVZXD%5BD(]0C'_ .F&NXD-&=!]K ?Y>D)D/DI\=,13BKRW?
MO2N,I3(L0J<AVI@J*/6X)"ZY*]5U$ V%[FQ]F47*VYW!TQV=TQXT6WE)I]@0
M](I=^L8!J>X@4<*M-&!_-NDC5?-#XC4<IAE^3'1;N%5KTO:&'KD]7_-R"KD2
M_P#4:KC\^UR<A[VXJ+"[_.WE'^%1TC/-NUK_ ,3+;_G/&?\  W2,KOYA?PKQ
M\/W$_P B^OI$UK'IH:JIR;W:_P#NNFII9-/')T6'Y/(]K8_;/?I306,_YJ%'
M[6('29^>-H05-W#^35_P5Z1>1_FD? _&3M35'?=%-*L:R7QVP=U9:,AOH!-2
MX*:'5_4>2X_-O9C%[0<QS#4+,@?TIK=3^QI0?Y=(9?<C9(30W(/^ECF8?M6,
MC^?2-K/YNOP<IHO)#V+N7(/K"_;T?7.;1[&_JO44<$=A;_5WYX!YLN3V3YA8
MT,"#YF>'_(YZ2M[I;*HQ,Q^0BE_RH.N>S?YLWP\WOOO;6PL7N'>-#5;IRM%A
M<?N#.[3.'Q<=1D6T0+55$M0):='F*1^1J?QHSAG=8PSK6_\ 9C?=NMI+EXXR
M(U+LB2!I"JY- !0T&:5KC KCJUI[F[3>SI DCU=@H9D*I4X%2>%3BM*=67>X
MIZD#KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z#;>?<?5?7FM=Z=@;4V]4HI<XZMS$)K"%^I2BC9ZN0#\Z83S8?4CV'=YY
MMVOE_P#W-NH(3Q"O(H<@>B5U'\@>F);F.'XF ^5<_LX]%*WI_,6Z4P)D@VGC
M=U;[J0K&*HI: ;>HV(^@:6NT5:W_ ,,>W'^/'N)=Y^\3L=ABU6>Z-,%4\*.O
MS,NEQ^49Z+Y=YB3X06_*@_GG^712MZ_S'>W,WY(=F[=VML>F<,$J)8WW16(3
M]"):@0TAM_C0&Y_PX]Q+O7WD=VO.VR@@MAZMJGD'V%M"?MC/1?+O4C?" O\
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M KR9(,GCZ:CB(:XL,BX(L;@DA22X]O[V*NAHW'E1BI_XTH'\^I+VG[V?+=Z
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M_.&11^UE _GT"V]-D[OZYW+D]F[[VWF-I;JPLD,>5V_GJ%\=50&HC2:/R12
M,HDBD1U-K,K!@2"/9_M^XP;K"L]M(LD;5TNA#*:$@T(]"".B>]L9MNE,,Z,C
MK34K"A%14?R/6T9_*G^;I[YV!_H2[(RWF[>ZSQ,"XG)5\X:;<&!I=,45268Z
MYLCC+QPU9(U2QF"I+22/4F/$#WC]O_ZMW/U]JM+:=CJ4#$,QR5^2ODKZ'4N
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MG9IHC3\V=CQ9CYL?,_8    ,3=XWBXWZX:YN6U.W^\JODJCR4>0_,U))-O\
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M#XBCI\?C,=11"&*&&E4)'&BC@*J@#_>3S[Z!6EI%81)!"JI'&H1$445544
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M6(@#TA:&,CU2,S7<54'\NM+@TZNE]M=7Z][]U[KWOW7NO>_=>Z][]U[JD?\
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M4).(9C0!ODK85_(8:H -8N]R^3OW];_5VZ_KPJ< 9EC%25^;#BOKE?,4U?\
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M<EW9F))R.M[:.T01Q*J*."J  /V=$N[;O=;[.UU>RR3RO\4DK%V-, 5). ,
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MPQ@Y8^I\E7&IB!4"I$#6MLUTX5?S/H.MBSK;KK:_5.S</LC:-"M%B,1!I+D
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MTA])/I/'X/OW7NJ3?[B?SWO^?T?%#_SU1_\ V)^W:I\^J5;HNGQ7QGR:Q/\
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MNQ'J',40F8M+5XXE99\+6F[,[(DM)*2?N$D<1R1]">6_?#D/[QZ+$9OW3NY
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MD.E/8>2NG4JP\<((5K"9X@=7MCD;VNW3GM@T">';UHUS("(Q0T(0<9&%#A<
MX9EZ$%K8R79P*#^(\/\ 9ZM=P/P%Z%QNR9MKY?'Y;/YNK"RU.]Y<B]!7QS*K
M -21Q,:6"%"S6B>&96]/F,S*K#+"P]A=@M;(VDL;RR-EKEG*S!LY7315 KA:
M$'&K417H0)M$*KI()/\ %6A_+RZ(?W)\!.T-A?=Y?8+_ .DO;47DE^WQ]/\
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MS]SMDMX?%7<$6QLW*[U4O5^\*R:MPLI(NRXW)%9Z[',2"5BJ!50EFTK+2Q*
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MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW59/\
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M6U5-2P 'JEE=N.3[GS9.6[#EN/PK"WB@7%?#0 M3%6;XF..+$GY]&\4"0"B
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M[R^#;H7:E:5   \R20 /M/2SDWD?=?<"\^@VB!KB;27*AD1412 69Y&15 )
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M0)&@H .)/FS'S8\23QZQ0W;=I][G:YN6+.Q_(#R 'D!Y#_+U>1_+._EG>?\
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MU#HP93D,I!!'R(Z.]TM\Y^V.L#38G=$\G96THO'$*'/UC#(4Z+Q_DN2*R3,
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MR#NET@=I[JE^BCXS&$G'X?#T#.S-2XW%XS'4Q=F+E8X8((8P2S,2JHBJ238
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M8U5OF#L6;Y&]I?WHIO*L#1;C>GQZI/\ KA&%C"X7[=R%8P_P_P 194?1J12
ML>8[YI/%\>35]O;_ +S\/Y4ZG%/9WE>.T-B-LM/"-*UCK+4<#XQ)FK\]=:$B
MM">K..A?YZ796WQ1X?Y#]<8GL+'H5CFWCL-DVIE@@',DV/D+8JME)O98FQZ
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M/^-T^70%W;VVVG=JGPO!8_B@.C_C-"G_ !FO5:N^OY07R*ZGGJLO\<NVMO\
M86)#O4'9V[HCL^LE']F)0[U>)J9;"QF>IH3_ *G3[,.;]WY,]YX!;\V[6!(%
MTQWD&9X?.J2IHF5:Y\/]5"?B5N@2WMSNG+[%]KN5D6M3%*--?E^)"?GV'YCH
MK.X!VGU15KA_D%U'O/J6M$R4B;ARF(EJ,#42,=($&6B$U$=3<#152H/S+[PC
M]Q_N77=HKWW)=['O5L 6^D++'N<:C/\ 9]JS4&25$3G@L+'I1#S!-8D1[I;R
M6K8'B$%H&)]'%0/VD#S;I1TE6DBT]=052NI\=125E),&'%F22.1#^#8A@?\
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M];'ZPTB[\T)3N /S(J!^9'1R-G_RZN[\ZL,^Y\AM#8\#']ZEK<FV=K$Y_$=
MDU(_ O\ \#Q]1_C8?;5]W#>KL@W4MM IXC4TL@_)%"G_ )R='$6S2O\ %1?S
MJ?Y8_GT9G:G\M+K^A6&3>?86ZMPSHP>2' T-+MB%OSH83#)3%?P2LJ$_4:#]
M)*VG[M.VVX!O;JXF(-2(U2!#\J$3-]M&!/RZ71[(@^)B?LH/\_1E-J_#WXY;
M2T/2=98?+U"Z"]1NJ:?=.LI^6AKI9J47_(6!5/Y'N2MJ]H>7-H^"RB<^9GU3
MU_*5G4?D .EL>VPQ\%!^W/\ AZ,5C<7C<-1PX[$8ZAQ6/IETT]#C:2.AAC!_
M"11*J*/]91[D."WCM4$<2JBC@J@*H^P  #I:JA10"@^74[V]UOKWOW7NBC]U
M_.WXH= ?=TO8O<VU8L_1ZTDVAMFH;>.7$B_2*6@QBU4M(S$6#57@C_JX'/LF
MO^8;/;:B6501^%>YOV+4C\Z=2/RK[1\Q<YT:QLIC&W":0"&&GJ'E**U/1-1^
M750W=?\ /BC'W>-^//3+.?6E-N[MNOT"XXU#"8F<DC^TK-FP?IJB^H]@F_\
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M:L/R]_F(=]_+RMJ<5N#)?W&ZL6J$V,ZKVK6R)1$1,&B?*U-HYLS4H55@TR+
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ML7_T+L?_ /5'OWU47\:_[T/\_7OW%??\H\__ #BD_P"@>O?Z4.L_^?B;%_\
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MWKF\ALEU3.D8]795'[6(ZL\JQ"K$#[2!_AZL)ZN_E%_-?LE8*K(;$P?5V+J
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M+-/-*RQQ11(K,[LP55!)( ]U9@@+,0 ,DG  '3L,+W+K'&K,[$*JJ"S,Q-
M!4DDX &2>M7+^8]_-)RG=$^:Z ^-N1KZ#JV=ZG [QWQ0HT-;NAGD$;46-T_O
M4^#DL58C3-D%<HRQTQ:.HB'FSG+ZD-!;MIB /B25IK XT/DGJ?,>@XY_>R/L
M!#RDB[YS $^I0>+% Y'AV:@:O$E)[3*O'/;%354O0H6OI#JJ'KC;OGR$<;[J
MS4<<V8GX?P)]8Z.-AQHB^KD$ZY"3<JJ6PPYRYF/,%Q1"1#&2(QPU'S<_,^7H
M/F37$/[P_O._NKNGA6K$;=:,RVRY'C/P:=@:&K\$!^".F S/6S[X;?&]^ZMY
M_P!X]S4CGK?9U7!-EED0A<E5K:2+&*?H8B-+U1!N(BL?I:974=^S'ML><[SZ
MJZ7_ !.W8%P1B>04(C_TO R?T:+^*H@O;;+ZIM3?"./S/I_GZN'[L[^Z=^-N
MRI-Y=M;QP^S<%!&]/BJ*1A)65TM.EUH\7CX@:BLGTV]$416-?7(8XE9UZ"[3
MLUQN\@AM8RQQP%%4<*D\%'V_8.AG!;O<'2@J?Y#_ #=4F;N_GVXJ*MJJ?87Q
MLR%?CU>0466W=V3'B)F4,X0RX^BQ%:D;%/$Q"Y-P&+("P D:4[;VC<@&:Y /
MF$C+#]K.O_'?\W1XG+Y([G ^Q:_X2/\ !T7W<O\ /6^2-<Q7:G5?2^WH&$@+
M9>CS6Y9Q<)I*21Y;'0@J1)?53."&464J2QQ![3V2?VDTS'^CH0?S5_\ #TI3
M8(Q\3,?LH/\ (>@'W/\ SAOG/N#6,;O[:>S%<\KMCKK$SV!+D@-EJ?*.+AP+
MAM0"*00VHL;V_MKM4/Q(\G^GD8?\<*=*$V6!>()^TG_)3H!MQ_S"OFONI)8\
MG\DNS:59@P<[<RZ;.8:@H.EL1%0LG"BVDBQN18L23:#DS:K<U6VC/^F!?_CY
M;I]=M@3@@_//^&O0#[A[P[JW;J.Z^W^T=S%S=SN'L#+9JYNYN?N:N2_,CG_7
M9C^3[-H=HM+?^S@A7_2QH/\  HZ4+;QIP51]B@?Y.@N]F/3W3IA<'FMR9.EP
MNW</E,]F*Z3Q46)PN/ERE3,Q_LQ00))+(W^"H3[;EF2!2[L%4<2Q  _,XZJS
M!!4D >IQT>OJO^6!\U^U_MJBBZ;RFR,14*K',]GUD.Q5C#_I+4-6PR[ BYO'
MC7 'UM=;A+<.?=KV^H,PD(_#$"_\QV_\:Z03;K!#^*I]%S_/A_/JR+JK^0Y6
MO]G6]W][TU.-'^7;;ZLV^U42Q_XY9K+>(*%_VK M>_U%O4"=P]VAD6L'V-*W
M^%$_Z#Z+)M__ -]I^;'_ "#_ #]62]6?RK?A-U:L$R]3Q]AY6%45LQVGE9=X
M&31;F3'MX,+<GDE<6OUM^GCV"+_G[=+_ /T8QCTB 2GYCN_XUT62[K/+^*G^
MEQ_L_P ^C[;=VQMK:&+I\'M/;V#VQA:152EP^W<33X6EB"@ ".GIHXHD
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M=K]C;#:0)-ZO5'GX:.L*?F\O<P^Q4/SZ!4GN/N>_$ILEA-+FFH123MZ_!""
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M?\H\'_.*/_H'KW^N=S+_ -';<_\ LONO^MO7O]D[^(__ 'BS\<O_ $2&V?\
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MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JD?_NNW_P"6E_\
M$>W/P?G_ ).J^?Y=7<>V^K=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO==,RJI9B%5069F-@ /J2?P![\33KW1:>T/EOT;U935JY#>%'N7/4H=(]
MK[.ECSU6\J$ Q2/&XI*1EO=ON*F(V!TAFLIC[?\ W3V'ELE+F[C+BH,<-9Y
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MX_2/VV)C/(*V)NICY2VZ/A"OKEG;_CS'HDN_?WG"\)+[E**BGZ<<$0I]D42
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M/U]B*TYUW6S^&YD/_-0B3_JX&Z61[E/'P<_GW?X:]5_=Y?R-.JL[CY:_X_\
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MEU2?NW>&[-^Y_(;KWON7.[OW-EI?/D\_N3*SYJLG;Z RU%0\DKZ18*"UE
M  'N4K:UCLT$<2JBC@J@*!^0Z/418Q10 /08ZL ^,_\ *T^4/R(?'YFOVX_3
M_7M6(IVWEV-138Z::&3^WC<,0F0K2RV:-W6GI9%(*U7(N#M\Y_L-FJJMXT@_
M!&00#_2?*C\JD>G1;=;M%;8!U'T'#\SP_P /5_\ T'_*:^)736$J(-T;1B[N
MW3DL?/097<O9=-'70JM4FB08W%)_D6/_ *QS'S5L3<I5CBT0;O[A;CN;U1_
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M.!*I=&*TX/IH2N<E5Z0[SNV_;?;&38MQOK*XC[D%K=30+*!DQNJ.JL#^'4"
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M/]I"Q,LLV,'N7[B2\\7(2(&*R@)6V@&!05'B.!C6PX#@B]HR69N6^^[W/O\
M</<7#O([NSL[L6=W8U+,34EC7I'=8=S=D=/94978.YZ_#AY5DKL4S_=T%78
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MG^<;_P!NX?D9_P"4B_\ >[VO[<B^(?ZO+JK\.M%WVLZ9ZW!_^$_'_9&G9?\
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MSJI8ICF>R_)29&2*07/VV!A#9'R@%2%K%HHV!],I((]BO;>2KV_HS@1+ZO\
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M;4G,].VXFJ(\]N6IB)(#+4F,4>)\B<E:>&6>-N8Z[B_L;['[86MC1[QO'?\
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M*.GE/J]4<M4@%CZB2H ^X>[%O'46L+N?XI"$6OV#62/]YZ*YM_0? I/S./\
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MJL'GJ)I(XHUMKD74#[K[&^S$_NYN)\:3Z3;+4H^X7S"JQ(U=,48_'/+I*QH
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M*9G*2^:65Y3Z8XT0+%!!&"%B@AC2&) L<4:(JJ,NMLVRWV6!;>U18HD%%5<
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M;'Z9/[#45&(*>4*. 9$=[7NQ)8G%/F+W%WKFFHO+N5D-08D/A14/D4CTA@.
MU:C3SR>@]->2S_$QIZ<!^P= K-+%34]15U$D<%+20M45=3,XBCBC2P,DCL0J
M("1=B0!?Z^PSM>T7>^3K:V4,MQ,YHD4$;RRN?14C5F/Y#I%)(L*EG(51DDD
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M]K_W(FC0C\)8:O\ >15OY=,RW4<'QL!\JY_9QZLDZJ_DE?*;>7VM9V-G>O\
MJ'&S1J]12UV4;>>5C+V( I,6&Q[$"^J^84@V !N2 3N'NE86U1 LDQ\C30A_
M-N[_ (ST63;[$GP@M_(?SS_+JRKJO^2'\8MH_;U79FZ>P.W:^-8A44<E>NQ,
M7(5Y8BFQK-DD#'\?QDV'YOZO8'W#W2O[G$"QPCR('B-^U^W_ (ST62[Y*_P@
M+^53_/'\NK*.K/C%\>NDQ$W5?3?7VS*V%509O&;;IY,FP06 DRLZRY*8"YMK
MJFL2Q'+&X(O]\O-T_P!R)I''HS'3^2_"/R'19+<R3_&Q/VG'[.AU]E73'7O?
MNO=>]^Z]U[W[KW17NZ?A?\8/D!%4-V=TYM#*Y><&^Z\31':^9# 64G*XUJ6M
MF6/ZK'--)%?ZQD$@FFT;U=;":VDC1BI)1?[-B>)*'M)^9%?GT_;W,EJ?TV(\
MZ>1^T<.J;.^/Y%51&*S+_&[M=*@7>6'9/;$?A:WZBD&<QM.59K:EC2;$H/TB
M2IY9Q*FT>Z_!;Z+_ )N1?Y48_MHWV#RZ/;??O*5?S7_,?\_5+W=?Q4^0WQWJ
MW@[@ZIW5M&C6588MPO2+EL1,TALBPY>A>IQLCMQ^V*KR"X#(IX]R?M7,-EO0
M_P 6E1S_  UTN/\ :M1OSI3H[@O(KGX&!^7 _L.>@8P6YMP;8JOO=OYG(XBH
MNI=J&I:$/HY E0'1*O\ M+JR_P"'M)S/R=M7.D'TV[6EO=QYHL\:N4)%*H2-
M2-_20JP\CUJZLH;U=,J*X^8K3[#Q'Y=&6VA\N]][<AFBR-%'DY98! U;B\E+
MMF:0 WM.84EBE6X!LL*"X_VV)G-'W)MGO)C-L5_=[7J/ZD5#=1%:UHNJ6&0?
M[>20<,=!.ZY)AD-89&CKQ%-8_+*G]I/4;(?*_=LMQB]M;>H02>:UZC)$ W^F
MB2F&H<<E2.#QSPBVK[B/+T%#>[AN$U*8B^G@4G''5%.:'. P.<'&:0\BP+\<
MDC?Z72O^$-TB<A\C.U:XGPYJBQ:F]TQ^'IOS^-4\<[BW^# _X^Y*VK[H7(FV
MT+V4MP1YSW=R?Y121*?S4CY=&4/*%C%Q1F_TSM_SZ5Z1&0[1[%RG_ O>NY"I
MN#'3966A0WM]4@:-#]!:Z\?CZGW)>U>RG*.RT-OL^W C@SVL,KCCP:578<36
MASY]&<6R6<'PPQ_FH8_M:O2-JZZMKY/-75E56RVMY:NH>H;_ )*<D_[S[D2S
MV^#;ET6\<<2_PQHJ+^Q0!T81Q+$*( H]  /\'6"..2:2.**-Y9976.**-2[,
MSFRJJBY+$D  "Y/M433)Z<Z%C&] ][9G&5.:P_2G;>5PU'2S5M9EL;UQF:ZE
MBAIU#2323Q4;Q1Q(I!9V<*HY) ]ELF]V4)TO<0J?0RH#_-NF#<QK@NH_VP_S
M]!-ZXV(]2.I(/U4@C@C^H/LS1^#*?0@@_F"".KR1).I1P&5A0@@%2#Y$'!'7
M.29IH_%,!( ;HQX93_@?\?R""#_K@$ _W"Y*L_<JT6WW"OB1U,%PM/&A)X@,
M?B1L:D:H/$:6 8'WM=O<GM#?O>;,!%'.1]59@D6MP!P8Q\(Y%!.B2/2PK1]:
M50P&@8?I(8?[8_[[_8^\-N:/N][YL57M E[$,UB[9J?.)S4GT",YZSFY6^\+
ML6_42Z+V4IQ2;NBK\I5% /FZQCJZ_P#EM?S1,CT3)A.B_D%E*O)]+7%!M/>5
M1%-D*W:VLCQ4\H02356!!N!&$>:C!'AU4ZB! ?L',<^P2?0[@KH%.FDBLLD)
M]&5@#I^1%1Y8QT />OV(M^>XVWWE[PVNG&N2.)T,-Z/-T8'2)CYFNF3SHY+-
MM28O*8S.8S'YK"Y"BRV(RU%2Y+%Y3&U25M/4T]:BR0SP31LT<L,L;*R.K%64
M@@D'W*Z.) &4@@BH(R"#US[G@>U=HI59'1BKHP*LK*:$$&A!!%"#D'J?[MTU
MU[W[KW6"JJJ6AI:FMK:F"CHJ.":JJZNJF6GBBBIU+R222.0B1H@+,S$!0"20
M![VJEC09)P //KP%>J=_EA_.+Z4Z=_B6TNC(:+O#L& 34S9BCJVBVO03 +I:
M7(16?,%=0/CH'\+69&K8I 1[DCE[VVNMSI)=5@CXT(_58?)3\/VMGSTD='-I
MLTD^7[5_XT?R\OS_ &=:WOR#^5/>GR?W#_'NX=]9'/PT]3-487;%+_N+P^-$
MI8!*#&PV@C94;1YG$E3(@'FGD/)FW9N7K384TVT84D49SEV^UCGYT%!Z =":
MVM([0404]3YG\_\ 4.@ I:2IKJB*EI(9*BHG=(H884,C,TATJJJ 22S$  "Y
M) ') ]VN][AMIUM$U37+@LMO%1I= XNU2JQQCSDE9(QPU5('1M)9?26;[E>.
MEK9QG2]U.66+6:D1II5GFE:ATPPI)*>(2@)ZVG_Y>_\ *MV)U=MG;W;?R,VM
M1;Q[>RL4&9Q6R-QTJ5V+VU'*NJG2:AD#0UN:52'E>H1XZ231'3Q+- :F2#^;
MN>KK<)&M[>0)$*J3$320\#WD*S+Q PH89*] B^W\78I;*Z(?Q2 +,PK7*JS"
M/%.T,S#-7(.D78          6M;W&_1#T W<7Q=^/??]+)3]O]1[+WK4/3RT
ML>;K<4M%E84F 5EILO2&GRE-?2O^:JTY53]5%BZ^VFVW(4GC5_*I'</L84(_
M(]"_ECG[>N36U;9>3P"H8HKDQ,1PU1/JC;_;*>)]>J0_E-_(^AIZ3(;M^*6Z
M:^IFB62IEZIWW7Q2NX]1*8C,D0+J'H5(*X<^IFKR=,9(4]MMNOVT_426I/PN
MR>/"#@48 K(H\RP,I\@E,C(78/O@;OM:JNY6,-\HPSP2?2W!&231@\+MP 7]
M!:9+5XT#;XZTWWUMN/);0WUM;-;6W-AYO!DL%G,=+C*J)C^DF"9$D9''*.JL
MCJ0R,RD$H=]]A^9-FB^J@@6^MB"1<;>_U*$#CV*!*M//5&*>? TG?DK[VW(_
M.4@MFOOW==&@-KNB?12 M@ 2.3;N2< 1S,3BG$51(,D3@C7%+&P8$71E*\@_
M@@@^X@EB>W8HZE64T*L"K _,&A!ZR/AFCNT#QLKHPJ&4AE8'S!%00>CO]*?S
M'/F'T3]I2;7[ASFY-NTITC:78Q_OY0>,6M#$:\O74<0(N%I*VGYO^&8$]L.:
M;[;J!)2R_P ,G>/YY'Y$=13S5[&<L<W5:>R2*0_Z-:_XO)7U(CHC'YNC?X.K
MB_CK_/+VKNS/X+:GR(ZUINO5RE124%3V/LW+39/%4\M1J4SUF+JHVK:*C5]&
MIXZ^M9%8LR:4+$<;7[@I.P2Z316@UJ:J#\P<@?F>L8N=_NDW.V0R7.R71N=
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M0):E@\DLE'%')B*J61Q=GJ,;+(26(<%F)D;E_P!UM[Y>HJ7!FC%/T[C]5:#
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MK(004B\UBP[BADTA@H"S"-V-WQO6I[Y[ZW#DMW;BRCK/@8,NP,<<2,S1&&E
M$%'0P%B::GBC2,$F73R&<"_>U^\9:\E6TG(G)[")@#'NEW"2&CJ &MT<&K2L
M,7$E3H'Z(.HN(\&>7=IN-^F_>NYL78YB1N%/(Z> 4?@ _P!-Z$FHZ^V!NCL_
M=N(V5L['MD<YF9_'"A;QQ11QC5+45$EB(J>! 6=[&P%E#,54\TN7>7;KFJ\C
ML;--<DAQ7"JHXLQS15&2?R )(!DZ&%IV"KQ/6P]T)T9M?H79%/M?!*E;E:OQ
M5>Z=R20+%/D*M0?4UKE*:#4RT\6HB-"22TCR2/T0Y$Y'M>0[%;2W[G-&FF(
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M64K%&JQ(4AC15)3/>;LZ^/))<S-1=1%6=C_"J !:DX1 %'!0!T27%R:&29^
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MI-MK]IQG?=,RBP6-:JID7+T\2 >E*?)PH/IIM["6Z<B[9NE2T0C8_BB_3/[
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M>6VWN''T^5PF;H*C&Y3'U*ZDEAJE*NIL0RFQNK*0RL RD, 0DO[&'<X7M[A
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MA(O6O>^7!-"[6:JLP%55B1&Y&=)I737@"!0')!&.D_*/O9N>T2)'?O\ 4P5
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M"Z02&(T_X9I" ?,L,XX]![>N>-FY=)%]?6L#+Q22>-9,_P! MK/Y#AGAT/\
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MR21R*R/&Z A@587!'O,[=-JLN9[-[6ZCCN+:=*,C49)$:A!!'Y,K*:@T92"
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M(JDDD "_OA5?7UWS%=O<7#RW%S<2EG=BTDLTLC5))-69F8_,DGJ?8HA$ B
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M]XSF7?25@F6R0UQ:J5DH>'ZKEW!'JA3.:<*$FBBBA18H8XXHT%ECB01J /P
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M7'25M13U!0 #DQ@MJ!0,+VEG;/8/FW=K;ZJ+;Y N-*RO%#*P-<B.:1&H*#B
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MO_;N'Y&?^4B_][O:_MR+XA_J\NJOPZT7?:SIGK<'_P"$_'_9&G9?_BS>\O\
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MH0<W[N]]=L@(14@#CCA/#BC>0UJ#))1!@8IJ,$\_>W/*?/\ >):\E;1-9VT
M*2;A/<SF:\>N99(WEDMK=:$%(88]86A8L21U<BO\GS<@VWCI6[SPC[O-,KY>
MA78T\>-$S@%HZ:J_B;51BB:ZB1Z,-*/7XX?\W["1]ZX_%8"T;PZ]I\4:Z>I'
MATJ?0''"IX]!VZ^Z56,&#<J/3N5[>J$_)EE!%/72:\:#AT7C>7\K[Y2[8$\F
M%QFS=_01$LG]UMU1TDK(.;^++QXOUA?JBLYO<(7XN)+'W9VFZH)#+"?^&1DB
MOVQF3]M!\Z=1QN_W9N9MN!,"V]T <"&8*Q'V3K"*TX@,?05Z*;O/X_=X]>F<
M[SZF[ P%/3W\N1J]KU;T?IO<K6Q124C@6/*SD6Y]C&QYEV_<J>!<0N3P42*&
M_P!Y)#?RZBO>/;[?-A)^KL+J,#BYA=H_][4,A_)N@?\ 9YT#^I%5555;/)55
MM345=5,09:FJF:HD8J  6=R68@ #D_06]U1%C&E0 !P % /V=.S3O<L7D9F8
M\68EF/EDFIZ,[U9\+ODGVZ:>?;766:QF&J' _O)O!/[I4(1EU"5&K?%/51<@
M7IH)^>+<-8)[OSUM>S5$LZLP_!%^HWI3MJ ?],1U)?+'LUS'S60;>SDCC)_M
M;C]","E:CQ*,P\JHK9^PTL@ZN_E%8N%(*WN7M"LK9BD+S;?ZYI%HHD=>74Y/
M(PRR3QL;#TXR!K D,"1IC#=O>9VJMC  ,T>8U)'EV(0 ?]LPZR&Y9^ZC#& ^
M\7C.<$Q6JA%!\QXDJL6!X8C0T\\XL;ZM^*'Q\Z;^WGV+UAMVER],=4>Y,O V
MY,F&/ZF2NKVJ)X-5N5A>-/Z*!Q[C#=^;MRWRHN)W93^!3HC_ -Y32#]I!/SZ
MR&Y9]L=AY0H;&SA1QPE<>+-GC^I*785] 0/ET8CV&^AYU[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW3/N#;^#W7A,GMO<N)H,[@<U1S8_+8C*4R5E/40SBSQRQN
M"K*?];@V(L0#[>M[B2T=98F*.I!5E-""/,$=);ZQAW.%[>X19(I%*/&ZAE=3
M@@@X(ZUR/FK\$L[T!75F_NO(,CN+IRLF:6=VO5U6WY*B0*E+6MR\U"S.JT]4
M1?\ W54$2:):C)OD3W"CYB46UT52Y&!Y+, .*^C8[E_-<5"\^/>3V.GY&=K_
M &X/+8,26_$]J2?A?S:/-%?B/A?-&<K?Q]^0O8'QPWU!O38U8DD-0D='N7;-
M<[FARM(I)\%2BD%9(RS-!,O[D+DE24>2.07<R<M6W-%N8+@4(S'(*:XV]1\C
M^(<"/F 1&'('N!?^W=\+RR:JFBS0L3X<\8/!@.!%24<94^H+*VS[\?OD/UY\
MCMDP;OV-D M53I3P;FVQ62 5V*JYE),%2@MJC8J_AG0>*95)4AE=$Q0YCY;N
M>69S!<+@U*./@D7U'^4'(\^NE?(O/NW^X-D+RQ?(H)8F_M(7(^%A^W2P[6&0
M>( [>P_T->FC.[AP&U\;49K<V<P^W</2+JJLMG<E#B*:( $WDGJ'CB06!/+C
M@'V]!;R73A(E9V/!54LQ^P $]);R^AVZ,S7$B11KEGD=411\V8@#\ST0OM;^
M9A\;>NS-1;;R>6[5S<9:/[;9=)IHD< D>7)UA@IWC/ U4HJK$BX^MI"V?VLW
M3<^Z55MU]93W'[$6I!_TVGJ#^:?O&<N<O52"1[V08TVRUC&*YE<JA'S37]G'
MJM7M3^:;W[O5:F@V%CMN]48J90J3XV+^\V4 )NP-=6QBE *V ,>,B=>2'!(T
MREM'M'MUC1KEGN&'D3X<?^\H=7[7(^76.?,_WGM\W@%+!(;%#YJ/'F&<]\BA
M,C&(@1D@\*5Z[MWQO/?V4;-[XW7N+=^78,O\1W)F:C-3*KG441ZB20I'?Z(M
ME'T  'N2K+;H-M3P[>-(U]$4*#]M *GYG/4!;OOM[O\ +XU]/-</GNFD:0BI
MK0:B:#Y"@^72^ZP^/'=O<KQ_Z-NMMS[EHY)#%_&XZ+^'8U65BC*^3JV@QZ,K
M!@5-2&X;C@V+MVYFL-C_ -RIXT/\%=3^OP+5OSI3H^Y9]O=ZYPH=NLYI5/\
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M]U[KWOW7NL4\$%5!-35,,5135$4D%13SQB5'24%71T8%61E)!!!!!L?=702
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M:N%E+R;/[1RE" K>.CW+@(LKJ/X!J:6>BT#^I%*W^M[BC>?N=VDF=OW&6/\
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MO'44\MCI="1<%39U91@?S%RY><JW36=]&8Y%]<JZ^3(W!E/D1\P:$$ *30M
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M[KWOW7NO>_=>ZK)_G&_]NX?D9_Y2+_WN]K^W(OB'^KRZJ_#K1=]K.F>MP?\
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M/E4-(/EZV5=4?R]?C'U8*>J?99[#SD&ACF>QYDW$-0Y)3'B.'%J W*DT32*
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M[%VBTFK1)M[9T=24U:[:?XK-DU-M0MJ5OT+>]VU']M[2[1 :L)I/D\E*\/\
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M\5?,KK4<%C'5HW6/=G6?;]!]YL3=-#E*B.(2UN%F;['(4P/!\]'+IG50UP)
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M/^*Y>1"50&Q\40^DE0R\A?HH]3D J&+OO ?>&VGV&VX2W/Z]].K?1V*, \K
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M*961T)5T=2K*PP00P!!'F"*CJ5[>Z9Z][]U[KBS*BL[LJ(BEF9CI "\DDG@
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M_%1ZL"ZFE%/"I^77/<?Q*^1.V%>2NZNSU?$NK3)MR2FW26"_D18Z>IF%_P
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MB,%B(#-554QN23PD42#US3S/98XU!9V( 'LEYBYBL^5+.6_OY5B@B74[M^P
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MV?\ 9<2!-UWF/!H]O;./L(DE'S_"A\LL. Z%6V[96DD@^Q3_ (3_ )NK;
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ME3 HM8@  $FI)U 4"4HOC,)^Z/L7M/N4K3D?37M.VZB4=Y H!,F!(, 5J'
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M4M'14<"TT444"A4CCC0!$1%  4   6 ]Y_6]NEJBQ1*J(BA510%55 H  *
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MU=Q[;ZMU&JZ*CKX&IJZDIJVF?]=/5P+4H?QRCAE/!/X]M30)<+ID564\0P#
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MCZ^QSMWLMP-W<_:L*?X&<_\ /G4.[Y][(97;;#R[9+F6F?G'$#_U=Z)COO\
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M&4:?8(W#VHVF\S&LD)I_H;DBOV2!_P!@IU+VR?>5YFVJBSO!=K45\>$*VGS
M: PY]"P;/&O#HY^Q?YO6S*OQP=D]1[DP3C2DF0V9FZ;<R,3]7^VK5Q;PJ/\
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M]X0\_>]F_>X1:.YF\&V-:6MO6.(C.'R6D^>MBM<A5ZS:Y"]F-A]O@KVL'BW
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MP+SSU$KN1_B"?<5[C_>66]J/#VWEXZ1P,U^L0 K_ +[BLW&1_3%#Z]3)M_\
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M$C'D3Z]22;\GDGDD^P637)Z'(%,#K*)IA!-3"644U2NFHIQ(0D@_HZ7TL/\
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M1P14M)1TD*T\44<"A4CCC0!$1% "JH    %O?0*&%+9%CC5550%55 554"@
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M"OY ?(="5B?AG\;<.PDBZUI:V4$$R9;.Y/*@Z3<7BFK7AX^G$0N.#?V,=O\
MN^<G[<=2;<CGUEEN)AC^C)*R_P L^=>@=??>$YOOQ1MP9!Z10V\9_P!Z2$-_
M/'ET)&,Z'Z3PX7^']2]=0NBE%G?9]!4RV*Z"/-+ \IU+]?7SR3<D^Q?9>VG+
MNW$&';+!2!35]) 6I2GQ%"<CCG/GT$;SW-YCO_[7<[\@FM!=3*M:U^%7"X/#
M&/+I)[@^*?QXW*KK7]5;9I"]_7M^*7:Q!)O=?X;+2@6/XM;\$$7'LBW7V0Y3
MWA2LNV6RU\X%-L1YX-NT7^;RX='FU>^'-FSD&+<KAJ>4Y6YK]OU"R?Y_.M>@
M/W#_ "\.D<H6DPN4WQMB0ZM$-)EX,G +_2Z5=++.;'Z?Y2/S>_%HVW;[IW+-
M\:V[WEL<X299$_,31R-CY./GY4DG:OO8<R66+F.SN!YEHGC?]L4BK_Q@] =N
M#^6GEXS(^UNU,=5@\PTNX-M2XZW^#3TU55:O]<4R_P!+<7,:;I]SF5239;FC
M#\*SVY4C[7CE>OVA!]GGU).U_?"@>@O=MD7U:"X62OV+)''3[-9^WH"]Q? G
MY#X-7>@Q&VMUJFHG^[NY8HS9?J0N27',W'T !8_0 GCW&6[?=;YLVT$Q1VUU
M3R@N%!_[.%M_\_RZDO:?O/\ *>Y$"66XMJ_[_MV(K]MN9P/MX?/H#=P=!=V;
M69AF^K-\TT:&S55/MZHR5.#:]ON:5)H+V_YN?@_T/N-=V]J.9=D-+C;+P#^)
M('E3_>X@Z_S_ ,'4E;5[H\N;T!]-N5FQ/!6GCC?_ 'B0HW\N@GG@GII7@J89
M:>>)M,D,\9B=3_1E8 @_ZX]@*:%[=BDBE6&"K @C[0:$=#F.59E#(0P/ @@@
M_81TJ-F[$WCV%F(\#LG;F5W+E9-)--C*4S"-6-O)/*;14\5_K)*Z(/RP]G?+
MG*NX\W7 M=MMY;B0\5C6H4'S=C147^DY ^?1+S#S/M_*EN;K<;B*WB'XI& U
M'T5<L[?T5!;Y=/7;WQ\^2_5M)+5573>XZO&QHKS;BP@AW?31*5!+NF*FJY8%
M0DJ7J%B4,/HRE2>AWL9]R3:-S9+KG#<DU8(VRU=HJ_T9;F14K7S2 5])NN8_
MWE?OY<Q\M)):<C;),ZY4[O=HLZ+CXH;2!W8 >4ER5 (HT!!%2'U&<S<N1BR<
MV2KDR=),LM-51SM320/$;@Q%"OA96%QHTV//U]]5^4N1=FY%L1MVSV=O:6P_
MT*&-55R10LYRTC$<7<LQ\R>N('/7N=S%[D[D=VW[<+J\O*]LTTK5BH:Z8E72
ML*@Y"1*B \%'1M.L?GW\H>KS34]+V'4;SP]-&(EP?8L!W7$0I&D?=R/'E$5!
M=55,@BA3:W"Z46Z^W.T[M4F$1,?Q0GPS_O-"G_&>A-RW[\<S<M45;HW,8%/#
MNU\8<?XZK+C@/U*4\L"EB_6'\W'9>2\-%V]UOF=L5)T1MG=E5:;BI&)'J>2C
MJ32U5-&#^$FJF]QENWLU<0U:RF20?P2 QM]@(U*?ST]9!\M?>KL;JB;K:20'
MAXD#":/AQ*MH=1\AXAZL5ZR^2G1/<*0#KWL[:V<KJC2(\%+7?P?)W;\'&UHI
MZ[Z\7%.5)^A/N,]UY8W#9"?J8)$ _'34G^]K5?Y]9 \M^X.R\W ?N^\AE8_Z
M'JT3#[8Y-+C_ 'GH<?9#T,NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>ZCU5)2UT#TU;34]932@K)3U4*U","+$,C
M@J18GZCVW+"DZE74,IXA@"#^1Z=AG>V8/&S*PX,I*D?810]!7N#H/I3="S?Q
MOJS8U5+4*ZS5D&W*;'5)U_4_=4T<-0#R;$2@@\@@^P5NOMER[O=3=;;9.S @
MO]/&LAK_ $T57_/5CRZ&^U>Z',>RT^FW*\4+2B&>22,4_H2%T_+30^?1'^U/
MY=&'K34Y/J'=#X6<@R)M?=CO6TI/'I@R$:O50K8&PEAJ"6/,BK],;.>/NCVM
MUJFV"X,#<1;7):2*N,+* 9%'GWB4DGB!PR0Y)^]K<6VF'?[<3+P-S; )+]K1
M,0C'YHT8 _"3QKC['Z8[.ZGK&I=][0RN&A,QAI\MXOO*"<_4>&MA,E,[,O.C
MR"11^I%-P,0^</;C>N1'*[G:R1+6BS :X']-,B:DJ>.DD,/-0<=9<<H^X>S<
M\QZ]LNHY32K15T3)_IHWTN*'%::3Y$C/4'8':W8G5M><CL+=N7VY*\@DJ*:E
MG$U+.5L!]Q1S"2DJ+  #R0M;\6]I.5.?-WY(E\7:[J6 DU9%.J)SCXXW#1MP
MXLI(\CTIYIY'VGG6+PMTM8IP!1684D0?T)%*NG^U85\^K%NJOYC,;?;XSN':
MWB-UC;=.ST++R2 U1CII"PL-.IH:AK\E8!POO+KD?[W*2:8>8+;2>'U-J"5\
M\M$[$C%*E':IK1!PZQ+YW^Z25U3;!<U\_IKHT/V+*BT^P.@\JOY]6)["[0Z^
M[/QW\4V'NS$;DIE1'GBHJC140:[6%322B.JIF-QQ+"A_P]Y9\L<Y;7SG#X^U
MW,5PE 3H;O2N:.C4=#G@ZJ?EUB=S/R7NO)DW@;G;2V[5(4NM8WI_!(NI''S5
MB.E[[$W07Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z!_<W0O5&\-^X#LO<&T,=7;OVZRR4N092B3M +0/6P"
MT59)2D PM*C-&0MC9$"A+<N1MJW>_BW*XMT>XA^!SYD?"7 PY3BA8$J:$<!T
MG>TCD<.0-0\_\_K\NA@]BWI1U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U#R&1Q^)HZC(Y2NH\;CZ2-IJJNR%
M2E'#$B?5I)9&5$4?DE@/;%S<QV<;2S.J(HJSNP55 \R6( 'S/2BUM);Z18H$
M>1V-%1%+NQ/D%4$D_(#HF':'SQZ;V-]Q0[6DJ^RLY%Y46+ .*3'JZ?02Y*5&
M1T8_1J:"I'UO;B^//.OWG.7>6-4=DS;A,*T6W($ 8#&J9@5(/K&LM/3K(;DS
M[L?,',NF2]"[?":&LXU3D'^&%2""/21HSU77V?\ -7N[L;[BBHLU'L+ R^6,
M8O9Q>AF>-^ )\@S-6.P6X;QR0QM<WCM8#$GG3[R',G-NJ.&46,!J/#M:JY4_
MQ3$F0D?T#&#4U7A3+/DS[NO+?*.F22$WLXH?$NZ.@8?PQ ","N1J#L*8;HJ,
M<==E:Y8XDJ\EDLA4Z4CC5ZR>>:I;Z #5)++(Y_Q9B?R3[@M$FW"6BAY99&P
M&>1W8_F68D_,D]3@SQ6,=6*QQHN2:(B(H_(  #Y #HWO6'P=[L[ ^UKLSC8.
MN\#/H=J[=8:.L*,+WBQB?Y3K%QZ9_MP?P_%O<_<E_=GYCYITRW2+80-0EKFO
MC:2*]L*]U?E(8OMQU O.?WD^7.5M4=O(U_,*@);4,0(_BF/93YQ^(?EU9IT?
M\0>L.E:N'/Q"JWAO**-1%N/<$,6FE8BSMCJ5%*4A?GUM)-,H+*LP1F4YE>VW
ML)LOMPXND#75V!BXG"_IFE#X2 4CKG)+/0D:Z$CK#CW(]^]Z]Q8S:MIM;0G-
MO 6K(*U E<FKT] $0FA*5 (-9[F_J#^O>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>ZXE5)5BJED)*$BY%Q8V_I<>]4KUL$C'KQ
MZY>]]:Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJR?YQO\ V[A^1G_E(O\ WN]K^W(O
MB'^KRZJ_#K1=]K.F>MP?_A/Q_P!D:=E_^+-[R_\ >5V7[2S\?RZ=3AU>C[9Z
MOU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW5(_\ W7;_ /+2_P#B/;GX/S_R=5\_RZNX]M]6Z][]U[KW
MOW7NO>_=>Z][]U[KQ (((N#P0>?K[]UX&G5:WR@^$5)N8Y+L#INBI\?N-VEK
M<WLF(K2TU<2"SS8_Z1TU6QY:$E89225,<@M+B![T_=NCWWQ-UY?18[DU>:T%
M%CG/$M%P"2'S7".<]K5U9@>R_P!X]]F\/:N8'9X!1(;PU:2$< LO$O'Z/ETX
M'4N4J5BES>V,RLL3Y/;^X,)7$JZF7%U=)4T3V/\ J)H)HG4@CAE(L;'W@=')
M=;%<ZE,MO<0OQ[HI8I%/^U96!X\".LZG2VWFWTL(YX)DX=LD4L;C\U96!^8(
MZM[^+_S9H-Z?PW8/;M72XG=[F"BPV[7"T=)DV-D2*J TQTE?(UK, L$S'2HB
M?2DF??LM]XZ'F7P]KWUEBNS1(KDT2*Y.  _ 1RD^E$<X722%.!7O/]W*7EWQ
M-TV%6EM15Y;45>6W&22G$O$!Q!JZ#)++5EL8]Y:]8E=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=,VX-Q8':F)J\[N;,XW X:A0/5Y
M/+5D=!!&&-@#)(RKJ8V"K?4S$*H)('M!N>ZVVRP-<WDL<,2"KR2NJ(H^98@9
MX <2<#/1AM>TW6^3K:V<4D\KFBQQ(SNWV!030<2> &3CJN3N7^89@\8M3A>F
M,3_'Z\%HFWAN&EDI:%/QJI*(F.IJ3SPTW@52/\W*I]XC^X7WL+2P#6W+T7U$
MG#ZJ=66!?FD=5=S\VT '-''66_M]]U&YO"MQS#+X"<?I8&5IC\GD[D3YA-9(
M/Q(>JK]V[NW)OO<&1W3NW+U><SV5E$U;D*QP6;2 JHJJ D<4:@*B(JHB@*J@
M"WO!_F#F&\YINY+Z_E::>0U9V^6  !0*H& H  & .LVMBV&SY9M8[*QB6&&(
M41$&!YDDFI+$Y+$DDY))ZLJ^)WPM,W\+[.[CQC+$#3Y+:VQ*V,>O^W'59:)E
M)"?I:.E-B38U "WA;,CV*^[M3PMZY@CSVR6UDX_,/.I'V%8CP_T0?@ZP^]\_
MO$>'XFS<OR5/='<WJ'AY%(&!X\0THP/]#SWBUE5"@*H"JH"JJBP 'T 'X ]Y
MO 4ZP@)KD]=^]]:Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZXLJNK(ZJZ.
MI5E8:@0W!!!X((]Z(#"AZVK%348(R"/+JHSY;?#1MOC)]G]1XV6;"-++7;GV
M50PZVH0_J>KQT: LU&&U-+  33@ZHQX 5AP/]]_N\?N[Q-ZV",F.I>YLT%?"
M!R9(0,Z*U+1CX.*=@HN>'L3]X,;KX>R[](!-0);W;F@FI@)*3@24H%<_VG!N
M^A>O39^]=V=?YR#<FS,]D=NYNGBE@2OQTWC8QSVUQ2*0T<L364E'1E)"FUU!
M&)G+O,M_RG<B\VV=[>905UH>*MQ5@05930'2P(J :5 /65N_\N6/-5L;/<8(
MYX6(8I(*@,.# BA5A4T92#0D5H3U!W!N3<&Z\G/FMSYO*[@R]3_G\EF:^7(S
M,+DA?)*SL%!8V4'2+\ >TV[[U=[_ #FYOII9Y6XR2NTC4J32K$T J: 8'D.E
M.U;1:['"+>RAB@B7A'$BQH. K10!7&3Q/GT.75?Q5[H[:\%7A=L2X3;\Q0_W
MGW7KPE&4?D/ '1JFL0B_JIZ>1+BS,I]R;R1[%\Q\]:9(+<P0&G^,7588R#0U
M4$%Y!0X*(RUP6!ZC7G;WNY=Y%U1W-P)IQ7_%[:DTH(\FH0D9^4CJ:9 /5E'5
M?P!ZLV=]ODM^U55V/FHVCE^UJD;$XN-DY %)%(TM38\'SU#1N+7@7D',/DC[
MK6Q\NZ9MS9MPF%#1QX=LI&<1JQ+_ #\1V4_P#/6('._WI-[Y@U0[6JV$)J-2
MTEN6!Q_:,H5/EH0,IX.<='CQ6(Q6"Q]-B<)C,?A\71QB*DQV+HXZ"")1]%CB
MB5(T'^ 4>\D[*RAVZ)8+>-(HT%$CC5410/(*H  ^P=8V7U_/N<K3W,CRR.:M
M)([.['U+,23^9Z<?:KI)U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=(O?'76Q^R<2^#WSMG%;DQS!O&F0IPTD)<6+T]0NFHII;$^N*5'_P ?
M8?YCY4V[FZW-KN5O%<1G@)%J5)%*HPHR-_24@CUZ$7+?-FY<H3BYVVXEMY,5
M*-VL!Y.IJKCY,"/EU6=W#_+NKZ7[K,]+YS^)0C7-_<W<U0D$X^IT4>0LD,O)
M 5*A8K 7:H<^\-_<#[I;QZKCEV;6,GZ2Y8!O,TCEP#Z!9 /4R'K,7D#[V$4V
MFWYAA\,X'U=NI*'YR199?4F,M4\(P.JX]V[+W9L/+RX'>6WLMMO+PC4U%EJ-
MZ1F6Y DB+#1-$Q!TR1LR-_98^\0M_P"6K_E:X-KN-O+;RC\,JE:CU4\&7T92
M5/D>LN-BYBL>9X!=;?/%<1'\<3A@#Z&F58>:L P\QT-?4?RM[BZA>DH\5N!]
MP[8IPD1VGNAGR=*L:$>FE<N*BBTKJTB&58P3=XGM;W)/(7OMS!R$5CBG-Q;+
M0?37),B!13"-77'05"A6T FI1N'4<\]^Q_+_ #Z&DG@$%PU3]3;4CD+'S<4*
M25/'6I:F R\>K4.GOFUU'V=]KB\W5_Z.]US^./\ A6Y*I!1S2/8::3)VC@>[
M$*JS+3RNW"1M]?>;OM_]XS8.=M,$[_0W34'@W# 1NQH*1S81JDT ?PW8\$/6
M$W/_ -W+?N3-4ULOU]L*GQ;=3XJJ/.2&K,,"I*&10,LPZ.(CI(B21NLD<BJZ
M.C!@P87!!'!!'T/N?E8,*C(.01Y]0 RE"010C!!X@])_.[OVGM>,S;FW1MW;
ML*J7:7.YNFQ"@ 7N6J)8Q:WYO[+-RWRRV92]Y<00*!4M-+'$ /6KLHZ-=LV&
M^WHZ;.VGG-:4AADE-?L16Z K<7S!^.FVKK4]E8S)SZ2R0;=H:O<.JWX$M)3R
MTZG_ (-,ON,]W]_.4=FQ)N,4A\A;K)<5_.%'4?FPZDS:?8+FW>,IM\D8\S.\
M4%/]K*ZN?R4] -N+^8[U90&:/;6S=Z[AEC'[<M<*3 02$B_I?SU<X7\7:F!O
M?TD6)B_=OO=;%:EEM+6\N".#,(H8VQY$N[@>64!^5.,G;3]T;>[JAO+NT@!X
MA/%G=?M&B):_8Y^WT ?<7\R3L*KU+M;KW:&"5BP#9JNK-RNH-[6,+8Q-0XY,
M9'^T_CW%^[??"W2<4L;"UA^<TDMP:?[3Z85_:/EU)NT_="VJ#-[?74W_ #12
M*W!/^W%P:?80?GT VXOFC\C=Q&1#O]\)32(4^UV[AJ+%:=7U*SK U6#_ (_<
M\?BQO[C#=_O&\W;L32]\!2*:+>&&,#YABC25_P!OCRIU)^T_=XY1VFA^A$S
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MQO\ C%%E_/PZ4\^/1.ZJEK,;5RTE;355!74DICGIJJ%Z66)X_JKHX5T=3^"
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M1Z5-3F@/5<W9_P#,<J'-1CNH]H) GKC3<V\_W'/)&J#'4\FE>!J1I:IKW&N
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M^;^?MWY[F\;=+F2:A)1"=,,?'X(UHBX-*@:B/B)ZS3Y2Y%VGD>'P-KMHX00
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M6'X8(Y9J_8R(4_:XZ'C;G\M_LVN"R;HWOLW;R. ?%C(ZO<4R_P"#JT5##?\
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M,MZ&W"89)G&F &E#2%201\I&D'#S'6(W.?WGM_YDU16.C;X34?HG7<$5\YF
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MD[M022YG*+Z !70D#T8M7S)ZF.\^\QS==QB-;F*(A0I>.VAUMZDZU< G^B%
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MO>_=>Z][]U[KWOW7NO>_=>Z][]U[K%/!!50R4]3#%44\R-'-!/&)4=6^JLK
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MC,;10K3T>/Q]*E%!#&GT2**-5CC0?@*H _I[RIM;6*RC6&%%C1 %1$4*BJ.
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MWW8.6^8M4EHLEA*36MN=4)-*9BD)4#Y1F/K(+E+[S_,7+^F.\,=_$*"DXT3
M?*6, D_.19#T@NKOY=^RMNU[9/LS<51OLP5+M0X3'0/@*%D1OVVJF65ZJ9F
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MP/V\1Y$=!'G#D;;.>K?Z;<H1(!70X[98B?-'&5X"HRK4HP(QUK[?)_X =J=
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MF'!9.5A8>.HE9CC)Y&!M#42&(DJL=0\CB(8\<V>UUSLVJ>RU3PBI*TK*@^8
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MX@^A!R#\B ?RZP8YDY7O^4;EK3<87AD&0&':Z_Q(PJKJ?5216HX@CHWWQ?\
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MAR4'HT!C7\V1CY]%BW7_ "W-]T7DDV7O_;.X8P69:?/4-1MJ6U^%4P_Q&)V
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MDWEOY%JZ@CZ%Z;%4\I@B-Q='GJY@5/KIU/ F+8O9Q5H^XRU/^^H<#\W85/S
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MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NB;]E_
MGXR=I[GJMWY[8TN*SF1+R927:>6FVW#52R,7:HFIJ<BG-2[,Q>58U>0G5(7;
MGV-MK]PMUVB(01351?A$BJY4<* L":>@K0>5.HEYC]C^6^9[EKNXM=,K9<PN
M\(<DU+,J$*6).6I5OQ$])RE_EM?#^G=6FZUR-<%328ZK?N?0$_ZH^#)0M?\
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M;%[4[?M='N:W+_T^V,'Y(#G_ &Q8?+K%+G+[RF^<PUBL--A":_V9USL,\96
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M:"(,X_T63ODKZ@D44_Z4+U@GSA[P;_SMJ2[N2D+5!MX*PPT(H00"6<?*1GZ
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M;AP&6IVI<GALQ11Y"FGC;G3)%*K(UB 1Q<$!@00#[?MKF2S<2Q,R.IJK*2K
M_(CI)?V$&Z0O;W,:2Q.-+QR*'1@?(A@0>J./E7_+%R^W/XEOKXZ1U>X,$GEJ
M\AUI5U)J<C2J/4QQ4\AOD($6]H)7^Z  $;53MI6?.4/==+G3;[G1&X+.!1&_
MTX'PG^D!I]0HSUA;[H?=KDLM=[R\#)'\3V;-61!Y^$S'O _@8Z_X2Y('52>-
MR6XMF[@I\EBJW+[8W/M[(F2FK*2:7$UM'54+E39E*3031."I'# W4CZCW,LL
M45_$5<+)&ZY!HRLI_:"#UBE;7-SLEP)(FD@GA?#*6CDC=30^A4@U!'V@]'IZ
MZ_F8?*#8[009O/8+LG&1%5-)O3"1^<)^0M;CS0U32?6SS//8_4,./<?;G[5;
M3?U,:O WK$YI7_2OK'Y"G4W\O_>1YEV:BSR17B5X3Q@/3T#P^&:_-M?Y\.CY
M=<_S;^L\N::D[.ZZW1LRID81393;=9#NZB7CF61'%!61(3?T1PU##CEN2(]W
M/V:NX*M:S1RCR5P8W/R'QJ?M)7J<>7OO5;7>:4W*UGMF)H7B*W$0^9_LW'V!
M'(^?1\>NOE3\>.U13Q[)[:VA7U]580X3)9#^[F08DV*KC\DM)6.0W%UA8?0@
MD$$QYN?*6Y;/4W%O(H'%@-:?[TFI?Y]3CR][E[#S306-] [-PC9_"E]/[.70
M_P#QG_".C ^P[T.>O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KHD $D@  DDFUK>_=>ZJ/^8_\ ,>Q>Q3E^LN@JVBSF
M](Q/C\[V#&$KJ#%2?I>+'!@\.0KX^=4A#4T#6'[\@=(IDY(]L7W'3=[B"D6"
MD.0\@]6\U4_DQ'H*$XK>[OWA8M@\3;=C99;D522YPT4#<"$K422#URBG!U$,
MHHCJ*C<>\]P25-3-F=T[IW'DM4DLK39FOKJS(/\ DGR3U-1-(UA^IV8V%R?>
M0BI%814 6.-%^2HB@?D !^SK!Z22YWJX+,9)YYGR3JDEED8_FS,3]I/5S?Q>
M_E=8^LQ%%O'Y)_Q%*NM6*IH.L<1DCC_#$X!'\8K*<^<3.#S3TTT;1<>2<N6B
MC@WFSW:=7,&UZ:#!G9:U/]!6Q3YL#7R &3F'[:_=FB>);OF/46:A6SC<J%!_
MWZZ'5J/\*,-/FQ-0+@-C]=[$ZTPT>WNO]I8#9^&CTDT. QD6/61DO^Y,R*'G
ME-S>21G=B22Q)/N%K_<KC=)/%N9'D;U=BQ_*O ?(8ZRQV;8K+EZ$6]C!%!&/
MP1(J GU- *GU)J3YGI9>T71MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=5D_SC?^W</R,_\I%_[W>U_;D7Q#_5Y=5?
MAUHN^UG3/6X/_P )^/\ LC3LO_Q9O>7_ +RNR_:6?C^73J<.KT?;/5^O>_=>
MZ][]U[KWOW7NJ0_A;W-B.NOG=\V.I^]*VFV[VOVEVK#7[%SN>FCI4R=!B*BO
M3$XFFGD5-/EQ-;C)<="7O/%>,*LR*DCSK501TVIH<]"Y\]S6[^^27P>ZMZLF
MDG[JVYVLG:62JL5'KFP6TZ"2FCR==D9T(>FQ];X'3Q,=%8:=H"&=HDDJF ?2
ME/SZVWET*'\T'O[+] ?$_=-?M;)28G>?8V6Q_6.VLE3R,DU-_>"*HGR-3"4(
M>.6/%4=<L4P93#/)#(&UA%;T2ZCUMC0=#1\)>LL9U-\4.BMGT5!!15$G7.V]
MQ[A2.$(9,IO"FCR>2>4VO*WW=5*@9N?&B+8*JJ*N:D]>7 Z(%\*]YOTE\]_E
MG\.*8S4W7F4S.2[5ZXPC$K!BJG(1T&2J**CB-O%35.-RL1 'I"T,9'JD9FNX
MJH/Y=:7!IU=+[:ZOU[W[KW7O?NO=>]^Z]U[W[KW5(_\ W7;_ /+2_P#B/;GX
M/S_R=5\_RZNX]M]6Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NFG/8'";HPV2V[N3$X[.X+,4DM#E</EJ1*^FJ(9A9HYH9%9'4_T(^MB
M.0/;UO<26KK)$S(ZD%64D,I'F".'26]LH=QB>"X1)(Y%*O&ZAD=3Q!# @@^A
MZHN^6W\L_+[7.4[!^.]-6[@VVODK,GUF6>MR-$HNSOBI&9I,C3*/I3M>J0"R
M-4ZM*3_R;[J)=:;;<R$?@L_!&]-8X*?Z7P^H7B<*?=7[N$FWZ]PY?#21?$]E
MEI$]3$2:NO\ PL]X_"7J *H-N;DW/L3<=!N+;&7RNV-SX&M\]#D\;4/CZFGF
MA)5AJ72P_M*Z,-+*61U*D@S#=6L.XQ&*55DC<4*L 58'_54'\QUBQMVY76P7
M*W%L\D$\355U)5T88(_R$'!%0014=62[=_FR_(/%T5)19S:75VY7I:*"F?)R
MXG(XJKJ)(@ :BH,&3^T+R6)98:.%-1NJJHT^XNNO9S;96+1R3I4DZ=2,H!\A
M5*X^;$]9%[=]ZC?;90EQ;V<U% UZ)8W9A3N;3*5J?,*BBO  8Z47_#NW<7_/
MK^M/^IN4_P#JWVE_UF+/_E(F_8G_ $#T9?\ !8[I_P H-K_O<O\ T%T\0_S?
M>PUBC%1T[LR6<(HEDAW!70(S?DJC1R%0?P"[6_J?;#>RUO7%U)3YQJ?^?ATJ
M7[V=Z -6WP$^9$\@%?LT'_">I5/_ #@-[+,C572NUIH!J\D=/NRKIG/!M9VI
M)56QL3^V;BXXO<5;V5A(Q=.#\XE/_/XZ=C^]K= ]VVQ$>8%PX/[3$W^#IR_X
M>%SW_/AL1_Z,*;_ZT>VO]91/^4MO^< _ZV]*/^"WE_Z-:_\ 98?^V;J?3?SB
M:I8[5GQZIYY=1.NF[3:D6W%AI;;LQO\ 7G7_ + >Z-[)@\+PC[;>O_68=.)]
M[A@.[:@3\KVG^&T/7&J_G$5KJHHOCY2T[ACK:J[1>L!'] $V_ 0;_FY_UO?E
M]DP.-X3]EO3_ *S'KS_>X8_#M0'VWI/^"T'2:K/YOV_7\_\ #^F=H4VH-]M]
MYN:MKM!MQKT04_D /UMHO_4?7VI3V5@%-5U(?6D:C_"QI_/I!+][2\-=&W0C
MTU7#M3[:1K7^721K_P";CWU(8OX7U[U%1J WF%?CLSDBQ-M.DQYFET6YO<-?
MCZ6Y71>S.WBNN:X/II,:_P"&-O\ )T47/WKM[>G@VEBO&NM9Y*^E-,\=/Y_E
MTE*O^:O\G:E9%AH.K: N^I7I-J5CE!>^E?/E)U(MQZ@QM^;\^U:>S^U+Q:X/
MVR)_DC'17+]Z/F204$=BOS6&6H_WJX;I,U?\SKY95,ODAW-M.@30%\%)LFB=
M+B_JO.LSW-_]7;C@#FZI/:?9U%"DI^9E;_)3HOE^\OS1(:B2W7Y+;K3_ (T6
M/\^D55?S#?F+5QB.7N2I15<.#2[)VW1-< CEX</&Q')X)M>QM<"Q@OMILB\+
M8?G+.?\ #*>B-_O <W.*'<#^5M9C_!;CIRV-_,,^3FV=[X/=&Y.P<EOC"T-=
M%)FMH92"CH*2NIBOCEAO34B?;2%"6CE1?1*%=ED&I&9W#VTVFZMWBBA$3D=L
MBEV9&X@]S&H]0>(P*8(5[)]X'F7;KV.YNKIKF)6!D@98D21*4(JD8TFF0PX,
M 2"*@[(G5O9VT.XMB;?[$V-D5R.W]PT:U$!;2DU/*OIGI*J-6;Q55+*&CE34
M0&6ZLR%6;&#=MJFV6X>VN%TNAH?0CR(]01D'TZZ'<M\QVG-EE%N%D^N*5=2G
MS4\"K#-&4U5AY$>F>A!]EW1YU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= +W_\CNL_CCM-MR;^RO\ EU8E
M0FW-J8]DFR.3F@%RE-"6&F)"5$L[E88M2ZFU,B,(>7>6;KF>;PK9<"FN0U"1
M@^9/KZ 9/D./0(YY]P-M]OK7ZF_DH6KX4*T,LS#R1:C J*L:*M14Y%=:CY)?
M*GLWY,[C_B.[JW^%[5Q]5+-MC8>+J'-!0 @HLC7TFLKC&2'J9$#'4XB2&)A$
M,I>5N4+3E6+3"-4C"DDS :W\Z#^%:\%'RJ2<]<Y_<;W1W+W(N-=TWAP(Q,-J
MA/AQ\0">&MZ&A<@<3I"@Z>E-\6?ASV-\F\TM1CXY-L=<8ZL6'<._:^E9X@4L
M7I<=$2GWU=IM=5<1Q AII$U(LB3F[G>VY4CHWZD[#LB!S]K'\*_S/D.)!G[8
M>T&X>Y$P=08;-6I+<LN#3BL8--;_ /&5XL> .R?TOT=UST'L^GV9UQ@XL90K
MXILIDY]-179&H1=)JJ^ITJT\S<V%ECC!T0I'& HQ=WS?KGF*<SW3ECP5>"HO
MHH\A_,\22<]=$^4.3-OY'M!9[=$$04+L<R2O2FMVI5F/[ ,* *#H7/9-T*>O
M>_=>Z][]U[H-^T^H^O.Z=J5>S.R-M4.X\)47D@%0OCJ*6:Q5:FBJ4TSTE2@)
M DC=25)1]4;,K&>T[S<[',)[5RCCTX,/1@<$?(_;QZ#_ #+RM8<WVK6>XPK-
M&V0&'<C4IJ1A1D85PRD'B.!(ZUZ/E;_+\[#Z"-?N_9OWW875,1DGES$%.'R6
M*C!X&5IHE4-" ?\ @7 GAX)F2FNBODGRA[D6W,5(;BD-QP"D_IR'^@2<'^B3
M7T+9I@/[H^PE_P C:KNQUW=D*DN #- /^&JH%5_X8@T\=2IBI/NJ^W.PNEMU
MTF\^M]R5NW,W3 13&!A+!50Z@S4U;3.&AJJ9R!=)$(! ==+JK :[QLMMOT)@
MND#J>%<,I]5(R#\Q]AJ,=1'RMS;N')ETMYMTS12#!IE)%_A=3AE/H1CB*$ C
M83^*/\P3KWOM<9L[>WV/7W;,RQTZ8N><QXS+2C2M\54S,2D\K&XHIG,PN%AD
MJ=+LN-O.'MQ<\NEIX*S6_'4!WQC^F!Y#^,8]0M0.L^O:[WWV_GL):7>FUOB*
M>&3^E.105B9O,\?#8ZQP4N 6ZL-]QMU/77O?NO=!_OSM?K3J^B.0[#WWM79U
M.4,D0S^:@H)90/Q3T[N)ZAOKZ8HW8V/'!]F.W[1=;JVFVBDE/]!"P'VD"@_,
MCHCWOF;;N6T\2_N8+=?+Q9%0G_2@D%C\@">J^^SOYK/1.UA4TG76"W3VAD8T
M/V]8M.=GXQF^EFJ*Z,Y 6Y^F*(-N&YN)'VKVAW&\H;EHX%\P3XCT^Q#I_P"-
MCJ!N9/O0;%M=5L(YKUZ&A"F"&OH6E&O\Q$1U7AV=_,Z^2>^C4TFUZW =78>;
MT)#M7&+6UQ0@7$F0K_N'#ZKD/3PTQ L/ZDR7M7M1M=A0S!YV'\;:4K\E2G[&
M+=0#S)]Y7F+>B5M#%91G@(4#RT^<DNK-?-%0_P"4A^ZMY;NWSE),YO3=&X-V
M9B6X?*;CS%1FIR";Z1+422.%'X4$ ?0 #W(5G80;>GAP1I&O\**%'[% Z@W=
M=ZO-]E\:]GEGD_CFD:1OL!<F@^0QTK]A='=P]HQM4=>]:;TW;1HE0[9+$8"H
MGI!]K?6IK"BTOD!! 3RZV;TJI;CVBW'F&QV@TN9XHSCM9QJS_1&:?.E.C?8>
M1]XYG&JPL[B=:$ZTC;P^WB-9 2OE2M2< 5ZFYKX\]];<:1<YTMVIC%B-FGJ=
M@Y183RHNLPI3"XU,HNKD7(%[^VX.9MNN15+JW-?+QHZ_LU5_ET_>>WF_;>2)
MMNO5IQ/TLQ7\F"%3Q\B>@IK:"NQM2]'D:.KH*N*WDI:VG>ED74+C4D@5A<?U
M'LYCE68:D(8>H((_:.@I<6TEHQ2561AQ5U*L/R(!ZB>[],]"%A.V^UMM:/[N
M=F]A8#QF\?\ !-Z9+%:>0?3X*F.W(!X_('LLGV2RNO[6W@?_ $T4;?X5/0BM
M.<-VL/["]NXZ?[[N9D_XZXZ&+!_-CY6;>2..@[QWM4+$BHISE5#N=B$4*-39
M*"K9S91<L22;L26)))+CD+9[DU:UB'^DU1_\<9>A=9>]/--@ J;C.:"GZFB8
MX%,F9')X<22:YX]#)@OYGGRQQ"HN0W%M'=)6UWSNRJ.G+6U?7^&#'#G4/H!^
ME?\ :M1'<>T^SSGM26/_ $DK'_JYKZ%]C]Y;FBT $DEO/3SEMU!/'CX)A'GY
M <!\ZCWM3^;YO^D\*[XZ?VAGK$B>;:V?K=J&Q^C*E6F8%Q]2"X#?2Z_4!V\]
MEK=Z_3W,B>@D19/YJ8_\'0YVO[V5[$ +W;X9#YF"9X?V*ZS_ +-6?4=&8VG_
M #9NA<LT<.ZMG]C;1F=$+U$5#1;BI48_J!DAJXJH@7X(HC< W"FP(5O/9W<8
M<Q202?+4R,?]Z6G_ !KJ2-K^]-L-V0MS#=VYIEBD<J _:DFK_C'[.'1EMI_.
MWXG;QTKC^Y=N8N8MH>'=E/6;.TFU[&7)TU+ PM_:65E_%[\>PM>>W^\6/Q6L
MC?\ -/3+_P!6RQ_EU(NU>]?*V[_V>X0H>%)]=O\ /C.L8/V@D>5:]&0VWO;9
MF\J=:O:&[ML;JI7C69*G;>?I,Y&4< A@]++*I4@@@WL1[#%S8SV1TS1O&1Y.
MC*?V,!U(>W[M:[L@DM9HIE(!#12)(I!R""A(H>E/[2]&'7O?NO=>]^Z]T67N
M/Y@?'WHT55-O3?V.J=PTNI3L[:Y&Y,KY I812TU.Q2C9@.#5S4Z'CU\BXIV3
MDO<M_H;>%M!_T1^R.E:5!;XJ>BAC\NHZYN]UMAY)!6]ND\4?Z!%^K/6A-"B5
MT5I@R%%^>>JH^Y/YL?86X/N\5TKM'';"QKK)%%N?<PCW)E2&7TRQ4MOX;1NI
M)]$BURFP.H7*^Y@V/V=MK>CW\AE;B8XZI']A;XF'V:.L7.;_ +T]]>ZHMFMU
MMD-0)YZ2S9'$(/TT(/DWB@X^SJL3??96_P#L_,-GNP]X[AWCEBTQBJL_E):_
MPB<@M'3QNQBIHB56T<2)&+ !0 /<K[=M5MM">';1)$N*A% K3U/$GYDD]8U[
M]S+N',\OC[A<2W#YH97+!:TJ%'PH,#"@#Y="#U%\9>\>\IXAUUU_FLIBWE$<
MNYJV(8?%16;2Y;(51BIG:/ZM'$\DUAZ8V/'LMWKFO;]@!^IF56_WV.Z0_P"U
M6I%?4T'SZ/\ E+VTWOG8C]WVLC1DT,[CPX!FA/B/0&GF%U-\NK7>G/Y2FWL?
M]KE>\]]U&X*E=$DFTMB!\71!A]4GR=1&*RIC-[$14M(P(N)2#;W#^]^\DLM4
MV^((/]^2T9_R0'2#]I<?+K*/E#[JUM;:9=[N6F;!,%M6.*M,AI&&MA_I5C..
M)X=6D=;=-]6]/XS^$=9[%V[L^E:-8JB7%4(^ZJ EK&KK9#)6UC"P]4]1(W Y
MX]Q+NF]7>]/KNI7D/EJ/:/\ 2J**OV  =9,\O<I[;RG%X.W6T5NM #X:@,U/
MXW-7<XXLQ/SZ$OV5]"'KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NBO=R?#?X]]ZY&?/;YV-&NZJB!8)-U[=R$^WZYP@TJ\QI
MW%-5R(+!7J::9@H"@Z1;V*]DYVW+E]1';RGPP:^&ZJZ?EJ!*U\])'4;\W>TN
MP\[R&>_M@9B*>-&SQ2'%!4H0'(\M8:@QPZKQ[#_E"0D2U/4_;DJ$*W@PW8>(
M$MSS8OD\:J:1] 0,2?R;_P!GW)>V^]##%Y;@^K0M3'^D>M?]['4 ;_\ =.0U
M;:[YAC$=T@:I_P":D(6@_P";1_R=$-[$^ WRGZY^XGJ^LJ_=>+IP[?Q;8-3'
MNU'"?5EI:<_Q)5 YN]"G'^L;2%MGN-M&YT G$;'\,P,=/]L>S_C74'\P>P_,
M_+U6:T-P@%?$M6$P/V(*2_MC'^'HHN1QN1Q%;4XS+4%;B\E1R&&LQ^1I7HIX
MG')62*55D1K$<,H/L:13).H=&#*<AE(((^1&#U$MS:RV4C13(T;J:,CJ593Z
M$, 1^8Z&3KSY+=^=5>&/8?:^\L)14ZJL&'DRK9C'J%%A;&UPJ:#@6'_ ;Z<?
M3V1[ERIMN[U-Q;Q,3Q8+H<_[9-+?SZ&.P>Y6_<L4%C?7$:@4$9?Q8@!Z1RAT
M'^\]'RZ[_FU=N83PTO9.P]H[[I$,2O7X::;9M<1?UNY K:*1K<JJ4<(OP3S<
M1YN?LW9SYM9I(CG#@2K\OX&'YENIRY?^]7NEI1=QM8+A<=T1:WDIYDU\5"?0
M!4'S]#Y==?S//C+O00T^X\AN;K/)2,L31;LPC5E*78#_ #=9C&K4$5R1KGCI
M^0;@"Q,>;G[4[M89C5)UXUC>C4^:OH-?DNKJ<>7_ +R/+6]46=YK-R:4N(R4
M)IY/"95 ^;Z.' 8J>W:>]-H;\P\.X-D[GP&[<)4'3%E=NY:#,0%@+E#) \BK
M(M[,A(93PP!X]Q_>64VWN8YT>-QQ5U*M^P@=3;MF[6N]1">SFBGC;A)$ZR(?
MS4D5'F.(\^E-[2]&'7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW3)N/<F V?
M@\GN;=.8QV V_AJ26MRF7RM4E'!!%$+EGD<@#^@'U8D*H)('M^VMI+R18HE9
MW8T55!))/H!TDO[^#:X7N+F1(HHU+/([!551Q))QUK]?,;^8EG^W!E.N.F:C
M);5ZS=IJ++;C&O'Y/.Q?I9+<2T&,EY_:NL\Z$"H,:-)3>\C>2?;./9]-U?A9
M)\%8\-'$?7T9QZ_"#\-31NL#_=W[P4_-&O;MF9X;3*R3Y2:Y'"@X&.,^F'<8
M;2"R&O?K+JW?G<.[L?L?KO;U;N/<.1)84],H2*")"!)4U<[E8:6EBN-4LCJH
M)502[*IDK=MWM]CA-Q=.$0>O%CY!1Q)/H/MX ]0%RSRO?<WW:V6WQ-+*WD,*
MB^;.QPJCS)/H!4D ['7Q'^#&Q?CA14VY\[]EO3MRIIK5FYY8-5-C?.MI*;#1
M2*&B6Q*O5.HJ)EN!X8W:'WC%SES_ ''-#&)*Q6X.(P<O3@7(X_)?A'S.>NAG
MM5[*V/MW&+B73<7S#NG([8JC*P@_"/(N>]L_"IT@]WN/NILZ][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[JLG^<;_ -NX?D9_Y2+_ -[O:_MR+XA_J\NJOPZT7?:SIGK<'_X3\?\ 9&G9
M?_BS>\O_ 'E=E^TL_'\NG4X=7H^V>K]>]^Z]U[W[KW7O?NO=4P_-WHWK7YQ=
MUMTYU'BZ"C[_ .I,+29?LCO#[N2@QF!HJI7DQ>WLDM-#-+F<G7U#!X8U\3XZ
M)9YQ4,4FHI748H*^1\NFV&H] Y\&?DGN7XR=ZY_XI?+S9K8'MG?FXZ&*A[QR
MU7-G,AG*BO*TV%I<KE:B2>3(XJ5 *?&544XAIC:EDAC8321V==0J/V=>5J8/
M2^_GHQ5)Z*Z9G19/LX^V:J*=@?0)9L/6F(,+\L5CFT\< -_7G4''\NMOPZN-
MZT_YEQL#_P ,G:O_ +@0>V>K]4:X&"LR/\]_=U5C*LBCQ>#2?,B%#*LD,76&
M.HC$[ $)XZZ6G))L-<83ZD#V^?@_U>O3?XNM@#VQTYU[W[KW7O?NO=1,A]Y]
MA6_P_P ?W_VE3]CY?T^;0WBU7XTZ]-_\/?NO=4I?]CV__ 2_]X]N=GS_ )=5
MS\NBX_%G_9FO^'AX_P#9M/[B_P"EO_9:\QY?]'EOX=_#K1?96M_N[_.Z_P#8
M>[-33CU_R=:''/IULC>V>K]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]T0CY2? +K+Y$5$FZL+4Q=:]ERRH]?NC%XI:ZF
MR2W]7\3H%EIEGJ=-PM2DL<WT$QG1$19#Y2]Q;OED>"X\>#RC9J%/](U&H/52
M"/2A)/4'^YGL7MON"QN8B+2\)&J=$#+*/^&QAD#-3 <$-P#%E  )!5_R?=VH
M$^Q[PV[4$EO(*O9=316^EM)3(3ZK\WN!;_'\#U/>N(_%:./LE!_ZQCJ%Y?ND
MW ^#<HSZZK5E_P $[?Y.H7_#0._?^?S;0_\ 0:K?^O\ [O\ Z]4'_*+)_P Y
M%_Z!Z9_X$N\_Z.,/_.!_^MG3/+_*([=$L@A[3ZWDA$CB*26FR<+,H/I+(*5P
MK$6N [ 'C4?K[?'O19TS;S5\\H?\HZ2-]T[<P32^M2*X)24&GV4-/VG[>H59
M_*+[N2!FH.R.JJFJ!71#63Y>AC()YO(F,J&! N1^T;GCCZ^W(_>>Q)[H)P/4
M>&3^PNO^'IB?[J&[JI,5Y9LWD&\9%_:(W/\ QD],W_#27R._Y[7I+_T(\]_]
MC?M1_KR;7_OJZ_WB+_K?T@_X%3F'_E(V[_G-<_\ ;)TWU/\ *>^2\$ICBS_4
M58ND'S4VZ,FJ\_BTV$B>X_X);^A/NZ^\6U'BER/MCC_R2GII_NL<QJ:":P/S
M$T_^6V'7*E_E._):HD*2[AZ@HE"%A+5;GRCJ2"!I AP<S7-R>5 L#S>P/F]X
MMK7@ER?LCC_RRCK:?=8YB8YFV\?,S3_Y+4]*J@_E%=U21P')]E]74DS/:I2@
M;+9%4741='DQU*9#HL;%$]7IO8:BCE]Y[$$Z()R/+5X:D_;1FI^T_P"3HUM_
MNH;LRCQKVT4_B""9P!7R+)'7&<@9Q\^E;2?R?MWN7^^[OVW3@!?&:39E56WO
M>^K77P:;<6L6O_A;E$_O5$/AM'/VR@?\^'HUB^Z5<'X]RC'IIMF;_#,O^7I4
M4'\G>(/ ^3^04DD=KU5-0=7B%KD'B.>3<#@ -;DT_(XL+W"63WL)!T68!\B9
MZ_R$(_P]&-O]TA0P,NZ$C\2I9A3P\F-TW_'3TKZ/^4%UZB,,AW'O.ID+W1Z/
M;U#0J%L."KR5!)O?G4/Z6_)0O[T71^&VB'VLY_P:>CB+[IVV@=]]<D_T4B44
M_,-_AZ55-_*-Z&20&L["[=GBTD,E-D,-2-?\$,^&G '^&@_Z_M*WO+N)X0VP
M^U93_P!91T9)]U/81\5U?G['MQ_AMCU6A\T_AQD_C!N:@R&WZC+;AZHW*4@V
M_N'*&*:JIJR.,M-CLB]/#3P^<A'EAD6"-)8KA5UQ2VE/D7G=.;(BDH5+A,NB
MU"LM<,M233-""20?D1UCE[Q^T$GMK<)+;M)+8S46.5])=) *F.0JJBIH65@J
M@BHI537WPB^6V1^-6^_X;GIJNNZGWC64T.[<8C-+]C,VF*/,TL7/[T"!5G11
MJG@73S)'#I]S]R:O--OKB %Q$#X;<-8XZ"?0_A/DQ]">O>RONL_MU>^#<%FL
M;A@)E%3X3X43*/4"@<#+(!Q*J.MG?%97&YW%X[-8:OI,KB,O0TN3Q>3H)UJH
M*BGKD66&>&5"4DBEC965E)#*00;>\4IH7MW,;@JRDJRD4((-""#P(/722VN8
M[R-9H65T=5='4AE96 (8$8((-01Q'4_VWT_U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5/_/7
MYWYSIG/XSJSI;*8Y-^4,M/E=\YRHH:?,Q4$,J:H,6L,Z21&KJ4=)IF*WAB\2
MJ=<K&*7_ &\]OH]]C:[OE;P358E!*ES6A>HH=(X#U-?(9Q?]\O>^;DR=-LV=
MD^J4A[F1E618E(JL>DU&MP0S5RJTIEJJ3?;O\V+Y$XQXDSNVNL-S4PMYFEPE
M=B:AK%CZ9:;(B!";@&](PLHL ;DCBY]G=ME'Z<DZ'R[D9?V%*_\ &NH@V_[U
M&_VY'CP64J^?9+&Y_-9BH_W@]#SMS^<' SQQ;MZ+EB2P,M?MS?0G-_0++25.
M,C%OUFYK?]2MOJWL.W7LJP%8;L$^CQ4]?-7/_'?\W0XV[[VL;&EWMK**9:&Y
M#&N/P/"GS_'Z#Y]#SMS^:Y\;<N5CS>&[,VI+Z=<N0V]29.#U!CZ7H<A43L!I
M -Z9>6%@0&*AZZ]H-T@S&T$GR5V4_P#&T4?SZ'.W?>AY<O,3)=P<,O"CKY\/
M"ED.*>:CB*>=!ZVW\\_B5NC2*+N; X^4D*T6Y,;D=K:22HL9,A1TT)'K'*R%
M;7-[*U@]=>WV\V?Q6KG_ $A23_CC,?+_ %5Z'.V^]W*NZ?V>X0KFE)ED@]/]
M_(@\^(-..<&@[[<[?ZFW@B2;4[.Z^W*KVT_P+>6.RIN038K!4.RL #<$ BQN
M!8^P]=;-=V)I-!-'_IXW7_"!T.-NYHVS>!JM+NVF!\XIXI/^.L<_+H1?9;T>
M]$'^7?SLV1\=*.MVIMG[#>G;\U.!3[=2<R4F*-0MTJ,Q)$P9"%*NE(C+/*I4
MLT$;K+[D/DSV_N.9V$TM8K8'+T[GIY(#Q]"W 9XD4Z@[W7][++V\1K:#3<7Y
M';"#V0U%0TQ'#!J(Q1VQ\*G4-<GL?LK>_;>[<EOCL'<%=N3<>391-6UC@+'%
M&28Z>GB4"*FIHM1T11HJ+<D"Y).3FU[5;[+"MO;($1?(<2?,D\23YDYZYZ\Q
M\RWO-MV][N$K2ROYG@JBM%4#"J*X44'$\22;&?AQ_+JSO:1Q79/=E+D-L]</
MX*_#;4.N@R6;0V9'E_3)C\9*+'7Q/.AO"(D9*@QCSO[FQ[5JM; AYLAI,%(C
M\O)F'^\@\:FHZR&]HON^3<QZ-QWM6AM<-';Y66X'$%N!CC/^]N.&D48W^;>V
M]@MIX3&;;VSB,?@<!A:2*@Q6'Q5*E%3T\,/Z4BB0!5'U)XN223<DGWCI<7,E
MW(TLK%W8U9F)))/F2>LZK&QAVR%+>W18XHU"I&BA451P  P!T\^V>E?7O?NO
M=>]^Z]U[W[KW7O?NO=<71)$:.15>-U9'1U# AA8@@\$$?4>]@TZT17!ZJA^5
M_P#+2VQV"<GOOH:/&[+WK)Y*S(;(95H<-DY/JQI--DQ-4XOPJ_:R-;4M.6DF
M,O\ )_NE-MFFWW#5+%P$O&6,?/\ C7[>X#@30+UB_P"Z7W=+7F+7?;)HMKDU
M9X/AMYC_ $:8B<_(:&/$*27ZH;W7M'=.P=Q9+:N\,%E=L;EPM28,AB<M2O13
MQ.O*M9@-2.MFCD4E)$*O&S(P8Y#6=[#N42S0.LB,*AE-0?\ 9\B#D'!%>L&M
MUVBZV"X>UO(GAFC-&1P58'R/S!XJPJ"*$$@@]6#](_S.NX^K-HU.TMW8>B[:
M2DI8J?:N:W%F)L=74?B 41UE0D,[Y2G5!Z1(8Z@,3JJ732BQKOWM19;M,)H&
M-O4DR(BAD;_2@E=!^RJ^BCSGWDS[RN[\M6IM;R-;[2H$,DLA25*8H[!7\44X
M5TO6M7;  8=F_P POY1]EBII1OI-A8BI5T;$]<T7]V[!C_9KR\^6!MQQD "+
M\<GV;;5[:;1M="8C,P_%,=?_ !D!4_:O0:YD^\!S-S$"@N!:QD$%+1?"/_.0
MEY0?L<?9T3')9/)9FNJ<GE\A797)5CB6KR&2JY*Z>5@ NJ265FD=K "[,38
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MKBY DL_>2PE_MX9HS_1T2+^W4A_XST MU^ZIO-L:VEU:3C^GXL+_ +-$J_\
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M(9*H1;BFH:;4K2.;KK<E8H@0\TB+S[.]AY>NN8YQ!;+4_B8X1%]6/D/EQ/
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MF&%[8W=VM-VMMBKR]2(VW+@LS/D'AJ\;)*0U8M.)1*X4LRFHD0@/3U"QNOD
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M=(7LKKC:7;6R-P=?[XQ<66VYN.B>DK(' #QN/5#4T[V)BJ::4))%(.4=0?\
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MTGGDFD8N/(L)$2TYMY^NN:J1D>%"*?I*U=3>K-0:L\!0 8Q6I+OME[+[;[<
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M][]U[JLG^<;_ -NX?D9_Y2+_ -[O:_MR+XA_J\NJOPZT7?:SIGK<'_X3\?\
M9&G9?_BS>\O_ 'E=E^TL_'\NG4X=7H^V>K]>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U2/_ -UV_P#R
MTO\ XCVY^#\_\G5?/\NKN/;?5NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KA+%%/%)#-''-#-&\4L4J"16606964W#*P)!!%B/>P:9'6
MF4,*'(."#P(Z*YV/\*_C)VCYYMP]3[=QV3G=IFS>T(WV;5&1KWED;&M3Q5+F
MYO\ <12@FQ()"D"O:^>=UVB@BN'*C&F0^*M/0!]5/]K3J-N8?:#EOF>K7-C"
M')J9(0;>0MZDPE-1_P!.&'RJ!T07L?\ E#X:<3574O:^0Q[@2M#A.P<6F21B
MPNH_B6/6F>)%-QSC)F((-[KZY%VOWGD7%Y;JW#NA8J1_M7U5/^V'^:"N8?NG
MV\E6VJ^=.-([I!("?(>)%X94#_FFY_9D@W9'\O\ ^4W6_GGGZYJ-Z8N!2W\6
MZ[JUW6K:20=-%&$RHL+&[8]18\&X8+(NU^Y&T;I0>-X3'\,P\/\ XUE/^-=0
M5S#["<S\O58VOU* 5UVC":OV)VR_/^SI_.A/LEC,EAJZIQF7Q]=BLE1N(JO'
MY*DDH9XF(#:9(I561&L0;,H-B#[&T,R7"AXV#*>#*00?L(J#U$5U:RV,ABF1
MXW4T9'4HZGCD, 1Q\QT-'7/R<[^ZF^WCV'VMN_#T-*$6#"U&1.<QRB/Z!<=7
MK54*CFW%.#;\\#V0[GRGMN\5-Q;QL3Q8#0Y_VR:6_GT,^7O<W?\ E:@LKZ=%
M% (V;Q8@!Y".4.@_)1T8+LK^8QWYVGU3F.KMP)M;'#/F"DS.ZMMT$^(K:F@"
MM]Q12I]S)3JM6V@2O%%%>(/%HTR,?8;VOVQV[:+Q;N,R-HJ5C<JRJ_DP.D'M
M\@:YH:XZ'W,7WAM\YFVN3;)Q AEHLD\*NDC14[D(+LHU_B*T[:K3->BO])=.
M;M[X[(V]UMLVGU9#,S^2OR4D3208^AIRIJLA5%;:8*9#>UP9)"D*7DD12+=_
MWR'EVU>ZG.%%%6N7<\%'S/\ (5)P#U&7)7)]USUN,6W6@[G-7<@E8HA35(U/
M)0>%1J8A1EAUMB]0=4;2Z2Z\V[UOLJD^VPNWZ01M42A3/65,WKJ:ZJ=0/)4U
M4I9W-@JW$:!8T1%P\WG=YM]N7NIS5W-:>2CR4>@ P/VG-3UU,Y5Y8M>3K"';
MK-=,<2TJ::G8Y9V(I5F-23^0H  !+]E?0AZ][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[JLG^<;_P!NX?D9_P"4B_\ >[VO[<B^(?ZO+JK\.M%WVLZ9ZW!_
M^$_'_9&G9?\ XLWO+_WE=E^TL_'\NG4X=7H^V>K]>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U2/_P!U
MV_\ RTO_ (CVY^#\_P#)U7S_ "ZNX]M]6Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z1&]>M.O.R*+^';_
M -C[5WE2*A2*+<F"ILN8[WYA>:-WA8:B0T;*P))!!]KK'<[G;&U6\LD1]4=E
MK]M"*_GT3[QR_8<P)X5];PW"^0FB20#[-0-#\Q0]$3[(_E<?&_>/W%5M'^]/
M6&2E,LL8P&6;-4/DEY)>CR?W,GC!N1'#60*M]*V4!1(.V>[.Z6-!-X<ZX'>N
MEJ#T:/3GYL&ZA+F'[M'+F\5:U$UFY)/Z,A>.I]4F\2@] C(!P%!CH@/8_P#*
MB[UVRM15=?[DVAV91Q([14?F;9V1D*_0+3UCRT O^+Y4<^Y&VSWAV^Z(6YCD
M@)/'$J#\U ;_ (QU!',/W6MZVX%[">"\4 G2:V\I/H%<M'GYRCJTGX1?%2B^
M-77"RYR"FJ.T]YP4E?O?(H5G^U507@P]-(I9?!1ZSY61B)Z@N^IHU@"1)SYS
M>W--UV$B"(E8EX:O5R/5J8]%H.-:Y->S7M@GMSMWZH#7EP%>Y<4.GS6)2/PI
M7)'Q/5N&D ['L"]3%U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5
MD_SC?^W</R,_\I%_[W>U_;D7Q#_5Y=5?AUHN^UG3/6X/_P )^/\ LC3LO_Q9
MO>7_ +RNR_:6?C^73J<.KT?;/5^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZI'_ .Z[?_EI?_$>W/P?
MG_DZKY_EU=Q[;ZMU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW59/\XW_MW#\C/_*1?^]WM?VY
M%\0_U>757X=:+OM9TSUN#_\ "?C_ +(T[+_\6;WE_P"\KLOVEGX_ETZG#J]'
MVSU?KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NJ1_P#NNW_Y:7_Q'MS\'Y_Y.J^?Y=7<>V^K=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U63_.-_[=P_(S_RD7_O=[7]N1?$/]7EU5^'6B[[6=,];@__
M  GX_P"R-.R__%F]Y?\ O*[+]I9^/Y=.IPZO1]L]7Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JD?\
M[KM_^6E_\1[<_!^?^3JOG^75W'MOJW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=5D_SC?^W<
M/R,_\I%_[W>U_;D7Q#_5Y=5?AUHN^UG3/6X/_P )^/\ LC3LO_Q9O>7_ +RN
MR_:6?C^73J<.KT?;/5^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZI'_ .Z[?_EI?_$>W/P?G_DZKY_E
MU=Q[;ZMU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW59/\XW_MW#\C/_*1?^]WM?VY%\0_U>75
M7X=:+OM9TSUN#_\ "?C_ +(T[+_\6;WE_P"\KLOVEGX_ETZG#J]'VSU?KWOW
M7NO>_=>Z][]U[KBS*BL[LJ(BEG=CI "\DDG@ #W[KW1<<;\K.HMT[DR.U.M:
MK<_;V4PM7)09^LZLVC7[MQ%!/'IO3U>X8XH]O1U(U"\ RK3J/4T83U>]E2.M
M5KT8V-M:(Y1XRZ*Q20 ,NH7LUB1<?GD^]=;Z*QF/F3TK093=N.PDF_.PZ7KZ
MJ>A[ W)U;UKF^Q<3A:B @ST]=DL515-*U321DR5$$#SS0(&,J*01[MI/5=0Z
M,'LS>FT^Q-L8?>FQMPXG=6U,_2BMPV>PE8E=35$=RI*2(2-2.K(ZFS(ZLCA6
M4@:(IU;CTI_>NO=>]^Z]U[W[KW7O?NO=>]^Z]U2/_P!UV_\ RTO_ (CVY^#\
M_P#)U7S_ "ZNX]M]6Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[JLG^<;_P!NX?D9_P"4B_\
M>[VO[<B^(?ZO+JK\.M%WVLZ9ZW!_^$_'_9&G9?\ XLWO+_WE=E^TL_'\NG4X
M=7H^V>K]>]^Z]U[W[KW7O?NO=4U?)3M?>/R]^5E'\!>J-P5^V>L-LT[YSY.[
MUP4Y@JZFCQ@ADJ\%33H;Q4VJHI*.>US+65!BF7[>FF2=U1H&H_EU0G4:=6S[
M#V%L[K':6#V)L';V-VMM/;E##CL/A<5 (8HHX0!<GEY99#=I)9&:25RSR.SL
M6+9->K\.B._S0>_LOT!\3]TU^ULE)B=Y]C9;']8[:R5/(R34W]X(JB?(U,)0
MAXY8\51URQ3!E,,\D,@;6$5KQ+J/56-!T-'PEZRQG4WQ0Z*V?14$%%42=<[;
MW'N%(X0ADRF\*:/)Y)Y3:\K?=U4J!FY\:(M@JJHJYJ3UY<#H@7PKWF_27SW^
M6?PXIC-3=>93,Y+M7KC",2L&*J<A'09*HHJ.(V\5-4XW*Q$ >D+0QD>J1F:[
MBJ@_EUI<&G5TOMKJ_7O?NO=>]^Z]U[W[KW7O?NO=4C_]UV__ "TO_B/;GX/S
M_P G5?/\NKN/;?5NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZK)_G&_]NX?D9_Y2+_WN]K^W
M(OB'^KRZJ_#K1=]K.F>MP?\ X3\?]D:=E_\ BS>\O_>5V7[2S\?RZ=3AU>C[
M9ZOU[W[KW7O?NO=0LE6KC<?7Y!T:1*"BJJUXT(!84J,Y4$\ D+;W[KQQUKH?
MRENF:'Y#5GR3[@[2SF\*T;EW?C:+/X/;^Z*G:5'F*K-/6Y>O;*2XV:GRE1"E
M140.M,*V.DD+'[F.JTH(5$ITT Z;05STIOG#U35?RX-[=5?)[XFU66V-M#<.
M[DVGV3UD<_6U^$R%7% ]=3134]3+.\D&4HJ7)I,&E)IGBCFHS%*Q9=(?$P>O
M,-/#I:?SIL]#O'XQ?'7>F(6I_@&Y=]4.>I3,#&0FX=O5-72"5/Q*83)^.+,.
M/SJ'C^76WX=76=:?\RXV!_X9.U?_ ' @]L]7ZHUP,%9D?Y[^[JK&59%'B\&D
M^9$*&59(8NL,=1&)V (3QUTM.238:XPGU('M\_!_J]>F_P 76P![8Z<Z][]U
M[KWOW7NHF0:L6@K6QZ1R5ZTE2U#'*;*TP1O$&N5&DOI!]0X_(]^Z]U2;_?O^
M>]_SY?XH?^?6/_[+/;M$^?5*-T1;$UG\QQOYC#[OS.QNFD^63=+#&1[4I*J,
M;>7;R@DU!E.;<-6,+<??@@C_ #9OPY1=/G2O5:FO5C_]\_YT7_/I?C5_Y\H?
M_LF]MT3Y]6JW7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\ .B_Y]+\:
MO_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW7O[Y_P Z
M+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]1/GUZK=>
M_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$
M^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_&K_SY0__
M &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\ .B_Y]+\:
MO_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW7O[Y_P Z
M+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]1/GUZK=>
M_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$
M^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_&K_SY0__
M &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\ .B_Y]+\:
MO_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW7O[Y_P Z
M+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]1/GUZK=>
M_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$
M^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_&K_SY0__
M &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\ .B_Y]+\:
MO_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW7O[Y_P Z
M+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]1/GUZK=>
M_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$
M^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_&K_SY0__
M &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\ .B_Y]+\:
MO_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW7O[Y_P Z
M+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]1/GUZK=>
M_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$
M^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_&K_SY0__
M &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\ .B_Y]+\:
MO_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW7O[Y_P Z
M+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]1/GUZK=>
M_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$
M^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_&K_SY0__
M &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\ .B_Y]+\:
MO_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW7O[Y_P Z
M+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]1/GUZK=>
M_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$
M^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_&K_SY0__
M &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\ .B_Y]+\:
MO_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW7O[Y_P Z
M+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]1/GUZK=>
M_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$
M^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_&K_SY0__
M &3>_43Y]>JW0'=Z?+W^:A\<L-MC/=J==_'K$8W>&ZZ/9>"EQ\#YII,A7Q33
M11.E-N-VC1HX)#K8!1:Q-R/=E16]>M%B.AQ_OG_.B_Y]+\:O_/E#_P#9-[K1
M/GUNK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9
M-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#
M_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O
M_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]
M+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.
MB_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_
MOG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZ
MK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1
M/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9
M-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#
M_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O
M_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]
M+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.
MB_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_
MOG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZ
MK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1
M/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9
M-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#
M_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O
M_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]
M+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.
MB_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_
MOG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZ
MK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1
M/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9
M-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#
M_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O
M_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]
M+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.
MB_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_
MOG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZ
MK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1
M/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9
M-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#
M_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O
M_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]
M+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.
MB_Y]+\:O_/E#_P#9-[]1/GUZK=>_OG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=>_
MOG_.B_Y]+\:O_/E#_P#9-[]1/GUZK=)#L#NS^<!UELC=G8>[NKOCA1;7V5@,
MGN7<%733K721TF(B::=TABW*TDK+&C$*JEC] +^]A4/KUZIZ;.J?D'_-S[HZ
M]VSVAL'K+XYY'9^[Z.>OP=;6.,9))'3SRTS%X)MR)+&?+#(+,H-@#]#[\513
M3/6@2>A"_OG_ #HO^?2_&K_SY0__ &3>]43Y];JW7O[Y_P Z+_GTOQJ_\^4/
M_P!DWOU$^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_
M&K_SY0__ &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\
M.B_Y]+\:O_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW
M7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]
M1/GUZK=>_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/
M_P!DWOU$^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_
M&K_SY0__ &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\
M.B_Y]+\:O_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW
M7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]
M1/GUZK=>_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/
M_P!DWOU$^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_
M&K_SY0__ &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\
M.B_Y]+\:O_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW
M7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]
M1/GUZK=>_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/
M_P!DWOU$^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_
M&K_SY0__ &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\
M.B_Y]+\:O_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW
M7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]
M1/GUZK=>_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/
M_P!DWOU$^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_
M&K_SY0__ &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\
M.B_Y]+\:O_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW
M7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]
M1/GUZK=>_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/
M_P!DWOU$^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_
M&K_SY0__ &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\
M.B_Y]+\:O_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW
M7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]
M1/GUZK=>_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/
M_P!DWOU$^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_
M&K_SY0__ &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\
M.B_Y]+\:O_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW
M7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]
M1/GUZK=>_OG_ #HO^?2_&K_SY0__ &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/
M_P!DWOU$^?7JMU[^^?\ .B_Y]+\:O_/E#_\ 9-[]1/GUZK=>_OG_ #HO^?2_
M&K_SY0__ &3>_43Y]>JW7O[Y_P Z+_GTOQJ_\^4/_P!DWOU$^?7JMU[^^?\
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M8?4G6/5Z5XZ]V'M;9\N6:%LO68/#PT=36&F18XS6507[FK,:(JJ997*J %L
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M@@CW;6?4]:H.AZIZ>"D@@I:6"&FI::&.GIJ:GC6&...%0J(B* J(B@
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M5*Q]W1]'5675U6A#VA\U_P"5SV!MG%=[[DRG?GQBW-E!B(-Q/7U.?:F0"_\
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M5+P00W-FDE0?GVR!4TZN33K7V_F%]7[BZX^"?3F4[!#2=N=L_(6L[@[=J9E
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M]?DK_P ];AO_ $$<=_\ 4_OW^O\ \R?[]A_YP)U[][3^H_8/\W7O]GU^2O\
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MY0NVJ3!?!SK_ "E-3QP3;TW3V-N7(2H1>::ES-5AUD>P!U"GQ,$?))THO-K
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M[=P_(S_RD7_O=[7]N1?$/]7EU5^'6B[[6=,];@__  GX_P"R-.R__%F]Y?\
MO*[+]I9^/Y=.IPZO1]L]7Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[H.^V.J]D=V]>;HZN[%Q"YO9^[
MJ 4.5HO*:=P89$GIZB"5?5#4TM3%%-#(.4E16L0""9[-O%QL%U'>6K:)8S53
MQ&0001Y@@D$>8)Z0[GML.[P/;7"ZHW%&'YU!'H00"#Y$5ZJ J_Y&/1[U,S4/
M<_:M-2,]X(*NAQ%;(J_T>5*2G5S?\B%/];W-Z?>&W$#NM;8GS(,H'["Y_P /
M45-[,6).)YP/GX9/_'!_@ZC_ /#%_37_ #^[LW_ST8K_ *]>[?\ !#[A_P H
MMO\ [U)_T%UK_68LO]_S_LC_ .@>O?\ #%_37_/[NS?_ #T8K_KU[]_P0^X?
M\HMO_O4G_077O]9BR_W_ #_LC_Z!Z]_PQ?TU_P _N[-_\]&*_P"O7OW_  0^
MX?\ *+;_ .]2?]!=>_UF++_?\_[(_P#H'KW_  Q?TU_S^[LW_P ]&*_Z]>_?
M\$/N'_*+;_[U)_T%U[_68LO]_P _[(_^@>O?\,7]-?\ /[NS?_/1BO\ KU[]
M_P $/N'_ "BV_P#O4G_077O]9BR_W_/^R/\ Z!Z]_P ,7]-?\_N[-_\ /1BO
M^O7OW_!#[A_RBV_^]2?]!=>_UF++_?\ /^R/_H'KW_#%_37_ #^[LW_ST8K_
M *]>_?\ !#[A_P HMO\ [U)_T%U[_68LO]_S_LC_ .@>O?\ #%_37_/[NS?_
M #T8K_KU[]_P0^X?\HMO_O4G_077O]9BR_W_ #_LC_Z!Z]_PQ?TU_P _N[-_
M\]&*_P"O7OW_  0^X?\ *+;_ .]2?]!=>_UF++_?\_[(_P#H'H^7Q$^!W3?P
MZ3<&0V-4;AW/O'=5)38[-;RW;/3RU(I*=EE^QHXJ:"GAI*1YU65UTO)(ZQ^6
M5UBB"1SSM[C7_/)1;D)'%&24BC!"ZCC4Q8L6:F!P %: 5-1KRMR59\IAC!K=
MW #22$%M(S04  %<^IQ4F@H-^>[AQ^WN^^NNE<B*2GE[(Z]["W9@:N5]$LU;
ML*JPZR4,8+@,TE!D*NHL(R=%+(VI0+, J8KT+JYIUP[R^.O3GR.VM)M+M[9.
M*W30JLO\,R4D?VF1Q\DHMYL=D(M-5227L2$DT26TRI(EU/E8KPZ\17JE;^7M
MLS=WQ=_F*=^?%/$;FR&Y.O*/9]=FZU:BVEE@CP^0PN1GCB)ACKX:/+K23N@1
M7>5@46T:(](=2@]47!ITJOB9V;#\IOYGO=F[^R9TR/\ H:VYO?#]$[4R4JRT
M^*@P.:I,0]=24[#2,A)3-+-,XNPEJG8$K##XM,-*CY\>O U/0L?S:/B1DNPM
MF8[Y/]60U=)VOTI21U^>.%(I:JMP6(D-9]['*FF7[[;TH>JB97#?;&H U21P
M)[U$],'@>MNM<]9O@[\A*KY][EV;NOM"MVSC\C\9\/CLC2]=TE2LM1FMW9>G
MGHGWQ/3/&BPT./H'F@H8(O)X*VLJI9'311 ^=?#_ #Z\IU=6^U&7Q=)D<=AZ
MK(4=/E<Q'738K'S5"QS5"XP1M4-#&3JD$"RQE](.D,"?K[:ZOU1/_-)(7YH?
M )F(55WG@"S$V  W7A;DGV]'P;[/\_3;]7T^V>G.O>_=>Z][]U[KWOW7NB1_
MS&L9M7+_  Q[RHMU4]/4A]MTQVQ#)$)IGSQK*=<)'1K<2-5S9)J>)%CN[AV0
M*X9D:\?$=5;AU,H>A=QY3X!8_P".>;(3><_QAH.N9P["=*?,Q;>2FBC!=D#Q
M4F06-5NR72,<QW]/M7=7YUZ\!BG19OY-6X!4_%3.;&KJ:;&[CZR[=WKMO/8B
MLA--40O6I25RF6)F+H?+45$)#*A#P2*5].IK3#-?7K2<.@:_F7[<J>[/FE\%
M.B,0PJZ^/(93=6:HXI"STV+S&5Q[UU8ZH Z(E!MRO<'79O"0-)!8[C.E2>M-
MDTZY?.7;4W5G\R+X6?(>LIY$V9NW+;5ZXS.3: &"ER%)D*JD>6>;R($!Q^;@
MD4, =%),Z>72T:^3*D?GUML$'JYCL?=-+L;KS?>]:ZJBHJ/:.S=S[FJJR:18
M4BCP-%/5/(SL&50BQ$DE2!;Z'Z>V@*]6/53'\DKK/)[5^.&]>PLG3O3)VCV#
M-)@]88>;'[-@%$M0+V6S9"3)1\#GQ7)/ #LQJ>JH.KF_;/5^O>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z#'N3I_8??76NZ>I^RL2<QL_=U$E)DJ:*;[::-Z:1)Z>JII@"8:J
MEJ(HI8GL=+H-2LNI2DOK*/<8FAE%584(_F"/F#D='W+',MYRA?1;C8/HFA;4
MAI4$$%65AYJRDJP\P3]O5.M7_(9Z'>IF:@[L[<IJ-GO3P5='AJV15_H\J45.
MKG_$0I_K>P0?;JVKB67_ (P?^?1UDY']\#>0HUV-D3YD&=0?L!D:G[3U&_X8
M7Z3_ .?Y=I_^>G$_]>/>O];JW_W[)^Q?\W5_^#!W?_E L_\ >IO^@^O?\,+]
M)_\ /\NT_P#STXG_ *\>_?ZW5O\ []D_8O\ FZ]_P8.[_P#*!9_[U-_T'U[_
M (87Z3_Y_EVG_P">G$_]>/?O];JW_P!^R?L7_-U[_@P=W_Y0+/\ WJ;_ *#Z
M]_PPOTG_ ,_R[3_\].)_Z\>_?ZW5O_OV3]B_YNO?\&#N_P#R@6?^]3?]!]>_
MX87Z3_Y_EVG_ .>G$_\ 7CW[_6ZM_P#?LG[%_P W7O\ @P=W_P"4"S_WJ;_H
M/KW_  POTG_S_+M/_P ].)_Z\>_?ZW5O_OV3]B_YNO?\&#N__*!9_P"]3?\
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M^.06FMY):>)+*07(6M% 4*%45. *D\2:"AA:6268.FI)XD]!5\\?^96]8_\
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M$CGVR<=.#/1&?YN/_9"O:/\ VO>MO_>AQWMR+XA_J\NJ/PZ&[X"?]D8_&_\
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M+(NO*;4VA5;)I6011*1]E5YK/2"0S"9]0KM.ATCT7C,DE3U;H"_C9\4^N/C
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MZ.V9D-@TF:JZ*W@;-9/)9G+9*2E@NY%/#)&I=A*'26.)ET'T\!G]O7B*\>K
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ML;Z!869)KU<"G2GR>/I\MCZS&54E=%35]-+2SR8S)U.%J%686)AJZ.:"KII
M#Z9(IDD4\JP//O76^J!N^Z3?F _F<]2_'_!]\_)'"=2]EXC;F<R^U\9\A-X+
MX6R$672>.EJILQ-4PQR38U)-(E(0NRII32JOCX2:#]@^73?G3JTK_9-MI_\
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M[NVY6;][6WSMFN.*SM714E-DJJ/;^$JP=='-4T^.=YIHQY52171],$T,_E%
M6Z\34TZ&K*_ _KO&XZ6KZ?[$[RZ:[!BC66AW[A.Y]S;L:6HBCB16RF*SV5R6
M*R5-(((A- :6,.@"H\>F,IK7ZT_9ULKU!^ 7^EY^K^UL9WWN"MW/VGB._NQM
MN;KSTKK3_<G#4V+I:>:E$$=.D-)+21PO3"**(")D*JI/OST\O3KR_/JMO^9.
M>PNH_DC\=-I]7]]_(_8VV>X&QN)W1A\-W[NNICC=,Q28]ZJB-=E:PT\\E-5
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M2'_H%9/_ .OWOW^M7MO\4_\ O:?]:^O?N*'U?]H_Z!Z]_P /=_,7_G1=(?\
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M=FHH'S&+H<GB\?DBMI8J;-/2RU<"L.?%424-&[J>&:")B+HI'NO=41?SJ_\
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MC_@/60S\.JO.X0/Y>_\ ,WVOW# 1B>D/DO\ ?C=DA*P4U/\ WBJ:>/<.JS(
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MVGKW_ G\L?[\O_\ G/%_VS]>_P"'#N^?^=?UY_Z#U7_]<O?O^"TYG_WUM_\
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M &_O;YP]H]NU.S^P<_UO\:.G=R-U]AI>O*FGHLQO',1+(U5D9\T]///CL-!
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M$4'2)77W>( K:5/F1/05^SP33]I^WH]','K'_P :_P"A>L'_  P/_P"!8_\
ML"?_ ,\O>_\ 7>_Y=/\ JO\ ]<>M_P!8?^%_\;_Z%Z]_PP/_ .!8_P#L"?\
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M!8_^P)__ #R]^_UWO^73_JO_ -<>O?UA_P"%_P#&_P#H7KW_  P/_P"!8_\
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M[_@-/^DQ_P!T_P#[?>O?\&/_ -(C_NH?]N77O^&R_P#O]G_L-_\ \O\ OW_
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M5%3YC)*6=II"AC] 1T2 "E/Y_P"QU0K4UZ-">K_F<00/EMU>I((##XHFXO\
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@TTUQ7JK5IU1!_#NK_P#GL-^_^BWQW_V5>WL]4QU__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310098730608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Feb. 20, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference [Text Block]</a></td>
<td class="text"><p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:6pt;text-align:left;text-indent:24pt;margin-top:6pt;">The information required by Part III of this Report, to the extent not set forth herein, is incorporated herein by reference from the registrant&#8217;s definitive proxy statement relating to the Annual Meeting of Stockholders to be held in 2024, which definitive proxy statement shall be filed with the Securities and Exchange Commission within 120&#160;days after the end of the fiscal year to which this Report relates. &#160;<span class="CharOverride-9" style="font-size:8pt;">&#160;</span></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">WisdomTree, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000880631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-10932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3487784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 948,550,832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityContactPersonnelLineItems', window );"><strong>Entity Contact Personnel [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">250 West 34th Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">3rd Floor<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPhoneFaxNumbersLineItems', window );"><strong>Entity Phone Fax Numbers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">801-2080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151,853,699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=wt_CommonStock001ParValueMember', window );">Common Stock, $0.01 par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">WT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=wt_PreferredStockPurchaseRightsMember', window );">Preferred Stock Purchase Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsLineItems', window );"><strong>Entity Listings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Preferred Stock Purchase Rights<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">None<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityContactPersonnelLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityContactPersonnelLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPhoneFaxNumbersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPhoneFaxNumbersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=wt_CommonStock001ParValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=wt_CommonStock001ParValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=wt_PreferredStockPurchaseRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=wt_PreferredStockPurchaseRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310098303296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorTable', window );"><strong>Auditor [Table]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst&#160;& Young LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">New York<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310097493648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents (including $5,007 and $0 invested in WisdomTree Government Money Market Digital Fund at December 31, 2023 and 2022, respectively)</a></td>
<td class="nump">$ 129,305<span></span>
</td>
<td class="nump">$ 132,101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsOwnedAtFairValue', window );">Financial instruments owned, at fair value (including $47,559 and $25,283 invested in WisdomTree products at December 31, 2023 and 2022, respectively)</a></td>
<td class="nump">58,722<span></span>
</td>
<td class="nump">126,239<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable (including $28,511 and $24,139 due from related parties at December 31, 2023 and 2022, respectively)</a></td>
<td class="nump">35,473<span></span>
</td>
<td class="nump">30,549<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">5,258<span></span>
</td>
<td class="nump">4,684<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">1,036<span></span>
</td>
<td class="nump">390<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">229,794<span></span>
</td>
<td class="nump">293,963<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Fixed assets, net</a></td>
<td class="nump">427<span></span>
</td>
<td class="nump">544<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_IndemnificationReceivableNoncurrent', window );">Indemnification receivable (Note 22)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,353<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesNoncurrent', window );">Securities held-to-maturity</a></td>
<td class="nump">230<span></span>
</td>
<td class="nump">259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets, net</a></td>
<td class="nump">11,057<span></span>
</td>
<td class="nump">10,536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments (Note 7)</a></td>
<td class="nump">9,684<span></span>
</td>
<td class="nump">35,721<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use assets&#8212;operating leases (Note13)</a></td>
<td class="nump">563<span></span>
</td>
<td class="nump">1,449<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill (Note 24)</a></td>
<td class="nump">86,841<span></span>
</td>
<td class="nump">85,856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Intangible assets, net (Note 24)</a></td>
<td class="nump">605,082<span></span>
</td>
<td class="nump">603,567<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other noncurrent assets</a></td>
<td class="nump">459<span></span>
</td>
<td class="nump">571<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">944,137<span></span>
</td>
<td class="nump">1,033,819<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Fund management and administration payable</a></td>
<td class="nump">30,085<span></span>
</td>
<td class="nump">36,521<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Compensation and benefits payable</a></td>
<td class="nump">38,111<span></span>
</td>
<td class="nump">24,121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Payable to Gold Bullion Holdings (Jersey) Limited (&#8220;GBH&#8221;) (Note 12)</a></td>
<td class="nump">14,804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Income taxes payable</a></td>
<td class="nump">3,866<span></span>
</td>
<td class="nump">1,599<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities (Note 13)</a></td>
<td class="nump">578<span></span>
</td>
<td class="nump">1,125<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertible notes&#8212;current (Note 10)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">59,197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DeferredConsiderationCurrent', window );">Deferred consideration&#8212;gold payments (Note 9)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">16,796<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accounts payable and other liabilities</a></td>
<td class="nump">15,772<span></span>
</td>
<td class="nump">9,075<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">103,216<span></span>
</td>
<td class="nump">148,434<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_CarryingValueOfConvertibleNotes', window );">Convertible notes (Note 10)</a></td>
<td class="nump">274,888<span></span>
</td>
<td class="nump">262,019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrentAndNoncurrent', window );">Payable to GBH (Note 12)</a></td>
<td class="nump">24,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DeferredConsiderationNoncurrent', window );">Deferred consideration&#8212;gold payments (Note 9)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">183,494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities (Note 13)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">339<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other noncurrent liabilities (Note 22)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,353<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">402,432<span></span>
</td>
<td class="nump">595,639<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital', window );">Preferred stock&#8212;Series A Non-Voting Convertible, par value $0.01; 14.750 shares authorized, issued and outstanding; redemption value of $96,869 and $77,969 at December 31, 2023 and 2022, respectively) (Note 11)</a></td>
<td class="nump">132,569<span></span>
</td>
<td class="nump">132,569<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Contingencies (Note 14)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $0.01; 2,000 shares authorized:</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.01; 400,000 shares authorized; issued and outstanding: 150,330 and 146,517 at December 31, 2023 and 2022, respectively</a></td>
<td class="nump">1,503<span></span>
</td>
<td class="nump">1,465<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">312,440<span></span>
</td>
<td class="nump">291,847<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(548)<span></span>
</td>
<td class="num">(1,420)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">95,741<span></span>
</td>
<td class="nump">13,719<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">409,136<span></span>
</td>
<td class="nump">305,611<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 944,137<span></span>
</td>
<td class="nump">$ 1,033,819<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsOwnedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value as of the balance sheet date of financial instruments and other positions owned by the entity including: (1) mortgages, mortgage-backed and asset backed securities; (2) US government and agency obligations; (3) state and municipal government obligations; (4) other sovereign government debt; (5) corporate obligations; (6) corporate equities; (7) principal investments; (8) derivative contracts; and (9) physical commodities. Includes both pledged and unpledged holdings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481961/940-320-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsOwnedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of the par value of temporary equity outstanding. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_CarryingValueOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of convertible notes (with maturities initially due after one year), net of unamortized issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_CarryingValueOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_DeferredConsiderationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Consideration Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_DeferredConsiderationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_DeferredConsiderationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred consideration - noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_DeferredConsiderationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_IndemnificationReceivableNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indemnification receivable noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_IndemnificationReceivableNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310097442096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parentheticals) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in Dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in Dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">150,330<span></span>
</td>
<td class="nump">146,517<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">150,330<span></span>
</td>
<td class="nump">146,517<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Non-Voting Convertible</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Preferred stock, par value (in Dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">14.75<span></span>
</td>
<td class="nump">14.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">14.75<span></span>
</td>
<td class="nump">14.75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">14.75<span></span>
</td>
<td class="nump">14.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_PreferredStockRedemptionValue', window );">Preferred stock redemption value (in Dollars)</a></td>
<td class="nump">$ 96,869<span></span>
</td>
<td class="nump">$ 77,969<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_RelatedPartiesAxis=us-gaap_RelatedPartyMember', window );">Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable from related parties (in Dollars)</a></td>
<td class="nump">28,511<span></span>
</td>
<td class="nump">24,139<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=wt_WisdomtreeETFMember', window );">WisdomTree ETF</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAndCash', window );">Cash and cash equivalents (in Dollars)</a></td>
<td class="nump">5,007<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value (in Dollars)</a></td>
<td class="nump">$ 47,559<span></span>
</td>
<td class="nump">$ 25,283<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480833/946-310-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481058/954-310-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAndCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of investments and unrestricted cash as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAndCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instruments held by a broker-dealer for their own account (proprietary securities) for trading or investment purposes determined by management based upon quoted prices of a financial instrument with similar characteristics or on a valuation technique or model.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481961/940-320-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_PreferredStockRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Preferred Stock Redemption Value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_PreferredStockRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_RelatedPartiesAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_RelatedPartiesAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=wt_WisdomtreeETFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=wt_WisdomtreeETFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310098368048">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Operating Revenues:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 349,035<span></span>
</td>
<td class="nump">$ 301,345<span></span>
</td>
<td class="nump">$ 304,318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Compensation and benefits</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">109,532<span></span>
</td>
<td class="nump">97,897<span></span>
</td>
<td class="nump">88,163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FundManagementAndAdministration', window );">Fund management and administration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">71,348<span></span>
</td>
<td class="nump">64,761<span></span>
</td>
<td class="nump">58,912<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketingAndAdvertisingExpense', window );">Marketing and advertising</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17,256<span></span>
</td>
<td class="nump">15,302<span></span>
</td>
<td class="nump">14,090<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDevelopment', window );">Sales and business development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">13,584<span></span>
</td>
<td class="nump">11,871<span></span>
</td>
<td class="nump">9,907<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ContractualGoldPayments', window );">Contractual gold payments (Note 9)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,069<span></span>
</td>
<td class="nump">17,108<span></span>
</td>
<td class="nump">17,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">18,969<span></span>
</td>
<td class="nump">13,800<span></span>
</td>
<td class="nump">7,616<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommunicationsInformationTechnologyAndOccupancy', window );">Occupancy, communications and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,684<span></span>
</td>
<td class="nump">3,898<span></span>
</td>
<td class="nump">4,629<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">872<span></span>
</td>
<td class="nump">262<span></span>
</td>
<td class="nump">738<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ThirdPartyDistribution', window );">Third-party distribution fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,377<span></span>
</td>
<td class="nump">7,656<span></span>
</td>
<td class="nump">7,176<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,852<span></span>
</td>
<td class="nump">8,705<span></span>
</td>
<td class="nump">6,933<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">261,543<span></span>
</td>
<td class="nump">241,260<span></span>
</td>
<td class="nump">215,260<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">87,492<span></span>
</td>
<td class="nump">60,085<span></span>
</td>
<td class="nump">89,058<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other Income/(Expenses):</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(15,242)<span></span>
</td>
<td class="num">(14,935)<span></span>
</td>
<td class="num">(12,332)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_GainLossFromChangeInDeferredConsideration', window );">Gain on revaluation/termination of deferred consideration&#8212;gold payments (Note 9)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">61,953<span></span>
</td>
<td class="nump">27,765<span></span>
</td>
<td class="nump">2,018<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,099<span></span>
</td>
<td class="nump">3,320<span></span>
</td>
<td class="nump">2,009<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairments (Note 26)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(7,942)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(16,156)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt (Note 10)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(9,721)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingGainsLosses', window );">Other losses, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,631)<span></span>
</td>
<td class="num">(36,285)<span></span>
</td>
<td class="num">(7,926)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">119,008<span></span>
</td>
<td class="nump">39,950<span></span>
</td>
<td class="nump">56,671<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense/(benefit)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,462<span></span>
</td>
<td class="num">(10,734)<span></span>
</td>
<td class="nump">6,874<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 102,546<span></span>
</td>
<td class="nump">$ 50,684<span></span>
</td>
<td class="nump">$ 49,797<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per share&#8212;basic (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.66<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per share&#8212;diluted (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.64<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares&#8212;basic (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">144,707<span></span>
</td>
<td class="nump">143,020<span></span>
</td>
<td class="nump">143,847<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares&#8212;diluted (in Shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">170,413<span></span>
</td>
<td class="nump">158,914<span></span>
</td>
<td class="nump">161,263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividends declared per common share (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
<td class="nump">$ 0.12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember', window );">Advisory fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Operating Revenues:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 333,227<span></span>
</td>
<td class="nump">$ 293,632<span></span>
</td>
<td class="nump">$ 298,052<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=wt_OtherServicesIncomeMember', window );">Other income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Operating Revenues:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 15,808<span></span>
</td>
<td class="nump">$ 7,713<span></span>
</td>
<td class="nump">$ 6,266<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Gains on revaluation/termination of deferred consideration&#8212;gold payments result from a decrease in spot gold prices, a decrease in the forward<span class="nobreak">-looking</span> price of gold, a decrease in the perpetual growth rate and an increase in the discount rate used to compute the present value of the annual payment obligations.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business development involves the development of products and services, their delivery, design and their implementation. Business development includes a number of techniques designed to grow an economic enterprise. Such techniques include, but are not limited to, assessments of marketing opportunities and target markets, intelligence gathering on customers and competitors, generating leads for possible sales, follow-up sales activity, formal proposal writing and business model design. Business development involves evaluating a business and then realizing its full potential, using such tools as marketing, sales, information management and customer service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommunicationsInformationTechnologyAndOccupancy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of communications, data processing and occupancy expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.6)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.14)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommunicationsInformationTechnologyAndOccupancy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingAndAdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total expense recognized in the period for promotion, public relations, and brand or product advertising.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingAndAdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4,6)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7,9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ContractualGoldPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual gold payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ContractualGoldPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_FundManagementAndAdministration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fund management and administration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_FundManagementAndAdministration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_GainLossFromChangeInDeferredConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain/loss from revaluation of deferred consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_GainLossFromChangeInDeferredConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ThirdPartyDistribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Third Party Distribution.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ThirdPartyDistribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=wt_OtherServicesIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=wt_OtherServicesIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310107323984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 102,546<span></span>
</td>
<td class="nump">$ 50,684<span></span>
</td>
<td class="nump">$ 49,797<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive income/(loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment, net of income taxes</a></td>
<td class="nump">872<span></span>
</td>
<td class="num">(2,102)<span></span>
</td>
<td class="num">(420)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income/(loss)</a></td>
<td class="nump">872<span></span>
</td>
<td class="num">(2,102)<span></span>
</td>
<td class="num">(420)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 103,418<span></span>
</td>
<td class="nump">$ 48,582<span></span>
</td>
<td class="nump">$ 49,377<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310097692064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Stockholders&#8217; Equity - USD ($)<br></strong></div></th>
<th class="th">
<div>Series C </div>
<div>Preferred Stock</div>
</th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income/(Loss)</div></th>
<th class="th"><div>(Accumulated Deficit)/Retained Earnings</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,487,000<span></span>
</td>
<td class="nump">$ 317,075,000<span></span>
</td>
<td class="nump">$ 1,102,000<span></span>
</td>
<td class="num">$ (53,399,000)<span></span>
</td>
<td class="nump">$ 266,265,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2020</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">148,716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Restricted stock issued and vesting of restricted stock units, net</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 13,000<span></span>
</td>
<td class="num">(13,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Restricted stock issued and vesting of restricted stock units, net (in Shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Shares repurchased</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (51,000)<span></span>
</td>
<td class="num">(34,455,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(34,506,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Shares repurchased (in Shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(5,121)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options, net</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">813,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">815,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, net (in Shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">9,998,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">9,998,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(420,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(420,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(19,459,000)<span></span>
</td>
<td class="num">(19,459,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">49,797,000<span></span>
</td>
<td class="nump">49,797,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,451,000<span></span>
</td>
<td class="nump">289,736,000<span></span>
</td>
<td class="nump">682,000<span></span>
</td>
<td class="num">(22,445,000)<span></span>
</td>
<td class="nump">269,424,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">145,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes', window );">Reclassification of equity component related to convertible notes, net of deferred taxes of $1,022, upon the implementation of Accounting Standards Update 2020-06 (Note 10)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(3,682,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">616,000<span></span>
</td>
<td class="num">(3,066,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_TemporaryStockholdersEquity', window );">Balance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,487,000<span></span>
</td>
<td class="nump">313,393,000<span></span>
</td>
<td class="nump">1,102,000<span></span>
</td>
<td class="num">(52,783,000)<span></span>
</td>
<td class="nump">263,199,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_TemporaryEquityShareOutstanding', window );">Balance (in Shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">148,716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Restricted stock issued and vesting of restricted stock units, net</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="num">(20,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Restricted stock issued and vesting of restricted stock units, net (in Shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Shares repurchased</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (6,000)<span></span>
</td>
<td class="num">(3,412,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(3,418,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Shares repurchased (in Shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(593)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">10,385,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">10,385,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,102,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,102,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,842,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(14,520,000)<span></span>
</td>
<td class="num">(19,362,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">50,684,000<span></span>
</td>
<td class="nump">50,684,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,465,000<span></span>
</td>
<td class="nump">291,847,000<span></span>
</td>
<td class="num">(1,420,000)<span></span>
</td>
<td class="nump">13,719,000<span></span>
</td>
<td class="nump">305,611,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">146,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Restricted stock issued and vesting of restricted stock units, net</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 34,000<span></span>
</td>
<td class="num">(34,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Restricted stock issued and vesting of restricted stock units, net (in Shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">3,412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Shares issued in connection with convertible notes that matured on June 15, 2023 (Note 10)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">45,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Shares issued in connection with convertible notes that matured on June 15, 2023 (Note 10) (in Shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Shares issued in connection with termination of the deferred consideration&#8212;gold payments obligation, net of issuance costs (Note 9)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">86,801,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">86,801,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Shares issued in connection with termination of the deferred consideration&#8212;gold payments obligation, net of issuance costs (Note 9) (in Shares)</a></td>
<td class="nump">13<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Shares repurchased that were issued in connection with termination of the deferred consideration&#8212;gold payments obligation, net of issuance costs (Notes 12 and 23)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(78,835,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(78,835,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Shares repurchased that were issued in connection with termination of the deferred consideration&#8212;gold payments obligation, net of issuance costs (Notes 12 and 23) (in Shares)</a></td>
<td class="num">(13)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Shares repurchased</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (6,000)<span></span>
</td>
<td class="num">(3,564,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(3,570,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Shares repurchased (in Shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(636)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">16,190,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">16,190,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">872,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">872,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(20,524,000)<span></span>
</td>
<td class="num">(20,524,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">102,546,000<span></span>
</td>
<td class="nump">102,546,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,503,000<span></span>
</td>
<td class="nump">$ 312,440,000<span></span>
</td>
<td class="num">$ (548,000)<span></span>
</td>
<td class="nump">$ 95,741,000<span></span>
</td>
<td class="nump">$ 409,136,000<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2023</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">150,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -SubTopic 405<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481071/942-405-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reclassification of equity component related to convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_TemporaryEquityShareOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary equity shares outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_TemporaryEquityShareOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_TemporaryStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary stockholders equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_TemporaryStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100103616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Stockholders&#8217; Equity (Parentheticals)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ReclassificationOfEquity', window );">Reclassification of equity component related to convertible notes, net of deferred taxes</a></td>
<td class="nump">$ 1,022<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ReclassificationOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reclassification of equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ReclassificationOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310098425200">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 102,546<span></span>
</td>
<td class="nump">$ 50,684<span></span>
</td>
<td class="nump">$ 49,797<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_GainLossFromChangeInDeferredConsideration', window );">Gain on revaluation of deferred consideration&#8212;gold payments</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(61,953)<span></span>
</td>
<td class="num">(27,765)<span></span>
</td>
<td class="num">(2,018)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_AdvisoryFeesReceivedInGold', window );">Advisory fees received in gold and other precious metals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(49,400)<span></span>
</td>
<td class="num">(57,290)<span></span>
</td>
<td class="num">(74,970)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,190<span></span>
</td>
<td class="nump">10,385<span></span>
</td>
<td class="nump">9,998<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,721<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,942<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">16,156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ContractualGoldPayments', window );">Contractual gold payments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,069<span></span>
</td>
<td class="nump">17,108<span></span>
</td>
<td class="nump">17,096<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_AmortizationOfIssuanceCostsConvertibleNotes', window );">Amortization of issuance costs&#8212;convertible notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,817<span></span>
</td>
<td class="nump">2,592<span></span>
</td>
<td class="nump">2,187<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of right of use asset</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,285<span></span>
</td>
<td class="nump">963<span></span>
</td>
<td class="nump">1,950<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">872<span></span>
</td>
<td class="nump">262<span></span>
</td>
<td class="nump">738<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Losses on financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">517<span></span>
</td>
<td class="nump">16,516<span></span>
</td>
<td class="nump">3,715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(481)<span></span>
</td>
<td class="num">(1,296)<span></span>
</td>
<td class="nump">316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Imputed interest on payable to GBH</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">297<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealizedInvestmentGainsLosses', window );">Losses on investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">242<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Gain on sale&#8212;Canadian ETF business, including remeasurement of contingent consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(787)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,984)<span></span>
</td>
<td class="num">(272)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(6,212)<span></span>
</td>
<td class="num">(720)<span></span>
</td>
<td class="num">(3,506)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(518)<span></span>
</td>
<td class="num">(808)<span></span>
</td>
<td class="num">(139)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_IncreaseDecreaseInGoldAndOtherPreciousMetals', window );">Gold and other precious metals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">42,150<span></span>
</td>
<td class="nump">41,847<span></span>
</td>
<td class="nump">57,417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">281<span></span>
</td>
<td class="num">(309)<span></span>
</td>
<td class="num">(394)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_IncreaseDecreaseInFundManagementAndAdministrationPayable', window );">Fund management and administration payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,837<span></span>
</td>
<td class="nump">3,723<span></span>
</td>
<td class="nump">1,348<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Compensation and benefits payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,209<span></span>
</td>
<td class="nump">4,485<span></span>
</td>
<td class="nump">10,242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable', window );">Income taxes payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,260<span></span>
</td>
<td class="num">(2,308)<span></span>
</td>
<td class="nump">3,101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_IncreaseDecreaseInOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,284)<span></span>
</td>
<td class="num">(965)<span></span>
</td>
<td class="num">(15,560)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities', window );">Accounts payable and other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,213<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="num">(1,097)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">85,600<span></span>
</td>
<td class="nump">55,087<span></span>
</td>
<td class="nump">75,318<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_PurchaseOfFinancialInstrumentsOwnedAtFairValue', window );">Purchase of financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(57,364)<span></span>
</td>
<td class="num">(67,734)<span></span>
</td>
<td class="num">(115,526)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_PurchaseOfInvestments', window );">Purchase of investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(11,228)<span></span>
</td>
<td class="num">(21,863)<span></span>
</td>
<td class="num">(5,750)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment', window );">Cash paid&#8212;software development</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,149)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPaymentsToAcquireBusinesses', window );">Cash paid&#8212;acquisition of Securrency Transfers, Inc. (net of cash acquired)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(985)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of fixed assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(113)<span></span>
</td>
<td class="num">(220)<span></span>
</td>
<td class="num">(293)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue', window );">Proceeds from the sale of financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">123,564<span></span>
</td>
<td class="nump">52,115<span></span>
</td>
<td class="nump">19,441<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments', window );">Proceeds from the exit from investment in Securrency, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">28,818<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds from receipt of contingent consideration related to the sale of Canadian ETF business</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,477<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity', window );">Proceeds from held-to-maturity securities maturing or called prior to maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">29<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="nump">136<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by/(used in) investing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">82,049<span></span>
</td>
<td class="num">(37,657)<span></span>
</td>
<td class="num">(99,632)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfNotesPayable', window );">Repurchase and maturity of convertible notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(184,272)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_PaymentOfDeferredConsideration', window );">Termination of deferred consideration&#8212;gold payments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(50,005)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Repurchase of Series C Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(40,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(20,144)<span></span>
</td>
<td class="num">(19,362)<span></span>
</td>
<td class="num">(19,459)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Shares repurchased</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,570)<span></span>
</td>
<td class="num">(3,418)<span></span>
</td>
<td class="num">(34,506)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_PaymentOfConvertibleNotesIssuanceCosts', window );">Issuance costs&#8212;convertible notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,548)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,297)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Issuance costs&#8212;Series C Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(97)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ProceedsFromIssuanceOfConvertibleNotes', window );">Proceeds from the issuance of convertible notes (Note 10)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">130,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">150,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">815<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in)/provided by financing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(171,636)<span></span>
</td>
<td class="num">(22,780)<span></span>
</td>
<td class="nump">92,553<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Increase/(decrease) in cash flow due to changes in foreign exchange rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,191<span></span>
</td>
<td class="num">(3,258)<span></span>
</td>
<td class="num">(955)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease)/increase in cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,796)<span></span>
</td>
<td class="num">(8,608)<span></span>
</td>
<td class="nump">67,284<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents&#8212;beginning of year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">132,101<span></span>
</td>
<td class="nump">140,709<span></span>
</td>
<td class="nump">73,425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents&#8212;end of year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">129,305<span></span>
</td>
<td class="nump">132,101<span></span>
</td>
<td class="nump">140,709<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,156<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="nump">8,456<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 10,709<span></span>
</td>
<td class="nump">$ 12,313<span></span>
</td>
<td class="nump">$ 9,898<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Gains on revaluation/termination of deferred consideration&#8212;gold payments result from a decrease in spot gold prices, a decrease in the forward<span class="nobreak">-looking</span> price of gold, a decrease in the perpetual growth rate and an increase in the discount rate used to compute the present value of the annual payment obligations.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligations incurred but not paid, and operating obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPaymentsToAcquireBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with other payments to acquire businesses including deposit on pending acquisitions and preacquisition costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPaymentsToAcquireBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from long-term debt supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedInvestmentGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedInvestmentGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_AdvisoryFeesReceivedInGold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Advisory fees received in gold and other precious metals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_AdvisoryFeesReceivedInGold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_AmortizationOfIssuanceCostsConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization of issuance costs &#8211; convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_AmortizationOfIssuanceCostsConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ContractualGoldPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual gold payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ContractualGoldPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_GainLossFromChangeInDeferredConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain/loss from revaluation of deferred consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_GainLossFromChangeInDeferredConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_IncreaseDecreaseInFundManagementAndAdministrationPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in fund management and administration payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_IncreaseDecreaseInFundManagementAndAdministrationPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_IncreaseDecreaseInGoldAndOtherPreciousMetals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash realized upon sale of gold and other precious metals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_IncreaseDecreaseInGoldAndOtherPreciousMetals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_IncreaseDecreaseInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase or decrease in operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_IncreaseDecreaseInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_PaymentOfConvertibleNotesIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of convertible notes issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_PaymentOfConvertibleNotesIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_PaymentOfDeferredConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of deferred consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_PaymentOfDeferredConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of Proceeds from held-to-maturity securities maturing or called prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ProceedsFromIssuanceOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ProceedsFromIssuanceOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from the sale of financial instruments owned, at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_PurchaseOfFinancialInstrumentsOwnedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase of financial instruments owned, at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_PurchaseOfFinancialInstrumentsOwnedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_PurchaseOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase of investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_PurchaseOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310105319472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Description of Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization and Description of Business [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Organization and Description of Business</a></td>
<td class="text"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">1. Organization and Description of Business</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">WisdomTree, Inc., through its global subsidiaries (collectively, &#8220;WisdomTree&#8221; or the &#8220;Company&#8221;), is a global financial innovator, offering a well<span class="nobreak">-diversified</span> suite of exchange<span class="nobreak">-traded</span> products (&#8220;ETPs&#8221;), models, solutions and products leveraging blockchain technology. Building on its heritage of innovation, the Company is also developing and has launched next<span class="nobreak">-generation</span> digital products, services and structures, including digital or blockchain<span class="nobreak">-enabled</span> mutual funds (&#8220;Digital Funds&#8221;) and tokenized assets, as well as its blockchain<span class="nobreak">-native</span> digital wallet, WisdomTree Prime. The Company has the following wholly<span class="nobreak">-owned</span> operating subsidiaries:</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">WisdomTree Asset Management, Inc.</span> is a New&#160;York based investment adviser registered with the SEC, providing investment advisory and other management services to the WisdomTree Trust (&#8220;WTT&#8221;) and WisdomTree exchange<span class="nobreak">-traded</span> funds (&#8220;ETFs&#8221;). The WisdomTree ETFs are issued in the U.S.&#160;by WTT.&#160;WTT is a non<span class="nobreak">-consolidated</span> Delaware statutory trust registered with the SEC as an open<span class="nobreak">-end</span> management investment company. The Company has licensed to WTT the use of certain of its own indexes on an exclusive basis for the WisdomTree ETFs in the U.S.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">WisdomTree Management Jersey Limited </span>(&#8220;ManJer&#8221;) is a Jersey based management company providing management services to seven issuers (the &#8220;ManJer Issuers&#8221;) in respect of the ETPs issued and listed by the ManJer Issuers covering commodity, currency, cryptocurrency and leveraged<span class="nobreak">-and-inverse</span> strategies.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">WisdomTree Multi Asset Management Limited</span> (&#8220;WTMAML&#8221;) is a Jersey based management company providing management services to WisdomTree Multi Asset Issuer PLC (&#8220;WMAI&#8221;) in respect of the ETPs issued by WMAI.&#160;WMAI is a non<span class="nobreak">-consolidated</span> public limited company domiciled in Ireland.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">WisdomTree Management Limited</span> (&#8220;WML&#8221;) is an Ireland based management company providing management services to WisdomTree Issuer ICAV (&#8220;WTICAV&#8221;) in respect of the WisdomTree UCITS ETFs issued by WTICAV.&#160;WTICAV is a non<span class="nobreak">-consolidated</span> public limited company domiciled in Ireland.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">WisdomTree UK Limited</span> (&#8220;WTUK&#8221;) is a U.K. based company registered with the Financial Conduct Authority currently providing distribution and support services to ManJer, WTMAML and WML.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">WisdomTree Europe Limited</span> is a U.K. based company which is the legacy distributor of the WMAI ETPs and WisdomTree UCITS ETFs. These services are now provided directly by WTUK.&#160;WisdomTree Europe Limited is no longer regulated and does not provide any regulated services.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">WisdomTree Ireland Limited</span> is an Ireland based company authorized by the Central Bank of Ireland providing distribution services to ManJer, WTMAML and WML.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">WisdomTree Digital Commodity Services, LLC</span> is a New&#160;York based company that serves as the sponsor of the WisdomTree Bitcoin Fund, which is currently effective with the SEC.&#160;The WisdomTree Bitcoin Fund is an exchange<span class="nobreak">-traded</span> fund that issues common shares of beneficial interest and is listed on the Cboe BZX Exchange, Inc. The WisdomTree Bitcoin Fund provides exposure to the spot price of bitcoin.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">WisdomTree Digital Management, Inc.</span> (&#8220;WT Digital Management&#8221;) is a New&#160;York based investment adviser registered with the SEC, providing investment advisory and other management services to the WisdomTree Digital Trust (&#8220;WTDT&#8221;) and WisdomTree Digital Funds. The WisdomTree Digital Funds are issued in the U.S.&#160;by WTDT.&#160;WTDT is a non<span class="nobreak">-consolidated</span> Delaware statutory trust registered with the SEC as an open<span class="nobreak">-end</span> management investment company. Each Digital Fund uses blockchain technology to maintain a secondary record of its shares on one or more blockchains (e.g., Stellar or Ethereum), but does not directly or indirectly invest in any assets that rely on blockchain technology, such as cryptocurrencies.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">WisdomTree Digital Movement, Inc. </span>(&#8220;WT Digital Movement&#8221;) is a New&#160;York based company operating as a money services business registered with the Financial Crimes Enforcement Network. WT Digital Movement has obtained and is seeking additional state money transmitter licenses to operate a platform for the purchase, sale and exchange of tokenized assets, while also providing blockchain<span class="nobreak">-native</span> digital wallet services through WisdomTree Prime to facilitate such activity.</p><p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">WisdomTree Securities, Inc. </span>is a New&#160;York based limited purpose broker<span class="nobreak">-dealer</span> (i.e., mutual fund retailer), facilitating transactions in WisdomTree Digital Funds.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">WisdomTree Transfers, Inc. </span>is a New&#160;York based transfer agent registered with the SEC, providing transfer agency and registrar services for the Digital Funds. The transfer agent maintains the official record of share ownership in book entry form and reconciles the official record with the secondary record of ownership of shares on one or more blockchains.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">WisdomTree Digital Trust Company, LLC</span> is a New&#160;York based limited liability trust company that has been formed to operate as a limited purpose trust company under New&#160;York Banking Law upon receiving a charter from the New&#160;York State Department of Financial Services.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100241376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2. Significant Accounting Policies</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Basis of Presentation</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">These consolidated financial statements have been prepared in conformity with U.S.&#160;generally accepted accounting principles (&#8220;GAAP&#8221;) and in the opinion of management reflect all adjustments, consisting of only normal recurring adjustments, necessary for a fair presentation of the financial statements. The consolidated financial statements include the accounts of the Company&#8217;s wholly<span class="nobreak">-owned</span> subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Consolidation</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company consolidates entities in which it has a controlling financial interest. The Company determines whether it has a controlling financial interest in an entity by first evaluating whether the entity is a voting interest entity (&#8220;VOE&#8221;) or a variable interest entity (&#8220;VIE&#8221;). The usual condition for a controlling financial interest in a VOE is ownership of a majority voting interest. If the Company has a majority voting interest in a VOE, the entity is consolidated. The Company has a controlling financial interest in a VIE when the Company has a variable interest that provides it with (i)&#160;the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (ii)&#160;the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company reassesses its evaluation of whether an entity is a VOE or VIE when certain reconsideration events occur.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Segment and Geographic Information</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company, through its subsidiaries in the U.S.&#160;and Europe, conducts business as a single operating segment as an ETP sponsor and asset manager which is based upon the Company&#8217;s current organizational and management structure, as well as information used by the chief operating decision maker to allocate resources and other factors.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Foreign Currency Translation</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Assets and liabilities of subsidiaries whose functional currency is not the U.S.&#160;dollar are translated based on the end of period exchange rates from local currency to U.S.&#160;dollars. Results of operations are translated at the average exchange rates in effect during the period. The impact of the foreign currency translation adjustment is included in the Consolidated Statements of Comprehensive Income as a component of other comprehensive income/(loss).</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Use of Estimates</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The preparation of the Company&#8217;s consolidated financial statements in conformity with U.S.&#160;GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the balance sheet dates and the reported amounts of revenues and expenses for the periods presented. Actual results could differ materially from those estimates.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Revenue Recognition</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company earns substantially all of its revenue in the form of advisory fees from its ETPs and recognizes this revenue over time, as the performance obligation is satisfied. Advisory fees are based on a percentage of the ETPs&#8217; average daily net assets. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice.</p><div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Contractual Gold Payments</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Contractual gold payments are measured and paid monthly based upon the average daily spot price of gold (Note&#160;9). The Company&#8217;s obligation to continue making these payments terminated on May&#160;10, 2023.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Marketing and Advertising</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Marketing and advertising costs, including media advertising and production costs, are expensed when incurred.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Depreciation and Amortization</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Depreciation and amortization is provided for using the straight<span class="nobreak">-line</span> method over the estimated useful lives of the related assets as follows:</p>
		<table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;">


				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 74.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Equipment</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 23.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:right;">3&#160;to&#160;5 years</p>	</td>
				</tr>
				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 74.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Internally<span class="nobreak">-developed</span> software</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 23.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:right;">3&#160;years</p>	</td>
				</tr>

		</table>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The assets listed above are recorded at cost less accumulated depreciation and amortization.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Stock-Based Awards</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Accounting for stock<span class="nobreak">-based</span> compensation requires the measurement and recognition of compensation expense for all equity awards based on estimated fair values. Stock<span class="nobreak">-based</span> compensation is measured based on the grant<span class="nobreak">-date</span> fair value of the award and is amortized over the relevant service period. Forfeitures are recognized when they occur.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Third-Party Distribution Fees</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company pays a percentage of its advisory fee revenues based on incremental growth in assets under management (&#8220;AUM&#8221;), subject to caps or minimums, to marketing agents to sell WisdomTree ETPs and for including WisdomTree ETPs on third<span class="nobreak">-party</span> customer platforms and recognizes these expenses as incurred.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Cash and Cash Equivalents</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company considers all highly liquid investments with an original maturity of 90&#160;days or less at the time of purchase to be classified as cash equivalents. The Company maintains deposits with financial institutions in an amount that is in excess of federally insured limits.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Accounts Receivable</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Accounts receivable are customer and other obligations due under normal trade terms. The Company measures credit losses, if any, by applying historical loss rates, adjusted for current conditions and reasonable and supportable forecasts to amounts outstanding using the aging method.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Impairment of Long-Lived Assets</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company performs a review for the impairment of long<span class="nobreak">-lived</span> assets when events or changes in circumstances indicate that the estimated undiscounted future cash flows expected to be generated by the assets are less than their carrying amounts or when other events occur which may indicate that the carrying amount of an asset may not be recoverable.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Financial Instruments Owned and Financial Instruments Sold, but Not yet Purchased (at Fair Value)</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Financial instruments owned and financial instruments sold, but not yet purchased are financial instruments classified as either trading or available<span class="nobreak">-for-sale</span> (&#8220;AFS&#8221;). These financial instruments are recorded on their trade date and are measured at fair value. All equity instruments that have readily determinable fair values are classified by the Company as trading. Debt instruments are classified based primarily on the Company&#8217;s intent to hold or sell the instrument. Changes in the fair value of debt instruments classified as trading and AFS are reported in other income/(expenses) and other comprehensive income, respectively, in the period the change occurs. Debt instruments classified as AFS are assessed for impairment on a quarterly basis and an estimate for credit loss is provided when the fair value of the AFS debt instrument is below its amortized cost basis. Credit<span class="nobreak">-related</span> impairments are recognized in earnings with a corresponding adjustment to the instrument&#8217;s amortized cost basis if the Company intends to sell the impaired AFS debt instrument or it is more likely than not the Company will be required to sell the instrument before recovering its amortized cost basis. Other credit<span class="nobreak">-related</span> impairments are recognized as an allowance with a corresponding adjustment to earnings. Impairments resulting from noncredit<span class="nobreak">-related</span> factors are recognized in other comprehensive income. Amounts recorded in other comprehensive income are reclassified into earnings upon sale of the AFS debt instrument using the specific identification method.</p>
		</div><div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Securities Held-to-Maturity</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company accounts for certain of its securities as held<span class="nobreak">-to-maturity</span> on a trade date basis, which are recorded at amortized cost. For held<span class="nobreak">-to-maturity</span> securities, the Company has the intent and ability to hold these securities to maturity and it is not more<span class="nobreak">-likely-than-not</span> that the Company will be required to sell these securities before recovery of their amortized cost bases, which may be maturity. Held<span class="nobreak">-to-maturity</span> securities are placed on non<span class="nobreak">-accrual</span> status when the Company is in receipt of information indicating collection of interest is doubtful. Cash received on held<span class="nobreak">-to-maturity</span> securities placed on non<span class="nobreak">-accrual</span> status is recognized on a cash basis as interest income if and when received.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company reviews its portfolio of held<span class="nobreak">-to-maturity</span> securities for impairment on a quarterly basis, recognizing an allowance, if any, by applying an estimated loss rate after consideration for the nature of collateral securing the financial asset as well as potential future changes in collateral values and historical loss information for financial assets secured with similar collateral.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Investments in pass<span class="nobreak">-through</span> government<span class="nobreak">-sponsored</span> enterprises (&#8220;GSEs&#8221;) are determined to have an estimated loss rate of zero due to an implicit U.S.&#160;government guarantee.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Investments</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company accounts for equity investments that do not have a readily determinable fair value under the measurement alternative prescribed in Accounting Standards Codification (&#8220;ASC&#8221;) Topic&#160;321, <span class="Italic" style="font-style:italic;font-weight:normal;">Investments&#160;&#8211;&#160;Equity Securities </span>(&#8220;ASC&#160;321&#8221;), to the extent such investments are not subject to consolidation or the equity method. Under the measurement alternative, these financial instruments are carried at cost, less any impairment (assessed quarterly), plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. In addition, income is recognized when dividends are received only to the extent they are distributed from net accumulated earnings of the investee. Otherwise, such distributions are considered returns of investment and are recorded as a reduction of the cost of the investment.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Investments in debt instruments are accounted for at fair value, with changes in fair value reported in other income/(expenses).</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Goodwill</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Goodwill is the excess of the purchase price over the fair values of the identifiable net assets at the acquisition date. The Company tests goodwill for impairment at least annually and at the time of a triggering event requiring re<span class="nobreak">-evaluation</span>, if one were to occur. Goodwill is considered impaired when the estimated fair value of the reporting unit that was allocated the goodwill is less than its carrying value. If the estimated fair value of such reporting unit is less than its carrying value, goodwill impairment is recognized based on that difference, not to exceed the carrying amount of goodwill. A reporting unit is an operating segment or a component of an operating segment provided that the component constitutes a business for which discrete financial information is available and management regularly reviews the operating results of that component.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Goodwill is allocated to the Company&#8217;s U.S.&#160;business and European business components. For impairment testing purposes, these components are aggregated as a single reporting unit as they fall under the same operating segment and have similar economic characteristics.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Goodwill is assessed for impairment annually on November&#160;30<span class="Superscript" style="vertical-align:super;font-size:58%;">th</span>. When performing its goodwill impairment test, the Company considers a qualitative assessment, when appropriate, and a quantitative assessment using the market approach and its market capitalization when determining the fair value of the reporting unit.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Intangible Assets</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Indefinite<span class="nobreak">-lived</span> intangible assets are tested for impairment at least annually and are also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indefinite<span class="nobreak">-lived</span> intangible assets are impaired if their estimated fair values are less than their carrying values.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Finite<span class="nobreak">-lived</span> intangible assets, if any, are amortized over their estimated useful life, which is the period over which the assets are expected to contribute directly or indirectly to the future cash flows of the Company. These intangible assets are tested for impairment at the time of a triggering event, if one were to occur. Finite<span class="nobreak">-lived</span> intangible assets may be impaired when the estimated undiscounted future cash flows generated from the assets are less than their carrying amounts.</p>
		</div><div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company may rely on a qualitative assessment when performing its intangible asset impairment test. Otherwise, the impairment evaluation is performed at the lowest level of reasonably identifiable cash flows independent of other assets. The annual impairment testing date for all of the Company&#8217;s intangible assets is November&#160;30<span class="Superscript" style="vertical-align:super;font-size:58%;">th</span>.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Software Development Costs</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Software development costs incurred after the preliminary project stage is complete are capitalized if it is probable that the project will be completed and the software will be used as intended. Capitalized costs consist of employee compensation costs and fees paid to third parties who are directly involved in the application development efforts and are included in intangible assets, net in the Consolidated Balance Sheets. Such costs are amortized over the estimated useful life of the software on a straight<span class="nobreak">-line</span> basis and are included in depreciation and amortization in the Consolidated Statements of Operations. Once the application development stage is complete, additional costs are expensed as incurred.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Leases</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company accounts for its lease obligations in accordance with ASC Topic&#160;842, <span class="Italic" style="font-style:italic;font-weight:normal;">Leases </span>(&#8220;ASC&#160;842&#8221;), which requires the recognition of both (i)&#160;a lease liability equal to the present value of the remaining lease payments and (ii)&#160;an offsetting right<span class="nobreak">-of-use</span> asset. The remaining lease payments are discounted using the rate implicit in the lease, if known, or otherwise the Company&#8217;s incremental borrowing rate. After lease commencement, right<span class="nobreak">-of-use</span> assets are assessed for impairment and otherwise are amortized over the remaining lease term on a straight<span class="nobreak">-line</span> basis. These recognition requirements are not applied to short<span class="nobreak">-term</span> leases which are those with a lease term of 12&#160;months or less. Instead, lease payments associated with short<span class="nobreak">-term</span> leases are recognized as an expense on a straight<span class="nobreak">-line</span> basis over the lease term.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">ASC&#160;842 also provides a practical expedient which allows for consideration in a contract to be accounted for as a single lease component rather than allocated between lease and non<span class="nobreak">-lease</span> components. The Company has elected to apply this practical expedient to all lease contracts, where applicable.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Deferred Consideration&#8212;Gold Payments</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Deferred consideration&#8212;gold payments represented the present value of an obligation to pay gold to a third party into perpetuity and was measured using forward<span class="nobreak">-looking</span> gold prices observed on the CMX exchange, a selected discount rate and perpetual growth rate (Note&#160;9). Changes in the fair value of this obligation were reported as gain on revaluation/termination of deferred consideration&#8212;gold payments in the Consolidated Statements of Operations.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Convertible Notes</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Convertible notes are carried at amortized cost, net of issuance costs. The Company accounts for convertible instruments as a single liability (applicable to the convertible notes) or equity with no separate accounting for embedded conversion features unless the conversion feature meets the criteria for accounting under the substantial premium model or does not qualify for a derivative scope exception. Interest expense is recognized using the effective interest method and includes amortization of issuance costs over the life of the debt.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Contingencies</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company may be subject to reviews, inspections and investigations by regulatory authorities as well as legal proceedings arising in the ordinary course of business. The Company evaluates the likelihood of an unfavorable outcome of all legal or regulatory proceedings to which it is a party and accrues a loss contingency when the loss is probable and reasonably estimable.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Contingent Payments</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company recognizes a gain on contingent payments when the contingency is resolved and the gain is realized.</p>
		</div><div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Earnings per Share</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Basic earnings per share (&#8220;EPS&#8221;) is computed by dividing net income available to common stockholders by the weighted<span class="nobreak">-average</span> number of common shares outstanding for the period. Net income available to common stockholders represents net income of the Company reduced by an allocation of earnings to participating securities. The Series&#160;A non<span class="nobreak">-voting</span> convertible preferred stock (Note&#160;11) and unvested share<span class="nobreak">-based</span> payment awards that contain non<span class="nobreak">-forfeitable</span> rights to dividends or dividend equivalents (whether paid or unpaid) are participating securities and are included in the computation of EPS pursuant to the two<span class="nobreak">-class</span> method. Stock<span class="nobreak">-based</span> equity awards that do not contain such rights are not deemed participating securities and are included in diluted shares outstanding (if dilutive).</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Diluted EPS is calculated under the treasury stock method and the two<span class="nobreak">-class</span> method. The calculation that results in the lowest diluted EPS amount for the common stock is reported in the Company&#8217;s consolidated financial statements. The treasury stock method includes the dilutive effect of potential common shares including unvested stock<span class="nobreak">-based</span> awards, the Series&#160;A non<span class="nobreak">-voting</span> convertible preferred stock and the convertible notes, if any. Potential common shares associated with the Series&#160;A non<span class="nobreak">-voting</span> convertible preferred stock and the convertible notes are computed under the if<span class="nobreak">-converted</span> method. Potential common shares associated with the conversion option embedded in the convertible notes are dilutive when the Company&#8217;s average stock price exceeds the conversion price.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Income Taxes</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company accounts for income taxes using the liability method, which requires the determination of deferred tax assets and liabilities based on the differences between the financial and tax bases of assets and liabilities using the enacted tax rates in effect for the year in which differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is more<span class="nobreak">-likely-than-not</span> that some portion or all the deferred tax assets will not be realized.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Tax positions are evaluated utilizing a two<span class="nobreak">-step</span> process. The Company first determines whether any of its tax positions are more<span class="nobreak">-likely-than-not</span> to be sustained upon examination, based solely on the technical merits of the position. Once it is determined that a position meets this recognition threshold, the position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. The Company records interest expense and penalties related to tax expenses as income tax expense.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Global Intangible Low<span class="nobreak">-Taxed</span> Income (&#8220;GILTI&#8221;) provisions of the Tax Reform Act requires the Company to include in its U.S.&#160;income tax return foreign subsidiary earnings in excess of an allowable return on the foreign subsidiary&#8217;s tangible assets. An accounting policy election is available to either account for the tax effects of GILTI in the period that is subject to such taxes or to provide deferred taxes for book and tax basis differences that upon reversal may be subject to such taxes. The Company accounts for the tax effects of these provisions in the period that is subject to such tax.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Non<span class="nobreak">-income</span> based taxes are recorded as part of other liabilities and other expenses.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Recently Issued Accounting Pronouncements</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On November&#160;27, 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU&#160;2023<span class="nobreak">-07</span>, <span class="Italic" style="font-style:italic;font-weight:normal;">Segment&#160;Reporting&#8212;Improvements to Reportable Segment Disclosures</span>, which requires public entities to provide disclosures of significant segment expenses and other segment items. The guidance requires public entities to provide in interim periods all disclosures about a reportable segment&#8217;s profit or loss and assets that are currently required annually and also applies to public entities with a single reportable segment. Entities are permitted to disclose more than one measure of a segment&#8217;s profit or loss if such measures are used by the chief operating decision<span class="nobreak">-maker</span> to allocate resources and assess performance, as long as at least one of those measures is determined in a way that is most consistent with the measurement principles used to measure the corresponding amounts in the consolidated financial statements. The guidance is applied retrospectively to all periods presented in financial statements, unless it is impracticable, and is effective for fiscal&#160;years beginning after December&#160;15, 2023, and for interim periods beginning after December&#160;15, 2024. Early adoption is permitted. This standard will only impact disclosures and will be adopted by the Company on January&#160;1, 2024.</p>
		</div><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On December&#160;13, 2023, the FASB issued ASU&#160;2023<span class="nobreak">-08</span>, <span class="Italic" style="font-style:italic;font-weight:normal;">Accounting for and Disclosure of Crypto Assets</span>, which contains final guidance requiring all entities to measure certain crypto assets at fair value each reporting period and to reflect changes from remeasurement in net income. Entities are required to present crypto assets measured at fair value separately from other intangible assets on the balance sheet and present changes from the remeasurement of crypto assets separately from changes in the carrying amounts of other intangible assets in the income statement. Entities are required to provide interim and annual disclosures about the types of crypto assets they hold and any changes in their holdings of crypto assets. The guidance is effective for fiscal&#160;years beginning after December&#160;15, 2024, including interim periods within those fiscal&#160;years. Early adoption is permitted. The Company has determined that this standard will not have a material impact on its financial statements and will early adopt the standard on January&#160;1, 2024.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On December&#160;14, 2023, the FASB issued ASU&#160;2023<span class="nobreak">-09</span>,<span class="Italic" style="font-style:italic;font-weight:normal;"> Improvements to Income Tax Disclosures</span>, which establishes new income tax disclosure requirements in addition to modifying and eliminating certain existing requirements. Under the new guidance, entities must consistently categorize and provide greater disaggregation of information in the rate reconciliation. They must also further disaggregate income taxes paid. The standard is intended to benefit investors by providing more detailed income tax disclosures that would be useful in making capital allocation decisions. The guidance applies to all entities subject to income taxes and is effective for annual periods beginning after December&#160;15, 2024. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively. Early adoption is permitted. The Company plans to adopt this standard on January&#160;1, 2025.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Recently Adopted Accounting Pronouncements</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On January&#160;1, 2021, the Company early adopted ASU&#160;2020<span class="nobreak">-06</span>, <span class="Italic" style="font-style:italic;font-weight:normal;">Debt&#160;&#8211;&#160;Debt with Conversion and Other Options </span>(ASU&#160;2020<span class="nobreak">-06</span>) under the modified retrospective approach. Under the ASU, the accounting for convertible instruments was simplified by removing major separation models required under current GAAP.&#160;Accordingly, more convertible instruments are reported as a single liability or equity with no separate accounting for embedded conversion features. Certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception are removed and, as a result, more equity contracts will qualify for the scope exception. The ASU also simplifies the diluted earnings<span class="nobreak">-per-share</span> calculation in certain areas. Upon the adoption of this ASU, the Company reclassified the equity component related to the convertible notes, net of deferred taxes, reducing accumulated deficit by $616, increasing the carrying value of the convertible notes by $4,088, reducing additional paid<span class="nobreak">-in</span> capital by $3,682 and reducing deferred tax liabilities by $1,022. These updates also reduced interest expense recognized on the Company&#8217;s convertible notes by approximately $420 per quarter and $1,680 for the year ended December&#160;31, 2021 (Note&#160;10) and the impact on earnings per share was negligible.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310099519696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and Cash Equivalents<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsDisclosureTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">3. Cash and Cash Equivalents</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Of the total cash and cash equivalents of $129,305 and $132,101 at December&#160;31, 2023 and 2022, $116,895 and $131,104, respectively, were held at three financial institutions. At December&#160;31, 2023 and 2022, cash equivalents were approximately $50,226 and $930, respectively.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Certain of the Company&#8217;s subsidiaries are required to maintain a minimum level of regulatory capital, which was $29,156 and $25,988 at December&#160;31, 2023 and 2022, respectively. These requirements are generally satisfied by cash on hand.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for cash and cash equivalent footnotes, which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100068768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Measurements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">4. Fair Value Measurements</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;">The fair value of financial instruments is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., &#8220;the exit price&#8221;) in an orderly transaction between market participants at the measurement date. ASC&#160;820, <span class="Italic" style="font-style:italic;font-weight:normal;">Fair Value Measurement</span>, establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from independent sources. Unobservable inputs reflect assumptions that market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into three levels based on the transparency of inputs as follows:</p>
		<table class="Basic-Table" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="Basic-Table _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 3.85%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">

					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 5.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Level&#160;1</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 2.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 85.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Quoted prices for identical instruments in active markets.</p>
					</td>
				</tr>
				<tr class="Basic-Table _idGenTableRowColumn-9" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 3.85%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 5.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;">Level&#160;2</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 2.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 85.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;">Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model<span class="nobreak">-derived</span> valuations whose inputs are observable or whose significant value drivers are observable.</p>
					</td>
				</tr>
				<tr class="Basic-Table _idGenTableRowColumn-10" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 3.85%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 5.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;">Level&#160;3</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 2.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 85.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;">Instruments whose significant drivers are unobservable.</p>
					</td>
				</tr>

		</table>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The availability of observable inputs can vary from product to product and is affected by a wide variety of factors, including, for example, the type of product, whether the product is new and not yet established in the marketplace, and other characteristics particular to the transaction. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by management in determining fair value is greatest for instruments categorized in Level&#160;3. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level input that is significant to the fair value measurement in its entirety.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The tables below summarize the categorization of the Company&#8217;s assets and liabilities measured at fair value. During the&#160;years ended December&#160;31, 2023 and 2022, there were no transfers between Levels 2 and 3.</p>
		<table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="No-Table-Style TCH" style="width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="11" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 55.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, 2023</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="No-Table-Style TCH _idGenCellOverride-1" style="width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Total</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Level 1</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Level 2</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Level 3</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Assets:</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Recurring fair value measurements:</p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:30pt;">Cash equivalents</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">50,226</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">50,226</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-142; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-143; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:30pt;">Financial instruments owned, at fair value:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:50pt;">ETFs</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">35,181</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">35,181</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-144; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-145; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:50pt;">Pass-through GSEs</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">10,240</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-146; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">10,240</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-147; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:50pt;">Other assets&#8212;seed capital (WisdomTree Digital Funds):</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:70pt;">U.S.&#160;treasuries</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">5,007</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">5,007</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-148; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:70pt;">Equities</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,337</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,337</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-149; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-150; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:70pt;">Fixed income</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,957</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,008</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">949</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-151; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">108,948</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">92,752</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">16,196</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-152; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Non-recurring fair value measurements:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:30pt;">Fnality International Limited&#8212;Series&#160;B-1 Preference Shares<span class="Superscript" style="vertical-align:super;font-size:6pt;">(</span><span class="CharOverride-5" style="font-size:6pt;vertical-align:super;">1)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">9,684</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-style:normal;font-weight:normal;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-153; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-style:normal;font-weight:normal;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-style:normal;font-weight:normal;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-154; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-style:normal;font-weight:normal;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">9,684</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:30pt;">Other investments<span class="Superscript" style="vertical-align:super;font-size:6pt;">(</span><span class="CharOverride-5" style="font-size:6pt;vertical-align:super;">2</span><span class="Superscript" style="vertical-align:super;font-size:6pt;">)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-155; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-156; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-157; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-158; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">9,684</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-159; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-160; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">9,684</p>	</td>
				</tr>

		</table><p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>Fair value determined on October 31, 2023</p><p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:0pt;"><span class="Superscript" style="vertical-align:super;font-size:6pt;"> (2)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>Fair value determined on September 30, 2023</p><table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="11" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 55.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, 2022</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Total</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Level 1</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Level 2</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Level 3</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Assets:</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Recurring fair value measurements:</p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Cash equivalents</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">930</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">930</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-161; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-162; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Financial instruments owned, at fair value:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ETFs</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">23,772</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">23,772</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-163; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-164; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">U.S.&#160;treasuries</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">2,980</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">2,980</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-165; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-166; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Pass-through GSEs</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">96,837</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">23,290</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">73,547</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-167; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Fixed income</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">885</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-168; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">885</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-169; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other assets&#8212;seed capital (WisdomTree Digital Funds):</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,765</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-170; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,765</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-171; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Investments in Convertible Notes</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Securrency, Inc.&#8212;convertible note (Note&#160;7)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">14,500</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-172; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-173; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">14,500</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Fnality International Limited&#8212;convertible note (Note&#160;7)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,921</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-174; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-175; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,921</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">148,590</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">50,972</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">76,197</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">21,421</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Non-recurring fair value measurements:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other investments<span class="Superscript" style="vertical-align:super;font-size:58%;">(</span><span class="CharOverride-6" style="font-size:58%;vertical-align:super;">1)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">312</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-176; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-177; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">312</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-top:1pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Liabilities:</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Recurring fair value measurements:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deferred consideration (Note&#160;9)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">200,290</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-178; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-179; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">200,290</p>	</td>
				</tr>

		</table><p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;">&#8203;<span class="CharOverride-6" style="font-size:58%;vertical-align:super;">(1)&#160;&#160;&#160;&#160;&#160;</span>Fair value determined on May 10, 2022</p><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;"> Recurring Fair Value Measurements&#160;-&#160;Methodology</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Cash Equivalents (Note&#160;3) &#8211; </span>These financial assets represent cash invested in highly liquid investments with original maturities of less than <span style="-sec-ix-hidden: hidden-fact-185">90</span>&#160;days. These investments are valued at par, which approximates fair value, and are classified as Level 1 in the fair value hierarchy.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Financial instruments owned (Note&#160;5) &#8211; </span>Financial instruments owned are investments in ETFs, pass<span class="nobreak">-through</span> GSEs, U.S.&#160;treasuries, equities and fixed income. ETFs, U.S.&#160;treasuries and equities are generally traded in active, quoted and highly liquid markets and are therefore classified as Level 1 in the fair value hierarchy. Pricing of pass<span class="nobreak">-through</span> GSEs and fixed income includes consideration given to collateral characteristics and market assumptions related to yields, credit risk and timing of prepayments and are therefore generally classified as Level&#160;2. Pass<span class="nobreak">-through</span> GSE positions invested in through a fund structure with a quoted market price on an exchange are generally classified as Level 1.</p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Fair Value Measurements classified as Level 3</span> &#8211;&#160;The following table presents a reconciliation of beginning and ending balances of recurring fair value measurements classified as Level 3:</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-left:24pt;text-indent:0pt;margin-top:6pt;">These instruments consist of the following:</p>
		<table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;">


				<tr class="Table75-" style="height:12pt;">
					<td class="Table75-" style="border-left-width:1pt;border-left-style:solid;border-left-color:#000000;border-top-width:1pt;border-top-style:solid;border-top-color:#000000;border-right-width:1pt;border-right-style:solid;border-right-color:#000000;border-bottom-width:1pt;border-bottom-style:solid;border-bottom-color:#000000;padding-top:4pt;padding-bottom:4pt;padding-left:4pt;padding-right:4pt;vertical-align:top;width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="5" style="width: 37.50%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75-" style="border-left-width:1pt;border-left-style:solid;border-left-color:#000000;border-top-width:1pt;border-top-style:solid;border-top-color:#000000;border-right-width:1pt;border-right-style:solid;border-right-color:#000000;border-bottom-width:1pt;border-bottom-style:solid;border-bottom-color:#000000;padding-top:4pt;padding-bottom:4pt;padding-left:4pt;padding-right:4pt;vertical-align:top;width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December 31, <br/>2023</span></p>
					</td>
					<td class="Table75- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December 31, <br/>2022</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Investments in Convertible Notes (Note&#160;7):</p>
					</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Beginning balance</p>
					</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">21,421</p>	</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-180; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Purchases</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">11,228</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">21,863</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Settlements</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(28,818)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-181; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Conversions<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)</span></p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(9,684)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-182; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net realized gains/(losses)<span class="Superscript" style="vertical-align:super;font-size:6pt;">(2)</span></p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">5,853</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(442)</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Ending balance</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-183; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">21,421</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deferred Consideration (Note&#160;7):</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Beginning balance</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">200,290</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">228,062</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net realized losses<span class="Superscript" style="vertical-align:super;font-size:6pt;">(3)</span></p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,069</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">17,108</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net unrealized gains<span class="Superscript" style="vertical-align:super;font-size:6pt;">(4)</span></p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(61,953)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(27,765)</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Settlements</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(144,406)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(17,115)</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Ending balance</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-184; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">200,290</p>	</td>
				</tr>

		</table><p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;">&#8203;<span class="CharOverride-5" style="font-size:6pt;vertical-align:super;">(1)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>The Fnality convertible notes converted into Series B<span class="nobreak">-1</span> Preference Shares on October 31, 2023 (Note 7).</p><p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:0pt;"><span class="CharOverride-5" style="font-size:6pt;vertical-align:super;"> (2)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>Recorded in impairments and other losses, net in the Consolidated Statements of Operations.</p>
		<p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:0pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(3)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>Recorded as contractual gold payments expense in the Consolidated Statements of Operations.</p>
		<p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:0pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(4)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>Recorded as gain on revaluation/termination of deferred consideration&#8212;gold payments in the Consolidated Statements of Operations.&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100209680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments Owned<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract', window );"><strong>Financial Instruments Owned [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsDisclosureTextBlock', window );">Financial instruments owned</a></td>
<td class="text"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">5. Financial instruments owned</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-left:24pt;text-indent:0pt;margin-top:8pt;">These instruments consist of the following:</p>
		<table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;">


				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1 _idGenCellOverride-2" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2023</span></p>
					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2022</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Financial instruments owned:</p>
					</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Trading securities</p>
					</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">45,421</p>	</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">124,474</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other assets&#8212;seed capital (WisdomTree Digital Funds)</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">13,301</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,765</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">58,722</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">126,239</p>	</td>
				</tr>

		</table>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:6pt;">The Company recognized net trading losses on financial instruments owned that were still held at the reporting dates of $536 and $12,721 during the&#160;years ended December&#160;31, 2023 and 2022, respectively, which were recorded in other losses, net, in the Consolidated Statements of Operations.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100107024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Securities Held-to-Maturity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Securities Held-to-Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesTextBlock', window );">Securities Held-to-Maturity</a></td>
<td class="text"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">6. Securities Held-to-Maturity</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">The following table is a summary of the Company&#8217;s securities held<span class="nobreak">-to-maturity</span>:</p>
		<table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;">


				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2023</span></p>
					</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2022</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Debt instruments: Pass-through GSEs (amortized cost)</p>
					</td>
					<td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">230</p>	</td>
					<td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">259</p>	</td>
				</tr>

		</table>

		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">During the&#160;years ended December&#160;31, 2023 and 2022, the Company received proceeds of $29 and $45, respectively, from held<span class="nobreak">-to-maturity</span> securities maturing or being called prior to maturity.</p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The following table summarizes unrealized gains, losses, and fair value (classified as Level 2 within the fair value hierarchy) of securities held<span class="nobreak">-to-maturity</span>:</p>
		<table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;">


				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1 _idGenCellOverride-2" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="5" style="width: 37.50%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Cost/amortized cost</p>
					</td>
					<td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">230</p>	</td>
					<td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">259</p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Gross unrealized losses</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(15)</p>	</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(20)</p>	</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Gross unrealized gains</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-186; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-187; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Fair value</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">215</p>	</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">239</p>	</td>
				</tr>

		</table>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;">An allowance for credit losses was not provided on the Company&#8217;s held<span class="nobreak">-to-maturity</span> securities as all securities are investments in pass<span class="nobreak">-through</span> GSEs which are determined to have an estimated loss rate of zero due to an implicit U.S.&#160;government guarantee.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The following table sets forth the maturity profile of the securities held<span class="nobreak">-to-maturity</span>; however, these securities may be called prior to maturity date:</p>
		<table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;">


				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1 _idGenCellOverride-2" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="5" style="width: 37.50%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-10 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Due within one year</p>
					</td>
					<td class="Table70- TB CellOverride-11 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-3 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-188; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"> &#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-11 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-3 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-189; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"> &#8212;</p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-10" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Due one year through five&#160;years</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-190; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-191; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-10" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Due five&#160;years through ten&#160;years</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">22</p>	</td>
					<td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">27</p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-10" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Due over ten&#160;years</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="top">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="top">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">208</p>	</td>
					<td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="top">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="top">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">232</p>	</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-10" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="top">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="top">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"> 230</p>	</td>
					<td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="top">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="top">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">259</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5B<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5A<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5B<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5B<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310099952544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTextBlock', window );">Investments</a></td>
<td class="text"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">7. Investments</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The following table sets forth the Company&#8217;s investments:</p>
		<table class="Table90-" style="width: 90.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0.33in 0pt 0.33in;">


				<tr class="Table90-" style="height:12pt;">
					<td class="Table90-" style="border-left-width:1pt;border-left-style:solid;border-left-color:#000000;border-top-width:1pt;border-top-style:solid;border-top-color:#000000;border-right-width:1pt;border-right-style:solid;border-right-color:#000000;border-bottom-width:1pt;border-bottom-style:solid;border-bottom-color:#000000;padding-top:4pt;padding-bottom:4pt;padding-left:4pt;padding-right:4pt;vertical-align:top;width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="5" style="width: 27.93%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December 31, 2023</span></p>
					</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="5" style="width: 30.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December 31, 2022</span></p>
					</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90-" style="border-left-width:1pt;border-left-style:solid;border-left-color:#000000;border-top-width:1pt;border-top-style:solid;border-top-color:#000000;border-right-width:1pt;border-right-style:solid;border-right-color:#000000;border-bottom-width:1pt;border-bottom-style:solid;border-bottom-color:#000000;padding-top:4pt;padding-bottom:4pt;padding-left:4pt;padding-right:4pt;vertical-align:top;width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Carrying <br/>Value</span></p>
					</td>
					<td class="Table90- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Cost</span></p>
					</td>
					<td class="Table90- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Carrying <br/>Value</span></p>
					</td>
					<td class="Table90- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 15.54%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Cost</span></p>
					</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TCH CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Securrency, Inc.:</p>
					</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="2" style="width: 15.54%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1 _idGenCellOverride-3" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Series&#160;A Shares</p>
					</td>
					<td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-192; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-193; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">8,488</p>	</td>
					<td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">8,112</p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Series&#160;B Shares</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-194; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-195; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">5,500</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">5,500</p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Convertible note</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-196; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-197; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">14,500</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">15,000</p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Subtotal&#8212;Securrency, Inc.</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-198; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-199; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">28,488</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">28,612</p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Fnality International Limited:</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Convertible note</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-200; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-201; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,921</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,863</p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Series&#160;B-1 Preference Shares</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">9,684</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">8,091</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-202; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-203; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Subtotal&#8212;Fnality International Limited</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">9,684</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">8,091</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,921</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,863</p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other investments</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-204; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">250</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">312</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">250</p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">9,684</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">8,341</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">35,721</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">35,725</p>	</td>
				</tr>

		</table>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:8pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Securrency, Inc.</span></p>
		<p class="H4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:12pt;margin-top:8pt;margin-top:6pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Exit from Investment&#160;&#8211;&#160;Year Ended December&#160;31, 2023</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;">On December&#160;7, 2023, the Company received proceeds of $28,818 relating to the exit from its investment in Securrency, Inc. (&#8220;Securrency&#8221;), a developer of institutional<span class="nobreak">-grade</span> blockchain<span class="nobreak">-based</span> financial and regulatory technology, in connection with the sale of Securrency to an unaffiliated third party. This resulted in a net impairment charge of $7,630 and additional losses of $1,777, recorded in other losses, net, recognized during the year ended December&#160;31, 2023.</p><div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:12pt;margin-top:12pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Disclosures Pertaining to December&#160;31, 2022</span></p>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-left:24pt;margin-top:8pt;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Preferred Stock</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company owned approximately 22% (or 18% on a fully<span class="nobreak">-diluted</span> basis) of the capital stock of Securrency, issued as a result of strategic investments totaling $13,612. In consideration of such investments, the Company had received 5,178,488<span class="nobreak"> </span>shares of Series&#160;A convertible preferred stock (&#8220;Series&#160;A Shares&#8221;) in December&#160;2019 and 2,004,665<span class="nobreak"> </span>shares of Series&#160;B convertible preferred stock (&#8220;Series&#160;B Shares&#8221;) in March&#160;2021. The Series&#160;B Shares contained a liquidation preference that was pari passu with shares of Series&#160;B<span class="nobreak">-1</span> convertible preferred stock (which were substantially the same as the Series&#160;B Shares except that they had limited voting rights) and senior to that of the holders of the Series&#160;A Shares, which were senior to the holders of common stock. Otherwise, the Series&#160;A Shares and Series&#160;B Shares had substantially the same terms, were convertible into common stock at the option of the Company and contained various rights and protections including a non<span class="nobreak">-cumulative</span> 6.0% dividend, payable if and when declared by the board of directors of Securrency. In addition, the Series&#160;A Shares and Series&#160;B Shares (together with the Series&#160;B<span class="nobreak">-1</span> convertible preferred stock) were separately redeemable, with respect to all of the shares outstanding of the applicable series of preferred stock (subject to certain regulatory restrictions of certain investors), for the original issue price thereof, plus all declared and unpaid dividends, upon approval by holders of at least 60% of the Series&#160;A Shares (at any time on or after December&#160;31, 2029) and 90% of the Series&#160;B Shares (at any time on or after March&#160;31, 2031).</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">These investments were accounted for under the measurement alternative prescribed in ASC&#160;321, as they did not have a readily determinable fair value and were not considered to be in<span class="nobreak">-substance</span> common stock. The investments were assessed for impairment and similar observable transactions on a quarterly basis. There was no impairment recognized during the&#160;years ended December&#160;31, 2022 and 2021 based upon a qualitative assessment.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">During the year ended December&#160;31, 2021, the Company recognized a gain of $376 on its Series&#160;A Shares, which were re<span class="nobreak">-measured</span> to fair value upon the issuance of Securrency&#8217;s Series&#160;B Shares. Fair value was determined using the backsolve method, a valuation approach that determines the value of shares for companies with complex capital structures based upon the price paid for shares recently issued. Fair value was allocated across the capital structure using the Black<span class="nobreak">-Scholes</span> option pricing model.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The table below presents the inputs used in the backsolve valuation approach (classified as Level 3 in the fair value hierarchy):</p>
		<table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;">


				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TCH CellOverride-1 _idGenCellOverride-2" style="width: 55.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table55- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TCH CellOverride-2 _idGenCellOverride-2" colspan="3" style="width: 42.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="CharOverride-7" style="font-style:normal;font-weight:bold;">Inputs</span></p>
					</td>
				</tr>
				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TCH CellOverride-1" style="width: 55.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table55- TCH CellOverride-5" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TCH CellOverride-2" style="width: 19.69%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="CharOverride-7" style="font-style:normal;font-weight:bold;">June&#160;9, <br/>2021</span></p>
					</td>
					<td class="Table55- TCH CellOverride-5" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TCH CellOverride-2" style="width: 21.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="CharOverride-7" style="font-style:normal;font-weight:bold;">March&#160;8, <br/>2021</span></p>
					</td>
				</tr>
				<tr class="Table55-" style="background: #CCEEFF;height:12pt;">
					<td class="Table55- TB CellOverride-1 _idGenCellOverride-3" style="width: 55.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Expected volatility</p>
					</td>
					<td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 19.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">50%</p>	</td>
					<td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 21.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">55%</p>	</td>
				</tr>
				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 55.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Time to exit (in&#160;years)</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 19.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">4.75</p>	</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 21.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">5.00</p>	</td>
				</tr>

		</table>
		<p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-left:24pt;margin-top:14pt;margin-top:14pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Convertible Note</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In April and November&#160;2022, the Company participated in a convertible note financing, making an aggregate investment of $15,000 in Securrency. In consideration for its investment, the Company was issued a 7% Convertible Promissory Note maturing on April&#160;21, 2023.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The note was convertible into either Securrency&#8217;s common stock or the class of securities convertible into, exchangeable for, or conferring the right to purchase Securrency&#8217;s common stock that was issued in the event of a future equity financing at a conversion price equal to a discount of 25% (or, if applicable, a greater discount offered to other holders of convertible securities in such future equity financing round) to the lowest price paid per equity share issued in the future equity financing round.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The note was redeemable upon the occurrence of a corporate transaction for an amount which was the greater of (i)&#160;the principal amount and all accrued interest and (ii)&#160;the amount that would be received had the note been converted to common stock immediately prior to the occurrence of the corporate transaction. At maturity, redemption or conversion could occur upon the election by the holders of a majority<span class="nobreak">-in-interest</span> of the aggregate principal amount of outstanding notes. If no such election was made, Securrency could elect to pay or convert the notes in its sole discretion.</p>
		</div><div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The note was accounted for at fair value. Fair value was determined by the Company using the probability<span class="nobreak">-weighted</span> expected return method (&#8220;PWERM&#8221;), a valuation approach that estimated the value of the note assuming various outcomes. During the year ended December&#160;31, 2022, the Company recognized an unrealized loss of $500 when re<span class="nobreak">-measuring</span> the notes to fair value.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The table below presents the probability ascribed to potential outcomes used in the PWERM (classified as Level 3 in the fair value hierarchy) and the time to exit:</p>
		<table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;">


				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TCH CellOverride-1" style="width: 78.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table55- TCH CellOverride-5" style="width: 1.64%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TCH CellOverride-2" style="width: 19.70%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="CharOverride-7" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2022</span></p>
					</td>
				</tr>
				<tr class="Table55-" style="background: #CCEEFF;height:12pt;">
					<td class="Table55- TB CellOverride-1 _idGenCellOverride-3" style="width: 78.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Conversion of note upon a future equity financing</p>
					</td>
					<td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.64%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 19.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">60%</p>	</td>
				</tr>
				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 78.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Redemption of note upon a corporate transaction</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.64%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 19.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">25%</p>	</td>
				</tr>
				<tr class="Table55-" style="background: #CCEEFF;height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 78.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Default</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.64%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 19.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">15%</p>	</td>
				</tr>
				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 78.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Time to potential outcome (in&#160;years)</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.64%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 19.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">0.33</p>	</td>
				</tr>

		</table>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Fnality International Limited</span></p>
		<p class="H4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:12pt;margin-top:8pt;margin-top:8pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Series&#160;B-1 Preference Shares (December&#160;31, 2023)</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company owns approximately 5.4% (or 4.8% on a fully<span class="nobreak">-diluted</span> basis) of capital stock of Fnality International Limited (&#8220;Fnality&#8221;), a company incorporated in England and Wales and focused on creating a peer<span class="nobreak">-to-peer</span> digital wholesale settlement ecosystem comprised of a consortium of financial institutions, offering real time cross<span class="nobreak">-border</span> payments from a single pool of liquidity. The Company&#8217;s ownership interest is represented by 2,340,378 Series&#160;B<span class="nobreak">-1</span> Preference Shares, resulting from the conversion of its investment of &#163;6,000 ($8,091) in convertible notes upon Fnality&#8217;s qualified equity financing which occurred in October&#160;2023. The Series&#160;B<span class="nobreak">-1</span> Preference Shares carry a 1.0x liquidation preference, are convertible into ordinary shares at the option of the Company and contain various rights and protections.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">This investment is accounted for under the measurement alternative prescribed in ASC&#160;321, as it does not have a readily determinable fair value and is otherwise not subject to the equity method of accounting. The investment is assessed for impairment and similar observable transactions on a quarterly basis. During the year ended December&#160;31, 2023, the Company recognized a gain of $1,534 on its investment in Fnality which was re<span class="nobreak">-measured</span> to fair value upon the issuance by Fnality of Series&#160;B<span class="nobreak">-2</span> Preference Shares to new investors in the qualified equity financing. The Series&#160;B<span class="nobreak">-2</span> Preference Shares carry a 1.5x liquidation preference, rank pari passu to the Series&#160;B<span class="nobreak">-1</span> Preference Shares and automatically convert into Series&#160;B<span class="nobreak">-1</span> Preference Shares if certain conditions are met no later than June&#160;30, 2024.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Fair value of the Company&#8217;s investments in Fnality were determined using the backsolve method, a valuation approach that determines the value of shares for companies with complex capital structures based upon the price paid for shares recently issued. Fair value is allocated across the capital structure using the Black<span class="nobreak">-Scholes</span> option pricing model.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The table below presents the inputs used in the backsolve valuation approach (classified as Level 3 in the fair value hierarchy):</p>
		<table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;">


				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TCH CellOverride-1" style="width: 85.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table55- TCH CellOverride-5" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TCH CellOverride-2" style="width: 13.41%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2023</span></p>
					</td>
				</tr>
				<tr class="Table55-" style="background: #CCEEFF;height:12pt;">
					<td class="Table55- TB CellOverride-1 _idGenCellOverride-3" style="width: 85.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Expected volatility</p>
					</td>
					<td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 13.41%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">60%</p>	</td>
				</tr>
				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 85.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Time to exit (in&#160;years)</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 13.41%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">5.00</p>	</td>
				</tr>
				<tr class="Table55-" style="background: #CCEEFF;height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 85.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Probability that Series&#160;B-2 Preference Shares convert into Series&#160;B-1 Preference Shares</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 13.41%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">75%</p>	</td>
				</tr>

		</table>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">There was no impairment recognized during the year ended December&#160;31, 2023 based upon a qualitative assessment.</p>
		<p class="H4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:12pt;margin-top:12pt;"><span class="Italic" style="font-style:italic;font-weight:normal;">Convertible Note (December&#160;31, 2022)</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In February&#160;2022, the Company participated in a convertible note financing, making a &#163;5,000 ($6,863) investment in Fnality International Limited (&#8220;Fnality&#8221;), a company incorporated in England and Wales and focused on creating a peer<span class="nobreak">-to-peer</span> digital wholesale settlement ecosystem comprised of a consortium of financial institutions, offering real time cross<span class="nobreak">-border</span> payments from a single pool of liquidity. In consideration for its investment, the Company was issued a 5% Convertible Unsecured Loan Note maturing on December&#160;31, 2023.</p>
		</div><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The note was convertible into equity shares in the event of a future financing round at a conversion price equal to the lower of (i)&#160;a discount of 20% to lowest price paid per equity share issued pursuant to such future financing round and (ii)&#160;an amount paid per share subject to a pre<span class="nobreak">-money</span> valuation cap. Mandatory conversion could occur on or after the maturity date or, if earlier, in the event a future financing round had not been completed within a specified time from an initial closing of such financing round (&#8220;Long Stop Date&#8221;), upon the approval of holders of at least 75% of the outstanding notes. The note was also convertible, at the option of the Company, following the earlier of the maturity date or such Long Stop Date.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The note was redeemable upon the occurrence of a change of control for an amount which was the greater of (i)&#160;the principal amount and all accrued interest and (ii)&#160;the amount that would have been received had the note been converted to equity shares immediately prior to the occurrence of the change of control. Redemption could also occur on or after maturity or prior to maturity upon approval by holders of at least 50% and 75%, respectively, of the outstanding notes, or in connection with bankruptcy or other liquidation events.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The note was accounted for at fair value. Fair value was determined by the Company using the PWERM and was also remeasured for changes in the British pound and U.S.&#160;dollar exchange rate. During the year ended December&#160;31, 2022, the Company recognized a gain of $58 when re<span class="nobreak">-measuring</span> the notes to fair value.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The table below presents the probability ascribed to potential outcomes used in the PWERM (classified as Level 3 in the fair value hierarchy) and the time to exit:</p>
		<table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;">


				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TCH CellOverride-1" style="width: 78.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table55- TCH CellOverride-5" style="width: 1.86%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TCH CellOverride-2" style="width: 20.12%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2022</span></p>
					</td>
				</tr>
				<tr class="Table55-" style="background: #CCEEFF;height:12pt;">
					<td class="Table55- TB CellOverride-1 _idGenCellOverride-3" style="width: 78.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Conversion of note upon a future financing round</p>
					</td>
					<td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.86%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 20.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">85%</p>	</td>
				</tr>
				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 78.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Redemption of note upon a change of control</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.86%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 20.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">10%</p>	</td>
				</tr>
				<tr class="Table55-" style="background: #CCEEFF;height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 78.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Default</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.86%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 20.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">5%</p>	</td>
				</tr>
				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 78.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Time to potential outcome (in&#160;years)</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.86%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 20.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">0.25</p>	</td>
				</tr>

		</table>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:14pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Other Investments</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">During the year ended December&#160;31, 2023, the Company recognized an impairment of $312 on its other investments.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//320/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Topic 321<br> -Publisher FASB<br> -URI https://asc.fasb.org//321/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Topic 325<br> -Publisher FASB<br> -URI https://asc.fasb.org//325/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100065424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fixed Assets, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Fixed Assets, net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Fixed Assets, net</a></td>
<td class="text"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">8. Fixed Assets, net</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The following table summarizes fixed assets:</p>
		<table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;">


				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1 _idGenCellOverride-2" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="5" style="width: 37.50%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Equipment</p>
					</td>
					<td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,097</p>	</td>
					<td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">962</p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Less: accumulated depreciation</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(670)</p>	</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(418)</p>	</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">427</p>	</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">544</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100047536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Consideration&#8212;gold payments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DeferredConsiderationAbstract', window );"><strong>Deferred Consideration Gold Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DeferredConsiderationTextBlock', window );">Deferred Consideration&#8212;gold payments</a></td>
<td class="text"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">9. Deferred Consideration&#8212;gold payments</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;">Deferred consideration&#8212;gold payments represented an obligation the Company assumed in connection with its acquisition of the European exchange<span class="nobreak">-traded</span> commodity, currency and leveraged<span class="nobreak">-and-inverse</span> business of ETFS Capital Limited (&#8220;ETFS Capital&#8221;) which occurred on April&#160;11, 2018 (&#8220;ETFS Acquisition&#8221;). The obligation was for fixed payments to ETFS Capital of physical gold bullion equating to 9,500 ounces of gold per year through March&#160;31, 2058 and then subsequently reduced to 6,333 ounces of gold continuing into perpetuity (&#8220;Contractual Gold Payments&#8221;). ETFS Capital passed through these payments to other parties to meet its payment obligations under prior royalty agreements it had with such parties, including to Gold Bullion Holdings (Jersey) Limited (&#8220;GBH&#8221;), a subsidiary of the World Gold Council (&#8220;WGC&#8221;), Graham Tuckwell (&#8220;GT&#8221;), and Rodber Investments Limited (&#8220;RIL&#8221;), an entity controlled by GT, who is also the Chairman of ETFS Capital.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:5.5pt;">On May&#160;10, 2023, the Company terminated its Contractual Gold Payments obligation for aggregate consideration totaling $136,903 pursuant to a Sale, Purchase and Assignment Deed (the &#8220;SPA Agreement&#8221;) with WisdomTree International Holdings Ltd, Electra Target HoldCo Limited, ETFS Capital, WGC, GBH, GT and RIL.&#160;Under the terms of the transaction, GBH received approximately $4,371 in cash and 13,087<span class="nobreak"> </span>shares of Series&#160;C Preferred Stock, convertible into 13,087,000<span class="nobreak"> </span>shares of the Company&#8217;s common stock, and RIL received approximately $45,634 in cash.</p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:5.5pt;">On November&#160;20, 2023, the Company repurchased the 13,087<span class="nobreak"> </span>shares of Series&#160;C Preferred Stock issued to GBH for aggregate consideration of $84,411, $40,000 of which was paid on the closing date, with the remaining $44,411 payable in equal, interest<span class="nobreak">-free</span> installments on the first, second and third anniversaries of the closing date. See Note&#160;12 for additional information.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:5.5pt;">The Company determined the present value of the deferred consideration of $0 and $200,290 at December&#160;31, 2022 using the following assumptions:</p>
		<table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 20.22%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, 2022</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-12 _idGenCellOverride-3" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Forward-looking gold price (low)&#8212;per ounce</p>
					</td>
					<td class="Table60- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-14 _idGenCellOverride-3" style="width: 2.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-14 _idGenCellOverride-3" style="width: 17.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,858</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-12" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Forward-looking gold price (high)&#8212;per ounce</p>
					</td>
					<td class="Table60- TB CellOverride-14" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-14" style="width: 2.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-14" style="width: 17.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">3,126</p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-12" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Forward-looking gold price (weighted average)&#8212;per ounce</p>
					</td>
					<td class="Table60- TB CellOverride-14" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-14" style="width: 2.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-14" style="width: 17.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">2,237</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-12" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Discount rate</p>
					</td>
					<td class="Table60- TB CellOverride-14" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-14" style="width: 2.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-14" style="width: 17.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">11.0%</p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-12" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Perpetual growth rate</p>
					</td>
					<td class="Table60- TB CellOverride-14" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-14" style="width: 2.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-14" style="width: 17.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1.3%</p>	</td>
				</tr>

		</table>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:7pt;margin-top:7pt;">The forward<span class="nobreak">-looking</span> gold prices at December&#160;31, 2022 were extrapolated from the last observable CMX exchange price (beyond 2028) and the weighted<span class="nobreak">-average</span> price per ounce was derived from the relative present values of the annual payment obligations. The perpetual growth rate at December&#160;31, 2022 was determined based upon the increase in observable forward<span class="nobreak">-looking</span> gold prices through 2028. This obligation is classified as Level 3 as the discount rate, the extrapolated forward<span class="nobreak">-looking</span> gold prices and perpetual growth rate are significant unobservable inputs. An increase in spot gold prices, forward<span class="nobreak">-looking</span> gold prices and the perpetual growth rate would result in an increase in deferred consideration, whereas an increase in the discount rate would reduce the fair value.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:5.5pt;">Current and long<span class="nobreak">-term</span> amounts payable were $16,796 and $183,494, respectively, at December&#160;31, 2022.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:5.5pt;">During the&#160;years ended December&#160;31, 2023 and 2022, the Company recognized the following in respect of deferred consideration:</p>
		<table class="Table90-" style="width: 90.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0.33in 0pt 0.33in;">


				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TCH CellOverride-1 _idGenCellOverride-2" style="width: 45.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TCH CellOverride-1" style="width: 45.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="2" style="width: 16.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="2" style="width: 16.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="2" style="width: 17.65%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-12 _idGenCellOverride-3" style="width: 45.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Contractual gold payments</p>
					</td>
					<td class="Table90- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">6,069</p>	</td>
					<td class="Table90- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">17,108</p>	</td>
					<td class="Table90- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 15.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">17,096</p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-12" style="width: 45.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Contractual gold payments&#8212;gold ounces paid</p>
					</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-14" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">3,167</p>	</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-14" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">9,500</p>	</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-14" style="width: 15.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">9,500</p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-12" style="width: 45.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Gain on revaluation/termination of deferred consideration&#8212;gold payments<span class="Superscript" style="vertical-align:super;font-size:6pt;">(</span><span class="CharOverride-5" style="font-size:6pt;vertical-align:super;">1</span><span class="Superscript" style="vertical-align:super;font-size:6pt;">)</span></p>
					</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-14" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">61,953</p>	</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-14" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">27,765</p>	</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-14" style="width: 15.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">2,018</p>	</td>
				</tr>

		</table><p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:11pt;margin-top:12pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>Gains on revaluation/termination of deferred consideration&#8212;gold payments result from a decrease in spot gold prices, a decrease in the forward<span class="nobreak">-looking</span> price of gold, a decrease in the perpetual growth rate and an increase in the discount rate used to compute the present value of the annual payment obligations.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_DeferredConsiderationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_DeferredConsiderationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_DeferredConsiderationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>DeferredConsiderationTextBlock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_DeferredConsiderationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100271424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Notes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract', window );"><strong>Convertible Notes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Convertible Notes</a></td>
<td class="text"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;"> 10. Convertible Notes</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:6pt;">On February&#160;14, 2023, the Company issued and sold $130,000 in aggregate principal amount of 5.75% Convertible Senior Notes due 2028 (the &#8220;2023 Notes&#8221;) pursuant to an indenture dated February&#160;14, 2023, between the Company and U.S.&#160;Bank Trust Company, National Association, as trustee (or its successor in interest, the &#8220;Trustee&#8221;), in a private offering to qualified institutional buyers pursuant to Rule&#160;144A under the Securities Act&#160;of&#160;1933, as amended (&#8220;Rule&#160;144A&#8221;).</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On June&#160;14, 2021, the Company issued and sold $150,000 in aggregate principal amount of 3.25% Convertible Senior Notes due 2026 (the &#8220;2021 Notes&#8221;) pursuant to an indenture dated June&#160;14, 2021, between the Company and the Trustee, in a private offering to qualified institutional buyers pursuant to Rule&#160;144A.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;">On June&#160;16, 2020, the Company issued and sold $150,000 in aggregate principal amount of 4.25% Convertible Senior Notes due 2023 (the &#8220;June&#160;2020 Notes&#8221;) pursuant to an indenture dated June&#160;16, 2020, between the Company and the Trustee, in a private offering to qualified institutional buyers pursuant to Rule&#160;144A.&#160;On August&#160;13, 2020, the Company issued and sold $25,000 in aggregate principal amount of 4.25% Convertible Senior Notes due 2023 at a price equal to 101% of the principal amount thereof, plus interest deemed to have accrued since June&#160;16, 2020, which constitute a further issuance of, and form a single series with, the Company&#8217;s June&#160;2020 Notes (the &#8220;August&#160;2020 Notes&#8221; and together with the June&#160;2020 Notes, the &#8220;2020 Notes&#8221;).</p><div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In connection with the issuance of the 2023 Notes, the Company repurchased $115,000 in aggregate principal amount of the 2020 Notes. As a result of this repurchase, the Company recognized a loss on extinguishment of approximately $9,721 during the year ended December&#160;31, 2023. The remainder of the 2020 Notes matured on June&#160;15, 2023 and were settled for $59,955 in cash and 1,037,288<span class="nobreak"> </span>shares of common stock, as the conversion option was in the money.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">After the repurchase and maturity of the 2020 Notes and the issuance of the 2023 Notes (and together with the 2021 Notes, the &#8220;Convertible Notes&#8221;), the Company had $280,000 in aggregate principal amount of Convertible Notes outstanding.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Key terms of the Convertible Notes are as follows:</p>
		<table class="Table85-" style="width: 85.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 10% 0pt 0.33in;">


				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TCH CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table85- TCH CellOverride-5" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TCH CellOverride-2" colspan="2" style="width: 20.17%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023 Notes</span></p>
					</td>
					<td class="Table85- TCH CellOverride-5" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TCH CellOverride-2" colspan="2" style="width: 18.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021 Notes</span></p>
					</td>
				</tr>
				<tr class="Table85-" style="background: #CCEEFF;height:12pt;">
					<td class="Table85- TB CellOverride-1 _idGenCellOverride-3" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Principal outstanding</p>
					</td>
					<td class="Table85- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">130,000</p>	</td>
					<td class="Table85- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">150,000</p>	</td>
				</tr>
				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Maturity date (unless earlier converted, repurchased or redeemed)</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">August&#160;15,&#160;2028</p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">June&#160;15,&#160;2026</p>	</td>
				</tr>
				<tr class="Table85-" style="background: #CCEEFF;height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Interest rate</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">5.75%</p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">3.25%</p>	</td>
				</tr>
				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Conversion price</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">9.54</p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">11.04</p>	</td>
				</tr>
				<tr class="Table85-" style="background: #CCEEFF;height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Conversion rate</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">104.8658</p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">90.5797</p>	</td>
				</tr>
				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Redemption price</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">12.40</p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">14.35</p>	</td>
				</tr>

		</table>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:42pt;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Interest rate: </span>Payable semiannually in arrears on February&#160;15 and August&#160;15 of each year for the 2023 Notes and on June&#160;15 and December&#160;15 of each year for the 2021 Notes.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:42pt;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Conversion price: </span>Convertible at an initial conversion rate into shares of the Company&#8217;s common stock, per $1,000 principal amount of notes (equivalent to an initial conversion price set forth in the table above), subject to adjustment.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:42pt;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Conversion: </span>Holders may convert at their option at any time prior to the close of business on the business&#160;day immediately preceding May<span class="nobreak">&#160;</span>15, 2028 and March<span class="nobreak">&#160;</span>15, 2026 for the 2023 Notes and 2021 Notes, respectively, only under the following circumstances: (i)&#160;if the last reported sale price of the Company&#8217;s common stock for at least 20&#160;trading days during a period of 30 consecutive&#160;trading days ending on the last&#160;trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the respective Convertible Notes on each applicable&#160;trading day; (ii)&#160;during the <span style="-sec-ix-hidden: hidden-fact-209">five</span> business&#160;day period after any <span style="-sec-ix-hidden: hidden-fact-210">ten</span> consecutive&#160;trading day period (the &#8220;measurement period&#8221;) in which the trading price per $1,000 principal amount of the Convertible Notes for each&#160;trading day of the measurement period was less than 98% of the product of the last reported sales price of the Company&#8217;s common stock and the conversion rate on each such&#160;trading day; (iii)&#160;upon a notice of redemption delivered by the Company in accordance with the terms of the indentures but only with respect to the Convertible Notes called (or deemed called) for redemption; or (iv)&#160;upon the occurrence of specified corporate events. On or after May<span class="nobreak">&#160;</span>15, 2028 and March<span class="nobreak">&#160;</span>15, 2026 in respect of the 2023 Notes and the 2021 Notes, respectively, until the close of business on the second scheduled&#160;trading day immediately preceding the maturity date, holders may convert their Convertible Notes at any time, regardless of the foregoing circumstances.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:42pt;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Cash settlement of principal amount: </span>Upon conversion, the Company will pay cash up to the aggregate principal amount of the Convertible Notes to be converted. At its election, the Company will also settle its conversion obligation in excess of the aggregate principal amount of the Convertible Notes being converted in either cash, shares of its common stock or a combination of cash and shares of its common stock.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-left:42pt;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Redemption price: </span>The Company may redeem for cash all or any portion of the Convertible Notes, at its option, on or after August<span class="nobreak">&#160;</span>20, 2025 and June<span class="nobreak">&#160;</span>20, 2023 in respect of the 2023 Notes and the 2021 Notes, respectively, and on or prior to the 55<span class="CharOverride-6" style="font-size:58%;vertical-align:super;">th</span> scheduled&#160;trading day immediately preceding the maturity date, if the last reported sale price of the Company&#8217;s common stock has been at least 130% of the conversion price for the respective Convertible Notes then in effect for at least 20&#160;trading days, including the&#160;trading day immediately preceding the date on which the Company provides notice of redemption, during any 30 consecutive&#160;trading day period ending on, and including, the&#160;trading day immediately preceding the date on which the Company provides notice of redemption, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding the redemption date. No sinking fund is provided for the Convertible Notes.</p>
		</div><p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-left:42pt;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Limited investor put rights: </span>Holders of the Convertible Notes have the right to require the Company to repurchase for cash all or a portion of their notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of certain change of control transactions or liquidation, dissolution or common stock delisting events.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:42pt;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Conversion rate increase in certain customary circumstances: </span>In certain circumstances, conversions in connection with a &#8220;make<span class="nobreak">-whole</span> fundamental change&#8221; (as defined in the indentures) or conversions of Convertible Notes called (or deemed called) for redemption may result in an increase to the conversion rate, provided that the conversion rate will not exceed 167.7853<span class="nobreak"> </span>shares and 144.9275<span class="nobreak"> </span>shares of the Company&#8217;s common stock per $1,000 principal amount of the 2023 Notes and the 2021 Notes, respectively (the equivalent of 43,551,214<span class="nobreak"> </span>shares of the Company&#8217;s common stock), subject to adjustment.</p>
		<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:42pt;margin-top:6pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span><span class="Italic" style="font-style:italic;font-weight:normal;">Seniority and Security: </span>The 2023 Notes and 2021 Notes rank equal in right of payment, and are the Company&#8217;s senior unsecured obligations, but are subordinated in right of payment to the Company&#8217;s obligations to make certain redemption payments (if and when due) in respect of its Series&#160;A Non<span class="nobreak">-Voting</span> Convertible Preferred Stock (Note&#160;11).</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The indentures contain customary terms and covenants, including that upon certain events of default occurring and continuing, either the Trustee or the respective holders of not less than 25% in aggregate principal amount of the respective series of Convertible Notes outstanding may declare the entire principal amount of all such respective Convertible Notes to be repurchased, plus any accrued special interest, if any, to be immediately due and payable.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The following table provides a summary of the Convertible Notes at December&#160;31, 2023 and December&#160;31, 2022:</p>
		<table class="Table90-" style="width: 90.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0.33in 0pt 0.33in;">


				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TCH CellOverride-1 _idGenCellOverride-2" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 39.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, 2023</span></p>
					</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 40.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, 2022</span></p>
					</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TCH CellOverride-1" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 12.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023 Notes</span></p>
					</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 12.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021 Notes</span></p>
					</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 12.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Total</span></p>
					</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 12.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021 Notes</span></p>
					</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 12.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2020 Notes</span></p>
					</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 13.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Total</span></p>
					</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1 _idGenCellOverride-3" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Principal amount</span></p>
					</td>
					<td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">130,000</span></p>	</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">150,000</span></p>	</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">280,000</span></p>	</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">150,000</span></p>	</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">175,000</span></p>	</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">325,000</span></p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Plus: Premium</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-205; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-206; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-207; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-208; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">250</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">250</span></p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Gross proceeds</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">130,000</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">150,000</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">280,000</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">150,000</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">175,250</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">325,250</span></p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Less: Unamortized issuance costs</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(2,987)</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(2,125)</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(5,112)</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(2,981)</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(1,053)</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(4,034)</span></p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Carrying amount</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">127,013</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">147,875</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">274,888</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">147,019</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">174,197</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">321,216</span></p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-15" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"><span class="CharOverride-8" style="font-size:9pt;">Effective interest rate</span><span class="Superscript" style="vertical-align:super;font-size:6pt;">(</span><span class="CharOverride-5" style="font-size:6pt;vertical-align:super;">1)</span></p>
					</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-16" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">6.25%</span></p>	</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-16" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">3.83%</span></p>	</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-16" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">4.96%</span></p>	</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-16" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">3.83%</span></p>	</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-16" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.26%</span></p>	</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-16" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">4.60%</span></p>	</td>
				</tr>

		</table><p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;">&#8203;<span class="CharOverride-5" style="font-size:6pt;vertical-align:super;">(1)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>Includes amortization of the issuance costs and premium.</p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"> Interest expense on the Convertible Notes during the&#160;years ended December&#160;31, 2023, 2022 and 2021 was $14,945, $14,935 and $12,332, respectively. Interest payable of $3,041 and $621 at December&#160;31, 2023 and 2022, respectively, is included in accounts payable and other liabilities on the Consolidated Balance Sheets.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The fair value of the Convertible Notes (classified as Level 2 in the fair value hierarchy) was $281,897 and $320,513 at December&#160;31, 2023 and 2022, respectively. The if<span class="nobreak">-converted</span> value of the Convertible Notes did not exceed the principal amount at December&#160;31, 2023 and 2022.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310105821760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Series A Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract', window );"><strong>Series A Preferred Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockTextBlock', window );">Series A Preferred Stock</a></td>
<td class="text"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">11. Series&#160;A Preferred Stock</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On April&#160;10, 2018, the Company filed a Certificate of Designations of Series&#160;A Non<span class="nobreak">-Voting</span> Convertible Preferred Stock with the Secretary of State of the State of Delaware establishing the rights, preferences, privileges, qualifications, restrictions, and limitations relating to the Series&#160;A Preferred Stock (defined below). The Series&#160;A Preferred Stock is intended to provide ETFS Capital with economic rights equivalent to the Company&#8217;s common stock on an as<span class="nobreak">-converted</span> basis. The Series&#160;A Preferred Stock has no voting rights, are not transferable and have the same priority with regard to dividends, distributions and payments as the common stock.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">As described in the Certificate of Designations, the Company will not issue, and ETFS Capital does not have the right to require the Company to issue, any shares of common stock upon conversion of the Series&#160;A Preferred Stock, if, as a result of such conversion, ETFS Capital (together with certain attribution parties) would beneficially own more than 9.99% of the Company&#8217;s outstanding common stock immediately after giving effect to such conversion.</p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In connection with the completion of the ETFS Acquisition, the Company issued 14,750<span class="nobreak"> </span>shares of Series&#160;A Non<span class="nobreak">-Voting</span> Convertible Preferred Stock (the &#8220;Series&#160;A Preferred Stock&#8221;), which are convertible into an aggregate of 14,750,000<span class="nobreak"> </span>shares of common stock. The fair value of this consideration was $132,750, based on the closing price of the Company&#8217;s common stock on April&#160;10, 2018 of $9.00 per share, the&#160;trading day prior to the closing of the acquisition.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The following is a summary of the Series&#160;A Preferred Stock balance:</p>
		<table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;">


				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.60%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31,<br/>2023</span></p>
					</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 19.20%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31,<br/>2022</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Issuance of Series&#160;A Preferred Stock</p>
					</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">132,750</p>	</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">132,750</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Less: Issuance costs</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(181)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(181)</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Series&#160;A Preferred Stock&#8212;carrying value</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">132,569</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">132,569</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Cash dividends declared per share (quarterly)</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">0.03</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">0.03</p>	</td>
				</tr>

		</table>

		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:6pt;">Temporary equity classification is required for redeemable instruments for which redemption triggers are outside of the issuer&#8217;s control. ETFS Capital has the right to redeem all the Series&#160;A Preferred Stock specified to be converted during the period of time specified in the Certificate of Designations in the event that: (a)&#160;the number of shares of the Company&#8217;s common stock authorized by its certificate of incorporation is insufficient to permit the Company to convert all of the Series&#160;A Preferred Stock requested by ETFS Capital to be converted; or (b)&#160;ETFS Capital does not, upon completion of a change of control of the Company, receive the same amount per share of Series&#160;A Preferred Stock as it would have received had each outstanding share of Series&#160;A Preferred Stock been converted into common stock immediately prior to the change of control. However, the Company will not be obligated to make any such redemption payments to the extent such payments would be a breach of any covenant or obligation the Company owes to any of its secured creditors or is otherwise prohibited by applicable law.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Any such redemption will be at a price per Preferred Share equal to the dollar volume<span class="nobreak">-weighted</span> average price for a share of common stock for the 30<span class="nobreak">-trading</span>&#160;day period ending on the date of such attempted conversion or change of control, as applicable, multiplied by 1,000. Such redemption payment will be made in one payment no later than 10&#160;business days following the last&#160;day of the Company&#8217;s first fiscal quarter that begins on a date following the date ETFS Capital exercises such redemption right. The redemption value of the Series&#160;A Preferred Stock was $96,869 and $77,969 at December&#160;31, 2023 and 2022, respectively.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:12pt;">The carrying amount of the Series&#160;A Preferred Stock was not adjusted as it was not probable that such shares would become redeemable.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100023312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Payable to Gold Bullion Holdings Jersey Limited GBH<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_PayableToGoldBullionHoldingJerseyLimitedGBHAbstract', window );"><strong>Payable to Gold Bullion Holdings Jersey Limited GBH [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_OtherPayablesTextBlock', window );">Payable to Gold Bullion Holdings Jersey Limited GBH</a></td>
<td class="text"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">12. Payable to Gold Bullion Holdings (Jersey) Limited (&#8220;GBH&#8221;)</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On November&#160;20, 2023, the Company repurchased its Series&#160;C Preferred Stock which was convertible into 13,087,000<span class="nobreak"> </span>shares of the Company&#8217;s common stock, from GBH, a subsidiary of WGC, for aggregate cash consideration of approximately $84,411. Under the terms of the transaction, the Company paid GBH $40,000 on the closing date, with the remainder of the purchase price payable in equal, interest<span class="nobreak">-free</span> installments on the first, second and third anniversaries of the closing date. The implied price per share was $6.02 when considering the interest<span class="nobreak">-free</span> financing element of the transaction. The investor rights agreement that the Company and GBH entered into in May&#160;2023 in connection with the issuance of the Series&#160;C Preferred Stock, which provided GBH with certain rights and obligations with respect to the shares, including registration rights, was terminated in this transaction.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Under U.S.&#160;GAAP, the obligation was recorded at its present value utilizing a market rate of interest on the closing date of 7.0% and the corresponding discount is being amortized as interest expense pursuant to the effective interest method of accounting over the life of the obligation. The aggregate consideration payable was valued at $38,835 on the closing date and the carrying value of this obligation is as follows:</p>
		<table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1" style="width: 76.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 21.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2023</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 76.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Current:</p>
					</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 19.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">14,804</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 76.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Long-term</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 19.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">24,328</p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 76.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 19.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">39,132</p>	</td>
				</tr>

		</table>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;">Interest expense recognized during the year ended December&#160;31, 2023 was $297 and is included as a component of total interest expense recognized on the Statements of Operations.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_OtherPayablesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_OtherPayablesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_PayableToGoldBullionHoldingJerseyLimitedGBHAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_PayableToGoldBullionHoldingJerseyLimitedGBHAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310099937456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text"><div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">13. Leases</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;">The Company has entered into operating leases for its corporate headquarters office facilities, financial data terminals and equipment. The Company has no finance leases.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The following table provides additional information regarding the Company&#8217;s leases:</p>
		<table class="Table85-" style="width: 85.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 10% 0pt 0.33in;">


				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TCH CellOverride-1 _idGenCellOverride-2" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" colspan="5" style="width: 35.64%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended<br/>December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TCH CellOverride-1 _idGenCellOverride-2" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.34%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.82%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
				</tr>
				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TCH CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Lease cost:</p>
					</td>
					<td class="Table85- TCH CellOverride-5" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TCH CellOverride-2" colspan="2" style="width: 16.34%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table85- TCH CellOverride-5" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TCH CellOverride-2" colspan="2" style="width: 17.82%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table85-" style="background: #CCEEFF;height:12pt;">
					<td class="Table85- TB CellOverride-1 _idGenCellOverride-3" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Operating lease cost</p>
					</td>
					<td class="Table85- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,285</p>	</td>
					<td class="Table85- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">963</p>	</td>
				</tr>
				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Short-term lease cost</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">191</p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">223</p>	</td>
				</tr>
				<tr class="Table85-" style="background: #CCEEFF;height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total lease cost</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,476</p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,186</p>	</td>
				</tr>
				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other information:</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table85-" style="background: #CCEEFF;height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Cash paid for amounts included in the measurement of operating liabilities (operating leases)</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,284</p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">965</p>	</td>
				</tr>
				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Right-of-use assets obtained in exchange for new operating lease liabilities</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-211; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">n/a</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-212; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">n/a</p>
					</td>
				</tr>
				<tr class="Table85-" style="background: #CCEEFF;height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Weighted-average remaining lease term (in&#160;years)&#8212;operating leases</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">0.4</p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1.2</p>	</td>
				</tr>
				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Weighted-average discount rate&#8212;operating leases</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">5.9%</p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6.4%</p>	</td>
				</tr>

		</table>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;">None of the Company&#8217;s leases include variable payments, residual value guarantees or any restrictions or covenants relating to the Company&#8217;s ability to pay dividends or incur additional financing obligations.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On September&#160;9, 2021, the Company entered into a Surrender Agreement to terminate the lease for its principal executive office at 245 Park Avenue, New&#160;York, New&#160;York effective immediately. In consideration for the landlord&#8217;s agreement to enter into the Surrender Agreement and accelerate the expiration date of the term of the lease from August&#160;31, 2029, the Company paid a termination fee of $12,725. As a result, the Company recognized a loss on the termination of a lease of $9,277 during the year ended December&#160;31, 2021, which was inclusive of the write<span class="nobreak">-off</span> of the right<span class="nobreak">-of-use</span> asset, broker fees and a reduction in operating lease liabilities. This loss is included in impairments in the Company&#8217;s Consolidated Statements of Operations (Note&#160;26).</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Additionally, the Company recognized an impairment loss of $303 resulting from the derecognition of a right<span class="nobreak">-of-use</span> asset upon exiting its London office in February&#160;2021, as well as costs incurred to restore the office space to its original condition.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company&#8217;s leases also included extension, automatic renewal and termination provisions. These provisions were also not reasonably certain of being exercised and were therefore not recognized as part of the right<span class="nobreak">-of-use</span> asset and lease liability.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The following table discloses future minimum lease payments at December&#160;31, 2023 with respect to the Company&#8217;s operating lease liabilities:</p>
		<table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2024</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">584</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2025</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-213; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2026</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-214; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2027</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-215; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2028</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-216; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2029 and thereafter</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-217; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total future minimum lease payments (undiscounted)</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">584</p>	</td>
				</tr>

		</table>
		</div><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The following table reconciles the future minimum lease payments (disclosed above) at December&#160;31, 2023 to the operating lease liabilities recognized in the Company&#8217;s Consolidated Balance Sheets:</p>
		<table class="Table60-" style="width: 60%; border-collapse: collapse; border: #000 0pt solid; border-width: 0pt; margin: 6pt 30% 0pt 0.33in">


				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1" colspan="4" style="border-width: 0pt; vertical-align: bottom; padding: 0in 0in 3px"><p class="Tbody" style="border-width: 0; font: normal 10pt Times New Roman PS Std, serif; margin: 0; padding: 0; margin-bottom: 0; margin-left: 10pt; margin-right: 0; margin-top: 0; orphans: 1; page-break-after: auto; page-break-before: auto; text-align: left; text-indent: -10pt; widows: 1">Amounts recognized in the Company&#8217;s Consolidated Balance Sheets</p>

</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 74%; padding: 0in 0in 3px; border-width: 0pt; vertical-align: bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Lease liability&#8212;short term</p>
					</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 2%; padding: 0in 0in 3px; border-width: 0pt; vertical-align: bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.67%; padding: 0in 0in 3px; border-width: 0pt; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 21.33%; padding: 0in 0in 3px; border-width: 0pt; vertical-align: bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">578</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Lease liability&#8212;long term</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-218; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Subtotal</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">578</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Difference between undiscounted and discounted cash flows</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6</p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total future minimum lease payments (undiscounted)</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">584</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100122384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Contingencies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDisclosures', window );">Contingencies</a></td>
<td class="text"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">14. Contingencies</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company may be subject to reviews, inspections and investigations by regulatory authorities as well as legal proceedings arising in the ordinary course of business.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Closure of the WisdomTree WTI Crude Oil 3x Daily Leveraged ETP</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In December&#160;2020, WMAI, WTMAML, WTUK and WisdomTree Ireland Limited (&#8220;WT Ireland&#8221;) were served with a writ of summons to appear before the Court of Milan, Italy. In January&#160;2021, WTUK was served with a writ of summons to appear before the Court of Udine, Italy. Investors had filed actions seeking damages resulting from the closure of the WisdomTree WTI Crude Oil 3x Daily Leveraged ETP (&#8220;3OIL&#8221;) in March&#160;2020. The product was dependent on the receipt of payments from a swap provider to satisfy payment obligations to the investors. Due to an extreme adverse move in oil futures relative to the oil futures&#8217; closing price, the swap contract underlying 3OIL was terminated by the swap provider, which resulted in the compulsory redemption of 3OIL, all in accordance with the prospectus.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In February&#160;2022, the Court of Udine ruled in the Company&#8217;s favor. Also in February&#160;2022, WMAI, WTMAML, WTUK and WT Ireland were served with another writ of summons to appear before the Court of Milan by additional investors seeking damages resulting from the closure of 3OIL.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In March&#160;2022, WMAI and WTUK were served with a writ of summons to appear before the Court of Turin and two writs of summons to appear before the Court of Milan by additional investors seeking damages. These writs also were served on the intermediary brokers for the respective claimants, with the claimants alleging joint and several liability of WMAI, WTUK and such intermediary brokers. In July&#160;2023, the Court of Milan ruled in favor of WMAI and WTUK in respect of one of these claims.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Total damages sought by all investors related to these claims are approximately &#8364;15,200 ($16,778) at December&#160;31, 2023.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Additionally, in July&#160;2023, WT Ireland received a letter from counsel on behalf of additional investors seeking damages of up to approximately &#8364;8,400 ($9,272) resulting from the closure of 3OIL.&#160;The claim is in its preliminary stages and a writ of summons has not been served.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:12pt;">The Company is currently assessing these claims with its external counsel. The Company expects that losses, if any, arising from these claims will be covered under its insurance policies, less a $500 deductible. An accrual has not been made with respect to these matters at December&#160;31, 2023 and 2022.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480102/450-20-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480102/450-20-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450-20/tableOfContent<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450-30/tableOfContent<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483049/450-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100215776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Variable Interest Entities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract', window );"><strong>Variable Interest Entities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityDisclosureTextBlock', window );">Variable Interest Entities</a></td>
<td class="text"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">15. Variable Interest Entities</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:6pt;">VIEs are entities with any of the following characteristics: (i)&#160;the entity does not have enough equity to finance its activities without additional financial support; (ii)&#160;the equity holders, as a group, lack the characteristics of a controlling financial interest; or (iii)&#160;the entity is structured with non<span class="nobreak">-substantive</span> voting rights.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;">Consolidation of a VIE is required for the party deemed to be the primary beneficiary, if any. The primary beneficiary is the party who has both (a)&#160;the power to direct the activities of a VIE that most significantly impact the entity&#8217;s economic performance and (b)&#160;an obligation to absorb losses of the entity or a right to receive benefits from the entity that could potentially be significant to the entity. The Company is not the primary beneficiary of any entities in which it has a variable interest as it does not have the power to direct the activities that most significantly impact the entities&#8217; economic performance. Such power is conveyed through the entities&#8217; boards of directors and the Company does not have control over the boards.</p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The following table presents information about the Company&#8217;s variable interests in non<span class="nobreak">-consolidated</span> VIEs:</p>
		<table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;">


				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1 _idGenCellOverride-2" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.02%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2023</span></p>
					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2022</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Carrying Amount&#8212;Assets (Securrency):</p>
					</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 16.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;">Preferred stock&#8212;Series&#160;A Shares</p>
					</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-219; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">8,488</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;">Preferred stock&#8212;Series&#160;B Shares</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-220; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">5,500</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;">Convertible note</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-221; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">14,500</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Subtotal&#8212;Securrency</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-222; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">28,488</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Carrying Amount&#8212;Assets (Fnality):</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;">Convertible note</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-223; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,921</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;">Series&#160;B-1 Preference Shares</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">9,684</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-224; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Subtotal&#8212;Fnality</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">9,684</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">6,921</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Carrying Amount&#8212;Assets (Other investments):</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-225; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">312</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total (Note&#160;7)</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">9,684</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">35,721</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-15" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Maximum exposure to loss</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">9,684</p>	</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">35,721</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100052016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues from Contracts with Customers<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenues from Contracts with Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenues from Contracts with Customers</a></td>
<td class="text"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">16. Revenues from Contracts with Customers</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The following table presents the Company&#8217;s total revenues from contracts with customers:</p>
		<table class="Table80-" style="width: 80.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 15% 0pt 0.33in;">


				<tr class="Table80-" style="height:12pt;">
					<td class="Table80- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table80-" style="height:12pt;">
					<td class="Table80- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table80-" style="height:12pt;">
					<td class="Table80- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Revenues from contracts with customers:</p>
					</td>
					<td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table80-" style="background: #CCEEFF;height:12pt;">
					<td class="Table80- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Advisory fees</p>
					</td>
					<td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">333,227</p>	</td>
					<td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">293,632</p>	</td>
					<td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">298,052</p>	</td>
				</tr>
				<tr class="Table80-" style="height:12pt;">
					<td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">15,808</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">7,713</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,266</p>	</td>
				</tr>
				<tr class="Table80-" style="background: #CCEEFF;height:12pt;">
					<td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total operating revenues</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">349,035</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">301,345</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">304,318</p>	</td>
				</tr>

		</table>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:6pt;">The Company recognizes revenues from contracts with customers when the performance obligation is satisfied, which is when the promised services are transferred to the customer. A service is considered to be transferred when the customer obtains control, which is represented by the transfer of rights with regard to the service. Transfer of control happens either over time or at a point in time. When a performance obligation is satisfied over time, an entity is required to select a single method of measuring progress for each performance obligation that depicts the entity&#8217;s performance in transferring control of services to the customer.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Substantially all the Company&#8217;s revenues from contracts with customers are derived primarily from investment advisory agreements with related parties (Note&#160;17). These advisory fees are recognized over time, are earned from the Company&#8217;s ETPs and are calculated based on a percentage of the ETPs&#8217; average daily net assets. There is no significant judgment in calculating amounts due which are invoiced monthly in arrears and are not subject to any potential reversal. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">There are no contract assets or liabilities that arise in connection with the recognition of advisory fee revenue. In addition, there are no costs incurred to obtain or fulfill the contracts with customers, all of which are investment advisory agreements with related parties.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;">Other income includes revenues the Company earns from swap providers associated with certain of the Company&#8217;s European listed ETPs, the nature of which are either based on a percentage of the ETPs&#8217; average daily net assets or flows associated with certain products. There is no significant judgment in calculating amounts due, which are invoiced monthly or quarterly in arrears and are not subject to any potential reversal. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice.</p><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Geographic Distribution of Revenues</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The following table presents the Company&#8217;s total revenues geographically as determined by where the respective management companies reside:</p>
		<table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;">


				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1 _idGenCellOverride-2" rowspan="2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" rowspan="2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Revenues from contracts with customers:</p>
					</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">United&#160;States</p>
					</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">220,117</p>	</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">184,036</p>	</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">179,016</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Jersey</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">113,325</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">103,692</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">114,623</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Ireland</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">15,593</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">13,617</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">10,679</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total operating revenues</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">349,035</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">301,345</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">304,318</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100111808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">17. Related Party Transactions</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Investment Advisory Agreements</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company&#8217;s revenues are derived primarily from investment advisory agreements with related parties. Under these agreements, the Company has licensed to related parties the use of certain of its own indexes for the U.S.&#160;WisdomTree ETFs, WisdomTree Digital Funds and WisdomTree UCITS ETFs. The relevant board of trustees or board of directors (including certain officers of the Company) of each of the related parties is primarily responsible for overseeing the management and affairs of the entities for the benefit of their respective stakeholders and have contracted with the Company to provide for general management and administration services. The Company is also responsible for certain expenses of the related parties, including the cost of transfer agency, custody, fund administration and accounting, legal, audit, and other non<span class="nobreak">-distribution</span> services, excluding extraordinary expenses, taxes and certain other expenses, which are included in fund management and administration in the Consolidated Statements of Operations. In exchange, the Company receives fees based on a percentage of the ETPs&#8217; and the Digital Funds&#8217; average daily net assets. A majority of the independent members of the respective board of trustees or board of directors are required to initially and annually (after the first two&#160;years) approve the advisory agreements of the U.S.&#160;WisdomTree ETFs and the Digital Funds and these agreements may be terminated by such board of trustees or board of directors upon notice.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The following table summarizes accounts receivable from related parties which are included as a component of accounts receivable in the Consolidated Balance Sheets:</p>
		<table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;">


				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1" rowspan="2" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" rowspan="2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="5" style="width: 38.40%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.60%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 19.20%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Receivable from WTT</p>
					</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">21,226</p>	</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">16,399</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Receivable from ManJer Issuers</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">4,411</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">4,485</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Receivable from WMAI and WTICAV</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">2,874</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">3,255</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">28,511</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">24,139</p>	</td>
				</tr>

		</table>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:6pt;">The allowance for credit losses on accounts receivable from related parties is insignificant when applying historical loss rates, adjusted for current conditions and supportable forecasts, to the amounts outstanding in the table above. Amounts outstanding are all invoiced in arrears, are less than 30&#160;days aged and are collected shortly after the applicable reporting period.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The following table summarizes revenues from advisory services provided to related parties:</p>
		<table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;">


				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1" rowspan="2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" rowspan="2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table75- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table75- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Advisory services provided to WTT</p>
					</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">218,834</p>	</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">183,409</p>	</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">178,511</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Advisory services provided to ManJer Issuers</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">98,800</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">96,606</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">108,862</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Advisory services provided to WMAI and WTICAV</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">15,593</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">13,617</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">10,679</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">333,227</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">293,632</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">298,052</p>	</td>
				</tr>

		</table><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;">Pursuant to a license agreement between WisdomTree, Inc. (&#8220;WTI&#8221;) and WML to provide indices for a number of the sub<span class="nobreak">-funds</span> of WTICAV, WTI earned revenue amounting to &#8364;1,044 ($1,128), &#8364;642 ($671) and &#8364;612 ($710) for the&#160;years ended December&#160;31, 2023, 2022 and 2021, respectively, which has been eliminated in consolidation. No other revenue was earned by WTI from providing indices for use in the European Union during 2023, 2022 or 2021.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Investments in WisdomTree Products</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company also has investments in certain WisdomTree products of approximately $52,566 and $25,283 at December&#160;31, 2023 and 2022, respectively. This includes $18,308 and $1,765, respectively, of investments in certain consolidated affiliated Digital Funds advised by WT Digital Management, referred to herein as &#8220;other assets&#8211;seed capital.&#8221; Net unrealized and realized gains and losses related to trading WisdomTree products during the&#160;years ended December&#160;31, 2023, 2022 and 2021 were $1,294, ($107) and ($451), respectively, which are recorded in other losses, net on the Consolidated Statements of Operations.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Deferred Consideration&#8212;Gold Payments &#8211; Termination</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On May&#160;10, 2023, the Company terminated its contractual gold payments obligation to ETFS Capital, which included the payment of $45,634 to an entity controlled by GT, a stockholder of the Company. See Note&#160;9 for additional information.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100209680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Awards<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Stock-Based Awards [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Awards</a></td>
<td class="text"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">18. Stock-Based Awards</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On July&#160;15, 2022, the Company&#8217;s stockholders approved the 2022 Equity Plan under which the Company may issue up to 16,000,000<span class="nobreak"> </span>shares of common stock (less one share for every share granted under the 2016 Equity Plan since March&#160;31, 2022 and inclusive of shares available under the 2016 Equity Plan as of March&#160;31, 2022) in the form of stock options and other stock<span class="nobreak">-based</span> awards.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company grants equity awards to employees and directors which include restricted stock awards (&#8220;RSAs&#8221;), restricted stock units (&#8220;RSUs&#8221;), performance<span class="nobreak">-based</span> restricted stock units (&#8220;PRSUs&#8221;) and stock options. Certain awards described below are subject to acceleration under certain conditions.</p>
		<table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">	<tr class="No-Table-Style _idGenTableRowColumn-49" style="height:12pt;">	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 18.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:24pt;">Stock options:</p>	</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 80.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Generally issued for terms of ten&#160;years and may vest after at least one year of service and have an exercise price equal to the Company&#8217;s stock price on the grant date. The Company estimates the fair value of stock options (when granted) using the Black<span class="nobreak">-Scholes</span> option pricing model.</p>	</td>	</tr>	<tr class="No-Table-Style _idGenTableRowColumn-39" style="height:12pt;">	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 18.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:24pt;margin-top:8pt;">RSAs/RSUs:</p>	</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 80.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;">Awards are valued based on the Company&#8217;s stock price on grant date and generally vest ratably, on an annual basis, over three&#160;years.</p>	</td>	</tr>	<tr class="No-Table-Style _idGenTableRowColumn-50" style="height:12pt;">	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 18.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:24pt;margin-top:8pt;">PRSUs:</p>	</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>	<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 80.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;">These awards cliff vest three&#160;years from the grant date and contain a market condition whereby the number of PRSUs ultimately vesting is tied to how the Company&#8217;s total shareholder return (&#8220;TSR&#8221;) compares to a peer group of other publicly traded asset managers over the three<span class="nobreak">-year</span> period. A Monte Carlo simulation is used to value these awards.</p>	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;">The number of PRSUs vesting ranges from 0% to 200% of the target number of PRSUs granted, as follows:</p>	<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:18pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>If the relative TSR is below the 25<span class="Superscript" style="vertical-align:super;font-size:58%;">th</span> percentile, then 0% of the target number of PRSUs granted will vest;</p>	<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:18pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>If the relative TSR is at the 25<span class="CharOverride-6" style="font-size:58%;vertical-align:super;">th</span> percentile, then 50% of the target number of PRSUs granted will vest;</p>	<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:18pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>If the relative TSR is above the 25<span class="CharOverride-6" style="font-size:58%;vertical-align:super;">th</span> percentile, then linear scaling is applied such that the percent of the target number of PRSUs vesting is 100% at the 50<span class="CharOverride-6" style="font-size:58%;vertical-align:super;">th</span> percentile and capped at 200% of the target number of PRSUs granted for performance at the 85<span class="CharOverride-6" style="font-size:58%;vertical-align:super;">th</span> percentile; and</p>	<p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:18pt;"><span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;">&#8226;<span style="width: 20px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>If the Company&#8217;s TSR is negative, the target number of PRSUs vesting is capped at 100% regardless of the relative TSR percentile.</p>	</td>	</tr>	</table><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">During the&#160;years ended December&#160;31, 2023, 2022 and 2021, total stock<span class="nobreak">-based</span> compensation expense was $16,190, $10,385 and $9,998, respectively, and the related tax benefit recognized on the Consolidated Statements of Operations was $3,919, $2,371 and $2,327, respectively.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The actual tax benefit realized for the tax deductions for share<span class="nobreak">-based</span> compensation was $1,820, $1,548 and $2,032 during the&#160;years ended December&#160;31, 2023, 2022 and 2021, respectively.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">A summary of unrecognized stock<span class="nobreak">-based</span> compensation expense and average remaining vesting period is as follows:</p>
		<table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1" rowspan="2" style="width: 42.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" rowspan="2" style="width: 2.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" colspan="4" style="width: 55.60%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="CharOverride-7" style="font-style:normal;font-weight:bold;">December&#160;31, 2023</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 24.63%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="CharOverride-7" style="font-style:normal;font-weight:bold;">Unrecognized <br/>Stock-Based <br/>Compensation</span></p>
					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 2.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" style="width: 28.73%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="CharOverride-7" style="font-style:normal;font-weight:bold;">Weighted-Average <br/>Remaining <br/>Vesting Period <br/>(Years)</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 42.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Employees and directors</p>
					</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 2.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 21.64%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">19,165</p>	</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 2.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 28.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">0.92</p>	</td>
				</tr>

		</table>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Stock Options</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">There was <span style="-sec-ix-hidden: hidden-fact-235"><span style="-sec-ix-hidden: hidden-fact-236">no</span></span> option activity during the&#160;years ended December&#160;31, 2023 and 2022 and there were no options outstanding as of December&#160;31, 2023 and 2022. The total intrinsic value of options exercised during the year ended December&#160;31, 2021 was $51. Cash received from option exercises during the year ended December&#160;31, 2021 was $815.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">RSAs, RSUs and PRSUs</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The aggregate fair value of RSAs, RSUs and PRSUs that vested during the&#160;years ended December&#160;31, 2023, 2022 and 2021 was $10,158, $9,466 and $10,940, respectively. A summary of activity is as follows:</p>
		<table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-57" style="height:12pt;">
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="4" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 22.65%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">RSA</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="4" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 22.65%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">RSU</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="4" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 23.72%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">PRSU</span><span class="Bold-Superscript" style="font-style:normal;font-weight:bold;vertical-align:super;font-size:58%;">(1)</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-58" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Shares</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Weighted <br/>Average <br/>Grant Date <br/>Fair Value</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Shares</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Weighted <br/>Average <br/>Grant Date <br/>Fair Value</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Shares</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 11.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Weighted <br/>Average <br/>Grant Date <br/>Fair Value</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-59" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Unvested Balance at January&#160;1, 2021</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">3,580,743</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.38</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">39,408&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">4.46</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">341,312&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.17</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Granted</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">1,642,266</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.46</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">31,170&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.43</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_b" style="-sec-ix-hidden: hidden-fact-226; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">257,043</span><span class="Superscript" style="vertical-align:super;font-size:6pt;">(2)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">6.49</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Vested</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(1,897,699)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.78</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(15,136)&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">4.73</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-227; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-228; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Forfeited</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(288,405)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.11</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(452)&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.37</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(47,669)&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.74</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-59" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Unvested Balance at December&#160;31, 2021</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">3,036,905</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.20</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">54,990&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">4.93</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">550,686&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.73</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Granted</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">2,170,432</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.71</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">116,247&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.18</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="-sec-ix-hidden: hidden-fact-229; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">319,838</span><span class="Superscript" style="vertical-align:super;font-size:6pt;">(2)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">6.80</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Vested</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(1,621,201)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.31</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(27,894)&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.10</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(202,336)&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">6.24</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Forfeited</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(195,054)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.43</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(1,380)&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.73</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-230; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-231; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-59" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Unvested Balance at December&#160;31, 2022</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">3,391,082</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.46</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">141,963&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.09</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">668,188&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">6.09</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Granted</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">3,363,501</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.63</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">152,265&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">6.24</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="-sec-ix-hidden: hidden-fact-232; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">576,240</span><span class="Superscript" style="vertical-align:super;font-size:6pt;">(2)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">6.49</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Vested</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(1,629,925)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.28</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(72,461)&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.66</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(108,113)&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">3.11</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Forfeited</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(114,436)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.55</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(34,385)&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.70</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-233; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Stock dividends accrued</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">2,762&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">6.24</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">37,777&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">6.49</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-59" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Unvested Balance at December&#160;31, 2023</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5,010,222</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.63</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="-sec-ix-hidden: hidden-fact-234; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">190,144</span><span class="Superscript" style="vertical-align:super;font-size:6pt;">(</span><span class="CharOverride-5" style="font-size:6pt;vertical-align:super;">3</span><span class="Superscript" style="vertical-align:super;font-size:6pt;">)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.70</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">1,174,092&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">6.58</span></p>	</td>
				</tr>

		</table><p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>Represents the target number of PRSUs granted and outstanding. The number of PRSUs that ultimately vest ranges from 0% to 200% of this amount. During the years ended December 31, 2023, 2022 and 2021, 200%, 77% and 0%, respectively, of the target number of PRSUs granted ultimately vested, inclusive of accrued stock dividends.</p><p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:6pt;text-align:left;margin-top:6pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(2)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>A Monte Carlo simulation was used to value these awards using the following assumptions for the Company and the peer group: (i) beginning 90<span class="nobreak">-day</span> average stock prices; (ii) valuation date stock prices; (iii) correlation coefficients based upon the price data used to calculate the historical volatilities; and (iv) the following additional assumptions:</p>
		<table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Granted in <br/>2023</span></p>
					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Granted in <br/>2022</span></p>
					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Granted in <br/>2021</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1 _idGenCellOverride-4" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Historical stock price volatility (low)</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">37%</p>	</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">33%</p>	</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">34%</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Historical stock price volatility (high)</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">56%</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">57%</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">57%</p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Historical stock price volatility (average)</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">47%</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">44%</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">44%</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Risk free interest rate</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">3.80%</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">1.28%</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">0.17%</p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Expected dividend yield</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">0.00%</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">0.00%</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">0.00%</p>	</td>
				</tr>

		</table>
		<p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:6pt;margin-top:6pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(3)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>Includes 57,779 deferred RSUs that have vested.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100215776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholder Rights Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DisclosureOfStockholderRightsPlanAbstract', window );"><strong>Stockholder Rights Plan [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DisclosureOfStockholderRightsPlanTextBlock', window );">Stockholder Rights Plan</a></td>
<td class="text"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">19. Stockholder Rights Plan</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;">On March&#160;17, 2023, the Board of Directors of the Company adopted a stockholder rights plan, as set forth in the Stockholder Rights Agreement, dated March&#160;17, 2023, between the Company and Continental Stock Transfer&#160;&amp; Trust Company, as Rights Agent, as amended by Amendment No. 1 thereto, dated May&#160;4, 2023 (&#8220;Amendment No. 1&#8221;), and by Amendment No. 2 thereto, dated May&#160;10, 2023 (&#8220;Amendment No. 2&#8221;) (as amended, the &#8220;Stockholder Rights Agreement&#8221;). At the Company&#8217;s 2023 Annual Meeting of Stockholders held on June&#160;16, 2023, the Company&#8217;s stockholders ratified the adoption by the Board of Directors of the Stockholder Rights Agreement.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Pursuant to the terms of the Stockholder Rights Agreement, the Board of Directors declared a dividend distribution of (i)&#160;one Right (as defined below) for each outstanding share of common stock, par value $0.01 per share, of the Company&#8217;s common stock and (ii)&#160;1,000 Rights for each outstanding share of the Company&#8217;s Series&#160;A Non<span class="nobreak">-Voting</span> Convertible Preferred Stock (&#8220;Series&#160;A Preferred Stock&#8221;), to stockholders of record as of the close of business on March&#160;28, 2023 (the &#8220;Record Date&#8221;). In addition, one Right will automatically attach to each share of common stock and 1,000 Rights will automatically attach to each share of Series&#160;A Preferred Stock, in each case, issued between the Record Date and the earlier of the Distribution Date (as defined below) and the expiration date of the Rights. Each &#8220;Right&#8221; entitles the registered holder thereof to purchase from the Company a unit consisting of one ten<span class="nobreak">-thousandth</span> of a share (a &#8220;Unit&#8221;) of Series&#160;B Junior Participating Cumulative Preferred Stock, par value $0.01 per share, of the Company (the &#8220;Series&#160;B Preferred Stock&#8221;) at a cash exercise price of $32.00 per Unit (the &#8220;Exercise Price&#8221;), subject to adjustment, under certain conditions specified in the Stockholder Rights Agreement and summarized below.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Initially, the Rights are not exercisable and are attached to and trade with all shares of common stock and Series&#160;A Preferred Stock outstanding as of, and issued subsequent to, the Record Date. The Rights will separate from the common stock and Series&#160;A Preferred Stock and will become exercisable upon the earlier of (i)&#160;the close of business on the tenth calendar&#160;day following the first public announcement that a person or group of affiliated or associated persons (an &#8220;Acquiring Person&#8221;) has acquired beneficial ownership of 10% (or 20% in the case of a person or group which, together with all affiliates and associates of such person or group, is the beneficial owner of shares of common stock of the Company representing less than 20% of the shares of common stock of the Company then outstanding, and which is entitled to file, and files, a statement on Schedule&#160;13G pursuant to Rule&#160;13d<span class="nobreak">-1</span>(b)&#160;or Rule&#160;13d<span class="nobreak">-1</span>(c)&#160;of the General Rules and Regulations under the Exchange&#160;Act as in effect at the time of the first public announcement of the declaration of the Rights dividend with respect to the shares of common stock beneficially owned by such person or group) or more of the outstanding shares of common stock, other than as a result of repurchases of stock by the Company or certain inadvertent actions by a stockholder (the date of such announcement being referred to as the &#8220;Stock Acquisition Date&#8221;), or (ii)&#160;the close of business on the tenth business&#160;day (or such later&#160;day as the Board of Directors may determine) following the commencement of a tender offer or exchange offer that could result upon its consummation in a person or group becoming an Acquiring Person (the earlier of such dates being herein referred to as the &#8220;Distribution Date&#8221;). A person or group who beneficially owned 10% or more (or 20% or more in the case of passive stockholders) of the Company&#8217;s outstanding common stock prior to the first public announcement by the Company of the adoption of the Stockholder Rights Agreement will not trigger the Stockholder Rights Agreement so long as they do not acquire beneficial ownership of any additional shares of common stock at a time when they still beneficially own 10% or more (or 20% or more in the case of passive stockholders) of such common stock, subject to certain exceptions as set forth in the Stockholder Rights Agreement.</p><div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">For purposes of the Stockholder Rights Agreement, beneficial ownership is defined to include ownership of securities that are subject to a derivative transaction and acquired derivative securities. Swaps dealers unassociated with any control intent or intent to evade the purposes of the Stockholder Rights Agreement are excepted from such imputed beneficial ownership. Pursuant to Amendment No.<span class="nobreak"> </span>1, beneficial ownership did not include the right to vote pursuant to any agreement, arrangement or understanding with respect to voting on the proposal to approve and ratify the Stockholder Rights Agreement presented to the Company&#8217;s stockholders at the Company&#8217;s 2023 annual meeting of stockholders. Pursuant to Amendment No.<span class="nobreak"> </span>2, the parties to the SPA Agreement are not deemed to be &#8220;Acquiring Persons&#8221; solely by virtue of, or as a result of, the parties&#8217; entry into the SPA Agreement, the issuance of the Series&#160;C Preferred Stock to GBH, and the performance or consummation of any of the other transactions contemplated by the SPA Agreement, among other conditions, under the terms and conditions set forth in Amendment No. 2.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In the event that a Stock Acquisition Date occurs, proper provision will be made so that each holder of a Right (other than an Acquiring Person or its associates or affiliates, whose Rights shall become null and void) will thereafter have the right to receive upon exercise, in lieu of a number of shares of Series&#160;B Preferred Stock, that number of shares of common stock of the Company (or, in certain circumstances, including if there are insufficient shares of common stock to permit the exercise in full of the Rights, Units&#160;of Series&#160;B Preferred Stock, other securities, cash or property, or any combination of the foregoing) having a market value of two times the Exercise Price of the Right (such right being referred to as the &#8220;Subscription Right&#8221;). In the event that, at any time following the Stock Acquisition Date, (i)&#160;the Company consolidates with, or merges with and into, any other person, and the Company is not the continuing or surviving corporation, (ii)&#160;any person consolidates with the Company, or merges with and into the Company and the Company is the continuing or surviving corporation of such merger and, in connection with such merger, all or part of the shares of common stock are changed into or exchanged for stock or other securities of any other person or cash or any other property, or (iii)&#160;50% or more of the Company&#8217;s assets or earning power is sold, mortgaged or otherwise transferred, each holder of a Right (other than an Acquiring Person or its associates or affiliates, whose Rights shall become null and void) will thereafter have the right to receive, upon exercise, common stock of the acquiring company having a market value equal to two times the Exercise Price of the Right (such right being referred to as the &#8220;Merger Right&#8221;). The holder of a Right will continue to have the Merger Right whether or not such holder has exercised the Subscription Right. Rights that are or were beneficially owned by an Acquiring Person may (under certain circumstances specified in the Stockholder Rights Agreement) become null and void.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Rights may be redeemed in whole, but not in part, at a price of $0.01 per Right (payable in cash, common stock or other consideration deemed appropriate by the Board of Directors) by the Board of Directors only until the earlier of (i)&#160;the time at which any person becomes an Acquiring Person or (ii)&#160;the expiration date of the Stockholder Rights Agreement. Immediately upon the action of the Board of Directors ordering redemption of the Rights, the Rights will terminate and thereafter the only right of the holders of Rights will be to receive the redemption price.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Stockholder Rights Agreement may be amended by the Board of Directors in its sole discretion at any time prior to the time at which any person becomes an Acquiring Person. After such time the Board of Directors may, subject to certain limitations set forth in the Stockholder Rights Agreement, amend the Stockholder Rights Agreement only to cure any ambiguity, defect or inconsistency, to shorten or lengthen any time period, or to make changes that do not adversely affect the interests of Rights holders (excluding the interests of an Acquiring Person or its associates or affiliates).</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Until a Right is exercised, the holder will have no rights as a stockholder of the Company (beyond those as an existing stockholder), including the right to vote or to receive dividends. While the distribution of the Rights will not be taxable to stockholders or to the Company, stockholders may, depending upon the circumstances, recognize taxable income in the event that the Rights become exercisable for shares of common stock, other securities of the Company, other consideration or for common stock of an acquiring company.</p>
		</div><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Rights are not exercisable until the Distribution Date and will expire at the close of business on March&#160;16, 2024, unless previously redeemed or exchanged by the Company.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Stockholder Rights Agreement provides the holders of the common stock with the ability to exempt an offer to acquire, or engage in another business combination transaction involving, the Company that is deemed a &#8220;Qualifying Offer&#8221; (as defined in the Stockholder Rights Agreement) from the terms of the Stockholder Rights Agreement. A Qualifying Offer is, in summary, an offer determined by a majority of the independent members of the Board to have specific characteristics that are generally intended to preclude offers that are coercive, abusive or highly contingent. Among those characteristics are that it be: (i)&#160;a fully financed all<span class="nobreak">-cash</span> tender offer or an exchange offer offering shares of common stock of the offeror, or a combination thereof, for any and all of the common stock; and (ii)&#160;an offer that is otherwise in the best interests of the Company&#8217;s stockholders. The Stockholder Rights Agreement provides additional characteristics necessary for an acquisition offer to be deemed a &#8220;Qualifying Offer,&#8221; including if the consideration offered in a proposed transaction is stock of the acquiror.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Pursuant to the Stockholder Rights Agreement, if the Company receives a Qualifying Offer and the Board of Directors has not redeemed the outstanding Rights or exempted such Qualifying Offer from the terms of the Stockholder Rights Agreement or called a special meeting of stockholders (the &#8220;Special Meeting&#8221;) for the purpose of voting on whether to exempt such Qualifying Offer from the terms of the Stockholder Rights Agreement, in each case by the end of the 90 business&#160;day period following the commencement of such Qualifying Offer, provided such offer remains a Qualifying Offer during such period, the holders of 10% of the common stock may request that the Board call a Special Meeting to vote on a resolution authorizing the exemption of the Qualifying Offer from the terms of the Stockholder Rights Agreement. If such a Special Meeting is not held by the 90th business&#160;day following the receipt of such a request from stockholders to call a Special Meeting, the Qualifying Offer will be deemed exempt from the terms of the Stockholder Rights Agreement on the 10th business&#160;day thereafter.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_DisclosureOfStockholderRightsPlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_DisclosureOfStockholderRightsPlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_DisclosureOfStockholderRightsPlanTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of stockholder rights plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_DisclosureOfStockholderRightsPlanTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100072624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Employee Benefit Plans [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee Benefit Plans</a></td>
<td class="text"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">20. Employee Benefit Plans</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company has a 401(k)&#160;savings plan covering all eligible employees in which the Company can make discretionary contributions from its profits. The amounts included in the table below are recorded in compensation expense in the Consolidated Statements of Operations.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">A summary of discretionary contributions made by the Company is as follows:</p>
		<table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;">


				<tr class="Table55-">
					<td class="Table55- TCH CellOverride-2" colspan="8" style="width: 100.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">

						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December 31,</span></p>
					</td>
				</tr>
				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 30.26%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table55- TCH CellOverride-7" style="width: 3.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table55- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 30.26%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table55- TCH CellOverride-7" style="width: 3.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table55- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 33.33%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table55-" style="background: #CCEEFF;height:12pt;">
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 4.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table55- TB CellOverride-23 _idGenCellOverride-3" style="width: 26.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:6pt;">1,450</p>	</td>
					<td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 3.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 4.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 26.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,342</p>	</td>
					<td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 3.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 4.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 29.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,080</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480794/715-70-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//715/tableOfContent<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480126/715-20-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480266/715-60-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100012224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:14pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">21. Earnings Per Share</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The following tables set forth reconciliations of the basic and diluted earnings per share computations for the periods presented:</p>
		<table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;">


				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December 31,</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1 _idGenCellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table75- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table75- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-15" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Basic Earnings per Share</span></p>
					</td>
					<td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-16" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-16" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-16" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-15 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Net income</p>
					</td>
					<td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">102,546</p>	</td>
					<td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">50,684</p>	</td>
					<td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">49,797</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Add: Gain on repurchase of Series&#160;C Preferred Stock</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">7,966</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-237; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-238; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Less: Income distributed to participating securities</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(2,770)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(2,186)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(2,168)</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Less: Undistributed income allocable to participating securities</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(12,680)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(3,528)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(3,378)</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net income available to common stockholders&#8212;Basic EPS</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">95,062</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">44,970</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">44,251</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-15" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Weighted average common shares (in<span class="nobreak"> </span>thousands)</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">144,707</p>	</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">143,020</p>	</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">143,847</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Basic earnings per share</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">0.66</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">0.31</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">0.31</p>	</td>
				</tr>

		</table>
		<table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;">


				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-15" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Diluted Earnings per Share</span></p>
					</td>
					<td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-16" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-16" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-16" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-15 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Net income available to common stockholders</p>
					</td>
					<td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">95,062</p>	</td>
					<td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">44,970</p>	</td>
					<td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">44,251</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Add back: Undistributed income allocable to participating securities</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">12,680</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">3,528</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">3,378</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Less: Reallocation of undistributed income allocable to participating securities considered potentially dilutive</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(12,449)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(3,522)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(3,353)</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net income available to common stockholders&#8212;Diluted EPS</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">95,293</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">44,976</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">44,276</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-15" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"><span class="CharOverride-9" style="text-decoration:underline;">Weighted Average Diluted Shares (in thousands)</span>:</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Weighted average common shares</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">144,707</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">143,020</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">143,847</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Dilutive effect of common stock equivalents, excluding participating securities</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">3,120</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">275</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,208</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Weighted average diluted shares, excluding participating securities (in thousands)</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">147,827</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">143,295</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">145,055</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-15" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Diluted earnings per share</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">0.64</p>	</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">0.31</p>	</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">0.31</p>	</td>
				</tr>

		</table>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;">Diluted earnings per share presented above is calculated using the two<span class="nobreak">-class</span> method as this method results in the lowest diluted earnings per share amount for common stock. The year ended December&#160;31, 2023 includes a gain of $7,966 recognized upon the repurchase of the Series&#160;C Preferred Stock, which is excluded from net income, but required to be added to net income to arrive at income available to common stockholders in the calculation of earnings per share.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Total antidilutive non<span class="nobreak">-participating</span> common stock equivalents were 405 and 132 during the&#160;years ended December&#160;31, 2022 and 2021, respectively (shares herein are reported in thousands). There were no antidilutive non<span class="nobreak">-participating</span> common stock equivalents during the year ended December&#160;31, 2023.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">There were no potential common shares associated with the conversion option embedded in the Convertible Notes included in weighted average diluted shares for the&#160;years ended December&#160;31, 2023 and 2022 as the Company&#8217;s average stock price was lower than the conversion price. Potential common shares associated with the conversion option embedded in the Convertible Notes for the year ended December&#160;31, 2021 were 1,186 (shares herein are reported in thousands).</p>
		</div><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The following table reconciles weighted average diluted shares as reported on the Company&#8217;s Consolidated Statements of Operations for the&#160;years ended December&#160;31, 2023, 2022 and 2021, which are determined pursuant to the treasury stock method, to the weighted average diluted shares used to calculate diluted earnings per share as disclosed in the table above:</p>
		<table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="5" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 46.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December 31,</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Reconciliation of Weighted Average Diluted Shares (in</span><span class="nobreak"> </span><span class="Bold" style="font-style:normal;font-weight:bold;">thousands)</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Weighted average diluted shares as disclosed on the Consolidated Statements of Operations</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;">170,413</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;">158,914</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;">161,263</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Less: Participating securities:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Weighted average shares of common stock issuable upon conversion of the Series&#160;A Preferred Stock (Note&#160;11)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(14,750)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(14,750)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(14,750)</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Weighted average shares of common stock issuable upon conversion of the Series&#160;C Preferred Stock (Note&#160;11)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(6,992)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-239; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-240; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Potentially dilutive restricted stock awards</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(844)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(869)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(1,458)</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Weighted average diluted shares used to calculate diluted earnings/(loss) per share as disclosed in the table above</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">147,827</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">143,295</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">145,055</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310099925360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:8pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">22. Income Taxes</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Income before Income Tax Expense&#160;&#8211;&#160;Domestic and Foreign</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The U.S.&#160;and foreign components of income before income tax expense for the&#160;years ended December&#160;31, 2023, 2022 and 2021 are as follows:</p>
		<table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;">


				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Year Ended December 31,</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-12 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">U.S.</p>
					</td>
					<td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">4,652</p>	</td>
					<td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(4,067)</p>	</td>
					<td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">15,986</p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Foreign</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">114,356</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">44,017</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">40,685</p>	</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">119,008</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">39,950</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">56,671</p>	</td>
				</tr>

		</table>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Income Tax Expense/(Benefit) &#8211; By Jurisdiction</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The components of current and deferred income tax expense included in the Consolidated Statement of Operations for&#160;years ended December&#160;31, 2023, 2022 and 2021 are as follows:</p>
		<table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;">


				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Current:</p>
					</td>
					<td class="Table70- TCH CellOverride-26" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-14" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-26" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-14" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-26" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-14" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-12 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">Federal</p>
					</td>
					<td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">6,957</p>	</td>
					<td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">4,685</p>	</td>
					<td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">5,857</p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">State and local</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,883</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,415</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,538</p>	</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">Foreign</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">8,103</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(15,538)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(837)</p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">16,943</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(9,438)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">6,558</p>	</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">Deferred:</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">Federal</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(494)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(6)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(1,217)</p>	</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">State and local</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(102)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(1)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(251)</p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">Foreign</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">115</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(1,289)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,784</p>	</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(481)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(1,296)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">316</p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">Income tax expense/(benefit)</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">16,462</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(10,734)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">6,874</p>	</td>
				</tr>

		</table><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Reconciliation of Statutory Federal Income Tax Rate to the Effective Income Tax Rate</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">A reconciliation of the statutory federal income tax expense and the Company&#8217;s total income tax expense is as follows:</p>
		<table class="Table90-" style="width: 90.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0.33in 0pt 0.33in;">


				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TCH CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="8" style="width: 51.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December 31,</span></p>
					</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TCH CellOverride-1 _idGenCellOverride-3" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-7" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 15.79%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table90- TCH CellOverride-7" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 15.79%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table90- TCH CellOverride-7" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 17.22%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">U.S.&#160;federal statutory income tax</p>
					</td>
					<td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">24,992</p>	</td>
					<td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">8,386</p>	</td>
					<td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">11,901</p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Gain on revaluation/termination of deferred consideration<span class="Superscript" style="vertical-align:super;font-size:58%;">(1)</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(13,007)</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(5,842)</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(424)</p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Non-deductible loss on extinguishment of convertible notes</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">2,263</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Foreign operations</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(1,868)</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(2,919)</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(3,211)</p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Non-deductible executive compensation</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,833</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">789</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">881</p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Decrease in unrecognized tax benefits, net</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(1,386)</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(19,871)</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(4,998)</p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Change in valuation allowance&#160;&#8211;&#160;Capital losses</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,340</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">4,761</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">5</p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Expiration of capital losses</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">796</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Stock-based compensation tax shortfalls</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">373</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">507</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">647</p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Change in tax-related indemnification assets, net</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">291</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">4,173</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,053</p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Change in foreign net operating losses (&#8220;NOLs&#8221;)</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">174</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Blended state income tax rate, net of federal benefit</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">153</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(134)</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">526</p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Change in valuation allowance&#8212;Foreign NOLs and interest carryforwards</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(1,609)</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">GILTI</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">499</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other differences, net</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">508</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">526</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">494</p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Income tax expense/(benefit)</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">16,462</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(10,734)</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">6,874</p>	</td>
				</tr>

		</table><p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>The gain on revaluation of deferred consideration is not adjusted for income taxes as the obligation was assumed by a wholly<span class="nobreak">-owned</span> subsidiary that is based in Jersey, a jurisdiction where the Company is subject to a zero percent tax rate.</p><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;"> Income Tax Payments</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">A summary of income taxes paid by jurisdiction for the&#160;years ended December&#160;31, 2023, 2022 and 2021 is as follows:</p>
		<table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December 31,</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table60- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table60- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-15 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Federal</p>
					</td>
					<td class="Table60- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">4,824</p>	</td>
					<td class="Table60- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">6,424</p>	</td>
					<td class="Table60- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-16 _idGenCellOverride-4" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-16 _idGenCellOverride-4" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">4,258</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">State and local</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,457</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,431</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,020</p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Foreign</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">9,875</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">4,645</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">3,178</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">16,156</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">12,500</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">8,456</p>	</td>
				</tr>

		</table><div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;">
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Deferred Tax Assets</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">A summary of the components of the Company&#8217;s deferred tax assets at December&#160;31, 2023 and 2022 is as follows:</p>
		<table class="Table6in" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TCH CellOverride-1 _idGenCellOverride-2" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table6in TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.60%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table6in TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 19.20%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TCH CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deferred tax assets:</p>
					</td>
					<td class="Table6in TCH CellOverride-5" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TCH CellOverride-2" colspan="2" style="width: 17.60%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table6in TCH CellOverride-5" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TCH CellOverride-2" colspan="2" style="width: 19.20%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1 _idGenCellOverride-3" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Capital losses</p>
					</td>
					<td class="Table6in TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table6in TB CellOverride-2 _idGenCellOverride-3" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">22,489</p>	</td>
					<td class="Table6in TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table6in TB CellOverride-2 _idGenCellOverride-3" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">17,541</p>	</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Accrued expenses</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,000</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,030</p>	</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Stock-based compensation</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">2,468</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,526</p>	</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">NOLs&#8212;Foreign</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,502</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,609</p>	</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Goodwill and intangible assets</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">895</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,085</p>	</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Unrealized losses</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">335</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">3,821</p>	</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Foreign currency translation adjustment</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">146</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">173</p>	</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">NOLs&#8212;U.S.</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">127</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">255</p>	</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Operating lease liabilities</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">96</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">313</p>	</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Outside basis differences</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-241; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">122</p>	</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">401</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">341</p>	</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deferred tax assets</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">34,459</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">32,816</p>	</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-27" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-28" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-28" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-28" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-28" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-28" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-28" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deferred tax liabilities:</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Fixed assets and prepaid assets</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">296</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">278</p>	</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Unremitted earnings&#8212;European subsidiaries</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">186</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">205</p>	</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Right of use assets&#8212;operating leases</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">96</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">313</p>	</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deferred tax liabilities</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">578</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">796</p>	</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total deferred tax assets less deferred tax liabilities</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">33,881</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">32,020</p>	</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Less: Valuation allowance</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(22,824)</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(21,484)</p>	</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deferred tax assets, net</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">11,057</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">10,536</p>	</td>
				</tr>

		</table>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:14pt;text-indent:0pt;margin-top:14pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Net Operating and Capital Losses &#8211; U.S.</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company&#8217;s tax effected NOLs at December&#160;31, 2023 were $127, which expire in <span style="-sec-ix-hidden: hidden-fact-246">2024</span>. The net operating loss carryforwards have been reduced by the impact of annual limitations described in the Internal Revenue Code Section&#160;382 that arose as a result of an ownership change.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company&#8217;s tax effected capital losses at December&#160;31, 2023 were $22,489. These capital losses expire between the&#160;years 2024 and 2028. During the year ended December&#160;31, 2023, tax effected capital losses in the amount of $3,278 expired.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Net Operating Losses &#8211; Europe</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">One of the Company&#8217;s European subsidiaries generated NOLs outside the U.S.&#160;These tax effected NOLs, all of which are carried forward indefinitely, were $1,502 at December&#160;31, 2023.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Valuation Allowance</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company&#8217;s valuation allowance has been established on its net capital losses, unrealized losses and outside basis differences, as it is more<span class="nobreak">-likely-than-not</span> that these deferred tax assets will not be realized.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">During the year ended December&#160;31, 2022, the Company released the valuation allowance on its European net operating losses of $1,609 as it is more<span class="nobreak">-likely-than-not</span> that these deferred tax assets will be realized.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Uncertain Tax Positions</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Tax positions are evaluated utilizing a two<span class="nobreak">-step</span> process. The Company first determines whether any of its tax positions are more<span class="nobreak">-likely-than-not</span> to be sustained upon examination, based solely on the technical merits of the position. Once it is determined that a position meets this recognition threshold, the position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement.</p>
		</div><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In connection with the ETFS Acquisition, the Company accrued a liability for uncertain tax positions and interest and penalties at the acquisition date. The Company also recorded an offsetting indemnification asset provided by ETFS Capital as part of its agreement to indemnify the Company for any potential claims. The table below sets forth the aggregate changes in the balance of these gross unrecognized tax benefits:</p>
		<table class="Table80-" style="width: 80.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 15% 0pt 0.33in;">


				<tr class="Table80-" style="height:12pt;">
					<td class="Table80- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">


					</td>
					<td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Total</span></p>
					</td>
					<td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Unrecognized <br/>Tax Benefits</span></p>
					</td>
					<td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Interest and <br/>Penalties</span></p>
					</td>
				</tr>
				<tr class="Table80-" style="background: #CCEEFF;height:12pt;">
					<td class="Table80- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Balance at January&#160;1, 2022</p>
					</td>
					<td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">21,925</p>	</td>
					<td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">18,218</p>	</td>
					<td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">3,707</p>	</td>
				</tr>
				<tr class="Table80-" style="height:12pt;">
					<td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Decrease&#8212;Settlements<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)</span></p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(13,052)</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(11,865)</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(1,187)</p>	</td>
				</tr>
				<tr class="Table80-" style="background: #CCEEFF;height:12pt;">
					<td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Decrease&#8212;Lapse of statute of limitations<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)</span></p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(6,845)</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(4,825)</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(2,020)</p>	</td>
				</tr>
				<tr class="Table80-" style="height:12pt;">
					<td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Increases</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">26</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-242; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">26</p>	</td>
				</tr>
				<tr class="Table80-" style="background: #CCEEFF;height:12pt;">
					<td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Foreign currency translation<span class="Superscript" style="vertical-align:super;font-size:6pt;">(2)</span></p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(701)</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(571)</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(130)</p>	</td>
				</tr>
				<tr class="Table80-" style="height:12pt;">
					<td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Balance at December&#160;31, 2022</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,353</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">957</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">396</p>	</td>
				</tr>
				<tr class="Table80-" style="background: #CCEEFF;height:12pt;">
					<td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Decrease&#8212;Lapse of statute of limitations</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(1,353)</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(957)</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(396)</p>	</td>
				</tr>
				<tr class="Table80-" style="height:12pt;">
					<td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Balance at December&#160;31, 2023</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-243; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-244; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-245; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>

		</table><p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>In January 2022, an audit of ManJer&#8217;s tax returns (a Jersey<span class="nobreak">-based</span> subsidiary) for the years ended December&#160;31, 2014, 2016, 2017 and 2018 were resolved in favor of ManJer. The settlement, as well as the reduction in unrecognized tax benefits from the lapse of the statute of limitations totaling $19,897 during the year ended December 31, 2022 was recorded as an income tax benefit along with an equal and offsetting amount recorded in other losses and gains, net, to recognize a reduction in the indemnification asset.</p><p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="Superscript" style="vertical-align:super;font-size:6pt;"> (2)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>The gross unrecognized tax benefits were accrued in British pounds.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The gross unrecognized tax benefits and interest and penalties totaling $1,353 at December&#160;31, 2022 is included in other non<span class="nobreak">-current</span> liabilities on the Consolidated Balance Sheets.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Income Tax Examinations</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company is subject to U.S.&#160;federal income tax as well as income tax of multiple state, local and certain foreign jurisdictions.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">ManJer&#8217;s tax returns (a Jersey<span class="nobreak">-based</span> subsidiary) were previously under review for the&#160;years ended December&#160;31, 2014, 2016, 2017 and 2018. In January&#160;2022, the audit was resolved in favor of ManJer. In addition, the Company&#8217;s tax returns were previously under review by the State of Michigan for the&#160;years ended 2017 through 2020. In August&#160;2022, the audit was resolved in favor of the Company.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">As of December&#160;31, 2023, with few exceptions, the Company was no longer subject to income tax examinations by any taxing authority for the&#160;years before 2019.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Undistributed Earnings of Foreign Subsidiaries</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">ASC&#160;740<span class="nobreak">-30</span> Income Taxes provides guidance that U.S.&#160;companies do not need to recognize tax effects on foreign earnings that are indefinitely reinvested. The Company repatriates earnings of its foreign subsidiaries and therefore has recognized a deferred tax liability of $186 and $205 at December&#160;31, 2023 and 2022, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310107087632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shares Repurchased<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureTextBlockSupplementAbstract', window );"><strong>Shares Repurchased [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockTextBlock', window );">Shares Repurchased</a></td>
<td class="text"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">23. Shares Repurchased</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;">On February&#160;22, 2022, the Company&#8217;s Board of Directors approved an increase of $85,709 to the Company&#8217;s share repurchase program to $100,000 and extended the term for <span style="-sec-ix-hidden: hidden-fact-247">three</span>&#160;years through April&#160;27, 2025. Included under the Company&#8217;s share repurchase program are purchases to offset future equity grants made under the Company&#8217;s equity plans and purchases made in open market or privately negotiated transactions. This authority may be exercised from time to time, subject to regulatory considerations. The timing and actual number of shares repurchased will depend on a variety of factors including price, corporate and regulatory requirements, market conditions and other corporate liquidity requirements and priorities. The repurchase program may be suspended or terminated at any time without prior notice. Shares repurchased under this program are returned to the status of authorized and unissued on the Company&#8217;s books and records.</p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">During the&#160;years ended December&#160;31, 2023, 2022 and 2021, the Company repurchased 635,653, 593,261 and 5,120,496<span class="nobreak"> </span>shares of its common stock, respectively, under this program for an aggregate cost of $3,570, $3,418 and $34,506, respectively. Shares repurchased under this program were returned to the status of authorized and unissued on the Company&#8217;s books and records.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">As of December&#160;31, 2023, $96,406 remained under this program for future purchases.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In addition, as further described in Note&#160;11, the Company also repurchased its Series&#160;C Preferred Stock, which was convertible into 13,087,000<span class="nobreak"> </span>shares of common stock, from GBH, for aggregate cash consideration of $84,411. Under the terms of the transaction, the Company paid GBH $40,000 on the closing date, with the remainder of the purchase price payable in equal, interest<span class="nobreak">-free</span> installments on the first, second and third anniversaries of the closing date.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureTextBlockSupplementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureTextBlockSupplementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505-30/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310107165664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">24. Goodwill and Intangible Assets</span></p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Goodwill</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The table below sets forth goodwill which is tested annually for impairment on November&#160;30<span class="Superscript" style="vertical-align:super;font-size:58%;">th</span>:</p>
		<table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 23.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Total</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Balance at January&#160;1, 2023</p>
					</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">85,856&#160;&#160;</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Changes</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="Superscript" style="vertical-align:super;font-size:6pt;">&#160;</span></p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="-sec-ix-hidden: hidden-fact-248; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">985<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Balance at December&#160;31, 2023</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">86,841&#160;&#160;</p>	</td>
				</tr>

		</table><p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>On April 11, 2023, the Company acquired 100% of the capital stock of Securrency Transfers, Inc. (renamed WisdomTree Transfers, Inc.) for an aggregate purchase price of $985 (net of cash acquired). The acquisition has been accounted for under the acquisition method of accounting in accordance with ASC Topic 805, Business Combinations, and resulted in all consideration being allocated to goodwill.</p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"> Goodwill was tested for impairment on November&#160;30, 2023. The quantitative impairment test was performed using a market approach, whereby the market capitalization of the Company (a single reporting unit) was compared to its carrying value. The market capitalization was derived from the Company&#8217;s publicly traded stock price plus a reasonable control premium. The fair value of the reporting unit exceeded its carrying value and therefore no impairment was recognized.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Of the total goodwill of $86,841 at December&#160;31, 2023, $85,042 is not deductible for tax purposes as the acquisitions that gave rise to the goodwill were structured as stock acquisitions. The remainder of the goodwill is deductible for U.S.&#160;tax purposes.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Intangible Assets</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The table below sets forth the Company&#8217;s intangible assets which are tested annually for impairment on November&#160;30<span class="Superscript" style="vertical-align:super;font-size:58%;">th</span>:</p>
		<table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Balance at December&#160;31, 2023</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-left:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Item</span></p>
					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Gross Asset</span></p>
					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Accumulated <br/>Amortization</span></p>
					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Net Asset</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ETFS acquisition</p>
					</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">601,247</p>	</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-249; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">601,247</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Software development</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">4,519</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(684)</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">3,835</p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Balance at December&#160;31, 2023</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">605,766</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(684)</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">605,082</p>	</td>
				</tr>

		</table>
		<table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Balance at December&#160;31, 2022</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Item</span></p>
					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Gross Asset</span></p>
					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Accumulated <br/>Amortization</span></p>
					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Net Asset</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ETFS acquisition</p>
					</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">601,247</p>	</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-250; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">601,247</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Software development</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">2,370</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(50)</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">2,320</p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Balance at December&#160;31, 2022</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">603,617</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(50)</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">603,567</p>	</td>
				</tr>

		</table><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:14pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">ETFS Acquisition (Indefinite-Lived)</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">In connection with the ETFS Acquisition, which was completed on April&#160;11, 2018, the Company identified intangible assets valued at $601,247 related to the right to manage AUM through customary advisory agreements. These intangible assets were determined to have indefinite useful lives and are not deductible for tax purposes.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company performed its indefinite<span class="nobreak">-lived</span> intangible asset impairment test related to these customary advisory agreements on November&#160;30, 2023. The results of this analysis identified no indicators of impairment to be recognized based upon a quantitative assessment (discounted cash flow analysis) which relied upon significant unobservable inputs including a projected revenue growth rate of 3% and a weighted average cost of capital of 10.5%.</p>
		<p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Software Development (Finite-Lived)</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Internally<span class="nobreak">-developed</span> software is amortized over a useful life of <span style="-sec-ix-hidden: hidden-fact-252">three</span>&#160;years. During the&#160;years ended December&#160;31, 2023 and 2022, the Company recognized amortization expense on internally<span class="nobreak">-developed</span> software of $634 and $50, respectively.</p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">As of December&#160;31, 2023, expected amortization expense for the unamortized finite<span class="nobreak">-lived</span> intangible assets for the next <span style="-sec-ix-hidden: hidden-fact-253">five</span>&#160;years and thereafter is as follows:</p>
		<table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2024</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,375</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2025</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,440</p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2026</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">873</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2027</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">130</p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2028</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">17</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2029 and thereafter</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-251; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-15" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Total expected amortization expense</p>
					</td>
					<td class="Table60- TB CellOverride-16" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-16" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-16" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">3,835</p>	</td>
				</tr>

		</table>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;">The weighted<span class="nobreak">-average</span> remaining useful life of the finite<span class="nobreak">-lived</span> intangible assets is <span style="-sec-ix-hidden: hidden-fact-254">2.6</span>&#160;years.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100047536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingent Payments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionContingentConsiderationLiabilityAbstract', window );"><strong>Contingent Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ContingentPaymentTextBlock', window );">Contingent Payments</a></td>
<td class="text"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">25. Contingent Payments</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company recognized a gain of $1,477 and $787 during the&#160;years ended December&#160;31, 2023 and 2021, respectively, from remeasuring contingent payments arising from the sale of its former Canadian ETF business to their realizable value. These gains were recorded in other losses, net.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionContingentConsiderationLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionContingentConsiderationLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ContingentPaymentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent payment text block.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ContingentPaymentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100052016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Impairments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentChargesAbstract', window );"><strong>Impairments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentChargesTextBlock', window );">Impairments</a></td>
<td class="text"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">26. Impairments</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The following table summarizes impairments recognized by the Company:</p>
		<table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;">


				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Lease termination&#8211;New&#160;York office (Note&#160;13)</p>
					</td>
					<td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-255; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-256; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">9,277</p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Fixed assets&#8211;New&#160;York office (Note&#160;8)</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-257; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-258; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,576</p>	</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Lease termination&#8211;London office (Note&#160;13)</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-259; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-260; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">303</p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Securrency (Note&#160;7)</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">7,630</p>	</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-261; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-262; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other investments (Note&#160;7)</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">312</p>	</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-263; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-264; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">7,942</p>	</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-265; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">16,156</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentChargesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the details of the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value. Disclosure may also include a description of the impaired asset and facts and circumstances leading to the impairment, amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired asset is reported.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentChargesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310099952544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:14pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">27. Subsequent Events</span></p>
		<p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company evaluated subsequent events through the date of issuance of the consolidated financial statements. There were no events requiring disclosure.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100269584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">$ 102,546<span></span>
</td>
<td class="nump">$ 50,684<span></span>
</td>
<td class="nump">$ 49,797<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310098507888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310098989792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounting Policies, by Policy (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Basis of Presentation</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">These consolidated financial statements have been prepared in conformity with U.S.&#160;generally accepted accounting principles (&#8220;GAAP&#8221;) and in the opinion of management reflect all adjustments, consisting of only normal recurring adjustments, necessary for a fair presentation of the financial statements. The consolidated financial statements include the accounts of the Company&#8217;s wholly<span class="nobreak">-owned</span> subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Consolidation</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company consolidates entities in which it has a controlling financial interest. The Company determines whether it has a controlling financial interest in an entity by first evaluating whether the entity is a voting interest entity (&#8220;VOE&#8221;) or a variable interest entity (&#8220;VIE&#8221;). The usual condition for a controlling financial interest in a VOE is ownership of a majority voting interest. If the Company has a majority voting interest in a VOE, the entity is consolidated. The Company has a controlling financial interest in a VIE when the Company has a variable interest that provides it with (i)&#160;the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (ii)&#160;the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE.</p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company reassesses its evaluation of whether an entity is a VOE or VIE when certain reconsideration events occur.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment and Geographic Information</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Segment and Geographic Information</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company, through its subsidiaries in the U.S.&#160;and Europe, conducts business as a single operating segment as an ETP sponsor and asset manager which is based upon the Company&#8217;s current organizational and management structure, as well as information used by the chief operating decision maker to allocate resources and other factors.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Foreign Currency Translation</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Assets and liabilities of subsidiaries whose functional currency is not the U.S.&#160;dollar are translated based on the end of period exchange rates from local currency to U.S.&#160;dollars. Results of operations are translated at the average exchange rates in effect during the period. The impact of the foreign currency translation adjustment is included in the Consolidated Statements of Comprehensive Income as a component of other comprehensive income/(loss).</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The preparation of the Company&#8217;s consolidated financial statements in conformity with U.S.&#160;GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the balance sheet dates and the reported amounts of revenues and expenses for the periods presented. Actual results could differ materially from those estimates.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Revenue Recognition</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company earns substantially all of its revenue in the form of advisory fees from its ETPs and recognizes this revenue over time, as the performance obligation is satisfied. Advisory fees are based on a percentage of the ETPs&#8217; average daily net assets. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ContractualGoldPaymentsPolicyPolicyTextBlock', window );">Contractual Gold Payments</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Contractual Gold Payments</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Contractual gold payments are measured and paid monthly based upon the average daily spot price of gold (Note&#160;9). The Company&#8217;s obligation to continue making these payments terminated on May&#160;10, 2023.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Marketing and Advertising</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Marketing and Advertising</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Marketing and advertising costs, including media advertising and production costs, are expensed when incurred.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RegulatoryDepreciationAndAmortizationPolicy', window );">Depreciation and Amortization</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Depreciation and Amortization</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Depreciation and amortization is provided for using the straight<span class="nobreak">-line</span> method over the estimated useful lives of the related assets as follows:</p><table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;">


				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 74.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Equipment</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 23.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:right;">3&#160;to&#160;5 years</p>	</td>
				</tr>
				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 74.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Internally<span class="nobreak">-developed</span> software</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 23.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:right;">3&#160;years</p>	</td>
				</tr>

		</table><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The assets listed above are recorded at cost less accumulated depreciation and amortization.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-Based Awards</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Stock-Based Awards</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Accounting for stock<span class="nobreak">-based</span> compensation requires the measurement and recognition of compensation expense for all equity awards based on estimated fair values. Stock<span class="nobreak">-based</span> compensation is measured based on the grant<span class="nobreak">-date</span> fair value of the award and is amortized over the relevant service period. Forfeitures are recognized when they occur.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ThirdPartyDistributionFeesPolicyTextBlock', window );">Third-Party Distribution Fees</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Third-Party Distribution Fees</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company pays a percentage of its advisory fee revenues based on incremental growth in assets under management (&#8220;AUM&#8221;), subject to caps or minimums, to marketing agents to sell WisdomTree ETPs and for including WisdomTree ETPs on third<span class="nobreak">-party</span> customer platforms and recognizes these expenses as incurred.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Cash and Cash Equivalents</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company considers all highly liquid investments with an original maturity of 90&#160;days or less at the time of purchase to be classified as cash equivalents. The Company maintains deposits with financial institutions in an amount that is in excess of federally insured limits.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Accounts Receivable</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Accounts receivable are customer and other obligations due under normal trade terms. The Company measures credit losses, if any, by applying historical loss rates, adjusted for current conditions and reasonable and supportable forecasts to amounts outstanding using the aging method.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Impairment of Long-Lived Assets</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company performs a review for the impairment of long<span class="nobreak">-lived</span> assets when events or changes in circumstances indicate that the estimated undiscounted future cash flows expected to be generated by the assets are less than their carrying amounts or when other events occur which may indicate that the carrying amount of an asset may not be recoverable.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Financial Instruments Owned and Financial Instruments Sold, but Not yet Purchased (at Fair Value)</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Financial Instruments Owned and Financial Instruments Sold, but Not yet Purchased (at Fair Value)</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Financial instruments owned and financial instruments sold, but not yet purchased are financial instruments classified as either trading or available<span class="nobreak">-for-sale</span> (&#8220;AFS&#8221;). These financial instruments are recorded on their trade date and are measured at fair value. All equity instruments that have readily determinable fair values are classified by the Company as trading. Debt instruments are classified based primarily on the Company&#8217;s intent to hold or sell the instrument. Changes in the fair value of debt instruments classified as trading and AFS are reported in other income/(expenses) and other comprehensive income, respectively, in the period the change occurs. Debt instruments classified as AFS are assessed for impairment on a quarterly basis and an estimate for credit loss is provided when the fair value of the AFS debt instrument is below its amortized cost basis. Credit<span class="nobreak">-related</span> impairments are recognized in earnings with a corresponding adjustment to the instrument&#8217;s amortized cost basis if the Company intends to sell the impaired AFS debt instrument or it is more likely than not the Company will be required to sell the instrument before recovering its amortized cost basis. Other credit<span class="nobreak">-related</span> impairments are recognized as an allowance with a corresponding adjustment to earnings. Impairments resulting from noncredit<span class="nobreak">-related</span> factors are recognized in other comprehensive income. Amounts recorded in other comprehensive income are reclassified into earnings upon sale of the AFS debt instrument using the specific identification method.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Securities Held-to-Maturity</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Securities Held-to-Maturity</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company accounts for certain of its securities as held<span class="nobreak">-to-maturity</span> on a trade date basis, which are recorded at amortized cost. For held<span class="nobreak">-to-maturity</span> securities, the Company has the intent and ability to hold these securities to maturity and it is not more<span class="nobreak">-likely-than-not</span> that the Company will be required to sell these securities before recovery of their amortized cost bases, which may be maturity. Held<span class="nobreak">-to-maturity</span> securities are placed on non<span class="nobreak">-accrual</span> status when the Company is in receipt of information indicating collection of interest is doubtful. Cash received on held<span class="nobreak">-to-maturity</span> securities placed on non<span class="nobreak">-accrual</span> status is recognized on a cash basis as interest income if and when received.</p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company reviews its portfolio of held<span class="nobreak">-to-maturity</span> securities for impairment on a quarterly basis, recognizing an allowance, if any, by applying an estimated loss rate after consideration for the nature of collateral securing the financial asset as well as potential future changes in collateral values and historical loss information for financial assets secured with similar collateral.</p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Investments in pass<span class="nobreak">-through</span> government<span class="nobreak">-sponsored</span> enterprises (&#8220;GSEs&#8221;) are determined to have an estimated loss rate of zero due to an implicit U.S.&#160;government guarantee.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Investments</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company accounts for equity investments that do not have a readily determinable fair value under the measurement alternative prescribed in Accounting Standards Codification (&#8220;ASC&#8221;) Topic&#160;321, <span class="Italic" style="font-style:italic;font-weight:normal;">Investments&#160;&#8211;&#160;Equity Securities </span>(&#8220;ASC&#160;321&#8221;), to the extent such investments are not subject to consolidation or the equity method. Under the measurement alternative, these financial instruments are carried at cost, less any impairment (assessed quarterly), plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. In addition, income is recognized when dividends are received only to the extent they are distributed from net accumulated earnings of the investee. Otherwise, such distributions are considered returns of investment and are recorded as a reduction of the cost of the investment.</p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Investments in debt instruments are accounted for at fair value, with changes in fair value reported in other income/(expenses).</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Goodwill</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Goodwill is the excess of the purchase price over the fair values of the identifiable net assets at the acquisition date. The Company tests goodwill for impairment at least annually and at the time of a triggering event requiring re<span class="nobreak">-evaluation</span>, if one were to occur. Goodwill is considered impaired when the estimated fair value of the reporting unit that was allocated the goodwill is less than its carrying value. If the estimated fair value of such reporting unit is less than its carrying value, goodwill impairment is recognized based on that difference, not to exceed the carrying amount of goodwill. A reporting unit is an operating segment or a component of an operating segment provided that the component constitutes a business for which discrete financial information is available and management regularly reviews the operating results of that component.</p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Goodwill is allocated to the Company&#8217;s U.S.&#160;business and European business components. For impairment testing purposes, these components are aggregated as a single reporting unit as they fall under the same operating segment and have similar economic characteristics.</p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Goodwill is assessed for impairment annually on November&#160;30<span class="Superscript" style="vertical-align:super;font-size:58%;">th</span>. When performing its goodwill impairment test, the Company considers a qualitative assessment, when appropriate, and a quantitative assessment using the market approach and its market capitalization when determining the fair value of the reporting unit.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Intangible Assets</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Intangible Assets</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Indefinite<span class="nobreak">-lived</span> intangible assets are tested for impairment at least annually and are also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indefinite<span class="nobreak">-lived</span> intangible assets are impaired if their estimated fair values are less than their carrying values.</p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Finite<span class="nobreak">-lived</span> intangible assets, if any, are amortized over their estimated useful life, which is the period over which the assets are expected to contribute directly or indirectly to the future cash flows of the Company. These intangible assets are tested for impairment at the time of a triggering event, if one were to occur. Finite<span class="nobreak">-lived</span> intangible assets may be impaired when the estimated undiscounted future cash flows generated from the assets are less than their carrying amounts.</p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company may rely on a qualitative assessment when performing its intangible asset impairment test. Otherwise, the impairment evaluation is performed at the lowest level of reasonably identifiable cash flows independent of other assets. The annual impairment testing date for all of the Company&#8217;s intangible assets is November&#160;30<span class="Superscript" style="vertical-align:super;font-size:58%;">th</span>.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock', window );">Software Development Costs</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Software Development Costs</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Software development costs incurred after the preliminary project stage is complete are capitalized if it is probable that the project will be completed and the software will be used as intended. Capitalized costs consist of employee compensation costs and fees paid to third parties who are directly involved in the application development efforts and are included in intangible assets, net in the Consolidated Balance Sheets. Such costs are amortized over the estimated useful life of the software on a straight<span class="nobreak">-line</span> basis and are included in depreciation and amortization in the Consolidated Statements of Operations. Once the application development stage is complete, additional costs are expensed as incurred.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Leases</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company accounts for its lease obligations in accordance with ASC Topic&#160;842, <span class="Italic" style="font-style:italic;font-weight:normal;">Leases </span>(&#8220;ASC&#160;842&#8221;), which requires the recognition of both (i)&#160;a lease liability equal to the present value of the remaining lease payments and (ii)&#160;an offsetting right<span class="nobreak">-of-use</span> asset. The remaining lease payments are discounted using the rate implicit in the lease, if known, or otherwise the Company&#8217;s incremental borrowing rate. After lease commencement, right<span class="nobreak">-of-use</span> assets are assessed for impairment and otherwise are amortized over the remaining lease term on a straight<span class="nobreak">-line</span> basis. These recognition requirements are not applied to short<span class="nobreak">-term</span> leases which are those with a lease term of 12&#160;months or less. Instead, lease payments associated with short<span class="nobreak">-term</span> leases are recognized as an expense on a straight<span class="nobreak">-line</span> basis over the lease term.</p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">ASC&#160;842 also provides a practical expedient which allows for consideration in a contract to be accounted for as a single lease component rather than allocated between lease and non<span class="nobreak">-lease</span> components. The Company has elected to apply this practical expedient to all lease contracts, where applicable.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DeferredConsiderationGoldPaymentsPolicyTextBlock', window );">Deferred Consideration&#8212;Gold Payments</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Deferred Consideration&#8212;Gold Payments</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Deferred consideration&#8212;gold payments represented the present value of an obligation to pay gold to a third party into perpetuity and was measured using forward<span class="nobreak">-looking</span> gold prices observed on the CMX exchange, a selected discount rate and perpetual growth rate (Note&#160;9). Changes in the fair value of this obligation were reported as gain on revaluation/termination of deferred consideration&#8212;gold payments in the Consolidated Statements of Operations.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Convertible Notes</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Convertible Notes</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Convertible notes are carried at amortized cost, net of issuance costs. The Company accounts for convertible instruments as a single liability (applicable to the convertible notes) or equity with no separate accounting for embedded conversion features unless the conversion feature meets the criteria for accounting under the substantial premium model or does not qualify for a derivative scope exception. Interest expense is recognized using the effective interest method and includes amortization of issuance costs over the life of the debt.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Contingencies</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Contingencies</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company may be subject to reviews, inspections and investigations by regulatory authorities as well as legal proceedings arising in the ordinary course of business. The Company evaluates the likelihood of an unfavorable outcome of all legal or regulatory proceedings to which it is a party and accrues a loss contingency when the loss is probable and reasonably estimable.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ContingentPaymentsPolicyTextBlock', window );">Contingent Payments</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Contingent Payments</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company recognizes a gain on contingent payments when the contingency is resolved and the gain is realized.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings per Share</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Earnings per Share</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Basic earnings per share (&#8220;EPS&#8221;) is computed by dividing net income available to common stockholders by the weighted<span class="nobreak">-average</span> number of common shares outstanding for the period. Net income available to common stockholders represents net income of the Company reduced by an allocation of earnings to participating securities. The Series&#160;A non<span class="nobreak">-voting</span> convertible preferred stock (Note&#160;11) and unvested share<span class="nobreak">-based</span> payment awards that contain non<span class="nobreak">-forfeitable</span> rights to dividends or dividend equivalents (whether paid or unpaid) are participating securities and are included in the computation of EPS pursuant to the two<span class="nobreak">-class</span> method. Stock<span class="nobreak">-based</span> equity awards that do not contain such rights are not deemed participating securities and are included in diluted shares outstanding (if dilutive).</p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Diluted EPS is calculated under the treasury stock method and the two<span class="nobreak">-class</span> method. The calculation that results in the lowest diluted EPS amount for the common stock is reported in the Company&#8217;s consolidated financial statements. The treasury stock method includes the dilutive effect of potential common shares including unvested stock<span class="nobreak">-based</span> awards, the Series&#160;A non<span class="nobreak">-voting</span> convertible preferred stock and the convertible notes, if any. Potential common shares associated with the Series&#160;A non<span class="nobreak">-voting</span> convertible preferred stock and the convertible notes are computed under the if<span class="nobreak">-converted</span> method. Potential common shares associated with the conversion option embedded in the convertible notes are dilutive when the Company&#8217;s average stock price exceeds the conversion price.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Income Taxes</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Company accounts for income taxes using the liability method, which requires the determination of deferred tax assets and liabilities based on the differences between the financial and tax bases of assets and liabilities using the enacted tax rates in effect for the year in which differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is more<span class="nobreak">-likely-than-not</span> that some portion or all the deferred tax assets will not be realized.</p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Tax positions are evaluated utilizing a two<span class="nobreak">-step</span> process. The Company first determines whether any of its tax positions are more<span class="nobreak">-likely-than-not</span> to be sustained upon examination, based solely on the technical merits of the position. Once it is determined that a position meets this recognition threshold, the position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. The Company records interest expense and penalties related to tax expenses as income tax expense.</p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">The Global Intangible Low<span class="nobreak">-Taxed</span> Income (&#8220;GILTI&#8221;) provisions of the Tax Reform Act requires the Company to include in its U.S.&#160;income tax return foreign subsidiary earnings in excess of an allowable return on the foreign subsidiary&#8217;s tangible assets. An accounting policy election is available to either account for the tax effects of GILTI in the period that is subject to such taxes or to provide deferred taxes for book and tax basis differences that upon reversal may be subject to such taxes. The Company accounts for the tax effects of these provisions in the period that is subject to such tax.</p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">Non<span class="nobreak">-income</span> based taxes are recorded as part of other liabilities and other expenses.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_RecentlyIssuedAccountingPronouncementsPolicyTextBlock', window );">Recently Issued Accounting Pronouncements</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Recently Issued Accounting Pronouncements</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On November&#160;27, 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU&#160;2023<span class="nobreak">-07</span>, <span class="Italic" style="font-style:italic;font-weight:normal;">Segment&#160;Reporting&#8212;Improvements to Reportable Segment Disclosures</span>, which requires public entities to provide disclosures of significant segment expenses and other segment items. The guidance requires public entities to provide in interim periods all disclosures about a reportable segment&#8217;s profit or loss and assets that are currently required annually and also applies to public entities with a single reportable segment. Entities are permitted to disclose more than one measure of a segment&#8217;s profit or loss if such measures are used by the chief operating decision<span class="nobreak">-maker</span> to allocate resources and assess performance, as long as at least one of those measures is determined in a way that is most consistent with the measurement principles used to measure the corresponding amounts in the consolidated financial statements. The guidance is applied retrospectively to all periods presented in financial statements, unless it is impracticable, and is effective for fiscal&#160;years beginning after December&#160;15, 2023, and for interim periods beginning after December&#160;15, 2024. Early adoption is permitted. This standard will only impact disclosures and will be adopted by the Company on January&#160;1, 2024.</p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On December&#160;13, 2023, the FASB issued ASU&#160;2023<span class="nobreak">-08</span>, <span class="Italic" style="font-style:italic;font-weight:normal;">Accounting for and Disclosure of Crypto Assets</span>, which contains final guidance requiring all entities to measure certain crypto assets at fair value each reporting period and to reflect changes from remeasurement in net income. Entities are required to present crypto assets measured at fair value separately from other intangible assets on the balance sheet and present changes from the remeasurement of crypto assets separately from changes in the carrying amounts of other intangible assets in the income statement. Entities are required to provide interim and annual disclosures about the types of crypto assets they hold and any changes in their holdings of crypto assets. The guidance is effective for fiscal&#160;years beginning after December&#160;15, 2024, including interim periods within those fiscal&#160;years. Early adoption is permitted. The Company has determined that this standard will not have a material impact on its financial statements and will early adopt the standard on January&#160;1, 2024.</p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On December&#160;14, 2023, the FASB issued ASU&#160;2023<span class="nobreak">-09</span>,<span class="Italic" style="font-style:italic;font-weight:normal;"> Improvements to Income Tax Disclosures</span>, which establishes new income tax disclosure requirements in addition to modifying and eliminating certain existing requirements. Under the new guidance, entities must consistently categorize and provide greater disaggregation of information in the rate reconciliation. They must also further disaggregate income taxes paid. The standard is intended to benefit investors by providing more detailed income tax disclosures that would be useful in making capital allocation decisions. The guidance applies to all entities subject to income taxes and is effective for annual periods beginning after December&#160;15, 2024. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively. Early adoption is permitted. The Company plans to adopt this standard on January&#160;1, 2025.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements</a></td>
<td class="text"><p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"><span class="BoldItalic" style="font-style:italic;font-weight:bold;">Recently Adopted Accounting Pronouncements</span></p><p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;">On January&#160;1, 2021, the Company early adopted ASU&#160;2020<span class="nobreak">-06</span>, <span class="Italic" style="font-style:italic;font-weight:normal;">Debt&#160;&#8211;&#160;Debt with Conversion and Other Options </span>(ASU&#160;2020<span class="nobreak">-06</span>) under the modified retrospective approach. Under the ASU, the accounting for convertible instruments was simplified by removing major separation models required under current GAAP.&#160;Accordingly, more convertible instruments are reported as a single liability or equity with no separate accounting for embedded conversion features. Certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception are removed and, as a result, more equity contracts will qualify for the scope exception. The ASU also simplifies the diluted earnings<span class="nobreak">-per-share</span> calculation in certain areas. Upon the adoption of this ASU, the Company reclassified the equity component related to the convertible notes, net of deferred taxes, reducing accumulated deficit by $616, increasing the carrying value of the convertible notes by $4,088, reducing additional paid<span class="nobreak">-in</span> capital by $3,682 and reducing deferred tax liabilities by $1,022. These updates also reduced interest expense recognized on the Company&#8217;s convertible notes by approximately $420 per quarter and $1,680 for the year ended December&#160;31, 2021 (Note&#160;10) and the impact on earnings per share was negligible.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 35<br> -Topic 720<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 450<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480598/954-450-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 60<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482053/820-10-60-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 30<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 12<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RegulatoryDepreciationAndAmortizationPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for systematically allocating capitalized costs to periods that benefit from the use thereof. Includes, but is not limited to, methods used, such as composite depreciation, descriptions of regulatory treatment for estimated removal and disposal costs, and description of amortization of plant-related regulatory assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RegulatoryDepreciationAndAmortizationPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 4<br> -SubTopic 50<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482610/350-50-25-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -SubTopic 40<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482633/350-40-30-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ContingentPaymentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ContingentPaymentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ContractualGoldPaymentsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual gold payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ContractualGoldPaymentsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_DeferredConsiderationGoldPaymentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounting policy related to deferred consideration - gold payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_DeferredConsiderationGoldPaymentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_RecentlyIssuedAccountingPronouncementsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recently issued accounting pronouncements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_RecentlyIssuedAccountingPronouncementsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ThirdPartyDistributionFeesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to third-party distribution fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ThirdPartyDistributionFeesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310107082688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_StraightLineDepreciationMethodMember', window );">Depreciation Method, Straight-Line [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_SignificantAccountingPoliciesTablesLineItems', window );"><strong>Significant Accounting Policies (Tables) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Depreciation and Amortization</a></td>
<td class="text">Depreciation and amortization is provided for using the straight<span class="nobreak">-line</span> method over the estimated useful lives of the related assets as follows:<table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;">


				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 74.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Equipment</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 23.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:right;">3&#160;to&#160;5 years</p>	</td>
				</tr>
				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 74.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;">Internally<span class="nobreak">-developed</span> software</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 23.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:right;">3&#160;years</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_SignificantAccountingPoliciesTablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_SignificantAccountingPoliciesTablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_StraightLineDepreciationMethodMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_StraightLineDepreciationMethodMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310107067168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Measurements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of Assets and Liabilities Measured at Fair Value</a></td>
<td class="text">The tables below summarize the categorization of the Company&#8217;s assets and liabilities measured at fair value. During the&#160;years ended December&#160;31, 2023 and 2022, there were no transfers between Levels 2 and 3.<table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="No-Table-Style TCH" style="width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="11" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 55.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, 2023</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="No-Table-Style TCH _idGenCellOverride-1" style="width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Total</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Level 1</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Level 2</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Level 3</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Assets:</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Recurring fair value measurements:</p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:30pt;">Cash equivalents</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">50,226</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">50,226</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-142; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-143; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:30pt;">Financial instruments owned, at fair value:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:50pt;">ETFs</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">35,181</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">35,181</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-144; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-145; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:50pt;">Pass-through GSEs</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">10,240</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-146; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">10,240</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-147; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:50pt;">Other assets&#8212;seed capital (WisdomTree Digital Funds):</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:70pt;">U.S.&#160;treasuries</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">5,007</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">5,007</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-148; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:70pt;">Equities</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,337</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,337</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-149; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-150; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:70pt;">Fixed income</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,957</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,008</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">949</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-151; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">108,948</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">92,752</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">16,196</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-152; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Non-recurring fair value measurements:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:30pt;">Fnality International Limited&#8212;Series&#160;B-1 Preference Shares<span class="Superscript" style="vertical-align:super;font-size:6pt;">(</span><span class="CharOverride-5" style="font-size:6pt;vertical-align:super;">1)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">9,684</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-style:normal;font-weight:normal;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-153; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-style:normal;font-weight:normal;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-style:normal;font-weight:normal;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-154; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="Bold" style="font-style:normal;font-weight:bold;font-style:normal;font-weight:normal;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">9,684</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:30pt;">Other investments<span class="Superscript" style="vertical-align:super;font-size:6pt;">(</span><span class="CharOverride-5" style="font-size:6pt;vertical-align:super;">2</span><span class="Superscript" style="vertical-align:super;font-size:6pt;">)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-155; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-156; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-157; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-158; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">9,684</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-159; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-160; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">9,684</p>	</td>
				</tr>

		</table><p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>Fair value determined on October 31, 2023</p><p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:0pt;"><span class="Superscript" style="vertical-align:super;font-size:6pt;"> (2)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>Fair value determined on September 30, 2023</p><table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="11" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 55.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, 2022</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Total</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Level 1</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Level 2</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Level 3</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Assets:</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Recurring fair value measurements:</p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Cash equivalents</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">930</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">930</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-161; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-162; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Financial instruments owned, at fair value:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ETFs</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">23,772</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">23,772</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-163; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-164; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">U.S.&#160;treasuries</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">2,980</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">2,980</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-165; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-166; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Pass-through GSEs</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">96,837</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">23,290</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">73,547</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-167; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Fixed income</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">885</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-168; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">885</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-169; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other assets&#8212;seed capital (WisdomTree Digital Funds):</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,765</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-170; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,765</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-171; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Investments in Convertible Notes</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Securrency, Inc.&#8212;convertible note (Note&#160;7)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">14,500</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-172; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-173; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">14,500</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Fnality International Limited&#8212;convertible note (Note&#160;7)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,921</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-174; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-175; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,921</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">148,590</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">50,972</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">76,197</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">21,421</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Non-recurring fair value measurements:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other investments<span class="Superscript" style="vertical-align:super;font-size:58%;">(</span><span class="CharOverride-6" style="font-size:58%;vertical-align:super;">1)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">312</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-176; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-177; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">312</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-top:1pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Liabilities:</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Recurring fair value measurements:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deferred consideration (Note&#160;9)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">200,290</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-178; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-179; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">200,290</p>	</td>
				</tr>

		</table><p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;">&#8203;<span class="CharOverride-6" style="font-size:58%;vertical-align:super;">(1)&#160;&#160;&#160;&#160;&#160;</span>Fair value determined on May 10, 2022</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Beginning and Ending Balances of Recurring Fair Value Measurements Classified</a></td>
<td class="text">These instruments consist of the following:<table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;">


				<tr class="Table75-" style="height:12pt;">
					<td class="Table75-" style="border-left-width:1pt;border-left-style:solid;border-left-color:#000000;border-top-width:1pt;border-top-style:solid;border-top-color:#000000;border-right-width:1pt;border-right-style:solid;border-right-color:#000000;border-bottom-width:1pt;border-bottom-style:solid;border-bottom-color:#000000;padding-top:4pt;padding-bottom:4pt;padding-left:4pt;padding-right:4pt;vertical-align:top;width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="5" style="width: 37.50%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75-" style="border-left-width:1pt;border-left-style:solid;border-left-color:#000000;border-top-width:1pt;border-top-style:solid;border-top-color:#000000;border-right-width:1pt;border-right-style:solid;border-right-color:#000000;border-bottom-width:1pt;border-bottom-style:solid;border-bottom-color:#000000;padding-top:4pt;padding-bottom:4pt;padding-left:4pt;padding-right:4pt;vertical-align:top;width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December 31, <br/>2023</span></p>
					</td>
					<td class="Table75- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December 31, <br/>2022</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Investments in Convertible Notes (Note&#160;7):</p>
					</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Beginning balance</p>
					</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">21,421</p>	</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-180; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Purchases</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">11,228</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">21,863</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Settlements</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(28,818)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-181; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Conversions<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)</span></p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(9,684)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-182; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net realized gains/(losses)<span class="Superscript" style="vertical-align:super;font-size:6pt;">(2)</span></p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">5,853</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(442)</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Ending balance</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-183; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">21,421</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deferred Consideration (Note&#160;7):</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Beginning balance</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">200,290</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">228,062</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net realized losses<span class="Superscript" style="vertical-align:super;font-size:6pt;">(3)</span></p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,069</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">17,108</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net unrealized gains<span class="Superscript" style="vertical-align:super;font-size:6pt;">(4)</span></p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(61,953)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(27,765)</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Settlements</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(144,406)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(17,115)</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Ending balance</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-184; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">200,290</p>	</td>
				</tr>

		</table><p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;">&#8203;<span class="CharOverride-5" style="font-size:6pt;vertical-align:super;">(1)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>The Fnality convertible notes converted into Series B<span class="nobreak">-1</span> Preference Shares on October 31, 2023 (Note 7).</p><p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:0pt;"><span class="CharOverride-5" style="font-size:6pt;vertical-align:super;"> (2)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>Recorded in impairments and other losses, net in the Consolidated Statements of Operations.</p><p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:0pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(3)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>Recorded as contractual gold payments expense in the Consolidated Statements of Operations.</p><p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:0pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(4)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>Recorded as gain on revaluation/termination of deferred consideration&#8212;gold payments in the Consolidated Statements of Operations.&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2C<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2C<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100247872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments Owned (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract', window );"><strong>Financial Instruments Owned [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock', window );">Schedule of Financial Instruments Owned</a></td>
<td class="text">These instruments consist of the following:<table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;">


				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1 _idGenCellOverride-2" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2023</span></p>
					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2022</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Financial instruments owned:</p>
					</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Trading securities</p>
					</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">45,421</p>	</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">124,474</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other assets&#8212;seed capital (WisdomTree Digital Funds)</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">13,301</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,765</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">58,722</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">126,239</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments held by the entity for its own account for trading or investment purposes that are carried at fair value and pledged to counterparties as collateral for financing transactions. Description may include equity, fixed income, debt or other securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481444/860-30-45-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481420/860-30-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100143120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Securities Held-to-Maturity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Securities Held-to-Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Securities Held-to-Maturity</a></td>
<td class="text">The following table is a summary of the Company&#8217;s securities held<span class="nobreak">-to-maturity</span>:<table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;">


				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2023</span></p>
					</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2022</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Debt instruments: Pass-through GSEs (amortized cost)</p>
					</td>
					<td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">230</p>	</td>
					<td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">259</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock', window );">Schedule of Unrealized Losses, Gains and Fair Value of Securities Held-to-Maturity</a></td>
<td class="text">The following table summarizes unrealized gains, losses, and fair value (classified as Level 2 within the fair value hierarchy) of securities held<span class="nobreak">-to-maturity</span>:<table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;">


				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1 _idGenCellOverride-2" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="5" style="width: 37.50%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Cost/amortized cost</p>
					</td>
					<td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">230</p>	</td>
					<td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">259</p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Gross unrealized losses</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(15)</p>	</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(20)</p>	</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Gross unrealized gains</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-186; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-187; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Fair value</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">215</p>	</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">239</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of Maturity Profile of the Securities Held-to-Maturity</a></td>
<td class="text">The following table sets forth the maturity profile of the securities held<span class="nobreak">-to-maturity</span>; however, these securities may be called prior to maturity date:<table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;">


				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1 _idGenCellOverride-2" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="5" style="width: 37.50%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-10 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Due within one year</p>
					</td>
					<td class="Table70- TB CellOverride-11 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-3 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-188; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"> &#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-11 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-3 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-189; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"> &#8212;</p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-10" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Due one year through five&#160;years</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-190; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-191; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-10" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Due five&#160;years through ten&#160;years</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">22</p>	</td>
					<td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">27</p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-10" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Due over ten&#160;years</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="top">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="top">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">208</p>	</td>
					<td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="top">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="top">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">232</p>	</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-10" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top">
						<p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="top">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="top">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"> 230</p>	</td>
					<td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top">&#160;</td>
					<td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="top">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="top">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">259</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of unrealized gains and losses on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100134064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTableTextBlock', window );">Schedule of Investments</a></td>
<td class="text">The following table sets forth the Company&#8217;s investments:<table class="Table90-" style="width: 90.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0.33in 0pt 0.33in;">


				<tr class="Table90-" style="height:12pt;">
					<td class="Table90-" style="border-left-width:1pt;border-left-style:solid;border-left-color:#000000;border-top-width:1pt;border-top-style:solid;border-top-color:#000000;border-right-width:1pt;border-right-style:solid;border-right-color:#000000;border-bottom-width:1pt;border-bottom-style:solid;border-bottom-color:#000000;padding-top:4pt;padding-bottom:4pt;padding-left:4pt;padding-right:4pt;vertical-align:top;width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="5" style="width: 27.93%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December 31, 2023</span></p>
					</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="5" style="width: 30.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December 31, 2022</span></p>
					</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90-" style="border-left-width:1pt;border-left-style:solid;border-left-color:#000000;border-top-width:1pt;border-top-style:solid;border-top-color:#000000;border-right-width:1pt;border-right-style:solid;border-right-color:#000000;border-bottom-width:1pt;border-bottom-style:solid;border-bottom-color:#000000;padding-top:4pt;padding-bottom:4pt;padding-left:4pt;padding-right:4pt;vertical-align:top;width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Carrying <br/>Value</span></p>
					</td>
					<td class="Table90- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Cost</span></p>
					</td>
					<td class="Table90- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Carrying <br/>Value</span></p>
					</td>
					<td class="Table90- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 15.54%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Cost</span></p>
					</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TCH CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Securrency, Inc.:</p>
					</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="2" style="width: 15.54%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1 _idGenCellOverride-3" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Series&#160;A Shares</p>
					</td>
					<td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-192; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-193; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">8,488</p>	</td>
					<td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">8,112</p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Series&#160;B Shares</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-194; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-195; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">5,500</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">5,500</p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Convertible note</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-196; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-197; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">14,500</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">15,000</p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Subtotal&#8212;Securrency, Inc.</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-198; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-199; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">28,488</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">28,612</p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Fnality International Limited:</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Convertible note</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-200; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-201; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,921</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,863</p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Series&#160;B-1 Preference Shares</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">9,684</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">8,091</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-202; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-203; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Subtotal&#8212;Fnality International Limited</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">9,684</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">8,091</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,921</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,863</p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other investments</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-204; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">250</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">312</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">250</p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">9,684</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">8,341</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">35,721</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">35,725</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of Backsolve Valuation Approach</a></td>
<td class="text">The table below presents the inputs used in the backsolve valuation approach (classified as Level 3 in the fair value hierarchy):<table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;">


				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TCH CellOverride-1 _idGenCellOverride-2" style="width: 55.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table55- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TCH CellOverride-2 _idGenCellOverride-2" colspan="3" style="width: 42.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="CharOverride-7" style="font-style:normal;font-weight:bold;">Inputs</span></p>
					</td>
				</tr>
				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TCH CellOverride-1" style="width: 55.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table55- TCH CellOverride-5" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TCH CellOverride-2" style="width: 19.69%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="CharOverride-7" style="font-style:normal;font-weight:bold;">June&#160;9, <br/>2021</span></p>
					</td>
					<td class="Table55- TCH CellOverride-5" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TCH CellOverride-2" style="width: 21.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="CharOverride-7" style="font-style:normal;font-weight:bold;">March&#160;8, <br/>2021</span></p>
					</td>
				</tr>
				<tr class="Table55-" style="background: #CCEEFF;height:12pt;">
					<td class="Table55- TB CellOverride-1 _idGenCellOverride-3" style="width: 55.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Expected volatility</p>
					</td>
					<td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 19.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">50%</p>	</td>
					<td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 21.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">55%</p>	</td>
				</tr>
				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 55.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Time to exit (in&#160;years)</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 19.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">4.75</p>	</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 21.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">5.00</p>	</td>
				</tr>

		</table><table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;">


				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TCH CellOverride-1" style="width: 85.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table55- TCH CellOverride-5" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TCH CellOverride-2" style="width: 13.41%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2023</span></p>
					</td>
				</tr>
				<tr class="Table55-" style="background: #CCEEFF;height:12pt;">
					<td class="Table55- TB CellOverride-1 _idGenCellOverride-3" style="width: 85.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Expected volatility</p>
					</td>
					<td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 13.41%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">60%</p>	</td>
				</tr>
				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 85.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Time to exit (in&#160;years)</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 13.41%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">5.00</p>	</td>
				</tr>
				<tr class="Table55-" style="background: #CCEEFF;height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 85.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Probability that Series&#160;B-2 Preference Shares convert into Series&#160;B-1 Preference Shares</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 13.41%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">75%</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfCondensedFinancialStatementsTableTextBlock', window );">Schedule of Presents the Probability Ascribed to Potential Outcomes Used in the Pwerm</a></td>
<td class="text">The table below presents the probability ascribed to potential outcomes used in the PWERM (classified as Level 3 in the fair value hierarchy) and the time to exit:<table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;">


				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TCH CellOverride-1" style="width: 78.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table55- TCH CellOverride-5" style="width: 1.64%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TCH CellOverride-2" style="width: 19.70%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="CharOverride-7" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2022</span></p>
					</td>
				</tr>
				<tr class="Table55-" style="background: #CCEEFF;height:12pt;">
					<td class="Table55- TB CellOverride-1 _idGenCellOverride-3" style="width: 78.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Conversion of note upon a future equity financing</p>
					</td>
					<td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.64%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 19.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">60%</p>	</td>
				</tr>
				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 78.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Redemption of note upon a corporate transaction</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.64%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 19.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">25%</p>	</td>
				</tr>
				<tr class="Table55-" style="background: #CCEEFF;height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 78.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Default</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.64%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 19.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">15%</p>	</td>
				</tr>
				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 78.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Time to potential outcome (in&#160;years)</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.64%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 19.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">0.33</p>	</td>
				</tr>

		</table><table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;">


				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TCH CellOverride-1" style="width: 78.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table55- TCH CellOverride-5" style="width: 1.86%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TCH CellOverride-2" style="width: 20.12%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2022</span></p>
					</td>
				</tr>
				<tr class="Table55-" style="background: #CCEEFF;height:12pt;">
					<td class="Table55- TB CellOverride-1 _idGenCellOverride-3" style="width: 78.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Conversion of note upon a future financing round</p>
					</td>
					<td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.86%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 20.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">85%</p>	</td>
				</tr>
				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 78.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Redemption of note upon a change of control</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.86%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 20.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">10%</p>	</td>
				</tr>
				<tr class="Table55-" style="background: #CCEEFF;height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 78.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Default</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.86%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 20.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">5%</p>	</td>
				</tr>
				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TB CellOverride-1" style="width: 78.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Time to potential outcome (in&#160;years)</p>
					</td>
					<td class="Table55- TB CellOverride-2" style="width: 1.86%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2" style="width: 20.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">0.25</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedFinancialStatementsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph (a)<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedFinancialStatementsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//320/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Topic 321<br> -Publisher FASB<br> -URI https://asc.fasb.org//321/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Topic 325<br> -Publisher FASB<br> -URI https://asc.fasb.org//325/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100196352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fixed Assets, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Fixed Assets, net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Fixed Assets</a></td>
<td class="text">The following table summarizes fixed assets:<table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;">


				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1 _idGenCellOverride-2" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="5" style="width: 37.50%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Equipment</p>
					</td>
					<td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,097</p>	</td>
					<td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">962</p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Less: accumulated depreciation</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(670)</p>	</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(418)</p>	</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">427</p>	</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">544</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310106219984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Consideration&#8212;gold payments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DeferredConsiderationAbstract', window );"><strong>Deferred Consideration Gold Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DisclosureOfValuationOfDeferredConsiderationTableTextBlock', window );">Schedule of Valuation of Deferred Consideration</a></td>
<td class="text">The Company determined the present value of the deferred consideration of $0 and $200,290 at December&#160;31, 2022 using the following assumptions:<table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 20.22%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, 2022</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-12 _idGenCellOverride-3" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Forward-looking gold price (low)&#8212;per ounce</p>
					</td>
					<td class="Table60- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-14 _idGenCellOverride-3" style="width: 2.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-14 _idGenCellOverride-3" style="width: 17.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,858</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-12" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Forward-looking gold price (high)&#8212;per ounce</p>
					</td>
					<td class="Table60- TB CellOverride-14" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-14" style="width: 2.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-14" style="width: 17.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">3,126</p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-12" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Forward-looking gold price (weighted average)&#8212;per ounce</p>
					</td>
					<td class="Table60- TB CellOverride-14" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-14" style="width: 2.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-14" style="width: 17.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">2,237</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-12" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Discount rate</p>
					</td>
					<td class="Table60- TB CellOverride-14" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-14" style="width: 2.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-14" style="width: 17.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">11.0%</p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-12" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Perpetual growth rate</p>
					</td>
					<td class="Table60- TB CellOverride-14" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-14" style="width: 2.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-14" style="width: 17.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1.3%</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ScheduleOfDeferredConsiderationTableTextBlock', window );">Schedule of Deferred Consideration</a></td>
<td class="text">During the&#160;years ended December&#160;31, 2023 and 2022, the Company recognized the following in respect of deferred consideration:<table class="Table90-" style="width: 90.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0.33in 0pt 0.33in;">


				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TCH CellOverride-1 _idGenCellOverride-2" style="width: 45.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TCH CellOverride-1" style="width: 45.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="2" style="width: 16.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="2" style="width: 16.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="2" style="width: 17.65%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-12 _idGenCellOverride-3" style="width: 45.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Contractual gold payments</p>
					</td>
					<td class="Table90- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">6,069</p>	</td>
					<td class="Table90- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">17,108</p>	</td>
					<td class="Table90- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 15.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">17,096</p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-12" style="width: 45.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Contractual gold payments&#8212;gold ounces paid</p>
					</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-14" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">3,167</p>	</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-14" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">9,500</p>	</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-14" style="width: 15.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">9,500</p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-12" style="width: 45.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Gain on revaluation/termination of deferred consideration&#8212;gold payments<span class="Superscript" style="vertical-align:super;font-size:6pt;">(</span><span class="CharOverride-5" style="font-size:6pt;vertical-align:super;">1</span><span class="Superscript" style="vertical-align:super;font-size:6pt;">)</span></p>
					</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-14" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">61,953</p>	</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-14" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">27,765</p>	</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-14" style="width: 15.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">2,018</p>	</td>
				</tr>

		</table><p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:11pt;margin-top:12pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>Gains on revaluation/termination of deferred consideration&#8212;gold payments result from a decrease in spot gold prices, a decrease in the forward<span class="nobreak">-looking</span> price of gold, a decrease in the perpetual growth rate and an increase in the discount rate used to compute the present value of the annual payment obligations.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_DeferredConsiderationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_DeferredConsiderationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_DisclosureOfValuationOfDeferredConsiderationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of valuation of deferred consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_DisclosureOfValuationOfDeferredConsiderationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ScheduleOfDeferredConsiderationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of deferred consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ScheduleOfDeferredConsiderationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310107074928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Notes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract', window );"><strong>Convertible Notes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Key Terms of Convertible Notes</a></td>
<td class="text">Key terms of the Convertible Notes are as follows:<table class="Table85-" style="width: 85.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 10% 0pt 0.33in;">


				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TCH CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table85- TCH CellOverride-5" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TCH CellOverride-2" colspan="2" style="width: 20.17%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023 Notes</span></p>
					</td>
					<td class="Table85- TCH CellOverride-5" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TCH CellOverride-2" colspan="2" style="width: 18.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021 Notes</span></p>
					</td>
				</tr>
				<tr class="Table85-" style="background: #CCEEFF;height:12pt;">
					<td class="Table85- TB CellOverride-1 _idGenCellOverride-3" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Principal outstanding</p>
					</td>
					<td class="Table85- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">130,000</p>	</td>
					<td class="Table85- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">150,000</p>	</td>
				</tr>
				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Maturity date (unless earlier converted, repurchased or redeemed)</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">August&#160;15,&#160;2028</p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">June&#160;15,&#160;2026</p>	</td>
				</tr>
				<tr class="Table85-" style="background: #CCEEFF;height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Interest rate</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">5.75%</p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">3.25%</p>	</td>
				</tr>
				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Conversion price</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">9.54</p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">11.04</p>	</td>
				</tr>
				<tr class="Table85-" style="background: #CCEEFF;height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Conversion rate</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">104.8658</p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">90.5797</p>	</td>
				</tr>
				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Redemption price</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">12.40</p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">14.35</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">Schedule of Convertible Notes</a></td>
<td class="text">The following table provides a summary of the Convertible Notes at December&#160;31, 2023 and December&#160;31, 2022:<table class="Table90-" style="width: 90.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0.33in 0pt 0.33in;">


				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TCH CellOverride-1 _idGenCellOverride-2" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 39.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, 2023</span></p>
					</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 40.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, 2022</span></p>
					</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TCH CellOverride-1" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 12.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023 Notes</span></p>
					</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 12.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021 Notes</span></p>
					</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 12.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Total</span></p>
					</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 12.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021 Notes</span></p>
					</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 12.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2020 Notes</span></p>
					</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 13.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Total</span></p>
					</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1 _idGenCellOverride-3" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Principal amount</span></p>
					</td>
					<td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">130,000</span></p>	</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">150,000</span></p>	</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">280,000</span></p>	</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">150,000</span></p>	</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">175,000</span></p>	</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">325,000</span></p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Plus: Premium</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-205; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-206; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-207; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-208; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">250</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">250</span></p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Gross proceeds</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">130,000</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">150,000</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">280,000</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">150,000</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">175,250</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">325,250</span></p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Less: Unamortized issuance costs</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(2,987)</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(2,125)</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(5,112)</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(2,981)</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(1,053)</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(4,034)</span></p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Carrying amount</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">127,013</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">147,875</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">274,888</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">147,019</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">174,197</span></p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">321,216</span></p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-15" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"><span class="CharOverride-8" style="font-size:9pt;">Effective interest rate</span><span class="Superscript" style="vertical-align:super;font-size:6pt;">(</span><span class="CharOverride-5" style="font-size:6pt;vertical-align:super;">1)</span></p>
					</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-16" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">6.25%</span></p>	</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-16" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">3.83%</span></p>	</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-16" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">4.96%</span></p>	</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-16" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">3.83%</span></p>	</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-16" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.26%</span></p>	</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="Table90- TB CellOverride-16" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">4.60%</span></p>	</td>
				</tr>

		</table><p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;">&#8203;<span class="CharOverride-5" style="font-size:6pt;vertical-align:super;">(1)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>Includes amortization of the issuance costs and premium.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310098368928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Series A Preferred Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract', window );"><strong>Series A Preferred Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfPreferredUnitsTextBlock', window );">Schedule of Series A Preferred Stock Balance</a></td>
<td class="text">The following is a summary of the Series&#160;A Preferred Stock balance:<table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;">


				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.60%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31,<br/>2023</span></p>
					</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 19.20%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31,<br/>2022</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Issuance of Series&#160;A Preferred Stock</p>
					</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">132,750</p>	</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">132,750</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Less: Issuance costs</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(181)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(181)</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Series&#160;A Preferred Stock&#8212;carrying value</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">132,569</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">132,569</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Cash dividends declared per share (quarterly)</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">0.03</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">0.03</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfPreferredUnitsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of preferred units of master limited partnerships that have priority over limited partner units in areas including liquidation, redemption, conversion, tax status of distribution or sharing in distributions. This schedule ordinarily includes a description of the preferred units that details various rights including redemption, conversion, liquidation, and sharing in distributions; capital contributed by preferred partners; number of preferred units authorized to be issued, issued, and outstanding; aggregate cumulative cash distributions made to the preferred partners; aggregate cumulative net income earned by the preferred partners; capital account balance of the preferred partners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB TOPIC 4.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfPreferredUnitsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100196352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Payable to Gold Bullion Holdings Jersey Limited GBH (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_PayableToGoldBullionHoldingJerseyLimitedGBHAbstract', window );"><strong>Payable to Gold Bullion Holdings Jersey Limited GBH [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ScheduleOfAggregateConsiderationPayableTableTextBlock', window );">Schedule of Aggregate Consideration Payable</a></td>
<td class="text">The aggregate consideration payable was valued at $38,835 on the closing date and the carrying value of this obligation is as follows:<table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1" style="width: 76.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 21.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2023</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 76.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Current:</p>
					</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 19.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">14,804</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 76.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Long-term</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 19.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">24,328</p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 76.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 19.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">39,132</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_PayableToGoldBullionHoldingJerseyLimitedGBHAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_PayableToGoldBullionHoldingJerseyLimitedGBHAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ScheduleOfAggregateConsiderationPayableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular of  aggregate consideration payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ScheduleOfAggregateConsiderationPayableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310107162416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Additional Information Related to Operating Lease</a></td>
<td class="text">The following table provides additional information regarding the Company&#8217;s leases:<table class="Table85-" style="width: 85.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 10% 0pt 0.33in;">


				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TCH CellOverride-1 _idGenCellOverride-2" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" colspan="5" style="width: 35.64%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended<br/>December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TCH CellOverride-1 _idGenCellOverride-2" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.34%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.82%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
				</tr>
				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TCH CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Lease cost:</p>
					</td>
					<td class="Table85- TCH CellOverride-5" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TCH CellOverride-2" colspan="2" style="width: 16.34%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table85- TCH CellOverride-5" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TCH CellOverride-2" colspan="2" style="width: 17.82%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table85-" style="background: #CCEEFF;height:12pt;">
					<td class="Table85- TB CellOverride-1 _idGenCellOverride-3" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Operating lease cost</p>
					</td>
					<td class="Table85- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,285</p>	</td>
					<td class="Table85- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">963</p>	</td>
				</tr>
				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Short-term lease cost</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">191</p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">223</p>	</td>
				</tr>
				<tr class="Table85-" style="background: #CCEEFF;height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total lease cost</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,476</p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,186</p>	</td>
				</tr>
				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other information:</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table85-" style="background: #CCEEFF;height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Cash paid for amounts included in the measurement of operating liabilities (operating leases)</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,284</p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">965</p>	</td>
				</tr>
				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Right-of-use assets obtained in exchange for new operating lease liabilities</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-211; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">n/a</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-212; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">n/a</p>
					</td>
				</tr>
				<tr class="Table85-" style="background: #CCEEFF;height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Weighted-average remaining lease term (in&#160;years)&#8212;operating leases</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">0.4</p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1.2</p>	</td>
				</tr>
				<tr class="Table85-" style="height:12pt;">
					<td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Weighted-average discount rate&#8212;operating leases</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">5.9%</p>	</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6.4%</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Lease Payments</a></td>
<td class="text">The following table discloses future minimum lease payments at December&#160;31, 2023 with respect to the Company&#8217;s operating lease liabilities:<table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2024</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">584</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2025</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-213; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2026</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-214; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2027</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-215; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2028</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-216; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2029 and thereafter</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-217; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total future minimum lease payments (undiscounted)</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">584</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock', window );">Schedule of Reconciliation of Future Minimum Lease Payments to Balance Sheet</a></td>
<td class="text">The following table reconciles the future minimum lease payments (disclosed above) at December&#160;31, 2023 to the operating lease liabilities recognized in the Company&#8217;s Consolidated Balance Sheets:<table class="Table60-" style="width: 60%; border-collapse: collapse; border: #000 0pt solid; border-width: 0pt; margin: 6pt 30% 0pt 0.33in">


				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1" colspan="4" style="border-width: 0pt; vertical-align: bottom; padding: 0in 0in 3px"><p class="Tbody" style="border-width: 0; font: normal 10pt Times New Roman PS Std, serif; margin: 0; padding: 0; margin-bottom: 0; margin-left: 10pt; margin-right: 0; margin-top: 0; orphans: 1; page-break-after: auto; page-break-before: auto; text-align: left; text-indent: -10pt; widows: 1">Amounts recognized in the Company&#8217;s Consolidated Balance Sheets</p>

</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 74%; padding: 0in 0in 3px; border-width: 0pt; vertical-align: bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Lease liability&#8212;short term</p>
					</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 2%; padding: 0in 0in 3px; border-width: 0pt; vertical-align: bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.67%; padding: 0in 0in 3px; border-width: 0pt; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 21.33%; padding: 0in 0in 3px; border-width: 0pt; vertical-align: bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">578</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Lease liability&#8212;long term</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-218; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">
						<p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Subtotal</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">578</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Difference between undiscounted and discounted cash flows</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6</p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total future minimum lease payments (undiscounted)</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">584</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule For Supplemental Balance Sheet Information Related To Operating Lease</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310098685360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Variable Interest Entities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract', window );"><strong>Variable Interest Entities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock', window );">Schedule of Information about Variable Interests</a></td>
<td class="text">The following table presents information about the Company&#8217;s variable interests in non<span class="nobreak">-consolidated</span> VIEs:<table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;">


				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1 _idGenCellOverride-2" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.02%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2023</span></p>
					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31, <br/>2022</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Carrying Amount&#8212;Assets (Securrency):</p>
					</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 16.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;">Preferred stock&#8212;Series&#160;A Shares</p>
					</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-219; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">8,488</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;">Preferred stock&#8212;Series&#160;B Shares</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-220; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">5,500</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;">Convertible note</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-221; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">14,500</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Subtotal&#8212;Securrency</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-222; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">28,488</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Carrying Amount&#8212;Assets (Fnality):</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;">Convertible note</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-223; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,921</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;">Series&#160;B-1 Preference Shares</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">9,684</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-224; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Subtotal&#8212;Fnality</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">9,684</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">6,921</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Carrying Amount&#8212;Assets (Other investments):</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-225; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">312</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total (Note&#160;7)</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">9,684</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">35,721</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-15" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Maximum exposure to loss</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">9,684</p>	</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">35,721</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-5A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-9<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfVariableInterestEntitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310095209472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues from Contracts with Customers (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenues from Contracts with Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock', window );">Schedule of Revenues from Contracts with Customers</a></td>
<td class="text">The following table presents the Company&#8217;s total revenues from contracts with customers:<table class="Table80-" style="width: 80.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 15% 0pt 0.33in;">


				<tr class="Table80-" style="height:12pt;">
					<td class="Table80- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table80-" style="height:12pt;">
					<td class="Table80- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table80-" style="height:12pt;">
					<td class="Table80- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Revenues from contracts with customers:</p>
					</td>
					<td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table80-" style="background: #CCEEFF;height:12pt;">
					<td class="Table80- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Advisory fees</p>
					</td>
					<td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">333,227</p>	</td>
					<td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">293,632</p>	</td>
					<td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">298,052</p>	</td>
				</tr>
				<tr class="Table80-" style="height:12pt;">
					<td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">15,808</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">7,713</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,266</p>	</td>
				</tr>
				<tr class="Table80-" style="background: #CCEEFF;height:12pt;">
					<td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total operating revenues</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">349,035</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">301,345</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">304,318</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Schedule of Geographic Distribution of Revenues</a></td>
<td class="text">The following table presents the Company&#8217;s total revenues geographically as determined by where the respective management companies reside:<table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;">


				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1 _idGenCellOverride-2" rowspan="2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" rowspan="2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Revenues from contracts with customers:</p>
					</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">United&#160;States</p>
					</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">220,117</p>	</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">184,036</p>	</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">179,016</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Jersey</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">113,325</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">103,692</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">114,623</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Ireland</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">15,593</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">13,617</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">10,679</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total operating revenues</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">349,035</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">301,345</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">304,318</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -SubTopic 10<br> -Topic 280<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of revenues categorized as revenues from contracts with customers and other sources of revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310099961504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock', window );">Schedule of Accounts Receivable from Related Parties</a></td>
<td class="text">The following table summarizes accounts receivable from related parties which are included as a component of accounts receivable in the Consolidated Balance Sheets:<table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;">


				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1" rowspan="2" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" rowspan="2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="5" style="width: 38.40%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.60%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="2" style="width: 19.20%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Receivable from WTT</p>
					</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">21,226</p>	</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">16,399</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Receivable from ManJer Issuers</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">4,411</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">4,485</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Receivable from WMAI and WTICAV</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">2,874</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">3,255</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">28,511</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">24,139</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Schedule of Revenues from Advisory Services Provided to Related Parties</a></td>
<td class="text">The following table summarizes revenues from advisory services provided to related parties:<table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;">


				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1" rowspan="2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" rowspan="2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table75- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table75- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Advisory services provided to WTT</p>
					</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">218,834</p>	</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">183,409</p>	</td>
					<td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">178,511</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Advisory services provided to ManJer Issuers</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">98,800</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">96,606</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">108,862</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Advisory services provided to WMAI and WTICAV</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">15,593</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">13,617</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">10,679</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">333,227</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">293,632</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">298,052</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Accounts Receivable From Related Party [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310107162288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Awards (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Stock-Based Awards [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock', window );">Schedule of Unrecognized Stock-Based Compensation Expense and Average Remaining Vesting Period</a></td>
<td class="text">A summary of unrecognized stock<span class="nobreak">-based</span> compensation expense and average remaining vesting period is as follows:<table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1" rowspan="2" style="width: 42.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" rowspan="2" style="width: 2.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" colspan="4" style="width: 55.60%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="CharOverride-7" style="font-style:normal;font-weight:bold;">December&#160;31, 2023</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 24.63%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="CharOverride-7" style="font-style:normal;font-weight:bold;">Unrecognized <br/>Stock-Based <br/>Compensation</span></p>
					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 2.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" style="width: 28.73%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="CharOverride-7" style="font-style:normal;font-weight:bold;">Weighted-Average <br/>Remaining <br/>Vesting Period <br/>(Years)</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 42.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Employees and directors</p>
					</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 2.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 21.64%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">19,165</p>	</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 2.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 28.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">0.92</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Activity and Restricted Stock Unit</a></td>
<td class="text">A summary of activity is as follows:<table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-57" style="height:12pt;">
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="4" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 22.65%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">RSA</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="4" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 22.65%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">RSU</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="4" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 23.72%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">PRSU</span><span class="Bold-Superscript" style="font-style:normal;font-weight:bold;vertical-align:super;font-size:58%;">(1)</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-58" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Shares</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Weighted <br/>Average <br/>Grant Date <br/>Fair Value</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Shares</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Weighted <br/>Average <br/>Grant Date <br/>Fair Value</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Shares</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 11.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Weighted <br/>Average <br/>Grant Date <br/>Fair Value</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-59" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Unvested Balance at January&#160;1, 2021</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">3,580,743</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.38</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">39,408&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">4.46</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">341,312&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.17</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Granted</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">1,642,266</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.46</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">31,170&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.43</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_b" style="-sec-ix-hidden: hidden-fact-226; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">257,043</span><span class="Superscript" style="vertical-align:super;font-size:6pt;">(2)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">6.49</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Vested</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(1,897,699)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.78</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(15,136)&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">4.73</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-227; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-228; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Forfeited</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(288,405)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.11</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(452)&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.37</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(47,669)&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.74</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-59" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Unvested Balance at December&#160;31, 2021</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">3,036,905</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.20</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">54,990&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">4.93</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">550,686&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.73</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Granted</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">2,170,432</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.71</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">116,247&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.18</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="-sec-ix-hidden: hidden-fact-229; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">319,838</span><span class="Superscript" style="vertical-align:super;font-size:6pt;">(2)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">6.80</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Vested</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(1,621,201)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.31</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(27,894)&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.10</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(202,336)&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">6.24</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Forfeited</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(195,054)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.43</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(1,380)&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.73</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-230; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-231; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-59" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Unvested Balance at December&#160;31, 2022</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">3,391,082</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.46</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">141,963&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.09</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">668,188&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">6.09</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Granted</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">3,363,501</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.63</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">152,265&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">6.24</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_rb" style="-sec-ix-hidden: hidden-fact-232; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">576,240</span><span class="Superscript" style="vertical-align:super;font-size:6pt;">(2)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">6.49</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Vested</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(1,629,925)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.28</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(72,461)&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.66</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(108,113)&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">3.11</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Forfeited</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(114,436)</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.55</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">(34,385)&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.70</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-233; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;&#160;&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Stock dividends accrued</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#8212;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">2,762&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">6.24</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">37,777&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">&#160;</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">6.49</span></p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-59" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="CharOverride-8" style="font-size:9pt;">Unvested Balance at December&#160;31, 2023</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5,010,222</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.63</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="-sec-ix-hidden: hidden-fact-234; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"><span class="CharOverride-8" style="font-size:9pt;">190,144</span><span class="Superscript" style="vertical-align:super;font-size:6pt;">(</span><span class="CharOverride-5" style="font-size:6pt;vertical-align:super;">3</span><span class="Superscript" style="vertical-align:super;font-size:6pt;">)</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">5.70</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">1,174,092&#160;&#160;</span></p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">$</span></p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"><span class="CharOverride-8" style="font-size:9pt;">6.58</span></p>	</td>
				</tr>

		</table><p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>Represents the target number of PRSUs granted and outstanding. The number of PRSUs that ultimately vest ranges from 0% to 200% of this amount. During the years ended December 31, 2023, 2022 and 2021, 200%, 77% and 0%, respectively, of the target number of PRSUs granted ultimately vested, inclusive of accrued stock dividends.</p><p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:6pt;text-align:left;margin-top:6pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(2)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>A Monte Carlo simulation was used to value these awards using the following assumptions for the Company and the peer group: (i) beginning 90<span class="nobreak">-day</span> average stock prices; (ii) valuation date stock prices; (iii) correlation coefficients based upon the price data used to calculate the historical volatilities; and (iv) the following additional assumptions:</p><p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:6pt;margin-top:6pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(3)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>Includes 57,779 deferred RSUs that have vested.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share Based Payment Awards Other than Options Valuation Assumptions</a></td>
<td class="text">the following additional assumptions:<table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Granted in <br/>2023</span></p>
					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Granted in <br/>2022</span></p>
					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Granted in <br/>2021</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1 _idGenCellOverride-4" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Historical stock price volatility (low)</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">37%</p>	</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">33%</p>	</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">34%</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Historical stock price volatility (high)</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">56%</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">57%</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">57%</p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Historical stock price volatility (average)</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">47%</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">44%</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">44%</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Risk free interest rate</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">3.80%</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">1.28%</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">0.17%</p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Expected dividend yield</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">0.00%</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">0.00%</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">0.00%</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Unrecognized Stock Based Compensation Expenses And Average Remaining Vesting Period Table [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310105104256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Employee Benefit Plans [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock', window );">Summary of Discretionary Contributions</a></td>
<td class="text">A summary of discretionary contributions made by the Company is as follows:<table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;">


				<tr class="Table55-">
					<td class="Table55- TCH CellOverride-2" colspan="8" style="width: 100.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">

						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December 31,</span></p>
					</td>
				</tr>
				<tr class="Table55-" style="height:12pt;">
					<td class="Table55- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 30.26%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table55- TCH CellOverride-7" style="width: 3.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table55- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 30.26%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table55- TCH CellOverride-7" style="width: 3.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table55- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 33.33%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table55-" style="background: #CCEEFF;height:12pt;">
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 4.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table55- TB CellOverride-23 _idGenCellOverride-3" style="width: 26.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:6pt;">1,450</p>	</td>
					<td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 3.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 4.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 26.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,342</p>	</td>
					<td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 3.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 4.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 29.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,080</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 715<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480482/715-20-55-17<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310105319472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Reconciliation of Basic and Diluted Earnings Per Share</a></td>
<td class="text">The following tables set forth reconciliations of the basic and diluted earnings per share computations for the periods presented:<table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;">


				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table75- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December 31,</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1 _idGenCellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table75- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table75- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-15" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Basic Earnings per Share</span></p>
					</td>
					<td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-16" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-16" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-16" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-15 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Net income</p>
					</td>
					<td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">102,546</p>	</td>
					<td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">50,684</p>	</td>
					<td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">49,797</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Add: Gain on repurchase of Series&#160;C Preferred Stock</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">7,966</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-237; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-238; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Less: Income distributed to participating securities</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(2,770)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(2,186)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(2,168)</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Less: Undistributed income allocable to participating securities</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(12,680)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(3,528)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(3,378)</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net income available to common stockholders&#8212;Basic EPS</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">95,062</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">44,970</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">44,251</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-15" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Weighted average common shares (in<span class="nobreak"> </span>thousands)</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">144,707</p>	</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">143,020</p>	</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">143,847</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Basic earnings per share</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">0.66</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">0.31</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">0.31</p>	</td>
				</tr>

		</table><table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;">


				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TCH CellOverride-15" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Diluted Earnings per Share</span></p>
					</td>
					<td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-16" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-16" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TCH CellOverride-16" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-15 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Net income available to common stockholders</p>
					</td>
					<td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">95,062</p>	</td>
					<td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">44,970</p>	</td>
					<td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">44,251</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Add back: Undistributed income allocable to participating securities</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">12,680</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">3,528</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">3,378</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Less: Reallocation of undistributed income allocable to participating securities considered potentially dilutive</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(12,449)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(3,522)</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(3,353)</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Net income available to common stockholders&#8212;Diluted EPS</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">95,293</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">44,976</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">44,276</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-15" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"><span class="CharOverride-9" style="text-decoration:underline;">Weighted Average Diluted Shares (in thousands)</span>:</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Weighted average common shares</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">144,707</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">143,020</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">143,847</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Dilutive effect of common stock equivalents, excluding participating securities</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">3,120</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">275</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,208</p>	</td>
				</tr>
				<tr class="Table75-" style="height:12pt;">
					<td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Weighted average diluted shares, excluding participating securities (in thousands)</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">147,827</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">143,295</p>	</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">145,055</p>	</td>
				</tr>
				<tr class="Table75-" style="background: #CCEEFF;height:12pt;">
					<td class="Table75- TB CellOverride-15" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Diluted earnings per share</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">0.64</p>	</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">0.31</p>	</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table75- TB CellOverride-16" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">0.31</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Schedule of Weighted Average Number of Shares</a></td>
<td class="text">The following table reconciles weighted average diluted shares as reported on the Company&#8217;s Consolidated Statements of Operations for the&#160;years ended December&#160;31, 2023, 2022 and 2021, which are determined pursuant to the treasury stock method, to the weighted average diluted shares used to calculate diluted earnings per share as disclosed in the table above:<table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;">


				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" colspan="5" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 46.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December 31,</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="height:12pt;">
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"><span class="Bold" style="font-style:normal;font-weight:bold;">Reconciliation of Weighted Average Diluted Shares (in</span><span class="nobreak"> </span><span class="Bold" style="font-style:normal;font-weight:bold;">thousands)</span></p>
					</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Weighted average diluted shares as disclosed on the Consolidated Statements of Operations</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;">170,413</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;">158,914</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;">161,263</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Less: Participating securities:</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Weighted average shares of common stock issuable upon conversion of the Series&#160;A Preferred Stock (Note&#160;11)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(14,750)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(14,750)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(14,750)</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Weighted average shares of common stock issuable upon conversion of the Series&#160;C Preferred Stock (Note&#160;11)</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(6,992)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-239; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-240; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Potentially dilutive restricted stock awards</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(844)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(869)</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(1,458)</p>	</td>
				</tr>
				<tr class="No-Table-Style _idGenTableRowColumn-16" style="height:12pt;">
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Weighted average diluted shares used to calculate diluted earnings/(loss) per share as disclosed in the table above</p>
					</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">147,827</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">143,295</p>	</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">145,055</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310098696352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Domestic and Foreign Components of Income before Income Tax Expense</a></td>
<td class="text">The U.S.&#160;and foreign components of income before income tax expense for the&#160;years ended December&#160;31, 2023, 2022 and 2021 are as follows:<table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;">


				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Year Ended December 31,</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-12 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">U.S.</p>
					</td>
					<td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">4,652</p>	</td>
					<td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(4,067)</p>	</td>
					<td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">15,986</p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Foreign</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">114,356</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">44,017</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">40,685</p>	</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">119,008</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">39,950</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">56,671</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Current and Deferred Income Tax Expense</a></td>
<td class="text">The components of current and deferred income tax expense included in the Consolidated Statement of Operations for&#160;years ended December&#160;31, 2023, 2022 and 2021 are as follows:<table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;">


				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Current:</p>
					</td>
					<td class="Table70- TCH CellOverride-26" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-14" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-26" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-14" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-26" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-14" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-12 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">Federal</p>
					</td>
					<td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">6,957</p>	</td>
					<td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">4,685</p>	</td>
					<td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">5,857</p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">State and local</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,883</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,415</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,538</p>	</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">Foreign</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">8,103</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(15,538)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(837)</p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">16,943</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(9,438)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">6,558</p>	</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">Deferred:</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">Federal</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(494)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(6)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(1,217)</p>	</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">State and local</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(102)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(1)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(251)</p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">Foreign</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">115</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(1,289)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,784</p>	</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(481)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(1,296)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">316</p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">Income tax expense/(benefit)</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">16,462</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(10,734)</p>	</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">6,874</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation of Statutory Federal Income Tax Rate and Company's Effective Rate</a></td>
<td class="text">A reconciliation of the statutory federal income tax expense and the Company&#8217;s total income tax expense is as follows:<table class="Table90-" style="width: 90.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0.33in 0pt 0.33in;">


				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TCH CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table90- TCH CellOverride-5" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2" colspan="8" style="width: 51.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December 31,</span></p>
					</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TCH CellOverride-1 _idGenCellOverride-3" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-7" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 15.79%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table90- TCH CellOverride-7" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 15.79%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table90- TCH CellOverride-7" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 17.22%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">U.S.&#160;federal statutory income tax</p>
					</td>
					<td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">24,992</p>	</td>
					<td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">8,386</p>	</td>
					<td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">11,901</p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Gain on revaluation/termination of deferred consideration<span class="Superscript" style="vertical-align:super;font-size:58%;">(1)</span></p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(13,007)</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(5,842)</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(424)</p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Non-deductible loss on extinguishment of convertible notes</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">2,263</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Foreign operations</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(1,868)</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(2,919)</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(3,211)</p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Non-deductible executive compensation</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,833</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">789</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">881</p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Decrease in unrecognized tax benefits, net</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(1,386)</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(19,871)</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(4,998)</p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Change in valuation allowance&#160;&#8211;&#160;Capital losses</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,340</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">4,761</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">5</p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Expiration of capital losses</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">796</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Stock-based compensation tax shortfalls</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">373</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">507</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">647</p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Change in tax-related indemnification assets, net</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">291</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">4,173</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,053</p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Change in foreign net operating losses (&#8220;NOLs&#8221;)</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">174</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Blended state income tax rate, net of federal benefit</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">153</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(134)</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">526</p>	</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Change in valuation allowance&#8212;Foreign NOLs and interest carryforwards</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(1,609)</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">GILTI</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">499</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table90-" style="background: #CCEEFF;height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other differences, net</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">508</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">526</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">494</p>	</td>
				</tr>
				<tr class="Table90-" style="height:12pt;">
					<td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Income tax expense/(benefit)</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">16,462</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(10,734)</p>	</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">6,874</p>	</td>
				</tr>

		</table><p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>The gain on revaluation of deferred consideration is not adjusted for income taxes as the obligation was assumed by a wholly<span class="nobreak">-owned</span> subsidiary that is based in Jersey, a jurisdiction where the Company is subject to a zero percent tax rate.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock', window );">Schedule of Income Tax Payments By Jurisdiction</a></td>
<td class="text">A summary of income taxes paid by jurisdiction for the&#160;years ended December&#160;31, 2023, 2022 and 2021 is as follows:<table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December 31,</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table60- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table60- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-15 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Federal</p>
					</td>
					<td class="Table60- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">4,824</p>	</td>
					<td class="Table60- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">6,424</p>	</td>
					<td class="Table60- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-16 _idGenCellOverride-4" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-16 _idGenCellOverride-4" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;">4,258</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">State and local</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,457</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,431</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,020</p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Foreign</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">9,875</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">4,645</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">3,178</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">16,156</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">12,500</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">8,456</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Components of the Company&#8217;s Deferred Tax Assets</a></td>
<td class="text">A summary of the components of the Company&#8217;s deferred tax assets at December&#160;31, 2023 and 2022 is as follows:<table class="Table6in" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TCH CellOverride-1 _idGenCellOverride-2" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table6in TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.60%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table6in TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 19.20%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TCH CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deferred tax assets:</p>
					</td>
					<td class="Table6in TCH CellOverride-5" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TCH CellOverride-2" colspan="2" style="width: 17.60%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table6in TCH CellOverride-5" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TCH CellOverride-2" colspan="2" style="width: 19.20%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1 _idGenCellOverride-3" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Capital losses</p>
					</td>
					<td class="Table6in TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table6in TB CellOverride-2 _idGenCellOverride-3" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">22,489</p>	</td>
					<td class="Table6in TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table6in TB CellOverride-2 _idGenCellOverride-3" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">17,541</p>	</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Accrued expenses</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,000</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,030</p>	</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Stock-based compensation</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">2,468</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,526</p>	</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">NOLs&#8212;Foreign</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,502</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,609</p>	</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Goodwill and intangible assets</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">895</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,085</p>	</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Unrealized losses</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">335</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">3,821</p>	</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Foreign currency translation adjustment</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">146</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">173</p>	</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">NOLs&#8212;U.S.</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">127</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">255</p>	</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Operating lease liabilities</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">96</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">313</p>	</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Outside basis differences</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-241; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">122</p>	</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">401</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">341</p>	</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deferred tax assets</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">34,459</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">32,816</p>	</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-27" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-28" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-28" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-28" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-28" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-28" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-28" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deferred tax liabilities:</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Fixed assets and prepaid assets</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">296</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">278</p>	</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Unremitted earnings&#8212;European subsidiaries</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">186</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">205</p>	</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Right of use assets&#8212;operating leases</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">96</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">313</p>	</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deferred tax liabilities</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">578</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">796</p>	</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total deferred tax assets less deferred tax liabilities</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">33,881</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">32,020</p>	</td>
				</tr>
				<tr class="Table6in" style="height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Less: Valuation allowance</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(22,824)</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(21,484)</p>	</td>
				</tr>
				<tr class="Table6in" style="background: #CCEEFF;height:12pt;">
					<td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Deferred tax assets, net</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">11,057</p>	</td>
					<td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">10,536</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Changes in Balance of Gross Unrecognized Tax Benefits</a></td>
<td class="text">The table below sets forth the aggregate changes in the balance of these gross unrecognized tax benefits:<table class="Table80-" style="width: 80.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 15% 0pt 0.33in;">


				<tr class="Table80-" style="height:12pt;">
					<td class="Table80- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">


					</td>
					<td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Total</span></p>
					</td>
					<td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Unrecognized <br/>Tax Benefits</span></p>
					</td>
					<td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TCH CellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Interest and <br/>Penalties</span></p>
					</td>
				</tr>
				<tr class="Table80-" style="background: #CCEEFF;height:12pt;">
					<td class="Table80- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Balance at January&#160;1, 2022</p>
					</td>
					<td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">21,925</p>	</td>
					<td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">18,218</p>	</td>
					<td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">3,707</p>	</td>
				</tr>
				<tr class="Table80-" style="height:12pt;">
					<td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Decrease&#8212;Settlements<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)</span></p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(13,052)</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(11,865)</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(1,187)</p>	</td>
				</tr>
				<tr class="Table80-" style="background: #CCEEFF;height:12pt;">
					<td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Decrease&#8212;Lapse of statute of limitations<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)</span></p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(6,845)</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(4,825)</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(2,020)</p>	</td>
				</tr>
				<tr class="Table80-" style="height:12pt;">
					<td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Increases</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">26</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-242; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">26</p>	</td>
				</tr>
				<tr class="Table80-" style="background: #CCEEFF;height:12pt;">
					<td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Foreign currency translation<span class="Superscript" style="vertical-align:super;font-size:6pt;">(2)</span></p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(701)</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(571)</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(130)</p>	</td>
				</tr>
				<tr class="Table80-" style="height:12pt;">
					<td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Balance at December&#160;31, 2022</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,353</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">957</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">396</p>	</td>
				</tr>
				<tr class="Table80-" style="background: #CCEEFF;height:12pt;">
					<td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Decrease&#8212;Lapse of statute of limitations</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(1,353)</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(957)</p>	</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(396)</p>	</td>
				</tr>
				<tr class="Table80-" style="height:12pt;">
					<td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Balance at December&#160;31, 2023</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-243; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-244; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-245; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>

		</table><p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>In January 2022, an audit of ManJer&#8217;s tax returns (a Jersey<span class="nobreak">-based</span> subsidiary) for the years ended December&#160;31, 2014, 2016, 2017 and 2018 were resolved in favor of ManJer. The settlement, as well as the reduction in unrecognized tax benefits from the lapse of the statute of limitations totaling $19,897 during the year ended December 31, 2022 was recorded as an income tax benefit along with an equal and offsetting amount recorded in other losses and gains, net, to recognize a reduction in the indemnification asset.</p><p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:6pt;margin-top:6pt;"><span class="Superscript" style="vertical-align:super;font-size:6pt;"> (2)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>The gross unrecognized tax benefits were accrued in British pounds.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 9<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 12<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of income tax payments by jurisdiction [table text block].</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100584960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text">The table below sets forth goodwill which is tested annually for impairment on November&#160;30<span class="Superscript" style="vertical-align:super;font-size:58%;">th</span>:<table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 23.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Total</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Balance at January&#160;1, 2023</p>
					</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">85,856&#160;&#160;</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Changes</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"><span class="Superscript" style="vertical-align:super;font-size:6pt;">&#160;</span></p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="-sec-ix-hidden: hidden-fact-248; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">985<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Balance at December&#160;31, 2023</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">86,841&#160;&#160;</p>	</td>
				</tr>

		</table><p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;">&#8203;<span class="Superscript" style="vertical-align:super;font-size:6pt;">(1)<span style="width: 12px;display: inline-block;">&#160;&#160;&#160;&#160;&#160;</span></span>On April 11, 2023, the Company acquired 100% of the capital stock of Securrency Transfers, Inc. (renamed WisdomTree Transfers, Inc.) for an aggregate purchase price of $985 (net of cash acquired). The acquisition has been accounted for under the acquisition method of accounting in accordance with ASC Topic 805, Business Combinations, and resulted in all consideration being allocated to goodwill.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Intangible Assets</a></td>
<td class="text">The table below sets forth the Company&#8217;s intangible assets which are tested annually for impairment on November&#160;30<span class="Superscript" style="vertical-align:super;font-size:58%;">th</span>:<table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Balance at December&#160;31, 2023</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-left:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Item</span></p>
					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Gross Asset</span></p>
					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Accumulated <br/>Amortization</span></p>
					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Net Asset</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ETFS acquisition</p>
					</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">601,247</p>	</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-249; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">601,247</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Software development</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">4,519</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(684)</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">3,835</p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Balance at December&#160;31, 2023</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">605,766</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(684)</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">605,082</p>	</td>
				</tr>

		</table><table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Balance at December&#160;31, 2022</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Item</span></p>
					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Gross Asset</span></p>
					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Accumulated <br/>Amortization</span></p>
					</td>
					<td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TCH CellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Net Asset</span></p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">ETFS acquisition</p>
					</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">601,247</p>	</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-250; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">601,247</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Software development</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">2,370</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;">(50)</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">2,320</p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Balance at December&#160;31, 2022</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">603,617</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;">(50)</p>	</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">603,567</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Expected Amortization Expense</a></td>
<td class="text">As of December&#160;31, 2023, expected amortization expense for the unamortized finite<span class="nobreak">-lived</span> intangible assets for the next <span style="-sec-ix-hidden: hidden-fact-253">five</span>&#160;years and thereafter is as follows:<table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;">


				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2024</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">1,375</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2025</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">1,440</p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2026</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">873</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2027</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">130</p>	</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2028</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">17</p>	</td>
				</tr>
				<tr class="Table60-" style="height:12pt;">
					<td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">2029 and thereafter</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-251; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table60-" style="background: #CCEEFF;height:12pt;">
					<td class="Table60- TB CellOverride-15" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;">Total expected amortization expense</p>
					</td>
					<td class="Table60- TB CellOverride-16" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table60- TB CellOverride-16" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table60- TB CellOverride-16" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">3,835</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310105294672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Impairments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentChargesAbstract', window );"><strong>Impairments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock', window );">Schedule of Summarizes Impairments Recognized</a></td>
<td class="text">The following table summarizes impairments recognized by the Company:<table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;">


				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">

					</td>
					<td class="Table70- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">Years Ended December&#160;31,</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TCH CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2023</span></p>
					</td>
					<td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2022</span></p>
					</td>
					<td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom">
						<p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"><span class="Bold" style="font-style:normal;font-weight:bold;">2021</span></p>
					</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Lease termination&#8211;New&#160;York office (Note&#160;13)</p>
					</td>
					<td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-255; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-256; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">9,277</p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Fixed assets&#8211;New&#160;York office (Note&#160;8)</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-257; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-258; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">6,576</p>	</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Lease termination&#8211;London office (Note&#160;13)</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-259; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-260; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">303</p>	</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Securrency (Note&#160;7)</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">	<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">7,630</p>	</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-261; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">
						<p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-262; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table70-" style="background: #CCEEFF;height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Other investments (Note&#160;7)</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">	<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">312</p>	</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-263; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#160;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom">
						<p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-264; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
				</tr>
				<tr class="Table70-" style="height:12pt;">
					<td class="Table70- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom">
						<p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;">Total</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">7,942</p>	</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-265; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">&#8212;</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom">&#160;</td>
					<td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">
						<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;">$</p>
					</td>
					<td class="Table70- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom">	<p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;">16,156</p>	</td>
				</tr>

		</table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for impairment of long-lived assets held and used by an entity which includes a description of the impaired long-lived asset and facts and circumstances leading to the impairment, aggregate amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired long-lived asset is reported.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310101640928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_PercentageOfTaxRateRealizedOnSettlement', window );">Benefit percentage of tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">$ 616<span></span>
</td>
<td class="nump">$ 95,741<span></span>
</td>
<td class="nump">$ 13,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Increasing carrying value of convertible notes</a></td>
<td class="nump">4,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther', window );">Additional paid-in capital</a></td>
<td class="nump">3,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">$ 1,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,242<span></span>
</td>
<td class="nump">$ 14,935<span></span>
</td>
<td class="nump">$ 12,332<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=wt_ImplementationOfASU202006Member', window );">Accounting Standards Update 2020-06 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,680<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in additional paid in capital (APIC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147477123/405-50-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482477/820-10-65-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482477/820-10-65-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483482/832-10-65-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483482/832-10-65-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480530/250-10-S99-5<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483194/926-20-65-2<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483194/926-20-65-2<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483194/926-20-65-2<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 69: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 70: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 71: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 72: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 73: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 74: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-6<br><br>Reference 75: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 76: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 77: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 78: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 79: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 80: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 81: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 82: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 83: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 84: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 85: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 86: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 87: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 88: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 89: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 90: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481925/310-20-65-2<br><br>Reference 91: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481925/310-20-65-2<br><br>Reference 92: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_PercentageOfTaxRateRealizedOnSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_PercentageOfTaxRateRealizedOnSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=wt_ImplementationOfASU202006Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=wt_ImplementationOfASU202006Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310098553536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies (Details) - Schedule of Depreciation and Amortization<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Depreciation and Amortization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Depreciation and Amortization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Software Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Schedule of Depreciation and Amortization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310101424592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash and Cash Equivalents (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsLineItems', window );"><strong>Cash and Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Total cash and cash equivalents</a></td>
<td class="nump">$ 129,305<span></span>
</td>
<td class="nump">$ 132,101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents, at carrying value</a></td>
<td class="nump">50,226<span></span>
</td>
<td class="nump">930<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=wt_EuropeanBusinessSegmentMember', window );">European Business Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsLineItems', window );"><strong>Cash and Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements', window );">Net liquid assets international subsidiary regulatory capital requirements</a></td>
<td class="nump">29,156<span></span>
</td>
<td class="nump">25,988<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=wt_TwoFinancialInstitutionsMember', window );">Two Financial Institutions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsLineItems', window );"><strong>Cash and Cash Equivalents [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Total cash and cash equivalents</a></td>
<td class="nump">$ 116,895<span></span>
</td>
<td class="nump">$ 131,104<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum regulatory net liquid asset requirement for certain of the Company's international subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=wt_EuropeanBusinessSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=wt_EuropeanBusinessSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=wt_TwoFinancialInstitutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=wt_TwoFinancialInstitutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100504992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Measurements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_CashEquivalentsMaturityPeriod', window );">Liquid investments, original maturities</a></td>
<td class="text">90 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_CashEquivalentsMaturityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash equivalents maturity period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_CashEquivalentsMaturityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310092134928">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - Schedule of Assets and Liabilities Measured at Fair Value - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_RecurringFairValueMeasurementsAbstract', window );"><strong>Recurring fair value measurements:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 50,226<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 930<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments in Convertible Notes</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">108,948<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">148,590<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_RecurringFairValueMeasurementsAbstract1', window );"><strong>Recurring fair value measurements:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_BusinessCombinationDeferredConsiderationLiability', window );">Deferred consideration (Note 9)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">200,290<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Securrency, Inc.&#8212;convertible note [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments in Convertible Notes</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments in Convertible Notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | ETFs [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">35,181<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,772<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Pass-through GSEs [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,240<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">96,837<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | U.S. treasuries [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,980<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Corporate bonds [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">885<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | WisdomTree Digital Funds [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,765<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Level 1 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_RecurringFairValueMeasurementsAbstract', window );"><strong>Recurring fair value measurements:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">50,226<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">930<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments in Convertible Notes</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">92,752<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">50,972<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_RecurringFairValueMeasurementsAbstract1', window );"><strong>Recurring fair value measurements:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_BusinessCombinationDeferredConsiderationLiability', window );">Deferred consideration (Note 9)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Level 1 [Member] | Securrency, Inc.&#8212;convertible note [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments in Convertible Notes</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments in Convertible Notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Level 1 [Member] | ETFs [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">35,181<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,772<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Level 1 [Member] | Pass-through GSEs [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,290<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Level 1 [Member] | U.S. treasuries [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,980<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Level 1 [Member] | Corporate bonds [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Level 1 [Member] | WisdomTree Digital Funds [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Level 2 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_RecurringFairValueMeasurementsAbstract', window );"><strong>Recurring fair value measurements:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments in Convertible Notes</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,196<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">76,197<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_RecurringFairValueMeasurementsAbstract1', window );"><strong>Recurring fair value measurements:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_BusinessCombinationDeferredConsiderationLiability', window );">Deferred consideration (Note 9)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Level 2 [Member] | Securrency, Inc.&#8212;convertible note [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments in Convertible Notes</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments in Convertible Notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Level 2 [Member] | ETFs [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Level 2 [Member] | Pass-through GSEs [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,240<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">73,547<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Level 2 [Member] | U.S. treasuries [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Level 2 [Member] | Corporate bonds [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">885<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Level 2 [Member] | WisdomTree Digital Funds [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,765<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Level 3 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_RecurringFairValueMeasurementsAbstract', window );"><strong>Recurring fair value measurements:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments in Convertible Notes</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">21,421<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_RecurringFairValueMeasurementsAbstract1', window );"><strong>Recurring fair value measurements:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_BusinessCombinationDeferredConsiderationLiability', window );">Deferred consideration (Note 9)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">200,290<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Level 3 [Member] | Securrency, Inc.&#8212;convertible note [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments in Convertible Notes</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments in Convertible Notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Level 3 [Member] | ETFs [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Level 3 [Member] | Pass-through GSEs [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Level 3 [Member] | U.S. treasuries [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Level 3 [Member] | Corporate bonds [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Level 3 [Member] | WisdomTree Digital Funds [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Fnality International Limited&#8212;convertible note [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments in Convertible Notes</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments in Convertible Notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,921<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Fnality International Limited&#8212;convertible note [Member] | Level 1 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments in Convertible Notes</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments in Convertible Notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Fnality International Limited&#8212;convertible note [Member] | Level 2 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments in Convertible Notes</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments in Convertible Notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Fnality International Limited&#8212;convertible note [Member] | Level 3 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments in Convertible Notes</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments in Convertible Notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,921<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Nonrecurring [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments in Convertible Notes</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,684<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Nonrecurring [Member] | Fnality International Limited&#8212;B-1 Preference Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_NonRecurringFairValueMeasurementsAbstract', window );"><strong>Non-recurring fair value measurements:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Non-recurring fair value measurements</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">9,684<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Nonrecurring [Member] | Other Investments [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_NonRecurringFairValueMeasurementsAbstract', window );"><strong>Non-recurring fair value measurements:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Non-recurring fair value measurements</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">312<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Nonrecurring [Member] | Level 1 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments in Convertible Notes</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Nonrecurring [Member] | Level 1 [Member] | Fnality International Limited&#8212;B-1 Preference Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_NonRecurringFairValueMeasurementsAbstract', window );"><strong>Non-recurring fair value measurements:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Non-recurring fair value measurements</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Nonrecurring [Member] | Level 1 [Member] | Other Investments [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_NonRecurringFairValueMeasurementsAbstract', window );"><strong>Non-recurring fair value measurements:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Non-recurring fair value measurements</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Nonrecurring [Member] | Level 2 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments in Convertible Notes</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Nonrecurring [Member] | Level 2 [Member] | Fnality International Limited&#8212;B-1 Preference Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_NonRecurringFairValueMeasurementsAbstract', window );"><strong>Non-recurring fair value measurements:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Non-recurring fair value measurements</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Nonrecurring [Member] | Level 2 [Member] | Other Investments [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_NonRecurringFairValueMeasurementsAbstract', window );"><strong>Non-recurring fair value measurements:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Non-recurring fair value measurements</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Nonrecurring [Member] | Level 3 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments in Convertible Notes</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,684<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Nonrecurring [Member] | Level 3 [Member] | Fnality International Limited&#8212;B-1 Preference Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_NonRecurringFairValueMeasurementsAbstract', window );"><strong>Non-recurring fair value measurements:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Non-recurring fair value measurements</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">9,684<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Fair Value, Nonrecurring [Member] | Level 3 [Member] | Other Investments [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_NonRecurringFairValueMeasurementsAbstract', window );"><strong>Non-recurring fair value measurements:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Non-recurring fair value measurements</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 312<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasuries [Member] | Fair Value, Recurring [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,007<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasuries [Member] | Fair Value, Recurring [Member] | Level 2 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,007<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasuries [Member] | Fair Value, Recurring [Member] | Level 3 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember', window );">Equities [Member] | Fair Value, Recurring [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,337<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember', window );">Equities [Member] | Fair Value, Recurring [Member] | Level 1 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,337<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember', window );">Equities [Member] | Fair Value, Recurring [Member] | Level 2 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember', window );">Equities [Member] | Fair Value, Recurring [Member] | Level 3 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_FixedIncomeInvestmentsMember', window );">Fixed income [Member] | Fair Value, Recurring [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,957<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_FixedIncomeInvestmentsMember', window );">Fixed income [Member] | Fair Value, Recurring [Member] | Level 1 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,008<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_FixedIncomeInvestmentsMember', window );">Fixed income [Member] | Fair Value, Recurring [Member] | Level 2 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">949<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_FixedIncomeInvestmentsMember', window );">Fixed income [Member] | Fair Value, Recurring [Member] | Level 3 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0', window );"><strong>Financial instruments owned, at fair value:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned', window );">Financial instruments owned, at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Fair value determined on October 31, 2023</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Fair value determined on September 30, 2023</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Fair value determined on May 10, 2022</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in security owned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instruments held by a broker-dealer for their own account (proprietary securities) for trading or investment purposes determined by management based upon quoted prices of a financial instrument with similar characteristics or on a valuation technique or model.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481961/940-320-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_BusinessCombinationDeferredConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability arising from deferred consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_BusinessCombinationDeferredConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_FinancialInstrumentsOwnedAtFairValueAbstract0">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_FinancialInstrumentsOwnedAtFairValueAbstract0</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_NonRecurringFairValueMeasurementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_NonRecurringFairValueMeasurementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_RecurringFairValueMeasurementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_RecurringFairValueMeasurementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_RecurringFairValueMeasurementsAbstract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_RecurringFairValueMeasurementsAbstract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=wt_SecurrencyConvertibleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=wt_SecurrencyConvertibleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis=us-gaap_ExchangeTradedFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis=us-gaap_ExchangeTradedFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis=wt_FederalAgencyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis=wt_FederalAgencyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis=us-gaap_AllOtherCorporateBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis=us-gaap_AllOtherCorporateBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis=wt_OtherAssetsseedCapitalWisdomtreeDigitalFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis=wt_OtherAssetsseedCapitalWisdomtreeDigitalFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=wt_FnalityConvertibleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=wt_FnalityConvertibleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=wt_FnalityInternationalLimitedBOnePreferenceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=wt_FnalityInternationalLimitedBOnePreferenceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_FixedIncomeInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_FixedIncomeInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310098412880">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - Schedule of Beginning and Ending Balances of Recurring Fair Value Measurements Classified - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments in Convertible Notes (Note 7):</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 21,421<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Purchases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,228<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">21,863<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales', window );">Settlements</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(28,818)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions', window );">Conversions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(9,684)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome', window );">Net realized gains/(losses)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">5,853<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(442)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">21,421<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=wt_DeferredConsiderationObligationMember', window );">Deferred Consideration Obligation [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments in Convertible Notes (Note 7):</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">200,290<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">228,062<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales', window );">Settlements</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(144,406)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(17,115)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome', window );">Net realized gains/(losses)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">6,069<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings', window );">Net unrealized gains</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">(61,953)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(27,765)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 200,290<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The Fnality convertible notes converted into Series B<span class="nobreak">-1</span> Preference Shares on October 31, 2023 (Note 7)</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Recorded in impairments and other losses, net in the Consolidated Statements of Operations.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Recorded as contractual gold payments expense in the Consolidated Statements of Operations.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Recorded as gain on revaluation/termination of deferred consideration&#8212;gold payments in the Consolidated Statements of Operations.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sales of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fair value measurement with unobservable inputs reconciliation recurring basis liability conversions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value measurement with unobservable inputs reconciliation recurring basis liability net unrealized gain loss included in earnings and other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Realized Gain Loss Included In Earnings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=wt_DeferredConsiderationObligationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=wt_DeferredConsiderationObligationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100129696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments Owned (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralLineItems', window );"><strong>Financial Instruments Owned [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingGainsLosses', window );">Net trading losses</a></td>
<td class="nump">$ 536<span></span>
</td>
<td class="nump">$ 12,721<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481444/860-30-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) resulting from the difference between the acquisition price and the selling price or fair value of trading assets and trading liabilities, conducted separately from customer trading activities. Includes, but is not limited to, changes in fair value of trading assets and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4F<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481961/940-320-45-5<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481992/940-320-35-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.13(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310099213472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments Owned (Details) - Schedule of Financial Instruments Owned - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAbstract', window );"><strong>Financial instruments owned:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsOwnedAtFairValue', window );">Financial instruments owned</a></td>
<td class="nump">$ 58,722<span></span>
</td>
<td class="nump">$ 126,239<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=wt_TradingSecuritiesMember', window );">Trading Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAbstract', window );"><strong>Financial instruments owned:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsOwnedAtFairValue', window );">Financial instruments owned</a></td>
<td class="nump">45,421<span></span>
</td>
<td class="nump">124,474<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=wt_OtherAssetsseedCapitalWisdomTreeDigitalFundsMember', window );">Other assets&#8212;seed capital (WisdomTree Digital Funds) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FinancialInstrumentsOwnedAbstract', window );"><strong>Financial instruments owned:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsOwnedAtFairValue', window );">Financial instruments owned</a></td>
<td class="nump">$ 13,301<span></span>
</td>
<td class="nump">$ 1,765<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsOwnedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value as of the balance sheet date of financial instruments and other positions owned by the entity including: (1) mortgages, mortgage-backed and asset backed securities; (2) US government and agency obligations; (3) state and municipal government obligations; (4) other sovereign government debt; (5) corporate obligations; (6) corporate equities; (7) principal investments; (8) derivative contracts; and (9) physical commodities. Includes both pledged and unpledged holdings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481961/940-320-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsOwnedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_FinancialInstrumentsOwnedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_FinancialInstrumentsOwnedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=wt_TradingSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=wt_TradingSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=wt_OtherAssetsseedCapitalWisdomTreeDigitalFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=wt_OtherAssetsseedCapitalWisdomTreeDigitalFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310099961504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Securities Held-to-Maturity (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Securities Held-to-Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities', window );">Proceeds received</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100298752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Securities Held-to-Maturity (Details) - Schedule of Securities Held-to-Maturity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=wt_FederalAgencyMember', window );">Federal Agency [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-Sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt instruments: Pass-through GSEs (amortized cost)</a></td>
<td class="nump">$ 230<span></span>
</td>
<td class="nump">$ 259<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=wt_FederalAgencyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=wt_FederalAgencyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310101426224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Securities Held-to-Maturity (Details) - Schedule of Unrealized Losses, Gains and Fair Value of Securities Held-to-Maturity - Level 2 [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityLineItems', window );"><strong>Securities Held-to-Maturity (Details) - Schedule of Unrealized Losses, Gains and Fair Value of Securities Held-to-Maturity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Cost/amortized cost</a></td>
<td class="nump">$ 230<span></span>
</td>
<td class="nump">$ 259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss', window );">Gross unrealized gains</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Fair value</a></td>
<td class="nump">$ 215<span></span>
</td>
<td class="nump">$ 239<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310101700752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Securities Held-to-Maturity (Details) - Schedule of Maturity Profile of the Securities Held-to-Maturity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAbstract', window );"><strong>Schedule of Maturity Profile of the Securities Held to Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount', window );">Due within one year</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount', window );">Due one year through five years</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount', window );">Due five years through ten years</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount', window );">Due over ten years</a></td>
<td class="nump">208<span></span>
</td>
<td class="nump">232<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss', window );">Total</a></td>
<td class="nump">$ 230<span></span>
</td>
<td class="nump">$ 259<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310089076160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Details)<br> &#8364; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 07, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;) </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 20, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 28, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 28, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments', window );">Proceeds received (in Dollars)</a></td>
<td class="nump">$ 28,818<span></span>
</td>
<td class="nump">$ 28,818<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Net impairment charge (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForOtherLosses', window );">Additional losses (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Preferred stock investment (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleSharesIssuable', window );">Convertible preferred stock (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,087,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Dividend payable, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainOrLossOnSaleOfStockInSubsidiary', window );">Gain on shares (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Convertible notes (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ConvertibleNoteDiscountRate', window );">Conversion price discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Recognized gain (loss) (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (517)<span></span>
</td>
<td class="num">$ (16,516)<span></span>
</td>
<td class="num">(3,715)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Ownership interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_CostMethodInvestmentFairValueDisclosure', window );">Investment of fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (8,091)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (6,863)<span></span>
</td>
<td class="nump">&#8364; 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Recognized gain of investment (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,294<span></span>
</td>
<td class="num">(107)<span></span>
</td>
<td class="num">$ (451)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_CostMethodInvestmentOwnershipPercentage', window );">Ownership interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_PercentageOfDiscountOnFutureEquityFinancingForPreferredStock', window );">Percentage of discount on future equity financing for preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_PercentageOfOutstandingConvertibleNotes', window );">Percentage of outstanding convertible note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity', window );">Percentage of voting approval required to redeem all of the outstanding notes at maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity', window );">Percentage of voting approval required to redeem all of the outstanding notes before maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInvestments', window );">Other investment (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=wt_FnalityInternationalLimitedMember', window );">Fnality International Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Recognized gain (loss) (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_CapitalStockPercentage', window );">Capital stock, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_CapitalStockPercentage', window );">Capital stock, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=wt_ConvertiblePromissoryNoteMember', window );">Convertible Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentRate', window );">Percentage of convertible promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Convertible debt, maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr. 21,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Recognized gain (loss) (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember', window );">Series A convertible preferred stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleSharesIssuable', window );">Convertible preferred stock (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,004,665<span></span>
</td>
<td class="nump">5,178,488<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_SharesPercentage', window );">Shares percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_SharesPercentage', window );">Shares percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_FnalityInternationalLimitedMember', window );">Fnality International Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Ownership interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOwnershipInterestsUnitsIssued', window );">Ownership interest shares (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,340,378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,340,378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Recognized gain of investment (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Dividend or interest rate associated with the financial instrument issued in exchange for the original debt being converted in a noncash or part noncash transaction. Noncash are transactions that affect recognized assets or liabilities but that do not result in cash receipts or cash payments. Part noncash refers to that portion of the transaction not resulting in cash receipts or cash payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainOrLossOnSaleOfStockInSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(g))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainOrLossOnSaleOfStockInSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(h))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOwnershipInterestsUnitsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of units of other ownership interests issued in a limited partnership or master limited partnership. Does not include limited or general partners' ownership interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB TOPIC 4.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOwnershipInterestsUnitsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleSharesIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common shares issuable upon conversion of preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleSharesIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-12A(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForOtherLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to other loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForOtherLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column B)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B)(Footnote 10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-5A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_CapitalStockPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital stock percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_CapitalStockPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ConvertibleNoteDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Convertible notes discount rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ConvertibleNoteDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_CostMethodInvestmentFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost method investment fair value disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_CostMethodInvestmentFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_CostMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost method investment ownership percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_CostMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_PercentageOfDiscountOnFutureEquityFinancingForPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of Discount on future equity financing for preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_PercentageOfDiscountOnFutureEquityFinancingForPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_PercentageOfOutstandingConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of outstanding convertible note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_PercentageOfOutstandingConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting approval required to redeem all of the outstanding notes at maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting approval required to redeem all of the outstanding notes before maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_SharesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_SharesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=wt_FnalityInternationalLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=wt_FnalityInternationalLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wt_ConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wt_ConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_FnalityInternationalLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_FnalityInternationalLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310095148544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments (Details) - Schedule of Investments - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_SecurrencyIncAbstract', window );"><strong>Securrency, Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Carrying value of investment</a></td>
<td class="nump">$ 9,684<span></span>
</td>
<td class="nump">$ 35,721<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Cost of investment</a></td>
<td class="nump">8,341<span></span>
</td>
<td class="nump">35,725<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=wt_SecurrencyseriesaconvertiblepreferredstockMember', window );">Securrency, Inc. Series A convertible preferred stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_SecurrencyIncAbstract', window );"><strong>Securrency, Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Carrying value of investment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">8,488<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Cost of investment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">8,112<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=wt_SecurrencyseriesbconvertiblepreferredstockMember', window );">Securrency, Inc. Series B convertible preferred stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_SecurrencyIncAbstract', window );"><strong>Securrency, Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Carrying value of investment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">5,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Cost of investment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">5,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=wt_SecurrencyConvertibleNoteMember', window );">Securrency Convertible Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_SecurrencyIncAbstract', window );"><strong>Securrency, Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Carrying value of investment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">14,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Cost of investment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">15,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=wt_SecurrencyIncSubTotalMember', window );">Securrency Inc Sub Total [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_SecurrencyIncAbstract', window );"><strong>Securrency, Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Carrying value of investment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">28,488<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Cost of investment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">28,612<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=wt_ConvertibleNoteMember', window );">Convertible note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_SecurrencyIncAbstract', window );"><strong>Securrency, Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Carrying value of investment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">6,921<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Cost of investment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">6,863<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=wt_B1ConvertiblePreferenceSharesMember', window );">B-1 convertible preference shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_SecurrencyIncAbstract', window );"><strong>Securrency, Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Carrying value of investment</a></td>
<td class="nump">9,684<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Cost of investment</a></td>
<td class="nump">8,091<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=wt_SubtotalFnalityInternationalLimitedMember', window );">Subtotal&#8212;Fnality International Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_SecurrencyIncAbstract', window );"><strong>Securrency, Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Carrying value of investment</a></td>
<td class="nump">9,684<span></span>
</td>
<td class="nump">6,921<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Cost of investment</a></td>
<td class="nump">8,091<span></span>
</td>
<td class="nump">6,863<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember', window );">Other Investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_SecurrencyIncAbstract', window );"><strong>Securrency, Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Carrying value of investment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtCost', window );">Cost of investment</a></td>
<td class="nump">$ 250<span></span>
</td>
<td class="nump">$ 250<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of the investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_SecurrencyIncAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_SecurrencyIncAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=wt_SecurrencyseriesaconvertiblepreferredstockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=wt_SecurrencyseriesaconvertiblepreferredstockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=wt_SecurrencyseriesbconvertiblepreferredstockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=wt_SecurrencyseriesbconvertiblepreferredstockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=wt_SecurrencyConvertibleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=wt_SecurrencyConvertibleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=wt_SecurrencyIncSubTotalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=wt_SecurrencyIncSubTotalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=wt_ConvertibleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=wt_ConvertibleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=wt_B1ConvertiblePreferenceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=wt_B1ConvertiblePreferenceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=wt_SubtotalFnalityInternationalLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=wt_SubtotalFnalityInternationalLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310098463664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Details) - Schedule of Backsolve Valuation Approach<br></strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Jun. 09, 2021</div></th>
<th class="th"><div>Mar. 08, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ScheduleOfBacksolveValuationApproachAbstract', window );"><strong>Schedule Of Backsolve Valuation Approach Abstract</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Time to exit (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">4 years 9 months<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ProbabilityThatSeriesB2PreferenceSharesCovertIntoSeriesB1PreferenceShares', window );">Probability that Series B-2 Preference Shares convert into Series B-1 Preference Shares</a></td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ProbabilityThatSeriesB2PreferenceSharesCovertIntoSeriesB1PreferenceShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Probability that series B-2 preference shares covert into series B-1 preference shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ProbabilityThatSeriesB2PreferenceSharesCovertIntoSeriesB1PreferenceShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ScheduleOfBacksolveValuationApproachAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ScheduleOfBacksolveValuationApproachAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310106172912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Details) - Schedule of Presents the Probability Ascribed to Potential Outcomes Used in the Pwerm - Fair Value, Inputs, Level 3 [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ConversionOfNotesUponAFutureEquityFinancing', window );">Conversion of note upon a future equity financing</a></td>
<td class="nump">60.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_RedemptionOfNoteUponACorporateTransaction', window );">Redemption of note upon a corporate transaction</a></td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_FairValueAssumptionOfDissolutionRate', window );">Default</a></td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_TimeToPotentialOutcomeinYear', window );">Time to potential outcome (in years)</a></td>
<td class="text">3 months 29 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ConversionOfNoteUponAFutureFinancingRound', window );">Conversion of note upon a future financing round</a></td>
<td class="nump">85.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_RedemptionOfNoteUponAChangeOfControl', window );">Redemption of note upon a change of control</a></td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_Default', window );">Default</a></td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_TimeToPotentialOutcomesinYears', window );">Time to potential outcome (in years)</a></td>
<td class="text">3 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph a<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 5<br> -Subsection 04<br> -Paragraph c<br> -Subparagraph Schedule I<br> -Publisher SEC<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 7<br> -Subsection 05<br> -Paragraph c<br> -Subparagraph Schedule II<br> -Publisher SEC<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 9<br> -Subsection 06<br> -Publisher SEC<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ConversionOfNoteUponAFutureFinancingRound">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of conversion of note upon a future financing round.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ConversionOfNoteUponAFutureFinancingRound</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ConversionOfNotesUponAFutureEquityFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of conversion of note upon a future equity financing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ConversionOfNotesUponAFutureEquityFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_Default">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of default.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_Default</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_FairValueAssumptionOfDissolutionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value assumption of dissolution rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_FairValueAssumptionOfDissolutionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_RedemptionOfNoteUponAChangeOfControl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of redemption of note upon a change of control.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_RedemptionOfNoteUponAChangeOfControl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_RedemptionOfNoteUponACorporateTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of redemption of note upon a corporate transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_RedemptionOfNoteUponACorporateTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_TimeToPotentialOutcomeinYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Time to potential outcome.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_TimeToPotentialOutcomeinYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_TimeToPotentialOutcomesinYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Time to potential outcome.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_TimeToPotentialOutcomesinYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310097662416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fixed Assets, Net (Details) - Schedule of Fixed Assets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">$ (670)<span></span>
</td>
<td class="num">$ (418)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total</a></td>
<td class="nump">427<span></span>
</td>
<td class="nump">544<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Equipment</a></td>
<td class="nump">$ 1,097<span></span>
</td>
<td class="nump">$ 962<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310098238416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Consideration&#8212;gold payments (Details)<br> g in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 20, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>May 10, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>oz </div>
<div>g </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 15, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>g</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Deferred Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceOtherMeasure', window );">Deferred consideration | g</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,290<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,955<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of stock shares converted (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,087,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DeferredConsiderationCurrent', window );">Deferred consideration current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,796<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DeferredConsiderationNoncurrent', window );">Deferred consideration noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 183,494<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=wt_SeriesCRedeemableConvertiblePreferredStockMember', window );">Series C Redeemable Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Deferred Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock shares issued (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,087<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of stock shares converted (in Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,087,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=wt_SeriesCRedeemableConvertiblePreferredStockMember', window );">Series C Redeemable Convertible Preferred Stock [Member] | Gold Bullion Holdings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Deferred Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=wt_SeriesCRedeemableConvertiblePreferredStockMember', window );">Series C Redeemable Convertible Preferred Stock [Member] | Rodber Investments Limited [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Deferred Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_AgreementAxis=wt_SpaAgreementMember', window );">SPA Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Deferred Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration', window );">Aggregate consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 136,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=wt_ETFSCapitalMember', window );">ETFS Capital [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Deferred Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceOtherMeasure', window );">Deferred consideration | oz</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=wt_ContractualGoldPaymentsMember', window );">Contractual gold payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Deferred Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceOtherMeasure', window );">Deferred consideration | oz</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=wt_FirstInstallmentsMember', window );">First Installments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Deferred Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate consideration</a></td>
<td class="nump">$ 84,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=wt_SecondInstallmentsMember', window );">Second Installments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Deferred Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate consideration</a></td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=wt_ThirdInstallmentsMember', window );">Third Installments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Deferred Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate consideration</a></td>
<td class="nump">$ 44,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=wt_GoldBullionHoldingsJerseyLimitedMember', window );">Gold Bullion Holdings (Jersey) Limited [Member] | Series C Redeemable Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Deferred Consideration [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchased shares (in Shares) | shares</a></td>
<td class="nump">13,087<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contingent consideration recognized as part of consideration transferred in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedBalanceOtherMeasure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Quantity of the investment. Indicate the measure in the unit of measure. This is commonly used for investments other than securities. For example, if the investment is gold, the balance would be the number of ounces and the unit of measure would indicate "ounces".</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5D<br> -Subparagraph (SX 210.12-13D(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedBalanceOtherMeasure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:massItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_DeferredConsiderationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Consideration Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_DeferredConsiderationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_DeferredConsiderationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred consideration - noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_DeferredConsiderationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=wt_SeriesCRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=wt_SeriesCRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=wt_GoldBullionHoldingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=wt_GoldBullionHoldingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=wt_RodberInvestmentsLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=wt_RodberInvestmentsLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_AgreementAxis=wt_SpaAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_AgreementAxis=wt_SpaAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=wt_ETFSCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=wt_ETFSCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=wt_ContractualGoldPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=wt_ContractualGoldPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=wt_FirstInstallmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=wt_FirstInstallmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=wt_SecondInstallmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=wt_SecondInstallmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=wt_ThirdInstallmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=wt_ThirdInstallmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=wt_GoldBullionHoldingsJerseyLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=wt_GoldBullionHoldingsJerseyLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310098284304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Consideration&#8212;gold payments (Details) - Schedule of Valuation of Deferred Consideration<br> oz in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>oz</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DisclosureOfValuationOfDeferredConsiderationLineItems', window );"><strong>Disclosure Of Valuation Of Deferred Consideration [Line Item]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_BusinessCombinationConsiderationTransferredDeferredPaymentInterest', window );">Discount rate</a></td>
<td class="nump">11.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DeferredConsiderationPerpetualGrowthRate', window );">Perpetual growth rate</a></td>
<td class="nump">1.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DisclosureOfValuationOfDeferredConsiderationLineItems', window );"><strong>Disclosure Of Valuation Of Deferred Consideration [Line Item]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ForwardsLookingGoldPrice', window );">Forward Looking Gold Price</a></td>
<td class="nump">1,858<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DisclosureOfValuationOfDeferredConsiderationLineItems', window );"><strong>Disclosure Of Valuation Of Deferred Consideration [Line Item]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ForwardsLookingGoldPrice', window );">Forward Looking Gold Price</a></td>
<td class="nump">3,126<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DisclosureOfValuationOfDeferredConsiderationLineItems', window );"><strong>Disclosure Of Valuation Of Deferred Consideration [Line Item]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ForwardsLookingGoldPrice', window );">Forward Looking Gold Price</a></td>
<td class="nump">2,237<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_BusinessCombinationConsiderationTransferredDeferredPaymentInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount rate used to value the deferred consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_BusinessCombinationConsiderationTransferredDeferredPaymentInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_DeferredConsiderationPerpetualGrowthRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate at which represents the deferred consideration perpetual growth.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_DeferredConsiderationPerpetualGrowthRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_DisclosureOfValuationOfDeferredConsiderationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_DisclosureOfValuationOfDeferredConsiderationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ForwardsLookingGoldPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Forward looking gold price per ounce.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ForwardsLookingGoldPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:massItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310107314832">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Deferred Consideration&#8212;gold payments (Details) - Schedule of Deferred Consideration<br> oz in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>oz</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>oz</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>oz</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ScheduleOfDeferredConsiderationAbstract', window );"><strong>Schedule Of Deferred Consideration [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ContractualGoldPayments', window );">Contractual gold payments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 6,069<span></span>
</td>
<td class="nump">$ 17,108<span></span>
</td>
<td class="nump">$ 17,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ContractualGoldPaymentgoldOuncesPaid', window );">Contractual gold payments&#8212;gold ounces paid (in Ounces) | oz</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,167<span></span>
</td>
<td class="nump">9,500<span></span>
</td>
<td class="nump">9,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_GainLossFromChangeInDeferredConsideration', window );">Gain on revaluation/termination of deferred consideration&#8212;gold payments</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 61,953<span></span>
</td>
<td class="nump">$ 27,765<span></span>
</td>
<td class="nump">$ 2,018<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Gains on revaluation/termination of deferred consideration&#8212;gold payments result from a decrease in spot gold prices, a decrease in the forward<span class="nobreak">-looking</span> price of gold, a decrease in the perpetual growth rate and an increase in the discount rate used to compute the present value of the annual payment obligations.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ContractualGoldPaymentgoldOuncesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual gold payments gold ounces paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ContractualGoldPaymentgoldOuncesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:massItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ContractualGoldPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual gold payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ContractualGoldPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_GainLossFromChangeInDeferredConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain/loss from revaluation of deferred consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_GainLossFromChangeInDeferredConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ScheduleOfDeferredConsiderationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ScheduleOfDeferredConsiderationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310097064176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Notes (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 14, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 14, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 13, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 15, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 16, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Convertible Senior Notes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax', window );">Loss on extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,955<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,330<span></span>
</td>
<td class="nump">146,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense on the convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,242<span></span>
</td>
<td class="nump">$ 14,935<span></span>
</td>
<td class="nump">$ 12,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember', window );">Accounts Payable and Accrued Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Convertible Senior Notes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Interest payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,041<span></span>
</td>
<td class="nump">621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=wt_ConvertibleSeniorNotesDue2028Member', window );">Convertible Senior Notes due 2028 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Convertible Senior Notes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="nump">$ 130,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">5.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=wt_ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember', window );">Convertible Senior Notes due 2026 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Convertible Senior Notes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion price ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price equal percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_MaximumConversionRate', window );">Maximum conversion rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167.7853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=wt_ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember', window );">Convertible Senior Notes due 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Convertible Senior Notes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="nump">$ 280,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Principal interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_MinimumPercentageOfLendersRequiredToHaveEntirePrincipalAmountOfConvertibleNotesRepurchasedByTheCompanyUponCertainEventsOfDefault', window );">Aggregate principal amount, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=wt_TwoThousandAndTwentyNotesMember', window );">Two Thousand And Twenty Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Convertible Senior Notes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115,000<span></span>
</td>
<td class="nump">175,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,037,288,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=wt_ConvertibleSeniorNotesMember', window );">Convertible Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Convertible Senior Notes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountIssued1', window );">Conversion shares value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_NumberOfThresholdTradingDaysForDeterminingTheSharePrice', window );">Measurement days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_MeasurementPeriodForDeterminingSharePrice', window );">Measurement period for determining share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_PrincipalAmountOfTradingPrice', window );">Principal amount of trading price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_SharePriceAsAPercentageOfLastReportedPriceAndConversionRate', window );">Parentage of sale and conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price equal percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_MaximumConversionRate', window );">Maximum conversion rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144.9275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_MaximumNumberOfSharesIssuableUponConversion', window );">Number of shares issuable upon conversion | shares</a></td>
<td class="nump">43,551,214<span></span>
</td>
<td class="nump">43,551,214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Convertible Senior Notes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense on the convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,945<span></span>
</td>
<td class="nump">14,935<span></span>
</td>
<td class="nump">$ 12,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=wt_ConvertibleNotesMember', window );">Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Convertible Senior Notes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 280,000<span></span>
</td>
<td class="nump">325,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentRate', window );">Conversion price of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Convertible Senior Notes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of the convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 281,897<span></span>
</td>
<td class="nump">$ 320,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-21<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480555/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Dividend or interest rate associated with the financial instrument issued in exchange for the original debt being converted in a noncash or part noncash transaction. Noncash are transactions that affect recognized assets or liabilities but that do not result in cash receipts or cash payments. Part noncash refers to that portion of the transaction not resulting in cash receipts or cash payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-7<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -SubTopic 470<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480848/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the reacquisition price and the net carrying amount of the extinguished debt recognized currently as a component of income in the period of extinguishment, net of tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_MaximumConversionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum conversion rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_MaximumConversionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_MaximumNumberOfSharesIssuableUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum number of shares issuable upon conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_MaximumNumberOfSharesIssuableUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_MeasurementPeriodForDeterminingSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Measurement period for determining share price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_MeasurementPeriodForDeterminingSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_MinimumPercentageOfLendersRequiredToHaveEntirePrincipalAmountOfConvertibleNotesRepurchasedByTheCompanyUponCertainEventsOfDefault">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage amount of minimum percentage of lenders required to have entire principal amount of convertible notes repurchased by the Company upon certain events of default.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_MinimumPercentageOfLendersRequiredToHaveEntirePrincipalAmountOfConvertibleNotesRepurchasedByTheCompanyUponCertainEventsOfDefault</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_NumberOfThresholdTradingDaysForDeterminingTheSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Threshold Trading Days For Determining The Share Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_NumberOfThresholdTradingDaysForDeterminingTheSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_PrincipalAmountOfTradingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal amount of trading price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_PrincipalAmountOfTradingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_SharePriceAsAPercentageOfLastReportedPriceAndConversionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share price as a percentage of last reported price and conversion rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_SharePriceAsAPercentageOfLastReportedPriceAndConversionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsPayableAndAccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wt_ConvertibleSeniorNotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wt_ConvertibleSeniorNotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wt_ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wt_ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wt_ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wt_ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wt_TwoThousandAndTwentyNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wt_TwoThousandAndTwentyNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wt_ConvertibleSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wt_ConvertibleSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wt_ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wt_ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310099026064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Notes (Details) - Schedule of Key Terms of Convertible Notes<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=wt_TwoThousandAndTwentyThreeNotesMember', window );">2023 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Schedule of Key Terms of Convertible Notes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal outstanding | $</a></td>
<td class="nump">$ 130,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date (unless earlier converted, repurchased or redeemed)</a></td>
<td class="text">Aug. 15,  2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">5.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price</a></td>
<td class="nump">$ 9.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion rate</a></td>
<td class="nump">104.8658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DebtInstrumentRedemptionPrice', window );">Redemption price</a></td>
<td class="nump">$ 12.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=wt_TwothousandandtwentyonenotesMember', window );">2021 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Schedule of Key Terms of Convertible Notes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal outstanding | $</a></td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date (unless earlier converted, repurchased or redeemed)</a></td>
<td class="text">Jun. 15,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price</a></td>
<td class="nump">$ 11.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion rate</a></td>
<td class="nump">90.5797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DebtInstrumentRedemptionPrice', window );">Redemption price</a></td>
<td class="nump">$ 14.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-7<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_DebtInstrumentRedemptionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument redemption price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_DebtInstrumentRedemptionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wt_TwoThousandAndTwentyThreeNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wt_TwoThousandAndTwentyThreeNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wt_TwothousandandtwentyonenotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wt_TwothousandandtwentyonenotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310102314064">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Convertible Notes (Details) - Schedule of Convertible Notes - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=wt_TwoThousandAndTwentyThreeNotesMember', window );">2023 Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 130,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Plus: Premium</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross proceeds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">130,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Less: Unamortized issuance costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,987)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 127,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">6.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=wt_TwothousandandtwentyonenotesMember', window );">2021 Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Plus: Premium</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross proceeds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">150,000<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Less: Unamortized issuance costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,125)<span></span>
</td>
<td class="num">(2,981)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 147,875<span></span>
</td>
<td class="nump">$ 147,019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3.83%<span></span>
</td>
<td class="nump">3.83%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=wt_ConvertibleNotesMember', window );">Convertible Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 280,000<span></span>
</td>
<td class="nump">$ 325,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Plus: Premium</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross proceeds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">280,000<span></span>
</td>
<td class="nump">325,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Less: Unamortized issuance costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(5,112)<span></span>
</td>
<td class="num">(4,034)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 274,888<span></span>
</td>
<td class="nump">$ 321,216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">4.96%<span></span>
</td>
<td class="nump">4.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=wt_TwoThousandAndTwentyNotesMember', window );">2020 Notes [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 115,000<span></span>
</td>
<td class="nump">$ 175,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Plus: Premium</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Gross proceeds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Less: Unamortized issuance costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,053)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 174,197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.26%<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes amortization of the issuance costs and premium.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wt_TwoThousandAndTwentyThreeNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wt_TwoThousandAndTwentyThreeNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wt_TwothousandandtwentyonenotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wt_TwothousandandtwentyonenotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wt_ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wt_ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=wt_TwoThousandAndTwentyNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=wt_TwoThousandAndTwentyNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310089074080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Series A Preferred Stock (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 10, 2018</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredUnitsLineItems', window );"><strong>Preferred Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_OutstandingCommonStockPercentage', window );">Outstanding common stock percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredUnitsLineItems', window );"><strong>Preferred Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_PreferredStockRedemptionValue', window );">Preferred shares redemption value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96,869<span></span>
</td>
<td class="nump">$ 77,969<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=wt_ETFSAcquisitionMember', window );">ETFS Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredUnitsLineItems', window );"><strong>Preferred Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Fair value of consideration</a></td>
<td class="nump">$ 132,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Common stock per share (in Dollars per share)</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=wt_ETFSAcquisitionMember', window );">ETFS Acquisition [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredUnitsLineItems', window );"><strong>Preferred Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Convertible into common stock (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=wt_ETFSAcquisitionMember', window );">ETFS Acquisition [Member] | Series A Non-Voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredUnitsLineItems', window );"><strong>Preferred Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Issued shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredUnitsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredUnitsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_OutstandingCommonStockPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of outstanding common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_OutstandingCommonStockPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_PreferredStockRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Preferred Stock Redemption Value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_PreferredStockRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=wt_ETFSAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=wt_ETFSAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=wt_SeriesANonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=wt_SeriesANonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310107246784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Series A Preferred Stock (Details) - Schedule of Series A Preferred Stock Balance - Preferred Shares [Member] - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredUnitsLineItems', window );"><strong>Preferred Units [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Issuance of Series A Preferred Stock</a></td>
<td class="nump">$ 132,750<span></span>
</td>
<td class="nump">$ 132,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Less: Issuance costs</a></td>
<td class="num">(181)<span></span>
</td>
<td class="num">(181)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Series A Preferred Stock&#8212;carrying value</a></td>
<td class="nump">$ 132,569<span></span>
</td>
<td class="nump">$ 132,569<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsPerShareDeclared', window );">Cash dividends declared per share (quarterly) (in Dollars per share)</a></td>
<td class="nump">$ 0.03<span></span>
</td>
<td class="nump">$ 0.03<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of preferred stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredUnitsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredUnitsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310101609280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Payable to Gold Bullion Holdings Jersey Limited GBH (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 20, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems', window );"><strong>Payable to Gold Bullion Holdings Jersey Limited GBH (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleSharesIssuable', window );">Convertible preferred stock shares (in Shares)</a></td>
<td class="nump">13,087,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Aggregate cash</a></td>
<td class="nump">$ 84,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_RepurchasePricePerShareInterestRateTransaction', window );">Repurchase price per share interest rate transaction (in Dollars per share)</a></td>
<td class="nump">$ 6.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_PresentValueOfMarketRateInterest', window );">Present value of market rate interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_AggregateConsiderationPayable', window );">Aggregate consideration payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,835<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndDebtExpense', window );">interest expense recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 297<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=wt_GBHMember', window );">GBH [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems', window );"><strong>Payable to Gold Bullion Holdings Jersey Limited GBH (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Transaction paid</a></td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479908/805-50-55-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest and debt related expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 835<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleSharesIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common shares issuable upon conversion of preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleSharesIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_AggregateConsiderationPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of aggregate consideration payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_AggregateConsiderationPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_PresentValueOfMarketRateInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of market rate interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_PresentValueOfMarketRateInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_RepurchasePricePerShareInterestRateTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repurchase price per share interest rate transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_RepurchasePricePerShareInterestRateTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=wt_GBHMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=wt_GBHMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310098014144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Payable to Gold Bullion Holdings Jersey Limited GBH (Details) - Schedule of Aggregate Consideration Payable<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansPayableAbstract', window );"><strong>Schedule of Aggregate Consideration Payable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Current:</a></td>
<td class="nump">$ 14,804<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Long-term</a></td>
<td class="nump">24,328<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Total</a></td>
<td class="nump">$ 39,132<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansPayableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansPayableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310106242320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_PaymentOfLeaseTerminationFee', window );">Termination fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnContractTermination', window );">Lease termination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,277<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Operating lease, impairment loss</a></td>
<td class="nump">$ 303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnContractTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnContractTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479365/842-20-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_PaymentOfLeaseTerminationFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment of lease termination fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_PaymentOfLeaseTerminationFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310098272304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details) - Schedule of Additional Information Related to Operating Lease - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 1,285<span></span>
</td>
<td class="nump">$ 963<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease cost</a></td>
<td class="nump">191<span></span>
</td>
<td class="nump">223<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">1,476<span></span>
</td>
<td class="nump">1,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_OtherInformationAbstract', window );"><strong>Other information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for amounts included in the measurement of operating liabilities (operating leases)</a></td>
<td class="nump">1,284<span></span>
</td>
<td class="nump">965<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for new operating lease liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term (in years)&#8212;operating leases</a></td>
<td class="text">4 months 24 days<span></span>
</td>
<td class="text">1 year 2 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate&#8212;operating leases</a></td>
<td class="nump">5.90%<span></span>
</td>
<td class="nump">6.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_OtherInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_OtherInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310097442976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Details) - Schedule of Future Minimum Lease Payments<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ScheduleOfFutureMinimumLeasePaymentsAbstract', window );"><strong>Schedule of Future Minimum Lease Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 584<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2028</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">2029 and thereafter</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments (undiscounted)</a></td>
<td class="nump">$ 584<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ScheduleOfFutureMinimumLeasePaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ScheduleOfFutureMinimumLeasePaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310107314960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Details) - Schedule of Reconciliation of Future Minimum Lease Payments to Balance Sheet - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ScheduleOfReconciliationOfFutureMinimumLeasePaymentsToBalanceSheetAbstract', window );"><strong>Schedule of Reconciliation of Future Minimum Lease Payments to Balance Sheet [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liability&#8212;short term</a></td>
<td class="nump">$ 578<span></span>
</td>
<td class="nump">$ 1,125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liability&#8212;long term</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 339<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Subtotal</a></td>
<td class="nump">578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Difference between undiscounted and discounted cash flows</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments (undiscounted)</a></td>
<td class="nump">$ 584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ScheduleOfReconciliationOfFutureMinimumLeasePaymentsToBalanceSheetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ScheduleOfReconciliationOfFutureMinimumLeasePaymentsToBalanceSheetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100593840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Details)<br> &#8364; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainContingenciesLineItems', window );"><strong>Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Loss contingency acrual</a></td>
<td class="nump">$ 9,272<span></span>
</td>
<td class="nump">&#8364; 8,400<span></span>
</td>
<td class="nump">$ 16,778<span></span>
</td>
<td class="nump">&#8364; 15,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_LossContingencyCoveredByInsuranceDeductible', window );">Amount of deductible</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483049/450-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_LossContingencyCoveredByInsuranceDeductible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss contingency covered by insurance deductible.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_LossContingencyCoveredByInsuranceDeductible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310097238032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Variable Interest Entities (Details) - Schedule of Information about Variable Interests - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_CarryingAmountAssetsSecurrencyAbstract', window );"><strong>Carrying Amount&#8212;Assets (Securrency):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Carrying Amount&#8212;Assets</a></td>
<td class="nump">$ 9,684<span></span>
</td>
<td class="nump">$ 35,721<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_SecurrencyseriesaconvertiblepreferredstockMember', window );">Securrency, Inc. Series A convertible preferred stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_CarryingAmountAssetsSecurrencyAbstract', window );"><strong>Carrying Amount&#8212;Assets (Securrency):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Carrying Amount&#8212;Assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">8,488<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_SecurrencyseriesbconvertiblepreferredstockMember', window );">Securrency, Inc. Series B convertible preferred stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_CarryingAmountAssetsSecurrencyAbstract', window );"><strong>Carrying Amount&#8212;Assets (Securrency):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Carrying Amount&#8212;Assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">5,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_SecurrencyConvertibleNoteMember', window );">Securrency Convertible Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_CarryingAmountAssetsSecurrencyAbstract', window );"><strong>Carrying Amount&#8212;Assets (Securrency):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Carrying Amount&#8212;Assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">14,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_SecurrencyIncSubTotalMember', window );">Securrency Inc Sub Total [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_CarryingAmountAssetsSecurrencyAbstract', window );"><strong>Carrying Amount&#8212;Assets (Securrency):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Carrying Amount&#8212;Assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">28,488<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_ConvertibleNoteMember', window );">Convertible note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_CarryingAmountAssetsSecurrencyAbstract', window );"><strong>Carrying Amount&#8212;Assets (Securrency):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Carrying Amount&#8212;Assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">6,921<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_B1ConvertiblePreferenceSharesMember', window );">B-1 Preference Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_CarryingAmountAssetsSecurrencyAbstract', window );"><strong>Carrying Amount&#8212;Assets (Securrency):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Carrying Amount&#8212;Assets</a></td>
<td class="nump">9,684<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_SubtotalFnalityInternationalLimitedMember', window );">Subtotal&#8212;Fnality [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_CarryingAmountAssetsSecurrencyAbstract', window );"><strong>Carrying Amount&#8212;Assets (Securrency):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Carrying Amount&#8212;Assets</a></td>
<td class="nump">9,684<span></span>
</td>
<td class="nump">6,921<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_OtherInvestmentMember', window );">Other investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_CarryingAmountAssetsSecurrencyAbstract', window );"><strong>Carrying Amount&#8212;Assets (Securrency):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Carrying Amount&#8212;Assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_MaximumExposureToLossMember', window );">Maximum exposure to loss [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_CarryingAmountAssetsSecurrencyAbstract', window );"><strong>Carrying Amount&#8212;Assets (Securrency):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Carrying Amount&#8212;Assets</a></td>
<td class="nump">$ 9,684<span></span>
</td>
<td class="nump">$ 35,721<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_CarryingAmountAssetsSecurrencyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_CarryingAmountAssetsSecurrencyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_SecurrencyseriesaconvertiblepreferredstockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_SecurrencyseriesaconvertiblepreferredstockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_SecurrencyseriesbconvertiblepreferredstockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_SecurrencyseriesbconvertiblepreferredstockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_SecurrencyConvertibleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_SecurrencyConvertibleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_SecurrencyIncSubTotalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_SecurrencyIncSubTotalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_ConvertibleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_ConvertibleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_B1ConvertiblePreferenceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_B1ConvertiblePreferenceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_SubtotalFnalityInternationalLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_SubtotalFnalityInternationalLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_OtherInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_OtherInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_MaximumExposureToLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=wt_MaximumExposureToLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310098413456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues from Contracts with Customers (Details) - Schedule of Revenues from Contracts with Customers - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Schedule of Revenues from Contracts with Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total operating revenues</a></td>
<td class="nump">$ 349,035<span></span>
</td>
<td class="nump">$ 301,345<span></span>
</td>
<td class="nump">$ 304,318<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember', window );">Advisory fees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Schedule of Revenues from Contracts with Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total operating revenues</a></td>
<td class="nump">333,227<span></span>
</td>
<td class="nump">293,632<span></span>
</td>
<td class="nump">298,052<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=wt_OtherServicesIncomeMember', window );">Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Schedule of Revenues from Contracts with Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total operating revenues</a></td>
<td class="nump">$ 15,808<span></span>
</td>
<td class="nump">$ 7,713<span></span>
</td>
<td class="nump">$ 6,266<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=wt_OtherServicesIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=wt_OtherServicesIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310084801248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues from Contracts with Customers (Details) - Schedule of Geographic Distribution of Revenues - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_RevenuesFromContractsWithCustomersAbstract', window );"><strong>Revenues from contracts with customers:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total operating revenues</a></td>
<td class="nump">$ 349,035<span></span>
</td>
<td class="nump">$ 301,345<span></span>
</td>
<td class="nump">$ 304,318<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_RevenuesFromContractsWithCustomersAbstract', window );"><strong>Revenues from contracts with customers:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total operating revenues</a></td>
<td class="nump">220,117<span></span>
</td>
<td class="nump">184,036<span></span>
</td>
<td class="nump">179,016<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_JE', window );">Jersey [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_RevenuesFromContractsWithCustomersAbstract', window );"><strong>Revenues from contracts with customers:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total operating revenues</a></td>
<td class="nump">113,325<span></span>
</td>
<td class="nump">103,692<span></span>
</td>
<td class="nump">114,623<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_RevenuesFromContractsWithCustomersAbstract', window );"><strong>Revenues from contracts with customers:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total operating revenues</a></td>
<td class="nump">$ 15,593<span></span>
</td>
<td class="nump">$ 13,617<span></span>
</td>
<td class="nump">$ 10,679<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_RevenuesFromContractsWithCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_RevenuesFromContractsWithCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_JE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_JE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310099123072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="6">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>May 10, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Earned revenue</a></td>
<td class="num">$ (1,128)<span></span>
</td>
<td class="nump">&#8364; 1,044<span></span>
</td>
<td class="num">$ (671)<span></span>
</td>
<td class="nump">&#8364; 642<span></span>
</td>
<td class="num">$ (710)<span></span>
</td>
<td class="nump">&#8364; 612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Net gains (losses) related to certain WisdomTree ETFs</a></td>
<td class="nump">1,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(107)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (451)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractualObligation', window );">Contractual obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,634<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=wt_WisdomTreeProductsMember', window );">WisdomTree Products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">52,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=wt_WisdomTreeProductsMember', window );">WisdomTree Products [Member] | Affiliated Blockchain Enabled Funds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">$ 18,308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation, including, but not limited to, long-term debt, lease obligation, purchase obligation, and other commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(h))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=wt_WisdomTreeProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=wt_WisdomTreeProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=wt_AffiliatedBlockchainEnabledFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=wt_AffiliatedBlockchainEnabledFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310098575600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Related Party Transactions (Details) - Schedule of Accounts Receivable from Related Parties - Related Party [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Schedule of Accounts Receivable from Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable from related parties</a></td>
<td class="nump">$ 28,511<span></span>
</td>
<td class="nump">$ 24,139<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=wt_ReceivableFromWTTMember', window );">Receivable from WTT [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Schedule of Accounts Receivable from Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable from related parties</a></td>
<td class="nump">21,226<span></span>
</td>
<td class="nump">16,399<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=wt_ReceivableFromManJerIssuersMember', window );">Receivable from ManJer Issuers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Schedule of Accounts Receivable from Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable from related parties</a></td>
<td class="nump">4,411<span></span>
</td>
<td class="nump">4,485<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=wt_WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember', window );">Receivable from WMAI and WTICAV [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Schedule of Accounts Receivable from Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable from related parties</a></td>
<td class="nump">$ 2,874<span></span>
</td>
<td class="nump">$ 3,255<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480833/946-310-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481058/954-310-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_RelatedPartiesAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_RelatedPartiesAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=wt_ReceivableFromWTTMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=wt_ReceivableFromWTTMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=wt_ReceivableFromManJerIssuersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=wt_ReceivableFromManJerIssuersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=wt_WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=wt_WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310096887184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details) - Schedule of Revenues from Advisory Services Provided to Related Parties - Related Party [Member] - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Schedule of Revenues from Advisory Services Provided to Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues from advisory services</a></td>
<td class="nump">$ 333,227<span></span>
</td>
<td class="nump">$ 293,632<span></span>
</td>
<td class="nump">$ 298,052<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Advisory services provided to WTT [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Schedule of Revenues from Advisory Services Provided to Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues from advisory services</a></td>
<td class="nump">218,834<span></span>
</td>
<td class="nump">183,409<span></span>
</td>
<td class="nump">178,511<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Advisory services provided to ManJer Issuers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Schedule of Revenues from Advisory Services Provided to Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues from advisory services</a></td>
<td class="nump">98,800<span></span>
</td>
<td class="nump">96,606<span></span>
</td>
<td class="nump">108,862<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Advisory services provided to WMAI and WTICAV [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Schedule of Revenues from Advisory Services Provided to Related Parties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues from advisory services</a></td>
<td class="nump">$ 15,593<span></span>
</td>
<td class="nump">$ 13,617<span></span>
</td>
<td class="nump">$ 10,679<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=wt_AdvisoryServicesProvidedToWTTMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=wt_AdvisoryServicesProvidedToWTTMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=wt_AdvisoryServicesProvidedToManJerIssuersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=wt_AdvisoryServicesProvidedToManJerIssuersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=wt_AdvisoryServicesProvidedToWMAIAndWTICAVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=wt_AdvisoryServicesProvidedToWMAIAndWTICAVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310088915904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Awards (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 15, 2022</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Common stock, shares issued (in Shares)</a></td>
<td class="nump">16,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms', window );">Stock-based awards,description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The number of PRSUs vesting ranges from 0% to 200% of the target number of PRSUs granted, as follows:	&#8226;&#160;&#160;&#160;&#160;&#160;If the relative TSR is below the 25th percentile, then 0% of the target number of PRSUs granted will vest;	&#8226;&#160;&#160;&#160;&#160;&#160;If the relative TSR is at the 25th percentile, then 50% of the target number of PRSUs granted will vest;	&#8226;&#160;&#160;&#160;&#160;&#160;If the relative TSR is above the 25th percentile, then linear scaling is applied such that the percent of the target number of PRSUs vesting is 100% at the 50th percentile and capped at 200% of the target number of PRSUs granted for performance at the 85th percentile; and	&#8226;&#160;&#160;&#160;&#160;&#160;If the Company&#8217;s TSR is negative, the target number of PRSUs vesting is capped at 100% regardless of the relative TSR percentile.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,190<span></span>
</td>
<td class="nump">$ 10,385<span></span>
</td>
<td class="nump">$ 9,998<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Related tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,919<span></span>
</td>
<td class="nump">2,371<span></span>
</td>
<td class="nump">2,327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherTaxExpenseBenefit', window );">Tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,820<span></span>
</td>
<td class="nump">1,548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit', window );">Actual tax benefit for share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value of options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Cash received from option exercises</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">815<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Aggregate fair value of awards that vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,158<span></span>
</td>
<td class="nump">$ 9,466<span></span>
</td>
<td class="nump">$ 10,940<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VestingAxis=wt_BelowTwentyFifthPercentileMember', window );">Below Twenty Fifth Percentile [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Shares granted and outstanding, vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="nump">77.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_StockOptionMember', window );">Stock options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Stock option issuance period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wt_PerformanceBasedRestrictedStockUnitMember', window );">Performance Based Restricted Stock Unit [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Shares granted and outstanding, vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wt_PerformanceBasedRestrictedStockUnitMember', window );">Performance Based Restricted Stock Unit [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Shares granted and outstanding, vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Deferred RSUs that have vested (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,779<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of modification of award under share-based payment arrangement. Includes, but is not limited to, terms for expiration date, vesting rights and exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense reduction and deferred tax asset recorded in the transaction in which equity securities were issued to pay for goods or nonemployee services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=wt_BelowTwentyFifthPercentileMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=wt_BelowTwentyFifthPercentileMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wt_PerformanceBasedRestrictedStockUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wt_PerformanceBasedRestrictedStockUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310099519696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Awards (Details) - Schedule of Unrecognized Stock-Based Compensation Expense and Average Remaining Vesting Period - Employees And Directors [Member]<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized Stock-Based Compensation</a></td>
<td class="nump">$ 19,165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-Average Remaining Vesting Period (Years)</a></td>
<td class="text">11 months 1 day<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=wt_EmployeesAndDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=wt_EmployeesAndDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310098134416">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Awards (Details) - Schedule of Restricted Stock Activity and Restricted Stock Unit - $ / shares<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">RSA [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested Beginning Balance, Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,391,082<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,036,905<span></span>
</td>
<td class="nump">3,580,743<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, Beginning Balance, Weighted Average Grant Date Fair Value (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 5.46<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 5.2<span></span>
</td>
<td class="nump">$ 5.38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted, Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,363,501<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,170,432<span></span>
</td>
<td class="nump">1,642,266<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted, Weighted Average Grant Date Fair Value (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 5.63<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 5.71<span></span>
</td>
<td class="nump">$ 5.46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested, Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,629,925)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,621,201)<span></span>
</td>
<td class="num">(1,897,699)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested, Weighted Average Grant Date Fair Value (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 5.28<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 5.31<span></span>
</td>
<td class="nump">$ 5.78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited, Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(114,436)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(195,054)<span></span>
</td>
<td class="num">(288,405)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited, Weighted Average Grant Date Fair Value (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 5.55<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 5.43<span></span>
</td>
<td class="nump">$ 5.11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, Ending Balance, Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,010,222<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,391,082<span></span>
</td>
<td class="nump">3,036,905<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, Ending Balance,Weighted Average Grant Date Fair Value (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 5.63<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 5.46<span></span>
</td>
<td class="nump">$ 5.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSU [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested Beginning Balance, Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">141,963<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">54,990<span></span>
</td>
<td class="nump">39,408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, Beginning Balance, Weighted Average Grant Date Fair Value (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 5.09<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 4.93<span></span>
</td>
<td class="nump">$ 4.46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted, Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">152,265<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">116,247<span></span>
</td>
<td class="nump">31,170<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted, Weighted Average Grant Date Fair Value (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 6.24<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 5.18<span></span>
</td>
<td class="nump">$ 5.43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested, Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(72,461)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(27,894)<span></span>
</td>
<td class="num">(15,136)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested, Weighted Average Grant Date Fair Value (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 5.66<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 5.1<span></span>
</td>
<td class="nump">$ 4.73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited, Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(34,385)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,380)<span></span>
</td>
<td class="num">(452)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited, Weighted Average Grant Date Fair Value (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 5.7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 5.73<span></span>
</td>
<td class="nump">$ 5.37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockDividendsShares', window );">Stock dividends, Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,762<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Stock dividends, Weighted Average Grant Date Fair Value (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 6.24<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, Ending Balance, Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">141,963<span></span>
</td>
<td class="nump">54,990<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, Ending Balance,Weighted Average Grant Date Fair Value (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 5.7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 5.09<span></span>
</td>
<td class="nump">$ 4.93<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=wt_PerformanceBasedRestrictedStockUnitMember', window );">PRSU [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested Beginning Balance, Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">668,188<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">550,686<span></span>
</td>
<td class="nump">341,312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, Beginning Balance, Weighted Average Grant Date Fair Value (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 6.09<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 5.73<span></span>
</td>
<td class="nump">$ 5.17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted, Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted, Weighted Average Grant Date Fair Value (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 6.49<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 6.8<span></span>
</td>
<td class="nump">$ 6.49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested, Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(108,113)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(202,336)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested, Weighted Average Grant Date Fair Value (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 3.11<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 6.24<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited, Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="num">(47,669)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited, Weighted Average Grant Date Fair Value (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 5.74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockDividendsShares', window );">Stock dividends, Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">37,777<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Stock dividends, Weighted Average Grant Date Fair Value (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 6.49<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, Ending Balance, Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,174,092<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">668,188<span></span>
</td>
<td class="nump">550,686<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, Ending Balance,Weighted Average Grant Date Fair Value (in Dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 6.58<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 6.09<span></span>
</td>
<td class="nump">$ 5.73<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Represents the target number of PRSUs granted and outstanding. The number of PRSUs that ultimately vest ranges from 0% to 200% of this amount. During the years ended December 31, 2023, 2022 and 2021, 200%, 77% and 0%, respectively, of the target number of PRSUs granted ultimately vested, inclusive of accrued stock dividends.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Includes 57,779 deferred RSUs that have vested.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">A Monte Carlo simulation was used to value these awards using the following assumptions for the Company and the peer group: (i) beginning 90<span class="nobreak">-day</span> average stock prices; (ii) valuation date stock prices; (iii) correlation coefficients based upon the price data used to calculate the historical volatilities; and (iv) the following additional assumptions:</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableAmountPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share amount of a dividend declared, but not paid, as of the financial reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableAmountPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockDividendsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common and preferred stock issued as dividends during the period. Excludes stock splits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockDividendsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=wt_PerformanceBasedRestrictedStockUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=wt_PerformanceBasedRestrictedStockUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310092109472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Awards (Details) - Schedule of Share Based Payment Awards Other than Options Valuation Assumptions<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ScheduleOfShareBasedPaymentAwardsOtherThanOptionsValuationAssumptionsAbstract', window );"><strong>Schedule of Share Based Payment Awards Other than Options Valuation Assumptions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Historical stock price volatility (low)</a></td>
<td class="nump">37.00%<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Historical stock price volatility (high)</a></td>
<td class="nump">56.00%<span></span>
</td>
<td class="nump">57.00%<span></span>
</td>
<td class="nump">57.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Historical stock price volatility (average)</a></td>
<td class="nump">47.00%<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">1.28%<span></span>
</td>
<td class="nump">0.17%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ScheduleOfShareBasedPaymentAwardsOtherThanOptionsValuationAssumptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ScheduleOfShareBasedPaymentAwardsOtherThanOptionsValuationAssumptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310089509824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholder Rights Plan (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 17, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DisclosureOfStockholderRightsPlanLineItems', window );"><strong>Stockholder Rights Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Right for outstanding shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par or stated value per share (in Dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par or stated value per share (in Dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_PercentageOfAssetsSold', window );">Percentage of assets sold</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_PercentageOfCommonStock', window );">Percentage of common stock</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=wt_SeriesANonVotingConvertiblePreferredStockMember', window );">Series A Non Voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DisclosureOfStockholderRightsPlanLineItems', window );"><strong>Stockholder Rights Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Right for outstanding shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_AgreementAxis=wt_StockholderRightAgreementMember', window );">Stockholder Right Agreement [Member] | Series A Non Voting Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DisclosureOfStockholderRightsPlanLineItems', window );"><strong>Stockholder Rights Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par or stated value per share (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember', window );">Board of Directors Chairman [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DisclosureOfStockholderRightsPlanLineItems', window );"><strong>Stockholder Rights Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Right for outstanding shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=wt_StockholderRightAgreementMember', window );">Stockholder Right Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DisclosureOfStockholderRightsPlanLineItems', window );"><strong>Stockholder Rights Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ExercisePricePerUnit', window );">Exercise price per unit (in Dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_PercentageOfCommonStockAcquired', window );">Percentage of common stock acquired</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=wt_StockholderRightAgreementMember', window );">Stockholder Right Agreement [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DisclosureOfStockholderRightsPlanLineItems', window );"><strong>Stockholder Rights Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par or stated value per share (in Dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=wt_StockholderRightAgreementMember', window );">Stockholder Right Agreement [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DisclosureOfStockholderRightsPlanLineItems', window );"><strong>Stockholder Rights Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_PercentageOfBeneficialOwnership', window );">Percentage of beneficial ownership</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=wt_StockholderRightAgreementMember', window );">Stockholder Right Agreement [Member] | Minimum [Member] | Acquiring Person [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DisclosureOfStockholderRightsPlanLineItems', window );"><strong>Stockholder Rights Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=wt_StockholderRightAgreementMember', window );">Stockholder Right Agreement [Member] | Minimum [Member] | Passive stockholders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DisclosureOfStockholderRightsPlanLineItems', window );"><strong>Stockholder Rights Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=wt_StockholderRightAgreementMember', window );">Stockholder Right Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DisclosureOfStockholderRightsPlanLineItems', window );"><strong>Stockholder Rights Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_PercentageOfBeneficialOwnership', window );">Percentage of beneficial ownership</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=wt_StockholderRightAgreementMember', window );">Stockholder Right Agreement [Member] | Maximum [Member] | Acquiring Person [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DisclosureOfStockholderRightsPlanLineItems', window );"><strong>Stockholder Rights Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=wt_StockholderRightAgreementMember', window );">Stockholder Right Agreement [Member] | Maximum [Member] | Passive stockholders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DisclosureOfStockholderRightsPlanLineItems', window );"><strong>Stockholder Rights Plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_DisclosureOfStockholderRightsPlanLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_DisclosureOfStockholderRightsPlanLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ExercisePricePerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ExercisePricePerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_PercentageOfAssetsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of assets sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_PercentageOfAssetsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_PercentageOfBeneficialOwnership">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of beneficial ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_PercentageOfBeneficialOwnership</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_PercentageOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_PercentageOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_PercentageOfCommonStockAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of common stock acquired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_PercentageOfCommonStockAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=wt_SeriesANonVotingConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=wt_SeriesANonVotingConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_AgreementAxis=wt_StockholderRightAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_AgreementAxis=wt_StockholderRightAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=wt_StockholderRightAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=wt_StockholderRightAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=wt_AcquiringPersonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=wt_AcquiringPersonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=wt_PassiveStockholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=wt_PassiveStockholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310107079904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans (Details) - Summary of Discretionary Contributions - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Employee Benefit Plans [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Discretionary contributions</a></td>
<td class="nump">$ 1,450<span></span>
</td>
<td class="nump">$ 1,342<span></span>
</td>
<td class="nump">$ 1,080<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310106256272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_EarningsPerShareDetailsLineItems', window );"><strong>Earnings Per Share (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Recognized redemption (in Dollars)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,966<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive non-participating common stock equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">405<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Conversion option embedded in the Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,186<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_EarningsPerShareDetailsLineItems', window );"><strong>Earnings Per Share (Details) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Recognized redemption (in Dollars)</a></td>
<td class="nump">$ 7,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-42<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_EarningsPerShareDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_EarningsPerShareDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310092089424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Details) - Schedule of Reconciliation of Basic and Diluted Earnings Per Share - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_BasicEarningsPerShareAbstract', window );"><strong>Basic Earnings per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 102,546<span></span>
</td>
<td class="nump">$ 50,684<span></span>
</td>
<td class="nump">$ 49,797<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Add: Gain on redemption of Series C Non-Voting Convertible Preferred Stock</a></td>
<td class="nump">7,966<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_IncomeDistributedToParticipatingSecurities', window );">Less: Income distributed to participating securities</a></td>
<td class="num">(2,770)<span></span>
</td>
<td class="num">(2,186)<span></span>
</td>
<td class="num">(2,168)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic', window );">Less: Undistributed income allocable to participating securities</a></td>
<td class="num">(12,680)<span></span>
</td>
<td class="num">(3,528)<span></span>
</td>
<td class="num">(3,378)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income available to common stockholders&#8212;Basic EPS</a></td>
<td class="nump">95,062<span></span>
</td>
<td class="nump">44,970<span></span>
</td>
<td class="nump">44,251<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_UndistributedIncomeAllocableToParticipatingSecurities', window );">Add back: Undistributed income allocable to participating securities</a></td>
<td class="nump">12,680<span></span>
</td>
<td class="nump">3,528<span></span>
</td>
<td class="nump">3,378<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted', window );">Less: Reallocation of undistributed income allocable to participating securities considered potentially dilutive</a></td>
<td class="num">(12,449)<span></span>
</td>
<td class="num">(3,522)<span></span>
</td>
<td class="num">(3,353)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net income available to common stockholders&#8212;Diluted EPS</a></td>
<td class="nump">$ 95,293<span></span>
</td>
<td class="nump">$ 44,976<span></span>
</td>
<td class="nump">$ 44,276<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares (in Shares)</a></td>
<td class="nump">144,707<span></span>
</td>
<td class="nump">143,020<span></span>
</td>
<td class="nump">143,847<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Dilutive effect of common stock equivalents, excluding participating securities (in Shares)</a></td>
<td class="nump">3,120<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="nump">1,208<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities', window );">Weighted average diluted shares, excluding participating securities (in thousands) (in Shares)</a></td>
<td class="nump">147,827<span></span>
</td>
<td class="nump">143,295<span></span>
</td>
<td class="nump">145,055<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share (in Dollars per share)</a></td>
<td class="nump">$ 0.64<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per share (in Dollars per share)</a></td>
<td class="nump">$ 0.66<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 65<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-65<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 66<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-66<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 65<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-65<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 66<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-66<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_BasicEarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_BasicEarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_IncomeDistributedToParticipatingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Dividends to participating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_IncomeDistributedToParticipatingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_UndistributedIncomeAllocableToParticipatingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Undistributed income allocable to participating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_UndistributedIncomeAllocableToParticipatingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average number of diluted shares outstanding excluding participating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310098973712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Details) - Schedule of Weighted Average Number of Shares - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedLineItems', window );"><strong>Schedule of Weighted Average Number of Shares [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average diluted shares as disclosed on the Consolidated Statements of Operations</a></td>
<td class="nump">170,413<span></span>
</td>
<td class="nump">158,914<span></span>
</td>
<td class="nump">161,263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_LessParticipatingSecuritiesAbstract', window );"><strong>Less: Participating securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares', window );">Weighted average shares of common stock issuable upon conversion of the Preferred Shares</a></td>
<td class="num">(14,750)<span></span>
</td>
<td class="num">(14,750)<span></span>
</td>
<td class="num">(14,750)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_PotentiallyDilutiveRestrictedStockAwards', window );">Potentially dilutive restricted stock awards</a></td>
<td class="num">(844)<span></span>
</td>
<td class="num">(869)<span></span>
</td>
<td class="num">(1,458)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities', window );">Weighted average diluted shares used to calculate diluted earnings/(loss) per share as disclosed in the table above</a></td>
<td class="nump">147,827<span></span>
</td>
<td class="nump">143,295<span></span>
</td>
<td class="nump">145,055<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_LessParticipatingSecuritiesAbstract', window );"><strong>Less: Participating securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares', window );">Weighted average shares of common stock issuable upon conversion of the Preferred Shares</a></td>
<td class="num">(6,992)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_LessParticipatingSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_LessParticipatingSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_PotentiallyDilutiveRestrictedStockAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Potentially dilutive restricted stock awards .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_PotentiallyDilutiveRestrictedStockAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average number of diluted shares outstanding excluding participating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average shares of common stock issuable upon conversion of the preferred shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310084757184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ScheduleOfIncomeTaxLineItems', window );"><strong>Schedule Of Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss</a></td>
<td class="nump">$ 127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_OperatingLossCarryForwardExpirationYear', window );">NOL expiration date</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards', window );">Capital losses</a></td>
<td class="nump">$ 22,489<span></span>
</td>
<td class="nump">$ 17,541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DeferredTaxAssetsCapitalLossCarryforwardsSubjectToExpiration', window );">Tax effected capital losses</a></td>
<td class="nump">3,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax', window );">Tax of carried forward</a></td>
<td class="nump">$ 1,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">European net operating losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,609)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Uncertain tax rate</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,353<span></span>
</td>
<td class="nump">$ 21,925<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings', window );">Deferred tax liabilities and earnings of foreign subsidaries</a></td>
<td class="nump">$ 186<span></span>
</td>
<td class="nump">205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other Noncurrent Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ScheduleOfIncomeTaxLineItems', window );"><strong>Schedule Of Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Unrecognized tax benefits and interest and penalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=wt_ManJersMember', window );">ManJers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ScheduleOfIncomeTaxLineItems', window );"><strong>Schedule Of Income Tax [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsCapitalLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_DeferredTaxAssetsCapitalLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets capital loss carryforwards subject to expiration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_DeferredTaxAssetsCapitalLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets, operating loss carryforwards, net of tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_OperatingLossCarryForwardExpirationYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating loss carry forward expiration year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_OperatingLossCarryForwardExpirationYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:gYearListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ScheduleOfIncomeTaxLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ScheduleOfIncomeTaxLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=wt_ManJersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=wt_ManJersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310107549552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - Schedule of Domestic and Foreign Components of Income before Income Tax Expense - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseLineItems', window );"><strong>Income Taxes (Details) - Schedule of Domestic and Foreign Components of Income before Income Tax Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">income tax expense</a></td>
<td class="nump">$ 119,008<span></span>
</td>
<td class="nump">$ 39,950<span></span>
</td>
<td class="nump">$ 56,671<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseLineItems', window );"><strong>Income Taxes (Details) - Schedule of Domestic and Foreign Components of Income before Income Tax Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">income tax expense</a></td>
<td class="nump">4,652<span></span>
</td>
<td class="num">(4,067)<span></span>
</td>
<td class="nump">15,986<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=wt_ForeignMember', window );">Foreign [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseLineItems', window );"><strong>Income Taxes (Details) - Schedule of Domestic and Foreign Components of Income before Income Tax Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">income tax expense</a></td>
<td class="nump">$ 114,356<span></span>
</td>
<td class="nump">$ 44,017<span></span>
</td>
<td class="nump">$ 40,685<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=wt_ForeignMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=wt_ForeignMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310098167392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - Schedule of Components of Current and Deferred Income Tax Expense - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 6,957<span></span>
</td>
<td class="nump">$ 4,685<span></span>
</td>
<td class="nump">$ 5,857<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State and local</a></td>
<td class="nump">1,883<span></span>
</td>
<td class="nump">1,415<span></span>
</td>
<td class="nump">1,538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">8,103<span></span>
</td>
<td class="num">(15,538)<span></span>
</td>
<td class="num">(837)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="nump">16,943<span></span>
</td>
<td class="num">(9,438)<span></span>
</td>
<td class="nump">6,558<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(494)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(1,217)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State and local</a></td>
<td class="num">(102)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(251)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">115<span></span>
</td>
<td class="num">(1,289)<span></span>
</td>
<td class="nump">1,784<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred</a></td>
<td class="num">(481)<span></span>
</td>
<td class="num">(1,296)<span></span>
</td>
<td class="nump">316<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense/(benefit)</a></td>
<td class="nump">$ 16,462<span></span>
</td>
<td class="num">$ (10,734)<span></span>
</td>
<td class="nump">$ 6,874<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100762208">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - Schedule of Reconciliation of Statutory Federal Income Tax Rate and Company's Effective Rate - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">U.S. federal statutory income tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 24,992<span></span>
</td>
<td class="nump">$ 8,386<span></span>
</td>
<td class="nump">$ 11,901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration', window );">Gain on revaluation/termination of deferred consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(13,007)<span></span>
</td>
<td class="num">(5,842)<span></span>
</td>
<td class="num">(424)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_NondeductibleLossOnExtinguishmentOfConvertibleNotes', window );">Non-deductible loss on extinguishment of convertible notes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_IncomeTaxReconciliationInternationalOperations', window );">Foreign operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,868)<span></span>
</td>
<td class="num">(2,919)<span></span>
</td>
<td class="num">(3,211)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense', window );">Non-deductible executive compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,833<span></span>
</td>
<td class="nump">789<span></span>
</td>
<td class="nump">881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_IncomeTaxReconciliationUnrecognizedTaxBenefits', window );">Decrease in unrecognized tax benefits, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,386)<span></span>
</td>
<td class="num">(19,871)<span></span>
</td>
<td class="num">(4,998)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses', window );">Change in valuation allowance &#8211; Capital losses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,340<span></span>
</td>
<td class="nump">4,761<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_IncomeTaxReconciliationExpirationOfCapitalLosses', window );">Expiration of capital losses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock-based compensation tax shortfalls</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">373<span></span>
</td>
<td class="nump">507<span></span>
</td>
<td class="nump">647<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets', window );">Change in tax-related indemnification assets, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">291<span></span>
</td>
<td class="nump">4,173<span></span>
</td>
<td class="nump">1,053<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ChangeInForeignNetOperatingLosses', window );">Change in foreign net operating losses (&#8220;NOLs&#8221;)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">Blended state income tax rate, net of federal benefit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">153<span></span>
</td>
<td class="num">(134)<span></span>
</td>
<td class="nump">526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance&#8212;Foreign NOLs and interest carryforwards</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,609)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount', window );">GILTI</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other differences, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">508<span></span>
</td>
<td class="nump">526<span></span>
</td>
<td class="nump">494<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense/(benefit)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 16,462<span></span>
</td>
<td class="num">$ (10,734)<span></span>
</td>
<td class="nump">$ 6,874<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The gain on revaluation of deferred consideration is not adjusted for income taxes as the obligation was assumed by a wholly<span class="nobreak">-owned</span> subsidiary that is based in Jersey, a jurisdiction where the Company is subject to a zero percent tax rate.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense from difference to expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to global intangible low-taxed income (GILTI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ChangeInForeignNetOperatingLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in foreign net operating losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ChangeInForeignNetOperatingLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective income tax reconcilation changes in tax related indemnification assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation change in valuation allowance capital losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_IncomeTaxReconciliationExpirationOfCapitalLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation expiration of capital losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_IncomeTaxReconciliationExpirationOfCapitalLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation gain on revaluation termination of deferred consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_IncomeTaxReconciliationInternationalOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation international operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_IncomeTaxReconciliationInternationalOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation nondeductible executive compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_IncomeTaxReconciliationUnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_IncomeTaxReconciliationUnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_NondeductibleLossOnExtinguishmentOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-deductible loss on extinguishment of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_NondeductibleLossOnExtinguishmentOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310100558272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - Schedule of Income Tax Payments By Jurisdiction - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_IncomeTaxDisclosureLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 6,957<span></span>
</td>
<td class="nump">$ 4,685<span></span>
</td>
<td class="nump">$ 5,857<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">8,103<span></span>
</td>
<td class="num">(15,538)<span></span>
</td>
<td class="num">(837)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid net</a></td>
<td class="nump">16,156<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="nump">8,456<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_IncomeTaxDisclosureLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">4,824<span></span>
</td>
<td class="nump">6,424<span></span>
</td>
<td class="nump">4,258<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and local [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_IncomeTaxDisclosureLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit', window );">State and local</a></td>
<td class="nump">1,457<span></span>
</td>
<td class="nump">1,431<span></span>
</td>
<td class="nump">1,020<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_IncomeTaxDisclosureLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">$ 9,875<span></span>
</td>
<td class="nump">$ 4,645<span></span>
</td>
<td class="nump">$ 3,178<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_IncomeTaxDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_IncomeTaxDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310089592512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Details) - Schedule of Components of the Company&#8217;s Deferred Tax Assets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGrossAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards', window );">Capital losses</a></td>
<td class="nump">$ 22,489<span></span>
</td>
<td class="nump">$ 17,541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Accrued expenses</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="nump">6,030<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">2,468<span></span>
</td>
<td class="nump">1,526<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign', window );">NOLs&#8212;Foreign</a></td>
<td class="nump">1,502<span></span>
</td>
<td class="nump">1,609<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Goodwill and intangible assets</a></td>
<td class="nump">895<span></span>
</td>
<td class="nump">1,085<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DeferredTaxAssetUnrealizedLosses', window );">Unrealized losses</a></td>
<td class="nump">335<span></span>
</td>
<td class="nump">3,821<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses', window );">Foreign currency translation adjustment</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DeferredTaxAssetOperatingLossCarryForwardUnitedStates', window );">NOLs&#8212;U.S.</a></td>
<td class="nump">127<span></span>
</td>
<td class="nump">255<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DeferredTaxAssetsOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">313<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DeferredTaxAssetsOutsideBasisDifference', window );">Outside basis differences</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">401<span></span>
</td>
<td class="nump">341<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred tax assets</a></td>
<td class="nump">34,459<span></span>
</td>
<td class="nump">32,816<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses', window );">Fixed assets and prepaid assets</a></td>
<td class="nump">296<span></span>
</td>
<td class="nump">278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings', window );">Unremitted earnings&#8212;European subsidiaries</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DeferredTaxLiabilitiesRightOfUseAssets', window );">Right of use assets&#8212;operating leases</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">313<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">578<span></span>
</td>
<td class="nump">796<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_DeferredTaxAssetsLiabilitiesGross', window );">Total deferred tax assets less deferred tax liabilities</a></td>
<td class="nump">33,881<span></span>
</td>
<td class="nump">32,020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: Valuation allowance</a></td>
<td class="num">(22,824)<span></span>
</td>
<td class="num">(21,484)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax assets, net</a></td>
<td class="nump">$ 11,057<span></span>
</td>
<td class="nump">$ 10,536<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsCapitalLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsCapitalLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses on foreign currency transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_DeferredTaxAssetOperatingLossCarryForwardUnitedStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset operating loss carryforward united states.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_DeferredTaxAssetOperatingLossCarryForwardUnitedStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_DeferredTaxAssetUnrealizedLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Asset Unrealized Losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_DeferredTaxAssetUnrealizedLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_DeferredTaxAssetsLiabilitiesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets Liabilities Gross</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_DeferredTaxAssetsLiabilitiesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_DeferredTaxAssetsOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets operating lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_DeferredTaxAssetsOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_DeferredTaxAssetsOutsideBasisDifference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets outside basis difference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_DeferredTaxAssetsOutsideBasisDifference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax consequences attributable to taxable temporary differences derived from fixed assets and prepaid expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_DeferredTaxLiabilitiesRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities right of use assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_DeferredTaxLiabilitiesRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310088933248">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - Schedule of Changes in Balance of Gross Unrecognized Tax Benefits - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,353<span></span>
</td>
<td class="nump">$ 21,925<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,353<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Decrease&#8212;Settlements</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,052)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Decrease&#8212;Lapse of statute of limitations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,353)<span></span>
</td>
<td class="num">(6,845)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation', window );">Foreign currency translation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(701)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis=wt_UnrecognizedTaxBenefitsMember', window );">Unrecognized Tax Benefits [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">957<span></span>
</td>
<td class="nump">18,218<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">957<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Decrease&#8212;Settlements</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,865)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Decrease&#8212;Lapse of statute of limitations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(957)<span></span>
</td>
<td class="num">(4,825)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation', window );">Foreign currency translation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(571)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis=wt_InterestAndPenaltiesMember', window );">Interest And Penalties [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">396<span></span>
</td>
<td class="nump">3,707<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">396<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Decrease&#8212;Settlements</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,187)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Decrease&#8212;Lapse of statute of limitations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (396)<span></span>
</td>
<td class="num">(2,020)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation', window );">Foreign currency translation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (130)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">In January 2022, an audit of ManJer&#8217;s tax returns (a Jersey<span class="nobreak">-based</span> subsidiary) for the years ended December&#160;31, 2014, 2016, 2017 and 2018 were resolved in favor of ManJer. The settlement, as well as the reduction in unrecognized tax benefits from the lapse of the statute of limitations totaling $19,897 during the year ended December 31, 2022 was recorded as an income tax benefit along with an equal and offsetting amount recorded in other losses and gains, net, to recognize a reduction in the indemnification asset.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">The gross unrecognized tax benefits were accrued in British pounds.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits and interest/penalties resulting from foreign currency translation." through out the disclosure as per the table structure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis=wt_UnrecognizedTaxBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis=wt_UnrecognizedTaxBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis=wt_InterestAndPenaltiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis=wt_InterestAndPenaltiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310101567376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shares Repurchased (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 22, 2022</div></th>
<th class="th"><div>Feb. 22, 2022</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_SharesRepurchasedDetailsLineItems', window );"><strong>Shares Repurchased [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramPeriodInForce1', window );">Stock repurchase program period in force</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramExpirationDate', window );">Stock repurchase program period in force date</a></td>
<td class="text">Apr. 27,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Aggregate cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,570,000<span></span>
</td>
<td class="nump">$ 3,418,000<span></span>
</td>
<td class="nump">$ 34,506,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remained future purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96,406,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Convertible shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,087,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Purchase price payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (40,000,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_SharesRepurchasedDetailsLineItems', window );"><strong>Shares Repurchased [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Common stock purchase authorized amount</a></td>
<td class="nump">$ 85,709,000<span></span>
</td>
<td class="nump">$ 85,709,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_SharesRepurchasedDetailsLineItems', window );"><strong>Shares Repurchased [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Common stock purchase authorized amount</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=wt_WorldGoldCouncilMember', window );">World Gold Council [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_SharesRepurchasedDetailsLineItems', window );"><strong>Shares Repurchased [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Aggregate cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84,411,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember', window );">Board of Directors [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_SharesRepurchasedDetailsLineItems', window );"><strong>Shares Repurchased [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchased shares (in Shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">635,653<span></span>
</td>
<td class="nump">593,261<span></span>
</td>
<td class="nump">5,120,496<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=wt_GoldBullionHoldingsMember', window );">Gold Bullion Holdings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_SharesRepurchasedDetailsLineItems', window );"><strong>Shares Repurchased [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Purchase price payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiration date for the purchase of an entity's own shares under a stock repurchase plan, in the YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramPeriodInForce1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramPeriodInForce1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_SharesRepurchasedDetailsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_SharesRepurchasedDetailsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=wt_WorldGoldCouncilMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=wt_WorldGoldCouncilMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=wt_GoldBullionHoldingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=wt_GoldBullionHoldingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310096991904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 11, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Apr. 11, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill and Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86,841<span></span>
</td>
<td class="nump">$ 85,856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 605,082<span></span>
</td>
<td class="nump">603,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_PercentageOfRevenueGrowth', window );">Revenue growth rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PercentageOfWeightedAverageCostInventory', window );">Percentage of weighted average cost capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 684<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Software Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill and Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 634<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Finite-lived intangible assets remaining useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 219 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=wt_SecurrencyMember', window );">Securrency [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill and Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of equity interest Acquired</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Aggregate purchase price</a></td>
<td class="nump">$ 985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 86,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill not deductible for tax purposes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 85,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=wt_ETFSAcquisitionMember', window );">ETFS Acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill and Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1', window );">Acquisition completion date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr. 11,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 601,247<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the acquirer obtains control of the acquiree, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 7<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479405/805-10-25-7<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 6<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479405/805-10-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PercentageOfWeightedAverageCostInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of weighted average cost inventory present at the reporting date when inventory is valued using different valuation methods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PercentageOfWeightedAverageCostInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_PercentageOfRevenueGrowth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of revenue growth.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_PercentageOfRevenueGrowth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=wt_SecurrencyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=wt_SecurrencyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=wt_ETFSAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=wt_ETFSAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310107081296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Details) - Schedule of Goodwill<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 85,856<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Changes</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 86,841<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On April 11, 2023, the Company acquired 100% of the capital stock of Securrency Transfers, Inc. (renamed WisdomTree Transfers, Inc.) for an aggregate purchase price of $985 (net of cash acquired). The acquisition has been accounted for under the acquisition method of accounting in accordance with ASC Topic 805, Business Combinations, and resulted in all consideration being allocated to goodwill</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310099125024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Details) - Schedule of Intangible Assets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Asset</a></td>
<td class="nump">$ 605,766<span></span>
</td>
<td class="nump">$ 603,617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(684)<span></span>
</td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Asset</a></td>
<td class="nump">605,082<span></span>
</td>
<td class="nump">603,567<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=wt_ETFSAcquisitionMember', window );">ETFS acquisition [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Asset</a></td>
<td class="nump">601,247<span></span>
</td>
<td class="nump">601,247<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Asset</a></td>
<td class="nump">601,247<span></span>
</td>
<td class="nump">601,247<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember', window );">Software development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Asset</a></td>
<td class="nump">4,519<span></span>
</td>
<td class="nump">2,370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(684)<span></span>
</td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Asset</a></td>
<td class="nump">$ 3,835<span></span>
</td>
<td class="nump">$ 2,320<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=wt_ETFSAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=wt_ETFSAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R118.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310107158064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets (Details) - Schedule of Expected Amortization Expense<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ScheduleOfExpectedAmortizationExpenseAbstract', window );"><strong>Schedule of Unamortized Finite-Lived Intangible Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 1,375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">1,440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026</a></td>
<td class="nump">873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027</a></td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2028</a></td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">2029 and thereafter</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total expected amortization expense</a></td>
<td class="nump">$ 3,835<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ScheduleOfExpectedAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ScheduleOfExpectedAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R119.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310107081296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingent Payments (Details)<br> $ in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>CAD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=wt_SaleOfCanadianETFBusinessMember', window );">Sale of Canadian ETF Business [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wt_ContingentPaymentsLineItems', window );"><strong>Contingent Payments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Recognized a gain</a></td>
<td class="nump">$ 1,477<span></span>
</td>
<td class="nump">$ 787<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wt_ContingentPaymentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wt_ContingentPaymentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=wt_SaleOfCanadianETFBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=wt_SaleOfCanadianETFBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R120.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140310095081664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Impairments (Details) - Schedule of Summarizes Impairments Recognized - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total</a></td>
<td class="nump">$ 7,942<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 16,156<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=wt_SecurrencyIncMember', window );">Securrency [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total</a></td>
<td class="nump">7,630<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OtherInvestmentsMember', window );">Other investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total</a></td>
<td class="nump">312<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=wt_LeaseTerminationMember', window );">Lease termination [Member] | New York office [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">9,277<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=wt_LeaseTerminationMember', window );">Lease termination [Member] | London office [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">303<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=wt_FixedAssetsMember', window );">Fixed assets [Member] | New York office [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems', window );"><strong>Impaired Long-Lived Assets Held and Used [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 6,576<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=wt_SecurrencyIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=wt_SecurrencyIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=wt_LeaseTerminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=wt_LeaseTerminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=wt_NewYorkOfficeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=wt_NewYorkOfficeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=wt_LondonOfficeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=wt_LondonOfficeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=wt_FixedAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=wt_FixedAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>143
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M-6"_T//;:D.C#?03@1[RLI?*UO[M,UR%'@3)^+]UR$O)0"\IAX)/?(TC<CV
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MP3%A\@+X?DFIV!W(&]3_*\'-?P!02P,$%     @ ZWU76*DET88N @  J 4
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MUKS)ZL_J\8/H'6)&7Z*RJOT+'GM9N !)4]4J[Q=K"W)9=/_YMSX0HP6(SBS
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M>X4CMXH2\Q0RS65&%,PGSC6]FM&A=2@LOG)8Z:UK8E-YEO+5#OZ.)XYGB4!
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M9:,"+PR(0<M&^5%,*$PK.M"*G+0^\^J[:$.\([0759TI?0VQB>Q1"JD?&&P
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MUAX^E-FN?E_J?5:6V;;^<R/"M<@K _G[0Y:5WS]4KV ]OC;XZO]02P,$%
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M?P6.<=++%8V=9$B8^4GX*M<1O,QD.\$ G0$Q:X"9#8&0'$ZH<UH"EF-\8HN
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M_?E,-M/5BT$<P+U*1P-PI=%U40(Y"X74*R'YV:\L920,H86?^-Z&A[E!N1O
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MZ!;(0JP0@! 2*)R@=/D'(HLY/&8A;.!#L,.U8*"E>*^QI1B\IP>S#:TI3 A
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M5A,WJ(!,6\[&(ZF_Y"*=U7G(5;A<YJ"79ON05^X+RZWJGE7N7-5OR;E>2Y?
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M>5#JZ1^A_<O8XW"6/.\_?K:MT>$T',TBWP%G$ZK1"=7H!(,D#H<0_<$2/59
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M3/M/>/[%JK7[;#97UJK"#5>"(Q<D@/6%0C+J%U+0?D>]_ ]02P,$%     @
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MLP3<T$2'!=DN-JZ-)6Z#<=KP?P==<.#]VEIZ7H0$AS_9^C]02P,$%     @
MZWU76!*'4;V6 P  LP@  !D   !X;"]W;W)K<VAE971S+W-H965T,34N>&UL
MG599;^,V$'[WKQAH@T4".)%,VSEM SGV*-  P6;;/A1]H*6112Q%JB1EK_?7
M=TC)BK;Q&MV^B-?,-]\<Y&BVT>:++1 =?"VELO.H<*ZZCF.;%EAR>Z8K5'22
M:U-R1TNSBFUED&=!J90Q2Y+SN.1"18M9V'LRBYFNG10*GPS8NBRYV=ZAU)MY
M-(IV&Y_$JG!^(U[,*K["9W2_54^&5G&'DHD2E15:@<%\'MV.KN\F7CX(_"YP
M8WMS\)XLM?[B%[]D\RCQA%!BZCP"IV&-]RBE!R(:?[>846?2*_;G._3WP7?R
M9<DMWFOYA\A<,8\N(\@PY[5TG_3F([;^3#U>JJ4-7]@TLN.K"-+:.EVVRL2@
M%*H9^=<V#CV%R^0'"JQ58(%W8RBP?.".+V9&;\!X:4+SD^!JT"9R0OFD/#M#
MIX+TW.(9T]H()]#"1Y39J=.GC]SYK>TL=F3 B\5I"W;7@+$?@(T8/&KE"@OO
M5(;9]P Q,>OHL1V].W80\0'3,QB/AL 2-CZ -^[<'0>\\<^["W_>+JTS5"9_
M[?.\P9WLQ_57Y]I6/,5Y1'?#HEECM'C[9G2>W!Q@/>E83PZA_VR2#H.=G\&A
M*'PN$'(MZ;(*M0+'EQ)!6."[:PLZ!T<R][JLN-J^?7/)1A<W%NP+9D&8X$'+
M%G1 :<1RB<:G\M^+I0.A*/ U775GK^&)6WOJ"J/K50$?GM]9..:E-DY\PPQ2
M;=W)X C8./'?Z14\D 5/E"AMD1L+Z$L/^D9"\0!7F9^P89\^O2LITK.0065T
MBIA9[]\1NPKB1Y/ID"1LA>'MD-LAY$:7KQW<&[4F8$3;0JWHP93!@Q4]E'8(
M4EN+-'HS.1<&UES6",>I)/=%+DB26_@5R2HP>A-<(50@WA,N!!INTF)[XDG_
M]P3X</@/&]Q3../OH]L/[N"#(9I]]@WMP?%H>C(X9LG):XG@WR"4!;OIQO<=
M:X\\F@8K5W!+S[(/&E>ICY^!U& F7&L&-A0"I9W/S5KXK&JUM_9>YZ,KH+V)
M06>]-5<$M$Z)S.2"SML*_S\!?:"TM,G2JJG(P5$7A9>9E]L)P(YK3C76%/&K
M^'GYE^-.PZ%J%<@VNVA@U\2J=Y!<#MB8#3YKQV4_N?O>I;C72$HTJ] N+=5%
MK5S34[K=KB/?-HWH1;QIYX_<K*@20&).JLG9Q30"T[3(9N%T%=K24CMJ<F%:
MT%\%&B] Y[G6;K?P!KK_E,4_4$L#!!0    ( .M]5UC7L A%_@D  /D=   9
M    >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;-U9:V_;.!;][E]!>)I! MB.
M)=N)FQ>0I"FVB^E,T'2V6"SV RW1-B>2J"&I.-Y?O^>2DBP_XJ0[ ^QB@3:6
M*/+R/L\]E"X62C^:N1"6/:=)9B[;<VOSL^-C$\U%RDU/Y2+#DZG2*;>XU;-C
MDVO!8[<H38[#?O_D..4R:U]=N+%[?76A"IO(3-QK9HHTY7IY(Q*UN&P'[6K@
MBYS-+0T<7UWD?"8>A/TUO]>X.ZZEQ#(5F9$J8UI,+]O7P=G-D.:["7^38F$:
MUXPLF2CU2#>?XLMVGQ02B8@L2>#X>1*W(DE($-3XO939KK>DA<WK2OI'9SML
MF7 C;E7R3<9V?MD>MUDLIKQ([!>U^(LH[1F1O$@EQOUE"S\W'+195!BKTG(Q
M-$AEYG_Y<^F'QH)Q_X4%8;D@='K[C9R6'[CE5Q=:+9BFV9!&%\Y4MQK*R8R"
M\F UGDJLLU>?LB=A++QLS<6QA4 :/H[*Q3=^<?C"XB!DGU5FYX;=9;&(UP4<
M0Y-:G;!2YR;<*_&#B'IL$'18V \'>^0-:O,&3M[@=?/8/ZXGQFJDP3]W6>KE
M#'?+H=(X,SF/Q&4;N6^$?A+MJQ]_"$[ZYWNT'-9:#O=)?RT(^Q>?]EC3RJ]S
MP:8J0;');,8LGR2"&8$'*& [9Q:/;U6:\VSYXP_C,#@]-TRNEI^U$ &13H2N
MH[ U$K9NN=9+B&_=*F,W[AY$5&@MLFC9@5Y1[PPC6@K#KMG#G,-WK7<MMW-X
MWKQBX\YP/':_01!6:VZJ-=6\ZG?4&?7[Y=];!?VUE61IIJS8FAP,W;Q@U.GC
MYZ&86&5Y4C[=U'=K=>@UP\\)%/N8\43:):9:H3-.R,(3]I-,I17QV>NZG'3>
MAP'^CD\&M9'=@-T#BP1I(2J+WW=.QL/6N--_'VP)V3!AKTYK@IJ[_X)4T,W8
MKRP>]5L#V$J_7VD?A,5+H? ,A@%^!Z/.:5A?C-BF&]G=L[1LJE7:R$[F=@C.
MV=\%UQXSV%:^L5^RU>"I'^LT\Q:](!* \ICE6D5"Q(:I*7N' (V#,1XF\ "E
MOG*+1*V'M,U4Q^6VTH>D8-AO)(4;",Z/.HP#[)_0Q'*HA?UD9JRT1>GL[DSS
M6+ N-8BX]4&:*%&F0!S9/=(!O;'4:*N6RLAK6/-@5?3HZK<R5"TRC/,<=CY+
M=""1+%D8'K!#I5DP/F#4U=BT2##<C652(-P,R=2-BK0@+SP)NH5$(YJ!9@ND
M&OIAI(J,E@ 96(%@:.>P5'#2W/F()V5&01+A7J3E! O@NNN'6S8(800WM&K)
M8AE3QK,YQUS.B"!(Z!4+2$#?<C@TY5*S)YX4F)'%7@U:$RDT>>P/T?#1A)1E
M75, KCE5Q(="._=!N24ECMB9.,%6DJA9)O]%#F0S1, ER>#TA+Q&J; !2QVV
MF,MH[I7"OV[I!WCT(9JK1'AH]8 Z(3+C/.+\2?O*+"]P61CO'QJ:\.C1J 3^
M()NY9R$43(Y]#J.$&R.GDA0T["?*+3:HEC8\-9="<QW-ET=GK4]ND]9?BTR@
M(EN?:1PEV;I[SL%R(.E)4=P=&HSZ!VPT.FA]!8<BM[I".(1\\J$Y8L/>Z8B-
M>OT^:X+6SP MU *[SK5,7)1^5D_>SY2NZS[..59%,N?6&\TIDFOXQZ8(?18A
M?!VPED<*(\>\V4R+&58UZY'"XR%ZO32IO=49XIU(";M>S>MZ+>!0:4SA8G]Z
ML&;@/:  SY1>>EM15CZ]5&5T6 )1SP7<64$"FZ;)C!PJ'8*N8X5KJ)%*4X@S
MKJ"5+RL7;C+2T'QI*?<V1780I&C.LYGPY:)TAY9C&D%$50.:B"9%-"\0?@#.
MJRK8.;=-IY1)AI3S?B<0@1<P\GM!J5,'C6%=%51'P^&@R$T#YD$#8"*@CF"$
MQ(0C!TT=)J>4YXF,R Q"3H0;T=;-V=.JW)7S(BH,X74.:GJEX2PH;0JD^TNJ
M:@B.CRK81WTB-4I]<PYP(MPN%QFJ^ UG[!6[D0K07.!L1 H6N?+K553&0'B/
M1DKG2E..@W-FAD=UYE(!I,X+)>)X"*V=A.6'\L@-0?V,ZBNI5E!!\B0A\-9>
M>:P@0^G!H2R7E9-]V%61Q(2I==><\]C-<N9,A,@JC_MXK&6.3%,12]]YH SE
MLMIAKDOP70;WV+4M2\RBR9+CTMQYPN=UE5>1T]()7;FT/KI-ENZ^D2,<0G]3
M))1U9=:MW-!:"]-ZAX,O5JC:8Q]7"$MSJSZ%R>5N%9@4IBH\(/>$3SRZ=A?N
MO$?MP3<*FK2W0317\ZJ34A5#W<Q*Q!AG9CA?K#>1^V]W7S[_)]W"I00]M8T&
ML,[O2[KJ(@"G.L<Y[[\,""?]@]:71A375^U.>N "MG4'918T.M*6Y<WVU.\-
M!FPOLV7[^#,[W"*61YO<RFQ0JU%OZ+G5L/<2N;*JFPO([$Z4)L)$;(L8EERG
MEINY]T?8%;IVK&#0=Y(KZ."0=2&-)UG@4[^AGFI>[".;"CM7L2LIKS&"[-%N
MPQYCA#&E.1(NE-K;@*T,XI& EZD)'8R=,HWP&^])M P@C(;6X,C2]-[(ZK:I
M_PY6%W1&@V'%Z]8I?I5!*ZA=YW:A^^>BV$"$$M+V')379!-E; #("C%6#-#[
MF7KA#B[H@+H6X.&B5L3X?)XZP"1]*.<7X![N-A'/+.*YQ"D-D*V+R+I3ASN'
MK)"TT09)3BF2.D)F$1'?"=<PD4*>)"IRU(Y'6AFOUM9>#6MO$IC[OT27U[!N
M%T<F-'N)'Q,U;MTW0-M%J<:<< ?FE'W4T\.]Z'0*J@3_:-]\,M4LJ4:.QV^K
MD6:X7:5!7P\KOFQ);&^;YF]!9'A$7/NCF&@4Z_)/(_R,7I0-SCVW/WSG7C\<
MO5"GNY&^.I>7LYJ'\JA4#42I:CY.M;MLECBVA/_?..4C74U5Y%*.* ?1+:^?
MA_1-;'^%_3>HI'F946\0R=<(=45=:Q:XP;!QIL.LMY-;'!%,P3.'^DWVO*56
M11]7Y+26ZP4VV@>G4@:(J@SG_N\GQNZ 4Q)]JU7R7R/%KILZ OQ6;KP1].\@
MQYM&]UB#17GVRQ.C2@KL^3&?DN45>Z:1>I=ZT-<\H23@CZAKDR1;EJ#16?<J
M@'P!U"$.;@@(86X"1E[J!P)&+UMBR@BRW;B#IW3F9R4+=SUGPK-'7>0V<OKX
MLULBX9;8 [:K +-Q7OJSB;CGQ.X5$DDGOQ&E*GNZZY3.WW5=WM 9TLS!.*MD
M_[7WT .O2HBW5(=N1N#Q5F(2OH68C,9(9Y=?_]_'A$TX&8_VGA*V$"#HKTX(
M;S\@A"/F7V(WOW_\85J9-7NQ>V<8A!6W5)OOS'N[OOX<-S['I4+/W$=':B&H
M ?]EKAZMOVM>^\]YJ^G^H^AGKF<2%#H14RSM]TY';?_^I[JQ*G<?]R;*6I6Z
MRSE.!T+3!#R?*OBPO*$-ZJ^]5_\&4$L#!!0    ( .M]5U@@']ZT9P(  #H%
M   9    >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;(U476_;(!1]]Z] WC2U
M4A5_Q$W3++&4]$.=M$Y5VVT/TQZ(?1VC8G !-]E^_2[8\3(UC?8"7+CG<"YP
MF*ZE>M(E@"&;B@L]\TMCZDD0Z*R$BNJ!K$'@2B%510V&:A7H6@'-':CB01R&
MHZ"B3/CIU,W=J70J&\.9@#M%=%-55/U: )?KF1_YVXE[MBJ-G0C2:4U7\ #F
M:WVG, IZEIQ5(#23@B@H9OX\FBP2F^\2OC%8ZYTQL94LI7RRP:=\YH=6$'#(
MC&6@V+W !7!NB5#&<\?I]UM:X.YXRW[M:L=:EE3#A>3?66[*F3_V20X%;;BY
ME^L;Z.HYM7R9Y-JU9-WFQN<^R1IM9-6!44'%1-O337<..X!Q^ 8@[@"QT]UN
MY%1>4D/3J9)KHFPVLMF!*]6A41P3]E(>C,)5ACB37K,-Y&2N-1A]0KZ F08&
M:>UBD'44BY8B?H,BBLFM%*;4Y$KDD/]+$*">7E2\%;6(#S)>0C8@P^B$Q&$\
M/, W[(L<.K[A?Q4I\*G_F"^U4?@D?NZKMV5+]K-9FTQT33.8^>@##>H%_/3#
MNV@4?CR@->FU)H?87VO=)_ PQ7A 7E?\6 (I)$<3,K$BABXY=$YDOT&3P@&H
M TP\O "HEJ#L)7CV$FP3>U?/#:O1D<9[3Z*3\/P,^_-1['T&K2=HL*RI&DX-
M$N6 1Y,Q:IWG'8W.PF/O*(G&Q]ZC-)0C+(DM^#1)]AU9L/.>*U KYUI-,MD(
MTS[M?K;_&.:M'_ZFM[_*+54K)C3A4" T')R=^D2U3FT#(VOGCJ4TZ#4W+/%S
M V43<+V0TFP#NT'_7:9_ %!+ P04    " #K?5=8@^XX-KX$  #\"@  &0
M 'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6RE5FUOVS80_NY?<7#3(@$46R^)
M7_)B(''2M$"[&4VZ8ACV@9'.,E&)5$DJ3O;K=T?)KM.XWH9]L47R[KGG7GB\
MLZ4V7^T"T<%C62A[WETX5YWT^S9=8"EL3U>HZ&2N32D<+4W>MY5!D7FELNC'
M83CHET*J[N3,[\W,Y$S7KI *9P9L79;"/%UBH9?GW:B[VO@D\X7CC?[DK!(Y
MWJ+[7,T,K?IKE$R6J*S4"@S.S[L7T<GE$<M[@=\D+NW&-[ G]UI_Y<7[[+P;
M,B$L,'6,(.CO :=8% Q$-+ZUF-VU25;<_%ZAO_6^DR_WPN)4%U]DYA;GW5$7
M,IR+NG"?]/(=MOX<,UZJ"^M_8=G('I%P6ENGRU:9&)12-?_BL8W#AL(H_(E"
MW"K$GG=CR+.\$DY,SHQ>@F%I0N,/[ZK7)G)2<5)NG:%327IN<H5S- 8SF&H*
M=(9&<+#>O!K%47R:ZR*#2CQ1$IP]ZSNRQUK]M,6^;+#CGV!',7S4RBTL7*L,
ML^< ?2*Z9ANOV%[&.Q&O,.U!$@40AW&R R]9>Y]XO.0_>0\W[/>L]1O^N+BW
MSE#Y_+DM!(V!H^T&^$J=V$JD>-ZE.V/1/&!W\N95- A/=] _6M,_VH7^/Y.W
M&WO<@W\/_UTT_4=1@SX2RI&T4*#O"YDW87<+)%-E)=03"$MM@B2D8DC5WN&E
M= N0!"+2;[6TTF_JN=>\K@VU*D+$QW0A5(YP2%FCNH-#H;)#J1[06(1?%7P4
M3Q"%31$%SZPZ-'3'!%-C*^2W3WPMBA]J8H,U-480>6Z0UOC<?W#:"0IL#GM1
M,@C&80)5;6PME*,C$' K"@Q@5AMB3-R()UQ8*W/%5BBHQ&.?^7$@X_#T=G8!
M%V0)^=CO1:<'35"^2)OI\H[.X#V%UBA/@'B_(][$P,('EP5PS=W0"+@3)J>.
MSX=3#1]D*<EG.KY[>PM344FB'<"7FVD -Y?OZ.?.<_OT_D,//M-=-CYJ'"V[
M"C^A*BM\FKP2Y3E%:KB4Y*HR^E%2!\7B"?:.@F08^;P*N_"P41*$HR%GYA?]
M@.4]P<=;TT.ETX8J\_NMXN&<W;[;$,RPR60KUQ8</(BBQA7A;&O)\NE>Z&GM
MT<,6Q&-:<"K2AEC;?&*H+>>5@>:ZH*>-5[YH*X:Q)YT7*AUZ1I;"9(<%O5$L
MWMP+(U.$?4(X:*]+13JZ5BEV]B *1L>CG8H+>G:V:29!% ]V:B[]B\4)HIM!
M#_ VE#B(DV'G2MJ4=AQ0C+ 31;WP=6>&ID)_,W+J6E2!S5DO>>TS,6\,P]KR
M86ME8^?%Q[2FA) 9CGZA^833"%>U6<7Z"86Q@/R<O,A)XO4XTC]63:IS)?]J
MB^%[NB2/%;:B&\%9WUX/)YW?O<GK%R8[;++C$TL_46>S63SK>!3&01 .QIS.
M81"%H^8C' ]^KK/9.7TN+!W)K$-9'0P[X^ X#-O?&QJ\P ](7-V><W_5QMIZ
MWN[9UN:\#Q$<,.$H&!\G7 ##8#@X]I401B/?B,+D%/:C@W7:MCUD_8V)I$3J
M-3QW6?!5U PGZ]WU:'?13#3?Q9NY\".U*JDL%#@GU; W/.Z":6:M9N%TY>>;
M>^UH6O*?"QI/T;  G<^U=JL%&U@/O)._ 5!+ P04    " #K?5=8TZHD!A0(
M   K%@  &0   'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6S%6%ESY+81?N>O
M0(VU+JF*YO"<2T>5M+83)[N.:K7K/*3R@"$Q0]22! V &DU^?;H!DL.Y9#FU
M57F0. 2![J^OKYN\V0CY5>6,:?)2%I6Z'>5:UXOQ6*4Y*ZGR1,TJ>+(2LJ0:
M;N5ZK&K):&8.E<4X]/W)N*2\&MW=F+5'>7<C&EWPBCU*HIJRI'+[P JQN1T%
MHV[A$U_G&A?&=S<U7;,GIK_4CQ+NQKV4C)>L4EQ41++5[>@^6#S$N-]L^(VS
MC1K\)FC)4HBO>/-+=COR$1 K6*I1 H7+,WO/B@(% 8S?6YFC7B4>'/[NI/]L
M; =;EE2Q]Z+X)\]T?CN:C4C&5K0I]">Q^2MK[4E07BH*9?Z3C=T;SD<D;906
M97L8$)2\LE?ZTOIA<&#FGSD0M@="@]LJ,BA_I)K>W4BQ(1)W@S3\84PUIP$<
MKS H3UK"4P[G]-U[43TSJ?FR8.17H9FZ&6L0BP_':2OBP8H(SX@(0O)15#I7
MY*<J8]F^@#'@Z4&%':B'\%6)/[+4(U'@DM /HU?D1;V1D9$7O=5(\J_[I=(2
M4N+?I^RUTN+3TK!,%JJF*;L=01TH)I_9Z.[[[X*)?_T*UKC'&K\F_6T!>57$
M:8 D\#UR[(A_5.1GMI0-%"0)8NMQE^B<P=ZRIM66<*4:EA%:942)(B,70>2[
MON\3#C6U7DNVIIJ16O(JY34M""U%4VDB5B3QILF[/9U/K.)"MJJSAJ&Z&;E$
M==]_-PM#_QKUV^=F(;B^(G4C54-!I!:  M1FK-*-9"0#Q=DI^$NF-XQ5>V8@
M_B_>DT<>:/65?)906MTSE_Q*D2( _+U2(N7FSB54$8W[&".7@)IK!=R5I@SV
M2+2>5YJ!?[7U5VO 9WNB0^\:-Z%[GM%-8K5BX*DUVO)[0PN^XF "KY3FNFDQ
M+)LMDVK/[$\-."^(XWO2@/72Z'MB:2.YYN#)^]3X.YA'D4%-@36A$LEEBZD_
MWJ'R,.Y_:RK6.2WXHY@G;XQYY(5OB/GD,.;!GXOY ?1S\<;[-A[?. X#!TX,
M"O];.3!^DP.C/0<:( CB?_%BC___Y,7[9HVU&$1O\F.8?%LW4FWM21EA: +B
M"_S@'<I ($>R85$RL7))732JIP 8!%@)0.%T3I\9#!NI1. *3K-#1V]RGN8D
M%:V?8#=9-1(%&WLI'D$-:#6.7? <Y*S!!N!RK/<-U_F>GS#BP?1:D8-,V,N2
MUM%'>6*#+-;,($#91O2!J#V2.\XUS_FE0I.J=MKJQ0PL,O<[@M^/M&20(FD.
M Q962_#&,+<26S >\#<X"P(",YE]S-5 \J'&5*PK_A_,+U((I0C@9B\:7-UP
ME0.'&AFTKJ5XX3  LF)++N;N%-@J:VS>@[@MHY)8OH6YA95+<&(WNWCD,^R0
M#*=CY.TCQ##*84%FJ-IF2>*VB0E!V4!N0<RU+IC)!'*1S-UYDJ!?4JIRLREP
M_6CJAK,9N5_IMC?L3#9;C!*NMR?T=P5^/DSD\G1^[%A[+S6.1HQ=)QPZ/Z=8
MS+,WDN+QW +O%TH#,(B"1_[.M@1,+U6'_G@_!4]"9UR) EY#U,+9V>?L#'$>
M>]T#^<X%:4<>_&5YW/G8N12IE%PV50%C 8%4*#@X*;7Z6>;NY35$$&)MF.+*
MZ7C/!GSF#,,_@6IJB46"?,=,4H[IK8ZUS;P4&=X"4',OB1%;X/GQ\+DY&_BQ
M-YLD,V?N>\ET/G4^ 82RUD,!0>C%QKK8BQ(;R<DUV<.PZ)</ 9QZLB K>-F"
MH%2[AYBP-IF[TCH,]4[2(<8%A+5_^(&77)M&\PSHP*EU QCQ]4N=1(GP87,*
M+ZV*F=J!V%"\FO<KG!U3+M.FQ(C#>+<@/VQR4;!>EFT=&&TLA7;PVL*VWP2R
MA2GROKDJC/Z!>)N<>#@5SZR"/JBPE:9%DUD:@3;4U&*'C,$N;=*Y?<,D(@6M
MAG2LF HT-W#K$L9-80[:-"::I0%5,_/:2\">#/LP2*R$)B9;06U%L$V^B68'
MPMHV]$>%";P#]<'2 HL/18!-7)[60(L"A^M\J.98.+37Y9#=LK8-FU&E:[EP
MG(/LW73.5\1,^?8T+Z'\N&5S' /0G37=4M!BZ=IRA(D++@)<\<PSY)#NT\4K
M-*./FX#1<+@:+IRCC4<KX1F:^BPT+88+.T)OGST>N/@DAUV0EH#WUH)ITOZ*
M[+#E/(*+%^01VAAO2L?,&N'UV6N8^.;O+Q);*C@O92Q33J>^4]2I[NY1+1Y#
MI7C] !FZ(%\JP \>QB;=MZA4**V<R]"=SZ97> W"!*Z)&P3AE5T/X J-,8G@
M&D.#C*^<]U3*K:D?ZY$@G+I^$!G6F[JS:8+^F,;N;#9KU_Q@;OP1NP'0)OHC
M<,-@XOP$8Z_-4#YD2'))0.W$D'3DS:)W3NS-)]WOQ LGN#+QWQE>\:-K<AE<
M[4B6O=2L GX2U9G<.I@YU+FAPZ:.R3J3(AOH>Q?PLC2/H;F8'\#Q^/0B"-TH
M"MU!S15;;X>HK0K,]HO(]>/ GIJ S+-YCJKW!4+]J9;K#&=CH6( 5"\?SPG#
M806G2U[8E]J='V#RY_:-Y8$6)@.>\'N7:LN5<DF>:=&P\V5Y"1RDE'T] 6]\
M 'HM2(A@]+Z$'+HW!6[97EFWA;/ G<VGUO (AO<DB/Z,\18B$- /_4APZAO1
M>/ !KV1R;3Y38B,!/]EO>?UJ_R7TWGX W&VWGU$_4KF&-S!@^!4<]6%P&-G>
MV-UH49O/@4NAH3N9GSFCT!QP SQ?"7!9>X,*^N_#=_\%4$L#!!0    ( .M]
M5U@_<VJJI 4  -,-   9    >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;)57
MVV[;1A!]SU<LE#:P 5E7V_$=D.T$"="T1IRF#T4?EN10W'K)97:74M2O[YDE
MQ5"")2,O$I><.3MS9N8L>;4T]LEE1%Y\SW7AKGN9]^7%<.CBC'+I!J:D D]2
M8W/IL;3SH2LMR20XY7HX&8U.A[E41>_F*MQ[L#=7IO):%?1@A:OR7-K5+6FS
MO.Z->^L;G]4\\WQC>'-5RCD]DO^S?+!8#5N41.54.&4*82F][LW&%[?';!\,
MOBI:NLZUX$PB8YYX\3&Y[HTX(-(4>T:0^%O0'6G-0 CC6X/9:[=DQ^[U&OU]
MR!VY1-+1G=%_J<1GU[VSGD@HE97VG\WR S7YG#!>;+0+OV)9VTY/>R*NG#=Y
MXXP(<E74__)[PT/'X6RTPV'2.$Q"W/5&(<I[Z>7-E35+8=D::'P14@W>"$X5
M7)1';_%4P<_?/))5Y,1,/( -LI82\>A-_'0U]$!GFV'<(-W62),=2..)^&0*
MGSGQKD@HV008(JPVMLDZMMO)7L1[B@=B.NZ+R6@RW8,W;7.=!KSI3^8J_IY%
MSELTR#_/I5V#'C\/RD-SX4H9TW4/4^'(+JAW\^;U^'1TN2?DXS;DXWWH/U6>
M_4CC\4#L)."/0LQ*J[08CYCM\5E?^(S$G<E+6:Q$JC1,I;@CZU6J8NE)F%3<
MDU/S0O)T.5ZW\+]CW(Z^&J^*N3B*3;& 'P!F#O/B8JLB+%11;[$;<C.&I=):
M%,8+Y5Q%?2&+1+S[\OY1W,E2>:E%8K W&V1R0<'5\D0*;R >WRIE:0,/MUND
ME7"91/$X@MCD.<)W@9>JQ&6=0% A/&>,73SVA4J!YT 5T* +[."J..M@]#>C
M/O!F3L"T2-###G1 287T'C150;A*"8K('4+?*IV(B H"84IJO1)F68C<A-1D
M(<X'Y^>_KH-L$GWS^FPR?GN)W"KO/%CCHFPDJ?*<$H4" $^F'J',U8*M*$VA
MG<S45@X#\3'04C32&D+G/8%;:O(=JD*RLQC\.^5#^MTBA HD8GS<?WLR:EOF
M"RQ2HW%>\$HQG<V9\5(!(-!:%C%=O()V4!XA%^C'YN(C]F2;C8[=PGGUBQA/
M)QQ4Y^HW<NY"M.ZQ<=Z].AB?C0^;WUUHH023RUA:N^*,%E)7U "?G)YWKNZD
MRT0"]A,J$IZ66$N&*1%[:%%Q\*U".Y#5JT/XC0:C:?,GOE!>&LLD<;?[E8"O
M<_5L<4' 8S,'"=BU6"2$ S[2A%F$_%4X:KT+CY:90KW9("^#+YIQ/D?M!8?
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M,>MHQ6M_,7 8TG.A(VBAE8R55G[+";2T:.C@*L"\+X*Z258ZT&G2WX="1\Y
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M,BV65]V;\/QV2/O=AM^EV)B#,2--%DI]I8_[]*H[($(B%XDE!(X_:W$G\IR
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MO3$UXJ4S#(9A2+_3T6O AYM[GV_S^[N;WSM1,)T,.W$0C4:=N4)*TG'38 0
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MT :L+Q54:#[H@-W_+J[_!%!+ P04    " #K?5=8:%-)_#0'  !W$   &0
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M],O]W2Y%X0B4M;+E(I&OD%[H&D4')VI8U[3N9F61P06T0+1LDDT# ,AI;,2
MW/.E>AY.;2)^.0)FAP#,+%1/%3LQZ^)4<&*SW5B1>@'SKY7[W/&P.BJDQ/D
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M3Y.+Z,L)M;-![>P4^T<?Y31)?#Z&8[8?*Z3]NF%R2UV5J5+R5\R!04DM#*J
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M$DC9,C<W<O45FGCZEB^6N:Z^9%7[TM E\5(;631@5%!P48_LN;F'+<#0?P=
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MSDXXLT.O#AN/;>R/#7KJMKALZ'D#&QSHO$+T^TU(,#Z8^1]02P,$%     @
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M3.3@6VB ^4F4.D_ED_ETK>.LJQ5_XH(2%<U&3^[>5$3\S:;?R%_Z#I2RO0)
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M](02W9FT"ZQJO#&6RJ+-_+3"=PVT2\#]4BF["=P!PTN9_0%02P,$%     @
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MAVQ#BQ>^.=N_;]9*2^R-?\[EVZ)%Y]',O,Q4S5-8N#@0"N0SN,L/[^@XN+[
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M,A@70.=+K>W.<0G:01__!5!+ P04    " #K?5=8VD]IF:0"  "Y!0  &0
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M>NACZE4[L]J-D8V;$QMI<.HXL<0Q#\HJX/>ME.:\L0ZZ/P[3SU!+ P04
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M=O@>%EU5_'/O_I9;9M8<$Q%08V@\>G]!B>GJM3.<;D.-%-IAQ85A@U\<&.^
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MS1J;NBS3+$*%<NGIN]\%3)2=($JH84.Z]H"U@0SZX'K,X@'[4-?Y8U&6/80
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MA,:;WC8K?%J!-!-P?"V$/G1,@.&Q-O\;4$L#!!0    ( .M]5UBZ+;>#U@(
M &$&   9    >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;(U5;4_;,!#^GE]A
MA0FM4D7>VK24-A(O0T,"ABC;A*9]<)-+8Y'8G>U2NE^_LY-F991J7_QZSW//
M^7*7\4K()U4 :/)2E5Q-W$+KQ<CS5%I 1=616 #'FUS(BFK<RKFG%A)H9D%5
MZ86^'WL59=Q-QO;L3B9CL=0EXW GB5I6%97K,RC%:N(&[N;@GLT+;0Z\9+R@
M<YB"_KJXD[CS6I:,5< 5$YQ(R"?N:3 ZZQE[:_"-P4IMK8F)9";$D]E<91/7
M-X*@A%0;!HK3,YQ#61HBE/&KX71;EP:XO=ZP7]K8,98957 NRN\LT\7$';HD
M@YPN2WTO5I^AB:=O^%)1*CN256W;BUV2+I4650-&!17C]4Q?FG?8 @S]=P!A
M PBM[MJ157E!-4W&4JR(--;(9A8V5(M&<8R;I$RUQ%N&.)U<50O*)+ZR5N3C
M YV5H#IC3R.SN??2AN6L9@G?80E"<B.X+A3YQ#/(7A-X**G5%6YTG85[&2\@
M/2)1T"6A'T9[^*(VSLCR1?\1YX_3F=(2OX>?NR*M>7J[>4R-C-2"IC!QL0@4
MR&=PD\.#(/9/]JCLM2I[^]B3*=9<MBR!B)Q,;9FPWZ#(MOA[2,6<XW&V2_Q^
M^H<"2"Y*+$3&YT2;;#?5:-VP+3>R=4-F:Z(1>"[PFJ]'SB-0V22:8)J@FH$T
MJ7),JLP0FB%PK@&KA6B0^-E24X*'!\,P"$YNL50?L50QR)RE0#[>"@TDB#K.
M!\>:A"?;*W+<#0<#YY*]H#^J%&BUEVC8:;&;.>[V!_&[>JX%S[ _O%'S+TOD
M1\X4TJ64P--U8SCH.(-N'/EOK+_@FTG"^#,HW937!A %X1OS!Z%IB<$.NL>]
M\%7X0=P-^O&NC\O;*OL*Y-PV-T52L>2Z[@#M:=L_3^NV\=>\;KXW5,X95Z2$
M'*'^T:#O$EDWM'JCQ<(VD9G0V)+LLL!_ $AC@/>YP.":C7'0_E62/U!+ P04
M    " #K?5=846"6CQ($   :$P  &0   'AL+W=O<FMS:&5E=',O<VAE970V
M,"YX;6RUF&UOVS80Q[\*H15#"S36HV4[LPW$L89E6("@7K87Q5[0TMDF2I$:
M2=OI/GU)25$L65'C0GMCBQ+O=^3_Q..)TR,77^0.0*&GE#(YLW9*9=>V+>,=
MI%@.> 9,/]EPD6*EFV)KRTP 3G*CE-J>XX1VB@FSYM/\WH.83_E>4<+@02"Y
M3U,LOBZ \N/,<JWG&Y_(=J?,#7L^S? 65J >LP>A6W9%24@*3!+.D(#-S+IQ
MKR/7,P9YC[\('.7)-3)367/^Q33NDIGEF!$!A5@9!-9_![@%2@U)C^/?$FI5
M/HWAZ?4S_==\\GHR:RSAEM._2:)V,VMLH00V>$_5)W[\#<H)#0TOYE3FO^A8
M] U'%HKW4O&T--8C2 DK_O%3*<2)@1N\8N"5!E[3('S%P"\-_+=Z"$J#X*T&
MP](@G[I=S#T7;HD5GD\%/R)A>FN:N<C5SZVU7H29%V6EA'Y*M)V:K\B6D0V)
M,5/H)H[YGBG"MNB!4Q(3D.C]$A0F5'Y 5^AQM43OWWU [Q!AZ,\=WTO,$CFU
ME1Z'H=EQZ?.V\.F]XM/UT#UG:B=1Q!)(Z@!;3Z":A?<\BX772?P=LP%RW(_(
M<SRW;4#=YDN(!\@OS/T6\^7;S;T6\^CMYFZ'&'X54C_G^3\8TL]_: -TIR"5
M_[2,=E'0@W:Z25S7,L,QS"R=F22( UCSGW]R0^>7-N'[A"W[A$4]P6HA"JH0
M!5WT^0(8;(A"&8@8F-(9&?$-4O@)":R@+2B=O$N#4L F.<SL)(>Y,QA.[<.I
MUGTZC'J"U;0>5EH/.[762V"?[JG6-3$[B%X#JDW@ C(\T21TP[HFM^=])L-1
MX#:4.^_E^B-W4N\5=0[Z!R4)*TG"3DGN6*R+"FFR0HR%^&HN#ICN\[<PYNP
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M)6E[0TR )=3>D?PZ"GW5ZPTJO4&CWO-<XB>7<G*6*]Q2BHQAAI]!3>ZO()N
MK"VO1LZ/EM>>R+;LMRO[[4\Z8>U]IF!/9%LIZ%0IZ#16P&^\BU.&SF-"E0*T
MSK@&R:FYQO#LJ7RB6,SP#L5K<9:G5 L<1G3.S,F4IM8E9&\=QLZKDO5Z;K!;
MV#510:_;K2_M;F6LV_SI6 IRP3CE$4.AEUQIIG-C2C76=B/I1__8/9%M^>]5
M_GN?5-N]?:9@3V1;*7"=E_;!V??]L6+<NAG<=K>W>X'4Q?FNZ[1VRM;>Z'Y,
MZWE%Y8QA$:8P1:!S8GHU679SY42+>=$0383&]JH8)M@!@S0!N#\50J\GIL>J
M>NKP/U!+ P04    " #K?5=8S#>]YR "  # !   &0   'AL+W=O<FMS:&5E
M=',O<VAE970V,RYX;6R5E&]KVS 0QK^*T&!L4.(_2;,MLPU)L[+! J%EW8NQ
M%XI]CD5ER97.<?OM)\F.ET$:V)M8)]WSTW/.G9-.Z4=3 2!YKH4T*:T0FT40
MF+R"FIF):D#:DU+IFJ$-]3XPC096>%$M@C@,YT'-N*19XO>V.DM4BX)+V&IB
MVKIF^F4%0G4IC>AQXX[O*W0;098T; _W@#^:K;91,%(*7H,T7$FBH4SI,EJL
M9B[?)SQPZ,S)FKA*=DH]NN!;D=+0&0(!.3H"LX\#W( 0#F1M/ U,.E[IA*?K
M(_W6UVYKV3$#-TK\Y 56*?U(20$E:P7>J>XK#/5<.UZNA/&_I.MS9R$E>6M0
MU8/8.JBY[)_L>7@/)X)H_HH@'@2Q]]U?Y%VN&;(LT:HCVF5;FEOX4KW:FN/2
M_2GWJ.TIMSK,;AG7Y(&)%L@&F&DUV#>.AKQ; S(NS/LD0'N-2P[R ;GJD?$K
MR"@F&R6Q,N2++*#X%Q!8?Z/)^&AR%5\DKB&?D&ET1>(PGE[@3<>BIYXW_<^B
M?RUW!K5ME-_GJNZ9L_-,-SP+T[ <4FJGPX ^ ,W>OHGFX><+CF>CX]DE>O:=
M/[6\(%P>P* W>T64YGLNF;#M@*WFR,&<LWT9_"DD!7LQYRP&)UU5@][[V3$D
M5ZW$OL'&W7$\EWU7_DWO9WO#M+5JB(#22L/)AVM*=#\O?8"J\3VZ4V@[WB\K
M^XD![1+L>:D4'@-WP?C1ROX 4$L#!!0    ( .M]5UC6C;#;3!   (+"   9
M    >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;+6=;6_;MAJ&_XK@#<,&M+6H
M=V5I@#5ISBFP;L72;1^*?5!L)A%F6YDD)RMP?OR1'">D9.FA2=W\TB:.=(M\
MQ,>ZQ+?[]+$H_Z[N.*^=?]>K3?5V=E?7]R?S>;6XX^NL>E/<\TWSEYNB7&=U
M\VMY.Z_N2YXM=R>M5W//=:/Y.LLWL[/3W6>?RK/38ENO\@W_5#K5=KW.RJ_O
M^*IX?#MCL^</?LMO[^KV@_G9Z7UVRZ]X_?O]I[+Y;?ZBLLS7?%/EQ<8I^<W;
MV4_LY)(E07O&[I _<OY823\[;5VNB^+O]I</R[<SMRT27_%%W6IDS7\/_)RO
M5JU44Y!_]JJSEXNV)\H_/ZM?[FK?U.8ZJ_AYL?HS7]9W;V?)S%GRFVR[JG\K
M'O_+]S4*6[U%L:IV_SJ/^V/=F;/85G6QWI_<E&"=;Y[^S_[=1T(Z@?DC)WC[
M$[S^"<'("?[^!/_8*P3[$X)CKQ#N3PB/O4*T/R':Q?XI6+M(7V1U=G9:%H].
MV1[=J+4_[&[7[NPFP/FF;5I7==G\-6_.J\\NL[QT_LA66^Y\Y%FU+7G3;NK*
M^?Z"UUF^JGYP7CM737M>;E?<*6Z<GZJ*-W_.-DOGYSR[SE=YG?/J^=RED]6.
M)/G:^?WJPOG^VQ^<;YU\XWR^*[95<VIU.J^;LK<EF"_VY3Q_*J<W4LX+OGCC
M^.R5X[F>/W#Z^^-/][JGSYN(O83->PF;M],+E&%[Y?S&%]NRS#>WSI>/?'W-
MR[^&JD?JM5\@)]5]MN!O9\TW1,7+!SX[^^X;%KD_#E46)-:INO]2=7^G[H]4
M753WI@W"P^Y&KZ6V<S)4?1]9?9!8I_K!2_4#\LZ?9]6=P__9YDW%V]H.5?9)
M(=PIM-_M#V=AT^RBT_F#7(O#HU+??3FF4[CPI7 A>6\^;!YX53]E<)-OYT7S
M>UGGUTWN_E+4?+"P(?+.@,0ZE8]>*A^1=^9S46>KH1H^G19)@69ND@9)[WX,
M'!8D83IR2^*74L46TB5&WA206*?ZR4OU$_*F7/ ;7K8/AD71X,B2E]D.*+YO
MFZ.3_C!4=U)0M^[)P4UMH,L;NZGI2ZW2"5__SO^<J]V'?+/X^LKYL%F\^>Z;
MQ&/>CPLI(3=M!*@G!ED$W3B Q#K18JZ #!?^O;27!-4?I=8-@$19C&PP1@$@
M);4#P :^WD)W)!&8 "$VA82:5'C_^;(BVSE] >UZVF C)N"(T71TF6^RS2+/
M5LUMKNIR^W3+B\<-7[YJX5@\! :_]QF4DU!JW5@(4F(T*AT?B\%0! <-U@]9
MPGI/[8'#/#^.O9%V+4B*D:RB;M>?LJIZ7=^5Q?;VSOG/U7M%(X=B%DJM&QL!
M6BRRVLA)CM..!4BM&PN!=XS$IZF-/!Y@4R]P^XW\\+ T2OQXI)$+.&,TG2D;
M^>]OKMXX=;G#U?8]GVSB4'!#J74C(P"/I5:;.!3>4&K=K@Y!;QX)1Q.;."VN
MW?/A'G[=I\D(Q7B"SSR:SY2)<%Z4]T7S\L*=ZV*SI!.!OI9VC4%JW<A('5V>
MS43PL/U>-N#.$W#GD< T-1&@;+=7DQ,A2<*1/!#(YBF0394'?^;5LEA_+CEW
M+O+;O&YB<;E5)@1Y4>V:@]2Z(1)@Z-%];%,3 @J"*+5N+ 0(>G27V\2$@'*@
M-]!_%T=C&2'XSE/PG2HC?N8/?.4P.@&@_7DHM6Y$!#1ZB84>30]*ARBU;@@$
M'7IT_]\Q@P![";D]#HT"#!PV.@S@"V3S\1UN/A344&K=  B@\VF@&QT,\ _[
MP5(O#KW>;1DX+'33L6X%7^"43^.4X>@9E*)0:MT02..'-$49# G0BMKU-U!S
MJ*H+O/(GXE7_80(:2J"+I1T_&P#F"P#S\8.</I2Z4&K=  CJ\FGJ,@H E+5,
MU,@,$CCF@W'LF!$(^IK:P;&!9[[ ,Y_&LXGO)SZ4TU!JW5@(3O,5X[23WD_\
M0S0;&H$8.(P8@0@$PP6*;C>#IJXW*$$70/=>H]2ZX1+$%S";[3Z =MJAU+JQ
M$)09* 9E)[5[6ORH;_=]%+R!S!B=?!$(@@P4_7 &F:$SDD%?7KLM6)FN)LU7
M"ZSF!10=46K=6 AT#!2#NM/R @J1>[7C1C(" 8>!HDO.(#=T!C?HRVL'P<;@
M;2!H,J GYTW-#2@WHM2ZL1#<&"C&@J?E!A0;3=2H]XM $&,P<6;?0/H8C8G0
MY= .F(T1XE"@:DAW-T[,HQ#*H2BU;BP$AX:*H>1)>42+:X?"0(W*HU 0:#AQ
M6N!3'GEDCM#7T Z&C6[/4$!K:&/=1 A%491:-P0"1</I:R=H"8V7#X!0MYK2
M(@P+JS"PRS!L=%"&@D%#PY48X< 8;<32_IC8P&%Q<]C(=+=0X%YH8RU&"*4\
ME%HW!(+R0OAZ#%I1N_Y@M L%VH40M//0@R]TL;3C9X/T(D%Z$7Y@.8+B'4JM
M&P"!=Q%^)0<MJ1T ,-1% NHB,-0=,_A"7U,[.#8@+Q*0%UE=_A%!:0^EUHV%
MH+U(,=@]Z46(%M?@0(!0-P"" Z.)2T@&TD5O (<N@'9[L;)Z5UJ^:W55203M
MF$2I=6,A2#6RN:HD.FY5R<!AL1\&(Y@="<:,)JXJ&6CW.L,S].6U[[2-(>I(
M4&ED=:%)!(5+E%IWI;R R]CF0A-:7'O1O($:]=B(!6'&$]>B#*2/S@@.?7GM
M.-D8Z8X%DL96EZ?$4/A$J75C(> SMKD\A1;7#H7&\I18(&4,F3_I31Z=H<NA
M'0P;H]ZQX-#8ZHJ5& J9*+5N+ 1DQC97K-#BVJ'06;$22QO.0*9(^G0"8'>@
ML='I&0L@C6VL6(FAF(E2ZX9 8&8\?<4*+:'QR@T0ZFXV) @RP7=/)E!N1*EU
M R#@,3%<]T*?IW%SD\.5,1X+/#;\M94(DDMLK(Q)H "'4NN&0 !< E\90RMJ
MU_^0VJCMLA(!;@D$W'STV M=+.WPV."X1'!<@A]73J#PAE+K!D# 6X)?^$)+
M:@=@:)/ T5VT$L%L"9C9CAE9H:^I774KVPA*^PA:7=:28'<5M %SB8"YQ.:R
M%EI<AP3 F)<*S$LA2V-\\Y$5N@"Z[06EU@V7@,+4ZM*8%-IAB%+KQD)@9FIS
M:0PMKI$[ *%N  1DII#%,[[IZ Q]>>W68F,,.Q7<F@96,P>*GRBU;BP$?J8V
M%\_0XMJA,% CTT<P: I97^.;CL[0E]>.DXUA[%1@;6IU?4T*!5B46C<6 F!3
MF^MK:''M4( G8:;2QMF029C^Y!$<NAS: ;.S?[:\@;;5%3;/\J!PP.1Z\9#V
MTW9MKK)1J.N' SPED[F>%(F)DS(O-]DJK[\Z'S8U+S>[+L4F;#_GZ[SF2Y-.
M-46)]*-G9<MN5]JSVZ5G;9IM3X_=JALEUPN"M%FW2W?1F@4!"KC/<G+W6I2.
M#2TP5]K,VYTX%7-2DARY"Z"BD/K1LK(+N"MM ^[2,S;-F@QV]V^47"\(TO[?
M+MUU:Q8$*-D:R='/'VD+<7?B;$],:M$K116%U ^HE=W'76G[<9>>%FK6JK"[
MCJ/D>IXI$O32KBR&KBE8TC61(U.K8QHS<28H)K7HF4"*0NH'U$;_+Y,-:Q@]
MT<"L56&1UXY+C6Q30WN_& 8!B[SL<+8!07NR[XS*>$;*FU^*37F40:-"5+]V
M-GIKF6Q@P_#3!1C8I\:.48WL5$/;OXS/AWH^L>>I$O2=5^S8R\C^,BJ#&55C
M/O(Y\.XU<SZ5[0PCOEEPY^HN*U6&+G3)]!N#C0Y8)KO=,'H.01.^UZ71-#,&
M-K>QXVXCV]O0GC''A6*@Z.]4PE_82%L:V.=\*-VL,*?D=<-49C='I-NO]1TO
M'?G[E?:WPQ(I2JX7(@E+/7HZP80TPEKCP.1ZH9!8DG:<,4ZC<X7P\3,)+E1%
M_.(-M<KWSZ=U=K=EO6WP+Y7B_E]D)"4@57GK')%W1W6R86UV8'*]P$@PZ]%3
M$(PP#NNX Y/K!4%B6=K(AL X$P><P1DY1DI'5%)B596;CD$*V(,_K#L/3*X7
M78FC/7HNPI2G%I:#K?CW,,G A]'V.!/@3R$\!G\F=CTC26H%G"7G'Z:P_C%,
M4EUDQ/;DHN1ZIL@252O\B"8D']:6"";7"X5$SPIG(G-DI(5UD%%1Q#%D1!7@
M4ED &BLENR5&FQEII*MB@ EKP023ZP5&]BFW,.<!Z\,$D^L%06)KA1_3.%::
M>!P-/[&LN"4QR2Z)T79$1BE@#RNQ3DPPN5YT)6CWZ3D04YYL6,)&R?5"(1&V
MPIO)'"L5PF-8:>*T-)*D5I!<,FUBM!.2:9)J8B76W DFUXN:!.,^/4MB2O)A
M"1LEUPV%9!;%%&Y1YEAIXMLTC)6*(HYA):H E\H"T%@I>4TQVL!)(UT5DRNP
MME,PN5Y@)-X.+$RN,#&<HH)@A:TE>RJF\*<:Q\K@<,K#T"B8%<LH)GE&,=J(
MR:A]VV-&K <53*X778G( WIFQH3'%M:#"B;7"X6$SPJ[*G-F5 B/,6-PW+0/
M*\943'*F8K3=DVD&:@(AUL$*)M>+FH31@;49'E@'*YA<+Q02&RN<K"8 (6B#
MB M5$4>!\.FTD!Z:5HG3L">96S':,>IL;/5[^\ C9^@.1A=K=@63ZT5'0N'0
MZN82#.MX!9/KQ4,B8)7SU;25B>'AM(S0=>/^\\F*F163W*P8[15EGA3'=KAC
MG:]@<KV 24@=TO,X)N<)%H)1<KUX2!!,FU!-SI-#^]3!/+$"N)(5%E-X84W/
M$T4/ GU]_79A!7PECRZF,.F:G"=8I+7BU\4DPRZF<.R:FB>PJ1<H'[!>)"2B
M51AXO?]GF]<  ,/V_%HQY&*2(Q=36')-31BL/1=,KA</"4@5#ET3$R8ZW-\V
M\OV#!PO*TZM738DS(YHS];/AV!FT](7U&X055)4\N9A=4RZ&=>6"R?7B(9&H
M56.N9W5E@E@!3,E]BRGLMR8DB.+5!&N[!9/K14IB5+O.6PQKO063Z\5#0E"K
M[EL*=1WD,E$Z(A(2?"JLO";DD.*U!6OB!9/K14J"4[L^7@QKY 63Z\9#LO)B
M5KV\%.HZ.82R!>M%0N)1E9]7_B]?-E%8%&L^\=4%:]T%D^N%1F)8N^Y=#&O?
M!9/KQ4,B5:L.7FS =(NEX0&9H9R^>M64 %1EXV64$<>^OF"]NV!RO6A)'&O7
MOHMA_;M@<KUX2+1JU<*+#;ENN6YRD"16(%1R\6(J&Z]I2:)XA<'Z>\'D>M&2
M0%5A\34Y2; X:L7MBTEV7TSA]S4U209V:PC2@QRQ IF2VQ>CW;2FYHCB%05K
M# :3ZT5+ M'$[DB]B848%0\K]"D9CC':SFMJCIB8A0V_HEBQ'6,[W['>1Q*C
M*1R[OK"_+L6<H26O>;EN#EDZQ<;Y=5$73=8X/GOE>*[G?_'&C[WB]_4NQQS?
MW1_MCQ_],?OJL*?CO*&ZS:L[SNN+K,[.3M>\O.7G?+6JG$6QW=3MA"'I4Z?D
M-VT]3]ZQV?S@\W-V<C'T^7MV<CGT>1,O_^1]&]/!OP7MWX+V;W-1K+/3^^R6
M?\S*VZ9].2M^TQ31?=/R4YG?WKW\4A?WS:V9.==%71?KW8]W/%ORLCV@^?M-
M4=3/O[07>"S*OW=A./L_4$L#!!0    ( .M]5UCU</<V9@0  #<1   9
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M*P@%YN08F'VM<8Y".");QH^>,QA2.N#V><-^YK5;+;?,X%R)K[R@<AJ\":#
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MDLQ<(9LP& W-"6QV#;V/<O$ >^,F;$^JWTCU.Z4^"!)3MD8+B I!%06)?MU
MM@3QNTUJ)]E7CZ@GLCW?0>,[Z+4V@SZ-]T2V9WS0&!_T69L5V6"GZOS Q^Z;
MVGP?Y6+?'_KMM3ELI X[I=ZJ! 0B4H*21P<C[.)S"?K"C$A.E39P_$1ES+,'
M 8#F=%VN717ZYCSIK.'.3;]ZE#V1[>5GU.1GU&L-C_HTWA/9GO%Q8WS<9PV/
MW]^<GN>\K>&6J.$@>%/!]D[;8%JV&R+66@-*8:5ASME0XT75!E43Q?.RDUAR
MI?N2<ICHSA&$"=#?5YRKUXEI3II>-/P'4$L#!!0    ( .M]5UAT]\$B50(
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M33#K"RGI.;"MI?^3I/\!4$L#!!0    ( .M]5UA(HY6#Y@(  )H(   9
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M+"MK#N$C;E#  +[=8+%$_7T:6HK,\0O3)HKS.HID3Q1Q C=*VMS >YEA]CM
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M3L;6J45B6-*"ZUNQ^0ZUG[[ABP17Y2_9U+&.1:)":9'68%20LJSZTJ<Z#RV
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MM9:Y9:-KF<>&S#^WV]!*72NKKKI(&%O!.@4L?S0_#)RSYL.F9,CB^&YQ:EQ
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MS&>&#2(([8#S*>?J?J 7Z%K.Z"]02P,$%     @ ZWU76"S8Q6L"#   $9@
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M^+[C7?OR2=NB6P6)[,Q)[Y@Y.1+81DZ".B>!\1VX%Y2%-"4QTCNP5'H14;9
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MG$?>@*?'!7C[YAUX Z(4_+FC&0_3-9_80E:6Z]LK5<7\6 5JJ6)!5K< PY\
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MX$&(FC5KPEP'NRTE5T!&9B#W0 <Z_SJ ?#<(@F:)YW%80A".6FJLB(S,1+X
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MK0.UM:J_DT.)K7G;FM4E!#;7$*;TKNX;/K'TPU<F=3W6U/B<^L/LQMGR6JU
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M0JU'01P\+7SEB]*ZA3 ;+MD"9VCOEK>:9F'+4O *I>%*@L;Y*+B*+R<#A_>
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MV@%H?ZZ4?9JX ]K_A^PO4$L#!!0    ( .M]5UA"EU1]L ,  &<-   9
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M:#QFY\T8WX1 F@%X?RV$WG>,@^K=:OH/4$L#!!0    ( .M]5UC"OR$Q6P(
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MHZ77&R,K6>7FJJ)%:;/53&C,?;:8X74&I!F _7,A]*9B)F@N2-%?4$L#!!0
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MB+\3V,O&,]%2UIS_U(/':&XYFA&D$"H-0?%O!TM(4XV$//ZI0*WZFSJQ^7Q
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M:;#'NV&*ERHH&X#[B93F,+&-OKZFPW]02P,$%     @ ZWU76$PY::;D @
MX @  !D   !X;"]W;W)K<VAE971S+W-H965T.3 N>&ULK59=3]LP%/TK5P$A
MD 9IDWX-VDK0"FW2D"H*V\.T!S>Y:2P<N[.=%O[];">-"DTCAGAI;,?G])SC
MCYOA1L@GE2)J>,X85R,OU7IUZ?LJ2C$CZD*LD)LWB9 9T:8KE[Y:222Q V7,
M#UJMGI\1RKWQT(W-Y'@H<LTHQYD$E6<9D2\WR,1FY+6][< ]7:;:#OCCX8HL
M<8[Z<363IN=7+#'-D"LJ.$A,1MYU^W+2M_/=A)\4-VJG#=;)0H@GV_D>C[R6
M%80,(VT9B'FL<8*,62(CXV_)Z55_:8&[[2W[K?-NO"R(PHE@OVBLTY$W\"#&
MA.1,WXO--RS]="U?))ARO[ IY[8\B'*E15:"C8*,\N))GLL<=@#MS@% 4 *"
M]P+"$A ZHX4R9VM*-!D/I=B M+,-FVVX;!S:N*'<KN)<2_.6&IP>_T"3@8+3
M*6I"F3J#<YB;G1+G#$$D<(^1X!%EE+C0S<AMKG.)<$<YS?(,'!YFY,6LK%:@
M!=P01GB$,'>;\!P>YU,X/3Z#8Z <'E*1*\)C-?2U46\U^%&I]*90&AQ0.L7H
M L+V%PA:05@#G[P?'KR&^R:S*KB@"BYP?.$!OD]-Z??U0FEIMO2?NEP*(9UZ
M(?:87ZH5B7#DF7.L4*[1&Y\<M7NMJ[J4/HGL569AE5G8Q%YL-C Q+4Q6^N7D
M:!"T@RN5"JE!H\SJS!>,7<=HKZ3UN-L?#/WUKJ?].>UVT*TFO=+:J;1V/J"5
M";X\*+61L#Y:J%NBSIZ=,/Q:[Z9;N>DVNIGG"RTT876R"V2O,>%&]@_NFEZE
MO=>H?4J3!"7:T[) O4'DD/.8JDCD7&,,YCJ!G6Y$5 J)J4ZU=TQOSVSOC=5&
M,1^TVJ^L]ANM/M@U@J2X/++R\F!N)ZZVE\?IKOFS.H_]_2,SZ+QQV:CC?UWZ
M._7'UOX[(I>4*Z,\,?2MB[[1(HMZ6G2T6+F2M!#:%#C73,TG"$H[P;Q/A-#;
MCJURU4?-^!]02P,$%     @ ZWU76 L)+8'- @  5PD  !D   !X;"]W;W)K
M<VAE971S+W-H965T.3$N>&ULK99=3]LP%(;_BI4A!!(B7TW;E382-)W&!!*"
ML5U,NW"3T\;"L3O;:>'?SW;2K(70%:DW36R?]SD?=G,\7''Q)', A9X+RN3(
MR95:#%Q7ICD46)[S!3"],N.BP$H/Q=R5"P$XLZ*"NH'G==T"$^;$0SMW)^(A
M+Q4E#.X$DF518/%R!92O1H[OK"?NR3Q79L*-APL\AP=0CXL[H4=N0\E( 4P2
MSI" V<BY] >3R-A;@Q\$5G+C'9E,IIP_F<%U-G(\$Q!02)4A8/U8PA@H-2 =
MQI^:Z30NC7#S?4W_8G/7N4RQA#&G/TFF\I'3=U &,UQ2=<]77Z'.QP:8<BKM
M+UI5ME'DH+24BA>U6$=0$%8]\7-=APU!$+PC"&I!L*\@K 7AOH).+>CL*XAJ
M@4W=K7*WA4NPPO%0\!42QEK3S(NMOE7K>A%FSLF#$GJ5:)V*QYPIPN; 4@(2
MG22@,*'R%!U_ZH?=S@4B#'W/>2DQR^09.MH:#UVE(S <-ZV]757>@G>\^>A6
M^\LEFK ,LA9]\A]]L /@ZM2;_(-U_E?!3N*WDIZCT#]#@1>$Z/$A02='IRV!
MC3^"F3S>HY.Z@FVP9#<L@72OF"8?P>R(::MP87-P0DL/]SHXOV[T,KI64,C?
M;<>B8G7:6>9;.) +G,+(T1\["6()3GS\R>]Z%VU;<4A8<DC8Y$"PK0WI-!O2
MV46/;[B4*&UVY45_@T6):=MN5*#(@DPC6<:?@UXP=)>;5:Z,?'_#JM_QO&VK
MY"W*[_9Z_6VK20O+CX(-V%;&49-QM#/CRX*73"$^TYTA*W7'F5)H2W<GY:.'
M[Y"P)'I3O>AUA2<'<EA5V-WH% 6(N6W1YMCH0E;__6:VN05<VN;W:O[*'XS]
MEOE$WQJJ)O\/7UTY;K&8$R81A9EVY9WW=&*B:N/50/&%[5-3KG37LZ^YOOF
M, 9Z?<:Y6@^,@^8N%?\%4$L#!!0    ( .M]5UB\6OJOJ00  .$>   9
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M!B0%K@W4\QUC\CS0+VC_^EC]#U!+ P04    " #K?5=8G6GR<*($  "R'P
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M[H"$P)2![-]0*DX5-4!UFS3[#U!+ P04    " #K?5=8@AS:"SH'    ,
M&0   'AL+W=O<FMS:&5E=',O<VAE970Y."YX;6S%6MMNXS80?>Y?$-[M(@&R
ML2A;ON1B((FTZ!8-$.2R?5CT@9%H6UA)=$DZ3H!^?$E*EBQ'9JSMH,E#K OG
MS/ ,-9H9\6S%^ \QIU2BYS3)Q'EG+N7BI-L5X9RF1!RS!<W4G2GC*9'JE,^Z
M8L$IB8Q0FG1=QQET4Q)GG<F9N7;#)V=L*9,XHS<<B66:$OYR21.V.N_@SOK"
M;3R;2WVA.SE;D!F]H_)A<</56;=$B>*49B)F&>)T>MZYP">!.]("9L2WF*[$
MQC'24WED[(<^^1J==QQM$4UH*#4$43]/](HFB492=OQ=@'9*G5IP\WB-_L5,
M7DWFD0AZQ9(_XTC.SSNC#HKHE"P3><M6O]%B0I[&"UDBS'^TRL<.QQT4+H5D
M:2&L+$CC+/\ESP41&P*XOT/ +03<+8&1LT.@5PCT]M70+P3Z^PIXA8"9>C>?
MNR'.)Y),SCA;(:Y'*S1]8-@WTHJO.-,+Y4YR=3=6<G)R)UGXX_.EHCI"%RO"
M(X$.?"I)G(A#]!D]W/GHX.,A^HCB#-W/V5*0+!)G7:E4:X!N6*BYRM6X.]1@
M%UVS3,X%"K*(1G6 KK*Y--Q=&W[I6A%_7R;'"'M'R'5<M\D@N[A/PV/4PT:\
MUR#N[R_>I#W87QQ;R.B57NP9O-XN+\X)IX47KUBJHH@@YCF\X)QD,ZJ>;(D>
M7]#FN!OR8BX;KZ/O?RA(]%725/S5,)_+7'^_6;^.9B=B04)ZWE'A2E#^1#N3
M3Q_PP#EM<@TDF \)%@"!U9S8+YW8MZ%/E.-2Y3*AG\@C)+2K!(J%6"IG':C'
MSSA/'#9Y)P<>&&#]:GB:*)O,WUGW:9-YJP5MF8<$"X# :LQ[)?.>E?EO5,@X
MFZ$%Y3&+F@BVRK==_G9C,'JAA#?Q#6E$  16XWM0\CVP3C%_Z3R:,$3,2^<H
MHB+D\4('K2;^K7AM^;<;=S^G*%NFCY0C-D4WMW</ CT5"\0$4X&FG*7(^15)
MI@*X^E7CI)*2A,]4:K<M/%-2DD9'B"A)EJC43)S\\NG#R'4'I[F1N_Y_S7$Y
M38A.I]#]W:T*".A1IW?FCNO)N5ZUH0KD<4*/],4,[6N12C62Q,SM]#_90Z3%
M&.]_M^:1J9/=!FE_$Y4JAR31+M42BT42*P/$,IRK,<5T"L$WC%^O# 6#]5(H
MA#VGIAJIK F%2H]>\++%HE$+AFL<4Q%D(5WCC^I3.]4*6K&FLP22O6@1/#P5
M:_(R.C-D'NTYYVI.9O9<B?,HH4*LIU?S3F7P<5-\@WS( R"P6GP;EO%MN'=\
M"S?3,?JLCVE3A+,BMHUP.9A7RP?P>"L9\!M&.;V15Q\5O!XU'H]'Y: :0:.2
MH)&5H%N]*A0YDCRK:);1:2R;.+&"M.5D]"I'ZHWQ>(N2UX/<WA!O,=(TR!TV
M,S(N&1G;WSIV)JS";9D8O\X61^[VXF@8Y/5'6TP F55C##M5Z>I8.;L(Y9(D
MFXO(A$N3.3<\?4V\VC6T)184S0=%"PJTVJIU>F[SJL4;[0-L7[=,*A?$F>1Q
M)N(0/9%D277P9R:7$RKDJ: ?B^V:OZ#?"MZ:_I] 0XW, P$%!= FZ1[>0;E;
M4>[:ZT0BYNJ]&E+U6HWR7#0GN^2ZJ4%S:4=MS?5/H#5S#004%$";7(^PMX/L
MJK&"K27_Y&(VTTF-I&A*8EXM[[QLR;-%G0_M6-^@;9,"K?["QMY64/8;AHW[
M@\%6Z&X$&_>='81530QL[V*8WC.Z7ZD\[P5]B:<J3[VI\N#OUU3GDHTM)CMP
M:[) 6QV@: $46MU%5;<#>^_<+<2@_1)0-!\4+8!"J[NR:J3@-SHI>9=P72WJ
M,I,MI9#J0%5H1V6I5E1>9-98>]B5M'97CC;>S#2V0]3K(<[Q<+@=HAI&[0A/
M566&]RC-RN3$&HY *S)0-!\4+8!"J[NDJ@7QZ+W#$6@A"8KF@Z(%4&AU5U9%
M++97L9M/E_ET87I6N]OJ=KC6CK$;AQW366]*CGU00P(HM/J'T:HN=NUU\<U&
MOS!_7&[5:X#'H7Y%Y"YZR%2QO(Y^Z!]T'6=QNDRM =&NM:VS0-%\4+0 "JWN
MOZJF=O$[!T07M.X&1?-!T0(HM+HKJUK=M=?J,/F974EK=[F6M*KP :3"  JM
M[H.JA'?M)?S/A$/R_'8X!*WM0=%\4+0 "JWNOZJCX/;?.QR"=AY T7Q0M  *
MK>[*JO/@VO<V (5#T.Y"@68K5T$5!E!H=1]4+0/7WC)H#'X"'>A/NX?VB ?:
M)@!%\T'1 BBTNHNJ)H4[?.^(!]K< $7S0=$"*+2Z*ZOFAFO_TNW3*>5<YQQZ
MYX3Y7# G3[3X9O#6OCX[>&LWO?YP[0V'P^UOX*!* RBTG/_NQD[GE/*9V6(N
M4,B6F<SW#I=7RVWL%V;S]M;U*WP2Y)O1*YA\;_PUX;,X$RBA4P7I' ]5N.;Y
M=O/\1+*%V4_]R*1DJ3F<4Q)1K@>H^U/&Y/I$*R@W_4_^!5!+ P04    " #K
M?5=8Y%Q17J\"   B!@  &0   'AL+W=O<FMS:&5E=',O<VAE970Y.2YX;6R-
M56UOVC 0_BNGK)I::6U(*-W6020HG59IE5!9.TU5/YCD2*S&=F8;4O;K=W8@
M8U+*]@6_Y.ZYYSG?'<-:Z6=3(%IX$:4THZ"PMKH,0Y,6*)@Y4Q5*^K)46C!+
M1YV'IM+(,N\DRC#N]2Y"P;@,DJ&_F^EDJ%:VY!)G&LQ*"*8W$RQ5/0JB8'=Q
MQ_/"NHLP&58LQSG:^VJFZ12V*!D7* U7$C0N1\$XNIP,G+TW>.!8F[T]."4+
MI9[=X28;!3U'"$M,K4-@M*SQ"LO2 1&-GUO,H WI'/?W._3/7CMI63"#5ZK\
MSC-;C((/ 62X9*O2WJGZ"V[U>(*I*HW_A7IKVPL@71FKQ-:9& @NFY6];/.P
MYQ#'KSC$6X?8\VX">9939EDRU*H&[:P)S6V\5.]-Y+ATCS*WFKYR\K/)W*KT
M^71"NC(8UTQG!HZG:!DOS0F<PIR*(%N5"&H)]U)CJG+)?Y'MOM^5$E0CAODT
M7[^X/0*3!+A&32\+=^C*@\L<'M!8M\Y0<Y51@&M1E6J#:&!,#E-.(:S2!AYO
M42Q0/\$1< G?"K4RA&B&H271CGJ8;@5.&H'Q*P*C&&Z5M(6!:YEA]C= 2-EJ
M4Q;O4C:)#R).,3V#?O0.XE[<A_OY%(Z/3@[@]MNGZ'O<_FM/43"-72D=:\UD
MCM0*%A8;V+>;L8V_]D\'CU\)$FXL"O/4E:DF_GEW?-?^EZ9B*8X"ZF^#>HU!
M\O9-=-'[=$#=>:ON_!!Z\E_5TT6Z@1UX6#=BUDGT,;H8#,-U!YM!RV9PD,UW
MWZV8G?ZS1(]_(-/FI(O9X1!1!*(IO @RMNE*8;C7MP)U[J>3@52MI&U:N+UM
M!^"XZ?L_YLWTO&4ZY]) B4MR[9V])W*ZF4C-P:K*3X&%LC13_+:@(8[:&=#W
MI5)V=W !VK^%Y#=02P,$%     @ ZWU76&!.5A;C"   KS0  !H   !X;"]W
M;W)K<VAE971S+W-H965T,3 P+GAM;,5;;6^CN!;^*U;V[FI':A/\ H1N6ZE)
MR[TCW9&J]L[LAVH_T,1MT/"2!:?=_OMK Q.".1A:D=WY, WPG(//8V,_YV#.
M7]/L>[[A7*"_XBC)+R8;(;9GLUF^VO XR*?IEB?RRE.:Q8&0A]GS+-]F/%@7
M1G$T(Y;ES.(@3":7Y\6YV^SR/-V)*$SX;8;R71P'V=N"1^GKQ01/?IRX"Y\W
M0IV879YO@V=^S\77[6TFCV9[+^LPYDD>I@G*^-/%Y J?^8PI@P+Q+>2O^<%O
MI$)Y3-/OZN#S^F)BJ1;QB*^$<A'(/R]\R:-(>9+M^+-R.MG?4QD>_O[AW2^"
ME\$\!CE?IM'OX5IL+B;S"5KSIV 7B;OT]3^\"LA6_E9IE!?_H]<*:TW0:I>+
M-*Z,90OB,"G_!G]51!P88-IA0"H#HALX'0:T,J!#[\ J Z8;L X#NS*PAQHX
ME8%3<%^253!]'8C@\CQ+7U&FT-*;^E%T5V$M"0X3-;+N12:OAM).7-Z+=/7]
M="'[9HVN7H-LG:-?K[D(PBC_A$[1O1S)ZUW$4?J$[G@NLG E)+*P0E=J5(3B
M#07)NGWU:Q(*Z>%?:(;R39#Q_'PF9(/5;6>KJG'+LG&DHW&8H"]I(C8YNDG6
M?-UT,).1[L,E/\)=$J/':[Z:(HI/$+$(!1IT,]R< .;^<'-LB(;N.X\6_EB'
MO[O[*_3PA<>///L#8M=HK>:LLWP;K/C%1$Y*.<]>^.3REY^P8_T&,3.F,W\D
M9PW6V)XU5GBG74->C<9JR"_36,[1>5#,<E=9%B3/7,Z; CV^H4/<;?!6G"X>
M$?3P7^D2?18\SD'>V9B\C^G,'\E9@W=[S[MM'*U?DQ<Y1T@R%_PY3)(P>4:+
M( J2%3\IN09GB-*G4_A4R^3+):4>MN;R\7LYI G 6=3Q++N)\P&</;=<1O>X
M1G#./CAG4' G4'2_%^N;FF%?>";7:_1O.= $DA,V1WX09NA;$.TX^C5,T'4:
M14&6HRW/RFGS$T1*V1;W( A[RAR-D1*$:0.ET>9#GN@<YL+=<^$:N2BB4U1T
M]ZH+]*I#;0MK,;1Q!+L6HWH8;1QV&"&. T<RWT<R'Q;)Z#TX!WAWJ!8]!'(U
MBGP(Q#KB]O9Q>\:XOU5CN;L#O1;AI]@AGD>TY^T&!F*B=[4/ >>>ZW@>' NV
M:HEC#8IF]$ZL[MODGLPU!D 4U<,'46['DX@/Y!TVQB[E]Q,/>SJS\M'D'C-&
M]2D%!'JV93,]&@!(YG-V,!TW R)U0&1H0./W)P'ZP-9'-(AB5&< 0F'<$7ZM
M^+!9\M7KC)3$ Y?0RN5A9\B95BI8?0T%@.!BZT- ;;5MQE=K,VR4(-WQC=_9
M;,@4#*+TI=:O4)UK;9.,6C!ALV*ZN_]JU/=F\_<*S5&]^6-Y:U)7RS'L_,,B
M'QL%X;O)'].;/Y:W)OFU_L-F ?@QI8\!$<>PUWXDVSB;>9ZE/Y. QO28U;6B
MUI(0FS7AWZOT,23O+$^GI(UB4Z^U)$&H+JF(:ZV(S6)Q@-S';7&';2G/6TLK
M@)-JD;EZ)&T<Q3(Q@$,AM5(D9J5X/+U/VO+.F1)--MT *"D:-$'I@ZBN!);4
M4I&8I6*_Z"> JG,)<_2L#<(1=^[I*A'"81O3CB%):I%(S"+Q:(J?0*K.T65R
MA=+D@*[X 5]LZG9U8ZT0B5DA#E+\I"W@3BFC<_V!A'"8SO6Y%H(QNT/_D%H,
M$K,8/*;6)Z!DTR::ZYX&/F!(&MP02#2Z^G0,HJC;05HM&HE9-);5]W7X$JYY
MLLX-HV#1XPF.;DG:)33B.GHN8?;]7D$SEK<FI[6:).;J7HO3L8?CHJ<!75W1
M+M]!J\JHVG(L;\VNJ+4E&:8MWY, FUW"34: H^N>MCT0>#H8)FQ] -<4MDW*
M:L5*ABK68^?454/,D^H-&:)I?0#5T+1-,FJU2LQJ];8OJ3;;OS>O&]6;/Y:W
MYMO&6AY3ZQ].JJE1G[_[E>68WORQO#7)K^4Y-<OS#R75BQZG'>L*;0MSQYGC
MN5[:!G"V;3ESO3X&X"C#%'<H1%H+?6H6^G]K,K[H:4P7F6V=[[13>  %:$80
MA3LT(SW81V#.&?I3^$6/!QG[R0.%X__ RWYH];T9RY$_@J,FT75&0\T)P]$*
M#(N>&W>-S78.XDQ9:VP"N9(SU<L2?;Z:E-7Y##5G(;UEB46/@Z[0VVG,*;;F
M&.OU1@BHM@_I;\=\<SL^,*SJ_(2:TX-CU3L6/??MHK:=EM##=U\5KT.2%]_<
M@@^06F<:U*SFAQ12%CT^N@@:*2&Y&<N13]NYQRES':?K\:V3#VI./HY8PUGT
MW+J+?*/5NS7F![S!/0#N]F =_-?Y#C7G.\/+04L*5-5=^4]_;D=-:<;RUMP*
M6*<TS%SQ/WIE9\F@RG]KB34W\]W;_(Z1JK Z56'#4I5WU&@6/2X[GF763BPP
M=IGEZ>5(  AE-#Z TS*:)B=UIL*&9BI'+L(L>AK2Q224I=AZP@>B6J4; &5W
MOME@*DMIGCG8R=NK:N]X,803D2.QX4@$V3,7*-FI^H[:M:[J/3EZ+G5WL5,]
MW8E<!$4G3-'_I(T.%IM H%TDPECV0?2&5,>AHL"1HZ<LC9'U,Q(I(I;\*XW$
M)LQ1$*>[1$S1]2Y3G:N:\L957W&U<QU=\U51<=KO/2^WD!?M49O!3PIO)\AU
M?R[.J=\RK"TO/KR(WD[*&_7&I[5:#;<P646[7'I1Z&"URG82ES>GO>D#^>.S
MPJUEB+9[XKJ>^CR#9YG$UIQL NFE]#N5R=Y5L3N?HV6012G*PW@7E>6@UR!'
M.U7\D2R]%*-7-CWG*"@_,)"MJ2AZD@,Z?55'09[OXJVREARG67%5E9B"I/R\
M0!UON0SY.4MWVS/Y.'Q"C_N4W[/0Z3IX@R:OV<&W$3&7Y*FO6'*T4MU5[EW>
MG]U_*;,HO@_1SB_QF8^A\^3L&L)?,7IVPRAXA<DKQ1<BL[I)Y:<\7V3_AI*#
MB#_)YEE35^846?EU3'D@TFWQ-<=C*D0:%S\W/%CS3 'D]:<T%3\.U WVWRA=
M_A]02P,$%     @ ZWU76(\J<_$I P  8PH  !H   !X;"]W;W)K<VAE971S
M+W-H965T,3 Q+GAM;*U676_:,!3]*U8F39NT-9]0UD$D:#9U#]6JHG4/TQ[<
MY$*L.G%F&RC_?M=)R" SM%++ XF=<X[ON3>Q[W@CY(/* 31Y+'BI)DZN=77A
MNBK-H:#J3%10XI.%D 75.)1+5U42:%:3"NX&GC=T"\I*)Q[7<S<R'HN5YJR$
M&TG4JBBHW,Z B\W$\9W=Q"U;YMI,N/&XHDN8@_Y1W4@<N9U*Q@HH%1,ED;"8
M.%/_(AD9? VX8[!1>_?$.+D7XL$,OF43QS,! 8=4&P6*ES5< N=&",/XTVHZ
MW9*&N'^_4_]:>T<O]U3!I> _6:;SB3-R2 8+NN+Z5FRNH/4S,'JIX*K^)YL6
MZSDD72DMBI:,$12L;*[TL<W#'L$?'B$$+2'H$Z(CA+ EA,\E1"TAJC/36*GS
MD%!-X[$4&R(-&M7,39W,FHWV66G*/M<2GS+DZ7BN1?KP<8:9R\AT0V6FR+L$
M-&5<O2<?R1Q?LVS%@8@%F>=4 FF@-W2+M=<[RG>=@R0ZIR7Y7IEZ*G)'^8K6
MI9TJ?*>:V;&K,6:SLINV\<V:^((C\?D!N1:ESA7Y4F:0'0JX:+9S'.P<SX*3
MB@FD9R3T/Y# "T)+0)?/IP<6>O)\NG_"3=C5+ZSUPF/U>]T"D5_3>Z4E?HV_
M;;5J8HGLL9@=ZD)5-(6)@UN0 KD&)W[[QA]ZGVUY?DVQY)7$#FH0=36(3JG'
M5PP_4\E2RHDRGQ.I< !D+3CFES.])>]P=WUO2V@C_*D6-COT.O;.PO.QN]Y/
ME!44'H(2*RCJ0 ?&!IVQP4N-Y;BO6IT-+/$,AM[^S^_YM%)ZR4B> !WX''8^
MAR_U2=<@\1BT6AU:0HKZ1;2"HIZY)T 'YLX[<^<GS=TR]4 6$H"P4@.^_9I(
MJL%FI!'RO8/UO7#4LV*'^4$/E]AQGG^D6J/.T.BDH2^/%38-N,=E;,TR*#.R
M9< SFZ'1__GL>7D2D9Q"-/&[>\=O 7)9MS&*I&)5ZN9<ZF:[3FE:-PB]^1EV
M4$W#\T^F:;^NJ5PRW)XY+%#2.SO'ST V+4TST**J#_E[H;%EJ&]S[ )!&@ ^
M7PBA=P.S0-=7QG\!4$L#!!0    ( .M]5UB)=$P@8P8  (LW   :    >&PO
M=V]R:W-H965T<R]S:&5E=#$P,BYX;6RUFUUOVS84AO\*X0U#"W211#G.QQP#
MB=EA!98M:+#NHM@%(],V44ET2=K.@/WX41\135=AI/3H)I%D\3WD*QZ*CT1-
M]T)^46O&-'K,TEQ=C=9:;RZ#0"5KEE%U(C8L-[\LA<RH-KMR%:B-9'11%LK2
M (?A),@HST>S:7GL3LZF8JM3GK,[B=0VRZC\]X:E8G\UBD9/!S[RU5H7!X+9
M=$-7[)[IOS9WTNP%C<J"9RQ77.1(LN75Z#JZ)&-<%"C/^,397AULHZ(I#T)\
M*78^+*Y&85$CEK)$%Q+4_-NQ.4O30LG4XVLM.FIB%@4/MY_4?RT;;QKS0!6;
MB_1OOM#KJ]'Y""W8DFY3_5'L?V-U@TX+O42DJOR+]O6YX0@E6Z5%5A<V-<AX
M7OVGC[41!P6BR3,%<%T 'Q<8/U,@K@O$70N,ZP+CTIFJ*:4/A&HZFTJQ1[(X
MVZ@5&Z6996G3?)X7U_U>2_,K-^7T[%Z+Y,M:I LF47G1%;I+:8[>$*8I3]5;
M]#/Z$05(K:ED:AIH$[,H&22U_DVECY_1CS"Z%;E>*_0^7["%*Q"8RC8UQD\U
MOL%>1<*2$Q1'[Q .<=Q2H;F_^"V5)R@Z>[8XZ1X=>UH3-_['I5[<T__/OYL3
MT0?-,O5/F^N5ZKA=M1@L+M6&)NQJ9$8#Q>2.C68__1!-PE_:'(,4(T!BCIOC
MQLVQ3WU6.HC,:(C,$*<TS1<\7]5]%[WA.;HO-]^V.>I5[NMH)38IQ8JA=S>+
MIL'NT":@<(Y-IXU-IUZ;YB++S)BKBK[W#FVHL<O<"C35;(%V--TRM#'=L;2M
M=(V(-*52V:.M!E8QSP[:')Z$1\V>>RO6MZN]$-'Q9M)X,_%Z<V?N.TQ*XP2P
M/9,N]GCKUM>>%R(Z]IPU]ISY[6$R8;DV4P(DEH@JQ<R(I<SXU=;D2NK"J<#I
M48N]X?JV&$C,<>:\<>:\AS/)08JU67/>8LUQ9_#&ZVL-D)ACS45CS877FGLF
MN1F K]$?QI)/0A>#\ESD.R8U?T@9LCE7W@[1YUN6/3#9>N/S1NH[3$.*$2 Q
MQ^$HM/.X<)")1"T+9"BH&H%2<RT]F!I'@\TF_-*];8V^G4^$87@TI8"*Z=J%
MK5W8G^7'/1!=KR1C!A)UD]'H/P0Y&/AKU-ME2#4"I>9>#<L5T3!@$8&2!:@:
M@5)S+;5P$?GI8K"IH3]N;\_''6::!"JFZZ4ED,B/(#>"RD4Q42)<LD0+X]%\
M3;G,BB[JRWA(@)B#JA$H-==2"R[19)B,AX2..:@:@5)S+;6P$_EIY[MF )!D
M,Z_57IH!# % D26@R(] 768 K59!DLX<5(U J;F66G**+H9):E!. E4C4&KN
MXV-+2MB+#;/WCX;4N3*W:LF3ZH:]S;GN<;_V!^AK;JUV>I#:,3Y*;*B(KF66
MA+"?A)Y_MH%H\G5K;N&MSW]J5?<IQU'3YO[0??L6E)IKE&4@#,) ]0/8EP''
M'ZYW3P,%'"@UUVH+.'@8P,&@@ .J1J#47$LMX& _X SS7@!WX9%YI[.(OP&O
M-<A2"_932\?TON4YS[:9/[-!0094C4"IN2Y;D,'#@ P&!1E0-0*EYEIJ00;W
M>6WSP'*VY FG*1+[G$FUYIM60]M>X'R3N*!O<*#47)\LP>#O)YB6!#>'KLMY
M4(&'QFLE_$\Q_+7HW5-!@0=*S;T"%GCP,,"#08$'5(U J;DK3"SPQ'[@^?,I
MQXL;=3T,M*XI"3NDNS]6[\4B0W!-;+DF]G/-Z]/]CBK%=ZR:*U4*RIOR_IKT
M7K$#"DU0:NY5L- 4XV'60('"$:@:@5)S+3U85>8EA>XI'W=)>=CU84,P3FP9
M)_8S3M>4IX\O3N']D7KW/T@U J7FNFQ!*3X=)J5!J0A4C4"IN99:*HI?6)CV
MJBE\+>I_!.>/W-NG(5 GMJ@3^U'GE0G>=PKOKT7OG@H*45!J[A6P$!6?#Y/\
MH%0$JD:@U%Q++17%_A5TG>_G%UW2'11NH-3<!=\6;L9^N'E]NO>>POMKTGN)
M."A(0:FY5\&"U#@:).7'H%0$JD:@U%Q++16-_:^2NJ9\+>-/>7^LWLZ PDUP
M\/52QN2J_ I,H41L<UU]R-0<;;XTNRZ_KPKLZ=5G:K=4KGBN4,J6IFAX<F:F
M;++Z\JO:T6)3?@OU(+066;FY9M3TVN($\_M2"/VT4P1HOK^;_0]02P,$%
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M&&/!"%M*= T"W698 #J*0&%"Y3%Z@^YN(W3T\AB]1(2A3QE?2<Q2.7&5#FT
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M8A4ML(76U+1VO+C_&N\/V*;!75A%"VRA-16M#3,VF]VC+2O?OY0IT%E5/M@
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M?"TI"^3053KQY/&NGR4YW29)*I+$!-URII827;, @C* JQGGM,D;[2FQ(L[
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MU]S6.Y)MJS6BMTQ*EE>;&TH2RLL"ZO\58_)YIZR@7?D\_P]02P,$%     @
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M 6JG0/<[I>SSP3GH/S,6_P!02P,$%     @ ZWU76&[BU>=3 P  .@X  !H
M  !X;"]W;W)K<VAE971S+W-H965T,3$W+GAM;*U776^;,!3]*Q:KIDY:"X9
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M=7/('N?J<@=<!ZC^*6/RJ:&O#^5UT?\'4$L#!!0    ( .M]5U@/3B3_IP(
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M++A*=+RH*W7=4;RRU7'!E:ZUMEGHQPV$6:#G<\[5KF,*;OM<IG\!4$L#!!0
M   ( .M]5UA*4"=,@ (  +L&   :    >&PO=V]R:W-H965T<R]S:&5E=#$Q
M.2YX;6RM56%/VS 0_2NG#$T@(=(D+44LC413T)! JBAL'] ^N,DUL4CLS'9:
MV*^?[:2A92UB$E\:GWWW[KU+_1*NN'B2.:*"Y[)@<N3D2E7GKBN3'$LB3WB%
M3)\LN"B)TJ'(7%D))*DM*@O7[_5.W9)0YD2AW9N**.2U*BC#J0!9ER41+V,L
M^&KD>,YZXXYFN3(;;A16),,9JH=J*G3D=B@I+9%)RAD(7(R<"^\\'IA\F_"#
MXDINK,$HF7/^9(+K=.3T#"$L,%$&@>C'$F,L"@.D:?QN,9VNI2G<7*_1KZQV
MK65.),:\^$E3E8^<,P=27)"Z4'=\]1U;/99@P@MI?V'5Y)[JCDDM%2_;8AV7
ME#5/\MS.8:/ ]_<4^&V!_]&"H"T(K-"&F94U(8I$H> K$"9;HYF%G8VMUFHH
M,V]QIH0^I;I.13%GBK(,F8(I>=&O1TDXG* BM)!'< "4P7W.:TE8*H_?Q*&K
M- .#XR9MMW'3S=_3S?/A5C?,)5RR%--M %=3[_C[:_YC_UW$"28G$'C'X/?\
M !YF$S@\.-I!+/XXC ?QQ0Z8+7I!-][ XO;WX,Y(@< 7$!-&4DH87-Y?P;B6
M.DU*>+S%<H[BUZY!OHMK[O:YK$B"(T=?7HEBB4[T]8MWVONV2_PG@6V-H-^-
MH&_1@__XASW>Z"2X5EC*G>+[GRG^D\"VQ \Z\8-WW_\=)CQC] ^F0"#3IKI+
M;0,QL!#&=9>1UQ\.0W>YJ>+?I.'9:TY#SMWP@1)%9NU10L)KIIHKU>UV#GQA
MC>?-_E@[<V.DKS"-K=\2D5$FH<"%ANR=##4CT5AE$RA>6;>9<Z6]RRYS_75!
M81+T^8)SM0Y,@^Y[%?T%4$L#!!0    ( .M]5UB#VV:F, 0  &X9   :
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M$H;F/;CS/@K6[ZF@^?_E\ ]02P,$%     @ ZWU76)>*NQS     $P(   L
M  !?<F5L<R\N<F5L<YV2N6[#, Q ?\70GC 'T"&(,V7Q%@3Y 5:B#]@2!8I%
MG;^OVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XU
MA]) 1-MC0[!:+#Y +AEFM[UD%J=SI%>(7->=I3W;+T]!;X"O.DQQ0FE(2S,.
M\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_'<?VD-/IKV,B
MM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " #K?5=8NO/33M0'
M  !/3@  #P   'AL+W=O<FMB;V]K+GAM;,6<46_:.AB&_XK%U8ZT'D(@"4SK
MI+9T&]*VHE+U=G(3 ]9"S'$<.O;KCY.L9S:$5^?F*U=M H0'._X>^[.=]\]*
M_WA2Z@?[N<F+\K*W-F;[KM\OT[78\/)OM16%?66I](8;>ZA7_7*K!<_*M1!F
MD_?#((C[&RZ+WH?W+]>:Z[Y[H(Q(C52%/5F?>)3BN?SS>GW(=K*43S*79G_9
M:_[/18]M9"$W\I?(+GM!CY5K]?Q9:?E+%8;GBU2K/+_L#=H7'H4V,CTZO:@A
M'_A3V9PQ_.F>6Y#+7AS8"RZE+DWSCN;ZW#+NA'US>U09]5'F1N@I-^*35M56
M%JOZ,O97])V?T93#R]^V$-_I_U.,:KF4J9BJM-J(PK3EJ$5> Q;E6F[+'BOX
M1ESV;M1.Z/KWV"^89>UO,Q;**2G]3MH7]"QK\.A0KJI,&C8KV@_;5QVL$&"%
MM%@W]ECE,K/?GK%KGO,B%:RIV=(!' + X=D V9LY=R!' '+TBI"+&J+^0,G4
MDMUMO3LP I#1V2!OU&;K0,8 ,CX?Y)J[C28!D,D9(;^'#N080([/!\G+M0,Y
M 9 36L@[O>*%_-6\P'B1L:DH4RVWS;%:NJ$[0+$[H,5<R%4A[7MY8=A5FJJJ
M,%9I;&[+-Y7"C90#J!ABQ]3UVI1B\\_M/Y7<\;RN=!<0R69 ;)N/7&KVR/-*
ML*^"EY5N[TD7#ZEF0.R:C[*P>I$\MYXNC:[:!G/W7(C,142B&1";9B'22DMC
M;SKV6>39A5$77[FI3^U=1*29 ;%G9L5.E.:H8I%4!L16^2A_VB!X59:VU_"6
M?1/&!4,B&1";9"J60FO+5D=KF0G=O.7[2N49VW*O2I%*!O0NV=7#!/NM[)L=
MDW@5B_0Q(/;'0NBZ*5RQN7XIR851Z0^W<XW$$1*+8\[WO"XTH]BGNDZOJSRO
MU?;9'EB#N)A('"&Q.+[88.Q5:@B')/1CDEJOHCAP:XC<$!*[X9%KV53EK+ C
M6QO@V*VE- >$2 TAL1KNQ4X4E6T-2ZTV=4 QV@[,2_8LS9K=5"XFTD-(K(?[
M^J1MIW.NS9X]:%Z4O,EQ> 6);!$2VZ*)(!?7MDE89SQSG7ED2!<AL2X:LK6-
M'4*S>[E:V]J=Y]ZH*$2:"(DU<;O9YFHO!+L6A5A*T\!YA8=<$1*[XI;KPH85
M6V2V]!9KKH6;X4"6&!);8E:D:B/8 __I19,A4L*06 E- 97L7FPKG:[KMN"2
M(3T,B?7P2:GL6>9Y,]*QT9@7JZ9CTG;O7$J8MJ+/6[42LZV [P][PT,DBB&Q
M*&:;K1V''2$A*0R)I;"HGDKQ3U67UNWN$ RY8$CL EMW;->$C.;C=?)Q*LLT
M5_7@U85$6A@2:V'6CAUJF=:]2G:EK5571V/K(7+#D-@-'6F3M^QIWQ[LF8N)
M)#&D'E"@3(^7VALA8XR(C7$BD<+>/-1]5+?21T@B(V*)@(1*C>IB(J.,B(T"
MDBJ'F$@I(V*E.(F5EXK^RV6#$R#$3CG*L'02(L6,B!4#4RU^RT;"&=%/@/BI
MELZ"1+8940]"3N1<?H.ZF$@X(V+AP-2+7]](."-BX;2IEZY*CI!@(F+!G$YW
M-*@N)A),1"P8F//P*CE"@HF(!7,ZYW%4FD@P$;%@CA,?G?<E\DQ$[)GN%$,G
M)IQJ)Y;-<:ZA$Q&))B(6C9MTZ(1#CHF('8/'^.YH(4*.B8@=XXRD.XL0B24Z
MZTAFZ"[W0**)SSFU_GWD8B+1Q.>:6F=OIL*X0X08B28^SP1["RES%Q.))J:>
M:$>8GK9C))N8>E #,;TFA&03$\L&CK*G;H<\ABN[R"?A :9?Z4@],?GP!B0#
M_-)$ZHF)U0,Q_=)$%HK))^@1IMN$$F2AA-I"$-.U4((LE!!;R,L M2'=ZW D
MR#T)L7LZX=@%6]AK9Y7KG@2Y)WG-+-HAIM=P$N2>A'J2!F)Z#0>Y)R%WSU'>
MSX5U,9%[$F+WX.2?5YIP7?$YEX/Y80BY)R%V#\:,7$SDGH38/1VIU(Z8.4;>
M&1-[!R >-)\Q\LZ8>O2#,/T%[\A 8_)YG%.9Z8;6Q40&&E.GV1"F7YK(0&-B
M ^$$NALSQ\A 8V(#84PW9HZ1@<;$!GK)\W=%(*2<,;%R#KG^=-A$O57$Q82;
M68B5 S']-H.4,WZEV9QN3+?-3)!V)O3:^;/"MO.>G"#=3(AU@R:?IM[B_0G2
MS81\5@=-/GF5C70S(=8-QG0#Y 3I9D*^?/GT'-E!I2/=3,ZV?-EB>H%H@G0S
M(=8-QO3N362?R6LL:#Z8<>R*1D@]$^I,&V"T\=W%A#LIJ3-M"-.[,0<!WDM)
MG6N#H$,/%.ZF#*B70'>OMN^83!D$<%=E0"RB4Y/BOTO5 X7[*P-B%75-BW<T
M]T$ MU@&U&L, *7?X <!W&@9G&&5P:DF#[=?!J^ZUJ"SQN$NS(!\ 747WW^=
M=P\4[L,,J!<<(-"#&H?[,@-B&V%0+\CCG?W46_LQZ,@#Q7O[R>=^$&CD@4(;
M46_RQZ"Q!PIM1+W=_WB+4W=LPAO^J7?\PZ50?I/'V_ZI]_UC4+_)0QM1/PT
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M7MGV +>]PNT!<GNEVP/L]HJW!^@=5.\ T#NHW@&@=S!_; /T#JIW .@=5.\
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M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( .M]5UCI?+O@[@   "L"   1
M          "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( .M]
M5UB97)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ ZWU76) 81E1E"0  H4   !@
M ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( .M]
M5UBI)=&&+@(  *@%   8              " @:@1  !X;"]W;W)K<VAE971S
M+W-H965T,BYX;6Q02P$"% ,4    " #K?5=8"& 1:: (   B)@  &
M        @($,%   >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%
M  @ ZWU76![2SE7] P  81   !@              ("!XAP  'AL+W=O<FMS
M:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( .M]5UC0SP020P@  )TG   8
M              " @14A  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"
M% ,4    " #K?5=8/RVD%QT#  !V"@  &               @(&.*0  >&PO
M=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ ZWU76"]LG:QN"@
M0E@  !@              ("!X2P  'AL+W=O<FMS:&5E=',O<VAE970W+GAM
M;%!+ 0(4 Q0    ( .M]5UCL=:_E> (  "X%   8              " @84W
M  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " #K?5=8K<HS
MT%T,  #6/P  &               @($S.@  >&PO=V]R:W-H965T<R]S:&5E
M=#DN>&UL4$L! A0#%     @ ZWU76#A&>/HX P  7P@  !D
M ("!QD8  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " #K
M?5=8)9?9UUT1  "2+0  &0              @($U2@  >&PO=V]R:W-H965T
M<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( .M]5UB\0M%-]P(  ,8&   9
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M970Q-BYX;6Q02P$"% ,4    " #K?5=8(!_>M&<"   Z!0  &0
M    @(&K>   >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    (
M .M]5UB#[C@VO@0  /P*   9              " @4E[  !X;"]W;W)K<VAE
M971S+W-H965T,3@N>&UL4$L! A0#%     @ ZWU76-.J) 84"   *Q8  !D
M             ("!/H   'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"
M% ,4    " #K?5=8/W-JJJ0%  #3#0  &0              @(&)B   >&PO
M=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( .M]5UCN9(NRR0,
M %((   9              " @62.  !X;"]W;W)K<VAE971S+W-H965T,C$N
M>&UL4$L! A0#%     @ ZWU76.=D+1,5!@  XPX  !D              ("!
M9)(  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " #K?5=8
M\%_'VN$%  !X#@  &0              @(&PF   >&PO=V]R:W-H965T<R]S
M:&5E=#(S+GAM;%!+ 0(4 Q0    ( .M]5UA&<ED!R 0  )4+   9
M      " @<B>  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%
M  @ ZWU76(;F=;'\!0  71   !D              ("!QZ,  'AL+W=O<FMS
M:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " #K?5=8<TWD?CP'  #'$
M&0              @('ZJ0  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+
M 0(4 Q0    ( .M]5UAH4TG\- <  '<0   9              " @6VQ  !X
M;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ ZWU76(']VA;\
M"P  820  !D              ("!V+@  'AL+W=O<FMS:&5E=',O<VAE970R
M."YX;6Q02P$"% ,4    " #K?5=8UU"9G=0"  !/!@  &0
M@($+Q0  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( .M]
M5U@\K[97[@4  /\0   9              " @1;(  !X;"]W;W)K<VAE971S
M+W-H965T,S N>&UL4$L! A0#%     @ ZWU76*62C.6^"@  F1L  !D
M         ("!.\X  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
M    " #K?5=8NNATR X#  "W!@  &0              @($PV0  >&PO=V]R
M:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( .M]5UAT-;GO?04  ) -
M   9              " @77<  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL
M4$L! A0#%     @ ZWU76%N[9&B7 @  Q@4  !D              ("!*>(
M 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    " #K?5=8+BCY
MQ,("  !&!@  &0              @('WY   >&PO=V]R:W-H965T<R]S:&5E
M=#,U+GAM;%!+ 0(4 Q0    ( .M]5UC0*3>)30(  #P%   9
M  " @?#G  !X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @
MZWU76) PR;]E @  A@8  !D              ("!=.H  'AL+W=O<FMS:&5E
M=',O<VAE970S-RYX;6Q02P$"% ,4    " #K?5=89#JB:T,"  "*!@  &0
M            @($0[0  >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4
M Q0    ( .M]5U@>HYN%,!,  "@]   9              " @8KO  !X;"]W
M;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ ZWU76):4\,F# @
M"P8  !D              ("!\0(! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX
M;6Q02P$"% ,4    " #K?5=8= GJ;:X%  !6#P  &0              @(&K
M!0$ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( .M]5UCH
M[OM6F (  *D%   9              " @9 + 0!X;"]W;W)K<VAE971S+W-H
M965T-#(N>&UL4$L! A0#%     @ ZWU76-NV\H%R P  .@D  !D
M     ("!7PX! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .M]5UB_[2IGE (  /0%   9              "
M@3XA 0!X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @ ZWU7
M6-I/:9FD @  N04  !D              ("!"20! 'AL+W=O<FMS:&5E=',O
M<VAE970T.2YX;6Q02P$"% ,4    " #K?5=8_SP?9D8$  !1"P  &0
M        @('D)@$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0
M   ( .M]5UBOJ4OX)@,  %0'   9              " @6$K 0!X;"]W;W)K
M<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ ZWU76,M(&Y], P  +P@
M !D              ("!OBX! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q0
M2P$"% ,4    " #K?5=8B %@$&<#  !$"   &0              @(%!,@$
M>&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( .M]5UB,?8V5
M, 4  "P,   9              " @=\U 0!X;"]W;W)K<VAE971S+W-H965T
M-30N>&UL4$L! A0#%     @ ZWU76&CYTXM? @  0 4  !D
M ("!1CL! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4    " #K
M?5=82-N5K7@%  !K#P  &0              @('</0$ >&PO=V]R:W-H965T
M<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( .M]5UBC=Q UIP@  ! 7   9
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M970V,2YX;6Q02P$"% ,4    " #K?5=8(HJ($R #  !?"P  &0
M    @(%[6@$ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    (
M .M]5UC,-[WG( (  , $   9              " @=)= 0!X;"]W;W)K<VAE
M971S+W-H965T-C,N>&UL4$L! A0#%     @ ZWU76-:-L-M,$   @L(  !D
M             ("!*6 ! 'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q02P$"
M% ,4    " #K?5=8]7#W-F8$   W$0  &0              @(&L< $ >&PO
M=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( .M]5UCDK\\S6@(
M +0%   9              " @4EU 0!X;"]W;W)K<VAE971S+W-H965T-C8N
M>&UL4$L! A0#%     @ ZWU76(BKH\;6 @  EPH  !D              ("!
MVG<! 'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6Q02P$"% ,4    " #K?5=8
M=/?!(E4"  "M!0  &0              @('G>@$ >&PO=V]R:W-H965T<R]S
M:&5E=#8X+GAM;%!+ 0(4 Q0    ( .M]5U@NYB[%>@(  %4&   9
M      " @7-] 0!X;"]W;W)K<VAE971S+W-H965T-CDN>&UL4$L! A0#%
M  @ ZWU76$BCE8/F @  F@@  !D              ("!)( ! 'AL+W=O<FMS
M:&5E=',O<VAE970W,"YX;6Q02P$"% ,4    " #K?5=8R"4_H*D"  """
M&0              @(%!@P$ >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+
M 0(4 Q0    ( .M]5UB-^CLV 0X  (K,   9              " @2&& 0!X
M;"]W;W)K<VAE971S+W-H965T-S(N>&UL4$L! A0#%     @ ZWU76+Z3&A\"
M!0  S2$  !D              ("!690! 'AL+W=O<FMS:&5E=',O<VAE970W
M,RYX;6Q02P$"% ,4    " #K?5=8.!BZ%/$"   &"0  &0
M@(&2F0$ >&PO=V]R:W-H965T<R]S:&5E=#<T+GAM;%!+ 0(4 Q0    ( .M]
M5UC2?GV'0 ,  "L)   9              " @;J< 0!X;"]W;W)K<VAE971S
M+W-H965T-S4N>&UL4$L! A0#%     @ ZWU76)@YM?&H @  20@  !D
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M=#@P+GAM;%!+ 0(4 Q0    ( .M]5UA(!^$6#@0  $D2   9
M  " @<>] 0!X;"]W;W)K<VAE971S+W-H965T.#$N>&UL4$L! A0#%     @
MZWU76+Q[@DM<!0  $1\  !D              ("!#,(! 'AL+W=O<FMS:&5E
M=',O<VAE970X,BYX;6Q02P$"% ,4    " #K?5=8X\-&PBH$   :%P  &0
M            @(&?QP$ >&PO=V]R:W-H965T<R]S:&5E=#@S+GAM;%!+ 0(4
M Q0    ( .M]5UCR/83H!P,  $L(   9              " @0#, 0!X;"]W
M;W)K<VAE971S+W-H965T.#0N>&UL4$L! A0#%     @ ZWU76$*75'VP P
M9PT  !D              ("!/L\! 'AL+W=O<FMS:&5E=',O<VAE970X-2YX
M;6Q02P$"% ,4    " #K?5=8PK\A,5L"  !6!0  &0              @($E
MTP$ >&PO=V]R:W-H965T<R]S:&5E=#@V+GAM;%!+ 0(4 Q0    ( .M]5UBA
MY.5<N0(  "P)   9              " @;?5 0!X;"]W;W)K<VAE971S+W-H
M965T.#<N>&UL4$L! A0#%     @ ZWU76)GB;OFL P  VPL  !D
M     ("!I]@! 'AL+W=O<FMS:&5E=',O<VAE970X."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .M]5U@>0*WT.P,  .0-   9              "
M@43J 0!X;"]W;W)K<VAE971S+W-H965T.3,N>&UL4$L! A0#%     @ ZWU7
M6!?!?KJ< P  !A$  !D              ("!MNT! 'AL+W=O<FMS:&5E=',O
M<VAE970Y-"YX;6Q02P$"% ,4    " #K?5=8G6GR<*($  "R'P  &0
M        @(&)\0$ >&PO=V]R:W-H965T<R]S:&5E=#DU+GAM;%!+ 0(4 Q0
M   ( .M]5UA;C,Z5(0,  !D.   9              " @6+V 0!X;"]W;W)K
M<VAE971S+W-H965T.38N>&UL4$L! A0#%     @ ZWU76$.G?'NY P  61(
M !D              ("!NOD! 'AL+W=O<FMS:&5E=',O<VAE970Y-RYX;6Q0
M2P$"% ,4    " #K?5=8@AS:"SH'    ,   &0              @(&J_0$
M>&PO=V]R:W-H965T<R]S:&5E=#DX+GAM;%!+ 0(4 Q0    ( .M]5UCD7%%>
MKP(  "(&   9              " @1L% @!X;"]W;W)K<VAE971S+W-H965T
M.3DN>&UL4$L! A0#%     @ ZWU76&!.5A;C"   KS0  !H
M ("! 0@" 'AL+W=O<FMS:&5E=',O<VAE970Q,# N>&UL4$L! A0#%     @
MZWU76(\J<_$I P  8PH  !H              ("!'!$" 'AL+W=O<FMS:&5E
M=',O<VAE970Q,#$N>&UL4$L! A0#%     @ ZWU76(ET3"!C!@  BS<  !H
M             ("!?10" 'AL+W=O<FMS:&5E=',O<VAE970Q,#(N>&UL4$L!
M A0#%     @ ZWU76*5?_+1[ @  O 8  !H              ("!&!L" 'AL
M+W=O<FMS:&5E=',O<VAE970Q,#,N>&UL4$L! A0#%     @ ZWU76$I(?U9@
M P  90\  !H              ("!RQT" 'AL+W=O<FMS:&5E=',O<VAE970Q
M,#0N>&UL4$L! A0#%     @ ZWU76!KH,UC]!   WQ(  !H
M ("!8R$" 'AL+W=O<FMS:&5E=',O<VAE970Q,#4N>&UL4$L! A0#%     @
MZWU76"/1B=OS P  7P\  !H              ("!F"8" 'AL+W=O<FMS:&5E
M=',O<VAE970Q,#8N>&UL4$L! A0#%     @ ZWU76 .RO@Q_!   [Q8  !H
M             ("!PRH" 'AL+W=O<FMS:&5E=',O<VAE970Q,#<N>&UL4$L!
M A0#%     @ ZWU76$#=D+L^ P  ;0X  !H              ("!>B\" 'AL
M+W=O<FMS:&5E=',O<VAE970Q,#@N>&UL4$L! A0#%     @ ZWU76&$>'>J.
M P  K@P  !H              ("!\#(" 'AL+W=O<FMS:&5E=',O<VAE970Q
M,#DN>&UL4$L! A0#%     @ ZWU76)G!BV'W!0  ^18  !H
M ("!MC8" 'AL+W=O<FMS:&5E=',O<VAE970Q,3 N>&UL4$L! A0#%     @
MZWU76$DFC06[ P  ]!$  !H              ("!Y3P" 'AL+W=O<FMS:&5E
M=',O<VAE970Q,3$N>&UL4$L! A0#%     @ ZWU76'V\1C;/!   /A(  !H
M             ("!V$ " 'AL+W=O<FMS:&5E=',O<VAE970Q,3(N>&UL4$L!
M A0#%     @ ZWU76+2K$Y(B!0  &QH  !H              ("!WT4" 'AL
M+W=O<FMS:&5E=',O<VAE970Q,3,N>&UL4$L! A0#%     @ ZWU76,2CV#&;
M!0  !2T  !H              ("!.4L" 'AL+W=O<FMS:&5E=',O<VAE970Q
M,30N>&UL4$L! A0#%     @ ZWU76+<OYH=_!0  5B4  !H
M ("!#%$" 'AL+W=O<FMS:&5E=',O<VAE970Q,34N>&UL4$L! A0#%     @
MZWU76#T5\L!] P  <@@  !H              ("!PU8" 'AL+W=O<FMS:&5E
M=',O<VAE970Q,38N>&UL4$L! A0#%     @ ZWU76&[BU>=3 P  .@X  !H
M             ("!>%H" 'AL+W=O<FMS:&5E=',O<VAE970Q,3<N>&UL4$L!
M A0#%     @ ZWU76 ].)/^G @  .@<  !H              ("! UX" 'AL
M+W=O<FMS:&5E=',O<VAE970Q,3@N>&UL4$L! A0#%     @ ZWU76$I0)TR
M @  NP8  !H              ("!XF " 'AL+W=O<FMS:&5E=',O<VAE970Q
M,3DN>&UL4$L! A0#%     @ ZWU76(/;9J8P!   ;AD  !H
M ("!FF," 'AL+W=O<FMS:&5E=',O<VAE970Q,C N>&UL4$L! A0#%     @
MZWU76!5L3398 P  S!0   T              ( ! F@" 'AL+W-T>6QE<RYX
M;6Q02P$"% ,4    " #K?5=8EXJ[',     3 @  "P              @ &%
M:P( 7W)E;',O+G)E;'-02P$"% ,4    " #K?5=8NO/33M0'  !/3@  #P
M            @ %N; ( >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ ZWU7
M6&SRAGM, P  :T8  !H              ( !;W0" 'AL+U]R96QS+W=O<FMB
M;V]K+GAM;"YR96QS4$L! A0#%     @ ZWU76(/_L%J7 @  BT,  !,
M         ( !\W<" %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     (  @ !,
)(P  NWH"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>405</ContextCount>
  <ElementCount>550</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>135</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995300 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995301 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>995302 - Statement - Consolidated Balance Sheets (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals</Role>
      <ShortName>Consolidated Balance Sheets (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>995303 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>995304 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>995305 - Statement - Consolidated Statements of Changes in Stockholders??? Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3</Role>
      <ShortName>Consolidated Statements of Changes in Stockholders??? Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995306 - Statement - Consolidated Statements of Changes in Stockholders??? Equity (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3_Parentheticals</Role>
      <ShortName>Consolidated Statements of Changes in Stockholders??? Equity (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995307 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995308 - Disclosure - Organization and Description of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/OrganizationandDescriptionofBusiness</Role>
      <ShortName>Organization and Description of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995309 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995310 - Disclosure - Cash and Cash Equivalents</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/CashandCashEquivalents</Role>
      <ShortName>Cash and Cash Equivalents</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995311 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995312 - Disclosure - Financial Instruments Owned</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwned</Role>
      <ShortName>Financial Instruments Owned</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995313 - Disclosure - Securities Held-to-Maturity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturity</Role>
      <ShortName>Securities Held-to-Maturity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995314 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995315 - Disclosure - Fixed Assets, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNet</Role>
      <ShortName>Fixed Assets, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995316 - Disclosure - Deferred Consideration???gold payments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpayments</Role>
      <ShortName>Deferred Consideration???gold payments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995317 - Disclosure - Convertible Notes</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotes</Role>
      <ShortName>Convertible Notes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995318 - Disclosure - Series A Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStock</Role>
      <ShortName>Series A Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995319 - Disclosure - Payable to Gold Bullion Holdings Jersey Limited GBH</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBH</Role>
      <ShortName>Payable to Gold Bullion Holdings Jersey Limited GBH</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995320 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995321 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995322 - Disclosure - Variable Interest Entities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntities</Role>
      <ShortName>Variable Interest Entities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995323 - Disclosure - Revenues from Contracts with Customers</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/RevenuesfromContractswithCustomers</Role>
      <ShortName>Revenues from Contracts with Customers</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995324 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995325 - Disclosure - Stock-Based Awards</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwards</Role>
      <ShortName>Stock-Based Awards</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>995326 - Disclosure - Stockholder Rights Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlan</Role>
      <ShortName>Stockholder Rights Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>995327 - Disclosure - Employee Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/EmployeeBenefitPlans</Role>
      <ShortName>Employee Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>995328 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>995329 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>995330 - Disclosure - Shares Repurchased</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchased</Role>
      <ShortName>Shares Repurchased</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>995331 - Disclosure - Goodwill and Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssets</Role>
      <ShortName>Goodwill and Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>995332 - Disclosure - Contingent Payments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ContingentPayments</Role>
      <ShortName>Contingent Payments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>995333 - Disclosure - Impairments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/Impairments</Role>
      <ShortName>Impairments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>995334 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>996000 - Disclosure - Accounting Policies, by Policy (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy</Role>
      <ShortName>Accounting Policies, by Policy (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>996001 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>996002 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurements</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>996003 - Disclosure - Financial Instruments Owned (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedTables</Role>
      <ShortName>Financial Instruments Owned (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwned</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>996004 - Disclosure - Securities Held-to-Maturity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturityTables</Role>
      <ShortName>Securities Held-to-Maturity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturity</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>996005 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/Investments</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>996006 - Disclosure - Fixed Assets, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNetTables</Role>
      <ShortName>Fixed Assets, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNet</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>996007 - Disclosure - Deferred Consideration???gold payments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsTables</Role>
      <ShortName>Deferred Consideration???gold payments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpayments</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>996008 - Disclosure - Convertible Notes (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesTables</Role>
      <ShortName>Convertible Notes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotes</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>996009 - Disclosure - Series A Preferred Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockTables</Role>
      <ShortName>Series A Preferred Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStock</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>996010 - Disclosure - Payable to Gold Bullion Holdings Jersey Limited GBH (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHTables</Role>
      <ShortName>Payable to Gold Bullion Holdings Jersey Limited GBH (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBH</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>996011 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/Leases</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>996012 - Disclosure - Variable Interest Entities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesTables</Role>
      <ShortName>Variable Interest Entities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntities</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>996013 - Disclosure - Revenues from Contracts with Customers (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/RevenuesfromContractswithCustomersTables</Role>
      <ShortName>Revenues from Contracts with Customers (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/RevenuesfromContractswithCustomers</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>996014 - Disclosure - Related Party Transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsTables</Role>
      <ShortName>Related Party Transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactions</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>996015 - Disclosure - Stock-Based Awards (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsTables</Role>
      <ShortName>Stock-Based Awards (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwards</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>996016 - Disclosure - Employee Benefit Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/EmployeeBenefitPlansTables</Role>
      <ShortName>Employee Benefit Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/EmployeeBenefitPlans</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>996017 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShare</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>996018 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxes</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>996019 - Disclosure - Goodwill and Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssets</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>996020 - Disclosure - Impairments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ImpairmentsTables</Role>
      <ShortName>Impairments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/Impairments</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>996021 - Disclosure - Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesDetails</Role>
      <ShortName>Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>996022 - Disclosure - Significant Accounting Policies (Details) - Schedule of Depreciation and Amortization</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDepreciationandAmortizationTable</Role>
      <ShortName>Significant Accounting Policies (Details) - Schedule of Depreciation and Amortization</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>996023 - Disclosure - Cash and Cash Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/CashandCashEquivalentsDetails</Role>
      <ShortName>Cash and Cash Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/CashandCashEquivalents</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>996024 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>996025 - Disclosure - Fair Value Measurements (Details) - Schedule of Assets and Liabilities Measured at Fair Value</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable</Role>
      <ShortName>Fair Value Measurements (Details) - Schedule of Assets and Liabilities Measured at Fair Value</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>996026 - Disclosure - Fair Value Measurements (Details) - Schedule of Beginning and Ending Balances of Recurring Fair Value Measurements Classified</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBeginningandEndingBalancesofRecurringFairValueMeasurementsClassifiedTable</Role>
      <ShortName>Fair Value Measurements (Details) - Schedule of Beginning and Ending Balances of Recurring Fair Value Measurements Classified</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>996027 - Disclosure - Financial Instruments Owned (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedDetails</Role>
      <ShortName>Financial Instruments Owned (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>996028 - Disclosure - Financial Instruments Owned (Details) - Schedule of Financial Instruments Owned</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFinancialInstrumentsOwnedTable</Role>
      <ShortName>Financial Instruments Owned (Details) - Schedule of Financial Instruments Owned</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>996029 - Disclosure - Securities Held-to-Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturityDetails</Role>
      <ShortName>Securities Held-to-Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturityTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>996030 - Disclosure - Securities Held-to-Maturity (Details) - Schedule of Securities Held-to-Maturity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSecuritiesHeldtoMaturityTable</Role>
      <ShortName>Securities Held-to-Maturity (Details) - Schedule of Securities Held-to-Maturity</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturityTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>996031 - Disclosure - Securities Held-to-Maturity (Details) - Schedule of Unrealized Losses, Gains and Fair Value of Securities Held-to-Maturity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable</Role>
      <ShortName>Securities Held-to-Maturity (Details) - Schedule of Unrealized Losses, Gains and Fair Value of Securities Held-to-Maturity</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturityTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>996032 - Disclosure - Securities Held-to-Maturity (Details) - Schedule of Maturity Profile of the Securities Held-to-Maturity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofMaturityProfileoftheSecuritiesHeldtoMaturityTable</Role>
      <ShortName>Securities Held-to-Maturity (Details) - Schedule of Maturity Profile of the Securities Held-to-Maturity</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturityTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>996033 - Disclosure - Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails</Role>
      <ShortName>Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>996034 - Disclosure - Investments (Details) - Schedule of Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInvestmentsTable</Role>
      <ShortName>Investments (Details) - Schedule of Investments</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>996035 - Disclosure - Investments (Details) - Schedule of Backsolve Valuation Approach</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBacksolveValuationApproachTable</Role>
      <ShortName>Investments (Details) - Schedule of Backsolve Valuation Approach</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>996036 - Disclosure - Investments (Details) - Schedule of Presents the Probability Ascribed to Potential Outcomes Used in the Pwerm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofPresentstheProbabilityAscribedtoPotentialOutcomesUsedinthePwermTable</Role>
      <ShortName>Investments (Details) - Schedule of Presents the Probability Ascribed to Potential Outcomes Used in the Pwerm</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>996037 - Disclosure - Fixed Assets, Net (Details) - Schedule of Fixed Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFixedAssetsTable</Role>
      <ShortName>Fixed Assets, Net (Details) - Schedule of Fixed Assets</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNetTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>996038 - Disclosure - Deferred Consideration???gold payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails</Role>
      <ShortName>Deferred Consideration???gold payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>996039 - Disclosure - Deferred Consideration???gold payments (Details) - Schedule of Valuation of Deferred Consideration</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofValuationofDeferredConsiderationTable</Role>
      <ShortName>Deferred Consideration???gold payments (Details) - Schedule of Valuation of Deferred Consideration</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>996040 - Disclosure - Deferred Consideration???gold payments (Details) - Schedule of Deferred Consideration</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDeferredConsiderationTable</Role>
      <ShortName>Deferred Consideration???gold payments (Details) - Schedule of Deferred Consideration</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>996041 - Disclosure - Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails</Role>
      <ShortName>Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>996042 - Disclosure - Convertible Notes (Details) - Schedule of Key Terms of Convertible Notes</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofKeyTermsofConvertibleNotesTable</Role>
      <ShortName>Convertible Notes (Details) - Schedule of Key Terms of Convertible Notes</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>996043 - Disclosure - Convertible Notes (Details) - Schedule of Convertible Notes</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofConvertibleNotesTable</Role>
      <ShortName>Convertible Notes (Details) - Schedule of Convertible Notes</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>996044 - Disclosure - Series A Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockDetails</Role>
      <ShortName>Series A Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>996045 - Disclosure - Series A Preferred Stock (Details) - Schedule of Series A Preferred Stock Balance</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSeriesAPreferredStockBalanceTable</Role>
      <ShortName>Series A Preferred Stock (Details) - Schedule of Series A Preferred Stock Balance</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>996046 - Disclosure - Payable to Gold Bullion Holdings Jersey Limited GBH (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHDetails</Role>
      <ShortName>Payable to Gold Bullion Holdings Jersey Limited GBH (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>996047 - Disclosure - Payable to Gold Bullion Holdings Jersey Limited GBH (Details) - Schedule of Aggregate Consideration Payable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAggregateConsiderationPayableTable</Role>
      <ShortName>Payable to Gold Bullion Holdings Jersey Limited GBH (Details) - Schedule of Aggregate Consideration Payable</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>996048 - Disclosure - Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/LeasesDetails</Role>
      <ShortName>Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/LeasesTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>996049 - Disclosure - Leases (Details) - Schedule of Additional Information Related to Operating Lease</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAdditionalInformationRelatedtoOperatingLeaseTable</Role>
      <ShortName>Leases (Details) - Schedule of Additional Information Related to Operating Lease</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/LeasesTables</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>996050 - Disclosure - Leases (Details) - Schedule of Future Minimum Lease Payments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFutureMinimumLeasePaymentsTable</Role>
      <ShortName>Leases (Details) - Schedule of Future Minimum Lease Payments</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/LeasesTables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>996051 - Disclosure - Leases (Details) - Schedule of Reconciliation of Future Minimum Lease Payments to Balance Sheet</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofFutureMinimumLeasePaymentstoBalanceSheetTable</Role>
      <ShortName>Leases (Details) - Schedule of Reconciliation of Future Minimum Lease Payments to Balance Sheet</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/LeasesTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>996052 - Disclosure - Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ContingenciesDetails</Role>
      <ShortName>Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/Contingencies</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>996053 - Disclosure - Variable Interest Entities (Details) - Schedule of Information about Variable Interests</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInformationaboutVariableInterestsTable</Role>
      <ShortName>Variable Interest Entities (Details) - Schedule of Information about Variable Interests</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesTables</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>996054 - Disclosure - Revenues from Contracts with Customers (Details) - Schedule of Revenues from Contracts with Customers</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromContractswithCustomersTable</Role>
      <ShortName>Revenues from Contracts with Customers (Details) - Schedule of Revenues from Contracts with Customers</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/RevenuesfromContractswithCustomersTables</ParentRole>
      <Position>93</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>996055 - Disclosure - Revenues from Contracts with Customers (Details) - Schedule of Geographic Distribution of Revenues</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGeographicDistributionofRevenuesTable</Role>
      <ShortName>Revenues from Contracts with Customers (Details) - Schedule of Geographic Distribution of Revenues</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/RevenuesfromContractswithCustomersTables</ParentRole>
      <Position>94</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>996056 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsTables</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>996057 - Disclosure - Related Party Transactions (Details) - Schedule of Accounts Receivable from Related Parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAccountsReceivablefromRelatedPartiesTable</Role>
      <ShortName>Related Party Transactions (Details) - Schedule of Accounts Receivable from Related Parties</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsTables</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>996058 - Disclosure - Related Party Transactions (Details) - Schedule of Revenues from Advisory Services Provided to Related Parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromAdvisoryServicesProvidedtoRelatedPartiesTable</Role>
      <ShortName>Related Party Transactions (Details) - Schedule of Revenues from Advisory Services Provided to Related Parties</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsTables</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>996059 - Disclosure - Stock-Based Awards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails</Role>
      <ShortName>Stock-Based Awards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsTables</ParentRole>
      <Position>98</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>996060 - Disclosure - Stock-Based Awards (Details) - Schedule of Unrecognized Stock-Based Compensation Expense and Average Remaining Vesting Period</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable</Role>
      <ShortName>Stock-Based Awards (Details) - Schedule of Unrecognized Stock-Based Compensation Expense and Average Remaining Vesting Period</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsTables</ParentRole>
      <Position>99</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>996061 - Disclosure - Stock-Based Awards (Details) - Schedule of Restricted Stock Activity and Restricted Stock Unit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRestrictedStockActivityandRestrictedStockUnitTable</Role>
      <ShortName>Stock-Based Awards (Details) - Schedule of Restricted Stock Activity and Restricted Stock Unit</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsTables</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>996062 - Disclosure - Stock-Based Awards (Details) - Schedule of Share Based Payment Awards Other than Options Valuation Assumptions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofShareBasedPaymentAwardsOtherthanOptionsValuationAssumptionsTable</Role>
      <ShortName>Stock-Based Awards (Details) - Schedule of Share Based Payment Awards Other than Options Valuation Assumptions</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsTables</ParentRole>
      <Position>101</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>996063 - Disclosure - Stockholder Rights Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails</Role>
      <ShortName>Stockholder Rights Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlan</ParentRole>
      <Position>102</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>996064 - Disclosure - Employee Benefit Plans (Details) - Summary of Discretionary Contributions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/SummaryofDiscretionaryContributionsTable</Role>
      <ShortName>Employee Benefit Plans (Details) - Summary of Discretionary Contributions</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/EmployeeBenefitPlansTables</ParentRole>
      <Position>103</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>996065 - Disclosure - Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShareTables</ParentRole>
      <Position>104</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>996066 - Disclosure - Earnings Per Share (Details) - Schedule of Reconciliation of Basic and Diluted Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofBasicandDilutedEarningsPerShareTable</Role>
      <ShortName>Earnings Per Share (Details) - Schedule of Reconciliation of Basic and Diluted Earnings Per Share</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShareTables</ParentRole>
      <Position>105</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>996067 - Disclosure - Earnings Per Share (Details) - Schedule of Weighted Average Number of Shares</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofWeightedAverageNumberofSharesTable</Role>
      <ShortName>Earnings Per Share (Details) - Schedule of Weighted Average Number of Shares</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShareTables</ParentRole>
      <Position>106</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>996068 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesTables</ParentRole>
      <Position>107</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>996069 - Disclosure - Income Taxes (Details) - Schedule of Domestic and Foreign Components of Income before Income Tax Expense</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable</Role>
      <ShortName>Income Taxes (Details) - Schedule of Domestic and Foreign Components of Income before Income Tax Expense</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesTables</ParentRole>
      <Position>108</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>996070 - Disclosure - Income Taxes (Details) - Schedule of Components of Current and Deferred Income Tax Expense</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable</Role>
      <ShortName>Income Taxes (Details) - Schedule of Components of Current and Deferred Income Tax Expense</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesTables</ParentRole>
      <Position>109</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>996071 - Disclosure - Income Taxes (Details) - Schedule of Reconciliation of Statutory Federal Income Tax Rate and Company's Effective Rate</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable</Role>
      <ShortName>Income Taxes (Details) - Schedule of Reconciliation of Statutory Federal Income Tax Rate and Company's Effective Rate</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesTables</ParentRole>
      <Position>110</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>996072 - Disclosure - Income Taxes (Details) - Schedule of Income Tax Payments By Jurisdiction</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIncomeTaxPaymentsByJurisdictionTable</Role>
      <ShortName>Income Taxes (Details) - Schedule of Income Tax Payments By Jurisdiction</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesTables</ParentRole>
      <Position>111</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>996073 - Disclosure - Income Taxes (Details) - Schedule of Components of the Company???s Deferred Tax Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable</Role>
      <ShortName>Income Taxes (Details) - Schedule of Components of the Company???s Deferred Tax Assets</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesTables</ParentRole>
      <Position>112</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>996074 - Disclosure - Income Taxes (Details) - Schedule of Changes in Balance of Gross Unrecognized Tax Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable</Role>
      <ShortName>Income Taxes (Details) - Schedule of Changes in Balance of Gross Unrecognized Tax Benefits</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesTables</ParentRole>
      <Position>113</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>996075 - Disclosure - Shares Repurchased (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails</Role>
      <ShortName>Shares Repurchased (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchased</ParentRole>
      <Position>114</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>996076 - Disclosure - Goodwill and Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsTables</ParentRole>
      <Position>115</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>996077 - Disclosure - Goodwill and Intangible Assets (Details) - Schedule of Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGoodwillTable</Role>
      <ShortName>Goodwill and Intangible Assets (Details) - Schedule of Goodwill</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsTables</ParentRole>
      <Position>116</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>996078 - Disclosure - Goodwill and Intangible Assets (Details) - Schedule of Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIntangibleAssetsTable</Role>
      <ShortName>Goodwill and Intangible Assets (Details) - Schedule of Intangible Assets</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsTables</ParentRole>
      <Position>117</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R118.htm</HtmlFileName>
      <LongName>996079 - Disclosure - Goodwill and Intangible Assets (Details) - Schedule of Expected Amortization Expense</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofExpectedAmortizationExpenseTable</Role>
      <ShortName>Goodwill and Intangible Assets (Details) - Schedule of Expected Amortization Expense</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsTables</ParentRole>
      <Position>118</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R119.htm</HtmlFileName>
      <LongName>996080 - Disclosure - Contingent Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsDetails</Role>
      <ShortName>Contingent Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/ContingentPayments</ParentRole>
      <Position>119</Position>
    </Report>
    <Report instance="wt-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R120.htm</HtmlFileName>
      <LongName>996081 - Disclosure - Impairments (Details) - Schedule of Summarizes Impairments Recognized</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSummarizesImpairmentsRecognizedTable</Role>
      <ShortName>Impairments (Details) - Schedule of Summarizes Impairments Recognized</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.wisdomtreeinvestmentsinc.com/role/ImpairmentsTables</ParentRole>
      <Position>120</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="wt-20231231.htm">wt-20231231.htm</File>
    <File>wt-20231231.xsd</File>
    <File>wt-20231231_cal.xml</File>
    <File>wt-20231231_def.xml</File>
    <File>wt-20231231_lab.xml</File>
    <File>wt-20231231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>tbarchart_001.jpg</File>
    <File>tbarchart_002.jpg</File>
    <File>tbarchart_003.jpg</File>
    <File>tbarchart_004.jpg</File>
    <File>tbarchart_005.jpg</File>
    <File>tbarchart_006.jpg</File>
    <File>tbarchart_007.jpg</File>
    <File>tlinechart_001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2023</BaseTaxonomy>
    <BaseTaxonomy items="1348">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="42">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>150
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "wt-20231231.htm": {
   "nsprefix": "wt",
   "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
   "dts": {
    "inline": {
     "local": [
      "wt-20231231.htm"
     ]
    },
    "schema": {
     "local": [
      "wt-20231231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023_def.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023_lab.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023_pre.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-sub-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "wt-20231231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "wt-20231231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "wt-20231231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "wt-20231231_pre.xml"
     ]
    }
   },
   "keyStandard": 434,
   "keyCustom": 116,
   "axisStandard": 35,
   "axisCustom": 2,
   "memberStandard": 43,
   "memberCustom": 72,
   "hidden": {
    "total": 270,
    "http://fasb.org/us-gaap/2023": 244,
    "http://xbrl.sec.gov/dei/2023": 4,
    "http://www.wisdomtreeinvestmentsinc.com/20231231": 22
   },
   "contextCount": 405,
   "entityCount": 1,
   "segmentCount": 135,
   "elementCount": 1121,
   "unitCount": 8,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 1348,
    "http://xbrl.sec.gov/dei/2023": 42,
    "http://xbrl.sec.gov/ecd/2023": 4,
    "http://fasb.org/srt/2023": 1
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/dei/role/document/AuditInformation",
     "longName": "995300 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet",
     "longName": "995301 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals",
     "longName": "995302 - Statement - Consolidated Balance Sheets (Parentheticals)",
     "shortName": "Consolidated Balance Sheets (Parentheticals)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPershares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement",
     "longName": "995303 - Statement - Consolidated Statements of Operations",
     "shortName": "Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:LaborAndRelatedExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedComprehensiveIncome",
     "longName": "995304 - Statement - Consolidated Statements of Comprehensive Income",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3",
     "longName": "995305 - Statement - Consolidated Statements of Changes in Stockholders\u2019 Equity",
     "shortName": "Consolidated Statements of Changes in Stockholders\u2019 Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c22",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c22",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3_Parentheticals",
     "longName": "995306 - Statement - Consolidated Statements of Changes in Stockholders\u2019 Equity (Parentheticals)",
     "shortName": "Consolidated Statements of Changes in Stockholders\u2019 Equity (Parentheticals)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c20",
      "name": "wt:ReclassificationOfEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20",
      "name": "wt:ReclassificationOfEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow",
     "longName": "995307 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "wt:AdvisoryFeesReceivedInGold",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/OrganizationandDescriptionofBusiness",
     "longName": "995308 - Disclosure - Organization and Description of Business",
     "shortName": "Organization and Description of Business",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPolicies",
     "longName": "995309 - Disclosure - Significant Accounting Policies",
     "shortName": "Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/CashandCashEquivalents",
     "longName": "995310 - Disclosure - Cash and Cash Equivalents",
     "shortName": "Cash and Cash Equivalents",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurements",
     "longName": "995311 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwned",
     "longName": "995312 - Disclosure - Financial Instruments Owned",
     "shortName": "Financial Instruments Owned",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturity",
     "longName": "995313 - Disclosure - Securities Held-to-Maturity",
     "shortName": "Securities Held-to-Maturity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:HeldToMaturitySecuritiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:HeldToMaturitySecuritiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/Investments",
     "longName": "995314 - Disclosure - Investments",
     "shortName": "Investments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:InvestmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:InvestmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNet",
     "longName": "995315 - Disclosure - Fixed Assets, Net",
     "shortName": "Fixed Assets, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpayments",
     "longName": "995316 - Disclosure - Deferred Consideration\u2014gold payments",
     "shortName": "Deferred Consideration\u2014gold payments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "wt:DeferredConsiderationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "wt:DeferredConsiderationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotes",
     "longName": "995317 - Disclosure - Convertible Notes",
     "shortName": "Convertible Notes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStock",
     "longName": "995318 - Disclosure - Series A Preferred Stock",
     "shortName": "Series A Preferred Stock",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PreferredStockTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PreferredStockTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBH",
     "longName": "995319 - Disclosure - Payable to Gold Bullion Holdings Jersey Limited GBH",
     "shortName": "Payable to Gold Bullion Holdings Jersey Limited GBH",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "wt:OtherPayablesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "wt:OtherPayablesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/Leases",
     "longName": "995320 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/Contingencies",
     "longName": "995321 - Disclosure - Contingencies",
     "shortName": "Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:LossContingencyDisclosures",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:LossContingencyDisclosures",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntities",
     "longName": "995322 - Disclosure - Variable Interest Entities",
     "shortName": "Variable Interest Entities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesfromContractswithCustomers",
     "longName": "995323 - Disclosure - Revenues from Contracts with Customers",
     "shortName": "Revenues from Contracts with Customers",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactions",
     "longName": "995324 - Disclosure - Related Party Transactions",
     "shortName": "Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwards",
     "longName": "995325 - Disclosure - Stock-Based Awards",
     "shortName": "Stock-Based Awards",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlan",
     "longName": "995326 - Disclosure - Stockholder Rights Plan",
     "shortName": "Stockholder Rights Plan",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "wt:DisclosureOfStockholderRightsPlanTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "wt:DisclosureOfStockholderRightsPlanTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/EmployeeBenefitPlans",
     "longName": "995327 - Disclosure - Employee Benefit Plans",
     "shortName": "Employee Benefit Plans",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShare",
     "longName": "995328 - Disclosure - Earnings Per Share",
     "shortName": "Earnings Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxes",
     "longName": "995329 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchased",
     "longName": "995330 - Disclosure - Shares Repurchased",
     "shortName": "Shares Repurchased",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:TreasuryStockTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:TreasuryStockTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssets",
     "longName": "995331 - Disclosure - Goodwill and Intangible Assets",
     "shortName": "Goodwill and Intangible Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPayments",
     "longName": "995332 - Disclosure - Contingent Payments",
     "shortName": "Contingent Payments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "wt:ContingentPaymentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "wt:ContingentPaymentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/Impairments",
     "longName": "995333 - Disclosure - Impairments",
     "shortName": "Impairments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:AssetImpairmentChargesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:AssetImpairmentChargesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/SubsequentEvents",
     "longName": "995334 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R38": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c58",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c58",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy",
     "longName": "996000 - Disclosure - Accounting Policies, by Policy (Policies)",
     "shortName": "Accounting Policies, by Policy (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesTables",
     "longName": "996001 - Disclosure - Significant Accounting Policies (Tables)",
     "shortName": "Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c63",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c63",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsTables",
     "longName": "996002 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedTables",
     "longName": "996003 - Disclosure - Financial Instruments Owned (Tables)",
     "shortName": "Financial Instruments Owned (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:FinancialInstrumentsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:FinancialInstrumentsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturityTables",
     "longName": "996004 - Disclosure - Securities Held-to-Maturity (Tables)",
     "shortName": "Securities Held-to-Maturity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:HeldToMaturitySecuritiesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:HeldToMaturitySecuritiesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsTables",
     "longName": "996005 - Disclosure - Investments (Tables)",
     "shortName": "Investments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:InvestmentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:InvestmentTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:InvestmentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:InvestmentTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNetTables",
     "longName": "996006 - Disclosure - Fixed Assets, Net (Tables)",
     "shortName": "Fixed Assets, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsTables",
     "longName": "996007 - Disclosure - Deferred Consideration\u2014gold payments (Tables)",
     "shortName": "Deferred Consideration\u2014gold payments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "wt:DisclosureOfValuationOfDeferredConsiderationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "wt:DisclosureOfValuationOfDeferredConsiderationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesTables",
     "longName": "996008 - Disclosure - Convertible Notes (Tables)",
     "shortName": "Convertible Notes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockTables",
     "longName": "996009 - Disclosure - Series A Preferred Stock (Tables)",
     "shortName": "Series A Preferred Stock (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfPreferredUnitsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfPreferredUnitsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHTables",
     "longName": "996010 - Disclosure - Payable to Gold Bullion Holdings Jersey Limited GBH (Tables)",
     "shortName": "Payable to Gold Bullion Holdings Jersey Limited GBH (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "wt:ScheduleOfAggregateConsiderationPayableTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "wt:OtherPayablesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "wt:ScheduleOfAggregateConsiderationPayableTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "wt:OtherPayablesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/LeasesTables",
     "longName": "996011 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesTables",
     "longName": "996012 - Disclosure - Variable Interest Entities (Tables)",
     "shortName": "Variable Interest Entities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesfromContractswithCustomersTables",
     "longName": "996013 - Disclosure - Revenues from Contracts with Customers (Tables)",
     "shortName": "Revenues from Contracts with Customers (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "wt:SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "wt:SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsTables",
     "longName": "996014 - Disclosure - Related Party Transactions (Tables)",
     "shortName": "Related Party Transactions (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "wt:ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "wt:ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsTables",
     "longName": "996015 - Disclosure - Stock-Based Awards (Tables)",
     "shortName": "Stock-Based Awards (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "wt:ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "wt:ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/EmployeeBenefitPlansTables",
     "longName": "996016 - Disclosure - Employee Benefit Plans (Tables)",
     "shortName": "Employee Benefit Plans (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShareTables",
     "longName": "996017 - Disclosure - Earnings Per Share (Tables)",
     "shortName": "Earnings Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesTables",
     "longName": "996018 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsTables",
     "longName": "996019 - Disclosure - Goodwill and Intangible Assets (Tables)",
     "shortName": "Goodwill and Intangible Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ImpairmentsTables",
     "longName": "996020 - Disclosure - Impairments (Tables)",
     "shortName": "Impairments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:AssetImpairmentChargesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:AssetImpairmentChargesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesDetails",
     "longName": "996021 - Disclosure - Significant Accounting Policies (Details)",
     "shortName": "Significant Accounting Policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "wt:PercentageOfTaxRateRealizedOnSettlement",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "wt:PercentageOfTaxRateRealizedOnSettlement",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDepreciationandAmortizationTable",
     "longName": "996022 - Disclosure - Significant Accounting Policies (Details) - Schedule of Depreciation and Amortization",
     "shortName": "Significant Accounting Policies (Details) - Schedule of Depreciation and Amortization",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c64",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c64",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/CashandCashEquivalentsDetails",
     "longName": "996023 - Disclosure - Cash and Cash Equivalents (Details)",
     "shortName": "Cash and Cash Equivalents (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "us-gaap:CashAndCashEquivalentsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsDetails",
     "longName": "996024 - Disclosure - Fair Value Measurements (Details)",
     "shortName": "Fair Value Measurements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R64": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable",
     "longName": "996025 - Disclosure - Fair Value Measurements (Details) - Schedule of Assets and Liabilities Measured at Fair Value",
     "shortName": "Fair Value Measurements (Details) - Schedule of Assets and Liabilities Measured at Fair Value",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c71",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c71",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBeginningandEndingBalancesofRecurringFairValueMeasurementsClassifiedTable",
     "longName": "996026 - Disclosure - Fair Value Measurements (Details) - Schedule of Beginning and Ending Balances of Recurring Fair Value Measurements Classified",
     "shortName": "Fair Value Measurements (Details) - Schedule of Beginning and Ending Balances of Recurring Fair Value Measurements Classified",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c6",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedDetails",
     "longName": "996027 - Disclosure - Financial Instruments Owned (Details)",
     "shortName": "Financial Instruments Owned (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:TradingGainsLosses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "us-gaap:FinancialInstrumentsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:TradingGainsLosses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "us-gaap:FinancialInstrumentsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFinancialInstrumentsOwnedTable",
     "longName": "996028 - Disclosure - Financial Instruments Owned (Details) - Schedule of Financial Instruments Owned",
     "shortName": "Financial Instruments Owned (Details) - Schedule of Financial Instruments Owned",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:FinancialInstrumentsOwnedAtFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c147",
      "name": "us-gaap:FinancialInstrumentsOwnedAtFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:FinancialInstrumentsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturityDetails",
     "longName": "996029 - Disclosure - Securities Held-to-Maturity (Details)",
     "shortName": "Securities Held-to-Maturity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "us-gaap:HeldToMaturitySecuritiesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "us-gaap:HeldToMaturitySecuritiesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSecuritiesHeldtoMaturityTable",
     "longName": "996030 - Disclosure - Securities Held-to-Maturity (Details) - Schedule of Securities Held-to-Maturity",
     "shortName": "Securities Held-to-Maturity (Details) - Schedule of Securities Held-to-Maturity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c151",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:HeldToMaturitySecuritiesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c151",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:HeldToMaturitySecuritiesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable",
     "longName": "996031 - Disclosure - Securities Held-to-Maturity (Details) - Schedule of Unrealized Losses, Gains and Fair Value of Securities Held-to-Maturity",
     "shortName": "Securities Held-to-Maturity (Details) - Schedule of Unrealized Losses, Gains and Fair Value of Securities Held-to-Maturity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c153",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c153",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofMaturityProfileoftheSecuritiesHeldtoMaturityTable",
     "longName": "996032 - Disclosure - Securities Held-to-Maturity (Details) - Schedule of Maturity Profile of the Securities Held-to-Maturity",
     "shortName": "Securities Held-to-Maturity (Details) - Schedule of Maturity Profile of the Securities Held-to-Maturity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails",
     "longName": "996033 - Disclosure - Investments (Details)",
     "shortName": "Investments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c157",
      "name": "us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "us-gaap:InvestmentTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c157",
      "name": "us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "us-gaap:InvestmentTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInvestmentsTable",
     "longName": "996034 - Disclosure - Investments (Details) - Schedule of Investments",
     "shortName": "Investments (Details) - Schedule of Investments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:InvestmentOwnedAtCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:InvestmentTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBacksolveValuationApproachTable",
     "longName": "996035 - Disclosure - Investments (Details) - Schedule of Backsolve Valuation Approach",
     "shortName": "Investments (Details) - Schedule of Backsolve Valuation Approach",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c58",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c58",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofPresentstheProbabilityAscribedtoPotentialOutcomesUsedinthePwermTable",
     "longName": "996036 - Disclosure - Investments (Details) - Schedule of Presents the Probability Ascribed to Potential Outcomes Used in the Pwerm",
     "shortName": "Investments (Details) - Schedule of Presents the Probability Ascribed to Potential Outcomes Used in the Pwerm",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c189",
      "name": "wt:ConversionOfNotesUponAFutureEquityFinancing",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c189",
      "name": "wt:ConversionOfNotesUponAFutureEquityFinancing",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFixedAssetsTable",
     "longName": "996037 - Disclosure - Fixed Assets, Net (Details) - Schedule of Fixed Assets",
     "shortName": "Fixed Assets, Net (Details) - Schedule of Fixed Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R77": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails",
     "longName": "996038 - Disclosure - Deferred Consideration\u2014gold payments (Details)",
     "shortName": "Deferred Consideration\u2014gold payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:InvestmentOwnedBalanceOtherMeasure",
      "unitRef": "g",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "wt:DisclosureOfValuationOfDeferredConsiderationTableTextBlock",
       "p",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:InvestmentOwnedBalanceOtherMeasure",
      "unitRef": "g",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "wt:DisclosureOfValuationOfDeferredConsiderationTableTextBlock",
       "p",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R78": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofValuationofDeferredConsiderationTable",
     "longName": "996039 - Disclosure - Deferred Consideration\u2014gold payments (Details) - Schedule of Valuation of Deferred Consideration",
     "shortName": "Deferred Consideration\u2014gold payments (Details) - Schedule of Valuation of Deferred Consideration",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "wt:BusinessCombinationConsiderationTransferredDeferredPaymentInterest",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "wt:BusinessCombinationConsiderationTransferredDeferredPaymentInterest",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R79": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDeferredConsiderationTable",
     "longName": "996040 - Disclosure - Deferred Consideration\u2014gold payments (Details) - Schedule of Deferred Consideration",
     "shortName": "Deferred Consideration\u2014gold payments (Details) - Schedule of Deferred Consideration",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "wt:ContractualGoldPayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "wt:ContractualGoldPaymentgoldOuncesPaid",
      "unitRef": "oz",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "unique": true
     }
    },
    "R80": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails",
     "longName": "996041 - Disclosure - Convertible Notes (Details)",
     "shortName": "Convertible Notes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ExtinguishmentOfDebtGainLossNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ExtinguishmentOfDebtGainLossNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofKeyTermsofConvertibleNotesTable",
     "longName": "996042 - Disclosure - Convertible Notes (Details) - Schedule of Key Terms of Convertible Notes",
     "shortName": "Convertible Notes (Details) - Schedule of Key Terms of Convertible Notes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "c226",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c228",
      "name": "us-gaap:DebtInstrumentMaturityDate",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "unique": true
     }
    },
    "R82": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofConvertibleNotesTable",
     "longName": "996043 - Disclosure - Convertible Notes (Details) - Schedule of Convertible Notes",
     "shortName": "Convertible Notes (Details) - Schedule of Convertible Notes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "c226",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c226",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "unique": true
     }
    },
    "R83": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockDetails",
     "longName": "996044 - Disclosure - Series A Preferred Stock (Details)",
     "shortName": "Series A Preferred Stock (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "wt:OutstandingCommonStockPercentage",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "p",
       "us-gaap:PreferredStockTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "wt:OutstandingCommonStockPercentage",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "p",
       "us-gaap:PreferredStockTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R84": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSeriesAPreferredStockBalanceTable",
     "longName": "996045 - Disclosure - Series A Preferred Stock (Details) - Schedule of Series A Preferred Stock Balance",
     "shortName": "Series A Preferred Stock (Details) - Schedule of Series A Preferred Stock Balance",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "c240",
      "name": "us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c240",
      "name": "us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R85": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHDetails",
     "longName": "996046 - Disclosure - Payable to Gold Bullion Holdings Jersey Limited GBH (Details)",
     "shortName": "Payable to Gold Bullion Holdings Jersey Limited GBH (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "c242",
      "name": "us-gaap:PreferredStockConvertibleSharesIssuable",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "wt:OtherPayablesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c243",
      "name": "us-gaap:AssetAcquisitionConsiderationTransferred",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "wt:OtherPayablesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "unique": true
     }
    },
    "R86": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAggregateConsiderationPayableTable",
     "longName": "996047 - Disclosure - Payable to Gold Bullion Holdings Jersey Limited GBH (Details) - Schedule of Aggregate Consideration Payable",
     "shortName": "Payable to Gold Bullion Holdings Jersey Limited GBH (Details) - Schedule of Aggregate Consideration Payable",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:NotesPayableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:LongTermNotesPayable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "wt:OtherPayablesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "unique": true
     }
    },
    "R87": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/LeasesDetails",
     "longName": "996048 - Disclosure - Leases (Details)",
     "shortName": "Leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "wt:PaymentOfLeaseTerminationFee",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "wt:PaymentOfLeaseTerminationFee",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R88": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAdditionalInformationRelatedtoOperatingLeaseTable",
     "longName": "996049 - Disclosure - Leases (Details) - Schedule of Additional Information Related to Operating Lease",
     "shortName": "Leases (Details) - Schedule of Additional Information Related to Operating Lease",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R89": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFutureMinimumLeasePaymentsTable",
     "longName": "996050 - Disclosure - Leases (Details) - Schedule of Future Minimum Lease Payments",
     "shortName": "Leases (Details) - Schedule of Future Minimum Lease Payments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R90": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofFutureMinimumLeasePaymentstoBalanceSheetTable",
     "longName": "996051 - Disclosure - Leases (Details) - Schedule of Reconciliation of Future Minimum Lease Payments to Balance Sheet",
     "shortName": "Leases (Details) - Schedule of Reconciliation of Future Minimum Lease Payments to Balance Sheet",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:OperatingLeaseLiabilityCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:OperatingLeaseLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "unique": true
     }
    },
    "R91": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ContingenciesDetails",
     "longName": "996052 - Disclosure - Contingencies (Details)",
     "shortName": "Contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "91",
     "firstAnchor": {
      "contextRef": "c246",
      "name": "us-gaap:LossContingencyDamagesSoughtValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "us-gaap:LossContingencyDisclosures",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c246",
      "name": "us-gaap:LossContingencyDamagesSoughtValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "us-gaap:LossContingencyDisclosures",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R92": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInformationaboutVariableInterestsTable",
     "longName": "996053 - Disclosure - Variable Interest Entities (Details) - Schedule of Information about Variable Interests",
     "shortName": "Variable Interest Entities (Details) - Schedule of Information about Variable Interests",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "92",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c248",
      "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "unique": true
     }
    },
    "R93": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromContractswithCustomersTable",
     "longName": "996054 - Disclosure - Revenues from Contracts with Customers (Details) - Schedule of Revenues from Contracts with Customers",
     "shortName": "Revenues from Contracts with Customers (Details) - Schedule of Revenues from Contracts with Customers",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "93",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R94": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGeographicDistributionofRevenuesTable",
     "longName": "996055 - Disclosure - Revenues from Contracts with Customers (Details) - Schedule of Geographic Distribution of Revenues",
     "shortName": "Revenues from Contracts with Customers (Details) - Schedule of Geographic Distribution of Revenues",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "94",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c265",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "unique": true
     }
    },
    "R95": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsDetails",
     "longName": "996056 - Disclosure - Related Party Transactions (Details)",
     "shortName": "Related Party Transactions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "95",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OtherIncome",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:OtherIncome",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R96": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAccountsReceivablefromRelatedPartiesTable",
     "longName": "996057 - Disclosure - Related Party Transactions (Details) - Schedule of Accounts Receivable from Related Parties",
     "shortName": "Related Party Transactions (Details) - Schedule of Accounts Receivable from Related Parties",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "96",
     "firstAnchor": {
      "contextRef": "c9",
      "name": "us-gaap:AccountsReceivableNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c279",
      "name": "us-gaap:AccountsReceivableNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "unique": true
     }
    },
    "R97": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromAdvisoryServicesProvidedtoRelatedPartiesTable",
     "longName": "996058 - Disclosure - Related Party Transactions (Details) - Schedule of Revenues from Advisory Services Provided to Related Parties",
     "shortName": "Related Party Transactions (Details) - Schedule of Revenues from Advisory Services Provided to Related Parties",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "97",
     "firstAnchor": {
      "contextRef": "c294",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c294",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R98": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails",
     "longName": "996059 - Disclosure - Stock-Based Awards (Details)",
     "shortName": "Stock-Based Awards (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "98",
     "firstAnchor": {
      "contextRef": "c297",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c297",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R99": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable",
     "longName": "996060 - Disclosure - Stock-Based Awards (Details) - Schedule of Unrecognized Stock-Based Compensation Expense and Average Remaining Vesting Period",
     "shortName": "Stock-Based Awards (Details) - Schedule of Unrecognized Stock-Based Compensation Expense and Average Remaining Vesting Period",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "99",
     "firstAnchor": {
      "contextRef": "c305",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c305",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R100": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRestrictedStockActivityandRestrictedStockUnitTable",
     "longName": "996061 - Disclosure - Stock-Based Awards (Details) - Schedule of Restricted Stock Activity and Restricted Stock Unit",
     "shortName": "Stock-Based Awards (Details) - Schedule of Restricted Stock Activity and Restricted Stock Unit",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "100",
     "firstAnchor": {
      "contextRef": "c319",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c307",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "unique": true
     }
    },
    "R101": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofShareBasedPaymentAwardsOtherthanOptionsValuationAssumptionsTable",
     "longName": "996062 - Disclosure - Stock-Based Awards (Details) - Schedule of Share Based Payment Awards Other than Options Valuation Assumptions",
     "shortName": "Stock-Based Awards (Details) - Schedule of Share Based Payment Awards Other than Options Valuation Assumptions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "101",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R102": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails",
     "longName": "996063 - Disclosure - Stockholder Rights Plan (Details)",
     "shortName": "Stockholder Rights Plan (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "102",
     "firstAnchor": {
      "contextRef": "c327",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "wt:DisclosureOfStockholderRightsPlanTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c327",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "wt:DisclosureOfStockholderRightsPlanTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R103": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/SummaryofDiscretionaryContributionsTable",
     "longName": "996064 - Disclosure - Employee Benefit Plans (Details) - Summary of Discretionary Contributions",
     "shortName": "Employee Benefit Plans (Details) - Summary of Discretionary Contributions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "103",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R104": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShareDetails",
     "longName": "996065 - Disclosure - Earnings Per Share (Details)",
     "shortName": "Earnings Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "104",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c19",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "unique": true
     }
    },
    "R105": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofBasicandDilutedEarningsPerShareTable",
     "longName": "996066 - Disclosure - Earnings Per Share (Details) - Schedule of Reconciliation of Basic and Diluted Earnings Per Share",
     "shortName": "Earnings Per Share (Details) - Schedule of Reconciliation of Basic and Diluted Earnings Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "105",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "wt:IncomeDistributedToParticipatingSecurities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "unique": true
     }
    },
    "R106": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofWeightedAverageNumberofSharesTable",
     "longName": "996067 - Disclosure - Earnings Per Share (Details) - Schedule of Weighted Average Number of Shares",
     "shortName": "Earnings Per Share (Details) - Schedule of Weighted Average Number of Shares",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "106",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "wt:WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "unique": true
     }
    },
    "R107": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesDetails",
     "longName": "996068 - Disclosure - Income Taxes (Details)",
     "shortName": "Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "107",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R108": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable",
     "longName": "996069 - Disclosure - Income Taxes (Details) - Schedule of Domestic and Foreign Components of Income before Income Tax Expense",
     "shortName": "Income Taxes (Details) - Schedule of Domestic and Foreign Components of Income before Income Tax Expense",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "108",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c265",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "unique": true
     }
    },
    "R109": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable",
     "longName": "996070 - Disclosure - Income Taxes (Details) - Schedule of Components of Current and Deferred Income Tax Expense",
     "shortName": "Income Taxes (Details) - Schedule of Components of Current and Deferred Income Tax Expense",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "109",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "unique": true
     }
    },
    "R110": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable",
     "longName": "996071 - Disclosure - Income Taxes (Details) - Schedule of Reconciliation of Statutory Federal Income Tax Rate and Company's Effective Rate",
     "shortName": "Income Taxes (Details) - Schedule of Reconciliation of Statutory Federal Income Tax Rate and Company's Effective Rate",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "110",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R111": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIncomeTaxPaymentsByJurisdictionTable",
     "longName": "996072 - Disclosure - Income Taxes (Details) - Schedule of Income Tax Payments By Jurisdiction",
     "shortName": "Income Taxes (Details) - Schedule of Income Tax Payments By Jurisdiction",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "111",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c350",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "unique": true
     }
    },
    "R112": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable",
     "longName": "996073 - Disclosure - Income Taxes (Details) - Schedule of Components of the Company\u2019s Deferred Tax Assets",
     "shortName": "Income Taxes (Details) - Schedule of Components of the Company\u2019s Deferred Tax Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "112",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:DeferredTaxAssetsCapitalLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "unique": true
     }
    },
    "R113": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable",
     "longName": "996074 - Disclosure - Income Taxes (Details) - Schedule of Changes in Balance of Gross Unrecognized Tax Benefits",
     "shortName": "Income Taxes (Details) - Schedule of Changes in Balance of Gross Unrecognized Tax Benefits",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "113",
     "firstAnchor": {
      "contextRef": "c6",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c19",
      "name": "us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "unique": true
     }
    },
    "R114": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails",
     "longName": "996075 - Disclosure - Shares Repurchased (Details)",
     "shortName": "Shares Repurchased (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "114",
     "firstAnchor": {
      "contextRef": "c372",
      "name": "us-gaap:StockRepurchaseProgramExpirationDate",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:TreasuryStockTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c372",
      "name": "us-gaap:StockRepurchaseProgramExpirationDate",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:TreasuryStockTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R115": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsDetails",
     "longName": "996076 - Disclosure - Goodwill and Intangible Assets (Details)",
     "shortName": "Goodwill and Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "115",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "wt:PercentageOfRevenueGrowth",
      "unitRef": "pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "unique": true
     }
    },
    "R116": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGoodwillTable",
     "longName": "996077 - Disclosure - Goodwill and Intangible Assets (Details) - Schedule of Goodwill",
     "shortName": "Goodwill and Intangible Assets (Details) - Schedule of Goodwill",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "116",
     "firstAnchor": {
      "contextRef": "c6",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R117": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIntangibleAssetsTable",
     "longName": "996078 - Disclosure - Goodwill and Intangible Assets (Details) - Schedule of Intangible Assets",
     "shortName": "Goodwill and Intangible Assets (Details) - Schedule of Intangible Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "117",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R118": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofExpectedAmortizationExpenseTable",
     "longName": "996079 - Disclosure - Goodwill and Intangible Assets (Details) - Schedule of Expected Amortization Expense",
     "shortName": "Goodwill and Intangible Assets (Details) - Schedule of Expected Amortization Expense",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "118",
     "firstAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c5",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R119": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsDetails",
     "longName": "996080 - Disclosure - Contingent Payments (Details)",
     "shortName": "Contingent Payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "119",
     "firstAnchor": {
      "contextRef": "c388",
      "name": "us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "wt:ContingentPaymentTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c388",
      "name": "us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "wt:ContingentPaymentTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R120": {
     "role": "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSummarizesImpairmentsRecognizedTable",
     "longName": "996081 - Disclosure - Impairments (Details) - Schedule of Summarizes Impairments Recognized",
     "shortName": "Impairments (Details) - Schedule of Summarizes Impairments Recognized",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "120",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:RestructuringCostsAndAssetImpairmentCharges",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:AssetImpairmentChargesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "us-gaap:RestructuringCostsAndAssetImpairmentCharges",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "us-gaap:AssetImpairmentChargesTextBlock",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "wt-20231231.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAndAccruedLiabilitiesMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Payable and Accrued Liabilities [Member]",
        "label": "Accounts Payable and Accrued Liabilities [Member]",
        "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and other liabilities",
        "label": "Accounts Payable and Other Accrued Liabilities, Current",
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payable to GBH (Note 12)",
        "label": "Accounts Payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r1354"
     ]
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableTradeCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fund management and administration payable",
        "label": "Accounts Payable, Trade, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r38"
     ]
    },
    "us-gaap_AccountsReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNet",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAccountsReceivablefromRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable from related parties (in Dollars)",
        "verboseLabel": "Accounts receivable from related parties",
        "label": "Accounts Receivable, after Allowance for Credit Loss",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business."
       }
      }
     },
     "auth_ref": [
      "r871",
      "r1001",
      "r1054",
      "r1357"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable (including $28,511 and $24,139 due from related parties at December 31, 2023 and 2022, respectively)",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r357",
      "r358"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFixedAssetsTable": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFixedAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r241",
      "r773"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive loss",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r51",
      "r140",
      "r249",
      "r770",
      "r809",
      "r813"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income/(Loss)",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r24",
      "r51",
      "r621",
      "r624",
      "r689",
      "r804",
      "r805",
      "r1202",
      "r1203",
      "r1204",
      "r1216",
      "r1217",
      "r1218"
     ]
    },
    "wt_AcquiringPersonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "AcquiringPersonMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquiring Person [Member]",
        "label": "Acquiring Person Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1123"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-In Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r569",
      "r570",
      "r571",
      "r829",
      "r1216",
      "r1217",
      "r1218",
      "r1333",
      "r1364"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r1167"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r1167"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r1165"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r1129"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r1129"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r1129"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1129"
     ]
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update [Axis]",
        "documentation": "Information by amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r284",
      "r285",
      "r286",
      "r287",
      "r296",
      "r359",
      "r360",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r438",
      "r569",
      "r570",
      "r571",
      "r595",
      "r596",
      "r597",
      "r598",
      "r607",
      "r608",
      "r609",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r648",
      "r649",
      "r652",
      "r653",
      "r654",
      "r655",
      "r664",
      "r665",
      "r668",
      "r669",
      "r670",
      "r671",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r737",
      "r738",
      "r739",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalOther",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Adjustments to Additional Paid in Capital, Other",
        "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdvertisingCostsPolicyTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketing and Advertising",
        "label": "Advertising Cost [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for advertising cost."
       }
      }
     },
     "auth_ref": [
      "r202"
     ]
    },
    "wt_AdvisoryFeesReceivedInGold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "AdvisoryFeesReceivedInGold",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Advisory fees received in gold and other precious metals",
        "documentation": "Advisory fees received in gold and other precious metals.",
        "label": "Advisory Fees Received In Gold"
       }
      }
     },
     "auth_ref": []
    },
    "wt_AdvisoryServicesProvidedToManJerIssuersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "AdvisoryServicesProvidedToManJerIssuersMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromAdvisoryServicesProvidedtoRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advisory services provided to ManJer Issuers [Member]",
        "label": "Advisory Services Provided To Man Jer Issuers Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_AdvisoryServicesProvidedToWMAIAndWTICAVMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "AdvisoryServicesProvidedToWMAIAndWTICAVMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromAdvisoryServicesProvidedtoRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advisory services provided to WMAI and WTICAV\t[Member]",
        "label": "Advisory Services Provided To WMAIAnd WTICAVMember"
       }
      }
     },
     "auth_ref": []
    },
    "wt_AdvisoryServicesProvidedToWTTMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "AdvisoryServicesProvidedToWTTMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromAdvisoryServicesProvidedtoRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advisory services provided to WTT [Member]",
        "label": "Advisory Services Provided To WTTMember"
       }
      }
     },
     "auth_ref": []
    },
    "wt_AffiliatedBlockchainEnabledFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "AffiliatedBlockchainEnabledFundsMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Affiliated Blockchain Enabled Funds [Member]",
        "documentation": "Affiliated blockchain enabled funds.",
        "label": "Affiliated Blockchain Enabled Funds Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_AggregateConsiderationPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "AggregateConsiderationPayable",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate consideration payable",
        "documentation": "Amount of aggregate consideration payable.",
        "label": "Aggregate Consideration Payable"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1085",
      "r1097",
      "r1113",
      "r1141"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r1088",
      "r1100",
      "r1116",
      "r1144"
     ]
    },
    "wt_AgreementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "AgreementAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Agreement [Axis]",
        "documentation": "Agreement.",
        "label": "Agreement Axis"
       }
      }
     },
     "auth_ref": []
    },
    "wt_AgreementDomainDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "AgreementDomainDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AgreementDomain [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r1129"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r1136"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r1092",
      "r1101",
      "r1117",
      "r1136",
      "r1145",
      "r1149",
      "r1157"
     ]
    },
    "us-gaap_AllOtherCorporateBondsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllOtherCorporateBondsMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate bonds [Member]",
        "label": "Other Corporate Bonds [Member]",
        "documentation": "Investments in corporate fixed maturity debt securities classified as other."
       }
      }
     },
     "auth_ref": [
      "r1366"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r1155"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "wt_AmortizationOfIssuanceCostsConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "AmortizationOfIssuanceCostsConvertibleNotes",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of issuance costs\u2014convertible notes",
        "documentation": "Amortization of issuance costs \u2013 convertible notes.",
        "label": "Amortization Of Issuance Costs Convertible Notes"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r1093"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive non-participating common stock equivalents",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r317"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r611"
     ]
    },
    "us-gaap_AssetAcquisitionConsiderationTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionConsiderationTransferred",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate cash",
        "label": "Asset Acquisition, Consideration Transferred",
        "documentation": "Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer."
       }
      }
     },
     "auth_ref": [
      "r1046",
      "r1330",
      "r1331",
      "r1332"
     ]
    },
    "us-gaap_AssetAcquisitionConsiderationTransferredContingentConsideration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionConsiderationTransferredContingentConsideration",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate consideration",
        "label": "Asset Acquisition, Consideration Transferred, Contingent Consideration",
        "documentation": "Amount of contingent consideration recognized as part of consideration transferred in asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r1330",
      "r1331",
      "r1332"
     ]
    },
    "us-gaap_AssetAcquisitionContingentConsiderationLiabilityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionContingentConsiderationLiabilityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent Payments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetImpairmentChargesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetImpairmentChargesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetImpairmentChargesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetImpairmentChargesTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/Impairments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairments",
        "label": "Asset Impairment Charges [Text Block]",
        "documentation": "The entire disclosure for the details of the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value. Disclosure may also include a description of the impaired asset and facts and circumstances leading to the impairment, amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired asset is reported."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r245",
      "r274",
      "r325",
      "r345",
      "r351",
      "r396",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r612",
      "r614",
      "r651",
      "r765",
      "r876",
      "r1048",
      "r1064",
      "r1286",
      "r1287",
      "r1342"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "verboseLabel": "Assets:",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r237",
      "r252",
      "r274",
      "r396",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r612",
      "r614",
      "r651",
      "r1048",
      "r1286",
      "r1287",
      "r1342"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r1093"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r1077",
      "r1080",
      "r1093"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r1077",
      "r1080",
      "r1093"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r1077",
      "r1080",
      "r1093"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gross unrealized losses",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r367"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSecuritiesHeldtoMaturityTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instruments: Pass-through GSEs (amortized cost)",
        "verboseLabel": "Cost/amortized cost",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r364",
      "r412",
      "r764"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesGrossUnrealizedLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleDebtSecuritiesGrossUnrealizedLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross unrealized gains",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss",
        "documentation": "Amount of unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r1233"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesTransfersToTradingGainsLossesNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesTransfersToTradingGainsLossesNetAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Unrealized Losses Gains And Fair Value of Securities Held to Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r1152"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r1153"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r1148"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r1148"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r1148"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r1148"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1148"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r1148"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRestrictedStockActivityandRestrictedStockUnitTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r1151"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r1150"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r1149"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r1149"
     ]
    },
    "wt_B1ConvertiblePreferenceSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "B1ConvertiblePreferenceSharesMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInformationaboutVariableInterestsTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "B-1 convertible preference shares [Member]",
        "verboseLabel": "B-1 Preference Shares [Member]",
        "label": "B1 Convertible Preference Shares Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BalanceSheetLocationAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Location [Axis]",
        "documentation": "Information by location on balance sheet (statement of financial position)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BalanceSheetLocationDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Location [Domain]",
        "documentation": "Location in the balance sheet (statement of financial position)."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r109"
     ]
    },
    "wt_BasicEarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "BasicEarningsPerShareAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofBasicandDilutedEarningsPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic Earnings per Share",
        "label": "Basic Earnings Per Share Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "wt_BelowTwentyFifthPercentileMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "BelowTwentyFifthPercentileMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Below Twenty Fifth Percentile [Member]",
        "documentation": "Below Twenty Fifth Percentile",
        "label": "Below Twenty Fifth Percentile Member"
       }
      }
     },
     "auth_ref": []
    },
    "srt_BoardOfDirectorsChairmanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "BoardOfDirectorsChairmanMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Board of Directors Chairman [Member]",
        "verboseLabel": "Board of Directors [Member]",
        "label": "Board of Directors Chairman [Member]",
        "documentation": "Leader of board of directors."
       }
      }
     },
     "auth_ref": [
      "r1222"
     ]
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Acquiree [Domain]",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r606",
      "r1041",
      "r1042"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r99",
      "r606",
      "r1041",
      "r1042"
     ]
    },
    "us-gaap_BusinessAcquisitionEffectiveDateOfAcquisition1": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionEffectiveDateOfAcquisition1",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisition completion date",
        "label": "Business Acquisition, Effective Date of Acquisition",
        "documentation": "Date when the acquirer obtains control of the acquiree, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r4",
      "r26"
     ]
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issued shares (in Shares)",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Consideration [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r606"
     ]
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of equity interest Acquired",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill not deductible for tax purposes",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes."
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionSharePrice",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock per share (in Dollars per share)",
        "label": "Business Acquisition, Share Price",
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationConsiderationTransferred1",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate consideration",
        "verboseLabel": "Fair value of consideration",
        "netLabel": "Transaction paid",
        "label": "Business Combination, Consideration Transferred",
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r7",
      "r21"
     ]
    },
    "wt_BusinessCombinationConsiderationTransferredDeferredPaymentInterest": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "BusinessCombinationConsiderationTransferredDeferredPaymentInterest",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofValuationofDeferredConsiderationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount rate",
        "documentation": "Discount rate used to value the deferred consideration.",
        "label": "Business Combination Consideration Transferred Deferred Payment Interest"
       }
      }
     },
     "auth_ref": []
    },
    "wt_BusinessCombinationDeferredConsiderationLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "BusinessCombinationDeferredConsiderationLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred consideration (Note 9)",
        "documentation": "Amount of liability arising from deferred consideration in a business combination.",
        "label": "Business Combination Deferred Consideration Liability"
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r1080",
      "r1093"
     ]
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/OrganizationandDescriptionofBusiness"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization and Description of Business",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r156",
      "r157"
     ]
    },
    "us-gaap_BusinessDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales and business development",
        "label": "Business Development",
        "documentation": "Business development involves the development of products and services, their delivery, design and their implementation. Business development includes a number of techniques designed to grow an economic enterprise. Such techniques include, but are not limited to, assessments of marketing opportunities and target markets, intelligence gathering on customers and competitors, generating leads for possible sales, follow-up sales activity, formal proposal writing and business model design. Business development involves evaluating a business and then realizing its full potential, using such tools as marketing, sales, information management and customer service."
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "wt_CapitalStockPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "CapitalStockPercentage",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital stock, percentage",
        "documentation": "Capital stock percentage.",
        "label": "Capital Stock Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "wt_CarryingAmountAssetsSecurrencyAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "CarryingAmountAssetsSecurrencyAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInformationaboutVariableInterestsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carrying Amount\u2014Assets (Securrency):",
        "label": "Carrying Amount Assets Securrency Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "wt_CarryingValueOfConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "CarryingValueOfConvertibleNotes",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible notes (Note 10)",
        "documentation": "Carrying value of convertible notes (with maturities initially due after one year), net of unamortized issuance costs.",
        "label": "Carrying Value Of Convertible Notes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Cash",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash",
        "label": "Cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r201",
      "r767",
      "r840",
      "r870",
      "r1048",
      "r1064",
      "r1197"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/CashandCashEquivalentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents (including $5,007 and $0 invested in WisdomTree Government Money Market Digital Fund at December 31, 2023 and 2022, respectively)",
        "verboseLabel": "Total cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r239",
      "r1018"
     ]
    },
    "us-gaap_CashAndCashEquivalentsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsDisclosureTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/CashandCashEquivalents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents Disclosure [Text Block]",
        "documentation": "The entire disclosure for cash and cash equivalent footnotes, which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r767"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/CashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and cash equivalents\u2014beginning of year",
        "periodEndLabel": "Cash and cash equivalents\u2014end of year",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r153",
      "r271"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net (decrease)/increase in cash and cash equivalents",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r153"
     ]
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/CashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents, at carrying value",
        "label": "Cash Equivalents, at Carrying Value",
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r1197",
      "r1356"
     ]
    },
    "wt_CashEquivalentsMaturityPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "CashEquivalentsMaturityPeriod",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liquid investments, original maturities",
        "documentation": "Cash equivalents maturity period.",
        "label": "Cash Equivalents Maturity Period"
       }
      }
     },
     "auth_ref": []
    },
    "wt_CashandCashEquivalentsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "CashandCashEquivalentsDetailsTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/CashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ChangeInForeignNetOperatingLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ChangeInForeignNetOperatingLosses",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in foreign net operating losses (\u201cNOLs\u201d)",
        "documentation": "Change in foreign net operating losses.",
        "label": "Change In Foreign Net Operating Losses"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1127"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofWeightedAverageNumberofSharesTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3",
      "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r246",
      "r247",
      "r248",
      "r274",
      "r301",
      "r302",
      "r312",
      "r316",
      "r322",
      "r323",
      "r396",
      "r455",
      "r457",
      "r458",
      "r459",
      "r462",
      "r463",
      "r495",
      "r496",
      "r498",
      "r499",
      "r502",
      "r651",
      "r820",
      "r821",
      "r822",
      "r823",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r841",
      "r862",
      "r885",
      "r909",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1177",
      "r1210",
      "r1220"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right for outstanding shares (in Shares)",
        "label": "Class of Warrant or Right, Outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r1128"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r1128"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingencies (Note 14)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r124",
      "r766",
      "r861"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingencies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingencies",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r1002"
     ]
    },
    "wt_CommonStock001ParValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "CommonStock001ParValueMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock, $0.01 par value",
        "label": "Common Stock001 Par Value Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockDividendsPerShareDeclared",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash dividends declared per common share (in Dollars per share)",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3",
      "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "verboseLabel": "Common Stock [Member]",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r1051",
      "r1052",
      "r1053",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1216",
      "r1217",
      "r1333",
      "r1359",
      "r1364"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in Dollars per share)",
        "verboseLabel": "Common stock, par or stated value per share (in Dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r862"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r134",
      "r862",
      "r882",
      "r1364",
      "r1365"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value $0.01; 400,000 shares authorized; issued and outstanding: 150,330 and 146,517 at December 31, 2023 and 2022, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r769",
      "r1048"
     ]
    },
    "us-gaap_CommunicationsInformationTechnologyAndOccupancy": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommunicationsInformationTechnologyAndOccupancy",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Occupancy, communications and equipment",
        "label": "Communications, Information Technology and Occupancy",
        "documentation": "The aggregate amount of communications, data processing and occupancy expenses."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r196"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r1133"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r1132"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r1134"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r1131"
     ]
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Benefit Plans [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Awards",
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive income",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r255",
      "r257",
      "r264",
      "r755",
      "r778"
     ]
    },
    "srt_CondensedFinancialStatementsCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "CondensedFinancialStatementsCaptionsLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofPresentstheProbabilityAscribedtoPotentialOutcomesUsedinthePwermTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Financial Statements, Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r227",
      "r228",
      "r229",
      "r279",
      "r1179"
     ]
    },
    "srt_ConsolidatedEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidatedEntitiesAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "documentation": "Information by consolidated entity or group of entities."
       }
      }
     },
     "auth_ref": [
      "r217",
      "r279",
      "r612",
      "r613",
      "r614",
      "r615",
      "r698",
      "r1012",
      "r1194",
      "r1195",
      "r1196",
      "r1285",
      "r1288",
      "r1289"
     ]
    },
    "srt_ConsolidatedEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidatedEntitiesDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "documentation": "Entity or group of entities consolidated into reporting entity."
       }
      }
     },
     "auth_ref": [
      "r217",
      "r279",
      "r612",
      "r613",
      "r614",
      "r615",
      "r698",
      "r1012",
      "r1194",
      "r1195",
      "r1196",
      "r1285",
      "r1288",
      "r1289"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r1020"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r1080"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "wt_ContingenciesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ContingenciesDetailsTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingencies (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ContingentPaymentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ContingentPaymentTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPayments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent Payments",
        "documentation": "Contingent payment text block.",
        "label": "Contingent Payment Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ContingentPaymentsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ContingentPaymentsDetailsTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent Payments (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ContingentPaymentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ContingentPaymentsLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent Payments [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ContingentPaymentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ContingentPaymentsPolicyTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent Payments",
        "documentation": "Contingent payments.",
        "label": "Contingent Payments Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ContractualGoldPaymentgoldOuncesPaid": {
     "xbrltype": "massItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ContractualGoldPaymentgoldOuncesPaid",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDeferredConsiderationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contractual gold payments\u2014gold ounces paid (in Ounces)",
        "documentation": "Contractual gold payments gold ounces paid.",
        "label": "Contractual Gold Paymentgold Ounces Paid"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ContractualGoldPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ContractualGoldPayments",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow",
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDeferredConsiderationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contractual gold payments (Note 9)",
        "verboseLabel": "Contractual gold payments",
        "documentation": "Contractual gold payments.",
        "label": "Contractual Gold Payments"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ContractualGoldPaymentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ContractualGoldPaymentsMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contractual gold payments [Member]",
        "label": "Contractual Gold Payments Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ContractualGoldPaymentsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ContractualGoldPaymentsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contractual Gold Payments",
        "documentation": "Contractual gold payments.",
        "label": "Contractual Gold Payments Policy Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractualObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractualObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contractual obligation",
        "label": "Contractual Obligation",
        "documentation": "Amount of contractual obligation, including, but not limited to, long-term debt, lease obligation, purchase obligation, and other commitments."
       }
      }
     },
     "auth_ref": [
      "r1214"
     ]
    },
    "wt_ConversionOfNoteUponAFutureFinancingRound": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ConversionOfNoteUponAFutureFinancingRound",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofPresentstheProbabilityAscribedtoPotentialOutcomesUsedinthePwermTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of note upon a future financing round",
        "documentation": "The percentage of conversion of note upon a future financing round.",
        "label": "Conversion Of Note Upon AFuture Financing Round"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ConversionOfNotesUponAFutureEquityFinancing": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ConversionOfNotesUponAFutureEquityFinancing",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofPresentstheProbabilityAscribedtoPotentialOutcomesUsedinthePwermTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of note upon a future equity financing",
        "documentation": "The percentage of conversion of note upon a future equity financing.",
        "label": "Conversion Of Notes Upon AFuture Equity Financing"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockAmountIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConversionOfStockAmountIssued1",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion shares value",
        "label": "Conversion of Stock, Amount Issued",
        "documentation": "The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r63",
      "r64"
     ]
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConversionOfStockSharesConverted1",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of stock shares converted (in Shares)",
        "verboseLabel": "Convertible shares (in Shares)",
        "label": "Conversion of Stock, Shares Converted",
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r63",
      "r64"
     ]
    },
    "us-gaap_ConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible notes (in Dollars)",
        "label": "Convertible Debt",
        "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r190",
      "r1355"
     ]
    },
    "us-gaap_ConvertibleDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleDebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible notes\u2014current (Note 10)",
        "label": "Convertible Debt, Current",
        "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "us-gaap_ConvertibleDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleDebtMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Note [Member]",
        "label": "Convertible Debt [Member]",
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r465",
      "r466",
      "r476",
      "r477",
      "r478",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034"
     ]
    },
    "us-gaap_ConvertibleDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleDebtTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Convertible Notes",
        "label": "Convertible Debt [Table Text Block]",
        "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Notes [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ConvertibleNoteDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ConvertibleNoteDiscountRate",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion price discount rate",
        "documentation": "Convertible notes discount rate.",
        "label": "Convertible Note Discount Rate"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ConvertibleNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ConvertibleNoteMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInformationaboutVariableInterestsTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible note [Member]",
        "label": "Convertible Note Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ConvertibleNotesDetailsScheduleofConvertibleNotesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ConvertibleNotesDetailsScheduleofConvertibleNotesTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofConvertibleNotesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Notes (Details) - Schedule of Convertible Notes [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ConvertibleNotesDetailsScheduleofKeyTermsofConvertibleNotesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ConvertibleNotesDetailsScheduleofKeyTermsofConvertibleNotesTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofKeyTermsofConvertibleNotesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Notes (Details) - Schedule of Key Terms of Convertible Notes [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ConvertibleNotesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ConvertibleNotesDetailsTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Notes (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ConvertibleNotesMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofConvertibleNotesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Notes [Member]",
        "label": "Convertible Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleNotesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleNotesPayableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increasing carrying value of convertible notes",
        "label": "Convertible Notes Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_ConvertibleNotesPayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertibleNotesPayableMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Notes Payable [Member]",
        "label": "Convertible Notes Payable [Member]",
        "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r188"
     ]
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertiblePreferredStockMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series A convertible preferred stock [Member]",
        "label": "Convertible Preferred Stock [Member]",
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option."
       }
      }
     },
     "auth_ref": [
      "r495",
      "r496",
      "r498",
      "r1055",
      "r1056",
      "r1057",
      "r1058"
     ]
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible into common stock (in Shares)",
        "label": "Convertible Preferred Stock, Shares Issued upon Conversion",
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r85",
      "r133",
      "r170",
      "r500"
     ]
    },
    "wt_ConvertiblePromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ConvertiblePromissoryNoteMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Promissory Note [Member]",
        "label": "Convertible Promissory Note Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ConvertibleSeniorNotesDue2028Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ConvertibleSeniorNotesDue2028Member",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Senior Notes due 2028 [Member]",
        "label": "Convertible Senior Notes Due2028 Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Senior Notes due 2026 [Member]",
        "documentation": "Convertible Senior Notes Due Two Thousand And Twenty Six [Member]",
        "label": "Convertible Senior Notes Due Two Thousand And Twenty Six Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Senior Notes due 2023 [Member]",
        "documentation": "Convertible senior notes due two thousand and twenty three [Member].",
        "label": "Convertible Senior Notes Due Two Thousand And Twenty Three Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ConvertibleSeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ConvertibleSeniorNotesMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Senior Notes [Member]",
        "documentation": "Convertible Senior Notes.",
        "label": "Convertible Senior Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_CostMethodInvestmentFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "CostMethodInvestmentFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment of fair value",
        "documentation": "Cost method investment fair value disclosure",
        "label": "Cost Method Investment Fair Value Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "wt_CostMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "CostMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership interest percentage",
        "documentation": "Cost method investment ownership percentage.",
        "label": "Cost Method Investment Ownership Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentFederalStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIncomeTaxPaymentsByJurisdictionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State and local",
        "label": "Current Federal, State and Local, Tax Expense (Benefit)",
        "documentation": "Amount of current federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1182"
     ]
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIncomeTaxPaymentsByJurisdictionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "label": "Current Federal Tax Expense (Benefit)",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1182",
      "r1213",
      "r1329"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentForeignTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIncomeTaxPaymentsByJurisdictionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Current Foreign Tax Expense (Benefit)",
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1182",
      "r1213"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current",
        "label": "Current Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r594",
      "r602",
      "r1213"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current:",
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State and local",
        "label": "Current State and Local Tax Expense (Benefit)",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1182",
      "r1213",
      "r1329"
     ]
    },
    "us-gaap_DebtConversionConvertedInstrumentRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtConversionConvertedInstrumentRate",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of convertible promissory note",
        "verboseLabel": "Conversion price of convertible notes",
        "label": "Debt Conversion, Converted Instrument, Rate",
        "documentation": "Dividend or interest rate associated with the financial instrument issued in exchange for the original debt being converted in a noncash or part noncash transaction. Noncash are transactions that affect recognized assets or liabilities but that do not result in cash receipts or cash payments. Part noncash refers to that portion of the transaction not resulting in cash receipts or cash payments."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r64"
     ]
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Notes",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r273",
      "r464",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r480",
      "r487",
      "r488",
      "r490"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofConvertibleNotesTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofKeyTermsofConvertibleNotesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r128",
      "r129",
      "r188",
      "r190",
      "r279",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r471",
      "r476",
      "r477",
      "r478",
      "r479",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r667",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1211"
     ]
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principal interest rate",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofConvertibleNotesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross proceeds",
        "label": "Long-Term Debt, Gross",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r190",
      "r491"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofKeyTermsofConvertibleNotesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion price",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "documentation": "The price per share of the conversion feature embedded in the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r467"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofKeyTermsofConvertibleNotesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion rate",
        "verboseLabel": "Conversion price ratio",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r85",
      "r170",
      "r171",
      "r467"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consecutive trading days",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading days",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofConvertibleNotesTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofKeyTermsofConvertibleNotesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principal outstanding",
        "verboseLabel": "Principal amount",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r117",
      "r465",
      "r667",
      "r1031",
      "r1032"
     ]
    },
    "us-gaap_DebtInstrumentFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of the convertible notes",
        "label": "Debt Instrument, Fair Value Disclosure",
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r650",
      "r1031",
      "r1032"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofConvertibleNotesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective interest rate",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r115",
      "r493",
      "r667"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofKeyTermsofConvertibleNotesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r466"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofConvertibleNotesTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofKeyTermsofConvertibleNotesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Key Terms of Convertible Notes [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]",
        "verboseLabel": "Convertible Senior Notes [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r279",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r471",
      "r476",
      "r477",
      "r478",
      "r479",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r489",
      "r667",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1211"
     ]
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentMaturityDate",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofKeyTermsofConvertibleNotesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maturity date (unless earlier converted, repurchased or redeemed)",
        "verboseLabel": "Convertible debt, maturity date",
        "label": "Debt Instrument, Maturity Date",
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r212",
      "r1030",
      "r1335"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r279",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r471",
      "r476",
      "r477",
      "r478",
      "r479",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r667",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1211"
     ]
    },
    "wt_DebtInstrumentRedemptionPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "DebtInstrumentRedemptionPrice",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofKeyTermsofConvertibleNotesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redemption price",
        "documentation": "Debt instrument redemption price.",
        "label": "Debt Instrument Redemption Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redemption price equal percentage",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentUnamortizedDiscount",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofConvertibleNotesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: Unamortized issuance costs",
        "label": "Debt Instrument, Unamortized Discount",
        "documentation": "Amount, after accumulated amortization, of debt discount."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r117",
      "r1291"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedPremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentUnamortizedPremium",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofConvertibleNotesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plus: Premium",
        "label": "Debt Instrument, Unamortized Premium",
        "documentation": "Amount, after accumulated amortization, of debt premium."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r117",
      "r1291"
     ]
    },
    "us-gaap_DebtPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtPolicyTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Notes",
        "label": "Debt, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSecuritiesHeldtoMaturityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale [Table]",
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Securities Held-to-Maturity",
        "label": "Debt Securities, Available-for-Sale [Table Text Block]",
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r1229",
      "r1230",
      "r1231",
      "r1232",
      "r1233",
      "r1234",
      "r1235",
      "r1236",
      "r1237",
      "r1238",
      "r1239",
      "r1258"
     ]
    },
    "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofMaturityProfileoftheSecuritiesHeldtoMaturityTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofMaturityProfileoftheSecuritiesHeldtoMaturityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss",
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r361",
      "r378",
      "r380",
      "r754"
     ]
    },
    "us-gaap_DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Maturity Profile of the Securities Held to Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_Default": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "Default",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofPresentstheProbabilityAscribedtoPotentialOutcomesUsedinthePwermTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Default",
        "documentation": "The percentage of default.",
        "label": "Default"
       }
      }
     },
     "auth_ref": []
    },
    "wt_DeferredConsiderationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "DeferredConsiderationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Consideration Gold Payments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_DeferredConsiderationCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "DeferredConsiderationCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet",
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred consideration\u2014gold payments (Note 9)",
        "verboseLabel": "Deferred consideration current",
        "documentation": "Deferred Consideration Current",
        "label": "Deferred Consideration Current"
       }
      }
     },
     "auth_ref": []
    },
    "wt_DeferredConsiderationGoldPaymentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "DeferredConsiderationGoldPaymentsPolicyTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Consideration\u2014Gold Payments",
        "documentation": "Accounting policy related to deferred consideration - gold payments.",
        "label": "Deferred Consideration Gold Payments Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "wt_DeferredConsiderationNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "DeferredConsiderationNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet",
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred consideration\u2014gold payments (Note 9)",
        "verboseLabel": "Deferred consideration noncurrent",
        "documentation": "Deferred consideration - noncurrent.",
        "label": "Deferred Consideration Noncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "wt_DeferredConsiderationObligationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "DeferredConsiderationObligationMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBeginningandEndingBalancesofRecurringFairValueMeasurementsClassifiedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Consideration Obligation [Member]",
        "documentation": "DeferredConsiderationObligationMember",
        "label": "Deferred Consideration Obligation Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_DeferredConsiderationPerpetualGrowthRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "DeferredConsiderationPerpetualGrowthRate",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofValuationofDeferredConsiderationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Perpetual growth rate",
        "documentation": "Rate at which represents the deferred consideration perpetual growth.",
        "label": "Deferred Consideration Perpetual Growth Rate"
       }
      }
     },
     "auth_ref": []
    },
    "wt_DeferredConsiderationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "DeferredConsiderationTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpayments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Consideration\u2014gold payments",
        "documentation": "DeferredConsiderationTextBlock",
        "label": "Deferred Consideration Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "wt_DeferredConsiderationgoldpaymentsDetailsScheduleofValuationofDeferredConsiderationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "DeferredConsiderationgoldpaymentsDetailsScheduleofValuationofDeferredConsiderationTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofValuationofDeferredConsiderationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Consideration\u2014gold payments (Details) - Schedule of Valuation of Deferred Consideration [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_DeferredConsiderationgoldpaymentsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "DeferredConsiderationgoldpaymentsDetailsTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Consideration\u2014gold payments (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1213",
      "r1328",
      "r1329"
     ]
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r1213",
      "r1328"
     ]
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets, net",
        "label": "Deferred Income Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r576",
      "r577"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred",
        "terseLabel": "Deferred income taxes",
        "label": "Deferred Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r180",
      "r210",
      "r601",
      "r602",
      "r1213"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable": {
       "parentTag": "wt_DeferredTaxAssetsLiabilitiesGross",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred tax liabilities",
        "label": "Deferred Tax Liabilities, Gross",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r131",
      "r189",
      "r588"
     ]
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State and local",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1213",
      "r1328",
      "r1329"
     ]
    },
    "wt_DeferredTaxAssetOperatingLossCarryForwardUnitedStates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "DeferredTaxAssetOperatingLossCarryForwardUnitedStates",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NOLs\u2014U.S.",
        "documentation": "Amount of deferred tax asset operating loss carryforward united states.",
        "label": "Deferred Tax Asset Operating Loss Carry Forward United States"
       }
      }
     },
     "auth_ref": []
    },
    "wt_DeferredTaxAssetUnrealizedLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "DeferredTaxAssetUnrealizedLosses",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized losses",
        "documentation": "Deferred Tax Asset Unrealized Losses.",
        "label": "Deferred Tax Asset Unrealized Losses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsCapitalLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsCapitalLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital losses",
        "label": "Deferred Tax Assets, Capital Loss Carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible capital loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r1326"
     ]
    },
    "wt_DeferredTaxAssetsCapitalLossCarryforwardsSubjectToExpiration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "DeferredTaxAssetsCapitalLossCarryforwardsSubjectToExpiration",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax effected capital losses",
        "documentation": "Deferred tax assets capital loss carryforwards subject to expiration.",
        "label": "Deferred Tax Assets Capital Loss Carryforwards Subject To Expiration"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and intangible assets",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable": {
       "parentTag": "wt_DeferredTaxAssetsLiabilitiesGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred tax assets",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r589"
     ]
    },
    "us-gaap_DeferredTaxAssetsGrossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsGrossAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets:",
        "label": "Deferred Tax Assets, Gross [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_DeferredTaxAssetsLiabilitiesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "DeferredTaxAssetsLiabilitiesGross",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred tax assets less deferred tax liabilities",
        "documentation": "Deferred Tax Assets Liabilities Gross",
        "label": "Deferred Tax Assets Liabilities Gross"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Deferred tax assets, net",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1325"
     ]
    },
    "wt_DeferredTaxAssetsOperatingLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "DeferredTaxAssetsOperatingLeaseLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "documentation": "Deferred tax assets operating lease liabilities.",
        "label": "Deferred Tax Assets Operating Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsForeign",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NOLs\u2014Foreign",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Foreign",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r1326"
     ]
    },
    "wt_DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax of carried forward",
        "documentation": "Deferred tax assets, operating loss carryforwards, net of tax.",
        "label": "Deferred Tax Assets Operating Loss Carryforwards Net Of Tax"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Deferred Tax Assets, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r1326"
     ]
    },
    "wt_DeferredTaxAssetsOutsideBasisDifference": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "DeferredTaxAssetsOutsideBasisDifference",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Outside basis differences",
        "documentation": "Deferred tax assets outside basis difference.",
        "label": "Deferred Tax Assets Outside Basis Difference"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r1326"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r1326"
     ]
    },
    "us-gaap_DeferredTaxAssetsUnrealizedCurrencyLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsUnrealizedCurrencyLosses",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation adjustment",
        "label": "Deferred Tax Assets, Unrealized Currency Losses",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from unrealized losses on foreign currency transactions."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r1326"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: Valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "us-gaap_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liabilities",
        "label": "Deferred Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r1325"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liabilities:",
        "label": "Deferred Tax Liabilities, Gross [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed assets and prepaid assets",
        "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from fixed assets and prepaid expenses.",
        "label": "Deferred Tax Liabilities Fixed Assets And Prepaid Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "wt_DeferredTaxLiabilitiesRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "DeferredTaxLiabilitiesRightOfUseAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right of use assets\u2014operating leases",
        "documentation": "Deferred tax liabilities right of use assets.",
        "label": "Deferred Tax Liabilities Right Of Use Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesUndistributedForeignEarnings",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsoftheCompanysDeferredTaxAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unremitted earnings\u2014European subsidiaries",
        "verboseLabel": "Deferred tax liabilities and earnings of foreign subsidaries",
        "label": "Deferred Tax Liabilities, Undistributed Foreign Earnings",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences."
       }
      }
     },
     "auth_ref": [
      "r1326"
     ]
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SummaryofDiscretionaryContributionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discretionary contributions",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r1105",
      "r1106",
      "r1120"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      },
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow",
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r77"
     ]
    },
    "us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ImpairmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Summarizes Impairments Recognized",
        "label": "Details of Impairment of Long-Lived Assets Held and Used by Asset [Table Text Block]",
        "documentation": "Tabular disclosure for impairment of long-lived assets held and used by an entity which includes a description of the impaired long-lived asset and facts and circumstances leading to the impairment, aggregate amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired long-lived asset is reported."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r165"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwards"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Awards",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r534",
      "r537",
      "r565",
      "r566",
      "r568",
      "r1044"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-Based Awards [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_DisclosureOfStockholderRightsPlanAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "DisclosureOfStockholderRightsPlanAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholder Rights Plan [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_DisclosureOfStockholderRightsPlanLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "DisclosureOfStockholderRightsPlanLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholder Rights Plan [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_DisclosureOfStockholderRightsPlanTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "DisclosureOfStockholderRightsPlanTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholder Rights Plan",
        "documentation": "Disclosure of stockholder rights plan.",
        "label": "Disclosure Of Stockholder Rights Plan Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "wt_DisclosureOfValuationOfDeferredConsiderationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "DisclosureOfValuationOfDeferredConsiderationLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofValuationofDeferredConsiderationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Valuation Of Deferred Consideration [Line Item]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_DisclosureOfValuationOfDeferredConsiderationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "DisclosureOfValuationOfDeferredConsiderationTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Valuation of Deferred Consideration",
        "documentation": "Disclosure of valuation of deferred consideration.",
        "label": "Disclosure Of Valuation Of Deferred Consideration Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureTextBlockSupplementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureTextBlockSupplementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares Repurchased [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow",
      "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gain on sale\u2014Canadian ETF business, including remeasurement of contingent consideration",
        "terseLabel": "Recognized a gain",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal",
        "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r436",
      "r1209",
      "r1276"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r1105",
      "r1106",
      "r1120"
     ]
    },
    "us-gaap_Dividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Dividends",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Dividends",
        "label": "Dividends",
        "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r172"
     ]
    },
    "us-gaap_DividendsPayableAmountPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsPayableAmountPerShare",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRestrictedStockActivityandRestrictedStockUnitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock dividends, Weighted Average Grant Date Fair Value (in Dollars per share)",
        "label": "Dividends Payable, Amount Per Share",
        "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r1080"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r1077",
      "r1080",
      "r1093"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r1077",
      "r1080",
      "r1093",
      "r1137"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r1077",
      "r1080",
      "r1093",
      "r1137"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r1078"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r1066"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r1080"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r1080"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r1121"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r1069"
     ]
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIncomeTaxPaymentsByJurisdictionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal [Member]",
        "label": "Domestic Tax Authority [Member]",
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile."
       }
      }
     },
     "auth_ref": []
    },
    "wt_ETFSAcquisitionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ETFSAcquisitionMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIntangibleAssetsTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ETFS acquisition [Member]",
        "verboseLabel": "ETFS Acquisition [Member]",
        "label": "ETFSAcquisition Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ETFSCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ETFSCapitalMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ETFS Capital [Member]",
        "label": "ETFSCapital Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofBasicandDilutedEarningsPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings per share\u2014basic (in Dollars per share)",
        "verboseLabel": "Basic earnings per share (in Dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r265",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r298",
      "r301",
      "r312",
      "r315",
      "r316",
      "r320",
      "r637",
      "r638",
      "r756",
      "r779",
      "r1023"
     ]
    },
    "us-gaap_EarningsPerShareBasicLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasicLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofBasicandDilutedEarningsPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Reconciliation of Basic and Diluted Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r302",
      "r312"
     ]
    },
    "wt_EarningsPerShareDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "EarningsPerShareDetailsLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_EarningsPerShareDetailsScheduleofReconciliationofBasicandDilutedEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "EarningsPerShareDetailsScheduleofReconciliationofBasicandDilutedEarningsPerShareTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofBasicandDilutedEarningsPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share (Details) - Schedule of Reconciliation of Basic and Diluted Earnings Per Share [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_EarningsPerShareDetailsScheduleofWeightedAverageNumberofSharesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "EarningsPerShareDetailsScheduleofWeightedAverageNumberofSharesTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofWeightedAverageNumberofSharesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share (Details) - Schedule of Weighted Average Number of Shares [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_EarningsPerShareDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "EarningsPerShareDetailsTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofBasicandDilutedEarningsPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings per share\u2014diluted (in Dollars per share)",
        "verboseLabel": "Diluted earnings per share (in Dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r265",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r301",
      "r312",
      "r315",
      "r316",
      "r320",
      "r637",
      "r638",
      "r756",
      "r779",
      "r1023"
     ]
    },
    "us-gaap_EarningsPerShareDilutedLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDilutedLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofWeightedAverageNumberofSharesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Weighted Average Number of Shares [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r301",
      "r302",
      "r312"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings per Share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r67"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings Per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r297",
      "r317",
      "r318",
      "r319"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase/(decrease) in cash flow due to changes in foreign exchange rate",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r657"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r1171"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Uncertain tax rate",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationGiltiAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateReconciliationGiltiAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GILTI",
        "label": "Effective Income Tax Rate Reconciliation, GILTI, Amount",
        "documentation": "Amount of reported income tax expense from difference to expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to global intangible low-taxed income (GILTI)."
       }
      }
     },
     "auth_ref": [
      "r1323"
     ]
    },
    "wt_EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in tax-related indemnification assets, net",
        "documentation": "Effective income tax reconcilation changes in tax related indemnification assets.",
        "label": "Effective Income Tax Reconcilation Changes In Tax Related Indemnification Assets"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r1171"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r1172"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r1171"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r1172"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r1170"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r1172"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r1174"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation and benefits payable",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r567"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-Average Remaining Vesting Period (Years)",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r567"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related tax benefit",
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r564"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "wt_EmployeesAndDirectorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "EmployeesAndDirectorsMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employees And Directors [Member]",
        "documentation": "Employees and Directors [Member]",
        "label": "Employees And Directors Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'.  This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r1068"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r1072"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1068"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/CashandCashEquivalentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromAdvisoryServicesProvidedtoRelatedPartiesTable",
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1068"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r1173"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r1068"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r1163"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r1162"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r1093"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1068"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r1068"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r1068"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1068"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r1164"
     ]
    },
    "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromContractswithCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Revenues from Contracts with Customers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquipmentMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDepreciationandAmortizationTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFixedAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equipment [Member]",
        "label": "Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r232",
      "r259",
      "r260",
      "r261",
      "r280",
      "r281",
      "r282",
      "r285",
      "r293",
      "r295",
      "r321",
      "r400",
      "r406",
      "r503",
      "r569",
      "r570",
      "r571",
      "r597",
      "r598",
      "r619",
      "r621",
      "r622",
      "r623",
      "r624",
      "r626",
      "r636",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r689",
      "r804",
      "r805",
      "r806",
      "r829",
      "r909"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInformationaboutVariableInterestsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "documentation": "Name of investment including named security. Excludes entity that is consolidated."
       }
      }
     },
     "auth_ref": [
      "r393",
      "r394",
      "r395"
     ]
    },
    "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net impairment charge (in Dollars)",
        "label": "Equity Method Investment, Other than Temporary Impairment",
        "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment."
       }
      }
     },
     "auth_ref": [
      "r1262"
     ]
    },
    "us-gaap_EquitySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquitySecuritiesMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equities [Member]",
        "label": "Equity Securities [Member]",
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r1059",
      "r1060",
      "r1061",
      "r1366"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1130"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r1085",
      "r1097",
      "r1113",
      "r1141"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r1082",
      "r1094",
      "r1110",
      "r1138"
     ]
    },
    "wt_EuropeanBusinessSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "EuropeanBusinessSegmentMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/CashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "European Business Segment [Member]",
        "documentation": "European Business Segment [Member]",
        "label": "European Business Segment Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ExchangeTradedFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ExchangeTradedFundsMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ETFs",
        "verboseLabel": "ETFs [Member]",
        "label": "Exchange Traded Funds [Member]",
        "documentation": "Investment that follows an index, commodity or basket of assets that trades similar to a stock on an exchange."
       }
      }
     },
     "auth_ref": [
      "r1295",
      "r1334"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r1136"
     ]
    },
    "wt_ExercisePricePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ExercisePricePerUnit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price per unit (in Dollars per share)",
        "documentation": "Exercise price per unit.",
        "label": "Exercise Price Per Unit"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r1169"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r1169"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ExtinguishmentOfDebtAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ExtinguishmentOfDebtAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extinguishment of Debt [Axis]",
        "documentation": "Information pertaining to the debt extinguished including the amount of gain (loss), the income tax effect on the gain (loss), and the amount of gain (loss), net or the related income tax, by debt instrument."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_ExtinguishmentOfDebtGainLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ExtinguishmentOfDebtGainLossNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss on extinguishment",
        "label": "Extinguishment of Debt, Gain (Loss), Net of Tax",
        "documentation": "The difference between the reacquisition price and the net carrying amount of the extinguished debt recognized currently as a component of income in the period of extinguishment, net of tax."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "us-gaap_ExtinguishmentOfDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ExtinguishmentOfDebtTypeDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extinguishment of Debt, Type [Domain]",
        "documentation": "Type of debt extinguished."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Assets and Liabilities Measured at Fair Value [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r641",
      "r642",
      "r646"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r641",
      "r642",
      "r646"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Assets and Liabilities Measured at Fair Value",
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r111",
      "r113",
      "r185"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Backsolve Valuation Approach",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Class [Domain]",
        "documentation": "Class of asset."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBeginningandEndingBalancesofRecurringFairValueMeasurementsClassifiedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Beginning and Ending Balances of Recurring Fair Value Measurements Classified [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "wt_FairValueAssumptionOfDissolutionRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "FairValueAssumptionOfDissolutionRate",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofPresentstheProbabilityAscribedtoPotentialOutcomesUsedinthePwermTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Default",
        "documentation": "Fair value assumption of dissolution rate.",
        "label": "Fair Value Assumption Of Dissolution Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByAssetClassAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Class [Axis]",
        "documentation": "Information by class of asset."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r113"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofPresentstheProbabilityAscribedtoPotentialOutcomesUsedinthePwermTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r642",
      "r704",
      "r705",
      "r706",
      "r1031",
      "r1032",
      "r1038",
      "r1039",
      "r1040"
     ]
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByLiabilityClassAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBeginningandEndingBalancesofRecurringFairValueMeasurementsClassifiedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability Class [Axis]",
        "documentation": "Information by class of liability."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r184"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r641",
      "r642",
      "r643",
      "r644",
      "r647"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r640"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1 [Member]",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r516",
      "r521",
      "r642",
      "r704",
      "r1038",
      "r1039",
      "r1040"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2 [Member]",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r516",
      "r521",
      "r642",
      "r705",
      "r1031",
      "r1032",
      "r1038",
      "r1039",
      "r1040"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofPresentstheProbabilityAscribedtoPotentialOutcomesUsedinthePwermTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 3 [Member]",
        "verboseLabel": "Fair Value, Inputs, Level 3 [Member]",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r642",
      "r706",
      "r1031",
      "r1032",
      "r1038",
      "r1039",
      "r1040"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBeginningandEndingBalancesofRecurringFairValueMeasurementsClassifiedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value by Liability Class [Domain]",
        "documentation": "Represents classes of liabilities measured and disclosed at fair value."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBeginningandEndingBalancesofRecurringFairValueMeasurementsClassifiedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r113"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Beginning and Ending Balances of Recurring Fair Value Measurements Classified",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r113"
     ]
    },
    "wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBeginningandEndingBalancesofRecurringFairValueMeasurementsClassifiedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversions",
        "documentation": "The amount of fair value measurement with unobservable inputs reconciliation recurring basis liability conversions.",
        "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Conversions"
       }
      }
     },
     "auth_ref": []
    },
    "wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBeginningandEndingBalancesofRecurringFairValueMeasurementsClassifiedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net realized gains/(losses)",
        "documentation": "Fair value measurement with unobservable inputs reconciliation recurring basis liability net unrealized gain loss included in earnings and other comprehensive income.",
        "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Net Unrealized Gain Loss Included In Earnings And Other Comprehensive Income"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBeginningandEndingBalancesofRecurringFairValueMeasurementsClassifiedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchases",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases",
        "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "wt_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBeginningandEndingBalancesofRecurringFairValueMeasurementsClassifiedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net unrealized gains",
        "documentation": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Realized Gain Loss Included In Earnings",
        "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Realized Gain Loss Included In Earnings"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBeginningandEndingBalancesofRecurringFairValueMeasurementsClassifiedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Settlements",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Sales",
        "documentation": "Amount of sales of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBeginningandEndingBalancesofRecurringFairValueMeasurementsClassifiedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r704",
      "r705",
      "r706",
      "r1031",
      "r1032",
      "r1038",
      "r1039",
      "r1040"
     ]
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsNonrecurringMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Nonrecurring [Member]",
        "label": "Fair Value, Nonrecurring [Member]",
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r647"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Recurring [Member]",
        "label": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r640",
      "r647"
     ]
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments Owned and Financial Instruments Sold, but Not yet Purchased (at Fair Value)",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r33"
     ]
    },
    "wt_FederalAgencyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "FederalAgencyMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSecuritiesHeldtoMaturityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pass-through GSEs [Member]",
        "verboseLabel": "Federal Agency [Member]",
        "documentation": "Federal Agency [Member]",
        "label": "Federal Agency Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFinancialInstrumentsOwnedTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSecuritiesHeldtoMaturityTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSummarizesImpairmentsRecognizedTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r413",
      "r414",
      "r415",
      "r489",
      "r501",
      "r627",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r777",
      "r1028",
      "r1185",
      "r1186",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1258",
      "r1259",
      "r1260",
      "r1261"
     ]
    },
    "us-gaap_FinancialInstrumentsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentsDisclosureTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwned"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial instruments owned",
        "label": "Financial Instruments Disclosure [Text Block]",
        "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures."
       }
      }
     },
     "auth_ref": []
    },
    "wt_FinancialInstrumentsOwnedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "FinancialInstrumentsOwnedAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFinancialInstrumentsOwnedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial instruments owned:",
        "label": "Financial Instruments Owned Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentsOwnedAndPledgedAsCollateralLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments Owned [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r714",
      "r854"
     ]
    },
    "us-gaap_FinancialInstrumentsOwnedAndPledgedAsCollateralTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentsOwnedAndPledgedAsCollateralTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFinancialInstrumentsOwnedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments Owned and Pledged as Collateral [Table]",
        "documentation": "Financial instruments held by a broker-dealer for its own account (proprietary securities) for trading or investment purposes that are carried at fair value and pledged to counterparties as collateral for financing transactions. Description may include equity, fixed income, debt or other securities."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r714",
      "r854"
     ]
    },
    "us-gaap_FinancialInstrumentsOwnedAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentsOwnedAtFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFinancialInstrumentsOwnedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial instruments owned, at fair value (including $47,559 and $25,283 invested in WisdomTree products at December 31, 2023 and 2022, respectively)",
        "verboseLabel": "Financial instruments owned",
        "label": "Financial Instruments, Owned, at Fair Value",
        "documentation": "The aggregate fair value as of the balance sheet date of financial instruments and other positions owned by the entity including: (1) mortgages, mortgage-backed and asset backed securities; (2) US government and agency obligations; (3) state and municipal government obligations; (4) other sovereign government debt; (5) corporate obligations; (6) corporate equities; (7) principal investments; (8) derivative contracts; and (9) physical commodities. Includes both pledged and unpledged holdings."
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "wt_FinancialInstrumentsOwnedAtFairValueAbstract0": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "FinancialInstrumentsOwnedAtFairValueAbstract0",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial instruments owned, at fair value:",
        "label": "Financial Instruments Owned At Fair Value Abstract0"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialInstrumentsOwnedAtFairValueByTypeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentsOwnedAtFairValueByTypeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments Owned [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_FinancialInstrumentsOwnedDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "FinancialInstrumentsOwnedDetailsTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments Owned (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-lived useful life",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accumulated Amortization",
        "terseLabel": "Amortization expense",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r434"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofExpectedAmortizationExpenseTable": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofExpectedAmortizationExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029 and thereafter",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofExpectedAmortizationExpenseTable": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofExpectedAmortizationExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofExpectedAmortizationExpenseTable": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofExpectedAmortizationExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofExpectedAmortizationExpenseTable": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofExpectedAmortizationExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofExpectedAmortizationExpenseTable": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofExpectedAmortizationExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofExpectedAmortizationExpenseTable": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofExpectedAmortizationExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r433",
      "r434",
      "r435",
      "r736",
      "r740"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r76"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofExpectedAmortizationExpenseTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofExpectedAmortizationExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total expected amortization expense",
        "label": "Finite-Lived Intangible Assets, Net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r160",
      "r736"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-lived intangible assets remaining useful life",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r736"
     ]
    },
    "wt_FirstInstallmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "FirstInstallmentsMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "First Installments [Member]",
        "label": "First Installments Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_FixedAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "FixedAssetsMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSummarizesImpairmentsRecognizedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed assets [Member]",
        "label": "Fixed Assets Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FixedIncomeInvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FixedIncomeInvestmentsMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed income [Member]",
        "label": "Fixed Income Investments [Member]",
        "documentation": "Investments that regularly generate a fixed amount of interest income. Examples include, but are not limited to, bonds, certificates of deposit, notes and debt securities."
       }
      }
     },
     "auth_ref": [
      "r1055",
      "r1056",
      "r1057",
      "r1058"
     ]
    },
    "wt_FnalityConvertibleNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "FnalityConvertibleNoteMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fnality International Limited\u2014convertible note [Member]",
        "documentation": "Fnality convertible note.",
        "label": "Fnality Convertible Note Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_FnalityInternationalLimitedBOnePreferenceSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "FnalityInternationalLimitedBOnePreferenceSharesMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fnality International Limited\u2014B-1 Preference Shares [Member]",
        "label": "Fnality International Limited BOne Preference Shares Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_FnalityInternationalLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "FnalityInternationalLimitedMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fnality International Limited [Member]",
        "documentation": "Fnality international limited.",
        "label": "Fnality International Limited Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCountryMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIncomeTaxPaymentsByJurisdictionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign [Member]",
        "label": "Foreign Tax Authority [Member]",
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currency Translation",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r656"
     ]
    },
    "wt_ForeignMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ForeignMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign [Member]",
        "label": "Foreign Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r1089",
      "r1101",
      "r1117",
      "r1145"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r1089",
      "r1101",
      "r1117",
      "r1145"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r1089",
      "r1101",
      "r1117",
      "r1145"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r1089",
      "r1101",
      "r1117",
      "r1145"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r1089",
      "r1101",
      "r1117",
      "r1145"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r1079",
      "r1104"
     ]
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ForwardsLookingGoldPrice": {
     "xbrltype": "massItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ForwardsLookingGoldPrice",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofValuationofDeferredConsiderationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forward Looking Gold Price",
        "documentation": "Forward looking gold price per ounce.",
        "label": "Forwards Looking Gold Price"
       }
      }
     },
     "auth_ref": []
    },
    "wt_FundManagementAndAdministration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "FundManagementAndAdministration",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fund management and administration",
        "documentation": "Fund management and administration.",
        "label": "Fund Management And Administration"
       }
      }
     },
     "auth_ref": []
    },
    "wt_GBHMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "GBHMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GBH [Member]",
        "label": "GBHMember"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainContingenciesLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingencies [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r1284"
     ]
    },
    "wt_GainLossFromChangeInDeferredConsideration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "GainLossFromChangeInDeferredConsideration",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow",
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDeferredConsiderationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain on revaluation/termination of deferred consideration\u2014gold payments (Note 9)",
        "negatedLabel": "Gain on revaluation of deferred consideration\u2014gold payments",
        "verboseLabel": "Gain on revaluation/termination of deferred consideration\u2014gold payments",
        "documentation": "Gain/loss from revaluation of deferred consideration.",
        "label": "Gain Loss From Change In Deferred Consideration"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnContractTermination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnContractTermination",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/LeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease termination",
        "label": "Gain (Loss) on Contract Termination",
        "documentation": "Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform."
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "us-gaap_GainLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnInvestments",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recognized gain of investment (in Dollars)",
        "verboseLabel": "Net gains (losses) related to certain WisdomTree ETFs",
        "label": "Gain (Loss) on Investments",
        "documentation": "Amount of realized and unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r1175"
     ]
    },
    "us-gaap_GainOrLossOnSaleOfStockInSubsidiary": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainOrLossOnSaleOfStockInSubsidiary",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain on shares (in Dollars)",
        "label": "Gain (Loss) on Disposition of Stock in Subsidiary",
        "documentation": "Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries."
       }
      }
     },
     "auth_ref": [
      "r1206",
      "r1207",
      "r1209",
      "r1351"
     ]
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow",
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss on extinguishment of debt (Note 10)",
        "negatedLabel": "Loss on extinguishment of debt",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r81",
      "r82"
     ]
    },
    "wt_GoldBullionHoldingsJerseyLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "GoldBullionHoldingsJerseyLimitedMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gold Bullion Holdings (Jersey) Limited [Member]",
        "label": "Gold Bullion Holdings Jersey Limited Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_GoldBullionHoldingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "GoldBullionHoldingsMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gold Bullion Holdings [Member]",
        "label": "Gold Bullion Holdings Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet",
      "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGoodwillTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "terseLabel": "Goodwill (Note 24)",
        "verboseLabel": "Goodwill",
        "label": "Goodwill",
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r242",
      "r419",
      "r753",
      "r1029",
      "r1048",
      "r1266",
      "r1273"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Intangible Assets",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure for goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined."
       }
      }
     },
     "auth_ref": [
      "r418",
      "r431",
      "r1029"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Assets",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillImpairmentLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow",
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairments",
        "negatedLabel": "Impairments (Note 26)",
        "label": "Goodwill, Impairment Loss",
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r420",
      "r426",
      "r431",
      "r1029"
     ]
    },
    "us-gaap_GoodwillLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGoodwillTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill and Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r1029"
     ]
    },
    "us-gaap_GoodwillPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GoodwillPeriodIncreaseDecrease",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGoodwillTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes",
        "label": "Goodwill, Period Increase (Decrease)",
        "documentation": "Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r1265"
     ]
    },
    "wt_GoodwillandIntangibleAssetsDetailsScheduleofIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "GoodwillandIntangibleAssetsDetailsScheduleofIntangibleAssetsTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets (Details) - Schedule of Intangible Assets [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_GoodwillandIntangibleAssetsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "GoodwillandIntangibleAssetsDetailsTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofMaturityProfileoftheSecuritiesHeldtoMaturityTable": {
       "parentTag": "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofMaturityProfileoftheSecuritiesHeldtoMaturityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due five years through ten years",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, after Year 5 through 10",
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r383",
      "r760"
     ]
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofMaturityProfileoftheSecuritiesHeldtoMaturityTable": {
       "parentTag": "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofMaturityProfileoftheSecuritiesHeldtoMaturityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due one year through five years",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, after Year One through Five",
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r382",
      "r759"
     ]
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofMaturityProfileoftheSecuritiesHeldtoMaturityTable": {
       "parentTag": "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofMaturityProfileoftheSecuritiesHeldtoMaturityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due over ten years",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, after Year 10",
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r384",
      "r761"
     ]
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofMaturityProfileoftheSecuritiesHeldtoMaturityTable": {
       "parentTag": "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofMaturityProfileoftheSecuritiesHeldtoMaturityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due within one year",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date, Year One",
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r381",
      "r758"
     ]
    },
    "us-gaap_HeldToMaturitySecuritiesFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value",
        "label": "Debt Securities, Held-to-Maturity, Fair Value",
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r198",
      "r385",
      "r754",
      "r764"
     ]
    },
    "us-gaap_HeldToMaturitySecuritiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securities held-to-maturity",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss, Noncurrent",
        "documentation": "Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity), classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r362",
      "r1241",
      "r1264"
     ]
    },
    "us-gaap_HeldToMaturitySecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securities Held-to-Maturity",
        "label": "Debt Securities, Held-to-Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of information about investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r1240",
      "r1241",
      "r1242",
      "r1243",
      "r1244",
      "r1245",
      "r1246",
      "r1247",
      "r1248",
      "r1249",
      "r1250",
      "r1251",
      "r1252",
      "r1253",
      "r1254",
      "r1255",
      "r1256",
      "r1257"
     ]
    },
    "us-gaap_HeldToMaturitySecuritiesTransfersAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HeldToMaturitySecuritiesTransfersAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Securities Held-to-Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "country_IE": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "IE",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGeographicDistributionofRevenuesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ireland [Member]",
        "label": "IRELAND"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r1077",
      "r1080",
      "r1093"
     ]
    },
    "us-gaap_ImpairedLongLivedAssetsHeldAndUsedLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairedLongLivedAssetsHeldAndUsedLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSummarizesImpairmentsRecognizedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impaired Long-Lived Assets Held and Used [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of Long-Lived Assets",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r165"
     ]
    },
    "wt_ImplementationOfASU202006Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ImplementationOfASU202006Member",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Standards Update 2020-06 [Member]",
        "label": "Implementation Of ASU202006 Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_IncomeDistributedToParticipatingSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "IncomeDistributedToParticipatingSecurities",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofBasicandDilutedEarningsPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: Income distributed to participating securities",
        "documentation": "Dividends to participating securities.",
        "label": "Income Distributed To Participating Securities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income before income taxes",
        "terseLabel": "income tax expense",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r141",
      "r193",
      "r325",
      "r344",
      "r350",
      "r352",
      "r757",
      "r775",
      "r1025"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIncomeTaxPaymentsByJurisdictionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Authority [Axis]",
        "documentation": "Information by tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIncomeTaxPaymentsByJurisdictionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Authority [Domain]",
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxContingencyLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes [Line Items]",
        "label": "Income Tax Contingency [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_IncomeTaxDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "IncomeTaxDisclosureLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIncomeTaxPaymentsByJurisdictionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r276",
      "r572",
      "r580",
      "r586",
      "r592",
      "r599",
      "r603",
      "r604",
      "r605",
      "r825"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofComponentsofCurrentandDeferredIncomeTaxExpenseTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income tax expense/(benefit)",
        "terseLabel": "Income tax expense/(benefit)",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r211",
      "r294",
      "r295",
      "r333",
      "r578",
      "r600",
      "r783"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r574",
      "r575",
      "r586",
      "r587",
      "r591",
      "r593",
      "r819"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in valuation allowance\u2014Foreign NOLs and interest carryforwards",
        "verboseLabel": "European net operating losses",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1323"
     ]
    },
    "wt_IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Change in valuation allowance \u2013 Capital losses",
        "documentation": "Income tax reconciliation change in valuation allowance capital losses.",
        "label": "Income Tax Reconciliation Change In Valuation Allowance Capital Losses"
       }
      }
     },
     "auth_ref": []
    },
    "wt_IncomeTaxReconciliationExpirationOfCapitalLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "IncomeTaxReconciliationExpirationOfCapitalLosses",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Expiration of capital losses",
        "documentation": "Income tax reconciliation expiration of capital losses.",
        "label": "Income Tax Reconciliation Expiration Of Capital Losses"
       }
      }
     },
     "auth_ref": []
    },
    "wt_IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gain on revaluation/termination of deferred consideration",
        "documentation": "Income tax reconciliation gain on revaluation termination of deferred consideration.",
        "label": "Income Tax Reconciliation Gain On Revaluation Termination Of Deferred Consideration"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. federal statutory income tax",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "wt_IncomeTaxReconciliationInternationalOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "IncomeTaxReconciliationInternationalOperations",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Foreign operations",
        "documentation": "Income tax reconciliation international operations.",
        "label": "Income Tax Reconciliation International Operations"
       }
      }
     },
     "auth_ref": []
    },
    "wt_IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Non-deductible executive compensation",
        "documentation": "Income tax reconciliation nondeductible executive compensation expense.",
        "label": "Income Tax Reconciliation Nondeductible Executive Compensation Expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation tax shortfalls",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount",
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1323"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other differences, net",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r1323"
     ]
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Blended state income tax rate, net of federal benefit",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r1323"
     ]
    },
    "wt_IncomeTaxReconciliationUnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "IncomeTaxReconciliationUnrecognizedTaxBenefits",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Decrease in unrecognized tax benefits, net",
        "documentation": "Income tax reconciliation unrecognized tax benefits.",
        "label": "Income Tax Reconciliation Unrecognized Tax Benefits"
       }
      }
     },
     "auth_ref": []
    },
    "wt_IncomeTaxesDetailsScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "IncomeTaxesDetailsScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes (Details) - Schedule of Changes in Balance of Gross Unrecognized Tax Benefits [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes (Details) - Schedule of Domestic and Foreign Components of Income before Income Tax Expense [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "IncomeTaxesDetailsScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes (Details) - Schedule of Domestic and Foreign Components of Income before Income Tax Expense [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_IncomeTaxesDetailsScheduleofIncomeTaxPaymentsByJurisdictionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "IncomeTaxesDetailsScheduleofIncomeTaxPaymentsByJurisdictionTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIncomeTaxPaymentsByJurisdictionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes (Details) - Schedule of Income Tax Payments By Jurisdiction [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_IncomeTaxesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "IncomeTaxesDetailsTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIncomeTaxPaymentsByJurisdictionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for income taxes",
        "verboseLabel": "Income taxes paid net",
        "label": "Income Taxes Paid, Net",
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and other liabilities",
        "label": "Increase (Decrease) in Accounts Payable and Other Operating Liabilities",
        "documentation": "Amount of increase (decrease) in obligations incurred but not paid, and operating obligations classified as other."
       }
      }
     },
     "auth_ref": [
      "r1208"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 21.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation and benefits payable",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "wt_IncreaseDecreaseInFundManagementAndAdministrationPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "IncreaseDecreaseInFundManagementAndAdministrationPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fund management and administration payable",
        "documentation": "Increase (decrease) in fund management and administration payable.",
        "label": "Increase Decrease In Fund Management And Administration Payable"
       }
      }
     },
     "auth_ref": []
    },
    "wt_IncreaseDecreaseInGoldAndOtherPreciousMetals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "IncreaseDecreaseInGoldAndOtherPreciousMetals",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 23.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gold and other precious metals",
        "documentation": "Cash realized upon sale of gold and other precious metals.",
        "label": "Increase Decrease In Gold And Other Precious Metals"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes payable",
        "label": "Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes."
       }
      }
     },
     "auth_ref": [
      "r1208"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_IncreaseDecreaseInOperatingLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 25.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Operating lease liabilities",
        "documentation": "Amount of increase or decrease in operating lease liabilities.",
        "label": "Increase Decrease In Operating Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 24.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other assets",
        "label": "Increase (Decrease) in Other Operating Assets",
        "documentation": "Amount of increase (decrease) in operating assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 22.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses",
        "label": "Increase (Decrease) in Prepaid Expense",
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion option embedded in the Convertible Notes",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method."
       }
      }
     },
     "auth_ref": [
      "r307",
      "r308",
      "r316"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet",
      "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets, net (Note 24)",
        "verboseLabel": "Intangible assets, net",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "wt_IndemnificationReceivableNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "IndemnificationReceivableNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indemnification receivable (Note 22)",
        "documentation": "Indemnification receivable noncurrent.",
        "label": "Indemnification Receivable Noncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r1092",
      "r1101",
      "r1117",
      "r1136",
      "r1145",
      "r1149",
      "r1157"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r1155"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r1081",
      "r1161"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r1081",
      "r1161"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r1081",
      "r1161"
     ]
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Asset",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r242"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Asset",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r75"
     ]
    },
    "us-gaap_InterestAndDebtExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestAndDebtExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "interest expense recognized",
        "label": "Interest and Debt Expense",
        "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "wt_InterestAndPenaltiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "InterestAndPenaltiesMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest And Penalties [Member]",
        "label": "Interest And Penalties Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement",
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense",
        "terseLabel": "Interest expense recognized",
        "verboseLabel": "Interest expense on the convertible notes",
        "label": "Interest Expense",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r197",
      "r262",
      "r329",
      "r666",
      "r894",
      "r1062",
      "r1361"
     ]
    },
    "us-gaap_InterestExpenseDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpenseDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Imputed interest on payable to GBH",
        "label": "Interest Expense, Debt",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r484",
      "r494",
      "r1033",
      "r1034"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for interest",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r267",
      "r269",
      "r270"
     ]
    },
    "us-gaap_InterestPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest payable",
        "label": "Interest Payable",
        "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r1354"
     ]
    },
    "us-gaap_InvestmentAdvisoryManagementAndAdministrativeServiceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentAdvisoryManagementAndAdministrativeServiceMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromContractswithCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advisory fees",
        "verboseLabel": "Advisory fees [Member]",
        "label": "Investment Advisory, Management and Administrative Service [Member]",
        "documentation": "Investment advisory, asset management and administrative service. Includes, but is not limited to, distribution and shareholder service; and accounting, tax, legal, regulatory filing, share registration and shareholder correspondence activities."
       }
      }
     },
     "auth_ref": [
      "r1294"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r1106",
      "r1107",
      "r1108",
      "r1109"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r1122"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r1122"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r1122"
     ]
    },
    "us-gaap_InvestmentIncomeInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentIncomeInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Investment Income, Interest",
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r328"
     ]
    },
    "us-gaap_InvestmentOwnedAtCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentOwnedAtCost",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of investment",
        "label": "Investment Owned, Cost",
        "documentation": "Cost of the investment."
       }
      }
     },
     "auth_ref": [
      "r815",
      "r848",
      "r849",
      "r928",
      "r938",
      "r955",
      "r986",
      "r1053",
      "r1064",
      "r1360"
     ]
    },
    "us-gaap_InvestmentOwnedAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentOwnedAtFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-recurring fair value measurements",
        "label": "Investment Owned, Fair Value",
        "documentation": "Fair value of investment in security owned."
       }
      }
     },
     "auth_ref": [
      "r815",
      "r842",
      "r843",
      "r844",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r853",
      "r854",
      "r865",
      "r866",
      "r915",
      "r924",
      "r925",
      "r934",
      "r948",
      "r949",
      "r962",
      "r963",
      "r964",
      "r973",
      "r976",
      "r985",
      "r987",
      "r990",
      "r1053",
      "r1064",
      "r1360"
     ]
    },
    "us-gaap_InvestmentOwnedBalanceOtherMeasure": {
     "xbrltype": "massItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentOwnedBalanceOtherMeasure",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred consideration",
        "label": "Investment Owned, Balance, Other Measure",
        "documentation": "Quantity of the investment. Indicate the measure in the unit of measure. This is commonly used for investments other than securities. For example, if the investment is gold, the balance would be the number of ounces and the unit of measure would indicate \"ounces\"."
       }
      }
     },
     "auth_ref": [
      "r967"
     ]
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentPolicyTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments",
        "label": "Investment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for investment in financial asset."
       }
      }
     },
     "auth_ref": [
      "r781",
      "r815",
      "r816",
      "r817",
      "r818",
      "r935",
      "r937"
     ]
    },
    "us-gaap_InvestmentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Investments",
        "label": "Investment [Table Text Block]",
        "documentation": "Tabular disclosure of investment."
       }
      }
     },
     "auth_ref": [
      "r1183",
      "r1184",
      "r1227"
     ]
    },
    "us-gaap_InvestmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/Investments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments",
        "label": "Investment [Text Block]",
        "documentation": "The entire disclosure for investment."
       }
      }
     },
     "auth_ref": [
      "r1183",
      "r1184",
      "r1227"
     ]
    },
    "us-gaap_InvestmentTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentTypeAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Type [Axis]",
        "documentation": "Information by type of investments."
       }
      }
     },
     "auth_ref": [
      "r843",
      "r845",
      "r846",
      "r848",
      "r850",
      "r915",
      "r924",
      "r941",
      "r949",
      "r962",
      "r966",
      "r968",
      "r987",
      "r991",
      "r992",
      "r993",
      "r994",
      "r1053"
     ]
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentTypeCategorizationMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Domain]",
        "documentation": "Asset obtained to generate income or appreciate in value."
       }
      }
     },
     "auth_ref": [
      "r843",
      "r845",
      "r846",
      "r848",
      "r850",
      "r915",
      "r924",
      "r941",
      "r949",
      "r962",
      "r966",
      "r968",
      "r987",
      "r991",
      "r992",
      "r993",
      "r994",
      "r1053"
     ]
    },
    "us-gaap_Investments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Investments",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock investment (in Dollars)",
        "verboseLabel": "Investments",
        "label": "Investments",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments."
       }
      }
     },
     "auth_ref": [
      "r763"
     ]
    },
    "us-gaap_InvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBeginningandEndingBalancesofRecurringFairValueMeasurementsClassifiedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]",
        "terseLabel": "Investments in Convertible Notes",
        "verboseLabel": "Investments in Convertible Notes (Note 7):"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsAndCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsAndCash",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents (in Dollars)",
        "label": "Investments and Cash",
        "documentation": "Sum of investments and unrestricted cash as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r1353",
      "r1356"
     ]
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Maturity Profile of the Securities Held-to-Maturity",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Held-to-Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_InvestmentsDetailsScheduleofInvestmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "InvestmentsDetailsScheduleofInvestmentsLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Investments [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_InvestmentsDetailsScheduleofInvestmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "InvestmentsDetailsScheduleofInvestmentsTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments (Details) - Schedule of Investments [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_InvestmentsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "InvestmentsDetailsTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments in Convertible Notes",
        "label": "Investments, Fair Value Disclosure",
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method."
       }
      }
     },
     "auth_ref": [
      "r641"
     ]
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInformationaboutVariableInterestsTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments (Note 7)",
        "verboseLabel": "Carrying value of investment",
        "netLabel": "Carrying Amount\u2014Assets",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate."
       }
      }
     },
     "auth_ref": [
      "r1199"
     ]
    },
    "country_JE": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "JE",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGeographicDistributionofRevenuesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Jersey [Member]",
        "label": "JERSEY"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LaborAndRelatedExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LaborAndRelatedExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation and benefits",
        "label": "Labor and Related Expense",
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit."
       }
      }
     },
     "auth_ref": [
      "r1205"
     ]
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAdditionalInformationRelatedtoOperatingLeaseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total lease cost",
        "label": "Lease, Cost",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r677",
      "r1047"
     ]
    },
    "us-gaap_LeaseCostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCostAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAdditionalInformationRelatedtoOperatingLeaseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease cost:",
        "label": "Lease, Cost [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Additional Information Related to Operating Lease",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1338"
     ]
    },
    "wt_LeaseTerminationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "LeaseTerminationMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSummarizesImpairmentsRecognizedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease termination [Member]",
        "label": "Lease Termination Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/CashandCashEquivalentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromAdvisoryServicesProvidedtoRelatedPartiesTable",
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r1065"
     ]
    },
    "wt_LessParticipatingSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "LessParticipatingSecuritiesAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofWeightedAverageNumberofSharesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less: Participating securities:",
        "label": "Less Participating Securities Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Future Minimum Lease Payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1339"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFutureMinimumLeasePaymentsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofFutureMinimumLeasePaymentstoBalanceSheetTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFutureMinimumLeasePaymentsTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofFutureMinimumLeasePaymentstoBalanceSheetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total future minimum lease payments (undiscounted)",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r684"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFutureMinimumLeasePaymentsTable": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFutureMinimumLeasePaymentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029 and thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r684"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFutureMinimumLeasePaymentsTable": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFutureMinimumLeasePaymentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r684"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFutureMinimumLeasePaymentsTable": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFutureMinimumLeasePaymentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r684"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFutureMinimumLeasePaymentsTable": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFutureMinimumLeasePaymentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r684"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFutureMinimumLeasePaymentsTable": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFutureMinimumLeasePaymentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r684"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFutureMinimumLeasePaymentsTable": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFutureMinimumLeasePaymentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r684"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofFutureMinimumLeasePaymentstoBalanceSheetTable": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofFutureMinimumLeasePaymentstoBalanceSheetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Difference between undiscounted and discounted cash flows",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r684"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r672"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r274",
      "r396",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r613",
      "r614",
      "r615",
      "r651",
      "r860",
      "r1024",
      "r1064",
      "r1286",
      "r1342",
      "r1343"
     ]
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities",
        "verboseLabel": "Liabilities:",
        "label": "Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders\u2019 equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r191",
      "r772",
      "r1048",
      "r1212",
      "r1263",
      "r1336"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r238",
      "r274",
      "r396",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r613",
      "r614",
      "r615",
      "r651",
      "r1048",
      "r1286",
      "r1342",
      "r1343"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "wt_LondonOfficeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "LondonOfficeMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSummarizesImpairmentsRecognizedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "London office [Member]",
        "label": "London Office Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofConvertibleNotesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carrying amount",
        "label": "Long-Term Debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r190",
      "r477",
      "r492",
      "r1031",
      "r1032",
      "r1355"
     ]
    },
    "us-gaap_LongTermNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAggregateConsiderationPayableTable": {
       "parentTag": "us-gaap_NotesPayable",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAggregateConsiderationPayableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term",
        "label": "Notes Payable, Noncurrent",
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "wt_LossContingencyCoveredByInsuranceDeductible": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "LossContingencyCoveredByInsuranceDeductible",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount of deductible",
        "documentation": "Loss contingency covered by insurance deductible.",
        "label": "Loss Contingency Covered By Insurance Deductible"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LossContingencyDamagesSoughtValue",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss contingency acrual",
        "label": "Loss Contingency, Damages Sought, Value",
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter."
       }
      }
     },
     "auth_ref": [
      "r1279",
      "r1280",
      "r1281"
     ]
    },
    "us-gaap_LossContingencyDisclosures": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LossContingencyDisclosures",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/Contingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingencies",
        "label": "Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made."
       }
      }
     },
     "auth_ref": [
      "r445",
      "r446",
      "r447",
      "r449",
      "r451",
      "r452",
      "r453",
      "r454"
     ]
    },
    "wt_ManJersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ManJersMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ManJers [Member]",
        "label": "Man Jers Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketableSecuritiesPolicy",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securities Held-to-Maturity",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for investment classified as marketable security."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "us-gaap_MarketingAndAdvertisingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketingAndAdvertisingExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketing and advertising",
        "label": "Marketing and Advertising Expense",
        "documentation": "The total expense recognized in the period for promotion, public relations, and brand or product advertising."
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "wt_MaximumConversionRate": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "MaximumConversionRate",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum conversion rate",
        "documentation": "Maximum conversion rate.",
        "label": "Maximum Conversion Rate"
       }
      }
     },
     "auth_ref": []
    },
    "wt_MaximumExposureToLossMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "MaximumExposureToLossMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInformationaboutVariableInterestsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum exposure to loss [Member]",
        "label": "Maximum Exposure To Loss Member"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDepreciationandAmortizationTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofValuationofDeferredConsiderationTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum [Member]",
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r448",
      "r450",
      "r451",
      "r452",
      "r532",
      "r734",
      "r801",
      "r851",
      "r852",
      "r918",
      "r939",
      "r945",
      "r946",
      "r978",
      "r1013",
      "r1014",
      "r1027",
      "r1035",
      "r1043",
      "r1050",
      "r1290",
      "r1344",
      "r1345",
      "r1346",
      "r1347",
      "r1348",
      "r1349"
     ]
    },
    "wt_MaximumNumberOfSharesIssuableUponConversion": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "MaximumNumberOfSharesIssuableUponConversion",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares issuable upon conversion",
        "documentation": "Maximum number of shares issuable upon conversion.",
        "label": "Maximum Number Of Shares Issuable Upon Conversion"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r1128"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r1128"
     ]
    },
    "wt_MeasurementPeriodForDeterminingSharePrice": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "MeasurementPeriodForDeterminingSharePrice",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement period for determining share price",
        "documentation": "Measurement period for determining share price",
        "label": "Measurement Period For Determining Share Price"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDepreciationandAmortizationTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofValuationofDeferredConsiderationTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum [Member]",
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r448",
      "r450",
      "r451",
      "r452",
      "r532",
      "r734",
      "r801",
      "r851",
      "r852",
      "r918",
      "r939",
      "r945",
      "r946",
      "r978",
      "r1013",
      "r1014",
      "r1027",
      "r1035",
      "r1043",
      "r1050",
      "r1290",
      "r1344",
      "r1345",
      "r1346",
      "r1347",
      "r1348",
      "r1349"
     ]
    },
    "wt_MinimumPercentageOfLendersRequiredToHaveEntirePrincipalAmountOfConvertibleNotesRepurchasedByTheCompanyUponCertainEventsOfDefault": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "MinimumPercentageOfLendersRequiredToHaveEntirePrincipalAmountOfConvertibleNotesRepurchasedByTheCompanyUponCertainEventsOfDefault",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate principal amount, percentage",
        "documentation": "Represents the percentage amount of minimum percentage of lenders required to have entire principal amount of convertible notes repurchased by the Company upon certain events of default.",
        "label": "Minimum Percentage Of Lenders Required To Have Entire Principal Amount Of Convertible Notes Repurchased By The Company Upon Certain Events Of Default"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership percentage",
        "label": "Subsidiary, Ownership Percentage, Parent",
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r1148"
     ]
    },
    "srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSummarizesImpairmentsRecognizedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Real Estate, Type of Property [Axis]",
        "documentation": "Information by type of real estate property."
       }
      }
     },
     "auth_ref": [
      "r216",
      "r226",
      "r1000",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011"
     ]
    },
    "srt_MortgageLoansOnRealEstateNamePropertyTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MortgageLoansOnRealEstateNamePropertyTypeDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSummarizesImpairmentsRecognizedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Real Estate [Domain]",
        "documentation": "Land and any structures permanently fixed to it."
       }
      }
     },
     "auth_ref": [
      "r216",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r1156"
     ]
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them.  The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1129"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash (used in)/provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r268"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities:",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by/(used in) investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r268"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities:",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r154",
      "r155"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities:",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow",
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedComprehensiveIncome",
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofBasicandDilutedEarningsPerShareTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income",
        "verboseLabel": "Net income",
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r155",
      "r194",
      "r236",
      "r253",
      "r256",
      "r261",
      "r274",
      "r284",
      "r288",
      "r289",
      "r290",
      "r291",
      "r294",
      "r295",
      "r309",
      "r325",
      "r344",
      "r350",
      "r352",
      "r396",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r638",
      "r651",
      "r776",
      "r884",
      "r907",
      "r908",
      "r1025",
      "r1062",
      "r1286"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofBasicandDilutedEarningsPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income available to common stockholders\u2014Basic EPS",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r266",
      "r288",
      "r289",
      "r290",
      "r291",
      "r298",
      "r299",
      "r311",
      "r316",
      "r325",
      "r344",
      "r350",
      "r352",
      "r1025"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofBasicandDilutedEarningsPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income available to common stockholders\u2014Diluted EPS",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r266",
      "r300",
      "r303",
      "r304",
      "r305",
      "r306",
      "r311",
      "r316"
     ]
    },
    "wt_NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/CashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net liquid assets international subsidiary regulatory capital requirements",
        "documentation": "Minimum regulatory net liquid asset requirement for certain of the Company's international subsidiaries.",
        "label": "Net Liquid Assets International Subsidiary Regulatory Capital Requirements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r290",
      "r296",
      "r320",
      "r359",
      "r360",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r438",
      "r569",
      "r570",
      "r571",
      "r595",
      "r596",
      "r597",
      "r598",
      "r607",
      "r608",
      "r609",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r648",
      "r649",
      "r652",
      "r653",
      "r654",
      "r655",
      "r664",
      "r665",
      "r668",
      "r669",
      "r670",
      "r671",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r737",
      "r738",
      "r739",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recently Adopted Accounting Pronouncements",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r1106",
      "r1107",
      "r1108",
      "r1109"
     ]
    },
    "wt_NewYorkOfficeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "NewYorkOfficeMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSummarizesImpairmentsRecognizedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New York office [Member]",
        "label": "New York Office Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r1168"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r1168"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r1128"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r1089",
      "r1101",
      "r1117",
      "r1136",
      "r1145"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1126"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1125"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r1136"
     ]
    },
    "wt_NonRecurringFairValueMeasurementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "NonRecurringFairValueMeasurementsAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-recurring fair value measurements:",
        "label": "Non Recurring Fair Value Measurements Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r1156"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r1156"
     ]
    },
    "wt_NondeductibleLossOnExtinguishmentOfConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "NondeductibleLossOnExtinguishmentOfConvertibleNotes",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofStatutoryFederalIncomeTaxRateandCompanysEffectiveRateTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Non-deductible loss on extinguishment of convertible notes",
        "documentation": "Non-deductible loss on extinguishment of convertible notes.",
        "label": "Nondeductible Loss On Extinguishment Of Convertible Notes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Income/(Expenses):",
        "label": "Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesAndLoansPayableAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesAndLoansPayableAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Aggregate Consideration Payable [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAggregateConsiderationPayableTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAggregateConsiderationPayableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Notes Payable",
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r190",
      "r1355"
     ]
    },
    "us-gaap_NotesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAggregateConsiderationPayableTable": {
       "parentTag": "us-gaap_NotesPayable",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAggregateConsiderationPayableTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payable to Gold Bullion Holdings (Jersey) Limited (\u201cGBH\u201d) (Note 12)",
        "verboseLabel": "Current:",
        "label": "Notes Payable, Current",
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "wt_NumberOfThresholdTradingDaysForDeterminingTheSharePrice": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "NumberOfThresholdTradingDaysForDeterminingTheSharePrice",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement days",
        "documentation": "Number Of Threshold Trading Days For Determining The Share Price",
        "label": "Number Of Threshold Trading Days For Determining The Share Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Expenses:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating income",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r325",
      "r344",
      "r350",
      "r352",
      "r1025"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAdditionalInformationRelatedtoOperatingLeaseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease cost",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r678",
      "r1047"
     ]
    },
    "us-gaap_OperatingLeaseImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/LeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease, impairment loss",
        "label": "Operating Lease, Impairment Loss",
        "documentation": "Amount of loss from impairment of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r1337"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofFutureMinimumLeasePaymentstoBalanceSheetTable": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofFutureMinimumLeasePaymentstoBalanceSheetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Subtotal",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r674"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofFutureMinimumLeasePaymentstoBalanceSheetTable": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofFutureMinimumLeasePaymentstoBalanceSheetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities (Note 13)",
        "verboseLabel": "Lease liability\u2014short term",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r674"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofFutureMinimumLeasePaymentstoBalanceSheetTable": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofFutureMinimumLeasePaymentstoBalanceSheetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities (Note 13)",
        "verboseLabel": "Lease liability\u2014long term",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r674"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAdditionalInformationRelatedtoOperatingLeaseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for amounts included in the measurement of operating liabilities (operating leases)",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r675",
      "r680"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right of use assets\u2014operating leases (Note13)",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r673"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of right of use asset",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r1209"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAdditionalInformationRelatedtoOperatingLeaseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average discount rate\u2014operating leases",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r683",
      "r1047"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAdditionalInformationRelatedtoOperatingLeaseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average remaining lease term (in years)\u2014operating leases",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r682",
      "r1047"
     ]
    },
    "wt_OperatingLossCarryForwardExpirationYear": {
     "xbrltype": "gYearListItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "OperatingLossCarryForwardExpirationYear",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NOL expiration date",
        "documentation": "Operating loss carry forward expiration year.",
        "label": "Operating Loss Carry Forward Expiration Year"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss",
        "label": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization and Description of Business [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current assets",
        "label": "Other Assets, Current",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r1048"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other noncurrent assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r244"
     ]
    },
    "wt_OtherAssetsSeedCapitalWisdomtreeDigitalFundsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "OtherAssetsSeedCapitalWisdomtreeDigitalFundsAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets\u2014seed capital (WisdomTree Digital Funds):",
        "label": "Other Assets Seed Capital Wisdomtree Digital Funds Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "wt_OtherAssetsseedCapitalWisdomTreeDigitalFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "OtherAssetsseedCapitalWisdomTreeDigitalFundsMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFinancialInstrumentsOwnedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets\u2014seed capital (WisdomTree Digital Funds) [Member]",
        "label": "Other Assetsseed Capital Wisdom Tree Digital Funds Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_OtherAssetsseedCapitalWisdomtreeDigitalFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "OtherAssetsseedCapitalWisdomtreeDigitalFundsMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "WisdomTree Digital Funds [Member]",
        "documentation": "Other assets\u2014seed capital (WisdomTree digital funds)",
        "label": "Other Assetsseed Capital Wisdomtree Digital Funds Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation adjustment, net of income taxes",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r23",
      "r183"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income/(loss)",
        "label": "Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedComprehensiveIncome",
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other comprehensive income/(loss)",
        "terseLabel": "Other comprehensive income",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r23",
      "r183",
      "r254",
      "r257"
     ]
    },
    "us-gaap_OtherExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Expenses",
        "documentation": "Amount of expense classified as other."
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "us-gaap_OtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherIncome",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earned revenue",
        "label": "Other Income",
        "documentation": "Amount of revenue and income classified as other."
       }
      }
     },
     "auth_ref": [
      "r782",
      "r886",
      "r982",
      "r983",
      "r984"
     ]
    },
    "wt_OtherInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "OtherInformationAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAdditionalInformationRelatedtoOperatingLeaseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other information:",
        "label": "Other Information Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "wt_OtherInvestmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "OtherInvestmentMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInformationaboutVariableInterestsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other investments [Member]",
        "label": "Other Investment Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherInvestments",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other investment (in Dollars)",
        "label": "Other Investments",
        "documentation": "Amount of investments classified as other."
       }
      }
     },
     "auth_ref": [
      "r1198"
     ]
    },
    "us-gaap_OtherInvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherInvestmentsMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInvestmentsTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSummarizesImpairmentsRecognizedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Investments [Member]",
        "verboseLabel": "Other investments [Member]",
        "label": "Other Investments [Member]",
        "documentation": "Primary financial statement caption encompassing other investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other noncurrent liabilities (Note 22)",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNoncashIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other",
        "label": "Other Noncash Income (Expense)",
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other."
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNoncurrentLiabilitiesMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Noncurrent Liabilities [Member]",
        "label": "Other Noncurrent Liabilities [Member]",
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNonoperatingGainsLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingGainsLosses",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other losses, net",
        "label": "Other Nonoperating Gains (Losses)",
        "documentation": "Amount of gain (loss) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "us-gaap_OtherOwnershipInterestsUnitsIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherOwnershipInterestsUnitsIssued",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership interest shares (in Shares)",
        "label": "Other Ownership Interests, Units Issued",
        "documentation": "The number of units of other ownership interests issued in a limited partnership or master limited partnership. Does not include limited or general partners' ownership interests."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "wt_OtherPayablesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "OtherPayablesTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBH"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payable to Gold Bullion Holdings Jersey Limited GBH",
        "documentation": "The disclosure of other payables.",
        "label": "Other Payables Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherPaymentsToAcquireBusinesses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherPaymentsToAcquireBusinesses",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cash paid\u2014acquisition of Securrency Transfers, Inc. (net of cash acquired)",
        "label": "Other Payments to Acquire Businesses",
        "documentation": "The cash outflow associated with other payments to acquire businesses including deposit on pending acquisitions and preacquisition costs."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r1128"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r1080"
     ]
    },
    "wt_OtherServicesIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "OtherServicesIncomeMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromContractswithCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income",
        "verboseLabel": "Other [Member]",
        "label": "Other Services Income Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax benefit",
        "label": "Other Tax Expense (Benefit)",
        "documentation": "Amount of other income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r275",
      "r1322",
      "r1327"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1087",
      "r1099",
      "r1115",
      "r1143"
     ]
    },
    "wt_OutstandingCommonStockPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "OutstandingCommonStockPercentage",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding common stock percentage",
        "documentation": "Percentage of outstanding common stock.",
        "label": "Outstanding Common Stock Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1090",
      "r1102",
      "r1118",
      "r1146"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r1090",
      "r1102",
      "r1118",
      "r1146"
     ]
    },
    "srt_OwnershipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OwnershipAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment."
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OwnershipDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "wt_PassiveStockholdersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "PassiveStockholdersMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Passive stockholders [Member]",
        "label": "Passive Stockholders Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "wt_PayableToGoldBullionHoldingJerseyLimitedGBHAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "PayableToGoldBullionHoldingJerseyLimitedGBHAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payable to Gold Bullion Holdings Jersey Limited GBH [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payable to Gold Bullion Holdings Jersey Limited GBH (Details) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "PayabletoGoldBullionHoldingsJerseyLimitedGBHDetailsTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payable to Gold Bullion Holdings Jersey Limited GBH (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_PaymentOfConvertibleNotesIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "PaymentOfConvertibleNotesIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Issuance costs\u2014convertible notes",
        "documentation": "Payment of convertible notes issuance costs.",
        "label": "Payment Of Convertible Notes Issuance Costs"
       }
      }
     },
     "auth_ref": []
    },
    "wt_PaymentOfDeferredConsideration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "PaymentOfDeferredConsideration",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Termination of deferred consideration\u2014gold payments",
        "documentation": "Payment of deferred consideration.",
        "label": "Payment Of Deferred Consideration"
       }
      }
     },
     "auth_ref": []
    },
    "wt_PaymentOfLeaseTerminationFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "PaymentOfLeaseTerminationFee",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/LeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination fee",
        "documentation": "Amount of payment of lease termination fee.",
        "label": "Payment Of Lease Termination Fee"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Shares repurchased",
        "label": "Payments for Repurchase of Common Stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "us-gaap_PaymentsOfDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfDividends",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Dividends paid",
        "label": "Payments of Dividends",
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Issuance costs\u2014Series C Preferred Stock",
        "label": "Payments of Stock Issuance Costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireBusinessesGross",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate purchase price",
        "label": "Payments to Acquire Businesses, Gross",
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r610"
     ]
    },
    "us-gaap_PaymentsToAcquireInProcessResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireInProcessResearchAndDevelopment",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cash paid\u2014software development",
        "label": "Payments to Acquire in Process Research and Development",
        "documentation": "The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of fixed assets",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1127"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1127"
     ]
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/EmployeeBenefitPlans"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Benefit Plans",
        "label": "Retirement Benefits [Text Block]",
        "documentation": "The entire disclosure for retirement benefits."
       }
      }
     },
     "auth_ref": [
      "r513",
      "r514",
      "r515",
      "r521",
      "r522",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r1040"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1126"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r1136"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r1129"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1125"
     ]
    },
    "wt_PercentageOfAssetsSold": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "PercentageOfAssetsSold",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of assets sold",
        "documentation": "Percentage of assets sold.",
        "label": "Percentage Of Assets Sold"
       }
      }
     },
     "auth_ref": []
    },
    "wt_PercentageOfBeneficialOwnership": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "PercentageOfBeneficialOwnership",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of beneficial ownership",
        "documentation": "Percentage of beneficial ownership.",
        "label": "Percentage Of Beneficial Ownership"
       }
      }
     },
     "auth_ref": []
    },
    "wt_PercentageOfCommonStock": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "PercentageOfCommonStock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of common stock",
        "documentation": "Percentage of common stock.",
        "label": "Percentage Of Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "wt_PercentageOfCommonStockAcquired": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "PercentageOfCommonStockAcquired",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of common stock acquired",
        "documentation": "Percentage of common stock acquired.",
        "label": "Percentage Of Common Stock Acquired"
       }
      }
     },
     "auth_ref": []
    },
    "wt_PercentageOfDiscountOnFutureEquityFinancingForPreferredStock": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "PercentageOfDiscountOnFutureEquityFinancingForPreferredStock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of discount on future equity financing for preferred stock",
        "documentation": "Percentage of Discount on future equity financing for preferred stock.",
        "label": "Percentage Of Discount On Future Equity Financing For Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "wt_PercentageOfOutstandingConvertibleNotes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "PercentageOfOutstandingConvertibleNotes",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of outstanding convertible note",
        "documentation": "Percentage of outstanding convertible note.",
        "label": "Percentage Of Outstanding Convertible Notes"
       }
      }
     },
     "auth_ref": []
    },
    "wt_PercentageOfRevenueGrowth": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "PercentageOfRevenueGrowth",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue growth rate",
        "documentation": "Percentage of revenue growth.",
        "label": "Percentage Of Revenue Growth"
       }
      }
     },
     "auth_ref": []
    },
    "wt_PercentageOfTaxRateRealizedOnSettlement": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "PercentageOfTaxRateRealizedOnSettlement",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Benefit percentage of tax rate",
        "documentation": "Percentage of tax rate.",
        "label": "Percentage Of Tax Rate Realized On Settlement"
       }
      }
     },
     "auth_ref": []
    },
    "wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of voting approval required to redeem all of the outstanding notes at maturity",
        "documentation": "Percentage of voting approval required to redeem all of the outstanding notes at maturity.",
        "label": "Percentage Of Voting Approval Required To Redeem All Of The Outstanding Notes At Maturity"
       }
      }
     },
     "auth_ref": []
    },
    "wt_PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of voting approval required to redeem all of the outstanding notes before maturity",
        "documentation": "Percentage of voting approval required to redeem all of the outstanding notes before maturity.",
        "label": "Percentage Of Voting Approval Required To Redeem All Of The Outstanding Notes Before Maturity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PercentageOfWeightedAverageCostInventory": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PercentageOfWeightedAverageCostInventory",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of weighted average cost capital",
        "label": "Percentage of Weighted Average Cost Inventory",
        "documentation": "The percentage of weighted average cost inventory present at the reporting date when inventory is valued using different valuation methods."
       }
      }
     },
     "auth_ref": []
    },
    "wt_PerformanceBasedRestrictedStockUnitMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "PerformanceBasedRestrictedStockUnitMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRestrictedStockActivityandRestrictedStockUnitTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PRSU [Member]",
        "verboseLabel": "Performance Based Restricted Stock Unit [Member]",
        "label": "Performance Based Restricted Stock Unit Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r1066"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r1066"
     ]
    },
    "wt_PotentiallyDilutiveRestrictedStockAwards": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "PotentiallyDilutiveRestrictedStockAwards",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofWeightedAverageNumberofSharesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Potentially dilutive restricted stock awards",
        "documentation": "Potentially dilutive restricted stock awards .",
        "label": "Potentially Dilutive Restricted Stock Awards"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r1073"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r1074"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r1066"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r1066"
     ]
    },
    "us-gaap_PreferredStockConvertibleSharesIssuable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockConvertibleSharesIssuable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible preferred stock (in Shares)",
        "verboseLabel": "Convertible preferred stock shares (in Shares)",
        "label": "Preferred Stock, Convertible, Shares Issuable",
        "documentation": "Number of common shares issuable upon conversion of preferred stock."
       }
      }
     },
     "auth_ref": [
      "r497"
     ]
    },
    "us-gaap_PreferredStockDividendRatePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockDividendRatePercentage",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividend payable, percentage",
        "label": "Preferred Stock, Dividend Rate, Percentage",
        "documentation": "The percentage rate used to calculate dividend payments on preferred stock."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r919",
      "r940",
      "r944",
      "r979"
     ]
    },
    "us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockDividendsAndOtherAdjustmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Preferred Stock [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockDividendsPerShareDeclared": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockDividendsPerShareDeclared",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSeriesAPreferredStockBalanceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash dividends declared per share (quarterly) (in Dollars per share)",
        "label": "Preferred Stock, Dividends Per Share, Declared",
        "documentation": "Aggregate dividends declared during the period for each share of preferred stock outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSeriesAPreferredStockBalanceTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred Stock",
        "verboseLabel": "Preferred Shares [Member]",
        "netLabel": "Preferred Stock [Member]",
        "label": "Preferred Stock [Member]",
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company."
       }
      }
     },
     "auth_ref": [
      "r1051",
      "r1052",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1359",
      "r1364"
     ]
    },
    "us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Preferred Stock Balance [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, par value (in Dollars per share)",
        "verboseLabel": "Preferred stock, par or stated value per share (in Dollars per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r495"
     ]
    },
    "wt_PreferredStockPurchaseRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "PreferredStockPurchaseRightsMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred Stock Purchase Rights",
        "label": "Preferred Stock Purchase Rights Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_PreferredStockRedemptionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "PreferredStockRedemptionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock redemption value (in Dollars)",
        "verboseLabel": "Preferred shares redemption value",
        "documentation": "Preferred Stock Redemption Value.",
        "label": "Preferred Stock Redemption Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r862"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock shares issued (in Shares)",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r495"
     ]
    },
    "us-gaap_PreferredStockTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStock"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series A Preferred Stock",
        "label": "Preferred Stock [Text Block]",
        "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock."
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSeriesAPreferredStockBalanceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, par value $0.01; 2,000 shares authorized:",
        "verboseLabel": "Series A Preferred Stock\u2014carrying value",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r768",
      "r1048"
     ]
    },
    "us-gaap_PreferredUnitsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredUnitsLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSeriesAPreferredStockBalanceTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Units [Line Items]",
        "terseLabel": "Preferred Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses",
        "label": "Prepaid Expense, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r416",
      "r417",
      "r1019"
     ]
    },
    "wt_PresentValueOfMarketRateInterest": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "PresentValueOfMarketRateInterest",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Present value of market rate interest",
        "documentation": "Present value of market rate interest.",
        "label": "Present Value Of Market Rate Interest"
       }
      }
     },
     "auth_ref": []
    },
    "wt_PrincipalAmountOfTradingPrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "PrincipalAmountOfTradingPrice",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principal amount of trading price",
        "documentation": "Principal amount of trading price.",
        "label": "Principal Amount Of Trading Price"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ProbabilityThatSeriesB2PreferenceSharesCovertIntoSeriesB1PreferenceShares": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ProbabilityThatSeriesB2PreferenceSharesCovertIntoSeriesB1PreferenceShares",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBacksolveValuationApproachTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Probability that Series B-2 Preference Shares convert into Series B-1 Preference Shares",
        "documentation": "Probability that series B-2 preference shares covert into series B-1 preference shares.",
        "label": "Probability That Series B2 Preference Shares Covert Into Series B1 Preference Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from receipt of contingent consideration related to the sale of Canadian ETF business",
        "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested",
        "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "wt_ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from held-to-maturity securities maturing or called prior to maturity",
        "documentation": "The amount of Proceeds from held-to-maturity securities maturing or called prior to maturity.",
        "label": "Proceeds From Heldtomaturity Securities Maturing Or Called Prior To Maturity"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ProceedsFromIssuanceOfConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ProceedsFromIssuanceOfConvertibleNotes",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from the issuance of convertible notes (Note 10)",
        "documentation": "Proceeds from issuance of convertible notes.",
        "label": "Proceeds From Issuance Of Convertible Notes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow",
      "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repurchase of Series C Preferred Stock",
        "verboseLabel": "Purchase price payable",
        "label": "Proceeds from Issuance of Convertible Preferred Stock",
        "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_ProceedsFromRepaymentsOfNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromRepaymentsOfNotesPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repurchase and maturity of convertible notes",
        "label": "Proceeds from (Repayments of) Notes Payable",
        "documentation": "Amount of cash inflow (outflow) from long-term debt supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds received",
        "label": "Proceeds from Sale and Maturity of Held-to-Maturity Securities",
        "documentation": "Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r1228"
     ]
    },
    "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleMaturityAndCollectionsOfInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow",
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from the exit from investment in Securrency, Inc.",
        "verboseLabel": "Proceeds received (in Dollars)",
        "label": "Proceeds from Sale, Maturity and Collection of Investments",
        "documentation": "The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from exercise of stock options",
        "verboseLabel": "Cash received from option exercises",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r29"
     ]
    },
    "wt_ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from the sale of financial instruments owned, at fair value",
        "documentation": "Proceeds from the sale of financial instruments owned, at fair value.",
        "label": "Proceeds From The Sale Of Financial Instruments Owned At Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement",
      "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromContractswithCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "documentation": "Information by product and service, or group of similar products and similar services."
       }
      }
     },
     "auth_ref": [
      "r353",
      "r735",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r1016",
      "r1036",
      "r1049",
      "r1181",
      "r1282",
      "r1283",
      "r1293",
      "r1358"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromContractswithCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "auth_ref": [
      "r353",
      "r735",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r1016",
      "r1036",
      "r1049",
      "r1181",
      "r1282",
      "r1283",
      "r1293",
      "r1358"
     ]
    },
    "us-gaap_ProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProfessionalFees",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Professional fees",
        "label": "Professional Fees",
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer."
       }
      }
     },
     "auth_ref": [
      "r1062",
      "r1362",
      "r1363"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed Assets, net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDepreciationandAmortizationTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFixedAssetsTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed Assets, net",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r205",
      "r208",
      "r209"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFixedAssetsTable": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFixedAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equipment",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r240",
      "r774"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGrossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentGrossAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Fixed Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDepreciationandAmortizationTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFixedAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Depreciation and Amortization [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFixedAssetsTable": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFixedAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "terseLabel": "Fixed assets, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r762",
      "r774",
      "r1048"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/FixedAssetsNetTables",
      "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Depreciation and Amortization",
        "verboseLabel": "Schedule of Fixed Assets",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFixedAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDepreciationandAmortizationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated useful lives",
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProvisionForOtherLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProvisionForOtherLosses",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional losses (in Dollars)",
        "label": "Provision for Other Losses",
        "documentation": "Amount of expense related to other loss."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r143",
      "r192"
     ]
    },
    "wt_PurchaseOfFinancialInstrumentsOwnedAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "PurchaseOfFinancialInstrumentsOwnedAtFairValue",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of financial instruments owned, at fair value",
        "documentation": "Purchase of financial instruments owned, at fair value.",
        "label": "Purchase Of Financial Instruments Owned At Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "wt_PurchaseOfInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "PurchaseOfInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of investments",
        "documentation": "Purchase of investments.",
        "label": "Purchase Of Investments"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r1124"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDepreciationandAmortizationTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofValuationofDeferredConsiderationTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r448",
      "r450",
      "r451",
      "r452",
      "r514",
      "r532",
      "r560",
      "r561",
      "r562",
      "r707",
      "r734",
      "r801",
      "r851",
      "r852",
      "r918",
      "r939",
      "r945",
      "r946",
      "r978",
      "r1013",
      "r1014",
      "r1027",
      "r1035",
      "r1043",
      "r1050",
      "r1053",
      "r1278",
      "r1290",
      "r1345",
      "r1346",
      "r1347",
      "r1348",
      "r1349"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDepreciationandAmortizationTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofValuationofDeferredConsiderationTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r448",
      "r450",
      "r451",
      "r452",
      "r514",
      "r532",
      "r560",
      "r561",
      "r562",
      "r707",
      "r734",
      "r801",
      "r851",
      "r852",
      "r918",
      "r939",
      "r945",
      "r946",
      "r978",
      "r1013",
      "r1014",
      "r1027",
      "r1035",
      "r1043",
      "r1050",
      "r1053",
      "r1278",
      "r1290",
      "r1345",
      "r1346",
      "r1347",
      "r1348",
      "r1349"
     ]
    },
    "us-gaap_RealizedInvestmentGainsLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RealizedInvestmentGainsLosses",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Losses on investments",
        "label": "Realized Investment Gains (Losses)",
        "documentation": "Amount of realized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r780"
     ]
    },
    "us-gaap_ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nature of Uncertainty [Axis]",
        "documentation": "Information by nature of uncertainty related to unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "wt_ReceivableFromManJerIssuersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ReceivableFromManJerIssuersMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAccountsReceivablefromRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivable from ManJer Issuers [Member]",
        "label": "Receivable From Man Jer Issuers Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ReceivableFromWTTMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ReceivableFromWTTMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAccountsReceivablefromRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivable from WTT [Member]",
        "label": "Receivable From WTTMember"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReceivablesPolicyTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable",
        "label": "Receivable [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable."
       }
      }
     },
     "auth_ref": [
      "r1223",
      "r1224",
      "r1225",
      "r1226"
     ]
    },
    "wt_RecentlyIssuedAccountingPronouncementsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "RecentlyIssuedAccountingPronouncementsPolicyTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recently Issued Accounting Pronouncements",
        "documentation": "Disclosure of accounting policy for recently issued accounting pronouncements.",
        "label": "Recently Issued Accounting Pronouncements Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ReclassificationOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ReclassificationOfEquity",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification of equity component related to convertible notes, net of deferred taxes",
        "documentation": "Reclassification of equity.",
        "label": "Reclassification Of Equity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1082",
      "r1094",
      "r1110",
      "r1138"
     ]
    },
    "wt_RecurringFairValueMeasurementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "RecurringFairValueMeasurementsAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recurring fair value measurements:",
        "label": "Recurring Fair Value Measurements Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "wt_RecurringFairValueMeasurementsAbstract1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "RecurringFairValueMeasurementsAbstract1",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recurring fair value measurements:",
        "label": "Recurring Fair Value Measurements Abstract1"
       }
      }
     },
     "auth_ref": []
    },
    "wt_RedemptionOfNoteUponAChangeOfControl": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "RedemptionOfNoteUponAChangeOfControl",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofPresentstheProbabilityAscribedtoPotentialOutcomesUsedinthePwermTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redemption of note upon a change of control",
        "documentation": "The percentage of redemption of note upon a change of control.",
        "label": "Redemption Of Note Upon AChange Of Control"
       }
      }
     },
     "auth_ref": []
    },
    "wt_RedemptionOfNoteUponACorporateTransaction": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "RedemptionOfNoteUponACorporateTransaction",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofPresentstheProbabilityAscribedtoPotentialOutcomesUsedinthePwermTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redemption of note upon a corporate transaction",
        "documentation": "The percentage of redemption of note upon a corporate transaction.",
        "label": "Redemption Of Note Upon ACorporate Transaction"
       }
      }
     },
     "auth_ref": []
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r1066"
     ]
    },
    "us-gaap_RegulatoryDepreciationAndAmortizationPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RegulatoryDepreciationAndAmortizationPolicy",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and Amortization",
        "label": "Regulatory Depreciation and Amortization, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for systematically allocating capitalized costs to periods that benefit from the use thereof. Includes, but is not limited to, methods used, such as composite depreciation, descriptions of regulatory treatment for estimated removal and disposal costs, and description of amortization of plant-related regulatory assets."
       }
      }
     },
     "auth_ref": []
    },
    "wt_RelatedPartiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "RelatedPartiesAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAccountsReceivablefromRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Parties [Axis]",
        "label": "Related Parties Axis"
       }
      }
     },
     "auth_ref": []
    },
    "wt_RelatedPartiesDomainDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "RelatedPartiesDomainDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RelatedPartiesDomain [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAccountsReceivablefromRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party, Type [Domain]",
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r523",
      "r693",
      "r694",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r881",
      "r883",
      "r914"
     ]
    },
    "us-gaap_RelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAccountsReceivablefromRelatedPartiesTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromAdvisoryServicesProvidedtoRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party",
        "verboseLabel": "Related Party [Member]",
        "label": "Related Party [Member]",
        "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r278",
      "r693",
      "r694",
      "r695",
      "r696",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r881",
      "r883",
      "r914"
     ]
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r693",
      "r694",
      "r1341"
     ]
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Domain]",
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAccountsReceivablefromRelatedPartiesTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromAdvisoryServicesProvidedtoRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Accounts Receivable from Related Parties [Line Items]",
        "terseLabel": "Schedule of Revenues from Advisory Services Provided to Related Parties [Line Items]",
        "verboseLabel": "Related Party Transactions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r889",
      "r890",
      "r893"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAccountsReceivablefromRelatedPartiesTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromAdvisoryServicesProvidedtoRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party, Type [Axis]",
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests."
       }
      }
     },
     "auth_ref": [
      "r523",
      "r693",
      "r694",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r881",
      "r883",
      "r914",
      "r1341"
     ]
    },
    "wt_RelatedPartyTransactionsDetailsScheduleofAccountsReceivablefromRelatedPartiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "RelatedPartyTransactionsDetailsScheduleofAccountsReceivablefromRelatedPartiesTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAccountsReceivablefromRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions (Details) - Schedule of Accounts Receivable from Related Parties [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_RelatedPartyTransactionsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "RelatedPartyTransactionsDetailsTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transactions",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r690",
      "r691",
      "r692",
      "r694",
      "r697",
      "r826",
      "r827",
      "r828",
      "r891",
      "r892",
      "r893",
      "r912",
      "r913"
     ]
    },
    "wt_RepurchasePricePerShareInterestRateTransaction": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "RepurchasePricePerShareInterestRateTransaction",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repurchase price per share interest rate transaction (in Dollars per share)",
        "documentation": "Repurchase price per share interest rate transaction.",
        "label": "Repurchase Price Per Share Interest Rate Transaction"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchDevelopmentAndComputerSoftwarePolicyTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Software Development Costs",
        "label": "Research, Development, and Computer Software, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r5",
      "r126"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r1083",
      "r1095",
      "r1111",
      "r1139"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r1084",
      "r1096",
      "r1112",
      "r1140"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r1091",
      "r1103",
      "r1119",
      "r1147"
     ]
    },
    "us-gaap_RestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRestrictedStockActivityandRestrictedStockUnitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSA\t[Member]",
        "label": "Restricted Stock [Member]",
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRestrictedStockActivityandRestrictedStockUnitTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSU [Member]",
        "verboseLabel": "Restricted Stock Units (RSUs) [Member]",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringCostAndReserveAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSummarizesImpairmentsRecognizedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Type [Axis]",
        "documentation": "Information by type of restructuring cost."
       }
      }
     },
     "auth_ref": [
      "r439",
      "r440",
      "r442",
      "r443"
     ]
    },
    "us-gaap_RestructuringCostsAndAssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringCostsAndAssetImpairmentCharges",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSummarizesImpairmentsRecognizedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total",
        "label": "Restructuring Costs and Asset Impairment Charges",
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet",
      "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained earnings",
        "verboseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r172",
      "r771",
      "r808",
      "r813",
      "r824",
      "r863",
      "r1048"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "(Accumulated Deficit)/Retained Earnings",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r280",
      "r281",
      "r282",
      "r285",
      "r293",
      "r295",
      "r400",
      "r406",
      "r569",
      "r570",
      "r571",
      "r597",
      "r598",
      "r619",
      "r622",
      "r623",
      "r626",
      "r636",
      "r804",
      "r806",
      "r829",
      "r1364"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues from Contracts with Customers [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesfromContractswithCustomers"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues from Contracts with Customers",
        "label": "Revenue from Contract with Customer [Text Block]",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512"
     ]
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesfromContractswithCustomersTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Geographic Distribution of Revenues",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition",
        "label": "Revenue [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r887",
      "r1015",
      "r1021"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGeographicDistributionofRevenuesTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromAdvisoryServicesProvidedtoRelatedPartiesTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromContractswithCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total revenues",
        "verboseLabel": "Total operating revenues",
        "netLabel": "Revenues from advisory services",
        "label": "Revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r263",
      "r274",
      "r326",
      "r327",
      "r343",
      "r348",
      "r349",
      "r353",
      "r354",
      "r356",
      "r396",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r651",
      "r757",
      "r1286"
     ]
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Revenues:",
        "verboseLabel": "Revenues from contracts with customers:",
        "label": "Revenues [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_RevenuesFromContractsWithCustomersAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "RevenuesFromContractsWithCustomersAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGeographicDistributionofRevenuesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues from contracts with customers:",
        "label": "Revenues From Contracts With Customers Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "wt_RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGeographicDistributionofRevenuesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues from Contracts with Customers (Details) - Schedule of Geographic Distribution of Revenues [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "RevenuesfromContractswithCustomersDetailsScheduleofGeographicDistributionofRevenuesTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGeographicDistributionofRevenuesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues from Contracts with Customers (Details) - Schedule of Geographic Distribution of Revenues [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_RevenuesfromContractswithCustomersDetailsScheduleofRevenuesfromContractswithCustomersTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "RevenuesfromContractswithCustomersDetailsScheduleofRevenuesfromContractswithCustomersTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromContractswithCustomersTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues from Contracts with Customers (Details) - Schedule of Revenues from Contracts with Customers [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAdditionalInformationRelatedtoOperatingLeaseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets obtained in exchange for new operating lease liabilities",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r681",
      "r1047"
     ]
    },
    "wt_RodberInvestmentsLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "RodberInvestmentsLimitedMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rodber Investments Limited [Member]",
        "documentation": "Rodber Investments Limited member.",
        "label": "Rodber Investments Limited Member"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r1156"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r1156"
     ]
    },
    "wt_SaleOfCanadianETFBusinessMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "SaleOfCanadianETFBusinessMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ContingentPaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Canadian ETF Business [Member]",
        "label": "Sale Of Canadian ETFBusiness Member"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioForecastMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScenarioForecastMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forecast [Member]",
        "label": "Forecast [Member]",
        "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact."
       }
      }
     },
     "auth_ref": [
      "r533",
      "r1192",
      "r1219"
     ]
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShareDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGoodwillTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofBasicandDilutedEarningsPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts."
       }
      }
     },
     "auth_ref": [
      "r296",
      "r533",
      "r1178",
      "r1219"
     ]
    },
    "wt_ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation of Future Minimum Lease Payments to Balance Sheet",
        "documentation": "Schedule For Supplemental Balance Sheet Information Related To Operating Lease",
        "label": "Schedule For Supplemental Balance Sheet Information Related To Operating Lease Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ScheduleOfAccountsReceivableFromRelatedPartiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfAccountsReceivableFromRelatedPartiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Accounts Receivable from Related Parties [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accounts Receivable from Related Parties",
        "documentation": "Schedule Of Accounts Receivable From Related Party [Table Text Block]",
        "label": "Schedule Of Accounts Receivable From Related Party Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ScheduleOfAdditionalInformationRelatedToOperatingLeaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfAdditionalInformationRelatedToOperatingLeaseAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule for Summary of Additional Information Related to Operating Lease [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ScheduleOfAggregateConsiderationPayableTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfAggregateConsiderationPayableTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/PayabletoGoldBullionHoldingsJerseyLimitedGBHTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Aggregate Consideration Payable",
        "documentation": "Tabular of  aggregate consideration payable.",
        "label": "Schedule Of Aggregate Consideration Payable Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Assets And Liabilities Measured At Fair Value Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSecuritiesHeldtoMaturityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374"
     ]
    },
    "wt_ScheduleOfBacksolveValuationApproachAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfBacksolveValuationApproachAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Backsolve Valuation Approach Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ScheduleOfBeginningAndEndingBalancesOfRecurringFairValueMeasurementsClassifiedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfBeginningAndEndingBalancesOfRecurringFairValueMeasurementsClassifiedAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Beginning And Ending Balances Of Recurring Fair Value Measurements Classified Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ScheduleOfChangesInBalanceOfGrossUnrecognizedTaxBenefitsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfChangesInBalanceOfGrossUnrecognizedTaxBenefitsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Changes In Balance Of Gross Unrecognized Tax Benefits Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ScheduleOfComponentsOfCurrentAndDeferredIncomeTaxExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfComponentsOfCurrentAndDeferredIncomeTaxExpenseAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Components Of Current And Deferred Income Tax Expense Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Current and Deferred Income Tax Expense",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "wt_ScheduleOfComponentsOfTheCompanySDeferredTaxAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfComponentsOfTheCompanySDeferredTaxAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Components of the Company\u2019s Deferred Tax Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScheduleOfCondensedFinancialStatementsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfCondensedFinancialStatementsTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofPresentstheProbabilityAscribedtoPotentialOutcomesUsedinthePwermTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Financial Statements [Table]",
        "documentation": "Disclosure of information about condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r227",
      "r228",
      "r229",
      "r279",
      "r1179"
     ]
    },
    "srt_ScheduleOfCondensedFinancialStatementsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfCondensedFinancialStatementsTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Presents the Probability Ascribed to Potential Outcomes Used in the Pwerm",
        "label": "Condensed Financial Statements [Table Text Block]",
        "documentation": "Tabular disclosure of condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows."
       }
      }
     },
     "auth_ref": [
      "r1193",
      "r1215"
     ]
    },
    "wt_ScheduleOfConvertibleNotesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfConvertibleNotesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Convertible Notes [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDebtTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Key Terms of Convertible Notes",
        "label": "Schedule of Debt [Table Text Block]",
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation."
       }
      }
     },
     "auth_ref": []
    },
    "wt_ScheduleOfDeferredConsiderationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfDeferredConsiderationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Deferred Consideration [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ScheduleOfDeferredConsiderationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfDeferredConsiderationTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Deferred Consideration",
        "documentation": "Tabular disclosure of deferred consideration.",
        "label": "Schedule Of Deferred Consideration Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of the Company\u2019s Deferred Tax Assets",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/EmployeeBenefitPlansTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Discretionary Contributions",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table Text Block]",
        "documentation": "Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r87",
      "r88",
      "r89",
      "r90"
     ]
    },
    "wt_ScheduleOfDepreciationAndAmortizationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfDepreciationAndAmortizationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Depreciation And Amortization Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation of Basic and Diluted Earnings Per Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1221"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation of Statutory Federal Income Tax Rate and Company's Effective Rate",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInformationaboutVariableInterestsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "documentation": "Information by name of investment including named security. Excludes entity that is consolidated."
       }
      }
     },
     "auth_ref": [
      "r393",
      "r394",
      "r395"
     ]
    },
    "wt_ScheduleOfExpectedAmortizationExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfExpectedAmortizationExpenseAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Unamortized Finite-Lived Intangible Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ScheduleOfFinancialInstrumentsOwnedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfFinancialInstrumentsOwnedAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Financial Instruments Owned Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Financial Instruments Owned",
        "label": "Schedule of Financial Instruments Owned and Pledged as Collateral [Table Text Block]",
        "documentation": "Tabular disclosure of financial instruments held by the entity for its own account for trading or investment purposes that are carried at fair value and pledged to counterparties as collateral for financing transactions. Description may include equity, fixed income, debt or other securities."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r1350"
     ]
    },
    "wt_ScheduleOfFutureMinimumLeasePaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfFutureMinimumLeasePaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Future Minimum Lease Payments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ScheduleOfGeographicDistributionOfRevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfGeographicDistributionOfRevenuesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Geographic Distribution Of Revenues Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ScheduleOfGoodwillAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfGoodwillAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Goodwill [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfGoodwillTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGoodwillTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Goodwill [Table]",
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons."
       }
      }
     },
     "auth_ref": [
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r1029"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfGoodwillTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Goodwill",
        "label": "Schedule of Goodwill [Table Text Block]",
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule."
       }
      }
     },
     "auth_ref": [
      "r1029",
      "r1265",
      "r1266",
      "r1267",
      "r1268",
      "r1269",
      "r1270",
      "r1271",
      "r1272",
      "r1273",
      "r1274",
      "r1275"
     ]
    },
    "us-gaap_ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfImpairedLongLivedAssetsHeldAndUsedTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSummarizesImpairmentsRecognizedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Impaired Long-Lived Assets Held and Used [Table]",
        "documentation": "For a long-lived asset to be held and used by an entity, the table may include a description of the impaired long-lived asset and facts and circumstances leading to the impairment, amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired long-lived asset is reported."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Domestic and Foreign Components of Income before Income Tax Expense",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r1213"
     ]
    },
    "wt_ScheduleOfIncomeTaxLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfIncomeTaxLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Income Tax [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ScheduleOfInformationAboutVariableInterestsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfInformationAboutVariableInterestsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Information About Variable Interests Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ScheduleOfIntangibleAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfIntangibleAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Intangible Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Intangible Assets",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_ScheduleOfInvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInvestmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Investments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfInvestmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfInvestmentsLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r936",
      "r938",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r969",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990"
     ]
    },
    "wt_ScheduleOfKeyTermsOfConvertibleNotesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfKeyTermsOfConvertibleNotesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Key Terms Of Convertible Notes Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPreferredUnitsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPreferredUnitsTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSeriesAPreferredStockBalanceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Preferred Units [Table]",
        "documentation": "Schedule providing details of the units of a Master Limited Partnership that have priority over limited partner units in areas including liquidation, redemption, conversion, tax status of distribution or sharing in distributions. Details include the preferred units authorized, issued and outstanding, the cumulative cash distributions made to preferred partners, the cumulative net income shared by preferred partners, and the aggregate account balances of preferred partners."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "us-gaap_ScheduleOfPreferredUnitsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPreferredUnitsTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Series A Preferred Stock Balance",
        "label": "Schedule of Preferred Units [Table Text Block]",
        "documentation": "Tabular disclosure of preferred units of master limited partnerships that have priority over limited partner units in areas including liquidation, redemption, conversion, tax status of distribution or sharing in distributions. This schedule ordinarily includes a description of the preferred units that details various rights including redemption, conversion, liquidation, and sharing in distributions; capital contributed by preferred partners; number of preferred units authorized to be issued, issued, and outstanding; aggregate cumulative cash distributions made to the preferred partners; aggregate cumulative net income earned by the preferred partners; capital account balance of the preferred partners."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "wt_ScheduleOfPresentsTheProbabilityAscribedToPotentialOutcomesUsedInThePwermAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfPresentsTheProbabilityAscribedToPotentialOutcomesUsedInThePwermAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Presents The Probability Ascribed To Potential Outcomes Used In The Pwerm Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDepreciationandAmortizationTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFixedAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "wt_ScheduleOfReconciliationOfFutureMinimumLeasePaymentsToBalanceSheetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfReconciliationOfFutureMinimumLeasePaymentsToBalanceSheetAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Reconciliation of Future Minimum Lease Payments to Balance Sheet [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRevenuesfromAdvisoryServicesProvidedtoRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r119",
      "r889",
      "r890",
      "r893"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Revenues from Advisory Services Provided to Related Parties",
        "label": "Schedule of Related Party Transactions [Table Text Block]",
        "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates."
       }
      }
     },
     "auth_ref": []
    },
    "wt_ScheduleOfRestrictedStockActivityAndRestrictedStockUnitAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfRestrictedStockActivityAndRestrictedStockUnitAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Restricted Stock Activity And Restricted Stock Unit Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ScheduleOfRevenuesFromAdvisoryServicesProvidedToRelatedPartiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfRevenuesFromAdvisoryServicesProvidedToRelatedPartiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Revenues from Advisory Services Provided to Related Parties [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ScheduleOfRevenuesFromContractsWithCustomersAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfRevenuesFromContractsWithCustomersAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Revenues From Contracts With Customers Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share Based Payment Awards Other than Options Valuation Assumptions",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "wt_ScheduleOfShareBasedPaymentAwardsOtherThanOptionsValuationAssumptionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfShareBasedPaymentAwardsOtherThanOptionsValuationAssumptionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share Based Payment Awards Other than Options Valuation Assumptions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Restricted Stock Activity and Restricted Stock Unit",
        "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year."
       }
      }
     },
     "auth_ref": []
    },
    "wt_ScheduleOfSummarizesImpairmentsRecognizedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfSummarizesImpairmentsRecognizedAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Summarizes Impairments Recognized Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfTradingSecuritiesAndOtherTradingAssetsLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFinancialInstrumentsOwnedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt and Equity Securities, FV-NI [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "wt_ScheduleOfUnrecognizedStockBasedCompensationExpenseAndAverageRemainingVestingPeriodAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfUnrecognizedStockBasedCompensationExpenseAndAverageRemainingVestingPeriodAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Unrecognized Stock Based Compensation Expense And Average Remaining Vesting Period Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Unrecognized Stock-Based Compensation Expense and Average Remaining Vesting Period",
        "documentation": "Schedule Of Unrecognized Stock Based Compensation Expenses And Average Remaining Vesting Period Table [Text Block]",
        "label": "Schedule Of Unrecognized Stock Based Compensation Expenses And Average Remaining Vesting Period Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Changes in Balance of Gross Unrecognized Tax Benefits",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r1045",
      "r1324"
     ]
    },
    "wt_ScheduleOfValuationOfDeferredConsiderationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfValuationOfDeferredConsiderationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Valuation Of Deferred Consideration Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInformationaboutVariableInterestsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Variable Interest Entities [Table]",
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r106",
      "r107",
      "r612",
      "r613",
      "r614",
      "r615",
      "r715",
      "r716",
      "r717"
     ]
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfVariableInterestEntitiesTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Information about Variable Interests",
        "label": "Schedule of Variable Interest Entities [Table Text Block]",
        "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r106",
      "r107"
     ]
    },
    "wt_ScheduleOfWeightedAverageNumberOfSharesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ScheduleOfWeightedAverageNumberOfSharesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Weighted Average Number Of Shares Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Weighted Average Number of Shares",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit)."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Expected Amortization Expense",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "wt_SecondInstallmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "SecondInstallmentsMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Second Installments [Member]",
        "label": "Second Installments Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Held-to-Maturity (Details) - Schedule of Unrealized Losses, Gains and Fair Value of Securities Held-to-Maturity [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "SecuritiesHeldtoMaturityDetailsScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofUnrealizedLossesGainsandFairValueofSecuritiesHeldtoMaturityTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Held-to-Maturity (Details) - Schedule of Unrealized Losses, Gains and Fair Value of Securities Held-to-Maturity [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1067"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r1071"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r1070"
     ]
    },
    "us-gaap_SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Owned and Sold, Not yet Purchased, at Fair Value [Axis]",
        "documentation": "Group of financial instruments held by a broker-dealer for their own account (proprietary securities) for trading or investment purposes that are carried at fair value including securities sold, not yet purchased."
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityNameDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Owned and Sold, Not yet Purchased Fair Value, Security Name [Domain]",
        "documentation": "Type of financial instrument held by a broker-dealer for their own account (proprietary securities) for trading or investment purposes that are carried at fair value including securities sold, not yet purchased."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial instruments owned, at fair value (in Dollars)",
        "verboseLabel": "Financial instruments owned, at fair value",
        "label": "Security Owned and Sold, Not yet Purchased Fair Value, Security Owned",
        "documentation": "Fair value of financial instruments held by a broker-dealer for their own account (proprietary securities) for trading or investment purposes determined by management based upon quoted prices of a financial instrument with similar characteristics or on a valuation technique or model."
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r1075"
     ]
    },
    "wt_SecurrencyConvertibleNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "SecurrencyConvertibleNoteMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInformationaboutVariableInterestsTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securrency, Inc.\u2014convertible note [Member]",
        "verboseLabel": "Securrency Convertible Note [Member]",
        "documentation": "Securrency convertible note.",
        "label": "Securrency Convertible Note Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_SecurrencyIncAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "SecurrencyIncAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securrency, Inc.:",
        "label": "Securrency Inc Abstract"
       }
      }
     },
     "auth_ref": []
    },
    "wt_SecurrencyIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "SecurrencyIncMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSummarizesImpairmentsRecognizedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securrency [Member]",
        "documentation": "Securrenc, Inc.",
        "label": "Securrency Inc Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_SecurrencyIncSubTotalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "SecurrencyIncSubTotalMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInformationaboutVariableInterestsTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securrency Inc Sub Total [Member]",
        "label": "Securrency Inc Sub Total Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_SecurrencyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "SecurrencyMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securrency [Member]",
        "documentation": "Securrency.",
        "label": "Securrency Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_SecurrencyseriesaconvertiblepreferredstockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "SecurrencyseriesaconvertiblepreferredstockMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInformationaboutVariableInterestsTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securrency, Inc. Series A convertible preferred stock [Member]",
        "documentation": "SecurrencySeriesAConvertiblePreferredStock .",
        "label": "Securrencyseriesaconvertiblepreferredstock Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_SecurrencyseriesbconvertiblepreferredstockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "SecurrencyseriesbconvertiblepreferredstockMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInformationaboutVariableInterestsTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securrency, Inc. Series B convertible preferred stock [Member]",
        "documentation": "SecurrencySeriesBConvertiblePreferredStock .",
        "label": "Securrencyseriesbconvertiblepreferredstock Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/CashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r356",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r441",
      "r444",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r1029",
      "r1181",
      "r1358"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGeographicDistributionofRevenuesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "documentation": "Geographical area."
       }
      }
     },
     "auth_ref": [
      "r216",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r354",
      "r355",
      "r844",
      "r847",
      "r849",
      "r924",
      "r941",
      "r962",
      "r987",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1017",
      "r1037",
      "r1053",
      "r1293",
      "r1358"
     ]
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment and Geographic Information",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r354",
      "r1026"
     ]
    },
    "wt_SeriesANonVotingConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "SeriesANonVotingConvertiblePreferredStockMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series A Non-Voting Convertible Preferred Stock [Member]",
        "verboseLabel": "Series A Non Voting Convertible Preferred Stock [Member]",
        "documentation": "Series a non voting convertible preferred stock.",
        "label": "Series ANon Voting Convertible Preferred Stock Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_SeriesAPreferredStockDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "SeriesAPreferredStockDetailsTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Preferred Stock (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeriesAPreferredStockMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series A Non-Voting Convertible",
        "verboseLabel": "Series A Preferred Shares [Member]",
        "label": "Series A Preferred Stock [Member]",
        "documentation": "Series A preferred stock."
       }
      }
     },
     "auth_ref": [
      "r1200",
      "r1201",
      "r1292"
     ]
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeriesBPreferredStockMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series B Preferred Shares [Member]",
        "label": "Series B Preferred Stock [Member]",
        "documentation": "Series B preferred stock."
       }
      }
     },
     "auth_ref": [
      "r1200",
      "r1201",
      "r1292"
     ]
    },
    "us-gaap_SeriesCPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeriesCPreferredStockMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofWeightedAverageNumberofSharesTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series C",
        "verboseLabel": "Series C Preferred Stock [Member]",
        "label": "Series C Preferred Stock [Member]",
        "documentation": "Series C preferred stock."
       }
      }
     },
     "auth_ref": [
      "r1200",
      "r1201",
      "r1292"
     ]
    },
    "wt_SeriesCRedeemableConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "SeriesCRedeemableConvertiblePreferredStockMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series C Redeemable Convertible Preferred Stock [Member]",
        "label": "Series CRedeemable Convertible Preferred Stock Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "verboseLabel": "Stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r1044"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRestrictedStockActivityandRestrictedStockUnitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Forfeited, Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r554"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRestrictedStockActivityandRestrictedStockUnitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited, Weighted Average Grant Date Fair Value (in Dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r554"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRestrictedStockActivityandRestrictedStockUnitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted, Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r552"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRestrictedStockActivityandRestrictedStockUnitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted, Weighted Average Grant Date Fair Value (in Dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r552"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRestrictedStockActivityandRestrictedStockUnitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Unvested Beginning Balance, Shares",
        "periodEndLabel": "Unvested, Ending Balance, Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r549",
      "r550"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRestrictedStockActivityandRestrictedStockUnitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Unvested, Beginning Balance, Weighted Average Grant Date Fair Value (in Dollars per share)",
        "periodEndLabel": "Unvested, Ending Balance,Weighted Average Grant Date Fair Value (in Dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r549",
      "r550"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRestrictedStockActivityandRestrictedStockUnitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Vested, Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r553"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate fair value of awards that vested",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRestrictedStockActivityandRestrictedStockUnitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested, Weighted Average Grant Date Fair Value (in Dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r553"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofShareBasedPaymentAwardsOtherthanOptionsValuationAssumptionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected dividend yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r561"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBacksolveValuationApproachTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r560"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofShareBasedPaymentAwardsOtherthanOptionsValuationAssumptionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Historical stock price volatility (high)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofShareBasedPaymentAwardsOtherthanOptionsValuationAssumptionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Historical stock price volatility (low)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofShareBasedPaymentAwardsOtherthanOptionsValuationAssumptionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk free interest rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r562"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofShareBasedPaymentAwardsOtherthanOptionsValuationAssumptionsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Historical stock price volatility (average)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r560"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRestrictedStockActivityandRestrictedStockUnitTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r535",
      "r536",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in Shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total intrinsic value of options exercised",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based awards,description",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Plan Modification, Description and Terms",
        "documentation": "Description of modification of award under share-based payment arrangement. Includes, but is not limited to, terms for expiration date, vesting rights and exercise price."
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563"
     ]
    },
    "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Actual tax benefit for share-based compensation",
        "label": "Share-Based Goods and Nonemployee Services Transaction, Tax Benefit",
        "documentation": "The amount of income tax expense reduction and deferred tax asset recorded in the transaction in which equity securities were issued to pay for goods or nonemployee services."
       }
      }
     },
     "auth_ref": [
      "r199"
     ]
    },
    "wt_SharePriceAsAPercentageOfLastReportedPriceAndConversionRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "SharePriceAsAPercentageOfLastReportedPriceAndConversionRate",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Parentage of sale and conversion price",
        "documentation": "Share price as a percentage of last reported price and conversion rate",
        "label": "Share Price As APercentage Of Last Reported Price And Conversion Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares granted and outstanding, vesting percentage",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "documentation": "Percentage of vesting of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1296"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofBacksolveValuationApproachTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Time to exit (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r559"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock option issuance period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred RSUs that have vested (in Shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares",
        "documentation": "Number of options vested."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance (in Shares)",
        "periodEndLabel": "Balance (in Shares)",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "wt_SharesPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "SharesPercentage",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares percentage",
        "documentation": "Percentage of shares.",
        "label": "Shares Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "wt_SharesRepurchasedDetailsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "SharesRepurchasedDetailsLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares Repurchased [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_SharesRepurchasedDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "SharesRepurchasedDetailsTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares Repurchased (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAdditionalInformationRelatedtoOperatingLeaseTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term lease cost",
        "label": "Short-Term Lease, Cost",
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less."
       }
      }
     },
     "auth_ref": [
      "r679",
      "r1047"
     ]
    },
    "wt_SignificantAccountingPoliciesDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "SignificantAccountingPoliciesDetailsTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_SignificantAccountingPoliciesTablesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "SignificantAccountingPoliciesTablesLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Tables) [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_SignificantAccountingPoliciesTablesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "SignificantAccountingPoliciesTablesTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Policies (Tables) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r272"
     ]
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleNatureOfUncertaintyDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Nature of Uncertainty [Domain]",
        "documentation": "The nature of the uncertainty for which it is reasonably possible that the total amount of the unrecognized tax benefit will significantly increase or decrease within twelve months of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SoftwareDevelopmentMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/GoodwillandIntangibleAssetsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDepreciationandAmortizationTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIntangibleAssetsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Software Development [Member]",
        "verboseLabel": "Software development [Member]",
        "label": "Software Development [Member]",
        "documentation": "Internally developed software for sale, licensing or long-term internal use."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r1076"
     ]
    },
    "wt_SpaAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "SpaAgreementMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SPA Agreement [Member]",
        "label": "Spa Agreement Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofIncomeTaxPaymentsByJurisdictionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State and local [Member]",
        "label": "State and Local Jurisdiction [Member]",
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/CashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r235",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r356",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r437",
      "r441",
      "r444",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r1029",
      "r1181",
      "r1358"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSeriesAPreferredStockBalanceTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofWeightedAverageNumberofSharesTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3",
      "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r246",
      "r247",
      "r248",
      "r274",
      "r301",
      "r302",
      "r312",
      "r316",
      "r322",
      "r323",
      "r396",
      "r455",
      "r457",
      "r458",
      "r459",
      "r462",
      "r463",
      "r495",
      "r496",
      "r498",
      "r499",
      "r502",
      "r651",
      "r820",
      "r821",
      "r822",
      "r823",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r841",
      "r862",
      "r885",
      "r909",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1177",
      "r1210",
      "r1220"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SeriesAPreferredStockDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r49",
      "r232",
      "r259",
      "r260",
      "r261",
      "r280",
      "r281",
      "r282",
      "r285",
      "r293",
      "r295",
      "r321",
      "r400",
      "r406",
      "r503",
      "r569",
      "r570",
      "r571",
      "r597",
      "r598",
      "r619",
      "r621",
      "r622",
      "r623",
      "r624",
      "r626",
      "r636",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r689",
      "r804",
      "r805",
      "r806",
      "r829",
      "r909"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGeographicDistributionofRevenuesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "documentation": "Information by geographical components."
       }
      }
     },
     "auth_ref": [
      "r216",
      "r226",
      "r354",
      "r355",
      "r844",
      "r847",
      "r849",
      "r924",
      "r941",
      "r962",
      "r987",
      "r1000",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1017",
      "r1037",
      "r1053",
      "r1293",
      "r1358"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement",
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r281",
      "r282",
      "r321",
      "r735",
      "r815",
      "r841",
      "r853",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r862",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r872",
      "r873",
      "r874",
      "r875",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r883",
      "r887",
      "r888",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r909",
      "r1054"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShareDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGoodwillTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofBasicandDilutedEarningsPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts."
       }
      }
     },
     "auth_ref": [
      "r296",
      "r533",
      "r1178",
      "r1180",
      "r1219"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement",
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r281",
      "r282",
      "r321",
      "r735",
      "r815",
      "r841",
      "r853",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r862",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r872",
      "r873",
      "r874",
      "r875",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r883",
      "r887",
      "r888",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r909",
      "r1054"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r1086",
      "r1098",
      "r1114",
      "r1142"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "wt_StockBasedAwardsDetailsScheduleofRestrictedStockActivityandRestrictedStockUnitTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "StockBasedAwardsDetailsScheduleofRestrictedStockActivityandRestrictedStockUnitTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRestrictedStockActivityandRestrictedStockUnitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-Based Awards (Details) - Schedule of Restricted Stock Activity and Restricted Stock Unit [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_StockBasedAwardsDetailsScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "StockBasedAwardsDetailsScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-Based Awards (Details) - Schedule of Unrecognized Stock-Based Compensation Expense and Average Remaining Vesting Period [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "wt_StockBasedAwardsDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "StockBasedAwardsDetailsTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock-Based Awards (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockDividendsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockDividendsShares",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofRestrictedStockActivityandRestrictedStockUnitTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock dividends, Shares",
        "label": "Stock Dividends, Shares",
        "documentation": "Number of shares of common and preferred stock issued as dividends during the period. Excludes stock splits."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued in connection with convertible notes that matured on June 15, 2023 (Note 10) (in Shares)",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r48",
      "r85",
      "r172",
      "r481"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesOther",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued in connection with termination of the deferred consideration\u2014gold payments obligation, net of issuance costs (Note 9) (in Shares)",
        "label": "Stock Issued During Period, Shares, Other",
        "documentation": "Number of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted stock issued and vesting of restricted stock units, net (in Shares)",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r133",
      "r134",
      "r172"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of stock options, net (in Shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r133",
      "r134",
      "r172",
      "r546"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSeriesAPreferredStockBalanceTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued in connection with convertible notes that matured on June 15, 2023 (Note 10)",
        "verboseLabel": "Issuance of Series A Preferred Stock",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r49",
      "r172"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSeriesAPreferredStockBalanceTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: Issuance costs",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r133",
      "r134",
      "r172",
      "r829",
      "r909",
      "r996",
      "r1063"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueOther",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued in connection with termination of the deferred consideration\u2014gold payments obligation, net of issuance costs (Note 9)",
        "label": "Stock Issued During Period, Value, Other",
        "documentation": "Value of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "wt_StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification of equity component related to convertible notes, net of deferred taxes of $1,022, upon the implementation of Accounting Standards Update 2020-06 (Note 10)",
        "documentation": "Amount of reclassification of equity component related to convertible notes.",
        "label": "Stock Issued During Period Value Reclassification Of Equity Component Related To Convertible Notes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted stock issued and vesting of restricted stock units, net",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r172"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r133",
      "r134",
      "r172"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of stock options, net",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r49",
      "r172"
     ]
    },
    "us-gaap_StockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockOptionMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options [Member]",
        "label": "Equity Option [Member]",
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option)."
       }
      }
     },
     "auth_ref": [
      "r1053"
     ]
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock purchase authorized amount",
        "label": "Stock Repurchase Program, Authorized Amount",
        "documentation": "Amount of stock repurchase plan authorized."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchaseProgramExpirationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramExpirationDate",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock repurchase program period in force date",
        "label": "Stock Repurchase Program Expiration Date",
        "documentation": "Expiration date for the purchase of an entity's own shares under a stock repurchase plan, in the YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchaseProgramPeriodInForce1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramPeriodInForce1",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock repurchase program period in force",
        "label": "Stock Repurchase Program, Period in Force",
        "documentation": "Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remained future purchases",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "documentation": "Amount remaining of a stock repurchase plan authorized."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares repurchased that were issued in connection with termination of the deferred consideration\u2014gold payments obligation, net of issuance costs (Notes 12 and 23) (in Shares)",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "documentation": "Number of shares that have been repurchased and retired during the period."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r133",
      "r134",
      "r172"
     ]
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares repurchased that were issued in connection with termination of the deferred consideration\u2014gold payments obligation, net of issuance costs (Notes 12 and 23)",
        "label": "Stock Repurchased and Retired During Period, Value",
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital)."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r133",
      "r134",
      "r172"
     ]
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchasedDuringPeriodShares",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3",
      "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Shares repurchased (in Shares)",
        "terseLabel": "Repurchased shares (in Shares)",
        "label": "Stock Repurchased During Period, Shares",
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r133",
      "r134",
      "r172",
      "r823",
      "r909",
      "r998"
     ]
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchasedDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3",
      "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Shares repurchased",
        "terseLabel": "Aggregate cost",
        "label": "Stock Repurchased During Period, Value",
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r133",
      "r134",
      "r172",
      "r829",
      "r909",
      "r998",
      "r1063"
     ]
    },
    "wt_StockholderRightAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "StockholderRightAgreementMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholder Right Agreement [Member]",
        "documentation": "Stockholder right agreement.",
        "label": "Stockholder Right Agreement Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_StockholderRightsPlanDetailsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "StockholderRightsPlanDetailsTable",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholder Rights Plan (Details) [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet",
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders\u2019 equity",
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r137",
      "r138",
      "r158",
      "r864",
      "r882",
      "r910",
      "r911",
      "r1048",
      "r1064",
      "r1212",
      "r1263",
      "r1336",
      "r1364"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders\u2019 equity",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StraightLineDepreciationMethodMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StraightLineDepreciationMethodMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation Method, Straight-Line [Member]",
        "label": "Depreciation Method, Straight-Line [Member]",
        "documentation": "Method of calculating depreciation equally over useful life."
       }
      }
     },
     "auth_ref": [
      "r1277"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r699",
      "r700"
     ]
    },
    "wt_SubtotalFnalityInternationalLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "SubtotalFnalityInternationalLimitedMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInformationaboutVariableInterestsTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInvestmentsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subtotal\u2014Fnality International Limited [Member]",
        "verboseLabel": "Subtotal\u2014Fnality [Member]",
        "label": "Subtotal Fnality International Limited Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Income Tax Payments By Jurisdiction",
        "documentation": "Schedule of income tax payments by jurisdiction [table text block].",
        "label": "Summary Of Income Taxes Paid By Jurisdiction Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "wt_SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/RevenuesfromContractswithCustomersTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Revenues from Contracts with Customers",
        "documentation": "Summary of revenues categorized as revenues from contracts with customers and other sources of revenues.",
        "label": "Summary Of Revenues Categorized As Revenues From Contracts With Customers And Other Sources Of Revenues Table Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosure of cash flow information:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r1135"
     ]
    },
    "us-gaap_TaxesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TaxesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes payable",
        "label": "Taxes Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityAccretionToRedemptionValueAdjustment",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/EarningsPerShareDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofBasicandDilutedEarningsPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Add: Gain on redemption of Series C Non-Voting Convertible Preferred Stock",
        "verboseLabel": "Recognized redemption (in Dollars)",
        "label": "Temporary Equity, Accretion to Redemption Value, Adjustment",
        "documentation": "Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, par value (in Dollars per share)",
        "label": "Temporary Equity, Par or Stated Value Per Share",
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r84"
     ]
    },
    "wt_TemporaryEquityShareOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "TemporaryEquityShareOutstanding",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance (in Shares)",
        "documentation": "Temporary equity shares outstanding.",
        "label": "Temporary Equity Share Outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquitySharesAuthorized",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized",
        "label": "Temporary Equity, Shares Authorized",
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquitySharesIssued",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares issued",
        "label": "Temporary Equity, Shares Issued",
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquitySharesOutstanding",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares outstanding",
        "label": "Temporary Equity, Shares Outstanding",
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityValueExcludingAdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock\u2014Series A Non-Voting Convertible, par value $0.01; 14.750 shares authorized, issued and outstanding; redemption value of $96,869 and $77,969 at December 31, 2023 and 2022, respectively) (Note 11)",
        "label": "Temporary Equity, Par Value",
        "documentation": "Carrying amount of the par value of temporary equity outstanding. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r84"
     ]
    },
    "wt_TemporaryStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "TemporaryStockholdersEquity",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ShareholdersEquityType2or3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance",
        "documentation": "Temporary stockholders equity.",
        "label": "Temporary Stockholders Equity"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ThirdInstallmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ThirdInstallmentsMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Third Installments [Member]",
        "label": "Third Installments Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ThirdPartyDistribution": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ThirdPartyDistribution",
     "crdr": "debit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Third-party distribution fees",
        "documentation": "Third Party Distribution.",
        "label": "Third Party Distribution"
       }
      }
     },
     "auth_ref": []
    },
    "wt_ThirdPartyDistributionFeesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "ThirdPartyDistributionFeesPolicyTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Third-Party Distribution Fees",
        "documentation": "Disclosure of accounting policy related to third-party distribution fees.",
        "label": "Third Party Distribution Fees Policy Text Block"
       }
      }
     },
     "auth_ref": []
    },
    "wt_TimeToPotentialOutcomeinYear": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "TimeToPotentialOutcomeinYear",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofPresentstheProbabilityAscribedtoPotentialOutcomesUsedinthePwermTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Time to potential outcome (in years)",
        "documentation": "Time to potential outcome.",
        "label": "Time To Potential Outcomein Year"
       }
      }
     },
     "auth_ref": []
    },
    "wt_TimeToPotentialOutcomesinYears": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "TimeToPotentialOutcomesinYears",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofPresentstheProbabilityAscribedtoPotentialOutcomesUsedinthePwermTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Time to potential outcome (in years)",
        "documentation": "Time to potential outcome.",
        "label": "Time To Potential Outcomesin Years"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofUnrecognizedStockBasedCompensationExpenseandAverageRemainingVestingPeriodTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "documentation": "Information by title of individual or nature of relationship to individual or group of individuals."
       }
      }
     },
     "auth_ref": [
      "r1222",
      "r1340"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/DeferredConsiderationgoldpaymentsDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "documentation": "Title of individual, or nature of relationship to individual or group of individuals."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1127"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r1134"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r1155"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r1157"
     ]
    },
    "us-gaap_TradingGainsLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TradingGainsLosses",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/FinancialInstrumentsOwnedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net trading losses",
        "label": "Trading Gain (Loss)",
        "documentation": "Amount of gain (loss) resulting from the difference between the acquisition price and the selling price or fair value of trading assets and trading liabilities, conducted separately from customer trading activities. Includes, but is not limited to, changes in fair value of trading assets and trading liabilities."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r120",
      "r122",
      "r195"
     ]
    },
    "wt_TradingSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "TradingSecuritiesMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFinancialInstrumentsOwnedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Securities [Member]",
        "label": "Trading Securities Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofFinancialInstrumentsOwnedTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSummarizesImpairmentsRecognizedTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r489",
      "r501",
      "r627",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r777",
      "r1185",
      "r1186",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1258",
      "r1259",
      "r1260",
      "r1261"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r1158"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r1159"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r1157"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r1157"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r1160"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r1158"
     ]
    },
    "us-gaap_TreasuryStockTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchased"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares Repurchased",
        "label": "Treasury Stock [Text Block]",
        "documentation": "The entire disclosure for treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "wt_TwoFinancialInstitutionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "TwoFinancialInstitutionsMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/CashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Two Financial Institutions [Member]",
        "documentation": "Two Financial Institutions Member.",
        "label": "Two Financial Institutions Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_TwoThousandAndTwentyNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "TwoThousandAndTwentyNotesMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConvertibleNotesDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofConvertibleNotesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2020 Notes [Member]",
        "verboseLabel": "Two Thousand And Twenty Notes [Member]",
        "documentation": "Two thousand and twenty notes.",
        "label": "Two Thousand And Twenty Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_TwoThousandAndTwentyThreeNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "TwoThousandAndTwentyThreeNotesMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofConvertibleNotesTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofKeyTermsofConvertibleNotesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023 Notes [Member]",
        "documentation": "Two thousand and twenty three notes [Member].",
        "label": "Two Thousand And Twenty Three Notes Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_TwothousandandtwentyonenotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "TwothousandandtwentyonenotesMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofConvertibleNotesTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofKeyTermsofConvertibleNotesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021 Notes [Member]",
        "documentation": "TwoThousandAndTwentyOneNotes.",
        "label": "Twothousandandtwentyonenotes Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfAdoptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TypeOfAdoptionMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update [Domain]",
        "documentation": "Amendment to accounting standards."
       }
      }
     },
     "auth_ref": [
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r284",
      "r285",
      "r286",
      "r287",
      "r296",
      "r359",
      "r360",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r438",
      "r569",
      "r570",
      "r571",
      "r595",
      "r596",
      "r597",
      "r598",
      "r607",
      "r608",
      "r609",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r648",
      "r649",
      "r652",
      "r653",
      "r654",
      "r655",
      "r664",
      "r665",
      "r668",
      "r669",
      "r670",
      "r671",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r737",
      "r738",
      "r739",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r611"
     ]
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TypeOfRestructuringDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofSummarizesImpairmentsRecognizedTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Type of Restructuring [Domain]",
        "documentation": "Identification of the types of restructuring costs."
       }
      }
     },
     "auth_ref": [
      "r439",
      "r440",
      "r442",
      "r443"
     ]
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "US",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofDomesticandForeignComponentsofIncomebeforeIncomeTaxExpenseTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofGeographicDistributionofRevenuesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States [Member]",
        "verboseLabel": "U.S. [Member]",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "USTreasurySecuritiesMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAssetsandLiabilitiesMeasuredatFairValueTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. treasuries [Member]",
        "label": "US Treasury Securities [Member]",
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years)."
       }
      }
     },
     "auth_ref": [
      "r1022",
      "r1038",
      "r1040",
      "r1352"
     ]
    },
    "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofBasicandDilutedEarningsPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: Undistributed income allocable to participating securities",
        "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Basic",
        "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method."
       }
      }
     },
     "auth_ref": [
      "r310",
      "r313",
      "r314"
     ]
    },
    "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofBasicandDilutedEarningsPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: Reallocation of undistributed income allocable to participating securities considered potentially dilutive",
        "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted",
        "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method."
       }
      }
     },
     "auth_ref": [
      "r310",
      "r313",
      "r314",
      "r1176"
     ]
    },
    "wt_UndistributedIncomeAllocableToParticipatingSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "UndistributedIncomeAllocableToParticipatingSecurities",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofBasicandDilutedEarningsPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Add back: Undistributed income allocable to participating securities",
        "documentation": "Undistributed income allocable to participating securities.",
        "label": "Undistributed Income Allocable To Participating Securities"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r1154"
     ]
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrealizedGainLossOnInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedCashFlow",
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Losses on financial instruments owned, at fair value",
        "terseLabel": "Recognized gain (loss) (in Dollars)",
        "label": "Unrealized Gain (Loss) on Investments",
        "documentation": "Amount of unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrealizedGainLossOnInvestmentsTableTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SecuritiesHeldtoMaturityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Unrealized Losses, Gains and Fair Value of Securities Held-to-Maturity",
        "label": "Unrealized Gain (Loss) on Investments [Table Text Block]",
        "documentation": "Tabular disclosure of unrealized gains and losses on investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesDetails",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "terseLabel": "Unrecognized tax benefits",
        "label": "Unrecognized Tax Benefits",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r573",
      "r582"
     ]
    },
    "wt_UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation",
        "documentation": "Amount of increase in unrecognized tax benefits and interest/penalties resulting from foreign currency translation.\" through out the disclosure as per the table structure.",
        "label": "Unrecognized Tax Benefits And Interest And Penalties Increases Resulting From Foreign Currency Translation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Decrease\u2014Settlements",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities."
       }
      }
     },
     "auth_ref": [
      "r584"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized tax benefits and interest and penalties",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r581"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increases",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return."
       }
      }
     },
     "auth_ref": [
      "r583"
     ]
    },
    "wt_UnrecognizedTaxBenefitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "UnrecognizedTaxBenefitsMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized Tax Benefits [Member]",
        "label": "Unrecognized Tax Benefits Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "crdr": "debit",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofChangesinBalanceofGrossUnrecognizedTaxBenefitsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Decrease\u2014Lapse of statute of limitations",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations."
       }
      }
     },
     "auth_ref": [
      "r585"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/AccountingPoliciesByPolicy"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r69",
      "r70",
      "r203",
      "r204",
      "r206",
      "r207"
     ]
    },
    "us-gaap_VariableInterestEntityDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityDisclosureTextBlock",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/VariableInterestEntities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entities",
        "label": "Variable Interest Entity Disclosure [Text Block]",
        "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss."
       }
      }
     },
     "auth_ref": [
      "r182"
     ]
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityLineItems",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofInformationaboutVariableInterestsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Information about Variable Interests [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r612",
      "r613",
      "r614",
      "r615",
      "r715",
      "r716",
      "r717"
     ]
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableInterestEntityOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityOwnershipPercentage",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/InvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership interest percentage",
        "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage",
        "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly)."
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "us-gaap_VestingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VestingAxis",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting [Axis]",
        "documentation": "Information by vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1296",
      "r1297",
      "r1298",
      "r1299",
      "r1300",
      "r1301",
      "r1302",
      "r1303",
      "r1304",
      "r1305",
      "r1306",
      "r1307",
      "r1308",
      "r1309",
      "r1310",
      "r1311",
      "r1312",
      "r1313",
      "r1314",
      "r1315",
      "r1316",
      "r1317",
      "r1318",
      "r1319",
      "r1320",
      "r1321"
     ]
    },
    "us-gaap_VestingDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VestingDomain",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/StockBasedAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting [Domain]",
        "documentation": "Vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1296",
      "r1297",
      "r1298",
      "r1299",
      "r1300",
      "r1301",
      "r1302",
      "r1303",
      "r1304",
      "r1305",
      "r1306",
      "r1307",
      "r1308",
      "r1309",
      "r1310",
      "r1311",
      "r1312",
      "r1313",
      "r1314",
      "r1315",
      "r1316",
      "r1317",
      "r1318",
      "r1319",
      "r1320",
      "r1321"
     ]
    },
    "srt_WeightedAverageMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "WeightedAverageMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofValuationofDeferredConsiderationTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average [Member]",
        "label": "Weighted Average [Member]",
        "documentation": "Average of a range of values, calculated with consideration of proportional relevance."
       }
      }
     },
     "auth_ref": [
      "r1013",
      "r1014",
      "r1344",
      "r1346",
      "r1349"
     ]
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofBasicandDilutedEarningsPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dilutive effect of common stock equivalents, excluding participating securities (in Shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation."
       }
      }
     },
     "auth_ref": [
      "r1221"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofWeightedAverageNumberofSharesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average common shares\u2014diluted (in Shares)",
        "verboseLabel": "Weighted average diluted shares as disclosed on the Consolidated Statements of Operations",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r300",
      "r316"
     ]
    },
    "wt_WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofBasicandDilutedEarningsPerShareTable",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofWeightedAverageNumberofSharesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average diluted shares, excluding participating securities (in thousands) (in Shares)",
        "verboseLabel": "Weighted average diluted shares used to calculate diluted earnings/(loss) per share as disclosed in the table above",
        "documentation": "Weighted average number of diluted shares outstanding excluding participating securities.",
        "label": "Weighted Average Number Of Diluted Shares Outstanding Excluding Participating Securities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedIncomeStatement",
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofReconciliationofBasicandDilutedEarningsPerShareTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average common shares\u2014basic (in Shares)",
        "verboseLabel": "Weighted average common shares (in Shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r298",
      "r316"
     ]
    },
    "wt_WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofWeightedAverageNumberofSharesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average shares of common stock issuable upon conversion of the Preferred Shares",
        "documentation": "Weighted average shares of common stock issuable upon conversion of the preferred shares.",
        "label": "Weighted Average Shares Of Common Stock Issuable Upon Conversion Of The Preferred Shares"
       }
      }
     },
     "auth_ref": []
    },
    "wt_WisdomTreeProductsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "WisdomTreeProductsMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "WisdomTree Products [Member]",
        "label": "Wisdom Tree Products Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_WisdomtreeETFMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "WisdomtreeETFMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ConsolidatedBalanceSheet_Parentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "WisdomTree ETF",
        "documentation": "WisdomTree ETF.",
        "label": "Wisdomtree ETFMember"
       }
      }
     },
     "auth_ref": []
    },
    "wt_WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/ScheduleofAccountsReceivablefromRelatedPartiesTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivable from WMAI and WTICAV [Member]",
        "documentation": "Wisdomtree Multi Asset Issuer plc And Wisdomtree issuer icav",
        "label": "Wisdomtree Multi Asset Issuer Plc And Wisdomtree Issuer Icav Member"
       }
      }
     },
     "auth_ref": []
    },
    "wt_WorldGoldCouncilMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.wisdomtreeinvestmentsinc.com/20231231",
     "localname": "WorldGoldCouncilMember",
     "presentation": [
      "http://www.wisdomtreeinvestmentsinc.com/role/SharesRepurchasedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "World Gold Council [Member]",
        "label": "World Gold Council Member"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r1166"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "940",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "4",
   "SubTopic": "50",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482610/350-50-25-4"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-6"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "7",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-7"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "SubTopic": "40",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482633/350-40-30-1"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "7",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "8",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "SubTopic": "405",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-1"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "835",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "30",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c),(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2C",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2C"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "e",
   "SubTopic": "470",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "a",
   "SubTopic": "10",
   "Topic": "280",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "60",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482053/820-10-60-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(27)",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "320",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//320/tableOfContent"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "((a)(1),(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "460",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481244/470-50-50-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB TOPIC 4.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-5"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b),(f(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-6"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-9"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4F"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "940",
   "SubTopic": "320",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481992/940-320-35-3"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "940",
   "SubTopic": "320",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481961/940-320-45-2"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "940",
   "SubTopic": "320",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481961/940-320-45-5"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "320",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-5"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//205/tableOfContent"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4,6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7,9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//350/tableOfContent"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//360/tableOfContent"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//470/tableOfContent"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481284/470-20-25-10"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-5"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r171": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7"
  },
  "r172": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r173": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505-30/tableOfContent"
  },
  "r174": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r175": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r176": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r177": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r178": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r179": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r180": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r181": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r182": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//810/tableOfContent"
  },
  "r183": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r184": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r185": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r186": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A"
  },
  "r187": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r188": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r189": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r190": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r191": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r192": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r193": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r194": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r195": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.13(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r196": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.14)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r197": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r198": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r199": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "210",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-20"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "35",
   "Topic": "720",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//606/tableOfContent"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column G",
   "Publisher": "SEC"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column H",
   "Publisher": "SEC"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column I",
   "Publisher": "SEC"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "5",
   "Subsection": "04",
   "Paragraph": "c",
   "Subparagraph": "Schedule I",
   "Publisher": "SEC"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "7",
   "Subsection": "05",
   "Paragraph": "c",
   "Subparagraph": "Schedule II",
   "Publisher": "SEC"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "9",
   "Subsection": "06",
   "Publisher": "SEC"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(210.5-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-6"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//260/tableOfContent"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-42"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "65",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-65"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "66",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-66"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//350-20/tableOfContent"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-2"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147477123/405-50-65-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450-20/tableOfContent"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450-30/tableOfContent"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483049/450-30-50-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//715/tableOfContent"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(r)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480126/715-20-S99-2"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-3"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//830/tableOfContent"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//842-20/tableOfContent"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//850/tableOfContent"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//855/tableOfContent"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "35A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(h))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-3"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-21"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column B)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "12",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-12"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "19",
   "Subparagraph": "(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "19",
   "Subparagraph": "(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "19",
   "Subparagraph": "(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5D",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5D",
   "Subparagraph": "(SX 210.12-13D(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5D",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r979": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r980": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r981": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r982": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r983": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r984": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r985": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r986": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 5)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r987": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r988": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r989": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r990": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r991": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r992": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r993": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r994": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r995": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
  },
  "r996": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r997": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r998": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r999": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481058/954-310-45-1"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "450",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480598/954-450-50-1"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482663/740-10-55-217"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479908/805-50-55-1"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation",
   "URI": "www.leiroc.org",
   "URIDate": "2013-08-21"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii",
   "Section": "6"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r1167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r1168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r1169": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r1170": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r1171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r1172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r1173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r1174": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r1175": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r1176": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60"
  },
  "r1177": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r1178": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10"
  },
  "r1179": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-11"
  },
  "r1180": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3"
  },
  "r1181": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4H",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H"
  },
  "r1182": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r1183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Topic": "321",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//321/tableOfContent"
  },
  "r1184": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Topic": "325",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//325/tableOfContent"
  },
  "r1185": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r1186": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r1187": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r1188": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r1189": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r1190": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r1191": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r1192": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "11",
   "Subsection": "03",
   "Publisher": "SEC"
  },
  "r1193": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r1194": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r1195": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r1196": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r1197": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1198": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1199": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1200": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1201": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r1202": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r1203": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r1204": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r1205": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(b)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r1206": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r1207": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r1208": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r1209": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r1210": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r1211": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r1212": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r1213": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r1214": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r1215": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r1216": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r1217": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r1218": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r1219": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r1220": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
  },
  "r1221": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r1222": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13"
  },
  "r1223": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2"
  },
  "r1224": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1"
  },
  "r1225": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-2"
  },
  "r1226": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-4"
  },
  "r1227": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//320/tableOfContent"
  },
  "r1228": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11"
  },
  "r1229": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r1230": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r1231": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r1232": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r1233": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r1234": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r1235": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r1236": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r1237": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r1238": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r1239": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r1240": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r1241": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r1242": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r1243": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r1244": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r1245": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r1246": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r1247": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r1248": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r1249": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r1250": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r1251": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r1252": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r1253": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r1254": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r1255": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r1256": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r1257": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r1258": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
  },
  "r1259": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r1260": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r1261": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r1262": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1"
  },
  "r1263": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r1264": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1"
  },
  "r1265": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1266": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1267": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1268": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1269": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1270": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1271": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1272": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1273": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r1274": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A"
  },
  "r1275": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2"
  },
  "r1276": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-5"
  },
  "r1277": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r1278": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r1279": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1"
  },
  "r1280": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r1281": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r1282": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r1283": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r1284": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483049/450-30-50-1"
  },
  "r1285": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r1286": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r1287": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r1288": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r1289": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r1290": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r1291": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r1292": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r1293": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r1294": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r1295": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r1296": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1297": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1298": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1299": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1300": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1301": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1302": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1303": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1304": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1305": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1306": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1307": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1308": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1309": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1310": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1311": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1312": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1313": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1314": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1315": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1316": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1317": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1318": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1319": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1320": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1321": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r1322": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r1323": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r1324": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r1325": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r1326": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6"
  },
  "r1327": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r1328": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r1329": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r1330": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480060/805-50-25-1"
  },
  "r1331": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-1"
  },
  "r1332": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-2"
  },
  "r1333": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r1334": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r1335": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r1336": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r1337": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479365/842-20-25-6"
  },
  "r1338": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r1339": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r1340": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r1341": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3"
  },
  "r1342": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r1343": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r1344": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1345": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1346": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r1347": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1348": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1349": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r1350": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1"
  },
  "r1351": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(13)(g))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r1352": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2"
  },
  "r1353": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1354": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1355": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1356": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1357": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r1358": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r1359": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r1360": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r1361": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r1362": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r1363": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r1364": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r1365": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r1366": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>151
<FILENAME>0001214659-24-003435-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001214659-24-003435-xbrl.zip
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MTDO5M8X*H(89#$WC>B6Q*GC]\-/1Q?@J\(L(CLKATT]'0!+CJ/!A@G4H^8)
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MJA.]'K=O'_(T^E7V<<O(UCO@<=M0\8B,>. ].>Q(!&Q0SE&I0YL=72+!!1H
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M3@/@:'D0+50U*-#M;" JL'+!-T8%#"#?&!6(@DN-,;H9H J>U43: EF OKW
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MDC:,HL)QF< GCQ(>2\S1$BK4CQF<[)"=)^D7ZVZG*JJIK:+"0P)(U/&X$G0
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MS^D"(XN.%I5^,+7ZFP>C@C^M307O JK^R)S;Z\PM+E?R$]_Q(AH\:B43UHS
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M,M_K#R>_P%_OAN]/C_X?4$L#!!0    ( .Q]5UBH%L)!U08  "G0   *
M97@R,2TQ+FAT;>V=6V_:2!B&KU.I_V%$U6I7"HE)VFX#%"D!&FC)0>!V-U?5
M8 ]D6MMCC8<0]M?O^!@#39NN$FDLO1?$GL&>P_L='@_8H3VPST:=Y\_:@_YQ
MK].VA_:HWVGOY]ND]ODSTCZYZ%V1B7TUZK^O^53.>="T6B%U71[,]=Y42)?)
M^I*[ZEH7%;M5]6^+2/'9JJXD]YLD7 2.6E#%1= B60O$:I&\#=*P0M6J==J]
MX9>'=Y1NWUI6>-LJ&B5TH81NZOFSG:2U[NAX,GE?^\K=4Q9<3+\Q1TW4RF,7
M-TQ*[K)ZH_;P'M>+R9!U/SOMR[R;P<%OM#83@:K/J,^]5=/F/HO(.5N2L?!I
M0"XG9*+<71(QR6?ID1'_ES43H=)B/(MF(*1/O;3FADI. [56MV1\?JV:4^&Y
MF4;UJ5!*^+K_K.RQF;HKR>3XHJA$V&P<Z#Z%#*]I$#6/CO2$YJP^E8Q^K].9
M8K));P1WR]53-A.2-1-3).Y /3X/FIE3I%4\<%F@4C.*9=1LE(],1K$U!NT@
M'R[.[5SL$SVI0NY[-"G/O];IWU[S*5?DH+'7:._';6DWOX0-G\2&CGZ+R<<W
MXF0QC;C+M5!:;3$CZIJ1,9OS2$FMW*99[>.343_O[%S4;3KU6#U) 46WJ3%U
M$K+VK)<MDIG8$9Y'PX@U2;Z7OZ733'A+(N%QE[RP+*LX)6LHMF^1YF)KZ[24
M;K*$L7/W1X]P_./AD31G)35CL>P*;^$']=?%J*]353)1T\9T:[V\-?ND.#0;
M7NHUI?25U<?>LUV;>-%VM39DJ3(+C-PA#TM5B4^6*U*W+-?$3A&7=2Y6W*%>
MYCEI8^L-65L-6=LGZO8R*I W!WM'1R]+B+%XD+P.M>GTMK5MLC65FF2IO5LL
M8X<F#6V[0 2% ^1*IJZ:>D*K1KX<CX:GY^]K>AB%07;R[5V"L;N#K_&<GCC-
MO'N:+/,V5.MYYC!<R]16D68:/\@R<3;Y=9*).[HOPZQEO,?()^?49W$>*?+*
M:B.'Q,;;MWL(L8T0:^P=O/N]"%M><\7J44@='36!6$H:;H;-JQ>WED6M%A3_
M@>*OW^S]=6A"4D,R>_QD=K@YED?);A\7DD<N=^*U5YSEAH&CIR1DLAC[::+3
MN^,.KE%^,YP?]8KDU]&GW4K%XG^-<ZF9ZY:LZF=AF+1\_^+E2:*PGG1:1&*M
M\[>.$^';DK&<0<=1Q%1>.*.![L37I^[F53J6]G"1@(L$LQ3_'Q<)#\\SE4TQ
MVW1][ SSBT]&:IT>\^B22@;< K? [39NA_'GA4%R84J]O/)4BD6X2X!:H-8\
MQ8%:H!:H!6HK@UK2XW.NJ$>ZPO>%R]6*3)B\X0Z+=LEHU 5B@5BS% =B@5@@
M%HBM'F('PHOEB[!X!5E-5!QD!5E!5I"U>F0M?14+MH*M!BH.MH*M8"O86AVV
M3IBSD%QQAO4JF&JDXF JF JF@JG586JQ7A4W6*V"K,8J#K*"K" KR%H=LMI2
M=S9C$HM5(-5(Q8%4(!5(!5*K@]1\L6I+'4+Q_<$A#5:X*1AT-5!QT-50NNKI
MYXY[)>1W0!:0!60?^*1K?K\P&2D7R 5RS5(<R#44N9\#[=@N^:35TED&Q 5Q
M0=QMXO874H1L$[5Y><3].(A 75#7+,5!74.I^Y')B*U 6] 6M.U[S%&2$EMW
MS%3RW&M7$# 53#52<3 53 53P52CF5KZ8K;X7/B/-$#^!%J!5C,5!UJ!5J 5
M:*T*6N_^D028"J::J3B8:BA3AY)Y-+@G8P"J@"J@FEYV@JU@JYF*@ZV&LA7K
M5:#5@$@P#JT+3W&2_"P=UJ[@J_&*@Z_@*_@*OE:%KY\_@:5@J9F*@Z6&LA0/
MX("I!D6$:4Q-G[S!0ZU@JGF*@ZE@*I@*IE:-J=FM!UBL JQF*@ZP&@I6W+0$
MHIH0"J81]8S%__OP[D=P@%:@U4S%@59#T8KO5$%6 R+!-+)VA>\+EZL5Z JZ
M&J\XZ JZ@JZ@:U7H.F#NG+F +"!;(<4!64 6D 5DJP+9#[H%?1+IWSJZVSD#
M64%6,Q4'64%6D!5DK0I9L^4KOGT%8*NA.  +P *P &Q5 #N,H@63>4K_!V %
M6,U4'& %6 %6@-5HL)X*SR4G"\_C(L!R%50U7G%0M=)4C?_HTO')J-])]WO#
M+_%>4B@L,AX/*FL+ZXDMX;#XM[;O,T2F%M'ST_&@7]F.BD-FHT-"O25=12VR
MED?TN?J,2'C<;9'2V'5+>TD[:]-+8HZLZ[%Y9")+>F!I'B2;"+DS2G%BV:(D
M,:FV:&+0RXDV9WW,Y@N/ZG,=X0D]D:E'G>^M<NI,W3!QK-3'VOLG%[TKO1G8
M9Z/.?U!+ P04    " #L?5=8-PE0$.H#  #P#@  "@   &5X,C,M,2YH=&WM
MEVUOVS80QU\W0+[#P0.*%HACR5Z#578-Y,%&TGFI81LK\FJ@I)/-12(UDHKM
M??H=*5E1TGKPN@T;BL(Q+%+'>_K]Q8B#Z\5/D^'QT>!Z='XU'"QN%I/1<-#9
M_;K9XR,87'RXNH/YXFXR>M?*F%IR$7C]G,4Q%TNZ"J6*4;77/#8K&AK<F/:O
MA38\V;:-XED >2$B4S##I>A#Y0&\/NQ\@._EIM\:#JYN?CX\4/E[YGGYIE\[
M!5882:Z.CUXX;Y>3\_G\7>N":1ZU%S:UL6(9M@X/4PVUV:88:)GRN'3_8C#=
M>;_N_@5_B12FG;",I]M@P3/4<(MKF,F,"9C.86[B$]"H>%)::OX[!JX_Y="E
M(:3*6%K./##%F3!/YM;(ERL3A#*-J]:T0VF,S"A^-4XQ,8\CY>SKH9%YX'<I
MIE3YB@D=O'U+!2VQ'2ID]VV6&%0!>Y#4B\9TB(E4&#@"3@4LY4L15%HHI[B(
M49B2GESKP&]:NBP^R8%T,?YPNZA14E%UN_?TI%E_:SC:K'C(#71[I_Z@8WV1
MNJ?/&?I?.T/_RQ%&Q S5/H+_.+!+*33% )G #47+T86$&2ZYICPPAFD1ICR"
M\RB2A3#$",9<97OAV@?_ER0M].K_";F:^E+,9PW*W<]0MC3_YG/::UK:A)['
M;PT_(D05."/!K!"XB"@MJ=S.#^$6%":$3T3VEK,HD58&<\,,9K1> XW&U).7
MWVT\CWG]^1-!">GJ: W;/U3$X=6M/-T9]WJ]/>9=GS[U&B;B Y:<G?6ZNUWC
M->2H#./""JZJ$7\KN-E"GE+SK6 _<AW+;*$03TB\T2DD/"7!KKE9.?LY1H7B
MAI.<* $8;2+"MD2XE%G&M;9]H+_WA<!=<EWO!+J>?^;LWQ?IMK[QQM[H=FU8
M62CJ+O6:FA=3&V,88Z@*IAZM>\[Z^Y,R%X4ZQZA&9<G9_VUN:<(%$Q%G*>@&
MDL_49C.:%Z'F,2=Q5R6YKB0).></*%"[I=QN(((\4B"C9 KR 54C4)F[[>M!
M<4A9:1%3JDY'7,.Y$ 6YF3DW\*HI'M_;P_;'&BL]#R[M+3(%=K>)X0HCS$)4
MM41\U[[>Z;?=Y=_873[933JZ R,EM-D!>,FRO ]WM-\O83*9?L/PGVSRU)T=
MD#NI[D_@V<3@8C;<M_/4R#KT9FZOGO*;S:Z_2G#>G[Z!'8;MD!<P=XS:@/U6
M%\8>L9X%!):NV5;WH>IG50[XM*(\W4 C=_)TZOP\*0\\7A_D'AT\M71M*0T;
M=4!5"#Q"J1<VB8)#2D0=T.F<<+;I7:%(&:V-9"JID#!ET3U)<B>SG;R<L$J-
M#3KV[&K/LO:D^P=02P,$%     @ ['U76"QQ@[2O"0  F%$   H   !E>#,Q
M+3$N:'1M[5QM4]NX%O[<SO0_:+*S.S"3@!.@2Q,V,U#HEEUN82#3._NIH]AR
MHJTL>24Y(??7WW,D.W%>8$/+#7#7'R"QK)>C<YY'YY&CY.AC[U\7W3>OCSZ>
M'9]VCWKGO8NS[M%N\>I*W[PF1R>7IW^0F]X?%V>_U!*J!URV@TY*HXC+ ;SK
M*QTQW1CSR [ATK);V_@S,Y;'DX;5/&F3-).AS:CE2G9(W@,).J3H@S2#U'9J
MW:/3\\_K#^1?WP9!>MN9=DIH9A5T]>;U*]?;^XOCFYM?:E]X]"N3E_T_66AO
M[$2PRQ'3FD>LT:RM/^+\I3,9QGEU=%4,\['U@-YB)6TCI@D7DW:/)\R03VQ,
MKE5");FZ(3<VJA/#-(]]3</_P]K.4?X29]&62B=4^)(1U9Q*.U<V9GPPM.V^
M$E'NHT9?6:L2&#^_%BRVLROMZD\OK4K;S1:,J70ZI-*TW[V#"0U8HZ\9_=J@
ML66Z34>*1^7B/HN59FT7"@<'*OA MG-0^"(N(R:M#Z,:FW:S7--9L60# .3#
MY:=>X>P3F-34W7?XI#S_6O?L=LC[W)*]YD[S:!?[ IA?+<;P(8AXD3%L?GL(
M0X@9TW=%\-$#]IYI0 P/W=)Q9\1Z8,V76&1F^#PCEQ=]:^S>ED+76A$Z#-%W
MDF]O5<T%$VK=\SKY34EJP1+P#^.RS_2@3D(7I F!<MM>CLZGBR_)BXU+:S^U
M]X3F\%%"@R/-Q:7AAIW&9B$02W%I[GB:Y3[VGB0MS(L1-ZF@DS;A4G )=@@5
M?H4F/_UP&P0TZ*S[FG/OG SIB!'-1IR-600AYX90*3,JH#!5VA(ER0?P:]&P
M&<PM 5(Y3]2ZC=_S+HF*R;^YB532TXS5R;D,=SH5BC:/HM;&4'1"#6 '@)),
MR%>IQH)% XB\ U..HDA!R*2R) 1/4RX!9!.22:LS1HREEB4P0X0.!3T)3N(
MP)B&4*2)2B#%6^7K+560+&3&4#W!*@G]RF#<4I\&RB(P!H84&"D< RN$7(=9
M M4D- =+ &QD/.3AD)@,_\W:CYEF>2<X@80;P2BBE(RY'<($30HB%$?'?E,P
M344P3="CX)3^I.R&B@=/P(.]I^<!(S&7@#0$[0Q9=2 !5(?;NG2?RQ@=CP()
MWH<BBZ!/0&\)1G5 /M=B0E( '_(&^23$C!@Y)LW"T,"]B&/'=:R1":@ ;%
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MW_IW+I*I$?NO-*&*!UJ()CM)@LU^#:L' *ONO<'JD!N "<B)9^QSHJ:1""\
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MM,RE(_C\+IKS=$;4+>#!#N#X>/XVU&8W,;PG&*L<9P3:!.KV_(?C%P-4/>X
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MM0(/!'P/-RN:0>AS[XJ#V0$@]A1F:\< :F?@2!/X G@C'](VXX+<(]POTY2
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M=-,NJ1*TFS:F-#[H>U+2;.#<-JRKVL*@Z&Y-H034NB+GZW^$@!U\=\\SFZJ
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M-2)C64ZD<4V*1X 2^8K#,@^8[9"O3MVJ",:]X'2\A=^ 3T\,ZIP)9NU.C\B
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MP7P?P9Y<E+MV'73SCH[!H570WO;'WA&@ Z #__V310)QW7:".3B#G/[:0XZ
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M\*V,NX]6!<A <J\Q94*$NJCV#!336-!W$UD="#E[N:A0)=JW#Y[?.:1C:,
M*__TD[TV_P-WWE1'\-932TOY+A.MOJ+0DM";SEI7>('5ML9,:N_:U%='DIUH
MH_C=LHAT-B+R.OA](D*JOH4'*BA#F"JW*?VBY-WL:?G:C?/R^Q6;#.UJREBM
MZ] -+1.16,D?0-FS #,NYS,)SD0D#;.;SP(U+J/V6%3-VG\\I?Z' _L=Q=\1
MZ)QG\FROQ][8J*!'K!!3ZT_'E'*4A=EZ1IV<=0GD5#/EN#VBIB%X05723?BM
M0Y;[N#8UH#$UOD!/S7Q#W$Q^G4\("-Q6%B@NUH5"[6G,R6:Z8BX'=*Z6T/&A
MRH-0 70I]S8/[ ]\Z)5#@L2Z0C=WFZ%G-6LNIB3=>.&GYSVT)&''E\3B,W2!
MIO\C8E-A1/ 9(YX%0MHNK9#R6@<=-E0E&P+F.QNCLGD21Y;@F8,K'76R2;57
M,\^A#!3%W47&0^P9E1'0FMPDAD]13CR@W/8QIFV#ZM??CZ>JF_)6_?HG0@MM
MT(VW&<_MH28)ID1!>GPA037J^7$4"P3_:;=$1C0_>O#I6,%5<8=CSZ0!3RT)
M0$RZ$RG+U\)9($"O)=PNU:8(P+,DF5RQ0S80 G@]XZ2Y8>"' 3^"\I@W [W<
MTUU8VG.J0B#(8+;6]SWC1>1EI\@50?$EP?CLC@A>]LM?)#B **@Z30]G8#!
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MKP_6J]>4-)JM"7:')Y]JR&PW&NZ,Z-)^T3:@!C$[XWXOG2\M%Q6?_V<"Z:J
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MLG1QLBZ=GT)[@[.:NBKK5\=5AW(LD,[(#K8_HW<><L9A;QHVP!^?[6/\BZS
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M!_Z_ !#8[@ _"R0JPS3;+6"!-%@@\U)].C/T%!&$F+OO!67HI")W!^T;AL+
M*>;W!2\8>FR'_1W*U3\76'K- B&AF_KC0IV1T_=[QVRX= SKU-T8583(O$89
MS[=^)E6"H4_S\TO&![FKRHM]31Q$/G]\?N31A+@LI/+&P %]5S^@/[9?Z3H-
MHQNS0.*8>+7TH8K64>3E8,0TU#Y0G;&:V?:6>E0[A"(J?$ADN[[(WU0XU]8(
M*GSNW9_N$#MLRVF53-W@1PXW !="4<E%JT S!P:'R</M?L 3THL;=1&R#;.,
M[XI>(W1H$ITW AMP=@VWTK"1,;X]\/"#P[Q=@<RP=%1FQ/%UVH]^#D,(5\Z
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MC*XCTBPAD&N/Z8\9NN/B!E/Q]7-'!U!YLA8Y,5*-S1.^E9:1 HG1D-HK;%N
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MG^L"'=F$8UWF\ /'-F$'<GN@9Y@$PPM"1_B%+6KW](EG#S9,!5].G*2>#$S
M?]FOI)[S=^  (21^T%"#_Y>]4)B[HJLX0(8)7\AXJ: MMA?V!)U5+BB7<< W
M%/087@*MV#Q8P$*?XDL4B5DN_+S$T-CK*<YXX^#-.B66>U%QO'M*5<>$#77"
M ?U>\/.%"?C4T>_+B4'1;#@@#?D /[.4"QQP544(.M2% W921K!3YZB_?OG/
MX1>3XK"!5926_!%V8Y:\)'+ 7KEX&X-U>,Q@1:2B%=\ZK*'1VW4OR]HL4<;X
M+KG4#NQ:8'."\_UE@?TRNPEWCF*='8ZG,1L$=0PUH5-Y:9<TC2V!*YV7)M@N
M6F:,IFHN^ONG7"4)%KUNR=YX_"1X[954P3TE\A?Y#(FFT8.9.SJ#H'_^5V6N
M]8%6>^1N_^*,5TN1X_/"'"*J\7B?*BU5_=I\;D[6C8.$Q/P[,JI/1)@#RJ_D
M$=V3;?J!"@1Y&)JA%IS<\QRJ6X,R%)A_&1^R6[3J($V?A*[F@ =F-L?M?6;$
M$'B/V56S[+A;9859<:TF@Q]%O3"Q\=+^ 6,A'R,U"6-;'Z+# 0$39V]Q@&@
M/E0&9ZAP@.'%#[H]]D-W]-H"MMMD^S'H5\D*_$P.'UMXYZ<)B])=:J9W=Y=
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M%_B?V8(KQDSA@'(8$HX1P<> $XO/@>'"PMD;0=!98>JQ,6<#%<H'!\3P6N.
M%!<<H&6Z48@./(\__R?B;P:Z[' 17?,2NG1_:^%B:!"] ZVF.RBR QT5EN*
M2NWZ)8?ZA8/*7;JCJED0@M,^(-4DY;W8GV2]?WG@[\7/_\4!\$(2Z 2L/X$#
M O$Q@&3D:E9 H_&Y(F =!_!'8PNE)DQ\=^$'.7:&A_W0K9UD\E1''*!.]T_$
MGYX#Q@Y/36X;*IB7<WIX]2-,YQ-^TH(%%^5B8V+I3D(>O%%"Z6$UDY>QL0V!
M%]E]@R,[+H.$?Y3Y_N6!ORW/_@L#U@V'%MCN@GH<L+=C>-&:C>J"0J&KCK,X
M8*T<.O:Y?L=A#H75Z"O >@Y<Z$=G5"#IMDS^D<C#\T(H_$1Y[L;O@T,%4)2,
MY&X9=A+:756) X;+6[!#QMM!S=O0[I%&Z/ $GI JZ^HI?<+> <=_DO7^Y0$P
MGK0A!#B@*P1?0<*M08,X8&Q[1!R:*NG^G>XL.BD.!]PSM\"_1]L!DAJ^.C82
M*!,](V;X'TUI?X%_#"C2\K7% 5-@=T,L#3X(:K\VGW'M[F**J5(QXRKG90_T
M0]'-.* [H0HZ((17GN6NFCXM%XH^_T0 VL'W:[!=,^F@?2*( W9CP^<$-$-R
MIEF=>JZI#9UFUW<2G',XTW4//]=%TIW$"4JJE V\H/V3;/<O#_S]K^)_;0"V
MVY>*9BW>Q@$M95#4O;@%QHL+?*)H<<$!B5TX0//)=AG<?>%,7:#D;!UT[*8<
M/% +S0__1VBI!BN IR415R;L8_LBO'ZE(6GN0+_% :SC(SA OH<$+152_!2-
M?X5->1\'*.BW8(?7-JQ.A#:N_%$6_)<'_MXP\@\#H7IZ,J&9!9TKUIMYW$=D
M(^,36IK]7TM;B%D?,B9:F;)&ME&R\?(^ [^6>T2"M[]-Y('>V:[]%QS0"DJD
M8X''3G1,WT9ME7SNT?/OPF0C,4=)=,4'4U_X]CJB ZV,G78O-A:>+9OD94TP
M./_:,.?GYA/2? %!E[C:"9 <.KQYT.M;=GKCD'<)ZH"1/Z.9F^SN1D;TJ9LS
M-_04H0KCA:U@Y:5V3?M!@30B76'!]SU-NNQZ3?<R7]H\RHJ"1;&&0Y"E.. Y
M=%UI?^$,=&P^->#&>85W>FYL^MEZA[*KVT27I'_J4[=S&=1#ZG8URRU2P@^Y
M>2F)#UG]:?0ENYXFRK-&4V/I(,B/H'AH+^E9)(;DU(>D__;&J?_^2*F P$BX
MR2IZ.5,XKLY=V+XO/7@N1J.2=US=G,TMZ[2HY>G3C/IO$R5[O:Y\GROD65E9
M,J-R0!!DH<6OW7Z#SU@C.K)SU.\C8V;E&A=OF_<]K1.[E5;EXV^%W6RP5>%_
M:D.>&-+#*$JNG5CO.:QCDA\;:SEFG0][FAW+DHHG)&5?-QSPLY5IR[YMP$3\
M/D8BI/Z<U Y9/Q<I<Q!2@2(PM$<@!F+:/-O>B#@G?J1\8LVWE\"R];27[_AU
M0=?)'>E[,OA\NH0#HK@.#S9+UJ\$S3?<+\$36AHT^L(L@"H7 B&;R7:WHU6Y
M/*8ZA ,\!) 2^9:LUODL,!CS8HF?+D-4@'6B*8^&C*B+8#U*#\#'RX8 DG-N
MN]EO*Z45.3\S.ZHG6%A?8+%>LW8^]Q#8);_/:Z?>!09SAS%ZFCN1F<J0.366
M=VH^CUR!J".;QJY"F Z#SB(/6A;=NTK60/N&2R#-@?V/&=L-M#6%PMLU(D3\
MX0MS,1\V@_D*9L_>>!DYZ2B:S^09TDI30VY5)LC9L+$8Q,PGZPHGB$W45W*M
M5F ZFL6A?*!0"E"4(9U-P6:>LKQ=_J3(%<?3Y5X[NY9POYO!C0)*3SC(OI2.
MCO2IJ)/RD6L<=+";WMOO0#8-8?_CN.SOSNY?X-\!_E[&^T\"&XDX@%L\<P=[
M<?KPD"JK7K?1Q,ND"BO@3OM]^RS4J?V&<U+F-3TY!5GKN$1PL:?O9!]VZUX"
MJ.+WQV-DVE76=J=P !D.B"/L'UA].->DFE \==$DV<0]<[_<6K*JAK9E'D)>
M^6QM7Z<7XBS!*,WJN:^92'AG8ME&,W-(K2*>I6FB_CS/^,%2ZB'1-!VEN")$
MQ<BV>&5:3&5ZSUU+WBWV>_>/%#_J8A&JV)DZ5G56.D:^DO">E8V"O#7M]=S$
M'E$6T4M:^'1 #U^TP@&WO(8KZL7%,?L_EE"<.QLW.1/;,#X+_*YDTM4A%FM[
M,X&\,1T:$Y7.L=E9<RRU4J*\8LQ!-LRB]\8>VC!;7?QN&MN#3RJA;@N'#[$J
M32%[:O9-\WH?SS)1.5U3<'*!&NU%@54#K8=PUIHF" $]?0-W@B6+68<QK2AW
M83$LJTM%]G&A6JD*(S,_MU<)I(SP0!6K>L;U$=J=R['7LV+W$NS@$"F$[-JA
MBYRTBZE;NS.B,#TY:[^0_WUHU6J*P9!VHL6$>6L]TZ-CMDI]6*D7PH'/"TTG
M<2]<Z8R\?>;@M VDQ6Y\.(#VH.$RW-S\_%P?+B/S*?NGA/S0:?Y&[%TY*9JK
ML@RYEDN&U1[#LI7E++3;<][X#+OX /\9$2)/Z#/QU3-&F?""G*W^Z%-TZA35
M1W'OP19QKVKGYT/!;8]?ERFW?R2-*XA1>!;XXPH/02P3_@$^@K\77;X#ACVI
M49!$#\I&G#H6?X-E.?N,],"]V$WYB+2P=\!_<A+3CMS_:1+U?-QP^52L&177
MV<P7P2[],EH2V308A -N=,_$SZ9BF-@LC+?&+3+GDO36LL7U-?6O9MNOSY/=
MNSY)E/TKR-;S<3&T!;_8=4^A/Y^B<0"H1MP44WS:B= 2&$0XA!V)M<*F")^-
MK E;.)HXO=[(8AX*+.[8I5Q@7]( K41(]S";/L,/]BCY;_+ZF[S^2.!O\OHG
M@4W!1O>PD>V^]/J&*[Y(1=K>R1DJNW7!L,-YJE26VR14P:V(1!T;9R'V4#N%
M#A4924F9JR,#HN7L3J_"Z<MA4?A">:P!2[:)R?&E=2]I 46DBA>XF2FWG"GM
MHTNBW4=.I']$W1)!)GJ;?AV]N^0.8?O!+ZZ;PIPK>4U;UOFUQV-_-O%!,=[?
MO\O0'>SL&*X1XFGN%.N8_';OL":E/M#2;=W^V%W?_0%X"<5W9I?>X$C3%/WQ
M2NC\*4$LQ7)B >UP8B+E0$5VH7E6$KDNR]A6F@I^%9OA '\*'" PO[+=?[')
MM;*_[T)2O:<?<G >7G2"LD/18J8JDS_(A;6@YMTR;4R>3=HR.BO):1FR1RJ!
M]=15E9Y(7<H-"%72*.^3P6</,NC/3]!%(1&5,WN(^<Q9P5Z!2)--/;V]J1OG
M,#(TJ=X%WL8CHL42B;8U%W1=YE$V+H@F3>B[:0ECF9>#,3M#!A.UL'2L+6%X
MXUL;GBHL'-Y&<JU=P]1M63>_6-VJL;#%."+>I+Y:01/1JUEON].R!I(&];YU
M3A#<EZ9B(1=04_3>A>FP^K:Q643"6+-KZE'2,F<_4!U.R+E0!4R5.&F0\P*_
MN+6=;?M$JICT,;?J<;CN2I:B_=Z.3T=$5BQABPSY-2DI K*+;O"8F;E66G".
MO) Q?BT-)9X2[GU<YCI(/,T>7Z \;[9UHZ= !Q)*UM=@K:]OE,_,>.WFL^31
ML1@NCQ].K%CH>K"D:;IFI/O=].@>'K8VQ*M0E=]I!H+/]J,"MU=G#7O"E[&G
M+<LPME(?]X,%^V9$WH<KP<(^$U4H#G(.C8[7;$1:P>^\-NE[5.]%\1/A*P43
MT*+P&4P)CO?Y]\FZ\[9$:T6"SK.JV.+@"/:H^/VD"B\-X2<5&0F4_$<!D*N1
MSI?@^,"MRL(!GS2/JY?[\577;H1^IAQ I5",?6RO5)5<]*BJG":D_J1B:3/P
MU\/-/4\K>Y7A;^]O%Y34HPR50?]Q!/:_M6=9J\#N*,4P(BQ%QHU7NXALL,D#
M<X8] (CRF7\^;7[]?:PQ &A$*0%71H_E&+2_5MP!KD8Y @\9+I*UX-8G ]WO
MSM\$'&XGY^I5";=_,,OO6$UZ$-:UPKJQ>$O*^PCR,P-&Z6E2F2EU\_-RF14%
M@4EBRCS: 8'X&HG06YUU]RK\JO.8]$V;PZVUCS_DC+C;^XLF(?(*8B]4WS\+
MG$UU;NIH#-.?>%ON)9;SS$"H5[-\MN_RZ.D >4?0DTPNCY'KPU_96S6.Z#%:
M9P]BD-</J4S<6UXEU5R3H55CW;KNSZHY%"=K&KEXZY6+!%\D(?-56P8%U@C[
M:^@6+WH[1'J@XPS1!4U+O*X018.$0"SDTN<">EC9)=CW]()G3SX.-(0W3]!N
MLJ-]-\I"9EQ);]!3WO?@OVK.HIX]E"!IE1&Q_2*+LG,A&1'?Z6X_O^'CKT=P
M'Y93B ]P[Z^J*ZNY("M&$_5!2>$FP81'X,:H-M8;%(_#!Q<35W8M.6SKU-:3
M4/'3$ T.*U,&RRB)I<+':Q[=75EU/S,?#_);(W5!_08'^@:'D)JGML/LMW=S
M#H[:RQL-TT:^^C,0TY:^!\_I2T9DWXZ%O8,WH=Q5W.U VB>:QAQ3%:C+QK#2
MAN9<&J6@DJSP9P84T_G,1CF9B11;F5%"-T<RK]*^;OUX5[CRY*,M2B2&"CKY
M5L"]>DTCI8\QUL8SA5+D>N\N.PQ!Q?:(4SHS+?C.KZC#>?V!::2]LO["NEX/
M6R31CW?[4L2];$*FZLPU8<P)FE)FQF7Y-_E'(]2SX[J0AWW'4@0SWVVWWNFX
MAQWFI[!2=F^T[JM)*NY+#WM,?O+,CC+5/IXC([0@^'X'/H<#IME4G'+J&N<>
MML5$Y7LL,QI848M<&^4A!]^PXS.6?R^M\K*DD:M1T'?ZAXU9U1/^8W1Y^P'0
M=?.Q%$?6X'WSB&MCT\QM']*N@71F&TH*&U!VQP*( 8&]&:\&JIK8.,'(]J'E
M BL;%V(.=NB^0TYFSCO/@B</--^7L[\/$KO*/593->, <K8;X$94XP IB 5C
MEP=]K*=1['77;NALT%/';5*C@O>].06SS'+NR.I5!$IX^J!_W='!SN%M]9 3
M^VLI)^+6U45#%"4S/?-!CH1\GB/$+4+)=W56.S3S?0_2]EAMR/C95]X5MBVJ
M)(;+YQIOK"/[8LB<^\$R#%X='($F=6MZD[;L@XTCG67MF6/AI!MIX/@]\-5O
MM\M5H MVGN;==C^/6QWUVH=E.[HT'*_T!?T,8_Q\A2EM.Z=<#^W\JZ FYS0O
M-HQF[HUSDHI%$[D8:.^;*GR:H;SCIH8*&/Q0QXRG>U%""OQEV] DW+50P"[@
M0*S \C7"@L[?TZM8^KRGT<,?G!Q)'_I!ZGJ!>E[4LMP&$4(?>PR?ZFIPN/7:
MH&M99XIBR3"S8N#3PY@KC>4LM\^G*L=>?A(.E"2I;<F7^;L'\9\5^./V(+:J
ML6 HKW+ZZ?H!::XOI>U<:I.X-*9_UU*/JPPK"E$8;-.2^)3-PZ^Y/E?W)4:)
MD\L&,:W-LLW(.]I]3)HM"K>2>ZT1CI^8IN\<U@W*55]A[SV%P &Q=#W]MCB@
MH^1S*I>@1<?%6;,OI=LG_;*$J?BFDAJW6.?R&A?$7(M*S9;+T7.83Q>-DL&O
MUAXE^3+1,HW%LJ/3]NZ5IHGZ:MH>K)&85#4\CA.--9WSH7'# 5NWN-I]N@X4
MC%^/2PCTY_>K#KU=ZS+.HV$S.ES.Z5:N/)J(C6_DX,RDNIN%MWF.^P4A?1-H
M5T_/$+\.8'CI684#\-,O9#K3Q1<XV2(N9TG>TUN@SWHNO^Y?,1K:'=@5M_!T
MXZ-[#'.W_/Y6P)ZG@%$OTMMK9\=X]('EHZP@)5>M/-@G_9)L_/ <L!8+>X6)
MJ:MGA^&-S;0[^/+T-&RKXRA6TNK7-OH!XP+/CD!A2=^OLH1W&^I4MT=["U67
MMWA(Y/+&8R,7W9C??\#[((,8!TAT[JJ@Q\<G<, PK  '(*"_5_2&^-.3?LQN
MR9<FDKF+I(EGQ[?/$<B"J>2X6N%FZF5[PU]<37D9G6TAL76;>8DY&5$I&63)
MH0Q,O33>-C8D$.27WPT/JBBP#H9[^5_<#_K/LNO%'QWC@+8OA)WU*? I+WHV
M.,I'R[UOHH/NVSS90/1S":G;XWU9J3:!>:W*PQ=+-5'YBY:1Z8SX>5['^Q,'
M8%A':G% /+R/\\LIM (>ES,W#:&IJ-TVFA59%)>:0)I^7Q18)596YXV+#17@
M8!TXB3\7PJ@VZ0LKO1[\;OZEFPJ_%O32T7^.1/HW@ TD5&_AA@D]53HD61[_
MGDJDU(Q>7AKHY$R8 HN$E2NZ"8O"+>W8FTDHCX_O_ #SD<GIZ-](>943,_RH
MMTSV.PO^,9HX(#F5'I2@V8F566#!<D"?.7P0:Q*TL%,)=SJNUEI[H.@05K_@
MXY64-7.LW<GBKFQ_J<%)+XZ80U]4U6=6 VV<GIC76#8T\FKM.EYV\7GEGNFY
MIQZ^PMJ)/<9T8LV. M&L"]18>COB#WX;"^%Z/2Z(IH5)KQ;>B83>ZM7T'OOS
MY"3]A):WI5\3,!&)[,;(PKQ$2@UU\N==IAKX8IP.!X!*5O(/]%:YNA9"4WL[
M?D'$I^=3&7P%1R'+2-_PN89$L?2+E8^YAP-U @@#$B8=,7&!6Z%BIE5DQQK'
M_*Y. \I#"L1J*I>",^>\,B4P_36@_I(UICU"%XS@AL/JPERRS2R(^00[/R,6
M7=<L9<\15%/M8#AD7!Y?&&:L.UM%@.R:,(>9ZUJEM8NSD6@]+3FH>^N_+$N'
M?Q@QIA$4-_X+JX #>MCX1Z!T)\1:/:"HKX/K:!777]7S+B03-DWNR,W@L,^2
M2A&S9XKBO _\VM757ZNS5X&'%)U&N81;.+Q_)N(U2V7G3LEJ#0ZX>;CS^^HO
MAZBO2= 5D(:;BM>ZE3/Z\.(JYF(R623,VAL4*RK])"6$</HHW8F"54<WE>YJ
MN>)@JTZBW--8JRP\'W;@@&C#@Y]87VW0FMR@SR)FI$:PRW:AHS^@_<3@M+5M
MSE!@GXY^X^FLIUA#],RIKH?C: /:=4Q25,V"J5 ^\D5DNY5\9;<I^'??@ XL
MV3JF&?I-JZ<D&D2!ZOC![,56>LYK82LLS*H4.:Y?]F5K4Z#YHMW<!F;H/ Z]
MT_]K6O=+@'#! YJG4@R13LMT/+Q#"1_!OW\P!=EXW^[R[L-JU2Y\!#T7S-AM
M[IF'T[R;,7<GM/^59W0(A;K%BM"\1C=0AY*]KCQJR/"W>7W];5BVI/1^&]GN
M'?S$0K /7"<.>;!Z>&L[K#@<X)G&E*V\6<+M2_A"@]X2#N@*RYX7N78.9PO?
M#19*">1H8)@56;!#%I+L?2F6>316&?(^+R$]B-Z_N]'E=U/,*.BCA16$%";#
ME\/BI/]HP*BFI,O^I-<(E>MMW]>D*/XSLE2C7.+S]&1B;C K;%;S*MB46D/Q
M\QAY3%5TUNN?^Z]2MN<,!O[C:*!*_ZP"!YB!YZ"G;ES8)37T"AP./ZBUAQ[J
M@+9:]=T$D6A\_60^A@-$U['%74,Z*))C[N/_GM7?,(0)94:QF,@9QU *&4=*
M%K"%\)0G^67=N_ZDU:O1F4_QH=S5.Q($G^Y&2%!?/Q ##YFI%5["(^17J>](
M+)$HBE3P?YG1,W2TJ" @;UTLG:+V=^[E+")G5^RC345X L/W)XQ? -$[R[$G
M!:%HI^J*JK%E%5'5=JW/%HY7M'I46E4BR \VDA($;7P^VM<UU0\_]KMA%JUU
M^?.G2!7AX?>>X\EW=S_2Z$7\6'))3D[(MM::'2U[ZS;J(K4<F?<V0D%5?4"<
M,G_YO<SWT<=<W>5TGE:H6A0!S?C2@E&5T=)8+TI*24.Y6XVO8^F5!4=[RJ,W
M=UH*7Z"3T2[B S9.O8)6:7-I?H,\0Z'UU371H  9#:*?&6(ZFNJ#W+79^'I^
M@6]YEJKDHN-M@;MG3UMT_F5FWP%7]2YE5H78D<5<SUG9B:/XE.5AF3H54Y7C
M'R>E4XB% A[MS[<4XO81-&\ZY+74/_^04 S4=2I1548SG<]Y57+5< W[*2P\
M-/.=Q!#5)CYFE,OY:G7=Q6".V(!L>T&X7/M-B:D=4ZO6:U-8YI3C#YVGXNG6
M.T7ZFH/T?&9?!8NEB7PT;2+-];:1X6\AU3M:(2[4D2S-YA)/RK6.'M]Z840L
M\H+)7^KYQ_'F4]1X4MB%J5U6F-;]QV_:?VP0M[9=8I4MUO[0P?]+1MIPI41V
M5[ECY@):+Q EI==X(L5@7$($YG-%:#"1#9>%KIA^4KJZ5\;<FR'E=JF*M> '
M;2NZHLJ9_V2Y!LG08>;SF+L_N/<)JZEJ'K/YX,8O F"3E959[LT'%%Z0<<RD
MVE;/==A>VJT^HD3,Q2C^^*3L&L=:/[1<'/7"J#T@C: E88NC:QH'/*F>,%_9
M@Z -S79F#2;RP?T>F;"BHI8>#FOU#A6RX?(.XE=YY9TGTG=+PSLIZ.P1S:O:
M7DY=#_2N-;6ZNT^4S^6>-E>0W5$NN.3F)G6U_#%S@>:U@"(^,?X&+T,H4D5L
MVH6XK3$V]OZSZ6?GH9=UD(_<OSW)$+F3A[Q2H2JK1JK-OVE6"UT6.7%'L5)I
M0+0T33>W4:WU<B$<R7X(I<_PS=C$CT&L6A$&0_4A[=B?:";,#ZSAQ=9%0S."
M5,8('M;_(X]V[1MX[=3X^2-WEI:2ETV[6!.Z9[Z;RHA4RQC3V=NN!DBB.9HB
M#SY'C,LMOU%I.B)7'H7I"SLEO%OM-FO2$U.9:Q_.%0P9!5>&! NQ0G_Q05Y=
ML4Q49;IJ52L0LG2RX%O[6;E:D%&7BT8FP%O:KW)?$X2@!&WZLT781([F<]6B
M;]V+U\5.\O1R3"8\:%$(9TY4V1E7D>TA^-%.\O+.H_<2M:)^0N?HJW>5 [Y/
M_-5:_UF!/TYK;:\Y85:]EM?H#KSQ4H%Z'13/<7L^W /1/]"*X!@8YT;F;060
MN-JF(JO9K.SULZJ6GK[QE2$7(]O$*@_W2- O\[BH]Q ;2Z@BF\8[Z/:2P]?8
M]@/7>:#<E:WK>R(*%5@I[QV$0Y0KZ"%JWC[ KN^B;RX9.J[]L*"YB[HMMEWJ
M:ZOI)E-BO&R9_^<Q&174LTR\G9S0+6?.1YK'I^IE." .^<:LHUT_'Z2W>###
M&57\[@;/C&'!X=>Z:9I\=2TEU6NOM+OSN4_/A<>UN-1?1(\D/TWKQ"?QZS10
M3'/SM6/.:]7K>MZ<I[EESP@<FO+39GPN57'?[>-ICZ1,S DA*U%7,P[FM\JQ
MB(DAXXW(F-^>L_F >2\@_N/,!-.+ Y("#]6FDA1,?YW')E7&+6JU:;OQE>5P
MLM]N"Z$2L'@<GIF6F_USI.5;V]*)M)Q!,B-40.&1:+UY;$;#G%?!U!;7*M>>
M8)&@_2$BN6^_(AN=ND)B>N)@<H*\V.U?V*96>6NO6SA@OK)=3I[AU\!/()])
M]"4KH"Z/.2]O/8R"^4G8E<(S6A5\48#!^C8]'@(]\;7& 2PEJU0C<U(C22+<
M!US-X5#OSWF3\>R^W[NE)I(-B:TUAOH=^9ZMTD9S!>7.'S^SSO<CU??/?5S5
M;FV)=_RL7W!8-(V,7'A:CE]8@%_B36%68<M6[C9RUD]ASX=>:,@.@34N&0&_
M>VG+VL\@B).'];6F:+HF=:S?W&_92@YJ$'G@:6YC(6^9[Y3$$^ =ZCK X*_Z
MRG7T@%;VP>^V$(;<7,'0O9R+CR,5)^P7:$QI/=M*[!)2)=*G;<$G9KHAU7U(
MH2[7?K9?(2+ 3^@ #>*I&$%X"Z6WFJ1;+0;N6+(\DLH*!?"E<\U;[&MX;\UO
M/<QS\TWSZNG'<2_2;)%#L\75)&_(?2CL!&7HP&XO7JVN>/PU1MLU-HGK4UZD
M";'8[9>&=Z*NE@1$6:F1XNO!]3]H]^O_ N)13Z=FO'H((V=$X Z_4)HS/3\K
MS^R:ZKB?63!;9\KH7-90 \NPDSZ*O/O>8Y+@M9VC&%XRG?TA@__W@3'WM8&+
M&"T(#EB<A*.#%':CL%@<T+U8AP/Z3'% P5W(Y$+#+B8_20MSF'K>P"1E,0L:
M[?@?Z/(5?;W( JR&\Q@'2*,+G#4E)Y*,83>;YN[?"[;]T+?"PC!&R]M#>'=Y
M(TL)S*29;SY"_<Y;B:FQ\Z1D^O;;28&2A22?2KLZ?7K&A.1A[K?VV]*IBJED
MPQ]E_9DCQU+JCR !M-OHGAX]+ (=Z%P/F;&C,3@V"I/S;5ZE+'" "6_ZW==7
MI^5Z^E77DF.PJ]17>H>S9>Z4.'#\:*SJM4Q8IY:9M;637;!?6 @I81ASVDOP
MEU!51M8/R_N%NO['Y)<YU[E,:L+D9SC=0X^'M+LH7^8S)\KE)K[H[;>4CO![
MZ57U('U1M[LQ!J^4!D2RF_M*"\,R6!@2IN\'/#?RYX.E\0F'5!H1"U^V[K,4
M?N#>/[%]T1(4FUM:FF3#]+E5BL-FW%Y8ED%>XXN!W-7AD._U,GF!>F'$%^W?
MTGM%QGN<Z:>8ZH.M/DO05-1::?]B>=7R[=<=J]71I#Y,0[E#;+O2P?RXMA'Q
M8Z^L+X6LUW0^UNZ0+4E0+(]Y[=PN[7!/]:@^_VYG;5<V+,)9'<5.,FU,0'LK
M;N_&C;#G)C<S5.H+#_I>3]M'TI'YFQOYK)4(>7T 57IG"23-5-<O.)BXB-=]
M&=;S>8GBO:<<26UF\EGSR[+N%0J^G[?E3PY(/#Q;4'TQ&;JV]^\]F;%\+T$S
M,<+->O?%I48YB!R;6OKMP*S  G'4 ++^X2#+[,PZU\>TUIWD*)/4<J^;&6\X
M)T.Z',H_L_ G>#9G&W6TY/^H@2D](J@@<>ZH^I9IU] G@&@ NS55O4))I\XT
M0>6G? S,T^B[;-2J"/.2Y@P<ZJ<6 ZVFF6=RUMJ)) QW[L7$;E[<NUK@O2 +
MK+@.U9W4;JF$4[40E9L5A#40EE>,27(6*KT9<WFYJQ7A25B U/\2M46P\8+(
M*/A2'-?A@_-5EZJ8^9T['6)'1+]2=]08'9]\NA)Z.?@K!LS?0QLB%!@''>^)
M+"D2\%M2\"**([W5Q] N8,5D_G"?(M;'\--P_&OA)\]9WY&<2*.RRM@)<B\8
MU134NL_C%9G:I/F)DCE.VMB?'T6,KZUSU7AFTR*T"^Z/H/-_!K\F&W%K3\G4
M%CHF.\C5MJF0)#D?,"SWGT /$458OTKA2 Q>)VRAI_MIHSB1>;R?1)_4[:JE
M/VY/F*(88@S;'->-4FCB)S=3)&-O*U:&,6]VVB0KF&/0+0Z^.T5N6(?9C(J;
M]/N1GW6M[G5=59._!EHL/*:5SNPI'$'##0WL19.K%;RUN]]"KFWG9X1YFGQ*
M7!DG?TD2GWZXX8:Z _F_!>B_G:B9P0%4T)WD>E(<<*=&$P<@PP(73"Y*<4",
MC14.R#8+O,AHFR#U&<<#N1YXH'@1!UBYN/*AJ8\N_5%D]B\/_'E7H[B^]E7"
M6)\&8EKJ2RI]>3$?IKT>- K83\]6)IGX(-*CY)R]M)Q&WW)/=3\-+@\V[40T
M==PG=%QR)MNE'M2@I/87S1)C-+J'?_!!XED^IA0K!^4,ZSMC.6A8TMS9N;2_
MO@CM3V[;U[HR_[QOECMIV7;]9(W49IV[3K1ER7+?<43-='&N4N.UEMJU8/G*
MQ,2,E'@E>=;?)Q[U<0 ]_!N^<#\+P 'L V&&C&CSL*C4*A>*BXDR$=H:VJ!;
M#]EKM-;8''G-,X.?+X8E5ZB^;M'GN]M:ICZJPG[G(YEEQYQ7(7R :A6A\I-D
MU>+@L-$QX>:.^7E<$4RXII"M[.L@>%3=7GDYD:,JN%.*1I6L#T/[)MK4]!ZA
M(3E#;+#;R"U\50O!A(G3]>UYG>EZ2VU@^@4J'C1OO5M*JA*1#V$4$P,K4B75
MKD8[FUD^C?IZT_VY)P]+Z)?V?E$^IX]\.[=^=T*T3<%[?G3Y3*T(.N"P7H09
MAR9PZKB ]?7W0_- <?#V!)[+?C<5$%;C8D.J"F2TNNUL N0'=_I$>V"IKL)D
M[!DWZ2#(Z@Z\KX;5O7>4PJ?0("?(KMG.7/ZD%Z&',:Q4K\9D-[E!IL'Q3)YR
M,<=:-(RGF3*8=4LG+C#8DE:0FB<2'X&PNEV5%1%,NO@+Q*VP@3G0)7$AV\\V
MF2JW%S>:&],W;C6QETYV\(O+6$CYIZH]N]K!$IMB."+*T]X;B)>YCP47#EJ0
MT!4I#!H:VR^R'/<6F?)S*S72!SU1&Y8]^U [(U4(7.-^^U<;H@A=A1(3%[XI
M+Y]ON7<&9XB)&/HA?W3\3)-!XU!=MO3WN<.=/T 0_B<&_K<.FF1,J$I$9A1T
MC"9^4-%3XF=8BRJW]:YG)2OP6,_UR/7?44H1(A\]*+Q..)TDDEL6\S1<.6]*
M'Y(A6__5CY\AN/-G)FNWQMZCL&@#7<8CE:N)E9V%H>GS@L/?/V8OFT+XGIL9
M?5^Y\XX3!^QD>..33*H7#B@Q=\$!Q;YK\%-&SQEL&.C$XNWOYE42J7O/G 4O
MJ$ [AXXXH+HY3H0P\UU%(4^59U-HE?J-K\4=S9PYI6L\#P6L/1G"S+_<[*[W
M?S$L27H/=F.8TVZ'L5\<<4@"FLG.V76S"!:ZVIU"W/A"ECR"_VT CV7Q=XW(
MZ+  T9@=%*>7IS/*2RR^)E&VEQ,KUMO:KO.F9+N/&2AGX0,2;QT=IFYSY#98
MQV:ZC:P(BHF"B=55 GI7K9^V9Y)"FGF$Z--2.XSNYN3&3.Q-L,O9]R$)5GN<
M3KULI"S;7/GV)"GJWRIB&]@4JY9>V0?[,%\CKBEQ.)DWCQ!?*]?/,^ZY>B@[
MGC:>4;W50[29:Q5)$QB9S_]&;5AM<$121E))149.B;)%14'AYD@')=,EU3O7
MI.C> U<FI=?6%+HH=9*SW!@3YD)X2=<4[LF=10\V3T^+/!]G!JN27=.0N@DC
M!"Z_!V@_YM-.;B(C/.:;6DQ0X^YEC+"N57=:&QJ9@ #%K-*^^^+!7V+1BLXR
M5Y6N\LIZ1VU[TLP2<!Q?-8'V3V@U2#6WYY,)E,H>/OLDW-2[&W[/>?BY&QBA
M]!BL!3BF";1$<;#7A(3NI^@4YP8]4N<.C9J^RK^71D1))F./&M5/*-?+[HWL
MX'.68K=B5\N485=CAI@YF6NJ.VKX25S5#G]+L6(9SQ-U_9$?\77Z1W[/[ZZ\
MHQ!FAX'?/_*[_B3MH]]U48F-9E"[<M7_P=Y;A[75O&NCJ;= 2XL5IT6*0W$G
M;2E>G.!27(-[@+2T:)$"Q8M[< U.*>Y>)$AQ=PF0D)QTG^L[U]YGGW-]USG?
MNW_?;^_]YK_,FEEK9M8S]W/?LYZ9X8^;%C9V5MLM3O,3DI%]K[;&$$S*Z?:>
M)1'G(K]_MGZBYLLSE4.F>5V4%2W W-JX&<TUK==\JM4U)M&Y;-DH]V!"&Z5R
M)T)>=)8L)K>Q,<+D*:IE]RXKQ_BV^D_]:$^NV1C83/,/P%W,<+?:JWM!L1R:
M^#.S+)*C:NIF!5O.IR0C:B,CX^WRN)=!'B2<E:\:W162P9;% @!P .!UMMO;
M^EM&WDEI\A2I\Z$<^QU5/,R,,;8J91K2)<5:/(R/83G.L"SZ#S!<F8);   +
MX+=H[!Y00?3?./Y_\ETE(EDS4\6_*E*/;D>+1PM'.Q*3F#C)-51^E?T=0,B
MRVC8S>A2X)4CKQJO>E3N[,8D5U=7]^S3]7TXKHWU_]\_XN8EHS'XI(8A719\
M.N$.BDX3P[(?NJ=6,[/3&FQU!L8Z94DB*S5[J16&^BFKV&YV +AQ98IU!P=K
MSSO<B/:5VCXA1BU<W.H,#)(&JLGC"HM+ZP)BOD_(DR?#P)Q9C$P+W0HI?X)>
M#_Y?VWPWAM]Z=%7:6Y%#;H"D0E4G\%[,J]LI_B)_KOV[ ,)_<.?\QP5W_-,M
MBM<[WK &)G/_A*[[G6BOOFB[* (.E'TPYN5-96I<F4EEGX%HW&H]]U_;;H'/
M0GCAO#SZK<]K6>V6!FB:#A7ER4PS]2CM_=ZZC"DB'P_O-T\J8 $NDM90/KJH
MUD$LX/=B]T&(6'?AIJ0V%B"HU%[7^*4)H^$@$1K<?E;+[ @>2NS3-K%[J6/8
MUG@B4H*D F\_,/U"%15+HZ)B_-""RX^7I(M%8JIA=OC2!\VP8[PV=8@%Y$D^
M/S,$.>@[G!G=+17/V^PM5"A><'2>'(X=6K=]W,L=6*FKUU!H]M'<>NL]CWJ'
MKVH&[<X\2/NDYN++L>QE #H,HP,E$X1K6 @]_7G=>*S^:55E\%%'D:WH=PXO
M3%.U5TF];A2L.-\^9%"UMZXP!Y1;),=8E)VLT_2^&$="[15@L$S-.Z ;($T=
M@.0'PA^TN#?,B07P"!F[V$>%80'/X,!NOR_?=EM076>"IT:)T],^(5O,/0[A
M@235T\+HL7X"U78R!5MOR^CU"'7R55?Z&P4X;FILW /\W;6#,5[L%\L5_51]
MC@4@(2WP/%E/I'8/I6V(30L2-3I]-BR$6(6QYA<I;*.5'Q%P\>K%:@LEC@3)
MZ#0YYS<@7WNB6?I7A(:!<5A /YQI<K$?R5I'5]$ZEC8ZZ&'Y8U:L-,%LS=-R
M*""!62GZI[KYCIWS"(?SU*09^S:KDKV2OHHL$^_EES"]*/?]#XYK^$?,EW6G
M0L?*^X\^[=/VIY2UV%E:-^8!0_CGT^M9/ =EC517#T^K4[3IXOLU'K8KC+SP
MH YZDT;V+OBP3Z^'=>');PR=TG[SJ#C&B(X9NJ2\2(+T5RQL\?:]L]@JTE!V
M,3"1N#"$H$GY54>#"-/)?MQQ2F'M^DT8W!V:)A=O2*&96Q8^S!BS.LF@(( ;
M-Z='P,?(J3[") G\DZJUM.X?[HUHU6D$ZLZ1[,H@E__#RYB?ZXUYU.:0(H\#
M@GF2RO>Y R4ON*+HPKN6[TAS$C%)N\WXAD_RCYCAS*F&\'\OC]1$H@=0*34-
M<*\S,)WAP?5HE8T+P@ZH$9O_PX(Q0WXU#Q;(X$WZ,"E.]P-P!-5NW,PMX4B=
M[@[/F_$4*(]G'0AXD>%21G[[]V'ACHCDEGAPE6M@Y-*++2M'M]%AO"[+<!%I
MZ[FO[#^(1(L=SQU:E*'#Q[O0Z_OK6$ 8JA-XMKL^?"6*DW3-42?N"<8[#'W
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M,+NPHL3NVP^NZW.DT3B+VDYM>;P+Q@+00[5YBNN$@PJ[>?IYR,B5N8OA2"R
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M7T!)X%V+/6WSR" Z>6N[P7$UZH3SPAU>>1FVG[A9NM%FWI#P(+&G_ZNPEY"
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M_LCXK(0:P;Q;)$=YDM1I\R4Q#0EV;:#G^7H!/"Z*7PP^[Q&I:/UL>)O_$;/
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M^!U#T'W57F=GGMLARZ^5WKUB#@'<U/G /BK;B=[Z$3'V4JRQM HA16N;E9?
MK!%+ZDZR#+&)AWTL9$UC^5E999TL\Z"O*.56C'[P/-$)TKL1X<D.Z>4GTXGG
M?-*;5Z.S3JQ GOQ8@#Y@FLE%AA>,!?CJ/Z_W(]NJ-9CN+E'M.PZ.D=#,5GP0
M1 ^[<7O+4]3EUGOBD;-J9W7JSS6:HZHA=Q2U%'F['X='O)%B>)S)GS*7HK_
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M;UL:PB02RLKL"6K=.:GDT/+")Z2OK!8?V]Y)O&94M[_EY+'PUJKH+B^LRJJ
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M>51QNI7LXP(!N%+%)&X&GT7N'I-NBHF[.9JY_W[GZ>?(QO.,]YI[$<IP,:&
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M1++YN6\['@@6^4E6&<)LM9S&['2A8*$G @F8JY[ZSNS7?U?UPSM3X14O"(@
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M-H&/GEF X9I!<-T+C*'A"U=/D9K)/XK"[.B3:$P?U!,\.V -AHW%S3/"@[!
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M@7.AUY_A4(LI\2]-#H3$UO!WBXF=DIKX:*.U"$!<WBYVOQQG;!Q"'XY?5B8
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M/C',CT\G27 GIK.%:6N'=<G3=VE$Y<?EBP]*I#\?H,YC'KQIW/RC'D3JBBN
MQFDL-TYY;X]90CJ=8UV=G+IFM57OYW<=HMI*HCW,UU\\&;N8->-SZHF[6V!.
M^YG\N3:L*$R-6J;9KS0OX#\[J_/OT/"_?46ZQ/\[ :@*G(4>5TX1 $Q5/MIB
M:<PD1"=]!Y7RAZ<WJD52VW;Z%+1!&5U:9J\;7I VY1MR&3TL",[("*)5SD^<
M#E(:TH_'72:^4[Q;YH>L"S3=9>AD J]PP]]GB@9XMR_7C\F(9M2[K'$;7<#E
M72T)RX^FSN=0-@J2BO\2>9/?V(7>>+/-=GUT5RI8<HD /#\F/\Y.<T-93TT[
M"S22^55[6Z"?U8H(/T?(,Z4Q@Y_;FB:9O8V[&"6LI=+!2^RU3!JL+E:+2!/:
MNP7!YI;M..YJ3+HSM$<4?%6,G/%(:+!S<'!=VC!DP@*J6)H%'_M-AH@$+03W
M$YKNZQ /7ZOT%R$=91-0!%SNU3'848H83%""^5 Q#5+O):H)B91U[CF1QI';
M(R-2L:7?$SRTE"_/P[-N2Y-\:AYI)'*/99+NFGI&KZM#N(OQJ>'2<=,^\ @=
MOV(/*JV)2;;\.!"\S32F6.=IWY":@(Y[$I=. 7S^W-  &E7\_V@>[@'(9#2V
M+V"+  03.173,";GU^9&9['9\;CZ7XC%P"$'EPA -(+(BG[-$#D]2L6/" A'
M]C:;F^=A_[Q>]_HT@ !8=,[.G[RR@JR#T:BZ1X?/( GSV)ZY80+0B@\A !Z#
M?FC=0&D62&H]V*FI9!8R=>)O::7M]//7*4-Y8WYV$$SF2PI^,RG;0YY#PJ<I
M/BLA_<IZ6/NST.)9'PHBY4I&LL/+&P.9MFD9FAML[;WRU"'F&FG35TF""^BT
MHSO'\UX5CM&R*57E%MUZC]F4:Z,5; \83[3QI6\1.GQFU(U%"@38-F["7@_M
MTC9WIWZQ^/% *L%9.375ES;V%M78K0%U@T'!TU>)-54I%Z(]5H6EA2SPM&C1
MTPV9Q),MQ)9H!IWS4=+1P*H8Q2MSM[B5W)+.4=47ARY+-HQA5ZESY6-3.5X$
M1SUJTVQI]!"D\-C1$5EW0LD7SH(1K N*6CJZIGO067_NXX[%S@JWMY.?;'+R
M0QC9*Z_%]BM2RE(F(C\DN3_LZ6O9DAO/\@S<V8@J[85D&=4EGI(-&&]'+XE,
M/S W9>]O8;W^+NQ<66Y>CJ(2>U";C%Z1A[LI'8WY.*I692W+L,R/Q\+S^UC6
M7'-  Y<8XTR7<*R\H4KY-;8*PVZ27SV5 QJ:C'EC]+'%;W2F5;EDMIYJYPW\
M+3=YU7:<6C?O3R!CFVME2>Z>,N?/DA4>R+$*7->XX*H+IC>>SW7!2V&BO)S<
MX-,HBR!JEL+1BXE;*N3"KT')!O,[R;/.R:?CIE6S3F5B)$FK?$Z5J@Z5P3]Z
MIQB'%2[4]T?Y\A. #3HQ L#=4'X6*X:#'!OA&^Y OU)@B#;^XWN(R2^:?20V
MSPEZD#&"G_!%GRGT$X">,AY\KAH!,,%A<*\?@-XQH9,)0&FZ'_Z"C!X!2"@=
MP;M-0:8IC F TB3R%-P.&0U%$J<O$E)V<>V7''Z? !Q5ET.^6/<0@/U$..2[
MGP;&=&O^G\1 [QY]:<)?@<R9X.L\=D_(3DWP6O4:IP.V!,!!V@_':D5$^7I4
M!$"+@P"4XW'_*',SD;M!>8A2ZFX0 /$=T$Y(.23781X+6T1N/IT_(@#SR/'S
M!R?,!, '<C8YCOPIM (Y59D%K4D7X"J.=@\CB7PK\:4>3BD-C\2@SWX:0TA
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MG/B%?> -B#]QIV5J'S]T(WC>J4J'L6Y/\M9FWV9?YVH;%*K*]!_'Z/@/8]R
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M[201$+Y:98*).$*M/I4 ;[,Q;L^$D<-A4S5R7[KLKM*^$3/^EF[!^8<IIQN
M+86LVGN*X5F)& 1MJ;SMTP7ZOTY;-NV<E\0K)3$=S$ VVYJ-[S1JE[G]A51+
MJ_- +4ZI'JG]:=F[U_'EB5F$UIG=8NW.4>U 0R_4PB*)FU*2[FW!IZU,D)OJ
MH[(Z7&_[4]^7LFHJI2H=6&X*L"$:#-JO!.'4G$_**RA^T^GYFJ,4HM?ZQQNK
M8-!3?2@^OQZK-]_DA>? %?R'JZ]0,,B*&>0L=7[/)'!O_B3M...?KM&"%Q$I
M8"@!V+2'M =@.B&+SE.^_W0AUV8!7I>3 !01_2D5>I>!Z#B1MO_ATJQ_B_"W
M$$&O$5O!YB-!X24<A5)T7OO"WQZ)?+>#%T?S[/,DU[@J@TIFW$Y8M]*0_CS>
M.XVID^9@64S5+?GGV4BP+\_C2RYC41A:C[ _(IV_Y^*1D4F?,]YRS83(TM;
M!*!!R(\)$X!?5OWO9]/^H LX( #+D42B(4W4F"[;^I"_E7O@N\U@!3W-ZLI"
ME0I3[U8><A#WEW<@DAL^Q[2KS*I$\K.: PDIFI^DOMYCJ'D)N:A)YOM6#D,N
M<:O(*V.P;$9D6B7<W7&S>20BTK)KI\>_76ILD*?PM66> =FZ,)6Y.S59[L3#
M1GN#GMA0E4=R7WO2.;>%"^0^BL<[P9L"6B2+O> ?+[##^VG2SU&A(D2SWI$K
MGJ?XM(G$.[N33Y6T._8?5%6X?YK=^31W-R!',[I=CH%VQ>1UJ.[Y(?X$N[:4
M.S^*BY:L!:EO%FG.<SA7L4K=$A H<?A9JQYYFU,F8?\H[]'1QWG?!S;;Y7P[
M:*,JDJ@SPP9'&A;2=^LS=CJPL OW7DF^*=*:@MV^:?[HA#._<W $K(86T3ET
M']09A70JL\CK03)QSZZ>490WX)_0A-XE2:5(-DBVI9.C9$U_5IB5=O()N(K]
M[DOJ5UQE!S]PT&ZM+R0 $9Z7?I6K58Y/D)Q7*.P:OW8U5_LP-UMN-;T_%ORD
MFK\B(&4;\QH9DT+^*8=VQ?DIHXG]ZPOCF12-G]>Q4+-BJPP1W,R[<><W%MVO
ML30A&!3S/"O]Q=ML.HPQ(H9VU4MKG0$8DZ!2<6FT1KT8^?:,9%4V,^_89-^'
M9P?+;&1T+UIY+E!*?XD2T446)O:ZBNU\8W=1ZLVU>_^NX_KYZ-[HOL-;4,OX
M*49U9-(8UG"EK@'1 #?5RS@=K.X;*WU2_^WZ8_!S^SBE2ZQT:N!??OZ[*M5\
M5MMI]84'D0V;RR)4V7EV @ES8)C]=Z:GU91S:O++GLA"#*,JL]'F(X4;C_4>
M?]O(2=4.B<&]+U&8WHYSMG]0KWQ->MJI^[43?=(G%?:Z\.<QZ!\1';6E!I%N
M8PG^EG,TLZ=#1GZ-:-XJ':LM@=I#<*V;*]%,+Y3!,J.RGSB\4%[,5V;X>"1$
MO4SW:>O3#F7'L7[.MW=7+KP9S2HZO:5>K3>!-T>L?@=/[Y:'VLYQ*GJ>Y/[B
M2 +6@E1+3$,/V*!0.625>I[3O[.Q_TH-_V6RL3H'>T+X'F+((UH4T0_/OL,D
MB1?@E6]"^J$G"UN?D5[S9][C!."(2+QJ8L>@GIV&SSWG.KNWI<I,'@2UKW)D
M^IY]9GT:#S=?50D*.U#D)K$UCZC/7KX6<!5-M^,7[JC-NPGKJ\VT&V%)_,JH
M6+*&OA"7A;YFGVS;D&IC]JG#PH;T*FG'UKT7\(8L2ZJ.QP50<._$?"^"+Z(#
M;'$VXL/0"E:]H()P>SW$(6';9+;RJB04>TEO34691-7OPOTS3$P="F)PEZ_/
M5Q9$2_D8H[,*-059ZYM_A[CY;&?:'DNVOMZLI1Z_7XD8?&WP?&/4_SU+V)Y+
M9Q;D9XBM\_7>CW/ICLU67;KC'H<3!Q&P7JFXL?;KYJ.R(A?E5+>8K$4>W0PQ
MZRD;^A5[[Z+4;IV<P]Z,W&/V2UFVN;%/[FJ/TN,2#S85,$5NJRLMAG/;B!RE
M?<<=IN #:D&8>"PM)Q]TV 9C9W>!ZLMCB;OL)T75Z]-5MJ)1/P>V^Y'3P@D)
M:;W.9J8YA2%JO''=_GXZVEV'QO*%14^0"-J2[S=O\)J27A;JPU]-U%5X$T\G
MFND*H+*H\L[M/^I>,J#5,!6==I[3W#F8,?B*8&%?:7I"K<(C%!@:)RI@1RD1
M.Y,I3EHL/]P[<;O"H>_2T ERZ%?G^QG)EN!L"=AZK?J$PQ4SP118T3GR,0_>
M 7K>/EKE])HJP<Z=+6JQ..5&8S2;Q7.F0V40*47,8@"P7I_V2OU%3<VRD][Y
M:^$-$T*E^I/Z%Y11GR-2Z.,*E2_FFC^YPF Q:U10)P.RD$A>6C-R+-R?#I'F
MOW,S*CNC<'AD4,L"UC*SS),;)1;GL\F)"4T'Z]2E6,8.K[.-U4WR8ZOG9V02
MC9ZI<1N\&U<9_7E.%@,<Y-7CB40LS+$@_MC>E*_]:_#]P;J//X.5_86$\W2J
M$77U]X 74=N]4S3*X\A[.3,,M4T2<IZ+10\1XP[*PI^F9ARU1S4MN1;"N'J?
MQK/TJSWG6E4FD\^CO1#+-=3CA_LP/:7H=XLZ\N0=8"'"*BS,DIW8.3DT?Q_3
MA$ ^G'-M6:!L];-3CERRLG$R)XT#R[WI.J,7>**OE2M>H* WX554_"^4&<\S
M6<TB $Q(;<A"<0,(S<_D @$1 'N*,P4"<&4K"^0Z<,J)@AP,7<:]"(05S$!^
MV/\I@<2?J0>#MZ#>)0:PKU"B6^&?1_.Y,F&""<"! 7(I]J@?U**!+3E&'A:_
MQP_O^E91F#M5/O@+TTX&)I^0Q]H!1"@;HDD 9NP@KTT$"4#C"*2  -S;JI#Y
M2@!ZTHE,8 "$LXC/'MF.+H+\TP^%(YVQKZ=G9R9.T&4GVP(1;:,ZX*77#;Y-
M,C*I--PZK*!'!IR)-=>Y+3.>9-:EV=E#=Z1:.7JUR5SL3)_TL;&])4)_@"F&
M0:YER>^!-2HZ&)&.6EAXVK?7>FU*D;::]%::J*?P%][^QVI<VN!Q78\ )FW'
M'NF"X%G#>LGZO<I^:O[W;KU1,(QEAF[B!]=A<YL"T]*Y;\I&.@*DP/FN>NDN
M5!R-T4U]K+Q(V&(*V3;(4H+*E8E5<0<7YW@\KN<VW78EE%\-X?VJTHPJNS[H
M8Y$PF3Y@(U5XY9BI-3*DN7YF-C9T9KK3# 6'+W>/_7"$G21>USJ'!U/$L8I(
M;<M/Y"Y<7;[''BI>L;JQG7GFJ;3\^/Z%][_.:&EO'D?ED+_&U.](#2$84'.K
M^QT[,TJ[CBQO+,^GCFM1*PIWZP)$NV.+$W,,K,S_-FI6Y1?M[A38.F!*Z=%F
M)1:@)H6TL=-N9TL8'4TXK"F2;'<7:M+26;?6$$UAT$]:<Q&ZI#_$HIN?%\&X
M2;M<::ZRFG@A^*%$@JB,LEIM=NKQZMKK#&#N]K@CS:]P_CA-YJC[K50[>Z0U
M<%5^N-!Y3C_^=>=!5<6Q;/6)+L^ZI?ZRP*HT"NH+9D2^$91Z][7[R,L?<(&B
MSV!=/7':32E-P4[O1'>Z"PHS&W9\YD;WZHIH:P696I?OW^G269-6/,:&ET/B
M(<UIG1X?#"=:%VQ4[W^WO)?"]+(*&J9V_\GQN8(L,?:HK#[SXCUQ%26>O48)
MB<^!3\+R2&+[+YH)N[9M>EO$TB1$=\GTYL1FO=I4NO?NRN*5+NGKNPZ+,Z9^
M/D/&XIHYL7?!1O14EJQ]-Y2D;QV=>(7G3Z64578X]Z5?UG&ZOD3]W]A[[ZBF
MNFYO-#Z(6%"D20>E5Q%I2A7I(""]@P+2>X< 451ZD=ZD]]!K:"$J)53I-014
M.B&A$UJ2+\\]=XS[O>?<<<<=9[SW?.?<[^3/-7;VFGOM67Z_N=>:\W@ /?9K
M8GJM=[^:MWE\?;F\O]G,:1OWU)8KQT!C.<SB2?V12W.5]\1'*?COR!FE,N_7
M%+$\'Z_EL=B"<4MNOQ ;\P7=Z;+@/_M6PVZ_JBS.8NY?-__(==T@_LFX3-KK
M$&UQB1S@M>C%-D$5Q+<)>&+/FX/CMI%WS';U"8QB-V.]-45-+!JX,I&9R>JG
MM'G^[?Y)HZ;1-J'J8Z:D36B)R[O51D91'!$W9WF_>!J\H"%?VQ]\SL,C*W/I
M4LSZGP[MCM]9M&:7,-9SORT+:1<!EK5V0"AT<F(LN&BY7KWDS]IY:&B?UY'5
M^V&[A//F0(.U+N>'*#P.=Q1DC4%W*39Z^'>6'(TYL!S*QCU(5F)/!D8!N($H
M^SGPPN"UV]O\BE1J5.4<0,5V'USQLNFP:U2*&.>KPRIG@_C!:X^^Z"532,VV
M_5)SP_^<,P2-R<_+G_]=-.$$L<1! /"HG1( ^/BK'@+ +L<#A^Y@( "^3703
M +!=^4TA.*[QF//$8R ^#0$,;W)#=UEM%]46]4S;KV=(*JMK4<9D!P<R&!;4
M5OH\"LX<N/%$D&GZ)F!T^4<H4? ]ZBZM1M?TSA+J[PY<1]#C!TF]-@G P)LW
M[J#2Y\#K-TG_VB;7_ OP\&?0::3WVAVEKJ[TA8D-DQ>?U^VG!SG"%7OH2SGD
M_&I$>C]H!J!- L(8BZFY77S0VWG/NZ=$FK&DVBM5Y>E*=J9)O_QB;%EK-%F4
M]%^:_#4A'MG5MB. LI)?@\^SL>/]CO?<]_*.S]\>WFT""C=NM>;1N%XMW_%X
MR>?0-V4DF2Z!..%6?S4E667"Z"IT+N&E#9TI\ _HQV 1:2R675*@=>.!KZ/V
MTYB?7P?WT-%041.6GO@Q-[JE^0J((4W5@^62JG#'>F%K&8^[&AD'S5R:&LG*
MA7,=]3K!_V^4@Q2*G+V%E%5<8-'DWEVZI)6F<-@XS?&XFV4FLO JX"#*3+BC
M.#7\@=J)][/ICA2]G6G9N0Z;,^04V2I<Y02F*7&)A&8B0]_C;U]NALR*^^L\
M').9N<N)&7ND]D>4OO+/85MXWK/">S^>P)' 0MC_+<V(OYHA *:,?IXU='3J
MKR8Z[W4W8P19#[?14$@*67Z4;:/6/*+N3LN#F,98GKOV<M>%<]1#]N$Z#Y.Y
MGFI,H%3G44@RT&#=AOO)N?[!JH\K'C,\:Q>F%A*RPA :B2 32STVO9V) CN7
M]QG/Z.E']9)7L5@])P#>DN@DI+4+AJ(_2V&--BTM5>.*J@?M^-\6%\ GIXV-
MC0R>Q3PK+%'D;%2#?U:;,,W, US_NU^725W,RF.\?D@SWCGK;EK[I4M]*UV_
M++(>0A?DEZ'WBZ<<L='DB*NFN=0([OA4;%%*.?9:4SD[E[U&_4,%Y3D'^43-
M0 $*Z;JGKLE"RR7$+/1Z?U*_1Y-Z9F;X2VJ-U"=]P:.NE+%' .=D=59520=[
M&_5RJQW5_S.JEZC:N%X@SYL;.\TB@1[WNO/Y=,38EMVB3;42!A76XB=>T=**
MM811U0YR5\QP=O!'_T5GA+7:*0)]"3M=#HW<URCW]\ AV[$_MP>Q&>\D-+WW
MR$^,-@8,Z'_WD8K.&@W+OBJY=Z/R;F2G)"MT9O9_;DX6BZ,;R$W)/!=)/>L+
MKRX>]M"JFFX\K;T4:RE2Z84G#8Z_?KM5'J^;@?&FU#+7&YHL^=)#*YVYP#\Q
MAP06_WT>#MR)]S"?J[_0_+7GC<5JG\IA46&CJ 4I^!FWL?LF2Z65$+S3,].L
MPEDDS44__HLLMUY!-"G_"(NMG%Y5R8*RCM5VYV]A\U/5T"O-,R*406#708/$
M9TJ9S0'ZNRM&(.>9_821[^YWY7M<0^C1%Y$=5R9%L:7LJ=;YRIT0 )K81..0
M_#X'-MAE0&N8/$8[9:5MY.?X[DZ7BO&9'*9_P[^ZS7G1K-J?@TFZYTM/ZV\5
M]:Q>/277$9[X1UBKK5W@W#^BJP)(9\=WZ?(*($>E'3(GWZ;\[>[5\I3;[R8!
M%6F^!+S('66L@?>7EX.LM:J,&7K.EF:1'=A7\DP7#K@,]SA40D9*F/O/8=D@
M" 'P4;T;.^-4,VB<GN<<D5ZXL,9'HV)+0QEDH:#%_#KR+;TM!CI-D9C_Z-1X
MD-GZG;M[)[ADV!47BP"6@T6 Z>%->V^&AIOX&E9 YB37#2Z]DBNKRS\GK24X
M%FBD?JG^;DPT.0+@O],#_P_I 7%['[%,?IZZFD@!7?* KD!76O??F?A0L6.:
M$_&[^!^BZ/FWHA))):"R=[J7)A^N+A3:,")H+P8[4Q,*WC?9OPD SO#GS'C-
M&;4K_QX/9,ZA#D\WA,+HM(S'V9VQ9IMRT-"OUEGQ+X=WP3'V:8^*DV8Q#57W
MJ^ET>=Z;: "OZBW1P]=]7OX,E[E5/*BKJ%%_?C(&LC]%(]+/%]UFCUR0["WM
M+A-_NA&!OK>6!CZ'_^BU W@Z6:RR#P*+?4[E$*BXB-\[;@TW=I">T.OC;P]I
M]$<( #=1$IEHI61]@S%=1DI'1<$,SBV;;HE$"2 0&/N!92I5T:R>(S%=[2%%
M/L7^27;>^AYP=KAQ,&CX=-C/O^QI_4""3H3:K-+;8G_/KOOW9PXYG1Y1Z(44
M#GHPBO?M)93OAK9T%7+S\35("W E%U6^<0/SF3V<MEC1F^Z LVT4MC?4HH9=
M'/T49(39*I-(*)J-Y='>H5*)LEW8GV%V<0H=://XFE_?379K[<(5=ZKU&D)Z
M2_B)<9[B)=LK/]<<29[YRR,1Y1OR?O[=._E>:R*>&BWR/=N4I6*^POQ-<"&-
M\[+TTE4Y[NR721EJR2H*G1B04?VW3ZD?Q$AZ]&UJ7KU^0THF1BO&F1#!BO!^
MM-Z.95G\_4"Z9G9K29WJR_+U%Y!(RC=J#HP+Z^_0C_N,]< -]R^IP]Y<C#G8
M8_-^I=;<8$T=9!&S"W(&<TGQ;3]DWLDKLXD*7Z*N6%!X1/HY%B,J*')@"Q^X
MQYG_A4&6_#D\&QW$XY;CW25??GN:]VS]RV\.A0U,+W^BOO[[X'M2PF\W1<2R
MN@=V;^XMX')D&$)[[JBO6[QC?D$ 4/R8(@ J8B+^*GIQ2TC$[=5O@\LGRW5Z
M>JW[(-N[AO)E*]%CHXD4&2_&7)X;H3P2W% !;)@Q[W?9OXR*%N_+J\S(/N"2
M7:XU27:D4/ZX%C:P).VQ!M,-\+'=K)GW/9<M3EC*,O-U>&6]/S1X_82VE'9$
MK$I3,E7C&]>JK[UB07U&1IUM&\*AL8;KT0(-7JJBP%I?5\-K@!VJD'=T",4,
M_[Q4%0MTXXH9=*(= =]ZT,U<4[E>(&5+V0UU: 4/:<RXT%5+J.C7A]GOW=OI
M41;+]8/LN/P4]2FB5DW)"Y'ZW>M+O9^F:Z6^?MAK)<L+\5C21'A#S5GRI"7+
M8[XYZ_2^5_\30,'QGM?1YW!;GN.P^6H%8[DIBK@A[=<I_]F;;&MI8-;F9Y+D
M+;KV%3.J9MV\W^;<6%:_['\\G>2P,C2'MX?8@O[()A( _@9Y\*\?_Z\&@+/,
MH4>PM>B_O[' \=6:,[^!:5*;DO]Q:=09HDZ+4YSA+G((@+N61)[=[GD9>TX
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MEIR=IVEGSGG-+=7(.6!35O%IV"#EQP&G.EE.G:]1&+4??)  2 =6G>>&A*W
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M2!@'"<W]?MBG&+&_2RD!_X_V20V)7YDDUP,</.IB<ATF3J03/8XEMG=W2PB
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M F&YQ;Z-[2<^!JD5/MB[+QVH!/6BK]?W;CL\1R%E_5AXWH:\PGOJ^?($8 F
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MJG^[@^+?,6"*/6PA$M::^96S1%L" )G&T[#YD !HIP*-RI^?^46RA>R=LYN
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MYH"S31I/S'/:V=?#[ +A# I,=5;;BDOYS,'4:T(WI!F6967G+*LT(Y/5/0F
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M/]Z6^V>I!%M#DMXNR<[DX*J*,<?F&!]2@@/WRYW6.,,Q+DW;:5](.L>)[">
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M*)MDUTOM)&I -B&JK3PPYZD^ EAT&^FBB92\%3A@?OE?(;7]OW.@O(H(M(:
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M*,\.H"CSJQYR]^'4M*QH5[;D;-&K1$J)[Y<O3,G^0)LG[-^#Y\IR'S\>*1Q
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M4?'3MV5[;NOOW6&)SK8T:2V"B>-JB3WC4VJ=ABE;P1S@5<F!T(,#W.]8A=G
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MPP(71Q)L;T;U33$7!?"F8UV<^9,M>K$G#?)UUQ'HH *!_P0;,Q3[R'EDS+Y
M!D2"R0 6@Z"!W,<4WJ$ )8XK[1YATG,I>6$_LID,&+(G \K%#XP48DZB_]/+
MEC4N,4E4W;TW*=RO&4X !RJ)-M97^0>,*ZUP_L2\R,W8I)W'4R%A!FH=^ZDH
MK4*9XL[I8Q@TMN#UTMJ@OHWX1/484D2H[F2S+)&' (ESRB(#^E[:.7#3R&Y8
M8*K,52[?SK79I/T4:V?S\%XEK= :HJIQ[_DUY;II-?=5=>/^29L/5>$\+N=>
MFE;J) T\5M$6TJD8L-]R*T,V"[JUU/VJ]W]J=)>SX6ENRW/ E<GK#2NE.:]9
M"A-G$LX< <X\UK([$#B3(Z2 ^;?#3YYY)9N,+WE),[7>V[M_[PYP%6&[6D:O
M\6!7=>B*B+CQ->%:*OT5]6<@T]G?EIC,_K&VOX9/O>!RI*L*EM%=*=\S67)?
MZL8*XGTO.![<[";U;*/;)QI .K<Z[=9_-9^.6%L^N-K^.%TR,JLUAN?SCI9J
M;X(1)2W%(^$#!-E]?OSH#S+@XTW;+1K,^*GD=\L+#8'92^>[MM!M>M5^OK^&
M)\8=EBOF\4--AM]791HYF=5:76H._-M7&/C<\VMS@$+BQR>!IOI-E.$5_7MS
MI[*2=&T YZK+WAHKL?($=]N2U+^@KE77%HG/]3AM2:/OL[B:*QP_O'Z\&K\"
M\0O^(*KFJ?JVGND>E63[#>,>5G10.2-^9S>/?R_HATF_;K0"2(85N$KP7FIZ
M>:CS#?A>A4,NOD[D?5;R#?JHZV^HJ'4$ED(N$U[-04X>_M[:]#9(B K%:D&Z
MD;IGC=?:R<U>:#/!OX,/N\K,3BO1\W09VN$Z5CK'L96)S4"_"/ZS-$IS4VZ"
MP&A7V-E59Q8H756: /S]N\HWOTEE6_J>T[%?>\=9,D X+PK,$,3RF6]+L6V:
M$"X)=_Y9ICF]OF]9UNS-"A>(C7:JI!^U<:D;'^6)VDA]<=TR)DT1@S9#_H/5
MIOOG$OS757H_SYKMZ_' V"I06&8D6^P1VRLIHSZV0:;>-QF6?UAK75>:#JI^
M%GQ2QA/@\_7T="L!CTOE/!0L(,7A8-S(2J!B3A"!,,.YOR.HM&FD=LJZ,ZL&
MM9H(D</A<+5*:_.&X E(PHGL0GV"%:ST!+2SLV,''FFGI.-E1IP''G!G#EB0
MW@%F86&^EPS("] C _0A2NL+H6,*@4<%&T@X')9(!BCN%9"*#,&C':>%@8?;
M:N-0,#B(FQ2RHG:J26FH((2@?HB932BQ(I&.U(B$_H235$H[JH2C1 RR@5,'
M]K\KO<V-A/Z7*+U^$_]'/2Z]EZ-J&.3N 5Q]Q;2U;<P(<2T6C=OD5WY7'E%S
MIJ+?]O;LU>*E=>V6([\!U(#7]JQE#\/,64#E,]HBH667M>]JN2V:HD$H7A2_
M7QRO>-+N:U-_+^&PK#?,=_[ @RC4[M?T7?#P4HW2?I_N[Q6&/DY,-XAT''FZ
M06%:$Y2N/A-/X8T"Z>"=NQ22RAY$8CU/AY_SY2<%") !F 4X&,J )"QRXDK(
M@-^4[8V:"QF0,@#'98#7:6%D $WX!2)6_@89\""%##C<68 CHS&GNW2$<4I?
M0,%?"AHH\<E^@3"H])=#>"*^AI/\V*,HS%,3?(*CT-1_4P4)_Z$W2P:L2.R<
MKG+^/H.G\\57,D ^OHMRC5?I-(A"'Q=;R8!@9=(!&;"&6?AU9QN\E^E'VJ?[
M?0C/S^H79$ .P@:\EI1'@E%H]JXEN.,VA5:#]P]WCNE]X?BG;61 0.3O4WC^
MQB"$4_\J^,)5"M%5PI_@B-3RUL1BBMG:._]R",^Q*Y/2FN=T'GZYY"^STZ1V
M$^N=]^#Y/.)I$(F*'4HR$"4#YE_^Y0@>HLP5SOWF+5WBG@$9@(13F+N5$!37
MI;2C2PJ%_6GHOY.AF>$Q"S?KK&_Z62VB@WPC0=C .$13NH>N1E:/B(1JC &-
M;N*5BTR-I0]K%A'3)EGX17>7**ZT>]^Y,51:+#\2)/<W-8Z0,P.ZKEB^YL9<
MY]C1][TIMP#G:?0^JWJ.HO\&,,Y2!O;3P/]&('E&!HB!DW6_ZF;#9CC[.+:/
MP].*=^H,WE7V^L)-??DPFZX-(-79Z-PK;I;>/[RD# _O7PDV](FB<C$X77:^
MHBXH]22ZXU^0<;3YF+"K5D62M2^5=1C<('V;/TV._;8L,R79+$\&-,E"^T1^
MJL0.1(N;176[:^,RYIB?,K)4+ZU;!;N+YL=P2E6K2:542N#I_D4QGU=*_R'0
MYOOM22XQ</;'SQR/SN1T-@7QWW]]W "'M#G:'00SI.BY5G1@PL[2WO3$N@8W
M.^^U/(]'^@;&/N8#YB9EE<7NC>O>TO]?^G;]QS8MYV]12D,:^J;WGO[<(SBZ
M8F>/47N.=8$]=45M?DTD^35G&5CH]FRFLJJ0)_.F\/R-5S^+LJJRPJ(_KI3M
MILRLWRXI(CRME*HWU!__:Q10-?B)Z\$V'+..^8LEY#&&WM,[C#1[L8F1J(PO
M3+Z=5@'MM3LXG=(52:H,P.P%L+QA XY/Z&S5(.BOK8<QY>O^%=M'_R%"S#]G
M7$PG%AU/?L1K9\\&P+KCT?)6EB71O38;G[XMJ>CWMUQ*<@BXLJYN?P?0Q'A"
M8/7*DQOH=^9285%ZW]_5PI7UB.DS_O!:4.8V0TG+V%>1P?''+TR,KIV3:TCE
M:YWX-1[M8T0&_ V,,5(@Y]_05R_RSRCP_[<H\*>A_[VA?0))XB#?S>/.ZEK"
M!0^W+=)J_@#VY'1!)-3A75F1ALMZS8$V=07UU9ZR!-5S^WX>7SB^/!@?]/(V
M^C:G"7EG>VU4@^M-3GDR EX&18$]?AQ-=6^Y%2;9)_E^K'^C?-YI,3[G$[7^
MK1"@KJKL_P8&6](4F+FU^=\);&/*0@PZ08*9<VN/W8*'W96:=E<EVO2%X_1/
M2\3-\X%^&?[O681)>=VPOT*;)AGP_ZC][V"DOYSB9\2:)[ON;J?M8:B0CWL[
MEC#7/-PV?8 2S./^B):(J@W(6O>LKQ^=7/&2_(/7Z#GDD(%N,TW-_7_AZ>,+
M_]&7^ES>[JC G&9/X^<79SFO!H*!1ZOK)26%<^B2QI."F^%S 4QE3\+N8.I2
MFH]K09X]O"E< X8_E6&O)SS^"KTTG/^$:/\/'J+,%;[^$BUI#I+T]W4P=MM]
MW^MQ!;JK6>&N=(V^^MO\G<515O5W_;-W V1;</Q;'6O/7=-J9@OU)'I:E<6!
M'Y.S./-,=X86_-S@'V4%< )55;8!TY)<PH'&T>5QFKI4^^O2?XL>6^/_?N#2
MD '_[&#S)ZK_:>C_"T,;)R,GVPA07\;>:2EYSML?\J<)RFYNU'(GD(""-/_&
M27HIO2&N_'4S'O6S=ZW^X)L+BI9E+6B>TWHU<=Z,X_$%@&7,5:%EH2DM5WGS
M+4:9(_$T^\8P)H:LK,R7<;;GONL7BFB+6Z62 7^#,4X'"59Q_V-!S:=^!A7N
M[; ,M?S:N/RE2,Z@0:@W22REU]J4XZ&2^N4#4L>!BMRT] 8("[/X1YJQ_.<1
M_-U/T?Q3\*?@3\$_^;^C?PK^%/S?":+50HCC&]!X^4[66GE:A?F9BJK9 K1A
MR1_A,?QTLT@C8WV^,@[(&=Z][R.@[P\M^8C35^Z#D\1:TAAS49UC5;9R"QH3
M#!;O:.]TEM;EG/Z8.>UHTQ+Y,LCC;VS_:W&JE7GY48ZR=%S-ALX;SF.06,S"
M+J*6##BX'DX&5'&,*$WE^9(!;\F 8=V3FY_\B#>>UV! 9, ]I?70".Q;?,FX
M-7=3A)8=:#D(YFU:V6#6"HD'7V"4X&SX#"DH#)'@-5P>6*D*&_ATIC7NN(9[
ME5:]8Z74."B/3NM>K%.(FIZQ.SU3?F[$@\2=\R-8&M2,VZHMU^-QV2C&=]^A
M+&R;]RMB$C0/%'TC[5VQ'S$Y.[.P\+2$"[6!.-=56?>U_MX.90:.ZS=SK=EL
M)Z6&;SS1$YDW8^9^:/GZ%JE($>*X>'Y_9V'5\_6<$D_;V6H"W2=%(7N<Z$^4
MY8VQ$/&6Y6GFP2'&V=) EO:C]?E[/0D/:K/6!6]%)]^T?G3%2_F.0Z:176Z7
M =1'@!A]3$"3 2R!(R"_R&\=:]C8B$T,FXY:P#))$>?HN!;Z:#MN)N9;:1FT
M^PFJ$2[6_*J%H2#^\WIA]ZKSX.0?+S(YAY83C*!6ZP@B"SZ.PKKO=RBZQ>]-
M?_BHHJVMHHI>")()[*XJ_>I8(W!C:LDAU>A!V5(N=;1SL)-#8>XE\WOH6:E=
M>@Q:[*1S6:=O>QB]$U\Q8Y02D+Q[4FZSC5[Y^+F202\6BXGD-C&)_L,  ;VI
MK?N8SS[S?6D6T$]]N=C-'(,V3/,XO;T%7T.,M5VX/0<K[Y#A6S^N;&V32W!R
MWYZ:-&T'^3YTCS5<C&308& 4S5#ZY9.T\80#^\@+$MVX1SS!F:"PL/\3'M3A
M9^VWVO$HN'1N@2XPYM6RS.K8AF5-4U-Z/W88)8W12 RS7!Y^Q4IWR839N::%
MK?L!@Y'9@[>/!.^LVT@=W!A?=B!D*8Q#?<2(9<>P1WO62QV.2_.2-7YPK>\F
M?,@$AC:YS?KQJ3&U^LU;6=0.-%S2*FQ19Q \X%>QG1I[E@&_$%;KX!G6%ZZ5
MZ?4R3H.K.*99"^L_&L__G&M \"=!F5C4RT)QM_6_2*NXF<0,/"BTTC#+. W!
M0'U*_WTX> (MSJJ-:$S*[8 RZ!EI&&B?UW]S*RG0,8>Z\HF0$8VVI-;EJ^M\
M)6E<7RYQ^[3F@;"E\C]@OOANRD!(6&680B4WM"G5'F$1F!R(;]:1XD[I7.6C
M\TOI?Z1(I22V:)J;!SH++4?S1N2*+QDARP;:3'^Q!Y43<5;_IH"QV'Y@>(!M
MZ 7<_.D,>]TL^\N/TVVJR4*/T9XM-X"G*$/[FFHM=C=#>C*@:_:2@%WIN_R(
M#B8T'YA+_IQ0#0+J<[KK_<((A]NK6Z]J'O3(66DH)^@NZG2C\!Q?4 $.,;):
MHC^_C!>F_IKLMYPOL4CS&H(\--,Z,QL93V>U/D5TWPC?72H(7"C*#L'.#[IW
M? %3A>QWN+"T\7]PS 5&)/DY?BCT9(XUW UX_DB7[5GD2R;;*MCWA?]WX)9/
MR5"5N'QUU>P#/5P=7>YLRJ8'^DY]WZQ\TVA>;S!AI)$%B3G. 99J<&[7W%MX
ML"<;JSH> I/48#7L^=W,78Z_MI6$&G=<])M'];G%3F2: Y_&NBSU_O Z9 VZ
MK28ES$'=3WVBP07)KRA.-5K,$F!(C5S1,,#"1J6/)_=N^"JC+8M^M<$E?<S<
M?VW&*HJ!747V;A5W-IY.R\>;A(6_8J$.N6;@L&ODV:$D37\5\712/=6GC$V:
M+S<[)*A@;<?ROQ[E(4VD31HR(/DF&2 4.O'[[_]R9'$P)9&,V'FMM,\O*T;B
M&1PA;5;/8Y0X!\I+:!/X&P/A_RA4ZD_!_Q"!"XR( F\5-)J0;HNTD %MVWT[
M/"&Y9$"2'7Q_@@PX!')4G]TQH;@P#?Q4B.+#]=D=D*4YZ)0DR(D,Z-<B]<L'
M4E+CZW-@0@<J=#'!'[R<>9-XR']JGEV128" ^SL]R0#-#?@VW_CG$1+]V=SA
ME_!T6EQ!9U91P1PL=3*#O?=@_B$5]7(H,4#3]&)6:\2[D-"PP?*3: *":FD*
M?$!Y/$U'B3V69&U-)U"3V,D@E4.%;+ED#/BLK6H5+=?:* =@F:]RSCR>>-Z8
M;[Z\OHM!<VC8Q#LM1SB-F=JK19L6/>*J[17N[W=G-KU^D:LK"/E[B^:Q;B/-
M/O/.JMAH3 ;:W[TE_'[UB_P85W?@:8.E,D\#"LHQ]GVEU#'RMK*)GHJ*+JLN
MC:;.DXO]/Y--VN#I5NM6)#TRX*;<4>@IR>Z>L.\Z]K3\[09=%O-I26TU@7/Y
M_/Z,5-VS[:=3/R+B'VPKBLEJT2[;1T?3)^Y%&>]]3K07K>UE'01_1;8RA.HL
MX8ZL\?M$EZ[##C!=?1.C[H\J_6CMF70$F,75G@U?]8TA-45*-$[;+"6:_7&2
M7,%1C*1P@X >O;:68CM<$3:FM,(WOI6W@MZW^ %W!BWT09/8<QI(3_TLQ;1Q
M$9W8X;YTL+[=K6'D8IE51U**BG)"81J31%V?[A6I#]T:T@IR^A<%LDQU(P)Q
MQIS[Z2L,'I:^\)Z1V SA='NWS*"]MF"L#F*!76T*CQV;RX 53*5HZ9EHA_6X
M51A[BS$:*'S(C7]OTAF=?>S&7%%.I_LL9;SX-=1JLR'4=K7M<G%Y*Q2FE)8F
MA(]SUYG\MM.N(]D0Z (^0/;&+37B5-%2!E*3+4X$UK,*\B;*"C0T0AK:E@P&
M17:3 B0]YH^FU+MD +_5N@;))WL-WABI2K3'SC=@:5<PK8J#V.&"Z:#T3[<&
M]+98^$E'BQ)F\/K>*?V?SG["("7/**F&ZBF[U2+J+7CG9.K7L4-L0NZW8XVY
M;+^5833^9:NBDY_B1DGI;$"[ATUP:+F=O$QQD_B3@XF#8TU3WH+PFZ^[M+DF
M]+_*R$!OBSRY9FBX7)AFGB=3CFRM5D!DE:""@A2:(:.%15]>UF9",L8CG':?
M/< 6A/>9]K)Q'B; *%P"0;I!!E@W$RXO(?K$/J#0Y]J0'1T61XQ; \OM9( G
M[AHBME,7)")<6_ALN7ROIB?I:C_D(A6SZ4P-Q2? N>=-FGPO? O91Z'U%M U
M$ZEMC^'V+S&^2"ND[5VI%J>F"/<$9ODINV0F/Q&I[YW&P3:1\EHZ7R0F#$9*
M)0*\ G&/U7H=MHU)QA*^_.8X63N0^S$&'FD84BB9S16LAK9;F6V38?M8C9Q:
MJ<EDF7[IJ2O4WGS2*KBXNJ&O^[G^WB$VYD(G.#8G==\6[W] J]L2:A+\=C;1
M04;4O<#=X.#H-,_%2,-,QD 0CI"ULBD2K&,MX3N\8D>_9VRPM/B>QR$KL%!Z
M>RD<V7I5*9FN;[A[RSH"G1OZ>,<U8G>8:+-=U85YGO=R=;.HW\CXI8RO+&=*
M?'%CE:^T42H]'&1Q,^V9/="_C!B_AU$\0@<5E73>-B(BY,(%]NI@W@J1'(BM
MTY7IC*K839J2:3RIIF=[J+Q!(OGEK:06F6%K-N^@-$@;@\F#&986!ZF*;VQ>
M8UT\$NO1ME ?7K"8* 3?,/;[SXFIO#NRA98)$\VT7Y6VH!Y/CP[<,"U\J+&A
MYP^8S<L8RCF8RFXRVC+4-1@:-!AJ6F4\I#!PGZ<D-C!J3RFSA,0M6D,&S-$4
M[3B^QJ =8R3A@0/X=="(NMOPXDX@-@MMS2R!?I>TN;TV+P^MONN2 GR^+98K
MR+9J?9OE#5$BUYZF''$_2?T " @:V,>@%<@ R?8(_&9".GQ R ?4Y.G7V!_>
MHFAUN&#EF];[!>>^7HAB;C=W/.HE!%8V$/6J>Q-H5 PE>>@]58SH]WB?>Y]0
M!P2?X%0=\6^"<Q:"N$.#7QZ_&6/]X-JQ@?>;MD;C@ZXYOZA,!VZSMXYJ-=<>
M7#/Z:J AZFYNDB0,'+BLRF-6:!.?* O[ ]DJ!!]*6#P_-4T&  B((%#>2S]%
M]%RVELO+%72=N^(:6B%2N\VS@?F!FT((XV+^B'VME)'1=:!F5F!]<7Q^5CZ/
M*4]TSDI4>WL@3N=0[TA&'L]V&$_$<&QLN:?/P6Q_@3T\9I]&/B<#+I:D<Q&"
M7)0-V&GLC949K#\4%-M>.YVS=%"L>1[!P$O?1=BGY"?*Z5_,*>,<O.+XW4UC
M+B2UGL#O ^H)[- 9^39E@Z,-!2+[[?LS@3@=^?O:W(9:2]<'>#A>P5<AMX+4
M6Q\$XIYHX9^YZFSB1WX%B5C/*PD$+3$W2:#[IO.Z!4_60@U?X*S<H8A8FYDX
MI'%JRT5QJ9A\N><.]_1[7%>K K,"KD?3-%)HM#?I64@<ZAXM&K_QJZZ6(._G
MQWAY,<]U\4Y@7;!'>V'F5DN7NV;%BKS>U-1PC^,UM9A/:?=Z2A?3@(7O"\_0
M<WA8P<8&*MJ\O8D=)/L%X4#)$"S-3/3Z3A2K@;.-3+JQVU"W99W3?F;.U!NO
M^T,(OOOK0OOBWRJEI'RD&:XO76,1K-$YU&+7A>F'0WTL]G9Q4PB2J^XOOQ?!
MS?A+R)!KLPH*EO,6RM>B^E\2J*'NR]1&6;%NTKY'W["!&;_<^#AO_1KCJ4'H
M %_&,QK&%NP,0$$U+\X!+@D_!-0T#,'YOES.^\6!0;966F>!N7&-G!T=?,'\
MFS2=!K6$FRLRZW.9"JAI0_IG)I,_?*W-1[53AMEL#('1PE,.N6F0K/BRSZEW
MNHQN' \.7("]0;9>4K0*EL8+U"I]1SJ!1;5W.\05VNJ:IB02:F7( .?@L#E"
M$UVK[_*OIH]KG]!FP3!157_!EZ\U1-]6.O%E_D@9H;EG39=GM7Z5%'"?1-H<
MAJ[K#&!T#K>VZU3:0I5!"$.LU4<4:W2D\P\,&1"[M#>C:Z4?0W=^,5$0>+?G
MTE2YD *K\AVN-^HO4%:PT;I"DK5E61K^]LU>!<(^>-G!@*[EB.,G*B=GC-76
M;UE&]!)DOUY,6R?;N.V/#YW&;NVJC'Z:6=+F ;5>AH_8#LWN<P!K%"E@SP<>
M,."?R>'>7UMIZLQ+#EG;.]L8=-9MJ49^;2D"W-@&!7E0LS4.9JY)WU"+J^IE
M8YMYI&T1%5!H+IO(%WZ;_7Z4 -]DW<=#;/R"XU9L4S"1B JR<#[:"0*11H]/
MQXRRQUN=Y!9:_&3&N^UE+S@;JVE5US28!@;^#$O=-?1WZTXI4U8#)DJ?D]Z=
MTN\?%6W%&>U^;QY)MRPB?E/*\.L^@6<HU+=).MK(#7#R.R)7G);GFH-%?[RI
MU1MS$P8Q"G$VO,J$[,!-@1+5/Q>E1A\^I:^=&*!1X1NAC'2:IN=Y// 4M6%H
M/),:_AJ:DXO$2:Q&IZ N\T9B*X<,8'M,T9M9FW*"9>^>YBU_MROC&]0W02CP
M*MSN>]@@E3S>9E"Q!+Z*08N!LV010XEB^SPD4_G7#@35;/EYRYII?YJ?F8BC
MU:4>P]'1;>;&9-N-H[F#F3N%LV4Z^.#P\"B@JC.O\_/Z7'@@&V60'1'7=IZG
M[YT<]]4UZFJLRKIO8#FPV\_%GAX,>[00SDJC&NB9+4\EZ_'!\;J>R&4O(Y^,
M#.4L?]ZR))Y<3:=!U0P-3MB50VP:#/Z+$7I_PDP@L+.#I+P-3VE^+K3J"PW5
M0*.2BLMOYR$0J^JUT^:Q==L%;_HF;T4_M_/O+2U[$2*5^.VJ=2?4IX]8'.J&
M_5W"C2D;=*1]SG]^$<.^\ '#,6KJI/1.S<0B-BP7DL?+?L>(OK@JK8C1Z7%I
M/$3P]?O$=0ZBBASNR1+^DX?Y?#C)@;,_J/677:<)K,G]>(,=>73(EPEY%=!>
MA>HQ['QVABJ7Q1078OE4O*V6Y:WQ&3X],5AIJ4)0Y1L8\K^>Y?_]J^G_Q_,%
MK/O9RR8A(%$4"N:]2Z$/.V+)Z#Q&&\N\)HA==,*U\.X7[>)([--#2VUCQ6AJ
M4T&7.V5E-J6]8Y5&3^?4!\[5-"*L,.:NT'UODBO\8L>39VX>V<>"#[ <Q8'"
M'8[ELN>[4??.)=-8ZG$-Z#7*GI\JB1 LB3,V_93[-%[SH];-^$_R%9'H@_!.
M**@Q=PM_>[)-:<E7><5*5V)GPM!23WO.!Q]H9V8/Z;*K&5TN59%ZV3]@8$U_
ML/N5*4A#N/0-S.1HP6HS]21YE7_(.I7S,NDI&7!7NVR.*3ZEY^  5IF-H4OP
MU^E $08N6$=N$)_<CZY'F[EV2+AU&WRHBIWX!HWMM^52C>.[FGC[G8@F"PB;
MD/"-<U4+F2>DR+9&TL4^ .-D!2;I,_MIL;/^[QW[3].T7/74+&]W/?DR,36^
MXNP0IGDQI4\@S;H6*?)$="A? -E:I$3IQGOP7*C5,T-B;$()L$.,Z![#?2YC
MD%Y>U^%(Q4B$QG543>T42QC-&K'ESXQ6$TY0BXJRS^Z")#'!IBF0T$3Q$ %B
MMR 9D"&FCGU>?/CM9^..-TC4D:&IC9NSZ:SR(Q/:']$!-?>C-0,<<@/5,5-)
MK?SO5E[5C0V.RL:E<H]3@["M)'NE0:%FQ6N@>).0+:7HMKS0%^M[TZ=-8FX>
M[$/OOVX'"FYU:K'?=;7GT ^9^: L#&S-9DXH\.82#CCO>]&'*A"G9;TBOV?=
MT/$\^#XJY.<<_JF50;"[-GZ&WKOQQN7S9Y)RT^E2LJCE- /]&4F"3@QZ5F:\
M.5_:Z]1QMJOT"D'E=W!5?_=\^C\4&+;MCR_#]QF'L=NCXTH#)@4+WB-(^N\J
MJ)S=K.?4!J/VY1O7:UZQNM.,6JA%]=LY.4%*2RKLPV_I:XRE;R>I+XN]U%6$
M3;J!17;69/=RVU:,+RR:#)=N2)K1;+<78^1$AI)G#-D]F^_*%P?,9D4R)^7W
MC-N*[QL8F5!]IB11-/$0N:B78.%H#AF46 8&;5ZR;T*RQ>N^M?"KE,.5[;+Z
M>1+?[SSO7&Q44<3L:\5T/NM^0)_L4'MWO%9+#U)5S"3P8H^K]UM 9HZ ^24(
MI9L>B@V(98<<$JO:ZI:NL._/@1;X KGA&[C4"R^FW&G;4 19Z49@X_/F>Q@O
MT[,-XOZEFY[555Z7C"-:TQHAZHMIO!42[5Y\7R:1K770U 5N67[-0UHE3Y\1
M2Q,<W--7&\0XLS[<\.6^T_Y]MB+AAH4 ,_W8,HWPGJ47I97E90$V[U58OCF^
M6XM_9 6;JCS=)@Z"<Q#?<J=1F0DIT^QM3;ZK&UG!\3<K)5 7@/8R,!]Z!\[6
M@L]S\O:;M:J!(!_12.\!O0N9'$[]4L#GU'2TL*FQ'(4],J"BS661<1:?"*CJ
M JU:5]9:OLE J!9(FZGPS1'>2TR7)GVT:FU-X%<Q46%1_;S)K_+D(?;JLV@0
MMF$<G[<?@]\\7*'2[>T]\2U?) -ZUFOO:L1^5:X_\K STO\^-43O Y[?@3%7
M'$D$9!1Z]1[X9Z29M6N6W8Y!OV8/*@>3]/,&]:'XL(/XE7Z/YZ*L[CA9_55/
MBZ!:<<(K*2F&5]B+)=DW,@I+TIS7"N-ASD+Y_E8FEQ6$AV[XS^@KW"VQVD0J
M_#=$C_^L0&]S<\-) .A2#KQ=6)!?DE55!<E_=,531:=H.1']WNC)0ZWKK@">
MW[4^3#FSE*3!'SN6N]SC3XZ+QLRP&<?AC=P5 ]N5NZ*CLVUP[]5?AD+<5<N]
M/V0O]CDX>8+J6X5LKV[WJDB+1F85JUQ7=_\4<(B-L]YS) $M$&M&HH1-CMU/
MJ(/3A:EC0<N?:LV^DRP_-_:/!01O?RZ#9+U6W]"VCJ\J*]"8I=)T9JPZD_BX
M_^O!@ YLK*ZQ(^1(S ,LGM- ;%&4QF[2UA9]M:W+U#G8<7HEQ=HDKJ$7WJ6=
M%BPS\YG"B5Y,Y7/NW1,$NC@)3MIGV:E?*QV9"\R 6FUR(J"KK/!&V?T;VV(K
M97O6/GI'?(ZL)C&AR3M_-#DUYBK?F;%L4F[E[G(79%-1D*$WUHBM\* QXF6@
MU]8[^^6%B,$9Q&(SU&K='[^]I[:J.-^OYR.[1]@XMUVU#T$=$-I"/9YN36^%
M7G:RJ=4?HI7F*1U$+NXR, ]VCB*E%:0FN[JI[F>6.9HMCG_^#1RT/OS[^?CM
MW;P5WIL:9( X4_ZP6P^:*:=ANCX[[^6+(UH/MT=9N\+WHZESX!HQ/5/?'R<A
M#%=-(;:0PHF)R4N0^PISI0_D<!:&P=';V^,3*,&,0ZBEG7Q0LU^N^G9H.09(
M/?UKU\0N]Q+0KJQ_N;A!AILJMB@,F+79EVFDIY_%R6MO)'R]"=DZ=7.5?QB^
M%OY+J]HW@KC3/_^9W:4=L_*4 S73QD_7[.LZ*?5D2)'E>=A7#FP!A'Z@\LE,
MBK/-Q,'>X/=AFU> 0)R%<K #MI\SB9.S%0S;G0XX.I0%NHK VVG/%WL:3NBO
MW#8N+=JGTI/X^HQ7)?DQGD%YP])<V9$]Z// _W=0+T <"QRO:4KOI<E+GF4]
M&^1>X<HNW[3.W[L-*[?^^(8_1K;9SLD*:,H;9V^Z$A7-.,$P^;[NC-?EV;BI
M*81[(G_6G>FY%NH]KNL/[J@X=;$8LA%;O\+;$<)8BZG3<XV^Z9*?JJ,N=YZK
M+7WIZ:.9]/[+5286S\\71B"4O/T1^T\R0-&E 7Y@2>%V)PES.:<O493 SK=
M\E:C7 ;%DP$3(CC2[Q7+(S5/,L#\I!:\XC:5$U<7^M#C2N[.-"L*N.2X@?[Z
MZ+R:EYLYD8WN00L,QO4MV>@1O9N0&GW%59G\TD&JE$0F K1U=L%MM/"&"O?E
M%%[])UX7WMVMI$_63,S+,[N&<US)&;!?*$G;&UL])W/]4\"G-%YA=Q'U9Y;T
MUQ\GZTB=PX,<X;*DNXL=-L3GV_"$3)9I<:-LU!]L;1;WGU6-?G<X.MBU>W7H
M]7[[=DG";2U J=&A@KP6TZDQ+N'+>,7R>C@9P-^QW^=654H&V+$NGY, X?JM
M8Q*24&.N;@,EK'I9LPW2WH8_]^^I^EU*_U0<!BH*<$X-4V$7'C,U[-EI/,2@
M.3RRP*(RNEU5GX;=7=^Y!N1.SMT[&;R@#E+EXLX<QL8-)2N?Y^>,[1JO:&CP
MS-JX18CB+@%%B#Q!#WIVO*:,RQ**!F+AK 4_/7KF4G6!WVQVW/=&QGTO.!IH
MZ[$''R^',28P1)1"'I,!WGJ/DR='GLV;,0 Q@GKLD\H=TTBHSS,R(,TOX%!6
M-[B6Y&ZA7-O40^>X\P Y9+G6XMLS,#1Q&F\MK9TVUQ:?%ONB9HP*,F1H;#CU
MK/L*O>>05(*).H-2_R>)@/96W&,Z=_<K;-:_/H-C?;Q6:G:-.-^:578(+$.>
M>%M*.[XP*;IU+@S($97V(J^T1_D/C]#?*[_:2L-CK=')+4JI+R'E1<77@A%?
M3#2!@M?9[XZM^"+2'"94,PHFI.\?5';WPN%B>3,4WKX?--=&!BQ&]N6%+PSJ
M>FP']^Q@XM/[/#BJL%?<KP>\K;$-HI8\%ZK",]J3ZC-I]B3,[*TG^&I\A$"A
MB(AB@J@GLE4NA7.HY*?,WJRI:\(SWR(E=U_%??/G'E8^OF-=2/:9M,'ER;3D
MZ],M9;;);$^7M%4L]:*CLW@#HX#GJ'G<GAUBHTSV=X8[+BSJ=I4U84TN:#<[
M==CZ5/GY* IKT(C?8Z]K';:"Q.>JI95OO<BU;QB,C^+1W!K^1K!6JH."P#X-
MAI/U$X<IH*M&HY-?&8QX+87+'W@AY"+CU9<?&XU.A%5<.G?U45/K(39+5H=6
M8:11EF,VS:\XYM4/K^/[@K9_9$D/&/3I6#YJYCV7?I.42\ED\D>.=95VT76[
M!K!6#W^N40^.3+SM-$I-.F+L36F_3;6 L.B 0V*$<9ZP]-V3.\_4+2XK<<"^
M]Q%/@,X_2&:P$?K#J\HB[IL;)\![*ZFVSG:6X]$9B*L\S&S*]%5&[C[<#?5E
MW'T(J(\P3M2658V8*\_*K6!W)J(<[^-.S0(L_*">(.I295=89&3/(YN5[Y_H
M&B"LL.Z)06N2="=]&I0&+!9CZP^E]KMI.P<-!H0EA2&U>FL2-8.Q_>HFT4_L
M07R;7R( 80K'NQBT"73O :H9.WQ<MK]FTYE23(_:7R[Q<EOH*,H!GC'886^)
M+X@OTV2<9!6.[_WV\R"'9YJ "@C)"2J\L!>.1TY97_>E)9*LR0#))E&AI1VG
MX) MD17&A:HMEKP?][(VV4Y]4B<-^Q(SC;/DWDM(2TO??5"KQ@"BL9<ZT):H
M*/+]UH)!6X$?!F>B./GK4 C/ [3Z'.Q:/7>XJVW;0QM@Z3J.8W%??4;JBZ[^
M;<*<SOF+G\* O3\" R']F;=+,CN^V1S\1+9"Q")2)PS #^"K=A\FQ_KW0"56
M/,[LC^\[(,;<[D  @*2GUT]XSA[(%E7XXVR_@+"9'>H>-)5C2B/0)5U[WV'P
MS6HY7&"P0?_6%NTQFD$KLJOCV5#K)X* UXWUHI(,;04N3AX(9-+P\WM)!-B3
M/:C0;]\#SS\>D(LGF;$6N'FX\JW,Y&CM*SMAM?'3_JZQTD' =Z]FM.LLC30)
M;YXOKE04%$2ME<>S1-%<46%IVB9^CWK0 7:TPO#O6Z$GV1_MC>#]R  )[08V
M]KC=)>C>N&OE?ENCBOI<2GV]6?^,LE&WP9.=<QC+N-X5*M9+L9*&8Q6TG4-,
M8%&@'$YU'%],S#C&P^%IUL'+OFI>AU/;X;5''*)Y-BI-?MJB5@7\/)D/0I1Y
M%7BN*^CYWXXV*:6ASK)7D^90H'&C50CZU.3FFV"QP[G,W5+:6$R<98UNL@\^
ME^RX0RVL^+,(FLV0FN#2ITR4Y:;WJD\Q&C*C3^21%%3? JBX:>H0*:$&-EI#
MTC>+=9?'VQ*M!XVF'G'(TDUEGK2GFGZ0>Y+1WF$&N?Q!.Y9+=D+Q4QB=XH'_
M(38:0>0'%F>!5W9X[DX\DIH(P<S<->JF+^=^LF=@PVN8^(B7.3])]H_7O&86
MZX]P34O(5DIV+<QRP@)=!1%_4DG;\SY*KFMT>D3U6-L[H0_K! 2,:0_>N,:6
MM\DY-N6N</R+/:@XM!^[$\5*AZ_P<\ A<*MSQR%S"M:3%JSVOL5!U37:::C3
M;(/V_/Q>:O./ADE+%6V.-U0B52O"Q=7,3*15E-Y*RR@Z0@YIY'!JEY=D;'\<
M;>,?M<HOL.\1BCO4B'5;;N4J-=5[BWY59SG$Y<$,SO P-_8F+0L#$UU=GNCQ
M20T1J\>MJF)5139^<?4NR-8&<" &[=))7 (V(7K$4JRIX!E3="[V?F#K@U!O
M:60.5"OR$4]]"FO9O-1*)=L%_D=)PP;*#X8_\+XHC%"CT6-R^8V>U<Q*67Z=
M:&2#S!:,'<4*;B68U"P5=1_J:KEVEU7-!0CW6(D8I@2PO7AM],/YA8U=K]$R
M=TE81); :NHV1]HDG=5Z(EBI8HXU:#&O6Q:-_VAN+TX9L:T>LCEEQ7%EMOY'
M)!0ZDM]"]ZF5\U0:,]]CU;(K-NK?ZR0O;P>3AF&3^+%) ^-Q@RF]B4<F:B;G
MC Q3?6HK=@?8-CGN<R=>,E'3IZ[FN?KH_#P&V5JPL,:,E&^";)(4*$[=\?&;
MVH<M>*3%U+N@\_%9K-IITVU5MAK66E)15\:8!.PJ2M]EJ]-/9#Y]9USTBU![
M L(FI'\5*<MFU\K<L=R-3KXV Q?V*]9:EME#3';9EB%&L9! <\N2L S)7KUJ
M5KG(LRH\+]XQB$_TE3ROE70ZQ)87_%S=13$EK-D2AWS==:65'[7X14QN9&W7
M1$$RE$6\W((Y;B&C7TU=U]!)K<?V7@JA^GBF=,77GQ8VAL)GNC&3G@57DJSA
MC(T UZJ-&?8!NC[WA5[;QY.B4[/RS!N/C>PO3AYY.181LH*=$A_F%E_-4[6T
M8L*@;X&SJ[90.=[[UGC%(]63@3$WMS?U!'@CRF='N)/EN;NTUXTM<?K423M_
M9RZN^SF%J9/7[Q1GSMA$JUE?"4>V.I% ;4&2"PM,)\@5NA[S$]$^"JTAM"\$
M+F-\MSR:G8!.-5$Z+<+Q<D#M5RL;K\S,@7<PN;FV])=IU34$%:YL=EC!)N$@
M<#\V85LIGBDAY3B$T+@>&%WNT/AK!*M)['HV_O/=.:ZGJ8R:9@]LLNJ8[R9=
M6DS4ZRHK49EY-"F',YHA?@CD]@,E(&@'MG,V7E?-&N7="2KW\1.=G)TQOQ9?
M48@";=#?,RY_6Y]PI2%:$,(=V__#0$MG4R,Q"D6):G3$.=\X1R\RX"YXY?($
M$Q-W^<"8;^/)0D IFU3KJ^F*JJ%^.P?QM[)7EV2&C1]>-HN^VB--=;KMSP&;
MZK3:^)^RCW\"5%AD7N:2EI7CXE 2E@3L?O<$RB"DOOMDS,)"C75(2##97G09
M8+J #JJT!.>*&:\J.@:/'RO_VB\5>%FU?5%FGC1GL29.=<-8+?S+#H3XP'-Y
M;_C=$Q__WKMF<E!6S2J2Z=)[9N /,]'BG* "3^+.>LTI+[%T>=,M_4KS=KE&
MYGKHI^XQ_5X!8V'CD:S<_"3&)W^8\R9<>)H%N!S$F3^]0<'F\+P5O4?*%L2$
M-M'HVNBDJ@3^V@Z+\>4R0><D?PAW:?& ,I<N:YF&WN(?3'=OE12&W<.M4O"9
M]W>Q+K9)%9T5?$"MD*')"V U3+S-]E,%5_'%\E=&+;U+N??8S1A])1_WJ(S-
MEOWDUXN72$N&@D(YAY2J??,LR  QCS0SMY^\3 5S[+)M)P0:7=-\91F+FK*\
MRU&F^EWMHR;&7R4^B#&][W>MJ:,6XX"-*I*4X31-2MT[T?>U"=/3 7<5$O>4
MI-\O2&=HSMY0MGC4]*M^3+G)"3,)O566"-R3)LE0?^<-[.1QEGNJL!VG:[6Q
MCS\E U"-0:QDP'4Z S!VDRY41R$("KZE2_ =>4YQD4?;>:=HW9T1!!3DTX'Y
MQ]H]_*]^KB#-*\+RP,=GXJ!F0,_ A,?G>P7UV%3OV) 0%8"9-Q6-3A#>,HOB
MR:-X(3!N+(_])[Z<>$C +5?-=H]K?5=B:=/U6/%FS10_6?=B;:JH]I_C4XR(
ML'5:J23]6N(=T!"\Q&!3/-5M7I4Y?_BIQ&J]D0RX)S)@U*+T<4?EATM[W;.M
MV;R8-H?XW'S=!U;"\3[V*Z/,+'H<SPO?I"'TSN551B#?8-!LUL<&E;S<AR5=
M$%Q12>"FV^&L3\IA)75]3;=%0F?[*,];%_750'_FB:ML".87FB+U'P-Q)L[$
MEGTCUH$?T,ZAR6P]RSS=^%-0E"O,F2'U:3U3O]Q]2PA[<!&DH^<2;]MU+,1.
MM)\5K<L!FS0&?XOD*ML6;3G.WO6&_M)W)^UO)WP0R)LFN-P$E%8%/CC/R1T#
MX>U(F4B:7+MCKL%C]YY7*EG^XD:A7:TM%.1E?:WCWL\.\6#+#=WX :*85(YC
M7?7!_:SI.^=\&C)+<FI;GL?>56?Z5#8\8F3"[-(;V]\=&V[2FFP%^RY-'"=<
M<#Z$[QWA[=/FK^M%*WP=#X)#JR<.HWDD[=M8,G\UI[X3UAIB +G>$#BS^SZV
M>(#U[AZ%?=_869;_A?(F6AT7I"S XB*3S\YP<N^;QNV;O:W\+"5=SPJ^K,TC
M[QL/,]^CSF2$<ELOO:@\8U(AH9I<V#D_/7&(A5Y !_[#3/C]JR ,DI;5F)4?
M7YM+W2K7S%M47@B)<HPW7=-/4N-QIXB2F-5OA3UBI-S^W0/-_J8^,+V$(%O;
M-#"J7"?#T8EFS?,L\CK_;OW7A(&VB+SJH[V0;R51MH!,YB[@I1=TK3CS;3+@
MFQ>)U3VT;?HT:H\0^G.Y<\*7Q)'P$B0B$G*IN#S9?6DSK4D@]0JI1CFC=WQI
M+,-9EVMIZ.&>LK1\=@LE?T^@Y._: T8=9,!'>,#.\Y*TX/C58KQL2W%2K6YK
MJOV0X\]4*/?E],N2?)_=+[&=]0AR/PL%7<:GK99,PT=BRG&^"WH)_6.^:ET/
M)I\>G'O69\!#\[;$4X]+9.6&WK>4D8I[3H"H<%6IH+U?&+1[#0VOR(,&@Z_:
MNN<.QWE57+]_JVD?4V-Y#!6Z<U[-U";NK#@/EV!XT4.:0VR#*AZV.\^YRDS<
M/E(S=MVRE%%[>2!K#E)1ZHM#<"AA2YTW7C$+Y_Z ?*Y(?U\([1^U+Q5_5ESR
M\K9-[ZC>Q'LLS04KC"NG#P;MO$'$*SH:'IW';^3%L^*6\GRVK HPI*'0+G1
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M!#?:GC'#8XHQ[K'GSLRU2@Q:U,\5II_-V*RF42'R8?_R:@@ _PG^U:]:!@
M /!O=Z<D    @'\. #L> P  ?W& G6 6J;.O.K!*F6;L&#;./FV%M2G2".*
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ME5"#WK@Z"M[%*#$)$/&&+SZT;1=R)'I]A"[!?JTHR %5 JF8GQVN.-GPOWI
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MO)NU,/&/X.0_B6&Q0ODE>O1/U)$]*(>PMW9E*;^WY4?9@;GC:E9L0_R6#I+
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MT*VUF\#T2B.CF5UPG4JME4 55HJ,LG@5SU9\CO]_T=6)*^#.]VR2/:L=LOI
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M'5$T5RI#I%Z,?$&Q[/Z0USA?4G,(_K5E.K__T<;:]H2\/L,X_%/O7W;VSX\
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M-$'\PJI/HE84@MTSSM0OUW?"36>TV @C#@\79+?H&[BY',UUO5K@^\%=]^
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M%)B3)[4S@OD>ZD;G=7N<:+9]X8A[/C@T/&P\-)B<W*_?J*.E<\9@261@8!
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MF;K7_%[GKW/?#!R=X$M(<NZG"R=?Y5;4QN6>-=Q[0L]H85!ILI\T/SARDK+
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M8L;^7IR+^.&QWN^NGTQ<:_87%--LG<UF;GU0W#7[;J"A-O1;@GXN'@O?TQ2
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MYJ 1'2-GGOTQ+60K>G3?WTS#H+X$"\L_QD@+&O&"U[+W;A]B_I0N@O(\0'K
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M=15W=FF:[)]A@;B?R<N:.UB.7Q\/GHW.?3W2>2?EHWZ(=:PB^6*1QX==6'7
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M1#\"H>#-@E TO[)QKU$S(;3;X;-?1EA=>;HOYHQZM53TNZWE7-U@OFO^M]6
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MN:-#C@=BW=@Y?Y^?;F;+*$\/PN#P>C^)'R56>R--B^N.C*S <5^*ZHDJLP+
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MHS/Q@0^7Y>^:&ANT*<M0\-X8_DC+-TP6R"U(;&%V)N2N_KGP\DAA U>;LN/
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ME.?P -(P*EE]:J8];<.[\D[R; .LQ-'ITH!90U!7WQ]^&3.2%;ZG$HTL[@\
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MY&4.O0-?!.%,!G5L.IA90<UIVC@L.)U F*W,29_E'T)I-3?9N6T3&W^>\WE
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M<%AT?Q2R*K4'7<:)=^6B4(:4+'7WQ(F,4"A5&S.51H/+TB3SP:3R4.A940&
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M[^J^>=7EC=]9%M;ZWN[#3R+J70=5QQW5;J1NG?3VM3;[T?[F4<UO]:WPA_<
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MLTD5A2Y\)WC'IG$(4@WX^E3,/<DBONR8AX 3_.ASMP'^A#L-EK+Z#P-/C9T
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M7/QD#;*TT=UW"1\S1N(-"QH5G^$_(U2^B;M7+ZTE($=8B(O>.(4KCT);N=/
MJ>:Z)5'LZ9^(4GVXQ3]OE>".'_[W4M6?=_1F<Q1_*9C-49S-49S-4?SOVTL\
M7#/C^#_..'X03UY0YDMI_!3D(?Q:QXUXI;0,D2GULYVV:UGP&2CYK')B-0H5
M -.J!IA6&]"U7=H#]\4 +@+S,YK&1R(E (63B=/U+66*XY24GC^RMSV;[#B;
M[#B;[#B;[/@YFE95 /=T=&#X3ZL!5YV+L'*19ERCNM#P<.V8=BO\BE&?QCKD
M\^HS-I?R5B'Z.($6+-*'1<_$%;ABHB2'/JR.-!?&8D,!L:1/+4$AJ^E6NZ[M
M4WO^R)[V;)K;WPEFT]Q*9M/<?K7GLVENLVENLVENLVENLVEN_V)I;AZ-L?6G
M^:4KM[P0S/N1NNS:ZR--O1-M.GE;C/?N-5QVV-3\R,?M7]].>- ZAA4ZTCR^
M@'-NC <AL 7@W?77Z5+\*"+O0[*QH_VMG-L%Y)Q_NCSQ$0K5U-^9VK6U>8]"
M;79"K*_)_E5G#HJ,J[8^=]]P,5D,IVR%^%.%X2%&'U<;2>-3#[Y,F?,>A:YE
MJ*#0A_XI%(KUI$N?XZ8$7604RIR)7K8\0UI0Z+'/&\SP)C!WF[/A"GAP6PE"
MT:9)>+F %8*/1BN5(@76*R6)96)KY J;U728A1RU1Z$[*/3>ABQ5)!)$ ^ #
M,_51B. GEE[*4Q<=#N#GSUR/F1Q-E\15H1"(SA\7"J;W=-%Y=0P4R@M 2L6"
MZ3X7PD2T+(<X/9\&']6&109AB 8*[25Q)[U+X($8X!E<9:5^ NY4=2N];R>F
MG34I:XO$N:'01)"RQ!&YRF8-\GS %.D2D';,M)C+8H=GP=4NN%SZH&*)=%\G
M"O6MP OKI5\QZ+\8/8O.4#V#0O=;8>>92T*G P'IJ-Y*':=.+Z+!\;5L%-K#
M@<7G8#:7#O]BE@13RX#MW;?"]> F5]JBD&$T _$&%L<'D\Q@^:/0R8P@Q/2T
M-./GBTK_ZXQF,D2[^?-J!JE\\.(&I+=\1)9K.;T>X<*7E<?@%<A\) R%@OR2
M AWHUX3EVJ'\_(=^+_5$/ 7*=NG*]^_"+L.F- ,R2:H7U22C<UBO+E'6::=N
M"66X-'-3$.%*O+GN<V%SPH+N9/^N3(;TD?H= F\ZSQ#QW0A\''QA_LVNF$,Z
ME:##CHMZ5DJ0C! 4HBZ IZFLXIV3[/;9!W__8)^NZ+Z 9>)9_T:QK+7S8FLT
M\;+;2*;UZ5K*R^[A+J?I%UE%K#DAF:$;0C>7QUV-,EHSLLMTU("?=/':6=9W
M!847EQ_,F>?Y4>O'X5V6@=]Y+!)\6>'*<(I:1%)76I4<'_@TN?+N+@A_HNR7
MVE;\XI<:%$R8-;7?;VJ_ [Q<UTD*D!\FZ>82K:'.@%8_2IYGQ-@K^*EZCSRL
M9C%NOQV%RG5-?1TNHM#%M1</S(^(5)H[Y*#W\ O!+;U!5EDQ-U][9^:&0(G"
MMF+YP\4'SY^XH&+8UW)@8LG](MO&N2L7'C,8)VWYI'5824;NT]=8!1K_0NEV
MN'ZX#2,:BT2A%.E/>W9.#IY.)W'_]H&XC&A2,BO_/W(C0IW&LYT$,IP]A-S2
MWJ0. S(%-W % 6(ZCBK$C]=/GI8HCTK2EA2CT*MA7\\2B=HHS-=X,.+MSO8O
MM ]X,^VZAMT9/ZQU[*>Q)E7^E"R9EM7)I1I/AF@6[O'S.<],>Y7@9*B@S =O
M^H6>C_Z-HLFBT*SU_#/QJ#!Q3M] A8_+BA6Q_OUM1_'SE!46?\#Z/NF)4-EU
M[$"K'[U)[COQRZ ;:DI+7^8L%>.M_)9!CS%[$9D8>MMK(9@!7)H]//":@"3Q
MZX'7(QQGLT:Z?<$<4INS<;QN=10R%0O  _*?\F#0[^7 ,W'\HJ .,KP.'_&J
M?_!\]N5',4HK$VB/TP,=$E.3+BV_3SI5[;)+;_!B<Z'G__RZ45PX+VWW R9]
MN=AYR]4JBS.7UE.<>LI=%W/Q1S;GZ+*=N[.;XHZ_U5'9HCJ0% X_#\V.E<U?
M+W>ZV3K 0#X%1./T_<32#+8--[+3+^MP1)?U'(?1]!@];=V<[LI7]SITO10B
M,VY>58D)M%K_.MMBQYML8]6O((VL(OGG;];8I5Z?GX!"$BUB)5TT0@;V_*,"
M\++MO*YB]PFVSWR@EC<SA (4PE(N@:! /QLGMB4+@OUMR#^P66/-=,69BY!'
M"=*O/4&HX5SO/UY?0SNG0$;6Y/>P)'QLS<SUPX @<[RY7;M%),X<&EQF(2'/
M7'5< $^N:\-(:5AQ)6Y;R6,25^C$HL"\5H$Z<ET7!&*Y _3+ WV,YS(E*+3$
M>IR+D!7[9FYFMH?YQ0+N6DDA_PJ#WIWFCYVYO;B#/OW-" 5AQ$I[J)&V[W4$
M?S\@ULR VF<'](<'Y'&D]+QDZS K&&O]4Y=8"4>?*'#)!+[7]<1MO^9P9F[K
M9"7#M;,Y,N+<F3>N)]=>/;U)9J/%>2N/G*O7P\]>VKTH2C&UQN0N]^\'PO0'
M+W;]-YK)V0']P0$9+.HEOJ[+&)9I$%9E[VR!8<89<CQ<E>MEL-]=-=_ITO)5
MDQW6<[[9]-)X;^[%D')M"LEL9^JMU,AC^SV.[R@*7'<*GV2N>M"#"/_=JYE@
M[&E_Z;'_K_N8_Z(#6NP3E'(1L\;?F^.?QN94%@WGQ?8/#TM&/17*0RN;FNR'
M(X)(6$TY^/7V70=L5VVH,-RJ\C["<L/PGB_R7)U-V2T_-?CDL_Z[1/#?L;'Y
M#=R/1R'[HF@4*BL"Q&.T7%HD6]Z,"3"61HXK]=CXU[63FF.TLX=553WKYF6F
MQIU8<"BLJ>G3D$/L>=F.13D:$<K35)\=&-OBY1Z),V=E0'0ML@$?)U8$3\=W
M%>^?^@_7_S</6#,/VF<?_!L^V*=;6BB;R&?5$(/$JE\QHMU7YFK#XS!WY\*(
MB'V/:R\KAY\6M[Y[FG</6J'$3'V3@CUR6Y%"$2O35]$'JD<H$@$PUV;%]G%Y
M1MJ@ ED:QKI#X/5Y&B)D8'C#%'\@G['M6?F_I?R;KKA!DT>UD@Z1'$/D5LP,
M%ZL[N[JH.70QPY=G[]1>9GX4GW/B_-#Z;Z^F5Y2>,5*6=/-[=C?(FB]4-:%$
M_JV.,6=T[*\WQEGYGR/?Y)7TAG+70U[7T_+H9%=-4GH<<_=PX8E;R1N_W6MZ
M."@U:D$\[H)+]=M5F&'LR $_GP]'&^:(7."V;=VXL=$NC#@+3X[^!*+T^'%.
M)NU_.,Y_'%^L0Y7O4K IF"Y2#\]\;9>/&R.\J+8[<]6GG?"Q*&#9B[BQ<K.%
M"L3 XTS+#R=#:DO:K(UH)]:7J/!7-":V6LL[N#CI%+ '^;:-S"*3T,(4I>#$
MO/^'O3>/9GMM]\:S=W?GJMT:6E6T-15%S46Q55'4+!2-M.8IYD2-V9W8U:+F
MHFC-8JHQ)$C5/-<81*1F$HFI1(CD%\]SWM]ZW[/>\Y[?^^SG/+^]SNH?_'&M
ME>^ZK_GZW/=U7W>ZU\SR^CIP1,@2&,3]1O7EM_.0CD8.<[L&F:&J:13A'VCD
M_\\)VEOS*1T-HEUJT5'C$^3F)%S D]()+;1@6:OYD,5(C[E69/_,4-S0)ZX3
M/1F!0OY/L.O&Z)QE!6*)0L"C@^'B?^I:_A?"A?[97>H+BN364/J26)UL77!_
M(CX6+2,OS_D]P=P9 9:IWCJ6<&T;4"E26G#)3H)7G_!6#0^^)XA%Q-F]$4!!
MO?Z!\___CSW;3$#<[L'+3OH?G^FO0AEFMQ>/N_957\5U&=_S-1_J.^O,826I
MR?_X"D-^\3/NJT81%?*@P";?8_!WJAWRS]Q:T,2Z02V[** \]<[5,YXT2+VY
MK?;;M)@L0?#K.$3%9FK10^"<NUC>3P^F"GW8%QD[%\MT608G)5.W]]!(Y3G7
MG0CQ&TY<4NHQBH%Q.7DYSU3< ]R$;O3>T?G)62BKB%J&'"'\5^GR;ZOW6EDI
M?=I W>E:[6M^55@\S1=$%< _?!%T/_J&O$! [U:0JQC"_EE(LL92''F7^JCU
M%!1A]=$ '_Q?8_?_[Q$U]S<5C_*=#B<*8ZIEUEV,.K;W,;_#ZV'.@BSP5\LA
M,Q'E*S$W/+=ES;_\UJ9)C)(7U:N?)P2_XB19;"V;L83V7[8PZ&GAV+P>A^(-
M8*=3=M<@T($D:/5D4M^F4RB_4#M>MB0W]\4QLQ-[L:R?7=U#(FJ-#2'7%77!
M<RZMY&[WR:D7\E">2_3<U\"WB886B^7"IN9B9[[,&+S5X*96ME4&?^5<UOZ?
M5_^OZ)K[0?A77='\0?BKW%W\6XKE6'3I953L&HRNP[CW<:"<"72*KR/!"QJI
M^UVGM1L6&Q3(OZ8OMFE8LT=X]#C*P%K>8J02:&G1)ZP@>>-<JKOH&RXV2N.H
M-=V-"7AY/M293$@(D9X]WHF) 4MC4K#!.WEVTKPCJB&++F9ZH[N4CMY%HLC'
M%@@=%*:CH[<BX4'\R/F @,G-+RA!)(OK!Z>4I(D'4NV("TVZH=%$@5<':NB0
M@8; .V30T^JKV?JOOF67]B[Y3_2V0=4%/5?)&;45)J.6"UM!47N=,KOO@6?D
M+( 6 Y=-KTIVL%A+9 )NG@G_,M7(]I*F^[4Q9T.#?=-#(W*\4;<A1$MM-!6/
M9(=XV=Q.-O (B'7%;H_MX>/(&:-)!>VHN:L9Q(TD()RBF"4AHOTQ/QT?DB.Y
MJ37O8D6W(*IUX?F0;WN&(6%-KH5%,KS@(PEX'"&($MJG[[ SUC;.JW3\*!#F
MH)R,2!*3&2?>PR_$40+:RT@L,7&2UW;-1=L;JW XCI)P![H*;9O>\$FM(.&A
M+AB&[?5ZF5X23!*T5H!*"M].G:1M<8R8#/T$XDRROOZM-#O'TLU#_$J!N<9A
M+[BNM;WK"Y(0Y+2.L'722.L@UYC0^2/VN?XADU/[+/E5^1#ZX'-2),8C57.:
MCR?=!>*L.J"!W4=6^Z7V8JR]HE]A+X*2:GTV' LKQQL[,*ZP>5S$Y>KXVQ<G
MR?5ZB1W*.<6;5AU"$IQ-)+PU\L_9,[&)$0B7.=NXJQ"!DS<+6.N$)ZH-8P1+
MB\<U>!FBVW8N=2'I/M\V@)S5J8T+ULA/#/GV;X7"I1'B[S,\*XH-Q%N,DCCL
M9"B-@]J[O/1=AF3H!.UTTFX(J[B=UVB!IUA86-\H$YPC]-@U\GDT4)/E.*)X
M5I].OJ;K5.O9'OW9$"PB7JMRJ2,OOQ!1$!'L'OS*GK6DSG"+T$H2^RM5"2^*
M(=6X/M!N==5P*8)T-F6EO^%#Q^*^0X.JE6\J_/?M)=MOLD$/^6[4^.6>'QD=
MF_>H&%\-$^*P<BQVN_XM.8!JMZR& RO=Y 0Q 9\8-P/7;"CE,6HM4[8N:JA@
MJ82@I1V=Q0D0EK^OP\$OA EP]Y1<JU(Z9G-LZMT)/S?3MY\=KWXL2DX2+NL(
M.^#DDFNA- XE_"4=<K[I7N@;(A,0E:%;KYI3N\D3#"E']G%QB0AZ?/,+08>L
MJ0VD%MT/GQQ''W'^]@U1UNLB.VJ6)Z+*I\?;4*G6_VX4'X9%96<T,@&G''>Q
MM2$A]M#87G@D6!V3DGR\>M/C#Q)EDA;]M0H:"W+T$"G+RRU(4 6KVP='7?I-
M(CN^6/@R5[6%>Y^DTUU.HLMA9=IU?45<* [5=3FJ_/(?S8.#GYT"G(1^U:P3
M9,6TAW^BR@'&]A,6"RK5+U :P):KA#=P:75((-12*M:/(I6[ZS*4.CW;OYT_
MT'6III62.=SE$!KP[H$?FZ;*G-M\D+O[;>DK3]U&>M6PJ/M,@"1\27-#@_:.
MHMY&S&QJW4FY%YJXLF>]R9>QD3 O,A)IO[,XU6KF-/<9ZU*X\=;1[ZV5Z= 8
MT-S<\;:YI.&9FL0ND.%]]Z(&E@?R$N(%;M8J=33B1L+T]&J57'SH+]=ZFPQX
M1_A.CQ5XU^Y,/<BH/Z.0/E<A1V,;3L?5-7"/X!*'\W0\U!)+GRG(:NOI\GGI
MY\='Y.!#"M4TM^2<=BZ$>GM'A6RY>ZG'TA0J8= ++AVCO*2KM7[2XR"-^#X@
M>5)JB@@:J*E2CKI!X5;9T]),T':WH3O=?]L6_S&/2S[6E&6J1Y8"MWXE$9X_
M@%1IBQJQ<($67G539;+Q^09F%@Y<#(FL1YYEYS(UT$N?!J:'L,_=]SKUS&;<
MOJAKK.=2=66)_(JIPAP_"<\)?HH9B)W%]F6]K0='HK.*F[3H2C2HMG9\]ZRZ
M&KV&-#B&'@ARD+GU,;.3KQ#3ZG$WZ9.)T.BF?;'#QY)@&_<HQ!.7_(+"9&DH
MI00]O];5]W'#__&05R_EZRIE&*^:(,,_3@I/7>%+!8Z#FB?34<%N)$'<OIR'
M^8A)*_=UM]RBS@4_Z)-59Y4T)43GV-!PCCY+@:7P-QH#[(7H\@6*ZK>L8+H#
MS73=8[Z=W-Q3%XQTIG^<" GYZ0]RVJF'("]G%%LT2G%Z<6 8:*%K'%T(!3QQ
M<@_Z& -#1-V[@ \IKOO'"NU_ZJ,T]QA?"/MR"$7N;?+9]JDGC5G8 _]JZEG:
M]'Z5,I"/FQ<"D2QZ5=SO=9EB5F;&K1*LK\_CDC0P:))UV%*;LJE$ZX0KV,5W
M>!'>OLN:ATZDPI_C-(QFLBJ5-#JGD<W4-KC5L&O6U7$>>.R[4VJXNIO<><XE
MGK [SUSR7BI8&1KO-[%#*659WV+[,I,8CPG<>RT+*9J63O/C?"F:X%#%^>Q8
M'M0.;.FS(_&3+=+)JR1 ;E27#Z;8],P],/YD04&A)A_PQO#0P)FAD/* H^2!
M][BE^2PXJPS5HPM-A-F.XSQF8\S*R_;G&E4U/OGC0AYI;HJYOO2CAY#HEMV3
MO$U(,5#DJ\2UV_-#9N8SBVFGQ(,]2Q\71T7B0SZ"9R+[&E,W2>Q3MZQKR=Y
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M9J;B5LC&=D:V]DX:XM9B?OS):TG<]R9T450+[;]4V/$.^W-[)\#BK83%I<"
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M1':F9:3$V0L^3AORHW&W(7PB7DW\EA]P^! $JX!Z>7L[[((?_'K_)"E4O;N
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M'I6OHL(^-Q<\[RZVD/_2IICWF*(5[(6YD!T)+\$$S)@2=F9CWQ-HG@3Z1;C
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MGTELD:#D]J65<-GO3C SOF;;JID>4]IU3*-JA/NEVS$'77-+F1F+V3EM9J/
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M,M6$<?JDFEBO2![[5)" P?J[!6^4-PAL?87\5KD+GGOAZ7%O>T3[BJC4\&E
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M7BI0NK1#.$(_^ZND-+NP6EDH7';CHKS+K<+8NWF/!#8([A<9@'-_S" " Q@
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MZ*\I_T)"[M&&H$GG[<C8)TL/-<7_.'OS@P8+=8T;_ALCVM^)RS;+3,'1.1F
MYF*X'?1R?6 ,=%?MY[I^49/<47!1X/-Z^G+))KDF\G1F/T17K:VVL&?8!/S
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M?'BC:>LN/.L$\9 &.D<@FQ^RW1:4"77=)_;2<40J,(8?99BU3B.O?YW/N7?
M 1[R1C_#6=+>;K2;C2R+=.;E.5=QCI5(7'8I+1$RMN&3865Y?VK^&J%&;.)6
MN&RU<:VB)#52\F%-5(>SX"!EU77_@+)Q7HW4@E;OO)=YM1 ^M]<%6=^LE7^A
MH&\W/PLY@1^IE9_\#6HM1J,SN9G:$4X4\T'=!LVKH ;[?&A3I1LQJRVM4G &
MP ?N>M"Q6IQ3%'EAVE9SYX^0\H5-J?+"V1I-4SW#QH,Q5Y,7=W^N+^=G!%7*
M)_N=SBUQ4]\@0&5^S5#K]@9WA?LAKWZ9>L$5CS>:71PG*"C? PN+K?*Z#7+-
MUPXM*T$;[A,)LVDT,YO4ETN>=XH*8E]?,+;0CBOP^)@,,;XW;.3<,H&I9U6@
MF%0P <L/J#-21GHY?M:6=^1ZK\26/^3SRG>R5/D,+":N,'2L";/3&K0!+Y06
M2BK."T_ B;SK62IV=TMQ=Y(;B-<7].FY4X&A6..1[=;(](JNK67"!$J( 4C%
M#;:,V/_:K9MHW<#6G%)_^+PZU.6-=5GG. %6HR3P;78,FPF,33V=6A!7\=/3
MJ6C@_-WU6V7V]4YB&!9VD0CYAZHQ@?NVP5U#OT6[/'>9 N\E'%>,,J/E8$]Y
M*WY9#@7$Y.4'Y]4=5#AMA:9JSU2.C#RO06#APGVV-5H-E59BO>NZ7K5-NCEZ
MAIRR+/O(I$.1THCH'X$[&U3QG8H<E;G$6JPVNG[@? WTN>Q+VH -6T0DJ!E^
M,-X//>Z)^G(:7=P%P? 1'@?>NM*G#WPML!(<%>PKL<TTV4>H\PQ AG8OD]4A
M:>'(3!0\)&V2%^KBW8HY'-E5<ML,Z]@(.8-T)=E2HU\O#&P/M!@(1(NG]=\K
M;Q\WJY/4!_-;O4]]&Y"_K<]*]N"H+@S ?4@,@?E)%AZTO3BA7Z]78(\'\0L-
MTC8AZ+:5L <Z!&6UEK\_E?0>H+1QD"&29<UD<\&#^.6B@JY^*T40F>;O$=UA
MS!2<F0UM+TQP7VFWG>YH?T'%X@<?5KPV$/]L&"[%O=K06UZ2R-T8/%(47*[6
M4W5SZDBOZLCF1'3O0K5JS0V:'.RCU,2SCTWG@\1/F0X+J5ED9S(Q%I !> M$
M*AFF@GJ!Y>I";=NJGP_LG( SREF4UX2LBFE>>U_HQ;(ZO-V\8N6,S1F5IXIZ
MWB:=R?WX[,_=F@I@=WCD21/1M0+C![7T#8(=]$L893,ND>E\6V5I;TGT%N_2
M3?*/-4)F:T-]^]&SF%/W^<C0&_Q:%I/?76^LKZUY-'[.+T*[9=P5NZ/#3["*
MPU >6P1"U5"5]\ V>6'>_775\#'VI"%SLB0AJY/4S"58EWQYV!@/3OTV9FS:
M-=PGJW4]Z(3;\U(_5N)GHIMWN:@G]OT LOT=!=3[GLWQ1R ;?A.X>W>=C"\F
M2; /N\+KX.T;K;-35\F0^?!RO+:)[/7E2,C8Z#!XZ-Q"Z2L3#]<442=75B$
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M<&"UE-$&+IQK_.G<2>93%%=[GQR_C'?UW4O7O<$OG;.47Q[QLH=;44B?E39
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MD" N2]A4@4:3P_5U-+5:>*->@2[^MH 4]A?.84_ !4!*!.2M0/CW29M2*+)
MJF?S4LO<$"2FA<>[MU?EQ-.[GW:-M!0@D-+DNTRE:0%%\&JO1EK3ZJAR5>J/
M*2M.2_C.VC5@C#+J76AIQE0+K&ZW#B:B-L<96O">N-\"?3,3H*PV7!6#4S04
MU8_#&X\;][S/R$@YI^7(POR6<8<6'([>TA% %622VZ!W3E%N9Z!4?UR3Z(B2
M ='EPVRC5.*<FD[33T6#,,QU.^U.LX[9H-X;#M";]U;$K^KG0^PV"%"ERH98
MZ<H#J3[BH>'-]JVLH@:EV)MZ],!#NY6.H97B!Q\Y+*+JI+^L,LFP[N!_C;3O
M_T<#U@R %&[SL_J?#,#\<C(#0"!_/U@/D:3"_G57^B #D!XZBSO,E",>Y;<A
M]IJUIR82(\V-2>45_Z6^XG_YP) (_1DL()WC-9&W]*=8R8:[9_#!>8Q*KTY>
M27YI?DF?BW 1NJ#X;99@[".?GS^?/-<X]9IU$( ^;AX,ZJXNK9/AS:1FA^A.
M^_1-\FJR26DO#UH_+^:;V"(4O"T,OX_ >YL,B^ZX^"0E=2H)J8=[5&T+>53K
M::B,,]%$ '*>3Y42?."V,TZ]V(S@@+E1ZC?+J8LM574SJ?[+8KM6O>N2-=OV
M"]<FOK39)E6D!!4>/0OC24D0CI]J]KDI.,,ZHN$[4GI][O,A$Y:>=Z,*C0$5
MBZN/Q*'PP6Y@<J@63;<BU-N@ ;^@9.@&5W"EKTN0/?TA+7UU'O;<*/G[DW>O
MC\K+*7I'Y8S\=855HGL\CI2J6,X:LST>M;]9H\9;?;=55[]EFQ=1>"3M1_;N
M(!P7V#=O3SX=T'W-55]]@S2678X^DC"7OF-A?.-*F[Z&'MC8>#$_PLT>1JZ]
MSP"\+47.C 1S, "<)TM!A[=;P2RS7YOG#V4?\S?2M-*1A*D)\8=J\<'^;'G&
MJ7Q#W $_KF]0;NN8M5UWCOW]'TWA?^4G>3+=F#2K=%>$A=V@QZT68<B%TS^1
MQRL;+%JR-T(]R0 XJQ)PAVC;1 :@-5*!M3RW0?,7B=N_D;+V- 4ZDYV39Y98
M1T__P[;SD0%H;)9EO@O# /1?8 !"(_M8O-.>0I.,I!/ZM^,8 &Y[" .P%;W%
MJE6QY=@YP0 T*""EXVA_-3( QVM*W,P7U3ZGFZ(HW!'VK*>I.<BM2BJ"^7]S
MCI;F!@<#4FD21:7_C;TWCV=[Z_J&<T[G09T.J"II:ZJYYI:BJJHHJ2$416N>
MM8@@2$M+S34716N>8YY2<K2(F2*FB-0\)4&4)$3RQ/6Y_WR?]W[^N,[[G/>Z
MS[]+[,_>Z[?76M_OWGNM)=N2H7TP_LT7U9,=N_\=(8.)O1+N\Q-VL:)^T-+=
M_*M;_ E;"D]89.%)C9+5TH)D]GR-; @IAHLNZ5*2N89*.7:A)ZPDBSV=P^@>
M>X520)/JS0X],?85HN9-:YK#X<KKF8 _K6.\?\!%XB*8@(NMFL3;)58-/]'@
M7R@?PMFIN6H#35#VZB>3<;PREWCMYJC!@,A<E[&MX[ H/YPG>.$G#<C2TS$F
M( 'T(#"-.D^?5S5C FZ^[6"-M5:![K/?HRR^<[#)RKP0_):Z/E$;%!$Q\V-(
M;N:.,Z7U])?=@(>&N@:^NL:BI=_R6<R& SY[+]-T"M@S3J/0_1G/45=W!W2E
MP>0C$+=8VN2^[KEH/%Y_>G+RKJ(5%&XX9##WTFAT%2<'F=A%;&E9&XAG?/N2
MX^X6K\4RT"&N.2F0"=V9FCV>P174'=VS,>TQ/K K#'.H_+B0]WF&=W[2_]FX
M*X5!RD-W&QC9]WFT3*8C8D6$4G5&1;FN'Q;>+C\.S_"D"P?'IC[7IF/5$NO7
M'B^CW;MKJX B/'GU[UY\\V@MPFX/P?-$*]JI^Y\Z3-H0W-%1F@'N17UWSFH8
M]O*IZN0_<EIEK:L:%6$]X+I \8)_<PT&40K=).<'Z#F3R%*I3>%\),\9#9#J
M&BGX&S%:V)S06H&7UK#Z.&7FW=@$\T=%ZO(8^V?\CGEG7YRY>OC!ZC;:U&(N
M(\*!;,$R=,OVDV9*&@4*0NV])NJ7_BBPA<S?\D&T0,^@=<REA72E52"!S6=^
MWQ&'R)-8T_AQ@G;._1G:'/XM3S70+69>R^CU]"4S]JRD6_/;?RC(U-RHX]UX
M,S"W+OT+HVGNY/KJBY>/UWT[[6)>%QO'MQ&'V$(2_NTC$Y!:L<=XCN_5\)[=
M"SW_83IH9&LD<):AL4,:[C@:&+97B'TJT5$/G>G-#264VF<5!/*M552@#8VH
M><6(SN%[?,,R#<T48PH+FGZ@L=6L!]^E?Z?F*U@I!1W4[1>>(9\!AA2E#3^N
M&,;O<[E!QBQ$(M_DB<Z%U)2MS"'LGAA1WUWS:AL!L2:30H_=4$G<2OP,RUA0
MM%T4V=SGR6\>\?<U6404Q>;8/_/XT6:RQ)=^Q5PNQ7^YR 5<6%CPAL\L/_E&
MA+D66'4=%SBD-GLS^QA2;7%\6UCMCF('IT-#2;"878/"P31R7>11,#J0_AI/
M?88[/H&]5+<CI\>FYRY%"2OTMGLG&R$2//.V=YYC=)&%:"SAW\9>-5U&I2VC
M/[77<E3-N;8>WYE1B!(1%%^-+>N::U6G?RSI>6(X5FLC(EP0):LE^.!11ZYY
MH]F?%[YX0D@56@Q.B]0.37H5X])/^ZXA= :"IE8C\^MV>,D[+[!?&0A-&LWM
ML7,NBHK@.^U<X_,*)%IL[%*4_%[F)FL55H/_SZXEG EX"Y:)6\K$W_MP)O W
MHOR31\<R#C[&11+M3ZRYY3$!AZ]A(/6>=-&0^CA!>G2PP<(KC ^&ND=G CK3
MIZZLB<R5Y);GEM X,++#F&'P/;) _*,$,?0-63&QWT^=8/E2=6NZ@#!C>K86
MM?4"-LX$^#8>5M=V0=$+U4A29U$,2=3V?28 _X),8?U8@]+=DIVU*D4U YDX
MPA02]Q%OB?!D-5Y*N)5]Z57Y<ZM_[@I;NF<U3]7Y3=XXAR8ILG'H_Q$.'C'5
M$P7JA+/6>46*^@P#5L; Q4\+)K.![P+E1 M> Y_Y['@%&D2FFP!_3$4^09'[
M#A_5L?SN:]25Y1R&$? B0S@P:NJ5<8MG6VSI:O#J!'==AUU.9+;:R.UR1*NO
MI)GS;%'N)Z..#T6=@WG&#QD*!]UM9!8+,V?Y=(&L]S39+32M,["&87 JBB&,
ML8S[V+NST7NZKT-%2>#@U-9XE=/^Q8LMN9^=OWJ-; 1R:!!^1>>EY!!2BL"F
M[W3V$3ZLF/'MC1*B5BT9L;U!W::W!=\A?DJQ*5TXOC;)NUVSF\++C6K-;*JI
M]O/X2F+D?\YM_UE8/-+LM%Y%M)Z+;<TQ4WRG\6!J\D8<#H;XC/A&BN^E!U"[
M,2K.2,>.!9C(+1K;%NX.79YKD^Y+V&C%#-K#-%HHR?+7LXIS']>3<+1/(?RZ
M(@^*C,?:#H^;QVKA S6TBSZ.V^_P07@\\&S#S/AZ=A:*CR(I6P1;=UNVC4QT
MH$AZ<F'VE0,(G_1IZ>\6BMJ7'^)QU$=5RIDY16$! CJG&T\;:1AILB"/$FN'
M901VTQIJ6K4#HQ@&UC<K]SM1[H&>ZSA\\TLYY3%_,BQNOI.P'MPVF0G)6GM$
M+O+ZH_LU@K$C1VU,J%M=Q?,RYK\FU;WM(+4,'V%P*1H<,8:+[6FF*Q2' -/!
M%^]=YK8-*6;<U 3)%HZ*U5W] EKHQ(^P]I)%$?W4^MF&1W0NJN4PC9:>JSQJ
M?;%5"1+F\F4U)6*YUXTO>Q)KQ"]KD ]^^;9V(M7VCZSG#<.\Q"+6%SE\+?=W
M (S_WP@PKG060*FNI&HP >$IIDP %*F!+=YL6,3PO%_']ZHQ["E>3,"<VR"<
ME'AL8W@+Z&BESVNF5=^,^CNMXJ\5',F<QRB'-BE(FMJY,\A$1DBJK,:'SC%/
MU22K(KV5I#11D[RD)Z:[@^#=#D'QHHI^-DWYLT8/T89=)PU9])T#O[A#;]D$
M]N86*6S<@\1UPY-XFT:4):^V*'1,P*_)\@*;BW?!0JX"7MM#/Q4E.U>R&@:"
MRN1E1[6UM4R32@I?@[6O&HCKGF89%.9U[__!2T_M5C8Z8(5]<;D>.?^"[MH.
M)JHV;$C%8Y$+7]8WG;G<(0/S,_L7RWVMO)W<3IN;F]OJOGFX_K;\\V?O:WG[
MX_FOR\5O:0*;*> #^@\6I;N+/\H$I,?N=T*%'1I>^(P'#!O8;G%7C*^Z$.M8
MF*F/3RA!1]Q$MO(6,MN=I'0U:OB!;61*BTU!^:/BN4)Y-KTK]UDZX(8O4NA%
MS8X_+\!Y<TA2":B;RH8J**$?[2S4.C#=NUL!LW%;BY@K+I]L,7B;)7K69*(3
MK"*A;%*@$.,BVCHE6%R<<COG <5J]2)]5"W!\3MH:5Z]4I3Q(+9SLB4*,YHF
MKH\F!N=.^_6=VT 3^P;NQPFG3-',);I?X_P^Q9RM,3AE8_[5N_\Q66>T1F/Y
MDR[+-?5289O;",;EG7>*EFX'%%QF2VI*!CNH"1F^ '?QX%LB!:WSX;_<)K )
M_9S!1B1VJ,=%:IORA'4:V6[56K^ZDY?WKO#C86)65O_\&GDB,$LF]$X25K[N
M%_A2+3+\U+D+N=+OLIPF^;MMKTU_#&J+\\\1?N9JIF%ZZIIKQ-@:"VF-(5D:
M$<R8A0Z@/BBO+XQW>Z:H]9T(W$4_UXMY5J!S[D]J=\AWFZK+XO:2%SV(Y74-
ME2R\["SB](JZIW3Y<\CE1(OD@,@(X=+T@ C6:(T2RYLYJ$J&X ;JO<7(XF!/
M]"Z&H%^;701E=^IB GBD<?T';=U$<V)JD[0<+)QM"\D381Y=?EQ]OJR[^VU*
MW;-3Q2XB^>)$UH+8&1; +N%Y.+EPIB6M156$GDJ+/^*[.Q3E[-G2,)$1/N^Q
MB?4WZ5#_Q*/LU7')^G+E3J7=2S!/6$G#59MR<V?!((Y?F-J.XL%FRCT*FD5_
M'E/:/6/P<EO OB// XMIXV9D1YZ)H-#)'6R--XD)B*+=?;B LZQ2;]ZR3)2$
MNAL$ZG<,^\E>PLZ+L3V0<WYXP[S:.?IL?#6+QKY"I9\@^ZUZ+@V&3/((+Z1V
M224A065[^]X*N]@6^V':0,34_E-/_I B["O2LU@-*!V.IS6GOR^6X:CJN-KD
M_7L0??$%EQ[?.HY=[63KT1>JQ^CV[8%/UN#Q3("@8K:%&UW!]L38'7U<EX\O
M8:;%0C.M;ZF&+#0Z8*,DYMIADK1C-JG'ICJ;-V THGE)KO);;94X/PY64L5"
M+(_CVE%Q>.FM;)7FY<7EP690XBAO7*NR/B+87C&\0SQ3" KQ#;1(B:O.D*VW
MH[[].*_W*7_&S%RG2V2U.$3S&1/@XKSP-$L-0BH+I;UF L38H_!]U@><'E:X
M@AEEGN8]KE=/2*1PVOE1_Q*)*BS.H+$JK<QC[DOQ-[MJO[)=U?IT);JFBOG0
M8A5F4^!'A,VCQ8/#(Z@C\OAN1!',>]':)+"=5HRS;-IVK%6Z"(S(70E"8"]G
ME4Q9*F)V&C%A)4&#FF,J9I4*00H@"7!\89R4O(F#"W6LY/*5F_RQ*0FW55@[
M[/!%^ 7WT$V>SWO+RZ:!3,"MF):WCY#+"\ GD&S]C=/S,6UH/=VP]9[F8E$R
M=8WZ*G[\8,8C*]3#8/%!'>A2O/M=^P]RIH=NU5J2<=3'M%]O<4L,1N%3RFF0
MV-Q>>,B^X&B)/J8J$_"L]6?;K%?2'\2@SJ;3H@6!C^N&YV6VVX[<'P8_+ZJK
MN5^M*=Q,T7KQ0U K]H$9?[R90,RHDM)MT:ZU/T-.*EP[K+ 4X2M%5LA=!<6<
MVCHSG[U]F48<!@)ED;\'O9GDA45-!W%-R&'3SRYQ/A:B#Q(L>[&\_*VRV-.(
MNW5&HV!#PM=6(,^Q!X,&FNH@ P%R/ZEE"*5&!E/?Q:U)A0!YZP4E%R?P0,;Q
MP/BVP++) V<M\R:6@YV?^JYBT #E<O6X^VY=+!J<47C=\DF1[<7:XL=_/GGH
MS*+ I4&'^.H+O!\XEP6E!<)O6T=F#SI6W/(W8RB/+6WA].AM3KL?$0'EJ>]F
M++0D1K3Q/(7G=2Z(9K: (@=L'7KEX@K2D1Y/,)>G=.+DK-9Q[B/JUAK)7W)Z
M;-:=99[V)0O*!ROSJQNQV;,%L=F)&&A;:)KJD[7$9= WNJ_&UXB)'3=4/X3D
MQNNX;)9'F NCTD1 VT;SK4225(B:U'!!:Z$4#G5Q>]_:HPUUW%RIMF_(%P[V
M)'Y!U6=YI+>LI>3>0(07I%2XN$"+TZW_,"*UC+*S#*=[IF&),8WE==Z.6M[H
M17U0X7I=ADT+7-;\N1*L^HNO@\C65F]3OB\^Z&+R*UN7>'5 ?T=>VNX8FX(1
MKR:'I0#'I5]#W6?M6?NK5C*42AN&<^Z5NOR"H[.JIRPU1_=%TP."&JIVK23O
M6O&]'3/NM8RO2._4=BD571-.**AOK3!;<W&(7\HR$_3U9@5'"!,@O[& VE*C
M(8E\K1T4C!5U(H-2XNHEX\8WM;8W+<&YV3%;$Z.S'^YL5TSAY%'1L(PN"[@L
MO-FO+QCF9*+CG\.NI,?R@/>)(.IC]+<9.A53R5"A#'9Y?L(ALR<RT.S-1:T/
M-F9^_>DY0W-3P&,SLMU^-J>R91-(37CJ5\[NW'"?7CEEZ&\1G;G&1D8@ SER
M1W'+>'/=X&OK$_5P\B9UL;95 E+X$IKJMN-IK:#/A[*B]N[4STTC%=E3!^PI
MO [3'<M[3$#IWH!.)$?9@/ZO'PL)+:OS6R-&W1QR!M]8@10\ILBXJ+4IZQ38
M.ZTFTQQ>H_K\USG7 #NH)"@((J5!?]V]XVE!VM@H,'&;8?GILZT3WX8]IH):
MDDKBA<JQH\KI*='4&V$"D<G'U%@4,&Y\^RC#3,6(WJ&J/!SXA!",WPA.H^YS
M3_8FKGO&<?"*U$G[K^FC*D*%:ZK23A/WARW3+$!:Z@;JFN)R'WL^!2JB1\+N
ME\RR".[#P_,\Y7'KWC,%T+A[="^:&GE$"K-?*-](L9+]#<N-B$-B6#C3WR/:
M@8LK <=SKCYUON)W<^B1(T=78\I<Z"^*_$L$/B>81V2!(*3W<=KP;W;!@O1@
M6EPTC3BN)J4:-!R8]9D0M#4%@6V+?%45L5N519;6S$W7!B5-9M8(MPN@K[@M
M2I)[ADW407J/+X@N[QN!;K0?ICO; ?M.T)X&6C%LF("5&J]=HL+6!&Y\"!D9
M#O51ZXK-[3=PCYU9B^F([K>%<K#I7Q1,['"LVJG],3XGLC86+A&+>",4K7M!
M2XITV/2(NX*A%Z2!S1;=JUD2[M=?(PYFJ'P9^DC7 VH0@R?:=TR&5UL1Y9UE
M\D:D ,FJM?XW-:O5_BYE,7?]_4MJ9$T[ZY[\^4/]JD]M?!MKO[8?%A%,= .^
MQIT85U-"+M/>NA-N:.+5KNV%ENU!_4RO>IQ3<GFF: 7&:)NFHDV_1\>B2-L^
MOWB\XD0%2_SRHISGQ=_D'*;?--.@F_PYK2Z>4A$6^,8M#$>39WCVC5MP?B72
M;9&MQ.%%RG'V,TF?PUU)\ET&8-DY^XI4[M2LDU<X$TJ/:9:G<R2(L Q0^; =
M2HG>++WTU@;9>P'4EQ5)@Y)KYC:ZXA+\<7'6K=LX<,8:KG>< PE#[(4BFA-_
MJZT^X)D^>#&YKWLC7O+;G?<UX,M?TD-*A4TY5'5$3UG%LP:THI]C/#VXOJG\
MDI+M3"1.3EIBR1H+C/6@93+70AS$OM+?HXOPK+)[D3SJ-W%SM_Z(ZXO-QDAM
M62,)/F'VV+QW_(\,OD:!3K#8;0DO+6XK$K@,I6\KP9SF/W/'O07V.(1?1MU0
MW%$13U;VKE1]Y,'6$4-XC$>?/6>(Y#"-Z=*^JNSM9DCJ<8&FZ"A9HT+,1$H*
M<@_OKJ>/_$VHQ3]I$O\C!>K=\])-7R'!0-FX+[US,DF0R_0L*6%MD'5LUQ"X
M?1,\-#Z$T1(WTA!]U"U@*"8F<BWD\%8AE"]I9:"6NE%MLZ[_^1O87;(9O2!4
MBN7AEDW[6C$Q\9%6[%1L.Q44%-FW('/J[9\C02DE9\\I$E=N?JU(\MF\;R+/
M\C?/_DU+&;: $<]Z,*:4H^P=7*&<:N>;I<%/G^5;C4S3#E*;;J#'KX>5O6AP
MP'39>/FMSBC8F7\- LL_"(C2$/?@0#=3]%2L,9:NPQG"[..\VE7U:$NWQ[^/
M,@&GIK!:Y[7>?1_NMP3+!S^L'/Z!OIQ04)*3HY/>7*S;?W?XZXAR%P&-@^4S
M 7^#UZ3_=-O]_ZT@_N#-! ^P1$&52!CHPR'A+W9(W[$TO?&OE*SU'L,7"C,3
M6#\=;5?R9-F8>>O3%R%9)U\X"R0\!/QV<'C$$KM:,8H@\58Q/MR80(;:$L07
MY/S/M1;CSZB>@7EDH@RNDF,&,R8X_*@EM^22#:BBTK63HF_B_1R$6D-Y9/QX
M6-%LA2"UA.#S*CTO_!T8K;*UK>AH *U5D?BZ;UM>W.SM!)$PF>W4EA<B3/$Z
MML V6I0D%"7-L\KY7MN]?.)P:Q-L8&*(,<E_H'IX=<AM'9W==Z1 57_7T>:7
MQ'$,*3:%=GU4V=%C0W*(2L,?O$B=L'Q3NUNP7EJ,)AYTZWU"@YKJL^"\1D::
M*G?]><N;O&OSYQ0^EO(?/FZ,.PP52/H  ^:)6EP=SN"J;]Z?7?:C_^C=D)R=
MRGQA.A[$H9%4/JWL>C'S2[^]%VS\YBTD*&!P+N0JSXC!/:?<V)+6DI0$G1+U
MVVE!X\U5S6;]>A+RND:#CS!_:"@;8D0%P=(I\A]&1O,,'^<\P.1_0P+4J_@/
MR:7C_ZO?,6GXQIZ-W%[<"*!/K_9C-\=;5>5F6P5V^Z4L"*0!HEOPPU07>GB'
M;L+,99<8;%5>Q=1^@,#3Q<E^$Y$5E^T/]6HB+)C9+N_Z.PSA W!@ CXQ>CXS
MW-2 J&1>J<Z*M0[/ 2(6A@W ^([;J7(]=W_FT#=UH(=M28R8MI!U+IY.<YOV
M/UV17_2]VL[(78Y-O(9!P;X79NTG_ "0-DA +)X?NRQ!:VZ5AYKZ8C9XNS+$
MG$V>9Y^IW"NP7%;%=9$B59"-,&4EKYU;VO)\DO[@+0O8[=+=;;'5!*%#C9LJ
M?R@)N')Z:F)5U'4A+Z^X)#8LQF!=S"J+*]E9Q% KYG'"I:$W:>HVDEKCA]]G
MDEZEZK^1O<3U(V.D$<H$M)_;H+Y(F<KL0.YUAE<@A\-%M!H55=D]AYY[-993
M(NYD%E<OWS+NR+Z4_"&2^T8^(J<T+[*BTJB6Y4A+^?ZW68-FR.R%F6GJ%E*A
MA,)WNL'99VR[J).XQL<$<%2:$'@S4-7)_1K14RVM8:?-ZC&2X.6"T%.-0O)^
MW25I*Z5KKY)E;'.[6=IV^!]UGOX/*ON_)S"?#]PET<=[I9:O;QK1='\*->A
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M=9:95<-GI?#G5#V8 $E\Y,'@EO>25H<>;I3;O9<L^PI:,$ZXC 3-I[YP^U3
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M=9Z1V%;%GG=T&T3U@I[<W!PU"BH9O/H#PW)=/M5X]GT0[0W\UD:4M6*KCL^
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M13FSM.067(GQ8I>39[Y")^"Q.Z?BJ\"7:YFT%OZIC/$CO$?E-@1Y?=(F-K=
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MU/RXXH1:6'%9?DGAAR,%3^TA"C<HA]ES8+5MS?!NT)(N'=G*;21C2B#%%\_
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MD/?-D%1>W"#2D&FUTFTR"Q4">KO[3FWN+'@[Q#X\6\ 9F_/!%I/G^%Y,[,%
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M_'1:M(GLQO]B[[OCFLRVM>-8L"%C044$QH)T$! 0$**#B$B3#B*@5.D*!)
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M7X"<7$"+M)RLNO6)RYJ&\+RVP<$;)\KCO\+/L]_3Y?Z;"KX1A%\4[+(^KZH
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MQ0:]JV>R*A&D;<#ZX!6DU?\PY18;&=XT"Q8"*>_K#G!9# K6\-BZM7Z3/L"
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M/I.%CRI#NR9F3LKR.JI>9^=6CDM5LP'.6A8%[O9;:NM0B&9[!6Y,X"^@*1C
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M[+<XW>UQ8;6TZZ!K/#OVHY\V.6XJZ4FA>I1-V!,H OG&R\99JJWY-?E>A,=
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M=4C5C$/GH(./B>.JDI"Y+V_6FWB#Y/. W1JQU-DNU+5EQ4;<,IU=OHHDC'!
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M>:?V#USEK,$EG ,,9AFK%AY#Z4F<DV8\.1BW,1RG"?]+M>I;C&#(51=]5]8
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MSDJ4[-Z'6SIP0/WYX$55'@<C^P:U17F%EG9THOW2GBMBGA3@-/Y;M+A)9N=
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MK(W>V2Z'7H*2>(QJ9=WWM4QFU[;\3;_EZSUB;!DIRTM5;9<??DB&3UQK?#'
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M;PF]R*P+8<GCOH/T+%]+72MS4Q.!F^^2LZKS -QT^Q*R\)V_BV$?R@$IKEO
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MA%1A,^V[H*NKB.C$7D=U";CD1XS^XP;U(^4GZ ;E@P_,-RAE8=VLO@?7;QC
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MY>E4 'ZM8&GVP3]P8/99^.AX-P$54']"VC$$O+%1^+F(2"JEQ8B7U;W[LA<
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M5S[LZ2_G,^;G"X8N>\N]OO.*4+>O)\>D^PL<=(4$K\&6?OGV;(L#DJ&DMG)
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M\82WA*CDJ/ HW(5[LK+W_!^]S?N01[@[<*O?3/;R-1 (Q%V=A]Q\=!NHA3?
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ML&URG./:>NM7IEKJR-GX*%_#X#-669A[JHXG,XD-_@LI1C?#T\W12%9#C*;
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M#A?P.=GF1SNQA";,F+WSV:>NGECSF>GE;OK>H:'BG3]K4U1!B<!_(Q#M1XC
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M@;X'() $JX9^\=O"\U:XRDL@D$U<;1>$^'.+MC991'#J?P!02P,$%     @
M['U76 MJ0,U8\P$ /D$# !$   !T8F%R8VAA<G1?,# S+FIP9^R\!U13V[<O
M'$6QH@=%41"BT@1!!"E*A!Q%0,"(2!,14)!>(BT! N0H1Q 4$9 N1$%ZKP$"
MR;'0F_020J27D 1"26)"\FW^]]XWOO&^^XWWWBWCM;.'X!AK[ZPUYUISSM_O
MM_8*_%'^3]!O1OJ&^J!=NW?M4MRE" +QJ2#%>ZYP?[B?*_S9V2N7+H.NWC2$
M"5!!.]=O.T^ =H%V_<O_?!KH^(VG< <GT-,_=EKV@G8;WN(307\"C_QW7+MW
MKG_ZO7NW@(# SL\_7__R!/!/X)]N_FO7GIWKGW[_UQ?_+Y#P?H&X/?H"NX1!
MNX5W"0COXG_?E058*;A;8!?HOUS[]@ONW7- X.#N7:!#0+/@SLC_Y29P2V#?
M[OV[#H .'OH-M'N7P)Y=_V3E;L$# 8!E>X3W'A,\M^_X>=!^%9$;JE(G#IC>
M//E$^HKH?9_GIQSB9'0_5:S*JOD>//VE3UUNRDSCQ5I\UBUS/SU]30/'"Q:6
M5F*57_NG&4_#_1/^=,JN^C8P(W_5>3U X9K6;4.C!]8/75S=W!'(P*#@EQ&1
MKZ*BWR<F):>DIGW.R<W++RBLKJG%UM4W?&]N:6UK[Q@<&AX9'1N?G9M?6%Q:
MWMC<8K+8OX1W3-X-S-!>8$($!?=Z 28+[SEW;*^*(.C\\1NF^U2?B/CLO_E<
M*N[$_4\.)Z\<J)#^TJ?KNRHZ]4)-)M[LE..MM:Q*6?73YAIZ3^4.^H4GZ/OO
MV&OA%&"I^>?+?QB\+B_V_G/U]\'9C<2<FN:AN<T+!E;.5Q$12;FU+</S6R[(
MR.0\;.O( O/V ]? 5RGY=6VCBZQKAM9N05&I!?7M8TML!2VCA^[!T6F%#1WC
MR[_XXZ##P/+L%A80!D%!8_NFP<U"10S=0@I*#HTP\;WO+8_-1)^XI[&UVF)F
M.FA@+*A:;M%3'X--3\V+8QP[?:;7L?6S>'R6P8_QWR74"D^9;[BAIVJ"(WEA
MF#;E[2,:K7S0X\RE:<R-H>HC37R04-$@='V#=P.]Z%,+Y>QATD5^'6GZ&$!G
M>=E]XH,P>8Q#?)!N3 4?-"I'",S[$4 5*$-_<]\\RMV&OK/_=<8KEO=%F].L
M$U[F*H'BB5OEHQ>6N"_XH!\SGNBM _1)^0T)U.\4\NIXDRX?!#69%>5%BCOR
M0>4F86LF'RGC^^SXH(BA93#[%_HL8>,J$;S] L6,#MUG]T.+R=4HN\<']0ZP
M]_)!GUI&^:"5X^1&LT6MK><CA/^/0]N 0R-_._2W0W\[]+=#?SOT?X-#A5,L
MW(]TW2:>[I;R@RU)&^0L@M=)1+64"9D)^DAU!5T6I\!_YB=E5>9&EQQ4LXZ:
MO/7VPI>X&E#CB_4*\[W!6=%IDL6 [\=G[+G%6P:\EU?IO-:FJAFHU3^<D&LA
ML*U78K</^I"W8U',-]O_F(]1C!@?-.=2"=V0;T5O:=,GKVS^8V8=0CSXH,3,
M-F &\R0 &YF$P-Y_]BMJK8QGB9+B@VY^0/)!CI/;,U"[OT?X>X2_1_A[A+]'
M^+]AA*R,)KS8IN0H&SY@*Q%=-!E5"9%RHKVIG6>X%*0K*;(>.=,[^W1-K"45
MI!\T<ISCQC4CC-_7G1U]'77J$UQER#_&?!& 4443CFP#AFLHGL<'!1!1)%G6
MK\IGR]^;:H9^,0D!M"8Z"56&8MI1)K='&OYN^$=#H3;/'KIEG3$'L)589S1]
M<"QLL',[A0^R2H;)298=&O?.^%_!S/\E&XJP-7P0=08J"ET3I].WYU%08M%V
M0ICM/:YC&?J_BD5R+NL7X^]8_#L6_X[%_RT:_H[%_VUB,8K><S2)LAHYPW3@
M)O9L]#IL\4&V 9(#;?2P[WF4,]A'_=XADB/?36ZKUC]\9.4 A\4*N?</]"IY
M]ID-J;4HN#QP3',\HTQK&K+A2O/"1LGS5VHTYYDL%VX=WI-Y:8RB. _UHGM&
M>_-!?XKO71UK+-6X@]=YJ;*=S5AX.F21*C_E)M"G>^_%N'7X.SQ@DAH?)(Y.
MJU$.XO:UAQQ;@;[$*(?),V%'C;TO,;,*Z%S1^\V5FI?:B#8)+M2'2QH1-,J1
MT97@.\68@";Y'TV'$[Z=CG"=3[KV7G^20K(!__N69#D#FN:R'DM!S\F%CZ83
M9^5:+_V:S' ;$Z\D//4*W1Y,;+J6^@F2%2F(>ZEB'7*$0A7").:Y1[M>E,PT
MS\H$,P[<JKS5N[N;UC0H^9[G&5K/4,[6D&N_])YG3M#2Y(-@".])V$ %UO)B
M>=BN_A&7U?LF%D:)Y2LKV*Z5,-_S3[/B;JF?&G5JX,7>)Y-0V1)<'#KE;0_/
M 257S[0;6SK"9K'3%[VI71M@AX"RMJ:J/\8EHB+)5R6*JIG>>@J7KPIU-YP\
M92DT!1/;_EYQV_;,*VZP!."AW"G"@EO21(8<R5X6@6%TL:?J=*[Y*XGZ.S,)
M_C";-;"+EWM3P8_CM-LX3>3*A,D3+F;\=./<7C'JF?!;/@\*"US4>D54KB_W
M'0V@/<?\25C-%HKBMDA3]X>=1BM#T[>'H'=^>+W!/#7KG^>)KZ1]V"NYGO"L
MN3;SH'<'VZK*_NPFK,;C:_.;A^V_?>%$9][>Y)3YHW@JZ"NQ6YYAT)!P&@W+
M"F7 =]7SKB!=G/V5G;FHE='@],?,1Q!*D=:,,T+'.U8XMG/KR=?ZPM>AIO=^
M'&SL/A4?>I<J(6\4P;1;_#-$C@]Z>6[39?UP&P)V]#MFCKW^K8Z85\Y2Y(.<
MS+R8K.<1W8]]()EY%_6>Y[=.H?;-(5H2+LK<&G7_DQ/B:&'T0K4G^N RT-,:
M'Z3,!RW<6'5DQ\*%2(,D&1RRI96]=Z3Z1*H0'[2&PVO(&A>A\EQ;HP!BOW?"
M?RA%JYX1N#S^1N\91['KU)M<O47G"PI_&BLJR34P+7'_[S #A9EQWU%B7X'/
M<))GZ=X6@_T!9$-/1=KV1-;S)PGR<9'"=V!'! X)W1I<:[>/+THZ'+K'Y/P!
M!86LFYV%,R34IXLEG$,N"++=BMT@I6L+XK\BV3XN#@_S+.F,*LHK;5[8RJ5^
MZUNHY3F"K0T5UXR%8$HA]UO6< 56>XY=8]*:^MS9?0P>-!P,ANR;;?FY9-=%
MNU2W'(JUP'%.'BDHH\R1(&C/'\/W!F;]+D\A:8PQ-VLA:76XM;E\H=VM%YGZ
M#TA_Z *]*/*L['O0I81T_2MH;\);^],ZNE1O'$5I"%OK32-O5T%-O%947:H&
M?9UD6Z<N(/@@%UKA\ICK!:YZ0,?[-F&%G_M[&*Z2%)*8?3)8<YU\G)FG1Y77
MN< <0?1S(VF*^_0\A=H'3Y ,+&(^DSF17O-8)S74U]A@A'Y/48OCS,=QMGL4
M [ZG7#]ES+BRZJ\J5)E_+)O*_;Z,3F[5-^/^N4*(UN:#QCA',@D'HDGFI',6
M0S;? CR7)_KGC :?;DTZEB.^;YJ;\T'?[EE8S(1MW%(X:2W\^&V6:^A(PR'T
M>^;Z1Q:62T8PGSF%0:F\CM'3O(1NK^(P^FA&O5[U&J[RC@[]4UD!D8@5%?Q!
M2L>G>08 0?1+E0_RK6Q5%S_@J!<OF PD[A2C=1;_G85:6ZC"ZV]I"TYU4_&U
M7P>&]6HT F0DC5'T[M[T3L>MGC9*2>2KLK(6 ]O,B6L?A@1%A6ZZO!FTM-(]
MF'%7FU,68(KNA/)$A/LQW7Y56()UB!VKB/$B\VX-\12)2,!&.O)!GY0JJC4F
MKZBDQAZ*S$DK A-3E^LI'A+N3W-S\[(3S/W5#W>E"98%T,J8Y :F'1 '(TU
MO_0P"@GU/]9@0.A<X'5>:22L]JWT;O]*5QY/15>!EQE+GV>&IE"P@:;_P?[^
MVPTWP5T+[.V-/,:'E9BH$8Q<F')(8EOK^%7%K6E*]\RPA;9X?6W/;*O7AZ[
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M7_RACBKS%Z*5L4QE^:#EW@69>FBBU6.N Y&8?AI;=2VF*9:J4T5BMS/QG(D
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M2G:.!VFU[ZET7.74U*)<9G\K-!"=Z-'0/ACZ-:LA+TVM/Z&M!"C5W?MX)TL
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M_(]=D"Y0N"%:\X4 I&*!+EL"/2'/!_4@=WC,!PQ7@ \"[_ 8-! JQ\F @$S
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MEY)6I#_9OEX+W_4GD1I=-*;M,E-4ZF=B=;U;.L9$4N'DB[1W,$/3=T9=.4A
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MP9@L:&;%:FD$S/V ="=NK,E%0=$KHC0R_S<WJ]>K8)$HSQBW'V#V/,;WC79
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MVSUR;.?.M ".IH)(WS]'Z9ASF)W"P6?[.]'Q=E:SW-W(J!%Z0H"[JK^HD-/
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M^AV"[TL_V,*%^6*W0H)%E9+T7^:C'YY'@5[7')T&NS-$00+C&H9UP#2$1NN
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M-K,7>[,Z=^[F%L@-<U;5D^=,VY7((Z?@&F:/R!S'<X8I4)6_^?:T0)MZ*T.
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MW:KC,Y0M,O/S'XO?KC*ZN-W*UN1+$K*G8(X%,&!<1=.>^V1"G1D1^X>BUBQ
MWI2TW0>E!-_TJ?(."(2]MV,LKQ!])_/;VGXINU?QJ$SGRG"V.$KA6I&XI0R;
MTC@<,)^9I\J$'P;OH,O#?D.4DLG/NW^2N;'T"/BZ?@B.'X,U\7%5&A5]NE 5
M;PG-6JDKIEJX\<M!3T)"JU 5':8F.E8GC! 6%^MNM[$5_68Q+(@1VLY0'V<!
ME*L:>_)G5V*')K-,&[#EZC['S>TJD OP(9'Z>JJI]R-+8:!-1&2*?'KW)F?@
M-<>NX>^M^B"URRLK'\*#<X[BQH8P<&#$(ZIH.S-G _J6OG-,C^)5&21DOQ$V
M-*&VXQ+(;;?.23Y6CBEP'W)6<\OIKG\Z/MF3K.QLV8'B8Q@[O%[]\$SH&O^6
MHAZ6>N\E;1M:BOJ*C UU9O0''N=Y%XCZ7+ZQRI@VW']06^N_I]?1M[-NGS78
MM#0@D&V3TV0LH'%IK<UE+M_SG&./HZR*R'7;BT>6-.0=NH"A\[IZ,ULF827Q
MDX1-+Y_#A?KJ6P_SPDA3^^D/IB_7<9J(QTDI!O@JU'!;'8\-90-0T;^]^;^2
MX!_IS4= +(#Z)U^H!.,]/C5+FI3: N9MR^[M,K\3U5UR*OPK"\ []7WEG"'T
MIE)XN8;E91ADN'Y8XRAK;I TK,*]<(W1*-JA=]%\FZ&Y/,E_Z=QOVO;1X^.E
MOL;:/T1@&D8W^JB[$.>*L:-^DMJB/9/2N9O("*!\H.;BYPWC+O9?"9D+AZMO
M7OO\?:G*>F,.<_#%AQ0;6\&?EEL81?9,$(OM-.LI-N"_GJS$^<O5-:)7WC8X
M3[F#8L'TP9]F\C/\-K@(3<W'6  %J20BO1X]5^'H2K'+KIA#N0:0K$TF^'O;
MQH)7N\1%Z.*-HOFO/WTVU)#ODSMO86X&LCQBU$^@;%U :#LES-G73#W\?@58
M$4_]@GC)ULQ0RHX8"]#PA@5X)\,40-]A :@]\X?LW57(]&8!]@Y8@'UC#N8-
M_%%?X69XSI%BJTW8Y+P.L8*D1T4M=##E!'R0FXO['6P_D<>QX[*V2 3W49D7
M9I+&K5=78[O;H,B4QJPE4$2;_L.?A_(U]1%6"]4\]!Q9([-!,],A)1,QHWOQ
M9K7R^DE%>MF\WQ/8CT;31E@ O[LL@#")85613J+/:&H=58.3MCZ@Z>*;^R9(
MIN+2>R!U'F9U%":P *?W6 #,'5\2P]HAD@4@EGL=U3JR &QS0Q+2\:E YA^/
M(I@_,X+88G,+!O'D%@OP7COL"@L0:%OII-?6O^ +YP1=KY6J86M"4/=6RA\V
MPZ7 CC[.HH<=WZY?JKH!KX!AIN5E1XDCWX?YEV]^G0^)J#N(1XM=^6DVV/NR
M;*ULNV:P4$-AX.OW.HFYIV')I]Y_.%2:.RJR<68!9"0OT5M8@"^JFA;(4+&G
MYM;K'0\80WV["YH&\1^/VC+(\9=NAA>_%C>3^SFB8EU==[OGKYRW=6)_3+%U
M[2N@S9PQ*6$!VB]N(IF_,%@ ]AM7(A[MIPP+J1S=W/I-4SI(ESQE'_I\0R8:
M>7DY,/EPDB?^.SDK9?*9[F=?X^JIU%-#WR&>.WPA9I7& QVJR2\?^5S'LK5L
M>["S@-K195H*W6B69%@QO8#+FXN8KQ7O-&9JL$)SR/X8U OFJ4D!4 /&?WZ[
M*?C5QN'[]\=L5,WY;+5,I.X.MEF9-R)JVD"7V=-T16]]4$\6YF&D E-Y+'WQ
M C$Y*7E%VY7#KI"BPI7<[L6@Z?[6C8/?\DOB%1058;O#P[5^Q\IMWWZ,O3VH
M>I35;V-S*76E'P32-P(M8$;9Z*J>0'8[0F2_3?]=^T).881HM <6ZAZ)\(%)
M/;1Q3,Z6N2)C<KWD+NCKM[S3*!BY5.+OA+!_PION_^J"?USAMW[O3&W]'G-2
MK> Q><I5TPL"-6K,F+1#<UEB5^0(<+\Y\4I:J:N94*G_D*7A!52G/QO7BM\S
M'Q)AV&8^V"5_FGM@MJ%R_!3R(M7X(.S%-/W=P_!-D[<"'2$N&*C5YA2/_7&%
M2B,KC!U,LY_(MS\;^PCF)I>M]]:CVKJQ.'0,^XB*IZQTS=<(2:E9S;EW2B^M
M<AU2*ES(N1O9A4SA*N64NX$D1\/A.V%Y!+4$^3KZ!5=?U<.F=X^,A]L?+W1N
M/&H_TWWQUJ[?"%_.$)NR=G_'<P0BK?>Z$6GK61MXM:7Y7A-;4YB2?+6:=(%W
M'J_E;OS(D.L:MK\@T+B# -<[];)]>-2L34FWT:/X:>.E@C?S<HIB5_2%V'B9
MP%:.1? 4_AN^'(=9PA]]S]>HA:*]<(E$[H])%>RMP\*]-AY$='P+*R((^(?,
M4'U)TWQI]7OPN?:9+LOHI$M[Y06%V3AYTX?%SEN]%^Z]8J.FZ#POI7&-'7@A
ME315$9M3;$AG&F\XC.\7Z3<6AIAXKD?B4>:'3O5%F':@< 3IE$TX$2Q(];7\
MM%!(N9F<M^8/JO6\Z)8XU'E9EXW_J&ZA!;_*,# B83^'@H8C$FEZ56JB,X%!
M?KX.;SZNLGT5ZAFQ*+P7*EL[.UT7/.5&V=]L%I<S3(EP'0"-:H.L!R3OZA3<
M5TQ@+VF)0FZX <06$ER\*K'X(IO/M;S$UKRX+/[6R-7RO%N>A>_/WS?'O7%Z
M^XOS!Q[O'+8)3)#[%R)&#F,H!/Z=H2*</TY3!M%4,+[/+)LBE@S;9!5EM 8B
MS>>*5Y[*PM#NL COHP]$[(X7%+:;F@A_-WV\]BGQXJ (1)_3EQV>\AEG[J?4
MJ.*K,7IPWRQB$[U_7GJK)08=3VX>]\FG9YP:2Z1A&7LRI4HG2>,X*Y<?@>1?
MDR$SY1D7WN87=FJH*]I$EF8]#9U@(V=-D RE8JU\@[8Y .P!/4&\H^E@Z#5S
M;AS^/K[9DW30M6T*NCBP?6JZ(92 H8;?]&G*WM]N>&J1(Z+35%*T*EK>,VPN
MGLJ0OS=PC<T\[M.&&&4AA*4E",-YH[R'QD7Q*J/@?\>9G"(V"6-"_$6^CY>5
MO=JPQZ40TGHT*3U:X_;')A1I_!\*)X?;/"&4\V8G/,U!D[KL73>\N:C&J SI
MH*%_:I+VYRC'FL)T-XPKOY+53Y)['P8P#7/K1T$(LD;-25U))4/8@K*5+C3"
M](++M+/16SYL8)RPVYOEHQLH=T6[35XT(-/PYX.$6ING:!<HUU'.FY\$SQ+6
ML^C5\\O>0AY[5\]'78ONZM)&=UG^5'(^<U_<M4V/*O.JY;']"/&8N.+1^7G5
M"@L0+@@:(7$K85JRAMY-D?X(X87\9 J___"56B?=TN>R8Z_]?)+O,"IBPBZ!
M'E6E2A6RX>3K\0Y8>[@_8_8U^$;:_.EN=KAIM6JR (I9<4C\QC"> ,LVVPTQ
M-$KSNG_<)O)8-1Y02E1J0M8TQ86[ YA]-, A[)#9L9$<7FX ,2_HS[<,Y[C]
MW=73V7H4""-'BW;V/\\RI!R;*0?_"!?RAY)B\4+R&OZHE94MY-69-<E+!E'%
M53_-K=E,*A@G5*:F&1\9:2!^3N=&;:VI^9M<?\&[]^^]),)SSZK1?+U+H11Z
M(=.N$A%!NWXH -2U9'@+%-O&_L4"&/[^LUS/=61WP:T["LC;L5]U0_-J52'S
M< MJ"S@KCL#XDYL&#5U8 /&PJG'2B7HK"@OPD<9#*1 ;/G3.6HM>LH*N;A!&
M[CBLKP6M^GYMWXO]DCM)(#D%C';G>RS+-4!  O-5P?R<OY\."HRN1L/(KSDQ
MG]>5W<G@6$+4 H=_H.BW6TR)S4_*OKN7SE0I+8%\,B]0PR<)NW0XA)K,:(.E
M@+VQB/+%5KV,+J/PVSHQ[:;]CT9,G37)ER%OV( IB>ZMR2L)0VYD5S!M"+Y*
M903[KDE[JTG@;?GAH=%6#BN&Z:K1BLGXR"D;.U1\9DO&-"'">:Y^>C1/ODWA
M+Q>*WXUW3JO?V&#TY-DG!^"IZ XGOXM/G*NL(T^K.\@+&;P0AUP)/:$>D&@>
M,!![Z4[.6].+H;\^/^J5Q/P[>TS\4[:A^A<6%&LPP< ]FZP%]BY'N2$WAR?"
MAKL/4UD JQ0CT:L59R9]L_[FCE VAQEU&".'Z4Y?SDM T?A)F]2@DV-=_;\]
MRI_NN1=SQLJIVI1OJ<#S0]Q*<;(8#T1L(3G;[\;Y+@%X14#>_VJB<[-^NH\@
M<,_M+.'+P]G\*9OTK-:&$L?H9L,G[I"Y\%/5M*G<#44=5[WPY,L!R?DV-G^\
MN/5[J:QN%!L)4OZ=)_E7$_RC<]/_RH)_&^._C?&?1O#W&F- %I&.\5[G*FK$
MC.[V.0>V]TVD<K:O$N$)\A:"EX1_P2@Q-7,DTGOFUT2N/2[(R\^-]\QU=KUW
MXS]:*.DT@O=-H:U<<1,X-0@5JH.@[@\-A28T^JGIE6D^1L3OIWS"@F?KZ;V+
MLP;1CE^A]DMQ'8N>*ZZONAYZ/54+B>1SS"TJ+H:$6"..NJ6V4Z&=5XOVJ6.5
M>U!W7X_M#*A(@U)8'^&<LUBQ?&/O3K,:MXI6?0@+X.S]Z)*8..3I!&):3\Q$
M+^9CCOY5J\2KPE9'7]'^O94Q,Z$0.C8*%**C2^A!<U8N0;$"L@DKJF'S^6NV
M,563P49UL07=Y)C7]9A^4*"[I]/<U/ZJ?GJY/?Y=V<>2PH*"[(_/)<1^I)NS
M1UL[*C5(9Q31/F"8<GHGA;@&2,+-IH$Q#N<P"AJRV\YECNNAASIU;2ZIRQC=
MI<)>7R[TJ]:'O1KJVZ9*(!E##?C B%Y,05EZ^K,$(CS?A$V\>V3FQG8NK\:T
M3-J?IB]Q@*J4RT%E:N!BNKMG5R4.68 3/77Q@IN2J(OW4ODW$9%0X-0)?R,K
MFU\"XA6RLL4L-,:PZLW_>&;UWZJ]VK^ZX&\NQ37QS2K"!-5?"FW$5@70/O%8
M.-RLK^&Q' I-\FYXT'3VZ0OQY<?QU]2%_&->]1M)-[C_^;TO_BY%=WJ-:*&W
MTSO^K&^-:4<<V:[.<)G#2=1I&ENMAT7OTZH@?1J0IX(S.&K8=1\T[M9B!=>/
MEYXZ,273*I'C2;EY;8X2Q;]BHG/83%@/F:D+OK8UBJ()!I8SBCL7P]00IK2Z
M(9S[O!(C_C2&0%!%2PRKA&40!#N:5GER;,4YO=.B8PS'+!Z\B1_.O90,>?/A
M:/OA]\T*H-X0H4@P)\;*:I,KJ[%9]P<R%?R5V;5?]OHS=-66JP6G#%,R?&+J
M]=GJAVA%VG92ZOKZ\"[,X73ZGW6W.[MO?,P4@I'K?=G@^=UB$DZ'!(1W3PL6
M)$W0E_STM._1U/MD"E4+@@,QSKZ>LG>ZTI,SA&JP)*@O9[WN>RV='P6_G@0L
MOY%+UM%<(YIM4C0WT6_0(LHR.R<V?1/+2!G:\T&!C-27E<T@1L!&V?N0I6KL
MZ>((;]"Z0]4D32--PGA0Q!CH-3QFM3!76&0076=I(-'VPQI$A)=0_]F<UK_V
M<?"_N.#O3DU\OT !SV/T$<!EYF<:+T4X;%:55'C0?YI6-M!8W2L<5VZ](MO@
MK:2:)E)8T34O7A >Q1^3$PN)Q*;-OOAM6N_H(]1>&6/HK=S^^:9T8A4CG$Q*
M?1S6^< G[$+)00G/=L?")4O4!R4'V _OIHO!$UBE[(1KV)U3>L9!N@[)145Q
M?T3Q1LL-:FD$LDV_[,4>WN]G 9(!)@AV3SR+:<2$2#3N<=W<0YTB!3R3-+Z.
M+\5HJ/3Y0(B'&.JG)V:#EQGW:M,NE[IIG3%+Z[E@/^M\=$Y@,X$\=H!>#.K>
M1.%(A4Q%&+6-!5B(V>*MEK/'C^! 'C_#AE9"9-)9 &GGB/7;H;BWXP%VVC[#
M.I5[VC?*7O6;#PW%=(!!IA:Z=:G^>N^.ND+&38,5#\XX,5I6-E_0HU0:WM.X
MIK-\/M'!%94*!#6_D8WBWJRJDT8U22J"*US'G#W=Z\]7=AB)Z.+''\[*FQJ(
MLGF'Z@9^,8K1S 0R7G4R'FUN)A'UOQ\.Q(SO7VU/X2"F=85D>(_X2'4KF:'/
M@=^N][( AICZ-N]JS:L?;&,39!7O7AS</GF4<-3IF(VXZX0![FC0T(PO!W,G
MM,-7FN>7A5"'9UX3 U(W9X3Q<(DR>?B0!!X7Q7_N0X%W\J4,'E!=_;20'^\S
MBBBON2=G[6V0>3_;M+[\K0WJ_M\+2D'])R0OF _W\F@HJIN9F)JJO[WXN]9Y
M?I%T3Q?QXLABF[0W@#-'%]-Y8XMHK[<EFJBQBVO-[VC:VW,-&&9W\D<N4M4!
M!ALR5ZD<-I8<'UP$&7KBTU34*#>2F"U6E!<.4I=]%2\F[*7N6\(V^))FN'S9
MP9<7*(F)T)?5JCN\<:5,(507-&OL^:0YS\@LO[@1EZ!;&%[H2LVSF6#U^SV3
MYG6EI]A;9?#"&0I\SG*N>TZ).4WC&FA<WX,TI_"&?W&">SDNR-&\LP*ZC'1B
MVYT]_'=ZU7?TKW=<E!7&U9QXJ']TRJV=PGY;K)N%6<_=XA<]/7]:/)36%UT^
MND[U,C1M*LMPG.;=?*8"+O\8VE-/@A3N#,/E V:"M&?$;T&<<LH^=G>]+"TW
M@*2Z%,:XYJ?%FX_FO?OU%-NN]/\=O/WW"-[^4V 4?.4JKXS419JWIHR8IIQ[
M87MO7,>@93<J6^?4C6$S\U:QMQ-_GL@1OW])E/UKXVSV1OH\7%L!XG$> M6Y
MR!H>5S3B] %Q7JCU49 U-J_.24VL?O&+N,S/HTX<$3:O6^<A8L44ODQ7F 4_
MEQ[(1LO0PM3@VZP%Q+/@[<1OKIRGXSKQ8T<#A_WC@>$_!<>:M0.D!VBRH[OV
MRA,RIG8C:@42,2R  5SUE(28TWI3$DK>RAS6YWX-5?$^7=+8N/JT2.^?^??*
M.SHLHM,X>:J/>B67R^R\9MK@+S U];8DYBM:C./6*B*!LGMZ_= 8#:\AJ>T$
MMQG5L!),(5PBZ*9:Y0$]T&>ZL7WFCY[/&?X\B3WSD-699.NJ9Y\R_7L9JOG-
M*J%CV"9T A*@*</X/IW![<<H6U/GA6_$EGY9*E+=*<&L6LT?$,XT!B%^=F,Q
MHU;NR',/?.TD1*Y>#W_)#XK+R=JN.DVJ"5 YC6*ON\6B$,T?<6H"V8N>.SFV
MW[6M/,<"F+@TWPSH=V14;_0.C&:8\-11Q<EAWQ&HNPR?B0F3F8L>@Z8C'P-/
M_O!P3?JSD!!P@:=22Q1+M3M]A.IVP%2\S!ZZ6V;1+IYI%]Q,=&C8C]HV+-O2
MZ-Z)C_!RE1-:X9B/91)]8K_!D&U7+)4]I0)#2GQN:H*R2 K6D9[IS8E(SE+9
M0?7M(T<QA;"C_;+MC@_9^PA]&QHQ:D>H"!F2!]K,;Q'=I;@$1>U\!7$FQN)*
M9X,\AH;FEEHL!]K4[\U)W%H1B1$TB1;C8)N3+NC?A/&_!6'\>P2\ =$GXT8N
M5O_A[OC^4WE5^U]55VKN6 C%_WGER)I3_B=1.#=BUJNA(VFA0!D>?-9,SE;)
M"5X)F^%\%_K5H"W!]D57X9E8G:./<=0<_=>; +< *]UG/VF_WY9,;QNS?>GG
MUWGT697&_Y\W,E5PF,#Q<35GM2;E_"#^>J7\\78+-W\:H]<\P+K'4BY27DK'
MWOY>+N#]&8"T];OB,[\?=1"@0AT+U82J]JC=Z'>_ZXW2_<MOTY.Y8W <57(!
MN$"?J/"I.^T%TQISX]:9-:8=**)-].,F'D%!PT_[DC<26E3R*[ZY%CD>=>[_
ML6/=V_6JE2PI8C;F5+/_*<SKW*.JWM.CSG*U[\8>6D@JRK9>/W4]ZXKDFV@9
M-\#449.->F1RQU1@!UT1J50-#A6E*PM=I^H=R"1<8\@R27-Z'6 9K9_0K;=5
MTT;64R2JMDJS1UWG#Q8 D1L'G9<[ZB#^;MA7"J^?T>&37DJ^G/'4[=9:-5\,
MWC3A8X1R8L?LY(FN,><J,^.:?BZ5XC<FDJ;5[2[V+A#>HQ87Z 6OVM60$MH(
M4O,P"_]$,;6O98-K:)NW*?#LCZXQ!1+)-[9GPV&P?2Z?D"A_MTWL]H1X36Q)
M4>1'G?@@6[?8"_>P;.V;,AQ6U)<>(;_$ %-']U9+']P)BUK??,D"" 9%="I\
M#$:&CS)*NC=E9IJ"3;G4?S_M(4[RW'BPIR?\"RPMKUO*JR24=M2SNW+I7Z8W
MR;^XH'AC TE_UM_6S]"ETUF X.S^O54VX)!2S(%\:Z3N"\RN\@(6X+SN"@M
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M]N;!IM-M>#"&*HW\26V>L(@18+^!P'H HX-U+I$[H_)7NAK"@]V>]H7XP@I
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M;+CA00C8TS6(1CF[IH4VUNO??_T*>7SOQZ/.28"?<_B#62E)YSQ':!)Z.=M
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M')SU8>BSK=KF[G).T(N!VFNS0;^5NI(G(0QIGT1"KMQD.()<W43J9<)@-#W
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M/M63!ZOU$R:?/!4-F@JOY=%"U56:$R##TG*T'[S9M)8N<H]@1_P;R1-_&7G
M?C9>F_YDO%@XVDCJ')FK%ODY[+(GY,>0J;6)"8:6 * >DBD;9:9:V2"_7">
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MIO\>B3=OBOXO!<=?O)]A]D4N\%W2K=AK"POR3QR>A'8JREI?\HLWR'WSM,U
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M,U&0K[@CLZ'&5HA*"FAOI,JRP!Q0].W9-7B!GH/;+.-J@TS:HD5T%S*2,TE
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M<7 [;/.Y8%H3$+:"?B\^$>BP?)8/6&000Q,6AVO4!&IW"_^!YK*[)'@1<)"
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M\.2I:'0^9>;9IS=E125%G0-[[^?'I.KL$),9+H3]A4L$90ZW-*[B\?V1(8R
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M+,WLQ@43;N&3^*#<@?\PK^R6_HXH^FU6\>L8,A)B,Q&B,Y;NIU)C@2Q3&G"
ME45,D(6K*>ZQ2&5>/L<M=T<QGD>UM93(INE*)NFS!<5I+G+:8HPC<RT/K$EK
MY',3 ;S#W9MQ;PB<?F-(A"WB-&%K.MI)T[?9>HT;1B0H'):XP2?3X4VFML\=
M$8KGGQ:[B)Y+E)6  *[SFBV#'+(CM("67\DFTT$['@L%FH;;KN"YH^[$@D"=
M,J7N=+]!_UG)RIE?[F75KQ^1?1[VS!=?+$N)>GQT:+7&,T$']6S\A!A[%$L,
MK6->6__Y>Z!:*LF7@SS; <PU)D2F6F%<K:FH-PE:8X&"NS?#[XOD.HH+Q(^*
M22D(,""*>P#X<ZGB?PVG;M%! \3RLY@/D#Y\@:Y]&3YHH[  QRWFMO SB[_A
MT&^N9"8HX',;K)GCO"\'M);),->Y*/M],?_#;S>K@8Q:-$&[9/,+-U_PHV))
MJ_JWQ[)'IUK!)A&[3J2#B#%M6L#D;@1^9'U/0,EP9I9/C]50FM6$0GXN=!DO
MN(UG,R5D?V!Y$F%]/GJ;^R9 (NOAG9/I_*7RH;B-_KJI(^N* [:^MB'85DZ5
MG_Y)CMJZY/%O"S9/@D,Y/6 S/.*L/!P"9[[<*"@(OSMX3O0E )W9!8W(Y!72
MT:QE9^A]^, ;,*<"'Z(N,,JW;]J\/':C-':O&)\R7:PTX[=9WC<&HPAFB4'D
MU<[^U:5K7Q23;93PBN'/KHC^;Y/HK&H%SJ<'^CW3&6$3.,P%:/VA8^<L+NA2
MDU_H\K=Q[%QI*Y&U_E-N>4YI7I*JM/&H^LT[/XL8$:WZEHS8D3PQS(&Y]@MY
MM04\'ZJT./SE>09'W-KQ2YW1 ,W28H[]VFMJZ A02G%J?J&AL>RN47."WE%_
M)\0,<*?<11I_L''?7IW,@I_'@@)VDX"-%L'*\V?+6"I,!, _=;;P%FQ[&0WY
M9JK#1^?L ETP@<R/_NH2*GL(9X1S)([0L_O3:G@2ARV5+VB%O$UW*@NZL"JX
MR=:,(W KN9VKK!]-*3)R?YJ.=;'S<Y [K5>4*>C/"E-9EC<P:F?H6 DE]7GK
M#NOHBD^)"XA.CS@,G_U,CWYZ_&_U_,"58CY/P1MCCU([ 2 $N;9KI;33],!1
MC*INQYET.YC';7&_&?Q1$'-3W8$^_VF=DXU2LM=Z)>Y?V@]'<286%+^"TD$N
M"?*,1,&?]6L$T]U#VR_X!>C@AX2%"CKH7QDWB,:%H)@C9VMH(.0:-]67#MKR
M9F3P+0L-K82<$JR]BTC)SO[>R)"9P?AW#B@/C,<$P@05M+R]=E/[\CM^ (2J
MJBI/_<DPAC9"DM1.>X(; 7_$!V$I@<'7\>D%8$LUB&HC0K)]]G7_RFZ :/*$
M\?N>9>GT/XJS\P/8)6\/*TLM)C)^,/W5MV=U+;?B3M9Y-F2@PK#\'7&M/RM'
M_:/U3CW7$2!I:<5BVR#G'PV(-9Z)/"<EE,#X1>B1,B6(RDSLFX)B@C[.,;?S
MX@AR@UB(9?.1\H*9K@=^RAQR/E'G/(=%E*][<YG]VQA#?M'F]C\V_VY4 (P8
ML$[+6M>/GQX-XL[[75_>%.%@EQ-[/71@_3B^SH]M_'/XGZW"A0>TT4Y;EYM0
M-I_B^Y^?XC: >RU$%PR'*,[Z/Y:?\/6UMO(C3N4K6O-.;?9EO" HPS"Q-M+*
M;G>$<$=I84):PD78I?75_(NM<S^+DOE]XE\"(,0W3.!0DPM^7H%/A;]=+2]=
M?]I/30N'K:5/HB29ZW?3"^?7LK/;OV?U&0QAH5#6ZW\*7#;9U=TQ[HRZ+OSV
MCSA?8@0=]+]?=_Y?]H+K__Q N<3:194$)>QUUP&!V.\7+IQP1#C^!0(U"@%F
MT5Y5B!TJSN1RA8W4BXJZ"L:R!/K+^'<Y908\U;I\IX/'6$99A@EJH'VK#?@P
M!.K[(>6WBYO8>E%AT5\G\HM+,D5=G:&IAKK5O3^*SSYC^K'(P.'\S=!%7*-+
MGX08^$W7Z-MI8TA<]^"X_LW[7Q;OC$#X79B^W1KG9(! X/]WD7QZB_-2WD"9
M4E->%']^F@ 99*#1+7#+D20M\!A ARPJA Z",G+F!E]BY])GN<>E;]CT4QX.
M<46'/.5X?]9 Q+]W=/AATPO/A^@.AF8J^'_MH$/DV:XZB!K&HA1")W 7S6Y7
M:/#.#<Q[5CQ^?]E\-NDYU*?S[W HF]'!J.0^X[;B3V]-U\I)#8W 86A#<]GL
M,T7/^NP<BI+]8&+G/;6,>OLA)_Z^10,^:/ _-'U:IS>+MWC]:;LK")8%9+3\
M*7L1-@<OON?"@ O6W=9;N3SK>"%@SWG<9WWL7Q)O;-S(X&]7MV+ MJ_?WW<5
M78G,/"%NLC,\\L A-=Y7^W87ESBQ=TZCB\'RC1AH\R&'$,3'GY1X,F[6P@BE
M>,%0@BO.RU:TJO(CU.>BW>?2@#=MKR0^O0)7 %=/"OUWMZF]5$_L_+;D\LN\
M;Z7F5V-3I?YH@WO=?-M"5:V8F=B]AZ/DW]T_'+W$OCSL_C+Z[24#B(OVE'/<
M%]>-XK@;OIJS-)ZL\:E1# ZQU"EUM>R^Q_0@^OX;@4E/IF/@]H[^PQ,?;B>-
M&HP;VRV5YD6VU'$51RI=$[WQJ+M!6$]IO$]/MY_WP>NQ=D%[HTO=:6]')8GH
MT8I_&);\]\M%_ZL#_[,[++Z[[^B@-W\AA?NV7E/ )&M*./4OW(<@;LZ=W0L[
M&U4HG-.^.\<1Y/G6[=F@2\U5QL%)4[5W/]7*^B#;\B;O'O9JO,W/3LYT6ZX0
MB+-6 2SN'D5]@?F4_)T&QUS=4,I!C7CHD0YS#XC</+,H?KD8K/;;K9CR:JQZ
M&!%?'5Y8(#LR/ Z!7#:?%LX!MU5I^&IQB,,5\QD'+2+%@.C-NJZF-*\&'?>)
MT-EDJZF8(<C1(#UI/[8^L8I+/"K.3*]T<_$B^U<!2B/LFM9E-S;P)8B B4E\
M'(_L!:$"P!G4#[V1=[8C>$ZBZM7:-V=7<K+QRB=9XV;P!3'3%@J506IJ'Z85
M'XN)>N%P+21+ZQJ%)(G6[[HIE%29],Y@GA,C=- ?JCI(7V**FBE2&A-.8 \5
M5M]5J%4N<1S?2Y[_/KP46"%7M4N&C8#]%V6N/BH]F,1EJ$C5DM0_E78;&W;)
M2>6GM+[/39+IX9 UZLW<P$,/29HT/[P<]9O?%>MCZ<,L$QC[AV,<2;UQ>7T@
M2LM_I.X(AX;45XX:;;(VOL+Y0KU-3%B"V:8R,3?,6+1X]!Y-F+[]8OY$%EAH
M.^8'2;R*%^QC->P3% Q65W^6\)?\<>:OR3"&)WS,HHH@BY3JF:G'@0HN/YLV
M')[Y#=AL#KSS#=H^^1)W-_B6&&+<$27I"7N*AL]_Z1@VTC)3U5?@T+DG.R*&
M^JYW62-2\W-0A>\>8BMT@USQ*ZAL#2'I#F^I)D^,2ID9+]C-7%,)X>W8"'9\
MY*4>@QTT7?(BKS]U.+]_\CM$B^/!>Q6:ZI\1.W<8=0]9+G204L62X0@W7RF*
M#TE=7BU6S9@)+_H](%(OT\BH ]KX_'G67!_=Y;3Z"X^,Q',,V;IX/U;:]+6R
MS4]C$1;\4G3)Y.9(KS' %-^A0J%4]\DL/AN*)>H(6_J5C\O5CS:$]\&O6*.\
MQ,;EE-V0]K]2+#]^*L /C6H_W&M40G?=T].2?FBJ+3H/5;!AV":+C^1)#/U"
M\Z2#1)#I$8^I6]LS^7S^=- ==$%5T]'G?F_)>INM3Z9CV -)^^U-A)5/J )8
MN\E%> XW^?L19Q:G^O6:M?,0_N3;^\P 2J..YC@?(27!9.,(4A[Y^^!H8_@4
M3M*.BOAXHU%!0X/)CT2P2'8Y\HO@;U:(5>>,;3?NLU:YV^V*G,PKB!06>?9*
M>%C84*OIT((6'$X)VFF;K['05IZHD0H"*TQ"]R<SZR=3-O67""%%4XWN,,E9
MLWDE;.'OW;. ,%\H"9<WVFO0U0C^W,6U.G;S-. 50EC"1_!UFE%'TTB.LA9[
MLW?Z'Q5\L9NP*(O8&6ZQFM]8D:3<HQD_OAJE.*3-0<L*#EK566H:I_P6V^>/
MU[7)\066[%6IQZXXF3.5V$"3MVTQWI=77Y1-?U7@*JEIM"*87G]Z*3LOK05U
MZMC_0\3M6@/C$6U#%?&'7'=S I[>=NU5G6CJPR!3A;[SEA$?JRG[*73KYTU9
M'IIG?M^*]M"#JQS9'LE(9>$YOMH=E(LQ516[)-ZPEGCBVF#7P7)7Z&A$%NGJ
M</&&!T!THS$_U#*_^27WK=T>W\OO])NP>59RJ-FUL=YK%<@X>GWVIKNE?)"G
MK5=?Y)C@%7E=_/6 )^7\7P(+D\N^.!F$3#2!ZC&[@F2M"<ND21X(*FB#6;WI
M=WB\6U!F4YC[-KYM G_CTM"PO4U4<Q "#M.M&YGR[H(\2?IS!!X]>\O\IKG]
M _MP6R!DN5IJ-V.B9E21U4'&I0AYF4!?@@VLUY0XQ8TYRS\0/G-DIZS-$\JM
M_*XPX6YT3:V!;J)Q-U,&CR4\]Q+C$$BDA$H?LP?U"\TMJ]<-8<:B%_5Q^VX+
MOT_G?$_?O=.2EW8V?F;.%.,LMCUM0\?P"YV+1\P*:&GI@:?!I)#/OB:YE[N!
MJ9P&?\#^:/ZX&T;DB\_JE0PV=LI:D-1!Z)LM;'_CS9ZY.ET*'^HT@#UEFQGP
MP"2F;J$L_:M0/7(2<WF?.Y=<^?V^&7581G^^TV?X(2$''U0L1/E"[5(F4+XC
M5=1J:0:J?#-!(WEJ?\+*=V;P9C/&OH[>4K4(Y(^K@5K,C?68'^8R1R47U$ZW
M7+<;V3]P@_\L7'-=S''0Z.E-*I.]O$?;P,.VII#=!91@/P26#CJP$*,)^81.
M;Y3">0-98^2[-V**:NL19D[@-SJ1G1ZSM;/^I8 RO-!0J/ZNJ-JD5ANZ:-$E
M\/*30M/ADVHZJ#4 G%[_ Q:Q6]& 3"#T2TS/6"XE3ZG&X7FL=P8:$;D!HL?[
M5PY6K^=O9,]:NC7MCB5-!49&.ZIS5TE?TQ5H?-*4NEHL8H\-6=+U-;DS#.2W
MNOPMFBT?<QU[X%RH%&"=8XVJ%G6XWE!=G15^+0/7^!.7\2YK!C<B"7DY-=DL
M,=4KR*-GV ,=ZV"3?GSQX7ITX3.$Z2G@.K-T$,V&<":PH,DSZSI*>7';V'<E
M&.[>.?MMJSQW%I4@7HE!\!HC'$^?=&E[@6M,*5P7,Q9Y$HKC4976X=#9.8=A
ME-UZ4);I(&5:&LT$?2-S&N>A6E^?U1?:.@T5'T;_+1@G(C%Y[4.7G5=(XQ1Y
MVK7;W,7OF$/C_);>N:[SC4J1CGGY-Z[D9Z<#H&-'P0=?G4+V>'LA6L26([3]
M.%WWA3KU&JFFK[*^WN&.\UD.U5H,Y/;?YODXP5$#;>2R,6Y4N*)3NJNM%5>8
M)E2<]BI/AY6MAX@>+Z.#?N3DA2H!( T)Q\BI"5(G*>)-N10('G/'CP[JBJ32
M^+QA@=L)0?5N^P2K3:JE_@)'T B<6)=X\CSE2;07[PDFF6;#^_PLC/K]^TZD
M_E5B/7F,#F*9WYZ-7+]]$=;?M*%?03A"P!94,@/#6(*1&UR]X<9"9MDRAI;6
M9F:&UN^+'%A5]72KOHXR]ALM>JC_C8/_0!R\C;IDMX<=8(]][-XYC"_Z@%.F
M@UR'#YCO(2:LS09B\,I"4FFM/6J=1+7<V3^UF* <)MI/DRZ/F2P9%:>9%:0Z
MY10FBP!&*2<L!E%[%9SZB5E$WC0*"_D1.#WK-$I9?.=PB4/^9 <;>X"C']'.
M$]8L!(>E2>G%^1?N&L.N)ZGJBNOH+)1A39)>714H8+R::,7Y#Z+;_]F!<OPN
M'>0AN8:AFLT4T%8.*NJU#H2V_HM.4__'#SQ(+%D5?HZ15H//DSZ8I-YVU"EO
M$1NT]QK;&QPWF!@<A]$6"DJRRW(+M?F3K]G%YR0H<B0E17[]*YY1L',"DSY!
M(FW3063(QX&6>IHC7\_![7#FA2L_-_GF4Y143)*@_O#2F:FBO/0 JO^FBG^!
MJ%_H0G9"=M99@3C)S9J:M)^E.3F9 ,NOOT"#$N2%:5ITT.W0!<I2M3Q<"Y9/
M)F#NH-HX*KT3C<U,[:0G86U-SZMAE/5*DA+DS]*VKLO&$N$)-V.[N"L9E;&?
MV<DZFK^WB<#M!%&[JFIP)Y\=KK@%OZ P-0D0@>"WFK7,:/#FL'PS^N'.$-+?
MZS(>TC+;],JUN=S1J]SY1G-U&ZO2F^>,0E_]9K+(KC+%"\B);G10*J*C(E5Y
MHPPQJ^ZV;_TCHV-$QC=YI9_8K#:V7C8P\5BTT<]G2KRCVD_OX1WB&9G4,]FN
M@2^B$@<3R<EW_P+T5 =PF?O(K7YN'3KH"B<:>>CVAO'0>?!?U3ZIP#\_88@W
MK*.09%NJ AU$&&MFE$'5\E%%6^X2*'S48J<'?A&^U.<)MQQ,G7/!-W^WW-Q)
M8$O,-[6(XI;BN\\0DN4.$/-]XCG:A1OW6J2XQ=P'/<0W)L.>P\M&3O.^==I-
MG4'L\O>XLUS/\#/_XC+]\"LJ-.[:-3;0*]"+QW45OL0Z;3KH==5RU53%8LC.
MV2H*5V_B/ GSU]<&BIA38*J+U]WM>'0)+YCG<E6R!ZN20N0I@;<+T)C;;XL9
M+W6"R0]) D@PYE.-5S;V>E ]_.9-89,'5FO;'"8:!B#0N7\=P]Y#24+./,/T
M1-!!K.QQ?$?51 S@?P]7::UXC" =-.>8$7Y<&=^S)(7A.,!XPGCC<+Z^#^;J
MX)?<]Q0.C6[<^WNO4B2V1?][[\KU]Q9$TCGA^&3A,B)Z-):R&3.R@Z5=L1O#
M%N57M X%?YHZOE=U-,"D;FY*[J.#WLW@N:&UTQ52]\"SG5EMX=A6^_DCY[5O
M67\*VG*YI@H>6JVQ PDS9(.U@XK&I&*_@5<$1ZXJ%N)$FN5;V.OM6^^%8SLR
M-B62BCZ78@U71'5U9/>5,7;0\:TIP=1;Y[3J]CCC#D:/*GQ. NL8+Q_[:^ML
MJ 027!&#2R@O</P9%&>S1P<9+7E=O2HF9:(L5#R%XLL/JA>#0F)?MD&WJ7Z'
M6*[IQN+5]<)8W"-S.^DW10 H>5DOX4B2#DBI1VG6R\Q5:SQ^'$Y:^QC(?K O
M>?KNAB<JRN?G <&3FIR;WZ4.322%U"%$ZNO@^J*!J3>BA+ZZV9+TC1\SB@A[
M5WHDE_GIH+.%-!NPJ"=^=P1&P)Q6<PR.VE2;*"KN+C5Z%N3-@:X_K2,NL3ME
M0:FL;M-HYF];ZN"=PZ7Z/[F6GV,_.)KED< HPR9^7%[IV([+^G& 6I9L_;V3
MM*KW<2=+0DWRF4"R4O!K[HD;EN;CQY#A"FT=B.DO>ZDC++]&C05OO,G J;W.
MS)'NUYBF0PW"DC66.O!M@*R+":"&8C5=#_._DYF;Z@B.]L)V1=K5^(AI_U2A
M[:V)Q[_7EY-(UV#[F3_&^E029#.=7+*2&2\022%;=8777# )%5IZ$,AY&?L@
MXT4.!Y_X[)RQ,2$W^/E $Y,[)XW?"MN\E5K1?:3V@@'RQH3%BLA"\CZPSI]F
M0FQF4*;9XML*?M2ER:MIQUW1LF.3K"/OIT/J&[X>]?!1K5)7SJ9WV.7G?2G-
M?^;JXKVZ)C;<WPGQ);9D9S("%@ $B;*HQJ,<&D?CU%%8^5H)Z;%>'K6U)>B0
M=ZEWX4GTO;<;O59D(D'"XH:<KJ^P2/%*_Z =VQN)[808?GN$^25 3+=1B4CB
M;? 2$G!028H3'?3+G+'IN\%)%9:AS0?3S B4N#C:>8 @ BA;<HH.>E-+!TVQ
M!#^D@SIJ/M)!P8<VC(G981\D4@R:G]_LNI[5TQ<_-"JMI- Y7QI;>N:O,%MV
M1L>]-B"P'R&!;]8SOAG%^*85HPH>'0P ;<.0FC5R[LLD@<IN:<;8]>3AF[2H
M7\10;X]\)=1)*P;G*\RW3!!9<X:.X.6%G^3[6F&9X;3U!\+"O,F"4A-=DXJ?
M%A+.A<S><[@HW<&!GFB*)ZC&-X7>!2*A-[!A7W:,_$0R,1U<*&\=\+/0391P
M#;.CG)[C6H>"+@L+'4V.D#TGR;J?K&$\=R_-GRI5US,6:-G WP#0 (*V:<!\
MK-^]2V:F+C;9,<MQ.RB$3WP_V$QY>&>27(U^,UPKRY&RKK*D_<XQLP"QZ=J$
M1PE4"WQW/IA]M4.;SO(EOD"2C6X-S?)\D>P86-G?03V'CF[.L'MMJF6M/RWG
M/\GD*!IAOV^A8+<WX+?D6K0S>-<530?%SI(7+,SD+'F@%W N.K<=#6K5-O!P
M,2HJ5&.S8EG$6(?Z[<"2O[RU=)56OT:KB,5P:_' .;W@GWAQ1+Z$T0]3PJY5
MH9"Z_B7Y@[ZN#HBQ@)3] :N[E7:W&^\&WB7@$\6!VHZ<D^/K%5K2YVX)A*$.
M?V)[!^)#(J;WY<RAD;KL<-OZNI]=#GFS06)(>7E_Y_K7_L$-.3/*WI+GU&5'
MW=.X$K=($"!SD D]62%4N\V*U];7$1_;=%^6D;$?-J:= U\E0%A,MF#UD3\6
M/4G[QR$"-T=KE>'EKPI.&#[HF$W3=?M[F[^S'\APKC+4%#$QI0D:AQ9U7JG"
M!>Y297$):1Q<0,!E\5I%!IH?^A#X?V,#[S<5QM_O>5.ZJ3(NP=22&^MBEW(-
MSM NA_]VJ_W_S(%U%&+@N!F33P?M6#_/.LJ:;L'S36;5%_-%^VXOO:.#[">,
M@3CE]Z&#B"B/H#T"GY4^S^./=4V8?PJ'^\\,1'HK?9<QUKI<*W8Y/%-D.=!?
M\-,-*2VY!YY0:7ZY,*6.&P9PCC([(GK,S<?)FDH'X9#R+3H' VZ;R+>R=-#U
MH'2F$7_Q*+V)XZV9U/[5*>1JYD>O!3=I[JQ+#:$R6]&W3);-$*-CXJKRQMP'
MK%H<X.0&_?T[014^GBV:5,0Z>[(J_Q0?S]&*LZ%'9N$6K-JZ%A$Z6QK@LI@<
M60>>^F%;9=)W?<^<13%9J3DD1 8K)_= JN]2Z5M&(=0C9!(SB9)(\:;>MGY#
MP7?H3"F;N?HA \9@,=_-3X&]&INPE0@BPAOFC]!@N7=*Y_U3/Y@PJ;*#JW6W
M0^Q!-N<]!H,-;F*G<-)!\M9+@KOJ*&4MRGU >;=M#>Q\1(L4%8HVE2SS&M<%
M^^MJ@OD_]&X%2_S*F7Q\[3D'::N^>VS8IKIAD^HK\]WR3ED>ZL< $!8_CK-^
MX2K5-*@<E L[88M@7V,X[R1%8\QBP^% R&DSI.0]#H^LD<&UN;;@.K!C(7:?
M9HX2GH8RLWT=N;KJ^GP,"BU/XI"#.N87X0%N5<&^J$&M4PL!.#$\;8; B=JM
M#U6"ET?B0J8P*/YR:55##50USSO45QS&8\[+8 L](+$^C=*/.AL;B^*3\'OP
MPDF:%6HPZF;-<4KX%J-]KYG$A5[7BK],I4H:8ZY]4X(NFGPH%'IUO[:E#ORO
MCC->5!SRO=.N",V&#NJM=PY>WD"W_?)^!E.K:M\;9W?>1*_-JAZ:-]2S2AK#
M'^%_NAWR:++/^VK(G4\:"W!9:[\\/''F2PQ?-[&W!'"8?CI($?D&(PU.E22M
MX:W_;"IAWTFW\9-T(\+K*P@!L]^)_2.T)?=>L#417S89?:1SHUY-WE&LVE<N
M@*>1>E?#/.:[@,_ H96V(-@92 RF_>H48>IO(">^WON)2?S<%PRV^MGNT5B<
M7LO^_/#^?O7F5"C$,527#OKS K*JDZ+912'9G3O@LW_OC\4?+W\YZ /N*0-Y
M*^L-GQ@F>8(T,PV^@-+_N#!.W0HM[#V Z]@O'C"[^VG]5IWUW*9]GT&_/&51
MH-K0=(DUH55.-CUI[?JPC?>7\0M_#3_.!N+&$OD#20%2W1V^I0B2QU*<9W#"
M %5U4[6>-)S%D3 #Q8M,X_MQ88[P8%,2WJ+JWMLIW,)"YFQ>^9<2V(I)%BHK
M-R%K*YMOB=?4&8 C-TH0-1.<LA)*!ZE(1-%<4*+5<_(R)6IJCDH%K/5*$SX(
M1)"1Q_'"UT :2E7>B3^]J)UJT;-0V1BYB*_=TM-CTKR?]@FK7Z'Z]T5E1BTJ
M[3X=))S9,TT']445T$&?(&VW8[_#QR)8K6O43*B>FZP3*9,H<-,=Q4QTR8:(
M@G[_YB?>CEDC0T?GPF+GXK0X_HC+M;L_"W-=(X5<PR2;#@W59)%"@.D;Z*!T
M,V_D74(:136)TWGY60=L.QJ @=]TD.\RBM]E+_S<V8FKL05AOD08I>$@LX<C
MH"G:ZE9VGM3D)WM96=^ XO67QN8R&K<!;[N.7%&E-A5ATMB_P0?('7'I)R(W
M\WM@\+8UV$1#T<^$,!<_^$!7>&Y%8,&7BN0TI4U3+;$W)9E)1M9UW?J1T^9)
M ./PH5A0JW]C4. DB4.:>9 87U3;UGE$9R\S9 ^M[R FYN)7M[U>RG;3*AUO
M?FVE++-<*[</]A0&\QDP%AAA5TC6/E]N@0_Z@J+X4#5;@_\D@W?2YQTO+Q2D
MYP=6GWB)-W\*O>R_SH.=G.+XZ.47NO$J5M%5]GSY7.\BZ<03\Q26]US:9R0
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MF0-(L)^\D7SKH!-"$ZF0L2G1C5^.K</<H()Y*;>W?$9K!HPE<4:E7C6QAAE
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MXMPEA0E\<<<6YX<2<G_'+]C;[#,]5&%L"S(A!\QH\U]IA@0R(/&R:&RLC%Z
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M$3A NVF//#R^+)&;,O$NX\>&D?H[QD6D5)UCRG!0S](#G5)WR9 \C3AM+Q:
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M_?@.$D5IR 4<S,'#4[I!;XI;Q(;S<TH%PJ\*'4"M/ZJ7EF,3V_++;+59B*U
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M'%?.%I'6XKPD^GKI\O09^NVO5(0GZ@\2C']GX!]]7ZH,/BO#!)U7L(1/CL0
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M8M3#?@.Z1ZM!%-[]OA$^-P2(IRTR_J/6UM(H%P)>J;INQ B8906*PV0 W=9
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MYOL#_V[VA @G&^2@0+$C*G0 T3J#4C-$PR=K.!AW[^>-)6LF)QKIQ $Y\6*
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MV0\KY_L3*_S1?%LAH4<JMDYFP9^ZFRD99)W]+(+^>.:4$$#?N(JD V%1#,-
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MZ[SZ^T$BS[3RLCDG[LN4E&3*AWJ'?,S)RWMZYLK?D5)JIAI#G5"HL'6U^E\
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M34)D0][-XNON)Q^Q#Z.JBW+9.-GX_ER\W7S2Q.7+?ROVTUH! !$IGI66Y4G
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M =7ERWW#%QK>R6'EO1:2A'D HY?SWXY@:G,Q'G[V&):-(G283E9,?7( D#X
MK'M;@]1B%G0Q^YE/D<2-W>!_$Z?1@F\'8[-B],#X4F-QWJ<G#VG(K11<A.N8
MWPDGQJ>5]<3]_$T;P83+A1B\H(.[#O6H)U-<U]>%B?.IP-G^NCGM8.T1+"P@
MH6KH:&MH_JC0RD[X[S+?Z+1D%00C=IK+#42+(]<[*J*)"K^H9;KIS1&Z88-T
M@<:5^.@IH)?9^-5'O]:K=!6"YK6,1(Y1K FDS[AL\]_E'[3+E JGEJM:#P_9
M?/%R31F0.J[2P+3Y;:)IQ>$S2CWOU[=T;'#_3C<39@4V"G!PD?X\UX%HE_!^
M*#W "*<V7R*+$8];^UN'%F^L@^0Q4G2'U ]%MQ/)(HD4% ^9#@"]^;[;11"D
M2M<G]$VFH _GP4I?6TX+,CIH9\?V0>/]1IE.\HX8N%J7SX/FU]+T).,U]XBO
MJ^K.9S?OY96Y-(N$$HP8Y$V!83;/8J9(YE80:V>T:?PGIO#JGE ] =&,IH7O
M3TB(H21+M7;'^A X]C??A))<NKVWGHV#=*._<+6-^]\#,\N5"U= 0]<#8I00
M;D ]RVX>/)BM01:#$VADHB'"%7T.9+13T2VP3<I>:O;D:C!MQ'P0A;MKC(9E
MI6U*<(/NR<_J=L VAX1$X;==(_<Z\%)MIJE9DN=N7JC+/7OY3@T/5^^PEC@=
MS:#@ T '\0WZLL]27U#[%"ME<G]K&'/E25/ADZ!Z\W3J 4#,(Y5@%*W[AB0:
MWY6(_1@5]_5M_J</I<5"0V,&00GY/1 )'@Z:,[G>>WRENQ)MY;,TIY?K>A)F
M8=_)#D(>81'3UWX!LU+Z;. "4ZW\7X=)#M5:4/>U%B@]DS)Z\\(#Z\ NF\J[
M>8F71X3+W](/+_&0,5=*S2.*'B)L[^P*^B+[A<IP>$]X#J&@A\:?8C%6%[]Q
M#HISGZ0Z)(; &DX%B7(^9:&EA<75$D)_8%H6,LN][]@6%A^.<SR^*K%8L6&,
MXTK!P>F5"\$V/23]1Q-V3F_HH#)*B+T1(_SEILKI>E4QI6;=<1J%\+:_PXZ@
M$*@;)YK0>F_.>W6N/"Q;<KAW\.Y%5 7"'MSK$N$1C!Y0F4<H[[,Z"*&H8+<(
M.%KLV_K=?0][1H;4EX17M(+^G>99<M9)?P;?AYY!Z_DK\M+M-;4:F@"]&N%:
MM)_5+(]DNCG_W\V/<ASFSQ#?]<UP[J.KBQO7:#76X OX:?=8O7B@_F.+A<^?
MK18J177<BA,@%[='K>^-W)"?3+Z=.A+YG[$FPYS"F8(XML,!0/FXEZ=_W<P;
MEO2&K H4$M/^_?$59^EWR_K/4[JA'8GM5I8WQ" 64*FA/^?^L>O"'VJF(-;7
M\3U)'TX^]_$>!N9W5T#HR3IH9P4;/_JNW<6K>&UKV(4KO7W7&IY4'*7II??8
MXZ'@A?E@[6!WGA3\[0#0/^#.2:6">^(:GU"%D84^E:@+Z9)C67'^"/.I;N@,
M7N+)SA\3M.RR'(9Y88NKZD:/1>D3/W*$ =#"S#Q1":HQ/&1XL<J\$LR#DY9"
MPCC;$JV7\&8J'#U"0I7_8LY#.O0WQK)?XAK$*K5@DMB] \ <V'V[D/X%5N?/
M"N.7 9U(;QDVC4[G3RXF49_^L[TU8'+O\CN3HTYK%%\''I:7*\?(ZP5<[KH8
MVR4%RQT<_&IC;'/TKQN5AS5;^Q"T=/,VUY$B4@_.@@VPS4A@09VBD'GB>VK?
M;=P?8^M^2\,$8X2;UDOAB(ZVN9)=I%"$ZY52;T\7K%W)CX0H.4DA[WB^-V_"
MQQN(B7' MI]WGL\1D9SUY==+CCO,=J>6:?W:B>SXR?O>=[4FU^XV&7><6OS!
MVFA$(9,?V.A$R16OE80:R4;6'Z4^A9A!](P,KJHPFH8<FM 992(= E43E#D>
MOSG7_,_#4)\:;;SS#J.=XJ5B.X")\]]MGOM&;Z[-^MRPC^=<=VPR?)>BD6PL
M]7-D9,CK+]>5*_(4N8$&YLT(*GNG*A#<*\&+;.43TQ6T7KX .B9NE*A<N=?0
M;!9M.X8J*OE!][6]=Z]003IF&L&^K8:PTZM(NK)6J8%]<Y,NA6W7X!&E')!V
M&)6W%JE HI)6@F3)GH,['!RM7T6Y/JGK$-!2N6G'WU9/<OF!^CVJZ.&([_Y:
MO=R:EW>QMK0*J=9ZY(RHA&EKVF&1_9:'.X]YF.=.$GMD%R%]\)?. FH$6[[O
MI(Y%9;1_4+.!T)B^DD4RK?\MEO(41J4U[1L^'X!:M0'=C>$CH[87(+-/O2,M
M0"/=O9=XJ56XFB>!0%P6A9,'4@MCLF]L.,]W>#Z2YZ4.7TIV2W,HKB@W&.0B
MM9\TIFLJG<3HF-IB:EW GCKF[J 6H]-S$5KCWBPG?R6O\$Y,"2\.:IWFV,H4
MPW&*6=/,JM_&I*CX#YI S5H\H2KT * ]MO.45>V(<8:8OJ[PWO_:A.0J%TDD
M%B7[%MI@HQH^&B3F8DL-TZZ9\1ZD7JG>:-&8],XU9##GG%N@4%7D8/I-ZU29
M\://88=E6U/B &')V2WL%.M8&D5?**GH&R>&?62*<&26^ _C0D,(U@M7X;+[
MS4-^GE)>:WW]A&NZZ,NI^MAN.>_9D'-5\FCY3L%8"(*1B&X[ +S<E]Q ?^3)
M(7-Z7VXTN99/&*+B":?,&4 (VE3$^E3WE92078@/C/Y5&!&!4GU7HC9@:Y><
M&7SYQIF5EV<T><AX?67Z&6N#4ZM5T<L8[5A$,BW#D%1@M-UF*7(.FW/*O&NE
M4XMIA, XK'O?/2:L+Z4Z^,@FO<BK2B/HKPP;OM*TM.1K)?D%A;R,^3':#:U&
MSQA$>13NP8F_3/&_?.;0P8SXK.J?^EL-1EV?OB$6/:J\Y8I_C14U(=/X$/-;
M8E; [!S<GW]W0<QL^8_6GC;.O(9WAS*=5@7VN9ZH(^X<*ID(4)60 )D@!<,>
M12B[14#]?H7GXWYQ]0F3#G?2(X9VFF7]:'>G%VGA3:<0J?7J4(D-8#L))?C[
MT+DLJ=S#:N-M\PJNK_-*RC'*'KP"]%=8S4!8,8L^*80H\N,8'1]\*[;F:7-*
M_$C0'!,$J:UR[#(>?R[D_)K\Q/KQM/ZXM/N-O&S5;83IT2H>L;@+C./0([1W
MQC='4]C9(SO&G69?1]Y]ZC/JGZ8@7DXYV @,KIE_:]_]")3$3.YQ4\!-3]XU
M&'<P8E]V0*S,DC^9W(M9L<D5O7%8\*9A%DNJ?SDW_4*5ZB;."78+U*^IO'E*
M3NA:44F^;E;].3 ;/;&?>*.R-'A;5T)X' 7^C)=X9 F=E]M 6-\/ZO'E!(WN
MO E9\5KX=ZX8CF"D[<MR6HMU91<*G6>*O#@>ZP> N/U:Q]'Z\HW52V3T,D8A
MDI%32$)AGWO"E-IP513#R:9T 9V&V"+U&TKF@IK2_$%/QA3TY+OD91N8$(?G
M2_W*19Y,B'M0HN%N12>WG+77$)S31W.<&ZW=#TEV#Q:QLS8UF:I+R/O"R)Z+
M+*%HBKF'WLG4RQS>SS.U-=8_IW/G5Z?KOSQDM!_F<%D5R:QP7'/0#UUY_KX-
M*LJ/4ILU08H^\KISE,&_DC;]M$&_H$:'":.Q'Q9UFC:H72>_$ O%_":E"BTW
MA]2D7DZ2&N1I<%VT:CP[FW( T",FC1"8<^+T%3HEE=W$@9]L4M_)]FEP3?E=
M1[(J77=L+R[ 5ZFC3ORYBJ'5FP_%Z1>&1KZ/ #:_VXSNUT+B**C2JVN89&=Q
MIO,6/UM]6,QA3GGM:UCY:F(\)9# 4\!/W+1D'?UZJ;X[,-M@QBJ(,$$R19G5
M/^YT+1XBB#EJ7NWIBL^+M7NV*6=W@4=?8\8WE[FN5-EF,Y6MJ],.Q%D/#X9G
MLT[8"ONW093L0P27LW(JVYSR@;4U2M%_EE7DC]"MJ$)Z4!EZ.*=3Y2Z,))&_
MO*LCCW6]<MGD^9AQRLP!8.NOM?4,XBF%")@OK)I6%CV^'3-5:)8TE>*KA)\\
MSPZ%^S,<2YN*F2!UB29UZ_-/9TJG$*\_NU9=O1;=H9&G^>:P5#\>9.LQ'FQ[
M#T'UL]T9VU[UH#D6/)^V;@J?*/*+W\%5DN* D-3V[[ &OP(,Y>S9G6\GZOK,
M%#5W_A"1T7ZX^@55$:3X?_(^T/VB_Y?].J,];&38B^5Z],Q-B8'8--"/-:UP
M)B[BZ*AOE\"OJ8VVAKS5YF>Y4^&Q),3'[MSR\P\2W#,3I4;RW K3H":QZG_S
M@N$=,24Z9+M9^R,8TVXL20KWN7$#O 7CNNY''W.#L4C6-3MB)P/H^_\:X[4+
M]*KGWX#DFSWM+\AORXAF!QG1R(>MLTW:@BZ^GL0D#X[, 0 _1[EFSZUB#7#Z
M#P#ITS_9QYLJA;^[:S'O^,7'81B^6NO]R CC<Z->+PH[;&VLOH^:)FFL <WN
MGJ7=&FY-9#2-_43Y5.*0:Q,UE(S8WI9SK9_:QI=*\%I.UY_<KT=.ZZ_VP!)!
MCZY$SKE'OAD;M@6]<_L8LFKQ6KF<%S\?55@0L!MBFL4B; 9*5&N/?:<\/07?
M$F6/IW;>\Z.WQ?3:?)]E:H>Z,\^1NT:'[D$'I()VMD5#[;NO4VZ:\=\*,.K]
M=)SG#LJ\9.$(STY_SC7%2"-A'DAZHPUCFI RMP,:F&)?G-9*?,*(J01?^M6A
M^]:,&)53J!-+Q.6U0J'F#^-;_:TZZ6Z6AWU3P7CTECX7@HHK07*:$CE?(TYZ
M?$8I_1JOR6T9Y&!6WN\NY5/TS7)(V4DU/I6ZD&.-I9M;\YY5!*=DSV(O+ZGB
MI+FK(>^J>>E[M1F=R1<$ ^6R(9QX=&:P-UUIKX9[.:@0-4^7[5SU12H\@84R
M8B140'J6-*=\*A#SG'2-D]D"B1.NU9B<HJL @3<T@C;-=Y*>'G;AJ!T +H>B
MYL>W&KEVX4F#8NU953I3A!EP?]JW7?$3T3($]<#]?MM\K)2NE;ZSL?$Y\VMG
M\T9&[F7\2+#16'2NBPW)X]FH"JW43%O%O)Z +Z5LJ..8SDSXPCDZ+[9[^9IQ
M13=,$C.KJ_%$2^1N^T3B>'C\^)ZMB/+-"J5GY?EMX0M&CRY%YKP4G6HJR7W5
M/[U&$39O6X=]R#T O.A *Q6K __%:\U/^!T .$VJM96PS 62P#!BO-.\O@^>
ML6P4XM(&!<E'1=WYM8JUTK@W;/\4Z.+FP@.]I . IGCO1+8?ATR<T:=*,<N7
MVA_I'#E>#WZ7UM_#E*K*+*_K@)7_8 W7(-=M_%;+*#=K-4SMZDHOIYU24LWJ
MNN]5I+'V=Z1ESAKE/&8)6(T7)ZU,O^9Z R^]ZNR@@'M03\"=H60S,WX;/C"1
M*\UX('766>$7''S#4?C41JWYJ)K;7$%Y"&@*_^='UOPHCU"7GF0Y?@[4]2E1
MV),->_CQ"Y+:%4]_SY8@O?O5J;JQ6*F;^-FS\BP*[.+AK5J)M;;VI6?C<?U=
M)CW]?0*D.*8KX#K/T.3_85^6_0#+1F!_\CQDOF=3UM5=&TEJARLM$$"@CIK=
M;)B/!*2.*=H1//:U;QPG=E+IYLB(E,8[^>X8IVN34+F/4O&'#--V<+QZ!Q)
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M'F!!<GY^A6'FF3_-T_GU76O%7/(_H]":0!L%N82S]7<4TQY??Q3[X"50S;P
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M?1\>0U4@C,$_L[D]:TU]&=Q L6 8O"P7TS^/SB[JG^YIGWU"2CR=4M&%F%[
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MF/WB3NCKZJ_GZ-,$^YRDDH+2[%.ZER/=;JE=YS%A[ .N$U&:)]3 '0+170<
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M^K;JG:0?"2:VR>JFFOM#W(X[VC(*DN*@LP]X;B-UN>V3D1JUI\QA%!#U[&+
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M&76*.N1+[V*C6%$@Z-4Z%HFR=#H1JI9V$*^6\0UPM^R8SAAIJVYDD6J]"8%
M]LK,!I:;7< &RW4^#(\T7UX;?0'!,MJ'/"M,O_X^IZBDK#2-+Y/BQC'_3J67
M?^H^.M-TOT$DD.L+Y#3$,_S9B$/9ZZF-\@;6T(MF%C'[HR!F&H7:1T=4]U.@
M?%#8YRK"&M=:)Z3VOEMOY>$9HS8>D((&3;!G98:0J2F#!G>VXRVZP7U.%,60
M^B!)&;45Q[M.[A4K8G<3]6;5)HP(MVZMX:@@D)R<).E86 1RU-WO8-U0/E6=
MT'WMUD,=R*4#[S3UTPJI!$7&7TKYM1&755%XUMBV2>ION+S\NPH%A7>5D\Y?
M?&<X9M9W^9=()Z6\H\;+ 91^?:91Z*WD#8S^#19)X?H,>["'C3N4X[^<EJUG
M_I>F9<]_$FBN-F?23466-)N5+75)6]"1 5E5A$<;:H%FLC,^#<;VJ!^U9VU4
MIF]@02S*[94*/QC)@)<8C[-J"W54Y\O-^557*F_#^CFRAW[U4LI/P:Q$%FQ\
MQ*:L5O=AOT*+?F% D8UMK2'+ULR+NN!X2^M//0Z^6GHFGBS$66R)31CC.Z0^
M4L:NH'<Y>!)1_1_9V_[5WO[;@ -35?9N(J&B)B'RRX04=7?2R->31.+U2>"M
M(U)5%4%DKJAO!#+OB%K;^-(BM=KI#OVQ>5YRTMU@HZ*@M.+UT_-G/* 4A-:X
M*:67QZ8B[QP*8TE*I@G8"@'RB%C%)4":'._T@N(ZZ[]>L1R4L,!\C;Y)P2[8
M_WO*Z=\-?V\H#8- )6FK;DFO%MGY:.N]E+'.AJ:$8#'-3"N^+BCP%@>FJMN]
MM6AZJH4,0#=RY$QAWP_V-CE#($*"=#8/&8\=U8ROUAO0F@I2<S(S=R91V!QS
MD%;@32#:MLZO[VKKPZ+G\:?=0!X-1K?;I,>&+#[(AU^2 =%3;Z@A<H6Z,D6<
MA<H@ PZ@+GA81UQQ^K*DZ//M@-8V;.O/?O  V"0H:!9=%*/N5)>A!B?\^@8N
MSUR88V[<2#Q$_#C 0^1#]0^2/C&[**+X$ 1U4,H>G_@'HF4]B?W %_F]<Z.R
M%YW!-H/>?(?Q>3R8U1S@ZX4E%6'D>&KW3+"1?U7[JVYNEH*TO=M?%?4NO#8T
M*%-<3DOI,%62H$0LCG^8NO][+-/_:L\?30))#)9D  =R-X0,Z%X-HJ?8$?J:
M>N_&D>0#O!>B'^3: [U?#NO^OF%57[0SOYJ($UH<LL<B6F+KX5I,_EM6J"K,
MI]LKYWWO?D(.)1;E?\2:!3BG5H^GEJ9$J!D*+CF<"ZSRF9B;)P-X2:)D@+1\
MR>'*5-;]9OKER.<G7PYK=J\TKLZR%]4BPFCX-"#&RCNTT;*>/LD:I0?GV]/8
M6W2C,(G#,0XZJ\X*17&FF\ZOSMMMMXP&YLB8KS+M/259LHA^;F-JG@7B-A'-
MB4+3Z5F+%RS6'*6Z1/5<,VHFV%L:#^1[9^06HOOPW_=+!]403I!SM>Z?0UG'
M"DD/.\YPZ^I_,P4B"(H..T2WF=G^M;5NV$K:<6YTI<S#N@5W\"JXWW)]XEJ%
MW65-K?694]#;3?G" 3"HV9I=F,[<<]F+,<E?I? Q<\TAPB^'(7$BN--J$WV!
M#;@LVAN227*4.2;:[X1,?M_!-.] W^.S!$A<OICUV711@>D,C?19\^]5=@=0
M[9VS,5T+CKZ,C+QI0=T7N!*ZHM[9?=:;,'@YW:"PW3)N' 0A"I]TARB1 >T!
MR#WI?C+@ <?H]/S=)];EK68$=3TWNI+#-;KOV $8Z&#'OA_63A 1E1DS)62&
M>Z3?MW7D/RA/5[^8FVYIX#-:^H0RJ_Q(IKXJ@UH9Z]I_9@V\NKD[Y*W"Z>AK
MW1Y;-@V\+H8.'O]PXM2+!_:Q+S1 ,J'T"I*0@:IY3LP39M\Y_<(?*7Z''+DQ
MLH]FU"''NE2F(^*%W6B?57G7!=)U_);E%R;7(,?HY4EWPWTW2FCMJ>P"RR/[
M\+ZF;J57)QWM:[Q-MFRR'%]MUDDRKZ3<>PEC8M ;10WJO*)$[&:BURMH*CO]
MRR#$1EM*LW2UIQQCK>_VU&#0 ^*9V6FZ#S#XL5"E= A0R!QQP&F/Q<3WC^L*
M6XU4%H0F1(OI*L'2N4!&%8*RU7]1MY'+_FL4NK\;_D\:LIF6AWJM\@YC46QU
MK3)P.>.PJ6;-12?6^\I\=QL)RJMS@8FB2G!(<M^TC/%U6I"[N71J[\OUFL,!
M-VX]#=F]TC=,^J((@EF.3^OWP2!?DK-E$8Y^=77T^WYD._V:6EM=EO#19K$
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M2G=4O_@$.UB[_"BA3)0EP9PN0]>?)9V2GYQO&C,J]@= E,(IH8(_ZYK\63)
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MB;GY%1D0TF8=F!>D020#PBKB+E21I_\-4$L#!!0    ( .Q]5UAI&7*6_JT
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M7!K?'<8Q" AJPRHYL#R0<?\7\ OX#P.E'ES0#E;C/1>DIK==5?[O(\W..[;
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MC%@W9(.W^S>&/)H.-O->=MKL]-[MQQ26YJ6<4>J.S2YT=7V\E><V_R/LYAV
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M"^H-ZP/!"<:XM>[(DJC'WPR2$OE5U@:O;<G^F<1O<BW)]R#C_GP%%R3N'2/
M._N0'1V"IF)2T:(AYL@9B<X56-R;QCK2$][7P1CM2"(DQX5];U%XRO C+5J[
MWB[!]T!AC^E%(32BUOV@@4MNVC$W,TN+3GD<XX8\6U+RO5KY!H1S%RZJ/CSK
MW%8>)QS=EW&&""$X;168_X"$?\ M^DMT;ND0>R.CYT9(HKX3V /H$Q'Q]>G>
MGM="W1^Z.A85IY5%B0;YV -488/^(MEH2.>"'FYANC$QD(T J@9Y.%@:_LVF
MJ7 ]/5PIL?O2UZ@/4COZWM3=&BQ)&FY1[5]PO^$K3"\Z-^;0^73JS)'[>;%
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MSY&W]-:[R'!KG.KD:/TKGN'2WE)#_<^F,&.=1.^+\9&AH3DQ>8[/?M[81CG
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M7L&@6*R^E]@E7CTD6S2423A81V^9(9Z:K0);'4J.QPN+BSL(YB3+ X[AOU=
MHU)+&0UJ^4,KF'3,!6R!OC?/LQ$-;3Q*1#4]>WL5AX<>#B,'Y\'KU;D@_]4>
M[*)<^27-R/P$U"<9)8A%K.>,DW5$MO7\&V5 V@RF;<5:>?"D+#4D##285Z^1
M^$IQ4QX/:YU:1TDA;TP>UHZ/DC8O3ST^FW9(!>(2>99?'P^IQ[=U+7<!9<4
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MD79;<(Y(O7_UI+8?0NSWZP=: 2>9[]"$9BU\O=FU\X2_R'M.?^YDQU*//VW
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M)_5==BHU+?,UN=Q#G5<G$E\[JCW^E#_LY6?Z2^_:J^<Z#H'D"B7*%TL,^X#
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MV/CQ7:^^OH[!5PC:B@K_,5BT=X[J\AL$XVMJ86!L]P">U\7 ^\7.B_"S=\)
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M&7$V-\S_OIWL<]K3#"9[ECJET*=NGUL9C^,\?-?HG-QI6,-V'9^)^/"&)C=
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ML%7L8E>JP8VK)0?,7N$/T7>ZX!CD<Z\2)/PW7?=UP"H0<_L1"K]WOH,[ZJ/
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MO[)X@$R$#LSIHVBJW'NV2,LN,6BM)3E-;]8N9_(Z>##C'0T_/R5FAI6N+*U
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MCHR<HY.)5_:[>'DN7RRKK,Z73>=KV2 OO?\D9_ZGI@S^ GX!_Y273+^ _R'
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MJ"\-=320K,\P)9;NR'.?:(.UY? ^.D.<(H\OX.;RH*L]N!=RWG^O3BT).]%
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M%%YO<IV;S8X3J7#4J+_!S;ISS)C0VY!R]1MAU_<U#![>M& K-L T]Y+\]*Z
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M"0-"V"5LD>*+.[K)7ZOO>=C8M7[2*K,HX]RQ]I[4*(C:UU5=>C;=E7%]?<]
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M.8>J*\(#'A^/O7XC89]$-'*8!9GK=>[56H^ "ZT!G;.O42:W:TTX>.8#:52
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M/ LV'"[8QET&\W_]XV0*Z:R#,-#*I,AP+MU!TO%D\(A:X'?B.&Z].1]4H&B
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M_D.5S/,'I*YE7M,CHU[-"]=$&AUL>9BGOR7>AM[Q?;J/S><I^N-A?S\$.<'
M*E8(J55CJF'@?ELU58F0! .Q;AU0*GI!(JA(9IC,DD:<:!N.K?DLE\X0]]SX
M]^9[_0P@>QE]<%3W*\@N35_%M*)IF$I$DGV)LT.>CD6(W42J5[JE#%(+NS=0
MD[AV/U9"S]V<OR%^DY^$8SYA"\. 9V]MN^\]2'L_D=[)Q[6P?%8>P=@#LM+$
M.1Y57_!DS;6/N_XHQ*GH2!RG(WQT/;/P0Q0'U;&ID<.0UBJ1_@6<[?:29<M
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M>4J*\H-_9#16:9#@H*2_CF)!3BQ06) )%_A'<<HLH(/=Y."@P@NSMI( K3V
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M&(8S7B!(L'%4.-.Z7IZ*'5SJ*\AD068G00@96\+B;ZIL, +''OUPH]PN^>\
MB+L-_\D&;U/ BJ'XP_TM4PMZ,SA^_"SO^D LT36UP2OU4IRGJ2O:Y0/]=*%I
M3^^\0(N>KJ'A*_J'"'/'9S_*/W@LRUE"0=C\ @JX0Z!P0,XG@/$"U+EUBP6
MW :VJ7CJAW9#^:25Z%C]\>$/5JYIP-H X:Z;R%,>0].G3Q(K1/??M%UXV678
M*0QOBAWDZ=&X O;-Y?E:UB/?XE6J\[J0CU^AK P35],@Y2W^G: =^-5L >EC
M[ULLDOOH/;I<N^#B_%SAD;W%>W[><W4.?!)+[%L?B58%W+P/.2QNIM,R+)2$
MRI"W#5(_BJ+D2FU\;60$7(V,9D$\.5)#ZAAF-D,IY/K[CQ_L:W\*NMQ9%D1B
MA 5YS>=,.[PBWKI:C*4B3(?HAV>;V[X$M[43CCX/ VB-HV]6CLJ>GJ:_M$[
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M8SZ.6.;-+?M!SLQ4:/-MZ&K4T4=FM0T:&G4?J7R@9G)",5O),^8B2(Q5@CL
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MF#:::7\>Z4-X-?PO9 (Y8Q^;+S[1W^=KRJ,F>>-\6'&MB&_?\$\?ZO8\N+&
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M_5-^S]3*U*D&>_-B"\D0]LJMV^-R#]/P!3!F0;YU!ZUT];_*[EI-F_P0RO&
M<DF"7^-NQO>"=R69N#@#$X/.9U(ZIXJCCPZ^8",AQ5O"K<]O\=9FKO>=%96N
MY>7;'6/7TB8/6/FI#/) ?:;5+:ZR((V8_>>-C(L5A6^YQ7T2R?[E^V/^8R&@
M"XKMF- U: F<LF+,.H7RV@5B: B?;CO;!NDMC7;>@ALU=*$%%<.']G[*'%8N
M1XIU+D26%(]OG%$0F2CV\C,]9Z*>GBZB.4OGO=.^Z>VNSVDG5$O1['Z,Z^8!
M3N:OB<ZR('#&?2J%)!^ .-0H)MGM!@)$%&\DO%K>=Z;]13]_-7GSU+BR;>NB
M-"?_W></^OYHT=4]Y;VN>BBHQ,<+UB5!R_8I(17CHQ-70MN7W?I7QVZO$!@<
MFO=*T_0U=.!6^]S<HLNK;]_+2Q L\#IZJF"?F)*GGJ&D60]'"?B,!?*TS4V*
MYP97&W8^BX&K]<KU@P=_!P[X<CQP1<0PW8>#$-2M[XHGJR^?B"BYKG;*SC96
M25#4O@<_>(23<Z-2NE+YG$_"84)];RAP']$-G3U %J/&C6!_@B7(:M@&5],<
MR3S.);HYWSYO-*^/&EFJNKN_O) U,8[TL9.N=M'EO"3!&Y7N%""4FX?.C0A\
M8YO6=#FF&]0"5X.EJ40D-69=>A;1?,7>P&557M4;8^7CO.C$@:X-047F9*&+
M+K;_:CRH(?/YYS\>?[G\TV_@Y/<F_HL439]BB._I)OQ1K-S*BM4X9NOV:&Y^
M=A9*N8;T>GKIA,50[Q%7I968\(3J.Q9S:\K%XU4=46/Z1PO=KSP[<4+VRM<C
M<3<,D2JQ4W!53+-=6I_,WI^_?38Z^3CN1CJHX?_7LGN__L?J@R=9D/]82"^(
MF5;R D:)G11F0;).GF5!!OF8_[%2WR81[SO(@@C[XL@IL.W#)8B*RO4# ,DR
M&[;QP :VG87#YBGB&.] 3O?M(.P'7SW3;0P[+SX.>(%,Z(:WU.:BHT^+Z[03
M1LC,/:H$NW;*7&LM(3DM._GI=5U..YD[>H+27;<)D0JJAK?G#PZ<OOG@2N/H
MZ<4/5B[EOQ3/Q'*)G+OR0C\B]C>9>Y+&%QO>;3C;5(\3'MI6Q0C>\4Z,>OK'
MISW:^=<S]J,D^\BC?CI_4_-('YOFP$S8 DG&KSD@'YU,]YNR"]H'XBC8S?0:
MQ/*$LHW$1QC)6(^V@ 2*=09O!J761OSC?N^*03J$]')G0<;B.$&HY*=TXDM6
MX4QIQ+/-M->,PUL<:]Z4U>BW.V-.0P"P[3%TX"^&:U+!2&%!5BKR$.MGW;$4
MM-ZC[@86A'0#1N[EH$+S5<<D:**(KI>P+VFN)<3#@>T[5PS:+2SUEX/M%I;:
M+2RU6UCJ_Y &_7>%[]&!;Y;0^6B!K-35Y=DG/LF9KR%3UW^.U=\H5;!H_LKC
M!0Y/OLJ_CU7*>DVGN$,7 RH9V<[$( FPL+F+Q>NTRH?#,[[]):H66_51#>'@
M?6^G_VTV#AB V"?S' J5"+X':&.[3I9N&^;)?>M;26?@TGA'F"VCY86CS+9J
M3\N*>E]K:[O6Q7*I03O!EK[!.1$U3H[)0PIGWJCI[-6\ K+W$<0,C!F+;(8Q
M3(N30.1UYV'7/3C,_AE%WP/M9Q!)&/(XX!E2/XD[UV!#B*XDKOA]9<#-W6_'
M4.MJZ[QXK"Y]'O7'S;B(>GQ03VK:,U 8V.? 9Y0HG9UUGYUK"U!Y&(,-OR*D
M%$+F]=8=JMY/\/0739XLV\X-< U&6A$*^?)/GQ1TXY+0TU7ZD'_GRP%TMJS,
M2_U O[>WC]B UY_:41'N9<12A_OAXH'AL![<>;E4]X:<R0 K5,*DXO4*'^IE
M*?C$VZ9CGM&QE>N#,G$#-O/%+8:'T*;QGTWWUP;T:;YG+P@Z/Z\-I-S?U&"(
MU$USW/4)ZQQC!@S3I6GR"W) WZBBZ#[=*@^S]G-N:RLCW]]GO,N*X':R\+>Y
M@X[YBH9\9T^+,PSLE6D2V74\*!)T>M'N!8X/6V%[9&LQMV>I?J23AS%50^--
M>F];38=L?9NU10*U113,YO/1^>DF1M&7LQQ\+QAKG?\S1Q61A"4W4L/7#&F!
M#.DECJ1)![+A[)9.GH)ED4)6J1_Q0? UW)GZDAN)C;V",B^D\J,2M=],V8IR
M/8G5$JCN/[XPA9]T%1U@5@REX8=Y%#';?D&KWUKQ?)^^]+N))3?()6I)C3"B
M>/7O51AVGSV_Y.,=\PO'J;QUS?R+4D@?PC.)_UN3[S6^;__3\\%"-9KA(\3P
MWI]A+>"G5J B6*H-YWC15'^KNM-:D5?0N3 A]DY/DV:_U.D+V9+HY%_$YT[7
M5T*7V?IA]E^H>Y>+L6^%F#%RRZ!<62S!4JX%)84@69"$)R#CEV<\VCQ'+P#C
MNR.LOXF=(NPD3)3;;K+^ZVZ.1/9JEFW&"(Q:.E[!@@349Q,Y5-80)/-PP!^D
M& 4495M,!8*DDP0$HH"B&X-M04]J$__&(W>YV2XWV^5FN]QLEYO]MV@P]>M6
M2:*-DJ#,LYL'FF QXQHS>G?<5*N75;0IZ4)N'75!E[A%N%_]UO*]%DC/-CWX
M,K_+0.NM16&788=^M*1!FX8>?P5\,@BMR8(\:]RL4LRI,Z1]]]G/#ZN3MQ9"
M8Y-S;3>K)+R)*^-N+@1ME(VMWS'Q(V'. DL\<U*#,7V%@PE7(ASR @1%#H^S
M/<V6O1TF/)A Y:QL0*P68_!NG81B!CXT?6R\0+1&D;]80:),I+;>;X[3Z(1^
M_SV*G!Y?&US\YW2M]WFQL6=/=E^.>O5BK1D/!M-\%N3;89IS< B@ELHQ:TH^
M 1@G6$6N]]?Z(MN^E2\S&_O- -P$?9QW[,TJCM?8QK46?61*0]H<;LA_WTY,
MXZ!3@*.(Z)Q,D;(RSV?P=ALJ?TLS Q'3^HKA/\F3KM&Z7X1?#T\2$: .'V_6
MB'N^O.?&!&_HMYQ?%W0UT4UAJ7\<A*FRR5XPU2OMBVV#6+!C5HN]A_FA6G>D
MLI23X\/R7P>USNC6O3(1CZF3,G^Q_[O9.CMYO[^ABP9?QY32<>4-5U="E_&K
M_:3#N5<WS@(]RTKBH2(34\>00EL-W!';:ILWPXEY3SUOV6?^=-Y0Q D<T-]&
MF'6#5JD:Z:T^W78NRC35RHKQ)&>WB**,NH?R)VP\@Z2J@GWAO*^=M.9/&8_4
M;END.%5?ZA536M<ZA8Y^=:"68E&PV>^#]4)\^5"1EK2^WQ63.&JEL<9U 1/J
M2HS&?-6 ORR>"K!@5'**PR3?9*AE)"D-=%>8&L5U*#T]K"POIGHM%QPPMQWW
M2.BC\<*2&WU#IH.&^@:_[=$U-E7H5W_\XH[Y!#I/X'';]FME\,L%IEYNKB &
MK17IO32_.7%&HUF-D>4G>*6&L_U3SY7< %_']0]?],[$=N9J.8]$7^<#IV?T
M:>A6KN6FWUU"P]2*&+'*-]QT):0N?C*U+G2!U-/W8)TZ(> N:.6J:VYSXL;/
M_(FN&C'WO=@'P#]-PY"Z9\57?C S2)8'<+RFL!8FW?1IRPHP4SCE;192#S>L
M\>SXHZ6O,:XP,?V-L8D#K^3:EV_E]<YB(AEOGX%T^5+#O2UD4UKXNGNUGWO'
M.1;$$AHUF.9:^VY%(82NKQ;S=4&2\T.LFF&TMM-C&7,MT;X;>V5ZFV3B.@0\
M6GCJ+H-W,!AF".#O;?DV KI6OTW&Z+QI[G6W[B$<90Y=*YRZY*)4ZOH*T#H=
M;1;[J$26[W8#2B@F)^V.AK*RK>=7:SDM*&B4<?_*.&$LKD=K#;[Q=:[\#+I:
MT8%0EC#HOXTZW9[C0]+7[&V(8]RR\A$N*ZVF2#:NN-$41$OZ>^.O,@T_12 _
M#[C*U];=.M;:;)$O@M#KY(8V#4"I@1SAL/5&#&SC%S"0XG,QL"$HR#.3$+1.
MQ(]C(+I;%64-N=- N%?U(?[/7\8B"E7H+ C(C,AO6) >WB"F;Q72'+L(91[M
MZ>V!=6;-HMK$.YM\-.XVC>C4>IVZ'OR<W^UHV3&II)9GN8')E9T)_>68:+D^
M)?N%1F1).9_=5HG/O*7ZQ]JU8%D[P\S?NTP5U&60,)0Z'0I;930^$BOJ3&FU
MYX[3S(QX.[!YCV_6+6SG$1NT0ES3HU]T'61!PKOA",(CBC@="NJ=O7"RMCMU
M>ODZQ130[$/D1@(J"@.&4ZZ;$?5_,<!^7"L=:%,M1:S?QS@ Y""=*;X_F4\%
M!V,=I,>FA, V=W9EL"0)QB:,:?&T():RST=LYQFTR$(H=--%5Z# !=UDD# H
M$3^V;QT&-$'ZK^P)XFIU8#/<'S&'1I&[H,R[2>@7%'F?4W^!-/R&%<A7^19
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MV3)]/S"B=JP]?_1";D[.D^L"L1J/\B+^O:C+5Y_G*C- *.IZ8.1\E+K0A3!
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M168/HOW\ZMJ7RH2L")E7ZR7,A#W4#6HL?C5>%O[EF. *!_(ZLFR$S!9!H[:
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M:8TUCU1V<&;T@  VSR(",MJC@1I^!$W7C)QCZ'P*^?[#Q)$ @6P8FL1R-"O
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M4^E"*7Z[ 1JF&Y@<]ZWT7N&D%%Y"H5UGZ@OX[;03<7^=O3^+#W-T'O&7_%2
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MJ/F=78Q,$/!?^^:9YY3UQ,?K]0S4Q: DF:O-(YXUSJTBXM8%9>CEPA26Z,=
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M&BO1D-+?B5G['A5% X%?8F\91\].;7THO%_[^H]'T1W\'D,#>1:V9R]">3L
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M'KMZ%?G85OW>B:UZ/1,LD\WD*+U[KN=Q,A]25,,T-(8C2=3P<XC@.SNQ!TZ
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MD:]8MPDYN4CCBQ))YLLRIE/>,8G<']M&9-M%9-@Y&FQ#^65NBT];6-^QC9X
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M++N"NLA9N4JI52. LW4S^BJUK2(I-!!J054E^&.VZ>Q,AB+>LU1F;*ARI$M
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M:]/A*.Z2<OFB@ZM?4*N+T\VZ:P>^RH5&SM#]9,=T^>3U0INV-FV/^E PQMB
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M&G"I.SYZR;7K"M-V;U)GT$<2.I()92S1ZD0+KG!_7<+ O92<& W^I-,6V$X
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M9?OB(FUO4:>_K]NZL8ALY64+)G5JZ6EHG,6N%J3(&6B=KMPQTT"W&=YO X-
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ML>^_F/W_;8.\[,WBA&[;_OO%_ Y(I*&=$Y$+PJ.JBF#3[4AX_&%DHMQH^UO
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M'63A'JY7<4GP1V2(;P?9WF]KAUI""L._F@]&> JTS0(F"?Q\$&'%8,O]35'
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MBL4T[H77D2 ^G9I'IO>7Z@X%@K:L#C _FQ4NNH^%9P]\[X?U;+.*XS_D75W
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MYEO<I_KCY^<I\Q%8U VC^TDJUIP."MOGJ$WH&_Z4B1-Y"M CA"E.@F2C<C;
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MQ1QP-OMY8#FUN>5@\CI7?JOOJ8,FV]7^<TRU+WK87-)+7G N.LW'F\!D_7W
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MZ58J;V!8Z#ZM6R'61.'1&P-I&WJO1ALO_,X=15\5,.)H6W?[9I+;^>*]"62
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M0J0><+T5;6HJDI33C:C 7*0#1@DF6ASLQ2[;KG\%W7\#?PO@.J:+ <P-572
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MK+$*J ?Z2>IFI=N>O]L].C#SI[<=C6H^=!#0^R9FH/O1D2U0JE%1 AB4W-C
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ML.;*L@DGOE>%G<T<DA*2[RU7B+?&5C[%AJ:\Q!?P1EGF6(&1-8\.=- !2FR
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M_K(V$QO6^=5J/NP<%MRZ\D':7.%<0VA2H<?E,>>CL;>\GMOS3S#$IF<69 T
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MZ-:P%?.YM_E=9M[W[EJ'\CTH8^76.I-7[$BC@1&[-:>%[C';^U+?$<5>PG1
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ME?^ -<=_%)/D#^O\4OI@G5T==CFJ'GW=K<HV 1Q4D6QTX+38F@9TRZ^1#MS
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MF&TLW;-4$J7O1$K&NSLTJ-\5?"G\0'+DY&G*HR#O7+_MZQ6Y)0ATPR-K,24
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M^_)MK#>]?&3A?%2DW-GM&DO[>WM.FEN1>")-?8;,37W>J/ 4_"']\? (E]V
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M#BV @3VXQ5=+M'_J32;;LBCH&C@NP=[:]>/VY:WP"C"<K;RHE[7HF=*VWCD
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MNM,(1",=NE'%%=86EAF=%^E4'=R8TSYJC\I9S$[31^0M_>@SAW.^J5"]F[)
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M'A-V6EVU):RV50I^KG*60D\SR"OU/RCK**)]:%U&RR0>"\I1:'3\'4OJ'BV
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MP0*KLLK<%S#POUU)6X&/5_U,!5N$-2HD<ZZ-/;L4\QXY=>^B2V.<IJFI"?4
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M(#.;\J7LF/#P#2JR,\9.6XRLRBE2^O5HV$5QR6;OTHXMH)OZZ09S<^E_C1;
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M*H&B]?(0A86RDP=]'G+/-4IK9&"05T91G6-*K!:C!-O]JGKZB/I[$S:U=AK
MJ+4SH$C5&-EBVN5<1!_&OW>/_^ JI_3.U@9A977@4S21$%Z;F>2YMICM=Q?Y
M@2[F?2?/J%#SK8<UEG&OT6IZ(T# QR=_^&#?@/Z2ADJ6>V\LIC+3U8*Y6T]
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M_AE__%PW9$E9]&I<587 Z7C>/"K9_\;C+[(P].\:NT8^+0_?%09)T>4I5XF
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M@9HZ&4?3)ER?J[;:A6.W>F0KK*R?Q*:OWTMZ<KB[]9$*[+KF /^ 9#\@>FL
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ML*.](:\&YN9O%.,;?.(RU.O3L!(G/I)O)G94J<;;_R;WXY[@7!A4%R0_B#Z
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M3SL(J7X-5SF6=E8TS&X:R-US=!9@*;P<08P$:JA&F@8#-.I8#ZQ/11_VEHF
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M1/R-  @Z#0AOKYB_$0"YIDXG(O\6_YLE0/QG[,4_Y._Q7\( X8'X7M5&_$&
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M*'X#4 _)MQB@.#8&*-)TINLY>%*?-L0 %>(>T\<9H!\("J![#78*,"YS6O_
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MP)+)21^N)K([X4K":7(0)[31(1M:&/@>N7#@=67;2M+?N^4EE JEZ&@VB$5
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M\9_UELA*K6, LU&NX+HG!(%H=0KX@.%I=%5BSCQ-JJ6$FL8 QF]X<-+YR0R
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MG.U(H-0W;?WN$2NX2XOBK1:]2$NL :3,%HWEY8)R57*@#^\ 83]=:E70P_X
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M4_CBY-,$63\A FFTY9>, +[6Y&%"U5:M:N:-TD\'YX!'/*7,BRT'9U!WC9F
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MC7<]KG7)%B[%,0'PR[D7O:^/5#_\4 ',ZJ.-1J8"[/>:X8K^5AQ1:V>5UD?
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M%$P?83RCN3"F_\!AFY<FAB:"@R)6,>"4"8>0,X$^ZM3Y*9B"(W?_<YM(+,V
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M0+<5_+3)C__X(G22ZZ4//H'3 UV^!,GWBH@$O4"I&)O((X>2"L\?!Z DP+E
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M3CV#HC\UID+X1!7RW-N?GV^NRMX,?<_9BC'.?JU#FXWZ<K4VS$%PW:6P.+/
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M ,(<IB&G5*J]%VIM\QJHC1PL%U:V#ZQ+N*VN[M'/"R#R$?GA[GR9@KE/%C
MQZ80!K(*X,[8[.H=E4U2ZC9U&>P6/-')_$;72J)4'N )UZ"L-<^S Q);GQ^
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M3EY?J%Z__5Z4R(.7L#H0H"DG4>?&]!P]8#-MG+4:+FO.*Q;G,<(#R30D9-1
M;WC1^I@-/^V<0\9\Q1W5IN7M,Q/D4HG66P>\CR5%^MR,5_ZR8=)Y-M?&Y#X6
M<,Q;KF&EIP%:=9T3S1*RZ4V3\<;MP:$22J2F<G_2EFI:Y-N^>>CC2%%CHD)R
M\IK*0[;V8JYF!S1T]8R0@W)[VO>_E;4A[$%BX1>!*,QP0DGS0 GC:EH:B'W6
MFZU33!WZ;*,/3+91,3!UT;ZF>Y.K()1,[KLD@HMO="(F<E*A7A33 X:^_EL_
MDOG2B^[I.5E7#&;OW^%"\\L11#1E>2VZ!R!I=BWE-:%-\]T?F*@:[FG.XZRE
M=X5F93[(PC/Q72Z(O9/DMR_:VP3=A%[FY(Y97$W>$Y.97H1%8/+U53+T79-[
MX#1,[!3#A?.=!WK% W$P+/@J#U3&/1J(966L\%/& Y>78]-.(6TGVFR&$>>\
M/"GL(R5".*+(??.JWKZ!M.ICWNK0V(SXA3E*2794HT;<UQ# HT?4AP1S2I:Y
M[VGDV1]PK35FW6?D/JQ2HD+DM@!11$/'_M=7@]"VZ;03=6KN)^<+O7\&TGYU
M/'S2^1,_&1]Q ]TVU:+=;"L7I %$6;?I%1=%N@(")0V-2^N(D%H!3]/Z6:3$
M.4@2SHZ,K*GWLX3QOQS[6%B37^-QACPD'ENKD?5\>"9X\Y/V7E7#8L/8()R<
MHJ%L<TP$"9F1-JE@PHE9AC$-NVG,,*-5=+UZ15T9#[2W 96S26ZG41LD+6?6
MV)BXV:F78:*O?T %[%0AI_OZPO67WJ??Z;IO6.8?8P/POZQ%3B*X^7D3IY:K
MN"31S&RBH[+Q!$=FR_"V%2&6<=[ I3K8$>N]T2(@<3PWPHUZ-ATSQ@Z-&;3P
MZ; ZKG36R+=R?=X&/%P"(2$S ;78W[H@MXIFON,T;^VC0+4Y\7/U-!:KBXZH
M*$L,GF=NX]3O&8:VT[JPE2OK\>LJ[+!]Z(R M[:2L>_2HW(P!:,JSQTL_'>^
M$[?B@?YQKNTQ]W>.!0GI-2NY)L=UMVLI0Z39600V?M]X]&T^"MM%U4\F$6Z4
MJA_U=%3=FE&J%7OX_&#*<0/_88<G;AG?F,0S1G?X%,9-^T<,5(35ZADZMMRC
M!5%+\KFCXYU?TVH#1"D,(W._M#41%A\=C)5A(R<9#S8*9U2CMG):Q#QU7_N
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MBM]2K+29JDAR[/EJ,W<Q,M^$Z8QE>Y^I;N.U()?63>"-_3%D6X3ZZH;O+04
M=9%0*WV%JY!M?FRK8!,7L)C@'J-WZ< "DK*J0UV^*H^7NG%[F,%I9&%=!1C
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MU,TM#\Q8MNG$ /H#X227V;VKXH$^GECK61)@]*(NJ'<\",RE1;T=V^;#@\T
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M /,JAV^NFF(HH'<M5RB@!M.<S64"S10YN$#^;@G+E)SY/SIY_P#_.8! D8W
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MYV5-=A<9]%V+L5/3(]<8:Y;Z74@?)C[ K"4?V3L4\#E$^*VUPB2B:4<JT'#
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M$>_VQ8/?3J'OR4ZU.%JDYTJK*M@+&X7>O4>VG^TU(9ZC@"3DD*-"N+1R>8=
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M>F%+N(B726% P%GA<R*F,)R@<&BF[_,FF7W;/ODN#-+XI=(HD^<4;R623LQ
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M-E;+]&O:-@5%]M7</UMNR,N$/79;@YVHWT8*B%Z&5(S:,H:#('N1A^L44,7
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M[.1XZ2]8%\39";HW'DWHU6TD5.DP7\7=N?;AHB1?<FG%4J'&0\X3S\U$+#)
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M<M[K@B:=;O5R\N'I.R=R<NI'QX3%L:*7 O3VJL(B,L1,"M*3:WCHJ#GB^('
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M?LNN'_.F\\EK?/2+:+7\ .M'SVV:7CRNO_SPQ* TEF;QO,Y>O"$@)&83ZXT
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M7B&R:)_C&2ZV$)&I/??MKP= >])$_-/C-IY" PVXDM9H("GP$@&O:@W+G>R
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MN] 7]89&[ST;V__\BO'LE8/3%?#C8-N]E!GM\\DL,5\Z#-C8#2 QV='12D]
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MWVYT:)GH>SC#AHJ,G"Z<R=&Y?$WY573,3I%KX<V.Q34!\?WAT5$MEONI <N
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M;MM>1"Q5(? R6#30CVK,@6&.R'+>6Y14<2TQ$')R<CK?U 7D@^]T4)N/O,:
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M**F:$9KQB+B0B[*XL-4R9 !X"Q-BG [Z1KW>0\61#])0MH%E-+AY*L.>8%'
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MAOKT&+=TPZU/75-YAM_CX 00_ )>PS9!P-B.CV;XSHLM_A0FUG(4E)X5R^Y
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M%R;.>,TEU+QW[8)=Q&/2Q;-5@U\[%ADO8QL?B&0)CIU?K3X39A#V8,<F_YN
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M"2XOIYBT!:V8KS0//>\/V)>Q6<?J @?:'&951;F#/JF%IZ<'7#P>=/$$K)(
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M'+..1WX==R]M\,A_IY_1M0B3*0I_<>]L>P4 T<F3_V/-82'[BSR0^5Y:-^V
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M_;A&@2;1Y:\OA>=GB25TKX4$>5L=8SJNB@'$:,(R&1(SXR1R]0-HS5%H?\+
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MLDH?'Q?0TJE?'VS2FU]T>OP-3OH+,>93YXL(^Y'CV$P]ETZH&7& -FO&JSO
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M%E77U-9]J4>WMK5W='9U#PV/C(Z-3RPL+BVOK*[M[1-)!^3?EX^&?!+0T&E
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M(%XY(V7_Z TYHQT:66D;^85RIMAJ&*_P><R,5.2Q)VXP7^QA_(67).2UBWN
M;BOIT.O3TIGU=Z]Y*#H[9[+? K@GB?J4'%!+0U(%U\%)V!M%O)^KS0<KG:ID
M%6(J*]QMK5L7MX83C;]F"$AK1I;EQ=FW+?$*%"PY.BX:B?ID>D<E2 /^F>]_
MY)_ZU&I\S-*)F /(..Q4[3VXNU)C0T.QV UP3$.=P)>J<:&!D1L!K6,;=C=W
M8QZ%!\5S?]EF3AB^R1Y97?V*ZE]SDW^<;W4UUQ,@)S'=(@=ZR;OL-#/P=_43
MVR1RN+_&05?-;Q%/%SP*D]/LJ;#2#X_JBIQD:\\K"A=L$UXI+@_F^%C\J>A3
M5ZXF)U[0>TI2.OKCMW/]$*#&Y&U>ZAXS#QAE2ZNKPVPTXRTJQ]/$A<: ?FJ9
MOQT"CFE^_B*G<\1F+3^NF57-\49.JHKEJA)7#,!!G8Q^8GOIH.5D()$C4V'\
MD*21YH/1822' I<17./:-V0B&QCAY;6$U^AKGMRC).6%\KLTH+VB(59ZZHKR
M=_F2GBUJA-W1+-&I%DLB6:PTTT%WL,LI830WL_,U%7[E17R_X5@T=VVC%G5R
MTIM'_\O]FX)VVY2"%;&QU*(/>EGO:S0OVHCK: ON*.8]O)+GF?C58ATG"==>
M%L $JM)!8NE-U")L4AE;P2XN>7C2WM<5'HL2\,M"W<'6NO:QG3-EU4@29ZGQ
M(EJ?>(_S4?//4XZYJM/A:?T\LTLS\V>I@Z,.$'C;VVSD=KA:^9+9!!W4?7[9
MHG?],&T'96O]JV\?[(E@45!T<8YNRRQHTB$\G<MJ7MXQD<-<E;QWK58M)$^C
MUC!E.HQ;FQ2KK7D! 8S-F?&?J#O^%P:*><CM=-#DET!EY.)=.FAZTXGB+O(6
M6=Q3A+U4;4ZLRO.= M.N;@,]O\,X\J#*KX<.\C%/Q@M2D<+I6AP6,;6^V'^F
MR:I_80 &%,8#(_@AQB@0.7=Z!7DXTG]D[/R95B2%&QR)/"@W%P&*ZK3T$4VH
M ^K4L+345BM2B Z*,4->A,5^FI"M6[HWECL=^V-(59/#VDHJFE#2/F#X F&R
MBIE[R/]&3$#9D>]Y1K/:JW&@:Y&%;"6P&CO007':[63KXNC,]3I29WC16[W1
MUX/^RY:7Y5.BL]GY1.YHI5R/,$D#&@ 1[.P=,GX]C.:>!@;7/#=Y:5;\J6&&
M85R/E9B];<FWO4=^RJ[,M\3RA"#G>D).DPO$*.ZC_O@V<&HV0!S/OZ*#*LL.
M@ XP?!\+(>4<K=I0D:R?/\CW;K5\DII>_I35C2]MV@XK^IP6=CU.9V]?XJ%Y
MX:/3SZX6WKYAEQ_WY*5F>/S1]()C'?5K)?BTS/6E_DZFMY"MC+[$M"I9N#O^
MM_Z.QU*_UV8)Z?F^BNDOXB'"TW-LX\G=,A1W8W&\@,3C9+!FW">-0OW;_=IG
M9&I-80A"S13-8,\D$D[E7V:+GC*IF6H("EZ6[O<5),QK/'OUZ'U);AOQ&0+:
M',X3Q__(2.9KUJG8."$+22OFJ\#H>\%;-7 *(OD1'31'!^W;TRAEP\!=_=@'
M6/)9.JCN@8L(U=@"^&\*+7(T+?*/A)G>017FI-E?WP'P5H<=1CK(*PT&&%2M
M%T]-@HP#%>C-C+\" 16^QU84O$!H6?U",7)W?F9WT-L+E'X7%A?KA6V]6;LR
M%+.'Y\N?'29O17653;-XLD]K/H\#F'_$=2H7#_D#XGH'X?<4'72:DNR(P$P6
MD+G3-% JI \3!@^F2*2/CYC%G+_W^=QF232.')87U+/BS/BDHAX?;6JSHV#(
M'0S8N@0[JVO6X^U<OA"_0RRV'X7.W^L?VLOKG6(9T@_W.</I!2]M4(K[.Z[$
ME/^ 6\*#E]^4]=T)&==2@&3P 9ZI\4+!A@C>V<*7,+5KQ\U<EP'#-V")DR-I
M'GCA]@/[CYLETVIU+_'IN4:W?I7TSC?$6.KG("1FW7[H(T]YA<OI6$-%WJLP
MH4F&)&H6]GT9B68X(XQY3,WM\I\*QJP$/G5N''XSW0B-//B%DW^<$DE;_#1E
M4/_%*6>FH<SP1L4MT[ASAGE+@I'1^ZQ9)X \.=1"V[Q%!WT/0>X(' 7:4W R
MF*@&X8%L6S1D _GP:_+19 L#H'N@.QTW\@<TU^8[AJ3\!!+MRCND%(P27B=+
M!T74;P%R!(?3D2$S>7;1@)&?T$&B2*H!YA<=A'MVE).'KM+^W*YY"4W'4IOK
M2K444LU[ZGSGYZ?'6Q9OG7)XGH4CRX]"WP<]/)=RF=^NV=ID^)G #9TO5@5&
M1]?<8ZZN;L\L+/R4[U@_453X*<1*3&VMR.9] >L"_]OS;'',Y\>.5KS]/T/B
M88=M(5' .*MI0 =$Z? Z6KQ]@STPK3MLE/Y$!VW_)5-%!P6*. )-^?JJY4\Z
M:)?'%T4'7<YK!49J+O*/3Q]=J@XR:S=#)"H -]/&NP8^7"-M K(Z)MHS9+<Z
MV85T?>> 9BY?-05F0H?5DFCP7QUM&D25AQ/&$V6MRD53#6#X@E,&/WNON:M"
M.K\ E\\%G9\=?P[IZNHD'BT]$#=P\54RR\Z61",+/$=%A93K=([IA3,_Q[^P
MFI='9KX^>Y=5YMR-3[EY;Z\\?3H'/94A#R3$G:D#S7'SQ08Z:!8JGQLW>1@Q
M0F%H((T"I2M=WKM.5A'MBREO%&WP,F65Q\=DY04SQ.#8[OJBWXE^&",>LMT+
M3'3X53PZGZ+_#>#A+MI4X(YGY>D@861*F+NGMS\I;%=FK31J;.:66_&CD7JM
M1!ILG*,H84<Q,4;\M,WVHM^HC&UQ7GFX=%3B $B'5>HWH,*5$F3S>$M,$.3R
MD\CRVV2;.>4GHH66576G._6^&US=.QV%28;  '4:,U&Y=AU<J#P[FBOL>=(W
M5;7-L'Y7%Z3F<1[<$HY.CJO>2=9GV:L2_[*S;9][<?O,XXZ.*Y]D6*! /JZ&
M+=6=8L9VEY/C]?456>0E(3L4\KO3\G*7W\9>$:Z?4GO[]A-_5L'1\_F,CPB
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MZ IL-5[M3#;X@+HJJ7:%"\H3$P\N*(Q-CA5!S[((73J9(:.F]FKH)6=H!N^
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MVEE@8J*K5H4ES)"5&$+WN/_&L;+%'N#!S+TXK$+& 0'@Z6E*K&,S0/S=>P2
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M6SN;!=T^5[]T%&[M1'XH;<'VYH!QXH!A1EXQF,&[A5^RO#,L_-ZTKSBJ"!)
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MN3BN8L]B2Z92.EFE#U8@Y5A( -@UMZ\4' \X3E3]=H;J8QEN&0"_9-.>R>K
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M3K'5P,FTP-W]9F?)P(\ZSU[.J_X*C9N<CO;SR$F!24/4;CY>;ZT5W=V?BMM
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M@:X],&"'##:8USX6DU@NB3G  &"S;0,PD\H)WC@.XF_%"8#+-L"&U@>*M1W
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M4=@2T"\-7A&XA&UN0E@Q*H&9\0H,LL1 \Z(3B?=^;]4,']IB30#4 +T) )/
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M+<P.M;'2P-CO>!T"@.1\JW1;40L<Y.:Q] QZ*O*[ G[I&&^9(] 9X8]WCB4
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MG=\ZC]V.!K8\,J37?[(\*6,K-=EE[CQ<V&?_C%R"L;OS%DVRHM*J7L8^;E$
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M\;1A#8UX\:BQQ8A6!;5)(DC+ M5\.-.1(6M$NFEIG/215>;JD8JV?,6>?%H
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M+M-V%C^?,G+GL?!^D.:J763HXQ=>5#:"(^JU LOE77VBD'S]6Q_)&EX.RC,
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M?P*4G,$07YX<Y9L9 GYG:9-$=2^#?B17N=C ]\+<)WX6N-M#'A2IR(B4L#>
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M#+P42GN(*7Z<\.]7^WB7CTP?**DF74?UT=%:47NAF#L^VR/M0K[+BWZ:>PA
MTFU6>:X)T<X=.L\,H#9(7J[; VM3ZZ'2>V!8?!GO.)7KN1*>U>WB':WC8FW^
M;DTCR9K!7_V'.FU4S;XI#[*ZON'VPL )5OP7+D=<2RAJ3\M9.I.=4X +^BEI
M?N^<M+&2@_Y3*)@ERKK4=AFAUE!$< ^ J9L)J,N.+X;!TW_@OU^HPKZ:OO[9
MT<'RDHH";W1!IX>*HXYZ-;\H")J/<TGEP0H,<#KV)/3@=VJISW#X:K_>T&R\
M]8V1\34RBRH!4T&5ZNOFS-7(JC:)G ($,?\BJ:A_F]==<73P-ZXV9W8\NV1Y
M8[("&24%]I2[^H)9,Q3Q8[0U@^>UYWH\R5=[GN[IZ@.^=4O>.7:REW\TW,)^
M=?;GD"*:E>[@#E]S=$%09UW=S'"/!3*M4VCQ^Q B/T\S]KU:BMB;/9A%^<!F
M^3YV KGF_G;VQQB6WV ?;V'6?76FNQ&CH2&3\'GH]_7&QC#@Z&&-'#&8/?D3
M/-_<%3UT3X;/J$251"<P%! 22I 0HG?O5%IXYWAB4:SK95X\=6=!K8IG;0#Y
MY<5L9QY<P\X;3%&,4;8#:GL"!#9S!ZK6I>(JT.JI#J0GB_2_6:+6_6<2@IN(
MW/Y^D?*@/@E<MZ[02T,/2PD#[4FO77V[U2[/W!_+#>J;3<V\YS+%P[Q!&"SX
MLL%XYRFQ3]->:D^R&:Q!X04)S+IR '1!@2MJ7,#;!.JVZ\\K0D4J2V0PXRSY
MF)"=-W@/50G!0<\+EIDAZT5!OT(^/0'LBE"S=,-8Q8V0\!3/!J-*Y 3YWRIW
M])0"NY0SFJ W#6EF0U/:VF4;>96E"<;7=U;+91G,AYL"Q)G@N)2]-SH "6/Z
MW06:97;7:>WS_H>B^_H]_!70\&OPD:9NH[\SI>I>'LZX:@M\NN/S1-TS;K7\
MXF8*G4=I9;=.H@^"K+5<@7>_#1UO*Z]<&_E=^2D?1(-2"Q(A22\>&),F]0-:
M^KZT0JH3GP"@&]&RAY..1HBU'=Q'Z&;Q'4U?-KP)W(+ZB3VQ]5G@C,W /E^K
M[X.F?%+E2*KQ7;?)=::+7_;JXLJ'<\7 N36%PK)"^!- 3HJ.*Z)V>/*[&MA?
MW;&MKN/.P6.@YM;*>DN,RG-R".^C3X%7?K=%]Z:AX[:M&5+</[+UBY?21V X
M/33M"X;V0.Z"<^#N:B>%(IR#/_:MI&Y)2.+&>S71U'=V"ZCJ59,^GRQO!.:@
M"E]Z4POZX,RBYG8UX<O=,/4>M@(:PQ69$(Z'^/"RGA/U% I#R8/E^FH2+]*^
MA%QEU8R83/2]KU1OB\=4:*%F30/L\3VQX[*_Z?R^#OP+9'\5AV7)3FHW+^KH
M7UD'_A"A$1R363FXIR['G7>OP.P5,B%:>:>_Q*5/1_Q;Z[D UI_&";3UH_%(
M5,0Y?[DD^>4]R4??O5K$"GM\=EZ5:!_QGM);S2(S8O>Q?)*^=?9,X "O>CZO
M=A]GD=0 E^PF5;M/T^D:)?U[<?LO1]*[193?$G D)Z3&-%B%S^.H:UZE6YK:
MP1)$KQ67K5,,WP:S@-+41"<1+0&E-9)2WBP^=7<@,2X?CQT;]% +:!'T<TUI
MW\;>$-_$WXGR5]3F*>X3BA.J3,F2'HY4SZLY%TJ^9W^*!PEYBW^$Y-#Q7P$
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MEN0'O<S4@\_/P4I)N;O]7E4?Y@)+R82CK>.THD(C?V3MJJL"JJ[':JW=J7X
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MDZY'5?%S$-\#FI*0OU+5V.%8NE1_5.NPU\ C*Y/M,\#K1?5CF.QV"X0](C'
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M!M;R]X>&!X5+^KZJ6QBIZW[6FMI#+>'FZ%ZSY32C !>F1=0SDW)S%H1.!DV
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MU_:-$N0XEI]]6^;3N1:]3F?UP6W,TV7=QYJ3&M^'0O+P"A__+0R3V#T6/?3
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MV\#:CK_8U8CP=:$0'-9V_W@G2@H__%<\J*%BJ<8_/>\VQBCC >#T1+K!$%8
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MDA+EDIK9<5S$,[Q9V)L7OM1>GS!=+LOX\M;P_>8!6@^(+"49])_ PSJ>BYA
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M,OR/^U]&*-_B5D,*7]0_ ++#:R%7/ ,/@&MPMY^&87_WJ13ZW@=)BD3G3SP
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M -8H-&2!_MGV'AS2\W\2X3QMT'&\,V)H[-=POT9YZC$HIDN.UL0;=7J3&_L
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M<-QD8S33_\YD!A<VHZ_  SY]36,GDVTQY;?A$3*B9-&R564B>07*P3UAS5M
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ML'!]^_5-;$P7$3>JSPEEE__<L5KRIC2 '#P:=K'?WUJ&>*8-G9^!0_PF-:)
M6S"G,CZD%DD?^H-E[3)=#F2AFLOO3KI#+*-K*2?.#G=NHNE&#;PK&O%J!0.L
MV"!J,  =!@!K*TYG#3:M\6N7/^?6Z)OS^:1%5D=3E)CL3?%./_7MT>K?Q4QY
M [T[AUOOZ\?0G:,)#'#WLE>$ 8L-$7UR,RL=?UPW=%."3@8=8@#1F,8E&)6=
MM>G>J9^*T^?KWA=Q6FS.2*_G*B$%WUF!QWM[>>%,   \%GAQ39)FU6PZP<M+
MR_R#"6W906?YVE:>96=RI['UOS9=GV';^9)&8<MN&9Z9^7A!MRA3G(0ANXV7
MEZ@TVU6>C_:Z]-.8>2;@(F(=FUN46S>W(M#)=*6HU=7>=E%%7Y7-V9#B_\@,
MN6/X/!A"_5/ HJHT6H)KS_OGW!?[QZ*]5#I-R)D+22>K#]JKQYDDH!0;=S:0
MR>Z'9K?0V88I)3<BQO R.Q?T]'O^\]V0:_!%\\U>D^AZ>J4GN;FGDKO$Z;2V
MI&)-3>W*[HO<7(7V+UD'941</0VN.#$-?EBM2V-+BCC &5!?2S@@481RRI99
M.WFVY*2&XSKL'X5C#>%CAF[0$'5VHSTQ &,3>5I6%1^+WE4/:7"[QWO-:3\8
M/45+8UKXCQ+KQ]@'9:2./LW4?G'7T#;TK$-Z2=&OVP<U]*@@2PP0=?D$"H]'
M^^OW/)6\U<MW@FF"SC*_ZYB@EA$."Q:S/G ,8#:EH4"M%/5[&]JBJ?Z$H#\^
M[''*_@< ]2@HY):KHQ]IU=3V:O0NY!=P#UM5X5V'-HK5J!BQ"+3[DA?WD6-!
M42[_-\(%QL>$VX(<;DI<4K6CPK4JPN?"DTJ\J33+$KJIJ3\XA^69$EQ]1'O9
M<P! ]2D@@#5FDE)3,O"!Z8RE0!1DZA3UMYH/V_*X?7V:*5Z]$>0X8]X=07;U
MSO*Q\2=#+E=N.ZH[D=PLM\:&XJ1/\;\\Y")4&O/=*VE:UU>QJ=7?"+_+>Q\X
MB#T6$G4S?B[TCM$>W(<^&GH2E_]MP[=(Q(A&=3[57Y.P^ %!_ZT?5W*Z9[&H
M$$RZB$:'*.84JIB0!*<0I=)/N!9GN_?B2R83-*Y__S].)>FSMD:ZYQ)6XBD+
MDP[KI$2<7?37/:"LL=_@':7@:PUP"Q5!@Z2Q?AJE9S/D9KOT+H_F95<_K'V]
MS.9-\?^9$9-8--^7@TN#JN[TM,"Q3,_F&?>AO^ ^H]EJK*&F<E[Q2OVJ>'%+
M.7*U\?6PT=C+Q_,U?T1O1HWRRME<S-&>K9]#!Q3?##'P& ,\_9K#^!R5+>JX
M*6599VF_^,17L]ABR).6QS1ZP0D[(+(A>[ U:C I9L*!_G*?+6N%UCAB+5YG
M1,C$1>U@)0\TNC7^TVCRA,1%+IGL.-'E_&@Z:^MB5ZP/PG22K%5:6.3F[DA7
MS\9F$'TV-"CYOHH"J=2A^;YBI)]9@,^L9\C\?H*8*Q,O-?KG1ES#E:$[]Z8)
MM?*3-X+LXR'QC-/!_EQH->_EV)5J3TB@U766A57CP;C6H4-5T]Z^[=MWB>.^
M,,9/TU.7$]I3&G+D1T23Y6K5R% "UN_B%!<G'3'#?+VCCO)TLL5ILASK@LYC
MK4_P'M^,R#,V/6@-\\\Y,K6OBTB?E<^P-I/&E6@ZHQ&S93Q=Q>J+8O.D714M
M^/]$\NC_TC9+_S_J)!!+$[P0X#?=7)>\ JLC;-R+=)57(7!0+DV+(=_7TY/K
MFM820)6KMH#2"<V%, #O$:J*/ HB[%QI4]&6EBGWI7QG,SLS-6V-CLP5]P9B
MI94 PP##?FRZ<('H9!CT+_W46=1*ZVIT97ZP2V4R=?GEF4&05E&\74F=6-1E
MKZ,3LJ\],<PB3*S_]L=O3N_P_,^Q(N*N+CU8N]$[OBS$>/ZC"%S$;<7(4H>7
MX]WP:#-_YOJ0HT&/=->L11EM1:*C7#1=G]2;$I:/+J6]>2&J(AN6%YW+;D][
MUZ]M7L6B64RM14B=U79+ 5K)7%UFF^A"IJPLB1TME.E1]*R"028_ 2UL0:/>
MMZGR].=J30]UQ'NA_DX]V#GYT7J<!SXO-Q-!"^^"X4%&>$/[*P%]4>$_<7@;
MK*RZ9[^+.0Q>T( ?1B9L_P1USX$.T88@A^!Q"%ZK/%MM!W0I0+Z5G_,5!;Y3
M])\NAT,#'KX*CF<\MJ<-Y!,;J%+YZ<O]3WF?Q8:6I9$UX@U[\?J*&;TN:0WM
MA62,-Z:JOR,Q0"[Y.=VSI)OTP(7W!BJ/16L5PL$F)JB#L?0YR'#1FJRFR71"
MD[-0JYXWSJ>CINF?%6U;'B$R*;F^8LT+GTF#.GWGGB/I%HEX["RO$P(6OT=Q
M49*14A;FL^:%/3IFW"P-_!?G2+MZ1&4[M<B8Q1QV]:0HV<D:U4^C%>,!$>8Z
M2D+^LA+ST.:V&4^*?[<4$*/J1>;&&)@<02%UJJ8V#+UPK6TAP  J8\@D3ZB9
M/5\LTW*5IL^-]0%>H!.W&V&-*NKVH?RQZ Z4))WYV\1VVC=UY64H#EV0JT!=
M0(9FF NJX@2-3+(X^K>V)%09*O_"K,F6I^1[=Q['$[*\KG$\ U/!:G4*&VQ?
MG<R'H=?"0_WM<=^Y^9H-7#C<GM9M^C2V,/4+<T@:N/?=CB,31JD] [:EA-_/
M&^C_=O7VCNNAR*$0E;(:RKV<GK)>T,L%7TU1X"+="8Y>K,'C-D?:8[VPZ&G5
MQ-U8,D29PV23SZR^]TET%!VK'6L?22*S_Q:=J?B8D;UYIKF8*HP!OC[*'HO^
M^?))H]2T:N/A8FJY-A>JC/<HH+PMMX7"(?NNPE$25VZ<GY^1N4():O]%#C@!
M^Z$-:C4NG8T,.MGFJ=_^TEGWXA0!UUV=%UC0)"!;?1;NPF8,CCQ+/B8(3PJ,
ML+ZX5Z<4-WU'OP4-?58@#WPC9"0((S(RSLE=)!D&"*S<KI6>C?<Q8N>GG-[8
M!\HDYK%B>Y<N- X/YRH^=')VXKD[;#)<+K,#31;A24FTD%UXDKP![[WS$':%
MPMTE/TL:.Q+++<J?FF>(9_^6N!Z4AD2H72"P'7 O>I:%=,@4@_9'(Y;$9Y&!
M/]S55E<'IA45'S]^,:ZQ45)]*O,:=R_25\RXM\JY!][*[W5L$?>^97VB__PM
M4CYGWPD6N.UG$8_CAZB/QB=H5RU&8MG@/HM-S!H5VGZH$_.G+A"\46\W?>W'
M+WA[I;?0N>$VZL#'-UFT[Q3(J1GPMP/\A1@]C0&&Z'=U0$N@)(U(9$1 G?[&
MW?:XK_@FY->]\,";%E=J%CQYIC4_9-9ZG:;^^S[PW2TF2LJA/F'?R5]G("Z<
M'1^]O;ZGPFPB5.+P3UOW5+(5<CG+%!@0GO%HGGN[ZP+.-&%WTE*\9AM6'/W4
MR=!!D)BV0CO*_"-11I[J#-:6JSW^"Q.(C?XO^"L,(%,T%X<!QFA XG#7S;E[
M;N5Q&\6J:+!,B=J[(BU!8)UG[SWYB39;$:@]8)]&Q1T^_C:!R+HQ^.DM\9B_
MEI)=P8T24E^"?]/0411HN\BT(836D[T!=A=6YCK5&PLS:A?'-*#="=<'GE4+
M;F,.28B8\]D/S(J;:"7XYH"V&>]$#\QG0=!M?;)PJEI'5CF(3,/B.X%1U;3;
M$>-)4ZU+IA.B?S7PM\WX75,#JLD:B+&%]7!(V!_-UQEWCR<)^X\^==X%#\/#
M/!P%[-C@A$[7T;Y9],I3B:>6?MA</^77/<;,4JW*/))XVLD^2S<W=!0FN#3_
M))KHM_NJ8V:\X"O0L$50V%TF;F%#H5&BH"\1HD+YI9@UT"Q?>Q$FE.!ML<>'
MGH#-CTQF5@60"BBU_"@>F?FX,L%N:[V5)HG&"UOPSO&98V>S%'[P11X5)C.+
M#.F<)<[<_[06%<C&[!%%?F1%1SA\92'"B\I&6WC6J6GO7"<Q%O$=Z81J#WI:
MZEKOHQP"?-]<2M2]2BBFEM5247A"1Z[FJ688PV1LI%K[/7GZ'V196BE0)D.<
M>A*>NA5H.!6K *\-CWI1K* S6#N0\UBTV/AP?_%6 T&+\I@W36!<3&_R@O,9
MO8\J?:LY00O]F]296XA'43 X4!1"@#)];^)J^C!(K2"LZ;KQDK=.(4#TX5W0
M_CTU#S0TLWH?<-@T,E/2*$D03OM,=DI%&40:SD@+G2<1"7 (*V_5*;XU(T-1
ME0K"+#VN1<:8)1P<H$KA\7[ZTUIJU*:YE<HO3M[5?JAN<Q:)K."DKS%\DYN-
M#@\V;OP%$:T9#=S.&$IC.O.B2CW6[Q]A%#"._V*=MYG][!L&L+VE_[_F27:@
M/T-XGH7=I"K%_M:<[9M;:J,FO XP:S@G1K!M66A';A]\&7E!^4I'9N)L2'/W
MSWI!W!/G-UN="FW;#-2$SRBWM5\RWC(^C)D7-V)R-[-J'/#)Q$?)HC([;'O.
M([:+_/T;1BF/AQ=/5!JL#VC+'*]ZEZUZU]YB@&+&"KY&V\$&61.XELJ[:TM-
M]^_?9P+F/NA-)JO'<AF$OZM(=AKM]P_!K5#V)5OXU&<I).,_=P;>1@KVG?FM
M0?Q0#:/4D$\."2_F<\H5E'KFTL,&HOZ:_<!*92HE;M.<QK$P45*BGIQ/3"7A
M,:=:0>3>#UO78!!>;I?L--3O/X);H"QXM73I:=:\,R#[?.9/FQ""#F70>QAN
M_PJ^1)/1RE]>/X32\#.I<T=::'N)5;K<;.=7%GYYZ%?+)5_FAVZA"&"@:H'+
M.OM$QCV> ;.&[Y/BCK1]2MB1P,VFP=U<*3!;* 7 /'*7'S  0// [P"!?X27
MQ=1A=?[<U>2R8KWOI")5L>5]IK?M<( 11Z_HKW#R6]H/JPN32RTZ2#]WIU^.
M&H@WD-/HC)B4E_YRA'/W5(W ]U7; 8+9OQ5F6>I0E+1?V9,?(Y__E;C5EN_.
M/B@XP'FKN'AW_;/3[WX!#K/2S>+G>GY%34KB#$,4%Z6A:H@R$LBRKSXM$M]?
M/&Q+#16#$'PE=+)J/!S=?-ZX>[,SO_V8(LEWI"Y8Z#CC0422[Z_GF]GW#UT8
M#N;N+3L[5+$905J<7'N]#8A>IKB+?[CG[A=)<NJ!.D-3NFOSS/DW/NK,(_O5
ML^D\KR#[=GK#=4I]HY3!Y"Z5/E5=RNF4G;#NID!WBH?H]RF[..X%#8?V4W8"
MV:&BCB*HU[^_9?ZAO<OI=98Z WD#^O5P,LNEU'JJBLV\-'(^.F+/5:3M]C^J
M/_)YLK31I5WH=X1:WDDJW[&O@R!=X\,'QMMN%W;EI343ZEZ>?CX;UH9/;Y0'
MB[X&2&M^Y]HH+JN0';(1)ADW-TW:0.W,K$4<2RY4!9=C/4&ID7P+"/)$3S-N
M35!X%C.CWB$JP<F$6].#_CYHKP[9=H)'^)M\(P,>,H[27RB:0N=UFRP?R583
M<M;O5B3W,7ZXE*F>#2'G4>9RHW02G3%8F#Y<_ C]/24/WGUQ5W9.0[)XJ)P:
MN4\;AHOJ0WBX=D#F#0,68)[IGE>%5S"J$X?I6]/A(X-ABF+LF&G2*&QHJ/<H
M(6FPN<Q#0ZU@V@W%-K9RZC[!=_9@_!(-%*HS@&2 2LKZ]]==:4%]I.+T?VWP
M^H,_$,(-^I'%@+Z%^EXY<C]LXQBN580*WKP:'DJU$,OTV2J,.7+E90_!LRMA
M#ZK&LN<Z#'/92N>:*)3[;78SV5"V;_,5/4=;H*P,+TI!@!3T#-O^UC]87J_K
MRJ<<PQ6,?=[790X6+8'68X#8D\\3CH)\>X';"RT=>?KQH>S]?K2A10_C^S3D
M5-]%O!+$6S HZWU?4Z_)?UELI B\WVE2QZ7%*=7\=8##$W.='8H!(J\24!WP
MWW7QCZ@J(DMX2M@==(W80 (,VC*1U,]X$%G)VBNG& #AX<[?K<?^L9.*FG_'
M+LV,5K$>KD3JH!G%$Y(D+,VU&4;X<3G'>FE?]V7^M 97$*7]KQJ'6@*%]P,[
MC$\Q0 /H6T#J%4NY(YQW>61CL>CM\(J*C5Y!_D?WSZO]<SS55[:L'S2-8F9K
M0*HG_U4]P[UD3']KO-&Y))35W(:+55MS0ETA+F^L;LMQH$?L1@NF>3!D:$B'
M^FZSHC(]6#%:)U)GU;)LW-48]0LQ=A]?>X,"S=TO^4Z<K8.RS@,Z,U2=!JIV
M(*UU=OJ-@9Q'V'76U,*XM<@'X>EL/_FGWF^<_BEUF?KV1EN>?:M\IG!$$3_&
M=;OG2$]6GA]W!K*B%D]^5_<Y*\40_$KDL8,G'2];U:7L?^5-7U_)&OZ8[PB!
MZ:?5^7A:GB_J[[C-DK ,'W_,;_D@8<M9W;-I6G]YEB0J8*H9_G9/2FMCL<+"
MY!GL93C.IRD?5NP+T:)M5U^1<.9O-F( PMVZDQ9U>@P)2P^&M#8<M=S"F T2
MA8K*ZA*5KLF8RVLUU>1M0.1QK)PL(0H#YF1OE;^'YU,/#?*U]V=L2&6K6:@M
MBLK>)&]Z^Q!GQAL=[?GRAIZ;]%U<T3BTG?EMG2CZ-RZ EHTJ%_'<7MZPI7L<
M?NQBIK4B9A9;L]V3;(K/@*GW:.'+J[ ]+6.)8XIZ"PO8&JHT3.AJ-J#<C;6@
M)I0\V"=X?$&#\[I\>:1XXU!4-D_\,"+_OU7K3<I G%:]C*@8F[QDGA.W\*&-
M4G?/YSC1?-0]-)K<IN.:ZE-,L2H4=(:&%$J=F7M,=CR)SB^IB<3H8E)$V.K:
MTYT2K9J\PJ4$X^7FX\;#TFICQ1%?QYZC!U:Z(<B>K&CC6R:^40R@+Y(<N%&+
M 7YZ@W=((9>$$AC@ZM^V\:V0(^3:V./^NB\<R0(AQ@ G+P(_0'9C8> [>_C)
MHJ?Q>0PN:CT&'7RP<I Q#+WT7,0 AYT'Z,:KDVME-..]:.=$N6* <?I&R.W\
MR4KS(72+EA#1 [K#GH7."J5"=H]:,,!\P.R=P\'*809*%@.TZ]YLW:LS2?M[
M"^I6H"[SD$%AT$4X^#]ET95>//=CP=PP0"VRZA8V"YT7NHG! -YU9T,80"IT
M'@,<6$'_N_<PP@ &QQ88(*]Q!P-8P(VOFJH@M5YG(/29U48R^@=!'0:8&0V\
MZ[N_A?44\H\5 ^S2=J!;%N_'DW4810\=0P^<5)I'([.HJNOKU$Q$P9>%)$E>
M\;J?NSPL"4D*MK1D$E"9H4)R6IIV+^S8+W[7Z0BW-"W+F"0M+(V=R83RY-^.
M57!<;(SSG8WH%[TI"H/X>+@6?E7JZ9[DPF(RE37Y(D_[[5(#:85P/S3L@>LJ
MEXQ,V=OGA<6]^:"=P!ON>454POBB,N]IMV'#%'NP^3>_+XBFXX.F8]^"A4V^
M6LJL)V5,.)OK17J:F735V%_<'S7/QUU03 0\DT7T7>S7"BENS#JZ'_[S:ARO
M+.QY(NSB^-$:S1$5?XV/UGEL_N-77,$K8CF?2^> #9;W?F[MKBZOKI?:P6P;
M=W(JA-U0 KN@-?ES&N)1*^:F[K?[/(*/:ZYJ-^Q*7(DD8XHSX]7>J5F\U6QI
M=15K.IZ8D13A'!K=BW]A/-),VY4N@_"J'GQ5GYAGLB=1<6[Q62ML()B&?0'>
M-A(7,3_Z[JGS1W5A\QC)_/"8IKS)J1666QG"QAXO[M[ [,J8ZW6A)BN/:)(G
M06L>TV86!<1R\FU"?]2( %VVE+,3!H3*R@WY1_V17[)!9T<;8OXA>J_N\O,(
MXVE#9M!;QQLDR\L!N=M.IW88 /=P?[ 5;HL2/?KH=282/+OTO'E-;D(OS5:Y
MHTM:"_#3/[;>RHDN38FW%XZMP #D\'B_1R=U;A^-7B_/7'!AT6MY5$!^X(5I
MG'\6% K+Y%<,UH2V@:^>OX=8=F; K;I5(O37HZR]9/LRTP>D7[H\'9I-:<7[
MWIU5+*FEI$3PD;Z<.]>B!<@4JYF"<67\SNNZ]QWK;/08QWCOTK'L&P>NTA67
M#@D;M2N>Q'=K6I;LD#>^KV!(!)\__;)IR6F;CI]'@9;&P-OB.=A^J85.;)(@
MW;^G(^]LW&Y)F*5I?SX&:LA&&1TN4.SC69IN:-PI<+)ZZ @\:WND\HMN=JLJ
M4-#3:O[4(OOT958J4^:K#I* .]37W:5]=M^V32TE85_(P!L8THQ+EP7M:'XV
M/0: 9[JSS/E%%[^F6#&.">H@2D!GRP4.62<1#$%MH0OYB(Z./VH(628G#* C
MR-2&1'"C9N?/IE2:3N_\YL?^#O>G<_A+2_/2@<MZ,L/PWH=LYK;5B/Z<<7#%
MSY2"?F4G4;FLDL0 5/A3%74!>RTZ;O16?NGJWJFKG-EWC4<?4/VTA1DD47=G
MA%OD.NUY_I>$=JM[.1$CKS3M6Q<S ",G]*;U>G$V9V,;:_%4;G?08Z;0';/V
M>O0$!>ZH/ =26O9B7VN^X]_6$8HP?]%^,4$LU%T>O$,= KJ85(XHXV#D$:P5
M?*NM32G'\0>'5AQW7D<RUBYNK*D^4-QKUGB\+WHN8 D&8P&1/E$D>S1^^.L?
M+,0T>L'L4_&!B3CEG*[$7"!NP]BQ%]]ZW!![-*DNC>PY8_;,QH ^W^FV8AL^
MVUR\HI(=3KG\NKSWW.S.6' DHNH"][FJ;4F@*ORP-B6-H45T;F0[KRY6GFA&
M>Y3(\6&Z3/9K+""]6 F-()#N7OD5#?FK(C5+.W7>,['G4.;TH.&P_@LOTDSZ
M'4([ XP!ZN 7BNASJR;HY>LL-,?1R@$S!D"B5>!Y$Z"KU"WCV_?WJ/>/_AX*
MD8@"#.##"UNY)5?! &3PD_]VYRQTQBH1LCMKA0$$PG3WH"F@$3WY]>*(3:A=
M?1Q?OEY&_U5- GJ:=(A)&?PG-N847C/<M&^W,8"T0].6L-2VE]"Q>[8I@.0N
MLQ;RB1&T69"U@<![4%^6/:FZ3;['WWUN1PR@!P?!D8$]_VE*(8^NH<Z[%_W]
MX.5[DRHR_-#4R3O<=YN!MQB@Q!L#H'/OC3/:0&, ISGH?V'TIVBU>XPV!YVH
MW^/QO\H+Q/V [RE%UP2BHQ&,J;WK0LI3*2.)<^]EA!U>;_E0F(:'UP.Q&E84
MJ5+V.0P5+ KE'H+:V0&#BZO<)4[N8@E8QD$)F_Y?(8S79]TG_N@3E<$%N$,4
MS>'Y)"R\;2&:.?F'M6R&[?@94Z7VA4B_B*GQ_]CJ\93>_KZP!9FE(J..DGA,
MW\24CLZL]L?ZL2X"!@KF)%WJ;]$"X[JI*4&E3YBPCL]Z)ZJU<.+% +QX90!P
M82FMPWF8,H:EK@Q@9]<5(0^*VN#8:BV"D&H^-*)G7+.#5O9&2U)639&=EU6A
ME6V"<E#C5>C;U,_B['IR$;V2SP-.DKE;',7)+KGQB=6*3<(N/VFI_/LVMCIV
M:=APHMVV0,%EH4M*2<-"A_J3 V*/C(QT?XUDWAW];ZO0#H/;SC?L&H;I@QO.
MEPI_].HX#%^(TNGO/DW@H6.Y@WC)+4A*XV2)L4.2]1^T"W+Y-6UC@&Z:6 NE
MKG/)8L;,!U*7WE$'LBVE1!$9W$J1\;4>=H039KAQ?0P[GJBJYB4+KD*ZTU=\
M:LA/6!,_:U)O& /_@KO&]&>SAF?78FRN1?'+^:SLWUNN+EZ$4S]TU+?9NFYX
MJ&20M5V<5,8A+452FGUKHDN,4VL3SF=C],X#WA[5<G1:?]XE;=! 0Q-TE<O[
MV>?VZ2_WRW2#,S9+@V<?<#  @R^8]J\A^?]DN>+,A\+03 I;=N;HQW11VYD^
MOZ2^QST8/AZ6*"W](O_JMVO (=ZJQW&9QJ;LA?Y-SO@#*/'W)<+%MH6? X]A
M 1;O=/4^;>G?VO':KW31:WW6%L=IT"*NKM-81O?"^)N0H2<R;*LY*/5I>1#S
M3<Q@-O;!>$;CY/M>FWS?1G R[;W#J5RX(U26<MOPZWGJE\AK2]O'GZH83?7S
MU$JSC-LVX80G=DKC?)E2&^,@G*: <]EW+GYR<+<1S^C[];46RD0&.I%N!3?.
MYW[E6@[T!ULA#J8-IZ>G=:8U9W4TI[1GM:>4='1U=7@UA]XU<!K)6\0-"<?+
M'>JF_N"49XH/B$Z-GV=WSV5=MRXMQ=T$L,]IJ'OP%?XPJLO3:VEJQCL#V#\N
ML8L=&+BW=VZYP6=5SE ^)+SF?,DL..JPB_(S8Q?NK7KF B3_C'"HI.UG0-#*
MAX2/R7B<.>\$BW![Z## 4XDHXX04]'+,:!?D6PLHUGXI?4'W>M\I2LB-ZY&0
MZS6S1\D^C\?K6QD.(%Z:M;2,VR+-!;]+KC5U1E;E25\%<CE@(R7/KJRL8.'Z
M\C.^1"^?J1R65&'EB &-H'9B:9H[\\[4%MCD",7]A)]K?++F]1[3F]#>%D8]
MAJHT-@)&'YXJ+]GD;:_SGQ%D7]-;.\FUY.<, [CH^\U;)R*X[G8JB\*9F?>K
MW^=L)7 K ,Q[1K(5,KC=5WHHYTT5!F31HR-2&S=VP69:F@F>>E="+FD_".S9
MY(XR"XE]TYD[1$=NRI9"##\K]C>JYMI#FE>22[AV<DJ:Z?D?IMA1G/&4)5H>
MK;CI(/9!<1QB9V_1K2$D?L#ZHZ9FJ22V%Y'1V!QL&$!+?/V9C.^+H[:?2*D]
M-SM&:4YS'KG0R*)-V:H' L1?57U)!(M:D7ZY7L"2H<B<7][G[==9KC=/$R0)
M%'I?<GK4.VWF]4NT_B">FAP,FO^R#T3RPPGG(XX5K18]7\0=A>BNX=17Q]2)
M<II-?=D7I9OBGC$XCVE)9VFM+IP<T;[>=H-1U[(2#RJ)DI-:,]M:*;+7_(U3
MS3#B[B/<R8HO0!*TG8=5A:ISV6!?R^K^_5D7=!C.5/EGE/W/JUC#S:3X2L8"
MB1ZIHZO(1JCS]]RE D@1"#2B<D%W]S6[2?AN?/Q*90@NJ*PRL40B^\ Z@;6X
M\D%9R3\],<&.S$0$:'R%X4U67ZM3;>,,O#":M:"R;^. @$\FYM_KW#8*]>I-
MUHA/P=N%8C."BE@05YK0/:>6RF(: Y\@5]$Q:]EMP6YEF\TH6'SAJ9>BKL-<
M/%FJ'=5D] ]R=3!2&RP:>F)WBW>9L01KL[?GJDM?UI\4B8!1Z3B:[0Q:\<ZG
MU><4%G[YY9N?)$OW3 [O@Z5I<78=H)=FWB1Q3E2:FY\@AJOH>=0:L.S>T!"U
ME:3]A-JZ(&/N%""\PDJ(;F!&FX*'9]W]\_HW6]M*K0:.0#$WMR5L.^I'LH:M
MRTE:U@>N\@5,A7T<,A5*$DKHA.EE#6K2ZC[>"[/CS2X";6($A:C5F"_WMEOP
M!*%YQ]>F31RE/M<G?.N_B?_DU>&HEE+&3EC&L&"=]L&T7?O.RDHD4_Q SI,T
MK/_X*DCW[.+V;*\UKK 3OV" #/7@;J43*I'N[30=IR ,,&*)BWZ+UD8EWX2I
MCB[/+H_B\+,[N%H$W6VPT^*Y<@73FJL5%B6E# Q'3,=[D&L?O]Y827&(:-QH
MD)&05(OO[P_)R<DMY("_KXNSD\6KKF:RBXMG%EP2QW9U8C>X*%RC":D>HE&^
M+ ZGDRD"T^MA;7=S/Y\%'U4L;/WEWCFG[:",B3,>/L@+I'-X+ A:GW[$V,#?
M"\M/)]=J?JB2Y61F._<VL["V\E>9%8^*JL<0 6?)@SH>$0,GXB+X3):C2#J5
MQR^^6Z6.<ML'%;A1KVT_37VN*>'\FY\6DE.E[CE?'9^G8_L,U+VR755REV$7
M!EL:7Z"Y:#^ 8P#[$\[.B\4K#- $3_T0%)Y)QE3!1<9IPE9LP\B4&/HX+Y)D
MI$B#ESH&YMD6D$M/T(JCMM>=I>Z=<"&"_SF8:U8![UDT;I_*5L!YW6;27)B?
MP^&SI3DJT4Z!HC^.SZ;Z9QR*S]4^EJ_[XMD:!,ITVJH_V/LUP41RH/$TGM4U
MI^,@R_,N7N7)?+[+&:>XOOPE4VTXJE3NHDCNV.N30W2\O*B)M0U2;O?\Z&23
M:YY,%'QBW&\8%\*</'2W/*^%S)*;>JUS;/>6\KNA%';A)I;SLVS2]*5^':20
M%7@O7PL#/(#*4:60.DL$3JJ<TX8Y-*%"?1L3&:BZH'"TIUC>,,S)9J,QMV9B
MEKU!PU*!0)H@@A^(6/K*]A%]M%ASQ^$]>\?+BP&^RLK#(&ZGN3'U"6C'L(HF
MU,_.EZLH*]:[IO;PQ>9%_6T\L5D+1\@W,Q=S@+2X!E>1*G[A$ZG*<> >?]<:
MR^VG PP LMH3<G)K(F \!.VPY&S<:W".E2]^FF7C[H^>,[]I;&GBV_IWG"&K
MR#6L^[1 6O!T)R1$^F]# WNLALNH7\-HCW/7'4,NI$^3-B5@8NVF!14$6L7.
M.7#T5[[IJ+?0RV@X@^577_WX.SOA$?I2,[B$=L5URD$T]BP/:[/:@L N LF:
ME<)]+,W4G!&6D]A_EU:R,^'5EGC3!KKN0]T1S+6_!N'B+JRY" R+L.*)PLC%
M7X@*,1^^D_K>;@"+?AV0V!Y%7T:B,IR IDUARA3Y@"S2^^^6_7,]SC5VG/K
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M%]*Z4] *L]46*_Z1TG<D*,_#)#N(X-&0Y?)OE6N>59_A9XQ7:=YPWQX9]<4
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MWGXTV53Z:_Q##3PI #X;,<2&$W:PL.G&,R9M0WYI_\-:0V. -UG@-P*@1-F
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M63.KS2OT<*4%%7JPC$P6:H/SZ1F+JH!;>.JVRUB<LGFF-(7C.^,^9S?\!
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M@QM0$,AW*42Y<S+> ^I_4HR@2XG;3EA>!0K0W7(WUD>.NW^.((U&D49#$5<
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MV4(V>QNN%GTQQF%RP*]D&L%/6-YTQ?&#+,MAU(BWB%R$Q#^E!0)M._%=5[P
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M=G5=O;LP.OJZ-L\6+]4Y,.?S%BY. &?:I)VR/ !Y]9G)W7T$[E--GAU.^E?
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M__?*JNS[W%&1GE>I^3[DA9KU?*7=!R49<MLQ#I72<]BM<++3/L2Y(^- TI'
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M]4QC,O+L#\T+,6ZZ873+G_=**,O(]2K90@N!-,?8E(-P;.$S_U&5_)98F1<
M:%$JYP*+H%-8XV!*Q&O/L-=T? ZK[.F;;=SSD0?GKE* (8H?54W3"T#/DLCY
M;N%^W8](* ]_SS,UH,QI8I3,]AU=<FW?C#2X5&RZ!46.<7EBI\' \6C+4)I\
M^(F'IIG@=@X3>\PJOXUB8,<!C+LA&].N%IFDHH^C=BUT//NH YMX2EH"VL6=
M?1%?.A]C$Y!G*<M32DF?(0ML>'CTS ,Q]^_U#=.^1Y=3SI_:?P&<"LPWSY=G
M*VJ+?THW?0'X>,[#R;$EYM+KX.W->FJ.*1Q$B_"/0H\ELR\ XJK),N\CX/[D
M%55CQR1%LY> [&\HO=S;I8V1(GTTW+^&?WQ*/7-($]"=[]1G>$'(WZ[.<3>?
MTS;N]>M=H@JI(I$@D)OHZ1-$,A?LCN44<7!F4$&PUG5P.<97!5^B9[Z/#S#4
M(R3Z^'WMY\B7A?4QTYL'VX=47_)&H@]8ZAGF 9+]HMATZLQ4GRMEFVO]?-B_
M#K+4<G5KH^A2_:3&F4(P:WM@?>?Y%5SX7G8H-DNL;C:+J ,.4YNF(N4Z23E[
M?@%$K,YK\4UJ1*SBG[JV9%P6YO)YMX(\U&7,;TG2<;,%@&U\9CFFC@:[SX.9
M=--FZ$)O8CZ<18C"LTIR9_DJ"W:QI?PV>?1<K^W:4M1;M+;/]E;R"Y_K<V]H
M*_P"E,$?*;=/"Y)6*5"C S*6Z]*/TMPT1?4H)K70UR4C%@TIR5LIM7\JB2J-
M>6Q<VR6W1]:LU(^W",XK,/ES:P6I+(<F/3>FB-O,X8T%G*T;+XB@7+[?T<O[
M&;</@=F*1PL7'UFLB?2*SHPSV+F?@WH34'93#L87%[46VUL81]4T-/AB$'/G
M@]<J+5ULVCBJUK%\QHDT3%3Q .QJK/Q@\_8DX4(OH("G&5R>\?[./H<8F/0?
M/Z_N-'%Z*'+*V7_\[@'L+3M*K7/3EEG19=-=H!'5=8$H+K2.X^D^)Y>">I[6
M+V(WZ]Y$.5'I< WDR@6IC#=W+F45/PRJQ['#U7Q:9A1G;Z^N9@<LJ8Z\.>'V
M<5MB]H)7.]M$$OY&?<]Q&J>^"N3]4NAO#/PL=2WK4A8 5.*?M;#)E:7'\(]0
MN.QJNPH37:+28:NN^P?S?LP6;\IP[_MR3*-U'I6T[Q@AFR9[?I0&2@(U/QBW
MXZ%RFW94EVB<N8=C?FCN_WV7C/\?&_Z_TYXLA'+EG/+/X7..88<?HXO:V1/!
M^YD84<A^2=+QA]\1Z5]J#9),"?")$A((?A(Z9OX148 D&8A&TT82)Q1F^V C
M1_*A9,6\RX\&Z$Y+T,11*[C090!0Y,4#L1A+F]:,Q\'8?\P@OP_;.[]G:;YO
M<5A.(FA0>+>7B2=/%X"+RC*I1Y/HHXZ2@0\%KFV8[)IM=8R[6&/RK1E!K(?%
M);O,</BN\6I0(Q]3SP7=EC+XOF3_&, ^';PYS+HG&E+>.Z,5]9L$']A=S<*0
M_AX6$]L'I .KYS1-T7P^Q[Y*H#CSJZ&/Z!<WA1+Y[F=$C;;H84I$8/\@P$Z0
MNPU%"IPOF9UDS+U=3)R\XBXN?@5'_50^TZ^DHJ:C1N>L/O-YGL"#5RA2J$ 1
MB2ZVCX6:SC "8'QRRMMP1N2W>V)G@=&$]S%?&MF)K1)$0*MM!L-*D*?I*?KU
M0RU1'O#JAC'L4^/NQ5E0,(^DM(Y&<^E4RM76]OQ[X([:![E_%#[:4N6NHW%T
MTJEC^^EJPH2A(Y*B],U$V6)%M[&:TULOU$=>8A6\(U7'G<E&0GY-,U9LID$G
M^'3N4[\ODNOF!\'&G8K?_0Y+U09*KOQ<T[-:YJQ'>2SS;#A?YF%$Q8.STD/S
M;%&D,ASC-$$NJ4\M4/[[G55^O!OE7<XB"6W%J.^U@;6160*7PSO<B* ,I<\A
M\I#*QC)EYX,>(K,5)PN=(LJ-"9]^,D"Z*"]IU6T,8,>H7&<GX AA] (@9ZEY
M3KL6_+,#(]E(-A6M9'4X8V](W_A)CAQU$F%]S&(-N?)A2VRF^G/'BH%%U(V&
MKP\1&PNX.A7APVQP[7OOL,!7P%[4VD\_2-X2\2EO IW0-O'43B+I5PA48/\D
ML2DS!>)3IB6HT5?3$R W84X')@J34.Y64V>$;MZL)>9GV*L,5!9GA^J9H0D6
M._&IT$EE"H6@1I6ETG2YD=?N+3LYN/>]QB!JAD>H_9X!WL^\ *985,[F81YI
M_CG0SS,]2H^7[['O";7R;LMK\Q-NU(B6=DJ_G&\F/<.N.>F?9%M$)-V=A&8*
MSJTO/?B#0P@4$&W\##0)WP9FA70L%I+S90S>>#95$VZUK9V'U@V-'PHQP?%5
ML9>-:IN2GSN66RCX'#P3/MG(Q&-J" V0ZK!_(*Y 5Z4$N"_/=E+ >W??:%4_
M?UP0J0N8ZV<*KJS"CKN:FN5&^U0^/,<G=,P:JBYZIQ;BXE0"5:2HW'$5_A:3
M,Q<4=)_T"<@[$VMU$%.01'LEJ%CBT$V@Y5D>#2P@#4UX"" 0,\SY!*;Q7[<I
M'/=//2/FFAN8D:_QK=#YH"G!\GG.\N0OW)I<;WXGA$S]]]\BN89PN,/]50SI
MN0+XLVC.>'CQ*>K9";[/Z(4/N4>423T'>(_FHL$?06QFFT.#+M?)=WSIR[LM
M.V@<BQ^!K>IAM+Q*0H4=7.PV_,5-+WV^Q2*34W^>Y$U,G/@'U1JD1S.UP1K$
M9IW^F6F\3"DX*HKJ?J 8-ENNM/]/777X.!ADK=6QV])4AFL^Y7\JP9Y44DD7
MPUCM]+,_[^C6=HR!MC:>CZUZW\T;9*^39/ACTND\HI:4)C(%.>625JH \$[/
M-U84!W'ZHD^]62"FX ]&0=:A_RE'+9$T;^_X C@@N\RQ/;"]3/9+\W>2.YR(
MX,V4M)!7^W2.SDJGOJ@BP;8B]VR#+M450A[+:=+0U+A:U(/*%&'<<XX4\,VV
M>,GM6)A7*<.+()>*QFW&#$'9N97VY'SV GA^!>E\//HWN*M>!VX9WR0A?AQO
MMC BXLY.-B_O7@ 8G3MA3B^ 0TRE%\"B2L +P !S%D'P O@(/#1JAR>"#Q$;
M[2\ ;./+4820YPL $3BW^>P.O?@_9COYOSE;\OM_KT[?>7KQJUK\7J?O1GZD
MS'9L+[>*;D8N^+DB-\K\]\C3($X1Q^PLZ:SR&+LK[&";$Z:B]3P*S'T!^%)8
MJAS07GID:35YPJ)Y6=*I*J^1F1B/W<OXP^:6Y1&!\,7'E?/-B_H7P*\(1$ [
M/&-G"MR.%=NDXI_[ -NLGYZ<,VRJ$RQ2[*90W&*J+9-.^4&/$J)IRM(OKOY3
M5Q"V(K6G"])<XFZQU\F4*!KC2/^=S_([.YJE^%KL0\:*(CA&[JD&[NTN"F<^
MBOV_QJ0?"<-FU;?\>E_:082<))+H<]J[KOQJ4]T8+@@(?8:V[H[T4QT7TB.\
M]D/\#U5Y40 !8T60$846T5#5 <Y57/$/3Z**W^47%7O*=#$TRW>L$D&QTN3O
M;F8&Z33RFC^4,-NI7J/G0:GM.U8WS]UM IM4= @2<^CP@1?2O@*-RT4Y[$OB
M_F KV-$\FG\,PM*8!2%3*8F9N%%<V4A@4_*CD5'?QW-/M%JIPE\/;8MV]YKE
MBDO/++7JS)Q6?6;0SR]-P$AJ]5Z?2X500AEFW4=U6,%7Z6U:,'=+W;BRU3C.
M3Z4]>4J.^A  PL>J/'8</J_8E*A^++/<APZ<#MO:^BL3_E10YZ,6O</[J."K
M8'W./RE:TY-&NNYTJMCLJ.J@EEY)H8::Z?L(X%$9>NVKQS?\^M@5 +NK3>L%
M[ZY6"X]M0R^&(36@@@[3RX6INSL<'\\-@4]:BQ?\Y:Y6MF8T8[4TJL&&& 2?
MZ#;^(BR@'':/O6:Z!7_-@2M-RRJ!H*Q-[M[<\?/;F?O^%;'_=',1?/!M&[&U
M]17V9CK\&YJ:F$H,@=C8Y.O2Q@KAL\B2,J&%1_ZG$AL 8+"F+V^FD>B='=XZ
M?F'X/\.G<E';$!SNV$-K7DM>1+H.%9NBFA=*DCFIR3NN<_\@<[EP5)V/A-1]
MOBC:3F/;M:R"&-U/< 6ZVI[28* PG)'RIB1@GE\#%ILLX4%?4\I-Q4D+<SZ.
M$__\ J!EJV#<M K@]?SB8XTD.NWQ K#FF=;\46-&P>"8B*/"FUH[2*&$(H0^
MEF(OP:"YW+[P)@)$ -Q*, ^P'KR/5QGV%6O:_%/TC\B,@2=A'@J@G*O>]D<S
M=[73B?'CK),&04+U&B:NY!1=&U;3H7'F5V;]\S,^A]?1>L$O@$1-I>-;1*YL
MR^=>_[JU'9YN'IX@;>$23=]J6X*GKL-KUI(#TI0@I%AO4,,6[,[D!4#R DC*
M&:K\FT35+.(V.+6*ZX(B'P?\PF,06<HXL_*MEPYRCY*FSVO.6)S!4 <J'.U^
MX]2QM^PPK^BTF/1#!R<DFUWYXCXW&/C^L/'$-Y:<T0?F#VR:O'YNMZ>_JOHK
M.Y 3Q:VQ<'<^%,?93A/W93VA/8-],-.T9^S;KUX"\8^ZSJ/2BE\J@1.HHO P
MP0F'CLUQ1E_&9!NMN'O-I/L:QMRS^:<F,,[@933V/5@\UJIZ4>Z_]F<4Y_!F
M! 7W]:AEX_R9V)]:<^O<$C(#/U-WM7VN&^6/B9$E96\B?B+1BP[3BS:B;'.4
M'/O4N&$N<BIN&S1B\G\8$8+%7>)\%HU3J'#<F"X-.Z.4K9 +,/5_=YX3EGZ0
MY#;5>'I"_L-.PR%[KFNZ<TGY:Q*%P&>1H8=?$<K^>!_EWX(;,O+,$M)H?.PR
MSWP2F,*D<KVD!IO]YQ#TL.@X+A9AHF7'=[[<H3<:@]=W%/0=C$\SYSGA(I#:
M9X^TKZ&S(PL2XA<GT;MQXHP,D")]2=(L38]M>G2*K\(6!BQ##-_YV I^MA@M
MIM/.<A4$2:4$\+\ A!<C<T;"Q(RN^SEEO:@8R&5A@Z,5S>+T_JM'QC_)OIHW
M$NJ:-%4*)S"L9YEE0R+9&C^F*?RIR:4VY^Y?EO*(1R+!B.*9G=!''C3Z)[XJ
M#9*^])2HF)<98B(L[S1R%*)OL=MJ$L>F0T5_.@-/GUJ%Q'NS:(^Q%!EC>J<U
MS6MA:.3:P@D8#5HPEN;#;Q&R\X6IVKK3X+YJRM-P<[[_=D"*V:-='L9[YMRP
M/1C,=;J\,6X30!R-:ORI :.<>.]MWO#V.D^G7PT+B!.ILTG-U]P,+B#Z!<@3
M6AT_RI'(4JBK<ZO<SS%>HQ9-.R2-=[^%NR HRQ3_X40. PVW&*/\K8Q"=;TZ
MJ!)<#T76'<<>,F:@Q;5]*KME6&Z>O)==5"5?\E,X$-0H040KZ!<\\QX5PX</
M)]@#$8)4IO\"FU?ETD/_N>QIOL/^_F?I[Q> 0L[A 8X6>L]2;&E??SV:#P>Z
M=&*[C*M@335K"JD]VG)EGU,3'-2PI/I@Q/RF(27J!3#@'/9\4"#4&$[S)-PY
M2_H"8,/>FT99,\AQO<"HD/'R/"??/YS0.B+0R^I/+1F?'RT^VBV!).IE+PJT
MY9@^L.\T&.+\I\13*7Y %^"P_[T,4^ZK0Q34SW$Z3_87&\>)!,<3N9OPE6S7
MD9:OXJLE]KY'PBII]#2R<6'S@^>:5:)^G)V;]O>=T/^-N[<,BC.(V@6'0 )!
M0W!W]\&"0W 2@KN[,[C#( &"NP=W=_?@[@08++@3W(:9F^^[6UO[[?ZY=VMO
M[=:^5>^?KJ[SOM75_9SGZ=-]#K7U;-PO;=M_6A\/M+\ W)!%'N[SJ\Q=':FD
M/:G=2[G.\O:OMC*S\H$#RIP;96I5OA@D.QRF1'?_>).$3T(^B';28R+'!R!)
M1! *[]#$7_K FD1!HX@"YKOX)QAN=?A>/OI1MEY3S(A-5#*?].Z%7T59OW9K
M63KF])VO/2Y3J<C2^9Q]U0_U-F6JKUJE10=3#"N&'\!JC?T'-EA>?HK7_Q+^
M04X3\/O\/ZVQ/[% *3GVU:!7T(Z&V*K'H:O3HD'%)7_^WQ!@"YXZ49<EI#2)
MOO]M8!*+X$1B.EJ6787=QT&7X>VHU^L;-SC A3YAI)!KX8GCEQC5G'DK4.FJ
M7LQFY.S(_5YC@>R_Q"JU.DO_@(>QXK'5^:W<#F;']P_?O=3B2'GTF'/BJ[JT
M+1=79Y@]5[DJ_N-\PQ*4F0XD2\N_[&QH9)CEI6%3$3L*Y/,!YEJ'"_</0-W<
M!5/AX[V N8$*^\NX/0T5PJH)J..Y6QF!M\FJ2#U%:/5SI,3/X844RY;B&/K!
MO%=JA1R=P?(FW]I^4 $<D)4 3B&$K?&O"'?\'Q!]B</3:$@I?HOL9!-S^R1[
MJ<EZ62.,[==M5.K@UWD2ZH&T?)^?]K'K 2L5UVB!HZ5Q+@%+DWQZLW  ?@HI
M'(#AU@8'V"Z"II./+M!&:P+>(>_WP09R@J+Q#]9)3"LO/6!6-#_*.M)LB5._
MB\:*IR#,,<,!31T-<$!XT\^9,8B6H,0MI+FX>]V[8(:X_;,T\_<8N:WYSU7"
M<;H=#6%W;N.1NP<L2G57%&DR>M9^G5N^+D0%HW.R2:G:2!AZ46-?6BSC$7V_
MF<B;IC@B-/P*WGUMH7>57<^RZDJ?JC?:./>).Y&6=,?678ZJT#:G.-^+=QJ1
M$*J1#Y/4-K<^'533AC:4WB<MVH>/OT+8ACD<'$X^R!\TGP"E$,$E$4QA^2-T
M<MM7,R@MM6UQ'!*2OFV..*KI4<?;JLXCZFJ9I-N< OW#-EC4?;VDB?S/!BRP
M#QO4+A0T0IIMN9BV4?@E#U\#R+-N'I>$7=M:'SG%=B\4UGJ.]"-:9KN36Y&\
M9SQ=P,FJ4J4WJJ(&1)+C^%S.,J#;Z:V;8\,$(LRY,_U2*-IF9WQY&]>"A46^
MI*^_ZKL8K%G=TY'=$_\Q7ZV&GX4-LY"S%R>:$)$J8-MN?[&6R>!RN*@_T5"#
M3O_? 8J#_+ASV]N8RIKJVJ0I QT-/;;J_<HRG[!_/OEG$NSF0JH1L@U)D^YR
M'NP=(&;F.%-&EL$>K$>E1!4!($+)C&,%Z!,_%<3LIVII[T3RLD].VU=4L'_Y
M* Y 2SI7X1D[G@Z-!HD_M%@1J64.W)8Z[#LMNC5J+EO4=SMGU!1'$KMCT,XK
MX9$,D<H5X7LX50C08EDT@#R4LSF<47,EF1&AD!*,2;O@$S$(ULTMCL^NJ8C<
MB9R8!F4L"BSOA5MV>]P?A1)F'"S8E4![HM)G8?(9Y:V<J!0I]F\!>IO"JZ](
M@22%Y$1*CQ17T& 4L=- <;%U=H7&!^8YAP?4QX3%?J>FJWR&'^@!M/:V,F7"
M,JD(00_-D/6<V:WN@TDDE6G9)9U@Z>H^4L*17P*X. 5RMW75%+H:Z.^"PH^I
MPE_,8"^O<5U\!W&=FT_U&N=O# >YM3LM2Z<9>!EF:01.!=KU+M'J08M?"NY5
M?ZHZ'E5>IT@#GCJ&!3O@@/UFZ!Q0!(<>IP F8<%\[<_F+-'TD"*E9L[BT=(@
MK'[]_:.B1M"[;1GL@T(D+W>ULB"$%V2NF3KY6Z'@CK>"-M0-8^]O+8PQ<Q/P
MR+5'Q+%\7G^T'K9!_/<O,6I^VB5^RD;G+YR:"YJG%[7L,+\I3)QJIN=@BIXV
MXWJJ8O\<Q?9C0D5UK][[JX.JYL+BPG+!&/I?11(>EP%6^ZK8*HWDX/?(ZS6Q
MM C)P2AE-)0AOT4/@\X-"E)TR @K"]]4595\_V M@:0<$N^3>['!^Y_[;,$5
M%:EAJ24M+26H@LR?Z"LJ*RLR;'8BF=TY:!/E]JAE?J!Q<R&(T\8C=U>D\A Q
M +!$N][ZE()3*:8YB@4]'U/GCT:M.P?JC''4^$QCJPO6;G$ ';KZWS7]^@W$
M'X\H?BV;VZX4(?DF"OA"[*JG$PTT41YGXY9,KM7^OE;GBM"ZN=HTRHL:-8-W
M9:^OH7" E>XF-.1);3.7X0'KZN+/E@XIE.>.6]W$8XCC)6I@5ZHX4 '=GB^8
M3]V!W.JC^FB@=VG\M>5&5EHU'^Z" Z&J--&T0<^RP-.LL@_";.;:O)"$%.Z=
MJ-4-'*!\!"@N*J\IBTQ-)&)F9G"+)#21I.&6<ZNH")1G'00 _N/ .N)&S4.;
M0ZF>U!+O1/ $"(_8 #&J6:'*.4Z SCS::4D5669>QY\NZT(K-K7%.9O#7< B
M2J<<NR3%*E,S?P&=B;;TA\(;GS7PDR\<P+P1L02Q GELC4Y52W?Y^K+@$OW4
M'%UW*S>(@JB,=Y3/VQ(A2NIE:E#M^WSW.J:=(Q/^PO.N1$XLJ_WDU"FA^GSO
M_8>*)&R>^+\B>RS *T140O-:\:ASJ$&D'DL!Q1 E&C?J;^:J7\)J3=R<4_HA
M10:!@/_^Z"X_D-Q*SF*L&Q$$B#R\LB:_]B[Z<O@LB@@WU1^<.G_YIV?I$71L
M&F[#<ID4_5E@MM4"&F(:^.P]:PZM5/*[6M?E9 -G)I_%:&9[4P5>?/:6EUH,
ME0!EII%[@X-.2S@G,;T0IAU_GR*QY*W19V*?KV'GC\4==B>6$>;E:16>&WZJ
MG7$J3#\F$]Z<D(?*L82+EMA>NPW+J4$<.EZ;7J52BZ#L8[N_,-\2OFE@O&%%
M+QVE P()C%^V'5]T*RXT.;<8!X0_^K/U$]'.A?PZ[WO[^K;DBU8,(BBV:<O?
MH>U:3]+?P7YY>7W%NXN(%=^5C!U802]6E$XOE9 PPGA2%5L$Y&9"RM_R#S]0
MS.2H"'[;TT*9X-S:NYB/&&<:Q+PPHVZ:XX?!$*#P G$1$Y!CRWQY<)_+X^LL
M\,<-; %\%."[D._#GAS<^2FM0CF&$\P[Q&I/B.UFP3(J%HPBNO/>U->#\40C
M>;;R3176)/$'G]%'R]ASQ.'QHU_YR6&:R)/8RA)'E[>E-Z1/X7-B-O+-+^$"
M[7SG3/-\:684E_O(T;JS@W83OU4&4=IT%=8"0(^62/<#F:"6$Z3D?XX2/7OW
M:2] RAWW1JO^9_W4DLU9(A/6,V_M8U?*';4@#456(3BD,NKQ%'I]7W,VL]U2
M.AK;7'*Z-*ZNJJQ^+SHUH9@TI#:A4O[U+KVC;*TE,L9(IC2VISE!NY$^F566
MQ*B-20BI0Q$O;[FD FN2-.@IISXJ&W;,+V0.U#]+DSD4M\1?H)3/D$V4*Y7L
M9@E."/E*G.EN Z879;]MG7*L*.Z_J)?0><!]GWD:.PL!@XQT8NQ_VK!J>)TT
M+Z9\>A[$)LJ[)F0N1/FMH_J^(+W=,X-AA0X'TJQ17LZBGN!7J=2*#A3])3'H
MENA08BF#'ENE*;>.1Y4<KQ&4CT0<O4?>=/ D=F77',#@P:MEY.%(6Z266=%=
MW,FHDDN2E1^L^*8FS.S6HL.[?#WB>#7%0IF8SR]C12!X*ST/1]R%D0QK,.8(
M/.I%P<'Y]C[-QJLC[8;<^-83G :^ :[G$IPZ;VA!</8>M,0UEWC<>FAYGS!J
MV=R"<BH"<?;*AM*L?#(_R*OJ^D@<7$NHXQ^*2BO>DD39TO417>N(7XO&'&TE
MF5%A[C='U=P.P 'T_^#I\,4'PF][4=W<PW=!X6E_=L'BZA S((FI]#[GEV;)
MY]0*U"#W1*)"UMC2>'M'0CQCP@]<)U[D2Y,N3)IJ,IJXE''*/B@-R;38GS^%
M+, !+3ZU_R4"@@]*IF 3=-TQ''786M/9X+V;6RQ96-5.3-'QF[S=MHV,S,CX
M/$1D?J,^/J:$8H%%WQI#>F.Z?YICDO:K51_5SO6[N-\8'  @$I4LUFR)\UA3
M]B\=]>^VI;A!.Z1P@@YM?&[TTLSN_+T2.6:U^FH26IGTZ/[ACEE= R=OSR6,
MGOE.-6^A?#E'T.OGR"6-@%T*6[NMH ROG*Q?E5#<*!@5&GX@3X;.6O5QU(S5
MJWX7UG<"&L@->AVZP7&I<,C47,NVBZZ2\S2RL3PJ2@Q+9U*CXT47'U[]FA/B
M7AHK+=61F7$\MS3EG995W6XC--TN=Q:AY/S42L9R(W"+7&UX\=Z<._5:9>3F
MELQAZZIPIU<)JKI2=Q9;T8>JE<VTM][9R%!0RY9>'NKP((":%U$Q6!]+."_H
M)<D91KNX5C_CMU7C'0S"_U,)9>3\(8(+3E[,!?H@KV^(0&Q=[[&H[MV^B:4K
MW;"L;N%R:;QZ_G;9>4@;1<]&8R6L95Y6<6BNE+:N=%6(\2BWWONHIKPN'/*U
M,7W;&CI7"[Q1]P6F%Q1^E<6D8CG8VB,/\-H5]64[4_S=-E]]?N3%MV??C=H]
MAA2<H.Y45CC6[X)?A9DMTYIZO9E=VLVMM^!CV0 9\;TD;?R]?WUW8<=<<5*)
MHH&@K@W@D47G*A@AM4V0BB"F1M'UWNN*'Z-B/;.5'Z.% RH",4F1#1C6[CN_
MZ3=]T5.78]M69(Q:^Q&5E/24:BI/^^]EJ"QZW+K"*A4ELN^2'>_-)<?N.##:
M,1"XZO^C</9SR8VUH5_+2-Q"H[QZ:8=)D4N7&<\MB8IA75!"2<A7[^SUDF>=
MQ<N=.MI]AQ&_E[3ZYTX^,$#JCQ/.)=U#30O$.,EA]8#E_6*2@0Q8<V\^C,4Y
M&(?'V[DR..7;,;GOESU/D%_.5']G)RE9:5.YI6UUZ"+A>#MMX3!-V'N]) ^Y
M++HLK_3:3+D4IMF&A8%O%BE?F1X2'R+'Q7!2!"R-\#=(9/;;JEG U G/G"F6
M:-;1S(L,(T[,NCRJT*>6CH[-%0-#+'3GL'4<N7ZH4E#%9Q%I7&. _/%$J:"G
MUX/'=='JR^<4]X;7:2,N]5@FKMLR?PT\]LA!M&<S<=Y_C.55GK!SC#3-<T9K
MPLJ>)RY21XZ.*FXJADG5BWG1UA8U2!.Y97G*;4WK1E2R\O3(*&8#=/6 I:;4
M5/^KU?6@H)2DUF]O1P<H@*/T3 U$B]3W0VH-CJ6FBDY-@38#9U3XY?C8:C!U
M(?EK56D#+<'%:E-[X%@=%$3]F@ &&E1\'K2/U(R9 W91H,5QYDM%QP":;XA[
MA6,R;^5Y30=#C+A[4.Y DQ@-YN.T0I+-7+@!&*6K7L]X.5[+U&?) HQ!T7M<
MT1<CP^8Z5)9 "6I#J525/25G#@%RQ_$QQ^$&\>%(+T^FZ;018N6_QLZ?,1WV
M.AWMHGH;+'!CC8&BB@.JT*ZV8,'%K(YG_C91-@\1F;$S>VF/I?65 Y\N/BL2
M%:JB435DZ_E> MT"L;;B-/GZ!KFPJQE2U<KA]A@K_R;?M)8.H*2G'? H<]-K
M7GJT7-[,Z5?AH;)7.75XE>%&2]2F>OO? PS2J&0W^FBQ"$+5PGOLOD#G^<MJ
MF)2ZK(YL^)D 7OW"!)G !L]MZ%[);_>/2PM]Q:5!A/D)^='3]>'F826*7"VH
MOE.O6R^&]PU&+GZ]DO_D4'YVYA<!/8:O+EPVE P3*HFBJ/B\HX1GHG_&2%@]
M!U3_7JE[<DPE^TDN!Q*KS\4*"D(JC9<Q>N/*9OX<-[QP>^T.?<,1^C9WX"R@
MX.V-)6OP/C'3Y;M/BOEUWW95%&F%NBN-Y_ZFV3W(7;,M=A?4U9ITNZ];36;W
MMV-)&WO(UK8DNHG6'0C1!R+EX/<7TOZP1;E#,H8#RL@K>UL"1/;X>C<<,3)3
MB RZ.DK*AWTJF,M^G\AM-TL+WIR\6O=6<6(P]$2_H#TT-A[F8MD>()+5;%LG
MS'QOZ70$F,\SZ3UBF;7V25!S,=H+KZ0U1>Y$,0#6\>" 27#"=2EF<$[Y><W0
M,<;ECS/#Z@T=Q=S.N@;;XK%=NKI$/@L;IHI\X]FEN9EBJ3I%DB%*@" )FB7]
M;DM_IY1QF_C1INSH<\@@]IZ,#\$4ZCI[&AYRX9?KB:=0SZV)<;+.P,TE0H?R
MQK\\;M7LLZM<ZF9'IPW4'U($B!>$[W"FKP62!M 43$HBFIB[PG3VW]MO;CAT
M2DVXJ VG\EF&'A1ZT2YJO'T3/N_VF+R,8%RLL8*+#Y'BFZK)3">?7UVX]X/Y
M^3,91LW(0@/.+Q,ZA\EB%B <#)V-LD/LGWW<=759_3XFBA[2&' IZ#*#O^@4
MQQ,1>NWHT#)_5^H$\4%H#=DFOI-+1G'=*@.5'H6/!/6<75(KRZ=$1)16EV>W
MT/_12A4_[Z^&C^?-0YY83K^8*JE26Z*G6O\VCEBUL(?E(U2512H5.^C[7)3=
MWB[&DNAC3,+^Z%]J1&[6#22(@U5&;G]LBQ5P[7UQP^O9R#EL%M)ZRFV%;OTY
M(H 9@Z<,0TSX[(IA0(LR5[U%NF_<GO?-N&-&TN%6!ECRH19+&(XJO!1TFB7!
M"6F?69>(IU@CSDL;'=J/>C=2$DEY//;PO - ?14^'(.[GW1M ]M/UX<@=SKG
M@SSM6ND69J)1>U,G7DS#BC8U,D)DG4)8'FIF]8NK4[O=GK%.TDI*'[)XX\?,
MN=7TK_V2%I?49ZA8!QN%N"QI$_WW>1KZF\4-QJ5QY9.^R\TA[P$ QM[N<7,C
M[+N,&ABTB?Q3V1MQ!_*T>W>-M==0F)8V>7S<^W6R%XF8]=<A:Z"OKTW]UU1^
M^\::LM4+=-ZGMN8WEHT27QCA #J@()V:J5A[P*7\)-V9Q_S<VKZA4MB7.*/,
M87]1>@H\A'F@4()_:YPYFKL/W@6GQJ<BL3VK.V%<*&])H0MLNZ8XIWX*G??#
MA)(*KFN_, C][]=@=;=D/ L+8XV4Y'@)?)J02]LA11F449J):FQ]\A\@#S ;
MQP^#S>;F#,S&XA62S/K2Y(N>J@0^"_'4XI QUF1G67KJ"AU2@YQ"$M;OJ53]
MEO0R^W" >VN/84%Q?R:7TD+;JT9>'T($9I[W6R=1[2."+E__9I &!TK,%%B5
M8L'V9Z(XL?Q30TX%1:=8(K^C0Z-1\E%/'Z0[)3KZ"R_[ZH8"GZ%QH,@':65=
M>T7UW!#:9EQ&T+/6.J3.?]N^IBPKF@/1F(CF51LVSWDB*BYPPK(I\K,]N-J"
M>1SX67X%#C 64 VP$C\I?M'*?TDKO);$@QC8=-Z3224^VMARKW@;%Y4;$\(!
MB5J,/LS]%H[&9?$^>CD8)=E9&:P"H>ZK2KB_4J@(\55>Z7@LH'TG[!M\+%,I
M31N?KY[>3*PIC86JPZ3N!BI]%]J>E6C;#4O/JG?K3@*V-=0E6F]<5>?5/RGW
M[B?3948VNX42VS+M&1+$R;4\Q.K7';R=\T520U4F$->1)5]^3'LM)[.SW^+@
MLURRXTDX*&(AHYW/, KMY?01]08=(M]PL-71K>:.>&AR"W#)[9]5R<Q&QO',
MV;!0(P%%R8EHA9],AJ2.9Z(+;2QBJ>[Y3<,.1Q98*.$ <9OWD<W#UJ1!1_HA
MAT9<73UGCO/]?S1Y00\GQ>2Y)G3,_I\CO=UUL\*=+V*N<JO624H%LC<Z<WE5
M&WX?N+83W:0LJ<E;O-,Y]+;*F$%E'WP%0+%<NJN+A-P^,ZI0Q[S#PZ5F? (
MR&0]"8!;<N8IF;)FJ:8Z$2^*\B>3,$XX@"DN/ON0G-_5 UVV\/F^JNA4I^-J
M_LO/RN^Y2[(A;.BSE8%N8WILG,R:VHENU%<<_+X++2[W90[@X0/"(GLD9G Q
MO41IP;M;.B55?K87/?^N>;VX*Z]8WR$+D^NO:N>F(N(TU1&B_%"RQ],KC\1,
MQXY5GKO.?J9!O.ZXCENKQJ0TY0;"DQS>. K2/ RG.4E%-&T"&9#*,+GM [+;
MP3WUB2IUM13V$A5Y=M[2CQJT5#'1TAJCO5-,/<3C7>)C298'.2\MAD">4>7"
M_;F.^_='*O^?JA7WO[1!&2CPU9(Z^Q2X2HQN0/W&L))&BPS7&&O,6T?='US;
M],#OK,/DG4VC,I0=7 9="9K/^L)4NRZ+!*(A1R-NK(<FX\PRM8LJ0\%K!48[
MV97-#(GOF&@)F8?7K]\951P-%^O9(H<X][?QU3>Y=[Y,C4,(012NS72*J+_@
M .6^.#:^'34C?;.9<A+K>Z-,SPXO$H=19,K)X%6;4[V0#Z6/?AW(MG! .M;(
MFFT$59C_OA$Q;VI-DH-U#!PP)'7W81P92DPG]N="+/=2<=R92R/QN _ZQ;Y?
M:;4ZH=>:#&O[I>I&?90H=>[]3K6S)H7C=_?7[W=+_#=O'E^%,^G2O.=J$C=U
MLYN('-F&\LM2+L#;+;NGE[.OQ^W?)&5\BYZ:&['A ")+L8GJJ0?M@[(A=5VQ
M,4=&\*Y*&<S_VS\AN;7;"KWPY( %+Y$OP@']8N-BUPEBKTF*_];B;1;L+<P>
M#O#7@P-6O_I_VA%U\0N8LG!N\Q%>WL;+T#W1=V?(LE<O(+(S,(OF!JQ)>*CX
M:AL>QMGQP0%=:<R.KB,.N#=V*?,\U4U]!!ZH>=F?RBFU[F\3X8"+U2D]MX_Z
M\NC$IC()Y<Y$@LKX/$B1VVZ@[ADR\?^:B.;_+R4&I:+^N9@9P\1'<$@*OZ:T
MIY'%\ARO#.2DNE>':%2IB@+W[EI7:G!WM1JF B1PHCC/*S<W?Z,8G@(2B.B5
ML Y\4+A#Z<UF'MECN<F;^<+&:MXE4DAN[X793/4D<+W5+JIUR?2@96DE-S)$
M&]5Z[TB7DT80'91YBL'S-L(#@*$ZJJM#:&O9VSZ2(M)3MV_U'"AL5U"L>R#.
M&\I#1T.$+6/-7)F:!^2)YG5CKE_;;;@@FSDXC%L101X-,+_5V2[+2;4^8;+,
MS"P@P$+_*V?B9G++/"[)1+%(8::797U)8UTB[6:LD; (K!.60$>AV?/A=/N(
MRHE$3AD9,A=^"DK*NJD]/3X!>DVUKK:=N,VGLP_HIT@A!5E8YN(E#N[1,MO;
MWU65+%M0YGJ]3O:ZYR@<R/<4K=!U-=.^<LNC?[4S/#*SB$VY5F[>]J%.2ZEB
M)Q4:%J_6EEEC%M5 1WZ9V5_&O'P263,X5?F"[_M2V\Q7PZ>1B_T[VS-0L3RX
M.)E*\E/AM1*=A=X[WR5-]<7%U<CWWSW$)5[%#WKMC;V>OJ[(XOA9SB^CL*]K
M!?&_T7<2*V5DE7;[';TU3IIQ;GEA9G ]?*E+7+NTH<16!E)EA65H/VEJHP"N
M=B3<$BOJDFJ\PVHKPKA"8'W:X"[?D5C[@TV;3,UP[\YU2>(DW.OIJ&,5(N8\
MBJ-J+)W2,?)U%\.%CS-U#A %=D#F\MKJSP4:]8KB,8IY4UD5_Y%LA6[T3H+=
MVH![EX4OO[O9UGS'4^L_*OB%;:QD"&<SR6NIME=&9I0G\JFB>"0SM=7O^1J!
MFM<W9H=PH[$R"[%?;+X%=_8*GW4BF/CZVZ"QHXXY?VRCG,]$LV78>^LC_*H$
MS>FQ\:!7S62;:ZSSEV[=R/?)[N]IY<7[\F,=MAU.%IE+97A3X/+1NGS7S(*;
MHZPL;";A\D*O6\H.^JT/UE<<$[#FWRWU<^3AY[Y#*M"A)/'^Z_PGZ@1IOXH;
M5FO<7%YV63*&Z:, ,3"]4M2&VKU.[+3?B-]%AS-NM.<G&&)PK/8(&R9^HB8W
M$UV0PMKSZ(]Z['("FN[6! ?6H_EE2U@JSNL>>&;P+DKX\*'@ --L"2\LI@='
MY5GD 8E"YR<JQ4\;HJ<[^W2RWJ"UE4Q6S)5?IGP':"2H"[MU;:3VGR+E:(P*
M)!6_)0Q\Q.I31X2*1!?&F" HOT4,! #$J)8%-C85P32*0EV)7)7"T=-G_E^X
M:'.;;M5>;@YGAD"QU U1=4*R.'H=Y?@2KP.KX,O+R8P/'ZE2,^.;/CV1,LW;
M53"9"?L,#0V^R#(97;IQ#KKEWLJ>*:VM@]>" PP,-W_IY88JBGQ#OH$#&-3C
MMOZM=()F?MDMDP!A>V$M[1USG;P0;Q V_L54G3LQ0W"4TE^?]W@1MPH9='S(
MRNU&+JDSY^H?5"[-@10\"@7^WZ%2_IF"(JTK&JY,2]>$%*T1, ,UL.4#@>V#
MJ',KA9T'_OG64XPK#YY0+K^HHLW@>7EA4>AZO^Q;6(($KG/MG#*6BT78*JBY
M),IKGNL5#Y#;=,5P("]")OU&G#$0J\ZM\20NRHC:=SRRD&GQ5:BGM88\72Q)
M*/I7UZ?K.;&80H7G. S2QLIUPD2/>)T(/98/2<X')&Q%QVT9V+W?,UM1]Z7E
M*(!,"ZX&0Z!P8ZS2W#,RM'\0O$[Q"7Q)VKH%39&  Y9R)L"U)$K0HM(S\#-R
M"=CGGP<AA($/3K?^S_U>7[W6P/MT8F9PP*R([T-Q[U7<(<RQ&P[ Z+\)AUU-
M^,,!8^H4KSJ76[]C2F&J:O=BKXB_>_]G[24M^*$\92-.D.82=SK^[2QL\E6U
M2;H?0ZHL*;+8#=-DEJ5,F&D=^>3@  =\-(4#?$ZVNO)@O$?4&V1HD!=F-:5.
M/G8]T%(8R[V /--Q!7MUT=K/J4,J[=4?L1.OE;X"#3U1SI-(;7<:IKTMR3#_
MMYY@EW:P\=#!KM5[&$$.YT$ZCVXJS\VP\#.:RFF]QABKDE;,V*[MTFX"T=%A
M:4[,!0K-UP1%W"@GZ0SM )3[XN1/^?G_$1R3.+) 'W.+HK6OB<U/20[3U,1#
MPE:6>)<7C3UW=PPZ\+QA*0IEPQ=J.NE$!*DR24%$ZA%!Z2A(>"IZK/66!3%O
MEU19JYPKLJGLRXNH.ES(5SO4T[OXQ")Q\F#CN'! ].\BUW-EI4>W7(V1ZS_0
MCM9OJ3 ?$:,<VZ]6OG>6NRMX#9_"#&;J3WY[[XHI3B[,?V4"\B2<=!Q]U^H]
MYJ\7I,E>6(OZ8;N<6!7RJ&\-JB,M?_F6$U&Z8N!*\NZ)E.(Z[J^[O8'0=>-N
M*5@:QYT"=#;U1X_5$+S]8:\WU"*!PT'US^ER&M/'=3VUN3)8^+IONSU!I\ _
MIA(ZZ[0HK?P:W:SV1!YIV9RXM:LJ&F#49%;X]JRPZ']/R#J/7-^I5MT1#E+L
M>)'T._</;<U;%HMTC![\E)PP:WLE3N?NDQE&44*8L.]J_&,PZ-P@^SLDZM&)
M1FYD#+<>>MSG-RWH\BG33!HI-[Y6/?>:Y6GGC*W'KHZ"F(_M'RD:8YY"_S?#
MP)(JK4XG]\1TQ4-,46Q&V.UM94G$X[+'[OP/C/8]2XHBY,\2_X28_X@,>*JA
M\/KWW$;+X%3&M]SXL=<NY)N3"*'=_=Y14&+*I1ID(R-W_=.<6$Z<S?PD9YNN
M:1'N7]-R)'63!84@EL&;YB!OG?8'UG/25HOZ2#VI"K_UAW]#86\+II*X/H)M
MCK,8!8F+=BF='[,M@,E]:_?PG1Q@V:<Q4SUVJM*Q#94$TCOY14NF&!X*'N$4
MGXLXZW-*A-817,29^45.?EL:> (KL"@5M5\CF4>NR0Q]T\]##0+A *RSW:4#
M/S>83%WIW]>!:]^ZR?-BJ[0:GW%)XA 73<'U\Z\2Z3;S=+&IH?;N*)4H"),J
MW;Y5NN4F9&)_$J^@\69GM+F9MY*NO3@_P@^V#N  K=6E?3<XX//MH?CY38N@
M;RW?\L#0EQW>4@QIF(;V[)N/"L]/7YN7KLMHD<O*4OJV/WQZP+L0:IZ^@-%-
MQE!=+SJ)]O=AQ2,6,)7ZAFC1YN9^/FRXR/A_Y!I)R!!I&#>M]0'#]: !HHT=
MWF+K,V]&Z @?;8#_1=/IANM#S?\ EUL@/X (>7IO U^T/+:O]-(<K,HLAP_J
M!,91KMU2E-71A-7Z@5TN-& 9M:D?>XCG*PR^5A]EAG04-9+C)<B-8ZNJE!>)
ML?MB1>PT;BJ?1 _Y^*\<%QX+I1,WA'B1FMM[\FS,Q_;K(UNMDM!XHF_VRQ;!
MX]RI-9$#DLO(U$2]R:]C>IEZ%T@L?W7JL'L7@D+%N-;\;I\BJOCC;^7K_+)&
M7WMR05B-%=)K)",^[F$70Q?G:3E39U.'S=<4KC&3IK;FPQKS,PB,I\[%@33J
M+L/;A?G6>YHR%L#LJ2:][S("&@:DYMC*LL\-*'\&W7R.&ME3 2%+,1=PP"'V
MC:N[PS,K'O[E:B>[CP^Q#_/K0!.?- \1ZG+HYVZI:ZV6SSGO#VG4,@5MU349
M!A.JD]]4=S>OG:^WZY"JQ]<<RCUA4,DC'BA-=^/33[S)C%<:_0EF=C=ZC5CW
MKX>D; WZ2C9XCAAK1*P5T&] <AH%$[C?B)DR1^0PNZ,J5 S^J.A) 3B?F5@T
M0QP*4J]DR9E6\N5?Y/#$<F6XQ..AJ,@K3 N:8Z>QO\ZZDDR>3TTOR5Y2XP8M
MAL\VFO7:2R4$J-"&I-&G(X=TAP+?C>1@M;)?YM49J(TFQ&E9*-O TF-;:2OQ
MM8/NX\4&EB+<0=?@I^*53>;HY7F(B$I42H&)W@HDAY'.W%&[&I,)F#)&'5>@
MA$3 1_#F#,$3MG?NH2WC'5=D;6/4?(NU:AAEL6D<%\1VCW6S4,ETTKLGOTR8
MVUIU87BP\3*=3Q?KS0G!P5)LL&%-[?JXN/2S64/*7M+6:SEA/(M1AGB4PNG!
M=$=?[W-"I+.+.:@)(0^K[N2HP> 5LJTLNIY[#4[[9S(W,/>#H/G\HGU/Q"IP
MWX9BZMWVQB*H%_B>K<HBLA)X-Z\F0  '<.THOT?-^R@2S(_IL.ZI$&'E0\Y<
M.J#K]\L&^:96.LEH2FSP\(R08CR;Y*@@$J4PC' WC-!,KB"2%KNBRG2\HJ!?
M0QP 8$6N.^8]IM!_/?T?$3CX'6%1#+(:L6,J\WM<=W7RBCJ2!M]2G*9(![Z,
ML*J^D\=.CM=(#OY$LY$2^4&",CJ84U;O7;;FB-\_/3?S(WO9[CH]NU!MH;.C
M=HQRQMVM/+S8!F/UZZ/\1WV).+V/< !(49'E%?W7N#C$^@'99:VL&&I.$6:X
M^\1'<E9.Z>-F >I4?/>_I0FM( ## 33@1"^'D7M_SU[!$;]SFXT>B%!F==6J
MAC- L><BY+R!,0V_/KBEX. !;6C/5\R]JDAAAK0,#OB5KT]1MP1.)R,=Z961
M=:D3#0Z';K"TY%Z37U0L2?8(C53>[^+?U2P-6GAFA]<>V>[T&[3%Q2*7MPO*
M-/T6/==C>F6D ]V>E<.P<"I$82%_9,1L$*%X1^,.2GN\B[<V'[9$GE9\(Z5!
M6P[E+5R=G)R]<_CU-T,8;>U6AUD!(@GKOLTN([=Y$;*I+59P '+XO-;6.I2Q
M\)P6#@C.)E(LAV8&?'!8^?.U9W7KY:H (-Q96U?)N/8%Z9^F#*HADA#4?L8#
MZ^D=9<JSBTQL6/)JQ8HERI3D7OH\?WU9/.\+ND> Z=Y:M(ST481VRG\4UAJN
M*:O4/L.]\&\FOW-$("^9S+QW?/^<-!6WB'@6&>"X?H&A>V "2QD'C_#<IK2^
MWXIJW;.!H;I9\!T,K$ $>:.LSZ9*FPL,=,T@61YQ[PIU3)=Q9P??3K0+NVC#
M 6IGB7;ECMPTC> 2TZT_#$55^X^) 0OSM1 RK0I<F&GNVWLV>MO2UGH2F93[
MGN-:&I<6=AQ)418Z_4FI7]H\G/DU">D%8Q6,%>]C^RV"N=[<S !O9!O58/?[
MIV.:PUKD(C]S:^UPJ[Q^["W2R"LB<!U9!,SV 0/U1/:79_WD2+\S,/HF4]0M
MISRIG?]98KC8BFS^ZVWK8>@A>-3'VM:UC3M_]:B0_GOP#$Q<\ -KPC>Q'?ER
MP<J[A-RLP<Z#Y]W!9(;)4VKHS(] L/0^?2]*J:PFZ75U5#+-LWS""R8XXT60
MV5M?Y@NRD5;4A,J,I)&DT,*2VK<6QB-[Z:'%N%'*>.D?M!_\#W.6VOJ[UR3!
MUJ=LW8-VK-STJG+KZA_ ":3J2]IO4(ZT6BY3?7OR'8!RZG/)_#X4QTR%' =O
M960$'2FQ31$H9J->V+;:]1P/?D!%?FTRC0 ,9(KA (6=Z"ZO<N3\EOZIK#06
M^1V'!V"?G2IV)\DKD+C0":K@TPP*W)H\]/;[]OYW=I1L]EE 5+Q 7O^<AM23
M8B]K[+QPFYGZE:0(Z]GE?GYF"2/TNR+Z+&<&,W5Y=W(X",DAJ2-_--BU&N>5
M-M!.8S?LH_I?&MY:$5!(KEQ'>S#CI33B^B]TTST$I>4XEBIE5:FYV&79<Y:&
M4BGHQF/_-8^:ZEVXW?ES]Y!J)0Q:!8UI;I2(4%;A6OI%5'';R,CQY3!R#X&J
MMP[_?/SAA=V1RKAWN'L,=MN,>,8CQEX@%$7DT,/+<[<C9GV$_:0'G88)0$V(
MR+K?Z0@9-94+UX&=^+Y]9DI-];K@L03F6Q8-XYE8_6"]L^GGZ?A6:]G5.]K:
M>4>A%(H-!T@Y2<O>:KWM6>>8*3WG:W>\462!RD)#9J 4HLUY3_+0/IB,7TU9
MQ0A(<;K3JM;0F8Y"^ZR1G0$7GYZ>6_=KG%IRMDRB;HE5]"<.=$[$HF]"R/2K
M+H\8Q*=)TUKYH(DQV166$Z7/OHH=+%^#-&$T(]>W1_&)@'9*K!/_J@-V&\C3
M-T3GMJ_Q)39E#P)OFJ3QK,3HD)[^'IE,^)6WN;KM0$!!!WZVS(P_,)G/K,M$
M[67SRD\,>&E3\%V]\L0@)B<FL%FQ'26*V8]L9X@3+^&<OK_@@(M\$ONU4]EU
M*^7?W+%(>K)_0P8)Z(*OEDFMZ45W;RB8_3=VYKH$+TGFE.<<-"]+UM83E'^[
MJ"GK!W\,R@T/4\X@,*W=9_G[CH&0(\6@^SL%B$0VX=BA-*6HI_4S,=N<&FG!
M>5&@<]J[0VBS/7["E,"A"^2)?/.;T4H_^D%G*$0@<6='0;DH,>?03&W'Z4T)
M+\#6L%Z7[9]$>K"\XH>9QG-&VT#."I50I^=9/YA\UU!QXOG9J2S4^*'((,[?
M\V#F2*1H]?77+E5&#8Y$"U\U[^<!M?@<3@Y3#2ANO:T:SSZ1&1*@EF6$9&=$
MY&8_ETHG*RNI0J8L["VE<(W(ISEIF5+*4'+IR/*/&QO5!2>.HI*3M_(^W$_A
MDJE3BD$7:ZCH='Q*--PF#Y:8&<N9";8&_VC((YH\93#G9S8%?$H;[N+F:2I1
MF9>!XMOA+1^I[T*YF%[]?V>Y>'00: ,_O7\++@)4NFG9=9WP)*MVH6R+;MW<
M6:OCW0KH,NNG AO2J.)J@IDKF$^8EBN("M+?R=,DH-$4,B%]D*,YOF3(SV97
M,8\)80&,CTMH(O_[I,3=T>V'7X7E 1NG_@0S\6 "P2][%VNP"X^#J<+)"47T
MA#_\TGCU[3_-Y$ 5(=21EA'NJYD$UVH*XC>2E #?C]>_^2](B_FC+)@4H,XY
M1T5PP-=PY#VG@='8'P_3^HT'C%"AL@&U/R;A2K=50-%IY$GRYM(G9VBI;V7^
M;X9.GQWFV+.3-3/:<[6P8?R972K:1+LKE??$7OEZMA6%0+:4XDQ4*?R'>#[A
MW^.;I]1KE_<>$TXR\0N,\ULWWYQ+Y,9@'R?V$+E.Q" U3Q.KI?RD]>V&L@"Z
M:.51A<6G,?OG/XFY@RI=8QIDZDUMF58'?%X8(X@/FENG.!5PP#5%'8CW=88O
MNR^#+ZJ\FG#Q437(%6OTS5<7QJ=&N0 #<S EV.O^M?EM>'K+B]T=[CM?2SY/
MW!M+ ^[/AWN5*$^Q&<SE=,5.#6B5+HD<LW# $ HT[C'X_:]<I]?6#9'&[F>1
M<<%WY6%NB\;9TLPJ/_"H\X#Q1/)XN,Q*BMUY#[FF#ZWV)*D3O&YSCFQ%\ZV:
M#<1S%M*6)14?8]%H MWJ"Q%LC"8.G]) 2A%/"N1=9TQ 7\CNO4S3^[K^(46/
M]<3J_M1.])G)Y.']PY'&']FU; )A'LF+U/LU=DF6U$RV?Y,&IE@.>CDTH$,8
MMA@/I2MV1LYF=J<?XAV9>RE0+@()Y6WZNU)UU3%_+^:[V1^O^+M>71Z"I"0D
M$[.P5\A<N[D&6)H>4K=R^"I'%H%K@F<.:C1CD@G%\;BI3#1M+'1LYJQAVE]?
M)M8'Z->/O2VW0WY:D/DMA:??D4K<TM0X.Y+X'S)OBE0O@M"ON'1HG#]CS2QB
MQTM+( $3441LZ6XX_FA903]MA2-WY/E=_)I>TN0WNN?%$%#XFOR!S)!HD>"%
M]2=VRLV"$(DK+1LKG;D _P3I C)PJ%S(7%E8;@9/M'!)*0$:@_49C62_6S>:
M<Z<G]\R-V>\]S*3S\L_%3ISC/UT7 1*-F-*<$-U=&0/RW.)H'&,D_Q(NUB0N
MGB_1]4@PKC"0@+I:YP!ACGNC[0G"4@7?D.V>."E"R_>/O.+21Q0=26PW4:,_
M;?L'R%;W^DPTWA.XV$<3F-Z5' X[GN>V'>-7$J4/S>SKO=(&F_,E9M9D7Y+^
M58C@ ;+(,K.4(Y*"JBPA%M96JK$EH4J/LF7"$H0T-'EN]3RL&J$HU\>^YPR*
M_UGE5"-\>NO ^S<%/M68^WT?X?3HI2N:U"/CB=_*)*)"Z=?VL3_&P\6.1%Q7
M@M,3EMG'"3O>LEVEHXTW"#A?M+=AS)[RU^)^O45.PA429,0K#@Z>ZQOEIP<!
M,S=WY9?V'H>F#V&/$_?\-A=5J9<;JZ5&'6-[Y@!97//T\G)C\7A557'"'WEA
M/)&<WU*0$ET('"'&:Z8?]/*DR"4GGY,&DPZ^^1!(HD)JDG$1*ZT><:#%#TK_
M=/*[<W!"<GM,W.)\.O"38KQP>M7R3M0=S==O&?6$&=T,8R9::MCT/\7C\(S:
M+K.Z!^/LET"FDA/Q\\YR,Q-CZ>"ND.%V,IP+DK[P!F;\&V%Q.$  9@32DW1@
M*VSV@0/L=_C")OI,^4H6(8OR$N'])HR%P_,+DAC3Z3O1S-5CK%//&5%"'P>3
M$-?UY3T.Y+4;N2JYB1,#S&_Q+8'$B?*B 585NC 3L:DD^SL#3-?2'N A5V=M
M,]W+I.C^F2!E.ZGA.I_UO@*10 A=9G22:8^"KBQ^\A2P6U!6>&I:WAP=_SM/
M!OHN<ZY5 FA/^,1Y6?N%[<&E[8 _SG6KT,M^."URHZ)APSM&<B>6YJ:P[=&M
M'-,]+(QL=^6E21K54>2FQS/69FW@PI->C2E^0D$G/>F@HJJR/&."^^.UT$=Y
MVJ0+NC=?6J'?S@+L)T?N$Y5TGB_MZB#JCYKW?QEN3<,89Y7!J!5EN(@ S.IP
MLS_/OD^.RD,=K:^8ZQ>Y/UU5>1XQ.V(K6*<AIQX54M;,W.[8;U*R,EG2."68
M. -^; ),:\HF9BP"+OF%CA4'G-XQVBD/OID4H48R?R+"LOU)WX"E7_4RYW^E
MYG3%9Q 1%RAD;J)A,U/U_8,J!V\4YDZ8(E5P8"/*1LP6R7)IC^^ITUZKQ\ZX
MX$Q0"'O?"*G<Y!RAC?@'E=D^[4Q;KT*Y?GH#X3 GCLW?ET1V8YKS+@P,=1&!
M7!=I3HG$@H'$&Z3$355<SG3?@IXI3]AI^G,,UASYCWM]+NP-8DUE_BC1E :J
M/ +@ ,4C^;+3\Z .(3&/'3[-Z9$668&,W!%4_*LA7.<8U45U>5/JTB $*U\2
M! OT(?6;+VG>'J>9M33UC8HN<L[ZS&4[DZ[2*HE@RO>41(*$NAZH74IZ6&X,
M,@X!H:NX+T9(Y7HIE5<:%]ECM&BX3ZC-R(O+[0K6O,"%H;(?LXE?Y*[E7C_L
M?9-MWA/":VJ]<)7)- 78%-V)1K)(&?T2D:>-=F#3G..)%;5:A ,JPR4]ZVL5
M_G-W)A"40$'24;D'ZZL\O5CL*Y%)>K#E%#@1X5EEE=8K0].)J6">0BI4./U,
M3+3H=1@K-V9D*JI]4#FMTDZ@"2KZZR80*PTC,.(Z\@I)H3PL,'@P;CGXA-$]
M?T*J$49&\@_58%+&P5S+!5N<,&R/UH%7R+UO9G8K@\&!'4.4I8<A<\)\9+WF
M6=-2A">,+%D[=#-3EJJI4VU,6&Z:VRRAN[_Q\(<=]M]#96%MP@>.*2];A;\F
M PB!M)CU5EG>P-,4NJ+L*RY1TG$AI;'>T![9N#_T83\#&*"3F[G$#;QZG@PQ
M16<]<1MX3*\O)V3C^#61QO>:-<-$J=(C%F9*164] E65RK%F87)?_"?N*QT>
MV.?R.V/%".0U$N(Y:1[-U:Y*H3;?U*-# E0/A6*U_1GNV%9@16P#KT"M/Z"]
M=:P$ G#TX]0\!9,@C'S[,:27.CBVCK-VA:3 ,WY6(Z\K_22<7O?,0MU#4-59
M#;>OJF[1OY$V9BS7/> $HUY_C"R!;P'S#WIQSJ;*GFD2*\+3:?ZY(*/X:'5W
MM7<8@JOIG=J0$AZ(ER8RX:;:*T2!O )QKW4 8[6YX0ZDT73JP7[ED>G-Y3Z+
MPO4D0E&CH) ^H<H3+=<5/S[;"/XYOU]T#SIGV!3SN4_4OA=UB_1LQ)5S3"=B
M:%61N(KYO(-7^Y:-U@Q5^VTT&E^ 198M-5K=T*=W.^.B6X.]D]X^;MA0VT?%
ME8V[WK]Z,A6II2#)I%KKDEAU"J?DVZ+,S'8O\^*B($2NA'X;%/4P?AL:!NJG
MWY<BQHZ%JT]* ^NUI8#'[?JZIL^(1'06S.;,&'X\-"(QU+TFV$8WZK92FLD)
M,SO3H4\Y>"_(YS6"ZS0E@F9EHHSN;.Q3JVZ?%+,;[Z=%KGW3G/=HH\B77-4&
M,0SU./18L&BGRST2=12&B*OD5 GGU)-GO#L%'Z_E7;E5W+$U/<1^E0%TD[Z+
MXSHI(TNE$="'R><&TF7\ " D^@52U&&6$3P%@WE):ZU:[$IZ^/8K_XHX?GW<
M6%K%7;M:>MJ_&V%C%WRVS!\815FB2RPI\Y$+^]GE3J1QGMM8WG3<NY%BZ,?C
M1 R4[ L#TX,E4HRRU+X)N?YNCP%7+#B:UCMYAQ$K41-,,LR\[9'<*>LI.B$?
MO!2Y"S^-K87POI2Z'Q2]1C+S+I!^*&1,K6GP:.))5K938[WN&$X#9'_-F^K<
M?+*;:)ER]Z:,Y;T1EK_6(-6)X7P'9K[#<Q!2''X0A$"H/$%4?5C D4"5 Z5'
MN5,'< AX8JL&1FU"M2Z (]W=V<DB;KQ.<J%K]B=?(=XO'4JJ&N/6E/\MPHI2
M76.E*8<Q4DTZ-."/;X;[]+67G78U[A)5C7;<$!4%CG?0W]H41>U]"OIKME[F
MDD9Y=D*5_1( #!<Y\$Y8;P;WS<#KL CF_S5J#QK?<=99]]=DX(\>.>#2J$^W
M<\[09;S&O:'Q5]6VU(J5%IM+CG.4YN[KWS6M OY'*>D$(C)5N65EC4#**Z0W
M6'L^U1<G,+5<;"%[#:WMEA+)4D_2!_=Q]QC=7<8)P.<(SJ7W*E':$GO5O"(L
MK5!W\GW%D$W_2XN",<IVB4?'=R70HK>&O<=16&GB&+L0LDKW2E;+=S#&;PFP
MOQ)**PA/=[KN<,#H2'/AEILV%.1^IE#3G*-#W.JVM'U:SHU[54JEA5JB*[]G
M%UAD.:>8D26=HJL5=XEEZ1 E4E3@_(OSR-0,#N#E[ -/-3[=D8LU/+QQJG0F
M"I\:YXP'-Y4CGR^+3M<@[E)<0Q_WKQP%[4L6U^" S>F^&!INCV^/<JX"/.[O
M#LE[>(L'2\O#GUBYQL<L,FV:0BZP#K9<6K\YT3$D#82/HU0D+#SKT$V+85.2
M ]R9KR]ISJ%-B)\S]VY2%;AAV@5P0/.;'O-;3_] 0<+_MP_T_"]M<,M:SQJQ
ML5_CCM_HS$5HL0YL*Y^Q.+YB]*Y#M4K@Y1(&L,O7 9) %D(]KV9ULKM&^A*.
M(5<SS%(]/PW2(OK(K1 +_0O3+I^"E5"'-WW#882FWDHU;DREY0P \UN]5HHI
M."#6UVL"5V^XUGGQUV2M4BLG7DI@"AR@(CRG-O])3%PS+^ZJM2W<\V7D.G9>
M(6I "),%A#Z/>"\@'0U36NQN\H<\M;KGVTD'*;UKRZ%]K8B^QII"%L??@UD(
M?0-H6=_E[(S7F^(;C&64] '$T%53@+IQ+TH)X.W-G:FMR_#60;%!OI<()6C7
M%U( EM'"<^9K^HM/LD=<^^MM[T7 +I(1BU=13N_/L,U<!ZS5V;=M<$!ZFML^
MVDC0K[/L>@1-[#%\OD(.Y>)>>H7,)$1MW:V]D*Q-* *!(QS@ZVC21:LK8>78
M-&*>)(?U;!7/\:H&!YBJK 4<KW=:2+KS[@]XAU!+$T$+XY3_=8<#S!'7P4RB
M$H[%"<#LR@[C6.7Q*^,*FK43C9CQA.C8Q). [R3K3HXB0UF]W=#5[N!&1RU4
MK.2W;/6Z"U #4Q[H-:=/,E^<A;>6>7ZX0XOI)Z*4&D5_\#"Q/AR01I.GQ) V
M87FBV\J=/+I_2A%6.;8\8<0$!QC*ZZS# :T/)%L76B2%CVG ,6XX@+1FGO_<
M14F5-^4[B8N7Q]7(1TRT_WX55?]*^^NT3Y'*]A71URF3>MRVBO<N0-?;US85
M2.Y=-P2T5M-J]??<)-421ECH37)/R5"QY:CY8NJ5!ASY" ?@UM37GKL@2V)R
M[S* ]X\U&^+*/3/%]T*)T%4&Y1R>_BZET\V#D:5_['T4&>43';\Q_$.8*-)P
M].\W RA#ZU^)(OE7;"0'W1"Z'I)2JDA'Z ^MY>  _U$ZHX>RD.H C;*;$VFE
MH=KXIH0(NA.'M9/I#ZBV/-5V\4HLZ(F<I/YRK;.&>[X!(#/O%@1-"#NF#21_
MYDS6[.GO<;K_Z;[\%(%K,V&M*RY%\Y+L_DB9V%GSPR7TF>T!#LAYW[N3LP"N
MZN6% ^9J+F'.N3>WI:]> GJPV%2CFVRQF?F9&E%13T>*>I\7IM23[*LOT7E;
M>I\KJ=38-\H2J,-(8[@2Y7D*L7%M/#QH%/)8!QEI49Z$U@PM()Y1:%$Q+>>F
ML<]S169H'\K8:2J)U8\166W$$>@#<69]LUZ7]J<&K'N",::GBGQ9BF.DCM $
M@L4!Y62#?V0_6K^5)[/'N"Q_=1GX+]&\2H:G83@ TA8@ ]ZG_@=]EW8O+AP_
MP)43%;V830;WC24^ZQ0PG*M_$\YF%?S8Z#L!!W@;I)VS0L'LV=_(#.-:?'K_
M;P+&$@T<L.$!!US/PP$[(NV/8F+7[D9B$Y5M]UN:_Q/AR Q^^GU()S]BRH90
MJT $1,CNK32[+&_.]![UD,I\/Z!S2D5%B%9%IG<I'6W%7ZG5).A"7Y8XU9)'
M0UF>]@GPZ<Y"]2!0/0?@?&H(SH #IKU+]'L-_*1CM57O"*%I[@=7?XB";NLA
M*R>A= C/J.,KDG%:D0ERL7F3?O7G<>\?*)K$2V&B S#!TG-AV<\L;$E7BK!K
ML7'PJ!A(]]G252_<RZJR,0-:8N3J:/_JN[3GTJX[UG#7G,(;,YDXQ2+/<R,W
MZ#(YJ42^_V^V0 J@V$/$B5[4U(SE#($ !%4OA)SO(O4<\0#_0(1%]!BFH=';
M9M92&B+SLB+)*O&MSXEM?#<<]PF@O&P@-G67)*$ ''!)\K;.SB'DZ]3 *:$F
M]DV$TGTN T_T=EF"G(AY:3/YX)?)DZS8"W(2F4)I3%6[T'YT9^T=$$T$J7J9
M!A.-9%A.A\6U+)&Y</"^,C9LH2PJ"@Y0NNL>V=S*=7I8YH=\WM27I4F<X9)T
MH%%?#CM.Y5)03A]=4%!7QBP"N3W%K6U^000=D,3TS&L7XD9^.+CFR6-6T*F<
MBK?-7SPMY[%-6OA)F+D601V&JU-AE?C)I#10N.:2J:&@3"_55!R@G]3WD/DS
MM]%59)+V,G59\ZR@N*#=DH&BCR9!,\=J1,Q*__4PSOL)]9=3%L;ROD?5XF6#
MNO042XV\<3PTL+5VNNN=X<AC_S5)69W7QLRJ >^*GIC#?ID-$#<#V@(I4Z!3
MV+5.+"G&_E-8[B@V=D+.-#1<-C3T8->CLR4W.R#\[61(H;*<-I9GQNFI6G:F
M<()LFFP(;Y>A[0U>2L*0M$L-(N)I;&#;^O Q]7?3V!I\N64+.HSA(J?14W"9
M!>4K"LW&@TC!;Y\? ][HKC)>164UO0Z$Q!2?@<(='QRRNC<G&&*L>.K$,)Q&
MKYI%F+\3^[6Y6V[AB66(@$8L\T<NL&(-WO?4.]E$.O2W/L,!.,MZR;5HGN.[
M7.=?U#4^_T.5$2):9MYO[]DNN+OO[6PGM"L@7-?JFDJ',A27,CG9W+T@H5(N
M<+O60R(<(*,782%QSR* >'T"!_AP/%7YB5ST2\=5;*FZTQ]7-)!U0SZ,M!0N
M?Q)E[9@0Q4O(_,5%YZ?VB>9>HR8/L=/EW7ZS^F, ,]80%AAJ&=2SN>;W'%>Z
M9ADRH7SWSS>PBTT4SG7ZBE7?XR\)'?I<3N4W>X!"&>)<#UOQZ(%ATBGN,E3E
MJ1J15LG@+.W53$GCH C$%=7-8;MV8<:$#3@@5#WU-= MB-H&,P4I5YQ[2?H?
M8MXT'3F$V=5UD[5P_S?FWC(JKJCI]^P0" 2"6W""NUNPQIN&X.X)[@1W#Q"L
M<0_NC;N[NT.@<7>"0VA@\MS[:=:=63/K76O>N5_KPU[[[+-WU>]_=IVJS)GL
ML)$/GG^GZ,:ZJ8.+5<?4T,R8?6S?,S4_&,?J#6F8S],89*^<C(WRSK&@P8&D
MV=5DU-?6,9PS YU#-&E.>%Z.P/T77U60GS]7=@H%Y8 Y4.3W+0F%E28C1"%I
MX8AM,M?4V#YA,D$^L2*ZYTU^Z? 8=C45AX.GO.6N79M%/HL?=<P0*^F+1"!H
M!8\B&]3XI,\'1U(JLWB.V9NA@\$<'.U/!S#65E(_+!ZL$GWV^;A*L#XPE5Y>
MXL2>AZIKN9>E52W,A'NJ(7QD6[AK)DVJ\U.#PHJ'C,T"A:G_S?%WP8;*X!<%
M(P9OE9+:CN3O:[@-U@AR%RV_+>H<2)X_".A^#@BO1#&MJ,R/\^OD(]]9VUB%
MH:&6$Q?[']X5/\U]^$>1B#Y_&9K7MR/?:P%9,%?\AP7;*@-?U+.Q_PHH[U[I
M21ANK>.UTMH-K!BR[ G*LH"+^E@<MTVD':'<O+Q2E]D%N]?G+.LBW:ONUB7^
M2)A;$5"K:^MDH'#@U2%DQRU]!W]6A)!B*D:37DTO8.5A>*6V"KOI^SS'$"*K
MFK! NJ5)B&U)892CS,\< %+ 6XA(<#Q_LS6#N<DA&HX_4U9X<3-D67YT-$*@
MCD/E"4Q&.+%US;Y]/H1/,2149S+%REROIGK6'NS F+2XF1N)3>82N!#X 36:
M/K2IAC:%YAP6(BRDXQQKX,.IU"@1G//N['R#U3:PW7?P=Q(/,^[#.<H 3S>-
M=7 08XQHQ/GYBTT7674T#8D)TN^,%3/Z(35P:%&/*@?AWQ$#+7S=A(&N824*
M54Q$/;.S=T??F9DE"4=^U?D/XL4\+*D4G=WG[L%PB];8SI42:.2)_98-2%XX
M9_3_;<Z):Q\-ELM3T:R59B[:;TI:;>Y(AH>M&&]Y\!RW>=HP;)D^,FY?V,39
MI=1.TZ(/C$<?4TO' &V(@-U MGPRV(69.R75D$.H\%W]M?#O6V;B'LFK1:MC
M+^:VMD>(3]W:EQ/DKRIV3&"T!.EZMP$D /% @&[$3Z:31 :Z12A\=35 K'9L
MY3E]+DKATVT\"#@B5W5US+OF=TFZT)(UEMBD?]>#:/+"2S7\\,@/TW?1XG=P
M<&M\OJJ\.ZUX;*-*6P<5KPK5=K&C<!EN?<IR#\?2#X &JG\'D'H3+)\F>[M^
MP)(D(K<B9GS.47\NN"6R;]]H<T@B3$E1>T>3E.QIP'U8/B#V" !\1,A$]IL0
MQ'"Q\6*N;>6GG%^SN6HK<[LWOXUVDHP>.#^J*4+O:Y2J%%'7\<)52K65.V:E
MI7%UAZP<36=^'T?8S])M26_RUJ] [SXW1;XISKE6TU@Z[+>XI.!,,!SQ?G8>
MCFJSWZ&),9;%;M2I (M*"N9-R.U6X5'\R,B:?9'-5.JL<73 C%I;, K.'?^'
M!02]VTU> YT<M]@:125(Y)IA9R>,1PH].& "\6%XPCE+S;W,\< X_Y]W3"XU
MND.4E/O0!41XF]=AX]H$LR>.7"%M]#P7F 2AO/A3(#XB=F\BF0;0V9_%(<V7
M(8EW6;2T?"/#+\FU<^<X/;@SM]J8*!H/N\B<85HG;6]@B#BWQ4'^*)9OT@?&
M+_>&/73HSS@/Q0K8Z&'!"QCL&N1C/>M+0C$5=GT8*JAE7);%J%I%DC"X4 LF
M*9N94A(A^1V$D4:5SDC03\)5#<<^U4<=[93"O@O"?! _[/L@(GYXZ])TS?X8
M,TMA PX[BX+<P^8+8#9WORQ\Y[@BD:*MH:;Z'<*RR(6,5]]S_EHU52<?#;>9
M'ZG.H/Q^8>CZ\M+-DUU?*D*9;1/DQRQY_$]GF#RZVHMPPF];GUCJ?Y\_'NN_
M3%90,12NKKEK9T #4V/T:W=.B"&-$,H-:4A>RR/%SKG@ZG-)%E-# 73GP928
MY!31&OEZ;D;X":W2Y*L?"!F>#R<#4%#[9V%^/3?:)O'?T1PI/FG_$LF"[3!Q
M^8$DF*=G(2 Y@[A(7P,Q0BZ6SB> KR/Y#IF$O<%1$M3ICW7Y9P=:_%OO@S\K
MT$&.M9%6?]3F/^FV,0^"A8J#9^2#9VM#*FUM0&][N_OF8]?0T7/;]F4=;+)E
M.,?[CX6\@G5\/[])A;^II8*(C!((^9!8>[@=UI1<*2/Y6<S#)Y1 <1+5T0P
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M2 [>4W/)@4=^^9,Y,[7:XR8W-#790^='Y&+'10KB=)L.M+Q;0R,<NX5HULJ
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M<:">G$5L DV4QM_HH7 L=I02O[43;X<I_:/%=_0?#5QD5P ;_.906<SLO*1
M).";J'J6Z+-DA\VJJJB\=,MI4C9\+ZA<APJ2I9E8,080X)-SNOV0O)1ZYCVW
M72^ZMR*$]4UM#8(:TJOM'U^!3V%C:\AVE<"5H6I@%U.6(S%G#=Q=;P1YE5TE
M\[W_;=N8,C3I^S&2%W,D$^[R%L>@<2I/155*4;=9ZN09L'IFOI/6]'&E;*.U
MV>$A/Y:GT%04O=M)ZI_>J]W2F:Y"=<1(0< S8'QU'?SP#$A%,!WC(%H_S#\#
M9!3:'P; HQ-;3U8/^H@H#Z.K(-#HM)!GOY<05_K6";ONS[>M08GBAWLA>I6
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MQ/=;33J'=7Q?SO"-Q$R&"DWF)5V6KQU\Y_ZH\1>'AL.?]/FB]$Z&.][UH@+
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M"1F9)H]1UZ:LH2D&NDZU2'%=&N91E&%83!.MG Q4 '5E<%AK9=+!N)&0AF.
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M1<Q#/^!S#^G+U/JZ1Y'NI/\+BQ7] #ZC=P^8I]F9$[@"K?GZK2$IH(3VXJ9
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M]N95"R^ E9+MSX_X,\^="+.= NIY9SI0F/<^.GG+F)7&"R#W</(-%O:1C)I
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MACC@-YE):UG:0,!'< "G=Y??L4^V:[+>\7VZ+$DE\U2[;*$L<S\ >^"5N)C
M;,I]=  '<^,09J^6EEN,HCUI3A4_T$\I3EJ]^>ARRCKJO1XI,IC9E9/>6T#J
M504!I,#WF:B$2WEIW68Z4<7  # ?VVF]7(H)R4(>Z*YZ <@UE=BJP1"S,U(7
MEI9Q&X:</8E3R=X=Y.QJ/=6:!]GLEPETTRVD*2G4D;J':A#;-L6I/O(M3X?>
M#*H<B;\ U$E^G/ODRJB?GZ\A6D$I;1\R6I2]V#^,]6JCT1H%G[CDXE7ZQ!]
M,-X*H%^MLPR/X$Z C-77:3[ZAI52[O;<(QJEVO*R.1@?7#3I?BSF2,3Q+"G)
MW3\>%JR^E66.<?<PUDE=@6_,-V5MV7<<VM<ZD/;TZ>Q^),;I)J)34&61D9D@
M 7S<34UF[@NHJHJRBS#Z[II[0=&1G\WI.ZX9<+&_.>SPNL^]T<:$F!?,#6I5
MMIKKT=B5^S$YIRGU9YL$*]HI_AG4S0ZW08^(6QRW$/6V7&TT?2+C:6_%/FW[
M1X7L;UT$5Z*K">HEM5_>4I-]+116.?+8V0UU:L:3C/G73KH/'P YR 2 5UT
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MAOVG=&2#$AZW TY71*E%K^(#SCWJGYH)>T1G=V<-PW19X3K3PO;8+P"TNQ=
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M5/^KTD%-=57URL^W?[RLS7 0^KS!^/;V(V)" .4[GS2_C*\IZM5=%P'[MR\
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MV^EJB3PL(XQ-.CJ\E CLQ09,1QZ(Q)]E+GK$QZXBI(+KC5 <?/'C[3817D9
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MZU9%_P<V(<.'\Q]\JMIBVA\ZC>S3=F<AC5SUEJ76XD;&:B6_X.%+ZTLZXB\
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M]'F#@-;_3_/'T,QBB7;2K7")C*23=<R<2"!]K",CMO@:"+*T73ZE[&(ZX?_
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M76VSXI*2XJ2OL1\WU,:!L3V,'^AI4G\ D!(<7)-!W^6;T2$87!P  +(L< /
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MV5/+:B#'.?NO KEQY!4DWTY=)*2X>*I[7(&81@?+^P3SY[D_'OC; $+ XPM
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M0B933\N</HIW@2'[4#[FTS:CHB&W!#-& CU95?G R!+;<948U]BJ'$9.$1!
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M:QB+O!<ZD_(\@0W%7G#4CK&')C(SU?3O?(_03@D!.('67#-P?MG5ZOZ(, E
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M=..#$P8*Q1996B)URI>J8D%EAX'*X,6B7.C.$H]4V=*SA:I@26T[Q<R'2_[
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M^76AW"F] MI_442%PQ#W?M8)NQ^RB*+Z^N4>O (PRF6Z;'VID,.B;O<!KP#
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MM>ELGQJ4[_4TJFNMHCZD98E6A]3*X<6&]*9TDY.>)8*Q</;=LO2A#EA<75
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M9DKR;8/^IM_&BC"E+3ES.(SV?FD91*G=C(Z<R!?)MC28>9;DQXQPB9.KO&.
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MEY&HX8BN28$E1H/8I1!PNW'%^'9/EC7_*PB?@?3QK"]/2$Q26Z_);<D#\U#
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ML$MR&]_!C=GK73+,:Q"R!EH[OO2WY//],J#.PD@?R;]G$/,%X$PLANF5?.*
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M>'2K,\#_N-P^R7U+:<V,9MB3XR1H\7*2/:3#:;K9 *TOUAY;#T $I"92?$_
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M7U-1U$H#PEU\4=UO[L0\4?!5_^O8=8A_:G:0X89@$!6?Q=<Z4YJ V;3<VAR
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MBF%2E8M^8TA%3 4RB,@.N8"^@CZDXCNV_\\GLSV*W[8=X(<GG4Q?''W(;@B
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M3B"Y3S2L:UT/^CAEEHU-'2V4(6R1>"LDDNTM)+J? S5V:!U$W1W.C\.NSV<
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M+%.U.3BYPD['!_<ROE,E.JK4[B9R5>I^9Y*C2E*3&Z'*IGK*_D87S(;S&0
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MID>C((5^E H=[(N*L/ZD+_-..KCOZQ#)GA]*_8IMM)0=MFIN$2;= C?VUC>
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MK\1N#]7@_["&?'<C0?7M1<7[I=+RJ3-O%\+@ GWBV:914[NHSNH;'.F2"D=
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M7)P%V3HXT=2!,'&]EYPMS$KNRQ *!6,7'=H'3=LC^0N$U#1TT5^5$8\K191
MC&=%[:95:SFD)'$6YQK?2W),M17? +TG&?:R!1EC(U&E+N6C'C,--H9<8^4J
MKAL,?G7"">CGFJDB[X#0\H""J[BE5=<E8G/:5E+/"J5-[H6^XF5;C17NP&P)
M*%82%NG$A]Q\R[8"PXO:AS1]1P%H43?/NK[MN9!=2OG %WJ"5"6!#"V=D385
M%7(M]@FL#C4T#<<Q\W/0R@,>K\ZWA?-Z2F=+;I)&$9/(70*,?8%?#A>F'7OM
M88W=8;+41O04OV<*-4B0B\.B"RM<X&+CA@8V]GF7H!SL6:+UH5Z6=U7\L9F?
MRDJOOUPYUP" FJ,]6NK]HDK<"LYYYF'>E(8T OL;]@[@3O5EM0^3LK"WA:(S
ML%NTCVEG#'(UZMW-(&^'ON1&/4??&N;WL%CZZ=K/3$.=,I?\I=A(Q_ "W8'E
MYRPMYQ-UJ&<G2K.QJRUI5]1FZG([90694O/W\W,U-H?'@ /)B+;PJH_D6GPG
M[:=@?>QBPM)EGNN:]R3ETGC^O4\N)P(^5ED\KR[-N'[N1UQ?@HZ$A_NU%<H*
M*/]&0\5HU5L:/\9#J?\Y6:19&C_[LXE9:9>5')C059U[9!14+]SW>J2&-1"W
M(0HWTT!1DK$'YOQ9G^@^'V3U05LD)0+YL [GK?#KPS'[=<=[.2$[_OVO5QO(
M<5CF^Z$J4N$^+V2/3^TO];-GD6L_#>EX*_\\R0P%@3X5_=#X74IZQE4!&GG6
MP]]G;0<QN,'K.NC-#S^>45F7W4LO;Y/>Q+W\5%SM?(C?[PR+?/C@&7)I*$TE
M>F&S-0KB%<:.N7L!>\'3I994\][SL@1]4E0^*_"7S$4[K3)D*XW4ICPJS\3I
MGEM)@'4377W=9NB:\D]$HZO^/;AQDTBVF2,_6'!P,'<V)NHWIGN8U9F<0/)>
M7QNS9MD\J<^2U+SUR5T1O#&D?'(2)]1>4L-YN7/T$D-CA:O,.2=&R8,IK(F1
M3:<93B8_W=15CDAF/L0)$1W_45!6PT1[N="42HTU(/88]<N 3DBZDW8.%K@@
M?CW5;M ^L:PU^@Q+J98@NXX\+R)&@S@N UO(=DOECCJ]L&!>GEL]-#_W>V%F
MN$%="S@Y5S]X<FN]*UX=+0J''C"4NJCV1[;^UQEA67D;N[;Z,5*\V%/([]?_
MI\E(YO]N,I)V,O,?>8*I@U.5ZLCQ,,_7!,:LS[T!UG'(T7#+OL21P5<S,0+
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M)D<RI0KOU7&H+C!D4+1J,A,BA"G ,*G1@1LFHM*KGUR-/\V/+FZK)[L<CO5
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M-ZK84^2HXY@A.VK?B)\=52?+P@/@C=#<2XV_\ZMN>V%6Z'D@8U "QDB!HXD
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MW\-?XT#>C4++SN6:\IF2FTZII"@ 6\ZY]-?F4D!2;?,]O\"X+D;]N]\92!'
MW,#G( DR,9C?V.S7;)+B,#4,W+?X]I34L]$\PP)'?MI0CET*1W/F]=MSA=:T
M_J\4NC;[Q_@?7J AG42_0)8Y"WC[%)3!P>I4GF3G*#9,0W5U  2=4WV08X3D
M;@9#("G/)$(J.K>3]I9*!^^6<\)-["TXM;+6#I(JH$S&J*;&B@X:N=ED7]VN
M;TOX%!G+2]>15/!C.57%Z8^P5K<ZC'3[NSKL-X_;OLUI9%9F[5#0L5P)QI7%
MN&<:I<N;L4Y5!WDVA;Y:V9..6Y'_T=7=3+DPX$).A5RQF)"&W//#4]VC535
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ML8.;/4W*7I08W0MXAE=U#Q.;F+TU^93ZO-?)4&XAJ[6!P48 &=^,\#>?>!3
M<D;2_EAXG.]8V@@%D&8&WC579GM'K>FDL )PI6V%!'<:%<$4PL^^N\/1?GI!
MA8[!N_#. T'F#GY?<[,RJ0SK\LSRI:#^_:%XBR0BH/*+;^NRE3,8MD()C1X/
M0B.A^S3BL?#BJ'OR5RZ=[?%'(B]6.XBQD_W-@F',92A K;JWI(21!0K 8Q,X
MS&5W4IZYL"QA]NF=$L%+PLU\"5 1\=O2L"(_'\P<7L *8]5;G7$SUS>.^-'2
M%S,#_0\'?[Y( I5:0EXMOUQ\X?ARM;E ,\\A"V0I78ID1WQP,FG('%L/7>Z7
MV4(DVACNLF9OK,9=IPI(UQ^9#$XK__RUOJ2EY4O42?%K/F/]E!!$4!:! G!=
M#:, ZL/ G9D?]9[S0\N=,,_O#&[*WG^4KC!GV>>'K)@=[2MCGC788NI0NB4L
MZ&29M"1^2PM2:+UWP!D39X?Y^:IF*%^*,L 3YXC=T4@H9IK+EIA"(;P0]IY<
MRM/GV*J5$C)G7J",]A(_E"K: 9-!*OL ?/Q.@OQ_5 &3)B>@)"#0@TM-Q5;^
M(;)XA:LE[NBX0F)["/XH 4=67J&78?';[]E1A> H ZK-]%C(#2LR:(UPPG<2
M6,.O'O^D@\F#P>@"RK][ZMQ (?W$UB:V%[B/XU-VG<W%$#^I_7E R<<=6H2(
MA5?#"'\CVC1DCLE<?O6U#.+K9#IBWM"I!AG(52LOWUJ3%M-/4LTS5O$'#B&2
M>$!FUN7[-Q?$.J&1_'F^7VQ#@Q=SRW1W48!VH>N3H@8KYP8Q1?H,R&A,#^4#
M%R6<-^R5\%@IGC=,'04XNN\V:\5V.R'?2F!E#RL%Q25T_J*GK',Z;WU3G$.K
M/MD3^J8*301]I;+16GWYHYO+)(ULV'=%9K!*3V8RS76$YPW'"=GXNZ@F75D[
M>';\\)-R)GPOAO?OL[ 3/V(K>9F<4EQDO)W7\TT9,EQ3(FM-:7@;W"MN.K53
M0R#!9&:.+"<#T\Q1)"V<'S5Z[+9W?L: FJK9WBR<1*, ]=HQ!BJBE_M_2+"]
M;@V^$+4*J^$RGAC;ZOYF^OTV2L1BETC%JZ5^+0VIG.H)A#7K7ZX[D_KG.TG3
M32WXG3N)!L_2#\Y(,#,9\5;C*$^]I]I4?MG>C5AO@PRK+F]B@M8ADYD7(DX!
ML$0@6TU4G#!T;F[)9.U$V[3KO8[ZAU*YH)B@!N"!.F<D?;!ZS-PJ[VP[*!R)
M,^=)9'-TIQYA6)1(\%$8FD5;9GEHS*$^][[J&JQ$;<>WM2+;8JOA.7W8$K\M
MK!UEC@+(Y(1U?@8XQPJV#WG:,O;^/IZ;U"D'")-\&P5O.6HX1K+TW-_A/L1?
MO?TWM /";AR\>&]OUIJ)+Y?WC"1:2W*>^,O/-SK@'=_M87*5CEBLJ*@-^'?I
M%Z28/G\4D*>S4&F\9SV<."-IRWC651D$K<A,R)*9'Y<FE[A?/6;K'KL@/CWV
M2PISFZSM?=O[1.8U613KER+V[I+S(]#.LV>X,]<@&YGOS&[O5X-#<%<N#>&"
ME@4Q5X^QI.]340"SE<0&Q$0W4<+ONSI6.=\\C_F'(V> +0K@M,UM70$/8B>?
M>EJ, J1$!_ZIGU(E[]-?K_7<OKS(K/#9].BHJ5QU:[$[OM?Y/-/?JO3+6\O"
M8OR<5I&O=:(0>$@JI6/6M"RQ)T*/4WW/B4X.6J88OYU7]'WOB3URWZYN)6;W
M3:.G_LM[D.%S6801<&,_9]N^F4S<6H&3553GQZ#2P)>R_FT+_3"W- =UJ7RU
M&)(>NR'LZCP5&BCY&XZT(&5,ZFT);"76T;(&92X5:@FH^0!4+>[N]4\<>&20
M0AN<=3U=;2/J"ZSCXI>22DG9&W>.\J3^(J4O7ZWMBK-^:_K^M"T$@HT]$YFL
M6]OE>]ODP(0OLL<1QE/KX]F172?J#\/XA+SS.$7X.(GGA@ /208GX*D0D*T5
M::W7_/UL"J;0O21P$H,E<WUK4;!8WV,P=R)2GA-3/E2B].M=E^"*9&IFK8OC
M[IP%%5^W']-]IU_PKD[Q<"+RVC,_G\B^WG_#?A7'RIUQ5]Y+E7[BB>CEE;">
M\_VX,,>IZ$OAK0$;F]I!J6$\\=;W$5HR>M]0 %ZM<,L9'-V8"K<#^-/?+_ H
M;'QF3N:((Y2=MS37(L I'0$&$"C4_J\F;12KK:K6FA4O75Q3>!Q=!OA9O B\
M(Y+L*9.G2\;5$NDE]JO?BP*9:*UV\1AR6GJM"0'L:)_9% ?1!TJIUD:^!ZET
M ]QN@&M:\HW-D4YN*W_VXG($)KE\J^FQ5?LG^MH4QBT;W$^'5,!1:0(*HY#+
M _G_)[O^+Z)KFFYK)>EE9L#@B?5T4O]G'B0)1'NEP(!9-<Y.%/_C3H8D)?8^
MQFSH\RP(1N-Q>5Y;C&&HUFH$@2JNM/ W)P@2^;*"J*DYABJ,F^5"X(F:4@_$
M?J[3@+TS*<&W\:E*!;]I+FV]Q^B2)4O#%LDY7/#((!^R(BL:GIBYU#+._YH)
MRWQ*Q7-@31HV)I0I/WNK1=^E>3;9X^U-W%_Y"[M;1>(0_6$5T04>)8$=)V>0
MRI7%[M UDS%\>+,EG.3ZQIJRAN3FD*U\/;V[M1H!K(!=VVRM\.%JJDPS2&6%
M8N*JSH[M?,G/#]M2K>$OHE7%/2HQ+E]V;5S8X"52P,&H)!06E<0%9R'<T&>>
M# M6>H_>6)DT]DP-K8D]_[$[UO\\=R1V_XDTX,CY'/B[K_=V0UR^^;+3I%W
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M8^2O0R1%4N9)=FM)+,%.*F^T+3$1+&0%!>@#RZV?31E0=^[5'[Q[P+Q<?XA
M*"';4@T0T,.'S7=WZU/8MP1\P4AEGE/XJ",*\#6==P8%8#R%G,D8_0#-J/W(
M W+S[ ^67-[6+4AE;"&?V>Z#6RO;=)0V$ZF/(T$7,AX6R$.RO@)_*_1+/#!2
MY\L\D\&.P(5VSD?("456CF+@]WJ=3 :H%*7%(S*R44<'=T46;-XJ85NWAOK?
MB?1'?WYAB'_)>XXO--)TN7]D% 1G!<N48.\0K"I+H@W"##24Y<8MX[*^-H@K
M.>,XN;//%(CE]/7BS1ZT!^5$&K@?B?)3ID6QZI/$PB93,NM0@-A<'=^6H*,A
M0:ME<5 (9?)/@@N6F'GB >+^\7QK^@N?U1.#T]9.Z^EO1'T6/"9JUJ>>T'F#
MIZGV5H2=MSIQX%-5L8TZ1]@0QOVM!_>/DW@['Z$A]H."Q=1[SG=P#U5%7WJW
M@)]P4+2R-'FEFKSH["9A,T;(7JS=!P!W,]=]),L[NP2PYS,,\22,@>3#^^_4
M]T)OEA^F\-]SG'R/ZBDVQ3^[,'):/Y^>ZHB"BSI#J;&"[4_YDU^L4D39*DX4
MZ;QZWA;_.'4]7>Q.YT*QLYU(<J,AQ+ML[Y[$X\./D_0&OW5O!_"5,BW^?;=O
M<+X:[T7$OG$TR=BOX\7-*3%:'K&74O/WK\>#TM"0)-AWR*G&MM;0C9=5"'45
M%$!+4D+Z1F5!LM?9QZ>_$;C1(*0>/ H*)@:%DZ8$O&V$<BP'E_ R2O$@-X;>
M%)04E$5R3!O5O ._%!1VP-D)$O?G2F .U+.7M0#'N*_RU5!! F6_#^?,,+/:
M#2O+<WY\1@.,(3=*;/.9D#XN_R5K,R5KQ$W(9R#M%/T\:9NIA,E<2Y/)GXE1
MC?OFU[N$16"$SNFMC8=ERTGA&G?<Q,F*(:<LC),G*7=DJG?\5,1/W4FIQ(T(
MS"'Y*M/QAJZ2:_DP!,W^M3"IW=R'??H))-YV_T1&^U%ER_CQ[&F G5:9S9MG
M<:JWX$ \ANM'?C^'*<EDB@[-O-0U2--[MVHU+>_D*JC?B<G&]F[OTVL7,3$>
MQI@$N9E\5);*CXB/CXL>$GVZ=BYCKK\Z8O.\!E*6I^C_$I/RC/)Z2M8JZ91:
M*]O$R5E#4IE82_/1&YR_;"SLR<&P=?"_U[7LGZXQ@"[G]WP<"QQOQ\H.OA;P
M\>Y@U<'U+M.*L@M'>D6QBDNPM+OYI7%*BR6E"PP;@][A%L\SO\E' 6R%.J*\
M(RI.X]OPU$)%F73G J$,3I'H,_,#9D0/%S<=-G+I/*/IL="XX.:8>&/-N+ R
M#WF)QL><&DQU!=HE\K#3/SH*+]PM5J"AI=M1Y85[BBZM"UUVF>:=2<% R.O4
M;[92OX98T)JI?V2:N2Q*'@SR ]FV31X"F?_JJ5 N(Z])'YHI! F5*S.-JYOO
MYPQS'WY?"1Z/[V&@"]K;K/U(H*GBF#\>O:+GO7K!2JO P6X[9V/E.U/>47XD
MX'Q4BJ9ITR4<12#D-3M^[WJ_^HKGM+WLJX5K0TV8278SEE74S[/"\?,[[$RQ
ML16D52:IPX[1Z$8KIZ7LP3R;F*VR\>_KI\*)V0.J"C\M &O)[E\^BQAF'U::
M\TIQDHK2#^K%_>&Y2<G+?<=&[WUWATL\VA4RCK/<RDSLYUJO&'=S0PK3,<H;
M+\<WU?>G&%I3T:/BHLL)M_NV71H@,C^(.?"=)F(.R<H"K1T]F36%G(]AEV;G
MVLTH@)0R^':+_0(%4/,@.^ZX<:@X>,C8>+X;EVP<,/UP'R)X&Z# UY5UVBC@
M6]SH3Y.J4MN"<"A=!I^Q[D0.I4;+AW4I'I4!>!\_8K%Y$E5U/3?J:FC!A2>)
MS. U./.;V++9C:AU(REG.R[ &&/<C$7R]X/8OAN8M%-<B2+U[H\6@>0,ARX%
MBXB7!\N7*G[@1F5'6CJ&&=:I7'8:.6),Y8JXD&'!$M5:4=*RCFUA.1AR*WE!
MGM6PX4]YO5<(0>^?:$3+H%$I$ECU]61I;Y-H")#OA9-7!2R^%!>3D\0B">DE
MKSXKGN$>//(96GMH;'70V:IR?>*RO>+.H\1M;?2MNI>8CM_#+0ZSN#AGQDF<
MA(EU\-%V;&RJ_JQMS:\&V  .T8 ]_4AL3^RN@L=>)?LEZRG/:OO)!K,L,SSC
M>4Z=&OKSG"8ET9YSFE3B6_O[EMKV/'N]V-6XYI>U\]B_*[NMQ2H":%/%3"43
MKP:C^F18G,\%]VTQ0XF9L(S&D+O]]9;U56]W!RS>*U-?7)@"3RG/BXL.W[;G
M(#KD1SQXR8^U276Y7.!:-ABO=?PB.9&PK: 8"5YX8P/LA<4&>ZKMUTWV6[*G
MA! F+'4@@4R<ZM59]YTR0_03I6OZ'Q!I7II,MP-[1]J5")8RO879Y%":V%WI
M0_ZRKU^6W\IZ.FEN1GS,,\]64K4#8*%-CS=X:/ROZ4ST*8:$CT"?5UU24O%G
M$"%E0-=C;\GV (4Z<3N/$F \"C L^]7EV>!I1U 4:<U-68;,2-" B389CP*X
ME$2>1TY>Y<=9*:R&NYZ5SX*. P6@1^3S+!:LV\VRZ#YN,PG_4RE'^*S]_H G
MTFZ( K08N,KJ&\Y[UY@W-'.;!6PT)J$ $DFAXP/F1CV,M'?9[?-UK@I=*UJL
MI6WOM?2JF^WJZ;""Z%EEKE1Z#H?JDUY*'9I&BM/2?*PDY7AO%#WG6G6BQ#+!
M/Q#.1"POB@*8#01$VXE[=)7/F[<LL%',7= 'F8\2DQ%\]HH:H6#ZE17V6HKR
M^O,#]?U8:U0I3X3"U.J"!]N2C(QF,:S"RMZ4KE]#Z?:;$KG)1S&!'<99C#PI
MHR(LA9)$>8;JBH=C\83C]RE/>:YI!D*R8SJG_#5$$4P=88)[:W*(H9/[>DMK
M6VJ=8Z;''+)OI963<JLTSL4_:,C.U;O\1 LV10'>=\9Y)S!92-S)!X84:TCT
M7(\2W=AT1<&LAL<3GJ[81P-^G _"K.L]+>JLG>BH.;%[V>=1 &(T%5BE:(4Q
MXJ<C+_LC_]_:?:)/6(E^@2ZC$^. U?V+D^R#QA=:*="T#(.W>O&#ZA\2*M]"
M2B$M[IJ EKP$=0OR,D K.P_ DUSLN4Z1U Q3Y/,L@/!/!@S%G=F9QBEB4]>8
MA=GTA=;J#4A/;/?(U>>6_DW>@8I5A$6#K;J-1*]JR^,5/JA]_?D=Z2&5VC9)
M!O]WD9<]%.KW3UA$WI;/I[NTI^18?9\!/0+B'!Y\*@<MJQ2C)SSD[;)99M?7
MQ+VEOC:E>.PD_"5_N@A;""UJJ%W35=.7H6P4O*3A2F0^N47-:UG>.C^#0<T=
M=: 45RF5$_KS0<2(3N>L3&3&2&]YS4F[//SQG6!?P,/&,_J'(^]T<%O]C6+,
M5<>I!U%D43F1$MRG+ OM\H&*^2<\%><0.P#XYJ[TF,F>W"IB)3GE8V1K@ _[
MZBSMU@-'F1KEA"A3AIBH) Y&C-%XT[3+WO&\6Q'$11SD_VY:V\/E!@>9'*6%
M/JP_?+'.;&'.L@41SSZW >E!!?M#5560,1I"I%*4_BEOB@^RPS(R,.<8/ONS
MXU)EU924?"O)L@,04G2-]$8H2%\*R3#XOR<0 7Q&^X;Q3W>%GW821PS]LJAQ
MNR.+Y\/"(KB*F7O[BD4BF2 QIFLKYN2 ^I-E7@#T&0;<:::*]N<T52FV!"!J
M;P*<<;LW(9 AF0F:2M>(+8'<'9;P4'">O,HYDEQAY1@W'#NVI8?2=K0A/C3L
MZO5-*#.7!E+X6S#N[)1DZ#TYA6,8K9*J]:V;4-O-S$TD;H)[<]JD!=U2SO?)
MQE& =Z<AK=\3BP^.7/BM(+6?>9\:H!>J_T#.LGHI<O]"@X:6NS";&DJO-C:U
MCE80[H0@4R20'5^_P^^N<#IAS/&\>!K+6\J"FQ!SM^DA1D4*BL_37)L>3R]1
M@*'<+38MS<W#5DZKP6OPADY&2CT;&J')@-$A><(V[N,P-\+/[QR';5U=S879
M'V<>Y%(C/QQ,2/Q1(-W#&D97$2L82"+^QN/SW$1@U5:4R.YO)!CQT3GNV.9P
M):GQ^HV*G36)[MD=A" EI9;$78^R2O_ELG1'M*OUJ=SA0WV9]6&.!/CV8G!"
MS Y1H"6%/76"U^?5IFD4Y^-! ER&3P_GW+2"XBK=-Q?SEG2V*EQ-WIL^XE\*
M.ZY7EOP=DI)0DIDAVOZYNKZ"300ROB;[S+<QR'S\RDFJLU$9>#LNPCI_4MRV
M3+*DIZT *MS\A0+4?BI% 4B!F3%FJ[[H'5K6:,SS3KN>S&#<NA_",^79JRVS
MOHRO^$MR"E" 23FT\7GY,N^PLH>>Q4ISPAW53$:"K<(EO8\H +\SZ4E&KZ/Z
MK/(<KE0N?Y9;01&<Q68<;H&Q,VFSLHSG];7YL4"_Z4E[(:?T!HZ-=;N6GR&,
M7DJ[R)"_K,S::@%X<*1BT;2\C@)\87'P'>750 $B8V><FX^($.\0R=:"!%P4
M7!SB&5RG:F/\<EV"5[7B*O)<==>O^0>QSJ2^.)EL<]1$#_U\P.2%%<=]>/N-
M\AR#\DH+O_P%QD<UOR(3FM?>HL3DKP3 VRC 0$2T$:E5BP!%$&8H^X2J34I9
M/26-9HRD%JTXZ\#]K2_ZW0N,4S[9KYW(N3F\2YP27L34$]!X=M_\B>_[H_Y[
M _M6]%M]LW@,A+1LY<7^T#%XU_VBUD827TMP;6SM\+4:AO,QIJ$A_AGQ.:YA
M<D033;HD5-JJL:I]KPXA/EC"4NT[RO<,>*TH/1/:X+W3G&NK2.MI%>8^"GB,
M HP]#3CZ0_U"3Q^Z+QNW$QU"]VM:U_0R&\U(#*RNH8/U!TFDJZ;I)K'4RI&8
M+\EFISY]Q0PGA9C5(#SKC^),?O3:W^[F!5_@8PI_8@ )!]POGV:R7SHKG0BG
M4",#+#15SS>74B3*'5[$]__B9[SU8C.RVRZV6\!2 /,E5D2+B8=U3\C&%B>/
M3QKZ/W8W-GH@D(9Q9&P*J'+(#(5]J'U=(CPEA5Y4,M1GW2<>M,:;(/$KSWSL
MR$<F*Q;^JDR@$)1 [^M"O[3=.-!W3;B61!.^_-T7?ZCF0Q/[9O$V!<\]QZR:
M"C\*4 0"VV?<G'2L-LQ:7^MV7@D8 :VJQA%JG[T]!BB4$'6GK=<TG8Q&..-0
MG[QMK]R/  3Y1-0&=)[?$>[J90NUK:NL6%9V,=TIG'X[ZH(1Q?R\J9H.2SO'
M*$;L13;D63[X]LBG8^/A=*5\VKTD5/ QR)^DN' 4JGF_+R*<;@)D0& ,MQ47
M2 1#=XG/;8HI,:*^.N&$43PN_G*O1V'^+]+B3Y;_3HORF/^<%O^#S9<I>@_G
M2GT7H3=9ZPB@I2W_)SUV\68[_.9,X'Q2BEOZQF?I6FK&QQ#L^CF!]+&%I?(=
M"/4A:<W\<3;!_1W]*MRG.PFONZ,Q:,/K^R3--^\4OVQX^)6$)Q%<_]YR3<(R
MO?+IP2%+>/C%NQLKCD5^CM/K>>E8@G#<F[=OB[YA9]7<>4?!QEUX=<ADC-+=
M?'(F.]=RIS.3,8HTDH2/O1K;U,KGK'CI.K/?&M/<Y:U1HF\'@DSYWZZ&WA<(
M)#XR+3Y,/ZA%/ H4#&2H^:B7'&TCK2:UP^WTLO])*C60IV8!0L-:NR; '*XG
M3D,_:\'D.UX&HA42O>^Z45\M"[5NV7T1/_[5KWP'#@ I88\DZL(]7G?TWQZO
M"4G1)5;=M;H>M[S!U.+D-%SJ)'OAC6]\@'4+LSTCH$$!@IOQK':].]VS&IHB
M!G^WU'4BNBUL=V:(1X173]-*57Q-!&4^#.;JBB%M)"M M_-2Z;$+.H?EM3A[
ML*<G*P*@]X'O]!IK:HV(YSCMR7[1J650.[IMJTL\#E)^1C%_0FK2 <T@'[&@
MNN,/RO?J=0,F9>\G&N^2GNBD]E=EZ+BSK^+56!;& LR[[U@PA8U*!0\Z=[L7
M$$Y*FZV9%ENM&"0I5*D.QZ<4R\-/E(QHZC9\@V:;*3V4^=D':<?15\ =G@+6
MCAK5T;_6E-KU057 ",GERK+X'>QV[H>@I,8DPITG:"DDXD*,/84P&ZMMP;>S
M%5=[(P91WIN,Q2XNR*R<%6X25>N7\];UL7,_@62*JN_#JK]1[2:XSSA"?R\!
MU^#,#@M,9H%AV%=2B*W"8N8S%*#AN8_>7PN_MNJRG'#HX''APR/;R92ZIW[Z
M*0?Z[ E X?";JDIET#];G.AZ&^M"MN<W9JJV%#VCM/@TLH2DSV0+<M]"BL2;
M"K(+9LJI4RL::0U#7E]*_1BO;0].K&B.M']2,X.D^_#)0%U8;*?G#)#AK[LW
MAG!]NY@Z^DND-#HF?)@3!7C.ZN"M0""AZ9=17PD7NT#4^,B;I=ZV?TIUK3R?
ME6=;67@#+; TK].EE;?ZUNFMKWI)72359>+_H5NX+7>'3:9^1Q,:H#LBL/LE
ML]HWT$>,?B1-)=UG%]'8A(CAP\5[F9/2:UF^Q-B5]V$.!> ,_)VE"ED]3]UT
M-?%*79&(M58AHQOM4Y6DV%UOYC>U9!+YVO?FR<3</,=K=<R5U\_KQO&_ I?3
MYL?4VXK)3?AWOBP^S]B%9_!K[+K!'WF CQOK=:*:>4D^4Q"TD,@[0;VX+J?:
MN-M!F!^Z#+/\7=3V?:/TK,Z7S<7K^1&OJ1*, R^7(6TL<+*T\Q_NI?3/&P&Q
M.32J0912$81'"JR7&!QZCBQ]5@F5Y)CO0X3P?;^GQ.YZ['?2.%"L#A#Z3_WB
MM^.0F>$8Z3X74-38?D+@QD#^2GC @_@_0C=_ZS&-&[C/# J0@PWIY/)@KDOZ
MXFGDZE*W6M[ ='%-Q;/2Q#("QPBJ)*7)XS:<#OU4@5_+6!2#B0U6K&Z! ^Z+
M9XE"H;Z7JM R>A?%>Y_#T4025:_H(5@#S\M@.A)Q)*VH7P))T)@),Q>'[%,\
M((L37MO104[V6YP/K)2VGYQFX,Z[!/OCON]!D?69=$AV6^M@_T+M],/OD%B?
MKR0.,=6IK VXAG$A4P2:VP-*XUH24=LB$8K$J2+.EGU+\AZUSR/;SV+;8+N(
MV]3YUF![TZ(JOHJ*)2X][V551)!QUVCPT/7,B\@*)#,9$D?DDI5I9G&60%F1
M)5^F,DWQ.O_#?I'7DT/!1G.O.#C]93]O:&G?L?[8R"Y/E*0O09@F?657MPJ8
MU/0[)Q.7HJJR$?NDR!PO73GA9 Y7@J,($>PZGX ;NB%4_[_Q5LSS152L([4-
M[B4;01A[2(72/;BS*\4R]._AB. ?P'_*P4S@4473DEY]#2^&P6FXKI9U<]-^
M!J0& R!H(Z0X,]T>&E:0H@@1I]PA%T4!'G5:K>PN[LDFO2G-+A+NR+KS?R^9
M)(3G^*K+:I3084$_"T*L(<NX*=C->&%"R5$U0(DS5P*DZ1 Z.8U838Q=:(VA
MJ"5^&_NVCI?_HV$ 8V3,0)@3$15_" HP.M-=E%3P^-$YE_)@8EOY2-6E>,F*
M>!!Y3?\>*3RJZEQE5PB3TN%FQ4:D%7;HX,G\39M3HS$E3BNG GLP&,/@UUJ)
M6N@54M> 0Z%_<,()VW3GX]'(JMF/2L?9:2U[M>L+7/MI 5(VX18-.CH:3";-
M +<]5BS7$U_J!X?TH4E?)7%3$6$N]"W@E"(GM'F3D_]AS7OM89KJ2" 6^3U"
M5EH3!3"B!AZ%@OP&CT"!Y]'=\G>(?I_:U'^O9TF&UQA<.OQV=,YA7E%:6FM1
MH)SIW!/C!7?^"R8&/&.H$4A;T,W)L.%A,87!3<-5M)#Z(O52;4&]*(B?:TQ(
M, ZX::GH\3R3Z4WFZJG#)FS=FB-;O3556;O'<55NH/N6NHC^-JEDQK)H=BXG
MU\Y6J)];7BZ9M;_%5<$D/T%B/KJLHG)DU,&WGF:6@'/PBLC4I:I9^&*2D!GS
M&XGRA_EM AS)"P#VXCRG,63+HYFE=S?#G4E!6]HDIM/"U @>.UMN!(JS-=KF
M*<!F55KRM,)I<7C3HCW2,3=P# T@>"DNPC+3V<,(+40$?<=_=2A56JFI.%1R
MBCU\REWGR/'"U;S[=<VS)YK80K3BS >E97D-B"(#L!59I3>NW$ Y#>L+@HB0
M8@,<8_[BG^GHW 4<'X^[[TN1BE^&TW2NYXY$=/K>IU;(\'[IK>!P4GU>)KIM
M1:EYX4T;4=Z^NF1ZVW.. A2$XZ  ;UQ0  S1U-,6%(!#>_Z7%5]P0FBZ-/#2
MA>'G0T?SAB*>_?U;N$$]1)K#&]AFF4 I^[*IKK4K(@ HL\EDE7RK<B>ZVPW]
MB4/0"#JZ,0UU?H,"@$O8$<9JY&BNV"9\I=;*4];3T:!U";[Q3#3T 3#V6R3.
M!$[3W5Y5@T.KS7%H6T--WY*Q=7\#<]47Z<\)1FJ/U?F3)4$0C!G$ZZ63A,:^
MZ%'\X#M<:A2@7WH?N^EB;:O6?]ZE\3U:S^CC:K]H$$EE,GJ>;?T#[E7]<GO\
M0JLHKE!^9V/%O-3HEGQK2VF5G_OL ?YT#T9I!D@0\:YER=I6WC2($;NT[Y_>
MCL@=[4QN9,U[4M?:_/W5(\:=<&QAS*V"<!<!AU/O?G!DW]3.C0)TI9DC6D4E
MK]ER::DM(,'HH;DP18LX.6D%(LM^EVD[S*+C)9Y49M_7)D^@I*JR#2 #W =+
M'9=7N"['D,G^Y2&)KC)($VD)3J9)@8!'8F<OO?B1NF[Z[;I@XYMV\E=;ZZ$;
ME=U?72<-(GI V&3QF26"01*<-GP%?I6Y8]!8.L'+QN8IFY1REPMELJ#$MSMD
MF!26A0_[D5P$Y&;OZGQ=F_A<NU=<Z[4J BD$O+AX]D)8=V@"'C; W47?'G3H
MFSS+<O\52=9V[W_;.VM XW)Z%@$//C<USXYW@5WV?,\?W%I3\+4T+*,K-+H[
MV-4(1 $4U:)I0FAVQBS;=D*=EWDM;K<LDU:\^F.NOGP4LE 4\;HY_B/.R3L#
M?($> 1L*?UB'_E8[J,1KTD^E+QX0)C3NRYP)J=.!%5I9W_(T>%I^JU5RX59P
M(*-](<GXN53IT[BP DE\XXDD >U'1FJY*48LLV%?EX;&1CSI39HT+#39>A_Y
MI>\>N*KWP9HZWC?&NPRV$?6=?BSX):MU_A\&A.7BW<4\ C64MOMS;>= 0YQ6
MD][UMK8N-BH"'"W2/.B&DW2$F9/(0\N[WJ*B#%Z>9AD9LT<;FKAOT'D-W L@
MI2:/LI!\TBZ(CQ71V$N:SLP.ZZLR4VM1+6O2[$5TS,XX] MZU[7HT$<D/FME
MH#(?9B\O*'9#JN&UZ7S6D#+NF0U9.O&*%K<I32V=).4LM[TE_54_$R4AF@@
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MNJI5 )$4EHLP\?:Q]'$CR<O(*<A1 #Q)7_JUC1BFU6RX+>+J)[.X4/LDB@
M?,::LVD225<'3>>Y+@=5>O,2M$AA"::@9*&OJV>>F^E$?2=-VFW'0H(/Q>V,
M!Z6-Z6[3[Q;[A.P,&5=TW8IMW9.E<6<(K9*F7C<5CK>MK4PZ2PT2GN-2&6Q>
M.U[:OA//VM*^2ER,^HJW7-Y2"[!E U@%X_,+SM&"?L4/WH-5NJ4P/!>PBV/_
MLPNX_[H M,8WS?:A-7C;#*G\[N$$UME(=1M\U]92>G8HOF[%;U;>A0)L@( P
MB?1$%. ';UOG3?RBS]1X_\7!S,;L/L*L]/K?R43*H(=Y6Q2 ]1V2>CDSX!(%
MH%>[O&]IC;*^MOE[B]$_@/\TX/.JCH[MJ7=SRI).)8%TVG)J,%#IQXAA:>Z%
M)!>WK*G*%5-WD*0R.1ES+C/#6_'\E02.LHEJ#0FLL@_^H%GXV0'A3J-HZ_*@
ME<,/&N5L:9Q M?A 3!2 ??.5A,=L[LY>[VC7>52U20_ORC;LO['WEF%Q_5N>
M;R4A(2%(2' -[B$X*2@($%P**]S="5*X)! @N$. X%)02.$0-(3@[E)(<'>W
MXN;?<^?.[>ZY]^F9.<\YZ3Z\J1>?M?=^:O_DN];/UGZTZ &_\?^6JR@W>A!E
MD@UGOE_LC0N5!@"D<AG>9HD&)\PD]I4=Z58WL':)<'I0TE,.V;.+*;JI'K',
M(FS,3Y'O.4(:<WY6%77T>0W=D+.(78N&,2D#-JZ;42;"XKL6EP.EY0H>D2[+
MZ"%U)48]'SHAY-1E]N^_7"8,5UE^#YLNL%$S_2*\*TSK\[N?;>XD7AOQ=#[@
M>GEX47HMU(R3^PC5ZMEX(UM+:O;K%K#(U6Q=UE94?%[Q@U=X&AO#\V"VT/"F
MK($WX;0]S]ALU[NY[H 3C2D&F93L-8.N44NA94G[5NI:#W4 W^RW)ACB%+01
M?EJ@<D7T8-S'%IE;O4>4/*R1%[;OEFJBHI_\'*AT)3^,^G<5XS\WNKT#&ZE_
M^M>:> D>/]8WT3&NAR][!$M$5895J&BZ5"!<M [%%V9H41E1II4[*O;J3VP!
MA=\RCA\$,PS>B_&@7M4SKEH1('9]VC&$QY)_6?8+GMWW)0HNV+6E,G>YVS=U
M^*#\:#:RGHZ)5T)%/J"U@RF!S$XH*67'PJ"QD8/E^4X.L:DEG0%QY]D7G?K2
MUAZ7 FN<!-V&V0$"8?NH0SP*7<>)M(OQK?0:)KZGV?*2<DK^D,"7_[(:#EXT
MTO*KW)SP3;#_J5\5$KH<:;3TN" _ GRL%% 2.$T=+R.=&L-+"8>PD>-_+[<N
M &SE11ON0=\,_&2PKK9Y@'K]_8"&FN/4P3>5L.MCMWY]4!6E0F&OMI_K:V%Q
M4IR QYE?_5>_#_^U)E[PN,[WO;EFP#\ZT/LG!W>CL#OPYX-!X;E4A@K/6T )
ME[=3(Y.8LHGQ59B$'F."S%=3;V -TH2)*$I-0_.SZ2B!1K(4;8,C/X/VHROA
M5[ITH^@L@?H_UMT*O2(/N6E>.N.MZ2E4K!4WR3>=6)4P1Z![<6)L1./$LOFT
M*T/@12)CL&\HX&F'N!WK'*'G#N:.$ M^=$Q$I+M84 &_QWG//2QQ.O?(G5DS
M-;&,3MKPE [JH@_Y/;:A2=L7?K1NM/)R51P$^K@X7UBTEL;C!"6 J^IO/%WK
M#L5_ENF)L >1;FA'D]X(ALCCQV_ ZK(K4]^FTJIGP.QWO7LJRSE63DL6^FV_
M5KXMTI1O3LAO5644#DA+EEIY<&-VZN!DB;^YGO1<'$6HV'-%A#NH;C_[RB58
M4%LZ-^#<.D3R=Q>>B_*_O@3>.%QW^BC;X#SD\=EJ/Z5_]=Q_V_64SI'3$LVJ
MRIM%:9E\TANS2OF#^[ [&OJW*]W*71XF4M&Y,HX'-RM5[-L/"M(3FPZ\^LJ&
M3),%*O%VOH41P-*]?$ACO#6J0$!AD,/UC,<5/=.&@&RQ*_U(@5%93\(T=' W
M61:9I/<$U0Y':SY5V=7P53F/J &;E606:BG$X"Q$$2&WT:Q53E-!"@V-9T7(
MDO64U)SQY5\-K!4=IU'O[- [T4&4:;47F@=+5:@Y4#Q20*:&2A40A!Y;@MI9
M)JY]J.9/75FEC$][7YE>V>>3'T[MGO,*>8]Y06U-]-O%7];@LYS1YH&"D<3&
MWDEWN%_[*;K+ BE? /OU4AP-J@TF@3/IE#FAL9I,XF::GY_ _]*/+]E]U>$Y
M];NG7%P<&'#X$]J4>UUGI4]),&._0]4,/L2\!:C&?@!L:3:G_8ZZZ2^>-/O6
MI4C4@8]ERZS-@] 7'0L22N25^A*CWI-PYF;GH.D:LC'DPJ ZL-.M6$DVY/E(
MY$'PVS']8^[%%SM']FF"%?WZWHUC@A?>QRZV*!J;GU1D#'&JQ&#X@<8M(%OM
M6A6K&0W%H'H=OLV^I)T<DR64.SGF/*8-S^O#6+82S_''0O/K4/TQH-IICR],
MDAWC1E2_2\@?H5F]OT"S28<F(3QO_;U3LL=O(M0C@":GJ<-38^[7_(WX<'IF
MM8&9(-JP0='+ZWV3/%'CAZ,G%:D\/#SX/"!R<D&\..<H<7E96?GG+61*WS.?
M\P\!5-\IWL__E^VV!TI?OM'&2//0+L=X;)!0_\Q4_6L;+B. "'#O.W;%%4+]
MCXI\__G W7Z<._"? RRP*H'QHOK(G,2X[?'*9/S$3:,TX^-F.$MIGXE_/BNU
MC!Y/$L,@\_?#N0]D28W<1RPQ6%RLSH# -0Y3;V;S;.8&PT]ME:(1[B8VUBIM
MRJNKMP 'O(R4YT\PWB*LUU(G+#)"%KK#+*/."\%O*2'"TR/YR"_>&2M-YH4Z
MDS_(DI.H'LV)SN7\4%&Z!2@0><'1WQ&6W0+BA$@<>-253YO$*'[)#"X(H!,D
MT1K]V!0.-AY/6A3G(UNB-WK,5W>YK(N8<R<D3-B<$<@TRO&M\H8([P1=9)08
M7L&076K3B%3^88&<Y_>]@H() U5Q+O+63DW\720/;P$7\N,H][6MY/"-T(^R
MO@1;=56S5M/2Z/)XAIQ9/]IW(I6,6VH-RE]-[$H,U2FZS;V@;'V]?PM8T@2?
M3RBJO[YZ\E?Z?]YFY0_JNME/"D\9;)J%MS>NU\'E&KT))'4PXL2.":-R53OJ
MPH[E MK,-/J7O$G4\6KOK)_9=&-]%FH?[$W$H.#%A/DSH5&6AOB/BD.MV<("
MF:*7H-PF4,9-M^77: Y'Y%CD3H=.S74I.TN3WL7U^\?<F028;!+OUCBZ:2X?
M=J@70S B;-OX>:_W05&[7K#J/7P^@H,R00TL;%\D?0+*&_/"<V;V%A"?SXJ
MB>/=Y[4G>(D>%:&X+DQ'3O2J&V5,?C'MK?)E<^=[BC89URJ&7/\FTOG%(HN5
MQ?V:&269="<Z8+&VQ?,&)7$W_[9LN3#OP--F&Y>=K .[)4[>D/CP[O+"B]=
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M&IXP:)QXJ$<T3GIJF_<D6&BS:_JWMDJJ:%A&&X>-0QY>)5>04,.33!WA &T
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MS>H<O@9U#V@+QHR8U*=[C"\LN74_+ECJ6+!,PHMZ4% (@WN&ABNH;^8\[3N
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M,_SACY@2C TGJF?OV,<T"P;11_6%;P&)ZN"=Y 8H>B?PIJ>.:^S([K<7;:H
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M6P"4-LSQF<"X2.LJR_A$(5HT6G2#C0[KY\[V-R3T%:'DK#F<Z>LB:-XBZ+/
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MM\?<XX.0D0*.CK2\C@XO,PG^Y (2HO6<H^': (O*7[Z+=5,4J5BI;Y " HW
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MH?8NB!/(_1.(6A]W[L(&LTW_.YK_KX:YK7O364%U! V'/\_D#O*<YMF<&,;
MX58-&;P/P(E,G[D Z1LAAD:*;VXP69@RID0VA5K7_0F0?.)._TKO \-EA>L/
M0WDQ=@_N0%R55;6T;@X7,G_<_#1T7M.\6^@%FB:,\6C<8_'2U1G^ 5$!1SU%
MGBL(G2W^=B#4NMJ>+"S\M7;]<\[<=\@';ST?,8P]T8(LS>%#T^Q'F(8(8L!;
MQ.82F 3XF.-*1IV6G!GZB\N3"(_B0_9I*=SY,[<?9(9):04>S9'SD H!=TY)
M<#\OG"?V(LCVG! #_$SL('-4C0_%^7G9WYN49X7.))80OQWF(.N"&R?DW[S
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M_JC#UN#U'S8V64C'Y,<)_RN0S+B+Y(@?B'-9$2"A?9:(8[]& (Y,9?[KJ75
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M[#8TDIS_TW6H+K)BV,&+\4:8#.U$>F.&XT;*] <HR]M!T&E A?GV)Q(@HSR
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M-SS^4@>Y>7TS_B]U"/!$*M<LX_@MR/A\^,%'S!Q\(O[%ZT.E>2N,$.)E(PE
MLY?"%G%" E2A:B:H(DX[I]L<IK.RYBV@2TF^#4[N9351,X2 =W92VZQIRA][
M5A^7P,7$TIMEZI1<U71-N<2JD;3'W8. &D9;Q[;==):_M&NO2BGMD "1),"#
M^HT^V6Z,E0#&^<U>UD!S?0J[U5K]$ 09!7L%?DP5"[M9][TS';=5BORH>R-9
M=,* 7XLS<81E1[G>1"^9"-D![SZNV_YQT8!J+@5F6@UL^)VCY@,T'C9*H]U<
M7%LJ[WDJUKY+#T[)%#" -K-%PK05.9X=?#)Z>4TN_6%L5(9X30+=?(Y;089,
M<ZZ%!?-PY;3%4=79XNVLYI8*NY-GFYVCKP\S?8/M_/T;Z/CE8ZU8*C(*(OQ>
MBM0E/7C!'0X+&;S5GT+51<A]@+6F5OI[7W2:@P>6!.@;W._O!Z8$. M,2\,?
M9D'GTP>+D1$N=LK/EL>J?R%I Q;X''^'//^M[J->P7<]?XHSOY>S*9[F'_U0
MGM339I8J(I-L<O;\2-Q;'&]0%.E)US@8F)[A9W]Y\F!LP-"<DZ;F%4S\U6!^
M*$=04!WJ[':+EY-/\-$<HVS+Y$)D7?-*ONCGOA5GKZ;%9N@2ZBFY_^09LL/>
MS)L\?Y#!,ZOU^.TVO:D*ORT/@?8(K2IK/-7COGZX9'5/V#R?8F))R&=V&>>F
M$"&0C'2SBG',4(;FQN3>4^CT5WSB<DAG?$U%@>:ECCP7,AY(<TX"3&_G.O[:
M:O-G_Y.-F4,1?("9<U9O'ZO3%T$'=I:B?]GP3TK*&YOP%2^F:&D.4M_]"15A
MLTE@L%J0OSR )X^GR5[ND7S>T0O]SYM[^6ABT4_#OL3<Z3FWZ-N/+9T\U+C
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M"W*UT\4_3&RA1GVGY(WQ,ZON^N1O0H*5)ZECJ32*EC&"2=G)GH+]<;?WN_
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MA_ ]O4"B$&W2Z"G(6',3.I3) )OU5ZJ64P@_9$UNF.F"B&#S"^SN_)9!-1Y
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MQ]E9(Q)/?JV3U5B@<%TYF5NAC1%3;8M>!\?-$QFB%_2D53VV[E!(5+>>0JB
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M"XOXI<$NUM+K^DR'0:YHAZU(C-A\%^(<"=+ ?:B:QWJ?[AZG32$BEG!O.+#
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M!L>/,8-+ KXCXO><D'I\"3YY4(9/62_"R70_T&W>L6=[^YZ72ISU^3ET!1G
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MPO;QAG)<.PQ1!.D.V8G?/QS^:%%0U^M"9-!/LP4M.KH(A/OS%11WV=U,M8I
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MV\\;6QMUK&>(P@&%YGLDCOEOB4CFOX;-<KXT=&_I;<OYBDC._8*ISOW&HA1
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MQ'>9Y:(ZS'7'/RTF,LW"5$WR\C$-H9KA)<[ NS1N/KH+1^?<]"\["+I\X0^
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M1@*DCFH@U;'0H-@=#JA._*C;9IW.MSO;+_IU0C\-TGX #UB2_O_E(I8S6P(
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M*_B,L1&%9B/52HL, "#(&P(N;L(VCE*5J\#*>3!;A5;$>_E!-8",L_'%!(_
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M'X.EZE26;LC005QDHR=)4'MW(T5+@NHU'[9Q\%,@1JD<_+SQE[,O1YU.=^.
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MP5<J9: 7SQ!<(5D/0'%J@'D) +HH &(4_2!3P D%O.,/6>.7EIB.5#@20"$
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MD>+ JJ"JS"13U"9NXZALPJ$Y LH<9B<M.>\:*=TTM)*MAH*$_P^E'J;!9+3
M->*/XE>>>W-FQ*I=?Y:GO$.P1O"\L2&4 BP+IC"5%-;U!D8&'[*9Z$0*4!P$
MYQJ/H3BMM:2(MC@,0]@=8_<X^<GF)/\?05($Z8R9K]L"UNUURR"_]S*4X[Y,
M^=<M_GFKQ6>$,Z9""F.Q,6J18$E)8&X0P_OCVP43(-4+-88+P#;Z:[>];X.U
M,808>6]*V4A7/!8T3Z\%SS5F 6)ZR=-?_'5OJ_-2]/G)%,9B0R0Y(+MF[O$@
M&"1ATGU+-XE)' ;+:D'J,/#2.<BCG%=]&J11?=@RJ$E5.K8,[FF+[_BX6$F,
MK<!PPQSD1H2;'!7$SARM-&)QTLQ#ML(4-'/W;1D47R;#M$2L8/TB7$$;F5@+
MG5V:POO1I_#Z%-X;I/#N^A1>G\+K8<0=I/"Z:@* @"X R*5ZFH]:I<7&GZL0
M5X,HRO#[*=9U(*79HH2>$FN0KP2LPE0AE.US1A#8=29I:!#00;^/[EN_Z+ZG
M:L8= V3B$V8D[B&L&*QA";I$,$6 ([.LC$!'.49D"\]%8P<]>3%/;R:#E(*6
MOV:V0@P:; &=#P3EX!R33=#.($%X\N&OG\Q)F1O"[(*V"@C.59^A69))2><#
MS)9HA1+^4GPT5T.V5:P=F*H!7 ._E/B1BK^D^,0PE8%)4,%SC($."XJ9KU+S
M0W@9X%I@)O02.:F.%"AG7*E5Y/TB()D$8\30=3Q)J:. IP%1.N"RU4"6-%6.
M'#^CIP8YJB6[G;+<7)HY)T#FE!I5O8&3%M!\&3JLJ:44D.1*R^C^;*0&%--@
MMY(/?9Q7KR?C:"*.!A;'Z91K/R<N@7QD:5H3Y5S^C$MW%KW25;B_#8[B,UZ3
M9Y!)#*8',S  $Z^P1[5SASMX7T61=?G>),QJ*]"4)'<Z\8A1)[!MUMSP_KPU
M]N<]937P27/*P4#*1<.N.+;;C91>:7 W14E5NNI#*0%,FI(IRX)2JY+J?<Q!
MQ-!+CK$B\8(BSV:I&O^ADX)XA0#PEO4KFE%:HF\ST#&64649Q7%BQA'E>9OH
M3CP\H)3S*G^HQ4'H9A:X07_\=/MP\M($X8@2=4D2"4T*.\:=QI=#D3_$O,F@
M4@_5B01H99-T=88NDZL]O'RJB"55N\DS&0^LB\7L!)X5XE$C5VB3Z9)Q*WI<
M(,Y;1C031C?'E2T\9D&40=R>\>.D=>(R7.?H&D=7F]2NMC@%E2^;F66\1"8!
MB]+<Z-B_4:&DX5UB6F+]2#K-B'@GI9:M!B_RO<A_H.">1)M<,\-0' 2*GFRG
MN,_7S*0W3D5P'JB8/" HMLY5B@P #,+U.YRS$*?\XA427UHV'D N"\$!-M]$
ML)5F5AJTG!!PK+H!U)#PNS1KJU"<>W6Q>$&"P-HB)NB>"G(AQ,R$(>2RQL%+
M)YU_VO -Y"144SG&DZJLZ-,!$ZD;M!MHE;()B'E3!L1%B8I77[JE*FMS+6&_
M^W94*&P,?X8.SJW>F( U51%ST#5(J-34C(&5RTQ1)MI8$DR#0L9N00/CW&#1
M6MHMK!:=,[&1=A-@3>Y"'<O; X_+\77+I/6X#].IF3D#=5,DAPAF9G?*"TXO
M.!]$<!YAV"Z50Y)C/N %6[F4F(?$!A:N]8,^F- :1%YJ,5D535D_@@2V+HRQ
MF,I<I9+D#<<;N^+&H G'H0+S(#\ Y0 MK+Q+UGVF8ZY@TC)Q7XF0XPDFX+!/
MHQGL25.9@#X(U8115\[!8=81BI%;.K6^@<QUT= D,324 %AHC'888B )^2)P
MF@/G"_P"\Q?QT&,U)"'B/+_"<;;4@!-V:CP/SEF?2AU$5Z)&1&BX."JY*MAE
MDZ/E&//&;6,"S2F?M,KMH@ES"()LY'>UT"F#664 +>-<+=.%J&;MPUG;UDH4
MPS1L8NB@5N_ I82%E9+G"*!-SCX8O:;YR@SWJ8SC)9/,0.E72X2O+25#WT3*
MR"!O(+N8D#6IFM(?A9U4)K63W\9Y<D8@G<HDS$"##!U_):N*!43#92&J0_X(
MT]I2:6*SV PC8/[5+4U!KD['T61Q4N5#FL<$4PGZ>E06T\DJ>]+A+(H>8>U-
MY%Q5_@RJLWY.YD'6Q&F5IPRLG[WV\]KOH:H:,AIEUVN)Q9C5ZP+<.2@CZ:LP
M\'X8ZS[RTD@F(&X2%#-<-M<B;IXZP^"<"F:9Z+',."<R#.CY76/2&0YM!D0F
M(>%(H5C)K/11!^-R(M9]K9+&TXPD)F\M\J(YM, ,6+S8/&(I\OREMYZ<1WMV
MT_-7ZEUEV6A_?P$?87FNU;1]*)^WP,6XB#Z7O>O&P9<B!77!LG+!8<M[-:32
M<92\F97\X</S[OM</3(;85DVUS]DHOY3(4^2<.&(2OS)<)3H6 ]GK"Y',IZX
M1C2?L)SK^-Q%C%A+A_+R.+0L<2U,V(L ':V88Q[,JI0\/K8WVKZJK\6!I/4I
M5QIYA GV*OR!-4$G $^&"467)@B/<>AB; ((C93A-'T U321"H#-Q2H.5#HF
MSTF"*V _]H,$*\("T/^QU&\: 0JI:LDZQCSA3(Y2P&EG$RZ;5R03=#[C1B(V
MBO2$L5;-&<#^(A+8\XZ06LC<XKW#+&2+B"WBZF.>XSRNXAV]D&%5<W%^8VD>
MKH'$@$VA?ZF<#1$,K[&LAUOX, L?9O&@E=/?+>02L,EC/<O,^0(50Z7^.$$:
MF08S.M2Q*0LTHBHYIG(FN4+Y3(5REVV"/E^443<E0D5I 3R-')C(?*K3'S6)
MQ++.Q#[(J!:78.18Q8I.B3R>T0(11V$$A*JL?9M24&..90,!W('=9UONP.@*
MON:*A]Z^>5C[ICEGZF&W0J/G2HSS:#C\.-1@SZC0C>4P'D%8=XR3CUKL_:FJ
M9)5\2RP2RX *7J48*R)K6*3E%L -;'7*01I4S@JL"I+Y9E$^TGS5D>:O?:2Y
MCS3WVM=KWW76OJ<YK/48Y^"@X:8&MIX%&P+E&OM.3*V%OD[,D&D(LM"L;8N3
MG-N'4 'L8-F9"-JE=D(O$AFDPF2DO@1.R/.83'X \$6$];KY"(D/ PU"?LMJ
M/S< H2R83Y%LR&,M;C"B*0083]@P9S9-\5@0^TI*V*DJAR$I, >1@J9S.;%1
MKI@1*".%!4_Q9?Y=*%.%,PA'I5>7/*H8LQ&3L0_ 9X %5$))?M7Z>8FU2^CL
MLC_CN5.P Q[^RQ0-!?A69;Y>RAH(G>=YI(%44@O^KUBH>;ZQV&1'Q]88X]0'
MJ87H9+>7E6J132X1#53"L_35L7>1^)1]HC"29.N"6JE0CQ3,!2C%$S)D2Z@!
M-U2ADVP.JHJ=/'N6)ED8Q%:Z#*B&:(-GV;;W?8<\,SY8+;]A&HS'A'_#8,+$
MJAQM?F;"RJ@3$(; E.DNUE],5 _KE5.$#?(D:* AJGVB[<J)UN+>:PJ_;8DH
MR#$J0)T'&'T7%EF.<3NFV86M%R%>R/:PW1+__-?1J\-/'U\"%<] @V)L'!I?
MZMPXKP<R8$^V;4)FWDM2^=U^H6(,R;!!T<SS&-R7R?C<%W;Q[/=00+K2#W^@
M]+*"6I=GC!H)2QN]8@L=$2N9TSENY^<@: <34F!J9)OOF;/VE.K!, #.5,S0
MG)S7I2/,MSBYK[HJ<6#2-!W//6"=L<33@PQ/2G-3WQMKJ=2/29>?Y;KQT.;T
MU@8F6AL,T4D6 G&YC3*1-MDO@D%C02)UD<4S0T]TK$F)IR-:=(DFH3/M+$Q!
M1W!X2&VF='1R;B+2^834'ANB]S9%.(B::%@I'&=8,G4DMU,P&D(FL/XAG^0:
M@GV).=^LB/CK(A]I6^R\\=KAK(]!@@:[811F1,?4Z":V'2)'9) -<BZ^=XZO
MCXWSJ$"+.5<WC8QP=9&#:O.LCI[Q3#DM)CF&R+]$CL,(Q*HJB],!P^2H.\?6
M$XVI2V#!N4?7UL[.< ]8#9.^=7O:F-M08(R"<X4EY.&V5]A?+@4SV$:!CU5&
M&44@3@*KW4OE;/*$#Q$8N\=2=%9-JU*6)^VG"N/0N:O?I"K'-@]^&S2[K-@V
MV?PE;C?W4D0@QA')<1^0!SY[RG&!@N(-R9@ND\JP SC0A4*P\UY^4#9(&$UW
MS&JZE)>N-J^:96./SEM5I0)[D%],N-X_GY'#LI9Q$!P"'',:M:%Y11'#',6I
MJDP2XHI@HB)*"P&BHV2V21!R 1YJQH7I;WG.;H6^Y-SP/"VHJ9<)#T@Y_K.9
MH%)_!S$L5,0M_RC?C(,FDZ%+@E;$X%\Q*#9M C!)SI@0,[HP 9E?LK-7+/>A
M6(Y FLM<5:2T/,*&VH0;8$!]P@61G4W/;U&\>RFO**H8Y&^&?>]4-I)1332$
MZ/FB:$*-5@( -Q \,DB7]AJ&<88+TA =36;)MNKG'"2V_ES*9/\[R/$L4JP'
MF/[H-!"K'"=#2X:I[F._4T>QE'J/C!3KDQN;<$A,Z$2U5S)TJ(LXLETQR;0P
MH Q5@IG9C).1</7E'ZS\?*C/5,[GZ&<%Q;</"DJ7O-+ R+4VW6PAI]ODH;J.
MMO7WT)XSX=3<H!G#$HA:_SB1%- *]E8L!3T:B#\P]U93A$4EMRM1U[*]&=QV
MT"%%.1@/C]G26MS#XA6 Y[#%2,$<8VTRD;DG-RIWXS)R8[:<2@YN48X6V9&D
MA(N)YCQ8F#R6K\!_<C)];6P%-39DC!;$'.?%H2;21%*9/#:G5 23M07F%*IU
MS1"MQ=MX"2CTL;5K'EM;2FU@5CQU28;Y:&D<K0^H\P%U=^.G^([)1W=?J<(2
MQ=V4JP#)5V5 8:BM*H.$J\9A305<IF1C_I6H)DB-Q& ,-P 9U/$@R'+;J>#R
M@J@4,S@%(T!B @593:A0RJ)'IF8-)E7!T,%P08+4X@CF16G)\")\<2WNV^8V
M5LF_9'+.JQ76/13YBW.\#+UASY6T:GZ8E8"SH9),RF)J>J]BK(X:S&CX\BY:
M(F!++#ZZ[)AWI)(?3L.(RA0U=81XL5G1XS1N9F?6XJ"]L_BAG<4^6N.:T1H:
MK;8,S#<275RI0;()X(B/7 9C5Q!RY3<Z.PE*U$^Q#9$IT9^!,*$.$R6.YC$^
M82]TD"7(SHT?.1'"R=K 3#*=+A([)?NB[$F5C7F@JN5E-$G6NL1^*WUBK3+K
MP9@6I<_">7]JM('JP()X=)X4B3F*<@1KS95*[G0N7,DF<T/2X4N7+L[,!?Q6
M!\D+E97/=$P?])(L:"./22RF=VNM5RW+^45-=9O9/P$U#2$3"I^Q$A^7[;W;
M2-X3WT?2-.]ATP3U6JNY1I@Z+?% +S5G^:Y[;U%-S[OS83G$5'-BS=OFN.4E
M1=>SG1,W+;W*F\H81009V;]###:P9RY@4$9<EX B^C6=]A2)4[#?-AM$7Q_9
M@9)F8/:?27]$*I/"_I.:I>TXD!T""SC9V51-*7M(45)X0NE5$<Q,P9-<A@T=
MFZ3!>FZ,5S](@6?32Z.D?3UN'R5]DRCI/1\E[:.D/>Y><]Q]@Y8\3Q%YNRYP
MMW0#07!6XGJ:6%"':4L,GNV9H3G3-:<<M@*CV[\$\$P@Q@#OK0F/YXF(:$ -
M<W5)6V0YE0#.<"((4A(J*-<6[V8F<BO+6XU*R@9GIF7UG#"8T/M:%P*?^K--
MD4O&, P\Z##99F2;ZA \2 6DN0]R8'$-8_'(M$IVX!*_954T4RUU"%"$<^4-
MH/E311N)"Q'80J2U8PECJ%3U*9#.T6%/2UROI<<KZ53 XP(]IF/MW)L8+X2\
M,+.?*Y[,KTJNG;W.?RV="A;LIIY^C%Z='CBP1FEY_ -<)_*I%O\N\&3$G"%/
M) SNOJ^Y>&O)$F)A<3>5O=NYPH48$D\Q*LWZ0?76-3M_\(Z*FGW"A^U-- IV
MEI\1ED^N+X?WSCRXEG U0$,A/&$7^7M;^DL%QBSE(@L2?0]8^HPYMZKKP(%Z
M%5N:R;0%GON4YBM-K1825/, H\T'LR@K1]3ZQI=-0!<)LJHHZ.Q6)4%G5R\(
M.K/Q41SG!?2+1[A99D-9YJ1GU9:@+!54LUXC=E'%09&$&'>0 %$N>8.J')B5
M&]8%4;E5:OYNM^I893S;@C8?2@%>90VP+X/WK]KF3%R]'(:74P\@IV@ZNPWH
MNMWXV%YPHKL.HHM;@R#Y6XCU7661'I^E4HJOJ:+6"'VL]P5Z.%:V;B&%+OR1
MUX\YNLDN4PSA,15@Z/PFXW,:="1R0^-E1S5Z$U!F5HRK\R%X>I+(ZEB-0BMX
MO(1/F02=)]W=8<Y;/J6KUH:JM)?%T*H:S/"TK3TL#9++6D&S5E4PC612#>V\
M9K13+WXVT1,3Y_+6RP O U8C VKGNM=/?XO5#S")1K,,*TR+(=;A>Z':LMWB
MOVGT["6Q847($;K'T\Q>R1_MM9ZV/6VO@+:[6TW(1;&/%,%M3Y3F-)Y3X\T-
M_Q_K1-IZYGR(6%5UM]J-#?,R5-*D*C@5?^=\ <8/4X9*LF;$%/;%:1ATQJ.X
MW7* V:(:BTW-[#E-65T9SX3XP(=+2E%0"/6&2CF4U4GNL3D0IZ!UD ?ADF-*
MSRC&GA$](ZZ"$;D4&9DP*LTPD,CBS@#/#W/15WFH56*ZK928QY.?)[\581PF
M/*0O3.J)HI+D;.,**X,]S7F:6RG-$0@FL*!B#LP\5P$9T4$(ZM^$*QI+[[C
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MN6$TUS;)VN(#LF,+&RZ J:_&Y?9=+]E'Q"J4"35IX$[C96E1TV3"O,V@[/J
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M&F=NIC6N(3?QX?)5N*36?EA86MYKG8?Q%SZSSC['9=OI,E1VK",9,UW'6!"
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M[Q_/?/S"CZL2+Y-:]$DHHD'_J@B&C>B/#7\6E3GV'Y_NN/1^I!Q0UIWT.'B
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M>L6#$W772O .!L^&UP2A.2,ST5[Y:#FJQ:*^*'=Z&FGC>\/YAG9KLR@.9O2
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M)F#(8V"XC/2&3\A/K0N%':C;*>"')?P*-BBS\M)Z]*)/#' .R^(PQ4YJ^3=
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MO?)(PD>PIL$D-N5.I=$I;Z#D;DB8:._[>W58HX.""O'VTQU8$@_\",S,P^'
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M@7A'9O>QP*U%]E=UG?#W?1'2TI"#]@#?S07*@+W$+K5)?.VN2UYE)>BE9H-
M#!QO)N],##"'NL6BFMD;K0PK[_C<!CO\I=(P?;IQ_O<B8E)7C?O)WD7&]^/4
MS\5UL7?'T6I?!HA#7X09>2HQM/RE.:/-]"\Q(KR]8MGCL(XP-^S4E_+3F-='
MQ5=ETA+C?)09MY0,KX(Y766<<2)53,LT=^%]QZ%+LFE2ZL !)+-33-8<EM.2
M0BL(LN*+!9.6BA%)8^DD:7NL&HSW!$6$F<I1+N(_07##NRGVVW)J*0?HP<,4
M.[1RQVE>_(K'TH.CH]?MP^P2HEZ$NW!?"U-AT@50S!7^#NG9XUEGK=2S)DB!
M_,'K/QT\5 &AF3(7\'IX9\;_5UJ=[X-,W$BPV!#?I#F=A3*UU"9#65Z4U0S'
MC_/)WQVS0;^1RRUOBK7G.J^(1\FS6$TW1CSE3I7L=)UK3[6^41$CDD":SB=Y
MP4QWDF6MZ6"@1VI7\L(%$ZD^A\ND*FHTF+2[!.RQ1]VRDZUKI=;#J7-#.9H
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M'!V>-*#AV11':]XKM,Q_/3YZ1[]]M'V7O CI5NEW\MW+VKY)T03/T%F,4V1
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MZZ[F[YQ%R;ZSF=#B=J_5AU->(=K!']#'R1OT'*U[03&+Y0324HJ(DJ\*/BD
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MW8SZFC.:C!**<;A0F^/9<(^8AG9E<XAOFW7[PB66;]BO,1#4#WC2SX4G_6[
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M+_;LM+M+Q[+'0Q3I,?M"&W-G[O7Z*H%L2Z53YHW'5S0>$;<B!,.!%QYF@'E
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ML)S9P[5=&10_^G%=L_R?<4['M><ILXRNFDZ0A1\,CT5O,=#S#G#JSPZG_GZ
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MU8WN07YB/66O-E3.,M5F-Z/D#OL#DHNO$JCVQJ8U9MZUFF+)EUCEB.;V-LL
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MBO$/Z./-?HO12(8WO=&8;KC]"_Q,?H-;OJH,(G&:I7!STNHD3;S=KHEQ:B[
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M/T9JZ6UM6S[[)]I2C$Y6&,F-^2F0U5?"&498!8(7=QN(1<DARS@_9I-)]&.
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M_#O8(IO^UZE#_B- ['%@$S$-T%IUX".W.]=).==;A+1YK46K*CC<V:U2^H%
MHKOTV9B +I* KH$>DG@Z\50B/6Y47( $&ZK<)@'H T0MU=.*G+S L0M[';LN
M)<%I< EA6J">62$_P_=)DI,D7U.2+?;.9;"<9+/T6K"A=<E]SV/O:Y[VD(_
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M6'ETNG]6H*K*1_'X=]JZ8^+T1-B[@.2@J<\%0.*'. SHU2C1QUY5X]#Z=4$
MI3/Y8L+!>"Y+P#FDV1#;SJ8N[5L=,%T)FR*"C+@@F#@$NDR&C%'2^P ,)GGC
M[">F@^4=5"JC/(8;;'&+@K,+(D71([.>MM?ME/ &5HHT..K,);M,.LAI9X 1
M.JC@-*#3!&J7:WFTRE36G<4TS. ,#";+[<UH%#;3%H8)"#B4YX*5P-[-4,8*
MX:O,22U5^:@D6<K/F "9]POS<F4M"7(K P6U26.DL5OF6J"Z&F(TT62<CZ_<
M<1.T869J(21R@9<@;L.#;H18@FYS7 #Q8W>8$&+XBI?U%O";(OJ7L5YSVG2=
M@3C1_Z9ZEANO9]G;3O4L?])ZEI1EOT=9=E2TP@.5MI4:?E!LI=B]@TZ<ZN1Q
MXZV6>?%@:C:K)0A9\A9 4D:RVZPZYP0M)QI^)I@3.D['H"OKA]WZ\:9L(.@V
M%G+A=Q';6DHQWWJ*V2VZAZ/;U?=6H;":"IT/2T_KY4EI3K5UF^]2SKQV<\Y,
MYQ_9-+./1/B<([$SI:1T?6QJ0(UAGLUMWV*)>;AZ9A_=G0L?92A,BI4G<>Y6
M2VT#Z9XUVF'']^&Y#KR=G,2-@&ZI2+=78I Q/0)O@:+ECI5<Q("M#5>/<X"M
M=$OA:FSV)=T4<+Z>-M=*S5Z$=!IAX8IH?G.M[I:DY'%>LBLM$S6R_T$3!E?/
M=3\&Z^\TZ/1B;]&&<\H]3?_5Y\!O Y%WR 29'*K1^G%PF"R&+?5<.QX$H_1"
MZ6.S!NH+JH!<0R6/M>];UTHDYMW!$P+I<JMKKXX<@T;G3:96&@+KG,;%":%N
M9>I2"]ZS+K,WUYF[ATG,K&.]L1/(5O:B'BF0=WW;N+6UB8")2EF$[M>RIUB"
M@N&!-LP@B=&901=HP2S1R,YR)A$*!D1NG=D@>K'^UYY#+BS I\P-'@8#;@-Y
MQ8!CV#(0(HFT80/V2[OUM*S WZ<QS*:XS%?HOFNK#F0A^1MM[3IQ?K"-C!9H
M\5E _PEI&JH46"UA!%Q'Z+IDJWPWVOB2&TYV="WN+^V_;?4-/5WYIQE'P[<)
MBER$.4UNH^V*XU!9/B)U;G+7RR*2A7>'+;R#O$.*H5[2WI?V5=42#=&G$A#A
MUM!MPO#=+P-K'X$L4IA,F]AUY'"3MLX;E.*=&W<43;+IZGAC?9;\SE%P5]"$
MZ*I;M'G+7=5P[AI40VG[<!L&GX8219^."-0:GU*@MVU.9\+0\JHU$=R5E6FK
MC7>?"@ZDZ9<.NB^K-Q:,?H9T&FV"" H%6ZC/2\FB^? B*S6U 3Z:50"'TF@]
M9_Z">#T/E92P0]>[L;,M!"8>!K+P<:\'>%>SKM\\WJBBT.I71.7FB'=.C;=J
M<[<LOLDX/8M[.M.6XA;3GA>0,UMB-@L++EN%?'V4U O;D<.5J\7.0DQU8<B8
MU?7@RCA>/YXS9/S<:-JIJ0"2H /V2%HF:&J\94-9*D4C'<. _J"'L8WR:A+Q
M\WIA:BM:[85>C_;D#-??=F4>;:1YB0E>-VX,%YK]$^]:7*7'IC<HV; ;MMKT
M=Y77\Y!=7R/:!@G7R/OHL=G0OUI[&W)KP*"Z0OD;U^6K#05,#?U0O 9F51Z:
MV6*?((%F"W08N"4V:,S?Q.8Q&/[5 _.%-'%;/'<PT6A9*<AJQYU7!=&ASM&U
MQ2E&@NBN")L(\NIX^-D"#%.-%7D7Q1C:4U;AA""/OP3H#Z]0:*4*B;K,K;U^
MC;-Y38N.E+VD*M:[6<7ZP0-#4A'KO2UBY3*C(*_.?!^*R6F&M84!%DAQ.&%M
MX$C_=8 B=WY\MNF'"&TH2F'%;7-\&7T(06('$Z:AOSB&(H'->-Z=<SW4<EE:
M@.(D?*Z'1=@"2!O1<YVH53<'"4BE+K16'7NS^6*D7B,.@CBM%_NE8=UH=E;4
MI:^7"FI%I7JP40!F67A477)?;BT^+%07,*IA,XG==AIT&A%C642W/M<.Y$'(
M3C="#*USTFS["4^&W=PC<DRQGCIKB:[O*1#=!%$Z,[ G![^?D5\DFX">!I-,
MMCS>E./.I >894B#<9[O.P"$6D-CK<RXC5M3V]FXOKF<?S1VU @!+LCZL!W4
M%? 0S*@@X\:G?FR^AB31HF7<LJ#-0-[Y"J^V4WC=65^B1YGMTE"1O#%/B)DI
M#:B4@O<P4,^*IF]-4/"I[D4 R0IK-G,$E'/;M7VH"6NKO@*3L@T4=1LS4P>1
MR,MU6-S1G*?&FWLNI"PY$FLP_U:TLWKQH2'/]5V#6."B/D;>(=#"H_5Q0^2C
M0G:XN_C8370-72L-\<&D&=70J@\!JVW83;S)E\7,PLVT?22=>? O3_J<1+XS
MFN<9MG.P;JB#8@KID[9VGX6/]"RSFI4IPI1'N#@CL6%'*^N$8")A3\1N9=V=
MR0Y6'3XQC9ZE,AC! Q4QEE]I^H5-U_M<L;.TL,7Z=LJ$P$*IITC>'/C(KJKV
M$(\@<U_BZ--YDXQ1WU23@9\5@/2XP$P0?EH*ZFN&DVMQ7UR+OW&1RH$T-TK>
MQ?WU+@8036N7A-7-#I4L!.& 7'!$!(K.EY.*DIDV?=%Q!-05*R2S^-;,8N2I
M%?AI3=^P;[/VYO56\WIAD1;\3NPBLZE@RX;U]^U',KIL_PXP$W:\,O;;I<$9
M ]-KXL/BPZXR")\B--E,(IH*"QH/:E,8B4H'"$Z;\ 05&KZXXL7+("-M/8.+
M+VSVO6QA0@ )0'8S)U%M?MDV4I3?2'E,QXXQWE/  /+( .8!9,)9,>OSDF>:
M5K QBT&';*FR 8'G1WS#.=1IO5"^2@2UVS"A?D$G8VW_:3N>1BW&U&*;%2>L
MJC6WK@..VF;I),M<\3BK5@Q$6M)3Y)^ME64DGMEKLD(VO3C8+"6ND62P "^X
MSVH.^VRB*/TS-C)*B1:LETDP',-3Y0=2&6HG&!C*Z'<""U&HFJH@81.^"4D=
M@-]G!MX/NG,J,Z=M">O,WNA7PN(_B<*GC@*2DT@&IA4O7EB!AZ_$!+-1Y&$T
MV&TJ6UD?J<XU-I3JD@SJQ#*57AVJG3H/)*3VC2.U=Q)2.R&UD_=V5[VW0TD-
M\I%PD+>GV6MO4"1?[E[[<AX"(P6B-K1&JG?:]7E 3W<1%'(LZYN<N-LKHMQ@
MT35&#634^@F <Y&?5$6'2D3+=AUBHIB$7B7!##E-@7;2('U #P":&+)3X8,T
M[,TQIB?TWP(?Y=3D,X:D,"%/P^Z/$'VKV1W9U1/OJDW$L.V*EO_AG3F-R-N7
M8 SZE&/N,&$K,W4=1M>"Y;^9 ([B*@>DIU?D#$7 7_<HFA7;^Y@?*?W<M %R
MWFA\M3JY ENY\C7"(V8W#78\3<>T6()$@%R1*?HRT)L#ZQ3M5!LPM8.ZUJ9U
M2WZ&I>.6QHJ#AT;0OZ:@Z[TYME\YPI_W/E2?SNM[>UX?>-(45F T%-KE!?KC
M2B7X)TDQV]8>FJ#A. 8H'%#6'0!#8I9R7T(NI"5KD0)<5-75@X"Z99CL%)IG
MJ=^K!/2:#(';!CD$1IT3F% TAH'>F/IW*WM;.=O !T0!32YF!4T@8K._?<CV
M<30&?L&$R7(N[FUJ YK!"('\;#&?UCXY.CP04EAM'U-T;9AXU#Q]M\KZ:J8A
MS: MVKZ6K-&)V?D#?H%F.BS&J[BCN<8A)>,Z>D-E,,'])O);6X*J#$!!_MS/
M%JCT: ;09Y3-&XD+CLP:"N4X(+D^65NCUV.2&<^<+8REO< PWKS8MQSL=O[9
M>N. Z4P0*N!EX74&V@"X;YT%UUJ'NZ)>\*N)C5!>M(!V)/C[P8L/\6I>LI('
M[KF'BN"5^>35C"$"VF;<5A1R_[.YDOTZ0BNH.;84K4&DTJ[MJO@KFHFI0S'X
M):21YHUC!AE?VEB4I41MY/WH<2]>OGF_KW?XH%*NMB?$&\8O;+59O<3-FQ[8
M"5KOV<(#38:M>FBB3%.!TGLLLQ&]\"2TY"<V9CYRL6R91K=-Z!UJYX,R/U_C
M^K<O"L#+<(=$-&#\J4LT!;6"8-IB^6>^<<]Y!)\#%8I27V?'P/Y#H_45ZM,X
M+X'9@RS6.>H<%58$VUO]DY[4HI#$!<#5G@[;8(5]INP]9FC:4Y3L+G0"O9H[
M ?*U?:[O&[^&\\%H/_\'C?*EO-LD^_7@Y8<C$2F,8?"+WU[OOU31.<P]<"=8
M@6/:,W;RPU>2"K^^52ESUW/-#DHD<^ZDQK];0,L-EFBLD($K*)QHTQ)S4F4B
M8H;E0SIO#JNB:*;] O4L6A,PQ=_*";(7KALS?]PTW&C;Y_@"7AI)-BFV'A-C
ML6!#5AQ;,2R((\0Y658YZ6R/OG;<@)D@Q-T*"+6' RMCHTEPB98 >VH;6L0=
MO<_J:72ZBA[60@M).(VI^$/42!1,#:;W5<N-U/=)CFIJ+J5@^8W&X@4K:Q<H
MD %PIZY,!T].:C\G6H\N^:!E?PR$(JT9G>'<)H[]/:Z2]G1?:!UG7_"*(SA>
M>='R97WK[3/D3.A#_KVP0I1'$^U3Y1@T,S-,[XVDQ:)*W.!,EGYQRAD8-LZC
M9\0=,Q/_U^WUZ EKZ>.F%306@"TA0*&@1:=.N!/9XITYZQ,]<5CXA-H20#J<
ML2KJ<'RDP ;%<TTA %6PE8<Z V+V3[H[>TX,T_-55&=:.6YFTL?2\D4$[3."
MFC[O)&7[:\3]VC13H31SYN?BOGMXPFEQ+$WQL$M,=2),H;A]T.C16_2.R%/0
M!Y&9:_7+\<HJ*KMWAQ:&:\EIE%(LJ)KSOJ0<OJT%%EM\\D4;TN%[;7F;0A1]
M(T" " 9]";NHB8AR'6XAE25=@3I?!QBN7DWB+,5L?%9(,U1^=L!V&AYO@I6.
M1^QK)2V0V:%B+4R"82CA1"=]<CMXID!'F.JL:.K*TN,Z,@H+8F,K-S;BX7[,
M;?6)0"*4_M8+%0L=.4^58JR/#4E8DQ=\:G>.PUM03ODQ"!I@VUG+A;9?6\!
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MQ$U?5;YYU*:4L;R/SQB[MW9DZ&P^A#>S/W'7#E%DLJ!8L8]^1C@?"^O(MMV
M^? ]$IZD0WZPH[XHW&7' *L\ARHPI29H\>H,D=:[.!M5;&4-7P'78RWW1C90
M;CV@?=?1&+E/';OS#X/=>[P28&*$M.ZKL$3?3>&\S,]MQG<!%#B)9O2B/C05
M"*#[N9ILO3"SZYBX=4DKDD>[\H23/P.#36ADFX\8;KCWAE:E9T6S\R>+C:WF
M]XQG)K<^[H3M46>NVTR7^#5VGXX,#ECV8&)'NZ1\!L OT> F@-]G ?P>)8#?
MGQC@EQRR>^"0[=-9]> UX[M>Y1R]PK'SO5I,^Z]?.7LI>6VWGI^>&1>78OQ7
MA!\0ZJ^Z6BUJ26 O6]//[+]]M'A@ (BI,,^G,-0X#<VH%\/]Q)DE#%0($LJ;
MLS4)62F]K+!!1&JC1M;35N3B<T!2F4EH(J@MLNRF13/M%V<PD! CU%@:;+N-
MUC,]S8$MXX=R-R*$R$<>/E8@C2@]+81D#I;<3ZX+*X@;%L*+L^Q7IVAP+P>8
MW:54&A*W8P10D 2AY]J Y&?,$39LQ)>F-%-S/)&+5#S@2>B#:7RG-(\TF8A:
MA\T9@GR'&Y(/[#N;UY>'KX48M3>#OX+].I35*^.:L7EC'J=%FCG^W-727/R3
M"8NGHAX_3Z(LXK$^+A4YI@L#G.4JQ1KOU]'V'-7"EHXBG5ZW>GJ]'(?ZC)+Y
M,3FF1 (NP_,*Q2UG"6FZ.VX5IM0_0BNKD'4$L31M&E0;A[AQM-^S571<F#PO
MM)^9OUR@3U6KM(Z7_^('Y5JW2DP@S<*ES9[]N*ZG6>;@WRFGJ2]2RQ*!]56#
M 2MAB-&=A3N!CT9?=LA*SBH^U? ZI7R.Z70RUU*O%)(8"_CH;"AJ?';E# VJ
M*"^/0D@\Y(SCT,'1?&KRLCM-^O=+Z-_+.TM_-H-<9X_FI'AOU6VPAA_'$1'<
M[1&=E2W=FK+DOZ!KJFYRYOHAG5,+J?_08:")CNN()3S--+?"/E7\JR]FFM 8
M_'J=S"HH,F<K^8RYHAB#XKD] +O)D4V>F;,B=]##>0GG1__-B A9,_:/2J N
MVK"@'7;H*:^M@1O@">IXA@(3E]R=?]&_VGQN/AJSE()Y13RMI\%5]PE;G-0>
M?#2K=OWM1S18:D-X-]L0BO(ZT"XI%W8A3*?073Z%WIMV65<NF6)ARW.-3[0=
MK)GI1R@[3LBX#J[DC;?2?1R@\])W+Q:@CL+IF<%Z]$[0=.>PDLB"^B2=&$QK
M35V#A/&2])MGZA5#[Y<Z;[@&[3DSWM6-8_I5*)\J4,L\J+T>!,\6L7(<U[WV
M27$M981%+\#SI?;EMWY /^\Y_# O4)8A^+Z5R6G9&>6'M:6_[+&WPT@Z!E+A
M*)1,L)<X*X8+:;F,/*H+0DG1;]U,,FW%T]4GAC6<9+4[Z1@N%R'8PV/B$7R/
M!VHX^*5>D?VUJ?NEBPP+);RT^"F1(?>_WQO]O?WE!-@ 277W-L-9-)YU2^ '
MJ+_KC IOS5B3&>"' M&$$3(3#GSU6>PA/K*5%&X232VY4!4@IJ\-HT5Y'$?!
M1M[*WE;9ZWREV,M'$_[Y1/JBNE[;-5=0^I8*.>P9KB\,)^ @N&+?7N'FT;G%
M\3R[]40!*WXT&R^A#&M>>-^CP$,W^LA<T V!$."1=S6,%#1>*"H_TUK:NES6
M!=S1<UT,V&D.D8*[K(V8W%(WT</Y'4ZOM+B(-"<O)'=J.W,OT!:?_-,O6&#N
M[:"H:- 673KBK6S\A!B^F-7^@[49.R2"6XP?#5Q0^_N. *T>]Y'I/A'VWT9_
MY+'UC2'>+YWN'6^73HX%UWJCREL")!+/:6WL9^3\GBA2FB2"<<E<W,9)%K Q
MLWQ OH(;G0+@VWN+%H _+G $2.WMN-1)M:)K<H>2CS/M>*%T'E(%W3/YR,0U
M55'L]]1%T+4R/YXC'WN+9XGK\TW)O)%R'IP5YMRR>A25OR<G(VI17%+AA[M)
M.1D.! 21VDB3.S0>,'AVZ:8Y30FH$]B8P\0IV?.RS+GX$VF.]@)-6C=76+)+
MN23 9F+8CGNZMI%_>?6/^9W>Q"5-I/SP 6E93H$])?L3R9KP.V1QGJ)UT(6[
M_F'@T'V]C?]@Y\F&G;\;[_R=K9$DQ7$/%ON!:^+F]9N?^9!__$Q^HQ<IY]'N
M]O+3,YH4$K?54Y*@D@ZL!PSJXM_!ZMCTO\YLYS^:30?9^"G$_";NT%KS*R:L
MGC81X7 8FY[D6$)!STJ_:K37:&=-N,W;1L/I!7.R."VC%-0&4:JV+]C*]=VW
M=%\-"TM'D6Z6*#KLK+.1-OK9V)Y;I#VW!I5+.R[8<2167,2_UNV)G6\(H9IL
M_AC(I?22BPE1$Z<'A\N\+.Q:7NW 4=K&T ]$21=O9UO4Q+L)(W452?F@45H4
M&&!T<-#BHW6U_]R0<?I1&7S!<,(%7B[1S\0UR[(N.I^^LYW*N!7'>D\JBVWU
M$ *WV3WRI#">.H'YHDDM,%\TJ&Q00BH,/M)I-O-M9H6LD_U+R=951EA=/(^H
M-ME-VS]M_^MO?P%D"S1%(XJ>\$A"<F%)<Y2M<)8B/59S)ZX6$PY!W8#5&\'"
MI9GV4JEM>P[ZS>P)& #A8N7 5NRLYK(+R\)7<%^*>6G+?(-N?""!R[EA6.E:
MY\20)<]/1U^G?7+;^V0X9M3GW,?-4\R#&GQAT+&!'SW41DX^I;5TU'4@.YSE
M$SX0@#0;LP,#ZAOQMARB3PJ9(B&W)J:&^VL+A<Q=_4K@8 Z=VL22G(HH;KR(
MXG$JHOB3%E&D)/-]23+O.PR>>$9-75KKR09<I4X3(P<\3CC\Z1TUN25-ZQTS
M;Q /<8DD1>EI= =6W&]%.ZL7'Y#F\)2XI?!/''YX(>;<<T6@O #9+RHIM0HY
M2)]\ &FQHF\&]^6O)N$G]G[\C<1P3NGLMD$EA&*Y4+2V72!K2X5Y:H*70:FB
M]T'MG(GES"68P@CD>Y$ID0@'MIC%AQ-N_+/2%9W2_%G#6N<]9;:_1FYD@\WY
M*W?"\^%]%FB[(?:!V<VKR\3>=;;L$0" S-E>'[# 4#'N]I3;3UQX+O$%J?)
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M'<G WP6)# (?=69 (0FLYYB7!SPKQPF=G]>=%LUL ^\*NFW;)$]V9JI9W0Q
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M1B)T!(8)X.*7/O^(KNW(Z^FXF(0BF.-'3[ZCIW>GUE YZAJ#WHY[-W/CQEE
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MT:&EKG3\A'5MMG ^Q*=(W]U'#-*UAF!56ZGTSYLYN[5P5"K9K&]LUZO@823
MW2D*XC"B<2-VZQ(3-S9%O_WI\=;#>%8$!#$^*KR[MF_WG;+LWI!-K_OC3?V
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MYM)1)74)$HEP9>7'KE=4[N[OZ[>?/R6$&E<MBNNV\^3.R)3$(=7$*Z+1Y/Q
MP82"J9G@9#N/7E#,KO+%[&YB;0 H*%4A9"1S/ "19):E/&WZB9!]-%!"8@N8
MB J;D<<%W''H9TJF!>&KD3)(/#02N7%12C.(*WU.?3-(#N=E+N=6U**_B+ B
MJ:8)!J\X@PM7)I,Q4W4V)@4YM8NK/L.'CW^$"LW\O/NX%&_N8"P=6U3^B_^P
M2-!S<;RWE.=64JQ7BOO )!%NB_*R] [=@B@4FVU=D=].H""^3 00'?;98V88
M^N8DC+\E9W__7=#336WZ.H%%X+FN."^<9IJS12#J%-NN_%:V,BU_Z+G8W#'=
MN.+NS%L(/J$&YS2U$=.;,4U+IE,^":,SR\5L0;;08?^O[=,L9*T49'*U0-99
M%M?/?_1D&A0P:4?CN!*QG.PO9U2A*0]IIZ?RTO6'>':T@KC1F31)55^?!PLG
M#)0L7EIV0 )+WCB<Z?3.]%J<4!^[@2S_7.Q44<W0-4Y,#N 3I]@'[*M/?1-]
ML&)C'2:(EY3K9"$-+%.G6USBRJ-?"\-\8Y,QBB4A&F#?<[\ZPJP=FV; Q*-F
MN'8U6=;338MEAU(,;]AWLKHDZE(+^U]YP+DY^2;JAT:EKLTP=0+[_Q)"7SK*
MG1W>+@_RELPN^,!TA6-1YR=D3\/%@TCLY30@+Q-_)-<=Q.H;080LTKT(HK7!
MJ6G[\5K#C(>WGAP:ZALR;KG$E'V&&-_D&E1T=[L<2![U88?]36;BYU]3R;\.
M0<&,FZ+B.>%0M)XAQSTJU[JR2DG=0()*6$2F\;BXJ[R!"(4E!GE?77*^M)AX
M?+'T8/3OHBUZ=((2V[-2;,#ASCA?YUCGZPQPO@[.U\&,JUHSKM\7<HJ]HA=,
M:V:[-%_W<3)+N6KQX<'8>>JU48%>2A!9H3U2.,%R>G- 4%(H43G[X)G5&;K\
MF_AT$O%$RXKPJ>U<_?EE5FF[$2O2T0]?)F>AO/(6H9AX93\3L=]78DJUU="Z
MPZU)TR>RM9?:<*NQK0SX>.$X/%R#CK0;15+.4-?[OT:_6:W4KY.(^97Z@&;/
M) ALU[%=NE5Q%,VO23)/T?^GT"+_F:?GX&1<(!L1?AXLQ@5FFH0EXZ9>_ J3
MJY3)9;8-)']6T )E2H$YF8C%GV0Y915_85>PJ_WM:K((0L\22W+"HNBU/%0E
M.70+-@6;VM^FXH29F5P9A@G!A/8W(>(T-YARG]&CNY-[&!&,:'\C6I-+H?D#
MQ :#.F0:Z-MN)OG#=F2D:,J"6]/G43"'B: '#:4#$X.)/<+$9)I?>JPBIG4P
MH\>:D3V1E7NBT"O0"&;T"#.RQ.J2/5ZDF<XP(YC1_F;D\*_Q I.(^SBV/-X>
M4APF]7B32O??B?X6,ASH!%-Z[%K3(@@YCP\US^S<A#G!G!ZS2,#G9I("/66^
MS#D+Q;Y47YYC'V_SDHL',#&8V*-F=\'"%R(*Y@/S>43,-RY30#\E61[OC@W-
M'\1X IM@4["IO6W*DSNMLQDIWY=3/.SG*:?*C,BL=+U0[*Z:BZU8(KU:[@WY
M02,B-Y"(6BF)O%4BGX_FY3$D1,.89G)FMOO()$V1,HG!+*MD$ V"W$]C,G<Q
M&].XD)R,=_V+$8E37=E$5/812)Z;I9CX8%K90%;6^7P;SW?B/%NY)6E["B/W
MDZVN2?$4L:W0CW8MW5+'13<H[42>X":@8+:8!6+CCC2=I+"*'Q7.$34.?M%[
MBJJJXN9^T8:J?"V^?L]%:10OV@!$;XA-'R(QB>YYI96 C7EXQ[G+U(ZJ/9.V
MK'9ZZC/9BNE2Q\F:0-'Y[W%A'U'.QPSEKD9O02V(IYQ[-G66K+@2Q%TO@WO1
M;B;7E-NWX\>C+HQKN*P7$Q)=F;A2E,>\W!0E,AK,2501QG:7J:.B?E#RI:C0
M2WP;<+02'&W=$01<+O,&)$0J;"T;16$;43KYUFK$)5Y*6%NF$@ZSLE%NZ=I1
M52[R);+6R$-]+K8+)ZM;J[\UQ5KJV';3B29U^&UDVG3=9:L2LZ4KF4&:AX]J
M Q7?^_(NK2P1)?K*RHNB%@RVO)0&#85CL+K3)=J;N[7(P,H&%VPYJ=;\JJ);
M3K+V)FPI+A(E_IUY$O,GYFQNQIO/2<X(6R2R".U$L4??C'8_\1\)_PAR('-9
M+U8S]J61WU$KHAP-%I:J9:3U6 2PA&[UYND&05GLA+LRW!OOEKKC8QH;CH4F
MV-@C%R_C&GPQ**[$6F8I8Z=9F)A$E51;;5F]1ZPQ9=DKV>L;%4EQZ,=<%%Q;
M%ND-;^VT<--F@5Y1X4BJJN@K] E-Q>44.IEI1X5!Y I'4HXIKIBJR$LF193H
M4M'2@6C2\^4_8KELS+-52.2Z1%*4-5TV$1,K6=E7+@3$5^RP/[P[PCQ?8=:"
M)ZMDJSVQ7#H(Q#)[M(00Q/5TY/W=$Y.[F345>3O$]:(JC_PV_?Q._)_)+#X1
MCI/4H(GL';7CJCZ;^V0Z\7I 4NZ/9:@24[K2@&K[0&!>UR0Y4]%Y'?&3J.HM
M%P=%(2/!8%$Y 5$9WYUR44"<IY&7U"23 P$":<+T%Z+_5;.X>@CH2#2(DFWF
M,CB46!<I*V[Z))%";LY@7["O_>TK J@$OP)O&M[)**'G84\<+.HQ%K4\YF5N
MWB>E=U;#K'2OWB1:^8Q+;?*T6K]@UDS!_BC2%NW93 K0RJD@=SC-'*?K9\Y@
MJ:HB=KM^UZ[G\OH9\W(O3)(RM3RU)M^.LS,4,EZQ>B^#NC)S()G&Q"O_]O=,
MME5.A=2/J)"*"JF/J9 Z1(545$C%NF*UUA6%58CE[@4QRE=Z*]%'.).BO"7%
MPC%("YG[XHBX@,OR^-1IWIBN$PE37Q1MER<'+J*,3E*A(Z6GJC07=R?1T8VR
M39'(*&,#D3J]73LV,D[ACT\S%#$,&=UPS:^R;OKM?2#R0T5H@="</I9M1HF@
M\EB<Y1U%ASB$MBM*P4<G.T3ABO2I[L3)-O(L2ZE2Z#?OS/M(Z&BJ0CI)-SKL
M$]W47U[(H_='21"%^DK2G_SE[^EA$)]">B-J7:;?Q=$?N3=A*FPB_TP(@%&E
MP.B#[TU)B48#)\0L0*@T$-KH^X=J,"?'7HD$T4SVJW1_?^[YZ<FTHI)R%.Z0
MV4-19BQU7;1[(/V.PJ)YC?@X$.?=V*XXMD'.6<:F^TU^Y78AQHNPD+! HIL?
MSX'$W2P<V6R'Y3Q+YJ22Y8+XX16B,[L;_M<.+&_VV2?<^N"+R7]V'_"RZ^11
M'')OA5P>H&N*C.[OHB>3;"R9N1MD[C/G\%&!A>(HL"!:FA D$.-??*J&6'?H
ML.MD4\9*S#@Z_"24C2Q#S=&HT@TM+R=RZ,5=BG^!GA5'S_>3R8*:$<GEQ.6S
MA2N3R;WXT"=A(H@5EYS4LMN(+ _'28X7C;PTB:@L\?26F]9_%P1)$::*[H[T
MT3^>_XU=R^.-E@F9WG1J9^* 4:/QOI$(-<7V37E#<.Z*._>;S"'1R2%N?FC_
M'PZQ*->EMXY#9KXFSZ:+YEHKWY!'<=/]N6(R5: YXM7:Y7%;:00L>]1=]D9$
M:2VY88Y:XF%Z_+CX2?H];IW'=R(41'0REA K1.]3^WL\SQ)$#S"H.AA\%H(U
MDJ9LH[X:P*#$G7\[3APV!BGKH>D<*[.[3DDG*^FJR<RTI+-R-UK1)1)?.?5[
MYEEBXRE]8YPJ"3E52,*<.T]SYJ07Q**)% OI]L.IS"Z:S6PYL2IH9TJ(DC03
M^F:T 391&P1$,C<IE&<%3";BS.+UJ<[*1"U]]GCQ9^<GF"WW77V5#="#_"D.
M$66O9V2O$U/VV-O -[D#M*LXVKT7Q@-4*V_6LEK (?=X\[1\D'#JF;V8$:+%
MZ>?KTXYEK8B $[C9LO8 #75T["C/STM4V'PQIB_)S']Q1NIF:\M94;H(4Y07
MF7M,;(S#RY4I>9[J+J>?KAQL6GB<[1U?/]'62@ZHS8$<O9H&?!#D:'JYF".O
MEP,Z>7!3]*S1*>V>*UF#K"5RAK<R.G+^_":VOA>R(@3[* Q:!E_^DELTBD *
MA%(I0GD;'[*<@ FXI<RB-.D^J?2PZW3:O CB:"'C\C#ZZ&#Y^$OQ4=;QB?+)
M2ID,9*Y-L,62MCSA7DG9*3XJ.EA(SI(K8=!]%7?3CUQ409&C>IZ$BY,1%A,)
MG\=!*(M'^S?E8>W:KTAC>*JEL;Q!H2FN)Y>VQ=LNE]6+EHF)-Y]__\1>3T@X
M1?FETD]%?H"(9L7'Q'-3E&J2A4^79[C'6$$W+M16@6IS/._;LN!)G%OAR]T*
MWE@$\Y8U=*[?_7_I5%=A8EN#2.6ESQ,P85% 4^P8YOZ<1\D:OG<7WLI/Q$36
M#K)Y$#MD.42Y"G.:QO^0)]V3MOY%,P8=-?H:69HCTA:0"]%"]$M%2I29 QPK
M#<?6>CY9JK.#[!9O"55B$<L70$#30UML!(CVJ,?;OT7V@ES_6@GA3<Q R)?0
M2Y5-T923FWX&O*:I?]/<._07TL&WY6G_B3QMY&D_)D][A#QMY&E##E1+#KR/
M\S4"N?;I<J3QE"D(XF":J*-BNS)H]]6TXS2>:$PD]\L9B2!_0?FYA,V\.S>M
M )&D-\8U9L3R=YJNG61ARP2"E?U=<].VV/@^DY-=N&8M,K57)C\B85L1LP(:
MC4QH;[F5;$:S'>XXILM%65N;YA%!A[W.Q.0L^?1YSQS*:J..*'DCTPW-'P7W
M%:^8)S<FQF#FVM,X-RI.86"+>3PSXS_F]K(^D^PHFN L0GD5QYZ1S\@4)OE<
M25C5%8OQR2:YZ91:E%(L*>.SJN5L-U/!/JTBA#7ZZJ[11^OQ[+,H/@X@++5(
MUZ:G)!'"('9[ZK:XE-64BU4@1TGK9 O/Y3%J3I+SW.+TA 25Z"9OO2A,"!^L
ML _&L3#V[X5MR57U:5QK_1^1-'X3%3]_PR=<E)&.5JX,3:Y[=1$GJX7FO,[&
MN6\0*WL"M%U)-4CP-G$TN3N#;W,T(71D0ID;.O=,K$?-DF2%[ D*FCI<6W..
M3E/0-MX6@!V:W^2&EFBC7V:E?TZZ48C66]OG*Y6!Q8T6B$'NYJ=5F-9_%K$Z
MCBXJXGQR"V,FT!==2";&60L9AX_V#LK"]Y&R%=(UN<M \I YMAV1IA&I/I&-
M]IVO7EM&)RR?WE_9N1252R3-&(K<M+@8;5PCTN??N=CP*/7F7'8(_2+FRBA,
MH,1+.6(8R9"2WI2)+Z*02!29$-$%N4@O$-6.TTOB 9$I?YQNBB0YW:25/"0-
M<KPCR8KC+)E!H?L4&T$CCHWRXL0WHI@ @J!5Q^ W*Y5 /\6'B@"%RXMJK@Q
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M$U "QCRZY2/GNI9FGC?'[ ]QX :B$^V)3KQUIPZ]!II#)D(F5@H>:LF?2*C
M:DJ-;'NK+>>?O=96.P8K@A6!'&!%L&+C;7M[3 %!>+ B6!'( 59$'*%-MKW5
MEH>YM=&PT0&AA/:$$MZ9_C<>,G,^]_G$-D/;<\^?6WSYUPM@/91C597C2H^<
MY,2K?9O<O'O],<?M:+5%M:HP/U1MK8_4A-^UP>]T/3=SIZU.!WD!>5$.S(V;
M@W-&I7'.@+Z OH#C/97C/==[ ZQ@0&) 8F FU>B9%!3&X7&Y9B@,^%VI>X_4
M'O8>(6#8GH#AC6NA)AH$-@1VVN258TZ^,;W3H_8L;T%P7M!B\N'&W6N/(7J]
MMCA6?:+'7OIZK>;!!1OG@CDNU]5PF"F4!I0&8*XY, >E :4!%ZR:TD#56B@-
M* W 7)-@#DJC7O%#N&#C7#!O9WY^M=]'QP\U[$+,]6_QL_X<0<8Z!!DSEXNR
M^%[38%.K<;2160N?.I*%MSP.0X*V"@T=VKWD[D;QBV:1=6(ID,^'.0:*1S7!
M"_+V\'5Q7@7XMS+=#?YM)O* ?\&_\((\_C50\AC\6YGN!O\V$WG OX<Y!LI$
M-L$+\B(XFG[4"(ZNMG<+6/9GPWD9T9K:NHY6J3C-4%KH!=&XFW3OE>=8:>\6
M=$'\N&/ZJ@CS.'1SKAG:WWEP<2[:N@2C%#H%E&W)W5VFL@4L'0Q+ZYR>C.>*
M$IBC=L(NMG^,Q2/@"F"\"MT-& >,M]3V >. \:9T-V <,-Y2VS_&4O(ZKN#4
MF^.,XNE7+)%??G@1JRM.UW.IMU#**@=W(&G*Z5Z$RAL2)$1L' <)M\#,<X/?
M2#X#8X(Q 25@3# FS/QAQM3[&@P;C G&!)2 ,4]H^<BWKJ69YS&FAB,V$)UH
M473BK3MUZ#70'#(1,K%2\%!+_D1"!593:F3;6VVYB\43L")8$<@!5@0KMLFV
MM]KR"*P(5@0K CG BH@CM,FVM^>FC4X4-L!&ASE""?4();PS_6\\9.9\[O.)
M;8:VYYX_M_CRKQ? >BC'JBK'E1XYR3E7^S:Y>??Z8P[9T6J+:E5A?JC:6A^C
M";]K@]_I.$43Z@+JHG24&S<'YHQ*PYP!>0%Y <=[*L=[WM6Q?@&% 86!>52C
MYU$0&(='Y9HA,.!W9?K=<8_FQKXC! LK'2R\<2W40X.\AKQ.F[QRS,DWIG=Z
MU)[E+0C."UI,/MRX>^TQ-*_7%L>J3_/81U^OI3RX8.-<,"]7;X!#Q*$TH#0
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M?X1(OQ$B_6+LGU]N"/5]X!)>6%6(U,%E.PV47+D"7 (NB^#RFN[W*X>&; A
M8G!VRKX<E)L4#5"L%RA^X+ZX)),*\D&$?'1]EN%>BVA9[0/7+G!MHS/:$WCA
MVJUR;1&FP12PR-.*,I1KH'P CX!'P.,1X%$'/-8?'E$S\#A[71X?G$7-P#)J
M!EY[,Y%W888B5<=T+3;F+I_:8?/+!VZ]8'6 J%%]OD_W#D^RTQ"'F&-O>\4M
M7^^H>U;2@9E7P,QSS%I31TK/T!MOW*#22@,*J+0I& ,J!96VP,QSS'HT4(:C
M0>-M&TQ::3P!DS8%8L"D>UG^<._"3[#R"EAYWIQ44_HHUP[.++%4X[[)@KM#
M1WV/6%O;WOM$1<.V%PG3.J-GQ8>T'B%"BF@HHJ&5BH;^OG M1L]/3<U$_JH(
MB)K6S';M(/1EC!3$">+$9+-2R%%+&8[#S[%66R/;WFK+ W$FQQ"V#&8$,P(]
MP(Q@QA;9]E9;[G>505^#+8,9P8Q #S CHI+M,>WMQ*CTALW/Y@$O5J5[$82L
M:Q!2[>BG#4)BF^8<@<FJ!R;?F?XW+NMD1R%).:P!_0T.!8=B;EDIP*B* ,?<
M$JNN3;7M[2FN T7O]6'+8$8P(] #S AF;)%M;V?&GF*HS:]' &:L3/>"&6N%
M'F!&Q",;:MK;B5$9];JP9/ BXI&(1VZ-1^J=(39%(O;8HMCC)].A;I"U81>!
M[?(@8!;_SAUO+O9(@C1!FIA,5@HUJJ*X,9G$,FM3;7O[;-)0>D-,)\&,8$:@
M!Y@1S-@FV][.C)HR'&!#))@1S CT #,B -DBTWX@ #G0#%@R>!$!2 0@MP8@
MNYTN-D0B*-GRH.0UW;-O3L*%Z;"OGF/1"-V+<&3SSZT$AU:F>S&WK)4 Q]P2
MJZY-M>VMMMQ7U/X(I@QB!#$"/$",(,86V?;V5=>!HJFH7 YF;"@S8B7VA"NQ
M(,(2HX^PY!-:\G--4U1C] *V#")$_!%8L14K^MU.[UDN5&#S(^*,38LS?O"]
M*0\"VW--ATTY1WP1'-G0R6)M@:(J2TU81L4R:E-M>_LRZE 9(< (9@0S CW
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M>\P(MPAI?_6]N_"6)D),((8 /-_F[D2T2L+B3[$EB[V>T9L3$^A1 _2(2WL
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M6^?A=KMNO._NZ8='V'@O!H<P/!J<'@:G:'#T?J?7?6J4S %)X.,A\[C,..=
M9!XX%CWMV>4_8H9_(V;X%V/__')CEK\/7,(+JPJ1.KALIX'2.GT-< FX+(3+
M:[K?KQP:LB$ B<'9K81='Z (4"P$Q0_<%Y=D4D$^B)"/+CX[W&O)+*M]X-IP
M;;CV8UQ;Q'@Q!2SRM**JCS50/H!'P"/@\0CPJ ,>ZP^/.!#A./6#'Q^<;?R!
M")4XG>VM@$<>I%N5&E] ?.L%JX,_C>KS?;IW=)*B[44%O>M[W)!Z<NFT7R7O
M==39N+NSRU\:#RY[&+K:Z>\YDX!55Z(^_7.MI^A=_47CC1E,66D  5/6%%/
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MGEV^#IC)/G!_$A\/\)%_Y^Z"!Z\NSD7#EP_**_C>KN)L,"I=G(G!(2"/!L?
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MPO;ED@G;%TR<$D;[+8_1/K:OLP+8OBKUPO;EDHDF&H*)4\)HW_59R8_MZZP
MMJ]*O;!]N62BB89@XI0PVF\Z[9*;:%S'G8_O1^ETT'UA/;V\O+IZ\^8EC36V
M$I#&&EH::ZQ=3H:'I3\.CR;FI?GW*.Y,IG'?>I_VNP8.7[,>&V-,C8RNL@)D
M=%51@XPNETP\D1-,G!*($GFN!U,P?IT5P/A5Z1?&+Y=,&+]@XF#\@IB"\9^_
M AB_*OW"^.62">,73)S"B>+:(?VUL'VE%<#V5:D7MB^73#3:$$R<PHD2V$%$
M?RUL7V<%L'U5ZH7MRR43HWW!Q"G!]ET:;6#[2BN [:M2+VQ?+IFP?<'$*<7V
M0WB"[:NL +:O2KVP?;EDHM&&8.*4,<D?,,F/[>NL +:O2KVP?;EDHM&&8.*4
M8?NA4W*C#9IJ;"4;335HJO'DU>^C]"89CWOI(.Y;-TE",PURN,X*D,-5Q0ER
MN%PR\=1-,'$*)XIO>PY];K%]G17 ]E6I%[8OETS8OF#BE&#[+7=7GUMX@NW+
MK0"VKTJ]L'VY9,+V!1.G<*)$MN]SF!VVK[,"V+XJ]<+VY9*)1AJ"B5/*:)^M
M-=B^S@I@^ZK4"]N72R9&^X*)4SA1/+O99&L-MJ^S MB^*O7"]N62"=L73)P2
M;-]OTC\+V]=9 6Q?E7IA^W+)1",-P<0I84>M[T3P!-M760%L7Y5Z8?MRR40C
M#<'$*<'V@W#72OZC&VD$T3VIXL[']Z-T.NB^L)Y>7EY=O7GSDN8:6PE(<PTM
MS37"U<OQC^;AVTYG:OZJ\]6V.NGM[71@(#7II8.Q%0^Z5O+O:6]X:RX'1R.@
MJZP  5U5SB"@RR43C^,$$Z=PHKBVQ[P<MJ^T MB^*O7"]N62"=L73)Q2;)\S
MZ[%]G17 ]E6I%[8OETS8OF#BE&#[;LN#)]B^R@I@^ZK4"]N72R8Z; @F3AFV
M3QMM;%]I!;!]5>J%[<LE$Z-]P<0IP_;=7:?8P1-L7VX%L'U5ZH7MRR43MB^8
M.(43I1W15@O3UUD!3%^5=F'Z<LE$?PW!Q"EAK.\$')F%[>NL +:O2KVP?;ED
MHK^&8.(43I16N&L5_]'=-;S[)@YTTMA*-3IIU+"3QM^3X2CI]/+N&7GSC/@V
M-;CZO_P;.!8!7&4%"."J<@0!7"Z9>-@FF#B%$\7W.;H.T]=9 4Q?E79A^G+)
MA.D+)D[QIN]P@@VFK[,"F+XJ[<+TY9()TQ=,G.)7V'ALH<7T=58 TU>E79B^
M7#+1.4,P<8HW?8=%M9B^S@I@^JJT"].72R9&^H*)4X+I![ $TU=9 4Q?E79A
M^G+)A.D+)D[A1 DY!0O/UUD!/%^5=.'Y<LE$TPS!Q"G>\SD""\_760$\7Y5T
MX?ERR43'#,'$*9PHP:ZE^T4TS+B..Q_?C]+IH/O">GIY>77UYLU+FFAL91]-
M-&K81./=A]ZH^^,P'DV^6MW>>#+J74_SAAHW23+&Q,CD*BM )E<5+<CD<LG$
MLS?!Q"F<*)X=TKP6VU=: 6Q?E7IA^W+)A.T+)DX)MM]LL](6V]=9 6Q?E7IA
M^W+)A.T+)D[QVVOL***5!K:OLP+8OBKUPO;EDHE6&H*)4\)HWV.]+;:OM +8
MOBKUPO;EDHG1OF#BE##:;[6Q?6Q?9P6P?57JA>W+)1.V+Y@X94SR^]@^MJ^S
M MB^*O7"]N62B8X:@HE3ANV[--+"]G56 -M7I5[8OEPRT51#,''*>+;O>B7W
MU:"'QE:RT4-#2P^-M<O)\+#TQ^'1)'P[^9",,"NRM\H*')J]EV[:"^NSX4_Z
M.6.2Y0XGIB2#Y*6U?&-GVF*-TWZON[& CWS)]:OWYE>_?[29]A.]8BLEWC N
MD$OTPY\"/I*5D+H:I"YAS.*W:#I"7-)9 >(2RDI<JCS1B4N06DI<:CKLVB8N
MZ:P <0EE)2Y5GNC$)4@M)BZY(1PF+JFL '$)924N59[HAS?@(2Y!ZK*: ^TZ
MF L.$Y?D5H"XA+(2ERI/=&:7(+64N!1XQ"7BDLX*$)=05N)2Y8E.7(+44N*2
M[W'0%'%)9P6(2R@K<:GR1#^\419Q"5*7$Y=<AYUQQ"6=%2 NH:S$I<H3_? &
M8\0E2%U2S]-@UU+OHYN?1?=\CSL?WX_2Z:#[PGIZ>7EU]>;-2_JAG:S_F:^6
M=,&Z>YVS_YD7KEZ.ORP"_M$L?)=.XKZ5#I-1/#&%L9(OPV0P3L:8ZRYS9=QR
MMCO..(5(PSBE<L3FJ3<DEC$N:09VQ#PN^4?H'2?_()WDG\H1F_P#B87D']]N
M<1@5^4?H'2?_()WDG\H1F_P#B87DGY8=!IS!3?Z1><?)/T@G^:=RQ*:G&"06
MDG]".VB1?\@_,N\X^0?I)/]4CMC,_T!B(?G'M<,V1_:0?V3><?(/TDG^J1RQ
MR3^06$;^";/G7^0?\H_,.T[^03K)/Y4C-FV\(+&,_--T[2!@_Q?Y1^8=)_\@
MG>2?RA&;OER06$C^<>QF:U?^.;HQ5]"Z>U.Z<"V_4O->">C*I;HKUW&D>WO7
M@*LWZ*2W"9ZY;V_+!\QA.'+^"APZ/-FO ML2A%HIDY(>OCD$6("'$<&YN77X
M$V)X=+X47C!OO*;M^+NZY<(;4H'<"I *5*D9J4 -MT@%@GET@E30<D@%I *=
M%2 5J%(S4H$:;I$*!/.H;-ZXD>U&+. F%>BL *E E9J1"M1PZ_ >0_"H.JF@
M:8<M4@&I0&<%2 6JU(Q4H(9;S!4(YE'IJ<"U6RZ;G4@%.BM *E"E9J0"-=PB
M%0CF4>FI(+ C6@"3"I16@%2@2LU(!6JX=7B7%GA4G500VI$3P!M2@<H*D I4
MJ1FI0 VW#N]= H^JDPI:=C,JNUW(==SY^'Z43@?=%];3R\NKJS=O7M)"9"LA
M2VPAHI:/[KJ7G*EYR#T05ABY0L#7:;^[0KNU>S+__-?F5U^N,O/MY$,RLG[-
M^XD\O[CZ,DP&XV3\[ 4>1X)768%3)GATKI@F21N"QU)>(:_K?+:';N$<>BJ
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M.XPMGW+(PTE#@HE2.#&R(-T,(08^+O*.X^.JY D?ET,>?%PP48IOAQ#9D>=
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MTNGEBWGSM;SQ;6HJ^W_Y-S!T#+VZLHRA@YSCD.,PY$$A:X!S%!+D'*N0++U
M(:N/<Q2R)L@I?3FO0[=S%%,>[E%,D",$.2@D"ED'G*.0( >%1"'!.0H)<E!(
M01<%SI7@'(4$.2@D"@G.44B0<P:%+&(Y+[U[6>); %[??>B-NC\.X]'DJ]7M
MC2>CWO4T7^Y[DR1C3!Z3KZY48_(@YSCD>(V(81 *67F<HY @Y]AC\/;8U2A"
MC%!(<(Y"@IQS+_'U&AZ*B6)*PSV*"7*$(,?;YU@\$6*$0H)S%!+DG%XA:3V
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MLAJY=KOM(ZO(JC8"(*N@2JRLMAP[:D7(*K*JC0#(*JB2*ZN![3L>LHJL:B,
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M"N"" !N:D44+L\ LX!IF@5E4%, % 3:(;"? +# +N(998!85!7!19M'*#B'
M+# +N(998!;5!'!Q(XNFM^^9C4?O&N+P' D8K\_^H9_-KYAKG>\<LKK3D2F/
M-?F0S+<452L0G>BBMNF^6CZHTWQQH>54P@O(U 6+9MMNN:WJCD(1W9KP =$%
M9&I$-[(=I\)[6Q#=FO !T05D:D37,TEWWRDT$?J&Z,('1!>0*1;=L&T'OH/H
M(KK*^8#H C(UHNO;S2JO+$)T:\('1!>0:1'=P"3=9H6;VR&Z->$#H@O(U(AN
M9'LMIA<07>U\0'0!F1K1;=E!NUWV6O2 $RQ8@;YK!?IQX/WG]/8Z&66G5ER]
M>S/^CZ>1YWHOD]DY%BP\)T6H%/C'*OK9HC-0.C&4"H=.BRDO=%,HV-%-H"15
M-R-FK=!-H6!'-X$2NHEN G9T$]U$-]%-P(YNHIL*H%3\_.:^#SI%2!2Z62>P
MHYM 2:QNTMX"W10*=G03*(G537JQH9M"P8YN B7UNGF_('GV/]E_9L@Z:'ER
MZ.R]/'FU<_:FE<J7OVQN-#\'@#5.^[WN70_X;P/]07/YY5=X/ ,N?_DK@U+)
M%(B.8L!UVN\>AG^_>/RO+6W^MI)F;_TM[+LKV%^[+P_O0?[VW:23CN))+QV\
M,'!,1OW>(#%O<?6O/][^?O7S/ZU__/KGNZN_6U?O?A];"\8\?/O7YI4.>=,G
MKRXVO4PYG\(@W0"J;[X]+N;:G^WK.V?G:G$1+?LH1J6RS_VW)]Y9/]8>5\I-
MYZ9ST[GIW'1N.C>=F\Y-YZ8O7^G1NXV]^W')EOW% LZ[,F6<O:+G-MSP!S8?
M:]M\_#HQKS+(SKA*;^8[C>=G7\F>Z+\#GL&=^X/(:?\'EQA$6ZG!S&V)#P$J
MW\/D#F.MAA> ,<4/FKPP._4*T45TM1,"T05C6D2W9;>:/J*+Z&HG!*(+QK2(
M;ML.0I(NHJN>$'4276?[["X84R"Z3=OQ'$07T=5.B#J)+DE7M^AZ=N2'B"ZB
MJYT0B"X8TR*Z+=L)F%Y =-43HCZBVVPTP9AFT?4=NQ61=!%=]82HC^A&#;<)
MQA2+KM>VO6:[C).N'JP]+V(K.8=>L>Y\!;L7;Z>3F[YYCV?/>X/\"]GA061<
MV"[>UVHQ[ZPC[ S:O46KC\>[FCXR($<8<B[<*-J[$03B",3U01QQ!#G'BJ/=
M=)%'Y+'*($<>0<Z1\MCV/,2Q2'%4B_#:S(JJ44N@)*UCJV?[WJ[Y=!'*A%S6
M">/()5"2*I>N[?@><LG0N[H#*#7J"'*$(>?"LYUFR. ;>:PPR)%'D'.D/ 9>
M$W%$'"L,<<01Y!S[V,9W=XGCT>MZ@TA!3VD6\VI;S/M;//J83*QX.!PEG5Y^
M,-+SBVYR_Z^*.?V\OM9G<YO3S]D-M]SA9-$9?NTRO5V7^:#!_,//.O]V7IE-
M/\AJN/3]0C+$M)_H)9B4>5;I4_82T0M0JPA4SW:=BCU/E4B>PJ1?[T#@%(=H
M%DBILPTJ)<(7I%82J1>!5[6%V1+9@_C7AU*(/TC5@=2+5JMJ"\\ELH=)G]J,
MI=%^@*H"J*[M.A'2C_3#**0?Z:\34#W;#86?IH;T,Y#6-)!&^T&J#J1>&/4/
M6DSZ(/^0"OE'_FN&U O?]EWF_!7)?W4X5=7Q-.H/4%4 U;.#G4<N';UAY7Z_
M"GWHV;JR<^O*@PLZ/L5<#;I6>F,-S:U-NY;YRV12L<;T"U-XW3<4LKR&N9=6
M-YT:UFVX2%=3H/'4\DN-3RS()>Z0''FH!L"2 5Q4[FG93;^BBQWD4 F#4,<O
M# *#4 W@H@PBM%NN\,.(,0CXA4'(0S4 E@S@XD80K69%U\S)H1(&H8Y?& 0&
MH1K 11E$VPY"1A 8!/S"(#"("@&X*(-HVH[G8! 8!/S"(#"(Z@"X*(/P[,@/
M,0@, GYA$!A$=0!<W#,(9^?R;0P"@Z@COS (#$(U@ L"K._8K6C7".+H_3VA
MPX$T[.HI_$":G\VOF(N;;^"QNM.1J8<U^9#,=_94*^N<Z**V2;I: JB3<W%Y
MY%1*"\C490:O:4=!Q1Y+(;0UX0!""\C4"&W+;E7M\0Y"6Q,.(+2 3(W01G;4
M;"*T"*U"#B"T@$R1T#JMBG750&AKP@&$%I"I$5K?;K<#A!:A5<@!A!:0J1':
MT/9<%Z%%:!5R *$%9&J$MFT'3:8.$%J-'$!H 9D6H?4=VW=W+>\Z>DEXP)D/
M$H!=X=7A_YS>7B>C[)R'JW>_C__C:>2YWLMD=O(#:\0)$2KU_;&"_LBSIH@*
M:J!4.'2\)E-;B*4@A".60$FN6/+ %;$4A'#$$B@AEH@E"$<L@9)JL608CE@*
M0CAB"93DBB6]*1!+00A'+(&27+%L(Y:(I1R$(Y9 2:Y85JR5-F*I&^&()5"2
M*Y:['O <OX:XI;BMM%J4NK*6#*^M& Z727.WY6+Q4N$W8!QN@?&6FSF_<==I
MOSM[GV[224?QI)<.7A@X)J-^;Y"8-_S]C[=__]?E.^ORYW=7__GVCU^O_B0_
M%)8?(%,Q9-JV76EA%=4)#R+!+?*B8!R,@W$P#L;!.!@'XV"<,G"+O"@8!^-@
M'(R#<3 .QL$X&*<,W"(O"L;!N#(85\0C:M5MKJ#0HRETW\]JA4,KG'F=]KLK
M3-GYT'F53/]J_-F8X??JW]/>Y"N/F3$2.2RHN9&( +?(BX)Q, [&P3@8!^-@
M'(R#<<K +?*B8!R,@W$P#L;!.!@'XV"<,G"+O"@8!^-$/6;V[D\@TK<3FB.4
MI!ZA]#HQKS(P-<C.3)J=EV29OT\F8QXJ%V8;-*PHL?<)ARV"*K$==;S0;@:T
MOD=*58 >*055<J6T:3L.C?&14A6@1TI!E5PI#>S0)Y4BI2I CY2"*LE2ZKH>
M4HJ4:@ ]4@JJY$JI8[=#I!0I50%ZI!14R952UW;"""E%2C6 'BD%57*EU+=;
M/E**E*H /5(*JB1+:;3SM.8B%D>K[L'%.FFIZZ1_'=STS3L\OTBGD_RK9T0"
M(D&-Q%O<SAJ@I.5LR"#B(%W$4A#"$4N@)%4LHYT'Z8K0)<2R3@A'+(&25+$,
M7,2R2+&\5@MQ9QE2OBB 'S_MI$8;08XPY%RX09LY2I*D(/LG20(EJ4G2M1V/
MM<?(I2",(Y= 2:Y<>GX;N40NY6 <N01*4N72=YJ()6(I!^&()5"2*I:MUJYD
M>?PYO1$-E%D87/C"X-_BT<=D8L7#X2CI].))+QT\O^@F]_^JV"3\O+[69W.;
MT\_9#;?<X<0:I_U>=\-E>KLN<_Z2!@)+GW7^[;PRFWZ0U7#I^X5DBFD_T4LP
M*68@/5=(1"] K2)0?=OQ0J1?C?3K7<"P1JDS+6'8DU)G6PPC$;X@M9)(O7!M
MSW-)_GKDOSJ<JFJ@0OT!J@J@9KVW?*0?Z8=12#_27R>@AJV*'5 CD3H(?VWX
MA/ #5!5 ]6RW:DTB)9*'V?[ZS*&B_2!5!U(O7-L/0F;[D7](A?PC_S5#ZH5G
MMZ,F\H_\0RKD'_FO&5(OVL[.E3Y';UBYWZ]"3WNVKNS<NO+@@HX'\M6@:Z4W
MUM#<VK1KF;],)N-JAIK7?4,ARVN8>VEUTZEAW8:+=#5%&D\MO]0\(EB02]P1
M._)0#8 E [BH1UYMVPTKUM9 'I4P"'7\PB P"-4 +LH@0KL95*P_MSPJ81#J
M^(5!8!"J 5R4031MQZGH@FDY5,(@U/$+@\ @5 .X*(,([-!G!(%!P"\, H.H
M$("+,PC7K=BQ'?*HA$&HXQ<&@4&H!G!1!N'8[1"#P"#@%P:!050(P$491-:M
MJZ([]^50"8-0QR\, H-0#>"B#,*W6SM;NQR]OR=T.)"&73V%'TCSL_D5<W'S
M#3Q6=SHR]; F'Y+YSIYJ99T37=0V25=+ '5R+BZ/G$II 9F^S-"THZJM?$9H
M:\(!A!:0*1+:L&HKB!':FG  H05D:H0VL%M^Q9ZC([0UX0!""\@T"6W5SHU%
M:&O" 806D*D16M\.VB1:A%8C!Q!:0*9&:+WJ;>)%:&O" 806D"D26K])HD5H
M-7( H05D:H36M]V=B7:V)-S\;[;@._O6?<W_\<<O:NOMK-S@HFO=,>5-1KN+
M_<(RG^^+E?UW_D7.SY4WM.+^Y_CK^&[KQF+OB&O^8GX&S(-K-Z_4R%]GZ>-E
M1+_[UMT++/]F?EMFO_C@<UCS#V+=%^7N#Q]6U,I+:BJ:%_3W/TTY?_PC>3_M
MQ^9OY_L KK/=+@9S37\.M ?R8=[QKYO^=/RADHC*N+; E%?<*OP[1'FK;V;$
M(+8^C)*;OSUY^N[MI>.X3U[E6S:R4S$NS0<S?S[^Z7D\HWS^GY]RAF_9])%_
M?2<GS;LBS9W%=9P?[@!JJMV/AV,#E,57BQ^]L)XZCI/A?('<#0:UX(;1-"O_
MW2>O\JL[:#^*=[^=8[[M)#]O9M.VD\M?5NUR5MXY0'9<Z68K?; C:_D5#O;8
MG29_]LLN+BEG'\5 );.@OSWQ-G^LO8^_VOUA3K]=[K)LCXR.$K3KM-\]+!"5
M<.;5/B;Y( &M))S7YB.LY)JU._#PTZY&G_\*GGO^OID:ND$WZ/8HNOG0#;I!
MMU/1S8-NT VZG8IN+G2#;M#MA&.WO1\/0C?H!MT>.W:#;M -NIUL[ ;=H!MT
M.]G8;1?=9DL@OOONF,9X06OU063>_\X :G.;/%&-\=0^BW?%M,3;2)D-#?$>
MB^'+]/8V[?8F7V<"^Q_QK1'AR^EHE PZ7UE'6=@Z2BA13)?(;<LF%^I_](*V
M!9;$+)44"6Z1%P7C8!R,@W$P#L;!.!@'XY2!6^1%P3@8!^-@'(R#<3 .QL$X
M9> 6>5$P#L:5P;BC3V![L.-U_='RZ/WUA><$MN='MA>&SSB,K2PB5?@PMM>)
M>95!=@!;>C,_?VU^,!O/E^G3HZ&%"HUY0%5IC7D>W8G'L8,FW=*14A6@1TI!
ME5PI]6P_HDTO4JH"]$@IJ)(KI8'=]I!2I%0%Z)%24"572CW;:;>04J14 ^B1
M4E E5DK=MATV.2L=*54!>J045(F54L^WFPSPD5(=H$=*095<*6W:OL.A94BI
M"M CI:!*KI0&=MAN?[,GUPQ3CSP92%%#+A9'2UT<??%V.KGIF_=X]KPWR+\@
M!Q28 Z[58MY91]@9!'N+0!^/=W$;:4".$N1<!$'[&>*(.%87XH@CR#E2'%T[
M<D/D$7FL,,B11Y!SM#R&KH\\,L5>I\E0-7H)E,H1S$?,H]N.L_>QA,@E&$<N
MD4LU4"H<.JUV$[%DZ%W= 90:;00YPI!SX=ENY##T1AXK#'+D$>0<^U2[Q6,;
MQ+'*$$<<0<[1CVV<<.=CFZ.7\P81;8\% +?"*WM_BT<?DXD5#X>CI-.+)[UT
M\/RBF]S_JV*V/Z_OOL>L>[LNLZA3U@L)%--^HI=@4J9<I<_>2T0O0*TB4%W;
M]QRD7XWTZQT5K%'J3.."/2EUMA&F1/B"U$HB]<)U G(_X@^E$'_$OV9(S:8S
MO1;RKT?^J\.IJHZF47^ J@*H4=6:)4JD#L)?&SXA_ !5!5!=NQ4PWZ]'^AE(
MBQ](H_T@50=2L[XL4=4:#TCD#_)?'U(A_R!5!U(O/-MSD']%\E\=3E5U/(WZ
M U050/7L5KBK+<31>U?NMZ[0B9[]*CN3U/'1Y6K0M=(;:VAN;=JUS%\FDXJU
MIE\XP>N^X8WE-<R]M+KIU%!MPT6ZFE*,IY9?:LQA02YQI^'(0S4 E@S@HL*.
M:_M^Q9I@R:,2!J&.7Q@$!J$:P$49A&,'S1"#P"#@%P:!050'P$49A&?[4477
M2,NA$@:ACE\8! :A&L!%&41@MZNZB48.E3 (=?S"(# (U0 N;@3AM%L8! 8!
MOS (#*(Z "X(L&[;#ILN!H%!P"\, H.H#H"+&D'X=I,I)@P"?F$0&$25 %R4
M031MW_'*V-03.AQ((P#8]=G@\[/Y%7.M\ZT]5G<Z,N6Q)A^2^9Z?:J6@$UW4
M-K%7RP=U0B\NJ9Q*> &9OC3A&C>OV' 3H:T)!Q!:0*9&:#W;:T4(+4*KD ,(
M+2!3([2![?@^0HO0*N0 0@O(U BM;T=.Q=:Z(K0UX0!""\C4"*UC^T'%^E8@
MM#7A $(+R-0(K6LW/806H=7( 806D*D1VM!N-2O6JA.AK0D'$%I IDAHH_:N
M[:9'+Q8/6HJ/@%"+8U?,VO!]EX*_3OO=%7BNW9/YY[\VO_IR%<%O>E^2KO7K
MH)/>)@2&P@(##"AF=\2V?+!P@*.5^Y%G3!6OI"+!+?*B8!R,@W$P#L;!.!@'
MXV"<,G"+O"@8!^-@'(R#<3 .QL$X&*<,W"(O"L;!N#(8=_1S9>^^<1=-R&A"
MMK,)V7'<>9V85QEDG<;2FWFCL7D',IXOLR!-PUHA5J"!JM)6H!6PB:)5M2-P
MD-*J@AXI!55RI=2Q/9?]:$BI"M CI:!*K)2ZD=UR:+^(E*H /5(*JN1*:6A[
M+1HL(J4J0(^4@BJY4NK:S38#?*14!>B14E E5DK;MMO>=2J>"-%"2<$\2@JJ
M1"MI: <N,Z4HJ0K,HZ2@2JR2!K8?[NIR6,0B:7W-MU@9+75E],7;Z>2F;][C
MV?/>(/^"&%!@#+A6BWEG'6%GT.LM^GP\WL7MH@$Y2I!ST7+#9X@C8Z0:I5DU
M:@F4RI'+1SSGM)NM75V(12@3<EDGC".70$FN7 ;()7(I">/()5"2*I>^';JL
M1T8N!6$<N01*<N729Z4<<BD)X\@E4)(JEY[=]%@.AUP*PCAR"92DRF5@.SYR
MB5P*PCAR"92DRJ5K>\&NP?CQY_-&]%$6 -P*KQ;^+1Y]3"96/!R.DDXOGO32
MP?.+;G+_KXHMD)O7U_IL;G/Z.;OAECN<6..TW^MNN$QOUV7.7]) 8.FSSK^=
M5V;3#[(:+GV_D( Q[2=Z"2;%&:2'#(GH!:A5!*I;M9:E$JE3F/#KW5JP1J@S
M;2[8DU!GVZ8B$;X@M9)(O8C:A'X]VE\=0E4U2R'] %4%4/U=?0[0?5FZ3Y(2
MGZ00?I"J ZD7K8C,KT?[JT.HJD8II!^@J@"J&Q'Z]0@_44I\E$+Y0:H.I%ZX
M7M7Z7TED#^)?'THA_B!5!U(OO&: ^"/^4 KQ1_QKAM0+-W)VB?_1&U;N]ZO0
MTIY-*CO)=#QZKP9=*[VQAN;6IEW+_&4RJ5B/^X45O.X;WEA>P]Q+JYM.#=4V
M7*2K*<=X:OFEYHG @ESB3M61AVH +!G !0'6<VVWW<(@, CXA4%@$-4!<'$&
MT<(@, CXA4%@$%4"<%$&X=A>5??#RZ$2!J&.7Q@$!J$:P(4MHK9;3L4:9LJC
M$@:ACE\8! :A&L!%&41H>ZV*'6\DCTH8A#I^81 8A&H %V40KMUL,\6$0< O
M# *#J!" "P)LVW:K=N"?/";A#^KHA3_@#ZH!7!!@0SMP=SV!.'I+C^MP!HT
M7-=G>\_/YE?,M<XW]EC=Z<B4QYI\2.8[?JH5@DYT4=NT7BT?U.F\N*!R*N$%
M9.K"A.?:4=1&:!%:A1Q : &9&J%U[':S8H]]$-J:< "A!61:A-9MVVZ$T"*T
M&CF T (R-4+;LMU6Q5K*([0UX0!""\C4"*UOMYL56Q&$T-:$ P@M(%,CM([M
MM"K6'@BAK0D'$%I ID5H6W;@,7. SFJD #H+R+3H;& WVVX92\7#^Z7B^HY_
M4 MC5\S*\'T7@K].^]T5=*[=D_GGOS:_^G(5P+\.S+4/XDDO'<1]Z^_)IZ2?
M#I.N]5L\^IA,K*M_3WN3KP2)PH($U"AFT\2VW+!PAJ,5_9$G3Q4OL2+!+?*B
M8!R,@W$P#L;!.!@'XV"<,G"+O"@8!^-@'(R#<3 .QL$X&*<,W"(O"L;!N#(8
M=_0#9^^^GQ>]R>A-MK,WV7'<>9V85QED#<C2FWG_L7EC,IXOLU!-PQHB5J:!
MJM)6IA6QB<UA$QM2J@+T2"FHDBRE@5>Q(\:0TJJ"'BD%57*EU+4#'RE%2E6
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M:7I$?"7-AI_M,H(VU*B[N+ZV\E [GJ^<H;(IX@7(ZF=,D$;O;UDI:!#MCL@
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M1J^_I2EPU9$DZ(?:B1?T _1#K0&\,OU@;=MYR=63).B'VHD7] /T0ZT!O"+
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MG7[H8?T _0#Q@GZ ?M@B *],/_3:6UIGL3J2!/U0._&"?H!^J#6 5Z8?^M8
M^@'Z >(%_0#]L#T 7F%\>MF17(_>S--KX=R9"N!Z=S;V'-(EU%:SI4<X24C3
M(^(K:?;Z;)<1M*%&W<7UM96'VO%\Y0R531$O0%9'8Z*U9<Y(\.R.B !X%B"K
M$<\>;%E2 'AV1T0 / N0U8=G]P^V+'@"GMT1$0#/ F0UXMG>EAT<!9[=$1$
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M7 D?/:BR0O@&50)*5:7*-LS*57+EL+8(;Y41U:D4OA_O<JH--0(Y%4/.GC6
M>Q)V9(64/^Q(0*FJ=J0%.Q)<62& @RL!I<IR)?9B@"LK!'!P):!45:Y$72]P
M994 #JX$E*K*E>V#M9RY.T!MY J@=HO3@O^PPV\R%O9T&LJ1:\=NX+_><V3^
MUY;YX<W\BAL:YN"&!UQ8TUA$@><Z"YK97M9,\TB"0*FOYFLU,XM^X#DL?;\2
MZR+Q9'T%K"IJH>H61A71"Z!N(U"M97N;P/O5XOWZYB_,R=,S93#<4YZ>+1>F
MBO %4K<2J7N6!9N_/MR_/0*UK:84J!] K050MRV/J(J2 ][?&7$"[P.HM0"J
MM65Q_BI*#GP]N[."!O$#J?5 ZMZV;;.JHNR ^G='H$#]0&H]D+IG]<#]X'Y(
M%+@?W+]C2-UKM\']]>'^[1&H;?6@@OH!U%H ==G)'X_>I9)O4D'!>NQ,6961
M<NP[(AB+*8UEX BZ4\;1=AHM[ST2%-%NTN ))TA(MA8TTJJ3R=*NK4!57Q-4
M[DR<ZL$8B*T48E=EN^SO@__!_[LN3>!_\'^]$+LJ_M^V>C35$QSP?_6E"?P/
M_J\78E?%_]T6^!_\O^O2!/X'_]<+L:OB_]:6U>ZMGN" _ZLO3>!_\'^]$+LJ
M_K=@_X/_=UZ:P/_@_WHA%O9_700'_%]]:0+_@__KA=B5\?^6G2U?/<$!_U=?
MFL#_X/]Z(79%"&T?K&7W2J^%,U8J .-:[&0I-.CQ&UL.Z1)JJ]G2(IPDI.D1
M\94T>UVVR\C94*/NHO;:RD-M:#T5ALK9)9LB7H!L<R!;62K9EI4Z!LONB "
M90$RL"Q8%@( E@7+UAIDJV+9]I:E18%E=T0 P+( 66U8MC4 RX)E:R@ 8%F
MK#XLNV4I/F#9'1$ L"Q 5AN6M98ETE2"T,"R$ "P+$!68Y9M'QR 9<&R-10
ML"Q 5AN6W5_F,7AT4GAWO\9G&M06Q%9E<L#OF_+]/O"<&6S.C8GI_Y N?3L+
MWT_2=D:$IABF DR%W67Q)YZ?!/N@-LA:?P0!OBU0:84 #RH%LNI)I7!@@4HK
M!7A0*9!55RJU0*6@TNH 'E0*9-642O=AE8)**P1X4"F055<JA:\45%HAP(-*
M@:RZ4NF6G4T**JTWX$&E0%9-J;0/*@655@CPH%(@JZ94VOMQQ>R?U ?.?N9O
M"W/,7XV#(/:#6/X]J>U<M[MSDKMXJMN/GNI_)U'LCF_+:<7JO6;".W=1";=
M=;V$DP6_OWCWA:;AC?@:RFLW2"+O5KA1E$B'IL6.77K_*!(3^U8,I0@E?T<_
M.8D4<2#&B<]T$40)_2)L^B,.;4<*V^&&3^B5D8$'9G_CL]];/OD]-??G01*R
M"?"7&SG!Y"*4<F["/E7T  .5];YLAEI+ID=MN4AGZ.!@P11=!Z[SF*S_>2[.
MWO?$#'^65/_5[X>'7\5'U[?]D6M[X@]IL_0962LR<D'DJ'E_4_.J.8_WD+5E
M,]DO3.3C16UN&A>*6?J^%^].?*([(<?TL)B9<!H&UZYB/L>-W<"GF7'],?>,
M_R+BO+1#'FE!\L8TFG@Q$68D'$F-G+@^<>KP5O#<-L0-/<:+ N&X$7.K%".R
MGFPRL?S +P'(#U2?7KQ3H#"S7WHOF?FC*W[@4'JNO)9I.R.11'*<>(JS)]+V
MJ6G\9^'>ICBEIM)\T]@QN@3K!WD3\7$"U*;[M66<X712P"DU2]+@7=M>0J\R
M@Y)?.I6A:H4_DJI]Z7 %8Q'0;ZIUT5MN1Z@FLU'LH!N3^DI[5YB8TJBX\14_
M=2I':O(>TJ-2/VB2: [I"1%93:01K^C5U$+U8)<:0RW.![ IOCS\#4Y [8K%
ME7W-8W'+.MEW&$K_*[.):Z17A7+JT8*./H>"VQ,EZMB'D%NH:...Z>!!YNL3
MWW._23( Z'K2]J-@,K5#5M>JBRZ1@1VF=U)'Z3]TNT9NP+.A[_!=&37%Q=-1
M$ET%B>?HEO@136)([R(QX/,LZ!N65CV5#!_5/X,4]?:GO9N?;RNQ5"^D>3V3
M4Y9UUQ]YB2/?S*O)SH;IU8V)ND;K59/]S6K)!>L15I(GJJ>+5&5Q#,JJ\E"9
MH#1_OE23%DPTF3BNE_#7T@Y9=I2\:O%M0GUN3'W^)7/M9C]XIIATGR3=)--J
MOIC70BW71;TLOY.,1X; W5A.6.G9L>+(N]\;RE$2\H$[Z<N)>)F51T&H")3?
M8/07J;PAO<"7$7'57T7MK"C5'-KS5/[,=+WK7]/"+0@C39>VYE,:<]+J-[:B
M>])2WNW_2M7(@OY="8^KX72DXNUQX'G!#<O,G)B]_USQU:!'0Z9O?#4-(F7F
MO0F2F#53\;?X=BK?,+J7RF1WL'3YN":Q?&4-BG(YVVJ:9OD#/AXFGB?C!7ZA
M9>JI/([LAQRTV_VW^L'F2<:YV&Y-O[^ET2-+YO8-(=<C*7DU](+1M\Q_>==_
M,_[6_U=L]8,T2-;,/WT:7$^96I=D#$0LT419$6%-V?3&@ W\U]J(U]8E<88C
MQS)D:R4U7-0OW&NK_?:2%)28VK=*.-X(T]P/][Z%1)9--A$,:8Z-0:N._$HF
MVERA)_AL@*:6+LO=\<7'<W$X^D_B:N!J0N,GC6PB+;J1_AS;;BBX4TKNR>9A
M[F."S"P]=928_DM?R+TMMX5M;N*4L?N=K@\2(A%EN:LNN#[_*L.IC!,WOE4T
M3Z\Q;.$(YL1+XHCPADS<.PC'"X)O!9+50Q.Z(S8ZCTA>+A7A&;)YP(/4,[*6
M<LM&Y:>Q2/-^>D%3(WF%X7!?V>0E-;5X9/A+V_<37M3HV2N,5*2M^BN;WD;+
M!((0,Z=+%C2M2@)CYM+DW/*8E!ZY&%ZJS5J-L4:CGW,^S@QC4C8Y':<SK)9C
M(]L;)5Z^'GL2Y=O\9 6O^VA MM9U0\P-F4E ,YB:!+']7:H'\P@4L<_28,!/
M"Q&;>D,ZYO:.M@<W9-.GC8^2(0V?:X>W:FV9A$;/T[@,[4@+T_^AY9R\;=!S
M_YV$;N2X1K!X\:GD3JVSAO\V2TE;_*\,%<9'/-O4: 67IOB0G\4729HW1_PG
ML6F60GYUN]7NJ%5LRB-*U*@9A7[R4-B7E^Q)B.7,S,<!LQ@]WIZ2TO_N,IIH
M&?>+U=EOMC0YDI[T>%6?JMW7CGNM7?29 CX[^U1I_?M8$W<5,1>>31DN7\*\
M$=2_[X+_-1]4G&SFA<+VR.:*LB-F37?X^%H1!1XMIT2A[?2DIGI.J7L<<,N^
MRAY0OE(-B[ZPT ]A.B+R2<EN+,ZH4%-*,ZHF].LY3>>K,WE)!$'WFO(T0SZ5
ME]1DO[=XR30F(_IJ*Q$U6(]UEB&J/?LR,L)L<17*\3]>_'QQ>M1J62_>J4 *
ML\<1^T*4^]?6BU?ZY[]^(_E.9T/7(3I5)*4J$V4!OH<<ZEK^4S4*]COL]PK;
M[[_/&^VYO4(_Q6&BS15E%;Q)S0*RD>R1-O58Z9:=TW.W*9,DM)5S/V(7  %+
M1@WC>@\EF=SL+=7K^>+=VLF:V;XE^UL;[GK1P6:=Z4!FV7$P(/.6S%AUZCW*
M:;$6NXXMF+F&D6$?!DY"!O1UP._RV+JG1F:^F]3%? ]S$(Z!YR>6IW!(;>CA
M@HSS&^K_V/8\C=#HBL1+_YE,B2W8;:;,:OI-?B>;WHV4QHUB:O"BAF3"M(+F
MO5)KD)7W6JU8I1^9-2,OD',OA(FBY)Q%?XR"2]]-/1OQLC%CTB*ASQ=L-&C\
MJLR-J&F)Y(D^JP'F-RP?Y,5451R:11W2N2CT\(G-C6=BI-640[T:Q;0P(@8*
MI:>762K\)_QD,M1K,?, TZK7:8L4S]](STLYT'''M J7'*0<ROA&2M_X (P;
M@=E-=2%=RSNV<1.H-ZAUZV5H*[=*VMJ92[@-[$0)U<592S;.][?@=_![_?C]
M1'GFE-=1<N8:"Z**;]BW:5#[]_>?4K-/-Z+@IAG3M62$+7+3D!V6A*,KY2/B
M)YX3W&2DGW#$F73&/W?.\I^:@LK9&O@J%99?KYRA98>-U6E:)7>-CG=%*9\0
MTTWX2_W8<1A,N >SKB$[NIKQ#S&ME3U#@VZS6W8,B3]]%1&[TEZH*'4VDFU+
MW*J\7JKO4]MUU%M_Z;9FG$N9UY*L0AY%IK-&[H,F4K%=]1+SZ'00#6FF\\*\
M0J/N-;*9NX/ QBI=+<UZB0@*GC',C?_7#:.XD?K;-,FZ(7_R79J&R.992QM3
M;'0Z&'\VSYNZASHS9\;UZ$9*/1([*?/=C:,9%W#"3/F_2KFQ6^:;-,YC#BL6
M0#G[>OY]O]GZ-=,+2E]%I##5*B-S1-/[[0EI7Q6AL*/\F4;M\@!'B>VG22Z<
MKV0R4[)+)S*^"AR%$+WF47KCVB#!<\>9USGO^";=R#/VQUP7W66A8!:%]!7*
MHT\T$;*[UXR'R6;-\*XT5MY-:*KGUU1P<2QMYJG*NU+F7V;$SX4M2QX$)4[\
MF]&&.CE R5NC&/+*@DQLQU,+I28U8V5S%)\3!.@>(XE\$R= :.^$IJM(ZMP"
MP?KCFF:2Z&%""N225 D'NMQ0Q<3HK>$E/\I6S>26$2!(I!(WNM)1,XZI#F-M
M9JI>%7N2+24BV\ML[R/;MQT2%PY]9L:GV-/Y6ZF.9Z+)^(;O9(:@'U6KBBKT
MI;)N#><YJZ>Z97&9SXC+("[SF+A,'W&9W8W+J(U7BP^F>#&CT*P6(>W7#/D$
M(\^>1H3 ]%/ZTQLE1$H:Q,^M5BN[I;@S,!4ZTLRBQ5^)%C?II\<<EF$-9@_+
M,!LIYG<K'A%)AC1)1++_>)%O62E)LP&C%N?R+[H'%CW<?,\H* RJ^5:!;OYK
MPL.B9_/7^;5F!E-8=PM?*61W"E_DIT2DWS#DN.\S6RG-#LO2@\RQ$SPCO7:S
MU_]U\79-14+S$SC#?^SM"VY4LC6-CE#VEU@TJH8E7["90"WCH3>;/.=W>1Y]
M^IM;NF82&JQG7]'<'L^9PSS6<IC(0S8//WF?498\_86LOI,\)?>#2<D]+J;D
MGK.+XDUFV?Y@4S'$M"2FY0<5!-=JM@</D]M%6_KGA7%I@0&>'.)\/3D#3,Y=
MD]/M-ZW><[/J E(%GSYEG;!*!OV7M,/H)Z'^.?9YR?A!CJ2*,76LQCK.%6NW
M'F0J96(.#KZ;@[M-JP4QAYC?*>8<$7J(Y;-;DK:H,ZW9%U3<"@(]@AY!CX^G
MQS;H$?2X19/V@,GI-3L/G!W0XZ[1X[+#>QZ]%#S(A3([4_J-^/GHZ/CXX\>W
M/UH=SI7]FR.HQPKNG1+:>;B$=C;A"K^/0.%8[*<=B_WBW9=L)T-#9_SH30X/
MKT]9,Z N?6%%E7_=Q_PAP[MOK6-X4?)TX\5T9]EHKK4OWOVR]6SS .2WFYV#
M]2A*P'S]-:.+L+9:[4:OV]]Z<$.55II0H$JWA6.@2J%*=P#F"V#=:S7Z@^[6
M8QN:M-)\ DVZ+10#3?HPY'>:_0<R"V!> 9@O@'7WH+%_L+_2B(=U_^2WK1.9
M]8<W>-[_KN@I(/<0DDX5@AP?I).,XC>":U(]JGHL= &,S.TT,H>U99:9O8AK
M2$EXU%EO>6MR3(,\-N&2 937".6]OM4XZ'5> LS0A-"$H ]H0FC"W83R7GN_
ML=_O01-"$T(3@CZ@":L<7 "4UZH)&RUKL% 1KB*8@/T34P08ZA%@.'0<P7!]
M(S[?64.Q6'[8#V(NN<C'2*BZJODA6U ,L"JWTZJL+</4,LX/,Q/9H#7"]E(L
M'S3Z7.D%4(9BA&($>4 Q0C'N#+9_@&5U0CG #-4(U0CZ@&JL4V@"V'XFU;B"
MTDX(0R ,4>DPQ$EVP!/"## 983+6@$&JHE9A,L*;LJW87HKE?J-E(<P Q0C%
M"/* 8H1BW"5L(\P U5BEX85JK!5]0#4BS+"MV%Z*9:O=:'?75DX).R"F"#W4
M+?1P_'TJ_8C&Q/5'B2JEY'+%I6@:T+<B#@0-DCV*W6LWBL7(YD#%I8\@!0Q.
M&)S5YYJJ*&48G/#%;"NVEV*YV^CVVH R%",4(\@#BA&*<8>PO13+G49G?_O/
M6H)BK,SP0C'6BCR@&!&BV%9L;WPG!(Y\0#RB+O&($W]$CXHDAR&RTQUB^[O(
MSH 0MN<%-[8_DERY:>SZ]-&U/;HABL-$;:(0P8U/M]D^1S.N912K;Z$@8&["
MW*P4^51%)</<A!]F6[&]%,OMAH5=%%",4(P@#RA&*,:=PO8/(O?[[0- &8H1
MBA'D <6( ,4.87OC 8I>[C[')HHI@A;U"%J4SJD.Y2BX]*G7CAB'P43$5U)$
M-@$^&(LCV[<=ZJTXOO@HADGD^C**&KQYPDMXM.GFB;2CA/\O.WV"#Z3@OW"R
M-0S2'3!(<?033C';$L<,H+S.4\RL1G=_'\=Y0A%NJ2*L+7E49?4*STQE-2.P
MC<)/4(U;-+Q8(VZ-80U-N,D8!:"\SC7B_F#Q"A$[*!",V-)@Q*'90?%ZSU%A
MB9=OQ)\^/=)3(0DOB*+7>Y>VZ[\L1BH"7P1)6-PC@<I.L"AWR**L+>=494$*
M9PN<+=N*[:58[K<6UA'=52!#+4(M@CJ@%J$6MQ[;R_<3'K0 9*C%[52+<-HB
M_H#X Z#\P_A#>]!=6_P!&R2FB$G4*R;Q1GP.(CYC8GF]IH:P8S&VW5#5>I((
M1<"XW"'CLK944Y5U*7PN\+EL*[:78KES@",FH!:A%D$=4(M0B[N$[:58MMJ-
M7JL'+$,S0C."/: 9ZQ2> +;76_2WMSA[;14%G!"+0"RBVK$(-W8O]4D2,CW\
MFL8Z&+EV+!UQX\978D13SU6=IF%P[49T:<2!"*[I=!X'HV]7@4?#+<ZX,Y$X
MO REJMR$B 4,4!B@U2>DJBAI&*!PS6PKMI='+/K8/ &U"+4(ZH!:A%K<)6S_
M ,LHX 35"-4(^H!J1,ABU[#]6-6(314(9.QD(.-D,DTX8N'Z] (9Q;R]8FK?
M,LA%'(C?WW]"0 +F)<S+ZA-+550PS$MX7K85V\LS8MI= !EJ$6H1U &U"+6X
M0]A&0 *JL4K#"]58*_J :D1 8ENQ_9P!"00?$'RH8/ A/?+ZPOXN;NBBL>UY
MD4BF@2_X" D:1F'[CI#?93AR(W7X=<0;)EX-[4@2>H,);[C0FR_L&SMT$(V
M;;FEMB5*+*):Z)9X60#EM9YHO=_'>=90@U"#X ZH0:C!'87R7J]K00U"#4(-
M@CN@!JL<6 "4U[H:M%HX.P*1!D0:=*3A@QS1@R(I:&8<.99A*!W>QZ#.B#"!
M!,\+;FQ_)'D#A-KP,)6AK8(1GCEW8BQL<9R$] .-:)0,(]=Q[? 6&@/F9E7-
MS=*(O%'1MN"&1498TYC&VY=O17G4- ^(*/!<9^'L//&1\ZUOF];?WW9(/&G5
MEABKDIB I)L-NXB>*#B0N^V0.^3*PJ2HTO#"I$BIK;XNB3EN>R:GQ#UM"OC;
M8%- \#;H#6ST6P<(B\&H@%&!]5+=UDOP4VPXAK<=-@7DKFX;EPZP;VE]T<3:
MBH/U_''$PNL&"I&'SK^3B(NF<9Q05T6#RH%Q757C&KO;JVW IL0R2TD+].XO
MX!F4A-DNU"] >;_=V.]8@#I4*E0JR 4J%2H5J'^B2NU:C7[_ %"'2H5*!;E
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M2Y-!#\"&(-C>.V)[O_>(OZD5/;K7"1)B^3ON3G^<:ZGU&!.@#1/@F8K9:I,
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MR)&<#&7XPY:8$_GF#W"'O&U<WF9;K4[ ?(H0WE,$:B*ILQLEWYA'"_U#[++
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MHQ<8ANUJLLR3#$-5HG:#EJ$IB3MG&BXR"N_JJPK@+[+L[[(.8=)7RJ2?"Q?
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M3<C4_IM\MV%>4B&4E^QLX:7E-!EZG*:1EUX<N^%$IVW,N]6CU$N3;OL8<>8
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M4#43=@2DPLK%KD&$+=M5FG!;#DO='?U4 9$I"UT4P ) R;J__F8F0!)<!1(
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ME/#F5@,,0SP<YM)</'PA/"^7NC,51\E""!73/CW5=09:GW6J=B\:#J72LA6
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MH[K&P-+LX2E;Y1'M1+2SN]'.JRFWU>"[,B%>3/+C1E=*.2W$-^%TM']=X'1
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MO\XI%7JM5><,>6FLN9F$WJ%T4!N+V*M :-+FV.LWDGA^0,8*\:* K@4"K7!
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M)*V ,"$E^4/2(E+5OEU=8QO4(^5@5@^2CC2<LW(Q%=M775O3AT/$ID#D(')
M'H@<1(Y=?=J44S5,/E!=2[/,%X^C[:KM@<G!Y, \,#FR3-C5=9\%4H[)ASRS
MI+_HDU>064)SU139)DFR30]3SX\V^I[,'AJ?H');JG+15HW9 -*'I[")I1RO
M]UL8CI_\R63)NX6/M#-TU>UK0PS9 TUW@J:E!3@IW7;P=AV\_>+>/HO)Z,S_
M<7;OC^DJOE'2_]*]/$JHK_96P=X_R=[G4T"P^4&E[:12. OP>*5/XV 3RSD-
MKXS+RP;+]S3#Z=4W% \-04C1")VB8=;"AMO1U]!'-O/C>V9#Z4R[VR2?M3%T
M9&V@8:%A!4,1">@?&A99&^DW<8U9&\\/8L;#)+X*/J[P\-7=!\K">34;\SUP
MMD_6FJH[U/JF@4P.J+L#U"TMZ$D:S0:7BY;),9#)028'5-K&QPLJ;3.<@$JK
M3^V4HU(35-HTE:)%!OF7[N1?KI)[$BD3'OW1E( DX .H2U'5Y<H3>:,\T4T=
M/K'MK1C3A#[O@+Q55I]::K-*'$[\\=;5*?F1FU=O9E=?7!G,)L20-W2^0?\-
M!<\+TC\R0E5%D4I:S@D-#R8G@,G5E[_B$N9+&(13/HPY^)Y+:!V8NF+'E&H]
M"ZDK*"(H(BBB#L$S%!$4$4Q.($54:BQ@A9+(5EVKIYF#S:.HH(F@B:")H(E:
M"]#01.43I-!$,+G*-%&I3KT*-9'#9]68Z-N3,V\LK4D;(F2,T_&D2OK^[!PO
M)?%^D!A,":= 5*< A8DR%6=!=Y^B7P^[6IC1X>4FAS,*7AQ32S_6#V9T%:^F
MV>&T\7M^B^GK;AA3?_R11!Y=83_PHN?+A#S$5!BS"XK"R82^]:#AXT9/=0UC
MJ.GZBP?;=M5^H0:@!H";4 -0 ]C5]1\)UK <Z*NN-=2&#HX5@QJ &@!N0@T(
MEI.#&A!M5]=YK%C#:F"@NDY/Z_4W:ZIQ-!GR9]W-GR7>#X7\F)(@)K^\NB4!
MN?,3#+B$2A96);>WK$Y:/)-2ZT#!H], %B>,=U'>N:!.P\=4R+Q/94PQQV#(
MI]_;O<T3WQ FA "" $)?05N+G*& H(!@<@+U%520;]TK@EYN*3!UJH9TK6_9
M:+.$'((<0CRH,]XIU!"Z+&%QPL2#*L@V'Q<0,@W5[6F#_J8"JBI1;%K=[:K,
MOZTW1998["QQ[NM2_^57*I2"^>-]'T[&BZ>[XQ%DMWM+7TK?_H4D6:?FK[^P
M3W)!MSM- H[&B1^W>(['^XDW^E.AT$@_;QS.*(GL^,3Y'S>NWCC&\9!WE+GX
M,F@=?+?(HI\!BKNMM.D(;9TF"6,4W"<IXY)0Z;.L@2WFB)@L%FMJCKTYX*7C
ML5A()C$>-R034!J227 KA62",<K90GR$9K)4U]&UWN#%Z"W0 9()D@F2J94H
M#<E4SDJ;SGQ#,K7(&$^:^3Y",MFJ:P^U_K!_BH0W6J-WPPZ2X'(DP3]Z44 ?
M7:Q,2:3$]UY$LF.<;[W8'X%7X6R(\KCA;$#?P-D0W$H1GX4QBI'2OOSRZ2!G
M8RZ$OI+HFLF@]TS_+)P.?=7IH"_B6BE>]3X<U=7/>\AP0T$)^;BAH #:4%""
M6RD4%(Q1D QW$Q*JQR24]>)@2Z %)!0D%"14*U$;$@H9;T@H08RQ7,:["0G5
M+R:AT/*-;#>RW5FV>^Q/9@D9@U7A:HCRN.%J0-W U1#<2A&MA3&V(]_](55
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M>%JK0! + ,H@%@#D02Q 5$MIOLR^C]@]^%IT,P%?UQR11/,M4*;S9@"4@5<
MY(%7T+BE-.\5#. 5@*]%-Q/P-?@:R .^;MQ2JFB^+<?70_ U^%IT,P%?MXJO
M;Z4E;'W5U"VA@.?X*B/0\P[#J**E%?M?^/W_:F_%K56FXI87\%WDZ_<N@U'X
M0#Z'<?R%)%=W-]Z/KV'$OO5=DD3^[2QA):\WX5<OHG>?+[^-^;8ZVU>':ZBN
M;>H;5;BO,3$#:J*M:D):,!7%CX'WW]D&7%N'^P_W7W@[ 6&WB;#A_@CF_H"?
M=U6WU=%OB^TOV/;?[_V7ZK<]K?=O'N3]XU3<:N C,W\TYG:J,?>#_TA?$(S1
MB0NY?NJ: 73B(BC0>3, RK0J* #D011?3DMIO.;>-A#$!U^+;B;@ZYICE>C$
M!<ITW@R ,O *@#SP"AJWE.:] A-> ?A:=#,!7X.O@3S@Z\8MI?%.7-L"7X.O
M13<3\#7X&L@#OF[>4AH_;=:V0=@@;.'M!(3=)L)&\X!@S0/@YYW\7#X COTO
M_/Y_872&4:)Y9E%B7^P,.DMUC:%F.T.,OX B@"( (D(1"&48Z*;MQ/:OL9OV
M0$%@'RH(<"SMX>:>F2NZ7SO5_?J%)(K/.]G!<]#7@K>_KCR1-\H3-97PB1F-
M8DP3^KP#\E99?6HI$BAQ./''9=^^>:5F=J7%-?YL0@QI81 YAZZ9*!!0L A#
M20C;MCI Q7:@(@H8I&D0:)F.V5M;X:"V CI'=!.&SJDY8'QH2W/+$!((" 04
MVT2!@/#T@(IRH"(\/7AZ GIZ/7AZT#FBFS!T#G0.=(X<J B=(TT+?9=T3A\Z
M!SI'=!.&SH'.@<Z1 Q6A<^09/= EH3. T('0$=Z&(70@="!TI$!%"!UY9CC(
M(W1@K')(F/KF2WPAR?(TUF(MI8[JVD.M/^QOM)1BQ 34%=05U)5T@ UU)<T\
M#(BKCMOJ:<55J5D=1XBKWH'B"@?85X-0&<)@A,>FX8LSPJ/LQ([WWL0+1B0+
M"'\@(_)P2Z*4FRU#HZMO&N!H.#*"S_*H>H;W$,DJ8<0(DE5 (3G"*3AT R&+
M+EI*XX=:.CKX&GPMNIF KVL.G)8_ZAZL+#Z^[,_\6OG@Y.673P=%)Z_I%9#X
M:I;$B1>P15Y$*/5<A#+FKUH-4O95U[ =S="1 @8&PF<!.I;V6=9CP16AY\_0
M976X+S -^=SY X3$@5G.ZR0<_7D?3N@BQQ__FOG)<[%4YX"J",UV#&@(: AH
M"  E-(0L1G/XD -HB/9K"+L!#3%477,PU/I6#RH"*@(J E )%2&-T1P^0@ R
MHOTRPCF]C!CJJML;F) 0D!"=D1 X,[:J3.]>Q7!\L3H40Q6]^#@^N77')UN]
MVA1"S'?*V3ZI8*BN:6JV[10]4+FKM@JYT":Y("U$BN]5(>(@;K<Y @[M#SCT
M&P@XF%1%](::;=IU]WFS>$KV6-#47<+NT=1=4U,WOQRS0N_A&XF3R!\E9$Q?
M0<U3\>-X1O_A!6/ED?Z-KHX2WBG1^LN8M<::$I $S DUWZT><,= 3YDP/1_H
M*0,*(:8 Y&G><4(/^'9+:;X'W 1?@Z]%-Q/P=<WA3/2 =P%?]H<OAZ5ZP%GD
MXY+'1S[,(KK(7^ERA>.T-7P92.$O>_?D1>,O)+FZ^Q1&=\1/9KPQO%C/^-!2
M75/3=0M%5D!,>#C 4G@X0EL*VL2%M(<FM<4QJ=%-:?%/;S(C!RF+O8E4F\H*
M'9H"FJ(SF@+5JH)5JT)"[$IJUM$ECNTOV/;?7ZQMESD_HTH)4:"TV]FJ)5#6
M#3'16C$A+9B*XI A0"%S]WBY'*R%'*PP<0SD8$'8(&P@#PA;6$NIHGF['&';
M(&P0MO!V L(&80-Y0-A-6TH5W=+E^-H!7TO$USB*NAJ#S P*7<N=ZEI.2VZ5
MB$QGT>C>B\D8C 1IW+$NY!X(7R+"[ZB9 (7@H -YX* W;BG-=R'WP=?@:]'-
M!'Q=<YBPCBYDE/E*5>9;01?RMV7D8[,5N7";<4]UG>%FDS&*>(&(K?5@@)6"
M824<EOH<%FQ_X;?_(5+AF(Z@'4J!MP45ZQKNJ^[F@9'0"- (T @ 26@$= UC
M^TO>-5Q>(PQ4U])L8_-42.@$Z(36Z@1I<5*4O ZRH=UM"!X@'8ITJ/!V L(&
M80-Y0-B-6TKS#<%#$#8(6W@[ 6&WB; 1BA0L% E^WE785\=IR=C^@FW__9%X
M0X!L_3"-Q ^*1N(K:$1&TW'EFEQ:NV]STS$ST+-;9IO4[!^F)(@]9ED@0XCP
M]K4>RP8\</6[9@9 F5:Y^D >Q.;EM)3&6XOIJB T#[X6W$S US5'(,NW%H.;
M@3*2FP%0!EX!D =>0>.6TKQ78, K %^+;B;@:_ UD =\W;BEU--+"WL0C8F;
M.8&73^9ZSVH'+G*E T5*>OJZKKJ&KED#9Z.F!\VU4!)0$D!.* FA+*7QYMJ>
M"==?&,$!UQ^$#<(&\H"PA;64QIMK>Q8(&X0MO)V L$'80!X0=M.64D^W+>Q!
M-":NN=NVAEB]<6"L'N< 5P,5F:FC);=3+;E7R3V)>#-N1.ZIH?J/1)F$<0S&
MA'1'2V[3P--:68(  5 & 0(@#P($HEI*\\7W-@+ZX&O1S01\77.8$BVY0)G.
MFP%0!EX!D =>0>.6TKQ7X, K %^+;B;@:_ UD =\W;BE5-&26XZO>^!K\+7H
M9@*^;A5?X] /P0[] #WO,(PJ^ERQ_X7?_R\</V^4*,/E!7P7^?J]RV 4/I#/
M81Q_(<G5W8WWXVL8L6]]ER21?SM+6!GL3?C5B^C=YVMR8[ZMSO85YYJJ:VJ&
MCE/JH2<ZI">DA5-1/!GX_]WMR^TC (  @/!V L)N$V'# 1+, 0(_[ZIOPZ&W
M'=C^-1YZ>UK_WSK0_\?9N(>#16;L:,3M5"/N!_^1OB 8H_,6XOS4-0+HO$4(
MH/-F )1I50@ R(.8O9R6TGR-_0 A>_"UZ&8"OJXY,HG.6Z!,Y\T * .O ,@#
MKZ!Q2VG>*QC"*P!?BVXFX.M6\34J&02K9  ][TJBU7'V+;:_8-O_A4:>,F??
M+@H BHW)MU77U@8V.G&@!SJD!Z3%0U$\$?CO,K?ZEG+@^SH<>#CPPML)"+M-
MA T/1C /!OR\DY_+!]BQ_X7?_R]X\.;I/'A'=0U;<TP=+CP4 10!$!&*0"C#
M0&]N)[9_C;VY!PJ"'A4$0\WJG;*[%D??+@T>';>=ZKC]0A+%Y[WRX#YH;L%;
M;E>>R!OEB9I*^,2,1C&F"7W> 7FKK#ZU% F4.)SXX[)OW[Q2,[O2XKI_-B&&
MM#"(/$373!0(*%C4H22$;5L=H&([4!%%#=(T);1,Q^RMMS!0;P&=([H)0^?4
M'$0^M(VZ90@)! 0"BFVB0$!X>D!%.5 1GAX\/0$]/1.>'G2.Z"8,G0.= YTC
M!RI"YTC3Q]\EG6-!YT#GB&["T#G0.= Y<J B=(X\XPBZ)'1L"!T('>%M&$('
M0@="1PI4A-"19ZZ#/$('QBJ'A*EOYL07DBS/>RW69MI774?7>@-[H\T48R>@
MKJ"NH*ZD VRH*VEF9$!<==Q63RNN2LWO.$)<#0X45Q6,\,"XCL+@@W$=)QO7
M478ZQWMOX@4CD@5_/Y 1>;@E4<K#EJ'1U3=-\#&<%L'G=E0]P]M!8DH8X8'$
M%%!(CM )#MU >**+EM+XH9G]'O@:?"VZF8"O:PZ2'CH#HD@P$JPL&K[LS_+:
M^4#DY9=/!T4BK^D5D/AJEL2)%[!%7D0C]5PT,N:O6@U(#MDI SW-,?I(]P(#
MX;, '<OZ+.NQX(K0\V?HLCK<%YB&?.[\ 4+BP(SF=1*._KP/)W21XX]_S?SD
MN5!:T]"IBM#LG@,- 0T!#0&@A(:0Q6@.'V@ #=%^#>$TH"$,U36'AC:P$8F
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M%HH$/^\J[$-O<@>V_^EZDX\,Q!L\$-_73]B'C)[CRB6YM&;?YIYC9J!GM_Q
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M>Y"G0_<D00#GD"  3LL]'!\R^T9?;J?Z<C_XC_0%P3@&+T*@HPVW::1IK?A
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MX8,23DGD):QVB!6-/?J)3^(W$".[S&57B2U$BL"+5JNOAF@N3*9]BP:3@<G
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M"A]]UGM]^[RK2!*D",TNTPJ<4K,#SZK!,WT-SCBG+'8]$.C$\3W #0!?GA4
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ML8%L5VL%0+8KQ3E MJMIH(/@5S(E[TIK>DVQ/XJ[)?EUM]:SNLB^ S6H\ J
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MS[J')5]?JC!*QZSUSCNSA5&F*Q0CGPO^L=+ 0<G\8SJ?ZSH>BA"*#ER[6BL
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M,C9E)5WY1)@NB2]]TW3IP]/OD7!RL<D7*6-:RF]OFK5>IUT_:Z!\,<A6A5<
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MZH$R@3*!,ATV:H,R5<LW#<IT0)OOT(+XSI8.XD.*-!S8Q^# _IGXE)_,YX?
M<]+I7/#.^OWNZ*MT^<UD//;$B&YM>X;C1GTOB":A8)]WUEW7]14*T#9[]_-/
M_, >-#:.*64]IFQ2I@A@M#X83;.1 FD9(Q)U5\4) 13 8> P<!@X#!PNPUP"
MAX'#P&'@\&L5Z9P&"N2MP.QW6,BB\U;&MNNP@=YP_7XP$D9L_Q#H% 8F4EHF
M@@""TJ%9^7V8""! S"4"""H20+!)2?8KR6)NF<1\(V;S52Q9-OV\UC//ZF9[
MMGL:XBA!@T"#0(,. 8E!@T"#0(,J0H,V:EJW+@_J< YNO=UH@ >!!X$'@0<=
M)!2#!R&?!#RH(CQHHQ9]Z_(@V5>W];(Y:'V_< ,Y(G 65]=93#<740PEB9,!
M3@8X&1P,.<') !92G PJ<C+8[&"@&,PJIX+S1JUGHOT+.! X$#C0X<(P.! X
M$#A013C0AE[B-4B0*5W$3;,)$@02!!($$G20. P2!!<Q2%!%2-"&+N(U2)!5
MZW7KG6YG.?_P7^0/[ #FO^:DB=[@CX$WB8:5%:;&U.KE!8E7+A$E:WN^R522
MFM,/FRIE=SFTPVM"MM!U! M%H:B=G!;E7O]Z_?7D\N+F5^/B\O;J'U>W5Y]N
MBB7JIE:,QH'U6GZ]K-8X?F;)KGWCOVQ_8H=/BN&:=<-J6/3_\5 8E\&(UN')
M"(5< '?@"D=^P&WVXB>"@=&8-(4?TS<\.^8/ _DYX8/4:;3G2)?$(JH;OHBY
M)J$C!B02_$V."JG3A<ZD3RMGV/W^9#11=Z$ON7TW-NZ>C+^=F6=U3H^FEX[X
M>_+V=A@^\2^D*R:RU.'<A\KK6_5&IY-_#@D*8X7M*8<ZZ9Z^/7:Y>B)_O5D_
MZUBRGV!Z17[(AN?:=ZY'=]"W-^L-RZH;$YH'.0AWE%1CE$!)0[OH]X.)'_.=
M;F*ZL1TZD?'[V*$W-=YPDT*K\?[BYG?YD_G^K5H&6H-&83?Y@5SV6N^D<99L
MC_SG5_0";G]>Z4A7?C)/4FN]NO%1W,7JD;)?HOE>_<)_)E(0#TD&>%8C?AF>
ME6MZR="X'O/;17H@QINO--U:?AIO3[%O][)O?[.3/=N0F[99W+1N%$U(:(D;
M-CKG\V7)T L8$533#).PWM"4BDC=]M+X&O@+A/ ? 0MTLOZ7N9WW+4RVRTT<
M$"E\PV/28EZ\^]0WDPU@O)&[VC'LV/A;YXSU_%NY2P/?%XI^2,'D^]($CUP_
MW6IN'&6[E;X?D>H)Y:>Z&>A]X#FT[9]X@]+[WM'4RX]/C=MA$ E#3\0C41(C
MFMQ%A'/T38\1<#P)^T,[HAO3L[X&#V)T)\)DLZKYE\$Y]OU]*.YY<Q<&P,.S
MQ^,P^$$L*!9TR[]U6O6624@KW^9OK4:]T6@H3-)8PJ5<)0#QW7CS\1]#,;)9
M1,($]I*!&>/0[0M^.Z8Z/&,T>D(UV_?Y']>/" @\_>;J 0,WC&+>1S141S_!
M#?DGW^5-;_-RI?":&XT>M!_0<$@5A!+Q&/SIZ6EXTBE)DS"^2B0V37E[TU)S
ME&%PKC(M<&-/^G[B)V#=?@XXZHWFTKA!3&!$0A6I+6]'.84L54<P5AN7/G&5
M[-'7Q=/"C4T2,0F98M"]_W:FMD:VLTC2_;X[9N$>L6[E;[5.K?;?"TAT(WR7
MA$T)H$,\@5]U@9#)8\ ?EX)%%]*V4-KZ<H+6.P^LQU!N21B(&BK19/A1S([D
MC@!%0LU]**E<&&N@BA3RLIE"DLD!*0B2%OH2 6 LD2J:.F#\Y+@/ZIR82L67
M[[\>I!QLP[SPG!0D]H5W!KW?#X/_TS_$;/69>J!A>X_V4S1E+'HGK4'*T&3D
MQDYW.I7W*;R>-!L9Q?F8_J:<%O7%W'L8^D6,;%'2"_,K:L@EI165"_KMAI;S
MY+NXI\,*7=L/O(!>Y(XM8"2OGT_,QC,0<Y RU=FQI<&:?A@ABVT,0[8-_?7V
M^K+1, DH).LA"+ADVY3<X[;:X/R___B9MGBR'"HEX/KN7Z1U9)) :J8P5UB?
MXJ]CG2E  V-+U6V[<4ZCY"&D4O#K*G??X^K+1@+KKKTTXCP'*0\![>+M8$KV
MP(V[)OS3C9Q@=!L*HK)7?O]4LM,;8ORNXTK6N\@$A47<U2(6[(7FDLN9\@3%
M\N@$<IG7_9]3W7^3Z?Z[\*?>]DPH;ZY\/CQ.(I*@J&Y\^M$7X]BX&2J&XAC?
MZ*2F?KN07#5Z.R5:RH3]=3(B0>C/A%CR[ZY/?/PB)N#Z,*$CF(BBCR+JAZ[D
MU!>^\\&.W.AZ0.?I*#$\L<;YX!$9/^DW_N![_$$S2A?98WJS.)R(:3O\ZG?.
M3/)FI],F!,YMDI*Z9[:W2;K=]7?)8D6W Z S3XWK\-[VW?]59@@6R=P:L\),
MEAY6][V=PJ?5#Q_ PV!R/Y0FK'LON./C2DX=&6^(9WI\2GX0WE,],:AE]]'6
M,X,.O#F#FS[2)Z:U.IWM#3NY?W8P<GT_>+#C(*R3/ QH7=A.;CP*SUM@_G.D
M>4CZ Q(;8#1Q8\F_Q(\^S>:]6'!I'-I.=M4X#)Q)G]XYL81_NOT69<,=!8[P
M"%4)T2?2XBSE-[W($S0,^YZ'>\>01 ]FZX+H#WUBY?=/IR3;KL<BRA8OGMHA
MO5Q,RRFMA>JMZ;;3]@\ZED2!X=#=O6 L)X.>.K3I@?;$[P])L?BTU@M>\%[X
MVN:7O*3CWDO_0C)N*?L/;E^HUXD(C_OQ)&1WB.OWO8D<<'(1+6CV;@L>*7PF
MO^FDCB8Q6_P&$])(Z<1^U/?[S']-;:W2YA?\*0@?V.(:18*'9T=R\?E?GK07
MG\\6V <Q_;J/-DEL7#<R(36^A00&;&S-9GNHC44#DN_@D=_\<4@_/BUX5/#H
M9R\:C.5,TS7YO?)N!L$^?/EC5&KT\MQ(7W@R#B)I&WT73&(V'^<_BY_&XAWW
M^'H6[EJ=&:_^'A"/6,"SD%=8S[L)BT91DVUQPJ<YFA3WL_=J"/J9.A;&:HQ_
MO*<I'7LV'?1=WR-5>"(%/JWNONC_4WVY+2J9VR@7O!.-WVR?%H)9JU(3B=Q+
M%*<I4N/XGR#\T[B3K@G7?Q!1+(WQMO/@TIP9H;@G 1+L$4FMJS>?+NN,1@^N
MA)KIJX+P20)#('U]HW00&6QI-V]NP+?A)(I3L/GG[6T!8G)?7$D]%"'LT^WG
M%+D4B.3NRQ]*LZ V7VLS\^^G-Z=JFNZ>#!J6_H5^4K/H+W1QY8V(R7@^"L]^
MY(>P*9%V!$U4+%]\P2PS@MIL_1:+H3N#[6RB<RNB39^SH$EB)/Q(^=SY=?B1
MDT@U_A-AS)I0N\0(,PW>I3^$]/S0,&@1/&)]#X+EAN9AH&G#]'SF)A&@"E"M
M.*AF<&K\%]%7\61\<4<NVPGTXQ*@H2_^%SMW-8))H-!7*)S-;56]/W-PN@ P
M(Z*3OD*G,"JXQ=7CC"OU4?98GV E&A/I3URP3(X3?&-892FF'PG9^-/B;6A@
M#XK)2]^<X\9T;.A/PE#X??XI?!K'0?*[NIMBTX1V\Z&*OG/B2H]>2O6(NA(\
MWA/I CX 'RJ/#Q,O=F>H5P(2:;!3RG%^N_CMRY9!8L%HU)XVOGVYS![_V\75
MDE#!S(>^G5 ?^G$=[C.>W-$D$N8HR$Q>B8;K]EU/,:XKC@/T'8 !P*#R8/ R
M $SM_E3\M[/_]9Z_NKSX1PYS^-=GMGWN^M\OKVYO-(W/<$#>(#T$R9L#"X %
MP(+GL.#W_UY, G[_[R(%^/WTOT\U /33\/E9XT#FF;P,?+8*&Q>3>!C(F#?%
MRCGL-,,+FI0X=.\FJ1,GFHS'05A$#W4"J!N*FBC+RV]?L .Q ZN^ S]-PF L
MIG?AH@WW.'3[0_Z4=YHG[FTZX:8;*$@CIR43ED1YRD:9J4YI=N/ \-1A$W)R
MR:/>F9RKXH:D?VFO2NWZ^W\GNG71V'E8?F!X@7^OK+,ZYX6'X 2"/XR3NQL:
M/?17DD%@0V-#5WU#)U1YSHZ>YM')KK:5@OS?S.+%\=H<_?O!]O_D39U<MT!M
M0E5B9QW^SDH<_9>)V9>3NJ3<UXTO7RY?]"$FVRT>VHI=LM93JC0:\UDPG'/8
M_.#&_8 .?1Q=4,_T;\9DQ6"@HE<*_C&M+&\7WTPCPLI>0S5\>?"-TNR4-%WE
M3O@RQ53&OJAL)0D!;I38U'6&U.5=0./Y__\OQ_7) >APT>=&K)5W1(.F'3DA
MPJ#=I31]L<[2XC&H:P Y@)Q#@9Q%\0K9:7G.5XO'YW)%-22CG8YN^+@PO*$0
M9C6#$X5/7XY6^)B%*WRL7+S")YMT0/Z%.3HAFA^HQU//::TR:L'6":EV*"L/
M$-HE@0P)@-,(?<&1<2/:[+D[1L8;<7I_6J<]*#S/#ODKGWBYQ63TMFX0#<R.
M6.FY31;43W]3;\+K(2FG#(A3NB3DI%UZ]-P7H!T_H=>EZ2LX5N$8+0>^3X]:
MUC<"Z&\']#D7/H7\Z5"*/.3K+[X,^ D%S>([&9=4RG &UW<Z;OTE^VHHE^L3
M)YKW%5Q]%?$C/>W4F#,Z&5L5W#$2::L,#3,2XL^IXB$RF50/B>BG']$YEL:0
MA&5);:+&+VCHM'8Q)[JGD59)UCY)C>VI3)&$XTIZ/1.32YR:O\>!R9F.VR@R
M-Z?X=/#Y=*0NO\/ [G.]$WX-!7',XNE4(7$M*<"DLU<6)=-^1S(MDFG72Z8U
MD4Q;MF3:0BXM9XCU3WA-3CZ']DBLL":U)/U-Y[BI!"5.*MLLSZT'J@6J=5!4
MZT;TN1J*RR:\/,E:2*"2P QB&6.N:W07$I\(%R5S"6(@87I6=T\%G:!R.43$
MKX@-T5?H")6R 5F*C6F/JKPH0\47'H-Q!'K]?8DMN-$6O&59'XAPV1T8Z^\;
MM'#^0GM+WEY5N$*'9*O+0CO,N'IR@)AC:)IZ9F)04;;[8* -WIE)19I3.#N$
M7FOHCGD+WP7!GP9[U9YD$5<]"%*L'-8U_T;I^\RSVF0W3Y[WG/D&0 &@J#I0
M%$W&.F%K.<];HK63&J.)L;;@D6/SQ)T0OMR?*OLK-3/PC:=5?_$6$UDYL/AP
M]IXS 'VQ'U4=4]J^@L[X,@F<-F;(9HU!&(SD+B]>*\MJ&!\%U]^2UA/:YKFB
M&_F %6DKR%/]E:M?W)#XN@0^M".SHJK?Z&3+=M:5*UXL=[=\E8NNU465BU)6
MN;!.C=QRYDON)@NZ2=$5=>R<$I(G]?^K%UI9ZFX%L6M:!;%K[EGL\L"W*[$[
MVZ_4Y?1LS@PR+8,KZ0(MB7)Y&07S5HJ<\,VSF,XW@:PJ=3U4;-EAQ9;;Y0I+
MDGKFI&K6S^.0M:+R[=)UK*Y9I4NZG/EY5;40SWOB*I=B+"-!,_32A4Z9>B<.
ME5\N+KX5G,_:=<R%2G1!GYQC-A0#KAICV%S-P_G71#EIZ1 CBQ-'\B%,TWT:
M@%H7UOZ34)6 R5_@$RF((EL=#(@8#&PWY'=,A3R)"IHW+>I\\O+LJ?(G0MY'
M3T-:?SA7R\8\?Q^M4"8D7QSDU+CP=-!/&E>8/$@60\G;-++%%$RK?#EPM9SZ
M19*RQ9N3F\O\/=?4+<_=HZA1.M HV]4H<XY*ZZJ0PBJNJ#K6D"E+2<:R @@U
MLV,UDQ;YR,%EQ#89U72"X$>'5ZJSH"W7/"0L9,C.U_1*JK#G[^D(53*?B]P/
MA8R$6O(^*B1&C4,F.\CB\8;@8OW*')S<4#8(45^31]T'V2L@NY'^+%%H_[C^
ME.HSJ5GDFJH2]@NNN$JO4&\WB=A6S=8G:8#1&FJ)]S'HX3S(@IG*)@7Z+Y6)
M-37T4^.JH(OTQ"WZ>OJ(^M2<Y!7A;&&7)4=^]8EGW)\SGMD)E):#-"[5U:T]
MWKBZVX@,2 @>>>T"'1BE5;#T]>>: /!3Y<U& =TVRLY<'#I%8] 7ZA62>IJM
M@IP7:HQ%*&O]^WT5[_#&S3\_:\; @[#OHB"\,[P@BHH/U]9/N6'YB\I6(71$
M+RGQU%"1#I6T.W=]"-B1Z4JJ=2?R0T_B_NB"YW7Y+$E?$F"!F?O"3.X21!(3
M"56Y+D$GQ4X3@,I@3.(38P")5;JADNI)TNZ=Z^#!]5N8CO:)'V_+HB7NF?A^
M%YS*N:EE8:F;%6A@JPT:6%H:J)=30N4O(K@/[3'I?>,J:YBRCEEA58D#=.T)
MNHHE8 NU7V>"PUDD5%:I/,BK8JAI.*3D -RJAT-XL@J9B3C)".]/M]_2;!Z^
MFXPRU(:#,,O?47Z)M+G9]!%<I_<0>F85AF7'H4+QB[2^:;&P:";''!B>YO3U
MAZX8Y,;-?2-E"YF1_:<B**3"@SZ['8C:!),P*:.JXOH'1$&"<%L>A\^TR+2N
ME[I,UFW..'#A._)73]XY6A.SUWY  <?;#>!X:7%<+[&1K+&16]5U$'P;,@E4
MWR6J7ZBL$56A+VL7R1$0>5A_E"WG!A._KW$SK<;GJA25(N@[@4QIX9"-6"^R
M2%*D-3X+7P9=$':Z02Z>/)06!'DP8N3,/8C0=/H!T:GQ74033QE>-0[+RMO%
M!]OZB*AJ!DX_C+O/R8Q/PYF$2=M.-2YUX-6'Q<1FK/=(-K!,C'-F:)X8;2).
M[=Z%?@]9EP<5O#H:AX(HO:QT>N7W@Y%VDF>-2_D=I>+H%[[LRB__](8/H&^W
MI$Q^C\3UX%,4RP: T;(:HGA5$?9!W\L+^[^K4KSIRJT#]0LE!OB]:U:NO'<%
MQ]8,^UW"G?6,YX\=>4G[S"C/EV4NY)\$J<G")PQ],E)M=Y59RU;XJGJ"\FF.
M07F4NLSL^4K(3JUI=[8G37'14!#U=]('+;IAR/:/B?Z2^#%664YI/I/$]BCQ
M"+)=\Z(O0XA#K4V4&<YQN<$$]W>D"Z0Q3AOL6!>F;[PEQ/VNAOQ=](-[W]W
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M,QFQ555>_%T=NC=QS"QYNYP!HMMHP$%37GOG3<RK_T$Z)R](QSMK1<BO+F7
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M?IMYIXJ,88ML/*K&2G+WU0GV@B3D35465,U^54UK(U7330!_"YK&F+959;&
MS]BH1,3V%)?PDY-6'O/N] QYBG6#V:*@B_A+E1,X[D!!(R=FJ&834J,D2DC\
M<%4#G_QM3HW?TS!??G "//5,GXTF!4L%[3RVE=P'(8F=QGH%FTDL!8TX:0R?
M%!7R5;1$KK=!J.PM=-^^ZZD^"!)+GM3SI$5J, DEMN=N*(KQ=)QAHB HQ0 W
M:W"AXE=4P(>J&Q*HI"4U8IX+:90BR+)=3]HSYDR[MJ,]!A//T6TTN$$$O<?(
M_E-.L.JBD<\B2@Q0TW">L[$5.$/.HUEXO[FV$JV25C5T% :26BJTR4>69!YG
M5A_M^4VM4AKZ<[5K<U,^92]:06&,B3>HV=!@GM<5\]&\O:4H;8+4YW%]S>CM
M5>^;=^%9#52AJH +[T*;][;EPY,'[PWD$6QCQVQC#@R9]8)I-T=)IUA'8Q'K
M.-OF 9<+9:I'2B>*^5[]PG]6('Z9Y;JP4I&]!HWKL8H.35I@K#3NM[D,(<D^
M9EP'K"O"@,ZW>99!SU!3-U6/<5$U2"[U&\G.$_(!LN#7B-0W*V_[7T&8'!EE
MQ"@75HRR,YT:H/9^&;]<7'S3T6 7LL,(N[.>ZHH#+"Q&.56/=TYERNW4G#PU
M+C51RZ(T^7N.CN!-G7GIVPVR!S,0R"+QK$OSQ215;/JB<I+Z?C2=JC!/7;VA
MRAC4$S/S!$D=II\Q4Z?R5BVU(G+I^N72_.B)2;C= DDCSG 2Y8H9%%(;V:JB
MY\OFQ$(2L;&V1J2\(ZFOG(I<+MZ5'Z8D2J8T)"^9]@7(A;K.S^73U4Z+$71U
ME:T@R5B_/QGI=$_ZDNR;0L+[MV>#C-O=?)3Q27.I,..LN:0*TT[2?R^R$7Q4
M TC#C)NY*.-)Y!2#C,]KO3/V#$Q%&==5]Q8[S0-)C3&%+C:SR7J[?>M<F5I9
M9OB;_<3F]4NUZ9=[8V)=K7JCTYGSSMEZ9AW3^-2Q,'@M$U9U*GCQ[<\:&[S]
MA?,O.BY)J+H-+M(A?J,17OFZO9_$^N4FHEOK->MG'6MF(G0]03T7A6R70N[1
M3I<ZR1"BL_27[*%+O5FG4>N9]88U^V9)@Y[)V)&Y3!*PDIRCF8#X7*G=8&$V
M]*S\2T7X0P;A>R_*@[G!%"7E@3^I\2XW-\0@6]9L6H$L($) '\9"F<Q?&+>U
M[W%;O*9GG3DC+Z2A*5M \5C<U"RN4'"C\3;-C<[,D7/*J3 E\<4]L4EW<47-
M=4ZHS]8UMJ,AUZZE?SYE93<RD]+\ Z59/%!:Y3P7;'2@-*W]GBCE\^8<*>=1
M]D7O2C#+W5>CH10X^4-N47/'QUG?/ YW6SW<*=(2!ZRJ^\F"R!_RQ6V(V[R@
MUS9A,'-W]D5\J?G5/YA>+8>(34)$JUMO-MKS-?@+"%Z.EVC12S2MNMDPY[Q$
M/!_(F_+UZ >K_M)+GI?C+=OTEN99O=-=;ZDZY7B+,UXKD]:J-9<[9T;ANFIM
M,Q2>]#5S$F<^"YV/W&X\T1V-+Y98Y9D]^JB;HRU-M#;=LYO.W3DG<]8M:_:H
MM8>]NNG@B5=TF[/,J[CHIU!A>^C3HLT@Q0IWZ7DD34V<%_' 74Z5#<48N;X[
MFHP,CQN'\\URA>KU63;Q5C+_?4$ZUSGF/<;OOHKXBTO#<U0@CCP5J%1SV[M)
M<RR_IR/3)]SO.8_F<N)+!UW2DV9[K;UWOLZ)?8]OUZ7#KM6N=^<8-)92H(4M
MG/:OG>I9>R]\$<H,@HA>(4J,LQ*6:<)H$^2*74PY0&18,\IW(XAY*T',YPAB
M/NH@YJ5=_I]M-Y04)Q>(L[)__]F;%&PO4UUL87LIB^VE=6KP*AIR&8W?LGA4
M6%[V05L9468 YG:F-6KQ<)CX8V5:W4"&E^HB/ZJN8S%&*R2*XSXHCAO)+E"^
MBJ]E9ZTL4,R.O9#>>,"V[7R;0?=4G-8-G1LK?8,_W%@]),N2]64#6UYOCH7B
M^VB>F-18H_?[4\19.6!?Q7U/)_BQRX&.NVE+=*NQE6B ^=*=QAODHPT)UUWB
M<6%_^*33Z,:36*<;<HB;O%SZK[/%D7,]LNF8+1O"\$M-5-<LU4O75DYT>2-F
ME?)H,?W5B3_[Y;NG7%"]CAX6*E5RSI=U#J@L_YG63CDUKF?'$*8_ZJ'/+HX2
M'1Z;JZJ!)E[.5&PR&7'XB!2,F? F9>?T+6D];1JJ+I<E(]AY-XR%W!*&SB[E
M<(C9]TEB_>F!D]$XY_3?P7!ET#[[M?*1F5G]F23:W@W[DQ''X_632BZ9L-!&
MO N#/VGN:8?[JDNSLNK($^14'4*Y1^@-9#L@&1&J5H9+P7!MG>A=@KDJL3C!
M=JYH?R*I1KH'%, 2<23F^/>4R1(M].QQ1(PR^2GYZ)TDQ9+=&G]M-!KI)?I&
M.=[ZSB L-!K\)Z/!!(//*#RF<,Z #,5KY,_?@\?+P)N,_)-6.LZAVI1:9<D;
MT9V<5*5\2+]9(.,YAJ/_SL@Z^U<)Y+-_)D3-_5%KIT0G-'-_DFHA_P>E&?)_
M873FWZ4_DXZ=&NG5S8HW:LS<J#%[(=WOO9[TYFFG_7<^H"CMR4<%^5^3CRYT
M;)A=HAJ##]V%6%DPKO7^HB?TI]C!W!;GUCRU.JO-[>/0C<4)[<\^[1\_> SM
M\?1\*P6%Z9Z=[O:IV=Q,E/]#36B!;<8%S#LDNKD-B\ASQX5:[PLK(.W3UVH%
M4 &H>/WIMD[-%J"B3%"A"PP!)8 2I9GN3ONT 9@H%4S\?Y. X[BE%4B7]><O
MR2+7!>L4UWB5D?;JT!Z=SD,6^BGLK7RR[.)DF>V>_(W.=GO2/':@6GZJH2=>
M=?IQ$"V7VL@]JBF1.G<NM< X@2R5F7Z<6TN.+#C& E2J-OTXYI8=569/O9%+
M\R0[NSUSYGUO_/N9X_+BN^C+LTQWKA.F;OU>Q1%P>O^"Q%N9Y)YUETG[Q'%O
MK" JA +D7.\T&/5QON*W"G)P^'[A]!5;/,^;#1SH<: O]51#0^) #P6YU(&^
M">X-9*G,].- 7W)DP8$>H%*UZ<>!ONRH<I6OJS=S[LV?>//1^<^<>64RIUP@
MY,OLH=FNCM#790?GI5O00M*6"G7U_'$8.!-55CCY45<4MF5%896R:QN/7+Z9
M)TRH^P[L/I=*SM6,KZMJ@S_LT9A[."7%[_G+^L[UM FY2LI1CW-5/6M^*EMS
MGD2<RSYQDD0#9?D9>W9?]X=2-?W[0YOSEFG1(X*<2&= <!IH4I<OEWIS:MRJ
MO]&4<JZ%M"*E9B"9KI F:Z@RD5FV2VIQDEVKBO:AJ3R5W'CKNKJBJG>?%KO.
M)<JD3>!D)<5_31S=+:U0?E+=Y)XS)^CJY$OT&B+LN[K)&6T"$JBDWT/R2+>8
MEI.V,X]BG<J3[?:L9+><]/S!Y=2XRFHI]FF.HKING)!E N5Z6N0>R(U_!US'
M6B9_)%V"XR0!1!<DR%V09H_(9\J>;OJ!/-Y<I?/Q)!P'Z4A420(]]_-NEW0P
M4.4)IKXUU2R#VPNP+3)D6>?13[=J*^2M>,$C3V<R@O$D:QV?ATXMCLL]%54Q
M]@"7ZR4&J\(,%[Z3JR^H,^B<:_^[X%*RM!STA:^!'R:_LJDWDM;=];.)M_;D
M8B4(4RD.J:(Y98[DF?;=B*:+J_>K*IX:&5( FU=%)&E=0]B<K_<XOWW,J?%Q
MHE/X1+Y3R3.%^/+E)QC[A2KGXV=9FE&:6_E%P8LE+VF>3A>82';7LVVI=KGD
MNHGN;J6J5TR4^QHH5\.)3+ WY,]STNR3@]*KY,Y-C7&^4Z2]K%-D^HTO?YU^
MRU;SU#Q;]SRB8.ZE/+/<0XL'0 6PJJ3&O*.AN<'1<,Z]GSTQME8_,5H+3XR+
MSKE+G"1W=$I/5NK9@SHO% DW.P?_LV::Q[9JRZ].NWW:7G'3%&;J'7$QGY0R
M:UN#YHO6RQ=3]6;T7.B*,W/VW(P9X'+7Q8$Z:S&C%VMG,!<I,*/F.-ZV!6"9
MZD"Y==ZX>L9\_5VLG/&R>WS7RD#?\5)XWF(]N!4-\2+N'!?4//O *F@'Z]A6
M;(7%L4[/3"@'*(>%RN&6"RD_HPL C@#'2JT8P!'@N"UPE(8KPP0\ AX/9<4
MCX#'[<*C!7@$/![*BJVP.,W33A?P"'A\ 1Y?V=!ZA*@[LX>WZEZ<V7)W@?-4
MV3@0>><]!SR>F'I1DF(]&^XSY:U_!QIRR"Y@,)%M'M3@%,.6.;Q%PY;!EL&6
MP9:IS.QCRU1PT79J(GIY)6 S@,T -H->&H2_((<G[4\#0\#+^@9^BJJM)'@;
M]A'V$?91M6<?^^A05A+["/L(^^AXC0M9%\T[N__G?1A,?.>=\=?+RT^?/G]^
M?W3E4G=O/>"#\1^KM&,OEPW!>GT;0GXX33GUO4L[&AI< H;60'47/_!J;E54
M$%6?\U6F]WQ%IK3<],Y'E#_"RJ+)3/1@[@_;@A-YXQ>"!],EG0DFG,:EF='6
M>G\[>+190?(;I]W&IHH3 KY' 9\CT+JBT^=0U7LKEG0Z)^[BB+Y+;T[K<]*L
M&:JO/5="HBF9C$Z<(#[1WY@NPL1Z^L)W^)]/F;9.R_=\3.N2T8*3%-*5=/^)
M[ZIG3R*G6'/)JO7:C;IEG265B9(ARV#"0]V-T/VE1D#H_D.!1NA^Z/Z#%O"5
M=;]5'MW?A.Z'[B\; D+W'PHT0O?O7_>_*.8GD>B?N#].AJY#"_K.4/^><!'U
M$[-EI052L0]V21&.I6,*=&VI$0>Z]E P!KIVU4 <<T5DV;JN;4+7OK:NW4+(
M!\([$-Y1A?".SZYO^WW7]@J==H)'7]#D%!IBO)P\<G R#0)Z# 2TLHA2@J2S
M:<5;T,]:S2J1!G9LTYX#H  . X>!P\!AX' 9YA(X#!P&#@.'@</ X4.>7N P
M</A0A7L;OB\DSU;:NV)5%G.:Y<*<M@*93[>?#S]A%O2D--.+N)U#CE< 84%2
M3 6D>H,DF/8&23 W7/W2C9^N.7;APG=N L_Y&L3_(^)OD[ _M"/AI!DQA>\N
MEQ33JO6:[;K9,8\J*0:ZO333"]U>*12$;H=N/SRIWD"WGY57M[>AVZ';H=N!
M@M#M5='M&R;9M)!DLQ,*<"P)K-"=I9E>Z,Y*P0=TYZL[Z3?4G6WHSGWK3B2D
M(F3B2$(FOM'\GL3#,)C<#XU?;CXA?@)<$ERR7,A1%G4*+OGJ=AA(=9E\+-WR
M^EC.:CVS4;=:#?A8H-NAVX&"T.UEU^T;VHG.8">"CP6Z\Q"F%[JS4O !W?GJ
MNA-27:)S<6>3QEH[/A>?XUP,W0[=#A2$;C^2^(ESG(LK$S]AGJ$.!8(J*A]4
M<1T/16C0)(LXTMLD$H+DU!Z[L>T9;_[I1DXPN@V%,#ZZ]_)OGTG2H[>H^@TJ
M>I!4M+((@^I:E11N5#D$#E=E>H'#P.%#%6[@,'"X*M,+' 8.'ZIP X>!PU69
M7N P</A0A;ND5;_A6=F-9Z5967QIE0M?SA6@_'YZ<ZK$/Z8[1Y/0%<A8!34Y
M2&J"Z!U$[U3_T BI+E-D;K.\D;F=6J]=;S3.$9@+U0[5#A"$:B^[:H=LERSN
M]EB%&:H1JA'P =58'M4(J2[3J;=5WE-O%Z=>J':H=H @5'M%O.\;IJ-VD(Y:
MF714=$5'S$3U8R8^_7OBQHB3 *T$K2P;8)1%LX)6PF)T>%*]@<6HM-U3NXU&
MK7=6;S9A,8)JAVH'"$*U0[4?GU1OH-K/RZO:3:AVJ':H=H @5'M%5/N&SJ N
MG$&(D83N/(3IA>ZL%'Q =U8\D*+=@.ZL8" %@B80-%&%H(G/[@_A&*[?#T8"
MP \:658:69B1=\8C"7CPR*)NF..8YML7[XWBK*G]:T2!YSIS5V?#6\Z.WM*C
M7YX"3#QA5A;0RJ+E07'W;![:<./L<=]AQY7,*]5ME-<K9=5Z9KW;AE<*E B4
M")2HR@ -2@1*!$I4$4I4VB["W4:3*5&CT0$E B4")0(EJC! @Q*!$H$25802
M6>6E1*U:K]OJ@A"!$($0@1!5&)Y!B/8<&58=0K34OGL^:LU$U%H%H]90_F>\
MCTBVRNJN$C1CJ_5N@]CVH(I NH^7='_P"*@-Z[1-]W."":'Y@CLF'\Z,WEQ'
M^5N5!:ZRZ/;%I'L: N?H_K\!],ICD-SE%L3F>_T3[[,&RO--?+87423B*+5!
M?G2COA=$DU L9X!LUWIFHU/OMN"5!1\"'P(?.DQ(!A\"'P(?J@H?VL1ANR$?
M.JOUNE;]O&V!#H$.@0Z!#ATD(H,.@0Z!#E6%#FW2?GQ#.G1>ZYEG=;-[!CH$
M.@0Z!#ITD(@,.E2M:+57WX+/1ZM9B%;;4Q@I:JXA4NUH(M6^!O1P3C$):<:,
M 5%ZGO:),$;"9D8_HJNB=]!3(.=E)>>;5.\%=FRG4F/*=Q,=/$9&QJ[JW ,H
M@,/ 8> P<!@X7(:Y! X#AX'#P&'@,'#XD*<7. P</E3AWD8/H6F@6-M;8IXA
MV7^_+A39MJ:ZY6JL<H%.4Z',9Y\NC9^,*Y^>X]L<WV1[QA=W1&K!T5[&&YHC
M$:F=\^'$-+Z%8B!"X?>%<3.T0Q']3/K#3];J9C(68=0/W7&<KM64#$7\E=RD
M*Y_FFY]_XOOT"G>[I =<T^6AZXB3=GK#XK5S;U_KF6^3.P)$0< .D("AK2.*
M=U7_: RI+E/%T-9*$=<J8/J/QA\<_S4=@'WE/X@HYM@,54(T3F.Q%T9@][KU
MLTX+$=?0W=#=0+FMYIGD3Q4? L^9.DO,S)&>CSOZZJ)I+$Y9MI%PZ-@!3=BP
M^W,3D<F[81-[V5<ZVAD;"XP C !(!490]9U5 D;0 B, (SBXC05& $8 I()]
MOSPA%Y#J,MGWS]>Q[YO[M>\CA1GQ-T<2?W,=#T5HN.E.*FLLC37OAFL/#X$Y
M(.YE)^Z%&4''OS) >%GH%PX5E2XI^>K[[GF[9!MVR7UW_#O6G0C. <X!SE$)
M: /G .?8'><X ^< YP#G.(3I!>< YP#G*,-6!.=XEG.<@W. <X!S',+T@G.
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M,6- >XBG?2*,D;!Y"\G8U'=0E#@=E/5T@+:XKX,=TR0 ;7%W870$4 "'@</
M8> P<+B<<PD<!@X#AX'#P&'@\"%/+W 8.'RHPKV-%D730(%Z U7QH,AN--5U
MAS9?'W-JO>MX*$+#S>IY_$S([R?3?#,9BS#JA^XX3J=Y:ODC_DINOMJT(6N]
M-S__Q/?I%>YV.;3#:[H\=!UQDO5I*EX[]_:UGODVN2/@#]2II-1I]P%?J(UV
M<#$G"/BJ5@ \RJ0=T.9;O6S::@'P*E[K#^L/+IR[N(K:]:,OG(LX#05;& #6
M:YI(!P0; AL"&SI,0 8; AM::0L^7ZC^#(7J]U3-&87K04= 1T!'#@OJ0$=
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M("!-C_)PX7=0WD$3BI^)*+5U@+/9^2N\O7^ Z@8K_X0$]MF:+^"94<I*(P_
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M0VUV&^W31G;F"3JZ/;8-W-M)KF\]W4@%.S0/'^R0QPB.1#?LK4?^+]<=EWV
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M'I](DWB?;-Y7BI/R8Y$D,0PQ3 48YA#!I[M5;Z^"BD(G F4JRDX82R'_%^=
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M,IRRR2[5(G9IOY_!<4^V,=[%,DW[%/%]G;12^0[&GU E4]./3K4V:#=8N)U
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MS(1OUPT8\,^0_S".(^]1<+,VR*C=_?.VPB<OBGMWT+B(>TO.O3M$3Y>0>UO
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MQ3 =#V/+02KIF/H4F=<D2'"1)<!B::VK_8ML*RROR)U?MZCB=/5UD"9KVL^
MO-$ <RR'Y]\DXLP3V[;QL80+I\:%53[H*EO 'OD,R25[C6",-N:/1K.4A.Q%
M56@F",W/QO"SN@,ZA-M?&:^E+/#S$"Q4M\S@-E%NSS0Q-\R11 *W(4'A#Z^,
MZ+W^'1(-[(4YQI2ML(8#)E9[P<2&G%L!>4OBCP&*,9OQL2'S86%$JYSO^,0%
M[F5-O<%N/%_F>LNZ6,*9GXOM1.%F)$8I'KI:7.Y7N0S2BZ.)J/#0OVQ\Z)H<
M"MC&8('"/ H_*S=42%-+#%=$TWAQ@5Q0I2:81288/1P1[MY,'P.21 I%RDF(
M:P1JZ\O5++UPR05LH";FVD!)"#\.%TL5,+2H#IAAZ,:8_0O5"Z1Z@;O5"]1>
M6L&ORZX7V,Q1+U [1[U TD>.JX_$D\1!U*^2HC:E7/K"-+#[5RF)<\<>R@RD
M=4)5+MTJ1Y0'<6,@P1:.Y6=NAC5[OO[WP[??HD6@U^5S MV*@FGC>#IGJ*1@
M 9X9#C.HT0)2&M04%,X%4H"U]2G 6-X9YFB*3UCZ-X^':I^:7G^$K\/,8)D7
M7+3.5U/#N)^,PLRB-LN61%]8M##3-U1,8CF_9&"4+<7T?C3EXP4FCX,,@:>[
M?/PQ*'5^[P'_"-HIEC'J.M[U+L^-4V)S2_)G!%J F?U*%:@BVR@*L5)[P-&Q
M!%$!(+MD@@J;"'_U(N$2.Z:'[K7J0;;GGEOW@I(WDW/J]AJ=SIGR-#/22CH%
MHZ).G8G5/6TC.$HKJ6I:25I%"E)+M JFEAP&)2A>\>#QBJNS/E2IA3;OUTU:
MX]T^>N+).1%\U\23HJB>(QYK6%FZ/@4N[Q&/U<P3NKYC)>V0F>XF>$KF_@&L
M=/-1,)+L__,Q8*.\AV:M[.*)YXT^)S0O*9I_BYS?Q-$\\_3GD 'I98)M0FA"
MZ&R$7C&(1&@!T+<!;SRL6",O/K>S@QIVPN>#JN6$V17![/=\HB],C["8L/AE
M87%&1L+=Y#T&@YJB]6B1V+(.1N*2FEQ^<B\%Y 9)FJGCC6-F;!(H5X=*JP3*
M:U+*^EM3R@""<:4?[*\!&]Q)+C"L_Q6710&V6QLHC68J^GW/?+!/S1.32,Z6
ME5O/'O*>5/?[1VU8&3FH3F9Y%6I1Z9\Y?+1T<03\V?);%XC&T5]DMZ)UB5_4
M=O0H;4>W]Z'<K0EIK +\E<J^KMIJ!5U(LKMEOZ;,OW.UK72+=*U4=F]9]2<N
M(\#V9S\R^P/@MK>\>[:XXTZ->>$F.,T>9A&W=FIFV>F6:!Y]+#9PV"Z7J0Z7
M&\$WC-GSKXI&[8U\0C&LT,DK(G0^6(^F2$J ?_\+LY1]NR;V2(3PX()C:H/L
MF#;GW%DS \^^$K_Z,Q@;CV+<SZ('@BX2;CS/E#UO^,AVEZ['9V)0CB%>)/,N
M+-=V/&,QP\^3(+0&ANG"U@ASSZW+%!^10<,QK0FU=-&M8<W()*@$ YO+9'>7
M31Q[!J_$N$EL(V;;HA68;"4(2R>;W/C<%:9IV0%QK/(V#$PI\<.D9%SF%HKM
M[=X%4G3B"PDTH%OW#R!)T0*2C_,V@&PIV "RV5+JS6Z:8HNU8TO)AKK?;Q7W
M2"RS3"R)'B''<UCQ&WQ9\\W&M6OO$*HISMM<[S<1T[J*S0R]"JMNVYG1FGP1
MUW!;:FW0R<SE9:\V1YJ>;O"NL+>N-L2<MK3:H%=7^FIJ%J(+9S(EW)7'0Q%0
M$<P@6B:)>+Y4;IM,CO*SBP3,W(T\.YJ7WLSH[5F8T  >'6<)7*PVE!]KVH "
M]F7UEP10@-$ZRZ U3-X6DUL:3%*X[4GT'B.&'D8RBG[O5FN&Q\8V=XMV6H.!
MV$&S5'%OI"ND2(63?.('V*/(D\,&*D@V51.3.GA'M0)Q]LV]6VTEE+,=>FWM
M%E'?:M8&:KW=3&N407^MZ#*'N!;)Z#Q8>RW0!H*GY^PVK*T'.WB9!3@0]@P-
M8J?7XW!^C-WPVA7&MM=C+)#>W]$^RS[![PGO0B\%L ":,4:B>7"0ABDP?,^G
M&ZL^K/!8V<[6%=("&!2314V1TNL!NK%5Q?NF(MBC14A_ J2/Y#_%17*HA$3;
M4$9Y&;OD75B'.H,:U%TDD9>@X5IV!LT9.IQI+SE)IM=NJ.WR),FT2ITDTVRT
M5$J2>3%),L5+$JY/C6E6,#7F,-A 42(7T77EG,B\6_)+<;2FR)&21(ZL<6=?
M1-N&5BD39PCK2XKUIVK;4"9\/PV44UWYL]65;Y>NK'RK7:"L_%G390BI2XK4
M7R.E:H0K-Q[0IF6=<ZP]6LB*?R.X)\W]Y6CNS]YUA*,>@*$D@[S35HPA^>+6
M1B;Z##SD7Z$FK\BKFG=J@V[>9)V"O47H_.+ YQ>.K$]HV=$PA4C(P+A W$'T
MH$R7A]N>#-J0\1#X[/2Y%,67'R6^W%>1#A!1GNP0LR: 7*, \I.VCOG(A\Y"
M=Y:';1B3)YI3[?1+$,_9!5-CIWC.4PX_1T1G#^-2>YUF9D1G5K03!9 ?.X#\
MB,U[=FC=LX;R=D]W:/6!=;;T[?G#$GTV8$)?;%C:5.^>; V@6 W];U1#GVKH
M[U9#OTDU],M70_]4%>XSHYTVE^@?D#9ZOO9=D0Y+8>ASNB56HK_2MHY804>G
M>.>> GVR=I/$*V$K:IF(5]U9F24 /]J.]*" %+WW1,WN7.*YC1E>&4>;..O\
M/:S@L1C*+C(8HDVR4LL<ZUZTZI(4/EP^-9(/H6.<X[HP>]OBRT#A6@4YCO1Y
M@_T&K](][ 2XIO&0[$HD*%6F@/A]BQCV_F-^%S&N.Z;!\>\H(:VE(FRVA/D<
M?I\EC/%%[1=#?H5-Y,YABT7,I= FI6H(D *[@^HGJO1"XYGXBYAX?*!U?['A
M*]CD.<,^@ROE.PP:%F&>3[K0-*-]E#QF<AUV] @MW:*D>K=JJY3H]);7J]=6
ML[UZ07AW1N.F>+<,T[6CV%#?F+A5ASF:0.R![\G?]>"J)&7(S8EO D5 E[)!
MF^BZZ/?T\QPPO<[?G$WDB0F R-NC+2'2"C1I2TZ_P2(U/248"DY)(V)(\_!-
M^);P2^ET#4!FN#P'R/QIH[/@QA_$-UPD((D'^YN@BQO3O)L O42@2.#/3=BB
M-2\2B;XK&4B$>UW**;X3S%9TFLULP!4YVG@ #X1J+NMK\5=T-)494E;0-0\3
M78:Z];>SF'LC04FRU68T.4P(5$J'K7P[*=F\!7DB%+^83BO3/F0&E "C4"5_
MAUU5W2F;AWKA'XW[A@3.,29G.&'77(8^Q$,U?\J;E-I5SMSPJ=T"X,FHN4#]
MGBK%<:7ODK0AIVO/9D@O.$6KVVLH>X?#'"Y%JU>P<.A)4[0TI:%JE*)%*5HO
MIWO1 ;"!@D%/W[THX8\[>O[6.6%[I_RM': \3]!_=<- E:-C<3FKL2=[%T5:
M%X4G%M^0A_*Z)]JU0:^,)=D)R<N(Y!LZ%R5=HH<,T"\37A,T$S07:%HDV$+8
M^<@4>5$9&V4<*BWVV/V*"*G+B-1'Z%=$*%PA(GRI*.S3?5Z@[6;&T)+V6S9R
M+@6FGJ4AT0M$W<I2:>5K$>S5D,B5'8GBA>[;/6Q)M&J^22V)\AVFGJ ED=I*
MY!JVLL\4=NE1)#HEL,C1/&45GNQT_#!%QJUH*O'6L(Y=NBO$NFH4CN+HUP9-
M55M;8EQ&1$6J$XO C&Q4V0"(2HUQ&,T<1N,Y"YX<^E?'GG/'6WXU@8!NK#'&
MCL_Q=:L\PO  /S)\570DCJ"95D[RWPO-8JG3IX"SC%3IXD>BO0;[:/P !I#E
M=NO,XAYAU\FP:PLO^JS+QS< +=_7<E\Z:$;=D8^SN+>K=!09@Q2);A<!.>YB
M!C."/7/91!"1+HCH.DOY61L<5&A66:% 7245"M15CA4*I,A0(.PZ"?K^VFB@
MZ)CR&,IP?48T4-99:<HHZ2B-?L&"/KN$"&6.,/,T-\.H:Y_'J"LT9J -A+W_
MU%)Q3\UNHUVP#RT%%KWLP**=PHD. QI'P8?=6"TC@K!42!!A^C1H=1MJGYB>
MF'XMTV^I[/X"6*37Z!:L1DDL\M)89+?(VJ@HW/5 7Q#T3I&UAU&IZ43J\,T/
M MLP/^#N&#)[3A#>+62VH?2.0[)T0+7W 97T/J48:.ZER#_C .O?.Q-[SF89
M[89:T+RE4\VS$LWZ4\XUP27]?9)0USKH?L4B=KE.+SHJMDA5^MW4^47B7)0P
MG#"\<NQ8!@SO-#I=PO *$4UQ#%?/C.%:;=#OI$^@<P</[N3>W!8\>$13#7?U
M>Y'"?^5B :T,!ML7[KK76"1D,5N8HH+OF,\=H%%Q +@[*)9;V.\OU_?TD^UY
M>WJDFC_2_/K&PN1J=</)R])V(Z?\D 'F ;$>C*F*&X;5H5NBV#.D0+PZ6E#=
MS4K$O(](&/C;Y*)IF#6^F6&I]O\3WZ_5A_*I0LW:H---)ZR]WL6:)5E6&DP@
M67:YLJRX@5P=NB6*+9TLZU1&EK5J@Y::K@^8E&5G.*NE8]F*',L^V)Z>KP &
M*4!["Y)WV$\$1M&&>\?V H:]YN[@Q]1(U5T4H)*F;%R$+_BX!PBE,^N/2<%$
MNR4_Q]C'R%^KZ?S.<RH[;5!VM,.<0I/8*@W3D]AZ"6+KW!8\B:T+HMVB8FL?
M>WY_L=6I#=JM5KZC]XU%)9*9F=O3P6,IJ,_>]_=^;[#;:*O1W FHLF+1A@?$
MLL;['<H:+V76>+_!@FUDL7W$'F*J]N81+@L[UU(Z^0G2R7MQ@)6],,,]&FW;
M(^9POZF$K(5A#^'],DD[6C #]@U@8IS5H >+4.@C0#;7B'9&^[! \(,G!DU8
MUK5C=O0Q'P?-1D;V;&9C5^,Z\WM1+47;"9.#>@"K-E[S%+CFRA 5@WGPJ"'V
MEN&N:"GUX>'C/;O5YZ+3<[(%=?3'H!6>W]C+[X@ENDO?S!W#E"JY*HJ*J+WX
M(VY6BQ \1C:5BZPI]K;!7C8R:S[<!,^.#Q&&/)\N70,D!!/;-5R8INAV],]"
MMKB&.[9$C6E1P?7Y]X^%)%>\;_/XG0X2;,1% 9/?9$^>4'XI$?EE_U]<?'4!
M,>KMK*;G]@*>)_9&DB-W9 T7;^K8B\<I^PU[CD1+N+1[0?\1"[L[NK 2,#H3
M:[F,%R/9^63+BC1+L"*B?7JSF6Z?GEP17_SB7HNVI+!"<^Z)/FX!U8E:JW [
MMAC]%>_YZM/3BOQB5#7'*@WC<(EAZ"Z/T:"L)3/7'<^0[7YFG'N"P?VK(J3L
MPAS'/.CMYMA+W<0^-(\.ETU=X#;1EDY@A.AWZ#\76V&.S,78IV(Q\'<^>7^"
M#_"]RU[]#[+R\G6*67]]]RG:*QXIP1@;NK,,<.>_M@,/%$^]Q24US/#>__YZ
MN[KW5T>?ZC/VL!C]_0SFQ^H%#Y'G \%]L\?#>(6GU)B^??X2O8=AL3!O&=2'
M-F77JU\?ZMACGAE^<RN!KE.L.Z1;28BBWDI'K\ 2^=A&PPY+>5F .DL?X96L
MLE&RBYF(9D2F6,M_4<07W=$>@2T>L?=G3!X#^6-=,>"#+:W$^JU]#A6Q-$M$
M-L75;P<6/53+4;+ ^&-7Y+-3^K6!VNS4^TH&L$5;^^KL7L=FJE\7 .\ZP ^R
M&(P0-E#@RWN.?(5K[O/6_=<;=A. RDHZ(ZC\UW#']NP!?@/NA*VQQ'AA+T(4
M^8(T_L$$;<71V0/L.* 9_GAK!SQ<C_%=G0%$ #2\^P3_>9#L__F+WU/N#P%W
MHO\5D($;X(V'*RBG*NY<->44[2U_P):(3IO;MG@?]^BM+MK(;]^GKE(;M.K-
MKIK>)=3LX#';NU*J_9A)K!2TB*,=IN]%0]+/H@-TIO24'4OC4\",HF9=Z64X
M<S-U0^8KA'[W4]BV>T ][LI=O67AD)@84SW=$7S+<G1W7XYHEXO(BMP&S5O5
MW*NB!:M25S+4K;PK$P$[82QTW[A2)0>=2RZ.SQ.[4GGO)%3>!"IOUSO-M.,D
M(/-5D;R$3^27L?$D72FA[/WR[=B%!<XC=D]55^":J5AL"__U__#019IX(6A%
MS_K237A6KX7KU ^,BHP=GM2(U.CRIR=\K"R^'LDKQ;+("R/S8/Y$V&I3PANC
M.\K$EL*.B@W]>@_;>?6-/RY,'>X=V:8-$QFBNQCTB8]76BM;D9N8"T'*ET=3
MO>.H<B%-:6E?QUN=31V$@9\>[FX5!<2#.%I .$.51CJB=.F%PJ)M;X'#@]V0
M&79WP[] 1;C'9<J(0=J^/?&/0;!3JNC=C@Y536);$0_L@ R'$QL.O]M/D3I@
M6J;UX/"YK_7*-JI;1&5_=[5"J!+?5J^3A7*_PI[9XWM?><BI5[2.JVV!.8S*
MGW $@.Z\R5C:6II74_9)=G_GNPMAMX:&-"7664IJ/BT$.XZUZBTUK6S7M\YD
MGY3/P\^D _J4DJE8XJY(5REZ-N>Z(5RE2-U8%1A-VS'L9%T:;/BUPV>Z86VW
M>8%]2K4$75B"[,U$WY@N;07AGC71P07PPUUOC;-Z B9KX*4V+!<,3]-W&_C=
MEPW']1!C847&OM?3</ ORT!S04>&"M3UZ#HW@-DXPYY,OA=#DQP%0.^;QH8E
M5Q$^D9/I'+*BZ*%K6%[[;O*G;DI-XFZ2K0EDM]'><""[\\/CO-&318(#.3?F
MTD_FBSG_>,EO)^Y3[3CS@.JXY=<+>/"C4/ 8GVR_-LB 0632S2/?)X[@("/O
M*5B63:EK_:SQ>]EU\S6V<(,:^ZLBT.(T4'2 *U;R^5 $G54,NI,N!MTY5C'H
M9LYBT)V"A0\ZN>JZ8MND@@5*=ZG[G#F8C*J5G8)C.5#L8^;P-E:MU)2&1FWB
MJ6IED3;Q.]>Q[!P@-ZJ3E1N5KRS083"",J8.GC'UT7:>=6=\9=KVWRA*9?0#
M"$[.7H%T?>W'Z& \A @(R!5&FTDHS9S%TLZ)W\DQMW)62],*5A^F:FDEB+P]
M6-3X'J2C=AO]O2OM$=64.%Y;4YH[6%I@#?O(['Z1R(P!'5\1ES--JT185T^4
MN>RUT]G4N9.I=[(54LH!Z0$7H =,85 '5 3*+O-)O%\$4!]9O),DKSJ!%)?D
MNX0][BO)M=J@65>USF$D^6%-?Y+N%R#=Y50P<DZFM)"D)TE?+2 G24\$<F!)
MO\NY[KZ2OED;:'6MN;4H"-GLYZ?Y4DAU/+L&">TQ1_=(2I.4KAP(%ZBM2J*Y
MRE2QNRB.A=#FEL,%XBV#2!\_5_*S'RH92FR,X0A%]ER$-D6%-L8CJXUT!-//
M9)Y7@D-*(<B_REQZ+*[@V,_>E 0Z"?2R0#<)=***0PKT]DX"/3,>-X3-7P5J
M?@/0S"NVVR"V&^G: -E2>V,A,\I8.%;&0C=.VEU!6P\B\%MX6=9DL_@^[B"A
M9>7J=C=$E3^#TL=@4"#G;-D>;.+8,Q%F#L_'.C.P!T\BR/OVM_\OK"$5^-"'
M?(FI,?"HWNN@+! +'.OK2D1)=WLP3OFDT.DN\I> 3D1.>S@6A\/@X*MX$D.8
M>Z-;UD+4U4D5QY&%G^99>L:F51%C"+,GAB)5<#'WTX(,:P13<46B461]=MZ=
MH X0KB*.UXC5+8%/XF'&Q,"S"I=]X4_<9$W\4V1P1)TA,M$QOI\[$XTU7K=P
M0#-8*02&-,)Z(@LKL@R&-5]XL.XW5FRAW+GM11]?WV]@WMI=?;87<"F0R<+T
M\,5Z?!S9"2]8$HCC-<G+4RL</A^+7<ET#-UP)#U2)M<Y,KEN17TZ3Y:GLX%D
MUM2W VX.J$F?X7ZZ8<:@0,'#IPVMD]_^B',E//8Z(+$[]6X_?1!^I&2G=:/^
MW;9&10;>A8'WFO56/UW]HX[\.<?BA0!ER_IZ)":.JD!NY/UH"FAH\D.E0Q9Z
M7ISF>K6!S+%'9):DA-4,7<9A)<;91-84?(34EBP3,+)!QOV?GSZYRKH#L>"3
M+^H?V0(E=SK>819S59MBU\W(2N7KIU/Y^L=*Y9,I?+FR^?H%3_OZF=E\66'J
M*<]A"UCB!"E^F2/,3##*Z'G0*EB3_4 NKD)C#I,!>\GQM[7"+:4H&3"_F^0"
MD@'_5P#XAVP WRDG\#  <A2LV(WM,K*!2X4*F[*!U4Y#/6U?% * :@$ ZF@;
M^)Q8A%B$6&1C>OP+8)%NHU/P+)58Y*6QB+JWMKAKG$I_]PH2AS%!*7CEX,$K
MT:KSB78[>1%XUU(1YX3E'?/]&_VCM&:D\)?J9IWL0TZMPB6D*#RF;$%3^>-?
M\Y]<14!9)*'XD)SOQ*J//8&43K]P=UH"<P+S:K(E@3E1S?'!7.V?'LW[2FV@
M=NNJLK46$,$YP?F%,&8IX+Q=..N"X+Q2<*Z=03GOJP+.E8PXN-P99SN=^V[-
M+B,'7=4<=-'^RWZW5^R8L0<PEEP-((G_DK"[0#):3G(A ZV45%$2[QKBZ)V
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M'CXTZVEK*NY:X^V5:1=8I=BS8<*S^<*3Q6EC]9)SE$L6V!^LO) =>>3#VU]
M. 3E#?-6C@1@&GK8RLFTW863OT+DPKUZU/7Y]9K;(P=MJM;N1T'HDU9.W-E:
MCV-3S5#!\ 'D]/L9F/-D@ZS= 732:A.^KS<_0#$.IBH-!D)$P ^6G?P=R,V-
MG\Y0S=>CU'SMQ>6%1/@[BWWD0V>A.TL)T&I+UD:-ET0U7'>!1<@!C5P$Q<W%
MAS5EE_+#4?;^;+G ^0A2'\&2OA%5F_-EB_1J [6IU)6,(W91%/SQT>&/")H
MR-;(F ,<RJ+0B)%%9M7:8U)!SR5LX'#O8;7VK]S!NCBPW3D;.O0!X-J-;MHQ
M\W.,O>ZY9=B.Y#(V!DF M>;9*]Q;E(B:\D84PA6_BR_4-Z\9O,Q=8'UWD"E"
M^"!AP0#86!267T<P0^X]<V[%" <IYH_&?4->^TZW_F8/#NC1P05U]KN0)+ -
M-ZYKCPR_*CO6N,?K.&>O8/P&"&MW,0)![.(G2ZK@L(*23/VI/,@[@GG4Q8;C
M1C_AAML3T M$A6";_0-B4-;5!WW",[R%/X;A8@F:4FP!OH'^&\RT=0,[ F@C
M7GK/1PO'\ Q8V)N1)R^Q)_ZE_6933 *(0-2O?.4/,?ZT8*14[?KHU:X%U/W/
MPN(QJE7W@[GNF6!.53#'N7TDF.N6!^941:T-F@UM%YCK)&%.+09S6<2R#N+P
MLX\^QT =PH?#XT,2$#IBCY7] *%W-D#0C@@(O3(!0K,V:.T&",T8(*RV'K=]
M9V@(R>9<T"#_!%J^63S"6_Q?FH>@YEV2%0Y#S:W:0&L?AYC[92+F]A[$K'N2
MED:<<20?I(W-<U=C1Q;:'G-_I[N&>S\'^!W?67^B((!QXD*H>6>.W6T4-6/B
MOJLJM;,>]FFR)W4V-Q=NJ/_#?/A,>K^F^A-G^FCD((V[!K84R^+3YZDQF@K?
MH& SN(5-%@X^7?"';@DW75UP":X/_ X/>X1M0.$(&_!L>-,87PG78O>-R[(@
M)88Y419-H8Y$"_N1B['@6\1+LAX:LWK2\-4(W7>1/B3BY$=XZV**Q+=OQRY5
M>QX=XE25:J^9B@U/\%__#W'RDW@AT\UG?>DFZ@K#O4&OE/ P2AQJJ4HCTB=E
MTT%6XDIYE"4NC)YC^1.)GD$%-^YZ"/7Q"F$K2RN= '].+Y*F>L?12T.:TC+<
MK3J;.HB@/SW<W2IH#8D#-41)S$F156=UZ3G%KCF;VPQM];S[[81R>.@'XEC8
MWW=9'>AN^!<?>?>X(1G-,K830OQCD+Y"-L\1?2*?!8%87&H+H<R)"$+Q>>4C
M3';* L$^FHHNF5N4254]FS*)_>C47;5)?_J^A&VP&Q<4 O_<4/QLN)%E6-M(
M3&? 2N+D$I8$2'5AN%-Y!C=A^GSNV#]@WAXWEUO6<9?\M6 5/\3>C&?Z0R^(
M/OF=PQ</^H]\*]K#++:NEE;?0#L-FK Q[+^VL?V:;-'J\)EN"*=J:K5!JJ'1
M-<9EBZAR[4CW-M' T>6>9\J.IUO)4-MC 6]U(=AR+! ZY_OU?CNMV2/%C> Y
M8O1;QMJ,CO7S[Q^+#=:>S6SKW@/8OI_J0+&?A?67.7Y77!";@HH>QKK2[-:U
M7D9L4>:9-_//\>3C<#]'8A" US"*>M"X=B1,&U<<U\\E\.AN<+(-E_,E^;M.
M@/TW^'"_R7* 7X(J!=<9WC*#(0.'QGH!P5YEFS$K_VO,>$D=!:\.;Z)(.M6W
M"YC6N00,B+:!UMO5]Y9: 68O/->#502J)D8X 2,4BEV)AL0-O6(M3@-JV_2,
M.&5IM<'_RY<,(YS"GN=I@L&VW("@LE&IF[L#J=#T<\XGJTMHKYWJ$MIK'ZE+
MJ*K\G*M%:'1,>3+AX?H<'?[:W49_[X2;[=U ,P>3U9RI8&3Y@7(F,H>WL3F3
MIC34@OD=U)PI?PS]931G:F;%@+TP1E%[U R7&&5;%[.MC+*^:DQ4+NY:-4:0
M=3+S*5=E\,/(3ZHD<_!*,E]#@R1B=.2'X 0Q=/)V2C@C+">&G*\5G]KH%VS#
M2GF@)4WS.U@>Z![4U&NHE!M:):(IG!NJG2L 7E6;ZP/@M^7L$Z83IE>1/<N
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M2OG44K\!%@YX.-)M,(;B5[";5\:/JZDQ!K%TS>3_09:,O"OL #Z8P.M]R,F
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MNF^P&"Z(^X5<;B=N1.-AF.NAKN>?'I$W\?P 2%AWV!A9/^!U!'OBXA\K1EH
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MR:-G:$(DWXQ 57 -3PCIJ+X@E(7Q9NFJ-6,NI<^_?RSD4WJW<,$*<-W(&#[
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M^)@X[)]6(@>%\::^(I.;@5 3T,?895GV8$.=QO\:).Q02%3!^8)]?84S$/:
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M)+[&F"6*U$=NZ:B+Q5<8VOV2FDIYJ0$@&\-N2\DVI@;LD\X<0121B51BZ:=
M5_98])"RN+#WLI0?KB@@'&"(&[74,P DY!U"=TLR!^X6\H:HI!JYF( R?C>>
M(]0'?=[,;U%B)BI5KNJ7&>R/&F&$G0#E:U/MQ*+18B_GV#7D12WTA!T1>0GD
MPC?#IM"B01^8HIX?(E_4K0])"$$".3+RMII>:L%(E3B^*B$1^X_674O2QB\W
M-U\D1B=<@+A7+D"(B[0!5(K*Q (V&<E6N@$"W[3,_Q-F#=:I_YO[S(W=U6&7
M]QQHW-I8)16U4<:VQK$)4_KS]'<Q'D2."$6*]9S3%!T,[%86Y'\,@11=X"Y2
MOR-=3Q/3$[W/T?TYXJ&-!^K,_X4&6[00_/N"VYX ?V32F'-D_SGT=L>7SKD_
MDZ<385]UX>)Z#(6L94YC!E]N5XN5:?/PY"<:']Q$.DM*0(;F@3@>+]S\ ;9A
MI^>F=Z MC>:$+I52HR)YB00J"%&0YV;)M$LE#IC,QBD44QLZC:'>;_;U3B&U
M84EDJ0S5N-M.@C]-T9=4.OB\4DTO#K#[>:TPNDJF%0:&6Q^E%8:N%&N%D1Q3
MD2!RN+Y *XQ>M]7M'[\51NY@<BKZ]P9GB?K*'=[&BOZ:VNIH5-&?*OH7K^C/
MBO3"6)]$DN3_7<M!"#K?J:3_87""LDT.GVT2@ H'7Q0*#LS;_Z+%G,\)S3L6
M<]9+#IF*.5<@FO!@D;"[4XXZ.$ =<"*:"H>@=O;PQWYR?.Z%5D6(OL7LIZYH
M9=I7VKMGDNYD!&S+)"797E'9_IMC/URADW%WO*NV'-]?9->GP "5R*B*9"A1
MXK(83Y57%^I#MD2PIZQP>635!07*/<B3I I33'?I-89:NZEK_</H+@=U8) ^
M4Q-]YM[Q#8MTF?JG6%*2\ 6Z1BJGUE"2\ 71[KD\-,74FWYCJ ^:JIZ-K=HA
M YA"?HZ8 -P8?ER-0\'0G@=;A*DD$F.?N>%B4A5\NB:59'L4X#Y=3Z)AWMB3
M=WSDOY>#+4:. ]"V![W\?!Z1,(NA:3(JQQ!)J8"L8= >JEC94)W$$H6A&G>^
MX?,PUG+*/B_": EOF5J1",$0]#XQ'U>RVW_[>NSSYO/0]:F.FT'&8K (_A?^
MXJ,06WDA,ZPGX]E;D7W70KB%]GQB[/"D5B+&))R>D((LO1ZK5XIED1<FYL'"
MB;#EIL0W)G>4B2V%'14;^N4.MO/J*W\(+ /N'3N6 Q,9H4 '#OYPA79D7G#D
MU J\V4725/\X6!G3E)8%RI\--G,17WZX_WRK8-2W4/Z0WV\1Y6SL\V?(, 0,
M.BH3=O<-NP9R'N*&_? ;-[Q$ZM2VZ+K8(;'Q*:D$K%X/9@08%-&+/,C[//H/
M'_MWN)$Y#H'M!)3^,_(\4*+701.]0I?.OIE>>HM) J%4K=-76^G'&:!1?#\6
M-TG%]CL1&S-+;)-((Q(%0,)Z'YS-N#$)T[Q1[YB*I'IC;%JBSVTS2D3 RAN&
M;T0!]I:,W,<R+@M4660J0G(<MA/>RL-W4_#]"8+O2PH,V)=;Q_/+Q6$O)47N
M[2F]654DA29*!0B!%^:% !7!1J.6*U1DJ<N+G [^8+B3R'!8S9R3!%4J++G
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MQJN=QE!7LMT<0J!"$A=8C3,&>I%S70)22<9BP<+!_#I3/!@EX&\.F(AV)/2
M*S[PD0L:UW-(W@('  ">P%3%G]@NP).Z$HI>$$^HC<$.BQ&&CQ'.$/P.W^#
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MT!D0&.!<$\__#(:!A@L0 !@,(S22])B%UBD]OS M(6KBUY@A56(Q)'Q5SN1
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M1W+JC:':;;%P@STVA2UFT1Y[@.'^C$7;[/W\$[YI&$J9!(;"P+_!P*NYPP4
M=-,>=Q-;K!W.[Z2UEVXG/6=/2[#[D__M+IC#(YX_3Z.-O 4L>W!<6+;)C1=]
MF.1?+\G B'HB ^7."=PQ]Y;/$1I#8;QX\J]/-)(T_&J-X?V,@TRP+.<)<VP$
MMK(%X#>B/H,' E'/@7B?14!T[PU\)@*!W!3AC].$/XX&=1W!>K@?,0NL(+48
MU%FV8_BSG')2T>LK5ZM:75]I*3_&>M08ULM8>*!#1;]%7Z%"]UWJ9>P'15'B
M6Q+J7A3 SX!B05W\$3]D2DO74>4"F97K8$^.J8@S':YG][>_KFBK[)LY^87;
MF\_*VMV6NG^!^JWJ=.X(M4(C!#NW<Q8[M]28@380]O^WT5\=?T=KZ24-]3UM
MA"+&Z>VO1Y9#_>,H&ADM7C^\%C\&..1NX7I8>^L6_^:&Z['W\*8)>\?'?#[B
MKJ1.76VFU8D4EZT_H:L;@!R6%VN-']GQ=UN*0OA!^+$6/S1%TS? !#$3,1,Q
M4PEFTHB9BC%3K_0$B)E>&C.I9U1@CV/L4CC9P?/-OA9U,.T*R)G(PHIA[X%U
MED.-BY;MY2U;>:&^3R_A)-#O&DLL)KEZ5I^GS>@G% C4AVM_L7 S>30]QWUF
M4UZPQ58>*73S2*%=+19=36DI1+W4D?-B0C\.%K>T!S6U6TK)<PKJV%F%>*'"
M 4+J/@&SD8I>+-1';PQU76]J6J]T]"M!.$%X';F1()R(YO@0OD^(9SD(;S>&
MVD!O=O6M5:,(P@G"+X(;JP#AG59'(PBO$=&4AO!]RN&4@_ .0GB_J73V*/RW
MTTG,ML)_Y'>KM-]-A-7N#G35%NIU2%2D:L@O04R4Z/Y;C)++FW]4 OF%$^P>
M>LP^A8[*Z3'=QE#M-/M*_R"6*,DGDD\OE=U)/I%\JA7![B&?>B>33[W&L-?L
MJ3J))Q)/Q.VU%4_E7:\DGEXXP>XAGOHG$T]];,RJ=;N'<0(?-$J3(O1K$J$O
M.\(X"^X:/M:.B$I"D)>8RMG5AI.J(C7.=0)=.8.<RM==$.V6U8#V:6=?3@'"
MFO?M05/1.V2AD^@B]B?11:*+:'<?XWUP*MG554!V*6I3;Y/L(ME%_'\1LNO<
MCF:271=$NV5EEW8RNZN+!;^5=E-7MP;N%*CX3<64CU5,N9\F:4E#]\MJP,SE
M8^?!A@7Q"I8"9D\S;HN"P@ON"O*RQYPY(QA86 +88Q[\YDU-#LL.0G<\P\^6
MM\'338]/<$<>S3&\S\"N8BXLR11@%;[P'7%A],H6NXFNQ0?!P#S WO#"4?K6
M^"W1S3 RWS!M3\['L1(C<GE8'QGN&SV+NZ)',6?*Q.Z%LW?Y@^'& PL'TV+W
MB<O#Y[.9L5AP>!\W,=*:.2 JF \TR1R7&3XSV *KZS, 6ORTQ?["$1M%%G/Y
MK"8#PH:!F_ZSG,A_ S-<#X];?(RO\8!3+,[FW)\Y$QS@G!M>X**#'W;@ 6;N
M(3HP;L!JK'F[/X,13_C"'(<UI.4[XQ+2R=MP0M%&X$NB]8 WQQN]NK%42/WX
MA=2QRX,/$S(-RWIF\$]N,?""O(^<"HMO/@*Q+5R0(BXLN[S'C)M,,".J[6$
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M3H#AW9-A>+<Q5/MZLZUL#?0@#"<,OPAVK *&EV\33AA>,PSOG0S#L6!GKU"
M^8F3YL@15TM'W/'J=U9)[).$?TE@??!L?++"*DD4^TCL_LDD=K\Q'/2;?44Y
M5D88 2WQ% $M 6TU@7:?/-QR0#L H.TVN\IA^M 0T!+07B[0DD^JDD2Q!] .
M]DD>+06T\*:AJH!*V]5J4#F9_%*U]$L=L8[R98GQ/<-T\R9')2PO0YK4S9:C
M$I8OG&#W47_V:=)33OU10?WI-#L#G>Q,$E#$[R2@2$"]%(+=1T#MT^2HG(#2
M0$#IS:[:(P%% HKXO;8"JKR3E@34"R?8?034/MUIR@DH'1W(S6ZO:EW'R5=<
M45_QP0O_DP933H.ARLHU%0B5J:Q\;FN;*BM?$.V65V[VZ7!43KEI-X:ZKC<U
MC<QO$EX$ "2\2'@1[>XGO$Y6YF. 93X&>K.K;PWM(N%%PHL H ["Z]QN9!)>
M%T2[Y877R>J;P)M >/6;2J=@7/+&1C:K?17$Q1/S4=X64]UO7X]=P_0\W3Y.
M5<(4\ D;0>!_X2\^ L#*"YEA/1G/W@IN7 M@",^>$F.')[7$<U+3$PC"TNNQ
M>J58%GEA8AXLG A;;DI\8W)'F=A2V%&QH5_N8#NOOO*'P#+@WK%C.3"1$8(A
M,,V'*U2Q\OK'3*W FUTD36$UWB-TD(EI2EM]&6"3P68N@L4/]Y]O%45M#(7@
M9,Z4W2),V;[W\T^&K'B+#45^!@Z/=D,6=_D\^@\?^W>X3#D'1]NW)_UG=$*5
MWYYE75.6=Z8WMAPO<-=T9J$&1"=HN"4)ZDO@>@$VQ_(=9C#+!&CP.#,>7,[G
MV/EJQ/TGSFWVE^E-G/D]?-QD'^UQB[WZGQ_ZFJ:\^>O^H_A-??-:YC?\_AL^
M*\Q]8# HD0N!W;0,!N)QQ%VD5NQ%Y06C5)%GVQ$S;0ROIH$]\<+JS7BU3)IH
MXD_&#=?FDZC'4-AM2[0A<AB,1.^VWVR4X*F\(J64^/X,HW9A]LZ<QQ)<24AP
M'KAI"8[5;9I*.UMCDKWZ9_%!EE0R\D:)59R$HGFU2>'HXW!5K9\9[NMFH:55
M!R=<VT%CV&UG-:-M*ZOND\"[Z]+JB@*C[65K'$F>*;*VVNGH5D>YTE7+KZUV
M#K+5%:TQ[*G9<A2O!>C 4Z4SY5GTVN'YO788MB<1_VIB1[!Z?!,PQEN L#0?
MN?7<9$\S<SQC,\,#4 1$Y)8Y-VW1N\P4ZR 4-R']6NR3PQR<3PQ33W!;B%RC
M9X%CHC>:A$G9(7 )E(''HXZ![P/767# R#]L7.Y)X.+%B='"Y3C8;/.^7_43
M2TW3!XDTWBHUMW8C*"HS!X,<H?GH@/*\C]*EKKXNIQ/!1S'3O'X$R35(]R/X
M:#]RST>9BFTI$_*4?7&=23#VO72W E*"CMB%$?L7WCIS6.YG,,4\1W"UF=ZA
M,7=]([U3BW"G4"4Q%O#7=P R'\"!;<'%WC['M0G**>(WT!6],>QHS4XW6SA"
M8-NVL>[CG2\]UG9CJ'6:6C^;?,0,?PU.1PBMI1&ZQ>YGHN?KV HF0/+;YKF/
M(Z?T/#M8J[:I*UG=JM">[%.0L?18L:YNL]?M9(:Z*A&!#=8PS5(<8E_:Z=2T
M3/'K._,!(9)]0 5?=@:-)&+\W>^&#0R/C\3W3<%&E2G4($XYML/U6&AZ2 D+
M&,E]#S]2U3<>AVO'Q@(?U KM$L ^'V8+^&$!SLDVN?$?#S!:V=0W[# <]2/%
M9KZN(41S'@*$@GAW[8(]P72V[/L^ZM0O,+'?8$J?[=+[+ZP6;9"U6II'5:ZW
MCKB *H@6C)(-5)%J]C&UUT,,'BR:=B?'1LA71+'3L\O'*/B%!BJY05)QD]E
M\XY4(6^3O'CGPP_)KL"]GQ?<%1JK1_ICQ?7'=Q$2XG::DW#?!.QI;WZ!:]@7
MXUEN;(B%[)Z[PD*!ZTBW/)EN^=D&"?8LL5]5(NSW$QJG'^X+\BUL%X(0\GH
MLN\!-W(1;:0S@A%(?RJ(H_?W'^[8K91M$0B$RLY$/#^\#QE[FSZQ3[G(V^5X
M/\<#+"195 41KMG-:;HB_(]@5-N^Z3_+)<$N]D(W^.6^R0P@4&?\]PS69^E
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M*I1P&6<1?H[4F_U4,$OV8R#BQ(<A D1\IR<^$JR7_&#9!SKZ!!D"_X;%]TT
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M;$-;TOI(ZR.+_\@JWK(&^^9B>^T+*+:G5\HSH.\L/=2!TE3;[0@?DT^X"Q8
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MRWASF6 6SXRMK*4^",-9^D4*R+SHTZ7,0P@6X\(^> E9&(XCQW,WAV\G'#V
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M>#UB)7W5!_'HR)/ J#^\ PL%0\&G+N"O1^EM%R%+S]O7+G2I28+9&@AE; C
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MU)^Y2R?+[N%YIT@G2^DD6?@9CT9F<(WA/XM+C54BU@M1L=9MJ27;G=:'C(F
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MILV?@?TLM2.8'@U,MUE;/SJ8*I7!]! 5%LX)(3#6=NZQMH73]##6AI2FR3.
M_N&)41I54QK(:=36L-L>#!:/'T3_$,&T,3-0!YB6\\%<0O9%0,T+^^?%V+8
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M"X,>O'GE>$'PFDRI']]4+-5LQZ6:0Y[<9CQX3Q1#F\BI&C4#Q_:+KQS#_(L
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M0HNOC(C0*!0U(G3-<:\]0717:@U[_<6 & (T K1HNMC\)"@4"H$ NN8 V;X
M6FX-^WTL;R6^1@@1)/M 37@ .U71!9EBQS@^NM!MBY^X^! 77@O:Q*4A1LIP
MV:MQ2QX-<;M0!DXDR^N/'(3"CTGERFJK7EV%1;_**A1CM@'";J-4#F$79>"@
M65X[X:X*N#MH]WOKTPT0>!%XA5:ZAD2Q4 9.)<UK)^#56D-V,-/Z;0V8YB6D
M,@@1P;J&-SSR^%56N8P8CN,]&ZY)8SSDNUKE=_$?U\;4#@V'UY3"<E&X>"7H
M.@5F%Z!0")O_%6/N%_=?*>)>IH";H.M7#JX;KESI//ZE29A<@/@LO"HB/J-0
MB)O]M1^ [C)_K===FUR  (T ?71=Q.PO% IQL[_V ]"]UE#'S"_AM4&(N-G'
MGU/;S\XP-#$JAD9=?/Q&KPN%0MBHV Q1;T:[6/%^:]@;U'-./>(QXC'B,=89
M%@V5L7XZXIK(PMO\X!&*AF"XACE,0HJ5$+&8V] SX78CH%:A.A7?A1>,/3\<
M&8Z#81DTEV)B8O/= !2*AH=EHN#BT3"F%7?;\XWUMV/#IU<,=/.[[J^](*R6
MOCQH#=4>UJI"@!9?%Q&@42B.G:UT>(3N2:VA+O40H1&AA5?&YD><4"@$0NBM
MTI6.@-!R:]C5UB(TYBP=726$B)/-]OJ%QL\+GSI&2"W"KIZX]L@VD]U_04"Q
M:!6:>Y&1'1TR%(KC)S)]'(VHR<I.+EC\7))R\,7E/W"P_5+$VDL.M=5,O=(:
M*@/<.X+H++XB(CJC4!P[7'9H>%;9YCX9US,0H!N@BQ@M0Z$X=K3LT "ML?(8
MDKX6H#'13$@M$2R QAX ][ @&?'BXSG=QV3['WG%\A@5Z=VWFZ\!_RB_>XVA
M-.0"0L(^.FLH%,</I:4;^C_%N/J-AC<IJBYN EQNY%D-K)Z&/ACBKO JUGS<
M1=$0;(\,XAKBVM&%M_FQ)10-P7 -\Y>.+D)"A%^N',I2Z& ,C9!%85C0D._Q
M T>!MN-8S(B,* RCX:3'[Z&A1$,I)!HVWP% H6AXX&5-QO(MP]E+U_KJF8:3
M75,U%M-M#>7URRT(Q;M#,9X'U*0SH? POL;)P!X.XZL!>M?7PNOU (/5Q7@X
M'LR'?%@XZM/\P!$*A4!\>!];^'8CQ/W64%?6%B;%_",A%4*( -B:P_IX #59
M02<L^8@8+MO?!VV@04A,P_=?X,W/AF]A,2RD 6(B?O/#8B@:@JT?(:YAC$GH
M^(*0,(8R<.(QIC3G\@,=@2#Q \CC#16+IRIM&'8:L+T676F @2=DG.+3BN8'
MGE T!&.<F+%T=!$2(F#S^Y>O=U_0)4'#)R2Z8:@%10-#+8AKIR:\S<<U% J!
M5I)WBKV4U+@P0EH,Q/QN.Z%].?$BMUK9U[[4&FJ#Q>@*!E<0BT53.PRNH&C@
M47 8<#E0P.4F'%.?6#9879^Z)L4ZUF@=!89 ]%10*,3> \8!]=+Z,PK""32W
M6JIK7V8G!_7104$(%E[;$()1*$0)%M6*P4JE[0:(P8C!1U>WY@>)4"@$PN!]
M;/W:#H/9J0"#M?4H,5OHZ$(O1/#JRZRB$8W/!WSS*JEBA/6CT7:+"=/+;?>\
M[)? ^-_0E3I?^3A*="LY>/4JAM5J5IP='=%M:UT%G2G<:+9<XT3;9+02?]6&
MX"^*0\/WG"T'W/4;R?JLGK_4[F$)(^3"S>8Z!^;"&-)JF'P<)\2U#1GNMH;=
M=G_](2MQ4.L7_H$)[I#?P#IAN_'NXI)OV.66_93E<'&A8DCFTG<D$3$V8>09
MQMA[9N/!I'?A@D2"2. YME6B!TJ'W<4T <9Y6E"PD>>%KA?2T9RTQ^]EMQ!2
M;%=A[N(KBL)(+G2849(7 J)HK GO2$Z"" LNVJ.7Y,ODK[=Q 9\+4'3O$?!\
MG/R<"!FY2)^4[^0[,E,K,HA_SZLDX3H)*LDU\OLMZ./%#_H8.8;_#@3-\:!S
M#XYA_@7C<Y_[A\WQ^[E)(\D?U+H$\;O/A.N#'9B.%T0^O8/V7CF>^=>%*=VS
MJ^_56*:J7:RT%M_)[[XUQ]2*''HSJI)ES6>W_.GE$G _+P+- 3Q97QG.Y"].
M(4^I,Z*ISR*::N&-2A%QDR@VR_*4U'?O@;&XZ1S<1E/J!Z9O3\-L_,'2A3:
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M,W*B8'R2,L7JZ.[AU)Q,II3YEP%(&63L,[#X]>[F6I+DUI!;4';JS#7#*WZ
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MXT+:(6P(71#O7#$X:"PQ\ZTE8^.)D@=*70* &IDPL \O)(0[;1A[DU>7,UR
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M%'Y0>*AI.S9OY#5WB[^X&^8N!3PR?K'*^"G,^'6E16=HW[JS4F_0F@IE3?\
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MNFR!NMP63$[5%D@U&(*4"E6S!7-4.=F*5XL)(*PH_L%M@+;*!C# ?/1!]U;
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ME_>5=TB:$5)/5NQ%@%2]HV^XQQM)LVA8>4#2_(V&6U)FN3)E/G!Y+PR@"1I
MN_5&X3/+XK/H$W6\*4O9J[.XA4BF?W<KO^.215GG!"EZU%@M:J0QF>W&KTG/
M-G?:FE.K"P7VD#6X*K&=7>I:U!DB9(<SM75Y4$N $*U78ZT7UJT\:-U*-%\[
MFR^4V+W6D'RU1P/VR09[1+^RW=T+FWYF^6'YS+!JQHR=3-[7%DS9:[1E9V7+
M3@<8SM(3VSS6VW13A@)[(I[8]G%GK354VWUUL5[25E'GO=9<QDBTH)'H@]9<
M1C*T&1G".LP-M2VBU&$^NHN/=9A/2'8WY4FBQ*MUMCZOMWO=Q:.XT,L_*\.&
M\;\C6385+=O.E@V%]Z#++:N#V2*&LKL8RD8CAPSX=+RW8T>UT7L[(=D]IO>V
M?8R[%_MN4G^Q\N_FQ^J45:?<N:"D@@4EL: D%I3$TB^BE7Y9M[2C'*^@9!WK
M@RC-XDOS<C:"%2:Q;AZJS'X- %:81$U!3:FB*5AA$BM,HNY@A4E,2Q0D+1$K
M3&*QG+.)S(M0+ <K3#9,:#;?M- 5)!VOCQ4F$>'/2UE/!>%WJS"I2UAA$BM,
M(J2BV)\(I&*%R88)S7%)\_994 .L,-D<-1 B@(85)L5*!L>Z)N=@3+!$%]8U
M.;; [L)V>D*$"'N2U!HJ;;4GX7[=\[9>N.41*TPVRWRAQ!ZUPN0N!FP_VW)[
MDMP:ZHN6#'?EGI<I.QU<.$M'[-A;<=$1:YS BN*(;1MV[DD*=\.4M6X8%I@4
M4A&$"$17V(6(46DL4=(0E1+%M@A3HN38'CZ6*#DAV=V4)XF1T=J3V!D2DMKN
MRO5DM*)A:ZQAP_ ?%IALK&5#X16HP.0NMFU?D6P-(]EHXY  GXSS=NR@-CIO
M)R2[QW3>M@]QZ['KIG<K9E:OK"]97G'RC64_Q3=F$OGCQ[X+6.Q/$J6YJ:];
M"JO4KP#L8C4RV;_)AY"!P]P+B>$\&R_!'*:\Y:"1K)+EV@Y/ZN1*:R;=X^A"
MBN,Q?R4?EOC"7#](TA$RFY3LQOR,$CZE,*-\0K_?PG1>_*"/P-'@7M-S/.C(
M P-*4*A/%UIZ(%,.WN"=]R,G"L8G*5.L%$LJ54I]"Q693"GS+P/<,LC89W#Q
MZ]W-M<02.+A1)=Z(7#,(<\/@_1LCKG3":JV^!PW/"J@8@6U>L#FY "29T WF
MI+6\0&T*:I?N J/_8 >FXP617U*;5H6^9'+R63VP?-@AC+VY>]6<5=+1S4G'
M8% B'D\>Z/DN\B'G7R=K1;/+_RXIH?.%=[VLD$Y^4(J%='C-D\M9S1/RZ@LT
M9<1]N0ONS+TNEMB9@P!H^$D"0'<_ *!HLX5*=?Y]K>$73E=<&C.79SL<DW!,
MR?PDM0EX:N:8/!L!7#^9.I35$(,[$N[S+9K ()KSZ_MRD>Y8X(]?3."2,>,Y
M%Y;Q<O%"#?^"NO/,YRH*;)<&0:X)'T<CULHG^@&><C/*_2(7N4ZW-;R<^K83
MN\0R7W^5^RGO25HZ;/-^7D-?#/<%[H>QLD<V=,K.@(<8''D8YX[@!R,D?UN3
MSZ#L1/92+2B-:&Q)_'K+M]01G\:EX$*/CP672?8'Z ;(&;G\XY_PO>]%CV-B
M1@%(L^&_$,-ZL@./?7CT*67[K8(.N1O3@):,W#/E6[- ?B<PG?Q-8^.)79GV
ME40!'44.<:#/ 3%<&&:XQ?7 4Z)6! UE3X-1)*'QDTPC?^H%-.@@,NP?&>YR
MZC&E/I-DIATPJ[/9*Q@$U^/O;PTOV&1:"8@O2 6QX9FVSR0'>&00SHDAR-%*
M86.@\\U[RF=82/$1GEP,X6E!Y+#+1O TFXF4X;P$\"&GXJ['^F";1NCY_,I\
MDSSRP)YB>H\N3+E%'HP _AM-X;T&^6\$4PRVC>$0[TX0\+M>64!/O,AE_3"-
M8$Q&CO><O?MU@I[04SM]5@!S JTQX7F@OMX#B-H39U^V.XWX("?Z#F^=^MZ?
M@'UPJT^?J!M1\NA[SP#5/@P<:_]*6)+RH*14PJ3G\.UWZC-F#V)U,_H1O_5W
M_M(,=UBD)0,>4$U:1)Y^:Z@N8,YOL8J36#$8J#Y1GX&-Z8$D0$],8\JHP]I.
M%8YMV QH\SW[=]*.R[@9U]"*+RYT%@3CI6I'!ZTA.#R+QQ/_M@A3R$UWYZ;=
M^JAHMGOXPVSW,'GU":GHD:@H/!P0TWE98E:2/=XSTQ*D\\=P/E[F8:P4=!D@
M)B,6HQ@B^3,KU>]16D/@/90FKXFM#".JP'0^1#[#9#!4N:\)A0Y:2TZ6YHC'
M,@"+C#-G88S<"A6A/Z?4!2/(7.+M!P0ZO)JK=@5<>),E(*OJXLEN? 3746]5
MP/Z4;XEI,XXRC7T9YP6Y[ &@9967*K5($HB"*0YSIR1YHQ5R\2D*@0CD1>)C
MK+A+CD\"'Y6"R$QA.D,_HO,26.<[<S*H:^Q4X$O.<<O1J<T!AW/+4ACBKA?
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MC_DK^;#$%^;Z09*.D-FD9#?F9Y3P*849Y1/Z_1:F\P)D-W(,N-?T' \Z\N
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M=AB6Z$2<X9?HA+_ LH!.O.S@B;YOB^'U*WF5:(DN:Q'O],/R?E2,OBW^43:
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MKJY2% E)G*$(#4#*UG[Z \ W\20EVW#"5"KQB$#CU^@&T&@T&C_][6$>.DN
M< "C#UM[/^YN.2#RH!]$TP];=\/MP?#XXF+K;S\[SA]^^N/VMG,.(H#<&/C.
M>.4<P_EBZ 7."+D1GD T=_X4S__L;#NS.%Z\W]FYO[__T2-EL!<@@&&"/(#I
M#\[V-B&8DSQ&@!)\[YRAP#D#8V?_P-G=?;]_^'[_E7,W.G;V=\D?K,H??GK
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M$*]@HA1\-AE5W*$)%]+;CZ7-A_9R\C.MH3E-)@+E3E;,8WQ[2:\=Z\L)5E+
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M4S<&M0U-)@9%3+*^FO9,]A7GJ%M+^LTHY1QA?:N6M]';?2VS\/ S0OUWH^6
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M7Q\WUZXTI7=:- .85V$0'8K1R4!6;S66,/O9JHWU,X.A#]!M,)W%F"; EYA
MLF)&JQGGI:V0=%*:+/E^;PQU$F,RG[MH!2>TBQ%@?G6T8JZJS-W$3P>F54P6
M$\[!*GM8H3KD4P#LED@5@E/#T&M!]T<8^'$L*V$TA#G'J.@AAG[T;O)(G2R"
M-#FT?Q*$";&GA(]H&)VD&Q'2>S5>\R^H*'1 >YS.4#&;,<,E(-<?NW70HR^
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M74%JLJFT4$5=K!0(T$O2+;1<;"$'A<#E2??=M*77U-EJXO5"P<RKBYDL^G-
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M3UWR<*:P%AUX):3IG8>0JAXAX*WYD23KU-MM0O\BI!?_\*DH%U7-#M#L],B
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MW*,##_?4X&!YSY1C+]YGEZL588<-8;]'VO #> %_AJ@HUY? L_T/14JG%OJ
M7D8M*M .NN,"I*=EC6B] BDOH/YM,W+@Y]@YM076A#)7W>#I%2I-LJQI65(6
MJE @L#E;$(45<AW? G7M; T'KXF%,3@0NTLT+"S23%$SD[L9RP)[8B@I0!M
MI=5)5VG6B#FZ;RQ=& M>APIZ6LP%R;UP0.T;G;%!DK&%-4@&<M\_*,B!*@SS
M&<AV[YA0RDD:R#.4>=6X4)D%XI"-H>M=,2Q,UNR!]D!N!2-!+0]E1LM UK7'
M![*83M]7AVH6R7!@IH/H'77PVNX9$XIQDY26@?.Q(06Q?\N\EX',MP<!K+IS
MK$8R?(EWQT+.+1G(LFI8L/H6C620H9M2,AR8(A%5T(#@638F%..GOM"!/,N&
M TN#.&:(##[4.R.!+8;3FA9#%X)L/!#3NB>'92#?&B-#9>J>%+N TLF= 8<K
MYHO$Y];Z@B4UY-3F;<126%MY?6,V5K67^KIL2\I%U]6>69WH/_'Y!.&6%<=-
MXB\#LO***/_B0T6F.8_#&&&<?T6_\E7UF:^Z7Z].#V1>$_:^:\UJ^>WC8L!@
M=D.'2/WBB7QY(&S&KV@ [,7 @?ER2]@[E"&ZK:\>;J\87'I19,8;^\*!([I.
MPY@'\-U0VBVNR&M.XH 50RI_R[X,5;&\7FN4@RCQ6V0C5@8^26NJD?=$HG]\
M461?KCUO]_.AZ/;M,:OH+LGX#!9/&8]LZ@*9U7BLO.R)@U*-]Q739E^1*,_J
MWW#]QH$U(EGN<^/IE.=']>2%Q+^8QH'AXPI8I&W6Z8*I6:G6CNG"K[[-@GCL
M1)@G2JR2E)J4__CB:_H5OC/^[D<)M2K^\46>%DVWO+%LF =PT7$$+O)S+TWW
M+)B&>=N 9:5'L]Z]+J37NV*;XM*$3RD^&]%)_8F+8\(IL.2T2+K;=-IBTX.N
MDMHWX)NN&^KXF>05V]!ZL8]4:PK3E58_7)64OI5+R49$=RG9>6%0O;;AR$9,
M8P;;1P).)8GOP/<+C^UK<0<L"0&!F>P-$325'/X#=D=@XC\EZ.6+36JGZ=EG
M=FHHH3?"?,_\B-Q70(V,'3NN>%U^8&W40\JM2&R-Z7[TU,>[B<1>\I^OZ45R
M6P8%E/EAA^,JB7W1OA&XQG3&<&D9FXI"%Q;U*6ZW@=AC]?+P6'U\Q):)9/ V
MTB!X7%J3%Y\)C!K'OXT$.P&RC<8DH)+K(30_/T(?:FK[P%)4C:B+ZWBQ6O'H
M7I*Q&LUA$'K\D3W+$I__ENKC'Q**R(_TXT7*JF.!2G,8+_,3^$#LJS7Q)WC;
MO94<S5]%;U>/6?FH!&W&]]*:H=I5@%<)[<_ &K=^! 26SF'8>1J31U0JV/\"
M>[]B9A*'@MR$SZ3S_'KYZD<%B^!!DHXQ^7E*T1SE2MI_A95VXY:)9HJ*:<SO
M:)-@50GF;_#NV:KG"(*+8X;HUVC4UV781XQ&O4S<!\(>0O.321]JM9SD?HTA
M3Q9U89_4"Y"\XGV47'H^U"M5]&8AQ OE.; N;EV%>G;9!9:3FIY;"\%,7AKH
MP?H+:\(\2+Y:)3B"$E%P>!<RDXL0'@UGH8TH>&0IJBA$%&8C"B$\2$Z_]L6W
MYG./]/K73ZSI?)ZXB%2PZ7C^K**(CDD_%^0)*91!0F0^-H$,):7OS? =2IA!
M)I2)X &J]\LSV K*^:N=9@#V\2(.RENK[]-1\8TQ8_)SLLW,L<7QT*%+<7)R
MLEW5_7=5^' )NNE;$9>WG:K!2KVG^OZ\W)TZ@-3W&;D9#: (Z^T=!VAN3AV*
M3@\N:\^;#I2U%.&B[F0GJ$$4B^K[L]M,2D!J,<A-:\!K$-Z+@9+>O"1G@&,M
MP+X7<.N'GL89B/O:(R8T/P=W'VJUI.06_$#C#L^JFZ$D6KC4T,L-:RN_&]GN
MDM1+]RP^,]]S@^7P$'LLO7_GA<%U?.[MPMR#?OVV8F%.<9C#L*[E#OP(?IYL
MMV$9L\22J)IE-<!]1W)*<Q1C+W*UM'I>QNVR4@_%+;)R]:#EHDH)S4]_]J%6
MOV/ /@2VRQAAI &**#B-KE,MS)/DI2X\&@X)6P67Q&ARZ SO<GN8R*"+"UZN
MI?A,:W  [8Y0$YS-7M$!#^DQ=N'[Q;;@C_'\,L#*!Z=DPXIB/%=UPEFGSL^$
M*N2E]PKO4S*B[M:&,!*I*:[*%UX;Z=ZSXCSQL:Y_@ZL+BI\?0ML4&@1GLRMU
MP--XZ86Q =%MOYFZG$1(U:JR[Y0;Z+N@MP%T&2G)S?%&I<:PEEY_I8'__*I=
M;>A8O<E-%:*?[SSF-ML0UH CR@"*$E'NR37]$?J.+B PP.X[C%85+<=AM=6
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M2%@XGF3IZ[)S8K&,O'YU(:XB?U4 3-JD[P0H6P;V'(>YH0L\)^FVF?AX7E"
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MXY4HUF1=U-#NTPU7#)()(*+PEKU10D0U.^_!NZ2^ ?))?>/05]^S1HW<4M\
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MG>V;?T%HB&U V/$='VM+M=6QOAB0:K@V":%TV!80&.>JV=-AVWSYRZ2F[0B
MD0UXOVV)=!QX ;!DH]> >\B9RZ+L.IJR_\RLOX+GY7:OY"0@H<NB%+M(EREE
MTOJJ,RW5N[J$R+:G#!X1U$OO5"69@^Q V0R#6%.E&$-<;RYVM_MIN=0,-9!]
MSVGXNMRL.* KF2UT38D.K4]>_ -)>;?P5#=+0SW"G- 6(H"@EW\ZW/,_T1T8
M\LCVDNI=Y"_BX/CW\K?7OO>L*9 !0T];4D,P@VX%)V(:):Q-0,"A@TUE3,CL
M39PPM)I2UP;[3*!+#8IIC)\48^.A4> TEWK*1Q]]'?]8Q^+=I<ES&+ NQF+O
MY^_3_=FM?Z5W@<2M%6?" Z*F W%]#D1X]*BD=Q^G7=TXBWV#Z,M\=V:^.S/?
MG9EC.#,#$OY\0]9>5 :J*Q1B'5I"OU6*A/YPE(1H+"P1C*?BA @!.X 8C7)X
MI>)2BZ U$);YWJN<>A95C6A[MN!.RU,2O=K&'%(G:L40500_Y>_/):#GN1GF
M#S#VK,GNALM$WV^L,X:+9#69)JP<9%I3![5@>HG:>)/-1IN5#.Q<RW"K_]/B
MFCE)E]?GBQ^'[P/!:+.2AA .E&:A;S/><HB[9'Z9FH]Q2OQD'8>_D>"!%7P]
M\RB;Y\EV1VT2GK5Z^<I^)%Y<-W*_)PR[,%[_2,>F_[DC:9@$PYI5\#*%'=*+
ME.)>IH&?[8\?J9I]+%Z\-,!R6@(P9%%I^B  /E0W)@-86BHM.38_+KRB<"NO
MKOHXMA#'K_.S#'-VL[Z.@Y >.@58[J=X7,15H1,PY6A3UKEO$JQAWQN%A%B"
M 3\$F;=D$^Z6B::OPEK<"HHC^/4D::.]"UXJ*16 H!<6"PY DDMMA.@LXQ1#
MCDBQII?;793L"2_A>!%2#4,_I7O7[/NNHZP_2^U2G:F]8" %R=<TJQN6V$[X
MG)2U<JNS@1>3;_[]/,GRSTG^+Y+?'\X(8$L5CT\'2P7'*AM!I$@N5S2.2XOC
M*DFK7['/?3.7E2EFWFF,W\P6K$3\FL&$[MT6]X2E)OMY97$O_)P>*_F>6M@G
M?WFDW#0J!;\[)_"<$Q8R&>R L* Y8I$I=SX&&UFXRDOE4UC2#R*$9;7'GKHG
MP7X'M8)AVWB"/[)KK^I,MJR/',;!7>3%9JT^(16E#8MNW!"]NZ45LHDB%J1+
M%@:SX"%F:*O(:9B:DX6$5JWY1$$BA:>(:+C+E,!4P.U732&V:,4).D===O_P
M.(9$3VA-V?^!(]I3L*&#..BUDU=#COV2<0%Y31>G_DANHPBP!6D&JL;]?M0+
M<MEU[#JF#!<<#%Z(?+GQXML==PP??!N?"X3M/Q[?;] W-:+0L6K0CS"%GTBX
MWC#?7/GP^Y$.G5]X.;GRPO1'+RK T]&F,"47\7*S7^P:*P4EB@]O:GP*V75<
M.IMGL]!/V)ZR%3BQM7PJ<&4[[:FI[?8$WH[N-IW7NP)'7#/*5NC3VA,_\M-I
M=EK\A.UW+6XM<(VF\5->L6]'BYO.ZUV+(ZZ9:E?\>29:_"I)5R2<HR+O<OZ^
MK@?)O5JY?YG7RF7=R]^.*C>:U+OM@K18JIWP5VC+AKG=+UB<,XF#C,\$/ ),
M1.(M.IF%4%9R^QNT/_A B/+'HFL66U95CNI-3AA8A IB;U"8*GAK-[\R5,E]
M_*EX]J4ZRAM6)=4S)7195FS+WS6B44TC, \U;?K(+_O):_<V@J5F6P'3>B4>
MU'R#&Y:'Q]Y%?TQ8WDE$CY)[>B!\HBMF6VRG8CN8,SY^! K68@0Q$BPDCU+\
M;(P)>*\S7;H5X^]+=ZCD4:+I0"=P8HBWYS'EI=O/^/O2'2KY:3UGBR9P'V:_
M7+&RZW%.Z,TCG_J*%?+KPETVNZ4JEK3Z =OY$JV/A_IR-?4E*N3W?8E:2UKY
MFNSTPEQLMUZZ3U878>:GA)&A_^0M3*N^LMG0Y,P6L"Q1*@]3#BTC2:$H4B*^
M\@[>%B:4!Z1973 )L05T!(V% U>IP:D4V=*[ NVT&L:,RY<;BX72<EX-%,-<
M>N^RA/#8IU8:!RI94=44^AXKNQ$55/E<>BFK6Y357KM!C2A.!^.T.BY$J&H$
M_<3LBK2<C"G(Z+1 4^69PZ&*MC>E:=%ZXJ]+P.! /7JG"E8,YR&G1S<;]<$G
M5%^$"5#]-/&XCK.>4?=(7;-)@BAXA:UZ^,<XH\98N JI.095#DT^]ABEQR65
MSWJ7Z@%].2K0=;![R8$4-%.(P5GMLF&2T*M29GC\\9UZNC^U'YCZO^TNK=;H
M6%)   MYS>%GDE_'U'8C-TD&;2:UQW;6D4]K:37M\Q-,T*I>+,EVEZ34R"]C
M419^9?8ODWL2D/*J7M[<@W\7I:D-+"$;#IPXJXUE:(4M?%/><AW1&UUYB6-%
MU7G;/3_<>:Q:ZP/QBS1D;?B4.LY@* =17B8R,L0%JRWI8QP<Z==\LRV_B/@7
M>YCB4P7>BX/9F;C4X6!7NM(''X2+9WJO8)>#97*>;+=)S(/'-DE$":,(WY2Z
M(R_WL*-4!U6U#]I8![<67,E-N=0X)[;JV&Y4)Z%XAKK9$B^-W)[1]71U[Y^.
MIJX9FH<1!8&\,KD%X-[2JUAPUH Y_9D<SQ; HF2!G 1\E/4[JM?5[+;(L]RC
MJS->8YS&9K0GK],M(56G-(#)M5I*'4[0+KZV7,Q;UCHPJQ,B#,TOR:J3\7+Y
MZD<%^\'6,(.F-^VC&@-@C>0)B"=:G(-91F4^[D<I3K5<8 -TA3[J,1[,)[ZS
M%/C4PIA^@7NA?JCRCFQ3B!1KM?/$@;NY;]JA%]"1%QH J@XE"!I8%PCMH J9
M<'7#*G1P=%4Y_O D>AYY64:-8EXU';Z*O)P.GFD)$EJAOPG:2;=26%$2I9ID
M4,K "PB,\Y;?4\==N7:;$A$A!!U9(:<%7E!=(@^'Q= '2@,^NN+ &$FI>7]^
M1X$G:8I9W;R/DM.X7:EV:.FL/IR0*I4;WN'&\7=)J;N4H8E18HTN>'C3#<DR
MR7U;.\A)9XRY2$87$IVW_X$.J4K\JX:#^SK+"F;1/.Y8RS-ZP4J9VK]=+3?D
MJ!4$M5C4WJAAQ)SY, R6K]@I-1!D: .%E;I/Z!4[#^GE9\\7:OA,3GLF\;PM
MI82U!W+T9F\N.WUHX .FWKW%+K8GF,^X1U%/PA=&K3[6)IWE!%PE*04A9KE<
M2<R^DJS*A\\GLJ)_*G]>>J]5Q_6CH\PJ!) .1+I=VNS9D7C8I'&#>/3MPR*A
M>=)SQ6'21CR@.UZZ\996*V8326B#_7[6B5,?2;).O=V&,A]!)T]UQD:S 71\
M?"/LNDX251==^$2J<F4T*<$E4DG'GD(BE6SI'J0@1P;8C]%+#2:7JE\2[G.I
MK(4!WLC09VGBZ?[GQX<>W#/B_W&=/']5?;B$OOK'$?G&4 [BU[1V-\.W.6-0
M_4*U9J4.-9O)M3_M)%Q(&[7NY' <S\=XPBO*(*MH$,8%O3_<TB.+)^IF9^V3
MA627K_360KD)60T$;HQ\3F)F$M#)4Q+KNK8.L",4DU,G-\,1+<11I*W9OLW]
M1;,)Y7F1IO0GEH=>^;5DETOK*JY'<K<UN86<G$7A5DL"ML^X)8738<](3,67
MB]845F$>>T:<.6NA5D7KG7* 0-#R9RNFK@@=WXLZ7.$L!2DU=UGFPW>+0-1R
M5-7R'"!,;D[317I#/SR62!4TG;Y88XA6A3&P5_]T896VQEC;54;MK6U7*:I:
MGGG@$WK44]AM?P,4:4IA14E]K@V"2N6/(U--HFY;KL,*5Q=GZ!SH4_HM_3^N
MM+5(.VQ2A"-P/<#1$J@/ZZX\(T;>W_U$W^3^5N"LD1(]2,[C"KA'LF]*JBIQ
MRM.?!SA-L87X>]B6*L'U]6R;AC/QM*PE.T\*NG3VIY8$J^/MQ;Q"N!?OL\O5
MBO@\?(O^?F"FUX$&>C'L/DK6E\\C1"TL)6MC4;L_#DBW(,::, AO+MT5&HM$
MN#-AA +KF&J^GK3Y^TAAN(WOR7-=PG])TFT8\Q]O5_5Y0=54%@:5@M*/2AI.
MRMW!JRE^8&0UWX1,!/\Y8;J[H+J3ZDSVE'4;7[ZRD,<BS#9,4S/?.@M9YA_X
MG.0:D:8V8[H]AO7%:847:,\>^9KBCX?E$O*BH\5@NR-EP\U%5*8H@7J<Y/1;
M*^CRE?@\[/R\T6BA.@QLY:9/8,;ZTP!%A$)[$J8>XY3^>QV'OY& _K$ZS:TW
MH&RXF6] *4I*MQ",E,XWK)'0=7SL2Q1%R8L7^^3<VX6Y%S&UKEVFUGIXA[Z_
MP2+4AE#M (*1*=WL85H93R!2E _H] UFL.1Z@%)[=R#OHR<*G.MJ<>>O\P0I
M^FTH3]/?P< RT'0C&96DJ1TW'18;BB:[COD?(H_7:0W(-@Y7H5\WE2,:1RP4
MG;F<O6"X*JOD&0J\/CJJIX//)*]L\'BMJ;'5(\Q$16M H5&@#E0KB]_O3H6"
MI7^EU.?OZ9,#JZYU!RKA>M'5+B;Z@7*K=VVY<81NPM#D+ZR0X&O4W;,J9-<]
M&>C2//%.AE$>HO3"-*4^HYUO#&PMX)Y.R9 [G_?E/1; '4FG=Z@ZM)HME[[&
MQNYBBU5I[/?\6@XI/[M08/<OY(<)5)VOL[/]#T5*!PA]_HQDEU\C4'4WYG47
M1%\>YE\5)'-I :#-LBT!)$NDM_9!CVPT"A?HX3:\*ND@I;8H\DV2LC9F\ 5)
M)40F6ZC 9*$+5=P)F&C925V"* 5)I61&*(/94Y.T?^WV"T:_1@&D7,!+D_9*
MQFF)TN'"T:M2:KESZL3D\S*K'Z5$J9C&!&[2$FW1BD@5XX-4FK3EHVFJ6IS2
ML0IJ\Y"0$C.D%+M#'C_>QA&2F(9K64,P8H!04^1^M^G)!D:Z-F0X!4K:9%VD
M(.N1=M-";I@0-9.-X2K\GK+Q>TTW'B Y52YQCVMVD$5.LCLO##X3-+_=D8"S
MZARF,A&!HQF[Y]XM=]ZH@I-O2)V7TGGH:>2FP-3 61Z(/72(#:Q^HS7T\"2^
MPY@?4]:($R?51D',5;?#X3(5)?#)$$5I1-,AV@@K._?2=+]*4D%]<7B)2NFZ
MNTGI+?%>$<K1Q'IA$NBLU_IWU3%Y3S*24I5(K9V%[Z>%%Z%+5X\)AX^+ ++6
M!!KG:J#!33,BD')41VZ/%K:)PN);6S(60L+Q"G1X;46WM91998=C+Q<U T[=
M.P#+00-B]<T&R)I+DN EC"*Z!J]92<@U"S(61>LBV'8]I.>]W7M!55^6#&\<
MI^19YHX7L;P=S5!=Y0"SD(86$N@U;0Y\'FF77@Q_+Y(&_*Z2TIVU?2U'$[IX
MC6 9==7U5:FN'RF,534E\UVF-^I,CCI[U)3Y3 .%USALB<=*17M/8:37B\E@
MJ+EJR#YT=/*(ADNGR%GM!-;$/+L(5_2OI!/3KB4:\3AS4'HFL"CS?(#N "Q0
M%MW.YT1<AHY#F/(E4NH,(#C?ZR@^U[G+I4)*G;8S4"X-C8GO$Q<1>W,^<2&B
MH/UHV@JW0>\J?"5!Q6P<W*5DYX6UP\;(7- >TVVDOMXZ[IY1^I"-X/UN,/,8
M!R'K"_K$FD96KI2Z"_ HN[*7@:F8\@I1#X$8OO^JF(M[UBWT=O68"5U5VGNS
M,\Q,1&2 "VA1JU-.#[$ TEL5?%77TUO7'.2EAQMT9:O. =R@)C D=6Y9G1'F
M;7WH@:03$09BW:/G=FLF;\]8HD;8HC8O.%"&#Q\3DGBC<M.++YM&<%E9K26,
MS[R(+;!DQ16(I)":30IH)P:O+#V]YOYP<2(H7*RBD-:0VF""9#H;"%6'&#2]
ML7)*C82MD5EJA>WP1%.K!7Y/O"R)*0O[.\HB>SU]H/<,7O4HSNOR'!+.SWC'
M1H3,5""F\!3UT%36 ;NOJ<.AA(>5/Z;-S'76G<IG+R]2>M@]4GQ2BE^,E$:+
MQ26>6U<K#1=V8[=2W+#$.J]E")XUC+H0G68=SVXM@C=FI^>!A"_-[N+]WW;W
M^(JLXRMK2X$=M.^;G]YEXVGF:B>Q%S$OA::H>K[JUHTVCJSZD /=4_6TM*J,
M#];.$R\^KKJR*,%"J^D@H7A!_)0%PM"5EM&#@_+.FL8_D#PO+SS93V&^H9^G
M?ZBSN^%]WK"\3:(VW\"%8"L6+->MA,W[LDQS$K?YO/%V&551B]TNHFJ.V1F\
M81#]U4VX#7-1_P^L-32(P[>A5(8)22,N'W1)T5D+5GZ5&'U'TC!AGZ:G83CB
M*C)E:AKE. :N&V-)@ ?Z2Q@KLPPZUHV8W[K@2!5%O4R].(OT6H(ADY] )1T-
M#RNV#'2ZJ[A_ZJ@37(YY\C8JKQX%Z^FB.[Z]M^;PRM6>.K"O14(%\>"5/CM(
MA=-R=,A@ 7@W,!-4EN9EE2LVZH-/-R!5R+J/ /3+#?'0?QU%(Q\742A*1[[F
MLF2BZ@$&VD'!2544'N-L1WQZKR>!OG]<)0?IV(Z\VLI%=Q" ')51A:#G'1XF
M!B<^W>&2T*L@.>280SK='%_+M,Z)(P1(A09K J4=7IM=M=L "7D),:>W'2-Q
MR-#2K8'FWA ]3:\>$E4S W.47D#J4;QN;KF@-K4('=4];S@%M./8SEJ%0<U-
MS?4KAAZY"9])A_&S_2?OWTEZ'GE9AA#N8D+9I2T,N2=:I5E-D,<I#=[#PI&!
MS]Z6H(2@F%)W'%IBL5,TQ2W&&J5,FR$7X-$>5C)W&L4QKMAUZ\P;'NJ7RZN'
MA?]K$9;.8\TG??&WW%X'+%56W0]3C /*5GM(5OF+EU*S]YE$R8X=W3@5Y*5T
MG%X4!@A* T&T=_M37GF$ZN6K'Q5!&*^1KMJ:1&=P$=>%#ZL?@'S1+7R_V!:\
MQ^UBFZ1Y^)O@50KS?),Q,/WKO VJ:&7.3SGX3/*QMZ>0I+OG1:N-*89-)V/-
MO5.&I?_[)RNN*@EP>#"TKJK=,[A%(6V=T5"T79?>9RJ#Y0N)GLFG),XW(U[G
M=9AQ$45F*W==W:@C [1V;&:,_8MXZ?(E<;HF:AZ<M2H8>3$<,$>)#[;@A4H=
M^BG#E@OWV<;C+8$2=@V#:9QE<)44X#VT[)APT_['P1(H(<=I-F/!#?VL^P7
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M?-UO3:ZT>&\W3\G,P2L85<?6YR3^,6$95S"=FO7'<QA.HMFFV0 ;I.*2:D$
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M.GCO=, 8?+;8F20RYL[VS;\@1'08$$8S%G1"/$R6<O/@,0$6)U*@20<EHD-
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MQR/_W,$F">'H-\!XPGX)@A,@3%11"LY.]D\(QUE"^PT;Z  %!PFR"::30Q#
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MEN=]"S.41O@HFA7ZLW_"F?ZS(":^KV:6O[ I/IG@*%-.\F42Z4_QJ<H4?WE
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ML:*,EFE=GXM2-O"&&'7O B:CN1S:<G _X'ZWV039GFX_-0G0H@$8$6(VU60
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MK$QB OI%](3R--O?P^P)A3"_S5(2A!XMT]&:=!09)Y"TQNZPKNT>0ZK^044
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M$M<<'8+[7L-)\W(R'\TV[P1?Q4>P"X=TQ2Y,-YT":/^2.L<',$[N/Y9RQYO
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M$V:V,)0QIKI&U*;>RVNET6SSHOI(?]07AS?V>]P?AL0"W&:58Y[2G+/KP@\
M1CV/DIH7,U&:JLRX#X@:Q[!SQ3FCYQAV<*=L*"MK4MMV!XW[<&A;E/1\/#L<
MY,H4[@=)>$@X@D8&K?0A1H_TSTU<4K7-A&G.S;$UJR71AY'J[M',NO&;%>FB
M<HCM-L&YN-Y:/,T=VE^(\UH7Y8<2&&L'W<$M!L^:'$II8:("99QE-07B%2E[
MT^MJ_,F70=;T41HLSS"#OA='#D[?TEN@M]_Y/U?JX:^W0#2$-&Y#&"142MS+
M0F&D_6P2BMQ]X>MD;L<(33CJKYN6U$9L,9]@0=YZW68I>>\4G>T_8X+725TX
M<8%E^D0/(U/E:]9GP(-K79]+V<.Z59P^L\*K34W;H.["<W9G8T1TTCV;39BI
ME[UYB9 OTSM(AHEBB)EHWBLM4[] GX1%YSO*%*,0+)46*1(DG57$Z(Y0/>-)
MZ4\A655;1A$\[(>6E9]]84J0MM?>9#(:<Y1Q<DTKN8IU:W=9O6WU8<*H7Z=*
MKTQ=7P )F>'=[(@F'L"R,H'?0 T+$C!/H? ^3:-G%,?7FVV ,J)*B-:PO%P%
M1-PO5SXCHF38]4>>2]7)9=1)>2L>GZTUJI&'6,@,]_:UF6WF.'S[%Z\^$1NS
MKK\NGXM_MLMMW:RJ6^ES<AK6?MFJTY?;4JX:G(G,QE8/?<<!<S?T;BM]/:TS
MD"I[9J,[4\;>M=HJ_ #Q)G-'$OG<K+#!N,AS6+2YF*94N39Y+WFO-9E4Q&Y&
M.B+_V.40!*0OKS:)*1(Z.0=,9LH8NU6]!];9!)49>!0\U//H,2&V7FA*,E25
M],! VP9[DJB!'*;?G_WLUZB1"*Q;UX,_X%%%8,*,0/("EO]M'8?/@RTJ@G@B
MQY &8?>FL3IS(H<GK=R3DSN"EE.&+/:R\FZ,@@<4'SAHO !/5_Q=/&I-D_ZK
MZ#Z!JUT2?0R2X)&FP"#U6*,-2DB93JH^;\M%/6@*&G?L^!VU*9^BM$&X,=C4
MK<NRO)WVE5KTEB9DK,B9G3AJXLS?:??)7FZV<;J'D"47^= L_,D5JH2TA[U:
MG3N13FT[JPAR'V "5PAKU!YF9Z%)AR4OUZ4#$V1UTR]]Y$N2;H4M!/JHM/7K
M.QA"]-17KA/@5HN9.1@'.@P+B\TU"=IFBF<3C,@1KCUOAE'!?<HL959%%N\&
M-'2M.:8Y5-,ZO+A^C32*6]%QG_50G\"(+D_+>EA-8^_E%BU 1HY^W9DTMTH$
M80EEF4B/X2XR!N83[B+A4C'<!54]S#W<10$1"N$N0Q-F< V 28001K0J[G(-
M[X,8WJRN4!(D(0KBZP3WOJ/7)3?/"8P6Q56 ,DZ$,.<D:-ZSRVQJQEP*$%KU
M5^*3Q"GFN$OB<UU5G6+4UKV"E'1[!(("K'#/@)1EAAY3<XV& SLECIM60VND
M3910_$@>BZ%BCS> \S2.RWC2G)A!515?VS:("0>N+0\#'I6Q#E]0T=;,U!="
M FEAE4_Y".#]^EO/-L@(H+2UM.E,>GG,;,@L[Q*]EGM&#Q'=^GF^HZ7]RG;4
M.^4VS0M$MWKRVO5F=;;+40)) 5AZC".F0?EWZUEVC%AP[RDP85-)B5%$;^D=
M*<8:,;6(!NN\,&AGVFWO[^=!$D0H2,#E\@H\,#Y\7D&,@9-H*6A-MOZU1)O4
MSS".BG3#UEWSBKE<B<GC378>X(48W68HS99IM4"U[%)3&KXL5$-^E:"_QGT?
M%^EQU3O(Z^[+9_<T?V &0DH!; D)L@:J[V=BM8Z$#<=^'3/IAI:LX/S'#&A_
M?@49 _/Q*TBX5/0KK*H>YNY74$"$@E]A:,),PW[;J^@.5L_Q;E8TBHQ[HVS5
M@!&2]'GD$C$E3.I:O=NCWMQ:.9<&BBCHT+_I/21ND8$AG1YS1VV;1!7;V,F2
M4F=@HE'\$X)2A;I?@UJ!PV&P-MFMSN>6W<H0"R+$JDZ7^^<K!EQRC_N53+')
M%\)9W*'Z$:%1G/T@';40>\5NW$;7JS&E[#VL0^MYFQNWT)+/@\:P,#EGB8%9
M,@Y,[KBK'&1C'J;G(VQ^D"LE*$)1ZN79J#SEQ,IJ$V+=W-!U1XLXX^U&]*A6
M.YY9T@/VS+)L.ANGFUTQG8PP?R]7*Q@6-ZO+EY#&3]\%!;Q)R%22_Y/".D]!
M3(SNI@H"^0/-%-+^1>M+RPIE"@Y]J* )QB$.;*/Q+F]>12SRY37-G%.Y,D"T
MHV\PPB9B?L6*FT+&',@P=[[-\0FQV5YC4PG&/,O4;EO5FXQ)QU=89M<)%M&F
M+(8ZC6-/E:K[W%)JC(F2'K1:@PCE89SFNZRT).L%@9KNWGG.$*@G^\[S?(UY
M&A?)W$20(E()QWZXYB$!'_JZSX;,1;S%GQ M.J>RSV))'41)\L;IP_3CL\)]
MK=^-W<9SGWA^LCIFLL<8<-4#Q:G68K=W#U<Y!RPH+L*RC6=$<"7#>UUZN/ L
MO$">" C=M^^.,WH<,"$T?]F+XUYVG1F\,Y:AX/ ANL^7W6+%VYU<FBWM,4%_
MP.A+G.<33_M<CY%3E;EFY>BEUWM?S-2?VDO#ZSI)];2IJ=7UX2!?RJEV9Y 6
M746>LN2UPZF>'1U75?CBJ=;%XV-&94X3"'VM$AECZ\H(.$FZ/66J;3O+7C?%
M-B^9]<SPIIZ_6BEKM7\MT+#&4P.M1B O!2;(./ZU">K$-"CR I&@M22RO?R;
M?CVL\IJX8#'7?_<-B=[LMR7?'86!VY$DH(N>4)YF^RM8O4XGH8GOT_C@[IJ7
M?U#<U*W))N5%F)>Z; !6$+:>U&!E0(L8-&^XM_AO*-WE8 .+(/9U'%"25)53
M4#X7YB;"YR2#04R.H^\#E) \F#?)=*_ZAJBY3WHZP)$ :>0[##%\OIS_6U1-
M2;>5D<KD>/!P*K#%-Q0JSPMXQ.W JQBW?"UX<??5"&C4.[H[UGO3)Z&3E_"W
MK!ODM#P8%%*&!A5#\VS7;[23D@C;F!H>]@A 7:!\F^9!_#Y+=]M/:8%_+E\'
M[F#$LHJD28/EZG/K=JH9%UZ<^(;,"@!*/B3P)&\M6<IE[G/+(W(Q&^\B\G(G
M@QL8D"  ^@A=\J#3]Q8W$EU=.]Q\UIW?18Q@=F"C#.A6Z=>W-@^IGIB[WVG.
MI$]XH$&^+B^T)TK(+:3C17$)V1&H)OJ]WS3:0X+JY,N6#L_\5EJ4@\MA=D,.
M2?<G,Q6VAM*W9?67OF-=E(6JEI"MGW304#?U2=QFD,2%3!46,4#.WOW3&*1U
MF1*^=: ?5;?-WOV*JJ*4(XPS=!M)L8FKJDH?>,O<;Q^I]VW0)ZG5F3L]I<F9
MR!Y7\TSZ3G ]+#YA4NN!*;%;&*"3G9)6KI@^.2J7J)\ !S7F9/87JP PL^U2
M)M>!;/^B\6M;\UQP=XNF"%/R*FDU<5].S7<]WD18JBM*Q*0!/VNN;Z4V*#RA
M3I-/APFTJJ?AME*&ZG7G_&Y/CS^1 =9*D6!R#^/XQ;.1A*N7S_KSI7\FZ- 1
M7@)*T79PF><+5 H9-UO8X;GJ?6%#<.$C'=V(9"XL0\PR782_[U!&[?\TA#EY
MNP<Q[^35W@5\@G&Z)1]:MJ6TR?NQJG39''IRP?SN>;HJGH,,@JAIZO7!M2$8
M.N^O3:9JG&.U1[))ICB%?U5&SH?S8H@I13 &I%V.JOJ&39IAL,R")%_!+"\3
M#H-7I*Y[]1HT*,E%OG/5JB*AY\ =FCG3!-J'W>)5@&W&8G^+I4 J.Y''STY4
MJIBP#[2JLZ=D\[V0*ZJ# ^LL5.>@N*5*4SXI!LE@2P(WJPN6B.F\?6L[;-[)
MF[O$T2 W M@L8;;!AG.EWJ(JC5KG^IJI0AHL6.7.\Q<;J":TRC@<GA3CU)-U
M%L&IPH9Y%#S$^W#8& HEICNH;[^_1$ \+7,XO#%IUEF75VG6!*N3A%R;39I,
MDOYQF*!'X(BY,GE7YA-*PP+E(6M@_&;![+5F.TSSUBFLKKZ'R;MQ[6E58TOT
M<+O*\D?>O^5L]Y(]=O6T@2E)[G C&YX0\Q1_M2:DX)0 R>+6QB'EUYO!8TD'
M:+--2JL@7?Z^*)@/$W=^2_>=G)S>!J5?]B/</,!L4%=)&[O-2RIC15P#%S<I
ML7 $_G3R[<DI-I,\.]]5Y,$TT."0C:YW.BEPJT/L'7I<%[DB*A2Z<)6-78D;
M<=1,6UN ^D!?MO6:DE951G4Z6J4Y,+-[?D5YE&Z*#,++Y94B1'AM'&*"0UX
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M4@8B)Q\T6EL0)0G.XR#/T0IU*OCX# Z; *K<\##;DK*Q3%N2^145ZQ[]O,M
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MP" 7;F'C 2(GY@,J4HY$H*%?^;P 5I-:!SC# S6'$.Z+U'B;]%I/1,7'>5#
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M@\Z6K(W16<W%Y.A<K+ 0/4.TR\.<<=KA5 S6'T&01.1&+H,!:?%%8)>+!!,
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M\GF;?KY((OH,YYXB(V_ZT75Y.N+#L1O4S:B47*/S72?N85CY1!V*Q]AQU-(
MER\8;'@[JADXV[^'Z6,6;-<H7&0PD*XZF]N(-B?N7P:9,ZNPG)KV !^RBPP]
M[*HKAPH#/H]G%C CV(2,YM+L[:W"^E.UNC6Z<ID<3YTM)>LG[&KUL.KDG:=$
M9OH"9'I9<UY,GUR6=URW05;LEUF0Y+@_O(;SZ7VK.I1]^+(T^!,"L\PW1+L
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MM,SZD,IG$>X@8BJ?/KY67Q7-ML!=))XW"%LXXV\@5D0SP4E*XHN:9A \%]4
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M;V!^S"XD#LE\3C(8Q*04H6+HWV '+B\:AI@1/5BH/^.<WQR7%%.41U533&7
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MR2.)4BS3X:N7$) T=?R\3\R)Z(JV;E!7 ?#X$&%8!E4=/ODXS7U6%&;7FVV
M,M+M^3K('F$^E4MWB)IK+^T /Z)8Y[J!WZM^1=FU58W*@,>\ZRP"%.<WJX;"
MS>I#FCQ2W59JM)]A'"V2Z',.H[,]_=548!O+C0^OT4B>%6X*RC(AZ ^8@Q:.
MP5T=GNO[*: 5"'7?!8Z?4V/OTQW,BVP7%KL,JV^2UY1F$N:N0LOPUZ'L ^H:
M_ E@O4R+3FT4#W U$&\;FKIS8/ZP</>0P]]WN+O+)[+>)[NS%=+Q4=I$Q(Q(
M3=;?@[*!WXO3(9%U;D&E0S7U/"Z>L.(D-Z17:78?Q/ "/A3W,,1HI1E)PG"W
MV=$2XS0 IDG=]SY R1DDS\R7P8MM$](*3]9.Q3^66$S@(Z$IM35M,"X-JMK-
M)#'I)/#I6+'6IG*$>ZA%Y@)N,QB6Y?_POV/(LIRW3^^W)-%&5NQOL>#(8Z?+
MWW=H2_2[[?5ABRU[$0 ::\02\X)E\@'F^3L0-$1 U*+B>[58QE-GP=B<5^.$
MA0_%=4+L'=+3YR0H"6*.4!Y.4-!WF)Y-JU<=XX-\2<';^AZ@/-_1= 0AL1P]
M9^U1%&[W8*8R$^8V+WGV=XWG"'=(#>SR@0.I7 T_P6?Z%]N'+C6:/E2K$F=2
MZ%T+X.;'.M81;L=25IX'0SW'+VFRR#+R-H@ _6S??,*\N0N2.H-HV6+?+(@R
M%>AR'20W6YH[X!=\6B17!"7'MI'KBFT/IK>KL0F63_G1$2C?4OL.1G>-S\[B
M<RF(,55D)^,3GUA6$'V)R[C/N9=MS-WXQ+D\RN]Z"_JK6LQ"H+I9SWQIZ*?$
M+HNA7S0I )?I;8"MS!!M:3*ZQFTP>.NMT97#/4Z+,;E]1[L!K72)H$C!MMT3
MR.NN?*#>2)[L!EUSD@R-OTZVR2K-)"DKL8AI0PE9O$90:'DW&,V.!V-M+,\#
MQ^<VO%&)^(!V3!Y*J^#=D]EF"UG=E&86IMHL^JA#NER;BTH,YBK:K%>+5U-*
M^MJ(2U%QWB@"#T'XFR5HNTY!-@($=68QT\D<D9?2>-E<H)@TFH^:KQBR%7GE
M1,\SIJ6:_@Z6V*</84D^8N/E 3"(<Q1!DEI[FQ;86D6XW1X;2I@+] 2_X)WA
M (Z6]H:V>(Q*MI7+>!F\D*BD)$1Q>5U!KN]NDCOX%,0[^HLES#8HH?^\657Y
MF<^9M-026UHDY6X)6>5;=*6,>P)XZ61-7R3BHNJ,+*FH2C@?MOOSMIO81TWG
MZ&!MKLT,ID]I$L%H%Q8D.)RLPYOD\H6LNQW*UV5,&R;U!#/ZP:=4I8BA29]N
M+\W,F!3E TF3XZ8K&B-!$ X[O1%@ATU_("$=>CKLCI Y@Z[IY-E4VS3#:[DL
M@IC5PNOEY597S:+NG -3C[^!S,!I_:%7QXJN\.0:4C85-A'60?GE"S9$B%W6
M=DFRMS.FF%,G, <C0)E;-3T)JQZP7FRZF-LVKXT!.73UYM!L2Q>0%N3*-L6N
MJ+NYZ$L!?\(Z?V5:2E*-8]<NOD&*'CVPMD<@\9?TRUBP<D#*ILFF+BUSF%XG
MOU16+3GO/9.XC_-@BXH@YE5Q5T>C:O<^;E!,F95F@R5 K4\(U.% .P"T*M+I
M3X#U=!BQ.PO :F)!#F"=R32]Y^L1Q4H:9>Q$9@6_X@Y=>Y%U&12@M/F>GGSX
M:)R) AV4IAR!\JFQ4]M]5Y#3/KD=R2_0"O\5)N&PV:G:CU/K4I$I41'N\F/P
M0+X&4?VY+Q6G*2IA+7?Q'(R(-^J1Z2M)Z]'1PQ2=:C0-QJ1^_U_Z>^U<ZID.
MB59:%UXP#:9/NP3F9&5>=ROOW,.BB&D\3_XK*M;X>_R'Q:Y8I[Q[V:E*K!GR
MYB-*S>H(!DY"K+QFJQ?_%U(38$NA%-N(Z34.]^'70RP]!VG2Y>1#L,WAS6JQ
MW<:(WCK>%T&Q*_"O/J -MD8X;M&IUM(H#OV\FYE@)&HKBW9%C..\[(+\,VXZ
M\1G^.2'^%-;;Z*F?)*=G\]2M_:3-\K(R8,"+-:7/IRC.J/5HLOWY7),KRU&@
MFGU+,D6SRJLFYI-7*+Z3(QX>Y(C_'R9'@_+OS4NR+"#5OS^@!+9?U7Z$V+:(
M/L+- [2=A56)I/-2!PI,"7?:YG-0?G\$JOZ.28?@O\H._J_W]X;JPNX^-U2<
M'/.L6_7K[$D@=]B[ASPN!RR(')G55SS(>$",0"QM</ &9EQJ+5T5ST&&0?8$
MXW0Z/(CI^,CP(V)&E.&'?0]:#6:C888$V%$KTH';MDV>8/:0CI $SPBI11%)
M1?%%"\+ N,BSXI\?L26SV6W4ER]NU%JZ^*=FV?;[<[A,>\0%RY)]PUV)+A$@
MG'PB<?Y@#)S^M*/@Q:Z(._VY%G&;N$C$Y3?S$#%O\FL1]P8S)H5X@#*:6>(C
MK41>>B'O2* \R3PQR?ZL1-+U$4&%*5& )&Y*+W7@$:A;]&'DX]BJ(=S.055U
M,D8<"5Y"&FVQS(((1E>[),JG.1P(Z?@X)HB8$1T8EE>^L]@,RJES6I".SX/-
M)V6(9_.1&9_%TK4W[P8FWG/QSRM(7H3$BT>8A'O>RN3$B/#:N-+C?/*"=74;
MY/EQL<[2W>,:O+^_Y(C<\7*3SS@+]1 -<(+<R)*U)6:$MZ#8IZ#\]HN>YQ/C
M.]C[948WTGWS G&2S4Y"R+4])69%L"8_?WO_+2C*-N1)JV^DJ NO<P\I'_8X
M%VHQ-7X$1-Q76N4S(G&K%B+(>'*KBD5UZ%T5#-.X NI+E6/@.GF">4%-]VF.
M<3)2?NJ9BAD2'=U(D^JI_4S@HR+"[JWBP+"-S+\DB&GZJ];S.!H; :.SFP3>
M9I#%E98)QE0-1*->'1[43'D4P:OL"W0Z ZPW%KMS=GP*FDY9PC;?6!R+@,J0
M,IY+\[@;GNOB4TK"@UR[M#A4W8=DJ#&FX-EJ-YK'+8BFJ <=7()I&>%<I2D#
MI]Z'!43<&VU\1D2/+\C'H/7U3.[$Y2)K8T@R7,N'+05'EY@9WJ&\G'PDF_PO
M=.I/S"O)Q#'M]CS-MFD6%/ LG<HG+27EPW*6,22L4LD^!0_DVWGL""HR[!2=
M&!JWB>E,>RRC^G(((_:,[U>41^FFR""\0(_D%\(K#X[=;-"E._5OQ)\ 5663
M)6X"6!M &WG>'$9)E=G"AG.DJ\XP)>I/(&;U_B!QCB+:AMH[+J [P(XHCJIN
M=432!G_+3EN'>9-F<-!2%!>#D<ILV#\PRZ\#%'CBQE?5S4"K'?@D$LN7+I<3
MPR0L[!1MMIBEC;UX5G16L8H#989+6D5B71?)P&(>Y0FY3K:[(O] PO].I_5^
M<"BY/X9*N!$^R\:?@-.9G$ 5Y,9U90B&:WJ1P.GVK3/TO)T5>MXJH.?MC-'S
M5@\];Z=!SW?.T//=K-#SG0)ZOILQ>K[30\]W7/2X\H,-<,2-4&DYN<M61T H
ME2]>)OH.LE:.F4ZFX)N'&#VREV)*IJA:+\ZN2%0Y$CX,9*FE.XU!TWH&=JB6
MW [R"0W/B7X*-!*?V,G#KH@<43NWYQ<!%P)\L*]!\_D<#K4#$F 8D(W4MDMT
M:=\E*NAR-BY1/G_2B[* ]L1.O*3#.@_>*Y'/]+5?G_PHL2OX3"63.,IGFD,2
M?ABTO K;C*G$G!1FU7:B*G;H5I?ILJ?H9<7:C@9O+CH)ZNL. >UQ#GK05-X]
M;Y_&])EHSD-"#[9Q.=BA7UP.L:>)R[,O#9>J\A;@4FGZQN$23^_][F&98CVL
M#<%^6Y?6OX2/05@15 '<!M!&\T*.4"(]D/#'K6_7FUU-S.)V4><VXGSPIL&M
MR%7N%Q1O"54E?7;:ZM P"EBE#Z>VN@)# D20X-W^CD(#>7-1(*];C&@(C"%&
M=38</N=4YXKGX%..L/Y*)&/VX!-O! 79""0QVZK[NW)/KB-)5!D3;?^L/3N&
M2R^G9^#]TY9H91]H39/S8!,=[KAA)WPISL&$<R$PHR@4DG;D5TBRQ,%H@>43
M/'*-/*/$,/Q^7:H&(1>B*$7V+6 ?^]WD!V53Y8T1#]' D_^<+M?I+@^2:)%$
MRV>8%/LE!D%9H$_5K:_2B>,]0H4G 2S(\&CTVCP\_1H2JMS^JF,W.CK@W@O6
M._Y?07M/$YCH 6:H"X?Y)H:Y$0/E5 P4YS!1E$H#$I51FX4Z'IQ657$A:.;2
MF<1G0<&1,!,<R&>>[TP8\5Y=H&W&[AXSVSB4]HR3>>\9>MN%=*=P<#I0X(EW
M)L#-0-4.X(:@;"F4S!<N%M-(](-W=SI7];U6CI<GEPGIE;OT>:2/FW31Q+<O
MR[DC-#+76);)RY=M2EY(+U-2B$Y1XK*V+C=E"1\#24 A:P**M*S"/@/MK" 1
M!H6A<6MNUF&Z2XIL_T\\0>+C?@[#;Q_3IS?LX_+$SWYH#ORMKIP!H:$I2CV5
M4(\=*0+C/_5&?[*)4 _&X"ZPMDN8MW?2Q%U^[5>5.=,/?*W:__W2&NQQ5\YA
M__=+ >S_3EKR')\>)-?,<5MRC'5#=75M3V[7'N1V+9+;=09C8J?.8\U=<R5W
M;20YO'7=P1"B)U*3BQ3J^G6Y5#0Y1.W<AB\)N! (LOD:D#D%^'O?(04#T\_L
M"]DP3>X>N_U]#!*LFJ[S?(=GVDC\O!Y\ H'#CR(DRI: -?5^#E$6%!<HHFDP
M@4R3..$CJ>M'@X3+GF_C$)][F[^7O[T.@R=%+(WHVBW(S!E554@?%]> ;#6_
M+J_/%[_X]U*.ESH#YLBI,T'L(GI">4H2PV9/*(3Y;98^H0A&RU1]EU/IPVGH
ME )#HG*-K"7(65.P96W)F9N[%3H&FX; &*I49\/@@8*X:Y/M4J^WF2!*?1>5
M8VMP3YT-SH8W6/W9LHH]LD$0;4FWA_$ZC-/;3+#'8<U,KW5WU/_'?Y28D7"'
M]9U@O@S0=[G9QND>PASW=X$R&.*O5/6<K*U+1[2$#U%2\ZH%O8ZJV_CV3JK)
M@\%C:-2&R27N8%YD*"Q@="]Z^#0ZK02?ANLB"EPN1+;[_8*G33PD+)#*IYVJ
M0#P\\SH)!WT2UWY^=__9!4@.:#G/]2QE1XB:S[-(<J$D-@EV.(-U6Q5'F2_>
M%4K3"-!6@#8#KW!#[C/N6:QK"S+2KJB#-Y5;F*W2;!-@=L^"'$8<(HK&@7I/
MCF,5E!D3E;?BKFKGAH*VI)C9H#=\UQ%&6MSQ%GNK T![ -SE[]W]X41\QCDQ
MTPRB1]7,0]VO'6>];-,6I;DLOYG!FN7.:Y6JLC<2X]R4%^D&HP*%Y^5UX236
M&9^&:Q.>RX4(!JQ6WBQRJ4M%U-[EQ2,TM^)I* X^-7[ 7\5_WV4HC[ &$:0:
M&XV4(6JN,3/ C^AU(FE%?4MD;OWG)-"49:=DO<($F(.+Z;$I=0^7A(>"PSP^
M=/<@'RD/)1+JY#H4#<_ S?B9%/])'Q/T!XR6P<L93. *\4OV<"P,>6N'CY*D
MC CC'YLV #<"52O_=R-*4F'VR?#0S6Q-^IX6;W%8(=W")(@U$A=*FCH^4XHY
M$469L0;4_UPW\7XJ&18&0\/ @(UBXB^75_>+\/<=RI%&WE-^*\?RYS(A+CM_
M#X+F8]]!:=)IK^X:A.-S[2 0<B*H-W\/%K*I=G^_,V:V3<_SG^#S/]+LMYO5
M"H6J^:-X;1SNM!SR@O6$OP3D4Y#2;_WOJI+99@(6#<Y,NA]@D,,ES#8HT4D8
M+6CF\N*6SX(PESO^&!3-U_XE+9]Y)FS)(/7]\[0<<9FS5=4[UVOA4L(]ZM)2
MT64>7O]R%<YRY:OCCDI?FA_2)$H3+;7,:>+6X]IG0+1>Z8<2K>Q\M0IGNUJI
M_*&-SN"I*%I>&X<[+H?\<*).[TM5,M&\A)SC-MNZLF7TWSOV>/DJS?!NO@CI
MTQR4/-YF:8+_&99%CQ<O*+?L_-*C;5\WQ!ST&/$FBO"KFY GHTD49%$./F\C
MXG[]+]+.E_$^2OB=NJC:LV1:=9=Z>DE79[L<)3#/[^'C5+B4T[)M<\A0*.5$
MJ-(>62Z".4!,26X]E[YTR".TW>4+@28^C:Y)ES>K"_A03  @(1F7V!$Q(?+E
M=#['M@X@#?H@\H"A(:FUX2,=M=FA=/&808K(/E)X4>N=K]T:M!W:HDVI^L:O
M?A#-:Q4PWAN)<0A!I4=:;J@)EKR(R@3>6]FB%[ ARDK-ONXZ%GNP\+'F!Z36
M7O*R,9NC)H@#FC(9PH+<+D\%&Q$9ESN%B D1:LK/ ?T>5 UFL5,,2:T#&]FH
M1]@8OY @E^1Q K"T>[9\FI;!HT56@ CVQ4Q4!T< ;;D?#L<\/F2)O[E9+;(,
MSX7 0!@M<SX-A]+G,B!,5QGCUBDI!?@$0:L-C39J_UQF3BO600*ZC69Q:)$*
MMHTE\>3HHXID7KYY3K!YMT9;520-I,SN]N?&@]*C*TJ>5WWC66T(Y[U*A]T?
MC&%B]/IH>Q_"),A0:DG*_'X=69Y"!D3N"?9)3^J.12X51B5Z\< T;TA(9Z10
M:AHCXOZ++I."ULNTA !AUPXV"AE]<5KC^G-0?>_5@%213P4*Z6!-_9MW,";]
MW099L5_B[20/PHF.'#)*UA_1RRP+"2/"M#.T!:!-0*O-/,P&!1EV7[W)QV_T
MY WKJ2)XQ$;),GBYP]W?P2 F<8XWR3TLBI@JLT$?EFH_#J_T%%D2'5G+$$^P
MK7LA#LXB> '8[(1>7[[I"*QY.*4\%R,.LH=)W&^#/<GX=$ZO( O+6FF F(>0
M>#E'PF#8,(-!3@[#89!E>_*/IR#>4;R%!V4!<Y^A\VK2;>LKA0DQW?U:]XC+
M=!%%J*Q)=!N@Z#IAU9SID7&Z&^@!NJZ?]BAS)LPN4S4!6]SF&"55(7"OC\6T
M!2VX;5:8$W._S@6K?XMUZP<4/*"8FGB6H2<@XBZ-D9P1 :RJC^G>&3>?^]1D
M<G%U7B"*AVJ88N8\R->7O^\0UO'TCKHX9UK_%Z+T;>^1<F(^]D@I1Z+3'VX$
M_G_RWK5)<MM(%/TKN+$1#BFVQ];(Z[4W?.^'ZM>HO3-3?;I[)'L5CAOL(JJ+
M$HLLD:R>*?WZ@\2#!$D !$$2*'DCO*N9*2*1R$P F8E\X&;4!8JJSFT9VH5L
MQ];6Y3A,"8=<LX^X>I\0J#Q"L]6P[_'X7"9Q$A6G!_QR3 ' B1^"#T#=@D7>
M#"K[<\SA,PYW!GRUX?<5.=, M C?35H=.\L:.BIJ\.):)?_43! H_V5&<:G#
M^^<AMD.K\/:&^A!5QR*I3L3V2?)X4*C-HSW:K49$=.'&3 :EOC(7*"^2EP2$
M<,\@R'>N]Q9@-JP1G< &US_!0GTJHI@<L>^B)"NA<\GL2IIB I_I>'HT#"=8
MQ3ZFW6C"*F9Z]K3>T-2+<X[<N"_R#<9Q"87$'XG4K;)82-UZ^QU.:<E3]G<:
M3[V$<N^&0PC1<L)45TZ*PR)7(90'QW%H-6Z2*,@RZDXE9S&&0[,Z?<#5+H^;
M9EW4O'W:1=D3WA_R@MR]=WMBWQ=]M^[T(-;Q" 2P0,9C:3@ZD_HCM-E%Q0M&
M7R49NH8 A:+\.O#K@KM M.)CW>CEZMBCA7Y+HB[>Y@6=9)%K6C=+H -5A<NP
MFX[=USJ)"W-ZFGC7.1^UBW;).>-F!*T#U[QV6&C]RF%>V_LJ4=!Z0ICI6,+7
M%]+K5*BB&6:ZURJ]=HF.7K3F()K[9) A^W;A2W-K%2;A3J42(%E\VHLGQ$&@
M8(^\^;OK]%I'0X.$JH2&],EOBZ).M3*:HYG+&-VOTAO>(]%P< E]'^ 5;_8;
MV6Y6[[6O+1&SZ,=^Z&Q>V+$,2/![>Q3'V_>X/77"E,T>@:'J## QL*00_K?Q
M<71I;?4<UPDT],AB"$;1:6PSGRJ:*7U?\S9(Z5Y3^<?HP$(IU"K@&0B?F;MZ
MR3-0PZFN&A/?$19!;X#G:FK=^75!T>SH47+?<Q$*#85%!0K5>MPC+<#INZ;&
MXCH#O]IZ2\7F+FO>EF8^0FQF#.#&LD!+(SHP$N69?'OU[88 !\@(ULKGARTA
M7!U2TET(J>%S1VATH(<-6P04+!19&HIX5@:GADF:8,1ZF:XR 0 8/'!A<<@X
MOLO*JCB"%0;7U\R28C=GB&@P"[QT[HQ6=/6FI6KG^Z2DW>Y VL+JU:/8W0X?
MLZ7-S#JHA5UDC9O>*H*!A%-0XLP8K/ROR;-O7.*S.B'1UTE)RQ_USPN5L]HP
MUJO'6H^'\?*0Q"7F8SK9%)Y]U\.\$ [L@14[&L3?1T4"5IPH*$USPTYU]NAB
M5K']O+Y-8VO,!E.$$U%D7&T@!RDS,);=K2($HRCC;F#1Q[@:K)BMI!W6:,O?
M>&9AM)C0N\]W&"=[^3,X"0/(H#U[9>&SI(=;M:RKO*RZX06W45+0.&@X:M.\
M/!8VUZ,=')^QG'8H:5/#ZL<]HEYMR;A>K+OO"W,4I^K+TYX($YZMP _ O #+
M/0ZKY_!]22JQT"9 U^U77JC?9VOQ9AS(^:/E7M?=HUY\D%=D+3HJJPDBQH +
MY#9@L3M?HX(GJ%<YVA -$UCT0U+&^?ZIP!C=/-V&M:*FL\6U;8/JU!C4C"UO
MA9":KCU*$U7<\%?#@&8[DA)N8B1GO@NS;9W='BMRX[#(QMLDB[)-DKW<YD7[
M+6I0MB8!]^>IFXBIE>^N-NB)B;^E8&G"7G5"6P$8;?.B^X1^'H447 5#45W!
MB;@.?B1YSO6Q*J%:.('?S;@?)<(F.($*=QA0LA++O!G?\T\&2KD;R3F%C T1
M9?I)^7U."QX>#D7^6N?FQ4_Y XXQWJ_2=+U]VF$)#SKYJA(I#:/$;O)D_GNH
MSX:[E1"_TDE0Q&<1>:-4:2SH1"A*4UJ?9H=;(L\>ZJ)*Y "> G8@64*^%)MC
M%HXXA9I,Q^(2DRL2>]Q$G0F#J21S8.]E*SW3*57;Z;>VF=2R-MN&4O#&];&=
M.A^7\^GTP/MVYW01T-E]M #NF0;\ZWC4<R(;G3:.*2!@,<:\.#>=Y ..^A[C
M&3-#M!-Z?Z@8QFFH+ ]A;IG$N* E&D*^3-CS4YWX8"3 E'Y74,="ZA1P)1.,
M5F%DE"3_#@<EP:3UQ<Q".!6;$ F.$W'6MB5Y*? +=,8Z&Q&>251:%<QFH)US
M1CF4XIA9?BE([\<DS&JH+17VZ4.F<K= U-3#J^UL:G(Y9G_%-TP4-KU"1L4R
MJ9*_V"=TC#J[)WA^A8J5^JR*'A'<U:XFE(L'6C/8=9S<V[D/C,'Y0EQI@U@-
M!\(1&[,E;ALQ]EQ"1:PYW8^R'B+,[(X&BY=:*\R&,@#/*YAG.0Y],^&$$-VU
MKO+],V_[K=-:YCXL1DWM70L9@YVCTAM""EWXK>K&9DV6,'G$8]%4'26W=0P7
M#YA7L?!_!1._F4TM_"_&P0Q7<W+OK8)[<OL(*)']OXQE;UW#W"&CHDF?N(S*
MI'P\%#B*UYF(:H9(^KDO ^MI ^3<V>*FM5B2;),<HK2) >JTI0B4<3.&S=VD
M&VMZN#XDJ#K]BKBUC[BBK3%FED&K*7T;R#9(Z0K-DD\@Q >W0)Q?LV<=6X<:
M/RO),*.QO-I#<! SQ!>WE-N3!<LLUF$T;")S:RM@T/LX1AK-K/[:IV0?-X>E
M9)X^$4DJ=WD:\PJYU]%I_B848^8.?K,.(*@10?X%BLDGP9-81W-:?Z_:4&,Y
MH03E$F^.T+15FG19K6\,'F%2YYUP-71)Y%_71;U;,GR6(CP@%^/$V42P\2T%
M/A[WS[B  )?^;KG-BVM,6+Q/,O(O3SM6*>L>TIL'([=<X7H-T')$4B.;_#6>
M1JZ$DLGI'!5-+B:0QB'86Z(=:X/0GF.$X-E#\AQ4:XV8A7@=* ":;A W()@V
MR>H/A*HX,)J17-[&4<<M>E6X%)B>2F2;B;2=7)E'^TP>,"$RZ$V)]BR'95M?
MGT'%Q8HG(F1S<.%N:0&-;*W*E1P7^CXJJP=\R.'-B/V>Q8W18U709 ILCS(U
M 4V=Q$5%$Y-<1BE&41;S%^"F2DHHL9N!Y7+QOPF4FQ#YTE85(5AY?P"O-IUM
ML<HJMK-Z?WNT1$R;12Z^Y_5[\"]'Z!,:MOR\(ZOU!H69+&[GYX?H2[(_[D>>
MC.I1OG4R%1(Z_8M]*Y]A81ME&^DNU"KM IU4* Y.& ?MRLF?#J*86-F+"M8+
M@!4LCUZV<9CI&N?0H?3J:R+M8#0ZDN&2" 67GC&L;,N4-7E<FIU\(%H_F:-U
MH>(L)E";])SOHE<,-:+H_=O6#+M)H^0B)@*RBTH<7YZ(P7J5[P]1=J+(LIH4
M-Z^0L %/)-OHF%;#TAL:0<];(O!R!X.%#AT+1UDVW/,."RTBG6U[#BQT#M07
M%;GN657XJV,!]@71J3\2'K"_S*SHVLP8X/7' BUML2U13(4-#9L*9<W.=BZ4
MW>+G>>*I2W@M:D(ULX0(\];@HA&A=G0?)!!W2TX$ZL!KR4"]8=1>N8O*TJI9
ML=_GV=A.;8, ?%; '4)&E\+;JD8"XW@*0/@^;K;\X=>E%0$<PP5%7**4]<:J
MZ-1U)UD0Q;H0:G5?V9X]OVDFI )<B?-@KKLU68Z4L1%2T.#8>81(%38[ SUG
M:$FAS_,R.1SF;%MAC8'O,$<''"UZ7R09E&J4#^]S21"<(!6:/AFCR#8]84C:
M4;HG[27.\<ZC=^C#>?"I^ZJC.?"';:D<2/.OH5M06[%VX'15OFXO6LIA9IFS
MGC: =F"+VW ^6CN/_IS++ZCD;A0='$)X&H>0>%JB8BUT!GAXD-*+!JVAD> \
M/QR-PT[[YBB \#?'YJAK);U J$:=EC5P"/JUJ=QXSBTL!QHZQOW@DMALU+I?
M;S]$Q<^8 A<3683^# #P:9@/(:.O  '#&N?-GHYD\B6D+6"M6DL>U:% %D08
M'PQ;G_6MLY$[&P?%Q#S:8S2/$9%Q:=<]7[%_T;!B"I>+X95/T*V$<*VR&'R'
M-U\.."OG+\&FG,1_Y+X:$8WTU-<59I^AHF[*$%AC,C--];:@6/#XDX2('$NY
M>X_)_?9$PUBI+-YBBU!3TV"_[[XF5'2I1<U':(O#U>NW88&X3H96Z?QLV32-
M("<24>,VE01]YJ/#/)=WP]^(CB[Y%NB/JN:[D&^45KQ3=PC1K7C"[;,^T-LL
M>Z$TNML?HJ0 H84)9Q8DXU0A'BE-".D>HL00E,*8"Y34HQ!TI@GMO;=A9ZNT
M[! )G(\H@' E:BMN3M?1/GK!Y6-^?-E52[Q^#\\70L0&L3*5"]@T U&T*8Y1
M&O+<LF:H+%]VZW=Y%^] OLI?B9H57Y[NLO)80"G;:QP?-]0;/Z@9C8'E5U$:
M@9G. JLS<^+ZTV#*DP/3N"XUEA#.YQ8OMKW)]W.?4#+D0*7286Z-G-Q$189C
M8F&]XNP8O..K@@N*BNCU<B85&J$J%3E<U\]I\K*$!JV>(\"K;A\+_;NM^!;E
M]<?!*XGH.=5YA]4LU%U,J OY$J)2(2"56/ 4Z*H@1\\+S2Z]/#6?<+MO]3DJ
M8A'"L(IC^CP2I>PU>'6L=GD!GHR9A6U)3'V+[()KL7@BOK"I9QQF+W@01WE'
M+<V'B?OR>1BSYRYF:YJM5DKA>#_@A"BE.%X1S8(HJ0]X']$<<>DX ;O[VR7V
MJ^<5!'@N#[!,S1:G(3DH9TF9-($J8V^D21Z'O>$""G-OMP=@E6M0G_/I1/_?
M][@$HX)5AYB[IM*LJ/UF;E\%\IJ]R#_J[[[?UJUJ$*19KE$=00/HL_>$?Q_R
M.-DF&SKD&I>;(J$;?Y7%L)GG=ALOBJK_!] EEV.Z\=[0XQI% *J\B)O!04-O
M?<CA+%O0EOJ.J1LW^T.:GS!^Q,5KLL%J-)^B+Y<XP]NDNB5$E']9)FA@)J0"
M:)OS8*Z-KTLCZ#9215_0,P,0.!IA7NEIE?J=CY"3NEB2*3@L/M,2OMG^)/ZO
M!S4BNI@(I02&<M=J>=3SW*K7YWAT-C+Y+L_CDF7MXK;<EE+$9R.MBRDJHQ$)
M\33ICJ[NI8GYBZ5CD582I$XTKGULI+/A?+1]5[E1*Q9.U'1^KG)6:+BQ?O,%
M%YNDQ.5=QBR+I[R*TCMBGB=9F6R6>*GW@G(H%]?"Z])=!/ EQ%NS3YMP;.;F
M*A'FL./?IK;O(*RS:/UC.>/=A242:$6]@9+=K[LHXZB#UP#'+;R7JC\1:!%A
M[TZ?2QV,L=^VZF@P4Q]5NZA"KQ3L^5RY(<1\EA-A.@.G7?4N?GG9??@ #OER
ML3*>R^#X6WJO,BU$YY]CS\PO!#;X%:"B;=Z\H5S0S<N]Y+UB)[^QERH;49SE
M+6J0#9.NZ@FO8^Q\:%>V.)=-:$+1>Z#_$JO0;,!KT<;ZX?$3OS!WT2OFM^:Y
M-*U=4O+F?/_5$GY"FL)5&I7E>OM#!%A4ZX)N:>FA>>Z(O:'I_#L&AU#2.:OA
M,^J'D:X48]FA$*%]EMQM1?G9T&-\AITP]43N^*>LZR=4Q(\K!WEM.:/"0!?H
MRS^5B@,<R=?G50' Q 8>$:Y=LNO-_B')\D(J1[7^G!&*[Y)#HSE<GE@#@IF/
MFS$SAS!W1^"GRYL2(]1*;( SQX';\O$SEB0N*2YR35VI6" MMM(KMJ-*^!T8
M[[FXR0 ZN@H3]2C6^5LJX13QD8'.*$OVB&1@B]6[U2&1 +,GA4T2I;4\CI(2
MU?B 4J) QTI*GNMQ*!<# Y::L.200E!T!)@L*+1J4_F8I^-.$6F8U^(T2A2L
M1"&BGZ.2?!^L&961[@JN=Y;H4"9"?=:X7AB^BT.HL1A]/P0L.V2FO_E&F.8D
M7F55$B<I[>/YB#='HJ,DN+SYLDF/,8Y%?,ZQHC;]>@M9?\18*D65+)8M.K-Z
M.P].WAU0LZ"M>[.18*,LS]X<HJ)*H#-"U:MQ#6T47J,4'AM"UPF<4[A:101G
M(_6D0DP;UBDR2OEV9+E*554DSV1NZ):;-[5;6=_[!MN9-\U4;$+8B1-Q'NYK
MS[-V\/X9QT0P4)+1;@%RF>&/G6X!8:I#S2))[3)2TTGKGA-?5PF!+/RH*$[;
MO*"ORW.'8>HG\IXQKT5%UYP+5T0^Z_(PG6(P06O!Z+BFK@2C7*^3Q=&'><M@
MWGPY)*R(WC]P5 SJI;9P/!9#M$1))ROK]U#3CG^(XG;#/\\-+,8Q2?2Q&+%^
MM_Z/XE'N*?K"#**KZ)"0XZ\GGX_'YY_PIGK*FZD')6H2<*^>_2F8&L+&\79+
M/H:07 :.'ECRQ>E7".=@-I?,R01S*%+=FU-_FI)K8KTEWXT740N8GGUU#B@:
M1!+,=S(DP;0#/8P*=B9.X*=."BU)XY[2>4-W-#&@6%T< O"!5:PEDQ[)O!R!
M/)M;:1LQL?]G<WOD-)+YB<@)[3M($QNZK7F#9'N-9G0KHVL<01R3<CYE3:G>
M)M6AK.>\QUF4@F&RRN*Z0NYF4\S??VH*)MY=3A.0U8IO U%.S2EIF&%=8!G^
M<A# 0P8YS2 XLK1/)>@$=Q)UYLK-"/*7(MHWE6^8TVKVBA.6L_H/Y[-#S*IU
MCVAO$=6C>7O>P/5;QG&\%7,W@CJSRR0+5;_+B 6WP7X$LC.E]](F%D@9RP<5
M<H\5.IC7, &7Y!;&!XT4'<'F82E4D&5"X1'E%(T%=DV4$2\2V)GR/"2PC=1$
M"6R[E<Y&#-6\'A9#!6WF%L.Z/E5S\#;?^+ROK1 )DOCFC*ZVF 8,!9/_6!T+
M7-_M@1L^3Y>/88&VIIKSNXVB)Z <=/!]#OZ(NONJ.JYPB<:1-DB<0T=)"SRM
MHE(P31ILK*U5-W QA(A/$XZ!UI.VE)N@R_+,D_(IYQ %&KA\5\S?O6)P.O^^
MK2&4!O.%VWT"0ZH*MLR4Q<YJ^?.U4K^7NPJN4CJ>_#.4^_B<I"D4M($'E:?H
M2U.*?I%PJGEQ\R^VL^*OD7$Q$F5Y)34^H(E0X 4CDG_(0[UW+2ID0P?S-$K/
MMYUJ/S1H\^NM],O<*O;(R7U;@N/0T]9>JC^A1992'#BP8!KG!X1XB#Z3P^,?
M6!<,<HU\KG:#+[7ZD5XC!;1H:$TO^@UZH1_UGK;"A4PKJ:\(FNXOTC7U3X;:
MJ5E]E9?5748F(J-/<^N4MM,&*(!ABYN5 ?29 T 1@T#.*&(&\="3L ?46-:W
M-- Q-'*5S=LD2RK\GIQV\$)%:$RO9(@I^%3B[3%]GVSG]IA:3>G[GK1!2B.,
M;.B;%,:B(_T:I>3ST"_Y8U@KRYTU*=P=I/HIRL9OM<^+*ODUX@;_ O7S7;$(
M<%XZHFHCL4D-3Z2S%0*B6IK/2I2MY,5.NH<IZ7K(7D9E4H(FN0%3!\KLYVFR
M.;'__X2_5)=I+X%NNF%B-VD(/[\=:AKAI8/AVK\GN,']V"WW&L(.&<7@EOUA
M3PIG1SWTE2?P8B;/BPJ=<:H0HF9"2)\1U P)Z;:TX5NG-9UYK>[% ?$+.$,?
M\ $.1C_GE]V< 5ILV."E>UQG8VE W#L,[W2'7;)!=]DV+_;!Y6T4EULOD-8D
M<?3PW>8%,8"RJV-10']6J=(UA-;1OZ8LK'19F73'P[^<.N.J4QH9/"0 (@E$
M<%-GJGRT-,1)A',-:2Z)E7]35@DY!F;/]NT ]Q]XW)I?%TM<4F=._5EHF5)S
MI!7^VU_6A!=G[F]\8!'%RZMJP_.%T-<&L1IP-TL#)8OU__U_WKQ!/_[PX?L_
M_?/'OV\.QR__R/[T7_&O?WY]^<<I^W1]_/SNS\5__?F_O_WIT].I3/_\NOGU
MF_1OU1^J1_RW7__\QY^_O-V\K[[YG]O;;Q__^P^O7RZO_O'-:_Q8_./MV__Y
M9;7_/Y>_7#_^%WY]_O;33U^^_)(_O8W__N_;ZO,/?[K>9S_]^]]?+E=_^G)\
M^>^73W]ZN#FEY;L__L?]Z=.[Z#K^]_(OW__ZGY]VGVZ^_?M/JU_PT_6[?W]7
MKE;KR^SEOS[^)7U7WJQ^^OL?WG]^>KR\N_PE_H_3RT]_+%_S_(?+;[_[XY^/
M7][^]+>;_WFYO'W_PZ\__WI\6KV__(_HJ?SCS_]>_?#PGW]__/OSP^W_^</I
MZJ?GUYL__NG7O/KS]U\.U8>/?\[>[G[^C\>?_[]_HJO'AS=O0IE-UB(O[SH[
M"7&IB";UC7R7IZ+X:&FA["J>;48!\YA:/ 8OB_[=  ,)(.$>>%Q8Q]]\1A-D
MPAF_BFDEB9(V*2VKA;75H=E\^]@'\-%(VX>H^!G3J@=@-4DP0II*EHQL5:&Q
M6+V[1_T!OQQ3^/UTC0\%WB2LK'(6MWR9=,K9]0C[F<-H%-;X:0MX-^.8$$HC
M@_K%';C>ODK'D6:"![(I]<T;''HX_VQG]6X/62)F;+A*>X<@6AD];)S92-ZV
M'9;V=' K\_&T2PIRI1?5Z3HI63$C,M<MQF;14^AS]I \ETFP1DQ7' '&OZ$
MD P! 8B =4U'LX[K<^/HX7[C7D7ECAR5\)^;IH;>PB>:U9P!V@?8X*6S)L@@
M>JO2/TC#PYYJ8[C;.M.L2>'H*22&+R9@G].!,VP&Q4X[D6_+08^*-F*5OJ>6
MJ!D9VI\XS+>V:F9<L?NQ=;<_1$D!)NZZ( ?D(2^C=+U]GV<O-":"14(L*UA.
M*/@_U%S0U(AC PI<W #B#86!&)"P,8I3)*)51-*57JZ/@J+QW7I[FV11!H7,
MI=9YBQB[=G,&>.RSP4L?#<8&(&D$@I+PK%N<^G<H('Z!B'(%-5'1"5=()'_$
MZ*NH0H 1HBA]'3@X9Y2<M!X"K8GJ*,',M06'?%-+=1&Q-4SD^RK7HZ*-F1"?
MH>]P&K^I\C<?H@K^Z12XQ\L@]UHM7<SKGG"A9]!(#B1RX5M;.T^ >%@M,KH+
MN/X^:/VI05ZUBS*;UN@:BRIR\5A)JE;\J_AID2/(?E[?)Y(U9@/9H(&ON=&,
ME65M' W<#RO#/-V_^Y9"S?S>G<.C4=0>>75<?\?*."_A-//=4D@-E)D4DE-B
MLLC=-7[%:7Z@K4BSF#6+P,5COJT^1P5>V@OC@D.8AS8'3'5*'_\:2< 0?1L(
M?,I.$HFV@\>56LZO<.^A>@5^CZ$ TK)":YK)OW%LP$8C?NS;L.:%!;=D>1I:
MY/@^7Z+(-*05)#&OV]L/D;%_0AL-T&]GL+'H#;7[;L'YW;_]Y=NWW_Y5&RX5
MJ 3Y6-YVZH^/(I7SN07-9I8]KU0S>%?\%$@8>Q:I.A(%.*<,W)'/)]WJIK1M
MS_?[A!GU].JD^7,XVR1+7V\C)@[P%FN-G"&\LQX2^M5L/(\[ 29C:#'^CJQ!
M5JZ7XC $O[?@(#Y#4E,I[C?_P<!63)$B@(>7['Q]=?L)+GLV#<WFV[LV@(]&
MFL0HJ#J,Z+C =I\E$UN],"Q6/L7M+YH,+.SUUTSC73W28:)U?\'GB'P?5CT:
MXE.G#:-^B6X!D!!'DE7IZ:XLCSB6R@P4>4;^N,%.EY8;5+\7F1..VNPR!@LQ
M8*B!AMK@PF7 3&(TOPC=2>9\.7[$G\WS+'N\C9X^A&-U+))#0KR*\T-E*\4A
MSDQ7H9#/4B>BN60-WD$]S+TH1+/>KAX_$3'[YIO__ "-A(?;CPZ-]QQ./H".
M.=X21.FQBK(8LA+0IP-4"$4P_,TW_XE^9!#^&=#M9<DK?AS:D,*I&.C3Y[P5
M4)14-$:]M)28@>%>RX*:<=&E''S..U%E8M@Y"(D==T2VP?#Z'3I^WAR+_("C
M3%2GY056+.7#/-ICKK$1$9WEQ\<@,0B)HCD*T? K&%9<X7(QO/1)CL_:_WM?
M<%<\S0I3"<@<-;V,L_GV* S@HPTC+""$<(4VDO/\(,;SWF\]$0M3]<N&N9W"
M7X,4F=#-B%+NTH.DF68*4>A+BXU9QBY1/8;YKA376I#R7H-\;!?U,B_?R5G>
MB&F^3\HR+T[P?F5YKPV-]ZPI#Z!C\7;7#*//>(H;SKOCW(9!C=M\</T3TBL;
MZ/!TN/3-)LT1\#YKL+!\^3V+@\7(*LT]U5FIDQEUFT5I4IUH[Z>,VFA1^C[9
M)Q6.+4^480A^?9:#^.A2>-@XU!J(^,B@,C*&3?Q<L2."BZOFYNGV\8JU!; U
MI7HCO+U[J&;7V4SD.\0_/ ,S24=E81HI5^7V]JXHW&2O3!A&AR_(-70-U!6X
M7B"D[,!'A>>^%5?,I;>F&<D$[N,A6KT4&(_PF2B&^#WZ^PCHC(S[%:J_/ =_
MF9[:G,V:I;F<X,PHN7K ,0$'R72C7"$JOH\%Z%DJ1J)G-DRO4 ,(M0V1VEY5
M^T'\"Y4CHX7(N=#-12#AW+H\IBG14KXC?X1X#TO)TX_TZL#7HJ'-=B/7#1^
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MLI"\*>^:)8CM'*74P8KL]E8.20]'\L''/"M:*"_A39L/K[![RAWQ0:WL M5
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M #8W7^"/.,KBU2LNHA?\@ &E)'OY'I<5^<\]+I(\MBQ#Z!D?3]>Q_Y7I[G
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MSJ;S X>$ !373OD=#=#H10_PSJ[EUD@!41O38^@XQ>$W.,UB[K\1,WOVX8Q
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M2)VJ^M@6N)\8>/1"X8<S?&Q7;\-++=%F#[%V8>G@(6H>%<[K9\;+AC&JDR\
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MGTOW+RH  (W$)Q<S8_,Y'-R&)5JQ4$T7__K44('>88=1#0&85$IEC M6QOA
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MVQVB$J.4X,;]VE%ZEQ&=G XOX?$O7E5U(4T[+H(M*U*TMP(J9!@*L/1U-+X
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MCT=AS]:ESZ)#,3H*5X%X,SZ74!SSPE0LLB&%5\.^UF5X -X@6QI%3HPXHY+
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M69UN+$FOLYP 1G/5+A"'%WK?C5W_<.R)+0V]Y1K2\-7FD+C*"6*077Z7$7L
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MGA(C_PCM6 ;4 ?@:P>>(?Q_Z=%3CWR&_:9&>;C!>UH6';A"59+U]CS/HH_N
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MI_.!:R>)+T]_.Q9)&2<\9K=;UT')) :+%J*M<R"IZRNA92QEB*A;+".@L>5
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MW=*9D)@*B;G0$ZN,BO>(3$=K@.S(@&9&7AF'S8G$I.%"N><F7^<T6(8[?AM
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M 3RZ&9133PNSX@T533!.GL72%A"M^ES5_'9\YG:<,.F^E/UCLXFGI-O/,S$
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M"#JWCB_+LO,4C?H6#0E(T\<FP8 &&U70YDOQ3>;4V7,S)92[*=BGEML.LSJ
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M=_L-H#I^+%K0+\%_$/*3!U%A_:7^,%=F3U85_P^GR_1\&4[8]._ 0(29,S-
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M^/9MI(-$1^M5EYUUT@PZJUG0^=ER 5[\7O((V[3WW87^ *S$;I%LS_7"CS_
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M" 73751;V>5H3J- 24&VBC$T\KE5$YD,)#(EB8:V%--OGGSKRNU^][G:QI)
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MF#>CI@HCLGIQU88;BOG+./-CJX5X=8Z[N4*B+4:X[Q,ARN'1LPV3>/CP;Y\
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M9CT'1.K]]"=V'^M+@"5HG>F22M8Z0KQX876BS7[?O(4\@V?#VRP<5<GU95V
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M_[DW)CQVVS/C\<3.GBB]VO*J6SI2R9[9$R<<%(FJ@LTBRWQ(*G_Z"X!D%1\
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M_H]LOT/__"+%VUU(&6*_VR1H]<\O7C(RQ#??OO^F&.#_><E^27XYCZ,T#G%
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M.RK4W4@KLF%H<OBCP:@\+WA@QF[/B""1DU8DP9!9_F@PV-:""Z;N4WL@Z\$
M,X:'![9PZC;$N#,0D _B;U"0ARA>7:!=@LAIHTPK6&QCXO<460:,HK9]D*<
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M,41/KK72)VFAC]9* 0@)S=%Z]^%6W9&YN;ANEL.R\<":1\'QH6=(B5OO.+L
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MV.M*345H_3DL/GU=B%=E5\G;52M;N&Q3OHQKMWV?XJP=#^&D@UDB.^$L,EM
M ^?93[#8Q2^%&[=!&8$G3-]J7_SS"Y'"#*X[X1==YRHHUHH0 P"6P#*90I9>
MNKD*XY<O3&N/W*ZJH3JM,^&UO4O*K!H^'>\NB>GI(3C;/Z8HN(X.?0D7?D;.
M%33#Q%8#0'4&II)>WB/UEN.O##'D4GL[OHG;XVAK_RCU2C77]+$,8+J,B3F/
M(Q^'J,$E<7><KGHK+$[#196T"G:$Y"()\+/K56ES?>FUMP1I4*HB\T7PC-,X
MV5\AFH;B(_Q,Y_<A#H-!(?=\]:2EV@>9QK*%O:8?Y<JMYUKM9*4^A#!8OJZF
MY-]:8KK2"/DNFLZR=S[?IK>C*4%_G]S12WS0-HV4U]P+Z<YTY^T9!H.;NNA[
M+M^ V9:A$"O]S!K. 5#-+=O2N_H_RK@=#8E[D8_.XS1+E>\15,8Z93$K80K7
MW%(KC:::T0TBGL8][45UNR*379!-)JO/H^S)"9TWHTK^<]GJU>4"E5:CE5*#
M"$4?>V5_B3I_T$DV/90^C_V_%VNXOIYZYN0Q2I 7XC]04$4D;J/KX[4*L#(,
M43OE/48:<8VL(<&)0,\R% 3'Z7\]1.US4(A!Q %;B.KV0B]ZLI>,60@9\"B<
M=*2P%UK CJ%ZY3L+^W2T2K4X!K#@^VE]%BHP +=.=U%AA$@W 3O=Q2DY B=Q
MOB.G(/)O@@:988Z"<K)Q=-S-JH^#IVOK<>$XE6"T;4172)6" 80@M=^%?"*H
M$ @*2"R=7(5T/A,%Z0&Z4@&56"2@"A!N$GIJOD#%?VM3*^N96TI14" \F0P_
MJ<P#%40!KZ=@A+_P_3@GJZ&X0;70EDR*I,NCA_J"Z!<^#U'(M (@P=\E:.?A
MP([]'R3G=H5#B[R-)63Z@9J\N[S1JY1%5'0QN*.QL3A//Z*,9J</W5@H#39'
MB:JA!5C: VH1,SZ/K@D-?T,?&B6)NKYZ@%[2?&3A$@C,%O55'@4?O<A;,S^%
M!KJ#+8XPG2#%_,[;=W=RJ04N.;#36 '46I<%$3!W &;57VYW8;Q'J'QJ=8.]
M)QS:*"JJ1'J&.J$',5P!+RB%.$2S45IJ+:LU4/OUB.Z]$C-S]!J@Y. FMZ%G
MSNPV76A-I/8/\5CS.^(I(:618 ":6B@^AY::6'FUQSF,N&VH\#(_10&2 5AZ
M@MUWB\#*HD!XSIN%"K[ZI4RRF+!A7FR&QVEQ8^;P!6L? Z?Q@K478K *U"HZ
M<5?6PKQ=7>'(BWSLA=<1X2AG-RBW+Q$*%MF5AQ-.Z5B.OZ XG-,3A?XRH))6
M!<Y9@/C(J# 3K5>0K8RR^<N+EQX&$\C5,<95$OPR7OB_YSAAP>;81RDM5HT(
M.AOB4UR@9Q3&._I!8%.L3-YU&-!,"_11=QX;+B+6;;[/\A1'R$(JT2 YM[X:
MC!H,8^KZ05F'.3)CXE%F^[O08R%-6FIF%,,@)GP*FJ""LT:X&$0GF(5" 7OE
MOMR@!R\$<]NT1W;LEQOZ!/J NNWQ4&><<OW1RVA7JSW1T_,X#)'/2E?W>'SF
MYD&# Y=Q'R KH8,[7!387%DN,)LO;71RNSKN<RR(3?$I_@Y>2EZ+A9/85K2P
M=_&6K<[I#R@,LGA;*O>Q95ZA[M'Z-CGWB+8'=PF.DV5<K0*E;4:7QLEL.-H@
MPSURLQL\=!8T/ G+H8(S5#@94!]*+\I=,+F/@=,()O="[+117=W,W:-=>;2Z
M7;$G_]S4)5 /0TAR@@ZHQ#H1^1-B9%WU32X/T;08CTXQNX&O3S3R*"G!(6Q<
M%S2K:U95LJ/1.?FN8HH51;:X?&6H3W*'-UC+4HA#/2TQB4,2_;74/X9'88KW
M3:I2Y@$'&54VBRM?Q<FQ(2+5ONTVCJRL\&&")R3M/E@AP\>:^W.[#%.C1I/\
M/MT_S'R]+5F<-(+ @.\\CY;ET,Y#($- V\PA-6^_3 Y-C1@N4/;&D),@5YI.
M<I@9+UE)G "[[QE?W(S0PW68WHFLWF%<IYA\RYFEL^C829RI5'!V&36]7*V0
M3QR,RU>?E:N_)WO$;419I_^CN0;/7HC8&W,R6>R7K7<64=#\1>V3P(IC@T/7
MMD8U\&I%2JX?EQFQ7_2)ZR;*^V%.NP?6@2K  ];*D9F?V47!V*(UR&QH/F,8
M78^GI)9.O>Y15<S$_2XZBQ)VD\S4"3>: WC_6( M]?/0GEIK6@TGGM-/6+/S
M2[[;A6S27EA-^CI:Q<FV0-Y2-T-)JK/JZ"4-I8&K;GSST7CRC0-RP@ 6+8>
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M\E%ZYV&I;.;A01S7!#&44!L1-P=*VG>2]L.X(I,KDG*O(^[$!D4F/])<Y*:
MC?ZN(:B;-8&]X[_0GA;S2.-5JQ"L9A;G40+5R+>=D35V$8G!=+:2QDB=,^ 0
M-A+VS8R ]F4Z;9YS'1%@<IMYF"(JSOKR:N@>IP2RAB(X>CS>%("%W$L. 5?"
MA5JM[1Y3;?Q&OZ18OL3+39S3OM"+*%B^$$[V2R*_@G?)4LI2@SAOM<C75?98
M0@H$5X$9PEU6<D?^+V/<Q1&*U 0T-(3;#*%!^0PB .W;GI1Q<1GRY7-TY?G(
M2O]-(9D)V1]N_&@8)R@#9"Z]JA7B!7RESQY"+KOM: NP"97;WLY-SJK0,@U*
MLE>%P1U*?(KKVJY0>PE/:1]2$',_F(!U",WE7MM#CJ_>V>43=#U4>;JS7-J]
M0,*5>[ D\7N*L0.)EW1/1^(5D&[J0C09/%9"D+M6[__VY&WQP.1!*SY,(%P*
M'20%"(V.&!"U% 9]"WZ"!C]!0IYO@<[)!CK?PIMOX<VW\.;LPYMZ>[)>&])T
M&H_U^X4@FBI@LI:1U3(U6#.V53QY )91/('=%22^#Q]W> ORCQGD[Z;YF$OP
M,?**)_8HN$O0%N=;JY+DD)O2QJT@4AYPX%5>C&*"7I+L<;0>87VV2+DN0Z ?
M_6M!!MQ="&ZITEQVZU+ET9NM:+G@:;@:D&5#;N)H3:_]*:? DFP,/1L+VP0$
M+MP.?)=ZN5HA/\//R,%U*H_VI(Y="FMR$%.P\/XTHOM%&[O%7363ARSV?SOS
M0B_RD6[?MF,1G?J@GW)ZEKI=%6WR[KRRN4 4L![TQY=0]NK=FG$#5 BW9.(Q
MP@HMW!2FV4]+OYI4?2Q;%PPB*JYW>"!%%I6]Y:B$HTN'0YWO\]!+4S)%.E\+
M=P]B.A.J)RE<J0TYBA$;_=Z!KZY62J)R2;B6W9#R-@N\\3":<?\T;0T6FG:
MI%T]&T0$<IVF.3D5Y0DY^1+O"\<!,[+UABFUJ.4#\FFZ(VYW-P:P4R:\N%2#
M@0V[:<*, (>,'6JZ5ST3^(1>V%_&U(PC3;>G7)"5)*LI-: U-$(4PH#8 !E[
M5O>_@H+C!@S2ZYV+CKZS G,#T&3J C_C@!QR4Z)@S,V^0'Y(_A-8%:.8ZCQ%
MVX/B:54#6:S7";,<S3(HWI[Z/%440T<KBV2R*+B)O2@MQ[,4GN@E9; YLG'+
M\<[SA"J;#<Y;%)PN&!FIU5<-%R+75Z)5W+G.G*6 ?(.$XT.<JNSX,#DI6\53
M)XM+S;%S:;+(X"JHOYM*''T1!)A2\<+K:!4G6T;R'K%& EE\NV-[4K2^05ZJ
MM2,=C_5]E)8M2AJY]5K#Z[OJ;)SS.,TL;:O=\=TL&QCY-2Q?%SE7V;052TWF
M*6_ TN00<'TW(%3@NJQXP  *ZW_\Q__\\LMW_^?GCS_]]?_^GW_YN_SUW]%?
MOP_^^.YY_>]]]'B1OWSX+OG^N__ZYM?'Y3X-OWOV__@Z_#'[*GM /_[QW;>_
MO;[W;[*O__OJZIN'__KJ^?7L_-]?/P</R;_?O__OWQ?;_WWV^\7#]^CYZ9O'
M7U]??X^7[X-__6F5O?S\UXMM].N?_K4^6_SU-5__U_KQK_>7^S#]\.U?[O:/
M'[R+X$_IWW_ZXV^/F\?+;_[UZ^)WM+SX\*</Z6)Q>Q:MO__T]_!#>KGX]5]?
MW;PL'\ZNSWX/_K)?__IM^AS'/Y]]\\.WW^6O[W_]\?*_UV=7-S__\=L?^7)Q
M<_87;YE^^]N?LI_O__:OAW\]W5_][Z_VY[\^I>NK[X/WO[]/_W25_?;5MP^1
M?_9^Y__S_[X[?[C_\DMMZ_2PB9.,NA>V%)I#8!8*S0/&<::9+1$U)3-ML72E
M,7J>&+L$K>ULTBZ(\(MSW[#%B#A>,4W6^75%@;?L>A%2!T(=4D[QG@U1?A3@
M;'E/B]3?KAZ)IM&^T[=/F8<C%%Q'EZ\^J^1X%2=-QF^P]X1#G.V!Y6K"B1-#
MJB)[(Y@GM:I;;0WN$6VY>CB(D@T<NAB#,GE7_HZ^+9#!U.V+F%Y^JUQCFN)8
M9C:.J0,\\K/7 2ZFH-58)A#CNLJS/$%EOZ#&KFA:$T(\LD8$2V(P_:@\(OL!
M$IC^BLP%O0U_S98O*'Q&'^,HVT [5=ILN*W]+B_FYJ%&%W.7M>MDN?XW\I+E
M2^Q(02KJKL]8=C7C@+'3>R$E;FFE!)<ZP>@[+F@_@E(4,#NNE*?"\56<0^?R
M*I-W7^_'OF84.+NMIZ?$+WYV:2\8^<]"+QC.;JKNJ?*[6!%JCI6CR8/[NPV]
M%:6C+2WT7=_-RK+M2$]<YQV-J1E&?F@S_64:@8%[Y,>13Z;I%>U#Q68XB\NW
MI0\;A#+3L$&3;I_Y7S;H:@05C$D!Q?(.^F0GEW. F*-%"B]Q<6"O"["C?G,#
M['TB.(RI C5Z[OV\$=6@CC/D(PE091A'!3XOP4,FJ8([;(]14-XXH.#RU2<?
MM5)228^'TU0337G,(X3PF7G]#C6%=P[0B2.TT^ G<A2H7:9Z3W&>_>0EF'KY
M55V=5+>HS%%DC?M:'@D-]UY^3%TW[DBK/?9EE+$7MW:KP?13U9T5=]3]C:7Z
M,$/4W-YN*NLEOQ[,@'J,7!DF3>K+Y/+WG #^$66;.+@^V(+N;Q'ZY&V1;.$8
M0J,F??*OH^2-R3M^@:^VZ*E"F ,.4G=&64E$/%W$-#L*0 T&"+@1--3RJ"0_
MA&(M%J'L$[+:#F0B_CYE1=\\_UCWX: GJ:AD$&_[5!W0A7V&E) Z@H"YH$:R
M?H*6]>" IR;K801=O;@X<MHJY*XL6O[WG62!V!&E "#],[II7._(VG7D/^1/
M2WJL4Y9;][N.SM5VI,:!QE$=7KT%=J++JG\QP?2_DY;,V?L:.T49',1B-;1&
MIZ2<9,9P%=N$%)P45J48_P9B$Y5,8O[$@EM7D4?C9>S %!4!I? &;W&& ED#
M*3W2[->B FBE8+\;?[,K7UM4<Y.4(O];LY>8 (Q2.G\?UWI^]%YIO/OR=<<J
M%R_CFSB5M9I]WST!-Z07FE):WX.Y(?.(44E'?P%*R*IZ:(UV*>SU9GKT)*5O
M!B2'<5GA53+TSCPU25!<YR@>5V=Z'2U6*W8MAU*RN:4XP![K5)"FL<]^NXB"
M'V,<93^1C]-JZ\!W#6:\N% ,-=6OKV-#W$WJO6:3>^5XCYY1E*.4@DK\9 9:
M^H*SS7F>9O&6*+I9_:YJ_*OZ^#_7Q]=*3Y0>5-VF#B/2:2DH"^+0#"V2-K!3
MA:G]&0>H41&$T:42N'QE[G=84;1U'ZK/A^OW?NJ+@-HKFXH(<VNF?&UVE\1!
M[F>WR0-*GK$/=6?*'=:-T.U;C^KRC(\EA& UI4KWRI*7%.P>5#RVNRO0/BUN
M28>'B<FM9M>'603/.(V3_4<O\M:L(0@AN0BV.,+4I-"&7B4#5EJC&##B,K@X
M)$((G-WE3[-H2Z5VUQ%Q^V2#]^)O3EE:/?/5/Y,+ [LGMYL .'H@H0^M$F'E
M=('-VF%8UV\XC9WO1J&O UB@K9\F<(S]@.)UXNTVV+^@YA@_Y<7;O&K&M3Q<
MO7,LG\#1M=<XQ4H/J;$#:!@..0@M'&'E""MF<EK@0W"N'0>$UF'6Y6E6=2EH
MGF4E]=%%AG#5>N_(HA="I?\*QY[->5;)D!R2@,68.HI5/*!UFQ^P4ZUX;(>)
MO4-:?1"5&!B3HRU[3Y;L?WE\Z $X1?Z?U_'S5^6'"XS+?QPAK@WE[N9<!L[Z
MG)U4ZZH8^/$2#'0RU#Q IW,&RV+5 ?T:#O3KN8!^?0GX2/0D=T.[GNOH!W7
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MP*<XD\BYUAG3Z<%/4N!:6+DI1BNT7<26%*KHA4<_1G=IBX:;@S!5$7)3'E;
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MV3HN?D/<;B_RL1=>1W06=(>UDY/)I>(Z$0)DNQ%"")#[HK7'T%?#A!A]>OQ
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M+!@%[Z$(R3A)F%5P3\3XC%Z%LX\EM<*;AH)KU=QTN :'M'=(DKWE-$W]%TK
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MOO?+<]A<^V>O?X;M%@@S%\JG./)-Y%+[_BS6T" (^K4R>:T6G#W):S\XK[W
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MW:<T%.R(!@*#?H7RH].2CWK>@/$(3NOO"TU8*C.T^'@DRQM7:9??<K&]EU
M+T(;RJ<E:2=LW9^%1_CY#1^RC5:]7Y0GD?V47W5S&NWW*(<L-YD-0@%5K,15
M/F7I ]$.H%$C*_FHOC]1^2BA@"HRXBJ?69:1/'MDL=VR:7UV4FYFW]3!"G,
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M70)J!1OSJBK3>)2[(^%L*KTSLD3SLWUP6$-Z.XNB5+[T V&Z/R"*NS(T/4N
M?W<I<[3CX8YF8A<!0[@['J99T,S/$N*_.EJ$K\$+*7N2S<7%^GB(E0.B*;%N
M>I8(_\U%B9MDUG.-V"/7B&V5/_WTZ?-]D,KB 89G2.W'F&\L1ICJIPX>?&OX
M2MU)V*V#;![$ Y_IR=Y@B!.HSVL"!'"-&O6)YE^_"9Z>.''QK_\#4$L! A0#
M%     @ ['U76,=E94$U*0  +,@   L              ( !     &5X,3 M
M,S$N:'1M4$L! A0#%     @ ['U76*@6PD'5!@  *=    H
M ( !7BD  &5X,C$M,2YH=&U02P$"% ,4    " #L?5=8-PE0$.H#  #P#@
M"@              @ %;,   97@R,RTQ+FAT;5!+ 0(4 Q0    ( .Q]5U@L
M<8.TKPD  )A1   *              "  6TT  !E>#,Q+3$N:'1M4$L! A0#
M%     @ ['U76$X*@A^="0  ,4H   H              ( !1#X  &5X,S$M
M,BYH=&U02P$"% ,4    " #L?5=8X,(&[_\'   -40  "@
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M,# T+FIP9U!+ 0(4 Q0    ( .Q]5UBU9HTD](H! &Q1 P 1
M  "  9:2!P!T8F%R8VAA<G1?,# U+FIP9U!+ 0(4 Q0    ( .Q]5UAAGYK?
M?ZP! !0E!  1              "  ;D="0!T8F%R8VAA<G1?,# V+FIP9U!+
M 0(4 Q0    ( .Q]5UC>31JI_YP!  WY P 1              "  6?*"@!T
M8F%R8VAA<G1?,# W+FIP9U!+ 0(4 Q0    ( .Q]5UBPZ_ATQC4% -D2!P 2
M              "  95G# !T;&EN96-H87)T7S P,2YJ<&=02P$"% ,4
M" #L?5=8'(>CYQ@>!0":KG< #P              @ &+G1$ =W0M,C R,S$R
M,S$N:'1M4$L! A0#%     @ ['U76$U[#F 7*0  ] 4"  \
M ( !T+L6 '=T+3(P,C,Q,C,Q+GAS9%!+ 0(4 Q0    ( .Q]5UCA%WXH;A@
M *=/ 0 3              "  13E%@!W="TR,#(S,3(S,5]C86PN>&UL4$L!
M A0#%     @ ['U76#@3X,1VC@  Q> ( !,              ( !L_T6 '=T
M+3(P,C,Q,C,Q7V1E9BYX;6Q02P$"% ,4    " #L?5=8J$?^H< Y 0#X( \
M$P              @ %:C!< =W0M,C R,S$R,S%?;&%B+GAM;%!+ 0(4 Q0
M   ( .Q]5UCEG4S$!8H  )O@"  3              "  4O&& !W="TR,#(S
B,3(S,5]P<F4N>&UL4$L%!@     5 !4 _@0  (%0&0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>wt-20231231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:wt="http://www.wisdomtreeinvestmentsinc.com/20231231"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="wt-20231231.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wt:CommonStock001ParValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wt:PreferredStockPurchaseRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
        </entity>
        <period>
            <instant>2024-02-20</instant>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">wt:WisdomtreeETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">wt:WisdomtreeETFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="wt:RelatedPartiesAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="wt:RelatedPartiesAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:InvestmentAdvisoryManagementAndAdministrativeServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:InvestmentAdvisoryManagementAndAdministrativeServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:InvestmentAdvisoryManagementAndAdministrativeServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wt:OtherServicesIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wt:OtherServicesIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wt:OtherServicesIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
        </entity>
        <period>
            <instant>2021-01-01</instant>
        </period>
    </context>
    <context id="c60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-01</endDate>
        </period>
    </context>
    <context id="c61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">wt:ImplementationOfASU202006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">wt:ImplementationOfASU202006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:StraightLineDepreciationMethodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wt:TwoFinancialInstitutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wt:TwoFinancialInstitutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wt:EuropeanBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">wt:EuropeanBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">wt:FederalAgencyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">wt:FederalAgencyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">wt:FederalAgencyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">wt:FederalAgencyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:FixedIncomeInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">wt:FnalityInternationalLimitedBOnePreferenceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">wt:FnalityInternationalLimitedBOnePreferenceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">wt:FnalityInternationalLimitedBOnePreferenceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">wt:FnalityInternationalLimitedBOnePreferenceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:ExchangeTradedFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">wt:FederalAgencyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">wt:FederalAgencyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">wt:FederalAgencyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">wt:FederalAgencyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:AllOtherCorporateBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:AllOtherCorporateBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:AllOtherCorporateBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">us-gaap:AllOtherCorporateBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">wt:OtherAssetsseedCapitalWisdomtreeDigitalFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">wt:OtherAssetsseedCapitalWisdomtreeDigitalFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">wt:OtherAssetsseedCapitalWisdomtreeDigitalFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecurityOwnedAndSoldNotYetPurchasedAtFairValueAxis">wt:OtherAssetsseedCapitalWisdomtreeDigitalFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">wt:SecurrencyConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">wt:SecurrencyConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">wt:SecurrencyConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">wt:SecurrencyConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wt:FnalityConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wt:FnalityConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wt:FnalityConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wt:FnalityConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wt:DeferredConsiderationObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wt:DeferredConsiderationObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wt:DeferredConsiderationObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wt:DeferredConsiderationObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">wt:DeferredConsiderationObligationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">wt:TradingSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">wt:TradingSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">wt:OtherAssetsseedCapitalWisdomTreeDigitalFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">wt:OtherAssetsseedCapitalWisdomTreeDigitalFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">wt:FederalAgencyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">wt:FederalAgencyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
        </entity>
        <period>
            <startDate>2023-12-07</startDate>
            <endDate>2023-12-07</endDate>
        </period>
    </context>
    <context id="c158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="c161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="c162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="c164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="c165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:FnalityInternationalLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:FnalityInternationalLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="c170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wt:FnalityInternationalLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:SecurrencyseriesaconvertiblepreferredstockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:SecurrencyseriesaconvertiblepreferredstockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:SecurrencyseriesbconvertiblepreferredstockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:SecurrencyseriesbconvertiblepreferredstockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:SecurrencyConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:SecurrencyConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:SecurrencyIncSubTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:SecurrencyIncSubTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:ConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:ConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:B1ConvertiblePreferenceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:B1ConvertiblePreferenceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:SubtotalFnalityInternationalLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:SubtotalFnalityInternationalLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
        </entity>
        <period>
            <startDate>2021-03-09</startDate>
            <endDate>2021-06-09</endDate>
        </period>
    </context>
    <context id="c188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
        </entity>
        <period>
            <startDate>2020-12-09</startDate>
            <endDate>2021-03-08</endDate>
        </period>
    </context>
    <context id="c189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">wt:ETFSCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">wt:ContractualGoldPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="wt:AgreementAxis">wt:SpaAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-10</startDate>
            <endDate>2023-05-10</endDate>
        </period>
    </context>
    <context id="c195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wt:SeriesCRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wt:GoldBullionHoldingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-10</instant>
        </period>
    </context>
    <context id="c196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wt:SeriesCRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-10</instant>
        </period>
    </context>
    <context id="c197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wt:SeriesCRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-10</startDate>
            <endDate>2023-05-10</endDate>
        </period>
    </context>
    <context id="c198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wt:SeriesCRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wt:RodberInvestmentsLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-10</instant>
        </period>
    </context>
    <context id="c199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wt:GoldBullionHoldingsJerseyLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wt:SeriesCRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-20</startDate>
            <endDate>2023-11-20</endDate>
        </period>
    </context>
    <context id="c200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wt:FirstInstallmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-20</startDate>
            <endDate>2023-11-20</endDate>
        </period>
    </context>
    <context id="c201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wt:SecondInstallmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-20</startDate>
            <endDate>2023-11-20</endDate>
        </period>
    </context>
    <context id="c202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wt:ThirdInstallmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-20</startDate>
            <endDate>2023-11-20</endDate>
        </period>
    </context>
    <context id="c203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertibleSeniorNotesDue2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-14</instant>
        </period>
    </context>
    <context id="c207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-14</instant>
        </period>
    </context>
    <context id="c208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-16</instant>
        </period>
    </context>
    <context id="c209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-13</instant>
        </period>
    </context>
    <context id="c210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-13</startDate>
            <endDate>2020-08-13</endDate>
        </period>
    </context>
    <context id="c211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:TwoThousandAndTwentyNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
        </entity>
        <period>
            <instant>2023-06-15</instant>
        </period>
    </context>
    <context id="c213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:TwoThousandAndTwentyNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-15</instant>
        </period>
    </context>
    <context id="c214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertibleSeniorNotesDueTwoThousandAndTwentyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertibleSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertibleSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertibleSeniorNotesDueTwoThousandAndTwentySixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertibleSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-14</startDate>
            <endDate>2023-02-14</endDate>
        </period>
    </context>
    <context id="c221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertibleSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-14</startDate>
            <endDate>2021-06-14</endDate>
        </period>
    </context>
    <context id="c222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:TwoThousandAndTwentyThreeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:TwothousandandtwentyonenotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:TwoThousandAndTwentyThreeNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:TwothousandandtwentyonenotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:TwothousandandtwentyonenotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:TwoThousandAndTwentyNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">wt:ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wt:ETFSAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wt:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wt:ETFSAcquisitionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wt:ETFSAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-10</startDate>
            <endDate>2018-04-10</endDate>
        </period>
    </context>
    <context id="c237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wt:ETFSAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-04-10</instant>
        </period>
    </context>
    <context id="c238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
        </entity>
        <period>
            <instant>2023-11-20</instant>
        </period>
    </context>
    <context id="c243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
        </entity>
        <period>
            <startDate>2023-11-20</startDate>
            <endDate>2023-11-20</endDate>
        </period>
    </context>
    <context id="c244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wt:GBHMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-20</startDate>
            <endDate>2023-11-20</endDate>
        </period>
    </context>
    <context id="c245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="c246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="c247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:SecurrencyseriesaconvertiblepreferredstockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:SecurrencyseriesaconvertiblepreferredstockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:SecurrencyseriesbconvertiblepreferredstockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:SecurrencyseriesbconvertiblepreferredstockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:SecurrencyConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:SecurrencyConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:SecurrencyIncSubTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:SecurrencyIncSubTotalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:ConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:ConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:B1ConvertiblePreferenceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:B1ConvertiblePreferenceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:SubtotalFnalityInternationalLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:SubtotalFnalityInternationalLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:OtherInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:OtherInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:MaximumExposureToLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">wt:MaximumExposureToLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:JE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wt:WisdomTreeProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wt:WisdomTreeProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:AffiliatedBlockchainEnabledFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wt:WisdomTreeProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">wt:AffiliatedBlockchainEnabledFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wt:WisdomTreeProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
        </entity>
        <period>
            <instant>2023-05-10</instant>
        </period>
    </context>
    <context id="c279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wt:ReceivableFromWTTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="wt:RelatedPartiesAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wt:ReceivableFromWTTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="wt:RelatedPartiesAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wt:ReceivableFromManJerIssuersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="wt:RelatedPartiesAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wt:ReceivableFromManJerIssuersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="wt:RelatedPartiesAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wt:WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="wt:RelatedPartiesAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">wt:WisdomtreeMultiAssetIssuerPlcAndWisdomtreeIssuerIcavMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="wt:RelatedPartiesAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wt:AdvisoryServicesProvidedToWTTMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wt:AdvisoryServicesProvidedToWTTMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wt:AdvisoryServicesProvidedToWTTMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wt:AdvisoryServicesProvidedToManJerIssuersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wt:AdvisoryServicesProvidedToManJerIssuersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wt:AdvisoryServicesProvidedToManJerIssuersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wt:AdvisoryServicesProvidedToWMAIAndWTICAVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wt:AdvisoryServicesProvidedToWMAIAndWTICAVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">wt:AdvisoryServicesProvidedToWMAIAndWTICAVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
        </entity>
        <period>
            <startDate>2022-07-15</startDate>
            <endDate>2022-07-15</endDate>
        </period>
    </context>
    <context id="c298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wt:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wt:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">wt:BelowTwentyFifthPercentileMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">wt:BelowTwentyFifthPercentileMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">wt:BelowTwentyFifthPercentileMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">wt:EmployeesAndDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">wt:EmployeesAndDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wt:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wt:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c314">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wt:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wt:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wt:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wt:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">wt:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
        </entity>
        <period>
            <instant>2023-03-17</instant>
        </period>
    </context>
    <context id="c328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wt:StockholderRightAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-17</instant>
        </period>
    </context>
    <context id="c329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wt:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-17</instant>
        </period>
    </context>
    <context id="c330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-17</instant>
        </period>
    </context>
    <context id="c331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wt:SeriesANonVotingConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="wt:AgreementAxis">wt:StockholderRightAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-17</instant>
        </period>
    </context>
    <context id="c332">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wt:StockholderRightAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-17</instant>
        </period>
    </context>
    <context id="c333">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">wt:AcquiringPersonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wt:StockholderRightAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c334">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">wt:AcquiringPersonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wt:StockholderRightAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c335">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wt:StockholderRightAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c336">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">wt:PassiveStockholdersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wt:StockholderRightAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c337">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">wt:PassiveStockholdersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wt:StockholderRightAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c338">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wt:StockholderRightAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c339">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wt:StockholderRightAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c340">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">wt:StockholderRightAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c341">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c342">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c343">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c344">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c345">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">wt:ManJersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c346">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c347">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wt:ForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c348">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wt:ForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c349">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">wt:ForeignMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c350">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c351">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c352">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c353">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c354">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c355">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c356">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c357">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c358">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c359">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">wt:UnrecognizedTaxBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c360">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">wt:InterestAndPenaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c361">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">wt:UnrecognizedTaxBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c362">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">wt:InterestAndPenaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c363">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">wt:UnrecognizedTaxBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c364">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">wt:InterestAndPenaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c365">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">wt:UnrecognizedTaxBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c366">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">wt:InterestAndPenaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c367">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">wt:UnrecognizedTaxBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c368">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReasonablyPossibleSignificantChangeInUnrecognizedTaxBenefitsByItemAxis">wt:InterestAndPenaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c369">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-22</instant>
        </period>
    </context>
    <context id="c370">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-22</instant>
        </period>
    </context>
    <context id="c371">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-22</endDate>
        </period>
    </context>
    <context id="c372">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
        </entity>
        <period>
            <startDate>2022-02-22</startDate>
            <endDate>2022-02-22</endDate>
        </period>
    </context>
    <context id="c373">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c374">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c375">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c376">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">wt:WorldGoldCouncilMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c377">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">wt:GoldBullionHoldingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c378">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wt:SecurrencyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-11</instant>
        </period>
    </context>
    <context id="c379">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wt:SecurrencyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-11</startDate>
            <endDate>2023-04-11</endDate>
        </period>
    </context>
    <context id="c380">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wt:SecurrencyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c381">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wt:ETFSAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c382">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">wt:ETFSAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-04-11</instant>
        </period>
    </context>
    <context id="c383">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c384">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">wt:ETFSAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c385">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c386">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">wt:ETFSAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c387">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c388">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wt:SaleOfCanadianETFBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c389">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">wt:SaleOfCanadianETFBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c390">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">wt:NewYorkOfficeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wt:LeaseTerminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c391">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">wt:NewYorkOfficeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wt:LeaseTerminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c392">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">wt:NewYorkOfficeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wt:LeaseTerminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c393">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">wt:NewYorkOfficeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wt:FixedAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c394">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">wt:NewYorkOfficeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wt:FixedAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c395">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">wt:NewYorkOfficeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wt:FixedAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c396">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">wt:LondonOfficeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wt:LeaseTerminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c397">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">wt:LondonOfficeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wt:LeaseTerminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c398">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">wt:LondonOfficeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">wt:LeaseTerminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c399">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">wt:SecurrencyIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c400">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">wt:SecurrencyIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">wt:SecurrencyIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000880631</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="oz">
        <measure>utr:oz</measure>
    </unit>
    <unit id="g">
        <measure>utr:g</measure>
    </unit>
    <unit id="cad">
        <measure>iso4217:CAD</measure>
    </unit>
    <dei:DocumentType contextRef="c0" id="ixv-26434">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c0" id="ixv-30">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c0" id="ixv-26435">2023-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c0" id="ixv-26436">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c0" id="ixv-26437">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="c0" id="ixv-44">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c0" id="ixv-26438">001-10932</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-60">WisdomTree, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0" id="ixv-70">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c0" id="ixv-75">13-3487784</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c0" id="ixv-91">250 West 34th Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c0" id="ixv-26440">3rd Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c0" id="ixv-26442">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c0" id="ixv-26443">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c0" id="ixv-103">10119</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c0" id="ixv-26444">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c0" id="ixv-26445">801-2080</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c1" id="ixv-137">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c1" id="ixv-142">WT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c1" id="ixv-147">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c2" id="ixv-152">Preferred Stock Purchase Rights</dei:Security12bTitle>
    <dei:SecurityExchangeName contextRef="c2" id="ixv-159">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c0" id="ixv-26446">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c0" id="ixv-26447">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c0" id="ixv-26448">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c0" id="ixv-26449">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c0" id="ixv-26450">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c0" id="ixv-221">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c0" id="ixv-235">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="c0" id="ixv-241">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c0" id="ixv-244">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="c0" id="ixv-253">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="c3" decimals="0" id="ixv-26451" unitRef="usd">948550832</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="c4"
      decimals="INF"
      id="ixv-26452"
      unitRef="shares">151853699</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="c0" id="ixv-263">&lt;p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:8pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:0;widows:3;margin-top:6pt;text-align:left;text-indent:24pt;margin-top:6pt;"&gt;The information required by Part III of this Report, to the extent not set forth herein, is incorporated herein by reference from the registrant&#x2019;s definitive proxy statement relating to the Annual Meeting of Stockholders to be held in 2024, which definitive proxy statement shall be filed with the Securities and Exchange Commission within 120&#160;days after the end of the fiscal year to which this Report relates. &#160;&lt;span class="CharOverride-9" style="font-size:8pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c58" id="ixv-26453">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c58" id="ixv-26454">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c58" id="ixv-26455">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c58" id="ixv-26456">false</ecd:Rule10b51ArrTrmntdFlag>
    <dei:AuditorLocation contextRef="c0" id="ixv-26457">New York</dei:AuditorLocation>
    <dei:AuditorFirmId contextRef="c0" id="ixv-26458">42</dei:AuditorFirmId>
    <dei:AuditorName contextRef="c0" id="ixv-26459">Ernst&#160;&amp; Young LLP</dei:AuditorName>
    <us-gaap:InvestmentsAndCash contextRef="c7" decimals="-3" id="ixv-26460" unitRef="usd">5007000</us-gaap:InvestmentsAndCash>
    <us-gaap:InvestmentsAndCash contextRef="c8" decimals="-3" id="ixv-26461" unitRef="usd">0</us-gaap:InvestmentsAndCash>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c5" decimals="-3" id="ixv-26462" unitRef="usd">129305000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c6" decimals="-3" id="ixv-26463" unitRef="usd">132101000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned contextRef="c7" decimals="-3" id="ixv-26464" unitRef="usd">47559000</us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned contextRef="c8" decimals="-3" id="ixv-26465" unitRef="usd">25283000</us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned>
    <us-gaap:FinancialInstrumentsOwnedAtFairValue contextRef="c5" decimals="-3" id="ixv-26466" unitRef="usd">58722000</us-gaap:FinancialInstrumentsOwnedAtFairValue>
    <us-gaap:FinancialInstrumentsOwnedAtFairValue contextRef="c6" decimals="-3" id="ixv-26467" unitRef="usd">126239000</us-gaap:FinancialInstrumentsOwnedAtFairValue>
    <us-gaap:AccountsReceivableNet contextRef="c9" decimals="-3" id="ixv-26468" unitRef="usd">28511000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet contextRef="c10" decimals="-3" id="ixv-26469" unitRef="usd">24139000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c5" decimals="-3" id="ixv-26470" unitRef="usd">35473000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c6" decimals="-3" id="ixv-26471" unitRef="usd">30549000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="c5" decimals="-3" id="ixv-26472" unitRef="usd">5258000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="c6" decimals="-3" id="ixv-26473" unitRef="usd">4684000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c5" decimals="-3" id="ixv-26474" unitRef="usd">1036000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c6" decimals="-3" id="ixv-26475" unitRef="usd">390000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c5" decimals="-3" id="ixv-26476" unitRef="usd">229794000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c6" decimals="-3" id="ixv-26477" unitRef="usd">293963000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c5" decimals="-3" id="ixv-26478" unitRef="usd">427000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c6" decimals="-3" id="ixv-26479" unitRef="usd">544000</us-gaap:PropertyPlantAndEquipmentNet>
    <wt:IndemnificationReceivableNoncurrent contextRef="c6" decimals="-3" id="ixv-26480" unitRef="usd">1353000</wt:IndemnificationReceivableNoncurrent>
    <us-gaap:HeldToMaturitySecuritiesNoncurrent contextRef="c5" decimals="-3" id="ixv-26481" unitRef="usd">230000</us-gaap:HeldToMaturitySecuritiesNoncurrent>
    <us-gaap:HeldToMaturitySecuritiesNoncurrent contextRef="c6" decimals="-3" id="ixv-26482" unitRef="usd">259000</us-gaap:HeldToMaturitySecuritiesNoncurrent>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c5" decimals="-3" id="ixv-26483" unitRef="usd">11057000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c6" decimals="-3" id="ixv-26484" unitRef="usd">10536000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c5" decimals="-3" id="ixv-26485" unitRef="usd">9684000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c6" decimals="-3" id="ixv-26486" unitRef="usd">35721000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c5" decimals="-3" id="ixv-26487" unitRef="usd">563000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c6" decimals="-3" id="ixv-26488" unitRef="usd">1449000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill contextRef="c5" decimals="-3" id="ixv-26489" unitRef="usd">86841000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c6" decimals="-3" id="ixv-26490" unitRef="usd">85856000</us-gaap:Goodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c5" decimals="-3" id="ixv-26491" unitRef="usd">605082000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c6" decimals="-3" id="ixv-26492" unitRef="usd">603567000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent contextRef="c5" decimals="-3" id="ixv-26493" unitRef="usd">459000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c6" decimals="-3" id="ixv-26494" unitRef="usd">571000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c5" decimals="-3" id="ixv-26495" unitRef="usd">944137000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c6" decimals="-3" id="ixv-26496" unitRef="usd">1033819000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent contextRef="c5" decimals="-3" id="ixv-26497" unitRef="usd">30085000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent contextRef="c6" decimals="-3" id="ixv-26498" unitRef="usd">36521000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c5" decimals="-3" id="ixv-26499" unitRef="usd">38111000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c6" decimals="-3" id="ixv-26500" unitRef="usd">24121000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:NotesPayableCurrent contextRef="c5" decimals="-3" id="ixv-26501" unitRef="usd">14804000</us-gaap:NotesPayableCurrent>
    <us-gaap:TaxesPayableCurrent contextRef="c5" decimals="-3" id="ixv-26502" unitRef="usd">3866000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent contextRef="c6" decimals="-3" id="ixv-26503" unitRef="usd">1599000</us-gaap:TaxesPayableCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c5" decimals="-3" id="ixv-26504" unitRef="usd">578000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c6" decimals="-3" id="ixv-26505" unitRef="usd">1125000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ConvertibleDebtCurrent contextRef="c6" decimals="-3" id="ixv-26506" unitRef="usd">59197000</us-gaap:ConvertibleDebtCurrent>
    <wt:DeferredConsiderationCurrent contextRef="c6" decimals="-3" id="ixv-26507" unitRef="usd">16796000</wt:DeferredConsiderationCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c5" decimals="-3" id="ixv-26508" unitRef="usd">15772000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c6" decimals="-3" id="ixv-26509" unitRef="usd">9075000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c5" decimals="-3" id="ixv-26510" unitRef="usd">103216000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c6" decimals="-3" id="ixv-26511" unitRef="usd">148434000</us-gaap:LiabilitiesCurrent>
    <wt:CarryingValueOfConvertibleNotes contextRef="c5" decimals="-3" id="ixv-26512" unitRef="usd">274888000</wt:CarryingValueOfConvertibleNotes>
    <wt:CarryingValueOfConvertibleNotes contextRef="c6" decimals="-3" id="ixv-26513" unitRef="usd">262019000</wt:CarryingValueOfConvertibleNotes>
    <us-gaap:AccountsPayableCurrentAndNoncurrent contextRef="c5" decimals="-3" id="ixv-26514" unitRef="usd">24328000</us-gaap:AccountsPayableCurrentAndNoncurrent>
    <wt:DeferredConsiderationNoncurrent contextRef="c6" decimals="-3" id="ixv-26515" unitRef="usd">183494000</wt:DeferredConsiderationNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c6" decimals="-3" id="ixv-26516" unitRef="usd">339000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c6" decimals="-3" id="ixv-26517" unitRef="usd">1353000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c5" decimals="-3" id="ixv-26518" unitRef="usd">402432000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c6" decimals="-3" id="ixv-26519" unitRef="usd">595639000</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c11"
      decimals="INF"
      id="ixv-26520"
      unitRef="usdPershares">0.01</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="c12"
      decimals="INF"
      id="ixv-26521"
      unitRef="usdPershares">0.01</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="c11"
      decimals="3"
      id="ixv-26522"
      unitRef="shares">14.75</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="c12"
      decimals="3"
      id="ixv-26523"
      unitRef="shares">14.75</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c11"
      decimals="3"
      id="ixv-26524"
      unitRef="shares">14.75</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="c12"
      decimals="3"
      id="ixv-26525"
      unitRef="shares">14.75</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c11"
      decimals="3"
      id="ixv-26526"
      unitRef="shares">14.75</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="c12"
      decimals="3"
      id="ixv-26527"
      unitRef="shares">14.75</us-gaap:TemporaryEquitySharesOutstanding>
    <wt:PreferredStockRedemptionValue contextRef="c11" decimals="-3" id="ixv-26528" unitRef="usd">96869000</wt:PreferredStockRedemptionValue>
    <wt:PreferredStockRedemptionValue contextRef="c12" decimals="-3" id="ixv-26529" unitRef="usd">77969000</wt:PreferredStockRedemptionValue>
    <us-gaap:TemporaryEquityValueExcludingAdditionalPaidInCapital contextRef="c5" decimals="-3" id="ixv-26530" unitRef="usd">132569000</us-gaap:TemporaryEquityValueExcludingAdditionalPaidInCapital>
    <us-gaap:TemporaryEquityValueExcludingAdditionalPaidInCapital contextRef="c6" decimals="-3" id="ixv-26531" unitRef="usd">132569000</us-gaap:TemporaryEquityValueExcludingAdditionalPaidInCapital>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c5"
      decimals="INF"
      id="ixv-26532"
      unitRef="usdPershares">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c6"
      decimals="INF"
      id="ixv-26533"
      unitRef="usdPershares">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c5"
      decimals="0"
      id="ixv-26534"
      unitRef="shares">2000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="c6"
      decimals="0"
      id="ixv-26535"
      unitRef="shares">2000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c5"
      decimals="INF"
      id="ixv-26536"
      unitRef="usdPershares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c6"
      decimals="INF"
      id="ixv-26537"
      unitRef="usdPershares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c5"
      decimals="0"
      id="ixv-26538"
      unitRef="shares">400000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="c6"
      decimals="0"
      id="ixv-26539"
      unitRef="shares">400000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="c5"
      decimals="0"
      id="ixv-26540"
      unitRef="shares">150330</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c5"
      decimals="0"
      id="ixv-26541"
      unitRef="shares">150330</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="c6"
      decimals="0"
      id="ixv-26542"
      unitRef="shares">146517</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c6"
      decimals="0"
      id="ixv-26543"
      unitRef="shares">146517</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c5" decimals="-3" id="ixv-26544" unitRef="usd">1503000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c6" decimals="-3" id="ixv-26545" unitRef="usd">1465000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c5" decimals="-3" id="ixv-26546" unitRef="usd">312440000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c6" decimals="-3" id="ixv-26547" unitRef="usd">291847000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c5" decimals="-3" id="ixv-26548" unitRef="usd">-548000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c6" decimals="-3" id="ixv-26549" unitRef="usd">-1420000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c5" decimals="-3" id="ixv-26550" unitRef="usd">95741000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c6" decimals="-3" id="ixv-26551" unitRef="usd">13719000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c5" decimals="-3" id="ixv-26552" unitRef="usd">409136000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c6" decimals="-3" id="ixv-26553" unitRef="usd">305611000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c5" decimals="-3" id="ixv-26554" unitRef="usd">944137000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c6" decimals="-3" id="ixv-26555" unitRef="usd">1033819000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues contextRef="c13" decimals="-3" id="ixv-26556" unitRef="usd">333227000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c14" decimals="-3" id="ixv-26557" unitRef="usd">293632000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c15" decimals="-3" id="ixv-26558" unitRef="usd">298052000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c16" decimals="-3" id="ixv-26559" unitRef="usd">15808000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c17" decimals="-3" id="ixv-26560" unitRef="usd">7713000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c18" decimals="-3" id="ixv-26561" unitRef="usd">6266000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c0" decimals="-3" id="ixv-26562" unitRef="usd">349035000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c19" decimals="-3" id="ixv-26563" unitRef="usd">301345000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c20" decimals="-3" id="ixv-26564" unitRef="usd">304318000</us-gaap:Revenues>
    <us-gaap:LaborAndRelatedExpense contextRef="c0" decimals="-3" id="ixv-26565" unitRef="usd">109532000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense contextRef="c19" decimals="-3" id="ixv-26566" unitRef="usd">97897000</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense contextRef="c20" decimals="-3" id="ixv-26567" unitRef="usd">88163000</us-gaap:LaborAndRelatedExpense>
    <wt:FundManagementAndAdministration contextRef="c0" decimals="-3" id="ixv-26568" unitRef="usd">71348000</wt:FundManagementAndAdministration>
    <wt:FundManagementAndAdministration contextRef="c19" decimals="-3" id="ixv-26569" unitRef="usd">64761000</wt:FundManagementAndAdministration>
    <wt:FundManagementAndAdministration contextRef="c20" decimals="-3" id="ixv-26570" unitRef="usd">58912000</wt:FundManagementAndAdministration>
    <us-gaap:MarketingAndAdvertisingExpense contextRef="c0" decimals="-3" id="ixv-26571" unitRef="usd">17256000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense contextRef="c19" decimals="-3" id="ixv-26572" unitRef="usd">15302000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense contextRef="c20" decimals="-3" id="ixv-26573" unitRef="usd">14090000</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:BusinessDevelopment contextRef="c0" decimals="-3" id="ixv-26574" unitRef="usd">13584000</us-gaap:BusinessDevelopment>
    <us-gaap:BusinessDevelopment contextRef="c19" decimals="-3" id="ixv-26575" unitRef="usd">11871000</us-gaap:BusinessDevelopment>
    <us-gaap:BusinessDevelopment contextRef="c20" decimals="-3" id="ixv-26576" unitRef="usd">9907000</us-gaap:BusinessDevelopment>
    <wt:ContractualGoldPayments contextRef="c0" decimals="-3" id="ixv-26577" unitRef="usd">6069000</wt:ContractualGoldPayments>
    <wt:ContractualGoldPayments contextRef="c19" decimals="-3" id="ixv-26578" unitRef="usd">17108000</wt:ContractualGoldPayments>
    <wt:ContractualGoldPayments contextRef="c20" decimals="-3" id="ixv-26579" unitRef="usd">17096000</wt:ContractualGoldPayments>
    <us-gaap:ProfessionalFees contextRef="c0" decimals="-3" id="ixv-26580" unitRef="usd">18969000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="c19" decimals="-3" id="ixv-26581" unitRef="usd">13800000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="c20" decimals="-3" id="ixv-26582" unitRef="usd">7616000</us-gaap:ProfessionalFees>
    <us-gaap:CommunicationsInformationTechnologyAndOccupancy contextRef="c0" decimals="-3" id="ixv-26583" unitRef="usd">4684000</us-gaap:CommunicationsInformationTechnologyAndOccupancy>
    <us-gaap:CommunicationsInformationTechnologyAndOccupancy contextRef="c19" decimals="-3" id="ixv-26584" unitRef="usd">3898000</us-gaap:CommunicationsInformationTechnologyAndOccupancy>
    <us-gaap:CommunicationsInformationTechnologyAndOccupancy contextRef="c20" decimals="-3" id="ixv-26585" unitRef="usd">4629000</us-gaap:CommunicationsInformationTechnologyAndOccupancy>
    <us-gaap:DepreciationAndAmortization contextRef="c0" decimals="-3" id="ixv-26586" unitRef="usd">872000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c19" decimals="-3" id="ixv-26587" unitRef="usd">262000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c20" decimals="-3" id="ixv-26588" unitRef="usd">738000</us-gaap:DepreciationAndAmortization>
    <wt:ThirdPartyDistribution contextRef="c0" decimals="-3" id="ixv-26589" unitRef="usd">9377000</wt:ThirdPartyDistribution>
    <wt:ThirdPartyDistribution contextRef="c19" decimals="-3" id="ixv-26590" unitRef="usd">7656000</wt:ThirdPartyDistribution>
    <wt:ThirdPartyDistribution contextRef="c20" decimals="-3" id="ixv-26591" unitRef="usd">7176000</wt:ThirdPartyDistribution>
    <us-gaap:OtherExpenses contextRef="c0" decimals="-3" id="ixv-26592" unitRef="usd">9852000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses contextRef="c19" decimals="-3" id="ixv-26593" unitRef="usd">8705000</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses contextRef="c20" decimals="-3" id="ixv-26594" unitRef="usd">6933000</us-gaap:OtherExpenses>
    <us-gaap:OperatingExpenses contextRef="c0" decimals="-3" id="ixv-26595" unitRef="usd">261543000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c19" decimals="-3" id="ixv-26596" unitRef="usd">241260000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c20" decimals="-3" id="ixv-26597" unitRef="usd">215260000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c0" decimals="-3" id="ixv-26598" unitRef="usd">87492000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c19" decimals="-3" id="ixv-26599" unitRef="usd">60085000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c20" decimals="-3" id="ixv-26600" unitRef="usd">89058000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense contextRef="c0" decimals="-3" id="ixv-26601" unitRef="usd">15242000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c19" decimals="-3" id="ixv-26602" unitRef="usd">14935000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c20" decimals="-3" id="ixv-26603" unitRef="usd">12332000</us-gaap:InterestExpense>
    <wt:GainLossFromChangeInDeferredConsideration contextRef="c0" decimals="-3" id="ixv-26604" unitRef="usd">61953000</wt:GainLossFromChangeInDeferredConsideration>
    <wt:GainLossFromChangeInDeferredConsideration contextRef="c19" decimals="-3" id="ixv-26605" unitRef="usd">27765000</wt:GainLossFromChangeInDeferredConsideration>
    <wt:GainLossFromChangeInDeferredConsideration contextRef="c20" decimals="-3" id="ixv-26606" unitRef="usd">2018000</wt:GainLossFromChangeInDeferredConsideration>
    <us-gaap:InvestmentIncomeInterest contextRef="c0" decimals="-3" id="ixv-26607" unitRef="usd">4099000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c19" decimals="-3" id="ixv-26608" unitRef="usd">3320000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c20" decimals="-3" id="ixv-26609" unitRef="usd">2009000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:GoodwillImpairmentLoss contextRef="c0" decimals="-3" id="ixv-26610" unitRef="usd">7942000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c20" decimals="-3" id="ixv-26611" unitRef="usd">16156000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c0" decimals="-3" id="ixv-26612" unitRef="usd">-9721000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingGainsLosses contextRef="c0" decimals="-3" id="ixv-26613" unitRef="usd">-1631000</us-gaap:OtherNonoperatingGainsLosses>
    <us-gaap:OtherNonoperatingGainsLosses contextRef="c19" decimals="-3" id="ixv-26614" unitRef="usd">-36285000</us-gaap:OtherNonoperatingGainsLosses>
    <us-gaap:OtherNonoperatingGainsLosses contextRef="c20" decimals="-3" id="ixv-26615" unitRef="usd">-7926000</us-gaap:OtherNonoperatingGainsLosses>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c0" decimals="-3" id="ixv-26616" unitRef="usd">119008000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c19" decimals="-3" id="ixv-26617" unitRef="usd">39950000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c20" decimals="-3" id="ixv-26618" unitRef="usd">56671000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c0" decimals="-3" id="ixv-26619" unitRef="usd">16462000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c19" decimals="-3" id="ixv-26620" unitRef="usd">-10734000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c20" decimals="-3" id="ixv-26621" unitRef="usd">6874000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-26622" unitRef="usd">102546000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c19" decimals="-3" id="ixv-26623" unitRef="usd">50684000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c20" decimals="-3" id="ixv-26624" unitRef="usd">49797000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c0"
      decimals="INF"
      id="ixv-26625"
      unitRef="usdPershares">0.66</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c19"
      decimals="INF"
      id="ixv-26626"
      unitRef="usdPershares">0.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c20"
      decimals="INF"
      id="ixv-26627"
      unitRef="usdPershares">0.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c0"
      decimals="INF"
      id="ixv-26628"
      unitRef="usdPershares">0.64</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c19"
      decimals="INF"
      id="ixv-26629"
      unitRef="usdPershares">0.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c20"
      decimals="INF"
      id="ixv-26630"
      unitRef="usdPershares">0.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c0"
      decimals="0"
      id="ixv-26631"
      unitRef="shares">144707</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c19"
      decimals="0"
      id="ixv-26632"
      unitRef="shares">143020</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c20"
      decimals="0"
      id="ixv-26633"
      unitRef="shares">143847</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c0"
      decimals="0"
      id="ixv-26634"
      unitRef="shares">170413</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c19"
      decimals="0"
      id="ixv-26635"
      unitRef="shares">158914</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c20"
      decimals="0"
      id="ixv-26636"
      unitRef="shares">161263</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c0"
      decimals="INF"
      id="ixv-26637"
      unitRef="usdPershares">0.12</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c19"
      decimals="INF"
      id="ixv-26638"
      unitRef="usdPershares">0.12</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c20"
      decimals="INF"
      id="ixv-26639"
      unitRef="usdPershares">0.12</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-26640" unitRef="usd">102546000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c19" decimals="-3" id="ixv-26641" unitRef="usd">50684000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c20" decimals="-3" id="ixv-26642" unitRef="usd">49797000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c0" decimals="-3" id="ixv-26643" unitRef="usd">872000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c19" decimals="-3" id="ixv-26644" unitRef="usd">-2102000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c20" decimals="-3" id="ixv-26645" unitRef="usd">-420000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c0" decimals="-3" id="ixv-26646" unitRef="usd">872000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c19" decimals="-3" id="ixv-26647" unitRef="usd">-2102000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c20" decimals="-3" id="ixv-26648" unitRef="usd">-420000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c0" decimals="-3" id="ixv-26649" unitRef="usd">103418000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c19" decimals="-3" id="ixv-26650" unitRef="usd">48582000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c20" decimals="-3" id="ixv-26651" unitRef="usd">49377000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="c22"
      decimals="INF"
      id="ixv-26652"
      unitRef="shares">148716</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c22" decimals="-3" id="ixv-26653" unitRef="usd">1487000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c23" decimals="-3" id="ixv-26654" unitRef="usd">317075000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c24" decimals="-3" id="ixv-26655" unitRef="usd">1102000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c25" decimals="-3" id="ixv-26656" unitRef="usd">-53399000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c26" decimals="-3" id="ixv-26657" unitRef="usd">266265000</us-gaap:StockholdersEquity>
    <wt:ReclassificationOfEquity contextRef="c20" decimals="-3" id="ixv-26658" unitRef="usd">1022000</wt:ReclassificationOfEquity>
    <wt:StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes contextRef="c29" decimals="-3" id="ixv-26659" unitRef="usd">-3682000</wt:StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes>
    <wt:StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes contextRef="c31" decimals="-3" id="ixv-26660" unitRef="usd">616000</wt:StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes>
    <wt:StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes contextRef="c20" decimals="-3" id="ixv-26661" unitRef="usd">-3066000</wt:StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes>
    <wt:TemporaryEquityShareOutstanding
      contextRef="c33"
      decimals="INF"
      id="ixv-26662"
      unitRef="shares">148716</wt:TemporaryEquityShareOutstanding>
    <wt:TemporaryStockholdersEquity contextRef="c33" decimals="-3" id="ixv-26663" unitRef="usd">1487000</wt:TemporaryStockholdersEquity>
    <wt:TemporaryStockholdersEquity contextRef="c34" decimals="-3" id="ixv-26664" unitRef="usd">313393000</wt:TemporaryStockholdersEquity>
    <wt:TemporaryStockholdersEquity contextRef="c35" decimals="-3" id="ixv-26665" unitRef="usd">1102000</wt:TemporaryStockholdersEquity>
    <wt:TemporaryStockholdersEquity contextRef="c36" decimals="-3" id="ixv-26666" unitRef="usd">-52783000</wt:TemporaryStockholdersEquity>
    <wt:TemporaryStockholdersEquity contextRef="c37" decimals="-3" id="ixv-26667" unitRef="usd">263199000</wt:TemporaryStockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c28"
      decimals="INF"
      id="ixv-26668"
      unitRef="shares">1369</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c28" decimals="-3" id="ixv-26669" unitRef="usd">13000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c29" decimals="-3" id="ixv-26670" unitRef="usd">-13000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c28"
      decimals="INF"
      id="ixv-26671"
      unitRef="shares">5121</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c28" decimals="-3" id="ixv-26672" unitRef="usd">51000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c29" decimals="-3" id="ixv-26673" unitRef="usd">34455000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c20" decimals="-3" id="ixv-26674" unitRef="usd">34506000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c28"
      decimals="INF"
      id="ixv-26675"
      unitRef="shares">143</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c28" decimals="-3" id="ixv-26676" unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c29" decimals="-3" id="ixv-26677" unitRef="usd">813000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c20" decimals="-3" id="ixv-26678" unitRef="usd">815000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c29" decimals="-3" id="ixv-26679" unitRef="usd">9998000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c20" decimals="-3" id="ixv-26680" unitRef="usd">9998000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c30" decimals="-3" id="ixv-26681" unitRef="usd">-420000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c20" decimals="-3" id="ixv-26682" unitRef="usd">-420000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:Dividends contextRef="c31" decimals="-3" id="ixv-26683" unitRef="usd">19459000</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c20" decimals="-3" id="ixv-26684" unitRef="usd">19459000</us-gaap:Dividends>
    <us-gaap:NetIncomeLoss contextRef="c31" decimals="-3" id="ixv-26685" unitRef="usd">49797000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c20" decimals="-3" id="ixv-26686" unitRef="usd">49797000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c33"
      decimals="INF"
      id="ixv-26687"
      unitRef="shares">145107</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c33" decimals="-3" id="ixv-26688" unitRef="usd">1451000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c34" decimals="-3" id="ixv-26689" unitRef="usd">289736000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c35" decimals="-3" id="ixv-26690" unitRef="usd">682000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c36" decimals="-3" id="ixv-26691" unitRef="usd">-22445000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c37" decimals="-3" id="ixv-26692" unitRef="usd">269424000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c39"
      decimals="INF"
      id="ixv-26693"
      unitRef="shares">2003</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c39" decimals="-3" id="ixv-26694" unitRef="usd">20000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c40" decimals="-3" id="ixv-26695" unitRef="usd">-20000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c39"
      decimals="INF"
      id="ixv-26696"
      unitRef="shares">593</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c39" decimals="-3" id="ixv-26697" unitRef="usd">6000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c40" decimals="-3" id="ixv-26698" unitRef="usd">3412000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c19" decimals="-3" id="ixv-26699" unitRef="usd">3418000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c40" decimals="-3" id="ixv-26700" unitRef="usd">10385000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c19" decimals="-3" id="ixv-26701" unitRef="usd">10385000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c41" decimals="-3" id="ixv-26702" unitRef="usd">-2102000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c19" decimals="-3" id="ixv-26703" unitRef="usd">-2102000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:Dividends contextRef="c40" decimals="-3" id="ixv-26704" unitRef="usd">4842000</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c42" decimals="-3" id="ixv-26705" unitRef="usd">14520000</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c19" decimals="-3" id="ixv-26706" unitRef="usd">19362000</us-gaap:Dividends>
    <us-gaap:NetIncomeLoss contextRef="c42" decimals="-3" id="ixv-26707" unitRef="usd">50684000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c19" decimals="-3" id="ixv-26708" unitRef="usd">50684000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c44"
      decimals="INF"
      id="ixv-26709"
      unitRef="shares">146517</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c44" decimals="-3" id="ixv-26710" unitRef="usd">1465000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c45" decimals="-3" id="ixv-26711" unitRef="usd">291847000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c46" decimals="-3" id="ixv-26712" unitRef="usd">-1420000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c47" decimals="-3" id="ixv-26713" unitRef="usd">13719000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c6" decimals="-3" id="ixv-26714" unitRef="usd">305611000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c49"
      decimals="INF"
      id="ixv-26715"
      unitRef="shares">3412</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c49" decimals="-3" id="ixv-26716" unitRef="usd">34000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c50" decimals="-3" id="ixv-26717" unitRef="usd">-34000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c49"
      decimals="INF"
      id="ixv-26718"
      unitRef="shares">1037</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c49" decimals="-3" id="ixv-26719" unitRef="usd">10000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c50" decimals="-3" id="ixv-26720" unitRef="usd">35000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c0" decimals="-3" id="ixv-26721" unitRef="usd">45000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="c48"
      decimals="INF"
      id="ixv-26722"
      unitRef="shares">13</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c50" decimals="-3" id="ixv-26723" unitRef="usd">86801000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="c0" decimals="-3" id="ixv-26724" unitRef="usd">86801000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="c48"
      decimals="INF"
      id="ixv-26725"
      unitRef="shares">-13</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c50" decimals="-3" id="ixv-26726" unitRef="usd">-78835000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c0" decimals="-3" id="ixv-26727" unitRef="usd">-78835000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c49"
      decimals="INF"
      id="ixv-26728"
      unitRef="shares">636</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c49" decimals="-3" id="ixv-26729" unitRef="usd">6000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c50" decimals="-3" id="ixv-26730" unitRef="usd">3564000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c0" decimals="-3" id="ixv-26731" unitRef="usd">3570000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c50" decimals="-3" id="ixv-26732" unitRef="usd">16190000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c0" decimals="-3" id="ixv-26733" unitRef="usd">16190000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c51" decimals="-3" id="ixv-26734" unitRef="usd">872000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c0" decimals="-3" id="ixv-26735" unitRef="usd">872000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:Dividends contextRef="c52" decimals="-3" id="ixv-26736" unitRef="usd">20524000</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c0" decimals="-3" id="ixv-26737" unitRef="usd">20524000</us-gaap:Dividends>
    <us-gaap:NetIncomeLoss contextRef="c52" decimals="-3" id="ixv-26738" unitRef="usd">102546000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-26739" unitRef="usd">102546000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="c54"
      decimals="INF"
      id="ixv-26740"
      unitRef="shares">150330</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c54" decimals="-3" id="ixv-26741" unitRef="usd">1503000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c55" decimals="-3" id="ixv-26742" unitRef="usd">312440000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c56" decimals="-3" id="ixv-26743" unitRef="usd">-548000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c57" decimals="-3" id="ixv-26744" unitRef="usd">95741000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c5" decimals="-3" id="ixv-26745" unitRef="usd">409136000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-26746" unitRef="usd">102546000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c19" decimals="-3" id="ixv-26747" unitRef="usd">50684000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c20" decimals="-3" id="ixv-26748" unitRef="usd">49797000</us-gaap:NetIncomeLoss>
    <wt:GainLossFromChangeInDeferredConsideration contextRef="c0" decimals="-3" id="ixv-26749" unitRef="usd">61953000</wt:GainLossFromChangeInDeferredConsideration>
    <wt:GainLossFromChangeInDeferredConsideration contextRef="c19" decimals="-3" id="ixv-26750" unitRef="usd">27765000</wt:GainLossFromChangeInDeferredConsideration>
    <wt:GainLossFromChangeInDeferredConsideration contextRef="c20" decimals="-3" id="ixv-26751" unitRef="usd">2018000</wt:GainLossFromChangeInDeferredConsideration>
    <wt:AdvisoryFeesReceivedInGold contextRef="c0" decimals="-3" id="ixv-26752" unitRef="usd">49400000</wt:AdvisoryFeesReceivedInGold>
    <wt:AdvisoryFeesReceivedInGold contextRef="c19" decimals="-3" id="ixv-26753" unitRef="usd">57290000</wt:AdvisoryFeesReceivedInGold>
    <wt:AdvisoryFeesReceivedInGold contextRef="c20" decimals="-3" id="ixv-26754" unitRef="usd">74970000</wt:AdvisoryFeesReceivedInGold>
    <us-gaap:ShareBasedCompensation contextRef="c0" decimals="-3" id="ixv-26755" unitRef="usd">16190000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c19" decimals="-3" id="ixv-26756" unitRef="usd">10385000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c20" decimals="-3" id="ixv-26757" unitRef="usd">9998000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c0" decimals="-3" id="ixv-26758" unitRef="usd">-9721000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GoodwillImpairmentLoss contextRef="c0" decimals="-3" id="ixv-26759" unitRef="usd">7942000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c20" decimals="-3" id="ixv-26760" unitRef="usd">16156000</us-gaap:GoodwillImpairmentLoss>
    <wt:ContractualGoldPayments contextRef="c0" decimals="-3" id="ixv-26761" unitRef="usd">6069000</wt:ContractualGoldPayments>
    <wt:ContractualGoldPayments contextRef="c19" decimals="-3" id="ixv-26762" unitRef="usd">17108000</wt:ContractualGoldPayments>
    <wt:ContractualGoldPayments contextRef="c20" decimals="-3" id="ixv-26763" unitRef="usd">17096000</wt:ContractualGoldPayments>
    <wt:AmortizationOfIssuanceCostsConvertibleNotes contextRef="c0" decimals="-3" id="ixv-26764" unitRef="usd">1817000</wt:AmortizationOfIssuanceCostsConvertibleNotes>
    <wt:AmortizationOfIssuanceCostsConvertibleNotes contextRef="c19" decimals="-3" id="ixv-26765" unitRef="usd">2592000</wt:AmortizationOfIssuanceCostsConvertibleNotes>
    <wt:AmortizationOfIssuanceCostsConvertibleNotes contextRef="c20" decimals="-3" id="ixv-26766" unitRef="usd">2187000</wt:AmortizationOfIssuanceCostsConvertibleNotes>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c0" decimals="-3" id="ixv-26767" unitRef="usd">1285000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c19" decimals="-3" id="ixv-26768" unitRef="usd">963000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c20" decimals="-3" id="ixv-26769" unitRef="usd">1950000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:DepreciationAndAmortization contextRef="c0" decimals="-3" id="ixv-26770" unitRef="usd">872000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c19" decimals="-3" id="ixv-26771" unitRef="usd">262000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c20" decimals="-3" id="ixv-26772" unitRef="usd">738000</us-gaap:DepreciationAndAmortization>
    <us-gaap:UnrealizedGainLossOnInvestments contextRef="c0" decimals="-3" id="ixv-26773" unitRef="usd">-517000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments contextRef="c19" decimals="-3" id="ixv-26774" unitRef="usd">-16516000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments contextRef="c20" decimals="-3" id="ixv-26775" unitRef="usd">-3715000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c0" decimals="-3" id="ixv-26776" unitRef="usd">-481000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c19" decimals="-3" id="ixv-26777" unitRef="usd">-1296000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c20" decimals="-3" id="ixv-26778" unitRef="usd">316000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:InterestExpenseDebt contextRef="c0" decimals="-3" id="ixv-26779" unitRef="usd">297000</us-gaap:InterestExpenseDebt>
    <us-gaap:RealizedInvestmentGainsLosses contextRef="c0" decimals="-3" id="ixv-26780" unitRef="usd">-242000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal contextRef="c20" decimals="-3" id="ixv-26781" unitRef="usd">787000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c19" decimals="-3" id="ixv-26782" unitRef="usd">1984000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c20" decimals="-3" id="ixv-26783" unitRef="usd">272000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c0" decimals="-3" id="ixv-26784" unitRef="usd">6212000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c19" decimals="-3" id="ixv-26785" unitRef="usd">720000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c20" decimals="-3" id="ixv-26786" unitRef="usd">3506000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="c0" decimals="-3" id="ixv-26787" unitRef="usd">518000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="c19" decimals="-3" id="ixv-26788" unitRef="usd">808000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="c20" decimals="-3" id="ixv-26789" unitRef="usd">139000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <wt:IncreaseDecreaseInGoldAndOtherPreciousMetals contextRef="c0" decimals="-3" id="ixv-26790" unitRef="usd">-42150000</wt:IncreaseDecreaseInGoldAndOtherPreciousMetals>
    <wt:IncreaseDecreaseInGoldAndOtherPreciousMetals contextRef="c19" decimals="-3" id="ixv-26791" unitRef="usd">-41847000</wt:IncreaseDecreaseInGoldAndOtherPreciousMetals>
    <wt:IncreaseDecreaseInGoldAndOtherPreciousMetals contextRef="c20" decimals="-3" id="ixv-26792" unitRef="usd">-57417000</wt:IncreaseDecreaseInGoldAndOtherPreciousMetals>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c0" decimals="-3" id="ixv-26793" unitRef="usd">-281000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c19" decimals="-3" id="ixv-26794" unitRef="usd">309000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c20" decimals="-3" id="ixv-26795" unitRef="usd">394000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <wt:IncreaseDecreaseInFundManagementAndAdministrationPayable contextRef="c0" decimals="-3" id="ixv-26796" unitRef="usd">5837000</wt:IncreaseDecreaseInFundManagementAndAdministrationPayable>
    <wt:IncreaseDecreaseInFundManagementAndAdministrationPayable contextRef="c19" decimals="-3" id="ixv-26797" unitRef="usd">3723000</wt:IncreaseDecreaseInFundManagementAndAdministrationPayable>
    <wt:IncreaseDecreaseInFundManagementAndAdministrationPayable contextRef="c20" decimals="-3" id="ixv-26798" unitRef="usd">1348000</wt:IncreaseDecreaseInFundManagementAndAdministrationPayable>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c0" decimals="-3" id="ixv-26799" unitRef="usd">1209000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c19" decimals="-3" id="ixv-26800" unitRef="usd">4485000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c20" decimals="-3" id="ixv-26801" unitRef="usd">10242000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable contextRef="c0" decimals="-3" id="ixv-26802" unitRef="usd">2260000</us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable contextRef="c19" decimals="-3" id="ixv-26803" unitRef="usd">-2308000</us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable contextRef="c20" decimals="-3" id="ixv-26804" unitRef="usd">3101000</us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable>
    <wt:IncreaseDecreaseInOperatingLeaseLiabilities contextRef="c0" decimals="-3" id="ixv-26805" unitRef="usd">1284000</wt:IncreaseDecreaseInOperatingLeaseLiabilities>
    <wt:IncreaseDecreaseInOperatingLeaseLiabilities contextRef="c19" decimals="-3" id="ixv-26806" unitRef="usd">965000</wt:IncreaseDecreaseInOperatingLeaseLiabilities>
    <wt:IncreaseDecreaseInOperatingLeaseLiabilities contextRef="c20" decimals="-3" id="ixv-26807" unitRef="usd">15560000</wt:IncreaseDecreaseInOperatingLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities contextRef="c0" decimals="-3" id="ixv-26808" unitRef="usd">6213000</us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities contextRef="c19" decimals="-3" id="ixv-26809" unitRef="usd">-33000</us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities contextRef="c20" decimals="-3" id="ixv-26810" unitRef="usd">-1097000</us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c0" decimals="-3" id="ixv-26811" unitRef="usd">85600000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c19" decimals="-3" id="ixv-26812" unitRef="usd">55087000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c20" decimals="-3" id="ixv-26813" unitRef="usd">75318000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <wt:PurchaseOfFinancialInstrumentsOwnedAtFairValue contextRef="c0" decimals="-3" id="ixv-26814" unitRef="usd">57364000</wt:PurchaseOfFinancialInstrumentsOwnedAtFairValue>
    <wt:PurchaseOfFinancialInstrumentsOwnedAtFairValue contextRef="c19" decimals="-3" id="ixv-26815" unitRef="usd">67734000</wt:PurchaseOfFinancialInstrumentsOwnedAtFairValue>
    <wt:PurchaseOfFinancialInstrumentsOwnedAtFairValue contextRef="c20" decimals="-3" id="ixv-26816" unitRef="usd">115526000</wt:PurchaseOfFinancialInstrumentsOwnedAtFairValue>
    <wt:PurchaseOfInvestments contextRef="c0" decimals="-3" id="ixv-26817" unitRef="usd">11228000</wt:PurchaseOfInvestments>
    <wt:PurchaseOfInvestments contextRef="c19" decimals="-3" id="ixv-26818" unitRef="usd">21863000</wt:PurchaseOfInvestments>
    <wt:PurchaseOfInvestments contextRef="c20" decimals="-3" id="ixv-26819" unitRef="usd">5750000</wt:PurchaseOfInvestments>
    <us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment contextRef="c0" decimals="-3" id="ixv-26820" unitRef="usd">2149000</us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment>
    <us-gaap:OtherPaymentsToAcquireBusinesses contextRef="c0" decimals="-3" id="ixv-26821" unitRef="usd">985000</us-gaap:OtherPaymentsToAcquireBusinesses>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c0" decimals="-3" id="ixv-26822" unitRef="usd">113000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c19" decimals="-3" id="ixv-26823" unitRef="usd">220000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c20" decimals="-3" id="ixv-26824" unitRef="usd">293000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <wt:ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue contextRef="c0" decimals="-3" id="ixv-26825" unitRef="usd">123564000</wt:ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue>
    <wt:ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue contextRef="c19" decimals="-3" id="ixv-26826" unitRef="usd">52115000</wt:ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue>
    <wt:ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue contextRef="c20" decimals="-3" id="ixv-26827" unitRef="usd">19441000</wt:ProceedsFromTheSaleOfFinancialInstrumentsOwnedAtFairValue>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments contextRef="c0" decimals="-3" id="ixv-26828" unitRef="usd">28818000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested contextRef="c0" decimals="-3" id="ixv-26829" unitRef="usd">1477000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested contextRef="c20" decimals="-3" id="ixv-26830" unitRef="usd">2360000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <wt:ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity contextRef="c0" decimals="-3" id="ixv-26831" unitRef="usd">29000</wt:ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity>
    <wt:ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity contextRef="c19" decimals="-3" id="ixv-26832" unitRef="usd">45000</wt:ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity>
    <wt:ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity contextRef="c20" decimals="-3" id="ixv-26833" unitRef="usd">136000</wt:ProceedsFromHeldtomaturitySecuritiesMaturingOrCalledPriorToMaturity>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c0" decimals="-3" id="ixv-26834" unitRef="usd">82049000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c19" decimals="-3" id="ixv-26835" unitRef="usd">-37657000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c20" decimals="-3" id="ixv-26836" unitRef="usd">-99632000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfNotesPayable contextRef="c0" decimals="-3" id="ixv-26837" unitRef="usd">-184272000</us-gaap:ProceedsFromRepaymentsOfNotesPayable>
    <wt:PaymentOfDeferredConsideration contextRef="c0" decimals="-3" id="ixv-26838" unitRef="usd">50005000</wt:PaymentOfDeferredConsideration>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock contextRef="c0" decimals="-3" id="ixv-26839" unitRef="usd">-40000000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:PaymentsOfDividends contextRef="c0" decimals="-3" id="ixv-26840" unitRef="usd">20144000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends contextRef="c19" decimals="-3" id="ixv-26841" unitRef="usd">19362000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends contextRef="c20" decimals="-3" id="ixv-26842" unitRef="usd">19459000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c0" decimals="-3" id="ixv-26843" unitRef="usd">3570000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c19" decimals="-3" id="ixv-26844" unitRef="usd">3418000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c20" decimals="-3" id="ixv-26845" unitRef="usd">34506000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <wt:PaymentOfConvertibleNotesIssuanceCosts contextRef="c0" decimals="-3" id="ixv-26846" unitRef="usd">3548000</wt:PaymentOfConvertibleNotesIssuanceCosts>
    <wt:PaymentOfConvertibleNotesIssuanceCosts contextRef="c20" decimals="-3" id="ixv-26847" unitRef="usd">4297000</wt:PaymentOfConvertibleNotesIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c0" decimals="-3" id="ixv-26848" unitRef="usd">97000</us-gaap:PaymentsOfStockIssuanceCosts>
    <wt:ProceedsFromIssuanceOfConvertibleNotes contextRef="c0" decimals="-3" id="ixv-26849" unitRef="usd">130000000</wt:ProceedsFromIssuanceOfConvertibleNotes>
    <wt:ProceedsFromIssuanceOfConvertibleNotes contextRef="c20" decimals="-3" id="ixv-26850" unitRef="usd">150000000</wt:ProceedsFromIssuanceOfConvertibleNotes>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c20" decimals="-3" id="ixv-26851" unitRef="usd">815000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c0" decimals="-3" id="ixv-26852" unitRef="usd">-171636000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c19" decimals="-3" id="ixv-26853" unitRef="usd">-22780000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c20" decimals="-3" id="ixv-26854" unitRef="usd">92553000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c0" decimals="-3" id="ixv-26855" unitRef="usd">1191000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c19" decimals="-3" id="ixv-26856" unitRef="usd">-3258000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c20" decimals="-3" id="ixv-26857" unitRef="usd">-955000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c0" decimals="-3" id="ixv-26858" unitRef="usd">-2796000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c19" decimals="-3" id="ixv-26859" unitRef="usd">-8608000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c20" decimals="-3" id="ixv-26860" unitRef="usd">67284000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c6" decimals="-3" id="ixv-26861" unitRef="usd">132101000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c37" decimals="-3" id="ixv-26862" unitRef="usd">140709000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c26" decimals="-3" id="ixv-26863" unitRef="usd">73425000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c5" decimals="-3" id="ixv-26864" unitRef="usd">129305000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c6" decimals="-3" id="ixv-26865" unitRef="usd">132101000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c37" decimals="-3" id="ixv-26866" unitRef="usd">140709000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaidNet contextRef="c0" decimals="-3" id="ixv-26867" unitRef="usd">16156000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c19" decimals="-3" id="ixv-26868" unitRef="usd">12500000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c20" decimals="-3" id="ixv-26869" unitRef="usd">8456000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:InterestPaidNet contextRef="c0" decimals="-3" id="ixv-26870" unitRef="usd">10709000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c19" decimals="-3" id="ixv-26871" unitRef="usd">12313000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c20" decimals="-3" id="ixv-26872" unitRef="usd">9898000</us-gaap:InterestPaidNet>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="c0" id="ixv-18851">&lt;p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;1. Organization and Description of Business&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;WisdomTree, Inc., through its global subsidiaries (collectively, &#x201c;WisdomTree&#x201d; or the &#x201c;Company&#x201d;), is a global financial innovator, offering a well&lt;span class="nobreak"&gt;-diversified&lt;/span&gt; suite of exchange&lt;span class="nobreak"&gt;-traded&lt;/span&gt; products (&#x201c;ETPs&#x201d;), models, solutions and products leveraging blockchain technology. Building on its heritage of innovation, the Company is also developing and has launched next&lt;span class="nobreak"&gt;-generation&lt;/span&gt; digital products, services and structures, including digital or blockchain&lt;span class="nobreak"&gt;-enabled&lt;/span&gt; mutual funds (&#x201c;Digital Funds&#x201d;) and tokenized assets, as well as its blockchain&lt;span class="nobreak"&gt;-native&lt;/span&gt; digital wallet, WisdomTree Prime. The Company has the following wholly&lt;span class="nobreak"&gt;-owned&lt;/span&gt; operating subsidiaries:&lt;/p&gt;
		&lt;p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"&gt;&lt;span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;"&gt;&#x2022;&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;WisdomTree Asset Management, Inc.&lt;/span&gt; is a New&#160;York based investment adviser registered with the SEC, providing investment advisory and other management services to the WisdomTree Trust (&#x201c;WTT&#x201d;) and WisdomTree exchange&lt;span class="nobreak"&gt;-traded&lt;/span&gt; funds (&#x201c;ETFs&#x201d;). The WisdomTree ETFs are issued in the U.S.&#160;by WTT.&#160;WTT is a non&lt;span class="nobreak"&gt;-consolidated&lt;/span&gt; Delaware statutory trust registered with the SEC as an open&lt;span class="nobreak"&gt;-end&lt;/span&gt; management investment company. The Company has licensed to WTT the use of certain of its own indexes on an exclusive basis for the WisdomTree ETFs in the U.S.&lt;/p&gt;
		&lt;p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"&gt;&lt;span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;"&gt;&#x2022;&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;WisdomTree Management Jersey Limited &lt;/span&gt;(&#x201c;ManJer&#x201d;) is a Jersey based management company providing management services to seven issuers (the &#x201c;ManJer Issuers&#x201d;) in respect of the ETPs issued and listed by the ManJer Issuers covering commodity, currency, cryptocurrency and leveraged&lt;span class="nobreak"&gt;-and-inverse&lt;/span&gt; strategies.&lt;/p&gt;
		&lt;p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"&gt;&lt;span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;"&gt;&#x2022;&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;WisdomTree Multi Asset Management Limited&lt;/span&gt; (&#x201c;WTMAML&#x201d;) is a Jersey based management company providing management services to WisdomTree Multi Asset Issuer PLC (&#x201c;WMAI&#x201d;) in respect of the ETPs issued by WMAI.&#160;WMAI is a non&lt;span class="nobreak"&gt;-consolidated&lt;/span&gt; public limited company domiciled in Ireland.&lt;/p&gt;
		&lt;p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"&gt;&lt;span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;"&gt;&#x2022;&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;WisdomTree Management Limited&lt;/span&gt; (&#x201c;WML&#x201d;) is an Ireland based management company providing management services to WisdomTree Issuer ICAV (&#x201c;WTICAV&#x201d;) in respect of the WisdomTree UCITS ETFs issued by WTICAV.&#160;WTICAV is a non&lt;span class="nobreak"&gt;-consolidated&lt;/span&gt; public limited company domiciled in Ireland.&lt;/p&gt;
		&lt;p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"&gt;&lt;span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;"&gt;&#x2022;&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;WisdomTree UK Limited&lt;/span&gt; (&#x201c;WTUK&#x201d;) is a U.K. based company registered with the Financial Conduct Authority currently providing distribution and support services to ManJer, WTMAML and WML.&lt;/p&gt;
		&lt;p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"&gt;&lt;span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;"&gt;&#x2022;&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;WisdomTree Europe Limited&lt;/span&gt; is a U.K. based company which is the legacy distributor of the WMAI ETPs and WisdomTree UCITS ETFs. These services are now provided directly by WTUK.&#160;WisdomTree Europe Limited is no longer regulated and does not provide any regulated services.&lt;/p&gt;
		&lt;p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"&gt;&lt;span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;"&gt;&#x2022;&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;WisdomTree Ireland Limited&lt;/span&gt; is an Ireland based company authorized by the Central Bank of Ireland providing distribution services to ManJer, WTMAML and WML.&lt;/p&gt;
		&lt;p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"&gt;&lt;span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;"&gt;&#x2022;&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;WisdomTree Digital Commodity Services, LLC&lt;/span&gt; is a New&#160;York based company that serves as the sponsor of the WisdomTree Bitcoin Fund, which is currently effective with the SEC.&#160;The WisdomTree Bitcoin Fund is an exchange&lt;span class="nobreak"&gt;-traded&lt;/span&gt; fund that issues common shares of beneficial interest and is listed on the Cboe BZX Exchange, Inc. The WisdomTree Bitcoin Fund provides exposure to the spot price of bitcoin.&lt;/p&gt;
		&lt;p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"&gt;&lt;span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;"&gt;&#x2022;&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;WisdomTree Digital Management, Inc.&lt;/span&gt; (&#x201c;WT Digital Management&#x201d;) is a New&#160;York based investment adviser registered with the SEC, providing investment advisory and other management services to the WisdomTree Digital Trust (&#x201c;WTDT&#x201d;) and WisdomTree Digital Funds. The WisdomTree Digital Funds are issued in the U.S.&#160;by WTDT.&#160;WTDT is a non&lt;span class="nobreak"&gt;-consolidated&lt;/span&gt; Delaware statutory trust registered with the SEC as an open&lt;span class="nobreak"&gt;-end&lt;/span&gt; management investment company. Each Digital Fund uses blockchain technology to maintain a secondary record of its shares on one or more blockchains (e.g., Stellar or Ethereum), but does not directly or indirectly invest in any assets that rely on blockchain technology, such as cryptocurrencies.&lt;/p&gt;
		&lt;p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:6pt;"&gt;&lt;span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;"&gt;&#x2022;&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;WisdomTree Digital Movement, Inc. &lt;/span&gt;(&#x201c;WT Digital Movement&#x201d;) is a New&#160;York based company operating as a money services business registered with the Financial Crimes Enforcement Network. WT Digital Movement has obtained and is seeking additional state money transmitter licenses to operate a platform for the purchase, sale and exchange of tokenized assets, while also providing blockchain&lt;span class="nobreak"&gt;-native&lt;/span&gt; digital wallet services through WisdomTree Prime to facilitate such activity.&lt;/p&gt;&lt;p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-top:6pt;"&gt;&lt;span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;"&gt;&#x2022;&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;WisdomTree Securities, Inc. &lt;/span&gt;is a New&#160;York based limited purpose broker&lt;span class="nobreak"&gt;-dealer&lt;/span&gt; (i.e., mutual fund retailer), facilitating transactions in WisdomTree Digital Funds.&lt;/p&gt;
		&lt;p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"&gt;&lt;span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;"&gt;&#x2022;&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;WisdomTree Transfers, Inc. &lt;/span&gt;is a New&#160;York based transfer agent registered with the SEC, providing transfer agency and registrar services for the Digital Funds. The transfer agent maintains the official record of share ownership in book entry form and reconciles the official record with the secondary record of ownership of shares on one or more blockchains.&lt;/p&gt;
		&lt;p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-top:6pt;"&gt;&lt;span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;"&gt;&#x2022;&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;WisdomTree Digital Trust Company, LLC&lt;/span&gt; is a New&#160;York based limited liability trust company that has been formed to operate as a limited purpose trust company under New&#160;York Banking Law upon receiving a charter from the New&#160;York State Department of Financial Services.&lt;/p&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c0" id="ixv-18929">&lt;p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2. Significant Accounting Policies&lt;/span&gt;&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Basis of Presentation&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;These consolidated financial statements have been prepared in conformity with U.S.&#160;generally accepted accounting principles (&#x201c;GAAP&#x201d;) and in the opinion of management reflect all adjustments, consisting of only normal recurring adjustments, necessary for a fair presentation of the financial statements. The consolidated financial statements include the accounts of the Company&#x2019;s wholly&lt;span class="nobreak"&gt;-owned&lt;/span&gt; subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Consolidation&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company consolidates entities in which it has a controlling financial interest. The Company determines whether it has a controlling financial interest in an entity by first evaluating whether the entity is a voting interest entity (&#x201c;VOE&#x201d;) or a variable interest entity (&#x201c;VIE&#x201d;). The usual condition for a controlling financial interest in a VOE is ownership of a majority voting interest. If the Company has a majority voting interest in a VOE, the entity is consolidated. The Company has a controlling financial interest in a VIE when the Company has a variable interest that provides it with (i)&#160;the power to direct the activities of the VIE that most significantly impact the VIE&#x2019;s economic performance and (ii)&#160;the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company reassesses its evaluation of whether an entity is a VOE or VIE when certain reconsideration events occur.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Segment and Geographic Information&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company, through its subsidiaries in the U.S.&#160;and Europe, conducts business as a single operating segment as an ETP sponsor and asset manager which is based upon the Company&#x2019;s current organizational and management structure, as well as information used by the chief operating decision maker to allocate resources and other factors.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Assets and liabilities of subsidiaries whose functional currency is not the U.S.&#160;dollar are translated based on the end of period exchange rates from local currency to U.S.&#160;dollars. Results of operations are translated at the average exchange rates in effect during the period. The impact of the foreign currency translation adjustment is included in the Consolidated Statements of Comprehensive Income as a component of other comprehensive income/(loss).&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The preparation of the Company&#x2019;s consolidated financial statements in conformity with U.S.&#160;GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the balance sheet dates and the reported amounts of revenues and expenses for the periods presented. Actual results could differ materially from those estimates.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company earns substantially all of its revenue in the form of advisory fees from its ETPs and recognizes this revenue over time, as the performance obligation is satisfied. Advisory fees are based on a percentage of the ETPs&#x2019; average daily net assets. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice.&lt;/p&gt;&lt;div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;"&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Contractual Gold Payments&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Contractual gold payments are measured and paid monthly based upon the average daily spot price of gold (Note&#160;9). The Company&#x2019;s obligation to continue making these payments terminated on May&#160;10, 2023.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Marketing and Advertising&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Marketing and advertising costs, including media advertising and production costs, are expensed when incurred.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Depreciation and Amortization&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Depreciation and amortization is provided for using the straight&lt;span class="nobreak"&gt;-line&lt;/span&gt; method over the estimated useful lives of the related assets as follows:&lt;/p&gt;
		&lt;table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;"&gt;


				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1" style="width: 74.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

						&lt;p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;Equipment&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 23.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:right;"&gt;3&#160;to&#160;5 years&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1" style="width: 74.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;Internally&lt;span class="nobreak"&gt;-developed&lt;/span&gt; software&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 23.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:right;"&gt;3&#160;years&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The assets listed above are recorded at cost less accumulated depreciation and amortization.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Stock-Based Awards&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Accounting for stock&lt;span class="nobreak"&gt;-based&lt;/span&gt; compensation requires the measurement and recognition of compensation expense for all equity awards based on estimated fair values. Stock&lt;span class="nobreak"&gt;-based&lt;/span&gt; compensation is measured based on the grant&lt;span class="nobreak"&gt;-date&lt;/span&gt; fair value of the award and is amortized over the relevant service period. Forfeitures are recognized when they occur.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Third-Party Distribution Fees&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company pays a percentage of its advisory fee revenues based on incremental growth in assets under management (&#x201c;AUM&#x201d;), subject to caps or minimums, to marketing agents to sell WisdomTree ETPs and for including WisdomTree ETPs on third&lt;span class="nobreak"&gt;-party&lt;/span&gt; customer platforms and recognizes these expenses as incurred.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company considers all highly liquid investments with an original maturity of 90&#160;days or less at the time of purchase to be classified as cash equivalents. The Company maintains deposits with financial institutions in an amount that is in excess of federally insured limits.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Accounts Receivable&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Accounts receivable are customer and other obligations due under normal trade terms. The Company measures credit losses, if any, by applying historical loss rates, adjusted for current conditions and reasonable and supportable forecasts to amounts outstanding using the aging method.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company performs a review for the impairment of long&lt;span class="nobreak"&gt;-lived&lt;/span&gt; assets when events or changes in circumstances indicate that the estimated undiscounted future cash flows expected to be generated by the assets are less than their carrying amounts or when other events occur which may indicate that the carrying amount of an asset may not be recoverable.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Financial Instruments Owned and Financial Instruments Sold, but Not yet Purchased (at Fair Value)&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Financial instruments owned and financial instruments sold, but not yet purchased are financial instruments classified as either trading or available&lt;span class="nobreak"&gt;-for-sale&lt;/span&gt; (&#x201c;AFS&#x201d;). These financial instruments are recorded on their trade date and are measured at fair value. All equity instruments that have readily determinable fair values are classified by the Company as trading. Debt instruments are classified based primarily on the Company&#x2019;s intent to hold or sell the instrument. Changes in the fair value of debt instruments classified as trading and AFS are reported in other income/(expenses) and other comprehensive income, respectively, in the period the change occurs. Debt instruments classified as AFS are assessed for impairment on a quarterly basis and an estimate for credit loss is provided when the fair value of the AFS debt instrument is below its amortized cost basis. Credit&lt;span class="nobreak"&gt;-related&lt;/span&gt; impairments are recognized in earnings with a corresponding adjustment to the instrument&#x2019;s amortized cost basis if the Company intends to sell the impaired AFS debt instrument or it is more likely than not the Company will be required to sell the instrument before recovering its amortized cost basis. Other credit&lt;span class="nobreak"&gt;-related&lt;/span&gt; impairments are recognized as an allowance with a corresponding adjustment to earnings. Impairments resulting from noncredit&lt;span class="nobreak"&gt;-related&lt;/span&gt; factors are recognized in other comprehensive income. Amounts recorded in other comprehensive income are reclassified into earnings upon sale of the AFS debt instrument using the specific identification method.&lt;/p&gt;
		&lt;/div&gt;&lt;div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;"&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Securities Held-to-Maturity&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company accounts for certain of its securities as held&lt;span class="nobreak"&gt;-to-maturity&lt;/span&gt; on a trade date basis, which are recorded at amortized cost. For held&lt;span class="nobreak"&gt;-to-maturity&lt;/span&gt; securities, the Company has the intent and ability to hold these securities to maturity and it is not more&lt;span class="nobreak"&gt;-likely-than-not&lt;/span&gt; that the Company will be required to sell these securities before recovery of their amortized cost bases, which may be maturity. Held&lt;span class="nobreak"&gt;-to-maturity&lt;/span&gt; securities are placed on non&lt;span class="nobreak"&gt;-accrual&lt;/span&gt; status when the Company is in receipt of information indicating collection of interest is doubtful. Cash received on held&lt;span class="nobreak"&gt;-to-maturity&lt;/span&gt; securities placed on non&lt;span class="nobreak"&gt;-accrual&lt;/span&gt; status is recognized on a cash basis as interest income if and when received.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company reviews its portfolio of held&lt;span class="nobreak"&gt;-to-maturity&lt;/span&gt; securities for impairment on a quarterly basis, recognizing an allowance, if any, by applying an estimated loss rate after consideration for the nature of collateral securing the financial asset as well as potential future changes in collateral values and historical loss information for financial assets secured with similar collateral.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Investments in pass&lt;span class="nobreak"&gt;-through&lt;/span&gt; government&lt;span class="nobreak"&gt;-sponsored&lt;/span&gt; enterprises (&#x201c;GSEs&#x201d;) are determined to have an estimated loss rate of zero due to an implicit U.S.&#160;government guarantee.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Investments&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company accounts for equity investments that do not have a readily determinable fair value under the measurement alternative prescribed in Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic&#160;321, &lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;Investments&#160;&#x2013;&#160;Equity Securities &lt;/span&gt;(&#x201c;ASC&#160;321&#x201d;), to the extent such investments are not subject to consolidation or the equity method. Under the measurement alternative, these financial instruments are carried at cost, less any impairment (assessed quarterly), plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. In addition, income is recognized when dividends are received only to the extent they are distributed from net accumulated earnings of the investee. Otherwise, such distributions are considered returns of investment and are recorded as a reduction of the cost of the investment.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Investments in debt instruments are accounted for at fair value, with changes in fair value reported in other income/(expenses).&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Goodwill&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Goodwill is the excess of the purchase price over the fair values of the identifiable net assets at the acquisition date. The Company tests goodwill for impairment at least annually and at the time of a triggering event requiring re&lt;span class="nobreak"&gt;-evaluation&lt;/span&gt;, if one were to occur. Goodwill is considered impaired when the estimated fair value of the reporting unit that was allocated the goodwill is less than its carrying value. If the estimated fair value of such reporting unit is less than its carrying value, goodwill impairment is recognized based on that difference, not to exceed the carrying amount of goodwill. A reporting unit is an operating segment or a component of an operating segment provided that the component constitutes a business for which discrete financial information is available and management regularly reviews the operating results of that component.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Goodwill is allocated to the Company&#x2019;s U.S.&#160;business and European business components. For impairment testing purposes, these components are aggregated as a single reporting unit as they fall under the same operating segment and have similar economic characteristics.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Goodwill is assessed for impairment annually on November&#160;30&lt;span class="Superscript" style="vertical-align:super;font-size:58%;"&gt;th&lt;/span&gt;. When performing its goodwill impairment test, the Company considers a qualitative assessment, when appropriate, and a quantitative assessment using the market approach and its market capitalization when determining the fair value of the reporting unit.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Intangible Assets&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Indefinite&lt;span class="nobreak"&gt;-lived&lt;/span&gt; intangible assets are tested for impairment at least annually and are also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indefinite&lt;span class="nobreak"&gt;-lived&lt;/span&gt; intangible assets are impaired if their estimated fair values are less than their carrying values.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Finite&lt;span class="nobreak"&gt;-lived&lt;/span&gt; intangible assets, if any, are amortized over their estimated useful life, which is the period over which the assets are expected to contribute directly or indirectly to the future cash flows of the Company. These intangible assets are tested for impairment at the time of a triggering event, if one were to occur. Finite&lt;span class="nobreak"&gt;-lived&lt;/span&gt; intangible assets may be impaired when the estimated undiscounted future cash flows generated from the assets are less than their carrying amounts.&lt;/p&gt;
		&lt;/div&gt;&lt;div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;"&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company may rely on a qualitative assessment when performing its intangible asset impairment test. Otherwise, the impairment evaluation is performed at the lowest level of reasonably identifiable cash flows independent of other assets. The annual impairment testing date for all of the Company&#x2019;s intangible assets is November&#160;30&lt;span class="Superscript" style="vertical-align:super;font-size:58%;"&gt;th&lt;/span&gt;.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Software Development Costs&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Software development costs incurred after the preliminary project stage is complete are capitalized if it is probable that the project will be completed and the software will be used as intended. Capitalized costs consist of employee compensation costs and fees paid to third parties who are directly involved in the application development efforts and are included in intangible assets, net in the Consolidated Balance Sheets. Such costs are amortized over the estimated useful life of the software on a straight&lt;span class="nobreak"&gt;-line&lt;/span&gt; basis and are included in depreciation and amortization in the Consolidated Statements of Operations. Once the application development stage is complete, additional costs are expensed as incurred.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Leases&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company accounts for its lease obligations in accordance with ASC Topic&#160;842, &lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;Leases &lt;/span&gt;(&#x201c;ASC&#160;842&#x201d;), which requires the recognition of both (i)&#160;a lease liability equal to the present value of the remaining lease payments and (ii)&#160;an offsetting right&lt;span class="nobreak"&gt;-of-use&lt;/span&gt; asset. The remaining lease payments are discounted using the rate implicit in the lease, if known, or otherwise the Company&#x2019;s incremental borrowing rate. After lease commencement, right&lt;span class="nobreak"&gt;-of-use&lt;/span&gt; assets are assessed for impairment and otherwise are amortized over the remaining lease term on a straight&lt;span class="nobreak"&gt;-line&lt;/span&gt; basis. These recognition requirements are not applied to short&lt;span class="nobreak"&gt;-term&lt;/span&gt; leases which are those with a lease term of 12&#160;months or less. Instead, lease payments associated with short&lt;span class="nobreak"&gt;-term&lt;/span&gt; leases are recognized as an expense on a straight&lt;span class="nobreak"&gt;-line&lt;/span&gt; basis over the lease term.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;ASC&#160;842 also provides a practical expedient which allows for consideration in a contract to be accounted for as a single lease component rather than allocated between lease and non&lt;span class="nobreak"&gt;-lease&lt;/span&gt; components. The Company has elected to apply this practical expedient to all lease contracts, where applicable.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Deferred Consideration&#x2014;Gold Payments&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Deferred consideration&#x2014;gold payments represented the present value of an obligation to pay gold to a third party into perpetuity and was measured using forward&lt;span class="nobreak"&gt;-looking&lt;/span&gt; gold prices observed on the CMX exchange, a selected discount rate and perpetual growth rate (Note&#160;9). Changes in the fair value of this obligation were reported as gain on revaluation/termination of deferred consideration&#x2014;gold payments in the Consolidated Statements of Operations.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Convertible Notes&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Convertible notes are carried at amortized cost, net of issuance costs. The Company accounts for convertible instruments as a single liability (applicable to the convertible notes) or equity with no separate accounting for embedded conversion features unless the conversion feature meets the criteria for accounting under the substantial premium model or does not qualify for a derivative scope exception. Interest expense is recognized using the effective interest method and includes amortization of issuance costs over the life of the debt.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Contingencies&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company may be subject to reviews, inspections and investigations by regulatory authorities as well as legal proceedings arising in the ordinary course of business. The Company evaluates the likelihood of an unfavorable outcome of all legal or regulatory proceedings to which it is a party and accrues a loss contingency when the loss is probable and reasonably estimable.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Contingent Payments&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company recognizes a gain on contingent payments when the contingency is resolved and the gain is realized.&lt;/p&gt;
		&lt;/div&gt;&lt;div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;"&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Earnings per Share&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Basic earnings per share (&#x201c;EPS&#x201d;) is computed by dividing net income available to common stockholders by the weighted&lt;span class="nobreak"&gt;-average&lt;/span&gt; number of common shares outstanding for the period. Net income available to common stockholders represents net income of the Company reduced by an allocation of earnings to participating securities. The Series&#160;A non&lt;span class="nobreak"&gt;-voting&lt;/span&gt; convertible preferred stock (Note&#160;11) and unvested share&lt;span class="nobreak"&gt;-based&lt;/span&gt; payment awards that contain non&lt;span class="nobreak"&gt;-forfeitable&lt;/span&gt; rights to dividends or dividend equivalents (whether paid or unpaid) are participating securities and are included in the computation of EPS pursuant to the two&lt;span class="nobreak"&gt;-class&lt;/span&gt; method. Stock&lt;span class="nobreak"&gt;-based&lt;/span&gt; equity awards that do not contain such rights are not deemed participating securities and are included in diluted shares outstanding (if dilutive).&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Diluted EPS is calculated under the treasury stock method and the two&lt;span class="nobreak"&gt;-class&lt;/span&gt; method. The calculation that results in the lowest diluted EPS amount for the common stock is reported in the Company&#x2019;s consolidated financial statements. The treasury stock method includes the dilutive effect of potential common shares including unvested stock&lt;span class="nobreak"&gt;-based&lt;/span&gt; awards, the Series&#160;A non&lt;span class="nobreak"&gt;-voting&lt;/span&gt; convertible preferred stock and the convertible notes, if any. Potential common shares associated with the Series&#160;A non&lt;span class="nobreak"&gt;-voting&lt;/span&gt; convertible preferred stock and the convertible notes are computed under the if&lt;span class="nobreak"&gt;-converted&lt;/span&gt; method. Potential common shares associated with the conversion option embedded in the convertible notes are dilutive when the Company&#x2019;s average stock price exceeds the conversion price.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company accounts for income taxes using the liability method, which requires the determination of deferred tax assets and liabilities based on the differences between the financial and tax bases of assets and liabilities using the enacted tax rates in effect for the year in which differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is more&lt;span class="nobreak"&gt;-likely-than-not&lt;/span&gt; that some portion or all the deferred tax assets will not be realized.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Tax positions are evaluated utilizing a two&lt;span class="nobreak"&gt;-step&lt;/span&gt; process. The Company first determines whether any of its tax positions are more&lt;span class="nobreak"&gt;-likely-than-not&lt;/span&gt; to be sustained upon examination, based solely on the technical merits of the position. Once it is determined that a position meets this recognition threshold, the position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. The Company records interest expense and penalties related to tax expenses as income tax expense.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Global Intangible Low&lt;span class="nobreak"&gt;-Taxed&lt;/span&gt; Income (&#x201c;GILTI&#x201d;) provisions of the Tax Reform Act requires the Company to include in its U.S.&#160;income tax return foreign subsidiary earnings in excess of an allowable return on the foreign subsidiary&#x2019;s tangible assets. An accounting policy election is available to either account for the tax effects of GILTI in the period that is subject to such taxes or to provide deferred taxes for book and tax basis differences that upon reversal may be subject to such taxes. The Company accounts for the tax effects of these provisions in the period that is subject to such tax.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Non&lt;span class="nobreak"&gt;-income&lt;/span&gt; based taxes are recorded as part of other liabilities and other expenses.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;On November&#160;27, 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU&#160;2023&lt;span class="nobreak"&gt;-07&lt;/span&gt;, &lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;Segment&#160;Reporting&#x2014;Improvements to Reportable Segment Disclosures&lt;/span&gt;, which requires public entities to provide disclosures of significant segment expenses and other segment items. The guidance requires public entities to provide in interim periods all disclosures about a reportable segment&#x2019;s profit or loss and assets that are currently required annually and also applies to public entities with a single reportable segment. Entities are permitted to disclose more than one measure of a segment&#x2019;s profit or loss if such measures are used by the chief operating decision&lt;span class="nobreak"&gt;-maker&lt;/span&gt; to allocate resources and assess performance, as long as at least one of those measures is determined in a way that is most consistent with the measurement principles used to measure the corresponding amounts in the consolidated financial statements. The guidance is applied retrospectively to all periods presented in financial statements, unless it is impracticable, and is effective for fiscal&#160;years beginning after December&#160;15, 2023, and for interim periods beginning after December&#160;15, 2024. Early adoption is permitted. This standard will only impact disclosures and will be adopted by the Company on January&#160;1, 2024.&lt;/p&gt;
		&lt;/div&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;On December&#160;13, 2023, the FASB issued ASU&#160;2023&lt;span class="nobreak"&gt;-08&lt;/span&gt;, &lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;Accounting for and Disclosure of Crypto Assets&lt;/span&gt;, which contains final guidance requiring all entities to measure certain crypto assets at fair value each reporting period and to reflect changes from remeasurement in net income. Entities are required to present crypto assets measured at fair value separately from other intangible assets on the balance sheet and present changes from the remeasurement of crypto assets separately from changes in the carrying amounts of other intangible assets in the income statement. Entities are required to provide interim and annual disclosures about the types of crypto assets they hold and any changes in their holdings of crypto assets. The guidance is effective for fiscal&#160;years beginning after December&#160;15, 2024, including interim periods within those fiscal&#160;years. Early adoption is permitted. The Company has determined that this standard will not have a material impact on its financial statements and will early adopt the standard on January&#160;1, 2024.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;On December&#160;14, 2023, the FASB issued ASU&#160;2023&lt;span class="nobreak"&gt;-09&lt;/span&gt;,&lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt; Improvements to Income Tax Disclosures&lt;/span&gt;, which establishes new income tax disclosure requirements in addition to modifying and eliminating certain existing requirements. Under the new guidance, entities must consistently categorize and provide greater disaggregation of information in the rate reconciliation. They must also further disaggregate income taxes paid. The standard is intended to benefit investors by providing more detailed income tax disclosures that would be useful in making capital allocation decisions. The guidance applies to all entities subject to income taxes and is effective for annual periods beginning after December&#160;15, 2024. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively. Early adoption is permitted. The Company plans to adopt this standard on January&#160;1, 2025.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;On January&#160;1, 2021, the Company early adopted ASU&#160;2020&lt;span class="nobreak"&gt;-06&lt;/span&gt;, &lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;Debt&#160;&#x2013;&#160;Debt with Conversion and Other Options &lt;/span&gt;(ASU&#160;2020&lt;span class="nobreak"&gt;-06&lt;/span&gt;) under the modified retrospective approach. Under the ASU, the accounting for convertible instruments was simplified by removing major separation models required under current GAAP.&#160;Accordingly, more convertible instruments are reported as a single liability or equity with no separate accounting for embedded conversion features. Certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception are removed and, as a result, more equity contracts will qualify for the scope exception. The ASU also simplifies the diluted earnings&lt;span class="nobreak"&gt;-per-share&lt;/span&gt; calculation in certain areas. Upon the adoption of this ASU, the Company reclassified the equity component related to the convertible notes, net of deferred taxes, reducing accumulated deficit by $616, increasing the carrying value of the convertible notes by $4,088, reducing additional paid&lt;span class="nobreak"&gt;-in&lt;/span&gt; capital by $3,682 and reducing deferred tax liabilities by $1,022. These updates also reduced interest expense recognized on the Company&#x2019;s convertible notes by approximately $420 per quarter and $1,680 for the year ended December&#160;31, 2021 (Note&#160;10) and the impact on earnings per share was negligible.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c0" id="ixv-18932">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:8pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Basis of Presentation&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;These consolidated financial statements have been prepared in conformity with U.S.&#160;generally accepted accounting principles (&#x201c;GAAP&#x201d;) and in the opinion of management reflect all adjustments, consisting of only normal recurring adjustments, necessary for a fair presentation of the financial statements. The consolidated financial statements include the accounts of the Company&#x2019;s wholly&lt;span class="nobreak"&gt;-owned&lt;/span&gt; subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c0" id="ixv-18938">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Consolidation&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company consolidates entities in which it has a controlling financial interest. The Company determines whether it has a controlling financial interest in an entity by first evaluating whether the entity is a voting interest entity (&#x201c;VOE&#x201d;) or a variable interest entity (&#x201c;VIE&#x201d;). The usual condition for a controlling financial interest in a VOE is ownership of a majority voting interest. If the Company has a majority voting interest in a VOE, the entity is consolidated. The Company has a controlling financial interest in a VIE when the Company has a variable interest that provides it with (i)&#160;the power to direct the activities of the VIE that most significantly impact the VIE&#x2019;s economic performance and (ii)&#160;the obligation to absorb losses of the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE.&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company reassesses its evaluation of whether an entity is a VOE or VIE when certain reconsideration events occur.&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="c0" id="ixv-18945">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Segment and Geographic Information&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company, through its subsidiaries in the U.S.&#160;and Europe, conducts business as a single operating segment as an ETP sponsor and asset manager which is based upon the Company&#x2019;s current organizational and management structure, as well as information used by the chief operating decision maker to allocate resources and other factors.&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c0" id="ixv-18950">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Assets and liabilities of subsidiaries whose functional currency is not the U.S.&#160;dollar are translated based on the end of period exchange rates from local currency to U.S.&#160;dollars. Results of operations are translated at the average exchange rates in effect during the period. The impact of the foreign currency translation adjustment is included in the Consolidated Statements of Comprehensive Income as a component of other comprehensive income/(loss).&lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c0" id="ixv-18955">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The preparation of the Company&#x2019;s consolidated financial statements in conformity with U.S.&#160;GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the balance sheet dates and the reported amounts of revenues and expenses for the periods presented. Actual results could differ materially from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="c0" id="ixv-18960">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company earns substantially all of its revenue in the form of advisory fees from its ETPs and recognizes this revenue over time, as the performance obligation is satisfied. Advisory fees are based on a percentage of the ETPs&#x2019; average daily net assets. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice.&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <wt:ContractualGoldPaymentsPolicyPolicyTextBlock contextRef="c0" id="ixv-18970">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Contractual Gold Payments&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Contractual gold payments are measured and paid monthly based upon the average daily spot price of gold (Note&#160;9). The Company&#x2019;s obligation to continue making these payments terminated on May&#160;10, 2023.&lt;/p&gt;</wt:ContractualGoldPaymentsPolicyPolicyTextBlock>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="c0" id="ixv-18975">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Marketing and Advertising&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Marketing and advertising costs, including media advertising and production costs, are expensed when incurred.&lt;/p&gt;</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:RegulatoryDepreciationAndAmortizationPolicy contextRef="c0" id="ixv-18980">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Depreciation and Amortization&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Depreciation and amortization is provided for using the straight&lt;span class="nobreak"&gt;-line&lt;/span&gt; method over the estimated useful lives of the related assets as follows:&lt;/p&gt;&lt;table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;"&gt;


				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1" style="width: 74.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

						&lt;p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;Equipment&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 23.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:right;"&gt;3&#160;to&#160;5 years&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1" style="width: 74.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;Internally&lt;span class="nobreak"&gt;-developed&lt;/span&gt; software&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 23.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:right;"&gt;3&#160;years&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The assets listed above are recorded at cost less accumulated depreciation and amortization.&lt;/p&gt;</us-gaap:RegulatoryDepreciationAndAmortizationPolicy>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c63" id="ixv-18985">Depreciation and amortization is provided for using the straight&lt;span class="nobreak"&gt;-line&lt;/span&gt; method over the estimated useful lives of the related assets as follows:&lt;table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;"&gt;


				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1" style="width: 74.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

						&lt;p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;Equipment&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 23.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:right;"&gt;3&#160;to&#160;5 years&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1" style="width: 74.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;Internally&lt;span class="nobreak"&gt;-developed&lt;/span&gt; software&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 23.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;text-align:right;"&gt;3&#160;years&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c64" id="ixv-26873">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c65" id="ixv-26874">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c66" id="ixv-26875">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock contextRef="c0" id="ixv-19005">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Stock-Based Awards&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Accounting for stock&lt;span class="nobreak"&gt;-based&lt;/span&gt; compensation requires the measurement and recognition of compensation expense for all equity awards based on estimated fair values. Stock&lt;span class="nobreak"&gt;-based&lt;/span&gt; compensation is measured based on the grant&lt;span class="nobreak"&gt;-date&lt;/span&gt; fair value of the award and is amortized over the relevant service period. Forfeitures are recognized when they occur.&lt;/p&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <wt:ThirdPartyDistributionFeesPolicyTextBlock contextRef="c0" id="ixv-19013">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Third-Party Distribution Fees&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company pays a percentage of its advisory fee revenues based on incremental growth in assets under management (&#x201c;AUM&#x201d;), subject to caps or minimums, to marketing agents to sell WisdomTree ETPs and for including WisdomTree ETPs on third&lt;span class="nobreak"&gt;-party&lt;/span&gt; customer platforms and recognizes these expenses as incurred.&lt;/p&gt;</wt:ThirdPartyDistributionFeesPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c0" id="ixv-19019">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company considers all highly liquid investments with an original maturity of 90&#160;days or less at the time of purchase to be classified as cash equivalents. The Company maintains deposits with financial institutions in an amount that is in excess of federally insured limits.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ReceivablesPolicyTextBlock contextRef="c0" id="ixv-19024">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Accounts Receivable&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Accounts receivable are customer and other obligations due under normal trade terms. The Company measures credit losses, if any, by applying historical loss rates, adjusted for current conditions and reasonable and supportable forecasts to amounts outstanding using the aging method.&lt;/p&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="c0" id="ixv-19029">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company performs a review for the impairment of long&lt;span class="nobreak"&gt;-lived&lt;/span&gt; assets when events or changes in circumstances indicate that the estimated undiscounted future cash flows expected to be generated by the assets are less than their carrying amounts or when other events occur which may indicate that the carrying amount of an asset may not be recoverable.&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c0" id="ixv-19035">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Financial Instruments Owned and Financial Instruments Sold, but Not yet Purchased (at Fair Value)&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Financial instruments owned and financial instruments sold, but not yet purchased are financial instruments classified as either trading or available&lt;span class="nobreak"&gt;-for-sale&lt;/span&gt; (&#x201c;AFS&#x201d;). These financial instruments are recorded on their trade date and are measured at fair value. All equity instruments that have readily determinable fair values are classified by the Company as trading. Debt instruments are classified based primarily on the Company&#x2019;s intent to hold or sell the instrument. Changes in the fair value of debt instruments classified as trading and AFS are reported in other income/(expenses) and other comprehensive income, respectively, in the period the change occurs. Debt instruments classified as AFS are assessed for impairment on a quarterly basis and an estimate for credit loss is provided when the fair value of the AFS debt instrument is below its amortized cost basis. Credit&lt;span class="nobreak"&gt;-related&lt;/span&gt; impairments are recognized in earnings with a corresponding adjustment to the instrument&#x2019;s amortized cost basis if the Company intends to sell the impaired AFS debt instrument or it is more likely than not the Company will be required to sell the instrument before recovering its amortized cost basis. Other credit&lt;span class="nobreak"&gt;-related&lt;/span&gt; impairments are recognized as an allowance with a corresponding adjustment to earnings. Impairments resulting from noncredit&lt;span class="nobreak"&gt;-related&lt;/span&gt; factors are recognized in other comprehensive income. Amounts recorded in other comprehensive income are reclassified into earnings upon sale of the AFS debt instrument using the specific identification method.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:MarketableSecuritiesPolicy contextRef="c0" id="ixv-19049">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Securities Held-to-Maturity&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company accounts for certain of its securities as held&lt;span class="nobreak"&gt;-to-maturity&lt;/span&gt; on a trade date basis, which are recorded at amortized cost. For held&lt;span class="nobreak"&gt;-to-maturity&lt;/span&gt; securities, the Company has the intent and ability to hold these securities to maturity and it is not more&lt;span class="nobreak"&gt;-likely-than-not&lt;/span&gt; that the Company will be required to sell these securities before recovery of their amortized cost bases, which may be maturity. Held&lt;span class="nobreak"&gt;-to-maturity&lt;/span&gt; securities are placed on non&lt;span class="nobreak"&gt;-accrual&lt;/span&gt; status when the Company is in receipt of information indicating collection of interest is doubtful. Cash received on held&lt;span class="nobreak"&gt;-to-maturity&lt;/span&gt; securities placed on non&lt;span class="nobreak"&gt;-accrual&lt;/span&gt; status is recognized on a cash basis as interest income if and when received.&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company reviews its portfolio of held&lt;span class="nobreak"&gt;-to-maturity&lt;/span&gt; securities for impairment on a quarterly basis, recognizing an allowance, if any, by applying an estimated loss rate after consideration for the nature of collateral securing the financial asset as well as potential future changes in collateral values and historical loss information for financial assets secured with similar collateral.&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Investments in pass&lt;span class="nobreak"&gt;-through&lt;/span&gt; government&lt;span class="nobreak"&gt;-sponsored&lt;/span&gt; enterprises (&#x201c;GSEs&#x201d;) are determined to have an estimated loss rate of zero due to an implicit U.S.&#160;government guarantee.&lt;/p&gt;</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:InvestmentPolicyTextBlock contextRef="c0" id="ixv-19068">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Investments&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company accounts for equity investments that do not have a readily determinable fair value under the measurement alternative prescribed in Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic&#160;321, &lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;Investments&#160;&#x2013;&#160;Equity Securities &lt;/span&gt;(&#x201c;ASC&#160;321&#x201d;), to the extent such investments are not subject to consolidation or the equity method. Under the measurement alternative, these financial instruments are carried at cost, less any impairment (assessed quarterly), plus or minus changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. In addition, income is recognized when dividends are received only to the extent they are distributed from net accumulated earnings of the investee. Otherwise, such distributions are considered returns of investment and are recorded as a reduction of the cost of the investment.&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Investments in debt instruments are accounted for at fair value, with changes in fair value reported in other income/(expenses).&lt;/p&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy contextRef="c0" id="ixv-19076">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Goodwill&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Goodwill is the excess of the purchase price over the fair values of the identifiable net assets at the acquisition date. The Company tests goodwill for impairment at least annually and at the time of a triggering event requiring re&lt;span class="nobreak"&gt;-evaluation&lt;/span&gt;, if one were to occur. Goodwill is considered impaired when the estimated fair value of the reporting unit that was allocated the goodwill is less than its carrying value. If the estimated fair value of such reporting unit is less than its carrying value, goodwill impairment is recognized based on that difference, not to exceed the carrying amount of goodwill. A reporting unit is an operating segment or a component of an operating segment provided that the component constitutes a business for which discrete financial information is available and management regularly reviews the operating results of that component.&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Goodwill is allocated to the Company&#x2019;s U.S.&#160;business and European business components. For impairment testing purposes, these components are aggregated as a single reporting unit as they fall under the same operating segment and have similar economic characteristics.&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Goodwill is assessed for impairment annually on November&#160;30&lt;span class="Superscript" style="vertical-align:super;font-size:58%;"&gt;th&lt;/span&gt;. When performing its goodwill impairment test, the Company considers a qualitative assessment, when appropriate, and a quantitative assessment using the market approach and its market capitalization when determining the fair value of the reporting unit.&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy contextRef="c0" id="ixv-19087">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Intangible Assets&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Indefinite&lt;span class="nobreak"&gt;-lived&lt;/span&gt; intangible assets are tested for impairment at least annually and are also reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indefinite&lt;span class="nobreak"&gt;-lived&lt;/span&gt; intangible assets are impaired if their estimated fair values are less than their carrying values.&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Finite&lt;span class="nobreak"&gt;-lived&lt;/span&gt; intangible assets, if any, are amortized over their estimated useful life, which is the period over which the assets are expected to contribute directly or indirectly to the future cash flows of the Company. These intangible assets are tested for impairment at the time of a triggering event, if one were to occur. Finite&lt;span class="nobreak"&gt;-lived&lt;/span&gt; intangible assets may be impaired when the estimated undiscounted future cash flows generated from the assets are less than their carrying amounts.&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company may rely on a qualitative assessment when performing its intangible asset impairment test. Otherwise, the impairment evaluation is performed at the lowest level of reasonably identifiable cash flows independent of other assets. The annual impairment testing date for all of the Company&#x2019;s intangible assets is November&#160;30&lt;span class="Superscript" style="vertical-align:super;font-size:58%;"&gt;th&lt;/span&gt;.&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock contextRef="c0" id="ixv-19106">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Software Development Costs&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Software development costs incurred after the preliminary project stage is complete are capitalized if it is probable that the project will be completed and the software will be used as intended. Capitalized costs consist of employee compensation costs and fees paid to third parties who are directly involved in the application development efforts and are included in intangible assets, net in the Consolidated Balance Sheets. Such costs are amortized over the estimated useful life of the software on a straight&lt;span class="nobreak"&gt;-line&lt;/span&gt; basis and are included in depreciation and amortization in the Consolidated Statements of Operations. Once the application development stage is complete, additional costs are expensed as incurred.&lt;/p&gt;</us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c0" id="ixv-19112">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company accounts for its lease obligations in accordance with ASC Topic&#160;842, &lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;Leases &lt;/span&gt;(&#x201c;ASC&#160;842&#x201d;), which requires the recognition of both (i)&#160;a lease liability equal to the present value of the remaining lease payments and (ii)&#160;an offsetting right&lt;span class="nobreak"&gt;-of-use&lt;/span&gt; asset. The remaining lease payments are discounted using the rate implicit in the lease, if known, or otherwise the Company&#x2019;s incremental borrowing rate. After lease commencement, right&lt;span class="nobreak"&gt;-of-use&lt;/span&gt; assets are assessed for impairment and otherwise are amortized over the remaining lease term on a straight&lt;span class="nobreak"&gt;-line&lt;/span&gt; basis. These recognition requirements are not applied to short&lt;span class="nobreak"&gt;-term&lt;/span&gt; leases which are those with a lease term of 12&#160;months or less. Instead, lease payments associated with short&lt;span class="nobreak"&gt;-term&lt;/span&gt; leases are recognized as an expense on a straight&lt;span class="nobreak"&gt;-line&lt;/span&gt; basis over the lease term.&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;ASC&#160;842 also provides a practical expedient which allows for consideration in a contract to be accounted for as a single lease component rather than allocated between lease and non&lt;span class="nobreak"&gt;-lease&lt;/span&gt; components. The Company has elected to apply this practical expedient to all lease contracts, where applicable.&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <wt:DeferredConsiderationGoldPaymentsPolicyTextBlock contextRef="c0" id="ixv-19127">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Deferred Consideration&#x2014;Gold Payments&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Deferred consideration&#x2014;gold payments represented the present value of an obligation to pay gold to a third party into perpetuity and was measured using forward&lt;span class="nobreak"&gt;-looking&lt;/span&gt; gold prices observed on the CMX exchange, a selected discount rate and perpetual growth rate (Note&#160;9). Changes in the fair value of this obligation were reported as gain on revaluation/termination of deferred consideration&#x2014;gold payments in the Consolidated Statements of Operations.&lt;/p&gt;</wt:DeferredConsiderationGoldPaymentsPolicyTextBlock>
    <us-gaap:DebtPolicyTextBlock contextRef="c0" id="ixv-19133">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Convertible Notes&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Convertible notes are carried at amortized cost, net of issuance costs. The Company accounts for convertible instruments as a single liability (applicable to the convertible notes) or equity with no separate accounting for embedded conversion features unless the conversion feature meets the criteria for accounting under the substantial premium model or does not qualify for a derivative scope exception. Interest expense is recognized using the effective interest method and includes amortization of issuance costs over the life of the debt.&lt;/p&gt;</us-gaap:DebtPolicyTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="c0" id="ixv-19138">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Contingencies&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company may be subject to reviews, inspections and investigations by regulatory authorities as well as legal proceedings arising in the ordinary course of business. The Company evaluates the likelihood of an unfavorable outcome of all legal or regulatory proceedings to which it is a party and accrues a loss contingency when the loss is probable and reasonably estimable.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <wt:ContingentPaymentsPolicyTextBlock contextRef="c0" id="ixv-19143">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Contingent Payments&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company recognizes a gain on contingent payments when the contingency is resolved and the gain is realized.&lt;/p&gt;</wt:ContingentPaymentsPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c0" id="ixv-19153">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Earnings per Share&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Basic earnings per share (&#x201c;EPS&#x201d;) is computed by dividing net income available to common stockholders by the weighted&lt;span class="nobreak"&gt;-average&lt;/span&gt; number of common shares outstanding for the period. Net income available to common stockholders represents net income of the Company reduced by an allocation of earnings to participating securities. The Series&#160;A non&lt;span class="nobreak"&gt;-voting&lt;/span&gt; convertible preferred stock (Note&#160;11) and unvested share&lt;span class="nobreak"&gt;-based&lt;/span&gt; payment awards that contain non&lt;span class="nobreak"&gt;-forfeitable&lt;/span&gt; rights to dividends or dividend equivalents (whether paid or unpaid) are participating securities and are included in the computation of EPS pursuant to the two&lt;span class="nobreak"&gt;-class&lt;/span&gt; method. Stock&lt;span class="nobreak"&gt;-based&lt;/span&gt; equity awards that do not contain such rights are not deemed participating securities and are included in diluted shares outstanding (if dilutive).&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Diluted EPS is calculated under the treasury stock method and the two&lt;span class="nobreak"&gt;-class&lt;/span&gt; method. The calculation that results in the lowest diluted EPS amount for the common stock is reported in the Company&#x2019;s consolidated financial statements. The treasury stock method includes the dilutive effect of potential common shares including unvested stock&lt;span class="nobreak"&gt;-based&lt;/span&gt; awards, the Series&#160;A non&lt;span class="nobreak"&gt;-voting&lt;/span&gt; convertible preferred stock and the convertible notes, if any. Potential common shares associated with the Series&#160;A non&lt;span class="nobreak"&gt;-voting&lt;/span&gt; convertible preferred stock and the convertible notes are computed under the if&lt;span class="nobreak"&gt;-converted&lt;/span&gt; method. Potential common shares associated with the conversion option embedded in the convertible notes are dilutive when the Company&#x2019;s average stock price exceeds the conversion price.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c0" id="ixv-19171">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company accounts for income taxes using the liability method, which requires the determination of deferred tax assets and liabilities based on the differences between the financial and tax bases of assets and liabilities using the enacted tax rates in effect for the year in which differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is more&lt;span class="nobreak"&gt;-likely-than-not&lt;/span&gt; that some portion or all the deferred tax assets will not be realized.&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Tax positions are evaluated utilizing a two&lt;span class="nobreak"&gt;-step&lt;/span&gt; process. The Company first determines whether any of its tax positions are more&lt;span class="nobreak"&gt;-likely-than-not&lt;/span&gt; to be sustained upon examination, based solely on the technical merits of the position. Once it is determined that a position meets this recognition threshold, the position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement. The Company records interest expense and penalties related to tax expenses as income tax expense.&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Global Intangible Low&lt;span class="nobreak"&gt;-Taxed&lt;/span&gt; Income (&#x201c;GILTI&#x201d;) provisions of the Tax Reform Act requires the Company to include in its U.S.&#160;income tax return foreign subsidiary earnings in excess of an allowable return on the foreign subsidiary&#x2019;s tangible assets. An accounting policy election is available to either account for the tax effects of GILTI in the period that is subject to such taxes or to provide deferred taxes for book and tax basis differences that upon reversal may be subject to such taxes. The Company accounts for the tax effects of these provisions in the period that is subject to such tax.&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Non&lt;span class="nobreak"&gt;-income&lt;/span&gt; based taxes are recorded as part of other liabilities and other expenses.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <wt:PercentageOfTaxRateRealizedOnSettlement contextRef="c0" decimals="2" id="ixv-26876" unitRef="pure">0.50</wt:PercentageOfTaxRateRealizedOnSettlement>
    <wt:RecentlyIssuedAccountingPronouncementsPolicyTextBlock contextRef="c0" id="ixv-19187">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;On November&#160;27, 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU&#160;2023&lt;span class="nobreak"&gt;-07&lt;/span&gt;, &lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;Segment&#160;Reporting&#x2014;Improvements to Reportable Segment Disclosures&lt;/span&gt;, which requires public entities to provide disclosures of significant segment expenses and other segment items. The guidance requires public entities to provide in interim periods all disclosures about a reportable segment&#x2019;s profit or loss and assets that are currently required annually and also applies to public entities with a single reportable segment. Entities are permitted to disclose more than one measure of a segment&#x2019;s profit or loss if such measures are used by the chief operating decision&lt;span class="nobreak"&gt;-maker&lt;/span&gt; to allocate resources and assess performance, as long as at least one of those measures is determined in a way that is most consistent with the measurement principles used to measure the corresponding amounts in the consolidated financial statements. The guidance is applied retrospectively to all periods presented in financial statements, unless it is impracticable, and is effective for fiscal&#160;years beginning after December&#160;15, 2023, and for interim periods beginning after December&#160;15, 2024. Early adoption is permitted. This standard will only impact disclosures and will be adopted by the Company on January&#160;1, 2024.&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;On December&#160;13, 2023, the FASB issued ASU&#160;2023&lt;span class="nobreak"&gt;-08&lt;/span&gt;, &lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;Accounting for and Disclosure of Crypto Assets&lt;/span&gt;, which contains final guidance requiring all entities to measure certain crypto assets at fair value each reporting period and to reflect changes from remeasurement in net income. Entities are required to present crypto assets measured at fair value separately from other intangible assets on the balance sheet and present changes from the remeasurement of crypto assets separately from changes in the carrying amounts of other intangible assets in the income statement. Entities are required to provide interim and annual disclosures about the types of crypto assets they hold and any changes in their holdings of crypto assets. The guidance is effective for fiscal&#160;years beginning after December&#160;15, 2024, including interim periods within those fiscal&#160;years. Early adoption is permitted. The Company has determined that this standard will not have a material impact on its financial statements and will early adopt the standard on January&#160;1, 2024.&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;On December&#160;14, 2023, the FASB issued ASU&#160;2023&lt;span class="nobreak"&gt;-09&lt;/span&gt;,&lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt; Improvements to Income Tax Disclosures&lt;/span&gt;, which establishes new income tax disclosure requirements in addition to modifying and eliminating certain existing requirements. Under the new guidance, entities must consistently categorize and provide greater disaggregation of information in the rate reconciliation. They must also further disaggregate income taxes paid. The standard is intended to benefit investors by providing more detailed income tax disclosures that would be useful in making capital allocation decisions. The guidance applies to all entities subject to income taxes and is effective for annual periods beginning after December&#160;15, 2024. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively. Early adoption is permitted. The Company plans to adopt this standard on January&#160;1, 2025.&lt;/p&gt;</wt:RecentlyIssuedAccountingPronouncementsPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c0" id="ixv-19208">&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;On January&#160;1, 2021, the Company early adopted ASU&#160;2020&lt;span class="nobreak"&gt;-06&lt;/span&gt;, &lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;Debt&#160;&#x2013;&#160;Debt with Conversion and Other Options &lt;/span&gt;(ASU&#160;2020&lt;span class="nobreak"&gt;-06&lt;/span&gt;) under the modified retrospective approach. Under the ASU, the accounting for convertible instruments was simplified by removing major separation models required under current GAAP.&#160;Accordingly, more convertible instruments are reported as a single liability or equity with no separate accounting for embedded conversion features. Certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception are removed and, as a result, more equity contracts will qualify for the scope exception. The ASU also simplifies the diluted earnings&lt;span class="nobreak"&gt;-per-share&lt;/span&gt; calculation in certain areas. Upon the adoption of this ASU, the Company reclassified the equity component related to the convertible notes, net of deferred taxes, reducing accumulated deficit by $616, increasing the carrying value of the convertible notes by $4,088, reducing additional paid&lt;span class="nobreak"&gt;-in&lt;/span&gt; capital by $3,682 and reducing deferred tax liabilities by $1,022. These updates also reduced interest expense recognized on the Company&#x2019;s convertible notes by approximately $420 per quarter and $1,680 for the year ended December&#160;31, 2021 (Note&#160;10) and the impact on earnings per share was negligible.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c59" decimals="-3" id="ixv-26877" unitRef="usd">616000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c59" decimals="-3" id="ixv-26878" unitRef="usd">4088000</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther contextRef="c60" decimals="-3" id="ixv-26879" unitRef="usd">3682000</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:DeferredTaxLiabilities contextRef="c59" decimals="-3" id="ixv-26880" unitRef="usd">1022000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:InterestExpense contextRef="c61" decimals="-3" id="ixv-26881" unitRef="usd">420000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c62" decimals="-3" id="ixv-26882" unitRef="usd">1680000</us-gaap:InterestExpense>
    <us-gaap:CashAndCashEquivalentsDisclosureTextBlock contextRef="c0" id="ixv-19218">&lt;p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;3. Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Of the total cash and cash equivalents of $129,305 and $132,101 at December&#160;31, 2023 and 2022, $116,895 and $131,104, respectively, were held at three financial institutions. At December&#160;31, 2023 and 2022, cash equivalents were approximately $50,226 and $930, respectively.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Certain of the Company&#x2019;s subsidiaries are required to maintain a minimum level of regulatory capital, which was $29,156 and $25,988 at December&#160;31, 2023 and 2022, respectively. These requirements are generally satisfied by cash on hand.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsDisclosureTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c5" decimals="-3" id="ixv-26883" unitRef="usd">129305000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c6" decimals="-3" id="ixv-26884" unitRef="usd">132101000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c67" decimals="-3" id="ixv-26885" unitRef="usd">116895000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c68" decimals="-3" id="ixv-26886" unitRef="usd">131104000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c5" decimals="-3" id="ixv-26887" unitRef="usd">50226000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c6" decimals="-3" id="ixv-26888" unitRef="usd">930000</us-gaap:CashEquivalentsAtCarryingValue>
    <wt:NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements contextRef="c69" decimals="-3" id="ixv-26889" unitRef="usd">29156000</wt:NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements>
    <wt:NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements contextRef="c70" decimals="-3" id="ixv-26890" unitRef="usd">25988000</wt:NetLiquidAssetsInternationalSubsidiaryRegulatoryCapitalRequirements>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c0" id="ixv-19227">&lt;p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;4. Fair Value Measurements&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;"&gt;The fair value of financial instruments is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e., &#x201c;the exit price&#x201d;) in an orderly transaction between market participants at the measurement date. ASC&#160;820, &lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;Fair Value Measurement&lt;/span&gt;, establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from independent sources. Unobservable inputs reflect assumptions that market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into three levels based on the transparency of inputs as follows:&lt;/p&gt;
		&lt;table class="Basic-Table" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;"&gt;


				&lt;tr class="Basic-Table _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 3.85%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;

					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 5.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;Level&#160;1&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 2.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 85.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;Quoted prices for identical instruments in active markets.&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Basic-Table _idGenTableRowColumn-9" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 3.85%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 5.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;"&gt;Level&#160;2&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 2.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 85.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;"&gt;Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model&lt;span class="nobreak"&gt;-derived&lt;/span&gt; valuations whose inputs are observable or whose significant value drivers are observable.&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Basic-Table _idGenTableRowColumn-10" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 3.85%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 5.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;"&gt;Level&#160;3&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 2.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:6pt;vertical-align:top;width: 85.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:3pt;"&gt;Instruments whose significant drivers are unobservable.&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The availability of observable inputs can vary from product to product and is affected by a wide variety of factors, including, for example, the type of product, whether the product is new and not yet established in the marketplace, and other characteristics particular to the transaction. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by management in determining fair value is greatest for instruments categorized in Level&#160;3. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level input that is significant to the fair value measurement in its entirety.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The tables below summarize the categorization of the Company&#x2019;s assets and liabilities measured at fair value. During the&#160;years ended December&#160;31, 2023 and 2022, there were no transfers between Levels 2 and 3.&lt;/p&gt;
		&lt;table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;"&gt;


				&lt;tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;"&gt;
					&lt;td class="No-Table-Style TCH" style="width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="11" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 55.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, 2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;"&gt;
					&lt;td class="No-Table-Style TCH _idGenCellOverride-1" style="width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;"&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;"&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Recurring fair value measurements:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:30pt;"&gt;Cash equivalents&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;50,226&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;50,226&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-142; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-143; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:30pt;"&gt;Financial instruments owned, at fair value:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:50pt;"&gt;ETFs&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;35,181&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;35,181&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-144; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-145; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:50pt;"&gt;Pass-through GSEs&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;10,240&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-146; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;10,240&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-147; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:50pt;"&gt;Other assets&#x2014;seed capital (WisdomTree Digital Funds):&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:70pt;"&gt;U.S.&#160;treasuries&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;5,007&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;5,007&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-148; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:70pt;"&gt;Equities&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6,337&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6,337&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-149; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-150; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:70pt;"&gt;Fixed income&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,957&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,008&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;949&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-151; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;108,948&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;92,752&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;16,196&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-152; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Non-recurring fair value measurements:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:30pt;"&gt;Fnality International Limited&#x2014;Series&#160;B-1 Preference Shares&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(&lt;/span&gt;&lt;span class="CharOverride-5" style="font-size:6pt;vertical-align:super;"&gt;1)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;9,684&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;font-style:normal;font-weight:normal;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-153; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;font-style:normal;font-weight:normal;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;font-style:normal;font-weight:normal;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-154; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;font-style:normal;font-weight:normal;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;9,684&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:30pt;"&gt;Other investments&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(&lt;/span&gt;&lt;span class="CharOverride-5" style="font-size:6pt;vertical-align:super;"&gt;2&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-155; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-156; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-157; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-158; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;9,684&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-159; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-160; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;9,684&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;&lt;p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;"&gt;&#x200b;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(1)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;Fair value determined on October 31, 2023&lt;/p&gt;&lt;p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:0pt;"&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt; (2)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;Fair value determined on September 30, 2023&lt;/p&gt;&lt;table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;"&gt;


				&lt;tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;"&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="11" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 55.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, 2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;"&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;"&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;"&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Recurring fair value measurements:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Cash equivalents&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;930&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;930&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-161; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-162; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Financial instruments owned, at fair value:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;ETFs&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;23,772&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;23,772&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-163; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-164; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;U.S.&#160;treasuries&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;2,980&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;2,980&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-165; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-166; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Pass-through GSEs&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;96,837&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;23,290&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;73,547&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-167; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Fixed income&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;885&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-168; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;885&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-169; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Other assets&#x2014;seed capital (WisdomTree Digital Funds):&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,765&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-170; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,765&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-171; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Investments in Convertible Notes&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Securrency, Inc.&#x2014;convertible note (Note&#160;7)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;14,500&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-172; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-173; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;14,500&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-16" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Fnality International Limited&#x2014;convertible note (Note&#160;7)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6,921&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-174; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-175; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6,921&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;148,590&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;50,972&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;76,197&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;21,421&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Non-recurring fair value measurements:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Other investments&lt;span class="Superscript" style="vertical-align:super;font-size:58%;"&gt;(&lt;/span&gt;&lt;span class="CharOverride-6" style="font-size:58%;vertical-align:super;"&gt;1)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;312&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-176; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-177; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;312&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-top:1pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Liabilities:&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Recurring fair value measurements:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Deferred consideration (Note&#160;9)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;200,290&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-178; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-179; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;200,290&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;&lt;p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;"&gt;&#x200b;&lt;span class="CharOverride-6" style="font-size:58%;vertical-align:super;"&gt;(1)&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;Fair value determined on May 10, 2022&lt;/p&gt;&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt; Recurring Fair Value Measurements&#160;-&#160;Methodology&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Cash Equivalents (Note&#160;3) &#x2013; &lt;/span&gt;These financial assets represent cash invested in highly liquid investments with original maturities of less than &lt;span style="-sec-ix-hidden: hidden-fact-185"&gt;90&lt;/span&gt;&#160;days. These investments are valued at par, which approximates fair value, and are classified as Level 1 in the fair value hierarchy.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Financial instruments owned (Note&#160;5) &#x2013; &lt;/span&gt;Financial instruments owned are investments in ETFs, pass&lt;span class="nobreak"&gt;-through&lt;/span&gt; GSEs, U.S.&#160;treasuries, equities and fixed income. ETFs, U.S.&#160;treasuries and equities are generally traded in active, quoted and highly liquid markets and are therefore classified as Level 1 in the fair value hierarchy. Pricing of pass&lt;span class="nobreak"&gt;-through&lt;/span&gt; GSEs and fixed income includes consideration given to collateral characteristics and market assumptions related to yields, credit risk and timing of prepayments and are therefore generally classified as Level&#160;2. Pass&lt;span class="nobreak"&gt;-through&lt;/span&gt; GSE positions invested in through a fund structure with a quoted market price on an exchange are generally classified as Level 1.&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Fair Value Measurements classified as Level 3&lt;/span&gt; &#x2013;&#160;The following table presents a reconciliation of beginning and ending balances of recurring fair value measurements classified as Level 3:&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-left:24pt;text-indent:0pt;margin-top:6pt;"&gt;These instruments consist of the following:&lt;/p&gt;
		&lt;table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;"&gt;


				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75-" style="border-left-width:1pt;border-left-style:solid;border-left-color:#000000;border-top-width:1pt;border-top-style:solid;border-top-color:#000000;border-right-width:1pt;border-right-style:solid;border-right-color:#000000;border-bottom-width:1pt;border-bottom-style:solid;border-bottom-color:#000000;padding-top:4pt;padding-bottom:4pt;padding-left:4pt;padding-right:4pt;vertical-align:top;width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="5" style="width: 37.50%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Years Ended&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75-" style="border-left-width:1pt;border-left-style:solid;border-left-color:#000000;border-top-width:1pt;border-top-style:solid;border-top-color:#000000;border-right-width:1pt;border-right-style:solid;border-right-color:#000000;border-bottom-width:1pt;border-bottom-style:solid;border-bottom-color:#000000;padding-top:4pt;padding-bottom:4pt;padding-left:4pt;padding-right:4pt;vertical-align:top;width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December 31, &lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December 31, &lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Investments in Convertible Notes (Note&#160;7):&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Beginning balance&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;21,421&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-180; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Purchases&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;11,228&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;21,863&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Settlements&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(28,818)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-181; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Conversions&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(9,684)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-182; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Net realized gains/(losses)&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;5,853&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(442)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Ending balance&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-183; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;21,421&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Deferred Consideration (Note&#160;7):&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Beginning balance&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;200,290&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;228,062&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Net realized losses&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(3)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6,069&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;17,108&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Net unrealized gains&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(4)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(61,953)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(27,765)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Settlements&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(144,406)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(17,115)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Ending balance&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-184; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;200,290&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;&lt;p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;"&gt;&#x200b;&lt;span class="CharOverride-5" style="font-size:6pt;vertical-align:super;"&gt;(1)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;The Fnality convertible notes converted into Series B&lt;span class="nobreak"&gt;-1&lt;/span&gt; Preference Shares on October 31, 2023 (Note 7).&lt;/p&gt;&lt;p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:0pt;"&gt;&lt;span class="CharOverride-5" style="font-size:6pt;vertical-align:super;"&gt; (2)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;Recorded in impairments and other losses, net in the Consolidated Statements of Operations.&lt;/p&gt;
		&lt;p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:0pt;"&gt;&#x200b;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(3)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;Recorded as contractual gold payments expense in the Consolidated Statements of Operations.&lt;/p&gt;
		&lt;p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:0pt;"&gt;&#x200b;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(4)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;Recorded as gain on revaluation/termination of deferred consideration&#x2014;gold payments in the Consolidated Statements of Operations.&#160;&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock contextRef="c0" id="ixv-26891">The tables below summarize the categorization of the Company&#x2019;s assets and liabilities measured at fair value. During the&#160;years ended December&#160;31, 2023 and 2022, there were no transfers between Levels 2 and 3.&lt;table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;"&gt;


				&lt;tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;"&gt;
					&lt;td class="No-Table-Style TCH" style="width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="11" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 55.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, 2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;"&gt;
					&lt;td class="No-Table-Style TCH _idGenCellOverride-1" style="width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;"&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;"&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Recurring fair value measurements:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:30pt;"&gt;Cash equivalents&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;50,226&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;50,226&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-142; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-143; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:30pt;"&gt;Financial instruments owned, at fair value:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:50pt;"&gt;ETFs&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;35,181&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;35,181&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-144; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-145; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:50pt;"&gt;Pass-through GSEs&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;10,240&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-146; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;10,240&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-147; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:50pt;"&gt;Other assets&#x2014;seed capital (WisdomTree Digital Funds):&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:70pt;"&gt;U.S.&#160;treasuries&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;5,007&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;5,007&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-148; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:70pt;"&gt;Equities&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6,337&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6,337&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-149; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-150; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:40pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:70pt;"&gt;Fixed income&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,957&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,008&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;949&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-151; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;108,948&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;92,752&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;16,196&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-152; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Non-recurring fair value measurements:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:30pt;"&gt;Fnality International Limited&#x2014;Series&#160;B-1 Preference Shares&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(&lt;/span&gt;&lt;span class="CharOverride-5" style="font-size:6pt;vertical-align:super;"&gt;1)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;9,684&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;font-style:normal;font-weight:normal;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-153; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;font-style:normal;font-weight:normal;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;font-style:normal;font-weight:normal;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-154; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;font-style:normal;font-weight:normal;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;9,684&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:30pt;"&gt;Other investments&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(&lt;/span&gt;&lt;span class="CharOverride-5" style="font-size:6pt;vertical-align:super;"&gt;2&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-155; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-156; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-157; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-158; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;9,684&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-159; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-160; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;9,684&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;&lt;p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;"&gt;&#x200b;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(1)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;Fair value determined on October 31, 2023&lt;/p&gt;&lt;p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:0pt;"&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt; (2)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;Fair value determined on September 30, 2023&lt;/p&gt;&lt;table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;"&gt;


				&lt;tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;"&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="11" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 55.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, 2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;"&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;"&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;"&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Recurring fair value measurements:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.61%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 13.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Cash equivalents&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;930&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;930&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-161; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-162; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Financial instruments owned, at fair value:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;ETFs&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;23,772&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;23,772&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-163; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-164; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;U.S.&#160;treasuries&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;2,980&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;2,980&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-165; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-166; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Pass-through GSEs&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;96,837&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;23,290&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;73,547&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-167; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Fixed income&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;885&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-168; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;885&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-169; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Other assets&#x2014;seed capital (WisdomTree Digital Funds):&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,765&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-170; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,765&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-171; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Investments in Convertible Notes&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Securrency, Inc.&#x2014;convertible note (Note&#160;7)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;14,500&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-172; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-173; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;14,500&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-16" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:50pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Fnality International Limited&#x2014;convertible note (Note&#160;7)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6,921&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-174; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-175; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6,921&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;148,590&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;50,972&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;76,197&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;21,421&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Non-recurring fair value measurements:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Other investments&lt;span class="Superscript" style="vertical-align:super;font-size:58%;"&gt;(&lt;/span&gt;&lt;span class="CharOverride-6" style="font-size:58%;vertical-align:super;"&gt;1)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;312&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-176; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-177; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;312&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-17" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-top:1pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:1pt;padding-left:0pt;padding-right:0pt;padding-top:1pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Liabilities:&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Recurring fair value measurements:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 43.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Deferred consideration (Note&#160;9)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;200,290&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-178; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.90%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-179; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 12.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;200,290&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;&lt;p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;"&gt;&#x200b;&lt;span class="CharOverride-6" style="font-size:58%;vertical-align:super;"&gt;(1)&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;Fair value determined on May 10, 2022&lt;/p&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c71" decimals="-3" id="ixv-26892" unitRef="usd">50226000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c72" decimals="-3" id="ixv-26893" unitRef="usd">50226000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned contextRef="c75" decimals="-3" id="ixv-26894" unitRef="usd">35181000</us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned contextRef="c76" decimals="-3" id="ixv-26895" unitRef="usd">35181000</us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned contextRef="c79" decimals="-3" id="ixv-26896" unitRef="usd">10240000</us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned contextRef="c81" decimals="-3" id="ixv-26897" unitRef="usd">10240000</us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned contextRef="c83" decimals="-3" id="ixv-26898" unitRef="usd">5007000</us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned contextRef="c84" decimals="-3" id="ixv-26899" unitRef="usd">5007000</us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned contextRef="c86" decimals="-3" id="ixv-26900" unitRef="usd">6337000</us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned contextRef="c87" decimals="-3" id="ixv-26901" unitRef="usd">6337000</us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned contextRef="c90" decimals="-3" id="ixv-26902" unitRef="usd">1957000</us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned contextRef="c91" decimals="-3" id="ixv-26903" unitRef="usd">1008000</us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned contextRef="c92" decimals="-3" id="ixv-26904" unitRef="usd">949000</us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned>
    <us-gaap:AssetsFairValueDisclosure contextRef="c71" decimals="-3" id="ixv-26905" unitRef="usd">108948000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c72" decimals="-3" id="ixv-26906" unitRef="usd">92752000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c73" decimals="-3" id="ixv-26907" unitRef="usd">16196000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c94" decimals="-3" id="ix_0_fact" unitRef="usd">9684000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedAtFairValue contextRef="c97" decimals="-3" id="ix_1_fact" unitRef="usd">9684000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="c102"
      decimals="-3"
      id="ixv-26910"
      unitRef="usd">9684000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="c105"
      decimals="-3"
      id="ixv-26911"
      unitRef="usd">9684000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="c106"
      decimals="-3"
      id="ixv-26914"
      unitRef="usd">930000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="c107"
      decimals="-3"
      id="ixv-26915"
      unitRef="usd">930000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned
      contextRef="c110"
      decimals="-3"
      id="ixv-26916"
      unitRef="usd">23772000</us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned
      contextRef="c111"
      decimals="-3"
      id="ixv-26917"
      unitRef="usd">23772000</us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned
      contextRef="c114"
      decimals="-3"
      id="ixv-26918"
      unitRef="usd">2980000</us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned
      contextRef="c115"
      decimals="-3"
      id="ixv-26919"
      unitRef="usd">2980000</us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned
      contextRef="c118"
      decimals="-3"
      id="ixv-26920"
      unitRef="usd">96837000</us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned
      contextRef="c119"
      decimals="-3"
      id="ixv-26921"
      unitRef="usd">23290000</us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned
      contextRef="c120"
      decimals="-3"
      id="ixv-26922"
      unitRef="usd">73547000</us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned
      contextRef="c122"
      decimals="-3"
      id="ixv-26923"
      unitRef="usd">885000</us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned
      contextRef="c124"
      decimals="-3"
      id="ixv-26924"
      unitRef="usd">885000</us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned
      contextRef="c126"
      decimals="-3"
      id="ixv-26925"
      unitRef="usd">1765000</us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned
      contextRef="c128"
      decimals="-3"
      id="ixv-26926"
      unitRef="usd">1765000</us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="c130"
      decimals="-3"
      id="ixv-26927"
      unitRef="usd">14500000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="c133"
      decimals="-3"
      id="ixv-26928"
      unitRef="usd">14500000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="c134"
      decimals="-3"
      id="ixv-26929"
      unitRef="usd">6921000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="c137"
      decimals="-3"
      id="ixv-26930"
      unitRef="usd">6921000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="c106"
      decimals="-3"
      id="ixv-26931"
      unitRef="usd">148590000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="c107"
      decimals="-3"
      id="ixv-26932"
      unitRef="usd">50972000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="c108"
      decimals="-3"
      id="ixv-26933"
      unitRef="usd">76197000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="c109"
      decimals="-3"
      id="ixv-26934"
      unitRef="usd">21421000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="c138"
      decimals="-3"
      id="ix_2_fact"
      unitRef="usd">312000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="c141"
      decimals="-3"
      id="ix_3_fact"
      unitRef="usd">312000</us-gaap:InvestmentOwnedAtFairValue>
    <wt:BusinessCombinationDeferredConsiderationLiability
      contextRef="c106"
      decimals="-3"
      id="ixv-26937"
      unitRef="usd">200290000</wt:BusinessCombinationDeferredConsiderationLiability>
    <wt:BusinessCombinationDeferredConsiderationLiability
      contextRef="c109"
      decimals="-3"
      id="ixv-26938"
      unitRef="usd">200290000</wt:BusinessCombinationDeferredConsiderationLiability>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="c0" id="ixv-26940">These instruments consist of the following:&lt;table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;"&gt;


				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75-" style="border-left-width:1pt;border-left-style:solid;border-left-color:#000000;border-top-width:1pt;border-top-style:solid;border-top-color:#000000;border-right-width:1pt;border-right-style:solid;border-right-color:#000000;border-bottom-width:1pt;border-bottom-style:solid;border-bottom-color:#000000;padding-top:4pt;padding-bottom:4pt;padding-left:4pt;padding-right:4pt;vertical-align:top;width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="5" style="width: 37.50%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Years Ended&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75-" style="border-left-width:1pt;border-left-style:solid;border-left-color:#000000;border-top-width:1pt;border-top-style:solid;border-top-color:#000000;border-right-width:1pt;border-right-style:solid;border-right-color:#000000;border-bottom-width:1pt;border-bottom-style:solid;border-bottom-color:#000000;padding-top:4pt;padding-bottom:4pt;padding-left:4pt;padding-right:4pt;vertical-align:top;width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December 31, &lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December 31, &lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Investments in Convertible Notes (Note&#160;7):&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Beginning balance&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;21,421&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-180; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Purchases&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;11,228&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;21,863&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Settlements&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(28,818)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-181; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Conversions&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(9,684)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-182; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Net realized gains/(losses)&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;5,853&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(442)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Ending balance&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-183; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;21,421&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Deferred Consideration (Note&#160;7):&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Beginning balance&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;200,290&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;228,062&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Net realized losses&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(3)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6,069&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;17,108&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Net unrealized gains&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(4)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(61,953)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(27,765)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Settlements&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(144,406)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(17,115)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Ending balance&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-184; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;200,290&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;&lt;p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;"&gt;&#x200b;&lt;span class="CharOverride-5" style="font-size:6pt;vertical-align:super;"&gt;(1)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;The Fnality convertible notes converted into Series B&lt;span class="nobreak"&gt;-1&lt;/span&gt; Preference Shares on October 31, 2023 (Note 7).&lt;/p&gt;&lt;p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:0pt;"&gt;&lt;span class="CharOverride-5" style="font-size:6pt;vertical-align:super;"&gt; (2)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;Recorded in impairments and other losses, net in the Consolidated Statements of Operations.&lt;/p&gt;&lt;p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:0pt;"&gt;&#x200b;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(3)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;Recorded as contractual gold payments expense in the Consolidated Statements of Operations.&lt;/p&gt;&lt;p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:0pt;"&gt;&#x200b;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(4)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;Recorded as gain on revaluation/termination of deferred consideration&#x2014;gold payments in the Consolidated Statements of Operations.&#160;&lt;/p&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c6" decimals="-3" id="ixv-26941" unitRef="usd">21421000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases contextRef="c0" decimals="-3" id="ixv-26942" unitRef="usd">11228000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases contextRef="c19" decimals="-3" id="ixv-26943" unitRef="usd">21863000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales contextRef="c0" decimals="-3" id="ixv-26944" unitRef="usd">-28818000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales>
    <wt:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions contextRef="c0" decimals="-3" id="ix_4_fact" unitRef="usd">-9684000</wt:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions>
    <wt:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome contextRef="c0" decimals="-3" id="ix_5_fact" unitRef="usd">5853000</wt:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome>
    <wt:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome contextRef="c19" decimals="-3" id="ix_6_fact" unitRef="usd">-442000</wt:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c6" decimals="-3" id="ixv-26948" unitRef="usd">21421000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c142"
      decimals="-3"
      id="ixv-26949"
      unitRef="usd">200290000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c143"
      decimals="-3"
      id="ixv-26950"
      unitRef="usd">228062000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <wt:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome
      contextRef="c144"
      decimals="-3"
      id="ix_7_fact"
      unitRef="usd">6069000</wt:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome>
    <wt:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome
      contextRef="c145"
      decimals="-3"
      id="ix_8_fact"
      unitRef="usd">17108000</wt:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityNetUnrealizedGainLossIncludedInEarningsAndOtherComprehensiveIncome>
    <wt:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings
      contextRef="c144"
      decimals="-3"
      id="ix_9_fact"
      unitRef="usd">-61953000</wt:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings>
    <wt:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings
      contextRef="c145"
      decimals="-3"
      id="ix_10_fact"
      unitRef="usd">-27765000</wt:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales
      contextRef="c144"
      decimals="-3"
      id="ixv-26955"
      unitRef="usd">-144406000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales
      contextRef="c145"
      decimals="-3"
      id="ixv-26956"
      unitRef="usd">-17115000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c142"
      decimals="-3"
      id="ixv-26957"
      unitRef="usd">200290000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FinancialInstrumentsDisclosureTextBlock contextRef="c0" id="ixv-20281">&lt;p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;5. Financial instruments owned&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-left:24pt;text-indent:0pt;margin-top:8pt;"&gt;These instruments consist of the following:&lt;/p&gt;
		&lt;table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;"&gt;


				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-1 _idGenCellOverride-2" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Financial instruments owned:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Trading securities&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;45,421&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;124,474&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Other assets&#x2014;seed capital (WisdomTree Digital Funds)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;13,301&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,765&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;58,722&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;126,239&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:6pt;"&gt;The Company recognized net trading losses on financial instruments owned that were still held at the reporting dates of $536 and $12,721 during the&#160;years ended December&#160;31, 2023 and 2022, respectively, which were recorded in other losses, net, in the Consolidated Statements of Operations.&lt;/p&gt;</us-gaap:FinancialInstrumentsDisclosureTextBlock>
    <us-gaap:ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock contextRef="c0" id="ixv-26961">These instruments consist of the following:&lt;table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;"&gt;


				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-1 _idGenCellOverride-2" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Financial instruments owned:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Trading securities&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;45,421&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;124,474&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Other assets&#x2014;seed capital (WisdomTree Digital Funds)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;13,301&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,765&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;58,722&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;126,239&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:ScheduleOfFinancialInstrumentsOwnedAndPledgedAsCollateralTextBlock>
    <us-gaap:FinancialInstrumentsOwnedAtFairValue
      contextRef="c147"
      decimals="-3"
      id="ixv-26962"
      unitRef="usd">45421000</us-gaap:FinancialInstrumentsOwnedAtFairValue>
    <us-gaap:FinancialInstrumentsOwnedAtFairValue
      contextRef="c148"
      decimals="-3"
      id="ixv-26963"
      unitRef="usd">124474000</us-gaap:FinancialInstrumentsOwnedAtFairValue>
    <us-gaap:FinancialInstrumentsOwnedAtFairValue
      contextRef="c149"
      decimals="-3"
      id="ixv-26964"
      unitRef="usd">13301000</us-gaap:FinancialInstrumentsOwnedAtFairValue>
    <us-gaap:FinancialInstrumentsOwnedAtFairValue
      contextRef="c150"
      decimals="-3"
      id="ixv-26965"
      unitRef="usd">1765000</us-gaap:FinancialInstrumentsOwnedAtFairValue>
    <us-gaap:FinancialInstrumentsOwnedAtFairValue contextRef="c5" decimals="-3" id="ixv-26966" unitRef="usd">58722000</us-gaap:FinancialInstrumentsOwnedAtFairValue>
    <us-gaap:FinancialInstrumentsOwnedAtFairValue contextRef="c6" decimals="-3" id="ixv-26967" unitRef="usd">126239000</us-gaap:FinancialInstrumentsOwnedAtFairValue>
    <us-gaap:TradingGainsLosses contextRef="c0" decimals="-3" id="ixv-26968" unitRef="usd">536000</us-gaap:TradingGainsLosses>
    <us-gaap:TradingGainsLosses contextRef="c19" decimals="-3" id="ixv-26969" unitRef="usd">12721000</us-gaap:TradingGainsLosses>
    <us-gaap:HeldToMaturitySecuritiesTextBlock contextRef="c0" id="ixv-20346">&lt;p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;6. Securities Held-to-Maturity&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"&gt;The following table is a summary of the Company&#x2019;s securities held&lt;span class="nobreak"&gt;-to-maturity&lt;/span&gt;:&lt;/p&gt;
		&lt;table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;"&gt;


				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Debt instruments: Pass-through GSEs (amortized cost)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;230&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;259&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;

		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"&gt;During the&#160;years ended December&#160;31, 2023 and 2022, the Company received proceeds of $29 and $45, respectively, from held&lt;span class="nobreak"&gt;-to-maturity&lt;/span&gt; securities maturing or being called prior to maturity.&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The following table summarizes unrealized gains, losses, and fair value (classified as Level 2 within the fair value hierarchy) of securities held&lt;span class="nobreak"&gt;-to-maturity&lt;/span&gt;:&lt;/p&gt;
		&lt;table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;"&gt;


				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TCH CellOverride-1 _idGenCellOverride-2" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="5" style="width: 37.50%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Cost/amortized cost&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;230&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;259&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Gross unrealized losses&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(15)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(20)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Gross unrealized gains&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-186; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-187; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Fair value&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;215&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;239&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;"&gt;An allowance for credit losses was not provided on the Company&#x2019;s held&lt;span class="nobreak"&gt;-to-maturity&lt;/span&gt; securities as all securities are investments in pass&lt;span class="nobreak"&gt;-through&lt;/span&gt; GSEs which are determined to have an estimated loss rate of zero due to an implicit U.S.&#160;government guarantee.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The following table sets forth the maturity profile of the securities held&lt;span class="nobreak"&gt;-to-maturity&lt;/span&gt;; however, these securities may be called prior to maturity date:&lt;/p&gt;
		&lt;table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;"&gt;


				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TCH CellOverride-1 _idGenCellOverride-2" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="5" style="width: 37.50%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-10 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Due within one year&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-11 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-188; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt; &#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-11 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-189; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt; &#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-10" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Due one year through five&#160;years&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-190; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-191; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-10" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Due five&#160;years through ten&#160;years&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;22&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;27&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-10" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Due over ten&#160;years&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="top"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="top"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;208&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="top"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="top"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;232&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-10" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="top"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="top"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt; 230&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="top"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="top"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;259&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:HeldToMaturitySecuritiesTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock contextRef="c0" id="ixv-20350">The following table is a summary of the Company&#x2019;s securities held&lt;span class="nobreak"&gt;-to-maturity&lt;/span&gt;:&lt;table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;"&gt;


				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Debt instruments: Pass-through GSEs (amortized cost)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;230&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;259&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="c151"
      decimals="-3"
      id="ixv-26970"
      unitRef="usd">230000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="c152"
      decimals="-3"
      id="ixv-26971"
      unitRef="usd">259000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities contextRef="c0" decimals="-3" id="ixv-26972" unitRef="usd">29000</us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities contextRef="c19" decimals="-3" id="ixv-26973" unitRef="usd">45000</us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities>
    <us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock contextRef="c0" id="ixv-20387">The following table summarizes unrealized gains, losses, and fair value (classified as Level 2 within the fair value hierarchy) of securities held&lt;span class="nobreak"&gt;-to-maturity&lt;/span&gt;:&lt;table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;"&gt;


				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TCH CellOverride-1 _idGenCellOverride-2" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="5" style="width: 37.50%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Cost/amortized cost&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;230&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;259&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Gross unrealized losses&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(15)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(20)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Gross unrealized gains&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-186; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-187; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Fair value&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;215&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;239&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="c153"
      decimals="-3"
      id="ixv-26974"
      unitRef="usd">230000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="c154"
      decimals="-3"
      id="ixv-26975"
      unitRef="usd">259000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="c153"
      decimals="-3"
      id="ixv-26976"
      unitRef="usd">15000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="c154"
      decimals="-3"
      id="ixv-26977"
      unitRef="usd">20000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="c153"
      decimals="-3"
      id="ixv-26978"
      unitRef="usd">215000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="c154"
      decimals="-3"
      id="ixv-26979"
      unitRef="usd">239000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock contextRef="c0" id="ixv-20463">The following table sets forth the maturity profile of the securities held&lt;span class="nobreak"&gt;-to-maturity&lt;/span&gt;; however, these securities may be called prior to maturity date:&lt;table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;"&gt;


				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TCH CellOverride-1 _idGenCellOverride-2" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="5" style="width: 37.50%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-10 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Due within one year&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-11 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-188; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt; &#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-11 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-189; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt; &#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-10" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Due one year through five&#160;years&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-190; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-191; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-10" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Due five&#160;years through ten&#160;years&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;22&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;27&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-10" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Due over ten&#160;years&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="top"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="top"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;208&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="top"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="top"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;232&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-10" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;
						&lt;p class="Texttable_wrap" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="top"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="top"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt; 230&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="top"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="top"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;259&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount contextRef="c5" decimals="-3" id="ixv-26980" unitRef="usd">22000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount contextRef="c6" decimals="-3" id="ixv-26981" unitRef="usd">27000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount contextRef="c5" decimals="-3" id="ixv-26982" unitRef="usd">208000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount contextRef="c6" decimals="-3" id="ixv-26983" unitRef="usd">232000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount>
    <us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss contextRef="c5" decimals="-3" id="ixv-26984" unitRef="usd">230000</us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss contextRef="c6" decimals="-3" id="ixv-26985" unitRef="usd">259000</us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:InvestmentTextBlock contextRef="c0" id="ixv-20548">&lt;p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:6pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;7. Investments&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The following table sets forth the Company&#x2019;s investments:&lt;/p&gt;
		&lt;table class="Table90-" style="width: 90.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0.33in 0pt 0.33in;"&gt;


				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90-" style="border-left-width:1pt;border-left-style:solid;border-left-color:#000000;border-top-width:1pt;border-top-style:solid;border-top-color:#000000;border-right-width:1pt;border-right-style:solid;border-right-color:#000000;border-bottom-width:1pt;border-bottom-style:solid;border-bottom-color:#000000;padding-top:4pt;padding-bottom:4pt;padding-left:4pt;padding-right:4pt;vertical-align:top;width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2" colspan="5" style="width: 27.93%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2" colspan="5" style="width: 30.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December 31, 2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90-" style="border-left-width:1pt;border-left-style:solid;border-left-color:#000000;border-top-width:1pt;border-top-style:solid;border-top-color:#000000;border-right-width:1pt;border-right-style:solid;border-right-color:#000000;border-bottom-width:1pt;border-bottom-style:solid;border-bottom-color:#000000;padding-top:4pt;padding-bottom:4pt;padding-left:4pt;padding-right:4pt;vertical-align:top;width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Carrying &lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Cost&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Carrying &lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 15.54%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Cost&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TCH CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Securrency, Inc.:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2" colspan="2" style="width: 15.54%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1 _idGenCellOverride-3" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Series&#160;A Shares&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-192; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-193; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;8,488&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;8,112&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Series&#160;B Shares&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-194; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-195; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;5,500&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;5,500&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Convertible note&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-196; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-197; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;14,500&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;15,000&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Subtotal&#x2014;Securrency, Inc.&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-198; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-199; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;28,488&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;28,612&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Fnality International Limited:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Convertible note&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-200; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-201; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6,921&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6,863&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Series&#160;B-1 Preference Shares&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;9,684&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;8,091&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-202; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-203; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Subtotal&#x2014;Fnality International Limited&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;9,684&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;8,091&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6,921&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6,863&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Other investments&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-204; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;250&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;312&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;250&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;9,684&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;8,341&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;35,721&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;35,725&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:8pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Securrency, Inc.&lt;/span&gt;&lt;/p&gt;
		&lt;p class="H4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:12pt;margin-top:8pt;margin-top:6pt;"&gt;&lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;Exit from Investment&#160;&#x2013;&#160;Year Ended December&#160;31, 2023&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;"&gt;On December&#160;7, 2023, the Company received proceeds of $28,818 relating to the exit from its investment in Securrency, Inc. (&#x201c;Securrency&#x201d;), a developer of institutional&lt;span class="nobreak"&gt;-grade&lt;/span&gt; blockchain&lt;span class="nobreak"&gt;-based&lt;/span&gt; financial and regulatory technology, in connection with the sale of Securrency to an unaffiliated third party. This resulted in a net impairment charge of $7,630 and additional losses of $1,777, recorded in other losses, net, recognized during the year ended December&#160;31, 2023.&lt;/p&gt;&lt;div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;"&gt;
		&lt;p class="H4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:12pt;margin-top:12pt;"&gt;&lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;Disclosures Pertaining to December&#160;31, 2022&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-left:24pt;margin-top:8pt;margin-top:8pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Preferred Stock&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company owned approximately 22% (or 18% on a fully&lt;span class="nobreak"&gt;-diluted&lt;/span&gt; basis) of the capital stock of Securrency, issued as a result of strategic investments totaling $13,612. In consideration of such investments, the Company had received 5,178,488&lt;span class="nobreak"&gt; &lt;/span&gt;shares of Series&#160;A convertible preferred stock (&#x201c;Series&#160;A Shares&#x201d;) in December&#160;2019 and 2,004,665&lt;span class="nobreak"&gt; &lt;/span&gt;shares of Series&#160;B convertible preferred stock (&#x201c;Series&#160;B Shares&#x201d;) in March&#160;2021. The Series&#160;B Shares contained a liquidation preference that was pari passu with shares of Series&#160;B&lt;span class="nobreak"&gt;-1&lt;/span&gt; convertible preferred stock (which were substantially the same as the Series&#160;B Shares except that they had limited voting rights) and senior to that of the holders of the Series&#160;A Shares, which were senior to the holders of common stock. Otherwise, the Series&#160;A Shares and Series&#160;B Shares had substantially the same terms, were convertible into common stock at the option of the Company and contained various rights and protections including a non&lt;span class="nobreak"&gt;-cumulative&lt;/span&gt; 6.0% dividend, payable if and when declared by the board of directors of Securrency. In addition, the Series&#160;A Shares and Series&#160;B Shares (together with the Series&#160;B&lt;span class="nobreak"&gt;-1&lt;/span&gt; convertible preferred stock) were separately redeemable, with respect to all of the shares outstanding of the applicable series of preferred stock (subject to certain regulatory restrictions of certain investors), for the original issue price thereof, plus all declared and unpaid dividends, upon approval by holders of at least 60% of the Series&#160;A Shares (at any time on or after December&#160;31, 2029) and 90% of the Series&#160;B Shares (at any time on or after March&#160;31, 2031).&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;These investments were accounted for under the measurement alternative prescribed in ASC&#160;321, as they did not have a readily determinable fair value and were not considered to be in&lt;span class="nobreak"&gt;-substance&lt;/span&gt; common stock. The investments were assessed for impairment and similar observable transactions on a quarterly basis. There was no impairment recognized during the&#160;years ended December&#160;31, 2022 and 2021 based upon a qualitative assessment.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;During the year ended December&#160;31, 2021, the Company recognized a gain of $376 on its Series&#160;A Shares, which were re&lt;span class="nobreak"&gt;-measured&lt;/span&gt; to fair value upon the issuance of Securrency&#x2019;s Series&#160;B Shares. Fair value was determined using the backsolve method, a valuation approach that determines the value of shares for companies with complex capital structures based upon the price paid for shares recently issued. Fair value was allocated across the capital structure using the Black&lt;span class="nobreak"&gt;-Scholes&lt;/span&gt; option pricing model.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The table below presents the inputs used in the backsolve valuation approach (classified as Level 3 in the fair value hierarchy):&lt;/p&gt;
		&lt;table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;"&gt;


				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TCH CellOverride-1 _idGenCellOverride-2" style="width: 55.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-2 _idGenCellOverride-2" colspan="3" style="width: 42.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="CharOverride-7" style="font-style:normal;font-weight:bold;"&gt;Inputs&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TCH CellOverride-1" style="width: 55.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-5" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-2" style="width: 19.69%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="CharOverride-7" style="font-style:normal;font-weight:bold;"&gt;June&#160;9, &lt;br/&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-5" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-2" style="width: 21.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="CharOverride-7" style="font-style:normal;font-weight:bold;"&gt;March&#160;8, &lt;br/&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1 _idGenCellOverride-3" style="width: 55.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Expected volatility&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 19.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;50%&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 21.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;55%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1" style="width: 55.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Time to exit (in&#160;years)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 19.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;4.75&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 21.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;5.00&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;
		&lt;p class="Text_flush" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:3;margin-left:24pt;margin-top:14pt;margin-top:14pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Convertible Note&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;In April and November&#160;2022, the Company participated in a convertible note financing, making an aggregate investment of $15,000 in Securrency. In consideration for its investment, the Company was issued a 7% Convertible Promissory Note maturing on April&#160;21, 2023.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The note was convertible into either Securrency&#x2019;s common stock or the class of securities convertible into, exchangeable for, or conferring the right to purchase Securrency&#x2019;s common stock that was issued in the event of a future equity financing at a conversion price equal to a discount of 25% (or, if applicable, a greater discount offered to other holders of convertible securities in such future equity financing round) to the lowest price paid per equity share issued in the future equity financing round.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The note was redeemable upon the occurrence of a corporate transaction for an amount which was the greater of (i)&#160;the principal amount and all accrued interest and (ii)&#160;the amount that would be received had the note been converted to common stock immediately prior to the occurrence of the corporate transaction. At maturity, redemption or conversion could occur upon the election by the holders of a majority&lt;span class="nobreak"&gt;-in-interest&lt;/span&gt; of the aggregate principal amount of outstanding notes. If no such election was made, Securrency could elect to pay or convert the notes in its sole discretion.&lt;/p&gt;
		&lt;/div&gt;&lt;div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;"&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The note was accounted for at fair value. Fair value was determined by the Company using the probability&lt;span class="nobreak"&gt;-weighted&lt;/span&gt; expected return method (&#x201c;PWERM&#x201d;), a valuation approach that estimated the value of the note assuming various outcomes. During the year ended December&#160;31, 2022, the Company recognized an unrealized loss of $500 when re&lt;span class="nobreak"&gt;-measuring&lt;/span&gt; the notes to fair value.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The table below presents the probability ascribed to potential outcomes used in the PWERM (classified as Level 3 in the fair value hierarchy) and the time to exit:&lt;/p&gt;
		&lt;table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;"&gt;


				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TCH CellOverride-1" style="width: 78.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-5" style="width: 1.64%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-2" style="width: 19.70%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="CharOverride-7" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1 _idGenCellOverride-3" style="width: 78.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Conversion of note upon a future equity financing&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.64%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 19.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;60%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1" style="width: 78.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Redemption of note upon a corporate transaction&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 1.64%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 19.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;25%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1" style="width: 78.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Default&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 1.64%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 19.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;15%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1" style="width: 78.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Time to potential outcome (in&#160;years)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 1.64%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 19.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;0.33&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Fnality International Limited&lt;/span&gt;&lt;/p&gt;
		&lt;p class="H4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:12pt;margin-top:8pt;margin-top:8pt;"&gt;&lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;Series&#160;B-1 Preference Shares (December&#160;31, 2023)&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company owns approximately 5.4% (or 4.8% on a fully&lt;span class="nobreak"&gt;-diluted&lt;/span&gt; basis) of capital stock of Fnality International Limited (&#x201c;Fnality&#x201d;), a company incorporated in England and Wales and focused on creating a peer&lt;span class="nobreak"&gt;-to-peer&lt;/span&gt; digital wholesale settlement ecosystem comprised of a consortium of financial institutions, offering real time cross&lt;span class="nobreak"&gt;-border&lt;/span&gt; payments from a single pool of liquidity. The Company&#x2019;s ownership interest is represented by 2,340,378 Series&#160;B&lt;span class="nobreak"&gt;-1&lt;/span&gt; Preference Shares, resulting from the conversion of its investment of &#xa3;6,000 ($8,091) in convertible notes upon Fnality&#x2019;s qualified equity financing which occurred in October&#160;2023. The Series&#160;B&lt;span class="nobreak"&gt;-1&lt;/span&gt; Preference Shares carry a 1.0x liquidation preference, are convertible into ordinary shares at the option of the Company and contain various rights and protections.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;This investment is accounted for under the measurement alternative prescribed in ASC&#160;321, as it does not have a readily determinable fair value and is otherwise not subject to the equity method of accounting. The investment is assessed for impairment and similar observable transactions on a quarterly basis. During the year ended December&#160;31, 2023, the Company recognized a gain of $1,534 on its investment in Fnality which was re&lt;span class="nobreak"&gt;-measured&lt;/span&gt; to fair value upon the issuance by Fnality of Series&#160;B&lt;span class="nobreak"&gt;-2&lt;/span&gt; Preference Shares to new investors in the qualified equity financing. The Series&#160;B&lt;span class="nobreak"&gt;-2&lt;/span&gt; Preference Shares carry a 1.5x liquidation preference, rank pari passu to the Series&#160;B&lt;span class="nobreak"&gt;-1&lt;/span&gt; Preference Shares and automatically convert into Series&#160;B&lt;span class="nobreak"&gt;-1&lt;/span&gt; Preference Shares if certain conditions are met no later than June&#160;30, 2024.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Fair value of the Company&#x2019;s investments in Fnality were determined using the backsolve method, a valuation approach that determines the value of shares for companies with complex capital structures based upon the price paid for shares recently issued. Fair value is allocated across the capital structure using the Black&lt;span class="nobreak"&gt;-Scholes&lt;/span&gt; option pricing model.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The table below presents the inputs used in the backsolve valuation approach (classified as Level 3 in the fair value hierarchy):&lt;/p&gt;
		&lt;table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;"&gt;


				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TCH CellOverride-1" style="width: 85.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-5" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-2" style="width: 13.41%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1 _idGenCellOverride-3" style="width: 85.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Expected volatility&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 13.41%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;60%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1" style="width: 85.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Time to exit (in&#160;years)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 13.41%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;5.00&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1" style="width: 85.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Probability that Series&#160;B-2 Preference Shares convert into Series&#160;B-1 Preference Shares&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 13.41%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;75%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;There was no impairment recognized during the year ended December&#160;31, 2023 based upon a qualitative assessment.&lt;/p&gt;
		&lt;p class="H4" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:1;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:12pt;margin-top:12pt;"&gt;&lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;Convertible Note (December&#160;31, 2022)&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;In February&#160;2022, the Company participated in a convertible note financing, making a &#xa3;5,000 ($6,863) investment in Fnality International Limited (&#x201c;Fnality&#x201d;), a company incorporated in England and Wales and focused on creating a peer&lt;span class="nobreak"&gt;-to-peer&lt;/span&gt; digital wholesale settlement ecosystem comprised of a consortium of financial institutions, offering real time cross&lt;span class="nobreak"&gt;-border&lt;/span&gt; payments from a single pool of liquidity. In consideration for its investment, the Company was issued a 5% Convertible Unsecured Loan Note maturing on December&#160;31, 2023.&lt;/p&gt;
		&lt;/div&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The note was convertible into equity shares in the event of a future financing round at a conversion price equal to the lower of (i)&#160;a discount of 20% to lowest price paid per equity share issued pursuant to such future financing round and (ii)&#160;an amount paid per share subject to a pre&lt;span class="nobreak"&gt;-money&lt;/span&gt; valuation cap. Mandatory conversion could occur on or after the maturity date or, if earlier, in the event a future financing round had not been completed within a specified time from an initial closing of such financing round (&#x201c;Long Stop Date&#x201d;), upon the approval of holders of at least 75% of the outstanding notes. The note was also convertible, at the option of the Company, following the earlier of the maturity date or such Long Stop Date.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The note was redeemable upon the occurrence of a change of control for an amount which was the greater of (i)&#160;the principal amount and all accrued interest and (ii)&#160;the amount that would have been received had the note been converted to equity shares immediately prior to the occurrence of the change of control. Redemption could also occur on or after maturity or prior to maturity upon approval by holders of at least 50% and 75%, respectively, of the outstanding notes, or in connection with bankruptcy or other liquidation events.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The note was accounted for at fair value. Fair value was determined by the Company using the PWERM and was also remeasured for changes in the British pound and U.S.&#160;dollar exchange rate. During the year ended December&#160;31, 2022, the Company recognized a gain of $58 when re&lt;span class="nobreak"&gt;-measuring&lt;/span&gt; the notes to fair value.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The table below presents the probability ascribed to potential outcomes used in the PWERM (classified as Level 3 in the fair value hierarchy) and the time to exit:&lt;/p&gt;
		&lt;table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;"&gt;


				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TCH CellOverride-1" style="width: 78.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-5" style="width: 1.86%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-2" style="width: 20.12%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1 _idGenCellOverride-3" style="width: 78.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Conversion of note upon a future financing round&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.86%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 20.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;85%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1" style="width: 78.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Redemption of note upon a change of control&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 1.86%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 20.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;10%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1" style="width: 78.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Default&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 1.86%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 20.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;5%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1" style="width: 78.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Time to potential outcome (in&#160;years)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 1.86%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 20.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;0.25&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:14pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Other Investments&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;During the year ended December&#160;31, 2023, the Company recognized an impairment of $312 on its other investments.&lt;/p&gt;</us-gaap:InvestmentTextBlock>
    <us-gaap:InvestmentTableTextBlock contextRef="c0" id="ixv-26986">The following table sets forth the Company&#x2019;s investments:&lt;table class="Table90-" style="width: 90.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0.33in 0pt 0.33in;"&gt;


				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90-" style="border-left-width:1pt;border-left-style:solid;border-left-color:#000000;border-top-width:1pt;border-top-style:solid;border-top-color:#000000;border-right-width:1pt;border-right-style:solid;border-right-color:#000000;border-bottom-width:1pt;border-bottom-style:solid;border-bottom-color:#000000;padding-top:4pt;padding-bottom:4pt;padding-left:4pt;padding-right:4pt;vertical-align:top;width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2" colspan="5" style="width: 27.93%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December 31, 2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2" colspan="5" style="width: 30.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December 31, 2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90-" style="border-left-width:1pt;border-left-style:solid;border-left-color:#000000;border-top-width:1pt;border-top-style:solid;border-top-color:#000000;border-right-width:1pt;border-right-style:solid;border-right-color:#000000;border-bottom-width:1pt;border-bottom-style:solid;border-bottom-color:#000000;padding-top:4pt;padding-bottom:4pt;padding-left:4pt;padding-right:4pt;vertical-align:top;width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Carrying &lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Cost&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Carrying &lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 15.54%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Cost&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TCH CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Securrency, Inc.:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2" colspan="2" style="width: 13.29%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-5" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2" colspan="2" style="width: 15.54%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1 _idGenCellOverride-3" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Series&#160;A Shares&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-192; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-193; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;8,488&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;8,112&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Series&#160;B Shares&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-194; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-195; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;5,500&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;5,500&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Convertible note&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-196; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-197; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;14,500&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;15,000&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Subtotal&#x2014;Securrency, Inc.&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-198; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-199; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;28,488&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;28,612&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Fnality International Limited:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Convertible note&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-200; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-201; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6,921&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6,863&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Series&#160;B-1 Preference Shares&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;9,684&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;8,091&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-202; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-203; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Subtotal&#x2014;Fnality International Limited&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;9,684&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;8,091&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6,921&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6,863&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Other investments&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-204; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;250&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;312&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;250&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 39.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;9,684&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;8,341&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.49%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;35,721&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.35%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.80%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.74%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;35,725&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:InvestmentTableTextBlock>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c172"
      decimals="-3"
      id="ixv-26987"
      unitRef="usd">8488000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="c172"
      decimals="-3"
      id="ixv-26988"
      unitRef="usd">8112000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c174"
      decimals="-3"
      id="ixv-26989"
      unitRef="usd">5500000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="c174"
      decimals="-3"
      id="ixv-26990"
      unitRef="usd">5500000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c176"
      decimals="-3"
      id="ixv-26991"
      unitRef="usd">14500000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="c176"
      decimals="-3"
      id="ixv-26992"
      unitRef="usd">15000000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c178"
      decimals="-3"
      id="ixv-26993"
      unitRef="usd">28488000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="c178"
      decimals="-3"
      id="ixv-26994"
      unitRef="usd">28612000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c180"
      decimals="-3"
      id="ixv-26995"
      unitRef="usd">6921000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="c180"
      decimals="-3"
      id="ixv-26996"
      unitRef="usd">6863000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c181"
      decimals="-3"
      id="ixv-26997"
      unitRef="usd">9684000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="c181"
      decimals="-3"
      id="ixv-26998"
      unitRef="usd">8091000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c183"
      decimals="-3"
      id="ixv-26999"
      unitRef="usd">9684000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="c183"
      decimals="-3"
      id="ixv-27000"
      unitRef="usd">8091000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c184"
      decimals="-3"
      id="ixv-27001"
      unitRef="usd">6921000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="c184"
      decimals="-3"
      id="ixv-27002"
      unitRef="usd">6863000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="c185"
      decimals="-3"
      id="ixv-27003"
      unitRef="usd">250000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c186"
      decimals="-3"
      id="ixv-27004"
      unitRef="usd">312000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="c186"
      decimals="-3"
      id="ixv-27005"
      unitRef="usd">250000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c5" decimals="-3" id="ixv-27006" unitRef="usd">9684000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentOwnedAtCost contextRef="c5" decimals="-3" id="ixv-27007" unitRef="usd">8341000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c6" decimals="-3" id="ixv-27008" unitRef="usd">35721000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentOwnedAtCost contextRef="c6" decimals="-3" id="ixv-27009" unitRef="usd">35725000</us-gaap:InvestmentOwnedAtCost>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="c157"
      decimals="-3"
      id="ixv-27010"
      unitRef="usd">28818000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment contextRef="c0" decimals="-3" id="ixv-27011" unitRef="usd">7630000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:ProvisionForOtherLosses contextRef="c0" decimals="-3" id="ixv-27012" unitRef="usd">1777000</us-gaap:ProvisionForOtherLosses>
    <wt:CapitalStockPercentage
      contextRef="c158"
      decimals="2"
      id="ixv-27013"
      unitRef="pure">0.22</wt:CapitalStockPercentage>
    <wt:CapitalStockPercentage
      contextRef="c159"
      decimals="2"
      id="ixv-27014"
      unitRef="pure">0.18</wt:CapitalStockPercentage>
    <us-gaap:Investments contextRef="c6" decimals="-3" id="ixv-27015" unitRef="usd">13612000</us-gaap:Investments>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="c160"
      decimals="0"
      id="ixv-27016"
      unitRef="shares">5178488</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="c161"
      decimals="0"
      id="ixv-27017"
      unitRef="shares">2004665</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:PreferredStockDividendRatePercentage contextRef="c19" decimals="3" id="ixv-27018" unitRef="pure">0.06</us-gaap:PreferredStockDividendRatePercentage>
    <wt:SharesPercentage contextRef="c11" decimals="2" id="ixv-27019" unitRef="pure">0.60</wt:SharesPercentage>
    <wt:SharesPercentage
      contextRef="c162"
      decimals="2"
      id="ixv-27020"
      unitRef="pure">0.90</wt:SharesPercentage>
    <us-gaap:GainOrLossOnSaleOfStockInSubsidiary contextRef="c20" decimals="-3" id="ixv-27021" unitRef="usd">376000</us-gaap:GainOrLossOnSaleOfStockInSubsidiary>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="c0" id="ixv-27022">The table below presents the inputs used in the backsolve valuation approach (classified as Level 3 in the fair value hierarchy):&lt;table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;"&gt;


				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TCH CellOverride-1 _idGenCellOverride-2" style="width: 55.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-2 _idGenCellOverride-2" colspan="3" style="width: 42.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="CharOverride-7" style="font-style:normal;font-weight:bold;"&gt;Inputs&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TCH CellOverride-1" style="width: 55.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-5" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-2" style="width: 19.69%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="CharOverride-7" style="font-style:normal;font-weight:bold;"&gt;June&#160;9, &lt;br/&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-5" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-2" style="width: 21.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="CharOverride-7" style="font-style:normal;font-weight:bold;"&gt;March&#160;8, &lt;br/&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1 _idGenCellOverride-3" style="width: 55.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Expected volatility&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 19.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;50%&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 21.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;55%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1" style="width: 55.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Time to exit (in&#160;years)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 19.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;4.75&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 21.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;5.00&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;&lt;table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;"&gt;


				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TCH CellOverride-1" style="width: 85.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-5" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-2" style="width: 13.41%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1 _idGenCellOverride-3" style="width: 85.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Expected volatility&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 13.41%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;60%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1" style="width: 85.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Time to exit (in&#160;years)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 13.41%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;5.00&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1" style="width: 85.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Probability that Series&#160;B-2 Preference Shares convert into Series&#160;B-1 Preference Shares&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 13.41%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;75%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c187"
      decimals="2"
      id="ixv-27023"
      unitRef="pure">0.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c188"
      decimals="2"
      id="ixv-27024"
      unitRef="pure">0.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c187" id="ixv-27025">P4Y9M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c188" id="ixv-27026">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ConvertibleDebt
      contextRef="c163"
      decimals="-3"
      id="ixv-27027"
      unitRef="usd">15000000</us-gaap:ConvertibleDebt>
    <us-gaap:ConvertibleDebt
      contextRef="c164"
      decimals="-3"
      id="ixv-27028"
      unitRef="usd">15000000</us-gaap:ConvertibleDebt>
    <us-gaap:DebtConversionConvertedInstrumentRate
      contextRef="c165"
      decimals="2"
      id="ixv-27029"
      unitRef="pure">0.07</us-gaap:DebtConversionConvertedInstrumentRate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="c165" id="ixv-27030">2023-04-21</us-gaap:DebtInstrumentMaturityDate>
    <wt:ConvertibleNoteDiscountRate contextRef="c0" decimals="2" id="ixv-27031" unitRef="pure">0.25</wt:ConvertibleNoteDiscountRate>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="c166"
      decimals="-3"
      id="ixv-27032"
      unitRef="usd">500000</us-gaap:UnrealizedGainLossOnInvestments>
    <srt:ScheduleOfCondensedFinancialStatementsTableTextBlock contextRef="c0" id="ixv-27033">The table below presents the probability ascribed to potential outcomes used in the PWERM (classified as Level 3 in the fair value hierarchy) and the time to exit:&lt;table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;"&gt;


				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TCH CellOverride-1" style="width: 78.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-5" style="width: 1.64%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-2" style="width: 19.70%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="CharOverride-7" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1 _idGenCellOverride-3" style="width: 78.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Conversion of note upon a future equity financing&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.64%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 19.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;60%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1" style="width: 78.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Redemption of note upon a corporate transaction&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 1.64%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 19.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;25%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1" style="width: 78.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Default&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 1.64%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 19.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;15%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1" style="width: 78.66%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Time to potential outcome (in&#160;years)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 1.64%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 19.70%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;0.33&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;&lt;table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;"&gt;


				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TCH CellOverride-1" style="width: 78.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-5" style="width: 1.86%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-2" style="width: 20.12%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1 _idGenCellOverride-3" style="width: 78.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Conversion of note upon a future financing round&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.86%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 20.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;85%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1" style="width: 78.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Redemption of note upon a change of control&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 1.86%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 20.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;10%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1" style="width: 78.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Default&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 1.86%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 20.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;5%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-1" style="width: 78.01%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Time to potential outcome (in&#160;years)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 1.86%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2" style="width: 20.12%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;0.25&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</srt:ScheduleOfCondensedFinancialStatementsTableTextBlock>
    <wt:ConversionOfNotesUponAFutureEquityFinancing
      contextRef="c189"
      decimals="2"
      id="ixv-27034"
      unitRef="pure">0.60</wt:ConversionOfNotesUponAFutureEquityFinancing>
    <wt:RedemptionOfNoteUponACorporateTransaction
      contextRef="c189"
      decimals="2"
      id="ixv-27035"
      unitRef="pure">0.25</wt:RedemptionOfNoteUponACorporateTransaction>
    <wt:FairValueAssumptionOfDissolutionRate
      contextRef="c189"
      decimals="2"
      id="ixv-27036"
      unitRef="pure">0.15</wt:FairValueAssumptionOfDissolutionRate>
    <wt:TimeToPotentialOutcomeinYear contextRef="c189" id="ixv-27037">P0Y3M29D</wt:TimeToPotentialOutcomeinYear>
    <us-gaap:VariableInterestEntityOwnershipPercentage contextRef="c0" decimals="3" id="ixv-27038" unitRef="pure">0.054</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="c167"
      decimals="3"
      id="ixv-27039"
      unitRef="pure">0.048</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:OtherOwnershipInterestsUnitsIssued
      contextRef="c168"
      decimals="0"
      id="ixv-27040"
      unitRef="shares">2340378</us-gaap:OtherOwnershipInterestsUnitsIssued>
    <wt:CostMethodInvestmentFairValueDisclosure contextRef="c5" decimals="-3" id="ixv-27041" unitRef="eur">6000000</wt:CostMethodInvestmentFairValueDisclosure>
    <wt:CostMethodInvestmentFairValueDisclosure contextRef="c5" decimals="-3" id="ixv-27042" unitRef="usd">-8091000</wt:CostMethodInvestmentFairValueDisclosure>
    <us-gaap:GainLossOnInvestments
      contextRef="c167"
      decimals="-3"
      id="ixv-27043"
      unitRef="usd">1534000</us-gaap:GainLossOnInvestments>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="c58" decimals="2" id="ixv-27044" unitRef="pure">0.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c58" id="ixv-27045">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <wt:ProbabilityThatSeriesB2PreferenceSharesCovertIntoSeriesB1PreferenceShares contextRef="c58" decimals="2" id="ixv-27046" unitRef="pure">0.75</wt:ProbabilityThatSeriesB2PreferenceSharesCovertIntoSeriesB1PreferenceShares>
    <wt:CostMethodInvestmentFairValueDisclosure
      contextRef="c169"
      decimals="-3"
      id="ixv-27047"
      unitRef="eur">5000000</wt:CostMethodInvestmentFairValueDisclosure>
    <wt:CostMethodInvestmentFairValueDisclosure
      contextRef="c169"
      decimals="-3"
      id="ixv-27048"
      unitRef="usd">-6863000</wt:CostMethodInvestmentFairValueDisclosure>
    <wt:CostMethodInvestmentOwnershipPercentage contextRef="c5" decimals="2" id="ixv-27049" unitRef="pure">0.05</wt:CostMethodInvestmentOwnershipPercentage>
    <wt:PercentageOfDiscountOnFutureEquityFinancingForPreferredStock contextRef="c5" decimals="2" id="ixv-27050" unitRef="pure">0.20</wt:PercentageOfDiscountOnFutureEquityFinancingForPreferredStock>
    <wt:PercentageOfOutstandingConvertibleNotes contextRef="c0" decimals="2" id="ixv-27051" unitRef="pure">0.75</wt:PercentageOfOutstandingConvertibleNotes>
    <wt:PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity contextRef="c0" decimals="2" id="ixv-27052" unitRef="pure">0.50</wt:PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesAtMaturity>
    <wt:PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity contextRef="c0" decimals="2" id="ixv-27053" unitRef="pure">0.75</wt:PercentageOfVotingApprovalRequiredToRedeemAllOfTheOutstandingNotesBeforeMaturity>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="c170"
      decimals="-3"
      id="ixv-27054"
      unitRef="usd">58000</us-gaap:UnrealizedGainLossOnInvestments>
    <wt:ConversionOfNoteUponAFutureFinancingRound
      contextRef="c189"
      decimals="2"
      id="ixv-27055"
      unitRef="pure">0.85</wt:ConversionOfNoteUponAFutureFinancingRound>
    <wt:RedemptionOfNoteUponAChangeOfControl
      contextRef="c189"
      decimals="2"
      id="ixv-27056"
      unitRef="pure">0.10</wt:RedemptionOfNoteUponAChangeOfControl>
    <wt:Default
      contextRef="c189"
      decimals="2"
      id="ixv-27057"
      unitRef="pure">0.05</wt:Default>
    <wt:TimeToPotentialOutcomesinYears contextRef="c189" id="ixv-27058">P0Y3M</wt:TimeToPotentialOutcomesinYears>
    <us-gaap:OtherInvestments contextRef="c5" decimals="-3" id="ixv-27059" unitRef="usd">312000</us-gaap:OtherInvestments>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c0" id="ixv-21035">&lt;p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;8. Fixed Assets, net&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The following table summarizes fixed assets:&lt;/p&gt;
		&lt;table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;"&gt;


				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TCH CellOverride-1 _idGenCellOverride-2" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="5" style="width: 37.50%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Equipment&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;1,097&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;962&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Less: accumulated depreciation&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(670)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(418)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;427&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;544&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c0" id="ixv-27060">The following table summarizes fixed assets:&lt;table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;"&gt;


				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TCH CellOverride-1 _idGenCellOverride-2" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="5" style="width: 37.50%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TCH CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2" colspan="2" style="width: 17.19%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-5" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2" colspan="2" style="width: 18.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Equipment&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;1,097&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;962&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Less: accumulated depreciation&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(670)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(418)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-1" style="width: 60.94%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 15.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;427&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.56%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 2.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 16.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;544&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c190"
      decimals="-3"
      id="ixv-27061"
      unitRef="usd">1097000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="c191"
      decimals="-3"
      id="ixv-27062"
      unitRef="usd">962000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c5" decimals="-3" id="ixv-27063" unitRef="usd">670000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c6" decimals="-3" id="ixv-27064" unitRef="usd">418000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c5" decimals="-3" id="ixv-27065" unitRef="usd">427000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c6" decimals="-3" id="ixv-27066" unitRef="usd">544000</us-gaap:PropertyPlantAndEquipmentNet>
    <wt:DeferredConsiderationTextBlock contextRef="c0" id="ixv-21096">&lt;p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;9. Deferred Consideration&#x2014;gold payments&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;"&gt;Deferred consideration&#x2014;gold payments represented an obligation the Company assumed in connection with its acquisition of the European exchange&lt;span class="nobreak"&gt;-traded&lt;/span&gt; commodity, currency and leveraged&lt;span class="nobreak"&gt;-and-inverse&lt;/span&gt; business of ETFS Capital Limited (&#x201c;ETFS Capital&#x201d;) which occurred on April&#160;11, 2018 (&#x201c;ETFS Acquisition&#x201d;). The obligation was for fixed payments to ETFS Capital of physical gold bullion equating to 9,500 ounces of gold per year through March&#160;31, 2058 and then subsequently reduced to 6,333 ounces of gold continuing into perpetuity (&#x201c;Contractual Gold Payments&#x201d;). ETFS Capital passed through these payments to other parties to meet its payment obligations under prior royalty agreements it had with such parties, including to Gold Bullion Holdings (Jersey) Limited (&#x201c;GBH&#x201d;), a subsidiary of the World Gold Council (&#x201c;WGC&#x201d;), Graham Tuckwell (&#x201c;GT&#x201d;), and Rodber Investments Limited (&#x201c;RIL&#x201d;), an entity controlled by GT, who is also the Chairman of ETFS Capital.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:5.5pt;"&gt;On May&#160;10, 2023, the Company terminated its Contractual Gold Payments obligation for aggregate consideration totaling $136,903 pursuant to a Sale, Purchase and Assignment Deed (the &#x201c;SPA Agreement&#x201d;) with WisdomTree International Holdings Ltd, Electra Target HoldCo Limited, ETFS Capital, WGC, GBH, GT and RIL.&#160;Under the terms of the transaction, GBH received approximately $4,371 in cash and 13,087&lt;span class="nobreak"&gt; &lt;/span&gt;shares of Series&#160;C Preferred Stock, convertible into 13,087,000&lt;span class="nobreak"&gt; &lt;/span&gt;shares of the Company&#x2019;s common stock, and RIL received approximately $45,634 in cash.&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:5.5pt;"&gt;On November&#160;20, 2023, the Company repurchased the 13,087&lt;span class="nobreak"&gt; &lt;/span&gt;shares of Series&#160;C Preferred Stock issued to GBH for aggregate consideration of $84,411, $40,000 of which was paid on the closing date, with the remaining $44,411 payable in equal, interest&lt;span class="nobreak"&gt;-free&lt;/span&gt; installments on the first, second and third anniversaries of the closing date. See Note&#160;12 for additional information.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:5.5pt;"&gt;The Company determined the present value of the deferred consideration of $0 and $200,290 at December&#160;31, 2022 using the following assumptions:&lt;/p&gt;
		&lt;table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;"&gt;


				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TCH CellOverride-1" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-5" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2" colspan="2" style="width: 20.22%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, 2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-12 _idGenCellOverride-3" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Forward-looking gold price (low)&#x2014;per ounce&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-14 _idGenCellOverride-3" style="width: 2.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-14 _idGenCellOverride-3" style="width: 17.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;1,858&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-12" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Forward-looking gold price (high)&#x2014;per ounce&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-14" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-14" style="width: 2.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-14" style="width: 17.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;3,126&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-12" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Forward-looking gold price (weighted average)&#x2014;per ounce&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-14" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-14" style="width: 2.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-14" style="width: 17.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;2,237&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-12" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Discount rate&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-14" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-14" style="width: 2.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-14" style="width: 17.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;11.0%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-12" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Perpetual growth rate&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-14" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-14" style="width: 2.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-14" style="width: 17.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1.3%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:7pt;margin-top:7pt;"&gt;The forward&lt;span class="nobreak"&gt;-looking&lt;/span&gt; gold prices at December&#160;31, 2022 were extrapolated from the last observable CMX exchange price (beyond 2028) and the weighted&lt;span class="nobreak"&gt;-average&lt;/span&gt; price per ounce was derived from the relative present values of the annual payment obligations. The perpetual growth rate at December&#160;31, 2022 was determined based upon the increase in observable forward&lt;span class="nobreak"&gt;-looking&lt;/span&gt; gold prices through 2028. This obligation is classified as Level 3 as the discount rate, the extrapolated forward&lt;span class="nobreak"&gt;-looking&lt;/span&gt; gold prices and perpetual growth rate are significant unobservable inputs. An increase in spot gold prices, forward&lt;span class="nobreak"&gt;-looking&lt;/span&gt; gold prices and the perpetual growth rate would result in an increase in deferred consideration, whereas an increase in the discount rate would reduce the fair value.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:5.5pt;"&gt;Current and long&lt;span class="nobreak"&gt;-term&lt;/span&gt; amounts payable were $16,796 and $183,494, respectively, at December&#160;31, 2022.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;margin-top:5.5pt;"&gt;During the&#160;years ended December&#160;31, 2023 and 2022, the Company recognized the following in respect of deferred consideration:&lt;/p&gt;
		&lt;table class="Table90-" style="width: 90.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0.33in 0pt 0.33in;"&gt;


				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TCH CellOverride-1 _idGenCellOverride-2" style="width: 45.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Years Ended December&#160;31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TCH CellOverride-1" style="width: 45.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-5" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2" colspan="2" style="width: 16.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-5" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2" colspan="2" style="width: 16.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-5" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2" colspan="2" style="width: 17.65%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-12 _idGenCellOverride-3" style="width: 45.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Contractual gold payments&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;6,069&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;17,108&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 15.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;17,096&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-12" style="width: 45.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Contractual gold payments&#x2014;gold ounces paid&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;3,167&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;9,500&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 15.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;9,500&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-12" style="width: 45.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Gain on revaluation/termination of deferred consideration&#x2014;gold payments&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(&lt;/span&gt;&lt;span class="CharOverride-5" style="font-size:6pt;vertical-align:super;"&gt;1&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;61,953&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;27,765&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 15.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;2,018&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;&lt;p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:11pt;margin-top:12pt;"&gt;&#x200b;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(1)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;Gains on revaluation/termination of deferred consideration&#x2014;gold payments result from a decrease in spot gold prices, a decrease in the forward&lt;span class="nobreak"&gt;-looking&lt;/span&gt; price of gold, a decrease in the perpetual growth rate and an increase in the discount rate used to compute the present value of the annual payment obligations.&lt;/p&gt;</wt:DeferredConsiderationTextBlock>
    <us-gaap:InvestmentOwnedBalanceOtherMeasure
      contextRef="c192"
      decimals="INF"
      id="ixv-27067"
      unitRef="oz">9500</us-gaap:InvestmentOwnedBalanceOtherMeasure>
    <us-gaap:InvestmentOwnedBalanceOtherMeasure
      contextRef="c193"
      decimals="INF"
      id="ixv-27068"
      unitRef="oz">6333</us-gaap:InvestmentOwnedBalanceOtherMeasure>
    <us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration
      contextRef="c194"
      decimals="-3"
      id="ixv-27069"
      unitRef="usd">136903000</us-gaap:AssetAcquisitionConsiderationTransferredContingentConsideration>
    <us-gaap:Cash
      contextRef="c195"
      decimals="-3"
      id="ixv-27070"
      unitRef="usd">4371000</us-gaap:Cash>
    <us-gaap:PreferredStockSharesIssued
      contextRef="c196"
      decimals="0"
      id="ixv-27071"
      unitRef="shares">13087</us-gaap:PreferredStockSharesIssued>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="c197"
      decimals="0"
      id="ixv-27072"
      unitRef="shares">13087000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:Cash
      contextRef="c198"
      decimals="-3"
      id="ixv-27073"
      unitRef="usd">45634000</us-gaap:Cash>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c199"
      decimals="0"
      id="ixv-27074"
      unitRef="shares">13087</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="c200"
      decimals="-3"
      id="ixv-27075"
      unitRef="usd">84411000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="c201"
      decimals="-3"
      id="ixv-27076"
      unitRef="usd">40000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="c202"
      decimals="-3"
      id="ixv-27077"
      unitRef="usd">44411000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <wt:DisclosureOfValuationOfDeferredConsiderationTableTextBlock contextRef="c0" id="ixv-27078">The Company determined the present value of the deferred consideration of $0 and $200,290 at December&#160;31, 2022 using the following assumptions:&lt;table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;"&gt;


				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TCH CellOverride-1" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-5" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2" colspan="2" style="width: 20.22%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, 2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-12 _idGenCellOverride-3" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Forward-looking gold price (low)&#x2014;per ounce&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-14 _idGenCellOverride-3" style="width: 2.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-14 _idGenCellOverride-3" style="width: 17.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;1,858&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-12" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Forward-looking gold price (high)&#x2014;per ounce&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-14" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-14" style="width: 2.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-14" style="width: 17.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;3,126&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-12" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Forward-looking gold price (weighted average)&#x2014;per ounce&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-14" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-14" style="width: 2.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-14" style="width: 17.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;2,237&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-12" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Discount rate&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-14" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-14" style="width: 2.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-14" style="width: 17.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;11.0%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-12" style="width: 78.09%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Perpetual growth rate&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-14" style="width: 1.69%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-14" style="width: 2.25%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-14" style="width: 17.98%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1.3%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</wt:DisclosureOfValuationOfDeferredConsiderationTableTextBlock>
    <us-gaap:InvestmentOwnedBalanceOtherMeasure contextRef="c5" decimals="-3" id="ixv-27079" unitRef="g">0</us-gaap:InvestmentOwnedBalanceOtherMeasure>
    <us-gaap:InvestmentOwnedBalanceOtherMeasure contextRef="c6" decimals="-3" id="ixv-27080" unitRef="g">200290000</us-gaap:InvestmentOwnedBalanceOtherMeasure>
    <wt:ForwardsLookingGoldPrice contextRef="c203" decimals="-3" id="ixv-27081" unitRef="oz">1858000</wt:ForwardsLookingGoldPrice>
    <wt:ForwardsLookingGoldPrice contextRef="c204" decimals="-3" id="ixv-27082" unitRef="oz">3126000</wt:ForwardsLookingGoldPrice>
    <wt:ForwardsLookingGoldPrice contextRef="c205" decimals="-3" id="ixv-27083" unitRef="oz">2237000</wt:ForwardsLookingGoldPrice>
    <wt:BusinessCombinationConsiderationTransferredDeferredPaymentInterest contextRef="c0" decimals="3" id="ixv-27084" unitRef="pure">0.11</wt:BusinessCombinationConsiderationTransferredDeferredPaymentInterest>
    <wt:DeferredConsiderationPerpetualGrowthRate contextRef="c5" decimals="3" id="ixv-27085" unitRef="pure">0.013</wt:DeferredConsiderationPerpetualGrowthRate>
    <wt:DeferredConsiderationCurrent contextRef="c6" decimals="-3" id="ixv-27086" unitRef="usd">16796000</wt:DeferredConsiderationCurrent>
    <wt:DeferredConsiderationNoncurrent contextRef="c6" decimals="-3" id="ixv-27087" unitRef="usd">183494000</wt:DeferredConsiderationNoncurrent>
    <wt:ScheduleOfDeferredConsiderationTableTextBlock contextRef="c0" id="ixv-27088">During the&#160;years ended December&#160;31, 2023 and 2022, the Company recognized the following in respect of deferred consideration:&lt;table class="Table90-" style="width: 90.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0.33in 0pt 0.33in;"&gt;


				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TCH CellOverride-1 _idGenCellOverride-2" style="width: 45.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Years Ended December&#160;31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TCH CellOverride-1" style="width: 45.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-5" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2" colspan="2" style="width: 16.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-5" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2" colspan="2" style="width: 16.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-5" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2" colspan="2" style="width: 17.65%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-12 _idGenCellOverride-3" style="width: 45.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Contractual gold payments&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;6,069&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;17,108&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14 _idGenCellOverride-3" style="width: 15.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;17,096&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-12" style="width: 45.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Contractual gold payments&#x2014;gold ounces paid&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;3,167&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;9,500&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 15.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;9,500&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-12" style="width: 45.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Gain on revaluation/termination of deferred consideration&#x2014;gold payments&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(&lt;/span&gt;&lt;span class="CharOverride-5" style="font-size:6pt;vertical-align:super;"&gt;1&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;61,953&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 14.22%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;27,765&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 1.47%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 1.96%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-14" style="width: 15.69%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;2,018&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;&lt;p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:11pt;margin-top:12pt;"&gt;&#x200b;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(1)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;Gains on revaluation/termination of deferred consideration&#x2014;gold payments result from a decrease in spot gold prices, a decrease in the forward&lt;span class="nobreak"&gt;-looking&lt;/span&gt; price of gold, a decrease in the perpetual growth rate and an increase in the discount rate used to compute the present value of the annual payment obligations.&lt;/p&gt;</wt:ScheduleOfDeferredConsiderationTableTextBlock>
    <wt:ContractualGoldPayments contextRef="c0" decimals="-3" id="ixv-27089" unitRef="usd">6069000</wt:ContractualGoldPayments>
    <wt:ContractualGoldPayments contextRef="c19" decimals="-3" id="ixv-27090" unitRef="usd">17108000</wt:ContractualGoldPayments>
    <wt:ContractualGoldPayments contextRef="c20" decimals="-3" id="ixv-27091" unitRef="usd">17096000</wt:ContractualGoldPayments>
    <wt:ContractualGoldPaymentgoldOuncesPaid contextRef="c0" decimals="-3" id="ixv-27092" unitRef="oz">3167000</wt:ContractualGoldPaymentgoldOuncesPaid>
    <wt:ContractualGoldPaymentgoldOuncesPaid contextRef="c19" decimals="-3" id="ixv-27093" unitRef="oz">9500000</wt:ContractualGoldPaymentgoldOuncesPaid>
    <wt:ContractualGoldPaymentgoldOuncesPaid contextRef="c20" decimals="-3" id="ixv-27094" unitRef="oz">9500000</wt:ContractualGoldPaymentgoldOuncesPaid>
    <wt:GainLossFromChangeInDeferredConsideration contextRef="c0" decimals="-3" id="ix_11_fact" unitRef="usd">61953000</wt:GainLossFromChangeInDeferredConsideration>
    <wt:GainLossFromChangeInDeferredConsideration
      contextRef="c19"
      decimals="-3"
      id="ix_12_fact"
      unitRef="usd">27765000</wt:GainLossFromChangeInDeferredConsideration>
    <wt:GainLossFromChangeInDeferredConsideration
      contextRef="c20"
      decimals="-3"
      id="ix_13_fact"
      unitRef="usd">2018000</wt:GainLossFromChangeInDeferredConsideration>
    <us-gaap:DebtDisclosureTextBlock contextRef="c0" id="ixv-21259">&lt;p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt; 10. Convertible Notes&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:6pt;"&gt;On February&#160;14, 2023, the Company issued and sold $130,000 in aggregate principal amount of 5.75% Convertible Senior Notes due 2028 (the &#x201c;2023 Notes&#x201d;) pursuant to an indenture dated February&#160;14, 2023, between the Company and U.S.&#160;Bank Trust Company, National Association, as trustee (or its successor in interest, the &#x201c;Trustee&#x201d;), in a private offering to qualified institutional buyers pursuant to Rule&#160;144A under the Securities Act&#160;of&#160;1933, as amended (&#x201c;Rule&#160;144A&#x201d;).&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;On June&#160;14, 2021, the Company issued and sold $150,000 in aggregate principal amount of 3.25% Convertible Senior Notes due 2026 (the &#x201c;2021 Notes&#x201d;) pursuant to an indenture dated June&#160;14, 2021, between the Company and the Trustee, in a private offering to qualified institutional buyers pursuant to Rule&#160;144A.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;"&gt;On June&#160;16, 2020, the Company issued and sold $150,000 in aggregate principal amount of 4.25% Convertible Senior Notes due 2023 (the &#x201c;June&#160;2020 Notes&#x201d;) pursuant to an indenture dated June&#160;16, 2020, between the Company and the Trustee, in a private offering to qualified institutional buyers pursuant to Rule&#160;144A.&#160;On August&#160;13, 2020, the Company issued and sold $25,000 in aggregate principal amount of 4.25% Convertible Senior Notes due 2023 at a price equal to 101% of the principal amount thereof, plus interest deemed to have accrued since June&#160;16, 2020, which constitute a further issuance of, and form a single series with, the Company&#x2019;s June&#160;2020 Notes (the &#x201c;August&#160;2020 Notes&#x201d; and together with the June&#160;2020 Notes, the &#x201c;2020 Notes&#x201d;).&lt;/p&gt;&lt;div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;"&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;In connection with the issuance of the 2023 Notes, the Company repurchased $115,000 in aggregate principal amount of the 2020 Notes. As a result of this repurchase, the Company recognized a loss on extinguishment of approximately $9,721 during the year ended December&#160;31, 2023. The remainder of the 2020 Notes matured on June&#160;15, 2023 and were settled for $59,955 in cash and 1,037,288&lt;span class="nobreak"&gt; &lt;/span&gt;shares of common stock, as the conversion option was in the money.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;After the repurchase and maturity of the 2020 Notes and the issuance of the 2023 Notes (and together with the 2021 Notes, the &#x201c;Convertible Notes&#x201d;), the Company had $280,000 in aggregate principal amount of Convertible Notes outstanding.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Key terms of the Convertible Notes are as follows:&lt;/p&gt;
		&lt;table class="Table85-" style="width: 85.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 10% 0pt 0.33in;"&gt;


				&lt;tr class="Table85-" style="height:12pt;"&gt;
					&lt;td class="Table85- TCH CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table85- TCH CellOverride-5" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TCH CellOverride-2" colspan="2" style="width: 20.17%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023 Notes&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TCH CellOverride-5" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TCH CellOverride-2" colspan="2" style="width: 18.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021 Notes&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table85- TB CellOverride-1 _idGenCellOverride-3" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Principal outstanding&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;130,000&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;150,000&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="height:12pt;"&gt;
					&lt;td class="Table85- TB CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Maturity date (unless earlier converted, repurchased or redeemed)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;August&#160;15,&#160;2028&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;June&#160;15,&#160;2026&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table85- TB CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Interest rate&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;5.75%&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;3.25%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="height:12pt;"&gt;
					&lt;td class="Table85- TB CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Conversion price&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;9.54&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;11.04&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table85- TB CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Conversion rate&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;104.8658&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;90.5797&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="height:12pt;"&gt;
					&lt;td class="Table85- TB CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Redemption price&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;12.40&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;14.35&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;
		&lt;p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:42pt;margin-top:6pt;"&gt;&lt;span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;"&gt;&#x2022;&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;Interest rate: &lt;/span&gt;Payable semiannually in arrears on February&#160;15 and August&#160;15 of each year for the 2023 Notes and on June&#160;15 and December&#160;15 of each year for the 2021 Notes.&lt;/p&gt;
		&lt;p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:42pt;margin-top:6pt;"&gt;&lt;span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;"&gt;&#x2022;&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;Conversion price: &lt;/span&gt;Convertible at an initial conversion rate into shares of the Company&#x2019;s common stock, per $1,000 principal amount of notes (equivalent to an initial conversion price set forth in the table above), subject to adjustment.&lt;/p&gt;
		&lt;p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:42pt;margin-top:6pt;"&gt;&lt;span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;"&gt;&#x2022;&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;Conversion: &lt;/span&gt;Holders may convert at their option at any time prior to the close of business on the business&#160;day immediately preceding May&lt;span class="nobreak"&gt;&#160;&lt;/span&gt;15, 2028 and March&lt;span class="nobreak"&gt;&#160;&lt;/span&gt;15, 2026 for the 2023 Notes and 2021 Notes, respectively, only under the following circumstances: (i)&#160;if the last reported sale price of the Company&#x2019;s common stock for at least 20&#160;trading days during a period of 30 consecutive&#160;trading days ending on the last&#160;trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price for the respective Convertible Notes on each applicable&#160;trading day; (ii)&#160;during the &lt;span style="-sec-ix-hidden: hidden-fact-209"&gt;five&lt;/span&gt; business&#160;day period after any &lt;span style="-sec-ix-hidden: hidden-fact-210"&gt;ten&lt;/span&gt; consecutive&#160;trading day period (the &#x201c;measurement period&#x201d;) in which the trading price per $1,000 principal amount of the Convertible Notes for each&#160;trading day of the measurement period was less than 98% of the product of the last reported sales price of the Company&#x2019;s common stock and the conversion rate on each such&#160;trading day; (iii)&#160;upon a notice of redemption delivered by the Company in accordance with the terms of the indentures but only with respect to the Convertible Notes called (or deemed called) for redemption; or (iv)&#160;upon the occurrence of specified corporate events. On or after May&lt;span class="nobreak"&gt;&#160;&lt;/span&gt;15, 2028 and March&lt;span class="nobreak"&gt;&#160;&lt;/span&gt;15, 2026 in respect of the 2023 Notes and the 2021 Notes, respectively, until the close of business on the second scheduled&#160;trading day immediately preceding the maturity date, holders may convert their Convertible Notes at any time, regardless of the foregoing circumstances.&lt;/p&gt;
		&lt;p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:42pt;margin-top:6pt;"&gt;&lt;span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;"&gt;&#x2022;&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;Cash settlement of principal amount: &lt;/span&gt;Upon conversion, the Company will pay cash up to the aggregate principal amount of the Convertible Notes to be converted. At its election, the Company will also settle its conversion obligation in excess of the aggregate principal amount of the Convertible Notes being converted in either cash, shares of its common stock or a combination of cash and shares of its common stock.&lt;/p&gt;
		&lt;p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-left:42pt;margin-top:6pt;"&gt;&lt;span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;"&gt;&#x2022;&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;Redemption price: &lt;/span&gt;The Company may redeem for cash all or any portion of the Convertible Notes, at its option, on or after August&lt;span class="nobreak"&gt;&#160;&lt;/span&gt;20, 2025 and June&lt;span class="nobreak"&gt;&#160;&lt;/span&gt;20, 2023 in respect of the 2023 Notes and the 2021 Notes, respectively, and on or prior to the 55&lt;span class="CharOverride-6" style="font-size:58%;vertical-align:super;"&gt;th&lt;/span&gt; scheduled&#160;trading day immediately preceding the maturity date, if the last reported sale price of the Company&#x2019;s common stock has been at least 130% of the conversion price for the respective Convertible Notes then in effect for at least 20&#160;trading days, including the&#160;trading day immediately preceding the date on which the Company provides notice of redemption, during any 30 consecutive&#160;trading day period ending on, and including, the&#160;trading day immediately preceding the date on which the Company provides notice of redemption, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding the redemption date. No sinking fund is provided for the Convertible Notes.&lt;/p&gt;
		&lt;/div&gt;&lt;p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;list-style-type:none;margin-left:42pt;margin-top:6pt;"&gt;&lt;span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;"&gt;&#x2022;&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;Limited investor put rights: &lt;/span&gt;Holders of the Convertible Notes have the right to require the Company to repurchase for cash all or a portion of their notes at 100% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of certain change of control transactions or liquidation, dissolution or common stock delisting events.&lt;/p&gt;
		&lt;p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:42pt;margin-top:6pt;"&gt;&lt;span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;"&gt;&#x2022;&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;Conversion rate increase in certain customary circumstances: &lt;/span&gt;In certain circumstances, conversions in connection with a &#x201c;make&lt;span class="nobreak"&gt;-whole&lt;/span&gt; fundamental change&#x201d; (as defined in the indentures) or conversions of Convertible Notes called (or deemed called) for redemption may result in an increase to the conversion rate, provided that the conversion rate will not exceed 167.7853&lt;span class="nobreak"&gt; &lt;/span&gt;shares and 144.9275&lt;span class="nobreak"&gt; &lt;/span&gt;shares of the Company&#x2019;s common stock per $1,000 principal amount of the 2023 Notes and the 2021 Notes, respectively (the equivalent of 43,551,214&lt;span class="nobreak"&gt; &lt;/span&gt;shares of the Company&#x2019;s common stock), subject to adjustment.&lt;/p&gt;
		&lt;p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:42pt;margin-top:6pt;"&gt;&lt;span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;"&gt;&#x2022;&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;&lt;span class="Italic" style="font-style:italic;font-weight:normal;"&gt;Seniority and Security: &lt;/span&gt;The 2023 Notes and 2021 Notes rank equal in right of payment, and are the Company&#x2019;s senior unsecured obligations, but are subordinated in right of payment to the Company&#x2019;s obligations to make certain redemption payments (if and when due) in respect of its Series&#160;A Non&lt;span class="nobreak"&gt;-Voting&lt;/span&gt; Convertible Preferred Stock (Note&#160;11).&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The indentures contain customary terms and covenants, including that upon certain events of default occurring and continuing, either the Trustee or the respective holders of not less than 25% in aggregate principal amount of the respective series of Convertible Notes outstanding may declare the entire principal amount of all such respective Convertible Notes to be repurchased, plus any accrued special interest, if any, to be immediately due and payable.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The following table provides a summary of the Convertible Notes at December&#160;31, 2023 and December&#160;31, 2022:&lt;/p&gt;
		&lt;table class="Table90-" style="width: 90.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0.33in 0pt 0.33in;"&gt;


				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TCH CellOverride-1 _idGenCellOverride-2" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 39.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, 2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 40.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, 2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TCH CellOverride-1" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-5" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 12.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023 Notes&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 12.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021 Notes&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 12.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 12.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021 Notes&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 12.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2020 Notes&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 13.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1 _idGenCellOverride-3" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Principal amount&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;130,000&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;150,000&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;280,000&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;150,000&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;175,000&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;325,000&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Plus: Premium&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-205; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-206; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-207; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-208; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;250&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;250&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Gross proceeds&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;130,000&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;150,000&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;280,000&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;150,000&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;175,250&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;325,250&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Less: Unamortized issuance costs&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(2,987)&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(2,125)&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(5,112)&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(2,981)&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(1,053)&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(4,034)&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Carrying amount&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;127,013&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;147,875&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;274,888&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;147,019&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;174,197&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;321,216&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-15" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Effective interest rate&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(&lt;/span&gt;&lt;span class="CharOverride-5" style="font-size:6pt;vertical-align:super;"&gt;1)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;6.25%&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;3.83%&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;4.96%&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;3.83%&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.26%&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;4.60%&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;&lt;p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;"&gt;&#x200b;&lt;span class="CharOverride-5" style="font-size:6pt;vertical-align:super;"&gt;(1)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;Includes amortization of the issuance costs and premium.&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt; Interest expense on the Convertible Notes during the&#160;years ended December&#160;31, 2023, 2022 and 2021 was $14,945, $14,935 and $12,332, respectively. Interest payable of $3,041 and $621 at December&#160;31, 2023 and 2022, respectively, is included in accounts payable and other liabilities on the Consolidated Balance Sheets.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The fair value of the Convertible Notes (classified as Level 2 in the fair value hierarchy) was $281,897 and $320,513 at December&#160;31, 2023 and 2022, respectively. The if&lt;span class="nobreak"&gt;-converted&lt;/span&gt; value of the Convertible Notes did not exceed the principal amount at December&#160;31, 2023 and 2022.&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c206"
      decimals="-3"
      id="ixv-27098"
      unitRef="usd">130000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c206"
      decimals="4"
      id="ixv-27099"
      unitRef="pure">0.0575</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c207"
      decimals="-3"
      id="ixv-27100"
      unitRef="usd">150000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c207"
      decimals="4"
      id="ixv-27101"
      unitRef="pure">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c208"
      decimals="-3"
      id="ixv-27102"
      unitRef="usd">150000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c208"
      decimals="4"
      id="ixv-27103"
      unitRef="pure">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c209"
      decimals="-3"
      id="ixv-27104"
      unitRef="usd">25000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c209"
      decimals="4"
      id="ixv-27105"
      unitRef="pure">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c210"
      decimals="2"
      id="ixv-27106"
      unitRef="pure">1.01</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c211"
      decimals="-3"
      id="ixv-27107"
      unitRef="usd">115000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ExtinguishmentOfDebtGainLossNetOfTax contextRef="c0" decimals="-3" id="ixv-27108" unitRef="usd">9721000</us-gaap:ExtinguishmentOfDebtGainLossNetOfTax>
    <us-gaap:Cash
      contextRef="c212"
      decimals="-3"
      id="ixv-27109"
      unitRef="usd">59955000</us-gaap:Cash>
    <us-gaap:CommonStockSharesIssued
      contextRef="c213"
      decimals="INF"
      id="ixv-27110"
      unitRef="shares">1037288000</us-gaap:CommonStockSharesIssued>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c214"
      decimals="-3"
      id="ixv-27111"
      unitRef="usd">280000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="c0" id="ixv-27112">Key terms of the Convertible Notes are as follows:&lt;table class="Table85-" style="width: 85.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 10% 0pt 0.33in;"&gt;


				&lt;tr class="Table85-" style="height:12pt;"&gt;
					&lt;td class="Table85- TCH CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table85- TCH CellOverride-5" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TCH CellOverride-2" colspan="2" style="width: 20.17%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023 Notes&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TCH CellOverride-5" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TCH CellOverride-2" colspan="2" style="width: 18.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021 Notes&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table85- TB CellOverride-1 _idGenCellOverride-3" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Principal outstanding&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;130,000&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;150,000&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="height:12pt;"&gt;
					&lt;td class="Table85- TB CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Maturity date (unless earlier converted, repurchased or redeemed)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;August&#160;15,&#160;2028&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;June&#160;15,&#160;2026&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table85- TB CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Interest rate&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;5.75%&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;3.25%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="height:12pt;"&gt;
					&lt;td class="Table85- TB CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Conversion price&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;9.54&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;11.04&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table85- TB CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Conversion rate&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;104.8658&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;90.5797&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="height:12pt;"&gt;
					&lt;td class="Table85- TB CellOverride-1" style="width: 57.92%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Redemption price&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 18.19%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;12.40&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 16.96%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;14.35&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c226"
      decimals="-3"
      id="ixv-27113"
      unitRef="usd">130000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c227"
      decimals="-3"
      id="ixv-27114"
      unitRef="usd">150000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentMaturityDate contextRef="c228" id="ixv-27115">2028-08-15</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="c229" id="ixv-27116">2026-06-15</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c226"
      decimals="4"
      id="ixv-27117"
      unitRef="pure">0.0575</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c227"
      decimals="4"
      id="ixv-27118"
      unitRef="pure">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c226"
      decimals="INF"
      id="ixv-27119"
      unitRef="usdPershares">9.54</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c227"
      decimals="INF"
      id="ixv-27120"
      unitRef="usdPershares">11.04</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="c228"
      decimals="INF"
      id="ixv-27121"
      unitRef="pure">104.8658</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="c229"
      decimals="INF"
      id="ixv-27122"
      unitRef="pure">90.5797</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <wt:DebtInstrumentRedemptionPrice
      contextRef="c228"
      decimals="INF"
      id="ixv-27123"
      unitRef="usdPershares">12.4</wt:DebtInstrumentRedemptionPrice>
    <wt:DebtInstrumentRedemptionPrice
      contextRef="c229"
      decimals="INF"
      id="ixv-27124"
      unitRef="usdPershares">14.35</wt:DebtInstrumentRedemptionPrice>
    <us-gaap:ConversionOfStockAmountIssued1
      contextRef="c215"
      decimals="-3"
      id="ixv-27125"
      unitRef="usd">1000000</us-gaap:ConversionOfStockAmountIssued1>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="c216"
      decimals="0"
      id="ixv-27126"
      unitRef="pure">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="c216"
      decimals="0"
      id="ixv-27127"
      unitRef="pure">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtConversionConvertedInstrumentRate
      contextRef="c217"
      decimals="2"
      id="ixv-27128"
      unitRef="pure">1.30</us-gaap:DebtConversionConvertedInstrumentRate>
    <wt:PrincipalAmountOfTradingPrice
      contextRef="c215"
      decimals="-3"
      id="ixv-27129"
      unitRef="usd">1000000</wt:PrincipalAmountOfTradingPrice>
    <wt:SharePriceAsAPercentageOfLastReportedPriceAndConversionRate
      contextRef="c218"
      decimals="2"
      id="ixv-27130"
      unitRef="pure">0.98</wt:SharePriceAsAPercentageOfLastReportedPriceAndConversionRate>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="c219"
      decimals="0"
      id="ixv-27131"
      unitRef="pure">130</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="c219"
      decimals="0"
      id="ixv-27132"
      unitRef="pure">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="c215"
      decimals="0"
      id="ixv-27133"
      unitRef="pure">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="c215"
      decimals="2"
      id="ixv-27134"
      unitRef="pure">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="c219"
      decimals="2"
      id="ixv-27135"
      unitRef="pure">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <wt:MaximumConversionRate
      contextRef="c219"
      decimals="4"
      id="ixv-27136"
      unitRef="pure">167.7853</wt:MaximumConversionRate>
    <wt:MaximumConversionRate
      contextRef="c215"
      decimals="4"
      id="ixv-27137"
      unitRef="pure">144.9275</wt:MaximumConversionRate>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c218"
      decimals="0"
      id="ixv-27138"
      unitRef="usdPershares">1000</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <wt:MaximumNumberOfSharesIssuableUponConversion
      contextRef="c220"
      decimals="INF"
      id="ixv-27139"
      unitRef="shares">43551214</wt:MaximumNumberOfSharesIssuableUponConversion>
    <wt:MaximumNumberOfSharesIssuableUponConversion
      contextRef="c221"
      decimals="INF"
      id="ixv-27140"
      unitRef="shares">43551214</wt:MaximumNumberOfSharesIssuableUponConversion>
    <wt:MinimumPercentageOfLendersRequiredToHaveEntirePrincipalAmountOfConvertibleNotesRepurchasedByTheCompanyUponCertainEventsOfDefault
      contextRef="c214"
      decimals="2"
      id="ixv-27141"
      unitRef="pure">0.25</wt:MinimumPercentageOfLendersRequiredToHaveEntirePrincipalAmountOfConvertibleNotesRepurchasedByTheCompanyUponCertainEventsOfDefault>
    <us-gaap:ConvertibleDebtTableTextBlock contextRef="c0" id="ixv-27142">The following table provides a summary of the Convertible Notes at December&#160;31, 2023 and December&#160;31, 2022:&lt;table class="Table90-" style="width: 90.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0.33in 0pt 0.33in;"&gt;


				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TCH CellOverride-1 _idGenCellOverride-2" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 39.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, 2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 40.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, 2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TCH CellOverride-1" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-5" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 12.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023 Notes&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 12.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021 Notes&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 12.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 12.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021 Notes&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 12.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2020 Notes&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 13.61%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1 _idGenCellOverride-3" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Principal amount&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;130,000&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;150,000&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;280,000&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;150,000&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;175,000&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-4" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;325,000&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Plus: Premium&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-205; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-206; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-207; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-208; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;250&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;250&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Gross proceeds&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;130,000&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;150,000&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;280,000&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;150,000&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;175,250&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;325,250&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Less: Unamortized issuance costs&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(2,987)&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(2,125)&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(5,112)&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(2,981)&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(1,053)&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(4,034)&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Carrying amount&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:3pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;127,013&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;147,875&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;274,888&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;147,019&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;174,197&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;321,216&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-15" style="width: 16.83%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Effective interest rate&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(&lt;/span&gt;&lt;span class="CharOverride-5" style="font-size:6pt;vertical-align:super;"&gt;1)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;6.25%&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;3.83%&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;4.96%&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;3.83%&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 10.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.26%&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-16" style="width: 11.63%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;4.60%&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;&lt;p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;"&gt;&#x200b;&lt;span class="CharOverride-5" style="font-size:6pt;vertical-align:super;"&gt;(1)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;Includes amortization of the issuance costs and premium.&lt;/p&gt;</us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c226"
      decimals="-3"
      id="ixv-27143"
      unitRef="usd">130000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c227"
      decimals="-3"
      id="ixv-27144"
      unitRef="usd">150000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c230"
      decimals="-3"
      id="ixv-27145"
      unitRef="usd">280000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c231"
      decimals="-3"
      id="ixv-27146"
      unitRef="usd">150000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c232"
      decimals="-3"
      id="ixv-27147"
      unitRef="usd">175000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="c233"
      decimals="-3"
      id="ixv-27148"
      unitRef="usd">325000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="c232"
      decimals="-3"
      id="ixv-27149"
      unitRef="usd">250000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="c233"
      decimals="-3"
      id="ixv-27150"
      unitRef="usd">250000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="c226"
      decimals="-3"
      id="ixv-27151"
      unitRef="usd">130000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="c227"
      decimals="-3"
      id="ixv-27152"
      unitRef="usd">150000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="c230"
      decimals="-3"
      id="ixv-27153"
      unitRef="usd">280000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="c231"
      decimals="-3"
      id="ixv-27154"
      unitRef="usd">150000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="c232"
      decimals="-3"
      id="ixv-27155"
      unitRef="usd">175250000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="c233"
      decimals="-3"
      id="ixv-27156"
      unitRef="usd">325250000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="c226"
      decimals="-3"
      id="ixv-27157"
      unitRef="usd">2987000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="c227"
      decimals="-3"
      id="ixv-27158"
      unitRef="usd">2125000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="c230"
      decimals="-3"
      id="ixv-27159"
      unitRef="usd">5112000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="c231"
      decimals="-3"
      id="ixv-27160"
      unitRef="usd">2981000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="c232"
      decimals="-3"
      id="ixv-27161"
      unitRef="usd">1053000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="c233"
      decimals="-3"
      id="ixv-27162"
      unitRef="usd">4034000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="c226"
      decimals="-3"
      id="ixv-27163"
      unitRef="usd">127013000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="c227"
      decimals="-3"
      id="ixv-27164"
      unitRef="usd">147875000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="c230"
      decimals="-3"
      id="ixv-27165"
      unitRef="usd">274888000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="c231"
      decimals="-3"
      id="ixv-27166"
      unitRef="usd">147019000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="c232"
      decimals="-3"
      id="ixv-27167"
      unitRef="usd">174197000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="c233"
      decimals="-3"
      id="ixv-27168"
      unitRef="usd">321216000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c226"
      decimals="4"
      id="ix_14_fact"
      unitRef="pure">0.0625</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c227"
      decimals="4"
      id="ix_15_fact"
      unitRef="pure">0.0383</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c230"
      decimals="4"
      id="ix_16_fact"
      unitRef="pure">0.0496</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c231"
      decimals="4"
      id="ix_17_fact"
      unitRef="pure">0.0383</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c232"
      decimals="4"
      id="ix_18_fact"
      unitRef="pure">0.0526</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c233"
      decimals="4"
      id="ix_19_fact"
      unitRef="pure">0.046</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:InterestExpense
      contextRef="c216"
      decimals="-3"
      id="ixv-27176"
      unitRef="usd">14945000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="c222"
      decimals="-3"
      id="ixv-27177"
      unitRef="usd">14935000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="c223"
      decimals="-3"
      id="ixv-27178"
      unitRef="usd">12332000</us-gaap:InterestExpense>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="c224"
      decimals="-3"
      id="ixv-27179"
      unitRef="usd">3041000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="c225"
      decimals="-3"
      id="ixv-27180"
      unitRef="usd">621000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFairValue
      contextRef="c153"
      decimals="-3"
      id="ixv-27181"
      unitRef="usd">281897000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="c154"
      decimals="-3"
      id="ixv-27182"
      unitRef="usd">320513000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:PreferredStockTextBlock contextRef="c0" id="ixv-21744">&lt;p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;11. Series&#160;A Preferred Stock&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;On April&#160;10, 2018, the Company filed a Certificate of Designations of Series&#160;A Non&lt;span class="nobreak"&gt;-Voting&lt;/span&gt; Convertible Preferred Stock with the Secretary of State of the State of Delaware establishing the rights, preferences, privileges, qualifications, restrictions, and limitations relating to the Series&#160;A Preferred Stock (defined below). The Series&#160;A Preferred Stock is intended to provide ETFS Capital with economic rights equivalent to the Company&#x2019;s common stock on an as&lt;span class="nobreak"&gt;-converted&lt;/span&gt; basis. The Series&#160;A Preferred Stock has no voting rights, are not transferable and have the same priority with regard to dividends, distributions and payments as the common stock.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;As described in the Certificate of Designations, the Company will not issue, and ETFS Capital does not have the right to require the Company to issue, any shares of common stock upon conversion of the Series&#160;A Preferred Stock, if, as a result of such conversion, ETFS Capital (together with certain attribution parties) would beneficially own more than 9.99% of the Company&#x2019;s outstanding common stock immediately after giving effect to such conversion.&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;In connection with the completion of the ETFS Acquisition, the Company issued 14,750&lt;span class="nobreak"&gt; &lt;/span&gt;shares of Series&#160;A Non&lt;span class="nobreak"&gt;-Voting&lt;/span&gt; Convertible Preferred Stock (the &#x201c;Series&#160;A Preferred Stock&#x201d;), which are convertible into an aggregate of 14,750,000&lt;span class="nobreak"&gt; &lt;/span&gt;shares of common stock. The fair value of this consideration was $132,750, based on the closing price of the Company&#x2019;s common stock on April&#160;10, 2018 of $9.00 per share, the&#160;trading day prior to the closing of the acquisition.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The following is a summary of the Series&#160;A Preferred Stock balance:&lt;/p&gt;
		&lt;table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;"&gt;


				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-5" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.60%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31,&lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-5" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="2" style="width: 19.20%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31,&lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Issuance of Series&#160;A Preferred Stock&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;132,750&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;132,750&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Less: Issuance costs&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(181)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(181)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Series&#160;A Preferred Stock&#x2014;carrying value&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;132,569&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;132,569&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Cash dividends declared per share (quarterly)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;0.03&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;0.03&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;

		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:6pt;"&gt;Temporary equity classification is required for redeemable instruments for which redemption triggers are outside of the issuer&#x2019;s control. ETFS Capital has the right to redeem all the Series&#160;A Preferred Stock specified to be converted during the period of time specified in the Certificate of Designations in the event that: (a)&#160;the number of shares of the Company&#x2019;s common stock authorized by its certificate of incorporation is insufficient to permit the Company to convert all of the Series&#160;A Preferred Stock requested by ETFS Capital to be converted; or (b)&#160;ETFS Capital does not, upon completion of a change of control of the Company, receive the same amount per share of Series&#160;A Preferred Stock as it would have received had each outstanding share of Series&#160;A Preferred Stock been converted into common stock immediately prior to the change of control. However, the Company will not be obligated to make any such redemption payments to the extent such payments would be a breach of any covenant or obligation the Company owes to any of its secured creditors or is otherwise prohibited by applicable law.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Any such redemption will be at a price per Preferred Share equal to the dollar volume&lt;span class="nobreak"&gt;-weighted&lt;/span&gt; average price for a share of common stock for the 30&lt;span class="nobreak"&gt;-trading&lt;/span&gt;&#160;day period ending on the date of such attempted conversion or change of control, as applicable, multiplied by 1,000. Such redemption payment will be made in one payment no later than 10&#160;business days following the last&#160;day of the Company&#x2019;s first fiscal quarter that begins on a date following the date ETFS Capital exercises such redemption right. The redemption value of the Series&#160;A Preferred Stock was $96,869 and $77,969 at December&#160;31, 2023 and 2022, respectively.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:12pt;"&gt;The carrying amount of the Series&#160;A Preferred Stock was not adjusted as it was not probable that such shares would become redeemable.&lt;/p&gt;</us-gaap:PreferredStockTextBlock>
    <wt:OutstandingCommonStockPercentage contextRef="c0" decimals="4" id="ixv-27183" unitRef="pure">0.0999</wt:OutstandingCommonStockPercentage>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="c234"
      decimals="INF"
      id="ixv-27184"
      unitRef="shares">14750</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="c235"
      decimals="INF"
      id="ixv-27185"
      unitRef="shares">14750000</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="c236"
      decimals="-3"
      id="ixv-27186"
      unitRef="usd">132750000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="c237"
      decimals="2"
      id="ixv-27187"
      unitRef="usdPershares">9</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:ScheduleOfPreferredUnitsTextBlock contextRef="c0" id="ixv-27188">The following is a summary of the Series&#160;A Preferred Stock balance:&lt;table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;"&gt;


				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-5" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.60%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31,&lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-5" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="2" style="width: 19.20%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31,&lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Issuance of Series&#160;A Preferred Stock&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;132,750&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;132,750&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Less: Issuance costs&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(181)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(181)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Series&#160;A Preferred Stock&#x2014;carrying value&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;132,569&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;132,569&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Cash dividends declared per share (quarterly)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;0.03&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;0.03&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:ScheduleOfPreferredUnitsTextBlock>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="c240"
      decimals="-3"
      id="ixv-27189"
      unitRef="usd">132750000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="c241"
      decimals="-3"
      id="ixv-27190"
      unitRef="usd">132750000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c240"
      decimals="-3"
      id="ixv-27191"
      unitRef="usd">181000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="c241"
      decimals="-3"
      id="ixv-27192"
      unitRef="usd">181000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:PreferredStockValue
      contextRef="c238"
      decimals="-3"
      id="ixv-27193"
      unitRef="usd">132569000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="c239"
      decimals="-3"
      id="ixv-27194"
      unitRef="usd">132569000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockDividendsPerShareDeclared
      contextRef="c240"
      decimals="2"
      id="ixv-27195"
      unitRef="usdPershares">0.03</us-gaap:PreferredStockDividendsPerShareDeclared>
    <us-gaap:PreferredStockDividendsPerShareDeclared
      contextRef="c241"
      decimals="2"
      id="ixv-27196"
      unitRef="usdPershares">0.03</us-gaap:PreferredStockDividendsPerShareDeclared>
    <wt:PreferredStockRedemptionValue
      contextRef="c238"
      decimals="-3"
      id="ixv-27197"
      unitRef="usd">96869000</wt:PreferredStockRedemptionValue>
    <wt:PreferredStockRedemptionValue
      contextRef="c239"
      decimals="-3"
      id="ixv-27198"
      unitRef="usd">77969000</wt:PreferredStockRedemptionValue>
    <wt:OtherPayablesTextBlock contextRef="c0" id="ixv-21832">&lt;p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;12. Payable to Gold Bullion Holdings (Jersey) Limited (&#x201c;GBH&#x201d;)&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;On November&#160;20, 2023, the Company repurchased its Series&#160;C Preferred Stock which was convertible into 13,087,000&lt;span class="nobreak"&gt; &lt;/span&gt;shares of the Company&#x2019;s common stock, from GBH, a subsidiary of WGC, for aggregate cash consideration of approximately $84,411. Under the terms of the transaction, the Company paid GBH $40,000 on the closing date, with the remainder of the purchase price payable in equal, interest&lt;span class="nobreak"&gt;-free&lt;/span&gt; installments on the first, second and third anniversaries of the closing date. The implied price per share was $6.02 when considering the interest&lt;span class="nobreak"&gt;-free&lt;/span&gt; financing element of the transaction. The investor rights agreement that the Company and GBH entered into in May&#160;2023 in connection with the issuance of the Series&#160;C Preferred Stock, which provided GBH with certain rights and obligations with respect to the shares, including registration rights, was terminated in this transaction.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Under U.S.&#160;GAAP, the obligation was recorded at its present value utilizing a market rate of interest on the closing date of 7.0% and the corresponding discount is being amortized as interest expense pursuant to the effective interest method of accounting over the life of the obligation. The aggregate consideration payable was valued at $38,835 on the closing date and the carrying value of this obligation is as follows:&lt;/p&gt;
		&lt;table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;"&gt;


				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TCH CellOverride-1" style="width: 76.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-5" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2" colspan="2" style="width: 21.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 76.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Current:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 19.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;14,804&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 76.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Long-term&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 19.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;24,328&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 76.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 19.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;39,132&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;"&gt;Interest expense recognized during the year ended December&#160;31, 2023 was $297 and is included as a component of total interest expense recognized on the Statements of Operations.&lt;/p&gt;</wt:OtherPayablesTextBlock>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="c242"
      decimals="0"
      id="ixv-27199"
      unitRef="shares">13087000</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:AssetAcquisitionConsiderationTransferred
      contextRef="c243"
      decimals="-3"
      id="ixv-27200"
      unitRef="usd">84411000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="c244"
      decimals="-3"
      id="ixv-27201"
      unitRef="usd">40000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <wt:RepurchasePricePerShareInterestRateTransaction
      contextRef="c243"
      decimals="2"
      id="ixv-27202"
      unitRef="usdPershares">6.02</wt:RepurchasePricePerShareInterestRateTransaction>
    <wt:PresentValueOfMarketRateInterest contextRef="c0" decimals="3" id="ixv-27203" unitRef="pure">0.07</wt:PresentValueOfMarketRateInterest>
    <wt:ScheduleOfAggregateConsiderationPayableTableTextBlock contextRef="c0" id="ixv-27204">The aggregate consideration payable was valued at $38,835 on the closing date and the carrying value of this obligation is as follows:&lt;table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;"&gt;


				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TCH CellOverride-1" style="width: 76.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-5" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2" colspan="2" style="width: 21.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 76.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Current:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.39%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 19.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;14,804&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 76.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Long-term&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 19.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;24,328&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 76.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.79%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.39%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 19.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;39,132&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</wt:ScheduleOfAggregateConsiderationPayableTableTextBlock>
    <wt:AggregateConsiderationPayable contextRef="c0" decimals="-3" id="ixv-27205" unitRef="usd">38835000</wt:AggregateConsiderationPayable>
    <us-gaap:NotesPayableCurrent contextRef="c5" decimals="-3" id="ixv-27206" unitRef="usd">14804000</us-gaap:NotesPayableCurrent>
    <us-gaap:LongTermNotesPayable contextRef="c5" decimals="-3" id="ixv-27207" unitRef="usd">24328000</us-gaap:LongTermNotesPayable>
    <us-gaap:NotesPayable contextRef="c5" decimals="-3" id="ixv-27208" unitRef="usd">39132000</us-gaap:NotesPayable>
    <us-gaap:InterestAndDebtExpense contextRef="c0" decimals="-3" id="ixv-27209" unitRef="usd">297000</us-gaap:InterestAndDebtExpense>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c0" id="ixv-21877">&lt;div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;"&gt;
		&lt;p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;13. Leases&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;"&gt;The Company has entered into operating leases for its corporate headquarters office facilities, financial data terminals and equipment. The Company has no finance leases.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The following table provides additional information regarding the Company&#x2019;s leases:&lt;/p&gt;
		&lt;table class="Table85-" style="width: 85.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 10% 0pt 0.33in;"&gt;


				&lt;tr class="Table85-" style="height:12pt;"&gt;
					&lt;td class="Table85- TCH CellOverride-1 _idGenCellOverride-2" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" colspan="5" style="width: 35.64%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Years Ended&lt;br/&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="height:12pt;"&gt;
					&lt;td class="Table85- TCH CellOverride-1 _idGenCellOverride-2" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.34%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.82%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="height:12pt;"&gt;
					&lt;td class="Table85- TCH CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Lease cost:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TCH CellOverride-5" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TCH CellOverride-2" colspan="2" style="width: 16.34%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TCH CellOverride-5" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TCH CellOverride-2" colspan="2" style="width: 17.82%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table85- TB CellOverride-1 _idGenCellOverride-3" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Operating lease cost&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;1,285&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;963&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="height:12pt;"&gt;
					&lt;td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Short-term lease cost&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;191&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;223&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total lease cost&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;1,476&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;1,186&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="height:12pt;"&gt;
					&lt;td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Other information:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Cash paid for amounts included in the measurement of operating liabilities (operating leases)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;1,284&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;965&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="height:12pt;"&gt;
					&lt;td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Right-of-use assets obtained in exchange for new operating lease liabilities&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-211; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;n/a&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-212; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;n/a&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Weighted-average remaining lease term (in&#160;years)&#x2014;operating leases&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;0.4&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1.2&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="height:12pt;"&gt;
					&lt;td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Weighted-average discount rate&#x2014;operating leases&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;5.9%&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6.4%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;"&gt;None of the Company&#x2019;s leases include variable payments, residual value guarantees or any restrictions or covenants relating to the Company&#x2019;s ability to pay dividends or incur additional financing obligations.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;On September&#160;9, 2021, the Company entered into a Surrender Agreement to terminate the lease for its principal executive office at 245 Park Avenue, New&#160;York, New&#160;York effective immediately. In consideration for the landlord&#x2019;s agreement to enter into the Surrender Agreement and accelerate the expiration date of the term of the lease from August&#160;31, 2029, the Company paid a termination fee of $12,725. As a result, the Company recognized a loss on the termination of a lease of $9,277 during the year ended December&#160;31, 2021, which was inclusive of the write&lt;span class="nobreak"&gt;-off&lt;/span&gt; of the right&lt;span class="nobreak"&gt;-of-use&lt;/span&gt; asset, broker fees and a reduction in operating lease liabilities. This loss is included in impairments in the Company&#x2019;s Consolidated Statements of Operations (Note&#160;26).&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Additionally, the Company recognized an impairment loss of $303 resulting from the derecognition of a right&lt;span class="nobreak"&gt;-of-use&lt;/span&gt; asset upon exiting its London office in February&#160;2021, as well as costs incurred to restore the office space to its original condition.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company&#x2019;s leases also included extension, automatic renewal and termination provisions. These provisions were also not reasonably certain of being exercised and were therefore not recognized as part of the right&lt;span class="nobreak"&gt;-of-use&lt;/span&gt; asset and lease liability.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The following table discloses future minimum lease payments at December&#160;31, 2023 with respect to the Company&#x2019;s operating lease liabilities:&lt;/p&gt;
		&lt;table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;"&gt;


				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;2024&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;584&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;2025&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-213; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;2026&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-214; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;2027&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-215; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;2028&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-216; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;2029 and thereafter&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-217; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total future minimum lease payments (undiscounted)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;584&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;
		&lt;/div&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The following table reconciles the future minimum lease payments (disclosed above) at December&#160;31, 2023 to the operating lease liabilities recognized in the Company&#x2019;s Consolidated Balance Sheets:&lt;/p&gt;
		&lt;table class="Table60-" style="width: 60%; border-collapse: collapse; border: #000 0pt solid; border-width: 0pt; margin: 6pt 30% 0pt 0.33in"&gt;


				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TCH CellOverride-1" colspan="4" style="border-width: 0pt; vertical-align: bottom; padding: 0in 0in 3px"&gt;&lt;p class="Tbody" style="border-width: 0; font: normal 10pt Times New Roman PS Std, serif; margin: 0; padding: 0; margin-bottom: 0; margin-left: 10pt; margin-right: 0; margin-top: 0; orphans: 1; page-break-after: auto; page-break-before: auto; text-align: left; text-indent: -10pt; widows: 1"&gt;Amounts recognized in the Company&#x2019;s Consolidated Balance Sheets&lt;/p&gt;

&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 74%; padding: 0in 0in 3px; border-width: 0pt; vertical-align: bottom"&gt;
						&lt;p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Lease liability&#x2014;short term&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 2%; padding: 0in 0in 3px; border-width: 0pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.67%; padding: 0in 0in 3px; border-width: 0pt; vertical-align: bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 21.33%; padding: 0in 0in 3px; border-width: 0pt; vertical-align: bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;578&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom"&gt;
						&lt;p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Lease liability&#x2014;long term&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-218; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom"&gt;
						&lt;p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Subtotal&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;578&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Difference between undiscounted and discounted cash flows&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total future minimum lease payments (undiscounted)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;584&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LeaseCostTableTextBlock contextRef="c0" id="ixv-27210">The following table provides additional information regarding the Company&#x2019;s leases:&lt;table class="Table85-" style="width: 85.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 10% 0pt 0.33in;"&gt;


				&lt;tr class="Table85-" style="height:12pt;"&gt;
					&lt;td class="Table85- TCH CellOverride-1 _idGenCellOverride-2" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" colspan="5" style="width: 35.64%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Years Ended&lt;br/&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="height:12pt;"&gt;
					&lt;td class="Table85- TCH CellOverride-1 _idGenCellOverride-2" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.34%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.82%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="height:12pt;"&gt;
					&lt;td class="Table85- TCH CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Lease cost:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TCH CellOverride-5" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TCH CellOverride-2" colspan="2" style="width: 16.34%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TCH CellOverride-5" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TCH CellOverride-2" colspan="2" style="width: 17.82%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table85- TB CellOverride-1 _idGenCellOverride-3" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Operating lease cost&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;1,285&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;963&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="height:12pt;"&gt;
					&lt;td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Short-term lease cost&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;191&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;223&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total lease cost&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;1,476&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;1,186&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="height:12pt;"&gt;
					&lt;td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Other information:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Cash paid for amounts included in the measurement of operating liabilities (operating leases)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;1,284&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;965&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="height:12pt;"&gt;
					&lt;td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Right-of-use assets obtained in exchange for new operating lease liabilities&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-211; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;n/a&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-212; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;n/a&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Weighted-average remaining lease term (in&#160;years)&#x2014;operating leases&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;0.4&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1.2&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table85-" style="height:12pt;"&gt;
					&lt;td class="Table85- TB CellOverride-1" style="width: 62.87%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Weighted-average discount rate&#x2014;operating leases&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 14.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;5.9%&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.49%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 1.98%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table85- TB CellOverride-2" style="width: 15.84%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6.4%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost contextRef="c0" decimals="-3" id="ixv-27211" unitRef="usd">1285000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c19" decimals="-3" id="ixv-27212" unitRef="usd">963000</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost contextRef="c0" decimals="-3" id="ixv-27213" unitRef="usd">191000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost contextRef="c19" decimals="-3" id="ixv-27214" unitRef="usd">223000</us-gaap:ShortTermLeaseCost>
    <us-gaap:LeaseCost contextRef="c0" decimals="-3" id="ixv-27215" unitRef="usd">1476000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c19" decimals="-3" id="ixv-27216" unitRef="usd">1186000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments contextRef="c0" decimals="-3" id="ixv-27217" unitRef="usd">1284000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c19" decimals="-3" id="ixv-27218" unitRef="usd">965000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c5" id="ixv-27219">P0Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c6" id="ixv-27220">P1Y2M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c5" decimals="3" id="ixv-27221" unitRef="pure">0.059</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c6" decimals="3" id="ixv-27222" unitRef="pure">0.064</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <wt:PaymentOfLeaseTerminationFee contextRef="c0" decimals="-3" id="ixv-27223" unitRef="usd">12725000</wt:PaymentOfLeaseTerminationFee>
    <us-gaap:GainLossOnContractTermination contextRef="c20" decimals="-3" id="ixv-27224" unitRef="usd">9277000</us-gaap:GainLossOnContractTermination>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="c245"
      decimals="-3"
      id="ixv-27225"
      unitRef="usd">303000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c0" id="ixv-27226">The following table discloses future minimum lease payments at December&#160;31, 2023 with respect to the Company&#x2019;s operating lease liabilities:&lt;table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;"&gt;


				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;2024&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;584&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;2025&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-213; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;2026&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-214; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;2027&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-215; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;2028&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-216; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;2029 and thereafter&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-217; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 74.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total future minimum lease payments (undiscounted)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 21.33%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;584&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c5" decimals="-3" id="ixv-27227" unitRef="usd">584000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c5" decimals="-3" id="ixv-27228" unitRef="usd">584000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <wt:ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock contextRef="c0" id="ixv-27229">The following table reconciles the future minimum lease payments (disclosed above) at December&#160;31, 2023 to the operating lease liabilities recognized in the Company&#x2019;s Consolidated Balance Sheets:&lt;table class="Table60-" style="width: 60%; border-collapse: collapse; border: #000 0pt solid; border-width: 0pt; margin: 6pt 30% 0pt 0.33in"&gt;


				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TCH CellOverride-1" colspan="4" style="border-width: 0pt; vertical-align: bottom; padding: 0in 0in 3px"&gt;&lt;p class="Tbody" style="border-width: 0; font: normal 10pt Times New Roman PS Std, serif; margin: 0; padding: 0; margin-bottom: 0; margin-left: 10pt; margin-right: 0; margin-top: 0; orphans: 1; page-break-after: auto; page-break-before: auto; text-align: left; text-indent: -10pt; widows: 1"&gt;Amounts recognized in the Company&#x2019;s Consolidated Balance Sheets&lt;/p&gt;

&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 74%; padding: 0in 0in 3px; border-width: 0pt; vertical-align: bottom"&gt;
						&lt;p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Lease liability&#x2014;short term&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 2%; padding: 0in 0in 3px; border-width: 0pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.67%; padding: 0in 0in 3px; border-width: 0pt; vertical-align: bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 21.33%; padding: 0in 0in 3px; border-width: 0pt; vertical-align: bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;578&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom"&gt;
						&lt;p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Lease liability&#x2014;long term&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-218; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom"&gt;
						&lt;p class="Tbody-ind_2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:30pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Subtotal&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;578&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Difference between undiscounted and discounted cash flows&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="border-bottom: windowtext 1pt solid; padding: 0in 0in 2px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total future minimum lease payments (undiscounted)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="border-width: 0pt; padding: 0in 0in 3px; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="border-bottom: Black 2.5pt double; padding: 0in 0in 1px; border-top-width: 0pt; border-right-width: 0pt; border-left-width: 0pt; vertical-align: bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;584&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</wt:ScheduleForSupplementalBalanceSheetInformationRelatedToOperatingLeaseTableTextBlock>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c5" decimals="-3" id="ixv-27230" unitRef="usd">578000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiability contextRef="c5" decimals="-3" id="ixv-27231" unitRef="usd">578000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c5" decimals="-3" id="ixv-27232" unitRef="usd">6000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c5" decimals="-3" id="ixv-27233" unitRef="usd">584000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LossContingencyDisclosures contextRef="c0" id="ixv-22129">&lt;p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:6pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;14. Contingencies&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company may be subject to reviews, inspections and investigations by regulatory authorities as well as legal proceedings arising in the ordinary course of business.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Closure of the WisdomTree WTI Crude Oil 3x Daily Leveraged ETP&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;In December&#160;2020, WMAI, WTMAML, WTUK and WisdomTree Ireland Limited (&#x201c;WT Ireland&#x201d;) were served with a writ of summons to appear before the Court of Milan, Italy. In January&#160;2021, WTUK was served with a writ of summons to appear before the Court of Udine, Italy. Investors had filed actions seeking damages resulting from the closure of the WisdomTree WTI Crude Oil 3x Daily Leveraged ETP (&#x201c;3OIL&#x201d;) in March&#160;2020. The product was dependent on the receipt of payments from a swap provider to satisfy payment obligations to the investors. Due to an extreme adverse move in oil futures relative to the oil futures&#x2019; closing price, the swap contract underlying 3OIL was terminated by the swap provider, which resulted in the compulsory redemption of 3OIL, all in accordance with the prospectus.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;In February&#160;2022, the Court of Udine ruled in the Company&#x2019;s favor. Also in February&#160;2022, WMAI, WTMAML, WTUK and WT Ireland were served with another writ of summons to appear before the Court of Milan by additional investors seeking damages resulting from the closure of 3OIL.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;In March&#160;2022, WMAI and WTUK were served with a writ of summons to appear before the Court of Turin and two writs of summons to appear before the Court of Milan by additional investors seeking damages. These writs also were served on the intermediary brokers for the respective claimants, with the claimants alleging joint and several liability of WMAI, WTUK and such intermediary brokers. In July&#160;2023, the Court of Milan ruled in favor of WMAI and WTUK in respect of one of these claims.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Total damages sought by all investors related to these claims are approximately &#x20ac;15,200 ($16,778) at December&#160;31, 2023.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Additionally, in July&#160;2023, WT Ireland received a letter from counsel on behalf of additional investors seeking damages of up to approximately &#x20ac;8,400 ($9,272) resulting from the closure of 3OIL.&#160;The claim is in its preliminary stages and a writ of summons has not been served.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:12pt;"&gt;The Company is currently assessing these claims with its external counsel. The Company expects that losses, if any, arising from these claims will be covered under its insurance policies, less a $500 deductible. An accrual has not been made with respect to these matters at December&#160;31, 2023 and 2022.&lt;/p&gt;</us-gaap:LossContingencyDisclosures>
    <us-gaap:LossContingencyDamagesSoughtValue contextRef="c0" decimals="-3" id="ixv-27234" unitRef="eur">15200000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LossContingencyDamagesSoughtValue contextRef="c0" decimals="-3" id="ixv-27235" unitRef="usd">16778000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="c246"
      decimals="-3"
      id="ixv-27236"
      unitRef="eur">8400000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="c246"
      decimals="-3"
      id="ixv-27237"
      unitRef="usd">9272000</us-gaap:LossContingencyDamagesSoughtValue>
    <wt:LossContingencyCoveredByInsuranceDeductible contextRef="c5" decimals="-3" id="ixv-27238" unitRef="usd">500000</wt:LossContingencyCoveredByInsuranceDeductible>
    <us-gaap:VariableInterestEntityDisclosureTextBlock contextRef="c0" id="ixv-22141">&lt;p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;15. Variable Interest Entities&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:6pt;"&gt;VIEs are entities with any of the following characteristics: (i)&#160;the entity does not have enough equity to finance its activities without additional financial support; (ii)&#160;the equity holders, as a group, lack the characteristics of a controlling financial interest; or (iii)&#160;the entity is structured with non&lt;span class="nobreak"&gt;-substantive&lt;/span&gt; voting rights.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;"&gt;Consolidation of a VIE is required for the party deemed to be the primary beneficiary, if any. The primary beneficiary is the party who has both (a)&#160;the power to direct the activities of a VIE that most significantly impact the entity&#x2019;s economic performance and (b)&#160;an obligation to absorb losses of the entity or a right to receive benefits from the entity that could potentially be significant to the entity. The Company is not the primary beneficiary of any entities in which it has a variable interest as it does not have the power to direct the activities that most significantly impact the entities&#x2019; economic performance. Such power is conveyed through the entities&#x2019; boards of directors and the Company does not have control over the boards.&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The following table presents information about the Company&#x2019;s variable interests in non&lt;span class="nobreak"&gt;-consolidated&lt;/span&gt; VIEs:&lt;/p&gt;
		&lt;table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;"&gt;


				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-1 _idGenCellOverride-2" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.02%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Carrying Amount&#x2014;Assets (Securrency):&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-5" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="2" style="width: 16.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-5" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;"&gt;Preferred stock&#x2014;Series&#160;A Shares&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-219; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;8,488&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;"&gt;Preferred stock&#x2014;Series&#160;B Shares&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-220; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;5,500&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;"&gt;Convertible note&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-221; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;14,500&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Subtotal&#x2014;Securrency&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-222; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;28,488&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Carrying Amount&#x2014;Assets (Fnality):&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;"&gt;Convertible note&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-223; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6,921&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;"&gt;Series&#160;B-1 Preference Shares&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;9,684&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-224; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Subtotal&#x2014;Fnality&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;9,684&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;6,921&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Carrying Amount&#x2014;Assets (Other investments):&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-225; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;312&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total (Note&#160;7)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;9,684&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;35,721&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-15" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"&gt;Maximum exposure to loss&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"&gt;9,684&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"&gt;35,721&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:VariableInterestEntityDisclosureTextBlock>
    <us-gaap:ScheduleOfVariableInterestEntitiesTextBlock contextRef="c0" id="ixv-22153">The following table presents information about the Company&#x2019;s variable interests in non&lt;span class="nobreak"&gt;-consolidated&lt;/span&gt; VIEs:&lt;table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;"&gt;


				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-1 _idGenCellOverride-2" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.02%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.48%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, &lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Carrying Amount&#x2014;Assets (Securrency):&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-5" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="2" style="width: 16.02%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-5" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.48%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;"&gt;Preferred stock&#x2014;Series&#160;A Shares&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-219; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;8,488&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;"&gt;Preferred stock&#x2014;Series&#160;B Shares&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-220; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;5,500&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;"&gt;Convertible note&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-221; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;14,500&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Subtotal&#x2014;Securrency&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-222; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;28,488&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Carrying Amount&#x2014;Assets (Fnality):&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;"&gt;Convertible note&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-223; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6,921&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:25pt;"&gt;Series&#160;B-1 Preference Shares&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;9,684&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-224; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Subtotal&#x2014;Fnality&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;9,684&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;6,921&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Carrying Amount&#x2014;Assets (Other investments):&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-225; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;312&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total (Note&#160;7)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;9,684&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;35,721&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-15" style="width: 63.59%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"&gt;Maximum exposure to loss&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 14.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"&gt;9,684&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.46%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 15.53%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"&gt;35,721&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:ScheduleOfVariableInterestEntitiesTextBlock>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c248"
      decimals="-3"
      id="ixv-27239"
      unitRef="usd">8488000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c250"
      decimals="-3"
      id="ixv-27240"
      unitRef="usd">5500000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c252"
      decimals="-3"
      id="ixv-27241"
      unitRef="usd">14500000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c254"
      decimals="-3"
      id="ixv-27242"
      unitRef="usd">28488000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c256"
      decimals="-3"
      id="ixv-27243"
      unitRef="usd">6921000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c257"
      decimals="-3"
      id="ixv-27244"
      unitRef="usd">9684000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c259"
      decimals="-3"
      id="ixv-27245"
      unitRef="usd">9684000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c260"
      decimals="-3"
      id="ixv-27246"
      unitRef="usd">6921000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c262"
      decimals="-3"
      id="ixv-27247"
      unitRef="usd">312000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c5" decimals="-3" id="ixv-27248" unitRef="usd">9684000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c6" decimals="-3" id="ixv-27249" unitRef="usd">35721000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c263"
      decimals="-3"
      id="ixv-27250"
      unitRef="usd">9684000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c264"
      decimals="-3"
      id="ixv-27251"
      unitRef="usd">35721000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c0" id="ixv-22317">&lt;p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:6pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;16. Revenues from Contracts with Customers&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The following table presents the Company&#x2019;s total revenues from contracts with customers:&lt;/p&gt;
		&lt;table class="Table80-" style="width: 80.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 15% 0pt 0.33in;"&gt;


				&lt;tr class="Table80-" style="height:12pt;"&gt;
					&lt;td class="Table80- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Years Ended December&#160;31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table80-" style="height:12pt;"&gt;
					&lt;td class="Table80- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table80-" style="height:12pt;"&gt;
					&lt;td class="Table80- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Revenues from contracts with customers:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table80-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table80- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Advisory fees&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;333,227&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;293,632&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;298,052&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table80-" style="height:12pt;"&gt;
					&lt;td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Other&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;15,808&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;7,713&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6,266&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table80-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total operating revenues&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;349,035&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;301,345&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;304,318&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:6pt;"&gt;The Company recognizes revenues from contracts with customers when the performance obligation is satisfied, which is when the promised services are transferred to the customer. A service is considered to be transferred when the customer obtains control, which is represented by the transfer of rights with regard to the service. Transfer of control happens either over time or at a point in time. When a performance obligation is satisfied over time, an entity is required to select a single method of measuring progress for each performance obligation that depicts the entity&#x2019;s performance in transferring control of services to the customer.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Substantially all the Company&#x2019;s revenues from contracts with customers are derived primarily from investment advisory agreements with related parties (Note&#160;17). These advisory fees are recognized over time, are earned from the Company&#x2019;s ETPs and are calculated based on a percentage of the ETPs&#x2019; average daily net assets. There is no significant judgment in calculating amounts due which are invoiced monthly in arrears and are not subject to any potential reversal. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;There are no contract assets or liabilities that arise in connection with the recognition of advisory fee revenue. In addition, there are no costs incurred to obtain or fulfill the contracts with customers, all of which are investment advisory agreements with related parties.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;"&gt;Other income includes revenues the Company earns from swap providers associated with certain of the Company&#x2019;s European listed ETPs, the nature of which are either based on a percentage of the ETPs&#x2019; average daily net assets or flows associated with certain products. There is no significant judgment in calculating amounts due, which are invoiced monthly or quarterly in arrears and are not subject to any potential reversal. Progress is measured using the practical expedient under the output method resulting in the recognition of revenue in the amount for which the Company has a right to invoice.&lt;/p&gt;&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Geographic Distribution of Revenues&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The following table presents the Company&#x2019;s total revenues geographically as determined by where the respective management companies reside:&lt;/p&gt;
		&lt;table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;"&gt;


				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-1 _idGenCellOverride-2" rowspan="2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" rowspan="2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Years Ended December&#160;31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Revenues from contracts with customers:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;United&#160;States&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;220,117&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;184,036&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;179,016&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Jersey&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;113,325&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;103,692&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;114,623&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Ireland&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;15,593&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;13,617&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;10,679&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total operating revenues&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;349,035&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;301,345&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;304,318&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <wt:SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock contextRef="c0" id="ixv-27252">The following table presents the Company&#x2019;s total revenues from contracts with customers:&lt;table class="Table80-" style="width: 80.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 15% 0pt 0.33in;"&gt;


				&lt;tr class="Table80-" style="height:12pt;"&gt;
					&lt;td class="Table80- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Years Ended December&#160;31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table80-" style="height:12pt;"&gt;
					&lt;td class="Table80- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table80-" style="height:12pt;"&gt;
					&lt;td class="Table80- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Revenues from contracts with customers:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table80-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table80- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Advisory fees&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;333,227&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;293,632&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;298,052&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table80-" style="height:12pt;"&gt;
					&lt;td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Other&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;15,808&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;7,713&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6,266&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table80-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total operating revenues&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;349,035&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;301,345&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;304,318&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</wt:SummaryOfRevenuesCategorizedAsRevenuesFromContractsWithCustomersAndOtherSourcesOfRevenuesTableTextBlock>
    <us-gaap:Revenues contextRef="c13" decimals="-3" id="ixv-27253" unitRef="usd">333227000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c14" decimals="-3" id="ixv-27254" unitRef="usd">293632000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c15" decimals="-3" id="ixv-27255" unitRef="usd">298052000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c16" decimals="-3" id="ixv-27256" unitRef="usd">15808000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c17" decimals="-3" id="ixv-27257" unitRef="usd">7713000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c18" decimals="-3" id="ixv-27258" unitRef="usd">6266000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c0" decimals="-3" id="ixv-27259" unitRef="usd">349035000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c19" decimals="-3" id="ixv-27260" unitRef="usd">301345000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c20" decimals="-3" id="ixv-27261" unitRef="usd">304318000</us-gaap:Revenues>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock contextRef="c0" id="ixv-27262">The following table presents the Company&#x2019;s total revenues geographically as determined by where the respective management companies reside:&lt;table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;"&gt;


				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-1 _idGenCellOverride-2" rowspan="2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" rowspan="2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Years Ended December&#160;31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Revenues from contracts with customers:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;United&#160;States&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;220,117&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;184,036&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;179,016&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Jersey&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;113,325&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;103,692&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;114,623&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Ireland&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;15,593&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;13,617&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;10,679&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total operating revenues&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;349,035&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;301,345&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;304,318&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:Revenues
      contextRef="c265"
      decimals="-3"
      id="ixv-27263"
      unitRef="usd">220117000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c266"
      decimals="-3"
      id="ixv-27264"
      unitRef="usd">184036000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c267"
      decimals="-3"
      id="ixv-27265"
      unitRef="usd">179016000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c268"
      decimals="-3"
      id="ixv-27266"
      unitRef="usd">113325000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c269"
      decimals="-3"
      id="ixv-27267"
      unitRef="usd">103692000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c270"
      decimals="-3"
      id="ixv-27268"
      unitRef="usd">114623000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c271"
      decimals="-3"
      id="ixv-27269"
      unitRef="usd">15593000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c272"
      decimals="-3"
      id="ixv-27270"
      unitRef="usd">13617000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c273"
      decimals="-3"
      id="ixv-27271"
      unitRef="usd">10679000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c0" decimals="-3" id="ixv-27272" unitRef="usd">349035000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c19" decimals="-3" id="ixv-27273" unitRef="usd">301345000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c20" decimals="-3" id="ixv-27274" unitRef="usd">304318000</us-gaap:Revenues>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c0" id="ixv-22519">&lt;p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:8pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;17. Related Party Transactions&lt;/span&gt;&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Investment Advisory Agreements&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company&#x2019;s revenues are derived primarily from investment advisory agreements with related parties. Under these agreements, the Company has licensed to related parties the use of certain of its own indexes for the U.S.&#160;WisdomTree ETFs, WisdomTree Digital Funds and WisdomTree UCITS ETFs. The relevant board of trustees or board of directors (including certain officers of the Company) of each of the related parties is primarily responsible for overseeing the management and affairs of the entities for the benefit of their respective stakeholders and have contracted with the Company to provide for general management and administration services. The Company is also responsible for certain expenses of the related parties, including the cost of transfer agency, custody, fund administration and accounting, legal, audit, and other non&lt;span class="nobreak"&gt;-distribution&lt;/span&gt; services, excluding extraordinary expenses, taxes and certain other expenses, which are included in fund management and administration in the Consolidated Statements of Operations. In exchange, the Company receives fees based on a percentage of the ETPs&#x2019; and the Digital Funds&#x2019; average daily net assets. A majority of the independent members of the respective board of trustees or board of directors are required to initially and annually (after the first two&#160;years) approve the advisory agreements of the U.S.&#160;WisdomTree ETFs and the Digital Funds and these agreements may be terminated by such board of trustees or board of directors upon notice.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The following table summarizes accounts receivable from related parties which are included as a component of accounts receivable in the Consolidated Balance Sheets:&lt;/p&gt;
		&lt;table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;"&gt;


				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-1" rowspan="2" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" rowspan="2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="5" style="width: 38.40%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.60%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-5" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="2" style="width: 19.20%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Receivable from WTT&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;21,226&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;16,399&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Receivable from ManJer Issuers&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;4,411&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;4,485&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Receivable from WMAI and WTICAV&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;2,874&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;3,255&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;28,511&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;24,139&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:6pt;"&gt;The allowance for credit losses on accounts receivable from related parties is insignificant when applying historical loss rates, adjusted for current conditions and supportable forecasts, to the amounts outstanding in the table above. Amounts outstanding are all invoiced in arrears, are less than 30&#160;days aged and are collected shortly after the applicable reporting period.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The following table summarizes revenues from advisory services provided to related parties:&lt;/p&gt;
		&lt;table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;"&gt;


				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-1" rowspan="2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" rowspan="2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Years Ended December&#160;31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Advisory services provided to WTT&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;218,834&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;183,409&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;178,511&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Advisory services provided to ManJer Issuers&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;98,800&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;96,606&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;108,862&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Advisory services provided to WMAI and WTICAV&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;15,593&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;13,617&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;10,679&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;333,227&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;293,632&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;298,052&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;"&gt;Pursuant to a license agreement between WisdomTree, Inc. (&#x201c;WTI&#x201d;) and WML to provide indices for a number of the sub&lt;span class="nobreak"&gt;-funds&lt;/span&gt; of WTICAV, WTI earned revenue amounting to &#x20ac;1,044 ($1,128), &#x20ac;642 ($671) and &#x20ac;612 ($710) for the&#160;years ended December&#160;31, 2023, 2022 and 2021, respectively, which has been eliminated in consolidation. No other revenue was earned by WTI from providing indices for use in the European Union during 2023, 2022 or 2021.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Investments in WisdomTree Products&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company also has investments in certain WisdomTree products of approximately $52,566 and $25,283 at December&#160;31, 2023 and 2022, respectively. This includes $18,308 and $1,765, respectively, of investments in certain consolidated affiliated Digital Funds advised by WT Digital Management, referred to herein as &#x201c;other assets&#x2013;seed capital.&#x201d; Net unrealized and realized gains and losses related to trading WisdomTree products during the&#160;years ended December&#160;31, 2023, 2022 and 2021 were $1,294, ($107) and ($451), respectively, which are recorded in other losses, net on the Consolidated Statements of Operations.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Deferred Consideration&#x2014;Gold Payments &#x2013; Termination&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;On May&#160;10, 2023, the Company terminated its contractual gold payments obligation to ETFS Capital, which included the payment of $45,634 to an entity controlled by GT, a stockholder of the Company. See Note&#160;9 for additional information.&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <wt:ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock contextRef="c0" id="ixv-27275">The following table summarizes accounts receivable from related parties which are included as a component of accounts receivable in the Consolidated Balance Sheets:&lt;table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;"&gt;


				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-1" rowspan="2" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" rowspan="2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="5" style="width: 38.40%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;December&#160;31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="2" style="width: 17.60%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-5" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="2" style="width: 19.20%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Receivable from WTT&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;21,226&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;16,399&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Receivable from ManJer Issuers&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;4,411&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;4,485&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Receivable from WMAI and WTICAV&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;2,874&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;3,255&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;28,511&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;24,139&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</wt:ScheduleOfAccountsReceivableFromRelatedPartyTableTextBlock>
    <us-gaap:AccountsReceivableNet
      contextRef="c279"
      decimals="-3"
      id="ixv-27276"
      unitRef="usd">21226000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="c280"
      decimals="-3"
      id="ixv-27277"
      unitRef="usd">16399000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="c281"
      decimals="-3"
      id="ixv-27278"
      unitRef="usd">4411000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="c282"
      decimals="-3"
      id="ixv-27279"
      unitRef="usd">4485000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="c283"
      decimals="-3"
      id="ixv-27280"
      unitRef="usd">2874000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="c284"
      decimals="-3"
      id="ixv-27281"
      unitRef="usd">3255000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet contextRef="c9" decimals="-3" id="ixv-27282" unitRef="usd">28511000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet contextRef="c10" decimals="-3" id="ixv-27283" unitRef="usd">24139000</us-gaap:AccountsReceivableNet>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="c0" id="ixv-27284">The following table summarizes revenues from advisory services provided to related parties:&lt;table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;"&gt;


				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-1" rowspan="2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" rowspan="2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Years Ended December&#160;31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Advisory services provided to WTT&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;218,834&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;183,409&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;178,511&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Advisory services provided to ManJer Issuers&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;98,800&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;96,606&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;108,862&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Advisory services provided to WMAI and WTICAV&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;15,593&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;13,617&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;10,679&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;333,227&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;293,632&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;298,052&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <us-gaap:Revenues
      contextRef="c285"
      decimals="-3"
      id="ixv-27285"
      unitRef="usd">218834000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c286"
      decimals="-3"
      id="ixv-27286"
      unitRef="usd">183409000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c287"
      decimals="-3"
      id="ixv-27287"
      unitRef="usd">178511000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c288"
      decimals="-3"
      id="ixv-27288"
      unitRef="usd">98800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c289"
      decimals="-3"
      id="ixv-27289"
      unitRef="usd">96606000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c290"
      decimals="-3"
      id="ixv-27290"
      unitRef="usd">108862000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c291"
      decimals="-3"
      id="ixv-27291"
      unitRef="usd">15593000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c292"
      decimals="-3"
      id="ixv-27292"
      unitRef="usd">13617000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c293"
      decimals="-3"
      id="ixv-27293"
      unitRef="usd">10679000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c294"
      decimals="-3"
      id="ixv-27294"
      unitRef="usd">333227000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c295"
      decimals="-3"
      id="ixv-27295"
      unitRef="usd">293632000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="c296"
      decimals="-3"
      id="ixv-27296"
      unitRef="usd">298052000</us-gaap:Revenues>
    <us-gaap:OtherIncome contextRef="c0" decimals="0" id="ixv-27297" unitRef="eur">1044</us-gaap:OtherIncome>
    <us-gaap:OtherIncome contextRef="c0" decimals="-3" id="ixv-27298" unitRef="usd">-1128000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome contextRef="c19" decimals="0" id="ixv-27299" unitRef="eur">642</us-gaap:OtherIncome>
    <us-gaap:OtherIncome contextRef="c19" decimals="-3" id="ixv-27300" unitRef="usd">-671000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome contextRef="c20" decimals="0" id="ixv-27301" unitRef="eur">612</us-gaap:OtherIncome>
    <us-gaap:OtherIncome contextRef="c20" decimals="-3" id="ixv-27302" unitRef="usd">-710000</us-gaap:OtherIncome>
    <us-gaap:Investments
      contextRef="c274"
      decimals="-3"
      id="ixv-27303"
      unitRef="usd">52566000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="c275"
      decimals="-3"
      id="ixv-27304"
      unitRef="usd">25283000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="c276"
      decimals="-3"
      id="ixv-27305"
      unitRef="usd">18308000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="c277"
      decimals="-3"
      id="ixv-27306"
      unitRef="usd">1765000</us-gaap:Investments>
    <us-gaap:GainLossOnInvestments contextRef="c0" decimals="-3" id="ixv-27307" unitRef="usd">1294000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments contextRef="c19" decimals="-3" id="ixv-27308" unitRef="usd">-107000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments contextRef="c20" decimals="-3" id="ixv-27309" unitRef="usd">-451000</us-gaap:GainLossOnInvestments>
    <us-gaap:ContractualObligation
      contextRef="c278"
      decimals="-3"
      id="ixv-27310"
      unitRef="usd">45634000</us-gaap:ContractualObligation>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c0" id="ixv-22702">&lt;p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;18. Stock-Based Awards&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;On July&#160;15, 2022, the Company&#x2019;s stockholders approved the 2022 Equity Plan under which the Company may issue up to 16,000,000&lt;span class="nobreak"&gt; &lt;/span&gt;shares of common stock (less one share for every share granted under the 2016 Equity Plan since March&#160;31, 2022 and inclusive of shares available under the 2016 Equity Plan as of March&#160;31, 2022) in the form of stock options and other stock&lt;span class="nobreak"&gt;-based&lt;/span&gt; awards.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company grants equity awards to employees and directors which include restricted stock awards (&#x201c;RSAs&#x201d;), restricted stock units (&#x201c;RSUs&#x201d;), performance&lt;span class="nobreak"&gt;-based&lt;/span&gt; restricted stock units (&#x201c;PRSUs&#x201d;) and stock options. Certain awards described below are subject to acceleration under certain conditions.&lt;/p&gt;
		&lt;table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;"&gt;	&lt;tr class="No-Table-Style _idGenTableRowColumn-49" style="height:12pt;"&gt;	&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;vertical-align:top;width: 18.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;	&lt;p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:24pt;"&gt;Stock options:&lt;/p&gt;	&lt;/td&gt;	&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;	&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 80.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;"&gt;Generally issued for terms of ten&#160;years and may vest after at least one year of service and have an exercise price equal to the Company&#x2019;s stock price on the grant date. The Company estimates the fair value of stock options (when granted) using the Black&lt;span class="nobreak"&gt;-Scholes&lt;/span&gt; option pricing model.&lt;/p&gt;	&lt;/td&gt;	&lt;/tr&gt;	&lt;tr class="No-Table-Style _idGenTableRowColumn-39" style="height:12pt;"&gt;	&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 18.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;	&lt;p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:24pt;margin-top:8pt;"&gt;RSAs/RSUs:&lt;/p&gt;	&lt;/td&gt;	&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;	&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 80.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;"&gt;Awards are valued based on the Company&#x2019;s stock price on grant date and generally vest ratably, on an annual basis, over three&#160;years.&lt;/p&gt;	&lt;/td&gt;	&lt;/tr&gt;	&lt;tr class="No-Table-Style _idGenTableRowColumn-50" style="height:12pt;"&gt;	&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-top:10pt;vertical-align:top;width: 18.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="top"&gt;	&lt;p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-left:24pt;margin-top:8pt;"&gt;PRSUs:&lt;/p&gt;	&lt;/td&gt;	&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;vertical-align:top;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="top"&gt;&#160;&lt;/td&gt;	&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;padding-top:10pt;width: 80.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;"&gt;These awards cliff vest three&#160;years from the grant date and contain a market condition whereby the number of PRSUs ultimately vesting is tied to how the Company&#x2019;s total shareholder return (&#x201c;TSR&#x201d;) compares to a peer group of other publicly traded asset managers over the three&lt;span class="nobreak"&gt;-year&lt;/span&gt; period. A Monte Carlo simulation is used to value these awards.&lt;/p&gt;	&lt;p class="Texttable" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;The number of PRSUs vesting ranges from 0% to 200% of the target number of PRSUs granted, as follows:&lt;/p&gt;	&lt;p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:18pt;"&gt;&lt;span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;"&gt;&#x2022;&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;If the relative TSR is below the 25&lt;span class="Superscript" style="vertical-align:super;font-size:58%;"&gt;th&lt;/span&gt; percentile, then 0% of the target number of PRSUs granted will vest;&lt;/p&gt;	&lt;p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:18pt;"&gt;&lt;span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;"&gt;&#x2022;&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;If the relative TSR is at the 25&lt;span class="CharOverride-6" style="font-size:58%;vertical-align:super;"&gt;th&lt;/span&gt; percentile, then 50% of the target number of PRSUs granted will vest;&lt;/p&gt;	&lt;p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:18pt;"&gt;&lt;span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;"&gt;&#x2022;&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;If the relative TSR is above the 25&lt;span class="CharOverride-6" style="font-size:58%;vertical-align:super;"&gt;th&lt;/span&gt; percentile, then linear scaling is applied such that the percent of the target number of PRSUs vesting is 100% at the 50&lt;span class="CharOverride-6" style="font-size:58%;vertical-align:super;"&gt;th&lt;/span&gt; percentile and capped at 200% of the target number of PRSUs granted for performance at the 85&lt;span class="CharOverride-6" style="font-size:58%;vertical-align:super;"&gt;th&lt;/span&gt; percentile; and&lt;/p&gt;	&lt;p class="BL_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;list-style-position:outside;list-style-type:disc;margin-bottom:0;margin-left:48pt;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-18pt;widows:3;margin-left:18pt;"&gt;&lt;span class="bullet" style="font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-weight:normal;"&gt;&#x2022;&lt;span style="width: 20px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;If the Company&#x2019;s TSR is negative, the target number of PRSUs vesting is capped at 100% regardless of the relative TSR percentile.&lt;/p&gt;	&lt;/td&gt;	&lt;/tr&gt;	&lt;/table&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;During the&#160;years ended December&#160;31, 2023, 2022 and 2021, total stock&lt;span class="nobreak"&gt;-based&lt;/span&gt; compensation expense was $16,190, $10,385 and $9,998, respectively, and the related tax benefit recognized on the Consolidated Statements of Operations was $3,919, $2,371 and $2,327, respectively.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The actual tax benefit realized for the tax deductions for share&lt;span class="nobreak"&gt;-based&lt;/span&gt; compensation was $1,820, $1,548 and $2,032 during the&#160;years ended December&#160;31, 2023, 2022 and 2021, respectively.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;A summary of unrecognized stock&lt;span class="nobreak"&gt;-based&lt;/span&gt; compensation expense and average remaining vesting period is as follows:&lt;/p&gt;
		&lt;table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;"&gt;


				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TCH CellOverride-1" rowspan="2" style="width: 42.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" rowspan="2" style="width: 2.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" colspan="4" style="width: 55.60%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="CharOverride-7" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, 2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TCH CellOverride-2" colspan="2" style="width: 24.63%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="CharOverride-7" style="font-style:normal;font-weight:bold;"&gt;Unrecognized &lt;br/&gt;Stock-Based &lt;br/&gt;Compensation&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-5" style="width: 2.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2" style="width: 28.73%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="CharOverride-7" style="font-style:normal;font-weight:bold;"&gt;Weighted-Average &lt;br/&gt;Remaining &lt;br/&gt;Vesting Period &lt;br/&gt;(Years)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 42.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Employees and directors&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 2.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 21.64%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;19,165&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 2.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 28.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;0.92&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;text-indent:0pt;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Stock Options&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;There was &lt;span style="-sec-ix-hidden: hidden-fact-235"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-236"&gt;no&lt;/span&gt;&lt;/span&gt; option activity during the&#160;years ended December&#160;31, 2023 and 2022 and there were no options outstanding as of December&#160;31, 2023 and 2022. The total intrinsic value of options exercised during the year ended December&#160;31, 2021 was $51. Cash received from option exercises during the year ended December&#160;31, 2021 was $815.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;RSAs, RSUs and PRSUs&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The aggregate fair value of RSAs, RSUs and PRSUs that vested during the&#160;years ended December&#160;31, 2023, 2022 and 2021 was $10,158, $9,466 and $10,940, respectively. A summary of activity is as follows:&lt;/p&gt;
		&lt;table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;"&gt;


				&lt;tr class="No-Table-Style _idGenTableRowColumn-57" style="height:12pt;"&gt;
					&lt;td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="4" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 22.65%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;RSA&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="4" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 22.65%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;RSU&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="4" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 23.72%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;PRSU&lt;/span&gt;&lt;span class="Bold-Superscript" style="font-style:normal;font-weight:bold;vertical-align:super;font-size:58%;"&gt;(1)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-58" style="height:12pt;"&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Shares&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Weighted &lt;br/&gt;Average &lt;br/&gt;Grant Date &lt;br/&gt;Fair Value&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Shares&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Weighted &lt;br/&gt;Average &lt;br/&gt;Grant Date &lt;br/&gt;Fair Value&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Shares&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 11.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Weighted &lt;br/&gt;Average &lt;br/&gt;Grant Date &lt;br/&gt;Fair Value&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-59" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Unvested Balance at January&#160;1, 2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;3,580,743&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.38&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;39,408&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;4.46&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;341,312&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.17&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Granted&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;1,642,266&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.46&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;31,170&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.43&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_b" style="-sec-ix-hidden: hidden-fact-226; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;257,043&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;6.49&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Vested&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(1,897,699)&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.78&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(15,136)&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;4.73&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-227; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#x2014;&#160;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-228; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(288,405)&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.11&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(452)&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.37&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(47,669)&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.74&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-59" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Unvested Balance at December&#160;31, 2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;3,036,905&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.20&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;54,990&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;4.93&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;550,686&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.73&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Granted&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;2,170,432&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.71&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;116,247&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.18&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="-sec-ix-hidden: hidden-fact-229; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;319,838&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;6.80&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Vested&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(1,621,201)&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.31&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(27,894)&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.10&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(202,336)&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;6.24&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(195,054)&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.43&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(1,380)&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.73&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-230; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#x2014;&#160;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-231; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-59" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Unvested Balance at December&#160;31, 2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;3,391,082&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.46&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;141,963&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.09&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;668,188&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;6.09&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Granted&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;3,363,501&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.63&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;152,265&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;6.24&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="-sec-ix-hidden: hidden-fact-232; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;576,240&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;6.49&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Vested&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(1,629,925)&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.28&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(72,461)&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.66&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(108,113)&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;3.11&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(114,436)&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.55&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(34,385)&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.70&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-233; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#x2014;&#160;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Stock dividends accrued&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;2,762&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;6.24&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;37,777&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;6.49&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-59" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Unvested Balance at December&#160;31, 2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5,010,222&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.63&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2b" style="-sec-ix-hidden: hidden-fact-234; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;190,144&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(&lt;/span&gt;&lt;span class="CharOverride-5" style="font-size:6pt;vertical-align:super;"&gt;3&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.70&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;1,174,092&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;6.58&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;&lt;p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;"&gt;&#x200b;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(1)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;Represents the target number of PRSUs granted and outstanding. The number of PRSUs that ultimately vest ranges from 0% to 200% of this amount. During the years ended December 31, 2023, 2022 and 2021, 200%, 77% and 0%, respectively, of the target number of PRSUs granted ultimately vested, inclusive of accrued stock dividends.&lt;/p&gt;&lt;p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:6pt;text-align:left;margin-top:6pt;"&gt;&#x200b;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(2)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;A Monte Carlo simulation was used to value these awards using the following assumptions for the Company and the peer group: (i) beginning 90&lt;span class="nobreak"&gt;-day&lt;/span&gt; average stock prices; (ii) valuation date stock prices; (iii) correlation coefficients based upon the price data used to calculate the historical volatilities; and (iv) the following additional assumptions:&lt;/p&gt;
		&lt;table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;"&gt;


				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Granted in &lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Granted in &lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Granted in &lt;br/&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1 _idGenCellOverride-4" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Historical stock price volatility (low)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;37%&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;33%&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;34%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Historical stock price volatility (high)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;56%&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;57%&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;57%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Historical stock price volatility (average)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;47%&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;44%&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;44%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Risk free interest rate&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;3.80%&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;1.28%&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;0.17%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Expected dividend yield&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;0.00%&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;0.00%&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;0.00%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;
		&lt;p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:6pt;margin-top:6pt;"&gt;&#x200b;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(3)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;Includes 57,779 deferred RSUs that have vested.&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="c297"
      decimals="0"
      id="ixv-27311"
      unitRef="shares">16000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c298" id="ixv-27312">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c0" id="ixv-27313">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms contextRef="c0" id="ixv-22731">The number of PRSUs vesting ranges from 0% to 200% of the target number of PRSUs granted, as follows:	&#x2022;&#160;&#160;&#160;&#160;&#160;If the relative TSR is below the 25th percentile, then 0% of the target number of PRSUs granted will vest;	&#x2022;&#160;&#160;&#160;&#160;&#160;If the relative TSR is at the 25th percentile, then 50% of the target number of PRSUs granted will vest;	&#x2022;&#160;&#160;&#160;&#160;&#160;If the relative TSR is above the 25th percentile, then linear scaling is applied such that the percent of the target number of PRSUs vesting is 100% at the 50th percentile and capped at 200% of the target number of PRSUs granted for performance at the 85th percentile; and	&#x2022;&#160;&#160;&#160;&#160;&#160;If the Company&#x2019;s TSR is negative, the target number of PRSUs vesting is capped at 100% regardless of the relative TSR percentile.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms>
    <us-gaap:ShareBasedCompensation contextRef="c0" decimals="-3" id="ixv-27315" unitRef="usd">16190000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c19" decimals="-3" id="ixv-27316" unitRef="usd">10385000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c20" decimals="-3" id="ixv-27317" unitRef="usd">9998000</us-gaap:ShareBasedCompensation>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c0" decimals="-3" id="ixv-27318" unitRef="usd">3919000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c19" decimals="-3" id="ixv-27319" unitRef="usd">2371000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c20" decimals="-3" id="ixv-27320" unitRef="usd">2327000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:OtherTaxExpenseBenefit contextRef="c0" decimals="-3" id="ixv-27321" unitRef="usd">1820000</us-gaap:OtherTaxExpenseBenefit>
    <us-gaap:OtherTaxExpenseBenefit contextRef="c19" decimals="-3" id="ixv-27322" unitRef="usd">1548000</us-gaap:OtherTaxExpenseBenefit>
    <us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit contextRef="c20" decimals="-3" id="ixv-27323" unitRef="usd">2032000</us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionTaxBenefit>
    <wt:ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock contextRef="c0" id="ixv-22760">A summary of unrecognized stock&lt;span class="nobreak"&gt;-based&lt;/span&gt; compensation expense and average remaining vesting period is as follows:&lt;table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;"&gt;


				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TCH CellOverride-1" rowspan="2" style="width: 42.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" rowspan="2" style="width: 2.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" colspan="4" style="width: 55.60%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="CharOverride-7" style="font-style:normal;font-weight:bold;"&gt;December&#160;31, 2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TCH CellOverride-2" colspan="2" style="width: 24.63%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="CharOverride-7" style="font-style:normal;font-weight:bold;"&gt;Unrecognized &lt;br/&gt;Stock-Based &lt;br/&gt;Compensation&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-5" style="width: 2.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2" style="width: 28.73%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="CharOverride-7" style="font-style:normal;font-weight:bold;"&gt;Weighted-Average &lt;br/&gt;Remaining &lt;br/&gt;Vesting Period &lt;br/&gt;(Years)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 42.16%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Employees and directors&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 2.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.99%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 21.64%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;19,165&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 2.24%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 28.73%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;0.92&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</wt:ScheduleOfUnrecognizedStockBasedCompensationExpensesAndAverageRemainingVestingPeriodTableTextBlock>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="c305"
      decimals="-3"
      id="ixv-27324"
      unitRef="usd">19165000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c306" id="ixv-27325">P0Y11M1D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c20" decimals="-3" id="ixv-27326" unitRef="usd">51000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c20" decimals="-3" id="ixv-27327" unitRef="usd">815000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c0" decimals="-3" id="ixv-27328" unitRef="usd">10158000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c19" decimals="-3" id="ixv-27329" unitRef="usd">9466000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c20" decimals="-3" id="ixv-27330" unitRef="usd">10940000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock contextRef="c0" id="ixv-27331">A summary of activity is as follows:&lt;table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;"&gt;


				&lt;tr class="No-Table-Style _idGenTableRowColumn-57" style="height:12pt;"&gt;
					&lt;td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-top:2pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="TCH" rowspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="4" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 22.65%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;RSA&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="4" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 22.65%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;RSU&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="4" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 23.72%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;PRSU&lt;/span&gt;&lt;span class="Bold-Superscript" style="font-style:normal;font-weight:bold;vertical-align:super;font-size:58%;"&gt;(1)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-58" style="height:12pt;"&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Shares&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Weighted &lt;br/&gt;Average &lt;br/&gt;Grant Date &lt;br/&gt;Fair Value&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Shares&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Weighted &lt;br/&gt;Average &lt;br/&gt;Grant Date &lt;br/&gt;Fair Value&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Shares&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="2" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:2pt;padding-left:0pt;padding-right:0pt;padding-top:2pt;width: 11.75%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Weighted &lt;br/&gt;Average &lt;br/&gt;Grant Date &lt;br/&gt;Fair Value&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-59" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Unvested Balance at January&#160;1, 2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;3,580,743&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.38&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;39,408&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;4.46&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;341,312&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.17&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Granted&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;1,642,266&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.46&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;31,170&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.43&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_b" style="-sec-ix-hidden: hidden-fact-226; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;257,043&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;6.49&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Vested&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(1,897,699)&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.78&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(15,136)&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;4.73&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-227; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#x2014;&#160;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-228; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(288,405)&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.11&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(452)&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.37&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(47,669)&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.74&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-59" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Unvested Balance at December&#160;31, 2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;3,036,905&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.20&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;54,990&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;4.93&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;550,686&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.73&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Granted&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;2,170,432&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.71&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;116,247&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.18&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="-sec-ix-hidden: hidden-fact-229; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;319,838&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;6.80&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Vested&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(1,621,201)&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.31&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(27,894)&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.10&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(202,336)&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;6.24&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(195,054)&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.43&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(1,380)&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.73&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-230; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#x2014;&#160;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-231; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-59" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Unvested Balance at December&#160;31, 2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;3,391,082&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.46&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;141,963&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.09&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;668,188&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;6.09&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Granted&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;3,363,501&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.63&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;152,265&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;6.24&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="-sec-ix-hidden: hidden-fact-232; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;576,240&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;6.49&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Vested&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(1,629,925)&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.28&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(72,461)&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.66&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(108,113)&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;3.11&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(114,436)&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.55&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;(34,385)&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.70&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-233; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#x2014;&#160;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Stock dividends accrued&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;2,762&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;6.24&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;37,777&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;6.49&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-59" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;width: 27.14%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;Unvested Balance at December&#160;31, 2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5,010,222&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.63&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2b" style="-sec-ix-hidden: hidden-fact-234; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;190,144&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(&lt;/span&gt;&lt;span class="CharOverride-5" style="font-size:6pt;vertical-align:super;"&gt;3&lt;/span&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 8.97%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;5.70&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.68%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;1,174,092&#160;&#160;&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 1.71%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;$&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 10.04%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&lt;span class="CharOverride-8" style="font-size:9pt;"&gt;6.58&lt;/span&gt;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;&lt;p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;"&gt;&#x200b;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(1)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;Represents the target number of PRSUs granted and outstanding. The number of PRSUs that ultimately vest ranges from 0% to 200% of this amount. During the years ended December 31, 2023, 2022 and 2021, 200%, 77% and 0%, respectively, of the target number of PRSUs granted ultimately vested, inclusive of accrued stock dividends.&lt;/p&gt;&lt;p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:6pt;text-align:left;margin-top:6pt;"&gt;&#x200b;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(2)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;A Monte Carlo simulation was used to value these awards using the following assumptions for the Company and the peer group: (i) beginning 90&lt;span class="nobreak"&gt;-day&lt;/span&gt; average stock prices; (ii) valuation date stock prices; (iii) correlation coefficients based upon the price data used to calculate the historical volatilities; and (iv) the following additional assumptions:&lt;/p&gt;&lt;p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:6pt;margin-top:6pt;"&gt;&#x200b;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(3)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;Includes 57,779 deferred RSUs that have vested.&lt;/p&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c307"
      decimals="INF"
      id="ixv-27332"
      unitRef="shares">3580743</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c307"
      decimals="2"
      id="ixv-27333"
      unitRef="usdPershares">5.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c308"
      decimals="INF"
      id="ixv-27334"
      unitRef="shares">39408</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c308"
      decimals="2"
      id="ixv-27335"
      unitRef="usdPershares">4.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c309"
      decimals="INF"
      id="ix_20_fact"
      unitRef="shares">341312</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c309"
      decimals="2"
      id="ix_21_fact"
      unitRef="usdPershares">5.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c310"
      decimals="INF"
      id="ixv-27338"
      unitRef="shares">1642266</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c310"
      decimals="2"
      id="ixv-27339"
      unitRef="usdPershares">5.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c311"
      decimals="INF"
      id="ixv-27340"
      unitRef="shares">31170</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c311"
      decimals="2"
      id="ixv-27341"
      unitRef="usdPershares">5.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c312"
      decimals="2"
      id="ix_22_fact"
      unitRef="usdPershares">6.49</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c310"
      decimals="INF"
      id="ixv-27343"
      unitRef="shares">1897699</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c310"
      decimals="2"
      id="ixv-27344"
      unitRef="usdPershares">5.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c311"
      decimals="INF"
      id="ixv-27345"
      unitRef="shares">15136</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c311"
      decimals="2"
      id="ixv-27346"
      unitRef="usdPershares">4.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c310"
      decimals="INF"
      id="ixv-27347"
      unitRef="shares">288405</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c310"
      decimals="2"
      id="ixv-27348"
      unitRef="usdPershares">5.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c311"
      decimals="INF"
      id="ixv-27349"
      unitRef="shares">452</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c311"
      decimals="2"
      id="ixv-27350"
      unitRef="usdPershares">5.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c312"
      decimals="INF"
      id="ix_23_fact"
      unitRef="shares">47669</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c312"
      decimals="2"
      id="ix_24_fact"
      unitRef="usdPershares">5.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c313"
      decimals="INF"
      id="ixv-27353"
      unitRef="shares">3036905</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c313"
      decimals="2"
      id="ixv-27354"
      unitRef="usdPershares">5.2</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c314"
      decimals="INF"
      id="ixv-27355"
      unitRef="shares">54990</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c314"
      decimals="2"
      id="ixv-27356"
      unitRef="usdPershares">4.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c315"
      decimals="INF"
      id="ix_25_fact"
      unitRef="shares">550686</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c315"
      decimals="2"
      id="ix_26_fact"
      unitRef="usdPershares">5.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c316"
      decimals="INF"
      id="ixv-27359"
      unitRef="shares">2170432</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c316"
      decimals="2"
      id="ixv-27360"
      unitRef="usdPershares">5.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c317"
      decimals="INF"
      id="ixv-27361"
      unitRef="shares">116247</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c317"
      decimals="2"
      id="ixv-27362"
      unitRef="usdPershares">5.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c318"
      decimals="2"
      id="ix_27_fact"
      unitRef="usdPershares">6.8</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c316"
      decimals="INF"
      id="ixv-27364"
      unitRef="shares">1621201</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c316"
      decimals="2"
      id="ixv-27365"
      unitRef="usdPershares">5.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c317"
      decimals="INF"
      id="ixv-27366"
      unitRef="shares">27894</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c317"
      decimals="2"
      id="ixv-27367"
      unitRef="usdPershares">5.1</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c318"
      decimals="INF"
      id="ix_28_fact"
      unitRef="shares">202336</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c318"
      decimals="2"
      id="ix_29_fact"
      unitRef="usdPershares">6.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c316"
      decimals="INF"
      id="ixv-27370"
      unitRef="shares">195054</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c316"
      decimals="2"
      id="ixv-27371"
      unitRef="usdPershares">5.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c317"
      decimals="INF"
      id="ixv-27372"
      unitRef="shares">1380</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c317"
      decimals="2"
      id="ixv-27373"
      unitRef="usdPershares">5.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c319"
      decimals="INF"
      id="ixv-27374"
      unitRef="shares">3391082</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c319"
      decimals="2"
      id="ixv-27375"
      unitRef="usdPershares">5.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c320"
      decimals="INF"
      id="ixv-27376"
      unitRef="shares">141963</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c320"
      decimals="2"
      id="ixv-27377"
      unitRef="usdPershares">5.09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c321"
      decimals="INF"
      id="ix_30_fact"
      unitRef="shares">668188</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c321"
      decimals="2"
      id="ix_31_fact"
      unitRef="usdPershares">6.09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c322"
      decimals="INF"
      id="ixv-27380"
      unitRef="shares">3363501</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c322"
      decimals="2"
      id="ixv-27381"
      unitRef="usdPershares">5.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c304"
      decimals="INF"
      id="ixv-27382"
      unitRef="shares">152265</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c304"
      decimals="2"
      id="ixv-27383"
      unitRef="usdPershares">6.24</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c323"
      decimals="2"
      id="ix_32_fact"
      unitRef="usdPershares">6.49</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c322"
      decimals="INF"
      id="ixv-27385"
      unitRef="shares">1629925</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c322"
      decimals="2"
      id="ixv-27386"
      unitRef="usdPershares">5.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c304"
      decimals="INF"
      id="ixv-27387"
      unitRef="shares">72461</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c304"
      decimals="2"
      id="ixv-27388"
      unitRef="usdPershares">5.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c323"
      decimals="INF"
      id="ix_33_fact"
      unitRef="shares">108113</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c323"
      decimals="2"
      id="ix_34_fact"
      unitRef="usdPershares">3.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c322"
      decimals="INF"
      id="ixv-27391"
      unitRef="shares">114436</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c322"
      decimals="2"
      id="ixv-27392"
      unitRef="usdPershares">5.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c304"
      decimals="INF"
      id="ixv-27393"
      unitRef="shares">34385</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c304"
      decimals="2"
      id="ix_35_fact"
      unitRef="usdPershares">5.7</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:StockDividendsShares
      contextRef="c304"
      decimals="INF"
      id="ix_36_fact"
      unitRef="shares">2762</us-gaap:StockDividendsShares>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="c324"
      decimals="2"
      id="ix_37_fact"
      unitRef="usdPershares">6.24</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:StockDividendsShares
      contextRef="c323"
      decimals="INF"
      id="ixv-27397"
      unitRef="shares">37777</us-gaap:StockDividendsShares>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="c325"
      decimals="2"
      id="ixv-27398"
      unitRef="usdPershares">6.49</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c326"
      decimals="INF"
      id="ixv-27399"
      unitRef="shares">5010222</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c326"
      decimals="2"
      id="ixv-27400"
      unitRef="usdPershares">5.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c324"
      decimals="2"
      id="ixv-27401"
      unitRef="usdPershares">5.7</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c325"
      decimals="INF"
      id="ix_38_fact"
      unitRef="shares">1174092</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c325"
      decimals="2"
      id="ix_39_fact"
      unitRef="usdPershares">6.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="c299"
      decimals="2"
      id="ixv-27405"
      unitRef="pure">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="c300"
      decimals="2"
      id="ixv-27406"
      unitRef="pure">2</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="c301"
      decimals="2"
      id="ixv-27407"
      unitRef="pure">2</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="c302"
      decimals="2"
      id="ixv-27408"
      unitRef="pure">0.77</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="c303"
      decimals="2"
      id="ixv-27409"
      unitRef="pure">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c0" id="ixv-27410">the following additional assumptions:&lt;table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;"&gt;


				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Granted in &lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Granted in &lt;br/&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Granted in &lt;br/&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1 _idGenCellOverride-4" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Historical stock price volatility (low)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;37%&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;33%&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;34%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Historical stock price volatility (high)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;56%&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;57%&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;57%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Historical stock price volatility (average)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;47%&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;44%&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;44%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Risk free interest rate&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;3.80%&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;1.28%&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;0.17%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Expected dividend yield&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;0.00%&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;0.00%&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;0.00%&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="c0" decimals="2" id="ixv-27411" unitRef="pure">0.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="c19" decimals="2" id="ixv-27412" unitRef="pure">0.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="c20" decimals="2" id="ixv-27413" unitRef="pure">0.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="c0" decimals="2" id="ixv-27414" unitRef="pure">0.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="c19" decimals="2" id="ixv-27415" unitRef="pure">0.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="c20" decimals="2" id="ixv-27416" unitRef="pure">0.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate contextRef="c0" decimals="2" id="ixv-27417" unitRef="pure">0.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate contextRef="c19" decimals="2" id="ixv-27418" unitRef="pure">0.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate contextRef="c20" decimals="2" id="ixv-27419" unitRef="pure">0.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c0" decimals="4" id="ixv-27420" unitRef="pure">0.038</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c19" decimals="4" id="ixv-27421" unitRef="pure">0.0128</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c20" decimals="4" id="ixv-27422" unitRef="pure">0.0017</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c0" decimals="4" id="ixv-27423" unitRef="pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c19" decimals="4" id="ixv-27424" unitRef="pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c20" decimals="4" id="ixv-27425" unitRef="pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="c304"
      decimals="0"
      id="ixv-27427"
      unitRef="shares">57779</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <wt:DisclosureOfStockholderRightsPlanTextBlock contextRef="c0" id="ixv-23477">&lt;p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;19. Stockholder Rights Plan&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;"&gt;On March&#160;17, 2023, the Board of Directors of the Company adopted a stockholder rights plan, as set forth in the Stockholder Rights Agreement, dated March&#160;17, 2023, between the Company and Continental Stock Transfer&#160;&amp;amp; Trust Company, as Rights Agent, as amended by Amendment No. 1 thereto, dated May&#160;4, 2023 (&#x201c;Amendment No. 1&#x201d;), and by Amendment No. 2 thereto, dated May&#160;10, 2023 (&#x201c;Amendment No. 2&#x201d;) (as amended, the &#x201c;Stockholder Rights Agreement&#x201d;). At the Company&#x2019;s 2023 Annual Meeting of Stockholders held on June&#160;16, 2023, the Company&#x2019;s stockholders ratified the adoption by the Board of Directors of the Stockholder Rights Agreement.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Pursuant to the terms of the Stockholder Rights Agreement, the Board of Directors declared a dividend distribution of (i)&#160;one Right (as defined below) for each outstanding share of common stock, par value $0.01 per share, of the Company&#x2019;s common stock and (ii)&#160;1,000 Rights for each outstanding share of the Company&#x2019;s Series&#160;A Non&lt;span class="nobreak"&gt;-Voting&lt;/span&gt; Convertible Preferred Stock (&#x201c;Series&#160;A Preferred Stock&#x201d;), to stockholders of record as of the close of business on March&#160;28, 2023 (the &#x201c;Record Date&#x201d;). In addition, one Right will automatically attach to each share of common stock and 1,000 Rights will automatically attach to each share of Series&#160;A Preferred Stock, in each case, issued between the Record Date and the earlier of the Distribution Date (as defined below) and the expiration date of the Rights. Each &#x201c;Right&#x201d; entitles the registered holder thereof to purchase from the Company a unit consisting of one ten&lt;span class="nobreak"&gt;-thousandth&lt;/span&gt; of a share (a &#x201c;Unit&#x201d;) of Series&#160;B Junior Participating Cumulative Preferred Stock, par value $0.01 per share, of the Company (the &#x201c;Series&#160;B Preferred Stock&#x201d;) at a cash exercise price of $32.00 per Unit (the &#x201c;Exercise Price&#x201d;), subject to adjustment, under certain conditions specified in the Stockholder Rights Agreement and summarized below.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Initially, the Rights are not exercisable and are attached to and trade with all shares of common stock and Series&#160;A Preferred Stock outstanding as of, and issued subsequent to, the Record Date. The Rights will separate from the common stock and Series&#160;A Preferred Stock and will become exercisable upon the earlier of (i)&#160;the close of business on the tenth calendar&#160;day following the first public announcement that a person or group of affiliated or associated persons (an &#x201c;Acquiring Person&#x201d;) has acquired beneficial ownership of 10% (or 20% in the case of a person or group which, together with all affiliates and associates of such person or group, is the beneficial owner of shares of common stock of the Company representing less than 20% of the shares of common stock of the Company then outstanding, and which is entitled to file, and files, a statement on Schedule&#160;13G pursuant to Rule&#160;13d&lt;span class="nobreak"&gt;-1&lt;/span&gt;(b)&#160;or Rule&#160;13d&lt;span class="nobreak"&gt;-1&lt;/span&gt;(c)&#160;of the General Rules and Regulations under the Exchange&#160;Act as in effect at the time of the first public announcement of the declaration of the Rights dividend with respect to the shares of common stock beneficially owned by such person or group) or more of the outstanding shares of common stock, other than as a result of repurchases of stock by the Company or certain inadvertent actions by a stockholder (the date of such announcement being referred to as the &#x201c;Stock Acquisition Date&#x201d;), or (ii)&#160;the close of business on the tenth business&#160;day (or such later&#160;day as the Board of Directors may determine) following the commencement of a tender offer or exchange offer that could result upon its consummation in a person or group becoming an Acquiring Person (the earlier of such dates being herein referred to as the &#x201c;Distribution Date&#x201d;). A person or group who beneficially owned 10% or more (or 20% or more in the case of passive stockholders) of the Company&#x2019;s outstanding common stock prior to the first public announcement by the Company of the adoption of the Stockholder Rights Agreement will not trigger the Stockholder Rights Agreement so long as they do not acquire beneficial ownership of any additional shares of common stock at a time when they still beneficially own 10% or more (or 20% or more in the case of passive stockholders) of such common stock, subject to certain exceptions as set forth in the Stockholder Rights Agreement.&lt;/p&gt;&lt;div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;"&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;For purposes of the Stockholder Rights Agreement, beneficial ownership is defined to include ownership of securities that are subject to a derivative transaction and acquired derivative securities. Swaps dealers unassociated with any control intent or intent to evade the purposes of the Stockholder Rights Agreement are excepted from such imputed beneficial ownership. Pursuant to Amendment No.&lt;span class="nobreak"&gt; &lt;/span&gt;1, beneficial ownership did not include the right to vote pursuant to any agreement, arrangement or understanding with respect to voting on the proposal to approve and ratify the Stockholder Rights Agreement presented to the Company&#x2019;s stockholders at the Company&#x2019;s 2023 annual meeting of stockholders. Pursuant to Amendment No.&lt;span class="nobreak"&gt; &lt;/span&gt;2, the parties to the SPA Agreement are not deemed to be &#x201c;Acquiring Persons&#x201d; solely by virtue of, or as a result of, the parties&#x2019; entry into the SPA Agreement, the issuance of the Series&#160;C Preferred Stock to GBH, and the performance or consummation of any of the other transactions contemplated by the SPA Agreement, among other conditions, under the terms and conditions set forth in Amendment No. 2.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;In the event that a Stock Acquisition Date occurs, proper provision will be made so that each holder of a Right (other than an Acquiring Person or its associates or affiliates, whose Rights shall become null and void) will thereafter have the right to receive upon exercise, in lieu of a number of shares of Series&#160;B Preferred Stock, that number of shares of common stock of the Company (or, in certain circumstances, including if there are insufficient shares of common stock to permit the exercise in full of the Rights, Units&#160;of Series&#160;B Preferred Stock, other securities, cash or property, or any combination of the foregoing) having a market value of two times the Exercise Price of the Right (such right being referred to as the &#x201c;Subscription Right&#x201d;). In the event that, at any time following the Stock Acquisition Date, (i)&#160;the Company consolidates with, or merges with and into, any other person, and the Company is not the continuing or surviving corporation, (ii)&#160;any person consolidates with the Company, or merges with and into the Company and the Company is the continuing or surviving corporation of such merger and, in connection with such merger, all or part of the shares of common stock are changed into or exchanged for stock or other securities of any other person or cash or any other property, or (iii)&#160;50% or more of the Company&#x2019;s assets or earning power is sold, mortgaged or otherwise transferred, each holder of a Right (other than an Acquiring Person or its associates or affiliates, whose Rights shall become null and void) will thereafter have the right to receive, upon exercise, common stock of the acquiring company having a market value equal to two times the Exercise Price of the Right (such right being referred to as the &#x201c;Merger Right&#x201d;). The holder of a Right will continue to have the Merger Right whether or not such holder has exercised the Subscription Right. Rights that are or were beneficially owned by an Acquiring Person may (under certain circumstances specified in the Stockholder Rights Agreement) become null and void.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Rights may be redeemed in whole, but not in part, at a price of $0.01 per Right (payable in cash, common stock or other consideration deemed appropriate by the Board of Directors) by the Board of Directors only until the earlier of (i)&#160;the time at which any person becomes an Acquiring Person or (ii)&#160;the expiration date of the Stockholder Rights Agreement. Immediately upon the action of the Board of Directors ordering redemption of the Rights, the Rights will terminate and thereafter the only right of the holders of Rights will be to receive the redemption price.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Stockholder Rights Agreement may be amended by the Board of Directors in its sole discretion at any time prior to the time at which any person becomes an Acquiring Person. After such time the Board of Directors may, subject to certain limitations set forth in the Stockholder Rights Agreement, amend the Stockholder Rights Agreement only to cure any ambiguity, defect or inconsistency, to shorten or lengthen any time period, or to make changes that do not adversely affect the interests of Rights holders (excluding the interests of an Acquiring Person or its associates or affiliates).&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Until a Right is exercised, the holder will have no rights as a stockholder of the Company (beyond those as an existing stockholder), including the right to vote or to receive dividends. While the distribution of the Rights will not be taxable to stockholders or to the Company, stockholders may, depending upon the circumstances, recognize taxable income in the event that the Rights become exercisable for shares of common stock, other securities of the Company, other consideration or for common stock of an acquiring company.&lt;/p&gt;
		&lt;/div&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Rights are not exercisable until the Distribution Date and will expire at the close of business on March&#160;16, 2024, unless previously redeemed or exchanged by the Company.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Stockholder Rights Agreement provides the holders of the common stock with the ability to exempt an offer to acquire, or engage in another business combination transaction involving, the Company that is deemed a &#x201c;Qualifying Offer&#x201d; (as defined in the Stockholder Rights Agreement) from the terms of the Stockholder Rights Agreement. A Qualifying Offer is, in summary, an offer determined by a majority of the independent members of the Board to have specific characteristics that are generally intended to preclude offers that are coercive, abusive or highly contingent. Among those characteristics are that it be: (i)&#160;a fully financed all&lt;span class="nobreak"&gt;-cash&lt;/span&gt; tender offer or an exchange offer offering shares of common stock of the offeror, or a combination thereof, for any and all of the common stock; and (ii)&#160;an offer that is otherwise in the best interests of the Company&#x2019;s stockholders. The Stockholder Rights Agreement provides additional characteristics necessary for an acquisition offer to be deemed a &#x201c;Qualifying Offer,&#x201d; including if the consideration offered in a proposed transaction is stock of the acquiror.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Pursuant to the Stockholder Rights Agreement, if the Company receives a Qualifying Offer and the Board of Directors has not redeemed the outstanding Rights or exempted such Qualifying Offer from the terms of the Stockholder Rights Agreement or called a special meeting of stockholders (the &#x201c;Special Meeting&#x201d;) for the purpose of voting on whether to exempt such Qualifying Offer from the terms of the Stockholder Rights Agreement, in each case by the end of the 90 business&#160;day period following the commencement of such Qualifying Offer, provided such offer remains a Qualifying Offer during such period, the holders of 10% of the common stock may request that the Board call a Special Meeting to vote on a resolution authorizing the exemption of the Qualifying Offer from the terms of the Stockholder Rights Agreement. If such a Special Meeting is not held by the 90th business&#160;day following the receipt of such a request from stockholders to call a Special Meeting, the Qualifying Offer will be deemed exempt from the terms of the Stockholder Rights Agreement on the 10th business&#160;day thereafter.&lt;/p&gt;</wt:DisclosureOfStockholderRightsPlanTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c327"
      decimals="0"
      id="ixv-27428"
      unitRef="shares">1</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c328"
      decimals="INF"
      id="ixv-27429"
      unitRef="usdPershares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c329"
      decimals="0"
      id="ixv-27430"
      unitRef="shares">1000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c330"
      decimals="0"
      id="ixv-27431"
      unitRef="shares">1000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c331"
      decimals="INF"
      id="ixv-27432"
      unitRef="usdPershares">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <wt:ExercisePricePerUnit
      contextRef="c332"
      decimals="INF"
      id="ixv-27433"
      unitRef="usdPershares">32</wt:ExercisePricePerUnit>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="c333"
      decimals="2"
      id="ixv-27434"
      unitRef="pure">0.10</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="c334"
      decimals="2"
      id="ixv-27435"
      unitRef="pure">0.20</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <wt:PercentageOfCommonStockAcquired
      contextRef="c335"
      decimals="2"
      id="ixv-27436"
      unitRef="pure">0.20</wt:PercentageOfCommonStockAcquired>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="c336"
      decimals="2"
      id="ixv-27437"
      unitRef="pure">0.10</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="c337"
      decimals="2"
      id="ixv-27438"
      unitRef="pure">0.20</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <wt:PercentageOfBeneficialOwnership
      contextRef="c338"
      decimals="2"
      id="ixv-27439"
      unitRef="pure">0.10</wt:PercentageOfBeneficialOwnership>
    <wt:PercentageOfBeneficialOwnership
      contextRef="c339"
      decimals="2"
      id="ixv-27440"
      unitRef="pure">0.20</wt:PercentageOfBeneficialOwnership>
    <wt:PercentageOfAssetsSold contextRef="c0" decimals="2" id="ixv-27441" unitRef="pure">0.50</wt:PercentageOfAssetsSold>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c340"
      decimals="INF"
      id="ixv-27442"
      unitRef="usdPershares">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <wt:PercentageOfCommonStock contextRef="c0" decimals="2" id="ixv-27443" unitRef="pure">0.10</wt:PercentageOfCommonStock>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="c0" id="ixv-23508">&lt;p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;20. Employee Benefit Plans&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company has a 401(k)&#160;savings plan covering all eligible employees in which the Company can make discretionary contributions from its profits. The amounts included in the table below are recorded in compensation expense in the Consolidated Statements of Operations.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;A summary of discretionary contributions made by the Company is as follows:&lt;/p&gt;
		&lt;table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;"&gt;


				&lt;tr class="Table55-"&gt;
					&lt;td class="Table55- TCH CellOverride-2" colspan="8" style="width: 100.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;

						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 30.26%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-7" style="width: 3.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 30.26%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-7" style="width: 3.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 33.33%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 4.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-23 _idGenCellOverride-3" style="width: 26.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:6pt;"&gt;1,450&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 3.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 4.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 26.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;1,342&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 3.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 4.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 29.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;1,080&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock contextRef="c0" id="ixv-27444">A summary of discretionary contributions made by the Company is as follows:&lt;table class="Table55-" style="width: 55.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 22% 0pt 22%;"&gt;


				&lt;tr class="Table55-"&gt;
					&lt;td class="Table55- TCH CellOverride-2" colspan="8" style="width: 100.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;

						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="height:12pt;"&gt;
					&lt;td class="Table55- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 30.26%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-7" style="width: 3.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 30.26%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-7" style="width: 3.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 33.33%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table55-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 4.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-23 _idGenCellOverride-3" style="width: 26.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:6pt;"&gt;1,450&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 3.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 4.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 26.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;1,342&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-6 _idGenCellOverride-4" style="width: 3.08%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 4.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table55- TB CellOverride-2 _idGenCellOverride-3" style="width: 29.23%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;1,080&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="c0" decimals="-3" id="ixv-27445" unitRef="usd">1450000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="c19" decimals="-3" id="ixv-27446" unitRef="usd">1342000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount contextRef="c20" decimals="-3" id="ixv-27447" unitRef="usd">1080000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:EarningsPerShareTextBlock contextRef="c0" id="ixv-23549">&lt;div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;"&gt;
		&lt;p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:14pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;21. Earnings Per Share&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The following tables set forth reconciliations of the basic and diluted earnings per share computations for the periods presented:&lt;/p&gt;
		&lt;table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;"&gt;


				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-1 _idGenCellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-15" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Basic Earnings per Share&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-16" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-16" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-16" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-15 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"&gt;Net income&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"&gt;102,546&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"&gt;50,684&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"&gt;49,797&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Add: Gain on repurchase of Series&#160;C Preferred Stock&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;7,966&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-237; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-238; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Less: Income distributed to participating securities&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(2,770)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(2,186)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(2,168)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Less: Undistributed income allocable to participating securities&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(12,680)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(3,528)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(3,378)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Net income available to common stockholders&#x2014;Basic EPS&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;95,062&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;44,970&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;44,251&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-15" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"&gt;Weighted average common shares (in&lt;span class="nobreak"&gt; &lt;/span&gt;thousands)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;144,707&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;143,020&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;143,847&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Basic earnings per share&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;0.66&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;0.31&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;0.31&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;
		&lt;table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;"&gt;


				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Years Ended December&#160;31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-15" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Diluted Earnings per Share&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-16" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-16" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-16" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-15 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"&gt;Net income available to common stockholders&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"&gt;95,062&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"&gt;44,970&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"&gt;44,251&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Add back: Undistributed income allocable to participating securities&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;12,680&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;3,528&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;3,378&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Less: Reallocation of undistributed income allocable to participating securities considered potentially dilutive&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(12,449)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(3,522)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(3,353)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Net income available to common stockholders&#x2014;Diluted EPS&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;95,293&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;44,976&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;44,276&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-15" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"&gt;&lt;span class="CharOverride-9" style="text-decoration:underline;"&gt;Weighted Average Diluted Shares (in thousands)&lt;/span&gt;:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Weighted average common shares&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;144,707&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;143,020&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;143,847&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Dilutive effect of common stock equivalents, excluding participating securities&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;3,120&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;275&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,208&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Weighted average diluted shares, excluding participating securities (in thousands)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;147,827&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;143,295&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;145,055&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-15" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"&gt;Diluted earnings per share&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;0.64&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;0.31&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;0.31&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;"&gt;Diluted earnings per share presented above is calculated using the two&lt;span class="nobreak"&gt;-class&lt;/span&gt; method as this method results in the lowest diluted earnings per share amount for common stock. The year ended December&#160;31, 2023 includes a gain of $7,966 recognized upon the repurchase of the Series&#160;C Preferred Stock, which is excluded from net income, but required to be added to net income to arrive at income available to common stockholders in the calculation of earnings per share.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Total antidilutive non&lt;span class="nobreak"&gt;-participating&lt;/span&gt; common stock equivalents were 405 and 132 during the&#160;years ended December&#160;31, 2022 and 2021, respectively (shares herein are reported in thousands). There were no antidilutive non&lt;span class="nobreak"&gt;-participating&lt;/span&gt; common stock equivalents during the year ended December&#160;31, 2023.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;There were no potential common shares associated with the conversion option embedded in the Convertible Notes included in weighted average diluted shares for the&#160;years ended December&#160;31, 2023 and 2022 as the Company&#x2019;s average stock price was lower than the conversion price. Potential common shares associated with the conversion option embedded in the Convertible Notes for the year ended December&#160;31, 2021 were 1,186 (shares herein are reported in thousands).&lt;/p&gt;
		&lt;/div&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The following table reconciles weighted average diluted shares as reported on the Company&#x2019;s Consolidated Statements of Operations for the&#160;years ended December&#160;31, 2023, 2022 and 2021, which are determined pursuant to the treasury stock method, to the weighted average diluted shares used to calculate diluted earnings per share as disclosed in the table above:&lt;/p&gt;
		&lt;table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;"&gt;


				&lt;tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;"&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="5" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 46.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;"&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-16" style="height:12pt;"&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Reconciliation of Weighted Average Diluted Shares (in&lt;/span&gt;&lt;span class="nobreak"&gt; &lt;/span&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;thousands)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"&gt;Weighted average diluted shares as disclosed on the Consolidated Statements of Operations&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;"&gt;170,413&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;"&gt;158,914&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;"&gt;161,263&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Less: Participating securities:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Weighted average shares of common stock issuable upon conversion of the Series&#160;A Preferred Stock (Note&#160;11)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(14,750)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(14,750)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(14,750)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-16" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Weighted average shares of common stock issuable upon conversion of the Series&#160;C Preferred Stock (Note&#160;11)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(6,992)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-239; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-240; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Potentially dilutive restricted stock awards&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(844)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(869)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(1,458)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-16" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"&gt;Weighted average diluted shares used to calculate diluted earnings/(loss) per share as disclosed in the table above&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;147,827&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;143,295&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;145,055&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c0" id="ixv-27448">The following tables set forth reconciliations of the basic and diluted earnings per share computations for the periods presented:&lt;table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;"&gt;


				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-1 _idGenCellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-6 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-15" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Basic Earnings per Share&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-16" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-16" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-16" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-15 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"&gt;Net income&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"&gt;102,546&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"&gt;50,684&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"&gt;49,797&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Add: Gain on repurchase of Series&#160;C Preferred Stock&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;7,966&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-237; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-238; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Less: Income distributed to participating securities&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(2,770)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(2,186)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(2,168)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Less: Undistributed income allocable to participating securities&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(12,680)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(3,528)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(3,378)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Net income available to common stockholders&#x2014;Basic EPS&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;95,062&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;44,970&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;44,251&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-15" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"&gt;Weighted average common shares (in&lt;span class="nobreak"&gt; &lt;/span&gt;thousands)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;144,707&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;143,020&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;143,847&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Basic earnings per share&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;0.66&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;0.31&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;0.31&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;&lt;table class="Table75-" style="width: 75.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 18% 0pt 0.33in;"&gt;


				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Years Ended December&#160;31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TCH CellOverride-15" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Diluted Earnings per Share&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-16" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-16" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-24" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TCH CellOverride-16" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-15 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"&gt;Net income available to common stockholders&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"&gt;95,062&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"&gt;44,970&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"&gt;44,251&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Add back: Undistributed income allocable to participating securities&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;12,680&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;3,528&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;3,378&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Less: Reallocation of undistributed income allocable to participating securities considered potentially dilutive&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(12,449)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(3,522)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1br" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(3,353)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Net income available to common stockholders&#x2014;Diluted EPS&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;95,293&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;44,976&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;44,276&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-15" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"&gt;&lt;span class="CharOverride-9" style="text-decoration:underline;"&gt;Weighted Average Diluted Shares (in thousands)&lt;/span&gt;:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;margin-top:3pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Weighted average common shares&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;144,707&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;143,020&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;143,847&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Dilutive effect of common stock equivalents, excluding participating securities&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;3,120&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;275&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,208&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Weighted average diluted shares, excluding participating securities (in thousands)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;147,827&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;143,295&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;145,055&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table75-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table75- TB CellOverride-15" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"&gt;Diluted earnings per share&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;0.64&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;0.31&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table75- TB CellOverride-16" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;0.31&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="-3" id="ixv-27449" unitRef="usd">102546000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c19" decimals="-3" id="ixv-27450" unitRef="usd">50684000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c20" decimals="-3" id="ixv-27451" unitRef="usd">49797000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="c0" decimals="-3" id="ixv-27452" unitRef="usd">7966000</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <wt:IncomeDistributedToParticipatingSecurities contextRef="c0" decimals="-3" id="ixv-27453" unitRef="usd">2770000</wt:IncomeDistributedToParticipatingSecurities>
    <wt:IncomeDistributedToParticipatingSecurities contextRef="c19" decimals="-3" id="ixv-27454" unitRef="usd">2186000</wt:IncomeDistributedToParticipatingSecurities>
    <wt:IncomeDistributedToParticipatingSecurities contextRef="c20" decimals="-3" id="ixv-27455" unitRef="usd">2168000</wt:IncomeDistributedToParticipatingSecurities>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic contextRef="c0" decimals="-3" id="ixv-27456" unitRef="usd">12680000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic contextRef="c19" decimals="-3" id="ixv-27457" unitRef="usd">3528000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic contextRef="c20" decimals="-3" id="ixv-27458" unitRef="usd">3378000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c0" decimals="-3" id="ixv-27459" unitRef="usd">95062000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c19" decimals="-3" id="ixv-27460" unitRef="usd">44970000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c20" decimals="-3" id="ixv-27461" unitRef="usd">44251000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c0"
      decimals="0"
      id="ixv-27462"
      unitRef="shares">144707</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c19"
      decimals="0"
      id="ixv-27463"
      unitRef="shares">143020</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c20"
      decimals="0"
      id="ixv-27464"
      unitRef="shares">143847</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c0"
      decimals="2"
      id="ixv-27465"
      unitRef="usdPershares">0.66</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c19"
      decimals="2"
      id="ixv-27466"
      unitRef="usdPershares">0.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c20"
      decimals="2"
      id="ixv-27467"
      unitRef="usdPershares">0.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c0" decimals="-3" id="ixv-27468" unitRef="usd">95062000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c19" decimals="-3" id="ixv-27469" unitRef="usd">44970000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c20" decimals="-3" id="ixv-27470" unitRef="usd">44251000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <wt:UndistributedIncomeAllocableToParticipatingSecurities contextRef="c0" decimals="-3" id="ixv-27471" unitRef="usd">-12680000</wt:UndistributedIncomeAllocableToParticipatingSecurities>
    <wt:UndistributedIncomeAllocableToParticipatingSecurities contextRef="c19" decimals="-3" id="ixv-27472" unitRef="usd">-3528000</wt:UndistributedIncomeAllocableToParticipatingSecurities>
    <wt:UndistributedIncomeAllocableToParticipatingSecurities contextRef="c20" decimals="-3" id="ixv-27473" unitRef="usd">-3378000</wt:UndistributedIncomeAllocableToParticipatingSecurities>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted contextRef="c0" decimals="-3" id="ixv-27474" unitRef="usd">12449000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted contextRef="c19" decimals="-3" id="ixv-27475" unitRef="usd">3522000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted contextRef="c20" decimals="-3" id="ixv-27476" unitRef="usd">3353000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c0" decimals="-3" id="ixv-27477" unitRef="usd">95293000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c19" decimals="-3" id="ixv-27478" unitRef="usd">44976000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c20" decimals="-3" id="ixv-27479" unitRef="usd">44276000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c0"
      decimals="0"
      id="ixv-27480"
      unitRef="shares">144707</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c19"
      decimals="0"
      id="ixv-27481"
      unitRef="shares">143020</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="c20"
      decimals="0"
      id="ixv-27482"
      unitRef="shares">143847</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c0"
      decimals="0"
      id="ixv-27483"
      unitRef="shares">3120</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c19"
      decimals="0"
      id="ixv-27484"
      unitRef="shares">275</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="c20"
      decimals="0"
      id="ixv-27485"
      unitRef="shares">1208</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <wt:WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities
      contextRef="c0"
      decimals="0"
      id="ixv-27486"
      unitRef="shares">147827</wt:WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities>
    <wt:WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities
      contextRef="c19"
      decimals="0"
      id="ixv-27487"
      unitRef="shares">143295</wt:WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities>
    <wt:WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities
      contextRef="c20"
      decimals="0"
      id="ixv-27488"
      unitRef="shares">145055</wt:WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c0"
      decimals="2"
      id="ixv-27489"
      unitRef="usdPershares">0.64</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c19"
      decimals="2"
      id="ixv-27490"
      unitRef="usdPershares">0.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c20"
      decimals="2"
      id="ixv-27491"
      unitRef="usdPershares">0.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="c341"
      decimals="-3"
      id="ixv-27492"
      unitRef="usd">7966000</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c19"
      decimals="0"
      id="ixv-27493"
      unitRef="shares">405</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c20"
      decimals="0"
      id="ixv-27494"
      unitRef="shares">132</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="c20"
      decimals="INF"
      id="ixv-27495"
      unitRef="shares">1186</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock contextRef="c0" id="ixv-27496">The following table reconciles weighted average diluted shares as reported on the Company&#x2019;s Consolidated Statements of Operations for the&#160;years ended December&#160;31, 2023, 2022 and 2021, which are determined pursuant to the treasury stock method, to the weighted average diluted shares used to calculate diluted earnings per share as disclosed in the table above:&lt;table class="No-Table-Style TableOverride-1" style="width: 100.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0 0pt 0;"&gt;


				&lt;tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;"&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" colspan="5" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 46.15%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-15" style="height:12pt;"&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-top-width:0pt;padding-left:0pt;padding-right:0pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-left:0pt;padding-right:0pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-16" style="height:12pt;"&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Reconciliation of Weighted Average Diluted Shares (in&lt;/span&gt;&lt;span class="nobreak"&gt; &lt;/span&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;thousands)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;border-bottom-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TCH" style="border-bottom-style:solid;border-bottom-width:1pt;border-left-width:0pt;border-right-width:0pt;border-top-style:solid;border-top-width:0pt;padding-bottom:4pt;padding-left:3pt;padding-right:3pt;padding-top:2pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"&gt;Weighted average diluted shares as disclosed on the Consolidated Statements of Operations&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;"&gt;170,413&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;"&gt;158,914&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;border-top-width:0pt;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-top:3pt;margin-right:6pt;"&gt;161,263&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Less: Participating securities:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-16" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Weighted average shares of common stock issuable upon conversion of the Series&#160;A Preferred Stock (Note&#160;11)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(14,750)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(14,750)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(14,750)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-16" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Weighted average shares of common stock issuable upon conversion of the Series&#160;C Preferred Stock (Note&#160;11)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(6,992)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-239; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-240; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-4" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Potentially dilutive restricted stock awards&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(844)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(869)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(1,458)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="No-Table-Style _idGenTableRowColumn-16" style="height:12pt;"&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-top:3pt;width: 52.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"&gt;Weighted average diluted shares used to calculate diluted earnings/(loss) per share as disclosed in the table above&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;147,827&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 14.10%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;143,295&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 1.28%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="TB" style="border-bottom-width:0pt;border-left-width:0pt;border-right-width:0pt;border-top-width:0pt;padding-bottom:3pt;padding-left:3pt;padding-right:3pt;padding-top:3pt;vertical-align:bottom;padding-bottom:3pt;padding-left:0pt;padding-right:0pt;padding-top:3pt;width: 15.38%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;145,055&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c0"
      decimals="0"
      id="ixv-27497"
      unitRef="shares">170413</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c19"
      decimals="0"
      id="ixv-27498"
      unitRef="shares">158914</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="c20"
      decimals="0"
      id="ixv-27499"
      unitRef="shares">161263</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <wt:WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares
      contextRef="c0"
      decimals="0"
      id="ixv-27500"
      unitRef="shares">-14750</wt:WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares>
    <wt:WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares
      contextRef="c19"
      decimals="0"
      id="ixv-27501"
      unitRef="shares">-14750</wt:WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares>
    <wt:WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares
      contextRef="c20"
      decimals="0"
      id="ixv-27502"
      unitRef="shares">-14750</wt:WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares>
    <wt:WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares
      contextRef="c342"
      decimals="0"
      id="ixv-27503"
      unitRef="shares">-6992</wt:WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares>
    <wt:PotentiallyDilutiveRestrictedStockAwards
      contextRef="c0"
      decimals="0"
      id="ixv-27504"
      unitRef="shares">-844</wt:PotentiallyDilutiveRestrictedStockAwards>
    <wt:PotentiallyDilutiveRestrictedStockAwards
      contextRef="c19"
      decimals="0"
      id="ixv-27505"
      unitRef="shares">-869</wt:PotentiallyDilutiveRestrictedStockAwards>
    <wt:PotentiallyDilutiveRestrictedStockAwards
      contextRef="c20"
      decimals="0"
      id="ixv-27506"
      unitRef="shares">-1458</wt:PotentiallyDilutiveRestrictedStockAwards>
    <wt:WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities
      contextRef="c0"
      decimals="0"
      id="ixv-27507"
      unitRef="shares">147827</wt:WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities>
    <wt:WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities
      contextRef="c19"
      decimals="0"
      id="ixv-27508"
      unitRef="shares">143295</wt:WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities>
    <wt:WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities
      contextRef="c20"
      decimals="0"
      id="ixv-27509"
      unitRef="shares">145055</wt:WeightedAverageNumberOfDilutedSharesOutstandingExcludingParticipatingSecurities>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c0" id="ixv-24020">&lt;p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:8pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;22. Income Taxes&lt;/span&gt;&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:8pt;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Income before Income Tax Expense&#160;&#x2013;&#160;Domestic and Foreign&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The U.S.&#160;and foreign components of income before income tax expense for the&#160;years ended December&#160;31, 2023, 2022 and 2021 are as follows:&lt;/p&gt;
		&lt;table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;"&gt;


				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TCH CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-12 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;U.S.&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;4,652&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(4,067)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;15,986&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Foreign&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;114,356&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;44,017&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;40,685&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;119,008&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;39,950&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;56,671&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Income Tax Expense/(Benefit) &#x2013; By Jurisdiction&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The components of current and deferred income tax expense included in the Consolidated Statement of Operations for&#160;years ended December&#160;31, 2023, 2022 and 2021 are as follows:&lt;/p&gt;
		&lt;table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;"&gt;


				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Years Ended December&#160;31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TCH CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Current:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-26" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-14" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-26" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-14" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-26" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-14" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-12 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;Federal&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;6,957&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;4,685&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;5,857&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;State and local&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,883&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,415&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,538&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;Foreign&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;8,103&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(15,538)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(837)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;16,943&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;(9,438)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;6,558&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;Deferred:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;Federal&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(494)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(6)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(1,217)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;State and local&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(102)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(1)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(251)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;Foreign&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;115&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(1,289)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,784&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;(481)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;(1,296)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;316&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;Income tax expense/(benefit)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;16,462&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;(10,734)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;6,874&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Reconciliation of Statutory Federal Income Tax Rate to the Effective Income Tax Rate&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;A reconciliation of the statutory federal income tax expense and the Company&#x2019;s total income tax expense is as follows:&lt;/p&gt;
		&lt;table class="Table90-" style="width: 90.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0.33in 0pt 0.33in;"&gt;


				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TCH CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-5" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2" colspan="8" style="width: 51.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TCH CellOverride-1 _idGenCellOverride-3" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-7" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 15.79%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-7" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 15.79%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-7" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 17.22%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;U.S.&#160;federal statutory income tax&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;24,992&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;8,386&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;11,901&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Gain on revaluation/termination of deferred consideration&lt;span class="Superscript" style="vertical-align:super;font-size:58%;"&gt;(1)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(13,007)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(5,842)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(424)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Non-deductible loss on extinguishment of convertible notes&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;2,263&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Foreign operations&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(1,868)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(2,919)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(3,211)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Non-deductible executive compensation&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,833&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;789&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;881&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Decrease in unrecognized tax benefits, net&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(1,386)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(19,871)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(4,998)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Change in valuation allowance&#160;&#x2013;&#160;Capital losses&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,340&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;4,761&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;5&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Expiration of capital losses&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;796&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Stock-based compensation tax shortfalls&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;373&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;507&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;647&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Change in tax-related indemnification assets, net&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;291&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;4,173&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,053&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Change in foreign net operating losses (&#x201c;NOLs&#x201d;)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;174&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Blended state income tax rate, net of federal benefit&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;153&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(134)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;526&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Change in valuation allowance&#x2014;Foreign NOLs and interest carryforwards&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(1,609)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;GILTI&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;499&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Other differences, net&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;508&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;526&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;494&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Income tax expense/(benefit)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;16,462&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(10,734)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;6,874&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;&lt;p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;"&gt;&#x200b;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(1)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;The gain on revaluation of deferred consideration is not adjusted for income taxes as the obligation was assumed by a wholly&lt;span class="nobreak"&gt;-owned&lt;/span&gt; subsidiary that is based in Jersey, a jurisdiction where the Company is subject to a zero percent tax rate.&lt;/p&gt;&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt; Income Tax Payments&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;A summary of income taxes paid by jurisdiction for the&#160;years ended December&#160;31, 2023, 2022 and 2021 is as follows:&lt;/p&gt;
		&lt;table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;"&gt;


				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TCH CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-15 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"&gt;Federal&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"&gt;4,824&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"&gt;6,424&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-16 _idGenCellOverride-4" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-16 _idGenCellOverride-4" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"&gt;4,258&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;State and local&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,457&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,431&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,020&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Foreign&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;9,875&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;4,645&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;3,178&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;16,156&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;12,500&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;8,456&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;&lt;div class="_idGenObjectStyleOverride-1" style="margin:0;padding:0;border-width:0;border-width:0pt;"&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Deferred Tax Assets&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;A summary of the components of the Company&#x2019;s deferred tax assets at December&#160;31, 2023 and 2022 is as follows:&lt;/p&gt;
		&lt;table class="Table6in" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;"&gt;


				&lt;tr class="Table6in" style="height:12pt;"&gt;
					&lt;td class="Table6in TCH CellOverride-1 _idGenCellOverride-2" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table6in TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.60%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 19.20%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="height:12pt;"&gt;
					&lt;td class="Table6in TCH CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Deferred tax assets:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TCH CellOverride-5" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TCH CellOverride-2" colspan="2" style="width: 17.60%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TCH CellOverride-5" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TCH CellOverride-2" colspan="2" style="width: 19.20%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1 _idGenCellOverride-3" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Capital losses&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2 _idGenCellOverride-3" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;22,489&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2 _idGenCellOverride-3" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;17,541&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Accrued expenses&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6,000&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6,030&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Stock-based compensation&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;2,468&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,526&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;NOLs&#x2014;Foreign&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,502&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,609&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Goodwill and intangible assets&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;895&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,085&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Unrealized losses&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;335&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;3,821&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Foreign currency translation adjustment&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;146&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;173&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;NOLs&#x2014;U.S.&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;127&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;255&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Operating lease liabilities&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;96&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;313&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Outside basis differences&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-241; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;122&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Other&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;401&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;341&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Deferred tax assets&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;34,459&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;32,816&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-27" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-28" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-28" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-28" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-28" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-28" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-28" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Deferred tax liabilities:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Fixed assets and prepaid assets&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;296&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;278&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Unremitted earnings&#x2014;European subsidiaries&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;186&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;205&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Right of use assets&#x2014;operating leases&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;96&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;313&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Deferred tax liabilities&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;578&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;796&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total deferred tax assets less deferred tax liabilities&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;33,881&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;32,020&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Less: Valuation allowance&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(22,824)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(21,484)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Deferred tax assets, net&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;11,057&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;10,536&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:14pt;text-indent:0pt;margin-top:14pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Net Operating and Capital Losses &#x2013; U.S.&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company&#x2019;s tax effected NOLs at December&#160;31, 2023 were $127, which expire in &lt;span style="-sec-ix-hidden: hidden-fact-246"&gt;2024&lt;/span&gt;. The net operating loss carryforwards have been reduced by the impact of annual limitations described in the Internal Revenue Code Section&#160;382 that arose as a result of an ownership change.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company&#x2019;s tax effected capital losses at December&#160;31, 2023 were $22,489. These capital losses expire between the&#160;years 2024 and 2028. During the year ended December&#160;31, 2023, tax effected capital losses in the amount of $3,278 expired.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Net Operating Losses &#x2013; Europe&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;One of the Company&#x2019;s European subsidiaries generated NOLs outside the U.S.&#160;These tax effected NOLs, all of which are carried forward indefinitely, were $1,502 at December&#160;31, 2023.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Valuation Allowance&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company&#x2019;s valuation allowance has been established on its net capital losses, unrealized losses and outside basis differences, as it is more&lt;span class="nobreak"&gt;-likely-than-not&lt;/span&gt; that these deferred tax assets will not be realized.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;During the year ended December&#160;31, 2022, the Company released the valuation allowance on its European net operating losses of $1,609 as it is more&lt;span class="nobreak"&gt;-likely-than-not&lt;/span&gt; that these deferred tax assets will be realized.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Uncertain Tax Positions&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Tax positions are evaluated utilizing a two&lt;span class="nobreak"&gt;-step&lt;/span&gt; process. The Company first determines whether any of its tax positions are more&lt;span class="nobreak"&gt;-likely-than-not&lt;/span&gt; to be sustained upon examination, based solely on the technical merits of the position. Once it is determined that a position meets this recognition threshold, the position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement.&lt;/p&gt;
		&lt;/div&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;In connection with the ETFS Acquisition, the Company accrued a liability for uncertain tax positions and interest and penalties at the acquisition date. The Company also recorded an offsetting indemnification asset provided by ETFS Capital as part of its agreement to indemnify the Company for any potential claims. The table below sets forth the aggregate changes in the balance of these gross unrecognized tax benefits:&lt;/p&gt;
		&lt;table class="Table80-" style="width: 80.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 15% 0pt 0.33in;"&gt;


				&lt;tr class="Table80-" style="height:12pt;"&gt;
					&lt;td class="Table80- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;


					&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Unrecognized &lt;br/&gt;Tax Benefits&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Interest and &lt;br/&gt;Penalties&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table80-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table80- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Balance at January&#160;1, 2022&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;21,925&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;18,218&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;3,707&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table80-" style="height:12pt;"&gt;
					&lt;td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Decrease&#x2014;Settlements&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(13,052)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(11,865)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(1,187)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table80-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Decrease&#x2014;Lapse of statute of limitations&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(6,845)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(4,825)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(2,020)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table80-" style="height:12pt;"&gt;
					&lt;td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Increases&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;26&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-242; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;26&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table80-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Foreign currency translation&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(701)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(571)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(130)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table80-" style="height:12pt;"&gt;
					&lt;td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Balance at December&#160;31, 2022&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;1,353&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;957&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;396&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table80-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Decrease&#x2014;Lapse of statute of limitations&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(1,353)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(957)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(396)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table80-" style="height:12pt;"&gt;
					&lt;td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Balance at December&#160;31, 2023&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-243; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-244; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-245; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;&lt;p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;"&gt;&#x200b;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(1)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;In January 2022, an audit of ManJer&#x2019;s tax returns (a Jersey&lt;span class="nobreak"&gt;-based&lt;/span&gt; subsidiary) for the years ended December&#160;31, 2014, 2016, 2017 and 2018 were resolved in favor of ManJer. The settlement, as well as the reduction in unrecognized tax benefits from the lapse of the statute of limitations totaling $19,897 during the year ended December 31, 2022 was recorded as an income tax benefit along with an equal and offsetting amount recorded in other losses and gains, net, to recognize a reduction in the indemnification asset.&lt;/p&gt;&lt;p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:6pt;margin-top:6pt;"&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt; (2)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;The gross unrecognized tax benefits were accrued in British pounds.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The gross unrecognized tax benefits and interest and penalties totaling $1,353 at December&#160;31, 2022 is included in other non&lt;span class="nobreak"&gt;-current&lt;/span&gt; liabilities on the Consolidated Balance Sheets.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Income Tax Examinations&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company is subject to U.S.&#160;federal income tax as well as income tax of multiple state, local and certain foreign jurisdictions.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;ManJer&#x2019;s tax returns (a Jersey&lt;span class="nobreak"&gt;-based&lt;/span&gt; subsidiary) were previously under review for the&#160;years ended December&#160;31, 2014, 2016, 2017 and 2018. In January&#160;2022, the audit was resolved in favor of ManJer. In addition, the Company&#x2019;s tax returns were previously under review by the State of Michigan for the&#160;years ended 2017 through 2020. In August&#160;2022, the audit was resolved in favor of the Company.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;As of December&#160;31, 2023, with few exceptions, the Company was no longer subject to income tax examinations by any taxing authority for the&#160;years before 2019.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Undistributed Earnings of Foreign Subsidiaries&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;ASC&#160;740&lt;span class="nobreak"&gt;-30&lt;/span&gt; Income Taxes provides guidance that U.S.&#160;companies do not need to recognize tax effects on foreign earnings that are indefinitely reinvested. The Company repatriates earnings of its foreign subsidiaries and therefore has recognized a deferred tax liability of $186 and $205 at December&#160;31, 2023 and 2022, respectively.&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="c0" id="ixv-27510">The U.S.&#160;and foreign components of income before income tax expense for the&#160;years ended December&#160;31, 2023, 2022 and 2021 are as follows:&lt;table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;"&gt;


				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TCH CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-12 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;U.S.&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;4,652&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(4,067)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;15,986&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Foreign&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;114,356&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;44,017&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;40,685&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;119,008&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;39,950&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;56,671&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c265"
      decimals="-3"
      id="ixv-27511"
      unitRef="usd">4652000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c266"
      decimals="-3"
      id="ixv-27512"
      unitRef="usd">-4067000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c267"
      decimals="-3"
      id="ixv-27513"
      unitRef="usd">15986000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c347"
      decimals="-3"
      id="ixv-27514"
      unitRef="usd">114356000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c348"
      decimals="-3"
      id="ixv-27515"
      unitRef="usd">44017000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="c349"
      decimals="-3"
      id="ixv-27516"
      unitRef="usd">40685000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c0" decimals="-3" id="ixv-27517" unitRef="usd">119008000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c19" decimals="-3" id="ixv-27518" unitRef="usd">39950000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c20" decimals="-3" id="ixv-27519" unitRef="usd">56671000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c0" id="ixv-27520">The components of current and deferred income tax expense included in the Consolidated Statement of Operations for&#160;years ended December&#160;31, 2023, 2022 and 2021 are as follows:&lt;table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;"&gt;


				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Years Ended December&#160;31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TCH CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Current:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-26" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-14" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-26" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-14" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-26" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-14" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-12 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;Federal&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;6,957&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;4,685&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-13 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;5,857&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;State and local&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,883&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,415&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,538&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;Foreign&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;8,103&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(15,538)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(837)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;16,943&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;(9,438)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;6,558&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;Deferred:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;Federal&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(494)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(6)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(1,217)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;State and local&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(102)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(1)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(251)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;Foreign&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;115&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(1,289)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,784&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;(481)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;(1,296)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;316&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-12" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;Income tax expense/(benefit)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;16,462&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;(10,734)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-14" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;6,874&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c0" decimals="-3" id="ixv-27521" unitRef="usd">6957000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c19" decimals="-3" id="ixv-27522" unitRef="usd">4685000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c20" decimals="-3" id="ixv-27523" unitRef="usd">5857000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c0" decimals="-3" id="ixv-27524" unitRef="usd">1883000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c19" decimals="-3" id="ixv-27525" unitRef="usd">1415000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c20" decimals="-3" id="ixv-27526" unitRef="usd">1538000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c0" decimals="-3" id="ixv-27527" unitRef="usd">8103000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c19" decimals="-3" id="ixv-27528" unitRef="usd">-15538000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c20" decimals="-3" id="ixv-27529" unitRef="usd">-837000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c0" decimals="-3" id="ixv-27530" unitRef="usd">16943000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c19" decimals="-3" id="ixv-27531" unitRef="usd">-9438000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c20" decimals="-3" id="ixv-27532" unitRef="usd">6558000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c0" decimals="-3" id="ixv-27533" unitRef="usd">-494000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c19" decimals="-3" id="ixv-27534" unitRef="usd">-6000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c20" decimals="-3" id="ixv-27535" unitRef="usd">-1217000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c0" decimals="-3" id="ixv-27536" unitRef="usd">-102000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c19" decimals="-3" id="ixv-27537" unitRef="usd">-1000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c20" decimals="-3" id="ixv-27538" unitRef="usd">-251000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c0" decimals="-3" id="ixv-27539" unitRef="usd">115000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c19" decimals="-3" id="ixv-27540" unitRef="usd">-1289000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c20" decimals="-3" id="ixv-27541" unitRef="usd">1784000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c0" decimals="-3" id="ixv-27542" unitRef="usd">-481000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c19" decimals="-3" id="ixv-27543" unitRef="usd">-1296000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c20" decimals="-3" id="ixv-27544" unitRef="usd">316000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c0" decimals="-3" id="ixv-27545" unitRef="usd">16462000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c19" decimals="-3" id="ixv-27546" unitRef="usd">-10734000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c20" decimals="-3" id="ixv-27547" unitRef="usd">6874000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c0" id="ixv-27548">A reconciliation of the statutory federal income tax expense and the Company&#x2019;s total income tax expense is as follows:&lt;table class="Table90-" style="width: 90.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 0.33in 0pt 0.33in;"&gt;


				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TCH CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-5" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2" colspan="8" style="width: 51.67%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TCH CellOverride-1 _idGenCellOverride-3" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-7" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 15.79%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-7" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 15.79%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-7" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 17.22%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;U.S.&#160;federal statutory income tax&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;24,992&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;8,386&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;11,901&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Gain on revaluation/termination of deferred consideration&lt;span class="Superscript" style="vertical-align:super;font-size:58%;"&gt;(1)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(13,007)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(5,842)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(424)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Non-deductible loss on extinguishment of convertible notes&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;2,263&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Foreign operations&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(1,868)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(2,919)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(3,211)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Non-deductible executive compensation&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,833&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;789&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;881&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Decrease in unrecognized tax benefits, net&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(1,386)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(19,871)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(4,998)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Change in valuation allowance&#160;&#x2013;&#160;Capital losses&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,340&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;4,761&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;5&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Expiration of capital losses&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;796&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Stock-based compensation tax shortfalls&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;373&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;507&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;647&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Change in tax-related indemnification assets, net&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;291&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;4,173&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,053&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Change in foreign net operating losses (&#x201c;NOLs&#x201d;)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;174&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Blended state income tax rate, net of federal benefit&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;153&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(134)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;526&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Change in valuation allowance&#x2014;Foreign NOLs and interest carryforwards&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(1,609)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;GILTI&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;499&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Other differences, net&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;508&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;526&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;494&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table90-" style="height:12pt;"&gt;
					&lt;td class="Table90- TB CellOverride-1" style="width: 46.89%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Income tax expense/(benefit)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;16,462&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;text-align:left;margin-right:3pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 13.88%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(10,734)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.44%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 1.91%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table90- TB CellOverride-2" style="width: 15.31%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;6,874&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;&lt;p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;"&gt;&#x200b;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(1)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;The gain on revaluation of deferred consideration is not adjusted for income taxes as the obligation was assumed by a wholly&lt;span class="nobreak"&gt;-owned&lt;/span&gt; subsidiary that is based in Jersey, a jurisdiction where the Company is subject to a zero percent tax rate.&lt;/p&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c0" decimals="-3" id="ixv-27549" unitRef="usd">24992000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c19" decimals="-3" id="ixv-27550" unitRef="usd">8386000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c20" decimals="-3" id="ixv-27551" unitRef="usd">11901000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <wt:IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration contextRef="c0" decimals="-3" id="ix_40_fact" unitRef="usd">13007000</wt:IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration>
    <wt:IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration
      contextRef="c19"
      decimals="-3"
      id="ix_41_fact"
      unitRef="usd">5842000</wt:IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration>
    <wt:IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration
      contextRef="c20"
      decimals="-3"
      id="ix_42_fact"
      unitRef="usd">424000</wt:IncomeTaxReconciliationGainOnRevaluationTerminationOfDeferredConsideration>
    <wt:NondeductibleLossOnExtinguishmentOfConvertibleNotes contextRef="c0" decimals="-3" id="ixv-27555" unitRef="usd">-2263000</wt:NondeductibleLossOnExtinguishmentOfConvertibleNotes>
    <wt:IncomeTaxReconciliationInternationalOperations contextRef="c0" decimals="-3" id="ixv-27556" unitRef="usd">1868000</wt:IncomeTaxReconciliationInternationalOperations>
    <wt:IncomeTaxReconciliationInternationalOperations contextRef="c19" decimals="-3" id="ixv-27557" unitRef="usd">2919000</wt:IncomeTaxReconciliationInternationalOperations>
    <wt:IncomeTaxReconciliationInternationalOperations contextRef="c20" decimals="-3" id="ixv-27558" unitRef="usd">3211000</wt:IncomeTaxReconciliationInternationalOperations>
    <wt:IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense contextRef="c0" decimals="-3" id="ixv-27559" unitRef="usd">-1833000</wt:IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense>
    <wt:IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense contextRef="c19" decimals="-3" id="ixv-27560" unitRef="usd">-789000</wt:IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense>
    <wt:IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense contextRef="c20" decimals="-3" id="ixv-27561" unitRef="usd">-881000</wt:IncomeTaxReconciliationNondeductibleExecutiveCompensationExpense>
    <wt:IncomeTaxReconciliationUnrecognizedTaxBenefits contextRef="c0" decimals="-3" id="ixv-27562" unitRef="usd">1386000</wt:IncomeTaxReconciliationUnrecognizedTaxBenefits>
    <wt:IncomeTaxReconciliationUnrecognizedTaxBenefits contextRef="c19" decimals="-3" id="ixv-27563" unitRef="usd">19871000</wt:IncomeTaxReconciliationUnrecognizedTaxBenefits>
    <wt:IncomeTaxReconciliationUnrecognizedTaxBenefits contextRef="c20" decimals="-3" id="ixv-27564" unitRef="usd">4998000</wt:IncomeTaxReconciliationUnrecognizedTaxBenefits>
    <wt:IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses contextRef="c0" decimals="-3" id="ixv-27565" unitRef="usd">-1340000</wt:IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses>
    <wt:IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses contextRef="c19" decimals="-3" id="ixv-27566" unitRef="usd">-4761000</wt:IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses>
    <wt:IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses contextRef="c20" decimals="-3" id="ixv-27567" unitRef="usd">-5000</wt:IncomeTaxReconciliationChangeInValuationAllowanceCapitalLosses>
    <wt:IncomeTaxReconciliationExpirationOfCapitalLosses contextRef="c0" decimals="-3" id="ixv-27568" unitRef="usd">-796000</wt:IncomeTaxReconciliationExpirationOfCapitalLosses>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c0" decimals="-3" id="ixv-27569" unitRef="usd">373000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c19" decimals="-3" id="ixv-27570" unitRef="usd">507000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c20" decimals="-3" id="ixv-27571" unitRef="usd">647000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <wt:EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets contextRef="c0" decimals="-3" id="ixv-27572" unitRef="usd">291000</wt:EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets>
    <wt:EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets contextRef="c19" decimals="-3" id="ixv-27573" unitRef="usd">4173000</wt:EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets>
    <wt:EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets contextRef="c20" decimals="-3" id="ixv-27574" unitRef="usd">1053000</wt:EffectiveIncomeTaxReconcilationChangesInTaxRelatedIndemnificationAssets>
    <wt:ChangeInForeignNetOperatingLosses contextRef="c0" decimals="-3" id="ixv-27575" unitRef="usd">174000</wt:ChangeInForeignNetOperatingLosses>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c0" decimals="-3" id="ixv-27576" unitRef="usd">153000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c19" decimals="-3" id="ixv-27577" unitRef="usd">-134000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c20" decimals="-3" id="ixv-27578" unitRef="usd">526000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c19" decimals="-3" id="ixv-27579" unitRef="usd">-1609000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount contextRef="c19" decimals="-3" id="ixv-27580" unitRef="usd">499000</us-gaap:EffectiveIncomeTaxRateReconciliationGiltiAmount>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c0" decimals="-3" id="ixv-27581" unitRef="usd">508000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c19" decimals="-3" id="ixv-27582" unitRef="usd">526000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c20" decimals="-3" id="ixv-27583" unitRef="usd">494000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c0" decimals="-3" id="ixv-27584" unitRef="usd">16462000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c19" decimals="-3" id="ixv-27585" unitRef="usd">-10734000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c20" decimals="-3" id="ixv-27586" unitRef="usd">6874000</us-gaap:IncomeTaxExpenseBenefit>
    <wt:SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock contextRef="c0" id="ixv-27587">A summary of income taxes paid by jurisdiction for the&#160;years ended December&#160;31, 2023, 2022 and 2021 is as follows:&lt;table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;"&gt;


				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Years Ended December 31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TCH CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2 _idGenCellOverride-1" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-15 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"&gt;Federal&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"&gt;4,824&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-16 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-16 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"&gt;6,424&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-25 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-16 _idGenCellOverride-4" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-16 _idGenCellOverride-4" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-top:3pt;margin-right:6pt;"&gt;4,258&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;State and local&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,457&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,431&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,020&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Foreign&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;9,875&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;4,645&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;3,178&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;16,156&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;12,500&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;8,456&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</wt:SummaryOfIncomeTaxesPaidByJurisdictionTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="c350"
      decimals="-3"
      id="ixv-27588"
      unitRef="usd">4824000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="c351"
      decimals="-3"
      id="ixv-27589"
      unitRef="usd">6424000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="c352"
      decimals="-3"
      id="ixv-27590"
      unitRef="usd">4258000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit
      contextRef="c353"
      decimals="-3"
      id="ixv-27591"
      unitRef="usd">1457000</us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit
      contextRef="c354"
      decimals="-3"
      id="ixv-27592"
      unitRef="usd">1431000</us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit
      contextRef="c355"
      decimals="-3"
      id="ixv-27593"
      unitRef="usd">1020000</us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="c356"
      decimals="-3"
      id="ixv-27594"
      unitRef="usd">9875000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="c357"
      decimals="-3"
      id="ixv-27595"
      unitRef="usd">4645000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="c358"
      decimals="-3"
      id="ixv-27596"
      unitRef="usd">3178000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:IncomeTaxesPaidNet contextRef="c0" decimals="-3" id="ixv-27597" unitRef="usd">16156000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c19" decimals="-3" id="ixv-27598" unitRef="usd">12500000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c20" decimals="-3" id="ixv-27599" unitRef="usd">8456000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c0" id="ixv-27600">A summary of the components of the Company&#x2019;s deferred tax assets at December&#160;31, 2023 and 2022 is as follows:&lt;table class="Table6in" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;"&gt;


				&lt;tr class="Table6in" style="height:12pt;"&gt;
					&lt;td class="Table6in TCH CellOverride-1 _idGenCellOverride-2" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table6in TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 17.60%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TCH CellOverride-2 _idGenCellOverride-2" colspan="2" style="width: 19.20%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="height:12pt;"&gt;
					&lt;td class="Table6in TCH CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Deferred tax assets:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TCH CellOverride-5" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TCH CellOverride-2" colspan="2" style="width: 17.60%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TCH CellOverride-5" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TCH CellOverride-2" colspan="2" style="width: 19.20%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1 _idGenCellOverride-3" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Capital losses&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2 _idGenCellOverride-3" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;22,489&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-6 _idGenCellOverride-4" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2 _idGenCellOverride-3" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2 _idGenCellOverride-3" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;17,541&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Accrued expenses&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6,000&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6,030&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Stock-based compensation&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;2,468&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,526&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;NOLs&#x2014;Foreign&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,502&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,609&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Goodwill and intangible assets&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;895&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,085&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Unrealized losses&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;335&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;3,821&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Foreign currency translation adjustment&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;146&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;173&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;NOLs&#x2014;U.S.&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;127&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;255&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Operating lease liabilities&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;96&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;313&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Outside basis differences&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-241; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;122&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Other&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;401&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;341&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Deferred tax assets&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;34,459&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;32,816&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-27" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-28" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-28" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-28" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-28" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-28" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-28" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Deferred tax liabilities:&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-left:0pt;text-indent:0pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Fixed assets and prepaid assets&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;296&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;278&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Unremitted earnings&#x2014;European subsidiaries&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;186&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;205&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Right of use assets&#x2014;operating leases&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;96&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;313&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Deferred tax liabilities&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;578&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;796&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total deferred tax assets less deferred tax liabilities&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;33,881&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;32,020&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Less: Valuation allowance&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(22,824)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(21,484)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table6in" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table6in TB CellOverride-1" style="width: 60.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Deferred tax assets, net&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 15.47%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;11,057&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 1.60%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 2.13%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table6in TB CellOverride-2" style="width: 17.07%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;10,536&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsCapitalLossCarryforwards contextRef="c5" decimals="-3" id="ixv-27601" unitRef="usd">22489000</us-gaap:DeferredTaxAssetsCapitalLossCarryforwards>
    <us-gaap:DeferredTaxAssetsCapitalLossCarryforwards contextRef="c6" decimals="-3" id="ixv-27602" unitRef="usd">17541000</us-gaap:DeferredTaxAssetsCapitalLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals contextRef="c5" decimals="-3" id="ixv-27603" unitRef="usd">6000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals contextRef="c6" decimals="-3" id="ixv-27604" unitRef="usd">6030000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c5" decimals="-3" id="ixv-27605" unitRef="usd">2468000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c6" decimals="-3" id="ixv-27606" unitRef="usd">1526000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign contextRef="c5" decimals="-3" id="ixv-27607" unitRef="usd">1502000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign contextRef="c6" decimals="-3" id="ixv-27608" unitRef="usd">1609000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="c5" decimals="-3" id="ixv-27609" unitRef="usd">895000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets contextRef="c6" decimals="-3" id="ixv-27610" unitRef="usd">1085000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <wt:DeferredTaxAssetUnrealizedLosses contextRef="c5" decimals="-3" id="ixv-27611" unitRef="usd">335000</wt:DeferredTaxAssetUnrealizedLosses>
    <wt:DeferredTaxAssetUnrealizedLosses contextRef="c6" decimals="-3" id="ixv-27612" unitRef="usd">3821000</wt:DeferredTaxAssetUnrealizedLosses>
    <us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses contextRef="c5" decimals="-3" id="ixv-27613" unitRef="usd">146000</us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses>
    <us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses contextRef="c6" decimals="-3" id="ixv-27614" unitRef="usd">173000</us-gaap:DeferredTaxAssetsUnrealizedCurrencyLosses>
    <wt:DeferredTaxAssetOperatingLossCarryForwardUnitedStates contextRef="c5" decimals="-3" id="ixv-27615" unitRef="usd">127000</wt:DeferredTaxAssetOperatingLossCarryForwardUnitedStates>
    <wt:DeferredTaxAssetOperatingLossCarryForwardUnitedStates contextRef="c6" decimals="-3" id="ixv-27616" unitRef="usd">255000</wt:DeferredTaxAssetOperatingLossCarryForwardUnitedStates>
    <wt:DeferredTaxAssetsOperatingLeaseLiabilities contextRef="c5" decimals="-3" id="ixv-27617" unitRef="usd">96000</wt:DeferredTaxAssetsOperatingLeaseLiabilities>
    <wt:DeferredTaxAssetsOperatingLeaseLiabilities contextRef="c6" decimals="-3" id="ixv-27618" unitRef="usd">313000</wt:DeferredTaxAssetsOperatingLeaseLiabilities>
    <wt:DeferredTaxAssetsOutsideBasisDifference contextRef="c6" decimals="-3" id="ixv-27619" unitRef="usd">-122000</wt:DeferredTaxAssetsOutsideBasisDifference>
    <us-gaap:DeferredTaxAssetsOther contextRef="c5" decimals="-3" id="ixv-27620" unitRef="usd">401000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther contextRef="c6" decimals="-3" id="ixv-27621" unitRef="usd">341000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross contextRef="c5" decimals="-3" id="ixv-27622" unitRef="usd">34459000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c6" decimals="-3" id="ixv-27623" unitRef="usd">32816000</us-gaap:DeferredTaxAssetsGross>
    <wt:DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses contextRef="c5" decimals="-3" id="ixv-27624" unitRef="usd">296000</wt:DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses>
    <wt:DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses contextRef="c6" decimals="-3" id="ixv-27625" unitRef="usd">278000</wt:DeferredTaxLiabilitiesFixedAssetsAndPrepaidExpenses>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings contextRef="c5" decimals="-3" id="ixv-27626" unitRef="usd">186000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings contextRef="c6" decimals="-3" id="ixv-27627" unitRef="usd">205000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <wt:DeferredTaxLiabilitiesRightOfUseAssets contextRef="c5" decimals="-3" id="ixv-27628" unitRef="usd">96000</wt:DeferredTaxLiabilitiesRightOfUseAssets>
    <wt:DeferredTaxLiabilitiesRightOfUseAssets contextRef="c6" decimals="-3" id="ixv-27629" unitRef="usd">313000</wt:DeferredTaxLiabilitiesRightOfUseAssets>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c5" decimals="-3" id="ixv-27630" unitRef="usd">578000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c6" decimals="-3" id="ixv-27631" unitRef="usd">796000</us-gaap:DeferredIncomeTaxLiabilities>
    <wt:DeferredTaxAssetsLiabilitiesGross contextRef="c5" decimals="-3" id="ixv-27632" unitRef="usd">33881000</wt:DeferredTaxAssetsLiabilitiesGross>
    <wt:DeferredTaxAssetsLiabilitiesGross contextRef="c6" decimals="-3" id="ixv-27633" unitRef="usd">32020000</wt:DeferredTaxAssetsLiabilitiesGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c5" decimals="-3" id="ixv-27634" unitRef="usd">22824000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c6" decimals="-3" id="ixv-27635" unitRef="usd">21484000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="c5" decimals="-3" id="ixv-27636" unitRef="usd">11057000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="c6" decimals="-3" id="ixv-27637" unitRef="usd">10536000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:OperatingLossCarryforwards contextRef="c5" decimals="-3" id="ixv-27638" unitRef="usd">127000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsCapitalLossCarryforwards contextRef="c5" decimals="-3" id="ixv-27639" unitRef="usd">22489000</us-gaap:DeferredTaxAssetsCapitalLossCarryforwards>
    <wt:DeferredTaxAssetsCapitalLossCarryforwardsSubjectToExpiration contextRef="c5" decimals="-3" id="ixv-27640" unitRef="usd">3278000</wt:DeferredTaxAssetsCapitalLossCarryforwardsSubjectToExpiration>
    <wt:DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax contextRef="c0" decimals="-3" id="ixv-27641" unitRef="usd">1502000</wt:DeferredTaxAssetsOperatingLossCarryforwardsNetOfTax>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c19" decimals="-3" id="ixv-27642" unitRef="usd">-1609000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c0" decimals="2" id="ixv-27643" unitRef="pure">0.50</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock contextRef="c0" id="ixv-27644">The table below sets forth the aggregate changes in the balance of these gross unrecognized tax benefits:&lt;table class="Table80-" style="width: 80.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 15% 0pt 0.33in;"&gt;


				&lt;tr class="Table80-" style="height:12pt;"&gt;
					&lt;td class="Table80- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;


					&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Unrecognized &lt;br/&gt;Tax Benefits&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TCH CellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Interest and &lt;br/&gt;Penalties&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table80-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table80- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Balance at January&#160;1, 2022&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;21,925&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;18,218&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;3,707&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table80-" style="height:12pt;"&gt;
					&lt;td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Decrease&#x2014;Settlements&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(13,052)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(11,865)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(1,187)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table80-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Decrease&#x2014;Lapse of statute of limitations&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(6,845)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(4,825)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_rb" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(2,020)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table80-" style="height:12pt;"&gt;
					&lt;td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Increases&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;26&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-242; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;26&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table80-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Foreign currency translation&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(2)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(701)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(571)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(130)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table80-" style="height:12pt;"&gt;
					&lt;td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Balance at December&#160;31, 2022&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;1,353&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;957&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;396&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table80-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Decrease&#x2014;Lapse of statute of limitations&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(1,353)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(957)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(396)&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table80-" style="height:12pt;"&gt;
					&lt;td class="Table80- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Balance at December&#160;31, 2023&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-243; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-244; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table80- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-245; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;&lt;p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;"&gt;&#x200b;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(1)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;In January 2022, an audit of ManJer&#x2019;s tax returns (a Jersey&lt;span class="nobreak"&gt;-based&lt;/span&gt; subsidiary) for the years ended December&#160;31, 2014, 2016, 2017 and 2018 were resolved in favor of ManJer. The settlement, as well as the reduction in unrecognized tax benefits from the lapse of the statute of limitations totaling $19,897 during the year ended December 31, 2022 was recorded as an income tax benefit along with an equal and offsetting amount recorded in other losses and gains, net, to recognize a reduction in the indemnification asset.&lt;/p&gt;&lt;p class="Tablefootnote_m" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:0;orphans:2;page-break-after:auto;page-break-before:auto;text-align:justify;text-indent:-15pt;widows:3;margin-top:6pt;margin-top:6pt;"&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt; (2)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;The gross unrecognized tax benefits were accrued in British pounds.&lt;/p&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c37" decimals="-3" id="ixv-27645" unitRef="usd">21925000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="c359"
      decimals="-3"
      id="ixv-27646"
      unitRef="usd">18218000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="c360"
      decimals="-3"
      id="ixv-27647"
      unitRef="usd">3707000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="c19"
      decimals="-3"
      id="ix_43_fact"
      unitRef="usd">13052000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="c361"
      decimals="-3"
      id="ix_44_fact"
      unitRef="usd">11865000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="c362"
      decimals="-3"
      id="ix_45_fact"
      unitRef="usd">1187000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="c19"
      decimals="-3"
      id="ix_46_fact"
      unitRef="usd">6845000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="c361"
      decimals="-3"
      id="ix_47_fact"
      unitRef="usd">4825000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="c362"
      decimals="-3"
      id="ix_48_fact"
      unitRef="usd">2020000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c19" decimals="-3" id="ixv-27654" unitRef="usd">26000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="c362"
      decimals="-3"
      id="ixv-27655"
      unitRef="usd">26000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <wt:UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation
      contextRef="c19"
      decimals="-3"
      id="ix_49_fact"
      unitRef="usd">-701000</wt:UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation>
    <wt:UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation
      contextRef="c361"
      decimals="-3"
      id="ix_50_fact"
      unitRef="usd">-571000</wt:UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation>
    <wt:UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation
      contextRef="c362"
      decimals="-3"
      id="ix_51_fact"
      unitRef="usd">-130000</wt:UnrecognizedTaxBenefitsAndInterestAndPenaltiesIncreasesResultingFromForeignCurrencyTranslation>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c6" decimals="-3" id="ixv-27659" unitRef="usd">1353000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="c363"
      decimals="-3"
      id="ixv-27660"
      unitRef="usd">957000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="c364"
      decimals="-3"
      id="ixv-27661"
      unitRef="usd">396000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations contextRef="c0" decimals="-3" id="ixv-27662" unitRef="usd">1353000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="c365"
      decimals="-3"
      id="ixv-27663"
      unitRef="usd">957000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="c366"
      decimals="-3"
      id="ixv-27664"
      unitRef="usd">396000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="c345"
      decimals="-3"
      id="ixv-27665"
      unitRef="usd">19897000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="c346"
      decimals="-3"
      id="ixv-27667"
      unitRef="usd">1353000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings contextRef="c5" decimals="-3" id="ixv-27668" unitRef="usd">186000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings contextRef="c6" decimals="-3" id="ixv-27669" unitRef="usd">205000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:TreasuryStockTextBlock contextRef="c0" id="ixv-25247">&lt;p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;23. Shares Repurchased&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;"&gt;On February&#160;22, 2022, the Company&#x2019;s Board of Directors approved an increase of $85,709 to the Company&#x2019;s share repurchase program to $100,000 and extended the term for &lt;span style="-sec-ix-hidden: hidden-fact-247"&gt;three&lt;/span&gt;&#160;years through April&#160;27, 2025. Included under the Company&#x2019;s share repurchase program are purchases to offset future equity grants made under the Company&#x2019;s equity plans and purchases made in open market or privately negotiated transactions. This authority may be exercised from time to time, subject to regulatory considerations. The timing and actual number of shares repurchased will depend on a variety of factors including price, corporate and regulatory requirements, market conditions and other corporate liquidity requirements and priorities. The repurchase program may be suspended or terminated at any time without prior notice. Shares repurchased under this program are returned to the status of authorized and unissued on the Company&#x2019;s books and records.&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;During the&#160;years ended December&#160;31, 2023, 2022 and 2021, the Company repurchased 635,653, 593,261 and 5,120,496&lt;span class="nobreak"&gt; &lt;/span&gt;shares of its common stock, respectively, under this program for an aggregate cost of $3,570, $3,418 and $34,506, respectively. Shares repurchased under this program were returned to the status of authorized and unissued on the Company&#x2019;s books and records.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;As of December&#160;31, 2023, $96,406 remained under this program for future purchases.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;In addition, as further described in Note&#160;11, the Company also repurchased its Series&#160;C Preferred Stock, which was convertible into 13,087,000&lt;span class="nobreak"&gt; &lt;/span&gt;shares of common stock, from GBH, for aggregate cash consideration of $84,411. Under the terms of the transaction, the Company paid GBH $40,000 on the closing date, with the remainder of the purchase price payable in equal, interest&lt;span class="nobreak"&gt;-free&lt;/span&gt; installments on the first, second and third anniversaries of the closing date.&lt;/p&gt;</us-gaap:TreasuryStockTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="c369"
      decimals="-3"
      id="ixv-27670"
      unitRef="usd">85709000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="c370"
      decimals="-3"
      id="ixv-27671"
      unitRef="usd">100000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramExpirationDate contextRef="c372" id="ixv-27672">2025-04-27</us-gaap:StockRepurchaseProgramExpirationDate>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c373"
      decimals="0"
      id="ixv-27673"
      unitRef="shares">635653</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c374"
      decimals="0"
      id="ixv-27674"
      unitRef="shares">593261</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c375"
      decimals="INF"
      id="ixv-27675"
      unitRef="shares">5120496</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c0" decimals="-3" id="ixv-27676" unitRef="usd">3570000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c19" decimals="-3" id="ixv-27677" unitRef="usd">3418000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="c20"
      decimals="INF"
      id="ixv-27678"
      unitRef="usd">34506000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 contextRef="c5" decimals="-3" id="ixv-27679" unitRef="usd">96406000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="c0"
      decimals="0"
      id="ixv-27680"
      unitRef="shares">13087000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="c376"
      decimals="-3"
      id="ixv-27681"
      unitRef="usd">84411000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="c377"
      decimals="-3"
      id="ixv-27682"
      unitRef="usd">40000000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="c0" id="ixv-25263">&lt;p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;24. Goodwill and Intangible Assets&lt;/span&gt;&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Goodwill&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The table below sets forth goodwill which is tested annually for impairment on November&#160;30&lt;span class="Superscript" style="vertical-align:super;font-size:58%;"&gt;th&lt;/span&gt;:&lt;/p&gt;
		&lt;table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;"&gt;


				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TCH CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-5" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2" colspan="2" style="width: 23.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Balance at January&#160;1, 2023&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;85,856&#160;&#160;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Changes&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="-sec-ix-hidden: hidden-fact-248; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;985&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Balance at December&#160;31, 2023&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;86,841&#160;&#160;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;&lt;p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;"&gt;&#x200b;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(1)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;On April 11, 2023, the Company acquired 100% of the capital stock of Securrency Transfers, Inc. (renamed WisdomTree Transfers, Inc.) for an aggregate purchase price of $985 (net of cash acquired). The acquisition has been accounted for under the acquisition method of accounting in accordance with ASC Topic 805, Business Combinations, and resulted in all consideration being allocated to goodwill.&lt;/p&gt;&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt; Goodwill was tested for impairment on November&#160;30, 2023. The quantitative impairment test was performed using a market approach, whereby the market capitalization of the Company (a single reporting unit) was compared to its carrying value. The market capitalization was derived from the Company&#x2019;s publicly traded stock price plus a reasonable control premium. The fair value of the reporting unit exceeded its carrying value and therefore no impairment was recognized.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Of the total goodwill of $86,841 at December&#160;31, 2023, $85,042 is not deductible for tax purposes as the acquisitions that gave rise to the goodwill were structured as stock acquisitions. The remainder of the goodwill is deductible for U.S.&#160;tax purposes.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Intangible Assets&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The table below sets forth the Company&#x2019;s intangible assets which are tested annually for impairment on November&#160;30&lt;span class="Superscript" style="vertical-align:super;font-size:58%;"&gt;th&lt;/span&gt;:&lt;/p&gt;
		&lt;table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;"&gt;


				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Balance at December&#160;31, 2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TCH CellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-left:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Item&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Gross Asset&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Accumulated &lt;br/&gt;Amortization&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Net Asset&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;ETFS acquisition&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;601,247&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-249; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;601,247&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Software development&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;4,519&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(684)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;3,835&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Balance at December&#160;31, 2023&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;605,766&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;(684)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;605,082&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;
		&lt;table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;"&gt;


				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Balance at December&#160;31, 2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Item&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Gross Asset&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Accumulated &lt;br/&gt;Amortization&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Net Asset&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;ETFS acquisition&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;601,247&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-250; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;601,247&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Software development&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;2,370&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(50)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;2,320&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Balance at December&#160;31, 2022&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;603,617&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;(50)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;603,567&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:14pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;ETFS Acquisition (Indefinite-Lived)&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;In connection with the ETFS Acquisition, which was completed on April&#160;11, 2018, the Company identified intangible assets valued at $601,247 related to the right to manage AUM through customary advisory agreements. These intangible assets were determined to have indefinite useful lives and are not deductible for tax purposes.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company performed its indefinite&lt;span class="nobreak"&gt;-lived&lt;/span&gt; intangible asset impairment test related to these customary advisory agreements on November&#160;30, 2023. The results of this analysis identified no indicators of impairment to be recognized based upon a quantitative assessment (discounted cash flow analysis) which relied upon significant unobservable inputs including a projected revenue growth rate of 3% and a weighted average cost of capital of 10.5%.&lt;/p&gt;
		&lt;p class="H3" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:italic;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:6pt;"&gt;&lt;span class="BoldItalic" style="font-style:italic;font-weight:bold;"&gt;Software Development (Finite-Lived)&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;Internally&lt;span class="nobreak"&gt;-developed&lt;/span&gt; software is amortized over a useful life of &lt;span style="-sec-ix-hidden: hidden-fact-252"&gt;three&lt;/span&gt;&#160;years. During the&#160;years ended December&#160;31, 2023 and 2022, the Company recognized amortization expense on internally&lt;span class="nobreak"&gt;-developed&lt;/span&gt; software of $634 and $50, respectively.&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;As of December&#160;31, 2023, expected amortization expense for the unamortized finite&lt;span class="nobreak"&gt;-lived&lt;/span&gt; intangible assets for the next &lt;span style="-sec-ix-hidden: hidden-fact-253"&gt;five&lt;/span&gt;&#160;years and thereafter is as follows:&lt;/p&gt;
		&lt;table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;"&gt;


				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;2024&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;1,375&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;2025&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,440&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;2026&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;873&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;2027&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;130&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;2028&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;17&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;2029 and thereafter&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-251; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-15" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"&gt;Total expected amortization expense&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-16" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-16" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-16" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;3,835&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:8pt;margin-top:8pt;"&gt;The weighted&lt;span class="nobreak"&gt;-average&lt;/span&gt; remaining useful life of the finite&lt;span class="nobreak"&gt;-lived&lt;/span&gt; intangible assets is &lt;span style="-sec-ix-hidden: hidden-fact-254"&gt;2.6&lt;/span&gt;&#160;years.&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock contextRef="c0" id="ixv-25269">The table below sets forth goodwill which is tested annually for impairment on November&#160;30&lt;span class="Superscript" style="vertical-align:super;font-size:58%;"&gt;th&lt;/span&gt;:&lt;table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;"&gt;


				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TCH CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-5" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2" colspan="2" style="width: 23.08%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Total&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Balance at January&#160;1, 2023&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;85,856&#160;&#160;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody-ind_1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:20pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Changes&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="-sec-ix-hidden: hidden-fact-248; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;985&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(1)&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Balance at December&#160;31, 2023&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;86,841&#160;&#160;&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;&lt;p class="Tablefootnote_f" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:15pt;margin-right:0;margin-top:10pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-15pt;widows:3;margin-top:12pt;margin-top:12pt;"&gt;&#x200b;&lt;span class="Superscript" style="vertical-align:super;font-size:6pt;"&gt;(1)&lt;span style="width: 12px;display: inline-block;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/span&gt;On April 11, 2023, the Company acquired 100% of the capital stock of Securrency Transfers, Inc. (renamed WisdomTree Transfers, Inc.) for an aggregate purchase price of $985 (net of cash acquired). The acquisition has been accounted for under the acquisition method of accounting in accordance with ASC Topic 805, Business Combinations, and resulted in all consideration being allocated to goodwill.&lt;/p&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill contextRef="c6" decimals="-3" id="ixv-27683" unitRef="usd">85856000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c5" decimals="-3" id="ixv-27684" unitRef="usd">86841000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c378"
      decimals="2"
      id="ixv-27686"
      unitRef="pure">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="c379"
      decimals="-3"
      id="ixv-27687"
      unitRef="usd">985000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:Goodwill
      contextRef="c380"
      decimals="-3"
      id="ixv-27688"
      unitRef="usd">86841000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
      contextRef="c380"
      decimals="-3"
      id="ixv-27689"
      unitRef="usd">85042000</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="c0" id="ixv-25318">The table below sets forth the Company&#x2019;s intangible assets which are tested annually for impairment on November&#160;30&lt;span class="Superscript" style="vertical-align:super;font-size:58%;"&gt;th&lt;/span&gt;:&lt;table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;"&gt;


				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Balance at December&#160;31, 2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TCH CellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-left:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Item&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Gross Asset&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Accumulated &lt;br/&gt;Amortization&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Net Asset&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;ETFS acquisition&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;601,247&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-249; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;601,247&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Software development&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;4,519&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(684)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;3,835&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Balance at December&#160;31, 2023&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;605,766&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;(684)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;605,082&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;&lt;table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;"&gt;


				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TCH CellOverride-1 _idGenCellOverride-2" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2 _idGenCellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Balance at December&#160;31, 2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Item&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Gross Asset&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Accumulated &lt;br/&gt;Amortization&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TCH CellOverride-2" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Net Asset&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;ETFS acquisition&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;601,247&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-250; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;601,247&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Software development&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;2,370&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:3pt;"&gt;(50)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;2,320&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Balance at December&#160;31, 2022&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;603,617&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:3pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2b" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:3pt;"&gt;(50)&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;603,567&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="c384"
      decimals="-3"
      id="ixv-27690"
      unitRef="usd">601247000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c384"
      decimals="-3"
      id="ixv-27691"
      unitRef="usd">601247000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="c385"
      decimals="-3"
      id="ixv-27692"
      unitRef="usd">4519000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="c385"
      decimals="-3"
      id="ixv-27693"
      unitRef="usd">684000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c385"
      decimals="-3"
      id="ixv-27694"
      unitRef="usd">3835000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill contextRef="c5" decimals="-3" id="ixv-27695" unitRef="usd">605766000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c5" decimals="-3" id="ixv-27696" unitRef="usd">684000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c5" decimals="-3" id="ixv-27697" unitRef="usd">605082000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="c386"
      decimals="-3"
      id="ixv-27698"
      unitRef="usd">601247000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c386"
      decimals="-3"
      id="ixv-27699"
      unitRef="usd">601247000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="c387"
      decimals="-3"
      id="ixv-27700"
      unitRef="usd">2370000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="c387"
      decimals="-3"
      id="ixv-27701"
      unitRef="usd">50000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="c387"
      decimals="-3"
      id="ixv-27702"
      unitRef="usd">2320000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill contextRef="c6" decimals="-3" id="ixv-27703" unitRef="usd">603617000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c6" decimals="-3" id="ixv-27704" unitRef="usd">50000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c6" decimals="-3" id="ixv-27705" unitRef="usd">603567000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1 contextRef="c381" id="ixv-27706">2018-04-11</us-gaap:BusinessAcquisitionEffectiveDateOfAcquisition1>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="c382"
      decimals="-3"
      id="ixv-27707"
      unitRef="usd">601247000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <wt:PercentageOfRevenueGrowth contextRef="c0" decimals="2" id="ixv-27708" unitRef="pure">0.03</wt:PercentageOfRevenueGrowth>
    <us-gaap:PercentageOfWeightedAverageCostInventory contextRef="c5" decimals="3" id="ixv-27709" unitRef="pure">0.105</us-gaap:PercentageOfWeightedAverageCostInventory>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c66" decimals="-3" id="ixv-27710" unitRef="usd">634000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="c383"
      decimals="-3"
      id="ixv-27711"
      unitRef="usd">50000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="c0" id="ixv-25495">As of December&#160;31, 2023, expected amortization expense for the unamortized finite&lt;span class="nobreak"&gt;-lived&lt;/span&gt; intangible assets for the next &lt;span style="-sec-ix-hidden: hidden-fact-253"&gt;five&lt;/span&gt;&#160;years and thereafter is as follows:&lt;table class="Table60-" style="width: 60.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 30% 0pt 0.33in;"&gt;


				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;2024&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;1,375&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;2025&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;1,440&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;2026&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;873&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;2027&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;130&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;2028&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;17&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-1" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;2029 and thereafter&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-2" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-251; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table60-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table60- TB CellOverride-15" style="width: 75.00%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;margin-top:3pt;"&gt;Total expected amortization expense&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-16" style="width: 1.92%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-16" style="width: 2.56%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table60- TB CellOverride-16" style="width: 20.51%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;3,835&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="c5" decimals="-3" id="ixv-27712" unitRef="usd">1375000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c5" decimals="-3" id="ixv-27713" unitRef="usd">1440000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="c5" decimals="-3" id="ixv-27714" unitRef="usd">873000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="c5" decimals="-3" id="ixv-27715" unitRef="usd">130000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="c5" decimals="-3" id="ixv-27716" unitRef="usd">17000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c5" decimals="-3" id="ixv-27717" unitRef="usd">3835000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <wt:ContingentPaymentTextBlock contextRef="c0" id="ixv-25560">&lt;p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;25. Contingent Payments&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company recognized a gain of $1,477 and $787 during the&#160;years ended December&#160;31, 2023 and 2021, respectively, from remeasuring contingent payments arising from the sale of its former Canadian ETF business to their realizable value. These gains were recorded in other losses, net.&lt;/p&gt;</wt:ContingentPaymentTextBlock>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="c388"
      decimals="-3"
      id="ixv-27718"
      unitRef="usd">1477000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="c389"
      decimals="-3"
      id="ixv-27719"
      unitRef="cad">787000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:AssetImpairmentChargesTextBlock contextRef="c0" id="ixv-25564">&lt;p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:12pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;26. Impairments&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The following table summarizes impairments recognized by the Company:&lt;/p&gt;
		&lt;table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;"&gt;


				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Years Ended December&#160;31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TCH CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Lease termination&#x2013;New&#160;York office (Note&#160;13)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-255; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-256; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;9,277&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Fixed assets&#x2013;New&#160;York office (Note&#160;8)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-257; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-258; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6,576&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Lease termination&#x2013;London office (Note&#160;13)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-259; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-260; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;303&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Securrency (Note&#160;7)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;7,630&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-261; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-262; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Other investments (Note&#160;7)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;312&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-263; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-264; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;7,942&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-265; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;16,156&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:AssetImpairmentChargesTextBlock>
    <us-gaap:DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock contextRef="c0" id="ixv-27720">The following table summarizes impairments recognized by the Company:&lt;table class="Table70-" style="width: 70.0%; border-collapse: collapse; border: 0px solid #000; border-width: 0pt; margin: 6pt 20% 0pt 0.33in;"&gt;


				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TCH CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;

					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-5" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2" colspan="8" style="width: 52.36%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;Years Ended December&#160;31,&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TCH CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2023&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 16.00%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2022&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-7" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TCH CellOverride-2 _idGenCellOverride-3" colspan="2" style="width: 17.45%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;" valign="bottom"&gt;
						&lt;p class="TCH" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:8pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:6pt;margin-right:3pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:center;text-indent:0;widows:1;margin-right:0pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;2021&lt;/span&gt;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-1 _idGenCellOverride-3" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Lease termination&#x2013;New&#160;York office (Note&#160;13)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-255; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-256; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-6 _idGenCellOverride-4" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2 _idGenCellOverride-3" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;9,277&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Fixed assets&#x2013;New&#160;York office (Note&#160;8)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-257; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-258; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;6,576&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Lease termination&#x2013;London office (Note&#160;13)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-259; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-260; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;303&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Securrency (Note&#160;7)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;	&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;7,630&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-261; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody_r" style="-sec-ix-hidden: hidden-fact-262; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="background: #CCEEFF;height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Other investments (Note&#160;7)&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;312&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-263; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#160;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: windowtext 1pt none; border-bottom-style: solid; padding: 0in 0in 2px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule1" style="-sec-ix-hidden: hidden-fact-264; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
				&lt;/tr&gt;
				&lt;tr class="Table70-" style="height:12pt;"&gt;
					&lt;td class="Table70- TB CellOverride-1" style="width: 46.18%; padding: 0in 0in 3px 0in;border-width: 0pt;" valign="bottom"&gt;
						&lt;p class="Tbody" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:10pt;margin-right:0;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:-10pt;widows:1;"&gt;Total&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;7,942&lt;/p&gt;	&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 14.06%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="-sec-ix-hidden: hidden-fact-265; margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;&#x2014;&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.45%; padding: 0in 0in 3px 0in;border-width: 0pt;white-space: nowrap;" valign="bottom"&gt;&#160;&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 1.94%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;white-space: nowrap;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;
						&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;text-align:left;margin-right:6pt;"&gt;$&lt;/p&gt;
					&lt;/td&gt;
					&lt;td class="Table70- TB CellOverride-2" style="width: 15.52%; padding: 0in 0in 3px 0in;border-width: 0pt;border-bottom: windowtext 1pt none; border-bottom-style: solid;border-bottom: Black 2.5pt double; border-bottom-style: double; padding: 0in 0in 1px 0in;" valign="bottom"&gt;	&lt;p class="Tbody_rule2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:6pt;margin-right:6pt;margin-top:0;orphans:1;page-break-after:auto;page-break-before:auto;text-align:right;text-indent:0;widows:1;margin-left:0pt;margin-right:0pt;margin-right:6pt;"&gt;16,156&lt;/p&gt;	&lt;/td&gt;
				&lt;/tr&gt;

		&lt;/table&gt;</us-gaap:DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="c392"
      decimals="-3"
      id="ixv-27721"
      unitRef="usd">9277000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="c395"
      decimals="-3"
      id="ixv-27722"
      unitRef="usd">6576000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="c398"
      decimals="-3"
      id="ixv-27723"
      unitRef="usd">303000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="c399"
      decimals="-3"
      id="ixv-27724"
      unitRef="usd">7630000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="c402"
      decimals="-3"
      id="ixv-27725"
      unitRef="usd">312000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges contextRef="c0" decimals="-3" id="ixv-27726" unitRef="usd">7942000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges contextRef="c20" decimals="-3" id="ixv-27727" unitRef="usd">16156000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:SubsequentEventsTextBlock contextRef="c0" id="ixv-25698">&lt;p class="H2" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:bold;margin-bottom:0;margin-left:0;margin-right:0;margin-top:12pt;orphans:99;page-break-after:avoid;page-break-before:auto;text-align:left;text-indent:0;widows:1;margin-top:14pt;margin-top:14pt;"&gt;&lt;span class="Bold" style="font-style:normal;font-weight:bold;"&gt;27. Subsequent Events&lt;/span&gt;&lt;/p&gt;
		&lt;p class="Text_ind" style="margin:0;padding:0;border-width:0;font-family:Times New Roman PS Std, serif;font-size:10pt;font-style:normal;font-variant:normal;font-weight:normal;margin-bottom:0;margin-left:0;margin-right:0;margin-top:6pt;orphans:2;page-break-after:auto;page-break-before:auto;text-align:left;text-indent:24pt;widows:3;margin-top:6pt;"&gt;The Company evaluated subsequent events through the date of issuance of the consolidated financial statements. There were no events requiring disclosure.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <wt:IndemnificationReceivableNoncurrent
      contextRef="c5"
      id="hidden-fact-0"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="c5"
      id="hidden-fact-1"
      unitRef="usd"
      xsi:nil="true"/>
    <wt:DeferredConsiderationCurrent
      contextRef="c5"
      id="hidden-fact-2"
      unitRef="usd"
      xsi:nil="true"/>
    <wt:DeferredConsiderationNoncurrent
      contextRef="c5"
      id="hidden-fact-3"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="c5"
      id="hidden-fact-4"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="c5"
      id="hidden-fact-5"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c5"
      id="hidden-fact-6"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="c6"
      id="hidden-fact-7"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="c5"
      id="hidden-fact-8"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="c6"
      id="hidden-fact-9"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="c19"
      id="hidden-fact-10"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="c19"
      id="hidden-fact-11"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="c20"
      id="hidden-fact-12"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="c21"
      id="hidden-fact-13"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c21"
      id="hidden-fact-14"
      unitRef="usd"
      xsi:nil="true"/>
    <wt:StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes
      contextRef="c27"
      id="hidden-fact-15"
      unitRef="usd"
      xsi:nil="true"/>
    <wt:StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes
      contextRef="c28"
      id="hidden-fact-16"
      unitRef="usd"
      xsi:nil="true"/>
    <wt:StockIssuedDuringPeriodValueReclassificationOfEquityComponentRelatedToConvertibleNotes
      contextRef="c30"
      id="hidden-fact-17"
      unitRef="usd"
      xsi:nil="true"/>
    <wt:TemporaryEquityShareOutstanding
      contextRef="c32"
      id="hidden-fact-18"
      unitRef="shares"
      xsi:nil="true"/>
    <wt:TemporaryStockholdersEquity
      contextRef="c32"
      id="hidden-fact-19"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c27"
      id="hidden-fact-20"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c27"
      id="hidden-fact-21"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c30"
      id="hidden-fact-22"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c31"
      id="hidden-fact-23"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c20"
      id="hidden-fact-24"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c27"
      id="hidden-fact-25"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="c27"
      id="hidden-fact-26"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="c30"
      id="hidden-fact-27"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="c31"
      id="hidden-fact-28"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c27"
      id="hidden-fact-29"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c27"
      id="hidden-fact-30"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c30"
      id="hidden-fact-31"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="c31"
      id="hidden-fact-32"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c27"
      id="hidden-fact-33"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c28"
      id="hidden-fact-34"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c30"
      id="hidden-fact-35"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c31"
      id="hidden-fact-36"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="c27"
      id="hidden-fact-37"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="c28"
      id="hidden-fact-38"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="c29"
      id="hidden-fact-39"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="c31"
      id="hidden-fact-40"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:Dividends
      contextRef="c27"
      id="hidden-fact-41"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:Dividends
      contextRef="c28"
      id="hidden-fact-42"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:Dividends
      contextRef="c29"
      id="hidden-fact-43"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:Dividends
      contextRef="c30"
      id="hidden-fact-44"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c27"
      id="hidden-fact-45"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c28"
      id="hidden-fact-46"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c29"
      id="hidden-fact-47"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c30"
      id="hidden-fact-48"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="c32"
      id="hidden-fact-49"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c32"
      id="hidden-fact-50"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c38"
      id="hidden-fact-51"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c38"
      id="hidden-fact-52"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c41"
      id="hidden-fact-53"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c42"
      id="hidden-fact-54"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c19"
      id="hidden-fact-55"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c38"
      id="hidden-fact-56"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="c38"
      id="hidden-fact-57"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="c41"
      id="hidden-fact-58"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="c42"
      id="hidden-fact-59"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c38"
      id="hidden-fact-60"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c39"
      id="hidden-fact-61"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c41"
      id="hidden-fact-62"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c42"
      id="hidden-fact-63"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="c38"
      id="hidden-fact-64"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="c39"
      id="hidden-fact-65"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="c40"
      id="hidden-fact-66"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="c42"
      id="hidden-fact-67"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:Dividends
      contextRef="c38"
      id="hidden-fact-68"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:Dividends
      contextRef="c39"
      id="hidden-fact-69"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:Dividends
      contextRef="c41"
      id="hidden-fact-70"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c38"
      id="hidden-fact-71"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c39"
      id="hidden-fact-72"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c40"
      id="hidden-fact-73"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c41"
      id="hidden-fact-74"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="c43"
      id="hidden-fact-75"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c43"
      id="hidden-fact-76"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c48"
      id="hidden-fact-77"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c48"
      id="hidden-fact-78"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c51"
      id="hidden-fact-79"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c52"
      id="hidden-fact-80"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="c0"
      id="hidden-fact-81"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c48"
      id="hidden-fact-82"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="c48"
      id="hidden-fact-83"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="c51"
      id="hidden-fact-84"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="c52"
      id="hidden-fact-85"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="c48"
      id="hidden-fact-86"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="c49"
      id="hidden-fact-87"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="c49"
      id="hidden-fact-88"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="c51"
      id="hidden-fact-89"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="c52"
      id="hidden-fact-90"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="c48"
      id="hidden-fact-91"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="c49"
      id="hidden-fact-92"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="c49"
      id="hidden-fact-93"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="c51"
      id="hidden-fact-94"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="c52"
      id="hidden-fact-95"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c48"
      id="hidden-fact-96"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="c48"
      id="hidden-fact-97"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="c51"
      id="hidden-fact-98"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="c52"
      id="hidden-fact-99"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c48"
      id="hidden-fact-100"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c49"
      id="hidden-fact-101"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c51"
      id="hidden-fact-102"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="c52"
      id="hidden-fact-103"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="c48"
      id="hidden-fact-104"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="c49"
      id="hidden-fact-105"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="c50"
      id="hidden-fact-106"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="c52"
      id="hidden-fact-107"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:Dividends
      contextRef="c48"
      id="hidden-fact-108"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:Dividends
      contextRef="c49"
      id="hidden-fact-109"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:Dividends
      contextRef="c50"
      id="hidden-fact-110"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:Dividends
      contextRef="c51"
      id="hidden-fact-111"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c48"
      id="hidden-fact-112"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c49"
      id="hidden-fact-113"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c50"
      id="hidden-fact-114"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="c51"
      id="hidden-fact-115"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="c53"
      id="hidden-fact-116"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="c53"
      id="hidden-fact-117"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="c19"
      id="hidden-fact-118"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="c20"
      id="hidden-fact-119"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="c19"
      id="hidden-fact-120"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InterestExpenseDebt
      contextRef="c19"
      id="hidden-fact-121"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InterestExpenseDebt
      contextRef="c20"
      id="hidden-fact-122"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="c19"
      id="hidden-fact-123"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="c20"
      id="hidden-fact-124"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="c0"
      id="hidden-fact-125"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="c19"
      id="hidden-fact-126"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="c0"
      id="hidden-fact-127"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OtherPaymentsToAcquireBusinesses
      contextRef="c19"
      id="hidden-fact-128"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="c19"
      id="hidden-fact-129"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="c20"
      id="hidden-fact-130"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="c19"
      id="hidden-fact-131"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromRepaymentsOfNotesPayable
      contextRef="c19"
      id="hidden-fact-132"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromRepaymentsOfNotesPayable
      contextRef="c20"
      id="hidden-fact-133"
      unitRef="usd"
      xsi:nil="true"/>
    <wt:PaymentOfDeferredConsideration
      contextRef="c19"
      id="hidden-fact-134"
      unitRef="usd"
      xsi:nil="true"/>
    <wt:PaymentOfDeferredConsideration
      contextRef="c20"
      id="hidden-fact-135"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="c19"
      id="hidden-fact-136"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="c20"
      id="hidden-fact-137"
      unitRef="usd"
      xsi:nil="true"/>
    <wt:PaymentOfConvertibleNotesIssuanceCosts
      contextRef="c19"
      id="hidden-fact-138"
      unitRef="usd"
      xsi:nil="true"/>
    <wt:ProceedsFromIssuanceOfConvertibleNotes
      contextRef="c19"
      id="hidden-fact-139"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="c0"
      id="hidden-fact-140"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="c19"
      id="hidden-fact-141"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="c73"
      id="hidden-fact-142"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="c74"
      id="hidden-fact-143"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned
      contextRef="c77"
      id="hidden-fact-144"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned
      contextRef="c78"
      id="hidden-fact-145"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned
      contextRef="c80"
      id="hidden-fact-146"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned
      contextRef="c82"
      id="hidden-fact-147"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned
      contextRef="c85"
      id="hidden-fact-148"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned
      contextRef="c88"
      id="hidden-fact-149"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned
      contextRef="c89"
      id="hidden-fact-150"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned
      contextRef="c93"
      id="hidden-fact-151"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="c74"
      id="hidden-fact-152"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="c95"
      id="hidden-fact-153"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="c96"
      id="hidden-fact-154"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="c98"
      id="hidden-fact-155"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="c99"
      id="hidden-fact-156"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="c100"
      id="hidden-fact-157"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="c101"
      id="hidden-fact-158"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="c103"
      id="hidden-fact-159"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="c104"
      id="hidden-fact-160"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="c108"
      id="hidden-fact-161"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="c109"
      id="hidden-fact-162"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned
      contextRef="c112"
      id="hidden-fact-163"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned
      contextRef="c113"
      id="hidden-fact-164"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned
      contextRef="c116"
      id="hidden-fact-165"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned
      contextRef="c117"
      id="hidden-fact-166"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned
      contextRef="c121"
      id="hidden-fact-167"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned
      contextRef="c123"
      id="hidden-fact-168"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned
      contextRef="c125"
      id="hidden-fact-169"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned
      contextRef="c127"
      id="hidden-fact-170"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:SecurityOwnedAndSoldNotYetPurchasedFairValueSecurityOwned
      contextRef="c129"
      id="hidden-fact-171"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="c131"
      id="hidden-fact-172"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="c132"
      id="hidden-fact-173"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="c135"
      id="hidden-fact-174"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="c136"
      id="hidden-fact-175"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="c139"
      id="hidden-fact-176"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="c140"
      id="hidden-fact-177"
      unitRef="usd"
      xsi:nil="true"/>
    <wt:BusinessCombinationDeferredConsiderationLiability
      contextRef="c107"
      id="hidden-fact-178"
      unitRef="usd"
      xsi:nil="true"/>
    <wt:BusinessCombinationDeferredConsiderationLiability
      contextRef="c108"
      id="hidden-fact-179"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c37"
      id="hidden-fact-180"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales
      contextRef="c19"
      id="hidden-fact-181"
      unitRef="usd"
      xsi:nil="true"/>
    <wt:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversions
      contextRef="c19"
      id="hidden-fact-182"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c5"
      id="hidden-fact-183"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="c146"
      id="hidden-fact-184"
      unitRef="usd"
      xsi:nil="true"/>
    <wt:CashEquivalentsMaturityPeriod contextRef="c0" id="hidden-fact-185">P90D</wt:CashEquivalentsMaturityPeriod>
    <us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
      contextRef="c155"
      id="hidden-fact-186"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
      contextRef="c156"
      id="hidden-fact-187"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
      contextRef="c5"
      id="hidden-fact-188"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
      contextRef="c6"
      id="hidden-fact-189"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
      contextRef="c5"
      id="hidden-fact-190"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
      contextRef="c6"
      id="hidden-fact-191"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c171"
      id="hidden-fact-192"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="c171"
      id="hidden-fact-193"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c173"
      id="hidden-fact-194"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="c173"
      id="hidden-fact-195"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c175"
      id="hidden-fact-196"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="c175"
      id="hidden-fact-197"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c177"
      id="hidden-fact-198"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="c177"
      id="hidden-fact-199"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c179"
      id="hidden-fact-200"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="c179"
      id="hidden-fact-201"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c182"
      id="hidden-fact-202"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentOwnedAtCost
      contextRef="c182"
      id="hidden-fact-203"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c185"
      id="hidden-fact-204"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="c226"
      id="hidden-fact-205"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="c227"
      id="hidden-fact-206"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="c230"
      id="hidden-fact-207"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="c231"
      id="hidden-fact-208"
      unitRef="usd"
      xsi:nil="true"/>
    <wt:NumberOfThresholdTradingDaysForDeterminingTheSharePrice contextRef="c215" id="hidden-fact-209">P5Y</wt:NumberOfThresholdTradingDaysForDeterminingTheSharePrice>
    <wt:MeasurementPeriodForDeterminingSharePrice contextRef="c215" id="hidden-fact-210">P10Y</wt:MeasurementPeriodForDeterminingSharePrice>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="c0"
      id="hidden-fact-211"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="c19"
      id="hidden-fact-212"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="c5"
      id="hidden-fact-213"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="c5"
      id="hidden-fact-214"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="c5"
      id="hidden-fact-215"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="c5"
      id="hidden-fact-216"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="c5"
      id="hidden-fact-217"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="c5"
      id="hidden-fact-218"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c247"
      id="hidden-fact-219"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c249"
      id="hidden-fact-220"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c251"
      id="hidden-fact-221"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c253"
      id="hidden-fact-222"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c255"
      id="hidden-fact-223"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c258"
      id="hidden-fact-224"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="c261"
      id="hidden-fact-225"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c312"
      id="hidden-fact-226"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c312"
      id="hidden-fact-227"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c312"
      id="hidden-fact-228"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c318"
      id="hidden-fact-229"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c318"
      id="hidden-fact-230"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c318"
      id="hidden-fact-231"
      unitRef="usdPershares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c323"
      id="hidden-fact-232"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c323"
      id="hidden-fact-233"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c324"
      id="hidden-fact-234"
      unitRef="shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="c0"
      id="hidden-fact-235"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="c19"
      id="hidden-fact-236"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="c19"
      id="hidden-fact-237"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="c20"
      id="hidden-fact-238"
      unitRef="usd"
      xsi:nil="true"/>
    <wt:WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares
      contextRef="c343"
      id="hidden-fact-239"
      unitRef="shares"
      xsi:nil="true"/>
    <wt:WeightedAverageSharesOfCommonStockIssuableUponConversionOfThePreferredShares
      contextRef="c344"
      id="hidden-fact-240"
      unitRef="shares"
      xsi:nil="true"/>
    <wt:DeferredTaxAssetsOutsideBasisDifference
      contextRef="c5"
      id="hidden-fact-241"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="c361"
      id="hidden-fact-242"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="c5"
      id="hidden-fact-243"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="c367"
      id="hidden-fact-244"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="c368"
      id="hidden-fact-245"
      unitRef="usd"
      xsi:nil="true"/>
    <wt:OperatingLossCarryForwardExpirationYear contextRef="c0" id="hidden-fact-246">2024</wt:OperatingLossCarryForwardExpirationYear>
    <us-gaap:StockRepurchaseProgramPeriodInForce1 contextRef="c371" id="hidden-fact-247">P3Y</us-gaap:StockRepurchaseProgramPeriodInForce1>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="c0"
      id="hidden-fact-248"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="c384"
      id="hidden-fact-249"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="c386"
      id="hidden-fact-250"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="c5"
      id="hidden-fact-251"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c66" id="hidden-fact-252">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c5" id="hidden-fact-253">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="c66" id="hidden-fact-254">P2Y219D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="c390"
      id="hidden-fact-255"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="c391"
      id="hidden-fact-256"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="c393"
      id="hidden-fact-257"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="c394"
      id="hidden-fact-258"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="c396"
      id="hidden-fact-259"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="c397"
      id="hidden-fact-260"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="c400"
      id="hidden-fact-261"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="c401"
      id="hidden-fact-262"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="c403"
      id="hidden-fact-263"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="c404"
      id="hidden-fact-264"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="c19"
      id="hidden-fact-265"
      unitRef="usd"
      xsi:nil="true"/>
    <dei:AmendmentFlag contextRef="c0" id="ixv-27996">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="c0" id="ixv-27997">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-27998">0000880631</dei:EntityCentralIndexKey>
    <dei:TradingSymbol contextRef="c2" id="ixv-27999">None</dei:TradingSymbol>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#ix_1_fact"
          xlink:label="ix_1_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_0_fact"
          xlink:label="ix_0_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-154"
          xlink:label="hidden-fact-154"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-153"
          xlink:label="hidden-fact-153"
          xlink:type="locator"/>
        <link:footnote id="ix_0_footnote" xlink:label="ix_0_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Fair value determined on October 31, 2023</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_1_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_0_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-154"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-153"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_3_fact"
          xlink:label="ix_3_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-177"
          xlink:label="hidden-fact-177"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-176"
          xlink:label="hidden-fact-176"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_2_fact"
          xlink:label="ix_2_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_1_footnote" xlink:label="ix_1_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Fair value determined on May 10, 2022</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_3_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-177"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-176"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_2_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-158"
          xlink:label="hidden-fact-158"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-155"
          xlink:label="hidden-fact-155"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-157"
          xlink:label="hidden-fact-157"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-156"
          xlink:label="hidden-fact-156"
          xlink:type="locator"/>
        <link:footnote id="ix_2_footnote" xlink:label="ix_2_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Fair value determined on September 30, 2023</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-158"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-155"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-157"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-156"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_4_fact"
          xlink:label="ix_4_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_3_footnote" xlink:label="ix_3_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Fnality convertible notes converted into Series B<xhtml:span class="nobreak">-1</xhtml:span> Preference Shares on October 31, 2023 (Note 7)</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_4_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_5_fact"
          xlink:label="ix_5_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_6_fact"
          xlink:label="ix_6_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_4_footnote" xlink:label="ix_4_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Recorded in impairments and other losses, net in the Consolidated Statements of Operations.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_5_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_6_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_7_fact"
          xlink:label="ix_7_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_8_fact"
          xlink:label="ix_8_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_5_footnote" xlink:label="ix_5_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Recorded as contractual gold payments expense in the Consolidated Statements of Operations.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_7_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_8_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_10_fact"
          xlink:label="ix_10_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_9_fact"
          xlink:label="ix_9_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_6_footnote" xlink:label="ix_6_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Recorded as gain on revaluation/termination of deferred consideration&#x2014;gold payments in the Consolidated Statements of Operations.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_10_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_9_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_12_fact"
          xlink:label="ix_12_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_11_fact"
          xlink:label="ix_11_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_13_fact"
          xlink:label="ix_13_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_7_footnote" xlink:label="ix_7_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Gains on revaluation/termination of deferred consideration&#x2014;gold payments result from a decrease in spot gold prices, a decrease in the forward<xhtml:span class="nobreak">-looking</xhtml:span> price of gold, a decrease in the perpetual growth rate and an increase in the discount rate used to compute the present value of the annual payment obligations.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_12_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_11_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_13_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_16_fact"
          xlink:label="ix_16_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_18_fact"
          xlink:label="ix_18_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_14_fact"
          xlink:label="ix_14_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_15_fact"
          xlink:label="ix_15_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_17_fact"
          xlink:label="ix_17_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_19_fact"
          xlink:label="ix_19_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_8_footnote" xlink:label="ix_8_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes amortization of the issuance costs and premium.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_16_fact"
          xlink:to="ix_8_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_18_fact"
          xlink:to="ix_8_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_14_fact"
          xlink:to="ix_8_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_15_fact"
          xlink:to="ix_8_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_17_fact"
          xlink:to="ix_8_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_19_fact"
          xlink:to="ix_8_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-229"
          xlink:label="hidden-fact-229"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_31_fact"
          xlink:label="ix_31_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_36_fact"
          xlink:label="ix_36_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_30_fact"
          xlink:label="ix_30_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-228"
          xlink:label="hidden-fact-228"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_29_fact"
          xlink:label="ix_29_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_33_fact"
          xlink:label="ix_33_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_23_fact"
          xlink:label="ix_23_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_35_fact"
          xlink:label="ix_35_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_39_fact"
          xlink:label="ix_39_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-226"
          xlink:label="hidden-fact-226"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_37_fact"
          xlink:label="ix_37_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_32_fact"
          xlink:label="ix_32_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-230"
          xlink:label="hidden-fact-230"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_22_fact"
          xlink:label="ix_22_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-231"
          xlink:label="hidden-fact-231"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_27_fact"
          xlink:label="ix_27_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_26_fact"
          xlink:label="ix_26_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-227"
          xlink:label="hidden-fact-227"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_24_fact"
          xlink:label="ix_24_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_21_fact"
          xlink:label="ix_21_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_38_fact"
          xlink:label="ix_38_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_25_fact"
          xlink:label="ix_25_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-232"
          xlink:label="hidden-fact-232"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#hidden-fact-233"
          xlink:label="hidden-fact-233"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_20_fact"
          xlink:label="ix_20_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_34_fact"
          xlink:label="ix_34_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_28_fact"
          xlink:label="ix_28_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_9_footnote" xlink:label="ix_9_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the target number of PRSUs granted and outstanding. The number of PRSUs that ultimately vest ranges from 0% to 200% of this amount. During the years ended December 31, 2023, 2022 and 2021, 200%, 77% and 0%, respectively, of the target number of PRSUs granted ultimately vested, inclusive of accrued stock dividends.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-229"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_31_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_36_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_30_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-228"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_29_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_33_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_23_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_35_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_39_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-226"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_37_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_32_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-230"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_22_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-231"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_27_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_26_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-227"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_24_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_21_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_38_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_25_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-232"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-233"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_20_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_34_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_28_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnote id="ix_10_footnote" xlink:label="ix_10_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">A Monte Carlo simulation was used to value these awards using the following assumptions for the Company and the peer group: (i) beginning 90<xhtml:span class="nobreak">-day</xhtml:span> average stock prices; (ii) valuation date stock prices; (iii) correlation coefficients based upon the price data used to calculate the historical volatilities; and (iv) the following additional assumptions:</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-226"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-229"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-232"
          xlink:to="ix_10_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-234"
          xlink:label="hidden-fact-234"
          xlink:type="locator"/>
        <link:footnote id="ix_11_footnote" xlink:label="ix_11_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes 57,779 deferred RSUs that have vested.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-234"
          xlink:to="ix_11_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_40_fact"
          xlink:label="ix_40_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_41_fact"
          xlink:label="ix_41_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_42_fact"
          xlink:label="ix_42_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_12_footnote" xlink:label="ix_12_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The gain on revaluation of deferred consideration is not adjusted for income taxes as the obligation was assumed by a wholly<xhtml:span class="nobreak">-owned</xhtml:span> subsidiary that is based in Jersey, a jurisdiction where the Company is subject to a zero percent tax rate.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_40_fact"
          xlink:to="ix_12_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_41_fact"
          xlink:to="ix_12_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_42_fact"
          xlink:to="ix_12_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_48_fact"
          xlink:label="ix_48_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_44_fact"
          xlink:label="ix_44_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_43_fact"
          xlink:label="ix_43_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_47_fact"
          xlink:label="ix_47_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_45_fact"
          xlink:label="ix_45_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_46_fact"
          xlink:label="ix_46_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_13_footnote" xlink:label="ix_13_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">In January 2022, an audit of ManJer&#x2019;s tax returns (a Jersey<xhtml:span class="nobreak">-based</xhtml:span> subsidiary) for the years ended December&#160;31, 2014, 2016, 2017 and 2018 were resolved in favor of ManJer. The settlement, as well as the reduction in unrecognized tax benefits from the lapse of the statute of limitations totaling $19,897 during the year ended December 31, 2022 was recorded as an income tax benefit along with an equal and offsetting amount recorded in other losses and gains, net, to recognize a reduction in the indemnification asset.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_48_fact"
          xlink:to="ix_13_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_44_fact"
          xlink:to="ix_13_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_43_fact"
          xlink:to="ix_13_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_47_fact"
          xlink:to="ix_13_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_45_fact"
          xlink:to="ix_13_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_46_fact"
          xlink:to="ix_13_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_49_fact"
          xlink:label="ix_49_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_50_fact"
          xlink:label="ix_50_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_51_fact"
          xlink:label="ix_51_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_14_footnote" xlink:label="ix_14_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The gross unrecognized tax benefits were accrued in British pounds.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_49_fact"
          xlink:to="ix_14_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_50_fact"
          xlink:to="ix_14_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_51_fact"
          xlink:to="ix_14_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#hidden-fact-248"
          xlink:label="hidden-fact-248"
          xlink:type="locator"/>
        <link:footnote id="ix_15_footnote" xlink:label="ix_15_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On April 11, 2023, the Company acquired 100% of the capital stock of Securrency Transfers, Inc. (renamed WisdomTree Transfers, Inc.) for an aggregate purchase price of $985 (net of cash acquired). The acquisition has been accounted for under the acquisition method of accounting in accordance with ASC Topic 805, Business Combinations, and resulted in all consideration being allocated to goodwill</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="hidden-fact-248"
          xlink:to="ix_15_footnote"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
